<SEC-DOCUMENT>0001493152-25-003225.txt : 20250122
<SEC-HEADER>0001493152-25-003225.hdr.sgml : 20250122
<ACCEPTANCE-DATETIME>20250122160634
ACCESSION NUMBER:		0001493152-25-003225
CONFORMED SUBMISSION TYPE:	S-1/A
PUBLIC DOCUMENT COUNT:		98
FILED AS OF DATE:		20250122
DATE AS OF CHANGE:		20250122

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Sharps Technology Inc.
		CENTRAL INDEX KEY:			0001737995
		STANDARD INDUSTRIAL CLASSIFICATION:	SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841]
		ORGANIZATION NAME:           	08 Industrial Applications and Services
		IRS NUMBER:				823751728
		STATE OF INCORPORATION:			NV
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		S-1/A
		SEC ACT:		1933 Act
		SEC FILE NUMBER:	333-284237
		FILM NUMBER:		25545983

	BUSINESS ADDRESS:	
		STREET 1:		105 MAXESS ROAD
		STREET 2:		STE. 124
		CITY:			MELVILLE
		STATE:			NY
		ZIP:			11747
		BUSINESS PHONE:		(631) 574 -4436

	MAIL ADDRESS:	
		STREET 1:		105 MAXESS ROAD
		STREET 2:		STE. 124
		CITY:			MELVILLE
		STATE:			NY
		ZIP:			11747
</SEC-HEADER>
<DOCUMENT>
<TYPE>S-1/A
<SEQUENCE>1
<FILENAME>forms-1a.htm
<TEXT>
<XBRL>
<?xml version='1.0' encoding='ASCII'?>
<html xmlns="http://www.w3.org/1999/xhtml" xmlns:xs="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2015-02-26" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:dei="http://xbrl.sec.gov/dei/2024" xmlns:us-gaap="http://fasb.org/us-gaap/2024" xmlns:us-roles="http://fasb.org/us-roles/2024" xmlns:dtr-types="http://www.xbrl.org/dtr/type/2022-03-31" xmlns:country="http://xbrl.sec.gov/country/2024" xmlns:srt="http://fasb.org/srt/2024" xmlns:STSS="http://sharpstechnology.com/20240930">
<head>
     <title></title>
<meta http-equiv="Content-Type" content="text/html"/>
</head>
<!-- Field: Set; Name: xdx; ID: xdx_02D_US%2DGAAP%2D2024 -->
<!-- Field: Set; Name: xdx; ID: xdx_03E_STSS_sharpstechnology.com_20240930 -->
<!-- Field: Set; Name: xdx; ID: xdx_040_20240101_20240930 -->
<!-- Field: Set; Name: xdx; ID: xdx_055_edei%2D%2DAmendmentFlag_true -->
<!-- Field: Set; Name: xdx; ID: xdx_054_edei%2D%2DAmendmentDescription_AMENDMENT NO. 1 -->
<!-- Field: Set; Name: xdx; ID: xdx_051_edei%2D%2DEntityCentralIndexKey_0001737995 -->
<!-- Field: Set; Name: xdx; ID: xdx_075_XDX_Z%2D%2D\2025 OPERATIONS\EDGAR\01 JANUARY\Sharps Technology, Inc\01%2D20%2D2025\Form S%2D1A\Draft\Production\forms%2D1a.xdx -->
<!-- Field: Set; Name: xdx; ID: xdx_06B_USD_1_iso4217%2D%2DUSD -->
<!-- Field: Set; Name: xdx; ID: xdx_062_Shares_2_xbrli%2D%2Dshares -->
<!-- Field: Set; Name: xdx; ID: xdx_06D_USDPShares_3_iso4217%2D%2DUSD_xbrli%2D%2Dshares -->
<!-- Field: Set; Name: xdx; ID: xdx_069_Pure_4_xbrli%2D%2Dpure -->
<body style="font: 10pt Times New Roman, Times, Serif">
<div style="display: none">
<ix:header>
 <ix:hidden>
  <ix:nonNumeric contextRef="From2024-01-01to2024-09-30" id="Fact000003" name="dei:AmendmentFlag">true</ix:nonNumeric>
  <ix:nonNumeric contextRef="From2024-01-01to2024-09-30" id="Fact000004" name="dei:AmendmentDescription">AMENDMENT NO. 1</ix:nonNumeric>
  <ix:nonNumeric contextRef="From2024-01-01to2024-09-30" id="Fact000005" name="dei:EntityCentralIndexKey">0001737995</ix:nonNumeric>
  <ix:nonNumeric contextRef="From2024-01-01to2024-09-30" id="xdx2ixbrl0011" name="dei:DocumentType">S-1/A</ix:nonNumeric>
  <ix:nonFraction name="us-gaap:CommitmentsAndContingencies" contextRef="AsOf2023-12-31" id="xdx2ixbrl0089" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:CommitmentsAndContingencies" contextRef="AsOf2022-12-31" id="xdx2ixbrl0090" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="STSS:SubsequentEvents" contextRef="AsOf2023-12-31" id="xdx2ixbrl0092" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="STSS:SubsequentEvents" contextRef="AsOf2022-12-31" id="xdx2ixbrl0093" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:PreferredStockValue" contextRef="AsOf2023-12-31" id="xdx2ixbrl0098" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:PreferredStockValue" contextRef="AsOf2022-12-31" id="xdx2ixbrl0099" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" contextRef="From2023-01-012023-12-31" id="xdx2ixbrl0154" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" contextRef="From2022-01-012022-12-31" id="xdx2ixbrl0155" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:DeferredIncomeTaxExpenseBenefit" contextRef="From2022-01-012022-12-31" id="xdx2ixbrl0200" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2021-12-31_us-gaap_PreferredStockMember" id="xdx2ixbrl0233" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2021-12-31_us-gaap_AccumulatedOtherComprehensiveIncomeMember" id="xdx2ixbrl0237" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2022-01-012022-12-31_us-gaap_PreferredStockMember" id="xdx2ixbrl0245" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2022-01-012022-12-31_us-gaap_CommonStockMember" id="xdx2ixbrl0246" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2022-01-012022-12-31_custom_CommonStockSubscriptionReceivableMember" id="xdx2ixbrl0247" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2022-01-012022-12-31_us-gaap_AdditionalPaidInCapitalMember" id="xdx2ixbrl0248" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2022-01-012022-12-31_us-gaap_AccumulatedOtherComprehensiveIncomeMember" id="xdx2ixbrl0249" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="STSS:StockIssuedDuringPeriodValueInitialPublicOffering" contextRef="From2022-01-012022-12-31_custom_CommonStockSubscriptionReceivableMember" id="xdx2ixbrl0255" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="STSS:StockIssuedDuringPeriodValueInitialPublicOffering" contextRef="From2022-01-012022-12-31_us-gaap_AccumulatedOtherComprehensiveIncomeMember" id="xdx2ixbrl0257" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="STSS:StockIssuedDuringPeriodValueInitialPublicOffering" contextRef="From2022-01-012022-12-31_us-gaap_RetainedEarningsMember" id="xdx2ixbrl0258" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="STSS:StockIssuedDuringPeriodValueContingentStockLiability" contextRef="From2022-01-012022-12-31_custom_CommonStockSubscriptionReceivableMember" id="xdx2ixbrl0265" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="STSS:StockIssuedDuringPeriodValueContingentStockLiability" contextRef="From2022-01-012022-12-31_us-gaap_AccumulatedOtherComprehensiveIncomeMember" id="xdx2ixbrl0267" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="STSS:StockIssuedDuringPeriodValueContingentStockLiability" contextRef="From2022-01-012022-12-31_us-gaap_RetainedEarningsMember" id="xdx2ixbrl0268" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" contextRef="From2022-01-012022-12-31_us-gaap_PreferredStockMember" id="xdx2ixbrl0273" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" contextRef="From2022-01-012022-12-31_us-gaap_CommonStockMember" id="xdx2ixbrl0274" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" contextRef="From2022-01-012022-12-31_custom_CommonStockSubscriptionReceivableMember" id="xdx2ixbrl0275" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" contextRef="From2022-01-012022-12-31_us-gaap_AccumulatedOtherComprehensiveIncomeMember" id="xdx2ixbrl0277" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" contextRef="From2022-01-012022-12-31_us-gaap_RetainedEarningsMember" id="xdx2ixbrl0278" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="STSS:StockIssuedDuringPeriodValueFractionalShareAdjustment" contextRef="From2022-01-012022-12-31_us-gaap_PreferredStockMember" id="xdx2ixbrl0281" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="STSS:StockIssuedDuringPeriodValueFractionalShareAdjustment" contextRef="From2022-01-012022-12-31_us-gaap_CommonStockMember" id="xdx2ixbrl0282" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="STSS:StockIssuedDuringPeriodValueFractionalShareAdjustment" contextRef="From2022-01-012022-12-31_custom_CommonStockSubscriptionReceivableMember" id="xdx2ixbrl0283" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="STSS:StockIssuedDuringPeriodValueFractionalShareAdjustment" contextRef="From2022-01-012022-12-31_us-gaap_AdditionalPaidInCapitalMember" id="xdx2ixbrl0284" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="STSS:StockIssuedDuringPeriodValueFractionalShareAdjustment" contextRef="From2022-01-012022-12-31_us-gaap_AccumulatedOtherComprehensiveIncomeMember" id="xdx2ixbrl0285" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="STSS:StockIssuedDuringPeriodValueFractionalShareAdjustment" contextRef="From2022-01-012022-12-31_us-gaap_RetainedEarningsMember" id="xdx2ixbrl0286" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="STSS:StockIssuedDuringPeriodValueFractionalShareAdjustment" contextRef="From2022-01-012022-12-31" id="xdx2ixbrl0287" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueIssuedForServices" contextRef="From2022-01-012022-12-31_us-gaap_PreferredStockMember" id="xdx2ixbrl0291" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueIssuedForServices" contextRef="From2022-01-012022-12-31_custom_CommonStockSubscriptionReceivableMember" id="xdx2ixbrl0293" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueIssuedForServices" contextRef="From2022-01-012022-12-31_us-gaap_AccumulatedOtherComprehensiveIncomeMember" id="xdx2ixbrl0295" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueIssuedForServices" contextRef="From2022-01-012022-12-31_us-gaap_RetainedEarningsMember" id="xdx2ixbrl0296" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax" contextRef="From2022-01-012022-12-31_us-gaap_PreferredStockMember" id="xdx2ixbrl0301" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax" contextRef="From2022-01-012022-12-31_us-gaap_CommonStockMember" id="xdx2ixbrl0302" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax" contextRef="From2022-01-012022-12-31_custom_CommonStockSubscriptionReceivableMember" id="xdx2ixbrl0303" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax" contextRef="From2022-01-012022-12-31_us-gaap_AdditionalPaidInCapitalMember" id="xdx2ixbrl0304" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax" contextRef="From2022-01-012022-12-31_us-gaap_RetainedEarningsMember" id="xdx2ixbrl0306" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="STSS:StockIssuedDuringPeriodCollectionsOfCommonStockSubscriptionsValue" contextRef="From2022-01-012022-12-31_us-gaap_PreferredStockMember" id="xdx2ixbrl0309" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="STSS:StockIssuedDuringPeriodCollectionsOfCommonStockSubscriptionsValue" contextRef="From2022-01-012022-12-31_us-gaap_CommonStockMember" id="xdx2ixbrl0310" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="STSS:StockIssuedDuringPeriodCollectionsOfCommonStockSubscriptionsValue" contextRef="From2022-01-012022-12-31_us-gaap_AdditionalPaidInCapitalMember" id="xdx2ixbrl0312" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="STSS:StockIssuedDuringPeriodCollectionsOfCommonStockSubscriptionsValue" contextRef="From2022-01-012022-12-31_us-gaap_AccumulatedOtherComprehensiveIncomeMember" id="xdx2ixbrl0313" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="STSS:StockIssuedDuringPeriodCollectionsOfCommonStockSubscriptionsValue" contextRef="From2022-01-012022-12-31_us-gaap_RetainedEarningsMember" id="xdx2ixbrl0314" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2022-12-31_custom_ReverseStockSplitMember_us-gaap_PreferredStockMember" id="xdx2ixbrl0317" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2022-12-31_custom_ReverseStockSplitMember_custom_CommonStockSubscriptionReceivableMember" id="xdx2ixbrl0319" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2022-12-31_custom_ReverseStockSplitMember_us-gaap_PreferredStockMember" id="xdx2ixbrl0329" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2022-12-31_custom_ReverseStockSplitMember_custom_CommonStockSubscriptionReceivableMember" id="xdx2ixbrl0331" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2023-01-012023-12-31_custom_ReverseStockSplitMember_us-gaap_PreferredStockMember" id="xdx2ixbrl0349" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2023-01-012023-12-31_custom_ReverseStockSplitMember_custom_CommonStockSubscriptionReceivableMember" id="xdx2ixbrl0351" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2023-12-31_custom_ReverseStockSplitMember_us-gaap_PreferredStockMember" id="xdx2ixbrl0401" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2023-12-31_custom_ReverseStockSplitMember_custom_CommonStockSubscriptionReceivableMember" id="xdx2ixbrl0403" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2023-12-31_custom_ReverseStockSplitMember_us-gaap_PreferredStockMember" id="xdx2ixbrl0413" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2023-12-31_custom_ReverseStockSplitMember_custom_CommonStockSubscriptionReceivableMember" id="xdx2ixbrl0415" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:IssuanceOfStockAndWarrantsForServicesOrClaims" contextRef="From2023-01-012023-12-31" id="xdx2ixbrl0440" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:AmortizationOfDebtDiscountPremium" contextRef="From2023-01-012023-12-31" id="xdx2ixbrl0443" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="STSS:FairMarketValueAdjustmentForContingentWarrants" contextRef="From2023-01-012023-12-31" id="xdx2ixbrl0455" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:ImpairmentOfLongLivedAssetsHeldForUse" contextRef="From2022-01-012022-12-31" id="xdx2ixbrl0462" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:DeferredIncomeTaxExpenseBenefit" contextRef="From2022-01-012022-12-31" id="xdx2ixbrl0465" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:PaymentsForProceedsFromOtherInvestingActivities" contextRef="From2023-01-012023-12-31" id="xdx2ixbrl0494" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="STSS:PaymentsToAssetAcquisition" contextRef="From2023-01-012023-12-31" id="xdx2ixbrl0503" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:RepaymentsOfNotesPayable" contextRef="From2023-01-012023-12-31" id="xdx2ixbrl0521" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="STSS:ProceedsFromSubscriptionsReceivable" contextRef="From2023-01-012023-12-31" id="xdx2ixbrl0524" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:InterestPaidNet" contextRef="From2023-01-012023-12-31" id="xdx2ixbrl0545" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:IncomeTaxesPaidNet" contextRef="From2023-01-012023-12-31" id="xdx2ixbrl0548" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:IncomeTaxesPaidNet" contextRef="From2022-01-012022-12-31" id="xdx2ixbrl0549" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="STSS:FmvForCommonStockIssuedForContingentShares" contextRef="From2023-01-012023-12-31" id="xdx2ixbrl0554" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="STSS:FmvForWarrantsIssuedForContingentWarrants" contextRef="From2023-01-012023-12-31" id="xdx2ixbrl0557" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="STSS:CommonStockIssuedAndVestedStockOptionsForFixedAssetsAcquired" contextRef="From2023-01-012023-12-31" id="xdx2ixbrl0560" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="STSS:CommonStockIssuedAndVestedStockOptionsIssuedAsConsiderationForAcquisition" contextRef="From2023-01-012023-12-31" id="xdx2ixbrl0563" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:ImpairmentOfLongLivedAssetsHeldForUse" contextRef="From2022-01-012022-12-31" id="xdx2ixbrl0604" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:DepositsAssets" contextRef="AsOf2023-12-31" id="xdx2ixbrl0738" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonNumeric contextRef="From2023-01-012023-12-31_us-gaap_IPOMember" id="xdx2ixbrl0970" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1">P5Y</ix:nonNumeric>
  <ix:nonFraction name="STSS:WarrantLiability" contextRef="AsOf2022-12-31_custom_OfferingWarrantsFebruaryTwentyTwentyThreeMember" id="xdx2ixbrl1011" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="STSS:WarrantLiability" contextRef="AsOf2022-12-31_custom_OfferingWarrantsSeptemberTwentyTwentyThreeMember" id="xdx2ixbrl1014" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:ClassOfWarrantOrRightOutstanding" contextRef="AsOf2022-12-31_custom_OfferingWarrantsFebruaryTwentyTwentyThreeMember" id="xdx2ixbrl1028" unitRef="Shares" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:ClassOfWarrantOrRightOutstanding" contextRef="AsOf2022-12-31_custom_OfferingWarrantsSeptemberTwentyTwentyThreeMember" id="xdx2ixbrl1031" unitRef="Shares" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:ClassOfWarrantOrRightOutstanding" contextRef="AsOf2022-12-31_custom_WarrantsIssuedForServiceManagementMember" id="xdx2ixbrl1034" unitRef="Shares" xs:nil="true"></ix:nonFraction>
  <ix:nonNumeric contextRef="From2023-01-012023-12-31_custom_TwoThousandTwentyThreeEquityIncentivePlanMember" id="xdx2ixbrl1095" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1">P5Y</ix:nonNumeric>
  <ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" contextRef="AsOf2023-12-31_custom_ExercisePriceRangeOneMember" id="xdx2ixbrl1135" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1" contextRef="AsOf2023-12-31_custom_ExercisePriceRangeOneMember" id="xdx2ixbrl1141" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" contextRef="AsOf2023-12-31_custom_ExercisePriceRangeTwoMember" id="xdx2ixbrl1147" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1" contextRef="AsOf2023-12-31_custom_ExercisePriceRangeTwoMember" id="xdx2ixbrl1153" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" contextRef="AsOf2023-12-31_custom_ExercisePriceRangeThreeMember" id="xdx2ixbrl1159" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1" contextRef="AsOf2023-12-31_custom_ExercisePriceRangeThreeMember" id="xdx2ixbrl1165" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" contextRef="AsOf2023-12-31_custom_ExercisePriceRangeFourMember" id="xdx2ixbrl1171" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1" contextRef="AsOf2023-12-31_custom_ExercisePriceRangeFourMember" id="xdx2ixbrl1177" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" contextRef="AsOf2023-12-31_custom_ExercisePriceRangeFiveMember" id="xdx2ixbrl1183" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1" contextRef="AsOf2023-12-31_custom_ExercisePriceRangeFiveMember" id="xdx2ixbrl1189" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" contextRef="AsOf2023-12-31_custom_ExercisePriceRangeSixMember" id="xdx2ixbrl1195" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1" contextRef="AsOf2023-12-31_custom_ExercisePriceRangeSixMember" id="xdx2ixbrl1201" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" contextRef="AsOf2023-12-31_custom_ExercisePriceRangeSevenMember" id="xdx2ixbrl1207" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1" contextRef="AsOf2023-12-31_custom_ExercisePriceRangeSevenMember" id="xdx2ixbrl1213" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" contextRef="AsOf2023-12-31_custom_ExercisePriceRangeEightMember" id="xdx2ixbrl1219" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1" contextRef="AsOf2023-12-31_custom_ExercisePriceRangeEightMember" id="xdx2ixbrl1225" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" contextRef="AsOf2023-12-31_custom_ExercisePriceRangeNineMember" id="xdx2ixbrl1231" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1" contextRef="AsOf2023-12-31_custom_ExercisePriceRangeNineMember" id="xdx2ixbrl1237" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" contextRef="AsOf2023-12-31_custom_ExercisePriceRangeTenMember" id="xdx2ixbrl1243" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1" contextRef="AsOf2023-12-31_custom_ExercisePriceRangeTenMember" id="xdx2ixbrl1249" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:IncomeTaxReconciliationStateAndLocalIncomeTaxes" contextRef="From2023-01-012023-12-31" id="xdx2ixbrl1311" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:IncomeTaxExpenseBenefit" contextRef="From2022-01-012022-12-31" id="xdx2ixbrl1321" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:CashAndCashEquivalentsFairValueDisclosure" contextRef="AsOf2023-12-31_us-gaap_FairValueInputsLevel2Member" id="xdx2ixbrl1393" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:CashAndCashEquivalentsFairValueDisclosure" contextRef="AsOf2023-12-31_us-gaap_FairValueInputsLevel3Member" id="xdx2ixbrl1394" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:AssetsFairValueDisclosure" contextRef="AsOf2023-12-31_us-gaap_FairValueInputsLevel2Member" id="xdx2ixbrl1398" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:AssetsFairValueDisclosure" contextRef="AsOf2023-12-31_us-gaap_FairValueInputsLevel3Member" id="xdx2ixbrl1399" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="STSS:WarrantLiability" contextRef="AsOf2023-12-31_us-gaap_FairValueInputsLevel1Member" id="xdx2ixbrl1407" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="STSS:WarrantLiability" contextRef="AsOf2023-12-31_us-gaap_FairValueInputsLevel3Member" id="xdx2ixbrl1409" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:LiabilitiesFairValueDisclosure" contextRef="AsOf2023-12-31_us-gaap_FairValueInputsLevel1Member" id="xdx2ixbrl1412" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:LiabilitiesFairValueDisclosure" contextRef="AsOf2023-12-31_us-gaap_FairValueInputsLevel3Member" id="xdx2ixbrl1414" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:CashAndCashEquivalentsFairValueDisclosure" contextRef="AsOf2022-12-31_us-gaap_FairValueInputsLevel2Member" id="xdx2ixbrl1423" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:CashAndCashEquivalentsFairValueDisclosure" contextRef="AsOf2022-12-31_us-gaap_FairValueInputsLevel3Member" id="xdx2ixbrl1424" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:AssetsFairValueDisclosure" contextRef="AsOf2022-12-31_us-gaap_FairValueInputsLevel2Member" id="xdx2ixbrl1428" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="STSS:WarrantLiability" contextRef="AsOf2022-12-31_us-gaap_FairValueInputsLevel2Member" id="xdx2ixbrl1438" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="STSS:WarrantLiability" contextRef="AsOf2022-12-31_us-gaap_FairValueInputsLevel3Member" id="xdx2ixbrl1439" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:LiabilitiesFairValueDisclosure" contextRef="AsOf2022-12-31_us-gaap_FairValueInputsLevel2Member" id="xdx2ixbrl1443" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:LiabilitiesFairValueDisclosure" contextRef="AsOf2022-12-31_us-gaap_FairValueInputsLevel3Member" id="xdx2ixbrl1444" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:NotesPayableCurrent" contextRef="AsOf2023-12-31" id="xdx2ixbrl1549" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:CommitmentsAndContingencies" contextRef="AsOf2024-09-30" id="xdx2ixbrl1563" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:CommitmentsAndContingencies" contextRef="AsOf2023-12-31" id="xdx2ixbrl1564" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:PreferredStockValue" contextRef="AsOf2024-09-30" id="xdx2ixbrl1569" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:PreferredStockValue" contextRef="AsOf2023-12-31" id="xdx2ixbrl1570" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" contextRef="From2024-07-012024-09-30" id="xdx2ixbrl1624" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" contextRef="From2023-07-012023-09-30" id="xdx2ixbrl1625" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" contextRef="From2024-01-01to2024-09-30" id="xdx2ixbrl1626" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" contextRef="From2023-01-012023-09-30" id="xdx2ixbrl1627" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2023-12-31_us-gaap_PreferredStockMember" id="xdx2ixbrl1746" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2023-12-31_custom_CommonStockSubscriptionReceivableMember" id="xdx2ixbrl1748" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2024-01-012024-03-31_us-gaap_PreferredStockMember" id="xdx2ixbrl1758" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2024-01-012024-03-31_us-gaap_CommonStockMember" id="xdx2ixbrl1759" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2024-01-012024-03-31_custom_CommonStockSubscriptionReceivableMember" id="xdx2ixbrl1760" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2024-01-012024-03-31_us-gaap_AdditionalPaidInCapitalMember" id="xdx2ixbrl1761" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2024-01-012024-03-31_us-gaap_AccumulatedOtherComprehensiveIncomeMember" id="xdx2ixbrl1762" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" contextRef="From2024-01-012024-03-31_us-gaap_PreferredStockMember" id="xdx2ixbrl1766" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" contextRef="From2024-01-012024-03-31_us-gaap_CommonStockMember" id="xdx2ixbrl1767" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" contextRef="From2024-01-012024-03-31_us-gaap_AccumulatedOtherComprehensiveIncomeMember" id="xdx2ixbrl1770" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" contextRef="From2024-01-012024-03-31_us-gaap_RetainedEarningsMember" id="xdx2ixbrl1771" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="STSS:StockIssuedDuringPeriodValueExerciseOfPrefundedWarrants" contextRef="From2024-01-012024-03-31_us-gaap_PreferredStockMember" id="xdx2ixbrl1774" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="STSS:StockIssuedDuringPeriodValueExerciseOfPrefundedWarrants" contextRef="From2024-01-012024-03-31_us-gaap_AccumulatedOtherComprehensiveIncomeMember" id="xdx2ixbrl1778" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="STSS:StockIssuedDuringPeriodValueExerciseOfPrefundedWarrants" contextRef="From2024-01-012024-03-31_us-gaap_RetainedEarningsMember" id="xdx2ixbrl1779" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax" contextRef="From2024-01-012024-03-31_us-gaap_PreferredStockMember" id="xdx2ixbrl1784" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax" contextRef="From2024-01-012024-03-31_us-gaap_CommonStockMember" id="xdx2ixbrl1785" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax" contextRef="From2024-01-012024-03-31_us-gaap_AdditionalPaidInCapitalMember" id="xdx2ixbrl1787" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax" contextRef="From2024-01-012024-03-31_us-gaap_RetainedEarningsMember" id="xdx2ixbrl1789" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2024-03-31_us-gaap_PreferredStockMember" id="xdx2ixbrl1792" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2024-03-31_custom_CommonStockSubscriptionReceivableMember" id="xdx2ixbrl1794" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2024-04-012024-06-30_us-gaap_PreferredStockMember" id="xdx2ixbrl1804" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2024-04-012024-06-30_us-gaap_CommonStockMember" id="xdx2ixbrl1805" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2024-04-012024-06-30_custom_CommonStockSubscriptionReceivableMember" id="xdx2ixbrl1806" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2024-04-012024-06-30_us-gaap_AdditionalPaidInCapitalMember" id="xdx2ixbrl1807" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2024-04-012024-06-30_us-gaap_AccumulatedOtherComprehensiveIncomeMember" id="xdx2ixbrl1808" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" contextRef="From2024-04-012024-06-30_us-gaap_PreferredStockMember" id="xdx2ixbrl1812" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" contextRef="From2024-04-012024-06-30_us-gaap_CommonStockMember" id="xdx2ixbrl1813" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" contextRef="From2024-04-012024-06-30_us-gaap_AccumulatedOtherComprehensiveIncomeMember" id="xdx2ixbrl1816" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" contextRef="From2024-04-012024-06-30_us-gaap_RetainedEarningsMember" id="xdx2ixbrl1817" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="STSS:StockIssuedDuringPeriodValueExerciseOfPrefundedWarrant" contextRef="From2024-04-012024-06-30_us-gaap_PreferredStockMember" id="xdx2ixbrl1820" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="STSS:StockIssuedDuringPeriodValueExerciseOfPrefundedWarrant" contextRef="From2024-04-012024-06-30_us-gaap_AccumulatedOtherComprehensiveIncomeMember" id="xdx2ixbrl1824" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="STSS:StockIssuedDuringPeriodValueExerciseOfPrefundedWarrant" contextRef="From2024-04-012024-06-30_us-gaap_RetainedEarningsMember" id="xdx2ixbrl1825" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="STSS:StockIssuedDuringPeriodValueRegistrationOffering" contextRef="From2024-04-012024-06-30_us-gaap_PreferredStockMember" id="xdx2ixbrl1830" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="STSS:StockIssuedDuringPeriodValueRegistrationOffering" contextRef="From2024-04-012024-06-30_us-gaap_AccumulatedOtherComprehensiveIncomeMember" id="xdx2ixbrl1834" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="STSS:StockIssuedDuringPeriodValueRegistrationOffering" contextRef="From2024-04-012024-06-30_us-gaap_RetainedEarningsMember" id="xdx2ixbrl1835" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="STSS:StockIssuedDuringPeriodValueWarrantInducements" contextRef="From2024-04-012024-06-30_us-gaap_AccumulatedOtherComprehensiveIncomeMember" id="xdx2ixbrl1844" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="STSS:StockIssuedDuringPeriodValueWarrantInducements" contextRef="From2024-04-012024-06-30_us-gaap_RetainedEarningsMember" id="xdx2ixbrl1845" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax" contextRef="From2024-04-012024-06-30_us-gaap_PreferredStockMember" id="xdx2ixbrl1850" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax" contextRef="From2024-04-012024-06-30_us-gaap_CommonStockMember" id="xdx2ixbrl1851" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax" contextRef="From2024-04-012024-06-30_us-gaap_AdditionalPaidInCapitalMember" id="xdx2ixbrl1853" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax" contextRef="From2024-04-012024-06-30_us-gaap_RetainedEarningsMember" id="xdx2ixbrl1855" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2024-06-30_us-gaap_PreferredStockMember" id="xdx2ixbrl1858" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2024-06-30_custom_CommonStockSubscriptionReceivableMember" id="xdx2ixbrl1860" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2024-07-012024-09-30_us-gaap_PreferredStockMember" id="xdx2ixbrl1870" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2024-07-012024-09-30_us-gaap_CommonStockMember" id="xdx2ixbrl1871" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2024-07-012024-09-30_custom_CommonStockSubscriptionReceivableMember" id="xdx2ixbrl1872" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2024-07-012024-09-30_us-gaap_AdditionalPaidInCapitalMember" id="xdx2ixbrl1873" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2024-07-012024-09-30_us-gaap_AccumulatedOtherComprehensiveIncomeMember" id="xdx2ixbrl1874" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:StockRedeemedOrCalledDuringPeriodValue" contextRef="From2024-07-012024-09-30_us-gaap_PreferredStockMember" id="xdx2ixbrl1878" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:StockRedeemedOrCalledDuringPeriodValue" contextRef="From2024-07-012024-09-30_us-gaap_CommonStockMember" id="xdx2ixbrl1879" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:StockRedeemedOrCalledDuringPeriodValue" contextRef="From2024-07-012024-09-30_us-gaap_AdditionalPaidInCapitalMember" id="xdx2ixbrl1881" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:StockRedeemedOrCalledDuringPeriodValue" contextRef="From2024-07-012024-09-30_us-gaap_AccumulatedOtherComprehensiveIncomeMember" id="xdx2ixbrl1882" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:StockRedeemedOrCalledDuringPeriodValue" contextRef="From2024-07-012024-09-30_us-gaap_RetainedEarningsMember" id="xdx2ixbrl1883" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:StockRedeemedOrCalledDuringPeriodValue" contextRef="From2024-07-012024-09-30" id="xdx2ixbrl1884" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" contextRef="From2024-07-012024-09-30_us-gaap_PreferredStockMember" id="xdx2ixbrl1888" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" contextRef="From2024-07-012024-09-30_us-gaap_CommonStockMember" id="xdx2ixbrl1889" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" contextRef="From2024-07-012024-09-30_us-gaap_AccumulatedOtherComprehensiveIncomeMember" id="xdx2ixbrl1892" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" contextRef="From2024-07-012024-09-30_us-gaap_RetainedEarningsMember" id="xdx2ixbrl1893" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueOther" contextRef="From2024-07-012024-09-30_us-gaap_PreferredStockMember" id="xdx2ixbrl1896" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueOther" contextRef="From2024-07-012024-09-30_us-gaap_AccumulatedOtherComprehensiveIncomeMember" id="xdx2ixbrl1900" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueOther" contextRef="From2024-07-012024-09-30_us-gaap_RetainedEarningsMember" id="xdx2ixbrl1901" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="STSS:StockIssuedDuringPeriodValueWarrantExericse" contextRef="From2024-07-012024-09-30_us-gaap_PreferredStockMember" id="xdx2ixbrl1906" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="STSS:StockIssuedDuringPeriodValueWarrantExericse" contextRef="From2024-07-012024-09-30_us-gaap_AccumulatedOtherComprehensiveIncomeMember" id="xdx2ixbrl1910" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="STSS:StockIssuedDuringPeriodValueWarrantExericse" contextRef="From2024-07-012024-09-30_us-gaap_RetainedEarningsMember" id="xdx2ixbrl1911" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax" contextRef="From2024-07-012024-09-30_us-gaap_PreferredStockMember" id="xdx2ixbrl1916" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax" contextRef="From2024-07-012024-09-30_us-gaap_CommonStockMember" id="xdx2ixbrl1917" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax" contextRef="From2024-07-012024-09-30_us-gaap_AdditionalPaidInCapitalMember" id="xdx2ixbrl1919" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax" contextRef="From2024-07-012024-09-30_us-gaap_RetainedEarningsMember" id="xdx2ixbrl1921" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2024-09-30_us-gaap_PreferredStockMember" id="xdx2ixbrl1924" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2024-09-30_custom_CommonStockSubscriptionReceivableMember" id="xdx2ixbrl1926" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:SharesOutstanding" contextRef="AsOf2024-09-30_us-gaap_PreferredStockMember" id="xdx2ixbrl1932" unitRef="Shares" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2022-12-31_us-gaap_PreferredStockMember" id="xdx2ixbrl1936" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2022-12-31_custom_CommonStockSubscriptionReceivableMember" id="xdx2ixbrl1938" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2023-01-012023-03-31_us-gaap_PreferredStockMember" id="xdx2ixbrl1948" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2023-01-012023-03-31_us-gaap_CommonStockMember" id="xdx2ixbrl1949" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2023-01-012023-03-31_custom_CommonStockSubscriptionReceivableMember" id="xdx2ixbrl1950" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2023-01-012023-03-31_us-gaap_AdditionalPaidInCapitalMember" id="xdx2ixbrl1951" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2023-01-012023-03-31_us-gaap_AccumulatedOtherComprehensiveIncomeMember" id="xdx2ixbrl1952" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueNewIssues" contextRef="From2023-01-012023-03-31_us-gaap_AccumulatedOtherComprehensiveIncomeMember" id="xdx2ixbrl1960" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" contextRef="From2023-01-012023-03-31_us-gaap_PreferredStockMember" id="xdx2ixbrl1966" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" contextRef="From2023-01-012023-03-31_us-gaap_CommonStockMember" id="xdx2ixbrl1967" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" contextRef="From2023-01-012023-03-31_custom_CommonStockSubscriptionReceivableMember" id="xdx2ixbrl1968" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" contextRef="From2023-01-012023-03-31_us-gaap_AccumulatedOtherComprehensiveIncomeMember" id="xdx2ixbrl1970" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" contextRef="From2023-01-012023-03-31_us-gaap_RetainedEarningsMember" id="xdx2ixbrl1971" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax" contextRef="From2023-01-012023-03-31_us-gaap_PreferredStockMember" id="xdx2ixbrl1974" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax" contextRef="From2023-01-012023-03-31_custom_CommonStockSubscriptionReceivableMember" id="xdx2ixbrl1976" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax" contextRef="From2023-01-012023-03-31_us-gaap_AdditionalPaidInCapitalMember" id="xdx2ixbrl1977" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax" contextRef="From2023-01-012023-03-31_us-gaap_RetainedEarningsMember" id="xdx2ixbrl1979" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2023-03-31_us-gaap_PreferredStockMember" id="xdx2ixbrl1982" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2023-03-31_custom_CommonStockSubscriptionReceivableMember" id="xdx2ixbrl1984" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2023-04-012023-06-30_us-gaap_PreferredStockMember" id="xdx2ixbrl1994" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2023-04-012023-06-30_us-gaap_CommonStockMember" id="xdx2ixbrl1995" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2023-04-012023-06-30_custom_CommonStockSubscriptionReceivableMember" id="xdx2ixbrl1996" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2023-04-012023-06-30_us-gaap_AdditionalPaidInCapitalMember" id="xdx2ixbrl1997" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2023-04-012023-06-30_us-gaap_AccumulatedOtherComprehensiveIncomeMember" id="xdx2ixbrl1998" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" contextRef="From2023-04-012023-06-30_us-gaap_PreferredStockMember" id="xdx2ixbrl2002" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" contextRef="From2023-04-012023-06-30_us-gaap_CommonStockMember" id="xdx2ixbrl2003" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" contextRef="From2023-04-012023-06-30_custom_CommonStockSubscriptionReceivableMember" id="xdx2ixbrl2004" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" contextRef="From2023-04-012023-06-30_us-gaap_AccumulatedOtherComprehensiveIncomeMember" id="xdx2ixbrl2006" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" contextRef="From2023-04-012023-06-30_us-gaap_RetainedEarningsMember" id="xdx2ixbrl2007" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax" contextRef="From2023-04-012023-06-30_us-gaap_PreferredStockMember" id="xdx2ixbrl2010" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax" contextRef="From2023-04-012023-06-30_custom_CommonStockSubscriptionReceivableMember" id="xdx2ixbrl2012" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax" contextRef="From2023-04-012023-06-30_us-gaap_AdditionalPaidInCapitalMember" id="xdx2ixbrl2013" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax" contextRef="From2023-04-012023-06-30_us-gaap_RetainedEarningsMember" id="xdx2ixbrl2015" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2023-06-30_us-gaap_PreferredStockMember" id="xdx2ixbrl2018" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2023-06-30_custom_CommonStockSubscriptionReceivableMember" id="xdx2ixbrl2020" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2023-06-30_us-gaap_PreferredStockMember" id="xdx2ixbrl2030" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2023-06-30_custom_CommonStockSubscriptionReceivableMember" id="xdx2ixbrl2032" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2023-07-012023-09-30_us-gaap_PreferredStockMember" id="xdx2ixbrl2042" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2023-07-012023-09-30_us-gaap_CommonStockMember" id="xdx2ixbrl2043" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2023-07-012023-09-30_custom_CommonStockSubscriptionReceivableMember" id="xdx2ixbrl2044" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2023-07-012023-09-30_us-gaap_AdditionalPaidInCapitalMember" id="xdx2ixbrl2045" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2023-07-012023-09-30_us-gaap_AccumulatedOtherComprehensiveIncomeMember" id="xdx2ixbrl2046" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2023-07-012023-09-30_us-gaap_PreferredStockMember" id="xdx2ixbrl2050" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2023-07-012023-09-30_us-gaap_CommonStockMember" id="xdx2ixbrl2051" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2023-07-012023-09-30_custom_CommonStockSubscriptionReceivableMember" id="xdx2ixbrl2052" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2023-07-012023-09-30_us-gaap_AdditionalPaidInCapitalMember" id="xdx2ixbrl2053" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2023-07-012023-09-30_us-gaap_AccumulatedOtherComprehensiveIncomeMember" id="xdx2ixbrl2054" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" contextRef="From2023-07-012023-09-30_us-gaap_PreferredStockMember" id="xdx2ixbrl2058" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" contextRef="From2023-07-012023-09-30_custom_CommonStockSubscriptionReceivableMember" id="xdx2ixbrl2060" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" contextRef="From2023-07-012023-09-30_us-gaap_AccumulatedOtherComprehensiveIncomeMember" id="xdx2ixbrl2062" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" contextRef="From2023-07-012023-09-30_us-gaap_RetainedEarningsMember" id="xdx2ixbrl2063" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="STSS:StockIssuedDuringPeriodValueShelfRegistrationOffering" contextRef="From2023-07-012023-09-30_us-gaap_PreferredStockMember" id="xdx2ixbrl2066" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="STSS:StockIssuedDuringPeriodValuePrivatePlacement" contextRef="From2023-07-012023-09-30_us-gaap_PreferredStockMember" id="xdx2ixbrl2076" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax" contextRef="From2023-07-012023-09-30_us-gaap_PreferredStockMember" id="xdx2ixbrl2084" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2023-09-30_us-gaap_PreferredStockMember" id="xdx2ixbrl2092" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2023-09-30_custom_CommonStockSubscriptionReceivableMember" id="xdx2ixbrl2094" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2023-09-30_us-gaap_PreferredStockMember" id="xdx2ixbrl2104" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2023-09-30_custom_CommonStockSubscriptionReceivableMember" id="xdx2ixbrl2106" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:AmortizationOfDebtDiscountPremium" contextRef="From2023-01-012023-09-30" id="xdx2ixbrl2132" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:AmortizationOfFinancingCosts" contextRef="From2024-01-01to2024-09-30" id="xdx2ixbrl2137" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="STSS:EscrowDepositForfeited" contextRef="From2023-01-012023-09-30" id="xdx2ixbrl2141" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:ProceedsFromIssuanceOfLongTermDebt" contextRef="From2023-01-012023-09-30" id="xdx2ixbrl2180" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:ImpairmentOfLongLivedAssetsHeldForUse" contextRef="From2024-07-012024-09-30" id="xdx2ixbrl2233" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:ImpairmentOfLongLivedAssetsHeldForUse" contextRef="From2023-07-012023-09-30" id="xdx2ixbrl2235" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:ImpairmentOfLongLivedAssetsHeldForUse" contextRef="From2024-01-01to2024-09-30" id="xdx2ixbrl2237" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:ImpairmentOfLongLivedAssetsHeldForUse" contextRef="From2023-01-012023-09-30" id="xdx2ixbrl2239" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonNumeric contextRef="From2024-01-012024-09-30_us-gaap_WarrantMember" id="xdx2ixbrl2612" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1">P3Y</ix:nonNumeric>
  <ix:nonFraction name="STSS:WarrantLiabilitiesCurrent" contextRef="AsOf2023-12-31_custom_InducementWarrantsMember" id="xdx2ixbrl2743" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:ClassOfWarrantOrRightOutstanding" contextRef="AsOf2023-12-31_custom_InducementWarrantsMayTwoThousandTwentyFourMember" id="xdx2ixbrl2763" unitRef="Shares" xs:nil="true"></ix:nonFraction>
  <ix:nonNumeric contextRef="From2024-01-01to2024-09-30" id="xdx2ixbrl2813" name="STSS:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantedInYear">P5Y</ix:nonNumeric>
  <ix:nonFraction name="us-gaap:CashAndCashEquivalentsFairValueDisclosure" contextRef="AsOf2024-09-30_us-gaap_FairValueInputsLevel2Member" id="xdx2ixbrl2895" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:CashAndCashEquivalentsFairValueDisclosure" contextRef="AsOf2024-09-30_us-gaap_FairValueInputsLevel3Member" id="xdx2ixbrl2896" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:AssetsFairValueDisclosure" contextRef="AsOf2024-09-30_us-gaap_FairValueInputsLevel2Member" id="xdx2ixbrl2900" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:AssetsFairValueDisclosure" contextRef="AsOf2024-09-30_us-gaap_FairValueInputsLevel3Member" id="xdx2ixbrl2901" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:DerivativeLiabilities" contextRef="AsOf2024-09-30_us-gaap_FairValueInputsLevel1Member" id="xdx2ixbrl2909" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:DerivativeLiabilities" contextRef="AsOf2024-09-30_us-gaap_FairValueInputsLevel3Member" id="xdx2ixbrl2911" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:LiabilitiesFairValueDisclosure" contextRef="AsOf2024-09-30_us-gaap_FairValueInputsLevel1Member" id="xdx2ixbrl2914" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:LiabilitiesFairValueDisclosure" contextRef="AsOf2024-09-30_us-gaap_FairValueInputsLevel3Member" id="xdx2ixbrl2916" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:CashAndCashEquivalentsFairValueDisclosure" contextRef="AsOf2023-12-31_us-gaap_FairValueInputsLevel2Member" id="xdx2ixbrl2925" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:CashAndCashEquivalentsFairValueDisclosure" contextRef="AsOf2023-12-31_us-gaap_FairValueInputsLevel3Member" id="xdx2ixbrl2926" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:AssetsFairValueDisclosure" contextRef="AsOf2023-12-31_us-gaap_FairValueInputsLevel2Member" id="xdx2ixbrl2930" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:AssetsFairValueDisclosure" contextRef="AsOf2023-12-31_us-gaap_FairValueInputsLevel3Member" id="xdx2ixbrl2931" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:DerivativeLiabilities" contextRef="AsOf2023-12-31_us-gaap_FairValueInputsLevel1Member" id="xdx2ixbrl2939" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:DerivativeLiabilities" contextRef="AsOf2023-12-31_us-gaap_FairValueInputsLevel3Member" id="xdx2ixbrl2941" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:LiabilitiesFairValueDisclosure" contextRef="AsOf2023-12-31_us-gaap_FairValueInputsLevel1Member" id="xdx2ixbrl2944" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:LiabilitiesFairValueDisclosure" contextRef="AsOf2023-12-31_us-gaap_FairValueInputsLevel3Member" id="xdx2ixbrl2946" unitRef="USD" xs:nil="true"></ix:nonFraction>
  </ix:hidden>
 <ix:references>
  <link:schemaRef xlink:href="stss-20240930.xsd" xlink:type="simple"/>
  </ix:references>
 <ix:resources>
    <xbrli:context id="From2024-01-01to2024-09-30">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001737995</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-01-01</xbrli:startDate>
        <xbrli:endDate>2024-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2024-01-012024-09-30_dei_BusinessContactMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001737995</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="dei:EntityAddressesAddressTypeAxis">dei:BusinessContactMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-01-01</xbrli:startDate>
        <xbrli:endDate>2024-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-12-31">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001737995</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-12-31">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001737995</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-12-31_custom_ReverseStockSplitMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001737995</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">STSS:ReverseStockSplitMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-12-31_custom_ReverseStockSplitMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001737995</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">STSS:ReverseStockSplitMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2024-09-30">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001737995</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2024-09-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-01-012023-12-31">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001737995</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-01-01</xbrli:startDate>
        <xbrli:endDate>2023-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-01-012022-12-31">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001737995</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-01-01</xbrli:startDate>
        <xbrli:endDate>2022-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2024-07-012024-09-30">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001737995</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-07-01</xbrli:startDate>
        <xbrli:endDate>2024-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-07-012023-09-30">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001737995</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-07-01</xbrli:startDate>
        <xbrli:endDate>2023-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-01-012023-09-30">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001737995</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-01-01</xbrli:startDate>
        <xbrli:endDate>2023-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-12-31_us-gaap_PreferredStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001737995</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-12-31_us-gaap_CommonStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001737995</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-12-31_custom_CommonStockSubscriptionReceivableMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001737995</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">STSS:CommonStockSubscriptionReceivableMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-12-31_us-gaap_AdditionalPaidInCapitalMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001737995</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-12-31_us-gaap_AccumulatedOtherComprehensiveIncomeMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001737995</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-12-31_us-gaap_RetainedEarningsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001737995</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-12-31">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001737995</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-12-31_custom_ReverseStockSplitMember_us-gaap_PreferredStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001737995</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="STSS:AwardsTypeAxis">STSS:ReverseStockSplitMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-12-31_custom_ReverseStockSplitMember_us-gaap_CommonStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001737995</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="STSS:AwardsTypeAxis">STSS:ReverseStockSplitMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-12-31_custom_ReverseStockSplitMember_custom_CommonStockSubscriptionReceivableMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001737995</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="STSS:AwardsTypeAxis">STSS:ReverseStockSplitMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">STSS:CommonStockSubscriptionReceivableMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-12-31_custom_ReverseStockSplitMember_us-gaap_AdditionalPaidInCapitalMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001737995</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="STSS:AwardsTypeAxis">STSS:ReverseStockSplitMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-12-31_custom_ReverseStockSplitMember_us-gaap_AccumulatedOtherComprehensiveIncomeMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001737995</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="STSS:AwardsTypeAxis">STSS:ReverseStockSplitMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-12-31_custom_ReverseStockSplitMember_us-gaap_RetainedEarningsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001737995</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="STSS:AwardsTypeAxis">STSS:ReverseStockSplitMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-12-31_custom_ReverseStockSplitMember10880671">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001737995</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="STSS:AwardsTypeAxis">STSS:ReverseStockSplitMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-12-31_us-gaap_PreferredStockMember_custom_ReverseStockSplitMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001737995</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">STSS:ReverseStockSplitMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-12-31_us-gaap_CommonStockMember_custom_ReverseStockSplitMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001737995</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">STSS:ReverseStockSplitMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-12-31_us-gaap_PreferredStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001737995</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-12-31_us-gaap_CommonStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001737995</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-12-31_custom_CommonStockSubscriptionReceivableMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001737995</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">STSS:CommonStockSubscriptionReceivableMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-12-31_us-gaap_AdditionalPaidInCapitalMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001737995</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-12-31_us-gaap_AccumulatedOtherComprehensiveIncomeMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001737995</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-12-31_us-gaap_RetainedEarningsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001737995</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2024-03-31_us-gaap_PreferredStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001737995</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2024-03-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2024-03-31_us-gaap_CommonStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001737995</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2024-03-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2024-03-31_custom_CommonStockSubscriptionReceivableMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001737995</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">STSS:CommonStockSubscriptionReceivableMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2024-03-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2024-03-31_us-gaap_AdditionalPaidInCapitalMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001737995</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2024-03-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2024-03-31_us-gaap_AccumulatedOtherComprehensiveIncomeMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001737995</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2024-03-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2024-03-31_us-gaap_RetainedEarningsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001737995</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2024-03-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2024-03-31">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001737995</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2024-03-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2024-06-30_us-gaap_PreferredStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001737995</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2024-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2024-06-30_us-gaap_CommonStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001737995</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2024-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2024-06-30_custom_CommonStockSubscriptionReceivableMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001737995</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">STSS:CommonStockSubscriptionReceivableMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2024-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2024-06-30_us-gaap_AdditionalPaidInCapitalMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001737995</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2024-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2024-06-30_us-gaap_AccumulatedOtherComprehensiveIncomeMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001737995</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2024-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2024-06-30_us-gaap_RetainedEarningsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001737995</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2024-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2024-06-30">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001737995</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2024-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-12-31_us-gaap_PreferredStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001737995</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-12-31_us-gaap_CommonStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001737995</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-12-31_custom_CommonStockSubscriptionReceivableMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001737995</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">STSS:CommonStockSubscriptionReceivableMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-12-31_us-gaap_AdditionalPaidInCapitalMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001737995</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-12-31_us-gaap_AccumulatedOtherComprehensiveIncomeMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001737995</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-12-31_us-gaap_RetainedEarningsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001737995</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-03-31_us-gaap_PreferredStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001737995</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-03-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-03-31_us-gaap_CommonStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001737995</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-03-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-03-31_custom_CommonStockSubscriptionReceivableMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001737995</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">STSS:CommonStockSubscriptionReceivableMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-03-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-03-31_us-gaap_AdditionalPaidInCapitalMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001737995</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-03-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-03-31_us-gaap_AccumulatedOtherComprehensiveIncomeMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001737995</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-03-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-03-31_us-gaap_RetainedEarningsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001737995</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-03-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-03-31">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001737995</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-03-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-06-30_us-gaap_PreferredStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001737995</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-06-30_us-gaap_CommonStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001737995</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-06-30_custom_CommonStockSubscriptionReceivableMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001737995</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">STSS:CommonStockSubscriptionReceivableMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-06-30_us-gaap_AdditionalPaidInCapitalMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001737995</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-06-30_us-gaap_AccumulatedOtherComprehensiveIncomeMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001737995</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-06-30_us-gaap_RetainedEarningsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001737995</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-06-30">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001737995</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-01-012022-12-31_us-gaap_PreferredStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001737995</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-01-01</xbrli:startDate>
        <xbrli:endDate>2022-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-01-012022-12-31_us-gaap_CommonStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001737995</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-01-01</xbrli:startDate>
        <xbrli:endDate>2022-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-01-012022-12-31_custom_CommonStockSubscriptionReceivableMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001737995</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">STSS:CommonStockSubscriptionReceivableMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-01-01</xbrli:startDate>
        <xbrli:endDate>2022-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-01-012022-12-31_us-gaap_AdditionalPaidInCapitalMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001737995</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-01-01</xbrli:startDate>
        <xbrli:endDate>2022-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-01-012022-12-31_us-gaap_AccumulatedOtherComprehensiveIncomeMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001737995</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-01-01</xbrli:startDate>
        <xbrli:endDate>2022-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-01-012022-12-31_us-gaap_RetainedEarningsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001737995</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-01-01</xbrli:startDate>
        <xbrli:endDate>2022-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-01-012023-12-31_custom_ReverseStockSplitMember_us-gaap_PreferredStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001737995</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="STSS:AwardsTypeAxis">STSS:ReverseStockSplitMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-01-01</xbrli:startDate>
        <xbrli:endDate>2023-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-01-012023-12-31_custom_ReverseStockSplitMember_us-gaap_CommonStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001737995</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="STSS:AwardsTypeAxis">STSS:ReverseStockSplitMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-01-01</xbrli:startDate>
        <xbrli:endDate>2023-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-01-012023-12-31_custom_ReverseStockSplitMember_custom_CommonStockSubscriptionReceivableMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001737995</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="STSS:AwardsTypeAxis">STSS:ReverseStockSplitMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">STSS:CommonStockSubscriptionReceivableMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-01-01</xbrli:startDate>
        <xbrli:endDate>2023-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-01-012023-12-31_custom_ReverseStockSplitMember_us-gaap_AdditionalPaidInCapitalMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001737995</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="STSS:AwardsTypeAxis">STSS:ReverseStockSplitMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-01-01</xbrli:startDate>
        <xbrli:endDate>2023-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-01-012023-12-31_custom_ReverseStockSplitMember_us-gaap_AccumulatedOtherComprehensiveIncomeMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001737995</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="STSS:AwardsTypeAxis">STSS:ReverseStockSplitMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-01-01</xbrli:startDate>
        <xbrli:endDate>2023-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-01-012023-12-31_custom_ReverseStockSplitMember_us-gaap_RetainedEarningsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001737995</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="STSS:AwardsTypeAxis">STSS:ReverseStockSplitMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-01-01</xbrli:startDate>
        <xbrli:endDate>2023-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-01-012023-12-31_custom_ReverseStockSplitMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001737995</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="STSS:AwardsTypeAxis">STSS:ReverseStockSplitMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-01-01</xbrli:startDate>
        <xbrli:endDate>2023-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-01-012023-12-31_us-gaap_CommonStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001737995</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-01-01</xbrli:startDate>
        <xbrli:endDate>2023-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2024-01-012024-03-31_us-gaap_PreferredStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001737995</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-01-01</xbrli:startDate>
        <xbrli:endDate>2024-03-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2024-01-012024-03-31_us-gaap_CommonStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001737995</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-01-01</xbrli:startDate>
        <xbrli:endDate>2024-03-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2024-01-012024-03-31_custom_CommonStockSubscriptionReceivableMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001737995</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">STSS:CommonStockSubscriptionReceivableMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-01-01</xbrli:startDate>
        <xbrli:endDate>2024-03-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2024-01-012024-03-31_us-gaap_AdditionalPaidInCapitalMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001737995</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-01-01</xbrli:startDate>
        <xbrli:endDate>2024-03-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2024-01-012024-03-31_us-gaap_AccumulatedOtherComprehensiveIncomeMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001737995</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-01-01</xbrli:startDate>
        <xbrli:endDate>2024-03-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2024-01-012024-03-31_us-gaap_RetainedEarningsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001737995</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-01-01</xbrli:startDate>
        <xbrli:endDate>2024-03-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2024-01-012024-03-31">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001737995</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-01-01</xbrli:startDate>
        <xbrli:endDate>2024-03-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2024-04-012024-06-30_us-gaap_PreferredStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001737995</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-04-01</xbrli:startDate>
        <xbrli:endDate>2024-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2024-04-012024-06-30_us-gaap_CommonStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001737995</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-04-01</xbrli:startDate>
        <xbrli:endDate>2024-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2024-04-012024-06-30_custom_CommonStockSubscriptionReceivableMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001737995</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">STSS:CommonStockSubscriptionReceivableMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-04-01</xbrli:startDate>
        <xbrli:endDate>2024-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2024-04-012024-06-30_us-gaap_AdditionalPaidInCapitalMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001737995</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-04-01</xbrli:startDate>
        <xbrli:endDate>2024-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2024-04-012024-06-30_us-gaap_AccumulatedOtherComprehensiveIncomeMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001737995</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-04-01</xbrli:startDate>
        <xbrli:endDate>2024-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2024-04-012024-06-30_us-gaap_RetainedEarningsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001737995</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-04-01</xbrli:startDate>
        <xbrli:endDate>2024-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2024-04-012024-06-30">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001737995</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-04-01</xbrli:startDate>
        <xbrli:endDate>2024-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2024-07-012024-09-30_us-gaap_PreferredStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001737995</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-07-01</xbrli:startDate>
        <xbrli:endDate>2024-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2024-07-012024-09-30_us-gaap_CommonStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001737995</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-07-01</xbrli:startDate>
        <xbrli:endDate>2024-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2024-07-012024-09-30_custom_CommonStockSubscriptionReceivableMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001737995</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">STSS:CommonStockSubscriptionReceivableMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-07-01</xbrli:startDate>
        <xbrli:endDate>2024-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2024-07-012024-09-30_us-gaap_AdditionalPaidInCapitalMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001737995</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-07-01</xbrli:startDate>
        <xbrli:endDate>2024-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2024-07-012024-09-30_us-gaap_AccumulatedOtherComprehensiveIncomeMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001737995</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-07-01</xbrli:startDate>
        <xbrli:endDate>2024-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2024-07-012024-09-30_us-gaap_RetainedEarningsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001737995</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-07-01</xbrli:startDate>
        <xbrli:endDate>2024-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-01-012023-03-31_us-gaap_PreferredStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001737995</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-01-01</xbrli:startDate>
        <xbrli:endDate>2023-03-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-01-012023-03-31_us-gaap_CommonStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001737995</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-01-01</xbrli:startDate>
        <xbrli:endDate>2023-03-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-01-012023-03-31_custom_CommonStockSubscriptionReceivableMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001737995</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">STSS:CommonStockSubscriptionReceivableMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-01-01</xbrli:startDate>
        <xbrli:endDate>2023-03-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-01-012023-03-31_us-gaap_AdditionalPaidInCapitalMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001737995</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-01-01</xbrli:startDate>
        <xbrli:endDate>2023-03-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-01-012023-03-31_us-gaap_AccumulatedOtherComprehensiveIncomeMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001737995</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-01-01</xbrli:startDate>
        <xbrli:endDate>2023-03-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-01-012023-03-31_us-gaap_RetainedEarningsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001737995</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-01-01</xbrli:startDate>
        <xbrli:endDate>2023-03-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-01-012023-03-31">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001737995</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-01-01</xbrli:startDate>
        <xbrli:endDate>2023-03-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-04-012023-06-30_us-gaap_PreferredStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001737995</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-04-01</xbrli:startDate>
        <xbrli:endDate>2023-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-04-012023-06-30_us-gaap_CommonStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001737995</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-04-01</xbrli:startDate>
        <xbrli:endDate>2023-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-04-012023-06-30_custom_CommonStockSubscriptionReceivableMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001737995</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">STSS:CommonStockSubscriptionReceivableMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-04-01</xbrli:startDate>
        <xbrli:endDate>2023-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-04-012023-06-30_us-gaap_AdditionalPaidInCapitalMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001737995</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-04-01</xbrli:startDate>
        <xbrli:endDate>2023-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-04-012023-06-30_us-gaap_AccumulatedOtherComprehensiveIncomeMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001737995</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-04-01</xbrli:startDate>
        <xbrli:endDate>2023-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-04-012023-06-30_us-gaap_RetainedEarningsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001737995</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-04-01</xbrli:startDate>
        <xbrli:endDate>2023-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-04-012023-06-30">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001737995</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-04-01</xbrli:startDate>
        <xbrli:endDate>2023-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-07-012023-09-30_us-gaap_PreferredStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001737995</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-07-01</xbrli:startDate>
        <xbrli:endDate>2023-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-07-012023-09-30_us-gaap_CommonStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001737995</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-07-01</xbrli:startDate>
        <xbrli:endDate>2023-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-07-012023-09-30_custom_CommonStockSubscriptionReceivableMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001737995</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">STSS:CommonStockSubscriptionReceivableMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-07-01</xbrli:startDate>
        <xbrli:endDate>2023-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-07-012023-09-30_us-gaap_AdditionalPaidInCapitalMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001737995</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-07-01</xbrli:startDate>
        <xbrli:endDate>2023-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-07-012023-09-30_us-gaap_AccumulatedOtherComprehensiveIncomeMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001737995</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-07-01</xbrli:startDate>
        <xbrli:endDate>2023-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-07-012023-09-30_us-gaap_RetainedEarningsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001737995</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-07-01</xbrli:startDate>
        <xbrli:endDate>2023-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-12-31_custom_ReverseStockSplitMember_us-gaap_PreferredStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001737995</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">STSS:ReverseStockSplitMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-12-31_custom_ReverseStockSplitMember_us-gaap_CommonStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001737995</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">STSS:ReverseStockSplitMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-12-31_custom_ReverseStockSplitMember_custom_CommonStockSubscriptionReceivableMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001737995</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">STSS:ReverseStockSplitMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">STSS:CommonStockSubscriptionReceivableMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-12-31_custom_ReverseStockSplitMember_us-gaap_AdditionalPaidInCapitalMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001737995</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">STSS:ReverseStockSplitMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-12-31_custom_ReverseStockSplitMember_us-gaap_AccumulatedOtherComprehensiveIncomeMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001737995</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">STSS:ReverseStockSplitMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-12-31_custom_ReverseStockSplitMember_us-gaap_RetainedEarningsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001737995</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">STSS:ReverseStockSplitMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2024-09-30_us-gaap_PreferredStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001737995</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2024-09-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2024-09-30_us-gaap_CommonStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001737995</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2024-09-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2024-09-30_custom_CommonStockSubscriptionReceivableMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001737995</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">STSS:CommonStockSubscriptionReceivableMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2024-09-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2024-09-30_us-gaap_AdditionalPaidInCapitalMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001737995</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2024-09-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2024-09-30_us-gaap_AccumulatedOtherComprehensiveIncomeMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001737995</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2024-09-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2024-09-30_us-gaap_RetainedEarningsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001737995</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2024-09-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-09-30_us-gaap_PreferredStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001737995</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-09-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-09-30_us-gaap_CommonStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001737995</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-09-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-09-30_custom_CommonStockSubscriptionReceivableMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001737995</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">STSS:CommonStockSubscriptionReceivableMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-09-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-09-30_us-gaap_AdditionalPaidInCapitalMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001737995</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-09-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-09-30_us-gaap_AccumulatedOtherComprehensiveIncomeMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001737995</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-09-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-09-30_us-gaap_RetainedEarningsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001737995</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-09-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-09-30">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001737995</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-09-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-04-172022-04-19_us-gaap_IPOMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001737995</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:IPOMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-04-17</xbrli:startDate>
        <xbrli:endDate>2022-04-19</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2024-10-062024-10-16">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001737995</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-10-06</xbrli:startDate>
        <xbrli:endDate>2024-10-16</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-12-31_us-gaap_BuildingMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001737995</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:BuildingMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-12-31_us-gaap_MachineryAndEquipmentMember_srt_MinimumMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001737995</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:MachineryAndEquipmentMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-12-31_us-gaap_MachineryAndEquipmentMember_srt_MaximumMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001737995</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:MachineryAndEquipmentMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-12-31_custom_WebsiteMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001737995</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">STSS:WebsiteMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-01-012023-12-31_custom_PrefundendWarrantsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001737995</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">STSS:PrefundendWarrantsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-01-01</xbrli:startDate>
        <xbrli:endDate>2023-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-01-012023-12-31_custom_StockOptionsAndWarrantsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001737995</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">STSS:StockOptionsAndWarrantsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-01-01</xbrli:startDate>
        <xbrli:endDate>2023-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2024-09-30_us-gaap_BuildingMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001737995</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:BuildingMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2024-09-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2024-09-30_us-gaap_MachineryAndEquipmentMember_srt_MinimumMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001737995</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:MachineryAndEquipmentMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2024-09-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2024-09-30_us-gaap_MachineryAndEquipmentMember_srt_MaximumMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001737995</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:MachineryAndEquipmentMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2024-09-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2024-09-30_custom_WebsiteMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001737995</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">STSS:WebsiteMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2024-09-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2024-01-012024-09-30_custom_StockOptionAndWarrantsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001737995</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">STSS:StockOptionAndWarrantsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-01-01</xbrli:startDate>
        <xbrli:endDate>2024-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-12-31_us-gaap_LandMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001737995</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:LandMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-12-31_us-gaap_LandMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001737995</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:LandMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-12-31_us-gaap_BuildingMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001737995</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:BuildingMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-12-31_us-gaap_MachineryAndEquipmentMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001737995</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:MachineryAndEquipmentMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-12-31_us-gaap_MachineryAndEquipmentMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001737995</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:MachineryAndEquipmentMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-12-31_custom_ComputerSystemsAndWebsiteAndOtherWebsiteMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001737995</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">STSS:ComputerSystemsAndWebsiteAndOtherWebsiteMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-12-31_custom_ComputerSystemsAndWebsiteAndOtherWebsiteMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001737995</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">STSS:ComputerSystemsAndWebsiteAndOtherWebsiteMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-10-012023-12-31_us-gaap_MachineryAndEquipmentMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001737995</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:MachineryAndEquipmentMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-10-01</xbrli:startDate>
        <xbrli:endDate>2023-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-01-012022-12-31_us-gaap_StockOptionMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001737995</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:StockOptionMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-01-01</xbrli:startDate>
        <xbrli:endDate>2022-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-06-012020-06-30_custom_SharePurchaseAgreementMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001737995</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">STSS:SharePurchaseAgreementMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-06-01</xbrli:startDate>
        <xbrli:endDate>2020-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-06-012020-06-30_custom_SharePurchaseAgreementMember_us-gaap_CommonStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001737995</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">STSS:SharePurchaseAgreementMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-06-01</xbrli:startDate>
        <xbrli:endDate>2020-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-06-30_custom_SharePurchaseAgreementMember_us-gaap_CommonStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001737995</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">STSS:SharePurchaseAgreementMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-06-012020-06-30_custom_SharePurchaseAgreementMember_us-gaap_StockOptionMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001737995</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">STSS:SharePurchaseAgreementMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:StockOptionMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-06-01</xbrli:startDate>
        <xbrli:endDate>2020-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-06-012020-06-30_custom_SharePurchaseAgreementMember_custom_StockOptionOneMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001737995</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">STSS:SharePurchaseAgreementMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">STSS:StockOptionOneMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-06-01</xbrli:startDate>
        <xbrli:endDate>2020-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-07-052022-07-06_custom_SharePurchaseAgreementMember_custom_StockOptionOneMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001737995</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">STSS:SharePurchaseAgreementMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">STSS:StockOptionOneMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-07-05</xbrli:startDate>
        <xbrli:endDate>2022-07-06</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-01-012022-12-31_custom_SharePurchaseAgreementMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001737995</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">STSS:SharePurchaseAgreementMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-01-01</xbrli:startDate>
        <xbrli:endDate>2022-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-07-06_custom_SafegardMedicalIncMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001737995</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">STSS:SafegardMedicalIncMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-07-06</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-07-052022-07-06_custom_SafegardMedicalIncMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001737995</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">STSS:SafegardMedicalIncMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-07-05</xbrli:startDate>
        <xbrli:endDate>2022-07-06</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-12-31_us-gaap_FiniteLivedIntangibleAssetsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001737995</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:FiniteLivedIntangibleAssetsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-06-012020-06-30_custom_SafegardMedicalIncMember_custom_SharePurchaseAgreementMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001737995</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">STSS:SafegardMedicalIncMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">STSS:SharePurchaseAgreementMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-06-01</xbrli:startDate>
        <xbrli:endDate>2020-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-06-012020-06-30_custom_SafegardMedicalIncMember_custom_SharePurchaseAgreementMember_us-gaap_CommonStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001737995</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">STSS:SafegardMedicalIncMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">STSS:SharePurchaseAgreementMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-06-01</xbrli:startDate>
        <xbrli:endDate>2020-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-06-012020-06-30_custom_SafegardMedicalIncMember_custom_SharePurchaseAgreementMember_us-gaap_StockOptionMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001737995</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">STSS:SafegardMedicalIncMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">STSS:SharePurchaseAgreementMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:StockOptionMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-06-01</xbrli:startDate>
        <xbrli:endDate>2020-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-07-06_custom_SafegardMedicalIncMember_us-gaap_BuildingMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001737995</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">STSS:SafegardMedicalIncMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:BuildingMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-07-06</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-07-06_custom_SafegardMedicalIncMember_us-gaap_MachineryAndEquipmentMember_srt_MinimumMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001737995</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">STSS:SafegardMedicalIncMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:MachineryAndEquipmentMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-07-06</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-07-06_custom_SafegardMedicalIncMember_us-gaap_MachineryAndEquipmentMember_srt_MaximumMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001737995</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">STSS:SafegardMedicalIncMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:MachineryAndEquipmentMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-07-06</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2024-09-20_custom_SecuritiesPurchaseAgreementMember_custom_SeniorSecuredNoteMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001737995</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">STSS:SecuritiesPurchaseAgreementMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">STSS:SeniorSecuredNoteMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2024-09-20</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2024-09-202024-09-20_custom_SecuritiesPurchaseAgreementMember_custom_SeniorSecuredNoteMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001737995</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">STSS:SecuritiesPurchaseAgreementMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">STSS:SeniorSecuredNoteMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-09-20</xbrli:startDate>
        <xbrli:endDate>2024-09-20</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2024-09-202024-09-20_custom_SecuritiesPurchaseAgreementMember_custom_SeniorSecuredNoteMember_custom_PreReverseMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001737995</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">STSS:SecuritiesPurchaseAgreementMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">STSS:SeniorSecuredNoteMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">STSS:PreReverseMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-09-20</xbrli:startDate>
        <xbrli:endDate>2024-09-20</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-12-14_custom_NotePurchaseAgreementMember_custom_UnrelatedThirdPartyPurchasersMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001737995</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">STSS:NotePurchaseAgreementMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">STSS:UnrelatedThirdPartyPurchasersMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-12-14</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-12-132021-12-14_custom_NotePurchaseAgreementMember_custom_UnrelatedThirdPartyPurchasersMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001737995</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">STSS:NotePurchaseAgreementMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">STSS:UnrelatedThirdPartyPurchasersMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-12-13</xbrli:startDate>
        <xbrli:endDate>2021-12-14</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-12-14_custom_NotePurchaseAgreementMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001737995</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">STSS:NotePurchaseAgreementMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-12-14</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-12-31_custom_NotePurchaseAgreementMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001737995</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">STSS:NotePurchaseAgreementMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-01-012022-12-31_custom_NotePurchaseAgreementMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001737995</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">STSS:NotePurchaseAgreementMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-01-01</xbrli:startDate>
        <xbrli:endDate>2022-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-12-31_custom_NotePurchaseAgreementMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001737995</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">STSS:NotePurchaseAgreementMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-04-19_custom_NotePurchaseAgreementMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001737995</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">STSS:NotePurchaseAgreementMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-04-19</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-04-172022-04-19_custom_NotePurchaseAgreementMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001737995</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">STSS:NotePurchaseAgreementMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-04-17</xbrli:startDate>
        <xbrli:endDate>2022-04-19</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-01-012022-12-31_custom_NotePurchaseAgreementMember_us-gaap_NoteWarrantMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001737995</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">STSS:NotePurchaseAgreementMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:NoteWarrantMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-01-01</xbrli:startDate>
        <xbrli:endDate>2022-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-09-292023-09-29_custom_NotePurchaseAgreementMember_us-gaap_NoteWarrantMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001737995</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">STSS:NotePurchaseAgreementMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:NoteWarrantMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-09-29</xbrli:startDate>
        <xbrli:endDate>2023-09-29</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2017-12-11">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001737995</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2017-12-11</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2019-04-18">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001737995</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2019-04-18</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-03-192022-03-22">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001737995</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-03-19</xbrli:startDate>
        <xbrli:endDate>2022-03-22</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-03-21">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001737995</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-03-21</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-09-292023-09-29">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001737995</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-09-29</xbrli:startDate>
        <xbrli:endDate>2023-09-29</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-09-292023-09-29_custom_ShelfOfferingMember_custom_SecuritiesPurchaseAgreementMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001737995</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">STSS:ShelfOfferingMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">STSS:SecuritiesPurchaseAgreementMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-09-29</xbrli:startDate>
        <xbrli:endDate>2023-09-29</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-09-29_custom_ShelfOfferingMember_custom_SecuritiesPurchaseAgreementMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001737995</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">STSS:ShelfOfferingMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">STSS:SecuritiesPurchaseAgreementMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-09-29</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-09-29_custom_ShelfOfferingMember_custom_SecuritiesPurchaseAgreementMember_us-gaap_WarrantMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001737995</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">STSS:ShelfOfferingMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">STSS:SecuritiesPurchaseAgreementMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:WarrantMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-09-29</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-09-292023-09-29_us-gaap_PrivatePlacementMember_custom_SecuritiesPurchaseAgreementMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001737995</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:PrivatePlacementMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">STSS:SecuritiesPurchaseAgreementMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-09-29</xbrli:startDate>
        <xbrli:endDate>2023-09-29</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-09-292023-09-29_us-gaap_PrivatePlacementMember_custom_SecuritiesPurchaseAgreementMember_custom_PIPEPreFundedWarrantsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001737995</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:PrivatePlacementMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">STSS:SecuritiesPurchaseAgreementMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">STSS:PIPEPreFundedWarrantsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-09-29</xbrli:startDate>
        <xbrli:endDate>2023-09-29</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-09-292023-09-29_custom_NonTradingWarrantsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001737995</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">STSS:NonTradingWarrantsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-09-29</xbrli:startDate>
        <xbrli:endDate>2023-09-29</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-02-03_custom_PurchaseAgreementMember_custom_SecuritiesPurchaseAgreementMember_custom_PIPEPreFundedWarrantsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001737995</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">STSS:PurchaseAgreementMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">STSS:SecuritiesPurchaseAgreementMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">STSS:PIPEPreFundedWarrantsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-02-03</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-09-29_custom_SecuritiesPurchaseAgreementMember_us-gaap_PrivatePlacementMember_custom_PIPEPreFundedWarrantsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001737995</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">STSS:SecuritiesPurchaseAgreementMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:PrivatePlacementMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">STSS:PIPEPreFundedWarrantsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-09-29</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-09-29_us-gaap_PrivatePlacementMember_custom_SecuritiesPurchaseAgreementMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001737995</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:PrivatePlacementMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">STSS:SecuritiesPurchaseAgreementMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-09-29</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-12-31_us-gaap_PrivatePlacementMember_custom_SecuritiesPurchaseAgreementMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001737995</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:PrivatePlacementMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">STSS:SecuritiesPurchaseAgreementMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-02-012023-02-03_custom_PurchaseAgreementMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001737995</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">STSS:PurchaseAgreementMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-02-01</xbrli:startDate>
        <xbrli:endDate>2023-02-03</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-02-03_custom_PurchaseAgreementMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001737995</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">STSS:PurchaseAgreementMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-02-03</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-09-29_custom_PurchaseAgreementMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001737995</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">STSS:PurchaseAgreementMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-09-29</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-04-112022-04-13_us-gaap_WarrantMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001737995</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:WarrantMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-04-11</xbrli:startDate>
        <xbrli:endDate>2022-04-13</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-04-13_us-gaap_WarrantMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001737995</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:WarrantMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-04-13</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-04-19_us-gaap_WarrantMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001737995</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:WarrantMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-04-19</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-04-122022-04-14_us-gaap_IPOMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001737995</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:IPOMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-04-12</xbrli:startDate>
        <xbrli:endDate>2022-04-14</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-04-14">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001737995</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-04-14</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-04-122022-04-14">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001737995</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-04-12</xbrli:startDate>
        <xbrli:endDate>2022-04-14</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-01-012023-12-31_custom_NonTradingWarrantsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001737995</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">STSS:NonTradingWarrantsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-01-01</xbrli:startDate>
        <xbrli:endDate>2023-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-12-31_us-gaap_NoteWarrantMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001737995</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:NoteWarrantMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-09-012023-09-30_custom_NonTradingWarrantsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001737995</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">STSS:NonTradingWarrantsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-09-01</xbrli:startDate>
        <xbrli:endDate>2023-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-09-29_custom_NonTradingWarrantsMember_custom_PIPEWarrantMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001737995</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">STSS:NonTradingWarrantsMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">STSS:PIPEWarrantMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-09-29</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-12-31_custom_NonTradingWarrantsMember_custom_PIPEWarrantMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001737995</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">STSS:NonTradingWarrantsMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">STSS:PIPEWarrantMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-01-012023-12-31_custom_NonTradingWarrantsMember_custom_PIPEWarrantMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001737995</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">STSS:NonTradingWarrantsMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">STSS:PIPEWarrantMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-01-01</xbrli:startDate>
        <xbrli:endDate>2023-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-02-012023-02-28_custom_NonTradingWarrantsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001737995</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">STSS:NonTradingWarrantsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-02-01</xbrli:startDate>
        <xbrli:endDate>2023-02-28</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-02-28_custom_NonTradingWarrantsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001737995</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">STSS:NonTradingWarrantsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-02-28</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-12-31_custom_NonTradingWarrantsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001737995</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">STSS:NonTradingWarrantsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-04-012022-04-30_custom_TradingWarrantsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001737995</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">STSS:TradingWarrantsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-04-01</xbrli:startDate>
        <xbrli:endDate>2022-04-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-04-012022-04-30_us-gaap_OverAllotmentOptionMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001737995</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:OverAllotmentOptionMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-04-01</xbrli:startDate>
        <xbrli:endDate>2022-04-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-12-31_custom_TradingWarrantsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001737995</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">STSS:TradingWarrantsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-12-31_custom_TradingWarrantsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001737995</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">STSS:TradingWarrantsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-01-012023-12-31_custom_TradingWarrantsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001737995</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">STSS:TradingWarrantsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-01-01</xbrli:startDate>
        <xbrli:endDate>2023-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-01-012022-12-31_custom_TradingWarrantsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001737995</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">STSS:TradingWarrantsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-01-01</xbrli:startDate>
        <xbrli:endDate>2022-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-04-192022-04-19_us-gaap_NoteWarrantMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001737995</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:NoteWarrantMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-04-19</xbrli:startDate>
        <xbrli:endDate>2022-04-19</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-04-19_us-gaap_NoteWarrantMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001737995</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:NoteWarrantMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-04-19</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-01-012022-12-31_custom_NoteWarrantsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001737995</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">STSS:NoteWarrantsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-01-01</xbrli:startDate>
        <xbrli:endDate>2022-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-01-012023-12-31_custom_NoteWarrantsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001737995</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">STSS:NoteWarrantsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-01-01</xbrli:startDate>
        <xbrli:endDate>2023-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-12-31_us-gaap_IPOMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001737995</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:IPOMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-01-012023-12-31_us-gaap_IPOMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001737995</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:IPOMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-01-01</xbrli:startDate>
        <xbrli:endDate>2023-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-10-09_us-gaap_IPOMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001737995</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:IPOMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-10-09</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-03-22">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001737995</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-03-22</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2024-07-31">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001737995</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2024-07-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2024-09-232024-09-23_custom_SecuritiesPurchaseAgreementMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001737995</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">STSS:SecuritiesPurchaseAgreementMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-09-23</xbrli:startDate>
        <xbrli:endDate>2024-09-23</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2024-09-232024-09-23_custom_SecuritiesPurchaseAgreementMember_custom_PreReverseMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001737995</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">STSS:SecuritiesPurchaseAgreementMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">STSS:PreReverseMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-09-23</xbrli:startDate>
        <xbrli:endDate>2024-09-23</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2024-05-312024-05-31_custom_SubscriptionAgreementsMember_custom_InvestorsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001737995</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">STSS:SubscriptionAgreementsMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">STSS:InvestorsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-05-31</xbrli:startDate>
        <xbrli:endDate>2024-05-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2024-06-132024-06-13_custom_SubscriptionAgreementsMember_custom_InvestorsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001737995</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">STSS:SubscriptionAgreementsMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">STSS:InvestorsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-06-13</xbrli:startDate>
        <xbrli:endDate>2024-06-13</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2024-05-312024-05-31_custom_SubscriptionAgreementsMember_custom_InvestorsMember_custom_PreReverseMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001737995</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">STSS:SubscriptionAgreementsMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">STSS:InvestorsMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">STSS:PreReverseMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-05-31</xbrli:startDate>
        <xbrli:endDate>2024-05-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2024-06-132024-06-13_custom_SubscriptionAgreementsMember_custom_InvestorsMember_custom_PreReverseMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001737995</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">STSS:SubscriptionAgreementsMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">STSS:InvestorsMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">STSS:PreReverseMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-06-13</xbrli:startDate>
        <xbrli:endDate>2024-06-13</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2024-05-31_custom_SubscriptionAgreementsMember_custom_InvestorsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001737995</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">STSS:SubscriptionAgreementsMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">STSS:InvestorsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2024-05-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2024-06-13_custom_SubscriptionAgreementsMember_custom_InvestorsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001737995</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">STSS:SubscriptionAgreementsMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">STSS:InvestorsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2024-06-13</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2024-05-31_custom_SubscriptionAgreementsMember_custom_InvestorsMember_custom_PreReverseMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001737995</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">STSS:SubscriptionAgreementsMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">STSS:InvestorsMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">STSS:PreReverseMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2024-05-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2024-06-13_custom_SubscriptionAgreementsMember_custom_InvestorsMember_custom_PreReverseMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001737995</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">STSS:SubscriptionAgreementsMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">STSS:InvestorsMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">STSS:PreReverseMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2024-06-13</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2024-05-30_custom_InducementAgreementMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001737995</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">STSS:InducementAgreementMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2024-05-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2024-05-30_custom_InducementAgreementMember_custom_PreReverseMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001737995</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">STSS:InducementAgreementMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">STSS:PreReverseMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2024-05-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2024-05-29_custom_InducementAgreementMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001737995</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">STSS:InducementAgreementMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2024-05-29</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2024-05-29_custom_InducementAgreementMember_custom_PreReverseMember_srt_MaximumMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001737995</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">STSS:InducementAgreementMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">STSS:PreReverseMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2024-05-29</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2024-05-29_custom_InducementAgreementMember_custom_PreReverseMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001737995</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">STSS:InducementAgreementMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">STSS:PreReverseMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2024-05-29</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2024-05-29_custom_InducementAgreementMember_custom_PreReverseMember_srt_MinimumMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001737995</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">STSS:InducementAgreementMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">STSS:PreReverseMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2024-05-29</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2024-05-30_custom_InducementWarrantsMember_custom_WarrantHoldersMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001737995</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">STSS:InducementWarrantsMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">STSS:WarrantHoldersMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2024-05-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2024-05-30_custom_InducementWarrantsMember_custom_WarrantHoldersMember_custom_PreReverseMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001737995</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">STSS:InducementWarrantsMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">STSS:WarrantHoldersMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">STSS:PreReverseMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2024-05-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2024-05-302024-05-30_custom_InducementWarrantsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001737995</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">STSS:InducementWarrantsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-05-30</xbrli:startDate>
        <xbrli:endDate>2024-05-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2024-05-302024-05-30_custom_InducementAgreementMember_custom_WarrantHoldersMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001737995</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">STSS:InducementAgreementMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">STSS:WarrantHoldersMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-05-30</xbrli:startDate>
        <xbrli:endDate>2024-05-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2024-05-30_custom_InducementAgreementMember_custom_WarrantHoldersMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001737995</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">STSS:InducementAgreementMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">STSS:WarrantHoldersMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2024-05-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2024-05-30_custom_InducementAgreementMember_custom_WarrantHoldersMember_custom_PreReverseMember_srt_MaximumMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001737995</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">STSS:InducementAgreementMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">STSS:WarrantHoldersMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">STSS:PreReverseMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2024-05-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2024-05-30_custom_InducementAgreementMember_custom_WarrantHoldersMember_custom_PreReverseMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001737995</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">STSS:InducementAgreementMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">STSS:WarrantHoldersMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">STSS:PreReverseMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2024-05-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2024-05-30_custom_InducementAgreementMember_custom_WarrantHoldersMember_custom_PreReverseMember_srt_MinimumMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001737995</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">STSS:InducementAgreementMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">STSS:WarrantHoldersMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">STSS:PreReverseMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2024-05-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-09-292023-09-29_custom_ShelfOfferingMember_custom_SecuritiesPurchaseAgreementMember_custom_ReverseStockSplitMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001737995</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">STSS:ShelfOfferingMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">STSS:SecuritiesPurchaseAgreementMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">STSS:ReverseStockSplitMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-09-29</xbrli:startDate>
        <xbrli:endDate>2023-09-29</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-09-292023-09-29_custom_ShelfOfferingMember_custom_SecuritiesPurchaseAgreementMember_custom_PreReverseMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001737995</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">STSS:ShelfOfferingMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">STSS:SecuritiesPurchaseAgreementMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">STSS:PreReverseMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-09-29</xbrli:startDate>
        <xbrli:endDate>2023-09-29</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-09-29_custom_ShelfOfferingMember_custom_SecuritiesPurchaseAgreementMember_custom_ReverseStockSplitMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001737995</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">STSS:ShelfOfferingMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">STSS:SecuritiesPurchaseAgreementMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">STSS:ReverseStockSplitMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-09-29</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2024-05-30_custom_ShelfOfferingMember_custom_SecuritiesPurchaseAgreementMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001737995</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">STSS:ShelfOfferingMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">STSS:SecuritiesPurchaseAgreementMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2024-05-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-09-29_custom_ShelfOfferingMember_custom_SecuritiesPurchaseAgreementMember_custom_PreFundedWarrantsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001737995</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">STSS:ShelfOfferingMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">STSS:SecuritiesPurchaseAgreementMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">STSS:PreFundedWarrantsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-09-29</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-09-29_custom_ShelfOfferingMember_custom_SecuritiesPurchaseAgreementMember_custom_PreFundedWarrantsMember_custom_PreReverseMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001737995</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">STSS:ShelfOfferingMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">STSS:SecuritiesPurchaseAgreementMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">STSS:PreFundedWarrantsMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">STSS:PreReverseMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-09-29</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-09-292023-09-29_us-gaap_PrivatePlacementMember_custom_SecuritiesPurchaseAgreementMember_custom_PIPEPreFundedWarrantsMember_custom_ReverseStockSplitMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001737995</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:PrivatePlacementMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">STSS:SecuritiesPurchaseAgreementMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">STSS:PIPEPreFundedWarrantsMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">STSS:ReverseStockSplitMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-09-29</xbrli:startDate>
        <xbrli:endDate>2023-09-29</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-09-292023-09-29_us-gaap_PrivatePlacementMember_custom_SecuritiesPurchaseAgreementMember_custom_PIPEPreFundedWarrantsMember_custom_PreReverseMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001737995</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:PrivatePlacementMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">STSS:SecuritiesPurchaseAgreementMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">STSS:PIPEPreFundedWarrantsMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">STSS:PreReverseMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-09-29</xbrli:startDate>
        <xbrli:endDate>2023-09-29</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-09-292023-09-29_custom_NonTradingWarrantsMember_custom_ReverseStockSplitMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001737995</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">STSS:NonTradingWarrantsMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">STSS:ReverseStockSplitMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-09-29</xbrli:startDate>
        <xbrli:endDate>2023-09-29</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-09-292023-09-29_custom_NonTradingWarrantsMember_custom_PreReverseMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001737995</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">STSS:NonTradingWarrantsMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">STSS:PreReverseMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-09-29</xbrli:startDate>
        <xbrli:endDate>2023-09-29</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-02-03_custom_SecuritiesPurchaseAgreementMember_custom_PIPEPreFundedWarrantsMember_srt_MaximumMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001737995</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">STSS:SecuritiesPurchaseAgreementMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">STSS:PIPEPreFundedWarrantsMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-02-03</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-02-03_custom_SecuritiesPurchaseAgreementMember_custom_PIPEPreFundedWarrantsMember_custom_PreReverseMember_srt_MaximumMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001737995</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">STSS:SecuritiesPurchaseAgreementMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">STSS:PIPEPreFundedWarrantsMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">STSS:PreReverseMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-02-03</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-02-03_custom_SecuritiesPurchaseAgreementMember_custom_PIPEPreFundedWarrantsMember_srt_MinimumMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001737995</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">STSS:SecuritiesPurchaseAgreementMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">STSS:PIPEPreFundedWarrantsMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-02-03</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-02-03_custom_SecuritiesPurchaseAgreementMember_custom_PIPEPreFundedWarrantsMember_custom_PreReverseMember_srt_MinimumMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001737995</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">STSS:SecuritiesPurchaseAgreementMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">STSS:PIPEPreFundedWarrantsMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">STSS:PreReverseMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-02-03</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-09-29_custom_SecuritiesPurchaseAgreementMember_custom_PIPEPreFundedWarrantsMember_us-gaap_PrivatePlacementMember_custom_ReverseStockSplitMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001737995</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">STSS:SecuritiesPurchaseAgreementMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">STSS:PIPEPreFundedWarrantsMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:PrivatePlacementMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">STSS:ReverseStockSplitMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-09-29</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2024-05-30_custom_SecuritiesPurchaseAgreementMember_custom_PIPEPreFundedWarrantsMember_us-gaap_PrivatePlacementMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001737995</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">STSS:SecuritiesPurchaseAgreementMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">STSS:PIPEPreFundedWarrantsMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:PrivatePlacementMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2024-05-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-02-012023-02-03_custom_SecuritiesPurchaseAgreementMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001737995</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">STSS:SecuritiesPurchaseAgreementMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-02-01</xbrli:startDate>
        <xbrli:endDate>2023-02-03</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-02-012023-02-03_custom_SecuritiesPurchaseAgreementMember_custom_PreReverseMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001737995</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">STSS:SecuritiesPurchaseAgreementMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">STSS:PreReverseMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-02-01</xbrli:startDate>
        <xbrli:endDate>2023-02-03</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-02-03_custom_SecuritiesPurchaseAgreementMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001737995</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">STSS:SecuritiesPurchaseAgreementMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-02-03</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-02-03_custom_SecuritiesPurchaseAgreementMember_custom_PreReverseMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001737995</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">STSS:SecuritiesPurchaseAgreementMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">STSS:PreReverseMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-02-03</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-09-29_custom_SecuritiesPurchaseAgreementMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001737995</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">STSS:SecuritiesPurchaseAgreementMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-09-29</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2024-05-30_custom_SecuritiesPurchaseAgreementMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001737995</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">STSS:SecuritiesPurchaseAgreementMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2024-05-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-04-112022-04-13_us-gaap_IPOMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001737995</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:IPOMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-04-11</xbrli:startDate>
        <xbrli:endDate>2022-04-13</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-04-112022-04-13_us-gaap_IPOMember_custom_PreReverseMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001737995</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:IPOMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">STSS:PreReverseMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-04-11</xbrli:startDate>
        <xbrli:endDate>2022-04-13</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-04-13_us-gaap_IPOMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001737995</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:IPOMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-04-13</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-04-13_us-gaap_IPOMember_custom_PreReverseMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001737995</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:IPOMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">STSS:PreReverseMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-04-13</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-02-03_us-gaap_IPOMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001737995</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:IPOMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-02-03</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-09-29_us-gaap_IPOMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001737995</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:IPOMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-09-29</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2024-05-30_us-gaap_IPOMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001737995</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:IPOMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2024-05-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-04-172022-04-19_us-gaap_WarrantMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001737995</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:WarrantMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-04-17</xbrli:startDate>
        <xbrli:endDate>2022-04-19</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-04-172022-04-19_us-gaap_WarrantMember_custom_PreReverseMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001737995</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:WarrantMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">STSS:PreReverseMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-04-17</xbrli:startDate>
        <xbrli:endDate>2022-04-19</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2024-09-30_custom_WarrantHoldersMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001737995</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">STSS:WarrantHoldersMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2024-09-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2024-09-30_custom_WarrantHoldersMember_custom_PreReverseMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001737995</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">STSS:WarrantHoldersMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">STSS:PreReverseMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2024-09-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-02-28_custom_WarrantHoldersMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001737995</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">STSS:WarrantHoldersMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-02-28</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-09-30_custom_WarrantHoldersMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001737995</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">STSS:WarrantHoldersMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-09-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-02-28_custom_WarrantHoldersMember_custom_PreReverseMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001737995</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">STSS:WarrantHoldersMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">STSS:PreReverseMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-02-28</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-09-30_custom_WarrantHoldersMember_custom_PreReverseMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001737995</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">STSS:WarrantHoldersMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">STSS:PreReverseMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-09-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-02-28_custom_WarrantHolderMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001737995</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">STSS:WarrantHolderMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-02-28</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-09-29_custom_WarrantHolderMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001737995</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">STSS:WarrantHolderMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-09-29</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2024-07-012024-09-30_custom_WarrantHoldersMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001737995</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">STSS:WarrantHoldersMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-07-01</xbrli:startDate>
        <xbrli:endDate>2024-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2024-01-012024-09-30_custom_WarrantHoldersMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001737995</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">STSS:WarrantHoldersMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-01-01</xbrli:startDate>
        <xbrli:endDate>2024-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2024-09-30_us-gaap_WarrantMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001737995</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:WarrantMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2024-09-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2024-04-012024-06-30_custom_InducementWarrantsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001737995</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">STSS:InducementWarrantsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-04-01</xbrli:startDate>
        <xbrli:endDate>2024-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2024-04-012024-06-30_custom_InducementWarrantsMember_custom_PreReverseMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001737995</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">STSS:InducementWarrantsMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">STSS:PreReverseMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-04-01</xbrli:startDate>
        <xbrli:endDate>2024-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2024-01-012024-06-30_custom_InducementWarrantsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001737995</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">STSS:InducementWarrantsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-01-01</xbrli:startDate>
        <xbrli:endDate>2024-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-04-30_us-gaap_WarrantMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001737995</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:WarrantMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-04-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-04-30_us-gaap_WarrantMember_custom_PreReverseMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001737995</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:WarrantMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">STSS:PreReverseMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-04-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2024-07-012024-09-30_us-gaap_WarrantMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001737995</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:WarrantMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-07-01</xbrli:startDate>
        <xbrli:endDate>2024-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2024-01-012024-09-30_us-gaap_WarrantMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001737995</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:WarrantMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-01-01</xbrli:startDate>
        <xbrli:endDate>2024-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2024-01-012024-09-30_custom_PreReverseMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001737995</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">STSS:PreReverseMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-01-01</xbrli:startDate>
        <xbrli:endDate>2024-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-07-012023-09-30_us-gaap_WarrantMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001737995</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:WarrantMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-07-01</xbrli:startDate>
        <xbrli:endDate>2023-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-07-012023-09-30_custom_PreReverseMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001737995</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">STSS:PreReverseMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-07-01</xbrli:startDate>
        <xbrli:endDate>2023-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-01-012023-09-30_us-gaap_WarrantMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001737995</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:WarrantMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-01-01</xbrli:startDate>
        <xbrli:endDate>2023-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-01-012023-09-30_custom_PreReverseMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001737995</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">STSS:PreReverseMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-01-01</xbrli:startDate>
        <xbrli:endDate>2023-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-09-012023-09-30_custom_NonTradingWarrantsMember_custom_ReverseStockSplitMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001737995</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">STSS:NonTradingWarrantsMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">STSS:ReverseStockSplitMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-09-01</xbrli:startDate>
        <xbrli:endDate>2023-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-09-012023-09-30_custom_NonTradingWarrantsMember_custom_PreReverseMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001737995</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">STSS:NonTradingWarrantsMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">STSS:PreReverseMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-09-01</xbrli:startDate>
        <xbrli:endDate>2023-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2024-07-012024-09-30_custom_NonTradingWarrantsMember_custom_PIPEWarrantMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001737995</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">STSS:NonTradingWarrantsMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">STSS:PIPEWarrantMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-07-01</xbrli:startDate>
        <xbrli:endDate>2024-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2024-01-012024-09-30_custom_NonTradingWarrantsMember_custom_PIPEWarrantMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001737995</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">STSS:NonTradingWarrantsMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">STSS:PIPEWarrantMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-01-01</xbrli:startDate>
        <xbrli:endDate>2024-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-02-012023-02-28_custom_NonTradingWarrantsMember_custom_ReverseStockSplitMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001737995</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">STSS:NonTradingWarrantsMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">STSS:ReverseStockSplitMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-02-01</xbrli:startDate>
        <xbrli:endDate>2023-02-28</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-02-012023-02-28_custom_NonTradingWarrantsMember_custom_PreReverseMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001737995</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">STSS:NonTradingWarrantsMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">STSS:PreReverseMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-02-01</xbrli:startDate>
        <xbrli:endDate>2023-02-28</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2024-07-012024-09-30_custom_NonTradingWarrantsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001737995</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">STSS:NonTradingWarrantsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-07-01</xbrli:startDate>
        <xbrli:endDate>2024-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2024-01-012024-09-30_custom_NonTradingWarrantsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001737995</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">STSS:NonTradingWarrantsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-01-01</xbrli:startDate>
        <xbrli:endDate>2024-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-07-012023-09-30_custom_NonTradingWarrantsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001737995</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">STSS:NonTradingWarrantsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-07-01</xbrli:startDate>
        <xbrli:endDate>2023-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-01-012023-09-30_custom_NonTradingWarrantsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001737995</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">STSS:NonTradingWarrantsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-01-01</xbrli:startDate>
        <xbrli:endDate>2023-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-04-172022-04-19_custom_TradingWarrantsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001737995</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">STSS:TradingWarrantsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-04-17</xbrli:startDate>
        <xbrli:endDate>2022-04-19</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-04-172022-04-19_custom_TradingWarrantsMember_custom_PreReverseMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001737995</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">STSS:TradingWarrantsMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">STSS:PreReverseMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-04-17</xbrli:startDate>
        <xbrli:endDate>2022-04-19</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-04-172022-04-19_custom_OverAllotmentWarrantsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001737995</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">STSS:OverAllotmentWarrantsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-04-17</xbrli:startDate>
        <xbrli:endDate>2022-04-19</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-04-172022-04-19_custom_OverAllotmentWarrantsMember_custom_PreReverseMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001737995</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">STSS:OverAllotmentWarrantsMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">STSS:PreReverseMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-04-17</xbrli:startDate>
        <xbrli:endDate>2022-04-19</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2024-07-012024-09-30_custom_TradingWarrantsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001737995</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">STSS:TradingWarrantsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-07-01</xbrli:startDate>
        <xbrli:endDate>2024-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2024-01-012024-09-30_custom_TradingWarrantsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001737995</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">STSS:TradingWarrantsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-01-01</xbrli:startDate>
        <xbrli:endDate>2024-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-07-012023-09-30_custom_TradingWarrantsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001737995</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">STSS:TradingWarrantsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-07-01</xbrli:startDate>
        <xbrli:endDate>2023-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-01-012023-09-30_custom_TradingWarrantsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001737995</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">STSS:TradingWarrantsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-01-01</xbrli:startDate>
        <xbrli:endDate>2023-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-04-172022-04-19_custom_NoteWarrantsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001737995</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">STSS:NoteWarrantsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-04-17</xbrli:startDate>
        <xbrli:endDate>2022-04-19</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-04-172022-04-19_custom_NoteWarrantsMember_custom_PreReverseMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001737995</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">STSS:NoteWarrantsMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">STSS:PreReverseMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-04-17</xbrli:startDate>
        <xbrli:endDate>2022-04-19</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2024-07-012024-09-30_custom_NoteWarrantsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001737995</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">STSS:NoteWarrantsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-07-01</xbrli:startDate>
        <xbrli:endDate>2024-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2024-01-012024-09-30_custom_NoteWarrantsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001737995</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">STSS:NoteWarrantsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-01-01</xbrli:startDate>
        <xbrli:endDate>2024-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-07-012023-09-30_custom_NoteWarrantsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001737995</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">STSS:NoteWarrantsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-07-01</xbrli:startDate>
        <xbrli:endDate>2023-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-01-012023-09-30_custom_NoteWarrantsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001737995</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">STSS:NoteWarrantsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-01-01</xbrli:startDate>
        <xbrli:endDate>2023-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-04-19_us-gaap_IPOMember_custom_PreReverseMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001737995</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:IPOMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">STSS:PreReverseMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-04-19</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-04-19_us-gaap_IPOMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001737995</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:IPOMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-04-19</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-12-31_us-gaap_SeriesAPreferredStockMember_srt_DirectorMember_custom_AlanBlackmanMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001737995</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesAPreferredStockMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">srt:DirectorMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">STSS:AlanBlackmanMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-12-31_us-gaap_SeriesAPreferredStockMember_srt_DirectorMember_us-gaap_IPOMember_custom_AlanBlackmanMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001737995</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesAPreferredStockMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">srt:DirectorMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:IPOMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">STSS:AlanBlackmanMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2018-02-28_us-gaap_SeriesAPreferredStockMember_us-gaap_IPOMember_custom_AlanBlackmanMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001737995</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesAPreferredStockMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:IPOMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">STSS:AlanBlackmanMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2018-02-28</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2024-01-012024-09-30_us-gaap_SeriesAPreferredStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001737995</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesAPreferredStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-01-01</xbrli:startDate>
        <xbrli:endDate>2024-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-01-012023-12-31_us-gaap_WarrantMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001737995</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:WarrantMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-01-01</xbrli:startDate>
        <xbrli:endDate>2023-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-01-012023-12-31_srt_MinimumMember_us-gaap_WarrantMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001737995</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:WarrantMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-01-01</xbrli:startDate>
        <xbrli:endDate>2023-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-01-012023-12-31_srt_MaximumMember_us-gaap_WarrantMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001737995</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:WarrantMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-01-01</xbrli:startDate>
        <xbrli:endDate>2023-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2024-09-30_us-gaap_WarrantMember_us-gaap_MeasurementInputExpectedTermMember_srt_MinimumMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001737995</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:WarrantMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputExpectedTermMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2024-09-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2024-09-30_us-gaap_WarrantMember_us-gaap_MeasurementInputExpectedTermMember_srt_MaximumMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001737995</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:WarrantMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputExpectedTermMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2024-09-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-09-30_us-gaap_WarrantMember_us-gaap_MeasurementInputExpectedTermMember_srt_MinimumMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001737995</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:WarrantMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputExpectedTermMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-09-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-09-30_us-gaap_WarrantMember_us-gaap_MeasurementInputExpectedTermMember_srt_MaximumMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001737995</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:WarrantMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputExpectedTermMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-09-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2024-09-30_us-gaap_WarrantMember_us-gaap_MeasurementInputOptionVolatilityMember_srt_MinimumMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001737995</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:WarrantMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputOptionVolatilityMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2024-09-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2024-09-30_us-gaap_WarrantMember_us-gaap_MeasurementInputOptionVolatilityMember_srt_MaximumMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001737995</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:WarrantMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputOptionVolatilityMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2024-09-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-09-30_us-gaap_WarrantMember_us-gaap_MeasurementInputOptionVolatilityMember_srt_MinimumMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001737995</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:WarrantMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputOptionVolatilityMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-09-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-09-30_us-gaap_WarrantMember_us-gaap_MeasurementInputOptionVolatilityMember_srt_MaximumMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001737995</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:WarrantMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputOptionVolatilityMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-09-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2024-09-30_us-gaap_WarrantMember_us-gaap_MeasurementInputRiskFreeInterestRateMember_srt_MinimumMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001737995</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:WarrantMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputRiskFreeInterestRateMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2024-09-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2024-09-30_us-gaap_WarrantMember_us-gaap_MeasurementInputRiskFreeInterestRateMember_srt_MaximumMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001737995</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:WarrantMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputRiskFreeInterestRateMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2024-09-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-09-30_us-gaap_WarrantMember_us-gaap_MeasurementInputRiskFreeInterestRateMember_srt_MinimumMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001737995</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:WarrantMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputRiskFreeInterestRateMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-09-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-09-30_us-gaap_WarrantMember_us-gaap_MeasurementInputRiskFreeInterestRateMember_srt_MaximumMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001737995</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:WarrantMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputRiskFreeInterestRateMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-09-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2024-09-30_us-gaap_WarrantMember_us-gaap_MeasurementInputExpectedDividendRateMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001737995</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:WarrantMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputExpectedDividendRateMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2024-09-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-09-30_us-gaap_WarrantMember_us-gaap_MeasurementInputExpectedDividendRateMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001737995</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:WarrantMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputExpectedDividendRateMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-09-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-12-31_custom_TradingAndOverallotmentWarrantsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001737995</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">STSS:TradingAndOverallotmentWarrantsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-12-31_custom_TradingAndOverallotmentWarrantsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001737995</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">STSS:TradingAndOverallotmentWarrantsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-12-31_custom_NoteWarrantsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001737995</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">STSS:NoteWarrantsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-12-31_custom_NoteWarrantsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001737995</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">STSS:NoteWarrantsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-12-31_custom_OfferingWarrantsFebruaryTwentyTwentyThreeMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001737995</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">STSS:OfferingWarrantsFebruaryTwentyTwentyThreeMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-12-31_custom_OfferingWarrantsFebruaryTwentyTwentyThreeMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001737995</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">STSS:OfferingWarrantsFebruaryTwentyTwentyThreeMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-12-31_custom_OfferingWarrantsSeptemberTwentyTwentyThreeMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001737995</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">STSS:OfferingWarrantsSeptemberTwentyTwentyThreeMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-12-31_custom_OfferingWarrantsSeptemberTwentyTwentyThreeMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001737995</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">STSS:OfferingWarrantsSeptemberTwentyTwentyThreeMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2024-09-30_custom_TradingAndOverallotmentWarrantsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001737995</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">STSS:TradingAndOverallotmentWarrantsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2024-09-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-12-31_custom_TradingAndOverallotmentWarrantsMember10886187">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001737995</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">STSS:TradingAndOverallotmentWarrantsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2024-09-30_custom_NoteWarrantsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001737995</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">STSS:NoteWarrantsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2024-09-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-12-31_custom_NoteWarrantsMember10886187">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001737995</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">STSS:NoteWarrantsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2024-09-30_custom_OfferingWarrantsFebruaryTwoThousandTwentyThreeMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001737995</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">STSS:OfferingWarrantsFebruaryTwoThousandTwentyThreeMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2024-09-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-12-31_custom_OfferingWarrantsFebruaryTwoThousandTwentyThreeMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001737995</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">STSS:OfferingWarrantsFebruaryTwoThousandTwentyThreeMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2024-09-30_custom_OfferingWarrantsSeptemberTwoThousandTwentyThreeMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001737995</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">STSS:OfferingWarrantsSeptemberTwoThousandTwentyThreeMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2024-09-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-12-31_custom_OfferingWarrantsSeptemberTwoThousandTwentyThreeMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001737995</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">STSS:OfferingWarrantsSeptemberTwoThousandTwentyThreeMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2024-09-30_custom_InducementWarrantsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001737995</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">STSS:InducementWarrantsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2024-09-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-12-31_custom_InducementWarrantsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001737995</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">STSS:InducementWarrantsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-12-31_custom_WarrantsIssuedForServiceManagementMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001737995</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">STSS:WarrantsIssuedForServiceManagementMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-12-31_custom_WarrantsIssuedForServiceManagementMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001737995</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">STSS:WarrantsIssuedForServiceManagementMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2024-09-30_custom_InducementWarrantsMayTwoThousandTwentyFourMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001737995</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">STSS:InducementWarrantsMayTwoThousandTwentyFourMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2024-09-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-12-31_custom_InducementWarrantsMayTwoThousandTwentyFourMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001737995</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">STSS:InducementWarrantsMayTwoThousandTwentyFourMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2024-09-30_custom_WarrantsIssuedForServiceManagementMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001737995</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">STSS:WarrantsIssuedForServiceManagementMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2024-09-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-12-31_custom_WarrantsIssuedForServiceManagementMember10886343">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001737995</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">STSS:WarrantsIssuedForServiceManagementMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2024-07-012024-09-30_custom_InducementAgreementMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001737995</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">STSS:InducementAgreementMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-07-01</xbrli:startDate>
        <xbrli:endDate>2024-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2024-01-012024-09-30_custom_InducementAgreementMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001737995</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">STSS:InducementAgreementMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-01-01</xbrli:startDate>
        <xbrli:endDate>2024-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-01-24_custom_TwoThousandTwentyThreeEquityIncentivePlanMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001737995</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">STSS:TwoThousandTwentyThreeEquityIncentivePlanMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-01-24</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-01-242023-01-24_custom_TwoThousandTwentyThreeEquityIncentivePlanMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001737995</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">STSS:TwoThousandTwentyThreeEquityIncentivePlanMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-01-24</xbrli:startDate>
        <xbrli:endDate>2023-01-24</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-01-012023-12-31_custom_TwoThousandTwentyThreeEquityIncentivePlanMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001737995</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">STSS:TwoThousandTwentyThreeEquityIncentivePlanMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-01-01</xbrli:startDate>
        <xbrli:endDate>2023-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-12-31_custom_TwoThousandTwentyThreeEquityIncentivePlanMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001737995</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">STSS:TwoThousandTwentyThreeEquityIncentivePlanMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-01-012023-12-31_custom_EmployeesAndConsultantMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001737995</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">STSS:EmployeesAndConsultantMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-01-01</xbrli:startDate>
        <xbrli:endDate>2023-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-12-31_custom_EmployeesAndConsultantMember_srt_MinimumMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001737995</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">STSS:EmployeesAndConsultantMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-12-31_custom_EmployeesAndConsultantMember_srt_MaximumMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001737995</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">STSS:EmployeesAndConsultantMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-01-012023-12-31_custom_TwoThousandTwentyTwoEquityIncentivePlanMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001737995</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">STSS:TwoThousandTwentyTwoEquityIncentivePlanMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-01-01</xbrli:startDate>
        <xbrli:endDate>2023-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-12-31_custom_TwoThousandTwentyTwoEquityIncentivePlanMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001737995</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">STSS:TwoThousandTwentyTwoEquityIncentivePlanMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-01-012023-12-31_us-gaap_GeneralAndAdministrativeExpenseMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001737995</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:GeneralAndAdministrativeExpenseMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-01-01</xbrli:startDate>
        <xbrli:endDate>2023-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-01-012023-12-31_us-gaap_ResearchAndDevelopmentExpenseMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001737995</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-01-01</xbrli:startDate>
        <xbrli:endDate>2023-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-01-012022-12-31_us-gaap_GeneralAndAdministrativeExpenseMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001737995</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:GeneralAndAdministrativeExpenseMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-01-01</xbrli:startDate>
        <xbrli:endDate>2022-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-01-012022-12-31_us-gaap_ResearchAndDevelopmentExpenseMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001737995</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-01-01</xbrli:startDate>
        <xbrli:endDate>2022-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-01-012022-03-31">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001737995</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-01-01</xbrli:startDate>
        <xbrli:endDate>2022-03-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2024-01-012024-09-30_us-gaap_GeneralAndAdministrativeExpenseMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001737995</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:GeneralAndAdministrativeExpenseMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-01-01</xbrli:startDate>
        <xbrli:endDate>2024-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2024-01-012024-09-30_us-gaap_ResearchAndDevelopmentExpenseMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001737995</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-01-01</xbrli:startDate>
        <xbrli:endDate>2024-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-07-012023-09-30_us-gaap_GeneralAndAdministrativeExpenseMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001737995</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:GeneralAndAdministrativeExpenseMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-07-01</xbrli:startDate>
        <xbrli:endDate>2023-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-01-012023-09-30_us-gaap_GeneralAndAdministrativeExpenseMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001737995</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:GeneralAndAdministrativeExpenseMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-01-01</xbrli:startDate>
        <xbrli:endDate>2023-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-01-012023-12-31_custom_ExercisePriceRangeOneMember_srt_MinimumMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001737995</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis">STSS:ExercisePriceRangeOneMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-01-01</xbrli:startDate>
        <xbrli:endDate>2023-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-01-012023-12-31_custom_ExercisePriceRangeOneMember_srt_MaximumMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001737995</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis">STSS:ExercisePriceRangeOneMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-01-01</xbrli:startDate>
        <xbrli:endDate>2023-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-12-31_custom_ExercisePriceRangeOneMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001737995</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis">STSS:ExercisePriceRangeOneMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-01-012023-12-31_custom_ExercisePriceRangeOneMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001737995</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis">STSS:ExercisePriceRangeOneMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-01-01</xbrli:startDate>
        <xbrli:endDate>2023-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-01-012023-12-31_custom_ExercisePriceRangeTwoMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001737995</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis">STSS:ExercisePriceRangeTwoMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-01-01</xbrli:startDate>
        <xbrli:endDate>2023-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-12-31_custom_ExercisePriceRangeTwoMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001737995</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis">STSS:ExercisePriceRangeTwoMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-01-012023-12-31_custom_ExercisePriceRangeThreeMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001737995</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis">STSS:ExercisePriceRangeThreeMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-01-01</xbrli:startDate>
        <xbrli:endDate>2023-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-12-31_custom_ExercisePriceRangeThreeMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001737995</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis">STSS:ExercisePriceRangeThreeMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-01-012023-12-31_custom_ExercisePriceRangeFourMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001737995</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis">STSS:ExercisePriceRangeFourMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-01-01</xbrli:startDate>
        <xbrli:endDate>2023-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-12-31_custom_ExercisePriceRangeFourMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001737995</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis">STSS:ExercisePriceRangeFourMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-01-012023-12-31_custom_ExercisePriceRangeFiveMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001737995</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis">STSS:ExercisePriceRangeFiveMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-01-01</xbrli:startDate>
        <xbrli:endDate>2023-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-12-31_custom_ExercisePriceRangeFiveMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001737995</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis">STSS:ExercisePriceRangeFiveMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-01-012023-12-31_custom_ExercisePriceRangeSixMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001737995</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis">STSS:ExercisePriceRangeSixMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-01-01</xbrli:startDate>
        <xbrli:endDate>2023-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-12-31_custom_ExercisePriceRangeSixMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001737995</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis">STSS:ExercisePriceRangeSixMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-01-012023-12-31_custom_ExercisePriceRangeSevenMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001737995</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis">STSS:ExercisePriceRangeSevenMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-01-01</xbrli:startDate>
        <xbrli:endDate>2023-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-12-31_custom_ExercisePriceRangeSevenMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001737995</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis">STSS:ExercisePriceRangeSevenMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-01-012023-12-31_custom_ExercisePriceRangeEightMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001737995</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis">STSS:ExercisePriceRangeEightMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-01-01</xbrli:startDate>
        <xbrli:endDate>2023-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-12-31_custom_ExercisePriceRangeEightMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001737995</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis">STSS:ExercisePriceRangeEightMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-01-012023-12-31_custom_ExercisePriceRangeNineMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001737995</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis">STSS:ExercisePriceRangeNineMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-01-01</xbrli:startDate>
        <xbrli:endDate>2023-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-12-31_custom_ExercisePriceRangeNineMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001737995</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis">STSS:ExercisePriceRangeNineMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-01-012023-12-31_custom_ExercisePriceRangeTenMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001737995</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis">STSS:ExercisePriceRangeTenMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-01-01</xbrli:startDate>
        <xbrli:endDate>2023-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-12-31_custom_ExercisePriceRangeTenMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001737995</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis">STSS:ExercisePriceRangeTenMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-01-012023-12-31_srt_MinimumMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001737995</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-01-01</xbrli:startDate>
        <xbrli:endDate>2023-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-01-012023-12-31_srt_MaximumMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001737995</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-01-01</xbrli:startDate>
        <xbrli:endDate>2023-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-01-012022-12-31_srt_MinimumMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001737995</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-01-01</xbrli:startDate>
        <xbrli:endDate>2022-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-01-012022-12-31_srt_MaximumMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001737995</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-01-01</xbrli:startDate>
        <xbrli:endDate>2022-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2024-01-012024-09-30_srt_MinimumMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001737995</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-01-01</xbrli:startDate>
        <xbrli:endDate>2024-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2024-01-012024-09-30_srt_MaximumMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001737995</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-01-01</xbrli:startDate>
        <xbrli:endDate>2024-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-01-012023-09-30_srt_MinimumMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001737995</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-01-01</xbrli:startDate>
        <xbrli:endDate>2023-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-01-012023-09-30_srt_MaximumMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001737995</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-01-01</xbrli:startDate>
        <xbrli:endDate>2023-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-12-31_us-gaap_DomesticCountryMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001737995</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:DomesticCountryMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-12-31_us-gaap_DomesticCountryMember_custom_ExpiresOnTwoThousandTwentyEightMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001737995</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:DomesticCountryMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:StatementScenarioAxis">STSS:ExpiresOnTwoThousandTwentyEightMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-12-31_custom_NotExpireMember_us-gaap_DomesticCountryMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001737995</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:StatementScenarioAxis">STSS:NotExpireMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:DomesticCountryMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-12-31_us-gaap_ForeignCountryMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001737995</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:ForeignCountryMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-12-31_custom_OfficersAndDirectorsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001737995</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">STSS:OfficersAndDirectorsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-12-31_custom_OfficersAndDirectorsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001737995</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">STSS:OfficersAndDirectorsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2024-09-30_custom_OfficersAndDirectorsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001737995</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">STSS:OfficersAndDirectorsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2024-09-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-12-31_us-gaap_FairValueInputsLevel1Member">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001737995</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-12-31_us-gaap_FairValueInputsLevel2Member">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001737995</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-12-31_us-gaap_FairValueInputsLevel3Member">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001737995</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-12-31_us-gaap_FairValueInputsLevel1Member">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001737995</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-12-31_us-gaap_FairValueInputsLevel2Member">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001737995</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-12-31_us-gaap_FairValueInputsLevel3Member">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001737995</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2024-09-30_us-gaap_FairValueInputsLevel1Member">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001737995</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2024-09-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2024-09-30_us-gaap_FairValueInputsLevel2Member">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001737995</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2024-09-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2024-09-30_us-gaap_FairValueInputsLevel3Member">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001737995</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2024-09-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2017-07-012017-07-31_custom_RoyaltyAgreementMember_custom_BarryBerlerMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001737995</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">STSS:RoyaltyAgreementMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">STSS:BarryBerlerMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2017-07-01</xbrli:startDate>
        <xbrli:endDate>2017-07-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2018-09-012018-09-30_custom_RoyaltyAgreementMember_custom_BarryBerlerMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001737995</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">STSS:RoyaltyAgreementMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">STSS:BarryBerlerMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2018-09-01</xbrli:startDate>
        <xbrli:endDate>2018-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2018-09-30_custom_RoyaltyAgreementMember_custom_BarryBerlerMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001737995</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">STSS:RoyaltyAgreementMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">STSS:BarryBerlerMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2018-09-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2019-05-012019-05-31_custom_RoyaltyAgreementMember_custom_BarryBerlerMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001737995</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">STSS:RoyaltyAgreementMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">STSS:BarryBerlerMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2019-05-01</xbrli:startDate>
        <xbrli:endDate>2019-05-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-07-302022-08-01_custom_EmploymentAgreementMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001737995</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">STSS:EmploymentAgreementMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-07-30</xbrli:startDate>
        <xbrli:endDate>2022-08-01</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-08-312022-09-01_custom_EmploymentAgreementMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001737995</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">STSS:EmploymentAgreementMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-08-31</xbrli:startDate>
        <xbrli:endDate>2022-09-01</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-06-30_custom_Mr.BlackmanMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001737995</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">STSS:Mr.BlackmanMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-01-012023-03-31_custom_Mr.BlackmanMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001737995</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">STSS:Mr.BlackmanMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-01-01</xbrli:startDate>
        <xbrli:endDate>2023-03-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-07-012023-08-14_custom_Mr.BlackmanMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001737995</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">STSS:Mr.BlackmanMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-07-01</xbrli:startDate>
        <xbrli:endDate>2023-08-14</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-06-30_custom_Mr.BlackmanMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001737995</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">STSS:Mr.BlackmanMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-12-31_custom_Mr.BlackmanMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001737995</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">STSS:Mr.BlackmanMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-09-302022-09-30_custom_EmploymentAgreementMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001737995</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">STSS:EmploymentAgreementMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-09-30</xbrli:startDate>
        <xbrli:endDate>2022-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-10-012022-10-31_custom_ServiceAgreementMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001737995</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">STSS:ServiceAgreementMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-10-01</xbrli:startDate>
        <xbrli:endDate>2022-10-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-10-31_custom_ServiceAgreementMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001737995</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">STSS:ServiceAgreementMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-10-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-02-082023-02-09">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001737995</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-02-08</xbrli:startDate>
        <xbrli:endDate>2023-02-09</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-02-09">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001737995</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-02-09</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-06-012023-06-01_custom_EmploymentAgreementMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001737995</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">STSS:EmploymentAgreementMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-06-01</xbrli:startDate>
        <xbrli:endDate>2023-06-01</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-05-312023-05-31_custom_EmploymentAgreementMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001737995</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">STSS:EmploymentAgreementMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-05-31</xbrli:startDate>
        <xbrli:endDate>2023-05-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2024-07-102024-07-10_custom_BerlerMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001737995</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">STSS:BerlerMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-07-10</xbrli:startDate>
        <xbrli:endDate>2024-07-10</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2024-06-172024-06-17_custom_BerlerMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001737995</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">STSS:BerlerMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-06-17</xbrli:startDate>
        <xbrli:endDate>2024-06-17</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2024-04-032024-04-03_custom_PlastomoldMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001737995</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">STSS:PlastomoldMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-04-03</xbrli:startDate>
        <xbrli:endDate>2024-04-03</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-07-302022-08-01_custom_EmploymentAgreementMember_custom_AlanBlackmanMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001737995</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">STSS:EmploymentAgreementMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">STSS:AlanBlackmanMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-07-30</xbrli:startDate>
        <xbrli:endDate>2022-08-01</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-08-312022-09-01_custom_EmploymentAgreementMember_custom_AlanBlackmanMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001737995</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">STSS:EmploymentAgreementMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">STSS:AlanBlackmanMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-08-31</xbrli:startDate>
        <xbrli:endDate>2022-09-01</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-09-30_custom_EmploymentAgreementMember_custom_AlanBlackmanMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001737995</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">STSS:EmploymentAgreementMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">STSS:AlanBlackmanMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-09-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-01-012023-03-31_custom_EmploymentAgreementMember_custom_AlanBlackmanMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001737995</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">STSS:EmploymentAgreementMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">STSS:AlanBlackmanMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-01-01</xbrli:startDate>
        <xbrli:endDate>2023-03-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-07-012023-08-14_custom_AlanBlackmanMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001737995</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">STSS:AlanBlackmanMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-07-01</xbrli:startDate>
        <xbrli:endDate>2023-08-14</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-06-30_custom_AlanBlackmanMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001737995</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">STSS:AlanBlackmanMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-01-012023-12-31_custom_AlanBlackmanMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001737995</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">STSS:AlanBlackmanMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-01-01</xbrli:startDate>
        <xbrli:endDate>2023-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2024-05-192024-05-20_custom_AssetPurchaseAgreementMember_custom_InjectEZLLCMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001737995</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">STSS:AssetPurchaseAgreementMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:AssetAcquisitionAxis">STSS:InjectEZLLCMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-05-19</xbrli:startDate>
        <xbrli:endDate>2024-05-20</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2024-05-20_custom_AssetPurchaseAgreementMember_custom_InjectEZLLCMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001737995</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">STSS:AssetPurchaseAgreementMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:AssetAcquisitionAxis">STSS:InjectEZLLCMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2024-05-20</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2024-01-012024-09-30_custom_AssetPurchaseAgreementMember_custom_InjectEZLLCMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001737995</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">STSS:AssetPurchaseAgreementMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:AssetAcquisitionAxis">STSS:InjectEZLLCMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-01-01</xbrli:startDate>
        <xbrli:endDate>2024-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2024-01-01_us-gaap_WarrantMember_us-gaap_SubsequentEventMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001737995</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:WarrantMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2024-01-01</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2024-09-30_us-gaap_LandMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001737995</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:LandMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2024-09-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2024-09-30_us-gaap_MachineryAndEquipmentMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001737995</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:MachineryAndEquipmentMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2024-09-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2024-09-30_custom_ComputerSystemsAndWebsiteAndOtherMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001737995</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">STSS:ComputerSystemsAndWebsiteAndOtherMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2024-09-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-12-31_custom_ComputerSystemsAndWebsiteAndOtherMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001737995</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">STSS:ComputerSystemsAndWebsiteAndOtherMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:unit id="USD">
      <xbrli:measure>iso4217:USD</xbrli:measure>
    </xbrli:unit>
    <xbrli:unit id="Shares">
      <xbrli:measure>xbrli:shares</xbrli:measure>
    </xbrli:unit>
    <xbrli:unit id="USDPShares">
      <xbrli:divide>
        <xbrli:unitNumerator>
          <xbrli:measure>iso4217:USD</xbrli:measure>
        </xbrli:unitNumerator>
        <xbrli:unitDenominator>
          <xbrli:measure>xbrli:shares</xbrli:measure>
        </xbrli:unitDenominator>
      </xbrli:divide>
    </xbrli:unit>
    <xbrli:unit id="Pure">
      <xbrli:measure>xbrli:pure</xbrli:measure>
    </xbrli:unit>
  </ix:resources>
 </ix:header>
</div>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Registration
No. 333-284237</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<!-- Field: Rule-Page --><div style="width: 100%"><div style="border-top: Black 4pt solid; font-size: 1pt; border-bottom: Black 1pt solid">&#160;</div></div><!-- Field: /Rule-Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 18pt"><b>UNITED
STATES</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 18pt"><b>SECURITIES
AND EXCHANGE COMMISSION</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 12pt"><b>WASHINGTON,
D.C. 20549</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 18pt"><b>AMENDMENT
NO. 1</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 18pt"><b>TO</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 18pt"><b>FORM
<span id="xdx_90D_edei--DocumentType_dxL_c20240101__20240930_zFkmRHWpFCIf" title="::XDX::S-1%2FA"><span style="-sec-ix-hidden: xdx2ixbrl0011">S-1</span></span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>REGISTRATION
STATEMENT UNDER THE SECURITIES ACT OF 1933</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 18pt"><b><span id="xdx_90E_edei--EntityRegistrantName_c20240101__20240930_zbwavuVjRbPi"><ix:nonNumeric contextRef="From2024-01-01to2024-09-30" id="Fact000012" name="dei:EntityRegistrantName">Sharps
Technology, Inc.</ix:nonNumeric></span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(Exact
name of registrant as specified in its charter)</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td colspan="2" style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_90C_edei--EntityIncorporationStateCountryCode_c20240101__20240930_zdqC1IzhrlRa"><ix:nonNumeric contextRef="From2024-01-01to2024-09-30" format="ixt-sec:stateprovnameen" id="Fact000013" name="dei:EntityIncorporationStateCountryCode">Nevada</ix:nonNumeric></span></b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>3841</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_90C_edei--EntityTaxIdentificationNumber_c20240101__20240930_z8pOJHswZgK"><ix:nonNumeric contextRef="From2024-01-01to2024-09-30" id="Fact000014" name="dei:EntityTaxIdentificationNumber">82-3751728</ix:nonNumeric></span></b></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="border-top: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; width: 32%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(State
    or other jurisdiction of</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-top: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; width: 32%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(Primary
    Standard Industrial</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-top: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; width: 32%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(I.R.S.
    Employer</b></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td colspan="2" style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>incorporation
    or organization)</b></span></td>
    <td colspan="2" style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Classification
    Code Number)</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Identification
    Number)</b></span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Sharps
Technology, Inc.</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_90C_edei--EntityAddressAddressLine1_c20240101__20240930_zsBJTL4s1FZf"><ix:nonNumeric contextRef="From2024-01-01to2024-09-30" id="Fact000015" name="dei:EntityAddressAddressLine1">105
Maxess Road</ix:nonNumeric></span>, <span id="xdx_902_edei--EntityAddressAddressLine2_c20240101__20240930_zwvZymow7Xt3"><ix:nonNumeric contextRef="From2024-01-01to2024-09-30" id="Fact000016" name="dei:EntityAddressAddressLine2">Ste. 124</ix:nonNumeric></span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_908_edei--EntityAddressCityOrTown_c20240101__20240930_zZxwWQocizYk"><ix:nonNumeric contextRef="From2024-01-01to2024-09-30" id="Fact000017" name="dei:EntityAddressCityOrTown">Melville</ix:nonNumeric></span>,
<span id="xdx_903_edei--EntityAddressStateOrProvince_c20240101__20240930_zAVnfECIGSth"><ix:nonNumeric contextRef="From2024-01-01to2024-09-30" format="ixt-sec:stateprovnameen" id="Fact000018" name="dei:EntityAddressStateOrProvince">New York</ix:nonNumeric></span> <span id="xdx_906_edei--EntityAddressPostalZipCode_c20240101__20240930_zOtjoR00rQ15"><ix:nonNumeric contextRef="From2024-01-01to2024-09-30" id="Fact000019" name="dei:EntityAddressPostalZipCode">11747</ix:nonNumeric></span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_90A_edei--CityAreaCode_c20240101__20240930_zn71nhGLcll3"><ix:nonNumeric contextRef="From2024-01-01to2024-09-30" id="Fact000020" name="dei:CityAreaCode">(631)</ix:nonNumeric></span>
<span id="xdx_90C_edei--LocalPhoneNumber_c20240101__20240930_zULiOJUdXKgc"><ix:nonNumeric contextRef="From2024-01-01to2024-09-30" id="Fact000021" name="dei:LocalPhoneNumber">574 -4436</ix:nonNumeric></span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(Address,
including zip code, and telephone number, including area code, of registrant&#8217;s principal executive offices)</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_90B_edei--ContactPersonnelName_c20240101__20240930__dei--EntityAddressesAddressTypeAxis__dei--BusinessContactMember_zH9ZWw8kslyj"><ix:nonNumeric contextRef="From2024-01-012024-09-30_dei_BusinessContactMember" id="Fact000022" name="dei:ContactPersonnelName">Robert
M. Hayes</ix:nonNumeric></span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Chief
Executive Officer</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Sharps
Technology, Inc.</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_90B_edei--EntityAddressAddressLine1_c20240101__20240930__dei--EntityAddressesAddressTypeAxis__dei--BusinessContactMember_zhyV7MmNUaD7"><ix:nonNumeric contextRef="From2024-01-012024-09-30_dei_BusinessContactMember" id="Fact000023" name="dei:EntityAddressAddressLine1">105
Maxess Road</ix:nonNumeric></span>, <span id="xdx_905_edei--EntityAddressAddressLine2_c20240101__20240930__dei--EntityAddressesAddressTypeAxis__dei--BusinessContactMember_zGMjrvnMF0Jf"><ix:nonNumeric contextRef="From2024-01-012024-09-30_dei_BusinessContactMember" id="Fact000024" name="dei:EntityAddressAddressLine2">Ste. 124</ix:nonNumeric></span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_90D_edei--EntityAddressCityOrTown_c20240101__20240930__dei--EntityAddressesAddressTypeAxis__dei--BusinessContactMember_zSfDoVaZ3Gy6"><ix:nonNumeric contextRef="From2024-01-012024-09-30_dei_BusinessContactMember" id="Fact000025" name="dei:EntityAddressCityOrTown">Melville</ix:nonNumeric></span>,
<span id="xdx_909_edei--EntityAddressStateOrProvince_c20240101__20240930__dei--EntityAddressesAddressTypeAxis__dei--BusinessContactMember_zBU2vIHtGEPd"><ix:nonNumeric contextRef="From2024-01-012024-09-30_dei_BusinessContactMember" format="ixt-sec:stateprovnameen" id="Fact000026" name="dei:EntityAddressStateOrProvince">New York</ix:nonNumeric></span> <span id="xdx_90F_edei--EntityAddressPostalZipCode_c20240101__20240930__dei--EntityAddressesAddressTypeAxis__dei--BusinessContactMember_zz4hkJ6Bjema"><ix:nonNumeric contextRef="From2024-01-012024-09-30_dei_BusinessContactMember" id="Fact000027" name="dei:EntityAddressPostalZipCode">11747</ix:nonNumeric></span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_909_edei--CityAreaCode_c20240101__20240930__dei--EntityAddressesAddressTypeAxis__dei--BusinessContactMember_zMGqpDjBVE6j"><ix:nonNumeric contextRef="From2024-01-012024-09-30_dei_BusinessContactMember" id="Fact000028" name="dei:CityAreaCode">(631)</ix:nonNumeric></span>
<span id="xdx_90D_edei--LocalPhoneNumber_c20240101__20240930__dei--EntityAddressesAddressTypeAxis__dei--BusinessContactMember_zPjfiFluIogg"><ix:nonNumeric contextRef="From2024-01-012024-09-30_dei_BusinessContactMember" id="Fact000029" name="dei:LocalPhoneNumber">574 -4436</ix:nonNumeric></span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(Name,
address, including zip code, and telephone number, including area code, of agent for service)</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Copies
to:</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>&#160;</i></b></span></p>

<table cellspacing="0" cellpadding="0" style="width: 100%; border-collapse: collapse">
  <tr style="vertical-align: top">
    <td style="width: 49%"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Arthur
                                            Marcus, Esq.</b></span></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Sichenzia
    Ross Ference LLP</b></span></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>1185
    Avenue of the Americas</b></span></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>New
    York, NY 10036</b></span></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(212)
    930-9700</b></span></p></td>
    <td style="width: 2%">&#160;</td>
    <td style="width: 49%"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Anthony
                                            W. Basch, Esq.</b></span></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>J.
    Britton Williston, Esq.</b></span></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Shannon
    M. McDonough, Esq.</b></span></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Kaufman
    &amp; Canoles</b></span></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Two
    James Center, 14<sup>th</sup> floor</b></span></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Richmond,
    VA 23219</b></span></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Tel:
    (804) 771-5700</b></span></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"></p></td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Approximate
date of commencement of proposed sale to the public: As soon as practicable after this registration statement becomes effective.</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
any of the securities being registered on this Form are to be offered on a delayed or continuous basis pursuant to Rule 415 under the
Securities Act of 1933 check the following box. &#9746;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
this Form is filed to register additional securities for an offering pursuant to Rule 462(b) under the Securities Act, please check the
following box and list the Securities Act registration statement number of the earlier effective registration statement for the same
offering. &#9744;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
this Form is a post-effective amendment filed pursuant to Rule 462(c) under the Securities Act, check the following box and list the
Securities Act registration statement number of the earlier effective registration statement for the same offering. &#9744;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
this Form is a post-effective amendment filed pursuant to Rule 462(d) under the Securities Act, check the following box and list the
Securities Act registration statement number of the earlier effective registration statement for the same offering. &#9744;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Indicate
by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, smaller reporting company,
or an emerging growth company. See the definitions of &#8220;large accelerated filer,&#8221; &#8220;accelerated filer,&#8221; &#8220;smaller
reporting company,&#8221; and &#8220;emerging growth company&#8221; in Rule 12b-2 of the Exchange Act.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 80%; margin-right: auto">
<tr style="vertical-align: top; text-align: left">
  <td style="width: 50%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Large accelerated filer &#9744;</span></td>
  <td style="width: 50%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Accelerated filer &#9744;</span></td></tr>
<tr style="vertical-align: top; text-align: left">
  <td><span style="font-family: Times New Roman, Times, Serif"><span id="xdx_90E_edei--EntityFilerCategory_c20240101__20240930_zD1EHPiSIkCj"><ix:nonNumeric contextRef="From2024-01-01to2024-09-30" format="ixt-sec:entityfilercategoryen" id="Fact000030" name="dei:EntityFilerCategory">Non-accelerated filer</ix:nonNumeric></span> &#9746;</span></td>
  <td><span style="font-family: Times New Roman, Times, Serif">Smaller reporting company <span id="xdx_909_edei--EntitySmallBusiness_c20240101__20240930_zRhqx3Z2OXo5"><ix:nonNumeric contextRef="From2024-01-01to2024-09-30" format="ixt:booleantrue" id="Fact000031" name="dei:EntitySmallBusiness">&#9746;</ix:nonNumeric></span></span></td></tr>
<tr style="vertical-align: top; text-align: left">
  <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
  <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Emerging growth company <span id="xdx_908_edei--EntityEmergingGrowthCompany_c20240101__20240930_zuPZao9Bijzb"><ix:nonNumeric contextRef="From2024-01-01to2024-09-30" format="ixt:booleantrue" id="Fact000032" name="dei:EntityEmergingGrowthCompany">&#9746;</ix:nonNumeric></span></span></td></tr>
</table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 57pt; text-align: justify"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 57pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying
with any new or revised financial accounting standards provided pursuant to Section 7(a)(2)(B) of the Securities Act. <span id="xdx_900_edei--EntityExTransitionPeriod_c20240101__20240930_z1UmI3SsGlni"><ix:nonNumeric contextRef="From2024-01-01to2024-09-30" format="ixt:booleanfalse" id="Fact000033" name="dei:EntityExTransitionPeriod">&#9744;</ix:nonNumeric></span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>The
registrant hereby amends this registration statement on such date or dates as may be necessary to delay its effective date until the
registrant will file a further amendment which specifically states that this registration statement will thereafter become effective
in accordance with Section 8(a) of the Securities Act of 1933, as amended, or until the registration statement will become effective
on such date as the Securities and Exchange Commission, acting pursuant to said Section 8(a), may determine.</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>The registrant hereby amends this Registration Statement on such date or dates as may be necessary to delay its effective date until the
registrant shall file a further amendment which specifically states that this Registration Statement shall thereafter become effective
in accordance with Section 8(a) of the Securities Act of 1933 or until this Registration Statement shall become effective on such date
as the Commission, acting pursuant to said Section 8(a), may determine.</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b></b></span></p>

<!-- Field: Rule-Page --><div style="width: 100%"><div style="border-top: Black 1pt solid; font-size: 1pt; border-bottom: Black 4pt solid">&#160;</div></div><!-- Field: /Rule-Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>


<!-- Field: Page; Sequence: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 0pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="color: Red">The information
in this prospectus is not complete and may be changed. We may not sell these securities until the registration statement filed with the
Securities and Exchange Commission is effective. This prospectus is not an offer to sell these securities and is not soliciting an offer
to buy these securities in any jurisdiction where the offer or sale is not permitted. </span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: left">
  <td style="font: 10pt Times New Roman, Times, Serif; width: 33%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Red"><b>PRELIMINARY
  PROSPECTUS</b></span></td>
  <td style="font: 10pt Times New Roman, Times, Serif; text-align: center; width: 34%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Red"><b>SUBJECT
  TO COMPLETION</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right; width: 33%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Red"><b>JANUARY
    22, 2025</b></span></td></tr>
</table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><img src="forms-1_001.jpg" alt="" style="height: 113px; width: 270px"/></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Up
to 8,108,108 Units, with each Unit consisting of:</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>One
Share of Common Stock</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>One
Series A Warrant to Purchase One Share of Common Stock</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>One
Series B Warrant to Purchase One Share of Common Stock</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Up
to 8,108,108 Pre-Funded Units, with each Pre-Funded Unit consisting of:</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>One
Pre-Funded Warrant to Purchase One Share of Common Stock</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>One
Series A Warrant to Purchase One Share of Common Stock</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>One
Series B Warrant to Purchase One Share of Common Stock</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Up
to 8,108,108</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Shares of Common Stock Underlying the Pre-Funded Warrants</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Up
to 8,108,108 Shares of Common Stock Underlying the Series A Warrants</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Up
to 8,108,108 Shares of Common Stock Underlying the Series B Warrants</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Sharps
Technology Inc. (the &#8220;Company,&#8221; &#8220;Sharps,&#8221; the &#8220;registrant,&#8221; &#8220;we,&#8221; &#8220;our&#8221;
or &#8220;us&#8221;) is offering up to 8,108,108 units (the &#8220;Units&#8221;), each Unit consisting of: (i) one share of
common stock; (ii) one Series A Warrant to purchase one share of common stock (the &#8220;Series A Warrants&#8221;); and (iii) one
Series B Warrant to purchase one share of common stock (the &#8220;Series B Warrants,&#8221; together with the Series A Warrants,
the &#8220;Warrants&#8221;). Each Series A Warrant is exercisable at an exercise price of $2.3125 per share (125% of the
assumed public offering price per Unit), subject to certain anti-dilution and share combination event protections, and each Series B
Warrant is exercisable at an exercise price of $2.3125 per share (125% of the assumed public offering price per Unit) subject
to certain share combination event protections. The Series A Warrants will be exercisable from issuance and will expire five (5)
years after the Warrant Stockholder Approval (described below) and the Series B Warrants will be exercisable from issuance and will
expire two and one-half (2.5) years after the Warrant Stockholder Approval. See &#8220;Description of Securities.&#8221; We are
offering each Unit at an assumed public offering price of $1.85 per Unit, equal to the closing price of our common stock on
The Nasdaq Capital Market on January 17, 2025 (which assumed Unit offering price does not account for the $0.125 per
warrant purchase price).</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Under
the alternate cashless exercise option of the Series B Warrants, a holder of the Series B Warrant has the right to receive an aggregate
number of shares equal to the product of (x) the aggregate number of shares of common stock that would be issuable upon a cashless exercise
of the Series B Warrant and (y) three (3.0). In addition, the Warrants will contain a reset of the exercise price to a price equal to
the lesser of (i) the exercise price then in effect and (ii) the lowest volume weighted average price (&#8220;VWAP&#8221;) during the
five (5) trading day period commencing on the date we effect a reverse stock split in the future with a proportionate adjustment
to the number of shares underlying the Warrants, among other adjustments. Additionally, the Series A Warrants will provide for an adjustment
to the exercise price and number of shares underlying the Series A Warrants upon our issuance of our common stock or common stock equivalents
at a price per share that is less than the exercise price of the Series A Warrant, subject to certain exceptions.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Finally,
on the 11th trading day after the Warrant Stockholder Approval Date (the &#8220;Reset Date&#8221;), the exercise price of the Warrants
will be reset to a price equal to the lower of (i) the exercise price then in effect and (ii) the greater of (a) the lowest daily volume
weighted average price (&#8220;VWAP&#8221;) during the period commencing on the first trading day after the Warrant Stockholder Approval
Date and ending following the close of trading on the 10th trading day thereafter (the &#8220;Reset Period&#8221;), and (b) the floor
price set forth in the Warrants, and the number of shares issuable upon exercise will be increased such that the aggregate exercise price
of the Warrants on the issuance date for the shares of common stock underlying the Warrants then outstanding shall remain unchanged.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 2 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 0pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Any
reduction to the exercise prices of the Series A Warrants and the Series B Warrants and resulting increase in the shares of common stock
underlying the Warrants will be subject to a floor price. Prior to the date of Warrant Stockholder Approval (the &#8220;Warrant
Stockholder Approval Date&#8221;), the floor Price shall be equal to 50% of the Nasdaq Minimum Price at the pricing of this offering
and after the Warrant Stockholder Approval Date, the floor Price shall be 20% of the Nasdaq minimum Price.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Warrants will be exercisable from issuance, as further described in &#8220;<i>Description of Securities</i>---<i>Warrants and Pre-Funded
Warrants Offered in this Offering<span style="font-weight: normal">&#8221;</span></i> (the &#8220;Warrant
Stockholder Approval&#8221;). In the event that we are unable to obtain the Warrant Stockholder Approval, the Warrants may have substantially less value.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
are also offering the opportunity to purchase, if the purchaser so chooses and in lieu of Units, up to 8,108,108 pre-funded units
(the &#8220;Pre-Funded Units&#8221;) to purchasers whose purchase of Units in this offering would otherwise result in the purchaser,
together with its affiliates and certain related parties, beneficially owning more than 4.99% (or, at the election of the purchaser,
9.99%) of our outstanding common stock immediately following the consummation of this offering. Each Pre-Funded Unit consists of: (i)
one pre-funded warrant exercisable for one share of common stock (the &#8220;Pre-Funded Warrants&#8221;); (ii) one Series A Warrant;
and (iii) one Series B Warrant. The purchase price of each Pre-Funded Unit is equal to the price per Unit being sold to the public in
this offering, minus $0.0001, and the exercise price of each Pre-Funded Warrant included in the Pre-Funded Unit is $0.0001 per share.
The Pre-Funded Warrants will be immediately exercisable and may be exercised at any time until all of the Pre-Funded Warrants are exercised
in full.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.45in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
common stock and Pre-Funded Warrants, and the accompanying Warrants, as the case may be, can only be purchased together in this offering
but will be issued separately and will be immediately separable upon issuance. Pursuant to the registration statement related to this
prospectus, we are also registering the shares of common stock issuable upon exercise of the Warrants and Pre-Funded Warrants included
in the Units and Pre-Funded Units offered hereby.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.45in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
common stock is quoted on the Nasdaq Capital Market under the symbol &#8220;STSS.&#8221; On January 17, 2025, the last
reported sale price per share of our common stock was $1.85 (which assumed Unit offering price does not account for the $0.125 per warrant purchase price). There is no established trading market for the Units,
Pre-Funded Units, Warrants or Pre-Funded Warrants and we do not intend to list the Units, Pre-Funded Units, Warrants or Pre-Funded
Warrants on any securities exchange or nationally recognized trading system.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.45in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.45in">We have engaged
Aegis Capital Corp. to act as our exclusive underwriter on a firm commitment basis in connection with this offering. We have agreed to
pay to the underwriter the underwriting fees as set forth in the table below. We will bear all costs associated with the offering. See
&#8220;<i>Underwriting</i>&#8221; on page 42&#160;of this prospectus for more information regarding these arrangements.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.45in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.45in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
public offering price for the securities in this offering will be determined at the time of pricing and may be at a discount to the current
market price at the time. Therefore, the assumed public offering price used throughout this prospectus may not be indicative of the final
offering price. The final public offering price will be determined through negotiation between us, the Underwriter and the
investors based upon a number of factors, including our history and our prospects, the industry in which we operate, our past and present
operating results, the previous experience of our executive officers and the general condition of the securities markets at the time
of this offering.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.45in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.45in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
intend to use the proceeds from this offering for general corporate purposes, including working capital and investments. See &#8220;<i>Use
of Proceeds</i>.&#8221;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.45in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
may amend or supplement this prospectus from time to time by filing amendments or supplements as required. You should read the entire
prospectus and any amendments or supplements carefully before you make your investment decision.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.45in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Investing
in our common stock involves a high degree of risk. See &#8220;Risk Factors&#8221; beginning on page 7 of this prospectus for a
discussion of information that you should consider before investing in our securities.</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.45in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Neither
the Securities and Exchange Commission nor any state securities commission has approved or disapproved of these securities or determined
if this prospectus is truthful or complete. Any representation to the contrary is a criminal offense.</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.45in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.45in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.45in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.45in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b></b></span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td style="padding-bottom: 1pt; text-align: center; font-weight: bold">&#160;</td><td style="padding-bottom: 1pt; text-align: center; font-weight: bold">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center; font-weight: bold">Per Unit</td><td style="padding-bottom: 1pt; text-align: center; font-weight: bold">&#160;</td><td style="padding-bottom: 1pt; text-align: center; font-weight: bold">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center; font-weight: bold"><p style="margin-top: 0; margin-bottom: 0">Per Pre-</p>
                                                                  <p style="margin-top: 0; margin-bottom: 0">Funded Unit</p></td><td style="padding-bottom: 1pt; text-align: center; font-weight: bold">&#160;</td><td style="padding-bottom: 1pt; text-align: center; font-weight: bold">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center; font-weight: bold">Total</td><td style="padding-bottom: 1pt; text-align: center; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 46%; font-weight: bold">Public offering price</td><td style="width: 2%; font-weight: bold">&#160;</td>
    <td style="width: 1%; font-weight: bold; text-align: left">$</td><td style="width: 14%; font-weight: bold; text-align: right">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</td><td style="width: 1%; font-weight: bold; text-align: left">&#160;</td><td style="width: 2%; font-weight: bold">&#160;</td>
    <td style="width: 1%; font-weight: bold; text-align: left">$</td><td style="width: 14%; font-weight: bold; text-align: right">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</td><td style="width: 1%; font-weight: bold; text-align: left">&#160;</td><td style="width: 2%; font-weight: bold">&#160;</td>
    <td style="width: 1%; font-weight: bold; text-align: left">$</td><td style="width: 14%; font-weight: bold; text-align: right">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</td><td style="width: 1%; font-weight: bold; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Underwriter
    fees<sup>(1)</sup></b></span></td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">$</td><td style="font-weight: bold; text-align: right">&#160;&#160;&#160;&#160;&#160;&#160;</td><td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">$</td><td style="font-weight: bold; text-align: right"/><td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">$</td><td style="font-weight: bold; text-align: right"/><td style="font-weight: bold; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Proceeds, before expenses, to us<sup>(2)</sup></b></span></td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">$</td><td style="font-weight: bold; text-align: right"/><td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">$</td><td style="font-weight: bold; text-align: right"/><td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">$</td><td style="font-weight: bold; text-align: right"/><td style="font-weight: bold; text-align: left">&#160;</td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.45in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(1)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Represents
    a cash fee equal to 7.0% of the aggregate purchase price paid by investors in this offering. We have also agreed to pay a
    non-accountable expense of 1.0% and to reimburse the underwriter for the fees and disbursements of its legal counsel
    in an amount of $100,000. See &#8220;<i>Underwriting</i>&#8221; beginning on page 42 of this prospectus for a description
    of the compensation to be received by the Underwriter.</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(2)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
    amount of offering proceeds to us presented in this table does not give effect to any exercise of the Warrants or Pre-Funded Warrants.</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.45in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.45in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
delivery to purchasers of securities in this offering is expected to be made on or about&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;
, 2025, subject to satisfaction of certain customary closing conditions.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Aegis
Capital Corp.</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
date of this prospectus is [_____] , 2025</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 3 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 0pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="MT_001"></span><b>TABLE
OF CONTENTS</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; vertical-align: bottom; font: 10pt Times New Roman, Times, Serif; text-align: center; width: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Page</b></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif"><a href="#RM_001"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">GENERAL MATTERS</span></a></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif"><a href="#RM_002"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">USE OF MARKETA AND INDUSTRY DATA</span></a></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif"><a href="#RM_003"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">TRADEMARKS</span></a></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif"><a href="#RM_004"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">PROSPECTUS SUMMARY</span></a></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">3</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif"><a href="#RM_005"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>SUMMARY CONSOLIDATED FINANCIAL AND OTHER DATA</b></span></a></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif"><a href="#RM_006"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">RISK FACTORS</span></a></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">7</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif"><a href="#RM_007"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">SPECIAL NOTE REGARDING FORWARD-LOOKING STATEMENTS</span></a></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">15</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif"><a href="#RM_008"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">USE OF PROCEEDS</span></a></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">15</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#RM_009">DIVIDEND POLICY</a></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">16</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif"><a href="#RM_010"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">CAPITALIZATION</span></a></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">16</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif"><a href="#bs_001">DILUTION</a></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center">16</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif"><a href="#RM_011"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">MANAGEMENT&#8217;S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS</span></a></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">17</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif"><a href="#RM_012"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">BUSINESS</span></a></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">24</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif"><a href="#RM_013"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">MANAGEMENT</span></a></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">29</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif"><a href="#J_001"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">EXECUTIVE COMPENSATION</span></a></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">32</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><a href="#J_002"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>MARKET PRICE OF AND DIVIDENDS ON THE COMPANY&#8217;S COMMON STOCK AND RELATED STOCKHOLDER MATTERS</b></span></a></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><a href="#J_003"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>SECURITY OWNERSHIP OF CERTAIN BENEFICIAL OWNERS AND MANAGEMENT</b></span></a></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b></b></span></p></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif"><a href="#J_004"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">DESCRIPTION OF SECURITIES</span></a></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">36</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif"><a href="#J_005"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">CERTAIN RELATIONSHIPS AND RELATED PARTY TRANSACTIONS</span></a></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">40</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif"><a href="#J_006"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">PRIVATE PLACEMENT OF SHARES OF COMMON STOCK,AND WARRANTS</span></a></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">41</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif"><a href="#J_007"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">UNDERWRITING</span></a></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">42</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif"><a href="#J_008"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">LEGAL MATTERS</span></a></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">44</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif"><a href="#J_009"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">EXPERTS</span></a></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">44</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif"><a href="#J_010"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">WHERE YOU CAN FIND ADDITIONAL INFORMATION</span></a></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">44</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif"><a href="#RM_014"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">INDEX TO FINANCIAL STATEMENTS</span></a></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">F-1</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 4; Options: NewSection -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: LowerRoman; Name: PageNo -->i<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>ABOUT
THIS PROSPECTUS</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
incorporate by reference important information into this prospectus. You may obtain the information incorporated by reference without
charge by following the instructions under &#8220;Where You Can Find More Information.&#8221; You should carefully read this prospectus
as well as additional information described under &#8220;Information Incorporated By Reference,&#8221; before deciding to invest in our
securities.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Neither
we nor Aegis have authorized anyone to provide you with information different from or inconsistent with the information contained in
or incorporated by reference in this prospectus. We take no responsibility for, and can provide no assurance as to the reliability of,
any other information that others may give you. You should assume that the information appearing in this prospectus and the documents
incorporated by reference in this prospectus is accurate only as of the date of those respective documents, regardless of the time of
delivery of those respective documents. Our business, financial condition, results of operations and prospects may have changed since
those dates.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
information incorporated by reference or provided in this prospectus contains statistical data and estimates, including those relating
to market size and competitive position of the markets in which we participate, that we obtained from our own internal estimates and
research, as well as from industry and general publications and research, surveys and studies conducted by third parties. Industry publications,
studies and surveys generally state that they have been obtained from sources believed to be reliable. While we believe our internal
company research is reliable and the definitions of our market and industry are appropriate, neither this research nor these definitions
have been verified by any independent source.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
further note that the representations, warranties and covenants made by us in any agreement that is filed as an exhibit to any document
that is incorporated by reference into this prospectus were made solely for the benefit of the parties to such agreement, including,
in some cases, for the purpose of allocating risk among the parties to such agreement, and should not be deemed to be a representation,
warranty or covenant to you. Moreover, such representations, warranties or covenants were accurate only as of the date when made. Accordingly,
such representations, warranties and covenants should not be relied on as accurately representing the current state of our affairs.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
are offering to sell, and seeking offers to buy, shares of our common stock only in jurisdictions where offers and sales are permitted.
The distribution of this prospectus and the offering of our common stock in certain jurisdictions may be restricted by law. Persons outside
the United States who come into possession of this prospectus must inform themselves about, and observe any restrictions relating to,
the offering of our common stock and the distribution of this prospectus outside the United States. This prospectus does not constitute,
and may not be used in connection with, an offer to sell, or a solicitation of an offer to buy, any securities offered by this prospectus
by any person in any jurisdiction in which it is unlawful for such person to make such an offer or solicitation.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Sharps
Technology, Inc. and its consolidated subsidiaries are referred to herein as &#8220;Sharps,&#8221; &#8220;the Company,&#8221; &#8220;we,&#8221;
&#8220;us&#8221; and &#8220;our,&#8221; unless the context indicates otherwise.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">This
prospectus contains, or incorporates by reference, trademarks, tradenames, service marks and service names of Sharps Technology, Inc.
and its subsidiaries.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 5; Options: NewSection; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 0pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->1<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: left; width: 100%"><a href="#MT_001">Table of Contents</a></td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="RM_001"></span><b>GENERAL
MATTERS</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0.25in; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Unless
otherwise indicated, all references to &#8220;dollars,&#8221; &#8220;US$,&#8221; or &#8220;$&#8221; in this prospectus are to United
States dollars.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0.25in; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">This
prospectus contains various company names, product names, trade names, trademarks and service marks, all of which are the properties
of their respective owners.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0.25in; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0.25in; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Unless
otherwise indicated or the context otherwise requires, all information in this prospectus assumes no exercise of the over-allotment option.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0.25in; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0.25in; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Unless
otherwise indicated, all references to &#8220;GAAP&#8221; in this prospectus are to United States generally accepted accounting principles.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0.25in; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Information
contained on our websites, including sharpstechnology.com, shall not be deemed to be part of this prospectus or incorporated herein by
reference and should not be relied upon by prospective investors for the purposes of determining whether to purchase the securities offered
hereunder.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0.25in; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">For
investors outside the United States, neither we nor any of our agents have done anything that would permit this offering or possession
or distribution of this prospectus in any jurisdiction where action for that purpose is required, other than in the United States. You
are required to inform yourself about and to observe any restrictions relating to this offering and the distribution of this prospectus.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0.25in; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0.25in; margin: 0pt; text-align: center"><span id="RM_002"></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>USE
OF MARKET AND INDUSTRY DATA</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0.25in; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">This
prospectus includes market and industry data that has been obtained from third party sources, including industry publications, as well
as industry data prepared by our management on the basis of its knowledge of and experience in the industries in which we operate (including
our management&#8217;s estimates and assumptions relating to those industries based on that knowledge). Management&#8217;s knowledge
of such industries has been developed through its experience and participation in those industries. Although our management believes
such information to be reliable, neither we nor our management have independently verified any of the data from third party sources referred
to in this prospectus or ascertained the underlying economic assumptions relied upon by such sources. Furthermore, references in this
prospectus to any publications, reports, surveys or articles prepared by third parties should not be construed as depicting the complete
findings of the entire publication, report, survey or article. The information in any such publication, report survey or article is not
incorporated by reference in this prospectus.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0.25in; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="RM_003"></span>TRADEMARKS</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0.25in; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
own or have rights to various trademarks, service marks and/or trade names that we use in connection with the operation of our business.
This prospectus may also contain trademarks, service marks and trade names of third parties, which are the property of their respective
owners. Our use or display of third parties&#8217; trademarks, service marks and trade names or products in this prospectus is not intended
to, and does not imply a relationship with, or endorsement or sponsorship by us. Solely for convenience, the trademarks, service marks
and trade names referred to in this prospectus may appear without the <sup>&#174;</sup>, <sup>TM</sup> or <sup>SM</sup> symbols, but the
omission of such references is not intended to indicate, in any way, that we will not assert, to the fullest extent under applicable
law, our rights or the right of the applicable owner of these trademarks, service marks and trade names.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0.25in; margin: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>


<!-- Field: Page; Sequence: 6; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 0pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: left; width: 100%"><a href="#MT_001">Table of Contents</a></td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span id="RM_004"></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>PROSPECTUS
SUMMARY</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>This
summary highlights selected information that is presented in greater detail elsewhere in this prospectus. This summary does not contain
all of the information you should consider before investing in our securities. You should read this entire prospectus carefully, including
the sections titled &#8220;Risk Factors&#8221; and &#8220;Management&#8217;s Discussion and Analysis of Financial Condition and Results
of Operations&#8221; and our financial statements and the related notes included elsewhere in this prospectus, before making an investment
decision. Unless the context otherwise requires, the terms &#8220;the Company,&#8221; &#8220;Sharps,&#8221; &#8216;Sharps Technology,&#8221;
&#8220;we,&#8221; &#8220;us&#8221; and &#8220;our&#8221; in this prospectus refer to Sharps Technology, Inc.</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Company
Overview </b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Sharps
Technology, Inc. is a medical device company that has designed and patented various safety syringes which we are seeking to commercialize
and other syringe products currently marketable.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
safety syringes products, which we refer to as the Sharps Provensa&#8482; and Securgard<sup>&#8482;</sup>, are ultra-low waste and have
safety features, which we believe will provide us a competitive advantage over other syringes. Sharps Provensa is a patented and FDA-cleared
safety syringe addressing the important needs of the global healthcare market. We received FDA clearance for the Sharps Provensa on June
12, 2006, for subcutaneous and intramuscular injections into the human body.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Reincorporation
and Reverse Split</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Prior
to March 22, 2022, we were a Wyoming corporation and on March 22, 2022, we reincorporated (the &#8220;Reincorporation&#8221;) as a Nevada
corporation (&#8220;Sharps Nevada&#8221;) pursuant to a merger into a newly formed Nevada corporation which was approved by our board
of directors and the holders of the majority of our outstanding shares of common stock.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Corporate
Information</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company was incorporated in the State of Wyoming on December 16, 2017. On March 22, 2022, we reincorporated as a Nevada corporation.
Our principal business address is 105 Maxess Road, Melville, New York 11747. We maintain our corporate website at sharpstechnology.com.
The reference to our website is an inactive textual reference only. We make available free of charge on or through our website our Annual
Reports on Form 10-K, Quarterly Reports on Form 10-Q, Current Reports on Form 8-K and amendments to those reports filed or furnished
pursuant to Section 12(b) of the Exchange Act, as soon as reasonably practicable after we electronically file such material with or otherwise
furnish it to the SEC. Information on or accessed through our website or the SEC&#8217;s website is not incorporated into this Offering
Circular.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b></b></span></p>


<!-- Field: Page; Sequence: 7; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 0pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: left; width: 100%"><a href="#MT_001">Table of Contents</a></td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>THE
OFFERING</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 28%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Units
    offered by us</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 70%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Up
    to 8,108,108 Units in a &#8220;firm commitment&#8221; offering. Each Unit consists of: (i) one share of common stock; (ii)
    one Series A Warrant; and (iii) one Series B Warrant.</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Pre-Funded
    Units offered by us</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
    are also offering the opportunity to purchase, if the purchaser so chooses and in lieu of Units, up to 8,108,108 Pre-Funded
    Units to purchasers whose purchase of Units in this offering would otherwise result in the purchaser, together with its affiliates
    and certain related parties, beneficially owning more than 4.99% (or, at the election of the purchaser, 9.99%) of our outstanding
    common stock immediately following the consummation of this offering. Each Pre-Funded Unit consists of: (i) one Pre-Funded Warrant
    exercisable for one share of common stock; (ii) one Series A Warrant; and one Series B Warrant. The purchase price of each Pre-Funded
    Unit is equal to the price per Unit being sold to the public in this offering, minus $0.0001, and the exercise price of each Pre-Funded
    Warrant included in the Pre-Funded Unit is $0.0001 per share. The Pre-Funded Warrants will be immediately exercisable and may be
    exercised at any time until all of the Pre-Funded Warrants are exercised in full. For each Pre-Funded Unit we sell, the number of
    Units we are offering will be decreased on a one-for-one basis. Because we will issue one Series A Warrant and one Series B Warrant
    as part of each Unit or Pre-Funded Unit, the number of Warrants sold in this offering will not change as a result of a change in
    the mix of the Units and Pre-Funded Units sold. This offering also relates to the shares of common stock issuable upon exercise of
    any Pre-Funded Warrants and Warrants sold in this offering.</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Warrants
    offered by us</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
                                            Series A Warrants will be exercisable from issuance, have an exercise price of $2.3125
                                            per share (125% of the assumed public offering price per Unit), subject to certain anti-dilution
                                            and share combination event protections, and will expire five (5) years from the date of
                                            the Warrant Stockholder Approval.</span></p>
    <p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>
    <p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
    Series B Warrants will be exercisable from issuance, will have an exercise price of $2.3125 per share (125% of the assumed
    public offering price per Unit), subject to certain share combination event protections, and will expire two and one-half (2.5) years
    from the date of Warrant Stockholder Approval.</span></p>
    <p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>
    <p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Under
    the alternate cashless exercise option of the Series B Warrants, the holder of the Series B Warrant, has the right to receive three
    (3) shares of our common stock for each warrant share underlying the Series B Warrant. In addition, beginning on the 11th trading
    day after the Warrant Stockholder Approval Date (the &#8220;Reset Date&#8221;), the exercise price of the Warrants will reset to
    a price equal to the greater of (i) the Floor Price, as defined in the Warrants, in effect on the Reset Date and (ii) the lowest
    volume weighted average price (&#8220;VWAP&#8221;) during the period commencing on the first trading day immediately following the
    Warrant Stockholder Approval Date and ending on the close of trading on the 10th trading day thereafter. In addition, following
    a reverse stock split, the exercise price of the Warrants will be adjusted to equal the lowest single-day VWAP during the period
    from the trading day immediately following, until the fifth trading day following the reverse stock split, with a proportionate adjustment
    to the number of shares underlying the Warrants. Beginning on the Warrant Stockholder Approval Date, with certain exceptions, the
    Series A Warrants will provide for an adjustment to the exercise price and number of shares underlying the Series A Warrants upon
    our issuance of our common stock or common stock equivalents at a price per share that is less than the exercise price of the Series
    A Warrant.</span></p>
    <p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>
    <p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Prior
    to the Warrant Stockholder Approval Date, the Floor Price shall be equal to 50% of the Nasdaq Minimum Price at the pricing of this
    offering and after the Warrant Stockholder Approval Date, the Floor Price shall be 20% of the Nasdaq Minimum Price.
    See &#8220;Description of Securities.&#8221;</span></p></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 8; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 0pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: left; width: 100%"><a href="#MT_001">Table of Contents</a></td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 28%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Common
    stock outstanding prior to the offering<sup></sup></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 70%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2,046,225
    </span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">shares.</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Common
    stock to be outstanding after the offering</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10,154,333
    </span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(assuming no sale of any Pre-Funded Units)</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Use
    of Proceeds</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
    intend to use the net proceeds to us from this offering for working capital and other general corporate purposes and to repay the
    principal amount of $4,174,658 in outstanding senior notes of the Company. See &#8220;<i>Use of Proceeds</i>&#8221; beginning
    on page 15.</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Listing</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
    common stock is listed on The Nasdaq Capital Market under the symbol &#8220;STSS&#8221;. There is no established public trading market
    for the Units, Pre-Funded Units, Warrants or Pre-Funded Warrants, and we do not intend to list these securities on any national
    securities exchange or trading system.</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Assumed
Public Offering Price</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$1.85
    </span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">per Unit, the closing price of our common stock
    on January 17, 2025 (which assumed Unit offering price does not account for the $0.125 per warrant purchase price).</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Risk
    Factors</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">You
    should carefully consider the information set forth in this prospectus and, in particular, the specific factors set forth in the
    &#8220;<i>Risk Factors</i>&#8221; section beginning on page 7 of this prospectus before deciding whether or not to invest in shares
    of our common stock.</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Lock-Up
    Agreements</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
    officers, directors, and shareholders holding at least ten percent (10%) of our outstanding common stock have agreed,
    for a period of 90 days after the Warrant Stockholder Approval Date, subject to certain exceptions, not to offer, sell, contract
    to sell, encumber, grant any option for the sale of or otherwise dispose of any shares of our common stock or other securities convertible
    into or exercisable or exchangeable for shares of our common stock without the prior written consent of the underwriter.</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Unless
otherwise indicated, all information contained in this prospectus assumes the sale of all of the shares offered hereby at an assumed
public offering price of $1.85 per share (which assumed Unit offering price does not account for the $0.125 per warrant purchase price) and no sale of any Pre-funded Warrants. The number of shares of our common stock that are and will be outstanding
immediately before and after this offering as shown above is based on 2,046,225 shares outstanding as of December 31, 2024. The number
of shares outstanding as of December 31, 2024, as used throughout this prospectus, unless otherwise indicated, excludes, as of that date:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;
    </span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">154,310
    </span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">shares of common stock issuable upon the exercise
    of outstanding stock options with a weighted-average exercise price of $42.88 per share; </span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;
    </span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">265,000
    </span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">shares of common stock reserved for future issuance
    under our 2024 Equity Incentive Plan; and </span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">700,699
    </span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">shares of common stock issuable upon exercise
    of warrants to purchase common stock with a weighted-average exercise price of $9.34 per share.</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Emerging
Growth Company under the JOBS Act</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
qualify as an &#8220;emerging growth company&#8221; under the Jumpstart Our Business Startups Act of 2012, or the JOBS Act. As an emerging
growth company, we have elected to take advantage of reduced reporting requirements and are relieved of certain other significant requirements
that are otherwise generally applicable to public companies. As an emerging growth company:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">we
    may present only two years of audited financial statements and only two years of related Management&#8217;s Discussion and Analysis
    of Financial Condition and Results of Operations;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">we
    are exempt from the requirement to obtain an attestation and report from our auditors on whether we maintained effective internal
    control over financial reporting under the Sarbanes-Oxley Act;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">we
    are permitted to provide less extensive disclosure about our executive compensation arrangements; and</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">we
    are not required to give our stockholders non-binding advisory votes on executive compensation or golden parachute arrangements.</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.3in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
may take advantage of these provisions until December 31, 2027 (the last day of the fiscal year following the fifth anniversary of our
initial public offering) if we continue to be an emerging growth company. We would cease to be an emerging growth company if we have
more than $1.235 billion in annual revenue, have more than $700 million in market value of our shares held by non-affiliates or issue
more than $1.0 billion of non-convertible debt over a three-year period. We may choose to take advantage of some but not all of these
reduced burdens. We have elected to provide two years of audited financial statements. Additionally, we have elected to take advantage
of the extended transition period provided in Section 7(a)(2)(B) of the Securities Act of 1933, as amended, or the Securities Act, for
complying with new or revised accounting standards that have different effective dates for public and private companies until the earlier
of the date we (i) are no longer an emerging growth company or (ii) affirmatively and irrevocably opt out of the extended transition
period provided in Section 7(a)(2)(B) of the Securities Act.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>


<!-- Field: Page; Sequence: 9; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 0pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: left; width: 100%"><a href="#MT_001">Table of Contents</a></td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="RM_005"></span>SUMMARY
CONSOLIDATED FINANCIAL AND OTHER DATA</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
following tables present our summary financial data and should be read together with our audited consolidated financial statements for
the years ended December 31, 2023 and 2022 and the unaudited condensed consolidated financial statements for the nine months ended September
30, 2024 and accompanying notes and information in &#8220;Management&#8217;s Discussion and Analysis of Financial Condition and Results
of Operations&#8221; from the aforementioned periods appearing elsewhere in this prospectus. Our financial statements are prepared and
presented in accordance with U.S. generally accepted accounting principles (&#8220;GAAP&#8221;). Our historical results are not necessarily
indicative of our future results.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Balance
Sheet Data </b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td style="text-align: center">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center">December 31,</td><td style="font-weight: bold">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center">December 31,</td><td style="font-weight: bold">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center">September 30,</td><td style="font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: center">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2022</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2023</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2024</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold">Assets</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 10pt; width: 46%; font-weight: bold; text-align: left; padding-bottom: 1pt">Total current assets</td><td style="width: 2%; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; width: 1%; text-align: left">$</td><td style="border-bottom: Black 1pt solid; width: 14%; text-align: right">4,423,450</td><td style="width: 1%; padding-bottom: 1pt; text-align: left">&#160;</td><td style="width: 2%; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; width: 1%; text-align: left">$</td><td style="border-bottom: Black 1pt solid; width: 14%; text-align: right">4,838,551</td><td style="width: 1%; padding-bottom: 1pt; text-align: left">&#160;</td><td style="width: 2%; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; width: 1%; text-align: left">$</td><td style="border-bottom: Black 1pt solid; width: 14%; text-align: right">4,654,015</td><td style="width: 1%; padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 20pt; font-weight: bold; text-align: left; padding-bottom: 2.5pt">Total assets</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">11,839,656</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">11,789,268</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">11,253,898</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; text-align: left">Liabilities and Stockholders&#8217; Equity</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-bottom: 1pt; padding-left: 10pt; font-weight: bold; text-align: left">Total current liabilities</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">$</td><td style="border-bottom: Black 1pt solid; text-align: right">2,006,522</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">$</td><td style="border-bottom: Black 1pt solid; text-align: right">3,692,982</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">$</td><td style="border-bottom: Black 1pt solid; text-align: right">4,586,195</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 10pt; font-weight: bold; text-align: left; padding-bottom: 1pt">Total liabilities</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt; text-align: right">2,198,522</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt; text-align: right">3,854,982</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt; text-align: right">4,748,195</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 10pt; font-weight: bold; text-align: left; padding-bottom: 1pt">Total stockholders&#8217; equity</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">9,641,134</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">7,934,286</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">6,505,703</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 20pt; font-weight: bold; text-align: left; padding-bottom: 2.5pt">Total liabilities and stockholders&#8217; equity</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">11,839,656</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">11,789,268</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">11,253,898</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Statement
of Operations Data</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td style="text-align: center">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="6" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><p style="margin-top: 0; margin-bottom: 0">For the Years Ended</p>
                                                                                <p style="margin-top: 0; margin-bottom: 0">December 31,</p></td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><p style="margin-top: 0; margin-bottom: 0">For the</p>
                                                                                                  <p style="margin-top: 0; margin-bottom: 0">Nine
                                            Months</p>
                                                                                                  <p style="margin-top: 0; margin-bottom: 0">Ended</p>
                                                                                <p style="margin-top: 0; margin-bottom: 0">September 30,</p>
                                                                                <p style="margin-top: 0; margin-bottom: 0">2024</p></td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: center">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2023</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2022</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">(unaudited)</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold">Revenue</td><td>&#160;</td>
    <td colspan="2" style="text-align: right">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: right">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: right">&#160;</td><td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="width: 46%; font-weight: bold; text-align: left; padding-bottom: 1pt">Total operating expenses</td><td style="width: 2%; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; width: 1%; text-align: left">$</td><td style="border-bottom: Black 1pt solid; width: 14%; text-align: right">(10,126,650</td><td style="width: 1%; padding-bottom: 1pt; text-align: left">)</td><td style="width: 2%; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; width: 1%; text-align: left">$</td><td style="border-bottom: Black 1pt solid; width: 14%; text-align: right">(8,738,793</td><td style="width: 1%; padding-bottom: 1pt; text-align: left">)</td><td style="width: 2%; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; width: 1%; text-align: left">$</td><td style="border-bottom: Black 1pt solid; width: 14%; text-align: right">(5,780,362</td><td style="width: 1%; padding-bottom: 1pt; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 10pt; text-align: left">Loss from operations</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(10,126,650</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(8,738,793</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(5,780,362</td><td style="text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 10pt; text-align: left">Foreign currency</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(52,689</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">26,636</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(31,566</td><td style="text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 10pt; text-align: left">Other (expense) income</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">138,118</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(1,320,416</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(1,046,593</td><td style="text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 10pt; text-align: left; padding-bottom: 1pt">FMV gain adjustment for derivatives</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">169,583</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">5,392,911</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">2,088,747</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; text-align: left; padding-bottom: 1pt">Net Loss Before Provision for Taxes</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(9,871,638</td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(4,639,662</td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(4,769,774</td><td style="padding-bottom: 1pt; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 10pt; text-align: left; padding-bottom: 1pt">Deferred tax benefit</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">30,000</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">-</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">-</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; text-align: left; padding-bottom: 2.5pt">Net loss</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">(9,841,638</td><td style="padding-bottom: 2.5pt; text-align: left">)</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">(4,639,662</td><td style="padding-bottom: 2.5pt; text-align: left">)</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">(4,769,774</td><td style="padding-bottom: 2.5pt; text-align: left">)</td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 10; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 0pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->6<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: left; width: 100%"><a href="#MT_001">Table of Contents</a></td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="RM_006"></span>RISK
FACTORS</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.3in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Investing
in our securities involves a high degree of risk. You should carefully consider the risks and uncertainties described below, together
with all of the other information in this prospectus, including the section titled &#8220;Management&#8217;s Discussion and Analysis
of Financial Condition and Results of Operations&#8221; and our financial statements and related notes, before making a decision to invest
in our securities. Our business, financial condition, results of operations and prospects could be adversely affected by these risks.
In that event, the market price of our common stock could decline, and you could lose part or all of your investment.</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Risks
Related to Our Technology, Business, and Industry</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>We
are an early-stage company with a history of losses.</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
incurred net losses of $9,841,638 and $4,639,662 for the years ended December 31, 2023 and 2022, respectively and $4,769,774 for the
nine months ended September 30, 2024. We have not generated any significant revenues from the sale of syringe products to date, and we
had accumulated deficit of $29,918,777 as of September 30, 2024. We have developed our Sharps Provensa product line but there can be
no assurance that it will be commercially successful. Our potential profitability is dependent upon a number of factors, many of which
are beyond our control. If we are unable to achieve and sustain profitability, the value of our business and common stock may significantly
decrease.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>We
have a limited operating history and we may not succeed.</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
have a limited operating history, and we may not succeed. We have commercialized our Securgard syringe products in mid 2023 yet no significant
syringe revenues have occurred and have not yet commercialized our Sharps Provensa products. You should consider, among other factors,
our prospects for success in light of the risks and uncertainties encountered by companies that, like us, are in their early stages.
For example, unanticipated expenses, problems, and technical difficulties may occur and they may result in material challenges to our
business. We may not be able to successfully address these risks and uncertainties or successfully implement our operating strategies.
If we fail to do so, such failure could have a material adverse effect on our business, financial conditions and results of operation.
We may never generate significant revenues or achieve profitability.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>We
may not succeed in commercializing Sharps products or any future product.</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
may face difficulties or delays in the commercialization or sale of Sharps products, which could result in our inability to timely offer
products or services that satisfy the market. We may, for example, encounter difficulties due to:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">our
    inability to adequately market our products;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">our
    inability to effectively scale manufacturing as needed to maintain an adequate commercial supply of our products;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">our
    inability to attract and retain skilled support team, marketing staff and sales force necessary to increase the market for our products
    and to maintain market acceptance for our products; and</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
    difficulty of establishing brand recognition and loyalty for our products.</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
addition, to increase our production capacity, we will need to build inventory, which will require that we purchase certain additional
equipment, including molding machines and molds. We have not received any significant orders to date. Even if we succeed in building
inventory, and increasing our production capacity, there is no assurance we will receive additional orders for our Sharps = products
or any future products.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 11; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 0pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->7<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: left; width: 100%"><a href="#MT_001">Table of Contents</a></td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>We
may encounter significant competition and may not be able to successfully compete.</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">There
are many medical device companies offering safety syringes, and more competitors are likely to arrive. Some of our competitors have considerably
more financial resources than us. As a result, we may not be able to successfully compete in our market, which could result in our failure
to successfully commercialize Sharps Provensa, or otherwise fail to successfully compete. We anticipate that our major domestic competitors
will include Retractable Technologies, Inc., Becton, Dickinson &amp; Company, Medtronic Minimally Invasive Therapies, Terumo Medical
Corp., Smiths Medical, and B Braun. There can be no assurances that we will be able to compete successfully in this environment.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>We
are vulnerable to new technologies.</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Because
we have a narrow focus on particular product lines and technology (currently, safety needle products), we are vulnerable to the development
of superior or similar competing products and to changes in technology which could eliminate or reduce the need for our products. If
a superior or similar technology is created, the demand for our products could be adversely affected.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>We
are subject to product liability risk.</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
a manufacturer and provider of safety needle products, we will face an inherent business risk of exposure to product liability claims.
Additionally, our success will depend on the quality, reliability, and safety of our products and defects in our products could damage
our reputation. If a product liability claim is made and damages are in excess of our product liability coverage (which is currently
$5 million, and which we may increase as we commence and increase sales of our products), our competitive position could be weakened
by the amount of money we could be required to pay to compensate those injured by our products. In the event of a recall, we have recall
insurance.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Our
business may be affected by changes in the health care regulatory environment.</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
the U.S. and internationally, government authorities may enact changes in regulatory requirements, reform existing reimbursement programs,
and/or make changes to patient access to health care, all of which could adversely affect the demand for our products and/or put downward
pressure on our prices. Future healthcare rulemaking could affect our business. We cannot predict the timing or impact of any future
rulemaking or changes in the law.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>The
approval process for medical device products outside the United States varies among countries and may limit our ability to develop, manufacture
and sell our products internationally. Failure to obtain marketing and regulatory approval in international jurisdictions would prevent
our products from being marketed abroad.</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
order to market and sell our Provensa product line and any additional medical device products we may develop in the future in the European
Union and many other jurisdictions, we, and our collaborators, must obtain separate marketing approvals and comply with numerous and
varying regulatory requirements. We have not yet received approval or clearance to sell our products in any jurisdiction outside the
United States. The approval procedure varies among countries and may involve additional testing. We may conduct clinical trials for,
and seek regulatory approval to market, our product candidates in countries other than the United States. If we or our collaborators
seek marketing approval for a product candidate outside the United States, we will be subject to the regulatory requirements of health
authorities in each country in which we seek approval. With respect to marketing authorizations in Europe, we will be required to submit
a European Marketing Authorisation Application, or MAA, to the European Medicines Agency, or EMA, which conducts a validation and scientific
approval process in evaluating a product for safety and efficacy. The approval procedure varies among regions and countries and may involve
additional testing, and the time required to obtain approval may differ from that required to obtain FDA approval or clearance. In addition,
marketing approval or clearance by the FDA does not ensure approval or clearance by the health authorities of any other country.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>&#160;</i></b></span></p>


<!-- Field: Page; Sequence: 12; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 0pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->8<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: left; width: 100%"><a href="#MT_001">Table of Contents</a></td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>&#160;</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Ongoing
regulation of our products may limit how we market our products, which could materially impair our ability to generate revenue.</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Approval
or clearance of a medical device product may carry conditions that limit the market for the product or put the product at a competitive
disadvantage relative to alternative products. For instance, a regulatory approval or clearance may limit the indicated uses for which
we can market a product or the patient population that may utilize the product. These restrictions could make it more difficult to market
any product effectively. Accordingly we expect to continue to expend time, money and effort in all areas of regulatory compliance.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>We
are dependent on our management, without whose services our business operations could cease.</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">At
this time, our management is wholly responsible for the development and execution of our business plan. If our management should choose
to leave us for any reason before we have hired additional personnel, our operations may fail. Even if we are able to find additional
personnel, it is uncertain whether we could find qualified management who could develop our business along the lines described herein
or who would be willing to work for compensation the Company could afford. Without such management, the Company could be forced to cease
operations and investors in our common stock or other securities could lose their entire investment.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>We
may not be able to raise capital as needed to develop our products or maintain our operations.</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
expect that we will need to raise additional funds to execute our business plan and expand our operations. Additional financing may not
be available to us on favorable terms, or at all. If we cannot raise needed funds on acceptable terms, the Company&#8217;s business and
prospects may be materially adversely affected.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Health
care crises could have an adverse effect on our business.</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Particularly
during 2020, several states and local jurisdictions imposed, and others in the future may impose, &#8220;shelter-in-place&#8221; orders,
quarantines, executive orders and similar government orders and restrictions for their residents to control the spread of COVID-19. Although
the manufacturing facility we operate has continued to operate during the 2020-2021 COVID-19 pandemic due to its status as an essential
business, we continue to monitor the evolving situation and cannot guarantee that the situation would be the same for any future pandemic.
In the future, we may elect or be required to close temporarily which would result in a disruption in our activities and operations.
Our supply chain, including transportation channels, may be impacted by any such restrictions as well. Any such disruption could impact
our sales and operating results.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Health
systems and other healthcare providers in our markets that provide procedures that may use our products have suffered financially and
operationally and may not be able to return to pre-pandemic levels of operations. Travel and import restrictions may also disrupt our
ability to manufacture or distribute our devices. Any import or export or other cargo restrictions related to our products or the raw
materials used to manufacture our products could restrict our ability to manufacture and ship products and harm our business, financial
condition, and results of operations.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
key personnel and other employees could still be affected by COVID-19 or any future pandemic, which could affect our ability to operate
efficiently.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 13; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 0pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->9<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: left; width: 100%"><a href="#MT_001">Table of Contents</a></td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Our
business may be adversely affected by uncertainties in obtaining and enforcing intellectual property rights.</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
believe our main competitive strength is our technology, including patent protection and trade secrets relating to the manufacture and
design of our products. We are dependent on patent rights to prevent unlawful copying of our products, and if the patent rights are invalidated
or circumvented, our business would be adversely affected. We consider patent protection to be of material importance in the design,
development, and marketing of our products.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Our
patent pending applications may not issue as patents, which may have a material adverse effect on our ability to prevent others from
commercially exploiting products similar to ours.</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
have four issued patents, two pending patent applications in the United States, and four PCT (Patent Cooperation Treaty) patent application.
We cannot be certain that we are the first inventor of the subject matter to which we have filed a particular patent application, or
if we are the first party to file such a patent application. If another party has filed a patent application to the same subject matter
as we have, we may not be entitled to the protection sought by the patent application. Further, the scope of protection of issued patent
claims is often difficult to determine. As a result, we cannot be certain that the patent applications that we file will issue, or that
our issued patents will be broad enough to protect our proprietary rights or otherwise afford protection against competitors with similar
technology. In addition, the issuance of a patent is not conclusive as to its inventorship, scope, validity or enforceability. Our competitors
may challenge or seek to invalidate our issued patents, or design around our issued patents, which may adversely affect our business,
prospects, financial condition or operating results. Also, the costs associated with enforcing patents, confidentiality and invention
agreements, or other intellectual property rights may make aggressive enforcement impracticable.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Illegal
distribution and sale by third parties of counterfeit versions of our products could have a negative impact on us.</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Third
parties may illegally distribute and sell counterfeit versions of our products which do not meet our rigorous manufacturing and testing
standards. Our reputation and business could suffer harm as a result.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Risks
Related to This Offering and Our Securities</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Our
common stock could be subject to extreme volatility.</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
trading price of our common stock may be affected by a number of factors, including events described in the risk factors set forth in
this offering circular, as well as our operating results, financial condition and other events or factors. In addition to the uncertainties
relating to future operating performance and the profitability of operations, factors such as variations in interim financial results
or various, as yet unpredictable, factors, many of which are beyond our control, may have a negative effect on the market price of our
common stock. In recent years, broad stock market indices, in general, and smaller capitalization companies, in particular, have experienced
substantial price fluctuations. In a volatile market, we may experience wide fluctuations in the market price of our common stock and
wide bid-ask spreads. These fluctuations may have a negative effect on the market price of our common stock. In addition, the securities
market has, from time to time, experienced significant price and volume fluctuations that are not related to the operating performance
of particular companies. These market fluctuations may also materially and adversely affect the market price of our common stock.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>We
have never paid common stock dividends and have no plans to pay dividends in the future, as a result our common stock may be less valuable
because a return on an investor&#8217;s investment will only occur if our stock price appreciates.</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Holders
of shares of our common stock are entitled to receive such dividends as may be declared by our Board of Directors. To date, we have paid
no cash dividends on our shares of common stock and we do not expect to pay cash dividends on our common stock in the foreseeable future.
We intend to retain future earnings, if any, to provide funds for operations of our business. Therefore, any return investors in our
common stock will be in the form of appreciation, if any, in the market value of our shares of common stock. There can be no assurance
that shares of our common stock will appreciate in value or even maintain the price at which our stockholders have purchased their shares.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Our
shares will be subject to potential delisting if we do not maintain the listing requirements of the Nasdaq Capital Market.</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
shares of our common stock are listed on the Nasdaq Capital Market, or Nasdaq. Nasdaq has rules for continued listing, including, without
limitation, minimum market capitalization and other requirements. Failure to maintain our listing, or de-listing from Nasdaq, would make
it more difficult for shareholders to dispose of our common stock and more difficult to obtain accurate price quotations on our common
stock. This could have an adverse effect on the price of our common stock. Our ability to issue additional securities for financing or
other purposes, or otherwise to arrange for any financing we may need in the future, may also be materially and adversely affected if
our common stock is not traded on a national securities exchange.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
we fail to comply with the continued listing requirements of NASDAQ, we may face possible delisting, which would result in a limited
public market for our shares and make obtaining future debt or equity financing more difficult for us. Specifically, as disclosed in
a Current Report filed on Form 8-K on July 16, 2023, the Company had received a notice (the &#8220;Notice&#8221;) from the staff of the
Listing Qualifications Department (the &#8220;Staff&#8221;) of The Nasdaq Stock Market LLC (&#8220;Nasdaq&#8221;) notifying the Company
that it was not in compliance with Nasdaq Listing Rule 5550(a)(2) (the &#8220;Rule&#8221;) because it failed to maintain a minimum bid
price of $1.00 over the previous 30 consecutive business days dated May 26, 2023 to July 11, 2023. The Rules provide the Company a compliance
period of 180 calendar days in which to regain compliance. If at any time during this 180 day period the closing bid price of the Company&#8217;s
security is at least $1 for a minimum of ten (10) consecutive business days, the Staff will provide written confirmation of compliance
and this matter will be closed.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 14; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 0pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->10<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: left; width: 100%"><a href="#MT_001">Table of Contents</a></td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
July 12, 2023, The Nasdaq Stock Market LLC (&#8220;Nasdaq&#8221;) notified the Company that the bid price of its common stock had closed
at less than $1.00 per share over the previous 30 consecutive business days, and, as a result, the Company was no longer in compliance
with Nasdaq Listing Rule 5550(a)(2) (the &#8220;Nasdaq Rule&#8221;). In accordance with Listing Rule 5810(c)(3)(A), the Company was provided
180 calendar days, or until January 8, 2024, to regain compliance with the Rule. Subsequently, on January 16, 2024, the Company was provided
an additional 180 calendar day compliance period, or until July 8, 2024, to demonstrate compliance. Pursuant to Nasdaq&#8217;s letter
on July 9, 2024, the Company has not regained compliance with Listing Rule 5550(a)(2). Accordingly, its securities will be delisted from
the Nasdaq Capital Market unless the Company requests a hearing and appeals Nasdaq&#8217;s determination by July 16, 2024., the trading
of the Company&#8217;s common stock and warrants will be suspended at the opening of business on July 18, 2024. The Company filed a hearing
request before the deadline. In the interim, the Company&#8217;s common stock and warrants have remained listed on NASDAQ under its existing
symbols, &#8220;STSS&#8221; and &#8220;STSW&#8221; while it awaits the results from the hearing on August 13, 2024.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
July 15, 2024, the Company held a Special Meeting of its stockholders. At the Meeting, the following three (3) proposals were each approved.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
    Company&#8217;s stockholders approved the amendment to the Company&#8217;s articles of incorporation to increase the authorized shares
    of common stock from 100,000,000 shares to 500,000,000 shares;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
    Company&#8217;s stockholders approved a proposal to authorize the Company&#8217;s Board of Directors (the &#8220;Board&#8221;), in
    its discretion at any time within one year after stockholder approval is obtained, to amend the Company&#8217;s Articles of Incorporation
    to effect a reverse stock split of shares of the Company&#8217;s common stock, at a ratio of up to 1-for-8, with the exact ratio
    to be determined by the Company&#8217;s Board and included in a public announcement;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
    Company&#8217;s stockholders approved a proposal for the issuance of securities in one or more non-public offerings where the maximum
    discount at which the securities will be offered will be equivalent to a discount not to exceed 20% below the market price of our
    common stock in accordance with Nasdaq Marketplace Rule 5635(d);</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
October 7, 2024, the Company held a Special Meeting of its stockholders. The Company&#8217;s stockholders approved a proposal to authorize
the Company&#8217;s Board in its discretion at any time within one year after stockholder approval is obtained, to amend the Company&#8217;s
Articles of Incorporation to effect a reverse stock split of shares of the Company&#8217;s common stock, at a ratio with a range of 1-for-8
to 1 for 22, with the exact ratio to be determined by the Company&#8217;s Board. The Board approved the 1 for 22 reverse stock split
on October 7, 2024 which went into effect on October 16, 2024.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Nasdaq
notified the Company on November 13, 2024 that the Company regained compliance on November 5, 2024 with Listing Rule 5550(a)(2), (the
&#8220;Bid Price Rule&#8221;)</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>We
will incur increased costs as a result of operating as a public company, and our management will be required to devote substantial time
to compliance with our public company responsibilities and corporate governance practices.</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
a public company, we will incur significant legal, accounting and other expenses that we did not incur as a private company, which we
expect to further increase after we are no longer an &#8220;emerging growth company.&#8221; The Sarbanes-Oxley Act, the Dodd-Frank Wall
Street Reform and Consumer Protection Act, the listing requirements of the Nasdaq Capital Market, and other applicable securities rules
and regulations impose various requirements on public companies. Our management and other personnel will devote a substantial amount
of time to compliance with these requirements. Moreover, these rules and regulations will increase our legal and financial compliance
costs and will make some activities more time-consuming and costly. We cannot predict or estimate the amount of additional costs we will
incur as a public company or the specific timing of such costs.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>As
a result of being a public company, we are obligated to develop and maintain proper and effective internal controls over financial reporting,
and any failure to maintain the adequacy of these internal controls may adversely affect investor confidence in our company and, as a
result, the value of our common stock.</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
were required for 2023, pursuant to Section 404 of the Sarbanes-Oxley Act, to furnish a report by management on, among other things,
the effectiveness of our internal control over financial reporting as of the end of the fiscal year that coincides with the filing of
our second annual report on Form 10-K. This assessment will need to include disclosure of any material weaknesses identified by our management
in our internal control over financial reporting. In addition, our independent registered public accounting firm may be required to attest
to the effectiveness of our internal control over financial reporting in our first annual report required to be filed with the SEC following
the date we are no longer an &#8220;emerging growth company.&#8221; We have commenced the costly and time-consuming process of compiling
the system and processing documentation necessary to perform the evaluation needed to comply with Section 404, and we expect to be able
to complete our evaluation, testing and any required remediation in a timely fashion. Our compliance with Section 404 will require that
we incur substantial expenses and expend significant management efforts. We currently do not have an internal audit group, and we in
the future we may need to hire additional accounting and financial staff with appropriate public company experience and technical accounting
knowledge and compile the system and process documentation necessary to perform the evaluation needed to comply with Section 404.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 15; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 0pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->11<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: left; width: 100%"><a href="#MT_001">Table of Contents</a></td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
current controls and any new controls that we develop may become inadequate because of changes in conditions in our business. In addition,
changes in accounting principles or interpretations could also challenge our internal controls and require that we establish new business
processes, systems and controls to accommodate such changes. Additionally, if these new systems, controls or standards and the associated
process changes do not give rise to the benefits that we expect or do not operate as intended, it could adversely affect our financial
reporting systems and processes, our ability to produce timely and accurate financial reports or the effectiveness of internal control
over financial reporting. Moreover, our business may be harmed if we experience problems with any new systems and controls that result
in delays in their implementation or increased costs to correct any post-implementation issues that may arise.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Any
failure to maintain internal control over financial reporting could severely inhibit our ability to accurately report our financial condition
or results of operations. If we are unable to conclude that our internal control over financial reporting is effective, we could lose
investor confidence in the accuracy and completeness of our financial reports, the market price of our common stock could decline, and
we could be subject to sanctions or investigations by the SEC or other regulatory authorities. Failure to remedy any material weakness
in our internal control over financial reporting, or to implement or maintain other effective control systems required of public companies,
could also restrict our future access to the capital markets.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>A
sale of a substantial number of shares of our common stock may cause the price of the common stock to decline.</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
our stockholders sell substantial amounts of our common stock in the public market, the market price of our common stock could fall.
These sales also may make it more difficult for us to sell equity or equity-related securities in the future at a time and price that
we deem reasonable or appropriate. Stockholders who have held their shares for at least six months are able to sell their shares pursuant
to Rule 144 under the Securities Act. Almost all of our outstanding shares are available to be sold in the open market under Rule 144
or because they have been registered under the Securities Act We have also registered shares of our common stock for sale into the public
market which are issuable upon the exercise of warrants, by certain selling stockholders named therein. These shares represent a large
number of shares of our common stock, and if sold in the market all at once or at about the same time, could depress the market price
of our common stock during the period the registration statement remains effective and could also affect our ability to raise equity
capital.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Our
stock price may be volatile, and the value of our common stock may decline.</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
market price of our common stock is likely to be highly volatile and could fluctuate widely in price in response to various factors,
many of which are beyond our control, including the following:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">actual
    or anticipated fluctuations in our financial condition or results of operations;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">variance
    in our financial performance from expectations of securities analysts;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">changes
    in our projected operating and financial results;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">changes
    in laws or regulations applicable to our products;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">announcements
    by us or our competitors of significant business developments, acquisitions or new products;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">sales
    of shares of our common stock by us or our shareholders, as well as the anticipation of lock-up releases;</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 16; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 0pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->12<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: left; width: 100%"><a href="#MT_001">Table of Contents</a></td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">our
    involvement in litigation;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">future
    sales of our common stock by us or our stockholders;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">changes
    in senior management or key personnel;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
    trading volume of our common stock;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">changes
    in the anticipated future size and growth rate of our market;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">general
    economic and market conditions; and</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">other
    events or factors, including those resulting from war, incidents of terrorism, global pandemics or responses to these events.</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Broad
market and industry fluctuations, as well as general economic, political, regulatory and market conditions, may also negatively impact
the market price of our common stock. In the past, companies who have experienced volatility in the market price of their securities
have been subject to securities class action litigation. We may be the target of this type of litigation in the future, which could result
in substantial expenses and divert our management&#8217;s attention.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Purchasers
in the offering will suffer immediate dilution.</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
you purchase Offered Shares in this offering, the value of your shares based on our pro forma net tangible book value will immediately
be less than the offering price you paid. This reduction in the value of your equity is known as dilution. At a public offering price
of $1.85 per share (which assumed Unit offering price does not account for the $0.125 per warrant purchase price)
purchasers of common stock in this offering will experience immediate dilution of approximately $0.24 per share, representing
the difference between the public offering price per share in this offering and our pro forma as adjusted net tangible book value per
share as of September 30, 2024, after giving effect to the Pro Forma Adjustments (as defined herein), this offering, and after deducting
estimated offering expenses, including Underwriter fees, payable by us. See &#8220;Dilution.&#8221;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>We
do not intend to pay dividends on our common stock for the foreseeable future.</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
have paid no dividends on our common stock to date and we do not anticipate paying any dividends to holders of our common stock in the
foreseeable future. While our future dividend policy will be based on the operating results and capital needs of the business, we currently
anticipate that we will retain any earnings to finance our future expansion and for the implementation of our business plan. Investors
should take note of the fact that a lack of a dividend can further affect the market value of our common stock and could significantly
affect the value of any investment in the Company.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Our
articles of incorporation allow for our board to create new series of preferred stock without further approval by our stockholders, which
could adversely affect the rights of the holders of our common stock.</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
board of directors has the authority to fix and determine the relative rights and preferences of preferred stock. Our board of directors
has the authority to issue up to 1,000,000 shares of our preferred stock without further stockholder approval. Our board of directors
could authorize the creation of additional series of preferred stock that would grant to holders of preferred stock the right to our
assets upon liquidation, or the right to receive dividend payments before dividends are distributed to the holders of common stock. In
addition, subject to the rules of any securities exchange on which our stock is then listed, our board of directors could authorize the
creation of additional series of preferred stock that has greater voting power than our common stock or that is convertible into our
common stock, which could decrease the relative voting power of our common stock or result in dilution to our existing stockholders.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 17; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 0pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->13<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: left; width: 100%"><a href="#MT_001">Table of Contents</a></td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Our
executive officers, directors and principal stockholders, if they choose to act together, have the ability to control or significantly
influence all matters submitted to stockholders for approval.</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
executive officers, directors and principal stockholders in the aggregate, beneficially own approximately 7.62% of our common
stock. Such persons acting together, will have the ability to control or significantly influence all matters submitted to our stockholders
for approval, as well as our management and business affairs. This concentration of ownership may have the effect of delaying, deferring
or preventing a change in control, impeding a merger, consolidation, takeover or other business combination involving us, or discouraging
a potential acquiror from making a tender offer or otherwise attempting to obtain control of our business, even if such a transaction
would benefit other stockholders.	</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>The
Warrants and Pre-Funded Warrants are speculative in nature.</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Except
as otherwise set forth in the Pre-Funded Warrants and Warrants, the Pre-Funded Warrants and Warrants offered in this offering do not
confer any rights of common stock ownership on their holders, such as voting rights, but rather merely represent the right to acquire
shares of our common stock at a fixed price for a limited period of time. Specifically, commencing upon Warrant Stockholder Approval,
holders of the Series A Warrants may exercise their right to acquire the common stock and pay an exercise price of $2.3125 per
share (125% of the assumed offering price per Unit), subject to adjustment, from time to time, until the 5 year anniversary from the
date of the Warrant Stockholder Approval, after which date any unexercised Series A Warrants will expire and have no further value, and
holders of the Pre-Funded Warrants may exercise their right to acquire the common stock and pay an exercise price of $0.0001 per share,
subject to adjustment, from time to time, until all of the Pre-Funded Warrants have been exercised; and commencing upon Warrant Stockholder
Approval, holders of Series B Warrants may exercise their right to acquire the common stock and pay an exercise price of $2.3125
per share 125% of the assumed offering price per Unit), subject to adjustment, from time to time, until the two and one half year anniversary
from the date of Warrant Stockholder Approval, after which date any unexercised Series B Warrants will expire and have no further value.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Additional
stock offerings in the future may dilute then-existing shareholders&#8217; percentage ownership of the Company.</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Given
our plans and expectations that we will need additional capital and personnel, we anticipate that we will need to issue additional shares
of common stock or securities convertible or exercisable for shares of common stock, including convertible preferred stock, convertible
notes, stock options or warrants. The issuance of additional securities in the future will dilute the percentage ownership of then current
stockholders.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>We
are an &#8220;emerging growth company,&#8221; and we cannot be certain if the reduced reporting and disclosure requirements applicable
to emerging growth companies will make our common stock less attractive to investors.</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
are an &#8220;emerging-growth company,&#8221; as defined in the JOBS Act, and we have elected to take advantage of certain exemptions
from various reporting requirements that are applicable to other public companies that are not &#8220;emerging growth companies,&#8221;
including the auditor attestation requirements of Section 404 of the Sarbanes-Oxley Act, or Section 404, reduced disclosure obligations
regarding executive compensation in our periodic reports and proxy statements, and exemptions from the requirements of holding a nonbinding
advisory vote on executive compensation and stockholder approval of any golden parachute payments not previously approved. Pursuant to
Section 107 of the JOBS Act, as an emerging growth company, we have elected to use the extended transition period for complying with
new or revised accounting standards until those standards would otherwise apply to private companies. As a result, our consolidated financial
statements will not be comparable to the financial statements of issuers who are required to comply with the effective dates for new
or revised accounting standards that are applicable to public companies, which may make our common stock less attractive to investors.
In addition, if we cease to be an emerging growth company, we will no longer be able to use the extended transition period for complying
with new or revised accounting standards.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
will remain an emerging-growth company until the earliest of: (1) the last day of the fiscal year following the fifth anniversary of
this offering; (2) the last day of the first fiscal year in which our annual gross revenue is $1.235 billion or more; (3) the date on
which we have, during the previous rolling three-year period, issued more than $1 billion in non-convertible debt securities; and (4)
the date we qualify as a &#8220;large accelerated filer,&#8221; with at least $700 million of equity securities held by non-affiliates.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
cannot predict if investors will find our common stock less attractive as a result of choosing to rely on these exemptions. For example,
if we do not adopt a new or revised accounting standard, our future results of operations will not be as comparable to the results of
operations of certain other companies in our industry that adopted such standards. If some investors find our common stock less attractive
as a result, there may be a less active trading market for our common stock, and our stock price may be more volatile.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 18; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 0pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->14<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: left; width: 100%"><a href="#MT_001">Table of Contents</a></td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span id="RM_007"></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>SPECIAL
NOTE REGARDING FORWARD-LOOKING STATEMENTS</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.3in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">This
prospectus contains, in addition to historical information, forward-looking statements. These statements are based on our management&#8217;s
beliefs and assumptions and on information currently available to our management. The forward-looking statements are contained principally
under the headings &#8220;Prospectus Summary,&#8221; &#8220;Risk Factors,&#8221; &#8220;Management&#8217;s Discussion and Analysis of
Financial Condition and Results of Operations,&#8221; &#8220;Use of Proceeds&#8221; and &#8220;Business.&#8221; Forward-looking statements
include statements concerning:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">our
    possible or assumed future results of operations;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">our
    business strategies;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">our
    ability to attract and retain customers;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">our
    ability to sell products to customers;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">our
    cash needs and financing plans;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">our
    competitive position;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">our
    industry environment;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">our
    potential growth opportunities;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
    effects of future regulation; and</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
    effects of competition.</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.3in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">All
statements in this prospectus that are not historical facts are forward-looking statements. We may, in some cases, use terms such as
&#8220;anticipates,&#8221; &#8220;believes,&#8221; &#8220;could,&#8221; &#8220;estimates,&#8221; &#8220;expects,&#8221; &#8220;intends,&#8221;
&#8220;may,&#8221; &#8220;plans,&#8221; &#8220;potential,&#8221; &#8220;predicts,&#8221; &#8220;projects,&#8221; &#8220;should,&#8221;
&#8220;will,&#8221; &#8220;would&#8221; or similar expressions that convey uncertainty of future events or outcomes to identify forward-looking
statements.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.3in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
outcome of the events described in these forward-looking statements are subject to known and unknown risks, uncertainties and other factors
that may cause our actual results, performance or achievements to be materially different from any future results, performances or achievements
expressed or implied by the forward-looking statements. These important factors include our financial performance and the other important
factors we discuss in greater detail in &#8220;Risk Factors.&#8221; You should read these factors and the other cautionary statements
made in this prospectus as applying to all related forward-looking statements wherever they appear in this prospectus. Given these factors,
you should not place undue reliance on these forward-looking statements. Also, forward-looking statements represent our management&#8217;s
beliefs and assumptions only as of the date on which the statements are made. We undertake no obligation to publicly update any forward-looking
statements, whether as a result of new information, future events or otherwise, except as required by law. You should read this prospectus
and the documents that we reference in this prospectus and have filed as exhibits to the registration statement, of which this prospectus
is a part, completely and with the understanding that our actual future results may be materially different from what we currently expect.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="RM_008"></span>USE
OF PROCEEDS</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
estimate that the net proceeds to us from this offering will be $13.5 million after deducting Underwriter fees and other
estimated offering expenses payable by us for this offering.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
intend to use the net proceeds from this offering for working capital and other general corporate purposes and repay outstanding debt, including $4,174,658 in outstanding senior notes of the Company.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Investors
must rely on the judgment of our management, who will have broad discretion regarding the application of the remaining net proceeds of
this offering. The amounts and timing of our actual expenditures will depend upon numerous factors, including market conditions, cash
generated by our operations (if any), business developments and the rate of our growth. We may find it necessary or advisable to use
portions of the proceeds of this offering for other purposes. Pending these uses, we intend to invest the net proceeds of this offering
in a money market or other interest-bearing account.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>


<!-- Field: Page; Sequence: 19; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 0pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->15<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: left; width: 100%"><a href="#MT_001">Table of Contents</a></td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="RM_009"></span>DIVIDEND
POLICY</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.45in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
have never declared or paid any cash dividends on our common stock. We do not anticipate paying any cash dividends to stockholders in
the foreseeable future. In addition, any future determination to pay cash dividends will be at the discretion of the board of directors
and will be dependent upon our financial condition, results of operations, capital requirements, and such other factors as the Board
of Directors deem relevant. There are no restrictions in our articles of incorporation or bylaws that restrict us from declaring dividends.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span id="RM_010"></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>CAPITALIZATION</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 33pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
following table sets forth our cash and our capitalization as of September 30, 2024, on:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">an
                                            actual basis; and</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">&#160;</td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif"/><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">on
                                            a pro forma as adjusted basis to give effect to (i) the sale of 248,430 shares under a Reg.
                                            A offering in December 2024 with net proceeds of $399,784 under a Qualified Form 1 and
                                            103,685 warrants exercised at $0.0001, and the sale of 8,108,108 Common Units
                                            in this offering, at $1.85 per Common Unit (which assumed Unit offering price does not account for the $0.125 per warrant purchase price), before deducting underwriting
                                            discounts and commissions and estimated offering expenses payable by us.</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.45in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">You
should read this table in conjunction with &#8220;Use of Proceeds,&#8221; &#8220;Management&#8217;s Discussion and Analysis of Financial
Condition and Results of Operations,&#8221; and our unaudited financial statements for the nine months ended September 30, 2024 and
the related notes thereto, included in this prospectus.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td style="padding-bottom: 1pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1pt; text-align: center; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">Actual</span></td><td style="padding-bottom: 1pt; text-align: center; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1pt; text-align: center; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">Pro
    forma as adjusted</span></td><td style="padding-bottom: 1pt; text-align: center; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 1pt; width: 60%"><span style="font-family: Times New Roman, Times, Serif">Cash</span></td><td style="padding-bottom: 1pt; width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 1pt solid; width: 16%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">2,473,197</span></td><td style="padding-bottom: 1pt; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1pt; width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 1pt solid; width: 16%; text-align: right"><p style="margin: 0; text-indent: 0.5in">12,273,225</p></td><td style="padding-bottom: 1pt; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Total Assets</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">11,253,898</span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 1pt solid; text-align: right"><p style="margin: 0; text-indent: 0.5in">20,803,926</p></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Total liabilities (1)</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">4,748,195</span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1pt solid; text-align: right"><p style="margin: 0; text-indent: 0.5in">4,279,080</p><span style="font-family: Times New Roman, Times, Serif"></span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Stockholders&#8217; equity:</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Common Stock, $0.0001 par value: 500,000,000
    shares authorized; shares issued and outstanding, actual;1,694,110, shares issued and outstanding, 10,154,133, pro forma as
    adjusted*</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">170</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><p style="margin: 0">1,015</p><span style="font-family: Times New Roman, Times, Serif"></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Additional paid-in capital</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">35,941,738</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><p style="margin: 0">48,056,925</p><span style="font-family: Times New Roman, Times, Serif"></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Accumulated other comprehensive income</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">482,572</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">482,572</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">Accumulated deficit</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(29,918,777</span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1pt; text-align: right"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: right">(32,177,666</p>
<span style="font-family: Times New Roman, Times, Serif"></span></td><td style="padding-bottom: 1pt; text-align: left">)<span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Total stockholders&#8217;
    equity</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">6,505,703</span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">16,362,846</span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;Total Liabilities and Stockholders&#8217; Equity</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif">11,253,898</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><p style="margin: 0">20,803,926</p></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" border="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt">
<tr style="vertical-align: top">
    <td style="width: 0.25in">&#160;</td>
  <td style="text-align: justify; width: 0.25in">(1)</td>
  <td style="text-align: justify">Includes a $2.0M value ascribed to the 16.2 million Class A and B warrants in the Common
  Units offered based on the value of $0.125 per warrant.</td></tr>
</table>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="bs_001"></span>DILUTION</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Purchasers
of our common stock in this offering will experience an immediate and substantial dilution in the pro forma net tangible book value of
their shares of common stock. Dilution in pro forma net tangible book value represents the difference between the public offering price
per share and the pro forma as adjusted net tangible book value per share of our common stock immediately after the offering.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
historical net tangible book value of our common stock as of September 30, 2024 was $6,465,476 or $3.82 per share, which represents
our total tangible assets (total assets less intangible assets) less total liabilities divided by the number of shares of common
stock outstanding as of that date.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">After
giving effect to the issuance of an aggregate of 248,430 shares of common stock from September 30, 2024 and exercise of 103,685 warrants
at exercise price of $0.0001 until the date of this prospectus, our pro forma net tangible book value as of September 30, 2024 would
have been $6,843,604 or approximately $3.34 per share of our common stock.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">After
giving effect to the pro forma adjustments set forth above and the sale of 8,108,108 Units in this offering at an assumed public
offering price of $1.85 per Unit (which assumed Unit offering price does not account for the $0.125 per warrant purchase price), after deducting estimated underwriting discounts and commissions and estimated offering expenses and attributing the value
to the warrants and related costs, our pro forma adjusted net tangible book value as of September 30, 2024 would have been $16,322,619
or approximately $1.60 per share of common stock. This represents an immediate decrease in pro forma net tangible book value
per share of $1.74 to the existing stockholders and an immediate dilution in pro forma net tangible book value per share of $0.24
to new investors who purchase Units in the offering. The following table illustrates this per share dilution to new investors:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 82%; text-align: left">Assumed public offering price per Unit (1)</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 14%; text-align: right">1.85</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td>Historical net tangible book value per share as of September 30, 2024</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">3.82</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Decrease in net tangible book value per share attributable to the pro forma adjustments described
    above</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">(0.48</td><td style="text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td>Pro forma net tangible book value per share as of September 30, 2024</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">3.34</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Decrease in pro forma net tangible book value per share after giving effect to this offering</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">(1.74</td><td style="text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td>Pro forma as adjusted net tangible book value per share as of September 30, 2024 after the offering</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">1.60</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Dilution per share to investors in this public offering</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">0.24</td><td style="text-align: left">&#160;</td></tr>
  </table>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"></p>

<table cellpadding="0" cellspacing="0" border="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
<tr style="vertical-align: top">
    <td style="width: 0.25in">&#160;</td>
  <td style="width: 0.25in">(1)</td>
  <td>Does not give effect to the $0.125 per warrant purchase price, to be received by the Company.</td></tr>
</table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
dilution information discussed above is illustrative only and will change based on the actual public offering price and other terms of
this offering determined at pricing. A $0.50 increase or decrease in the assumed public offering price of $1.85 per Unit (which assumed Unit offering price does not account for the $0.125 per warrant purchase price), would increase or decrease our pro
forma adjusted net tangible book value per share, after this offering, by $0.37 to $1.97 or $1.24, respectively
per share. This illustrative example with a $0.50 increase or decrease would result in dilution per share to new investors purchasing
Units in this offering by $0.38 or $0.11, respectively, assuming that the number of Units offered by us, as set forth on
the cover page of this prospectus, remains the same and after deducting the estimated underwriting discounts and commissions and estimated
offering expenses payable by us.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>



<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">To
the extent that outstanding options or warrants are exercised, you will experience further dilution. In addition, we may choose to raise
additional capital due to market conditions or strategic considerations even if we believe we have sufficient funds for our current or
future operating plans. To the extent that additional capital is raised through the sale of equity or convertible debt securities, the
issuance of these securities may result in further dilution to our stockholders.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
dilution information set forth in the table above is illustrative only and will be adjusted based on the actual public offering price
and other terms of this offering determined at pricing.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 20; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 0pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->16<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: left; width: 100%"><a href="#MT_001">Table of Contents</a></td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="RM_011"></span>MANAGEMENT&#8217;S
DISCUSSION AND ANALYSIS OF</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>FINANCIAL
CONDITION AND RESULTS OF OPERATIONS</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>The
following discussion and analysis summarizes the significant factors affecting the consolidated operating results, financial condition,
liquidity and cash flows of our Company as of and for the periods presented below. The following discussion and analysis of our financial
condition and results of operations should be read in conjunction with our audited consolidated financial statements and notes included
in this offering circular and our Annual Report on Form 10-K as of and for the years ended December 31, 2023, and 2022. </i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Forward-Looking
Statements</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>The
information in this discussion contains forward-looking statements and information within the meaning of Section 27A of the Securities
Act of 1933, as amended, or the Securities Act, and Section 21E of the Securities Exchange Act of 1934, as amended, or the Exchange Act,
which are subject to the &#8220;safe harbor&#8221; created by those sections. These forward-looking statements include, but are not limited
to, statements concerning our strategy, future operations, future financial position, future revenues, projected costs, prospects and
plans and objectives of management. The words &#8220;anticipates,&#8221; &#8220;believes,&#8221; &#8220;estimates,&#8221; &#8220;expects,&#8221;
&#8220;intends,&#8221; &#8220;may,&#8221; &#8220;plans,&#8221; &#8220;projects,&#8221; &#8220;will,&#8221; &#8220;would&#8221; and similar
expressions are intended to identify forward-looking statements, although not all forward-looking statements contain these identifying
words. We may not actually achieve the plans, intentions, or expectations disclosed in our forward-looking statements and you should
not place undue reliance on our forward-looking statements. Actual results or events could differ materially from the plans, intentions
and expectations disclosed in the forward-looking statements that we make. These forward-looking statements involve risks and uncertainties
that could cause our actual results to differ materially from those in the forward-looking statements, including, without limitation,
the risks set forth in our filings with the SEC. The forward-looking statements are applicable only as of the date on which they are
made, and we do not assume any obligation to update any forward-looking statements</i>.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Overview</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Since
our inception in 2017 and through the fourth quarter of 2022, we have devoted substantially all of our resources to the research and
development of our safety syringe products Commencing in the fourth quarter of 2022 we started building inventory of syringe products.
To date, we have generated no revenue. We have incurred net losses of $9,841,638 and $4,639,662 for the years ended December 31, 2023
and 2022, respectively and $4,769,774 for the nine months ended September 30, 2024. Substantially all of our net losses resulted
from costs incurred in connection with our research and development efforts, payroll and consulting fees, stock compensation and general
and administrative costs associated with our operations, <span style="background-color: white">including costs incurred for being a public
company since April 14, 2022. See below Initial Public Offering, Liquidity and Capital Resources and Notes to Consolidated Financial
Statements</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
classify our operating expenses as research and development, and general and administrative expenses. We maintain a corporate office
located in Melville, New York, but employees and consultants in the US work remotely and will continue to do so indefinitely. In June
2020, in connection with the agreement to acquire Safegard, a syringe manufacturing facility in Hungary, which was completed on July
6, 2022, we were contractually provided the exclusive use of the facility for research and development and testing in exchange for payment
of the seller&#8217;s operating costs, including among others, use of Safegard&#8217;s work force, utility costs and other services.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 21; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 0pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->17<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: left; width: 100%"><a href="#MT_001">Table of Contents</a></td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Initial
Public Offering</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
April 13, 2022, our registration statement on Form S-1 (File No. 333-263715), as amended, related to our IPO was declared effective by
the SEC, and our common stock and warrants began trading on the Nasdaq Capital Market, or Nasdaq, on April 14, 2022. Our IPO closed on
April 19, 2022. Net proceeds from the IPO were approximately $14.2 million. In connection with the closing of the IPO, the Company used
net proceeds to repay the Note Payable of $2 million.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Critical
Accounting Policies and Significant Judgments and Estimates</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">This
management&#8217;s discussion and analysis of our financial condition and results of operations is based on our financial statements,
which we have prepared in accordance with accounting principles generally accepted in the United States. The preparation of our financial
statements requires us to make estimates and assumptions that affect the reported amounts of assets and liabilities and the disclosure
of contingent assets and liabilities at the date of our financial statements, as well as the reported revenues and expenses during the
reported periods. We evaluate these estimates and judgments on an ongoing basis. We base our estimates on historical experience and on
various other factors that we believe are reasonable under the circumstances, the results of which form the basis for making judgments
about the carrying value of assets and liabilities that are not readily apparent from other sources. Actual results may differ from these
estimates under different assumptions or conditions. The FMV adjustments, based on the trading price of outstanding warrants classified
as liabilities, could impact the operating results in the reporting periods.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Nature
of Business</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Sharps
Technology, Inc. (&#8220;Sharps&#8221; or the &#8220;Company&#8221;) is a pre-revenue medical device company that has designed and patented
various safety syringes and is seeking commercialization by manufacturing and distribution of its products.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
accompanying consolidated financial statements include the accounts of Sharps Technology, Inc. and its wholly owned subsidiaries, Safegard
Medical, Inc, and Sharps Acquisition Corp. collectively referred to as the &#8220;Company.&#8221; All intercompany transactions and balances
have been eliminated.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company&#8217;s fiscal year ends on December 31.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
April 13, 2022, the Company&#8217;s Initial Public Offering was deemed effective with trading commencing on April 14, 2022. The Company
received net proceeds of $14.2 million on April 19, 2022. (See Capital Structure and Note 8 to the Consolidated Financial Statements)</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"></p>

<!-- Field: Page; Sequence: 22; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 0pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->18<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: left; width: 100%"><a href="#MT_001">Table of Contents</a></td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Summary
of Significant Accounting Policies</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
significant accounting policies are described in Note 2 of the accompanying annual report on Form 10-K for the year ended December 31,
2023 and the accompanying unaudited condensed consolidated financial statements as of September 30, 2024,</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Off-Balance
Sheet Arrangements</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">During
the periods presented, we did not have any off-balance sheet arrangements as defined under Regulation S-K Item 303(a)(4).</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Results
of Operations - Years Ended December 31, 2023 and, 2022.</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td style="text-align: center">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="10" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Year Ended</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="text-align: center">&#160;</td><td style="padding-bottom: 1pt">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: center">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>December 31,</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>2023</b></span></p></td><td style="padding-bottom: 1pt">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>December 31,</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>2022</b></span></p></td><td style="padding-bottom: 1pt">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Change</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Change %</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 36%; text-align: left">Research and development</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 12%; text-align: right">1,605,547</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 12%; text-align: right">2,280,933</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 12%; text-align: right">(675,386</td><td style="width: 1%; text-align: left">)</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 12%; text-align: right">(30</td><td style="width: 1%; text-align: left">)%</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">General and administrative</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">8,521,103</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">6,457,860</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">2,063,243</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">32</td><td style="text-align: left">%</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Interest expense (income)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(138,118</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">1,320,416</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(1,458,534</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">110</td><td style="text-align: left">%</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">FMV gain adjustment for derivatives</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(169,583</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(5,392,911</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">5,223,328</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(97</td><td style="text-align: left">)%</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Foreign currency Loss</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">44,463</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">496</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">43,967</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">88</td><td style="text-align: left">%</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td>Other</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">8,226</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(27,132</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">35,358</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(130</td><td style="text-align: left">)%</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1pt">Deferred Tax (Benefit)</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(30,000</td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">-</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(30,000</td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">100</td><td style="padding-bottom: 1pt; text-align: left">%</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 2.5pt">Net loss</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">9,841,638</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">4,639,662</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">5,201,976</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td style="border-bottom: Black 2.5pt double; text-align: right">(112</td><td style="padding-bottom: 2.5pt; text-align: left">)%</td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Revenue</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company has not generated any revenue to date.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Research
and Development</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">For
the year ended December 31, 2023, Research and Development (&#8220;R&amp;D&#8221;) expenses decreased to $1,605,547 compared to $2,280,933
for the year ended December 31, 2022. The decrease of $675,386 was due to decreased R&amp;D costs incurred at the Safegard facility which
transitioned principally from R&amp;D activities to manufacturing. The decrease occurred in materials and general operating costs of
approximately $1M, of which, a) $575,000 related to cost incurred prior to the acquisition in July 2022 for utilization of the facility,
which included Safegard&#8217;s workforce and facility operating cost and b) decreases in material and other operating of $426,000 from
$545,000 in 2022 to $119,000 in 2023. Further, we had decreases in labor related costs of $224,000 specifically related to decreases
in stock compensation of $83,000 from $97,000 in 2022 to $14,000 in 2023, decreases in engineering and other labor costs of $141,000
from $492,000 in 2022 to $351,000 in 2023 and other decreases of $10,000. The overall decrease was partially offset by $560,000 charge
in 2023 for an impairment of certain molds.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>General
and Administrative</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">For
the year ended December 31, 2023, General and Administrative (&#8220;G&amp;A&#8221;) expenses were $8,521,103 as compared to $6,457,860
for the year ended December 31, 2022. The increase of $2,063,243 was primarily attributable to increases in payroll and related of: i)
payroll and consulting fees of $1,530,000 from $1,630,000 in 2022 to $3,160,000 in 2023, primarily due to increased amounts of payroll,
increased staffing and higher usage of various consulting services and ii) increase in stock compensation expense, due to timing of option
awards and vesting, of approximately $34,000 from $916,000 in 2022 to $950,000 in 2023. In addition, we had increases in G&amp;A for
the year ended December 31, 2023, of approximately $498,000 principally from increased: professional fees $318,000, depreciation $238,000,
general operating costs $251,000, insurance $126,000, technology related costs, including implementation of new ERP system $128,000 and
separation expense of $375,000 for former officer. These were partially offset by lower public company costs and investor relations $818,000,
travel $90,000 and patent fees $31,000.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 23; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 0pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->19<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: left; width: 100%"><a href="#MT_001">Table of Contents</a></td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Interest
expense (income)</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Interest
income, net of interest expense, was $138,118 for the year ended December 31, 2023, compared to interest expense of $1,320,416 for the
year ended December 31, 2022. Interest improved, net by $1,458,534 due to a) interest earned on invested cash in 2023 of $138,118 as
compared to $42,900 in 2022 and b) the decrease in interest expense and accreted interest of approximately $1,363,316 was primarily relating
to the financing entered in December 2021which was repaid at the IPO closing with net proceeds.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>FMV
Adjustment for Derivatives</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
value of the Note Warrants requires the Fair Market Value (&#8220;FMV&#8221;) to be remeasured at each reporting date while outstanding
with recognition of the changes in fair value to other income or expense in the statement of operations and comprehensive loss. For the
years ended December 31, 2023, and 2022 the Company recorded a $169,583 and $5,392,911 FMV gain adjustment respectively to reflect the
decrease in the Note Warrants and Warrants liabilities issued. (See Notes 7, 8 and 10 to the Consolidated Financial Statements)</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Liquidity
and Capital Resources</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">At
December 31, 2023, and 2022, we had a cash balance of $3,012,908 and $4,170,897, respectively. The Company has working capital of $1,145,569
as of December 31, 2023, vs working capital of $2,416,928, as of December 31, 2022. The decrease in our working capital, after net proceeds
from offerings of $8,029,628, was primarily related to the use of cash of $9,205,577 in operations and investing in fixed assets purchased.
The Company intends to finance its future development and commercialization activities and its working capital needs largely from the
sale of equity securities and/or with additional funding from other traditional financing sources.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
April 13, 2022, we completed its IPO which was declared effective by the SEC, and the Company&#8217;s common stock and warrants began
trading on the Nasdaq Capital Market or Nasdaq on April 14, 2022 and which closed on April 19, 2022. The net proceeds from the IPO were
approximately $14.2 million of which $5,778,750 was attributed to the warrant liability (See Notes 8 and 10 to the Consolidated Financial
Statements).</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
February 3, 2023, we completed a securities purchase agreement). On September 29, 2023, the Company completed two simultaneous offerings.
(See Liquidity and Capital Resources as of March 31, 2024 below)</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Cash
Flows</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Net
Cash Used in Operating Activities</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company used cash of $8,507,300 and $6,433,159 in operating activities for the year ended December 31, 2023 and 2022, respectively. The
increase in cash used was principally due to the Company incurring additional G&amp;A expenses, buildup of inventory partially offset
by lower R&amp;D activities as described above during year ended December 31, 2022.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Net
Cash Used in Investing Activities</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">For
the years ended December 31, 2023 and 2022, the Company used cash in investing activities of $698,277 and $3,117,916, respectively. In
both years, cash was used to acquire or pay deposits for machinery and equipment of $698,277 and $542,662, respectively. In the year
ended December 31, 2022, the Company used $2,365,576, for the acquisition of Safegard or related escrow payments.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 24; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 0pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->20<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: left; width: 100%"><a href="#MT_001">Table of Contents</a></td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Net
Cash Provided by Financing Activities</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">For
the year ended December 31, 2023 and 2022, the Company provided cash from financing activities of $8,029,628 and $12,235,475, respectively.
In the 2023 period, the cash provided was from the net proceeds from the Offerings in February and September 2023. In the 2022 period,
the cash provided was primarily from the IPO net proceeds of $14,202,975, prior to the effect of recording the liability attributed to
the warrants from the IPO, less the Notes repayment of $2,000,000.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Results
of Operations &#8211; Nine Months Ended September 30, 2024 and 2023.</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td style="text-align: center">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2024</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2023</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Change</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Change %</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 36%; text-align: left">Research and development</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 12%; text-align: right">523,347</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 12%; text-align: right">783,340</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 12%; text-align: right">(259,993</td><td style="width: 1%; text-align: left">)</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 12%; text-align: right">-33</td><td style="width: 1%; text-align: left">%</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">General and administrative</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">5,257,015</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">6,425,154</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(1,168,139</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-18</td><td style="text-align: left">%</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Other expense (income)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">1,046,593</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(94,492</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">1,141,085</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-1,208</td><td style="text-align: left">%</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">FMV (gain) loss adjustment for warrants</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(2,088,747</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(415,958</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(1,672,789</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">402</td><td style="text-align: left">%</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1pt">Foreign exchange loss</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">31,566</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">41,955</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(10,389</td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">-25</td><td style="padding-bottom: 1pt; text-align: left">%</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 2.5pt">Net loss</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">4,769,774</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">6,739,999</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">(1,970,225</td><td style="padding-bottom: 2.5pt; text-align: left">)</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td style="border-bottom: Black 2.5pt double; text-align: right">-29</td><td style="padding-bottom: 2.5pt; text-align: left">%</td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Revenue</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company has not generated any significant syringe revenue to date.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Research
and Development</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">For
the nine months ended September 30, 2024, Research and Development (&#8220;R&amp;D&#8221;) expenses decreased to $523,347 compared to
$783,340 for the nine months ended September 30, 2023. The decrease of $259,993 was primarily due to a shift to increased manufacturing
and reduced R&amp;D activities in 2024 as compared to the 2023 period which amounted to lower expenses of $121,600, principally materials
of $104,000. In addition, depreciation expense decreased $138,300.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>General
and Administrative</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">For
the nine months ended September 30, 2024, General and Administrative (&#8220;G&amp;A&#8221;) expenses were $5,257,015 as compared to
$6,425,154 for the nine months ended September 30, 2023. The decrease of $1,168,139 was primarily attributable to: i) increases in payroll
and consulting fees of $307,800 from $2,206,000 in 2023 to $2,514,502 in 2024, primarily due to compensation increases and additional
consulting fees, ii) decrease in stock compensation expense, due to the timing of option awards, vesting and option valuations, of approximately
$397,800 from $838,000 in 2023 to $441,200 in 2024, iii) decrease in public company and investor relations costs of $288,700 from $644,000
to $361,300 in 2024 primarily due to lower offering costs in the 2024 period and reduced investor relations activities. Further, we had
decreases due to lower: a) marketing costs ($278,400) relating to promoting the Company, b) travel ($65,900), c) insurance costs ($87,000)
and d) rent ($45,000) e) general operating costs ($85,300), f) computer costs ($13,600), g) patent maintenance and registration fees
($2,200) and a contract settlement of $375,000 in 2023. These decreases were partially offset by higher: a) professional fees ($68,000,
b) board costs ($41,500) and c) depreciation ($53,500).</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Other
expense (income)</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Other
was an expense of $1,046,593 for the nine months ended September 30, 2024, compared to income of $(94,492) for nine months ended September
30, 2023. In 2024 and 2023 the Company generated interest income of $(28,689) and $(94,492), respectively. The interest income in each
period was related to interest income earned from cash balances held in interest bearing accounts. In the second quarter of 2024, the
Company&#8217;s initial syringe sale of $10,871, which approximated cost, was to a distributor in South America. The escrow deposit of
$1M, relating to the Asset Purchase Agreement, was released to the Seller on July 19, 2024, under the terms of the agreement and recorded
as a forfeited agreement cost (See Note 15 to the Unaudited Condensed Consolidated Financial Statements). In addition, in the third quarter
of 2024, the Company recorded accreted interest expense of $75,192 in connection with the debt financing (See Note 7 to the Unaudited
Condensed Consolidated Financial Statements).</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 25; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 0pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->21<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: left; width: 100%"><a href="#MT_001">Table of Contents</a></td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>FMV
Adjustment for Derivatives</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Certain
Warrants require the Fair Market Value (&#8220;FMV&#8221;) to be remeasured at each reporting date while outstanding with recognition
of the changes in fair value to other income or expense in the consolidated statement of operations. For the nine months ended September
30, 2024 and 2023, the Company recorded a $2,088,747 and $415,958 FMV gain to reflect adjustments required for outstanding Warrants liabilities.
(See Notes 8 and 9 to the Unaudited Condensed Consolidated Financial Statements)</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Liquidity
and Capital Resources</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">At
September 30, 2024 and December 31, 2023, we had a cash balance of $2,473,197 and $3,012,908, respectively. The Company had working capital
of $67,820 and $1,145,569 as of September 30, 2024 and December 31, 2023, respectively. The decrease in our working capital was primarily
due to use of cash in operations and investing discussed below offset by net proceeds from the Reg A and Inducement Offerings in May
and June 2024 and the net proceeds from the debt financing in September 2024 (See below and Notes 7 and 8 to the Unaudited Condensed
Consolidated Financial Statements).</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company continues to assess liquidity requirements and plans to continue to seek funding through equity offerings and/or debt financing
opportunities.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
September 20, 2024, the Company entered into a securities purchase agreement (the &#8220;Securities Purchase Agreement&#8221;) and a
Senior Secured Note (the &#8220;Note&#8221;) for an aggregate principal amount of $4,375,000, including OID interest of $875,000 maturing
on January 31, 2025, with certain purchasers (the &#8220;Purchasers&#8221;), and the issuance of approximately 259,091 (pre-reverse -
5,700,006) unregistered shares of the Company&#8217;s Common Stock. The aggregate gross proceeds to the Company were approximately $3.5
million, before deducting fees to the placement agent and other offering expenses payable by the Company of $514,700 and after an escrow
deposit of $250,000 required until certain security liens are filed.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
May 31 and June 13, 2024, the Company entered into subscription agreements with certain institutional investors, pursuant to which the
Company agreed to issue and sell to the investors 4,197,000 shares (the &#8220;Shares&#8221;) of Common Stock, par value $0.0001 per
share of the Company at a price of $0.38 and received gross proceeds to the Company of $1.6M before expenses to the placement agent and
other offering expenses of $298,000 with net proceed, after reflecting par value, have been recorded in Additional Paid in Capital of
$1,296, 922. The shares issued in the offering were offered at-the-market under Nasdaq rules and pursuant to the Company&#8217;s Form
1-A (the &#8220;Offering Statement&#8221;), initially filed by the Company with the Securities and Exchange Commission under the Securities
Act of 1933, as amended on May 21, 2024, and qualified on May 30, 2024.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
May 30, 2024, the Company offered warrant inducements (the &#8220;Inducement Agreement&#8221;) to certain warrant holders (the
&#8220;Warrant Holders&#8221;) which references the warrants registered for sale under both the registration statements on Form S-1
(file No. 333-263715) and/or the registration statement on Form S-1 (File No. 333-275011) (collectively, the &#8220;Registration
Statements&#8221;) for up to a total of 499,932 (pre reverse:10,998,524) warrants to purchase shares of the Company&#8217;s common
stock, par value $0.0001 per share. Pursuant to the Inducement Agreement, the exercise price of the existing warrants was reduced
from $14.08 (pre reverse: $0.64) per share to $7.26 (pre reverse: $0.33) per share. In addition, for each warrant that was
exercised, as a result of the Inducement Agreement, the Company agreed to issue the Warrant Holders unregistered warrants with an
exercise price of $9.90 (pre reverse: $0.45) per share (&#8220;Inducement Warrants&#8221;). In the aggregate, 260,799 (pre
reverse:5,737,573) warrants were exercised as a result of the Inducement Agreement and accordingly, 260,799 Inducement Warrants were
issued. The Company received gross proceeds of $1.9M before expenses to the placement agent and other expenses of $285,000. The net
proceeds, after reflecting par value, has been recorded in Additional Paid in Capital of $978,407 and with respect to the Inducement
Warrants, a liability under ASC 815 was recorded in the amount of $693,064. Certain outstanding warrants, with an exercise price of
$14.08 (pre reverse: $0.64), were reduced to $7.26 (pre reverse $0.33) based on anti-dilution terms in the respective warrant
agreements.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
September 29, 2023, the Company completed two simultaneous offerings and received aggregate gross proceeds of approximately $5.6 million,
before expenses to the placement agent and other offering expenses of $716,000.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">a.</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
    first offering, the securities purchase agreement offering (the &#8220;Shelf Offering&#8221;) with institutional investors and the
    Company resulted in the Company receiving net proceeds from the Shelf Offering and the sale of pre-funded of approximately $2.5 million,
    includes the value of the pre-funded warrants recorded in APIC, net of $362,000 in fees relating to the placement agent and other
    offering expenses. The Shelf Offering was priced at the market under Nasdaq rules. In connection with the Shelf Offering, the Company
    issued 164,478 (pre reverse -3,618,521 shares of common at a purchase price of $14.08 per unit, adjusted to $7.26 (reverse effected)
    at May 30, 2024, based on anti-dilution terms in the warrants and 36,636 ( pre reverse -800,000) pre-funded warrants at $14.058 (
    pre reverse -0.639) per pre-funded warrants. The exercise price of the pre-funded warrants will be $0.001 per share.</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">b.</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
    second offering, the securities purchase agreement offering (&#8220;Private Placement&#8221;) with institutional investors and the
    Company received net proceeds from the Private Placement of approximately $2.4 million, net of $354,000 in fees relating to the placement
    agent and other offering expense. In connection with the Private Placement, the Company issued: (i) 117,340 (pre reverse 2,581,479)
    PIPE Shares (or PIPE Pre-Funded Warrants in lieu thereof) and (ii) PIPE Warrants (non-trading) to purchase 397,727 (pre reverse -8,750,003)
    shares of our common stock, at a combined purchase price of $23.63 (pre reverse-1.074) per unit (or $23.606 (pre reverse $1.073)
    per pre-funded unit). The PIPE Warrants have a term of five and one-half (5.5) years from the issuance date and are exercisable for
    one share of common stock at an exercise price of $14.08 adjusted to $7.26 (reverse affected) at May 30, 2024, based on anti-dilution
    terms in the warrants. The net proceeds, after reflecting par value, has been recorded in Additional Paid in Capital of $1.6 million
    and with respect to the PIPE Warrants recorded as a liability under ASC 815 of $985,204. On October 16, 2023, the Company filed an
    S-1 (Resale) Registration Statement in connection with the Private Placement and on October 26, 2023 the S-1 went effective. (See
    Note 10).</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
February 3, 2023, the Company completed a securities purchase agreement (&#8220;Offering&#8221;) with institutional investors and received
net proceeds from the Offering of approximately $3.2 million, net of $600,000 in fees relating to the placement agent and other offering
expenses. The Offering was priced at the market under Nasdaq rules. In connection with the Offering, the Company issued 102,206 (pre-reverse
- 2,248,521) units at a purchase price of $$37.18 (pre-reverse - 1.69 per unit. Each unit consisted of one share of common stock and
one non-tradable warrant (&#8220;Offering Warrants&#8221;) exercisable for one share of common stock at a price after effect of the October
reverse split, of $34.32, adjusted to $14.08 at September 29, 2023 and to $7.26 at May 30, 2024, based on anti-dilution terms in the
warrants and a term of five years. The Offering Warrants have a term of five years from the issuance date. On February 13, 2023, the
Company filed an S-1 (Resale) Registration Statement in connection with the Offering and on April 14, 2023, an Amendment to the S-1 was
filed and went effective. (See Note 10)</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
April 13, 2022, the Company&#8217;s initial public offering (&#8220;IPO&#8221;) was declared effective by the SEC pursuant to which the
Company issued and sold an aggregate of 170,454 ( pre reverse -3,750,000) units (&#8220;Units&#8221;), each consisting of one share of
common stock and two warrants, to purchase one share of common stock for each whole warrant, with an initial exercise price of $ 93.50
(pre reverse -$4.25) per share, adjusted to and with the effect of reverse split October 2024, $34.32 at February 3, 2023 and to $14.08
at September 29, 2023 and to $7.26 at May 30, 2024, based on anti-dilution terms in the warrants, and a term of five years. In addition,
the Company granted Aegis Capital Corp., as underwriter a 45-day over-allotment option to purchase up to 15% of the number of shares
included in the units sold in the offering, and/or additional warrants equal to 15% of the number of Warrants included in the units sold
in the offering, in each case solely to cover over-allotments, which the Aegis Capital Corp. partially exercised with respect to 51,136
( pre reverse -1,125,000) warrants on April 19, 2022.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company&#8217;s common stock and warrants began trading on the Nasdaq Capital Market or Nasdaq on April 14, 2022. The net proceeds from
the IPO, prior to payments of certain listing and professional fees were approximately $14.2 million. The net proceeds, after reflecting
par value, has been recorded in Additional Paid in Capital of $9.0 million and with respect to the Warrants as a liability under ASC
815 of $5.2M. (See Note 10)</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 26; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 0pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->22<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: left; width: 100%"><a href="#MT_001">Table of Contents</a></td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Cash
Flows</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Net
Cash Used in Operating Activities</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company used cash of $5,172,135 and $6,144,937 in operating activities for the nine months ended September 30, 2024 and 2023, respectively.
The decrease in cash used of $972,802 was principally due to lower operating expenses during the nine months ended September 30, 2024.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Net
Cash Used in Investing Activities</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">For
the nine months ended September 30, 2024 and 2023, the Company used cash in investing activities of $1,069,659 and $431,379, respectively.
In both periods cash was used to acquire or pay deposits for fixed assets, equipment and software. In 2024, the cash used for acquiring
or paying deposits for fixed assets equipment and software was $69,659 as compared to $431,379 in the 2023 period. In connection with
the Asset Purchase agreement the Company paid a non-refundable deposit of $1M to be held in escrow under an agreeable escrow agreement
as a deposit on the purchase price. Under the terms of the Asset Purchase Agreement, the escrow deposit was released to the Seller and
the Company recorded a forfeited agreement cost in Other Expenses (See Note 14 to the Unaudited Condensed Consolidated Financial Statements).</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Net
Cash Provided by Financing Activities</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">For
the nine months ended September 30, 2024 and 2023, the Company provided cash from financing activities of $5,707,946 and $<span style="background-color: white">8,029,628</span>,
respectively. In the 2023 period, cash was provided from the offerings completed in February and September 2023. In the 2024 period,
cash was provided from the exercise of pre-funded warrants, net proceeds from a Reg A offering and Warrant Inducements and a debt financing
arrangement during September 2024 (See Note 7 and 8 to the Unaudited Condensed Consolidated Financial Statements).</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Off-Balance
Sheet Arrangements</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
do not have any off-balance sheet arrangements as defined in Regulation S-K Item 303(a)(4).</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Emerging
Growth Company Status</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
are an &#8220;emerging-growth company&#8221;, as defined in the JOBS Act, and, for as long as we continue to be an emerging growth company,
we may choose to take advantage of exemptions from various reporting requirements applicable to other public companies but not to emerging
growth companies, including, but not limited to, not being required to have our independent registered public accounting firm audit our
internal control over financial reporting under Section 404 of the Sarbanes-Oxley Act, reduced disclosure obligations regarding executive
compensation in our periodic reports and proxy statements and exemptions from the requirements of holding a nonbinding advisory vote
on executive compensation and stockholder approval of any golden parachute payments not previously approved. As an emerging growth company,
we can also delay adopting new or revised accounting standards until such time as those standards apply to private companies. We intend
to avail ourselves of these options. Once adopted, we must continue to report on that basis until we no longer qualify as an emerging
growth company.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
will cease to be an emerging growth company upon the earliest of: (i) the end of the fiscal year following the fifth anniversary of the
initial public offering; (ii) the first fiscal year after our annual gross revenue are $1.07 billion or more; (iii) the date on which
we have, during the previous three-year period, issued more than $1.0 billion in non-convertible debt securities; or (iv) the end of
any fiscal year in which the market value of our common stock held by non-affiliates exceeded $700 million as of the end of the second
quarter of that fiscal year. We cannot predict if investors will find our common stock less attractive if we choose to rely on these
exemptions. If, as a result of our decision to reduce future disclosure, investors find our common shares less attractive, there may
be a less active trading market for our common shares and the price of our common shares may be more volatile.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
are also a &#8220;smaller reporting company,&#8221; meaning that the market value of our stock held by non-affiliates plus the aggregate
amount of gross proceeds to us as a result of the IPO is less than $700 million and our annual revenue was less than $100 million during
the most recently completed fiscal year. We may continue to be a smaller reporting company if either (i) the market value of our stock
held by non-affiliates is less than $250 million or (ii) our annual revenue was less than $100 million during the most recently completed
fiscal year and the market value of our stock held by non-affiliates is less than $700 million. If we are a smaller reporting company
at the time, we cease to be an emerging growth company, we may continue to rely on exemptions from certain disclosure requirements that
are available to smaller reporting companies. Specifically, as a smaller reporting company we may choose to present only the two most
recent fiscal years of audited financial statements in our Annual Report on Form 10-K and, similar to emerging growth companies, smaller
reporting companies have reduced disclosure obligations regarding executive compensation.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 27; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 0pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->23<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: left; width: 100%"><a href="#MT_001">Table of Contents</a></td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="RM_012"></span>BUSINESS</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Background
and Overview </i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Sharps
Technology, Inc. is a medical device company that has designed and patented various safety syringes and is seeking to commercialize them.
We were initially incorporated under the laws of the State of Wyoming on December 16, 2017. Prior to March 22, 2022, we were a Wyoming
corporation and on March 22, 2022, we reincorporated as a Nevada corporation pursuant to a merger into a newly formed Nevada corporation
which was approved by our board of directors and the holders of the majority of our outstanding shares of common stock Sharps was incorporated
to purchase, develop, and commercialize a body of intellectual property resulting in a family of smart safety syringe products and innovative
drug delivery devices. Sharps closed the acquisition of this intellectual property in the fourth quarter of 2017. The intellectual property
we purchased consisted of issued patent and patent files, new designs and iterations, samples, regulatory files, manufacturing files,
product testing files, and market research files relating to such safety syringe products.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
June 2020, we entered into an asset/share purchase agreement with Safegard Medical and certain other parties and in August 2020, October
2020, and July 2021, we entered into amendments to this agreement (as amended, the &#8220;Safegard Agreement&#8221;). Under the Safegard
Agreement, we received an option to purchase either the stock of Safegard or certain assets of Safegard, including a manufacturing facility
in Hungary registered with the FDA and CE for the manufacture of safety syringes, for $2.5 million in cash plus additional consideration
of common stock and stock options with a fair value of $200,000 and $183,135, respectively. . Under the Safegard Agreement, we were granted
the right to operate this facility at our expense and continued to do so through the closing date which occurred on July 6, 2022.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Sharps&#8217;
smart safety syringe products, which we refer to as Securgard&#8482;, Sologard&#8482;, and Sharps Provensa&#8482;, are ultra-low waste
syringes that incorporate both passive and active safety and reuse prevention features, which we believe will provide us a competitive
advantage over other syringes. The Sharps Securegard and Sologard lines, currently being marketed by the Company, are multi-feature safety
syringes that had gained market acceptance prior to Sharps&#8217; acquisition but not been marketed or sold for several years due to
a decision by the owners to wind down the business. Safegard and Sologard are both FDA and WHO approved and Safegard currently carries
the European CE Mark. The Sharps Provensa syringe is a patented passive safety syringe that gained FDA clearance for subcutaneous and
intramuscular injections in June 2006. All three of these product lines are focused on innovatively addressing the most important needs
of the global healthcare market in the area of disposable syringes. The Company has not yet generated any revenues from the sale of the
Sharps products.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
order to compete in the market, we must maintain inventory. Commencing in the 4<sup>th</sup> Quarter of 2022 we started building inventory.
We require commercial quantities of inventory to secure orders. Delivery is expected shortly after receiving orders.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Although
we currently have production capacity for our products and thus the ability to receive and fulfill orders, we have used the proceeds
from the February 2023, September 2023 fund raising and fund raising in the second and third quarter of 2024 to allow us to either increase
our production capacity, build inventory or support working capital requirements This will help us to generate and fulfill orders for
our current product line and advance our new innovative products in connection with recent collaboration arrangements. We have produced
commercial quantities of our products and built inventory to support orders in late 2024 and in 2025. (See Business Developments)</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Products,
Marketing and Sales</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
continue to be in discussions with healthcare companies and distributors for sales of our disposable syringe and prefillable syringe
products. We intend to market these products to the U.S. and foreign governments. We received a Purchase Order for our first Securegard
sales to a South America distributor which was shipped in June 2024. We will also look to sell our disposable syringe products to hospitals
and clinician offices as opportunities present themselves.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Sharps Securegard product line continues to represent our initial disposable syringe platform to be commercially available to the market.
The addition of the Sologard products and SafeR products from Roncadelle are recent expansions to the Company&#8217;s product portfolio.
These platforms have advanced features and benefits to support the needs of the market along with a high level of readiness for manufacturing
and the ability to provide large commercial quantities for customers.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
previously disclosed, there continue to be delays in the commercialization of the Sharps Provensa product line. The product&#8217;s specialized
technology requires further design and assembly optimization as identified in our previous commercialization efforts. This on-going product
refinement process is typical of the development of new technology for the healthcare market to ensure the products are safe and effective
for use every time. At this time Sharps is not able to determine a timeline for final commercialization of the Provensa product.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Research
and Development</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Substantially
all of our research and development expenses to date have been incurred in connection with our syringe products. We expect to continue
to incur research and development expenses for the foreseeable future as we continue to enhance our products to meet the market requirements
for our Sharps syringe product line for its various intended uses throughout the world.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>&#160;</i></span></p>


<!-- Field: Page; Sequence: 28; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 0pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->24<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: left; width: 100%"><a href="#MT_001">Table of Contents</a></td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>&#160;</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Competitive
Environment</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
anticipate our major domestic competitors will include Retractable Technologies, Inc., Becton Dickinson &amp; Company, Medtronic Minimally
Invasive Therapies (&#8220;Medtronic,&#8221; formerly known as Covidien), Terumo Medical Corp., Smiths Medical, and B Braun. Our competitors
may have greater financial resources, larger and more established sales, marketing, and distribution organizations; and greater market
influence, including long-term and/or exclusive contracts.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
anticipate that we will compete primarily on the basis of healthcare worker and patient safety, product performance, and quality. We
believe our competitive advantages will include the combination of passive safety and ultra low waste features.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Business
Developments:</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Asset
Purchase Agreement &#8211; Nephron Pharmaceuticals and Affiliates</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
September 29, 2022, the Company entered into an agreement (the &#8220;NPC Agreement&#8221;) with Nephron Pharmaceuticals Corporation
(&#8220;NPC&#8221;) and various affiliates of NPC, including InjectEZ, LLC. The NPC Agreement was intended to support several areas of
the Company&#8217;s development and growth. The Company and NPC intended to supplement the NPC Agreement by entering into a manufacturing
supply agreement, a sales and distribution agreement and a pharma services program to support growth, and a future agreement to support
manufacturing expansion. As noted below, the sales and distribution agreement was terminated on March 8, 2024, and replaced. The original
manufacturing supply agreement, noted above, was replaced as part of the Asset Purchase Agreement, entered into on September 22, 2023
and the Pharma Services agreement continues to be in place, although no activities have occurred to date. Further, under the additional
agreement with NPC and affiliates of NPC (&#8220;Nephron Agreement&#8221;), the Company would provide technical advice and assistance
to support manufacturing by InjectEZ, purchase certain quantities of syringes as they may order or require, and collaborate with Nephron
on certain related business endeavors, but no activities have occurred to date. The Company will continue working to amend the terms
of this NPC Agreement and Nephron Agreement, based on the Amended Asset Purchase Agreement below dated May 20, 2024. (See below)</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
March 8, 2024, the Company and Nephron Pharmaceuticals Corporation terminated their distribution agreement dated December 8, 2022, which
was partially replaced by the Agreement with Roncadelle, as stated below, and we continue to seek other parties to distribute for the
US domestic market. The Company entered into a new logistics services agreement on the warehousing side with Owens and Minor (&#8220;O&amp;M&#8221;)
to replace Nephron&#8217;s distribution services. The Company can utilize O&amp;M to provide 3PL services for both the Company and Roncadelle
products, in North and South America when needed.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company and Nephron continue to maintain the Pharma Services Program (PSP), although no activities have occurred to date, which focuses
on the creation of new business development and growth opportunities for both companies. These opportunities will include the development
and sale of next generation drug delivery systems that will be produced by the Company and can be purchased by the healthcare industry,
pharmaceutical markets, and Pharma companies such as Nephron and others.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
May 20, 2024, the Company entered into an Amendment to the Asset Purchase Agreement dated September 22, 2023, with Nephron and Nephron&#8217;s
InjectEZ, LLC, (collectively, the &#8220;Seller&#8221;). The September 22, 2023 agreement superseded the manufacturing and supply agreement
entered into in connection with the NPC Agreement on September 29, 2022, and the Nephron Agreement entered into on September 29, 2022.
The Amended Asset Purchase Agreement includes the purchase of certain assets for $35M plus assumed liabilities of $4M, continues to provide
for the Company to lease the Facility but excludes any leasehold improvements previously included. In connection with the Asset Purchase
agreement, the Company paid a non-refundable deposit of $1M to be held in escrow under an agreeable escrow agreement as a deposit on
the purchase price. The Asset Purchase agreement stipulated that the $1M deposit would be maintained until July 19, 2024, at which date,
if the contemplated transaction was not consummated, through no fault of the Seller, the escrow would be released to the Seller by the
escrow agent. The escrow deposit of $1,000,000 was released to the Seller and recorded in Other Expense as a forfeited agreement cost
in the three months ended June 30, 2024. The Company and Seller continue to work towards a further amendment of the Asset Purchase Agreement.
The closing of the Asset Purchase Agreement is contingent on obtaining further amendments and the necessary financing. There can be no
assurance that the closing of the asset sale will occur.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 29; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 0pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->25<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: left; width: 100%"><a href="#MT_001">Table of Contents</a></td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Sales
and Distribution Agreement &#8211; Roncadelle</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
March 4, 2024 (the &#8220;Effective&#8221;) Company entered into a cooperative sales and distribution agreement (the &#8220;Agreement&#8221;)
with Roncadelle Operations s.r.l (&#8220;Roncadelle&#8221;). In conjunction with the execution of the Agreement, Roncadelle appointed
the Company as its exclusive distributor of Roncadelle products in the United States, Canada, Central and South America and their territories.
The Company appointed Roncadelle as its exclusive distributor of Sharps products in Europe, Middle East, APAC, South Africa and Australia
and their territories. The Company and Roncadelle agreed to bear their own separate costs and expenses, including fees and other expenses,
relating to external advisors and the preparation, negotiation, execution and performance of this Agreement and any related documents.
The Agreement is effective as of the Effective Date for the initial period of one (1) year (the &#8220;Initial Term&#8221;). Upon expiration
of the Initial Term, the term of the Agreement shall automatically renew for additional successive one-year terms, unless either party
provides written notice of non-renewal at least ninety (90) days prior to the end of the then-current term, unless any renewal term is
terminated earlier pursuant to the terms of the Agreement or applicable law. The Company continues to work with Roncadelle for product
introductions and execution of the Agreement for future sales.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Supply
Agreement -Stericare Solutions</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
July 24, 2024, the Company, entered into a Supply Agreement (the &#8220;Supply Agreement&#8221;) with Stericare Solutions, LLC, a Texas
limited liability company, (&#8220;Stericare&#8221;), pursuant to which Stericare agreed to purchase 520 million units of 10ml polypropylene
(&#8220;PP&#8221;) Sologard syringes from the Company. The specific purchase price is confidential but revenues are expected in excess
of $50M. Pursuant to the Supply Agreement, Stericare has agreed to purchase 520 million units of 10ml PP Sologard syringes in the following
increments: 40 million units in the first year, and 120 million units every year for the remaining life of the Supply Agreement. The
Supply Agreement has a five (5) year term targeted to commence November 2024 (the &#8220;Initial Term&#8221;). Upon expiration of the
Initial Term, the Supply Agreement will automatically renew for additional one (1) year periods (each, a &#8220;Renewal Term&#8221;),
unless a party gives the other party written notice of termination at least ninety (90) days prior to the end of the Initial Term or
Renewal Term. The Agreement may be terminated by either party upon written notice to the other party if the other party breaches any
material term or condition of this Agreement and fails to cure such breach within thirty (30) days after receipt of written notice thereof.
The Agreement may be terminated by either party upon written notice to the other party if the other party becomes insolvent, makes an
assignment for the benefit of creditors, or a petition under any bankruptcy or insolvency Law is filed by or against such party and is
not dismissed within 120 days. If either party is acquired by a competitor of the other party, then either party can terminate the Agreement
with six (6) months written notice.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>NASDAQ
</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>&#160;</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
July 12, 2023, The Nasdaq Stock Market LLC (&#8220;Nasdaq&#8221;) notified the Company that the bid price of its common stock had closed
at less than $1.00 per share over the previous 30 consecutive business days, and, as a result, the Company was no longer in compliance
with Nasdaq Listing Rule 5550(a)(2) (the &#8220;Nasdaq Rule&#8221;). In accordance with Listing Rule 5810(c)(3)(A), the Company was provided
180 calendar days, or until January 8, 2024, to regain compliance with the Rule. Subsequently, on January 16, 2024, the Company was provided
an additional 180 calendar day compliance period, or until July 8, 2024, to demonstrate compliance. Pursuant to Nasdaq&#8217;s letter
on July 9, 2024, the Company has not regained compliance with Listing Rule 5550(a)(2). Accordingly, its securities will be delisted from
the Nasdaq Capital Market unless the Company requests a hearing and appeals Nasdaq&#8217;s determination by July 16, 2024., the trading
of the Company&#8217;s common stock and warrants will be suspended at the opening of business on July 18, 2024. The Company filed a hearing
request before the deadline. In the interim, the Company&#8217;s common stock and warrants have remained listed on NASDAQ under its existing
symbols, &#8220;STSS&#8221; and &#8220;STSW&#8221; while it awaits the results from the hearing on August 13, 2024.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
July 15, 2024, the Company held a Special Meeting of its stockholders. At the Meeting, the following three (3) proposals were each approved.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 24px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
    Company&#8217;s stockholders approved the amendment to the Company&#8217;s articles of incorporation to increase the authorized shares
    of common stock from 100,000,000 shares to 500,000,000 shares;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;2.</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
    Company&#8217;s stockholders approved a proposal to authorize the Company&#8217;s Board of Directors (the &#8220;Board&#8221;), in
    its discretion at any time within one year after stockholder approval is obtained, to amend the Company&#8217;s Articles of Incorporation
    to effect a reverse stock split of shares of the Company&#8217;s common stock, at a ratio of up to 1-for-8, with the exact ratio
    to be determined by the Company&#8217;s Board and included in a public announcement;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;3.</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
    Company&#8217;s stockholders approved a proposal for the issuance of securities in one or more non-public offerings where the maximum
    discount at which the securities will be offered will be equivalent to a discount not to exceed 20% below the market price of our
    common stock in accordance with Nasdaq Marketplace Rule 5635(d).</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
October 7, 2024, the Company held a Special Meeting of its stockholders. The Company&#8217;s stockholders approved a proposal to authorize
the Company&#8217;s Board in its discretion at any time within one year after stockholder approval is obtained, to amend the Company&#8217;s
Articles of Incorporation to effect a reverse stock split of shares of the Company&#8217;s common stock, at a ratio with a range of 1-for-8
to 1 for 22, with the exact ratio to be determined by the Company&#8217;s Board. The Board approved the 1 for 22 reverse stock split
on October 7, 2024 which went into effect on October 16, 2024.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Nasdaq
notified the Company on November 13, 2024 that the Company regained compliance on November 5, 2024 with Listing Rule 5550(a)(2), (the
&#8220;Bid Price Rule&#8221;)</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 30; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 0pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->26<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: left; width: 100%"><a href="#MT_001">Table of Contents</a></td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Government
Regulations </b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
the United States, the Federal Food, Drug and Cosmetic Act, or FDCA, FDA regulations and other federal and state statutes and regulations
govern, among other things, medical device design and development, preclinical and clinical testing, premarket clearance or approval,
registration and listing, manufacturing, labeling, storage, advertising and promotion, sales and distribution, export and import, and
post-market surveillance. The FDA regulates the design, manufacturing, servicing, sale and distribution of medical devices. Failure to
comply with applicable U.S. requirements may subject a company to a variety of administrative or judicial sanctions, such as FDA refusal
to approve pending applications, warning letters, product recalls, product seizures, total or partial suspension of production or distribution,
injunctions, fines, civil penalties and criminal prosecution.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Unless
an exemption applies, each medical device we wish to distribute commercially in the United States will require marketing authorization
from the FDA prior to distribution. The two primary types of FDA marketing authorization applicable to a device are premarket notification,
also called 510k clearance, and premarket approval, also called PMA approval. The type of marketing authorization is generally linked
to the classification of the device. The FDA classifies medical devices into one of three classes (Class I, II or III) based on the degree
of risk the FDA determines to be associated with a device and the level of regulatory control deemed necessary to ensure the device&#8217;s
safety and effectiveness. Devices requiring fewer controls because they are deemed to pose lower risk are placed in Class I or II. Class
I devices are deemed to pose the least risk and are subject only to general controls applicable to all devices, such as requirements
for device labeling, premarket notification and adherence to the FDA&#8217;s current Good Manufacturing Practices, or cGMP, known as
the Quality System Regulations, or QSR. Class II devices are intermediate risk devices that are subject to general controls and may also
be subject to special controls such as performance standards, product-specific guidance documents, special labeling requirements, patient
registries or post-market surveillance. Class III devices are those for which insufficient information exists to assure safety and effectiveness
solely through general or special controls and include life sustaining, life-supporting or implantable devices, devices of substantial
importance in preventing impairment of human health, or which present a potential, unreasonable risk of illness or injury. Our Sharps
Provensa has been cleared by the FDA under the 510k premarket notification process (Class II).</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Outside
of the United States, our ability to market our products will be contingent also upon our receiving marketing authorizations from the
appropriate foreign regulatory authorities, whether or not FDA approval or clearance has been obtained. The foreign regulatory approval
process in most industrialized countries generally encompasses risks similar to those we will encounter in the FDA approval or clearance
process. The requirements governing conduct of clinical trials and marketing authorizations, and the time required to obtain requisite
approvals, may vary widely from country to country and differ from those required for FDA approval or clearance.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
sale of medical products is subject to laws and regulations pertaining to health care fraud and abuse, including state and federal anti-kickback,
anti-self-referral, and false claims laws in the United States.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 31; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 0pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->27<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: left; width: 100%"><a href="#MT_001">Table of Contents</a></td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Intellectual
Property</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Intellectual
property rights, particularly patent rights, are material to our business. We own four patents used in the Sharps Provensa, which expire
between 2035 and 2040. Our issued patents include a design patent (USD743,025) for the ornamental design for a safety syringe which will
reach full term and expire on November 10, 2029, a patent (US 10,980,950) for an ultra low-waste needle and syringe system that automatically
and passively renders a needle safe during the injection process, a patent (US 11,154,663) for a pre-filled safety needle and syringe
system, and a patent (US 11,497,860) for a Ultra-Low Waste Disposable Safety Syringe for Low Dose Injections.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
have two additional pending patent applications in the United States and four PCT (Patent Cooperation Treaty) patent applications. The
patent applications, which we own, have an anticipated expiration date of 2039/2040. The pending patent applications are for (i) an ultra-low
waste disposable syringe with self-adjusting integrating safety features, and (ii) a needle and syringe system with automatic safety
shield that renders a needle safe. Our pending patent applications are for utility patents. With respect to the last of these patent
applications, we have, in addition to our United States patent application, also filed PCT patent applications. The PCT applications
have entered National Phase. Some of the issued US patents have issued in other countries, some are still pending.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
have certain trademarks for Sharps Provensa, Sharps Provensa Ultra-Low Waste and filed applications to register other trademarks for
use in our Sharps Provensa product line.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Employees</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
have fifty-six full-time employees, two of which are our Chief Executive Officer and Chief Financial Officer, and retain the services
of additional personnel, as needed, on an independent contractor basis to support R&amp;D, Finance, Marketing and Regulatory areas. We
do not have any part-time employees. Of the fifty-six employees, fifty work at our facilities in Hungary. We expect to add additional
employees as we increase production capacity.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Facilities</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
lease office space, on a month-to-month basis, at 105 Maxess Road, Melville, New York 11747. Our monthly rent is $200.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
operate a manufacturing facility in Hungary acquired in July 2022, which we previously used for development and testing of our products
and we currently use primarily for the manufacture of our safety syringe products. We are prepared to move our owned molds,
machinery and equipment to an alternative manufacturing location if necessary. See &#8220;Background and Overview.&#8221;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<!-- Field: Page; Sequence: 32; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 0pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->28<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: left; width: 100%"><a href="#MT_001">Table of Contents</a></td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Litigation</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">`From
time to time, we may become involved in legal proceedings arising in the ordinary course of our business. Regardless of outcome, litigation
can have an adverse impact on us due to defense and settlement costs, diversion of management resources, negative publicity, reputational
harm and other factors.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
July 10, 2024, Barry Berler (&#8220;Berler&#8221;), a co-founder and former Chief Technology Officer of the Company, commenced a lawsuit
in the United States District Court for the Eastern District of New York, Barry Berler v. Sharps Technology, Inc. and Alan Blackman,
Case No. 2:24-cv-04787. In this case, Berler asserts claims for damages of an aggregate of $456,000 for alleged (1) failure to make full
payment of certain monthly payments under his consulting agreement with the Company (the &#8220;Consulting Agreement&#8221;) in the amount
of $52,500, (2) failure to pay a bonus with a target of $216,000 under the Consulting Agreement, (3) $187,500, representing 50% of the
severance payment paid by the Company to Mr. Blackman, the Company&#8217;s co-founder and former Chief Operating Officer and Co-Chairman,
and a declaration and injunctive relief establishing that Berler is the rightful owner of 50% of the Company&#8217;s Series A Preferred
Stock (which preferred stock is no longer outstanding ). The Company has accrued for the claim for unpaid monthly consulting fees. The
Company believes that Berler&#8217;s claims are without merit, intends to defend itself vigorously and has requested dismissal of these
claims. In addition, on September 17, 2024, the Company filed an answer and counterclaims with respect thereto, including for recoupment
of certain compensation the Company has previously paid to Berler.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
June l7, 2024, Berler filed a demand for arbitration and statement of claim under the commercial arbitration rules of the American Arbitration
Association (&#8220;AAA&#8221;) asserting claims for payment of $500,000 plus interest, under the Company&#8217;s royalty agreement with
Berler, as amended, rescission thereof and reversion to Berler of the intellectual property rights subject thereto. The Company believes
that Berler&#8217;s claims are without merit and intends to defend itself vigorously in connection with these claims.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
April 3, 2024, Plastomold Industries Ltd. (&#8220;Plastomold&#8221;) commenced a lawsuit against the Company in the United States District
Court for the Eastern District of New York, Plastomold Industries Ltd v. Sharps Technology, Inc., Case No. 2:24-CV-02580, asserting claims
for damages in the amount of $1.762 million for alleged (1) failure to pay invoices, of which approximately $1 million would relate to
a maintenance agreement for units allegedly manufactured and sold using machinery that was defective and has never successfully produced
any saleable products, (2) breach of the implied covenant of good faith and fair dealing, (3) unjust enrichment, and (4) conversion.
Plastomold asserts it provided certain products and services to the Company for which its invoices were not fully paid. The Company believes
that Plastomold&#8217;s claims are without merit and intends to defend itself vigorously. On June 3, 2024, the Company filed an answer
and affirmative defenses and counterclaim, which counterclaim is for damages that the Company believes would exceed the claims asserted
by Plastomold, based on the insufficiency of Plastomold&#8217;s services and the results thereof, including the failure to provide machinery
capable of reliably manufacturing the designated products in compliance with design specifications and functionality requirements, and
with respect to which test results failed.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="RM_013"></span>MANAGEMENT</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
following table provides information regarding our executive officers and directors as of the date of this prospectus:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Name</b></span></td>
    <td style="text-align: center">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Age</b></span></td>
    <td>&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Position(s)</b></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF">
    <td style="border-top: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; width: 36%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Executive
    Officers:</i></b></span></td>
    <td style="width: 2%">&#160;</td>
    <td style="border-top: Black 1pt solid; text-align: center; font: 10pt Times New Roman, Times, Serif; width: 4%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 2%">&#160;</td>
    <td style="border-top: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; width: 66%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Robert
    M. Hayes</span></td>
    <td>&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">57</span></td>
    <td>&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Chief
    Executive Officer and Director</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Andrew
    R. Crescenzo</span></td>
    <td>&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">68</span></td>
    <td>&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Chief
    Financial Officer</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Non-Executive
    Directors:</i></b></span></td>
    <td>&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td>&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Soren
    Bo Christiansen, MD</span></td>
    <td>&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">68</span></td>
    <td>&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Chairman</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Paul
    K. Danner</span></td>
    <td>&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">66</span></td>
    <td>&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Director</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Timothy
    J. Ruemler</span></td>
    <td>&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">65</span></td>
    <td>&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Director</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Brenda
    Baird Simpson</span></td>
    <td>&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;65</span></td>
    <td>&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Director</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Jason
    Monroe</span></td>
    <td>&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">37</span></td>
    <td>&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Director</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Executive
Officers</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Robert
M. Hayes</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.45in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Robert
M. Hayes has been the Chief Executive Officer and director for Sharps Technology since September 2021. Before joining the Company, he
served as Senior Director of Product Management and Innovation and other roles with Gerresheimer Pharmaceutical Glass from 2010 to 2021
where he led commercial sales and strategic partnerships with top global healthcare companies. He has over 25 years&#8217; experience
in the healthcare, medical device, and pharmaceutical manufacturing industry. Mr. Hayes received his Bachelor of Business Administration
from University of Toledo. Mr. Hayes&#8217; healthcare industry and product management experience qualify him to serve on our board of
directors.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 33; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 0pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->29<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: left; width: 100%"><a href="#MT_001">Table of Contents</a></td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Andrew
R. Crescenzo</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Andrew
R. Crescenzo, CPA has been Chief Financial Officer for Sharps Technology since May 2019 under a consulting agreement with CFO Consulting
Partners LLP through September 30, 2022 and as an employee since October 1, 2022. Before joining the Company, Mr. Crescenzo served in
various finance roles from 2006 to 2019 in biotech, manufacturing and distribution, including, CFO of United Metro Energy from 2014 to
2016; Senior VP of Finance of Enzo Biochem (NYSE:ENZ) from 2006 to 2014. Prior to 2006, he was an Executive Director from 2002 to 2006
and a Senior Manager from 1997 to 2002 at Grant Thornton LLP. Mr. Crescenzo is a Certified Public Accountant and received his Bachelor
of Business Administration from Adelphi University.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Non-Executive
Directors</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Dr.
Soren Bo Christiansen</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Soren
Bo Christiansen, Chairman of the Board for Sharps Technology, joined the team in April 2018 as a Board member, became Chairman of the
Board in December 2018 (and has been co-Chairman since 2021) , and was CEO from April 2019 until he stepped down in September 2021. Dr.
Christiansen worked for Merck &amp; Co. Inc. for 30 years in Denmark, USA and Switzerland. He was Sr. VP Merck Vaccines (head of the
Global Commercial division), President Eastern Europe, Middle East &amp; Africa and during the last four years of his career, he was
President for Europe, Middle East, Africa and Canada. He holds a medical degree from University of Copenhagen Denmark. Dr. Christiansen&#8217;s
medical and pharmaceutical knowledge and experience qualifies him to serve on our board of directors.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Paul
K. Danner</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Paul
K. Danner, a member of the Board of Directors and Chairperson of the Audit Committee, joined Sharps Technology in September 2021. Since
2013, Mr. Danner has been chief financial and administrative officer of PAY2DAY Solutions, Inc. dba Authvia, a FinTech software developer
that provides merchants and consumers with a cloud-based CPaaS (Communications Platform as a Service) platform capable of providing end-to-end
payment flows, billing, consumer management, payment analytics, and consumer insights. From 2016 to 2018, Mr. Danner was chief executive
officer of Alliance MMA, Inc., which was a mixed martial arts organization offering promotional opportunities for aspiring mixed martial
arts fighters. As a senior business leader, Mr. Danner has served three Nasdaq-listed companies as the senior corporate executive. Additionally,
he has acquired extensive Board of Director expertise through six separate appointments totaling more than twenty-five years with three
Nasdaq and OTCQB listed companies including Chairman, Corporate Secretary and Audit Committee assignments, as well as two development-stage
ventures and one not-for-profit enterprise. Mr. Danner served as a Naval Aviator flying the F-14 Tomcat, and subsequently as an Aerospace
Engineering Duty Officer supporting the Naval Air Systems Command, for 8 years on active duty plus 22 years with the reserve component
of the United States Navy. He retired from the Navy in 2009 with the rank of Captain. Mr. Danner earned a BS degree in Business Finance
from Colorado State University, and he holds an MBA from the Strome College of Business at Old Dominion University. Mr. Danner&#8217;s
executive and marketing experience qualify him to serve on our board of directors.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 34; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 0pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->30<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: left; width: 100%"><a href="#MT_001">Table of Contents</a></td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Timothy
J. Ruemler</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Timothy
J. Ruemler, a member of the Board of Directors and Chairperson of the Nominating Committee, joined Sharps Technology in September 2021.
He was division President SW Florida for Centex Homes from 1993 to 2007, where he was responsible for all aspects of the Real Estate
division&#8217;s activities. Mr. Ruemler has been retired since 2007. While at Centex Homes, Mr. Ruemler also held the positions of Sales
Manager, Construction Manager, Controller, and Assistant Controller for the Naples, Raleigh and Tampa divisions from 1986 until 1993.
Prior to his career at Centex Homes, he held auditor positions. He holds a BS in Accounting from Indiana State University. Mr. Ruemler&#8217;s
business operational experience qualify him to serve on our board of directors.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Brenda
Baird Simpson</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Brenda
Baird Simpson has served on our board of directors in April 2022. Ms. Simpson has been senior vice president &amp; chief nursing officer
at Centura Health in Centennial, CO since 2021. She was system vice president &amp; chief nursing executive at Northeast Georgia Health
System from 2016 to 2021, and system senior vice president &amp; chief nursing officer at CHI St. Vincent Health System in Little Rock,
AR, from 2007 to 2016. Ms. Simpson received a DNP from the University of South Alabama, an MSN from the University of Tennessee, Knoxville,
a BSN from Tennessee State University, Nashville, and an AND from the University of Tennessee, Martin. Ms. Simpson&#8217;s medical experience
qualifies her to serve on our board of directors.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Jason
L. Monroe</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Jason
L. Monroe has served on our board of directors in April 2022 and serves as Chairperson of the Compensation Committee Mr. Monroe has been
sales manager at CVS Health since 2016, and was a pharmacy manager at CVS Health from 2014 to 2015. He was Adjunct Professor for Pharmacy
Technician program at Houston Community College from 2017 to 2019. Mr. Monroe received a PharmD from the Texas Southern University College
of Pharmacy &amp; Health Science and a BS from Prairie View A&amp;M University. Mr. Monroe&#8217;s healthcare experience qualifies him
to serve on our board of directors.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Board
Composition</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
board currently consists of five directors, Robert M. Hayes, Soren Bo Christiansen, Paul K. Danner, and Timothy J. Ruemler. Mr. Ruemler
and Mr. Danner, Ms. .Simpson and Mr. Monroe are <i>&#8220;</i>independent directors<i>&#8221;</i> within the meaning of the Listing Rules
of the Nasdaq Stock Market.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Family
Relationships</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">No
family relationships exist between any of our officers or directors.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Director
Independence</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Board evaluates the independence of each nominee for election as a director of our Company in accordance with the Nasdaq Listing Rules.
A majority of our Board Are &#8220;independent directors&#8221; within the meaning of the Nasdaq Listing Rules, and all directors who
sit on our Audit Committee, Nominating and Corporate Governance Committee and Compensation Committee must also be independent directors.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Board
of Directors Term of Office</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Directors
are elected at our annual meeting of shareholders and serve for one year until the next annual meeting of shareholders or until their
successors are elected and qualified.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Committees
of our Board of Directors</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
have established an Audit Committee, a Compensation Committee or a Nominating Committee, or any committees performing similar functions.
We have an audit committee that consists of Paul Danner, Jason Monroe and Brenda Simpson, a compensation committee consists of Timothy
Ruemler, Paul Danner, and Jason Monroe, and a nominating committee that consists of Timothy Ruemler, Jason Monroe, and Paul Danner.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Code
of Business Conduct and Ethics</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
have a Code of Business Conduct and Ethics (the &#8220;Code&#8221;) which applies to all of our directors, officers and employees. The
full text of our Code will be posted on our website under the Investor Relations section. We intend to disclose future amendments to,
or waivers of, our Code, as and to the extent required by SEC regulations, at the same location on our website identified above or in
public filings. Information contained on our website is not incorporated by reference into this prospectus, and you should not consider
information contained on our website to be part of this prospectus or in deciding whether to purchase our shares of common stock.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 35; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 0pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->31<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: left; width: 100%"><a href="#MT_001">Table of Contents</a></td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Involvement
in Certain Legal Proceedings</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
directors and executive officers have not been involved in any of the following events during the past ten years:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">any
                                            bankruptcy petition filed by or against such person or any business of which such person
                                            was a general partner or executive officer either at the time of the bankruptcy or within
                                            two years prior to that time;</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">any
                                            conviction in a criminal proceeding or being subject to a pending criminal proceeding (excluding
                                            traffic violations and other minor offenses);</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">being
                                            subject to any order, judgment, or decree, not subsequently reversed, suspended or vacated,
                                            of any court of competent jurisdiction, permanently or temporarily enjoining him from or
                                            otherwise limiting his involvement in any type of business, securities or banking activities
                                            or to be associated with any person practicing in banking or securities activities;</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">being
                                            found by a court of competent jurisdiction in a civil action, the SEC or the Commodity Futures
                                            Trading Commission to have violated a Federal or state securities or commodities law, and
                                            the judgment has not been reversed, suspended, or vacated;</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">being
                                            subject of, or a party to, any Federal or state judicial or administrative order, judgment
                                            decree, or finding, not subsequently reversed, suspended or vacated, relating to an alleged
                                            violation of any Federal or state securities or commodities law or regulation, any law or
                                            regulation respecting financial institutions or insurance companies, or any law or regulation
                                            prohibiting mail or wire fraud or fraud in connection with any business entity; or</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">6.</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">being
                                            subject of or party to any sanction or order, not subsequently reversed, suspended, or vacated,
                                            of any self-regulatory organization, any registered entity or any equivalent exchange, association,
                                            entity or organization that has disciplinary authority over its members or persons associated
                                            with a member.</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="J_001"></span>EXECUTIVE
COMPENSATION</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
amounts below represent the compensation awarded to or earned by or paid to our named executive officers who served as our chief executive
officer or had total compensation of at least $100,000 for the years ended December 31, 2024 and 2023.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
table and discussion below present compensation information for the following executive officers, who constitute our Named Executive
Officers (as defined in Item 402(m)(2) of Regulation S-K promulgated under the Securities Act:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; background-color: white">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Robert
    M. Hayes, Chief Executive Officer;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Alan
    R. Blackman, Former Chief Operating Officer and Co-Chairman of the Board terminated effective May 1, 2023; and</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Andrew
    R. Crescenzo, Chief Financial Officer</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Name and Principal Position</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Year</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Salary<br/> ($)</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Bonus<br/> ($)</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Stock<br/> Awards<sup>(1)<br/> </sup>($)</b></span></td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Option<br/> Awards<sup>(2)<br/> </sup>($)</b></span></td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">All Other<br/> Compensation<br/> ($)</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Total<br/> ($)</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 37%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Robert M. Hayes<sup>(1)</sup></span></td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: center">&#160;</td><td style="width: 5%; text-align: center">2024</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 5%; text-align: right">600,000</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 5%; text-align: right">&#160;</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 5%; text-align: right">&#160;</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 5%; text-align: right">23,790</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 5%; text-align: right">890</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 5%; text-align: right">624,680</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: center">&#160;</td><td style="text-align: center">2023</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">416,666</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">100,000</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">272,307</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">788,973</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: center">&#160;</td><td style="text-align: center">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>Alan R. Blackman</td><td>&#160;</td>
    <td style="text-align: center">&#160;</td><td style="text-align: center">2023</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">106,670</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">81,278</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">187,948</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: center">&#160;</td><td style="text-align: center">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Andrew R. Crescenzo<sup>(2)</sup></span></td><td>&#160;</td>
    <td style="text-align: center">&#160;</td><td style="text-align: center">2024</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">225,000</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">15,860</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">11,040</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">251,900</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: center">&#160;</td><td style="text-align: center">2023</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">225,000</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">20,629</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">11,232</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">258,861</td><td style="text-align: left">&#160;</td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(1)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Mr.
    Hayes was appointed our chief executive officer on September 15, 2021 Other payments reflect life insurance reimbursed.</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(2)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">Other payments in 2023 and 2024 reflect reimbursement
    for medical insurance.</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(3)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">See
    Note 11 to the audited consolidated financial statements for assumptions used in valuation.</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 36; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 0pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->32<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: left; width: 100%"><a href="#MT_001">Table of Contents</a></td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Executive
Employment Agreements</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
November 10, 2023, the Company executed an Employment Agreement with Robert Hayes, its Chief Executive Officer amending the employment
letter dated September 6, 2021. The agreement term automatically renews for successive one-year terms as of the commencement date unless
prior written notice by either party within ninety days prior to end of the current term. The agreement provides for termination of employment
and severance benefits under stated conditions and restrictive covenants. The agreement provides for annual compensation retroactive
to June 1, 2023 of $600,000 from $400,000 and a stated increase with the successful acquisition of InjectEZ and other terms of the acquisition
agreement. The agreement provides for bonus compensation for: (i) closing the Nephron acquisition agreement, (ii)
long-term incentives for achieving revenue targets and market caps for the Company&#8217;s stock and (iii) other Company achievements.
In addition, the agreement provides for benefits and paid time off.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
are party to an employment agreement, dated September 9, 2021, with Andrew R. Crescenzo, our chief financial officer. Under the agreement,
we pay Mr. Crescenzo an annual salary of $225,000 and was awarded, a one-time $18,750 incentive payment upon the commencement of the
Agreement. In 2021, Mr. Crescenzo, while serving as the Company&#8217;s CFO through a consulting arrangement with CFO Consulting Partners.
The agreement can be terminated by either party for any reason upon 90 days&#8217; written notice.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Outstanding
Equity Awards at Fiscal Year-End</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
following table discloses information regarding outstanding equity awards granted or accrued as of December 31, 2024, for our
named executive officers.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td style="font-weight: bold; text-align: justify">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="10" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: justify">Option Awards</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="10" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: justify">Stock Awards</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="border-bottom: Black 1pt solid; font-weight: bold">Name</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: justify"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Number of</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Securities</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Underlying</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Unexercised Options (#) Vested</b></span></p></td><td style="padding-bottom: 1pt">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: justify"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Number of Securities Underlying</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Unexercised Options (#) Unvested</b></span></p></td><td style="padding-bottom: 1pt">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold">Option Exercise Price ($)</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold">Option Expiration Date</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold">Number of Shares or Units of Stock (#) that Vested</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold">Market value of Shares or Units of Stock (#) that have not Vested</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: justify">&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: right">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: right">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: right">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: justify">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: right">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: right">&#160;</td><td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 34%; font-weight: bold; text-align: left">Robert M. Hayes</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 7%; text-align: right">7,006</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 7%; text-align: right">7,812</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 7%; text-align: right">30.14</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 7%; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1/25/2028</span></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%; font-weight: bold">&#160;</td>
    <td style="width: 1%; font-weight: bold; text-align: left">&#160;</td><td style="width: 7%; font-weight: bold; text-align: right">-</td><td style="width: 1%; font-weight: bold; text-align: left">&#160;</td><td style="width: 2%; font-weight: bold">&#160;</td>
    <td style="width: 1%; font-weight: bold; text-align: left">&#160;</td><td style="width: 7%; font-weight: bold; text-align: right">-</td><td style="width: 1%; font-weight: bold; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: justify">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">2,266</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">775</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">26.62</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">5/2/2027</span></td><td style="text-align: left">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; text-align: right">-</td><td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; text-align: right">-</td><td style="font-weight: bold; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: justify">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">4,329</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">651</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">154.00</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">9/9/2026</span></td><td style="text-align: left">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; text-align: right">-</td><td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; text-align: right">-</td><td style="font-weight: bold; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: justify">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: justify">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; text-align: left">Andrew R. Crescenzo</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">545</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">592</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">30.14</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1/25/2028</span></td><td style="text-align: left">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; text-align: right">-</td><td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; text-align: right">-</td><td style="font-weight: bold; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: justify">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">549</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">133</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">26.62</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">5/2/2027</span></td><td style="text-align: left">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; text-align: right">-</td><td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; text-align: right">-</td><td style="font-weight: bold; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: justify">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">325</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">154.00</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">9/30/2026</span></td><td style="text-align: left">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; text-align: right">-</td><td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; text-align: right">-</td><td style="font-weight: bold; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: justify">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">640</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">154.00</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">9/30/2026</span></td><td style="text-align: left">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; text-align: right">-</td><td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; text-align: right">-</td><td style="font-weight: bold; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">686</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">96.36</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10/1/2025</span></td><td style="text-align: left">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; text-align: right">-</td><td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; text-align: right">-</td><td style="font-weight: bold; text-align: left">&#160;</td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Equity
Incentive Plan</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify">On November 4, 2024 the Company&#8217;s
Board of Directors initially adopted the 2024 Equity Incentive Plan (the &#8220;2024 Plan&#8221;), to provide for the issuance of up
to 265,000 options and/or shares of restricted stock be available for issuance to officers, directors, employees and consultants. The
2024 Plan was approved by shareholders at the annual meeting on December 19, 2024.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
January 24, 2023, the Company&#8217;s Board of Directors initially adopted the 2023 Equity Incentive Plan (the &#8220;2023 Plan&#8221;),
to provide for the issuance of up to 63,636 (pre reverse -1,400,000) options and/or shares of restricted stock be available for issuance
to officers, directors, employees and consultants. The 2023 Plan was subsequently updated to provide for the issuance of up to 159,090
(pre reverse -3,500,000) options and/or shares of restricted stock. The 2023 Plan was approved by shareholders at the annual meeting.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
March 28, 2022, the Company adopted the Sharps Technology, Inc. 2022 Equity Incentive Plan (the &#8220;2022 Plan&#8221;), pursuant to
which up to an aggregate of 35,409 (pre reverse -779,000) shares of common stock are available for issuance. Awards under the 2022 Plan
may include options (including incentive stock options and non-qualified stock options), stock appreciation rights, restricted stock,
restricted stock units, performance share awards, or other equity-based awards, each as defined under the 2022 Plan.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">During
the year ended December 31, 2023, the Company granted five-year options (the &#8220;Options&#8221;) to purchase a total of:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">a)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">344,318
    (pre reverse &#8211;975,000) shares of the Company&#8217;s common stock, par value $0.0001 per share (the &#8220;Common Stock&#8221;)
    to its directors, executive officers, employees and consultants pursuant to the Company&#8217;s. 2022 and 2023 Equity Incentive Plans.
    The Options are exercisable at $30.17 (pre reverse -$1.37) per share which was the closing price on January 25, 2023.</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">b)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">4,090
    (pre reverse &#8211;90,000) shares of the Company&#8217;s Common Stock in connection with an employment or consulting agreements
    at the exercise price, representing the closing price on the grant date ranging from $18.04 to $28.60 (pre reverse - $0.82 to $1.30).</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">During
the nine months ended September 30, 2024, the Company granted five-year options (the &#8220;Options&#8221;) to purchase a total of 63,409
shares of the Company&#8217;s common stock, par value $0.0001 per share (the &#8220;Common Stock&#8221;) to its directors, executive
officers, employees and consultants pursuant to the Company&#8217;s 2023 Equity Incentive Plan. The Options are exercisable at an average
price of $6.27 per share which was based on the closing price on the respective grant dates.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 37; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 0pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->33<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: left; width: 100%"><a href="#MT_001">Table of Contents</a></td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Compensation
of Directors</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
following table sets forth compensation earned by our directors during the year ended December 31, 2024 (excluding compensation
under the Summary Compensation table above).</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center">Fees Earned or Paid in Cash</td><td style="font-weight: bold">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center">Stock Awards</td><td style="font-weight: bold">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center">Option Awards</td><td style="font-weight: bold">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center">All Other Compensation</td><td style="font-weight: bold">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center">Total</td><td style="font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="border-bottom: Black 1pt solid; font-weight: bold">Name</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">($)</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">($)</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">($)</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">($)</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">($)</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 35%; font-weight: bold; text-align: left">Timothy J. Ruemler (1)</td><td style="width: 2%; font-weight: bold">&#160;</td>
    <td style="width: 1%; font-weight: bold; text-align: left">&#160;</td><td style="width: 9%; font-weight: bold; text-align: right">30,000</td><td style="width: 1%; font-weight: bold; text-align: left">&#160;</td><td style="width: 2%; font-weight: bold">&#160;</td>
    <td style="width: 1%; font-weight: bold; text-align: left">&#160;</td><td style="width: 9%; font-weight: bold; text-align: right">-</td><td style="width: 1%; font-weight: bold; text-align: left">&#160;</td><td style="width: 2%; font-weight: bold">&#160;</td>
    <td style="width: 1%; font-weight: bold; text-align: left">&#160;</td><td style="width: 9%; font-weight: bold; text-align: right">11,393</td><td style="width: 1%; font-weight: bold; text-align: left">&#160;</td><td style="width: 2%; font-weight: bold">&#160;</td>
    <td style="width: 1%; font-weight: bold; text-align: left">&#160;</td><td style="width: 9%; font-weight: bold; text-align: right">-</td><td style="width: 1%; font-weight: bold; text-align: left">&#160;</td><td style="width: 2%; font-weight: bold">&#160;</td>
    <td style="width: 1%; font-weight: bold; text-align: left">&#160;</td><td style="width: 9%; font-weight: bold; text-align: right">41,393</td><td style="width: 1%; font-weight: bold; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="font-weight: bold; text-align: left">Paul K. Danner (1,4)</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; text-align: right">132,000</td><td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; text-align: right">-</td><td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; text-align: right">37,975</td><td style="font-weight: bold; text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; text-align: right">169,975</td><td style="font-weight: bold; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; text-align: left">Dr Soren Bo. Christiansen (2)</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; text-align: right">48,000</td><td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; text-align: right">-</td><td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; text-align: right">15,190</td><td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; text-align: right">-</td><td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; text-align: right">63,190</td><td style="font-weight: bold; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="font-weight: bold; text-align: left">Brenda Baird Simpson (3)</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; text-align: right">24,000</td><td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; text-align: right">-</td><td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; text-align: right">11,393</td><td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; text-align: right">-</td><td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; text-align: right">35,393</td><td style="font-weight: bold; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; text-align: left">Jason L. Monroe (3)</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; text-align: right">30,000</td><td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; text-align: right">-</td><td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; text-align: right">11,393</td><td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; text-align: right">-</td><td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; text-align: right">41,393</td><td style="font-weight: bold; text-align: left">&#160;</td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(1)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Appointed
    as Directors in September 2021</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(2)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Served
    as CEO and Chairman of the Board through September 15, 2021. Effective September 16, 2021, served as Co-Chairman of the Board through
    May1, 2024 and then appointed Chairman</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(3)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Appointed
    as Directors in April 2022</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(4)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Executive
    director</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> services performed</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="J_002"></span>MARKET
PRICE OF AND DIVIDENDS ON THE COMPANY&#8217;S COMMON STOCK</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>AND
RELATED STOCKHOLDER MATTERS</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Market
Information</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
common stock trades on the Nasdaq Capital Market under the symbol &#8220;STSS.&#8221;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Holders</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
of December 31, 2024, there were approximately 142 holders of record of our common stock. Because many of our shares of common
stock are held by brokers and other institutions on behalf of stockholders, this number is not indicative of the total number of stockholders
represented by these stockholders of record.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Dividends</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
have not paid any and have no present intention of paying any dividends on our capital stock. Our current policy is to retain earnings,
if any, for use in our operations and in the development of our business. As a result, we anticipate that only appreciation of the price
of our common stock, if any, will provide a return to investors for at least the foreseeable future.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="J_003"></span>SECURITY
OWNERSHIP OF CERTAIN BENEFICIAL OWNERS AND MANAGEMENT</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
following table sets forth certain information, as of December 31, 2024, with respect to the beneficial ownership of the outstanding
common stock by (i) any holder of more than ten (10%) percent; (ii) each of our executive officers and directors; and (iii) our directors
and executive officers as a group.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
table lists applicable percentage ownership based on 2,046,225 shares of common stock outstanding as of December 31, 2024.
In addition, under the rules beneficial ownership include shares of our common stock issuable pursuant to the exercise of stock options
and warrants that are either immediately exercisable or exercisable within 60 days of December 31, 2024. These shares are deemed
to be outstanding and beneficially owned by the person holding those options or warrants for the purpose of computing the percentage
ownership of that person, but they are not treated as outstanding for the purpose of computing the percentage ownership of any other
person.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
addition, under the rules beneficial ownership include shares of our common stock issuable pursuant to the exercise of stock options
and warrants that are either immediately exercisable or exercisable within 60 days of December 31, 2024. These shares are deemed
to be outstanding and beneficially owned by the person holding those options or warrants for the purpose of computing the percentage
ownership of that person, but they are not treated as outstanding for the purpose of computing the percentage ownership of any other
person.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 38; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 0pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->34<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: left; width: 100%"><a href="#MT_001">Table of Contents</a></td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
have determined beneficial ownership in accordance with the rules of the SEC. These rules generally attribute beneficial ownership of
securities to persons who possess sole or shared voting power or investment power with respect to those securities. Unless otherwise
indicated, the persons or entities identified in this table have sole voting and investment power with respect to all shares shown as
beneficially owned by them, subject to applicable community property laws. Except as otherwise noted below, the address for persons listed
in the table is c/o Sharps Technology, Inc, 105 Maxess Road, Ste. 124, Melville, New York 11747.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center">Percentage of</td><td style="font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center">Number of shares</td><td style="font-weight: bold">&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center">common stock</td><td style="font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="border-bottom: Black 1pt solid; font-weight: bold">Name and address of beneficial owner</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">of common stock</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">beneficially owned</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">beneficially owned</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; text-align: left">Directors and Executive Officers:</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="width: 40%; text-align: left">Robert M. Hayes (1)</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 16%; text-align: right"/><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 16%; text-align: right">33,133</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 16%; text-align: right">1.60</td><td style="width: 1%; text-align: left">%</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Andrew R. Crescenzo (2)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"/><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">6,478</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">*</span></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Dr. Soren Bo Christiansen (3)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"/><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">26,558</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">1.29</td><td style="text-align: left">%</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Paul K. Danner (4)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"/><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">17,208</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">*</span></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Timothy J. Ruemler (5)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"/><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">64,005</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">3.10</td><td style="text-align: left">%</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Brenda Baird Simpson (6)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"/><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">7,955</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">*</span></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Jason Monroe (7)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"/><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">8,084</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">*</span></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; text-align: left">All Directors and Officers as a Group</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"/><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">163,420</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">7.62</td><td style="text-align: left">%</td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">*</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Less
    than 1%.</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(1)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Represents
    23,774 shares underlying options.</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(2)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Includes
    5,773 shares underlying options.</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(3)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Includes
    19,416 shares underlying options.</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(4)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Includes
    17,208 shares underlying options.</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(5)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Includes
    15,747 shares underlying options.</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(6)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Includes
    7,955 shares underlying options.</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(7)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Includes
    7,955 shares underlying options.</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.45in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">A
copy of the 2024 Plan was filed as Exhibit 10.36.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 39; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 0pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->35<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: left; width: 100%"><a href="#MT_001">Table of Contents</a></td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="J_004"></span>DESCRIPTION
OF SECURITIES</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>General</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
authorized capital stock consists of 500,000,000 shares of common stock, par value of $0.0001 per share, and 1,000,000 shares of preferred
stock, par value $0.0001 per share.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.45in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Upon
completion of this offering, 10,154,333 shares of common stock will be issued and outstanding, which assumes no exercise of:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">392,045
shares underlying warrants offered per the&#160; IPO declared effective by the SEC on April 13, 2022; 19,218 shares underlying warrants
issued to other parties after the IPO;</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span>&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">28,636
                                            warrants issued to an advisor;</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">260,799
                                            warrants issued in May 2024.</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Common
Stock</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Holders
of our common stock are entitled to one vote for each share on all matters submitted to a stockholder vote. Holders of common stock do
not have cumulative voting rights. Therefore, holders of a one-third (1/3) of the voting power of our stockholders for the election
of directors can elect all of the directors. Holders of one-third (1/3) of the voting power of the Company&#8217;s stockholders,
outstanding and entitled to vote, represented in person or by proxy, are necessary to constitute a quorum at any meeting of stockholders.
A vote by the holders of a one-third (1/3) of the voting power of the Company&#8217;s stockholders is required to effectuate certain
fundamental corporate changes such as liquidation, merger or an amendment to the Company&#8217;s articles of incorporation.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Holders
of our common stock are entitled to share in all dividends that the board of directors, in its discretion, declares from legally available
funds. In the event of a liquidation, dissolution or winding up, each outstanding share entitles its holder to participate pro rata in
all assets that remain after payment of liabilities and after providing for each class of stock, if any, having preference over the common
stock. The Company&#8217;s common stock has no pre-emptive rights, no conversion rights and there are no withdrawal provisions applicable
to the Company&#8217;s common stock.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>IPO
Warrants</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
following summary of certain terms and provisions of the warrants included in the initial public offering (&#8220;IPO Warrants&#8221;)
hereby is not complete and is subject to, and qualified in its entirety by the provisions of the form of Warrant, which is filed as an
exhibit to the registration statement of which this prospectus is a part. Prospective investors should carefully review the terms and
provisions set forth in the form of Warrant.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Exercisability</i>.
The IPO Warrants are exercisable at any time after their original issuance and at any time up to the date that is five years after their
original issuance. The IPO Warrants are be exercisable, at the option of each holder, in whole or in part by delivering to us a duly
executed exercise notice and, at any time a registration statement registering the issuance of the shares of common stock underlying
the IPO Warrants under the Securities Act is effective and available for the issuance of such shares, or an exemption from registration
under the Securities Act is available for the issuance of such shares, by payment in full in immediately available funds for the number
of shares of common stock purchased upon such exercise. If a registration statement registering the issuance of the shares of common
stock underlying the IPO Warrants under the Securities Act is not effective or available and an exemption from registration under the
Securities Act is not available for the issuance of such shares, the holder may elect to exercise the IPO Warrants through a cashless
exercise, in which case the holder would receive upon such exercise the net number of shares of common stock determined according to
the formula set forth in the warrant. No fractional shares of common stock will be issued in connection with the exercise of the IPO
Warrants. In lieu of fractional shares, we will pay the holder an amount in cash equal to the fractional amount multiplied by the exercise
price.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 40; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 0pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->36<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: left; width: 100%"><a href="#MT_001">Table of Contents</a></td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>&#160;</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Exercise
Limitation</i>. A holder will not have the right to exercise any portion of the IPO Warrants if the holder (together with its affiliates)
would beneficially own in excess of 4.99% of the number of shares of our common stock outstanding immediately after giving effect to
the exercise, as such percentage ownership is determined in accordance with the terms of the warrants. However, any holder may increase
or decrease such percentage to any other percentage not in excess of 9.99%, provided that any increase in such percentage shall not be
effective until 61 days following notice from the holder to us.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Exercise
Price</i>. The exercise price per whole share of common stock purchasable upon exercise of the IPO Warrants is $93.50 and adjusted to
$14.08 with September 2023 offering and further adjusted to $7.26 (exercise prices reverse effected) with the warrant inducement offering.
The exercise price is subject to appropriate adjustment in the event of certain stock dividends and distributions, stock splits, stock
combinations, reclassifications or similar events affecting our common stock and also upon any distributions of assets, including cash,
stock or other property to our stockholders. The exercise price is also subject to adjustment in the event of subsequent sales of our
common stock (or securities exercisable for convertible into common stock) at a purchase price (or conversion or exercise price, as applicable)
less than the then-effective exercise price. In the event of such a subsequent sale, the exercise price will be reduced to such lower
price, subject to certain exceptions and subject to a minimum exercise price set forth in the IPO Warrants.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Forced
Exercise and Redemption. </i>The IPO Warrants will be subject to forced exercise commencing six months from issuance subject to the condition
that the volume weighted average price of the Company&#8217;s common stock exceeds 200% of the initial exercise price ($93.50) for twenty
consecutive trading days and subject to certain other conditions set forth in the Warrants. In the event that a holder fails to exercise
the IPO Warrants within 30 days of notice of a forced exercise in accordance with the terms of the IPO Warrants, the Company may redeem
the IPO Warrants at a redemption price of $0.01 per Warrant.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Transferability</i>.
Subject to applicable laws, the IPO Warrants may be offered for sale, sold, transferred or assigned without our consent.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Exchange
Listing</i>. The IPO Warrants are currently listed on the Nasdaq Capital Market under the symbol &#8220;STSSW&#8221;.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Warrant
Agent</i>. The IPO Warrants will be issued in registered form under a warrant agency agreement between VStock Transfer LLC, as warrant
agent, and us. The IPO Warrants shall initially be represented only by one or more global warrants deposited with the warrant agent,
as custodian on behalf of The Depository Trust Company (DTC) and registered in the name of Cede &amp; Co., a nominee of DTC, or as otherwise
directed by DTC.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Fundamental
Transactions</i>. In the event of a fundamental transaction, as described in the IPO Warrants and generally including any reorganization,
recapitalization or reclassification of our common stock, the sale, transfer or other disposition of all or substantially all of our
properties or assets, our consolidation or merger with or into another person, the acquisition of more than 50% of our outstanding common
stock, or any person or group becoming the beneficial owner of 50% of the voting power represented by our outstanding common stock, the
holders of the warrants will be entitled to receive upon exercise of the warrants the kind and amount of securities, cash or other property
that the holders would have received had they exercised the warrants immediately prior to such fundamental transaction.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Rights
as a Stockholder</i>. Except as otherwise provided in the warrants or by virtue of such holder&#8217;s ownership of shares of our common
stock, the holder of IPO Warrants does not have the rights or privileges of a holder of our common stock, including any voting rights,
until the holder exercises the IPO Warrants.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Governing
Law</i>. The IPO Warrants and the warrant agency agreement are governed by New York law.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 41; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 0pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->37<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: left; width: 100%"><a href="#MT_001">Table of Contents</a></td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Blank
Check Preferred Stock</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
articles of incorporation authorize the issuance of up to 1,000,000 shares of preferred stock, par value $0.0001 per share, in one or
more series, subject to any limitations prescribed by law, without further vote or action by the stockholders. Each such series of preferred
stock shall have such number of shares, designations, preferences, voting powers, qualifications, and special or relative rights or privileges
as shall be determined by our board of directors, which may include, among others, dividend rights, voting rights, liquidation preferences,
conversion rights and preemptive rights.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Warrants
and Pre-Funded Warrants Offered in this Offering</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>The
following summary of certain terms and provisions of the Warrants and Pre-Funded Warrants offered hereby is not complete and is subject
to, and qualified in its entirety by the provisions of the forms of Warrant and Pre-Funded Warrant, which are filed as exhibits to the
registration statement of which this prospectus is a part. Prospective investors should carefully review the terms and provisions set
forth in the forms of Warrant and Pre-Funded Warrant.</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Exercisability</i>.
The Pre-Funded Warrants are exercisable at any time after their original issuance until they are exercised in full. The Series A Warrants
will be exercisable from issuance until five (5) years after the Warrant Stockholder Approval Date., and the Series B Warrants
will be exercisable from issuance until two and one half (2.5) years after the Warrant Stockholder Approval Date. Each
of the Warrants and the Pre-Funded Warrants will be exercisable, at the option of each holder, in whole or in part by delivering to us
a duly executed exercise notice accompanied by payment in full in immediately available funds for the number of shares of common stock
subscribed for upon such exercise (except in the case of a cashless exercise as discussed below).</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Cashless
Exercise and Alternative Cashless Exercise</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
a registration statement registering the issuance of the shares of common stock underlying the Warrants or Pre-Funded Warrants under
the Securities Act is not effective or available, the holder may, in its sole discretion, elect to exercise the Warrants or Pre-Funded
Warrants through a cashless exercise, in which case the holder would receive upon such exercise the net number of shares of common stock
determined according to the formula set forth in the Warrants or Pre-Funded Warrants, as applicable.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">No
fractional shares of common stock will be issued in connection with the exercise of a Warrant or Pre-Funded Warrant. In lieu of fractional
shares, we will pay the holder an amount in cash equal to the fractional amount multiplied by the exercise price.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Under
the alternate cashless exercise option, the holder of the Series B Warrant has the right to receive an aggregate number of shares equal
to the product of (x) the aggregate number of shares of common stock that would be issuable upon a cashless exercise of the Series B
Warrant and (y) three (3.0).</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Exercise
Limitation. </i>A holder will not have the right to exercise any portion of the Pre-Funded Warrants or Warrants if the holder (together
with its affiliates) would beneficially own in excess of 4.99% (or, upon election by a holder prior to the issuance of any warrants,
9.99%) of the number of shares of common stock outstanding immediately after giving effect to the exercise, as such percentage ownership
is determined in accordance with the terms of the Warrants and Pre-Funded Warrants. However, any holder may increase or decrease such
percentage to any other percentage not in excess of 9.99%, upon at least 61 days&#8217; prior notice from the holder to us with respect
to any increase in such percentage.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Exercise
Price</i>. The exercise price of each Pre-Funded Warrant included in each Pre-Funded Unit is $0.0001 per share.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Series A Warrants will be exercisable from issuance, have an exercise price of $2.312 per share of common stock (equal to 125%
of the public offering price per Unit, subject to certain anti-dilution and share combination event protections, as further set forth
below) and will expire five (5) years from the date of Warrant Stockholder Approval.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Series B Warrants will be exercisable from issuance, will have an exercise price of $2.312 per share of common stock (equal to
125% of the public offering price per Unit, subject to certain share combination event protections, as further set forth below) and will
expire two and one-half (2.5) years from the date of Warrant Stockholder Approval.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Beginning
on the 11th trading day after the Warrant Stockholder Approval Date (the &#8220;Reset Date&#8221;), the exercise price of the Warrants
will reset to a price equal to the greater of (i) the Floor Price, as defined in the Warrants, in effect on the Reset Date, and (ii)
the lowest volume weighted average price (&#8220;VWAP&#8221;) during the period commencing on the first trading day immediately following
the Warrant Stockholder Approval Date and ending on the close of trading on the 10th trading day thereafter. In addition, following
a reverse stock split, the exercise price of the Warrants will be adjusted to equal the lowest single-day VWAP during the period from
the trading day immediately following, until the fifth trading day following the reverse stock split with a proportionate adjustment
to the number of shares underlying the Warrants.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 42; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 0pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->38<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: left; width: 100%"><a href="#MT_001">Table of Contents</a></td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>&#160;</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Adjustment
for Subsequent Issuances. </i>Subject to certain exceptions, if the Company sells any common stock (or securities convertible into or
exercisable into common stock) at a price per share (or conversion or exercise price, as applicable) less than the exercise price of
the Series A Warrants then in effect, then the exercise price of the Series A Warrants will be reduced to such lower price (subject to
a minimum exercise price of $1.115 prior to Stockholder Warrant Approval (50% of the Nasdaq Minimum Price as of the date of pricing
of this offering) and a minimum exercise price of $0.446 after Warrant Stockholder Approval (20% of the Nasdaq Minimum
Price as of the date of pricing of this offering)).</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Share
Combination Event Adjustment</i>. If at any time on or after the date of issuance there occurs any share split, share dividend, share
combination recapitalization or other similar transaction involving our common stock and the lowest daily volume weighted average price
during the period commencing on the trading day immediately following the applicable date of share combination event and ending on the
fifth trading day immediately following such date is less than the exercise price of the Warrants then in effect, then the exercise price
of the Warrants will be reduced to the lowest daily volume weighted average price during such period (subject to a minimum exercise price
of $1.115 prior to Stockholder Warrant Approval (50% of the Nasdaq Minimum Price as of the date of pricing of this offering)
and a minimum exercise price of $0.446 after Warrant Stockholder Approval (20% of the Nasdaq Minimum Price as of the date
of pricing of this offering)), and the number of shares issuable upon exercise will be proportionately adjusted such that the
aggregate price will remain unchanged.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Warrant
Stockholder Approval. </i>Under Nasdaq listing rules, the Warrants may not be exercised unless and until we obtain the approval of our
stockholders. While we intend to promptly seek stockholder approval, there is no guarantee that the Warrant Stockholder Approval will
ever be obtained. If we are unable to obtain the Warrant Stockholder Approval, the Warrants may not be exercised and will have substantially
less value. In addition, we will incur substantial cost, and management will devote substantial time and attention, in attempting to
obtain the Warrant Stockholder Approval.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Transferability.
</i>Subject to applicable laws, the Warrants and the Pre-Funded Warrants may be offered for sale, sold, transferred or assigned without
our consent.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Exchange
Listing.</i> We do not intend to apply for the listing of the Warrants or Pre-Funded Warrants offered in this offering on any stock exchange.
Without an active trading market, the liquidity of the Warrants and Pre-Funded Warrants will be limited.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Rights
as a Stockholder</i>. Except as otherwise provided in the Warrants or the Pre-Funded Warrants or by virtue of such holder&#8217;s ownership
of our shares of common stock, the holder of a Warrant or Pre-Funded Warrant does not have the rights or privileges of a holder of our
shares of common stock, including any voting rights, until the holder exercises the Warrant or Pre-Funded Warrant.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Fundamental
Transaction</i>. In the event of a fundamental transaction, as described in the Warrants and the Pre-Funded Warrants, and generally including,
with certain exceptions, any reorganization, recapitalization or reclassification of our shares of common stock, the sale, transfer or
other disposition of all or substantially all of our properties or assets, our consolidation or merger with or into another person, the
acquisition of more than 50% of our outstanding shares of common stock, or any person or group becoming the beneficial owner of 50% of
the voting power represented by our outstanding shares of common stock, the holders of the Warrants and the Pre-Funded Warrants will
be entitled to receive upon exercise thereof the kind and amount of securities, cash or other property that the holders would have received
had they exercised the warrants immediately prior to such fundamental transaction.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Governing
Law.</i> The Pre-Funded Warrants and the Warrants are governed by New York law.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Transfer
Agent and Registrar</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">VStock
Transfer LLC is transfer agent and registrar for our common stock.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Limitations
of Liability and Indemnification</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
articles of incorporation and bylaws limit the liability of our officers and directors and provide that we will indemnify our officers
and directors, in each case, to the fullest extent permitted by the Nevada Revised Statutes, or the NRS.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">NRS
Section 78.7502 provides that a corporation shall indemnify any director, officer, employee or agent of a corporation against expenses,
including attorneys&#8217; fees, actually and reasonably incurred by him in connection with any defense to the extent that a director,
officer, employee or agent of a corporation has been successful on the merits or otherwise in defense of any action, suit or proceeding
referred to in Section 78.7502(1) or 78.7502(2), or in defense of any claim, issue or matter therein.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">NRS
78.7502(1) provides that a corporation may indemnify any person who was or is a party or is threatened to be made a party to any threatened,
pending or completed action, suit or proceeding, whether civil, criminal, administrative or investigative, except an action by or in
the right of the corporation, by reason of the fact that he is or was a director, officer, employee or agent of the corporation, or is
or was serving at the request of the corporation as a director, officer, employee or agent of another corporation, partnership, joint
venture, trust or other enterprise, against expenses, including attorneys&#8217; fees, judgments, fines and amounts paid in settlement
actually and reasonably incurred by him in connection with the action, suit or proceeding if he: (a) is not liable pursuant to NRS 78.138;
or (b) acted in good faith and in a manner which he reasonably believed to be in or not opposed to the best interests of the corporation,
and, with respect to any criminal action or proceeding, had no reasonable cause to believe his conduct was unlawful.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 43; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 0pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->39<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: left; width: 100%"><a href="#MT_001">Table of Contents</a></td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">NRS
Section 78.7502(2) provides that a corporation may indemnify any person who was or is a party or is threatened to be made a party to
any threatened, pending or completed action or suit by or in the right of the corporation to procure a judgment in its favor by reason
of the fact that he is or was a director, officer, employee or agent of the corporation, or is or was serving at the request of the corporation
as a director, officer, employee or agent of another corporation, partnership, joint venture, trust or other enterprise against expenses,
including amounts paid in settlement and attorneys&#8217; fees actually and reasonably incurred by him in connection with the defense
or settlement of the action or suit if he: (a) is not liable pursuant to NRS 78.138; or (b) acted in good faith and in a manner which
he reasonably believed to be in or not opposed to the best interests of the corporation. Indemnification may not be made for any claim,
issue or matter as to which such a person has been adjudged by a court of competent jurisdiction, after exhaustion of all appeals there
from, to be liable to the corporation or for amounts paid in settlement to the corporation, unless and only to the extent that the court
in which the action or suit was brought or other court of competent jurisdiction determines upon application that in view of all the
circumstances of the case, the person is fairly and reasonably entitled to indemnity for such expenses as the court deems proper.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">NRS
Section 78.747 provides that except as otherwise provided by specific statute, no director or officer of a corporation is individually
liable for a debt or liability of the corporation, unless the director or officer acts as the alter ego of the corporation. The court
as a matter of law must determine the question of whether a director or officer acts as the alter ego of a corporation.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
indemnification provisions in our bylaws may discourage stockholders from bringing a lawsuit against directors for breach of their fiduciary
duties. They may also reduce the likelihood of derivative litigation against directors and officers, even though an action, if successful,
might provide a benefit to us and our stockholders. Our results of operations and financial condition may be harmed to the extent we
pay the costs of settlement and damage awards against directors and officers pursuant to these indemnification provisions.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">At
present, there is no pending litigation or proceeding involving any of our directors or officers as to which indemnification is required
or permitted, and we are not aware of any threatened litigation or proceeding that may result in a claim for indemnification.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Listing</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
have applied to list our common stock and warrants on the Nasdaq Capital Market under the symbols &#8220;SSTS&#8221; and &#8220;SSTSW&#8221;,
respectively.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Disclosure
of Commission Position on Indemnification for Securities Act Liabilities</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Insofar
as indemnification for liabilities under the Securities Act may be permitted to officers, directors or persons controlling the Company
pursuant to the foregoing provisions, the Company has been informed that is it is the opinion of the SEC that such indemnification is
against public policy as expressed in such Securities Act and is, therefore, unenforceable.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="J_005"></span>CERTAIN
RELATIONSHIPS AND RELATED TRANSACTIONS</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Other
than as set forth below and compensation arrangements, including employment, there have been no transactions since January 1, 2020, in
which the amount involved in the transaction exceeded or will exceed the lesser of $120,000 or one percent of the average of our total
assets as at the year-end for the last two completed fiscal years, and to which any of our directors, executive officers or beneficial
holders of more than 5% of our capital stock, or any immediate family member of, or person sharing the household with, any of these individuals,
had or will have a direct or indirect material interest.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 24pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
of December 31, 2023 and 2022, accounts payable and accrued liabilities include $32,974 and $105,667, respectively, payable to officers
and directors of the Company. At September 30, 2024, accounts payable and accrued liabilities includes $152,500 payable to officers and
directors of the Company. The amounts are unsecured, non-interest bearing and are due on demand.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Policies
and Procedures for Related Party Transactions</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 24pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
connection with this offering, we expect to adopt a written related party transactions policy that will provide that transactions with
directors, officers and holders of five percent or more of our voting securities and their affiliates, each a related party must be approved
by our audit committee. This policy will become effective on the date on which the registration statement of which this offering circular
is part is declared effective by the SEC. Pursuant to this policy, the audit committee will have the primary responsibility for reviewing
and approving or disapproving &#8220;related party transactions,&#8221; which are transactions between us and related persons in which
the aggregate amount involved exceeds or may be expected to exceed the lesser of (i) $120,000 or (ii) one percent of the average of our
total assets for the last two completed fiscal years, and in which a related person has or will have a direct or indirect material interest.
For purposes of this policy, a related person will be defined as a director, executive officer, nominee for director, or greater than
5% beneficial owner of our common stock, in each case since the beginning of the most recently completed year, and their immediate family
members.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
considering related-person transactions, our audit committee or another independent body of our board of directors will take into account
the relevant available facts and circumstances including, but not limited to:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-indent: 24.5pt; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; background-color: white; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
    risks, costs and benefits to us;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
    impact on a director&#8217;s independence in the event the related person is a director, immediate family member of a director or
    an entity with which a director is affiliated;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
    terms of the transaction;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
    availability of other sources for comparable services or products; and</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
    terms available to or from, as the case may be, unrelated third parties under the same or similar circumstances.</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
audit committee or other independent body of our board of directors will not approve any related party transaction unless it is on the
same basis as an arms&#8217; length transaction and approved by a majority of the disinterested directors.</span></p>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 44; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 0pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->40<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: left; width: 100%"><a href="#MT_001">Table of Contents</a></td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="J_006"></span>PRIVATE
PLACEMENT OF PRE-FUNDED WARRANTS AND WARRANTS</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>PIPE
Agreement</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
September 27, 2023, the Company entered into a Securities Purchase Agreement (the &#8220;PIPE Purchase Agreement&#8221;) with certain
accredited investors purchasing common stock in this offering for a Private Placement offering of (i) 117,340 (2,581,479 pre-reverse
) unregistered shares of our common stock (the &#8220;PIPE Shares&#8221;) (or pre-funded warrants in lieu thereof with each pre-funded
warrant exercisable for one share of common stock (the &#8220;PIPE Pre-Funded Warrants&#8221;)) and (ii) unregistered warrants to purchase
397,727 (8,750,003 pre-reverse) of our common stock (the &#8220;SS Warrants&#8221; and together with PIPE Shares (PIPE Pre-Funded
Warrants in lieu thereof), the &#8220;PIPE Securities&#8221;). Pursuant to the PIPE Purchase Agreement, the Company has issued and sold
117,340 (2,581,479 pre-reverse) PIPE Shares (or PIPE Pre-Funded Warrants in lieu thereof) together with SS Warrants to purchase
up to 397,727 (8,750,003 pre-reverse) shares of common stock at a combined offering price of $23.63 ($1.074 pre-reverse)
per unit (less $0.001 for each PIPE Pre-Funded Warrant). The PIPE Securities are not being registered under the Securities Act The
PIPE Securities are being offered pursuant to an exemption from the registration requirements of the Securities Act provided in Section
4(a)(2) of the Securities Act and/or Rule 506(b) of Regulation D promulgated thereunder.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
PIPE Pre-Funded Warrants are immediately exercisable, at a nominal exercise price of $0.001, and may be exercised at any time until all
of the PIPE Pre-Funded Warrants are exercised in full. Under the terms of the PIPE Pre-Funded Warrants, the Company may not effect the
exercise of any such warrant, and a holder will not be entitled to exercise any portion of any such warrant, if, upon giving effect to
such exercise, the aggregate number of shares of common stock beneficially owned by the holder (together with its affiliates, any other
persons acting as a group together with the holder or any of the holder&#8217;s affiliates, and any other persons whose beneficial ownership
of common stock would or could be aggregated with the holder&#8217;s for purposes of Section 13(d) or Section 16 of the Securities Exchange
Act of 1934, as amended) would exceed 4.99% of the number of shares of common stock outstanding immediately after giving effect to the
exercise, as such percentage ownership is determined in accordance with the terms of such warrant, which percentage may be increased
or decreased at the holder&#8217;s election upon 61 days&#8217; notice to the Company subject to the terms of such warrants, provided
that such percentage may in no event exceed 9.99%</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
SS Warrants have an exercise price of $0.64 per share (subject to adjustment as set forth in the warrant), are exercisable upon issuance
and will expire five years from the date of issuance. After effect of anti-dilution in the warrants and the reverse split the exercise
price is $7.26. The SS Warrants contain standard adjustments to the exercise price including for stock splits, stock dividend, rights
offerings and pro rata distributions.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Private Placement closed on September 29, 2023, subject to the satisfaction of customary closing conditions. The gross proceeds to the
Company from the private placement, before deducting placement agent fees and other estimated offering expenses payable by the Company,
were approximately $2.8 million. The Company intends to use the net proceeds from the Private Placement for working capital and
other general corporate purposes.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Registration
Rights Agreement</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
connection with the PIPE Agreement, the Company entered into a Registration Rights Agreement with the Purchasers (the
&#8220;Registration Rights Agreement&#8221;) dated September 27, 2023, requiring the Company to file a resale registration statement
(the &#8220;Registration Statement&#8221;) with the U.S. Securities and Exchange Commission (the &#8220;SEC&#8221;) to register the
shares and shares underlying the Warrants issued under the PIPE Agreement within fifteen (15) days after the closing date (the
&#8220;Filing Date&#8221;) . Pursuant to the Registration Rights Agreement, the Registration Statement shall be declared effective
the sooner of (a) two Trading Days (as defined therein) following receipt of a notice of no review from the SEC, provided that the
Company&#8217;s financial statements are current at such time or (b) within thirty (30) days after the Filing Date (or, in the event
of a full review by the Commission, sixty </span>(60) calendar days following the Filing Date). The Company will be obligated to pay
certain liquidated damages to the Purchasers if the Company fails to file the Registration Statement when required, fails to cause
the Registration Statement to be declared effective by the SEC when required,  if the Company fails to maintain the effectiveness
of the Registration Statement. This Registration Statement covers the securities in the Registration Rights Agreement.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Placement
Agent Agreement</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Aegis
Capital Corp. (&#8220;Aegis&#8221;) acted as the exclusive placement agent in connection with the PIPE Offering under a Placement Agent
Agreement, dated as of September 27, 2023, between the Company and Aegis (the &#8220;Placement Agent Agreement&#8221;). Pursuant to the
Placement Agent Agreement, Aegis was paid a commission equal to 8.0% of the gross proceeds received by the Company in the PIPE Offering.
The Company also paid Aegis non-accountable expenses of 1.0% of the gross proceeds and reimbursed Aegis $100,000 for certain fees
and expenses incurred by them, including attorney fees. The Company also agreed to pay Aegis 10.0% of the proceeds from the exercise
of the Warrants issued in the PIPE Offering.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
PIPE Agreement, the Registration Rights Agreement, the Placement Agent Agreement and the Warrant are filed as Exhibits 10.1, 10.2, 10.3
and 10.4, respectively, to the Current Report on Form 8-K filed on October 3, 2023, and also incorporated herein as Exhibits 10.29, 10.30,
10.31 and 10.32, respectively.</span></p>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 45; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 0pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->41<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: left; width: 100%"><a href="#MT_001">Table of Contents</a></td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i></i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.45in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="J_007"></span>UNDERWRITING</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 20pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
entered into an underwriting agreement (&#8220;Underwriting Agreement&#8221;) with Aegis Capital Corp. (&#8220;Aegis&#8221; or the
&#8220;underwriter&#8221;), as the sole underwriter and book-running manager relating to this offering. Subject to the terms and
conditions of the Underwriting Agreement, the underwriter has agreed to purchase, and we have agreed to sell to the underwriter, at the public offering price less the underwriting discounts and commissions
set forth on the cover page of this prospectus, the
number of securities listed next to its name in the following table.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 20pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 20pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Delivery
of the securities offered hereby is expected to occur on or about January [__], 2025, subject to satisfaction of certain customary closing
conditions.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 20pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 20pt"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 20pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 20pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
underwriting agreement provides that the underwriter&#8217;s obligation to purchase Units depends on the satisfaction of the conditions
contained in the underwriting agreement including:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 20pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 20pt"/><td style="font: 10pt Times New Roman, Times, Serif; width: 18pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
                                            representations and warranties made by us to the underwriter are true;</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 20pt"/><td style="font: 10pt Times New Roman, Times, Serif; width: 18pt">&#9679;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">there
                                            is no material change in our business or the financial markets; and</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 20pt"/><td style="font: 10pt Times New Roman, Times, Serif; width: 18pt">&#9679;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">we
                                            deliver customary closing documents to the underwriter.</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 20pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 20pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
underwriter has agreed to purchase all of the Units offered by this prospectus (other than those covered by the over-allotment option
described below), if any are purchased under the underwriting agreement.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 20pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 20pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
underwriter is offering the Units subject to various conditions and may reject all or part of any order. The underwriter has advised
us that it proposes to offer the units directly to the public at the public offering price per Unit that appears on the cover page of
this prospectus. In addition, the representative may offer some of the Units to other securities dealers at such price less a concession
of&#8201;$[&#9679;] per Unit. After the Units are released for sale to the public, the representative may change the offering price
and other selling terms at various times.</span></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 20pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 20pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 20pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company will be responsible for and will pay all expenses relating to the offering, including, without limitation, (a) all filing fees
and expenses relating to the registration of the securities with the Commission; (b) all FINRA Public Offering filing fees; (c) all fees
and expenses relating to the listing of the Company&#8217;s equity or equity-linked securities on an Exchange; (d) all fees, expenses
and disbursements relating to the registration or qualification of the securities under the &#8220;blue sky&#8221; securities laws of
such states and other jurisdictions as Aegis may reasonably designate (including, without limitation, all filing and registration fees,
and the reasonable fees and disbursements of the Company&#8217;s &#8220;blue sky&#8221; counsel, which will be Aegis&#8217;s counsel)
unless such filings are not required in connection with the Company&#8217;s proposed Exchange listing; (e) any fees for counsel to lead
investors in the offering; (f) all fees, expenses and disbursements relating to the registration, qualification or exemption of the securities
under the securities laws of such foreign jurisdictions as Aegis may reasonably designate; (g) the costs of all mailing and printing
of the offering documents; (h) transfer and/or stamp taxes, if any, payable upon the transfer of securities from the Company to Aegis;
(i) the fees and expenses of the Company&#8217;s accountants; and (j) $100,000 for reasonable legal fees and disbursements for Aegis&#8217;s
counsel.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 20pt"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 20pt"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 20pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 20pt">The following table shows the per Unit and total
underwriting discounts we will pay to Aegis. These amounts are shown assuming both no exercise and full exercise of the underwriter&#8217;s
option to purchase additional securities.</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 20pt"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 20pt">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td style="padding-bottom: 1pt; text-align: center">&#160;</td><td style="padding-bottom: 1pt; text-align: center; font-weight: bold">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center; font-weight: bold">Per Unit</td><td style="padding-bottom: 1pt; text-align: center; font-weight: bold">&#160;</td><td style="padding-bottom: 1pt; text-align: center; font-weight: bold">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center; font-weight: bold">Total</td><td style="padding-bottom: 1pt; text-align: center; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 60%">Public offering price</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 16%; text-align: right">&#160;&#160;&#160;&#160;&#160;&#160;&#160;</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 16%; text-align: right">&#160;&#160;&#160;&#160;&#160;</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Underwriter discounts and commissions on Units(1)</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Proceeds, before expenses, to us(2)</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in; text-align: justify">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(1)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Represents
    the underwriter discount of 7.0% and the non-accountable expense equal to 1.0%. Does not include reimbursement by us of the underwriter&#8217;s
    legal fees and disbursements of its counsel of $100,000.</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(2)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
    amount of offering proceeds to us presented in this table does not give effect to any exercise of the Warrants.</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 20pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
have agreed to pay the underwriter&#8217;s legal expenses relating to the offering in the amount of $100,000. We estimate the total expenses
payable by us for this offering, excluding the underwriter fees and expenses, will be approximately $153,037.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; letter-spacing: -0.2pt"><b>Over-Allotment
Option</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 20pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Solely
to cover over-allotments, if any, we have granted to the underwriter an option to purchase up to 1,216,216 additional shares of
common stock, representing 15.0% of the shares of Common Stock sold in the offering, and/or up to an additional 1,216,216 Series
A Warrants to purchase an aggregate of an additional 1,216,216 shares of common stock, representing 15.0% of the Series A Warrants
sold in the offering, and 1,216,216 Series B Warrants to purchase an aggregate of an additional 1,216,216 shares of common
stock, representing 15.0% of the Series B Warrants sold in the offering at the public offering price less underwriting discounts and
commissions. The underwriter may exercise this option in whole or in part at any time within forty-five (45) days after the date of the
offering. The underwriter may exercise the over-allotment option with respect to common stock only, Series A Warrants only, Series B
Warrants only, or any combination thereof. The purchase price to be paid per additional share of common stock will be equal to the public
offering price of each share of common stock and accompanying Warrants (less $0.00001 allocated to each full Warrant), as applicable,
less the underwriting discount, and the purchase price to be paid per over-allotment Warrant will be $0.00001. We will be obligated,
pursuant to the option, to sell these additional shares of common stock or Warrants to the underwriter to the extent the option is exercised.
If any additional shares of Common Stock, or Warrants are purchased, the underwriter will offer the additional shares of Common Stock,
and Warrants on the same terms as those on which the other shares of Common Stock, and Warrants are being offered hereunder. No underwriting
discounts or commissions will be paid on any Warrants purchased pursuant to the underwriter&#8217;s over-allotment option. If this over-allotment
option is exercised in full, the total offering price to the public will be approximately $17,250,000, and the total net proceeds, before
expenses and after deducting the underwriting discounts described above, to us will be approximately $16,200,000 (based upon a
public offering price of $1.85 per Unit which assumed Unit offering price does not account for the $0.125 per warrant purchase
price).</span></p>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 20pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 20pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 20pt"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Stabilization</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 20pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
accordance with Regulation M under the Exchange Act, the underwriter may engage in activities that stabilize, maintain or otherwise affect
the price of our Common Stock, including short sales and purchases to cover positions created by short positions, stabilizing transactions,
syndicate covering transactions, penalty bids and passive market making.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 20pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%"><tr style="vertical-align: top">
<td style="text-align: justify; width: 24pt"/><td style="text-align: justify; width: 18pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Short
                                            positions involve sales by the underwriter of shares of Common Stock in excess of the number
                                            of shares the underwriter is obligated to purchase, which creates a syndicate short position.
                                            The short position may be either a covered short position or a naked short position. In a
                                            covered short position, the number of shares involved in the sales made by the underwriter
                                            in excess of the number of shares they are obligated to purchase is not greater than the
                                            number of shares that they may purchase by exercising their option to purchase additional
                                            shares. In a naked short position, the number of shares involved is greater than the number
                                            of shares in their option to purchase additional shares. The underwriter may close out any
                                            short position by either exercising their option to purchase additional shares or purchasing
                                            shares in the open market. </span></td></tr>
<tr style="vertical-align: top">
<td style="text-align: justify"/><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Stabilizing
                                            transactions permit bids to purchase the underlying security as long as the stabilizing bids
                                            do not exceed a specific maximum price.</span></td></tr>
</table>

<p style="margin: 0"></p>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 46; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 0pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->42<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: left; width: 100%"><a href="#MT_001">Table of Contents</a></td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"></p>

<table cellpadding="0" cellspacing="0" style="width: 100%; font: 12pt Times New Roman, Times, Serif">
<tr style="vertical-align: top">
<td style="text-align: justify; width: 24pt"/><td style="text-align: justify; width: 18pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Syndicate
                                            covering transactions involve purchases of our shares of Common Stock in the open market
                                            after the distribution has been completed to cover syndicate short positions. In determining
                                            the source of shares to close out the short position, the underwriter will consider, among
                                            other things, the price of shares available for purchase in the open market as compared to
                                            the price at which they may purchase shares through the underwriter&#8217;s option to purchase
                                            additional shares. If the underwriter sells more shares than could be covered by the underwriter&#8217;s
                                            option to purchase additional shares, thereby creating a naked short position, the position
                                            can only be closed out by buying shares in the open market. A naked short position is more
                                            likely to be created if the underwriter is concerned that there could be downward pressure
                                            on the price of the shares in the open market after pricing that could adversely affect investors
                                            who purchase in the offering.</span></td></tr>
<tr style="vertical-align: top">
<td style="text-align: justify"/><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Penalty
                                            bids permit the representative to reclaim a selling concession from a syndicate member when
                                            the shares of Common Stock originally sold by the syndicate member is purchased in a stabilizing
                                            or syndicate covering transaction to cover syndicate short positions.</span></td></tr>
<tr style="vertical-align: top">
<td style="text-align: justify"/><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
                                            passive market making, market makers in our Common Stock who are underwriters or prospective
                                            underwriters may, subject to limitations, make bids for or purchase our Common Stock until
                                            the time, if any, at which a stabilizing bid is made.</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0pt; text-indent: 20pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 20pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">These
activities may have the effect of raising or maintaining the market price of our Common Stock or preventing or retarding a decline in
the market price of our Common Stock. As a result of these activities, the price of our Common Stock may be higher than the price that
might otherwise exist in the open market. These transactions may be effected on NASDAQ or otherwise and, if commenced, may be discontinued
at any time.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 20pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0pt; text-indent: 20pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Neither
we nor the underwriter makes any representation or prediction as to the direction or magnitude of any effect that the transactions described
above may have on the price of our Common Stock. In addition, neither we nor the underwriter makes any representation that Aegis will
engage in these stabilizing transactions or that any transaction, once commenced, will not be discontinued without notice.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 20pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Discretionary
Accounts</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0pt; text-indent: 20pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
underwriter has informed us that they do not expect to make sales to accounts over which they exercise discretionary authority in excess
of five percent (5%) of the securities being offered in this offering.</span></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 20pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 20pt">&#160; </p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Indemnification</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 20pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
have agreed to indemnify the underwriter, its affiliates, and each person controlling the underwriter against any losses, claims, damages, judgments, assessments, costs, and other liabilities,
as the same as incurred (including the reasonable fees and expenses of counsel), relating to or arising out of the offering, undertaken
in good faith. If we are unable
to provide this indemnification, we will contribute to payments that the underwriter may be required to make for these liabilities.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 20pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Electronic
Offer, Sale, and Distribution of Securities</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 20pt">A prospectus in electronic
format may be made available on the websites maintained by the underwriter, if any, participating in this offering and the underwriter
participating in this offering may distribute prospectuses electronically. The underwriter may agree to allocate a number of Units for
sale to its online brokerage account holders. Internet distributions will be allocated by the underwriter that will make internet distributions
on the same basis as other allocations. Other than the prospectus in electronic format, the information on these websites is not part
of, nor incorporated by reference into, this prospectus or the registration statement of which this prospectus forms a part, has not
been approved or endorsed by us or the underwriter in its capacity as underwriter, and should not be relied upon by investors.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 20pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Right
of First Refusal</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 20pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Pursuant
to the Underwriting Agreement, if, for the period ending thirty-six (36) months after the commencement of sales in the offering, the
Company or any of its subsidiaries (a) decides to finance or refinance any indebtedness, Aegis (or any affiliate designated by Aegis)
shall have the right to act as sole book-runner, sole manager, sole placement agent or sole agent with respect to such financing or refinancing;
or (b) decides to raise funds by means of a public offering (including at-the-market facility) or a private placement or any other capital
raising financing of equity, equity-linked or debt securities, Aegis (or any affiliate designated by Aegis) shall have the right to act
as the lead book-running underwriter or lead placement agent for such financing. If Aegis or one of its affiliates decides to accept
any such engagement, the agreement governing such engagement (each, a &#8220;<b>Subsequent Transaction Agreement</b>&#8221;) will contain,
among other things, provisions for customary fees for transactions of similar size and nature, but in no event will the fees be less
than those outlined in the Underwriting Agreement, and the provisions of the Underwriting Agreement, including indemnification, that
are appropriate to such a transaction. Notwithstanding the foregoing, the decision to accept the Company&#8217;s engagement under the
Underwriting Agreement shall be made by Aegis or one of its affiliates, by a written notice to the Company, within ten (10) days of the
receipt of the Company&#8217;s notification of its financing needs, including a detailed term sheet. Aegis&#8217;s determination of whether
in any case to exercise its right of first refusal will be strictly limited to the terms on such term sheet, and any waiver of such right
of first refusal shall apply only to such specific terms. If Aegis waives its right of first refusal, any deviation from such terms (including
without limitation after the launch of a subsequent transaction) shall void the waiver and require the Company to seek a new waiver from
the right of first refusal on the terms set forth in the Underwriting Agreement. </span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 20pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Lock-Up
Agreements</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 20pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company&#8217;s directors, executive officers</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">,
employees and shareholders holding at least ten percent (10%) of the outstanding common stock will enter into customary
&#8220;lock-up&#8221; agreements in favor of the Underwriter for a period of ninety (90) days after the Warrant Stockholder Approval
Date (the &#8220;Lock-Up Period&#8221;); provided, however, that any sales by parties to the lock-ups shall be subject to the
lock-up agreements and provided further, that none of such common stock shall be saleable in the public market until the expiration
of the Lock-Up Period.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 20pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 20pt">The underwriter, in its sole
discretion, may release the Common Stock and other securities subject to the lock-up agreements described above in whole or in part at
any time. When determining whether or not to release Common Stock and other securities from lock-up agreements, the underwriter will
consider, among other factors, the holder&#8217;s reasons for requesting the release, the number of shares of Common Stock and other
securities for which the release is being requested and market conditions at the time.</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Securities
Issuance Standstill</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 20pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
have agreed, subject to certain exceptions, for</span>&#160; <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">a
period of ninety (90) days after the Warrant Stockholder Approval Date, that without the prior written consent of Aegis, we will not (a)
offer, sell, issue, or otherwise transfer or dispose of, directly or indirectly, any equity of our Company or any securities convertible
into or exercisable or exchangeable for equity of our Company; (b) file or caused to be filed any registration statement with the Commission
relating to the offering of any equity of our Company or any securities convertible into or exercisable or exchangeable for equity of
our Company; or (c) enter into any agreement or announce the intention to effect any of the actions described in subsections (a) or (b)
hereof (all of such matters, the &#8220;Standstill Restrictions&#8221;). So long as none of such equity securities shall be saleable
in the public market until the expiration of the Standstill Period, the following matters shall not be prohibited by the Standstill Restrictions:
(i) the adoption of an equity incentive plan and the grant of awards or equity pursuant to any equity incentive plan, and the filing
of a registration statement on Form S-8; and (ii) securities issued pursuant to acquisitions or strategic transactions approved by a
majority of the disinterested directors of our Company, provided that such securities are issued as &#8220;restricted securities&#8221;
(as defined in Rule 144) and carry no registration rights that require or permit the filing of any registration statement in connection
therewith during the Standstill Period, and provided that any such issuance shall only be to a person or entity (or to the equityholders
of an entity) which is, itself or through its subsidiaries, an operating company or an owner of an asset in a business synergistic with
the business of our Company and shall provide to our Company additional benefits in addition to the investment of funds, but shall not
include a transaction in which our Company is issuing securities primarily for the purpose of raising capital or to an entity whose primary
business is investing in securities. In no event should any equity transaction during the Standstill Period result in the sale of equity
at an offering price to the public less than that of this offering.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 20pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Other
Relationships </b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 20pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 20pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
underwriter is a full service financial institution engaged in various activities, which may include sales and trading, commercial and
investment banking, advisory, investment management, investment research, principal investment, hedging, market making, brokerage and
other financial and non-financial activities and services. The underwriter has in the past provided, and may in the future provide, various
investment banking, commercial banking and other financial services for us and our affiliates for which they have received and may in
the future receive customary fees.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 20pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 20pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
the ordinary course of its business activities, the underwriter and its affiliates, officers, directors and employees may purchase, sell
or hold a broad array of investments and actively traded securities, derivatives, loans, commodities, currencies, credit default swaps
and other financial instruments for their own account and for the accounts of their customers, and such investment and trading activities
may involve or relate to assets, securities and/or instruments of the issuer (directly, as collateral securing other obligation or otherwise)
publish or express independent research views in respect of such assets, securities or instruments and may at any time hold, or recommend
to clients that they should acquire, long and/or short positions in such assets, securities and instruments.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 20pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 20pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-underline-style: double"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 47; Options: NewSection; Value: 43 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->43<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: left; width: 100%"><a href="#MT_001">Table of Contents</a></td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Offer
Restrictions Outside the United States</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 20pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-underline-style: double"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 20pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Other
than in the United States, no action has been taken by us or the underwriter that would permit a public offering of the securities offered
by this prospectus in any jurisdiction where action for that purpose is required. The securities offered by this prospectus may not be
offered or sold, directly or indirectly, nor may this prospectus or any other offering material or advertisements in connection with
the offer and sale of any such securities be distributed or published in any jurisdiction, except under circumstances that will result
in compliance with the applicable rules and regulations of that jurisdiction. Persons who come into possession of this prospectus are
advised to inform themselves about and to observe any restrictions relating to the offering and the distribution of this prospectus.
This prospectus does not constitute an offer to sell or a solicitation of an offer to buy any securities offered by this prospectus in
any jurisdiction in which such an offer or a solicitation is unlawful.</span></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 20pt"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 20pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Listing</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 20pt">Our common stock is listed on the Nasdaq Capital Market under the symbol
&#8220;STSS.&#8221; We do not intend to apply for listing of the Pre-funded Warrants or the Warrants on any securities exchange or other
nationally recognized trading system.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Transfer
Agent and Registrar</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">VStock
Transfer LLC is transfer agent and registrar for our common stock.</span></p>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="J_009"></span>EXPERTS</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
consolidated financial statements included in this offering statement as of December 31, 2023, and for the year ended December 31, 2023,
has been included herein in reliance upon the report of PKF O&#8217;Connor Davies, LLP independent registered public accounting firm,
appearing elsewhere herein, and upon the authority of said firm as experts in accounting and auditing.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
consolidated financial statements included in this offering statement as of December 31, 2022, and for the year ended December 31, 2022,
have been included herein in reliance upon the report of Manning Elliott LLP, independent registered public accounting firm, appearing
elsewhere herein, and upon the authority of said firm as experts in accounting and auditing.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="J_008"></span>LEGAL
MATTERS</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Certain
legal matters with respect to the Offered Shares offered by this Offering Circular will be passed upon by Sichenzia Ross Ference Carmel
LLP, New York, New York. The Underwriter is being represented by Kaufman &amp; Canoles, P.C.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="J_010"></span>WHERE
YOU CAN FIND ADDITIONAL INFORMATION</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
have filed with the SEC a registration statement on Form S-1 under the Securities Act with respect to the securities offered by this
prospectus. This prospectus, which constitutes a part of the registration statement, does not contain all of the information set forth
in the registration statement, some of which is contained in exhibits to the registration statement as permitted by the rules and regulations
of the SEC. For further information with respect to us and our securities, we refer you to the registration statement, including the
exhibits filed as a part of the registration statement. Statements contained in this prospectus concerning the contents of any contract
or any other document are not necessarily complete. If a contract or document has been filed as an exhibit to the registration statement,
please see the copy of the contract or document that has been filed. Each statement in this prospectus relating to a contract or document
filed as an exhibit is qualified in all respects by the filed exhibit. The SEC maintains an Internet website that contains reports, proxy
statements and other information about issuers, like us, that file electronically with the SEC. The address of that website is <i>www.sec.gov</i>.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
are subject to the information and reporting requirements of the Exchange Act and, in accordance with this law, will file periodic reports,
proxy statements and other information with the SEC. We also maintain a website at sharpstechnology.com. Upon completion of this offering,
you may access these materials free of charge as soon as reasonably practicable after they are electronically filed with, or furnished
to, the SEC. Information contained on our website is not a part of this prospectus and the inclusion of our website address in this prospectus
is an inactive textual reference only.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 48; Value: 43 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->44<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: left; width: 100%"><a href="#MT_001">Table of Contents</a></td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="RM_014"></span>&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"></p>


























<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center; width: 0.5in"><b>Page</b></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></td>
    <td style="border-bottom: Black 1pt solid; vertical-align: bottom; font: 10pt Times New Roman, Times, Serif; text-align: center"><b>No.</b></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif"><a href="#RM_015"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">REPORT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM</span></a></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">F-2</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif"><a href="#MT_002"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">CONSOLIDATED BALANCE SHEETS</span></a></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center">F-4</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif"><a href="#MT_003"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">CONSOLIDATED STATEMENTS OF OPERATIONS</span></a></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center">F-5</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif"><a href="#MT_005"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">CONSOLIDATED STATEMENTS OF COMPREHENSIVE LOSS</span></a></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">F-5</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif"><a href="#MT_006"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">CONSOLIDATED STATEMENTS OF STOCKHOLDERS&#8217; EQUITY FOR THE YEARS ENDED DECEMBER 31, 2022 AND 2021</span></a></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">F-7</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif"><a href="#MT_007"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">CONSOLIDATED STATEMENTS OF CASH FLOWS</span></a></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center">F-8</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif"><a href="#MT_007"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS FOR YEARS ENDED DECEMBER 31, 2022 AND 2021</span></a></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">F-9</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center; width: 0.5in"><b>Page</b></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"><b>No.</b></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif"><a href="#RM_016"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Condensed Consolidated Balance Sheets</span></a></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center">F-27</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif"><a href="#RM_017"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Condensed Consolidated Statements of Operations</span></a></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center">F-28</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif"><a href="#RM_018"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Condensed Consolidated Statement of Comprehensive Loss</span></a></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center">F-29</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif"><a href="#RM_019"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Condensed Consolidated Statements of Stockholders&#8217; Equity</span></a></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center">F-30</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif"><a href="#RM_021"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Condensed Consolidated Statements of Cash Flows</span></a></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center">F-32</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif"><a href="#RM_022"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Notes to the Condensed Consolidated Financial Statements </span></a></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">F-33</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt">&#160;</p>

<!-- Field: Page; Sequence: 49; Options: NewSection; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 0pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->1<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%"><a href="#RM_014">Table of Contents</a></td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="RM_015"></span><b>Report
of Independent Registered Public Accounting Firm</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><img src="form10-k_002.jpg" alt=""/></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>To
the Stockholders and Board of Directors</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Sharps
Technology, Inc.</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Opinion
on the Consolidated Financial Statements</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
have audited the accompanying consolidated balance sheet of Sharps Technology, Inc. (the &#8220;Company&#8221;) as of December 31, 2023,
and the related consolidated statements of operations, comprehensive loss, stockholders&#8217; equity and cash flows for the year ended
December 31, 2023, and the related notes (collectively referred to as the &#8220;consolidated financial statements&#8221;). In our opinion,
the consolidated financial statements present fairly, in all material respects, the financial position of the Company as of December
31, 2023, and the results of its operations and its cash flows for the year ended December 31, 2023, in conformity with accounting principles
generally accepted in the United States of America.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Going
Concern Uncertainty</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
accompanying consolidated financial statements have been prepared assuming that the Company will continue as a going concern. As discussed
in Note 2 to the consolidated financial statements, the Company has not generated revenue or cash flow from operations since inception,
and does not have an established source of funding sufficient to cover its operating costs. These conditions raise substantial doubt
about the Company&#8217;s ability to continue as a going concern. Management&#8217;s plans in regard to these matters are also described
in Note 2. The consolidated financial statements do not include any adjustments that might result from the outcome of this uncertainty.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Basis
for Opinion</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">These
consolidated financial statements are the responsibility of the Company&#8217;s management. Our responsibility is to express an opinion
on the Company&#8217;s consolidated financial statements based on our audit. We are a public accounting firm registered with the Public
Company Accounting Oversight Board (United States) (PCAOB) and are required to be independent with respect to the Company in accordance
with the U.S. federal securities laws and the applicable rules and regulations of the Securities and Exchange Commission and the PCAOB.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
conducted our audit in accordance with the standards of the PCAOB. Those standards require that we plan and perform the audit to obtain
reasonable assurance about whether the consolidated financial statements are free of material misstatement, whether due to error or fraud.
The Company is not required to have, nor were we engaged to perform, an audit of its internal control over financial reporting. As part
of our audit, we are required to obtain an understanding of internal control over financial reporting, but not for the purpose of expressing
an opinion on the effectiveness of the Company&#8217;s internal control over financial reporting. Accordingly, we express no such opinion.
</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
audit included performing procedures to assess the risks of material misstatement of the consolidated financial statements, whether due
to error or fraud, and performing procedures that respond to those risks. Such procedures included examining, on a test basis, evidence
regarding the amounts and disclosures in the consolidated financial statements. Our audit also included evaluating the accounting principles
used and significant estimates made by management, as well as evaluating the overall presentation of the financial statements. We believe
that our audit provides a reasonable basis for our opinion.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><img src="form10-k_004.jpg" alt=""/></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
have served as the Company&#8217;s auditor since December 20, 2023.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">New
York, New York</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">March
28, 2024</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">PCAOB
ID No. 127</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">*
* * * *</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">PKF
O&#8217;CONNOR DAVIES LLP</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">245
Park Avenue, New York, NY 10167 I Tel: 212.867.8000 or 212.286.2600 I Fax: 212.286.4080 I www.pkfod.com</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">PKF
O&#8217;Connor Davies LLP is a member firm of the PKF International Limited network of legally independent firms and does not accept
any responsibility or liability for the actions or inactions on the part of any other individual member firm or firms.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b></b></span></p>

<!-- Field: Page; Sequence: 50; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 0pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%"><a href="#RM_014">Table of Contents</a></td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><img src="form10-k_001.jpg" alt="" style="height: 85px; width: 480px"/></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>REPORT
OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM</b></span></p>

<!-- Field: Rule-Page --><div style="margin-top: 0pt; width: 100%; margin-bottom: 0pt"><div style="border-top: Black 1pt solid; margin-top: 0pt; font-size: 1pt; margin-bottom: 0pt">&#160;</div></div><!-- Field: /Rule-Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b></b></span></p>


<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">To
the Stockholders and the Board of Directors of Sharps Technology Inc.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Opinion
on the Consolidated Financial Statements</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
have audited the accompanying consolidated balance sheets of Sharps Technology Inc. and its subsidiary (the &#8220;Company&#8221;) as
of December 31, 2022 and 2021, the related consolidated statements of operations, comprehensive loss, stockholders&#8217; equity and
cash flows for the years then ended, and the related notes (collectively referred to as the &#8220;consolidated financial statements&#8221;).</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
our opinion, the consolidated financial statements present fairly, in all material respects, the financial position of the Company as
of December 31, 2022 and 2021, and the results of its operations and its cash flows for the years then ended in conformity with accounting
principles generally accepted in the United States of America.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Basis
for Opinion</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">These
consolidated financial statements are the responsibility of the Company&#8217;s management. Our responsibility is to express an opinion
on the Company&#8217;s consolidated financial statements based on our audits. We are a public accounting firm registered with the Public
Company Accounting Oversight Board (United States) (&#8220;PCAOB&#8221;) and are required to be independent with respect to the Company
in accordance with the U.S. federal securities laws and the applicable rules and regulations of the Securities and Exchange Commission
and the PCAOB.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
conducted our audits in accordance with the standards of the PCAOB. Those standards require that we plan and perform the audits to obtain
reasonable assurance about whether the consolidated financial statements are free of material misstatement, whether due to error or fraud.
The Company is not required to have, nor were we engaged to perform, an audit of its internal control over financial reporting. As part
of our audits we are required to obtain an understanding of internal control over financial reporting but not for the purpose of expressing
an opinion on the effectiveness of the Company&#8217;s internal control over financial reporting. Accordingly, we express no such opinion.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
audits included performing procedures to assess the risks of material misstatement of the consolidated financial statements, whether
due to error or fraud, and performing procedures that respond to those risks. Such procedures included examining, on a test basis, evidence
regarding the amounts and disclosures in the consolidated financial statements. Our audits also included evaluating the accounting principles
used and significant estimates made by management, as well as evaluating the overall presentation of the consolidated financial statements.
We believe that our audits provide a reasonable basis for our opinion.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><img src="form10-k_005.jpg" alt=""/></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">CHARTERED
PROFESSIONAL ACCOUNTANTS</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;<span style="display: none">Manning
Elliott LLP</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Vancouver,
Canada</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">March
30, 2023</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">PCAOB
ID:1524</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
have served as the Company&#8217;s auditor since 2018.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 51; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 0pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%"><a href="#RM_014">Table of Contents</a></td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span id="MT_002"></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>SHARPS
TECHNOLOGY, INC.</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>CONSOLIDATED
BALANCE SHEETS</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" id="xdx_304_111_ze8ckVw5a6X2" summary="xdx: Statement - Condensed Consolidated Balance Sheets" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" id="xdx_493_20231231_zfHxAnT28Hdg" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><p style="margin-top: 0pt; margin-bottom: 0pt">December 31,</p>
                                                                                <p style="margin-top: 0pt; margin-bottom: 0pt">2023</p></td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" id="xdx_495_20221231_z5WPcWzcomMk" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><p style="margin-top: 0pt; margin-bottom: 0pt">December 31,</p>
                                                                                <p style="margin-top: 0pt; margin-bottom: 0pt">2022</p></td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: center">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: center">&#160;</td><td>&#160;</td></tr>
  <tr id="xdx_40F_eus-gaap--AssetsAbstract_iB_zEfkwEcYZdL9" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>Assets:</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40F_eus-gaap--AssetsCurrentAbstract_i01B_zrsJUhPy3t3b" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Current Assets</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40E_eus-gaap--CashAndCashEquivalentsAtCarryingValue_i02I_maACzORs_zhEHxvMwSCdi" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 10pt; width: 60%">Cash</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 16%; text-align: right"><ix:nonFraction name="us-gaap:CashAndCashEquivalentsAtCarryingValue" contextRef="AsOf2023-12-31" id="Fact000041" format="ixt:numdotdecimal" decimals="0" unitRef="USD">3,012,908</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 16%; text-align: right"><ix:nonFraction name="us-gaap:CashAndCashEquivalentsAtCarryingValue" contextRef="AsOf2022-12-31" id="Fact000042" format="ixt:numdotdecimal" decimals="0" unitRef="USD">4,170,897</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr id="xdx_401_eus-gaap--PrepaidExpenseAndOtherAssetsCurrent_i02I_maACzORs_zlXw5ZmOkQbj" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 10pt; text-align: left">Prepaid expenses and other current assets</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:PrepaidExpenseAndOtherAssetsCurrent" contextRef="AsOf2023-12-31" id="Fact000044" format="ixt:numdotdecimal" decimals="0" unitRef="USD">116,508</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:PrepaidExpenseAndOtherAssetsCurrent" contextRef="AsOf2022-12-31" id="Fact000045" format="ixt:numdotdecimal" decimals="0" unitRef="USD">66,749</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40F_eus-gaap--InventoryNet_i02I_maACzORs_zAg0i9fwwpMc" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 10pt; text-align: left; padding-bottom: 1pt">Inventories, Net (<i>Note 3</i>)</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:InventoryNet" contextRef="AsOf2023-12-31" id="Fact000047" format="ixt:numdotdecimal" decimals="0" unitRef="USD">1,709,135</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:InventoryNet" contextRef="AsOf2022-12-31" id="Fact000048" format="ixt:numdotdecimal" decimals="0" unitRef="USD">185,804</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_40C_eus-gaap--AssetsCurrent_i01TI_mtACzORs_maAz44u_zzSvWHDWe4di" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 20pt; text-align: left">Current Assets</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:AssetsCurrent" contextRef="AsOf2023-12-31" id="Fact000050" format="ixt:numdotdecimal" decimals="0" unitRef="USD">4,838,551</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:AssetsCurrent" contextRef="AsOf2022-12-31" id="Fact000051" format="ixt:numdotdecimal" decimals="0" unitRef="USD">4,423,450</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_408_eus-gaap--PropertyPlantAndEquipmentNet_i01I_maAz44u_zOI3dAtoFz14" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Fixed Assets, net of accumulated depreciation <i>(Notes 4 and 5)</i></span></td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:PropertyPlantAndEquipmentNet" contextRef="AsOf2023-12-31" id="Fact000053" format="ixt:numdotdecimal" decimals="0" unitRef="USD">6,822,142</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:PropertyPlantAndEquipmentNet" contextRef="AsOf2022-12-31" id="Fact000054" format="ixt:numdotdecimal" decimals="0" unitRef="USD">7,004,890</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_406_eus-gaap--OtherAssetsNoncurrent_i01I_maAz44u_zFRIgyijsqe2" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Other Assets <i>(Notes 5 and 6) </i></span></td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:OtherAssetsNoncurrent" contextRef="AsOf2023-12-31" id="Fact000056" format="ixt:numdotdecimal" decimals="0" unitRef="USD">128,575</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:OtherAssetsNoncurrent" contextRef="AsOf2022-12-31" id="Fact000057" format="ixt:numdotdecimal" decimals="0" unitRef="USD">411,316</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_40E_eus-gaap--Assets_i01TI_mtAz44u_zPLQBqdjKHVa" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 2.5pt">TOTAL ASSETS</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right"><ix:nonFraction name="us-gaap:Assets" contextRef="AsOf2023-12-31" id="Fact000059" format="ixt:numdotdecimal" decimals="0" unitRef="USD">11,789,268</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right"><ix:nonFraction name="us-gaap:Assets" contextRef="AsOf2022-12-31" id="Fact000060" format="ixt:numdotdecimal" decimals="0" unitRef="USD">11,839,656</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_405_eus-gaap--LiabilitiesAbstract_iB_zvEGIzsMqjl3" style="vertical-align: bottom; background-color: White">
    <td>Liabilities:</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_404_eus-gaap--LiabilitiesCurrentAbstract_i01B_zmpUrEiSAE7f" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Current Liabilities</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_407_eus-gaap--AccountsPayableCurrent_i02I_maCzD8P_zZEzLM3n4XV2" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Accounts payable <i>(Note 4)</i></span></td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right"><ix:nonFraction name="us-gaap:AccountsPayableCurrent" contextRef="AsOf2023-12-31" id="Fact000068" format="ixt:numdotdecimal" decimals="0" unitRef="USD">794,107</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right"><ix:nonFraction name="us-gaap:AccountsPayableCurrent" contextRef="AsOf2022-12-31" id="Fact000069" format="ixt:numdotdecimal" decimals="0" unitRef="USD">543,226</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_404_eus-gaap--AccountsPayableAndOtherAccruedLiabilitiesCurrent_i02I_maCzD8P_zkLTdOHu4A8a" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 10pt; text-align: left">Accrued expenses and other</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:AccountsPayableAndOtherAccruedLiabilitiesCurrent" contextRef="AsOf2023-12-31" id="Fact000071" format="ixt:numdotdecimal" decimals="0" unitRef="USD">476,090</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:AccountsPayableAndOtherAccruedLiabilitiesCurrent" contextRef="AsOf2022-12-31" id="Fact000072" format="ixt:numdotdecimal" decimals="0" unitRef="USD">311,458</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_400_eus-gaap--NotesPayableCurrent_i02I_maCzD8P_z3Pe3pALHGId" style="display: none; vertical-align: bottom; background-color: White">
    <td style="display: none; text-align: left; padding-left: 10pt"><span style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt">Notes
    Payable <i style="display: none">(Note 7)</i></span></td><td style="display: none"><span style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="display: none; text-align: left"><span style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="display: none; text-align: right"><span style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></td><td style="display: none; text-align: left"><span style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="display: none"><span style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="display: none; text-align: left"><span style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="display: none; text-align: right"/><td style="display: none; text-align: left"><span style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
<tr id="xdx_40C_ecustom--WarrantLiabilitiesCurrent_i02I_maCzD8P_zHFgU0AsFgVg" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 10pt; text-align: left; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Warrant liability <i>(Notes 8 and 10)</i></span></td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="STSS:WarrantLiabilitiesCurrent" contextRef="AsOf2023-12-31" id="Fact000077" format="ixt:numdotdecimal" decimals="0" unitRef="USD">2,422,785</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="STSS:WarrantLiabilitiesCurrent" contextRef="AsOf2022-12-31" id="Fact000078" format="ixt:numdotdecimal" decimals="0" unitRef="USD">1,151,838</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_402_eus-gaap--LiabilitiesCurrent_i02TI_mtCzD8P_maCzV19_zF1xV0TLlFq9" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 20pt; text-align: left">Total Current Liabilities</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:LiabilitiesCurrent" contextRef="AsOf2023-12-31" id="Fact000080" format="ixt:numdotdecimal" decimals="0" unitRef="USD">3,692,982</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:LiabilitiesCurrent" contextRef="AsOf2022-12-31" id="Fact000081" format="ixt:numdotdecimal" decimals="0" unitRef="USD">2,006,522</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="font-style: italic">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_406_eus-gaap--DeferredIncomeTaxLiabilitiesNet_i01I_maCzV19_z5wZnmAuY9R" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 10pt; text-align: left; padding-bottom: 1pt">Deferred Tax Liability (<span><i>Note 12</i></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:DeferredIncomeTaxLiabilitiesNet" contextRef="AsOf2023-12-31" id="Fact000083" format="ixt:numdotdecimal" decimals="0" unitRef="USD">162,000</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:DeferredIncomeTaxLiabilitiesNet" contextRef="AsOf2022-12-31" id="Fact000084" format="ixt:numdotdecimal" decimals="0" unitRef="USD">192,000</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_40F_eus-gaap--Liabilities_i01TI_mtCzV19_maLASEz92D_zGOytJIdSXj1" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 20pt; text-align: left; padding-bottom: 1pt">Total Liabilities</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:Liabilities" contextRef="AsOf2023-12-31" id="Fact000086" format="ixt:numdotdecimal" decimals="0" unitRef="USD">3,854,982</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:Liabilities" contextRef="AsOf2022-12-31" id="Fact000087" format="ixt:numdotdecimal" decimals="0" unitRef="USD">2,198,522</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-style: italic">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40D_eus-gaap--CommitmentsAndContingencies_i01I_maLASEz92D_ztT3Xq42fcM3" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Commitments and Contingencies <i>(Note 15)</i></span></td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0089">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0090">-</span></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_409_ecustom--SubsequentEvents_i01I_maLASEz92D_zRxbF8rGbE3f" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Subsequent Events <i>(Note 16)</i></span></td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0092">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0093">-</span></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40F_eus-gaap--StockholdersEquityAbstract_i01B_zMHAV12bIFtd" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Stockholders&#8217; Equity:</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40A_eus-gaap--PreferredStockValue_i02I_maSEzlkr_ztWf0m2QiUE2" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 10pt; text-align: left">Preferred stock, $<span id="xdx_908_eus-gaap--PreferredStockParOrStatedValuePerShare_iI_pid_c20231231_zszCZSSNz5Qg" title="Preferred stock, par value"><span id="xdx_90C_eus-gaap--PreferredStockParOrStatedValuePerShare_iI_pid_c20221231_zLq6MXhuUctg" title="Preferred stock, par value"><ix:nonFraction name="us-gaap:PreferredStockParOrStatedValuePerShare" contextRef="AsOf2023-12-31" id="Fact000101" decimals="INF" unitRef="USDPShares"><ix:nonFraction name="us-gaap:PreferredStockParOrStatedValuePerShare" contextRef="AsOf2022-12-31" id="Fact000103" decimals="INF" unitRef="USDPShares">.0001</ix:nonFraction></ix:nonFraction></span></span> par value; <span id="xdx_902_eus-gaap--PreferredStockSharesAuthorized_iI_pid_c20231231_zCe5Kzfb0Av1" title="Preferred stock, shares authorized"><span id="xdx_907_eus-gaap--PreferredStockSharesAuthorized_iI_pid_c20221231_zU4wb2n6nkGe" title="Preferred stock, shares authorized"><ix:nonFraction name="us-gaap:PreferredStockSharesAuthorized" contextRef="AsOf2023-12-31" id="Fact000105" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares"><ix:nonFraction name="us-gaap:PreferredStockSharesAuthorized" contextRef="AsOf2022-12-31" id="Fact000107" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">1,000,000</ix:nonFraction></ix:nonFraction></span></span> shares authorized; <span id="xdx_90C_eus-gaap--PreferredStockSharesIssued_iI_pid_c20231231_zECmqSW1dec3" title="Preferred stock, shares issued"><span id="xdx_901_eus-gaap--PreferredStockSharesIssued_iI_pid_c20221231_zupuJAvVX8o2" title="Preferred stock, shares issued"><span id="xdx_900_eus-gaap--PreferredStockSharesOutstanding_iI_pid_c20231231_zfzIcmoVzz3c" title="Preferred stock, shares outstanding"><span id="xdx_90C_eus-gaap--PreferredStockSharesOutstanding_iI_pid_c20221231_zrShorh9CLDb" title="Preferred stock, shares outstanding"><ix:nonFraction name="us-gaap:PreferredStockSharesIssued" contextRef="AsOf2023-12-31" id="Fact000109" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares"><ix:nonFraction name="us-gaap:PreferredStockSharesIssued" contextRef="AsOf2022-12-31" id="Fact000111" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares"><ix:nonFraction name="us-gaap:PreferredStockSharesOutstanding" contextRef="AsOf2023-12-31" id="Fact000113" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares"><ix:nonFraction name="us-gaap:PreferredStockSharesOutstanding" contextRef="AsOf2022-12-31" id="Fact000115" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">1</ix:nonFraction></ix:nonFraction></ix:nonFraction></ix:nonFraction></span></span></span></span> share issued and outstanding</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0098">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0099">-</span></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_404_eus-gaap--CommonStockValue_i02I_maSEzlkr_z2hD7SUNh3V1" style="display: none; vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-left: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Common
    stock, $.0001
    par value; 500,000,000,
    shares authorized; (100,000,000
    in 2023), 1,694,110
    shares issued and outstanding (2023: 694,294)</span></td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:CommonStockValue" contextRef="AsOf2023-12-31" id="Fact000117" format="ixt:numdotdecimal" decimals="0" unitRef="USD">69</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_405_ecustom--CommonStockReverseSplitValue_i02I_maSEzlkr_zZ4TWyYR6Q1h" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 10pt; text-align: left">Common stock, $<span id="xdx_906_eus-gaap--CommonStockParOrStatedValuePerShare_iI_pid_c20231231_zwrlsAd3SUO7" title="Common stock, par value"><span id="xdx_902_eus-gaap--CommonStockParOrStatedValuePerShare_iI_pid_c20221231_zsrpNe5wkz21" title="Common stock, par value"><ix:nonFraction name="us-gaap:CommonStockParOrStatedValuePerShare" contextRef="AsOf2023-12-31" id="Fact000123" decimals="INF" unitRef="USDPShares"><ix:nonFraction name="us-gaap:CommonStockParOrStatedValuePerShare" contextRef="AsOf2022-12-31" id="Fact000125" decimals="INF" unitRef="USDPShares">.0001</ix:nonFraction></ix:nonFraction></span></span> par value; <span id="xdx_907_eus-gaap--CommonStockSharesAuthorized_iI_pid_c20231231_zh1i0k6E87Z9" title="Common stock, shares authorized"><span id="xdx_902_eus-gaap--CommonStockSharesAuthorized_iI_pid_c20221231_zUGUIbgQJbd" title="Common stock, shares authorized"><ix:nonFraction name="us-gaap:CommonStockSharesAuthorized" contextRef="AsOf2023-12-31" id="Fact000127" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares"><ix:nonFraction name="us-gaap:CommonStockSharesAuthorized" contextRef="AsOf2022-12-31" id="Fact000129" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">100,000,000</ix:nonFraction></ix:nonFraction></span></span>, shares authorized; <span id="xdx_90E_eus-gaap--CommonStockSharesIssued_iI_c20231231__us-gaap--AwardTypeAxis__custom--ReverseStockSplitMember_zEaJxigdzEwi" title="Common stock, shares issued"><span id="xdx_903_eus-gaap--CommonStockSharesOutstanding_iI_c20231231__us-gaap--AwardTypeAxis__custom--ReverseStockSplitMember_zvPioltv90Zc" title="Common stock, shares outstanding"><ix:nonFraction name="us-gaap:CommonStockSharesIssued" contextRef="AsOf2023-12-31_custom_ReverseStockSplitMember" id="Fact000131" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares"><ix:nonFraction name="us-gaap:CommonStockSharesOutstanding" contextRef="AsOf2023-12-31_custom_ReverseStockSplitMember" id="Fact000133" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">15,274,457</ix:nonFraction></ix:nonFraction></span></span> shares issued and outstanding and (2022: <span id="xdx_908_eus-gaap--CommonStockSharesIssued_iI_c20221231_zODLwIH98Lg5" title="Common stock, shares issued"><span id="xdx_908_eus-gaap--CommonStockSharesOutstanding_iI_c20221231_zPgkyaIvDPic" title="Common stock, shares outstanding"><ix:nonFraction name="us-gaap:CommonStockSharesIssued" contextRef="AsOf2022-12-31" id="Fact000135" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares"><ix:nonFraction name="us-gaap:CommonStockSharesOutstanding" contextRef="AsOf2022-12-31" id="Fact000137" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">9,407,415</ix:nonFraction></ix:nonFraction></span></span>)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="STSS:CommonStockReverseSplitValue" contextRef="AsOf2023-12-31" id="Fact000120" format="ixt:numdotdecimal" decimals="0" unitRef="USD">1,528</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="STSS:CommonStockReverseSplitValue" contextRef="AsOf2022-12-31" id="Fact000121" format="ixt:numdotdecimal" decimals="0" unitRef="USD">941</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40E_eus-gaap--AdditionalPaidInCapital_i02I_hus-gaap--AwardTypeAxis__custom--ReverseStockSplitMember_maSEzlkr_zLBbyKVhIeUj" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 10pt; text-align: left">Additional paid-in capital</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:AdditionalPaidInCapital" contextRef="AsOf2023-12-31_custom_ReverseStockSplitMember" id="Fact000139" format="ixt:numdotdecimal" decimals="0" unitRef="USD">32,489,950</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:AdditionalPaidInCapital" contextRef="AsOf2022-12-31_custom_ReverseStockSplitMember" id="Fact000140" format="ixt:numdotdecimal" decimals="0" unitRef="USD">24,733,306</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_404_eus-gaap--AccumulatedOtherComprehensiveIncomeLossNetOfTax_i02I_maSEzlkr_zIF5IqoRCIWd" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 10pt; text-align: left">Accumulated other comprehensive income</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" contextRef="AsOf2023-12-31" id="Fact000142" format="ixt:numdotdecimal" decimals="0" unitRef="USD">591,812</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" contextRef="AsOf2022-12-31" id="Fact000143" format="ixt:numdotdecimal" decimals="0" unitRef="USD">214,253</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_403_eus-gaap--RetainedEarningsAccumulatedDeficit_i02I_maSEzlkr_zPRQVJVAsus6" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 10pt; text-align: left; padding-bottom: 1pt">Accumulated deficit</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(<ix:nonFraction name="us-gaap:RetainedEarningsAccumulatedDeficit" contextRef="AsOf2023-12-31" id="Fact000145" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">25,149,004</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(<ix:nonFraction name="us-gaap:RetainedEarningsAccumulatedDeficit" contextRef="AsOf2022-12-31" id="Fact000146" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">15,307,366</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">)</td></tr>
  <tr id="xdx_404_eus-gaap--StockholdersEquity_i02TI_maLASEz92D_mtSEzlkr_zZXCyrgDbGE4" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 10pt; text-align: left; padding-bottom: 1pt">Total Stockholders&#8217; Equity</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2023-12-31" id="Fact000148" format="ixt:numdotdecimal" decimals="0" unitRef="USD">7,934,286</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2022-12-31" id="Fact000149" format="ixt:numdotdecimal" decimals="0" unitRef="USD">9,641,134</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_40A_eus-gaap--LiabilitiesAndStockholdersEquity_i01TI_mtLASEz92D_z8lB1sP42Y78" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 2.5pt">TOTAL LIABILITIES AND STOCKHOLDERS&#8217; EQUITY</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right"><ix:nonFraction name="us-gaap:LiabilitiesAndStockholdersEquity" contextRef="AsOf2023-12-31" id="Fact000151" format="ixt:numdotdecimal" decimals="0" unitRef="USD">11,789,268</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right"><ix:nonFraction name="us-gaap:LiabilitiesAndStockholdersEquity" contextRef="AsOf2022-12-31" id="Fact000152" format="ixt:numdotdecimal" decimals="0" unitRef="USD">11,839,656</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>The
accompanying notes are an integral part of these financial statements.</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 52; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 0pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%"><a href="#RM_014">Table of Contents</a></td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span id="MT_003"></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>SHARPS
TECHNOLOGY, INC.</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>CONSOLIDATED
STATEMENTS OF OPERATIONS</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" id="xdx_30C_113_zjM8ARD6gEXf" summary="xdx: Statement - Condensed Consolidated Statements of Operations" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" id="xdx_49E_20230101__20231231_zr7S1w1Ewynj" style="font-weight: bold; text-align: center">For the year ended</td><td style="font-weight: bold">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" id="xdx_491_20220101__20221231_zpxNZJWaH8Ob" style="font-weight: bold; text-align: center">For the year ended</td><td style="font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><p style="margin-top: 0pt; margin-bottom: 0pt">December 31,</p>
                                                                                <p style="margin-top: 0pt; margin-bottom: 0pt">2023</p></td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><p style="margin-top: 0pt; margin-bottom: 0pt">December 31,</p>
                                                                                <p style="margin-top: 0pt; margin-bottom: 0pt">2022</p></td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td></tr>
  <tr id="xdx_402_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_maCzndT_zRMzE4ZJNXPk" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1pt">Revenue, net</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">$</td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0154">-</span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">$</td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0155">-</span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40B_eus-gaap--OperatingExpensesAbstract_iB_zLofhxe6FIgi" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Operating expenses:</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40C_eus-gaap--ResearchAndDevelopmentExpense_i01_maOEzejP_zTEFLCnUq1Y8" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 10pt; width: 60%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Research and development <i>(Note 5)</i></span></td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 16%; text-align: right"><ix:nonFraction name="us-gaap:ResearchAndDevelopmentExpense" contextRef="From2023-01-012023-12-31" id="Fact000160" format="ixt:numdotdecimal" decimals="0" unitRef="USD">1,605,547</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 16%; text-align: right"><ix:nonFraction name="us-gaap:ResearchAndDevelopmentExpense" contextRef="From2022-01-012022-12-31" id="Fact000161" format="ixt:numdotdecimal" decimals="0" unitRef="USD">2,280,933</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr id="xdx_401_eus-gaap--GeneralAndAdministrativeExpense_i01_maOEzejP_zipp9VLCcqr5" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 10pt; text-align: left; padding-bottom: 1pt">General and administrative</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:GeneralAndAdministrativeExpense" contextRef="From2023-01-012023-12-31" id="Fact000163" format="ixt:numdotdecimal" decimals="0" unitRef="USD">8,521,103</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:GeneralAndAdministrativeExpense" contextRef="From2022-01-012022-12-31" id="Fact000164" format="ixt:numdotdecimal" decimals="0" unitRef="USD">6,457,860</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_40B_eus-gaap--OperatingExpenses_i01T_msCzndT_mtOEzejP_zZDLIaSsBjSi" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1pt">Total operating expenses</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(<ix:nonFraction name="us-gaap:OperatingExpenses" contextRef="From2023-01-012023-12-31" id="Fact000166" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">10,126,650</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(<ix:nonFraction name="us-gaap:OperatingExpenses" contextRef="From2022-01-012022-12-31" id="Fact000167" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">8,738,793</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">)</td></tr>
  <tr id="xdx_401_eus-gaap--OperatingIncomeLoss_iT_mtCzndT_maILFCOzF1f_zmdeVMw1kypk" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1pt">Loss from operations</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(<ix:nonFraction name="us-gaap:OperatingIncomeLoss" contextRef="From2023-01-012023-12-31" id="Fact000169" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">10,126,650</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(<ix:nonFraction name="us-gaap:OperatingIncomeLoss" contextRef="From2022-01-012022-12-31" id="Fact000170" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">8,738,793</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40A_eus-gaap--NonoperatingIncomeExpenseAbstract_iB_zgJ9RkL2mQgg" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Other income (expense)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40F_eus-gaap--InterestIncomeExpenseNet_i01_maNIEzX8q_zYKqHDB5dhfj" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 10pt; text-align: left">Interest income (expense)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:InterestIncomeExpenseNet" contextRef="From2023-01-012023-12-31" id="Fact000175" format="ixt:numdotdecimal" decimals="0" unitRef="USD">138,118</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction name="us-gaap:InterestIncomeExpenseNet" contextRef="From2022-01-012022-12-31" id="Fact000176" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">1,320,416</ix:nonFraction></td><td style="text-align: left">)</td></tr>
  <tr id="xdx_40D_eus-gaap--OtherNonoperatingIncomeExpense_i01_maNIEzX8q_zBn15ETuhh39" style="display: none; vertical-align: bottom; background-color: White">
    <td style="padding-left: 10pt; text-align: left">Other (expense) income</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_402_ecustom--FairMarketValueAdjustmentForContingentStockAndWarrants_i01N_di_msNIEzX8q_zfpPQtkd2Wre" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 10pt; text-align: left">FMV adjustment on contingent stock &amp; warrants</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="STSS:FairMarketValueAdjustmentForContingentStockAndWarrants" contextRef="From2023-01-012023-12-31" id="Fact000181" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">169,583</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="STSS:FairMarketValueAdjustmentForContingentStockAndWarrants" contextRef="From2022-01-012022-12-31" id="Fact000182" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">5,392,911</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_406_eus-gaap--GainLossOnSaleOfDerivatives_i01_maNIEzX8q_zdUvMu8dyeJ2" style="display: none; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 10pt; text-align: left">FMV adjustment  warrants</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"/><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"/><td style="text-align: left">&#160;</td></tr>
<tr id="xdx_405_ecustom--FairMarketValueAdjustmentForContingentWarrantsAndWarrants_i01N_di_msNIEzX8q_zBln24zMtAB" style="display: none; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 10pt; text-align: left">FMV adjustment warrants (Note 10)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr id="xdx_40D_ecustom--ForeignCurrencyAndNonOperatingIncomeExpenses_i01_maNIEzX8q_zw0sRHvzoj1b" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 10pt; text-align: left; padding-bottom: 1pt">Foreign currency and other</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(<ix:nonFraction name="STSS:ForeignCurrencyAndNonOperatingIncomeExpenses" contextRef="From2023-01-012023-12-31" id="Fact000190" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">52,689</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="STSS:ForeignCurrencyAndNonOperatingIncomeExpenses" contextRef="From2022-01-012022-12-31" id="Fact000191" format="ixt:numdotdecimal" decimals="0" unitRef="USD">26,636</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_409_eus-gaap--NonoperatingIncomeExpense_i01T_mtNIEzX8q_maILFCOzF1f_zj9aqQbfAbnl" style="display: none; vertical-align: bottom; background-color: White">
    <td style="padding-left: 10pt; text-align: left; padding-bottom: 1pt">Total
    other income (expense)</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">&#160;</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">&#160;</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_402_eus-gaap--IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_iT_maNILzGWj_mtILFCOzF1f_z7JlcrOP0G7l" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1pt">Net loss Before Provision for Taxes</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="padding-bottom: 1pt; text-align: left">$</td><td style="padding-bottom: 1pt; text-align: right">(<ix:nonFraction name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" contextRef="From2023-01-012023-12-31" id="Fact000196" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">9,871,638</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="padding-bottom: 1pt; text-align: left">$</td><td style="padding-bottom: 1pt; text-align: right">(<ix:nonFraction name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" contextRef="From2022-01-012022-12-31" id="Fact000197" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">4,639,662</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">)</td></tr>
  <tr id="xdx_408_eus-gaap--DeferredIncomeTaxExpenseBenefit_iN_di_msNILzGWj_zA3rytuQR6Rf" style="vertical-align: bottom; background-color: White">
    <td style="padding-bottom: 1pt; padding-left: 10pt; text-align: left">Deferred Tax Benefit</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:DeferredIncomeTaxExpenseBenefit" contextRef="From2023-01-012023-12-31" id="Fact000199" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">30,000</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0200">-</span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_406_eus-gaap--NetIncomeLoss_iT_mtNILzGWj_zWYc0pxOTIC1" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 2.5pt">Net Loss</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td style="border-bottom: Black 2.5pt double; text-align: right">(<ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2023-01-012023-12-31" id="Fact000202" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">9,841,638</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">)</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td style="border-bottom: Black 2.5pt double; text-align: right">(<ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2022-01-012022-12-31" id="Fact000203" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">4,639,662</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Net loss per share, basic and diluted</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right"><span id="xdx_902_eus-gaap--EarningsPerShareBasic_pid_c20230101__20231231_zJUMyc5EOkI1" title="Net loss per share, basic" class="xdx_phnt_U3RhdGVtZW50IC0gQ29uZGVuc2VkIENvbnNvbGlkYXRlZCBTdGF0ZW1lbnRzIG9mIE9wZXJhdGlvbnMA"><span id="xdx_902_eus-gaap--EarningsPerShareDiluted_pid_c20230101__20231231_zqMbjNJYEtkc" title="Net loss per share, diluted" class="xdx_phnt_U3RhdGVtZW50IC0gQ29uZGVuc2VkIENvbnNvbGlkYXRlZCBTdGF0ZW1lbnRzIG9mIE9wZXJhdGlvbnMA">(<ix:nonFraction name="us-gaap:EarningsPerShareBasic" contextRef="From2023-01-012023-12-31" id="Fact000205" format="ixt:numdotdecimal" decimals="INF" sign="-" unitRef="USDPShares"><ix:nonFraction name="us-gaap:EarningsPerShareDiluted" contextRef="From2023-01-012023-12-31" id="Fact000207" format="ixt:numdotdecimal" decimals="INF" sign="-" unitRef="USDPShares">0.76</ix:nonFraction></ix:nonFraction></span></span></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right"><span id="xdx_906_eus-gaap--EarningsPerShareBasic_pid_c20220101__20221231_zoPLYHOWIfa8" title="Net loss per share, basic" class="xdx_phnt_U3RhdGVtZW50IC0gQ29uZGVuc2VkIENvbnNvbGlkYXRlZCBTdGF0ZW1lbnRzIG9mIE9wZXJhdGlvbnMA"><span id="xdx_90F_eus-gaap--EarningsPerShareDiluted_pid_c20220101__20221231_zghNAbFj1ys8" title="Net loss per share, diluted" class="xdx_phnt_U3RhdGVtZW50IC0gQ29uZGVuc2VkIENvbnNvbGlkYXRlZCBTdGF0ZW1lbnRzIG9mIE9wZXJhdGlvbnMA">(<ix:nonFraction name="us-gaap:EarningsPerShareBasic" contextRef="From2022-01-012022-12-31" id="Fact000209" format="ixt:numdotdecimal" decimals="INF" sign="-" unitRef="USDPShares"><ix:nonFraction name="us-gaap:EarningsPerShareDiluted" contextRef="From2022-01-012022-12-31" id="Fact000211" format="ixt:numdotdecimal" decimals="INF" sign="-" unitRef="USDPShares">0.57</ix:nonFraction></ix:nonFraction></span></span></td><td style="text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 2.5pt">Weighted average shares used to compute net loss per share, basic and diluted</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td style="border-bottom: Black 2.5pt double; text-align: right"><span id="xdx_90C_eus-gaap--WeightedAverageNumberOfSharesOutstandingBasic_pid_c20230101__20231231_zBgSdQhxwBg9" title="Weighted average shares used to compute net loss per share, basic" class="xdx_phnt_U3RhdGVtZW50IC0gQ29uZGVuc2VkIENvbnNvbGlkYXRlZCBTdGF0ZW1lbnRzIG9mIE9wZXJhdGlvbnMA"><span id="xdx_904_eus-gaap--WeightedAverageNumberOfDilutedSharesOutstanding_pid_c20230101__20231231_zxUHS43uIEah" title="Weighted average shares used to compute net loss per share, diluted" class="xdx_phnt_U3RhdGVtZW50IC0gQ29uZGVuc2VkIENvbnNvbGlkYXRlZCBTdGF0ZW1lbnRzIG9mIE9wZXJhdGlvbnMA"><ix:nonFraction name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" contextRef="From2023-01-012023-12-31" id="Fact000213" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares"><ix:nonFraction name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" contextRef="From2023-01-012023-12-31" id="Fact000215" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">13,032,717</ix:nonFraction></ix:nonFraction></span></span></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td style="border-bottom: Black 2.5pt double; text-align: right"><span id="xdx_90A_eus-gaap--WeightedAverageNumberOfSharesOutstandingBasic_pid_c20220101__20221231_zeZkoytVkWb1" title="Weighted average shares used to compute net loss per share, basic" class="xdx_phnt_U3RhdGVtZW50IC0gQ29uZGVuc2VkIENvbnNvbGlkYXRlZCBTdGF0ZW1lbnRzIG9mIE9wZXJhdGlvbnMA"><span id="xdx_900_eus-gaap--WeightedAverageNumberOfDilutedSharesOutstanding_pid_c20220101__20221231_zBEZwaXf4Kli" title="Weighted average shares used to compute net loss per share, diluted" class="xdx_phnt_U3RhdGVtZW50IC0gQ29uZGVuc2VkIENvbnNvbGlkYXRlZCBTdGF0ZW1lbnRzIG9mIE9wZXJhdGlvbnMA"><ix:nonFraction name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" contextRef="From2022-01-012022-12-31" id="Fact000217" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares"><ix:nonFraction name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" contextRef="From2022-01-012022-12-31" id="Fact000219" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">8,100,410</ix:nonFraction></ix:nonFraction></span></span></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>The
accompanying notes are an integral part of these financial statements.</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>&#160;</i></span></p>


<!-- Field: Page; Sequence: 53; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 0pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%"><a href="#RM_014">Table of Contents</a></td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>&#160;</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span id="MT_004"></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>SHARPS
TECHNOLOGY, INC.</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>CONSOLIDATED
STATEMENTS OF COMPREHENSIVE LOSS</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" id="xdx_301_113_zWC9WmyZtHY8" summary="xdx: Statement - Condensed Consolidated Statements of Comprehensive Loss" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" id="xdx_49D_20230101__20231231_zoEyJVisOngc" style="font-weight: bold; text-align: center">For the year ended</td><td style="font-weight: bold">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" id="xdx_49F_20220101__20221231_zJGQ9C2iMzgg" style="font-weight: bold; text-align: center">For the year ended</td><td style="font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><p style="margin-top: 0pt; margin-bottom: 0pt">December 31,</p>
                                                                                <p style="margin-top: 0pt; margin-bottom: 0pt">2023</p></td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><p style="margin-top: 0pt; margin-bottom: 0pt">December 31,</p>
                                                                                <p style="margin-top: 0pt; margin-bottom: 0pt">2022</p></td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
  <tr id="xdx_40D_eus-gaap--NetIncomeLoss_maCINOTz4dD_zsRGhar9fYH5" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 60%; text-align: left">Net loss</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 16%; text-align: right">(<ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2023-01-012023-12-31" id="Fact000221" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">9,841,638</ix:nonFraction></td><td style="width: 1%; text-align: left">)</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 16%; text-align: right">(<ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2022-01-012022-12-31" id="Fact000222" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">4,639,662</ix:nonFraction></td><td style="width: 1%; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_404_eus-gaap--OtherComprehensiveIncomeLossTaxAbstract_iB_zPtUt4TIMOi5" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Other comprehensive income:</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40E_eus-gaap--OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent_i01_maCINOTz4dD_zYemQn63FtE7" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Foreign currency translation adjustments</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent" contextRef="From2023-01-012023-12-31" id="Fact000227" format="ixt:numdotdecimal" decimals="0" unitRef="USD">377,559</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent" contextRef="From2022-01-012022-12-31" id="Fact000228" format="ixt:numdotdecimal" decimals="0" unitRef="USD">214,253</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40C_eus-gaap--ComprehensiveIncomeNetOfTax_i01T_mtCINOTz4dD_z47HwHMEBkJ6" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; text-align: left; padding-bottom: 1pt">Comprehensive loss</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">$</td><td style="border-bottom: Black 1pt solid; text-align: right">(<ix:nonFraction name="us-gaap:ComprehensiveIncomeNetOfTax" contextRef="From2023-01-012023-12-31" id="Fact000230" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">9,464,079</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">$</td><td style="border-bottom: Black 1pt solid; text-align: right">(<ix:nonFraction name="us-gaap:ComprehensiveIncomeNetOfTax" contextRef="From2022-01-012022-12-31" id="Fact000231" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">4,425,409</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">)</td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>The
accompanying notes are an integral part of these financial statements.</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 54; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 0pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->6<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%"><a href="#RM_014">Table of Contents</a></td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="MT_005"></span><b>SHARPS
TECHNOLOGY, INC.</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>CONSOLIDATED
STATEMENTS OF STOCKHOLDERS&#8217; EQUITY</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>FOR
THE YEARS ENDED DECEMBER 31, 2023 AND 2022</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" id="xdx_309_114_z3cVHfwhjyC" summary="xdx: Statement - Condensed Consolidated Statement of Stockholders' Equity" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="display: none; vertical-align: bottom">
    <td style="display: none">&#160;</td><td style="display: none; font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; display: none; font-weight: bold; text-align: center">Shares</td><td style="display: none; padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="display: none; font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" id="xdx_4B0_us-gaap--StatementEquityComponentsAxis_us-gaap--PreferredStockMember_zAmeCrC3Zij3" style="border-bottom: Black 1pt solid; display: none; font-weight: bold; text-align: center">Amount</td><td style="display: none; padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="display: none; font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; display: none; font-weight: bold; text-align: center">Shares</td><td style="display: none; padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="display: none; font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" id="xdx_4B5_us-gaap--StatementEquityComponentsAxis_us-gaap--CommonStockMember_zjKjv3FLsmNa" style="border-bottom: Black 1pt solid; display: none; font-weight: bold; text-align: center">Amount</td><td style="display: none; padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="display: none; font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" id="xdx_4BB_us-gaap--StatementEquityComponentsAxis_custom--CommonStockSubscriptionReceivableMember_zHtH5uemBDU4" style="border-bottom: Black 1pt solid; display: none; font-weight: bold; text-align: center">Receivable</td><td style="display: none; padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="display: none; font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" id="xdx_4B6_us-gaap--StatementEquityComponentsAxis_us-gaap--AdditionalPaidInCapitalMember_zBjlB6MxlPHe" style="border-bottom: Black 1pt solid; display: none; font-weight: bold; text-align: center">Capital</td><td style="display: none; padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="display: none; font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" id="xdx_4B4_us-gaap--StatementEquityComponentsAxis_us-gaap--AccumulatedOtherComprehensiveIncomeMember_zLuTnZhB5pNi" style="border-bottom: Black 1pt solid; display: none; font-weight: bold; text-align: center">Income</td><td style="display: none; padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="display: none; font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" id="xdx_4B4_us-gaap--StatementEquityComponentsAxis_us-gaap--RetainedEarningsMember_zUY7q5cPloJ3" style="border-bottom: Black 1pt solid; display: none; font-weight: bold; text-align: center">Deficit</td><td style="display: none; padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="display: none; font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" id="xdx_4BB_zuQpSQFB1hbc" style="border-bottom: Black 1pt solid; display: none; font-weight: bold; text-align: center">Equity</td><td style="display: none; padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="6" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Preferred Stock</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="6" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Common Stock</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="padding-bottom: 1pt; font-weight: bold; text-align: center">Common Stock<br/> Subscription</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="padding-bottom: 1pt; font-weight: bold; text-align: center">Additional<br/> Paid-in</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="padding-bottom: 1pt; font-weight: bold; text-align: center">Accumulated <br/> Other<br/> Comprehensive</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="padding-bottom: 1pt; font-weight: bold; text-align: center">Accumulated</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="padding-bottom: 1pt; font-weight: bold; text-align: center">Total<br/> Stockholders&#8217;</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Shares</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Amount</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Shares</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Amount</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Receivable</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Capital</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Income</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Deficit</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Equity</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: right">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: right">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: right">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: right">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: right">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: right">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: right">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: right">&#160;</td><td>&#160;</td></tr>
  <tr id="xdx_43A_c20220101__20221231_eus-gaap--StockholdersEquity_iS_zGSYWPEi3Czh" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 28%; padding-bottom: 2.5pt">Balance &#8211; December 31, 2021</td><td style="width: 2%; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; width: 1%; text-align: left">&#160;</td><td id="xdx_982_eus-gaap--SharesOutstanding_iS_c20220101__20221231__us-gaap--StatementEquityComponentsAxis__us-gaap--PreferredStockMember_zp4gfyXPrME6" title="Balance, shares" style="border-bottom: Black 2.5pt double; width: 4%; text-align: right"><ix:nonFraction name="us-gaap:SharesOutstanding" contextRef="AsOf2021-12-31_us-gaap_PreferredStockMember" id="Fact000241" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">1</ix:nonFraction></td><td style="width: 1%; padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="width: 2%; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; width: 1%; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; width: 4%; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0233">-</span></td><td style="width: 1%; padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="width: 2%; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; width: 1%; text-align: left">&#160;</td><td id="xdx_987_eus-gaap--SharesOutstanding_iS_c20220101__20221231__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_z8hSCWnMUyhj" title="Balance, shares" style="border-bottom: Black 2.5pt double; width: 4%; text-align: right"><ix:nonFraction name="us-gaap:SharesOutstanding" contextRef="AsOf2021-12-31_us-gaap_CommonStockMember" id="Fact000243" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">5,187,062</ix:nonFraction></td><td style="width: 1%; padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="width: 2%; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; width: 1%; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; width: 4%; text-align: right"><ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2021-12-31_us-gaap_CommonStockMember" id="Fact000234" format="ixt:numdotdecimal" decimals="0" unitRef="USD">519</ix:nonFraction></td><td style="width: 1%; padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="width: 2%; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; width: 1%; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; width: 4%; text-align: right">(<ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2021-12-31_custom_CommonStockSubscriptionReceivableMember" id="Fact000235" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">32,500</ix:nonFraction></td><td style="width: 1%; padding-bottom: 2.5pt; text-align: left">)</td><td style="width: 2%; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; width: 1%; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; width: 4%; text-align: right"><ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2021-12-31_us-gaap_AdditionalPaidInCapitalMember" id="Fact000236" format="ixt:numdotdecimal" decimals="0" unitRef="USD">13,835,882</ix:nonFraction></td><td style="width: 1%; padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="width: 2%; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; width: 1%; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; width: 4%; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0237">-</span></td><td style="width: 1%; padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="width: 2%; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; width: 1%; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; width: 4%; text-align: right">(<ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2021-12-31_us-gaap_RetainedEarningsMember" id="Fact000238" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">10,667,704</ix:nonFraction></td><td style="width: 1%; padding-bottom: 2.5pt; text-align: left">)</td><td style="width: 2%; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; width: 1%; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; width: 4%; text-align: right">&#160;&#160;&#160;&#160;<ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2021-12-31" id="Fact000239" format="ixt:numdotdecimal" decimals="0" unitRef="USD">3,136,197</ix:nonFraction></td><td style="width: 1%; padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_403_eus-gaap--NetIncomeLoss_zJoFkqswNYLi" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Net loss for the year ended December 31, 2022</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0245">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0246">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0247">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0248">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0249">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2022-01-012022-12-31_us-gaap_RetainedEarningsMember" id="Fact000250" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">4,639,662</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2022-01-012022-12-31" id="Fact000251" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">4,639,662</ix:nonFraction></td><td style="text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_406_ecustom--StockIssuedDuringPeriodValueInitialPublicOffering_zCygh7m5T1Rg" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Shares issued in Initial Public Offering</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_989_ecustom--StockIssuedDuringPeriodSharesInitialPublicOffering_c20220101__20221231__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zhDpVHDyDVo5" title="Shares issued in Initial Public Offering, shares" style="text-align: right"><ix:nonFraction name="STSS:StockIssuedDuringPeriodSharesInitialPublicOffering" contextRef="From2022-01-012022-12-31_us-gaap_CommonStockMember" id="Fact000261" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">3,750,000</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="STSS:StockIssuedDuringPeriodValueInitialPublicOffering" contextRef="From2022-01-012022-12-31_us-gaap_CommonStockMember" id="Fact000254" format="ixt:numdotdecimal" decimals="0" unitRef="USD">375</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0255">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="STSS:StockIssuedDuringPeriodValueInitialPublicOffering" contextRef="From2022-01-012022-12-31_us-gaap_AdditionalPaidInCapitalMember" id="Fact000256" format="ixt:numdotdecimal" decimals="0" unitRef="USD">8,974,282</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0257">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0258">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="STSS:StockIssuedDuringPeriodValueInitialPublicOffering" contextRef="From2022-01-012022-12-31" id="Fact000259" format="ixt:numdotdecimal" decimals="0" unitRef="USD">8,974,657</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_404_ecustom--StockIssuedDuringPeriodValueContingentStockLiability_zLp6kvoV1fpd" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Issuance of shares for contingent stock liability</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_983_ecustom--StockIssuedDuringPeriodSharesContingentStockLiability_c20220101__20221231__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zc0jfdLR2cV3" title="Issuance of shares for contingent stock liability, shares" style="text-align: right"><ix:nonFraction name="STSS:StockIssuedDuringPeriodSharesContingentStockLiability" contextRef="From2022-01-012022-12-31_us-gaap_CommonStockMember" id="Fact000271" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">235,294</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="STSS:StockIssuedDuringPeriodValueContingentStockLiability" contextRef="From2022-01-012022-12-31_us-gaap_CommonStockMember" id="Fact000264" format="ixt:numdotdecimal" decimals="0" unitRef="USD">24</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0265">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="STSS:StockIssuedDuringPeriodValueContingentStockLiability" contextRef="From2022-01-012022-12-31_us-gaap_AdditionalPaidInCapitalMember" id="Fact000266" format="ixt:numdotdecimal" decimals="0" unitRef="USD">495,976</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0267">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0268">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="STSS:StockIssuedDuringPeriodValueContingentStockLiability" contextRef="From2022-01-012022-12-31" id="Fact000269" format="ixt:numdotdecimal" decimals="0" unitRef="USD">496,000</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_405_eus-gaap--AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_zMkqdvdAjS7j" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Share-based compensation charges</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0273">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0274">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0275">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" contextRef="From2022-01-012022-12-31_us-gaap_AdditionalPaidInCapitalMember" id="Fact000276" format="ixt:numdotdecimal" decimals="0" unitRef="USD">1,136,638</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0277">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0278">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" contextRef="From2022-01-012022-12-31" id="Fact000279" format="ixt:numdotdecimal" decimals="0" unitRef="USD">1,136,638</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_409_ecustom--StockIssuedDuringPeriodValueFractionalShareAdjustment_zuBkKhnishpi" style="vertical-align: bottom; background-color: White">
    <td>Fractional share adjustment</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0281">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_984_ecustom--StockIssuedDuringPeriodSharesFractionalShareAdjustment_c20220101__20221231__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zsD6YFAPYezg" title="Fractional share adjustment, shares" style="text-align: right"><ix:nonFraction name="STSS:StockIssuedDuringPeriodSharesFractionalShareAdjustment" contextRef="From2022-01-012022-12-31_us-gaap_CommonStockMember" id="Fact000289" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">59</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0282">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0283">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0284">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0285">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0286">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0287">-</span></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_400_eus-gaap--StockIssuedDuringPeriodValueIssuedForServices_zQVaPZrSiYNl" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Issuance of common stock for services</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0291">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98F_eus-gaap--StockIssuedDuringPeriodSharesIssuedForServices_c20220101__20221231__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_ztwp9y1L2Uf4" title="Issuance of common stock for services, shares" style="text-align: right"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodSharesIssuedForServices" contextRef="From2022-01-012022-12-31_us-gaap_CommonStockMember" id="Fact000299" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">235,000</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueIssuedForServices" contextRef="From2022-01-012022-12-31_us-gaap_CommonStockMember" id="Fact000292" format="ixt:numdotdecimal" decimals="0" unitRef="USD">23</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0293">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueIssuedForServices" contextRef="From2022-01-012022-12-31_us-gaap_AdditionalPaidInCapitalMember" id="Fact000294" format="ixt:numdotdecimal" decimals="0" unitRef="USD">290,528</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0295">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0296">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueIssuedForServices" contextRef="From2022-01-012022-12-31" id="Fact000297" format="ixt:numdotdecimal" decimals="0" unitRef="USD">290,551</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_400_eus-gaap--OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax_z4oRfMnJmbil" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Foreign currency translation</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0301">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0302">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0303">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0304">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax" contextRef="From2022-01-012022-12-31_us-gaap_AccumulatedOtherComprehensiveIncomeMember" id="Fact000305" format="ixt:numdotdecimal" decimals="0" unitRef="USD">214,253</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0306">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax" contextRef="From2022-01-012022-12-31" id="Fact000307" format="ixt:numdotdecimal" decimals="0" unitRef="USD">214,253</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_408_ecustom--StockIssuedDuringPeriodCollectionsOfCommonStockSubscriptionsValue_z49w5Wu7R5l9" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1pt">Collection of stock subscription</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">-</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0309">-</span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">-</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0310">-</span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="STSS:StockIssuedDuringPeriodCollectionsOfCommonStockSubscriptionsValue" contextRef="From2022-01-012022-12-31_custom_CommonStockSubscriptionReceivableMember" id="Fact000311" format="ixt:numdotdecimal" decimals="0" unitRef="USD">32,500</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0312">-</span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0313">-</span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0314">-</span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="STSS:StockIssuedDuringPeriodCollectionsOfCommonStockSubscriptionsValue" contextRef="From2022-01-012022-12-31" id="Fact000315" format="ixt:numdotdecimal" decimals="0" unitRef="USD">32,500</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_433_c20230101__20231231__custom--AwardsTypeAxis__custom--ReverseStockSplitMember_eus-gaap--StockholdersEquity_iS_zB9dvuSGpdR7" style="vertical-align: bottom; background-color: White">
    <td style="padding-bottom: 2.5pt">Balance &#8211; December 31, 2022</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td id="xdx_983_eus-gaap--SharesOutstanding_iS_c20230101__20231231__us-gaap--StatementEquityComponentsAxis__us-gaap--PreferredStockMember__us-gaap--AwardTypeAxis__custom--ReverseStockSplitMember_zQ3wApylBYw2" title="Balance, shares" style="border-bottom: Black 2.5pt double; text-align: right"><ix:nonFraction name="us-gaap:SharesOutstanding" contextRef="AsOf2022-12-31_us-gaap_PreferredStockMember_custom_ReverseStockSplitMember" id="Fact000325" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">1</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0317">-</span></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td id="xdx_98A_eus-gaap--SharesOutstanding_iS_c20230101__20231231__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember__us-gaap--AwardTypeAxis__custom--ReverseStockSplitMember_z5z423HmpqW5" title="Balance, shares" style="border-bottom: Black 2.5pt double; text-align: right"><ix:nonFraction name="us-gaap:SharesOutstanding" contextRef="AsOf2022-12-31_us-gaap_CommonStockMember_custom_ReverseStockSplitMember" id="Fact000327" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">9,407,415</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td style="border-bottom: Black 2.5pt double; text-align: right"><ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2022-12-31_custom_ReverseStockSplitMember_us-gaap_CommonStockMember" id="Fact000318" format="ixt:numdotdecimal" decimals="0" unitRef="USD">941</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0319">-</span></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right"><ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2022-12-31_custom_ReverseStockSplitMember_us-gaap_AdditionalPaidInCapitalMember" id="Fact000320" format="ixt:numdotdecimal" decimals="0" unitRef="USD">24,733,306</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right"><ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2022-12-31_custom_ReverseStockSplitMember_us-gaap_AccumulatedOtherComprehensiveIncomeMember" id="Fact000321" format="ixt:numdotdecimal" decimals="0" unitRef="USD">214,253</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">(<ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2022-12-31_custom_ReverseStockSplitMember_us-gaap_RetainedEarningsMember" id="Fact000322" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">15,307,366</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">)</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right"><ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2022-12-31_custom_ReverseStockSplitMember10880671" id="Fact000323" format="ixt:numdotdecimal" decimals="0" unitRef="USD">9,641,134</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_43D_c20230101__20231231__custom--AwardsTypeAxis__custom--ReverseStockSplitMember_eus-gaap--StockholdersEquity_iS_zv43yhWSnO14" style="display: none; vertical-align: bottom; background-color: White">
    <td style="padding-bottom: 2.5pt">Balance </td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td id="xdx_988_eus-gaap--SharesOutstanding_iS_c20230101__20231231__us-gaap--StatementEquityComponentsAxis__us-gaap--PreferredStockMember__us-gaap--AwardTypeAxis__custom--ReverseStockSplitMember_zP9DVkUbnhQ4" title="Balance, shares" style="border-bottom: Black 2.5pt double; text-align: right"><ix:nonFraction name="us-gaap:SharesOutstanding" contextRef="AsOf2022-12-31_us-gaap_PreferredStockMember_custom_ReverseStockSplitMember" id="Fact000337" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">1</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0329">-</span></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td id="xdx_98E_eus-gaap--SharesOutstanding_iS_c20230101__20231231__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember__us-gaap--AwardTypeAxis__custom--ReverseStockSplitMember_zEILyLlE8558" title="Balance, shares" style="border-bottom: Black 2.5pt double; text-align: right"><ix:nonFraction name="us-gaap:SharesOutstanding" contextRef="AsOf2022-12-31_us-gaap_CommonStockMember_custom_ReverseStockSplitMember" id="Fact000339" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">9,407,415</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td style="border-bottom: Black 2.5pt double; text-align: right"><ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2022-12-31_custom_ReverseStockSplitMember_us-gaap_CommonStockMember" id="Fact000330" format="ixt:numdotdecimal" decimals="0" unitRef="USD">941</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0331">-</span></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right"><ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2022-12-31_custom_ReverseStockSplitMember_us-gaap_AdditionalPaidInCapitalMember" id="Fact000332" format="ixt:numdotdecimal" decimals="0" unitRef="USD">24,733,306</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right"><ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2022-12-31_custom_ReverseStockSplitMember_us-gaap_AccumulatedOtherComprehensiveIncomeMember" id="Fact000333" format="ixt:numdotdecimal" decimals="0" unitRef="USD">214,253</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">(<ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2022-12-31_custom_ReverseStockSplitMember_us-gaap_RetainedEarningsMember" id="Fact000334" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">15,307,366</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">)</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right"><ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2022-12-31_custom_ReverseStockSplitMember10880671" id="Fact000335" format="ixt:numdotdecimal" decimals="0" unitRef="USD">9,641,134</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_403_eus-gaap--NetIncomeLoss_zuF3fE4W1Ked" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Net loss for the year ended December 31, 2023</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2023-01-012023-12-31_custom_ReverseStockSplitMember_us-gaap_RetainedEarningsMember" id="Fact000346" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">9,841,638</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2023-01-012023-12-31_custom_ReverseStockSplitMember" id="Fact000347" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">9,841,638</ix:nonFraction></td><td style="text-align: left">)</td></tr>
  <tr id="xdx_40E_eus-gaap--NetIncomeLoss_zmlRa0qceAeb" style="display: none; vertical-align: bottom; background-color: White">
    <td style="text-align: left">Net loss</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0349">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0351">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2023-01-012023-12-31_custom_ReverseStockSplitMember_us-gaap_RetainedEarningsMember" id="Fact000354" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">9,841,638</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2023-01-012023-12-31_custom_ReverseStockSplitMember" id="Fact000355" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">9,841,638</ix:nonFraction></td><td style="text-align: left">)</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_405_eus-gaap--AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_z6ipnkGomyAk" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Share-based compensation charges</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" contextRef="From2023-01-012023-12-31_custom_ReverseStockSplitMember_us-gaap_AdditionalPaidInCapitalMember" id="Fact000360" format="ixt:numdotdecimal" decimals="0" unitRef="USD">963,023</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" contextRef="From2023-01-012023-12-31_custom_ReverseStockSplitMember" id="Fact000363" format="ixt:numdotdecimal" decimals="0" unitRef="USD">963,023</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40F_eus-gaap--StockIssuedDuringPeriodValueNewIssues_zd7byz00urT2" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Shares issued in Offering</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_987_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_c20230101__20231231__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zjW9MUj2HON1" title="Shares issued in Offering, shares" style="text-align: right"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodSharesNewIssues" contextRef="From2023-01-012023-12-31_us-gaap_CommonStockMember" id="Fact000373" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">2,248,521</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueNewIssues" contextRef="From2023-01-012023-12-31_custom_ReverseStockSplitMember_us-gaap_CommonStockMember" id="Fact000366" format="ixt:numdotdecimal" decimals="0" unitRef="USD">225</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueNewIssues" contextRef="From2023-01-012023-12-31_custom_ReverseStockSplitMember_us-gaap_AdditionalPaidInCapitalMember" id="Fact000368" format="ixt:numdotdecimal" decimals="0" unitRef="USD">2,783,160</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueNewIssues" contextRef="From2023-01-012023-12-31_custom_ReverseStockSplitMember" id="Fact000371" format="ixt:numdotdecimal" decimals="0" unitRef="USD">2,783,385</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40B_ecustom--StockIssuedDuringPeriodValueShelfRegistrationOffering_zLDCZl1urfue" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Shelf Registration Offering &#8211; see Note 8</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98E_ecustom--StockIssuedDuringPeriodSharesShelfRegistrationOffering_c20230101__20231231__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_ze9uExuW87Lf" title="Shelf Registration Offering, shares" style="text-align: right"><ix:nonFraction name="STSS:StockIssuedDuringPeriodSharesShelfRegistrationOffering" contextRef="From2023-01-012023-12-31_us-gaap_CommonStockMember" id="Fact000383" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">3,618,521</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="STSS:StockIssuedDuringPeriodValueShelfRegistrationOffering" contextRef="From2023-01-012023-12-31_custom_ReverseStockSplitMember_us-gaap_CommonStockMember" id="Fact000376" format="ixt:numdotdecimal" decimals="0" unitRef="USD">362</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="STSS:StockIssuedDuringPeriodValueShelfRegistrationOffering" contextRef="From2023-01-012023-12-31_custom_ReverseStockSplitMember_us-gaap_AdditionalPaidInCapitalMember" id="Fact000378" format="ixt:numdotdecimal" decimals="0" unitRef="USD">2,457,642</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="STSS:StockIssuedDuringPeriodValueShelfRegistrationOffering" contextRef="From2023-01-012023-12-31_custom_ReverseStockSplitMember" id="Fact000381" format="ixt:numdotdecimal" decimals="0" unitRef="USD">2,458,004</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_404_ecustom--StockIssuedDuringPeriodValuePrivatePlacement_zHeZ7JEVCe5e" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Private Placement Offering &#8211; see Note 8</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="STSS:StockIssuedDuringPeriodValuePrivatePlacement" contextRef="From2023-01-012023-12-31_custom_ReverseStockSplitMember_us-gaap_AdditionalPaidInCapitalMember" id="Fact000388" format="ixt:numdotdecimal" decimals="0" unitRef="USD">1,552,819</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="STSS:StockIssuedDuringPeriodValuePrivatePlacement" contextRef="From2023-01-012023-12-31_custom_ReverseStockSplitMember" id="Fact000391" format="ixt:numdotdecimal" decimals="0" unitRef="USD">1,552,819</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_400_eus-gaap--OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax_zE9pizTZBJGl" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 1pt; text-align: left">Foreign currency translation</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">&#160;</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">&#160;</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">&#160;</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">&#160;</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">&#160;</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">&#160;</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax" contextRef="From2023-01-012023-12-31_custom_ReverseStockSplitMember_us-gaap_AccumulatedOtherComprehensiveIncomeMember" id="Fact000397" format="ixt:numdotdecimal" decimals="0" unitRef="USD">377,559</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">&#160;</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax" contextRef="From2023-01-012023-12-31_custom_ReverseStockSplitMember" id="Fact000399" format="ixt:numdotdecimal" decimals="0" unitRef="USD">377,559</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_436_c20230101__20231231__us-gaap--AwardTypeAxis__custom--ReverseStockSplitMember_eus-gaap--StockholdersEquity_iE_zf80hjF1rV1h" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 2.5pt">Balance &#8211; December 31, 2023</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td id="xdx_98E_eus-gaap--SharesOutstanding_iE_c20230101__20231231__us-gaap--StatementEquityComponentsAxis__us-gaap--PreferredStockMember__us-gaap--AwardTypeAxis__custom--ReverseStockSplitMember_zL0uQOloa2Nc" title="Balance, shares" style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="us-gaap:SharesOutstanding" contextRef="AsOf2023-12-31_custom_ReverseStockSplitMember_us-gaap_PreferredStockMember" id="Fact000409" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">1</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl0401">-</span></span></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td id="xdx_984_eus-gaap--SharesOutstanding_iE_c20230101__20231231__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember__us-gaap--AwardTypeAxis__custom--ReverseStockSplitMember_zFM6osqkOXMh" title="Balance, shares" style="border-bottom: Black 2.5pt double; text-align: right"><ix:nonFraction name="us-gaap:SharesOutstanding" contextRef="AsOf2023-12-31_custom_ReverseStockSplitMember_us-gaap_CommonStockMember" id="Fact000411" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">15,274,457</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td style="border-bottom: Black 2.5pt double; text-align: right"><ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2023-12-31_custom_ReverseStockSplitMember_us-gaap_CommonStockMember" id="Fact000402" format="ixt:numdotdecimal" decimals="0" unitRef="USD">1,528</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl0403">-</span></span></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right"><ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2023-12-31_custom_ReverseStockSplitMember_us-gaap_AdditionalPaidInCapitalMember" id="Fact000404" format="ixt:numdotdecimal" decimals="0" unitRef="USD">32,489,950</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right"><ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2023-12-31_custom_ReverseStockSplitMember_us-gaap_AccumulatedOtherComprehensiveIncomeMember" id="Fact000405" format="ixt:numdotdecimal" decimals="0" unitRef="USD">591,812</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">(<ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2023-12-31_custom_ReverseStockSplitMember_us-gaap_RetainedEarningsMember" id="Fact000406" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">25,149,004</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">)</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right"><ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2023-12-31_custom_ReverseStockSplitMember" id="Fact000407" format="ixt:numdotdecimal" decimals="0" unitRef="USD">7,934,286</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_430_c20230101__20231231__us-gaap--AwardTypeAxis__custom--ReverseStockSplitMember_eus-gaap--StockholdersEquity_iE_z3Szu7A6U7m1" style="display: none; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 2.5pt">Balance</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td id="xdx_984_eus-gaap--SharesOutstanding_iE_c20230101__20231231__us-gaap--StatementEquityComponentsAxis__us-gaap--PreferredStockMember__us-gaap--AwardTypeAxis__custom--ReverseStockSplitMember_zYyjkKmWwLXb" title="Balance, shares" style="border-bottom: Black 2.5pt double; text-align: right"><ix:nonFraction name="us-gaap:SharesOutstanding" contextRef="AsOf2023-12-31_custom_ReverseStockSplitMember_us-gaap_PreferredStockMember" id="Fact000421" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">1</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0413">-</span></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td id="xdx_98D_eus-gaap--SharesOutstanding_iE_c20230101__20231231__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember__us-gaap--AwardTypeAxis__custom--ReverseStockSplitMember_zfboObLP5ZWc" title="Balance, shares" style="border-bottom: Black 2.5pt double; text-align: right"><ix:nonFraction name="us-gaap:SharesOutstanding" contextRef="AsOf2023-12-31_custom_ReverseStockSplitMember_us-gaap_CommonStockMember" id="Fact000423" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">15,274,457</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td style="border-bottom: Black 2.5pt double; text-align: right"><ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2023-12-31_custom_ReverseStockSplitMember_us-gaap_CommonStockMember" id="Fact000414" format="ixt:numdotdecimal" decimals="0" unitRef="USD">1,528</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0415">-</span></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right"><ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2023-12-31_custom_ReverseStockSplitMember_us-gaap_AdditionalPaidInCapitalMember" id="Fact000416" format="ixt:numdotdecimal" decimals="0" unitRef="USD">32,489,950</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right"><ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2023-12-31_custom_ReverseStockSplitMember_us-gaap_AccumulatedOtherComprehensiveIncomeMember" id="Fact000417" format="ixt:numdotdecimal" decimals="0" unitRef="USD">591,812</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">(<ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2023-12-31_custom_ReverseStockSplitMember_us-gaap_RetainedEarningsMember" id="Fact000418" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">25,149,004</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">)</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right"><ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2023-12-31_custom_ReverseStockSplitMember" id="Fact000419" format="ixt:numdotdecimal" decimals="0" unitRef="USD">7,934,286</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
</table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>The
accompanying notes are an integral part of these financial statements.</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>


<!-- Field: Page; Sequence: 55; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 0pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->7<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%"><a href="#RM_014">Table of Contents</a></td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span id="MT_006"></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>SHARPS
TECHNOLOGY, INC.</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>CONSOLIDATED
STATEMENTS OF CASH FLOWS</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center">&#160;</p>

<table cellpadding="0" cellspacing="0" id="xdx_303_112_zbw3bM5uJLy7" summary="xdx: Statement - Condensed Consolidated Statements of Cash Flows" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" id="xdx_498_20230101__20231231_zCjizinR93F1" style="font: bold 10pt Times New Roman, Times, Serif; text-align: center"><p style="margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">For the year
                                                                                              ended</span></p></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" id="xdx_492_20220101__20221231_z9BJCbeKS8sj" style="font: bold 10pt Times New Roman, Times, Serif; text-align: center"><p style="margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">For the year
                                                                                              ended</span></p></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"><p style="margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">December 31,</span></p>
                                                                                <p style="margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2023</span></p></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"><p style="margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">December 31,</span></p>
                                                                                <p style="margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2022</span></p></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr id="xdx_404_eus-gaap--NetCashProvidedByUsedInOperatingActivitiesAbstract_iB_zoXLZi2OhJib" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 60%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">CASH
    FLOWS FROM OPERATING ACTIVITIES:</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 16%; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 16%; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr id="xdx_401_eus-gaap--NetIncomeLoss_i01_maNCPBUzEyK_zAjz3p0mY4Q6" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Net
    loss</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(<ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2023-01-012023-12-31" id="Fact000428" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">9,841,638</ix:nonFraction></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(<ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2022-01-012022-12-31" id="Fact000429" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">4,639,662</ix:nonFraction></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td></tr>
  <tr id="xdx_406_eus-gaap--AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_i01B_zqNaKoD3Hnyh" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Adjustments
    to reconcile net loss to net cash used in operating activities:</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr id="xdx_40E_eus-gaap--DepreciationAndAmortization_i02_maNCPBUzEyK_zuHbwTvtQPij" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Depreciation
    and amortization</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="us-gaap:DepreciationAndAmortization" contextRef="From2023-01-012023-12-31" id="Fact000434" format="ixt:numdotdecimal" decimals="0" unitRef="USD">882,177</ix:nonFraction></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="us-gaap:DepreciationAndAmortization" contextRef="From2022-01-012022-12-31" id="Fact000435" format="ixt:numdotdecimal" decimals="0" unitRef="USD">654,572</ix:nonFraction></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr id="xdx_40D_eus-gaap--ShareBasedCompensation_i02_maNCPBUzEyK_zWcUL8GIvqZb" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Stock-based
    compensation</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="us-gaap:ShareBasedCompensation" contextRef="From2023-01-012023-12-31" id="Fact000437" format="ixt:numdotdecimal" decimals="0" unitRef="USD">963,023</ix:nonFraction></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="us-gaap:ShareBasedCompensation" contextRef="From2022-01-012022-12-31" id="Fact000438" format="ixt:numdotdecimal" decimals="0" unitRef="USD">1,012,592</ix:nonFraction></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr id="xdx_400_eus-gaap--IssuanceOfStockAndWarrantsForServicesOrClaims_i02_maNCPBUzEyK_zNYCxVnb7FIj" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Issuance
    of common stock for services</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl0440">-</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="us-gaap:IssuanceOfStockAndWarrantsForServicesOrClaims" contextRef="From2022-01-012022-12-31" id="Fact000441" format="ixt:numdotdecimal" decimals="0" unitRef="USD">290,551</ix:nonFraction></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr id="xdx_40B_eus-gaap--AmortizationOfDebtDiscountPremium_i02_maNCPBUzEyK_zpgWcXfw8Jqb" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Accretion
    of debt discount</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl0443">-</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="us-gaap:AmortizationOfDebtDiscountPremium" contextRef="From2022-01-012022-12-31" id="Fact000444" format="ixt:numdotdecimal" decimals="0" unitRef="USD">1,299,985</ix:nonFraction></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr id="xdx_40F_eus-gaap--GainLossOnSaleOfDerivatives_i02N_di_msNCPBUzEyK_zTz0ARVDjId7" style="font: 10pt Times New Roman, Times, Serif; display: none; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 10pt; text-align: left">FMV adjustment for Warrants</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr id="xdx_401_eus-gaap--AmortizationOfFinancingCosts_i02_maNCPBUzEyK_z7fbywQv4O35" style="font: 10pt Times New Roman, Times, Serif; display: none; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 10pt; text-align: left">Equity Issuance costs</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr id="xdx_403_ecustom--EscrowDepositForfeited_i02_maNCPBUzEyK_zsjXtpxJnJWj" style="font: 10pt Times New Roman, Times, Serif; display: none; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 10pt; text-align: left">Escrow forfeited</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr id="xdx_409_ecustom--FairMarketValueAdjustmentForContingentWarrants_i02_maNCPBUzEyK_z1UMjG5pISJ1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">FMV
    for adjustment for contingent stock</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl0455">-</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(<ix:nonFraction name="STSS:FairMarketValueAdjustmentForContingentWarrants" contextRef="From2022-01-012022-12-31" id="Fact000456" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">181,000</ix:nonFraction></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td></tr>
  <tr id="xdx_400_ecustom--FairMarketValueAdjustmentForContingentWarrantsAndWarrants_i02_maNCPBUzEyK_zm4IBcldev9k" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">FMV
    adjustment for Contingent warrants and warrants</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(<ix:nonFraction name="STSS:FairMarketValueAdjustmentForContingentWarrantsAndWarrants" contextRef="From2023-01-012023-12-31" id="Fact000458" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">169,583</ix:nonFraction></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(<ix:nonFraction name="STSS:FairMarketValueAdjustmentForContingentWarrantsAndWarrants" contextRef="From2022-01-012022-12-31" id="Fact000459" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">5,211,911</ix:nonFraction></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td></tr>
  <tr id="xdx_406_eus-gaap--ImpairmentOfLongLivedAssetsHeldForUse_i02_maNCPBUzEyK_zVoE8f7J8UPk" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 10pt; text-align: left">Fixed asset impairment</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><p style="margin: 0"><ix:nonFraction name="us-gaap:ImpairmentOfLongLivedAssetsHeldForUse" contextRef="From2023-01-012023-12-31" id="Fact000461" format="ixt:numdotdecimal" decimals="0" unitRef="USD">560,000</ix:nonFraction></p></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><p style="margin: 0"><span style="-sec-ix-hidden: xdx2ixbrl0462">-</span></p></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr id="xdx_401_eus-gaap--DeferredIncomeTaxExpenseBenefit_i02_maNCPBUzEyK_zJ7HnpB1vug4" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 10pt; text-align: left">Deferred tax benefit</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">(<ix:nonFraction name="us-gaap:DeferredIncomeTaxExpenseBenefit" contextRef="From2023-01-012023-12-31" id="Fact000464" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">30,000</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">)</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><p style="margin: 0"><span style="-sec-ix-hidden: xdx2ixbrl0465">-</span></p></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr id="xdx_400_ecustom--IpoIssuanceCostsRelatingToWarrants_i02_maNCPBUzEyK_zb0vxpUzHzZj" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">IPO
    issuance costs relating to warrants</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="STSS:IpoIssuanceCostsRelatingToWarrants" contextRef="From2023-01-012023-12-31" id="Fact000467" format="ixt:numdotdecimal" decimals="0" unitRef="USD">205,112</ix:nonFraction></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="STSS:IpoIssuanceCostsRelatingToWarrants" contextRef="From2022-01-012022-12-31" id="Fact000468" format="ixt:numdotdecimal" decimals="0" unitRef="USD">550,433</ix:nonFraction></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr id="xdx_402_eus-gaap--ForeignCurrencyTransactionGainLossBeforeTax_i02N_di_msNCPBUzEyK_znAvxBA4Ajfi" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Foreign
    exchange loss</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="us-gaap:ForeignCurrencyTransactionGainLossBeforeTax" contextRef="From2023-01-012023-12-31" id="Fact000470" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">44,463</ix:nonFraction></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="us-gaap:ForeignCurrencyTransactionGainLossBeforeTax" contextRef="From2022-01-012022-12-31" id="Fact000471" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">496</ix:nonFraction></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr id="xdx_40C_eus-gaap--IncreaseDecreaseInOperatingCapitalAbstract_i02B_zLqk9qxESFs8" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Changes
    in operating assets</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr id="xdx_40E_eus-gaap--IncreaseDecreaseInPrepaidExpense_i03N_di_msNCPBUzEyK_zvnHXNvoy2Q2" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Prepaid
    expenses</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(<ix:nonFraction name="us-gaap:IncreaseDecreaseInPrepaidExpense" contextRef="From2023-01-012023-12-31" id="Fact000476" format="ixt:numdotdecimal" decimals="0" unitRef="USD">82,169</ix:nonFraction></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(<ix:nonFraction name="us-gaap:IncreaseDecreaseInPrepaidExpense" contextRef="From2022-01-012022-12-31" id="Fact000477" format="ixt:numdotdecimal" decimals="0" unitRef="USD">58,754</ix:nonFraction></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td></tr>
  <tr id="xdx_408_eus-gaap--IncreaseDecreaseInInventories_i03N_di_msNCPBUzEyK_zMYrZSptd2Wl" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Inventory</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(<ix:nonFraction name="us-gaap:IncreaseDecreaseInInventories" contextRef="From2023-01-012023-12-31" id="Fact000479" format="ixt:numdotdecimal" decimals="0" unitRef="USD">1,441,462</ix:nonFraction></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(<ix:nonFraction name="us-gaap:IncreaseDecreaseInInventories" contextRef="From2022-01-012022-12-31" id="Fact000480" format="ixt:numdotdecimal" decimals="0" unitRef="USD">34,109</ix:nonFraction></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td></tr>
  <tr id="xdx_408_eus-gaap--IncreaseDecreaseInOtherOperatingAssets_i03N_di_msNCPBUzEyK_zQ93gZTU6dvl" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Other
    assets</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(<ix:nonFraction name="us-gaap:IncreaseDecreaseInOtherOperatingAssets" contextRef="From2023-01-012023-12-31" id="Fact000482" format="ixt:numdotdecimal" decimals="0" unitRef="USD">12,735</ix:nonFraction></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(<ix:nonFraction name="us-gaap:IncreaseDecreaseInOtherOperatingAssets" contextRef="From2022-01-012022-12-31" id="Fact000483" format="ixt:numdotdecimal" decimals="0" unitRef="USD">12,000</ix:nonFraction></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td></tr>
  <tr id="xdx_407_eus-gaap--IncreaseDecreaseInAccountsPayableAndAccruedLiabilities_i03_maNCPBUzEyK_zBeYsdE17HDf" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Accounts
    payable and accrued liabilities</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" contextRef="From2023-01-012023-12-31" id="Fact000485" format="ixt:numdotdecimal" decimals="0" unitRef="USD">415,512</ix:nonFraction></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(<ix:nonFraction name="us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" contextRef="From2022-01-012022-12-31" id="Fact000486" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">104,352</ix:nonFraction></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td></tr>
  <tr id="xdx_40C_eus-gaap--NetCashProvidedByUsedInOperatingActivities_i01T_maCzRBP_mtNCPBUzEyK_zmZIh6kVfiD5" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Net
    cash used in operating activities</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(<ix:nonFraction name="us-gaap:NetCashProvidedByUsedInOperatingActivities" contextRef="From2023-01-012023-12-31" id="Fact000488" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">8,507,300</ix:nonFraction></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(<ix:nonFraction name="us-gaap:NetCashProvidedByUsedInOperatingActivities" contextRef="From2022-01-012022-12-31" id="Fact000489" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">6,433,159</ix:nonFraction></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr id="xdx_400_eus-gaap--NetCashProvidedByUsedInInvestingActivitiesAbstract_iB_z0x6t0kukzD9" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">CASH
    FLOWS FROM INVESTING ACTIVITIES:</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr id="xdx_409_eus-gaap--PaymentsForProceedsFromOtherInvestingActivities_i01N_di_msNCPBUzhyj_zJaJqOZZgZU8" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Deposits
    paid on fixed assets and components</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><p style="margin: 0"><span style="-sec-ix-hidden: xdx2ixbrl0494">-</span></p></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(<ix:nonFraction name="us-gaap:PaymentsForProceedsFromOtherInvestingActivities" contextRef="From2022-01-012022-12-31" id="Fact000495" format="ixt:numdotdecimal" decimals="0" unitRef="USD">209,678</ix:nonFraction></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td></tr>
  <tr id="xdx_40B_ecustom--EscrowPaymentUnderAgreement_i01N_di_msNCPBUzhyj_zelVgT9LzSbb" style="font: 10pt Times New Roman, Times, Serif; display: none; vertical-align: bottom; background-color: White">
    <td style="padding-left: 10pt; text-align: left">Escrow payment under agreement</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr id="xdx_405_eus-gaap--PaymentsToAcquirePropertyPlantAndEquipment_i01N_di_msNCPBUzhyj_zJzBJy8ztGdb" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Purchase
    of fixed assets</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(<ix:nonFraction name="us-gaap:PaymentsToAcquirePropertyPlantAndEquipment" contextRef="From2023-01-012023-12-31" id="Fact000500" format="ixt:numdotdecimal" decimals="0" unitRef="USD">698,277</ix:nonFraction></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(<ix:nonFraction name="us-gaap:PaymentsToAcquirePropertyPlantAndEquipment" contextRef="From2022-01-012022-12-31" id="Fact000501" format="ixt:numdotdecimal" decimals="0" unitRef="USD">542,662</ix:nonFraction></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td></tr>
  <tr id="xdx_40A_ecustom--PaymentsToAssetAcquisition_i01N_di_msNCPBUzbVF_msNCPBUzhyj_zJcSRmKu4qXi" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Asset
    acquisition</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl0503">-</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(<ix:nonFraction name="STSS:PaymentsToAssetAcquisition" contextRef="From2022-01-012022-12-31" id="Fact000504" format="ixt:numdotdecimal" decimals="0" unitRef="USD">2,365,576</ix:nonFraction></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td></tr>
  <tr id="xdx_409_eus-gaap--NetCashProvidedByUsedInInvestingActivities_i01T_maCzRBP_mtNCPBUzhyj_zCBXG9CzpfZk" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Net
    cash used in investing activities</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(<ix:nonFraction name="us-gaap:NetCashProvidedByUsedInInvestingActivities" contextRef="From2023-01-012023-12-31" id="Fact000506" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">698,277</ix:nonFraction></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(<ix:nonFraction name="us-gaap:NetCashProvidedByUsedInInvestingActivities" contextRef="From2022-01-012022-12-31" id="Fact000507" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">3,117,916</ix:nonFraction></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr id="xdx_402_eus-gaap--NetCashProvidedByUsedInFinancingActivitiesAbstract_iB_zoh2T2T907Pi" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">CASH
    FLOWS FROM FINANCING ACTIVITIES:</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr id="xdx_406_ecustom--NetProceedsFromInitialPublicOfferingAndAdditionalOffering_i01_maCzIaA_zbgQz7GRiix1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Net
    proceeds from Initial Public Offering and additional offerings</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="STSS:NetProceedsFromInitialPublicOfferingAndAdditionalOffering" contextRef="From2023-01-012023-12-31" id="Fact000512" format="ixt:numdotdecimal" decimals="0" unitRef="USD">8,029,628</ix:nonFraction></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="STSS:NetProceedsFromInitialPublicOfferingAndAdditionalOffering" contextRef="From2022-01-012022-12-31" id="Fact000513" format="ixt:numdotdecimal" decimals="0" unitRef="USD">14,202,975</ix:nonFraction></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr id="xdx_405_ecustom--NetProceedsFromOfferingsAndWarrantExercises_i01_maCzIaA_zeRYXDGEdUv8" style="font: 10pt Times New Roman, Times, Serif; display: none; vertical-align: bottom; background-color: White">
    <td style="padding-left: 10pt; text-align: left">Net proceeds from offerings and warrant exercises</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr id="xdx_40B_eus-gaap--ProceedsFromIssuanceOfLongTermDebt_i01_maCzIaA_zWcg98I79L54" style="font: 10pt Times New Roman, Times, Serif; display: none; vertical-align: bottom; background-color: White">
    <td style="padding-bottom: 1pt; padding-left: 10pt; text-align: left">Net proceeds from Debt financing</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr id="xdx_402_eus-gaap--RepaymentsOfNotesPayable_i01N_di_msCzIaA_zTslfZ2tAhLf" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Repayment
    of note payable</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl0521">-</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(<ix:nonFraction name="us-gaap:RepaymentsOfNotesPayable" contextRef="From2022-01-012022-12-31" id="Fact000522" format="ixt:numdotdecimal" decimals="0" unitRef="USD">2,000,000</ix:nonFraction></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td></tr>
  <tr id="xdx_401_ecustom--ProceedsFromSubscriptionsReceivable_i01_maCzIaA_zX2OMb3MMLd8" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Proceeds
    from subscriptions receivable</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl0524">-</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="STSS:ProceedsFromSubscriptionsReceivable" contextRef="From2022-01-012022-12-31" id="Fact000525" format="ixt:numdotdecimal" decimals="0" unitRef="USD">32,500</ix:nonFraction></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr id="xdx_40B_eus-gaap--NetCashProvidedByUsedInFinancingActivities_i01T_mtCzIaA_maCzRBP_zhDoWeVmjq43" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Net
    cash provided by financing activities</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="us-gaap:NetCashProvidedByUsedInFinancingActivities" contextRef="From2023-01-012023-12-31" id="Fact000527" format="ixt:numdotdecimal" decimals="0" unitRef="USD">8,029,628</ix:nonFraction></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="us-gaap:NetCashProvidedByUsedInFinancingActivities" contextRef="From2022-01-012022-12-31" id="Fact000528" format="ixt:numdotdecimal" decimals="0" unitRef="USD">12,235,475</ix:nonFraction></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr id="xdx_401_eus-gaap--EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations_maCzRBP_zV7GuouUxB" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Effect
    of exchange rate changes on cash</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations" contextRef="From2023-01-012023-12-31" id="Fact000530" format="ixt:numdotdecimal" decimals="0" unitRef="USD">17,960</ix:nonFraction></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations" contextRef="From2022-01-012022-12-31" id="Fact000531" format="ixt:numdotdecimal" decimals="0" unitRef="USD">7,331</ix:nonFraction></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr id="xdx_408_eus-gaap--CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_iT_mtCzRBP_zWsWjxoE66x1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">NET
    INCREASE (DECREASE) IN CASH</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(<ix:nonFraction name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" contextRef="From2023-01-012023-12-31" id="Fact000533" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">1,157,989</ix:nonFraction></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" contextRef="From2022-01-012022-12-31" id="Fact000534" format="ixt:numdotdecimal" decimals="0" unitRef="USD">2,691,731</ix:nonFraction></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr id="xdx_403_eus-gaap--CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations_iS_pp0p0_zFFHMKOHuHu6" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">CASH
    &#8212; BEGINNING OF YEAR</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations" contextRef="AsOf2022-12-31" id="Fact000536" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">4,170,897</ix:nonFraction></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations" contextRef="AsOf2021-12-31" id="Fact000537" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">1,479,166</ix:nonFraction></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr id="xdx_400_eus-gaap--CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations_iE_pp0p0" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">CASH
    &#8212; END OF YEAR</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations" contextRef="AsOf2023-12-31" id="Fact000539" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">3,012,908</ix:nonFraction></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations" contextRef="AsOf2022-12-31" id="Fact000540" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">4,170,897</ix:nonFraction></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr id="xdx_40A_eus-gaap--SupplementalCashFlowInformationAbstract_iB_zVLOeqcyBzB1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">SUPPLEMENTAL
    DISCLOSURE OF CASH FLOW INFORMATION:</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr id="xdx_409_eus-gaap--InterestPaidNet_i01_zOPHgnGBhOn8" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Cash
    paid for interest</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl0545">-</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="us-gaap:InterestPaidNet" contextRef="From2022-01-012022-12-31" id="Fact000546" format="ixt:numdotdecimal" decimals="0" unitRef="USD">47,111</ix:nonFraction></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr id="xdx_406_eus-gaap--IncomeTaxesPaidNet_i01_pp0p0" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Cash
    paid for taxes</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl0548">-</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl0549">-</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr id="xdx_402_eus-gaap--NoncashInvestingAndFinancingItemsAbstract_iB_zfDXhhuNhG65" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-decoration: underline; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Non-cash
    investing and financing activity:</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr id="xdx_40D_ecustom--FmvForCommonStockIssuedForContingentShares_i01_zq0bCWQkmiX6" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">FMV
    for Common stock issued for contingent shares</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl0554">-</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="STSS:FmvForCommonStockIssuedForContingentShares" contextRef="From2022-01-012022-12-31" id="Fact000555" format="ixt:numdotdecimal" decimals="0" unitRef="USD">496,000</ix:nonFraction></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr id="xdx_40B_ecustom--FmvForWarrantsIssuedForContingentWarrants_i01_zGKcE8UCBld5" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">FMV
    for Warrants issued for contingent warrants</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl0557">-</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="STSS:FmvForWarrantsIssuedForContingentWarrants" contextRef="From2022-01-012022-12-31" id="Fact000558" format="ixt:numdotdecimal" decimals="0" unitRef="USD">554,312</ix:nonFraction></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr id="xdx_404_ecustom--CommonStockIssuedAndVestedStockOptionsForFixedAssetsAcquired_i01_zYfZOU3QzkT8" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Common
    stock issued and vested stock options for fixed assets acquired</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl0560">-</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="STSS:CommonStockIssuedAndVestedStockOptionsForFixedAssetsAcquired" contextRef="From2022-01-012022-12-31" id="Fact000561" format="ixt:numdotdecimal" decimals="0" unitRef="USD">63,612</ix:nonFraction></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr id="xdx_40C_ecustom--CommonStockIssuedAndVestedStockOptionsIssuedAsConsiderationForAcquisition_i01_ztpticbguav2" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Common
    stock issued and vested stock options issued as consideration for acquisition</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl0563">-</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="STSS:CommonStockIssuedAndVestedStockOptionsIssuedAsConsiderationForAcquisition" contextRef="From2022-01-012022-12-31" id="Fact000564" format="ixt:numdotdecimal" decimals="0" unitRef="USD">60,435</ix:nonFraction></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  </table>


<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>The
accompanying notes are an integral part of these financial statements.</i></span></p>
<!-- Field: Split-Segment; Name: 001 -->
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>


<!-- Field: Page; Sequence: 56; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 0pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->8<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%"><a href="#RM_014">Table of Contents</a></td></tr></table></div>
    <!-- Field: /Page -->
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p id="xdx_04F_c20230101__20231231_z2RsnjRgHmN8" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="MT_007"></span>SHARPS
TECHNOLOGY, INC.</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTES
TO THE CONSOLIDATED FINANCIAL STATEMENTS</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>FOR
THE YEARS ENDED DECEMBER 31, 2023 AND 2022</b></span></p>

<p style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<ix:nonNumeric contextRef="From2023-01-012023-12-31" escape="true" id="Fact000566" name="us-gaap:BusinessDescriptionAndBasisOfPresentationTextBlock"><p id="xdx_801_eus-gaap--BusinessDescriptionAndBasisOfPresentationTextBlock_zxnnhTHlnSw1" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Note
1. <span id="xdx_82C_zYQA66NqDZNa">Description of Business</span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Nature
of Business</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Sharps
Technology, Inc. (&#8220;Sharps&#8221; or the &#8220;Company&#8221;) is a pre-revenue medical device company that has designed and patented
various safety syringes and is seeking commercialization by manufacturing and distribution of its products.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
accompanying consolidated financial statements include the accounts of Sharps Technology, Inc. and its wholly owned subsidiaries, Safegard
Medical (Hungary) KFT, collectively referred to as the &#8220;Company.&#8221; All intercompany transactions and balances have been eliminated.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company&#8217;s fiscal year ends on December 31.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
April 13, 2022, the Company&#8217;s Initial Public Offering was deemed effective with trading commencing on April 14, 2022. The Company
received net proceeds of $<span id="xdx_905_eus-gaap--ProceedsFromIssuanceInitialPublicOffering_pn5n6_c20220417__20220419__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--IPOMember_z7xqqpwnsDsa" title="Initial public offering"><ix:nonFraction name="us-gaap:ProceedsFromIssuanceInitialPublicOffering" contextRef="From2022-04-172022-04-19_us-gaap_IPOMember" id="Fact000568" format="ixt:numdotdecimal" decimals="-5" scale="6" unitRef="USD">14.2</ix:nonFraction> </span>million on April 19, 2022 (See Note 8).</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2023-01-012023-12-31" escape="true" id="Fact000570" name="us-gaap:SignificantAccountingPoliciesTextBlock"><p id="xdx_808_eus-gaap--SignificantAccountingPoliciesTextBlock_zrzxjXxnRAEb" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Note
2. <span id="xdx_828_zPLqBXWYIVWl">Summary of Significant Accounting Policies</span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<ix:nonNumeric contextRef="From2023-01-012023-12-31" escape="true" id="Fact000572" name="us-gaap:BasisOfAccountingPolicyPolicyTextBlock"><p id="xdx_84C_eus-gaap--BasisOfAccountingPolicyPolicyTextBlock_zKVaVj20gVgj" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i><span id="xdx_862_zp4lx1YGTOT3">Basis
of Presentation</span></i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
accompanying consolidated financial statements have been prepared by the Company in accordance with generally accepted accounting principles
(&#8220;GAAP&#8221;) in the United States (&#8220;U.S.&#8221;) and are expressed in U.S. dollars.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
accompanying consolidated financial statements have been prepared assuming that the Company will continue as a going concern. The Company
has not generated revenue or cash flow from operations since inception. As of December 31, 2023, the Company used cash in operations
of $<span id="xdx_90C_eus-gaap--NetCashProvidedByUsedInOperatingActivities_iN_di_c20230101__20231231_zB7ZnFfzNdP4" title="Cash in operations"><ix:nonFraction name="us-gaap:NetCashProvidedByUsedInOperatingActivities" contextRef="From2023-01-012023-12-31" id="Fact000574" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">8,507,300</ix:nonFraction></span> and has cash of $<span id="xdx_904_eus-gaap--Cash_iI_c20231231_ziEF5XUdcyl5" title="Cash"><ix:nonFraction name="us-gaap:Cash" contextRef="AsOf2023-12-31" id="Fact000576" format="ixt:numdotdecimal" decimals="0" unitRef="USD">3,012,908</ix:nonFraction></span> which is not sufficient to fund the Company&#8217;s planned operations for the next 12 months.
These factors raise substantial doubt regarding the Company&#8217;s ability to continue as a going concern. The Company&#8217;s ability
to continue as a going concern is dependent upon the Company&#8217;s ability to raise sufficient financing to acquire or commercialize
its products into a profitable business. The Company intends to finance its future development and commercialization activities and its
working capital needs largely from the sale of equity securities and/or with additional funding from other traditional financing sources
until such time that funds provided by operations are sufficient to fund working capital requirements. The financial statements of the
Company do not include any adjustments relating to the recoverability and classification of recorded assets, or the amounts and classifications
of liabilities that might be necessary should the Company be unable to continue as a going concern.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2023-01-012023-12-31" escape="true" id="Fact000578" name="us-gaap:UseOfEstimates"><p id="xdx_849_eus-gaap--UseOfEstimates_zEaXZ5pgfJRi" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i><span id="xdx_860_zAevqar0yAGg">Use
of Estimates</span></i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
preparation of financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the
reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements
and the reported amounts of revenues and expenses during the reporting periods. Actual results could differ from those estimates. As
of December 31, 2023, the most significant estimates relate to derivative liabilities and stock-based compensation.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-indent: 24.75pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2023-01-012023-12-31" escape="true" id="Fact000580" name="us-gaap:CashAndCashEquivalentsPolicyTextBlock"><p id="xdx_847_eus-gaap--CashAndCashEquivalentsPolicyTextBlock_zbV2MKSLSyA9" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i><span id="xdx_863_zpgJilAhQ4Bb">Cash
and Cash Equivalents</span></i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company considers all highly liquid investments purchased with an original or remaining maturity of three months or less at the date
of purchase to be cash equivalents. Cash and cash equivalents are maintained with various financial institutions. At December 31,
2023 and 2022, the Company had <span id="xdx_908_eus-gaap--CashEquivalentsAtCarryingValue_iI_do_c20231231_zWb6yOWVqK22" title="Cash equivalents"><span id="xdx_903_eus-gaap--CashEquivalentsAtCarryingValue_iI_do_c20221231_zMq2PeuJTbLk" title="Cash equivalents"><ix:nonFraction name="us-gaap:CashEquivalentsAtCarryingValue" contextRef="AsOf2023-12-31" id="Fact000582" format="ixt-sec:numwordsen" decimals="0" unitRef="USD"><ix:nonFraction name="us-gaap:CashEquivalentsAtCarryingValue" contextRef="AsOf2022-12-31" id="Fact000584" format="ixt-sec:numwordsen" decimals="0" unitRef="USD">no</ix:nonFraction></ix:nonFraction></span></span> cash equivalents.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2023-01-012023-12-31" escape="true" id="Fact000586" name="us-gaap:InventoryPolicyTextBlock"><p id="xdx_84D_eus-gaap--InventoryPolicyTextBlock_zOoB5UMrClt7" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i><span id="xdx_86F_zdkCVDwqh8qb">Inventories</span></i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company values inventory at the lower of cost (average cost) or net realizable value. Work-in-process and finished goods inventories
consist of material, labor, and manufacturing overhead. Net realizable value is the estimated selling price in the ordinary course of
business, less reasonably predictable costs of completion, disposal, and transportation. A reserve is established for any excess or obsolete
inventories or they may be written off. At December 31, 2023 and 2022, inventory is comprised of raw materials, components and finished
goods.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<ix:exclude><!-- Field: Page; Sequence: 57; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 0pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->9<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%"><a href="#RM_014">Table of Contents</a></td></tr></table></div>
    <!-- Field: /Page --></ix:exclude>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>SHARPS
TECHNOLOGY, INC.</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTES
TO THE CONSOLIDATED FINANCIAL STATEMENTS</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>FOR
THE YEARS ENDED DECEMBER 31, 2023 AND 2022</b></span></p>

<p style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Note
2. Summary of Significant Accounting Policies (continued)</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2023-01-012023-12-31" escape="true" id="Fact000588" name="us-gaap:FairValueMeasurementPolicyPolicyTextBlock"><p id="xdx_848_eus-gaap--FairValueMeasurementPolicyPolicyTextBlock_zcHPw9YdzgV4" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_86D_z5klkHhT9Lw9">Fair
Value Measurements</span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">ASC
820, Fair Value Measurements and Disclosures, require an entity to maximize the use of observable inputs and minimize the use of unobservable
inputs when measuring fair value. ASC 820 establishes a fair value hierarchy based on the level of independent, objective evidence surrounding
the inputs used to measure fair value. A financial instrument&#8217;s categorization within the fair value hierarchy is based upon the
lowest level of input that is significant to the fair value measurement. ASC 820 prioritizes the inputs into three levels that may be
used to measure fair value.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company&#8217;s outstanding warrants are fair valued on a recurring basis with the trading price or FMV using Black Sholes which
could cause fluctuations in operating results at the reporting periods.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Level
1</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Level
1 applies to assets or liabilities for which there are quoted prices in active markets for identical assets or liabilities. Valuations
are based on quoted prices that are readily and regularly available in an active market and do not entail a significant degree of judgment.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Level
2</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Level
2 applied to assets or liabilities for which there are other than Level 1 observable inputs such as quoted prices for similar assets
or liabilities in active markets; quoted prices for identical assets or liabilities in markets with insufficient volume or infrequent
transactions (less active markets); or model-derived valuations in which significant inputs are observable or can be derived principally
from, or corroborated by, observable market data.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Level
2 instruments require more management judgment and subjectivity as compared to Level 1 instruments. For instance: determining which instruments
are most similar to the instrument being priced requires management to identify a sample of similar securities based on the coupon rates,
maturity, issuer credit rating and instrument type, and subjectively select an individual security or multiple securities that are deemed
most similar to the security being priced; and determining whether a market is considered active requires management judgment.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Level
3</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Level
3 applied to assets or liabilities for which there are unobservable inputs to the valuation methodology that are significant to the measurement
of the fair value of the assets or liabilities. The determination for Level 3 instruments requires the most management judgment and subjectivity.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2023-01-012023-12-31" escape="true" id="Fact000590" name="us-gaap:PropertyPlantAndEquipmentPolicyTextBlock"><p id="xdx_846_eus-gaap--PropertyPlantAndEquipmentPolicyTextBlock_zg8LPGtNVQJf" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Fixed
Assets</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Fixed
assets are stated at cost. Expenditures for maintenance and repairs are charged to operations as incurred. The Company&#8217;s fixed
assets consist of land, building, machinery and equipment, molds, computer system and website. Depreciation is calculated using the straight-line
method commencing on the date the asset is operating in the way intended by management over the following useful lives: Building &#8211;
<span id="xdx_900_eus-gaap--PropertyPlantAndEquipmentUsefulLife_iI_dtY_c20231231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--BuildingMember_zDcXnDaTcg23" title="Property plant and equipment asset useful life"><ix:nonNumeric contextRef="AsOf2023-12-31_us-gaap_BuildingMember" format="ixt-sec:duryear" id="Fact000592" name="us-gaap:PropertyPlantAndEquipmentUsefulLife">20</ix:nonNumeric></span> years, Machinery and Equipment &#8211; <span id="xdx_903_eus-gaap--PropertyPlantAndEquipmentUsefulLife_iI_dtY_c20231231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--MachineryAndEquipmentMember__srt--RangeAxis__srt--MinimumMember_zvfMOOj4TIpk" title="Property plant and equipment asset useful life"><ix:nonNumeric contextRef="AsOf2023-12-31_us-gaap_MachineryAndEquipmentMember_srt_MinimumMember" format="ixt-sec:duryear" id="Fact000594" name="us-gaap:PropertyPlantAndEquipmentUsefulLife">3</ix:nonNumeric></span> -<span id="xdx_90A_eus-gaap--PropertyPlantAndEquipmentUsefulLife_iI_dtY_c20231231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--MachineryAndEquipmentMember__srt--RangeAxis__srt--MaximumMember_zUMsxKx0X3a1" title="Property plant and equipment asset useful life"><ix:nonNumeric contextRef="AsOf2023-12-31_us-gaap_MachineryAndEquipmentMember_srt_MaximumMember" format="ixt-sec:duryear" id="Fact000596" name="us-gaap:PropertyPlantAndEquipmentUsefulLife">10</ix:nonNumeric></span> years and Computer systems and Website &#8211; <span id="xdx_901_eus-gaap--PropertyPlantAndEquipmentUsefulLife_iI_dtY_c20231231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--WebsiteMember_zWiJepiw6Kn" title="Property plant and equipment asset useful life"><ix:nonNumeric contextRef="AsOf2023-12-31_custom_WebsiteMember" format="ixt-sec:duryear" id="Fact000598" name="us-gaap:PropertyPlantAndEquipmentUsefulLife">3</ix:nonNumeric></span> years. The expected life for Molds is
based lesser of the number of parts that will be produced based on the expected mold capability or 5 years.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>&#160;</i></b></span></p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2023-01-012023-12-31" escape="true" id="Fact000600" name="us-gaap:ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock"><p id="xdx_840_eus-gaap--ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock_zmMDNT8Ofh78" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i><span id="xdx_860_zlWnFrL4mQhi">Impairment
of Long-Lived Assets</span> </i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Long-lived
assets are reviewed annually for impairment or whenever events or changes in circumstances indicate that the carrying amount of an asset
may not be recoverable. Recoverability is measured by comparison of the carrying amount of an asset group to the future net undiscounted
cash flows that the assets are expected to generate. If such assets are considered to be impaired, the impairment to be recognized is
measured by the amount by which the carrying amount of the assets exceeds the projected discounted future net cash flows arising from
the asset.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company recorded an impairment of $<span id="xdx_90F_eus-gaap--ImpairmentOfLongLivedAssetsHeldForUse_c20230101__20231231_z0rVCogZaeT4" title="Impairment losses"><ix:nonFraction name="us-gaap:ImpairmentOfLongLivedAssetsHeldForUse" contextRef="From2023-01-012023-12-31" id="Fact000602" format="ixt:numdotdecimal" decimals="0" unitRef="USD">560,000</ix:nonFraction></span> during the year ended December 31, 2023 and <span id="xdx_900_eus-gaap--ImpairmentOfLongLivedAssetsHeldForUse_dxL_c20220101__20221231_zPneDqTLg4uj" title="Impairment losses::XDX::-"><span style="-sec-ix-hidden: xdx2ixbrl0604">no</span></span>
impairment during the year ended December 31, 2022.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<ix:exclude><!-- Field: Page; Sequence: 58; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 0pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->10<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%"><a href="#RM_014">Table of Contents</a></td></tr></table></div>
    <!-- Field: /Page --></ix:exclude>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>SHARPS
TECHNOLOGY, INC.</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTES
TO THE CONSOLIDATED FINANCIAL STATEMENTS</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>FOR
THE YEARS ENDED DECEMBER 31, 2023 AND 2022</b></span></p>

<p style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Note
2. Summary of Significant Accounting Policies (continued)</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2023-01-012023-12-31" escape="true" id="Fact000606" name="us-gaap:IntangibleAssetsFiniteLivedPolicy"><p id="xdx_841_eus-gaap--IntangibleAssetsFiniteLivedPolicy_ziROBe3KcNL9" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i><span id="xdx_86C_zxU4sxefa3ye">Purchased
Identified Intangible Assets</span></i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Identified
Intangible Assets</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company&#8217;s identified intangible assets are amortized on a straight-line basis over their estimated useful lives of 5 years. The
Company makes judgments about the recoverability of finite-lived intangible assets whenever facts and circumstances indicate that the
useful life is shorter than originally estimated or that the carrying amount of assets may not be recoverable. If such facts and circumstances
exist, the Company assesses recoverability by comparing the projected undiscounted net cash flows associated with the related asset or
group of assets over their remaining lives against their respective carrying amounts. Impairments, if any, are based on the excess of
the carrying amount over the fair value of those assets. If the useful life is shorter than originally estimated, the Company would accelerate
the rate of amortization and amortize the remaining carrying value over the new shorter useful life. The Company evaluates the carrying
value of finite-lived intangible assets on an annual basis, and an impairment charge would be recognized to the extent that the carrying
amount of such assets exceeds their estimated fair value.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>&#160;</i></b></span></p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2023-01-012023-12-31" escape="true" id="Fact000608" name="us-gaap:CompensationRelatedCostsPolicyTextBlock"><p id="xdx_843_eus-gaap--CompensationRelatedCostsPolicyTextBlock_zLto1WwGYnCh" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i><span id="xdx_864_zVx4yLq85QPc">Stock-based
Compensation Expense</span></i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company measures its stock-based awards made to employees based on the estimated fair values of the awards as of the grant date. For
stock option awards, the Company uses the Black-Scholes option-pricing model. For restricted stock awards, the estimated fair value is
generally the fair market value of the underlying stock on the grant date. Stock-based compensation expense is recognized over the requisite
service period and is based on the value of the portion of stock-based payment awards that is ultimately expected to vest. The Company
recognizes forfeitures of stock-based awards as they occur on a prospective basis.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Stock-based
compensation expense for awards granted to non-employees as consideration for services received is measured on the date of performance
at the fair value of the consideration received or the fair value of the equity instruments issued, whichever can be more reliably measured.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<ix:exclude><!-- Field: Page; Sequence: 59; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 0pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->11<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%"><a href="#RM_014">Table of Contents</a></td></tr></table></div>
    <!-- Field: /Page --></ix:exclude>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>SHARPS
TECHNOLOGY, INC.</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTES
TO THE CONSOLIDATED FINANCIAL STATEMENTS</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>FOR
THE YEARS ENDED DECEMBER 31, 2023 AND 2022</b></span></p>

<p style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Note
2. Summary of Significant Accounting Policies (continued)</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2023-01-012023-12-31" escape="true" id="Fact000610" name="us-gaap:DerivativesPolicyTextBlock"><p id="xdx_848_eus-gaap--DerivativesPolicyTextBlock_z4E35sPxqQwg" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i><span id="xdx_861_zfSFtOldWiqd">Derivative
Instruments</span></i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company accounts for common stock warrants as either equity-classified or liability-classified instruments based on an assessment of
the specific terms of the warrants and applicable authoritative guidance in Financial Accounting Standards Board (&#8220;FASB&#8221;)
Accounting Standards Codification (&#8220;ASC 480&#8221;), Distinguishing Liabilities from Equity (&#8220;ASC 480&#8221;) and ASC 815,
Derivatives and Hedging (&#8220;ASC 815&#8221;). The assessment considers whether the warrants are freestanding financial instruments
pursuant to ASC 480, meet the definition of a liability pursuant to ASC 480, and meet all of the requirements for equity classification
under ASC 815, including whether the warrants are indexed to the Company&#8217;s own stock and whether the holders of the warrants could
potentially require net cash settlement in a circumstance outside of the Company&#8217;s control, among other conditions for equity classification.
This assessment, which requires the use of professional judgment, is conducted at the time of warrant issuance and as of each subsequent
quarterly period end date while the warrants are outstanding.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">At
their issuance date and as of December 31, 2023, certain warrants (see Notes 8 and 10) are accounted for as liabilities as these instruments
did not meet all of the requirements for equity classification under ASC 815-40 based on the terms of the aforementioned warrants. The
resulting warrant liabilities are re-measured at each balance sheet date until their exercise or expiration, and any change in fair value
is recognized in the Company&#8217;s consolidated statements of operations.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2023-01-012023-12-31" escape="true" id="Fact000612" name="us-gaap:ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock"><p id="xdx_84B_eus-gaap--ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock_z2SbVpJcwPed" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i><span id="xdx_86F_zlEzljoZPcy4">Foreign
Currency Translation/Transactions</span></i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company has determined that the functional currency for its foreign subsidiary is the local currency. For financial reporting purposes,
assets and liabilities denominated in foreign currencies are translated at current exchange rates and profit and loss accounts are translated
at weighted average exchange rates. Resulting translation gains and losses are included as a separate component of stockholders&#8217;
equity as accumulated other comprehensive income or loss. Gains or losses resulting from transactions entered into in other than the
functional currency are recorded as foreign exchange gains and losses in the consolidated statements of operations.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2023-01-012023-12-31" escape="true" id="Fact000614" name="us-gaap:ComprehensiveIncomePolicyPolicyTextBlock"><p id="xdx_843_eus-gaap--ComprehensiveIncomePolicyPolicyTextBlock_zRifrGfr3Ls1" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i><span id="xdx_86A_zUWfwARhhYRk">Comprehensive
income (loss)</span></i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>&#160;</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Comprehensive
income (loss) consists of the Company&#8217;s consolidated net loss and foreign currency translation adjustments related to its subsidiary.
Foreign currency translation adjustments included in comprehensive loss were not tax effected as the Company has a full valuation allowance
at December 31, 2023 and 2022. Accumulated other comprehensive income (loss) is a separate component of stockholders&#8217; equity and
consists of the cumulative foreign currency translation adjustments.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>&#160;</i></b></span></p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2023-01-012023-12-31" escape="true" id="Fact000616" name="us-gaap:EarningsPerSharePolicyTextBlock"><p id="xdx_84B_eus-gaap--EarningsPerSharePolicyTextBlock_zymxba8U4w66" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i><span id="xdx_86C_z601WrOkquZf">Basic
and Diluted Loss Per Share</span></i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company computes net loss per share in accordance with ASC 260, Earnings per Share. ASC 260 requires presentation of both basic and diluted
earnings per share (EPS) on the face of the consolidated statements of operations. Basic EPS is computed by dividing net income (loss)
available to common stockholders (numerator) by the weighted average number of shares outstanding (denominator) during the period. Basic
EPS includes the <span id="xdx_907_eus-gaap--WeightedAverageNumberOfSharesOutstandingBasic_c20230101__20231231__us-gaap--StatementEquityComponentsAxis__custom--PrefundendWarrantsMember_zW6yW4DDWHHb" title="Weighted average shares outstanding basic"><ix:nonFraction name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" contextRef="From2023-01-012023-12-31_custom_PrefundendWarrantsMember" id="Fact000618" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">3,381,479</ix:nonFraction></span> of pre-funded warrants (see Note 8). Diluted EPS gives effect to all dilutive potential common shares outstanding
during the period using the treasury stock method and convertible preferred stock using the if-converted method. In computing diluted
EPS, the average stock price for the period is used in determining the number of shares assumed to be purchased from the exercise of
stock options or warrants. Diluted EPS excludes all dilutive potential shares if their effect is anti-dilutive. As of December 31, 2023,
there were <span id="xdx_90F_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_c20230101__20231231__us-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__custom--StockOptionsAndWarrantsMember_zxFr2uIC5do7" title="Antidilutive securities shares"><ix:nonFraction name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" contextRef="From2023-01-012023-12-31_custom_StockOptionsAndWarrantsMember" id="Fact000620" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">22,950,155</ix:nonFraction></span> stock options and warrants that could potentially dilute basic EPS in the future that were not included in the
computation of diluted EPS because to do so would have been anti-dilutive for the periods presented.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2023-01-012023-12-31" escape="true" id="Fact000622" name="us-gaap:IncomeTaxPolicyTextBlock"><p id="xdx_845_eus-gaap--IncomeTaxPolicyTextBlock_ziEbuahOcoKj" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i><span id="xdx_867_zl2OX7bMoBbl">Income
Taxes</span></i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company must make certain estimates and judgments in determining income tax expense for financial statement purposes. These estimates
and judgments are used in the calculation of tax credits, tax benefits, tax deductions, and in the calculation of certain deferred taxes
and tax liabilities. Significant changes to these estimates may result in an increase or decrease to the Company&#8217;s tax provision
in a subsequent period.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<ix:exclude><!-- Field: Page; Sequence: 60; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 0pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->12<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%"><a href="#RM_014">Table of Contents</a></td></tr></table></div>
    <!-- Field: /Page --></ix:exclude>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>SHARPS
TECHNOLOGY, INC.</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTES
TO THE CONSOLIDATED FINANCIAL STATEMENTS</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>FOR
THE YEARS ENDED DECEMBER 31, 2023 AND 2022</b></span></p>

<p style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Note
2. Summary of Significant Accounting Policies (continued)</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
provision for income taxes was comprised of the Company&#8217;s current tax liability and changes in deferred income tax assets and liabilities.
The calculation of the current tax liability involves dealing with uncertainties in the application of complex tax laws and regulations
and in determining the liability for tax positions, if any, taken on the Company&#8217;s tax returns in accordance with authoritative
guidance on accounting for uncertainty in income taxes. Deferred income taxes are determined based on the differences between the financial
reporting and tax basis of assets and liabilities. The Company must assess the likelihood that it will be able to recover the Company&#8217;s
deferred tax assets. If recovery is not likely on a more-likely-than-not basis, the Company must increase its provision for income taxes
by recording a valuation allowance against the deferred tax assets that it estimates will not ultimately be recoverable. However, should
there be a change in the Company&#8217;s ability to recover its deferred tax assets, the provision for income taxes would fluctuate in
the period of such change.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2023-01-012023-12-31" escape="true" id="Fact000624" name="us-gaap:ResearchAndDevelopmentExpensePolicy"><p id="xdx_842_eus-gaap--ResearchAndDevelopmentExpensePolicy_zNrWRCEvd1X5" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i><span id="xdx_86D_z3XLDfbXfP76">Research
and Development Costs</span></i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Research
and development costs are expensed as incurred.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Advance
payments for goods or services that will be used or rendered for future research and development activities are deferred and capitalized.
Such amounts are recognized as an expense as the related goods are delivered or the services are performed.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2023-01-012023-12-31" escape="true" id="Fact000626" name="us-gaap:CommitmentsAndContingenciesPolicyTextBlock"><p id="xdx_840_eus-gaap--CommitmentsAndContingenciesPolicyTextBlock_zMAjVtdbmft2" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i><span id="xdx_861_znjPtJzomxrk">Contingencies</span></i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Liabilities
for loss contingencies arising from claims, assessments, litigations, fines and penalties and other sources are recognized when it is
probable that a liability has been incurred and the amount of the assessment can be reasonably estimated. Gain contingencies are evaluated
and not recognized until the gain is realizable or realized.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2023-01-012023-12-31" escape="true" id="Fact000628" name="us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock"><p id="xdx_84E_eus-gaap--NewAccountingPronouncementsPolicyPolicyTextBlock_zC2pqT1WNqxh" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i><span id="xdx_868_z2mR3DbjnDI9">Recent
Accounting Pronouncements</span> </i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
August 5, 2020, the FASB issued ASU 2020-06, <i>Debt &#8211; Debt with Conversion and Other Options (Subtopic 470-20) and Derivatives
and Hedging &#8211; Contracts in Entity&#8217;s Own Equity (Subtopic 815-40)</i>, which simplifies the accounting for certain financial
instruments with characteristics of liabilities and equity, including convertible instruments and contracts on an entity&#8217;s own
equity. The ASU is part of the FASB&#8217;s simplification initiative, which aims to reduce unnecessary complexity in U.S. GAAP. ASU
2020-06 simplifies the guidance in U.S. GAAP on the issuer&#8217;s accounting for convertible debt instruments, requires entities to
provide expanded disclosures about &#8220;the terms and features of convertible instruments&#8221; and how the instruments have been
reported in the entity&#8217;s financial statements. It also removes from ASC 815-40-25-10 certain conditions for equity classification
and amends certain guidance in ASC 260, <i>Earnings per Share</i>, on the computation of EPS for convertible instruments and contracts
on an entity&#8217;s own equity. An entity can use either a full or modified retrospective approach to adopt the ASU&#8217;s guidance.
The ASU&#8217;s amendments are effective for smaller public business entities fiscal years beginning after December 15, 2023. The Company
is currently evaluating the impact of ASU 2020-06 on its consolidated financial statements and does not expect the adoption of this amended
guidance to have a material impact on the Company&#8217;s consolidated financial statements.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
December 2023, the FASB issued ASU 2023-09, <i>Income Taxes </i>(Topic 740)<i>: Improvements to Income Tax Disclosures</i>. The new guidance
requires disaggregated information about the effective tax rate reconciliation and additional information on taxes paid that meet a quantitative
threshold. The new guidance is effective for public companies for annual reporting periods beginning after December 15, 2024, and for
non-public companies for annual reporting periods beginning after December 15, 2025, with early adoption permitted for both. The Company
will adopt the new standard in the annual reporting period beginning after December 15, 2025 and is currently evaluating the impacts of the
new guidance on its disclosures within the consolidated financial statements.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company does not expect the adoption of any accounting pronouncements to have a material impact on the consolidated financial statements.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company reviewed all other recently issued accounting pronouncements and have concluded they are not applicable or not expected to be
significant to the accounting for our operations.</span></p>

</ix:nonNumeric><p id="xdx_85D_zBg1R3ZATai8" style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<ix:exclude><!-- Field: Page; Sequence: 61; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 0pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->13<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%"><a href="#RM_014">Table of Contents</a></td></tr></table></div>
    <!-- Field: /Page --></ix:exclude>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>SHARPS
TECHNOLOGY, INC.</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTES
TO THE CONSOLIDATED FINANCIAL STATEMENTS</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>FOR
THE YEARS ENDED DECEMBER 31, 2023 AND 2022</b></span></p>

<p style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2023-01-012023-12-31" escape="true" id="Fact000630" name="us-gaap:InventoryDisclosureTextBlock"><p id="xdx_80E_eus-gaap--InventoryDisclosureTextBlock_zbBN9a3Qqiwj" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Note
3. <span id="xdx_82B_zTkTm91WsZFf">Inventories</span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<ix:nonNumeric contextRef="From2023-01-012023-12-31" escape="true" id="Fact000632" name="us-gaap:ScheduleOfInventoryCurrentTableTextBlock"><p id="xdx_897_eus-gaap--ScheduleOfInventoryCurrentTableTextBlock_z3TdlfDLqDOh" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Inventories,
net consisted of the following at December 31, 2023 and 2022:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span id="xdx_8B6_zCRavWqfgD5i" style="display: none">Schedule of Inventories</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td style="text-align: center">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" id="xdx_499_20231231_zP3RLzx3Hdr8" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><p style="margin-top: 0pt; margin-bottom: 0pt">December 31,</p>
                                                                                <p style="margin-top: 0pt; margin-bottom: 0pt">2023</p></td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" id="xdx_494_20221231_zaiuNWHgSB5" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><p style="margin-top: 0pt; margin-bottom: 0pt">December 31,</p>
                                                                                <p style="margin-top: 0pt; margin-bottom: 0pt">2022</p></td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
  <tr id="xdx_400_eus-gaap--InventoryRawMaterialsNetOfReserves_iI_maINzcUe_zj891ZoM6wF1" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 60%; text-align: left">Raw materials</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 16%; text-align: right"><ix:nonFraction name="us-gaap:InventoryRawMaterialsNetOfReserves" contextRef="AsOf2023-12-31" id="Fact000634" format="ixt:numdotdecimal" decimals="0" unitRef="USD">254,461</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 16%; text-align: right"><ix:nonFraction name="us-gaap:InventoryRawMaterialsNetOfReserves" contextRef="AsOf2022-12-31" id="Fact000635" format="ixt:numdotdecimal" decimals="0" unitRef="USD">106,088</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr id="xdx_409_eus-gaap--InventoryWorkInProcessNetOfReserves_iI_maINzcUe_zl5kEwucRDCe" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Work in process</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:InventoryWorkInProcessNetOfReserves" contextRef="AsOf2023-12-31" id="Fact000637" format="ixt:numdotdecimal" decimals="0" unitRef="USD">170,464</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:InventoryWorkInProcessNetOfReserves" contextRef="AsOf2022-12-31" id="Fact000638" format="ixt:numdotdecimal" decimals="0" unitRef="USD">49,144</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40F_eus-gaap--InventoryFinishedGoodsNetOfReserves_iI_maINzcUe_zzZPgUwfNfLf" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1pt">Finished goods</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:InventoryFinishedGoodsNetOfReserves" contextRef="AsOf2023-12-31" id="Fact000640" format="ixt:numdotdecimal" decimals="0" unitRef="USD">1,284,210</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:InventoryFinishedGoodsNetOfReserves" contextRef="AsOf2022-12-31" id="Fact000641" format="ixt:numdotdecimal" decimals="0" unitRef="USD">30,572</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_406_eus-gaap--InventoryNet_iTI_mtINzcUe_zQlw3jmBTngg" style="vertical-align: bottom; background-color: White">
    <td style="padding-bottom: 1pt">Total</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">$</td><td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:InventoryNet" contextRef="AsOf2023-12-31" id="Fact000643" format="ixt:numdotdecimal" decimals="0" unitRef="USD">1,709,135</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">$</td><td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:InventoryNet" contextRef="AsOf2022-12-31" id="Fact000644" format="ixt:numdotdecimal" decimals="0" unitRef="USD">185,804</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  </table>

</ix:nonNumeric><p id="xdx_8AD_zMxV2pgkb3Mk" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2023-01-012023-12-31" escape="true" id="Fact000646" name="us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock"><p id="xdx_809_eus-gaap--PropertyPlantAndEquipmentDisclosureTextBlock_zoKkeKrJuN94" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Note
4. <span id="xdx_82C_zow7dKL8AaDa">Fixed Assets</span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<ix:nonNumeric contextRef="From2023-01-012023-12-31" escape="true" id="Fact000648" name="us-gaap:PropertyPlantAndEquipmentTextBlock"><p id="xdx_893_eus-gaap--PropertyPlantAndEquipmentTextBlock_zPUvEoseWjce" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Fixed
asset, net, as of December 31, 2023 and 2022, are summarized as follows:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;<span id="xdx_8B0_zAFXDcVkUXue" style="display: none">Schedule of Property, Plant and Equipment</span></span></span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 85%">
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" id="xdx_49F_20231231_zWFwv1Q28DAl" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><p style="margin-top: 0pt; margin-bottom: 0pt">December 31,</p>
                                                                                <p style="margin-top: 0pt; margin-bottom: 0pt">2023</p></td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2" id="xdx_49F_20221231_z3IwxSHnt11c" style="border-bottom: Black 1pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>December
31,</b></span></p>
                                                                                 <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>2022</b></span></p></td><td style="padding-bottom: 1pt">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: center">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: center">&#160;</td><td>&#160;</td></tr>
  <tr id="xdx_40A_eus-gaap--PropertyPlantAndEquipmentGross_iI_hus-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--LandMember_zMoBJf64Ur01" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 56%">Land</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 18%; text-align: right"><ix:nonFraction name="us-gaap:PropertyPlantAndEquipmentGross" contextRef="AsOf2023-12-31_us-gaap_LandMember" id="Fact000650" format="ixt:numdotdecimal" decimals="0" unitRef="USD">260,460</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 18%; text-align: right"><ix:nonFraction name="us-gaap:PropertyPlantAndEquipmentGross" contextRef="AsOf2022-12-31_us-gaap_LandMember" id="Fact000651" format="ixt:numdotdecimal" decimals="0" unitRef="USD">242,240</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr id="xdx_402_eus-gaap--PropertyPlantAndEquipmentGross_iI_hus-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--BuildingMember_zABltg7WUrg8" style="vertical-align: bottom; background-color: White">
    <td>Building</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:PropertyPlantAndEquipmentGross" contextRef="AsOf2023-12-31_us-gaap_BuildingMember" id="Fact000653" format="ixt:numdotdecimal" decimals="0" unitRef="USD">3,022,490</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:PropertyPlantAndEquipmentGross" contextRef="AsOf2022-12-31_us-gaap_BuildingMember" id="Fact000654" format="ixt:numdotdecimal" decimals="0" unitRef="USD">2,824,481</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_406_eus-gaap--PropertyPlantAndEquipmentGross_iI_hus-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--MachineryAndEquipmentMember_ziNklABgBeNb" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Machinery and Equipment</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:PropertyPlantAndEquipmentGross" contextRef="AsOf2023-12-31_us-gaap_MachineryAndEquipmentMember" id="Fact000656" format="ixt:numdotdecimal" decimals="0" unitRef="USD">4,464,317</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:PropertyPlantAndEquipmentGross" contextRef="AsOf2022-12-31_us-gaap_MachineryAndEquipmentMember" id="Fact000657" format="ixt:numdotdecimal" decimals="0" unitRef="USD">4,601,293</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_402_eus-gaap--PropertyPlantAndEquipmentGross_iI_hus-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--ComputerSystemsAndWebsiteAndOtherWebsiteMember_zUXGTRCvI5Hf" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1pt">Computer and Website</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:PropertyPlantAndEquipmentGross" contextRef="AsOf2023-12-31_custom_ComputerSystemsAndWebsiteAndOtherWebsiteMember" id="Fact000659" format="ixt:numdotdecimal" decimals="0" unitRef="USD">290,661</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:PropertyPlantAndEquipmentGross" contextRef="AsOf2022-12-31_custom_ComputerSystemsAndWebsiteAndOtherWebsiteMember" id="Fact000660" format="ixt:numdotdecimal" decimals="0" unitRef="USD">16,600</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_40F_eus-gaap--PropertyPlantAndEquipmentGross_iI_maPPAENzHVU_zO2D76mnsUuf" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>&#160;<span style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt">Total Fixed Assets</span> </td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:PropertyPlantAndEquipmentGross" contextRef="AsOf2023-12-31" id="Fact000662" format="ixt:numdotdecimal" decimals="0" unitRef="USD">8,037,928</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:PropertyPlantAndEquipmentGross" contextRef="AsOf2022-12-31" id="Fact000663" format="ixt:numdotdecimal" decimals="0" unitRef="USD">7,684,614</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_403_eus-gaap--AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_iNI_di_msPPAENzHVU_zaXpSGBuV5O7" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1pt">Less: accumulated depreciation</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(<ix:nonFraction name="us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" contextRef="AsOf2023-12-31" id="Fact000665" format="ixt:numdotdecimal" decimals="0" unitRef="USD">1,215,786</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(<ix:nonFraction name="us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" contextRef="AsOf2022-12-31" id="Fact000666" format="ixt:numdotdecimal" decimals="0" unitRef="USD">679,724</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">)</td></tr>
  <tr id="xdx_400_eus-gaap--PropertyPlantAndEquipmentNet_iTI_mtPPAENzHVU_zjZ9c7oVtg2e" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1pt">Fixed asset, net</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">$</td><td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:PropertyPlantAndEquipmentNet" contextRef="AsOf2023-12-31" id="Fact000668" format="ixt:numdotdecimal" decimals="0" unitRef="USD">6,822,142</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">$</td><td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:PropertyPlantAndEquipmentNet" contextRef="AsOf2022-12-31" id="Fact000669" format="ixt:numdotdecimal" decimals="0" unitRef="USD">7,004,890</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  </table>

</ix:nonNumeric><p id="xdx_8A4_zz5bPc94Na4f" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Depreciation
expense of fixed assets for the year ended December 31, 2023 and 2022 was $<span id="xdx_90A_eus-gaap--Depreciation_c20230101__20231231_zk7cwwg7uoV" title="Depreciation"><ix:nonFraction name="us-gaap:Depreciation" contextRef="From2023-01-012023-12-31" id="Fact000671" format="ixt:numdotdecimal" decimals="0" unitRef="USD">876,064</ix:nonFraction></span> and $<span id="xdx_90D_eus-gaap--Depreciation_c20220101__20221231_zsjIq3dAbRo1" title="Depreciation"><ix:nonFraction name="us-gaap:Depreciation" contextRef="From2022-01-012022-12-31" id="Fact000673" format="ixt:numdotdecimal" decimals="0" unitRef="USD">647,690</ix:nonFraction></span>, respectively. Substantially, all of
the Company&#8217;s fixed assets are located at the Company&#8217;s Hungary location.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
the fourth quarter of 2023, the Company recorded, in Research and Development expenses, an asset impairment of $<span id="xdx_90C_eus-gaap--AssetImpairmentCharges_c20231001__20231231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--MachineryAndEquipmentMember_zp7fG2VATTmb" title="Asset impairment"><ix:nonFraction name="us-gaap:AssetImpairmentCharges" contextRef="From2023-10-012023-12-31_us-gaap_MachineryAndEquipmentMember" id="Fact000675" format="ixt:numdotdecimal" decimals="0" unitRef="USD">560,000</ix:nonFraction> </span>
relating to Molds, which were included in Machinery and Equipment, due to a decision to discontinue usage of certain
molds.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">During
the year ended December 2022, the Company recorded $<span id="xdx_90F_eus-gaap--PaymentsToAcquireMachineryAndEquipment_c20220101__20221231__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember_zbpXwKAloy3j" title="Acquisition of machinery"><ix:nonFraction name="us-gaap:PaymentsToAcquireMachineryAndEquipment" contextRef="From2022-01-012022-12-31_us-gaap_StockOptionMember" id="Fact000677" format="ixt:numdotdecimal" decimals="0" unitRef="USD">63,612</ix:nonFraction></span> in fixed asset costs relating to the estimated fair market value for options
granted in 2021 for the acquired machinery. As of December 31, 2023, the Company has $<span id="xdx_906_ecustom--RemainingPaymentsDueOnMachinery_c20230101__20231231_zUjBnuOSWmMi" title="Balance due on machinery"><ix:nonFraction name="STSS:RemainingPaymentsDueOnMachinery" contextRef="From2023-01-012023-12-31" id="Fact000679" format="ixt:numdotdecimal" decimals="0" unitRef="USD">100,000</ix:nonFraction></span> in remaining payments for machinery purchased,
which is included in accounts payable.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2023-01-012023-12-31" escape="true" id="Fact000681" name="us-gaap:AssetAcquisitionTextBlock"><p id="xdx_808_eus-gaap--AssetAcquisitionTextBlock_zCulz1UGYe0g" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Note
5. <span id="xdx_82F_zH1pkZyQBVAe">Asset Acquisition</span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
June 2020, the Company entered into a Share Purchase Agreement (&#8220;Agreement&#8221;) with Safegard Medical (&#8220;Safegard&#8221;)
and amendments to the Agreement, collectively, the Agreements, to purchase either the stock or certain assets of a manufacturing facility
for $<span id="xdx_906_eus-gaap--AssetAcquisitionConsiderationTransferred_pn5n6_c20200601__20200630__us-gaap--TypeOfArrangementAxis__custom--SharePurchaseAgreementMember_zXXflAkB7AT7" title="Asset acquisition"><ix:nonFraction name="us-gaap:AssetAcquisitionConsiderationTransferred" contextRef="From2020-06-012020-06-30_custom_SharePurchaseAgreementMember" id="Fact000683" format="ixt:numdotdecimal" decimals="-5" scale="6" unitRef="USD">2.5</ix:nonFraction></span>M in cash, plus additional consideration of <span id="xdx_906_eus-gaap--StockIssuedDuringPeriodSharesAcquisitions_c20200601__20200630__us-gaap--TypeOfArrangementAxis__custom--SharePurchaseAgreementMember__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zoUph2Jvco1l" title="Additional consideration, shares"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodSharesAcquisitions" contextRef="From2020-06-012020-06-30_custom_SharePurchaseAgreementMember_us-gaap_CommonStockMember" id="Fact000685" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">28,571</ix:nonFraction></span> shares of common stock with an estimated fair market value of $<span id="xdx_90D_eus-gaap--SharePrice_iI_c20200630__us-gaap--TypeOfArrangementAxis__custom--SharePurchaseAgreementMember__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zusBsFuv4O28" title="Share price"><ix:nonFraction name="us-gaap:SharePrice" contextRef="AsOf2020-06-30_custom_SharePurchaseAgreementMember_us-gaap_CommonStockMember" id="Fact000687" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">7.00</ix:nonFraction></span>, <span id="xdx_90E_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod_c20200601__20200630__us-gaap--TypeOfArrangementAxis__custom--SharePurchaseAgreementMember__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember_znpAjWNBL8P" title="Stock options issued"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod" contextRef="From2020-06-012020-06-30_custom_SharePurchaseAgreementMember_us-gaap_StockOptionMember" id="Fact000689" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">35,714</ix:nonFraction></span>
stock options with an exercise price of $<span id="xdx_905_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_pid_c20200601__20200630__us-gaap--TypeOfArrangementAxis__custom--SharePurchaseAgreementMember__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember_zxoaLKrp7J9f" title="Exercise price"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" contextRef="From2020-06-012020-06-30_custom_SharePurchaseAgreementMember_us-gaap_StockOptionMember" id="Fact000691" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">7.00</ix:nonFraction></span> and <span id="xdx_901_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod_c20200601__20200630__us-gaap--TypeOfArrangementAxis__custom--SharePurchaseAgreementMember__us-gaap--AwardTypeAxis__custom--StockOptionOneMember_zJSxH3qrSPkj" title="Stock options issued"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod" contextRef="From2020-06-012020-06-30_custom_SharePurchaseAgreementMember_custom_StockOptionOneMember" id="Fact000693" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">50,000</ix:nonFraction></span> stock options with an exercise price of $<span id="xdx_90D_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_pid_c20220705__20220706__us-gaap--TypeOfArrangementAxis__custom--SharePurchaseAgreementMember__us-gaap--AwardTypeAxis__custom--StockOptionOneMember_zw6xZry15Fl5" title="Exercise price"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" contextRef="From2022-07-052022-07-06_custom_SharePurchaseAgreementMember_custom_StockOptionOneMember" id="Fact000695" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">4.25</ix:nonFraction></span>. The purchase price includes the
fair market value of the common stock of $<span id="xdx_904_ecustom--FairMarketValueOfCommonStock_c20200601__20200630__us-gaap--TypeOfArrangementAxis__custom--SharePurchaseAgreementMember__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zwJctNKXD3J6" title="Fair market value of common stock"><ix:nonFraction name="STSS:FairMarketValueOfCommonStock" contextRef="From2020-06-012020-06-30_custom_SharePurchaseAgreementMember_us-gaap_CommonStockMember" id="Fact000697" format="ixt:numdotdecimal" decimals="0" unitRef="USD">200,000</ix:nonFraction></span> and the vested options of $<span id="xdx_90E_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1_c20200601__20200630__us-gaap--TypeOfArrangementAxis__custom--SharePurchaseAgreementMember__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember_zfJ3E5Fk1Eeb" title="Vested options, value"><ix:nonFraction name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1" contextRef="From2020-06-012020-06-30_custom_SharePurchaseAgreementMember_us-gaap_StockOptionMember" id="Fact000699" format="ixt:numdotdecimal" decimals="0" unitRef="USD">183,135</ix:nonFraction></span>. The Agreements provided the Company various periods
for due diligence and post due diligence, requirements for escrow payments through the closing date (&#8220;Closing Date&#8221;).</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Through
the Closing Date, the Agreements provided the Company with the exclusive use of the facility in exchange for payment of the facility&#8217;s
operating costs. The monthly fee (&#8220;Operating Costs&#8221;), which primarily covered the facility&#8217;s operating costs, was mainly
comprised of the seller&#8217;s workforce costs, materials and other recurring monthly operating cost.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">During
the year ended December 31, 2022, the Company had remitted <span id="xdx_900_eus-gaap--OperatingCostsAndExpenses_c20220101__20221231__us-gaap--TypeOfArrangementAxis__custom--SharePurchaseAgreementMember_zTjHmH7uo4V2" title="Operating costs">$<ix:nonFraction name="us-gaap:OperatingCostsAndExpenses" contextRef="From2022-01-012022-12-31_custom_SharePurchaseAgreementMember" id="Fact000701" format="ixt:numdotdecimal" decimals="0" unitRef="USD">594,000</ix:nonFraction></span>, respectively for the aforementioned Operating Costs. The remittance
of operating costs was discontinued after the Closing Date. These costs were included in research and development expense in the consolidated
statement of operations as the activities at the facility in 2022 were related to design and testing of the Company&#8217;s products.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<ix:exclude><!-- Field: Page; Sequence: 62; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 0pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->14<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%"><a href="#RM_014">Table of Contents</a></td></tr></table></div>
    <!-- Field: /Page --></ix:exclude>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>SHARPS
TECHNOLOGY, INC.</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTES
TO THE CONSOLIDATED FINANCIAL STATEMENTS</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>FOR
THE YEARS ENDED DECEMBER 31, 2023 AND 2022</b></span></p>

<p style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Note
5. Asset Acquisition (continued)</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
acquisition of Safegard, which closed on July 6, 2022, did not meet the definition of a business pursuant to ASC 805-10, and accordingly
was accounted for as an asset acquisition in accordance with ASC 805-50. The cost of the acquisition was $<span id="xdx_90C_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets_iI_c20220706__us-gaap--BusinessAcquisitionAxis__custom--SafegardMedicalIncMember_zLK0DDXMciqc" title="Acquisition cost"><ix:nonFraction name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets" contextRef="AsOf2022-07-06_custom_SafegardMedicalIncMember" id="Fact000703" format="ixt:numdotdecimal" decimals="0" unitRef="USD">2,936,712</ix:nonFraction></span>, including transaction
costs of $<span id="xdx_90F_eus-gaap--FairValueOfAssetsAcquired_c20220705__20220706__us-gaap--BusinessAcquisitionAxis__custom--SafegardMedicalIncMember_zycTPxydM2i9" title="Fair value of assets acquired"><ix:nonFraction name="us-gaap:FairValueOfAssetsAcquired" contextRef="From2022-07-052022-07-06_custom_SafegardMedicalIncMember" id="Fact000705" format="ixt:numdotdecimal" decimals="0" unitRef="USD">53,576</ix:nonFraction></span>, with the allocation to the assets acquired on a relative fair value basis. The intangibles relate to permits and a
limited workforce acquired. Under ASC 805-50, no goodwill is recognized. The operating results for Safegard are included in the consolidated
balance sheet and consolidated statements of operations for the period beginning after the closing on July 6, 2022.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<ix:nonNumeric contextRef="From2023-01-012023-12-31" escape="true" id="Fact000707" name="us-gaap:ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock"><p id="xdx_897_eus-gaap--ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock_zYnRON4oCd9g" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
relative fair value of the assets acquired and related deferred tax liability is as follows:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify">&#160;<span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_8B4_zhBGM60lA9Y4" style="display: none">Schedule of Fair Value of the Assets Acquisition</span></span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 60%">
  <tr style="display: none; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_493_20220706__us-gaap--BusinessAcquisitionAxis__custom--SafegardMedicalIncMember_z8jfhEywzJwd" style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_407_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLand_iI_maBCRIAzqVv_zgKz5DNiWW1b" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 78%">Land</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 18%; text-align: right"><ix:nonFraction name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLand" contextRef="AsOf2022-07-06_custom_SafegardMedicalIncMember" id="Fact000709" format="ixt:numdotdecimal" decimals="0" unitRef="USD">226,000</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr id="xdx_407_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedBuildings_iI_maBCRIAzqVv_z4o0moTfk161" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Building and affixed assets</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedBuildings" contextRef="AsOf2022-07-06_custom_SafegardMedicalIncMember" id="Fact000711" format="ixt:numdotdecimal" decimals="0" unitRef="USD">2,684,000</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_404_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedEquipment_iI_maBCRIAzqVv_zxo4Cnum8AIj" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>Machinery</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedEquipment" contextRef="AsOf2022-07-06_custom_SafegardMedicalIncMember" id="Fact000713" format="ixt:numdotdecimal" decimals="0" unitRef="USD">158,000</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40A_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory_iI_maBCRIAzqVv_z8bi35VTpHfb" style="vertical-align: bottom; background-color: White">
    <td>Inventory</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory" contextRef="AsOf2022-07-06_custom_SafegardMedicalIncMember" id="Fact000715" format="ixt:numdotdecimal" decimals="0" unitRef="USD">32,000</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_400_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles_iI_maBCRIAzqVv_zs0rD6bcn8G4" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>Intangibles</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles" contextRef="AsOf2022-07-06_custom_SafegardMedicalIncMember" id="Fact000717" format="ixt:numdotdecimal" decimals="0" unitRef="USD">64,712</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40B_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities_iNI_di_msBCRIAzqVv_zY4qYyAyt4Md" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1pt">Deferred tax liability</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(<ix:nonFraction name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities" contextRef="AsOf2022-07-06_custom_SafegardMedicalIncMember" id="Fact000719" format="ixt:numdotdecimal" decimals="0" unitRef="USD">192,000</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40B_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets_iTI_mtBCRIAzqVv_zahGjZNGCkwk" style="vertical-align: bottom; background-color: White">
    <td style="padding-bottom: 1pt">Total</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">$</td><td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets" contextRef="AsOf2022-07-06_custom_SafegardMedicalIncMember" id="Fact000721" format="ixt:numdotdecimal" decimals="0" unitRef="USD">2,936,712</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  </table>

</ix:nonNumeric><p id="xdx_8AD_zhd8uPXxv0fk" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
useful lives for the acquired assets is Building - <span id="xdx_907_eus-gaap--FiniteLivedIntangibleAssetUsefulLife_iI_dtY_c20231231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--BuildingMember_zfpQnoySQNIb" title="Finite-lived intangible asset, useful life"><ix:nonNumeric contextRef="AsOf2023-12-31_us-gaap_BuildingMember" format="ixt-sec:duryear" id="Fact000723" name="us-gaap:FiniteLivedIntangibleAssetUsefulLife">20</ix:nonNumeric></span> years; Machinery &#8211; <span id="xdx_90C_eus-gaap--FiniteLivedIntangibleAssetUsefulLife_iI_dtY_c20231231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--MachineryAndEquipmentMember__srt--RangeAxis__srt--MinimumMember_zHaPVOotDqZ4" title="Finite-lived intangible asset, useful life"><ix:nonNumeric contextRef="AsOf2023-12-31_us-gaap_MachineryAndEquipmentMember_srt_MinimumMember" format="ixt-sec:duryear" id="Fact000725" name="us-gaap:FiniteLivedIntangibleAssetUsefulLife">5</ix:nonNumeric></span> to <span id="xdx_90A_eus-gaap--FiniteLivedIntangibleAssetUsefulLife_iI_dtY_c20231231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--MachineryAndEquipmentMember__srt--RangeAxis__srt--MaximumMember_zBlHM6Hpr8Fc" title="Finite-lived intangible asset, useful life"><ix:nonNumeric contextRef="AsOf2023-12-31_us-gaap_MachineryAndEquipmentMember_srt_MaximumMember" format="ixt-sec:duryear" id="Fact000727" name="us-gaap:FiniteLivedIntangibleAssetUsefulLife">10</ix:nonNumeric></span> years; Intangibles &#8211; <span id="xdx_908_eus-gaap--FiniteLivedIntangibleAssetUsefulLife_iI_dtY_c20231231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--FiniteLivedIntangibleAssetsMember_zBvMX8qJXeAi" title="Finite-lived intangible asset, useful life"><ix:nonNumeric contextRef="AsOf2023-12-31_us-gaap_FiniteLivedIntangibleAssetsMember" format="ixt-sec:duryear" id="Fact000729" name="us-gaap:FiniteLivedIntangibleAssetUsefulLife">5</ix:nonNumeric></span> years. The related
depreciation and amortization is being recorded on a straight-line basis.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2023-01-012023-12-31" escape="true" id="Fact000731" name="us-gaap:OtherAssetsDisclosureTextBlock"><p id="xdx_801_eus-gaap--OtherAssetsDisclosureTextBlock_zPmnljukSxi1" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Note
6. <span id="xdx_825_zznUHocMli91">Other Assets</span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<ix:nonNumeric contextRef="From2023-01-012023-12-31" escape="true" id="Fact000733" name="us-gaap:ScheduleOfOtherAssetsTableTextBlock"><p id="xdx_89A_eus-gaap--ScheduleOfOtherAssetsTableTextBlock_zIGFjiFojy87" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Other
assets as of December 31, 2023 and 2022 are summarized as follows:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;<span id="xdx_8B9_zuK22lThk6sf" style="display: none">Schedule of Other Assets</span></span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 80%">
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" id="xdx_49F_20231231_z5bdXbgC7sBh" style="font-weight: bold; text-align: center">December 31,</td><td style="font-weight: bold">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" id="xdx_491_20221231_zaS8ZjMFTSd6" style="font-weight: bold; text-align: center">December 31,</td><td style="font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2023</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2022</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td></tr>
  <tr id="xdx_403_eus-gaap--IntangibleAssetsNetExcludingGoodwill_iI_maOANzzDQ_z3R17s4dQmzc" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 60%; text-align: left">Intangibles, net</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 16%; text-align: right"><ix:nonFraction name="us-gaap:IntangibleAssetsNetExcludingGoodwill" contextRef="AsOf2023-12-31" id="Fact000735" format="ixt:numdotdecimal" decimals="0" unitRef="USD">52,513</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 16%; text-align: right"><ix:nonFraction name="us-gaap:IntangibleAssetsNetExcludingGoodwill" contextRef="AsOf2022-12-31" id="Fact000736" format="ixt:numdotdecimal" decimals="0" unitRef="USD">62,480</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr id="xdx_401_eus-gaap--DepositsAssets_iI_maOANzzDQ_zMNSmwMjaYWa" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Deposits or advance payments on machinery, molds and components (see Note 15)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><p style="margin: 0"><span style="-sec-ix-hidden: xdx2ixbrl0738">-</span></p></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:DepositsAssets" contextRef="AsOf2022-12-31" id="Fact000739" format="ixt:numdotdecimal" decimals="0" unitRef="USD">336,466</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40C_eus-gaap--OtherAssetsMiscellaneousNoncurrent_iI_maOANzzDQ_zdth0WrOGOm8" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 1pt">Other</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:OtherAssetsMiscellaneousNoncurrent" contextRef="AsOf2023-12-31" id="Fact000741" format="ixt:numdotdecimal" decimals="0" unitRef="USD">76,062</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:OtherAssetsMiscellaneousNoncurrent" contextRef="AsOf2022-12-31" id="Fact000742" format="ixt:numdotdecimal" decimals="0" unitRef="USD">12,370</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_409_eus-gaap--OtherAssetsNoncurrent_iTI_mtOANzzDQ_zOelROCnvAn1" style="vertical-align: bottom; background-color: White">
    <td style="padding-bottom: 1pt"><span style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt">Other
    assets</span></td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">$</td><td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:OtherAssetsNoncurrent" contextRef="AsOf2023-12-31" id="Fact000744" format="ixt:numdotdecimal" decimals="0" unitRef="USD">128,575</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">$</td><td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:OtherAssetsNoncurrent" contextRef="AsOf2022-12-31" id="Fact000745" format="ixt:numdotdecimal" decimals="0" unitRef="USD">411,316</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  </table>

</ix:nonNumeric><p id="xdx_8AF_z7FLsV8gq8he" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Intangibles
are related to the Asset Acquisition (see Note 5) and consist of an acquired workforce and permits. Amortization for the year ended December
31, 2023 was $<span id="xdx_903_eus-gaap--AmortizationOfIntangibleAssets_c20230101__20231231_zjVppxxqXbU1" title="Amortization of intangible assets"><ix:nonFraction name="us-gaap:AmortizationOfIntangibleAssets" contextRef="From2023-01-012023-12-31" id="Fact000747" format="ixt:numdotdecimal" decimals="0" unitRef="USD">15,184</ix:nonFraction></span>.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2023-01-012023-12-31" escape="true" id="Fact000749" name="us-gaap:DebtDisclosureTextBlock"><p id="xdx_803_eus-gaap--DebtDisclosureTextBlock_zkgtYdG5woL8" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Note 7. <span id="xdx_82A_zrkfsE3ylwCf">Debt Financing</span>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>
<p style="font: 10pt Times New Roman, Times, Serif; display: none; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
September 20, 2024, the Company entered into a securities purchase agreement (the &#8220;Securities Purchase Agreement&#8221;) and a
Senior Secured Note (the &#8220;Note&#8221;) for an aggregate principal amount of $<span id="xdx_900_eus-gaap--DebtInstrumentFaceAmount_iI_c20240920__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__us-gaap--DebtInstrumentAxis__custom--SeniorSecuredNoteMember_zUSgrLpLCko2"><ix:nonFraction name="us-gaap:DebtInstrumentFaceAmount" contextRef="AsOf2024-09-20_custom_SecuritiesPurchaseAgreementMember_custom_SeniorSecuredNoteMember" id="Fact000750" format="ixt:numdotdecimal" decimals="0" unitRef="USD">4,375,000</ix:nonFraction></span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">,
including OID interest of $<span id="xdx_902_eus-gaap--DebtInstrumentIncreaseAccruedInterest_c20240920__20240920__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__us-gaap--DebtInstrumentAxis__custom--SeniorSecuredNoteMember_zBiOuGzRoV8j" title="Original issue discount (OID)"><ix:nonFraction name="us-gaap:DebtInstrumentIncreaseAccruedInterest" contextRef="From2024-09-202024-09-20_custom_SecuritiesPurchaseAgreementMember_custom_SeniorSecuredNoteMember" id="Fact000752" format="ixt:numdotdecimal" decimals="0" unitRef="USD">875,000</ix:nonFraction> </span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">maturing
on <span id="xdx_909_eus-gaap--DebtInstrumentMaturityDate_dd_c20240920__20240920__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__us-gaap--DebtInstrumentAxis__custom--SeniorSecuredNoteMember_zuMKRwZ44Unl"><ix:nonNumeric contextRef="From2024-09-202024-09-20_custom_SecuritiesPurchaseAgreementMember_custom_SeniorSecuredNoteMember" format="ixt:datemonthdayyearen" id="Fact000753" name="us-gaap:DebtInstrumentMaturityDate">January
31, 2025</ix:nonNumeric></span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">, with certain purchasers (the
&#8220;Purchasers&#8221;), and the issuance of approximately <span id="xdx_909_ecustom--NumberOfUnregisteredCommonStockIssuedDuringPostReverseShares_pid_c20240920__20240920__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__us-gaap--DebtInstrumentAxis__custom--SeniorSecuredNoteMember_zsgBJOT2Re7b" title="Number of unregistered common stock issued during post reverse shares"><ix:nonFraction name="STSS:NumberOfUnregisteredCommonStockIssuedDuringPostReverseShares" contextRef="From2024-09-202024-09-20_custom_SecuritiesPurchaseAgreementMember_custom_SeniorSecuredNoteMember" id="Fact000755" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">259,091</ix:nonFraction> </span></span>(pre
reverse - <span id="xdx_908_ecustom--NumberOfUnregisteredCommonStockIssuedDuringPreReverseShares_pid_c20240920__20240920__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__us-gaap--DebtInstrumentAxis__custom--SeniorSecuredNoteMember__us-gaap--AwardTypeAxis__custom--PreReverseMember_zaQgLgiCUT1h" title="Pre reverse"><ix:nonFraction name="STSS:NumberOfUnregisteredCommonStockIssuedDuringPreReverseShares" contextRef="From2024-09-202024-09-20_custom_SecuritiesPurchaseAgreementMember_custom_SeniorSecuredNoteMember_custom_PreReverseMember" id="Fact000757" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">5,700,006</ix:nonFraction></span> ) unregistered shares of the Company&#8217;s Common Stock. The aggregate gross proceeds to the Company were
approximately $<span id="xdx_90B_eus-gaap--ProceedsFromIssuanceOfDebt_pn5n6_c20240920__20240920__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__us-gaap--DebtInstrumentAxis__custom--SeniorSecuredNoteMember_zMEoMg7hte0l"><ix:nonFraction name="us-gaap:ProceedsFromIssuanceOfDebt" contextRef="From2024-09-202024-09-20_custom_SecuritiesPurchaseAgreementMember_custom_SeniorSecuredNoteMember" id="Fact000758" format="ixt:numdotdecimal" decimals="-5" scale="6" unitRef="USD">3.5</ix:nonFraction> </span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">million,
before deducting fees to the placement agent and other offering expenses payable by the Company of $<span id="xdx_90E_ecustom--PlacementAgentAndOtherOfferingExpenses_pid_c20240920__20240920__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__us-gaap--DebtInstrumentAxis__custom--SeniorSecuredNoteMember_zss4mj0OW3bf" title="Closing costs"><ix:nonFraction name="STSS:PlacementAgentAndOtherOfferingExpenses" contextRef="From2024-09-202024-09-20_custom_SecuritiesPurchaseAgreementMember_custom_SeniorSecuredNoteMember" id="Fact000760" format="ixt:numdotdecimal" decimals="INF" unitRef="USD">514,700</ix:nonFraction> </span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">and
an escrow deposit of $<span id="xdx_902_eus-gaap--EscrowDeposit_iI_c20240920__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__us-gaap--DebtInstrumentAxis__custom--SeniorSecuredNoteMember_zrRvCfl3u0Z1"><ix:nonFraction name="us-gaap:EscrowDeposit" contextRef="AsOf2024-09-20_custom_SecuritiesPurchaseAgreementMember_custom_SeniorSecuredNoteMember" id="Fact000761" format="ixt:numdotdecimal" decimals="0" unitRef="USD">250,000</ix:nonFraction> </span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">required
until certain security liens are filed. The Note and the common stock were recorded at the relative fair values of $<span id="xdx_904_eus-gaap--DebtInstrumentFairValue_iI_pn5n6_c20240920__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__us-gaap--DebtInstrumentAxis__custom--SeniorSecuredNoteMember_zYdWHTDxdjGk"><ix:nonFraction name="us-gaap:DebtInstrumentFairValue" contextRef="AsOf2024-09-20_custom_SecuritiesPurchaseAgreementMember_custom_SeniorSecuredNoteMember" id="Fact000762" format="ixt:numdotdecimal" decimals="-5" scale="6" unitRef="USD">2.6</ix:nonFraction></span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">M
and $<span id="xdx_905_ecustom--CommonStockFairValue_iI_c20240920__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__us-gaap--DebtInstrumentAxis__custom--SeniorSecuredNoteMember_z0faco6l3FHk" title="Common stock fair value"><ix:nonFraction name="STSS:CommonStockFairValue" contextRef="AsOf2024-09-20_custom_SecuritiesPurchaseAgreementMember_custom_SeniorSecuredNoteMember" id="Fact000764" format="ixt:numdotdecimal" decimals="0" unitRef="USD">852,000</ix:nonFraction></span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">,
respectively, in accordance with ASC 470-20-25-2. The aforementioned expenses were allocated based on the aforementioned fair values
as a reduction to the carrying amount of the debt and a reduction of the equity in accordance with ASC 505-10. </span>For the three
and nine months ended September 30, 2024, the Company recorded accreted interest and fees of $<span id="xdx_909_ecustom--AccretedInterestFees_c20240101__20240930_zFgDKJLkZCsf" title="Accreted interest fees"><ix:nonFraction name="STSS:AccretedInterestFees" contextRef="From2024-01-01to2024-09-30" id="Fact000766" format="ixt:numdotdecimal" decimals="0" unitRef="USD">75,192</ix:nonFraction></span>.</p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2023-01-012023-12-31" escape="true" id="Fact000768" name="STSS:NotePurchaseAgreementTextBlock"><p id="xdx_807_ecustom--NotePurchaseAgreementTextBlock_zyE4rb7jrZB" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Note
7. <span id="xdx_820_zrPl3EgnjBmh">Note Purchase Agreement</span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
December 14, 2021, the Company entered into a Note Purchase Agreement (&#8220;NPA&#8221;) with three unrelated third-party purchasers
(&#8220;Purchasers&#8221;). The Purchasers provided financing to the Company in the form of bridge financing, aggregating principal of
$<span id="xdx_903_eus-gaap--DebtInstrumentFaceAmount_iI_c20211214__us-gaap--TypeOfArrangementAxis__custom--NotePurchaseAgreementMember__srt--TitleOfIndividualAxis__custom--UnrelatedThirdPartyPurchasersMember_zNKzG7EyFY2g" title="Debt instrument face amount"><ix:nonFraction name="us-gaap:DebtInstrumentFaceAmount" contextRef="AsOf2021-12-14_custom_NotePurchaseAgreementMember_custom_UnrelatedThirdPartyPurchasersMember" id="Fact000770" format="ixt:numdotdecimal" decimals="0" unitRef="USD">2,000,000</ix:nonFraction></span> (the &#8220;Notes&#8221;). The principal under the Notes shall be payable on the earlier of (i) December 14, 2022, and (ii)
the date on which the Company consummates an initial public offering (&#8220;IPO&#8221;), herein referred to as the &#8220;Maturity Date&#8221;.
The Notes bore interest at <span id="xdx_909_eus-gaap--DebtInstrumentInterestRateStatedPercentage_iI_pid_dp_uPure_c20211214__us-gaap--TypeOfArrangementAxis__custom--NotePurchaseAgreementMember__srt--TitleOfIndividualAxis__custom--UnrelatedThirdPartyPurchasersMember_z2KxI7DqUtib" title="Interest rate"><ix:nonFraction name="us-gaap:DebtInstrumentInterestRateStatedPercentage" contextRef="AsOf2021-12-14_custom_NotePurchaseAgreementMember_custom_UnrelatedThirdPartyPurchasersMember" id="Fact000772" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">8</ix:nonFraction></span>% with interest payments due monthly. The Company and the Purchasers had entered into a Security Agreement
whereby the Notes were collateralized by substantially all the assets of the Company, both tangible and intangible both currently owned
with stated exclusions, as defined, and any future acquired with stated exclusions, as defined.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<ix:exclude><!-- Field: Page; Sequence: 63; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 0pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->15<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%"><a href="#RM_014">Table of Contents</a></td></tr></table></div>
    <!-- Field: /Page --></ix:exclude>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>SHARPS
TECHNOLOGY, INC.</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTES
TO THE CONSOLIDATED FINANCIAL STATEMENTS</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>FOR
THE YEARS ENDED DECEMBER 31, 2023 AND 2022</b></span></p>

<p style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Note
7. Note Purchase Agreement (continued)</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
NPA provided for covenants that until all of the Notes have been converted, exchanged, redeemed or otherwise satisfied in accordance
with their terms, the Company shall not, and the Company shall not permit any of its subsidiaries without the prior written consent of
the Purchasers: a) incur or guarantee any new debt, b) issue any securities that would cause a breach or default under the NPA, c) incur
any liens other than permitted, d) redeem or repurchase shares, e) declare or pay any cash dividend or distribution, e) sell, lease or
dispose of assets other than in the ordinary course of business, or f) engage in different line of business.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_909_eus-gaap--DebtInstrumentDescription_c20211213__20211214__us-gaap--TypeOfArrangementAxis__custom--NotePurchaseAgreementMember__srt--TitleOfIndividualAxis__custom--UnrelatedThirdPartyPurchasersMember_zAcZWuH4Ihpg" title="Debt description"><ix:nonNumeric contextRef="From2021-12-132021-12-14_custom_NotePurchaseAgreementMember_custom_UnrelatedThirdPartyPurchasersMember" id="Fact000774" name="us-gaap:DebtInstrumentDescription">As
additional consideration to the Purchasers for providing the financing, the Company also agreed to a) issue each Purchaser a number of
shares of the Company&#8217;s Common Stock equal to 50% of the original principal amount of each Purchaser&#8217;s Note (the &#8220;Contingent
Stock&#8221;) and b) issue each Purchaser a number of warrants, which would allow the Purchasers to purchase additional shares of the
Company&#8217;s Common Stock, equal to 50% of the original principal amount each Purchaser&#8217;s Note for a term of 5.0 years (the
&#8220;Contingent Warrants&#8221;).</ix:nonNumeric></span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">For
both the Contingent Stock and the Contingent Warrants, the number of shares and warrants that each Purchaser will be issued was unknown
at the time of the NPA and was determined based on a formula of 50% of the original principal amount divided by a &#8220;Subsequent Offering
Price&#8221; based on the valuation in a future offering of Common stock or other equity interest in the Company (such offering referred
to as a &#8220;Consummated Offering&#8221;) during the period beginning on December 14, 2021 through and including the date the Company
consummates an initial public offering (&#8220;IPO&#8221;) (such period referred to as the &#8220;Subsequent Offering Period&#8221;).</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
accordance with ASC 480-10-25-14, a fixed monetary amount exists at inception for the total value of Contingent Stock that may be issued
to each Purchaser. The Contingent Stock is not considered outstanding at inception, as it will only be issued upon the consummation of
a Consummated Offering, and accordingly, is a conditional obligation. As such the fair market value (&#8220;FMV&#8221;) of the Contingent
Stock at inception was <span id="xdx_90B_ecustom--ContingentStockLiability_iI_c20211214__us-gaap--TypeOfArrangementAxis__custom--NotePurchaseAgreementMember_zp7B393ZHFh8" title="Contingent stock liability">$<ix:nonFraction name="STSS:ContingentStockLiability" contextRef="AsOf2021-12-14_custom_NotePurchaseAgreementMember" id="Fact000776" format="ixt:numdotdecimal" decimals="0" unitRef="USD">677,000</ix:nonFraction></span>, which was recorded as debt discount. Similarly, a fixed monetary amount further exists at inception
for the total value of Contingent Warrants that may be issued to each Purchaser. Accordingly, a conditional obligation exists and as
such the FMV of Contingent Warrants at inception was $<span id="xdx_908_ecustom--ContingentWarrantLiability_iI_c20211214__us-gaap--TypeOfArrangementAxis__custom--NotePurchaseAgreementMember_zh7oj8PGg1ck" title="Contingent warrants liability"><ix:nonFraction name="STSS:ContingentWarrantLiability" contextRef="AsOf2021-12-14_custom_NotePurchaseAgreementMember" id="Fact000778" format="ixt:numdotdecimal" decimals="0" unitRef="USD">585,000</ix:nonFraction></span>, which was recorded as debt discount. The Company incurred $<span id="xdx_90B_eus-gaap--PaymentsOfDebtIssuanceCosts_c20211213__20211214__us-gaap--TypeOfArrangementAxis__custom--NotePurchaseAgreementMember__srt--TitleOfIndividualAxis__custom--UnrelatedThirdPartyPurchasersMember_ziEU1TLBoVw9" title="Debt issuance costs"><ix:nonFraction name="us-gaap:PaymentsOfDebtIssuanceCosts" contextRef="From2021-12-132021-12-14_custom_NotePurchaseAgreementMember_custom_UnrelatedThirdPartyPurchasersMember" id="Fact000780" format="ixt:numdotdecimal" decimals="0" unitRef="USD">197,500</ix:nonFraction></span> of
debt issuance costs associated with the NPA. The debt issuance costs were allocated between the Notes, Contingent Stock and Contingent
Warrants in a manner that was consistent with the allocation of the proceeds of the Notes. The portion of the debt issuance costs which
were allocated to the Contingent Stock and Contingent Warrants, which was $<span id="xdx_901_ecustom--AllocationOfDebtIssuanceCostToContingentStockAndContingentWarrants_iI_c20211231__us-gaap--TypeOfArrangementAxis__custom--NotePurchaseAgreementMember_zt9cjTpr152i" title="Allocation of debt issuance cost to contingent stock and contingent warrants"><ix:nonFraction name="STSS:AllocationOfDebtIssuanceCostToContingentStockAndContingentWarrants" contextRef="AsOf2021-12-31_custom_NotePurchaseAgreementMember" id="Fact000782" format="ixt:numdotdecimal" decimals="0" unitRef="USD">124,460</ix:nonFraction></span>, was expensed during the year ended December 31, 2021.
The debt issuance costs allocated to the Notes were recorded as a debt discount.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Contingent Stock and Contingent Warrant liabilities were measured at FMV on the date of issuance (based on the Black-Scholes valuation
model).</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">At
inception, the Notes were recorded at the net amount of approximately $<span id="xdx_90D_eus-gaap--NotesPayable_iI_c20211231__us-gaap--TypeOfArrangementAxis__custom--NotePurchaseAgreementMember_zYJ5f1N3ps9j" title="Notes payable"><ix:nonFraction name="us-gaap:NotesPayable" contextRef="AsOf2021-12-31_custom_NotePurchaseAgreementMember" id="Fact000784" format="ixt:numdotdecimal" decimals="0" unitRef="USD">665,000</ix:nonFraction></span>, after adjusting for debt discounts of approximately $<span id="xdx_90C_eus-gaap--DebtInstrumentUnamortizedDiscount_iI_c20211231__us-gaap--TypeOfArrangementAxis__custom--NotePurchaseAgreementMember_zEWqvaCFQ1O1" title="Debt discount"><ix:nonFraction name="us-gaap:DebtInstrumentUnamortizedDiscount" contextRef="AsOf2021-12-31_custom_NotePurchaseAgreementMember" id="Fact000786" format="ixt:numdotdecimal" decimals="0" unitRef="USD">1,335,000</ix:nonFraction></span>
relating to the debt issuance costs, Contingent Stock and Contingent Warrants. Management calculates the effective interest rate (&#8220;EIR&#8221;)
to consider the potential repayment at redemption date by reference to the face value amount after taking into account the stated <span id="xdx_90F_eus-gaap--DebtInstrumentInterestRateStatedPercentage_iI_pid_dp_uPure_c20211231__us-gaap--TypeOfArrangementAxis__custom--NotePurchaseAgreementMember_zINeMPmlZFqg" title="Interest rate"><ix:nonFraction name="us-gaap:DebtInstrumentInterestRateStatedPercentage" contextRef="AsOf2021-12-31_custom_NotePurchaseAgreementMember" id="Fact000788" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">8</ix:nonFraction></span>%
interest rate. In 2022, through the repayment date, the Company recorded interest expense of $<span id="xdx_90E_eus-gaap--InterestExpense_c20220101__20221231__us-gaap--TypeOfArrangementAxis__custom--NotePurchaseAgreementMember_zUqbQ2PaQQ73" title="Interest expense"><ix:nonFraction name="us-gaap:InterestExpense" contextRef="From2022-01-012022-12-31_custom_NotePurchaseAgreementMember" id="Fact000790" format="ixt:numdotdecimal" decimals="0" unitRef="USD">39,111</ix:nonFraction></span> and accreted interest of $<span id="xdx_904_eus-gaap--InterestPayableCurrent_iI_c20221231__us-gaap--TypeOfArrangementAxis__custom--NotePurchaseAgreementMember_zMYXI25GYpsd" title="Accreted interest"><ix:nonFraction name="us-gaap:InterestPayableCurrent" contextRef="AsOf2022-12-31_custom_NotePurchaseAgreementMember" id="Fact000792" format="ixt:numdotdecimal" decimals="0" unitRef="USD">1,299,895</ix:nonFraction></span>
and repaid the $<span id="xdx_901_eus-gaap--RepaymentsOfDebt_c20220101__20221231__us-gaap--TypeOfArrangementAxis__custom--NotePurchaseAgreementMember_zCEEahMCeL1g" title="Notes payable"><ix:nonFraction name="us-gaap:RepaymentsOfDebt" contextRef="From2022-01-012022-12-31_custom_NotePurchaseAgreementMember" id="Fact000794" format="ixt:numdotdecimal" decimals="0" unitRef="USD">2,000,000</ix:nonFraction></span> in Notes with proceeds from the IPO that closed on April 19, 2022.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
value of the Contingent Stock and Contingent Warrants is required to be re-measured at FMV at each reporting date, using either the Black-Scholes
valuation model or other valuation method, if deemed more appropriate, with recognition of the changes in fair value to other income
or expense in the consolidated statement of operations in accordance with ASC 480, Debt and Equity. On April 19, 2022, the Company issued
<span id="xdx_900_eus-gaap--CommonStockSharesIssued_iI_c20220419__us-gaap--TypeOfArrangementAxis__custom--NotePurchaseAgreementMember_z1DOe5O9ZtR2" title="Common stock, shares issued"><ix:nonFraction name="us-gaap:CommonStockSharesIssued" contextRef="AsOf2022-04-19_custom_NotePurchaseAgreementMember" id="Fact000796" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">235,295</ix:nonFraction></span> shares of Common Stock to settle the Contingent Stock liability, re-measured the liability at its estimated FMV based on the
stock&#8217;s trading price and reclassified $<span id="xdx_901_eus-gaap--FairValueAdjustmentOfWarrants_c20220417__20220419__us-gaap--TypeOfArrangementAxis__custom--NotePurchaseAgreementMember_zTEQWt79rGU9" title="Fair market value of warrant"><ix:nonFraction name="us-gaap:FairValueAdjustmentOfWarrants" contextRef="From2022-04-172022-04-19_custom_NotePurchaseAgreementMember" id="Fact000798" format="ixt:numdotdecimal" decimals="0" unitRef="USD">496,000</ix:nonFraction></span> to Common Stock Par Value and Additional Paid in Capital.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
connection with the closing of the IPO, <span id="xdx_906_ecustom--ContingentWarrants_c20220101__20221231__us-gaap--TypeOfArrangementAxis__custom--NotePurchaseAgreementMember__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--NoteWarrantMember_zoNMbOLItd9d" title="Contingent warrant"><ix:nonFraction name="STSS:ContingentWarrants" contextRef="From2022-01-012022-12-31_custom_NotePurchaseAgreementMember_us-gaap_NoteWarrantMember" id="Fact000800" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">235,295</ix:nonFraction></span> warrants were issued to settle the Contingent Warrant liability (&#8220;Note Warrants&#8221;)
with an exercise price of $<span id="xdx_908_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice_c20220101__20221231__us-gaap--TypeOfArrangementAxis__custom--NotePurchaseAgreementMember__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--NoteWarrantMember_zu2ogRvBjg83" title="Exercise price"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice" contextRef="From2022-01-012022-12-31_custom_NotePurchaseAgreementMember_us-gaap_NoteWarrantMember" id="Fact000802" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">4.25</ix:nonFraction></span> adjusted to <span id="xdx_90E_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice_c20230929__20230929__us-gaap--TypeOfArrangementAxis__custom--NotePurchaseAgreementMember__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--NoteWarrantMember_z8wmUF9HzcFg" title="Exercise price">$<ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice" contextRef="From2023-09-292023-09-29_custom_NotePurchaseAgreementMember_us-gaap_NoteWarrantMember" id="Fact000804" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">0.64</ix:nonFraction></span> at September 29, 2023, based on anti-dilution terms in the warrants. The terms of the
Note Warrants continue to require classification as a liability under ASC 815 with recognition of the changes in fair value to other
income or expense in the consolidated statement of operations in accordance with ASC 480 Debt and Equity. (See Notes 8 and 10)</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<ix:exclude><!-- Field: Page; Sequence: 64; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 0pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->16<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%"><a href="#RM_014">Table of Contents</a></td></tr></table></div>
    <!-- Field: /Page --></ix:exclude>
<!-- Field: Split-Segment; Name: 002 -->
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>SHARPS
TECHNOLOGY, INC.</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTES
TO THE CONSOLIDATED FINANCIAL STATEMENTS</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>FOR
THE YEARS ENDED DECEMBER 31, 2023 AND 2022</b></span></p>

<p style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2023-01-012023-12-31" escape="true" id="Fact000806" name="us-gaap:StockholdersEquityNoteDisclosureTextBlock"><p id="xdx_80E_eus-gaap--StockholdersEquityNoteDisclosureTextBlock_zUx2arkJtLq2" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Note
8. <span id="xdx_827_zDDuBTPCQfHe">Stockholders&#8217; Equity</span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Capital
Structure</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
December 11, 2017, the Company was incorporated in Wyoming with <span id="xdx_909_eus-gaap--CommonStockSharesAuthorized_iI_c20171211_zXRQ4AJbPYel" title="Common stock, share authorized"><ix:nonFraction name="us-gaap:CommonStockSharesAuthorized" contextRef="AsOf2017-12-11" id="Fact000808" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">20,000,000</ix:nonFraction></span> shares of common stock authorized with a $<span id="xdx_903_eus-gaap--CommonStockParOrStatedValuePerShare_iI_c20171211_zwMurzbuPL5j" title="Common stock, par value"><ix:nonFraction name="us-gaap:CommonStockParOrStatedValuePerShare" contextRef="AsOf2017-12-11" id="Fact000810" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">0.0001</ix:nonFraction></span> par value.
Effective, April 18, 2019, the Company&#8217;s authorized common stock was increased to <span id="xdx_90F_eus-gaap--CommonStockSharesAuthorized_iI_c20190418_zhJZrLzOcNi6" title="Common stock, share authorized"><ix:nonFraction name="us-gaap:CommonStockSharesAuthorized" contextRef="AsOf2019-04-18" id="Fact000812" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">50,000,000</ix:nonFraction></span> shares of common stock. The articles
of incorporation also authorized <span id="xdx_90B_eus-gaap--PreferredStockSharesAuthorized_iI_c20190418_zd2nHb8NgPrh" title="Preferred stock, shares authorized"><ix:nonFraction name="us-gaap:PreferredStockSharesAuthorized" contextRef="AsOf2019-04-18" id="Fact000814" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">10,000</ix:nonFraction></span> preferred shares with a $<span id="xdx_906_eus-gaap--PreferredStockParOrStatedValuePerShare_iI_c20190418_zlxVAKE7IUzl" title="Preferred stock, par value"><ix:nonFraction name="us-gaap:PreferredStockParOrStatedValuePerShare" contextRef="AsOf2019-04-18" id="Fact000816" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">0.001</ix:nonFraction></span> par value.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Effective
March 22, 2022, the Company completed a plan and agreement of merger with Sharps Technology, Inc., a Nevada corporation (&#8220;Sharps
Nevada&#8221;). <span id="xdx_900_eus-gaap--ConversionOfStockDescription_c20220319__20220322_zRTCW2lPIq08" title="Conversion of stock, description"><ix:nonNumeric contextRef="From2022-03-192022-03-22" id="Fact000818" name="us-gaap:ConversionOfStockDescription">Pursuant to the merger agreement, (i) the Company merged with and into Sharps Nevada, (ii) each 3.5 shares of common
stock of the Company were converted into one share of common stock of Sharps Nevada and (iii) the articles of incorporation and bylaws
of Sharps Nevada, became the articles of incorporation and bylaws of the surviving corporation.</ix:nonNumeric></span> The Company&#8217;s authorized common
stock and preferred stock increased from <span id="xdx_90E_eus-gaap--CommonStockSharesAuthorized_iI_c20220321_zqWIuaVMR1ab" title="Common stock, share authorized"><ix:nonFraction name="us-gaap:CommonStockSharesAuthorized" contextRef="AsOf2022-03-21" id="Fact000820" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">50,000,000</ix:nonFraction></span> to <span id="xdx_900_eus-gaap--CommonStockSharesAuthorized_iI_c20231231_zKr6XrguyaE5" title="Common stock, share authorized"><ix:nonFraction name="us-gaap:CommonStockSharesAuthorized" contextRef="AsOf2023-12-31" id="Fact000822" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">100,000,000</ix:nonFraction></span> and <span id="xdx_90E_eus-gaap--PreferredStockSharesAuthorized_iI_c20220321_z02GsXf6DB4i" title="Preferred stock, shares authorized"><ix:nonFraction name="us-gaap:PreferredStockSharesAuthorized" contextRef="AsOf2022-03-21" id="Fact000824" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">10,000</ix:nonFraction></span> to <span id="xdx_900_eus-gaap--PreferredStockSharesAuthorized_iI_c20231231_zbGgSgndPBZ3" title="Preferred stock, shares authorized"><ix:nonFraction name="us-gaap:PreferredStockSharesAuthorized" contextRef="AsOf2023-12-31" id="Fact000826" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">1,000,000</ix:nonFraction></span> shares, respectively. The par value of preferred
stock decreased from $<span id="xdx_900_eus-gaap--PreferredStockParOrStatedValuePerShare_iI_c20220321_zUiO4KHVaUGf" title="Preferred stock, par value"><ix:nonFraction name="us-gaap:PreferredStockParOrStatedValuePerShare" contextRef="AsOf2022-03-21" id="Fact000828" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">0.001</ix:nonFraction></span> to $<span id="xdx_90B_eus-gaap--PreferredStockParOrStatedValuePerShare_iI_c20231231_zH9iCouNVhwg" title="Preferred stock, par value"><ix:nonFraction name="us-gaap:PreferredStockParOrStatedValuePerShare" contextRef="AsOf2023-12-31" id="Fact000830" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">0.0001</ix:nonFraction></span> per share.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>&#160;</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Common
Stock</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
September 29, 2023, the Company completed two simultaneous offerings and received aggregate gross proceeds of approximately $<span id="xdx_904_eus-gaap--ProceedsFromIssuanceOfCommonStock_pn5n6_c20230929__20230929_zYKahFVLFYRd" title="Gross proceeds"><ix:nonFraction name="us-gaap:ProceedsFromIssuanceOfCommonStock" contextRef="From2023-09-292023-09-29" id="Fact000832" format="ixt:numdotdecimal" decimals="-5" scale="6" unitRef="USD">5.6</ix:nonFraction> </span>million,
before expenses to the placement agent and other offering expenses of $<span id="xdx_902_eus-gaap--OtherExpenses_c20230929__20230929_zSC9FNlo8Kq8" title="Other offering expenses"><ix:nonFraction name="us-gaap:OtherExpenses" contextRef="From2023-09-292023-09-29" id="Fact000834" format="ixt:numdotdecimal" decimals="0" unitRef="USD">716,000</ix:nonFraction></span>.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">a.</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
    first offering, the securities purchase agreement offering (the &#8220;Shelf Offering&#8221;) with institutional investors and the
    Company resulted in the Company receiving net proceeds from the Shelf Offering and the sale of pre-funded warrants of approximately
    $<span id="xdx_906_eus-gaap--ProceedsFromIssuanceInitialPublicOffering_pn5n6_c20230929__20230929__us-gaap--SubsidiarySaleOfStockAxis__custom--ShelfOfferingMember__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember_zTu5kue36XS8" title="Net proceeds from the Shelf Offering"><ix:nonFraction name="us-gaap:ProceedsFromIssuanceInitialPublicOffering" contextRef="From2023-09-292023-09-29_custom_ShelfOfferingMember_custom_SecuritiesPurchaseAgreementMember" id="Fact000836" format="ixt:numdotdecimal" decimals="-5" scale="6" unitRef="USD">2.5</ix:nonFraction> </span>million,
    includes the value of the pre-funded warrants recorded in Additional Paid in Capital, net of $<span id="xdx_90B_eus-gaap--LegalFees_c20230929__20230929__us-gaap--SubsidiarySaleOfStockAxis__custom--ShelfOfferingMember__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember_zI2yRFb39Paf" title="Net fees"><ix:nonFraction name="us-gaap:LegalFees" contextRef="From2023-09-292023-09-29_custom_ShelfOfferingMember_custom_SecuritiesPurchaseAgreementMember" id="Fact000838" format="ixt:numdotdecimal" decimals="0" unitRef="USD">362,000</ix:nonFraction></span>
    in fees relating to the placement agent and other offering expenses. The Shelf Offering was priced at the market under Nasdaq rules.
    In connection with the Shelf Offering, the Company issued <span id="xdx_907_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_c20230929__20230929__us-gaap--SubsidiarySaleOfStockAxis__custom--ShelfOfferingMember__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember_z8GHUbCSXj" title="Shares issued"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodSharesNewIssues" contextRef="From2023-09-292023-09-29_custom_ShelfOfferingMember_custom_SecuritiesPurchaseAgreementMember" id="Fact000840" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">3,618,521</ix:nonFraction></span>
    shares of common at a purchase price of $<span id="xdx_90A_eus-gaap--SharesIssuedPricePerShare_iI_c20230929__us-gaap--SubsidiarySaleOfStockAxis__custom--ShelfOfferingMember__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember_z3RZkDYhS8wl" title="Purchase price"><ix:nonFraction name="us-gaap:SharesIssuedPricePerShare" contextRef="AsOf2023-09-29_custom_ShelfOfferingMember_custom_SecuritiesPurchaseAgreementMember" id="Fact000842" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">0.64</ix:nonFraction></span>
    per unit and <span id="xdx_903_eus-gaap--ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight_iI_c20230929__us-gaap--SubsidiarySaleOfStockAxis__custom--ShelfOfferingMember__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_zLtKnbYObrJb" title="Prefunded warrants"><ix:nonFraction name="us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight" contextRef="AsOf2023-09-29_custom_ShelfOfferingMember_custom_SecuritiesPurchaseAgreementMember_us-gaap_WarrantMember" id="Fact000844" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">800,000</ix:nonFraction></span>
    pre-funded warrants at $<span id="xdx_901_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_c20230929__us-gaap--SubsidiarySaleOfStockAxis__custom--ShelfOfferingMember__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_z2wcn5m3ZUed" title="Exercise price"><ix:nonFraction name="us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" contextRef="AsOf2023-09-29_custom_ShelfOfferingMember_custom_SecuritiesPurchaseAgreementMember_us-gaap_WarrantMember" id="Fact000846" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">0.639</ix:nonFraction></span>
    per pre-funded warrants. The exercise price of the pre-funded warrants will be $<span id="xdx_907_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_c20230929__us-gaap--SubsidiarySaleOfStockAxis__custom--ShelfOfferingMember__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember_zMcXQ1u7TWj3" title="Exercise price"><ix:nonFraction name="us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" contextRef="AsOf2023-09-29_custom_ShelfOfferingMember_custom_SecuritiesPurchaseAgreementMember" id="Fact000848" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">0.001</ix:nonFraction></span>
    per share.</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">b.</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The second offering, the
    securities purchase agreement offering (&#8220;Private Placement&#8221;) with institutional investors and the Company received net
    proceeds from the Private Placement of approximately $<span id="xdx_906_eus-gaap--ProceedsFromIssuanceOfPrivatePlacement_pn5n6_c20230929__20230929__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--PrivatePlacementMember__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember_zXZJYIRsMLId" title="Net proceeds from the Private Placement"><ix:nonFraction name="us-gaap:ProceedsFromIssuanceOfPrivatePlacement" contextRef="From2023-09-292023-09-29_us-gaap_PrivatePlacementMember_custom_SecuritiesPurchaseAgreementMember" id="Fact000850" format="ixt:numdotdecimal" decimals="-5" scale="6" unitRef="USD">2.4</ix:nonFraction></span> million, net of $<span id="xdx_90F_eus-gaap--LegalFees_c20230929__20230929__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--PrivatePlacementMember__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember_zlAFHAVIVlrl" title="Net fees"><ix:nonFraction name="us-gaap:LegalFees" contextRef="From2023-09-292023-09-29_us-gaap_PrivatePlacementMember_custom_SecuritiesPurchaseAgreementMember" id="Fact000852" format="ixt:numdotdecimal" decimals="0" unitRef="USD">354,000</ix:nonFraction></span> in fees relating to the placement agent and other
    offering expenses. In connection with the Private Placement, the Company issued: (i) <span id="xdx_901_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_c20230929__20230929__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--PrivatePlacementMember__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__us-gaap--StatementEquityComponentsAxis__custom--PIPEPreFundedWarrantsMember_z15DD4ln76Pf" title="PIPE shares"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodSharesNewIssues" contextRef="From2023-09-292023-09-29_us-gaap_PrivatePlacementMember_custom_SecuritiesPurchaseAgreementMember_custom_PIPEPreFundedWarrantsMember" id="Fact000854" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">2,581,479</ix:nonFraction></span> PIPE Shares (or PIPE Pre-Funded Warrants
    in lieu thereof) and (ii) PIPE Warrants (non-trading) to purchase <span id="xdx_902_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_pid_c20230929__20230929__us-gaap--SubsidiarySaleOfStockAxis__custom--NonTradingWarrantsMember_zF7aBomdByx1" title="Issuance of warrants"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodSharesNewIssues" contextRef="From2023-09-292023-09-29_custom_NonTradingWarrantsMember" id="Fact000856" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">8,750,003</ix:nonFraction></span> shares of our common stock, at a combined purchase price
    of $<span id="xdx_90E_eus-gaap--SharesIssuedPricePerShare_iI_c20230203__us-gaap--TypeOfArrangementAxis__custom--PurchaseAgreementMember__us-gaap--SubsidiarySaleOfStockAxis__custom--SecuritiesPurchaseAgreementMember__us-gaap--StatementEquityComponentsAxis__custom--PIPEPreFundedWarrantsMember_zqv98FUv5Cni" title="Shares issued price per share"><ix:nonFraction name="us-gaap:SharesIssuedPricePerShare" contextRef="AsOf2023-02-03_custom_PurchaseAgreementMember_custom_SecuritiesPurchaseAgreementMember_custom_PIPEPreFundedWarrantsMember" id="Fact000858" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">1.074</ix:nonFraction></span> per unit (or $1.073 per pre-funded unit). The PIPE Warrants have a term of five and one-half (<span id="xdx_908_eus-gaap--WarrantsAndRightsOutstandingTerm_iI_dtY_c20230929__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--PrivatePlacementMember__us-gaap--StatementEquityComponentsAxis__custom--PIPEPreFundedWarrantsMember_zHZTCxNDSJt3" title="Warrant term"><ix:nonNumeric contextRef="AsOf2023-09-29_custom_SecuritiesPurchaseAgreementMember_us-gaap_PrivatePlacementMember_custom_PIPEPreFundedWarrantsMember" format="ixt-sec:duryear" id="Fact000860" name="us-gaap:WarrantsAndRightsOutstandingTerm">5.5</ix:nonNumeric></span>) years from the issuance
    date and are exercisable for one share of common stock at an exercise price of $<span id="xdx_906_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_c20230929__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__us-gaap--StatementEquityComponentsAxis__custom--PIPEPreFundedWarrantsMember__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--PrivatePlacementMember_zVyh5j3TiDkd" title="Warrant exerice price"><ix:nonFraction name="us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" contextRef="AsOf2023-09-29_custom_SecuritiesPurchaseAgreementMember_us-gaap_PrivatePlacementMember_custom_PIPEPreFundedWarrantsMember" id="Fact000862" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">0.64</ix:nonFraction></span>. The net proceeds, after reflecting par value,
    has been recorded in Additional Paid in Capital of $<span id="xdx_909_eus-gaap--AdditionalPaidInCapital_iI_pn5n6_c20230929__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--PrivatePlacementMember__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember_zT7829pxvWjl" title="Additional paid in capital"><ix:nonFraction name="us-gaap:AdditionalPaidInCapital" contextRef="AsOf2023-09-29_us-gaap_PrivatePlacementMember_custom_SecuritiesPurchaseAgreementMember" id="Fact000864" format="ixt:numdotdecimal" decimals="-5" scale="6" unitRef="USD">1.6</ix:nonFraction> </span>million and with respect to the PIPE Warrants recorded as a liability under
    ASC 815 of $<span id="xdx_908_eus-gaap--FairValueAdjustmentOfWarrants_c20230929__20230929__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--PrivatePlacementMember__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember_zi2YNCQgSb8d" title="Warrants liability"><ix:nonFraction name="us-gaap:FairValueAdjustmentOfWarrants" contextRef="From2023-09-292023-09-29_us-gaap_PrivatePlacementMember_custom_SecuritiesPurchaseAgreementMember" id="Fact000866" format="ixt:numdotdecimal" decimals="0" unitRef="USD">985,204</ix:nonFraction></span>. On October 16, 2023, the Company filed an S-1 (Resale) Registration Statement in connection with the Private
    Placement and on October 26, 2023 the S-1 went effective. At December 31, 2023, the warrant liability is $<span id="xdx_908_eus-gaap--WarrantsAndRightsOutstanding_iI_c20231231__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--PrivatePlacementMember__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember_zPDkjUEgFjW8" title="Warrants liability"><ix:nonFraction name="us-gaap:WarrantsAndRightsOutstanding" contextRef="AsOf2023-12-31_us-gaap_PrivatePlacementMember_custom_SecuritiesPurchaseAgreementMember" id="Fact000868" format="ixt:numdotdecimal" decimals="0" unitRef="USD">1,036,875</ix:nonFraction></span>. (See Notes 8
    and 10). </span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
February 3, 2023, the Company completed a securities purchase agreement (&#8220;Offering&#8221;) with institutional investors and received
net proceeds from the Offering were approximately $<span id="xdx_90D_ecustom--NetProceedsFromIssuanceInitialPublicOffering_pn5n6_c20230201__20230203__us-gaap--TypeOfArrangementAxis__custom--PurchaseAgreementMember_z02g5b06SaD2" title="Net proceeds from offering"><ix:nonFraction name="STSS:NetProceedsFromIssuanceInitialPublicOffering" contextRef="From2023-02-012023-02-03_custom_PurchaseAgreementMember" id="Fact000870" format="ixt:numdotdecimal" decimals="-5" scale="6" unitRef="USD">3.2</ix:nonFraction></span> million, net of $<span id="xdx_906_eus-gaap--NoninterestExpenseOfferingCost_c20230201__20230203__us-gaap--TypeOfArrangementAxis__custom--PurchaseAgreementMember_znPveh7iLx48" title="Offering expenses"><ix:nonFraction name="us-gaap:NoninterestExpenseOfferingCost" contextRef="From2023-02-012023-02-03_custom_PurchaseAgreementMember" id="Fact000872" format="ixt:numdotdecimal" decimals="0" unitRef="USD">600,000</ix:nonFraction></span> in fees relating to the placement agent and other offering
expenses. The Offering was priced at the market under Nasdaq rules. In connection with the Offering, the Company issued <span id="xdx_904_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_c20230201__20230203__us-gaap--TypeOfArrangementAxis__custom--PurchaseAgreementMember_zJXhUki3jsp3" title="Shares issued"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodSharesNewIssues" contextRef="From2023-02-012023-02-03_custom_PurchaseAgreementMember" id="Fact000874" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">2,248,521</ix:nonFraction></span> units
at a purchase price of $<span id="xdx_90C_eus-gaap--SharesIssuedPricePerShare_iI_c20230203__us-gaap--TypeOfArrangementAxis__custom--PurchaseAgreementMember_z0TpS9HFbIfa" title="Shares issued price per share"><ix:nonFraction name="us-gaap:SharesIssuedPricePerShare" contextRef="AsOf2023-02-03_custom_PurchaseAgreementMember" id="Fact000876" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">1.69</ix:nonFraction></span> per unit. Each unit consists of one share of common stock and one non-tradable warrant exercisable for one
share of common stock at a price of $<span id="xdx_905_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_c20230203__us-gaap--TypeOfArrangementAxis__custom--PurchaseAgreementMember_zLrpt5IcwEv7" title="Warrant exerice price"><ix:nonFraction name="us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" contextRef="AsOf2023-02-03_custom_PurchaseAgreementMember" id="Fact000878" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">1.56</ix:nonFraction></span>, adjusted to $<span id="xdx_906_ecustom--ClassOfWarrantOrRightExercisePriceOfWarrantsAdjusted_iI_c20230929__us-gaap--TypeOfArrangementAxis__custom--PurchaseAgreementMember_z0stdfsrlADk" title="Warrant exerice price"><ix:nonFraction name="STSS:ClassOfWarrantOrRightExercisePriceOfWarrantsAdjusted" contextRef="AsOf2023-09-29_custom_PurchaseAgreementMember" id="Fact000880" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">0.64</ix:nonFraction></span> at September 29, 2023, based on anti-dilution terms in the warrants. The
warrants have a term of five years from the issuance date. On February 13, 2023, the Company filed an S-1 (Resale) Registration Statement
in connection with the Offering.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
April 13, 2022, the Company&#8217;s initial public offering (&#8220;IPO&#8221;) was declared effective by the SEC pursuant to which the
Company issued and sold an aggregate of <span id="xdx_908_ecustom--StockIssuedDuringPeriodSharesInitialPublicOffering_c20220411__20220413__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_zTStDgZNt6Ib" title="Initial public offering"><ix:nonFraction name="STSS:StockIssuedDuringPeriodSharesInitialPublicOffering" contextRef="From2022-04-112022-04-13_us-gaap_WarrantMember" id="Fact000882" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">3,750,000</ix:nonFraction></span> units (&#8220;Units&#8221;), each consisting of one share of common stock and two warrants,
to purchase one share of common stock for each whole warrant, with an initial exercise price of $<span id="xdx_906_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice_pid_c20220411__20220413__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_zeBqcDbb1GG1" title="Exercise price"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice" contextRef="From2022-04-112022-04-13_us-gaap_WarrantMember" id="Fact000884" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">4.25</ix:nonFraction></span> per share and a term of <span id="xdx_900_eus-gaap--WarrantsAndRightsOutstandingTerm_iI_dc_c20220413__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_zl4vuM4lSJS7" title="Warrants exercise price term"><ix:nonNumeric contextRef="AsOf2022-04-13_us-gaap_WarrantMember" format="ixt-sec:durwordsen" id="Fact000886" name="us-gaap:WarrantsAndRightsOutstandingTerm">five years</ix:nonNumeric></span>.
In addition, the Company granted Aegis Capital Corp., as underwriter a 45-day over-allotment option to purchase up to 15% of the number
of shares included in the units sold in the offering, and/or additional warrants equal to 15% of the number of Warrants included in the
units sold in the offering, in each case solely to cover over-allotments, which the Aegis Capital Corp. partially exercised with respect
to <span id="xdx_90A_eus-gaap--ClassOfWarrantOrRightOutstanding_iI_c20220419__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_zmyWhszUPMjl" title="Warrants exercised"><ix:nonFraction name="us-gaap:ClassOfWarrantOrRightOutstanding" contextRef="AsOf2022-04-19_us-gaap_WarrantMember" id="Fact000888" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">1,125,000</ix:nonFraction></span> warrants on April 19, 2022.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"></p>

<ix:exclude><!-- Field: Page; Sequence: 65; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 0pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->17<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%"><a href="#RM_014">Table of Contents</a></td></tr></table></div>
    <!-- Field: /Page --></ix:exclude>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>SHARPS
TECHNOLOGY, INC.</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTES
TO THE CONSOLIDATED FINANCIAL STATEMENTS</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>FOR
THE YEARS ENDED DECEMBER 31, 2023 AND 2022</b></span></p>

<p style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Note
8. Stockholders&#8217; Equity (continued)</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company&#8217;s common stock and warrants began trading on the Nasdaq Capital Market or Nasdaq on April 14, 2022. The net proceeds from
the IPO, prior to payments of certain listing and professional fees were approximately $<span id="xdx_90F_eus-gaap--ProceedsFromIssuanceInitialPublicOffering_pn5n6_c20220412__20220414__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--IPOMember_zlJEEwRhOnxk" title="Net proceeds from IPO"><ix:nonFraction name="us-gaap:ProceedsFromIssuanceInitialPublicOffering" contextRef="From2022-04-122022-04-14_us-gaap_IPOMember" id="Fact000890" format="ixt:numdotdecimal" decimals="-5" scale="6" unitRef="USD">14.2</ix:nonFraction></span> million. The net proceeds, after reflecting
par value, has been recorded in Additional Paid in Capital of $<span id="xdx_90D_eus-gaap--AdditionalPaidInCapital_iI_pn5n6_c20220414_zgjY5SnP4yTi" title="Additional paid in capital"><ix:nonFraction name="us-gaap:AdditionalPaidInCapital" contextRef="AsOf2022-04-14" id="Fact000892" format="ixt:numdotdecimal" decimals="-5" scale="6" unitRef="USD">9.0</ix:nonFraction></span> million and with respect to the Warrants as a liability under ASC
815 of $<span id="xdx_90F_eus-gaap--FairValueAdjustmentOfWarrants_pn5n6_c20220412__20220414_zYwV2UNmH7U7" title="Warrants liability"><ix:nonFraction name="us-gaap:FairValueAdjustmentOfWarrants" contextRef="From2022-04-122022-04-14" id="Fact000894" format="ixt:numdotdecimal" decimals="-5" scale="6" unitRef="USD">5.2</ix:nonFraction></span>M. (See Note 10)</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">During
the year ended December 31, 2022, the Company issued <span id="xdx_90F_eus-gaap--StockIssuedDuringPeriodSharesIssuedForServices_c20220101__20221231_zpVdD8C9ruH1" title="Common stock issued for services, shares"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodSharesIssuedForServices" contextRef="From2022-01-012022-12-31" id="Fact000896" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">235,000</ix:nonFraction></span> shares of common stock at the trading stock price in connection with services
provided to the Company and recorded a charge of $<span id="xdx_90A_eus-gaap--StockIssuedDuringPeriodValueIssuedForServices_c20220101__20221231_ztMvifOMz3Z6" title="Common stock issued for services, value"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueIssuedForServices" contextRef="From2022-01-012022-12-31" id="Fact000898" format="ixt:numdotdecimal" decimals="0" unitRef="USD">290,551</ix:nonFraction></span>, In addition, the Company issued <span id="xdx_90C_eus-gaap--StockIssuedDuringPeriodSharesIssuedForServices_c20220101__20221231__us-gaap--TypeOfArrangementAxis__custom--NotePurchaseAgreementMember_zizbjT07WXd4" title="Common stock issued for services, shares"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodSharesIssuedForServices" contextRef="From2022-01-012022-12-31_custom_NotePurchaseAgreementMember" id="Fact000900" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">235,295</ix:nonFraction></span> common shares relating to the Note
Purchase agreement. (See Note 7)</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Warrants</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">a)
                                                                              In connection with a one-year advisory services arrangement entered into in April 2023, the Company issued <span id="xdx_909_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_pid_c20230101__20231231__us-gaap--SubsidiarySaleOfStockAxis__custom--NonTradingWarrantsMember_zELgINyTRe3l" title="Issuance of warrants"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodSharesNewIssues" contextRef="From2023-01-012023-12-31_custom_NonTradingWarrantsMember" id="Fact000902" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">495,000</ix:nonFraction></span>
                                                                              warrants during the year ended December 31, 2023 at an exercise price of $<span id="xdx_90E_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_pid_c20231231__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--NoteWarrantMember_zfj84Rof6t3l" title="Exercise price"><ix:nonFraction name="us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" contextRef="AsOf2023-12-31_us-gaap_NoteWarrantMember" id="Fact000904" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">1.56</ix:nonFraction></span>.
                                                                              The warrants have a three-year term and were fully vested on issuance. The FMV of the warrants recorded for the year end ended
                                                                              December 31, 2023 was $<span id="xdx_901_eus-gaap--FairValueAdjustmentOfWarrants_c20230101__20231231_zIYSKGXPApI3" title="Fair value adjustment of warrants"><ix:nonFraction name="us-gaap:FairValueAdjustmentOfWarrants" contextRef="From2023-01-012023-12-31" id="Fact000906" format="ixt:numdotdecimal" decimals="0" unitRef="USD">42,915</ix:nonFraction></span>
                                                                              as computed using the Black Sholes valuation model. The assumptions for the year ended December 31, 2023 were: a) expected term
                                                                              &#8211; <span id="xdx_904_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_dtY_c20230101__20231231_zeP98f22ATXg" title="Expected term"><ix:nonNumeric contextRef="From2023-01-012023-12-31" format="ixt-sec:duryear" id="Fact000908" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1">3</ix:nonNumeric></span>
                                                                              years, b) expected volatility &#8211; <span id="xdx_900_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum_pid_dp_uPure_c20230101__20231231_z1bbxmYc29mg" title="Volatility, minimum"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum" contextRef="From2023-01-012023-12-31" id="Fact000910" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">24.49</ix:nonFraction></span>%
                                                                              to <span id="xdx_900_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum_pid_dp_uPure_c20230101__20231231_zbD4y9mhK2ij" title="Volatility, maximum"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum" contextRef="From2023-01-012023-12-31" id="Fact000912" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">44.83</ix:nonFraction></span>%,
                                                                              c) risk free rate- <span id="xdx_90B_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum_pid_dp_uPure_c20230101__20231231_zWi8cNWnaqwk" title="Risk free interest rate, minimum"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum" contextRef="From2023-01-012023-12-31" id="Fact000914" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">3.58</ix:nonFraction></span>%
                                                                              to <span id="xdx_90F_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum_pid_dp_uPure_c20230101__20231231_zv9rdpUvMzDf" title="Risk free interest rate, maximum"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum" contextRef="From2023-01-012023-12-31" id="Fact000916" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">4.67</ix:nonFraction></span>.%
                                                                              and d) dividend rate &#8211; <span id="xdx_905_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_pid_dp_uPure_c20230101__20231231_zdgoHMxRYC8i" title="Dividend rate"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" contextRef="From2023-01-012023-12-31" id="Fact000918" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">0</ix:nonFraction></span>%.</span></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">b)
    In connection with the Private Placement in September 2023, the Company issued <span id="xdx_904_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_pid_c20230901__20230930__us-gaap--SubsidiarySaleOfStockAxis__custom--NonTradingWarrantsMember_zgso18xUuiR2" title="Issuance of warrants"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodSharesNewIssues" contextRef="From2023-09-012023-09-30_custom_NonTradingWarrantsMember" id="Fact000920" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">8,750,003</ix:nonFraction></span> non-trading PIPE Warrants as a component
    of the Unit as noted in Common Stock above. The PIPE Warrants were recorded at the FMV, computed using the Black Sholes valuation
    method. The PIPE Warrant&#8217;s liability requires remeasurement at each reporting period. The PIPE Warrants are classified as a
    liability based on ASC 815. At the issuance date and December 31, 2023, the liability was $<span id="xdx_90B_eus-gaap--WarrantsAndRightsOutstanding_iI_c20230929__us-gaap--SubsidiarySaleOfStockAxis__custom--NonTradingWarrantsMember__us-gaap--StatementEquityComponentsAxis__custom--PIPEWarrantMember_z5DPxJD7guRj" title="Warrant liability"><ix:nonFraction name="us-gaap:WarrantsAndRightsOutstanding" contextRef="AsOf2023-09-29_custom_NonTradingWarrantsMember_custom_PIPEWarrantMember" id="Fact000922" format="ixt:numdotdecimal" decimals="0" unitRef="USD">985,204</ix:nonFraction></span> and $<span id="xdx_903_eus-gaap--WarrantsAndRightsOutstanding_iI_c20231231__us-gaap--SubsidiarySaleOfStockAxis__custom--NonTradingWarrantsMember__us-gaap--StatementEquityComponentsAxis__custom--PIPEWarrantMember_z3oaGHVnP3Uc" title="Warrant liability"><ix:nonFraction name="us-gaap:WarrantsAndRightsOutstanding" contextRef="AsOf2023-12-31_custom_NonTradingWarrantsMember_custom_PIPEWarrantMember" id="Fact000924" format="ixt:numdotdecimal" decimals="0" unitRef="USD">1,036,875</ix:nonFraction></span>, respectively and
    for the year ended December 31, 2023 a FMV loss adjustment of $<span id="xdx_905_eus-gaap--MarketRiskBenefitChangeInFairValueGainLoss_c20230101__20231231__us-gaap--SubsidiarySaleOfStockAxis__custom--NonTradingWarrantsMember__us-gaap--StatementEquityComponentsAxis__custom--PIPEWarrantMember_zxvFZGyJqz21" title="Fair market value adjustment"><ix:nonFraction name="us-gaap:MarketRiskBenefitChangeInFairValueGainLoss" contextRef="From2023-01-012023-12-31_custom_NonTradingWarrantsMember_custom_PIPEWarrantMember" id="Fact000926" format="ixt:numdotdecimal" decimals="0" unitRef="USD">51,671</ix:nonFraction></span> was recorded (See Note 10).</span></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">c)
    In connection with the Offering in February 2023, the Company issued <span id="xdx_904_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_pid_c20230201__20230228__us-gaap--SubsidiarySaleOfStockAxis__custom--NonTradingWarrantsMember_zH3NyuLUatJe" title="Issuance of warrants"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodSharesNewIssues" contextRef="From2023-02-012023-02-28_custom_NonTradingWarrantsMember" id="Fact000928" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">2,248,521</ix:nonFraction></span> non-trading warrants Offering Warrants as a component
    of the Unit as noted in Common Stock above. The Offering Warrant&#8217;s liability requires remeasurement at each reporting period.
    The Offering Warrants were recorded at the FMV, computed using the Black Sholes valuation method. The Offering Warrants are classified
    as a liability based on ASC 815. At the issuance date and at December 31, 2023 the liability was $<span id="xdx_90A_eus-gaap--WarrantsAndRightsOutstanding_iI_c20230228__us-gaap--SubsidiarySaleOfStockAxis__custom--NonTradingWarrantsMember_zcOYbfymT5Y4" title="Warrants liability"><ix:nonFraction name="us-gaap:WarrantsAndRightsOutstanding" contextRef="AsOf2023-02-28_custom_NonTradingWarrantsMember" id="Fact000930" format="ixt:numdotdecimal" decimals="0" unitRef="USD">455,326</ix:nonFraction></span> and $<span id="xdx_909_eus-gaap--WarrantsAndRightsOutstanding_iI_c20231231__us-gaap--SubsidiarySaleOfStockAxis__custom--NonTradingWarrantsMember_zyTwSDCYZzh" title="Warrants liability"><ix:nonFraction name="us-gaap:WarrantsAndRightsOutstanding" contextRef="AsOf2023-12-31_custom_NonTradingWarrantsMember" id="Fact000932" format="ixt:numdotdecimal" decimals="0" unitRef="USD">234,072</ix:nonFraction></span>, respectively.
    During the year ended December 31, 2023, the Company recorded a FMV gain adjustment of $<span id="xdx_904_eus-gaap--FairValueAdjustmentOfWarrants_c20230101__20231231__us-gaap--SubsidiarySaleOfStockAxis__custom--NonTradingWarrantsMember_zl0ywqe0H9z4" title="FMV gain adjustment"><ix:nonFraction name="us-gaap:FairValueAdjustmentOfWarrants" contextRef="From2023-01-012023-12-31_custom_NonTradingWarrantsMember" id="Fact000934" format="ixt:numdotdecimal" decimals="0" unitRef="USD">221,254</ix:nonFraction></span>. (See Note 10).</span></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">d)
    In connection with the IPO in April 2022, the Company issued <span id="xdx_90F_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_pid_c20220401__20220430__us-gaap--SubsidiarySaleOfStockAxis__custom--TradingWarrantsMember_znjXLidnQO22" title="Issuance of warrants"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodSharesNewIssues" contextRef="From2022-04-012022-04-30_custom_TradingWarrantsMember" id="Fact000936" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">7,500,000</ix:nonFraction></span>
    warrants (Trading Warrants) as a component of the Units and <span id="xdx_907_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_pid_c20220401__20220430__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--OverAllotmentOptionMember_zZkqoNebekPi" title="Issuance of warrants"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodSharesNewIssues" contextRef="From2022-04-012022-04-30_us-gaap_OverAllotmentOptionMember" id="Fact000938" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">1,125,000</ix:nonFraction></span>
    warrants to the underwriter (Overallotment Warrants), as noted in Common Stock above. The Trading and Overallotment Warrants were
    recorded at the FMV, being the trading price of the warrants, on the IPO effective date and the Warrants are classified as a
    Liability based on ASC 815. The Warrant liability requires remeasurement at each reporting period. At December 31, 2023 and 2022,
    the liability was $<span id="xdx_903_eus-gaap--WarrantsAndRightsOutstanding_iI_c20231231__us-gaap--SubsidiarySaleOfStockAxis__custom--TradingWarrantsMember_zMVfHLRw4r6e" title="Warrants liability"><span id="xdx_909_eus-gaap--WarrantsAndRightsOutstanding_iI_c20221231__us-gaap--SubsidiarySaleOfStockAxis__custom--TradingWarrantsMember_zYfUFBuwMDa6" title="Warrants liability"><ix:nonFraction name="us-gaap:WarrantsAndRightsOutstanding" contextRef="AsOf2023-12-31_custom_TradingWarrantsMember" id="Fact000940" format="ixt:numdotdecimal" decimals="0" unitRef="USD"><ix:nonFraction name="us-gaap:WarrantsAndRightsOutstanding" contextRef="AsOf2022-12-31_custom_TradingWarrantsMember" id="Fact000942" format="ixt:numdotdecimal" decimals="0" unitRef="USD">1,121,250</ix:nonFraction></ix:nonFraction></span></span>.
    During years ended December 31, 2023 and 2022, the Company recorded a FMV loss (gain) adjustment of $<span id="xdx_903_eus-gaap--FairValueAdjustmentOfWarrants_c20230101__20231231__us-gaap--SubsidiarySaleOfStockAxis__custom--TradingWarrantsMember_zVxkcAIjVx79" title="Fair value income adjustment"><ix:nonFraction name="us-gaap:FairValueAdjustmentOfWarrants" contextRef="From2023-01-012023-12-31_custom_TradingWarrantsMember" id="Fact000944" format="ixt:numdotdecimal" decimals="0" unitRef="USD">0</ix:nonFraction></span>
    and $(<span id="xdx_903_eus-gaap--FairValueAdjustmentOfWarrants_c20220101__20221231__us-gaap--SubsidiarySaleOfStockAxis__custom--TradingWarrantsMember_z4OtSAVVHNo5" title="Fair value income adjustment"><ix:nonFraction name="us-gaap:FairValueAdjustmentOfWarrants" contextRef="From2022-01-012022-12-31_custom_TradingWarrantsMember" id="Fact000946" format="ixt:numdotdecimal" decimals="0" unitRef="USD">4,784,559</ix:nonFraction></span>), <span>respectively</span>
    (See Note 10).</span></p></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<ix:exclude><!-- Field: Page; Sequence: 66; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 0pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->18<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%"><a href="#RM_014">Table of Contents</a></td></tr></table></div>
    <!-- Field: /Page --></ix:exclude>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>SHARPS
TECHNOLOGY, INC.</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTES
TO THE CONSOLIDATED FINANCIAL STATEMENTS</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>FOR
THE YEARS ENDED DECEMBER 31, 2023 AND 2022</b></span></p>

<p style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Note
8. Stockholders&#8217; Equity (continued)</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">e)
    The Company has issued <span id="xdx_901_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_pid_c20220419__20220419__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--NoteWarrantMember_zWkrZmKo9B98" title="Issuance of warrants"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodSharesNewIssues" contextRef="From2022-04-192022-04-19_us-gaap_NoteWarrantMember" id="Fact000948" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">235,295</ix:nonFraction></span>
    Warrants (&#8220;Note Warrants&#8221;) to the Purchasers of the Notes on April 19, 2022. The Note Warrants have an exercise price of
    $<span id="xdx_909_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_pid_c20220419__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--NoteWarrantMember_zTWD3cZiugV9" title="Exercise price"><ix:nonFraction name="us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" contextRef="AsOf2022-04-19_us-gaap_NoteWarrantMember" id="Fact000950" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">4.25</ix:nonFraction></span>
    and a term of <span id="xdx_901_eus-gaap--WarrantsAndRightsOutstandingTerm_iI_dc_c20220419__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--NoteWarrantMember_zDYKm0TNpUIb" title="Warrants exercise price term"><ix:nonNumeric contextRef="AsOf2022-04-19_us-gaap_NoteWarrantMember" format="ixt-sec:durwordsen" id="Fact000952" name="us-gaap:WarrantsAndRightsOutstandingTerm">five years</ix:nonNumeric></span>. At December 31,2023 and 2022, the liability was $<span id="xdx_901_ecustom--PaymentsForRepurchaseOfLiability_c20220101__20221231__us-gaap--SubsidiarySaleOfStockAxis__custom--NoteWarrantsMember_zcsKXB287fPj" title="Warrant outstanding"><ix:nonFraction name="STSS:PaymentsForRepurchaseOfLiability" contextRef="From2022-01-012022-12-31_custom_NoteWarrantsMember" id="Fact000954" format="ixt:numdotdecimal" decimals="0" unitRef="USD">30,588</ix:nonFraction></span>.
    During the years ended December 31, 2023 and 2022, the Company recorded a FMV loss (gain) of $<span id="xdx_90C_eus-gaap--FairValueAdjustmentOfWarrants_c20230101__20231231__us-gaap--SubsidiarySaleOfStockAxis__custom--NoteWarrantsMember_zosuRDpp1wzg" title="Fair value income adjustment"><ix:nonFraction name="us-gaap:FairValueAdjustmentOfWarrants" contextRef="From2023-01-012023-12-31_custom_NoteWarrantsMember" id="Fact000956" format="ixt:numdotdecimal" decimals="0" unitRef="USD">0</ix:nonFraction></span>
    and ($<span id="xdx_906_eus-gaap--FairValueAdjustmentOfWarrants_c20220101__20221231__us-gaap--SubsidiarySaleOfStockAxis__custom--NoteWarrantsMember_zLt5vdzjt1I4" title="Fair value income adjustment"><ix:nonFraction name="us-gaap:FairValueAdjustmentOfWarrants" contextRef="From2022-01-012022-12-31_custom_NoteWarrantsMember" id="Fact000958" format="ixt:numdotdecimal" decimals="0" unitRef="USD">127,059</ix:nonFraction></span>),
    respectively. (See Note 10)</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">f)
    The underwriter received <span id="xdx_909_eus-gaap--ClassOfWarrantOrRightOutstanding_iI_c20231231__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--IPOMember_zfYDNcLzcbFl" title="Warrants received"><ix:nonFraction name="us-gaap:ClassOfWarrantOrRightOutstanding" contextRef="AsOf2023-12-31_us-gaap_IPOMember" id="Fact000960" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">187,500</ix:nonFraction></span>
    warrants in connection with the IPO for a nominal cost of $<span id="xdx_902_eus-gaap--PaymentsOfStockIssuanceCosts_c20230101__20231231__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--IPOMember_z5dlVSTPXmI3" title="Nominal cost"><ix:nonFraction name="us-gaap:PaymentsOfStockIssuanceCosts" contextRef="From2023-01-012023-12-31_us-gaap_IPOMember" id="Fact000962" format="ixt:numdotdecimal" decimals="0" unitRef="USD">11,250</ix:nonFraction></span>.
    The Warrants have an exercise price of $<span id="xdx_908_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_pid_c20221009__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--IPOMember_zPg6cTkzlLob" title="Exercise price"><ix:nonFraction name="us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" contextRef="AsOf2022-10-09_us-gaap_IPOMember" id="Fact000964" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">5.32</ix:nonFraction></span>
    and are exercisable after October 9, 2022. The FMV at the date of issuance was $<span id="xdx_904_eus-gaap--FairValueAdjustmentOfWarrants_c20230101__20231231__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--IPOMember_zRSQVJyAfjge" title="Fair value adjustment of warrants"><ix:nonFraction name="us-gaap:FairValueAdjustmentOfWarrants" contextRef="From2023-01-012023-12-31_us-gaap_IPOMember" id="Fact000966" format="ixt:numdotdecimal" decimals="0" unitRef="USD">228,750</ix:nonFraction></span>
    computed using the Black Sholes valuation model with the following assumptions: a) volatility of <span id="xdx_903_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate_pid_dp_uPure_c20230101__20231231__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--IPOMember_zyCRFn78Azn3" title="Volatility"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate" contextRef="From2023-01-012023-12-31_us-gaap_IPOMember" id="Fact000968" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">93.47</ix:nonFraction></span>%, <span id="xdx_904_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_dxL_c20230101__20231231__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--IPOMember_zl1sIXJl71Pf" title="Expected term::XDX::P5Y"><span style="-sec-ix-hidden: xdx2ixbrl0970">five</span></span>-year
    term, risk free interest rate <span id="xdx_903_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_pid_dp_uPure_c20230101__20231231__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--IPOMember_zDjcnIFfCrNl" title="Risk free interest rate"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" contextRef="From2023-01-012023-12-31_us-gaap_IPOMember" id="Fact000972" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">2.77</ix:nonFraction></span>%
    and <span id="xdx_907_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_pid_dp_uPure_c20230101__20231231__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--IPOMember_za612j0WtE3b" title="Dividend rate"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" contextRef="From2023-01-012023-12-31_us-gaap_IPOMember" id="Fact000974" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">0</ix:nonFraction></span>%
    dividend rate. These warrants were recorded in Equity at the estimated FMV and classified as additional issuance
    costs.</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2023-01-012023-12-31" escape="true" id="Fact000976" name="us-gaap:PreferredStockTextBlock"><p id="xdx_80E_eus-gaap--PreferredStockTextBlock_zq5XTcnSoNye" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Note
9. <span id="xdx_82F_zUyqR4qiiuod">Preferred Stock</span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
February 2018, the Company Board of Directors issued one share of Series A Preferred Stock to Alan Blackman, the Company&#8217;s co-founder
and Director. The Series A Preferred Stock entitles the holder to vote on any matters related to the election of directors and was reduced
from <span id="xdx_90F_eus-gaap--EquityMethodInvestmentOwnershipPercentage_iI_pid_dp_uPure_c20221231__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesAPreferredStockMember__srt--TitleOfIndividualAxis__srt--DirectorMember__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--AlanBlackmanMember_zR88SUr4h0z3" title="Ownership interest percentage"><ix:nonFraction name="us-gaap:EquityMethodInvestmentOwnershipPercentage" contextRef="AsOf2022-12-31_us-gaap_SeriesAPreferredStockMember_srt_DirectorMember_custom_AlanBlackmanMember" id="Fact000978" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">50.1</ix:nonFraction></span>% at December 31, 2022 to <span id="xdx_90B_eus-gaap--EquityMethodInvestmentOwnershipPercentage_iI_pid_dp_uPure_c20221231__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesAPreferredStockMember__srt--TitleOfIndividualAxis__srt--DirectorMember__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--IPOMember__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--AlanBlackmanMember_zAtWfzVnO1Xb" title="Ownership interest percentage"><ix:nonFraction name="us-gaap:EquityMethodInvestmentOwnershipPercentage" contextRef="AsOf2022-12-31_us-gaap_SeriesAPreferredStockMember_srt_DirectorMember_us-gaap_IPOMember_custom_AlanBlackmanMember" id="Fact000980" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">29.5</ix:nonFraction></span>%, effective with the IPO. The Series A Preferred Stock has no right to dividends, or distributions
in the event of a liquidation and is not convertible into common stock. In the event the Company is sold during the two-year period following
completion of IPO at a price per share of more than 500% of the initial offering price per Unit in the IPO, the Series A Preferred Stock,
as in effect upon completion of the IPO, will entitle the holder to <span id="xdx_90A_eus-gaap--EquityMethodInvestmentOwnershipPercentage_iI_pid_dp_uPure_c20180228__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesAPreferredStockMember__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--IPOMember__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--AlanBlackmanMember_z6r901oEkGc5" title="Ownership interest percentage"><ix:nonFraction name="us-gaap:EquityMethodInvestmentOwnershipPercentage" contextRef="AsOf2018-02-28_us-gaap_SeriesAPreferredStockMember_us-gaap_IPOMember_custom_AlanBlackmanMember" id="Fact000982" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">10</ix:nonFraction></span>% of the total purchase price. (See Note 15)</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2023-01-012023-12-31" escape="true" id="Fact000984" name="STSS:WarrantLiabilityTextBlock"><p id="xdx_80A_ecustom--WarrantLiabilityTextBlock_zW1LKxolH2c1" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Note
10. <span id="xdx_82F_zOgOpLFNfquk">Warrant Liability</span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Warrants were accounted for as liabilities in accordance with ASC 815-40 and are presented as a Warrant liability in the accompanying
consolidated balance sheet. The warrant liabilities are measured at fair value at inception and on a recurring basis, with changes in
fair value presented within the consolidated statement of operations, The non-trading warrants, related to the February 2023 and September
2023 offerings, are valued using the Black-Scholes pricing model. The assumptions for the year ended December 31, 2023 were as follows:
(See Notes 7 and 8)</span></p>

<ix:nonNumeric contextRef="From2023-01-012023-12-31_us-gaap_WarrantMember" escape="true" id="Fact000986" name="us-gaap:ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock"><p id="xdx_898_eus-gaap--ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock_hus-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_z5jnmmRnTLx7" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_8B8_z3F43eQIYzn" style="display: none">Schedule
of Fair Value of Warrant</span></span></span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 80%">
  <tr style="vertical-align: bottom">
    <td style="text-align: center"><b>&#160;</b></td><td style="padding-bottom: 1pt"><b>&#160;</b></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"><p style="margin-top: 0pt; margin-bottom: 0pt"><b>Year Ended
                                            <br/> December 31,</b></p>
                                                                                <p style="margin-top: 0pt; margin-bottom: 0pt"><b>2023</b></p></td><td style="padding-bottom: 1pt"><b>&#160;</b></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Expected term (years)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_901_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_dtY_c20230101__20231231__srt--RangeAxis__srt--MinimumMember__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_zhDHBPzmJXlj" title="Expected term (in years)"><ix:nonNumeric contextRef="From2023-01-012023-12-31_srt_MinimumMember_us-gaap_WarrantMember" format="ixt-sec:duryear" id="Fact000988" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1">4.10</ix:nonNumeric></span> to <span id="xdx_90E_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_dtY_c20230101__20231231__srt--RangeAxis__srt--MaximumMember__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_ziMLFjAReNCe" title="Expected term (in years)"><ix:nonNumeric contextRef="From2023-01-012023-12-31_srt_MaximumMember_us-gaap_WarrantMember" format="ixt-sec:duryear" id="Fact000990" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1">5.50</ix:nonNumeric></span> </span></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Expected volatility</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_903_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_dp_c20230101__20231231__srt--RangeAxis__srt--MinimumMember__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_zs6weAVJO24l" title="Expected volatility"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" contextRef="From2023-01-012023-12-31_srt_MinimumMember_us-gaap_WarrantMember" id="Fact000992" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">45.30</ix:nonFraction></span>% to <span id="xdx_908_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_dp_c20230101__20231231__srt--RangeAxis__srt--MaximumMember__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_zOF8yLPihQW5" title="Expected volatility"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" contextRef="From2023-01-012023-12-31_srt_MaximumMember_us-gaap_WarrantMember" id="Fact000994" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">70.44</ix:nonFraction></span></span></td><td style="text-align: left">%</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Risk-free interest rate</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90F_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_dp_c20230101__20231231__srt--RangeAxis__srt--MinimumMember__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_zdXzuXI8kas6" title="Risk-free interest rate"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" contextRef="From2023-01-012023-12-31_srt_MinimumMember_us-gaap_WarrantMember" id="Fact000996" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">3.53</ix:nonFraction></span>% to <span id="xdx_908_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_dp_c20230101__20231231__srt--RangeAxis__srt--MaximumMember__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_ztxtPZ02OBVg" title="Risk-free interest rate"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" contextRef="From2023-01-012023-12-31_srt_MaximumMember_us-gaap_WarrantMember" id="Fact000998" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">4.54</ix:nonFraction></span></span></td><td style="text-align: left">%</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="width: 74%; text-align: left">Dividend rate</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 22%; text-align: right"><span id="xdx_909_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_dp_c20230101__20231231__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_zUjhAz4fKS7" title="Risk-free interest rate"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" contextRef="From2023-01-012023-12-31_us-gaap_WarrantMember" id="Fact001000" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">0</ix:nonFraction></span></td><td style="width: 1%; text-align: left">%</td></tr>
  </table>

</ix:nonNumeric><p id="xdx_8A6_zbvjlzTzd3eg" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<ix:nonNumeric contextRef="From2023-01-012023-12-31" escape="true" id="Fact001002" name="STSS:ScheduleOfWarrantLiabilityTableTextBlock"><p id="xdx_89C_ecustom--ScheduleOfWarrantLiabilityTableTextBlock_zofZl5BvTDx9" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Warrant liability at December 31, 2023 and 2022 was as follows:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span><span id="xdx_8B1_zuJdiIA68dbg" style="display: none">Schedule
of Warrant Liability</span></span></span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 60%">
  <tr style="vertical-align: bottom">
    <td style="padding-bottom: 1pt">&#160;</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td>
    <td colspan="2" id="xdx_49B_20231231_z2NFHWe8Bhh1" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2023</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td>
    <td colspan="2" id="xdx_499_20221231_zOWC0nsZdO0d" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2022</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
  <tr id="xdx_404_ecustom--WarrantLiability_iI_hus-gaap--SubsidiarySaleOfStockAxis__custom--TradingAndOverallotmentWarrantsMember_zRBDDKBQ78E7" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 60%; text-align: left">Trading and Overallotment Warrants</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 16%; text-align: right"><ix:nonFraction name="STSS:WarrantLiability" contextRef="AsOf2023-12-31_custom_TradingAndOverallotmentWarrantsMember" id="Fact001004" format="ixt:numdotdecimal" decimals="0" unitRef="USD">1,121,250</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 16%; text-align: right"><ix:nonFraction name="STSS:WarrantLiability" contextRef="AsOf2022-12-31_custom_TradingAndOverallotmentWarrantsMember" id="Fact001005" format="ixt:numdotdecimal" decimals="0" unitRef="USD">1,121,250</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr id="xdx_40D_ecustom--WarrantLiability_iI_hus-gaap--SubsidiarySaleOfStockAxis__custom--NoteWarrantsMember_zYT4PuI8bfC9" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1pt">Note Warrants</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="STSS:WarrantLiability" contextRef="AsOf2023-12-31_custom_NoteWarrantsMember" id="Fact001007" format="ixt:numdotdecimal" decimals="0" unitRef="USD">30,588</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="STSS:WarrantLiability" contextRef="AsOf2022-12-31_custom_NoteWarrantsMember" id="Fact001008" format="ixt:numdotdecimal" decimals="0" unitRef="USD">30,588</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_407_ecustom--WarrantLiability_iI_hus-gaap--SubsidiarySaleOfStockAxis__custom--OfferingWarrantsFebruaryTwentyTwentyThreeMember_z1ffBxrNWm7k" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 1pt">Offering Warrants &#8211; February 2023</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="STSS:WarrantLiability" contextRef="AsOf2023-12-31_custom_OfferingWarrantsFebruaryTwentyTwentyThreeMember" id="Fact001010" format="ixt:numdotdecimal" decimals="0" unitRef="USD">234,072</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl1011">-</span></span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_40B_ecustom--WarrantLiability_iI_hus-gaap--SubsidiarySaleOfStockAxis__custom--OfferingWarrantsSeptemberTwentyTwentyThreeMember_zhnUtscNzZ2f" style="vertical-align: bottom; background-color: White">
    <td style="padding-bottom: 1pt">Offering Warrants &#8211; September 2023</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="STSS:WarrantLiability" contextRef="AsOf2023-12-31_custom_OfferingWarrantsSeptemberTwentyTwentyThreeMember" id="Fact001013" format="ixt:numdotdecimal" decimals="0" unitRef="USD">1,036,875</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1014">-</span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_40A_ecustom--WarrantLiability_iI_zzc2JuUB9pr4" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 2.5pt">Total Warrant Liability</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right"><ix:nonFraction name="STSS:WarrantLiability" contextRef="AsOf2023-12-31" id="Fact001016" format="ixt:numdotdecimal" decimals="0" unitRef="USD">2,422,785</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td style="border-bottom: Black 2.5pt double; text-align: right"><ix:nonFraction name="STSS:WarrantLiability" contextRef="AsOf2022-12-31" id="Fact001017" format="ixt:numdotdecimal" decimals="0" unitRef="USD">1,151,838</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  </table>

</ix:nonNumeric><p id="xdx_8A4_zXdObG8qHmXi" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<ix:nonNumeric contextRef="From2023-01-012023-12-31" escape="true" id="Fact001019" name="us-gaap:ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock"><p id="xdx_89E_eus-gaap--ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock_z9SZsrKLqWS" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Warrants outstanding at December 31, 2023 and 2022 were as follows:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;<span id="xdx_8B8_zbnpCBFP3bg4" style="display: none">Schedule
of Warrant Outstanding</span></span></span></span></span></span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 80%">
  <tr style="vertical-align: bottom">
    <td style="padding-bottom: 1pt; text-align: center"><b>&#160;</b></td><td style="padding-bottom: 1pt; text-align: center"><b>&#160;</b></td>
    <td colspan="2" id="xdx_49A_20231231_zI5p3KsKabhh" style="border-bottom: Black 1pt solid; text-align: center"><p style="margin-top: 0pt; margin-bottom: 0pt"><b>December
                                            31,</b></p>
                                                                                <p style="margin-top: 0pt; margin-bottom: 0pt"><b>2023</b></p></td><td style="padding-bottom: 1pt; text-align: center"><b>&#160;</b></td><td style="padding-bottom: 1pt; text-align: center"><b>&#160;</b></td>
    <td colspan="2" id="xdx_496_20221231_zDuN70vGQSm4" style="border-bottom: Black 1pt solid; text-align: center"><p style="margin-top: 0pt; margin-bottom: 0pt"><b>December
                                            31,</b></p>
                                                                                <p style="margin-top: 0pt; margin-bottom: 0pt"><b>2022</b></p></td><td style="padding-bottom: 1pt; text-align: center"><b>&#160;</b></td></tr>
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: right">&#160;</td><td>&#160;</td></tr>
  <tr id="xdx_40D_eus-gaap--ClassOfWarrantOrRightOutstanding_iI_hus-gaap--SubsidiarySaleOfStockAxis__custom--TradingAndOverallotmentWarrantsMember_zSPQoDjVh74j" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 56%; text-align: left">Trading and Overallotment Warrants</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 18%; text-align: right"><ix:nonFraction name="us-gaap:ClassOfWarrantOrRightOutstanding" contextRef="AsOf2023-12-31_custom_TradingAndOverallotmentWarrantsMember" id="Fact001021" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">8,812,500</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 18%; text-align: right"><ix:nonFraction name="us-gaap:ClassOfWarrantOrRightOutstanding" contextRef="AsOf2022-12-31_custom_TradingAndOverallotmentWarrantsMember" id="Fact001022" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">8,812,500</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr id="xdx_400_eus-gaap--ClassOfWarrantOrRightOutstanding_iI_hus-gaap--SubsidiarySaleOfStockAxis__custom--NoteWarrantsMember_zo7OgdO4fGx1" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1pt">Note Warrants</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:ClassOfWarrantOrRightOutstanding" contextRef="AsOf2023-12-31_custom_NoteWarrantsMember" id="Fact001024" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">235,294</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:ClassOfWarrantOrRightOutstanding" contextRef="AsOf2022-12-31_custom_NoteWarrantsMember" id="Fact001025" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">235,294</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_400_eus-gaap--ClassOfWarrantOrRightOutstanding_iI_hus-gaap--SubsidiarySaleOfStockAxis__custom--OfferingWarrantsFebruaryTwentyTwentyThreeMember_zHoUIa6rrep2" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 1pt">Offering Warrants &#8211; February 2023</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:ClassOfWarrantOrRightOutstanding" contextRef="AsOf2023-12-31_custom_OfferingWarrantsFebruaryTwentyTwentyThreeMember" id="Fact001027" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">2,248,521</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><p style="margin: 0"><span style="-sec-ix-hidden: xdx2ixbrl1028">-</span></p></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_40E_eus-gaap--ClassOfWarrantOrRightOutstanding_iI_hus-gaap--SubsidiarySaleOfStockAxis__custom--OfferingWarrantsSeptemberTwentyTwentyThreeMember_zlCPbJattfxl" style="vertical-align: bottom; background-color: White">
    <td style="padding-bottom: 1pt">Offering Warrants &#8211; September 2023</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:ClassOfWarrantOrRightOutstanding" contextRef="AsOf2023-12-31_custom_OfferingWarrantsSeptemberTwentyTwentyThreeMember" id="Fact001030" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">8,750,003</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><p style="margin: 0"><span style="-sec-ix-hidden: xdx2ixbrl1031">-</span></p></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_40D_eus-gaap--ClassOfWarrantOrRightOutstanding_iI_hus-gaap--SubsidiarySaleOfStockAxis__custom--WarrantsIssuedForServiceManagementMember_zeaGnV6KO535" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1pt">Warrants issued for services arrangement</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:ClassOfWarrantOrRightOutstanding" contextRef="AsOf2023-12-31_custom_WarrantsIssuedForServiceManagementMember" id="Fact001033" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">495,000</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl1034">-</span></span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_402_eus-gaap--ClassOfWarrantOrRightOutstanding_iI_zTXE7CeC9Zqd" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 2.5pt">Total Warrants Outstanding</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td style="border-bottom: Black 2.5pt double; text-align: right"><ix:nonFraction name="us-gaap:ClassOfWarrantOrRightOutstanding" contextRef="AsOf2023-12-31" id="Fact001036" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">20,541,318</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td style="border-bottom: Black 2.5pt double; text-align: right"><ix:nonFraction name="us-gaap:ClassOfWarrantOrRightOutstanding" contextRef="AsOf2022-12-31" id="Fact001037" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">9,047,794</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  </table>

</ix:nonNumeric><p id="xdx_8A1_zHYTMlWynilh" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<ix:exclude><!-- Field: Page; Sequence: 67; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 0pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->19<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%"><a href="#RM_014">Table of Contents</a></td></tr></table></div>
    <!-- Field: /Page --></ix:exclude>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>SHARPS
TECHNOLOGY, INC.</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTES
TO THE CONSOLIDATED FINANCIAL STATEMENTS</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>FOR
THE YEARS ENDED DECEMBER 31, 2023 AND 2022</b></span></p>

<p style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Note
10. Warrant Liability (continued)</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">For
the years ended December 31, 2023 and 2022 the FMV loss (gain) adjustment, which is reflected in the FMV adjustment on Warrants in the
Consolidated Statements of Operations was ($<span id="xdx_90D_eus-gaap--MarketRiskBenefitChangeInFairValueGainLoss_c20230101__20231231_zHXdAWQi0xDa" title="Fair market value adjustment"><ix:nonFraction name="us-gaap:MarketRiskBenefitChangeInFairValueGainLoss" contextRef="From2023-01-012023-12-31" id="Fact001039" format="ixt:numdotdecimal" decimals="0" unitRef="USD">169,583</ix:nonFraction></span>) and ($<span id="xdx_905_eus-gaap--MarketRiskBenefitChangeInFairValueGainLoss_c20220101__20221231_zcmjOxeaHFV2" title="Fair market value adjustment"><ix:nonFraction name="us-gaap:MarketRiskBenefitChangeInFairValueGainLoss" contextRef="From2022-01-012022-12-31" id="Fact001041" format="ixt:numdotdecimal" decimals="0" unitRef="USD">4,784,559</ix:nonFraction></span>), respectively.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2023-01-012023-12-31" escape="true" id="Fact001043" name="us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock"><p id="xdx_804_eus-gaap--DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock_zpi01Ls8aMjh" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Note
11. <span id="xdx_82E_zQMlDZUjgcRe">Stock Options</span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On January 24, 2023, the Company&#8217;s Board of Directors initially adopted the 2023 Equity Incentive Plan (the
&#8220;2023 Plan&#8221;), to provide for the issuance of up to <span id="xdx_900_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_iI_c20230124__us-gaap--PlanNameAxis__custom--TwoThousandTwentyThreeEquityIncentivePlanMember_zI2Q6ZbymiB8" title="Stock available for issuance"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" contextRef="AsOf2023-01-24_custom_TwoThousandTwentyThreeEquityIncentivePlanMember" id="Fact001045" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">1,400,000</ix:nonFraction></span> options and/or shares of restricted stock be available for issuance
to officers, directors, employees and consultants. The 2023 Plan was subsequently updated to provide for the issuance of up to <span id="xdx_907_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod_c20230124__20230124__us-gaap--PlanNameAxis__custom--TwoThousandTwentyThreeEquityIncentivePlanMember_zUGy6rwkFzI5" title="Number of stock issuance"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod" contextRef="From2023-01-242023-01-24_custom_TwoThousandTwentyThreeEquityIncentivePlanMember" id="Fact001047" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">3,500,000</ix:nonFraction></span>
options and/or shares of restricted stock. The 2023 Plan was approved by shareholders at the annual meeting</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<ix:nonNumeric contextRef="From2023-01-012023-12-31" escape="true" id="Fact001049" name="us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock"><p id="xdx_894_eus-gaap--ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock_zxjRdzkmrjJa" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">A
summary of options granted and outstanding is presented below.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span><span id="xdx_8B2_zh8qQm1k4QP7" style="display: none">Schedule
of Stock Options Granted and Outstanding</span></span></span></span></span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="6" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2023</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="6" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2022</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Options</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Weighted<br/> Average<br/> Exercise <br/> Price</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Options</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Weighted<br/> Average<br/> Exercise <br/> Price</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 40%; text-align: left">Outstanding at Beginning of year</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td id="xdx_987_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionOutstandingNumber_iS_c20230101__20231231_zaUwzULDb3Bc" title="Stock option, beginning balance" style="width: 11%; text-align: right"><ix:nonFraction name="STSS:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionOutstandingNumber" contextRef="AsOf2022-12-31" id="Fact001051" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">1,358,122</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_987_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionOutstandingWeightedAverageExercisePrice_iS_c20230101__20231231_zNXsc1vFalU7" title="Weighted average exercise price, beginning balance" style="width: 11%; text-align: right"><ix:nonFraction name="STSS:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionOutstandingWeightedAverageExercisePrice" contextRef="AsOf2022-12-31" id="Fact001053" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">4.37</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td id="xdx_989_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iS_c20220101__20221231_zEpeaR5DmrI5" title="Stock option, beginning balance" style="width: 11%; text-align: right"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" contextRef="AsOf2021-12-31" id="Fact001055" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">1,137,479</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_98D_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iS_c20220101__20221231_zslpPQdBI7th" title="Weighted average exercise price, beginning balance" style="width: 11%; text-align: right"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" contextRef="AsOf2021-12-31" id="Fact001057" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">5.18</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td>Granted</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98B_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_c20230101__20231231_zjX1ZZxE5XLc" title="Shares, options granted" style="text-align: right"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" contextRef="From2023-01-012023-12-31" id="Fact001059" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">1,065,000</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_982_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_c20230101__20231231_z8uZ9XHkfcRh" title="Weighted average exercise price, options granted" style="text-align: right"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" contextRef="From2023-01-012023-12-31" id="Fact001061" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">1.35</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98D_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_c20220101__20221231_zh8BO9bo09Ll" title="Shares, options granted" style="text-align: right"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" contextRef="From2022-01-012022-12-31" id="Fact001063" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">367,500</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_989_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_c20220101__20221231_zdMAoRskatQ6" title="Weighted average exercise price, options granted" style="text-align: right"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" contextRef="From2022-01-012022-12-31" id="Fact001065" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">1.63</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>Cancelled</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_987_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod_iN_di_c20220101__20221231_zrwqbIejKl79" title="Shares, options cancelled" style="text-align: right">(<ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod" contextRef="From2022-01-012022-12-31" id="Fact001067" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">3,571</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_989_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice_iN_di_c20220101__20221231_zdkd51rjznaf" title="Weighted average exercise price, options cancelled" style="text-align: right">(<ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice" contextRef="From2022-01-012022-12-31" id="Fact001069" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">4.38</ix:nonFraction></td><td style="text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-bottom: 1pt">Forfeited</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_98A_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedNumberOfShares_iN_di_c20230101__20231231_zxzNhmrWXAq7" title="Shares, options forfeited" style="border-bottom: Black 1pt solid; text-align: right">(<ix:nonFraction name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedNumberOfShares" contextRef="From2023-01-012023-12-31" id="Fact001071" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">14,286</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">$</td><td id="xdx_984_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice_c20230101__20231231_zHLduwboIknd" title="Weighted average exercise price, options forfeited" style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice" contextRef="From2023-01-012023-12-31" id="Fact001073" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">1.75</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_98E_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_iN_di_c20220101__20221231_zjHSUDyUObu4" title="Shares, options forfeited" style="border-bottom: Black 1pt solid; text-align: right">(<ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" contextRef="From2022-01-012022-12-31" id="Fact001075" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">143,286</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">$</td><td id="xdx_98F_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice_iN_di_c20220101__20221231_zcid2FMo7Tpa" title="Weighted average exercise price, options forfeited" style="border-bottom: Black 1pt solid; text-align: right">(<ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice" contextRef="From2022-01-012022-12-31" id="Fact001077" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">3.77</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 2.5pt">Outstanding at end of year</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td id="xdx_987_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionOutstandingNumber_iE_c20230101__20231231_zEch1ZGM8U6k" title="Stock option, ending balance" style="border-bottom: Black 2.5pt double; text-align: right"><ix:nonFraction name="STSS:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionOutstandingNumber" contextRef="AsOf2023-12-31" id="Fact001079" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">2,408,836</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_981_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionOutstandingWeightedAverageExercisePrice_iE_c20230101__20231231_z6ygFRMgPhS" title="Weighted average exercise price, ending balance" style="border-bottom: Black 2.5pt double; text-align: right"><ix:nonFraction name="STSS:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionOutstandingWeightedAverageExercisePrice" contextRef="AsOf2023-12-31" id="Fact001081" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">3.03</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td id="xdx_98C_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iE_c20220101__20221231_zwehlMRbwH5g" title="Stock option, ending balance" style="border-bottom: Black 2.5pt double; text-align: right"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" contextRef="AsOf2022-12-31" id="Fact001083" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">1,358,122</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_982_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iE_c20220101__20221231_zzRFa28LDX26" title="Weighted average exercise price, ending balance" style="border-bottom: Black 2.5pt double; text-align: right"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" contextRef="AsOf2022-12-31" id="Fact001085" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">4.37</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 2.5pt">Exercisable at end of year</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td id="xdx_986_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_iE_c20230101__20231231_zKGeCfCEswbd" title="Stock option, exercisable" style="border-bottom: Black 2.5pt double; text-align: right"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" contextRef="AsOf2023-12-31" id="Fact001087" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">1,881,327</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_982_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_iE_c20230101__20231231_zG3VY1yrDYC1" title="Weighted average exercise price, exercisable" style="border-bottom: Black 2.5pt double; text-align: right"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" contextRef="AsOf2023-12-31" id="Fact001089" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">3.47</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td id="xdx_98E_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_iE_c20220101__20221231_zozaY861CnVe" title="Stock option, exercisable" style="border-bottom: Black 2.5pt double; text-align: right"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" contextRef="AsOf2022-12-31" id="Fact001091" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">1,132,861</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_98D_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_iE_c20220101__20221231_z7ewT5InYWcj" title="Weighted average exercise price, exercisable" style="border-bottom: Black 2.5pt double; text-align: right"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" contextRef="AsOf2022-12-31" id="Fact001093" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">4.59</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  </table>

</ix:nonNumeric><p id="xdx_8A7_zOV7srWKoCB7" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1)</span></td>
    <td colspan="3"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">During the year ended December 31, 2023, the Company granted <span id="xdx_903_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_dxL_c20230101__20231231__us-gaap--PlanNameAxis__custom--TwoThousandTwentyThreeEquityIncentivePlanMember_zPsIffusXqn1" title="Expected term::XDX::P5Y"><span style="-sec-ix-hidden: xdx2ixbrl1095">five</span></span>-year options (the &#8220;Options&#8221;) to purchase a total of:</span></p>

</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td colspan="3">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 0.25in">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">a)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_906_eus-gaap--StockIssuedDuringPeriodSharesShareBasedCompensation_c20230101__20231231__us-gaap--PlanNameAxis__custom--TwoThousandTwentyThreeEquityIncentivePlanMember_zSLNgQzsbhQh" title="Purchase of total shares"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation" contextRef="From2023-01-012023-12-31_custom_TwoThousandTwentyThreeEquityIncentivePlanMember" id="Fact001097" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">975,000</ix:nonFraction></span>
    shares of the Company&#8217;s common stock, par value $<span id="xdx_90E_eus-gaap--CommonStockParOrStatedValuePerShare_iI_c20231231__us-gaap--PlanNameAxis__custom--TwoThousandTwentyThreeEquityIncentivePlanMember_zCgflDU6YbHa" title="Common stock, par value"><ix:nonFraction name="us-gaap:CommonStockParOrStatedValuePerShare" contextRef="AsOf2023-12-31_custom_TwoThousandTwentyThreeEquityIncentivePlanMember" id="Fact001099" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">0.0001</ix:nonFraction></span> per share (the &#8220;Common Stock&#8221;) to its directors, executive
    officers, employees and consultants pursuant to the Company&#8217;s. 2022 and 2023 Equity Incentive Plans. The Options are exercisable
    at $<span id="xdx_90E_ecustom--ShareBasedCompensationOptionsExercisableWeightedAverageExercisePrice_iI_c20231231__us-gaap--PlanNameAxis__custom--TwoThousandTwentyThreeEquityIncentivePlanMember_zFk0jOxv1Ri7" title="Options exercisable"><ix:nonFraction name="STSS:ShareBasedCompensationOptionsExercisableWeightedAverageExercisePrice" contextRef="AsOf2023-12-31_custom_TwoThousandTwentyThreeEquityIncentivePlanMember" id="Fact001101" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">1.37</ix:nonFraction> </span>per share which was the closing price on January 25, 2023.</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td>&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">b)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90D_eus-gaap--StockIssuedDuringPeriodSharesShareBasedCompensation_c20230101__20231231__srt--TitleOfIndividualAxis__custom--EmployeesAndConsultantMember_zD1rIgmh3Yt1" title="Purchase of shares"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation" contextRef="From2023-01-012023-12-31_custom_EmployeesAndConsultantMember" id="Fact001103" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">90,000</ix:nonFraction></span>
    shares of the Company&#8217;s Common Stock in connection with an employment or consulting agreements at the exercise price, representing
    the closing price on the grant date ranging from $<span id="xdx_901_ecustom--ShareBasedCompensationOptionsExercisableWeightedAverageExercisePrice_iI_c20231231__srt--TitleOfIndividualAxis__custom--EmployeesAndConsultantMember__srt--RangeAxis__srt--MinimumMember_zAOt7mgEYNef" title="Options exercisable"><ix:nonFraction name="STSS:ShareBasedCompensationOptionsExercisableWeightedAverageExercisePrice" contextRef="AsOf2023-12-31_custom_EmployeesAndConsultantMember_srt_MinimumMember" id="Fact001105" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">0.82</ix:nonFraction></span> to $<span id="xdx_900_ecustom--ShareBasedCompensationOptionsExercisableWeightedAverageExercisePrice_iI_c20231231__srt--TitleOfIndividualAxis__custom--EmployeesAndConsultantMember__srt--RangeAxis__srt--MaximumMember_zjeNUVus5YQ4" title="Options exercisable"><ix:nonFraction name="STSS:ShareBasedCompensationOptionsExercisableWeightedAverageExercisePrice" contextRef="AsOf2023-12-31_custom_EmployeesAndConsultantMember_srt_MaximumMember" id="Fact001107" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">1.30</ix:nonFraction></span>.</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td>&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="3" style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">During the year ended December 31, 2023, <span id="xdx_90F_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_c20230101__20231231__us-gaap--PlanNameAxis__custom--TwoThousandTwentyThreeEquityIncentivePlanMember_zVxSy9wppG3h" title="Shares, options granted"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" contextRef="From2023-01-012023-12-31_custom_TwoThousandTwentyThreeEquityIncentivePlanMember" id="Fact001109" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">660,000</ix:nonFraction></span> Options have been granted under the 2023 Equity Incentive Plan and the remaining <span id="xdx_90C_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_c20230101__20231231__us-gaap--PlanNameAxis__custom--TwoThousandTwentyTwoEquityIncentivePlanMember_zdbKVrHFoQEh" title="Shares, options granted"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" contextRef="From2023-01-012023-12-31_custom_TwoThousandTwentyTwoEquityIncentivePlanMember" id="Fact001111" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">405,000</ix:nonFraction></span> Options were issued under the 2022 Equity Incentive Plan. At December 31, 2023, <span id="xdx_90C_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iI_c20231231__us-gaap--PlanNameAxis__custom--TwoThousandTwentyTwoEquityIncentivePlanMember_zJgJw3a7DfMc" title="Options outstanding"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" contextRef="AsOf2023-12-31_custom_TwoThousandTwentyTwoEquityIncentivePlanMember" id="Fact001113" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">1,748,836</ix:nonFraction></span> Options are outstanding under the 2022 Equity Incentive Plan. </span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">During
the years ended December 31, 2023 and 2022, the estimated weighted-average grant-date fair value of options granted was $<span id="xdx_901_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_pid_c20230101__20231231_zoysvO2ydjLd" title="Weighted-average grant-date fair value of options granted"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" contextRef="From2023-01-012023-12-31" id="Fact001115" decimals="INF" unitRef="USDPShares">.80</ix:nonFraction></span>
per share and $<span id="xdx_907_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_pid_c20220101__20221231_zKmxekvmuGb5" title="Weighted-average grant-date fair value of options granted"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" contextRef="From2022-01-012022-12-31" id="Fact001117" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">1.63</ix:nonFraction></span>
per share, respectively. As of December 31, 2023 and 2022, there was $<span id="xdx_90A_eus-gaap--EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized_iI_c20231231_zUhhSnLHdrBl" title="Unrecognized stock based compensation"><ix:nonFraction name="us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized" contextRef="AsOf2023-12-31" id="Fact001119" format="ixt:numdotdecimal" decimals="0" unitRef="USD">498,454</ix:nonFraction></span>
and $<span id="xdx_905_eus-gaap--EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized_iI_c20221231_zWE0SwUG2k3d" title="Unrecognized stock based compensation"><ix:nonFraction name="us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized" contextRef="AsOf2022-12-31" id="Fact001121" format="ixt:numdotdecimal" decimals="0" unitRef="USD">475,097</ix:nonFraction></span>,
respectively, of unrecognized stock-based compensation related to unvested stock options with a weighted average fair value of $<span id="xdx_90B_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue_iI_pid_c20231231_zoX2beRL7OB6" title="Unvested stock options weighted average fair value"><ix:nonFraction name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue" contextRef="AsOf2023-12-31" id="Fact001123" decimals="INF" unitRef="USDPShares">.94</ix:nonFraction></span> and $<span id="xdx_90C_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue_iI_pid_c20221231_zNaQhQeaH3Hb" title="Unvested stock options weighted average fair value"><ix:nonFraction name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue" contextRef="AsOf2022-12-31" id="Fact001125" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">2.05</ix:nonFraction></span> per share, respectively, which is expected to be recognized over a
weighted-average period sixteen months as of December 31, 2023.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<ix:nonNumeric contextRef="From2023-01-012023-12-31" escape="true" id="Fact001127" name="us-gaap:ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTextBlock"><p id="xdx_896_eus-gaap--ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTextBlock_zyEjtYLsdPz3" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
following table summarizes information about options outstanding at December 31, 2023:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span><span id="xdx_8B9_ztchLltpVJe3" style="display: none">Schedule
of Information About Options Outstanding</span></span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 90%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td colspan="2" style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Exercise
    <br/>
    Prices</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></td>
    <td colspan="2" style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Options
    <br/>
    Outstanding</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></td>
    <td colspan="2" style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Aggregate<br/>
    Intrinsic Value</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></td>
    <td colspan="2" style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Weighted
    Average <br/>
    Remaining<br/>
    Contractual Life</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></td>
    <td colspan="2" style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Options
    <br/>
    Exercisable</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Aggregate</b></span></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Intrinsic
    Value<br/>
    on Exercisable<br/>
    Shares</b></span></p></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td colspan="2" style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 12%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_903_eus-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit_c20230101__20231231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeOneMember__srt--RangeAxis__srt--MinimumMember_zBCE1r4eLcAe" title="Stock option, exercise price"><ix:nonFraction name="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit" contextRef="From2023-01-012023-12-31_custom_ExercisePriceRangeOneMember_srt_MinimumMember" id="Fact001129" decimals="INF" unitRef="USDPShares">.82</ix:nonFraction></span> to <span id="xdx_90E_eus-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit_c20230101__20231231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeOneMember__srt--RangeAxis__srt--MaximumMember_z4MAyw806t1h" title="Stock option, exercise price"><ix:nonFraction name="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit" contextRef="From2023-01-012023-12-31_custom_ExercisePriceRangeOneMember_srt_MaximumMember" id="Fact001131" decimals="INF" unitRef="USDPShares">.92</ix:nonFraction></span></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td id="xdx_989_eus-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions_iI_c20231231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeOneMember_zeXCfV64B6X8" title="Options, shares outstanding" style="font: 10pt Times New Roman, Times, Serif; width: 12%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions" contextRef="AsOf2023-12-31_custom_ExercisePriceRangeOneMember" id="Fact001133" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">40,000</ix:nonFraction></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td id="xdx_98A_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_iI_c20231231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeOneMember_zzO9XqLgXdkg" title="Stock option, aggregate intrinsic value" style="font: 10pt Times New Roman, Times, Serif; width: 14%; text-align: right">&#160;&#160;&#160;&#160;&#160;<span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl1135">-</span></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 14%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90A_eus-gaap--SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2_dtY_c20230101__20231231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeOneMember_z3n6ybZBvqUk" title="Stock option, weighted average remaining contractual life"><ix:nonNumeric contextRef="From2023-01-012023-12-31_custom_ExercisePriceRangeOneMember" format="ixt-sec:duryear" id="Fact001137" name="us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2">4.58</ix:nonNumeric></span></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td id="xdx_98F_eus-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions_iI_c20231231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeOneMember_zVb4oEeNxaec" title="Options, shares exercisable" style="font: 10pt Times New Roman, Times, Serif; width: 12%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions" contextRef="AsOf2023-12-31_custom_ExercisePriceRangeOneMember" id="Fact001139" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">18,794</ix:nonFraction></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td id="xdx_980_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1_iI_c20231231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeOneMember_zb0A1ijPx8A" title="Stock option, aggregate intrinsic value on exercisable shares" style="font: 10pt Times New Roman, Times, Serif; width: 14%; text-align: right">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl1141">-</span></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_907_eus-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit_c20230101__20231231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeTwoMember_zxQgIHiwv0Ld" title="Stock option, exercise price"><ix:nonFraction name="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit" contextRef="From2023-01-012023-12-31_custom_ExercisePriceRangeTwoMember" id="Fact001143" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">1.21</ix:nonFraction></span></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td id="xdx_98F_eus-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions_iI_c20231231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeTwoMember_zQrISQLiHbs9" title="Options, shares outstanding" style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions" contextRef="AsOf2023-12-31_custom_ExercisePriceRangeTwoMember" id="Fact001145" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">307,500</ix:nonFraction></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td id="xdx_989_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_iI_c20231231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeTwoMember_z97JRxHuAKD4" title="Stock option, aggregate intrinsic value" style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl1147">-</span></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_908_eus-gaap--SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2_dtY_c20230101__20231231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeTwoMember_zj2yoK181UGi" title="Stock option, weighted average remaining contractual life"><ix:nonNumeric contextRef="From2023-01-012023-12-31_custom_ExercisePriceRangeTwoMember" format="ixt-sec:duryear" id="Fact001149" name="us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2">3.42</ix:nonNumeric></span></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td id="xdx_98D_eus-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions_iI_c20231231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeTwoMember_zATG1bSK1wc" title="Options, shares exercisable" style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions" contextRef="AsOf2023-12-31_custom_ExercisePriceRangeTwoMember" id="Fact001151" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">240,386</ix:nonFraction></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td id="xdx_98A_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1_iI_c20231231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeTwoMember_zxoxvZBfRNf6" title="Stock option, aggregate intrinsic value on exercisable shares" style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl1153">-</span></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_903_eus-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit_c20230101__20231231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeThreeMember_zJbONXr9NGce" title="Stock option, exercise price"><ix:nonFraction name="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit" contextRef="From2023-01-012023-12-31_custom_ExercisePriceRangeThreeMember" id="Fact001155" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">1.30</ix:nonFraction></span></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td id="xdx_984_eus-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions_iI_c20231231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeThreeMember_zsdLopjx0gdf" title="Options, shares outstanding" style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions" contextRef="AsOf2023-12-31_custom_ExercisePriceRangeThreeMember" id="Fact001157" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">50,000</ix:nonFraction></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td id="xdx_983_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_iI_c20231231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeThreeMember_zfhQwORB1ved" title="Stock option, aggregate intrinsic value" style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl1159">-</span></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_903_eus-gaap--SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2_dtY_c20230101__20231231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeThreeMember_zEjbzr5a5Ubd" title="Stock option, weighted average remaining contractual life"><ix:nonNumeric contextRef="From2023-01-012023-12-31_custom_ExercisePriceRangeThreeMember" format="ixt-sec:duryear" id="Fact001161" name="us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2">4.21</ix:nonNumeric></span></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td id="xdx_988_eus-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions_iI_c20231231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeThreeMember_zAb9C5wh3HWd" title="Options, shares exercisable" style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions" contextRef="AsOf2023-12-31_custom_ExercisePriceRangeThreeMember" id="Fact001163" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">43,750</ix:nonFraction></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td id="xdx_98C_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1_iI_c20231231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeThreeMember_zKIzzXyAHRre" title="Stock option, aggregate intrinsic value on exercisable shares" style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl1165">-</span></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_902_eus-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit_c20230101__20231231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeFourMember_zcNnTjlC5kDk" title="Stock option, exercise price"><ix:nonFraction name="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit" contextRef="From2023-01-012023-12-31_custom_ExercisePriceRangeFourMember" id="Fact001167" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">1.37</ix:nonFraction></span></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td id="xdx_986_eus-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions_iI_c20231231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeFourMember_zjZBlmx33Pla" title="Options, shares outstanding" style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions" contextRef="AsOf2023-12-31_custom_ExercisePriceRangeFourMember" id="Fact001169" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">975,000</ix:nonFraction></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td id="xdx_984_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_iI_c20231231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeFourMember_zPmnrEYyYZD" title="Stock option, aggregate intrinsic value" style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl1171">-</span></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90A_eus-gaap--SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2_dtY_c20230101__20231231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeFourMember_zWykEPseBCKf" title="Stock option, weighted average remaining contractual life"><ix:nonNumeric contextRef="From2023-01-012023-12-31_custom_ExercisePriceRangeFourMember" format="ixt-sec:duryear" id="Fact001173" name="us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2">4.17</ix:nonNumeric></span></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td id="xdx_985_eus-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions_iI_c20231231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeFourMember_zec5JlVXfHI" title="Options, shares exercisable" style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions" contextRef="AsOf2023-12-31_custom_ExercisePriceRangeFourMember" id="Fact001175" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">561,719</ix:nonFraction></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td id="xdx_983_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1_iI_c20231231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeFourMember_zodRTTHznA4e" title="Stock option, aggregate intrinsic value on exercisable shares" style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl1177">-</span></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_908_eus-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit_c20230101__20231231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeFiveMember_zyIYAAlOEMPl" title="Stock option, exercise price"><ix:nonFraction name="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit" contextRef="From2023-01-012023-12-31_custom_ExercisePriceRangeFiveMember" id="Fact001179" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">1.75</ix:nonFraction></span></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td id="xdx_988_eus-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions_iI_c20231231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeFiveMember_zQptYFhsXte4" title="Options, shares outstanding" style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions" contextRef="AsOf2023-12-31_custom_ExercisePriceRangeFiveMember" id="Fact001181" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">54,285</ix:nonFraction></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td id="xdx_981_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_iI_c20231231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeFiveMember_zo1fFXH87n81" title="Stock option, aggregate intrinsic value" style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl1183">-</span></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_906_eus-gaap--SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2_dtY_c20230101__20231231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeFiveMember_zFcQNivy35Be" title="Stock option, weighted average remaining contractual life"><ix:nonNumeric contextRef="From2023-01-012023-12-31_custom_ExercisePriceRangeFiveMember" format="ixt-sec:duryear" id="Fact001185" name="us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2">2.25</ix:nonNumeric></span></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: right"></p>
    <p id="xdx_98F_eus-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions_iI_c20231231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeFiveMember_zzi5h6q58LCd" title="Options, shares exercisable" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions" contextRef="AsOf2023-12-31_custom_ExercisePriceRangeFiveMember" id="Fact001187" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">54,285</ix:nonFraction></span></p></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td id="xdx_981_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1_iI_c20231231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeFiveMember_zO1AmwXzm5oc" title="Stock option, aggregate intrinsic value on exercisable shares" style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl1189">-</span></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90F_eus-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit_c20230101__20231231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeSixMember_zL6tgR1vlWN4" title="Stock option, exercise price"><ix:nonFraction name="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit" contextRef="From2023-01-012023-12-31_custom_ExercisePriceRangeSixMember" id="Fact001191" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">2.80</ix:nonFraction></span></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td id="xdx_98D_eus-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions_iI_c20231231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeSixMember_z1ijSAqahwj2" title="Options, shares outstanding" style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions" contextRef="AsOf2023-12-31_custom_ExercisePriceRangeSixMember" id="Fact001193" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">141,429</ix:nonFraction></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td id="xdx_988_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_iI_c20231231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeSixMember_zsYNwWzfoq9j" title="Stock option, aggregate intrinsic value" style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl1195">-</span></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90F_eus-gaap--SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2_dtY_c20230101__20231231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeSixMember_zsCLsRLdkKyh" title="Stock option, weighted average remaining contractual life"><ix:nonNumeric contextRef="From2023-01-012023-12-31_custom_ExercisePriceRangeSixMember" format="ixt-sec:duryear" id="Fact001197" name="us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2">2.25</ix:nonNumeric></span></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td id="xdx_98C_eus-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions_iI_c20231231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeSixMember_zsdstAMVSRJ8" title="Options, shares exercisable" style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions" contextRef="AsOf2023-12-31_custom_ExercisePriceRangeSixMember" id="Fact001199" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">141,429</ix:nonFraction></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td id="xdx_98A_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1_iI_c20231231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeSixMember_z9tgdx3ulgGg" title="Stock option, aggregate intrinsic value on exercisable shares" style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl1201">-</span></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_900_eus-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit_c20230101__20231231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeSevenMember_zDANi0kfYtca" title="Stock option, exercise price"><ix:nonFraction name="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit" contextRef="From2023-01-012023-12-31_custom_ExercisePriceRangeSevenMember" id="Fact001203" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">1.39</ix:nonFraction></span></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td id="xdx_98B_eus-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions_iI_c20231231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeSevenMember_zpCZb5xXKeW4" title="Options, shares outstanding" style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions" contextRef="AsOf2023-12-31_custom_ExercisePriceRangeSevenMember" id="Fact001205" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">10,000</ix:nonFraction></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td id="xdx_985_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_iI_c20231231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeSevenMember_zUu60m0y0Tq7" title="Stock option, aggregate intrinsic value" style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl1207">-</span></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_903_eus-gaap--SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2_dtY_c20230101__20231231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeSevenMember_zgxXTuK5Yk09" title="Stock option, weighted average remaining contractual life"><ix:nonNumeric contextRef="From2023-01-012023-12-31_custom_ExercisePriceRangeSevenMember" format="ixt-sec:duryear" id="Fact001209" name="us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2">3.75</ix:nonNumeric></span></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td id="xdx_987_eus-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions_iI_c20231231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeSevenMember_zvlXcHh2AFB2" title="Options, shares exercisable" style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions" contextRef="AsOf2023-12-31_custom_ExercisePriceRangeSevenMember" id="Fact001211" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">10,000</ix:nonFraction></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td id="xdx_98A_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1_iI_c20231231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeSevenMember_zKme8A1lT2Le" title="Stock option, aggregate intrinsic value on exercisable shares" style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl1213">-</span></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_906_eus-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit_c20230101__20231231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeEightMember_zIGBcB7uZsOe" title="Stock option, exercise price"><ix:nonFraction name="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit" contextRef="From2023-01-012023-12-31_custom_ExercisePriceRangeEightMember" id="Fact001215" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">4.25</ix:nonFraction></span></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td id="xdx_98B_eus-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions_iI_c20231231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeEightMember_zBBjbohhBN6j" title="Options, shares outstanding" style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions" contextRef="AsOf2023-12-31_custom_ExercisePriceRangeEightMember" id="Fact001217" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">50,000</ix:nonFraction></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td id="xdx_98D_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_iI_c20231231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeEightMember_zcz5sVnxPIbc" title="Stock option, aggregate intrinsic value" style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl1219">-</span></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_909_eus-gaap--SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2_dtY_c20230101__20231231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeEightMember_zrO1ZuGNb9R8" title="Stock option, weighted average remaining contractual life"><ix:nonNumeric contextRef="From2023-01-012023-12-31_custom_ExercisePriceRangeEightMember" format="ixt-sec:duryear" id="Fact001221" name="us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2">3.75</ix:nonNumeric></span></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td id="xdx_989_eus-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions_iI_c20231231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeEightMember_zE2PWB9ZoCf9" title="Options, shares exercisable" style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions" contextRef="AsOf2023-12-31_custom_ExercisePriceRangeEightMember" id="Fact001223" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">50,000</ix:nonFraction></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td id="xdx_980_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1_iI_c20231231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeEightMember_z8KaCTDq5sw6" title="Stock option, aggregate intrinsic value on exercisable shares" style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl1225">-</span></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90C_eus-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit_c20230101__20231231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeNineMember_zg6IcBmTQjU3" title="Stock option, exercise price"><ix:nonFraction name="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit" contextRef="From2023-01-012023-12-31_custom_ExercisePriceRangeNineMember" id="Fact001227" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">4.38</ix:nonFraction></span></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td id="xdx_98C_eus-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions_iI_c20231231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeNineMember_zq47EDyJeyF1" title="Options, shares outstanding" style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions" contextRef="AsOf2023-12-31_custom_ExercisePriceRangeNineMember" id="Fact001229" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">244,286</ix:nonFraction></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td id="xdx_981_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_iI_c20231231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeNineMember_ziqdd7G72LNh" title="Stock option, aggregate intrinsic value" style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl1231">-</span></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_902_eus-gaap--SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2_dtY_c20230101__20231231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeNineMember_ztN3xB6cqDx6" title="Stock option, weighted average remaining contractual life"><ix:nonNumeric contextRef="From2023-01-012023-12-31_custom_ExercisePriceRangeNineMember" format="ixt-sec:duryear" id="Fact001233" name="us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2">1.25</ix:nonNumeric></span></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td id="xdx_981_eus-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions_iI_c20231231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeNineMember_z0Xhb2DgSedh" title="Options, shares exercisable" style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions" contextRef="AsOf2023-12-31_custom_ExercisePriceRangeNineMember" id="Fact001235" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">244,286</ix:nonFraction></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td id="xdx_987_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1_iI_c20231231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeNineMember_z2OxjzEZCZ4g" title="Stock option, aggregate intrinsic value on exercisable shares" style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl1237">-</span></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_903_eus-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit_c20230101__20231231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeTenMember_z65Kidvx3JX3" title="Stock option, exercise price"><ix:nonFraction name="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit" contextRef="From2023-01-012023-12-31_custom_ExercisePriceRangeTenMember" id="Fact001239" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">7.00</ix:nonFraction></span></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td id="xdx_983_eus-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions_iI_c20231231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeTenMember_zrWWgPsF0bfc" title="Options, shares outstanding" style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions" contextRef="AsOf2023-12-31_custom_ExercisePriceRangeTenMember" id="Fact001241" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">536,335</ix:nonFraction></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td id="xdx_98C_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_iI_c20231231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeTenMember_zFvHlCXX4VM9" title="Stock option, aggregate intrinsic value" style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl1243">-</span></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_904_eus-gaap--SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2_dtY_c20230101__20231231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeTenMember_zsSwHVvDh4Z6" title="Stock option, weighted average remaining contractual life"><ix:nonNumeric contextRef="From2023-01-012023-12-31_custom_ExercisePriceRangeTenMember" format="ixt-sec:duryear" id="Fact001245" name="us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2">2.00</ix:nonNumeric></span></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td id="xdx_986_eus-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions_iI_c20231231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeTenMember_zEku6u3Bb35h" title="Options, shares exercisable" style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions" contextRef="AsOf2023-12-31_custom_ExercisePriceRangeTenMember" id="Fact001247" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">516,679</ix:nonFraction></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td id="xdx_986_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1_iI_c20231231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeTenMember_zT2dgOLkzh3" title="Stock option, aggregate intrinsic value on exercisable shares" style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl1249">-</span></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  </table>
</ix:nonNumeric><p id="xdx_8A4_zXim3hru36g" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">At
December 31,2023, the stock options outstanding and the options exercisable have exercise prices that exceed the stock market price at
December 31, 2023 and as such no intrinsic value exist. Intrinsic value is defined as the difference between the exercise price of the
options and the market price of the Company&#8217;s common stock.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<ix:exclude><!-- Field: Page; Sequence: 68; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 0pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->20<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%"><a href="#RM_014">Table of Contents</a></td></tr></table></div>
    <!-- Field: /Page --></ix:exclude>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>SHARPS
TECHNOLOGY, INC.</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTES
TO THE CONSOLIDATED FINANCIAL STATEMENTS</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>FOR
THE YEARS ENDED DECEMBER 31, 2023 AND 2022</b></span></p>

<p style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Note
11. Stock Options (continued)</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
2023 and 2022, the Company recognized stock-based compensation expense of $<span id="xdx_90D_eus-gaap--AllocatedShareBasedCompensationExpense_c20230101__20231231_zY0qg8KJESb6" title="Share based compensation"><ix:nonFraction name="us-gaap:AllocatedShareBasedCompensationExpense" contextRef="From2023-01-012023-12-31" id="Fact001251" format="ixt:numdotdecimal" decimals="0" unitRef="USD">920,108</ix:nonFraction></span>, of which $<span id="xdx_905_eus-gaap--AllocatedShareBasedCompensationExpense_c20230101__20231231__us-gaap--IncomeStatementLocationAxis__us-gaap--GeneralAndAdministrativeExpenseMember_zrQvrcNADPh5" title="Share based compensation"><ix:nonFraction name="us-gaap:AllocatedShareBasedCompensationExpense" contextRef="From2023-01-012023-12-31_us-gaap_GeneralAndAdministrativeExpenseMember" id="Fact001253" format="ixt:numdotdecimal" decimals="0" unitRef="USD">906,745</ix:nonFraction></span> and $<span id="xdx_90E_eus-gaap--AllocatedShareBasedCompensationExpense_c20230101__20231231__us-gaap--IncomeStatementLocationAxis__us-gaap--ResearchAndDevelopmentExpenseMember_zSL8xRr5zLg7" title="Share based compensation"><ix:nonFraction name="us-gaap:AllocatedShareBasedCompensationExpense" contextRef="From2023-01-012023-12-31_us-gaap_ResearchAndDevelopmentExpenseMember" id="Fact001255" format="ixt:numdotdecimal" decimals="0" unitRef="USD">13,363</ix:nonFraction></span> was recorded in general
and administrative and research and development expenses, respectively and $<span id="xdx_900_eus-gaap--AllocatedShareBasedCompensationExpense_c20220101__20221231_zoJQkHHv8Awa" title="Share based compensation"><ix:nonFraction name="us-gaap:AllocatedShareBasedCompensationExpense" contextRef="From2022-01-012022-12-31" id="Fact001257" format="ixt:numdotdecimal" decimals="0" unitRef="USD">1,012,592</ix:nonFraction></span>, of which $<span id="xdx_904_eus-gaap--AllocatedShareBasedCompensationExpense_c20220101__20221231__us-gaap--IncomeStatementLocationAxis__us-gaap--GeneralAndAdministrativeExpenseMember_zY2v5U3RykU3" title="Share based compensation"><ix:nonFraction name="us-gaap:AllocatedShareBasedCompensationExpense" contextRef="From2022-01-012022-12-31_us-gaap_GeneralAndAdministrativeExpenseMember" id="Fact001259" format="ixt:numdotdecimal" decimals="0" unitRef="USD">915,797</ix:nonFraction></span> and $<span id="xdx_909_eus-gaap--AllocatedShareBasedCompensationExpense_c20220101__20221231__us-gaap--IncomeStatementLocationAxis__us-gaap--ResearchAndDevelopmentExpenseMember_zlKC4gc67N0f" title="Share based compensation"><ix:nonFraction name="us-gaap:AllocatedShareBasedCompensationExpense" contextRef="From2022-01-012022-12-31_us-gaap_ResearchAndDevelopmentExpenseMember" id="Fact001261" format="ixt:numdotdecimal" decimals="0" unitRef="USD">96,795</ix:nonFraction></span> was recorded in
general and administrative and research and development expenses, respectively. Further, in 2022, the Company recorded stock-based charges
of $<span id="xdx_90A_ecustom--StockBasedChargesRelatingToPurchaseOfMachinery_c20220101__20221231_z3l8vRBblJ82" title="Stock based charges relating to purchase of machinery"><ix:nonFraction name="STSS:StockBasedChargesRelatingToPurchaseOfMachinery" contextRef="From2022-01-012022-12-31" id="Fact001263" format="ixt:numdotdecimal" decimals="0" unitRef="USD">63,612</ix:nonFraction></span> relating to purchase of machinery (See Note 4) and $<span id="xdx_90B_ecustom--StockBasedChargesRelatingToAcquisition_c20220101__20220331_z2vCFm4wcxVb" title="Stock based charges relating to acquisition"><ix:nonFraction name="STSS:StockBasedChargesRelatingToAcquisition" contextRef="From2022-01-012022-03-31" id="Fact001265" format="ixt:numdotdecimal" decimals="0" unitRef="USD">60,435</ix:nonFraction></span> relating to an Acquisition. (See Note 5.)</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<ix:nonNumeric contextRef="From2023-01-012023-12-31" escape="true" id="Fact001267" name="us-gaap:ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock"><p id="xdx_897_eus-gaap--ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock_zaVNnRXOWKLh" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
fair value of stock option awards accounted for under ASC 718 was estimated at the date of grant using a Black-Scholes option-pricing
model with the following assumptions:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_8BB_zSEmShr3UWYk" style="display: none">Schedule
of Fair Value of Stock Option Awards</span></span></span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 90%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;&#160;</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></td>
    <td colspan="2" style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"><p style="margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: imes New Roman, Times, Serif; font-size: 10pt"><b>Year
                                            Ended <br/> December 31,</b></span></p>
                                                                                <p style="margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>2023</b></span></p></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></td>
    <td colspan="2" style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"><p style="margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: imes New Roman, Times, Serif; font-size: 10pt"><b>Year
                                            Ended <br/> December 31,</b></span></p>
                                                                                <p style="margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>2022</b></span></p></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Expected term (years)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_905_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_dtY_c20230101__20231231__srt--RangeAxis__srt--MinimumMember_zCwKHtEdnz3" title="Expected term (years)"><ix:nonNumeric contextRef="From2023-01-012023-12-31_srt_MinimumMember" format="ixt-sec:duryear" id="Fact001269" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1">2.88</ix:nonNumeric></span> to <span id="xdx_90B_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_dtY_c20230101__20231231__srt--RangeAxis__srt--MaximumMember_zZsfDdolkMLj" title="Expected term (years)"><ix:nonNumeric contextRef="From2023-01-012023-12-31_srt_MaximumMember" format="ixt-sec:duryear" id="Fact001271" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1">3.25</ix:nonNumeric></span></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90A_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_dtY_c20220101__20221231__srt--RangeAxis__srt--MinimumMember_zYZfHI8kOjj9" title="Expected term (years)"><ix:nonNumeric contextRef="From2022-01-012022-12-31_srt_MinimumMember" format="ixt-sec:duryear" id="Fact001273" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1">2.50</ix:nonNumeric></span> to <span id="xdx_903_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_dtY_c20220101__20221231__srt--RangeAxis__srt--MaximumMember_zE8ABMl1Ims5" title="Expected term (years)"><ix:nonNumeric contextRef="From2022-01-012022-12-31_srt_MaximumMember" format="ixt-sec:duryear" id="Fact001275" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1">3.00</ix:nonNumeric></span></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Expected volatility</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_900_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate_pid_dp_c20230101__20231231__srt--RangeAxis__srt--MinimumMember_zPnYpozJcvrf" title="Expected volatility"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate" contextRef="From2023-01-012023-12-31_srt_MinimumMember" id="Fact001277" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">75.40</ix:nonFraction></span>% to <span id="xdx_903_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate_pid_dp_c20230101__20231231__srt--RangeAxis__srt--MaximumMember_zGQCMRJibS6b" title="Expected volatility"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate" contextRef="From2023-01-012023-12-31_srt_MaximumMember" id="Fact001279" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">89.93</ix:nonFraction></span></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">%</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_907_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate_pid_dp_c20220101__20221231__srt--RangeAxis__srt--MinimumMember_zaSbi4LYP76j" title="Expected volatility"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate" contextRef="From2022-01-012022-12-31_srt_MinimumMember" id="Fact001281" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">100.81</ix:nonFraction></span>% to <span id="xdx_902_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate_pid_dp_c20220101__20221231__srt--RangeAxis__srt--MaximumMember_z1SLChj224j2" title="Expected volatility"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate" contextRef="From2022-01-012022-12-31_srt_MaximumMember" id="Fact001283" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">110.74</ix:nonFraction></span></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">%</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Risk-free interest rate</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90D_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_pid_dp_uPure_c20230101__20231231__srt--RangeAxis__srt--MinimumMember_zUNlHbmGIj35" title="Risk-free interest rate"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" contextRef="From2023-01-012023-12-31_srt_MinimumMember" id="Fact001285" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">3.71</ix:nonFraction></span>% to <span id="xdx_908_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_pid_dp_uPure_c20230101__20231231__srt--RangeAxis__srt--MaximumMember_zLZSAvDhMWhe" title="Risk-free interest rate"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" contextRef="From2023-01-012023-12-31_srt_MaximumMember" id="Fact001287" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">4.27</ix:nonFraction></span></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">%</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_907_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_pid_dp_uPure_c20220101__20221231__srt--RangeAxis__srt--MinimumMember_zPolfcc2Cfa3" title="Risk-free interest rate"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" contextRef="From2022-01-012022-12-31_srt_MinimumMember" id="Fact001289" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">2.90</ix:nonFraction></span>% to <span id="xdx_90F_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_pid_dp_uPure_c20220101__20221231__srt--RangeAxis__srt--MaximumMember_zNO3zYXQfz4i" title="Risk-free interest rate"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" contextRef="From2022-01-012022-12-31_srt_MaximumMember" id="Fact001291" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">3.47</ix:nonFraction></span></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">%</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 52%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Dividend rate</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 20%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90D_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_pid_dp_uPure_c20230101__20231231_zYPm6pxYJgwi" title="Dividend rate"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" contextRef="From2023-01-012023-12-31" id="Fact001293" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">0</ix:nonFraction></span></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">%</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 20%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90D_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_pid_dp_uPure_c20220101__20221231_zWDNTz6ynvnd" title="Dividend rate"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" contextRef="From2022-01-012022-12-31" id="Fact001295" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">0</ix:nonFraction></span></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">%</span></td></tr>
  </table>
</ix:nonNumeric><p id="xdx_8A9_zXrf4AdsGHX9" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2023-01-012023-12-31" escape="true" id="Fact001297" name="us-gaap:IncomeTaxDisclosureTextBlock"><p id="xdx_807_eus-gaap--IncomeTaxDisclosureTextBlock_ztcF7iu1yaMi" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Note
12. <span id="xdx_823_z8INrpPReKJe">Income Taxes </span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">A
reconciliation of the Federal statutory rate of <span id="xdx_903_eus-gaap--EffectiveIncomeTaxRateContinuingOperations_pid_dp_uPure_c20230101__20231231_z4h9c9j1s3k8" title="Effective tax rate"><ix:nonFraction name="us-gaap:EffectiveIncomeTaxRateContinuingOperations" contextRef="From2023-01-012023-12-31" id="Fact001299" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">21</ix:nonFraction></span>% and <span id="xdx_90C_eus-gaap--EffectiveIncomeTaxRateContinuingOperations_pid_dp_uPure_c20220101__20221231_zliMhxaMet98" title="Effective tax rate"><ix:nonFraction name="us-gaap:EffectiveIncomeTaxRateContinuingOperations" contextRef="From2022-01-012022-12-31" id="Fact001301" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">28</ix:nonFraction></span>% in the years ended December 31, 2023 and 2022, respectively to the total
effective rate applicable to income (loss) is as follows:</span></p>

<ix:nonNumeric contextRef="From2023-01-012023-12-31" escape="true" id="Fact001303" name="us-gaap:ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock"><p id="xdx_89F_eus-gaap--ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock_zGYVk5GmxaCd" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span><span id="xdx_8B4_zqY6jMnLLYnl" style="display: none">Schedule
of Reconciliation of Federal Statutory Rate to Total Effective Rate</span></span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 70%">
  <tr style="vertical-align: bottom">
    <td><b>&#160;</b></td><td><b>&#160;</b></td>
    <td colspan="2" id="xdx_495_20230101__20231231_z0UDmBlLfCNf" style="text-align: center"><b>Year Ended</b></td><td><b>&#160;</b></td><td><b>&#160;</b></td>
    <td colspan="2" id="xdx_49F_20220101__20221231_zoxx9DBcUfgb" style="text-align: center"><b>Year Ended</b></td><td><b>&#160;</b></td></tr>
  <tr style="vertical-align: bottom">
    <td><b>&#160;</b></td><td style="padding-bottom: 1pt"><b>&#160;</b></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"><b>December 31, 2023</b></td><td style="padding-bottom: 1pt"><b>&#160;</b></td><td style="padding-bottom: 1pt"><b>&#160;</b></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"><b>December 31, 2022</b></td><td style="padding-bottom: 1pt"><b>&#160;</b></td></tr>
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: right">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: right">&#160;</td><td>&#160;</td></tr>
  <tr id="xdx_408_eus-gaap--IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate_maITEBzVgo_zsoxYDO4XEEc" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 56%; text-align: left">Expected benefit at statutory federal tax rate</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 18%; text-align: right">(<ix:nonFraction name="us-gaap:IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate" contextRef="From2023-01-012023-12-31" id="Fact001305" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">2,073,230</ix:nonFraction></td><td style="width: 1%; text-align: left">)</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 18%; text-align: right">(<ix:nonFraction name="us-gaap:IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate" contextRef="From2022-01-012022-12-31" id="Fact001306" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">974,329</ix:nonFraction></td><td style="width: 1%; text-align: left">)</td></tr>
  <tr id="xdx_40A_eus-gaap--IncomeTaxReconciliationChangeInEnactedTaxRate_maITEBzVgo_zKbB9nlMYVCh" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Permanent differences &#8211; net</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction name="us-gaap:IncomeTaxReconciliationChangeInEnactedTaxRate" contextRef="From2023-01-012023-12-31" id="Fact001308" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">35,469</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction name="us-gaap:IncomeTaxReconciliationChangeInEnactedTaxRate" contextRef="From2022-01-012022-12-31" id="Fact001309" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">859,515</ix:nonFraction></td><td style="text-align: left">)</td></tr>
  <tr id="xdx_40B_eus-gaap--IncomeTaxReconciliationStateAndLocalIncomeTaxes_maITEBzVgo_zJ9nwI8YtwXc" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">State and local taxes, net of federal tax benefit</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1311">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction name="us-gaap:IncomeTaxReconciliationStateAndLocalIncomeTaxes" contextRef="From2022-01-012022-12-31" id="Fact001312" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">265,607</ix:nonFraction></td><td style="text-align: left">)</td></tr>
  <tr id="xdx_404_eus-gaap--IncomeTaxReconciliationOtherAdjustments_maITEBzVgo_zIb7QHZpsA5k" style="vertical-align: bottom; background-color: White">
    <td>Other</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction name="us-gaap:IncomeTaxReconciliationOtherAdjustments" contextRef="From2023-01-012023-12-31" id="Fact001314" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">24,569</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction name="us-gaap:IncomeTaxReconciliationOtherAdjustments" contextRef="From2022-01-012022-12-31" id="Fact001315" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">21,965</ix:nonFraction></td><td style="text-align: left">)</td></tr>
  <tr id="xdx_40B_eus-gaap--IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance_maITEBzVgo_zsw2QihYgKd8" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1pt">Change in valuation allowance</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance" contextRef="From2023-01-012023-12-31" id="Fact001317" format="ixt:numdotdecimal" decimals="0" unitRef="USD">2,103,268</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance" contextRef="From2022-01-012022-12-31" id="Fact001318" format="ixt:numdotdecimal" decimals="0" unitRef="USD">2,121,416</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_40A_eus-gaap--IncomeTaxExpenseBenefit_iT_mtITEBzVgo_zytKKJ8oxzZ8" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 2.5pt">Income tax expense (benefit)</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">(<ix:nonFraction name="us-gaap:IncomeTaxExpenseBenefit" contextRef="From2023-01-012023-12-31" id="Fact001320" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">30,000</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">)</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1321">-</span></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  </table>

</ix:nonNumeric><p id="xdx_8AD_zwZtbXllGFL9" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<ix:nonNumeric contextRef="From2023-01-012023-12-31" escape="true" id="Fact001323" name="us-gaap:ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock"><p id="xdx_890_eus-gaap--ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock_zGiKRNi3lW48" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
components of the Company&#8217;s deferred tax assets (liabilities) are as follows:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span><span id="xdx_8BD_zqVlxRt6W36c" style="display: none">Schedule
of Components of Deferred tax Assets</span></span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 70%">
  <tr style="vertical-align: bottom">
    <td><b>&#160;</b></td><td style="padding-bottom: 1pt"><b>&#160;</b></td>
    <td colspan="2" id="xdx_49B_20231231_z0J5g5RXGe7k" style="border-bottom: Black 1pt solid; text-align: center"><b>Year Ended <br/> December 31, <br/> 2023</b></td><td style="padding-bottom: 1pt"><b>&#160;</b></td><td style="padding-bottom: 1pt"><b>&#160;</b></td>
    <td colspan="2" id="xdx_499_20221231_ze9k3w767yP7" style="border-bottom: Black 1pt solid; text-align: center"><b>Year Ended <br/> December 31, <br/> 2022</b></td><td style="padding-bottom: 1pt"><b>&#160;</b></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Deferred tax assets (liabilities):</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40A_ecustom--DeferredTaxAssetsPropertyPlantAndEquipments_iI_msDTLzq2T_zTwV5gIYuNc2" style="vertical-align: bottom; background-color: White">
    <td style="width: 56%; text-align: left">Fixed assets</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 18%; text-align: right">(<ix:nonFraction name="STSS:DeferredTaxAssetsPropertyPlantAndEquipments" contextRef="AsOf2023-12-31" id="Fact001325" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">281,073</ix:nonFraction></td><td style="width: 1%; text-align: left">)</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 18%; text-align: right">(<ix:nonFraction name="STSS:DeferredTaxAssetsPropertyPlantAndEquipments" contextRef="AsOf2022-12-31" id="Fact001326" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">268,594</ix:nonFraction></td><td style="width: 1%; text-align: left">)</td></tr>
  <tr id="xdx_409_eus-gaap--DeferredTaxAssetInterestCarryforward_iI_msDTLzq2T_z96ErXhSyqjb" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>Interest</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:DeferredTaxAssetInterestCarryforward" contextRef="AsOf2023-12-31" id="Fact001328" format="ixt:numdotdecimal" decimals="0" unitRef="USD">35,178</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:DeferredTaxAssetInterestCarryforward" contextRef="AsOf2022-12-31" id="Fact001329" format="ixt:numdotdecimal" decimals="0" unitRef="USD">62,310</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_409_eus-gaap--DeferredTaxAssetsInProcessResearchAndDevelopment_iI_msDTLzq2T_z7ulqOLfvNJ4" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Research and development expenses</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:DeferredTaxAssetsInProcessResearchAndDevelopment" contextRef="AsOf2023-12-31" id="Fact001331" format="ixt:numdotdecimal" decimals="0" unitRef="USD">400,810</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:DeferredTaxAssetsInProcessResearchAndDevelopment" contextRef="AsOf2022-12-31" id="Fact001332" format="ixt:numdotdecimal" decimals="0" unitRef="USD">454,942</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_401_eus-gaap--DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost_iI_msDTLzq2T_zEB6thclwJQ" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Stock-based compensation</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost" contextRef="AsOf2023-12-31" id="Fact001334" format="ixt:numdotdecimal" decimals="0" unitRef="USD">895,509</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost" contextRef="AsOf2022-12-31" id="Fact001335" format="ixt:numdotdecimal" decimals="0" unitRef="USD">917,351</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_407_eus-gaap--DeferredTaxAssetsCharitableContributionCarryforwards_iI_msDTLzq2T_zq5rACDRarhh" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Charitable Contributions</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:DeferredTaxAssetsCharitableContributionCarryforwards" contextRef="AsOf2023-12-31" id="Fact001337" format="ixt:numdotdecimal" decimals="0" unitRef="USD">420</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_402_eus-gaap--DeferredTaxAssetsOperatingLossCarryforwardsDomestic_iI_msDTLzq2T_zmMXtHjgfas9" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Net operating losses - federal</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:DeferredTaxAssetsOperatingLossCarryforwardsDomestic" contextRef="AsOf2023-12-31" id="Fact001340" format="ixt:numdotdecimal" decimals="0" unitRef="USD">4,456,242</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:DeferredTaxAssetsOperatingLossCarryforwardsDomestic" contextRef="AsOf2022-12-31" id="Fact001341" format="ixt:numdotdecimal" decimals="0" unitRef="USD">2,898,411</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_405_eus-gaap--DeferredTaxAssetsOperatingLossCarryforwardsStateAndLocal_iI_msDTLzq2T_z44uMVdhXKF2" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Net operating losses &#8211; state and local</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:DeferredTaxAssetsOperatingLossCarryforwardsStateAndLocal" contextRef="AsOf2023-12-31" id="Fact001343" format="ixt:numdotdecimal" decimals="0" unitRef="USD">543,264</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:DeferredTaxAssetsOperatingLossCarryforwardsStateAndLocal" contextRef="AsOf2022-12-31" id="Fact001344" format="ixt:numdotdecimal" decimals="0" unitRef="USD">921,350</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40E_eus-gaap--DeferredTaxAssetsOperatingLossCarryforwardsForeign_iI_msDTLzq2T_zzGEKTr8ul1c" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Net operating losses - foreign</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:DeferredTaxAssetsOperatingLossCarryforwardsForeign" contextRef="AsOf2023-12-31" id="Fact001346" format="ixt:numdotdecimal" decimals="0" unitRef="USD">233,114</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:DeferredTaxAssetsOperatingLossCarryforwardsForeign" contextRef="AsOf2022-12-31" id="Fact001347" format="ixt:numdotdecimal" decimals="0" unitRef="USD">37,686</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40C_eus-gaap--DeferredTaxAssetsTaxCreditCarryforwardsResearch_iI_msDTLzq2T_zTWDpY8yRTj3" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1pt">Research credit</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:DeferredTaxAssetsTaxCreditCarryforwardsResearch" contextRef="AsOf2023-12-31" id="Fact001349" format="ixt:numdotdecimal" decimals="0" unitRef="USD">28,985</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:DeferredTaxAssetsTaxCreditCarryforwardsResearch" contextRef="AsOf2022-12-31" id="Fact001350" format="ixt:numdotdecimal" decimals="0" unitRef="USD">28,985</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_403_eus-gaap--DeferredTaxAssetsValuationAllowance_iNI_di_maDTLzq2T_ziUKAGcGlkJ5" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1pt">Less valuation allowance</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(<ix:nonFraction name="us-gaap:DeferredTaxAssetsValuationAllowance" contextRef="AsOf2023-12-31" id="Fact001352" format="ixt:numdotdecimal" decimals="0" unitRef="USD">6,474,449</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(<ix:nonFraction name="us-gaap:DeferredTaxAssetsValuationAllowance" contextRef="AsOf2022-12-31" id="Fact001353" format="ixt:numdotdecimal" decimals="0" unitRef="USD">5,244,441</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">)</td></tr>
  <tr id="xdx_40C_eus-gaap--DeferredTaxLiabilities_iNTI_di_mtDTLzq2T_zkOxNhILOU8e" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 2.5pt">Net deferred tax liability</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">(<ix:nonFraction name="us-gaap:DeferredTaxLiabilities" contextRef="AsOf2023-12-31" id="Fact001355" format="ixt:numdotdecimal" decimals="0" unitRef="USD">162,000</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">)</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">(<ix:nonFraction name="us-gaap:DeferredTaxLiabilities" contextRef="AsOf2022-12-31" id="Fact001356" format="ixt:numdotdecimal" decimals="0" unitRef="USD">192,000</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">)</td></tr>
  </table>

</ix:nonNumeric><p id="xdx_8AB_zaHXk6T49QI6" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<ix:exclude><!-- Field: Page; Sequence: 69; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 0pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->21<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%"><a href="#RM_014">Table of Contents</a></td></tr></table></div>
    <!-- Field: /Page --></ix:exclude>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>SHARPS
TECHNOLOGY, INC.</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTES
TO THE CONSOLIDATED FINANCIAL STATEMENTS</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>FOR
THE YEARS ENDED DECEMBER 31, 2023 AND 2022</b></span></p>

<p style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Note
12. Income Taxes (continued)</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
authoritative guidance requires the asset and liability method of accounting for deferred income taxes. Deferred tax assets and liabilities
are determined based on the difference between the financial statement and tax bases of assets and liabilities. Deferred tax assets or
liabilities at the end of each period are determined using the tax rate expected to be in effect when taxes are actually paid or recovered.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
guidance also requires that a valuation allowance be established when it is more likely than not that all or a portion of a deferred
tax asset will not be realized. A review of all available positive and negative evidence needs to be considered, including a company&#8217;s
current and past performance, the market environment in which the company operates, length of carryback and carryforward periods and
existing contracts that will result in future profits. After reviewing all the evidence, the company has recorded a full valuation allowance.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
of December 31, 2023, the Company had U.S. federal net operating loss carryforwards of approximately $<span id="xdx_901_eus-gaap--OperatingLossCarryforwards_iI_c20231231__us-gaap--IncomeTaxAuthorityAxis__us-gaap--DomesticCountryMember_zlhhhudquRJb" title="Net operating loss carryforwards"><ix:nonFraction name="us-gaap:OperatingLossCarryforwards" contextRef="AsOf2023-12-31_us-gaap_DomesticCountryMember" id="Fact001358" format="ixt:numdotdecimal" decimals="0" unitRef="USD">21,222,000</ix:nonFraction></span> of which $<span id="xdx_906_eus-gaap--OperatingLossCarryforwards_iI_c20231231__us-gaap--IncomeTaxAuthorityAxis__us-gaap--DomesticCountryMember__srt--StatementScenarioAxis__custom--ExpiresOnTwoThousandTwentyEightMember_zoEWHYZ2Rerj" title="Net operating loss carryforwards"><ix:nonFraction name="us-gaap:OperatingLossCarryforwards" contextRef="AsOf2023-12-31_us-gaap_DomesticCountryMember_custom_ExpiresOnTwoThousandTwentyEightMember" id="Fact001360" format="ixt:numdotdecimal" decimals="0" unitRef="USD">241,000</ix:nonFraction></span>, if
not fully utilized, expires by 2038 and which $<span id="xdx_900_eus-gaap--OperatingLossCarryforwards_iI_c20231231__srt--StatementScenarioAxis__custom--NotExpireMember__us-gaap--IncomeTaxAuthorityAxis__us-gaap--DomesticCountryMember_z6GOzQBVOLB3" title="Net operating loss carryforwards"><ix:nonFraction name="us-gaap:OperatingLossCarryforwards" contextRef="AsOf2023-12-31_custom_NotExpireMember_us-gaap_DomesticCountryMember" id="Fact001362" format="ixt:numdotdecimal" decimals="0" unitRef="USD">20,981,000</ix:nonFraction></span> do not expire. The Company has foreign net operating loss carryforwards of
$<span id="xdx_901_eus-gaap--OperatingLossCarryforwards_iI_c20231231__us-gaap--IncomeTaxAuthorityAxis__us-gaap--ForeignCountryMember_z429voBPRPL" title="Net operating loss carryforwards"><ix:nonFraction name="us-gaap:OperatingLossCarryforwards" contextRef="AsOf2023-12-31_us-gaap_ForeignCountryMember" id="Fact001364" format="ixt:numdotdecimal" decimals="0" unitRef="USD">2,590,000</ix:nonFraction></span>, if not fully utilized, expire through 2028. Utilization is dependent on generating sufficient taxable income prior to expiration
of the tax loss carryforwards.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<ix:nonNumeric contextRef="From2023-01-012023-12-31" escape="true" id="Fact001366" name="us-gaap:ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock"><p id="xdx_896_eus-gaap--ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock_zBaxIPJlllzi" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
geographical components of loss before income taxes consisted of the following for the years ended December 31:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span><span id="xdx_8B9_zO1BxVr7Nt6j" style="display: none">Schedule
of Geographical Components of Loss Before Income Taxes</span></span></span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 80%">
  <tr style="vertical-align: bottom">
    <td><b>&#160;</b></td><td><b>&#160;</b></td>
    <td colspan="2" id="xdx_496_20230101__20231231_z8rQAVv08OLf" style="text-align: center"><b>Year Ended</b></td><td><b>&#160;</b></td><td><b>&#160;</b></td>
    <td colspan="2" id="xdx_494_20220101__20221231_zQDtYGlN93ac" style="text-align: center"><b>Year Ended</b></td><td><b>&#160;</b></td></tr>
  <tr style="vertical-align: bottom">
    <td><b>&#160;</b></td><td style="padding-bottom: 1pt"><b>&#160;</b></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"><b>December 31, <br/> 2023</b></td><td style="padding-bottom: 1pt"><b>&#160;</b></td><td style="padding-bottom: 1pt"><b>&#160;</b></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"><b>December 31,<br/> 2022</b></td><td style="padding-bottom: 1pt"><b>&#160;</b></td></tr>
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2">&#160;</td><td style="padding-bottom: 1pt">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="text-align: right">&#160;</td><td style="padding-bottom: 1pt">&#160;</td></tr>
  <tr id="xdx_406_eus-gaap--IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic_maILFCOzLlh_z7Si8U5ZTw9j" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 60%; text-align: left">United Stated Operations</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 16%; text-align: right">(<ix:nonFraction name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic" contextRef="From2023-01-012023-12-31" id="Fact001368" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">8,173,807</ix:nonFraction></td><td style="width: 1%; text-align: left">)</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 16%; text-align: right">(<ix:nonFraction name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic" contextRef="From2022-01-012022-12-31" id="Fact001369" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">3,978,832</ix:nonFraction></td><td style="width: 1%; text-align: left">)</td></tr>
  <tr id="xdx_404_eus-gaap--IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign_maILFCOzLlh_zL5XFyf7DTp9" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1pt">International Operations</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(<ix:nonFraction name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign" contextRef="From2023-01-012023-12-31" id="Fact001371" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">1,667,831</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(<ix:nonFraction name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign" contextRef="From2022-01-012022-12-31" id="Fact001372" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">660,830</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">)</td></tr>
  <tr id="xdx_406_eus-gaap--IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_iT_mtILFCOzLlh_zust0jwVE531" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1pt">(Loss) Income before taxes</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(<ix:nonFraction name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" contextRef="From2023-01-012023-12-31" id="Fact001374" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">9,871,638</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(<ix:nonFraction name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" contextRef="From2022-01-012022-12-31" id="Fact001375" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">4,639,662</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">)</td></tr>
  </table>

</ix:nonNumeric><p id="xdx_8AB_z2rxrpXOIFui" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2023-01-012023-12-31" escape="true" id="Fact001377" name="us-gaap:RelatedPartyTransactionsDisclosureTextBlock"><p id="xdx_801_eus-gaap--RelatedPartyTransactionsDisclosureTextBlock_zazce8lT2Qij" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Note
13. <span id="xdx_82F_zersyNF85ovb">Related Party Transactions and Balances</span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
of December 31, 2023 and 2022, accounts payable and accrued liabilities include $<span id="xdx_90F_eus-gaap--AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent_iI_c20231231__srt--TitleOfIndividualAxis__custom--OfficersAndDirectorsMember_zTvswU3GK5Se" title="Accounts payable and accrued liabilities"><ix:nonFraction name="us-gaap:AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent" contextRef="AsOf2023-12-31_custom_OfficersAndDirectorsMember" id="Fact001379" format="ixt:numdotdecimal" decimals="0" unitRef="USD">32,974</ix:nonFraction></span> and $<span id="xdx_907_eus-gaap--AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent_iI_c20221231__srt--TitleOfIndividualAxis__custom--OfficersAndDirectorsMember_zlTqITki0d66" title="Accounts payable and accrued liabilities"><ix:nonFraction name="us-gaap:AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent" contextRef="AsOf2022-12-31_custom_OfficersAndDirectorsMember" id="Fact001381" format="ixt:numdotdecimal" decimals="0" unitRef="USD">105,667</ix:nonFraction></span>, respectively, payable to officers,
and directors of the Company. The amounts are unsecured, non-interest bearing and are due on demand (See Note 15).</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2023-01-012023-12-31" escape="true" id="Fact001383" name="us-gaap:FairValueMeasurementInputsDisclosureTextBlock"><p id="xdx_804_eus-gaap--FairValueMeasurementInputsDisclosureTextBlock_zgRFoxIvXin8" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Note
14. <span id="xdx_82C_zfLWUdTshi7h">Fair Value Measurements</span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company&#8217;s financial instruments include cash, accounts payable, notes payable, contingent stock and warrant liability and warrant
liability. Cash, contingent stock liability, contingent warrant liability and warrant liability are measured at fair value. Accounts
payable and notes payable are measured at amortized cost and approximates fair value due to their short duration and market rate for
similar instruments, respectively.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<ix:exclude><!-- Field: Page; Sequence: 70; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 0pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->22<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%"><a href="#RM_014">Table of Contents</a></td></tr></table></div>
    <!-- Field: /Page --></ix:exclude>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"></p><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>SHARPS
TECHNOLOGY, INC.</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTES
TO THE CONSOLIDATED FINANCIAL STATEMENTS</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>FOR
THE YEARS ENDED DECEMBER 31, 2023 AND 2022</b></span></p>


<p style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Note
14. Fair Value Measurements (continued)</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<ix:nonNumeric contextRef="From2023-01-012023-12-31" escape="true" id="Fact001385" name="us-gaap:ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock"><p id="xdx_891_eus-gaap--ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock_zxDqW0yAu905" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
of December 31, 2023, the following financial assets and liabilities were measured at fair value on a recurring basis presented on the
Company&#8217;s consolidated balance sheet:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_8BD_zYTR92xRFZoa" style="display: none">Schedule
of Assets and Liabilities Measured at Fair Value on Recurring Basis</span>&#160;</span></span></span></span></span></span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="display: none; vertical-align: bottom">
    <td style="text-align: center">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2" id="xdx_49C_20231231__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member_z2GHeg2d5sg2" style="border-bottom: Black 1pt solid; text-align: center">&#160;</td><td style="padding-bottom: 1pt">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2" id="xdx_497_20231231__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member_z7evLALGnlZ" style="border-bottom: Black 1pt solid; text-align: center">&#160;</td><td style="padding-bottom: 1pt">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2" id="xdx_491_20231231__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member_zkIsZFCa7663" style="border-bottom: Black 1pt solid; text-align: center">&#160;</td><td style="padding-bottom: 1pt">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" id="xdx_49C_20231231_z5mnI8unN3rb" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">&#160;</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: center"><b>&#160;</b></td><td style="padding-bottom: 1pt"><b>&#160;</b></td>
    <td colspan="10" style="border-bottom: Black 1pt solid; text-align: center"><b>Fair Value Measurements Using</b></td><td style="padding-bottom: 1pt"><b>&#160;</b></td><td style="padding-bottom: 1pt"><b>&#160;</b></td>
    <td colspan="2"><b>&#160;</b></td><td style="padding-bottom: 1pt"><b>&#160;</b></td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: center"><b>&#160;</b></td><td style="padding-bottom: 1pt"><b>&#160;</b></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"><b>Level 1</b></td><td style="padding-bottom: 1pt"><b>&#160;</b></td><td style="padding-bottom: 1pt"><b>&#160;</b></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"><b>Level 2</b></td><td style="padding-bottom: 1pt"><b>&#160;</b></td><td style="padding-bottom: 1pt"><b>&#160;</b></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"><b>Level 3</b></td><td style="padding-bottom: 1pt"><b>&#160;</b></td><td style="font-weight: bold; padding-bottom: 1pt"><b>&#160;</b></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><b>Total</b></td><td style="padding-bottom: 1pt; font-weight: bold"><b>&#160;</b></td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: center"><b>&#160;</b></td><td><b>&#160;</b></td>
    <td colspan="2" style="text-align: center"><b>&#160;</b></td><td><b>&#160;</b></td><td><b>&#160;</b></td>
    <td colspan="2" style="text-align: center"><b>&#160;</b></td><td><b>&#160;</b></td><td><b>&#160;</b></td>
    <td colspan="2" style="text-align: center"><b>&#160;</b></td><td><b>&#160;</b></td><td><b>&#160;</b></td>
    <td colspan="2" style="text-align: center"><b>&#160;</b></td><td><b>&#160;</b></td></tr>
  <tr id="xdx_402_eus-gaap--FinancialInstrumentsFinancialAssetsBalanceSheetGroupingsAbstract_iB_zKCKiuWV95S4" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold">Assets</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_403_eus-gaap--CashAndCashEquivalentsFairValueDisclosure_iI_zILPeMbyrX79" style="vertical-align: bottom; background-color: White">
    <td style="width: 40%">Cash</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 11%; text-align: right"><ix:nonFraction name="us-gaap:CashAndCashEquivalentsFairValueDisclosure" contextRef="AsOf2023-12-31_us-gaap_FairValueInputsLevel1Member" id="Fact001392" format="ixt:numdotdecimal" decimals="0" unitRef="USD">3,012,908</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 11%; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1393">-</span></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 11%; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1394">-</span></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 11%; text-align: right"><ix:nonFraction name="us-gaap:CashAndCashEquivalentsFairValueDisclosure" contextRef="AsOf2023-12-31" id="Fact001395" format="ixt:numdotdecimal" decimals="0" unitRef="USD">3,012,908</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 1pt">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">&#160;</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">&#160;</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">&#160;</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">&#160;</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_406_eus-gaap--AssetsFairValueDisclosure_iI_zG7RiQmAR0rg" style="vertical-align: bottom; background-color: White">
    <td style="font-weight: bold; text-align: left; padding-bottom: 1pt">Total assets measured at fair value</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right"><ix:nonFraction name="us-gaap:AssetsFairValueDisclosure" contextRef="AsOf2023-12-31_us-gaap_FairValueInputsLevel1Member" id="Fact001397" format="ixt:numdotdecimal" decimals="0" unitRef="USD">3,012,908</ix:nonFraction></td><td style="padding-bottom: 1pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1398">-</span></td><td style="padding-bottom: 1pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1399">-</span></td><td style="padding-bottom: 1pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right"><ix:nonFraction name="us-gaap:AssetsFairValueDisclosure" contextRef="AsOf2023-12-31" id="Fact001400" format="ixt:numdotdecimal" decimals="0" unitRef="USD">3,012,908</ix:nonFraction></td><td style="padding-bottom: 1pt; font-weight: bold; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_402_eus-gaap--FinancialInstrumentsFinancialLiabilitiesBalanceSheetGroupingsAbstract_iB_z0jzKRAX0egb" style="vertical-align: bottom; background-color: White">
    <td>Liabilities</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_405_ecustom--WarrantLiability_iI_zNVO650ZxiGk" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1pt">Warrant liability</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">$</td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1407">-</span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="STSS:WarrantLiability" contextRef="AsOf2023-12-31_us-gaap_FairValueInputsLevel2Member" id="Fact001408" format="ixt:numdotdecimal" decimals="0" unitRef="USD">2,422,785</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1409">-</span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">$</td><td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="STSS:WarrantLiability" contextRef="AsOf2023-12-31" id="Fact001410" format="ixt:numdotdecimal" decimals="0" unitRef="USD">2,422,785</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40B_eus-gaap--LiabilitiesFairValueDisclosure_iI_zgxCT7I3IgY4" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; text-align: left; padding-bottom: 2.5pt">Total liabilities measured at fair value</td><td style="font-weight: bold; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1412">-</span></td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right"><ix:nonFraction name="us-gaap:LiabilitiesFairValueDisclosure" contextRef="AsOf2023-12-31_us-gaap_FairValueInputsLevel2Member" id="Fact001413" format="ixt:numdotdecimal" decimals="0" unitRef="USD">2,422,785</ix:nonFraction></td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1414">-</span></td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right"><ix:nonFraction name="us-gaap:LiabilitiesFairValueDisclosure" contextRef="AsOf2023-12-31" id="Fact001415" format="ixt:numdotdecimal" decimals="0" unitRef="USD">2,422,785</ix:nonFraction></td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">&#160;</td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
of December 31, 2022, the following financial assets and liabilities were measured at fair value on a recurring basis presented on the
Company&#8217;s consolidated balance sheet:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="display: none; vertical-align: bottom">
    <td style="text-align: center">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2" id="xdx_49F_20221231__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member_zI2ZrE6i1D56" style="border-bottom: Black 1pt solid; text-align: center">&#160;</td><td style="padding-bottom: 1pt">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2" id="xdx_493_20221231__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member_zyEkrfBqNYPj" style="border-bottom: Black 1pt solid; text-align: center">&#160;</td><td style="padding-bottom: 1pt">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2" id="xdx_49D_20221231__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member_zepFhAwEIj67" style="border-bottom: Black 1pt solid; text-align: center">&#160;</td><td style="padding-bottom: 1pt">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" id="xdx_49F_20221231_zMO0YGfq3qv8" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">&#160;</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="text-align: center"><b>&#160;</b></td><td style="padding-bottom: 1pt"><b>&#160;</b></td>
    <td colspan="10" style="border-bottom: Black 1pt solid; text-align: center"><b>Fair Value Measurements Using</b></td><td style="padding-bottom: 1pt"><b>&#160;</b></td><td style="padding-bottom: 1pt"><b>&#160;</b></td>
    <td colspan="2"><b>&#160;</b></td><td style="padding-bottom: 1pt"><b>&#160;</b></td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: center"><b>&#160;</b></td><td style="padding-bottom: 1pt"><b>&#160;</b></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"><b>Level 1</b></td><td style="padding-bottom: 1pt"><b>&#160;</b></td><td style="padding-bottom: 1pt"><b>&#160;</b></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"><b>Level 2</b></td><td style="padding-bottom: 1pt"><b>&#160;</b></td><td style="padding-bottom: 1pt"><b>&#160;</b></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"><b>Level 3</b></td><td style="padding-bottom: 1pt"><b>&#160;</b></td><td style="font-weight: bold; padding-bottom: 1pt"><b>&#160;</b></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><b>Total</b></td><td style="padding-bottom: 1pt; font-weight: bold"><b>&#160;</b></td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: center"><b>&#160;</b></td><td style="padding-bottom: 1pt"><b>&#160;</b></td>
    <td colspan="2" style="text-align: center"><b>&#160;</b></td><td style="padding-bottom: 1pt"><b>&#160;</b></td><td style="padding-bottom: 1pt"><b>&#160;</b></td>
    <td colspan="2" style="text-align: center"><b>&#160;</b></td><td style="padding-bottom: 1pt"><b>&#160;</b></td><td style="padding-bottom: 1pt"><b>&#160;</b></td>
    <td colspan="2" style="text-align: center"><b>&#160;</b></td><td style="padding-bottom: 1pt"><b>&#160;</b></td><td style="padding-bottom: 1pt"><b>&#160;</b></td>
    <td colspan="2" style="text-align: center"><b>&#160;</b></td><td style="padding-bottom: 1pt"><b>&#160;</b></td></tr>
  <tr id="xdx_402_eus-gaap--FinancialInstrumentsFinancialAssetsBalanceSheetGroupingsAbstract_iB_zZ0h4m5zpCV6" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold">Assets</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_403_eus-gaap--CashAndCashEquivalentsFairValueDisclosure_iI_zFsKH6PntU33" style="vertical-align: bottom; background-color: White">
    <td style="width: 40%">Cash</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 11%; text-align: right"><ix:nonFraction name="us-gaap:CashAndCashEquivalentsFairValueDisclosure" contextRef="AsOf2022-12-31_us-gaap_FairValueInputsLevel1Member" id="Fact001422" format="ixt:numdotdecimal" decimals="0" unitRef="USD">4,170,897</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 11%; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1423">-</span></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 11%; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1424">-</span></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 11%; text-align: right"><ix:nonFraction name="us-gaap:CashAndCashEquivalentsFairValueDisclosure" contextRef="AsOf2022-12-31" id="Fact001425" format="ixt:numdotdecimal" decimals="0" unitRef="USD">4,170,897</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 1pt">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">-</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">-</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">-</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">&#160;</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_406_eus-gaap--AssetsFairValueDisclosure_iI_z9gso5OGflrl" style="vertical-align: bottom; background-color: White">
    <td style="font-weight: bold; text-align: left; padding-bottom: 1pt">Total assets measured at fair value</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right"><ix:nonFraction name="us-gaap:AssetsFairValueDisclosure" contextRef="AsOf2022-12-31_us-gaap_FairValueInputsLevel1Member" id="Fact001427" format="ixt:numdotdecimal" decimals="0" unitRef="USD">4,170,897</ix:nonFraction></td><td style="padding-bottom: 1pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1428">-</span></td><td style="padding-bottom: 1pt; font-weight: bold; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">&#160;</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right"><ix:nonFraction name="us-gaap:AssetsFairValueDisclosure" contextRef="AsOf2022-12-31" id="Fact001430" format="ixt:numdotdecimal" decimals="0" unitRef="USD">4,170,897</ix:nonFraction></td><td style="padding-bottom: 1pt; font-weight: bold; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_404_eus-gaap--FinancialInstrumentsFinancialLiabilitiesBalanceSheetGroupingsAbstract_iB_znHNORGK6ow4" style="vertical-align: bottom; background-color: White">
    <td>Liabilities</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_403_ecustom--WarrantLiability_iI_zeHj02xUXIze" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1pt">Warrant liability</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">$</td><td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="STSS:WarrantLiability" contextRef="AsOf2022-12-31_us-gaap_FairValueInputsLevel1Member" id="Fact001437" format="ixt:numdotdecimal" decimals="0" unitRef="USD">1,151,838</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1438">-</span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1439">-</span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">$</td><td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="STSS:WarrantLiability" contextRef="AsOf2022-12-31" id="Fact001440" format="ixt:numdotdecimal" decimals="0" unitRef="USD">1,151,838</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40B_eus-gaap--LiabilitiesFairValueDisclosure_iI_zArStOtPTi4i" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; text-align: left; padding-bottom: 2.5pt">Total liabilities measured at fair value</td><td style="font-weight: bold; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right"><ix:nonFraction name="us-gaap:LiabilitiesFairValueDisclosure" contextRef="AsOf2022-12-31_us-gaap_FairValueInputsLevel1Member" id="Fact001442" format="ixt:numdotdecimal" decimals="0" unitRef="USD">1,151,838</ix:nonFraction></td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1443">-</span></td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1444">-</span></td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right"><ix:nonFraction name="us-gaap:LiabilitiesFairValueDisclosure" contextRef="AsOf2022-12-31" id="Fact001445" format="ixt:numdotdecimal" decimals="0" unitRef="USD">1,151,838</ix:nonFraction></td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">&#160;</td></tr>
  </table>

</ix:nonNumeric><p id="xdx_8A7_zj88tgPEyzml" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2023-01-012023-12-31" escape="true" id="Fact001447" name="us-gaap:CommitmentsAndContingenciesDisclosureTextBlock"><p id="xdx_804_eus-gaap--CommitmentsAndContingenciesDisclosureTextBlock_zefowiuQzQ6b" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Note
15. <span id="xdx_827_z7839IJqGyv">Commitments and Contingencies</span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>&#160;</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Fixed
Assets and Other</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">At
December 31, 2023, the remaining amounts due under outstanding orders of $<span id="xdx_904_eus-gaap--AccountsPayableCurrentAndNoncurrent_iI_c20231231_zcPrOlkCQnKk" title="Accounts payable"><ix:nonFraction name="us-gaap:AccountsPayableCurrentAndNoncurrent" contextRef="AsOf2023-12-31" id="Fact001449" format="ixt:numdotdecimal" decimals="0" unitRef="USD">56,874</ix:nonFraction></span> is recorded in Accounts Payable. At December 31, 2022,
the Company has outstanding orders to purchase equipment, molds and component parts for research and development of $<span id="xdx_90E_ecustom--OrderCostsToPurchaseEquipmentMoldsAndComponentPartsForResearchAndDevelopment_c20220101__20221231_zHpZqn5gyJ34" title="Total order costs to purchase equipment, molds and component parts for research and development"><ix:nonFraction name="STSS:OrderCostsToPurchaseEquipmentMoldsAndComponentPartsForResearchAndDevelopment" contextRef="From2022-01-012022-12-31" id="Fact001451" format="ixt:numdotdecimal" decimals="0" unitRef="USD">609,953</ix:nonFraction></span> of which
advance payments of $<span id="xdx_904_ecustom--ProgressPayments_c20230101__20231231_zUnn4PRK9KC9" title="Progress payments"><ix:nonFraction name="STSS:ProgressPayments" contextRef="From2023-01-012023-12-31" id="Fact001453" format="ixt:numdotdecimal" decimals="0" unitRef="USD">209,678</ix:nonFraction></span> have been made and recorded in Other Assets (See Note 6).</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<ix:exclude><!-- Field: Page; Sequence: 71; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 0pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->23<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%"><a href="#RM_014">Table of Contents</a></td></tr></table></div>
    <!-- Field: /Page --></ix:exclude>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>SHARPS
TECHNOLOGY, INC.</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTES
TO THE CONSOLIDATED FINANCIAL STATEMENTS</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>FOR
THE YEARS ENDED DECEMBER 31, 2023 AND 2022</b></span></p>

<p style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Note
15. Commitments and Contingencies (continued)</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Contingencies</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">At
each reporting period, the Company evaluates whether or not a potential loss amount or a potential range of loss is probable and reasonably
estimable under the provisions of the authoritative guidance that addresses accounting for contingencies. The Company is currently not
involved in any material litigation or other loss contingencies.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Royalty
Agreement</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
connection with the purchase of certain intellectual property in July 2017, Barry Berler and Alan Blackman entered into a royalty agreement
which provides that Barry Berler will be entitled to a royalty of four percent (<span id="xdx_909_ecustom--RoyaltyPercentage_pid_dp_uPure_c20170701__20170731__us-gaap--TypeOfArrangementAxis__custom--RoyaltyAgreementMember__srt--TitleOfIndividualAxis__custom--BarryBerlerMember_zCKFauY0XfLa" title="Royalty percentage"><ix:nonFraction name="STSS:RoyaltyPercentage" contextRef="From2017-07-012017-07-31_custom_RoyaltyAgreementMember_custom_BarryBerlerMember" id="Fact001455" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">4</ix:nonFraction></span>%) of net sales derived from the use, sale, lease, rent
and export of products related to the intellectual property. The royalty continues until the patent expires or is no longer used in the
Company&#8217;s product. The royalty agreement was assumed by the Company in December 2017.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
September 2018, the Royalty Agreement was amended to reduce the royalty to <span id="xdx_90B_ecustom--RoyaltyPercentage_pid_dp_uPure_c20180901__20180930__us-gaap--TypeOfArrangementAxis__custom--RoyaltyAgreementMember__srt--TitleOfIndividualAxis__custom--BarryBerlerMember_zmTJWkuUvy2i" title="Royalty percentage"><ix:nonFraction name="STSS:RoyaltyPercentage" contextRef="From2018-09-012018-09-30_custom_RoyaltyAgreementMember_custom_BarryBerlerMember" id="Fact001457" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">2</ix:nonFraction></span>% and further provided for a single payment of $<span id="xdx_908_ecustom--SinglePaymentObligation_iI_c20180930__us-gaap--TypeOfArrangementAxis__custom--RoyaltyAgreementMember__srt--TitleOfIndividualAxis__custom--BarryBerlerMember_zL0b5olKvHjg" title="Single payment obligation"><ix:nonFraction name="STSS:SinglePaymentObligation" contextRef="AsOf2018-09-30_custom_RoyaltyAgreementMember_custom_BarryBerlerMember" id="Fact001459" format="ixt:numdotdecimal" decimals="0" unitRef="USD">500,000</ix:nonFraction></span> to
Barry Berler within three years in return for cancellation of all further royalty obligations of the Company. In May 2019, the Royalty
Agreement was further amended to change the payment date to on or before May 31, 2021 or during the term of the amended Royalty Agreement
should the Company be acquired or a controlling interest be acquired. The Company has not made the aforementioned payment or incur any
change in control as such the <span id="xdx_909_ecustom--RoyaltyPercentage_pid_dp_uPure_c20190501__20190531__us-gaap--TypeOfArrangementAxis__custom--RoyaltyAgreementMember__srt--TitleOfIndividualAxis__custom--BarryBerlerMember_zPAN73PHhcW5" title="Royalty percentage"><ix:nonFraction name="STSS:RoyaltyPercentage" contextRef="From2019-05-012019-05-31_custom_RoyaltyAgreementMember_custom_BarryBerlerMember" id="Fact001461" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">2</ix:nonFraction></span>% royalty remains in place.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Employment
Agreements</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
August 1, 2022, the Company cancelled the consulting agreement with Alan Blackman, Co- Chairman and Chief Operating Officer and entered
into an Employment Agreement which provides for annual salary of $<span id="xdx_904_eus-gaap--SalariesAndWages_c20220730__20220801__us-gaap--TypeOfArrangementAxis__custom--EmploymentAgreementMember_z5RdEglnML6c" title="Annual salary"><ix:nonFraction name="us-gaap:SalariesAndWages" contextRef="From2022-07-302022-08-01_custom_EmploymentAgreementMember" id="Fact001463" format="ixt:numdotdecimal" decimals="0" unitRef="USD">256,000</ix:nonFraction></span>, which provides for increases, and provisions compensation
adjustments, expense and tax differential reimbursements, benefits and bonuses. As of September 1, 2022, the annual salary is $<span id="xdx_901_eus-gaap--SalariesAndWages_c20220831__20220901__us-gaap--TypeOfArrangementAxis__custom--EmploymentAgreementMember_zszDBP8Hz4ze" title="Salaries and wages"><ix:nonFraction name="us-gaap:SalariesAndWages" contextRef="From2022-08-312022-09-01_custom_EmploymentAgreementMember" id="Fact001465" format="ixt:numdotdecimal" decimals="0" unitRef="USD">320,000</ix:nonFraction></span>.
At June 30, 2022, the Company approved and accrued a $<span id="xdx_904_eus-gaap--AccruedBonusesCurrentAndNoncurrent_iI_c20220630__srt--TitleOfIndividualAxis__custom--Mr.BlackmanMember_zmC2Lxzl00ya" title="Accrued bonus"><ix:nonFraction name="us-gaap:AccruedBonusesCurrentAndNoncurrent" contextRef="AsOf2022-06-30_custom_Mr.BlackmanMember" id="Fact001467" format="ixt:numdotdecimal" decimals="0" unitRef="USD">250,000</ix:nonFraction></span> bonus to Mr. Blackman for services provided in 2022, of which $<span id="xdx_90E_ecustom--PaymentForBonuses_c20230101__20230331__srt--TitleOfIndividualAxis__custom--Mr.BlackmanMember_zTXP89phwRC8" title="Payment for bonuses"><ix:nonFraction name="STSS:PaymentForBonuses" contextRef="From2023-01-012023-03-31_custom_Mr.BlackmanMember" id="Fact001469" format="ixt:numdotdecimal" decimals="0" unitRef="USD">65,000</ix:nonFraction></span> was
paid subsequent to December 31, 2022. The Company terminated Mr. Blackman&#8217;s Employment Agreement effective May 1, 2023. Mr. Blackman
continued to serve as the Co-Chairman and a member of the Board of Directors. Subsequent to June 30, 2023, the Company and Mr. Blackman
entered into a separation agreement whereby, Mr. Blackman will be paid severance payments of approximately $<span id="xdx_904_eus-gaap--SeveranceCosts1_c20230701__20230814__srt--TitleOfIndividualAxis__custom--Mr.BlackmanMember_zO0JJdrZaLP" title="Severance costs"><ix:nonFraction name="us-gaap:SeveranceCosts1" contextRef="From2023-07-012023-08-14_custom_Mr.BlackmanMember" id="Fact001471" format="ixt:numdotdecimal" decimals="0" unitRef="USD">346,000</ix:nonFraction></span>, which was recorded
as an expense and an accrued expense as of June 30, 2023, over thirteen months, continue his medical benefits for such period with a
cost of approximately $<span id="xdx_90D_ecustom--MedicalBenefitsCost_iI_c20230630__srt--TitleOfIndividualAxis__custom--Mr.BlackmanMember_zaW4S3Krdbth" title="Medical benefit cost"><ix:nonFraction name="STSS:MedicalBenefitsCost" contextRef="AsOf2023-06-30_custom_Mr.BlackmanMember" id="Fact001473" format="ixt:numdotdecimal" decimals="0" unitRef="USD">29,000</ix:nonFraction></span> which has been accrued at June 30, 2023. At December 31, 2023, the outstanding balance due Mr. Blackman
is $<span id="xdx_905_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue_iI_c20231231__srt--TitleOfIndividualAxis__custom--Mr.BlackmanMember_zXvEch9i2bGa" title="Outstanding balance"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue" contextRef="AsOf2023-12-31_custom_Mr.BlackmanMember" id="Fact001475" format="ixt:numdotdecimal" decimals="0" unitRef="USD">218,000</ix:nonFraction></span>, which is recorded in accrued expenses. Further, all unvested options were fully vested and the Company recorded a charge
of $<span id="xdx_904_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue_iI_c20231231_zoLvJBETXsHd" title="Fully vested"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue" contextRef="AsOf2023-12-31" id="Fact001477" format="ixt:numdotdecimal" decimals="0" unitRef="USD">60,000</ix:nonFraction></span>. In connection with the separation agreement, Mr. Blackman no longer serves as Co-Chairman or Board member and has agreed
to vote his Series A Preferred Stock in favor of the election, reelection, and/or designation of each individual nominated to serve as
a director on the Board of Director as shall be identified in an applicable proxy statement filed by the Company for such election of
directors. Once the payments due Mr. Blackman are fully paid, the Series A Preferred Stock shall be deemed immediately cancelled and
forfeited and without further consideration. The Series A Preferred shall at such time be returned to the status of an authorized but
unissued share of preferred stock of the Company.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<ix:exclude><!-- Field: Page; Sequence: 72; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 0pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->24<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%"><a href="#RM_014">Table of Contents</a></td></tr></table></div>
    <!-- Field: /Page --></ix:exclude>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"></p><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>SHARPS
TECHNOLOGY, INC.</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTES
TO THE CONSOLIDATED FINANCIAL STATEMENTS</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>FOR
THE YEARS ENDED DECEMBER 31, 2023 AND 2022</b></span></p>

<p style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Note
15. Commitments and Contingencies (continued)</b></span></p>


<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
September 30, 2022, the Company entered into a formal employment agreement, effective on such date and will continue until terminated
by either party, subject to the terms of the agreement, with Andrew R. Crescenzo who has been serving as the Company&#8217;s Chief Financial
Officer on a contract services basis for the last three years. The agreement provided for annual compensation of $<span id="xdx_90B_ecustom--AnnualCompensation_c20220930__20220930__us-gaap--TypeOfArrangementAxis__custom--EmploymentAgreementMember_zGqZGdJoj4ih" title="Annual compensation"><ix:nonFraction name="STSS:AnnualCompensation" contextRef="From2022-09-302022-09-30_custom_EmploymentAgreementMember" id="Fact001479" format="ixt:numdotdecimal" decimals="0" unitRef="USD">225,000</ix:nonFraction></span> and plus a
one-time $<span id="xdx_904_eus-gaap--PaymentForIncentiveFee_c20220930__20220930__us-gaap--TypeOfArrangementAxis__custom--EmploymentAgreementMember_zgjWTX2HcIU5" title="Payment  for incentive fee"><ix:nonFraction name="us-gaap:PaymentForIncentiveFee" contextRef="From2022-09-302022-09-30_custom_EmploymentAgreementMember" id="Fact001481" format="ixt:numdotdecimal" decimals="0" unitRef="USD">18,750</ix:nonFraction></span> incentive payment upon the commencement of the agreement. During the course of the term, Mr. Crescenzo will be eligible
for (i) performance bonuses to be granted at the discretion of the Company&#8217;s Compensation Committee and (ii) to participate in
the Company&#8217;s 2022 Equity Incentive Plan. The agreement contains customary employment terms and conditions.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
October 2022, the Company entered into a service agreement (&#8220;Service Agreement&#8221;) with an unrelated third-party for marketing
and investor relations services. The Service Agreement, which has a term of one year, has various deliverables and provides payments
to the third party as follows; a) an initial fee of $<span id="xdx_90B_ecustom--InitialFee_c20221001__20221031__us-gaap--TypeOfArrangementAxis__custom--ServiceAgreementMember_z16F9lSyXzJa" title="Initial fee"><ix:nonFraction name="STSS:InitialFee" contextRef="From2022-10-012022-10-31_custom_ServiceAgreementMember" id="Fact001483" format="ixt:numdotdecimal" decimals="0" unitRef="USD">90,000</ix:nonFraction></span>, b) monthly fees through the term of $<span id="xdx_90D_ecustom--MonthlyFee_c20221001__20221031__us-gaap--TypeOfArrangementAxis__custom--ServiceAgreementMember_z9y9NK2Xeg4f" title="Monthly fee"><ix:nonFraction name="STSS:MonthlyFee" contextRef="From2022-10-012022-10-31_custom_ServiceAgreementMember" id="Fact001485" format="ixt:numdotdecimal" decimals="0" unitRef="USD">12,500</ix:nonFraction></span>, c) <span id="xdx_906_eus-gaap--StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures_c20221001__20221031__us-gaap--TypeOfArrangementAxis__custom--ServiceAgreementMember_z9aPNmc6VNUf" title="Shares of restricted common stock"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures" contextRef="From2022-10-012022-10-31_custom_ServiceAgreementMember" id="Fact001487" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">200,000</ix:nonFraction></span> shares of restricted
common stock and d) $<span id="xdx_902_ecustom--ValueOfDigitalMarketingActivities_iI_c20221031__us-gaap--TypeOfArrangementAxis__custom--ServiceAgreementMember_zo6xW8uqi6w4" title="Value of digital marketing activities"><ix:nonFraction name="STSS:ValueOfDigitalMarketingActivities" contextRef="AsOf2022-10-31_custom_ServiceAgreementMember" id="Fact001489" format="ixt:numdotdecimal" decimals="0" unitRef="USD">300,000</ix:nonFraction></span> specifically related to digital marketing activities. As stated in Note 8, the <span id="xdx_90B_eus-gaap--StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures_c20221001__20221031__us-gaap--TypeOfArrangementAxis__custom--ServiceAgreementMember_zNBHiUObJaNj" title="Shares of restricted common stock"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures" contextRef="From2022-10-012022-10-31_custom_ServiceAgreementMember" id="Fact001491" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">200,000</ix:nonFraction></span> shares of restricted
common stock were valued at $<span id="xdx_906_eus-gaap--StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures_c20221001__20221031__us-gaap--TypeOfArrangementAxis__custom--ServiceAgreementMember_zgaDgDDNAXv5" title="Value of restricted common stock"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures" contextRef="From2022-10-012022-10-31_custom_ServiceAgreementMember" id="Fact001493" format="ixt:numdotdecimal" decimals="0" unitRef="USD">230,000</ix:nonFraction></span>, representative of the trading price on the issuance.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
February 9, 2023, the Company, appointed Justin Page, as Vice President of Technical Operations with a start date of February 15, 2023.
The agreement provides for annual compensation of $<span id="xdx_906_eus-gaap--EmployeeBenefitsAndShareBasedCompensation_c20230208__20230209_zUnxmjli64Yf" title="Compensation cost"><ix:nonFraction name="us-gaap:EmployeeBenefitsAndShareBasedCompensation" contextRef="From2023-02-082023-02-09" id="Fact001495" format="ixt:numdotdecimal" decimals="0" unitRef="USD">235,000</ix:nonFraction></span> and Options to purchase <span id="xdx_903_eus-gaap--StockIssuedDuringPeriodSharesShareBasedCompensation_c20230208__20230209_z0jVrcLx4Cal" title="Options to purchase shares"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation" contextRef="From2023-02-082023-02-09" id="Fact001497" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">50,000</ix:nonFraction></span> shares of Common Stock at the exercise price
of $<span id="xdx_907_eus-gaap--SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1_iI_c20230209_zETnKyLdlt4g" title="Stock option, exercise price"><ix:nonFraction name="us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1" contextRef="AsOf2023-02-09" id="Fact001499" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">1.30</ix:nonFraction></span>, the closing price on the grant date. During the course of the term, Mr. Paige will be eligible for (i) performance bonuses
to be granted at the discretion of the Company&#8217;s Compensation Committee and (ii) to participate in the Company&#8217;s Equity Incentive
Plan. The agreement contains customary employment terms and conditions and provides for severance of six months if a change in control
occurs, as defined.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
November 10, 2023, the Company executed an Employment Agreement with Robert Hayes, its Chief Executive Officer amending the employment
letter dated September 6, 2021. The agreement term automatically renews for successive one-year terms as of the commencement date unless
prior written notice by either party within ninety days prior to end of the current term. The agreement provides for termination of employment
and severance benefits under stated conditions and restrictive covenants. The agreement provides for annual compensation retroactive
to June 1, 2023 of $<span id="xdx_90D_ecustom--AnnualCompensation_c20230601__20230601__us-gaap--TypeOfArrangementAxis__custom--EmploymentAgreementMember_zxErqHiMWyNg" title="Annual compensation"><ix:nonFraction name="STSS:AnnualCompensation" contextRef="From2023-06-012023-06-01_custom_EmploymentAgreementMember" id="Fact001501" format="ixt:numdotdecimal" decimals="0" unitRef="USD">600,000</ix:nonFraction></span> from $<span id="xdx_905_ecustom--AnnualCompensation_c20230531__20230531__us-gaap--TypeOfArrangementAxis__custom--EmploymentAgreementMember_zI0ExhBPboic" title="Annual compensation"><ix:nonFraction name="STSS:AnnualCompensation" contextRef="From2023-05-312023-05-31_custom_EmploymentAgreementMember" id="Fact001503" format="ixt:numdotdecimal" decimals="0" unitRef="USD">400,000</ix:nonFraction></span> and a stated increase with the successful acquisition of InjectEZ and other terms of the acquisition
agreement (See Note 5). The agreement provides for bonus compensation for: (i) closing the Nephron acquisition agreement, (ii) long-term
incentives for achieving revenue targets and market caps for the Company&#8217;s stock and (iii) other Company achievements. In addition,
the agreement provides for benefits and paid time off.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2023-01-012023-12-31" escape="true" id="Fact001505" name="us-gaap:SubsequentEventsTextBlock"><p id="xdx_804_eus-gaap--SubsequentEventsTextBlock_zQ7JBnCW0Jad" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Note
16. <span id="xdx_822_zESbKdMP8av2">Subsequent Events</span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
January 2024, the holders of <span id="xdx_90B_eus-gaap--ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight_iI_c20240101__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_ziQEJ9963WM6"><ix:nonFraction name="us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight" contextRef="AsOf2024-01-01_us-gaap_WarrantMember_us-gaap_SubsequentEventMember" id="Fact001506" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">398,441</ix:nonFraction>
</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">of pre-funded warrants exercised their warrants
at the exercise price of $<span id="xdx_904_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_pid_c20240101__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_zB5i2WPshI4d"><ix:nonFraction name="us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" contextRef="AsOf2024-01-01_us-gaap_WarrantMember_us-gaap_SubsequentEventMember" id="Fact001507" decimals="INF" unitRef="USDPShares">.001</ix:nonFraction></span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">.</span></p>

</ix:nonNumeric><p id="xdx_81B_z6dBKIDw5VI5" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p id="xdx_041_zRrCL2kaoSMg" style="font: 10pt Times New Roman, Times, Serif; display: none; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>


<!-- Field: Page; Sequence: 73; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 0pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->25<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%"><a href="#RM_014">Table of Contents</a></td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"></p>



<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><img src="forms-1_002.jpg" alt=""/></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>REPORT
OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">To
the Stockholders and the Board of Directors of Sharps Technology Inc.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Opinion
on the Consolidated Financial Statements</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
have audited the accompanying consolidated balance sheets of Sharps Technology Inc. and its subsidiary (the &#8220;Company&#8221;) as
of December 31, 2022 and 2021, the related consolidated statements of operations, comprehensive loss, stockholders&#8217; equity and
cash flows for the years then ended, and the related notes (collectively referred to as the &#8220;consolidated financial statements&#8221;).</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
our opinion, the consolidated financial statements present fairly, in all material respects, the financial position of the Company as
of December 31, 2022 and 2021, and the results of its operations and its cash flows for the years then ended in conformity with accounting
principles generally accepted in the United States of America.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Basis
for Opinion</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">These
consolidated financial statements are the responsibility of the Company&#8217;s management. Our responsibility is to express an opinion
on the Company&#8217;s consolidated financial statements based on our audits. We are a public accounting firm registered with the Public
Company Accounting Oversight Board (United States) (&#8220;PCAOB&#8221;) and are required to be independent with respect to the Company
in accordance with the U.S. federal securities laws and the applicable rules and regulations of the Securities and Exchange Commission
and the PCAOB.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
conducted our audits in accordance with the standards of the PCAOB. Those standards require that we plan and perform the audits to obtain
reasonable assurance about whether the consolidated financial statements are free of material misstatement, whether due to error or fraud.
The Company is not required to have, nor were we engaged to perform, an audit of its internal control over financial reporting. As part
of our audits we are required to obtain an understanding of internal control over financial reporting but not for the purpose of expressing
an opinion on the effectiveness of the Company&#8217;s internal control over financial reporting. Accordingly, we express no such opinion.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
audits included performing procedures to assess the risks of material misstatement of the consolidated financial statements, whether
due to error or fraud, and performing procedures that respond to those risks. Such procedures included examining, on a test basis, evidence
regarding the amounts and disclosures in the consolidated financial statements. Our audits also included evaluating the accounting principles
used and significant estimates made by management, as well as evaluating the overall presentation of the consolidated financial statements.
We believe that our audits provide a reasonable basis for our opinion.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">/s/
Manning Elliott LLP</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">CHARTERED
PROFESSIONAL ACCOUNTANTS</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Vancouver,
Canada</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">March
30, 2023</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">PCAOB
ID:1524</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
have served as the Company&#8217;s auditor since 2018.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"></p>

<!-- Field: Page; Sequence: 74; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 0pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->26<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%"><a href="#RM_014">Table of Contents</a></td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="RM_016"></span><b><span id="a_001"></span>SHARPS
TECHNOLOGY, INC.</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>CONDENSED
CONSOLIDATED BALANCE SHEETS</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" id="xdx_304_111_z23CAhoJAIf2" summary="xdx: Statement - Condensed Consolidated Balance Sheets" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" id="xdx_498_20240930_zGxWaR7aqiK8" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">September
    30, 2024</span></td><td style="padding-bottom: 1pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" id="xdx_495_20231231_zcYSOuLIdAd4" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">December
    31, 2023</span></td><td style="padding-bottom: 1pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(Unaudited)</b></span></td><td style="font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(Audited)</b></span></td><td style="font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr id="xdx_404_eus-gaap--AssetsAbstract_iB_zTLmn6vNPUN9" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Assets:</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr id="xdx_40E_eus-gaap--AssetsCurrentAbstract_i01B_zNYmrJr7pB5e" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Current Assets</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr id="xdx_40D_eus-gaap--CashAndCashEquivalentsAtCarryingValue_i02I_maACzYPo_zyT8iN3yE60l" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 60%; padding-left: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Cash</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="width: 16%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="us-gaap:CashAndCashEquivalentsAtCarryingValue" contextRef="AsOf2024-09-30" id="Fact001515" format="ixt:numdotdecimal" decimals="0" unitRef="USD">2,473,197</ix:nonFraction></span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="width: 16%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="us-gaap:CashAndCashEquivalentsAtCarryingValue" contextRef="AsOf2023-12-31" id="Fact001516" format="ixt:numdotdecimal" decimals="0" unitRef="USD">3,012,908</ix:nonFraction></span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr id="xdx_40B_eus-gaap--PrepaidExpenseAndOtherAssetsCurrent_i02I_maACzYPo_z5tJrCYNgZyh" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-left: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Prepaid
    expenses and other current assets</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="us-gaap:PrepaidExpenseAndOtherAssetsCurrent" contextRef="AsOf2024-09-30" id="Fact001518" format="ixt:numdotdecimal" decimals="0" unitRef="USD">161,337</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="us-gaap:PrepaidExpenseAndOtherAssetsCurrent" contextRef="AsOf2023-12-31" id="Fact001519" format="ixt:numdotdecimal" decimals="0" unitRef="USD">116,508</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr id="xdx_405_eus-gaap--InventoryNet_i02I_maACzYPo_zv9fd569dnY9" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1pt; padding-left: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Inventories,
    net (<i>Note 3</i>)</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="us-gaap:InventoryNet" contextRef="AsOf2024-09-30" id="Fact001521" format="ixt:numdotdecimal" decimals="0" unitRef="USD">2,019,481</ix:nonFraction></span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="us-gaap:InventoryNet" contextRef="AsOf2023-12-31" id="Fact001522" format="ixt:numdotdecimal" decimals="0" unitRef="USD">1,709,135</ix:nonFraction></span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr id="xdx_407_eus-gaap--AssetsCurrent_i01TI_mtACzYPo_maAziOj_zeYOh0JaaHHd" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-left: 20pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Current
    Assets</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="us-gaap:AssetsCurrent" contextRef="AsOf2024-09-30" id="Fact001524" format="ixt:numdotdecimal" decimals="0" unitRef="USD">4,654,015</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="us-gaap:AssetsCurrent" contextRef="AsOf2023-12-31" id="Fact001525" format="ixt:numdotdecimal" decimals="0" unitRef="USD">4,838,551</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr id="xdx_40C_eus-gaap--PropertyPlantAndEquipmentNet_i01I_maAziOj_zKpFr0z8mxih" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Fixed Assets, net of accumulated
    depreciation <i>(Notes 4 and 5)</i></span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="us-gaap:PropertyPlantAndEquipmentNet" contextRef="AsOf2024-09-30" id="Fact001527" format="ixt:numdotdecimal" decimals="0" unitRef="USD">6,233,595</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="us-gaap:PropertyPlantAndEquipmentNet" contextRef="AsOf2023-12-31" id="Fact001528" format="ixt:numdotdecimal" decimals="0" unitRef="USD">6,822,142</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr id="xdx_40F_eus-gaap--OtherAssetsNoncurrent_i01I_maAziOj_zhzy9Uzl6nQ6" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Other
    Assets <i>(Notes 6 and 7)</i></span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="us-gaap:OtherAssetsNoncurrent" contextRef="AsOf2024-09-30" id="Fact001530" format="ixt:numdotdecimal" decimals="0" unitRef="USD">366,288</ix:nonFraction></span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="us-gaap:OtherAssetsNoncurrent" contextRef="AsOf2023-12-31" id="Fact001531" format="ixt:numdotdecimal" decimals="0" unitRef="USD">128,575</ix:nonFraction></span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr id="xdx_40B_eus-gaap--Assets_i01TI_mtAziOj_zwlRQS3PsFpj" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">TOTAL
    ASSETS</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="us-gaap:Assets" contextRef="AsOf2024-09-30" id="Fact001533" format="ixt:numdotdecimal" decimals="0" unitRef="USD">11,253,898</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="us-gaap:Assets" contextRef="AsOf2023-12-31" id="Fact001534" format="ixt:numdotdecimal" decimals="0" unitRef="USD">11,789,268</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr id="xdx_400_eus-gaap--LiabilitiesAbstract_iB_zS2wCqn1MmT5" style="vertical-align: bottom; background-color: White">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Liabilities:</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr id="xdx_40E_eus-gaap--LiabilitiesCurrentAbstract_i01B_z2kaAApORavg" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Current Liabilities</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr id="xdx_407_eus-gaap--AccountsPayableCurrent_i02I_maLCzsB3_zg2076lRFdDa" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-left: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Accounts
    payable</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="us-gaap:AccountsPayableCurrent" contextRef="AsOf2024-09-30" id="Fact001542" format="ixt:numdotdecimal" decimals="0" unitRef="USD">945,625</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="us-gaap:AccountsPayableCurrent" contextRef="AsOf2023-12-31" id="Fact001543" format="ixt:numdotdecimal" decimals="0" unitRef="USD">794,107</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr id="xdx_40B_eus-gaap--AccountsPayableAndOtherAccruedLiabilitiesCurrent_i02I_maLCzsB3_zhBtlhXbSQni" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-left: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Accrued
    and other current liabilities <i>(Notes 13 and 15</i>)</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="us-gaap:AccountsPayableAndOtherAccruedLiabilitiesCurrent" contextRef="AsOf2024-09-30" id="Fact001545" format="ixt:numdotdecimal" decimals="0" unitRef="USD">279,326</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="us-gaap:AccountsPayableAndOtherAccruedLiabilitiesCurrent" contextRef="AsOf2023-12-31" id="Fact001546" format="ixt:numdotdecimal" decimals="0" unitRef="USD">476,090</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr id="xdx_404_eus-gaap--NotesPayableCurrent_i02I_maLCzsB3_zMJU3JDrcO12" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-left: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Notes
    Payable <i>(Note 7)</i></span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="us-gaap:NotesPayableCurrent" contextRef="AsOf2024-09-30" id="Fact001548" format="ixt:numdotdecimal" decimals="0" unitRef="USD">2,334,142</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl1549">-</span></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr id="xdx_402_ecustom--WarrantLiabilitiesCurrent_i02I_maLCzsB3_zZxgKLsIArzk" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1pt; padding-left: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Warrant
    liability <i>(Notes 8 and 10)</i></span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="STSS:WarrantLiabilitiesCurrent" contextRef="AsOf2024-09-30" id="Fact001551" format="ixt:numdotdecimal" decimals="0" unitRef="USD">1,027,102</ix:nonFraction></span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="STSS:WarrantLiabilitiesCurrent" contextRef="AsOf2023-12-31" id="Fact001552" format="ixt:numdotdecimal" decimals="0" unitRef="USD">2,422,785</ix:nonFraction></span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr id="xdx_408_eus-gaap--LiabilitiesCurrent_i02TI_mtLCzsB3_maLzZAo_zHorB0aWd0ff" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-left: 20pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Total
    Current Liabilities</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="us-gaap:LiabilitiesCurrent" contextRef="AsOf2024-09-30" id="Fact001554" format="ixt:numdotdecimal" decimals="0" unitRef="USD">4,586,195</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="us-gaap:LiabilitiesCurrent" contextRef="AsOf2023-12-31" id="Fact001555" format="ixt:numdotdecimal" decimals="0" unitRef="USD">3,692,982</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr id="xdx_409_eus-gaap--DeferredIncomeTaxLiabilitiesNet_i01I_maLzZAo_zVCEiorgpCQ2" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Deferred
    Tax Liability</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="us-gaap:DeferredIncomeTaxLiabilitiesNet" contextRef="AsOf2024-09-30" id="Fact001557" format="ixt:numdotdecimal" decimals="0" unitRef="USD">162,000</ix:nonFraction></span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="us-gaap:DeferredIncomeTaxLiabilitiesNet" contextRef="AsOf2023-12-31" id="Fact001558" format="ixt:numdotdecimal" decimals="0" unitRef="USD">162,000</ix:nonFraction></span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr id="xdx_409_eus-gaap--Liabilities_i01TI_mtLzZAo_maLASEzzW8_zxMFm3tWo2Za" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Total
    Liabilities</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="us-gaap:Liabilities" contextRef="AsOf2024-09-30" id="Fact001560" format="ixt:numdotdecimal" decimals="0" unitRef="USD">4,748,195</ix:nonFraction></span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="us-gaap:Liabilities" contextRef="AsOf2023-12-31" id="Fact001561" format="ixt:numdotdecimal" decimals="0" unitRef="USD">3,854,982</ix:nonFraction></span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr id="xdx_40C_eus-gaap--CommitmentsAndContingencies_i01I_maLASEzzW8_z66hkE9kwCY2" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Commitments and Contingencies
    <i>(Note 15)</i></span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl1563">-</span></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl1564">-</span></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr id="xdx_402_eus-gaap--StockholdersEquityAbstract_i01B" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Stockholders&#8217; Equity:</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr id="xdx_400_eus-gaap--PreferredStockValue_i02I_maSEzF6A_zbQDXYtU37R7" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Preferred stock, $<span id="xdx_90C_eus-gaap--PreferredStockParOrStatedValuePerShare_iI_c20240930_z7dCs4IblzK9" title="Preferred stock, par value"><span id="xdx_907_eus-gaap--PreferredStockParOrStatedValuePerShare_iI_c20231231_z03dnBpEYaX3" title="Preferred stock, par value"><ix:nonFraction name="us-gaap:PreferredStockParOrStatedValuePerShare" contextRef="AsOf2024-09-30" id="Fact001572" decimals="INF" unitRef="USDPShares"><ix:nonFraction name="us-gaap:PreferredStockParOrStatedValuePerShare" contextRef="AsOf2023-12-31" id="Fact001574" decimals="INF" unitRef="USDPShares">.0001</ix:nonFraction></ix:nonFraction></span></span>
    par value; <span id="xdx_906_eus-gaap--PreferredStockSharesAuthorized_iI_c20240930_zRKZePN0SLB9" title="Preferred stock, shares authorized"><span id="xdx_901_eus-gaap--PreferredStockSharesAuthorized_iI_c20231231_zyDJn9kDjm52" title="Preferred stock, shares authorized"><ix:nonFraction name="us-gaap:PreferredStockSharesAuthorized" contextRef="AsOf2024-09-30" id="Fact001576" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares"><ix:nonFraction name="us-gaap:PreferredStockSharesAuthorized" contextRef="AsOf2023-12-31" id="Fact001578" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">1,000,000</ix:nonFraction></ix:nonFraction></span></span>
    shares authorized; <span id="xdx_90B_eus-gaap--PreferredStockSharesIssued_iI_c20240930_zTdBPQS59VY6" title="Preferred stock, shares issued"><span id="xdx_904_eus-gaap--PreferredStockSharesOutstanding_iI_c20240930_znaJmzGLcjSj" title="Preferred stock, shares outstanding"><ix:nonFraction name="us-gaap:PreferredStockSharesIssued" contextRef="AsOf2024-09-30" id="Fact001580" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares"><ix:nonFraction name="us-gaap:PreferredStockSharesOutstanding" contextRef="AsOf2024-09-30" id="Fact001582" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">0</ix:nonFraction></ix:nonFraction></span></span>
    shares issued and outstanding (2023: <span id="xdx_90E_eus-gaap--PreferredStockSharesIssued_iI_c20231231_zp7DhzDdpp4g" title="Preferred stock, shares issued"><span id="xdx_907_eus-gaap--PreferredStockSharesOutstanding_iI_c20231231_zajOYRVLICeb" title="Preferred stock, shares outstanding"><ix:nonFraction name="us-gaap:PreferredStockSharesIssued" contextRef="AsOf2023-12-31" id="Fact001584" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares"><ix:nonFraction name="us-gaap:PreferredStockSharesOutstanding" contextRef="AsOf2023-12-31" id="Fact001586" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">1</ix:nonFraction></ix:nonFraction></span></span>)</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl1569">-</span></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl1570">-</span></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr id="xdx_40F_eus-gaap--CommonStockValue_i02I_pp0p0_maSEzF6A_z7Szw9lbzlY4" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-left: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Common
    stock, $<span id="xdx_90C_eus-gaap--CommonStockParOrStatedValuePerShare_iI_c20240930_zNca22qkAWAc" title="Common stock, par value"><span id="xdx_90F_eus-gaap--CommonStockParOrStatedValuePerShare_iI_c20231231_z8l5WhfkUQL2" title="Common stock, par value"><ix:nonFraction name="us-gaap:CommonStockParOrStatedValuePerShare" contextRef="AsOf2024-09-30" id="Fact001591" decimals="INF" unitRef="USDPShares"><ix:nonFraction name="us-gaap:CommonStockParOrStatedValuePerShare" contextRef="AsOf2023-12-31" id="Fact001593" decimals="INF" unitRef="USDPShares">.0001</ix:nonFraction></ix:nonFraction></span></span>
    par value; <span id="xdx_90D_eus-gaap--CommonStockSharesAuthorized_iI_c20240930_zUWGOKYE3321" title="Common stock, shares authorized"><ix:nonFraction name="us-gaap:CommonStockSharesAuthorized" contextRef="AsOf2024-09-30" id="Fact001595" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">500,000,000</ix:nonFraction></span>,
    shares authorized; (<span id="xdx_902_eus-gaap--CommonStockSharesAuthorized_iI_c20231231_zIjfeYxcrlN5" title="Common stock, shares authorized"><span id="xdx_90F_eus-gaap--CommonStockSharesAuthorized_iI_c20231231_z2Sxx9Lhjls3" title="Common stock, shares authorized"><ix:nonFraction name="us-gaap:CommonStockSharesAuthorized" contextRef="AsOf2023-12-31" id="Fact001597" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares"><ix:nonFraction name="us-gaap:CommonStockSharesAuthorized" contextRef="AsOf2023-12-31" id="Fact001599" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">100,000,000</ix:nonFraction></ix:nonFraction></span></span>
    in 2023), <span id="xdx_909_eus-gaap--CommonStockSharesIssued_iI_c20240930_z3tL0xYK0ra2" title="Common stock, shares issued"><span id="xdx_90B_eus-gaap--CommonStockSharesOutstanding_iI_c20240930_zeGHnLt1PWff" title="Common stock, shares outstanding"><ix:nonFraction name="us-gaap:CommonStockSharesIssued" contextRef="AsOf2024-09-30" id="Fact001601" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares"><ix:nonFraction name="us-gaap:CommonStockSharesOutstanding" contextRef="AsOf2024-09-30" id="Fact001603" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">1,694,110</ix:nonFraction></ix:nonFraction></span></span>
    shares issued and outstanding (2023: <span id="xdx_90F_eus-gaap--CommonStockSharesIssued_iI_c20231231_zAVLX4sq8Jah" title="Common stock, shares issued"><span id="xdx_90C_eus-gaap--CommonStockSharesOutstanding_iI_c20231231_z6aEx6RsgfDj" title="Common stock, shares outstanding"><ix:nonFraction name="us-gaap:CommonStockSharesIssued" contextRef="AsOf2023-12-31" id="Fact001605" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares"><ix:nonFraction name="us-gaap:CommonStockSharesOutstanding" contextRef="AsOf2023-12-31" id="Fact001607" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">694,294</ix:nonFraction></ix:nonFraction></span></span>)</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="us-gaap:CommonStockValue" contextRef="AsOf2024-09-30" id="Fact001588" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">170</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="us-gaap:CommonStockValue" contextRef="AsOf2023-12-31" id="Fact001589" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">69</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr id="xdx_403_eus-gaap--AdditionalPaidInCapital_i02I_maSEzF6A_zO5hh2K3WgZj" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-left: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Additional
    paid-in capital</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="us-gaap:AdditionalPaidInCapital" contextRef="AsOf2024-09-30" id="Fact001609" format="ixt:numdotdecimal" decimals="0" unitRef="USD">35,941,738</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="us-gaap:AdditionalPaidInCapital" contextRef="AsOf2023-12-31" id="Fact001610" format="ixt:numdotdecimal" decimals="0" unitRef="USD">32,491,409</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr id="xdx_401_eus-gaap--AccumulatedOtherComprehensiveIncomeLossNetOfTax_i02I_maSEzF6A_z5HntuJc7hL4" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-left: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Accumulated
    other comprehensive income</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" contextRef="AsOf2024-09-30" id="Fact001612" format="ixt:numdotdecimal" decimals="0" unitRef="USD">482,572</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" contextRef="AsOf2023-12-31" id="Fact001613" format="ixt:numdotdecimal" decimals="0" unitRef="USD">591,812</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr id="xdx_401_eus-gaap--RetainedEarningsAccumulatedDeficit_i02I_maSEzF6A_zLIALrOgsWX9" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1pt; padding-left: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Accumulated
    deficit</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(<ix:nonFraction name="us-gaap:RetainedEarningsAccumulatedDeficit" contextRef="AsOf2024-09-30" id="Fact001615" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">29,918,777</ix:nonFraction></span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(<ix:nonFraction name="us-gaap:RetainedEarningsAccumulatedDeficit" contextRef="AsOf2023-12-31" id="Fact001616" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">25,149,004</ix:nonFraction></span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td></tr>
  <tr id="xdx_401_eus-gaap--StockholdersEquity_i02TI_pp0p0_maLASEzzW8_mtSEzF6A_zQZ2aSDwWvYb" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1pt; padding-left: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Total
    Stockholders&#8217; Equity</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2024-09-30" id="Fact001618" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">6,505,703</ix:nonFraction></span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2023-12-31" id="Fact001619" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">7,934,286</ix:nonFraction></span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr id="xdx_403_eus-gaap--LiabilitiesAndStockholdersEquity_i01TI_pp0p0_mtLASEzzW8_zIkLMNMbgo3" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">TOTAL
    LIABILITIES AND STOCKHOLDERS&#8217; EQUITY</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="us-gaap:LiabilitiesAndStockholdersEquity" contextRef="AsOf2024-09-30" id="Fact001621" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">11,253,898</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="us-gaap:LiabilitiesAndStockholdersEquity" contextRef="AsOf2023-12-31" id="Fact001622" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">11,789,268</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>The
accompanying notes are an integral part of these financial statements.</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>&#160;</i></span></p>


<!-- Field: Page; Sequence: 75; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 0pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->27<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%"><a href="#RM_014">Table of Contents</a></td></tr></table></div>
    <!-- Field: /Page -->


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>&#160;</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="RM_017"></span><b><span id="a_002"></span>SHARPS
TECHNOLOGY, INC.</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>CONDENSED
CONSOLIDATED STATEMENTS OF OPERATIONS</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>FOR
THE THREE AND NINE MONTHS ENDED SEPTEMBER</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(UNAUDITED)</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" id="xdx_306_113_zIdBh3VR87A3" summary="xdx: Statement - Condensed Consolidated Statements of Operations" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="display: none; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1.5pt">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td id="xdx_49E_20240701__20240930_zOKlmM3KMKh1" style="border-bottom: Black 1.5pt solid; text-align: right">&#160;</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td id="xdx_491_20230701__20230930_zkyRRuy1CUPl" style="border-bottom: Black 1.5pt solid; text-align: right">&#160;</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td id="xdx_496_20240101__20240930_z9eUkvvJrscd" style="border-bottom: Black 1.5pt solid; text-align: right">&#160;</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td id="xdx_49B_20230101__20230930_zbpH4xzFtc37" style="border-bottom: Black 1.5pt solid; text-align: right">&#160;</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="6" style="border-bottom: Black 1pt solid; text-align: center; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">THREE
    MONTHS ENDED<br/> SEPTEMBER 30,</span></td><td style="padding-bottom: 1pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="6" style="border-bottom: Black 1pt solid; text-align: center; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">NINE
    MONTHS ENDED<br/> SEPTEMBER 30,</span></td><td style="padding-bottom: 1pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2024</span></td><td style="padding-bottom: 1pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2023</span></td><td style="padding-bottom: 1pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2024</span></td><td style="padding-bottom: 1pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2023</span></td><td style="padding-bottom: 1pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr id="xdx_40D_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_maCziut_zSt27b5l4B2b" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Revenue,
    net</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl1624">-</span></span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl1625">-</span></span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl1626">-</span></span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl1627">-</span></span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr id="xdx_407_eus-gaap--OperatingExpensesAbstract_iB_zqYxx7DQnOml" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Operating expenses:</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr id="xdx_407_eus-gaap--ResearchAndDevelopmentExpense_i01_maCzERv_zJyjEKd5wXi4" style="vertical-align: bottom; background-color: White">
    <td style="width: 44%; text-align: left; padding-left: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Research
    and development</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="width: 10%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="us-gaap:ResearchAndDevelopmentExpense" contextRef="From2024-07-012024-09-30" id="Fact001634" format="ixt:numdotdecimal" decimals="0" unitRef="USD">145,611</ix:nonFraction></span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="width: 10%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="us-gaap:ResearchAndDevelopmentExpense" contextRef="From2023-07-012023-09-30" id="Fact001635" format="ixt:numdotdecimal" decimals="0" unitRef="USD">225,191</ix:nonFraction></span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="width: 10%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="us-gaap:ResearchAndDevelopmentExpense" contextRef="From2024-01-01to2024-09-30" id="Fact001636" format="ixt:numdotdecimal" decimals="0" unitRef="USD">523,347</ix:nonFraction></span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="width: 10%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="us-gaap:ResearchAndDevelopmentExpense" contextRef="From2023-01-012023-09-30" id="Fact001637" format="ixt:numdotdecimal" decimals="0" unitRef="USD">783,340</ix:nonFraction></span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr id="xdx_407_eus-gaap--GeneralAndAdministrativeExpense_i01_maCzERv_z5NvdY2ZPL08" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1pt; padding-left: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">General
    and administrative</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="us-gaap:GeneralAndAdministrativeExpense" contextRef="From2024-07-012024-09-30" id="Fact001639" format="ixt:numdotdecimal" decimals="0" unitRef="USD">1,869,598</ix:nonFraction></span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="us-gaap:GeneralAndAdministrativeExpense" contextRef="From2023-07-012023-09-30" id="Fact001640" format="ixt:numdotdecimal" decimals="0" unitRef="USD">2,133,167</ix:nonFraction></span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="us-gaap:GeneralAndAdministrativeExpense" contextRef="From2024-01-01to2024-09-30" id="Fact001641" format="ixt:numdotdecimal" decimals="0" unitRef="USD">5,257,015</ix:nonFraction></span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="us-gaap:GeneralAndAdministrativeExpense" contextRef="From2023-01-012023-09-30" id="Fact001642" format="ixt:numdotdecimal" decimals="0" unitRef="USD">6,425,154</ix:nonFraction></span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr id="xdx_404_eus-gaap--OperatingExpenses_i01T_mtCzERv_msCziut_zBGB4JdCBbDd" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Total
    operating expenses</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="us-gaap:OperatingExpenses" contextRef="From2024-07-012024-09-30" id="Fact001644" format="ixt:numdotdecimal" decimals="0" unitRef="USD">2,015,209</ix:nonFraction></span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="us-gaap:OperatingExpenses" contextRef="From2023-07-012023-09-30" id="Fact001645" format="ixt:numdotdecimal" decimals="0" unitRef="USD">2,358,358</ix:nonFraction></span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="us-gaap:OperatingExpenses" contextRef="From2024-01-01to2024-09-30" id="Fact001646" format="ixt:numdotdecimal" decimals="0" unitRef="USD">5,780,362</ix:nonFraction></span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="us-gaap:OperatingExpenses" contextRef="From2023-01-012023-09-30" id="Fact001647" format="ixt:numdotdecimal" decimals="0" unitRef="USD">7,208,494</ix:nonFraction></span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr id="xdx_408_eus-gaap--OperatingIncomeLoss_iT_mtCziut_maCz3Cg_zSYUD2zWGCph" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Loss
    from operations</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(<ix:nonFraction name="us-gaap:OperatingIncomeLoss" contextRef="From2024-07-012024-09-30" id="Fact001649" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">2,015,209</ix:nonFraction></span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(<ix:nonFraction name="us-gaap:OperatingIncomeLoss" contextRef="From2023-07-012023-09-30" id="Fact001650" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">2,358,358</ix:nonFraction></span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(<ix:nonFraction name="us-gaap:OperatingIncomeLoss" contextRef="From2024-01-01to2024-09-30" id="Fact001651" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">5,780,362</ix:nonFraction></span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(<ix:nonFraction name="us-gaap:OperatingIncomeLoss" contextRef="From2023-01-012023-09-30" id="Fact001652" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">7,208,494</ix:nonFraction></span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr id="xdx_409_eus-gaap--NonoperatingIncomeExpenseAbstract_iB_z7egxETQvqwk" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Other income (expense)</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr id="xdx_40D_eus-gaap--OtherNonoperatingIncomeExpense_i01_maCzoDw_zLHo64HfO8sa" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-left: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Other
    (expense) income <i>(Note 15)</i></span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(<ix:nonFraction name="us-gaap:OtherNonoperatingIncomeExpense" contextRef="From2024-07-012024-09-30" id="Fact001659" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">70,905</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="us-gaap:OtherNonoperatingIncomeExpense" contextRef="From2023-07-012023-09-30" id="Fact001660" format="ixt:numdotdecimal" decimals="0" unitRef="USD">17,620</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(<ix:nonFraction name="us-gaap:OtherNonoperatingIncomeExpense" contextRef="From2024-01-01to2024-09-30" id="Fact001661" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">1,046,593</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="us-gaap:OtherNonoperatingIncomeExpense" contextRef="From2023-01-012023-09-30" id="Fact001662" format="ixt:numdotdecimal" decimals="0" unitRef="USD">94,492</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr id="xdx_401_eus-gaap--GainLossOnSaleOfDerivatives_i01_maCzoDw_zsGfVr24EBc5" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-left: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">FMV
    adjustment warrants <i>(Note 10)</i></span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="us-gaap:GainLossOnSaleOfDerivatives" contextRef="From2024-07-012024-09-30" id="Fact001664" format="ixt:numdotdecimal" decimals="0" unitRef="USD">416,560</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="us-gaap:GainLossOnSaleOfDerivatives" contextRef="From2023-07-012023-09-30" id="Fact001665" format="ixt:numdotdecimal" decimals="0" unitRef="USD">321,981</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="us-gaap:GainLossOnSaleOfDerivatives" contextRef="From2024-01-01to2024-09-30" id="Fact001666" format="ixt:numdotdecimal" decimals="0" unitRef="USD">2,088,747</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="us-gaap:GainLossOnSaleOfDerivatives" contextRef="From2023-01-012023-09-30" id="Fact001667" format="ixt:numdotdecimal" decimals="0" unitRef="USD">415,958</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr id="xdx_405_eus-gaap--GainLossOnSaleOfDerivatives_i01_maCzoDw_zFIyBW5tntuj" style="display: none; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-left: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">FMV adjustment
warrants</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="us-gaap:GainLossOnSaleOfDerivatives" contextRef="From2024-07-012024-09-30" id="Fact001669" format="ixt:numdotdecimal" decimals="0" unitRef="USD">416,560</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="us-gaap:GainLossOnSaleOfDerivatives" contextRef="From2023-07-012023-09-30" id="Fact001670" format="ixt:numdotdecimal" decimals="0" unitRef="USD">321,981</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="us-gaap:GainLossOnSaleOfDerivatives" contextRef="From2024-01-01to2024-09-30" id="Fact001671" format="ixt:numdotdecimal" decimals="0" unitRef="USD">2,088,747</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="us-gaap:GainLossOnSaleOfDerivatives" contextRef="From2023-01-012023-09-30" id="Fact001672" format="ixt:numdotdecimal" decimals="0" unitRef="USD">415,958</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
<tr id="xdx_402_ecustom--FairMarketValueAdjustmentForContingentStockAndWarrants_i01N_di_msCzoDw_zIUsZ26Yky0g" style="display: none; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-left: 10pt">FMV adjustment on contingent stock &amp; warrants</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr id="xdx_406_ecustom--ForeignCurrencyAndNonOperatingIncomeExpenses_i01_maCzoDw_zS6ryfD7sMa2" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1pt; padding-left: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Foreign
    currency</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(<ix:nonFraction name="STSS:ForeignCurrencyAndNonOperatingIncomeExpenses" contextRef="From2024-07-012024-09-30" id="Fact001679" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">15,506</ix:nonFraction></span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(<ix:nonFraction name="STSS:ForeignCurrencyAndNonOperatingIncomeExpenses" contextRef="From2023-07-012023-09-30" id="Fact001680" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">3,587</ix:nonFraction></span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(<ix:nonFraction name="STSS:ForeignCurrencyAndNonOperatingIncomeExpenses" contextRef="From2024-01-01to2024-09-30" id="Fact001681" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">31,566</ix:nonFraction></span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(<ix:nonFraction name="STSS:ForeignCurrencyAndNonOperatingIncomeExpenses" contextRef="From2023-01-012023-09-30" id="Fact001682" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">41,955</ix:nonFraction></span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td></tr>
  <tr id="xdx_403_eus-gaap--NonoperatingIncomeExpense_i01T_mtCzoDw_maCz3Cg_z7XL5YK6atI" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Total
    other income (expense)</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="us-gaap:NonoperatingIncomeExpense" contextRef="From2024-07-012024-09-30" id="Fact001684" format="ixt:numdotdecimal" decimals="0" unitRef="USD">330,149</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="us-gaap:NonoperatingIncomeExpense" contextRef="From2023-07-012023-09-30" id="Fact001685" format="ixt:numdotdecimal" decimals="0" unitRef="USD">336,014</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="us-gaap:NonoperatingIncomeExpense" contextRef="From2024-01-01to2024-09-30" id="Fact001686" format="ixt:numdotdecimal" decimals="0" unitRef="USD">1,010,588</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="us-gaap:NonoperatingIncomeExpense" contextRef="From2023-01-012023-09-30" id="Fact001687" format="ixt:numdotdecimal" decimals="0" unitRef="USD">468,495</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr id="xdx_40A_eus-gaap--NetIncomeLoss_iT_mtCz3Cg_zX7ilUnmx33h" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Net
    Loss</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(<ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2024-07-012024-09-30" id="Fact001689" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">1,685,060</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(<ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2023-07-012023-09-30" id="Fact001690" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">2,022,344</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(<ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2024-01-01to2024-09-30" id="Fact001691" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">4,769,774</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(<ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2023-01-012023-09-30" id="Fact001692" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">6,739,999</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Net loss per share, basic
    and diluted</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_906_eus-gaap--EarningsPerShareBasic_pid_c20240701__20240930_zyfvBGw1ig5g" title="Net loss per share, basic" class="xdx_phnt_U3RhdGVtZW50IC0gQ29uZGVuc2VkIENvbnNvbGlkYXRlZCBTdGF0ZW1lbnRzIG9mIE9wZXJhdGlvbnMA"><span id="xdx_904_eus-gaap--EarningsPerShareDiluted_pid_c20240701__20240930_zCir9U7G7unl" title="Net loss per share, diluted" class="xdx_phnt_U3RhdGVtZW50IC0gQ29uZGVuc2VkIENvbnNvbGlkYXRlZCBTdGF0ZW1lbnRzIG9mIE9wZXJhdGlvbnMA">(<ix:nonFraction name="us-gaap:EarningsPerShareBasic" contextRef="From2024-07-012024-09-30" id="Fact001694" format="ixt:numdotdecimal" decimals="INF" sign="-" unitRef="USDPShares"><ix:nonFraction name="us-gaap:EarningsPerShareDiluted" contextRef="From2024-07-012024-09-30" id="Fact001696" format="ixt:numdotdecimal" decimals="INF" sign="-" unitRef="USDPShares">1.27</ix:nonFraction></ix:nonFraction></span></span></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_902_eus-gaap--EarningsPerShareBasic_pid_c20230701__20230930_z3pwNWsInt5f" title="Net loss per share, basic" class="xdx_phnt_U3RhdGVtZW50IC0gQ29uZGVuc2VkIENvbnNvbGlkYXRlZCBTdGF0ZW1lbnRzIG9mIE9wZXJhdGlvbnMA"><span id="xdx_900_eus-gaap--EarningsPerShareDiluted_pid_c20230701__20230930_zDXbW7APFBL" title="Net loss per share, diluted" class="xdx_phnt_U3RhdGVtZW50IC0gQ29uZGVuc2VkIENvbnNvbGlkYXRlZCBTdGF0ZW1lbnRzIG9mIE9wZXJhdGlvbnMA">(<ix:nonFraction name="us-gaap:EarningsPerShareBasic" contextRef="From2023-07-012023-09-30" id="Fact001698" format="ixt:numdotdecimal" decimals="INF" sign="-" unitRef="USDPShares"><ix:nonFraction name="us-gaap:EarningsPerShareDiluted" contextRef="From2023-07-012023-09-30" id="Fact001700" format="ixt:numdotdecimal" decimals="INF" sign="-" unitRef="USDPShares">3.77</ix:nonFraction></ix:nonFraction></span></span></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_907_eus-gaap--EarningsPerShareBasic_c20240101__20240930_z9ao0JnYMFV3" title="Net loss per share, basic" class="xdx_phnt_U3RhdGVtZW50IC0gQ29uZGVuc2VkIENvbnNvbGlkYXRlZCBTdGF0ZW1lbnRzIG9mIE9wZXJhdGlvbnMA"><span id="xdx_90C_eus-gaap--EarningsPerShareDiluted_c20240101__20240930_zy8jgwmfOo53" title="Net loss per share, diluted" class="xdx_phnt_U3RhdGVtZW50IC0gQ29uZGVuc2VkIENvbnNvbGlkYXRlZCBTdGF0ZW1lbnRzIG9mIE9wZXJhdGlvbnMA">(<ix:nonFraction name="us-gaap:EarningsPerShareBasic" contextRef="From2024-01-01to2024-09-30" id="Fact001702" format="ixt:numdotdecimal" decimals="INF" sign="-" unitRef="USDPShares"><ix:nonFraction name="us-gaap:EarningsPerShareDiluted" contextRef="From2024-01-01to2024-09-30" id="Fact001704" format="ixt:numdotdecimal" decimals="INF" sign="-" unitRef="USDPShares">4.53</ix:nonFraction></ix:nonFraction></span></span></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90A_eus-gaap--EarningsPerShareBasic_c20230101__20230930_z5mGPplraw2g" title="Net loss per share, basic" class="xdx_phnt_U3RhdGVtZW50IC0gQ29uZGVuc2VkIENvbnNvbGlkYXRlZCBTdGF0ZW1lbnRzIG9mIE9wZXJhdGlvbnMA"><span id="xdx_90C_eus-gaap--EarningsPerShareDiluted_c20230101__20230930_z3JrRA02VXpa" title="Net loss per share, diluted" class="xdx_phnt_U3RhdGVtZW50IC0gQ29uZGVuc2VkIENvbnNvbGlkYXRlZCBTdGF0ZW1lbnRzIG9mIE9wZXJhdGlvbnMA">(<ix:nonFraction name="us-gaap:EarningsPerShareBasic" contextRef="From2023-01-012023-09-30" id="Fact001706" format="ixt:numdotdecimal" decimals="INF" sign="-" unitRef="USDPShares"><ix:nonFraction name="us-gaap:EarningsPerShareDiluted" contextRef="From2023-01-012023-09-30" id="Fact001708" format="ixt:numdotdecimal" decimals="INF" sign="-" unitRef="USDPShares">13.01</ix:nonFraction></ix:nonFraction></span></span></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Weighted
    average shares used to compute net loss per share, basic and diluted (Note 1)</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_909_eus-gaap--WeightedAverageNumberOfSharesOutstandingBasic_c20240701__20240930_zGZIPwfcfAAl" title="Weighted average shares used to compute net loss per share, basic" class="xdx_phnt_U3RhdGVtZW50IC0gQ29uZGVuc2VkIENvbnNvbGlkYXRlZCBTdGF0ZW1lbnRzIG9mIE9wZXJhdGlvbnMA"><span id="xdx_901_eus-gaap--WeightedAverageNumberOfDilutedSharesOutstanding_c20240701__20240930_zhKUpgu43Zqd" title="Weighted average shares used to compute net loss per share, diluted" class="xdx_phnt_U3RhdGVtZW50IC0gQ29uZGVuc2VkIENvbnNvbGlkYXRlZCBTdGF0ZW1lbnRzIG9mIE9wZXJhdGlvbnMA"><ix:nonFraction name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" contextRef="From2024-07-012024-09-30" id="Fact001710" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares"><ix:nonFraction name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" contextRef="From2024-07-012024-09-30" id="Fact001712" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">1,331,891</ix:nonFraction></ix:nonFraction></span></span></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90C_eus-gaap--WeightedAverageNumberOfSharesOutstandingBasic_c20230701__20230930_zfkxlTi6Dp2f" title="Weighted average shares used to compute net loss per share, basic" class="xdx_phnt_U3RhdGVtZW50IC0gQ29uZGVuc2VkIENvbnNvbGlkYXRlZCBTdGF0ZW1lbnRzIG9mIE9wZXJhdGlvbnMA"><span id="xdx_90C_eus-gaap--WeightedAverageNumberOfDilutedSharesOutstanding_c20230701__20230930_z2Lj4gJJcTy9" title="Weighted average shares used to compute net loss per share, diluted" class="xdx_phnt_U3RhdGVtZW50IC0gQ29uZGVuc2VkIENvbnNvbGlkYXRlZCBTdGF0ZW1lbnRzIG9mIE9wZXJhdGlvbnMA"><ix:nonFraction name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" contextRef="From2023-07-012023-09-30" id="Fact001714" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares"><ix:nonFraction name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" contextRef="From2023-07-012023-09-30" id="Fact001716" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">536,886</ix:nonFraction></ix:nonFraction></span></span></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90B_eus-gaap--WeightedAverageNumberOfSharesOutstandingBasic_c20240101__20240930_z8hEC3pPYaNj" title="Weighted average shares used to compute net loss per share, basic" class="xdx_phnt_U3RhdGVtZW50IC0gQ29uZGVuc2VkIENvbnNvbGlkYXRlZCBTdGF0ZW1lbnRzIG9mIE9wZXJhdGlvbnMA"><span id="xdx_907_eus-gaap--WeightedAverageNumberOfDilutedSharesOutstanding_c20240101__20240930_z7ihc2IxZasj" title="Weighted average shares used to compute net loss per share, diluted" class="xdx_phnt_U3RhdGVtZW50IC0gQ29uZGVuc2VkIENvbnNvbGlkYXRlZCBTdGF0ZW1lbnRzIG9mIE9wZXJhdGlvbnMA"><ix:nonFraction name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" contextRef="From2024-01-01to2024-09-30" id="Fact001718" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares"><ix:nonFraction name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" contextRef="From2024-01-01to2024-09-30" id="Fact001720" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">1,053,259</ix:nonFraction></ix:nonFraction></span></span></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_907_eus-gaap--WeightedAverageNumberOfSharesOutstandingBasic_c20230101__20230930_zivWBWBbcos" title="Weighted average shares used to compute net loss per share, basic" class="xdx_phnt_U3RhdGVtZW50IC0gQ29uZGVuc2VkIENvbnNvbGlkYXRlZCBTdGF0ZW1lbnRzIG9mIE9wZXJhdGlvbnMA"><span id="xdx_901_eus-gaap--WeightedAverageNumberOfDilutedSharesOutstanding_c20230101__20230930_zVee39OioJoa" title="Weighted average shares used to compute net loss per share, diluted" class="xdx_phnt_U3RhdGVtZW50IC0gQ29uZGVuc2VkIENvbnNvbGlkYXRlZCBTdGF0ZW1lbnRzIG9mIE9wZXJhdGlvbnMA"><ix:nonFraction name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" contextRef="From2023-01-012023-09-30" id="Fact001722" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares"><ix:nonFraction name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" contextRef="From2023-01-012023-09-30" id="Fact001724" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">518,166</ix:nonFraction></ix:nonFraction></span></span></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>The
accompanying notes are an integral part of these financial statements.</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>&#160;</i></span></p>


<!-- Field: Page; Sequence: 76; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 0pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->28<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%"><a href="#RM_014">Table of Contents</a></td></tr></table></div>
    <!-- Field: /Page -->


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>&#160;</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="RM_018"></span><span id="a_003"></span>SHARPS
TECHNOLOGY, INC.</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>CONDENSED
CONSOLIDATED STATEMENTS OF COMPREHENSIVE LOSS</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>FOR
THE THREE AND NINE MONTHS ENDED SEPTEMBER 30</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(UNAUDITED)</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" id="xdx_305_113_zLXtIdBHluH4" summary="xdx: Statement - Condensed Consolidated Statements of Comprehensive Loss" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="display: none; vertical-align: bottom">
    <td style="display: none"><span style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="display: none; font-weight: bold; padding-bottom: 1pt"><span style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" id="xdx_49E_20240701__20240930_z1tUByUxpBg6" style="border-bottom: Black 1pt solid; display: none; font-weight: bold; text-align: center"><span style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt">2024</span></td><td style="display: none; padding-bottom: 1pt; font-weight: bold"><span style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="display: none; font-weight: bold; padding-bottom: 1pt"><span style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" id="xdx_491_20230701__20230930_zNeOHUB46G87" style="border-bottom: Black 1pt solid; display: none; font-weight: bold; text-align: center"><span style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt">2023</span></td><td style="display: none; padding-bottom: 1pt; font-weight: bold"><span style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="display: none; font-weight: bold; padding-bottom: 1pt"><span style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" id="xdx_496_20240101__20240930_zSWwhkWZVlbk" style="border-bottom: Black 1pt solid; display: none; font-weight: bold; text-align: center"><span style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt">2024</span></td><td style="display: none; padding-bottom: 1pt; font-weight: bold"><span style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="display: none; font-weight: bold; padding-bottom: 1pt"><span style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" id="xdx_49B_20230101__20230930_zHarVcgrmFMe" style="border-bottom: Black 1pt solid; display: none; font-weight: bold; text-align: center"><span style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt">2023</span></td><td style="display: none; padding-bottom: 1pt; font-weight: bold"><span style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
<tr style="vertical-align: bottom">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="6" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">THREE
    MONTHS ENDED<br/> SEPTEMBER 30,</span></td><td style="padding-bottom: 1pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="6" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">NINE
    MONTHS ENDED<br/> SEPTEMBER 30,</span></td><td style="padding-bottom: 1pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2024</span></td><td style="padding-bottom: 1pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2023</span></td><td style="padding-bottom: 1pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2024</span></td><td style="padding-bottom: 1pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2023</span></td><td style="padding-bottom: 1pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr id="xdx_408_eus-gaap--NetIncomeLoss_maCINOTzhvJ_zi886jBngDk" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 44%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Net loss</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="width: 10%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(<ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2024-07-012024-09-30" id="Fact001726" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">1,685,060</ix:nonFraction></span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="width: 10%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(<ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2023-07-012023-09-30" id="Fact001727" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">2,022,344</ix:nonFraction></span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="width: 10%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(<ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2024-01-01to2024-09-30" id="Fact001728" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">4,769,774</ix:nonFraction></span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="width: 10%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(<ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2023-01-012023-09-30" id="Fact001729" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">6,739,999</ix:nonFraction></span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr id="xdx_406_eus-gaap--OtherComprehensiveIncomeLossTaxAbstract_iB" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Other comprehensive income:</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr id="xdx_403_eus-gaap--OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent_i01_pp0p0_maCINOTzhvJ_zOYSDv7oivkh" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Foreign currency translation
    adjustments gain/(loss)</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent" contextRef="From2024-07-012024-09-30" id="Fact001736" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">130,723</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(<ix:nonFraction name="us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent" contextRef="From2023-07-012023-09-30" id="Fact001737" format="ixt:numdotdecimal" decimals="0" scale="0" sign="-" unitRef="USD">283,544</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(<ix:nonFraction name="us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent" contextRef="From2024-01-01to2024-09-30" id="Fact001738" format="ixt:numdotdecimal" decimals="0" scale="0" sign="-" unitRef="USD">109,241</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent" contextRef="From2023-01-012023-09-30" id="Fact001739" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">61,314</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr id="xdx_40E_eus-gaap--ComprehensiveIncomeNetOfTax_i01T_pp0p0_mtCINOTzhvJ_zLGEw6kS0aIf" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; text-align: left; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Comprehensive
    loss</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(<ix:nonFraction name="us-gaap:ComprehensiveIncomeNetOfTax" contextRef="From2024-07-012024-09-30" id="Fact001741" format="ixt:numdotdecimal" decimals="0" scale="0" sign="-" unitRef="USD">1,554,337</ix:nonFraction></span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td><td style="font-weight: bold; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(<ix:nonFraction name="us-gaap:ComprehensiveIncomeNetOfTax" contextRef="From2023-07-012023-09-30" id="Fact001742" format="ixt:numdotdecimal" decimals="0" scale="0" sign="-" unitRef="USD">2,305,888</ix:nonFraction></span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(<ix:nonFraction name="us-gaap:ComprehensiveIncomeNetOfTax" contextRef="From2024-01-01to2024-09-30" id="Fact001743" format="ixt:numdotdecimal" decimals="0" scale="0" sign="-" unitRef="USD">4,879,015</ix:nonFraction></span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td><td style="font-weight: bold; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(<ix:nonFraction name="us-gaap:ComprehensiveIncomeNetOfTax" contextRef="From2023-01-012023-09-30" id="Fact001744" format="ixt:numdotdecimal" decimals="0" scale="0" sign="-" unitRef="USD">6,678,685</ix:nonFraction></span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>The
accompanying notes are an integral part of these financial statements.</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>&#160;</i></span></p>


<!-- Field: Page; Sequence: 77; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 0pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->29<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%"><a href="#RM_014">Table of Contents</a></td></tr></table></div>
    <!-- Field: /Page -->


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>&#160;</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="RM_019"></span><span id="a_004"></span>SHARPS
TECHNOLOGY, INC.</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>CONDENSED
CONSOLIDATED STATEMENT OF STOCKHOLDERS&#8217; EQUITY</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>FOR
THE THREE AND NINE MONTHS ENDED SEPTEMBER 30, 2024</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(Unaudited)</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" id="xdx_302_114_z0r5CdjXK5A9" summary="xdx: Statement - Condensed Consolidated Statement of Stockholders' Equity" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="display: none; vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Shares</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" id="xdx_4B0_us-gaap--StatementEquityComponentsAxis_us-gaap--PreferredStockMember_zl9dl2jwUjk7" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Amount</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Shares</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" id="xdx_4B5_us-gaap--StatementEquityComponentsAxis_us-gaap--CommonStockMember_zJnXuDptA3If" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Amount</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td id="xdx_4B3_us-gaap--StatementEquityComponentsAxis_custom--CommonStockSubscriptionReceivableMember_zOTUhZ7mX0Z5" style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" id="xdx_4B6_us-gaap--StatementEquityComponentsAxis_us-gaap--AdditionalPaidInCapitalMember_zy0RsHLRhB99" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Capital</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" id="xdx_4B4_us-gaap--StatementEquityComponentsAxis_us-gaap--AccumulatedOtherComprehensiveIncomeMember_zLhgLA6FsSjf" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Income</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" id="xdx_4B4_us-gaap--StatementEquityComponentsAxis_us-gaap--RetainedEarningsMember_zmJRoF2ZC9n1" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Deficit</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" id="xdx_4BB_zLVE4t6ImgOe" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Equity</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; text-align: center; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="6" style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Preferred
    Stock</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; text-align: center; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; text-align: center; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="6" style="font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Common
    Stock</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; text-align: center; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; text-align: center; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Additional<br/>
    Paid in</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; text-align: center; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; text-align: center; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Accumulated<br/>
    Other<br/> Comprehensive</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; text-align: center; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; text-align: center; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Accumulated</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; text-align: center; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; text-align: center; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Total
    Stockholders</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; text-align: center; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; text-align: center; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Shares</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; text-align: center; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; text-align: center; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Amount</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; text-align: center; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; text-align: center; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Shares</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; text-align: center; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; text-align: center; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Amount</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; text-align: center; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; text-align: center; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Capital</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; text-align: center; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; text-align: center; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Income</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; text-align: center; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; text-align: center; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Deficit</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; text-align: center; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; text-align: center; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Equity</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; text-align: center; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr id="xdx_434_c20240101__20240331_eus-gaap--StockholdersEquity_iS_zsIQUajnceya" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: bold 10pt Times New Roman, Times, Serif; width: 28%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Balance
    -December 31, 2023</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td id="xdx_982_eus-gaap--SharesOutstanding_iS_c20240101__20240331__us-gaap--StatementEquityComponentsAxis__us-gaap--PreferredStockMember_z63cy9lEzs33" title="Balance, shares" style="font: 10pt Times New Roman, Times, Serif; width: 5%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="us-gaap:SharesOutstanding" contextRef="AsOf2023-12-31_us-gaap_PreferredStockMember" id="Fact001754" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">1</ix:nonFraction></span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 5%; text-align: right">&#160;&#160;&#160;&#160;&#160;&#160;<span style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl1746">-</span></span>&#160; &#160;</td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td id="xdx_98C_eus-gaap--SharesOutstanding_iS_c20240101__20240331__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zuRNCu2434ae" title="Balance, shares" style="font: 10pt Times New Roman, Times, Serif; width: 5%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="us-gaap:SharesOutstanding" contextRef="AsOf2023-12-31_us-gaap_CommonStockMember" id="Fact001756" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">694,294</ix:nonFraction></span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 5%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2023-12-31_us-gaap_CommonStockMember" id="Fact001747" format="ixt:numdotdecimal" decimals="0" unitRef="USD">69</ix:nonFraction></span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;<span style="-sec-ix-hidden: xdx2ixbrl1748">-</span></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 5%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2023-12-31_us-gaap_AdditionalPaidInCapitalMember" id="Fact001749" format="ixt:numdotdecimal" decimals="0" unitRef="USD">32,491,409</ix:nonFraction></span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 5%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2023-12-31_us-gaap_AccumulatedOtherComprehensiveIncomeMember" id="Fact001750" format="ixt:numdotdecimal" decimals="0" unitRef="USD">591,812</ix:nonFraction></span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 5%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(<ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2023-12-31_us-gaap_RetainedEarningsMember" id="Fact001751" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">25,149,004</ix:nonFraction></span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 5%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2023-12-31" id="Fact001752" format="ixt:numdotdecimal" decimals="0" unitRef="USD">7,934,286</ix:nonFraction></span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr id="xdx_403_eus-gaap--NetIncomeLoss_zmuVNzVOtC42" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Net
    loss for the three months ended March 31, 2024</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl1758">-</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl1759">-</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;<span style="-sec-ix-hidden: xdx2ixbrl1760">-</span></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl1761">-</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl1762">-</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(<ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2024-01-012024-03-31_us-gaap_RetainedEarningsMember" id="Fact001763" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">982,386</ix:nonFraction></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(<ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2024-01-012024-03-31" id="Fact001764" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">982,386</ix:nonFraction></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr id="xdx_405_eus-gaap--AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_zJPWXe6uLJw8" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Share-based
    compensation charges</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl1766">-</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl1767">-</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" contextRef="From2024-01-012024-03-31_us-gaap_AdditionalPaidInCapitalMember" id="Fact001769" format="ixt:numdotdecimal" decimals="0" unitRef="USD">126,387</ix:nonFraction></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl1770">-</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl1771">-</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" contextRef="From2024-01-012024-03-31" id="Fact001772" format="ixt:numdotdecimal" decimals="0" unitRef="USD">126,387</ix:nonFraction></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr id="xdx_40A_ecustom--StockIssuedDuringPeriodValueExerciseOfPrefundedWarrants_zlA69YInPnO" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Exercise
    of Pre-Funded Warrants</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl1774">-</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td id="xdx_98B_ecustom--StockIssuedDuringPeriodSharesExerciseOfPrefundedWarrants_c20240101__20240331__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_z7QvsD1KGaL" title="Exercise of Pre-Funded Warrants, shares" style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="STSS:StockIssuedDuringPeriodSharesExerciseOfPrefundedWarrants" contextRef="From2024-01-012024-03-31_us-gaap_CommonStockMember" id="Fact001782" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">18,020</ix:nonFraction></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="STSS:StockIssuedDuringPeriodValueExerciseOfPrefundedWarrants" contextRef="From2024-01-012024-03-31_us-gaap_CommonStockMember" id="Fact001775" format="ixt:numdotdecimal" decimals="0" unitRef="USD">2</ix:nonFraction></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="STSS:StockIssuedDuringPeriodValueExerciseOfPrefundedWarrants" contextRef="From2024-01-012024-03-31_us-gaap_AdditionalPaidInCapitalMember" id="Fact001777" format="ixt:numdotdecimal" decimals="0" unitRef="USD">394</ix:nonFraction></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl1778">-</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl1779">-</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="STSS:StockIssuedDuringPeriodValueExerciseOfPrefundedWarrants" contextRef="From2024-01-012024-03-31" id="Fact001780" format="ixt:numdotdecimal" decimals="0" unitRef="USD">396</ix:nonFraction></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr id="xdx_403_eus-gaap--OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax_z7v0LXZCMM7e" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Foreign
    Currency Translation</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl1784">-</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl1785">-</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl1787">-</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(<ix:nonFraction name="us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax" contextRef="From2024-01-012024-03-31_us-gaap_AccumulatedOtherComprehensiveIncomeMember" id="Fact001788" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">218,053</ix:nonFraction></span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl1789">-</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(<ix:nonFraction name="us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax" contextRef="From2024-01-012024-03-31" id="Fact001790" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">218,053</ix:nonFraction></span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr id="xdx_43D_c20240401__20240630_eus-gaap--StockholdersEquity_iS_zTUms3x3Z0L2" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Balance
    - March 31, 2024</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td id="xdx_988_eus-gaap--SharesOutstanding_iS_c20240401__20240630__us-gaap--StatementEquityComponentsAxis__us-gaap--PreferredStockMember_zpKppnUCrxBc" title="Balance, shares" style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="us-gaap:SharesOutstanding" contextRef="AsOf2024-03-31_us-gaap_PreferredStockMember" id="Fact001800" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">1</ix:nonFraction></span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl1792">-</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td id="xdx_98E_eus-gaap--SharesOutstanding_iS_c20240401__20240630__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zKzf0fOfjUo7" title="Balance, shares" style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="us-gaap:SharesOutstanding" contextRef="AsOf2024-03-31_us-gaap_CommonStockMember" id="Fact001802" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">712,314</ix:nonFraction></span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2024-03-31_us-gaap_CommonStockMember" id="Fact001793" format="ixt:numdotdecimal" decimals="0" unitRef="USD">71</ix:nonFraction></span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;<span style="-sec-ix-hidden: xdx2ixbrl1794">-</span></span></td>
    <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2024-03-31_us-gaap_AdditionalPaidInCapitalMember" id="Fact001795" format="ixt:numdotdecimal" decimals="0" unitRef="USD">32,618,190</ix:nonFraction></span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2024-03-31_us-gaap_AccumulatedOtherComprehensiveIncomeMember" id="Fact001796" format="ixt:numdotdecimal" decimals="0" unitRef="USD">373,759</ix:nonFraction></span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(<ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2024-03-31_us-gaap_RetainedEarningsMember" id="Fact001797" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">26,131,390</ix:nonFraction></span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2024-03-31" id="Fact001798" format="ixt:numdotdecimal" decimals="0" unitRef="USD">6,860,630</ix:nonFraction></span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr id="xdx_403_eus-gaap--NetIncomeLoss_z1yqw9Aa2tuk" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Net
    loss for the three months ended June 30, 2024</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl1804">-</span>&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">-</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1805">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;<span style="-sec-ix-hidden: xdx2ixbrl1806">-</span></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1807">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1808">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(<ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2024-04-012024-06-30_us-gaap_RetainedEarningsMember" id="Fact001809" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">2,102,327</ix:nonFraction></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(<ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2024-04-012024-06-30" id="Fact001810" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">2,102,327</ix:nonFraction></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr id="xdx_405_eus-gaap--AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_zTFejtQQu04d" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Share-based
    compensation charges</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1812">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1813">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" contextRef="From2024-04-012024-06-30_us-gaap_AdditionalPaidInCapitalMember" id="Fact001815" format="ixt:numdotdecimal" decimals="0" unitRef="USD">201,918</ix:nonFraction></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1816">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1817">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" contextRef="From2024-04-012024-06-30" id="Fact001818" format="ixt:numdotdecimal" decimals="0" unitRef="USD">201,918</ix:nonFraction></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr id="xdx_40B_ecustom--StockIssuedDuringPeriodValueExerciseOfPrefundedWarrant_zstOKpfsxRva" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Exercise
    of Pre-Funded Warrants</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">-</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1820">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td id="xdx_98F_ecustom--StockIssuedDuringPeriodSharesExerciseOfPrefundedWarrants_c20240401__20240630__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zoGR71u4ep1j" title="Exercise of Pre-Funded Warrants, shares" style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="STSS:StockIssuedDuringPeriodSharesExerciseOfPrefundedWarrants" contextRef="From2024-04-012024-06-30_us-gaap_CommonStockMember" id="Fact001828" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">135,683</ix:nonFraction></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="STSS:StockIssuedDuringPeriodValueExerciseOfPrefundedWarrant" contextRef="From2024-04-012024-06-30_us-gaap_CommonStockMember" id="Fact001821" format="ixt:numdotdecimal" decimals="0" unitRef="USD">14</ix:nonFraction></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="STSS:StockIssuedDuringPeriodValueExerciseOfPrefundedWarrant" contextRef="From2024-04-012024-06-30_us-gaap_AdditionalPaidInCapitalMember" id="Fact001823" format="ixt:numdotdecimal" decimals="0" unitRef="USD">2,971</ix:nonFraction></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1824">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1825">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="STSS:StockIssuedDuringPeriodValueExerciseOfPrefundedWarrant" contextRef="From2024-04-012024-06-30" id="Fact001826" format="ixt:numdotdecimal" decimals="0" unitRef="USD">2,985</ix:nonFraction></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr id="xdx_402_ecustom--StockIssuedDuringPeriodValueRegistrationOffering_zBP0AYKHmkjj" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Registration
    A Offering</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">-</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1830">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td id="xdx_98D_ecustom--StockIssuedDuringPeriodSharesRegistrationOffering_c20240401__20240630__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_z2FOsTlBO81k" title="Registration A Offering, shares" style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="STSS:StockIssuedDuringPeriodSharesRegistrationOffering" contextRef="From2024-04-012024-06-30_us-gaap_CommonStockMember" id="Fact001838" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">190,773</ix:nonFraction></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="STSS:StockIssuedDuringPeriodValueRegistrationOffering" contextRef="From2024-04-012024-06-30_us-gaap_CommonStockMember" id="Fact001831" format="ixt:numdotdecimal" decimals="0" unitRef="USD">19</ix:nonFraction></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="STSS:StockIssuedDuringPeriodValueRegistrationOffering" contextRef="From2024-04-012024-06-30_us-gaap_AdditionalPaidInCapitalMember" id="Fact001833" format="ixt:numdotdecimal" decimals="0" unitRef="USD">1,296,903</ix:nonFraction></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1834">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1835">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="STSS:StockIssuedDuringPeriodValueRegistrationOffering" contextRef="From2024-04-012024-06-30" id="Fact001836" format="ixt:numdotdecimal" decimals="0" unitRef="USD">1,296,922</ix:nonFraction></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr id="xdx_405_ecustom--StockIssuedDuringPeriodValueWarrantInducements_zYXMfHwQzp1d" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Warrant
    Inducements</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td id="xdx_987_ecustom--StockIssuedDuringPeriodSharesWarrantInducements_c20240401__20240630__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_z4EyBzIVBZ3b" title="Warrant Inducements, shares" style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="STSS:StockIssuedDuringPeriodSharesWarrantInducements" contextRef="From2024-04-012024-06-30_us-gaap_CommonStockMember" id="Fact001848" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">260,799</ix:nonFraction></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="STSS:StockIssuedDuringPeriodValueWarrantInducements" contextRef="From2024-04-012024-06-30_us-gaap_CommonStockMember" id="Fact001841" format="ixt:numdotdecimal" decimals="0" unitRef="USD">26</ix:nonFraction></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="STSS:StockIssuedDuringPeriodValueWarrantInducements" contextRef="From2024-04-012024-06-30_us-gaap_AdditionalPaidInCapitalMember" id="Fact001843" format="ixt:numdotdecimal" decimals="0" unitRef="USD">978,955</ix:nonFraction></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1844">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1845">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="STSS:StockIssuedDuringPeriodValueWarrantInducements" contextRef="From2024-04-012024-06-30" id="Fact001846" format="ixt:numdotdecimal" decimals="0" unitRef="USD">978,981</ix:nonFraction></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr id="xdx_405_eus-gaap--OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax_zaG8qSNUTcwj" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Foreign
    Currency Translation</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">-</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1850">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">-</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1851">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1853">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(<ix:nonFraction name="us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax" contextRef="From2024-04-012024-06-30_us-gaap_AccumulatedOtherComprehensiveIncomeMember" id="Fact001854" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">21,911</ix:nonFraction></span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1855">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(<ix:nonFraction name="us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax" contextRef="From2024-04-012024-06-30" id="Fact001856" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">21,911</ix:nonFraction></span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr id="xdx_43C_c20240701__20240930_eus-gaap--StockholdersEquity_iS_zduQytjxubUi" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Balance
    - June 30, 2024</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td id="xdx_983_eus-gaap--SharesOutstanding_iS_c20240701__20240930__us-gaap--StatementEquityComponentsAxis__us-gaap--PreferredStockMember_zXo2GyOVtVu5" title="Balance, shares" style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="us-gaap:SharesOutstanding" contextRef="AsOf2024-06-30_us-gaap_PreferredStockMember" id="Fact001866" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">1</ix:nonFraction></span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl1858">-</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td id="xdx_98C_eus-gaap--SharesOutstanding_iS_c20240701__20240930__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zdINbHuRqUq3" title="Balance, shares" style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="us-gaap:SharesOutstanding" contextRef="AsOf2024-06-30_us-gaap_CommonStockMember" id="Fact001868" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">1,299,569</ix:nonFraction></span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2024-06-30_us-gaap_CommonStockMember" id="Fact001859" format="ixt:numdotdecimal" decimals="0" unitRef="USD">130</ix:nonFraction></span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;<span style="-sec-ix-hidden: xdx2ixbrl1860">-</span></span></td>
    <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2024-06-30_us-gaap_AdditionalPaidInCapitalMember" id="Fact001861" format="ixt:numdotdecimal" decimals="0" unitRef="USD">35,098,937</ix:nonFraction></span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2024-06-30_us-gaap_AccumulatedOtherComprehensiveIncomeMember" id="Fact001862" format="ixt:numdotdecimal" decimals="0" unitRef="USD">351,848</ix:nonFraction></span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(<ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2024-06-30_us-gaap_RetainedEarningsMember" id="Fact001863" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">28,233,717</ix:nonFraction></span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2024-06-30" id="Fact001864" format="ixt:numdotdecimal" decimals="0" unitRef="USD">7,217,198</ix:nonFraction></span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr id="xdx_403_eus-gaap--NetIncomeLoss_zNOqxs5i8If9" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Net
    loss for the three months ended September 30, 2024</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl1870">-</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">-</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl1871">-</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;<span style="-sec-ix-hidden: xdx2ixbrl1872">-</span></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl1873">-</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl1874">-</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(<ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2024-07-012024-09-30_us-gaap_RetainedEarningsMember" id="Fact001875" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">1,685,060</ix:nonFraction></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(<ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2024-07-012024-09-30" id="Fact001876" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">1,685,060</ix:nonFraction></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr id="xdx_40B_eus-gaap--StockRedeemedOrCalledDuringPeriodValue_z5TIZc7u8egh" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Cancellation
    of Preferred Share</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td id="xdx_989_eus-gaap--StockRedeemedOrCalledDuringPeriodShares_c20240701__20240930__us-gaap--StatementEquityComponentsAxis__us-gaap--PreferredStockMember_zQ4b8BrOBtz8" title="Cancellation of Preferred Share, shares" style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(<ix:nonFraction name="us-gaap:StockRedeemedOrCalledDuringPeriodShares" contextRef="From2024-07-012024-09-30_us-gaap_PreferredStockMember" id="Fact001886" format="ixt:numdotdecimal" decimals="INF" sign="-" unitRef="Shares">1</ix:nonFraction></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl1878">-</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl1879">-</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl1881">-</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl1882">-</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl1883">-</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl1884">-</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr id="xdx_405_eus-gaap--AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_zqQPhgN3YSIf" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Share-based
    compensation charges</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1888">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1889">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" contextRef="From2024-07-012024-09-30_us-gaap_AdditionalPaidInCapitalMember" id="Fact001891" format="ixt:numdotdecimal" decimals="0" unitRef="USD">116,193</ix:nonFraction></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1892">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl1893">-</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" contextRef="From2024-07-012024-09-30" id="Fact001894" format="ixt:numdotdecimal" decimals="0" unitRef="USD">116,193</ix:nonFraction></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr id="xdx_40F_eus-gaap--StockIssuedDuringPeriodValueOther_zNFTMuPkKosi" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Issuance
    of Common Stock &#8211; see Note 7</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;,
                                            &#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1896">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td id="xdx_988_eus-gaap--StockIssuedDuringPeriodSharesOther_c20240701__20240930__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zy9Svqav89m3" title="Issuance of Common Stock, shares" style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodSharesOther" contextRef="From2024-07-012024-09-30_us-gaap_CommonStockMember" id="Fact001904" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">259,091</ix:nonFraction></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueOther" contextRef="From2024-07-012024-09-30_us-gaap_CommonStockMember" id="Fact001897" format="ixt:numdotdecimal" decimals="0" unitRef="USD">26</ix:nonFraction></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueOther" contextRef="From2024-07-012024-09-30_us-gaap_AdditionalPaidInCapitalMember" id="Fact001899" format="ixt:numdotdecimal" decimals="0" unitRef="USD">726,324</ix:nonFraction></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1900">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1901">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueOther" contextRef="From2024-07-012024-09-30" id="Fact001902" format="ixt:numdotdecimal" decimals="0" unitRef="USD">726,350</ix:nonFraction></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr id="xdx_405_ecustom--StockIssuedDuringPeriodValueWarrantExericse_zTUEqpxf1Uba" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Warrant
    exercise</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl1906">-</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td id="xdx_980_ecustom--StockIssuedDuringPeriodSharesWarrantExericse_c20240701__20240930__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_z1jbuPTQh1w4" title="Warrant exercise, shares" style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="STSS:StockIssuedDuringPeriodSharesWarrantExericse" contextRef="From2024-07-012024-09-30_us-gaap_CommonStockMember" id="Fact001914" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">135,450</ix:nonFraction></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="STSS:StockIssuedDuringPeriodValueWarrantExericse" contextRef="From2024-07-012024-09-30_us-gaap_CommonStockMember" id="Fact001907" format="ixt:numdotdecimal" decimals="0" unitRef="USD">14</ix:nonFraction></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="STSS:StockIssuedDuringPeriodValueWarrantExericse" contextRef="From2024-07-012024-09-30_us-gaap_AdditionalPaidInCapitalMember" id="Fact001909" format="ixt:numdotdecimal" decimals="0" unitRef="USD">284</ix:nonFraction></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1910">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1911">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="STSS:StockIssuedDuringPeriodValueWarrantExericse" contextRef="From2024-07-012024-09-30" id="Fact001912" format="ixt:numdotdecimal" decimals="0" unitRef="USD">298</ix:nonFraction></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr id="xdx_405_eus-gaap--OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax_z8qrmJsnRnK6" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Foreign
    Currency Translation</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl1916">-</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl1917">-</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl1919">-</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax" contextRef="From2024-07-012024-09-30_us-gaap_AccumulatedOtherComprehensiveIncomeMember" id="Fact001920" format="ixt:numdotdecimal" decimals="0" unitRef="USD">130,723</ix:nonFraction></span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"/><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1921">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax" contextRef="From2024-07-012024-09-30" id="Fact001922" format="ixt:numdotdecimal" decimals="0" unitRef="USD">130,723</ix:nonFraction></span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr id="xdx_43E_c20240701__20240930_eus-gaap--StockholdersEquity_iE_z5kP05GTSaBk" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Balance
    - September 30, 2024</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td id="xdx_98E_eus-gaap--SharesOutstanding_iE_c20240701__20240930__us-gaap--StatementEquityComponentsAxis__us-gaap--PreferredStockMember_zBlVHzDzbAE" title="Balance, shares" style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl1932">-</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl1924">-</span>
                                            </span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td id="xdx_982_eus-gaap--SharesOutstanding_iE_c20240701__20240930__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zRbJSytIKrKi" title="Balance, shares" style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="us-gaap:SharesOutstanding" contextRef="AsOf2024-09-30_us-gaap_CommonStockMember" id="Fact001934" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">1,694,110</ix:nonFraction></span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2024-09-30_us-gaap_CommonStockMember" id="Fact001925" format="ixt:numdotdecimal" decimals="0" unitRef="USD">170</ix:nonFraction></span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;<span style="-sec-ix-hidden: xdx2ixbrl1926">-</span></span></td>
    <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2024-09-30_us-gaap_AdditionalPaidInCapitalMember" id="Fact001927" format="ixt:numdotdecimal" decimals="0" unitRef="USD">35,941,738</ix:nonFraction></span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2024-09-30_us-gaap_AccumulatedOtherComprehensiveIncomeMember" id="Fact001928" format="ixt:numdotdecimal" decimals="0" unitRef="USD">482,572</ix:nonFraction></span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(<ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2024-09-30_us-gaap_RetainedEarningsMember" id="Fact001929" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">29,918,777</ix:nonFraction></span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2024-09-30" id="Fact001930" format="ixt:numdotdecimal" decimals="0" unitRef="USD">6,505,703</ix:nonFraction></span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>


<!-- Field: Page; Sequence: 78; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 0pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->30<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%"><a href="#RM_014">Table of Contents</a></td></tr></table></div>
    <!-- Field: /Page -->


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="RM_020"></span><b>SHARPS
TECHNOLOGY, INC.</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>CONDENSED
STATEMENT OF STOCKHOLDERS&#8217; EQUITY</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>FOR
THE THREE AND NINE MONTHS ENDED SEPTEMBER 30, 2023</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(Unaudited)</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="display: none; vertical-align: bottom">
    <td style="font-weight: bold">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: right">&#160;</td><td style="font-weight: bold">&#160;</td><td>&#160;</td>
    <td colspan="2" id="xdx_4B0_us-gaap--StatementEquityComponentsAxis_us-gaap--PreferredStockMember_zvfPe2zk3yw2" style="text-align: right">&#160;</td><td>&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: right">&#160;</td><td style="font-weight: bold">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" id="xdx_4B5_us-gaap--StatementEquityComponentsAxis_us-gaap--CommonStockMember_zWsdguxW7IY2" style="font-weight: bold; text-align: right">&#160;</td><td style="font-weight: bold">&#160;</td><td>&#160;</td>
    <td colspan="2" id="xdx_4B0_us-gaap--StatementEquityComponentsAxis_custom--CommonStockSubscriptionReceivableMember_zbYhh2rBJfc5" style="text-align: right">&#160;</td><td>&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" id="xdx_4B6_us-gaap--StatementEquityComponentsAxis_us-gaap--AdditionalPaidInCapitalMember_z8UD5qqg30x1" style="font-weight: bold; text-align: right">&#160;</td><td style="font-weight: bold">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" id="xdx_4B4_us-gaap--StatementEquityComponentsAxis_us-gaap--AccumulatedOtherComprehensiveIncomeMember_zw7nFJg7SHDd" style="font-weight: bold; text-align: right">&#160;</td><td style="font-weight: bold">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" id="xdx_4B4_us-gaap--StatementEquityComponentsAxis_us-gaap--RetainedEarningsMember_zqck0KJcHRoi" style="font-weight: bold; text-align: right">&#160;</td><td style="font-weight: bold">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" id="xdx_4BB_zmWHhBX6OaEh" style="font-weight: bold; text-align: right">&#160;</td><td style="font-weight: bold">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: center; font-weight: bold; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="6" style="border-bottom: Black 1pt solid; text-align: center; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Preferred
    Stock</span></td><td style="text-align: center; padding-bottom: 1pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: center; font-weight: bold; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="6" style="border-bottom: Black 1pt solid; text-align: center; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Common
    Stock</span></td><td style="text-align: center; padding-bottom: 1pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: center; font-weight: bold; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="text-align: center; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Common
    Stock Subscription</span></td><td style="text-align: center; padding-bottom: 1pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: center; font-weight: bold; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="text-align: center; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Additional
    Paid in</span></td><td style="text-align: center; padding-bottom: 1pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: center; font-weight: bold; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="text-align: center; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Accumulated
    Other Comprehensive</span></td><td style="text-align: center; padding-bottom: 1pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: center; font-weight: bold; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="text-align: center; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Accumulated</span></td><td style="text-align: center; padding-bottom: 1pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: center; font-weight: bold; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="padding-bottom: 1pt; text-align: center; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Total
    Stockholders&#8217;</span></td><td style="text-align: center; padding-bottom: 1pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: center; font-weight: bold; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Shares</span></td><td style="text-align: center; padding-bottom: 1pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: center; font-weight: bold; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Amount</span></td><td style="text-align: center; padding-bottom: 1pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: center; font-weight: bold; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Shares</span></td><td style="text-align: center; padding-bottom: 1pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: center; font-weight: bold; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Amount</span></td><td style="text-align: center; padding-bottom: 1pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: center; font-weight: bold; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Receivable</span></td><td style="text-align: center; padding-bottom: 1pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: center; font-weight: bold; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Capital</span></td><td style="text-align: center; padding-bottom: 1pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: center; font-weight: bold; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Income</span></td><td style="text-align: center; padding-bottom: 1pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: center; font-weight: bold; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Deficit</span></td><td style="text-align: center; padding-bottom: 1pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: center; font-weight: bold; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Equity</span></td><td style="text-align: center; padding-bottom: 1pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr id="xdx_43B_c20230101__20230331_eus-gaap--StockholdersEquity_iS_zMJKvxK6WCF9" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 28%; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Balance -December
    31, 2022</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td id="xdx_98C_eus-gaap--SharesOutstanding_iS_c20230101__20230331__us-gaap--StatementEquityComponentsAxis__us-gaap--PreferredStockMember_z0FnWM3yIw58" title="Balance, shares" style="width: 4%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;&#160;<ix:nonFraction name="us-gaap:SharesOutstanding" contextRef="AsOf2022-12-31_us-gaap_PreferredStockMember" id="Fact001944" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">1</ix:nonFraction></span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="width: 4%; text-align: right"><span style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;&#160;&#160;&#160;&#160;&#160;&#160;
                                            <span style="-sec-ix-hidden: xdx2ixbrl1936">-</span> &#160;</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="width: 2%; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 1%; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td id="xdx_989_eus-gaap--SharesOutstanding_iS_c20230101__20230331__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zihSKcTToGKe" title="Balance, shares" style="width: 4%; font-weight: bold; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="us-gaap:SharesOutstanding" contextRef="AsOf2022-12-31_us-gaap_CommonStockMember" id="Fact001946" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">427,610</ix:nonFraction></span></td><td style="width: 1%; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="width: 2%; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 1%; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="width: 4%; font-weight: bold; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2022-12-31_us-gaap_CommonStockMember" id="Fact001937" format="ixt:numdotdecimal" decimals="0" unitRef="USD">43</ix:nonFraction></span></td><td style="width: 1%; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="width: 4%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;&#160;&#160;&#160;&#160;<span style="-sec-ix-hidden: xdx2ixbrl1938">-</span></span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="width: 2%; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 1%; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="width: 4%; font-weight: bold; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2022-12-31_us-gaap_AdditionalPaidInCapitalMember" id="Fact001939" format="ixt:numdotdecimal" decimals="0" unitRef="USD">24,734,204</ix:nonFraction></span></td><td style="width: 1%; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="width: 2%; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 1%; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="width: 4%; font-weight: bold; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2022-12-31_us-gaap_AccumulatedOtherComprehensiveIncomeMember" id="Fact001940" format="ixt:numdotdecimal" decimals="0" unitRef="USD">214,253</ix:nonFraction></span></td><td style="width: 1%; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="width: 2%; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 1%; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="width: 4%; font-weight: bold; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(<ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2022-12-31_us-gaap_RetainedEarningsMember" id="Fact001941" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">15,307,366</ix:nonFraction></span></td><td style="width: 1%; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td><td style="width: 2%; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 1%; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="width: 4%; font-weight: bold; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2022-12-31" id="Fact001942" format="ixt:numdotdecimal" decimals="0" unitRef="USD">9,641,134</ix:nonFraction></span></td><td style="width: 1%; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr id="xdx_403_eus-gaap--NetIncomeLoss_z6CsrPXZAfk3" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Net loss for the three months ended March 31, 2023</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl1948">-</span></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl1949">-</span></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl1950">-</span></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl1951">-</span></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl1952">-</span></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(<ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2023-01-012023-03-31_us-gaap_RetainedEarningsMember" id="Fact001953" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">2,111,830</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(<ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2023-01-012023-03-31" id="Fact001954" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">2,111,830</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td></tr>
  <tr id="xdx_40F_eus-gaap--StockIssuedDuringPeriodValueNewIssues_zEJOS1bQmaW5" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Shares issued in Offering</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td id="xdx_985_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_c20230101__20230331__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zCJO7v2RGF2c" title="Shares issued in Offering, shares" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodSharesNewIssues" contextRef="From2023-01-012023-03-31_us-gaap_CommonStockMember" id="Fact001964" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">102,206</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueNewIssues" contextRef="From2023-01-012023-03-31_us-gaap_CommonStockMember" id="Fact001957" format="ixt:numdotdecimal" decimals="0" unitRef="USD">10</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueNewIssues" contextRef="From2023-01-012023-03-31_us-gaap_AdditionalPaidInCapitalMember" id="Fact001959" format="ixt:numdotdecimal" decimals="0" unitRef="USD">2,783,375</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl1960">-</span></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueNewIssues" contextRef="From2023-01-012023-03-31" id="Fact001962" format="ixt:numdotdecimal" decimals="0" unitRef="USD">2,783,385</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr id="xdx_405_eus-gaap--AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_zaNOrtmILoej" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Share-based compensation charges</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl1966">-</span></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl1967">-</span></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl1968">-</span></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" contextRef="From2023-01-012023-03-31_us-gaap_AdditionalPaidInCapitalMember" id="Fact001969" format="ixt:numdotdecimal" decimals="0" unitRef="USD">383,100</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl1970">-</span></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl1971">-</span></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" contextRef="From2023-01-012023-03-31" id="Fact001972" format="ixt:numdotdecimal" decimals="0" unitRef="USD">383,100</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr id="xdx_40F_eus-gaap--OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax_zeGcVPRWgtyl" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Foreign
    Currency Translation</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl1974">-</span></span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl1976">-</span></span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl1977">-</span></span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax" contextRef="From2023-01-012023-03-31_us-gaap_AccumulatedOtherComprehensiveIncomeMember" id="Fact001978" format="ixt:numdotdecimal" decimals="0" unitRef="USD">270,983</ix:nonFraction></span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl1979">-</span></span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax" contextRef="From2023-01-012023-03-31" id="Fact001980" format="ixt:numdotdecimal" decimals="0" unitRef="USD">270,983</ix:nonFraction></span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr id="xdx_436_c20230401__20230630_eus-gaap--StockholdersEquity_iS_zkxB1WbzRtck" style="vertical-align: bottom; background-color: White">
    <td style="font-weight: bold; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Balance
    - March 31, 2023</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td id="xdx_98B_eus-gaap--SharesOutstanding_iS_c20230401__20230630__us-gaap--StatementEquityComponentsAxis__us-gaap--PreferredStockMember_zH2m04FOvGo7" title="Balance, shares" style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="us-gaap:SharesOutstanding" contextRef="AsOf2023-03-31_us-gaap_PreferredStockMember" id="Fact001990" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">1</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl1982">-</span></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td id="xdx_981_eus-gaap--SharesOutstanding_iS_c20230401__20230630__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zQSf4sMfg8dc" title="Balance, shares" style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="us-gaap:SharesOutstanding" contextRef="AsOf2023-03-31_us-gaap_CommonStockMember" id="Fact001992" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">529,816</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><b><ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2023-03-31_us-gaap_CommonStockMember" id="Fact001983" format="ixt:numdotdecimal" decimals="0" unitRef="USD">53</ix:nonFraction></b></p></td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl1984">-</span></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2023-03-31_us-gaap_AdditionalPaidInCapitalMember" id="Fact001985" format="ixt:numdotdecimal" decimals="0" unitRef="USD">27,900,679</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2023-03-31_us-gaap_AccumulatedOtherComprehensiveIncomeMember" id="Fact001986" format="ixt:numdotdecimal" decimals="0" unitRef="USD">485,236</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(<ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2023-03-31_us-gaap_RetainedEarningsMember" id="Fact001987" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">17,419,196</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td><td style="font-weight: bold; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2023-03-31" id="Fact001988" format="ixt:numdotdecimal" decimals="0" unitRef="USD">10,966,772</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr id="xdx_403_eus-gaap--NetIncomeLoss_z2QlUDXdY8Mj" style="vertical-align: bottom; background-color: White">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Net loss for the three months ended June 30, 2023</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl1994">-</span></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl1995">-</span></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl1996">-</span></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl1997">-</span></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl1998">-</span></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(<ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2023-04-012023-06-30_us-gaap_RetainedEarningsMember" id="Fact001999" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">2,605,825</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(<ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2023-04-012023-06-30" id="Fact002000" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">2,605,825</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td></tr>
  <tr id="xdx_405_eus-gaap--AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_zypj5NqrTnFf" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Share-based compensation charges</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl2002">-</span></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl2003">-</span></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl2004">-</span></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" contextRef="From2023-04-012023-06-30_us-gaap_AdditionalPaidInCapitalMember" id="Fact002005" format="ixt:numdotdecimal" decimals="0" unitRef="USD">254,446</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl2006">-</span></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl2007">-</span></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" contextRef="From2023-04-012023-06-30" id="Fact002008" format="ixt:numdotdecimal" decimals="0" unitRef="USD">254,446</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr id="xdx_406_eus-gaap--OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax_zmSH5okLyvPd" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Foreign
    Currency Translation</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl2010">-</span></span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl2012">-</span></span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl2013">-</span></span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax" contextRef="From2023-04-012023-06-30_us-gaap_AccumulatedOtherComprehensiveIncomeMember" id="Fact002014" format="ixt:numdotdecimal" decimals="0" unitRef="USD">73,876</ix:nonFraction></span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl2015">-</span></span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax" contextRef="From2023-04-012023-06-30" id="Fact002016" format="ixt:numdotdecimal" decimals="0" unitRef="USD">73,876</ix:nonFraction></span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr id="xdx_434_c20230701__20230930_eus-gaap--StockholdersEquity_iS_z541JFHAqxL2" style="vertical-align: bottom; background-color: White">
    <td style="font-weight: bold; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Balance
    - June 30, 2023</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td id="xdx_98D_eus-gaap--SharesOutstanding_iS_c20230701__20230930__us-gaap--StatementEquityComponentsAxis__us-gaap--PreferredStockMember_zQomOH9QwyG8" title="Balance, shares" style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="us-gaap:SharesOutstanding" contextRef="AsOf2023-06-30_us-gaap_PreferredStockMember" id="Fact002026" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">1</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl2018">-</span></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td id="xdx_98B_eus-gaap--SharesOutstanding_iS_c20230701__20230930__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zosuN38cfp98" title="Balance, shares" style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="us-gaap:SharesOutstanding" contextRef="AsOf2023-06-30_us-gaap_CommonStockMember" id="Fact002028" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">529,816</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2023-06-30_us-gaap_CommonStockMember" id="Fact002019" format="ixt:numdotdecimal" decimals="0" unitRef="USD">53</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl2020">-</span></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2023-06-30_us-gaap_AdditionalPaidInCapitalMember" id="Fact002021" format="ixt:numdotdecimal" decimals="0" unitRef="USD">28,155,125</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2023-06-30_us-gaap_AccumulatedOtherComprehensiveIncomeMember" id="Fact002022" format="ixt:numdotdecimal" decimals="0" unitRef="USD">559,112</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(<ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2023-06-30_us-gaap_RetainedEarningsMember" id="Fact002023" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">20,025,021</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td><td style="font-weight: bold; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2023-06-30" id="Fact002024" format="ixt:numdotdecimal" decimals="0" unitRef="USD">8,689,269</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr id="xdx_434_c20230701__20230930_eus-gaap--StockholdersEquity_iS_zLo1vXVIiNed" style="display: none; vertical-align: bottom; background-color: White">
    <td style="display: none; font-weight: bold; padding-bottom: 2.5pt"><span style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt">Balance</span></td><td style="display: none; padding-bottom: 2.5pt"><span style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; display: none; text-align: left"><span style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td id="xdx_986_eus-gaap--SharesOutstanding_iS_c20230701__20230930__us-gaap--StatementEquityComponentsAxis__us-gaap--PreferredStockMember_zEaLN7IejzXb" title="Balance, shares" style="border-bottom: Black 2.5pt double; display: none; text-align: right"><span style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="us-gaap:SharesOutstanding" contextRef="AsOf2023-06-30_us-gaap_PreferredStockMember" id="Fact002038" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">1</ix:nonFraction></span></td><td style="display: none; padding-bottom: 2.5pt; text-align: left"><span style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="display: none; padding-bottom: 2.5pt"><span style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; display: none; text-align: left"><span style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="border-bottom: Black 2.5pt double; display: none; text-align: right"><span style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl2030">-</span></span></td><td style="display: none; padding-bottom: 2.5pt; text-align: left"><span style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="display: none; padding-bottom: 2.5pt"><span style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; display: none; text-align: left"><span style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td id="xdx_989_eus-gaap--SharesOutstanding_iS_c20230701__20230930__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zHWobb9XJnOb" title="Balance, shares" style="border-bottom: Black 2.5pt double; display: none; text-align: right"><span style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="us-gaap:SharesOutstanding" contextRef="AsOf2023-06-30_us-gaap_CommonStockMember" id="Fact002040" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">529,816</ix:nonFraction></span></td><td style="display: none; padding-bottom: 2.5pt; text-align: left"><span style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="display: none; font-weight: bold; padding-bottom: 2.5pt"><span style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; display: none; font-weight: bold; text-align: left"><span style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="border-bottom: Black 2.5pt double; display: none; font-weight: bold; text-align: right"><span style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2023-06-30_us-gaap_CommonStockMember" id="Fact002031" format="ixt:numdotdecimal" decimals="0" unitRef="USD">53</ix:nonFraction></span></td><td style="display: none; padding-bottom: 2.5pt; font-weight: bold; text-align: left"><span style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="display: none; padding-bottom: 2.5pt"><span style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; display: none; text-align: left"><span style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 2.5pt double; display: none; text-align: right"><span style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl2032">-</span></span></td><td style="display: none; padding-bottom: 2.5pt; text-align: left"><span style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="display: none; font-weight: bold; padding-bottom: 2.5pt"><span style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; display: none; font-weight: bold; text-align: left"><span style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="border-bottom: Black 2.5pt double; display: none; font-weight: bold; text-align: right"><span style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2023-06-30_us-gaap_AdditionalPaidInCapitalMember" id="Fact002033" format="ixt:numdotdecimal" decimals="0" unitRef="USD">28,155,125</ix:nonFraction></span></td><td style="display: none; padding-bottom: 2.5pt; font-weight: bold; text-align: left"><span style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="display: none; font-weight: bold; padding-bottom: 2.5pt"><span style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; display: none; font-weight: bold; text-align: left"><span style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="border-bottom: Black 2.5pt double; display: none; font-weight: bold; text-align: right"><span style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2023-06-30_us-gaap_AccumulatedOtherComprehensiveIncomeMember" id="Fact002034" format="ixt:numdotdecimal" decimals="0" unitRef="USD">559,112</ix:nonFraction></span></td><td style="display: none; padding-bottom: 2.5pt; font-weight: bold; text-align: left"><span style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="display: none; font-weight: bold; padding-bottom: 2.5pt"><span style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; display: none; font-weight: bold; text-align: left"><span style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="border-bottom: Black 2.5pt double; display: none; font-weight: bold; text-align: right"><span style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt">(<ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2023-06-30_us-gaap_RetainedEarningsMember" id="Fact002035" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">20,025,021</ix:nonFraction></span></td><td style="display: none; padding-bottom: 2.5pt; font-weight: bold; text-align: left"><span style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td><td style="display: none; font-weight: bold; padding-bottom: 2.5pt"><span style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; display: none; font-weight: bold; text-align: left"><span style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="border-bottom: Black 2.5pt double; display: none; font-weight: bold; text-align: right"><span style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2023-06-30" id="Fact002036" format="ixt:numdotdecimal" decimals="0" unitRef="USD">8,689,269</ix:nonFraction></span></td><td style="display: none; padding-bottom: 2.5pt; font-weight: bold; text-align: left"><span style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr id="xdx_407_eus-gaap--NetIncomeLoss_zNwRZKHjnEvg" style="vertical-align: bottom; background-color: White">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Net loss for the three months ended September 30, 2023</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl2042">-</span></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl2043">-</span></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl2044">-</span></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl2045">-</span></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl2046">-</span></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(<ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2023-07-012023-09-30_us-gaap_RetainedEarningsMember" id="Fact002047" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">2,022,344</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(<ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2023-07-012023-09-30" id="Fact002048" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">2,022,344</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td></tr>
  <tr id="xdx_40D_eus-gaap--NetIncomeLoss_zRbwSI0jgDL7" style="display: none; vertical-align: bottom; background-color: White">
    <td style="display: none"><span style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt">Net loss</span></td><td style="display: none"><span style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="display: none; text-align: left"><span style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="display: none; text-align: right"><span style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td><td style="display: none; text-align: left"><span style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="display: none"><span style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="display: none; text-align: left"><span style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="display: none; text-align: right"><span style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl2050">-</span></span></td><td style="display: none; text-align: left"><span style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="display: none"><span style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="display: none; text-align: left"><span style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="display: none; text-align: right"><span style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td><td style="display: none; text-align: left"><span style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="display: none"><span style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="display: none; text-align: left"><span style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="display: none; text-align: right"><span style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl2051">-</span></span></td><td style="display: none; text-align: left"><span style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="display: none"><span style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="display: none; text-align: left"><span style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="display: none; text-align: right"><span style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl2052">-</span></span></td><td style="display: none; text-align: left"><span style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="display: none"><span style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="display: none; text-align: left"><span style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="display: none; text-align: right"><span style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl2053">-</span></span></td><td style="display: none; text-align: left"><span style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="display: none"><span style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="display: none; text-align: left"><span style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="display: none; text-align: right"><span style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl2054">-</span></span></td><td style="display: none; text-align: left"><span style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="display: none"><span style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="display: none; text-align: left"><span style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="display: none; text-align: right"><span style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt">(<ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2023-07-012023-09-30_us-gaap_RetainedEarningsMember" id="Fact002055" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">2,022,344</ix:nonFraction></span></td><td style="display: none; text-align: left"><span style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td><td style="display: none"><span style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="display: none; text-align: left"><span style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="display: none; text-align: right"><span style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt">(<ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2023-07-012023-09-30" id="Fact002056" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">2,022,344</ix:nonFraction></span></td><td style="display: none; text-align: left"><span style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td></tr>
<tr id="xdx_405_eus-gaap--AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_zivkdciyESFf" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Share-based compensation charges</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl2058">-</span></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl2060">-</span></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" contextRef="From2023-07-012023-09-30_us-gaap_AdditionalPaidInCapitalMember" id="Fact002061" format="ixt:numdotdecimal" decimals="0" unitRef="USD">201,365</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl2062">-</span></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl2063">-</span></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" contextRef="From2023-07-012023-09-30" id="Fact002064" format="ixt:numdotdecimal" decimals="0" unitRef="USD">201,365</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr id="xdx_40B_ecustom--StockIssuedDuringPeriodValueShelfRegistrationOffering_zPEroAeuSQf2" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Shelf Registration Offering
    &#8211; see Note 8</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl2066">-</span></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td id="xdx_985_ecustom--StockIssuedDuringPeriodSharesShelfRegistrationOffering_c20230701__20230930__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zzRD1sbUmk0g" title="Shelf Registration Offering - see Note 8, shares" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="STSS:StockIssuedDuringPeriodSharesShelfRegistrationOffering" contextRef="From2023-07-012023-09-30_us-gaap_CommonStockMember" id="Fact002074" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">164,478</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="STSS:StockIssuedDuringPeriodValueShelfRegistrationOffering" contextRef="From2023-07-012023-09-30_us-gaap_CommonStockMember" id="Fact002067" format="ixt:numdotdecimal" decimals="0" unitRef="USD">16</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="STSS:StockIssuedDuringPeriodValueShelfRegistrationOffering" contextRef="From2023-07-012023-09-30_us-gaap_AdditionalPaidInCapitalMember" id="Fact002069" format="ixt:numdotdecimal" decimals="0" unitRef="USD">2,457,988</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="STSS:StockIssuedDuringPeriodValueShelfRegistrationOffering" contextRef="From2023-07-012023-09-30" id="Fact002072" format="ixt:numdotdecimal" decimals="0" unitRef="USD">2,458,004</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr id="xdx_404_ecustom--StockIssuedDuringPeriodValuePrivatePlacement_zYuJjK1Z4Bo8" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Private Placement Offering
    &#8211; see Note 8</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl2076">-</span></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="STSS:StockIssuedDuringPeriodValuePrivatePlacement" contextRef="From2023-07-012023-09-30_us-gaap_AdditionalPaidInCapitalMember" id="Fact002079" format="ixt:numdotdecimal" decimals="0" unitRef="USD">1,552,819</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="STSS:StockIssuedDuringPeriodValuePrivatePlacement" contextRef="From2023-07-012023-09-30" id="Fact002082" format="ixt:numdotdecimal" decimals="0" unitRef="USD">1,552,819</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr id="xdx_400_eus-gaap--OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax_zEMLMvEDPJJh" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Foreign Currency Translation</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl2084">-</span></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(<ix:nonFraction name="us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax" contextRef="From2023-07-012023-09-30_us-gaap_AccumulatedOtherComprehensiveIncomeMember" id="Fact002088" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">283,544</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(<ix:nonFraction name="us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax" contextRef="From2023-07-012023-09-30" id="Fact002090" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">283,544</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td></tr>
  <tr id="xdx_43F_c20230701__20230930_eus-gaap--StockholdersEquity_iE_zGuFqMyczDgk" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Balance
    - September 30, 2023</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td id="xdx_987_eus-gaap--SharesOutstanding_iE_c20230701__20230930__us-gaap--StatementEquityComponentsAxis__us-gaap--PreferredStockMember_z08DdcAABeWf" title="Balance, shares" style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="us-gaap:SharesOutstanding" contextRef="AsOf2023-09-30_us-gaap_PreferredStockMember" id="Fact002100" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">1</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl2092">-</span></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td id="xdx_985_eus-gaap--SharesOutstanding_iE_c20230701__20230930__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zdOQ7lKWx7E3" title="Balance, shares" style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="us-gaap:SharesOutstanding" contextRef="AsOf2023-09-30_us-gaap_CommonStockMember" id="Fact002102" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">694,294</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2023-09-30_us-gaap_CommonStockMember" id="Fact002093" format="ixt:numdotdecimal" decimals="0" unitRef="USD">69</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl2094">-</span></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2023-09-30_us-gaap_AdditionalPaidInCapitalMember" id="Fact002095" format="ixt:numdotdecimal" decimals="0" unitRef="USD">32,367,297</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2023-09-30_us-gaap_AccumulatedOtherComprehensiveIncomeMember" id="Fact002096" format="ixt:numdotdecimal" decimals="0" unitRef="USD">275,568</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(<ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2023-09-30_us-gaap_RetainedEarningsMember" id="Fact002097" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">22,047,365</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td><td style="font-weight: bold; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2023-09-30" id="Fact002098" format="ixt:numdotdecimal" decimals="0" unitRef="USD">10,595,569</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr id="xdx_437_c20230701__20230930_eus-gaap--StockholdersEquity_iE_zYgmHf04I3Sl" style="display: none; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="display: none; font-weight: bold; padding-bottom: 2.5pt"><span style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt">Balance</span></td><td style="display: none; padding-bottom: 2.5pt"><span style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; display: none; text-align: left"><span style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td id="xdx_981_eus-gaap--SharesOutstanding_iE_c20230701__20230930__us-gaap--StatementEquityComponentsAxis__us-gaap--PreferredStockMember_ze9Yi4VqhVOf" title="Balance, shares" style="border-bottom: Black 2.5pt double; display: none; text-align: right"><span style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="us-gaap:SharesOutstanding" contextRef="AsOf2023-09-30_us-gaap_PreferredStockMember" id="Fact002112" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">1</ix:nonFraction></span></td><td style="display: none; padding-bottom: 2.5pt; text-align: left"><span style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="display: none; padding-bottom: 2.5pt"><span style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; display: none; text-align: left"><span style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="border-bottom: Black 2.5pt double; display: none; text-align: right"><span style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl2104">-</span></span></td><td style="display: none; padding-bottom: 2.5pt; text-align: left"><span style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="display: none; padding-bottom: 2.5pt"><span style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; display: none; text-align: left"><span style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td id="xdx_98F_eus-gaap--SharesOutstanding_iE_c20230701__20230930__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zkBpuawxO32h" title="Balance, shares" style="border-bottom: Black 2.5pt double; display: none; text-align: right"><span style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="us-gaap:SharesOutstanding" contextRef="AsOf2023-09-30_us-gaap_CommonStockMember" id="Fact002114" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">694,294</ix:nonFraction></span></td><td style="display: none; padding-bottom: 2.5pt; text-align: left"><span style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="display: none; font-weight: bold; padding-bottom: 2.5pt"><span style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; display: none; font-weight: bold; text-align: left"><span style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="border-bottom: Black 2.5pt double; display: none; font-weight: bold; text-align: right"><span style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2023-09-30_us-gaap_CommonStockMember" id="Fact002105" format="ixt:numdotdecimal" decimals="0" unitRef="USD">69</ix:nonFraction></span></td><td style="display: none; padding-bottom: 2.5pt; font-weight: bold; text-align: left"><span style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="display: none; padding-bottom: 2.5pt"><span style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; display: none; text-align: left"><span style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 2.5pt double; display: none; text-align: right"><span style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl2106">-</span></span></td><td style="display: none; padding-bottom: 2.5pt; text-align: left"><span style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="display: none; padding-bottom: 2.5pt"><span style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; display: none; text-align: left"><span style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="border-bottom: Black 2.5pt double; display: none; text-align: right"><span style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2023-09-30_us-gaap_AdditionalPaidInCapitalMember" id="Fact002107" format="ixt:numdotdecimal" decimals="0" unitRef="USD">32,367,297</ix:nonFraction></span></td><td style="display: none; padding-bottom: 2.5pt; text-align: left"><span style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="display: none; padding-bottom: 2.5pt"><span style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; display: none; text-align: left"><span style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="border-bottom: Black 2.5pt double; display: none; text-align: right"><span style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2023-09-30_us-gaap_AccumulatedOtherComprehensiveIncomeMember" id="Fact002108" format="ixt:numdotdecimal" decimals="0" unitRef="USD">275,568</ix:nonFraction></span></td><td style="display: none; padding-bottom: 2.5pt; text-align: left"><span style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="display: none; padding-bottom: 2.5pt"><span style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; display: none; text-align: left"><span style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="border-bottom: Black 2.5pt double; display: none; text-align: right"><span style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt">(<ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2023-09-30_us-gaap_RetainedEarningsMember" id="Fact002109" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">22,047,365</ix:nonFraction></span></td><td style="display: none; padding-bottom: 2.5pt; text-align: left"><span style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td><td style="display: none; font-weight: bold; padding-bottom: 2.5pt"><span style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; display: none; font-weight: bold; text-align: left"><span style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="border-bottom: Black 2.5pt double; display: none; font-weight: bold; text-align: right"><span style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2023-09-30" id="Fact002110" format="ixt:numdotdecimal" decimals="0" unitRef="USD">10,595,569</ix:nonFraction></span></td><td style="display: none; padding-bottom: 2.5pt; font-weight: bold; text-align: left"><span style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
</table>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>The
accompanying notes are an integral part of these financial statements</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>


<!-- Field: Page; Sequence: 79; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 0pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->31<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%"><a href="#RM_014">Table of Contents</a></td></tr></table></div>
    <!-- Field: /Page -->


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="RM_021"></span><span id="a_005"></span>SHARPS
TECHNOLOGY, INC.</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>CONDENSED
CONSOLIDATED STATEMENTS OF CASH FLOWS</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>FOR
THE NINE MONTHS ENDED SEPTEMBER 30</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(UNAUDITED)</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" id="xdx_301_112_zfzM60PzTfk6" summary="xdx: Statement - Condensed Consolidated Statements of Cash Flows" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="display: none; vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" id="xdx_49A_20240101__20240930_zh3MvOKNX0jj" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">&#160;</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" id="xdx_49E_20230101__20230930_zyYyK66YxrAf" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">&#160;</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="text-align: center">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2024</td><td style="font-weight: bold">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2023</td><td style="font-weight: bold">&#160;</td></tr>
  <tr id="xdx_409_eus-gaap--NetCashProvidedByUsedInOperatingActivitiesAbstract_iB_z6DkvUMZ7kEb" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">CASH FLOWS FROM OPERATING ACTIVITIES:</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_403_eus-gaap--NetIncomeLoss_i01_maCzBgw_zyCWpBKKnD81" style="vertical-align: bottom; background-color: White">
    <td style="width: 60%; text-align: left">Net loss</td><td style="width: 2%">&#160;</td>
    <td style="border-bottom: Black 1pt solid; width: 1%; text-align: left">$</td><td style="border-bottom: Black 1pt solid; width: 16%; text-align: right">(<ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2024-01-01to2024-09-30" id="Fact002119" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">4,769,774</ix:nonFraction></td><td style="width: 1%; text-align: left">)</td><td style="width: 2%">&#160;</td>
    <td style="border-bottom: Black 1pt solid; width: 1%; text-align: left">$</td><td style="border-bottom: Black 1pt solid; width: 16%; text-align: right">(<ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2023-01-012023-09-30" id="Fact002120" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">6,739,999</ix:nonFraction></td><td style="width: 1%; text-align: left">)</td></tr>
  <tr id="xdx_405_eus-gaap--AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_i01B_zFF2BMqev2tb" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Adjustments to reconcile net loss to net cash used in operating activities:</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_402_eus-gaap--DepreciationAndAmortization_i02_maCzBgw_zqn0ths9ewX8" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 10pt; text-align: left">Depreciation and amortization</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="us-gaap:DepreciationAndAmortization" contextRef="From2024-01-01to2024-09-30" id="Fact002125" format="ixt:numdotdecimal" decimals="0" unitRef="USD">583,006</ix:nonFraction></span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:DepreciationAndAmortization" contextRef="From2023-01-012023-09-30" id="Fact002126" format="ixt:numdotdecimal" decimals="0" unitRef="USD">656,100</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_403_eus-gaap--ShareBasedCompensation_i02_maCzBgw_zxWJEftsUmxh" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 10pt; text-align: left">Stock-based compensation</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="us-gaap:ShareBasedCompensation" contextRef="From2024-01-01to2024-09-30" id="Fact002128" format="ixt:numdotdecimal" decimals="0" unitRef="USD">444,498</ix:nonFraction></span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:ShareBasedCompensation" contextRef="From2023-01-012023-09-30" id="Fact002129" format="ixt:numdotdecimal" decimals="0" unitRef="USD">838,911</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40C_eus-gaap--AmortizationOfDebtDiscountPremium_i02_maCzBgw_zvjjSp8kbN85" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 10pt; text-align: left">Accretion of debt discount</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:AmortizationOfDebtDiscountPremium" contextRef="From2024-01-01to2024-09-30" id="Fact002131" format="ixt:numdotdecimal" decimals="0" unitRef="USD">75,192</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2132">-</span></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_406_eus-gaap--GainLossOnSaleOfDerivatives_i02N_di_msCzBgw_zRhLWu1wKJp2" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 10pt; text-align: left">FMV adjustment for Warrants</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(<ix:nonFraction name="us-gaap:GainLossOnSaleOfDerivatives" contextRef="From2024-01-01to2024-09-30" id="Fact002134" format="ixt:numdotdecimal" decimals="0" unitRef="USD">2,088,747</ix:nonFraction></span></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction name="us-gaap:GainLossOnSaleOfDerivatives" contextRef="From2023-01-012023-09-30" id="Fact002135" format="ixt:numdotdecimal" decimals="0" unitRef="USD">415,958</ix:nonFraction></td><td style="text-align: left">)</td></tr>
  <tr id="xdx_40E_eus-gaap--AmortizationOfFinancingCosts_i02_maCzBgw_ztmXMXCNUbic" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 10pt; text-align: left">Equity Issuance costs</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl2137">-</span>&#160;</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:AmortizationOfFinancingCosts" contextRef="From2023-01-012023-09-30" id="Fact002138" format="ixt:numdotdecimal" decimals="0" unitRef="USD">205,112</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_409_ecustom--EscrowDepositForfeited_i02_maCzBgw_zQBAGQ2uizZ5" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 10pt; text-align: left">Escrow forfeited</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="STSS:EscrowDepositForfeited" contextRef="From2024-01-01to2024-09-30" id="Fact002140" format="ixt:numdotdecimal" decimals="0" unitRef="USD">1,000,000</ix:nonFraction></span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2141">-</span></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_403_eus-gaap--ForeignCurrencyTransactionGainLossBeforeTax_i02N_di_msCzBgw_zg4op8p1CE07" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Foreign exchange (gain)/loss</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="us-gaap:ForeignCurrencyTransactionGainLossBeforeTax" contextRef="From2024-01-01to2024-09-30" id="Fact002143" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">31,566</ix:nonFraction></span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:ForeignCurrencyTransactionGainLossBeforeTax" contextRef="From2023-01-012023-09-30" id="Fact002144" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">33,729</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_403_eus-gaap--IncreaseDecreaseInOperatingCapitalAbstract_i02B_zDxxuPef7a0c" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Changes in operating assets:</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_408_eus-gaap--IncreaseDecreaseInPrepaidExpense_i03N_di_msCzBgw_z8BbfhQbXhP5" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 10pt; text-align: left">Prepaid expenses and other current assets</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(<ix:nonFraction name="us-gaap:IncreaseDecreaseInPrepaidExpense" contextRef="From2024-01-01to2024-09-30" id="Fact002149" format="ixt:numdotdecimal" decimals="0" unitRef="USD">47,233</ix:nonFraction></span></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction name="us-gaap:IncreaseDecreaseInPrepaidExpense" contextRef="From2023-01-012023-09-30" id="Fact002150" format="ixt:numdotdecimal" decimals="0" unitRef="USD">23,032</ix:nonFraction></td><td style="text-align: left">)</td></tr>
  <tr id="xdx_40B_eus-gaap--IncreaseDecreaseInInventories_i03N_di_msCzBgw_z9eDRLiaWOt2" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 10pt">Inventory</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(<ix:nonFraction name="us-gaap:IncreaseDecreaseInInventories" contextRef="From2024-01-01to2024-09-30" id="Fact002152" format="ixt:numdotdecimal" decimals="0" unitRef="USD">349,317</ix:nonFraction></span></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction name="us-gaap:IncreaseDecreaseInInventories" contextRef="From2023-01-012023-09-30" id="Fact002153" format="ixt:numdotdecimal" decimals="0" unitRef="USD">1,039,152</ix:nonFraction></td><td style="text-align: left">)</td></tr>
  <tr id="xdx_408_eus-gaap--IncreaseDecreaseInAccountsPayableAndAccruedLiabilities_i03_maCzBgw_zfY6JQ89wsL8" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 10pt; text-align: left">Accounts payable and accrued liabilities</td><td>&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(<ix:nonFraction name="us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" contextRef="From2024-01-01to2024-09-30" id="Fact002155" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">51,326</ix:nonFraction></span></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" contextRef="From2023-01-012023-09-30" id="Fact002156" format="ixt:numdotdecimal" decimals="0" unitRef="USD">339,352</ix:nonFraction></td><td style="text-align: left">)</td></tr>
  <tr id="xdx_407_eus-gaap--NetCashProvidedByUsedInOperatingActivities_i01T_mtCzBgw_maCzSe1_z7sz60fO4MLe" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Net cash used in operating activities</td><td>&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(<ix:nonFraction name="us-gaap:NetCashProvidedByUsedInOperatingActivities" contextRef="From2024-01-01to2024-09-30" id="Fact002158" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">5,172,135</ix:nonFraction></span></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(<ix:nonFraction name="us-gaap:NetCashProvidedByUsedInOperatingActivities" contextRef="From2023-01-012023-09-30" id="Fact002159" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">6,144,937</ix:nonFraction></td><td style="text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_406_eus-gaap--NetCashProvidedByUsedInInvestingActivitiesAbstract_iB_zVZJQSVCpPN3" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">CASH FLOWS FROM INVESTING ACTIVITIES:</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40D_eus-gaap--PaymentsForProceedsFromOtherInvestingActivities_i01N_di_msCzWZa_z9HKVDjhjuEa" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 10pt; text-align: left">Acquisition of fixed assets or deposits paid</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(<ix:nonFraction name="us-gaap:PaymentsForProceedsFromOtherInvestingActivities" contextRef="From2024-01-01to2024-09-30" id="Fact002164" format="ixt:numdotdecimal" decimals="0" unitRef="USD">69,659</ix:nonFraction></span></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction name="us-gaap:PaymentsForProceedsFromOtherInvestingActivities" contextRef="From2023-01-012023-09-30" id="Fact002165" format="ixt:numdotdecimal" decimals="0" unitRef="USD">232,295</ix:nonFraction></td><td style="text-align: left">)</td></tr>
  <tr id="xdx_403_ecustom--EscrowPaymentUnderAgreement_i01N_di_msCzWZa_z7u2E6UgyU34" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 10pt; text-align: left">Escrow payment under agreement</td><td>&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(<ix:nonFraction name="STSS:EscrowPaymentUnderAgreement" contextRef="From2024-01-01to2024-09-30" id="Fact002167" format="ixt:numdotdecimal" decimals="0" unitRef="USD">1,000,000</ix:nonFraction></span></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(<ix:nonFraction name="STSS:EscrowPaymentUnderAgreement" contextRef="From2023-01-012023-09-30" id="Fact002168" format="ixt:numdotdecimal" decimals="0" unitRef="USD">199,084</ix:nonFraction></td><td style="text-align: left">)</td></tr>
  <tr id="xdx_40B_eus-gaap--NetCashProvidedByUsedInInvestingActivities_i01T_mtCzWZa_maCzSe1_zOff3Cas9zcb" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Net cash used in investing activities</td><td>&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(<ix:nonFraction name="us-gaap:NetCashProvidedByUsedInInvestingActivities" contextRef="From2024-01-01to2024-09-30" id="Fact002170" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">1,069,659</ix:nonFraction></span></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(<ix:nonFraction name="us-gaap:NetCashProvidedByUsedInInvestingActivities" contextRef="From2023-01-012023-09-30" id="Fact002171" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">431,379</ix:nonFraction></td><td style="text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40B_eus-gaap--NetCashProvidedByUsedInFinancingActivitiesAbstract_iB_zho3sn4P6Rpb" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">CASH FLOWS FROM FINANCING ACTIVITIES:</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40B_ecustom--NetProceedsFromOfferingsAndWarrantExercises_i01_maCz957_zYgTSRM779G3" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 10pt; text-align: left">Net proceeds from offerings and warrant exercises</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="STSS:NetProceedsFromOfferingsAndWarrantExercises" contextRef="From2024-01-01to2024-09-30" id="Fact002176" format="ixt:numdotdecimal" decimals="0" unitRef="USD">2,972,646</ix:nonFraction></span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="STSS:NetProceedsFromOfferingsAndWarrantExercises" contextRef="From2023-01-012023-09-30" id="Fact002177" format="ixt:numdotdecimal" decimals="0" unitRef="USD">8,029,628</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40B_eus-gaap--ProceedsFromIssuanceOfLongTermDebt_i01_maCz957_z7utUlpM2imh" style="vertical-align: bottom; background-color: White">
    <td style="padding-bottom: 1pt; padding-left: 10pt; text-align: left">Net proceeds from Debt financing</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:ProceedsFromIssuanceOfLongTermDebt" contextRef="From2024-01-01to2024-09-30" id="Fact002179" format="ixt:numdotdecimal" decimals="0" unitRef="USD">2,735,300</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2180">-</span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_405_eus-gaap--NetCashProvidedByUsedInFinancingActivities_i01T_mtCz957_maCzSe1_z2276Jq1tNCe" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 10pt; text-align: left">Net cash provided by financing activities</td><td>&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="us-gaap:NetCashProvidedByUsedInFinancingActivities" contextRef="From2024-01-01to2024-09-30" id="Fact002182" format="ixt:numdotdecimal" decimals="0" unitRef="USD">5,707,946</ix:nonFraction></span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:NetCashProvidedByUsedInFinancingActivities" contextRef="From2023-01-012023-09-30" id="Fact002183" format="ixt:numdotdecimal" decimals="0" unitRef="USD">8,029,628</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_409_eus-gaap--EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations_maCzSe1_zGlHgsQGvPS9" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Effect of exchange rate changes on cash</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(<ix:nonFraction name="us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations" contextRef="From2024-01-01to2024-09-30" id="Fact002185" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">5,863</ix:nonFraction></span></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction name="us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations" contextRef="From2023-01-012023-09-30" id="Fact002186" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">69,792</ix:nonFraction></td><td style="text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_406_eus-gaap--CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_iT_mtCzSe1_zjaejwhvAH19" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">NET INCREASE (DECREASE) IN CASH</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(<ix:nonFraction name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" contextRef="From2024-01-01to2024-09-30" id="Fact002188" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">539,711</ix:nonFraction></span></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" contextRef="From2023-01-012023-09-30" id="Fact002189" format="ixt:numdotdecimal" decimals="0" unitRef="USD">1,383,520</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_403_eus-gaap--CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations_iS_pp0p0_zp0a1MwAbn03" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">CASH &#8212; BEGINNING OF YEAR</td><td>&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations" contextRef="AsOf2023-12-31" id="Fact002191" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">3,012,908</ix:nonFraction></span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations" contextRef="AsOf2022-12-31" id="Fact002192" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">4,170,897</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_409_eus-gaap--CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations_iE_pp0p0_zn9xGRiUOvzg" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>CASH &#8212; END OF PERIOD</td><td>&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations" contextRef="AsOf2024-09-30" id="Fact002194" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">2,473,197</ix:nonFraction></span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right"><ix:nonFraction name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations" contextRef="AsOf2023-09-30" id="Fact002195" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">5,554,417</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  </table>



<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>The
accompanying notes are an integral part of these financial statements.</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>&#160;</i></span></p>


<!-- Field: Page; Sequence: 80; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 0pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->32<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%"><a href="#RM_014">Table of Contents</a></td></tr></table></div>
    <!-- Field: /Page -->


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>&#160;</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="RM_022"></span><span id="a_006"></span>SHARPS
TECHNOLOGY, INC.</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTES
TO THE CONDENSED CONSOLIDATED FINANCIAL STATEMENTS</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>FOR
THE THREE AND NINE MONTHS ENDED SEPTEMBER 30, 2024 AND 2023</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<ix:nonNumeric contextRef="From2024-01-01to2024-09-30" escape="true" id="Fact002197" name="us-gaap:BusinessDescriptionAndBasisOfPresentationTextBlock"><p id="xdx_80C_eus-gaap--BusinessDescriptionAndBasisOfPresentationTextBlock_z2aG7dHE8Noe" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Note
1. <span id="xdx_821_z1tr3jvM5ini">Description of Business</span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Nature
of Business and Going Concern</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Sharps
Technology, Inc. (&#8220;Sharps&#8221; or the &#8220;Company&#8221;) is a pre-revenue medical device company that has designed and patented
various safety syringes and is seeking commercialization by manufacturing and distribution of its products.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
accompanying condensed consolidated financial statements include the accounts of Sharps Technology, Inc., and its wholly owned subsidiaries,
Safegard Medical, Kft. and Sharps Technology Acquisition Corp. collectively referred to as the &#8220;Company.&#8221; The condensed consolidated
balance sheet as of September 30, 2024 and the condensed consolidated statements of operations, statements of comprehensive loss, statements
of stockholders&#8217; equity and the statements of cash flow for three and nine months ended September 30, 2024 and 2023 (the &#8220;interim
statements&#8221;) are unaudited. All intercompany transactions and balances have been eliminated. In the opinion of management, all
adjustments (which include normal recurring adjustments) necessary to present fairly the financial position and operating results for
the interim periods have been made. Certain information and footnote disclosure, normally included in annual financial statements prepared
in accordance with accounting principles generally accepted in the United States, have been condensed or omitted. The interim statements
should be read in conjunction with the consolidated financial statements for the year ended December 31, 2023 and notes thereto contained
in the Company&#8217;s Form 10-K filed with the Securities and Exchange Commission. The condensed consolidated balance sheet at December
31, 2023 has been derived from the audited financial statements at that date. The results of operations for the three and nine months
ended September 30, 2024 are not necessarily indicative of the results that may be expected for the fiscal year ending December 31, 2024.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
accompanying condensed consolidated financial statements have been prepared assuming that the Company will continue as a going concern.
The Company has not generated revenue or cash flow from operations since inception. As of September 30, 2024, the Company had a working
capital of $<span id="xdx_900_ecustom--WorkingCapital_iI_c20240930_zlkTftU9qWw3" title="Working capital"><ix:nonFraction name="STSS:WorkingCapital" contextRef="AsOf2024-09-30" id="Fact002199" format="ixt:numdotdecimal" decimals="0" unitRef="USD">67,820</ix:nonFraction></span> which is not expected to be sufficient to fund the Company&#8217;s planned operations for the next 12 months. These
factors raise substantial doubt regarding the Company&#8217;s ability to continue as a going concern. The Company&#8217;s ability to
continue as a going concern is dependent upon the Company&#8217;s ability to raise sufficient financing to acquire or commercialize its
products into a profitable business. The Company intends to finance its commercialization activities and its working capital needs largely
from the sale of equity securities and/or with additional funding from other traditional financing sources until such time that funds
provided by operations are sufficient to fund working capital requirements. The unaudited condensed consolidated financial statements
of the Company do not include any adjustments relating to the recoverability and classification of recorded assets, or the amounts and
classifications of liabilities that might be necessary should the Company be unable to continue as a going concern.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company&#8217;s fiscal year ends on December 31.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
April 13, 2022, the Company&#8217;s Initial Public Offering was deemed effective with trading commencing on April 14, 2022. The Company
received net proceeds of $<span id="xdx_900_eus-gaap--ProceedsFromIssuanceInitialPublicOffering_pn5n6_c20220417__20220419__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--IPOMember_zW1ccizfuWk1" title="Initial public offering"><ix:nonFraction name="us-gaap:ProceedsFromIssuanceInitialPublicOffering" contextRef="From2022-04-172022-04-19_us-gaap_IPOMember" id="Fact002201" format="ixt:numdotdecimal" decimals="-5" scale="6" unitRef="USD">14.2</ix:nonFraction></span> million on April 19, 2022 (See Note 7).</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Effective
October 16, 2024, <span id="xdx_908_ecustom--ReverseStockSplitDescription_c20241006__20241016_zv26HyC6O2li" title="Reverse stock split description"><ix:nonNumeric contextRef="From2024-10-062024-10-16" id="Fact002203" name="STSS:ReverseStockSplitDescription">the Company completed a 1 for 22 reverse split, whereby for each 22 shares of common stock the Company issued one share
of common stock .</ix:nonNumeric></span> All share, other equity instruments and per share information in the accompanying condensed consolidated financial
statements and footnotes have been retroactively adjusted for the effects of the reverse split for all periods presented.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"></p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2024-01-01to2024-09-30" escape="true" id="Fact002205" name="us-gaap:SignificantAccountingPoliciesTextBlock"><p id="xdx_801_eus-gaap--SignificantAccountingPoliciesTextBlock_zA9wf4rUPnq5" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Note
2. <span id="xdx_829_z09g9XOryKKi">Summary of Significant Accounting Policies</span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<ix:nonNumeric contextRef="From2024-01-01to2024-09-30" escape="true" id="Fact002207" name="us-gaap:BasisOfAccountingPolicyPolicyTextBlock"><p id="xdx_840_eus-gaap--BasisOfAccountingPolicyPolicyTextBlock_zzowRwhjjZ34" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Basis
of Presentation</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
accompanying condensed consolidated financial statements have been prepared by the Company in accordance with generally accepted accounting
principles (&#8220;GAAP&#8221;) in the United States (&#8220;U.S.&#8221;) and are expressed in U.S. dollars.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<ix:exclude><!-- Field: Page; Sequence: 81; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 0pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->33<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%"><a href="#RM_014">Table of Contents</a></td></tr></table></div>
    <!-- Field: /Page --></ix:exclude>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>SHARPS
TECHNOLOGY, INC.</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTES
TO THE CONDENSED CONSOLIDATED FINANCIAL STATEMENTS</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>FOR
THE THREE AND NINE MONTHS ENDED SEPTEMBER 30, 2024 AND 2023</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Note
2. Summary of Significant Accounting Policies (continued)</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>&#160;</i></b></span></p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2024-01-01to2024-09-30" escape="true" id="Fact002209" name="us-gaap:UseOfEstimates"><p id="xdx_84C_eus-gaap--UseOfEstimates_zGgGkPhMhNe2" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Use
of Estimates</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
preparation of financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the
reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements
and the reported amounts of revenues and expenses during the reporting periods. Actual results could differ from those estimates. As
of September 30, 2024, the most significant estimates relate to derivative liabilities, stock-based compensation, long-lived asset impairments and accounting for debt and equity financing.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2024-01-01to2024-09-30" escape="true" id="Fact002211" name="us-gaap:CashAndCashEquivalentsPolicyTextBlock"><p id="xdx_84D_eus-gaap--CashAndCashEquivalentsPolicyTextBlock_zpVN0CaOHznd" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Cash
and Cash Equivalents</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company considers all highly liquid investments purchased with an original or remaining maturity of three months or less at the date
of purchase to be cash equivalents. Cash and cash equivalents are maintained with various financial institutions. At September 30, 2024
and December 31, 2023, the Company had <span id="xdx_90E_eus-gaap--CashEquivalentsAtCarryingValue_iI_do_c20240930_zwmnXV8kgRR4" title="Cash equivalents"><span id="xdx_905_eus-gaap--CashEquivalentsAtCarryingValue_iI_do_c20231231_zGf0aAiwxUi6" title="Cash equivalents"><ix:nonFraction name="us-gaap:CashEquivalentsAtCarryingValue" contextRef="AsOf2024-09-30" id="Fact002213" format="ixt-sec:numwordsen" decimals="0" unitRef="USD"><ix:nonFraction name="us-gaap:CashEquivalentsAtCarryingValue" contextRef="AsOf2023-12-31" id="Fact002215" format="ixt-sec:numwordsen" decimals="0" unitRef="USD">no</ix:nonFraction></ix:nonFraction></span></span> cash equivalents.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2024-01-01to2024-09-30" escape="true" id="Fact002217" name="us-gaap:InventoryPolicyTextBlock"><p id="xdx_844_eus-gaap--InventoryPolicyTextBlock_zGOqIcJQKIza" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Inventories</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company values inventory at the lower of cost (average cost) or net realizable value. Work-in-process and finished goods inventories
consist of material, labor, and manufacturing overhead. Net realizable value is the estimated selling price in the ordinary course of
business, less reasonably predictable costs of completion, disposal, and transportation. A reserve is established for any excess or obsolete
inventories or they may be written off. At September 30, 2024, and December 31, 2023, inventory is comprised of raw materials, including
packaging, work in process (components) and finished goods.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2024-01-01to2024-09-30" escape="true" id="Fact002219" name="us-gaap:FairValueMeasurementPolicyPolicyTextBlock"><p id="xdx_84D_eus-gaap--FairValueMeasurementPolicyPolicyTextBlock_z8orLyWy9zmh" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Fair
Value Measurements</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">ASC
820, Fair Value Measurements and Disclosures, requires an entity to maximize the use of observable inputs and minimize the use of unobservable
inputs when measuring fair value. ASC 820 establishes a fair value hierarchy based on the level of independent, objective evidence surrounding
the inputs used to measure fair value. A financial instrument&#8217;s categorization within the fair value hierarchy is based upon the
lowest level of input that is significant to the fair value measurement. ASC 820 prioritizes the inputs into three levels that may be
used to measure fair value.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company&#8217;s outstanding warrants are valued on a recurring basis with the trading price which could cause fluctuations in operating
results at the reporting periods.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Level
1</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Level
1 applies to assets or liabilities for which there are quoted prices in active markets for identical assets or liabilities. Valuations
are based on quoted prices that are readily and regularly available in an active market and do not entail a significant degree of judgment.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Level
2</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Level
2 applied to assets or liabilities for which there are other than Level 1 observable inputs such as quoted prices for similar assets
or liabilities in active markets; quoted prices for identical assets or liabilities in markets with insufficient volume or infrequent
transactions (less active markets); or model-derived valuations in which significant inputs are observable or can be derived principally
from, or corroborated by, observable market data.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Level
2 instruments require more management judgment and subjectivity as compared to Level 1 instruments. For instance: determining which instruments
are most similar to the instrument being priced requires management to identify a sample of similar securities based on the coupon rates,
maturity, issuer credit rating and instrument type, and subjectively select an individual security or multiple securities that are deemed
most similar to the security being priced; and determining whether a market is considered active requires management judgment.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"></p>

<ix:exclude><!-- Field: Page; Sequence: 82; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 0pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->34<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%"><a href="#RM_014">Table of Contents</a></td></tr></table></div>
    <!-- Field: /Page --></ix:exclude>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;<br/></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>SHARPS
TECHNOLOGY, INC.</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTES
TO THE CONDENSED CONSOLIDATED FINANCIAL STATEMENTS</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>FOR
THE THREE AND NINE MONTHS ENDED SEPTEMBER 30, 2024 AND 2023</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Note
2. Summary of Significant Accounting Policies (continued)</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Level
3</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Level
3 applied to assets or liabilities for which there are unobservable inputs to the valuation methodology that are significant to the measurement
of the fair value of the assets or liabilities. The determination for Level 3 instruments requires the most management judgment and subjectivity.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2024-01-01to2024-09-30" escape="true" id="Fact002221" name="us-gaap:PropertyPlantAndEquipmentPolicyTextBlock"><p id="xdx_84A_eus-gaap--PropertyPlantAndEquipmentPolicyTextBlock_zeQSF2RpUG6k" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Fixed
Assets</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>&#160;</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Fixed
assets are stated at cost. Expenditures for maintenance and repairs are charged to operations as incurred. The Company&#8217;s fixed
assets consist of land, building, machinery and equipment, molds and website. Depreciation is calculated using the straight-line method
commencing on the date the asset is operating in the way intended by management over the following useful lives: Building &#8211; <span id="xdx_90D_eus-gaap--PropertyPlantAndEquipmentUsefulLife_iI_dtY_c20240930__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--BuildingMember_zfFFDUZ05bbg" title="Property plant and equipment asset useful life"><ix:nonNumeric contextRef="AsOf2024-09-30_us-gaap_BuildingMember" format="ixt-sec:duryear" id="Fact002223" name="us-gaap:PropertyPlantAndEquipmentUsefulLife">20</ix:nonNumeric></span>
years, Machinery and Equipment &#8211; <span id="xdx_901_eus-gaap--PropertyPlantAndEquipmentUsefulLife_iI_dtY_c20240930__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--MachineryAndEquipmentMember__srt--RangeAxis__srt--MinimumMember_zQDlHxyYqlR4" title="Property plant and equipment asset useful life"><ix:nonNumeric contextRef="AsOf2024-09-30_us-gaap_MachineryAndEquipmentMember_srt_MinimumMember" format="ixt-sec:duryear" id="Fact002225" name="us-gaap:PropertyPlantAndEquipmentUsefulLife">3</ix:nonNumeric></span> - <span id="xdx_907_eus-gaap--PropertyPlantAndEquipmentUsefulLife_iI_dtY_c20240930__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--MachineryAndEquipmentMember__srt--RangeAxis__srt--MaximumMember_zIimvDqNBFI6" title="Property plant and equipment asset useful life"><ix:nonNumeric contextRef="AsOf2024-09-30_us-gaap_MachineryAndEquipmentMember_srt_MaximumMember" format="ixt-sec:duryear" id="Fact002227" name="us-gaap:PropertyPlantAndEquipmentUsefulLife">10</ix:nonNumeric></span> years and Website and Computer Systems &#8211; <span id="xdx_909_eus-gaap--PropertyPlantAndEquipmentUsefulLife_iI_dtY_c20240930__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--WebsiteMember_zTb8yQXBBNHf" title="Property plant and equipment asset useful life"><ix:nonNumeric contextRef="AsOf2024-09-30_custom_WebsiteMember" format="ixt-sec:duryear" id="Fact002229" name="us-gaap:PropertyPlantAndEquipmentUsefulLife">3</ix:nonNumeric></span> years. The expected life for Molds is
based on the lesser of the number of parts that will be produced based on the expected mold capability or 5 years.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>&#160;</i></b></span></p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2024-01-01to2024-09-30" escape="true" id="Fact002231" name="us-gaap:ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock"><p id="xdx_844_eus-gaap--ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock_zcCTXfcljxD8" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i><span id="xdx_863_zFqcx8k1jJQ2">Impairment
of Long-Lived Assets</span></i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Long-lived
assets are reviewed for impairment or whenever events or changes in circumstances indicate that the carrying amount of an asset may not
be recoverable. Recoverability is measured by comparison of the carrying amount of an asset group to the future net undiscounted cash
flows that the assets are expected to generate. If such assets are considered to be impaired, the impairment to be recognized is measured
by the amount by which the carrying amount of the assets exceeds the projected discounted future net cash flows arising from the asset.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">There
were <span id="xdx_900_eus-gaap--ImpairmentOfLongLivedAssetsHeldForUse_dxL_c20240701__20240930_zcjUgtigXLBc" title="Impairment losses::XDX::-"><span id="xdx_905_eus-gaap--ImpairmentOfLongLivedAssetsHeldForUse_dxL_c20230701__20230930_zcIHlxLiKnng" title="Impairment losses::XDX::-"><span id="xdx_907_eus-gaap--ImpairmentOfLongLivedAssetsHeldForUse_dxL_c20240101__20240930_zqXBJ8ZjlUd2" title="Impairment losses::XDX::-"><span id="xdx_90D_eus-gaap--ImpairmentOfLongLivedAssetsHeldForUse_dxL_c20230101__20230930_zat4wV0dNvRi" title="Impairment losses::XDX::-"><span style="-sec-ix-hidden: xdx2ixbrl2233"><span style="-sec-ix-hidden: xdx2ixbrl2235"><span style="-sec-ix-hidden: xdx2ixbrl2237"><span style="-sec-ix-hidden: xdx2ixbrl2239">no</span></span></span></span></span></span></span></span> impairment losses recognized during the three and nine months ended September 30, 2024 and 2023.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Purchased
Identified Intangible Assets</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company&#8217;s identified intangible assets are amortized on a straight-line basis over their estimated useful lives of 5 years.
The Company makes judgments about the recoverability of finite-lived intangible assets whenever facts and circumstances indicate
that the useful life is shorter than originally estimated or that the carrying amount of assets may not be recoverable. If such
facts and circumstances exist, the Company assesses recoverability by comparing the projected undiscounted net cash flows associated
with the related asset or group of assets over their remaining lives against their respective carrying amounts. Impairments, if any,
are based on the excess of the carrying amount over the fair value of those assets. If the useful life is shorter than originally
estimated, the Company would accelerate the rate of amortization and amortize the remaining carrying value over the new shorter
useful life. The Company evaluates the carrying value of indefinite-lived intangible assets whenever events or changes in
circumstances indicate that the carrying amount of an asset may not be recoverable, and an impairment charge would be recognized to
the extent that the carrying amount of such assets exceeds their estimated fair value.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2024-01-01to2024-09-30" escape="true" id="Fact002241" name="us-gaap:CompensationRelatedCostsPolicyTextBlock"><p id="xdx_84D_eus-gaap--CompensationRelatedCostsPolicyTextBlock_zjY7X7QzGzUh" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Stock-based
Compensation Expense</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company measures its stock-based awards made to employees based on the estimated fair values of the awards as of the grant date. For
stock option awards, the Company uses the Black-Scholes option-pricing model. Stock-based compensation expense is recognized over the
requisite service period and is based on the value of the portion of stock-based payment awards that is ultimately expected to vest.
The Company recognizes forfeitures of stock-based awards as they occur on a prospective basis.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Stock-based
compensation expense for awards granted to non-employees as consideration for services received is measured on the date of performance
at the fair value of the consideration received or the fair value of the equity instruments issued, whichever can be more reliably measured.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<ix:exclude><!-- Field: Page; Sequence: 83; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 0pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->35<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%"><a href="#RM_014">Table of Contents</a></td></tr></table></div>
    <!-- Field: /Page --></ix:exclude>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>SHARPS
TECHNOLOGY, INC.</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTES
TO THE CONDENSED CONSOLIDATED FINANCIAL STATEMENTS</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>FOR
THE THREE AND NINE MONTHS ENDED SEPTEMBER 30, 2024 AND 2023</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Note
2. Summary of Significant Accounting Policies (continued)</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>&#160;</i></b></span></p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2024-01-01to2024-09-30" escape="true" id="Fact002243" name="us-gaap:DerivativesPolicyTextBlock"><p id="xdx_84D_eus-gaap--DerivativesPolicyTextBlock_zsOS2s0wxaTa" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Derivative
Instruments</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company accounts for common stock warrants as either equity-classified or liability-classified instruments based on an assessment of
the specific terms of the warrants and applicable authoritative guidance in Financial Accounting Standards Board (&#8220;FASB&#8221;)
Accounting Standards Codification (&#8220;ASC 480&#8221;), Distinguishing Liabilities from Equity (&#8220;ASC 480&#8221;) and ASC 815,
Derivatives and Hedging (&#8220;ASC 815&#8221;). The assessment considers whether the warrants are freestanding financial instruments
pursuant to ASC 480, meet the definition of a liability pursuant to ASC 480, and meet all of the requirements for equity classification
under ASC 815, including whether the warrants are indexed to the Company&#8217;s own stock and whether the holders of the warrants could
potentially require net cash settlement in a circumstance outside of the Company&#8217;s control, among other conditions for equity classification.
This assessment, which requires the use of professional judgment, is conducted at the time of warrant issuance and as of each subsequent
quarterly period end date while the warrants are outstanding.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">At
their issuance date and as of September 30, 2024, certain warrants (see Notes 8 and 10) were accounted for as liabilities as these instruments
did not meet all of the requirements for equity classification under ASC 815-40 based on the terms of the aforementioned warrants. The
resulting warrant liabilities are re-measured at each balance sheet date until their exercise or expiration, and any change in fair value
is recognized in the Company&#8217;s condensed consolidated statements of operations.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2024-01-01to2024-09-30" escape="true" id="Fact002245" name="us-gaap:ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock"><p id="xdx_840_eus-gaap--ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock_zSlJU8zMa6m6" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Foreign
Currency Translation/Transactions</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company has determined that the functional currency for its foreign subsidiary is the local currency. For financial reporting purposes,
assets and liabilities denominated in foreign currencies are translated at current exchange rates and profit and loss accounts are translated
at weighted average exchange rates. Resulting translation gains and losses are included as a separate component of stockholders&#8217;
equity as accumulated other comprehensive income or loss. Gains or losses resulting from transactions entered into in other than the
functional currency are recorded as foreign exchange gains and losses in the condensed consolidated statements of operations.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2024-01-01to2024-09-30" escape="true" id="Fact002247" name="us-gaap:ComprehensiveIncomePolicyPolicyTextBlock"><p id="xdx_848_eus-gaap--ComprehensiveIncomePolicyPolicyTextBlock_zTzYyPt3Ccmb" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Comprehensive
income (loss)</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>&#160;</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Comprehensive
income (loss) consists of the Company&#8217;s consolidated net loss and foreign currency translation adjustments related to its subsidiary.
Foreign currency translation adjustments included in comprehensive loss were not tax effected as the Company has a full valuation allowance
at September 30, 2024 and December 31, 2023. Accumulated other comprehensive income (loss) is a separate component of stockholders&#8217;
equity and consists of the cumulative foreign currency translation adjustments.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2024-01-01to2024-09-30" escape="true" id="Fact002249" name="us-gaap:EarningsPerSharePolicyTextBlock"><p id="xdx_842_eus-gaap--EarningsPerSharePolicyTextBlock_zFZgBIqoHRCg" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Basic
and Diluted Loss Per Share</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company computes net loss per share in accordance with ASC 260, Earnings per Share. ASC 260 requires presentation of both basic and diluted
earnings per share (EPS) on the face of the consolidated statements of operations. Basic EPS is computed by dividing net income (loss)
available to common stockholders (numerator) by the weighted average number of shares outstanding (denominator) during the period. Diluted
EPS gives effect to all dilutive potential common shares outstanding during the period using the treasury stock method and convertible
preferred stock using the if-converted method. In computing diluted EPS, the average stock price for the period is used in determining
the number of shares assumed to be purchased from the exercise of stock options or warrants. Diluted EPS excludes all dilutive potential
shares if their effect is anti-dilutive. As of September 30, 2024, there were <span id="xdx_90A_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_c20240101__20240930__us-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__custom--StockOptionAndWarrantsMember_zBLuoIKyQ3x3" title="Antidilutive shares amount"><ix:nonFraction name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" contextRef="From2024-01-012024-09-30_custom_StockOptionAndWarrantsMember" id="Fact002251" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">958,693</ix:nonFraction></span> stock options and warrants, post reverse split
effected, that could potentially dilute basic EPS in the future that were not included in the computation of diluted EPS because to do
so would have been anti-dilutive for the periods presented.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<ix:exclude><!-- Field: Page; Sequence: 84; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 0pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->36<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%"><a href="#RM_014">Table of Contents</a></td></tr></table></div>
    <!-- Field: /Page --></ix:exclude>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>SHARPS
TECHNOLOGY, INC.</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTES
TO THE CONDENSED CONSOLIDATED FINANCIAL STATEMENTS</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>FOR
THE THREE AND NINE MONTHS ENDED SEPTEMBER 30, 2024 AND 2023</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Note
2. Summary of Significant Accounting Policies (continued)</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>&#160;</i></b></span></p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2024-01-01to2024-09-30" escape="true" id="Fact002253" name="us-gaap:IncomeTaxPolicyTextBlock"><p id="xdx_848_eus-gaap--IncomeTaxPolicyTextBlock_zi2Qqocojtoj" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Income
Taxes</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company must make certain estimates and judgments in determining income tax expenses for financial statement purposes. These estimates
and judgments are used in the calculation of tax credits, tax benefits, tax deductions, and in the calculation of certain deferred taxes
and tax liabilities. Significant changes to these estimates may result in an increase or decrease to the Company&#8217;s tax provision
in a subsequent period.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
provision for income taxes was comprised of the Company&#8217;s current tax liability and changes in deferred income tax assets and liabilities.
The calculation of the current tax liability involves dealing with uncertainties in the application of complex tax laws and regulations
and in determining the liability for tax positions, if any, taken on the Company&#8217;s tax returns in accordance with authoritative
guidance on accounting for uncertainty in income taxes. Deferred income taxes are determined based on the differences between the financial
reporting and tax basis of assets and liabilities. The Company must assess the likelihood that it will be able to recover the Company&#8217;s
deferred tax assets. If recovery is not likely on a more-likely-than-not basis, the Company must increase its provision for income taxes
by recording a valuation allowance against the deferred tax assets that it estimates will not ultimately be recoverable. However, should
there be a change in the Company&#8217;s ability to recover its deferred tax assets, the provision for income taxes would fluctuate in
the period of such change.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2024-01-01to2024-09-30" escape="true" id="Fact002255" name="us-gaap:ResearchAndDevelopmentExpensePolicy"><p id="xdx_84F_eus-gaap--ResearchAndDevelopmentExpensePolicy_z4vvVMYju8i8" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Research
and Development Costs</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Research
and development costs are expensed as incurred.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Advance
payments for goods or services that will be used or rendered for future research and development activities are deferred and capitalized.
Such amounts are recognized as an expense as the related goods are delivered or the services are performed.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2024-01-01to2024-09-30" escape="true" id="Fact002257" name="us-gaap:CommitmentsAndContingenciesPolicyTextBlock"><p id="xdx_84F_eus-gaap--CommitmentsAndContingenciesPolicyTextBlock_zmDbhhayQWRa" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Contingencies</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Liabilities
for loss contingencies arising from claims, assessments, litigations, fines and penalties and other sources are recognized when it is
probable that a liability has been incurred and the amount of the assessment can be reasonably estimated. Gain contingencies are evaluated
and not recognized until the gain is realizable or realized.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2024-01-01to2024-09-30" escape="true" id="Fact002259" name="us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock"><p id="xdx_84A_eus-gaap--NewAccountingPronouncementsPolicyPolicyTextBlock_zLFMU2rpIkW6" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Recent
Accounting Pronouncements</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
August 5, 2020, the FASB issued ASU 2020-06, <i>Debt &#8211; Debt with Conversion and Other Options (Subtopic 470-20) and Derivatives
and Hedging &#8211; Contracts in Entity&#8217;s Own Equity (Subtopic 815-40)</i>, which simplifies the accounting for certain financial
instruments with characteristics of liabilities and equity, including convertible instruments and contracts on an entity&#8217;s own
equity. The ASU is part of the FASB&#8217;s simplification initiative, which aims to reduce unnecessary complexity in U.S. GAAP. ASU
2020-06 simplifies the guidance in U.S. GAAP on the issuer&#8217;s accounting for convertible debt instruments, requires entities to
provide expanded disclosures about &#8220;the terms and features of convertible instruments&#8221; and how the instruments have been
reported in the entity&#8217;s financial statements. It also removes from ASC 815-40-25-10 certain conditions for equity classification
and amends certain guidance in ASC 260, <i>Earnings per Share</i>, on the computation of EPS for convertible instruments and contracts
on an entity&#8217;s own equity. An entity can use either a full or modified retrospective approach to adopt the ASU&#8217;s guidance.
The ASU&#8217;s amendments are effective for smaller public business entities fiscal years beginning after December 15, 2023. The Company
does not expect the pronouncement to have a material impact on the Company and will disclose the nature and reason for any elections
that the Company makes.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<ix:exclude><!-- Field: Page; Sequence: 85; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 0pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->37<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%"><a href="#RM_014">Table of Contents</a></td></tr></table></div>
    <!-- Field: /Page --></ix:exclude>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>SHARPS
TECHNOLOGY, INC.</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTES
TO THE CONDENSED CONSOLIDATED FINANCIAL STATEMENTS</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>FOR
THE THREE AND NINE MONTHS ENDED SEPTEMBER 30, 2024 AND 2023</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Note
2. Summary of Significant Accounting Policies (continued)</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
December 2023, the FASB issued ASU 2023-09, <i>Income Taxes </i>(Topic 740)<i>: Improvements to Income Tax Disclosures</i>. The new guidance
requires disaggregated information about the effective tax rate reconciliation and additional information on taxes paid that meet a quantitative
threshold. The new guidance is effective for public companies for annual reporting periods beginning after December 15, 2024, a, with
early adoption permitted. The Company is currently evaluating the impacts of the new guidance on its disclosures within the consolidated
financial statements.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company does not expect the adoption of any accounting pronouncements to have a material impact on the condensed consolidated financial
statements.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
reviewed all other recently issued accounting pronouncements and have concluded they are not applicable or not expected to be significant
to the accounting for our operations.</span></p>

</ix:nonNumeric><p id="xdx_851_zdgaIXMbKH12" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2024-01-01to2024-09-30" escape="true" id="Fact002261" name="us-gaap:InventoryDisclosureTextBlock"><p id="xdx_80C_eus-gaap--InventoryDisclosureTextBlock_zEdsKAvhbrsc" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Note
3. <span id="xdx_828_zXZBFQxTrd1j">Inventories</span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<ix:nonNumeric contextRef="From2024-01-01to2024-09-30" escape="true" id="Fact002263" name="us-gaap:ScheduleOfInventoryCurrentTableTextBlock"><p id="xdx_890_eus-gaap--ScheduleOfInventoryCurrentTableTextBlock_zJyitDEwqaL5" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Inventories,
net consisted of the following at:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;<span id="xdx_8BC_za1wZlN0pa45" style="display: none">Schedule of Inventories</span></span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" id="xdx_494_20240930_z6wmSvdcayr1" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">September
    30, 2024</span></td><td style="padding-bottom: 1pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" id="xdx_493_20231231_zRTyYvpNNmr6" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">December
    31, 2023</span></td><td style="padding-bottom: 1pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr id="xdx_400_eus-gaap--InventoryRawMaterialsNetOfReserves_iI_maINzcUe_zz0MVJIAfoy8" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 60%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Raw materials</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="width: 16%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="us-gaap:InventoryRawMaterialsNetOfReserves" contextRef="AsOf2024-09-30" id="Fact002265" format="ixt:numdotdecimal" decimals="0" unitRef="USD">360,907</ix:nonFraction></span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="width: 16%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="us-gaap:InventoryRawMaterialsNetOfReserves" contextRef="AsOf2023-12-31" id="Fact002266" format="ixt:numdotdecimal" decimals="0" unitRef="USD">254,461</ix:nonFraction></span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr id="xdx_409_eus-gaap--InventoryWorkInProcessNetOfReserves_iI_maINzcUe_zckDXbS9KQsl" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Work in process</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="us-gaap:InventoryWorkInProcessNetOfReserves" contextRef="AsOf2024-09-30" id="Fact002268" format="ixt:numdotdecimal" decimals="0" unitRef="USD">140,025</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="us-gaap:InventoryWorkInProcessNetOfReserves" contextRef="AsOf2023-12-31" id="Fact002269" format="ixt:numdotdecimal" decimals="0" unitRef="USD">170,464</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr id="xdx_40F_eus-gaap--InventoryFinishedGoodsNetOfReserves_iI_maINzcUe_zfUcsK9k3fpk" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Finished
    goods</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="us-gaap:InventoryFinishedGoodsNetOfReserves" contextRef="AsOf2024-09-30" id="Fact002271" format="ixt:numdotdecimal" decimals="0" unitRef="USD">1,518,549</ix:nonFraction></span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="us-gaap:InventoryFinishedGoodsNetOfReserves" contextRef="AsOf2023-12-31" id="Fact002272" format="ixt:numdotdecimal" decimals="0" unitRef="USD">1,284,210</ix:nonFraction></span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr id="xdx_406_eus-gaap--InventoryNet_iTI_mtINzcUe_zXulI952NDfb" style="vertical-align: bottom; background-color: White">
    <td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Total</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="us-gaap:InventoryNet" contextRef="AsOf2024-09-30" id="Fact002274" format="ixt:numdotdecimal" decimals="0" unitRef="USD">2,019,481</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="us-gaap:InventoryNet" contextRef="AsOf2023-12-31" id="Fact002275" format="ixt:numdotdecimal" decimals="0" unitRef="USD">1,709,135</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  </table>

</ix:nonNumeric><p id="xdx_8A8_z97XYThhIUr7" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2024-01-01to2024-09-30" escape="true" id="Fact002277" name="us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock"><p id="xdx_80F_eus-gaap--PropertyPlantAndEquipmentDisclosureTextBlock_z3GzusgfC6l" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Note
4. <span id="xdx_825_zL2WlW1xwrM5">Fixed Assets</span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<ix:nonNumeric contextRef="From2024-01-01to2024-09-30" escape="true" id="Fact002279" name="us-gaap:PropertyPlantAndEquipmentTextBlock"><p id="xdx_89E_eus-gaap--PropertyPlantAndEquipmentTextBlock_zGUMepEmbKal" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Fixed
assets, net, is summarized as follows as of:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;<span id="xdx_8B4_zpuDSeb8BhG1" style="display: none">Schedule of Fixed
Assets, Net</span></span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" id="xdx_49E_20240930_zrvXo9riwRKl" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">September
    30, 2024</span></td><td style="padding-bottom: 1pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" id="xdx_492_20231231_zvHyMLKogLBi" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">December
    31, 2023</span></td><td style="padding-bottom: 1pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr id="xdx_40A_eus-gaap--PropertyPlantAndEquipmentGross_iI_hus-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--LandMember_z1rTGl6pzuqc" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 60%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Land</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="width: 16%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="us-gaap:PropertyPlantAndEquipmentGross" contextRef="AsOf2024-09-30_us-gaap_LandMember" id="Fact002281" format="ixt:numdotdecimal" decimals="0" unitRef="USD">253,781</ix:nonFraction></span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="width: 16%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="us-gaap:PropertyPlantAndEquipmentGross" contextRef="AsOf2023-12-31_us-gaap_LandMember" id="Fact002282" format="ixt:numdotdecimal" decimals="0" unitRef="USD">260,460</ix:nonFraction></span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr id="xdx_402_eus-gaap--PropertyPlantAndEquipmentGross_iI_hus-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--BuildingMember_zyflhsFXGV5j" style="vertical-align: bottom; background-color: White">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Building</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="us-gaap:PropertyPlantAndEquipmentGross" contextRef="AsOf2024-09-30_us-gaap_BuildingMember" id="Fact002284" format="ixt:numdotdecimal" decimals="0" unitRef="USD">2,949,900</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="us-gaap:PropertyPlantAndEquipmentGross" contextRef="AsOf2023-12-31_us-gaap_BuildingMember" id="Fact002285" format="ixt:numdotdecimal" decimals="0" unitRef="USD">3,022,490</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr id="xdx_406_eus-gaap--PropertyPlantAndEquipmentGross_iI_hus-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--MachineryAndEquipmentMember_zNLFIcNb5M7g" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Machinery and Equipment</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="us-gaap:PropertyPlantAndEquipmentGross" contextRef="AsOf2024-09-30_us-gaap_MachineryAndEquipmentMember" id="Fact002287" format="ixt:numdotdecimal" decimals="0" unitRef="USD">4,730,617</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="us-gaap:PropertyPlantAndEquipmentGross" contextRef="AsOf2023-12-31_us-gaap_MachineryAndEquipmentMember" id="Fact002288" format="ixt:numdotdecimal" decimals="0" unitRef="USD">4,464,317</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr id="xdx_40F_eus-gaap--PropertyPlantAndEquipmentGross_iI_hus-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--ComputerSystemsAndWebsiteAndOtherMember_z1Ova8mKjZO5" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Computer
    Systems and Website &amp; Other</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="us-gaap:PropertyPlantAndEquipmentGross" contextRef="AsOf2024-09-30_custom_ComputerSystemsAndWebsiteAndOtherMember" id="Fact002290" format="ixt:numdotdecimal" decimals="0" unitRef="USD">290,662</ix:nonFraction></span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="us-gaap:PropertyPlantAndEquipmentGross" contextRef="AsOf2023-12-31_custom_ComputerSystemsAndWebsiteAndOtherMember" id="Fact002291" format="ixt:numdotdecimal" decimals="0" unitRef="USD">290,661</ix:nonFraction></span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr id="xdx_40F_eus-gaap--PropertyPlantAndEquipmentGross_iI_maPPAENzHVU_zPE7Ix95vQ9a" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Total Fixed Assets</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="us-gaap:PropertyPlantAndEquipmentGross" contextRef="AsOf2024-09-30" id="Fact002293" format="ixt:numdotdecimal" decimals="0" unitRef="USD">8,224,960</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="us-gaap:PropertyPlantAndEquipmentGross" contextRef="AsOf2023-12-31" id="Fact002294" format="ixt:numdotdecimal" decimals="0" unitRef="USD">8,037,928</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr id="xdx_40E_eus-gaap--AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_iNI_di_msPPAENzHVU_zmpfKdrCxpAc" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Less:
    accumulated depreciation</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(<ix:nonFraction name="us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" contextRef="AsOf2024-09-30" id="Fact002296" format="ixt:numdotdecimal" decimals="0" unitRef="USD">1,991,365</ix:nonFraction></span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(<ix:nonFraction name="us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" contextRef="AsOf2023-12-31" id="Fact002297" format="ixt:numdotdecimal" decimals="0" unitRef="USD">1,215,786</ix:nonFraction></span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td></tr>
  <tr id="xdx_407_eus-gaap--PropertyPlantAndEquipmentNet_iTI_mtPPAENzHVU_zFNGJTNSCdXe" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Fixed
    asset, net</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="us-gaap:PropertyPlantAndEquipmentNet" contextRef="AsOf2024-09-30" id="Fact002299" format="ixt:numdotdecimal" decimals="0" unitRef="USD">6,233,595</ix:nonFraction></span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="us-gaap:PropertyPlantAndEquipmentNet" contextRef="AsOf2023-12-31" id="Fact002300" format="ixt:numdotdecimal" decimals="0" unitRef="USD">6,822,142</ix:nonFraction></span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  </table>

</ix:nonNumeric><p id="xdx_8A4_zESDx8k7cqI" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Depreciation
expense of fixed assets for the nine months ended September 30, 2024 and 2023 was $<span id="xdx_90B_eus-gaap--Depreciation_c20240101__20240930_z44woASc0boa" title="Depreciation"><ix:nonFraction name="us-gaap:Depreciation" contextRef="From2024-01-01to2024-09-30" id="Fact002302" format="ixt:numdotdecimal" decimals="0" unitRef="USD">574,719</ix:nonFraction></span> and $<span id="xdx_903_eus-gaap--Depreciation_c20230101__20230930_zKuOlP7v1XL6" title="Depreciation"><ix:nonFraction name="us-gaap:Depreciation" contextRef="From2023-01-012023-09-30" id="Fact002304" format="ixt:numdotdecimal" decimals="0" unitRef="USD">646,538</ix:nonFraction></span>, respectively. Substantially,
all the Company&#8217;s fixed assets are located at the Company&#8217;s Hungary location.</span></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<ix:exclude><!-- Field: Page; Sequence: 86; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 0pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->38<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%"><a href="#RM_014">Table of Contents</a></td></tr></table></div>
    <!-- Field: /Page --></ix:exclude>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>SHARPS
TECHNOLOGY, INC.</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTES
TO THE CONDENSED CONSOLIDATED FINANCIAL STATEMENTS</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>FOR
THE THREE AND NINE MONTHS ENDED SEPTEMBER 30, 2024 AND 2023</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2024-01-01to2024-09-30" escape="true" id="Fact002306" name="us-gaap:AssetAcquisitionTextBlock"><p id="xdx_803_eus-gaap--AssetAcquisitionTextBlock_zYtibF3qN6g5" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Note
5. <span id="xdx_827_z76AZ9ehjhP8">Asset Acquisition</span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Safegard
Medical, Kft</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
June 2020, the Company entered into a Share Purchase Agreement (&#8220;Agreement&#8221;) with Safegard Medical, Kft
(&#8220;Safegard&#8221;) and amendments to the Agreement, collectively, the Agreements, to purchase either the stock or certain
assets of a manufacturing facility for $<span id="xdx_90F_eus-gaap--PaymentsToAcquireBusinessesGross_pn5n6_c20200601__20200630__us-gaap--BusinessAcquisitionAxis__custom--SafegardMedicalIncMember__us-gaap--TypeOfArrangementAxis__custom--SharePurchaseAgreementMember_zkDcdYETiCs8" title="Consideration paid in cash"><ix:nonFraction name="us-gaap:PaymentsToAcquireBusinessesGross" contextRef="From2020-06-012020-06-30_custom_SafegardMedicalIncMember_custom_SharePurchaseAgreementMember" id="Fact002308" format="ixt:numdotdecimal" decimals="-5" scale="6" unitRef="USD">2.5</ix:nonFraction></span>M
in cash, plus additional consideration of common stock and options with a fair market value of $<span id="xdx_905_ecustom--FairMarketValueOfCommonStock_c20200601__20200630__us-gaap--BusinessAcquisitionAxis__custom--SafegardMedicalIncMember__us-gaap--TypeOfArrangementAxis__custom--SharePurchaseAgreementMember__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zq4qWnGl5RX6" title="Fair market value of common stock"><ix:nonFraction name="STSS:FairMarketValueOfCommonStock" contextRef="From2020-06-012020-06-30_custom_SafegardMedicalIncMember_custom_SharePurchaseAgreementMember_us-gaap_CommonStockMember" id="Fact002310" format="ixt:numdotdecimal" decimals="0" unitRef="USD">200,000</ix:nonFraction></span>
and $<span id="xdx_904_ecustom--FairMarketValueOfCommonStock_c20200601__20200630__us-gaap--BusinessAcquisitionAxis__custom--SafegardMedicalIncMember__us-gaap--TypeOfArrangementAxis__custom--SharePurchaseAgreementMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_z9nc5NNqGDaj" title="Fair market value of common stock"><ix:nonFraction name="STSS:FairMarketValueOfCommonStock" contextRef="From2020-06-012020-06-30_custom_SafegardMedicalIncMember_custom_SharePurchaseAgreementMember_us-gaap_StockOptionMember" id="Fact002312" format="ixt:numdotdecimal" decimals="0" unitRef="USD">183,135</ix:nonFraction></span>,
respectively. The Agreements provided the Company various periods for due diligence and post due diligence, requirements for escrow
payments through the closing date (&#8220;Closing Date&#8221;).</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Through
the Closing Date, the Agreements provided the Company with the exclusive use of the facility in exchange for payment of the facility&#8217;s
operating costs. The monthly fee (&#8220;Operating Costs&#8221;), which primarily covered the facility&#8217;s operating costs, was mainly
comprised of the seller&#8217;s workforce costs, materials and other recurring monthly operating cost.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
acquisition of Safegard, which closed on July 6, 2022, did not meet the definition of a business pursuant to ASC 805-10, and accordingly
was accounted for as an asset acquisition in accordance with ASC 805-50. The cost of the acquisition was $<span id="xdx_90B_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets_iI_c20220706__us-gaap--BusinessAcquisitionAxis__custom--SafegardMedicalIncMember_zrMoaIEQjGmg" title="Acquisition cost"><ix:nonFraction name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets" contextRef="AsOf2022-07-06_custom_SafegardMedicalIncMember" id="Fact002314" format="ixt:numdotdecimal" decimals="0" unitRef="USD">2,936,712</ix:nonFraction></span>, including transaction
costs of $<span id="xdx_904_eus-gaap--BusinessAcquisitionCostOfAcquiredEntityTransactionCosts_iI_c20220706__us-gaap--BusinessAcquisitionAxis__custom--SafegardMedicalIncMember_zq9QQxRurEB7" title="Transaction costs"><ix:nonFraction name="us-gaap:BusinessAcquisitionCostOfAcquiredEntityTransactionCosts" contextRef="AsOf2022-07-06_custom_SafegardMedicalIncMember" id="Fact002316" format="ixt:numdotdecimal" decimals="0" unitRef="USD">53,576</ix:nonFraction></span>, with the allocation to the assets acquired on a relative fair value basis. The intangibles relate to permits and a
limited workforce acquired. Under ASC 805-50, no goodwill is recognized. The operating results for Safegard are included in the condensed
consolidated financial statements for the period beginning after the closing on July 6, 2022.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<ix:nonNumeric contextRef="From2024-01-01to2024-09-30" escape="true" id="Fact002318" name="us-gaap:ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock"><p id="xdx_891_eus-gaap--ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock_zITHKT5SKAKj" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
relative fair value of the assets acquired and related deferred tax liability during 2022 was as follows:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span id="xdx_8BE_z5TwLTl3j1f" style="display: none">Schedule of Fair Value of  Assets Acquisition</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 70%">
  <tr style="display: none; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_497_20220706__us-gaap--BusinessAcquisitionAxis__custom--SafegardMedicalIncMember_zGwXKy86eZEl" style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_407_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLand_iI_maBCRIAzqVv_zG3wN4mZxHPc" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 80%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Land</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="width: 16%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLand" contextRef="AsOf2022-07-06_custom_SafegardMedicalIncMember" id="Fact002320" format="ixt:numdotdecimal" decimals="0" unitRef="USD">226,000</ix:nonFraction></span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr id="xdx_402_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment_iI_maBCRIAzqVv_z1rt3UafJmY8" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Building and affixed assets</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment" contextRef="AsOf2022-07-06_custom_SafegardMedicalIncMember" id="Fact002322" format="ixt:numdotdecimal" decimals="0" unitRef="USD">2,648,000</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr id="xdx_404_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedEquipment_iI_maBCRIAzqVv_zX1DNhQFnsO6" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Machinery</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedEquipment" contextRef="AsOf2022-07-06_custom_SafegardMedicalIncMember" id="Fact002324" format="ixt:numdotdecimal" decimals="0" unitRef="USD">158,000</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr id="xdx_40A_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory_iI_maBCRIAzqVv_zdmKJ0iRHiZj" style="vertical-align: bottom; background-color: White">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Inventory</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory" contextRef="AsOf2022-07-06_custom_SafegardMedicalIncMember" id="Fact002326" format="ixt:numdotdecimal" decimals="0" unitRef="USD">32,000</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr id="xdx_400_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles_iI_maBCRIAzqVv_zmc8vOTjXUl2" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Intangibles</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles" contextRef="AsOf2022-07-06_custom_SafegardMedicalIncMember" id="Fact002328" format="ixt:numdotdecimal" decimals="0" unitRef="USD">64,712</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr id="xdx_40B_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities_iNI_di_msBCRIAzqVv_zVKCI8dWFBO9" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Deferred
    tax liability</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(<ix:nonFraction name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities" contextRef="AsOf2022-07-06_custom_SafegardMedicalIncMember" id="Fact002330" format="ixt:numdotdecimal" decimals="0" unitRef="USD">192,000</ix:nonFraction></span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr id="xdx_40B_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets_iTI_mtBCRIAzqVv_zNz4Et0NTls1" style="vertical-align: bottom; background-color: White">
    <td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Total</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets" contextRef="AsOf2022-07-06_custom_SafegardMedicalIncMember" id="Fact002332" format="ixt:numdotdecimal" decimals="0" unitRef="USD">2,936,712</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  </table>

</ix:nonNumeric><p id="xdx_8A7_zA0IAGnDv4Ge" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
useful lives for the acquired assets is Building - <span id="xdx_904_eus-gaap--PropertyPlantAndEquipmentUsefulLife_iI_dtY_c20220706__us-gaap--BusinessAcquisitionAxis__custom--SafegardMedicalIncMember__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--BuildingMember_zqWUg6HknTCc" title="Fixed assets acquired, useful lives"><ix:nonNumeric contextRef="AsOf2022-07-06_custom_SafegardMedicalIncMember_us-gaap_BuildingMember" format="ixt-sec:duryear" id="Fact002334" name="us-gaap:PropertyPlantAndEquipmentUsefulLife">20</ix:nonNumeric></span> years; Machinery &#8211; <span id="xdx_900_eus-gaap--PropertyPlantAndEquipmentUsefulLife_iI_dtY_c20220706__us-gaap--BusinessAcquisitionAxis__custom--SafegardMedicalIncMember__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--MachineryAndEquipmentMember__srt--RangeAxis__srt--MinimumMember_z3PNPRElCD7f" title="Fixed assets acquired, useful lives"><ix:nonNumeric contextRef="AsOf2022-07-06_custom_SafegardMedicalIncMember_us-gaap_MachineryAndEquipmentMember_srt_MinimumMember" format="ixt-sec:duryear" id="Fact002336" name="us-gaap:PropertyPlantAndEquipmentUsefulLife">5</ix:nonNumeric></span> to <span id="xdx_902_eus-gaap--PropertyPlantAndEquipmentUsefulLife_iI_dtY_c20220706__us-gaap--BusinessAcquisitionAxis__custom--SafegardMedicalIncMember__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--MachineryAndEquipmentMember__srt--RangeAxis__srt--MaximumMember_zLb4EkCTMFtj" title="Fixed assets acquired, useful lives"><ix:nonNumeric contextRef="AsOf2022-07-06_custom_SafegardMedicalIncMember_us-gaap_MachineryAndEquipmentMember_srt_MaximumMember" format="ixt-sec:duryear" id="Fact002338" name="us-gaap:PropertyPlantAndEquipmentUsefulLife">10</ix:nonNumeric></span> years; Intangibles &#8211; <span id="xdx_905_eus-gaap--FiniteLivedIntangibleAssetUsefulLife_iI_dtY_c20220706__us-gaap--BusinessAcquisitionAxis__custom--SafegardMedicalIncMember_zCGxRPdh5eq" title="Intangible asset acquired, useful lives"><ix:nonNumeric contextRef="AsOf2022-07-06_custom_SafegardMedicalIncMember" format="ixt-sec:duryear" id="Fact002340" name="us-gaap:FiniteLivedIntangibleAssetUsefulLife">5</ix:nonNumeric></span> years. The related
depreciation and amortization is being recorded on a straight-line basis.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2024-01-01to2024-09-30" escape="true" id="Fact002342" name="us-gaap:OtherAssetsDisclosureTextBlock"><p id="xdx_809_eus-gaap--OtherAssetsDisclosureTextBlock_zR2EMEbczMoh" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Note
6. <span id="xdx_826_zFVszYWWG5Z6">Other Assets</span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<ix:nonNumeric contextRef="From2024-01-01to2024-09-30" escape="true" id="Fact002344" name="us-gaap:ScheduleOfOtherAssetsTableTextBlock"><p id="xdx_89D_eus-gaap--ScheduleOfOtherAssetsTableTextBlock_z0InxzEYOjck" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Other
assets as of September 30, 2024, and December 31, 2023 are summarized as follows:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span id="xdx_8B8_z1deStF3dQHc" style="display: none">Schedule of Other Assets</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" id="xdx_491_20240930_ziHbvl5Jyvj7" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">September
    30, 2024</span></td><td style="padding-bottom: 1pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" id="xdx_49C_20231231_ziJNYIIR20N8" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">December
    31, 2023</span></td><td style="padding-bottom: 1pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr id="xdx_403_eus-gaap--IntangibleAssetsNetExcludingGoodwill_iI_maOANzzDQ_z6mTdWXPecQl" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 60%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Intangibles, net &#8211; See Note 6</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="width: 16%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="us-gaap:IntangibleAssetsNetExcludingGoodwill" contextRef="AsOf2024-09-30" id="Fact002346" format="ixt:numdotdecimal" decimals="0" unitRef="USD">40,227</ix:nonFraction></span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="width: 16%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="us-gaap:IntangibleAssetsNetExcludingGoodwill" contextRef="AsOf2023-12-31" id="Fact002347" format="ixt:numdotdecimal" decimals="0" unitRef="USD">52,513</ix:nonFraction></span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr id="xdx_40D_eus-gaap--OtherAssetsMiscellaneousNoncurrent_iI_maOANzzDQ_zwGSSBFesi67" style="vertical-align: bottom; background-color: White">
    <td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Other &#8211; See Note 7</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="us-gaap:OtherAssetsMiscellaneousNoncurrent" contextRef="AsOf2024-09-30" id="Fact002349" format="ixt:numdotdecimal" decimals="0" unitRef="USD">326,061</ix:nonFraction></span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="us-gaap:OtherAssetsMiscellaneousNoncurrent" contextRef="AsOf2023-12-31" id="Fact002350" format="ixt:numdotdecimal" decimals="0" unitRef="USD">76,062</ix:nonFraction></span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr id="xdx_409_eus-gaap--OtherAssetsNoncurrent_iTI_mtOANzzDQ_zRCJl1BDGp56" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 1pt"><span style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;Total Other assets</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="us-gaap:OtherAssetsNoncurrent" contextRef="AsOf2024-09-30" id="Fact002352" format="ixt:numdotdecimal" decimals="0" unitRef="USD">366,288</ix:nonFraction></span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="us-gaap:OtherAssetsNoncurrent" contextRef="AsOf2023-12-31" id="Fact002353" format="ixt:numdotdecimal" decimals="0" unitRef="USD">128,575</ix:nonFraction></span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  </table>

</ix:nonNumeric><p id="xdx_8A9_zhGzMIuJgrDh" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<ix:exclude><!-- Field: Page; Sequence: 87; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 0pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->39<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%"><a href="#RM_014">Table of Contents</a></td></tr></table></div>
    <!-- Field: /Page --></ix:exclude>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>SHARPS
TECHNOLOGY, INC.</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTES
TO THE CONDENSED CONSOLIDATED FINANCIAL STATEMENTS</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>FOR
THE THREE AND NINE MONTHS ENDED SEPTEMBER 30, 2024 AND 2023</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2024-01-01to2024-09-30" escape="true" id="Fact002355" name="us-gaap:DebtDisclosureTextBlock"><p id="xdx_808_eus-gaap--DebtDisclosureTextBlock_zuFK5df5uaAa" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Note
7. <span id="xdx_82C_ze8D637EGr8h">Debt Financing</span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
September 20, 2024, the Company entered into a securities purchase agreement (the &#8220;Securities Purchase Agreement&#8221;) and a
Senior Secured Note (the &#8220;Note&#8221;) for an aggregate principal amount of $<span id="xdx_903_eus-gaap--DebtInstrumentFaceAmount_iI_c20240920__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__us-gaap--DebtInstrumentAxis__custom--SeniorSecuredNoteMember_zliuHirJYfLh"><ix:nonFraction name="us-gaap:DebtInstrumentFaceAmount" contextRef="AsOf2024-09-20_custom_SecuritiesPurchaseAgreementMember_custom_SeniorSecuredNoteMember" id="Fact002356" format="ixt:numdotdecimal" decimals="0" unitRef="USD">4,375,000</ix:nonFraction></span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">,
including OID interest of $<span id="xdx_903_eus-gaap--DebtInstrumentIncreaseAccruedInterest_c20240920__20240920__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__us-gaap--DebtInstrumentAxis__custom--SeniorSecuredNoteMember_zj0riSknwLdl" title="Original issue discount (OID)"><ix:nonFraction name="us-gaap:DebtInstrumentIncreaseAccruedInterest" contextRef="From2024-09-202024-09-20_custom_SecuritiesPurchaseAgreementMember_custom_SeniorSecuredNoteMember" id="Fact002358" format="ixt:numdotdecimal" decimals="0" unitRef="USD">875,000</ix:nonFraction> </span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">maturing
on <span id="xdx_903_eus-gaap--DebtInstrumentMaturityDate_dd_c20240920__20240920__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__us-gaap--DebtInstrumentAxis__custom--SeniorSecuredNoteMember_zBMDZZSxXTz4"><ix:nonNumeric contextRef="From2024-09-202024-09-20_custom_SecuritiesPurchaseAgreementMember_custom_SeniorSecuredNoteMember" format="ixt:datemonthdayyearen" id="Fact002359" name="us-gaap:DebtInstrumentMaturityDate">January
31, 2025</ix:nonNumeric></span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">, with certain purchasers (the
&#8220;Purchasers&#8221;), and the issuance of approximately <span id="xdx_90A_ecustom--NumberOfUnregisteredCommonStockIssuedDuringPostReverseShares_pid_c20240920__20240920__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__us-gaap--DebtInstrumentAxis__custom--SeniorSecuredNoteMember_zvzZ6q21X7ha" title="Number of unregistered common stock issued during post reverse shares"><ix:nonFraction name="STSS:NumberOfUnregisteredCommonStockIssuedDuringPostReverseShares" contextRef="From2024-09-202024-09-20_custom_SecuritiesPurchaseAgreementMember_custom_SeniorSecuredNoteMember" id="Fact002361" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">259,091</ix:nonFraction> </span></span>(pre
reverse - <span id="xdx_903_ecustom--NumberOfUnregisteredCommonStockIssuedDuringPreReverseShares_pid_c20240920__20240920__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__us-gaap--DebtInstrumentAxis__custom--SeniorSecuredNoteMember__us-gaap--AwardTypeAxis__custom--PreReverseMember_zcsLkCRMOkD6" title="Pre reverse"><ix:nonFraction name="STSS:NumberOfUnregisteredCommonStockIssuedDuringPreReverseShares" contextRef="From2024-09-202024-09-20_custom_SecuritiesPurchaseAgreementMember_custom_SeniorSecuredNoteMember_custom_PreReverseMember" id="Fact002363" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">5,700,006</ix:nonFraction></span> ) unregistered shares of the Company&#8217;s Common Stock. The aggregate gross proceeds to the Company were
approximately $<span id="xdx_90F_eus-gaap--ProceedsFromIssuanceOfDebt_pn5n6_c20240920__20240920__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__us-gaap--DebtInstrumentAxis__custom--SeniorSecuredNoteMember_zK4Q5qUBQddk"><ix:nonFraction name="us-gaap:ProceedsFromIssuanceOfDebt" contextRef="From2024-09-202024-09-20_custom_SecuritiesPurchaseAgreementMember_custom_SeniorSecuredNoteMember" id="Fact002364" format="ixt:numdotdecimal" decimals="-5" scale="6" unitRef="USD">3.5</ix:nonFraction> </span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">million,
before deducting fees to the placement agent and other offering expenses payable by the Company of $<span id="xdx_908_ecustom--PlacementAgentAndOtherOfferingExpenses_c20240920__20240920__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__us-gaap--DebtInstrumentAxis__custom--SeniorSecuredNoteMember_z4HeS0lGiHYh" title="Closing costs"><ix:nonFraction name="STSS:PlacementAgentAndOtherOfferingExpenses" contextRef="From2024-09-202024-09-20_custom_SecuritiesPurchaseAgreementMember_custom_SeniorSecuredNoteMember" id="Fact002366" format="ixt:numdotdecimal" decimals="0" unitRef="USD">514,700</ix:nonFraction> </span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">and
an escrow deposit of $<span id="xdx_903_eus-gaap--EscrowDeposit_iI_c20240920__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__us-gaap--DebtInstrumentAxis__custom--SeniorSecuredNoteMember_z98EFWS5ASe8"><ix:nonFraction name="us-gaap:EscrowDeposit" contextRef="AsOf2024-09-20_custom_SecuritiesPurchaseAgreementMember_custom_SeniorSecuredNoteMember" id="Fact002367" format="ixt:numdotdecimal" decimals="0" unitRef="USD">250,000</ix:nonFraction> </span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">required
until certain security liens are filed. The Note and the common stock were recorded at the relative fair values of $<span id="xdx_900_eus-gaap--DebtInstrumentFairValue_iI_pn5n6_c20240920__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__us-gaap--DebtInstrumentAxis__custom--SeniorSecuredNoteMember_zv0NsEqPWpIb"><ix:nonFraction name="us-gaap:DebtInstrumentFairValue" contextRef="AsOf2024-09-20_custom_SecuritiesPurchaseAgreementMember_custom_SeniorSecuredNoteMember" id="Fact002368" format="ixt:numdotdecimal" decimals="-5" scale="6" unitRef="USD">2.6</ix:nonFraction></span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">M
and $<span id="xdx_908_ecustom--CommonStockFairValue_iI_c20240920__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__us-gaap--DebtInstrumentAxis__custom--SeniorSecuredNoteMember_zL9KkwMAsE9c" title="Common stock fair value"><ix:nonFraction name="STSS:CommonStockFairValue" contextRef="AsOf2024-09-20_custom_SecuritiesPurchaseAgreementMember_custom_SeniorSecuredNoteMember" id="Fact002370" format="ixt:numdotdecimal" decimals="0" unitRef="USD">852,000</ix:nonFraction></span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">,
respectively, in accordance with ASC 470-20-25-2. The aforementioned expenses were allocated based on the aforementioned fair values
as a reduction to the carrying amount of the debt and a reduction of the equity in accordance with ASC 505-10. </span>For the three
and nine months ended September 30, 2024, the Company recorded accreted interest and fees of $<span id="xdx_903_ecustom--AccretedInterestFees_c20240101__20240930_zQAFf1QTzaZd" title="Accreted interest fees"><ix:nonFraction name="STSS:AccretedInterestFees" contextRef="From2024-01-01to2024-09-30" id="Fact002372" format="ixt:numdotdecimal" decimals="0" unitRef="USD">75,192</ix:nonFraction></span>.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
connection with the Securities Purchase Agreement and Note, the Company entered into a Registration Rights Agreement with the Purchasers
(the &#8220;Registration Rights Agreement&#8221;), requiring the Company to file a resale registration statement (the &#8220;Registration
Statement&#8221;) with the U.S. Securities and Exchange Commission (the &#8220;Commission&#8221;) to register the unregistered shares
of Common Stock. within forty-five (45) calendar days following the filing date, which is thirty (30) days after the closing date. The
Company filed the required resale registration statement on October 23, 2024.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2024-01-01to2024-09-30" escape="true" id="Fact002374" name="us-gaap:StockholdersEquityNoteDisclosureTextBlock"><p id="xdx_80E_eus-gaap--StockholdersEquityNoteDisclosureTextBlock_zlepTav0SE09" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Note
8. <span id="xdx_828_zc9BzTkVH4ze">Stockholders&#8217; Equity</span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Capital
Structure</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>&#160;</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
December 11, 2017, the Company was incorporated in Wyoming with <span id="xdx_909_eus-gaap--CommonStockSharesAuthorized_iI_c20171211_zObFdDWIxNJ5" title="Common stock, share authorized"><ix:nonFraction name="us-gaap:CommonStockSharesAuthorized" contextRef="AsOf2017-12-11" id="Fact002376" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">20,000,000</ix:nonFraction></span> shares of common stock authorized with a $<span id="xdx_903_eus-gaap--CommonStockParOrStatedValuePerShare_iI_c20171211_zzZomcI4bkch" title="Common stock, par value"><ix:nonFraction name="us-gaap:CommonStockParOrStatedValuePerShare" contextRef="AsOf2017-12-11" id="Fact002378" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">0.0001</ix:nonFraction></span> par value.
Effective, April 18, 2019, the Company&#8217;s authorized common stock was increased to <span id="xdx_90F_eus-gaap--CommonStockSharesAuthorized_iI_c20190418_zB4WALMVnysg" title="Common stock, share authorized"><ix:nonFraction name="us-gaap:CommonStockSharesAuthorized" contextRef="AsOf2019-04-18" id="Fact002380" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">50,000,000</ix:nonFraction></span> shares of common stock. The articles
of incorporation also authorized <span id="xdx_90B_eus-gaap--PreferredStockSharesAuthorized_iI_c20190418_zizPP87QWesf" title="Preferred stock, shares authorized"><ix:nonFraction name="us-gaap:PreferredStockSharesAuthorized" contextRef="AsOf2019-04-18" id="Fact002382" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">10,000</ix:nonFraction></span> preferred shares with a $<span id="xdx_906_eus-gaap--PreferredStockParOrStatedValuePerShare_iI_c20190418_zbxGU9fVvIwf" title="Preferred stock, par value"><ix:nonFraction name="us-gaap:PreferredStockParOrStatedValuePerShare" contextRef="AsOf2019-04-18" id="Fact002384" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">0.001</ix:nonFraction></span> par value.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Effective
March 22, 2022, the Company completed a plan and agreement of merger with Sharps Technology, Inc., a Nevada corporation (&#8220;Sharps
Nevada&#8221;). <span id="xdx_900_eus-gaap--ConversionOfStockDescription_c20220319__20220322_zantrWc3GQf2" title="Conversion of stock, description"><ix:nonNumeric contextRef="From2022-03-192022-03-22" id="Fact002386" name="us-gaap:ConversionOfStockDescription">Pursuant to the merger agreement, (i) the Company merged with and into Sharps Nevada, (ii) each 3.5 shares of common
stock of the Company were converted into one share of common stock of Sharps Nevada and (iii) the articles of incorporation and bylaws
of Sharps Nevada, became the articles of incorporation and bylaws of the surviving corporation.</ix:nonNumeric></span> The Company&#8217;s authorized common
stock and preferred stock increased from <span id="xdx_908_eus-gaap--CommonStockSharesAuthorized_iI_c20220321_z8IuS6QkXEV1" title="Common stock, share authorized"><ix:nonFraction name="us-gaap:CommonStockSharesAuthorized" contextRef="AsOf2022-03-21" id="Fact002388" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">50,000,000</ix:nonFraction></span> to <span id="xdx_90D_eus-gaap--CommonStockSharesAuthorized_iI_c20220322_z0abmZ0ilApb" title="Common stock, share authorized"><ix:nonFraction name="us-gaap:CommonStockSharesAuthorized" contextRef="AsOf2022-03-22" id="Fact002390" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">100,000,000</ix:nonFraction></span> and <span id="xdx_90F_eus-gaap--PreferredStockSharesAuthorized_iI_c20220321_zk63QZSibjyh" title="Preferred stock, shares authorized"><ix:nonFraction name="us-gaap:PreferredStockSharesAuthorized" contextRef="AsOf2022-03-21" id="Fact002392" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">10,000</ix:nonFraction></span> to <span id="xdx_900_eus-gaap--PreferredStockSharesAuthorized_iI_c20220322_zBhs3NS9Fxal" title="Preferred stock, shares authorized"><ix:nonFraction name="us-gaap:PreferredStockSharesAuthorized" contextRef="AsOf2022-03-22" id="Fact002394" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">1,000,000</ix:nonFraction></span> shares, respectively. The par value of preferred
stock decreased from $<span id="xdx_903_eus-gaap--PreferredStockParOrStatedValuePerShare_iI_c20220321_zzRUEw5Tmx4a" title="Preferred stock, par value"><ix:nonFraction name="us-gaap:PreferredStockParOrStatedValuePerShare" contextRef="AsOf2022-03-21" id="Fact002396" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">0.001</ix:nonFraction></span> to $<span id="xdx_907_eus-gaap--PreferredStockParOrStatedValuePerShare_iI_c20220322_zG9Rt3sweHO" title="Preferred stock, par value"><ix:nonFraction name="us-gaap:PreferredStockParOrStatedValuePerShare" contextRef="AsOf2022-03-22" id="Fact002398" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">0.0001</ix:nonFraction></span> per share.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
July 2024, the shareholders approved the increase of the authorized common stock from <span id="xdx_909_eus-gaap--CommonStockSharesAuthorized_iI_c20240731_zkRgJIXjFXq5" title="Common stock, share authorized"><ix:nonFraction name="us-gaap:CommonStockSharesAuthorized" contextRef="AsOf2024-07-31" id="Fact002400" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">100,000,000</ix:nonFraction></span> to <span id="xdx_905_eus-gaap--CommonStockSharesAuthorized_iI_c20240930_zToqCQmavXM1" title="Common stock, share authorized"><ix:nonFraction name="us-gaap:CommonStockSharesAuthorized" contextRef="AsOf2024-09-30" id="Fact002402" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">500,000,000</ix:nonFraction></span> which was subsequently
filed as an amendment to the articles of incorporation with the state of Nevada.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Common
Stock</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>&#160;</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
September 23, 2024, as noted in Note 7, in connection with the Securities Purchase Agreement and Note the Company issued <span id="xdx_901_eus-gaap--StockIssuedDuringPeriodSharesOther_pid_c20240923__20240923__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember_zlPmjF42fGHc" title="Issued shares of common stock"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodSharesOther" contextRef="From2024-09-232024-09-23_custom_SecuritiesPurchaseAgreementMember" id="Fact002404" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">259,091</ix:nonFraction></span>
(pre reverse - <span id="xdx_90A_eus-gaap--StockIssuedDuringPeriodSharesOther_pid_c20240923__20240923__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__us-gaap--AwardTypeAxis__custom--PrereverseMember_zKlqsPnmsBIj" title="Issued shares of common stock"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodSharesOther" contextRef="From2024-09-232024-09-23_custom_SecuritiesPurchaseAgreementMember_custom_PreReverseMember" id="Fact002406" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">5,700,006</ix:nonFraction></span>)
shares of unregistered common stock.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<ix:exclude><!-- Field: Page; Sequence: 88; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 0pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->40<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%"><a href="#RM_014">Table of Contents</a></td></tr></table></div>
    <!-- Field: /Page --></ix:exclude>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
May 31 and June 13, 2024, the Company entered into subscription agreements with certain institutional investors, pursuant to which
the Company agreed to issue and sell to the investors <span id="xdx_902_eus-gaap--SaleOfStockNumberOfSharesIssuedInTransaction_pid_c20240531__20240531__us-gaap--TypeOfArrangementAxis__custom--SubscriptionAgreementsMember__srt--TitleOfIndividualAxis__custom--InvestorsMember_zjJklAyq4mBb" title="Number of shares sold"><span id="xdx_907_eus-gaap--SaleOfStockNumberOfSharesIssuedInTransaction_pid_c20240613__20240613__us-gaap--TypeOfArrangementAxis__custom--SubscriptionAgreementsMember__srt--TitleOfIndividualAxis__custom--InvestorsMember_zzRvbFayOitl" title="Number of shares sold"><ix:nonFraction name="us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction" contextRef="From2024-05-312024-05-31_custom_SubscriptionAgreementsMember_custom_InvestorsMember" id="Fact002408" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares"><ix:nonFraction name="us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction" contextRef="From2024-06-132024-06-13_custom_SubscriptionAgreementsMember_custom_InvestorsMember" id="Fact002410" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">190,773</ix:nonFraction></ix:nonFraction></span></span>
(pre reverse - <span id="xdx_90B_eus-gaap--SaleOfStockNumberOfSharesIssuedInTransaction_pid_c20240531__20240531__us-gaap--TypeOfArrangementAxis__custom--SubscriptionAgreementsMember__srt--TitleOfIndividualAxis__custom--InvestorsMember__us-gaap--AwardTypeAxis__custom--PrereverseMember_zdQc4XC1X1B" title="Number of shares sold pre reverse"><span id="xdx_907_eus-gaap--SaleOfStockNumberOfSharesIssuedInTransaction_pid_c20240613__20240613__us-gaap--TypeOfArrangementAxis__custom--SubscriptionAgreementsMember__srt--TitleOfIndividualAxis__custom--InvestorsMember__us-gaap--AwardTypeAxis__custom--PrereverseMember_zhVEyFopSXWc" title="Number of shares sold pre reverse"><ix:nonFraction name="us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction" contextRef="From2024-05-312024-05-31_custom_SubscriptionAgreementsMember_custom_InvestorsMember_custom_PreReverseMember" id="Fact002412" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares"><ix:nonFraction name="us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction" contextRef="From2024-06-132024-06-13_custom_SubscriptionAgreementsMember_custom_InvestorsMember_custom_PreReverseMember" id="Fact002414" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">4,197,000</ix:nonFraction></ix:nonFraction></span></span>)
shares (the &#8220;Shares&#8221;) of Common Stock, par value $<span id="xdx_902_eus-gaap--CommonStockParOrStatedValuePerShare_iI_pid_c20240531__us-gaap--TypeOfArrangementAxis__custom--SubscriptionAgreementsMember__srt--TitleOfIndividualAxis__custom--InvestorsMember_zCcLihvcTRCc" title="Common stock par value"><span id="xdx_902_eus-gaap--CommonStockParOrStatedValuePerShare_iI_pid_c20240613__us-gaap--TypeOfArrangementAxis__custom--SubscriptionAgreementsMember__srt--TitleOfIndividualAxis__custom--InvestorsMember_znV6OeA4ElNj" title="Common stock par value"><ix:nonFraction name="us-gaap:CommonStockParOrStatedValuePerShare" contextRef="AsOf2024-05-31_custom_SubscriptionAgreementsMember_custom_InvestorsMember" id="Fact002416" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares"><ix:nonFraction name="us-gaap:CommonStockParOrStatedValuePerShare" contextRef="AsOf2024-06-13_custom_SubscriptionAgreementsMember_custom_InvestorsMember" id="Fact002418" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">0.0001</ix:nonFraction></ix:nonFraction></span></span>
per share of the Company at a price of $<span id="xdx_904_eus-gaap--SaleOfStockPricePerShare_iI_pid_c20240531__us-gaap--TypeOfArrangementAxis__custom--SubscriptionAgreementsMember__srt--TitleOfIndividualAxis__custom--InvestorsMember_z46HBaZP3Q36" title="Shares price"><span id="xdx_90C_eus-gaap--SaleOfStockPricePerShare_iI_pid_c20240613__us-gaap--TypeOfArrangementAxis__custom--SubscriptionAgreementsMember__srt--TitleOfIndividualAxis__custom--InvestorsMember_zxZI830ke7Y5" title="Shares price"><ix:nonFraction name="us-gaap:SaleOfStockPricePerShare" contextRef="AsOf2024-05-31_custom_SubscriptionAgreementsMember_custom_InvestorsMember" id="Fact002420" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares"><ix:nonFraction name="us-gaap:SaleOfStockPricePerShare" contextRef="AsOf2024-06-13_custom_SubscriptionAgreementsMember_custom_InvestorsMember" id="Fact002422" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">8.36</ix:nonFraction></ix:nonFraction></span></span>
(pre reverse -$<span id="xdx_901_eus-gaap--SaleOfStockPricePerShare_iI_pid_c20240531__us-gaap--TypeOfArrangementAxis__custom--SubscriptionAgreementsMember__srt--TitleOfIndividualAxis__custom--InvestorsMember__us-gaap--AwardTypeAxis__custom--PrereverseMember_zRmY7sFSEuI8" title="Shares price pre reverse"><span id="xdx_90D_eus-gaap--SaleOfStockPricePerShare_iI_pid_c20240613__us-gaap--TypeOfArrangementAxis__custom--SubscriptionAgreementsMember__srt--TitleOfIndividualAxis__custom--InvestorsMember__us-gaap--AwardTypeAxis__custom--PrereverseMember_zEkSalHRuA5g" title="Shares price pre reverse"><ix:nonFraction name="us-gaap:SaleOfStockPricePerShare" contextRef="AsOf2024-05-31_custom_SubscriptionAgreementsMember_custom_InvestorsMember_custom_PreReverseMember" id="Fact002424" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares"><ix:nonFraction name="us-gaap:SaleOfStockPricePerShare" contextRef="AsOf2024-06-13_custom_SubscriptionAgreementsMember_custom_InvestorsMember_custom_PreReverseMember" id="Fact002426" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">0.38</ix:nonFraction></ix:nonFraction>)</span></span>
and received gross proceeds to the Company of $<span id="xdx_907_eus-gaap--ProceedsFromIssuanceOfCommonStock_pn5n6_c20240531__20240531__us-gaap--TypeOfArrangementAxis__custom--SubscriptionAgreementsMember__srt--TitleOfIndividualAxis__custom--InvestorsMember_zdSw9e5h5gm6" title="Gross proceeds"><span id="xdx_90C_eus-gaap--ProceedsFromIssuanceOfCommonStock_pn5n6_c20240613__20240613__us-gaap--TypeOfArrangementAxis__custom--SubscriptionAgreementsMember__srt--TitleOfIndividualAxis__custom--InvestorsMember_ztepZgJsdaX3" title="Gross proceeds"><ix:nonFraction name="us-gaap:ProceedsFromIssuanceOfCommonStock" contextRef="From2024-05-312024-05-31_custom_SubscriptionAgreementsMember_custom_InvestorsMember" id="Fact002428" format="ixt:numdotdecimal" decimals="-5" scale="6" unitRef="USD"><ix:nonFraction name="us-gaap:ProceedsFromIssuanceOfCommonStock" contextRef="From2024-06-132024-06-13_custom_SubscriptionAgreementsMember_custom_InvestorsMember" id="Fact002430" format="ixt:numdotdecimal" decimals="-5" scale="6" unitRef="USD">1.6</ix:nonFraction></ix:nonFraction></span></span>M,
before expenses to the placement agent and other offering expenses of $<span id="xdx_901_eus-gaap--OtherExpenses_c20240531__20240531__us-gaap--TypeOfArrangementAxis__custom--SubscriptionAgreementsMember__srt--TitleOfIndividualAxis__custom--InvestorsMember_zxi72i936Se" title="Other offering expenses"><span id="xdx_90A_eus-gaap--OtherExpenses_c20240613__20240613__us-gaap--TypeOfArrangementAxis__custom--SubscriptionAgreementsMember__srt--TitleOfIndividualAxis__custom--InvestorsMember_zkTohxQGlF4k" title="Other offering expenses"><ix:nonFraction name="us-gaap:OtherExpenses" contextRef="From2024-05-312024-05-31_custom_SubscriptionAgreementsMember_custom_InvestorsMember" id="Fact002432" format="ixt:numdotdecimal" decimals="0" unitRef="USD"><ix:nonFraction name="us-gaap:OtherExpenses" contextRef="From2024-06-132024-06-13_custom_SubscriptionAgreementsMember_custom_InvestorsMember" id="Fact002434" format="ixt:numdotdecimal" decimals="0" unitRef="USD">298,000</ix:nonFraction></ix:nonFraction></span></span>
with net proceeds, after reflecting par value, have been recorded in Additional Paid in Capital of $<span id="xdx_904_eus-gaap--AdditionalPaidInCapital_iI_c20240531__us-gaap--TypeOfArrangementAxis__custom--SubscriptionAgreementsMember__srt--TitleOfIndividualAxis__custom--InvestorsMember_zii3a3KXY41b" title="Additional paid in capital"><span id="xdx_90F_eus-gaap--AdditionalPaidInCapital_iI_c20240613__us-gaap--TypeOfArrangementAxis__custom--SubscriptionAgreementsMember__srt--TitleOfIndividualAxis__custom--InvestorsMember_zsESKedJmNm9" title="Additional paid in capital"><ix:nonFraction name="us-gaap:AdditionalPaidInCapital" contextRef="AsOf2024-05-31_custom_SubscriptionAgreementsMember_custom_InvestorsMember" id="Fact002436" format="ixt:numdotdecimal" decimals="0" unitRef="USD"><ix:nonFraction name="us-gaap:AdditionalPaidInCapital" contextRef="AsOf2024-06-13_custom_SubscriptionAgreementsMember_custom_InvestorsMember" id="Fact002438" format="ixt:numdotdecimal" decimals="0" unitRef="USD">1,296,903</ix:nonFraction></ix:nonFraction></span></span>.
The shares issued in the offering were offered at-the-market under Nasdaq rules and pursuant to the Company&#8217;s Form 1-A (the
&#8220;Offering Statement&#8221;), initially filed by the Company with the Securities and Exchange Commission under the Securities
Act of 1933, as amended on May 21, 2024, and qualified on May 30, 2024.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
May 30, 2024, the Company offered warrant inducements (the &#8220;Inducement Agreement&#8221;) to certain warrant holders (the
&#8220;Warrant Holders&#8221;) which references the warrants registered for sale under both the registration statements on Form S-1
(file No. 333-263715) and/or the registration statement on Form S-1 (File No. 333-275011) (collectively, the &#8220;Registration
Statements&#8221;) for up to a total of <span id="xdx_906_eus-gaap--ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_iI_pid_c20240530__us-gaap--TypeOfArrangementAxis__custom--InducementAgreementMember_zGkXgpBPe3lj" title="Warrants to purchase shares"><ix:nonFraction name="us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" contextRef="AsOf2024-05-30_custom_InducementAgreementMember" id="Fact002440" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">499,932</ix:nonFraction></span>
(pre reverse - <span id="xdx_908_eus-gaap--ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_iI_pid_c20240530__us-gaap--TypeOfArrangementAxis__custom--InducementAgreementMember__us-gaap--AwardTypeAxis__custom--PrereverseMember_zoY733Kqztca" title="Warrants to purchase shares pre reverse"><ix:nonFraction name="us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" contextRef="AsOf2024-05-30_custom_InducementAgreementMember_custom_PreReverseMember" id="Fact002442" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">10,998,524</ix:nonFraction></span>)
warrants to purchase shares of the Company&#8217;s common stock, par value $<span id="xdx_904_eus-gaap--CommonStockParOrStatedValuePerShare_iI_pid_c20240530__us-gaap--TypeOfArrangementAxis__custom--InducementAgreementMember_zjehFMbIVIm8" title="Common stock, par value"><ix:nonFraction name="us-gaap:CommonStockParOrStatedValuePerShare" contextRef="AsOf2024-05-30_custom_InducementAgreementMember" id="Fact002444" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">0.0001</ix:nonFraction></span>
per share. Pursuant to the Inducement Agreement, the exercise price of the existing warrants was reduced from $<span id="xdx_90F_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_pid_c20240529__us-gaap--TypeOfArrangementAxis__custom--InducementAgreementMember_z4hJnZnQss5k" title="Exercise price"><ix:nonFraction name="us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" contextRef="AsOf2024-05-29_custom_InducementAgreementMember" id="Fact002446" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">14.08</ix:nonFraction></span>
(pre reverse -$<span id="xdx_905_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_pid_c20240529__us-gaap--TypeOfArrangementAxis__custom--InducementAgreementMember__us-gaap--AwardTypeAxis__custom--PrereverseMember__srt--RangeAxis__srt--MaximumMember_zCdxVbxuXyWj" title="Exercise price pre reverse"><ix:nonFraction name="us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" contextRef="AsOf2024-05-29_custom_InducementAgreementMember_custom_PreReverseMember_srt_MaximumMember" id="Fact002448" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">0.64</ix:nonFraction>)</span>
per share to $<span id="xdx_907_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_pid_c20240529__us-gaap--TypeOfArrangementAxis__custom--InducementAgreementMember__us-gaap--AwardTypeAxis__custom--PrereverseMember_zT3Ob0ZAbCig" title="Exercise price pre reverse"><ix:nonFraction name="us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" contextRef="AsOf2024-05-29_custom_InducementAgreementMember_custom_PreReverseMember" id="Fact002450" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">7.26</ix:nonFraction></span>
(pre reverse -$<span id="xdx_904_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_pid_c20240529__us-gaap--TypeOfArrangementAxis__custom--InducementAgreementMember__us-gaap--AwardTypeAxis__custom--PrereverseMember__srt--RangeAxis__srt--MinimumMember_zZryGGA7girl" title="Exercise price pre reverse"><ix:nonFraction name="us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" contextRef="AsOf2024-05-29_custom_InducementAgreementMember_custom_PreReverseMember_srt_MinimumMember" id="Fact002452" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">0.33</ix:nonFraction></span>)
per share. In addition, for each warrant that was exercised, as a result of the Inducement Agreement, the Company agreed to issue
the Warrant Holders unregistered warrants with an exercise price of $<span id="xdx_90F_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_pid_c20240530__us-gaap--TypeOfArrangementAxis__custom--InducementWarrantsMember__srt--TitleOfIndividualAxis__custom--WarrantHoldersMember_zWM0NL7Ow4ci" title="Exercise price"><ix:nonFraction name="us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" contextRef="AsOf2024-05-30_custom_InducementWarrantsMember_custom_WarrantHoldersMember" id="Fact002454" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">9.90</ix:nonFraction></span>
(pre reverse - $<span id="xdx_905_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_pid_c20240530__us-gaap--TypeOfArrangementAxis__custom--InducementWarrantsMember__srt--TitleOfIndividualAxis__custom--WarrantHoldersMember__us-gaap--AwardTypeAxis__custom--PrereverseMember_zqJxlYi0LXh7" title="Exercise price pre reverse"><ix:nonFraction name="us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" contextRef="AsOf2024-05-30_custom_InducementWarrantsMember_custom_WarrantHoldersMember_custom_PreReverseMember" id="Fact002456" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">0.45</ix:nonFraction>)</span>
per share (&#8220;Inducement Warrants&#8221;). In the aggregate, <span id="xdx_90F_eus-gaap--ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_iI_pid_c20240530__us-gaap--TypeOfArrangementAxis__custom--InducementWarrantsMember__srt--TitleOfIndividualAxis__custom--WarrantHoldersMember_z59LQFfsJ79k" title="Warrants exercised shares"><ix:nonFraction name="us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" contextRef="AsOf2024-05-30_custom_InducementWarrantsMember_custom_WarrantHoldersMember" id="Fact002458" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">260,799</ix:nonFraction></span>
(pre reverse -<span id="xdx_907_eus-gaap--ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_iI_pid_c20240530__us-gaap--TypeOfArrangementAxis__custom--InducementWarrantsMember__srt--TitleOfIndividualAxis__custom--WarrantHoldersMember__us-gaap--AwardTypeAxis__custom--PrereverseMember_z31dDJAIJ7vg" title="Warrants exercised shares pre reverse"><ix:nonFraction name="us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" contextRef="AsOf2024-05-30_custom_InducementWarrantsMember_custom_WarrantHoldersMember_custom_PreReverseMember" id="Fact002460" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">5,737,573</ix:nonFraction></span>)
warrants were exercised as a result of the Inducement Agreement and accordingly, <span id="xdx_903_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_pid_c20240530__20240530__us-gaap--SubsidiarySaleOfStockAxis__custom--InducementWarrantsMember_zjZB6rL7fYXe" title="Issuance of warrants"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodSharesNewIssues" contextRef="From2024-05-302024-05-30_custom_InducementWarrantsMember" id="Fact002462" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">260,799</ix:nonFraction></span>
Inducement Warrants were issued. The Company received gross proceeds of $<span id="xdx_90C_eus-gaap--ProceedsFromIssuanceOfWarrants_pn5n6_c20240530__20240530__us-gaap--TypeOfArrangementAxis__custom--InducementAgreementMember__srt--TitleOfIndividualAxis__custom--WarrantHoldersMember_zGuPLzmnMfk9"><ix:nonFraction name="us-gaap:ProceedsFromIssuanceOfWarrants" contextRef="From2024-05-302024-05-30_custom_InducementAgreementMember_custom_WarrantHoldersMember" id="Fact002463" format="ixt:numdotdecimal" decimals="-5" scale="6" unitRef="USD">1.9</ix:nonFraction></span>M
before expenses to the placement agent and other expenses of $<span id="xdx_90F_eus-gaap--OtherExpenses_pp0p0_c20240530__20240530__us-gaap--TypeOfArrangementAxis__custom--InducementAgreementMember__srt--TitleOfIndividualAxis__custom--WarrantHoldersMember_zql0aTwTBkHh" title="Other expenses"><ix:nonFraction name="us-gaap:OtherExpenses" contextRef="From2024-05-302024-05-30_custom_InducementAgreementMember_custom_WarrantHoldersMember" id="Fact002465" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">285,000</ix:nonFraction></span>.
The net proceeds, after reflecting par value, has been recorded in Additional Paid in Capital of $<span id="xdx_907_eus-gaap--AdditionalPaidInCapital_iI_pp0p0_c20240530__us-gaap--TypeOfArrangementAxis__custom--InducementAgreementMember__srt--TitleOfIndividualAxis__custom--WarrantHoldersMember_z7TznGm2OE6l" title="Additional paid in capital"><ix:nonFraction name="us-gaap:AdditionalPaidInCapital" contextRef="AsOf2024-05-30_custom_InducementAgreementMember_custom_WarrantHoldersMember" id="Fact002467" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">978,955</ix:nonFraction></span>
and with respect to the Inducement Warrants, a liability under ASC 815 was recorded in the amount of $<span id="xdx_906_eus-gaap--WarrantsAndRightsOutstanding_iI_pp0p0_c20240530__us-gaap--TypeOfArrangementAxis__custom--InducementAgreementMember__srt--TitleOfIndividualAxis__custom--WarrantHoldersMember_zrcguQvT5rT9"><ix:nonFraction name="us-gaap:WarrantsAndRightsOutstanding" contextRef="AsOf2024-05-30_custom_InducementAgreementMember_custom_WarrantHoldersMember" id="Fact002468" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">693,064</ix:nonFraction></span>.
Certain outstanding warrants, with an exercise price of $<span id="xdx_90C_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_pid_c20240530__us-gaap--TypeOfArrangementAxis__custom--InducementAgreementMember__srt--TitleOfIndividualAxis__custom--WarrantHoldersMember_zqvGZNhXawj1" title="Exercise price"><ix:nonFraction name="us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" contextRef="AsOf2024-05-30_custom_InducementAgreementMember_custom_WarrantHoldersMember" id="Fact002470" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">14.08</ix:nonFraction></span>
(pre reverse -$<span id="xdx_90E_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_pid_c20240530__us-gaap--TypeOfArrangementAxis__custom--InducementAgreementMember__srt--TitleOfIndividualAxis__custom--WarrantHoldersMember__us-gaap--AwardTypeAxis__custom--PrereverseMember__srt--RangeAxis__srt--MaximumMember_zfJw96W5IEvk" title="Exercise price"><ix:nonFraction name="us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" contextRef="AsOf2024-05-30_custom_InducementAgreementMember_custom_WarrantHoldersMember_custom_PreReverseMember_srt_MaximumMember" id="Fact002472" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">0.64</ix:nonFraction></span>),
were reduced to $<span id="xdx_908_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_pid_c20240530__us-gaap--TypeOfArrangementAxis__custom--InducementAgreementMember__srt--TitleOfIndividualAxis__custom--WarrantHoldersMember__us-gaap--AwardTypeAxis__custom--PrereverseMember_zGp9JEgHyrWd" title="Exercise price"><ix:nonFraction name="us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" contextRef="AsOf2024-05-30_custom_InducementAgreementMember_custom_WarrantHoldersMember_custom_PreReverseMember" id="Fact002474" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">7.26</ix:nonFraction></span>
(pre reverse -$<span id="xdx_90F_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_pid_c20240530__us-gaap--TypeOfArrangementAxis__custom--InducementAgreementMember__srt--TitleOfIndividualAxis__custom--WarrantHoldersMember__us-gaap--AwardTypeAxis__custom--PrereverseMember__srt--RangeAxis__srt--MinimumMember_zgNvNoqk9NMh" title="Exercise price"><ix:nonFraction name="us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" contextRef="AsOf2024-05-30_custom_InducementAgreementMember_custom_WarrantHoldersMember_custom_PreReverseMember_srt_MinimumMember" id="Fact002476" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">0.33</ix:nonFraction></span>)
based on anti-dilution terms in the respective warrant agreements.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company recorded a fair value charge in the three months and nine months ended September 30, 2024 to reflect the modification of the
exercise price at the initial inducement date for the non-trading warrants relating to the February and September 2023 warrants
below. (See Note 10)</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<ix:exclude><!-- Field: Page; Sequence: 89; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 0pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->41<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%"><a href="#RM_014">Table of Contents</a></td></tr></table></div>
    <!-- Field: /Page --></ix:exclude>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>SHARPS
TECHNOLOGY, INC.</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTES
TO THE CONDENSED CONSOLIDATED FINANCIAL STATEMENTS</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>FOR
THE THREE AND NINE MONTHS ENDED SEPTEMBER 30, 2024 AND 2023</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Note
8 Stockholders&#8217; Equity (continued)</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
September 29, 2023, the Company completed two simultaneous offerings and received aggregate gross proceeds of approximately $<span id="xdx_904_eus-gaap--ProceedsFromIssuanceOfCommonStock_pn5n6_c20230929__20230929_zwT9JuhYTNel" title="Gross proceeds"><ix:nonFraction name="us-gaap:ProceedsFromIssuanceOfCommonStock" contextRef="From2023-09-292023-09-29" id="Fact002478" format="ixt:numdotdecimal" decimals="-5" scale="6" unitRef="USD">5.6</ix:nonFraction></span> million,
before expenses to the placement agent and other offering expenses of $<span id="xdx_902_eus-gaap--OtherExpenses_c20230929__20230929_zTdtJzeQpnYe" title="Other offering expenses"><ix:nonFraction name="us-gaap:OtherExpenses" contextRef="From2023-09-292023-09-29" id="Fact002480" format="ixt:numdotdecimal" decimals="0" unitRef="USD">716,000</ix:nonFraction></span>.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"> <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>



<p style="margin: 0"></p>

<table cellpadding="0" cellspacing="0" border="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt">
<tr style="vertical-align: top">
  <td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 0.25in">a.</td>
  <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The first offering, the securities purchase agreement offering (the &#8220;Shelf Offering&#8221;) with institutional investors and the Company resulted in the Company receiving net proceeds from the Shelf Offering and the sale of pre-funded of approximately $<span id="xdx_90A_eus-gaap--ProceedsFromIssuanceOrSaleOfEquity_pn5n6_c20230929__20230929__us-gaap--SubsidiarySaleOfStockAxis__custom--ShelfOfferingMember__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember_zMi93dCDo9r9" title="Proceeds from shelf offering"><ix:nonFraction name="us-gaap:ProceedsFromIssuanceOrSaleOfEquity" contextRef="From2023-09-292023-09-29_custom_ShelfOfferingMember_custom_SecuritiesPurchaseAgreementMember" id="Fact002482" format="ixt:numdotdecimal" decimals="-5" scale="6" unitRef="USD">2.5</ix:nonFraction></span> million, includes the value of the pre-funded warrants recorded in APIC, net of $<span id="xdx_90D_eus-gaap--LegalFees_c20230929__20230929__us-gaap--SubsidiarySaleOfStockAxis__custom--ShelfOfferingMember__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember_z6cUgUbB9QEl" title="Placement agent fees"><ix:nonFraction name="us-gaap:LegalFees" contextRef="From2023-09-292023-09-29_custom_ShelfOfferingMember_custom_SecuritiesPurchaseAgreementMember" id="Fact002484" format="ixt:numdotdecimal" decimals="0" unitRef="USD">362,000</ix:nonFraction></span> in fees relating to the placement agent and other offering expenses. The Shelf Offering was priced at the market under Nasdaq rules. In connection with the Shelf Offering, the Company issued <span id="xdx_904_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_c20230929__20230929__us-gaap--SubsidiarySaleOfStockAxis__custom--ShelfOfferingMember__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__us-gaap--AwardTypeAxis__custom--ReverseStockSplitMember_zs1sCwOyAT4k" title="Shares issued"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodSharesNewIssues" contextRef="From2023-09-292023-09-29_custom_ShelfOfferingMember_custom_SecuritiesPurchaseAgreementMember_custom_ReverseStockSplitMember" id="Fact002486" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">164,478</ix:nonFraction></span> (pre reverse -<span id="xdx_90E_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_c20230929__20230929__us-gaap--SubsidiarySaleOfStockAxis__custom--ShelfOfferingMember__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__us-gaap--AwardTypeAxis__custom--PrereverseMember_zEgSqKjhVgAi" title="Shares issued"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodSharesNewIssues" contextRef="From2023-09-292023-09-29_custom_ShelfOfferingMember_custom_SecuritiesPurchaseAgreementMember_custom_PreReverseMember" id="Fact002488" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">3,618,521</ix:nonFraction>)</span> shares of common at a purchase price of $<span id="xdx_90E_eus-gaap--SharesIssuedPricePerShare_iI_c20230929__us-gaap--SubsidiarySaleOfStockAxis__custom--ShelfOfferingMember__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__us-gaap--AwardTypeAxis__custom--ReverseStockSplitMember_z6QtiMNK8xic" title="Purchase price"><ix:nonFraction name="us-gaap:SharesIssuedPricePerShare" contextRef="AsOf2023-09-29_custom_ShelfOfferingMember_custom_SecuritiesPurchaseAgreementMember_custom_ReverseStockSplitMember" id="Fact002490" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">14.08</ix:nonFraction></span> per unit, adjusted to $<span id="xdx_900_eus-gaap--SharesIssuedPricePerShare_iI_c20240530__us-gaap--SubsidiarySaleOfStockAxis__custom--ShelfOfferingMember__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember_zId9A6F1Q4Hd" title="Purchase price"><ix:nonFraction name="us-gaap:SharesIssuedPricePerShare" contextRef="AsOf2024-05-30_custom_ShelfOfferingMember_custom_SecuritiesPurchaseAgreementMember" id="Fact002492" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">7.26</ix:nonFraction></span> (reverse effected) at May 30, 2024, based on anti-dilution terms in the warrants and <span id="xdx_906_eus-gaap--ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight_iI_c20230929__us-gaap--SubsidiarySaleOfStockAxis__custom--ShelfOfferingMember__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__us-gaap--StatementEquityComponentsAxis__custom--PreFundedWarrantsMember_zwixuKBYAVw8" title="Prefunded warrants"><ix:nonFraction name="us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight" contextRef="AsOf2023-09-29_custom_ShelfOfferingMember_custom_SecuritiesPurchaseAgreementMember_custom_PreFundedWarrantsMember" id="Fact002494" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">36,636</ix:nonFraction></span> (pre reverse -<span id="xdx_903_eus-gaap--ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight_iI_c20230929__us-gaap--SubsidiarySaleOfStockAxis__custom--ShelfOfferingMember__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__us-gaap--StatementEquityComponentsAxis__custom--PreFundedWarrantsMember__us-gaap--AwardTypeAxis__custom--PrereverseMember_zd3AmckIbmDd" title="Prefunded warrants"><ix:nonFraction name="us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight" contextRef="AsOf2023-09-29_custom_ShelfOfferingMember_custom_SecuritiesPurchaseAgreementMember_custom_PreFundedWarrantsMember_custom_PreReverseMember" id="Fact002496" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">800,000</ix:nonFraction></span>) pre-funded warrants at $<span id="xdx_901_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_c20230929__us-gaap--SubsidiarySaleOfStockAxis__custom--ShelfOfferingMember__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__us-gaap--StatementEquityComponentsAxis__custom--PreFundedWarrantsMember_zY4ANT1DbBSd" title="Exercise price"><ix:nonFraction name="us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" contextRef="AsOf2023-09-29_custom_ShelfOfferingMember_custom_SecuritiesPurchaseAgreementMember_custom_PreFundedWarrantsMember" id="Fact002498" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">14.058</ix:nonFraction></span> (pre reverse -$<span id="xdx_90E_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_c20230929__us-gaap--SubsidiarySaleOfStockAxis__custom--ShelfOfferingMember__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__us-gaap--StatementEquityComponentsAxis__custom--PreFundedWarrantsMember__us-gaap--AwardTypeAxis__custom--PrereverseMember_z08wHwaj1G6l" title="Exercise price"><ix:nonFraction name="us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" contextRef="AsOf2023-09-29_custom_ShelfOfferingMember_custom_SecuritiesPurchaseAgreementMember_custom_PreFundedWarrantsMember_custom_PreReverseMember" id="Fact002500" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">0.639</ix:nonFraction></span>) per pre-funded warrants. The exercise price of the pre-funded warrants will be $<span id="xdx_901_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_c20230929__us-gaap--SubsidiarySaleOfStockAxis__custom--ShelfOfferingMember__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember_zzKGLoYcq4c9" title="Exercise price"><ix:nonFraction name="us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" contextRef="AsOf2023-09-29_custom_ShelfOfferingMember_custom_SecuritiesPurchaseAgreementMember" id="Fact002502" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">0.001</ix:nonFraction></span> per share.</span></td></tr>
<tr style="vertical-align: top">
  <td>&#160;</td>
    <td>&#160;</td>
  <td>&#160;</td></tr>
<tr style="vertical-align: top">
  <td/>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">b.</span></td>
  <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The second offering, the
  securities purchase agreement offering (&#8220;Private Placement&#8221;) with institutional investors and the Company received net
  proceeds from the Private Placement of approximately $<span id="xdx_906_eus-gaap--ProceedsFromIssuanceOfPrivatePlacement_pn5n6_c20230929__20230929__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--PrivatePlacementMember__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember_zZaMLPXzuCFi"><ix:nonFraction name="us-gaap:ProceedsFromIssuanceOfPrivatePlacement" contextRef="From2023-09-292023-09-29_us-gaap_PrivatePlacementMember_custom_SecuritiesPurchaseAgreementMember" id="Fact002503" format="ixt:numdotdecimal" decimals="-5" scale="6" unitRef="USD">2.4</ix:nonFraction> </span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">million,
  net of $<span id="xdx_904_eus-gaap--LegalFees_c20230929__20230929__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--PrivatePlacementMember__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember_zI0wKJ2Jy20c"><ix:nonFraction name="us-gaap:LegalFees" contextRef="From2023-09-292023-09-29_us-gaap_PrivatePlacementMember_custom_SecuritiesPurchaseAgreementMember" id="Fact002504" format="ixt:numdotdecimal" decimals="0" unitRef="USD">354,000</ix:nonFraction> </span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">in
  fees relating to the placement agent and other offering expense. In connection with the Private Placement, the Company issued: (i) <span id="xdx_90A_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_c20230929__20230929__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--PrivatePlacementMember__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__us-gaap--StatementEquityComponentsAxis__custom--PIPEPreFundedWarrantsMember__us-gaap--AwardTypeAxis__custom--ReverseStockSplitMember_zlWx1bLlQemf"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodSharesNewIssues" contextRef="From2023-09-292023-09-29_us-gaap_PrivatePlacementMember_custom_SecuritiesPurchaseAgreementMember_custom_PIPEPreFundedWarrantsMember_custom_ReverseStockSplitMember" id="Fact002505" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">117,340</ix:nonFraction> </span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(pre
  reverse - <span id="xdx_907_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_c20230929__20230929__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--PrivatePlacementMember__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__us-gaap--StatementEquityComponentsAxis__custom--PIPEPreFundedWarrantsMember__us-gaap--AwardTypeAxis__custom--PrereverseMember_zY8ysaXKY007"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodSharesNewIssues" contextRef="From2023-09-292023-09-29_us-gaap_PrivatePlacementMember_custom_SecuritiesPurchaseAgreementMember_custom_PIPEPreFundedWarrantsMember_custom_PreReverseMember" id="Fact002506" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">2,581,479</ix:nonFraction></span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)
  PIPE Shares (or PIPE Pre-Funded Warrants in lieu thereof) and (ii) PIPE Warrants (non-trading) to purchase <span id="xdx_901_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_pid_c20230929__20230929__us-gaap--SubsidiarySaleOfStockAxis__custom--NonTradingWarrantsMember__us-gaap--AwardTypeAxis__custom--ReverseStockSplitMember_zF3UM9xXW0Y1"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodSharesNewIssues" contextRef="From2023-09-292023-09-29_custom_NonTradingWarrantsMember_custom_ReverseStockSplitMember" id="Fact002507" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">397,727</ix:nonFraction> </span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(pre
  reverse -<span id="xdx_908_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_pid_c20230929__20230929__us-gaap--SubsidiarySaleOfStockAxis__custom--NonTradingWarrantsMember__us-gaap--AwardTypeAxis__custom--PrereverseMember_ze8yhyqxOWj4"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodSharesNewIssues" contextRef="From2023-09-292023-09-29_custom_NonTradingWarrantsMember_custom_PreReverseMember" id="Fact002508" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">8,750,003</ix:nonFraction></span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)
  shares of our common stock, at a combined purchase price of $<span id="xdx_908_eus-gaap--SharesIssuedPricePerShare_iI_c20230203__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__us-gaap--StatementEquityComponentsAxis__custom--PIPEPreFundedWarrantsMember__srt--RangeAxis__srt--MaximumMember_zCRGthkax2u5"><ix:nonFraction name="us-gaap:SharesIssuedPricePerShare" contextRef="AsOf2023-02-03_custom_SecuritiesPurchaseAgreementMember_custom_PIPEPreFundedWarrantsMember_srt_MaximumMember" id="Fact002509" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">23.63</ix:nonFraction> </span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(pre
  reverse -$<span id="xdx_907_eus-gaap--SharesIssuedPricePerShare_iI_c20230203__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__us-gaap--StatementEquityComponentsAxis__custom--PIPEPreFundedWarrantsMember__us-gaap--AwardTypeAxis__custom--PrereverseMember__srt--RangeAxis__srt--MaximumMember_zhifmEvjztv1"><ix:nonFraction name="us-gaap:SharesIssuedPricePerShare" contextRef="AsOf2023-02-03_custom_SecuritiesPurchaseAgreementMember_custom_PIPEPreFundedWarrantsMember_custom_PreReverseMember_srt_MaximumMember" id="Fact002510" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">1.074</ix:nonFraction></span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)
  per unit or $<span id="xdx_90B_eus-gaap--SharesIssuedPricePerShare_iI_c20230203__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__us-gaap--StatementEquityComponentsAxis__custom--PIPEPreFundedWarrantsMember__srt--RangeAxis__srt--MinimumMember_ztFZCkzU16z"><ix:nonFraction name="us-gaap:SharesIssuedPricePerShare" contextRef="AsOf2023-02-03_custom_SecuritiesPurchaseAgreementMember_custom_PIPEPreFundedWarrantsMember_srt_MinimumMember" id="Fact002511" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">23.606</ix:nonFraction> </span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(pre
  reverse - $<span id="xdx_901_eus-gaap--SharesIssuedPricePerShare_iI_c20230203__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__us-gaap--StatementEquityComponentsAxis__custom--PIPEPreFundedWarrantsMember__us-gaap--AwardTypeAxis__custom--PrereverseMember__srt--RangeAxis__srt--MinimumMember_zDHH1wwyXjV2"><ix:nonFraction name="us-gaap:SharesIssuedPricePerShare" contextRef="AsOf2023-02-03_custom_SecuritiesPurchaseAgreementMember_custom_PIPEPreFundedWarrantsMember_custom_PreReverseMember_srt_MinimumMember" id="Fact002512" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">1.073</ix:nonFraction></span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)
  per pre-funded unit. The PIPE Warrants have a term of five and one-half (<span id="xdx_90B_eus-gaap--WarrantsAndRightsOutstandingTerm_iI_dtY_c20230929__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--PrivatePlacementMember__us-gaap--StatementEquityComponentsAxis__custom--PIPEPreFundedWarrantsMember_zeMYe6lecPc7"><ix:nonNumeric contextRef="AsOf2023-09-29_custom_SecuritiesPurchaseAgreementMember_us-gaap_PrivatePlacementMember_custom_PIPEPreFundedWarrantsMember" format="ixt-sec:duryear" id="Fact002513" name="us-gaap:WarrantsAndRightsOutstandingTerm">5.5</ix:nonNumeric></span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)
  years from the issuance date and are exercisable for one share of common stock at an exercise price, after effect of the October
  2024 reverse split, of $<span id="xdx_905_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_c20230929__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__us-gaap--StatementEquityComponentsAxis__custom--PIPEPreFundedWarrantsMember__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--PrivatePlacementMember__us-gaap--AwardTypeAxis__custom--ReverseStockSplitMember_ziDup5ZsnOm2" title="Exercise price"><ix:nonFraction name="us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" contextRef="AsOf2023-09-29_custom_SecuritiesPurchaseAgreementMember_custom_PIPEPreFundedWarrantsMember_us-gaap_PrivatePlacementMember_custom_ReverseStockSplitMember" id="Fact002515" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">14.08</ix:nonFraction></span> </span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">adjusted
  to $<span id="xdx_903_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_c20240530__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__us-gaap--StatementEquityComponentsAxis__custom--PIPEPreFundedWarrantsMember__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--PrivatePlacementMember_zb4esqp6XZji" title="Exercise price"><ix:nonFraction name="us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" contextRef="AsOf2024-05-30_custom_SecuritiesPurchaseAgreementMember_custom_PIPEPreFundedWarrantsMember_us-gaap_PrivatePlacementMember" id="Fact002517" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">7.26</ix:nonFraction></span> </span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
  at May 30, 2024, based on anti-dilution terms in the warrants. See Note 8(a) Warrants below for further adjustment. The net
  proceeds, after reflecting par value, has been recorded in Additional Paid in Capital of $<span id="xdx_905_eus-gaap--AdditionalPaidInCapital_iI_pn5n6_c20230929__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--PrivatePlacementMember__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember_zNo37uMNWoL"><ix:nonFraction name="us-gaap:AdditionalPaidInCapital" contextRef="AsOf2023-09-29_us-gaap_PrivatePlacementMember_custom_SecuritiesPurchaseAgreementMember" id="Fact002518" format="ixt:numdotdecimal" decimals="-5" scale="6" unitRef="USD">1.6</ix:nonFraction> </span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">million
  and with respect to the PIPE Warrants recorded as a liability under ASC 815 of $<span id="xdx_907_eus-gaap--FairValueAdjustmentOfWarrants_c20230929__20230929__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--PrivatePlacementMember__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember_zchytfbAUqAb"><ix:nonFraction name="us-gaap:FairValueAdjustmentOfWarrants" contextRef="From2023-09-292023-09-29_us-gaap_PrivatePlacementMember_custom_SecuritiesPurchaseAgreementMember" id="Fact002519" format="ixt:numdotdecimal" decimals="0" unitRef="USD">985,204</ix:nonFraction></span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">.
  On October 16, 2023, the Company filed an S-1 (Resale) Registration Statement in connection with the Private Placement and on
  October 26, 2023 the S-1 went effective. (See Note 10).</span></td></tr>
</table>


<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
February 3, 2023, the Company completed a securities purchase agreement (&#8220;Offering&#8221;) with institutional investors and
received net proceeds from the Offering of approximately $<span id="xdx_902_eus-gaap--ProceedsFromIssuanceOrSaleOfEquity_pn5n6_c20230201__20230203__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember_zbzMZnujum06" title="Net proceeds from offering"><ix:nonFraction name="us-gaap:ProceedsFromIssuanceOrSaleOfEquity" contextRef="From2023-02-012023-02-03_custom_SecuritiesPurchaseAgreementMember" id="Fact002521" format="ixt:numdotdecimal" decimals="-5" scale="6" unitRef="USD">3.2</ix:nonFraction></span>
million, net of $<span id="xdx_908_eus-gaap--NoninterestExpenseOfferingCost_c20230201__20230203__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember_zWvZCfJADvC" title="Offering expenses"><ix:nonFraction name="us-gaap:NoninterestExpenseOfferingCost" contextRef="From2023-02-012023-02-03_custom_SecuritiesPurchaseAgreementMember" id="Fact002523" format="ixt:numdotdecimal" decimals="0" unitRef="USD">600,000</ix:nonFraction></span>
in fees relating to the placement agent and other offering expenses. The Offering was priced at the market under Nasdaq rules. In
connection with the Offering, the Company issued <span id="xdx_902_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_c20230201__20230203__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember_zc32l1L6epN6" title="Shares issued"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodSharesNewIssues" contextRef="From2023-02-012023-02-03_custom_SecuritiesPurchaseAgreementMember" id="Fact002525" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">102,206</ix:nonFraction></span>
(pre reverse - <span id="xdx_90E_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_c20230201__20230203__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__us-gaap--AwardTypeAxis__custom--PrereverseMember_zrErnecrmJ39" title="Shares issued"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodSharesNewIssues" contextRef="From2023-02-012023-02-03_custom_SecuritiesPurchaseAgreementMember_custom_PreReverseMember" id="Fact002527" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">2,248,521</ix:nonFraction></span>)
units at a purchase price of $<span id="xdx_90C_eus-gaap--SharesIssuedPricePerShare_iI_c20230203__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember_zXSzvTmpLF2a" title="Purchase price"><ix:nonFraction name="us-gaap:SharesIssuedPricePerShare" contextRef="AsOf2023-02-03_custom_SecuritiesPurchaseAgreementMember" id="Fact002529" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">37.18</ix:nonFraction></span>
(pre reverse - $<span id="xdx_908_eus-gaap--SharesIssuedPricePerShare_iI_c20230203__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__us-gaap--AwardTypeAxis__custom--PrereverseMember_zpx8ymIt6RAc" title="Purchase price pre reverse"><ix:nonFraction name="us-gaap:SharesIssuedPricePerShare" contextRef="AsOf2023-02-03_custom_SecuritiesPurchaseAgreementMember_custom_PreReverseMember" id="Fact002531" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">1.69</ix:nonFraction></span>)
per unit. <span id="xdx_90F_eus-gaap--SaleOfStockDescriptionOfTransaction_c20230201__20230203__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember_zPv94cdnKkvh" title="Units description"><ix:nonNumeric contextRef="From2023-02-012023-02-03_custom_SecuritiesPurchaseAgreementMember" id="Fact002533" name="us-gaap:SaleOfStockDescriptionOfTransaction">Each
unit consisted of one share of common stock and one non-tradable warrant (&#8220;Offering Warrants&#8221;) exercisable for one share
of common stock</ix:nonNumeric></span> at a price, after effect of the October 2024 reverse split, of $<span id="xdx_908_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_c20230203__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember_zgjUiahQHPua" title="Warrant exerice price"><ix:nonFraction name="us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" contextRef="AsOf2023-02-03_custom_SecuritiesPurchaseAgreementMember" id="Fact002535" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">34.32</ix:nonFraction></span>,
adjusted to $<span id="xdx_90D_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_c20230929__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember_zpEMl8ykMwm9" title="Warrant exerice price"><ix:nonFraction name="us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" contextRef="AsOf2023-09-29_custom_SecuritiesPurchaseAgreementMember" id="Fact002537" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">14.08</ix:nonFraction> </span>at
September 29, 2023 and to $<span id="xdx_902_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_c20240530__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember_zpvSffBdRaSh" title="Warrant exerice price"><ix:nonFraction name="us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" contextRef="AsOf2024-05-30_custom_SecuritiesPurchaseAgreementMember" id="Fact002539" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">7.26</ix:nonFraction></span>
at May 30, 2024, based on anti-dilution terms in the warrants and a term of <span id="xdx_903_eus-gaap--WarrantsAndRightsOutstandingTerm_iI_dc_c20230203__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember_zI5c9Pbupx87" title="Warrants term"><ix:nonNumeric contextRef="AsOf2023-02-03_custom_SecuritiesPurchaseAgreementMember" format="ixt-sec:durwordsen" id="Fact002541" name="us-gaap:WarrantsAndRightsOutstandingTerm">five
years</ix:nonNumeric></span>. See Note 8(a) for further adjustment. The Offering Warrants have a term of five years from the issuance date. On
February 13, 2023, the Company filed an S-1 (Resale) Registration Statement in connection with the Offering and on April 14, 2023,
an Amendment to the S-1 was filed and went effective. (See Note 10)</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
April 13, 2022, the Company&#8217;s initial public offering (&#8220;IPO&#8221;) was declared effective by the SEC pursuant to which the
Company issued and sold an aggregate of <span id="xdx_901_eus-gaap--SaleOfStockNumberOfSharesIssuedInTransaction_c20220411__20220413__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--IPOMember_zXZGKTT9mtX9" title="Number of units sold"><ix:nonFraction name="us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction" contextRef="From2022-04-112022-04-13_us-gaap_IPOMember" id="Fact002543" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">170,454</ix:nonFraction></span> ( pre reverse -<span id="xdx_906_eus-gaap--SaleOfStockNumberOfSharesIssuedInTransaction_c20220411__20220413__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--IPOMember__us-gaap--AwardTypeAxis__custom--PrereverseMember_ztgLtKSrAYog" title="Number of units sold"><ix:nonFraction name="us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction" contextRef="From2022-04-112022-04-13_us-gaap_IPOMember_custom_PreReverseMember" id="Fact002545" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">3,750,000</ix:nonFraction></span>) units (&#8220;Units&#8221;), <span id="xdx_90E_eus-gaap--SaleOfStockDescriptionOfTransaction_c20220411__20220413__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--IPOMember_zPgbjKCZ3Cjj" title="Units description"><ix:nonNumeric contextRef="From2022-04-112022-04-13_us-gaap_IPOMember" id="Fact002547" name="us-gaap:SaleOfStockDescriptionOfTransaction">each consisting of one share of
common stock and two warrants, to purchase one share of common stock for each whole warrant</ix:nonNumeric></span>, with an initial exercise price of $ <span id="xdx_90C_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_pid_c20220413__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--IPOMember_zhImK9jKO7g1" title="Exercise price"><ix:nonFraction name="us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" contextRef="AsOf2022-04-13_us-gaap_IPOMember" id="Fact002549" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">93.50</ix:nonFraction></span>
(pre reverse -$<span id="xdx_907_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_pid_c20220413__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--IPOMember__us-gaap--AwardTypeAxis__custom--PrereverseMember_zUKez6CaeCHj" title="Exercise price"><ix:nonFraction name="us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" contextRef="AsOf2022-04-13_us-gaap_IPOMember_custom_PreReverseMember" id="Fact002551" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">4.25</ix:nonFraction></span>) per share, adjusted to and with the effect of reverse split October 2024, $<span id="xdx_900_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_c20230203__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--IPOMember_z5VuSzGg04w7" title="Warrant exerice price"><ix:nonFraction name="us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" contextRef="AsOf2023-02-03_us-gaap_IPOMember" id="Fact002553" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">34.32</ix:nonFraction></span> at February 3, 2023 and to $<span id="xdx_900_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_c20230929__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--IPOMember_z9rvxvC88svi" title="Warrant exercise price"><ix:nonFraction name="us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" contextRef="AsOf2023-09-29_us-gaap_IPOMember" id="Fact002555" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">14.08</ix:nonFraction></span>
at September 29, 2023 and to $<span id="xdx_908_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_c20240530__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--IPOMember_z5JDqlFbSfwi" title="Warrant exercise price"><ix:nonFraction name="us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" contextRef="AsOf2024-05-30_us-gaap_IPOMember" id="Fact002557" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">7.26</ix:nonFraction></span> at May 30, 2024, based on anti-dilution terms in the warrants, and a term of <span id="xdx_900_eus-gaap--WarrantsAndRightsOutstandingTerm_iI_dc_c20220413__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--IPOMember_zAlCz1xbmWM8" title="Warrants exercise price term"><ix:nonNumeric contextRef="AsOf2022-04-13_us-gaap_IPOMember" format="ixt-sec:durwordsen" id="Fact002559" name="us-gaap:WarrantsAndRightsOutstandingTerm">five years</ix:nonNumeric></span>. In addition,
<span id="xdx_90B_ecustom--DescriptionForOfferingShares_c20220411__20220413__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--IPOMember_zRe0s0XmAgK4" title="Description for offering shares"><ix:nonNumeric contextRef="From2022-04-112022-04-13_us-gaap_IPOMember" id="Fact002561" name="STSS:DescriptionForOfferingShares">the Company granted Aegis Capital Corp., as underwriter a 45-day over-allotment option to purchase up to 15% of the number of shares
included in the units sold in the offering, and/or additional warrants equal to 15% of the number of Warrants included in the units sold
in the offering, in each case solely to cover over-allotments</ix:nonNumeric></span>, which the Aegis Capital Corp. partially exercised with respect to <span id="xdx_90C_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised_c20220417__20220419__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_z0lKPJ9XQYPj" title="Warrants exercised"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised" contextRef="From2022-04-172022-04-19_us-gaap_WarrantMember" id="Fact002563" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">51,136</ix:nonFraction></span>
( pre reverse -<span id="xdx_904_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised_c20220417__20220419__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember__us-gaap--AwardTypeAxis__custom--PrereverseMember_zRYFTrpixppk" title="Warrants exercised"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised" contextRef="From2022-04-172022-04-19_us-gaap_WarrantMember_custom_PreReverseMember" id="Fact002565" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">1,125,000</ix:nonFraction></span>) warrants on April 19, 2022.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company&#8217;s common stock and warrants began trading on the Nasdaq Capital Market or Nasdaq on April 14, 2022. The net proceeds from
the IPO, prior to payments of certain listing and professional fees were approximately $<span id="xdx_90F_eus-gaap--ProceedsFromIssuanceInitialPublicOffering_pn5n6_c20220417__20220419__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--IPOMember_zzkU3sKAUAd7" title="Net proceeds from IPO"><ix:nonFraction name="us-gaap:ProceedsFromIssuanceInitialPublicOffering" contextRef="From2022-04-172022-04-19_us-gaap_IPOMember" id="Fact002567" format="ixt:numdotdecimal" decimals="-5" scale="6" unitRef="USD">14.2</ix:nonFraction></span> million. The net proceeds, after reflecting
par value, has been recorded in Additional Paid in Capital of $<span id="xdx_90D_eus-gaap--AdditionalPaidInCapital_iI_pn5n6_c20220414_zX8ls53vu8L3" title="Additional paid in capital"><ix:nonFraction name="us-gaap:AdditionalPaidInCapital" contextRef="AsOf2022-04-14" id="Fact002569" format="ixt:numdotdecimal" decimals="-5" scale="6" unitRef="USD">9.0</ix:nonFraction></span> million and with respect to the Warrants as a liability under ASC
815 of $<span id="xdx_905_ecustom--WarrantLiabilitiesCurrent_iI_pn5n6_c20220414_zHlinw9uu5d3" title="Warrants liability"><ix:nonFraction name="STSS:WarrantLiabilitiesCurrent" contextRef="AsOf2022-04-14" id="Fact002571" format="ixt:numdotdecimal" decimals="-5" scale="6" unitRef="USD">5.2</ix:nonFraction></span>M. (See Note 10)</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"></p>

<ix:exclude><!-- Field: Page; Sequence: 90; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 0pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->42<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%"><a href="#RM_014">Table of Contents</a></td></tr></table></div>
    <!-- Field: /Page --></ix:exclude>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><br/></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>SHARPS
TECHNOLOGY, INC.</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTES
TO THE CONDENSED CONSOLIDATED FINANCIAL STATEMENTS</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>FOR
THE THREE AND NINE MONTHS ENDED SEPTEMBER 30, 2024 AND 2023</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Note
8. Stockholders&#8217; Equity (continued)</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Warrants</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>&#160;</i></b></span></p>

<table cellpadding="0" cellspacing="0" border="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">a)</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">In
                                                                                                                                                                                                                                     September 2024, the Company reduced the exercise price of the <span id="xdx_908_eus-gaap--ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight_iI_c20240930__srt--TitleOfIndividualAxis__custom--WarrantHoldersMember_zpD5QL7ymoli" title="Prefunded warrants"><ix:nonFraction name="us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight" contextRef="AsOf2024-09-30_custom_WarrantHoldersMember" id="Fact002573" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">230,091</ix:nonFraction></span> (pre reverse &#8211; <span id="xdx_908_eus-gaap--ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight_iI_c20240930__srt--TitleOfIndividualAxis__custom--WarrantHoldersMember__us-gaap--AwardTypeAxis__custom--PrereverseMember_ze9DnfeGT7Oh" title="Prefunded warrants"><ix:nonFraction name="us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight" contextRef="AsOf2024-09-30_custom_WarrantHoldersMember_custom_PreReverseMember" id="Fact002575" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">5,260,000</ix:nonFraction></span>)
                                                                                                                                                                                                                                     outstanding warrants issued in February 2023 and September 2023 offerings (see below) from $<span id="xdx_904_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_pid_c20230228__srt--TitleOfIndividualAxis__custom--WarrantHoldersMember_zIW3Jm2fwubk"><span id="xdx_90B_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_pid_c20230930__srt--TitleOfIndividualAxis__custom--WarrantHoldersMember_zPJDBL6kSOul"><ix:nonFraction name="us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" contextRef="AsOf2023-02-28_custom_WarrantHoldersMember" id="Fact002576" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares"><ix:nonFraction name="us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" contextRef="AsOf2023-09-30_custom_WarrantHoldersMember" id="Fact002577" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">7.26</ix:nonFraction></ix:nonFraction></span></span>
                                                                                                                                                                                                                                     (pre reverse - $<span id="xdx_90E_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_pid_c20230228__srt--TitleOfIndividualAxis__custom--WarrantHoldersMember__us-gaap--AwardTypeAxis__custom--PrereverseMember_zrd8UrCqFVt9"><span id="xdx_908_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_pid_c20230930__srt--TitleOfIndividualAxis__custom--WarrantHoldersMember__us-gaap--AwardTypeAxis__custom--PrereverseMember_zGhkgG6vsqP9"><ix:nonFraction name="us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" contextRef="AsOf2023-02-28_custom_WarrantHoldersMember_custom_PreReverseMember" id="Fact002578" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares"><ix:nonFraction name="us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" contextRef="AsOf2023-09-30_custom_WarrantHoldersMember_custom_PreReverseMember" id="Fact002579" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">0.33</ix:nonFraction></ix:nonFraction></span></span>)
                                                                                                                                                                                                                                     to $<span id="xdx_907_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_c20230228__srt--TitleOfIndividualAxis__custom--WarrantHolderMember_zNAUcyG87Tsa" title="Exercise price"><span id="xdx_908_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_c20230929__srt--TitleOfIndividualAxis__custom--WarrantHolderMember_zgzI8x9H2pkc" title="Exercise price"><ix:nonFraction name="us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" contextRef="AsOf2023-02-28_custom_WarrantHolderMember" id="Fact002581" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares"><ix:nonFraction name="us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" contextRef="AsOf2023-09-29_custom_WarrantHolderMember" id="Fact002583" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">0.0001</ix:nonFraction></ix:nonFraction></span></span>.
                                                                                                                                                                                                                                     In connection with the reduction in the exercise price the Company recorded a modification charge of $<span id="xdx_90B_ecustom--FairValueAdjustmentOfModificationCharge_c20240701__20240930__srt--TitleOfIndividualAxis__custom--WarrantHoldersMember_z1ppnhttWOWb" title="Fair value adjustment of modification charge"><span id="xdx_907_ecustom--FairValueAdjustmentOfModificationCharge_c20240101__20240930__srt--TitleOfIndividualAxis__custom--WarrantHoldersMember_zjROgu5KrCk1" title="Fair value adjustment of modification charge"><ix:nonFraction name="STSS:FairValueAdjustmentOfModificationCharge" contextRef="From2024-07-012024-09-30_custom_WarrantHoldersMember" id="Fact002585" format="ixt:numdotdecimal" decimals="0" unitRef="USD"><ix:nonFraction name="STSS:FairValueAdjustmentOfModificationCharge" contextRef="From2024-01-012024-09-30_custom_WarrantHoldersMember" id="Fact002587" format="ixt:numdotdecimal" decimals="0" unitRef="USD">155,703</ix:nonFraction></ix:nonFraction></span></span>
                                                                                                                                                                                                                                     in the three months ended September 30, 2024. At September 30, 2024, <span id="xdx_905_eus-gaap--ClassOfWarrantOrRightOutstanding_iI_c20240930__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_z9Q5hPqbkFXe" title="Class of warrant or right, outstanding"><ix:nonFraction name="us-gaap:ClassOfWarrantOrRightOutstanding" contextRef="AsOf2024-09-30_us-gaap_WarrantMember" id="Fact002589" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">103,685</ix:nonFraction></span>,
                                                                                                                                                                                                                                     after reverse split, warrants remain outstanding. Subsequent to September 30, 2024 such remaining warrants were
                                                                                                                                                                                                                                     exercised.</td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"></p>

<table cellpadding="0" cellspacing="0" border="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt">
<tr style="vertical-align: top">
  <td style="text-align: justify; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">b)</span></td>
  <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In connection with the
  Inducement Warrants in the second quarter of 2024, the Company issued <span id="xdx_905_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_pid_c20240401__20240630__us-gaap--SubsidiarySaleOfStockAxis__custom--InducementWarrantsMember_z0ReVNJqdGWb" title="Issuance of warrants"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodSharesNewIssues" contextRef="From2024-04-012024-06-30_custom_InducementWarrantsMember" id="Fact002591" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">260,799</ix:nonFraction></span>
  (pre reverse - <span id="xdx_906_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_pid_c20240401__20240630__us-gaap--SubsidiarySaleOfStockAxis__custom--InducementWarrantsMember__us-gaap--AwardTypeAxis__custom--PrereverseMember_z26XG8W3w3Fg" title="Issuance of warrants"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodSharesNewIssues" contextRef="From2024-04-012024-06-30_custom_InducementWarrantsMember_custom_PreReverseMember" id="Fact002593" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">5,737,573</ix:nonFraction></span>)
  non-trading Inducement Warrants as noted in Common Stock above. The Inducement Warrants are classified as a liability based on ASC
  815 and require remeasurement at each reporting period. The Inducement Warrants are recorded at the FMV, computed using the Black
  Scholes valuation method. and , recorded a FMV gain adjustment of <span id="xdx_904_eus-gaap--FairValueAdjustmentOfWarrants_c20240101__20240630__us-gaap--SubsidiarySaleOfStockAxis__custom--InducementWarrantsMember_z0WtQXwZAgbj" title="Fair market value adjustment">$<ix:nonFraction name="us-gaap:FairValueAdjustmentOfWarrants" contextRef="From2024-01-012024-06-30_custom_InducementWarrantsMember" id="Fact002595" format="ixt:numdotdecimal" decimals="0" unitRef="USD">293,684</ix:nonFraction> </span>(See
  Note 10).</span></td></tr>

<tr style="vertical-align: top">
  <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
  <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
<tr style="vertical-align: top">
  <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">c)</span></td>
  <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In connection with one-year
advisory services arrangement entered into in April 2023, the Company issued an aggregate of <span id="xdx_904_ecustom--ClassOfWarrantOrRightIssued_iI_c20230430__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_zNYQ5E5WuYh9"><ix:nonFraction name="STSS:ClassOfWarrantOrRightIssued" contextRef="AsOf2023-04-30_us-gaap_WarrantMember" id="Fact002596" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">28,636</ix:nonFraction>
</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(pre reverse - <span id="xdx_900_ecustom--ClassOfWarrantOrRightIssued_iI_c20230430__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember__us-gaap--AwardTypeAxis__custom--PrereverseMember_z273H14yIzwj"><ix:nonFraction name="STSS:ClassOfWarrantOrRightIssued" contextRef="AsOf2023-04-30_us-gaap_WarrantMember_custom_PreReverseMember" id="Fact002597" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">630,000</ix:nonFraction></span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)
warrants over the one-year term, at an exercise price of $<span id="xdx_90A_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_pid_c20230430__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_zsMpAYrXIZr7"><ix:nonFraction name="us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" contextRef="AsOf2023-04-30_us-gaap_WarrantMember" id="Fact002598" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">34.32</ix:nonFraction>
</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(pre reverse -$<span id="xdx_90D_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_pid_c20230430__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember__us-gaap--AwardTypeAxis__custom--PrereverseMember_z6luBNwfciel"><ix:nonFraction name="us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" contextRef="AsOf2023-04-30_us-gaap_WarrantMember_custom_PreReverseMember" id="Fact002599" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">1.56</ix:nonFraction>)
</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The warrants have a three-year term and were
fully vested on issuance. During the three and nine months ended September 30, 2024, the Company issued <span id="xdx_90B_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_pid_c20240701__20240930__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_zBZJzKyjzGbk"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodSharesNewIssues" contextRef="From2024-07-012024-09-30_us-gaap_WarrantMember" id="Fact002600" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">0</ix:nonFraction>
</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">and <span id="xdx_905_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_pid_c20240101__20240930__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_zQUBKxP88zvk"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodSharesNewIssues" contextRef="From2024-01-012024-09-30_us-gaap_WarrantMember" id="Fact002601" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">5,909</ix:nonFraction>
</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(pre reverse - <span id="xdx_909_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_pid_c20240101__20240930__us-gaap--AwardTypeAxis__custom--PrereverseMember_z6o812ywypE5"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodSharesNewIssues" contextRef="From2024-01-012024-09-30_custom_PreReverseMember" id="Fact002602" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">130,000</ix:nonFraction>)
</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">warrants with a FMV of $<span id="xdx_903_eus-gaap--FairValueAdjustmentOfWarrants_c20240101__20240930__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_zEfa6bIekdhh"><ix:nonFraction name="us-gaap:FairValueAdjustmentOfWarrants" contextRef="From2024-01-012024-09-30_us-gaap_WarrantMember" id="Fact002603" format="ixt:numdotdecimal" decimals="0" unitRef="USD">8,590</ix:nonFraction></span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">.
During the three and nine months ended September 30, 2023 the Company issued <span id="xdx_90C_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_pid_c20230701__20230930__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_zJNWH9ieFB0j"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodSharesNewIssues" contextRef="From2023-07-012023-09-30_us-gaap_WarrantMember" id="Fact002604" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">10,227</ix:nonFraction>
</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(pre reverse - <span id="xdx_904_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_pid_c20230701__20230930__us-gaap--AwardTypeAxis__custom--PrereverseMember_zXF2Nf6J53fc"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodSharesNewIssues" contextRef="From2023-07-012023-09-30_custom_PreReverseMember" id="Fact002605" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">225,000</ix:nonFraction>)
</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">and <span id="xdx_903_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_pid_c20230101__20230930__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_z9ngBbzWBXck"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodSharesNewIssues" contextRef="From2023-01-012023-09-30_us-gaap_WarrantMember" id="Fact002606" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">16,363</ix:nonFraction>
</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(pre-reverse <span id="xdx_90C_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_pid_c20230101__20230930__us-gaap--AwardTypeAxis__custom--PrereverseMember_zISrg5KSYGu3"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodSharesNewIssues" contextRef="From2023-01-012023-09-30_custom_PreReverseMember" id="Fact002607" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">360,000</ix:nonFraction></span></span>)
<span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">warrants with a FMV of $<span id="xdx_909_eus-gaap--FairValueAdjustmentOfWarrants_c20230701__20230930__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_zAsHDnt8OrZ6"><ix:nonFraction name="us-gaap:FairValueAdjustmentOfWarrants" contextRef="From2023-07-012023-09-30_us-gaap_WarrantMember" id="Fact002608" format="ixt:numdotdecimal" decimals="0" unitRef="USD">22,470</ix:nonFraction>
</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">and $<span id="xdx_90C_eus-gaap--FairValueAdjustmentOfWarrants_c20230101__20230930__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_zwdX5tD6Y7i4"><ix:nonFraction name="us-gaap:FairValueAdjustmentOfWarrants" contextRef="From2023-01-012023-09-30_us-gaap_WarrantMember" id="Fact002609" format="ixt:numdotdecimal" decimals="0" unitRef="USD">42,306</ix:nonFraction></span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">,
respectively. The FMV of the warrants issued in the nine months ended September 30, 2024 was computed using the Black Scholes valuation
model with the following assumptions: a) volatility of <span id="xdx_901_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum_pid_dp_uPure_c20240101__20240930__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_ztJfsXXqZFl7"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum" contextRef="From2024-01-012024-09-30_us-gaap_WarrantMember" id="Fact002610" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">33.46</ix:nonFraction></span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">%
to <span id="xdx_907_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum_pid_dp_uPure_c20240101__20240930__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_zEZ5aYmF05nb"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum" contextRef="From2024-01-012024-09-30_us-gaap_WarrantMember" id="Fact002611" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">81.62</ix:nonFraction></span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">%
<span id="xdx_902_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_pid_dxL_c20240101__20240930__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_z3FvfIxcrJee" title="::XDX::P3Y"><span style="-sec-ix-hidden: xdx2ixbrl2612">three-year
</span></span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">term, risk free interest rate of <span id="xdx_90E_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum_pid_dp_uPure_c20240101__20240930__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_zRQ4liQ8nkJi"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum" contextRef="From2024-01-012024-09-30_us-gaap_WarrantMember" id="Fact002613" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">4.20</ix:nonFraction></span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">%
to <span id="xdx_906_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum_pid_dp_uPure_c20240101__20240930__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_zUDDMyTnhAr2"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum" contextRef="From2024-01-012024-09-30_us-gaap_WarrantMember" id="Fact002614" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">4.25</ix:nonFraction></span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">%
and <span id="xdx_903_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_pid_dp_uPure_c20240101__20240930__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_zeE1GNLBwLX8"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" contextRef="From2024-01-012024-09-30_us-gaap_WarrantMember" id="Fact002615" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">0</ix:nonFraction></span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">%
dividend rate. The FMV of the warrants issued in the three and nine months ended September 30, 2023 was computed using the Black Scholes
valuation model with the following assumptions: a) volatility of <span id="xdx_909_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum_pid_dp_uPure_c20230101__20230930__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_zaUVM4t2Eux2"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum" contextRef="From2023-01-012023-09-30_us-gaap_WarrantMember" id="Fact002616" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">37.45</ix:nonFraction></span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">%
to <span id="xdx_909_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum_pid_dp_uPure_c20230101__20230930__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_zh74gQxaOyVe"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum" contextRef="From2023-01-012023-09-30_us-gaap_WarrantMember" id="Fact002617" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">44.83</ix:nonFraction></span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">%,
risk free interest rate of <span id="xdx_903_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum_pid_dp_uPure_c20230101__20230930__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_z5nuzQwlgKT4"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum" contextRef="From2023-01-012023-09-30_us-gaap_WarrantMember" id="Fact002618" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">3.58</ix:nonFraction></span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">%
to <span id="xdx_904_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum_pid_dp_uPure_c20230101__20230930__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_zNEr5jzZs9rg"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum" contextRef="From2023-01-012023-09-30_us-gaap_WarrantMember" id="Fact002619" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">4.43</ix:nonFraction></span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">.%
and <span id="xdx_90A_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_pid_dp_uPure_c20230101__20230930__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_zSg2peGEbWV1"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" contextRef="From2023-01-012023-09-30_us-gaap_WarrantMember" id="Fact002620" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">0</ix:nonFraction></span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">%
dividend rate (See Note 10).</span></td></tr>

<tr style="vertical-align: top">
  <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
  <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
<tr style="vertical-align: top">
  <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">d)</span></td>
  <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> In connection with the
  Private Placement in September 2023, the Company issued <span id="xdx_906_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_pid_c20230901__20230930__us-gaap--SubsidiarySaleOfStockAxis__custom--NonTradingWarrantsMember__us-gaap--AwardTypeAxis__custom--ReverseStockSplitMember_z8qmGYUmeEzi" title="Issuance of warrants"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodSharesNewIssues" contextRef="From2023-09-012023-09-30_custom_NonTradingWarrantsMember_custom_ReverseStockSplitMember" id="Fact002622" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">397,727</ix:nonFraction></span> (pre reverse <span id="xdx_902_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_pid_c20230901__20230930__us-gaap--SubsidiarySaleOfStockAxis__custom--NonTradingWarrantsMember__us-gaap--AwardTypeAxis__custom--PrereverseMember_z7I4NGPyNIu2" title="Issuance of warrants"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodSharesNewIssues" contextRef="From2023-09-012023-09-30_custom_NonTradingWarrantsMember_custom_PreReverseMember" id="Fact002624" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">8,750,003</ix:nonFraction></span>) non-trading PIPE Warrants as a component of
  the Unit as noted in Common Stock above. The PIPE Warrants are classified as a liability based on ASC 815 and require remeasurement
  at each reporting period. The PIPE Warrants are recorded at the FMV, computed using the Black Scholes valuation method. For the three
  and nine months ended September 30, 2024, the Company recorded a FMV gain (loss) adjustment of $<span id="xdx_901_eus-gaap--FairValueAdjustmentOfWarrants_c20240701__20240930__us-gaap--SubsidiarySaleOfStockAxis__custom--NonTradingWarrantsMember__us-gaap--StatementEquityComponentsAxis__custom--PIPEWarrantMember_zNzIm6SZImM1" title="Fair market value adjustment">(<ix:nonFraction name="us-gaap:FairValueAdjustmentOfWarrants" contextRef="From2024-07-012024-09-30_custom_NonTradingWarrantsMember_custom_PIPEWarrantMember" id="Fact002626" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">181,163</ix:nonFraction>)</span>, including the modification
  charge of $<span id="xdx_902_ecustom--FairValueAdjustmentOfModificationCharge_c20240701__20240930__us-gaap--SubsidiarySaleOfStockAxis__custom--NonTradingWarrantsMember__us-gaap--StatementEquityComponentsAxis__custom--PIPEWarrantMember_z1Im6BNWMXec" title="Fair value adjustment of modification charge">(<ix:nonFraction name="STSS:FairValueAdjustmentOfModificationCharge" contextRef="From2024-07-012024-09-30_custom_NonTradingWarrantsMember_custom_PIPEWarrantMember" id="Fact002628" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">148,091</ix:nonFraction>)</span> and $<span id="xdx_908_eus-gaap--FairValueAdjustmentOfWarrants_c20240101__20240930__us-gaap--SubsidiarySaleOfStockAxis__custom--NonTradingWarrantsMember__us-gaap--StatementEquityComponentsAxis__custom--PIPEWarrantMember_zRnaNjj6qwO4" title="Fair market value adjustment"><ix:nonFraction name="us-gaap:FairValueAdjustmentOfWarrants" contextRef="From2024-01-012024-09-30_custom_NonTradingWarrantsMember_custom_PIPEWarrantMember" id="Fact002630" format="ixt:numdotdecimal" decimals="0" unitRef="USD">470,721</ix:nonFraction></span> including the modification charge of $<span id="xdx_90A_ecustom--FairValueAdjustmentOfModificationCharge_c20240101__20240930__us-gaap--SubsidiarySaleOfStockAxis__custom--NonTradingWarrantsMember__us-gaap--StatementEquityComponentsAxis__custom--PIPEWarrantMember_z9dRpMFQazwa" title="Fair value adjustment of modification charge">(<ix:nonFraction name="STSS:FairValueAdjustmentOfModificationCharge" contextRef="From2024-01-012024-09-30_custom_NonTradingWarrantsMember_custom_PIPEWarrantMember" id="Fact002632" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">637,316</ix:nonFraction>)</span>, respectively (See Note 10).</span></td></tr>

<tr style="vertical-align: top">
  <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
  <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
<tr style="vertical-align: top">
  <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">e)</span></td>
  <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In connection with the
  Offering in February 2023, the Company issued <span id="xdx_90C_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_pid_c20230201__20230228__us-gaap--SubsidiarySaleOfStockAxis__custom--NonTradingWarrantsMember__us-gaap--AwardTypeAxis__custom--ReverseStockSplitMember_zIBgh5mwyN3e" title="Issuance of warrants"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodSharesNewIssues" contextRef="From2023-02-012023-02-28_custom_NonTradingWarrantsMember_custom_ReverseStockSplitMember" id="Fact002634" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">102,206</ix:nonFraction></span>
  (pre reverse -<span id="xdx_905_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_pid_c20230201__20230228__us-gaap--SubsidiarySaleOfStockAxis__custom--NonTradingWarrantsMember__us-gaap--AwardTypeAxis__custom--PrereverseMember_zApX3HKaENfk" title="Issuance of warrants"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodSharesNewIssues" contextRef="From2023-02-012023-02-28_custom_NonTradingWarrantsMember_custom_PreReverseMember" id="Fact002636" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">2,248,521</ix:nonFraction></span>)
  non-trading warrants Offering Warrants as a component of the Unit as noted in Common Stock above. The Offering Warrants are
  classified as a liability based on ASC 815 and require remeasurement at each reporting period. The Offering Warrants were recorded
  at the FMV, computed using the Black Scholes valuation method. For the three and nine months ended September 30, 2024 the Company
  recorded FMV gain (loss) adjustments of <span id="xdx_907_eus-gaap--FairValueAdjustmentOfWarrants_c20240701__20240930__us-gaap--SubsidiarySaleOfStockAxis__custom--NonTradingWarrantsMember_zOX6dOhUiLOc" title="FMV gain adjustment">$<ix:nonFraction name="us-gaap:FairValueAdjustmentOfWarrants" contextRef="From2024-07-012024-09-30_custom_NonTradingWarrantsMember" id="Fact002638" format="ixt:numdotdecimal" decimals="0" unitRef="USD">7,563</ix:nonFraction></span>,
  including a modification charge of $<span id="xdx_905_ecustom--FairValueAdjustmentOfModificationCharge_c20240701__20240930__us-gaap--SubsidiarySaleOfStockAxis__custom--NonTradingWarrantsMember_z6CSyQESIWJl" title="Fair value adjustment of modification charge"><ix:nonFraction name="STSS:FairValueAdjustmentOfModificationCharge" contextRef="From2024-07-012024-09-30_custom_NonTradingWarrantsMember" id="Fact002640" format="ixt:numdotdecimal" decimals="0" unitRef="USD">7,612</ix:nonFraction></span>
  referred to in Note 10, and $<span id="xdx_905_eus-gaap--FairValueAdjustmentOfWarrants_c20240101__20240930__us-gaap--SubsidiarySaleOfStockAxis__custom--NonTradingWarrantsMember_zgGkyvfKR2C9" title="FMV gain adjustment"><ix:nonFraction name="us-gaap:FairValueAdjustmentOfWarrants" contextRef="From2024-01-012024-09-30_custom_NonTradingWarrantsMember" id="Fact002642" format="ixt:numdotdecimal" decimals="0" unitRef="USD">214,019</ix:nonFraction></span>,
  including a modification charge of $<span id="xdx_90E_ecustom--FairValueAdjustmentOfModificationCharge_c20240101__20240930__us-gaap--SubsidiarySaleOfStockAxis__custom--NonTradingWarrantsMember_zNjxYCsBAaGf" title="Fair value adjustment of modification charge"><ix:nonFraction name="STSS:FairValueAdjustmentOfModificationCharge" contextRef="From2024-01-012024-09-30_custom_NonTradingWarrantsMember" id="Fact002644" format="ixt:numdotdecimal" decimals="0" unitRef="USD">153,640</ix:nonFraction></span>.
  For the three and nine months ended September 30, 2023, the Company recorded a FMV gain adjustment of $<span id="xdx_900_eus-gaap--FairValueAdjustmentOfWarrants_c20230701__20230930__us-gaap--SubsidiarySaleOfStockAxis__custom--NonTradingWarrantsMember_zRycgWMLH1t5" title="FMV gain adjustment"><ix:nonFraction name="us-gaap:FairValueAdjustmentOfWarrants" contextRef="From2023-07-012023-09-30_custom_NonTradingWarrantsMember" id="Fact002646" format="ixt:numdotdecimal" decimals="0" unitRef="USD">56,172</ix:nonFraction></span>&#160;and
  $<span id="xdx_90A_eus-gaap--FairValueAdjustmentOfWarrants_c20230101__20230930__us-gaap--SubsidiarySaleOfStockAxis__custom--NonTradingWarrantsMember_zCK38DObsane" title="FMV gain adjustment"><ix:nonFraction name="us-gaap:FairValueAdjustmentOfWarrants" contextRef="From2023-01-012023-09-30_custom_NonTradingWarrantsMember" id="Fact002648" format="ixt:numdotdecimal" decimals="0" unitRef="USD">238,752</ix:nonFraction></span>
  respectively (See Note 10).</span></td></tr>

<tr style="vertical-align: top">
  <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
  <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
<tr style="vertical-align: top">
  <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">f)</span></td>
  <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In connection with the IPO
  in April 2022, the Company issued <span id="xdx_905_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_pid_c20220417__20220419__us-gaap--SubsidiarySaleOfStockAxis__custom--TradingWarrantsMember_z4IuO605eRth" title="Issuance of warrants"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodSharesNewIssues" contextRef="From2022-04-172022-04-19_custom_TradingWarrantsMember" id="Fact002650" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">340,900</ix:nonFraction></span>
  (pre reverse -<span id="xdx_902_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_pid_c20220417__20220419__us-gaap--SubsidiarySaleOfStockAxis__custom--TradingWarrantsMember__us-gaap--AwardTypeAxis__custom--PrereverseMember_zj639Gmf3osa" title="Issuance of warrants"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodSharesNewIssues" contextRef="From2022-04-172022-04-19_custom_TradingWarrantsMember_custom_PreReverseMember" id="Fact002652" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">7,500,000</ix:nonFraction></span>)
  warrants (Trading Warrants) as a component of the Units and <span id="xdx_90C_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_pid_c20220417__20220419__us-gaap--SubsidiarySaleOfStockAxis__custom--OverAllotmentWarrantsMember_z3y6wi0pkQof" title="Issuance of warrants"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodSharesNewIssues" contextRef="From2022-04-172022-04-19_custom_OverAllotmentWarrantsMember" id="Fact002654" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">51,136</ix:nonFraction></span>
  (pre reverse - <span id="xdx_903_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_pid_c20220417__20220419__us-gaap--SubsidiarySaleOfStockAxis__custom--OverAllotmentWarrantsMember__us-gaap--AwardTypeAxis__custom--PrereverseMember_zEjQvpBa6S5k" title="Issuance of warrants"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodSharesNewIssues" contextRef="From2022-04-172022-04-19_custom_OverAllotmentWarrantsMember_custom_PreReverseMember" id="Fact002656" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">1,125,000</ix:nonFraction></span>)
  warrants to the underwriter (Overallotment Warrants), as noted in Common Stock above. The Trading and Overallotment Warrants were
  recorded at the FMV, being the trading price of the warrants, on the IPO effective date and the Warrants are classified as a
  Liability based on ASC 815. The Warrant liability requires remeasurement at each reporting period based on the trading price of the
  warrants. During the three and nine months ended September 30, 2024, the Company recorded an FMV gain adjustment of $<span id="xdx_90F_eus-gaap--FairValueAdjustmentOfWarrants_c20240701__20240930__us-gaap--SubsidiarySaleOfStockAxis__custom--TradingWarrantsMember_z2gevU8Gig62" title="Fair value income adjustment"><ix:nonFraction name="us-gaap:FairValueAdjustmentOfWarrants" contextRef="From2024-07-012024-09-30_custom_TradingWarrantsMember" id="Fact002658" format="ixt:numdotdecimal" decimals="0" unitRef="USD">198,375</ix:nonFraction></span>
  and $<span id="xdx_90F_eus-gaap--FairValueAdjustmentOfWarrants_c20240101__20240930__us-gaap--SubsidiarySaleOfStockAxis__custom--TradingWarrantsMember_zyh2cQSsSQaj" title="Fair value income adjustment"><ix:nonFraction name="us-gaap:FairValueAdjustmentOfWarrants" contextRef="From2024-01-012024-09-30_custom_TradingWarrantsMember" id="Fact002660" format="ixt:numdotdecimal" decimals="0" unitRef="USD">690,001</ix:nonFraction></span>,
  respectively. During the three and nine months ended September 30, 2023, the Company recorded an FMV gain adjustment of $<span id="xdx_907_eus-gaap--FairValueAdjustmentOfWarrants_c20230701__20230930__us-gaap--SubsidiarySaleOfStockAxis__custom--TradingWarrantsMember_zaODooa6ZvKl" title="Fair value income adjustment"><ix:nonFraction name="us-gaap:FairValueAdjustmentOfWarrants" contextRef="From2023-07-012023-09-30_custom_TradingWarrantsMember" id="Fact002662" format="ixt:numdotdecimal" decimals="0" unitRef="USD">258,750</ix:nonFraction></span>&#160;and
  $<span id="xdx_90E_eus-gaap--FairValueAdjustmentOfWarrants_c20230101__20230930__us-gaap--SubsidiarySaleOfStockAxis__custom--TradingWarrantsMember_zOKQ43R1Faqg" title="Fair value income adjustment"><ix:nonFraction name="us-gaap:FairValueAdjustmentOfWarrants" contextRef="From2023-01-012023-09-30_custom_TradingWarrantsMember" id="Fact002664" format="ixt:numdotdecimal" decimals="0" unitRef="USD">172,500</ix:nonFraction></span>,
  respectively. (See Note 10).</span></td></tr>

<tr style="vertical-align: top">
  <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
  <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
<tr style="vertical-align: top">
  <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">g)</span></td>
  <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company issued <span id="xdx_90C_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_pid_c20220417__20220419__us-gaap--SubsidiarySaleOfStockAxis__custom--NoteWarrantsMember_zdGV5lpE9Iu5" title="Warrants issued"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodSharesNewIssues" contextRef="From2022-04-172022-04-19_custom_NoteWarrantsMember" id="Fact002666" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">10,695</ix:nonFraction></span>
  (pre reverse -<span id="xdx_904_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_pid_c20220417__20220419__us-gaap--SubsidiarySaleOfStockAxis__custom--NoteWarrantsMember__us-gaap--AwardTypeAxis__custom--PrereverseMember_zvEOY5YvWTCd" title="Warrants issued"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodSharesNewIssues" contextRef="From2022-04-172022-04-19_custom_NoteWarrantsMember_custom_PreReverseMember" id="Fact002668" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">235,295</ix:nonFraction></span>) Warrants (&#8220;Note Warrants&#8221;) to the note holders in connection with the repayment on the IPO on April
  19, 2022. The Note Warrants, which are recorded at the FMV being the trading price of the warrants, are classified as a Liability based
  on ASC 815. The Note Warrants require remeasurement at each reporting period. During the three and nine months ended September 30,
  2024, the Company recorded a FMV gain of $<span id="xdx_908_eus-gaap--FairValueAdjustmentOfWarrants_c20240701__20240930__us-gaap--SubsidiarySaleOfStockAxis__custom--NoteWarrantsMember_zxXiZ8R7YWFi" title="FMV gain/(loss) adjustment"><ix:nonFraction name="us-gaap:FairValueAdjustmentOfWarrants" contextRef="From2024-07-012024-09-30_custom_NoteWarrantsMember" id="Fact002670" format="ixt:numdotdecimal" decimals="0" unitRef="USD">5,411</ix:nonFraction></span> and $<span id="xdx_90B_eus-gaap--FairValueAdjustmentOfWarrants_c20240101__20240930__us-gaap--SubsidiarySaleOfStockAxis__custom--NoteWarrantsMember_zvXtcem1Xkyj" title="FMV gain/(loss) adjustment"><ix:nonFraction name="us-gaap:FairValueAdjustmentOfWarrants" contextRef="From2024-01-012024-09-30_custom_NoteWarrantsMember" id="Fact002672" format="ixt:numdotdecimal" decimals="0" unitRef="USD">18,822</ix:nonFraction></span>, respectively. For the three and nine months ended September 30, 2023, the
  Company recorded a FMV gain/(loss) adjustment of $<span id="xdx_905_eus-gaap--FairValueAdjustmentOfWarrants_c20230701__20230930__us-gaap--SubsidiarySaleOfStockAxis__custom--NoteWarrantsMember_zOebmRjRs1w6" title="FMV gain/(loss) adjustment"><span id="xdx_906_eus-gaap--FairValueAdjustmentOfWarrants_c20230101__20230930__us-gaap--SubsidiarySaleOfStockAxis__custom--NoteWarrantsMember_zP4D3FuIHsf5" title="FMV gain/(loss) adjustment"><ix:nonFraction name="us-gaap:FairValueAdjustmentOfWarrants" contextRef="From2023-07-012023-09-30_custom_NoteWarrantsMember" id="Fact002674" format="ixt:numdotdecimal" decimals="0" unitRef="USD"><ix:nonFraction name="us-gaap:FairValueAdjustmentOfWarrants" contextRef="From2023-01-012023-09-30_custom_NoteWarrantsMember" id="Fact002676" format="ixt:numdotdecimal" decimals="0" unitRef="USD">7,059</ix:nonFraction></ix:nonFraction></span></span>. (See Note 10).</span></td></tr>
</table>




<p style="margin-top: 0; margin-bottom: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<ix:exclude><!-- Field: Page; Sequence: 91; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 0pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->43<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%"><a href="#RM_014">Table of Contents</a></td></tr></table></div>
    <!-- Field: /Page --></ix:exclude>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>SHARPS
TECHNOLOGY, INC.</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTES
TO THE CONDENSED CONSOLIDATED FINANCIAL STATEMENTS</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>FOR
THE THREE AND NINE MONTHS ENDED SEPTEMBER 30, 2024 AND 2023</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Note
8. Stockholders&#8217; Equity (continued)</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(h)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
    underwriter received <span id="xdx_900_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_c20220417__20220419__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--IPOMember_zAvuhFqxm9O9" title="Warrants issued"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodSharesNewIssues" contextRef="From2022-04-172022-04-19_us-gaap_IPOMember" id="Fact002678" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">8,523</ix:nonFraction></span>
    (pre reverse - <span id="xdx_900_eus-gaap--ClassOfWarrantOrRightOutstanding_iI_c20220419__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--IPOMember__us-gaap--AwardTypeAxis__custom--PrereverseMember_zytQuAlyCNg9" title="Warrants issued"><ix:nonFraction name="us-gaap:ClassOfWarrantOrRightOutstanding" contextRef="AsOf2022-04-19_us-gaap_IPOMember_custom_PreReverseMember" id="Fact002680" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">187,500</ix:nonFraction></span>)
    warrants in connection with the IPO for a nominal cost of $<span id="xdx_907_eus-gaap--WarrantsAndRightsOutstanding_iI_c20220419__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--IPOMember_z7HqYDAMofbh" title="Nominal cost of warrant"><ix:nonFraction name="us-gaap:WarrantsAndRightsOutstanding" contextRef="AsOf2022-04-19_us-gaap_IPOMember" id="Fact002682" format="ixt:numdotdecimal" decimals="0" unitRef="USD">11,250</ix:nonFraction></span>.
    The Warrants have an exercise price of $<span id="xdx_901_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_pid_c20220419__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--IPOMember_zS5x8otaHBI8" title="Exercise price"><ix:nonFraction name="us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" contextRef="AsOf2022-04-19_us-gaap_IPOMember" id="Fact002684" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">117.04</ix:nonFraction></span>
    (pre reverse - $<span id="xdx_906_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_pid_c20220419__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--IPOMember__us-gaap--AwardTypeAxis__custom--PrereverseMember_z1Fgloja1RRd" title="Exercise price"><ix:nonFraction name="us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" contextRef="AsOf2022-04-19_us-gaap_IPOMember_custom_PreReverseMember" id="Fact002686" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">5.32</ix:nonFraction></span>)
    and are exercisable after October 9, 2022. The FMV at the date of issuance was $<span id="xdx_90A_eus-gaap--FairValueAdjustmentOfWarrants_c20220417__20220419__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--IPOMember_zNuwLO2NxRd" title="Fair value adjustment of warrants"><ix:nonFraction name="us-gaap:FairValueAdjustmentOfWarrants" contextRef="From2022-04-172022-04-19_us-gaap_IPOMember" id="Fact002688" format="ixt:numdotdecimal" decimals="0" unitRef="USD">228,750</ix:nonFraction></span>
    computed using the Black Scholes valuation model with the following assumptions: a) volatility of <span id="xdx_904_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate_pid_dp_uPure_c20220417__20220419__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--IPOMember_zzQPXpOZuur1" title="Volatility"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate" contextRef="From2022-04-172022-04-19_us-gaap_IPOMember" id="Fact002690" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">93.47</ix:nonFraction></span>%,
    five-year term, risk free interest rate <span id="xdx_90C_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_pid_dp_uPure_c20220417__20220419__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--IPOMember_zM8xxJzsIXe2" title="Risk free interest rate"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" contextRef="From2022-04-172022-04-19_us-gaap_IPOMember" id="Fact002692" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">2.77</ix:nonFraction></span>%
    and <span id="xdx_902_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_pid_dp_uPure_c20220417__20220419__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--IPOMember_zV50liXjGu8i" title="Dividend rate"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" contextRef="From2022-04-172022-04-19_us-gaap_IPOMember" id="Fact002694" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">0</ix:nonFraction></span>%
    dividend rate. The estimated FMV was classified as additional issuance costs.</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2024-01-01to2024-09-30" escape="true" id="Fact002696" name="us-gaap:PreferredStockTextBlock"><p id="xdx_80E_eus-gaap--PreferredStockTextBlock_zWiVlYzABBmk" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Note
9. <span id="xdx_82A_zVQIH3ndTVXi">Preferred Stock</span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
February 2018, the Company Board of Directors issued one share of Series A Preferred Stock to Alan Blackman, the Company&#8217;s
co-founder and former Director. <span id="xdx_904_eus-gaap--PreferredStockVotingRights_c20240101__20240930__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesAPreferredStockMember_zK8gAUX3OIJk" title="Preferred stock, voting rights"><ix:nonNumeric contextRef="From2024-01-012024-09-30_us-gaap_SeriesAPreferredStockMember" id="Fact002698" name="us-gaap:PreferredStockVotingRights">The
Series A Preferred Stock entitled the holder to vote on any matters related to the election of directors and was reduced from 50.1%
at December 31, 2021 to 29.5%, effective with the IPO.</ix:nonNumeric></span> The Series A Preferred Stock has no right to dividends, or
distributions in the event of a liquidation and is not convertible into common stock. In connection with final settlement with
Mr. Blackman on August 2024, the Series A Preferred Stock were cancelled and forfeited without any further consideration. The
Series A Preferred was returned to the status of an authorized but unissued share of preferred stock of the
Company (See Note 15).</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2024-01-01to2024-09-30" escape="true" id="Fact002700" name="STSS:WarrantLiabilityTextBlock"><p id="xdx_80A_ecustom--WarrantLiabilityTextBlock_zXUVLEfd1gKd" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Note
10. <span id="xdx_82D_zjlLl9nSTeye">Warrant Liability</span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Certain
Warrants are accounted for as liabilities in accordance with ASC 815-40 and are presented as a Warrant liability in the accompanying
condensed consolidated balance sheets. The warrant liabilities are measured at fair value at inception and on a recurring basis, with
changes in fair value presented within the condensed consolidated statements of operations. The Black Scholes Option-Pricing model used
the following assumptions for the nine months ended September 30, 2024 and 2023 (See Note 8).</span></p>

<ix:nonNumeric contextRef="From2024-01-012024-09-30_us-gaap_WarrantMember" escape="true" id="Fact002702" name="us-gaap:FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock"><p id="xdx_893_eus-gaap--FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock_hus-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_zNfj4uwSz8Yc" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span id="xdx_8B0_z5C3vtvO3kFc" style="display: none">Schedule
of Fair Value of Warrant</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">September
    30, 2024</span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">September
    30, 2023</span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Expected
    term (years)</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_901_eus-gaap--WarrantsAndRightsOutstandingTerm_iI_dtY_c20240930__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputExpectedTermMember__srt--RangeAxis__srt--MinimumMember_zmXMpEpnfdA" title="Expected term (in years)"><ix:nonNumeric contextRef="AsOf2024-09-30_us-gaap_WarrantMember_us-gaap_MeasurementInputExpectedTermMember_srt_MinimumMember" format="ixt-sec:duryear" id="Fact002704" name="us-gaap:WarrantsAndRightsOutstandingTerm">3.37</ix:nonNumeric></span>
                                            to <span id="xdx_907_eus-gaap--WarrantsAndRightsOutstandingTerm_iI_dtY_c20240930__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputExpectedTermMember__srt--RangeAxis__srt--MaximumMember_z2fbJCh3v6Z" title="Expected term (in years)"><ix:nonNumeric contextRef="AsOf2024-09-30_us-gaap_WarrantMember_us-gaap_MeasurementInputExpectedTermMember_srt_MaximumMember" format="ixt-sec:duryear" id="Fact002706" name="us-gaap:WarrantsAndRightsOutstandingTerm">5.99</ix:nonNumeric></span></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_908_eus-gaap--WarrantsAndRightsOutstandingTerm_iI_dtY_c20230930__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputExpectedTermMember__srt--RangeAxis__srt--MinimumMember_zJ1OxdaSccMe" title="Expected term (in years)"><ix:nonNumeric contextRef="AsOf2023-09-30_us-gaap_WarrantMember_us-gaap_MeasurementInputExpectedTermMember_srt_MinimumMember" format="ixt-sec:duryear" id="Fact002708" name="us-gaap:WarrantsAndRightsOutstandingTerm">4.36</ix:nonNumeric></span>
                                                                                                                                                                       to <span id="xdx_902_eus-gaap--WarrantsAndRightsOutstandingTerm_iI_dtY_c20230930__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputExpectedTermMember__srt--RangeAxis__srt--MaximumMember_zLlKEu3UkqD5" title="Expected term (in years)"><ix:nonNumeric contextRef="AsOf2023-09-30_us-gaap_WarrantMember_us-gaap_MeasurementInputExpectedTermMember_srt_MaximumMember" format="ixt-sec:duryear" id="Fact002710" name="us-gaap:WarrantsAndRightsOutstandingTerm">5.5</ix:nonNumeric></span></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Expected
    volatility</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_903_eus-gaap--WarrantsAndRightsOutstandingMeasurementInput_iI_uPure_c20240930__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputOptionVolatilityMember__srt--RangeAxis__srt--MinimumMember_zXXVWT90ZRFe" title="Expected volatility"><ix:nonFraction name="us-gaap:WarrantsAndRightsOutstandingMeasurementInput" contextRef="AsOf2024-09-30_us-gaap_WarrantMember_us-gaap_MeasurementInputOptionVolatilityMember_srt_MinimumMember" id="Fact002712" format="ixt:numdotdecimal" decimals="INF" unitRef="Pure">58.78</ix:nonFraction></span>%
                                            to <span id="xdx_901_eus-gaap--WarrantsAndRightsOutstandingMeasurementInput_iI_uPure_c20240930__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputOptionVolatilityMember__srt--RangeAxis__srt--MaximumMember_zQzweK1Oo1sh" title="Expected volatility"><ix:nonFraction name="us-gaap:WarrantsAndRightsOutstandingMeasurementInput" contextRef="AsOf2024-09-30_us-gaap_WarrantMember_us-gaap_MeasurementInputOptionVolatilityMember_srt_MaximumMember" id="Fact002714" format="ixt:numdotdecimal" decimals="INF" unitRef="Pure">121.32</ix:nonFraction></span></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">%<span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90F_eus-gaap--WarrantsAndRightsOutstandingMeasurementInput_iI_uPure_c20230930__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputOptionVolatilityMember__srt--RangeAxis__srt--MinimumMember_zRv1T99jhtA4" title="Expected volatility"><ix:nonFraction name="us-gaap:WarrantsAndRightsOutstandingMeasurementInput" contextRef="AsOf2023-09-30_us-gaap_WarrantMember_us-gaap_MeasurementInputOptionVolatilityMember_srt_MinimumMember" id="Fact002716" format="ixt:numdotdecimal" decimals="INF" unitRef="Pure">45.31</ix:nonFraction></span>% to <span id="xdx_907_eus-gaap--WarrantsAndRightsOutstandingMeasurementInput_iI_uPure_c20230930__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputOptionVolatilityMember__srt--RangeAxis__srt--MaximumMember_zVYQVnOrBbRa" title="Expected volatility"><ix:nonFraction name="us-gaap:WarrantsAndRightsOutstandingMeasurementInput" contextRef="AsOf2023-09-30_us-gaap_WarrantMember_us-gaap_MeasurementInputOptionVolatilityMember_srt_MaximumMember" id="Fact002718" format="ixt:numdotdecimal" decimals="INF" unitRef="Pure">59.93</ix:nonFraction></span></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">%<span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Risk-free
    interest rate</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_904_eus-gaap--WarrantsAndRightsOutstandingMeasurementInput_iI_uPure_c20240930__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputRiskFreeInterestRateMember__srt--RangeAxis__srt--MinimumMember_zf5o1wA5v0Gi"><ix:nonFraction name="us-gaap:WarrantsAndRightsOutstandingMeasurementInput" contextRef="AsOf2024-09-30_us-gaap_WarrantMember_us-gaap_MeasurementInputRiskFreeInterestRateMember_srt_MinimumMember" id="Fact002719" format="ixt:numdotdecimal" decimals="INF" unitRef="Pure">3.41</ix:nonFraction></span>%
                                            to <span id="xdx_903_eus-gaap--WarrantsAndRightsOutstandingMeasurementInput_iI_uPure_c20240930__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputRiskFreeInterestRateMember__srt--RangeAxis__srt--MaximumMember_z0Kke4FDIzn8"><ix:nonFraction name="us-gaap:WarrantsAndRightsOutstandingMeasurementInput" contextRef="AsOf2024-09-30_us-gaap_WarrantMember_us-gaap_MeasurementInputRiskFreeInterestRateMember_srt_MaximumMember" id="Fact002720" format="ixt:numdotdecimal" decimals="INF" unitRef="Pure">4.56</ix:nonFraction></span></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">%<span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span id="xdx_904_eus-gaap--WarrantsAndRightsOutstandingMeasurementInput_iI_uPure_c20230930__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputRiskFreeInterestRateMember__srt--RangeAxis__srt--MinimumMember_zDCk21xxYKk" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="us-gaap:WarrantsAndRightsOutstandingMeasurementInput" contextRef="AsOf2023-09-30_us-gaap_WarrantMember_us-gaap_MeasurementInputRiskFreeInterestRateMember_srt_MinimumMember" id="Fact002721" format="ixt:numdotdecimal" decimals="INF" unitRef="Pure">3.53</ix:nonFraction>
</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">to <span id="xdx_90C_eus-gaap--WarrantsAndRightsOutstandingMeasurementInput_iI_uPure_c20230930__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputRiskFreeInterestRateMember__srt--RangeAxis__srt--MaximumMember_z5zagmsUuQyc"><ix:nonFraction name="us-gaap:WarrantsAndRightsOutstandingMeasurementInput" contextRef="AsOf2023-09-30_us-gaap_WarrantMember_us-gaap_MeasurementInputRiskFreeInterestRateMember_srt_MaximumMember" id="Fact002722" format="ixt:numdotdecimal" decimals="INF" unitRef="Pure">4.54</ix:nonFraction></span></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">%</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 60%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Dividend
    rate</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 16%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_909_eus-gaap--WarrantsAndRightsOutstandingMeasurementInput_iI_uPure_c20240930__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputExpectedDividendRateMember_zoaHYPOcVQj" title="Warrants liabilities measurement input"><ix:nonFraction name="us-gaap:WarrantsAndRightsOutstandingMeasurementInput" contextRef="AsOf2024-09-30_us-gaap_WarrantMember_us-gaap_MeasurementInputExpectedDividendRateMember" id="Fact002724" format="ixt:numdotdecimal" decimals="INF" unitRef="Pure">0</ix:nonFraction></span></span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 16%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90E_eus-gaap--WarrantsAndRightsOutstandingMeasurementInput_iI_uPure_c20230930__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputExpectedDividendRateMember_z51hakULv0cc" title="Warrants liabilities measurement input"><ix:nonFraction name="us-gaap:WarrantsAndRightsOutstandingMeasurementInput" contextRef="AsOf2023-09-30_us-gaap_WarrantMember_us-gaap_MeasurementInputExpectedDividendRateMember" id="Fact002726" format="ixt:numdotdecimal" decimals="INF" unitRef="Pure">0</ix:nonFraction></span></span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"></p>

</ix:nonNumeric><p id="xdx_8AF_zR9QUfS9Q5fd" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<ix:nonNumeric contextRef="From2024-01-01to2024-09-30" escape="true" id="Fact002728" name="STSS:ScheduleOfWarrantLiabilityTableTextBlock"><p id="xdx_89C_ecustom--ScheduleOfWarrantLiabilityTableTextBlock_zjFkl6PkXAg4" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Warrant liability at September 30, 2024 and December 31, 2023 was as follows:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span id="xdx_8B4_za9s8uaOy15c" style="display: none">Schedule
of Warrant Liability</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" id="xdx_496_20240930_ztB5zHqwIoE3" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">September
    30, 2024</span></td><td style="padding-bottom: 1pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" id="xdx_49B_20231231_ztgLDdeEkM03" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">December
    31, 2023</span></td><td style="padding-bottom: 1pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr id="xdx_408_ecustom--WarrantLiabilitiesCurrent_iI_hus-gaap--ClassOfWarrantOrRightAxis__custom--TradingAndOverallotmentWarrantsMember_zdShiQojQEQ5" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 60%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Trading and Overallotment
    Warrants</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="width: 16%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="STSS:WarrantLiabilitiesCurrent" contextRef="AsOf2024-09-30_custom_TradingAndOverallotmentWarrantsMember" id="Fact002730" format="ixt:numdotdecimal" decimals="0" unitRef="USD">431,250</ix:nonFraction></span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="width: 16%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="STSS:WarrantLiabilitiesCurrent" contextRef="AsOf2023-12-31_custom_TradingAndOverallotmentWarrantsMember10886187" id="Fact002731" format="ixt:numdotdecimal" decimals="0" unitRef="USD">1,121,250</ix:nonFraction></span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr id="xdx_403_ecustom--WarrantLiabilitiesCurrent_iI_hus-gaap--ClassOfWarrantOrRightAxis__custom--NoteWarrantsMember_zpnqIbvwgih7" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Note Warrants</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="STSS:WarrantLiabilitiesCurrent" contextRef="AsOf2024-09-30_custom_NoteWarrantsMember" id="Fact002733" format="ixt:numdotdecimal" decimals="0" unitRef="USD">11,765</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="STSS:WarrantLiabilitiesCurrent" contextRef="AsOf2023-12-31_custom_NoteWarrantsMember10886187" id="Fact002734" format="ixt:numdotdecimal" decimals="0" unitRef="USD">30,588</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr id="xdx_40D_ecustom--WarrantLiabilitiesCurrent_iI_hus-gaap--ClassOfWarrantOrRightAxis__custom--OfferingWarrantsFebruaryTwoThousandTwentyThreeMember_zyuTxZWwWzek" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Offering Warrants &#8211; February 2023</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="STSS:WarrantLiabilitiesCurrent" contextRef="AsOf2024-09-30_custom_OfferingWarrantsFebruaryTwoThousandTwentyThreeMember" id="Fact002736" format="ixt:numdotdecimal" decimals="0" unitRef="USD">20,053</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="STSS:WarrantLiabilitiesCurrent" contextRef="AsOf2023-12-31_custom_OfferingWarrantsFebruaryTwoThousandTwentyThreeMember" id="Fact002737" format="ixt:numdotdecimal" decimals="0" unitRef="USD">234,072</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr id="xdx_40B_ecustom--WarrantLiabilitiesCurrent_iI_hus-gaap--ClassOfWarrantOrRightAxis__custom--OfferingWarrantsSeptemberTwoThousandTwentyThreeMember_zZmHblQLt2bk" style="vertical-align: bottom; background-color: White">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Offering Warrants &#8211; September 2023</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="STSS:WarrantLiabilitiesCurrent" contextRef="AsOf2024-09-30_custom_OfferingWarrantsSeptemberTwoThousandTwentyThreeMember" id="Fact002739" format="ixt:numdotdecimal" decimals="0" unitRef="USD">216,911</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="STSS:WarrantLiabilitiesCurrent" contextRef="AsOf2023-12-31_custom_OfferingWarrantsSeptemberTwoThousandTwentyThreeMember" id="Fact002740" format="ixt:numdotdecimal" decimals="0" unitRef="USD">1,036,875</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr id="xdx_406_ecustom--WarrantLiabilitiesCurrent_iI_hus-gaap--ClassOfWarrantOrRightAxis__custom--InducementWarrantsMember_zzJAq6GcMpNd" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Inducement Warrants &#8211;
    May 2024</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="STSS:WarrantLiabilitiesCurrent" contextRef="AsOf2024-09-30_custom_InducementWarrantsMember" id="Fact002742" format="ixt:numdotdecimal" decimals="0" unitRef="USD">347,123</ix:nonFraction></span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl2743">-</span></span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr id="xdx_405_ecustom--WarrantLiabilitiesCurrent_iI_z8j6MBigIaFc" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Total
    Warrant Liability</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="STSS:WarrantLiabilitiesCurrent" contextRef="AsOf2024-09-30" id="Fact002745" format="ixt:numdotdecimal" decimals="0" unitRef="USD">1,027,102</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="STSS:WarrantLiabilitiesCurrent" contextRef="AsOf2023-12-31" id="Fact002746" format="ixt:numdotdecimal" decimals="0" unitRef="USD">2,422,785</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  </table>

</ix:nonNumeric><p id="xdx_8A5_zW9r07ak8D15" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<ix:nonNumeric contextRef="From2024-01-01to2024-09-30" escape="true" id="Fact002748" name="us-gaap:ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock"><p id="xdx_89E_eus-gaap--ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock_z7SUQBFelWU5" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Warrants outstanding at September 30, 2024 and December 31, 2023 were as follows:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span id="xdx_8BC_zh2iBmbU72ca" style="display: none">Schedule
of Warrant Outstanding</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" id="xdx_497_20240930_zmV3G9cnyhw9" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">September
    30, 2024</span></td><td style="padding-bottom: 1pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" id="xdx_49A_20231231_zDJP6QVAQr4h" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">December
    31,2023</span></td><td style="padding-bottom: 1pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr id="xdx_403_eus-gaap--ClassOfWarrantOrRightOutstanding_iI_hus-gaap--ClassOfWarrantOrRightAxis__custom--TradingAndOverallotmentWarrantsMember_zDhWk4Mq0iF6" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 60%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Trading,
    Overallotment and Underwriter Warrants</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="width: 16%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="us-gaap:ClassOfWarrantOrRightOutstanding" contextRef="AsOf2024-09-30_custom_TradingAndOverallotmentWarrantsMember" id="Fact002750" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">400,568</ix:nonFraction></span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="width: 16%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="us-gaap:ClassOfWarrantOrRightOutstanding" contextRef="AsOf2023-12-31_custom_TradingAndOverallotmentWarrantsMember10886187" id="Fact002751" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">400,568</ix:nonFraction></span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr id="xdx_402_eus-gaap--ClassOfWarrantOrRightOutstanding_iI_hus-gaap--ClassOfWarrantOrRightAxis__custom--NoteWarrantsMember_zBW58NrZrqm7" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Note Warrants</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="us-gaap:ClassOfWarrantOrRightOutstanding" contextRef="AsOf2024-09-30_custom_NoteWarrantsMember" id="Fact002753" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">10,695</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="us-gaap:ClassOfWarrantOrRightOutstanding" contextRef="AsOf2023-12-31_custom_NoteWarrantsMember10886187" id="Fact002754" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">10,695</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr id="xdx_40D_eus-gaap--ClassOfWarrantOrRightOutstanding_iI_hus-gaap--ClassOfWarrantOrRightAxis__custom--OfferingWarrantsFebruaryTwoThousandTwentyThreeMember_zVWcQ3pZzA8h" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Offering Warrants &#8211; February 2023</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="us-gaap:ClassOfWarrantOrRightOutstanding" contextRef="AsOf2024-09-30_custom_OfferingWarrantsFebruaryTwoThousandTwentyThreeMember" id="Fact002756" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">8,607</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="us-gaap:ClassOfWarrantOrRightOutstanding" contextRef="AsOf2023-12-31_custom_OfferingWarrantsFebruaryTwoThousandTwentyThreeMember" id="Fact002757" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">102,206</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr id="xdx_40F_eus-gaap--ClassOfWarrantOrRightOutstanding_iI_hus-gaap--ClassOfWarrantOrRightAxis__custom--OfferingWarrantsSeptemberTwoThousandTwentyThreeMember_zmnAWBb2GdWl" style="vertical-align: bottom; background-color: White">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Offering Warrants &#8211; September 2023</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="us-gaap:ClassOfWarrantOrRightOutstanding" contextRef="AsOf2024-09-30_custom_OfferingWarrantsSeptemberTwoThousandTwentyThreeMember" id="Fact002759" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">95,078</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="us-gaap:ClassOfWarrantOrRightOutstanding" contextRef="AsOf2023-12-31_custom_OfferingWarrantsSeptemberTwoThousandTwentyThreeMember" id="Fact002760" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">397,727</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr id="xdx_407_eus-gaap--ClassOfWarrantOrRightOutstanding_iI_hus-gaap--ClassOfWarrantOrRightAxis__custom--InducementWarrantsMayTwoThousandTwentyFourMember_zInelbDTIvz3" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Inducement Warrants &#8211; May 2024</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="us-gaap:ClassOfWarrantOrRightOutstanding" contextRef="AsOf2024-09-30_custom_InducementWarrantsMayTwoThousandTwentyFourMember" id="Fact002762" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">260,799</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl2763">-</span></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr id="xdx_404_eus-gaap--ClassOfWarrantOrRightOutstanding_iI_hus-gaap--ClassOfWarrantOrRightAxis__custom--WarrantsIssuedForServiceManagementMember_zLy9ajQEohl9" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Warrants
    issued for services arrangement</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="us-gaap:ClassOfWarrantOrRightOutstanding" contextRef="AsOf2024-09-30_custom_WarrantsIssuedForServiceManagementMember" id="Fact002765" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">28,636</ix:nonFraction></span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="us-gaap:ClassOfWarrantOrRightOutstanding" contextRef="AsOf2023-12-31_custom_WarrantsIssuedForServiceManagementMember10886343" id="Fact002766" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">22,500</ix:nonFraction></span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr id="xdx_404_ecustom--ClassOfWarrantsOrRightOutstanding_iI_zJQn2lMJMPx5" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Total
    Warrants Outstanding</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="STSS:ClassOfWarrantsOrRightOutstanding" contextRef="AsOf2024-09-30" id="Fact002768" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">804,383</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="STSS:ClassOfWarrantsOrRightOutstanding" contextRef="AsOf2023-12-31" id="Fact002769" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">1,194,495</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  </table>


</ix:nonNumeric><p id="xdx_8A8_zLpliDi8Ivtj" style="margin-top: 0; margin-bottom: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<ix:exclude><!-- Field: Page; Sequence: 92; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 0pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->44<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%"><a href="#RM_014">Table of Contents</a></td></tr></table></div>
    <!-- Field: /Page --></ix:exclude>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>SHARPS
TECHNOLOGY, INC.</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTES
TO THE CONDENSED CONSOLIDATED FINANCIAL STATEMENTS</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>FOR
THE THREE AND NINE MONTHS ENDED SEPTEMBER 30, 2024 AND 2023</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Note
10. Warrant Liability (continued)</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">For
the three months ended September 30, 2024, the FMV gain adjustment, which is reflected in the FMV adjustment on Warrants in the
Unaudited Condensed Consolidated Statements of Operations was <span id="xdx_906_eus-gaap--GainLossOnSaleOfDerivatives_c20240701__20240930_zGKZZGPJ0BM4" title="Fair market value adjustment">$<ix:nonFraction name="us-gaap:GainLossOnSaleOfDerivatives" contextRef="From2024-07-012024-09-30" id="Fact002771" format="ixt:numdotdecimal" decimals="0" unitRef="USD">416,560</ix:nonFraction></span>,
which includes the modification charge of <span id="xdx_907_ecustom--FairValueAdjustmentOfModificationCharge_c20240701__20240930_z8snirj6Sojj" title="Fair value adjustment of modification charge">$<ix:nonFraction name="STSS:FairValueAdjustmentOfModificationCharge" contextRef="From2024-07-012024-09-30" id="Fact002773" format="ixt:numdotdecimal" decimals="0" unitRef="USD">155,703</ix:nonFraction></span>
and $<span id="xdx_90F_eus-gaap--GainLossOnSaleOfDerivatives_c20240701__20240930__us-gaap--TypeOfArrangementAxis__custom--InducementAgreementMember_zdNnhiiuwGXb" title="Fair market value adjustment"><ix:nonFraction name="us-gaap:GainLossOnSaleOfDerivatives" contextRef="From2024-07-012024-09-30_custom_InducementAgreementMember" id="Fact002775" format="ixt:numdotdecimal" decimals="0" unitRef="USD">349,243</ix:nonFraction></span>,
gain for the warrants exercised in connection with the Inducement Agreements (See Note 8).</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">For
the nine months September 30, 2024, the FMV gain adjustment, which is reflected in the FMV adjustment on Warrants in the Unaudited Condensed
Consolidated Statements of Operations was <span id="xdx_90C_eus-gaap--GainLossOnSaleOfDerivatives_c20240101__20240930_z9GNOe5MpELk" title="Fair market value adjustment">$<ix:nonFraction name="us-gaap:GainLossOnSaleOfDerivatives" contextRef="From2024-01-01to2024-09-30" id="Fact002777" format="ixt:numdotdecimal" decimals="0" unitRef="USD">2,088,747</ix:nonFraction></span>, which includes the modification charge of <span id="xdx_902_ecustom--FairValueAdjustmentOfModificationCharge_c20240101__20240930_zRb4XmdMl2t6" title="Fair value adjustment of modification charge">$<ix:nonFraction name="STSS:FairValueAdjustmentOfModificationCharge" contextRef="From2024-01-01to2024-09-30" id="Fact002779" format="ixt:numdotdecimal" decimals="0" unitRef="USD">790,956</ix:nonFraction></span> and $<span id="xdx_906_eus-gaap--GainLossOnSaleOfDerivatives_c20240101__20240930__us-gaap--TypeOfArrangementAxis__custom--InducementAgreementMember_zkwlzy3XJQjg" title="Fair market value adjustment"><ix:nonFraction name="us-gaap:GainLossOnSaleOfDerivatives" contextRef="From2024-01-012024-09-30_custom_InducementAgreementMember" id="Fact002781" format="ixt:numdotdecimal" decimals="0" unitRef="USD">349,243</ix:nonFraction></span>, gain for the warrants
exercised in connection with the Inducement Agreements (See Note 8).</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">For
the three and nine months ended September 30, 2023, the FMV gain adjustment, which is reflected in the FMV adjustment gain (loss) on
Warrants in the Unaudited Condensed Consolidated Statements of Operations was $<span id="xdx_904_ecustom--GainLossOnSaleOfDerivative_di_c20230701__20230930_zARPB5Jc9pte" title="Fair market value adjustment"><ix:nonFraction name="STSS:GainLossOnSaleOfDerivative" contextRef="From2023-07-012023-09-30" id="Fact002783" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">321,981</ix:nonFraction></span> and
$<span id="xdx_904_ecustom--GainLossOnSaleOfDerivative_c20230101__20230930_zcog8MoFnMp7" title="Fair market value adjustment"><ix:nonFraction name="STSS:GainLossOnSaleOfDerivative" contextRef="From2023-01-012023-09-30" id="Fact002785" format="ixt:numdotdecimal" decimals="0" unitRef="USD">415,958</ix:nonFraction></span>,
respectively (see Note 8).</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2024-01-01to2024-09-30" escape="true" id="Fact002787" name="us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock"><p id="xdx_804_eus-gaap--DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock_zDTxhaFgOcBd" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Note
11. <span id="xdx_822_zLQpmKrEd85f">Stock Options</span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<ix:nonNumeric contextRef="From2024-01-01to2024-09-30" escape="true" id="Fact002789" name="us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock"><p id="xdx_894_eus-gaap--ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock_zxVZC5fUQAHc" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">A
summary of options granted and outstanding is presented below.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span id="xdx_8BE_z8LJXVDUa9I7" style="display: none">Schedule
of Stock Options Granted and Outstanding</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="6" style="border-bottom: Black 1pt solid; text-align: center; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">September
    30, 2024</span></td><td style="padding-bottom: 1pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Options</span></td><td style="padding-bottom: 1pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Weighted<br/>
    Average<br/> Exercise Price</span></td><td style="padding-bottom: 1pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 60%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Outstanding at
    Beginning of year</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td id="xdx_980_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iS_c20240101__20240930_z5mTF4VY3CHf" title="Stock option, beginning balance" style="width: 16%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" contextRef="AsOf2023-12-31" id="Fact002791" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">109,493</ix:nonFraction></span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td id="xdx_985_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iS_c20240101__20240930_zmy9UZAtMVBe" title="Weighted average exercise price, beginning balance" style="width: 16%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" contextRef="AsOf2023-12-31" id="Fact002793" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">67.12</ix:nonFraction></span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Granted</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td id="xdx_98E_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_c20240101__20240930_zPZ4EPLTqSUg" title="Shares, options granted" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" contextRef="From2024-01-01to2024-09-30" id="Fact002795" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">63,409</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td id="xdx_981_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_c20240101__20240930_z1SpI7FuhVFh" title="Weighted average exercise price, options granted" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" contextRef="From2024-01-01to2024-09-30" id="Fact002797" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">6.27</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Forfeited
    or cancelled</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td id="xdx_98D_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_iN_di_c20240101__20240930_zkXYANERjSc1" title="Shares, options forfeited" style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(<ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" contextRef="From2024-01-01to2024-09-30" id="Fact002799" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">18,592</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; text-align: left">)<span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td id="xdx_985_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice_c20240101__20240930_zdZHHWPmlmme" title="Weighted average exercise price, forfeited or cancelled" style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice" contextRef="From2024-01-01to2024-09-30" id="Fact002801" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">37.11</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Outstanding at end of
    period</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td id="xdx_988_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iE_c20240101__20240930_zYq0CLHwEJqe" title="Stock option, ending balance" style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" contextRef="AsOf2024-09-30" id="Fact002803" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">154,310</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_98B_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iE_c20240101__20240930_zKUWeRQybKq" title="Weighted average exercise price, ending balance" style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" contextRef="AsOf2024-09-30" id="Fact002805" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">42.88</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Exercisable at end of
    period</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td id="xdx_981_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_iE_c20240101__20240930_zpmMa4vDkomg" title="Stock option, exercisable ending balance" style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" contextRef="AsOf2024-09-30" id="Fact002807" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">122,243</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td id="xdx_98F_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_iE_c20240101__20240930_zpXujWLzQCOg" title="Weighted average exercise price, exercisable ending balance" style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" contextRef="AsOf2024-09-30" id="Fact002809" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">50.86</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  </table>

</ix:nonNumeric><p id="xdx_8A9_zBQec5uyUU1a" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">At
September 30, 2024, the Weighted Average Remaining Contractual Life is <span id="xdx_909_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_dt_c20240101__20240930_zD8h54r5Bfel" title="Weighted average remaining contractual life"><ix:nonNumeric contextRef="From2024-01-01to2024-09-30" format="ixt-sec:durwordsen" id="Fact002811" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2">39 months</ix:nonNumeric></span>.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">At
September 30, 2024, the stock options outstanding and the options exercisable have exercise prices that exceed the stock market price
at September 30, 2024 and as such no intrinsic value exists. Intrinsic value is defined as the difference between the exercise price
of the options and the market price of the Company&#8217;s common stock.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">During
the nine months ended September 30, 2024, the Company granted <span id="xdx_906_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantedInYear_dxL_c20240101__20240930_znTD0U8gTOpf" title="Granted options::XDX::P5Y"><span style="-sec-ix-hidden: xdx2ixbrl2813">five</span></span>-year options (the &#8220;Options&#8221;) to purchase a total of <span id="xdx_906_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_c20240101__20240930_zrnuXv6fdOQk" title="Granted shares"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" contextRef="From2024-01-01to2024-09-30" id="Fact002815" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">63,409</ix:nonFraction></span>
shares of the Company&#8217;s common stock, par value $<span id="xdx_906_eus-gaap--CommonStockParOrStatedValuePerShare_iI_c20240930_zQBxIXBncTX6" title="Common stock par value"><ix:nonFraction name="us-gaap:CommonStockParOrStatedValuePerShare" contextRef="AsOf2024-09-30" id="Fact002817" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">0.0001</ix:nonFraction></span> per share (the &#8220;Common Stock&#8221;) to its directors, executive
officers, employees and consultants pursuant to the Company&#8217;s 2023 Equity Incentive Plan. The Options are exercisable at an average
price of $<span id="xdx_90C_ecustom--ShareBasedCompensationOptionsExercisableWeightedAverageExercisePrice_iI_c20240930_zALWz1z2w3w8" title="Options exercisable"><ix:nonFraction name="STSS:ShareBasedCompensationOptionsExercisableWeightedAverageExercisePrice" contextRef="AsOf2024-09-30" id="Fact002819" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">6.27</ix:nonFraction></span> per share which was based on the closing price on the respective grant dates.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
of September 30, 2024, there was $<span id="xdx_901_eus-gaap--EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized_iI_c20240930_z2Qlgko1xeH3" title="Unrecognized stock-based compensation"><ix:nonFraction name="us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized" contextRef="AsOf2024-09-30" id="Fact002821" format="ixt:numdotdecimal" decimals="0" unitRef="USD">232,353</ix:nonFraction></span> of unrecognized stock-based compensation related to unvested stock options with a weighted average
fair value of $<span id="xdx_907_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue_iI_c20240930_zyI4ScBVBSBl" title="Unvested stock options weighted average fair value"><ix:nonFraction name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue" contextRef="AsOf2024-09-30" id="Fact002823" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">7.25</ix:nonFraction></span> per share, which is expected to be recognized over a weighted-average period of <span id="xdx_908_eus-gaap--EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_dt_c20240101__20240930_zzgJE3cNyuO2" title="Recognized over a weighted-average period"><ix:nonNumeric contextRef="From2024-01-01to2024-09-30" format="ixt-sec:durwordsen" id="Fact002825" name="us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1">12 months</ix:nonNumeric></span> as of September 30, 2024.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">For
the three and nine months ended September 30, 2024, the Company recognized stock-based compensation expense of $<span id="xdx_908_eus-gaap--AllocatedShareBasedCompensationExpense_c20240701__20240930_zTEAlE8Q4g5h" title="Stock-based compensation expense"><ix:nonFraction name="us-gaap:AllocatedShareBasedCompensationExpense" contextRef="From2024-07-012024-09-30" id="Fact002827" format="ixt:numdotdecimal" decimals="0" unitRef="USD">116,193</ix:nonFraction></span>
recorded in general and administrative and $<span id="xdx_90A_eus-gaap--AllocatedShareBasedCompensationExpense_c20240101__20240930_zOGfoVekGin5" title="Stock-based compensation expense"><ix:nonFraction name="us-gaap:AllocatedShareBasedCompensationExpense" contextRef="From2024-01-01to2024-09-30" id="Fact002829" format="ixt:numdotdecimal" decimals="0" unitRef="USD">435,908</ix:nonFraction></span>,
respectively, of which $<span id="xdx_90C_eus-gaap--AllocatedShareBasedCompensationExpense_c20240101__20240930__us-gaap--IncomeStatementLocationAxis__us-gaap--GeneralAndAdministrativeExpenseMember_zg7i2NaY8Smd" title="Stock-based compensation expense"><ix:nonFraction name="us-gaap:AllocatedShareBasedCompensationExpense" contextRef="From2024-01-012024-09-30_us-gaap_GeneralAndAdministrativeExpenseMember" id="Fact002831" format="ixt:numdotdecimal" decimals="0" unitRef="USD">432,567</ix:nonFraction></span>
and $<span id="xdx_909_eus-gaap--AllocatedShareBasedCompensationExpense_c20240101__20240930__us-gaap--IncomeStatementLocationAxis__us-gaap--ResearchAndDevelopmentExpenseMember_zBC01nnw40Yl" title="Stock-based compensation expense"><ix:nonFraction name="us-gaap:AllocatedShareBasedCompensationExpense" contextRef="From2024-01-012024-09-30_us-gaap_ResearchAndDevelopmentExpenseMember" id="Fact002833" format="ixt:numdotdecimal" decimals="0" unitRef="USD">3,341</ix:nonFraction></span>
was recorded in general and administrative and research and development expenses.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">For
the three and nine months ended September 30, 2023, the Company recognized stock-based compensation expense of $<span id="xdx_90C_eus-gaap--AllocatedShareBasedCompensationExpense_c20230701__20230930__us-gaap--IncomeStatementLocationAxis__us-gaap--GeneralAndAdministrativeExpenseMember_zJHfhaghib72" title="Share based compensation"><ix:nonFraction name="us-gaap:AllocatedShareBasedCompensationExpense" contextRef="From2023-07-012023-09-30_us-gaap_GeneralAndAdministrativeExpenseMember" id="Fact002835" format="ixt:numdotdecimal" decimals="0" unitRef="USD">178,895</ix:nonFraction></span>&#160;and $<span id="xdx_906_eus-gaap--AllocatedShareBasedCompensationExpense_c20230101__20230930__us-gaap--IncomeStatementLocationAxis__us-gaap--GeneralAndAdministrativeExpenseMember_z8Kdbhz4lupa" title="Share based compensation"><ix:nonFraction name="us-gaap:AllocatedShareBasedCompensationExpense" contextRef="From2023-01-012023-09-30_us-gaap_GeneralAndAdministrativeExpenseMember" id="Fact002837" format="ixt:numdotdecimal" decimals="0" unitRef="USD">796,606</ix:nonFraction></span>, respectively,
which was recorded in general and administrative.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<ix:exclude><!-- Field: Page; Sequence: 93; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 0pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->45<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%"><a href="#RM_014">Table of Contents</a></td></tr></table></div>
    <!-- Field: /Page --></ix:exclude>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>SHARPS
TECHNOLOGY, INC.</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTES
TO THE CONDENSED CONSOLIDATED FINANCIAL STATEMENTS</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>FOR
THE THREE AND NINE MONTHS ENDED SEPTEMBER 30, 2024 AND 2023</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Note
11. Stock Options (continued)</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<ix:nonNumeric contextRef="From2024-01-01to2024-09-30" escape="true" id="Fact002839" name="us-gaap:FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock"><p id="xdx_89E_eus-gaap--FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock_znTUjMvgAGr4" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
fair value of stock option awards accounted for under ASC 718 was estimated at the date of grant using a Black-Scholes option-pricing
model with the following assumptions for the options granted during the nine months ended September 30, 2024 and 2023.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span id="xdx_8B1_zemRJhENtd4g" style="display: none">Schedule of Fair Value of Stock Option Awards</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">September
    30, 2024</span></td><td style="padding-bottom: 1pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">September
    30, 2023</span></td><td style="padding-bottom: 1pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Expected term (years)</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_909_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_dtY_c20240101__20240930__srt--RangeAxis__srt--MinimumMember_zpofHFkTvUsf" title="Expected term (years)"><ix:nonNumeric contextRef="From2024-01-012024-09-30_srt_MinimumMember" format="ixt-sec:duryear" id="Fact002841" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1">2.66</ix:nonNumeric></span>
                                            to <span id="xdx_90A_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_dtY_c20240101__20240930__srt--RangeAxis__srt--MaximumMember_zolyGV3PtPZ5" title="Expected term (years)"><ix:nonNumeric contextRef="From2024-01-012024-09-30_srt_MaximumMember" format="ixt-sec:duryear" id="Fact002843" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1">3.06</ix:nonNumeric></span></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_903_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_dtY_c20230101__20230930__srt--RangeAxis__srt--MinimumMember_zN1micCDOphd" title="Expected term (years)"><ix:nonNumeric contextRef="From2023-01-012023-09-30_srt_MinimumMember" format="ixt-sec:duryear" id="Fact002845" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1">2.88</ix:nonNumeric></span>
                                            to <span id="xdx_900_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_dtY_c20230101__20230930__srt--RangeAxis__srt--MaximumMember_zcXeelFA7zeh" title="Expected term (years)"><ix:nonNumeric contextRef="From2023-01-012023-09-30_srt_MaximumMember" format="ixt-sec:duryear" id="Fact002847" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1">3.25</ix:nonNumeric></span></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Expected volatility</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_901_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate_dp_c20240101__20240930__srt--RangeAxis__srt--MinimumMember_zOQH52I5tpA9" title="Expected volatility"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate" contextRef="From2024-01-012024-09-30_srt_MinimumMember" id="Fact002849" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">81.15</ix:nonFraction></span>
                                            % to <span id="xdx_908_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate_dp_c20240101__20240930__srt--RangeAxis__srt--MaximumMember_zQHMcjPuGP3k" title="Expected volatility"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate" contextRef="From2024-01-012024-09-30_srt_MaximumMember" id="Fact002851" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">83.04</ix:nonFraction></span></span></td><td style="text-align: left">%<span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90B_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate_dp_c20230101__20230930__srt--RangeAxis__srt--MinimumMember_zfVirIaCcnNe" title="Expected volatility"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate" contextRef="From2023-01-012023-09-30_srt_MinimumMember" id="Fact002853" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">75.40</ix:nonFraction></span>%
                                            to <span id="xdx_909_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate_dp_c20230101__20230930__srt--RangeAxis__srt--MaximumMember_zolNsqKQktLc" title="Expected volatility"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate" contextRef="From2023-01-012023-09-30_srt_MaximumMember" id="Fact002855" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">89.93</ix:nonFraction></span></span></td><td style="text-align: left">%</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Risk-free interest rate</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_905_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_dp_c20240101__20240930__srt--RangeAxis__srt--MinimumMember_zsKXsFrWFgcl" title="Risk-free interest rate"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" contextRef="From2024-01-012024-09-30_srt_MinimumMember" id="Fact002857" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">4.71</ix:nonFraction></span>
                                            % to <span id="xdx_909_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_dp_c20240101__20240930__srt--RangeAxis__srt--MaximumMember_zEKLmLjcwsM4" title="Risk-free interest rate"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" contextRef="From2024-01-012024-09-30_srt_MaximumMember" id="Fact002859" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">4.76</ix:nonFraction></span></span></td><td style="text-align: left">%</td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_906_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_dp_c20230101__20230930__srt--RangeAxis__srt--MinimumMember_zhWFSgQx7L9g" title="Risk-free interest rate"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" contextRef="From2023-01-012023-09-30_srt_MinimumMember" id="Fact002861" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">3.71</ix:nonFraction></span>%
                                            to <span id="xdx_901_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_dp_c20230101__20230930__srt--RangeAxis__srt--MaximumMember_z5EFMmOaBfw8" title="Risk-free interest rate"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" contextRef="From2023-01-012023-09-30_srt_MaximumMember" id="Fact002863" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">4.27</ix:nonFraction></span></span></td><td style="text-align: left">%</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="width: 60%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Dividend rate</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="width: 16%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_906_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_dp_c20240101__20240930_zVwLNuNFqGv3" title="Dividend rate"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" contextRef="From2024-01-01to2024-09-30" id="Fact002865" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">0</ix:nonFraction></span></span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="width: 16%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_900_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_dp_c20230101__20230930_z6U4iGoN0Img" title="Dividend rate"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" contextRef="From2023-01-012023-09-30" id="Fact002867" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">0</ix:nonFraction></span></span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  </table>

</ix:nonNumeric><p id="xdx_8A2_zIKGmvNwZmhg" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2024-01-01to2024-09-30" escape="true" id="Fact002869" name="us-gaap:IncomeTaxDisclosureTextBlock"><p id="xdx_807_eus-gaap--IncomeTaxDisclosureTextBlock_zEs63vWWdPij" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Note
12. <span id="xdx_822_z5UBynET54th">Income Taxes</span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">At
the end of each interim reporting period, the Company estimates its effective tax rate expected to be applied for the full year.
This estimate is used to determine the income tax provision or benefit on a year-to-date basis and may change in subsequent interim
periods. Accordingly, the Company&#8217;s effective tax rate for the three and nine months ended September 30, 2024 and 2023 was <span id="xdx_906_eus-gaap--EffectiveIncomeTaxRateContinuingOperations_pid_dp_uPure_c20240701__20240930_zwvBQPUBlID2" title="Effective income tax rate percentage"><span id="xdx_90F_eus-gaap--EffectiveIncomeTaxRateContinuingOperations_pid_dp_uPure_c20240101__20240930_zwKuM2YB5qw1" title="Effective income tax rate percentage"><span id="xdx_90D_eus-gaap--EffectiveIncomeTaxRateContinuingOperations_pid_dp_uPure_c20230701__20230930_zPaj9o1cudx6" title="Effective income tax rate percentage"><span id="xdx_906_eus-gaap--EffectiveIncomeTaxRateContinuingOperations_pid_dp_uPure_c20230101__20230930_ztTCtrlJGXb7" title="Effective income tax rate percentage"><ix:nonFraction name="us-gaap:EffectiveIncomeTaxRateContinuingOperations" contextRef="From2024-07-012024-09-30" id="Fact002871" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure"><ix:nonFraction name="us-gaap:EffectiveIncomeTaxRateContinuingOperations" contextRef="From2024-01-01to2024-09-30" id="Fact002873" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure"><ix:nonFraction name="us-gaap:EffectiveIncomeTaxRateContinuingOperations" contextRef="From2023-07-012023-09-30" id="Fact002875" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure"><ix:nonFraction name="us-gaap:EffectiveIncomeTaxRateContinuingOperations" contextRef="From2023-01-012023-09-30" id="Fact002877" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">0</ix:nonFraction></ix:nonFraction></ix:nonFraction></ix:nonFraction></span></span></span></span>%.
The Company&#8217;s effective tax rates for both periods were affected primarily by a full valuation allowance on domestic net
deferred tax assets.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2024-01-01to2024-09-30" escape="true" id="Fact002879" name="us-gaap:RelatedPartyTransactionsDisclosureTextBlock"><p id="xdx_801_eus-gaap--RelatedPartyTransactionsDisclosureTextBlock_zlDv3gqVW3Cf" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Note
13. <span id="xdx_828_z36brOFxaPv9">Related Party Transactions and Balances</span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
of September 30, 2024 and December 31, 2023, accounts payable and accrued liabilities include $<span id="xdx_906_eus-gaap--AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent_iI_c20240930__srt--TitleOfIndividualAxis__custom--OfficersAndDirectorsMember_zg1bljdLBEpl" title="Accounts payable and accrued liabilities"><ix:nonFraction name="us-gaap:AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent" contextRef="AsOf2024-09-30_custom_OfficersAndDirectorsMember" id="Fact002881" format="ixt:numdotdecimal" decimals="0" unitRef="USD">152,500</ix:nonFraction></span> and $<span id="xdx_90F_eus-gaap--AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent_iI_c20231231__srt--TitleOfIndividualAxis__custom--OfficersAndDirectorsMember_zZnqLQuXkJHj" title="Accounts payable and accrued liabilities"><ix:nonFraction name="us-gaap:AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent" contextRef="AsOf2023-12-31_custom_OfficersAndDirectorsMember" id="Fact002883" format="ixt:numdotdecimal" decimals="0" unitRef="USD">32,974</ix:nonFraction></span>, respectively, payable
to officers and directors of the Company. The amounts are unsecured, non-interest bearing and are due on demand.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2024-01-01to2024-09-30" escape="true" id="Fact002885" name="us-gaap:FairValueMeasurementInputsDisclosureTextBlock"><p id="xdx_804_eus-gaap--FairValueMeasurementInputsDisclosureTextBlock_zrhCtJBoyF49" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Note
14. <span id="xdx_82E_zbuVPIlaYyd2">Fair Value Measurements</span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company&#8217;s financial instruments include cash, accounts payable, and warrant liability. Cash and warrant liability are measured
at fair value. Accounts payable is measured at amortized cost and approximates fair value due to its short duration.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<ix:nonNumeric contextRef="From2024-01-01to2024-09-30" escape="true" id="Fact002887" name="us-gaap:ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock"><p id="xdx_891_eus-gaap--ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock_zgaDCWQ8I281" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
of September&#160;30, 2024, the following financial assets and liabilities were measured at fair value on a recurring basis presented
on the Company&#8217;s condensed consolidated balance sheet:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span id="xdx_8BE_zzMRLNSAvI67" style="display: none">Schedule
of Assets and Liabilities Measured at Fair Value on Recurring Basis</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="display: none; vertical-align: bottom">
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" id="xdx_491_20240930__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member_z4KlOwEwXPZ2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Level
    1</span></td><td style="padding-bottom: 1pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" id="xdx_498_20240930__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member_z9m0JLmigtyh" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Level
    2</span></td><td style="padding-bottom: 1pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" id="xdx_49C_20240930__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member_zt9UPPoQnhf5" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Level
    3</span></td><td style="padding-bottom: 1pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" id="xdx_49C_20240930_z3HypJTQJmD9" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Total</span></td><td style="padding-bottom: 1pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
<tr style="vertical-align: bottom">
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="10" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Fair
    Value Measurements Using</span></td><td style="padding-bottom: 1pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Level
    1</span></td><td style="padding-bottom: 1pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Level
    2</span></td><td style="padding-bottom: 1pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Level
    3</span></td><td style="padding-bottom: 1pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Total</span></td><td style="padding-bottom: 1pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr id="xdx_400_eus-gaap--AssetsFairValueDisclosureAbstract_iB_zOAtVFrjKIAd" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Assets</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr id="xdx_405_eus-gaap--CashAndCashEquivalentsFairValueDisclosure_i01I_zChzjFxr6dm4" style="vertical-align: bottom; background-color: White">
    <td style="width: 44%; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Cash</span></td><td style="width: 2%; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="border-bottom: Black 1pt solid; width: 10%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="us-gaap:CashAndCashEquivalentsFairValueDisclosure" contextRef="AsOf2024-09-30_us-gaap_FairValueInputsLevel1Member" id="Fact002894" format="ixt:numdotdecimal" decimals="0" unitRef="USD">2,473,197</ix:nonFraction></span></td><td style="width: 1%; padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="width: 2%; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1pt solid; width: 10%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl2895">-</span></span></td><td style="width: 1%; padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="width: 2%; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1pt solid; width: 10%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl2896">-</span></span></td><td style="width: 1%; padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="width: 2%; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="border-bottom: Black 1pt solid; width: 10%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="us-gaap:CashAndCashEquivalentsFairValueDisclosure" contextRef="AsOf2024-09-30" id="Fact002897" format="ixt:numdotdecimal" decimals="0" unitRef="USD">2,473,197</ix:nonFraction></span></td><td style="width: 1%; padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr id="xdx_400_eus-gaap--AssetsFairValueDisclosure_iI_zf08RA74ZrVj" style="vertical-align: bottom; background-color: White">
    <td style="font-weight: bold; text-align: left; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Total
    assets measured at fair value</span></td><td style="font-weight: bold; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="us-gaap:AssetsFairValueDisclosure" contextRef="AsOf2024-09-30_us-gaap_FairValueInputsLevel1Member" id="Fact002899" format="ixt:numdotdecimal" decimals="0" unitRef="USD">2,473,197</ix:nonFraction></span></td><td style="padding-bottom: 1pt; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl2900">-</span></span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl2901">-</span></span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="us-gaap:AssetsFairValueDisclosure" contextRef="AsOf2024-09-30" id="Fact002902" format="ixt:numdotdecimal" decimals="0" unitRef="USD">2,473,197</ix:nonFraction></span></td><td style="padding-bottom: 1pt; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr id="xdx_402_eus-gaap--LiabilitiesFairValueDisclosureAbstract_iB_z1BkUetQEGba" style="vertical-align: bottom; background-color: White">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Liabilities</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr id="xdx_40E_eus-gaap--DerivativeLiabilities_i01I_zur1GJNBTzJb" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Warrant
    liability</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl2909">-</span></span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="us-gaap:DerivativeLiabilities" contextRef="AsOf2024-09-30_us-gaap_FairValueInputsLevel2Member" id="Fact002910" format="ixt:numdotdecimal" decimals="0" unitRef="USD">1,027,102</ix:nonFraction></span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl2911">-</span></span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="us-gaap:DerivativeLiabilities" contextRef="AsOf2024-09-30" id="Fact002912" format="ixt:numdotdecimal" decimals="0" unitRef="USD">1,027,102</ix:nonFraction></span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr id="xdx_405_eus-gaap--LiabilitiesFairValueDisclosure_i01I_zpUbWyljHVFk" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; text-align: left; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Total
    liabilities measured at fair value</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl2914">-</span></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="us-gaap:LiabilitiesFairValueDisclosure" contextRef="AsOf2024-09-30_us-gaap_FairValueInputsLevel2Member" id="Fact002915" format="ixt:numdotdecimal" decimals="0" unitRef="USD">1,027,102</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl2916">-</span></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="us-gaap:LiabilitiesFairValueDisclosure" contextRef="AsOf2024-09-30" id="Fact002917" format="ixt:numdotdecimal" decimals="0" unitRef="USD">1,027,102</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<ix:exclude><!-- Field: Page; Sequence: 94; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 0pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->46<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%"><a href="#RM_014">Table of Contents</a></td></tr></table></div>
    <!-- Field: /Page --></ix:exclude>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>SHARPS
TECHNOLOGY, INC.</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTES
TO THE CONDENSED CONSOLIDATED FINANCIAL STATEMENTS</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>FOR
THE THREE AND NINE MONTHS ENDED SEPTEMBER 30, 2024 AND 2023</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Note
14. Fair Value Measurements (continued)</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
of December 31, 2023, the following financial assets and liabilities were measured at fair value on a recurring basis presented on the
Company&#8217;s condensed consolidated balance sheet:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="display: none; vertical-align: bottom">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" id="xdx_496_20231231__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member_zIREGOpf8Hlk" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Level
    1</span></td><td style="padding-bottom: 1pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" id="xdx_49D_20231231__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member_zWeKG60u2CX2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Level
    2</span></td><td style="padding-bottom: 1pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" id="xdx_490_20231231__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member_zOAKMQuqd3G9" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Level
    3</span></td><td style="padding-bottom: 1pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" id="xdx_492_20231231_zDjoJdq81KQa" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Total</span></td><td style="padding-bottom: 1pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
<tr style="vertical-align: bottom">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="10" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Fair
    Value Measurements Using</span></td><td style="padding-bottom: 1pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Level
    1</span></td><td style="padding-bottom: 1pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Level
    2</span></td><td style="padding-bottom: 1pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Level
    3</span></td><td style="padding-bottom: 1pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Total</span></td><td style="padding-bottom: 1pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr id="xdx_404_eus-gaap--AssetsFairValueDisclosureAbstract_iB_zg3N3Dbmx0e2" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Assets</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr id="xdx_40B_eus-gaap--CashAndCashEquivalentsFairValueDisclosure_i01I_zbXBfNEtPmek" style="vertical-align: bottom; background-color: White">
    <td style="width: 44%; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Cash</span></td><td style="width: 2%; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="border-bottom: Black 1pt solid; width: 10%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="us-gaap:CashAndCashEquivalentsFairValueDisclosure" contextRef="AsOf2023-12-31_us-gaap_FairValueInputsLevel1Member" id="Fact002924" format="ixt:numdotdecimal" decimals="0" unitRef="USD">3,012,908</ix:nonFraction></span></td><td style="width: 1%; padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="width: 2%; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1pt solid; width: 10%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl2925">-</span></span></td><td style="width: 1%; padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="width: 2%; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1pt solid; width: 10%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl2926">-</span></span></td><td style="width: 1%; padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="width: 2%; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="border-bottom: Black 1pt solid; width: 10%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="us-gaap:CashAndCashEquivalentsFairValueDisclosure" contextRef="AsOf2023-12-31" id="Fact002927" format="ixt:numdotdecimal" decimals="0" unitRef="USD">3,012,908</ix:nonFraction></span></td><td style="width: 1%; padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr id="xdx_401_eus-gaap--AssetsFairValueDisclosure_iI_zw5BgyAgINO4" style="vertical-align: bottom; background-color: White">
    <td style="font-weight: bold; text-align: left; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Total
    assets measured at fair value</span></td><td style="font-weight: bold; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="us-gaap:AssetsFairValueDisclosure" contextRef="AsOf2023-12-31_us-gaap_FairValueInputsLevel1Member" id="Fact002929" format="ixt:numdotdecimal" decimals="0" unitRef="USD">3,012,908</ix:nonFraction></span></td><td style="padding-bottom: 1pt; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl2930">-</span></span></td><td style="padding-bottom: 1pt; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl2931">-</span></span></td><td style="padding-bottom: 1pt; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="us-gaap:AssetsFairValueDisclosure" contextRef="AsOf2023-12-31" id="Fact002932" format="ixt:numdotdecimal" decimals="0" unitRef="USD">3,012,908</ix:nonFraction></span></td><td style="padding-bottom: 1pt; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr id="xdx_40B_eus-gaap--LiabilitiesFairValueDisclosureAbstract_iB_zcWq2LrVT5vl" style="vertical-align: bottom; background-color: White">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Liabilities</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr id="xdx_40C_eus-gaap--DerivativeLiabilities_i01I_zPAr3DrFRLgg" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Warrant
    liability</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl2939">-</span></span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="us-gaap:DerivativeLiabilities" contextRef="AsOf2023-12-31_us-gaap_FairValueInputsLevel2Member" id="Fact002940" format="ixt:numdotdecimal" decimals="0" unitRef="USD">2,422,785</ix:nonFraction></span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl2941">&#8212;</span></span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="us-gaap:DerivativeLiabilities" contextRef="AsOf2023-12-31" id="Fact002942" format="ixt:numdotdecimal" decimals="0" unitRef="USD">2,422,785</ix:nonFraction></span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr id="xdx_405_eus-gaap--LiabilitiesFairValueDisclosure_iI_zp7vHk1W6RZ1" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; text-align: left; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Total
    liabilities measured at fair value</span></td><td style="font-weight: bold; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl2944">-</span></span></td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="us-gaap:LiabilitiesFairValueDisclosure" contextRef="AsOf2023-12-31_us-gaap_FairValueInputsLevel2Member" id="Fact002945" format="ixt:numdotdecimal" decimals="0" unitRef="USD">2,422,785</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl2946">-</span></span></td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="us-gaap:LiabilitiesFairValueDisclosure" contextRef="AsOf2023-12-31" id="Fact002947" format="ixt:numdotdecimal" decimals="0" unitRef="USD">2,422,785</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  </table>

</ix:nonNumeric><p id="xdx_8A2_zB8rdJcf3uw" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2024-01-01to2024-09-30" escape="true" id="Fact002949" name="us-gaap:CommitmentsAndContingenciesDisclosureTextBlock"><p id="xdx_804_eus-gaap--CommitmentsAndContingenciesDisclosureTextBlock_z3exny20ML15" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Note
15. <span id="xdx_82D_zipBBRJp1aE1">Commitments and Contingencies</span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>&#160;</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Contingencies</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
July 10, 2024, Barry Berler (&#8220;Berler&#8221;), a co-founder and former Chief Technology Officer of the Company, commenced a lawsuit
in the United States District Court for the Eastern District of New York, Barry Berler v. Sharps Technology, Inc. and Alan Blackman,
Case No. 2:24-cv-04787. In this case, Berler asserts claims for damages of an aggregate of $<span id="xdx_901_eus-gaap--LossContingencyDamagesSoughtValue_c20240710__20240710__srt--LitigationCaseAxis__custom--BerlerMember_zT5oHq9wVxdc" title="Loss contingency, claims for damages"><ix:nonFraction name="us-gaap:LossContingencyDamagesSoughtValue" contextRef="From2024-07-102024-07-10_custom_BerlerMember" id="Fact002951" format="ixt:numdotdecimal" decimals="0" unitRef="USD">456,000</ix:nonFraction></span> for alleged<span id="xdx_906_eus-gaap--LossContingencyDamagesSought_c20240710__20240710__srt--LitigationCaseAxis__custom--BerlerMember_za1JIGiE0tUe" title="Description of loss contingency"> <ix:nonNumeric contextRef="From2024-07-102024-07-10_custom_BerlerMember" id="Fact002953" name="us-gaap:LossContingencyDamagesSought">(1) failure to make full
payment of certain monthly payments under his consulting agreement with the Company (the &#8220;Consulting Agreement&#8221;) in the amount
of $52,500, (2) failure to pay a bonus with a target of $216,000 under the Consulting Agreement, (3) $187,500, representing 50% of the
severance payment paid by the Company to Mr. Blackman, the Company&#8217;s co-founder and former Chief Operating Officer and Co-Chairman
and a declaration and injunctive relief establishing that Berler is the rightful owner of 50% of the Company&#8217;s Series A Preferred
Stock (which preferred stock is no longer outstanding).</ix:nonNumeric></span> The Company has accrued for the claim for unpaid monthly consulting fees. The
Company believes that Berler&#8217;s claims are without merit, intends to defend itself vigorously and has requested dismissal of these
claims. In addition, on September 17, 2024, the Company filed an answer and counterclaims with respect thereto, including for recoupment
of certain compensation the Company has previously paid to Berler.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
June l7, 2024, Berler filed a demand for arbitration and statement of claim under the commercial arbitration rules of the American Arbitration
Association (&#8220;AAA&#8221;) asserting claims for payment of $<span id="xdx_908_eus-gaap--LossContingencyDamagesSoughtValue_c20240617__20240617__srt--LitigationCaseAxis__custom--BerlerMember_zHBek6ghPJVh" title="Loss contingency, claims for damages"><ix:nonFraction name="us-gaap:LossContingencyDamagesSoughtValue" contextRef="From2024-06-172024-06-17_custom_BerlerMember" id="Fact002955" format="ixt:numdotdecimal" decimals="0" unitRef="USD">500,000</ix:nonFraction></span> plus interest, under the Company&#8217;s royalty agreement with
Berler, as amended, rescission thereof and reversion to Berler of the intellectual property rights subject thereto. The Company believes
that Berler&#8217;s claims are without merit and intends to defend itself vigorously in connection with these claims.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
April 3, 2024, Plastomold Industries Ltd. (&#8220;Plastomold&#8221;) commenced a lawsuit against the Company in the United States District
Court for the Eastern District of New York, Plastomold Industries Ltd v. Sharps Technology, Inc., Case No. 2:24-CV-02580, asserting claims
for damages in the amount of $<span id="xdx_90D_eus-gaap--LossContingencyDamagesSoughtValue_pn3n6_c20240403__20240403__srt--LitigationCaseAxis__custom--PlastomoldMember_zNcHzYxfILc3" title="Loss contingency, claims for damages"><ix:nonFraction name="us-gaap:LossContingencyDamagesSoughtValue" contextRef="From2024-04-032024-04-03_custom_PlastomoldMember" id="Fact002957" format="ixt:numdotdecimal" decimals="-3" scale="6" unitRef="USD">1.762</ix:nonFraction></span> million for alleged <span id="xdx_906_eus-gaap--LossContingencyDamagesSought_c20240403__20240403__srt--LitigationCaseAxis__custom--PlastomoldMember_zI0TwB3Fpvi3" title="Description of loss contingency"><ix:nonNumeric contextRef="From2024-04-032024-04-03_custom_PlastomoldMember" id="Fact002959" name="us-gaap:LossContingencyDamagesSought">(1) failure to pay invoices, of which approximately $1 million would relate to
a maintenance agreement for units allegedly manufactured and sold using machinery that was defective and has never successfully produced
any saleable products, (2) breach of the implied covenant of good faith and fair dealing, (3) unjust enrichment, and (4) conversion.
Plastomold asserts it provided certain products and services to the Company for which its invoices were not fully paid. The Company believes
that Plastomold&#8217;s claims are without merit and intends to defend itself vigorously.</ix:nonNumeric></span> On June 3, 2024, the Company filed an answer
and affirmative defenses and counterclaim, which counterclaim is for damages that the Company believes would exceed the claims asserted
by Plastomold, based on the insufficiency of Plastomold&#8217;s services and the results thereof, including the failure to provide machinery
capable of reliably manufacturing the designated products in compliance with design specifications and functionality requirements, and
with respect to which test results failed.</span></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Commitments</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
August 1, 2022, the Company cancelled the consulting agreement with Alan Blackman, Co- Chairman and Chief Operating Officer and
entered into an Employment Agreement. which provided for annual salary of $<span id="xdx_90C_eus-gaap--SalariesAndWages_c20220730__20220801__us-gaap--TypeOfArrangementAxis__custom--EmploymentAgreementMember__srt--TitleOfIndividualAxis__custom--AlanBlackmanMember_z2oixmpIKNRf" title="Annual salary"><ix:nonFraction name="us-gaap:SalariesAndWages" contextRef="From2022-07-302022-08-01_custom_EmploymentAgreementMember_custom_AlanBlackmanMember" id="Fact002961" format="ixt:numdotdecimal" decimals="0" unitRef="USD">256,000</ix:nonFraction></span>,
which provides for increases, and provisions compensation adjustments, expense and tax differential reimbursements, benefits and
bonuses. As of September 1, 2022, the annual salary is $<span id="xdx_906_eus-gaap--SalariesAndWages_c20220831__20220901__us-gaap--TypeOfArrangementAxis__custom--EmploymentAgreementMember__srt--TitleOfIndividualAxis__custom--AlanBlackmanMember_zrVkYJ8pqmR8" title="Salaries and wages"><ix:nonFraction name="us-gaap:SalariesAndWages" contextRef="From2022-08-312022-09-01_custom_EmploymentAgreementMember_custom_AlanBlackmanMember" id="Fact002963" format="ixt:numdotdecimal" decimals="0" unitRef="USD">320,000</ix:nonFraction></span>.
At September 30, 2022, the Company approved and accrued a $<span id="xdx_908_eus-gaap--AccruedBonusesCurrentAndNoncurrent_iI_c20220930__us-gaap--TypeOfArrangementAxis__custom--EmploymentAgreementMember__srt--TitleOfIndividualAxis__custom--AlanBlackmanMember_zDTgDYGu6Jl2" title="Accrued bonus"><ix:nonFraction name="us-gaap:AccruedBonusesCurrentAndNoncurrent" contextRef="AsOf2022-09-30_custom_EmploymentAgreementMember_custom_AlanBlackmanMember" id="Fact002965" format="ixt:numdotdecimal" decimals="0" unitRef="USD">250,000</ix:nonFraction></span>
bonus to Mr. Blackman for services provided in 2022, of which $<span id="xdx_902_ecustom--PaymentForBonuses_c20230101__20230331__us-gaap--TypeOfArrangementAxis__custom--EmploymentAgreementMember__srt--TitleOfIndividualAxis__custom--AlanBlackmanMember_zapYwzPDjoVh" title="Payment for bonuses"><ix:nonFraction name="STSS:PaymentForBonuses" contextRef="From2023-01-012023-03-31_custom_EmploymentAgreementMember_custom_AlanBlackmanMember" id="Fact002967" format="ixt:numdotdecimal" decimals="0" unitRef="USD">65,000</ix:nonFraction></span>
was paid subsequent to December 31, 2022. The Company terminated Mr. Blackman&#8217;s Employment Agreement effective May 1, 2023.
Mr. Blackman continued to serve as the Co-Chairman and a member of the Board of Directors. Subsequent to June 30, 2023, the Company
and Mr. Blackman entered into a separation agreement whereby, Mr. Blackman was paid severance payments of approximately $<span id="xdx_90B_eus-gaap--SeveranceCosts1_c20230701__20230814__srt--TitleOfIndividualAxis__custom--AlanBlackmanMember_znIDk6xuoEAa" title="Severance costs"><ix:nonFraction name="us-gaap:SeveranceCosts1" contextRef="From2023-07-012023-08-14_custom_AlanBlackmanMember" id="Fact002969" format="ixt:numdotdecimal" decimals="0" unitRef="USD">346,000</ix:nonFraction></span>
plus other medical benefits of approximately $<span id="xdx_903_ecustom--MedicalBenefitsCost_iI_c20230630__srt--TitleOfIndividualAxis__custom--AlanBlackmanMember_zFym0JpKbrI" title="Medical benefit cost"><ix:nonFraction name="STSS:MedicalBenefitsCost" contextRef="AsOf2023-06-30_custom_AlanBlackmanMember" id="Fact002971" format="ixt:numdotdecimal" decimals="0" unitRef="USD">29,000</ix:nonFraction></span>
which were fully paid by August 31, 2024. Further, all unvested options were fully vested, and the Company recorded a charge of
$<span id="xdx_906_eus-gaap--ShareBasedCompensation_c20230101__20231231__srt--TitleOfIndividualAxis__custom--AlanBlackmanMember_zwhwXRCdfNS3" title="Share based compensation"><ix:nonFraction name="us-gaap:ShareBasedCompensation" contextRef="From2023-01-012023-12-31_custom_AlanBlackmanMember" id="Fact002973" format="ixt:numdotdecimal" decimals="0" unitRef="USD">60,000</ix:nonFraction></span>
in 2023. In connection with the separation agreement, Mr. Blackman no longer served as Co-Chairman or Board member and agreed to vote
his Series A Preferred Stock in favor of the election, reelection, and/or designation of each individual nominated to serve as a
director on the Board of Director as shall be identified in an applicable proxy statement filed by the Company for such election of
directors. Once the payments due Mr. Blackman were fully paid, the Series A Preferred Stock were deemed immediately cancelled and
forfeited and without further consideration. The Series A Preferred has been returned to the status of an authorized but unissued
share of preferred stock of the Company.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
May 20, 2024, the Company entered into an amendment to the Asset Purchase agreement (&#8220;Asset Purchase&#8221;) with InjectEZ,
LLC (&#8220;Seller&#8221;) for the purchase of certain assets for $<span id="xdx_907_eus-gaap--PaymentsToAcquireProductiveAssets_pn6n6_c20240519__20240520__us-gaap--TypeOfArrangementAxis__custom--AssetPurchaseAgreementMember__us-gaap--AssetAcquisitionAxis__custom--InjectEZLLCMember_zitcZPZRZTKf" title="Payments to acquire assets"><ix:nonFraction name="us-gaap:PaymentsToAcquireProductiveAssets" contextRef="From2024-05-192024-05-20_custom_AssetPurchaseAgreementMember_custom_InjectEZLLCMember" id="Fact002975" format="ixt:numdotdecimal" decimals="-6" scale="6" unitRef="USD">35</ix:nonFraction></span>M.
In connection with the Asset Purchase agreement the Company paid a non-refundable deposit of $<span id="xdx_907_eus-gaap--EscrowDeposit_iI_pn6n6_c20240520__us-gaap--TypeOfArrangementAxis__custom--AssetPurchaseAgreementMember__us-gaap--AssetAcquisitionAxis__custom--InjectEZLLCMember_zr4bvle1Pyp1" title="Escrow deposit"><ix:nonFraction name="us-gaap:EscrowDeposit" contextRef="AsOf2024-05-20_custom_AssetPurchaseAgreementMember_custom_InjectEZLLCMember" id="Fact002977" format="ixt:numdotdecimal" decimals="-6" scale="6" unitRef="USD">1</ix:nonFraction></span>M
to be held in escrow under an agreeable escrow agreement as a deposit on the purchase price. The Asset Purchase agreement stipulated
that the $<span id="xdx_907_eus-gaap--EscrowDeposit_iI_pn6n6_c20240520__us-gaap--TypeOfArrangementAxis__custom--AssetPurchaseAgreementMember__us-gaap--AssetAcquisitionAxis__custom--InjectEZLLCMember_zfUYDMCb6Idc" title="Escrow deposit"><ix:nonFraction name="us-gaap:EscrowDeposit" contextRef="AsOf2024-05-20_custom_AssetPurchaseAgreementMember_custom_InjectEZLLCMember" id="Fact002979" format="ixt:numdotdecimal" decimals="-6" scale="6" unitRef="USD">1</ix:nonFraction></span>M
deposit would be maintained until July 19, 2024, at which date, if the contemplated transaction was not consummated, through no
fault of the Seller, the escrow would be released to the Seller by the escrow agent. The escrow deposit of $<span id="xdx_907_eus-gaap--EscrowDepositDisbursementsRelatedToPropertyAcquisition1_c20240101__20240930__us-gaap--TypeOfArrangementAxis__custom--AssetPurchaseAgreementMember__us-gaap--AssetAcquisitionAxis__custom--InjectEZLLCMember_zGkdffamh7W6" title="Escrow deposit disbursements related to property acquisition"><ix:nonFraction name="us-gaap:EscrowDepositDisbursementsRelatedToPropertyAcquisition1" contextRef="From2024-01-012024-09-30_custom_AssetPurchaseAgreementMember_custom_InjectEZLLCMember" id="Fact002981" format="ixt:numdotdecimal" decimals="0" unitRef="USD">1,000,000</ix:nonFraction></span>
was released to the Seller and recorded a forfeited agreement cost in Other Expenses in the nine months ended September 30, 2024.
The Company and Seller are currently working towards a further amendment of the Asset Purchase Agreement. To the extent a further
amendment is executed, the closing of the Asset Purchase Agreement will be contingent on obtaining the necessary financing and there can
be no assurance that the closing of the asset sale will occur.</span></p>

</ix:nonNumeric><p id="xdx_81D_zJrPIkxEynD" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 95; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 0pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->47<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%"><a href="#RM_014">Table of Contents</a></td></tr></table></div>
    <!-- Field: /Page -->


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>PART
II</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>INFORMATION
NOT REQUIRED IN PROSPECTUS</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Item
13. Other Expenses of Issuance and Distribution.</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0.45in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
following table sets forth all expenses to be paid by the registrant in connection with the issuance and distribution of the securities
to be registered, other than underwriting discounts and commissions. All amounts shown are estimates except for the SEC registration
fee:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"></p>



  <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
      <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">SEC
                                            registration fee</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">8,037.75</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 78%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Legal
    fees and expenses</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 18%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1000,000</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Accounting
    fees and expenses</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">25,000</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Underwriter</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> non-accountable expense reimbursement</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Miscellaneous
    fees and expenses</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">20,100</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Total</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">153,137.75</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  </table>


<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Item
14. Indemnification of Directors and Officers.</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.45in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
articles of incorporation and bylaws limit the liability of our officers and directors and provide that we will indemnify our officers
and directors, in each case, to the fullest extent permitted by the Nevada Revised Statutes, or the NRS.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.45in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">NRS
Section 78.7502 provides that a corporation shall indemnify any director, officer, employee or agent of a corporation against expenses,
including attorneys&#8217; fees, actually and reasonably incurred by him in connection with any defense to the extent that a director,
officer, employee or agent of a corporation has been successful on the merits or otherwise in defense of any action, suit or proceeding
referred to in Section 78.7502(1) or 78.7502(2), or in defense of any claim, issue or matter therein.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.45in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">NRS
78.7502(1) provides that a corporation may indemnify any person who was or is a party or is threatened to be made a party to any threatened,
pending or completed action, suit or proceeding, whether civil, criminal, administrative or investigative, except an action by or in
the right of the corporation, by reason of the fact that he is or was a director, officer, employee or agent of the corporation, or is
or was serving at the request of the corporation as a director, officer, employee or agent of another corporation, partnership, joint
venture, trust or other enterprise, against expenses, including attorneys&#8217; fees, judgments, fines and amounts paid in settlement
actually and reasonably incurred by him in connection with the action, suit or proceeding if he: (a) is not liable pursuant to NRS 78.138;
or (b) acted in good faith and in a manner which he reasonably believed to be in or not opposed to the best interests of the corporation,
and, with respect to any criminal action or proceeding, had no reasonable cause to believe his conduct was unlawful.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.45in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">NRS
Section 78.7502(2) provides that a corporation may indemnify any person who was or is a party or is threatened to be made a party to
any threatened, pending or completed action or suit by or in the right of the corporation to procure a judgment in its favor by reason
of the fact that he is or was a director, officer, employee or agent of the corporation, or is or was serving at the request of the corporation
as a director, officer, employee or agent of another corporation, partnership, joint venture, trust or other enterprise against expenses,
including amounts paid in settlement and attorneys&#8217; fees actually and reasonably incurred by him in connection with the defense
or settlement of the action or suit if he: (a) is not liable pursuant to NRS 78.138; or (b) acted in good faith and in a manner which
he reasonably believed to be in or not opposed to the best interests of the corporation. Indemnification may not be made for any claim,
issue or matter as to which such a person has been adjudged by a court of competent jurisdiction, after exhaustion of all appeals there
from, to be liable to the corporation or for amounts paid in settlement to the corporation, unless and only to the extent that the court
in which the action or suit was brought or other court of competent jurisdiction determines upon application that in view of all the
circumstances of the case, the person is fairly and reasonably entitled to indemnity for such expenses as the court deems proper.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.45in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">NRS
Section 78.747 provides that except as otherwise provided by specific statute, no director or officer of a corporation is individually
liable for a debt or liability of the corporation, unless the director or officer acts as the alter ego of the corporation. The court
as a matter of law must determine the question of whether a director or officer acts as the alter ego of a corporation.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.45in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Insofar
as indemnification for liabilities arising under the Securities Act may be permitted to the Registrant&#8217;s directors, officers and
controlling persons pursuant to the foregoing provisions, or otherwise, the Registrant has been advised that in the opinion of the Commission,
such indemnification is against public policy as expressed in the Securities Act and is, therefore, unenforceable.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"></p>

<!-- Field: Page; Sequence: 96; Options: NewSection -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">II-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->1<!-- Field: /Sequence --></td></tr></table></div>
    <div style="page-break-before: always; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"></p>




<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Item
15. Recent Sale of Unregistered</b>&#160; <b>Securities</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">During
the quarter ended June 30, 2024, the Company, under Reg A, issued 190,773 (pre reverse: 4.1M) unregistered but qualified shares
of common stock.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0.45in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">During
the quarter ended September 30, 2024, the Company issued 259,091 (pre reserve: 5.7) shares of unregistered common stock which
were subsequently registered</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0.45in"><span style="font-size: 10pt">During
the quarter ended December 31, 2024, the Company issued 248,430 shares (post reverse) unregistered but qualified shares of common stock.</span></p>


<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.45in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
September 27, 2023, the Company entered into a Securities Purchase Agreement with certain accredited investors purchasing common stock
in this offering for a private placement offering of (i) 117,340 (pre reverse - 2,581,479) unregistered shares of our common stock
(or pre-funded warrants in lieu thereof with each pre-funded warrant exercisable for one share of common stock and (ii) unregistered
warrants to purchase 397,727 (pre reverse - 8,750,003) of our common stock. Pursuant to the PIPE Purchase Agreement, the Company
has agreed to issue and sell 117,430 (pre reverse - 2,581,479) PIPE Shares (or PIPE Pre-Funded Warrants in lieu thereof) together
with</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">SS
Warrants to purchase up to 397,727 (pre reverse - 8,750,003) shares of common stock at a combined offering price of $1.074
per unit (less $0.001 for each PIPE Pre-Funded Warrant). The PIPE Securities are not being registered under the Securities Act and are
not being offered pursuant to this prospectus supplement and the accompanying base prospectus. The PIPE Securities are being offered
pursuant to an exemption from the registration requirements of the Securities Act provided in Section 4(a)(2) of the Securities Act and/or
Rule 506(b) of Regulation D promulgated thereunder.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.45in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
offers, sales, and issuances of the above securities were exempt from registration under the Securities Act by virtue of Section 4(a)(2)
of the Securities Act as transactions by an issuer not involving any public offering, or in reliance on Rule 701 promulgated under Section
3(b) of the Securities Act because the transactions were pursuant to compensatory benefit plans or contracts relating to compensation
as provided under Rule 701.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Item
16. Exhibits and Financial Statement Schedules.</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Exhibits</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.3in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">See
the Exhibit Index immediately preceding the signature page hereto for a list of exhibits filed as part of this registration statement
on Form S-1, which Exhibit Index is incorporated herein by reference.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Financial
Statement Schedules</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.3in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">All
financial statement schedules are omitted because the information called for is not required or is shown either in the financial statements
or in the notes thereto.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Item
17. Undertakings.</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.3in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
undersigned registrant hereby undertakes to provide to the underwriters at the closing specified in the underwriting agreements certificates
in such denominations and registered in such names as required by the underwriters to permit prompt delivery to each purchaser.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.3in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Insofar
as indemnification for liabilities arising under the Securities Act may be permitted to directors, officers, and controlling persons
of the registrant pursuant to the foregoing provisions, or otherwise, the registrant has been advised that in the opinion of the Securities
and Exchange Commission such indemnification is against public policy as expressed in the Securities Act and is, therefore, unenforceable.
In the event that a claim for indemnification against such liabilities (other than the payment by the registrant of expenses incurred
or paid by a director, officer, or controlling person of the registrant in the successful defense of any action, suit, or proceeding)
is asserted by such director, officer, or controlling person in connection with the securities being registered, the registrant will,
unless in the opinion of its counsel the matter has been settled by controlling precedent, submit to a court of appropriate jurisdiction
the question whether such indemnification by it is against public policy as expressed in the Securities Act and will be governed by the
final adjudication of such issue.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.3in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
undersigned registrant hereby undertakes that:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(1)</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">For
                                            purposes of determining any liability under the Securities Act, the information omitted from
                                            the form of prospectus filed as part of this registration statement in reliance upon Rule
                                            430A and contained in a form of prospectus filed by the registrant pursuant to Rule 424(b)
                                            (1) or (4) or 497(h) under the Securities Act shall be deemed to be part of this registration
                                            statement as of the time it was declared effective.</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(2)</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">For
                                            the purpose of determining any liability under the Securities Act, each post-effective amendment
                                            that contains a form of prospectus shall be deemed to be a new registration statement relating
                                            to the securities offered therein, and the offering of such securities at that time shall
                                            be deemed to be the initial bona fide offering thereof.</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"></p>

<!-- Field: Page; Sequence: 97 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">II-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></td></tr></table></div>
    <div style="page-break-before: always; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font-family: Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.75in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.1in"/>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>EXHIBIT
    INDEX</b></span></td></tr>
  <tr style="font-family: Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Exhibit</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"/>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Number</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1pt; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Description</b></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: bottom">1.1</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: bottom">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: left"><a href="ex1-1.htm">Form of Underwriting Agreement, dated [___], 2025, between the Company and Aegis Capital Corp.</a></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.1</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><a href="ex3-1.htm">Amended and Restated Bylaws</a></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.2</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="https://www.sec.gov/Archives/edgar/data/1737995/000149315222007279/ex3-2.htm" style="-sec-extract: exhibit">Certificate
    of Designation of Series A Preferred Stock (incorporated by reference to the Form S-1/ Amendment 4 filed on April 12, 2022; registration
    number 333-263715)</a></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif">3.4*</td>
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><p style="margin: 0">Form of Series A Warrant</p></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif">3.5*</td>
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><p style="margin: 0">Form of Series B Warrant</p></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.6</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><a href="https://www.sec.gov/Archives/edgar/data/1737995/000149315222036665/ex3-1.htm" style="-sec-extract: exhibit"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Certificate of Amendment to Designation, filed on December 28, 2022 (incorporated by reference to 8-K filed on December 22, 2022)</span></a></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.1</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif"><span style="font-size: 10pt"><a href="ex5-1.htm">Legal Opinion of Sichenzia Ross Ference LLP*</a></span></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.1</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="https://www.sec.gov/Archives/edgar/data/1737995/000149315222007279/ex10-1.htm" style="-sec-extract: exhibit">Asset/Share
    Purchase Agreement, dated June 10, 2020, among the Company, Safegard Medical (Hungary) Ktf,, Numan Holding Ltd, Cortrus Services
    SA and Latitude Investments Limited (incorporated by reference to the Form S-1/ Amendment 4 filed on April 12, 2022; registration
    number 333-263715)</a></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.2</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="https://www.sec.gov/Archives/edgar/data/1737995/000149315222007279/ex10-2.htm" style="-sec-extract: exhibit">Amendment
    No. 1 to Asset/Share Purchase Agreement, dated June 24, 2020 (incorporated by reference to the Form S-1/ Amendment 4 filed on April
    12, 2022; registration number 333-263715)</a></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.3</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="https://www.sec.gov/Archives/edgar/data/1737995/000149315222007279/ex10-3.htm" style="-sec-extract: exhibit">Amendment
    No. 2 to Asset/Share Purchase Agreement, dated August 27, 2020 (incorporated by reference to the Form S-1/ Amendment 4 filed on April
    12, 2022; registration number 333-263715)</a> </span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.4</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="https://www.sec.gov/Archives/edgar/data/1737995/000149315222007279/ex10-4.htm" style="-sec-extract: exhibit">Amendment
    No. 3 to Asset/Share Purchase Agreement, dated October 28, 2020 (incorporated by reference to the Form S-1/ Amendment 4 filed on
    April 12, 2022; registration number 333-263715)</a> </span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.5</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="https://www.sec.gov/Archives/edgar/data/1737995/000149315222007279/ex10-5.htm" style="-sec-extract: exhibit">Amendment
    No. 4 to Asset/Share Purchase Agreement, dated July 19, 2021 (incorporated by reference to the Form S-1/ Amendment 4 filed on April
    12, 2022; registration number 333-263715)</a></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.6</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="https://www.sec.gov/Archives/edgar/data/1737995/000149315222007279/ex10-6.htm" style="-sec-extract: exhibit">Amendment
    No. 5 to Asset/Share Purchase Agreement, dated February 28, 2022 (incorporated by reference to the Form S-1/ Amendment 4 filed on
    April 12, 2022; registration number 333-263715)</a> </span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.7</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="https://www.sec.gov/Archives/edgar/data/1737995/000149315222007279/ex10-7.htm" style="-sec-extract: exhibit">Letter,
    dated September 23, 2021, from Numan Holding Ltd (incorporated by reference to the Form S-1/ Amendment 4 filed on April 12, 2022;
    registration number 333-263715)</a></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.8</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="https://www.sec.gov/Archives/edgar/data/1737995/000149315222007279/ex10-8.htm" style="-sec-extract: exhibit">Employment
    Agreement, dated September 9, 2021, between the Company and Robert Hayes (incorporated by reference to the Form S-1/ Amendment 4
    filed on April 12, 2022; registration number 333-263715)</a></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.9</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="https://www.sec.gov/Archives/edgar/data/1737995/000149315222007279/ex10-9.htm" style="-sec-extract: exhibit">Consulting
    Agreement between the Company and Alan Blackman (incorporated by reference to the Form S-1/ Amendment 4 filed on April 12, 2022;
    registration number 333-263715)</a></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.10</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="https://www.sec.gov/Archives/edgar/data/1737995/000149315222007279/ex10-10.htm" style="-sec-extract: exhibit">Amended
    Consulting Agreement, dated May 28, 2019, between the Company and Barry Berler (incorporated by reference to the Form S-1/ Amendment
    4 filed on April 12, 2022; registration number 333-263715)</a></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.11</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="https://www.sec.gov/Archives/edgar/data/1737995/000149315222007279/ex10-11.htm" style="-sec-extract: exhibit">Royalty
    Agreement, dated July 11, 2017, between Alan Blackman and Barry Berler (incorporated by reference to the Form S-1/ Amendment 4 filed
    on April 12, 2022; registration number 333-263715)</a></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.12</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="https://www.sec.gov/Archives/edgar/data/1737995/000149315222007279/ex10-12.htm" style="-sec-extract: exhibit">Amendment
    to Royalty Agreement, dated September 4, 2018 (incorporated by reference to the Form S-1/ Amendment 4 filed on April 12, 2022; registration
    number 333-263715)</a></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.13</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="https://www.sec.gov/Archives/edgar/data/1737995/000149315222007279/ex10-13.htm" style="-sec-extract: exhibit">Consulting
    Agreement, dated January 1, 2021, between the Company and Berry Berler (incorporated by reference to the Form S-1/ Amendment 4 filed
    on April 12, 2022; registration number 333-263715)</a> &#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.14</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="https://www.sec.gov/Archives/edgar/data/1737995/000149315222007279/ex10-14.htm" style="-sec-extract: exhibit">Note
    Purchase Agreement, dated December 14, 2021, among the Company and the purchasers named therein (incorporated by reference to the
    Form S-1/ Amendment 4 filed on April 12, 2022; registration number 333-263715)</a></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.15</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="https://www.sec.gov/Archives/edgar/data/1737995/000149315222007279/ex10-15.htm" style="-sec-extract: exhibit">Form
    of Note (incorporated by reference to the Form S-1/ Amendment 4 filed on April 12, 2022; registration number 333-263715)</a> </span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.16</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="https://www.sec.gov/Archives/edgar/data/1737995/000149315222007279/ex10-16.htm" style="-sec-extract: exhibit">Security
    Agreement among the Company and the secured parties named therein (incorporated by reference to the Form S-1/ Amendment 4 filed on
    April 12, 2022; registration number 333-263715)</a> </span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.17</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="https://www.sec.gov/Archives/edgar/data/1737995/000149315222007279/ex10-17.htm" style="-sec-extract: exhibit">Consent
    to be named as a director nominee of Jason Monroe (incorporated by reference to the Form S-1/ Amendment 4 filed on April 12, 2022;
    registration number 333-263715)</a> </span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.18</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="https://www.sec.gov/Archives/edgar/data/1737995/000149315222007279/ex10-18.htm" style="-sec-extract: exhibit">Consent
    to be named as a director nominee of Brenda Baird Simpson (incorporated by reference to the Form S-1/ Amendment 4 filed on April
    12, 2022; registration number 333-263715)</a></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.22</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="https://www.sec.gov/Archives/edgar/data/1737995/000149315222008116/ex10-22.htm" style="-sec-extract: exhibit">2022
    Equity Incentive Plan (incorporated by reference to the Form S-1/ Amendment 4 filed on April 12, 2022; registration number 333-263715)</a></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.23</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="https://www.sec.gov/Archives/edgar/data/1737995/000149315222009164/ex10-23.htm" style="-sec-extract: exhibit">Plan
    and Agreement of Merger, dated March 22, 2022, between Sharps Technology, Inc., a Wyoming corporation, and Sharps Technology, Inc.,
    a Nevada corporation (incorporated by reference to the Form S-1/ Amendment 4 filed on April 12, 2022; registration number 333- 263715)</a></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.24</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="https://www.sec.gov/Archives/edgar/data/1737995/000149315222009297/ex10-24.htm" style="-sec-extract: exhibit">Form
    of Warrant Agent Agreement (Warrants) (incorporated by reference to the Form S-1/ Amendment 4 filed on April 12, 2022; registration
    number 333-263715)</a></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.25</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="https://www.sec.gov/Archives/edgar/data/1737995/000149315222009164/ex10-25.htm" style="-sec-extract: exhibit">Form
    of Representative&#8217;s Warrant (incorporated by reference to the Form S-1/ Amendment 4 filed on April 12, 2022; registration number
    333-263715)</a></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.26</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="https://www.sec.gov/Archives/edgar/data/1737995/000149315222010435/ex10-2.htm" style="-sec-extract: exhibit">Amendment
    No. 6 to Asset/Share Purchase Agreement, dated April 13, 2022 (incorporated by reference to 8-K filed on April 19, 2022)</a></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.27</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="https://www.sec.gov/Archives/edgar/data/1737995/000149315222027499/ex10-1.htm" style="-sec-extract: exhibit">Agreement,
    dated September 29, 2022, by and among Sharps Technology, Inc., InjectEZ, LLC, Nephron Pharmaceuticals Corporation, Nephron SC, Inc.
    and Nephron Sterile Compounding Center LLC (incorporated by reference to 8-K filed on October 4, 2022)</a> &#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.28</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="https://www.sec.gov/ix?doc=/Archives/edgar/data/1737995/000149315222035248/form8-k.htm" style="-sec-extract: exhibit">Distribution
    Agreement, dated December 8, 2022, by and among Sharps Technology, Inc., Nephron Pharmaceuticals Corporation and Nephron SC, Inc.
    (incorporated by reference to 8-K filed on December 13, 2022)</a></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.29</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="https://www.sec.gov/Archives/edgar/data/1737995/000149315223035242/ex10-1.htm" style="-sec-extract: exhibit">PIPE
    Agreement, dated September 27, 2023 (incorporated by reference to 8-K filed on October 3, 2023) Rd Agreement, dated September 27,
    2023 (incorporated by reference to 8-K filed on October 3, 2023)</a></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.30</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="https://www.sec.gov/Archives/edgar/data/1737995/000149315223035242/ex10-3.htm" style="-sec-extract: exhibit">Registration
    Rights Agreement, dated September 27, 2023 (incorporated by reference to 8-K filed on October 3, 2023)</a></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.31</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="https://www.sec.gov/Archives/edgar/data/1737995/000149315223035242/ex10-4.htm" style="-sec-extract: exhibit">Placement
    Agent Agreement, dated September 27, 2023 (incorporated by reference to 8-K filed on October 3, 2023)</a> </span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.32</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="https://www.sec.gov/Archives/edgar/data/1737995/000149315223035242/ex10-5.htm" style="-sec-extract: exhibit">Form
    of Warrant (incorporated by reference to 8-K filed on October 3, 2023)</a> </span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.33</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="https://www.sec.gov/Archives/edgar/data/1737995/000149315223035242/ex10-6.htm" style="-sec-extract: exhibit">Form
    of RD Pre-Funded Warrant (incorporated by reference to 8-K filed on October 3, 2023)</a> </span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.34</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="https://www.sec.gov/Archives/edgar/data/1737995/000149315223035242/ex10-7.htm" style="-sec-extract: exhibit">Form
    of PIPE Pre-Funded Warrant (incorporated by reference to 8-K filed on October 3, 2023)</a></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.35</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="https://www.sec.gov/Archives/edgar/data/1737995/000149315223002771/ex10-1.htm" style="-sec-extract: exhibit">2023
    Equity Incentive Plan (incorporated by reference to 8-K filed on January 27, 2023)</a></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif">10.36</td>
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><a href="ex10-36.htm">2024 Equity Incentive Plan</a></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">23.1</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif"><a href="ex23-1.htm">Consent
    of Manning Elliott LLP</a></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif">23.2</td>
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif"><a href="ex23-2.htm">Consent
    of PKF O&#8217;Conner Davies, LLP</a></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">23.3</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif"><a href="ex5-1.htm"><span style="font-size: 10pt">Consent
    of Sichenzia Ross Ference LLP (included in Exhibit 5.1)</span></a></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif">24.1</td>
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><a href="ex24-1.htm">Power of Attorney</a>

</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">107</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif"><a href="ex107.htm"><span style="font-size: 10pt">Filing
    Fees Exhibit</span></a></span></td></tr>
  </table>
<p style="font: 12pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">*
To be filed by amendment.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"></p>

<!-- Field: Page; Sequence: 98 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">II-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></td></tr></table></div>
    <div style="page-break-before: always; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"></p>




<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>SIGNATURES</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0.3in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Pursuant
to the requirements of the Securities Act of 1933, the registrant has duly caused this registration statement on Form S-1 to be signed
on its behalf by the undersigned, thereunto duly authorized, in the city of Melville, State of New York, on the 22<sup>nd</sup>
day of January, 2025.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
<tr style="font-family: Times New Roman, Times, Serif; vertical-align: top; text-align: left">
  <td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
  <td colspan="2" style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif"><b>SHARPS TECHNOLOGY, INC</b></span></td></tr>
<tr style="font-family: Times New Roman, Times, Serif; vertical-align: top; text-align: left">
  <td style="font-family: Times New Roman, Times, Serif; width: 50%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
  <td style="font-family: Times New Roman, Times, Serif; width: 3%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
  <td style="font-family: Times New Roman, Times, Serif; width: 47%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr style="font-family: Times New Roman, Times, Serif; vertical-align: top; text-align: left">
  <td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
  <td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">By:</span></td>
  <td style="border-bottom: Black 1pt solid; font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif"><i>/s/ Robert M. Hayes</i></span></td></tr>
<tr style="font-family: Times New Roman, Times, Serif; vertical-align: top; text-align: left">
  <td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
  <td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
  <td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Robert M. Hayes</span></td></tr>
<tr style="font-family: Times New Roman, Times, Serif; vertical-align: top; text-align: left">
  <td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
  <td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
  <td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Chief Executive Officer and Director</span></td></tr>
</table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center; background-color: white; color: #212529"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>POWER
OF ATTORNEY</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center; background-color: white; color: #212529"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">KNOW
ALL PERSONS BY THESE PRESENTS, that each person whose signature appears below hereby constitutes and appoints </span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Robert
M. Hayes<span>, as his true and lawful attorney-in-fact and agent with full power of substitution, for him in
any and all capacities, to sign any and all amendments to this registration statement (including post-effective amendments or any abbreviated
registration statement and any amendments thereto filed pursuant to Rule 462(b) increasing the number of securities for which registration
is sought), and to file the same, with all exhibits thereto and other documents in connection therewith, with the Securities and Exchange
Commission, granting unto said attorney-in-fact, proxy and agent full power and authority to do and perform each and every act and thing
requisite and necessary to be done in connection therewith, as fully for all intents and purposes as he or she might or could do in person,
hereby ratifying and confirming all that said attorney-in-fact, proxy and agent, or his substitute, may lawfully do or cause to be done
by virtue hereof.</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; background-color: white; color: #212529"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; background-color: white; color: #212529"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Pursuant
to the requirements of the Securities Act of 1933, this registration statement on Form S-1 has been signed by the following persons in
the capacities and on the dates indicated.</span></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center; width: 35%; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Signature</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center; width: 2%; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center; width: 41%; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Title
    </b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center; width: 2%; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center; width: 20%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Date</b></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>/s/
    Robert M. Hayes</i></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Chief
    Executive Officer and Director</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">January
    22, 2025</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Robert
    M. Hayes</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(<i>Principal
    Executive Officer)</i></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>/s/
    Andrew R. Crescenzo</i></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Chief
    Financial Officer</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">January
    22, 2025</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Andrew
    R. Crescenzo</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(<i>Principal
    Financial and Accounting Officer)</i></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>/s/
    Dr. Soren Bo Christiansen*</i></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Chairman</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">January
    22, 2025</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Dr
    Soren Bo Christiansen</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>/s/
    Paul K. Danner*</i></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Director</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">January
    22, 2025</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Paul
    K. Danner</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>/s/
    Timothy J. Ruemler*</i></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Director</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">January
    22, 2025</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Timothy
    J. Ruemler</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif"><p style="margin: 0; line-height: 115%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>/s/
                                            Brenda Baird</i></span><i><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&#160;
                                            </span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Simpson*</span></i></p>


</td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">Director</td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: center"><p style="font: 10pt/115% Times New Roman, Times, Serif; margin: 0">January
                                            22, 2025</p></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif">Brenda Baird Simpson</td>
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif"><i>/s/ Jason L Monroe*</i></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">Director</td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: center">January 22, 2025&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif">Jason L Monroe</td>
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">*
    By: <i>/s/ Robert M. Hayes</i></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">January
    22, 2025&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Robert
                                            M. Hayes</span></p>
</td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Attorney-in-fact</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  </table>

<p style="margin: 0; font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="margin: 0; font-family: Times New Roman, Times, Serif"></p>

<!-- Field: Page; Sequence: 99; Options: Last -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">II-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence --></td></tr></table></div>
    <!-- Field: /Page -->

<p style="margin: 0; font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>





















































<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"></p>

</body>
</html>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-1.1
<SEQUENCE>2
<FILENAME>ex1-1.htm
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="text-align: right; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Exhibit
1.1</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-variant: small-caps"><B>Underwriting
Agreement</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">[&#9679;],
2025</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Aegis
Capital Corp.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1345
Avenue of the Americas, 27th Floor</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">New
York, NY 10105</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Ladies
and Gentlemen:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Sharps
Technology, Inc., a Nevada corporation (the &ldquo;<B><U>Company</U></B>&rdquo;), agrees, subject to the terms and conditions in this
agreement (this &ldquo;<B><U>Agreement</U></B>&rdquo;), to issue and sell to Aegis Capital Corp. (the &ldquo;<B><U>Underwriter</U></B>&rdquo;)
an aggregate of [&#9679;] of the Company&rsquo;s units (each, a &ldquo;<B><U>Closing Unit</U></B>&rdquo;), with each Closing Unit consisting
of either: (A) one (1) share of Common Stock, $0.0001 par value per share of the Company (the &ldquo;<B><U>Common Stock</U></B>&rdquo;);
one (1) Series A warrant (&ldquo;<B><U>Series A Warrant</U></B>&rdquo;) to purchase one (1) share of Common Stock at a per Share exercise
price of $[&#9679;] (representing 125.0% of the per Closing Common Unit (as defined below) offering price) and one (1) Series B warrant
(&ldquo;<B><U>Series B Warrant</U></B>&rdquo;) to purchase one (1) share of Common Stock at a per Share exercise price of $[&#9679;]
(representing 125.0% of the per Closing Common Unit offering price) (each, a &ldquo;<B><U>Closing Common Unit</U></B>&rdquo;); or (B)
one (1) pre-funded warrant (each, a &ldquo;<B><U>Pre-funded Warrant</U></B>&rdquo;) to purchase one (1) share of Common Stock at an exercise
price of $0.0001; one (1) Series A Warrant and one (1) Series B Warrant (each, a &ldquo;<B><U>Closing Pre-funded Unit</U></B>&rdquo;).
The shares of Common Stock referred to in this Section are hereinafter referred to as the &ldquo;<B><U>Closing Shares</U></B>&rdquo;;
the warrants referred to in this paragraph are hereinafter referred to as the &ldquo;<B><U>Closing Warrants</U></B>&rdquo;; and the Pre-funded
Warrants referred to in this Section are hereinafter referred to as the &ldquo;<B><U>Closing Pre-funded Warrants</U></B>.&rdquo; No Closing
Common Units will be certificated, and the Closing Shares and the Closing Warrants comprising the Closing Common Units will be separated
immediately upon issuance. No Closing Pre-funded Units will be certificated, and the Closing Pre-funded Warrants and the Closing Warrants
comprising the Closing Pre-funded Units will be separated immediately upon issuance. At the option of the Underwriter, the Company agrees,
subject to the terms and conditions herein, to issue and sell additional Option Securities (as defined in Section 4.2 hereof). The Closing
Units and the Option Securities are herein referred to collectively as the &ldquo;<B><U>Securities</U></B>&rdquo;. The number of Closing
Units and Option Securities to be purchased by the Underwriter is set forth opposite its name in Schedule 4.1.2 hereto. Aegis Capital
Corp. has agreed to act as the Underwriter in connection with the offering and sale of the Securities.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">

    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in; padding-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><U>Definitions</U></B>.</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="margin-left: 0.5in; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.1.
&ldquo;<B><U>Affiliate</U></B>&rdquo; has the meaning set forth in Rule 405 under the Securities Act.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-left: 0.5in; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.2.
&ldquo;<B><U>Applicable Time</U></B>&rdquo; means [&#9679;]:00 [a.m./p.m.] Eastern Time on the date hereof.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-left: 0.5in; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.3.
&ldquo;<B><U>Bona Fide Electronic Road Show</U></B>&rdquo; means a &ldquo;bona fide electronic road show&rdquo; (as defined in Rule 433(h)(5)
under the Securities Act) that the Company has made available without restriction by &ldquo;graphic means&rdquo; (as defined in Rule
405 under the Securities Act) to any person.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"></P>

<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-left: 0.5in; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.4.
&ldquo;<B><U>Business Day</U></B>&rdquo; means a Calendar Day other than a Saturday, Sunday or any other Calendar Day which is a federal
legal holiday in the United States or any Calendar Day on which the commercial banks in the City of New York are required by law or other
governmental action to close, provided that the commercial banks in the City of New York shall not be deemed to be required to be closed
due to a &ldquo;stay at home,&rdquo; &ldquo;shelter in place,&rdquo; &ldquo;non-essential employee&rdquo; or similar orders or restrictions
or the closure of any physical branch locations at the direction of any governmental authority so long as the electronic funds transfer
systems (including for wire transfers) of commercial banks in the City of New York generally are open for use by customers on such Calendar
Day.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-left: 0.5in; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.5.
&ldquo;<B><U>Calendar Day</U></B>&rdquo; means each and every day of the week (Sunday, Monday, Tuesday, Wednesday, Thursday, Friday and
Saturday).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-left: 0.5in; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.6.
&ldquo;<B><U>Commission</U></B>&rdquo; means the United States Securities and Exchange Commission.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-left: 0.5in; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.7.
&ldquo;<B><U>Emerging Growth Company</U></B>&rdquo; means an &ldquo;emerging growth company&rdquo; (as defined in Section 2(a) of the
Securities Act).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-left: 0.5in; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.8.
&ldquo;<B><U>Exchange Act</U></B>&rdquo; means the Securities Exchange Act of 1934, as amended, and the rules and regulations promulgated
thereunder.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-left: 0.5in; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.9.
&ldquo;<B><U>Final Prospectus</U></B>&rdquo; means the prospectus in the form first filed with the Commission pursuant to and within
the time limits described in Rule 424(b) under the Securities Act.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-left: 0.5in; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.10.
&ldquo;<B><U>Free Writing Prospectus</U></B>&rdquo; has the meaning set forth in Rule 405 under the Securities Act.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-left: 0.5in; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.11.
&ldquo;<B><U>Indebtedness</U></B>&rdquo; means (a) any liabilities for borrowed money or amounts owed in excess of $50,000 in aggregate
(other than trade accounts payable incurred in the ordinary course of business), (b) all guaranties, endorsements and other contingent
obligations in respect of indebtedness of others, whether or not the same are or should be reflected in the Company&rsquo;s consolidated
balance sheet (or the notes thereto), except guaranties by endorsement of negotiable instruments for deposit or collection or similar
transactions in the ordinary course of business; and (c) the present value of any lease payments in excess of $50,000 in aggregate due
under leases required to be capitalized in accordance with GAAP.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-left: 0.5in; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.12.
&ldquo;<B><U>Investment Company Act</U></B>&rdquo; means the Investment Company Act of 1940, as amended, and the rules and regulations
promulgated thereunder.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-left: 0.5in; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.13.
&ldquo;<B><U>Issuer Free Writing Prospectus</U></B>&rdquo; means an &ldquo;issuer free writing prospectus&rdquo; (as defined in Rule
433(h)(1) under the Securities Act).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-left: 0.5in; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.14.
&ldquo;<B><U>Person</U></B>&rdquo; means an individual or corporation, partnership, trust, incorporated or unincorporated association,
joint venture, limited liability company, joint stock company, government (or an agency or subdivision thereof) or other entity of any
kind.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<!-- Field: Page; Sequence: 2; Options: NewSection; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-left: 0.5in; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.15.
&ldquo;<B><U>Preliminary Prospectus</U></B>&rdquo; means any preliminary prospectus included in the Registration Statement prior to the
time at which the Commission declared the Registration Statement effective.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-left: 0.5in; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.16.
&ldquo;<B><U>Pricing Disclosure Package</U></B>&rdquo; means the Preliminary Prospectus collectively with this Agreement (including documents
attached hereto or incorporated by reference herein) and the documents and pricing information set forth in Schedule 1.16 hereto.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-left: 0.5in; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.17.
&ldquo;<B><U>Prospectus Delivery Period</U></B>&rdquo; means such period of time after the first date of the public offering of the Units
as in the opinion of counsel for the Underwriter a prospectus relating to the Units is required by law to be delivered (or required to
be delivered but for Rule 172 under the Securities Act) in connection with sales of the Units by the Underwriter or dealer.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-left: 0.5in; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.18.
&ldquo;<B><U>Registration Statement</U></B>&rdquo; means (a) the registration statement on Form S-1 (File No. 333-[&#9679;]), including
a prospectus, registering the offer and sale of the Closing Units under the Securities Act as amended at the time the Commission declared
it effective, including each of the exhibits, financial statements and schedules thereto, (b) any Rule 430A Information, and (c) any
Rule 462(b) Registration Statement, including in each case any documents incorporated by reference therein.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-left: 0.5in; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.19.
&ldquo;<B><U>Release Date</U></B>&rdquo; means the date that the Company obtains the Stockholder Approval or a Board Approval in lieu
of Stockholder Approval to effect the purposes of the Stockholder Approval.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-left: 0.5in; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.20.
&ldquo;<B><U>Rule 430A Information</U></B>&rdquo; means the information deemed, pursuant to Rule 430A under the Securities Act, to be
part of the Registration Statement at the time the Commission declared the Registration Statement effective.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-left: 0.5in; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.21.
&ldquo;<B><U>Rule 462(b) Registration Statement</U></B>&rdquo; means an abbreviated registration statement to register the offer and
sale of additional Units pursuant to Rule 462(b) under the Securities Act.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-left: 0.5in; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.22.
&ldquo;<B><U>Sarbanes-Oxley Act</U></B>&rdquo; means the Sarbanes-Oxley Act of 2002, as amended, and the rules and regulations promulgated
thereunder.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-left: 0.5in; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.23.
&ldquo;<B><U>Securities Act</U></B>&rdquo; means the Securities Act of 1933, as amended, and the rules and regulations promulgated thereunder.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-left: 0.5in; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.24.
&ldquo;<B><U>Standstill Period</U></B>&rdquo; has the meaning set forth in Section 5.11.1 hereof.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-left: 0.5in; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.25.
&ldquo;<B><U>Testing-the-Waters Communication</U></B>&rdquo; means any oral or Written Communication with potential investors undertaken
in reliance on Section 5(d) of the Securities Act and Rule 163B thereunder.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-left: 0.5in; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.26.
&ldquo;<B><U>U.S. Company Counsel</U></B>&rdquo; means Sichenzia Ross Ference Carmel LLP, with offices at 1185 Avenue of the Americas
31st Floor New York, NY 10036.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"></P>

<!-- Field: Page; Sequence: 3; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-left: 0.5in; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.27.
&ldquo;<B><U>Written Communication</U></B>&rdquo; has the meaning set forth in Rule 405 under the Securities Act.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-left: 0.5in; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.28.
&ldquo;<B><U>Written Testing-the-Waters Communications</U></B>&rdquo; means any Testing-the-Waters Communication that is a Written Communication.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">

    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in; padding-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><U>Representations
    and Warranties of the Company</U></B>. The Company hereby represents and warrants to, and agrees with, the Underwriter that the following
    matters are true and accurate and do not contain any untrue statement of a material fact or omit to state a material fact required
    to be stated therein or necessary to make the statements therein not misleading. Any certificate signed by an officer of the Company
    and delivered to the Underwriter or to counsel for the Underwriter shall be deemed to be a representation and warranty by the Company
    to the Underwriter as to the matters set forth therein.</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-left: 0.5in; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.1.
<B><U>Registration Statement</U>.</B> The Company has prepared and filed the Registration Statement with the Commission under the Securities
Act. The Commission has declared the Registration Statement effective under the Securities Act and the Company has not as of the date
of this Agreement filed a post-effective amendment to the Registration Statement. The Commission has not issued any order suspending
the effectiveness of the Registration Statement or any order preventing or suspending the use of the Registration Statement, the Final
Prospectus, any Preliminary Prospectus, any Issuer Free Writing Prospectus or any Testing-the-Waters Communication, and no proceedings
for such purpose or pursuant to Section 8A of the Securities Act have been initiated, are pending before or, to the Company&rsquo;s knowledge,
threatened by the Commission.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="text-indent: 0.5in; font: 10pt Times New Roman, Times, Serif; margin-left: 0.5in; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.1.1.
The Registration Statement, at the time it became effective, did not contain, and any post-effective amendment thereto, as of the effective
date of such amendment, will not contain, any untrue statement of a material fact or omit to state a material fact required to be stated
therein or necessary to make the statements therein not misleading; <U>provided</U> that the Company makes no representation or warranty
with respect to any statements or omissions made in reliance upon and in conformity with information relating to the Underwriter furnished
to the Company in writing by the Underwriter expressly for use in the Registration Statement (including any post-effective amendment
thereto), the Pricing Disclosure Package, the Final Prospectus (including any amendments or supplements thereto), any Preliminary Prospectus,
any Issuer Free Writing Prospectus or any Testing-the-Waters Communication, it being understood and agreed that the only such information
furnished by the Underwriter consists of the information described in Section 9.3 hereof (collectively, the &ldquo;<B><U>Underwriter
Information</U></B>&rdquo;).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-indent: 0.5in; margin-left: 0.5in; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.1.2.
Each of the Registration Statement and any post-effective amendment thereto, at the time it became effective and at the date hereof,
complied and will comply in all material respects with the Securities Act.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-left: 0.5in; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.2.
<B><U>Pricing Disclosure Package</U></B>. The Pricing Disclosure Package, as of the Applicable Time, did not, and as of the Closing Date
(as defined below) and as of any Additional Closing Date (as defined below), as the case may be, will not, contain any untrue statement
of a material fact or omit to state a material fact necessary in order to make the statements therein, in the light of the circumstances
under which they were made, not misleading; <U>provided</U> that the Company makes no representation or warranty with respect to any
statements or omissions made in reliance upon and in conformity with the Underwriter Information.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"></P>

<!-- Field: Page; Sequence: 4; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-left: 0.5in; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.3.
<B><U>Final Prospectus</U></B>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-indent: 0.5in; margin-left: 0.5in; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.3.1.
Each of the Final Prospectus and any amendments or supplements thereto, as of its date, as of the time it is filed with the Commission
pursuant to Rule 424(b) under the Securities Act, as of the Closing Date and as of any Additional Closing Date, as the case may be, will
not contain any untrue statement of a material fact or omit to state a material fact necessary in order to make the statements therein,
in the light of the circumstances under which they were made, not misleading; <U>provided</U> that the Company makes no representation
or warranty with respect to any statements or omissions made in reliance upon and in conformity with the Underwriter Information.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-indent: 0.5in; margin-left: 0.5in; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.3.2.
Each of the Final Prospectus and any amendments or supplements thereto, at the time it is filed with the Commission pursuant to Rule
424(b) under the Securities Act, as of the Closing Date and as of any Additional Closing Date, as the case may be, will comply in all
material respects with the Securities Act.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-left: 0.5in; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.4.
<B><U>Preliminary Prospectuses</U></B>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-indent: 0.5in; margin-left: 0.5in; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.4.1.
Each Preliminary Prospectus, when considered together with any amendments or supplements thereto, as of the time it was filed with the
Commission pursuant to Rule 424(a) under the Securities Act, if any, did not contain any untrue statement of a material fact or omit
to state a material fact necessary in order to make the statements therein, in the light of the circumstances under which they were made,
not misleading; <U>provided</U> that the Company makes no representation or warranty with respect to any statements or omissions made
in reliance upon and in conformity with the Underwriter Information.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-indent: 0.5in; margin-left: 0.5in; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.4.2.
Each Preliminary Prospectus, when considered together with any amendments or supplements thereto, at the time it was filed with the Commission
pursuant to Rule 424(a) under the Securities Act, if any, complied in all material respects with the Securities Act.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-left: 0.5in; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.5.
<B><U>Issuer Free Writing Prospectuses</U></B>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-indent: 0.5in; margin-left: 0.5in; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.5.1.
Each Issuer Free Writing Prospectus, when considered together with the Preliminary Prospectus accompanying, or delivered prior to the
delivery of, such Issuer Free Writing Prospectus, did not, as of the date of such Issuer Free Writing Prospectus, and will not, as of
the Closing Date and as of any Additional Closing Date, as the case may be, contain any untrue statement of a material fact or omit to
state a material fact necessary in order to make the statements therein, in the light of the circumstances under which they were made,
not misleading; <U>provided</U> that the Company makes no representation or warranty with respect to any statements or omissions made
in reliance upon and in conformity with the Underwriter Information.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<!-- Field: Page; Sequence: 5; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-indent: 0.5in; margin-left: 0.5in; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.5.2.
Each Issuer Free Writing Prospectus, at the time of filing with the Commission, complied or will comply in all material respects with
the Securities Act.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-indent: 0.5in; margin-left: 0.5in; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.5.3.
The Company has filed, or will file, with the Commission, within the time period specified in Rule 433(d) under the Securities Act, any
Free Writing Prospectus it is required to file pursuant to Rule 433(d) under the Securities Act. The Company has made available any Bona
Fide Electronic Road Show used by it in compliance with Rule 433(d)(8)(ii) under the Securities Act such that no filing of any &ldquo;road
show&rdquo; (as defined in Rule 433(h) under the Securities Act) (&ldquo;<B><U>Road Show</U></B>&rdquo;) is required in connection with
the offering of the Units.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-indent: 0.5in; margin-left: 0.5in; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.5.4.
Except for the Issuer Free Writing Prospectuses, if any, set forth in Schedule 2.5.4 hereto and electronic road shows, if any, each furnished
to the Underwriter before first use, the Company has not used, authorized the use of, referred to or participated in the planning for
use of, and will not, without the prior consent of the Underwriter, use, authorize the use of, refer to or participate in the planning
for use of, any Free Writing Prospectus.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-left: 0.5in; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.6.
<B><U>Testing-the-Waters Communications</U></B>. The Company has not (x) alone engaged in any Testing-the-Waters Communication other
than Testing-the-Waters Communications with the consent of the Underwriter or any underwriter that the Company has previously identified
to the Underwriter with entities that are qualified institutional buyers within the meaning of Rule 144A under the Act or institutions
that are accredited investors within the meaning of Rule 501 under the Act, and (y) authorized anyone other than the Underwriters, or
any underwriter that the Company has previously identified to the Representatives, to engage in Testing-the-Waters Communications.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-left: 0.5in; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.7.
<B><U>No Other Disclosure Materials</U></B>. Other than the Registration Statement, the Pricing Disclosure Package, the Final Prospectus
and the Road Show, the Company (including its agents and representatives, other than the Underwriter or any underwriter that the Company
has previously identified to the Underwriter, as to which no representation or warranty is given) has not, directly or indirectly, distributed,
prepared, used, authorized, approved or referred to, and will not distribute, prepare, use, authorize, approve or refer to, any offering
material in connection with the offering and sale of the Units.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-left: 0.5in; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.8.
<B><U>Ineligible Issuer</U></B>. At the time of filing of the registration statement on Form S-1 (File No. 333-[&#9679;]) registering
the offer and sale of the Securities submitted to the Commission on [&#9679;] and any amendment thereto and at the date hereof, the Company
was not and is not an &ldquo;ineligible issuer&rdquo; (as defined in Rule 405 under the Securities Act).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-left: 0.5in; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.9.
<B><U>Emerging Growth Company</U></B>. From the time of the initial filing of the Registration Statement with the Commission (or, if
earlier, the first date on which the Company engaged directly or through any person authorized to act on its behalf in any Testing-the-Waters
Communication) through the date hereof, the Company has been and is an Emerging Growth Company.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<!-- Field: Page; Sequence: 6; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->6<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-left: 0.5in; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.10.
<B><U>Smaller Reporting Company</U></B>. From the time of initial filing of the Registration Statement with the Commission (or, if earlier,
the first date on which the Company engaged directly or through any person authorized to act on its behalf in any Testing-the-Waters
Communication) through the date hereof, the Company has been and is a &ldquo;smaller reporting company,&rdquo; as defined in Rule 12b-2
under the Exchange Act.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-left: 0.5in; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.11.
<B><U>Due Authorization</U></B>. The Company has full right, power and authority to execute and deliver this Agreement and to perform
its obligations hereunder; and all action required to be taken for the due and proper authorization, execution and delivery by it of
this Agreement and the consummation by it of the transactions contemplated hereby has been duly and validly taken.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-left: 0.5in; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.12.
<B><U>Underwriting Agreement</U></B>. This Agreement has been duly authorized, executed and delivered by the Company and, assuming the
due authorization, execution and delivery by the other parties hereto, constitutes the legal, valid and binding obligation of the Company,
enforceable against the Company in accordance with its terms, except as (i) the enforcement may be limited by bankruptcy, insolvency,
fraudulent transfer, reorganization, moratorium or other similar laws relating to or affecting the rights and remedies of creditors generally
or by general equitable principles (whether considered in a proceeding at law or in equity) relating to enforceability and (ii) rights
to indemnification and contribution hereunder may be limited by applicable law and public policy considerations.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-left: 0.5in; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.13.
<B><U>No Material Adverse Change</U></B>. Except as otherwise disclosed in the Registration Statement, the Pricing Disclosure Package
and the Final Prospectus (in each case exclusive of any amendment or supplement thereto), since the date of the most recent financial
statements included or incorporated by reference in the Registration Statement, the Pricing Disclosure Package and the Final Prospectus:
(i) there has been no material adverse change, or any development that could result in a material adverse change, in or affecting the
condition (financial or otherwise), earnings, business, properties, management, financial position, stockholders&rsquo; equity, or results
of operations, whether or not arising from transactions in the ordinary course of business, of the Company and its subsidiaries, considered
as a whole; (ii) there has been no change in the share capital (other than (A) the issuance of Shares upon the exercise or settlement
(including any &ldquo;net&rdquo; or &ldquo;cashless&rdquo; exercises or settlements) of stock options, restricted stock units or warrants
described as outstanding, (B) the grant of options and awards under existing equity incentive plans, or (C) the repurchase of shares
of Common Stock by the Company, which were issued pursuant to the early exercise of stock options by option holders and are subject to
repurchase by the Company, in each case, as described in the Registration Statement, the Pricing Disclosure Package and the Final Prospectus),
or material change in the short-term debt or long-term debt of the Company or any of its subsidiaries, considered as a whole; and (iii)
the Company and its subsidiaries, considered as a whole, have not incurred any material liability or obligation, indirect, direct or
contingent (whether or not in the ordinary course of business); nor entered into any transaction or agreement (whether or not in the
ordinary course of business) that is material to the Company and its subsidiaries, considered as a whole; and (iv) there has been no
dividend or distribution of any kind declared, set aside for payment, paid or made by the Company or, except for dividends paid to the
Company or other subsidiaries of the Company, any of its subsidiaries on any class of capital stock or repurchase or redemption by the
Company or any of its subsidiaries of any class of capital stock.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<!-- Field: Page; Sequence: 7; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->7<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-left: 0.5in; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.14.
<B><U>Organization and Good Standing of the Company and its Subsidiaries</U></B>. The Company and each of its subsidiaries have been
duly incorporated and are validly existing and in good standing under the laws of their respective jurisdictions of organization, are
duly qualified to do business and are in good standing in each jurisdiction in which their respective ownership or lease of property
or the conduct of their respective businesses requires such qualification, and have all power and authority (corporate and other) necessary
to own, lease or hold their respective properties and to conduct the businesses in which they are engaged as described in the Registration
Statement, the Pricing Disclosure Package and the Final Prospectus, except where the failure to be in good standing, to be so qualified
or to have such power or authority could not, individually or in the aggregate, have a material adverse effect on the condition (financial
or otherwise), earnings, business, properties, management, financial position, stockholders&rsquo; equity, or results of operations of
the Company and its subsidiaries, considered as a whole, or adversely affect the performance by the Company of its obligations under
this Agreement (a &ldquo;<B><U>Material Adverse Effect</U></B>&rdquo;).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-left: 0.5in; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.15.
<B><U>Capitalization</U></B>. The capitalization of the Company is as set forth in the Registration Statement, the Pricing Disclosure
Package and the Final Prospectus under the heading &ldquo;Capitalization&rdquo;. All of the outstanding capital stock of the Company
has been duly authorized and validly issued and is fully paid and non-assessable. The Securities have been duly authorized and, when
issued and paid for as contemplated herein, will be validly issued, fully paid and non-assessable; the holders thereof are not and will
not be subject to personal liability by reason of being such holders; the Securities are not and will not be subject to the preemptive
rights of any holders of any security of the Company or similar contractual rights granted by the Company; and all corporate action required
to be taken for the authorization, issuance and sale of the Securities has been duly and validly taken. None of the outstanding shares
of Common Stock of the Company were issued in violation of any preemptive rights, rights of first refusal or other similar rights to
subscribe for or purchase securities of the Company. Except as disclosed in the Registration Statement, the Pricing Disclosure Package
and the Final Prospectus, there are no authorized or outstanding options, warrants, preemptive rights, rights of first refusal or other
rights to acquire, or instruments convertible into or exchangeable or exercisable for, any Shares of, or other equity interest in, the
Company or any of its subsidiaries. All of the outstanding shares of, or other equity interest in, each of the Company&rsquo;s subsidiaries
(i) have been duly authorized and validly issued, (ii) are fully paid and non-assessable and (iii) are owned by the Company, directly
or through the Company&rsquo;s subsidiaries, free and clear of any security interest, mortgage, pledge, lien, encumbrance, charge, claim
or restriction on voting or transfer (collectively, &ldquo;<B><U>Liens</U></B>&rdquo;).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-left: 0.5in; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.16.
<B><U>Common Stock Incentive Plans</U></B>. With respect to the Common Stock options (the &ldquo;<B><U>Stock Options</U></B>&rdquo;)
granted pursuant to the Common Stock-based compensation plans of the Company and its subsidiaries (the &ldquo;<B><U>Company Common Stock
Incentive Plans</U></B>&rdquo;), (i) each Stock Option intended to qualify as an &ldquo;incentive stock option&rdquo; under Section 422
of the Internal Revenue Code of 1986, as amended (the &ldquo;<B><U>Code</U></B>&rdquo;), so qualifies, (ii) each grant of a Stock Option
was duly authorized by all necessary corporate action, including, as applicable, approval by the board of directors of the Company (or
a duly constituted and authorized committee thereof) and any required stockholders approval by the necessary number of votes or written
consents, and the award agreement governing such grant (if any), to the Company&rsquo;s knowledge, was duly executed and delivered by
each party thereto, (iii) each such grant was made in all material respects in accordance with the terms of the Company Common Stock
Incentive Plans, and (iv) each such grant was properly accounted for in accordance with United States generally accepted accounting principles
applied on a consistent basis during the periods involved (&ldquo;<B><U>GAAP</U></B>&rdquo;) in the financial statements (including the
related notes) of the Company.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"></P>

<!-- Field: Page; Sequence: 8; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->8<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-left: 0.5in; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.17.
<B><U>No Violation or Default</U></B>. Neither the Company nor any of its subsidiaries is: (i) in violation of its charter, by-laws or
similar organizational documents; (ii) in default, and no event has occurred that, with notice or lapse of time or both, would constitute
such a default, in the due performance or observance of any term, covenant, condition or other obligation contained in any indenture,
mortgage, deed of trust, loan agreement, contract, undertaking or other agreement or instrument to which the Company or any of its subsidiaries
is a party or by which the Company or any of its subsidiaries is bound or to which any property, right or asset of the Company or any
of its subsidiaries is subject; or (iii) in violation of any law or statute applicable to the Company or any of its subsidiaries or any
judgment, order, rule or regulation of any court or arbitrator or governmental or regulatory authority having jurisdiction over the Company
or any of its subsidiaries, or any of their respective properties or assets, except, in the case of clauses (ii) and (iii) above, for
any such default or violation that would not, individually or in the aggregate, have a Material Adverse Effect.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-left: 0.5in; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.18.
<B><U>No Conflicts</U></B>. None of (i) the execution, delivery and performance of this Agreement by the Company, (ii) the issuance,
sale and delivery of the Closing Units or the Option Securities, (iii) the application of the proceeds of the offering as described under
&ldquo;Use of Proceeds&rdquo; in the Registration Statement, the Pricing Disclosure Package and the Final Prospectus, or (iv) the consummation
of the transactions contemplated herein will: (x) result in any violation of the terms or provisions of the charter, by-laws or similar
organizational documents of the Company or any of its subsidiaries; (y) conflict with, result in a breach or violation of, or require
the approval of stockholders, members or partners or any approval or consent of any persons under, any of the terms or provisions of,
constitute a default under, result in the termination, modification, or acceleration of, or result in the creation or imposition of any
lien, charge or encumbrance upon any property, right or asset of the Company or any of its subsidiaries pursuant to, any indenture, mortgage,
deed of trust, loan agreement, note agreement, contract, undertaking or other agreement, obligation, condition, covenant or instrument
to which the Company or any of its subsidiaries is a party or by which the Company or any of its subsidiaries is bound or to which any
property, right or asset of the Company or any of its subsidiaries is subject; or (z) result in the violation of any law, statute, judgment,
order, rule, decree or regulation applicable to the Company or any of its subsidiaries of any court, arbitrator, governmental or regulatory
authority, agency or body having jurisdiction over the Company or any of its subsidiaries or any of their respective properties or assets.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-left: 0.5in; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.19.
<B><U>No Consents Required</U></B>. No consent, approval, authorization, order, filing, registration, license or qualification of or
with any court, arbitrator, or governmental or regulatory authority, agency, or body is required for (i) the execution, delivery and
performance by the Company of this Agreement; (ii) the issuance, sale and delivery of the Securities ; or (iii) the consummation of the
transactions contemplated herein, except for such consents, approvals, authorizations, orders, filings, registrations or qualifications
as (x) have already been obtained or made and are still in full force and effect, (y) may be required by FINRA and the Nasdaq Capital
Market, and (z) may be required under applicable state securities laws in connection with the purchase, distribution and resale of the
Securities by the Underwriter.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"></P>

<!-- Field: Page; Sequence: 9; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->9<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-left: 0.5in; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.20.
<B><U>Independent Accountants</U></B>. PKF O&rsquo;Connor Davies, LLP, 245 Park Ave, New York, NY 10167, which expressed its opinion
with respect to the financial statements (which term as used in this Agreement includes the related notes thereto) and supporting schedules
included in the Registration Statement, the Pricing Disclosure Package and the Final Prospectus, is an independent registered public
accounting firm with respect to the Company and its subsidiaries within the meaning of the rules and regulations of the Commission and
the Public Company Accounting Oversight Board and as required by the Securities Act.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-left: 0.5in; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.21.
<B><U>Financial Statements and Other Financial Data</U></B>. The financial statements (including the related notes thereto), together
with the supporting schedules, included in the Registration Statement, the Pricing Disclosure Package and the Final Prospectus comply
in all material respects with the applicable requirements of the Securities Act and present fairly the consolidated financial position
of the entities to which they relate as of and at the dates indicated and the results of their operations and cash flows for the periods
specified. Such financial statements, notes and schedules have been prepared in conformity with GAAP applied on a consistent basis throughout
the periods involved, except as may be expressly stated in the notes thereto and except, in the case of unaudited interim financial statements,
subject to normal year end audit adjustments and the exclusion of certain footnotes as permitted by the applicable rules of the Commission.
The financial data set forth in the Registration Statement, the Pricing Disclosure Package and the Final Prospectus under the captions
&ldquo;Capitalization&rdquo; present fairly the information set forth therein on a basis consistent with that of the audited financial
statements included in the Registration Statement, the Pricing Disclosure Package and the Final Prospectus.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-left: 0.5in; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.22.
<B><U>Statistical and Market-Related Data</U></B>. The statistical and market-related data included in the Registration Statement, the
Pricing Disclosure Package and the Final Prospectus are based on or derived from sources that the Company reasonably and in good faith
believes to be accurate and reliable in all material respects.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-left: 0.5in; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.23.
<B><U>Forward-Looking Statements</U></B>. No forward-looking statement (within the meaning of Section 27A of the Securities Act and Section
21E of the Exchange Act) included in the Registration Statement, the Pricing Disclosure Package or the Final Prospectus has been made
or reaffirmed without a reasonable basis or has been disclosed other than in good faith.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"></P>

<!-- Field: Page; Sequence: 10; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->10<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-left: 0.5in; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.24.
<B><U>Legal Proceedings</U></B>. Except as disclosed in the Registration Statement, the Pricing Disclosure Package and the Final Prospectus,
(i) there are no legal, governmental or regulatory investigations, actions, demands, claims, suits, arbitrations, inquiries or proceedings
(collectively, &ldquo;<B><U>Actions</U></B>&rdquo;) pending to which the Company or any of its subsidiaries is or may be a party or to
which any property, right or asset of the Company or any of its subsidiaries is or may be the subject that, individually or in the aggregate,
if determined adversely to the Company or any of its subsidiaries, could have a Material Adverse Effect; and (ii) to the knowledge of
the Company, no such Actions are threatened or contemplated by any governmental or regulatory authority or by others.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-left: 0.5in; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.25.
<B><U>Labor Disputes</U></B>. No labor disturbance by or dispute with the employees of the Company or any of its subsidiaries exists
or, to the knowledge of the Company, is threatened or contemplated that could, individually or in the aggregate, have a Material Adverse
Effect.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-left: 0.5in; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.26.
<B><U>Intellectual Property Rights</U></B>. (i) The Company and its subsidiaries own or have the right to use all patents, patent applications,
trademarks, service marks, trade names, and other source indicators and registrations and applications for registration thereof, domain
name registrations, copyrights and registrations and applications for registration thereof, technology and know-how, trade secrets, and
all other intellectual property and related proprietary rights (collectively, &ldquo;<B><U>Intellectual Property Rights</U></B>&rdquo;)
necessary to conduct their respective businesses; (ii) other than as disclosed in the Prospectus, neither the Company nor any of its
subsidiaries has received any notice of infringement, misappropriation or other conflict with (and neither the Company nor any of its
subsidiaries is otherwise aware of any infringement, misappropriation or other conflict with) the Intellectual Property Rights of any
other person, except for such infringement, misappropriation or other conflict as could not have a Material Adverse Effect; and (iii)
to the knowledge of the Company, the Intellectual Property Rights of the Company and its subsidiaries are not being infringed, misappropriated
or otherwise violated by any person.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-left: 0.5in; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.27.
<B><U>Licenses and Permits</U></B>. (i) The Company and its subsidiaries possess such valid and current certificates, authorizations,
approvals, licenses and permits (collectively, &ldquo;<B><U>Authorizations</U></B>&rdquo;) issued by, and have made all declarations,
amendments, supplements and filings with, the appropriate state, federal or foreign regulatory agencies or bodies necessary to own, lease
and operate their respective properties and to conduct their respective businesses as set forth in the Registration Statement, the Pricing
Disclosure Package and the Final Prospectus; (ii) all such Authorizations are valid and in full force and effect and the Company and
its subsidiaries are in compliance with the terms and conditions of all such Authorizations; and (iii) neither the Company nor any of
its subsidiaries has received notice of any revocation, termination or modification of, or non-compliance with, any such Authorization
or has any reason to believe that any such Authorization will not be renewed in the ordinary course, except where, in the case of clauses
(i), (ii) and (iii), the failure to possess, make or obtain such Authorizations (by possession, declaration or filing) could not, individually
or in the aggregate, have a Material Adverse Effect.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"></P>

<!-- Field: Page; Sequence: 11; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->11<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-left: 0.5in; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.28.
<B><U>Title to Property</U></B>. The Company and its subsidiaries have good and marketable title to, or have valid and enforceable rights
to lease or otherwise use, all items of real property and personal property (other than with respect to Intellectual Property Rights,
which is addressed exclusively in Section 2.26) that are material to the respective businesses of the Company and its subsidiaries, in
each case, free and clear of all liens, encumbrances, claims, and defects and imperfections of title, except such liens, encumbrances,
claims, defects and imperfections as (i) are disclosed in the Registration Statement, the Pricing Disclosure Package and the Final Prospectus,
or (ii) do not materially affect the value of such property and do not materially interfere with the use made or proposed to be made
of such property by the Company and its subsidiaries. The Company and its subsidiaries have good and marketable title to, or have valid
and enforceable rights to lease or otherwise use, all items of real and personal property that are material to the respective businesses
of the Company and its subsidiaries, in each case, free and clear of all liens, encumbrances, claims and defects and imperfections of
title, except such liens, encumbrances, claims, defects and imperfections as (i) are disclosed in the Registration Statement, the Pricing
Disclosure Package and the Final Prospectus, or (ii) do not materially affect the value of such property and do not materially interfere
with the use made or proposed to be made of such property by the Company and its subsidiaries. All items of real and personal property
held under lease by the Company and its subsidiaries are held under valid, subsisting and enforceable leases, with such exceptions as
do not materially interfere with the use made or proposed to be made of such property by the Company and its subsidiaries.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-left: 0.5in; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.29.
<B><U>Taxes</U></B>. The Company and each of its subsidiaries have filed all federal, state, local and foreign tax returns required to
be filed through the date hereof or have timely requested extensions thereof and have paid all taxes required to be paid thereon (except
as currently being contested in good faith and for which reserves required by GAAP have been created in the financial statements of the
Company). The charges, accruals and reserves in respect of any income and other tax liability in the financial statements of the Company
referred to in Section 2.21 are adequate, in accordance with GAAP principles, to meet any assessments for any taxes of the Company accruing
through the end of the last period specified in such financial statements.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-left: 0.5in; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.30.
<B><U>Solvency</U></B>. Based on the consolidated financial condition of the Company as of the Closing Date, after giving effect to the
receipt by the Company of the proceeds from the sale of the Closing Units hereunder, (i) the fair saleable value of the Company&rsquo;s
assets exceeds the amount that will be required to be paid on or in respect of the Company&rsquo;s existing debts and other liabilities
(including known contingent liabilities) as they mature, (ii) the Company&rsquo;s assets do not constitute unreasonably small capital
to carry on its business as now conducted and as proposed to be conducted including its capital needs taking into account the particular
capital requirements of the business conducted by the Company, consolidated and projected capital requirements and capital availability
thereof, and (iii) the current cash flow of the Company, together with the proceeds the Company would receive, were it to liquidate all
of its assets, after taking into account all anticipated uses of the cash, would be sufficient to pay all amounts on or in respect of
its liabilities when such amounts are required to be paid. The Company does not intend to incur debts beyond its ability to pay such
debts as they mature (taking into account the timing and amounts of cash to be payable on or in respect of its debt). The Company has
no knowledge of any facts or circumstances which lead it to believe that it will file for reorganization or liquidation under the bankruptcy
or reorganization laws of any jurisdiction within one year after the Closing Date. The Registration Statement sets forth as of the date
hereof all outstanding secured and unsecured Indebtedness of the Company or any Subsidiary, or for which the Company or any Subsidiary
has commitments. Neither the Company nor any Subsidiary is in default with respect to any Indebtedness.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<!-- Field: Page; Sequence: 12; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->12<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-left: 0.5in; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.31.
<B><U>Investment Company Act</U></B>. Neither the Company nor any of its subsidiaries is or, after giving effect to the offer and sale
of the Securities and the application of the proceeds therefrom as described under &ldquo;Use of Proceeds&rdquo; in the Registration
Statement, the Pricing Disclosure Package and the Final Prospectus, will be required to register as an &ldquo;investment company&rdquo;
(as defined in the Investment Company Act).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-left: 0.5in; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.32.
<B><U>Insurance</U></B>. The Company and its subsidiaries are insured by recognized, financially sound institutions in such amounts,
with such amounts, with such deductibles and covering such losses and risks as the Company reasonably believes to be adequate for the
conduct of their respective businesses and the value of their respective properties and as is prudent and customary for companies engaged
in similar businesses in similar industries. All insurance policies and fidelity or surety bonds insuring the Company and its subsidiaries
or their respective businesses, assets, employees, officers and directors are in full force and effect; the Company and its subsidiaries
are in compliance with the terms of such policies in all material respects; neither the Company nor any of its subsidiaries has received
notice from any insurer or agent of such insurer that capital improvements or other expenditures are required to be made in order to
continue such insurance; and neither the Company nor any of its subsidiaries has been refused any insurance coverage sought or applied
for. There are no claims by the Company or any of its subsidiaries under any such policy as to which any insurer is denying liability
or defending under a reservation of rights clause; and neither the Company nor any of its subsidiaries has any reason to believe that
it will not be able to renew its existing insurance coverage as and when such coverage expires or to obtain similar coverage from similar
insurers as may be necessary to continue its business at a cost that could not have a Material Adverse Effect.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-left: 0.5in; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.33.
<B><U>No Stabilization or Manipulation</U></B>. None of the Company, nor its Affiliates, or, to the knowledge of the Company, any person
acting on its or any of their behalf (other than the Underwriter, as to which no representation or warranty is given) has taken, directly
or indirectly, any action designed to or that has constituted or that could reasonably be expected to cause or result in the stabilization
or manipulation of the price of any securities of the Company. The Company acknowledges that the Underwriter may engage in passive market
making transactions in the Common Stock on the Nasdaq Capital Market (the &ldquo;<B><U>Exchange</U></B>&rdquo;) in accordance with Regulation
M under the Exchange Act (&ldquo;<B><U>Regulation M</U></B>&rdquo;).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-left: 0.5in; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.34.
<B><U>Compliance with the Sarbanes-Oxley Act</U></B>. The Company and, to the knowledge of the Company, its officers and directors, in
their capacities as such, are and have been in compliance with all applicable provisions of the Sarbanes-Oxley Act.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"></P>

<!-- Field: Page; Sequence: 13; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->13<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-left: 0.5in; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.35.
<B><U>Accounting Controls</U></B>. The Company and its subsidiaries maintain systems of &ldquo;internal control over financial reporting&rdquo;
(as defined in Rule 13a-15(f) of the Exchange Act) that comply with the requirements of the Exchange Act and have been designed by, or
under the supervision of, their principal executive and principal financial officers, or persons performing similar functions, to provide
reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes
in accordance with GAAP. The Company and its subsidiaries maintain internal accounting controls sufficient to provide reasonable assurance
that (i) transactions are executed in accordance with management&rsquo;s general or specific authorizations; (ii) transactions are recorded
as necessary to permit preparation of financial statements in conformity with GAAP and to maintain asset accountability; (iii) access
to assets is permitted only in accordance with management&rsquo;s general or specific authorization; and (iv) the recorded accountability
for assets is compared with the existing assets at reasonable intervals and appropriate action is taken with respect to any differences.
Other than as disclosed in the Registration Statement, the Company maintains a system of internal control over financial reporting and
the Company is not aware of any other material weaknesses in its internal control over financial reporting (whether or not remediated).
Other than as disclosed in the Registration Statement, since the date of the most recent balance sheet included in the Registration Statement,
the Pricing Disclosure Package and the Final Prospectus, (x) the Company&rsquo;s auditors and the board of directors of the Company have
not been advised of (A) any new significant deficiencies or material weaknesses in the design or operation of the internal control over
financial reporting of the Company and its subsidiaries which could adversely affect the Company&rsquo;s ability to record, process,
summarize, and report financial data; or (B) any fraud, whether or not material, that involves management or other employees who have
a role in the internal control over financial reporting of the Company or its subsidiaries; and (y) there have been no significant changes
in the internal control over financial reporting of the Company or its subsidiaries or in other factors that could significantly affect,
such internal control over financial reporting, including any corrective actions with regard to significant deficiencies or material
weaknesses, since the respective dates as of which information is given in the Registration Statement, the Pricing Disclosure Package
and the Final Prospectus.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-left: 0.5in; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-left: 0.5in; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.36.
<B><U>Disclosure Controls and Procedures</U></B>. The Company and its subsidiaries have established and maintain disclosure controls
and procedures (as such term is defined in Rule 13a-15(e) under the Exchange Act) that are designed to comply with the requirements of
the Exchange Act; such disclosure controls and procedures are designed to ensure that information required to be disclosed by the Company
and its subsidiaries in the reports they file or submit under the Exchange Act is recorded, processed, summarized and reported within
the time periods specified in the Commission&rsquo;s rules and forms, including controls and procedures designed to ensure that such
information is accumulated and communicated to the Company&rsquo;s management as appropriate to allow timely decisions regarding required
disclosure; and such disclosure controls and procedures are effective to perform the functions for which they were established.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"></P>

<!-- Field: Page; Sequence: 14; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->14<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-left: 0.5in; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.37.
<B><U>Compliance with Environmental Laws</U></B>. The Company and each of its subsidiaries (i) are, and at all times prior hereto were,
in compliance with all Environmental Laws (as defined below) applicable to such entity, which compliance includes, without limitation,
obtaining, maintaining and complying with all permits and authorizations and approvals required by Environmental Laws to conduct their
respective businesses; and (ii) have not received notice or otherwise have knowledge of any actual or alleged violation of Environmental
Laws, or of any actual or potential liability for or other obligation concerning the presence, disposal or release of hazardous or toxic
substances or wastes, pollutants or contaminants, and, except as described in the Registration Statement, the Pricing Disclosure Package
and the Final Prospectus, (x) there are no proceedings that are pending, or known to be contemplated, against the Company or any of its
subsidiaries under Environmental Laws, other than such proceedings regarding which would not, individually or in the aggregate, have
a Material Adverse Effect; (y) to the knowledge of the Company, none of the Company or any of its subsidiaries is aware of any issues
regarding compliance with Environmental Laws, including any pending or proposed Environmental Laws, or liabilities or other obligations
under Environmental Laws or concerning hazardous or toxic substances or wastes, pollutants or contaminants, that could reasonably be
expected to have a material effect on the capital expenditures, earnings or competitive position of the Company and its subsidiaries;
and (z) none of the Company or any of its subsidiaries anticipates material capital expenditures relating to Environmental Laws. As used
herein, the term &ldquo;<B><U>Environmental Laws</U></B>&rdquo; means any laws, regulations, ordinances, rules, orders, judgments, decrees,
permits or other legal requirements of any governmental authority, including, without limitation, any international, foreign, national,
state, provincial, regional, or local authority, relating to pollution, the protection of human health or safety, the environment, or
natural resources, or to the use, handling, storage, manufacturing, transportation, treatment, discharge, disposal or release of hazardous
or toxic substances or wastes, pollutants or contaminants.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-left: 0.5in; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.38.
<B><U>ERISA</U></B>. Each &ldquo;employee benefit plan&rdquo; (within the meaning of Section 3(3) of the Employee Retirement Security
Act of 1974, as amended (&ldquo;<B><U>ERISA</U></B>&rdquo;)) for which the Company or any member of its &ldquo;Controlled Group&rdquo;
(defined as any organization which is a member of a controlled group of corporations within the meaning of Section 414 of the Code) would
have any liability (each, a &ldquo;<B><U>Plan</U></B>&rdquo;) complies in form with the requirements of all applicable statutes, rules
and regulations including ERISA and the Code, and has been maintained and administered in substantial compliance with its terms and with
the requirements of all applicable statutes, rules and regulations including ERISA and the Code; (ii) with respect to each Plan subject
to Title IV of ERISA or Section 302 of ERISA or Section 412 and 430 of the Code (A) no &ldquo;reportable event&rdquo; (within the meaning
of Section 4043(c) of ERISA) has occurred or is reasonably expected to occur, (B) no failure to satisfy the minimum funding standard
(within the meaning of Section 302 of ERISA or Section 412 and 430 of the Code), whether or not waived, has occurred or is reasonably
expected to occur, (C) the fair market value of the assets under each Plan (excluding for these purposes accrued but unpaid contributions)
exceeds the present value of all benefits accrued under such Plan (determined based on those assumptions used to fund such Plan) and
(D) neither the Company or any member of its Controlled Group has incurred, or reasonably expects to incur, any liability under Title
IV of ERISA (other than contributions to the Plan or premiums to the Pension Benefit Guaranty Corporation in the ordinary course and
without default) in respect of a Plan (including a &ldquo;multiemployer plan&rdquo;, within the meaning of Section 4001(a)(3) of ERISA);
(iii) each Plan that is intended to be qualified under Section 401(a) of the Code is so qualified and nothing has occurred, whether by
action or by failure to act, which would cause the loss of such qualification; and (iv) no prohibited transaction, within the meaning
of Section 406 of ERISA or Section 4975 of the Code, has occurred with respect to any Plan excluding transactions to which a statutory
or administrative prohibited transaction exemption applies.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"></P>

<!-- Field: Page; Sequence: 15; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->15<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-left: 0.5in; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.39.
<B><U>FDA</U></B>. As to each product subject to the jurisdiction of the U.S. Food and Drug Administration (&ldquo;<B><U>FDA</U></B>&rdquo;)
under the Federal Food, Drug and Cosmetic Act, as amended, and the regulations thereunder (&ldquo;<B><U>FDCA</U></B>&rdquo;) that is
manufactured, packaged, labeled, tested, distributed, sold, and/or marketed by the Company or any of its Subsidiaries (each such product,
a &ldquo;<B><U>Pharmaceutical Product</U></B>&rdquo;), such Pharmaceutical Product is being manufactured, packaged, labeled, tested,
distributed, sold and/or marketed by the Company in compliance with all applicable requirements under FDCA and similar laws, rules and
regulations relating to registration, investigational use, premarket clearance, licensure, or application approval, good manufacturing
practices, good laboratory practices, good clinical practices, product listing, quotas, labeling, advertising, record keeping and filing
of reports, except where the failure to be in compliance would not have a Material Adverse Effect. There is no pending, completed or,
to the Company&rsquo;s knowledge, threatened, action (including any lawsuit, arbitration, or legal or administrative or regulatory proceeding,
charge, complaint, or investigation) against the Company or any of its Subsidiaries, and none of the Company or any of its Subsidiaries
has received any notice, warning letter or other communication from the FDA or any other governmental entity, which (i) contests the
premarket clearance, licensure, registration, or approval of, the uses of, the distribution of, the manufacturing or packaging of, the
testing of, the sale of, or the labeling and promotion of any Pharmaceutical Product, (ii) withdraws its approval of, requests the recall,
suspension, or seizure of, or withdraws or orders the withdrawal of advertising or sales promotional materials relating to, any Pharmaceutical
Product, (iii) imposes a clinical hold on any clinical investigation by the Company or any of its Subsidiaries, (iv) enjoins production
at any facility of the Company or any of its Subsidiaries, (v) enters or proposes to enter into a consent decree of permanent injunction
with the Company or any of its Subsidiaries, or (vi) otherwise alleges any violation of any laws, rules or regulations by the Company
or any of its Subsidiaries, and which, either individually or in the aggregate, would have a Material Adverse Effect. The properties,
business and operations of the Company have been and are being conducted in all material respects in accordance with all applicable laws,
rules and regulations of the FDA. The Company has not been informed by the FDA that the FDA will prohibit the marketing, sale, license
or use in the United States of any product proposed to be developed, produced or marketed by the Company nor has the FDA expressed any
concern as to approving or clearing for marketing any product being developed or proposed to be developed by the Company.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-left: 0.5in; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.40.
<B><U>Related Party Transactions</U></B>. Except as disclosed in the Registration Statement, the Pricing Disclosure Package and the Final
Prospectus, no relationship, direct or indirect, exists between or among the Company or any of its subsidiaries, on the one hand, and
the directors, officers, stockholders, other Affiliates, customers or suppliers of the Company or any of its subsidiaries, on the other
hand, that would be required by the Securities Act to be described in the Registration Statement, the Pricing Disclosure Package and
the Final Prospectus.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"></P>

<!-- Field: Page; Sequence: 16; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->16<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-left: 0.5in; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.41.
<B><U>No Unlawful Contributions or Other Payments</U></B>. Neither the Company nor any of its subsidiaries, nor any director, officer
of the Company, nor, to the knowledge of the Company, any agent, employee, Affiliate or other person associated with or acting on behalf
of the Company or any of its subsidiaries has (i) used any corporate funds for any unlawful contribution, gift, entertainment or other
unlawful expense relating to political activity; (ii) made any direct or indirect unlawful payment to any foreign or domestic government
or regulatory official or employee; (iii) made any bribe, rebate, payoff, influence payment, kickback or other unlawful payment; or (iv)
violated or is in violation of any provision of (y) the Foreign Corrupt Practices Act of 1977, as amended, and the rules and regulations
thereunder (the &ldquo;<B><U>FCPA</U></B>&rdquo;), or (z) any non-U.S. anti-bribery or anti-corruption statute or regulation. The Company
and its subsidiaries have instituted and maintain and enforce policies and procedures designed to promote and ensure compliance with
all applicable anti-bribery and anti-corruption laws.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-left: 0.5in; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.42.
<B><U>Compliance with Anti-Money Laundering Laws</U></B>. The operations of the Company and its subsidiaries are and have been conducted
at all times in compliance with all applicable financial recordkeeping and reporting requirements, including those of the Currency and
Foreign Transactions Reporting Act of 1970, as amended, the applicable anti-money laundering statutes of all jurisdictions where the
Company or any of its subsidiaries conduct business, the rules and regulations thereunder and any related or similar rules, regulations
or guidelines issued, administered or enforced by any governmental agency (collectively, the &ldquo;<B><U>Anti-Money Laundering Laws</U></B>&rdquo;);
and no action, suit or proceeding by or before any court or governmental agency, authority or body or any arbitrator involving the Company
or any of its subsidiaries with respect to the Anti-Money Laundering Laws is pending or, to the knowledge of the Company, threatened.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-left: 0.5in; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.43.
<B><U>Compliance with OFAC</U></B>. Neither the Company nor any of its subsidiaries nor any director, officer of the Company, nor, to
the knowledge of the Company, any agent, employee or Affiliate of the Company or any of its subsidiaries is an individual or entity (an
&ldquo;<B><U>OFAC Person</U></B>&rdquo;), or is owned or controlled by an OFAC Person, that is currently the subject or target of any
sanctions administered or enforced by the U.S. government (including, without limitation, the Office of Foreign Assets Control of the
U.S. Treasury Department (&ldquo;<B><U>OFAC</U></B>&rdquo;) or the U.S. Department of State and including, without limitation, the designation
as a &ldquo;specially designated national&rdquo; or &ldquo;blocked person&rdquo;), the United Nations Security Council, the European
Union, His Majesty&rsquo;s Treasury, or other relevant sanctions authority (collectively, &ldquo;<B><U>Sanctions</U></B>&rdquo;), nor
is the Company or any of its subsidiaries located, organized or resident in a country or territory that is the subject or the target
of Sanctions, including, without limitation, Crimea, Cuba, Iran, North Korea, Sudan and Syria (each, a &ldquo;<B><U>Sanctioned Country</U></B>&rdquo;);
and the Company will not directly or indirectly use the proceeds of the offering, or lend, contribute or otherwise make available such
proceeds to any subsidiary, joint venture partner or other OFAC Person (i) to fund or facilitate any activities of or business with any
OFAC Person that, at the time of such funding or facilitation, is the subject or the target of Sanctions, (ii) to fund or facilitate
any activities or business in any Sanctioned Country or (iii) in any other manner that will result in a violation by any OFAC Person
(including any OFAC Person participating in the transaction, whether as underwriter, advisor, investor or otherwise) of Sanctions. Since
the Company&rsquo;s inception, the Company and its subsidiaries have not knowingly engaged in and are not now knowingly engaged in any
dealings or transactions with any OFAC Person that at the time of the dealing or transaction is or was the subject or the target of Sanctions
or with any Sanctioned Country.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"></P>

<!-- Field: Page; Sequence: 17; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->17<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-left: 0.5in; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.44.
<B><U>No Registration Rights</U></B>. Except as described in the Registration Statement, the Pricing Disclosure Package and the Final
Prospectus, there are no contracts, agreements or understandings between the Company or any of its subsidiaries, on the one hand, and
any person, on the other hand, granting such person any rights to require the Company or any of its subsidiaries to file a registration
statement under the Securities Act with respect to any securities of the Company or any of its subsidiaries owned or to be owned by such
person or to require the Company or any of its subsidiaries to include such securities in any securities to be registered pursuant to
any registration statement to be filed by the Company or any of its subsidiaries under the Securities Act.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-left: 0.5in; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.45.
<B><U>Subsidiaries</U></B>. The subsidiaries of the Company shall be referred to hereinafter each as a &ldquo;<B><U>Subsidiary</U></B>&rdquo;
and collectively as &ldquo;<B><U>Subsidiaries</U></B>.&rdquo; The description of the corporate structure of the Company and each of the
agreements among the Subsidiaries as set forth in the Registration Statement, the Pricing Disclosure Package and the Final Prospectus
under the caption &ldquo;Corporate History and Structure&rdquo; filed as Exhibit 21.1 to the Registration Statement is true and accurate
in all material respects and nothing has been omitted from such description which would make it misleading. The Subsidiaries of the Company
listed in Schedule 2.45 hereto are the only &ldquo;significant subsidiaries&rdquo; (as defined under Rule 1.02(w) of Regulation S-X under
the Securities Act) of the Company (the &ldquo;<B><U>Significant Subsidiaries</U></B>&rdquo;).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-left: 0.5in; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.46.
<B><U>No Restrictions on Subsidiaries</U></B>. Except as disclosed in the Registration Statement, the Pricing Disclosure Package and
the Final Prospectus, no Subsidiary of the Company is currently prohibited, directly or indirectly, from paying any dividends to the
Company, from making any other distribution on such Subsidiary&rsquo;s share capital or similar ownership interest, from repaying to
the Company any loans or advances to such Subsidiary from the Company or from transferring any of such Subsidiary&rsquo;s properties
or assets to the Company or any other Subsidiary of the Company.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-left: 0.5in; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.47.
<B><U>Exchange Listing</U></B>. The Common Stock is listed on the Exchange, and the Company has taken no action designed to, or likely
to have the effect of, delisting the Common Stock from the Exchange, nor has the Company received any notification that the Exchange
is contemplating terminating such listing, except as described in the Registration Statement, the Disclosure Package and the Prospectus.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-left: 0.5in; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.48.
<B><U>Exchange Act Registration</U></B>. The Common Stock is registered pursuant to Section 12(b) under the Exchange Act. The Company
has taken no action designed to, or likely to have the effect of, terminating the registration of the Common Stock under the Exchange
Act, nor has the Company received any notification that the Commission is contemplating terminating such registration.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-left: 0.5in; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.49.
<B><U>Prior Securities Transactions</U></B>. No securities of the Company have been sold by the Company or by or on behalf of, or for
the benefit of, any person or persons controlling, controlled by or under common control with the Company, except as disclosed in the
Registration Statement, the Disclosure Package and the Prospectus.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-left: 0.5in; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.50.
<B><U>Application of Takeover Protections</U></B>. The Company and the Board of Directors have taken all necessary action, if any, in
order to render inapplicable any control share acquisition, business combination, poison pill (including any distribution under a rights
agreement) or other similar anti-takeover provision under the Company&rsquo;s certificate of incorporation (or similar charter documents)
or the laws of its state of incorporation that is or could become applicable as a result of the Underwriter and the Company fulfilling
their obligations or exercising their rights hereunder (including documents incorporated herein by reference or attached hereto).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"></P>

<!-- Field: Page; Sequence: 18; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->18<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-left: 0.5in; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.51.
<B><U>D&amp;O Questionnaires</U></B>. To the Company&rsquo;s knowledge, all information contained in the questionnaires (the &ldquo;<B><U>Questionnaires</U></B>&rdquo;)
completed by each of the Company&rsquo;s directors, officers and beneficial holders of 5% or more of the Company&rsquo;s Common Stock
immediately prior to the Offering as supplemented by all information concerning the Company&rsquo;s directors, officers and principal
stockholders as described in the Registration Statement, the Disclosure Package and the Prospectus, provided to the Underwriter is true
and correct in all material respects and the Company has not become aware of any information which would cause the information disclosed
in the Questionnaires to become inaccurate and incorrect in any material respect.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-left: 0.5in; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.52.
<B><U>No Integrated Offering</U></B>. Neither the Company, nor any of its Affiliates, nor any Person acting on its or their behalf has,
directly or indirectly, made any offers or sales of any security or solicited any offers to buy any security, under circumstances that
would cause this offering of the Closing Units to be integrated with prior offerings by the Company for purposes of any applicable stockholder
approval provisions of any Trading Market on which any of the securities of the Company are listed or designated.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-left: 0.5in; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.53.
<B><U>Litigation; Governmental Proceedings</U></B>. There is no material action, suit, proceeding, inquiry, arbitration, investigation,
litigation or governmental proceeding pending or, to the Company&rsquo;s knowledge, threatened against, or involving the Company, any
of its Subsidiaries or, to the Company&rsquo;s knowledge, any executive officer or director which has not been disclosed in the Registration
Statement, the Disclosure Package and the Prospectus which is required to be disclosed.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-left: 0.5in; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.54.
<B><U>FINRA Matters</U></B>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="text-indent: 0.5in; font: 10pt Times New Roman, Times, Serif; margin-left: 0.5in; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.54.1.
<B><U>No Broker&rsquo;s Fees</U></B>. Except as disclosed in the Registration Statement, the Pricing Disclosure Package and the Final
Prospectus, neither the Company nor any of its subsidiaries is a party to any contract, agreement or understanding with any person (other
than this Agreement) that would give rise to a valid claim against any of them or the Underwriter for a brokerage commission, finder&rsquo;s
fee or like payment in connection with the offering and sale of the Securities.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-indent: 0.5in; margin-left: 0.5in; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.54.2.
<B><U>Payments Within Six (6) Months</U></B>. Except as described in the Registration Statement, the Disclosure Package and the Prospectus,
the Company has not made any direct or indirect payments (in cash, securities or otherwise) to: (i) any person, as a finder&rsquo;s fee,
consulting fee or otherwise, in consideration of such person raising capital for the Company or introducing to the Company persons who
raised or provided capital to the Company; (ii) any FINRA member; or (iii) any person or entity that has any direct or indirect affiliation
or association with any FINRA member, within the six (6) months prior to the initial filing of the Registration Statement, other than
the payment to the Underwriter as provided hereunder in connection with the Offering.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 19; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->19<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-indent: 0.5in; margin-left: 0.5in; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.54.3.
<B><U>Use of Proceeds</U></B>. None of the net proceeds of the Offering will be paid by the Company to any participating FINRA member
or its affiliates, except as specifically authorized herein.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-indent: 0.5in; margin-left: 0.5in; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.54.4.
<B><U>FINRA Affiliation</U></B>. There is no (i) officer or director of the Company, (ii) to the Company&rsquo;s knowledge, any beneficial
owner of 10% or more of any class of the Company&rsquo;s securities or (iii) to the Company&rsquo;s knowledge, any beneficial owner of
the Company&rsquo;s unregistered equity securities which were acquired during the 180-Calendar Day period immediately preceding the filing
of the Registration Statement that is an affiliate or associated person of a FINRA member participating in the Offering (as determined
in accordance with the rules and regulations of FINRA).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-indent: 0.5in; margin-left: 0.5in; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.54.5.
<B><U>Information</U></B>. All information provided by the Company in its FINRA questionnaire to Representative Counsel specifically
for use by Representative Counsel in connection with its Public Offering System filings (and related disclosure) with FINRA is true,
correct and complete in all material respects.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">

    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in; padding-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><U>Representations
    and Warranties of the Underwriter</U></B>. The Underwriter represents and warrants to, and agrees with, the Company:</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-left: 0.5in; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.1.
<B><U>No Testing-the-Waters Communications</U></B>. The Underwriter has not (i) alone engaged in any Testing-the-Waters Communication
and (ii) authorized anyone to engage in Testing-the-Waters Communications. The Underwriter has not distributed, or authorized anyone
else to distribute, any Written Testing-the-Waters Communications.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">

    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in; padding-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><U>Purchase
    and Resale</U></B>.</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-left: 0.5in; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.1.
<B><U>Agreements to Sell and Purchase</U></B>. On the basis of the representations, warranties and covenants herein and subject to the
conditions herein and any adjustments made in accordance with Section 4.3 hereof,</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-indent: 0.5in; margin-left: 0.5in; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.1.1.
The Company agrees to issue and sell the Closing Units to the Underwriter; and</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-indent: 0.5in; margin-left: 0.5in; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.1.2.
The Underwriter agrees to purchase from the Company the number of Closing Units set forth opposite the Underwriter&rsquo;s name in Schedule
4.1.2 hereto, subject to such adjustments as the Underwriter in its sole discretion shall make to eliminate any sales or purchases of
fractional Shares.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 20; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->20<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-indent: 0.5in; margin-left: 0.5in; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.1.3.
The Closing Units are to be offered initially to the public at the offering price set forth on the cover page of the Final Prospectus
(the &ldquo;<B><U>Public Offering Price</U></B>&rdquo;). The purchase price per Closing Unit to be paid by the Underwriter to the Company
shall be $[&#9679;] per Unit (the &ldquo;<B><U>Purchase Price</U></B>&rdquo;), which represents the Public Offering Price less an underwriting
discount of 7.0% and a non-accountable expense allowance of 1.0%.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-indent: 0.5in; margin-left: 0.5in; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.1.4.
Payment for the Closing Units (the &ldquo;<B><U>Closing Units Payment</U></B>&rdquo;) shall be made by wire transfer in immediately available
funds to the accounts specified by the Company to the Underwriter at the offices of Kaufman &amp; Canoles, P.C. at 10:00 a.m., ET, on
[&#9679;], 2025 or at such other place on the same or such other date and time, not later than the fifth (5th) Business Day thereafter,
as the Underwriter and the Company may agree upon in writing (the &ldquo;<B><U>Closing Date</U></B>&rdquo;). The Closing Units Payment
shall be made against delivery of the Closing Units to be purchased on the Closing Date to the Underwriter with any transfer taxes, stamp
duties and other similar taxes payable in connection with the sale of the Closing Units duly paid by the Company.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-left: 0.5in; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.2.
<B><U>Over-Allotment Option</U></B>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-indent: 0.5in; margin-left: 0.5in; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.2.1.
On the basis of the representations, warranties and covenants herein and subject to the conditions herein, the Underwriter is hereby
granted an option (the &ldquo;<B><U>Over-Allotment Option</U></B>&rdquo;) to purchase, in the aggregate, up to [&#9679;] additional shares
of Common Stock, representing 15.0% of the Closing Units and/or Pre-funded Warrants sold in the offering from the Company (the &ldquo;<B><U>Option
Shares</U></B>&rdquo;) and/or up to [&#9679;] Series A Warrants to purchase an aggregate of an additional [&#9679;] shares of Common
Stock, representing 15.0% of the Closing Units sold in the offering from the Company and [&#9679;] Series B Warrants to purchase an aggregate
of an additional [&#9679;] shares of Common Stock, representing 15.0% of the Closing Units sold in the offering from the Company (the
&ldquo;<B><U>Option Warrants</U></B>&rdquo;). The purchase price to be paid per Option Share shall be equal to the price per Closing
Unit set forth in Section 4.1 hereof (less $0.00001 attributable to each whole Option Warrant included in the Closing Unit) and the purchase
price to be paid per Option Warrant shall be equal to $0.00001 per Option Warrant. The Over-allotment Option is, at the Underwriters&rsquo;
sole discretion, for Option Shares and Option Warrants together, solely Option Shares, solely Option Warrants, or any combination thereof
(each, an &ldquo;<B><U>Option Security</U></B>&rdquo; and collectively, the &ldquo;<B><U>Option Securities</U></B>&rdquo;). The Closing
Units and the Option Securities are collectively referred to as the &ldquo;<B><U>Securities</U></B>&rdquo;. The Securities and the shares
of Common Stock issuable upon exercise of the Pre-funded Warrants and the Warrants (the &ldquo;<B><U>Underlying Shares</U></B>&rdquo;),
are collectively referred to as the &ldquo;<B><U>Public Securities</U></B>.&rdquo; The Public Securities shall be issued directly by
the Company and shall have the rights and privileges described in the Registration Statement, the Pricing Disclosure Package and the
Prospectus. The Closing Warrants and the Option Warrants, if any, shall be issued pursuant to, and shall have the rights and privileges
set forth in, the form of Warrant, and the Closing Pre-funded Warrants shall be issued pursuant to, and shall have the rights and privileges
set forth in, the form of Pre-funded Warrant. The offering and sale of the Public Securities is herein referred to as the &ldquo;<B><U>Offering</U></B>&rdquo;.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<!-- Field: Page; Sequence: 21; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->21<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-indent: 0.5in; margin-left: 0.5in; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.2.2.
upon an exercise of the Over-Allotment Option and subject to the terms and conditions herein, the Company agrees to issue and sell the
Option Securities to the Underwriter;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-indent: 0.5in; margin-left: 0.5in; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.2.3.
The Underwriter may exercise the Over-Allotment Option at any time in whole, or from time to time in part, on or before the forty-fifth
(45th) Calendar Day following the date of the Final Prospectus, by written notice from the Underwriter to the Company (the &ldquo;<B><U>Over-Allotment
Exercise Notice</U></B>&rdquo;). The Underwriter must give the Over-Allotment Exercise Notice to the Company at least one (1) Business
Day prior to the Closing Date or the applicable Additional Closing Date, as the case may be. The Underwriter may cancel any exercise
of the Over-Allotment Option at any time prior to the Closing Date or the applicable Additional Closing Date, as the case may be, by
giving written notice of such cancellation to the Company.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-indent: 0.5in; margin-left: 0.5in; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.2.4.
The Over-Allotment Exercise Notice shall set forth each of the following:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-indent: 0.5in; margin-left: 0.5in; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.2.4.1
the aggregate number of Option Securities as to which the Over-Allotment Option is being exercised.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-indent: 0.5in; margin-left: 0.5in; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.2.4.2
the Over-Allotment Option Purchase Price.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-indent: 0.5in; margin-left: 0.5in; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.2.4.3
the names and denominations in which the Option Securities are to be registered.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-indent: 0.5in; margin-left: 0.5in; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.2.4.4
the applicable Additional Closing Date, which may be the same date and time as the Closing Date but shall not be earlier than the Closing
Date nor later than the tenth (10th) full Business Day after the date of the Over-Allotment Exercise Notice.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-indent: 0.5in; margin-left: 0.5in; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.2.5.
Payment for the Option Securities (the &ldquo;<B><U>Option Securities Payment</U></B>&rdquo;) shall be made by wire transfer in immediately
available funds to the accounts specified by the Company to the Underwriter at the offices of Kaufman &amp; Canoles, P.C. at 10:00 a.m.
ET on the date specified in the corresponding Over-Allotment Exercise Notice, or at such other place on the same or such other date and
time, not later than the fifth (5th) Business Day thereafter, as the Underwriter and the Company may agree upon in writing (an &ldquo;<B><U>Additional
Closing Date</U></B>&rdquo;). The Option Securities Payment shall be made against delivery to the Underwriter for the respective accounts
of the Underwriter of the Option Securities to be purchased on any Additional Closing Date, with any transfer taxes, stamp duties and
other similar taxes payable in connection with the sale of the Option Securities duly paid by the Company. Delivery of the Option Securities
shall be made through the facilities of DTC unless the Underwriter shall otherwise instruct.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-left: 0.5in; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.3.
<B><U>Public Offering</U></B>. The Company understands that the Underwriter intends to make a public offering of the Units as soon after
the effectiveness of this Agreement as in the judgment of the Underwriter is advisable, and initially to offer the Units on the terms
set forth in the Final Prospectus. The Company acknowledges and agrees that the Underwriter may offer and sell Units to or through any
Affiliate of the Underwriter.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<!-- Field: Page; Sequence: 22; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->22<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">

    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in; padding-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><U>Covenants
    of the Company</U></B>. The Company hereby covenants and agrees with the Underwriter as follows:</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-left: 0.5in; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.1.
<B><U>Filings with the Commission</U></B>. The Company will:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-indent: 0.5in; margin-left: 0.5in; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.1.1.
prepare and file the Final Prospectus (in a form approved by the Underwriter and containing the Rule 430A Information) with the Commission
in accordance with and within the time periods specified by Rules 424(b) and 430A under the Securities Act.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-indent: 0.5in; margin-left: 0.5in; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.1.2.
file any Issuer Free Writing Prospectus with the Commission to the extent required by Rule 433 under the Securities Act.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-indent: 0.5in; margin-left: 0.5in; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.1.3.
file with the Commission such reports as may be required by Rule 463 under the Securities Act.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-left: 0.5in; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.2.
<B><U>Notice to the Underwriter</U></B>. The Company will advise the Underwriter promptly, and confirm such advice in writing:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-indent: 0.5in; margin-left: 0.5in; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.2.1.
when the Registration Statement has become effective.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-indent: 0.5in; margin-left: 0.5in; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.2.2.
when the Final Prospectus has been filed with the Commission.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-indent: 0.5in; margin-left: 0.5in; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.2.3.
when any amendment to the Registration Statement has been filed or becomes effective.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-indent: 0.5in; margin-left: 0.5in; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.2.4.
when any Rule 462(b) Registration Statement has been filed with the Commission.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-indent: 0.5in; margin-left: 0.5in; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.2.5.
when any supplement to the Final Prospectus, any Issuer Free Writing Prospectus, any Written Testing-the-Waters Communication or any
amendment to the Final Prospectus has been filed or distributed.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-indent: 0.5in; margin-left: 0.5in; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-indent: 0.5in; margin-left: 0.5in; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.2.6.
of (x) any request by the Commission for any amendment to the Registration Statement or any amendment or supplement to the Final Prospectus,
(y) the receipt of any comments from the Commission relating to the Registration Statement or (z) any other request by the Commission
for any additional information, including, but not limited to, any request for information concerning any Testing-the-Waters Communication.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-indent: 0.5in; margin-left: 0.5in; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.2.7.
of (x) the issuance by the Commission of any order suspending the effectiveness of the Registration Statement or preventing or suspending
the use of the Registration Statement, the Pricing Disclosure Package, the Final Prospectus, any Preliminary Prospectus, any Issuer Free
Writing Prospectus or any Written Testing-the-Waters Communication or (y) the initiation or, to the knowledge of the Company, threatening
of any proceeding for that purpose or pursuant to Section 8A of the Securities Act.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-indent: 0.5in; margin-left: 0.5in; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.2.8.
of the occurrence of any event or development within the Prospectus Delivery Period as a result of which, the Final Prospectus, the Pricing
Disclosure Package, any Issuer Free Writing Prospectus or any Written Testing-the-Waters Communication as then amended or supplemented
would include any untrue statement of a material fact or omit to state a material fact necessary in order to make the statements therein,
in the light of the circumstances existing when the Final Prospectus, the Pricing Disclosure Package, any such Issuer Free Writing Prospectus
or any such Written Testing-the-Waters Communication is delivered to a purchaser, not misleading.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 23; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->23<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-indent: 0.5in; margin-left: 0.5in; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.2.9.
of the issuance by any governmental or regulatory authority or any order preventing or suspending the use of any of the Registration
Statement, the Pricing Disclosure Package, the Final Prospectus, any Preliminary Prospectus, any Issuer Free Writing Prospectus or any
Testing-the-Waters Communication or the initiation or threatening for that purpose.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-indent: 0.5in; margin-left: 0.5in; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.2.10.
of the receipt by the Company of any notice with respect to any suspension of the qualification of the Units for offer and sale in any
jurisdiction or the initiation or, to the knowledge of the Company, threatening of any proceeding for such purpose.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-left: 0.5in; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.3.
<B><U>Ongoing Compliance</U></B>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-indent: 0.5in; margin-left: 0.5in; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.3.1.
If during the Prospectus Delivery Period:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-left: 1.5in; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.3.1.1
any event or development shall occur or condition shall exist as a result of which the Final Prospectus as then amended or supplemented
would include any untrue statement of a material fact or omit to state any material fact necessary in order to make the statements therein,
in the light of the circumstances existing when the Final Prospectus is delivered to a purchaser, not misleading, the Company will, as
soon as reasonably possible, notify the Underwriter thereof and forthwith prepare and, subject to Section 5.4 hereof, file with the Commission
and furnish, at its own expense, to the Underwriter and to such dealers as the Underwriter may designate such amendments or supplements
to the Final Prospectus as may be necessary so that the statements in the Final Prospectus as so amended or supplemented will not, in
the light of the circumstances existing when the Final Prospectus is delivered to a purchaser, be misleading; or</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-left: 1.5in; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.3.1.2
it is necessary to amend or supplement the Final Prospectus to comply with applicable law, the Company will, as soon as reasonably possible,
notify the Underwriter thereof and forthwith prepare and, subject to Section 5.4 hereof, file with the Commission and furnish, at its
own expense, to the Underwriter and to such dealers as the Underwriter may designate such amendments or supplements to the Final Prospectus
as may be necessary so that the Final Prospectus will comply with applicable law; and</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-indent: 0.5in; margin-left: 0.5in; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.3.2.
if at any time prior to the Closing Date or any Additional Closing Date, as the case may be:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<!-- Field: Page; Sequence: 24; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->24<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-left: 1.5in; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.3.2.1
any event or development shall occur or condition shall exist as a result of which the Pricing Disclosure Package as then amended or
supplemented would include any untrue statement of a material fact or omit to state any material fact necessary in order to make the
statements therein, in the light of the circumstances existing when the Pricing Disclosure Package is delivered to a purchaser, not misleading,
the Company will immediately notify the Underwriter thereof and forthwith prepare and, subject to Section 5.4 hereof, file with the Commission
(to the extent required) and furnish, at its own expense, to the Underwriter and to such dealers as the Underwriter may designate such
amendments or supplements to the Pricing Disclosure Package as may be necessary so that the statements in the Pricing Disclosure Package
as so amended or supplemented will not, in the light of the circumstances existing when the Pricing Disclosure Package is delivered to
a purchaser, be misleading; or</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-left: 1.5in; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.3.2.2
it is necessary to amend or supplement the Pricing Disclosure Package to comply with applicable law, the Company will immediately notify
the Underwriter thereof and forthwith prepare and, subject to Section 5.4 hereof, file with the Commission (to the extent required) and
furnish, at its own expense, to the Underwriter and to such dealers as the Underwriter may designate such amendments or supplements to
the Pricing Disclosure Package as may be necessary so that the Pricing Disclosure Package will comply with applicable law.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-left: 0.5in; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.4.
<B><U>Amendments, Supplements and Issuer Free Writing Prospectuses</U></B>. Before (i) using, authorizing, approving, referring to, distributing
or filing any Issuer Free Writing Prospectus, (ii) filing (x) any Rule 462(b) Registration Statement or (y) any amendment or supplement
to the Registration Statement or the Final Prospectus, or (iii) distributing any amendment or supplement to the Pricing Disclosure Package
or the Final Prospectus, the Company will furnish to the Underwriter and counsel for the Underwriter a copy of the proposed Issuer Free
Writing Prospectus, Rule 462(b) Registration Statement or other amendment or supplement for review and will not use, authorize, refer
to, distribute or file any such Issuer Free Writing Prospectus or Rule 462(b) Registration Statement, or file or distribute any such
proposed amendment or supplement (A) to which the Underwriter objects in a timely manner and (B) which is not in compliance with the
Securities Act. The Company will, pursuant to reasonable procedures developed in good faith, retain copies of each Issuer Free Writing
Prospectus that is not filed with the Commission in accordance with Rule 433 under the Securities Act.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-left: 0.5in; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.5.
<B><U>Delivery of Copies</U></B>. The Company will, upon request of the Underwriter, deliver, without charge, (i) to the Underwriter,
three signed copies of the Registration Statement as originally filed and each amendment thereto, in each case, including all exhibits
and consents filed therewith; and (ii) to each Underwriter (A) a conformed copy of the Registration Statement as originally filed and
each amendment thereto (without exhibits and consents) and (B) during the Prospectus Delivery Period, as many copies of the Final Prospectus
(including all amendments and supplements thereto and each Issuer Free Writing Prospectus) as the Underwriter may reasonably request.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<!-- Field: Page; Sequence: 25; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->25<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-left: 0.5in; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.6.
<B><U>Emerging Growth Company Status</U></B>. The Company will promptly notify the Underwriter if the Company ceases to be an Emerging
Growth Company at any time prior to the later of (i) completion of the distribution of the Units within the meaning of the Securities
Act and (ii) completion of the Standstill Period (as defined below).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-left: 0.5in; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.7.
<B><U>Blue Sky Compliance</U></B>. The Company will use its best efforts, with the Underwriter&rsquo;s cooperation, if necessary, to
qualify or register (or to obtain exemptions from qualifying or registering) the Units for offer and sale under the securities or Blue
Sky laws of such jurisdictions as the Underwriter shall reasonably request and will use its reasonable best efforts, with the Underwriter&rsquo;s
cooperation, if necessary, to continue such qualifications, registrations and exemptions in effect so long as required for the distribution
of the Units; <U>provided</U> that the Company shall not be required to (i) qualify as a foreign corporation or other entity or as a
dealer in securities in any such jurisdiction where it would not otherwise be required to so qualify, (ii) file any general consent to
service of process in any such jurisdiction or (iii) subject itself to taxation in any such jurisdiction if it is not otherwise so subject.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-left: 0.5in; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.8.
<B><U>Earning Statement</U></B>. The Company will make generally available to its security holders and the Underwriter as soon as practicable
an earning statement that satisfies the provisions of Section 11(a) of the Securities Act and Rule 158 under the Securities Act covering
a period of at least 12 months beginning after the &ldquo;effective date&rdquo; (as defined in Rule 158 under the Securities Act) of
the Registration Statement; <U>provided</U> that the Company will be deemed to have furnished such statement to its security holders
and the Underwriter to the extent it is filed on the Commission&rsquo;s Electronic Data Gathering, Analysis and Retrieval system (&ldquo;<B><U>EDGAR</U></B>&rdquo;).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-left: 0.5in; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.9.
<B><U>Stockholder Approval</U></B>. The Company shall hold a special meeting of stockholders (which may also be at the annual meeting
of stockholders) at the earliest practicable date after the date hereof, but in no event later than sixty (60) Calendar Days after the
Closing Date for the purpose of obtaining Stockholder Approval (as defined below), if required to effect the purpose thereof, with the
recommendation of the Board that such proposal be approved, and the Company shall solicit proxies from its stockholders in connection
therewith in the same manner as all other management proposals in such proxy statement and all management-appointed proxyholders shall
vote their proxies in favor of such proposal. The Company shall use its reasonable best efforts to obtain such Stockholder Approval,
and officers, directors and stockholders subject to Lock-Up Agreement pursuant to Section 8.9 shall cast their proxies in favor of such
proposal. If the Company does not obtain Stockholder Approval at the first meeting, the Company shall call a meeting every sixty (60)
days thereafter to seek Stockholder Approval until the earlier of the date Stockholder Approval is obtained or the Warrants are no longer
outstanding. &ldquo;<B><U>Stockholder Approval</U></B>&rdquo; has the meaning set forth in the Warrants.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-left: 0.5in; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.10.
<B><U>Use of Proceeds</U></B>. The Company shall apply the net proceeds from the sale of the Closing Units and the Option Securities
in the manner described under the caption &ldquo;Use of Proceeds&rdquo; in the Registration Statement, the Pricing Disclosure Package
and the Final Prospectus.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<!-- Field: Page; Sequence: 26; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->26<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-left: 0.5in; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.11.
<B><U>Clear Market</U></B>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-indent: 0.5in; margin-left: 0.5in; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.11.1.
For a period of ninety (90) days after the Release Date (the &ldquo;<B><U>Standstill Period</U></B>&rdquo;), the Company will not (x)
offer, pledge, sell, contract to sell, sell any option or contract to purchase, purchase any option or contract to sell, grant any option,
right or warrant to purchase, or otherwise transfer or dispose of, directly or indirectly, or file with the Commission a registration
statement under the Securities Act relating to, any shares of Common Stock or any securities convertible into or exercisable or exchangeable
for shares of Common Stock, or publicly disclose the intention to make any offer, sale, pledge, disposition or filing, or (y) enter into
any swap or other agreement that transfers, in whole or in part, any of the economic consequences of ownership of the shares of Common
Stock or any such other securities, whether any such transaction described in clause (x) or (y) above is to be settled by delivery of
shares of Common Stock or such other securities, in cash or otherwise, without the prior written consent of the Underwriter.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-indent: 0.5in; margin-left: 0.5in; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.11.2.
The restrictions contained in Section 5.11.1 hereof shall not apply to: (A) the Units, (B) any shares of Common Stock issued under Company
Common Stock Incentive Plans or warrants issued by the Company, in each case, described as outstanding in the Registration Statement,
the Pricing Disclosure Package and the Final Prospectus, (C) any options and other awards granted under a Company Common Stock Incentive
Plan as described in the Registration Statement, the Pricing Disclosure Package and the Final Prospectus, provided that such securities
are issued as &ldquo;restricted securities&rdquo; (as defined in Rule 144) and carry no registration rights that require or permit any
registration statement in connection therewith to be filed publicly or declared effective during the Standstill Period (D) the amendment
of a Company Common Stock Incentive Plan as described in the Registration Statement, the Pricing Disclosure Package and the Final Prospectus,
(E) the filing by the Company of any registration statement on Form S-8 or a successor form thereto relating to a Company Common Stock
Incentive Plan described in the Registration Statement, the Pricing Disclosure Package and the Final Prospectus and (F) shares of Common
Stock or other securities issued pursuant to acquisitions or strategic transactions (whether by merger, consolidation, purchase of equity,
purchase of assets, reorganization or otherwise) approved by a majority of the disinterested directors of the Company, provided that
such securities are issued as &ldquo;restricted securities&rdquo; (as defined in Rule 144) and carry no registration rights that require
or permit the filing of any registration statement in connection therewith during the Standstill Period, and provided that any such issuance
shall only be to a Person (or to the equityholders of a Person) which is, itself or through its subsidiaries, an operating company or
an owner of an asset in a business synergistic with the business of the Company and shall provide to the Company additional benefits
in addition to the investment of funds, but shall not include a transaction in which the Company is issuing securities primarily for
the purpose of raising capital or to an entity whose primary business is investing in securities; <U>provided</U>, <U>however</U>, that
any such shares of Common Stock or other securities issued or granted pursuant to clauses (B), (C) and (F) during the Standstill Period
shall not be saleable in the public market until the expiration of the Standstill Period.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<!-- Field: Page; Sequence: 27; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->27<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-indent: 0.5in; margin-left: 0.5in; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.11.3.
If the Underwriter, in its sole discretion, agrees to release or waive the restrictions set forth in any Lock-Up Agreement as described
in Section 8.9 and provides the Company with notice of the impending release or waiver substantially in the form of <B><U>Exhibit 5.11.3.1
</U></B>hereto at least three (3) Business Days before the effective date of the release or waiver, then the Company agrees to announce
the impending release or waiver by a press release substantially in the form of <B><U>Exhibit 5.11.3.2</U></B> hereto through a major
news service at least two (2) Business Days before the effective date of the release or waiver.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-left: 0.5in; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.12.
<B><U>No Stabilization or Manipulation</U></B>. None of the Company, its Affiliates or any person acting on its or any of their behalf
(other than the Underwriter, as to which no covenant is given) will take, directly or indirectly, any action designed to or that constitutes
or that could reasonably be expected to cause or result in the stabilization or manipulation of the price of any securities of the Company.
The Company acknowledges that the Underwriter may engage in passive market making transactions in the Common Stock on the Exchange in
accordance with Regulation M.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-left: 0.5in; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.13.
<B><U>Investment Company Act</U></B>. The Company shall not invest, or otherwise use the proceeds received by the Company from the sale
of the Closing Units or the Option Securities in such a manner as would require the Company or any of its subsidiaries to register as
an &ldquo;investment company&rdquo; (as defined in the Investment Company Act) under the Investment Company Act.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-left: 0.5in; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.14.
<B><U>Transfer Agent</U></B>. For the period of two years from the date of this Agreement, the Company shall engage and maintain, at
its expense, a registrar and transfer agent for the Common Stock.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-left: 0.5in; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.15.
<B><U>Reports</U></B>. For the period of two years from the date of this Agreement, the Company will furnish to the Underwriter, as soon
as they are available, copies of all reports or other communications (financial or other) furnished to holders of the Common Stock, and
copies of any reports and financial statements furnished to or filed with the Commission or any national securities exchange or automatic
quotation system; <U>provided</U> that the Company will be deemed to have furnished such reports and financial statements to the Underwriter
to the extent they are filed on the Commission&rsquo;s Electronic Data Gathering, Analysis and Retrieval system.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-left: 0.5in; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.16.
<B><U>Right of First Refusal</U></B>. The Company agrees that, if, for the period ending thirty-six (36) months after the commencement
of sales in the Offering, the Company or any of its subsidiaries: (a) decides to finance or refinance any indebtedness, the Underwriter
(or any affiliate designated by the Underwriter) shall have the right to act as sole book-runner, sole manager, sole placement agent
or sole agent with respect to such financing or refinancing; or (b) decides to raise funds by means of a public offering (including at-the-market
facility) or a private placement or any other capital raising financing of equity, equity-linked or debt securities, the Underwriter
(or any affiliate designated by the Underwriter) shall have the right to act as sole book-running manager, sole underwriter or sole placement
agent for such financing. If the Underwriter or one of its affiliates decides to accept any such engagement, the agreement governing
such engagement (each, a &ldquo;<B><U>Subsequent Transaction Agreement</U></B>&rdquo;) will contain, among other things, provisions for
customary fees for transactions of similar size and nature, but in no event will the fees be less than those outlined herein, and the
provisions of this Agreement, including indemnification, that are appropriate to such a transaction. Notwithstanding the foregoing, the
decision to accept the Company&rsquo;s engagement under this Section 5.16 shall be made by the Underwriter or one of its affiliates,
by a written notice to the Company, within ten (10) Calendar Days of the receipt of the Company&rsquo;s notification of its financing
needs, including a detailed term sheet. The Underwriter&rsquo;s determination of whether in any case to exercise its right of first refusal
will be strictly limited to the terms on such term sheet, and any waiver of such right of first refusal shall apply only to such specific
terms. If the Underwriter waives its right of first refusal, any deviation from such terms (including without limitation after the launch
of a subsequent transaction) shall void the waiver and require the Company to seek a new waiver from the right of first refusal on the
terms set forth in this Section 5.16.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<!-- Field: Page; Sequence: 28; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->28<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">

    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in; padding-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">6.</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><U>Covenants
    of the Underwriter</U></B>. The Underwriter hereby covenants and agrees with the Company as follows:</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-left: 0.5in; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">6.1.
<B><U>Underwriter Free Writing Prospectus</U></B>. The Underwriter has not used, authorized the use of, referred to or participated in
the planning for use of, and will not use, authorize the use of, refer to or participate in the planning for use of, any Free Writing
Prospectus (which term includes use of any written information furnished to the Commission by the Company and not incorporated by reference
into the Registration Statement and any press release issued by the Company) other than (i) a Free Writing Prospectus that contains no
&ldquo;issuer information&rdquo; filed or required to be filed pursuant to Rule 433(d) under the Securities Act (&ldquo;<B><U>Issuer
Information</U></B>&rdquo;) that was not included in the Preliminary Prospectus or a previously filed Issuer Free Writing Prospectus,
(ii) any Issuer Free Writing Prospectus listed in Schedule 2.5.4 hereto or prepared pursuant to Section 2.5.4 or Section 5.4 hereof (including
any electronic road show), or (iii) any Free Writing Prospectus prepared by the Underwriter and approved by the Company in advance in
writing.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-left: 0.5in; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">6.2.
<B><U>Section 8A Proceedings</U></B>. The Underwriter is not subject to any pending proceeding under Section 8A of the Securities Act
with respect to the offering of the Units and will promptly notify the Company if any such proceeding against it is initiated during
the Prospectus Delivery Period.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">

    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in; padding-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">7.</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><U>Payment
    of Expenses</U></B>.</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-left: 0.5in; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">7.1.
<B><U>Company Expenses</U></B>. The Company hereby agrees to pay on the Closing Date all expenses incident to the performance of the
obligations of the Company under this Agreement including, but not limited to: (a) all filing fees and expenses relating to the registration
of the Units with the Commission; (b) all filing fees and expenses associated with the review of the offering of the Units by FINRA;
(c) all fees and expenses relating to the listing of the Shares on the Exchange (to the extent relevant) or on such other stock exchanges
as the Company and the Underwriter together determine; (d) all fees, expenses and disbursements relating to the registration or qualification
of the Units under the &ldquo;blue sky&rdquo; securities laws of such states and other jurisdictions as the Underwriter may reasonably
designate (including, without limitation, all filing and registration fees, and the reasonable fees and disbursements of the Company&rsquo;s
&ldquo;blue sky&rdquo; counsel, which will be Underwriter&rsquo;s counsel) unless such filings are not required in connection with the
Company&rsquo;s proposed Exchange listing; (e) all fees, expenses and disbursements relating to the registration, qualification or exemption
of the Securities under the securities laws of such foreign jurisdictions as the Underwriter may reasonably designate; (f) the costs
of all mailing and printing of the underwriting documents, the Registration Statement, Pricing Disclosure Package, the Final Prospectus,
any Preliminary Prospectus, any Issuer Free Writing Prospectus or any Testing-the-Waters Communication and all amendments, supplements
and exhibits thereto as the Underwriter may reasonably deem necessary; (g) the costs of preparing, printing and delivering certificates
representing the Shares; (h) fees and expenses of the transfer agent for the Shares; (i) transfer and/or stamp taxes, if any, payable
upon the transfer of securities from the Company to the Underwriter; (j) the fees and expenses of the Company&rsquo;s accountants; and
(k) reasonable legal fees and disbursements for the Underwriter&rsquo;s counsel. The total amount payable by the Company pursuant to
(k) to the Underwriter shall not exceed $100,000. The Underwriter may deduct from the net proceeds of the Offering payable to the Company
on the Closing Date the expenses set forth herein to be paid by the Company to the Underwriter. Except as provided for in this Agreement,
the Underwriter shall bear the costs and expenses incurred by them in connection with the sale of the Units and the transactions contemplated
thereby.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<!-- Field: Page; Sequence: 29; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->29<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-left: 0.5in; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">7.2.
<B><U>Non-accountable Expenses</U></B>. On the Closing Date, the Company shall pay to the Underwriter, by deduction from the net proceeds
of the Offering a non-accountable expense allowance equal to one percent (1.0%) of the gross proceeds received by the Company from the
sale of the Closing Units), provided, however, that in the event that the Offering is terminated, the Company agrees to reimburse the
Underwriter pursuant to Section 12 hereof.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-left: 0.5in; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">7.3.
<B><U>Underwriter Expenses</U></B>. Except to the extent otherwise provided in this Section 7 or Section 9 hereof, the Underwriter will
pay all of its own costs and expenses, including the fees and expenses of their counsel, any stock transfer taxes on resale of any of
the Shares held by them, and any advertising expenses connected with any offers they may make.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-left: 0.5in; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">7.4.
<B><U>Company Reimbursement</U></B>. The provisions of this Section 7 shall not affect any agreement that the Company may make for the
sharing of such costs and expenses.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">

    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in; padding-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">8.</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><U>Conditions
    of the Obligations of the Underwriter</U></B>. The obligations of the Underwriter to purchase the Closing Units as provided herein
    on the Closing Date or the Option Securities as provided herein on any Additional Closing Date, as the case may be, shall be subject
    to the timely performance by the Company of its covenants and other obligations hereunder, and to each of the following additional
    conditions:</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-left: 0.5in; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">8.1.
<B><U>Registration Compliance; No Stop Order</U></B>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="text-indent: 0.5in; font: 10pt Times New Roman, Times, Serif; margin-left: 0.5in; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">8.1.1.
The Registration Statement and any post-effective amendment thereto shall have become effective, no stop order suspending the effectiveness
of the Registration Statement or any post-effective amendment thereto shall be in effect, and no proceeding for such purpose or pursuant
to Section 8A of the Securities Act shall be pending before or threatened by the Commission.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-indent: 0.5in; margin-left: 0.5in; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">8.1.2.
The Company shall have filed the Final Prospectus and each Issuer Free Writing Prospectus with the Commission in accordance with and
within the time periods prescribed by Section 5.1 hereof.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-indent: 0.5in; margin-left: 0.5in; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">8.1.3.
The Company shall have (A) disclosed to the Underwriter all requests by the Commission for additional information relating to the offer
and sale of the Units and (B) complied with such requests to the reasonable satisfaction of the Underwriter.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-left: 0.5in; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">8.2.
<B><U>Representations and Warranties</U></B>. The representations and warranties of the Company contained herein shall be true and correct
on the date hereof and on and as of the Closing Date or any Additional Closing Date, as the case may be, and the statements of the Company
and its officers made in any certificates delivered pursuant to this Agreement shall be true and correct on and as of the Closing Date
or any Additional Closing Date, as the case may be.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<!-- Field: Page; Sequence: 30; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->30<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-left: 0.5in; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">8.3.
<B><U>Auditor Comfort Letters</U></B>. On the date of this Agreement and on the Closing Date or any Additional Closing Date, as the case
may be, PKF O&rsquo; Connor Davies, LLP shall have furnished to the Underwriter, at the request of the Company, letters, dated the respective
dates of delivery thereof and addressed to the Underwriter, in form and substance reasonably satisfactory to the Underwriter, containing
statements and information of the type customarily included in accountants&rsquo; &ldquo;comfort letters&rdquo; to underwriters with
respect to the financial statements and certain financial information contained in each of the Registration Statement, the Pricing Disclosure
Package and the Final Prospectus; <U>provided</U> that the letter delivered on the Closing Date or any Additional Closing Date, as the
case may be, shall use a &ldquo;cut-off&rdquo; date no more than two (2) Business Days prior to the Closing Date or such Additional Closing
Date, as the case may be.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-left: 0.5in; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">8.4.
<B><U>No Material Adverse Change</U></B>. No event or condition of a type described in Section 2.13 hereof shall have occurred or shall
exist, which event or condition is not described in each of the Pricing Disclosure Package and the Final Prospectus (in each case, exclusive
of any amendment or supplement thereto), the effect of which in the judgment of the Underwriter makes it impracticable or inadvisable
to proceed with the offering, sale or delivery of the Units on the Closing Date or any Additional Closing Date, as the case may be, in
the manner and on the terms contemplated by this Agreement, the Pricing Disclosure Package and the Final Prospectus (in each case, exclusive
of any amendment or supplement thereto).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-left: 0.5in; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">8.5.
<B><U>Opinion and Negative Assurance Letter of Counsel to the Company</U></B>. U.S. Company Counsel shall each have furnished to the
Underwriter, at the request of the Company, its (i) written opinion, addressed to the Underwriter and dated the Closing Date or any Additional
Closing Date, as the case may be, and (ii) negative assurance letter, addressed to the Underwriter and dated the Closing Date or any
Additional Closing Date, as the case may be, in each case, in a form reasonably satisfactory to the Underwriter.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-left: 0.5in; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">8.6.
<B><U>Officer&rsquo;s Certificate</U></B>. The Underwriter shall have received as of the Closing Date or any Additional Closing Date
on the date of this Agreement, a certificate from the Company&rsquo;s CFO in form and substance reasonably satisfactory to the Underwriter,
containing statements and information confirming that the financial statements and certain financial information contained in the Registration
Statement is consistent with the Company&rsquo;s records and does not contain any material misstatements or omissions and shall have
received as of the Closing Date or any Additional Closing Date, as the case may be, a certificate of an executive officer of the Company
who has specific knowledge of the Company&rsquo;s financial matters and is satisfactory to the Underwriter, (i) confirming that such
officer has carefully reviewed the Registration Statement, the Pricing Disclosure Package, the Final Prospectus, each Issuer Free Writing
Prospectus and each Written Testing-the-Waters Communication and, to the knowledge of such officer, the representations set forth in
Sections 2.1.2, 2.2, 2.3.1, 2.4.1, 2.5.1, 2.6 and 2.8, hereof are true and correct on and as of the Closing Date or any Additional Closing
Date, as the case may be; (ii) to the effect set forth in clause (i) of Section 2.11 and Section 8.1 hereof; and (iii) confirming that
all of the other representations and warranties of the Company in this Agreement are true and correct on and as of the Closing Date or
any Additional Closing Date, as the case may be, and that the Company has complied with all agreements and covenants and satisfied all
other conditions on its part to be performed or satisfied hereunder at or prior to the Closing Date or any Additional Closing Date, as
the case may be.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"></P>

<!-- Field: Page; Sequence: 31; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->31<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-left: 0.5in; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">8.7.
<B><U>No Legal Impediment to Issuance and Sale</U></B>. No action shall have been taken and no statute, rule, regulation or order shall
have been enacted, adopted or issued by any federal, state or foreign governmental or regulatory authority that would, as of the Closing
Date or any Additional Closing Date, as the case may be, prevent the issuance, sale or delivery of the Closing Units or the Option Securities
by the Company; and no injunction or order of any federal, state or foreign court shall have been issued that would, as of the Closing
Date or any Additional Closing Date, as the case may be, prevent the issuance, sale or delivery of the Closing Units or the Option Securities.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-left: 0.5in; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">8.8.
<B><U>Good Standing</U></B>. The Underwriter shall have received on and as of the Closing Date and any Additional Closing Date, as the
case may be, satisfactory evidence of the good standing of the Company in its jurisdiction of incorporation, in writing from the appropriate
governmental authorities of such jurisdiction.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-left: 0.5in; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">8.9.
<B><U>Lock-Up Agreements</U></B>. The Lock-Up Agreements substantially in the form of <B><U>Exhibit 8.9</U></B> hereto executed by the
officers, directors and certain stockholders of the Company relating to sales and certain other dispositions of shares of Common Stock
or certain other securities, delivered to the Underwriter on or before the date hereof, shall be in full force and effect on the Closing
Date or any Additional Closing Date, as the case may be.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-left: 0.5in; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">8.10.
<B><U>Exchange Listing</U></B>. On the Closing Date or any Additional Closing Date, as the case may be, the Shares shall have been approved
for listing on the Exchange, subject to notice of issuance.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-left: 0.5in; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">8.11.
<B><U>Irrevocable Consent</U></B>. On or before the date hereof, the Company shall have received the irrevocable consents executed by
the Company&rsquo;s officers and directors in the form attached hereto as <B><U>Exhibit 8.11</U></B>, which Irrevocable Consents shall
not be waived or otherwise released by the Company, whereby such officers and directors agree to seek and vote all equity of the Company
held by them in favor of each corporate action contemplated in the definition of Stockholder Approval (as defined in Section 5.9 hereof
and in the Common Warrants), whether at a meeting of stockholders, by action taken at a meeting, by consent or otherwise.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-left: 0.5in; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">8.12.
<B><U>Additional Documents</U></B>. On or prior to the Closing Date or any Additional Closing Date, as the case may be, the Underwriter
and its counsel shall have received such information, certificates and other additional documents from the Company as they may reasonably
require for the purpose of enabling them to pass upon the issuance and sale of the Units as contemplated herein or in order to evidence
the accuracy of any of the representations and warranties, or the satisfaction of any of the covenants, closing conditions or other obligations,
contained in this Agreement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<!-- Field: Page; Sequence: 32; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->32<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">All
opinions, letters, certificates and other documents delivered pursuant to this Agreement will be deemed to be in compliance with the
provisions hereof only if they are reasonably satisfactory in form and substance to counsel for the Underwriter.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
any condition specified in this Section 8 is not satisfied when and as required to be satisfied, this Agreement and all obligations of
the Underwriter hereunder may be terminated by the Underwriter by notice to the Company at any time on or prior to the Closing Date or
any Additional Closing Date, as the case may be, which termination shall be without liability on the part of any party to any other party,
except that the Company shall continue to be liable for the payment of expenses under Section 7 and Section 12 hereof and except that
the provisions of Section 9 and Section 10 hereof shall at all times be effective and shall survive any such termination.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">

    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in; padding-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">9.</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><U>Indemnification</U></B>.</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-left: 0.5in; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">9.1.
<B><U>Indemnification of the Underwriter by the Company</U></B>. The Company agrees to indemnify and hold harmless the Underwriter, its
Affiliates, directors, officers, employees and agents and each person, if any, who controls the Underwriter within the meaning of Section
15 of the Securities Act or Section 20 of the Exchange Act from and against any and all losses, claims, damages and liabilities (including,
without limitation, all reasonable legal fees and other expenses incurred in connection with any suit, action or proceeding or any claim
asserted, as such fees and expenses are incurred), joint or several, that arise out of or are based upon (i) any untrue statement or
alleged untrue statement of a material fact contained in the Registration Statement (or any amendment or supplement thereto), or the
omission or alleged omission therefrom of a material fact required to be stated therein or necessary in order to make the statements
therein not misleading, or (ii) any untrue statement or alleged untrue statement of a material fact contained in any Pricing Disclosure
Package (including any Pricing Disclosure Package that has subsequently been amended), the Final Prospectus (or any amendment or supplement
thereto), any Preliminary Prospectus, any Issuer Information, any Issuer Free Writing Prospectus, any Written Testing-the-Waters Communication
or any Road Show, or the omission or alleged omission therefrom of a material fact necessary in order to make the statements therein,
in the light of the circumstances under which they were made, not misleading, in each case, except insofar as such losses, claims, damages
or liabilities arise out of, or are based upon, any untrue statement or omission or alleged untrue statement or omission made in reliance
upon and in conformity with the Underwriter Information. The indemnity agreement set forth in this Section 9.1 shall be in addition to
any liabilities that the Company may otherwise have.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-left: 0.5in; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-left: 0.5in; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">9.2.
<B><U>Indemnification of the Company by the Underwriter</U></B>. The Underwriter agrees to indemnify and hold harmless the Company, its
directors, each officer who signed the Registration Statement and each person, if any, who controls the Company within the meaning of
Section 15 of the Securities Act or Section 20 of the Exchange Act from and against any and all losses, claims, damages and liabilities
(including, without limitation, all reasonable legal fees and other expenses incurred in connection with any suit, action or proceeding
or any claim asserted, as such fees and expenses are incurred), joint or several, to the same extent as the indemnity set forth in Section
9.1 hereof; provided, however, that the Underwriter shall be liable only to the extent that any untrue statement or omission or alleged
untrue statement or omission was made in the Registration Statement (or any amendment or supplement thereto), any Pricing Disclosure
Package (including any Pricing Disclosure Package that has subsequently been amended), the Final Prospectus (or any amendment or supplement
thereto), any Preliminary Prospectus, any Issuer Information, any Issuer Free Writing Prospectus, any Written Testing-the-Waters Communication
or any Road Show in reliance upon, and in conformity with, the Underwriter Information relating to the Underwriter. The indemnity agreement
set forth in this Section 9 shall be in addition to any liabilities that the Underwriter may otherwise have.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<!-- Field: Page; Sequence: 33; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->33<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-left: 0.5in; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">9.3.
<B><U>Notifications and Other Indemnification Procedures</U></B>. If any suit, action, proceeding (including any governmental or regulatory
investigation), claim or demand shall be brought or asserted against any person in respect of which indemnification may be sought pursuant
to any of the preceding subsections of this Section 9, such person (the &ldquo;<B><U>Indemnified Person</U></B>&rdquo;) shall promptly
notify the person against whom such indemnification may be sought (the &ldquo;<B><U>Indemnifying Person</U></B>&rdquo;) in writing; <U>provided
</U>that the failure to notify the Indemnifying Person shall not relieve it from any liability that it may have under any of the preceding
subsections of this Section 9 except to the extent that it has been materially prejudiced by such failure; and <U>provided</U>, further,
that the failure to notify the Indemnifying Person shall not relieve it from any liability that it may have to an Indemnified Person
otherwise than under any of the preceding subsections of this Section 9. If any such proceeding shall be brought or asserted against
an Indemnified Person and it shall have notified the Indemnifying Person thereof, the Indemnifying Person shall retain counsel reasonably
satisfactory to the Indemnified Person (who shall not, without the consent of the Indemnified Person, be counsel to the Indemnifying
Person) to represent the Indemnified Person in such proceeding and shall pay the reasonable and documented fees and expenses of such
counsel related to such proceeding, as incurred. In any such proceeding, any Indemnified Person shall have the right to retain its own
counsel, but the fees and expenses of such counsel shall be at the expense of such Indemnified Person unless (i) the Indemnifying Person
and the Indemnified Person shall have mutually agreed to the contrary; (ii) the Indemnifying Person has failed within a reasonable time
to retain counsel reasonably satisfactory to the Indemnified Person; (iii) the Indemnified Person shall have reasonably concluded that
there may be legal defenses available to it that are different from or in addition to those available to the Indemnifying Person; or
(iv) the named parties in any such proceeding (including any impleaded parties) include both the Indemnifying Person and the Indemnified
Person and representation of both parties by the same counsel would be inappropriate due to actual or potential differing interest between
them. It is understood and agreed that the Indemnifying Person shall not, in connection with any proceeding or related proceedings in
the same jurisdiction, be liable for the fees and expenses of more than one separate firm (in addition to any local counsel) for all
Indemnified Persons, and that all such fees and expenses shall be paid or reimbursed as they are incurred. Any such separate firm for
(i) the Underwriter, its Affiliates, directors, officers, employees and agents and each person, if any, who controls the Underwriter
within the meaning of Section 15 of the Securities Act or Section 20 of the Exchange Act shall be designated in writing by the Underwriter;
and (ii) the Company, its directors, its officers who signed the Registration Statement and each person, if any, who controls the Company
within the meaning of Section 15 of the Securities Act or Section 20 of the Exchange Act shall be designated in writing by the Company.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-left: 0.5in; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">9.4.
<B><U>Settlements</U></B>. The Indemnifying Person under this Section 9 shall not be liable for any settlement of any proceeding effected
without its written consent, which consent may not be unreasonably withheld, but if settled with such consent or if there be a final
judgment for the plaintiff, the Indemnifying Person agrees to indemnify the Indemnified Person from and against any loss, claim, damage,
liability or expense by reason of such settlement or judgment. Notwithstanding the foregoing sentence, if at any time an Indemnified
Person shall have requested an Indemnifying Person to reimburse the Indemnified Person for any reasonably incurred and documented fees
and expenses of counsel as contemplated by this Section 9, the Indemnifying Person agrees that it shall be liable for any settlement
of any proceeding effected without its written consent if (i) such settlement is entered into more than forty-five (45) Calendar Days
after receipt by such Indemnifying Person of the aforesaid request, (ii) such Indemnifying Person shall not have reimbursed the Indemnified
Person in accordance with such request, or shall not have disputed in good faith the Indemnified Person&rsquo;s entitlement to such reimbursement,
prior to the date of such settlement and (iii) such Indemnified Person shall have given the Indemnifying Person at least forty-five (45)
Calendar Days&rsquo; prior notice of its intention to settle. No Indemnifying Person shall, without the prior written consent of the
Indemnified Person effect any settlement, compromise or consent to the entry of judgment in any pending or threatened action, suit or
proceeding in respect of which any Indemnified Person is or could have been a party and indemnity was or could have been sought hereunder
by such Indemnified Person, unless such settlement, compromise or consent (x) includes an unconditional release of such Indemnified Person,
in form and substance reasonably satisfactory to such Indemnified Person, from and against all liability on claims that are the subject
matter of such action, suit or proceeding and (y) does not include any statements as to or any findings of fault, culpability or failure
to act by or on behalf of any Indemnified Person.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<!-- Field: Page; Sequence: 34; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->34<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">

    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in; padding-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><U>Contribution</U></B>.</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-left: 0.5in; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.1.
To the extent the indemnification provided for in Section 9 hereof is unavailable to or insufficient to hold harmless an Indemnified
Person in respect of any losses, claims, damages, liabilities or expenses referred to therein, then each Indemnifying Person, in lieu
of indemnifying such Indemnified Person thereunder, shall contribute to the aggregate amount paid or payable by such Indemnified Person,
as incurred, as a result of any losses, claims, damages, liabilities or expenses referred to therein (i) in such proportion as is appropriate
to reflect the relative benefits received by the Company, on the one hand, and the Underwriter, on the other hand, from the offering
of the Units pursuant to this Agreement or (ii) if the allocation provided by clause (i) above is not permitted by applicable law, in
such proportion as is appropriate to reflect not only the relative benefits referred to in clause (i) above but also the relative fault
of the Company, on the one hand, and the Underwriter, on the other hand, in connection with the statements or omissions that resulted
in such losses, claims, damages, liabilities or expenses, as well as any other relevant equitable considerations. The relative benefits
received by the Company, on the one hand, and the Underwriter, on the other hand, in connection with the offering of the Units pursuant
to this Agreement shall be deemed to be in the same respective proportions as the total net proceeds from the offering of the Units pursuant
to this Agreement (before deducting expenses) received by the Company, on the one hand, and the total underwriting discounts and commissions
received by the Underwriter, on the other hand, in each case as set forth in the table on the cover of the Final Prospectus bear to the
aggregate initial offering price of the Units. The relative fault of the Company, on the one hand, and the Underwriter, on the other
hand, shall be determined by reference to, among other things, whether the untrue or alleged untrue statement of a material fact or omission
or alleged omission to state a material fact relates to information supplied by the Company, on the one hand, or the Underwriter, on
the other hand, and the parties&rsquo; relative intent, knowledge, access to information and opportunity to correct or prevent such statement
or omission.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-left: 0.5in; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.2.
The amount paid or payable by a party as a result of the losses, claims, damages, liabilities and expenses referred to above shall be
deemed to include, subject to the limitations set forth in Section 9 hereof, all reasonable legal or other fees or expenses incurred
by such party in connection with investigating or defending any action or claim. The provisions set forth in Section 9 hereof with respect
to notice of commencement of any action shall apply if a claim for contribution is to be made under this Section 10; <U>provided</U>,
however, that no additional notice shall be required with respect to any action for which notice has been given under Section 9 hereof
for purposes of indemnification.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-left: 0.5in; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.3.
The Company and the Underwriter agree that it would not be just and equitable if contribution pursuant to this Section 10 was determined
by pro rata allocation or by any other method of allocation which does not take account of the equitable considerations referred to in
this Section 10.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-left: 0.5in; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.4.
Notwithstanding the provisions of this Section 10, the Underwriter shall not be required to contribute any amount in excess of the amount
by which the total discounts and commissions received by the Underwriter in connection with the Units distributed by it exceeds the amount
of any damages the Underwriter has otherwise paid or become liable to pay by reason of any untrue or alleged untrue statement or omission
or alleged omission. No person guilty of fraudulent misrepresentation (within the meaning of Section 11 of the Securities Act) shall
be entitled to contribution from any person who was not guilty of such fraudulent misrepresentation.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<!-- Field: Page; Sequence: 35; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->35<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-left: 0.5in; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.5.
For purposes of this Section 10, each director, officer, employee and agent of the Underwriter and each person, if any, who controls
the Underwriter within the meaning of Section 15 of the Securities Act or Section 20 of the Exchange Act shall have the same rights to
contribution as the Underwriter, and each director and officer of the Company who signed the Registration Statement, and each person,
if any, who controls the Company with the meaning of Section 15 of the Securities Act or Section 20 of the Exchange Act, shall have the
same rights to contribution as the Company.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-left: 0.5in; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.6.
The remedies provided for in Section 9 and Section 10 hereof are not exclusive and shall not limit any rights or remedies which may otherwise
be available to any Indemnified Person at law or in equity.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">

    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in; padding-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">11.</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><U>Termination</U></B>.</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-left: 0.5in; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">11.1.
Prior to the delivery of and payment for the Units on the Closing Date or any Additional Closing Date, as the case may be, this Agreement
may be terminated by the Underwriter in the absolute discretion of the Underwriter by notice given to the Company if after the execution
and delivery of this Agreement: (i) trading or quotation of any securities issued or guaranteed by the Company shall have been suspended
or materially limited on any securities exchange, quotation system or in the over-the-counter market; (ii) trading in securities generally
on any of the New York Stock Exchange, the Nasdaq Stock Exchange or the over-the-counter market shall have been suspended or materially
limited; (iii) a general banking moratorium on commercial banking activities shall have been declared by federal or New York state authorities;
(iv) there shall have occurred a material disruption in commercial banking or securities settlement, payment or clearance services in
the United States; (v) there shall have occurred any outbreak or escalation of national or international hostilities or any crisis or
calamity, or any change in the United States or international financial markets, or any substantial change or development involving a
prospective substantial change in general economic, financial or political conditions in the United States or internationally, as in
the judgment of the Underwriter is material and adverse and makes it impracticable or inadvisable to proceed with the offering, sale
or delivery of the Units on the Closing Date or any Additional Closing Date, as the case may be, in the manner and on the terms described
in the Pricing Disclosure Package or to enforce contracts for the sale of securities; or (vi) the Company or any of its subsidiaries
shall have sustained a loss by strike, fire, flood, earthquake, accident or other calamity of such character as in the judgment of the
Underwriter may interfere materially with the conduct of the business and operations of the Company and its subsidiaries, considered
as one entity, regardless of whether or not such loss shall have been insured.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-left: 0.5in; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">11.2.
Any termination pursuant to this Section 11 shall be without liability on the part of: (x) the Company to the Underwriter, except that
the Company shall continue to be liable for the payment of expenses under Section 7; (y) the Underwriter to the Company; or (z) any party
hereto to any other party except that the provisions of Section 9, Section 10 and this Section 11 hereof shall at all times be effective
and shall survive any such termination.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<!-- Field: Page; Sequence: 36; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->36<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">

    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in; padding-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">12.</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><U>Reimbursement
    of the Underwriter&rsquo;s Expenses</U></B>. If (a) the Company fails to deliver the Units to the Underwriter for any reason at the
    Closing Date or any Additional Closing Date, as the case may be, in accordance with this Agreement or (b) the Underwriter declines
    to purchase the Units for any reason permitted under this Agreement, then the Company agrees to reimburse the Underwriter for all
    reasonable out-of-pocket costs and expenses (including the reasonable and documented fees and expenses of counsel to the Underwriter)
    incurred by the Underwriter in connection with this Agreement and the applicable offering contemplated hereby.</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">

    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in; padding-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">13.</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><U>Representations
    and Indemnities to Survive Delivery</U></B>. The respective indemnities, rights of contribution, agreements, representations, warranties
    and other statements of the Company and the Underwriter set forth in or made pursuant to this Agreement or made by or on behalf of
    the Company or the Underwriter pursuant to this Agreement or any certificate delivered pursuant hereto shall remain in full force
    and effect, regardless of any investigation made by or on behalf of the Underwriter, the Company or any of their respective officers
    or directors or any controlling person, as the case may be, and shall survive delivery of and payment for the Units sold hereunder
    and any termination of this Agreement.</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">

    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in; padding-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">14.</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><U>Notices</U></B>.
    All notices, requests, consents, claims, demands, waivers and other communications under this Agreement shall be in writing and shall
    be deemed to have been duly given (i) when delivered by hand (with written confirmation of receipt), (ii) when received by the addressee
    if sent by a nationally recognized overnight courier (receipt requested), (iii) on the date sent by facsimile (with confirmation
    of transmission) or email of a PDF document if sent during normal business hours of the recipient, and on the next Business Day if
    sent after normal business hours of the recipient, or (iv) on the third (3rd) Calendar Day after the date mailed, by certified or
    registered mail (in each case, return receipt requested, postage pre-paid). Such communications must be sent to the respective parties
    at the following addresses (or at such other address for a party as shall be specified in a notice given in accordance with this
    Section 14):</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; width: 1.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
    to the Underwriter:</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; white-space: nowrap; vertical-align: bottom"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Aegis
                                            Capital Corp.</FONT></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1345
    Avenue of the Americas, 27th Floor New York, NY 10105</FONT></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"></P></TD></TR>
</TABLE>

<P STYLE="margin: 0"></P>

<P STYLE="margin: 0"></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; text-align: left">
  <TD STYLE="width: 1.5in">&nbsp;</TD>
  <TD STYLE="width: 1in">Email:</TD>
  <TD>banking@aegiscap.com</TD></TR>
<TR STYLE="vertical-align: top; text-align: left">
  <TD>&nbsp;</TD>
  <TD>Attention:</TD>
  <TD>Robert Eide</TD></TR>
</TABLE>

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="margin: 0"></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; width: 1.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">with
    a copy to:</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; white-space: nowrap; vertical-align: bottom"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Kaufman
                                            &amp; Canoles, P.C.</FONT></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Two
    James Center, 14th Floor, 1021 E. Cary St., Richmond, VA 23219</FONT></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"></P></TD></TR>
</TABLE>

<P STYLE="margin: 0"></P>

<P STYLE="margin: 0"></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; text-align: left">
  <TD STYLE="width: 1.5in">&nbsp;</TD>
  <TD STYLE="width: 1in">Email:</TD>
  <TD>awbasch@kaufcan.com</TD></TR>
<TR STYLE="vertical-align: top; text-align: left">
  <TD>&nbsp;</TD>
  <TD>&nbsp;</TD>
  <TD>jbwilliston@kaufcan.com</TD></TR>
<TR STYLE="vertical-align: top; text-align: left">
  <TD>&nbsp;</TD>
  <TD>Attention:</TD>
  <TD>Anthony Basch</TD></TR>
<TR STYLE="vertical-align: top; text-align: left">
  <TD>&nbsp;</TD>
  <TD>&nbsp;</TD>
  <TD>J. Britton Williston</TD></TR>
</TABLE>
<P STYLE="margin: 0"></P>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; width: 1.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
    to the Company:</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; white-space: nowrap; vertical-align: bottom"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Sharps
                                            Technology, Inc.</FONT></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">105
    Maxess Road, Melville, New York 11747</FONT></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"></P></TD></TR>
</TABLE>

<P STYLE="margin: 0"></P>

<P STYLE="margin: 0"></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; text-align: left">
  <TD STYLE="width: 1.5in">&nbsp;</TD>
  <TD STYLE="width: 1in">Email:</TD>
  <TD>roberth@sharpstechnology.com</TD></TR>
<TR STYLE="vertical-align: top; text-align: left">
  <TD>&nbsp;</TD>
  <TD>Attention:</TD>
  <TD>Robert Hayes</TD></TR>
</TABLE>
<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="margin: 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; width: 1.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">with
    copy to:</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; white-space: nowrap; vertical-align: bottom"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Sichenzia
                                            Ross Ference Carmel LLP</FONT></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1185
    Avenue of the Americas, 31st Floor, New York, NY 10036</FONT></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"></P></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; text-align: left">
  <TD STYLE="width: 1.5in">&nbsp;</TD>
  <TD STYLE="width: 1in">Email:</TD>
  <TD>amarcus@SRFC.LAW</TD></TR>
<TR STYLE="vertical-align: top; text-align: left">
  <TD>&nbsp;</TD>
  <TD>Attention:</TD>
  <TD>Arthur Marcus</TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-left: 0.5in; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Any
party hereto may change the address or facsimile number for receipt of communications by giving written notice to the others in accordance
with this Section 14.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<!-- Field: Page; Sequence: 37; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->37<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">

    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in; padding-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">15.</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><U>Successors</U></B>.
    This Agreement shall inure solely to the benefit of and be binding upon the Underwriter, the Company and the other indemnified parties
    referred to in Section 9 and Section 10 hereof, and in each case their respective successors. Nothing in this Agreement is intended,
    or shall be construed, to give any other person or entity any legal or equitable right, benefit, remedy or claim under, or in respect
    of or by virtue of, this Agreement or any provision contained herein. The term &ldquo;successors,&rdquo; as used herein, shall not
    include any purchaser of the Units from the Underwriter merely by reason of such purchase.</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">

    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in; padding-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">16.</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><U>Partial
    Unenforceability</U></B>. The invalidity or unenforceability of any Section, paragraph or provision of this Agreement shall not affect
    the validity or enforceability of any other Section, paragraph or provision hereof. If any Section, paragraph or provision of this
    Agreement is for any reason determined to be invalid or unenforceable, there shall be deemed to be made such minor changes (and only
    such minor changes) as are necessary to make it valid and enforceable.</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">

    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in; padding-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">17.</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><U>Governing
    Law</U></B>. This Agreement and any claim, controversy or dispute arising under or related to this Agreement, whether sounding in
    contract, tort or statute, shall be governed by and construed in accordance with the internal laws of the State of New York applicable
    to agreements made and to be performed in such state (including its statute of limitations), without giving effect to the conflict
    of laws provisions thereof to the extent such principles or rules would require or permit the application of the laws of any jurisdiction
    other than those of the State of New York. The Company has irrevocably appointed Robert Hayes, as its agent to receive service of
    process or other legal summons for purposes of any such suit, action or proceeding that may be instituted in any state or federal
    court in the Borough of Manhattan in the City of New York, United States of America.</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">

    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in; padding-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">18.</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><U>Consent
    to Jurisdiction</U></B>. No legal suit, action or proceeding arising out of or relating to this Agreement or the transactions contemplated
    hereby (each, a &ldquo;<B><U>Related Proceeding</U></B>&rdquo;) may be commenced, prosecuted or continued in any court other than
    the courts of the State of New York located in the City and County of New York or in the United States District Court for the Southern
    District of New York, which courts (collectively, the &ldquo;<B><U>Specified Courts</U></B>&rdquo;) shall have jurisdiction over
    the adjudication of any Related Proceeding, and the parties to this Agreement hereby irrevocably consent to the exclusive jurisdiction
    the Specified Courts and personal service of process with respect thereto. The parties to this Agreement hereby irrevocably waive
    any objection to the laying of venue of any Related Proceeding in the Specified Courts and irrevocably waive and agree not to plead
    or claim in any Specified Court that any Related Proceeding brought in any Specified Court has been brought in an inconvenient forum.</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<!-- Field: Page; Sequence: 38; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->38<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">

    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in; padding-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">19.</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><U>Equitable
    Remedies</U></B>. Each party to this Agreement acknowledges and agrees that (a) a breach or threatened breach by the Company of any
    of its obligations under Section 5.11 or Section 5.16 would give rise to irreparable harm to the Underwriter for which monetary damages
    would not be an adequate remedy and (b) if a breach or a threatened breach by the Company of any such obligations occurs, the Underwriter
    will, in addition to any and all other rights and remedies that may be available to such party at law, at equity, or otherwise in
    respect of such breach, be entitled to equitable relief, including a temporary restraining order, an injunction, specific performance
    of the terms of Section 5.11 or Section 5.16 and any other relief that may be available from a court of competent jurisdiction, without
    any requirement to (i) post a bond or other security, or (ii) prove actual damages or that monetary damages will not afford an adequate
    remedy. Each party to this Agreement agrees that such party shall not oppose or otherwise challenge the existence of irreparable
    harm, the appropriateness of equitable relief or the entry by a court of competent jurisdiction of an order granting equitable relief,
    in either case, consistent with the terms of this Section 19.</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">

    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in; padding-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">20.</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><U>Waiver
    of Jury Trial</U></B>. The parties to this Agreement hereby irrevocably waive, to the fullest extent permitted by applicable law,
    any and all right to trial by jury in any Related Proceeding.</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">

    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in; padding-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">21.</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><U>No
    Fiduciary Relationship</U></B>. The Company acknowledges and agrees that: (i) the purchase and sale of the Units pursuant to this
    Agreement, including the determination of the offering price of the Units and any related discounts and commissions, is an arm&rsquo;s-length
    commercial transaction between the Company, on the one hand, and the Underwriter, on the other hand; (ii) in connection with each
    transaction contemplated hereby and the process leading to such transaction the Underwriter is and has been acting solely as a principal
    and is not the agent or fiduciary of the Company or its Affiliates, stockholders, members, partners, creditors or employees or any
    other party; (iii) the Underwriter has not assumed and will not assume an advisory or fiduciary responsibility in favor of the Company
    with respect to any of the transactions contemplated hereby or the process leading thereto (irrespective of whether the Underwriter
    has advised or is currently advising the Company on other matters) or any other obligation to the Company except the obligations
    expressly set forth in this Agreement; (iv) the Underwriter and its respective Affiliates may be engaged in a broad range of transactions
    that involve interests that differ from those of the Company, and the Underwriter has no obligation to disclose any of such interests
    by virtue of any fiduciary or advisory relationship; and (v) the Underwriter has not provided any legal, accounting, regulatory or
    tax advice in any jurisdiction with respect to the offering contemplated hereby, and the Company has consulted its own legal, accounting,
    regulatory and tax advisors to the extent they deemed appropriate. The Company waives and releases, to the full extent permitted
    by applicable law, any claims it may have against the Underwriter arising from an alleged breach of fiduciary duty in connection
    with the offering of the Units or any matters leading up to the offering of the Units.</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<!-- Field: Page; Sequence: 39; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->39<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">

    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in; padding-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">22.</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><U>Compliance
    with the USA Patriot Act</U></B>. In accordance with the requirements of the USA Patriot Act (Title III of Pub. L. 107-56 (signed
    into law October 26, 2001)), the Underwriter is required to obtain, verify and record information that identifies their respective
    clients, including the Company, which information may include the name and address of its clients, as well as other information that
    will allow the Underwriter to properly identify their respective clients.</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">

    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in; padding-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">23.</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><U>Entire
    Agreement</U></B>. This Agreement, together with any contemporaneous written agreements and any prior written agreements (to the
    extent not superseded by this Agreement) that relate to the offering of the Units, represents the entire agreement among the Company
    and the Underwriter with respect to the preparation of the Registration Statement, the Pricing Disclosure Package, the Final Prospectus,
    each Preliminary Prospectus, each Issuer Free Writing Prospectus, each Testing-the-Waters Communication and each Road Show, the purchase
    and sale of the Units and the conduct of the offering contemplated hereby.</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">

    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in; padding-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">24.</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><U>Amendments
    or Waivers</U></B>. No amendment or waiver of any provision of this Agreement, nor any consent or approval to any departure therefrom,
    shall in any event be effective unless the same shall be in writing and signed by all the parties hereto. No waiver by any party
    shall operate or be construed as a waiver in respect of any failure, breach or default not expressly identified by such written waiver,
    whether of a similar or different character, and whether occurring before or after the waiver. No failure to exercise, or delay in
    exercising, any right, remedy, power or privilege arising from this Agreement shall operate or be construed as a waiver thereof;
    nor shall any single or partial exercise of any right, remedy, power or privilege hereunder preclude any other or further exercise
    of any other right, remedy, power or privilege.</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">

    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in; padding-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">25.</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><U>Section
    Headings</U></B>. The headings herein are included for convenience of reference only and are not intended to be part of, or to affect
    the meaning or interpretation of, this Agreement.</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">

    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in; padding-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">26.</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><U>Counterparts</U></B>.
    This Agreement may be executed in counterparts, each of which will be deemed an original, but all of which together will be deemed
    to be one and the same agreement. Counterparts may be delivered via facsimile, email (including PDF or any electronic signature complying
    with the U.S. federal ESIGN Act of 2000) or other transmission method, and any counterpart so delivered will be deemed to have been
    duly and validly delivered and be valid and effective for all purposes.</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">

    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in; padding-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">27.</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><U>Recognition
    of the U.S. Special Resolution Regimes</U></B>.</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-left: 0.5in; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">27.1.
In the event that the Underwriter is a Covered Entity (as defined below) becomes subject to a proceeding under a U.S. Special Resolution
Regime, the transfer from the Underwriter of this Agreement, and any interest and obligation in or under this Agreement, will be effective
to the same extent as the transfer would be effective under the U.S. Special Resolution Regime (as defined below) if this Agreement,
and any such interest and obligation, were governed by the laws of the United States or a state of the United States.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-left: 0.5in; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">27.2.
In the event that the Underwriter is a Covered Entity or a BHC Act Affiliate (as defined below) of the Underwriter becomes subject to
a proceeding under a U.S. Special Resolution Regime, Default Rights (as defined below) under this Agreement that may be exercised against
the Underwriter is permitted to be exercised to no greater extent than such Default Rights could be exercised under the U.S. Special
Resolution Regime if this Agreement were governed by the laws of the United States or a state of the United States.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<!-- Field: Page; Sequence: 40; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->40<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-left: 0.5in; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">27.3.
As used in this section:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="text-indent: 0.5in; font: 10pt Times New Roman, Times, Serif; margin-left: 0.5in; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">27.3.1.
&ldquo;<B><U>BHC Act Affiliate</U></B>&rdquo; has the meaning assigned to the term &ldquo;affiliate&rdquo; in, and shall be interpreted
in accordance with, 12 U.S.C. &sect; 1841(k).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-indent: 0.5in; margin-left: 0.5in; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">27.3.2.
&ldquo;<B><U>Covered Entity</U></B>&rdquo; means any of the following:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-indent: 0.5in; margin-left: 0.5in; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">27.3.2.1
a &ldquo;covered entity&rdquo; as that term is defined in, and interpreted in accordance with, 12 C.F.R. &sect; 252.82(b);</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-indent: 0.5in; margin-left: 0.5in; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-indent: 0.5in; margin-left: 0.5in; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">27.3.2.2
a &ldquo;covered bank&rdquo; as that term is defined in, and interpreted in accordance with, 12 C.F.R. &sect; 47.3(b); or</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-indent: 0.5in; margin-left: 0.5in; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">27.3.2.3
a &ldquo;covered FSI&rdquo; as that term is defined in, and interpreted in accordance with, 12 C.F.R. &sect; 382.2(b).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-indent: 0.5in; margin-left: 0.5in; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">27.3.3.
&ldquo;<B><U>Default Right</U></B>&rdquo; has the meaning assigned to that term in, and shall be interpreted in accordance with, 12 C.F.R.
&sect;&sect; 252.81, 47.2 or 382.1, as applicable.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-indent: 0.5in; margin-left: 0.5in; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">27.3.4.
&ldquo;<B><U>U.S. Special Resolution Regime</U></B>&rdquo; means each of (i) the Federal Deposit Insurance Act and the regulations promulgated
thereunder and (ii) Title II of the Dodd-Frank Wall Street Reform and Consumer Protection Act and the regulations promulgated thereunder.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>[STSS
Underwriting Agreement Signature Page Follows]</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>&nbsp;</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"></P>

<!-- Field: Page; Sequence: 41; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->41<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>[STSS
Underwriting Agreement Signature Page]</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 24.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
the foregoing is in accordance with your understanding, please indicate your acceptance of this Agreement by signing in the space provided
below.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD>&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Very
                                            truly yours,</FONT></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>SHARPS
    TECHNOLOGY, INC.</B></FONT></P></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD>&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="width: 50%">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; width: 5%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">By:</FONT></TD>
    <TD STYLE="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif; vertical-align: top; width: 45%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD>&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name:</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Robert
    Hayes</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD>&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Title:</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Chief
    Executive Officer</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Confirmed
and accepted as of the date first above written:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>AEGIS
CAPITAL CORP.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 5%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 45%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 50%">&nbsp;</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">By:</FONT></TD>
    <TD STYLE="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif; white-space: nowrap; vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name:</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Robert
    Eide</FONT></TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Title:</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Chief
    Executive Officer</FONT></TD>
    <TD>&nbsp;</TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"></P>

<!-- Field: Page; Sequence: 42 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>SCHEDULE
1.16</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Pricing
Disclosure Package</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left">Number of Closing Units:</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">[&#9679;]</FONT></TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left">&#9679; Number of Units containing Firm Shares (&ldquo;Common Units&rdquo;)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">[&#9679;]</FONT></TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left">&#9679; Number of Units containing Pre-funded Warrants (&ldquo;Pre-funded Units&rdquo;)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">[&#9679;]</FONT></TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD>Number of Option Shares:</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">[&#9679;]</FONT></TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left">Number of Option Pre-funded Warrants:</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">[&#9679;]</FONT></TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left">Number of Option Series A Common Warrants:</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">[&#9679;]</FONT></TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left">Number of Option Series B Common Warrants:</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">[&#9679;]</FONT></TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left">Public Offering Price per Common Unit:</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">[&#9679;]</FONT></TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left">Public Offering Price per Pre-funded Unit:</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">[&#9679;]</FONT></TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="width: 78%">Exercise Price per Pre-Funded Warrant:</TD><TD STYLE="width: 2%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">$</TD><TD STYLE="width: 18%; text-align: right">0.0001</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD>Exercise Price per Series A Common Warrant:</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">[&#9679;]</FONT></TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD>Exercise Price per Series B Common Warrant:</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">[&#9679;]</FONT></TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left">Underwriting Discount per Common Unit and per Pre-funded Unit:</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">[&#9679;]</FONT></TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left">Non-accountable expense allowance per Common Unit and per Pre-funded Unit:</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">[&#9679;]</FONT></TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD>Purchase Price per Option Share:</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">[&#9679;]</FONT></TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left">Purchase Price per Option Pre-Funded Warrant:</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">[&#9679;]</FONT></TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left">Purchase Price per full Series A or B Option Common Warrant:</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">0.00001</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  </TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"></P>

<!-- Field: Page; Sequence: 43 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>SCHEDULE
2.5.4</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Free
Writing Prospectuses </B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"></P>

<!-- Field: Page; Sequence: 44 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>SCHEDULE
2.45</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Principal
Subsidiaries</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; white-space: nowrap; border-bottom: black 1pt solid; width: 49%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Principal
    Subsidiaries</B></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 2%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; border-bottom: black 1pt solid; width: 49%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Place
    of Incorporation</B></FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">[&#9679;]</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; white-space: nowrap; vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">[&#9679;]</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"></P>

<!-- Field: Page; Sequence: 45 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>SCHEDULE
4.1.2</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Closing
Securities</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; background-color: white">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><U>Underwriter</U></B></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Number
    of Closing Units to Be Purchased</B></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="3" STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Number
    of Option Securities to Be Purchased if the Maximum Over-Allotment Option Is Exercised</B></FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: white">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="3" STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: white">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 18%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Aegis
    Capital Corp.</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 2%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; width: 16%; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">[&#9679;]</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 2%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 44%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Number
    of Option Shares:</FONT></TD>
    <TD STYLE="width: 2%">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 16%; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">[&#9679;]</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: white">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Number
    of Option Pre-funded Warrants:</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">[&#9679;]</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: white">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Number
    of Option Series A Warrants:</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">[&#9679;]</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: white">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Number
    of Option Series B Warrants:</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">[&#9679;]</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"></P>

<!-- Field: Page; Sequence: 46 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>EXHIBIT
5.11.3.1 </B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P><P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Form
of Lock-Up Waiver </B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">[&#9679;],
202[&#9679;]</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">[Waiver
Recipient Name and Address]</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Re:
Lock-Up Agreement Waiver</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Ladies
and Gentlemen:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">[Pursuant
to Section 8.9 of the Underwriting Agreement, dated [&#9679;], 2025 (the &ldquo;<B><U>Underwriting Agreement</U></B>&rdquo;), among Sharps
Technology, Inc., a Nevada corporation (the &ldquo;<B><U>Company</U></B>&rdquo;), and Aegis Capital Corp. (the &ldquo;<B><U>Underwriter</U></B>&rdquo;),
and the Lock-Up Agreement, dated [&#9679;], 2025 (the &ldquo;<B><U>Lock-Up Agreement</U></B>&rdquo;), between you and the Underwriter
relating to the Company&rsquo;s shares of Common Stock, $0.0001 par value per share (the &ldquo;<B><U>Share</U></B>&rdquo;), the Underwriter
hereby gives its consent to allow you to sell up to [&#9679;] Share [solely from and including [DATE] to and including [DATE]].]</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">[Pursuant
to Section 5.11 of the Underwriting Agreement, the Underwriter hereby gives its consent to allow the Company to issue and sell up to
[&#9679;] Shares pursuant to an offering of the Shares to commence prior to the expiration of the Lock-Up Period as defined in the Underwriting
Agreement[, provided that such offering closes on or prior to [&#9679;]].]</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">AEGIS
CAPITAL CORP.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="width: 50%">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; width: 5%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">By:</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; white-space: nowrap; vertical-align: bottom; border-bottom: black 1pt solid; width: 45%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <TD>&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name:</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Robert
    Eide</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <TD>&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Title:</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Chief
    Executive Officer</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"></P>

<!-- Field: Page; Sequence: 47 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>EXHIBIT
5.11.3.2</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Form
of Lock-Up Waiver Press Release </B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Sharps
Technology, Inc.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>[Date]</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Sharps
Technology, Inc., a Nevada corporation (the &ldquo;Company&rdquo;) announced today that Aegis Capital Corp., acting as the Underwriter
in the Company&rsquo;s recent public offering of the Company&rsquo;s Units consisting of one (1) share of Common Stock; one (1) Series
A warrant to purchase one (1) share of Common Stock at a per-Share exercise price of $[&#9679;] (representing 125.0% of the per Closing
Common Unit offering price and one (1) Series B warrant to purchase one (1) share of Common Stock at a per-Share exercise price of $[&#9679;]
(representing 125.0% of the per Closing Common Unit offering price), is [waiving] [releasing] a lock-up restriction with respect to the
Company&rsquo;s shares of Common Stock held by [certain officers or directors] [an officer or director] of the Company. The [waiver]
[release] will take effect on [Date], and the Shares may be sold on or after such date.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>This
press release is not an offer or sale of the securities in the United States or in any other jurisdiction where such offer or sale is
prohibited, and such securities may not be offered or sold in the United States absent registration or an exemption from registration
under the Securities Act of 1933, as amended. </B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"></P>

<!-- Field: Page; Sequence: 48 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>EXHIBIT
8.9</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Form
of Lock-Up Agreement</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"></P>

<!-- Field: Page; Sequence: 49 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>EXHIBIT
8.11</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Form
of Irrevocable Consent</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"></P>

<!-- Field: Page; Sequence: 50; Options: Last -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"></P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-3.1
<SEQUENCE>3
<FILENAME>ex3-1.htm
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Exhibit
3.1</B></FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>AMENDED
AND RESTATED</B></FONT> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B> BYLAWS</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>OF</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>SHARPS
TECHNOLOGY, INC.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>(a
Nevada corporation)</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>TABLE
OF CONTENTS</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">
    <TD COLSPAN="3" STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">ARTICLE I &ndash; OFFICES</FONT></TD>
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif"></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; width: 0.5in">&nbsp;</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.1 </FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Registered Agent and Office</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">3</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.2 </FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Principal Office</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">3</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.3</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Other Offices</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">3</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.4</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Books and Records</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">3</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif">&nbsp;</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: White">
    <TD COLSPAN="3" STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">ARTICLE II - STOCKHOLDERS</FONT></TD>
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif">&nbsp;</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif"></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.1 </FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Place of meeting</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">3</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.2</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Participation by Remote Communication</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">3</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.3 </FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Annual Meeting</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">4</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.4</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Special Meetings</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">4</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.5</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Fixing the Record Date</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">4</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.6</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Notice of Stockholders&rsquo; Meeting</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">4</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.7</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Voting Lists</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">5</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.8</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Quorum of Stockholders</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">5</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.9</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Conduct of Meetings</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">6</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.10</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Voting of Stock</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">6</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.11</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Voting by Proxy</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">6</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.12</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Action by Stockholders Without a Meeting</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">7</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif">&nbsp;</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">
    <TD COLSPAN="3" STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">ARTICLE III &ndash; DIRECTORS</FONT></TD>
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif">&nbsp;</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif">&nbsp;</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.1 </FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Powers</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">7</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.2</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Number of Directors</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">7</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.3</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Term of Office</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">7</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.4</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Removal</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">7</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.5</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Resignation</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">7</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.6</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Vacancies</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">8</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.7</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Regular Meetings of Directors</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">8</TD></TR>
</TABLE>

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="margin: 0"></P>

<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="margin: 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.8</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Special Meetings of Directors</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right; width: 0.5in">8</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.9</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Participation by Electronic Communication</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">8</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.10</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Notice of Directors&rsquo; Meetings</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">8</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.11</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Quorum and Action by Directors</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">8</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.12</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Action by Directors Without Meeting</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">9</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.13</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Committees of the Board of Directors</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">9</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif">&nbsp;</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: White">
    <TD COLSPAN="3" STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">ARTICLE IV &ndash; OFFICERS</FONT></TD>
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif">&nbsp;</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif">&nbsp;</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.1</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Positions and Election</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">9</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.2</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Removal and Resignation</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">9</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.3</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Chairman of the Board of Directors</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">10</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.4</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Chief Executive Officer</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">10</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.5</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Secretary</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">10</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.6</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Chief Financial Officer</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">10</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.7</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Treasurer</FONT></TD>
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif">&nbsp;</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif">&nbsp;</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: White">
    <TD COLSPAN="3" STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">ARTICLE V &ndash; INDEMNIFICATION OF DIRECTORS,
    OFFICERS, EMPLOYEES, AND AGENTS</FONT></TD>
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif">&nbsp;</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif">&nbsp;</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.1</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Indemnification in Actions by Third Parties</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">11</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.2</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Indemnification in Actions by or on Behalf of the Corporation</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">11</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.3</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Indemnification Against Expenses</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">11</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.4</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Non-Exclusivity of Indemnification Rights</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">11</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">11</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">
    <TD COLSPAN="3" STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">ARTICLE VI &ndash; SHARE CERTIFICATES AND
    TRANSFER</FONT></TD>
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif">&nbsp;</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif">&nbsp;</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">6.1</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Certificates Representing Shares</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">12</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">6.2</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Transfer of Shares</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">12</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">6.3</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Registered Stockholders</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">12</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">6.4</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Lost, Stolen, or Destroyed Certificates</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">13</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif">&nbsp;</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: White">
    <TD COLSPAN="3" STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">ARTICLE VII &ndash; DISTRIBUTIONS</FONT></TD>
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif">&nbsp;</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif">&nbsp;</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">7.1</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Declaration</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">13</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">7.2</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Fixing Record Dates for Distributions and Share Dividends</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">13</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif">&nbsp;</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">
    <TD COLSPAN="3" STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">ARTICLE VIII &ndash; MISCELLANEOUS</FONT></TD>
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif">&nbsp;</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif">&nbsp;</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">8.1</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Checks, Drafts, Etc.</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">13</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">8.2</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Fiscal Year</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">13</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">8.3</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Conflict with Applicable Law or Articles of Incorporation</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">13</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">8.4</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Invalid Provisions</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">13</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">8.5</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Telephone and Similar Meetings</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">14</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">8.6</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Form of Notice</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">14</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">8.7</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Waiver of Notice</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">14</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif">&nbsp;</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">
    <TD COLSPAN="3" STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">ARTICLE IX &ndash; AMENDMENT OF BYLAWS</FONT></TD>
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif"></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif">&nbsp;</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">9.1</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">By the Board of Directors</FONT></TD>
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif">&nbsp;</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">9.2</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">By the Stockholders</FONT></TD>
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif">&nbsp;</TD></TR>
  </TABLE>
<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 2; Options: NewSection; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">BYLAWS</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">OF</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">SHARPS
TECHNOLOGY, INC.</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">ARTICLE
I</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>OFFICES</U></FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Section
1.1. Registered Agent and Office.</B> The registered agent of the Corporation (the &ldquo;<B>Corporation</B>&rdquo;) shall be as set
forth in the Corporation&rsquo;s articles of incorporation, as amended or restated (the &ldquo;<B>Articles of Incorporation</B>&rdquo;)
and the registered office of the Corporation shall be the street office of that agent. The board of directors of the Corporation (the
&ldquo;<B>Board of Directors</B>&rdquo;) may at any time change the Corporation&rsquo;s registered agent or office by making the appropriate
filing with the Nevada Secretary of State.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Section
1.2. Principal Office.</B> The principal office of the Corporation shall be at such place within or without the State of Nevada as shall
be fixed from time to time by the Board of Directors.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Section
1.3. Other Offices.</B> The Corporation may also have other offices, within or without the State of Nevada, as the Board of Directors
may designate, as the business of the Corporation may require, or as may be desirable.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Section
1.4. Books and Records.</B> Any records maintained by the Corporation in the regular course of its business, including its stock ledger,
books of account, and minute books, may be maintained on any information storage device or method that can be converted into clearly
legible paper form within a reasonable time. The Corporation shall convert any records so kept on the written request of any person entitled
to inspect such records pursuant to applicable law.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">ARTICLE
II</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>STOCKHOLDERS</U></FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Section
2.1. Place of Meeting.</B> Meetings of the stockholders shall be held either at the principal office of the Corporation or at any other
place, within or without the State of Nevada, as shall be fixed by the Board of Directors and designated in the notice of the meeting
or executed waiver of notice. The Board of Directors may determine, in its discretion, that any meeting of the stockholders may be held
solely by means of electronic communication in accordance with Section 2.2.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Section
2.2. Participation by Remote Communication. </B>If authorized by the Board of Directors, and subject to such guidelines and procedures
as the Board of Directors may adopt, stockholders and proxy holders not physically present at a meeting of stockholders may, by means
of remote communication, participate in the meeting and be deemed present in person and vote at the meeting, whether such meeting is
to be held at a designated place or solely by means of remote communication, provided that (i) the Corporation shall implement reasonable
measures to verify that each person deemed present and permitted to vote at the meeting by means of remote communication is a stockholder
or proxy holder, (ii) the Corporation shall implement reasonable measures to provide such stockholders and proxy holders a reasonable
opportunity to participate in the meeting and to vote on matters submitted to the stockholders, including an opportunity to read or hear
the proceedings of the meeting substantially concurrently with such proceedings, and (iii) if any stockholder or proxy holder votes or
takes other action at the meeting by means of remote communication, a record of such vote or other action shall be maintained by the
Corporation.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 3; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Section
2.3. Annual Meeting.</B> An annual meeting of stockholders, for the purpose of electing directors and transacting any other business
as may be brought before the meeting, shall be held on the date and time fixed by the Board of Directors and designated in the notice
of the meeting.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Section
2.4. Special Meetings.</B> Special meetings of stockholders may be called by the Board of Directors, the Chairman or by the Chief Executive
Officer. The only business which may be conducted at a special meeting of stockholders shall be the matter or matters set forth in the
notice of such meeting.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Section
2.5. Fixing the Record Date. </B>The Board of Directors may fix in advance a record date for the determination of the stockholders entitled
to notice of or to vote at any meeting of stockholders or to express consent to corporate action in writing without a meeting, or entitled
to receive payment of any dividend or other distribution or allotment of any rights in respect of any change, concession or exchange
of stock, or for the purpose of any other lawful action. Such record date shall not precede the date on which the resolution fixing the
record date is adopted and shall not be more than sixty (60) nor less than ten (10) days before the date of such meeting, nor more than
sixty (60) days prior to any other action to which such record date relates.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
no record date is fixed by the Board of Directors, the record date for determining stockholders entitled to notice of or to vote at a
meeting of stockholders shall be at the close of business on the day before the day on which notice is given, or, if notice is waived,
at the close of business on the day before the day on which the meeting is held. If no record date is fixed by the Board of Directors,
the record date for determining stockholders entitled to express consent to corporate action in writing without a meeting when no prior
action by the Board of Directors is necessary, shall be the day on which the first written consent is expressed. The record date for
determining stockholders for any other purpose shall be at the close of business on the day on which the Board of Directors adopts the
resolution relating to such purpose.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 6pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">A
determination of stockholders of record entitled to notice of or to vote at a meeting of stockholders shall apply to any adjournment
of the meeting; provided, however, that the Board of Directors may fix a new record date for the adjourned meeting.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Section
2.6. Notice of Stockholders&rsquo; Meeting.</B> Written notice stating the place (if any), date, and time of the meeting, the means of
any electronic communication by which stockholders may participate in the meeting, and, in the case of a special meeting, the purpose
or purposes for which the meeting is called, shall be given not less than ten (10), and not more than sixty (60), days before the date
of the meeting.</FONT></P>




<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Notice
to each stockholder entitled to vote at the meeting shall be given personally, by mail, or by electronic transmission if consented to
by a stockholder, by or at the direction of the Secretary or the officer or person calling the meeting. If mailed, the notice shall be
deemed to be given when deposited in the United States mail addressed to the stockholder at the stockholder&rsquo;s address as it appears
on the share transfer records of the Corporation, with postage thereon prepaid.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<!-- Field: Page; Sequence: 4; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Any
stockholder entitled to notice of a meeting may sign a written waiver of notice delivered to the Corporation either before or after the
meeting. A stockholder&rsquo;s participation or attendance at a meeting shall constitute a waiver of notice, except where the stockholder
attends for the specific purpose of objecting to the transaction of any business on the grounds that the meeting is not lawfully called
or convened.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Section
2.7. Voting Lists.</B> The Corporation shall prepare, as of the record date fixed for a meeting of stockholders, an alphabetical list
of all stockholders entitled to vote at the meeting (or any adjournment thereof). Such list will be open to the examination of any stockholder,
for any purpose germane to the meeting, during ordinary business hours, for a period of at least ten days prior to the meeting, at the
principal place of business of the Corporation. Such list will be produced and kept open at the time and place of the meeting during
the whole time thereof, and will be subject to the inspection of any stockholder who may be present</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
any stockholders are participating in the meeting by remote communication, the list shall be open to examination by the stockholders
for the duration of the meeting on a reasonably accessible electronic network, and the information required to access the list shall
be provided to stockholders with the notice of the meeting.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Corporation shall prepare, or cause to be prepared, at least ten (10) days before each meeting of stockholders, a complete list of the
stockholders entitled to vote at the meeting, arranged in alphabetical order, and showing the address of each stockholder and the number
of shares registered in the name of each stockholder (<I>provided, however,</I> if the record date for determining the stockholders entitled
to vote is less than ten days before the date of the meeting, the list shall reflect the stockholders entitled to vote as of the tenth
day before the meeting date). Such list shall be open to the examination of any stockholder, for any purpose germane to the meeting for
a period of at least ten (10) days prior to the meeting (1) on a reasonably accessible electronic network, provided that the information
required to gain access to such list is provided with the notice of the meeting, or (2) during ordinary business hours, at the principal
place of business of the Corporation. If the meeting is to be held at a place, the list shall also be produced and kept at the time and
place of the meeting during the whole time of the meeting, and may be inspected by any stockholder who is present. If the meeting is
to be held solely by means of remote communications, the list shall be open to the examination of any stockholder during the whole time
of the meeting on a reasonably accessible electronic network, and the information required to access such list shall be provided with
the notice of the meeting. This list shall determine the identity of the stockholders entitled to vote at the meeting and the number
of shares held by each of them. Except as provided by applicable law, the stock ledger of the Corporation shall be the only evidence
as to who are the stockholders entitled to examine the stock ledger and the list of stockholders or to vote in person or by proxy at
any meeting of stockholders</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><B>Section 2.8. Quorum of
Stockholders.</B>&nbsp;At each meeting of stockholders for the transaction of any business, one-third (1/3) of the outstanding
shares of the Company&rsquo;s common stock shall constitute a quorum and must be present to organize such meeting. The presence
in person, by means of remote communication, or by proxy of (1/3) of the voting power shall be required for the transaction
of business at a meeting of stockholders, except as otherwise required by the Articles of Incorporation, these Bylaws, or Chapter 78
of the Nevada Revised Statutes (the &ldquo;<B>Nevada Revised Statutes</B>&rdquo;). If any class or series of shares is permitted or
required to vote separately on any action, the presence in person, by means of remote communication, or by proxy of (1/3) of
the voting power of such class or series constitutes one-third (1/3) for the transaction of business.&rdquo;</P>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 5; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">The holders of (1/3) of the voting power represented in person,
by means of remote communication, or by proxy at a meeting may adjourn or postpone the meeting from time to time.</P>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Section
2.9. Conduct of Meetings.</B> The Board of Directors, as it shall deem appropriate, may adopt by resolution rules and regulations for
the conduct of meetings of the stockholders. At every meeting of the stockholders, the Chairman, or in the Chairman&rsquo;s &lsquo;s
absence or inability to act, a director or officer designated by the Board of Directors, shall serve as chair of the meeting. The Secretary
or, in the Secretary&rsquo;s absence or inability to act, the person whom the chair of the meeting shall appoint, shall act as secretary
of the meeting and keep the minutes thereof.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
chair of the meeting shall determine the order of business and, in the absence of a rule adopted by the Board of Directors, shall establish
rules for the conduct of the meeting. The chair of the meeting shall announce the close of the polls for each matter voted upon at the
meeting, after which no ballots, proxies, votes, changes, or revocations will be accepted. Polls for all matters before the meeting will
be deemed to be closed upon final adjournment of the meeting.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Section
2.10. Voting of Stock.</B> Each outstanding share of stock, regardless of class or series, shall be entitled to one vote on each matter
submitted to a vote at a meeting of stockholders, except as otherwise provided by these Bylaws and to the extent that the Articles of
Incorporation or the certificate of designation establishing the class or series of stock provides for more or less than one vote per
share or limits or denies voting rights to the holders of the shares of any class or series of stock.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Unless
a different proportion is required by the Articles of Incorporation, these Bylaws, or the Nevada Revised Statutes:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)
If a quorum exists, action other than the election of directors is approved if the votes cast in favor of the action exceed the votes
cast against the action.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)
If a quorum exists of any class or series of stock that is permitted or required to vote separately on any matter, action is approved
by the class or series if a majority of the voting power of a quorum of that class or series votes in favor of the action.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Stockholders
are prohibited from cumulating their votes in any election of directors of the Corporation.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Directors
are elected by a plurality of the votes cast by the shares entitled to vote in the election at a meeting at which a quorum is present.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Section
2.11. Voting by Proxy.</B> A stockholder may vote either in person or by proxy executed in writing by the stockholder or the stockholder&rsquo;s
attorney-in-fact. Any copy, communication by electronic transmission, or other reliable written reproduction may be substituted for the
stockholder&rsquo;s original written proxy for any purpose for which the original proxy could have been used if such copy, communication
by electronic transmission, or other reproduction is a complete reproduction of the entire original written proxy.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">No
proxy shall be valid after six months from the date of its creation unless the proxy specifies its duration, which may not exceed seven
years from the date of its creation. A proxy shall be revocable unless the proxy states that the proxy is irrevocable and the proxy is
coupled with an interest sufficient to support an irrevocable power.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 6; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->6<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">A
properly created proxy or proxies continues in full force and effect until either of the following occurs:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)
One of the following is filed with or transmitted to the Secretary of the Corporation or another person or persons appointed by the Corporation
to count the votes of the stockholders and determine the validity of proxies and ballots: (i) another instrument or transmission properly
revoking the proxy; or (ii) a properly created proxy or proxies bearing a later date.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)
The stockholder executing the original written proxy revokes the proxy by attending a stockholders&rsquo; meeting and voting its shares
in person, in which case any votes cast by that stockholder&rsquo;s previously designated proxy or proxies shall be disregarded by the
Corporation when the votes are counted.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Section
2.12. Action by Stockholders Without a Meeting.</B> Any action required or permitted by the Nevada Revised Statutes to be taken at a
meeting of stockholders may be taken without a meeting if, before or after the action, a written consent to the action is signed by stockholders
holding a majority of the voting power of the Corporation or, if different, the proportion of voting power required to take the action
at a meeting of stockholders.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">ARTICLE
III</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>DIRECTORS</U></FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Section
3.1. Powers.</B> The business and affairs of the Corporation shall be managed under the direction of the Board of Directors. Directors
must be natural persons at least 18 years of age and need not be stockholders of the Corporation.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Section
3.2. Number of Directors.</B> The number of Directors which shall constitute the entire Board of Directors shall be determined by resolution
of the Board of Directors at any meeting thereof, but shall never be less than one. No decrease in the number of Directors will have
the effect of shortening the term of any incumbent Director.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Section
3.3. Term of Office.</B> At the first annual meeting of stockholders and at each annual meeting thereafter, the holders of shares of
stock entitled to vote in the election of directors shall elect directors to hold office until the next succeeding annual meeting or
until the director&rsquo;s earlier death, resignation, disqualification, or removal. Despite the expiration of a director&rsquo;s term,
the director shall continue to serve until the director&rsquo;s successor is elected and qualified.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Section
3.4. Removal.</B> Any or all of the directors, or a class of directors, may be removed at any time, with or without cause, at a special
meeting of stockholders called for that purpose by a vote of the holders of two-thirds of the voting power of the issued and outstanding
stock entitled to vote.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Section
3.5. Resignation.</B> A director may resign at any time by giving written notice to the Board of Directors, its chair, or to the Secretary
of the Corporation. A resignation is effective when the notice is given unless a later effective date is stated in the notice. Acceptance
of the resignation shall not be required to make the resignation effective. The pending vacancy may be filled before the effective date,
but the successor shall not take office until the effective date.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 7; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->7<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Section
3.6. Vacancies.</B> Unless otherwise provided in the Articles of Incorporation, vacancies and newly created directorships, whether resulting
from an increase in the size of the Board of Directors or due to the death, resignation, disqualification, or removal of a director or
otherwise, may be filled by the affirmative vote of a majority of the remaining directors, even if less than a quorum. A director elected
to fill a vacancy shall hold office for the unexpired term of that director&rsquo;s predecessor in office and until that director&rsquo;s
successor is duly elected and qualified.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Section
3.7. Regular Meetings of Directors.</B> A regular meeting of the newly-elected Board of Directors shall be held, without other notice,
immediately after and at the place of the annual meeting of stockholders, provided a quorum is present. Other regular meetings of the
Board of Directors may be held at such times and places, within or without the State of Nevada, as the Board of Directors may determine.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Section
3.8. Special Meetings of Directors.</B> Special meetings of the Board of Directors may be called by the entire Board of Directors, any
two directors, the Chief Executive Officer or the Chairman on oral or written notice to each director, given either personally, by telephone,
by facsimile or by mail, delivered not less than twenty-four hours in advance of the meeting.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Section
3.9. Participation by Electronic Communication.</B> Directors not physically present at a meeting of the Board of Directors may participate
in the meeting by electronic communication, videoconference, teleconference, or other available technology if the Corporation implements
reasonable measures to:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)
Verify the identity of each director participating by electronic communication.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)
Provide the directors a reasonable opportunity to participate and vote, including an opportunity to communicate and read or hear the
proceedings in a substantially concurrent manner.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Directors
participating by electronic communication shall be considered present in person at the meeting.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Section
3.10. Notice of Directors&rsquo; Meetings.</B> Regular meetings of the Board of Directors may be held without notice of the date, time,
place, or purpose of the meeting. Notice may be given to each director personally, by mail, by electronic transmission, or by any other
means of communication authorized by the director.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">A
director entitled to notice of a meeting may sign a written waiver of notice delivered to the Corporation either before or after the
time of the meeting. A director&rsquo;s participation or attendance at a meeting shall constitute a waiver of notice, except where the
director attends for the specific purpose of objecting to the transaction of any business on the grounds that the meeting is not lawfully
called or convened.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Section
3.11. Quorum and Action by Directors.</B> A majority of the Board of Directors then in office shall constitute a quorum for the transaction
of business. The directors at a meeting for which a quorum is not present may adjourn the meeting until a time and place as may be determined
by a vote of the directors present at that meeting.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
act of the directors holding a majority of the voting power of the directors present at a meeting at which a quorum is present shall
be the act of the Board of Directors, unless the act requires approval by a greater proportion under the Articles of Incorporation or
these Bylaws.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 8; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->8<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Section
3.12. Action by Directors Without Meeting.</B> Any action required or permitted by the Nevada Revised Statutes to be taken at a meeting
of the Board of Directors or any committee thereof may be taken without a meeting if, before or after the action, all of the members
of the Board of Directors or committee sign a written consent describing the action and deliver it to the Corporation.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Section
3.13. Committees of the Board of Directors.</B> The Board of Directors, by resolution adopted by a majority of the directors, may establish
one or more committees, each consisting of one or more directors, to exercise the authority of the Board of Directors to the extent provided
in the resolution establishing the committee and allowed under the Nevada Revised Statutes.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Notwithstanding
the foregoing, a committee of the Board of Directors shall not have the authority to:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)
Fill vacancies on the Board of Directors or any committee thereof.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)
Amend the Articles of Incorporation.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c)
Adopt, amend, or repeal these Bylaws.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(d)
Authorize the issuance of shares of the Corporation&rsquo;s stock.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(e)
Authorize a distribution.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(f)
Approve any action that requires stockholder approval.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
designation of a committee of the Board of Directors and the delegation thereto of authority shall not operate to relieve the Board of
Directors, or any member thereof, of any responsibility imposed by law.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">ARTICLE
IV</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>OFFICERS</U></FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Section
4.1. Positions and Election.</B> The officers of the Corporation shall be elected by the Board of Directors and shall be a Chief Executive
Officer, Chief Financial Officer, a Secretary, a Treasurer, and any other officers, including assistant officers and agents, as may be
deemed necessary by the Board of Directors. Any two or more offices may be held by the same person.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Officers
shall be elected annually at the meeting of the Board of Directors held after each annual meeting of stockholders. Each officer shall
serve until a successor is elected and qualified or until the earlier death, resignation, disqualification, or removal of that officer.
Vacancies or new offices shall be filled at the next regular or special meeting of the Board of Directors. Election or appointment of
an officer or agent shall not of itself create contract rights.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Section
4.2. Removal and Resignation.</B> Any officer elected by the Board of Directors may be removed, with or without cause, at any regular
or special meeting of the Board of Directors by the affirmative vote of the majority of the directors in attendance where a quorum is
present. Removal shall be without prejudice to the contract rights, if any, of the officer so removed.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Any
officer may resign at any time by delivering notice to the Secretary of the Corporation. Resignation is effective when the notice is
delivered unless the notice provides a later effective date. Any vacancies may be filled in accordance with Section 4.1 of these Bylaws.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 9; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->9<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Section
4.3. Chairman of the Board of Directors</B>. If the Board of Directors has elected a Chairman of the Board, he will preside at all meetings
of the stockholders and the Board of Directors. Except where by law the signature of the Chief Executive Officer is required, the Chairman
will have the same power as the Chief Executive Officer to sign all certificates, contracts and other instruments of the Corporation.
During the absence or disability of the Chief Executive Officer, the Chairman will exercise the powers and perform the duties of the
Chief Executive Officer.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Section
4.4. Chief Executive Officer. </B>The Chief Executive Officer shall, subject to the provisions of these Bylaws and the control of the
Board of Directors, have general supervision, direction, and control over the business of the Corporation and over its officers. The
Chief Executive Officer shall perform all duties incident to the office of the Chief Executive Officer, and any other duties as may be
from time to time assigned to the Chief Executive Officer by the Board of Directors, in each case subject to the control of the Board
of Directors</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Section
4.5. Secretary.</B> The Secretary shall attend all meetings of the Board of Directors and stockholders, shall record all votes and the
minutes of all proceedings, and shall perform like duties for the standing committees when required. The Secretary shall give or cause
to be given notice of all meetings of the Board of Directors and stockholders and shall perform all other duties as the Board of Directors
or Chief Executive Officer shall assign. The Secretary shall be the custodian of the records of the Corporation. In the absence of the
Secretary, the minutes of all meetings of the Board of Directors and stockholders shall be recorded by the person designated by the Chief
Executive Officer or Board of Directors.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Section
4.6 Chief Financial Officer.</B> The Chief Financial Officer shall be the principal financial officer of the Corporation and shall have
such powers and perform such duties as may be assigned by the Board of Directors, the Chairman of the Board, or the Chief Executive Officer.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Section
4.7. Treasurer.</B> The Treasurer shall have the custody of the corporate funds and securities and shall keep full and accurate accounts
of receipts and disbursements of the Corporation, shall deposit all moneys and other valuable effects in the name and to the credit of
the Corporation in the depositories designated by the Board of Directors, and in general shall perform all the duties incident to the
office of Treasurer and such other duties as the Board of Directors or Chief Executive Officer shall assign.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Treasurer shall disburse the funds of the Corporation as may be ordered by the Board of Directors, taking proper vouchers for the disbursements.
The Treasurer shall keep and maintain the Corporation&rsquo;s books of account and shall render to the Chief Executive Officer and Board
of Directors an account of all transactions as Treasurer and of the financial condition of the Corporation and exhibit the books, records,
and accounts to the Chief Executive Officer or Board of Directors at any time.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 10; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->10<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">ARTICLE
V</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>INDEMNIFICATION
OF DIRECTORS, OFFICERS, EMPLOYEES, AND AGENTS</U></FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Section
5.1. Indemnification in Actions by Third Parties.</B> The Corporation shall, to the extent permitted by the Nevada Revised Statutes,
indemnify any person who is or was a director, officer, employee, or agent of the Corporation or is or was serving at the Corporation&rsquo;s
request as a director, officer, employee, or agent of another corporation, partnership, joint venture, trust, or other entity (each such
person, an &ldquo;<B>Indemnitee</B>&rdquo;) against expenses, including attorneys&rsquo; fees, judgments, fines, and amounts paid in
settlement, actually and reasonably incurred by the Indemnitee in connection with any threatened, pending, or completed action, suit,
or proceeding, whether civil, criminal, administrative, or investigative, other than a proceeding by or in the right of the Corporation,
to which the Indemnitee is, was, or is threatened to be made a party by reason of being an Indemnitee, if the Indemnitee either:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)
Did not breach, through intentional misconduct, fraud, or a knowing violation of law, the Indemnitee&rsquo;s fiduciary duties as a director
or officer to act in good faith and in the interests of the Corporation.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)
Acted in good faith and in a manner the Indemnitee reasonably believed to be in or not opposed to the best interests of the Corporation
and, with respect to any criminal action or proceeding, had no reasonable cause to believe the Indemnitee&rsquo;s conduct was unlawful.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Section
5.2. Indemnification in Actions by or on Behalf of the Corporation.</B> The Corporation shall, to the extent permitted by the Nevada
Revised Statutes, indemnify any Indemnitee against expenses, including attorneys&rsquo; fees and amounts paid in settlement, actually
and reasonably incurred by the Indemnitee in connection with any threatened, pending, or completed suit or action by or in the right
of the Corporation to which the Indemnitee is, was, or is threatened to be made a party by reason of being an Indemnitee, if the Indemnitee
either:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)
Did not breach, through intentional misconduct, fraud, or a knowing violation of law, the Indemnitee&rsquo;s fiduciary duties as a director
or officer to act in good faith and in the interests of the Corporation.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)
Acted in good faith and in a manner the Indemnitee reasonably believed to be in or not opposed to the best interests of the Corporation.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Section
5.3. Indemnification Against Expenses.</B> The Corporation shall, to the extent permitted by the Nevada Revised Statutes, indemnify any
Indemnitee who was successful, on the merits or otherwise, in the defense of any action, suit, proceeding, or claim described in Sections
5.1 and 5.2, against expenses (including attorneys&rsquo; fees) actually and reasonably incurred by the Indemnitee in connection with
the defense. Expenses may be paid by the Corporation in advance of the final disposition of such action, suit or proceeding upon receipt
of an undertaking by or on behalf of such Director or officer to repay such amount if it shall ultimately be determined that such person
is not entitled to be indemnified by the Corporation as authorized in this Article. Such expenses (including attorneys&rsquo; fees) incurred
by any Indemnitee may be so paid upon such terms and conditions, if any, as the Corporation deems appropriate.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Section
5.4. Non-Exclusivity of Indemnification Rights.</B> The rights of indemnification set out in this Article V shall be in addition to and
not exclusive of any other rights to which any Indemnitee may be entitled under the Articles of Incorporation, Bylaws, any other agreement
with the Corporation, any action taken by the disinterested directors or stockholders of the Corporation, or otherwise. The indemnification
provided under this Article V shall inure to the benefit of the heirs, executors, and administrators of an Indemnitee.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Section
5.5 Indemnification Agreements</B>. The Board is authorized to cause the Corporation to enter into agreements with any director, officer,
employee, agent or fiduciary of the Corporation, or any person serving at the request of the Corporation as a director, officer, employee,
agent, fiduciary, trustee, partner or managing member of another corporation, partnership, limited liability company, joint venture,
trust or other enterprise, including employee benefit plans, providing indemnification or advancement rights to such person. Such rights
may be greater than those provided in this Article V.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 11; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->11<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">ARTICLE
VI</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>SHARE
CERTIFICATES AND TRANSFER</U></FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Section
6.1. Certificates Representing Shares.</B> The shares of the Corporation shall be represented by certificates, provided that the Board
of Directors may provide by resolution or resolutions that some or all of any class or series of stock shall be uncertificated shares.
The Corporation shall, within a reasonable time after the issuance or transfer of any uncertificated shares, send to the registered owner
of the shares a written notice containing the information required to be set forth or stated on certificates pursuant to the Nevada Revised
Statutes. Shares represented by certificates shall be signed by officers or agents designated by the Corporation for such purpose and
shall state:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)
The name of the Corporation and that it is organized under the laws of Nevada.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)
The name of the person to whom the certificate is issued.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c)
The number of shares represented by the certificate.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(d)
Any restrictions on the transfer of the shares, such statement to be conspicuous.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Section
6.2. Transfers of Shares.</B> Shares of the Corporation shall be transferable in the manner prescribed by law and in these Bylaws. Transfers
of shares of the Corporation shall be made on the books of the Corporation only by the holder of record thereof or by such person&rsquo;s
attorney lawfully constituted in writing and, in the case of certificated shares, upon the surrender of the certificate thereof, which
shall be cancelled before a new certificate or uncertificated shares shall be issued. No transfer of shares shall be valid as against
the Corporation for any purpose until it shall have been entered in the stock records of the Corporation by an entry showing from and
to whom transferred.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Section
6.3. Registered Stockholders.</B> The Corporation may treat the holder of record of any shares issued by the Corporation as the holder
in fact thereof, for purposes of voting those shares, receiving distributions thereon or notices in respect thereof, transferring those
shares, exercising rights of dissent with respect to those shares, exercising or waiving any preemptive right with respect to those shares,
entering into agreements with respect to those shares in accordance with the laws of the State of Nevada, or giving proxies with respect
to those shares.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Neither
the Corporation nor any of its officers, directors, employees, or agents shall be liable for regarding that person as the owner of those
shares at that time for those purposes, regardless of whether that person possesses a certificate for those shares and shall not be bound
to recognize any equitable or other claim to or interest in such share or shares on the part of any other person, whether or not it shall
have express notice thereof, except as otherwise provided by law.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<!-- Field: Page; Sequence: 12; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->12<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Section
6.4. Lost, Stolen, or Destroyed Certificates.</B> The Board of Directors may direct a new certificate or certificates to be issued in
place of any certificate or certificates theretofore issued by the Corporation alleged to have been lost, stolen, or destroyed upon the
making of an affidavit of that fact by the owner of the allegedly lost, stolen, or destroyed certificate. When authorizing the issue
of a new certificate or certificates, the Board of Directors, in its discretion and as a condition precedent to the issuance thereof,
may require the owner of the allegedly lost, stolen, or destroyed certificate, or the owner&rsquo;s legal representative, to give the
Corporation a bond or other security sufficient to indemnify it against any claim that may be made against the Corporation or other obligees
with respect to the certificate alleged to have been lost, stolen, or destroyed or the issuance of such new certificate or certificates.</FONT></P>




<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">ARTICLE
VII</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>DISTRIBUTIONS</U></FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Section
7.1. Declaration.</B> The Board of Directors may authorize, and the Corporation may make, distributions to its stockholders in cash,
property (other than shares of the Corporation), or a dividend of shares of the Corporation to the extent permitted by the Articles of
Incorporation and the Nevada Revised Statutes.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Section
7.2. Fixing Record Dates for Distributions and Share Dividends.</B> For the purpose of determining stockholders entitled to receive a
distribution by the Corporation (other than a distribution involving a purchase or redemption by the Corporation of any of its own shares)
or a share dividend, the Board of Directors may, at the time of declaring the distribution or share dividend, set a date no more than
60 days prior to the date of the distribution or share dividend. If no record date is fixed for such distribution or share dividend,
the record date shall be the date on which the resolution of the Board of Directors authorizing the distribution or share dividend is
adopted.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">ARTICLE
VIII</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>MISCELLANEOUS</U></FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Section
8.1. Checks, Drafts, Etc.</B> All checks, drafts, or other instruments for payment of money or notes of the Corporation shall be signed
by an officer or officers or any other person or persons as shall be determined from time to time by resolution of the Board of Directors.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Section
8.2. Fiscal Year.</B> The fiscal year of the Corporation shall be as determined by the Board of Directors.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Section
8.3. Conflict with Applicable Law or Articles Of Incorporation.</B> Unless the context requires otherwise, the general provisions, rules
of construction, and definitions of the Nevada Revised Statutes shall govern the construction of these Bylaws. These Bylaws are adopted
subject to any applicable law and the Articles of Incorporation. Whenever these Bylaws may conflict with any applicable law or the Articles
of Incorporation, such conflict shall be resolved in favor of such law or the Articles of Incorporation.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Section
8.4. Invalid Provisions.</B> If any one or more of the provisions of these Bylaws, or the applicability of any provision to a specific
situation, shall be held invalid or unenforceable, the provision shall be modified to the minimum extent necessary to make it or its
application valid and enforceable, and the validity and enforceability of all other provisions of these Bylaws and all other applications
of any provision shall not be affected thereby.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<!-- Field: Page; Sequence: 13; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->13<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Section
8.5. Telephone and Similar Meetings</B>. Stockholders, directors and committee members may participate in and hold meetings by means
of conference telephone or similar communications equipment by which all persons participating in the meeting can hear each other. Participation
in such a meeting will constitute presence in person at the meeting, except where a person participates in the meeting for the express
purpose of objecting, at the beginning of the meeting, to the transaction of any business on the ground that the meeting has not been
lawfully called or convened.</FONT></P>




<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Section
8.6. Form of Notice</B>. Whenever by law, the Articles of Incorporation or of these Bylaws, notice is to be given to any director or
stockholder, and no provision is made as to how such notice will be given, such notice may be given: (i) in writing, by mail, postage
prepaid, addressed to such director or stockholder at such address as appears on the books of the Corporation or (ii) in any other method
permitted by law. Any notice required or permitted to be given by mail will be deemed to be given at the time the same is deposited in
the United States mail.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Section
8.7. Waiver of Notice</B>. Whenever any notice is required to be given to any stockholder or director of the Corporation as required
by law, the Articles of Incorporation or these Bylaws, a waiver thereof in writing signed by the person or persons entitled to such notice,
whether before or after the time stated in such notice, will be equivalent to the giving of such notice. Attendance of a stockholder
or Director at a meeting will constitute a waiver of notice of such meeting, except where such stockholder or Director attends for the
express purpose of objecting, at the beginning of the meeting, to the transaction of any business on the ground that the meeting has
not been lawfully called or convened.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>ARTICLE
IX</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><U>AMENDMENT
OF BYLAWS</U></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Board of Directors shall have the power to adopt, amend, alter or repeal the Bylaws. The affirmative vote of a majority of the Board
of Directors shall be required to adopt, amend, alter or repeal the Bylaws. The Bylaws also may be adopted, amended, altered or repealed
by the stockholders holding a majority of the total voting power of the stockholders.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>


<!-- Field: Page; Sequence: 14; Options: Last -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->14<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-5.1
<SEQUENCE>4
<FILENAME>ex5-1.htm
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Exhibit
5.1</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left"><IMG SRC="ex5-1_001.jpg" ALT="" Style="width:200px"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: right; text-indent: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">January
22, 2025</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1.5in; text-align: justify; text-indent: 279pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Sharps
Technology, Inc.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">105
Maxess Road, Ste. 124</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Melville,
New York 11747</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(631)
574 -4436</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">RE:
    </FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Sharps
    Technology, Inc..- Registration Statement on Form S-1</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Ladies
and Gentlemen:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
have acted as counsel to Sharps Technology, Inc., a Nevada corporation (the &ldquo;Company&rdquo;), in connection with the preparation
of the Company&rsquo;s registration statement on Form S-1 and the preliminary prospectus forming a part of the registration statement
(the &ldquo;Prospectus&rdquo;), under the Securities Act of 1933, as amended (the &ldquo;Securities Act&rdquo;), filed by the Company
with the Securities and Exchange Commission (the &ldquo;Commission&rdquo;) and, as thereafter amended or supplemented (the &ldquo;Registration
Statement&rdquo;). The Prospectus relates to the registration of the proposed (i) offering of (A) shares of common stock (the &ldquo;Shares&rdquo;),
par value $0.0001 per share, of the Company (the &ldquo;Common Stock&rdquo;) or pre-funded warrants (the &ldquo;Pre-Funded Warrants&rdquo;),
each having the right to purchase one share of Common Stock (&ldquo;Pre-Funded Warrant Share&rdquo;), in lieu of Shares, (B) Series A
warrants (the &ldquo;Series A Warrants&rdquo;), each having the right to purchase one share of Common Stock (the &ldquo;Series A Warrant
Shares&rdquo;), and (C) Series B warrants (the &ldquo;Series B Warrants&rdquo; and, together with the Series A Warrants, the &ldquo;Warrants&rdquo;),
each having the right to purchase one share of Common Stock (together with the Series A Warrant Shares, the &ldquo;Warrant Shares&rdquo;).
The proposed maximum aggregate offering price of the Shares or Pre-Funded Warrants in lieu thereof, the Series A Warrant Shares and the
Series B Warrant Shares is $15,000,000. For each Pre-Funded Warrant the Company sells, the number of Shares offered will be decreased
on a one-for-one basis. The Shares, the Pre-Funded Warrants, the Pre-Funded Warrant Shares, the Warrants, and the Warrant Shares, are
collectively referred to as the &ldquo;Securities.&rdquo;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
connection with this opinion, we have examined originals or copies (certified or otherwise identified to our satisfaction) of (i) the
Company&rsquo;s Certificate of Incorporation as currently in effect, (ii) the Company&rsquo;s Amended Bylaws as currently in effect,
(iii) the Registration Statement and related Prospectus, (iv) the form of Underwriting Agreement, (v) the form of Pre-Funded Warrant,
(vi) the form of Series A Warrant, (viii) the form of Series B Warrant, and (ix) such corporate records, agreements, documents and other
instruments, and such certificates or comparable documents of public officials or of officers and representatives of the Company, as
we have deemed relevant and necessary as a basis for the opinion hereinafter set forth.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
such examination, we have assumed the genuineness of all signatures, the legal capacity of all natural persons, the authenticity of all
documents submitted to us as originals, the conformity to original documents of all documents submitted to us as certified, conformed
or photostatic copies, and the authenticity of the originals of such latter documents. As to certain questions of fact material to this
opinion, we have relied upon certificates or comparable documents of officers and representatives of the Company and have not sought
to independently verify such facts.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Based
on the foregoing, and subject to the assumptions, qualifications, limitations and exceptions set forth herein, we are of the opinion
that:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.
The Shares have been duly authorized by all necessary corporate action on the part of the Company and, when issued and sold in accordance
with the Registration Statement and the Prospectus, the Shares will be validly issued, fully paid and nonassessable.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1185
AVENUE OF THE AMERICAS | 31ST FLOOR | NEW YORK, NY | 10036</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">T
(212) 930-9700 | F (212) 930-9725 | WWW.SRFC.LAW</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%; text-align: center">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.
The Pre-Funded Warrants have been duly authorized by all necessary corporate action on the part of the Company and, when issued and,
the Pre-Funded Warrants will constitute valid and binding obligations of the Company, enforceable against the Company in accordance with
their terms except as such enforceability may be limited by (i) any applicable bankruptcy, insolvency, reorganization, moratorium or
similar laws affecting creditors&rsquo; rights generally including, without limitation, fraudulent transfer or fraudulent conveyance
laws; (ii) public policy considerations, statutes or court decisions that may limit rights to obtain exculpation, indemnification or
contribution (including, without limitation, indemnification regarding violations of the securities laws and indemnification for losses
resulting from a judgment for the payment of any amount other than in United States dollars); and (iii) general principles of equity
(including, without limitation, concepts of materiality, reasonableness, good faith and fair dealing) and the availability of equitable
remedies (including, without limitation, specific performance and equitable relief), regardless of whether considered in a proceeding
in equity or at law.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.
The Pre-Funded Warrant Shares have been duly authorized by all necessary corporate action on the part of the Company and, assuming a
sufficient number of authorized but unissued shares of Common Stock are available for issuance when the Pre-Funded Warrants are exercised,
the Pre-Funded Warrant Shares, when and if issued upon exercise of the Pre-Funded Warrants in accordance with the terms of the Pre-Funded
Warrants, will be validly issued, fully paid and nonassessable.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.
The Warrants have been duly authorized by all necessary corporate action on the part of the Company and, when issued and sold in accordance
with the Registration Statement and the Prospectus, the Warrants will constitute valid and binding obligations of the Company, enforceable
against the Company in accordance with their terms except as such enforceability may be limited by (i) any applicable bankruptcy, insolvency,
reorganization, moratorium or similar laws affecting creditors&rsquo; rights generally including, without limitation, fraudulent transfer
or fraudulent conveyance laws; (ii) public policy considerations, statutes or court decisions that may limit rights to obtain exculpation,
indemnification or contribution (including, without limitation, indemnification regarding violations of the securities laws and indemnification
for losses resulting from a judgment for the payment of any amount other than in United States dollars); and (iii) general principles
of equity (including, without limitation, concepts of materiality, reasonableness, good faith and fair dealing) and the availability
of equitable remedies (including, without limitation, specific performance and equitable relief), regardless of whether considered in
a proceeding in equity or at law.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.
The Warrant Shares have been duly authorized by all necessary corporate action on the part of the Company and, assuming a sufficient
number of authorized but unissued shares of Common Stock are available for issuance when the Warrants are exercised, the Warrant Shares,
when and if issued upon exercise of the Warrants in accordance with the terms of the Warrants, will be validly issued, fully paid and
nonassessable.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
opinion expressed herein is limited to Chapter 78 of the Nevada Revised Statutes (the &ldquo;NRS&rdquo;), and with respect to the enforceability
of the Pre-Funded Warrants and the Warrants, the laws of the State of New York, and we express no opinion as to the effect on the matters
covered by this letter of the laws of any other jurisdiction.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
assume no obligation to update or supplement any of our opinions to reflect any changes of law or fact that may occur. We hereby consent
to the filing of this letter as an exhibit to the Registration Statement and to the reference to our firm under the caption &ldquo;Legal
Matters&rdquo; in the Prospectus which is a part of the Registration Statement. In giving such consents, we do not thereby admit that
we are in the category of persons whose consent is required under Section 7 of the Securities Act or the Rules and Regulations of the
Commission promulgated thereunder.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 50%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 50%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Very
    truly yours,</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>/s/
    Sichenzia Ross Ference Carmel LLP</I></FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Sichenzia
    Ross Ference Carmel LLP</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 4.25in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 50%; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 50%; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1185
    Avenue of the Americas | 37<SUP>th</SUP> Floor | New York, NY | 10036</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">T
    (212) 930 9700 | F (212) 930 9725 | WWW.SRF.LAW</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 2; Options: Last -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%; text-align: center">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.36
<SEQUENCE>5
<FILENAME>ex10-36.htm
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Exhibit
10.36</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>SHARPS
TECHNOLOGY, INC. 2024 EQUITY INCENTIVE PLAN</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" BORDER="0" STYLE="width: 100%; margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: top">
  <TD STYLE="width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.</FONT></TD>
  <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Purpose; Eligibility</U>.</FONT></TD></TR>
</TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.1
<U>General Purpose</U>. The name of this plan is the Sharps Technology, Inc., 2024 Equity Incentive Plan (the &ldquo;<B>Plan</B>&rdquo;).
The purposes of the Plan are to (a) enable Sharps Technology, Inc., a Nevada corporation (the &ldquo;<B>Company</B>&rdquo;), and any
Affiliate to attract and retain the types of Directors, Employees and Consultants who will contribute to the Company&rsquo;s long-range
success; (b) provide incentives that align the interests of Employees and Consultants with those of the shareholders of the Company;
and (c) promote the success of the Company&rsquo;s business.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.2
<U>Eligible Award Recipients</U>. The persons eligible to receive Awards are the Employees and Consultants of the Company and its Affiliates
and such other individuals designated by the Committee who are reasonably expected to become Employees, Consultants and Directors after
the receipt of Awards.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.3
<U>Available Awards</U>. Awards that may be granted under the Plan include: (a) Incentive Stock Options, (b) Non-qualified Stock Options,
(c) Stock Appreciation Rights, (d) Restricted Awards, (e) Performance Share Awards, (f) Cash Awards, and (g) Other Equity-Based Awards.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" BORDER="0" STYLE="width: 100%; margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: top">
  <TD STYLE="width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.</FONT></TD>
  <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Definitions</U>.</FONT></TD></TR>
</TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.75in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B>Affiliate</B>&rdquo;
means a corporation or other entity that, directly or through one or more intermediaries, controls, is controlled by or is under common
control with, the Company.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.75in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B>Applicable
Laws</B>&rdquo; means the requirements related to or implicated by the administration of the Plan under applicable state corporate law,
United States federal and state securities laws, the Code, any stock exchange or quotation system on which the shares of Common Stock
are listed or quoted, and the applicable laws of any foreign country or jurisdiction where Awards are granted under the Plan.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.75in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B>Award</B>&rdquo;
means any right granted under the Plan, including an Incentive Stock Option, a Non-qualified Stock Option, a Stock Appreciation Right,
a Restricted Award, a Performance Share Award, a Cash Award, or an Other Equity-Based Award.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.75in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B>Award
Agreement</B>&rdquo; means a written agreement, contract, certificate or other instrument or document evidencing the terms and conditions
of an individual Award granted under the Plan which may, in the discretion of the Company, be transmitted electronically to any Participant.
Each Award Agreement shall be subject to the terms and conditions of the Plan.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.75in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B>Beneficial
Owner</B>&rdquo; has the meaning assigned to such term in Rule 13d-3 and Rule 13d-5 under the Exchange Act, except that in calculating
the beneficial ownership of any particular Person, such Person shall be deemed to have beneficial ownership of all securities that such
Person has the right to acquire by conversion or exercise of other securities, whether such right is currently exercisable or is exercisable
only after the passage of time. The terms &ldquo;Beneficially Owns&rdquo; and &ldquo;Beneficially Owned&rdquo; have a corresponding meaning.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.75in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B>Board</B>&rdquo;
means the Board of Directors of the Company, as constituted at any time.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.75in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B>Cash
Award</B>&rdquo; means an Award denominated in cash that is granted under Section 10 of the Plan.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.75in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B>Cause</B>&rdquo;
means:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-left: 0.25in; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">With
respect to any Employee or Consultant, unless the applicable Award Agreement states otherwise:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-left: 0.25in; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)
If the Employee or Consultant is a party to an employment or service agreement with the Company or its Affiliates and such agreement
provides for a definition of Cause, the definition contained therein; or</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 1; Options: NewSection; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">A-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->1<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-left: 0.25in; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)
If no such agreement exists, or if such agreement does not define Cause: (i) the commission of, or plea of guilty or no contest to, a
felony or a crime involving moral turpitude or the commission of any other act involving willful malfeasance or material fiduciary breach
with respect to the Company or an Affiliate; (ii) conduct that brings or is reasonably likely to bring the Company or an Affiliate negative
publicity or into public disgrace, embarrassment, or disrepute; (iii) gross negligence or willful misconduct with respect to the Company
or an Affiliate; (iv) material violation of state or federal securities laws; or (v) material violation of the Company&rsquo;s written
policies or codes of conduct, including written policies related to discrimination, harassment, performance of illegal or unethical activities,
and ethical misconduct.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Committee, in its absolute discretion, shall determine the effect of all matters and questions relating to whether a Participant has
been discharged for Cause.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.75in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B>Change
in Control</B>&rdquo;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-left: 0.25in; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)
The direct or indirect sale, transfer, conveyance or other disposition (other than by way of merger or consolidation), in one or a series
of related transactions, of all or substantially all of the properties or assets of the Company and its subsidiaries, taken as a whole,
to any Person that is not a subsidiary of the Company;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-left: 0.25in; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)
The Incumbent Directors are replaced during any twelve-month period by directors whose appointment or election is not endorsed by a majority
of the Incumbent Directors before the date of appointment or election; or;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-left: 0.25in; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c)
The date which is 10 business days prior to the consummation of a complete liquidation or dissolution of the Company;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<!-- Field: Page; Sequence: 2; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">A-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-left: 0.25in; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(d)
The acquisition by any Person of Beneficial Ownership of 50% or more (on a fully diluted basis) of either (i) the then outstanding shares
of Common Stock of the Company, taking into account as outstanding for this purpose such Common Stock issuable upon the exercise of options
or warrants, the conversion of convertible stock or debt, and the exercise of any similar right to acquire such Common Stock (the &ldquo;<B>Outstanding
Company Common Stock</B>&rdquo;) or (ii) the combined voting power of the then outstanding voting securities of the Company entitled
to vote generally in the election of directors (the &ldquo;<B>Outstanding Company Voting Securities</B>&rdquo;); <I>provided, however</I>,
that for purposes of this Plan, the following acquisitions shall not constitute a Change in Control: (A) any acquisition by the Company
or any Affiliate, (B) any acquisition by any employee benefit plan sponsored or maintained by the Company or any subsidiary, (C) any
acquisition which complies with clauses, (i), (ii) and (iii) of subsection (e) of this definition or (D) in respect of an Award held
by a particular Participant, any acquisition by the Participant or any group of persons including the Participant (or any entity controlled
by the Participant or any group of persons including the Participant); or</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-left: 0.25in; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(e)
The consummation of a reorganization, merger, consolidation, statutory share exchange or similar form of corporate transaction involving
the Company that requires the approval of the Company&rsquo;s shareholders, whether for such transaction or the issuance of securities
in the transaction (a &ldquo;<B>Business Combination</B>&rdquo;), unless immediately following such Business Combination: (i) more than
50% of the total voting power of (A) the entity resulting from such Business Combination (the &ldquo;<B>Surviving Company</B>&rdquo;),
or (B) if applicable, the ultimate parent entity that directly or indirectly has beneficial ownership of sufficient voting securities
eligible to elect a majority of the members of the board of directors (or the analogous governing body) of the Surviving Company (the
&ldquo;<B>Parent Company</B>&rdquo;), is represented by the Outstanding Company Voting Securities that were outstanding immediately prior
to such Business Combination (or, if applicable, is represented by shares into which the Outstanding Company Voting Securities were converted
pursuant to such Business Combination), and such voting power among the holders thereof is in substantially the same proportion as the
voting power of the Outstanding Company Voting Securities among the holders thereof immediately prior to the Business Combination; (ii)
no Person (other than any employee benefit plan sponsored or maintained by the Surviving Company or the Parent Company) is or becomes
the Beneficial Owner, directly or indirectly, of 50% or more of the total voting power of the outstanding voting securities eligible
to elect members of the board of directors of the Parent Company (or the analogous governing body) (or, if there is no Parent Company,
the Surviving Company); and (iii) at least a majority of the members of the board of directors (or the analogous governing body) of the
Parent Company (or, if there is no Parent Company, the Surviving Company) following the consummation of the Business Combination were
Board members at the time of the Board&rsquo;s approval of the execution of the initial agreement providing for such Business Combination.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.75in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B>Code</B>&rdquo;
means the Internal Revenue Code of 1986, as it may be amended from time to time. Any reference to a section of the Code shall be deemed
to include a reference to any regulations promulgated thereunder.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 3; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">A-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.75in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B>Committee</B>&rdquo;
means a committee of one or more members of the Board appointed by the Board to administer the Plan in accordance with Section 3.3 and
Section 3.4.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.75in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B>Common
Stock</B>&rdquo; means the common stock, $0.0001 par value per share, of the Company, or such other securities of the Company as may
be designated by the Committee from time to time in substitution thereof.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.75in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.75in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B>Company</B>&rdquo;
means Sharps Technology, Inc. a Nevada corporation, and any successor thereto.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.75in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B>Consultant</B>&rdquo;
means any individual or entity which performs bona fide services to the Company or an Affiliate, other than as an Employee or Director,
and who may be offered securities registerable pursuant to a registration statement on Form S-8 under the Securities Act.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.75in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B>Continuous
Service</B>&rdquo; means that the Participant&rsquo;s service with the Company or an Affiliate, whether as an Employee, Consultant or
Director, is not interrupted or terminated. The Participant&rsquo;s Continuous Service shall not be deemed to have terminated merely
because of a change in the capacity in which the Participant renders service to the Company or an Affiliate as an Employee, Consultant
or Director or a change in the entity for which the Participant renders such service, <I>provided that</I> there is no interruption or
termination of the Participant&rsquo;s Continuous Service; <I>provided further that </I>if any Award is subject to Section 409A of the
Code, this sentence shall only be given effect to the extent consistent with Section 409A of the Code. For example, a change in status
from an Employee of the Company to a Director of an Affiliate will not constitute an interruption of Continuous Service. The Committee
or its delegate, in its sole discretion, may determine whether Continuous Service shall be considered interrupted in the case of any
leave of absence approved by that party, including sick leave, military leave or any other personal or family leave of absence. The Committee
or its delegate, in its sole discretion, may determine whether a Company transaction, such as a sale or spin-off of a division or subsidiary
that employs a Participant, shall be deemed to result in a termination of Continuous Service for purposes of affected Awards, and such
decision shall be final, conclusive and binding.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.75in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B>Deferred
Stock Units (DSUs)</B>&rdquo; has the meaning set forth in Section 8.1(b) hereof.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.75in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B>Director</B>&rdquo;
means a member of the Board.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.75in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B>Disability</B>&rdquo;
means, unless the applicable Award Agreement says otherwise, that the Participant is unable to engage in any substantial gainful activity
by reason of any medically determinable physical or mental impairment; <I>provided, however,</I> for purposes of determining the term
of an Incentive Stock Option pursuant to Section 6.10 hereof, the term Disability shall have the meaning ascribed to it under Section
22(e)(3) of the Code. The determination of whether an individual has a Disability shall be determined under procedures established by
the Committee. Except in situations where the Committee is determining Disability for purposes of the term of an Incentive Stock Option
pursuant to Section 6.10 hereof within the meaning of Section 22(e)(3) of the Code, the Committee may rely on any determination that
a Participant is disabled for purposes of benefits under any long-term disability plan maintained by the Company or any Affiliate in
which a Participant participates.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 4; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">A-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.75in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.75in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B>Disqualifying
Disposition</B>&rdquo; has the meaning set forth in Section 17.12.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.75in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B>Effective
Date</B>&rdquo; shall mean December 31, 2024.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.75in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B>Employee</B>&rdquo;
means any person, including an Officer or Director, employed by the Company or an Affiliate; <I>provided, that,</I> for purposes of determining
eligibility to receive Incentive Stock Options, an Employee shall mean an employee of the Company or a parent or subsidiary corporation
within the meaning of Section 424 of the Code. Mere service as a Director or payment of a director&rsquo;s fee by the Company or an Affiliate
shall not be sufficient to constitute &ldquo;employment&rdquo; by the Company or an Affiliate.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.75in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B>Exchange
Act</B>&rdquo; means the Securities Exchange Act of 1934, as amended.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.75in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B>Fair
Market Value</B>&rdquo; means, as of any date, the value of the Common Stock as determined below. If the Common Stock is listed on any
established stock exchange or a national market system, including without limitation, the New York Stock Exchange or the Nasdaq Stock
Market, the Fair Market Value shall be the closing price of a share of Common Stock (or if no sales were reported the closing price on
the date immediately preceding such date) as quoted on such exchange or system on the day of determination, as reported in the <I>Wall
Street Journal</I>.. In the absence of an established market for the Common Stock, the Fair Market Value shall be determined in good
faith by the Committee and such determination shall be conclusive and binding on all persons.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.75in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B>Fiscal
Year</B>&rdquo; means the Company&rsquo;s fiscal year.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.75in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B>Free
Standing Rights</B>&rdquo; has the meaning set forth in Section 7.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.75in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B>Good
Reason</B>&rdquo; means, unless the applicable Award Agreement states otherwise:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-left: 0.25in; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)
If an Employee or Consultant is a party to an employment or service agreement with the Company or its Affiliates and such agreement provides
for a definition of Good Reason, the definition contained therein; or</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-left: 0.25in; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)
If no such agreement exists or if such agreement does not define Good Reason, the occurrence of one or more of the following without
the Participant&rsquo;s express written consent, which circumstances are not remedied by the Company within thirty (30) days of its receipt
of a written notice from the Participant describing the applicable circumstances (which notice must be provided by the Participant within
ninety (90) days of the Participant&rsquo;s knowledge of the applicable circumstances): (i) any material, adverse change in the Participant&rsquo;s
duties, responsibilities, authority, title, status or reporting structure; (ii) a material reduction in the Participant&rsquo;s base
salary or bonus opportunity; or (iii) a geographical relocation of the Participant&rsquo;s principal office location by more than fifty
(50) miles.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 5; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">A-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.75in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.75in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B>Grant
Date</B>&rdquo; means the date on which the Committee adopts a resolution, or takes other appropriate action, expressly granting an Award
to a Participant that specifies the key terms and conditions of the Award or, if a later date is set forth in such resolution, then such
date as is set forth in such resolution.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.75in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B>Incentive
Stock Option</B>&rdquo; means an Option that is designated by the Committee as an incentive stock option within the meaning of Section
422 of the Code and that meets the requirements set out in the Plan.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.75in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B>Incumbent
Directors</B>&rdquo; means individuals who, on the Effective Date, constitute the Board, <I>provided that</I> any individual becoming
a Director subsequent to the Effective Date whose election or nomination for election to the Board was approved by a vote of at least
two-thirds of the Incumbent Directors then on the Board (either by a specific vote or by approval of the proxy statement of the Company
in which such person is named as a nominee for Director without objection to such nomination) shall be an Incumbent Director. No individual
initially elected or nominated as a director of the Company as a result of an actual or threatened election contest with respect to Directors
or as a result of any other actual or threatened solicitation of proxies by or on behalf of any person other than the Board shall be
an Incumbent Director.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.75in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B>Non-Employee
Director</B>&rdquo; means a Director who is a &ldquo;non-employee director&rdquo; within the meaning of Rule 16b-3.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.75in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B>Non-qualified
Stock Option</B>&rdquo; means an Option that by its terms does not qualify or is not intended to qualify as an Incentive Stock Option.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.75in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B>Officer</B>&rdquo;
means a person who is an officer of the Company within the meaning of Section 16 of the Exchange Act and the rules and regulations promulgated
thereunder.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.75in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B>Option</B>&rdquo;
means an Incentive Stock Option or a Non-qualified Stock Option granted pursuant to the Plan.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.75in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B>Option
holder</B>&rdquo; means a person to whom an Option is granted pursuant to the Plan or, if applicable, such other person who holds an
outstanding Option.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.75in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B>Option
Exercise Price</B>&rdquo; means the price at which a share of Common Stock may be purchased upon the exercise of an Option.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.75in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&ldquo;Other
Equity-Based Award&rdquo; </B>means an Award that is not an Option, Stock Appreciation Right, Restricted Stock, Restricted Stock Unit,
or Performance Share Award that is granted under Section 10 and is payable by delivery of Common Stock and/or which is measured by reference
to the value of Common Stock.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.75in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B>Participant</B>&rdquo;
means an eligible person to whom an Award is granted pursuant to the Plan or, if applicable, such other person who holds an outstanding
Award.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 6; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">A-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->6<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.75in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.75in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B>Performance
Goals</B>&rdquo; means, for a Performance Period, the one or more goals established by the Committee for the Performance Period based
upon business criteria or other performance measures determined by the Committee in its discretion.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.75in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B>Performance
Period</B>&rdquo; means the one or more periods of time not less than one fiscal quarter in duration, as the Committee may select, over
which the attainment of one or more Performance Goals will be measured for the purpose of determining a Participant&rsquo;s right to
and the payment of a Performance Share Award or a Cash Award.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.75in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B>Performance
Share Award</B>&rdquo; means any Award granted pursuant to Section 9 hereof.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.75in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B>Performance
Share</B>&rdquo; means the grant of a right to receive a number of actual shares of Common Stock or share units based upon the performance
of the Company during a Performance Period, as determined by the Committee.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.75in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B>Permitted
Transferee</B>&rdquo; means: (a) a member of the Option holder&rsquo;s immediate family (child, stepchild, grandchild, parent, stepparent,
grandparent, spouse, former spouse, sibling, niece, nephew, mother-in-law, father-in-law, son-in-law, daughter-in-law, brother-in-law,
or sister-in-law, including adoptive relationships), any person sharing the Option holder&rsquo;s household (other than a tenant or employee),
a trust in which these persons have more than 50% of the beneficial interest, a foundation in which these persons (or the Option holder)
control the management of assets, and any other entity in which these persons (or the Option holder) own more than 50% of the voting
interests; (b) third parties designated by the Committee in connection with a program established and approved by the Committee pursuant
to which Participants may receive a cash payment or other consideration in consideration for the transfer of a Non-qualified Stock Option;
and (c) such other transferees as may be permitted by the Committee in its sole discretion.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.75in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&ldquo;Person&rdquo;
</B>means a person as defined in Section 13(d)(3) of the Exchange Act.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.75in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B>Plan</B>&rdquo;
means this Sharps Technology, Inc. 2024 Equity Incentive Plan, as amended and/or amended and restated from time to time.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.75in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B>Related
Rights</B>&rdquo; has the meaning set forth in Section 7.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.75in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B>Restricted
Award</B>&rdquo; means any Award granted pursuant to Section 8.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.75in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B>Restricted
Period</B>&rdquo; has the meaning set forth in Section 8.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.75in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B>Rule
16b-3</B>&rdquo; means Rule 16b-3 promulgated under the Exchange Act or any successor to Rule 16b-3, as in effect from time to time.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.75in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.75in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B>Securities
Act</B>&rdquo; means the Securities Act of 1933, as amended.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.75in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B>Stock
Appreciation Right</B>&rdquo; means the right pursuant to an Award granted under Section 7 to receive, upon exercise, an amount payable
in cash or shares equal to the number of shares subject to the Stock Appreciation Right that is being exercised multiplied by the excess
of (a) the Fair Market Value of a share of Common Stock on the date the Award is exercised, over (b) the exercise price specified in
the Stock Appreciation Right Award Agreement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 7; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">A-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->7<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.75in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.75in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B>Stock
for Stock Exchange</B>&rdquo; has the meaning set forth in Section 6.4.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.75in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&ldquo;Substitute
Award&rdquo; </B>has the meaning set forth in Section 4.5.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.75in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B>Ten
Percent Shareholder</B>&rdquo; means a person who owns (or is deemed to own pursuant to Section 424(d) of the Code) stock possessing
more than 10% of the total combined voting power of all classes of stock of the Company or of any of its Affiliates.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.75in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&ldquo;Total
Share Reserve</B>&rdquo; has the meaning set forth in Section 4.1.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" BORDER="0" STYLE="width: 100%; margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: top">
  <TD STYLE="text-align: justify; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.</FONT></TD>
  <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Administration</U>.</FONT></TD></TR>
</TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.1
<U>Authority of Committee</U>. The Plan shall be administered by the Committee or, in the Board&rsquo;s sole discretion, by the Board.
Subject to the terms of the Plan, the Committee&rsquo;s charter and Applicable Laws, and in addition to other express powers and authorization
conferred by the Plan, the Committee shall have the authority:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="margin-left: 0.5in; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)
to construe and interpret the Plan and apply its provisions;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-left: 0.5in; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)
to promulgate, amend, and rescind rules and regulations relating to the administration of the Plan;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-left: 0.5in; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c)
to authorize any person to execute, on behalf of the Company, any instrument required to carry out the purposes of the Plan;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-left: 0.5in; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(d)
to delegate its authority to one or more Officers of the Company with respect to Awards that do not involve &ldquo;insiders&rdquo; within
the meaning of Section 16 of the Exchange Act;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-left: 0.5in; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(e)
to determine when Awards are to be granted under the Plan and the applicable Grant Date;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-left: 0.5in; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(f)
from time to time to select, subject to the limitations set forth in this Plan, those eligible Award recipients to whom Awards shall
be granted;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-left: 0.5in; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(g)
to determine the number of shares of Common Stock to be made subject to each Award;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-left: 0.5in; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(h)
to determine whether each Option is to be an Incentive Stock Option or a Non-qualified Stock Option;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-left: 0.5in; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(i)
to prescribe the terms and conditions of each Award, including, without limitation, the exercise price and medium of payment and vesting
provisions, and to specify the provisions of the Award Agreement relating to such grant;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 8; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">A-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->8<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-left: 0.5in; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(j)
to determine the target number of Performance Shares to be granted pursuant to a Performance Share Award, the performance measures that
will be used to establish the Performance Goals, the Performance Period(s) and the number of Performance Shares earned by a Participant;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-left: 0.5in; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(k)
to amend any outstanding Awards, including for the purpose of modifying the time or manner of vesting, or the term of any outstanding
Award; <I>provided, however</I>, that if any such amendment impairs a Participant&rsquo;s rights or increases a Participant&rsquo;s obligations
under his or her Award or creates or increases a Participant&rsquo;s federal income tax liability with respect to an Award, such amendment
shall also be subject to the Participant&rsquo;s consent;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-left: 0.5in; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(l)
to determine the duration and purpose of leaves of absences which may be granted to a Participant without constituting termination of
their employment for purposes of the Plan, which periods shall be no shorter than the periods generally applicable to Employees under
the Company&rsquo;s employment policies;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-left: 0.5in; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(m)
to make decisions with respect to outstanding Awards that may become necessary upon a change in corporate control or an event that triggers
anti-dilution adjustments;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-left: 0.5in; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(n)
to interpret, administer, reconcile any inconsistency in, correct any defect in and/or supply any omission in the Plan and any instrument
or agreement relating to, or Award granted under, the Plan; and</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-left: 0.5in; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(o)
to exercise discretion to make any and all other determinations which it determines to be necessary or advisable for the administration
of the Plan.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Committee also may modify the purchase price or the exercise price of any outstanding Award, <I>provided that</I> if the modification
effects a repricing, shareholder approval shall be required before the repricing is effective.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.2
<U>Committee Decisions Final</U>. All decisions made by the Committee pursuant to the provisions of the Plan shall be final and binding
on the Company and the Participants, unless such decisions are determined by a court having jurisdiction to be arbitrary and capricious.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.3
<U>Delegation</U>. The Committee or, if no Committee has been appointed, the Board may delegate administration of the Plan to a committee
or committees of one or more members of the Board, and the term &ldquo;<B>Committee</B>&rdquo; shall apply to any person or persons to
whom such authority has been delegated. The Committee shall have the power to delegate to a subcommittee any of the administrative powers
the Committee is authorized to exercise (and references in this Plan to the Board or the Committee shall thereafter be to the committee
or subcommittee), subject, however, to such resolutions, not inconsistent with the provisions of the Plan, as may be adopted from time
to time by the Board. The Board may abolish the Committee at any time and revest in the Board the administration of the Plan. The members
of the Committee shall be appointed by and serve at the pleasure of the Board. From time to time, the Board may increase or decrease
the size of the Committee, add additional members to, remove members (with or without cause) from, appoint new members in substitution
therefor, and fill vacancies, however caused, in the Committee. The Committee shall act pursuant to a vote of the majority of its members
or, in the case of a Committee comprised of only two members, the unanimous consent of its members, whether present or not, or by the
written consent of the majority of its members and minutes shall be kept of all of its meetings and copies thereof shall be provided
to the Board. Subject to the limitations prescribed by the Plan and the Board, the Committee may establish and follow such rules and
regulations for the conduct of its business as it may determine to be advisable.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 9; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">A-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->9<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.4
<U>Committee Composition</U>. Except as otherwise determined by the Board, the Committee shall consist solely of two or more Non-Employee
Directors. The Board shall have discretion to determine whether or not it intends to comply with the exemption requirements of Rule 16b-3.
However, if the Board intends to satisfy such exemption requirements, with respect to any insider subject to Section 16 of the Exchange
Act, the Committee shall be a compensation committee of the Board that at all times consists solely of two or more Non-Employee Directors.
Within the scope of such authority, the Board or the Committee may delegate to a committee of one or more members of the Board who are
not Non-Employee Directors the authority to grant Awards to eligible persons who are not then subject to Section 16 of the Exchange Act.
Nothing herein shall create an inference that an Award is not validly granted under the Plan in the event Awards are granted under the
Plan by a compensation committee of the Board that does not at all times consist solely of two or more Non-Employee Directors.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.5
<U>Indemnification</U>. In addition to such other rights of indemnification as they may have as Directors or members of the Committee,
and to the extent allowed by Applicable Laws, the Committee shall be indemnified by the Company against the reasonable expenses, including
attorney&rsquo;s fees, actually incurred in connection with any action, suit or proceeding or in connection with any appeal therein,
to which the Committee may be party by reason of any action taken or failure to act under or in connection with the Plan or any Award
granted under the Plan, and against all amounts paid by the Committee in settlement thereof (<I>provided, however</I>, that the settlement
has been approved by the Company, which approval shall not be unreasonably withheld) or paid by the Committee in satisfaction of a judgment
in any such action, suit or proceeding, except in relation to matters as to which it shall be adjudged in such action, suit or proceeding
that such Committee did not act in good faith and in a manner which such person reasonably believed to be in the best interests of the
Company, or in the case of a criminal proceeding, had no reason to believe that the conduct complained of was unlawful; <I>provided,
however</I>, that within 60 days after the institution of any such action, suit or proceeding, such Committee shall, in writing, offer
the Company the opportunity at its own expense to handle and defend such action, suit or proceeding.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 10; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">A-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->10<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" BORDER="0" STYLE="width: 100%; margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: top">
  <TD STYLE="width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.</FONT></TD>
  <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Shares Subject to the Plan</U>.</FONT></TD></TR>
</TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.1
Subject to adjustment in accordance with Section 14, no more than 265,000 shares of Common Stock shall be available for the grant of
Awards under the Plan (the &ldquo;<B>Total Share Reserve</B>&rdquo;). During the terms of the Awards, the Company shall keep available
at all times the number of shares of Common Stock required to satisfy such Awards.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.2
Shares of Common Stock available for distribution under the Plan may consist, in whole or in part, of authorized and unissued shares,
treasury shares or shares reacquired by the Company in any manner.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.3
Subject to adjustment in accordance with Section 14, no more than $100,000 worth of shares of Common Stock may be issued in the aggregate
pursuant to the exercise of Incentive Stock Options (the <B>&ldquo;ISO Limit&rdquo;</B>).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.4
Any shares of Common Stock subject to an Award that expires or is canceled, forfeited, or terminated without issuance of the full number
of shares of Common Stock to which the Award related will again be available for issuance under the Plan. Notwithstanding anything to
the contrary contained herein: shares subject to an Award under the Plan shall not again be made available for issuance or delivery under
the Plan if such shares are (a) shares tendered in payment of an Option, (b) shares delivered or withheld by the Company to satisfy any
tax withholding obligation, or (c) shares covered by a stock-settled Stock Appreciation Right or other Awards that were not issued upon
the settlement of the Award.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.5
Awards may, in the sole discretion of the Committee, be granted under the Plan in assumption of, or in substitution for, outstanding
awards previously granted by an entity acquired by the Company or with which the Company combines (&ldquo;<B>Substitute Awards</B>&rdquo;).
Substitute Awards shall not be counted against the Total Share Reserve; <I>provided, that</I>, Substitute Awards issued in connection
with the assumption of, or in substitution for, outstanding options intended to qualify as Incentive Stock Options shall be counted against
the ISO limit. Subject to applicable stock exchange requirements, available shares under a shareholder-approved plan of an entity directly
or indirectly acquired by the Company or with which the Company combines (as appropriately adjusted to reflect such acquisition or transaction)
may be used for Awards under the Plan and shall not count toward the Total Share Limit.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" BORDER="0" STYLE="width: 100%; margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: top">
  <TD STYLE="width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.</FONT></TD>
  <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Eligibility</U>.</FONT></TD></TR>
</TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.1
<U>Eligibility for Specific Awards</U>. Incentive Stock Options may be granted only to Employees. Awards other than Incentive Stock Options
may be granted to Employees, Consultants and Directors..</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.2
<U>Ten Percent Shareholders</U>. A Ten Percent Shareholder shall not be granted an Incentive Stock Option unless the Option Exercise
Price is at least 110% of the Fair Market Value of the Common Stock on the Grant Date and the Option is not exercisable after the expiration
of five years from the Grant Date.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 11; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">A-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->11<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">6.
<U>Option Provisions</U>. Each Option granted under the Plan shall be evidenced by an Award Agreement. Each Option so granted shall be
subject to the conditions set forth in this Section 6, and to such other conditions not inconsistent with the Plan as may be reflected
in the applicable Award Agreement. All Options shall be separately designated Incentive Stock Options or Non-qualified Stock Options
at the time of grant, and, if certificates are issued, a separate certificate or certificates will be issued for shares of Common Stock
purchased on exercise of each type of Option. Notwithstanding the foregoing, the Company shall have no liability to any Participant or
any other person if an Option designated as an Incentive Stock Option fails to qualify as such at any time or if an Option is determined
to constitute &ldquo;nonqualified deferred compensation&rdquo; within the meaning of Section 409A of the Code and the terms of such Option
do not satisfy the requirements of Section 409A of the Code. The provisions of separate Options need not be identical, but each Option
shall include (through incorporation of provisions hereof by reference in the Option or otherwise) the substance of each of the following
provisions:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">6.1
<U>Term</U>. Subject to the provisions of Section 5.2 regarding Ten Percent Shareholders, no Incentive Stock Option shall be exercisable
after the expiration of 10 years from the Grant Date. The term of a Non-qualified Stock Option granted under the Plan shall be determined
by the Committee; <I>provided, however</I>, no Non-qualified Stock Option shall be exercisable after the expiration of 10 years from
the Grant Date.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">6.2
<U>Exercise Price of an Incentive Stock Option</U>. Subject to the provisions of Section 5.2 regarding Ten Percent Shareholders, the
Option Exercise Price of each Incentive Stock Option shall be not less than 100% of the Fair Market Value of the Common Stock subject
to the Option on the Grant Date. Notwithstanding the foregoing, an Incentive Stock Option may be granted with an Option Exercise Price
lower than that set forth in the preceding sentence if such Option is granted pursuant to an assumption or substitution for another option
in a manner satisfying the provisions of Section 424(a) of the Code.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">6.3
<U>Exercise Price of a Non-qualified Stock Option</U>. The Option Exercise Price of each Non-qualified Stock Option shall be not less
than 100% of the Fair Market Value of the Common Stock subject to the Option on the Grant Date. Notwithstanding the foregoing, a Non-qualified
Stock Option may be granted with an Option Exercise Price lower than that set forth in the preceding sentence if such Option is granted
pursuant to an assumption or substitution for another option in a manner satisfying the provisions of Section 409A of the Code.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">6.4
<U>Consideration</U>. The Option Exercise Price of Common Stock acquired pursuant to an Option shall be paid, to the extent permitted
by applicable statutes and regulations, either (a) in cash or by certified or bank check at the time the Option is exercised or (b) in
the discretion of the Committee, upon such terms as the Committee shall approve, the Option Exercise Price may be paid: (i) by delivery
to the Company of other Common Stock, duly endorsed for transfer to the Company, with a Fair Market Value on the date of delivery equal
to the Option Exercise Price (or portion thereof) due for the number of shares being acquired, or by means of attestation whereby the
Participant identifies for delivery specific shares of Common Stock that have an aggregate Fair Market Value on the date of attestation
equal to the Option Exercise Price (or portion thereof) and receives a number of shares of Common Stock equal to the difference between
the number of shares thereby purchased and the number of identified attestation shares of Common Stock (a &ldquo;<B>Stock for Stock Exchange</B>&rdquo;);
(ii) a &ldquo;cashless&rdquo; exercise program established with a broker; (iii) by reduction in the number of shares of Common Stock
otherwise deliverable upon exercise of such Option with a Fair Market Value equal to the aggregate Option Exercise Price at the time
of exercise; (iv) by any combination of the foregoing methods; or (v) in any other form of legal consideration that may be acceptable
to the Committee. Unless otherwise specifically provided in the Option, the exercise price of Common Stock acquired pursuant to an Option
that is paid by delivery (or attestation) to the Company of other Common Stock acquired, directly or indirectly from the Company, shall
be paid only by shares of the Common Stock of the Company that have been held for more than six months (or such longer or shorter period
of time required to avoid a charge to earnings for financial accounting purposes). Notwithstanding the foregoing, during any period for
which the Common Stock is publicly traded (i.e., the Common Stock is listed on any established stock exchange or a national market system)
an exercise by a Director or Officer that involves or may involve a direct or indirect extension of credit or arrangement of an extension
of credit by the Company, directly or indirectly, in violation of Section 402(a) of the Sarbanes-Oxley Act of 2002 shall be prohibited
with respect to any Award under this Plan.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 12; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">A-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->12<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">6.5
<U>Transferability of an Incentive Stock Option</U>. An Incentive Stock Option shall not be transferable except by will or by the laws
of descent and distribution and shall be exercisable during the lifetime of the Option holder only by the Option holder. Notwithstanding
the foregoing, the Option holder may, by delivering written notice to the Company, in a form satisfactory to the Company, designate a
third party who, in the event of the death of the Option holder, shall thereafter be entitled to exercise the Option.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">6.6
<U>Transferability of a Non-qualified Stock Option</U>. A Non-qualified Stock Option may, in the sole discretion of the Committee, be
transferable to a Permitted Transferee, upon written approval by the Committee to the extent provided in the Award Agreement. If the
Non-qualified Stock Option does not provide for transferability, then the Non-qualified Stock Option shall not be transferable except
by will or by the laws of descent and distribution and shall be exercisable during the lifetime of the Option holder only by the Option
holder. Notwithstanding the foregoing, the Option holder may, by delivering written notice to the Company, in a form satisfactory to
the Company, designate a third party who, in the event of the death of the Option holder, shall thereafter be entitled to exercise the
Option.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Vesting
of Options</U>. Each Option that vests solely based on the continued service of the Participant shall vest and therefore become exercisable
in three equal installments on each of the first anniversaries of the Grant Date, subject to the Option holder&rsquo;s Continuous Service.
Each Option that vests based on the achievement of performance or other criteria shall vest and therefore become exercisable on the [third]
anniversary of the Grant Date, subject to the achievement of applicable performance goals and the Option holder&rsquo;s Continuous Service.
No Option may be exercised for a fraction of a share of Common Stock. Notwithstanding the above, the Committee shall have the right to
determine the vesting schedule. The Committee may, but shall not be required to, provide for an acceleration of vesting and exercisability
in the terms of any Award Agreement upon the occurrence of a specified event.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">6.7
<U>Termination of Continuous Service</U>. Unless otherwise provided in an Award Agreement or in an employment agreement the terms of
which have been approved by the Committee, in the event an Option holder&rsquo;s Continuous Service terminates (other than upon the Option
holder&rsquo;s death or Disability), the Option holder may exercise his or her Option (to the extent that the Option holder was entitled
to exercise such Option as of the date of termination) but only within such period of time ending on the earlier of (a) the date three
months following the termination of the Option holder&rsquo;s Continuous Service or (b) the expiration of the term of the Option as set
forth in the Award Agreement; <I>provided that</I>, if the termination of Continuous Service is by the Company for Cause, all outstanding
Options (whether or not vested) shall immediately terminate and cease to be exercisable. If, after termination, the Option holder does
not exercise his or her Option within the time specified in the Award Agreement, the Option shall terminate.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 13; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">A-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->13<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">6.8
<U>Extension of Termination Date</U>. An Option holder&rsquo;s Award Agreement may also provide that if the exercise of the Option following
the termination of the Option holder&rsquo;s Continuous Service for any reason would be prohibited at any time because the issuance of
shares of Common Stock would violate the registration requirements under the Securities Act or any other state or federal securities
law or the rules of any securities exchange or interdealer quotation system, then the Option shall terminate on the earlier of (a) the
expiration of the term of the Option in accordance with Section 6.1 or (b) the expiration of a period after termination of the Participant&rsquo;s
Continuous Service that is three months after the end of the period during which the exercise of the Option would be in violation of
such registration or other securities law requirements.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">6.9
<U>Disability of Option holder</U>. Unless otherwise provided in an Award Agreement, in the event that an Option holder&rsquo;s Continuous
Service terminates as a result of the Option holder&rsquo;s Disability, the Option holder may exercise his or her Option (to the extent
that the Option holder was entitled to exercise such Option as of the date of termination), but only within such period of time ending
on the earlier of (a) the date 12 months following such termination or (b) the expiration of the term of the Option as set forth in the
Award Agreement. If, after termination, the Option holder does not exercise his or her Option within the time specified herein or in
the Award Agreement, the Option shall terminate.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">6.10
<U>Death of Option holder</U>. Unless otherwise provided in an Award Agreement, in the event an Option holder&rsquo;s Continuous Service
terminates as a result of the Option holder&rsquo;s death, then the Option may be exercised (to the extent the Option holder was entitled
to exercise such Option as of the date of death) by the Option holder&rsquo;s estate, by a person who acquired the right to exercise
the Option by bequest or inheritance or by a person designated to exercise the Option upon the Option holder&rsquo;s death, but only
within the period ending on the earlier of (a) the date 12 months following the date of death or (b) the expiration of the term of such
Option as set forth in the Award Agreement. If, after the Option holder&rsquo;s death, the Option is not exercised within the time specified
herein or in the Award Agreement, the Option shall terminate.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">6.11
<U>Incentive Stock Option $100,000 Limitation</U>. To the extent that the aggregate Fair Market Value (determined at the time of grant)
of Common Stock with respect to which Incentive Stock Options are exercisable for the first time by any Option holder during any calendar
year (under all plans of the Company and its Affiliates) exceeds $100,000, the Options or portions thereof which exceed such limit (according
to the order in which they were granted) shall be treated as Non-qualified Stock Options.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 14; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">A-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->14<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">7.
<U>Stock Appreciation Rights</U>. Each Stock Appreciation Right granted under the Plan shall be evidenced by an Award Agreement. Each
Stock Appreciation Right so granted shall be subject to the conditions set forth in this Section 7, and to such other conditions not
inconsistent with the Plan as may be reflected in the applicable Award Agreement. Stock Appreciation Rights may be granted alone (&ldquo;<B>Free
Standing Rights</B>&rdquo;) or in tandem with an Option granted under the Plan (&ldquo;<B>Related Rights</B>&rdquo;).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">7.1
<U>Grant Requirements for Related Rights</U>. Any Related Right that relates to a Non-qualified Stock Option may be granted at the same
time the Option is granted or at any time thereafter but before the exercise or expiration of the Option. Any Related Right that relates
to an Incentive Stock Option must be granted at the same time the Incentive Stock Option is granted.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">7.2
<U>Term</U> The term of a Stock Appreciation Right granted under the Plan shall be determined by the Committee; <I>provided, however</I>,
no Stock Appreciation Right shall be exercisable later than the tenth anniversary of the Grant Date.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">7.3
<U>Vesting</U> Each Stock Appreciation Right shall vest and therefore become exercisable in three equal installments on each of the first
anniversaries of the Grant Date, subject to the Participant&rsquo;s Continuous Service. No Stock Appreciation Right may be exercised
for a fraction of a share of Common Stock. The Committee may, but shall not be required to, provide for an acceleration of vesting and
exercisability in the terms of any Award Agreement upon the occurrence of a specified event.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">7.4
<U>Exercise and Payment</U> Upon exercise of a Stock Appreciation Right, the holder shall be entitled to receive from the Company an
amount equal to the number of shares of Common Stock subject to the Stock Appreciation Right that is being exercised multiplied by the
excess of (i) the Fair Market Value of a share of Common Stock on the date the Award is exercised, over (ii) the exercise price specified
in the Stock Appreciation Right or related Option. Payment with respect to the exercise of a Stock Appreciation Right shall be made on
the date of exercise. Payment shall be made in the form of shares of Common Stock (with or without restrictions as to substantial risk
of forfeiture and transferability, as determined by the Committee in its sole discretion), cash or a combination thereof, as determined
by the Committee.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">7.5
<U>Exercise Price</U> The exercise price of a Free Standing Right shall be determined by the Committee, but shall not be less than 100%
of the Fair Market Value of one share of Common Stock on the Grant Date of such Stock Appreciation Right. A Related Right granted simultaneously
with or subsequent to the grant of an Option and in conjunction therewith or in the alternative thereto shall have the same exercise
price as the related Option, shall be transferable only upon the same terms and conditions as the related Option, and shall be exercisable
only to the same extent as the related Option; <I>provided, however</I>, that a Stock Appreciation Right, by its terms, shall be exercisable
only when the Fair Market Value per share of Common Stock subject to the Stock Appreciation Right and related Option exceeds the exercise
price per share thereof and no Stock Appreciation Rights may be granted in tandem with an Option unless the Committee determines that
the requirements of Section 7.1 are satisfied.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 15; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">A-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->15<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">7.6
<U>Reduction in the Underlying Option Shares</U> Upon any exercise of a Related Right, the number of shares of Common Stock for which
any related Option shall be exercisable shall be reduced by the number of shares for which the Stock Appreciation Right has been exercised.
The number of shares of Common Stock for which a Related Right shall be exercisable shall be reduced upon any exercise of any related
Option by the number of shares of Common Stock for which such Option has been exercised.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">8.
<U>Restricted Awards</U> A Restricted Award is an Award of actual shares of Common Stock (&ldquo;<B>Restricted Stock</B>&rdquo;) or hypothetical
Common Stock units (&ldquo;<B>Restricted Stock Units</B>&rdquo;) having a value equal to the Fair Market Value of an identical number
of shares of Common Stock, which may, but need not, provide that such Restricted Award may not be sold, assigned, transferred or otherwise
disposed of, pledged or hypothecated as collateral for a loan or as security for the performance of any obligation or for any other purpose
for such period (the &ldquo;<B>Restricted Period</B>&rdquo;) as the Committee shall determine. Each Restricted Award granted under the
Plan shall be evidenced by an Award Agreement. Each Restricted Award so granted shall be subject to the conditions set forth in this
Section 8, and to such other conditions not inconsistent with the Plan as may be reflected in the applicable Award Agreement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="margin-left: 0.5in; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">8.1
<U>Restricted Stock and Restricted Stock Units</U></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="margin-left: 0.5in; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)
Each Participant granted Restricted Stock shall execute and deliver to the Company an Award Agreement with respect to the Restricted
Stock setting forth the restrictions and other terms and conditions applicable to such Restricted Stock. If the Committee determines
that the Restricted Stock shall be held by the Company or in escrow rather than delivered to the Participant pending the release of the
applicable restrictions, the Committee may require the Participant to additionally execute and deliver to the Company (A) an escrow agreement
satisfactory to the Committee, if applicable and (B) the appropriate blank stock power with respect to the Restricted Stock covered by
such agreement. If a Participant fails to execute an agreement evidencing an Award of Restricted Stock and, if applicable, an escrow
agreement and stock power, the Award shall be null and void. Subject to the restrictions set forth in the Award, the Participant generally
shall have the rights and privileges of a shareholder as to such Restricted Stock, including the right to vote such Restricted Stock
and the right to receive dividends; <I>provided that</I>, any cash dividends and stock dividends with respect to the Restricted Stock
shall be withheld by the Company for the Participant&rsquo;s account, and interest may be credited on the amount of the cash dividends
withheld at a rate and subject to such terms as determined by the Committee. The cash dividends or stock dividends so withheld by the
Committee and attributable to any particular share of Restricted Stock (and earnings thereon, if applicable) shall be distributed to
the Participant in cash or, at the discretion of the Committee, in shares of Common Stock having a Fair Market Value equal to the amount
of such dividends, if applicable, upon the release of restrictions on such share and, if such share is forfeited, the Participant shall
have no right to such dividends.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 16; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">A-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->16<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-left: 0.5in; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)
The terms and conditions of a grant of Restricted Stock Units shall be reflected in an Award Agreement. No shares of Common Stock shall
be issued at the time a Restricted Stock Unit is granted, and the Company will not be required to set aside funds for the payment of
any such Award. A Participant shall have no voting rights with respect to any Restricted Stock Units granted hereunder. The Committee
may also grant Restricted Stock Units with a deferral feature, whereby settlement is deferred beyond the vesting date until the occurrence
of a future payment date or event set forth in an Award Agreement (&ldquo;<B>Deferred Stock Units</B>&rdquo;). At the discretion of the
Committee, each Restricted Stock Unit or Deferred Stock Unit (representing one share of Common Stock) may be credited with an amount
equal to the cash and stock dividends paid by the Company in respect of one share of Common Stock (&ldquo;<B>Dividend Equivalents</B>&rdquo;).
Dividend Equivalents shall be paid currently (and in no case later than the end of the calendar year in which the dividend is paid to
the holders of the Common Stock or, if later, the 15th day of the third month following the date the dividend is paid to holders of the
Common Stock).Dividend Equivalents shall be withheld by the Company and credited to the Participant&rsquo;s account, and interest may
be credited on the amount of cash Dividend Equivalents credited to the Participant&rsquo;s account at a rate and subject to such terms
as determined by the Committee. Dividend Equivalents credited to a Participant&rsquo;s account and attributable to any particular Restricted
Stock Unit or Deferred Stock Unit (and earnings thereon, if applicable) shall be distributed in cash or, at the discretion of the Committee,
in shares of Common Stock having a Fair Market Value equal to the amount of such Dividend Equivalents and earnings, if applicable, to
the Participant upon settlement of such Restricted Stock Unit or Deferred Stock Unit and, if such Restricted Stock Unit or Deferred Stock
Unit is forfeited, the Participant shall have no right to such Dividend Equivalents./Dividend Equivalents will be deemed re-invested
in additional Restricted Stock Units or Deferred Stock Units based on the Fair Market Value of a share of Common Stock on the applicable
dividend payment date and rounded down to the nearest whole share.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-left: 0.5in; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">8.2
<U>Restrictions</U></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-left: 0.5in; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)
Restricted Stock awarded to a Participant shall be subject to the following restrictions until the expiration of the Restricted Period,
and to such other terms and conditions as may be set forth in the applicable Award Agreement: (A) if an escrow arrangement is used, the
Participant shall not be entitled to delivery of the stock certificate; (B) the shares shall be subject to the restrictions on transferability
set forth in the Award Agreement; (C) the shares shall be subject to forfeiture to the extent provided in the applicable Award Agreement;
and (D) to the extent such shares are forfeited, the stock certificates shall be returned to the Company, and all rights of the Participant
to such shares and as a shareholder with respect to such shares shall terminate without further obligation on the part of the Company.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 17; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">A-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->17<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-left: 0.5in; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)
Restricted Stock Units and Deferred Stock Units awarded to any Participant shall be subject to (A) forfeiture until the expiration of
the Restricted Period, and satisfaction of any applicable Performance Goals during such period, to the extent provided in the applicable
Award Agreement, and to the extent such Restricted Stock Units or Deferred Stock Units are forfeited, all rights of the Participant to
such Restricted Stock Units or Deferred Stock Units shall terminate without further obligation on the part of the Company and (B) such
other terms and conditions as may be set forth in the applicable Award Agreement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-left: 0.5in; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c)
The Committee shall have the authority to remove any or all of the restrictions on the Restricted Stock, Restricted Stock Units and Deferred
Stock Units whenever it may determine that, by reason of changes in Applicable Laws or other changes in circumstances arising after the
date the Restricted Stock or Restricted Stock Units or Deferred Stock Units are granted, such action is appropriate.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-left: 0.5in; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">8.3
<U>Restricted Period</U></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-left: 0.5in; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Each
Restricted Award that vests solely based on the continued service of the Participant shall vest in three equal installments on each of
the first, second and third anniversaries of the Grant Date, subject to the Participant&rsquo;s Continuous Service. Each Restricted Award
that vests based on the achievement of performance or other criteria shall vest on the first anniversary of the Grant Date, subject to
the achievement of applicable performance goals and the Participant&rsquo;s Continuous Service.]</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-left: 0.5in; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">No
Restricted Award may be granted or settled for a fraction of a share of Common Stock. The Committee may, but shall not be required to,
provide for an acceleration of vesting in the terms of any Award Agreement upon the occurrence of a specified event.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">8.4
<U>Delivery of Restricted Stock and Settlement of Restricted Stock Units</U> Upon the expiration of the Restricted Period with respect
to any shares of Restricted Stock, the restrictions set forth in Section 8.2 and the applicable Award Agreement shall be of no further
force or effect with respect to such shares, except as set forth in the applicable Award Agreement. If an escrow arrangement is used,
upon such expiration, the Company shall deliver to the Participant, or his or her beneficiary, without charge, the stock certificate
evidencing the shares of Restricted Stock which have not then been forfeited and with respect to which the Restricted Period has expired
(to the nearest full share) and any cash dividends or stock dividends credited to the Participant&rsquo;s account with respect to such
Restricted Stock and the interest thereon, if any. Upon the expiration of the Restricted Period with respect to any outstanding Restricted
Stock Units, or at the expiration of the deferral period with respect to any outstanding Deferred Stock Units, the Company shall deliver
to the Participant, or his or her beneficiary, without charge, one share of Common Stock for each such outstanding vested Restricted
Stock Unit or Deferred Stock Unit (&ldquo;<B>Vested Unit</B>&rdquo;) [and cash equal to any Dividend Equivalents credited with respect
to each such Vested Unit in accordance with Section 8.1(b) hereof and the interest thereon or, at the discretion of the Committee, in
shares of Common Stock having a Fair Market Value equal to such Dividend Equivalents and the interest thereon, if any]; <I>provided,
however</I>, that, if explicitly provided in the applicable Award Agreement, the Committee may, in its sole discretion, elect to pay
cash or part cash and part Common Stock in lieu of delivering only shares of Common Stock for Vested Units. If a cash payment is made
in lieu of delivering shares of Common Stock, the amount of such payment shall be equal to the Fair Market Value of the Common Stock
as of the date on which the Restricted Period lapsed in the case of Restricted Stock Units, or the delivery date in the case of Deferred
Stock Units, with respect to each Vested Unit.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 18; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">A-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->18<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">8.5
<U>Stock Restrictions</U> Each certificate representing Restricted Stock awarded under the Plan shall bear a legend in such form as the
Company deems appropriate.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">9.
<U>Performance Share Awards</U> Each Performance Share Award granted under the Plan shall be evidenced by an Award Agreement. Each Performance
Share Award so granted shall be subject to the conditions set forth in this Section 9, and to such other conditions not inconsistent
with the Plan as may be reflected in the applicable Award Agreement. The Committee shall have the discretion to determine: (i) the number
of shares of Common Stock or stock-denominated units subject to a Performance Share Award granted to any Participant; (ii) the Performance
Period applicable to any Award; (iii) the conditions that must be satisfied for a Participant to earn an Award; and (iv) the other terms,
conditions and restrictions of the Award.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">9.1
<U>Earning Performance Share Awards</U> The number of Performance Shares earned by a Participant will depend on the extent to which the
performance goals established by the Committee are attained within the applicable Performance Period, as determined by the Committee.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.
<U>Other Equity-Based Awards and Cash Awards</U> The Committee may grant Other Equity-Based Awards, either alone or in tandem with other
Awards, in such amounts and subject to such conditions as the Committee shall determine in its sole discretion. Each Equity-Based Award
shall be evidenced by an Award Agreement and shall be subject to such conditions, not inconsistent with the Plan, as may be reflected
in the applicable Award Agreement. The Committee may grant Cash Awards in such amounts and subject to such Performance Goals, other vesting
conditions, and such other terms as the Committee determines in its discretion. Cash Awards shall be evidenced in such form as the Committee
may determine.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">11.
<U>Securities Law Compliance</U>. Each Award Agreement shall provide that no shares of Common Stock shall be purchased or sold thereunder
unless and until (a) any then applicable requirements of state or federal laws and regulatory agencies have been fully complied with
to the satisfaction of the Company and its counsel and (b) if required to do so by the Company, the Participant has executed and delivered
to the Company a letter of investment intent in such form and containing such provisions as the Committee may require. The Company shall
use reasonable efforts to seek to obtain from each regulatory commission or agency having jurisdiction over the Plan such authority as
may be required to grant Awards and to issue and sell shares of Common Stock upon exercise of the Awards; <I>provided, however</I>, that
this undertaking shall not require the Company to register under the Securities Act the Plan, any Award or any Common Stock issued or
issuable pursuant to any such Award. If, after reasonable efforts, the Company is unable to obtain from any such regulatory commission
or agency the authority which counsel for the Company deems necessary for the lawful issuance and sale of Common Stock under the Plan,
the Company shall be relieved from any liability for failure to issue and sell Common Stock upon exercise of such Awards unless and until
such authority is obtained.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 19; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">A-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->19<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">12.
<U>Use of Proceeds from Stock</U>. Proceeds from the sale of Common Stock pursuant to Awards, or upon exercise thereof, shall constitute
general funds of the Company.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">13.
<U>Miscellaneous</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">13.1
<U>Acceleration of Exercisability and Vesting</U>. The Committee shall have the power to accelerate the time at which an Award may first
be exercised or the time during which an Award or any part thereof will vest in accordance with the Plan, notwithstanding the provisions
in the Award stating the time at which it may first be exercised or the time during which it will vest.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">13.2
<U>Shareholder Rights</U>. Except as provided in the Plan or an Award Agreement, no Participant shall be deemed to be the holder of,
or to have any of the rights of a holder with respect to, any shares of Common Stock subject to such Award unless and until such Participant
has satisfied all requirements for exercise of the Award pursuant to its terms and no adjustment shall be made for dividends (ordinary
or extraordinary, whether in cash, securities or other property) or distributions of other rights for which the record date is prior
to the date such Common Stock certificate is issued, except as provided in Section 14 hereof.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">13.3
<U>No Employment or Other Service Rights</U>. Nothing in the Plan or any instrument executed or Award granted pursuant thereto shall
confer upon any Participant any right to continue to serve the Company or an Affiliate in the capacity in effect at the time the Award
was granted or shall affect the right of the Company or an Affiliate to terminate (a) the employment of an Employee with or without notice
and with or without Cause or (b) the service of a Director pursuant to the By-laws of the Company or an Affiliate, and any applicable
provisions of the corporate law of the state in which the Company or the Affiliate is incorporated, as the case may be.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">13.4
<U>Transfer; Approved Leave of Absence</U>. For purposes of the Plan, no termination of employment by an Employee shall be deemed to
result from either (a) a transfer of employment to the Company from an Affiliate or from the Company to an Affiliate, or from one Affiliate
to another, or (b) an approved leave of absence for military service or sickness, or for any other purpose approved by the Company, if
the Employee&rsquo;s right to reemployment is guaranteed either by a statute or by contract or under the policy pursuant to which the
leave of absence was granted or if the Committee otherwise so provides in writing, in either case, except to the extent inconsistent
with Section 409A of the Code if the applicable Award is subject thereto.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">13.5
<U>Withholding Obligations</U>. To the extent provided by the terms of an Award Agreement and subject to the discretion of the Committee,
the Participant may satisfy any federal, state or local tax withholding obligation relating to the exercise or acquisition of Common
Stock under an Award by any of the following means (in addition to the Company&rsquo;s right to withhold from any compensation paid to
the Participant by the Company) or by a combination of such means: (a) tendering a cash payment; (b) authorizing the Company to withhold
shares of Common Stock from the shares of Common Stock otherwise issuable to the Participant as a result of the exercise or acquisition
of Common Stock under the Award, <I>provided, however</I>, that no shares of Common Stock are withheld with a value exceeding the maximum
amount of tax required to be withheld by law; or (c) delivering to the Company previously owned and unencumbered shares of Common Stock
of the Company.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 20; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">A-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->20<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">14.
<U>Adjustments Upon Changes in Stock</U>. In the event of changes in the outstanding Common Stock or in the capital structure of the
Company by reason of any stock or extraordinary cash dividend, stock split, reverse stock split, an extraordinary corporate transaction
such as any recapitalization, reorganization, merger, consolidation, combination, exchange, or other relevant change in capitalization
occurring after the Grant Date of any Award, Awards granted under the Plan and any Award Agreements, the exercise price of Options and
Stock Appreciation Rights, the Performance Goals to which Performance Share Awards and Cash Awards are subject, the maximum number of
shares of Common Stock subject to all Awards stated in Section 4 will be equitably adjusted or substituted, as to the number, price or
kind of a share of Common Stock or other consideration subject to such Awards to the extent necessary to preserve the economic intent
of such Award. In the case of adjustments made pursuant to this Section 14, unless the Committee specifically determines that such adjustment
is in the best interests of the Company or its Affiliates, the Committee shall, in the case of Incentive Stock Options, ensure that any
adjustments under this Section 14 will not constitute a modification, extension or renewal of the Incentive Stock Options within the
meaning of Section 424(h)(3) of the Code and in the case of Non-qualified Stock Options, ensure that any adjustments under this Section
14 will not constitute a modification of such Non-qualified Stock Options within the meaning of Section 409A of the Code. Any adjustments
made under this Section 14 shall be made in a manner which does not adversely affect the exemption provided pursuant to Rule 16b-3 under
the Exchange Act. The Company shall give each Participant notice of an adjustment hereunder and, upon notice, such adjustment shall be
conclusive and binding for all purposes.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">15.
<U>Effect of Change in Control</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">15.1
Unless otherwise provided in an Award Agreement, notwithstanding any provision of the Plan to the contrary:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="margin-left: 0.5in; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)
In the event of a Participant&rsquo;s termination of Continuous Service without Cause or for Good Reason during the 12-month period following
a Change in Control, notwithstanding any provision of the Plan or any applicable Award Agreement to the contrary, all outstanding Options
and Stock Appreciation Rights shall become immediately exercisable with respect to 100% of the shares subject to such Options or Stock
Appreciation Rights, and/or the Restricted Period shall expire immediately with respect to 100% of the outstanding shares of Restricted
Stock or Restricted Stock Units as of the date of the Participant&rsquo;s termination of Continuous Service.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 21; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">A-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->21<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="margin-left: 0.5in; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)
With respect to Performance Share Awards and Cash Awards, in the event of a Change in Control, all incomplete Performance Periods in
respect of such Awards in effect on the date the Change in Control occurs shall end on the date of such change and the Committee shall
(i) determine the extent to which Performance Goals with respect to each such Performance Period have been met based upon such audited
or unaudited financial information then available as it deems relevant and (ii) cause to be paid to the applicable Participant partial
or full Awards with respect to Performance Goals for each such Performance Period based upon the Committee&rsquo;s determination of the
degree of attainment of Performance Goals or, if not determinable, assuming that the applicable &ldquo;target&rdquo; levels of performance
have been attained, or on such other basis determined by the Committee.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">To
the extent practicable, any actions taken by the Committee under the immediately preceding clauses (a) and (b) shall occur in a manner
and at a time which allows affected Participants the ability to participate in the Change in Control with respect to the shares of Common
Stock subject to their Awards.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">15.2
In addition, in the event of a Change in Control, the Committee may in its discretion and upon at least 10 days&rsquo; advance notice
to the affected persons, cancel any outstanding Awards and pay to the holders thereof, in cash or stock, or any combination thereof,
the value of such Awards based upon the price per share of Common Stock received or to be received by other shareholders of the Company
in the event. In the case of any Option or Stock Appreciation Right with an exercise price (or SAR Exercise Price in the case of a Stock
Appreciation Right) that equals or exceeds the price paid for a share of Common Stock in connection with the Change in Control, the Committee
may cancel the Option or Stock Appreciation Right without the payment of consideration therefor.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">15.3
The obligations of the Company under the Plan shall be binding upon any successor corporation or organization resulting from the merger,
consolidation or other reorganization of the Company, or upon any successor corporation or organization succeeding to all or substantially
all of the assets and business of the Company and its Affiliates, taken as a whole.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">16.
<U>Amendment of the Plan and Awards</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">16.1
<U>Amendment of Plan</U>. The Board at any time, and from time to time, may amend or terminate the Plan. However, except as provided
in Section 14 relating to adjustments upon changes in Common Stock and Section 16.3, no amendment shall be effective unless approved
by the shareholders of the Company to the extent shareholder approval is necessary to satisfy any Applicable Laws. At the time of such
amendment, the Board shall determine, upon advice from counsel, whether such amendment will be contingent on shareholder approval.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">16.2
<U>Shareholder Approval</U>. The Board may, in its sole discretion, submit any other amendment to the Plan for shareholder approval.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 22; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">A-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->22<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.75in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">16.3
<U>Contemplated Amendments</U>. It is expressly contemplated that the Board may amend the Plan in any respect the Board deems necessary
or advisable to provide eligible Employees, Consultants and Directors with the maximum benefits provided or to be provided under the
provisions of the Code and the regulations promulgated thereunder relating to Incentive Stock Options or to the nonqualified deferred
compensation provisions of Section 409A of the Code and/or to bring the Plan and/or Awards granted under it into compliance therewith.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">16.4
<U>No Impairment of Rights</U>. Rights under any Award granted before amendment of the Plan shall not be impaired by any amendment of
the Plan unless (a) the Company requests the consent of the Participant and (b) the Participant consents in writing.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">16.5
<U>Amendment of Awards</U>. The Committee at any time, and from time to time, may amend the terms of any one or more Awards; <I>provided,
however</I>, that the Committee may not affect any amendment which would otherwise constitute an impairment of the rights under any Award
unless (a) the Company requests the consent of the Participant and (b) the Participant consents in writing.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">17.
<U>General Provisions</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">17.1
<U>Forfeiture Events</U>. The Committee may specify in an Award Agreement that the Participant&rsquo;s rights, payments and benefits
with respect to an Award shall be subject to reduction, cancellation, forfeiture or recoupment upon the occurrence of certain events,
in addition to applicable vesting conditions of an Award. Such events may include, without limitation, breach of non-competition, non-solicitation,
confidentiality, or other restrictive covenants that are contained in the Award Agreement or otherwise applicable to the Participant,
a termination of the Participant&rsquo;s Continuous Service for Cause, or other conduct by the Participant that is detrimental to the
business or reputation of the Company and/or its Affiliates.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">17.2
<U>Clawback</U>. Notwithstanding any other provisions in this Plan, the Company may cancel any Award, require reimbursement of any Award
by a Participant, and effect any other right of recoupment of equity or other compensation provided under the Plan in accordance with
any Company policies that may be adopted and/or modified from time to time (<B>&ldquo;Clawback Policy&rdquo;</B>). In addition, a Participant
may be required to repay to the Company previously paid compensation, whether provided pursuant to the Plan or an Award Agreement, in
accordance with the Clawback Policy. By accepting an Award, the Participant is agreeing to be bound by the Clawback Policy, as in effect
or as may be adopted and/or modified from time to time by the Company in its discretion (including, without limitation, to comply with
applicable law or stock exchange listing requirements).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">17.3
<U>Other Compensation Arrangements</U>. Nothing contained in this Plan shall prevent the Board from adopting other or additional compensation
arrangements, subject to shareholder approval if such approval is required; and such arrangements may be either generally applicable
or applicable only in specific cases.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 23; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">A-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->23<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.75in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">17.4
<U>Sub-Plans</U>. The Committee may from time to time establish sub-plans under the Plan for purposes of satisfying securities, tax or
other laws of various jurisdictions in which the Company intends to grant Awards. Any sub-plans shall contain such limitations and other
terms and conditions as the Committee determines are necessary or desirable. All sub-plans shall be deemed a part of the Plan, but each
sub-plan shall apply only to the Participants in the jurisdiction for which the sub-plan was designed.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">17.5
<U>Deferral of Awards</U>. The Committee may establish one or more programs under the Plan to permit selected Participants the opportunity
to elect to defer receipt of consideration upon exercise of an Award, satisfaction of performance criteria, or other event that absent
the election would entitle the Participant to payment or receipt of shares of Common Stock or other consideration under an Award. Deferrals
by Participants will be made in accordance with Section 409A of the Code. The Committee may establish the election procedures, the timing
of such elections, the mechanisms for payments of, and accrual of interest or other earnings, if any, on amounts, shares or other consideration
so deferred, and such other terms, conditions, rules and procedures that the Committee deems advisable for the administration of any
such deferral program.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">17.6
<U>Unfunded Plan</U>. The Plan shall be unfunded. Neither the Company, the Board nor the Committee shall be required to establish any
special or separate fund or to segregate any assets to assure the performance of its obligations under the Plan.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">17.7
<U>Recapitalizations</U>. Each Award Agreement shall contain provisions required to reflect the provisions of Section 14.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">17.8
<U>Delivery</U>. Upon exercise of a right granted under this Plan, the Company shall issue Common Stock or pay any amounts due within
a reasonable period of time thereafter. Subject to any statutory or regulatory obligations the Company may otherwise have, for purposes
of this Plan, 30 days shall be considered a reasonable period of time.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">17.9
<U>No Fractional Shares</U>. No fractional shares of Common Stock shall be issued or delivered pursuant to the Plan. The Committee shall
determine whether cash, additional Awards or other securities or property shall be issued or paid in lieu of fractional shares of Common
Stock or whether any fractional shares should be rounded, forfeited or otherwise eliminated.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">17.10
<U>Other Provisions</U>. The Award Agreements authorized under the Plan may contain such other provisions not inconsistent with this
Plan, including, without limitation, restrictions upon the exercise of Awards, as the Committee may deem advisable.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 24; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">A-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->24<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.75in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">17.11
<U>Section 409A</U>. The Plan is intended to comply with Section 409A of the Code to the extent subject thereto, and, accordingly, to
the maximum extent permitted, the Plan shall be interpreted and administered to be in compliance therewith. Any payments described in
the Plan that are due within the &ldquo;short-term deferral period&rdquo; as defined in Section 409A of the Code shall not be treated
as deferred compensation unless Applicable Laws require otherwise. Notwithstanding anything to the contrary in the Plan, to the extent
required to avoid accelerated taxation and tax penalties under Section 409A of the Code, amounts that would otherwise be payable and
benefits that would otherwise be provided pursuant to the Plan during the six (6) month period immediately following the Participant&rsquo;s
termination of Continuous Service shall instead be paid on the first payroll date after the six-month anniversary of the Participant&rsquo;s
separation from service (or the Participant&rsquo;s death, if earlier). Notwithstanding the foregoing, neither the Company nor the Committee
shall have any obligation to take any action to prevent the assessment of any additional tax or penalty on any Participant under Section
409A of the Code and neither the Company nor the Committee will have any liability to any Participant for such tax or penalty.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">17.12
<U>Disqualifying Dispositions</U>. Any Participant who shall make a &ldquo;disposition&rdquo; (as defined in Section 424 of the Code)
of all or any portion of shares of Common Stock acquired upon exercise of an Incentive Stock Option within two years from the Grant Date
of such Incentive Stock Option or within one year after the issuance of the shares of Common Stock acquired upon exercise of such Incentive
Stock Option (a &ldquo;<B>Disqualifying Disposition</B>&rdquo;) shall be required to immediately advise the Company in writing as to
the occurrence of the sale and the price realized upon the sale of such shares of Common Stock.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">17.13
<U>Section 16</U>. It is the intent of the Company that the Plan satisfy, and be interpreted in a manner that satisfies, the applicable
requirements of Rule 16b-3 as promulgated under Section 16 of the Exchange Act so that Participants will be entitled to the benefit of
Rule 16b-3, or any other rule promulgated under Section 16 of the Exchange Act, and will not be subject to short-swing liability under
Section 16 of the Exchange Act. Accordingly, if the operation of any provision of the Plan would conflict with the intent expressed in
this Section 17.13, such provision to the extent possible shall be interpreted and/or deemed amended so as to avoid such conflict.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">17.14
<U>Beneficiary Designation</U>. Each Participant under the Plan may from time to time name any beneficiary or beneficiaries by whom any
right under the Plan is to be exercised in case of such Participant&rsquo;s death. Each designation will revoke all prior designations
by the same Participant, shall be in a form reasonably prescribed by the Committee and shall be effective only when filed by the Participant
in writing with the Company during the Participant&rsquo;s lifetime.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">17.15
<U>Expenses</U>. The costs of administering the Plan shall be paid by the Company.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">17.16
<U>Severability</U>. If any of the provisions of the Plan or any Award Agreement is held to be invalid, illegal or unenforceable, whether
in whole or in part, such provision shall be deemed modified to the extent, but only to the extent, of such invalidity, illegality or
unenforceability and the remaining provisions shall not be affected thereby.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">17.17
<U>Plan Headings</U>. The headings in the Plan are for purposes of convenience only and are not intended to define or limit the construction
of the provisions hereof.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">17.18
<U>Non-Uniform Treatment</U>. The Committee&rsquo;s determinations under the Plan need not be uniform and may be made by it selectively
among persons who are eligible to receive, or actually receive, Awards. Without limiting the generality of the foregoing, the Committee
shall be entitled to make non-uniform and selective determinations, amendments and adjustments, and to enter into non-uniform and selective
Award Agreements.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">18.
<U>Effective Date of Plan</U>. The Plan shall become effective as of the Effective Date, but no Award shall be exercised (or, in the
case of a stock Award, shall be granted) unless and until the Plan has been approved by the shareholders of the Company, which approval
shall be within twelve (12) months before or after the date the Plan is adopted by the Board.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">19.
<U>Termination or Suspension of the Plan</U>. The Plan shall terminate automatically on January 25, 2033. No Award shall be granted pursuant
to the Plan after such date, but Awards theretofore granted may extend beyond that date. The Board may suspend or terminate the Plan
at any earlier date pursuant to Section 16.1 hereof. No Awards may be granted under the Plan while the Plan is suspended or after it
is terminated.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">20.
<U>Choice of Law</U>. The law of the State of Nevada shall govern all questions concerning the construction, validity and interpretation
of this Plan, without regard to such state&rsquo;s conflict of law rules.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 25; Options: Last -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">A-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->25<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-23.1
<SEQUENCE>6
<FILENAME>ex23-1.htm
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Exhibit
23.1</B></FONT></P>

<P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">&nbsp;<IMG SRC="ex23-1_001.jpg" ALT=""></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<P STYLE="border-top: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"></P>

<P STYLE="border-bottom: Black 1pt solid; font: italic 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal"><B>CONSENT
OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
consent to the incorporation by reference in this Form S-1 Registration Statement of Sharps Technology, Inc. filed under the Securities
Act of 1933, of our report dated March 30, 2023, with respect to our audit of the consolidated financial statements of Sharps Technology
Inc. as of December 31, 2022 and 2021, and for the years then ended, originally appearing in the Annual Report on Form 10-K of Sharps
Technology, Inc. for the years ended December 31, 2022 and 2021, as filed with the U.S. Securities and Exchange Commission.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
also consent to the reference to our Firm under the heading &ldquo;Experts&rdquo; in such Registration Statement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><IMG SRC="ex23-1_002.jpg" ALT=""></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">CHARTERED
PROFESSIONAL ACCOUNTANTS</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Vancouver,
Canada</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">January
21, 2025</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"></P>


<!-- Field: Page; Sequence: 1; Options: Last -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->




</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-23.2
<SEQUENCE>7
<FILENAME>ex23-2.htm
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Exhibit
23.2</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left"><IMG SRC="ex23-2_001.jpg" ALT="">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><U>Independent
Registered Public Accounting Firm&rsquo;s Consent</U></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: -0.05pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
consent to the inclusion in this Registration Statement of Sharps Technology, Inc. Form S- 1/A filed under the Securities Act of 1933,
as amended, of our report dated March 28, 2024, with respect to our audit of the consolidated financial statements of Sharps Technology
Inc. as of December 31, 2023, and for the year then ended, originally appearing in the Annual Report on Form 10-K of Sharps Technology,
Inc. for the year ended December 31, 2023. We also consent to the reference to our Firm under the heading &quot;Experts&quot; in such
Registration Statement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><IMG SRC="ex23-2_002.jpg" ALT=""></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: left"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">New
York, New York</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">January
21, 2025</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">*
* * * *</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">PKF
O'CONNOR DAVIES, LLP</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">245
Park Avenue, New York, NY 10167 | Tel: 212.867.8000 or 212.286.2600 | Fax: 212.286.4080 | www.pkfod.com</FONT></P>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">PKF
O'Connor Davies, LLP is a member firm of the PKF International Limited network of legally independent firms and does not accept any
responsibility or liability for the actions or inactions on the part of any other individual member firm or firms.</FONT></P>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-right: 0; margin-bottom: 0; text-align: left"></P>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<!-- Field: Page; Sequence: 1; Options: Last -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-24.1
<SEQUENCE>8
<FILENAME>ex24-1.htm
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Exhibit
24.1</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>POWER
OF ATTORNEY</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">KNOW
ALL PERSONS BY THESE PRESENTS, that each person whose signature appears below hereby constitutes and appoints Robert M. Hayes, as his
true and lawful attorney-in-fact and agent with full power of substitution, for him in any and all capacities, to sign any and all amendments
to this registration statement (including post-effective amendments or any abbreviated registration statement and any amendments thereto
filed pursuant to Rule 462(b) increasing the number of securities for which registration is sought), and to file the same, with all exhibits
thereto and other documents in connection therewith, with the Securities and Exchange Commission, granting unto said attorney-in-fact,
proxy and agent full power and authority to do and perform each and every act and thing requisite and necessary to be done in connection
therewith, as fully for all intents and purposes as he or she might or could do in person, hereby ratifying and confirming all that said
attorney-in-fact, proxy and agent, or his substitute, may lawfully do or cause to be done by virtue hereof.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Pursuant
to the requirements of the Securities Act of 1933, this registration statement on Form S-1 has been signed by the following persons in
the capacities and on the dates indicated.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif; border-bottom: Black 1pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Signature</B></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Title</B></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Date</B></FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif; border-bottom: Black 1pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>/s/
    Robert M. Hayes</I></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Chief
    Executive Officer and Director</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">January
    22, 2025</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Robert
    M. Hayes</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(<I>Principal
    Executive Officer)</I></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif; border-bottom: Black 1pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>/s/
    Andrew R. Crescenzo</I></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Chief
    Financial Officer</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">January
    22, 2025</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Andrew
    R. Crescenzo</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(<I>Principal
    Financial and Accounting Officer)</I></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif; border-bottom: Black 1pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>/s/
    Dr. Soren Bo Christiansen*</I></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Chairman</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">January
    22, 2025</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Dr
    Soren Bo Christiansen</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif; border-bottom: Black 1pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>/s/
    Paul K. Danner*</I></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Director</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">January
    22, 2025</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Paul
    K. Danner</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif; border-bottom: Black 1pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>/s/
    Timothy J. Ruemler*</I></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Director</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">January
    22, 2025</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Timothy
    J. Ruemler</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif; border-bottom: Black 1pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>/s/
    Brenda Baird Simpson*</I></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Director</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">January
    22, 2025</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Brenda
    Baird Simpson</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif; border-bottom: Black 1pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>/s/
    Jason L Monroe* </I></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Director</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">January
    22, 2025 </FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Jason
    L Monroe</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 5%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">*
    By:</FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; width: 32%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>/s/
    Robert M. Hayes</I></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 2%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 41%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 2%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; width: 18%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">January
    22, 2025 </FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Robert
    M. Hayes </FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Attorney-in-fact</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 1; Options: Last -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>




</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-FILING FEES
<SEQUENCE>9
<FILENAME>ex107.htm
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Exhibit 107</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Calculation of Filing Fee Tables</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><U>S-1</U></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(Form Type)</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><U>Sharps Technology, Inc.</U></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(Exact Name of Registrant as Specified in its Charter)</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Table 1: Newly Registered and Carry Forward Securities</U></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="text-align: center">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Security<BR> Type</TD><TD STYLE="font-weight: bold; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="font-weight: bold; text-align: center; border-bottom: Black 1pt solid">Security<BR> Class Title</TD><TD STYLE="font-weight: bold; padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1pt solid">Fee<BR> Calculation<BR> or Carry<BR> Forward<BR> Rule</TD><TD STYLE="padding-bottom: 1pt; font-weight: bold">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1pt solid">Amount<BR> Registered</TD><TD STYLE="padding-bottom: 1pt; font-weight: bold">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1pt solid">Proposed<BR> Maximum<BR> Offering<BR> Price Per<BR> Share</TD><TD STYLE="padding-bottom: 1pt; font-weight: bold">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Maximum<BR> Aggregate<BR> Offering<BR> Price<SUP>(1)(2)</SUP></B></FONT></TD><TD STYLE="padding-bottom: 1pt; font-weight: bold">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1pt solid">Fee Rate</TD><TD STYLE="padding-bottom: 1pt; font-weight: bold">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1pt solid">Amount of<BR> Registration<BR> Fee</TD><TD STYLE="padding-bottom: 1pt; font-weight: bold">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left; width: 18%">Fees to be Paid</TD><TD STYLE="width: 2%">&nbsp;</TD>
    <TD STYLE="text-align: center; width: 6%">Equity</TD><TD STYLE="width: 2%; font-weight: bold">&nbsp;</TD>
    <TD STYLE="width: 12%; font-weight: bold; text-align: center">Units consisting of: (3)(4)</TD><TD STYLE="width: 2%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 6%; text-align: right">457</TD><TD STYLE="width: 1%; text-align: left">(o)</TD><TD STYLE="width: 2%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 6%; text-align: right">&mdash;</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 2%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 6%; text-align: right">&mdash;</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 2%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">$</TD><TD STYLE="width: 6%; text-align: right"> 17,250,000 </TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 2%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">$</TD><TD STYLE="width: 6%; text-align: right">0.00015310</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 2%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">$</TD><TD STYLE="width: 6%; text-align: right"> 2,640.98 </TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left">Fees to be Paid</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center">Equity</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center">(i) Common stock, $0.0001 par value per share(5)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&mdash;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&mdash;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&mdash;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&mdash;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&mdash;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&mdash;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left">Fees to be Paid</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center">Equity</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center">(ii) One Series A Warrant to purchase one share of Common Stock(5)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&mdash;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&mdash;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&mdash;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&mdash;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&mdash;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&mdash;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left">Fees to be Paid</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center">Equity</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center">(iii) One Series B Warrants to purchase a number of shares of Common Stock(5)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&mdash;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&mdash;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&mdash;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&mdash;</TD><TD STYLE="text-align: left"><SUP>(3)</SUP></TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&mdash;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&mdash;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left">Fees to be Paid</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center">Equity</TD><TD STYLE="font-weight: bold">&nbsp;</TD>
    <TD STYLE="font-weight: bold; text-align: center">Pre-Funded Units consisting of: (3)(4)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">457</TD><TD STYLE="text-align: left">(o)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&mdash;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&mdash;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&mdash;</TD><TD STYLE="text-align: left"><SUP>(3)</SUP></TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&mdash;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&mdash;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left">Fees to be Paid</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center">Equity</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center">(i) Pre-Funded Warrants to purchase shares of Common Stock(5)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&mdash;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&mdash;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&mdash;</TD><TD STYLE="text-align: left"><SUP>(3)</SUP></TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&mdash;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&mdash;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left">Fees to be Paid</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center">Equity</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center">(ii) One Series A Warrants to purchase one share of Common Stock(5)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&mdash;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&mdash;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&mdash;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&mdash;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&mdash;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&mdash;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left">Fees to be Paid</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center">Equity</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center">(iii) One Series B Warrant to purchase shares of Common Stock(5)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&mdash;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&mdash;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&mdash;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&mdash;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&mdash;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&mdash;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left">Fees to be Paid</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center">Equity</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center">Common stock underlying the Series A Warrants included as part of Units and Pre-Funded Units(6)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">457</TD><TD STYLE="text-align: left">(g)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&mdash;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&mdash;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right"> 21,562,500 </TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">0.00015310</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right"> 3,301.21 </TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left">Fees to be Paid</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center">Equity</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center">Common stock underlying the Series B Warrants included as part of Units and Pre-Funded Units(7)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">457</TD><TD STYLE="text-align: left">(g)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&mdash;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&mdash;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right"> 21,562,500 </TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">0.00015310</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right"> 3,301.21 </TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left">Fees Previously Paid</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center">&mdash;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center">&mdash;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&mdash;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&mdash;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&mdash;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&mdash;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&mdash;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right"> 8,037.75 </TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left">Carry Forward Securities</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center">&mdash;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center">&mdash;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&mdash;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&mdash;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&mdash;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&mdash;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&mdash;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&mdash;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-weight: bold; text-align: left; padding-bottom: 1pt">Total Offering Amounts</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="text-align: center; padding-bottom: 1pt">&nbsp;</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="text-align: center; padding-bottom: 1pt">&nbsp;</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1pt; text-align: right">&nbsp;</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1pt; text-align: right">&nbsp;</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1pt; text-align: right">&nbsp;</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="padding-bottom: 1pt; text-align: left">$</TD><TD STYLE="padding-bottom: 1pt; text-align: right"> 60,375,000 </TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1pt; text-align: right">&nbsp;</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">$</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right"> 9,243.41 </TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-weight: bold; text-align: left; padding-bottom: 1pt">Total Fees Previously Paid</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="text-align: center; padding-bottom: 1pt">&nbsp;</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="text-align: center; padding-bottom: 1pt">&nbsp;</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1pt; text-align: right">&nbsp;</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1pt; text-align: right">&nbsp;</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1pt; text-align: right">&nbsp;</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1pt; text-align: right">&nbsp;</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1pt; text-align: right">&nbsp;</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right"> 8,037.75 </TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-weight: bold; text-align: left; padding-bottom: 1pt">Total Fee Offset</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="text-align: center; padding-bottom: 1pt">&nbsp;</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="text-align: center; padding-bottom: 1pt">&nbsp;</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1pt; text-align: right">&nbsp;</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1pt; text-align: right">&nbsp;</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1pt; text-align: right">&nbsp;</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1pt; text-align: right">&nbsp;</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1pt; text-align: right">&nbsp;</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">&mdash;</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-weight: bold; text-align: left; padding-bottom: 2.5pt">Net Fee Due</TD><TD STYLE="padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="text-align: center; padding-bottom: 2.5pt">&nbsp;</TD><TD STYLE="padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="text-align: center; padding-bottom: 2.5pt">&nbsp;</TD><TD STYLE="padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="padding-bottom: 2.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 2.5pt; text-align: right">&nbsp;</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="padding-bottom: 2.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 2.5pt; text-align: right">&nbsp;</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="padding-bottom: 2.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 2.5pt; text-align: right">&nbsp;</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="padding-bottom: 2.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 2.5pt; text-align: right">&nbsp;</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="padding-bottom: 2.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 2.5pt; text-align: right">&nbsp;</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right"> 1,205.66 </TD><TD STYLE="padding-bottom: 2.5pt; text-align: left">&nbsp;</TD></TR>
  </TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" ALIGN="CENTER" STYLE="font: 10pt Times New Roman, Times, Serif; width: 90%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(1)</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Estimated
    solely for the purpose of calculating the amount of the registration fee pursuant to Rule 457(o) under the Securities Act of 1933,
    as amended (the &ldquo;Securities Act&rdquo;).</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(2)</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Pursuant
    to Rule 416(a) under the Securities Act of 1933, this registration statement shall also cover an indeterminate number of shares that
    may be issued and resold resulting from stock splits, stock dividends or similar transactions.</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(3)</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
    accordance with Rule 416(a), the Registrant is also registering an indeterminate number of additional shares that shall be issuable
    pursuant to Rule 416 to prevent dilution resulting from share splits, share dividends or similar transactions.</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(4)</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
    proposed maximum offering price of the units proposed to be sold in the offering will be reduced on a dollar-for-dollar basis based
    on the offering price of any pre-funded units offered and sold in the offering, and as such the proposed aggregate maximum offering
    price of the units together with the pre-funded units (including shares of common stock issuable upon exercise of the pre-funded
    warrants), if any, is $15,000,000.</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(5)</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">No
    separate registration fee required pursuant to Rule 457(g) under the Securities Act of 1933, as amended (the &ldquo;Securities Act&rdquo;).</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(6)</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
    Series A Warrants are exercisable at a price per share equal to 125% of the share offering price.</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(7)</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
    Series B warrants are exercisable at a price per share equal to 125% of the share offering price.</FONT></TD></TR>
  </TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<!-- Field: Page; Sequence: 1; Options: Last -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>10
<FILENAME>forms-1_001.jpg
<TEXT>
begin 644 forms-1_001.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  H'!PD'!@H)" D+"PH,#QD0#PX.
M#QX6%Q(9)" F)2,@(R(H+3DP*"HV*R(C,D0R-CL]0$! )C!&2T4^2CD_0#W_
MVP!# 0L+"P\-#QT0$!T]*2,I/3T]/3T]/3T]/3T]/3T]/3T]/3T]/3T]/3T]
M/3T]/3T]/3T]/3T]/3T]/3T]/3T]/3W_P  1" !Q 0X# 2(  A$! Q$!_\0
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MK7?2C.,;3=SBJ2C*5XHZGX=7#0>,K95)VRHZL/PS2?$?_D=+K_<3_P!!J_\
M"_2Y+G7GORI\FV0KG_:/&/RJA\1_^1TNO]Q/Y5@FGB-.QLTUAU?N<O77^%?
MO_"2Z6UW]N,&V0IM\O=T]\UR%>N?"S_D6)?^OAJO%5)0IWB]2<+34ZEI'*^)
MO )\.Z0;_P"W>=AU39Y>WK[YKC3UKV/XG<>#VQ_SV3^M>.=Z6%J2G"\F&*IJ
M$[(Z3X?_ /(YV/U;_P!!->H^++OR=,$(.#*<?AWKR[X?G_BM+'_@7_H)KN/%
MMT9M4$(/RPKC\37D9W4Y(NW4]G(Z7M)I=C#H'4?6BK^C:>FI7X@D9E7!.5ZU
M\A3@YR45U/L*DU"+E+9%6Z_X^I/K45;'B+2TTV>,H[MYN2<]JQQS5UH.G-QD
M10J1J4U*.QH:%=_8]6AD)PK'8WT-=7XJP?"NH^GD-_*N$!(.1P177:G=_;/
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MHW!2XM?(40AB<'E\X8#V%<E2I.KJSKI4X4M$;]%%%8'2%%%% !1110 4444
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MM=C15.M.6Y*HQ6Q5L4N%LHEOFCDN0/WC1C"D^PJQCT%.HK(VL%%%% !1110
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J:?\ >3^8HHJ(?:+E]@BNO^0W:?1ZU>]%%:4=Y>IC4VB*.E+1170C,__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>11
<FILENAME>form10-k_002.jpg
<TEXT>
begin 644 form10-k_002.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  ," @," @,# P,$ P,$!0@%!00$
M!0H'!P8(# H,# L*"PL-#A(0#0X1#@L+$!80$1,4%145# \7&!84&!(4%13_
MVP!# 0,$! 4$!0D%!0D4#0L-%!04%!04%!04%!04%!04%!04%!04%!04%!04
M%!04%!04%!04%!04%!04%!04%!04%!3_P  1" !C ,T# 2(  A$! Q$!_\0
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MWG*Y/@"Z9FW _P#+Q#R:^SX_^"KOPJAM%LX_!?B2*U6/REMUAM0BIC&T+YN
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-<444P&CO3Z**2 __V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>12
<FILENAME>form10-k_004.jpg
<TEXT>
begin 644 form10-k_004.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  ," @," @,# P,$ P,$!0@%!00$
M!0H'!P8(# H,# L*"PL-#A(0#0X1#@L+$!80$1,4%145# \7&!84&!(4%13_
MVP!# 0,$! 4$!0D%!0D4#0L-%!04%!04%!04%!04%!04%!04%!04%!04%!04
M%!04%!04%!04%!04%!04%!04%!04%!3_P  1"  @ 08# 2(  A$! Q$!_\0
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MEW=.0D$"#NTDC(H^M1_ /2?&NB_"+PU!\1=6_MGQJ]N;C4[A45%261B_DKM
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M'PEX^3P1\./%,\-YJ&E:+IB1ZC Z6\=NT%K<[MD$3I$A)$9=3G:1G->=6O[
M_BK6/V?[[X<>*_&MC?6.EZ5-I_AC2--MY(-.2X)9H[^^&=\\Y9LX^XG+!6;D
M %C4M1\7_&3]G7P;X9\4:E<VWB;XR:U]K%K#A)-%T7<+ITBX_P"65M'&NYLG
MS)QGKBNH^$MCK?AG]K?5_"FF>/\ Q=XW\/Z)X8$GB)_$U\MQ%;W\\Z-9QQ[(
MT5)/)65F 'W64FNY^!OP9\3Z/XFD\=_$>[TRZ\6C38]$TS2M$#G3]$L%*EHH
M6?#222,JL\A ^ZJ@87G@/"?PO^/?PY\3^/K'PI;>!TM/%'B6[UV3QCK%S<SW
M(BEVB.,V:JN6BC54 \T+A?>@# _:R^+GBKQM\0!\*? 6MW>A/#+:V-Y>:5-Y
M5Y=ZE<X>&VB<<I%;P![NX8?PB-,C><]7^UO\;CX U#X?^#[#5[VSD;6M,U#Q
M1K%F^TZ7HZ74<;2W##[BSRLD?NIE["N9\)_L>_%#P#\2/%_B'1O&WABXU7Q1
M.9[WQQJ6E2RZQ;+)&BS16MLKBVA&Y 0W)("!@VT5NM^PSJO]D>)]%_X7'XAN
M-(\6,W_"12WNE6%QJ.J(T?EF.2[:+<$"[@JA<(&.W'6@#ZL4AE!4@@\@BE)P
M":\IU#Q]I?P?\2?"OX6:98WVM7>KQ264'^D"26TLK2W&ZZG9N67/EIDXRS\9
MZ5ZMSCCK0!\Q:C%)^TO^TM]@E/\ Q;?X3WT<MPK?<U7Q$8PT:8/5+5'#'_II
M(/[M=-^UA\7;SP9X"L/#GA/4;6W\<>-KW^P-$NI)56.S=E)GNW8G $$6]\=2
MP0=ZO^,OV-?@YX^\77GB;6_!<-SK%ZYENI8;RYMTN)" /,DCCD5&?  W$9/>
MI-+_ &-_@GH^BWND0_#?0Y=+O98YY[2\A-S&TB!@K@2EMK88\K@G/.: +?AG
M5OAW^SG\%[+2K37M.B\/>%M'=RWVN-I9HX8R\LI ;+.Q#,<=68U\_?L^? WX
MMZYX7O\ XF:7\1K7P/K?Q1F_M_6K6Z\.1W]S:1.3]EBMYFD7;LMR@"R*X#$X
M%>]1_L>_!.#1=1TJV^&/ANRL]0C\FY%I8)"\B9!*^8F& .T9 (R.#7KMO!':
MV\<,,:PQ1J$2-  JJ!@  = !0!PGP;^"^B?!7P]=V&F7%[JFI:E=-J&K:YJL
9OG7NIW3 !IIGP,G  "@!5   HKOZ* /_V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>13
<FILENAME>form10-k_001.jpg
<TEXT>
begin 644 form10-k_001.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  ," @," @,# P,$ P,$!0@%!00$
M!0H'!P8(# H,# L*"PL-#A(0#0X1#@L+$!80$1,4%145# \7&!84&!(4%13_
MVP!# 0,$! 4$!0D%!0D4#0L-%!04%!04%!04%!04%!04%!04%!04%!04%!04
M%!04%!04%!04%!04%!04%!04%!04%!3_P  1"  Q DH# 2(  A$! Q$!_\0
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M\J0R&:7>%5B0O(QQZ5^A0Z5RXBB\/4=-N]C:G/VD>9"T445SF@4444 %%%%
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M $ 5HU\;>TK^9]?'X4?"O_!*GP[JWA[P+X[CU;2K[2I)-0M61+ZV>$L!"02
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MH **** "O(/B=\1O'?A'Q]X9T'1=%\/W]GXCN9+2RN+Z^GBDCDCMGG<R*L3
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MKI_#?P/A\.ZX^MGQ9XAU#6YKF"2[O[JXCWW4$*R+%:N%C"^2/-9B% );DDT
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M=M&TG+%44*"?? H ^/O%?_(U:U_U^S?^AFLJBBON8?!'T/SR?QR]6"_ZR/\
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
5HHH **** "BBB@ HHHH **** /_9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>14
<FILENAME>form10-k_005.jpg
<TEXT>
begin 644 form10-k_005.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  ," @," @,# P,$ P,$!0@%!00$
M!0H'!P8(# H,# L*"PL-#A(0#0X1#@L+$!80$1,4%145# \7&!84&!(4%13_
MVP!# 0,$! 4$!0D%!0D4#0L-%!04%!04%!04%!04%!04%!04%!04%!04%!04
M%!04%!04%!04%!04%!04%!04%!04%!3_P  1"  G .D# 2(  A$! Q$!_\0
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M\2_&3X@ZS\+? 'B)O!OA_P -1)=>./'L,@62P4J7%C;,1M$Q4;GD)_=K[\4
M?4/F>H(^M<?X,^,W@7XB>(-9T/PQXLTG7M7T8A=0L]/NDEDM\G'S 'ID$9'?
MBOBS2=%\1W?@OPK\&= \2>*(;#XG:Y?:N^J:Y?-/J=EX7@2/S7\T\H]T=NT8
M^47!&.M?0G[.?P_\+V_B74/$_@[1+/0?!FGV \,>'DLH507L$<N^XNV8#,BO
M*H5&8G(B+_\ +3- 'H?CWXAZWX1\<>!M$TSP3J7B2P\07DMO?ZQ9N!!H\:1[
MA)-P<ACP.G0\YP#WV<UYGX$^/WA7XE_$KQIX-\.M>7UWX2,4>IZDL(^PK.^[
M,"RY^:1=IW#&!Z\5Y/X!_:@\7_$/XA:/K%CI&BVOP;UC6;WP]I=W/-)_:M_+
M;PS.U\@SY:VY>WE0 _-C#'% 'U(3CMFO-/VAOC=8? #X4ZMXON[5M3NH3';:
M?I,;[9=0O)6"0P)P3EF/8' !..*^+?''[57C#]M#QQIO@7X5?#W6[OP]X7U2
M+4_%B7&K6U@UX(I#Y%L)U9E6-I$W,5)+!.!QDZ&M'XS?M/?M;:+I6H:/X+\.
MQ_"F./6;C3;B^GU2T6\NE(@,IC6/=/&J^8J\*..?FH ^_?#MW>W^@Z=<ZC9_
MV?J$UM'+<V@?>()60%X]W?:21GOBM&LCPK::Q8:';PZ_J5OJVK#)GN[6T^RQ
M.220%C+N5 &!RQ)QFM>@!*%;/;%8'C[QUH_PT\%:WXJ\070L]&T>TDO+J8]0
MBC. .Y/0#N2!7F/[)MUXX\3> ;[QQX]O)TO_ !A?-K&GZ'(PV:/IS*%M;=1V
M;RU5W_VG.><T >W4E>$^/?C7XAD_:4\$?"KP3#:7CB%];\7W=PA<6&G %(HP
M0?EEED/&>RYQ@YKU+XA^/-*^%_@;7?%>N3>1I.CVDEY<-W*J,[1ZLQPH'<D"
M@"]_PENB_P#"2'P[_:MG_;XMOMITOSU^T^1NV^;Y>=VS=QNQC-:GFK7Y?:XM
MEXJ^)7P]\0^&M5N=?_:?U7Q1:ZMK!T.1[BTT'2G #Z=<NN8TBBM\*5)W,PD)
MZU^H>: /"OVN_B%H?P7^%E]XU;1;+5/&X"Z5X8,EHDMT^HSDK D;$;@ QWG!
M'"FO)O&7@6U_8N_X)_>++"S@DU'Q7?Z6\.I:A#"9)K_5K[$3RNPY*AY< GHJ
MCOU^M_$GA'1?&$-C%K>DV>K1V-W'?VRWD*RB&XC.8Y4R.'4]#U%:<UO'<0F*
M5%E1NJNH8'G/0T ?.WP\^'MO^RC^Q/=::(E&HZ'X7N=1U*6,D-/>BV9Y6))S
MG< H] J@= *^14\81_#/7_A/X5UKPW>^+-8\&^ M,NO!?A.SLWEAU?7+R,F>
M\8X*[+=5QN/0LY'-?H3\?/"^H>,_@?\ $'0-*C,VIZIX?OK.UB4@>9*\#JBY
M/ R2!GWI/@;<1ZS\(/ M^^FW.FW:Z):Q-;ZC:M!=6[+$JO&RL-RD,IX[XS0!
M\'_L9_%GQ)=?#.\\*_#N^_X2KXV^-M7NO$/BO6-1LW2P\+-(_EL]QP/,E C4
MK".K,1P!SJ? .Q^*WB[XQ?&CX6^%?B3K5_X+LM3MTUGX@ZI(9;Z&Y$6VZM[!
M?]7%))(6^8<1K&" 217Z%Z;H&G:,URVGZ?:6#W4AFG:V@6,S.>K/M W-[GFH
M/#WA'1?"C:DVCZ59Z6VI7;W]Z;.%8_M%PP :5\#YG(49)]* /B?X3_'SQ=X1
ML/%OP2\/7>I^./BW8^*]1TW2/^$B$DO]E:2&4PW]_.0-\85BRC[SDJ@XP:X;
MX!?![QEXN_:#^-V@>&M=U+1_!YO++2/%/CJ5S_:FKW-O&WVJ.V;)6-YI97+.
M ?+0(JX)%?HY#H]G;ZA<7\-I;Q7URJI-=)$HEE5?NAF RP'8$\5/#:QV^_RH
MTCWL7;8H&6/4GU/O0!^?'P5^,$?[/6B_$SX/>"-#N-3^*K>-=6/A_P )3),(
MK:R9%>"[EE<$>0(UWEMQ+L<=6S3?V2?VDM'\(_ FP\/>!]+U#X@?%C5/M7B#
MQ3<3PR6MAIU[-(S3S:C=,-L:Q@ ;4#,P0 #)K] ETBS74GU!;2W%^T?E&Z$2
M^:4!R%+XSC/;-);Z/9VD=Q'!9VT*7+,\ZQQ*HE8\$L /F)]Z /A3X.?&']J+
MXG?!/6_B=877AV]TZQU&ZU#2=-DTMDF\1V4;8,$7S#[/'M23RW.Z1V(W$#KY
M)X]_:NU?XM?M31^*/A?IVF>)5TOPBCZ7JNNNZ6/@W>KOJ-U=QE1B==JQ\GH
M!NW8K]1](TBQ\/Z7;:=IMG;Z=I]K&(H+6UC$<42#HJJ   /05^>G[06BW'[0
M^FZ59:?;1:+X?^(GBN/1_#VD:0BV[:A:P.6OM:OR@!F(CBE$4;_*H9&(+,,
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' **** /_V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>15
<FILENAME>forms-1_002.jpg
<TEXT>
begin 644 forms-1_002.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0@)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" !D C$# 2(  A$! Q$!_\0
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MD4RN"/N 9.,>IJ]#IEO ULRER;<.$W-G[QR<U'/HUK<%]^_YRY.&Z%@,D?\
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M_M):R_#&H2:7XO\ 'E_$-TEO#(Z#WWT."MIV0<UG8]IFOK6WD"3W,,3'HKN
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M% !THHHH *" >M%% !@>E)@ 8P*6B@!" >HI:** #%&*** #  QVHP/2BB@
MP,YQ1110 48'I110 F !C Q2XHHH ,8HHHH ,"D  Z 4M% !THHHH ,"BBB@
M Q5>XL;>[93/'O*]/F(_/'7\:L44 (%48P!P,=*7I110 8'I1@>E%% !@>E%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
? 4444 %%%% !1110 4444 %%%% !1110 4444 ?_V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>16
<FILENAME>ex5-1_001.jpg
<TEXT>
begin 644 ex5-1_001.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0@)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" M@&QT# 2(  A$! Q$!_\0
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M !1110 M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!0:*#0 E%%% !1110 4444 %%%% !1110 4444 %%%%(04444 %%%% !1110
M 444M PHHHI@%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 &DI324 %%%% !1110
M 4444 %%%% !1110 4444 %+244 +1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444"$-%!HH ****0!1110 4444 %%%% PHHHI
M@%%%% !1110 4444 %%%% "T444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% "4444 )1110 4444P%%+2"BD M%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !24M)0 4M)2T %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !24M)0 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 +110: "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@!**** "BBBF,**** "BBB@ I:2EI""BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH *2EI*!"BBDI:!A1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4E%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %+24M !10:* "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *2EI* "BBB@ HH
MHH **** "BBB@ HHHH *6DI: "BBB@ HHHH #24II* "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHI: "BBB@ HHHS0 44F:,T +1FFYI,T[#'YHS3-U)NHL!)FC-1
M[J-U%@'YHS3-U&ZBP#\T9IFZC=18!^:7-1[J-U%@),T9J/=1NHL!)FC-1[J-
MU%@),T9J/=1NHL!)FC-1[J-U%@),T9J/=1NHL!)FC-1[J-U%@),T9J/=1NHL
M!)FC-1[J-U%@),T9J/=1NHL!)FC-1[J-U%@),T9J/=1NHL!)FC-1[J-U%@),
MT9J/=1NHL!)FC-1[J-U%@),T9J/=1NHL!)FC-1[J-U%@),T9J/=1NHL!)FC-
M1[J-U%@),T9J/=1NHL!)FC-1[J-U%@),T9J/=1NHL!)FC-1[J-U%@),T9J/=
M1NHL!)FC-1[J-U%@),T9J/=1NHL!)FC-1[J-U%@),T9J/=1NHL!)FC-1[J-U
M%@),T9J/=1NHL!)FC-1[J-U%@),T9J/=1NHL!)FC-1[J-U%@),T9J/=1NHL!
M)FC-1[J-U%@L29HS4>ZC=18+$F:,U'NHW46"Q)FC-1[J-U%@L29HS4>ZC=18
M"3-&:CW4;J+ /S1FF;J-U%@'YI<U'NHW46 DS29IFZES18!^:,TS-+FBP"YH
MI,TM(04444QA1110 4444 %%%%(04444 %%%% !1110 4444 %%%% !24M)0
M 4444 %%%% "BB@44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444@"BBB@ HHHH **** "BBB@ HHHH ***
M*8!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%%( HHHH **** "BBB@ HHHI@%%%% !110: "DS12$T +FC--S2%J8#\T
M;JBW4F^@";=1NJ#?1OHL,GW4;J@W^]&^BP$^ZES4&^G;J=@)<T9J/=2[J5@)
M,T9J/=1NHL!)FC-1[J-U%@),T9J/=1NHL!)13-U&ZBP#\T9IN:,T6$+FBDS1
M2 6BDI: "BBBD 4444 %%%% !1110 4444P"BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH ****  TE*:2@ HHHH **** %HHHH **** "BBEH **
M** "BBB@ HHHH **** "BBB@ HHHH **3-&: %HIN:,TQV'49IN:3=18+#\T
M9IFZDW46 DS1FH]U&ZBP$F:,U'NHW46 DS1FF;J-U%@'T4S=2YHL%AU%-S2Y
MI"%HI,T9H 6BBB@ HHHH **** "BBB@ HHHH **** "DQ2T4@$HHHH ****
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M2T %%)1F@!:*,T9H **,TF: %HHS1F@ HI,T9H 6BDHS0 M%)FB@!:*3-&:
M%HHS10 4444 %%%% !1110 4444 %)2TE !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% "T4E% "T4E+F@ HHS1F@ H
MHS1F@ HHS29H 6@TE% !1113&%%%% !1110 4444 %+249I"%HHS1F@ HHS1
MF@ HHHS0 449HS0 449I* %HI** %HI*7- !11FC- !11FDH 6BDHH 6BDHH
M 6BDHH 6BDHH 6BDHS0 M%)FC- "T4F:,T +129HH 6BDS1F@!:*3-&: %HI
M** %HI** %HI** %HI** %HI** %HI,T9H 6BC-&: "BC-% !1110 449I*
M%I*** "BBB@ HHHH ,TM)10 M%)10 M%)FC- "T4E&: %HI** %HI,T9H 6B
MDHH 6BDHH ,T444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %**2B@!30*#10 4444 %%%% !111F@ HI,T9H 6B
MDS10 M%)1F@!:*2C- "T49HS0 4444 %%%% !1110 4E+24 %%%% !1110 4
M444 %%%% !1110 4M)2T %%%% !1110 &DI324 %%%% !1110 4444 %%%%
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MRJ'VCWH^T>]%@-#S*/,JAY_O3A/[TK"+PDIP>J(FIXEI6 N;Z4-542T\24K
M6,T[-0!Z>&I6 EHIH-.%(0M%)3J0"8HI:*0"4444 %)0:* "BBBF 4M)2T %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4F*6B@!,44M% "44M%
M !1110 4444 +10:* "BBB@ HHHH **** "BC--+4 .I,TPO3#)5)#L2DTA:
MH#)3#+[U7*,L[Z0O54S4TS4^4"WOIN^JAG]Z:9_>GR@7/,]Z3?[U2,_O2>?1
MRB+WF4GF51^T>])]HI\H%_S!1Y@]:H?:*3[1[T6 T/,'K1YGO5#[11]HHL!H
M>91YGO5#[1[THN/>ER@7_,I=]4/M%*)_>CE&7]]+OJB)_>E$_O1R@7M]+OJD
M)J<)O>ER@7-U+FJ@EIXEJ>419S2U )*<'I<H6):*8'IVZE8+"T49HI""BBB@
M HHHH **** $HHHH **** "BBB@ HHHH ***44 )BC%+10 E%%% !29I"::6
MI@/S2;JC+4TO3L,EW4;J@,E-,M.P%G=1NJKYM'G4^4"UNHW54\ZCSJ.4"WN%
M&ZJGG4>=1RC+>ZC=57SJ/-]Z.4"UNI=U5?-IPDHY1%C=1NJ#S*<'I6 FS1FH
M@U.#4K")**;FEI +124M( Q1BEHH 3%%+2&@ HHHH **** "BBB@ %+110 F
M*7%%%( HHHH ****8!1110 444F: %HII:FEZ=AV'YI":C,E,,M/E"Q-NI"]
M5S+[TPS>]5RC+1>F[ZJF:FF>GR@6]_O1YE4C/2&?WI\H%WS/>D\RJ)N/>D-Q
M[T6 O>9[T>9[U0^T4GVCWHL(T/,]Z/,]ZS_M'O2_:/>BP&AYE'F5G_:/>G"?
MWHL!?\REWU0\_P!Z7S_>CE O[Z7?5$3TX34N4"\'I0U4A-[T\2TN4"X&I<U5
M$M2"2I<1$U%1AZ<&I6 =129I:0!1110 4444 %%%% "&B@T4 %%%% !1BEHH
M 3%&*6B@!,44M% "4444 %%%(33 7-)FFDTA:G88_-)NJ(O33)3L!/NI-U5S
M+33+3Y0+6ZDWU5\[WI/.]Z.49;WT;ZJ>=[T>=[T^41;WT;JJ>=[TOG4N4"WN
MHW55\VE$M'*!:W4;JKB6G!Z5A$^:7-0AZ<&I6 DHIH-+FE8!:!112 **** "
MBEH-(0E%%% !1110 4444#"BBBF 4444 %%%% !1110 &DI324P"C-(329H
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M0 N:,TE% "YHS244 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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MA&RLM2K)64D_O5E)<U+0&@&IX-5$>IU:H:$34M-%.J!!1110 4E+10 E%%%
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M Z?[?[T?;_>N8^W^]'V_WHY0.G^W^]'V_P!ZYC[?[T?;_>CE Z?[?[T?;_\
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M,IJK&:LK6; D%+2"EJ1!2T44A!24M% "44M% "44M)0 4444 %%%% !1110
M4444 %%%% !1110 44E% "T4E% "TM)2YH **,T9H *#1FDH **** "BB@T
M%%)10 M%)10 M%)2T %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% "T49HS0 449HS0 4E+FDH **** "BBBD 4444 %%%% !1
M110 4444 %%%%, HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **!12 **** "BEHH 2EHHI@%%%% !3&I],:@
M")JKN:G>J\E4@*TC52F?K5F4\5GSMUJD!6FDZUGS38SS4]P_6LJXDZU:&-FN
M,=ZHRW..],GEZUF3SGUK1(9:DN_>J[WOO6;-<>]4I+K'>J2&;+7WO3/M_O6
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MMQO6-!-G'-:,,E0T(T%-257C:IP:R:$Q:***D04444 )112T )1110 4444
M%%%%( HHHH ***6F E+110 4444 )43FI3TJ!S30R%VJK(]32M5&9\5: CEE
M]ZI2SX[T3RXSS6;//C/-:) 2RW/O5*2[]ZJ3W/O6;-=X[U:0S3>\QWJ!KWWK
M%DO/>JSWOO5I = ;[WI/MWO7-F^]Z;]N]ZJP'4"^]ZF2]]ZY5;[WJS%>^]%@
M.LBN\]ZNQ7.<<URD%WTYK3M[G..:AH#IX9\]ZOPRYKGK>?..:U+>7.*S: VX
MGS5N,YK,@?-:,)K)B+0Z4M(*6LQ!1110 Q^E5I&Q5B3I5.9JI#()7JE++CO4
MDSXS6;/+C-:) )-/CO5":ZQWJ.XGQGFLJ>YQGFM4AER6[QWJI)>X[UF3W?7F
ML^6]]ZM(#:>_]ZA:_P#>N?DOO>J[7_O56&=*=0_VJ/[0_P!JN6-_[T?;_P#:
MI\H'5#4/>GB_]ZY07_\ M4];_P!Z?*,ZL7_O2_;_ 'KEQ?\ O3A?>]'*!T_V
M_P!Z/M_O7,?;O>C[=[T<H'3_ &_WH^W_ .U7,?;O>C[=[T<HSI_M_P#M4GV_
MWKF?MWO2?;O>CE Z?[?_ +5'V_\ VJYC[=[T?;O>CE$=/]O_ -JC[?\ [5<Q
M]N]Z/MWO1R@=/]O_ -JC[?\ [5<Q]N]Z/MWO1R@=/]O_ -JD^W^]<S]N]Z/M
MWO1R@=-]O]Z/M_O7,_;O>D^W^]/E Z?[?[T?;_>N8^W^]'V[WHY0.H^W_P"U
M1]O]ZYC[=[T?;O>CE Z?[?[TOV_WKF/MWO2B^]Z.4#I_MWO2_;O>N8%][THO
MO>CE Z?[=[TOV[WKF1?>]*+[_:HY0.F^W>]+]N]ZYD7W^U3OMWO1R@=)]N]Z
M7[;[US7V[WI?MWO1R@=']N]Z3[=[USGV[WI/MWO1R@=)]N]Z3[=[US?V[_:I
M/MW^U1R@=+]N_P!JC[=_M5S7V[_:H^W>]+E Z47W^U3A>^]<P+[WIZWWO2Y0
M.J2]]ZL1W?O7*QWOO5R*\]ZEQ ZF*ZSWJ[%<9[US$%UGO6E!<9QS6;0CHXIL
M]ZO125A039[UIP29Q6;0C6C:K2&J$+9J]'TK-B):***@1&]5Y&JQ)5*9JM%%
M>62J,TV,\U+/)C-9=Q-C/-:) )-<8[U1ENL=Z@N+C&>:S)[KWK5(9?DO/>J[
M7OO61+>>]5'O?>M%$#=-][TPWWO7/-?>]1F^]Z?*!T9OO]JD^W>]<T;[WI/M
M_O1RC.G%][U(M][URJW_ +U.E][TK".J2\]ZL1W?O7+1WOO5R*[]ZFP'3QW6
M>]6XKCWKFHKK..:T(;CWI-".ABF]ZN1RYK"AFZ<UH0RYJ&@-B-ZLHU9L3U=C
M:LVA%Q34JU70U.M9L!]+114B"BBB@!**6DH **** "BBB@ HHHH **** "BE
MHH 2BEHH **** "BBB@!K57D:II#525L52&0ROBJ4LV.]/GDQFLR>?'>M$AC
MI;C'>J4MUCO5>>YQGFLR:[QWK5(9?DN_>J[WGO63+>>]4Y+WWK11&;;7OO49
MO?>L![[WJ)K[WJN4#H3?>]-^W>]<X;[WIIOO]JGRC.E^W>]+]N]ZYG[=[TOV
M[_:JN41TOV[WI/MWO7-_;O\ :I#?>]'*!TGV[_:I1?>]<S]N]Z47WO2Y0.I6
M^]ZF2]]ZY5;[WJ=+WWJ7$1U:7GO5J*[]ZY6*]]ZNPW?O4- =3%<^]78I_>N9
MANO>M*"XSCFH:$=!%+5N.2L6&;WK0ADS630C41JF4U3B>K2&LV!,.E+2#I2U
M(@I*6B@!**6DH **** "BBBD 4444 %%%%, HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ I:2E
MH **** "BBB@!&Z56E:IW/%4YFJDAE:9^M9MQ+C-6KA^M9%S+UK:*&5;F;&>
M:QKJXZ\U8NYNO-85W<=>:VBAD=U<]>:Q[F[Z\T7=QUYK$N;GKS6R0R:>[Z\U
MG2WG7FJD]SSUK.FN>O-6D,T)+SWJNUY[UE27/O5=KD^M7R@;/VSWH^V>]8?V
MGWI1<GUJN4#>%Y[TX7GO6"+CWIXN?>GRC-S[9[TOVSWK#^TGUI?M/O3Y0-S[
M9[T?;/>L/[3[TOVCWHY0-O[9[T?;/>L3[1[T?:/>CE&;?VSWH^V>]8GV@^M'
MV@^M'*!M_;/>C[9[UB?:?>D^T^]+E"QN?;/>C[9[UA_:?>C[3[T<H6-S[9[T
M?;/>L/[3[T?:?>CE"QN?;/>C[9[UA_:?>C[3[T<H6-S[9[T?;/>L3[3[T?:?
M>CE"QM_;/>C[9[UB?:?>C[3[T<H6-O[9[T?;/>L3[3[T?:?>CE"QM_;/>C[9
M[UB?:?>C[3[T<H6-O[9[T?;/>L3[3[T?:?>CE"QM_;/>C[9[UB?:?>C[3[T<
MH6-O[9[T?;/>L3[3[T?:?>CE"QM_;/>C[9[UB?:?>C[3[T<H6-O[9[T?;/>L
M3[0?6C[3[T^4#;^V>]'VSWK#^T^]'VGWHY0L;GVSWH^V>]8?VGWH^T^]'*%C
M<^V>]'VSWK#^T^]'VGWHY0L;GVSWH^V>]8?VGWH^T^]'*%C<^V>]'VSWK$^T
M^]'VCWHY0-O[9[T?;/>L3[1[T?:/>CE V_MGO1]L]ZQ/M'O1]H]Z.4#;^V>]
M'VSWK$^T>]'VCWHY0-O[9[T?;/>L3[1[T?:/>CE$;?VSWH^V>]8GVCWH^T>]
M'*%C;^V>]'VSWK$^T>]'VCWHY0L;?VSWH^V>]8GVCWH^T>]'*%C;^V>]'VSW
MK$^T>]'VCWHY0L;?VSWH^V>]8GVCWH^T>]'*!M_;/>C[9[UB?:/>C[1[T<HS
M;^V>]'VSWK$^T>]'VCWHY0-O[9[T?;/>L3[1[T?:/>CE V_MGO1]L]ZQ/M'O
M1]I]Z.41M_;/>C[9[UB?:3ZT?:?>ER@;?VSWH^V>]8?VGWH^T^]'*(W/MGO1
M]L]ZP_M/O1]I]Z.4#<^V>])]L]ZQ/M/O1]I/K1RC-O[9[T?;/>L3[3[TGVCW
MI\H&V;SWIAO/>L8W/O3#<^]+E V3>>]--Y[UBFY]Z8;GWJ'$EFZ+SWJ:*\]Z
MYT7/O4T5SSUJ; CK;>[Z<UM6ESG'-<9:W'3FMVSGZ<UFT!VMG/G'-=!9RYQ7
M&V,W3FNEL9.E9- =7:R9Q6S;MTKGK-^E;ELW K)H1KQ&K253A/%6TZ5DQ$PI
MPIJT\5FQ,****0@HHHH **** "DI:2@ HHHH **** "BBB@ HHHH **** "@
MT4&@!**** "BBB@ I:2EH **** "BBB@ HHHH *#10: $HHHH **** "EI*6
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MT*6D7I2UB2%%%% !1112 *,444 )1113 **** "BBB@ HHHH **** "BBB@
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MK]ZR///K2>>?6G8#8-W[TGVOWK(\\^M'GFBP&O\ :_>C[7[UD>>?6CSSZT6
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M+0W?O6A#=^]0X@=-%/[U<CF]ZYV&Z]ZT(KCIS630C<22IE>LJ*;/>K<<M9-
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M2]*6D7I2UB2PHHHH ****0!1110 E%%%, HHHH **** "BBB@ HHHH ****
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MXH92N)JS9IO>IKA^M9LS]:V2&-EF]ZJ//[TV62JCR5JD,G:?WIHGJJ7-)N-
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MS32^<?6JV:,T 6?.H\VJ^31DT[ 3F6F-+41)IC$T6 D:4^M1F8^M1,33#2:
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M!+12 TM9$A1110 &DI:*0"4444 %%%% @HHHIC"BBB@ HHHH **** "BBB@
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M1113 **** "BBB@ HHHH **** "BBB@ HHHH ****0!1110 HHH%% !1110
M4A-+32:8"$U"[4YFJM(]6D4,EDQ6?/+[U+-+UK+N9NM;Q0$%S/UYK&NKCKS4
M]U/UYK"N[CKS6J0R*[N>O-8=W==>:DN[GKS6%=W/7FM$AC;JZZ\UCW%SUYHN
M;CKS65//UYJT@'S7'O5&2?WJ.6:JCR5HD,F>:H&DS49;--S5@/WTNZHZ<HH
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MVK?-G[4QK3VIW Y]K7VJ)[?VK?>U]JK26_M5H9@O![57>+%;4L..U4I8L5:
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MQ*PD(G%.%-%.%9,0M%%%(04444 %%%%(!**** "BBB@ HHHH ****8!1110
M4444 %%%% !1110 4444 %%%% !1110 4M)2T %%%% !1110 E%%% !1110
M4444 %%%% !1112 **** "BBB@ Q1BBBD(,48HHH ,48HHH ,48HHH ,48HH
MH ,48HHH ,48HHH ,48HHH ,4444 %%%%,84444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHI@%%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1112 ***2@!
M32444QC3TIC5(:8U $9IIIQIIK-DL!4\/45 *GAZBH8(U;7J*W;+M6%:]16[
M9=JRD(Z2P[5TUCVKF;#M736/:L)$LZ.S[5NVO05A6?:MVUZ"N>1)JP=*N)5.
M#I5Q*P8B<4X4T4X5DQ"T444A!1110 4444@$HHHH **** "BBB@ HHHI@%%%
M% !1110 4444 %%%% !1110 4444 %%%% !2TE+0 4444 %%%% "4444 %%%
M% !1110 4444 %%%%( HHHH **** "BBBD(**** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHIC"BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHI@%%%% "4444 %%%% !2BDI10 4444 %%%%
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MXHQ0 E%+BB@3$Q1BEHH$)BC%+10 F*,4M% "8HI:* $HI:*0"44M% "44M%
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M,444 %%%% "44M%(!**6B@!**** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **6B@!**6B@!**6B@!**6B@!**6DH **** "BBB@ HI:* $HI
M:* $HI:* $HI:* $HI:* $HI:* $HI:* $HI:* $HI:* $HI:* $HI:* $HI
M324 %%%% !1110 4444 %%%%, HHHH **** $HHHH **** "E%&** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH ****0!1110 4444 %%%% "T
M4E% "T444 %%%%, HHHH 0C(JM*F:M5&XS51=AF3/#G-9=Q;YSQ702IFJ$T.
M>U;)C.9N+;.>*RY[7VKJIH,]JSYK;/:K3 Y2:T]JI26GM7436OM5.2U]JNXS
MGOLOM3UM^>E:YM?:D%M[47 IQ08[5?@BZ4^.W]JMQ0^U2V(EMTZ5JVZ]*J0Q
MXK1@3I4-@7H!6C%5&$5>CJ&(MI4M0I4HK-B'"BDI:D HHHH ****  TE!HH
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M%:,,'M201]*T(HZYI,D(H?:K:1#TI8TXJ=1@5A*0F-6,"GA0*6BL[DA1112
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MNDL>U<W8]JZ2Q[5RS).BL^U;EMT%8=GVK<MNE<TA&DGW:=34^[3JQ)"BBB@
MI#2TE #2*:5J2DQ3N,B*TTI4V*,4[@0&.F^75C%&VG<"MY='E>U6=M&VGS 5
MO*I/*JUMI-HHY@*_E4>55G;1MHY@*WE4>55G;1MHY@*WE"CRA5G;1MHY@*WE
M"CRA5G;1MHY@*WE"CRA5G;1MHY@*WE"E\OVJQMHVT<P%?R_:CRO:K&VEVT<P
M%;RO:G"+VJ?;2[:7,!$(Z<(Q4F*6ES!<CV4QDJ8TQC0F-,JR+5.4=:N2M6?/
M)@&NF RE.< UDW3C!J[<R\&L6[GX/-="&4;N3K6)=R]>:N7<_7FL*[GZ\UHA
ME2ZEZUC7,O6K5S/R>:R+B;KS6R&5[B3K6;,]3S250E>M$,AD:JKFI7:J[&J$
MQ":3-)FEI7$+2@9I!4J+0,$7-68X^:2..KT,.<<5#8#H(>E:MM!TXJ.WM^G%
M;-K;=.*S; DM;?IQ6W:6W3BH[6VZ<5N6EMTXK)L1):6W3BMRUMNG%1VMMTXK
M9MK?IQ638A]O!TXK3AAZ<4D$'3BK\46*YY,3"*/%7(UIJ)4Z+BLVR21!BGTB
MBEK-B"BBBD!7GZ5CW?0UKS]#6/=]#6L2T8-[T-<W?=ZZ.][US=]WKI@,YN]Z
MFN=O.]=%>]ZYV\[UUQ*,2Y[UF3=36G<]369-UK=#*CU7:K#U7:J C-)2FDI,
M0J]:LQ=:K+UJS%UI#-&"M2WZBLN"M2W[5# V+7M6Y:=JP[7M6[:=JS8C<M.U
M;MIVK#L^U;MIVK&0C9MNU:L':LJV[5K0=JYY$FC#VJW'52'M5R.L)")J***S
M)"BBB@ HHHI )112B@!**6BF E%%% !2TE+0 4444 %1R'BGFH)6XJHK4:*-
MPW!K&NWZUIW+]:P[M^M;)%&3>R=:YR]EZUL7LG6N;O9>M:I#,J]EZU@7<O)Y
MK2O9>M8-U)R:VBAE.XEZUGRR<U+/)R:HN_-;(8,U1]:0FE%:H!0*E1*1%S5F
M),U:&.CCJY%%[40Q5?A@Z<50#8H?:K20>U6(;?VJY';^U%P*2V_M2^1QTK46
MW]J#;^U)L#':#VJM)#6W)![53EA]JFX&)+'5"9*VIX^M9DZ=:5Q&7**IR5>F
M'6J$G6@",T@-!I*DFY,AJU$U4E-6(VYJAHU8'K5MI.16)"U:=N_(I-#.CM).
ME;MG+TKE[63I6Y:2=*S: ZNSEZ<UNVDG2N6LY.E;]I)TK"2).EMGZ5K0-TK!
MM9.E;%N_2N>2$:T1JP.E4X6Z5;4\5SR1+'4445 @HHHH ****  TE+24 %%%
M%, HHHH&%%%% !1112 ****!!1110 M%%% !1110 &DI324 %%%% !1110 4
M444 %%%% !2BDI10 4444 %%%%  :::=2&@"%QQ565:N,*KR+6D1F5<+UK(N
MDZUNSKUK)NDX-;18SF[Q.M8%XG6NGO$ZU@7J=:WBRCE[Q.M85TO)KI+Q.M8-
MVG)K:+&8-PO6LZ45K7"]:S)A6R&47%1FIG%0GK6J&-HH-)5#'4\&H\T\&J&2
M"G"F"GB@!12T@I: $-%!HI@%%%% !1110,**** "BBB@ HHHH ****8!1110
M(**** "BBB@ HHHH ****0!1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M113 ****0!1110 4444 %%%% !1110 4E+24 %%%% !1113&(:8U/-,:D!$:
M;3C3:ADL*L0]:KU8AZU# U+7J*W;+M6%:]16[9=JRD)G26':NFL.U<S8=JZ:
MP[5A(EG1V?:MVUK"L^U;MK7/(DU8>U7$JG#VJXE8L1,M/%,6GBL6)BT444A!
M1110 4444@$HHHH **** "BBB@ HHHI@%%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !112XH 2C%+10 4444 %%%% !1110 4444
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M***0!1110 4444 %%%% !1110(**** "BBB@ HHHH **6B@!**6B@!**6DH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBBD 4444 %%%%, HHHH **** "BBB@ HHHH **** "BBB@ I*
M6DH **,44 %%%!H&(:C:GFF-0!&:::<:::ADL!5B&JXJQ#4,#4M>HK=LNU85
MKU%;MEVK*0CI+#M736':N9L>U=-8]JPD2SH[/M6[:UA6?:MVU[5SR)-6'M5Q
M*IP]JN)6#$3+3Q3%IXK)B8M%%%(04444 %%%% "4444@"BBB@ HHHH ****8
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 HHHHH
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M1FF@TN:8QU%)2TP"BBBD,*2EI#0 4444A!1112 **** "BBB@ HHHI@%%%%
M!1110 4444 +1110 4444 %)2TE !1110 4444 %%%% !1113 **** "BBB@
M HHHH **** "BBBD 4444 %%%% !1110 4444@"BBB@ HHHH **** "BBBF
M4444 %%%% !1110 4444 %%%% !1112 *0TM(: "DI:2F,0U&U2&HVH 8:8:
M>:94,A@.M6(:KU8AJ&"-2VZBMZR[5@VW45O67:LI ='8]JZ>Q[5S-AVKIK'M
M6$A'1V?:MVU[5A6?:MVUZ"N>1)JP=JNI5*#H*NI6$B29>E.%-7I3A63$Q:**
M*0@HHHH **** $HHHI %%%% @HHHH&%%%%, HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH 6BDHH 6BDS1F@!:*3-&Z@!:*3=2;A0
MZBF[A1O% #J*;O%&\4 .HIN\4;Q0 ZBF[Q1NH =13=U&Z@!U%-W4;J '44W=
M1NH =13=U&Z@!U%-W4;J '44W=1NH =13=XHWB@!U%-WBC<* '44W>*-PH =
M13=U&Z@!U%-W4;J '44W=1NH =13=U&Z@!U%-W4;J '44W=1NH =13=U&Z@!
MU%-W4;Q0 ZBF[Q1O% #J*;O%&\4 .HIN\4;Q0 ZBF[Q1O% #J*;O%&\4 .HI
MN\4;Q0 ZBF[Q1O% #J*;O%&\4 .HIN\4;Q0 ZBF[Q1O% #J*;O%&\4 .HINZ
MC=0 ZBDW"C- "T4F:,T +1110 4444 %%%% !1110 E%+10 VBEHI )2T44
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M>E92$='8GI73V!Z5RUD>E=+8MTKFD!U5B>E=%9MTKF+%NE=%9OP*YI(#?@/
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MU=+8]JYJP[5TMCVKFF(Z*S[5N6W:L.S[5N6W:N61)I)]VG4U/NTZL26%%%%
M!1110 4444 %%%% !1110 4444 %%%% !1112 **** "BBBF 4444 %%%% !
M1110 444A.*  G%12/BAY,53FFQ6D8E6&S2XSS69<3XSS3KB?KS61=7/7FNA
M1&)=7/7FL2[NNO-+=W77FL*[N^O-:QB,+N[Z\UAW5UUYI+N[Z\UBW-UUYK9(
M8MS<]>:R;BXSGFDGN,]ZS9I\]ZT2&+--GO5"63)I99:JN_-58 =JA)H+9IM
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M24M !2&EHI )1114@%%%% !1110 4444 %%%%, HHHH **** "BBB@!:***
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M^]'G^]%@-#S:/-K/\_WH\_WHL!H>;1YM9_G^]'G^]%@-#S:/-K/\_P!Z//\
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MHH 3%)BG44 -Q0!2T4P$HI:* "@44"D M%%% !24M)0(**** "BBB@ HHHH
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M!****8!1112 **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M %%%% !1110 4444 %%%% !1112 **** "BBB@ HHHI@%%%% !1110 4444
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MUC?:O>D^U>]+E&;7VGWI/M/O6-]J]Z/M7O3Y0-G[3[T?:?>L;[5[T?:O>CE
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MM7(8\U+)+5K'R*WK*/I69:Q=*W[*+I4-C-FPCZ<5T]A'TK$L8NE=-81]*R;
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MG@TK"'4444@"BBB@ HHHH *2EHH 2BBB@ HHHH **** "BBB@ HHHH ****
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MQ:]JQ[;M6S:=!0!MV@Z5N6J\"L6T[5O68X%(#5MDZ5I119%5;5>E:L,?%0V
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MK5E13>]7(Y<]ZAQ O TM0H]2!JR:%8=1112$%%%% !1110 &DI:* $HI:2D
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MH1)124M0(*,444 )12T4 )12TE !1110 4444 %%%% !1110 4444 )1110
M4444 %**2E% !1110 4444 %%%% !1110 4444 %%%% !1110 HHH%% !111
M0 4QA3Z0T 5I$S5.6/-:3+4#I6B91B3PY[5E7-OUXKI)8LUGSP=>*U3 Y*ZM
MNO%8=W:]>*[2YM^O%8UU:]>*V4AG$7=KUXK%NK;KQ7;7=KUXK#NK7KQ6J8SC
MKBWZ\5F308[5U=S:]>*R+BVZ\5JF,YR6*JS1UM308[52DA]JT3&9Q2DQ5IH\
M5$RU:8R*BE(I*M,8H-.!IF:7-5<9(#3@:BS2YI@2@T9J/=2AJ8R3-*#3,TH-
M,!^:*;FC-,!^:*;FC- AU%)FB@ HHHH **** "BBBD 4444 %%%%( HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBBF 4444#"BBB@ HHHH **** "BBB@ HHHI""BBB@ HHHH *#1
M0: $HHHH&--,:GFF-0(C-,-/-,-0R6 JQ#5<58AJ&"-2VZBMZR[5@VW45O67
M:LI".DL.U=-8=JYFP[5TUAVK"0F='9]JW;7H*PK/M6[:]!7/(DU8:N)5.&KB
M5@Q$XIPIHIPK)B%HHHI""BBB@ HHHI )1110 4444 %%%% !1113 **** "B
MBB@ HHHH **** "BBB@ HHHH 6BBB@ HHHH *0TM(: $-1M4AJ)ZI#*\O2LZ
M<\&K\O2LZX/6M4,R[INM8=V_6M>[/6L&\;K6T4,Q[R3K6#=R]:UKU^M<]>2=
M:V2&4+F;KS65/-UYJQ=2=:R9Y>M:I#%DGYZU 9_>JTDO-0-+[UHD,O>?[T>?
M[UG^;1YM58#1$_O2B?WK.$M*):=@-(3TX3UFB6GB7WIV&:/GTOG^]9XE]Z/-
MHL!H>?[T>?[U0\VD\VBP%_SZ7S_>L_S?>CS?>BP&AY_O2>?[U0\WWH\WWHL!
M?\_WH\_WJAYM'FT<H%_SZ7S_ 'K/\VCS?>BPC0\^D\^J'F^]'F^]%@+_ )]+
MY_O6?YOO1YOO2L!?\_WH\_WJAYIH\VG89?\ /]Z//]ZH>;1YM'*!?\_WH\_W
MJAYM'FT<H%_S_>CS_>J'FT>;1R@7_/\ >CS_ 'JAYOO1YOO18"_Y_O1Y]4/-
M]Z/-]Z+ 7_/H\^J'F^]'F^]%@+_GT>?5#S?>CS?>BP%_SZ//JAYOO1YOO18#
M0\^CSZS_ #?>CS:+ :'GT>?6?YM'FT6"QH>?1Y]9_FT>;18+&AY]'GUG^;1Y
MM%@L:'GT>?[UG^;1YM%@+_G^]'G^]9_FT>;189H>?[T>?[UG^;1YM%@+_G^]
M'G^]4/-H\VBP%_SZ3S_>J/FT>;18"]YWO1YWO5#S:/-HL(T//I1/6?YM+YOO
M2L!HB?WIPG]ZS?-]Z42T6 U!<>]/%Q[UE":G";WI6 U1<^]2"Z]ZQQ/[THG]
MZ7*(VUN_>IEN_>L$7'O4BW/O2Y0.A2\]ZLQWOO7-+<^]3I=>]2X@=1%>^]7H
MKWWKDH[KWJ]#=^]0XB.O@O>G-:<%YTYKC8+SIS6G;WG3FH<0.RM[OIS6I!==
M.:XVWO.G-:MO=].:S<1'70W/3FM"&?WKEH+OIS6G!=>]0T(Z..:K*R9K$AN/
M>KL<V>]8M"--7S3P:II)4ROFLFA$]%-!IU2(**** "BBB@ I*6DI %%%%  :
M2E-)0 4444P"BBB@!:*** "BBB@ HHHH **** "BBB@04444 %%%% !1110,
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBBD 4444 %+24M !1110 4&BBF TBFE<U
M)28H K.F:J2Q5I,M02)6D648D\/7BLJYM^O%='-%6?/!GM6J8SE;JVSGBL6Z
MM>O%=A<6_M63<VO7BM4QG%W5KUXK&N;3KQ7:W-IUXK'N;3KQ6B8SC)[7KQ6=
M-;>U==<6?7BLR:S]JU3 Y:6W]JJ20>U=++:>U4I+3VK1,9S[0>U1F&MI[7VJ
M%K;VJTQF3Y1H\LUI&W]J:;?VJ@,[RS2;#6@8/:F&&@"EM-)M-6S%33'0!6Q1
MBI]E,*T 1XHI^*:10 9HS244 .W4;J910(DWTHDJ+-&:87)Q)3Q+57-+NH"Y
M<$M/6:J(8TX.:+#-%9O>I5G]ZRQ+3Q-18#66X]ZE6X]ZR!-[U()O>E8#86X]
MZD6Y]ZQA/[T\3^]%@-M;KWJ5;KWK"%Q[U(+CWI<HC>6[]ZE6\]ZY\7/O4BW/
MO2<0.B2\]ZL1WOO7-+=>]3)=>]2XB.ICO?>KL5[[UR4=W[U=BN_>H<0.PAO?
M>M&"\Z<UQL-Y[UI07GO4.('9P7?3FM*"ZZ<UQUO>=.:U+>[Z<UFXBL=?!<].
M:T(9_>N6M[KIS6I!<].:RE$#HXYO>K229K#AN/>K\4U8R1)IJ^:>#FJ<<F:L
M*U9-"9+130:7-2(6BBB@ HHHH *@FZ5/4$W2JCN-&5==ZP+WO6_==ZP+WO6T
M2SF[[O7,WW>NFON]<S?=ZZ(C.;O>]85UU-;M[WK"NNIKHB!E353?K5R:J;]:
MZ(C(C3:<:;6B&%**2E%,$3QU?@[50CJ_!VJ6!JVW:MFU[5C6W:MFU[5A(1MV
MG:MZS[5@VG:MZS[5SR)-^T[5N6O:L.T[5N6O:N:1)L6_:K\=4+?M5^.L&!,*
M#TH%!Z4@().E49^AJ])TJA<=#6L1F3==ZP;P]:W;KO6#>'K71$9@7AZU@79Z
MUO7O>N?N^];HHP[H]:QKD\FMBZ[UC7)Y-:(9F3'K5&0\U=F/6J,G6M$!&:*2
MEJD(6BBBJ&%2)UJ.I4ZT#+D'45KVG:LF#J*U[7M6;$;UEVKI;#M7-V7:NEL.
MU8R$=)8]JZ.S[5SMCVKHK/H*PD2;EMTK3BZ5F6W05IQ=*YIB+*TZFK2BN=DL
M6BBBD(**** "BBB@!**** "BBB@ HHHH **** "BBB@ HHHI@%%%% !1112
M6BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ I#2TAH
M C>J,_0U>>J,_0UM HR+OH:YZ^[UT-WT-<]?=#73$HYF_P"]<S?=ZZ:_[US-
M]U-;Q&<Y>=36'<]36Y>=36)<=ZWB49LO6H*GEJ"M4 4\4P4]:I /%.%-%.IC
M'"G@U'3A2 E!IX:H0:7-("P'IXDJJ&IVZI$6A+3A+5/?2[Z0%WSJ7SJI;Z7S
M*FPBYYWO1YWO5/?1YE*P%SSO>CSO>J?F4GF5-@+OG>])YU4]]&^BP%SSJ/.J
MEOH\RBP%WSJ/.JGOHWT6 N>=1YU4]])OIV N^=1YU4]]&^BP%SSO>E\[WJEO
MHWT6 N^=[T>=[U2WT>918"YYWO2>=[U3\RC?3L!;,M-,M5M])OHL!8,E,+U#
MNI-U4@)"U,+4W-(35H8I-,-&:2K10AJ,T\TPU0#324II*&(D2K4554[5:BZU
MFP+\/:M2W[5EP]JU+?M6,A&Q:]JW;3M6%:]JW;3M6$B3>L^U;MIVK"L^U;MI
MVKFD(V[;M6K!VK*MNU:L':L)"-*&K(Z56AJR.E9,EA1112$%-;I3J:W2FAHJ
MR=ZIR]*N2=ZIR]*T0S-N.]9%UWK7N.]9%UWK:)1AW?>L*\[UNW?>L*\[UO$:
M,*Z[UB75;=UWK$NJZ(C,BXK.FZUHW%9TW6MHE%-^M1&I7ZU$:T0Q***6J 44
MX4VG"D!(IJ934 IZFDQ%I7J59*J!J>&J0+RRXJ19O>J >GB2I$: G]Z>)_>L
MT24[S:5@-$7'O2_:/>LX2T>;4V$:!N/>C[1[UG>;1YM*P&A]H]Z//]ZS_-I/
M,J; :'VBC[1[UG^;[T>;[T6$:'V@^M'G^]9_F^]'F^]*PS0\_P!Z3[1[U0\V
MD\RG8"^;CWI/M'O5#S:0RT6 O_:/>D^T>]9_F^]'FTK"+_VCWI/M'O5 R>])
MYM*P&B+CWJ5)^>M9(DJ9)>:5@-N*?WK1MYNG-<_#)6E;2=*AH1TEM-TK;M9>
ME<S:OTK<M'Z5+0'2VC]*V[5NE<[:-TK=M#TK)B-RW;I6E":RK<]*TX363)+T
M=3K5>.K"UDQ$HZ44#I14 %%%% !1110 4444 02]#67==ZU)>AK+NN];P-$<
M_>]#7,W_ 'KIKWH:YF_[UTQ*.7O^]<Q?=373W_>N8ONIK9 <[=]36//U-;%W
MU-8\_4UJ@*QH%% ZT$D\5:$%9\5:$%44:ML>E;%J>E8MO6Q:GI2$=#9GI70V
M1Z5S=F>E=%9'I42 Z2S/2MRVZ"L&R/2MVUZ"N>3 U8AP*LA>*KP]!5Q!7.V(
MA=.*I3Q9K5*<57ECXJ>8#G+J#KQ6#>V_7BNON8<@UBW=OG/%:1D!Q%[;=>*Y
M^\M^O%=Q>6W7BN>O+;KQ71%C.-N8.O%9-Q#UXKJKNWZ\5BW,'7BMTQG.S1XS
M5*1*V;B*LZ9*U3&4"*3%2LM1D4R6A*6BB@$.!Q4BM4-*&I,HOQ25H6\W2L5'
MJ[#+4-".DM9^G-;MG<=.:Y&VFZ<UM6D_3FH:$=G9W'3FNAL[CIS7$6=QTYKH
M+.YZ<U#B!VUG<=.:V[:;.*X^SN.G-;UI/TYK*41'30R9%6E;BLBWFR!5^.3B
MN6<=1%K-02GBG;JCD/%9I 4+CO6/==ZV9^AK(NAP:M(#G[T=:YR]'6NEO1UK
MG+X=:WB!S5[WK N^]=#>CK7/W?>NB(&+<=ZSI:TKCO6=**V0RJW6F"GMUI@J
MT,E3K5^WZBJ"=:OV_450S:M.U=#9=JYZT[5T-EVK*0CI;'M72V/:N:L>U=+8
M]JY9B.BL^U;EMTK#L^U;EMTKED2:2?=IU-3[M.K EA1110 4444 %)2TE( H
MHHI@%%%% !1110 M%%% !1110 4444 %(3BD)J-WQ3 21\52FEQGFG32XS6;
M<3]>:UBBQEQ/C/-9-U<=>:?<W'7FL2[N>O-;QB,9=W77FL*[NNO-/N[KKS6%
M=W77FNB,1C;NZZ\UBW-SG/-+=7/7FLBXN,YYK9(!+B?KS69/+FG33=:H2R9K
M1(!LLE56;-*[9J(FF#"BDI12)%Q3@N:55S4Z)FF4-2/)JW%%S2Q1<U?@@Y'%
M)@+!!TXK5MK?..*;;V_3BMFUMNG%0V ^UMNG%;EI:].*9:6O3BMVTM>G%8M@
M/M+7IQ6Y:VW3BF6MMTXK9MK?IQ6,I$CK>WQCBM2&'&.*2"'IQ5^./%828@CC
MJRBXH5*D K%L!0*6BBH)"BBB@ HHHH *2BB@ HHHH 6BBB@04444#"BBB@ H
MHHH JW'0UCW?0UL7'0UCW?0UK$LY^]Z&N<ON]='>]#7.7W>NJ!1S5[WKGKSO
M70WO>N=O.]=41F)<]ZS9N]:5SU-9DW4UNAE5Z@:IGJ%JH",TE+24F(<M68NM
M5EZU9BZTAFC!6I;]JRX*U+?M4,#8M>U;EIVK#M>U;EIVK-B-VT[5NVG:L*T[
M5NVG:L9"-JVZ"M6"LJVZ"M6"N>1)HQ5<CJG%5R.L)$DU%%%9B"BBB@ HHHH
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MCI8IL]ZN1R9K!@N.G-:$,V>]9-"-9&J4'-4HY,U81LUFT(GHIH-.J!!1110
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M.E9,1L6W:M2#M69;#I6I .E92$78ZL+5>.K"UBR24=**!THJ "BBB@ HHHH
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MI)]VG4U/NTZL"6%%%% !1110 4E*:2D 4444P"BBB@ I:2EH **** "BBB@
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MHHH ****8!1110 4444 %%%% !1110 4444 %%%% "T444 %%%% !2&EI#0
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MV:R:$:JM4@-4XWS5A6S630B:BD!I:@04444 %%%%( I*6BF E%%% !24M)0
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M,****0@HHHH **** $HHHH **** "BBB@ HHHH **** "BBBF 4444 %%%%
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MDUB7,G6NB*&4KB3K69.W-6IWZUGRM6J K2'FH#4CGFHZH& '-6H1TJNHYJY
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M=BC% #<48IV*,4 -Q1BG8HQ0 F*3%.Q12 ;BC%.HI"&XHQ3J3%,!N*,4ZC%
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M4>*AL"6%*NQBH8TQ5I%K)L1(@J44Q14@K-L0X4M(*6I **** "BBBF 4444
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M5HPM6$D275/%/J)#4@K%B8M%%%(04444 %%%% A****!A1110 4444 %%%%
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MB@!,48I:* $Q1BEHH&)BBEHI )12T4 )12T4 )12T4 )1BEHH$)BDQ3L48H
M;1BEHQ0 W%&*=BC% QF*3%/Q1B@1'B@BGXI"*0$>**?BD*TK ,IM2$4W%2T)
MH92BEQ28J+$DJ-5J)ZI+4R-2:&:T,N,5I6\^,<U@QR8J]#-4-".HM;CIS6W:
M7/3FN0MY\$<UL6MQTYK-H1VMI<].:W;2XZ<UQ5G<].:W[.XZ<UC)".PMI^E:
MT$N:Y>TGSCFMJVESCFL)(1OPOFK:-67!)TJ_&W%8R1):%%-4TZL1!1110 44
M44 %%%% "48HHH 2EQ110 8HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M9I,U&6Q33)3L,FW4FZJYEIIF]Z?*!:WTF^J9G%(9ZKE&7=]&^J/V@4GVBCD
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MLFQ!1112$%%%% !2444@"BBBD 4444P"BBB@84"B@4 +1110(**** "BBB@
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MBB@ HI:*  4444""BBBD 4444@"DI:2@ HHHH 2BBB@ HHHH **** %HHHH
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MU0QM%%%6@%I124HIC' 4X"D%.%,8HI:04X4#$Q1BEH-,!,48HHH$)BC%+10
MF*,4M% "8HQ2T4@$Q1BEHH 3%&*6B@!,48I:*!"8HQ2T4 )BC%+10 F*7%%%
M !BC%%% !1113 **** "BBB@ HQ12T )BDQ2T4##%&*** #%&*** #%&***
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M=36//UK8O.IK'GZUJ@*YH%!H%,1-'5Z&J,=7H:HHT[?M6M:]163;]JUK7J*
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MI;BXZ\UF3S9S6B0QL\W7FL^63K3I9.M4I'S56 1WS41-!-)FF*XM&*2I%&:
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MS1FH\TN: 'YHS3,TN:8#\T9IN:,T .HI** %HHS10 4444@"BBB@ HHQ1B@
MHHQ1B@ HHHH **** "BBB@ HHHH ****8!1110 4444 )1110 AJ-JD-1M0
MPTPT\TPU#)8HJ>'K4 J>'K4,$:MKU%;MEVK"M>HK=LNU8R Z2P[5TUAVKF;#
MM736':L)$LZ.S[5NVO05A6?:MVUZ"N>1+-6#I5Q*IP=*N)6#$3BG"FBG"LF(
M6BBBD(**** "BBBD E%%% !1110 4444 %%%%, HHHH **** "BBB@ HHHH
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MZ5SR0CIK>3@5H1/6';2=.:U8'Z5A)"-.-JL+TJE$U6T/%9-")****D04444
M%%%%(!**** "BBB@ HHHH ****8!2TE+0 4444 %%%% "4444 %%%%( HHHH
M **** "BBB@ HHHI@%%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M/M7.V(Z5T5F.!7/(#:M^@JX.E5+<<"K8Z5S3(D+1114$A1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444K
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M9DW6MT,IO4#58>J[50$=)2TE)B%7K5F+K59>M68NM(9HP5JV_:LJ"M6W[5#
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M%% !1110 4444P"BBB@ HHHH **** "EI** %HI** %HI** %HI** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **,48H **** "BBB@ HHHH
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MM3"2L'$EHFHIF^EWTK$CJ*;NHW46 =13<TN:0"T4F:,T +129HS0 M%)FC-
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ME&%=]ZP[KO6Y=]ZP[KO71$9CW'>LN?O6I<5F3=ZV0RD]1U(_6HZL IPIM.%
M$B58CZU76K$=)@:-MU%;=GVK$M^U;-H>164A'1V)Z5TU@>E<M9'I72V+=*YI
M(#J;$]*Z*S;@5S%B_2NAM'X%<TD!T%NW%6P<BLVWDX%7D?BN>2(DB6BF[Q1O
M%9D#J*;O%-+T[ 245'OHWT6&245'OHWT6$245'OHWT6&245'OHWT6 DHJ/?1
MOHL%B2BH]]'F"BP6)**C\P4>8*+!8DHJ/S!1Y@HL%B2BH_,%'F"BP6)**B\P
M4>8*+!8EHJ+S*7S*+ 245'YE'F4A$E%,WTN^@!U%-W4NZ@!:*3-&: %HHHH
M*#THH/2@"O+TK,NN]:<O2LRZ[UO U1S]]T-<S?\ >NFONAKF;_O73$9RVH=Z
MYB^ZFNGU#O7,7W>MH@<]=]36//U-;%WU-8\_4UL@*]**2E%-")HZO0U1CJ]#
M5E&E!VK6M>U9-OVK7M>U)B-RS[5OV?:L"S[5OV?45C(1T%GVK=M>@K"L^U;M
MKT%<TQ&S;]JU(:R[?M6I#7-(DNITIU-3I3JQ8F%%%%(04444 %%%% !1110
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M%%% !1113 **** "BBB@ HHHH **** "BBB@ HHHH 6BBB@ HHHH *0TM(:
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M6 T/-H\VL_S_ 'I//]Z=AFAYM'G5G_:/>D^T>]%@-#SJ7SA6;]H]Z/M ]:+
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M)"BBB@ HHHH 2BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHI +2444 %%%% @I*4TE "T4E+0 M%)2T#"BBBF 4444 %%%
M% !1110 4AI:* (V6H62K)%-*U28RD\?M4#P^U:)2HS'57 RG@]J@>W]JV#%
M4;0>U',!BM:^U0/:>U;QM_:HVM_:J4AG.O:>U5I+/VKI7MO:J[VOM6BD,Y>6
MS]JIRV?M7526OM5.6T]JT4@.3EL_:J,MG[5UDUI[51EM/:M$P.3EM/:J,MI[
M5UDMI[51EL_:K3&<K):>U5)+7VKJ9;/VJG)9^U6I#.8DMO:JSVWM72R6GM56
M2T]JI2 YQ[?VJ!X/:N@DM?:JKVOM5IC,)H?:H6B]JVWMO:J[V_M57 QVCJ%D
MK5>#VJN\%.X&<4J,K5]HJA:*G<"H1258:.HRE.X$=%.VTF*86"EI,4N*=QA2
MTE+57&.!IP-,%.IW <*<#3,TN:+@/I:9FES1<8ZEIN:,TP'44W-+FD M%)10
M M%)FB@ HHHH *#10:8QIIC4\TQJ0B,TPT\TPU#)8"K$-5Q5B&H8(U+;J*WK
M+M6#;=16]9=JRD(Z2P[5TUAVKF;#M736':L)"9T=GVK=M>@K"L^U;MKT%<\B
M35AJXE4X:N)6#$3BG"FBG"LF(6BBBD(**** "BBBD E%%% !1110 4444 %%
M%%, HHHH **** "BBB@ HHHH **** "BBB@!:*** "BBB@ I#2TAH 0U$U2F
MHFJT459>E9EQWK3EZ5F7'>M8@8UWT-8%[WK?N^AK O>];Q&<[>]ZYV\ZFNBO
M>]<[>=371$HPKKO61<=:U[KO61<=:VB,H2=ZKFK$G>JYK9#&TM)2U0Q13A31
M3A5#'"G"FBG"@!PI12"G"@ H-%% "4444P"BBB@ HHHH ****0!1110 4444
M %%%% !1113 **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M4444 %%)10 M%)2T %%%%,84444 %%%% !1110 4444@"BBBD 4444 %%%%
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M920C<C>K"M6=#)5R-JYI(19!IU1J:D%9B"BBB@!**** "BBB@ HHHH ****
M"EI*6@ HHHH **** $HHHH **** "BBB@04444 %%%% !1110 4444 %%%%
MPHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBBD 4444 )12T4
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M2$%%%% !1110 E%%%( HHHH$%+24M PHHHI@%(:6@T )1110 4444@"BBB@
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M-@-^V;I6I$>!6/:GI6M >*4MAEFBBBL2!C]*R[OH:U'Z5F7?0UK TCL<Y?\
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MSU[WKH;WO7/7O>MXE&%==ZR)^M:]UWK(GZUM$90D[U7-6).]5S6J*$HHHJT
MM**2E%4 \4X4T4X4 .%.IHIU !2&EI#0 4444 %%%% !1110 4444@"BBB@
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MI4,1MVO:M>WZ5DVHZ5KV_05DP+\72K"U!'4ZUA(!XHH%%9DA1112 *2EI*0
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M,MATK4A[5SR$74Z4ZFITIU9$A1110 4444 !I*4TE( HHHI@%+24M !1110
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MP"BBBD 4444 %%%% !1110 4444@"BBB@ HHHH **** "BBBF 4444 %%%%
M!1110 4444A!2&EI#0 4444 %+24"F,6DH-%4,*::=330 AIIIQIIH$%!HHJ
M&(2E I13E%9,1)&*O0+TJI&O-:%NM9,1IVJ]*W[)>E8MHO(K?LEZ5BQ'06(Z
M5TUB.!7.V*]*Z6R' K)B-ZS' K:M^@K'M!TK9MQTK*1)?CJ:HH^E2URR$PHH
MHJ1!1112 *2EI* "BBB@04444#"BBBF 4M)2T %%%% !1110 E%%% !1110
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MQ3!3Q0 HIPI!2B@ I*6DH ****8!1112 **** "BBB@ HHHH **** "BBB@
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M_P!D]J/LGM1S 8'V+_9H^Q>U;_V3VH^R>U',!SYLO:F&R]JZ/[)[4TV?M1S
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M[1>E;5L*R8C2A[5<2JD(JVE9L1.M2"HUJ05FP%HHHI""BBB@!**** "BBBD
M4444 %%%% !1113 **** "BBB@ HHHI %%%% @HHHH **** %HHHIC"BBB@
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M?9O:M7R/:CR/:CF R?LWM1]F]JUO(]J/(]J.8#(-M[4GV;VK7-O[4GD>U/F
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M5K>1[4>1[4<P&3]F]J/LWM6MY'M1Y'M1S 9'V;VI/LOM6QY'M2>1[4<P&/\
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M+1124 %%%% !1110 4444 %%%%( HHHH **** "BBB@ HHHH **** "BBB@
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M 4444@"BBB@!**** "BBB@ HHHI@%%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 &:7-)10
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M_*I?*]JGP*7%',!7\KVH\KVJQBC%',!7\KVH\JK&*3%',!7\JCRJL8%&!1S
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M%%P(]M+MI]&*5P&[:-M/Q11<!NVEQ2T4A!1110 4444 %%%% !1110 4444
M%%%% !1110 4444 )1110 4444 %%%% !24M)0 4444 %%%% !2T"B@ I:2E
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *3M2TE !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %+244 +1110 4444 %%%
M% !1110 4444 %%%% !2$4M% #-M(5J2DIW CVTFVI:*=P(MM&RI<48HN,CV
MT;:DQ11<"/;2[:?12N W;3L4N**+B#%%%%( HHHH **** "BBB@ HHHH ***
M* "BBB@ [4E%% !1110 4444 %%%% !1110 4444 %%%% "T444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% "4444 %%%% PHHH
MH *,444 %%%% !2YI**!"YHS244 &:*** "BBB@ HHHH **** %HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ I,TM)
M0 4444 %%%% "T444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 )24M% "4444 +1113
M6BBBD 4444 %%%% !1110 4444 %%%% !1110 4444 %)2TE( HHHH ****
M"BBB@ HHHH ****8!1110 4444 %%%% "YI,T44 &:,T44 &:*** "EI*6@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *2EI* "
MBBB@ %+0** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@!**#
M10 4444 +1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !24M
M% "44M&* $I<444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 E
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% "BBD%+0 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4E+10 E%%% !1FBB@ HHHH *6DI: "BBB@ HHHH
M**** "BBB@ HHHH ,4E+10 E%%% !1110 4444 %%%% !1110 4444 %%%%
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M %%%% !1110 4444 %%%% !1113 **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ I:2B@!:*2C- "
MT4F:7- !11FB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BDS10 M%)10 444
M4 %%%% !1110 4444 %)2TE !1110 4444 ***!10 4M)10 M%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %)2TE !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !2TE% "T4E+0 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%)FB@!:2BB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH 6B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH 2BB
MB@ HHHH&%%%% !1110 4444 %%%% @HHHH **** "BBB@ HHHH **** "EI*
M* %HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "DI:2@ HHHH **** %HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHI* "BBB@ HHHH *
M*** %HI*6@ HHHH **** "BBB@ HHHH **** "BBB@ HHHI )FBBB@ HHHH
M**** "BBB@ HHHH ****8!1110 4444 %%%% !1110 4444 %%%% !1110 M
M%)2T %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444E !1110 4
M444 ***!10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 (:*#
M10 4444 +124M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !2444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !2TE% "T4"B@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBDH **** "BBB@ HI*6F 4M)2T@"BBB@ HHHH ****
M "BBB@ HHHH **** "DI:2@!<4E+12 2BEHH 2BEI* "BBB@ HHHH ****8!
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !24M)0 4444 %%%% "T444@"BBB@ HHHH$%%%% !1110 4444 %%%% PH
MHHH **** "BBBF 4444 %%%% !1110 4444@"BBB@ HHHH **** "BBB@!11
M244 +11FC-, HHS10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 &*:5IU% $92F%/:I\4F*JX[D&RDV5/BDQ3Y@(@E*%J7%&*+@,
M"TX"EQ2TKB$Q12T4@"BBB@ HHHI %%%% !1110 4444#"BBB@ HHHH$%%%%
M!1110 4444 %%%%( HHHH **** "BBB@!:***8!1110 4AI:0T (:B>I343]
M*M%%6;I69<=#6E+6;<=#6T0,:[Z&L"][UOW?>L"][UO$HYV][USUYWKH;WO7
M/7G4UO$9A77>LB?J:U[KO61/U-;Q&9\M0-4\M0-6J*&T445: 6E%)2BF,>*<
M*:*>*8#A2T@I:!A2&EH- "4444A!1113 ****8!1110 4444 %%%% !1110
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M ****!!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4M)10 M%)FEH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ H-%)0 4444 %%%%, S24M%(!**6B@ HH
MHH **** "DI:* $HI:* $HI:*  4444 %%%% "T444@"BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHI@%)2TE !1110 4444 %%%% !110: #-&:2B
MF N:,TE% "T4E+2 **** "BBB@ HHHH **** "C-%% !FEI** %HI*,T +11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%&
M: "BDHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH 6BDI
M<T %%%% !1124 +129I<T %%%% !1112 ****8!1112 **** "BBB@ HHHI@
M)1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% "T444@"BBB@ HHHH ****8!1110 4444 %%%% !1110 4444 %%%&: "
MBDHH 6DHHH **** "BBB@!:*** "BBBD 4444 %%%% !1110 4444 %%%% !
M1113 **** "BBB@ HHHH **** "BBBD 4444P"BBB@ HHHH **** "BBBD 4
M444 %%%% !24M)0 4444P#-+FDHH 6BBBD 4449I@%%&:,T %%)FB@!:2BB@
M HHHH **** "BBB@ HHHH 6BBBD 4444P"BBB@ HHHH ****0!1110 444E
M!1110 4444 %%%% !1110 4444P"BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH *6DHH 6BDS2T %%%% !1112 **** "BBB@ HHHH **** "BBB@
M I*6DI@%%%% !1110 HHI!2T %%%%( HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBBF 4444 %%%% !1112 **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****8
M!1112 ****8"&BBB@ HHHH *44E** "BBBD 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444P"BBB@ HHHH **** "BBB@ HHHI %%%%
M, HHI* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** %%%)2T %%%% !1112
M **** "BBB@ HHHH **** "BBBF 4444 %)2TE !1110 4444 )FC-)0:8Q<
MTFZFDTTM3 DW4;J@+TTR46 M;Z-U5/-I?-HL!;W49JJ):>)*+ 6,T5$'IX:E
M80ZBC-%( HHHH **** "BBB@ HHHI %)2T8H 2BBB@ HHHH ****8!1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%%( HHHH **** "BBB@04444 %%%% !1110 4444 %%%% PHHH
MH **** "BBBF 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% @HHHH **** #-+FDHH 6BDHH&+11FB@ HHHH **** "BBB@ H
MHHH **** "BBB@!,44M% "8HQ2T4 )BC%+10 8I*6@T )1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444@"BBB@ HHHH **** %
MHHHI@%%%% !2&EI#0 AJ)^E2FHGZ5:**DM9MQT-:4M9MQT-;1 QKOO6!>]ZW
MKOO6!>]ZWB4<[>]ZYZ\ZFNAO>]<]>=ZZ(E&'==ZR)^IK6NN]9$_6MHC*$M5S
M4\E0&MD,2EI**I#%%.%-I15 /%/%1BGB@!XI::*6@!:#24&@ HI** %HI**
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M ,T444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1FBB@!<T9I** %HI** %HI** %HI** %HI** %HI**
M%S29HHH **** "BBB@ HHHH **** "BBB@ HHHH **** #-+FDHH 6BDHH 6
MBDHH 6BDHH 6BDHH 6BDHH 6BDHH 6BDHH 6BDHH 6BDHH 6BDHH 6BDHH 6
MBDHH 6BDHH 6BDHH 6BDHH 6DHHH ****0!1110 444E "T4E%,!:*2B@!:*
M2BD M%)13 6BDI10 4444QA1110 4444 %%%% !1112$%%%% "YHI** %HI*
M* %HI** %HI**0"YHS244 &:*** "BBB@ HHHH ****8!1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 49HHH
M7-%)10 M%)10 M%)10 M%)10 M%)10 M&:2B@!<TE%% !1110 4444 %%%%
M!2YI** %S1244 +1244 +1244 +1244 +1244 +1244 +1244 +1244 +124
M4 +1244 +1244 +1244 +FC-)10 N:,TE% "T4E% "T4E% "T4E% "T4E% "
MT4E% "T4E% "T4E% "T4E% "T4E% "T4E% "T4E% "T4E% "YHS244 &:***
M %S2444 %%%% !1110 4444 %%%% "T4E% "T4E% "T4E% "T4E% "T4E% "
MT4E% "T9I** %S29HHH **** "ES244 +FBDHH 6BDHH 6BDHH 6BDHH 6BD
MHH 6C-)10 9HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HS110 N:*2B@!:*2B@!:2BC- !11FC-( HHS1FF "EI** %HI** %I***
M "BBB@ HHHH ;32:<:8U4BAC-43/2NV*K2/BJL YI*B,WO5>27%5WG]Z=@+O
MG^]'G^]9AN/>C[1[T6$:RS>]2K-FL=;CWJ=)_>BP&NLF:F5ZS(YO>K4<M*P%
MX&GU61ZF5JEH!]%&:*D04444 %%%% !1110 4444@"C%%% "44&BF 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%%( HHHI@%%%% !1110 4444 %%
M%% !112T )12T4 )12T&D E%%% !1110 4444""BBB@ HHHH **** "BBCO0
M 4444#"BBB@ HHHH ****8!1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110(**** "BBB@ HHHH **** "BBB@84444 %%%%( HHHH *
M6DHH 7-%)10 M%%% !1110 4444P"BBB@ HHHH *#10: $HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****0!1110 4444 %%%%
M"T444P"BBB@ I#2TAH 0U$_2I343]*M%%26LVXZ&M*:LVYZ&MH@8MWWK O>]
M;]WWKG[WO6\2CG;WO7/7G>NAO>]<[>=ZZ(C,.Z[UD3]:U[KO61/UK:)10DJ
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%%,84444 %%%%(04444 %%%% !1110 4444 %%%% !
M1110 4444 %%%%( HHHH **** "BBB@ HHHI@%%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %!HH- "4444P"BBB@ I:2EI %%%% !1110
M4444 %%%% !1113&%%%% !1110 4444""BBB@!**** "E%)2B@ HHHI %%%%
M !1110 4444 %%%% !1110 444M "44M% "44M% "4444 %%%% !1110 444
M4 %%%% !1110 444M "44N*,4 )12XHQ0 E%%% !1110 4444 %%%% PHHHH
M **** "BBB@ HHHH$%%%% !1110 4444 %%%% !1110 444E "T4E% "T4E%
M "T4E+0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444@"BBBF 4
M444 %%%% !1112 **** "BEQ1BF E%+BC%(!**** "BBB@ I*6DH ****8!1
M110 4444 %%%% !2BC%% !1113&&:,TE% "YHS244 +1124 +124M(04444
M%%%% !1110 4444@"BBB@ HHHH **** "BBB@ HHHH ****8!1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%+0 E%+10 E%+10 E%!HH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH ***6@!**6B@!**6B@!**6DH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "DI:2@ HHHH ****  4M)2T
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M "BBB@84444P"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M4@"BBB@ HHHS0 449HS3 **,T9H **** "BBB@ HHHH ****0!1110 4444
M%%%% !1113 *7%%% !1112 **** "BBBF 4444 %%%% !1110 4444 )BC%+
M10 E%+10 E+BBB@!**** "BBBD 4444 %%%% !1110 4444P"BBB@ HHHH *
M*** "BBB@ I:2B@!:*2B@!:*2B@ HHHH **** "BBB@ HHHI %%%% !1110
M4M)2T %%%% !1110 4E+13 3%+110 AHI:* $HQ2T4 &*,444 &*,444 &*,
M444 %%%% !1110 4444@"BBB@ HQ110 E%+24P"D-+2&D 4444 %%%% !2TE
M+0 4444 %%%%, HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****0!111
M0 4444 %%%% !1110 4444 %%%% !1BBC-,!:*** "BBBD 4444 %%%%, HH
MHH **** "BBB@ HHHI %%%% !1110 8I*6BF E%%%( HHHH ****0!1113 *
M*** "BBB@ HHHH *44E** "BBB@ HHHH *2EI* "BBB@ HHHH ****8!1110
M 4444 %%%% !1113&%%%% "44M% "44M% !2&EI#0(!2T@I:0!1110 4444
M%%%% !1112 **** "BBB@ HHHH **** "BBBF 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4M)2T %%%% !1110 &DI324 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %*
M*2E% !1110 4444 !I*4TE !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !4,O2IC4<O2JCN-&7<]ZQ+L]:V[GO6'>=ZV*,*[/6L&[;
M&:V[P]:Y^\;K5H#*N9.M9<TW)YJW=OUK'N).M6D Y[C!ZT@N>>M9TDW-0_:,
M'K6B0S>CN_>KD5Y[US"76.]68[OWJ[ =9#>^]:$-[[UQ\5Y[U?AO/>CE&=G!
M>>]:<%W[UQ=O>>]:MO>=.:EQ [&"ZZ<UH0W/3FN2M[SIS6G!=].:AQ$=1%/[
MU;CF]ZYV&Z]ZO17/O4.))O)+4Z/6/'<>]6XY_>LG$#2#4[-4TFJ59:R<0L6*
M*C$E.#5-A6'44F:6D(**** "BBB@ HHHH **** "BBB@!**7%)BD 448HH *
M***0!1110 4444 %%%%, HHHH&%%%% !2YI**!"YHS244P%S2444 %%%% !1
M110 4444 %%%% "BB@44 %%%% @HHHH&)1112 ****8!1110 4444 %%%% !
M1110 4444@"BBB@ HHHH **** "BBB@ HHHH ****8!1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%%( HHHH 2BEHH 2EHHH **** "BBB@ H
MHHI@%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%%( HHHH **** "BBB@!:***8!1110 4444 --1-4IJ)ZI#*DW
M2LRYZ&M26LRX'6MD,Q+SO7/WHZUT5V.#7/WHZUM$9S-Z.M<[>CK737J]:YZ\
M7K6R&<Y=#DUD3CK6[=)R:R)TZULF,RI!4!%79$J QUHF,AHJ391LIA8914FR
ME"50R/%. J01T\)3N!"!2[:F"4NRBXR#;1BI]E'ET7 @VT;:G\NCRZ+B(-M&
M*G\NC91<"#%&*GV4;*+@08HQ4^RC91<"#%&*GV4;*+@08HQ4^RC91<"#%&*G
MV4;*+@08HQ4^RC91<"#%&*G\NCRZ+@08HQ4_ET>71<"#%&*G\NC91<"#;1MJ
M?91LI7 @VT;:GV4;*+C(-M&VI]E&RBX$&VC;4^RC91<1!MHQ4^RC93N!!BC%
M3[*-E%P(,48J?91LHN!!BC%3[*-E%P(-M&*GV4>71<"#%&VI_+H\NBX$&VC;
M4_ET>71<"#;1MJ?91LHN!!MHQ4^RC92N,@Q1BIME+LHN!!BC%3^71Y=%P*^V
MEVU/Y=*(J5Q%?;1MJR(O:G>31<"KLIP2K0A]J>(/:E<156.IEBJRL'M5A+?V
MJ;@54A]JLQP>U6X[;VJY%:^U2Y 5(K?VJ_#:].*M0VG3BM&"TZ<5+D!5@M.G
M%:4%GTXJW;V?3BM6WL^G%9N0BG;V?3BM2WL_:KEO9].*TX+3IQ6;D(J06G3B
MM."UQCBK,-KTXK0AMO:LW(1##;X[5?BAQVJ6*#':K218K%R 9''BK2)0J5*%
MJ&R15%/I *6H8!1112$%%%% "4444 %%%% !1112 2BEHH ,48HHH ,4444
M%%%%, HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ I:2B@
MHHHI %%%% !1110 4444 %%!HIB"BBB@ HHHH **** "BBB@ HQ110,,48HH
MH ,48HHH ,48HHH **** "BBB@ HHHH **** "@44"@!:*** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHI &**** $H
MI:* $HI<48I )11BBF 4444 %%%% !1110 4&B@T )1113 **** %%% HH *
M***0!24M)3 **** "BBB@!:*** "BBB@ HHHI %%%% !1110 4444 %+28I:
M "BBB@ HHHH **** "BBBF 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%%( HHHH *2EHQ0 E%&** "BBB@ HHHH$%%%% !1110,****8!1110 444
M4 %%%% !1110 4444 %%%% PHHHH ****0@HHHH **** "BBB@ HHHH **7%
M% "44M% "44M% !1113 **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH ****  TE+1BD E(:=BDH 2BEHH 2BEHH 2EH[T4 %%%% !1110 4
M444P"BBB@ HHHH **** "BBB@ HHHH ****0!1110 4444 %%%% !1110 44
M44A!1113 ***7% Q**7%%  **** "BBB@ HHHI@%%%% !1110 4444 %%%%
M!1110 4444 %%%% !1112 ****0"44N*3% !1110 4444 %%%%, HHHH ***
M* "BBB@!<T9I** %S1FDHH **** "BBB@ HHHI@%%%% !1110 4444 %%%%
M!1110 4444 )12XHQ0 E%+BC% !1110 4444 %%%% !1110 4444 %%%% !1
M112 **** "BBB@ HHHI@%%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 N:,TE% "YHS244 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 N:,TE%
M"YHS244 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4E+24 %%%% !1110 M%%% !1110 4E+24 %%%
M% !1110 ZHI>E2U')TIK<:,NZ[UA7G>MVZ[UA7G>MT4<]>]ZYV]/6NAO>]<Y
M?=ZT0&!=MUK#N7ZUL7AZUA73<FM4@*$TG-56FYIT[<FJ3OS6J0RT)_>IDN/>
MLKS*<LOO6B0S<CNO>KL-UTYKG4G]ZM17'O56 ZF"[Z<UJV]W[UR$-STYK3@N
MO>ER@=A;WG3FM2"\Z<UQL%WTYK3@O.G-0X@=C!>=.:T(;OIS7'P7O3FM&&]Z
M<UFXB.NBN_>KL5U[URD5[[U>BO/>LFA'41W/O5A+CWKG(KSWJW'=Y[UFT!OK
M/[U*LU8J7.>]6$N/>LV@-99*D#UFI-[U.LOO4-"+H:ES599*D#U-A$V:6HPU
M/!I6$+1112 **** "BBB@ HHHH ****0!1112 *,444 )12TE !1113 ****
M!A1110 4444 %%%%,04444 %%%% !1110 4444 %%%% "BB@44 %%%% !111
M0 E%%% !1110 4444 %%%% !1110 4444 %%%%( HHHH **** "BBB@ HHHH
M **** "BBBF 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH ****0!1112 **** "DI:*8"44M)0 4444
M %!HH- "4444P"BBB@!110** "BBB@ I*6DQ0 448HQ0 448HQ0 M%%% !11
M10 4444@"BBB@ I:** "BBB@ HHHH ****8!1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444@"DI:* $HHH
MH ****!!1110,****8!1110 4444 %%%% !1110,**** "BBB@ HHHH ****
M0@HHHH **** "C%+10 4444 %%%% !1110 4444P"BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBBD 48HHH ,4E+
M12 2EQ110 E%+24P"BBB@ HHHI@%%%% !1110 4444 %%%% !1110 4444@"
MBBB@ HHHH ***6@!,44M% "4N***0!1113 **** "BBBF 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444K %%%%
M( HHHH 3%%+13 2BBB@ HHHH **** "BBB@ HHHH **** "BBBF 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M( HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M'F4<H6)LT5%YE&^BP6):*CWTN^E8+#Z*;NI<TA"T444 %%%% !1110 4444
M%%%% !1112 2EHHI@)1110 4444 %%%% !1110 4444 %%%%,84444 %%%%(
M HHHH **** "BBB@ I:2EI""BBB@ HHHH ****8!1110 4444 %%%% !129H
MW4 +13"])OIV'8DHJ+?1YE%@L2YHS4/F4>93Y0L39HS4/F4>9[T<H6)LT9J'
MS*7S*.4+$M%1>91OI6"Q+14>^E#T6$/HINZER*0"T444 %%%% !1110 4444
M %%%%( HHHH *#110 E%%%, HHHH **** "BBB@ HHHH **** "BBB@ HH[T
M4 %%%% PHHHI"%HHHH **** "BBB@ HHHI@%%%% !1110 444F: %HII84F^
MG8!]&:CWTF^BP$M&:A\RCS*?*.Q-FC-0^92^91RA8ES147F4>918+$M%1;Z7
M?2L%B2BH]]&^BP6)**9OI=U%@L.HI,TM(04444 %%%% !1110 4444 %%%%(
M HHHH *2EI* "BBBF 4444 %%%%( HHHH ****8!1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !24M% "44M% "44M% !1110 4444 %)2T4 )12T4
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M+0 4444 !I*4TE !24M)0 4444P"EI*6@ HHHI %%%% !1110 4444 %%%%
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MHL ZBDS2TA!1110 4444 %&*** $HI:* $HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M%%% "44M)0 4444 '>BBB@ HHHI %%%% !1110 4444 %%%% @HHHH ****
M"BBB@ HHHH&%%%%, HHHI %%%% !1110 4444P"BBB@ HHHH **** "BBB@
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M[TN4#0#4\&J:2U,KU#B!8%+4:M3P:AH!:***0@HHHH **** "DI:2@ HHHH
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M 4444 %%%% !24M% "4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1112 ****8!1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 444M "44M% "44M% "44II* "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **444 )12T4 )12T4 )1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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MB@T )1110 4444 %+24M( HHHH **** "BBEH 2BEHH ****8!1110 4444
M%%%&: "BC-&: "BC-&: "@T9I* "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH ****0@HHHH&+1110 4444P$-(:4TAIH:(V
M-0N:E8U6D-:(9%(U4Y9*EE?K5":3&:M(!LLN.]4I9_>FS38K.FGZ\U:0%B2X
M]ZJR77O5*:Y]ZHRW7O5)#--KOWJ(W?O6.]W[U"UW[U20&V;OWI/MGO6$;SWI
MOVSWJN49O_;/>C[7[U@?;/>C[9[U7*!T/VOWI?M?O7/_ &SWIWVSWI\H&_\
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MU"UY[UCM=>]1-<^].P&NUY[U&;OWK(-S[TPW'O18#6-W[TTW7O62;CWI//\
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M HHHH&%%%% !1110 4444 %%%% !1110(**** "BBB@ HHHH **** "BBB@
MHHHH **** "BBBD 4444 %%%% !1110 4444 %%%%,84444 %%%% !1110 4
M444 %%%% @HHHH **** "BBB@ HHHH$%%%% !1110 4444 %%%% !1110,**
M** "BBB@ HHHH **** "BBB@04444 ***04M !1110,**** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****0
M!1124@"BBB@ HHHH ****8@HHHH&%%%%, HHHH **** "BBB@!**** "BBB@
M I:2EH **** "BBB@ HHHH **** $Q1BEHH 3%&*6B@!*6BB@ HHI: $I:**
M "BBB@ HI,T9H 6BF%J87IV E+4PO4+2U$TM4HC)V>HR_O5=IJC,WO3L!:+T
MF^JGF^]*):+ 6P]/#54$E2*]*P%D-3P:@5JD4T@)0:=3 :=2$**6D%+0 4N*
M**0!BC%%% !1110 4E+24 %%%% !1110 4444 %%%% !1110 4444 %%%%(0
M4M)2T#"BBB@ HHHI@(::W2G&F-TIH:()*H3FKTG2L^<]:VB,S;ENM8MT_6M:
MZ/!K#NVZUJAF3=R=:Q+J7K6G>/UK!NWZUH@*%S-UYK)GFZ\U9NI.M8]Q+UK1
M(82S^]57G]Z@EEJJ\U6D,N&?WIAN/>J!F]Z89JT2 T?/]Z43^]9OG>]'G>]5
M8#3%Q[T[[1[UEB6G"6G8#2^T>](9_>J'FTGF46 O&?WIIG]ZI^92;Z0RV9_>
MD\_WJIOI-QJ1%LS>])YQJKN-&32 M><:/.-5<T9I 6O./K1YQ]:JYHS0!:\[
MWH\[WJKN-&XTP+7G>]+YQ]:J;C2[J0%KSO>CSO>JFZC=0(M^=[T>=[U4W4;J
M +?G>])YWO57<:"QH M><?6CSZJ;J3=0!<\_WH\_WJGNHWT 7O/]Z47'O5#?
M0'H TA<>]/6Y]ZR_,IPEI@:RW/O4@NO>L834\3^],#:6Z]ZE6[]ZPA<>].%S
M[T6 Z%+SWJQ'>>]<VMU[U,EU[TK =1'>>]7(KWWKE([OWJW%=^]0T!U\-[[U
MH07G3FN.AO/>M&"\Z<U#0CLX+SWK4M[OIS7&6]YTYK6MKOIS4-".Q@N?>M*&
MXSWKD[:ZZ<UK6]STYK-Q Z6*:KL<E8$%QTYK1AFSBH<0-A'J4&J$<N:LH]8R
MB(L44P-3@:S$+1110 4444 )12T8I )11BEH ,4444 %%%%, HHIC-B@ 9J@
M>2DDDJG+-6B0QTDN*HS3]>:9-/UYK.GN<9YK11&23W'7FLV>Z]Z@N+KKS65<
M7?7FM5$99GN_>LR>\Z\U4N+SKS67/>=>:T2 N3WG7FLZ>\Z\U1GO.O-9LUWU
MYK1(9?FO.O-4I;SWK.EN_>J<EU[U20&E)=^]57NO>LY[GWJ!KCWJAE][GWJ%
MKCWJBTWO49EJ@+K3^]1F;WJH9*-U,"R9:3S*@!IPH DWT;S30*<%H&+NHS2A
M*=LH ;DT9I^RCRZ &9I,U(4II2@!FXTFXTXI3"M !OI1(:81330(F$M.$WO5
M4FDW4 7UG]ZF6X]ZRQ)3A+0!L+<^]3I=>]8@F]ZD$_O4@;Z7?O5J.\]ZYM;G
MWJQ'=>])H1U,5Y[UH0WG3FN1BNO>K\-WTYJ&@.Q@O.G-:=O>=.:XR"[Z<UIV
M]YTYJ&A':6]WTYK4M[KWKC+>\Z<UKVUWTYK-Q Z^"YZ<UHPS^]<K;W73FM6"
MYZ<UFXB.CCFJTDF:Q(9^G-7HIO>H<0-57J0&J4<F:L*]9.(B:BF@TZH$%%%%
M !1112 ,48HHH **** $I:**8!29HI":  FHV:AFJ!Y*M(H'>JLDM)++[U1F
MG]ZT2 =+-[U0FN.O-1SW'7FLNXNNO-:*(R6XN>O-9=Q=]>:AN;KKS61<W?7F
MM$AEFXO.O-9<]YUYJI<7G7FLN>\Z\UJD!>FO/>LZ:\Z\U0FN_>J$MW[U:0S1
MEO/>J<EW[UG277O59[GWJT@-)KKWJ%KGWK--Q[TTS>]4!?:X]ZB:?WJD9::9
M*8RTTWO3#+5<M29H G,E-\RHZ4"@!^^EW4T+3PE  &IP- 2GA*0#<FC-/\NE
M\N@"/-&34GETTI0 S<:3=3BE-*T )O-'F4T@TTB@1*)33A-5:C- %P3^]2+<
M>]9^^E$E(#56Y]ZG6Y]ZQA+3Q/[T"-U;KWJ=+OWKGUN/>I5N?>D(Z6.\Z<U<
MBO/>N5CNO>K<5W[U+0'6PWOO6A#>^]<?%>>]7H;SIS4- =G!>=.:TX+SIS7%
M07O3FM2WO>G-9-".T@N^G-:<%STYKC;>\Z<UK6]WTYK-H#K8;C..:O135S-O
M=9QS6G!<^]0T(WXY,U81ZR(9\]ZNQRYJ&@-!33ZK(]3!JS: ?12 TM2(****
M "DI:* "BBB@ I":":8S4TAV$9J@DDHD>J<LM:QB,)9<=ZHS3^]-GGZ\UF7%
MSUYK11&/GN<9YK,N+KKS4-S=8SS61<W?7FM%$98N+OKS67/>=>:J7-YUYK*N
M+SKS6B0R]/>=>:SIKSWJA/>=>:SY;OWK1(#0EO/>J4EY[UG2W7O522Y]ZM(#
M2>[]ZKO=>]9K7/O41G]ZNP&BUS[U"UQ[U1,WO33+0!;:?WJ(S>]5B]-W4 6#
M+2>94&:49H EWT;J8 :>%H&+NI<T!*>$H ;DTN33@E+Y= #,FDS4OETA2@"/
M)I-QIY2FE* &[C1OH*TTB@!_F4HEJ$TA- %D3>]2+/[U1W4H>D(TEN/>I5N/
M>LH24X34 ;"W7O4R7?O6&)_>GBXQWI ="EW[U;BO/>N82Z]ZLQW7O2$=5%>>
M]7X;WWKD8KOWJ[#>>]0T!V,-[TYK3@O.G-<7#>=.:TX+WIS4-".T@N^G-:D%
MU[UQ=O>].:UK>\Z<UFT!V$%STYK0AG]ZY2WN^G-:D%UG'-9M".DBFS5N.2L&
M&XSCFM"*?WJ&@-9'J4&J$<M64>LVA%C-+48:G@U%A"T444@"BBBD 4E+24 %
M%%% !1113 **** "BBB@ HHHH **** "BBB@ HHHI %%%% !1110 4444P"B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@!:*** "BBB@ H-%!H 2BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** #-&:** #-&:** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** %HHHH **** "@
MT4&@!**** "BBB@ HHHH **** "BBB@ HHHH *,T44 &:,T44 &:*** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M0-2L!+FEI@-.%(!:***0@HHHH **** "BBB@ HHHH **** "C%%% "44M)0
M4444 %%%% !1110 44"B@84444 %%%% !1110 4444 %%%% @HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH ****0!1110 4444 %%%% !1110 4444QA1
M110 4444 %%%% !1110 4444""BBB@ HHHH **** "BBB@04444 %%%% !11
M10 4444 %%%% PHHHH **** "BBB@ HHHH ****!!1110 4444 +124M PHH
MHH ****0!1110 4444 %%%% !1110 4444 %%%%, HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****0!1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%!I* %S2444@"BBB@04444 %%%% !1113 ****8PHHHH ****
M "BBB@!**** "BBB@ I:2EH **** "BBB@ HHHH **** "BBB@ I<444 %&*
M** "BBB@ HHHH *0TM-)H 0FHV?%([57>3%6D,D:2H7FJ"2;WJK)<>]:) 6G
MGJ!Y_>J4ES[U6>Y]Z=@-!I_>F&?WK,-S[TW[1[T[ :OG^].6:LI;CWJ9)O>E
M8#522IT>LR.7WJW&]2T!H(U3J:IQMFK*&I: L"GBHUJ05+ 44M%%(0M%%%(
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M HHHH **** "BBB@ HHHIC"BBB@ HHHH ****!!1110 4444 %%%% !1110
M4444 %%%% @HHHH **** "BBB@ HHHH ****!A1110 4444 %%%% !1110 8
MHQ110 8HQ110 4444 %+244 !HHHH **** "BBBD,**** "BBB@ HHHIB"BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH 6BC-&: "BC-&: "BC-&:
M "BC-&: "BC-&: "BC-&: "BC-)0 4444 %%%% !1110 4444 %%%% !1110
M 4444 +FC-)12 7-%)10 M%%% !1110 49HI* %S1FDHH 7-&:2B@!<T9I**
M "BBB@ HHHH **** #-&:** #-&:** "BBB@04M)13 6DQ110 4444 %%%%
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M "BBB@ HHHI@%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% "T4E% "
MT4E% "T&DHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@!:
M*2B@!:*2B@!:#244 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M 4444 %%%% !1110 4444 %%%% PHHHH **** "BBB@04444 %%%% !1110
M4444 %%%% !1110(**** "BBB@ HHHH **** "BBB@84444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1113&%%%% !1110 4444 %%%% !1110 44
M44 %%%% @HHHH **** "BBB@ HHHH **** "BBB@ HHHI %%%% !1110 444
M4 %%%% !1110 4444 %%%%,84444 %%%% !1110 4444 %%%% !1110 4444
MA!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110(**** "BBB@ HHHH **** "BBB@84444 %%%% !1110 4448I
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M ****8!1110 4444#"BBB@ HHHH **** "BBB@ HHHH$%%%% !1110 4444
M%%%% !1110 4444 %%%%( HHHH **** "BBB@ HHHH **** "BBB@ HHHIC"
MBBB@ HHHH **** "BBB@ HHHH ****!!1112 **** $HHHH **** "EI*6@
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** %J.3I4E1R=*:W&MS-NNAK#N^AK<
MNNAK#N^AKH11S][WKG+WO71WO>N<O>]:Q&<[>=ZP[KO6Y>=ZP[KO6\0,B?O5
M"2K\_>J$E;Q**S]ZB-2OWJ(UNBAII*4TE:(8HIXI@IXJ@'"E%(*44#%HHHI
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M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%,84444 %%%%(04444
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MBIY5'E5:V4;*+C*GE4>55O91LHN!3\KVH\KVJWLH\NBX%3RJ/*JYY8H\L47
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M!PI12"E% Q:***0!1114B"BBBD 4444 %%%%, HHHJAA1113 **** "BBB@
MHHHH ****0!1BBEH 3%&*6B@ Q1BEHH 3%&*6B@!,4F*=24 -(I"*?332$-(
MII%/(IIH 8:::>::12 ::2E-)2 2BEI*DD,T9I**0AP:G!ZCHI#)UDJ59:J
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M **** "BBB@84444 %%%% !1110 4444 %%%% !1110 4444@"BBB@ HHHH
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M->*FQ4<9J2N!D,****1(4444 %%%% !1110 4444 %%%% !1110 4UES3J*
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M %%%% !1110 4444""BBB@ HHHH **** "BBB@84444 %%%% !1110 4444
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MM6,A&_9]JW+;M6'9]JW+;M7/(1KV_:M**LVWK1B-82$6ATI:1>E+6!(4444
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MBLATK*0'26/:NFL>U<U8CI72V(Z5S2$='9]JW+;M6'9CI6[;#@5S2$:472K
MZ5!'TJ;M63 1C5:1JF<U4F;@T) 59WQFLFZEZU=N9,9K%NY>M;Q0S/O)NO-<
M_>S=>:T;R;K7.WDW)YKIB@,^\FZ\U@W<O6K]W-UYK$N9.M;I#*-R_6LFX;.:
MO3OUK-F-6D!4D/-1&I'ZU&:&3(2G"FTX4(E$B#FK42U7C'-78EJS4LPI6G;Q
M]*J0)TK5MH^E)L"_:1=*W;.+I6=:1=*W[.+I6,F(TK.'I6_9P].*SK.+I6]:
M1=*YY,1?M8NE;%O'TJG;1]*U8$Z5S2D(L1IQ4ZBD1>*D%8-DA1114B"BBB@
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M 4444 %%%% !1110 4444 %%%% !1110 4444P"BBB@ HHHH ****0!1110
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M":G"6LP3^]/$_O18#1$M.\RJ F]Z>):5@+H>EWU4$M/$E%@+.ZES4 >GAJ+
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M,"EHH 3:*,"EHH 3%&*6B@!,48I:* #%&*** "BBB@ I*6DH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH&%%%% !1110 4444 %%%
M% @HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M10P]:.]!ZT=ZT0Q13A313A5C'BEI!2T +1112 ****D04444@"BBB@ HHHH
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MQ113 ,4E+24 %%%% !1110(**** "BBB@ HHHH **** "BBB@84444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% "4444 %%%% "T444 %+BDI: #%&*
M** $-%!HH ****  4M(*6@ HHHH ,4E+0: $HHHH **** "BBB@!:***0!11
M13 **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% PHHHH **** "BBB@ HHHH$%%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% "U')TJ2HY.E-;C6YF7/0UAWG>MRYZ&L.\[UT(LY^][USE[WKH[WO7.7O>
MM8C.>O.]85UWK=O.]85UWK>(&3/WJA)5^?O5"2MXC*S5$:E:HC6Z*&'K1WH/
M6CO6B&**<*:*<*L8\4M(*6@!:***0!1114B"BBBD 4444 %%%% !1115#"BB
MB@ HHHI@%%%%( HHHI""BBBD 4444 %%%% !1110 4444 %%%%, HHHH ***
M* "BBB@ HHHH *,T44 &:,T44P"BBB@ I*6B@!,4F*=10 W%)BGXHQ0 S%)B
MI,4F* &;:3;4F*,4@(]M)MJ3%)B@"/;28J3%)B@!E)3B*0TA"4F:#24@%S3@
MU,I,U(B</4BR55S3@U38"XLM3I-[UG!ZD62I: U4G]ZL)<>]8ZRU,LWO4M"-
MM+GWJS'=^]8"S^]3I<>]0T!T<5W[U>BO/>N7CN?>KD5U[U+B(ZJ&\]ZT8;SI
MS7(PW?O5^&[Z<U+B!V$%YTYK2@N^G-<?!>=.:TH+SIS4.(K'8077O6E!==.:
MY""\Z<UIP7?3FLW$1UD-S[U=CN/>N8@N_>K\5WTYK%Q Z-)_>IUE%8<5S[U;
MCN/>LW$1K"0&G!JH)-GO4RR9[U%A%K-%1*]/!I6$.HHHI %%%% !1110 4E+
M10 E%%% !1110(**** "BBB@ HHQ1B@ HHQ1B@ HHHH&%%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 E%%% !1110 M%%% !2TE+0 4444 (:*#1
M0 4444  I:04M !1110 4&B@T )1110 4444 %%%% !1129I@+FES3<TFZBP
M#\T9J/=1NHL,DS29IFZC=18!^:7-1;O>C=[T6 DS1FH]WO1N]Z+ 29HS4>ZC
M=18"7-)FF;J-U%@'YHS3-U&ZBP#\T9IFZC=[T6 ?FC-1[J-U%@),T9J/=1NH
ML%B3-&:CW4;J+ 29HS3-U&ZBP#\T9IFZDW46 DS1FH]U&ZG8"3-&:CW4;J+
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M(****0!1110 4444 %%%% !1110 4444P"BBB@ HHHH **** "BBB@ HHHH
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MVU'2L9"-:V'2M2 5FVPZ5J0"N>0B[%5I*K1U92L9$DM%%%9B"BBB@ I*6DI
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MN(&PDGO4RO69'-[U:26H<1%X&G571ZF#5FT)H=11FBI$%%%% !1110 4444
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MKD=S[TN4#;27-3I)61'/[U;CF]ZAQ TU:I :I)+4ZO6;B!/130U.J"0HHHH
M**** "DI:2@ HI:* $HI:* $HI:#0 E%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% PHHHH **** "BBB@ HHHH$%%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M0 4444 %%%% !2TE+0 4444 %)2TE !0:*#0 E%%% !2BDI10 4444 %%%%
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MM1 O2W7O5*6YSWJI)<>]5GG]ZKE&3RSY[U4DEJ)Y:@:2G8!SO5=VI6:HR:+
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M)*OS]ZH25O$96:HC4K5$:W10P]:.]*:2M$,44X4T4\50QPI:04HH !0:6BD
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M444@"BBB@ HHHH **** "@44"@!:*** "BBB@ I*6DH **** "BBB@ HHHH
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M(CJ(9_>K\4M<[;W'3FM.&?IS630C91ZF#5G12U:1ZS:$6J*C5J>#4"%HHHI
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M**** "BBBD E%!HI@%%%% !1110 4444 %%%% !1110 4444 %%%%( HHHH
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 M1R=*DJ.3I36XUN9EST-8=YW
MK<N>AK#O.]="+.?O>]<Y>]ZZ.][USE[WK6(SGKSO6%==ZW;SO6%==ZWB!DS]
MZH25?GZFJ$E;Q&5FJ(U*U1&MT4--)2FDK1#%%/%,%/%4 X4HI!2B@8M%%%(
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ML:XFY/-7KM^M8MP_)K5(HCEG]ZK-/[U%+)S5=I*T2 M>>?6CSO>J6\T;S5V
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M+Y K&2$:"FGU!&V:G%8,3"BBBD(**** $-%!HH **** "BBB@ HHHH ****
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M,**** "BBB@ HHHH ****!!1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M:=JV[7H*PD(UK?M6E%TK-M^U:472N>0BTO2EI%Z4M8$A1110 4444 %)2TE
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M4444@"BBB@!**#10 4444@"BBB@ HHHH ****8!1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M1110 4444 %%%% !1110 4444 %%%%( HHHH **** "BBB@ %+2"EI@%%%%
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MZUI(?:JDD6.U4AF>R5&5JXZ5 RU2 KD48J0BFD50#,44N*0T[""G*<&FT9I
M6XGQ5^"3I62C5<A>H: WK:7IS6S:S=*YF"3I6O;2]*RDA'56D_3FMZTGZ5R-
MI-TYK>M)NG-8R0CK;2;IS6U;2]*Y:TEZ5NVDG2N>2$=# _2M&)NE8UN_2M2!
MNE8,1HQFIATJO&>E6!TK-B"BBBD(**** $-%!HH ****0!1110 4444 %%%%
M, HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M@HHHH **** "BBBD 4444 %%%%,84444 %%%% !1110 4444 %%%% !1110
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M*** "BBB@ HHHH$%%%% !1110 4444 %%%%( HHHH **** "BBB@ %+2"EH
M****8!1110 4&B@]* (9.E4+CH:OR=*H3]#6T"C&N^]<_?=ZZ"[[US][WKIB
M,YJ_[US-[WKIK[O7-WO>MXC.=N^IK%N.];=V.36+<#K6Z*,V7K59JLR]:KMU
MK5#&T44M4 444M4,44X"D IPIC% I<4"EQ0 E&*7%&* &T4[%&* &TN*,4M
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M!1110 4444P"BBB@ HHHI""BBB@ HHHH **** "BBB@ HHHH&%%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444#"BBB@ HHHH **** "BBB@ %
M+2"EH$%%%% !24M)0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M1B@!,48I<48H 3%&*7%&* $Q1BEQ1B@!,48I<48H 3%&*7%&* $Q1BEQ1BF
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M HHHH ****8!1110 4444 %%%% !1110 4444@"BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ I*6DI@(:8:>::: (S333S3#28"4H-)14,1,C59CDJD#S
M4JMBH:$:L,O2M.VGY'-8,4E7X)>E9-".HM;CIS6[9W'3FN0MING-;=I/TYK&
M2$=E9W'3FM^TGZ<UQEG/TYKH+.?IS6,D(ZZVFZ<UK6\O2N8M9^G-;-M-TYK"
M2$;L;Y%3JU9T4N15M'K%HDL@TM1J:>*AB%HHHI %)2TE( -)2TE !2BDI10
M4444P"BBB@ HHHH **** "BBBF,**2EH ****0@HHHH ****0!1110 4444
M%+24N:8!1110 4444 %1LN:DI"* *DB52FBR*U&6JTD?%:)C,&YAZ\5AWD'!
MXKJKB+@UC7</7BMXLHXR^M^O%<Y>V_7BNVO8.O%<[>P=>*V3 XRZ@Y/%8\\.
M,UU5W!R>*QKF#KQ5IC,!XZC"<UHRP\]*@\OFKN 0KS6K;=15").:TK9>12;
MVK/M7061Z5S]H.E;]GVJ&(Z*S/2MZT/2N?LSTK>M#TK&0&Y;'@5JP]*R;;M6
MK#T%8R$7%Z4M-7I3JP)"BBB@ HHHH *2EHQ0 AI*6C%,!*448HH ****0!11
M10 4444 %%%% !1110 4444 %%%%(04HI*44#"BBB@ HHHI@)3&I],:FAHK2
MUGS]*T):SY^E=$2C(NN]8EWT-;=UWK#N^];H9@7G>L"\[UOWG>L"\[UJAF%=
M=ZQ;CJ:VKKO6-<=ZU0&9-5*2KLU4I*U0RNU1FI'J,U8,8:!0:!4F9-']ZM2U
MZBLN/[U:EKU%-FAOV7:NFL!TKF;'M73V'45E(1U%@.!736(X%<U8=JZ>Q[5A
M(1OV@X%:\*\5E6G05KP=*Y:FPBRHXIU(.E+7(0%%%% !1110 4444 %%%% !
M1110 4TKFG44 0.G%4IH^*TF'%5I4XK6$BD8-U%P>*P[R'K73W,?6L6[CZUT
MQ91R-[#UXKG;V'KQ78WD77BN>O(>O%;)@<?>0]>*P[J+K767D/7BL&ZAZ\5J
MF,YN>/DU2=*V;B+DUGR1XS6B&42*8:L.M0-UJT,3-.#4PT TV2V64>KD,E9J
MM5F-ZD29NVLO(K<M)NG-<O;2<BMJTEZ5+0SK;.;IS70V<W3FN0LY>E=!9R].
M:QDA'76DO3FMRVEZ5RMG+TK>M9>!7/)".A@>KT;5D6\G2M&)^*PDA%Y34@JN
MC5.IK%B8ZBBBI$%%%% !1110 4UNE.I&H0%.8<&LJY3K6Q**SKA>M;Q91SUW
M'UK!O(NO%=1=1]:P[N+K71%E')WL77BN?O(NM==>1=:Y^\AZUO%C.5NHNM9$
MZ=:Z.[BZ\5BW,?6MDQF+*N*IR#K6E.E9\HZU:&5C333FIAI,SD%/6F4X4($6
MHC5^%NE9L9J["U4:&Q;OTK8M9.E8$#]*UK:3I4M =-9R=*W[.3I7*V<G2M^S
MDZ5E)$G5V;]*WK5^E<O9R=*Z"TDZ5SR0CH+=NE:<)XK&MGZ5K0-Q7--"+@Z4
M4BG(I:YR HHHH **** "BBB@ HHHH *3%+10 4444@"BBBF 4444 %%%% !1
M110 UNE5935B0\52G>M((I%.=^M95S)UJ[<R=:QKJ7K75%%&?=R]:P;R7K6A
M>3=>:P+R;KS73%#,Z\EZU@7<G6M*[EZUAW4G6MDAF?=/UK(N#UK0N'ZUF3MU
MJP*4O6H#4LE1&DR9"4HI*44D2AXJQ&*@7K5J):HT1:B6M*W7D52@3D5J6R<B
MI; T;1.E;UG'TK+M(^E;]E'TK*3$:UE'TKH;./@5E6472M^TCX%828&E:Q]*
MUX$JC;)TK4A6N>3)+40XJ=:B08%29K)B'$U&STC/5=Y,5-A$K24PR^]57F]Z
MA:?WJDA%TS4TS^]9[7'O4;7'O3Y1F@9_>HVN/>LYKGWJ%KGWJE$9IM<>],-S
M[UDM=>],-U[U7*!LBX]Z<MQ[UB"Z]ZE6Y]Z.4#;6?WJPDM8D=Q[U;BG]Z30&
MPDF:G5LUF12YJY&^:AH1=!I:B1JE!K)H04444@"BBB@ HHHH **** "BBB@
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M 2BBB@ HHHI@%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444@
M"BBB@ HHHH **** "BBB@ HHHI@%%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1112 **** "BBB@ HHHH **
M**8!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 M1R=*DJ
M.3I36XUN9EST-8=YWK<N>AK#O.]="+.?O>]<Y>]ZZ.][USE[WK6(SGKSO6%=
M=ZW;SO6%==ZWB!DS]35"2K\_>J$E;Q&5FJ(U*U1&MT4,/6DI3UI*T0Q:>*93
MQ5C'"E%(*44 %+2"EI %%%%2(****0!1110(*6DH%,!:***!A1113 *2EI*!
MA1110(*,T44@#-&:** #-&:** #-&:** #-&:** "BBB@ HHHI@%%%% !111
M0 4444 %%%% !1110 4444 %%%% !1FBB@ S1FBB@ S1FBB@ S1FBB@ S2YI
M** %HI** %HI** %I*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHI@% HHI@+11FBD &F&GFF&DQ$;5&:E:HS4L!E%+14,
MD<O6K,=5U%6(ZEC+T)K5MCTK(A-:=L>E9L1O6C=*WK-NE<Y:MTK=LVZ5C(1T
MMFW2M^T;I7-6;=*W[1NE8R1)T-JW2M:!N!6):MTK7MS6$D(TXSQ5A>E58C5E
M>E82$/HHHJ!!1110 4444 %)2TE !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% "BB@44 %%%%
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M*6DH 3%+110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M %%%% !1110 4444 %%%% @HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M0!1110 4444 %%%% !1110 4444P"BBB@ HHHH **** "BBB@ HHHH ****
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M-Q;]>*T3 Y2>V]JH26_M72SVW7BJ$MO[5=QF)Y'/2IHXN>E73;\]*<L/M1<
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M=.:R:$;J2U.KUE1S>]6DEK)H"^K4\&JB25,KU+0B>BF!J<#4"%HHHH ****
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MVXZ5S2$:,':K8Z56A'2K0Z5DQ!1112$%%%%  :2E-)0 4444@"BBB@ HHHH
M****8!1110 4444 %%%% !1110 4444 %%%% !1110 4444#"BBB@ HHHH *
M*** "BBB@ HHHH$%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1112 **** "
MBBB@ HHHH **** "BBBF 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444@"BBB@ HHHH **** "BBB@ HHHH ***
M*8!1110 4444 %%%% @HHHH **** "BBB@84444 %%%% !1110 4444#"BBB
M@ HHHH ****!!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M]ZQ;CK6\2C.EZFJS59EZFJS5LAC*6DI:L8"G"FBG"F X4\4P4\4 .%+2"G4
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH ****0!1110 4444 %%%%, HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBBD
M 4444 %%%% !1110 4444P"BBB@ HHHH **** "BBB@04444 %%%% !1110,
M**** "BBB@ HHHH ****!A1110 4444 %%%% @HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** %J.3I4E1R=*:W&MS,N>AK#O.];EST-8=YWKH19S][WKG+WO7
M1WO>N<O>]:Q&<]>=ZPKKO6[>=ZPKKO6\0,F?O5"2K\_>J$E;Q&5FJ(U*U1&M
MT4--)2FDK1#%%/%,%/%4 X4ZFBG4 %%%% !1114B"BBBD 4444 %%%% !111
M5#"BBB@ HHHH **** "BBBD 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1113
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M99N;OKS61<W?7FH+B[Z\UE7%UUYK1(9+<W/7FLJ>XSGFF3W&<\UGS3Y[UHD
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M:,5+3%%/J&(****0!1110 AHHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH&%%%% !1110 4444""BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@04444 %%%% !1110,**** "BBB@ HHHH ****!A1110 4444 %%%% @HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MHS244 +FC-)10 N:,TE% "YHS244 +FC-)10 N:,TE% "YHS244 +FC-)10
MN:,TE% "YHS244 +FC-)10 N:,TE% "YHS244 +FC-)10 N:,TE% "YHS244
M +FBDHH 6DS110(,TN:2B@!<T9I** %HI*44#"C-!I* %S1FDHH 7-&:2B@!
M<T9I** %S1FDHH 7-&:2B@!<T9I** %S1FDHH 7-&:2B@!:*2BF M%)10 [-
M%)10 4TTXTTTA#349IYIAI -HHHI .%2+48J1:E@6(ZOP51CJ]!UJ&(U;;M6
MS:=JQK;M6U:=JQD2;MGVK?L^U8-GVK?L^U82$;MKVK:MNU8MKVK:MNU8R$:D
M'2KT?:J,'2KT?:L)$EA:=35IU9,04444@"BBB@ I#2TE @HHHH **** "BBB
M@84E+24 %%%% "T4@I: "BBB@ I*6DH **** "BBB@!:*** "@444 +1244
M+1244 +2444 +12"EH **** "BBB@ HHHH BDZ50N.]7Y.E4+CO6T"C&N^]<
M_?=#707?>L"][UT1&<U?=ZYJ^[UTU]WKFKWO71$:.>N^]8MQU-;=WU-8MSU-
M;Q*,V7K59JM2]:K-6R&,HHHJA@*<*;3A5 .%/%,%/% QU**04HH *#2TE "4
MHHQ10 49HI* %S1FDHH 7-&:2BD N:,TE% "YHS244 +FC-)10 N:,TE% "Y
MHS244 +FC-)10 N:*2EI@%&:2B@0N:,TE% "YHS244 +FBDI: "C-)10,7-&
M:2B@!<T9I** %S1FDHH 6BDHH 6BC-%,84HI** %I#2YI*0A#333S330 PBF
MD5(132* (R*;4A%,-2P&TY3BFT5+)+4;U>@DYZUEH>:MPO4- ;]M-C'-;5I/
MTYKEX)<8K6MIL8YK)HD["SN.G-;UI<=.:XRTN.G-;MI<].:QDA':6EQTYK:M
MI^G-<?:7/3FMRUN.G-820CJ(9>!S5Z-ZP;>?@<UIPRUBT(U4:I152)\U94UE
M)"'T445 @HHHH 2BBBD 4444@$Q2T44""EI**8Q:*2BF M)110 4444 %%%%
M !1110 4444@"BBB@ HHHH 6BBB@ HHHI@%%%% !24M(: $(IA%24A%,9 RU
M"\=6R*C9:I,"B\?M5=XO:M)DJ%HZJXS+:&HC#6FT51F*G<#/\GVI1%[5=\J@
M1T7 KK'4Z)4@CJ14I7$*BU.HIBK4JBD(D6I14:U(*E@.IU-%+4@+1110 444
M4@$-%%% !1110 4444 %%%% !1113&%%%%, HHHI""BBB@ HHHI""E%)2T#"
MBBB@ HHHI@)3&I],:FAHK2UGW'0UH2UGW'0UTP&8]UWK#O.];EUWK"O.];H9
M@7G>N?O.];]YWKG[SO6J&8=WU-8MQU-;-WWK&N.M:(9FS53DJW-51ZU0RNW6
MF&GMUIAJF)C#0*#0*@S)$ZBM*UZBLQ.M:5KU%,T6QOV745TMAVKF;+J*Z:P[
M5C(#J+#M73V/:N8L.U=/8]JYY".@M.@K8@[5CVG05L0=JPD27H^E2BH4J85S
ML3%HH%%2(**** "BBDH **** %HI** %HHHH **** "FD4ZDH B9:KR)5LBH
MG6K3&95Q'UK'NHNO%=#.G6LJYCZUO%E'+WD77BN?O8>O%=;=Q=:P;R'KQ71%
MC./O(>O%8-W%UKKKR'KQ6!=P]:WBP.6N8^M9<R8-=#=1=:R)X^36R91E.M0L
M*NR)BJKK5"(C32:<:8:ADL :E1JAS3E-2),T8'YK7M9.E8$+<UJVS\BAEG3V
M<O2NALING-<E:2=*W[*7I4- =A93=.:Z"TEZ<UQ]E-TYKH;.;IS64D(ZJVEZ
M<UJPR<"N<M9N!S6Q;R]*YY(1L1O5A36?$]6T:L&A%D&G4Q33ZS9(4444@"BB
MB@ HHHH 8PXJM*F:MFHG7-7%C,J>+.:R[B'.>*WY4JA-#6T6,YBZM^#Q6'=V
MW7BNPN(,@\5D75MUXK:+&<5=VO7BL.ZMNO%=M=6O7BL.[M>O%;18SC+FWQVK
M*G@Z\5UMU:]>*QKFVZ\5JF,YF:+VJC*E;UQ!UXK-FA]JNX&2PQ3:MR157*8H
M)L,IP-&*2@"16Q5B.2JE/5L4%&I%-CO5Z&X]ZQ4>K44M*PSHH+GIS6G!==.:
MYB*?WJ_#<8[TK =7!=].:TH+OIS7)0W73FM"&[Z<U+0CKX;SWJ_%>>]<A#>>
M]7XKSWJ'$#K8[SWJPEW[URT=[[U92]]ZAQ$=,MW[U*MW[US:WOO4JWOO4N('
M1B[]Z/M?O6 +WWH^V^]3R@;IN_>HVN_>L0WOO437OO340-IKOWJN]W[UCO>^
M]5WO?>K40-:6\]ZI37GO69+>>]4I;SWJE$#1FO.O-9T]Y[U1FN_>J$UW[U7*
M!<GN_>LV>ZZ\U5FNO>J$UQUYIV&3SW/7FLZ:?.>:CFG]ZI22YJD@'RS>]4Y)
M,T.^:@8Y-4A"%LTTTM)BF)B4HI<4](\T!8$7-6XH\XI(HO:K\,'3BBY0L,6>
MU:4$'3BBWM^G%:MM;=.*AL MK?IQ6Q:VW3BBUM>G%;5K:].*R;$.M+;IQ6Y:
M6W3BF6MMTXK:M;?IQ638B2UM^G%;%O#CM45O!C'%:<,59-B)8(\8K0C6H8DQ
M5I!6,F \"EHHK(D0U!*.*L&HG'%4AF9.G6LNXCSFMN5,U0GBS5H9S5U#UXK"
MNX.O%=?<09SQ6/=6V<\5H@.*N[?KQ6%=6W7BNWN[3KQ6'=6G7BM4!Q5S;\GB
MLFX@Z\5V-U:=>*QKFTZ\5LAG*3P]>*H21XKI+BUZ\5F36_M6B QR*9BKTD'M
M5=HR*=B'$BI12[:,46"PH-3(Y%0TX52+1?BE]ZO13X[UCHU64DHL4;T-Q[UH
MPW7O7-Q38[U=BN,=Z5@.GAN_>M"&\Z<URL5S[U=BNO>E8#K8;SIS5^*\]ZY&
M*[]ZNQ7GO4\H'6QWG3FK27GO7*QWGO5I+SWI<HCJ4N_>ITN_>N82\]ZG2]]Z
MGE Z9;OWJ47?O7-K>>]2"\]ZEQ$=$+OWIPN_>N>%Y[TX7OO2Y0.A%W[TOVOW
MKGQ>^]+]M]Z7*!O_ &OWI#=^]8/VSWIIO/>CE WC=^],-W[UA&]]Z8;WWHY0
M-QKOWJ![OWK&:]]ZA>]]ZI1 UI+OWJI+>>]94EY[U4EO/>K2&:<MY[U1FO.O
M-9TMY[U1FN^O-6D!>GN^O-9L]W[U3FN^O-49KGWJDAEF:Z]ZSIKC/>H);CWJ
MG)-FJL,EEGSWJG)+[TUY,U7=Z=@"1ZKLV33F-1T"$H%%."YI" #-3(F:$CJW
M'%3N V..KL,/(XIT,&>U:,%OTXI7 =:P=.*W+.WZ<5#:VW3BMVSMNG%0V!:L
MK?IQ706<' XJI9V_3BMZT@X'%8R8%FVAZ<5JPP\#BHK:'IQ6I#%6+8$:P^U#
M0^U7UBXI3#[5DY"9BS0<=*S+FWZ\5TTD''2L^XM^O%$6"..N[;KQ6%=VW7BN
MVNK7KQ6'=VG7BMTP.(N[?KQ6'=V_7BNVN[3KQ6%=VG7BM$,XVY@Z\5DSQ<GB
MNLNK7KQ6/<6W7BM4!SLB$&HB*U)K?VJF\)!IV):N5<4M/*8I-M*Q/*(#3@:3
M% IH$3(Y!JY%+6>*GC:JL:(UX9_>M"&X]ZPHY*MQS8IV&='#=>]:,%WTYKEX
MI\=ZO17..]*P'5PWG3FM&&\]ZY&*[Z<U>BO/>IL!U\5[TYJY'>>]<E%>=.:M
MQWOO4N(CK$O/>K"7GO7+1WOO5E+WWJ'$#IUN_>I5N_>N:2]]ZF6]]ZEQ$=&+
MOWIPN_>N=%[[T\7OO2Y0.A%W[T[[7[USPO?>G?;/>ER@;_VOWH^U^]8'VWWH
M^V^]'*,W3=^]--W[UA&]]Z:;WWHY0-PW?O437?O6*;WWJ)[WWJE$#8>[]ZK2
M7GO60][[U5DO?>K40-:2\]ZI2WOO67+>^]4I;SWJDAFE->>]9L]Y[U1FO/>J
M$UW[U5@+<]W[UG3W.>]5I;GWJE+/GO56&2S3YSS5&6;KS3))<U6D>G8!))*J
M.V:>[9J$T (32448H)%IP&:0+FIXX\TQV%1*M119I8H<]JOP6^<<4K@+;P].
M*U[6WZ<4RVMNG%;5I;=.*EL"6TM^G%;MI;].*AM+;IQ6[:6W3BLI,1-:6_3B
MMRU@Z<5!:V_3BMFV@QCBL9,1-;P].*TH8\"HX(JOQQUSR8A42K"BD5:D K)L
M0X4ZD%+4B"BBB@ I*** $HHHH 6BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBBF(**** "BBBD,**** "BBB@ HHHH **** "BBBD 4444 %%%% !111
M0 4444 %%%%, HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBBD 4444 %%%% !
M1110 4444 %%%%, HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH 6HY.E25')TIK<:W,RYZ&L.\[UN7/0UA
MWG>NA%G/WO>N<O>]='>]ZYR][UK$9SUYWK"NN];MYWK"NN];Q R9^]4)*OS]
MZH25T1&5FJ(U*U1&MD4,/6DI3UI*T0Q13Q3!3Q5 .%.IHIU !10** "BBBI$
M%%%%( HHHH **** "BBBJ&%%%% !111B@ HHQ1B@ HHHI %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% @HHHH **** "BBB@ HHHH&%%%% !1110
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M9JV0QE%%%4,*<*;3A5#'"G"FBG"@!XI1312B@!:2EI* "BBB@ HHHH ****
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M@+1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1113$%%%% !1112 ****!A
M1110 4444 %%%%( HHHH **** "BBB@ HHHH **** "BBBF 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%%( HHHH **** "BBB@ HHHH **** "BBBF 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M7,VL_3FMFWFZ<UC)"-R-\U85JS89<XJXCYKG:$RR*6F*:?69(4444@"DI:*
M$HHHH **** "BBBF 4444 %%%% !1110 4444 %%%%( HHHH **** "BBB@
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MK:DMO:JKV_M5 93)497FM!X/:H&BJD4BKTHW8J5HZB*XI@.$E2++[U!BDR:
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M>SZ\5JF,XZ:T]JHRVOM76SV?7BL^:S]JM,9RTEM[56>W]JZ.6T]JJ26OM57
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M HHHH **** "BBB@ HHHH$%%%% !1110 4444 %%%% !1110,**** "BBB@
MHHHI %%%% !1110 4444 %%%% !1110 4444P"BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHI %%%% !1110 4444 %%%% !1110 4444P"BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M9"-:U7I6Q;K6;:KTK6@7I6$A%V(<5;057B'%65%82)8M+1168@HHHH ****
M"DI:2@04444 %%%% !1110 4444#"BBB@ HHHH **** "BBB@ HHHH ****
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M444 %)110 4444 %%%% !112T %%%% !1110 &DI324 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110(*
M*** "BBB@ HHHH ****!A1110 4444 %%%% !1112 **** "BBB@ HHHH **
M** "BBB@ HHHI@%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1112 **** "BBB@ HHHH
M **** "BBB@ HHHI@%%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% "U')TJ2HY.E-;C6YF770UAW?>MVZZ&
ML.[Z&NA%G/7O>N<O>]='>]ZYR][UK$9SUYWK#NN];EYWK#NN];Q&9$_>J$M7
MY^]4)*WB,K-435*]1-6Z&,-%!ZT5HBA13A313A5 .%+2"G4P"BBBD M%%%2(
M****0!1110 444E,!:***8!1113&+1110(**** "DI:2D 4444 %%%% !111
M0 4444 %%%% PHHHHL 44446 ****+ %%%%%@"BBBBP@HHHH ****0!1110
M4444QA1110 4444""BBBD 4444P"BBBF 9I,TM% !1112 ****!!1FBB@844
M"BF 4444@"BBB@ HHHI %%%% !1113 **6B@8E%+10 E%+10(2BBBF M%%%
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M&/%.I@-+F@8ZD-)FC-,!:*;FC- #J*;FC- AU%-S1F@!U%-S1FD ZBFYHS0
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MB@ Q1BBB@ Q1BBB@!,44M% !1110 4HI*44 %%%%( HHHH ***3- "T49HH
M**** "BBBF 44F:* "BBB@ HHHH ****!!1112 **** "BBB@ HHHI@%%%%
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M.U]JM1VWM5Y+?VJ=(.G%2Y 4TM_:K*0>U6EAJ98JS<A%=(:L)'4JQU*J5#D
MQ4J55I0M. J&Q !2T45(@HHHH **** "DI:2@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH ****!!1110 4444 %%%% !1110 4444#"BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBBD 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444P"BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHI %%%% !1110 4444""BBB@ HHHH **** "BB
MB@84444 %%%% !1110 4444 %%%%, HHHH ****0!1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1113 **** "BBB@ HHHH **** "BBB@
M HHHIB"BBB@ HHHH **** "BBB@ HHHI#"BBB@ HHHH **** "BBB@ HHHH
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MC=3,T9H ?FC-1YHS0!)FC=4>:,T 2;J-U1YHS0!)NHW5'FC- $FZC-1YHS2
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****!!1110 4444
M%%%% !1110 4444#"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBBD 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%,
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHI %%%% !
M1110 4444""BBB@ HHHH **** "BBB@84444 %%%% !1110 4444 %%%%, H
MHHH ****0!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M13 **** "BBB@ HHHH **** "BBB@ HHHIB"BBB@ HHHH **** "BBB@ HHH
MI#"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M %%%% !1110 4M)2T %%%% !1110 9HS244 +FC-)10 4444 %%%% !1110
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MA:<%I<4A" 4X48I:0!2T44@"EI** %HI** %I*** "BBBD M&:2B@!:*2EH
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1113 **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBBD 4444 %%%% !1110(**** "BBB@844
M44 %%%% !1110 4444 %%%% !1110 4444P"BBB@ HHHI %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%%, HHHH **** "BBB@ HHHH
M **** "BBBF(**** "BBB@ HHHH **** "BBBD,**** "BBB@ HHHH ****
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MHV5;\KVH\KVHN!4V4FRKGE>U'E>U.X%/92[*M^52>51<"KLI-GM5ORJ/*IW
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MHQ2T4 -Q1BG44 -VTFVGT4[@,VT;:?1B@8S;1BGXHQ0 W%&*=BDQ2$&****
M"BBB@ HHHH **** "BBB@ HHHI %%%% !1110 9I:2BD M%)1F@!:***8!11
M13 **** "BBB@ I,4M% "8I-M.HH 9MHVT^BG<!FVDVU)11<9'MHVU)11<"/
M;1MJ2BBX$>VC;4E%%P(]M+MI]%%P&;:-M/HHN(;MHQ3J*+@)BC%+12 ****
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M*6BB@ HHHH **** "BBB@ HHHI %%%% !1244 %%%% !1110 4444P%HHHH
M**** "D-+2&@ HHHH **** "BBB@ HHHH ****!!1110 4444 %%%% !1110
M 4444#"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBBD 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%%, HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH ****0!1110 4444 %%%% !1110 4444 %%%%, HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH ****8@HHHH **** "BBB@ HHHH ****0PHHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MJCRJOB#VI?(]J+@9_E4>56AY'M1Y'M2N,S_*H\JK_D>U'D>U%P*'E4OE5?\
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1112 ***3- "FDS124P#-&:** #-%%% "T444@"BBBF
M M%)FES2 **,T9H *2BB@ HHHH **** #-+FDHH&+124M @HHHI@%%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444@"BBC- !244M "44M% "44M% "4444P"B
MBB@!:*,T9H **,T9H *0TN:2@ HHHH ***6@!**6B@!**6B@!**4TE @HHHH
M **** "BBB@ HHHH&%%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%%( HHHH **** "BBB@ HHHH ****8!1110 4444 %%%%
M !1110 4444@"BBB@ HHHH ****8!1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%%,84444 %%%%(04444 %%%% !1113 **** "BBB@ HHHH
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M^U9MB(HX<=JM)'BGI'4RI6;8"*M2 4 4X5#8A:***D04444 %%%% !24M)0
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M1112 0T4&BF 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 &DI324 %%%% !1110 M%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% "BB@44 %%%% "&B@T
M4 %%%)0 M%)FEH 6BD!I<T %%%% !1124 +129I<T %%&:,T %%)FC- "T4E
M% "YI,T44 %%%% !1113&%%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 48HHH$%%%% !1110 4444@#-+244 +1110 4444 %%%% !1110 4444
M%%%% !1110 4E%% !1113&%%%% !1110 4444 %%%% !1110 8I*6B@0E%+1
M0 E%+12 2BEHH 2BEHI@%%%% !2YI**0"T4E% "T4F:,T +11FC- !11FC-
M!1244 +1244 +1244 +1110 4444 %%%% !1110 4444 %%%% !11FDS0 M&
M:2B@ HHHH ****!A1BBB@ Q1BBBF 8HHHH **** "BBB@ HHHH **** "BBB
M@ HHHI %%%%%@"BBB@ HHHH ****+ %%%% !1113 **,T4 &:7-)12$+1249
MH 6BC-&: "BC-&: "BC-&: "BC-% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !11FDS0 M%)10 M)110 4444 %)2FDH ****8!1110
MM%%%( HHHH **** "BBB@ I,TM% "9HI:*+ )2T446 ****!A1113 *7-)12
M$+1244 +1244 +129HS0 M%&:,T %%&:,T %%&:* "BBB@ HHHH **2B@!:*
M2B@!:*** "BBB@ HHHH **** "BBB@ HHHH **,TF: %HS244 %%%% !2TE+
M0 4444 %%%% "4444 %%%% !1110 4444 %%%% !1110 4M)2T %%%% !111
M0 &DI324 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1112 **** "BBB@ HHHH ****8!1110 4444 %%%% !11
M10,**** "BBBF 4444 %%%% !1110 4444 %%%%(04444 %%%%, HHHH ***
M* "BBB@ HHHH ****0!1110 4444 %%%% !1110,****8!1110 4444 %%%%
M !1112$%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MHH **** "BBB@ HHHH **** "BBB@ HHHH 444"B@ HHHH 0T4&B@ I*6DH
M**** %%%)1F@!:*3-&: %HI,TM !1113 **** "BBB@ HHHH ****!A1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% @H
MHHH **** "BBB@ HS12T@#-&:** "DI:2@ HHHH **** "BBB@ HHHH ****
M8PHHHH **** "BBB@ HHHH **** "BBB@ HHHH$%%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1FDHH 7-&:2B@!<T4E% "YHS244
M@%HI*44 &:,T44 %%%% !1110 4444 %%%% !1110 4444 %%%%,84444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !24M)0 4444 %+FDI: "BBB@ HHHI""BB@T %&:2B@!<T9I*44 &:
M,T44 &:,T44 &:7-)10 N:3-%% !FC-%% !FC-%% !1110 4444 %%%% !12
M9HH 6BDHH 6BDI: "BBB@ -)2FDI@%%%% !1110 M%%%( HHHH **** "BBB
M@ HHHI@%%%% !1110 4444#"BBB@ HHHH **** "BBB@ HHHH ****!!1110
M 4444@"BBB@ HHHH ,T9I** %S1FDHH 7-%)10 N:,T44 &:*** "BBB@ HH
MHH **** "BBB@ HHHH **** "EI*6@ HHHH **** $HHHH **** "BBB@ HH
MHH **** "BBB@ I:2EH **** "BBB@ -)110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%( HHHH **** "B
MBB@ HHHI@%%%% !1110 4444 %%%% PHHHH ****8!1110 4444 %%%% !11
M10 4444A!1110 4444P"BBB@ HHHH **** "BBB@ HHHI %%%% !1110 444
M4 %%%%,84444 %%%% !1110 4444 %%%%(04444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M %%%% !1110 4444QA1110 4444 %%%% !1110 4444 %%%% !1110(****
M"BBBF 4444 %%%% !1110 4444 %%%%( HHHH **** "BBB@ HHHH *2EHH
M2BEHH ****0!1110 4444P"BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH ****8PHHHH ****0@HHHH **** "BBBF,**** "BBBD(**** "BBBF,
M**** "BBB@ HHHH$%)2T4 )12T4#$I:** "BBE%(0E%+10 E%+24@"BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBBF 4AI:0T %%%% !
M1110 4M)2T %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444P"
MBBB@ HHHH **** "BBB@ HHHH&%%%% !1112$%%%% !1110 4444 %%%+0 E
M%+12 2BEHH 0TE+10 E%+13 ****0!1113 **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHI %%%%, HHHH **** "
MBBB@ HHHH ****!A1110 4444 %%%% !1113 **** "BBB@ HHHI""BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M!**** "BBB@ HHHH **** "BBB@84444 %%%% !1110 4444 %%%% @HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBBF 8IN*=10,9BDVU)BC%%P(2E)Y=3XHQ3N%RMY5'E59VT;:?
M,%RKY/M1Y/M5K;1MHYAW*OD^U'D^U6MM&T4<P7*OD^U'D^U6MHHVT<P7*OD^
MU'D^U6MM&VCF"Y5\GVH\GVJUMHVT<P7*ODCTH\D>E6MM&VCF"Y5\D>E'DCTJ
MUMHVT<P7*ODCTH\D>E6MM&VCF"Y5\D>E'DCTJUMHVT<P7*ODCTH\D>E6MM&V
MCF"Y5\D>E'DCTJUMHVT<P7*ODCTH\D>E6MM&VCF"Y4\GVH\GVJWMHVT<P7*G
MD^U'D^U6]M&VCF"Y4\GVH\GVJWMHVT<P7*GD^U'D^U6]M&VCF"Y4\GVI?)]J
MM;:-M',%RKY/M1Y/M5K;1MHY@N5?)]J/)'I5K;1MHY@N5?)'I1Y(]*M;:-M'
M,%RKY(]*/)'I5K;1MHY@N5?)'I2>3[5;VT;:.8+E3R?:CR?:K>VC;1S!<J>5
M[4>5[5:VT;:.8+E7RO:CRO:K6VC;1S!<J^3[4>3[5:VTNVCF"Y4\GVI?)]JM
M;:-M',%RKY/M1Y/M5K;1MHY@N5?)]J/)]JM;:-M',%RKY/M1Y/M5K;1MHY@N
M5?)'I1Y(]*M;:-M',%RKY(]*/)'I5K;1MHY@N5?)'I1Y/M5K;1MHY@N5?)]J
M/)]JM;:-M',%RKY/M2>3[5;VT;:.8+E3R?:CR?:K>VC;1S!<J>3[4>3[5;VT
M;:.8+E7R?:CR1Z5:VT;:.8+E7R?:D\GVJWM%&T4<PKE3R/:D\@>E7-M&T4<P
M[E/R1Z4>2/2KFT4FVCF%<J>3[4OE5:VT;:?,!6\NE$=3[:-M+F B"4X+4FVC
M%*XAH%**7%%(!12BDH%(!:***0"4444 %%%% !1110 4444P"BBB@ HHHH *
M*** "BBB@ I*6DH **** "BBB@!:*** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHI %%%% "4444P"BBBD 4M)2T %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%%QA1111< H
MHHHN 44447 ****8!1110 4444 %%%% !24M% !1112$%**2BF M%%%( HHH
MH *2EI* "BBB@ HHHH **** "BBB@ HI*6F,**** "BBBD 4444 %%%)0 M%
M)10 M%)2T %%%% @HHHH *2EHI@)12T4 )12T9H 2BES1FD E**,T4 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1112 ****8!1110 4444 %%%%,
MHHHH **** "BBB@ HHHH **** "BBB@ HI** %HI** %HI*,T@%HHHH ****
M "BBBF,**** "BBB@04444 %%%% PHHHH *2EHS0(2BES1F@!**7-% !1110
M,***6D(2E%%% !1110 4E+24 %%%%( HHHH ****8!1110 4444 %%%% !11
M10 4444 %%%% !1113 *0TM(: "BBB@ HHHH *6DI: "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH *2EHI )12T4 )12T9I@)12YHS0 E I<T4
M%%%%(84444 %%%% @HHHH **** "BBB@ I:2B@!:*2BD M%)10 II*.U% !1
M110 4444P"BBB@ HHHH **** "BBB@ HHHH **** "BBBF 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%( HHHH ****
M"BBB@ HHHH **** "BBBF 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%%( HHHH **** "BBB@ HHHH **
M** "BBBF 4444 %%%% !1110 4444 %%%% !111FD 44E% "T4E% "T444 %
M%%%, HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH&%%
M%% !1110 4444 %%%% !1110 4444 %%%% @HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBBD 4444 %%%% !1113 **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%&:,T %(:7-)0 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%( HHHH **** "BBB
M@ HHHH **** "BBBF 4444 %%%% !1110 4444 %%%% !12T4 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !BDI:
M* $HHHH **** "BBB@ HHHI %%%%, HHHH **** "BBB@ HHHH **** "BBB
M@ I,4M% "8HQ2T4 )BC%+10 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444""BBB@ I:2B@!<T9I** %S2444#"BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH ****0!1110 4444 )12T4 )12T4 )2T44
M%%%% !1110 4444@"BBB@ HHHH **** "BBB@04444 %%%% PHHHH **** "
MBBB@ HHHH ***7% "44N*,4 )12XHQ0 E%+BC% "44N*2@ HHHH ****8!12
MXHQ0 E%&** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHQ2XH 2BEQ
M1BD E%%% !1110 4&BB@ HHHH **** "BBB@ HHHH *2EHI@)12T4 )2BBBD
M 4444""BBB@ HHHH **** "BBB@ HHHH **** "BBB@ I#2T4 %%%%,84444
M ***!10 4444 %)2TE !1110 4444 %%%% @HHHH&%)2T4 )11BEH&%)2T8H
M$%%%%(04448H&%%+BC% "44N*3% !1110(**** "BBB@84444 %)2T4 )12T
M4 )12T4 %%+BC% "44N*,4 )12XHQ0 E%+BC% "448HH **** "BBB@ HHHI
M@%%%% !1110 4444 %%%% !1110 4444 %%%%, HHHH 3%&*6B@!,48I:* $
MI:**0!1110 4444 %%%%( HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M2EHH 2BEHH 2E%%% !1110 4444 %%%% !1110(**** "BBB@ HHHH&%%%%
M!1110 4444 %%%% !1110 4444P"BBB@ HHHH **** "BBB@ HHHH 6BBB@
MHHHH *#110 E%%% !1110 4444 %%%&* "BBB@ HHHI@%%%% !1110 444"@
M!:*** "BBB@ HHHH **** $-%!HH **** "BBB@ HHHH$%%%%( HHHH ****
M "BBB@84444 %%%% !1112 **** "BBBF 4444 %%%% !1113 **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH *6DI: $HHHI %%%% !1110
M(****0!1110,6BBB@ HHHH **** "BBB@ HHHH **** "BBB@ I*6DH #24N
M*3%, HHHI %**2E%, HHHH$%%%% !1113&%%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444@"BBB@ HHHH **** "BBC% !12XHQ0 E%+BDI %
M%%% @HHHH ****8PHHHH **** "BBBD(**** "BBB@84444 %%%% !1110 4
M444 %%%% !1110 4444 %%%%, HHHH **** "BBB@ HHHH **** "BBBF 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBC- !1244 %%%%
M@HHHH **** "BBB@84444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444@"BBB@ HHHH **** "BBB@ HHHH ****8!1
M110 4444 %%%% !1110 4HI*44 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 )12TE !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444""BBB@ HH
MHH **** "BBB@ HHHH&%%%% !1110 4444 %%%% !1110 4444 %%%% !111
M2 **** "EQ110 8HHHH **** "BBB@ HHHH **** "BBBD 4444 %%%% !11
M10 4F*6B@!,48I:* $Q1BEHH 3%&*6B@!,48I:* $Q1BEHH 3%&*6B@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHI@%%%% !1110 4E+10 E%+28H **,
M4M "8I:** "BBB@ HHHH **** "BBB@ HHHI %&*** #%&*** #%&*** #%&
M*** #%%%% !1110 4444 %&*** #%&*** #%&*** #%&*** #%&*** #%&**
M* #%&*** #%&*** #%&*** #%&*** #%&*** #%)BEHI@%%%% !BDQ2T4  H
MHHH **** "DI:* $HQ2T4 %)2T4 )BC%+10 8HQ110 8HQ110 8HQ110 8HQ
M112 ,48HHH ,4444 %%%% !1110 8HQ110 8HQ110 8HQ110 8HQ110 8HQ1
M10 8HQ110 8HQ110 4444 %%%% !1110 4444 %%%% !1110 48HHH 3%%+1
M3 2BBB@ HHHI@%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44HH
MI &**** "BBBD 4444 %%%% !1110 4444 %%%% !1110 48HHH ,48HHH ,
M48HHH ,48HHH ,48HHH ,48HHH ,48HHH ,48HHH ,4F*6B@!,4N*** #%&*
M** #%&*** #%&*** "BBB@ HHHH **** "BBBF 4444 &*2EHH 2BBB@ HHH
MH **** "C%+10 4444 %%%%, HHHH ****0!1110 4444 %%%% !1110 444
M4P$HI:* $HHHH *!10* %HHHH **** "BBB@ HHHH 0T4&B@ HHHH ****!!
M1110 4444@"BBB@ HHHH&%+110 4444 %%%% !1110 4444 %%%% !1110 F
M**6B@!****8!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M2TE+0 E%%+2 2BEHH 2BEHH 3%+112 ****8!11118 HHHHL 4444 %%%% !
M1110 4444 %%%% !1110 4F*6BD E%+10 E%&**!!1113 **** "BBBF,***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BEHI )BEQ110 4444 %%%% !1
M110 4444 %%%%( HHHH ,48HHH ,48HHH ****8!1110 4444 &*,444@#%&
M*** "BBB@ HHHH ,4F*6B@!,48I:* $Q2T44 %%%% !1110 4444 %%%%, H
MHHH **** "BBB@ I,4M% "44M% "4444P"BBB@ HHHH **** "BBB@ HHHH
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M****0!1110 4444 %%%% !1110 4444 %%%%, HHHH **** "BBB@ HHHH *
M44E% "T444 %%%%( HHHH **** "BBB@ HHHH **** "BDHH 6BDHI +1244
M +1244 +1244 +1244 +1244 +1244 +1244 +1110 4444 %%%% !1110 4
M44E "T4E% "T4E% "T4E% "T4E% "T444 %%%% !1110 4444 %%%% !1110
M 4444 %%)10 M%)10 M%)10 M%)10 M%)10 M%)10 M%)10 M%)10 M%)10
MM%)10 M%)1F@!:*3-+0 4444 %%%% !1110 4444P"BBB@ Q24M% "44M)3
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH$%%%% !11
M10 44E% "FDHHH 7-&:2B@8N:,TE% "T444 %%%% !1110 4444 %%%% !11
M10 4444@"BBBF M%%%( HHHI@%%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444@"BBB@ HHHH **** "BBB@ HHHH **** "BBBF 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1112 **** "BBB@ HHHI@%%%%
M!1110 4444 %%%% !1110 4444 %%%%( HHHH **** "BBB@ HHHI@%%%% !
M1112 **** "BBB@ HHHI@%%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%%( HHHH **** "BBB@ HHHH ****8!1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1112 **** "BBB@ HHHH **** "BBB
M@ HHHH ****8!1110 4444 %%%%( HHHH **** "BBB@ HHHH #2444P"BBB
M@ HHHI@%%%%( HHHH **** "BBB@ HHHH **** "BBB@!:***0!1110 4444
MP"BBB@ HHHH **** "BBB@ HHHH **** "BBBD 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444P"BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHI %)2TE !1110 4M%% !1110 4444P"BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** $-%*:2@ HHHH 6BDHH 6BDHH 6BDH
MH 6BDHH #1110 4444 %%%% @HHHH ***,4 %%+BB@8E+112 **** "BBBF
M4444 %%%% !1110 4444 %%%% !1110 E%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !2TE+0 4444@"BBB@ HHHH **** "BBBF 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444@"BBB@ I*
M6B@!!2T44P$HHHH **** "BBB@ HHHH **** "BBB@ HHI: "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBBD 4444 %%%% !1113 **** "BBB@ HHH
MH **** "BBB@ HHHH ****0!1110 AHHHI@%%%% !1110 4444 %+BBB@ HH
MHH *#10: $HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M 4444 %%%% !1110(****8!1110 4444 %%%% !1110,**** "BBB@ HHHH
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M!!1113 **** "BBB@ HHHH ****!A1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1112 **** "BBB@ HHHH **** "
MBBEI@)12T4 )1110 4444 %%%% !1110 4444 %%%% !1110 4444@"BBB@
MHHHH **** "BBB@ HHHI""BBB@ HHS1F@ HHS1F@ HHS1F@ HHS1F@ HHS1F
M@ HHS1F@ HHS1F@ HHHH&%%%% !1110 4444 %%%% !1110(**** "BC-&:
M"BC-&: "BBB@84444 %%%% !1110 4444 %%%% !1110 4444""BBB@ HHHS
M0 449HS0 449HH **** "BBB@ HHHH **** "BBC- !11FC- !11FB@84444
M %%%% !1110 4444 +11FC- !11FC- !2444P"BBB@ HHHH ****8!1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 !HHHH$%%%% !1110 8HQ110,2BE-)0 4444
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M^EW55$M.$E+E LAJ4-5<24\/4N($X-+40>G!JEH+$E%-!IU22%%%% !1110
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M ****!A1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% @HHHH **** "BBB@ H
MHHH ****!A1110 4444 %%%% !1110 4444@"BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBBF,**** "BBBD 4444 %%%%, HHHH
M **** #%&***0@Q1BBB@ Q1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110,****0!1110 4444 %%%% !1113$%%%% !1110 4444 %%
M%% !1113 **** "BBB@ HHHH **** "BBB@ HHHQ0 448HQ0 448HQ0 448H
MQ0 448HQ0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444@"BBB@ HHHH 6BBB@ I*6DI@%(
M:6D-,!I--)I34;&J0Q&:HV>D=\57>2KL!(TE0M+4#R^]5GG]Z:0RXTU1&?WJ
M@]Q[U US[U20&F;CWIIN/>LEKKWJ,W?O5*(&Q]I]Z/M/O6*;OWI/M?O5<H&W
M]I]Z/M/O6)]K]Z/M8]:KE&;GVGWH^T^]8OVOWH^U^]/E V_M'O1]IK%^U^]+
M]K]Z.49L_:?>C[3[UB_;/>C[7[T<H&U]IH^TUB?;/>C[9[T<H&W]I]Z/M/O6
M)]L]Z/MGO1R@;?VGWH^T^]8GVSWH^V>]'*!M_:?>C[3[UB?;/>C[9[T<H&W]
MI]Z/M/O6)]L]Z/MGO1R@;?VGWH^T^]8GVSWH^V>]'*!M_:?>C[3[UB?;/>C[
M9[T<H&W]I]Z/M/O6)]L'K1]L'K1R@;?VGWI?M/O6']L'K1]L'K3Y1&Y]I]Z/
MM/O6']L'K1]L'K1R@;GVGWH^T^]8GVSWH^V#UI<H&U]I]Z3[3[UB_;/>D-X/
M6CE VOM/O1]I]ZQ#>#UIOVP>M+E W/M/O2_:?>L+[8/6E%Y[TN4#=%S[T\7'
MO6$+SWIZW?O2Y1&Z)_>I5FK#6Z]ZG2Y]Z30&TLWO4RR9K(CG]ZM1R^]0T!I*
M]2!JI1R9J=6J&@+(-+FH@U/S46$.)IA-!-1LU "LV*A:2D=ZK/)5) 2M+433
M>]5GFQWJN\_O5I 76GJ,S^]9SW/O4+77O5I#-0W'O3?M/O60UU[TPW?O5*(&
MS]IH^T^]8OVOWH^U^]/E&;?VGWH^T^]8GVOWI?M?O3Y0-O[1[T?:?>L3[6/6
ME^U^]'*,VOM/O2_:1ZUB?:QZT?;!ZT<HC;^T^]'VGWK$^V>]'VSWHY0-O[3[
MT?:?>L3[8/6C[8/6CE V_M/O1]I]ZQ/M@]:3[8/6CE W/M/O1]I]ZP_M@]:/
MM@]:.4#<^T^]'VGWK$^V#UH^V#UHY0-O[1[T?:!ZUB?;!ZT?;/>GR@;?VGWH
M^T^]8GVSWH^V>]'*(V_M'O1]I]ZQ/MGO1]L]Z.49M_:?>C[3[UB?;!ZT?;!Z
MTN4#;^T^])]I]ZQ/M@]:/MGO1R@;GVGWH^T^]8?VSWH^V>]'*!N?:?>D^T^]
M8GVSWH^V>]'*(V_M/O1]I'K6)]L]Z/M@]:?*,V_M(]:3[3[UB?;/>D-Y[TN4
M#;^TCUH^T^]89O!ZT?;!ZTN4#=%S[TX7/O6"+SWJ1;L>M)Q$;JW'O4JSUA)=
M>]3I<^]0T!M+-4RRUCI<>]64F]ZEH1J*]2AJSTEJRCU#0%H&G@U K5*#4")*
M*04M(84AI:8U- -8U$S4KM5>1\5:0Q6DJ%I:ADEQWJI)/[U:0%II_>HFN/>J
M$EQCO5=[KWJD@-0W/O33<^]8[7?O3#=^]5RC-K[3[TOVGWK#^V>]*+OWI\H&
MY]I]Z7[1[UB?:_>E^U^]5R@;7VCWH^TUB_:_>E^U^]/E&;/VGWI?M/O6+]K]
MZ3[7[T^4#;^T^])]I]ZQ?M?O1]K]Z.41M?:?>C[3[UB?;/>C[9[TN49M_:?>
MC[3[UB?;/>C[9[T<HC<^T^]'VGWK#^V>]'VP>M+E W/M/O1]I]ZP_M@]:/M@
M]:.41N?:?>C[3[UA_;/>C[8/6GR@;GVGWH^T^]8?VP>M'VP>M'*!N?:?>C[3
M[UA_;!ZT?;!ZT<H&Y]I]Z/M/O6']L'K1]L'K1R@;GVGWH^T^]8?VP>M'VP>M
M'*!N?:?>C[3[UA_;!ZT?;/>CE W/M/O1]I]ZP_MGO2_;/>GR@;GVD>M*+CWK
M#%Y[TX7?O2Y0-O[1[TX7'O6(+OWIPNAZTN49MB?WIPG]ZQ1=>]2+=>]+E$;2
MS^]2+-6,MR/6I5N/>I<0-A9?>I5EK)6X]ZF6?WJ'$#4$E/#UG+/[U,LWO4.(
M%X-2YJJLM2"2LW$5B>BHP].#4K!8=129I:0@HHHH **** "BBB@ HHHH ***
M* "DI:2@!*0FE-,)JD $TPM2,U1.U4D K/4;25&\E5WEJTADS2^]1--55Y\=
MZK/<>]789?:?WJ,W'O6:]S[U"UU[T^4#5-Q[TGVGWK'-W[TPW?O5<HS:^T^]
M'VGWK%^U^]'VL>M/E V_M/O1]I]ZQ?M8]:/M?O3Y0-O[1[T?:?>L3[6/6C[6
M/6GRC-O[1[T?::Q?M?O1]K]Z.4#:^TT?::Q?M?O2?;/>CE V_M-'VGWK$^V>
M]'VSWHY0-O[1[TOVD>M8?VSWH^V>]'*(W/M/O1]I]ZP_MGO1]L]Z.41N?:?>
MC[2/6L/[9[T?;/>CE&;?VGWI?M/O6']L]Z/M@]:7*!N?:?>D^T^]8OVP>M)]
ML]Z.4#<^T^]'VGWK#^V>]'VSWHY0-S[3[T?:?>L/[9[T?;/>GR@;GVD>M)]I
M]ZQ/MGO1]L]Z.4#;^T^]+]I]ZP_MGO1]L]Z?*!M_:?>C[1[UB?:_>C[7[T<H
M&W]I'K2?:?>L7[9[TGVSWI<H&W]I]Z3[3[UB&\]Z:;P>M+E W?M/O1]I]ZPO
MM@]:47GO2Y0-T7(]:>+CWK!%Y[U(MV/6ER@;HN/>I%G]ZPUNO>ITN?>I:$;2
MS5,LM8Z7'O5E)O>H: U%>I%:J*29JPCU#0BT#4@J!#4JU# D%% HJ1!333J:
MU" C8U"[TZ1L55D?%:)#%>3%0/-BH99<=ZJ23^]6D,MM/[U$;CWK.>YQWJ!K
MKWK11 U3<^])]I]ZQC=^]-^U^]5R@;?VGWH^T^]8GVOWH^U^]/E VOM/O2?:
M:Q3=^]-^V>]'*!M_:?>G"Y]ZPOMGO3A=^]+E&;HN/>I%N/>L%;OWJ5;OWI<H
MC>6?WJ99_>L)+KWJRESGO4N(&TLM3+)61'/[U:CFSWJ6@-)7J0-5%)*L(]9M
M"+ -.J)34@J& M%%%(04444 (:*#10 4444 %%%% !1110 4444 %%%%( HH
MI: "BBBF &FFG&FFF@&DU&6I6-0NU4@%9ZA:2FN^*K22X[U:0R9I:A::JTDW
MO562XQWJDAEYI_>HC<>]9SW/O4#77O56 UC<>])]I]ZQC=^])]K]Z+ ;8N?>
MG"X]ZPQ=^]/6Z]Z5@-U9_>IEF]ZPTNO>K,=Q[U+0C966IEDK*CGSWJU'+[U+
M0&@K5*IJFCYJPC5+ L TX4Q33Q4@+1112$%%%% "4444 %%%% !1110 444M
M A*6BB@84444 %%%&: "BD)II:@!V:0M4;/432U2B58F+U&TE5WF]Z@>?WK1
M1&66EJ%IO>JCW'O59[GWK11 O-/[U"UQ[UGO=>]5WNO>KY1&DUQ[U&US[UE/
M=^]0M=^]/E UFN?>F&Z'K6,UY[U&UY[T^4#9-U[TTW0]:PS>>]--[[T<H&X;
MKWI#=^]8)O?>D-[[T^4#>^U^])]K]ZP/MH]:3[:/6GR@=!]K]Z7[7[US_P!M
M'K2B]'K1R@= +OWIPN_>N>%[[TX7OO1R@="+KWIXNO>N>%[[U(MY[TN4#H1=
M>]2"Y'K7/+>>]2K>>]+E Z!;GWJ5;CWK 6[]ZF2[]Z7*!OK/[U,DWO6$EU[U
M82Y]ZEQ W%FJ99:QTN/>K"3^]9N(&JKU(&K/2;WJ=9:S<0L6\T5"LF:>&J+"
ML/HI :6D(**** "BBB@ I,TM)BD 4444 +1113 **** $I#2TPTT,0FHRU*Q
MJ%FJD@%9ZC:2F.]5GEQ5I 3-+43356>;WJL\_O5I#+S3^]1F?WK.>Y]ZA:Z]
MZJP&J;CWIIN?>L@W7O3#=^]5RC-G[3[T?:?>L3[6/6C[7[T^4#;^T^]+]I]Z
MQ/M?O2_:_>GR@;?VGWH^T>]8OVL>M'VL>M'*,V_M'O1]H]ZQ?M?O1]K]Z?*!
MM?:/>C[1[UB_:_>D^U^]'*(V_M'O1]I'K6)]L]Z/MGO1R@;?VGWH^T^]8?VS
MWH^V>]'*(W/M/O1]I]ZP_MGO1]L]Z.4#<^T^]'VGWK#^V>]'VSWHY0-S[3[T
M?:1ZUA_;/>C[9[T<HS;^T^]+]I]ZP_MGO1]L'K2Y0-S[3[T?:?>L3[8/6C[8
M/6CE V_M/O1]I]ZQ/M@]:/M@]:.4#;^T^]'VGWK$^V#UH^V#UHY0-O[1[T?:
M/>L3[8/6C[8/6CE&;?VGWI/M/O6)]L]Z/MGO3Y0-O[3[TGVGWK$^V>]'VSWH
MY1&W]I]Z/M/O6)]L]Z3[9[T<H&W]I]Z7[3[UA?;!ZT?;/>ER@;HN?>G"Y]ZP
M1>>]/%X/6I<1&\+CWIZS^]8:W?O4R77O4V VUF]ZE66L9+CWJRD_O4V U5DS
M4BO6>DN>]6$DJ6@+BM3P:K(U3*:AH"6G"F TX5+$.I:2EJ1!1110 E%%% !1
M110 4444#"BDHI@+FC-)10 M%(*6@0E+24M( HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** &4TTZFFK1S2():I2U=EJE+6B,64)JSIN]:,U9TW>MXF;*$W4U
M1E[U>FZFJ,O>NB)C(JO5=JL/4#5T1.>1$:::>:8:V1A(2BEI*U1DQ:6DI:H@
M*2EI*!B4445++0M**;3A6;-$2+4R5 M3I6;-$68ZMQ54CJW%64C:)>AJ_#5"
M*KT-82-XE^*KD=4XJN1USR-XEI.E3K4"5.M82-T2"G4T4ZLV:(6BBBD6%+11
M2&%)2TE PHI,T9H 7-&:2B@!<T4E+FD 4444P"BBB@ HHHH$%%%% !1110 4
M444#"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH ****8PHHHH ****0!1110 444
M4 %%%% !1110 4444""BBB@ HHHH$%%%% !1110 4444 %%%% !1110,****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH$%%%% !1110 4444 %%%% !1110,*
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH&%%%% !1110 4444 %%%% !1113 **** "BBBD
M(**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@8
M4444@"BBB@ HHHH **** "BBB@044M% "8I<444 %%%% !1110 4444P"BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M$HI:2@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MBDI10 4444 %%%%,04444 %%%% !1112&%%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444QA1110 4444@"BBB@ HHHI@%%%% !1110 4444A!1110 4444 %%
M%% !1110(**** "BBB@ HHHH&%%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 49HI
M*!"YHI** %HHHH ,4N*** #%%%!H 2BBB@84444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MN-+O- R[Y_O1Y_O5+>:7>:5A%WS_ 'I/./K50,:7<:0%KSCZT>=[U5R:7)H
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M'-:(JY?^T'UI?//K5#>:7>:JPR_Y_O1Y_O5$.:7?18"YYWO1YWO53<:4$U+
ML^<?6CS3ZU7R:7FI$3^;1YM0<TO-2!-YII/-J+FDP:!$WFFCS34/-'- $WFF
MCS34/-)S0!/YM'FFH.:.: )_--'FFH.:.: )_--'FFH.:7F@";S31YIJ'!I.
M:8$WFT>:?6H>:3F@"?SCZTOG&JQS02: +7G>].$_O5+<:-](#0$_O3UN/>LT
M.:<)* -9;GWJ9+GWK&$M2+-[T ;B77O5E+OWK 6?WJ9;CWHL!T,=W[U9CN_>
MN<2Y]ZL)<^]*P'317?O5R*\]ZY>.Z]ZMQ77O4V ZR&\]ZOPWGO7(Q7?O5Z&\
M]ZEQ ["&\Z<UHP7?3FN.AO.G-:<%YTYJ'$#L8+KWK1@N?>N1M[OIS6K;W73F
MLW$1U,4^<<U=BF]ZYV"YZ<UI0SYQS63B(VTDJ=6K,BESWJVDF:S:$6LTM1*U
M/!S46$.HHHI %%%% !1110!"]5935IZJ2]ZM#*4QZUEW#=:TIS63<GK6T1F5
M=/UK#NWZUKW9ZU@WC=:V2&9-W+UK#NI>M:=XW6L&[?K6J0RE<S=>:RYI_>I[
ME^365/)UJT@"2?WJNUQ[U!+)UJN7-6D,N?:/>C[1[U2W4;JI!<O_ &@^M'VC
MWJCN-+N-4.Y>%P?6E$Y]:H;C2AS3 O\ G^]'G^]4MYI0]("YYQ]:;YQ]:J[J
M7=2 L^<?6D\[WJMDTN34B+'G'UH\ZJ^31DT@+'G4>=[U7R:,T 6/.]Z/.]ZK
M9-&32 L^=[T>=[U7R:,F@"QYWO1YWO5?)HR: +'G>]'G>]5\FC)H L>=[T>=
M[U7R:,F@"QYWO1YWO5;)HR: +/G>]'G>]5LT9I@6?.H\ZJ^:,F@"QYU(9J@R
M::2:0$QF]Z89CZU"2:82:EB)_.]Z<)O>JN:52:D1H1S>]7(I>G-9<9JY$>E2
MP-FWEZ5K6TG2L&W/(K8M3TJ6(Z*TDZ5OV;]*YJS[5T-EVK-@=)9MTK=M3P*Y
M^S[5OVO05DP-JV/2M6#M65;=JU8.U9,"U1114$A4$_2IZKW'W351W&C%O3P:
MYN_;K717IX-<QJ!ZUT1*.=OY.M<O?2]:Z#4&ZURNH/UK>*&8UY/R>:Q;B?D\
MU=O9.36'<R<FMDAC9+CGK41N#ZU6=\FF;JL39<%Q[TOVCWJF&I<U:'=%OS_>
MD\_WJKFC-,+EKS_>G"<^M4\TN: N7UN/>ITN/>LH,:D60TK#-N*YYZUH07/3
MFN<CFYJ]#/[U+0'5VMUTYK;M+KIS7&VUQTYK;M+CIS6;0CM;.YZ<UO6EQTYK
MBK.YZ<UOV=STYK)H1V5K/P.:U[>;IS7*6EQTYK;MI^G-8M".BBDXJTKUD03<
M=:O1R5A)"+H-+4*M4@-9M$CJ***0!1110 E%+24 %%%% !2TE**0!1110 44
M44 %%%%, J&3O4U02]*I 49SUK)N3UK4N.]9%T>M;1&9-VW6L&\?K6S=GK7/
MWK=:WBAF->2]:Y^[FZ\UKWK=:YV\?K6J0S/N9NO-94T_)YJQ=/UK)G?K5V <
M\_O41GYZU5>2HO,-*P&BL_O5J&?IS6,LG-6H9.E2T!T=M/TYK=LYNG-<K:OT
MK?LGZ5FT(ZRREZ5T=D_2N4L6Z5TMBW2L6!U%FW2MVU/2N=LCTKH+0\"LF!LP
M=JN#I5.WZ"K@Z5FQ,****0@HHHH #24II* "EI!2T %%%% !1132: $8U$ST
M.U5I),5HD,<\E5)9L9YIDLV.]4)I\9YK1(9)-/UYK/FN>O-0SW/7FLNXNNO-
M:*(%F>ZZ\UFSW?7FJEQ=]>:S+B\Z\UJHC+<]Y[UF3WG7FJ<]YUYK-GN^O-6H
MC+<]Y[UGS7?O5*:[]ZH2W77FK2 NRW?7FJ4MU[U2DN>O-5)+CWJK 79+KWJH
M]S[U4>?WJ!Y3ZT[ 6WN/>H3.?6JIDIF^@"T9J:9:K[C2\TA$OF4N^H@#3PIH
M =N-+N- 0TX(: $R:,FG^6:7RS0!'DTFXU+Y9I#&: (]QI-YIY0TPH: #?0)
M*:5--(H F$I]:>)O>JF31NH OK.?6IDN#ZUEB0U(LIIC-J.Y]ZMQW7O6 DQ]
M:L).?6E8#HXKOWJ]#=].:Y>*X]ZNQ7/O2: ZR"\Z<UI07G3FN0ANNG-:,%WT
MYJ7$#LK>\Z<UJ07?3FN,M[SIS6I!>=.:AQ [*"[]ZTX+KIS7'V]YTYK4M[OI
MS6;B(ZR&XZ<U?BGSWKF;>ZZ<UIP7&<<UDXB-Z.7-6%?-9,,WO5V.3-9M"+RF
MGU71JF!K-H!U%%%2(**** "BBB@ /2J\M6#5>7I51&4)SUK+N3UK3GZ&LFY/
M6MD,RKINM85V_6MB[/6L&\;K6J&9%W)UK"NI>O-:EXW6L"[?K6J0RC<S=>:R
MIY^O-6+E^M9,\G6M4AB2S^]57G]ZCEDJHSDU:0%DW'O2?:#ZU4+4FZF*Y?%Q
M[T\7'O6>&IP<U0[FCY_O1Y_O5 .:7>:=AE[S_>D\_P!ZI;S1O-%@+GG'UI/.
M]ZJ[J,FE8"UYWO2><:KY-&32$6?-/K2>;4'-%("QYI]:3S:@HYJ1$_FT>;5?
M)HR: +'G4>=[U7R:,F@"SYWO2>=[U7R:,FD,L>=[T>=[U7R:,FF!8\[WH\[W
MJODT9- %CSO>CSO>J^31DT 6/.]Z/.]ZKY-)F@"SYWO1YWO5;-&:8%CSCZTG
MG'UJODT9I 6/.]Z0S>]5\TA-(1.9O>F^<<U 2:3)I,"TLQJS'*:SE)S5F(FH
M8&O!+R.:U;:7I6%!G(K7MNU2P.@M).E;UF_2N<L^U;UGVJ&!TEHW2MRU;I7/
MV?:MZU[5FQ&W;GI6G":R[;M6G#6;$7XZLI5:*K*5DQ$M%%%2(**** "DI:2D
M 444E,!:***8PHHHH **** "BBB@ HHHI""BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HI,TF: '9I*3-)F@!<T9IN:3-
M#LT9IF:-U #\TF:;FDW4 /S1FH]U&Z@!^:,U'NHW4 29I,TS=2;J 'YHS4>Z
MC=3 DS1FHMU&Z@"3-+NJ+=1NH EW4;JBW4;J0$N:,U%NI-U,";-&ZH=U+NH
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M8+0'TJ)HCZ5NO:>U5WM?:BX&*T9J,H16J]M[57>#VJAF?@T<BK30XJ(QTQC
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@!E
M--.IIJT<TB"6J4W0U=EJE-T-:(Q9GS5GS5H35GS5O$S9GS=ZI2U=F[U2EKHB
M82*KU U3O4#5T1.>1&:::<:::V1A(2D%+2"M49,6EI*6J)"D-+2&@!****EE
MH*<*;3A6;-$/6ITJ!:G2LV:(LQ]JMQ54C[5;BK)FT2]#5^&J$-7X:YY'1$O1
M=*N1U3BZ5<CK"1O$M)4ZU E3K6$C>)**6D%+69JA:44E**104444B@I*6DI
M%%%% PHHHH **** "BBB@04444P"BBBF(**** "BBB@ HHHI#"BBBD 4444
M%%%% "T444 %%%%, I*6B@!**6B@!**6B@!**6B@!**6B@!**6B@!**6B@!*
M*6B@!**6B@!**6BD E%+10 E%+10 E%+13 2BEHH 2BEHI )12T4 )12T4 )
M12T4P$HI:* $HI:* $HI:* $HI:* $HI:* $HI:* $HI:* $HI:*0"44M% "
M44M% "44M% "44M% "44M% "44M%,!**6B@!**6B@!**6BD E%+10 E%+10
ME%+10 E%+10 E%+10 E%+13 2BEHH 2BEHH 2BEHH 2BEHH 2BEHH 2BEHH
M2BEHH 2BEHH 2BEHH 2BEHH 2BEHH 2BEHH 2BEHH$)12T4 )12T4 )12T4
M)11BB@ HHHH&%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 M%%% !1112 *2EI*
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHI@%%%% !111B@ HI<44
M )12T4 )1BEHH **** "BBB@ HHI,T +1249H 6BFYHS0 ZC-,S1F@!V:,TW
M-)NH =FC-,W4FZ@!^:;FF[J:6H ?NI-U,+4FZ@!^ZDW5'NI"U,"0M2;JC+4A
M:@"7=2;JCW4W=0!-NI-U1;J3=0!+NH+5%NI"U $NZC=4.ZC=0!+NHW5#NI-]
M,";=1NJ#?1OH FW4;JAWTF^D!/NHW5!OHWT 3;J-U0[Z3?0!/NHW5!NHWTP+
M&ZE#57WTX/0,L!J4-4 :G!J + :G U &J0&D!*#3@:C!IP- $@I::*=2 6BB
MB@04444 %%%% !1112 **** "BBB@ HHHI@%%%% !1110,**** "BBB@ HHH
MH ****D0M%%% !1113 ****8"4QJ?3&IH:*TO>LZX[UHR]ZSKCO71$9CW0ZU
MA7@ZUO70ZUAW?>M4,YV\'6N?O!UKHKP=:P+P=:U0SGKL=:QKE>36Y=#K6-<C
MK6J&9,R]:IR+S6A,*IN*V0RJ13<5*PIF*NP-#,4N*6BBQ-@ IZKFD J:-:JQ
M2'(E6$BHC2KD45)@1)#[5.MO[59CASVJY';Y[5# H+;>U3+:^U::6OM5A;3V
MK-B,<6GM3A:>U;BV?M3Q9^U2(P?LGM1]D]JWQ9^U+]C]JD#G_LGM1]D]JZ#[
M'[4GV+VHN!S_ -D]J/LGM6_]B]J/L7M2N!S_ -D]J7[)[5O?8_:C[%[47 P?
MLGM1]D]JWOL7M2_8_:BX&!]D]J/LGM6_]C]J/L?M3N!@?9/:C[)[5O\ V/VH
M^Q^U%P,#[+[4?9/:M[['[4?8_:BX&#]D]J/LGM6_]C]J/L?M2N!SYM/:F&T]
MJZ(V?M3#9^U*X'.FT]J8;3VKHC9^U,-E[4K@8 M/:GK:>U;@LO:GBS]J5Q&,
MEI[5:BM?:M1+/VJS'9^U*X%*"V]JU+:WZ<5-#:>U:5O;8QQ28A]I!TXK>LX>
ME5;6WZ<5LVL/3BLV!>M8^E:\"<53MHNE:<*8K)L">->*EQQ2(.*<14B().E9
MUQT-:,O2LZXZ&J0S&N^AKG[SO707?>L"\[UM$9SUX.M8%V.M=#>=ZP;L=:WB
M,PKD=:R+@=:VKD=:R+@5O%%&5,M5&%7YA5-QS6J0R+%&*=BC%.Q-A,4X"E I
MZK3L580)4J1TY5J>-*E@,2*K"0^U21QU<CA]JAB*Z0>U6$MO:KD5OGM5R*V]
MJAB,];7VJ5;3VK5CM,]JLI9^U3<#%%G[4\6?M6\ME[4\67M4W Y[['[4?8_:
MNB^Q>U(;+VI7 YW['[4GV3VKH39>U)]B]J5Q'/?8_:C[)[5T'V+VH^Q>U*X'
M/?9/:C[)[5T'V+VH^Q?[-%P.?^R>U'V3VKH/L7^S1]B_V:+@<_\ 9/:C[)[5
MT'V+VH^Q>U%P.?\ LGM1]D]JZ#[%[4?8O:BX'/\ V3VH^R>U=!]B]J/L7M1<
M#G_LGM1]D]JZ#[%[4?8O:G<#G_L?M2?8_:N@^Q>U'V+VHN,YXV?M49L_:ND-
ME[4PV7M1<1SAL_:D^Q^U=$;+VI!9>U3<#!6S]JM16GM6NME[58CL_:I;$9\%
MK[5IV]MTXJS%:=.*T8+7D<5FV(;;6^,<5M6L.,5%;VV,<5K6\'3BLV(LVL72
MMFV3I5.WBQCBM2!.E9,"W"M78Q5>):MH*@"9*?3%I] #6JI-T-6FJI-T-:0&
M95WWKG[WH:Z"Z[U@7O0UTQ&<Q?CK7+WXZUU5\.M<Q?CK6R&<M?#K7/W:]:Z2
M]'6N?NQR:T0S%F'S5 15J<<U6(JK":&XIP% %. JDB4A0*<!0!4BBMDC1(0+
M4JI2JM3HE,8B1U82'VI\<=7(HNG%)B(HX/:K,=O[59B@]JO16WM6; HI:^U3
MI:>U:<5K[5;CM/:LV(QUL_:GBR]JW4LO:I19>U9M@<_]B]J/L7M71?8O:C[%
M[5-Q'.?8O:C[%[5T?V'VH-C[4K@<W]B]J/L7M71_8?:D^Q>U%P.<^Q^U'V/V
MKHOL7M1]B]J=QG._8_:C['[5T7V+VH^Q>U%Q'._8_:C['[5T7V+VH^Q>U%P.
M>^Q^U)]C]JZ/[%[4GV+VHN!SAL_:F&S]JZ0V7M3#9>U%P.::S]JC:T]JZ5K+
MVJ)K+VIW YEK3VJ![7VKIGLO:JTEG[55P.:>V]JKO;^U='):>U5)+7VJD!@-
M#[5 \6*VI+?':JDD&.U4AF6R5&5Q5YXL57=*L"O3@:4K3,4[ 2!L4X25#FDS
M18"V):D6;WJAN-*)"*5@-:.?WJ]#<^]8"2U;BF]ZEH#I[>YZ<UL6MUTYKD8)
M_>M:VN.G-2T!V=I==.:W+2YZ<UQ=I<].:W+2YZ<UFXB.TM;CIS6Q;3].:Y&T
MN.G-;EK/TYK&2$=-!+G%7XWK"MYNE:<,E820C4C:IP:I1/5M#Q6,D(?1114"
M"BBB@"*3O5.6KDG>JDM:1&9\]9-R.M:\]95R.M;Q*,.['6L&\'6N@N^AK!NQ
MUK>(SGKP=:PKL=:Z"['6L*Z'6MD,PKE>M9,Z]:V;D=:RIQUK1#,N5:@(JW*.
M35=AS5V CQ2XI<4N*=A6$Q2@4X"GA:JQ5AJK4R1TJ+S5B-* $2*K*0^U/BBJ
M[%#GM4L"!+?VJ=+;VJ[%;YQQ5V.U]JS8C,6U]JE6T]JV$M/:K"V?M4-B,(6?
MM2_8_:N@%E[4[[%[5#8'.?8_:D^Q^U=&;+VIILO:IN(YW['[4?8_:NA-E[4G
MV+VHN!S_ -D]J/LGM70?8O:C[%_LT7 Y_P"R>U'V3VKH/L7^S1]B_P!FBX'/
M_9/:C[)[5T'V+VH^Q>U%P.?^R>U'V3VKH/L7M1]B]J+@<_\ 9/:D^R>U=#]B
M]J3[%[4[@<_]D]J/LGM70?8O:C[%[47 P/L?M1]C]JZ#[%[4?8O:BXSG_LGM
M2&S]JZ'[%[4ALO:BXCG#9^U,-G[5TALO:F&R]JFX'._8_:E%G[5T'V+VI19>
MU*XC$2S]JM1VGM6LEE[58CL_:IN!GPVO3BM.WMNG%68K3VJ_!:].*3 ;:V_3
MBMJUAZ<5%;V^,<5JV\/3BLV(M6L?2MBW3I5.WBQCBM2!*S8%R!>!6C"*I0K5
MZ(5FP)J***@D*JW'2K1JK<=#5PW&C#O>]<UJ'>NEO>]<U?\ >NJ)1RFH#K7*
MWXZUUFH#K7+7XZUO$HY:]7DUAW*\FN@O!R:Q+@<FMXC,QAS3,5,XYIF*TL)H
M:!3@*4"G 5:0)#<4N*<!2XJTBK#,48I^*,4^4=AF*3%/Q28I-"L-I1Q1BBIL
M)%F)JO028Q68AQ5J)\8J&AFY;S8QS6Q:W'3FN9AEQ6G;3].:RDA'7VESTYK>
MM+GIS7%VMQTYK<M+GIS6,D([6TN.G-;5M/TYKCK2YZ<UNVMQTYK"2$=5;S=*
MT89,XKGK:;IS6M!+TYK)H1L1M4P-48GXJVC5C)"9)129I:@D**** "BBBD 4
M444@"BBB@ HHHI@%%%%, /2H)>E3GI4$O2JB-&?<=ZR+KH:UY^]9-UWKHB48
M=V.M<_>CK70W?>L"\[UO$9S=Z.M<[>#K727HZUS]X.M;H#GKI>M9,R]:VKH=
M:RIAUK2P&<ZU%MJRXJ+'-*P#47FK<*\BH5%6H1R*EH#2M5Z5O62]*Q;4=*W;
M(=*RD(Z"Q'2NFL1TKG+$=*Z6Q'2L) =#9#I6_:=JP;,=*W[3M6$A&O;]JN#I
M5.W[5<'2LF)BT444A!1110 4444 %%%(: $)IC-2L:@=ZM(H;(]4YI:=-)6=
M/-CO6T4 RXGQFLFYN.O-/N;CKS6-=7/7FMDAC+JYZ\UBW5UUYIUU==>:Q+JZ
MZ\UHD,2ZNNO-8US==>:2ZN>O-9%Q<]>:T2 ?/<\]:SYKCWJ*:?GK5&2;WK1(
M9/)/[U5>6H7EJ%G)JTADK25&7IA-)18D7.: * *E1>:=AH%2IDBS3XX\U<CA
MSVI,"!(,]JM1VWM5J*WSCBK\-K[5#$4H[7VJY':>U:$-GTXJ_%9>U9MB,N.S
M]JLI9>U;,5E[5;CL?:H;$8B67M4RV/M6\EC[5.MC[4N8# 6Q]J=]A]JZ);'V
MI_V'VI<P',FQ]J8UC[5U!L?:F-8^U',,Y5K+VJ![+VKJVL?:H'L?:GS <G)9
M>U59+/VKK9+'VJG+9>U4F,Y*2T]JIRVOM75S6?M6?-:=>*M <S);^U57AQVK
MH9K;VJC+;X[5HAF(\=0LN*TY(<=JJ21U:&5.E.!I67%,IV$R57Q4R2X[U4S2
MAB*5@-*.?WJW%<>]8JRU.DWO2: Z."YZ<UJ6]UTYKE89_>M*WN.G-9M".QM;
MKIS6Y:773FN*M;GIS6Y:7/3FH: [6TN>G-;=K<=.:XRSN>G-;UI<=.:S:$=;
M;S=.:TX9<@5S5K/TYK7MYLXYK&2$;<;U.K5G125:1ZYY("R#2TQ33A61(M%%
M% !4,O0U-4,O2FAHSKCO63<]ZU[CO63<]ZWB48EV.M8%X.M=!=CK6#>#K71$
M9SMX.M8-V.M=#>#K6#=CK6\1F#<KUK*G7K6S<CK65..M:I#,J5>M56'-7I1U
MJHXJTAD)%)BG&BE8BP 4X"D%/4<U:120Y5J94H1:L1I5%#4BJPD/M4D<=6XH
M?:DQ$"0>U6$MO:K<5O[5<BMO:H8&>EK[5,MI[5JQVOM5E+/VK-L1BBS]J>+/
MVK=6S]JD%E[5FV(Y_P"Q^U(;/VKHOL7M2&R]JFXCG#9^U--G[5T9LO:FFR]J
M5Q'._9/:C[)[5T'V+VI/L7M1<# ^Q^U'V/VKH/L7M1]B]J=QG/\ V3VH^R>U
M=!]B]J/L7M1<#G_LGM1]D]JZ#[%[4?8O:BX'/_9/:C[)[5T'V+VH^Q>U%P.?
M^R>U'V/VKH/L7M1]B]J+@<_]C]J3['[5T/V+VH^Q>U%P.>^Q^U)]C]JZ'[%[
M4GV+VHN!SWV/VI/L?M71?8O:D^Q>U*X'._8_:C['[5T/V+VH^Q>U3<# 6S]J
ML1V?M6RME[5.EE[4K@9D-ISTK1@M?:KD5G[5?AM?:I; AMK?IQ6O;08QQ1!;
M8QQ6G;P=.*EB)K:+&*U[:/I5:"+&*TX(^E0Q%F!>E:$0XJM$M7(QQ6; L1BI
MUJ)!4RUFQ#Z***D04444 %)2TE( -)2FDI@%%%%, I124HH ****0!1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 RFFG4TU:.:1!+5*;H:NR5
M2FK2)BS/FK/FK1FK/FK>)FS.F[U2DJ]-5*6NB)A(J/4#5.]0-71$YY$9IIIQ
MIIK9&$AM%'>BM49,6C%%+5$"4&EI*!B=Z2EHJ64@IPIM.%9LU0]:F2H5J9*S
M9HBU'5N*J<=7(JQD;1+T-7X:SXJOP]JQD=$2_%TJY'5**KL=<\C>):2IUJ!*
MG6L)&Z)12T@I169JA:44E**104444B@I*6DI %%%% PHHHH **** "BBB@04
M444P"BBBF(**** "BBBD 4444#"BBBD 4444 %%%% "T444 %%%%, HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****0!1113 **
M** "BBB@ HHHH ****0!1113 **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH ****0!1110 4444 %%%% !1113 **** "BBB@ HHHH ****
M "BBBD 4444 %%%% !1110 4444P"BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH$%%%% !1110 4444 %
M!HH- "4444#"BBB@ HHHH **** "BBB@ HHHH ****0!1110 4444 %%%%,
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M :A4U(II 2BGCI48IXH =112TA"44M% "4444 %%%%( HHHH **** "BBBF
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M3BM_:K\,&.U3QV_M5J.'IQ4M@-ABJ_%'TI(XL5:C2H8A\:U:0<5&BU84<5#
M>HJ5:8!3Q4,0\44E&:D0M%)FC- "TE%%( HHHI@%%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% #*::=335HYI$$E4I:NR5
M2EK2)BRA-6?-6A-6?-6\3-F?-5*7O5V:J4O>NB)A(J/4#5.]0-71$YY$9III
MQIIK9&$AO>BCO16J,6+2TE+5$A24M)0 E%%%2RT%.%-IPK-FJ'K4R5"M3)6;
M-$68^U7(JIQ]JN15E(VB78NU7X>M4(NU7X>M82.B)>B[5=CJE%VJ['7/(WB6
MDJ=:@2IUK"1NB44HI!2BLS5"THI*44B@HHHI%!24M)2 ****!A1110 4444
M%%%% @HHHI@%%%% @HHHH **** "BBB@84444@"BBB@ HHHH 6BBB@ HHHI@
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444""BBB@ HHS1F@
M HHS1F@ H-&:2@ HHHH&%%%% !1110 4444 %%%% !1110 4444@"BBB@ HH
MHH **** "BBBF 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%( HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHQ2XH 2EHQ10 4
M444P"BBB@ HHS29H 6BDS29H =FD)IN::6H <32$TPM2%J8#BU-+4TM3"U #
MRU-+4PM32U #RU(6J,M32U $A:D+U$6II>@"4M2;ZA+TF^@"8O3=U1;J3=0!
M+NI"U0[J3=0!*6I"U1;J0M0!*6II:HRU(6I@2;J3=4>ZDW4 2;J3=4>ZDW4
M2[J0M4>Z@M0 _=1NJ/=1F@"3=2;JCS1F@!^ZDW4S-)F@!Y:C=49-&: 'EJ-U
M,)I,T 2;J3=3,TF: '[J3=3,TF: )-U+NJ+-+F@9,&IP:H0:<#0!85JD4U74
MU*IH L*:F4U70U,M %A34JU"M2J: )EIXJ-:D%(!U+24M(04444 )1110 44
M44@"BBB@ HHHH ****8!1113&%%%% !1110 4444A!110:0"4444@%H%% H
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MJL06WM6C#;^U8R8BK':^U64MO:KT<'M4ZP5SR8%!;;VJ46_M5\0T\0UFY"*
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MW1**44@I169JA:44E**104444B@I*6DH ****0PHHHH **** "BBBF(****
M"BBB@04444 %%%% !1110,**** "BBBD 4444 &:**2F M%)29H =FC--S1F
M@!V:,TW-)F@!^:,TW-&: '9HS3,TN: '9HS3<T9H =FC--S1F@!V:,TW-&:
M'9HS3<T9H =FC--S1F@!V:,TW-&: '9HS3<T9H =FC--S1F@!V:,TW-&: '9
MHS3<T9H =FC--S1F@!V:,TW-&: '9HS3<T9H =FC--S1F@!V:,TW-&: '9HS
M3<T9H =FC--S1F@!V:,TW-&: '9HS3<T9H =FC--S1F@!V:,TW-&: '9HS3<
MT9H =FC--S1F@!V:,TW-&: '9HS3<T9H =FC--S1F@!V:,TW-&: '9HS3<T9
MH =FC--S1F@!V:,TW-&: '9HS3<T9H =FC--S1F@!V:,TW-&: '9HS3<T9H
M=FC--S1F@!V:,TW-&: '9HS3<T9H =FC--S1F@!V:,TW-&: '9HS3<T9H =F
MC--S1F@!V:,TW-&: '9HS3<T9H =FC--S1F@!V:3-)FDS0 _-&:9FES0 [-&
M:9FES0 [-&:;FC- #LT9IN:,T .S1FFYHS0(=FDS3<T9H =FC-,S1F@!^:,T
MS-+F@!V:*;FES0 M+24"@8M%%% !1110 4444 %%%% !1110 4444@"BBB@
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MJ9: )5J05&M2"D ZEI*6D(**** $HHHH ****0!1110 4444 %%%%, HHHH
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** &4TTZFFK1S2()*I2U=EJE+6B,64)JSYN]:$W>LZ;O6T3-E";O5
M&6KLW>J4E=,3&15>H&J9Z@:NB)SR&&F4XTVMD82$HHHK5&+%HHHJB0H-%)0"
M$HI:05#+0M.%-%.%0S1#UJ=*A6IDK-FJ+,=6XJJ1U;BK&1M$O0U?AJA#5^&L
M9&\2[%5V.J<72KD=<\C>):2IUJ!*G6L)&\244M(*6LS5"THI*44B@HHHI%!2
M4M)0 4444#"BBB@ HHHH ****!!1110 4444""BBB@ HHHH ****!A1110 4
M444 %)110 4F:*:30 N:3-(33<T .S1FF$TFZ@!^:-U1[J3=0!+NHW5%NHW4
M 2[J7-0[J7=0!+FC-1;J-U $N:,U%NHW4 2YHS46ZC=0!+FC-1;J-U $N:,U
M%NHW4 2YHS46ZC=0!+FC-1;J-U $N:,U%NHW4 2YHS46ZC=0!+FC-1;J-U $
MN:,U%NHW4 2YHS46ZC=0!+FC-1;J-U $N:,U%NHW4 2YHS46ZC=0!+FC-1;J
M-U $N:,U%NHW4 2YHS46ZC=0!+FC-1;J-U $N:,U%NHW4 2YHS46ZC=0!+FC
M-1;J-U $N:,U%NHW4 2YHS46ZC=0!+FC-1;J-U $N:,U%NHW4 2YHS46ZC=0
M!+FC-1;J-U $N:,U%NHW4 2YHS46ZC=0!+FC-1;J-U $N:,U%NHW4 2YHS46
MZC=0!+FC-1;J-U $N:,U%NHW4 2YHS46ZC=0!+FC-1;J-U $N:,U%NHW4 2Y
MHS46ZC=0!+FC-1;J-U,"7-&:BW4;J )<T9J+=1NH ES1FHMU&Z@"7-&:BW4;
MJ0$N:,U%NHW4P)<T9J+=1NH ES1FHMU&Z@"7-&:BW4;J )<T9J+=1NI 2YHS
M46ZC=3 DS1NJ/=1NH ?NHS4>ZES0 _-+FH\TH- $F:7-,!IPH ?2TT&G"D M
M+24M !1110 E%%% !1110 4444 %%%% !1112 ****8!1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444@"BBB@ HHHH **** "B
MBB@ HHHH 6BBB@ HHHH ****8!1110 44F:0F@!2::32$TTM0 I--+4TM3"U
M,!Q:FEJ86IA:@!Y:FEJC+4PM3 D+TTO49:F%J )2],+5&6II:@"0M32U1EJ0
MM0 \M32U,+4A:@!Q:D+4PFD)H =NII--S2$T .)I,TTFDS0 [-&:;FC- #LT
MF:;FEH =FDS244 +FBDHI@&:*** #-)110 4444 %%%% !1110 "C%%+B@!M
M%+BC% "48I<44 )BDQ3J2@!I%(13C2&@!,4N**6@!0*<*04\4#'K4JBHUJ51
M2 E6IUJ%:G6@"5:F6HEJ9: )%J05&M2"D ZE%)2BD(*#10: $HHHH **** "
MBBB@ HHHH$%%%% "TE+10,2BEHH 2BEHH 2BBB@ HHHI %%%% "BB@44@"BB
MBF 4444P$-,;I3Z8W2FAHK25GW'>M"2L^X[UT1&9%UT-8=WWK<NNAK#N^];H
M9@7G>L"\[UT%YWKG[OH:U0S!NNIK'N>];-UWK&N>]:Q*,R;J:J/5N;J:J/6R
M&5GJ(U*]1&J$QII*4TE29DBUH6W:L]:T+;J*KH:+8W+/M726(Z5SEEVKI+#M
M6<F!TU@.E=+9+TKG+ =*Z:Q'2L),1NVB]*V(%X%95H.!6S .*YY,DMQK4X%1
MQBI@*Y),  I<4N*6HN3<3%&*6BD(;BC%.HIW'<9MHVBGXHQ1<+C-HHVT_%&*
M+A<9MHVBGXHQ1<+C-M)MI^*,47"XW;2;:?BC%%PN,VT;:?BC%%PN,VT;:?BC
M%%PN,VT;:?BC%%PN,VT;:?BC%%PN,VTNVG447"XW%*!2T47 ,4M%%(04444
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MI*G6H$J=:PD;Q)12T@I:S-4+2BDI12*"BBBD4%)2TE !1110,**** "BBB@
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M-U $VZC=4.ZC=0!-NHW5#NHW4 3;J-U0[J-U $VZC=4.ZC=0!-NHW5#NHW4
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M;J )MU&ZH=U&Z@";=1NJ'=1NH FW4;JAW4;J )MU&ZH=U&Z@";=1NJ'=1NH
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M!3Q3!3Q2 6EI!2T %%%% "44&B@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ I:!10 4444 %%%% !1110 4A-!--)H 4FF$T$TPM0 I:F%J:6IA:@!Q:
MF%J86IA>F \M49>F%J86H >6J,M32U1EJ8#RU,+4TM32U,!Q:FDTTFFDT .)
MIN:0FDS0 N:3-)10 9HS244 +FDH[44 %%+24 %%*** $I*=BC% #<44N**
M$HI:* "BEQ1B@ HHHH **** "BBB@ HHHQ0 44N*,4 )12XHH !1110 4444
M %%%% !24M)0 AH-!H- "4M)2T .%/%,%.% $JU*M0K4JT 3K4RU M3+2&3K
M4JU"M3+0!(M2"HUJ04@'4M)2TA!0:*#0 E%%% !1110 4444 %%%% @HHHH
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MMUWK*FZFM!E)ZB-2O41ZTF Y:MP]155*M0]:A@:MKU%;UGVK!M>HK>L^U8R
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M2]%5R.J<57(ZPD;Q+25.M0)4ZUA(WB2BEI!2UF:H6E%)2BD4%%%%(H*2EI*
M"BBB@84444 %%%% !1110(**** "BBB@04444 %%%% !2TE+0,**** "D-+2
M&@!IIIIQIAH 8QJ)C4C5$QI@1,:B8U(QJ!C0 QC43&G,:B8TP M32U-)II-
M#MU*&J+-&: )MU+NJ$&G9H EW4;JCS1F@"3=1NJ/-&: )-U&ZH\T9H DW4;J
MCS1F@"3=1NJ/-&: )-U&ZH\T9H DW4;JCS1F@"3=1NJ/-&: )-U&ZH\T9H D
MW4;JCS1F@"3=1NJ/-&: )-U&ZH\T9H DW4;JCS1F@"3=1NJ/-&: )-U&ZH\T
M9H DW4;JCS1F@"3=1NJ/-&: )-U&ZH\T9H DW4;JCS1F@"3=1NJ/-&: )-U&
MZH\T9H DW4;JCS1F@"3=1NJ/-&: )-U&ZH\T9H DW4;JCS1F@"3=1NJ/-&:
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M5(* 'BG"FBG"D HI:04M !1110 AHH-% !1110 4444 %%%% !1110 4444
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MYP]:/.]Z?*%B]O%&\51\[WH\[WHY0+V\4F\52\_WH\_WHY0L7?,%+O%4?/\
M>CS_ 'I<H6+V\4;Q5'SZ//%%@+V\4;Q5+S_>E\[WHL!=W"C<*IB7WIPEI6$6
MMPHS5<24X/18";-+FH@U.!H ?FBDHI +1244 +2444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% #*::=335HYI$$M4I:NRU2EK1&+,^;H:SYN]:,W>LZ;O6
MT3-F?-UJC+WJ]-WJE+WKIB8R*CU U3O4#5T1.>1&:;3C336R,)"4445JC)BT
MM)2U1 4AI:2@:$I*6BH9:"G"FTX5#+0]:F2H5J9*S9JBU'5N*JD=6XJQ9M$O
M0U?AJA#5^&L)&\2]%5R.J<57(ZPD;Q+25.M0)4ZUA(WB2BEI!2UF:H6E%)2B
MD4%%%%(H*2EI* "BBB@84444 %%%% !1110(**** "BBB@04444 %%%% !2T
ME+0,**** "D-+0: &&F-3S3&H C:H6J9JA:@"!S4+5,U0/3 A8U$U2M4+4P&
M$TPFG&F&@ S1FFT4P'@TN:8*=0 [-&:2B@!<T9I** %S1FDHH 7-&:2B@!<T
M9I** %S1FDHH 7-&:2B@!<T9I** %S1FDHH 7-&:2B@!<T9I** %S1FDHH 7
M-&:2B@!<T9I** %S1FDHH 7-&:2B@!<T9I** %S1FDHH 7-&:2B@!<T9I**
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M:@!6:HV:FLU1EJ8#BU,+4TM3"U,!Q:F$TA--)H "::3032$T %)113 ****
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MJF_6MD,AI:*!5 /6ITJ%:F6@99C-6XFJBAJU&U2Q&I ]:=O)TK$B>K\,M9M
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M]>:S)[KKS6J0R:XNNO-9<]QUYJ.>Y]ZSYI_>M$ACIY^O-4)9:;+-[U5>2M+
M$CU4D-/=\U"QS3 8:8:>:;4LAB4X"@"GJM($A47)JY$E1Q1U?AB]J&42P1=*
MUK6+I5>WAZ<5L6L'3BLVQ%NTAZ5OV</3BJ-I!TXK?LX.G%8R8B]9P].*W[2+
MI5"TAZ<5N6L73BN>3$7K:/I6M;I5.WCZ5IPK6$F(F5:D% %+61(4&BBD!$]5
M):N/5.6M(C*,_2LJY[UJ3]#67<]ZWB48UUWK"N^];MUT-85WWKHB,P;OO6'=
M=ZW+OO6'==ZU0S%N>]9,_6M:Y[UDS]36B&9\O6JK=:M2]:K-UK1#&4M% JD
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"DI:2@!#2&E-(: "EI*6@!PIXI@IXH D6I5J):E6@"9:F6H5J9:0$RU*M1+4
MJT#)13Q3!3Q2 =2BDI12$%!HH- "4444 %%%% !1110 4444 %%%% !1110
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MB-^!^E:$35D6[=*TX3Q6;$7T-3+5:,U86H8$@I:04M0(**** "BBB@ HHHH
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M@HHHH **** "DI:2@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MH&J=J@:F!"U1-4K5$U,"(TTTXTTT -HHHI@+2T@IU !12T4 )12T4 )12T4
M)12T4 )12T4 )12T4 )12T4 )12T4 )12T4 )12T4 )12T4 )12T4 )12T4
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MJ6(LJ]2+)54&G!JD"X):<)JIAJ=NI"+@F]Z<)O>J(>G;ZD"[YU)YU4]]&^I
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MF E,;I3Z8W2FAHK250N.]7Y*H7'>NB(S'NNAK$N^AK;NNAK$N^];(9S]YWK
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M?%&*G\NCRZ0$&*3%3^71Y=("OBC%3^71Y= $&*,58\ND\NF!!BD(JQY=(8Z
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M.IHIU2(****0!1110 4444 ->J-QT-7GJC<=#6D"D8MYWKG+_O71WG>N<O\
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M<*<*0"GA:3 !3A2A:>$J&(:!3L4\)3A'4,1%BEJ81TOEUFQ$&*,5/Y='E5#
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MBB@ HHHI@%%%% !1113&%%%% !1112$%%%%( HHHI ***!10 4444P"BBBF
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M HHHH$%%%% !1110,**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M::<::: &T"B@4 .%+2"EH 6BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "DI:2@ I*6DH 2DI:2@!:<*:*>*0#@*D44P"I5% #U%3**8HJ=!0 Y
M14RBFH*F44 .45(HIJBI *0#A3A2"G"D 4444 %%%% !1110 E%%% !1110
M4444 %%%% "&B@T4 %%%% !1110 M%%% !1110 4444 %%%% !1110 4444
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH 9333J::M'-(@EJE+5V6J4M:(Q90FK.F[UHS5G3=
MZWB9LH3=35&7O5Z;J:HR]ZZ(F,BJ]5VJP]5VKHB<\B,TTTXTTULC"0E%%%:H
MR8M+24M40%)2TE T)1114LM"THI*45FS1$BU,E0K4R5FS1%F.K<55(ZMQ5BS
M:)>AJ_#5"&K\-82-XEZ*KD=4XJN1UA(WB6DJ=:@2IUK"1O$E%+2"EK,U0M**
M2E%(H****104E+24 %%%%(84444 %%%% !1113$%%%% !1110(**** "BBB@
M I:2EH&%%%% !1110 TU&U2&HVH B:HFJ5JB:F! U0-4[5 U,"%JA:IFJ%J8
M$9IIIQIIH ;0**!0 X4M(*6@!:*** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** $-)2GI24 )12TE "BGBF@4\"D ]14JBF**F44 2(*G05&@
MJ9!0!(HJ5135%2J*0#@*>!2 4X4 **6D%+2 **** "BBDH 6BDHH **** "B
MBB@ HHHH **** $-%+1B@!**7%&* $HI<44 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !112T %%%% !112&@!#2$TIIA-,!":8QH8U&S4 (S5"S4YF
MJ%FI@-9JB9J5FJ)C0 UC4;&E8TPFF A-,)I33: "B@T4 %%%% "BB@4M !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !24M)0 AI#2FD- !2TE+0 X4\4P4\4 2+4JU$M2
MK0!,M3+4*U,M("9:E6HEJ5: )13Q3!3Q2 >**!12 **** "BBBD 4E+24 %%
M%% !1110 4444P"BBBF,**** "BBB@ HHHI""BBBD 4444A"BBDI:!A1113
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MXZ5I16W'2N>4A&8+3VI?LGM6R+;VI?LWM6?,08GV3VI#:>U;GV;VIIMO:ES
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 ,IIIU--6CFD02U2EJ[+5*6M$8LH35G3=ZT9JSIN];Q,V4)NIJ
MC+WJ]-U-49>]=$3&15>J[58>J[5T1.>1&:::<:::V1A(2BBBM49,6EI*6J("
MDI:2@:$HHHJ66A:44E**S9HB1:F2H5J9*S9HBS'5N*JD=6XJQ9M$O0U?AJA#
M5^&L)&\2]%5R.J<57(ZPD;Q+25.M0)4ZUA(WB2BEI!2UF:H6E%)2BD4%%%%(
MH*2EI* "BBBD,**** "BBB@ HHHIB"BBB@ HHHH$%%%% !1110 4M)2T#"BB
MB@ HHHH ::C:I#4;4 1-435*U1-3 @:H&J=J@:F!"U0M4S5"U,",TTTXTTT
M-H%% H <*6D%+0 M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M+4JU$M2K0!**>*8*>*0#Q10**0!1110 4444@"DI:2@ HHHH **** "BBBF
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M3]ZU;GO65/WK5 9TW>J,G6KTW>J,O6J&0FDI33:EF;'BIHNM0"IXNM6BXFA
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M44E% "T4E% "T4E% !1110 449HH ***!0 M*!0*<!2 <!4BBFJ*D44 /05.
M@J-14Z"D!(@J914:BIE% #U%2 4U13Q2 44M%% !1110 4444 %)2TE !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%(
M HI**8"T4E+0 4448H *6BB@ HHI*  TPFE)IA- #6-1,:<QJ)S3 8QJ!FI[
MFH6-,!C-43&G,:A8TP FF$T$TTF@ )I**2@ HHHH *6@44 %%&*6@ %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%)10 M%)10 M%)2T
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M^]:J(&L][[U U][UAR7WO59[[WJN49T)O^>M)]O]ZYDW_O33?^]'*)G4"_\
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M1112 ****8!1110,*6DI: "BBB@ HHHH 2BBB@ HHHH **** "BBB@ HHHH
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M6IEH F6I5J):E6D!**>*8*>*0#Q10**0!1110 4444 %)2TE !1110 4444
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M$71THH'2BLB HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M5K0'I6/:]JUH*Y9B-&,\5+4,72IJYGN2PHHHI""BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH ****0"4444 %%%% !1110 4444P"BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M +1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 ***!10 4444 %(:6@T )BC%%% !BBBB@ HHHH ;2&G4E "4=Z**
M%%/%- IZT@)%J514:U,@H E05,HJ-!4RBD!*HJ514:BIE%(!RT\4T4\4 +2T
M44 %%%% !24M)0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1112 **** "BBB@!**6B@ %+0**8!1110 4TTZF&@!K&HF
M-/8U$QI@1L:A<T]C4+F@!C&H6-.8U$QI@,8U&33B:8: $---*:2F AI1110
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M %%%% !1110 4444P"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MM3+0!,M2K42U*M("44\4P4\4@'BB@44@"BBB@ HHHH *2EI* "BBB@ HHHH
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MLX<8XK"3)-*SCZ5N6R8 K.M8^E;%NO K"3$7(QQ3Z1.E.KG8F%-?I3J:_2A
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MO$D%**04HK(U0M**2E%!04444B@I*6DH ****0PHHHH **** "BBBF(****
M"BBBF(**** "BBBD 4M)2T#"BBB@ HHHH ::C:I#4;4 1-435*U1-3 @:H&J
M=J@:F!"U0M4S5"U,",TTTXTTT -H%% H <*6D%+0 M%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1112 **** "BBB@ HHHH ****8!1110 4
M444 %%%%  :2E-)0 4444 %%%% !2@4E.% #Q4BBF**E44@)%%3J*B45,HH
ME6IE%1J*E44@)%J04P"I!2 <*44@I10 4444 %%%% "&B@T4 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444@"BBB@!1
M10** "BBB@ I#2TAI@(::32DTTF@!K&HF-/8U"QI@,8U YJ1C4+&@")C43&G
ML:B8TP&,:C-.8TTT -HHHI@%%%% !1110 HHH%% !2TE+0 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MLU7JS')0!KPRUHP3].:P8I<5=BGQWJ6A'207'3FM"&Z]ZYB*YQWJW'=^]9M
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M3-7(VK(@DZ5HQ-630%]#4ZU5C-64K-B):***D04444 %%%% !24M)0 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 ,III
MU--6CFD0253EZ5<DJE+6B,649JSIJT)JSYJWB9LSYN]4I>]79N]49>]=$3&1
M5DJ!JG>H&KHB<\B,TPT\TPULC"0E HHK5&3 4M%+BJ($I*=3:!H2BEQ14,I
M*<.M- IPJ&:H>M3)4*U.E9LT19CJY%5..K<58R-HEZ&K\/:J$-7X:PD;Q+T5
M78^E4HJNQUA(WB6DJ=:@2IUK"1O$D%**04M9&J%I124HH*"BBBD4%)2TE !1
M112&%%%% !1110 4444Q!1110 4444Q!1110 4444@"EI*6@84444 %%%% #
M34;5(:C:@")JB:I6J)J8$#5 U3M4#4P(6J%JF:H6I@1FFFG&FF@!M HH% #A
M2T@I: %HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****0!11
M10 4444 %%%% !1113 **** "BBB@ HHHH #244E "T4F:* %HH%% "BG"D%
M.% #U%2J*8M2J*0$BBIU%1**F6@"5:F6HE%3+2 >!3Q313Q2 6E% HH ****
M "BBB@!#1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1112 **** %%%%% !1113 *0TM-- #2:8QIQ-1L: &,:A8U(
MQJ%C3 C8U"QI[&H6- #&-1,:>QJ,FF PFFFE--H ****8!2T44 %%%% !111
M0 4M)2T %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %)2TE "&D-*:
M0T %+24M #A3Q3!3Q0!(M2K42U*M $RU,M0K4RT@)EJ5:B6I5H E%/%,%/%(
M!XHH%%( HHHH **** "@T4E !1110(**** "BBB@84444 %%%% !1110 444
M4 %%%% !1112$%+110,**** "BBBF E,;I3S3&Z4T-%66L^X/6M"7O6=<=*Z
M(C,>Z/6L*\/6MRZ[U@WG>MD!S]Z>M<]>'K6_>]ZYZ\/6M4,P[MNM8MRW6M>[
M/6L6Y/6M4,SYFJF[<U9F/)JHW6M4QC2:832FF&DV9R8A-&:2BHN9$BFK=NWS
M526K4'WJTBS:#-^R;I726!Z5S%EVKI+#M4R+.KL#TKI[$]*Y:P[5U%CVKGD(
MZ.T/ K:M^U8EGT%;=OTKGD2:4?2K"U6BJPM82 E'2EI!TI:R)"BBB@ HHHH
M2BBBF 4444 %%%% "9HHHH&%%%% !FEI*!0 M%%% @HHHI %%%% !2XI*6@
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 ,IIIU--6CFD0
M2U2EJ[+5*6M$8LH35G3=ZT9JSIN];Q,V4)NIJC+WJ]-U-49>]=$3&15>J[58
M>J[5T1.>1&:;3C3:V1A(2BBBM49,6EI*6J("DI:2@:$HHHJ&4A12BD%**AFJ
M)%J9*A6IDK-FB+,?6K<55(^M6XJQ9M$O0U?AJA#5^&L9&\2]%TJY'5.+I5R.
MN>1O$M)4ZU E3K6$C>)**6D%+69JA:44E**104444B@I*6DH ****0PHHHH
M**** "BBBF(**** "BBBF(**** "BBBD 4M)2T#"BBB@ HHHH ::C:I#4;4
M1-435*U1-3 @:H&J=J@:F!"U0M4S5"U,",TTTXTTT -H%% H <*6D%+0 M%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1112 **** "BBB@ H
MHHH ****8!1110 4444 %%%% "4E+24 %%%% "BE%(*44 **>*:*>M $BBI5
MJ-14RBD!(HJ=142BIE% $JBI5J-:E6D \4X4T4\4@%HHHH **** "BBB@!**
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH ****0!1110 M%%% !1113 0TTTXTTT ,8U$QJ1C4+&@"-C4+&I'-0L:8$;
M&H6-/8U$QH 8QJ,T\FHS3 0TVE-)0 4"B@4P%HQ12T )BC%+10 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M:]*WK0=*QDQ&S;=JUH.U9=L.E:L Z5A(1H159'2JT561TK)B84444A!1110
M4&B@T@$HHHH **** "BBBF M%%% !1110 4UA3J#0!7=<U3FCSFM%EJ"1,UH
MF48=Q#G/%8]U!UXKIYHNO%95S!P>*Z(L9R%Y;]>*Y^\MNO%=K=V_7BL"\M^O
M%;)C.*O+?KQ6%=0=>*[.\MNO%8-W;=>*T3 Y*YAZ\5FS15TMS;]>*RYK?KQ6
MB8S#>/!J,J16E)![5 T/M6B8%(BD(JRT-,,1JB6BN11BIC$:3RC2(L18IP%2
M"(T]8N:120D:U=A7I4<<57(8NE0V47+9>16W9KTK,MH^E;5I'R*PDQ&W9#I7
M2V(Z5S]DG2NDLEZ5A)B.@LATKH+3H*P;)>E;]H.!7/(#8M^@JZ.E4[?H*N#I
M6;$PHHHI""BBB@!#10:* %HI*6@ I*6B@!A6HG2I\4UEJDQE"6.J$T.>U;#I
M5:2*K3&<_<6_7BLFYM>O%=1-!GM6=/;YSQ6J8'(7-IUXK'N;3KQ79W%KUXK(
MN;3KQ6\6,XNXM.O%95Q:^U=E<VG7BLFXM.O%:IC./GMNO%9TUO[5U=Q:=>*R
MY[7VK5,9S$L'M5*2'VKHYK7VJA+;>U6F!B-&1496M1[?VJ!K?VIA8HXHQ5DP
M>U,,1I"L0TX5)Y9HV4@!34BM3 M. HN,E$E2"2J]*#2N!;$M.$U4]U+NI"+H
MG]Z7SZI;Z-YH N^?2>?[U3WT;Z0%LS>],,U5MU!:@"<RU&TE1YI#3 &>HV:G
M$4W;3N!&:;4WEYH\HT[@0XI0M3B'VJ58/:F.Q55":GCA)[5:2W]JM16WM3N,
MKQ0=.*OPV_3BIX;7IQ6E!:=.*AL"O!;=.*TH+3IQ5FWM.G%:EO:=.*AL16M[
M3IQ6O;6G3BI[>SZ<5K6]ITXK)L1%;6G3BMBVM>G%/M[7IQ6K;VW3BL9,0VWM
M^G%:D$&,<40P8[5?BBQVK%L011=*N(E(B8J=5K)L 5:>!1BEJ20HHHI %%%%
M "&H):G/2H)>E5$9G7'>LFZ[UKSBLFY'6MT!AW8ZU@7@ZUT-T.M8-VO6MHC.
M<O!UK NUZUT=VG6L*ZCZULF,YZY7K65.O6MVYCZUE3Q5HF,QY5JLPQ6G+%51
MXO:KN,J$4F*G,1H\J@FQ"!3@*E$5*(C5(:1&!1BIQ%2^557&08IPJ7RZ/+IW
M&,%.!I=AI=E*XA QIP>DVT;:5Q#M]&\TW;1@U-P';S1O--P:,&E<!=])O-)M
M-&TU(A=YHWTFTTFTTP';Z-YINTTNTT7 7>:-YI-M&VG<!=]&\TW::-IHN [>
M:-YINTT;30 [>:-YINVEVT +OHWFF[31M-(!=YHWFDVT;:!!OI"]&VDVT@$+
MTF^@K2;:AB%#FI4<YJ'::D13FD-%V%S6E;OTK,A4UI6XZ4F,V+5^E;EHW2L&
MU'2MRT'2H8'06;=*WK0]*Y^S'2M^S'2LV(W;4]*V;<\"L6U[5LVW05BQ&I!V
MJ]'5&#M5Z*L6!-1114B"BBB@ HHHH *2EI* "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH ****0!1110 4444 %%%% !1113 *
M*** "BBB@ HHHH 2DI:2@ HHHH 44HI!3A0 X4]:8*E6@!ZU,HJ-:E44@)5J
M9:C45,M $BU(HIBU(M(!X%.%(*=2 **** "BBB@ HHHH 2BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBBD 4444
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"@T4&@!#24II* $I:2EH 44X4T4X4 /6I%IBU(M $JU,M1+4RT@)5J9:B6IE
MI 2+4@J-:E%(!PIU(*6D 4444 %%%% !2&EI#0 4444P"BBB@ HHHH ****
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MI?L/M1]A]J.8#FOL/M1]A]JZ7[#[4?8?:GS <U]B/I1]B]JZ7[#[4?8?:CF
MYO[%[4GV+VKI?L/M1]A_V:.8#FOL7M2?8O:NE^P_[-'V'VI<P'-?8O:D-E[5
MTOV'VI/L/M1S <R;+VH^P^U=*;'VI/L/M4W$<V++VIZV7/2NB%C[4];'VI7&
M8<=E[5=AL_:M9++VJU%9^U*X&?!:].*U+>VQCBK,5ITXK0AML8XJ6P&6T&,<
M5KVT72F00>U:4$.,<5#8B:"/I6E"O2J\,?2KT2UFP+$0JTE0(*L+6;$24445
M(!1110 4=Z2BD II***8@HHHH **** "BBB@ HHHH ****!A1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 ,IIIU--6CFD02U2EJ[+5*6M$8LH35G3=ZT9JSI
MN];Q,V4)NIJC+WJ]-U-49>]=$3&15>J[58>J[5T1.>1&:;3C3:V1A(2BBBM4
M9,6EI*6J("DI:2@:$HHHJ&4A12BD%**AFJ)%J9*A6IDK-FB+,?6K<55(^M6X
MJQ9M$O0U?AJA#5^&L9&\2]%TJY'5.+I5R.N>1O$M)4ZU E3K6$C>)**6D%+6
M9JA:44E**104444B@I*6DH ****0PHHHH **** "BBBF(**** "BBBF(****
M "BBBD 4M)2T#"BBB@ HHHH ::C:I#4;4 1-435*U1-3 @:H&J=J@:F!"U0M
M4S5"U $9IIIQIIH ;0**!3 <*6D%+0 M%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4&B@T
M(:2E-)0 E+24M "BGBF"GB@!ZU*M1+4RT 2K4RU$M3+2 E6IE%1**F44@'K4
M@I@J04@'"EI*6D 4444 %%%% !2&EI#0 4444P"BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH *!10* %HHHI %%%%, HHHH
M0U$U2&HFH B8U"QJ5JA<T 0N:@:IFJ!J8$35&U2-41I@----*:0T )2&EI#0
M M**2E% !2TE+0 4444 %%%% !1110 4444P"BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M!G1VN.U7(K?VJXEO[582#':I;$0Q08[5=BBQ3DBJRD>*AL!8TJR@IJ+4JBI
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M]D]J/LGM2Y@.?^Q>U'V+VKH/LH]*/LH]*.8#G_L7M1]B]JZ#[*/2C[*/2CF
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M""BBB@ HHHI@%%%% !1110 4444 %%%% PHHHH **** "BBB@ HHHH ****
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M 4444 %%%% !1FBDH 7-&:2B@!<T9I** %HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "D-+2&@!#24M
M)0 E*#Q24M #A3UI@IZT 2+4JU$M3+0!,M3+4*U.E("5:F6HEJ9:0#Q4@I@I
MXI .%%%%( HHHH *,TAHH 7-)110 4444P"BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH *6D%+2 **** "BBB@ I#2TAH ::
MB:I#434P(FJ%S4K5"],"%J@:IFJ%J (FJ,T]JC-,!II#2FFF@ HHHH *6DI:
M  4M HH **** "BBB@ HHHH ****8!1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MD6W]JT!![4X0^U*XBDL'M4RPU:$5/$=*X$*1U.J4\1U(%J;B&JM2@4!:<!2
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M\BG<#,%M[4X6_M6D(/:G"'VI7 SQ;^U/6#VJ\(:<(J5Q%58:E6*K CIXCI7
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M%&:,T )1112$%%%% !1113 **** "BBB@ HHHH ****!A1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 ,IIIU--6CFD02U2EJ[+5*6M$8LH35G3=ZT9JSIN];
MQ,V4)NIJC+WJ]-U-49>]=$3&15>J[58>J[5T1.>1&:;3C3:V1A(2BBBM49,6
MEI*6J("DI:2@:$HHHJ&4A12BD%**AFJ)%J9*A6IDK-FB+,?6K<55(^M6XJQ9
MM$O0U?AJA#5^&L9&\2]%TJY'5.+I5R.N>1O$M)4ZU E3K6$C>)**44@I169J
MA:44E**DL****!A24M)0 &DI324 %%%%(84444 +1113$%%%% !1113$%%%%
M !1112 *6DI:!A1110 4444 --1M4AJ-J (VJ%JF:H6H @:H&J=J@:F!"U1-
M4K5"U,",TTTXTPT )1113 <*6FBG4 +1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !24M)0 4444 %%%% "T444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !2&EI#
M0 E)2TE "4M)2T .%/6F"GK0!*M2K42U*M $ZU.E0+4Z4@)EJ5:B6IEI 2"G
MBF"GBD M%%% !1112 0T4&B@ HHHH ****8!1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444  I:04M( HHHH **** "FFG4TT
M,8U$QJ5C43&F!"QJ%S4S&H'-,"%JA:IFJ%J8$35&:D:HS0 TTTTXTTT %%%%
M !2TE+0 HHH%% !1110 4444 %%%% !1113 **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ I*6DH 0TAI32&@ I:2EH <*>*8*>* )%J5:B6I5H F6IEJ%:F
M6D!,M2K42U*M(9**>*8*>*0#J6DI:0@HHHH **** "DI:2F 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %&*
M** $Q2;:=BEQ3 C*TW94V*3%%QD.RD\NI\4N*+@5O+H\NK&*-HHN!6\NCRO:
MK.T4;11<"MY5)Y56MHHVBBX7*WE4OEU8P*,"BX$ CIVRI<4N*+B(MM.VT_%%
M(!N*6EHH 2BEI*0!1110(*2EI* "BBBD 4444 ***** "BBB@ HHHH&%%%%
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M4ZB@!A6F%*FHQ3N,@V4GEU8Q28%%P*_ETGE>U6<"C HN!6\KVH\JK.!1@47
MK>52^55C HQ1<"MY='EU9Q1MHN!7\NE"5/MHVT7 A"4X+4F*3% AN*!3L4E
M"BB@44 %+24M !1112 ,4W%.Q13 9MI-M28HQ0,BV4FRIL48HN!#Y=)Y=6,4
MF!1<"OY='EU8P*,"BX%;RZ/+JSM%&T47"Y6\NCRZL[11M%%P*_ET>75C:*-H
MHN!7\NCRZL;11M%%P*_ETOEU/@48%%P*_ET>75C HP*+@0>7[4>7[5/@48%%
MP(/+H\NI\"C HN!!Y='EU/@48%%P(/+H\NI\"C HN!!Y='EU/@48%%P(/+H\
MNI\"C HN!!Y='EU/@48%%P(/+H\NI\"C HN!!Y='EU/@48%%P(/+H\NI\"C
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MBBB@ I:2EH ****0!1112 **** "D-+2&@ HHHH *44E** %HI*,T +1110
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M !1110 4444 %%%% !1110 4444 %%%% !1110 M%%% !1110 4444 %%%%
M!1110 4AI:0T )24M)0 E+24M #A3UI@IZT 2K4R5"M3+0!,E3K4*5.M("9:
ME6HEJ5:0$@IXI@IXI +1110 4444@$-%!HH **** "BBBF 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 444HH 2BEHH 2EHHH ****0!1
M110 &F&G4TT ,:HFJ1JB:F!$U0/4S5"YI@0M4+5,U0M3 B:HR:D:HS3 ;2&E
M-(: "BDHS2 6EI*6@!112"EH **** "BBB@ HHHI@%%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %)2TE "&D-*:0T %+24M #A3Q3!3Q0!(M2K42U*
MM $RU,M0K4RT@)EJ5:B6I5I 2BGBF"GB@!U+2"EI %%%%( HHHH *2EI*8!1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4M HH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "DHHH *0TM% "44II*0!1110 4444 %%+10 E%+10 4444 %%%% !
M2TE+F@ HHS1F@ H-&:2@ HHHH ****8!12T4 )12T4 )10:2@!:*** "EH%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% "44M)0 E%+24QBT444""EH%%( HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ I*** "BBBD 4444 %%)1B
MF M%%%( HHHH **** "BBB@ HHHH **** %HI** %HHHH ****8!1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% "4E.-(: $HHHH *6DI:8!
M2BDI12 **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "DI:2@ HHI*8Q:**!2$+1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %)2TE !1110 4444""BBB@
M HHHH **** "BBB@ HHHH&%%%% !1110 4444 %+244 +124M @HHHH&%%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %)2TE  :2EI*8!2T
ME+0 4444@"BBB@ HHHH *0TM%(!**** "E%)2T %%%% "T444 %%%%, HHHH
M **** "BBB@ HHHH **** "BBB@ Q28I:* $VTFVG447 9MHVBGT4[CN,VTN
MVG447$)MHQ2T4@#%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M4E "TE%% !1110 4444 %%%% !1110 4444 +1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %)2TE !1110 4444""BBB@ HHHH **** "BBB@ HHHH ****
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH *2EI* $-(:4TAH *6DI: '"GBF"GB@"1:E6HEJ5:
M )EJ9:A6IEI 3+4JU$M2K0!**>*8*>*0#Q10**0!1110 4444 %)2TE !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4M)10 M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 449I*
M %I*** "BBBF E%+12 2BEHQ0 E%+BC% "44N*,4 )FES110 9HS110 4444
M6&%%%% !1110(**** "BBB@ HHHH **** %HHHH ****  TE*:2@ HHHH !2
MTE+0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4E+24 !I*6B@ Q1110 HHI*6@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "DH-% !1113&%%%%( HHHH
M**** "BBBF 4E+12 ,T9HHH$&:2EHHL E%+10 E%+10 4444 %+244 +1FDH
MH 6BDHS0 M%&:* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ -)110 4
M444 %%%% !1110 M% HH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *2BB@ HHHH *6@4
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 E%%% !1113 ****
M "BBBD 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% @HHHI@+124M
M( HHHH&%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4E%% !1113
M **** "BBBD 4444 %%%% !1110 4444 %%%% !1110 4M)10 M)FBB@!:*2
MB@!:*3-+F@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BDS10 M)FBB@!:*2B@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH 6BDI: "BBB@ HHHH **** "BBB@ HHHH ****
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 +1110 4444 %)2TE !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%%, I124M !2TE+2 **!10 4444 %%%% !111
M0 4AI:0T )24M)0 E+10*0#A3Q313UH D6IEJ):F6@"9*G6H4J9: )EJ5:B6
MI5I 2"GBF"GBD M%%% !1110 AHHHH **,T9H **,T9H **,T4 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4HI*44 %%%% !1110 4444 %%%
M% "&F&GFF&@"-JB:I6J)J (FJ!ZG:H'I@0M4+5,U0M3 C-1FI#49I@--(:4T
MAH 2BBB@!:44E**  4M(*6@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ I*6DH 0TAI32&@ I:2EH <*>*8*>* )%J5:B6I5H
M F6IEJ%:F6D!,M2K42U*M $HIXI@IXI /%% HI %%%% !1110 4E+24 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1112 **** %HHHH **** "BBB@ HHHH ****8!FC-)10 N:2BB@ HH
MHI@%%%% !1112 ****8!1110 4444 %%%% !1110 4444 %%%% PHHHH ***
M*0@HHHH **** "BBB@ HHHH 6BBB@ HHHH #24II* "BBB@ H%% H 6BBBD
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MBDHH 6BDHH 6BDHH 6BDHH 6C-)10 N:,TE% "YHS244 +FC-)10 N:,TE%
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MB@ HHHH **** "BDHI@+1244 +1244 +1244 +124M !1112 **** "BBB@
MHHHH **,T9H **,T9H **,T4 %%%% !2&EI#UI@%%%% !1110 4444 %%%%
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M "BBB@ HHHH **** "BBB@ HHHI %%%% !1110 4444 %%%% !1110 4444
M%+244 %%%%, HHHH **** "BBB@ HI<48H 2BEQ1B@!**** "BBBF 4444 %
M%%% !1110 4444#"BBB@ HHHI""BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH ****0!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4M)10 4444P"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH ****0!1110 N:,TE%,!<T4E% !1112 **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHI* %HI**8!2TE+0 4444 %%%%
M!1113 **** "BBB@84444 %%%% !1110(**** "BBEQ2 2BEQ10 4E+24 %%
M%% !1110 4444 %%%% !1110 4444 %%%%( HHHH **** "BBB@!<TE%%, H
MHHH *0TM(: "BBB@ HHHH 44N:;2T +FC-)10 N:,TE%( HHHH **** "BBB
MF 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444@"BBB@ HHHH **** "BBB@ HHHH$+2444
M%%%%,84444 %+FDHH 7-&:2B@!<T9I** %S1FDHH 7-)110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !24M)0 4444 %%%% "BB@44 %%%% !
M1110 4444 %%%% @HHHH **** "BBB@84444 %%%%( HHHH ****8!1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %)2TE !1110 4444 +10** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****0"T4E% "T49HI
M%%%% !110: "C-)13 7-)110 4444""BBB@ HHHIC"BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@!<T9I** %S
M1FDHH 7-)110 4444 %%%% !1112 **** "BDHH 6BDHH 6BDI: "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH ****8!1110,**** "BBB@ HHHH ****!!1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 RFF
MG4TU:.:1!)5.7I5R2J<O2M$8LH35G35HS5G35O$S9GS=ZI2]ZNS=ZI2]ZZ(F
M,BI)4#5/)4#5T1.>1&:8:>:8:V1A(2BBBM49,6EI*6J("DI:2@:$HHHJ&4A1
M2BD%**AFB)%J9*A6IDK-FJ+,?6KD54X^M7(JQD;1+L-7X>U4(:OP]JPD;Q+T
M578^E4HJNQ]*PD;Q+4=3K4$=3K6$C>)(*44@I161JA:44E**"@HHHI%!24M)
M0 4M)2T %%%%( HHHH 2BBBF 4444 %%%%,04444 %%%%( I:2EH&%%%% !1
M110 TTPT\TTT 1,*B85,14;"@"!A4+"K#"HF% %=EJ)EJRRU&5I@5BM-*U8*
MTW;0!!MHVU-LHV4 0[:=MJ3;3MM,"';1MJ;;1MH AVT;:FVT;: (=M&VIMM&
MV@"';1MJ;;1MH AVT;:FVT;: (=M&VIMM&V@"';1MJ;;1MH AVT;:FVT;: (
M=M&VIMM&V@"';1MJ;;1MH AVT;:FVT;: (=M&VIMM&V@"';1MJ;;1MH AVT;
M:FVT;: (=M&VIMM&V@"';1MJ;;1MH AVT;:FVT;: (=M&VIMM&V@"';1MJ;;
M1MH AVT;:FVT;: (=M&VIMM&V@"';1MJ;;1MH AVT;:FVT;: (=M&VIMM&V@
M"+;1MJ;;1MH AVT;:FVT;: (-M&VIMM&V@"';1MJ;;1MH AVTNVIMM&V@"';
M1MJ;;1MH AVT;:FVT;: (-M&VIMM&VF! 5I,5,5II6@"(BDQ4A%-(H 9BDIU
M)0 E%%% !1110 4444 %(:6D- "&DI32'K0 4HIM+2 >*D%1"I : )5J9:A6
MIEH G6IEJ%:F6@"=:D6HUJ1:0$@IXI@IXI +1110 4444 )1110 E%%% !11
M10 4HI*44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% "T444 %%%% !1110 AIAIYIAH C:HVJ5JB:F!"U0/4[5"U,"!JA:IVJ%A
M0!$:C-2-49I@--(:4TAH 2BBB@!:44E**  4M(*6@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M* $S1FEHH ****+C"BBBBX!1110 4444""BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHI %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%%, HHHI %%%&: "BC-% !1113 **** "BBBD
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%%, HHHI %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 AHH-% !1113 *6DI: "BBB@ HHHH
M*2EHH 3-&:6B@ HHHHN,****+@%)2T4"$S1FEHH **** "EI**0"T4E% "TE
M%%, HHHH ****0!1110 4444 %%&:,T %%&:,T %%%% !1112 **** "BBB@
M HHHI@%%%% !2&EI#3 **** "BBB@ I:2EH **** "BBBD 4444 %%%% !11
M13 **** "BBB@ HHHH **** "BBBD 4449H **3-% "T4E% "T4E+F@ HHS1
MF@ HHS1F@ HHS1F@ HHS1F@ HHS1F@ HHS10 4444 %%%% !1110 4444 %%
M%% @HHHH **** "BBBF,**** "BBB@ HHHH **** "BBB@ HHHH ****0!11
M10 4444 %%%% !1113 **** "BBB@ HHHH *2EI*0!1110 4444P%%%%% !1
M110 4444 %%%% !1110(**** "BBB@ HHHH&%%%%( HHHH ****0!111FF 4
M49HS0 449HS0 449HS0 449HS0 4444P"BBB@ HHHH **** "DI:2D 4444
M%%%% "BBBB@ HHHI@%%%%( HHHH **** "BBBF 4444 %%%%( HHHH ****
M"BBB@ HHHI %%%% !1110 4444Q!1110 4444 %%%% !111F@8449HS0 444
M4P"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBBD 4444 %%%% "4444 %%%% !2TE+0 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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MB@ HHHI@%%%%, HHHH **** "BBB@!:0T4IH&)1110 4E+24 %%%% !1110
M"EI!2T %%%% !1110 4444 %%%%( HHHH **** $HI:* $HI:* $I:** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@!<48HHH ,48HHH ,4E+24 %%%% !1110 4444 %%%% !1110 4444
M I:!10 4444P"D-+0: $HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MMH AVT;:FVT;: (=M+MJ7;2[:8$.VC;4VVC;0!#MHVU-MHVT 0[:-M3;:-M
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 ***!10 4444 %%%%  :::<::: (VJ-JE:HF%,"%JA:IF%0L*8
M$#5"U3-4+4 1-3#3VIAI@,-(:4TAH 2BBB@ I:2EH 444"B@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ I*6DH 0TAI32&@
MI:2EH <*>*8*>* )%J5:B6I5H F6IEJ%:F6D!,M2K42U*M $HIXI@IXI /%%
M HI %%%% !1110 4E+24 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%%  :2E-)0 4444 %%%% "T444 %%%% !1110 4444 %%%% !
M1110 4444@"BBB@ HHHH ****0@HHHH&%%%&* "BEHH 2BEHH 2BEHH 2BEH
MH 2BEHH 2BEHH **** "BBB@ Q24M% "44M)0 4444P"BBB@ HHHH ****8!
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% "T444@"@T44 )12XHI )1110 448HQ0 M%%% !111
M0 8HQ110 8I,4M% "8HQ2T4 )12T4 )12T8H 2BBBF 4444 %%%%, HHHH *
M*** "BBB@ HHHH **** "EI*6@ HHHH ****  TE*:2@ HHHH **** "BBEQ
M0 E%+BBD E%+10 F**6B@!**7%&*0"44N*,4 )2T44 %&*** #%)2T4 )12X
MHQ0 E%+BC% "44N*,4 )12XHQ0 E%+BC% "44N*,4 )12XHQ0 E%+BC% "44
MN*,4 )12XHQ0 E%+BC% "8HI:* $HI:* $HI:* $HI<4E !1110 4444P"BB
MB@ HHHH **** "BBB@ HHHI@%%%% !1110 4444 %%%% !1110 4444 %%+B
MB@!**6BD E&*6B@!,48HQ2XI )BC%%% !BBBB@04444#"BBB@ HHI<4 )12X
MHQ0 E%&*,4 %%%% !1110 448HI@%%%% !1110 4444P"BBB@ HHHH ****
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ML)&\2TE3K4"5.M82-XDHI:04M9FJ%I124HI%!1112*"DI:2@ HHHI#"BBB@
MHHHH ****8@HHHH ****8@HHHH **** "BBBD,**** "BBB@ HHHH 2BEI*
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M)2B@!112"EH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH *2EI* $-(:4TAH *6DI: '"GBF"GB@"1:E6HEJ5: )EJ9:A6IEI
M3+4JU$M2K0!**>*8*>*0#Q10**0!1110 4444 %)2TE !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 &DI:,4 )12XHQ0 E%+BC%
M!1110 4444 %%%% !1110 44AHI@+1244 +1244@%HHHH ****0!1110 48I
M:* "BBBD 4444P"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHI %%%
M% !24M%,!**6B@!**6B@!****8!1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% "T444@"BBB@ HH
MHH **** "BBBD 4444P"BBB@ HHHH **** "BBB@ HHHI %%%%, HHHH *3%
M+10 E%%%, HHHH **** "BBB@ HHHH **** "EI** %HI,T9H 6BDS1F@!32
M444 %%%% !2TE+0 4444 %%%%( HHHH **** "BBB@ HHHH **** "BBBD 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %)2T4P$HHHH **** "BBB@ HHHH **** "BB
MBF 4444 %%%% !1110 4444 %%%% "T444 %%%% !1112 **** "BBB@ HHH
MI %%%% !1110 4444 %%%% !1110 4444P"BBBD 8HHHI@%%%% !1110 E%%
M%, HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *,44
MM !1112 **** "BBB@ HHHH **** "BBBD 4444 %%%% !1113 **** "BBB
M@ HHHH **** "BBBF E%%% !1110 4444 %%%% "T444@"BBB@ HHHH ****
M "BBB@ HHHH **** "BBBD 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444P"BBB@ HHHH *
M*** "DHHI@%%%)0 M% HH *6DI: "BBB@ HHHI %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1113 *2EH- A**** "BBB@ HHHH&%)2TE !1110 444
M4  I:** "BBB@ HI110 E%+10 E%+12 2BBBF 4444 %%%%( HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M**8!1110 M%&:,T %%&:,T %)2YI* "BBB@ HHHI %%%% !1110 4444 %%%
M% "T4E% "T4E%,!:#244 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 RFFG4TU:.:1!+5*6KLM4I:T1BRA-6=-WK1FK.F[UO$S90F[U
M1E[U>F[U1E[UT1,9%5Z@:IWJ!JZ(G/(B---.---;(PD)1116J,F I:04M40%
M(:6D- Q****AEH44X4T4X5#-$/%3I4 J=*S9HBS'VJW%52/M5N*L9&T2]#5^
M&J$-7X:PD;Q+T57(ZIQ5<CK"1O$M)4ZU E3K6$C>)**6D%+69JA:44E**104
M444B@I*6DH ****0PHHHH **** "BBBF(**** "BBBF(**** "BBB@ HHHI#
M"BBB@ HHHH **** "BBB@ HHHH *,44M "8HI:* $Q1BEHH 3%+BBB@ Q1BB
MB@ Q1BBB@ Q1BBB@ Q1BBB@ Q1BBB@ Q1BBB@ Q1BBB@ Q1BBB@ Q1BBB@ Q
M1BBB@ Q1BBB@ Q1BBB@ Q1BBB@ Q1BBB@ Q1BBB@ Q1BBB@ Q1BBB@ Q1BBB
M@ Q1BBB@ Q1BBB@ Q1BBB@ Q1BBB@ Q1BBB@ Q1110 4444 %%%% !1BBB@
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !24M)0 AI#2FD- !2TE+0 X
M4\4P4\4 2+4JU$M2K0!,M3+4*U,M("9:E6HEJ5: )13Q3!3Q2 >**!12 ***
M* "BBB@ I*6DH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@!#10:*8!112T )2X
MHHI +BC%%% !1110 4444 %%%% !1110 4449H **3-&: %HI,T9H 6BDS1F
M@!:*3-&: %HI,T9H 6BDS1F@!:*,T4 %%%% !1110 4444 %%%% !1110 E%
M+10 E%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 +1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 )1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %+24M !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !BC%%% "8HI:* $HI:3% !1110 4444 %%%% !1110 4444 %%%%
M "T444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 )1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %+24M !1110 4444 %%%% !1110 4444 %
M%%% !111F@ HHS10 4444 %%%% !1110 4444 %%%% !24M)0 4444 %%%%
M!1110 4HI*44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4449H **** "BBB@ HHHH **** "BBB@ HHHH 2BBB@ HQ113 ****0!2TE+
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %)2TE
M @HHHI@%%%% !1112&%%%% !1110 4444 %%%% !1110 HHH%% !1110 444
M4 )12T4 )BC%+10 8HQ110 8I,4M% "8HI:* $HI:2@ HHHH **** "BBB@
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %)2TE "&D-*:0T %+24M #A
M3Q3!3Q0!(M2K42U*M $RU,M0K4RT@)EJ5:B6I5I 2BGBF"GBD \44"B@ HHH
MH ****0!24N:2F 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%%( HHHH ****8!1110 E&*7O13 ***6D
M4444 %%%% !1110 4444 %%%% !129I": %I,TTM3"U58JQ)FDW5&7II>GR@
M3;J3=4.^C?3Y0)MU&ZH/,H\RGR@3[J-U0>91OHY0+&ZC=4&^C?2Y0)]U+FH
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M&:+!8=13=U&ZBP6'49IN:-U%@L/HIN:7-(+"T4F:7- @HHHH **** "BBB@
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M !112T )12T4 )12T4 )12FDH **** %%%)2YH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ I*6B@!**** "EHHH **** "BBB@ HHHH ****
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MHHH **** "BBBD,**** "BBB@ HHHH **** "BBB@!:*2ES0 449HH ****
M"BBC- !11FC- !11FC- !11FC- !11FC- !11FC- !11FC- !11FC- !11FC
M- !11FC- !11FC- !11FC- !11FC- !11FC- !11FC- !11FC- !11FC- !1
M1FC- !11FC- !11FC- !11FC- !11FC- !11FC- !11FC- !11FC- !11FC-
M !11FC- !11FC- !11FB@ HHHH **** "BBB@!#4;4\TQC30$35 ]3L:@>F!
M ]0/4SU U,"%JB-2M41H 8:2E-)0 4444 %%%% !1110 4E+24 %%%% "BG"
MFBE% #Q4BU$*D4T 3*:F6H%-3*:0$ZFIE-0*:F4T 3*:E6H5-2K2 D%.IHIP
MI +1110 4444 %%%% "4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% "T444 %%%% "&HVJ0TQJ (6J%ZG
M85"PI@5V%0L*L,*@84P(&J)JF85$PI@1&FFGD4TT ,HI:2@ I124HH *6DI:
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "DI
M:2@!#2&E-(: "EI*6@!PIXI@IXH D6I5J):E6@"9:F6H5J9:0$RU*M1+4JT@
M)13Q3!3Q2 >**!12 **** "@T4&@!****8!1110,**** "BBB@ HHHH ****
M!!1110 4444 %%%% !1110 4444 %%%% !1110 4444@"BBB@ HHHH ****
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M]385A]%-W4N:0A:*,T4 %%%% !24M% "44M% "448HH ****0!1110 4444
M%%%% !1113 **** "BBB@ HHHH **** "BBB@ HHHI@%%%% !1129H&+FDS3
M2::6IV DW4W=41DIAD]Z:B,G+TA>JIEIAF]ZI1 M^92&2J9G]Z:9_>JY0+OF
M4GF>]4O/]Z3SZ?*!>\RCS/>J'G^]'G^]/E O^9[T>95#SZ//]Z.4"_YGO2^9
M5#SZ7S_>ER@7_,I?,J@)_>G";WI<H%[?3@]41-[U():EQ MAJ7=5824\/4M
M3YI:B#4\&IL(=2TE%(04444 %%%% !1112 **** "BBB@ HHHI@%%%% !111
M0 4444 %%%% !1110 444E !FC-(332:JP"YI-U,+4TO3L,DW4A>H3)49EJN
M499WTGF55,U,,WO5<H%SS*/,]ZHF?WI//I\H%[S?>CS?>J'G^]'G^]'*!?\
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M "BBB@ HHHH *6DHH 6BDHH 6BDHH 6BDS1F@!:*3-&: %HI,T9H 6BC-&:
M"BBB@ HHHH$)1110,6BDHH 6BDHH 6BDS1F@!:*3-&: %HI,T9H 6BC-&: "
MBBB@ HHHH 2BBB@ HHHH 6BDHS0 M%&:,T %%&:,T %%)FC- "T4FZC<* %H
MINX4;A0 ZBF[A2[A0 M%)FC- "T4F:6@ HHHH **** "BBB@!**** "BBB@
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%&: "@49H% "T444 %%%%
M !0:** &FF&GFF&J A:H7J9JA>@"N]0-4[U U,"%JB-2M41H 8:2E-)0 444
M4 %%%% !1110 4E+24 %%%% "BE%-%+0 \4]348IZT 3*:E4U"M2K2 G4U.I
MJNM3+0!.IJ534*U*II 2@T\5&*>*0#J*** "BBB@ HHHH 2BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M 6BBB@ HHHH 0TPU(:8: (F%1,*F:HF%,"NPJ%A5AA4+"F!785$PJ=A4+"F!
M"13"*E85&: &&DIQIM !2BDI10 4M)2T %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %)2TE "&D-*:0T %+24M #A3Q3!3Q0!
M(M2K42U*M $RU,M0K4RT@)EJ5:B6I5I 2BGBF"GBD \44"BD 4444 %!HH-
M"4444P"BBB@84444 %%%% !1110 4444""BBB@ HHHH **** "BBB@ HHHH
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MGO5N.6H:$:2OFIE:J4;U81JAH18!IU1J:D%9L HI:*0A**** "BBBD 4444
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M** "BBB@ I*6B@!**** "BBB@ HHHIC$--)IQIC4T QC4+-3G-5I'JD K25
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M**6FBG4A!1112 **** "EI*6@ HHHH ****  TE*:2@ HHHH **** "BBDH
M7-)FC--)I@+FC-,)II:@9)NI-U1EJ:7IV FW4;Z@WTGF46 L;J4-5??2AZ+
M6-U+FH U/#4@),TM,!IP- AU%)2T@$HHHH *3-%-)I@+FC--)II:F,?NI-U1
MEJ:7HL!-NHW5 7I-]%@+&ZE#56WTX/0!8W49J$/3@U(1+FEI@-.%(!:6DI:
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M$N:6F TX5(A:*** "BBBD E%%%, HHHH **** "BBB@ HHHH **** "BBB@
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M:E6D!**>*8*>*0#Q10** "BBB@ H-%%(!**6DI@%%%% !1110 4444 %%%%
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M%NE78S6,A%A:=35-.K(D**** "@T44@$HHHH *2@T4 +1110 M%%% !1113
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M3/[U5W&FEC189:,_O3#.?6JQ8TW<:+"+?G^]'GGUJEN-+NJ6@+HG/K3UG-4
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MBF(**** "BBB@ HHHI#"BBBD 4444 %%%% !1110 4448I@%%+BC% "44M%
M"44M% "44M% "44M% "44M% "44M% "44M% "44M% "44M% "44M% "44M%
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "DI:2@!#2&E-(: "EI
M*6@!PIXI@IXH D6I5J):E6@"9:F6H5J9:0$RU*M1+4JT 2BGBF"GBD \44"B
MD 4444 %%%% !24M)0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110(**** "BBB@ I:2EH&%%%% !1110 444A-  33&;%#-5>22J2&A)),
M53EFQFB:7'>L^>?&>:V2*$GGZ\UF7%SUYI+BYQGFL>YNNO-;*(QUS==>:Q[F
M[Z\U'=7?7FL6ZN^O-:J(R6YN^O-9-Q=]>:@N+OKS65/==>:U40+$]W[UFS77
MO4$US[U0EG]ZM("Q+<^]5)+CWJM)-[U7:6G8"TT_O49E]ZK&0TF\T[ 3F2FE
MJC#4HYI *:,4X+FI%CH C"U(L=3)#GM5A(/:@"NL52K#[5<2V]JLI;>U("@L
M'M4JV_M6BEK[5.MK[5(&6+?VI_V;VK66T]J>+3VH Q3;>U--O[5N&T]J8UI[
M4 836_M430>U;K6GM4+6OM0!AM#[5"T7M6V]K[56>V]J8&0T=1E:TWM_:J[P
MTP*6,4F<5.T=1E<4P$#4\28J,C%,)I@6A-[U*D_O6?NI1(:+ ;$=Q[U<AN?>
ML%)O>K,<_O2L!TL-U[UI07?O7*PW'O6A#<^]2T(["VN^G-:]M>=.:XNWNNG-
M:UM=].:AH#MK:[Z<UKVUUTYKB[6[Z<UM6MUTYK-Q ["WN.G-:4,WO7+VUSTY
MK6MY^G-9.(CH8I:MH^:QH)NG-:$4F:QDA&@K9I]5D>I@U8M"8^BDS2U(@HHH
MH **** $HHHH **** "E%)2B@ HHHI %%%% !1113 *:QIU1N::&02-5*9ZL
M2M6?._6M8H94N).M8]U+UJ[<R=:Q;N7K6\4,S[R;KS7/WDW7FM*\FZUSUY-U
MYK=(9G7DW6L.ZEZU>NY>M8ES)UK5("I<2=:SI9.:GG?K5"1LFK2&!>DWU$31
MFBQ),'IP:H :<#5)%(G#4NZH0:=FJL42;J0M3,TA-%A#BU-+TPFD)J6A,DWT
MY7JOFG U-B47X9*U+:7IS6'$W-:-O)TH:+.EM)NG-;]G-TYKD[67I6[9S=.:
MAH1V%E-TYKH+.;IS7'V4W3FNALYNG-8R0CJ[67I6M!)TKF[2;IS6S;R]*QDA
M&U$]6T-9L+U>C:N>2$6E-.IB&GUFR0HHHI %%%%( I*6DI@%%%%,84444 %%
M%% "BB@44A!1110 4444 %0R=*FJ&3H:J(%*;O65<]ZU)^]95SWK:(S&NSUK
M"O#UK<N^AK O#UK:(S#O&ZU@7;=:V[P]:P+L]:WBBC)N6ZUDSM6C<GK65.:U
M2&597JJ[5)(U5G:K2 "]-WU&33<T[")M]+OJ#-*#0!95Z>&JNK5*IIV*)@:6
MFJ*E5:+ )BEVU(L>:E6+VI 5ME+LJV(?:GB#VI 4ME'EU>\CVI?L_M2 H>71
MY=:'V?VH^S^U2!G^71Y9K0^S^U)]G]J0BAY?M1Y?M5[[/[4?9_:@"ALHV5?^
MS^U'V?VH H;*-E7_ +/[4?9_:F,H;*-E7_L_M1]G]J *'ETGEFM#[/[4TV_M
M0(SRAIA2M$V_M33;^U &<4--*&M P>U,,'M3 HE:3%6S#[4PQ>U %>ES4ACI
MA6@!-U+OII%,-.P$PEIPE]ZJ[L4F\T[ 7EF]ZE6?WK-#FG"4T[#-5+CWJQ'<
M^]8BS5,D_O18#H8;KWK0@NNG-<Q%<>]7H;CIS4-".MM[OIS6O;7?3FN-M[GI
MS6M;773FLV@.SMKOIS6Q;773FN+MKOIS6S:W73FLG$1V5O<^]:L$_3FN1MKK
MIS6Q;7.<<UE)".FBFJY')6'!/[UH0RY[UBT!JH]3 YJC&^:M(W%9M")J*0'B
MEJ"0HHHH **** $;I52;H:MMTJI-T-7 :,FZZ&L&]/6MZZ[U@7O0UT1*.<OC
MUKFKYNM='?=ZYF_/6MHH9S]XW6L.Y;K6Q>'K6%<GDUM%%%&5^:JL]2RGFJC-
M6J0Q^^C?4.:,U:0$V^DW5'FC-4D!(&I=U1 T[-.P$FZC=3,T9IV ?NI"U-S2
M&E80I:FEJ0FF$U+0F/WT!ZBS29K-HDMI)S5Z"3I62K8-7(7I-%&_;2\BMJTF
MZ5S-O)TK9M9>E0T!UEG-TYKH;.7I7(6<O3FNALI>G-9M".LM)>E;5M)TKF+.
M7I6[:R=*PDA&_"_2K\35D6[]*TH6Z5A)"-!#4E01FIQ63$PHHHI""BBB@ -)
M2FDI (:*#10 M%%% "T444 %%%%, I#2TUCQ0!#*>*SYWZU<F;BLVX?@UM%%
M%"YDZUC7<O7FK]U)UK!O)>O-;)#*%Y-UYK!O)^O-7KR;KS7/WDW7FM4@*=W-
MR>:Q;F;D\U:NINO-8]Q+DGFM4AD$\G6L^5ZFE?.:IR-FM4AD;M41:AC3:NP#
MMU*&IE**I(1*&IX:H13@:NQ1+NI=]19HS18"0O32],)IA-%ADA>F[Z833<U#
M1)+OJ1'JMFGHW-0T!?C>KL+UFQM5V$U#0&Q;MTK8M6Z5A6YY%;-J>E9- =#:
M-TK>M#TKGK,]*WK,]*R:$=#:GI6U;'I6':'I6W:]JS8C8M^@K2BZ"LRW[5I0
M]*RD(M+TIU-7I3JP8F%%%% @HHHH :_2J%QWJ\_2J%QT-:0&8MX>M<[?GK70
MWG>N<O\ H:Z(E',WYZUS%\W6NEU ]:Y:_/6MHH9@WC=:Q;A^36K>'K6+<'DU
MO%#*LC\U'OIKGFF9K2P$P>EWU"#2YJDAHFWTN^H<T9IV GWT;JB!IPI6 DS1
MFFBG@46 2C%2!*<(Z5@(=M&TU9$5.$/M0!5VT;*N"#VI?(]J0%/91L-71 ?2
ME\CVI 4=AHV&KQM_:D^S^U BELHV5=\CVH\CVI 4MAI-AJ]Y!]*/(/I0!2V&
MC8:N^0?2CR#Z4AE+8:-AJ[Y!]*/(/I0!2V&DV&KWD'TH\@^E BCL-+L-7?(/
MI1Y!]* *6RC95WR#Z4>0?2F,H[#2%#5_R#Z4TP'TI@9Y0TW8:T#![4SR/:D(
MH[*-AJ\;?VH\CVI,"D$-2*AJT(/:GK ?2LV(AB0UHVZ'BHXX/:M"W@Z<5FQ%
MZS7D5T=BO2L>TAY'%=!91=*QD(W[ =*Z:P'2N?L4Z5TEBO2L6!OV8Z5N6_W:
MQ;,=*VH/NUFQ$U%%%2(*KS]*L56GZ54=QHRKGO6+='K6S<]ZQ+KO6Z&8EX>M
M<_>'K6[>'K7/WAZUJAF'>-UK#NFZULWAZUA71ZUK% 9L[<FLV9ZNW!ZUFS-U
MK5(97E>JS/3Y6JNQK2P,"U)NIA-)FI,FR=6JS"_-45-683S32+B;-LW2MFU;
MI6#;'D5M6AZ5+11T5FW2NALSTKF[,]*Z&R/2L9(1T=F>E;MJ>!6!9]JWK7M7
M/(1LV_:M.&LNWZ"M.&L6!=CJP.E5XZL#I6;$%%%%(04444 )1110 4444#"B
MBB@04M)2T %%%% !1110 AZ56EJR>E5I>]-#*,QK-N&ZUH3FLNY/6M4,S;E^
MM8UU)UK3NFZUAW;]:U2 S[J7&>:R+B;KS5N[DZUBW$O6M$AB23\]:B\_GK52
M67GK47F\T[ :\4_/6M"WFZ<US\4O/6M*VDZ5+0'3VDN<5O6;YQ7+6<G2NBLG
MZ5#0CIK1NE;5N>E8%FW2MVV/ K-@:D?2I:BBZ5+6+W$PJ*3I4M12=*$"*<QZ
MUG3MUJ_,>M9EP>#6B&9MRW6L:ZDZUJ73=:P[M^M:I 9EU+UYK'N)NO-7;N3K
M6)<R<FM$AD4L_/6JYGYZU!-+S58R\T[ :D<_/6KT$W3FL&.7FM"WEY%2T(Z:
MTEY'-;UG)TKE;23I70V+]*EH#J;1LXK<MCTKG;)NE;]J>E0Q&O#T%3U!#TJ>
ML9;B"D/2EI&Z5($$AJE*:MR51F-6AE*=NM95R_6M"X;K6/=-UK5#,VZDZUB7
M4O7FM&[?K6'=R=:U2 I7,W7FLJ:;D\U/<R=:RII.:M(8KS<]:C\[WJL\G-,#
MU20R^LG-68WK-C;FKL1JTAFA&U6%;BJD9JP#Q56 D+U$TE(S57D?%.P#VFYZ
MTW[1[U3DEJ!I_>I: UEN?>K45U[USZW'O5B*Y]ZAH1U$%STYK5MKCIS7)V]S
MTYK7M;CIS6;0CK+:?IS6M;S=.:Y>UGSCFMJUEZ<UDQ'0P25H1/6+;R=*U('Z
M5DQ&E&:LKTJG$>E6TZ5FP)****0@HHHH *2EI* "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@!E--.IIJT<TB"6J4M79:I2UHC%E":LZ;O6C-6=-WK>)FRA-U-49>
M]7INIJC+WKHB8R*KU7:K#U7:NB)SR(S333C336R,)"4445JC)BTM)2U1 4E+
M24#0E%%%2RT+2BDI16;-$2+4R5"M3)6;-$68ZMQ54CJW%6+-HEZ&K\-4(:OP
MUA(WB7HJN1U3BJY'6$C>):2IUJ!*G6L)&Z)!3J:*=69JA:***12%HHHI%!24
MM)2 ****!A1110 4444 %%%%,04444 %%%%,04444 %%%%( HHHH&%%%%( H
MHHH **** "EHHH ****8!1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M#4;4\U&U $;5 ]3-4#TP('J!ZG>H'I@0-435*U1-0 PTE*:2F 4444 %%%%
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M]B]J/L7M1S <W]A]J/L/M72?8O:C[%[4^8#F_L/M1]A]JZ3[%_LT?8O]FGS
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MNE0P)J***D04444 %)2TE !1110 4444 %%%% !1110 4444 %%%% !1110
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MH ?FC-,S1F@!^:3--S1F@!V:,TW-&: '9HS3<T9H =FC--S1F@!V:,TW-&:
M'9HS3<T9H =FC--S1F@!^:,TW-&: '9HS3<T9H =FC--S1F@ )IC&E)IC&F
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M3!3Q0!(M2K42U*M $RU,M0K4RT@)EJ5:B6I5H E%/%,%/%(!XHH%%( HHHH
M**** "DI:2@ HHHI %%%%, HHHH **** "BBB@ HHHH **** "BBB@ HHHI
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M-NW%7XSQ63;OP*THFKGFA%H4M-!I:P)%HHHH **** $HHHH ****8!0**6D
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M+[4AM?:M?R/:D\CVJ>8#(^RCTI/LOM6OY'M2>1[4<P&3]E]J/LOM6MY'M1Y
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M%%% !1110 4444  I:04M !1110 4444 )1110 4444 %%%% !1110 4444
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M@5J0O6%:R=*U8'XKFDA&FK5(#5:-JF4UBT(EHI!2U @HHHH *#110 E%+10
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MD=82-XEI.E3K4"=*G6L)&Z)!3J:*=6;-$***!12+0HHH%%(84E+24#"BBBD
M4444 %%%% !1113 **** "BBB@04444 %%%% !1110,**** "BBB@ I*6FT
M!II-*:833 0FFDT$TPF@ +4TM32U,+4 /+4FZHRU-+4 3;J-U0;J-U,"?=1N
MJ#=2[J )]U&ZH=U&Z@";=1NJ'=1NI 3;J-U0[J-U $VZC=4.ZC=3 FW4;JAW
M4;J )MU&ZH=U&Z@";=1NJ'=1NI 3;J-U0[J-U $VZC=4.ZC=3 FW4;JAW4;J
M )MU&ZH=U&ZD!-NHW5#NHW4 3;J-U0[J-U,";=1NJ'=1NH FW4;JAW4;J )M
MU&ZH=U&ZD!-NHW5#NHW4 3;J-U0[J-U,";=1NJ'=1NH FW4;JAW4;J )MU&Z
MH=U&ZD!-NHW5#NHW4P)MU&ZH=U&Z@";=2%JBW4FZ@";=1NJ'=1NI 3;J-U0[
MJ-U $VZC=4.ZEW4P)MU&ZH=U&Z@"?=1NJ'=1NH GW4;J@W4;J )]U)NJ'=1N
MH D+4TM49:FEJ ',U1,:"U,)H 1C43&G,:C)I@----*::: $I*6DH *6DI:
M"BBB@ HHHH **** "BBB@ I*6DH ****0!1110 M*#3:4&@"0&I5-0 U(IH
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M@UE747!KIBQG)W<'7BL&\AZ\5UUY%UKG[R+K71%E')W<77BL*ZCZUU-Y'UK
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M* $VT;:6B@!,48I:* $Q2XHHH ,4444 %%%% !1110!&_>J<W0U<>J<W0UK
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M6I@2[J-U0[J-U $VZEW5!NI=U $^ZC=4.ZC=0!-NHW5#NHW4 3;J-U0[J-U
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M444 %%%% !1110 4444 %%%% !1110 "EI** %HI** %HI** "BBB@ HHHH
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MR'2MZT[5FQ&U;GI6C$:S;?M6C%TK"0BVM/%1K4@K%B8M%%%2(**** "BBB@
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M4"EJ1!1112 6BDHH 6BDHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M=4>:,T 2;J-U1YHS0!)NHW5'FC- $FZC=4>:,T 2;J-U1YHS0!)NHW5'FC-
M$FZC=4>:,T 2;J-U1YHS0!)NHW5'FC- $FZC=4>:,T 2;J-U1YHS0!)NHW5'
MFC- $FZC=4>:,T 2;J-U1YHS0!)NHW5'FC- $FZC=4>:,T 2;J-U1YHS0!)N
MHW5'FC- $FZC=4>:,T 2;J-U1YHS0!)NHW5'FC- $FZC=4>:,T 2;J-U1YHS
M0!)NHW5'FC- $FZC=4>:,T 2;J-U1YHS0!+NHW5%FC- $NZDW5'FC-,"3=1F
MH\T9H >329IN:,T *324E% "4444 )1110 4444 %%%% "T444 %%%% !111
M0 4444 %%%%  :0TII#0 AI*4TE #@:<#3!3A2 E4U*IJ &I5- %A34ZFJJF
MIU-("RIJ935934RF@"PIIX-0J:D!I 2"EI :6@ HHHH ****0!0:*#0 E%%%
M, HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH 6BBB@
M HHHH *2EI* "BBB@!110** "BBB@ I,4M% #2*:14E-(H A(J)EJP14;"F!
M69:A9:MLM0LM %1EJ)EJVRU"RT 5BM1D589:C*T 0D4TBI2*:13 CHIQ%-H
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ME- 4IN]9=SWK4F[UEW/>NJ(S%NN]85WWK=NN]85WWKHB48%YWK N^];]YWK
MN^];Q&C$NJR9^IK6NN]9,_4UJAE"6J<E7):IR50RLU1FI&J,U,B)"4]:93UJ
M4*)?M^HK;L^U8EOU%;=GVH9H=%8]JZ:Q[5S-CVKIK#M6;$=-8]JZ&SZ"N=L>
MU=%9]JRD(V[;H*T8NE9UMT%:,0XKFF(LK4@J-:DKE9+"BBBD(**** "BBB@
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M"\[UK$9@W?>L.ZZFMR[[UAW74UO$9D7%9LW4UI7%9LW4UNBBC+55JM2U5:M
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M44 %%%% !1110 4444 +1110 4444 %)2TE !1110 HHI** %HI*6@ HHHH
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M+9>E8MGVK=M1TK-L#0A3BK 3BDA7@5:"<4K@49(^*SKF+K6Y)'Q6=<Q\&K3
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M:8: &-435*U1-3 @:H7J=J@:@"NU0M4[5"U,"%J8:D:HS0 TTE*:*8!2T4M
M!12T4 )12T4 )12T4 )12T4 )12T4 )12T4 )12T4 )12T4 )12T4 )12T4
M)12T4 )12T4 )12T4 )12T4 )12T4 )12T4 )12T4 )12T4 )12T4 )12T4
M)12T4 )12T4 )12T4 )12T4 )12T4 )12T4 )12T4 )12T4 )12T8H 2BEQ1
MB@!**7%% "4M%% !1113 6BBB@ HHHH ****0!1110 4444 %%%% !1110 4
M444 %%%% !1110 4AI:0T %)2T4 )2T44@%%.!IE** )0:D4U #4BFD!94U,
MAJJIJ9#0!;0U,IJJC5,K4@+*FI :@5JD!H E%+3 :<* %HHHH **** "DI:2
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MGK6=-WK1#*<G6HC4LG6HC39+&THI*45*(1*G6K<55$ZU<AJS4OPBM.W7I6=
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MR/:GB'VI7$58X/:KD46*>D7M5E(\4K@$:8JW&M,1:G45-P'K3J04M2 4444
M%%&:* "DS2TE( HHHI@%%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MB@!**6B@!**6B@!**6B@!**6B@!**6BF E%+10 4444 %%%% !1112 ****
M"DI:2@ HHHH **** %%% HH **** "BBB@ HHHH **** "D-+0:0"&DI:2@
MIPIM** ) :D4U"#3P:0%A34RM5534JM0!:5JG5JJ*U3*U %I34JFJRM4JFD!
M.#3A48-/!H =1110 4444 %%%% !24M)0 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4M)10
MM%)2T %%%% "&BBB@!"*:13Z3% $1%,*U.13"* ("M1E:LE:85H JLE1LM6F
M6HRM,"J5J,K5IDJ-EH JE:85JR5J,K3 @(II%3%::5H A(I,5(12$4P&8I,4
M_%)B@!M%+B@B@!**7%%  **** "BBB@ HHHH **** "BBB@ H%% H 6BBB@
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M*QD(Z2Q[5TMEVKF;'M72V1Z5SR$=!:]!6M".*R;3H*UX>E8M@3A>*AE7@U9
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MUSAO/>C[9[TK".B^W^]--_[USIO?>F&]]Z0'1&_]Z47_ +US1O?>E%[SUI6
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1113 **** "BBB@ HH
MHI %%%% !24M)0 4444 %%%% "BB@44 %%%% !1110 4444 %%%% !0:*#2
M2DI:2@ I:2B@!PIP-,I0: )0:D5J@!J0&@"PK5,K555JF5J0%I6J96JJK5,K
M4 65-2 U IJ530!*#3JC!IU(!U%%% !1110 4E+10 E%+BDH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH 6BBB@!,4A%.HH C(II6I<4TB@"$K496K!%,
M*T 5F6HRM6BM1E:8%4I3"M6BM1E: *I6F%:LE:85I@5BM-*U8*TPK0! 5I,5
M,5II6@"+%(14A%-(I@,Q28I^*3% #:*6DQ0 4444 %%%)0 M)FBB@ S1FBB@
M S2TE% "T449H **,T9H **3-+F@ HHS1F@ HHHH **** #-&:** #-&:**
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M $HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M%HHHH **** "BBB@!*0TM(: $-(:6DH *6DI: '"GBF"GB@"1:F6H5J9:0$R
MU,M0K4RT 3+4RU"M3+0!(M2"HUJ04@'BB@44@"BBB@ HHHI %)2TE !1110
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M:JP$ADII>HR::33L \O3"]-)II-.PQQ:F[J2BF(7-&:2E H&.%2J*8HJ=%I
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MU-8UQU-;5YU-8MQU-=$2D9\G6H34TG>H#UK5%"BG"FBG"J&.H%%**!"T4"G
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH 2BBB@ HHHH ****0!1113 **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** &4TTZFFK1S2():I2
MU=EJE+6B,64)JSIN]:,U9TW>MXF;*$W4U1E[U>FZFJ,O>NB)C(JO4#5.]0-7
M3$YY$9IIIQIIK9&$A.])2]Z2M48L6EI*6J)"DI:2@:$HHHJ&4A:44E**S9JB
M1:F2H5J9*S9HBS'5N*JD=6XJQD;1+T-7X:H0U?AK"1O$O15<CJG%5R.L)&\2
MTE3K4"5.M82-XDHI:04M9FJ%I124HI%!1112*"DI:2@ HHHI#"BBB@ HHHH
M****8@HHHH ****8@HHHH ****0!2TE+0,**** "BBB@!IIIIQIIH C:HFJ5
MJB:F!"U0-4[5 U,"!JA:IFJ%J8$;4PT]J8: &FDI324 +2TE+0 M%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !0:*
M#0 E%%% "4444  I0:044@'@U(IJ(&G T 3J:E5JK U*K4 6E:IE:JBM4JM0
M!;5JE5JJJU3*U("P#3P:@5JD!H E!I:8#3LT@%HHHH **** "DI:* $HI:3%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 N:*2E% !1110 4444 %&*** $Q28IU% #
M,4TK4F*"* (2M,*U.132M %<K3"M6"M,*T 5BM,*U9*TPK3 K%:85JR5IA6@
M"L5II6K)2F%*8%<K3=M6"E-*4 0;:3;4Y6F[:8$.VDVU-MINV@"+%)BI=M)M
MH B(HQ4A%)B@"/%&*?BDQ0 RBG8HQ0 V@T[%(10 VBEHH 2BEQ1B@!**,4N*
M $HI<48H 2BC%&* "BBB@ HHHH **** "BBB@!:*** "BBB@ HHHH 2D-+2&
M@!*2EI* "EI*6D X4\4P4\4 2+4RU"M3+0!,M3+4*U,M $RU,M0K4RT 2+4@
MJ-:D%(!XHH%%( HHHH ****0!24M)0 4444 %%%% !1110 4444 %%%%, HH
MHH **** %HHHH **** "BBB@ IK4ZFMTIH"K*.*SK@=:TY1P:SK@=:WB,Q;H
M=:P[P=:WKH=:P[L=:WB,Y^\'6L"['6NAO!UK O!UKHB4C NAUK'N*V;L=:Q[
MBMD49DU49:O351EK095?K41J5^M1&DR9#30*#0*@S)$ZBK\':J*=:O0=JHT-
M:V/2MJT/2L2V[5M6IZ5# W[,]*W[,]*YZS/2M^S/2LI".AM#TK<M3P*P;0]*
MW+4\"L)"-B \5HPFLVW-:,)X%<\A%Z.I:ACJ:L&)A1112$%%%% !1110 &DI
M324 %%%% !1110 4444 %%%% !1110 4444 %%%% !2TE+0 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%)10 $U#(U2,>*K2MQ
M5Q6HT4[A^#6+=R=:TKE^#6'>2=:Z8H9D7LO6N;OI>O-;%]+UKFKZ7KS71%%&
M1>R]:Y^[EZUIWLO6L"[DZUO%%%"YDZUG2/R:GG?FJ3MS6B ":5:CJ5*8$\8J
M["G2JT0J_"O2AB+MNG2MJT3I69;)TK:M$Z5FP->S3I70V:=*QK->E;]FO2L)
M"-JS7I6Y;#I6/:#I6S;=JYY :UOT%:,1XK-@/2K\;<5A(19!I<U%OI-]96()
MLT9J'S*3S*+ 3YHS4'F4>918"?-(34/F4ADIV&+(U49C5AWJI*W6M8HHH7 S
MFLBZ7K6O.>M9=P.M=$1F!=IUK"NX^M=)=+UK#NUZUTQ&<U=Q]:Q+E.M='=IU
MK#NDZUJ@,&X3DUF3+UK:N5ZUE3KUJT,S)!5<CFK<HJL1S5 ,I1110"'J:F5J
M@!IRFF,O1/6C;R<BL>-JOV[]*A@=%:2\BN@LI>E<I:2<BM^RDZ5E)".PL9>E
M=)92=*X^QEZ5TEE)TKGDB3K+23I6S;OP*YNSDZ5MV[\"N>2$:Z'BI,U6B;BI
M@:YFB6/HI*6I$%%%% !1110 4444 (:B>I343U41HIS=ZR[FM2;O67<UTQ&8
MUWT-85WWK=N^AK"N^];Q&8%YWK N^];]YWK N^];Q*,2Y[UDSUK7/>LF>M4,
MSY:JR5:EJK)6B&0-3:<U,-,!:<M,IZT 2K4BBHUJ910,4"GA:<JU*J4@(PE.
M$=6%BJ58:D14$5.\KVJZL'M4@M_:I8C/$-+Y/M6B+?VI?L_M4L#-\FCR:T_L
MWM1]F]J@1F>3[4>36G]F]J/LWM2 R_)I1#6E]F]J46WM0!F>32>3[5J?9O:D
M^S^U,#,\GVI/*]JU/L_M33;^U,9F&*FF.M(V_M3&@]JH#-,=,*5H-#4+152
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M/WD76MTP.5NX^O%8MS'UKIKN+K6'=1]:I,9@3IR:H2+6O<)UK.E7FJ0%,BE
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M<\A&O;]!6E#6;;]!6E#7/(1<CZ"IQTJ"/H*G'2LF(6BBBD(**** $-%*:2@
M-)2T4P$I:** "BBB@ HHHH&%%%% !1112$%+244 +1244 +124N: "BBBD 4
M49HH **** "BBB@ HHHH **** "BBB@ HHHS0 449HS0 44E% "T4E% "T4E
M% "T4E% "T4E% "T4E% "T4E% "T444 %%%% !11FC- !11FC- !2&EI* "B
MBBF 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M;0!#MHVU+MHVT 0E:-M2E:-M $6VDVU+MHVT 1;:-M2[:3;0!'MHVU)MHVT
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M3I#5L0^U/$=2V(@6.I53%2!,4\+4MB&A:>!2XI<5(A12TE+2 **** "BBB@
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MJHK5*K4@+:M4BM556J56I 60U/!JNK5(&H F!IV:B!IX- #Z*:#3J "BBB@
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M0U@P+D?05..E0QU..E9,04444A!1110 &DI:* $HHHI %%%% !1110(****
M"BBB@84444 %%%% !1110 4444 %%%% !1110 44F:,T +129HS0 M%)FEH
M**** "BBB@ HHHH **** "BBB@04444 %%%% !1110 4444 %%%% !1110 4
M444#"BBB@ HHHH **** "BBB@ HHHI@%%%% !1110 4444@"BBBF 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 ,IIIU-
M-6CFD5Y*IR]*N253EZ5HC%E":LZ:M&:LZ:MXF;,^;O5*7J:NS=ZI2]371$QD
M57JNU6'JNU=$3"0PTRGGK3*W1A(2BEI!6B,F+2TE+5$!24M)0 AHH-%2RT+2
MBDI16;-$2+4R5"M3)6;-$68ZMQ54CJW%6+-HEZ&K\-4(:OPUA(WB7HJN1U3B
MJY'6$C>):2IUJ!*G6L)&\244M(*6LS5"THI*44B@HHHI%!24M)0 4444AA11
M10 4444 %%%%,04444 %%%%,04444 %%%%( I:2EH&%%%% !1110 TTTTXTT
MT 1M435*U1-3 A:H&J=J@:F!"U0M4S5"U,")J8:>U,- #:***0!2TE+3 6BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH ****8!1110 4444 %%%%( HH
MHH **** "BBB@ HHHH **** "DI:3% !28I:* "BBB@!10#244 2 T\&H<TX
M&D!.&J16JN#3PU %I6J56JHK5*K4@+:M4BM556J16H M!J>#5=6J16I 3@TX
M&H0U/#4 2YHI@-.!H 6BBB@ HHHH **** "BBBD &DI324 %%%% !1110 44
M44P"BBB@ HHHH **** "BBBD 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%%, I<TE% "T4E&: %HHS10 4444 %%%% !11FDS0 M(:** "BBB@!*3
M%.I,4P&XHQ3L48H 9BDQ4F*3%("/;1MJ3%&* (MM&VI<4FV@"+;1MJ7;1MH
MAVTFRI]M)MH @VT;*FVT;:8$&RDVU/MI"M $.VDVU-MHVT 0;:3;4^VDVT 0
ME:3;4Y6DVT 0E:3;4Q6C;0!#MI-M3[:3;0!#MHVU-MHVT 0[:7;4NVC;0!%M
MHVU+MHVT 1;:-M2[:-M $.VC;4VVC;0!#MHV5-MHVT 0[*7;4VVC;0!$%I0M
M2!:<%H&1A:<%IX6G!: & 4\"E IP%(0@%.HQ2T  IU(*6@ HHHH **** "BB
MBD 4444 %%%% !1110 4444 %%%% !1113 *2EI* "BBB@ %+24M !2TE+2
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MP"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MP%HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBBF 4444 %%%% !111
M2 **** "BBB@ HHHH **** "BBB@ HHHH **** "DI:2@ I*6D- "TH--HI
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MHQ0 S;1MJ3%&* (PM+BGXI<4#&8I<4[%+BD W%*!2XHQ0 F*6C%+0(!1110
M4444 %%%% !1112 **** "BBB@ HHHH **** "BBB@ HHHI@%)2TE !1110
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M7-(1J6XZ5HPCI5*W'2M&(5A(18C'%24U1Q3JR)"BBB@ HHHH **** "BBB@
MHHHI %%%% !1110 4444 %%%% !1113 **** "BBB@ HHHH **** $HI:2@
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M4M)2TP%HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBBF 4444 %%%%
M !1112 **** "BBB@ HHHH **** "BBB@ HHHH **** "DI:* $I#2T&@!#1
M112 *7-)10 \&G U'3@: )0:>&J$&G T 6%:I%:JP:I%:@"T&J16JJ&J16H
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M9TJULW"=:S)DY-;Q&9["HR*L.M0D5HAC*6BDJQBTE%%,04E+12 ;24ZDJ62
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"D-+FDH ****8PHHHH **** "BBB@ HHHI""BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH ****0!1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%%, HHHH **** "BBB@ HHHH **** "BBB@
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MA110**0PI*6DH&%%%%(84444 %%%% !1113$%%%% !1110 4444 (:6D-+0
M4444#%HHHH$%%%% #3333C330!&U1-4K5$U,"%J@:IFJ%J8$+5"U3-4+4 1-
M3#3VIAIB&T444AA2TE+3 6BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M****8!1110 4444 %%%%( HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "D(I:#2 3%&*** $HI324 %*#244 .S3@:9FC- $H-/#5"#3@: )PU2*
MU5@U/#4 6@U2*U50U2*U %I6J0-556J16I 6@U/#565JD#4 6 U.!J -3PU(
M";-*#40:G T /S2YIF:7- #J*3-+0 4444 %%%% !BC%%% !BDQ2T4 )12T4
M )12TF*0!1110 4444 %%%% !1110 4444 %%%%, HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** %S1244 +1244 +1244 +1
M244 +1244 +1244 +1244 +124M !1110 4444 %%%% !1110 4444 %%%%
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MX-18"7-+FHP:4&D ^BD%+0 4444 %%%% !1110 4444A!1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1112 **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBBF 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 ,IIIU--6CFD02U2E[U=EJE-T-:(Q9GS5GS=ZT)
MJSYN];Q,V9\W>J4O>KLW>J4E=$3"14>H&J=Z@:NF)A(C--IQIM;(YY"4445J
MC)BTM-I:HD*2EI*0PI***EE(6G"FBG"LV:(>M3)4*U,E9LU1:CJW%52.K<58
MR-8EZ*K\7:J,7:KT-82-XEZ*KD?2J<7:KD=82.B):3I4Z]*@2IUK"1M$D%.I
MHIPK-FJ%%% HI%H444"BD,*2EI*!A1112&%%%% !1110 4444Q!1110 4444
M %%%% "&EI#2T %%%% Q:*!10(**** &FFFG&FF@"-JB:I6J)J8$#5"U3M4#
M4P(&J)JF:H6H B:F&GM3#0(;1110,*6DI:8"T444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 E%+10 E)2T4 )1110 4444 **4&FT4 2 TX&
MH\TH- $P:GAJ@!IX:D!8#5(&JL&IX:@"TKU('JHK5(&H M!J>&JL&J0-2 L!
MJ>&JN&IX:@"<&E!J$-3PU $H-*#48-.!I 244T&G9H **** "BBB@ HHHH *
M*** "BBBD 4444 )12TE !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%%, HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH *6DI: "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ I*** "BBB@ HHHH **** "DI:
M2@ HHHH **** %%%%%( HHHH ****8!1110 4444 %%%% !1110 4444 %%%
M% !1112 6BDHH 6BDHI@+2&BEH :13&%24A%-,96=:I3QUI,M5I4K1,:,&YB
MZUBW</6NFN(^M9%U%UK5,9R5Y#UXK O(.O%=A=P]>*P;R#KQ6R8SCKN'K6)=
M1=:ZV\@Z\5A7</7BMHL#FIX^M9\JUN7,77BLR:.MDRC,<5&:LRI5=ABM!,8:
M*4TE(@<*FC;%0BI%-4BT7XGZ5H02XQ61&U7(I*311O6\^,<UKVUQTYKF(9O>
MM.WGQCFLVA'6VMSTYK:M;KIS7&VUSTYK8MKKIS63B([.VNNG-:T%STYKCK:Z
MZ<UK6]WTYK)Q$=;#<].:OQW'O7,0773FM"*Y]ZR<1&^LWO4RRUC1W'O5A)_>
MIY1&J)*>)*SEG]ZE6:ER@7@].WU2$M/$M2X#+6ZC?5;S:3S:7(!9WTA>JIE]
MZ:9J?((LM)432U6:;WJ!Y_>JY0+#S>]59)_>JTEQ[U2EN?>J41EF:Y]ZSI[K
MKS5>>ZZ\UF7%WUYK11 EN;KKS6/=777FF7-UUYK'N;KKS6J0PNKGKS6)=7'7
MFGW-SUYK)N)^O-;)#(KF;KS63<2]:GGEZUFS/DFM$AD$TE4V;)J61LFH#0R6
MQ":2B@"LV9BTX#)I *GCCS18M(=&F:T+>+D5'##G'%:MM;\CBLV46;2'I70V
M4'3BJ5G;=.*Z*QMNG%9,1H6,'3BNCLH>!Q5"QM^G%=#:0<#BL6P+EK%C%:\"
M8Q56WBP!6C$F!4W F3@4K-@4G05#(^*!D4\F :R;J;@U:N9>M8EY-UYK:" H
MWL_7FN<O9NO-:-[/UYKG;V?KS70D!G7LW6N?NY.M:-Y+G-8=S)G-78#/N7SF
MLN9N:NW#=:SY#S3L,B- I*<HH$3PBM&!:I0+6K;)G%,9=MX\XK7MH<XXJI:Q
M=*W+2#IQ1<":VM\XXK8M[7..*;:6_3BMRUMNG%2V(A@M.!Q5^*S]JNV]KP.*
MT8K7IQ6,Y 9B6?M4JV?M6PEK[5*+7VK!S$8PM/:G?9/:MH6WM3A;>U0Y",3[
M)[4?9/:MS[-[4?9O:ES$F$;/VIOV/VK>^S>U(;;VHY@,+[)[4GV/VK=^R^U)
M]E]J.8##^Q^U)]C]JW?LOM1]E]J.89A?8_:C['[5N_9?:C[+[4^8#"^R>U+]
MC]JW/LOM1]E]J.8##^Q^U+]D]JV_LOM2_9?:CF P_L?M1]D]JW/LWM1]F]J.
M8#$^Q^U+]C]JV_LWM2_9O:ES",/[)[4AL_:MW[+[4AMO:GSC.?>SXZ53FM.O
M%=2UKQTJE/:]>*I3&CCKFUZ\5CW5MUXKLKJVZ\5AW=OUXK:,BCCKJ#&>*QKF
M+K767<'7BL&[AZ\5O%C.;G3K6?*M;5S'R:S)DK9,9G.*B(JU(M0,*H"(TVGD
M4PTF 4]#3*53S2$786K2MWZ5DQ&K\#8J6AF_:R=*W+27I7,VTG2MFUEZ5+0C
MJ[.;I706<W3FN0M)NG-;]G-TYK*2$=;:3=*VK:3I7+6DW3FMRUEZ5SR0C?A>
MKL;5E02=*T(FKEDB2X.E+34/%.K(D*:W2G4C=* *,_>LFY[UK3]#63<]ZZ(E
M&)=]ZPKSO6[=]ZPKSO73$9@7G>L&[[UO7G>L"[[UTQ&8ESWK*GK5NN]9,_>M
MT44):IR5<EJG)5#*[5&:D:HS42(D)3EIM.6H$B_;]16S:=16-;]16S:=J3+.
MALNHKI+'J*YNR[5TECVK-B.EL>U=#:=JYVR[5T-IVK*0C;MNU:472LRVZ"M.
M+I7/(1:2IEJ%*F6N>0A]%%%02%%%%( HHHI  HHHI@%%%%, HHHH *1A2TAH
M A<54E3BKK"H)%K1,HRIX^#61=1=:WYDXK+N8^M;Q8SE[R+K7/WL76NMNXNM
M8%Y%UK=,9R%[%UK NX^M=9>Q=:Y^\BZUJF,YBYCZUE3)R:Z"ZCZUD3Q\FM$!
MF.M,Q5F1*A*U2)L,%/6DQ2BK2*1,K8JQ&]5 :D5J8&I#+S6K;3=.:Y^*3FM*
MVEY%)H9U5I-TYKH+*;IS7'VDW3FM^RFZ<UC)".QLYNE=!:2]*Y"RFZ5T-G+T
MK"2$=3;2=*U87Z5SUK+TK8@DZ5SR0C51N*E!JI&]6%:N=HDEHIH-.J!!1110
M 4444 %%%% "-TJK-T-6FZ55FZ&M(%(R;KO6%>]ZW;KO6%>=#75$9SE]WKF;
M[O737W>N:ON];Q*.:O>]8%V.3707O>N?N^IK=#,>>J3=:NW'4U2;K6@#14B5
M&*D3K0!9BK0@[5GQ=JT(.U0Q&K:UNV?:L*U[5NV?:LI".@LNU=%9]JYVR[5T
M5GVKGD(Z"T[5MVO:L2TZ"MNU[5SR UH.@J\O2J,':KR]*Q9+%HHHJ1!1110
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M*;:VW3BMRSM>G%92$265KTXKH[*UZ<57LK7IQ70V5KTXK"3 LV=MTXK=MH,
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M$D%.%-%.%9&J%%% HI%H6BBBD,*2EI*!A1112&%%%% !1110 4444Q!1110
M4444 %%%% "&EHHH ****!BBBBB@04444 ----.--- $;5$U2M434 0M4#5.
MU0/3 A:H6J9JA:F(B:F&I&J,T -HI324#"EH%%,!:*** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MF!SUYWK"NN];UX.M85T.M;Q8S&N.]9TU:=P.M9LPK>+&49!4)JQ(*@8<UJF
MVBEHIBL**<*0"G 5=RD/6I <5&*=2;&2AJD5ZKYI=U2V!;66I!-5'?2^94,#
M06?WIXN/>LT24OF^](1IBX]Z7[1[UF>;[T>;2 U/M/O1]I]ZS/.]Z/.]Z -+
M[1[T?:/>LWSO>D\Z@#2^T>]'VCWK-\VCS: -+[1[T?:/>LWS:/-H TOM'O1]
MH]ZS?-H\V@#2^T>]'VCWK-\VCS: -+[1[T?:/>LWS:/.H TOM'O1]H]ZS?.H
M\ZD!HFX]Z8;CWJ@9J89J +YN/>FFX]ZSC-[TAFJ62S2%Q[U(MQ[UDB:I$E]Z
M0&Y'<>]789^G-8$4OO5^"7IS4L#H[>;D<ULVLW2N8MI.16W:2=*S8CJ+23I6
M[:/TKF+-^E=!9MTK&0'1VK=*V;<U@VC=*V[8]*QD(UX>U75Z51@[5=7[M8L0
MZBBBD(**** "BBBD E%%%, HHHH **** "BBB@ HHHH$%%%% !1112 ****
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M:,T %%&:,T %%&:,T %%&:,T %%&:,T %%&:,T %%&:,T %%&:,T %%&:,T
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M%NIV: 'YHS3,TN: 'T9IN:7- #J*2C-(!:*** "BBBF 4444 %%%% !1110
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M]*JPI6A G2I;*+MN.E;-J.E9ENG2MBU7I638C8M!TK>LQTK%M%Z5NVB]*Q;
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M ****8!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 ,IIIU--6CGD0252EZ5=EJE-WK1&+*$U9\]7YJSYZVB9LSYJ
MI2U=FJC+73$PD57J!JF<U U=$3"0PTTTIIM;(PD(:**3-:HQ8HI:2BJ)%I**
M2D 44F:,U++0HIXI@-.%0RT2+4Z574U.E9LU1:CJY%5*.KD58R-8E^*K\/:L
M^&K\-82.B)?BJY'TJE%5V/H*PD;Q+25.M0)4ZUA(WB2"G4T4ZLV:(6BBE%(M
M!1112*"BBB@ H-%!I )1110,**** "BBBF 4444 )WI:3O2T""BBB@ HHHI
M%**2E% PHHHH$%)2TE,!#333C330!&U1-4K5$U,"%J@>IVJ!J (&J%JF:H6I
M@1FF&G-3#0 TT44E,!PHI*6@!:*** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBBD 4444 %%%%, HHHH **** "BBB@ HHHH ****0!1110 4
M444P"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***,T )11
M10 E%+1B@!**** "BBB@!:6FTM #LTN:;FC-("3-+FH\TN: )0U.#5#FG;J
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MG;].*5P+UE#TXKHK*'IQ6?90=.*Z"SAZ<5+8B_:1=.*V;>/@53M8NG%:T$?
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M+%703P<]*H2V_M6B8S#>&H6AK8>W]JA:W]JU3&9?DTHA]JT?LWM2BW]JJX%
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MNV'2LNU3I6Q;KTK%B-* =*O+TJE".E75Z5DP%HHHI""BBB@ HHHH #24II*
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MS0 N:*2B@!:*2ES0 4444 %%%% !1110 4444 %%%% !0*** %HHHH ****
M"DI:2@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M<8K6@%9]NN,5I0CBI8%H=*6D'2EK$D*AEJ:HI*:W&C/F%9MPG6M6450F3-:
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M&*S8BW;)TK4@6JD$>,5H0K63 N1#I5M>E5HQ5D=*R8A:***0@HHHH ****
MTE*:2@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M%+BC% "44N*,4 )12XHQ0 E%+BC% "44N*,4 )12XHQ0 E%+BC% "44N*,4
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MD]J/LGM1<# ^Q>U)]B]JZ#[)[4?9/:BX'/\ V+VH^Q>U;_V3VH^R>U*X'/\
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MQP^U6HXJS8AT28Q5V-:CC2K*+6; E05,.E1J*D%9L0ZBDI:0@HHI* %HI**
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M-M $6VC;4NVC;0!%MHVU+MHVT 1;:-M2[:-M $6VC;4NVC;0!%MHVU+MHVT
M1;:-M2[:-M $6VC;4NVC;0!%MHVU+MHVT 1;:-M2[:-M $6VC;4NVC;0!%MH
MVU+MHVT 1;:-M2[:-M $6VC;4NVC;0!%MHVU+MHVT 1;:-M2[:-M $6VC;4N
MVC;0!%MHVU+MHVT 1;:-M2[:-M $6VC;4NVC;0!%MHVU+MHVT@(MM&VI=M&V
M@"+;1MJ7;1MH BVT;:EVT;: (MM&VI=M&V@"+;1MJ7;1MI@1;:-M2[:-M $6
MVC;4NVC;0!%MHVU+MHVT 1;:-M2[:-M $6VC;4NVC;0!%MHVU+MHVT 1;:-M
M2[:-M $6VC;4NVC;0!%MHVU+MHVT 1;:-M2[:-M $6VC;4NVC;0!%MHVU+MH
MVT 1;:-M2[:-M $6VC;4NVC;0!%MHVU+MHVT 1;:-M2[:-M $6VC;4NVC;0!
M%MHVU+MHVT 1;:-M2[:-M $6VC;4NVC;0!%MHVU+MHVT 1;:-M2[:-M $6VC
M;4NVC;3 BVT;:EVT;: (MM&VI=M&V@"+;1MJ7;1MH BVT;:EVT;: (=M&VIM
MM&V@"';1MJ;;1LH AVT;:FV4;*0$.VC;4VRC90!#MI-M3%*-E $.VDVU-MHV
MT 0XHQ4NVC;0!%BE I^VEVT 1XI<4_;2[: &XI<4[;2[: &TX4NVC% "4M+B
MEQ2 !2BDQ2@4 +FES28I<4 +FES3<4M #LTH--I: '@TN::*6@!V:7--I10
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M1[4K@9@MO:I%M_:M'R*40U+8%)8,=JF6'VJT(O:G".I;$0K'4Z)BGA*>%J&
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M]JE6V]JT1 /2GB'VI7 I)!CM5A(O:K*Q5(L>*FXB)(\581:54J4+2N **>*
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M44 %%%%, HHHH ***7% "44N*,4 )2T8HH ****!!129HS0 II***!A1110
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M !1110 4444 %%%% !1112 ***2@!:*2EIC"BBB@ I:2B@0M%%% "4A%.HH
M85II2I<4F*=QD12D,=38HQ3Y@N0>72>75C%)BGS!<K^71Y56,48HYAE?RJ/*
MJQBC%',!6\NE\NK&VDVT^8"#RZ/+J?;1MHYA$.RC94VVC;2N!'MI0M/Q1BE<
M0@%+BEQ12 ,48I:*!C<4FVGT8HN!&5INRIL4F*=QD.RD,=3XHQ3Y@*_ET>75
MC;1MHY@*_E4>55C;1BCF K^51Y56,48HYA$'ETOEU/BC%+F B"4NVI,48HN
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M !1110 4444 %%%% !1113 **** "BBB@ HHHH **** "BBB@ HHHH ****
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MC90!!LHV5/LHV4 0;*-E3[*-E $&RC94^RC90!!LHV5/LHV4 0;*-E3[*-E
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4M)2T@"BBB@ HHHH 2BBB@ HHHH **** "BBBF "EI!2T %%%% !1110 E%%
M% !1110 4444 %%%% !1110 M%)2T %%%% !1110 4444 %%%% !1110 4F*
M6B@!,48I:* $Q28IU% #<48IU%,=QN*,4ZB@+C<48IU%(+C<4N*6B@+B8HQ2
MT4"$Q1BEHH **** "BBB@ HHHH **** "BBB@ HHHH **,TE !1110 4444
M%%%+0 E%+10 E&*6B@!,4N*** "BBB@ HHHH **** "BBB@ HHHH **** "D
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@84444 %%%% !1110 4444 %+244"%HHHH **** "BBB@ HHHH **** "BB
MB@ HQ110 F**6B@!,44M% "44M% "44M)0 4444 %%+10 F*7%%% !BBBB@
MQ1BBB@ HHHH **** "BBB@ HHHH **** "BBB@!**** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@!:*2EH **** "BBB@ HHHH
M**** "BBB@ HQ110 E&*6B@!,44M% "44M% "44M% "44M(: "BBB@ HHHH
M6BBB@04444#"BBB@ HHHH **** "BBB@ HHHH **** "BBB@!****8PHHHH
M**** "BBBD(**** "BBB@ HHHH *6DHH 6BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH *2EI* "BBB@ HHHH **** "BBB@ HHHH **** %HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "DI:* $HI:2@ HHHH ****
M"BBB@ I124HH 2EQ110 4444 %%%% !1110 4444 %%%% !1110 8HQ110 8
MHQ110 8HQ110 8HHHH *,444 &*,444 &*,444 &*,444 &*,444 %%%% !1
M110 48HHH ,48HHH ,48HHH ,48HHH ,4444 %%%% !1110 4444 %&*** $
MHI30* $HHHH **** "BBB@ HHI: $I:** "BBB@ HHHH **** "BBB@ Q1BB
MB@ Q1BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HQ
M110 8HQ110 8HQ110 8HQ110 8HQ110 8HQ110 8I,4M% !1BBB@!,44M% "
M44M)0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110(**** "
MBBB@ HHHH **** "BBB@84444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 )1113("DQ2T4"&XI-M/HIW$1[:394E%.XK$>RDV5+BDHN38CV"
MC8*DHQ3N+E(M@HV"I<4F*+BY2/8*-@J3%&*+ARD>P4;!4F*,47#E(]@I=@I^
M*7%%PY2/8*-E2447#E(]@HV"I**5Q\HS91LI^*7%%RK#-M*%IU%*X["8I<4M
M% [!BBBE-(I"4M':B@H**** "BBBD,**** "BBB@84444 %%%% !1110(***
M* "DI:2@ HHHH **** %%% HH&%%%% !1110 4E+10 F*6BB@0F*,4M% #<4
M$4ZC%,!FVC;3\48H 9MHVT_%&* &;:-M/Q1BD S;1MI]%,!FVC;3Z* &;:-M
M/HH 9MHVT^B@!FVC;3Z* &;:-M/HH 9MHVT^B@!FVC;3Z* &;:-M/HH 9MHV
MT^B@!FVC;3Z* &;:-M/HH 9MHVT^B@!FVC;3Z* &;:-M/HH 9MHVT^B@!FVC
M;3Z* &;:-M/HH 9MHVT^B@!FVC;3Z* &;:-M/HH 9MHVT^B@!FVC;3Z* &;:
M-M/HH 9MHVT^B@!FVC;3Z* &;:-M/HH 9MHVT^B@!FVC;3Z*0#-M&VGT4 ,V
MT;:?10 S;1MI]% #-M&VGT4 ,VT;:?10 S;1MI]% #-M&VGT4 ,VT;:?10 S
M;1MI]% #-M&VGT4 ,VT;:?13 9MHVT^B@!FVC;3Z* &;:-M/HH 9MHVT^B@!
MFVC;3Z* &;:-M/HH 9MHVT^B@!FVC;3Z* &;:-M/HH 9MHVT^B@!FVC;3Z*
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M **** "BBB@ HHHH ****!!1110 4444 %%%% !1110 4444#"BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
? "BBB@ HHHH **** "BBB@ HHHH **** "BBB@#_V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>17
<FILENAME>ex23-1_001.jpg
<TEXT>
begin 644 ex23-1_001.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  $! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_
MVP!# 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_P  1" !7 R # 2(  A$! Q$!_\0
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M%!..Q/T&: %HI"P]"<C/ [=J <]B/J,4 +3D^_\ \!;^:TVG)]__ ("W\UH
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M7I4,KIX2KAZ.(A6SS$T:"Q<Y0PU!473_ 'E5P]Z=*+FYSC+EBTG&7-&YU/\
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MA+XP^%K[PO%=33LSQ_V)H&O:9X3LX 76+3/#5EM?+$5^%?\ P2(_X)I^(?\
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MYH+5YYXOZL/^#5S:/V/?VV!DX/QTB<\$X)^"OAP$#@9 \O.>.21@ #/XT_\
M!NN!_P />/!@(S_Q;_\ :.93TP?^$?G&<=\JQ&<]"?:O1H8JME^8^*^-H<OM
ML'A<OQ%%U(*I#VM+"N5.4Z<O=ER3<:D5).//"#:LM>:I1IXG#<*T*B;I5:]:
MG-1E*+<98FKS<LHN,HMV>L9)ZM7U9[M_P5;_ ." ?AK]@S]EYOVGO@O\:_&_
MQ)L/ WBCP;H?Q8\.^/\ 1/"VD.ND>-=6B\*Z=XS\+ZEH/V8Q&R\8ZGX:L;KP
MU<6FH3)IFLS:K;ZM -#EM;OK/^"8_P"W7\8/V?/^"'G_  43?P5KUYI_B3X#
M?$'PMH/P/U[S!--X!O/VDY-(\/74FAI<QW,$3:#KZZOXMTBV:$VD?B36[B\G
MC83SY_HD_P"#AD@_\$C/VIE7O>_!!<]AN^/WPSR<=^I^O%?S<?\ !&K]ECQ!
M^V9_P2__ ."LW[/'@U[-/'/C37O@CJ?@2/4IOLMA>^-/!^FZSXS\.:/=7AF@
MBL8M=U'0X=#.HSSI:Z<=174+H?9K:53XV6YO5SW@:>-XFQ'U^.!XKRAU,5BH
MT_;1P[QF"GB)2JPI*,(NAB*U.JE1M*BESQFXV?;7P-++\]C2RRG]6>)RK'+V
M5*4DI5%0DH2O*4FY*6MV_>E;8\J_X(6?\$E_A/\ \%(;[XV_%O\ :/\ %7C&
MZ^'?PJ\2>'/"L?A/PWJ4.GZUX^\=>*K*\\6:WJ7B;QHS7.JV]CI.FM8S20V5
MDFH:YJ'B>2ZFU6V31\:GPW_!<O\ X)4_#W_@FUX]^#FO?!'Q5XIU3X,_'F+Q
MXEEX3\7WT6H:SX%\8> 3X8DN+&/5HK>T&O:#JVC^+()=(N+JU75=,GTO4[6]
MO+V*XLC%)_P2!_X*P-_P28\9_M!?!OX\_!SQ;XD\)^.?%NAR^+=$T.YL=$^(
M7PL^)7@:WU3P[JIU+P]JJ)9:I::QI\MGIFH6,^K:=>Z;<>&+>[TZ.^M-0F6W
MX/\ X+(_\%3M0_X*@>+?A7KO@OX7^(_AI^S[\%)O%WASP@WB>6TO];\6>/?%
MR:1J/B;5]6O]);^S;%H_#F@>%XM-\++-J,^EP->:G=W<DNKP0:;]9"/%\N/_
M &LJE9\)2I>UPRG/"T\O^JRP%&E2C1HJ*E'&0Q52E"4:45-1J>S4U"M)+R9/
M*?[ E34*7]JJ3<U:7UJ%25:I[=SDI1O1]G9Q333YFI1;O?\ L9_X-^D5?^"3
M?[+)R>8/B:>?]KXI^-"V.,=1QVX.>:_:$#'^?\\>E?C#_P &_9'_  Z;_9:(
MP08?B6?;_DJ?C88STQTY./R%?L]7X%Q,^;B3B%ZK_A<S3?5_[W5=[]=]>C9^
M@Y7IEN7KM@L-IV_=1[>H4445XQWA1110 4444 %%%% !1110 4444 >*?M >
M)OB=X-^%?BGQA\*&\!GQ+X3TC6_%5S;?$33_ !'?Z'J&A^'?#VKZQ?:;;CPQ
MJ>EW]KJU]<6=E;6E]+-/:6L#W<\EA>R)#"WS_I?Q(_;'^($B^*O"?AS]G_X?
M?"BY^%OPE\;Z'XJ^(C>,/%-_XEUGQEX1N/$GCVTM['PEXNT>?0='\#7(T^P@
MN-:LD?5X+^2_MYFAL9PWU7\4_#^H>+_AQX]\(Z2]O'J?BKP3XO\ #6G27;O%
M:QW^O>'=3TFRDN9(XY&CMTN[N,SNJETA5WC5V"H_Q]\<OV9/B7\9OV:?@G^S
M-8_$&]^&_A=;?X<Z'^T#XM\(WB6WB>_\"> /!D4UWX0\&7EQ$K0P^-O'FD>&
M](UZ_9(I/^$*_P"$@M%5);^+(!P'PI_;Z\6:S-^S!H?Q"^"OC;5]4_::\"?$
M;XJ>'O%7PG^'WC>_\*:=\.]-\<:-I/PGUO4=.U :QJ.DW/C+P!XCT'X@>-]/
MU75K>X^&UMKNB6.JK=-?)-2> /\ @HIX-L-6_:*T_P"-$7BK3]/^"_[3_P 2
M?@]JWCKPG\*O'FL?#/X=>#]*UKP]IO@.?XI^/M,TF_\ #>@ZC?1:S;7^KW']
MH2IH6F:A9:YXEM=!TB\@NI?H?XL^ ?B3IWQ0^ 7Q2^#WA+PGXFM?AEX<^(OP
MOUCP+K_BR7P)%:^$?B9)\-)H?$6A:Q#H'B6"];P>OPW@M)/#WV&"758-3W6>
MH136!@N/&S^RYX^/[-'[?GPD:3PX?$W[3OC_ /:R\2> V^VA=,2S^-.@#2O"
M \17GV=OL-]#,L/]HJT<KVD:QQQNSB,@ ]P_;'^.OB#]G;X!>)_B1X9\-ZUX
ME\4IJWA3PCX?MM&\'ZKXYAT?7O&OB33_  M8>)-;\/:1>Z5?7^A:%/J37K68
MU+3%UJ^CTS1AJFG/JL5RGR]\'_VT?$F@?$[]HC0/VDO%>F:'\-O@+^S-^S5\
M8[KQCXF^%>N?"+QE'K'QG^)W[3G@_6+7Q)\/'U_QEJ.GW,]E\*/ ^F^%/#>F
M-?:KK6LWMS+9VHGUS3-(L_M?]I+X=ZW\6/A!KW@KPU)91ZSJ?B'X<:I;OJ<[
M6MG]F\)_$WPAXNU(O,$<QLVE>'[T6RD8>?R86*[BP^+OC1^Q?\4?B;^T5^TE
M\6_#OB?P?X97QGX)_P""?&J_!^]UVVOM?MH?BG^QE\>/C;\:KS3O'GANQ:TN
M?^$.\2+XP\-:''?Z?>7&H6C7.H:W8VDMYH=E!=@'T_X2_;$^#?B9/'2ZQ=^,
M/A;?_#CP3<_$[Q3H_P :/A[XO^%.JV_PPLDN3>_$73K/Q9I]DVM^$K*2SN+;
M4[W26O)]#OGL]/UNUL+R^L(KJ'P)^V5\'?'NJ7F@VT?Q$\':ZG@35/B=X>TG
MXH?"SQU\.+[Q_P##W0X;>?5O%?@"#Q9I.FMXHM-.AO=.GU33+%F\2Z/!JNE3
MZOH5G#J%K+)X)X[_ &?/CS^TUK7B/Q9\5K#X>_ _4-'^ 'Q@^!_PZT;PQXAN
MOBX+WQ#\6?$OPU\6WGQ \7:Y_8/P^G3PGH]_\(O#&GVGP[LEFN=>M]4UV;6]
M1M!%802.\6? CX_?M%?%+X6?$GXT^&_AW\*H_P!GGPU\=(?!.B>"O'M_\09/
MB;\0/C/\*=6^$=QJ^I:I>>$?"DO@WX>Z)H&MZW?VGA^1=9U36M9O=*OM573W
M\+6SZB ?4'[.O[3'PU_:F\$V/Q-^#Q\7ZK\.]9TS0]8\-^,?$'@?Q)X-T'Q?
M8:_IYU""[\(W?B6STY_$5IISI<:;JU[IL,^GVNJ6\MK'>W 022^??&;X\_$;
MX2_M(?LY^!;G3O -Y\&_CC=_$K0M6U.6'Q-'\0O"6J?#;X/^./BS?ZS%-!>3
M>'-4T.ZMO"<&F+8C38-1B-Q<3I<7$B16[-^!^A_$7]GSX*_L-_ :X\*:7XFU
M'1? 7@CX,_%;6-&U.^CTOP-!\.O@!K%Y=>,+!H=)GL-3TO4?''@[1/"%O;WD
MVC7$[^,-/NK>6=[2YMSH?'[X'^(/BS\9/V4?&-D=+_X1'X.^,/C#J7CZ"\OA
M;:C>Z+\1O@%X[^%]E!HD:I,DUZ-5\66TERLK0FUM4>XBWNB*P!XIH/[7GQU@
M\!_";]I/X@_"'P+X6_9K^+WC+X;Z':Z78>+?$&K?&OX?^!/C=XNTSP/\%?BE
MXIM$T9/".M1>*M<\6_#Z]\=> =).G:Q\*_#WB>_U&[USQ5>>&=4TXZ<G[1'[
M0&G_ +8'@/\ 9CFU;]F;Q1?:S::O\2OB)X=T.'XCZ#XW^&_P#W^)]+\*>*Y-
M2UO6[SP_XA\8^)O%VE:;X:TWPK8:=%=7ENGB7Q:UO8^'-$:XEXS2?V=_VF=8
M^$_PE_9'^(ES\-[CX.?"?Q'\%KC6?CUH_B+4QXW^)OPV_9\\?>&?'O@?P?)\
M)7\.16GAGQ5XIM? 7A+PC\1O$+^--1T;[!-XFUGP]:SS:CI^E6?H'C3X9_M!
M?&7QM\.+/XC?";X$^%;;X9?%SP)\3K'X]^&/'6K>(/&AL?A[XNM_$#Z+X&\)
MZCX)TG6/#=_\1-#AG^'WBF#6O&M_H6F>$O$WBN$2:ZLEE97 !S&J_MA?'.Y^
M&WQ#_:@\#_"CX;^)/V8/AKXJ\=VEW97?C7Q!I?QG\6_"OX1^)-3\-?%WXQZ)
M#-H"^%-+F\,3>%O&VK^%/A=?QZAK/Q T+0[&XB\5^&]1UNRTD_3GQ\^,?BGX
M1Z5\(_&/A[0M!\1>!?$?QN^%W@#XHZEJFH75E>^%_ 'Q7UE? &A^-_#QM?.M
MKJXT[XC>)/A^-2L]4"6J>$-2US5#/!/II$?R;>_LU_M'Z)\%_B)^QG\/K+X:
M6OP-^(E]\5](L?C9K7BS6)/&W@7X5?'#QAXH\4>./"+_  PMO#3VOB#QQX<T
MWQIXB\*>"==M_&MEH$T,6A:[K,=O=65[IMQ]J_&CX.>&_C+\#/B?\#M4#:?X
M=^(_PQ\3_#EFLY-DVA6NM>'+C0],OM-N")'@O_#[M::EIEZ'=X;^S@O$RT4
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MX06'B+XJ^+KWP;\.? W]I>#O''C:[\3^)-1T[2]4O-4N?L7@>YT+POX2AN-
M/BOQ=K>B:"OB;1C=I<GX+^+/[&O[2_Q+\=:Q-XBU2'Q],O[3_P /_C#X3^+6
MK?M&_%?PQH/AOX/>#/V@O!/Q1TCX1VG[,6@VY^&MSK7@WP5H&H^#(=>U<ZA!
MXCU&*3QG?W*:QJJZ38?II\;[;Q[?^#3:^ _AQ\,_BO\ ;K\0>)_ ?Q4UN7P]
MH.N^%[FRO8[R&RU/_A&?&.F_VJ+A[8"QUK09M+U#3FOX)+^PF\B24 \!\?\
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MZ[I$VM^&]6F\,:MI1U76].\46<%Q%X<G\-QZLVLZI:7V@644GB&PNM*B^'/
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M3K1(X6O-8EMI]1/A[3V74=?&FV)^TGY \6?LY_M4Z3^S/\;?V,?A?H?P<O/
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MU@ ?2].3[_\ P%OYK3!R!QCV_P ]O2GI]_\ X"W\UH SM05"DWF*C1&,K*)
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M+'8_$8_LV/J=_JWV5_'EXWCT7NH?$JZ^+%VX\9_85ND3_A+[N8H%LSY6EE;
M,!EQXU_P2_\ ^"POPS_X*=^+/BUX4\!?!GXB?"NY^$7AOPMXBU&\\::[X8UB
MSUB'Q7J>K:;;V^G'0;B2>.6S?2GGFDNT4.DR*G*!1^R')8D=,DCZ$Y!'L1C
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M #_GKZ44 )@>_P"?Z^F>^<=:,#T]N.*7/^?\^G&?3(]13-WN/R)Q^OZ]#VH
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M>7#1V-K//#^$O_!J18ZR;#_@HMJ4D=R/#4GA#X$Z? [2,]M_PD4%E\;9[^,
MN9#>+IEQI18% %@:!(R&$B#YKZW@<\X1Q/%-;A[)L'F/#^<X*C#ZO1]GE^:4
M*E:BIX;$86+HQJP:KOGE&4ZM.=.+?NQ=,]'V=?+\U64PS#$XG#8[ 8B5ZDW.
MKAZD(U%"4:D9R<5)P6O-&Z;2<GO_ #O_ /!.G5/VT]&_:<\/7_\ P3WL;B__
M &EAX,\;P^';>RTWP3JTY\+SZ7$OBV:.R\>@^&I1%9"!F:<K+'&2;9@6(/\
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MTK6I]2URU\3:9X/\;376LVVK6^@6%KHSZ1#!<VNIWM\VH1#3A;7?YU?L??\
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MFYNSXD\,:/J.JI)9I.FF"T:TUC^S[Z>"T< [>R_;5^#G@7X,_!?XC?'+XF^
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MP[Q_U/?AC^MX?\DU_7N%8#&S_P =^F>C#K@9'Y8HVG_GF/\ OD__ !=?9_\
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M?XT8;^XWY#_&@ HHPW]QOR'^-&&_N-^0_P : "BC#?W&_(?XT8;^XWY#_&@
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M#YCDD  D\<D@#D@ $\DXR3S@/PW]QOR'^-&&_N-^0_QH 0 +G'<YQ@ #@
M 8    [#BD*!B"0,@@@X&<CI^7;MSTXY=AO[C?D/\:,-_<;\A_C0!&T:L.0#
M@D@'(!)SD$ C<IR?E;<!G..N3RDR3@<@C&!MP?5<;3]"" >5 .*DPW]QOR'^
M-&&_N-^0_P : (Q$@(('/?@#=UQNP #C.1P,$ \X&'D9!_'GJ<GCG/7BEPW]
MQOR'^-&&_N-^0_QH B,,9()1,]3A5Y/J202QYSEB23R><8#$K$EE'.<]\D@@
M\'( Y)^4 MQN.0,2X;^XWY#_ !HPW]QOR'^- #64,,'@@Y!&,J>F5)!VG'&1
M@X)]:8(E5MRJ QY)'? (&>.=H("\9QD9!P:EPW]QOR'^-&&_N-^0_P : &!
M"V% W9W$  L>.3@#)(^\QR2?;J*@4L1@%CD\ ?3H 3@<#)]?6GX;^XWY#_&C
M#?W&_(?XT 0F%#G(!W A@0&W DG#$K\PY(P1R"RGALAQC4C&%QP,;5Z#TXQV
M& 1CJ/3$F&_N-^0_QHPW]QOR'^- $?E)@#:,#.._7KD\$\\CG (! !%"Q*O0
M9P#C<6/7KDDYY[D8)ZG)YJ3#?W&_(?XT8;^XWY#_ !H B\H#@9P3G[S<$XSC
M<6QG_9QQD?5RH%  &U1P$7A% .?E4<*,^G)XR3TI^&_N-^0_QHPW]QOR'^-
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% '_
!V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>18
<FILENAME>ex23-1_002.jpg
<TEXT>
begin 644 ex23-1_002.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  $! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_
MVP!# 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_P  1"  M 1,# 2(  A$! Q$!_\0
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MU\5/!GAKP;/.]KX#\'>-)'CU'X;^&/C)\;%L?A_\(OAU:3V>CZU\'O GQO\
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M=7TA_#VGZ_)=_P!EZQXB_4/]LG_@DU\/OCI_P3 U#_@F%^SCXMB_99^%OE^
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M1XP\-^/-5_98^ 7A;3K_ ,&:Y:VT>K7,4>AV>L>'=7_H"_X)^?\ !)3X$_L
M'Q?XMT7XA_&3]H'X^>,_"FF_#.\_:3^/WB?3_%?Q9\._!?PWI>@:7X)^"7@6
MYT_1]*\/^$/AAX+'ARPU+1= T[1#-+J?EC4KZ]T;1_#&C:![%_P3Q_X)T_LZ
M_P#!,SX"_P#"A/V=K'Q%>6&J^*-9\=^/_B'X]U#3=:^)7Q1\<Z[(@O/$_C;6
M='T?P]I$US:Z=;V.B:1IVB:%HNBZ7I6GVZP:<=0N-4U'43IK:_DKWVZO[[6:
MW5VK-G5O[O)_UU\DK6;/SG_X)0?M9^)_A!^Q5^W7\0?V\OVJM2^)?@']C7]O
M?]K?X(G]H_XN6US8^-=7\"_"SQ=X>T$2^)M(TN76XI-5UGXAZSKFF?#KP5X)
MDUE_[+U?PAX"\+Z<U_#8:##R?_!&S]IWQE^T[I?[=/\ P5]_:-^-E_\ "W]F
M?]H'XO6WPZ_9K^$WQ/\ B#I_A_X3_ S]GK]GVYG\ :-XYUDZWXLN_"'@SXA_
M%+QAK&HV?C^.&;3K>[\2:$NHVEYJ-AXCT>UTWW_4?^"#_P"R?K'[9'B3]JK6
M?B)^T'K7P^\7?'NV_:P\1?L2ZO\ $"QU#]CO5_VHK7P])HD?QKU+X:7'A]]3
MU+7Y-2FN?&T]CJ7B.\L9?%EU/:N#X!%OX$@\L\._\&W_ .Q%;?%>+Q;\1_B?
M^U-\=O@;HOQ<^*'QO\%?L6?%_P")_A[Q!^R;X/\ 'OQ>NM7U+Q;=6GP\TWP)
MHNK:CIL&K:L;_1K#4/$\AE:S@M_%]QXQ@N=32_3Z:._6UOUWZ]O3:Q^+OV_'
MIKZ:'+2_\''GP \6?M<7?[*'[/W[,'[4_P"T;K.I?!^^\?\ PGU[X>?#^XM;
MCX_>);[Q;H>A^"!\+=&\0+IUM:_ ;Q!X=N?$?CG4_P!IWXCZ[X#^&FE^%M"M
M]<TH>(]!UK2]8N;?[67_  6TT9/^"3W[47[5GP8\'?$/X%_M!?#OXFR?L7:Y
M\/?CIH-CH/B[]FC]J/Q;J?AKP>==\>V>FCQEINI>&OAU:>-].^*.CZG86.M6
MOB[2++3+*?0[>_OM1T2Q^]/V1?\ @E]\(/V3/VK/VN?VP['QAXO^)WQ?_:DU
MO2]+T?4_&L>F6\'P*^ _A^RT4>&/V<OAE9:'#8Z38?#?PGJ.DVMKX<BM]*TV
M:T\%^&_AYX6O(=0O_"-]XH\3_EO_ ,%E?^"4G[#GB/4_B+^U-\4OVB?VJ?V;
M-%_:EUOX*?!KX]_L\?LH:?X8UN/]O7XF:)XAUB[^!'@G2?A2? FO77B_]I#7
M/%MY8V_A+Q;KP\0>'=!C\/Q^)M:TOPYI^G>+O&BM>>U]^NW1:W[KOMHM0_KK
MV_'O_P ,?CS^PE^VC_P3C\._M?\ _!-/]BOX+6MS\6/"_B+]H?QI\7?VP_\
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M-;^&?'VK^"]/TOXE:A\.X;3XL>/V@OM>\0>./$NI6-SXN\:7TMQ9_IG\7/\
M@@3^Q1XO^+7AGXV?L[^+/VA_^"=/C[0?A^/AIJ]__P $Z?'_ (0_9FL?'_AF
MSFTN?P^OCS3++X<>)[76-1\,S:/9/I]_8KI,NJ>1;)XL7Q(FG:4MA]-?LS_\
M$G?V(OV8OAW\4_ 6C_"T_&34?C]HC:!^T9\4?VD]1_X7A\6/VA-+DMUM9K#X
ML^+/&%K/#K>C30QP@^%M*TK1/"$,D$%Q:^'X+B)90NNVGW:76WF^FZ5M;Z!?
M;2V[T\_/?3976FMKW(_V3+?X3_LW_LTW_P"U)\=/VDOA!XW\7_M$II?QR^/W
M[5\OC+PYI_PF\7ZUK>A)<^'O"_PL\8ZL^F)!^S]\+= #^#O@+X8O+J6^L_!]
MC+K&IK>^-?$OB[5-5_#G]EI_"G_!<S_@IS\1/^"DGC[Q4EW_ ,$U_P#@FEJ<
M'PS_ &1OA[XSCU/PUH_CSXTVWA;PM\3?&/[1_C?0]>EL[/2/#>D1:IHOBS1[
MG5X;&?Q!H=C\))-<M;&T\(>(M-UC[N^&7_!L[_P2D^&?Q7/Q&7X6_$+X@>#K
M+Q'J'C#PK^SA\4_B=K'CG]FKP7XJOM8.K)K>C?#+4;5)-7DLK=I- CT[QSKW
MB[0]0\/S26.O:5J\H2Y79^/7_!O=^R-\?_VB/B+\9=7^,/[5?PZ^%OQL\6_#
M_P =_'G]D'X._%/2OAS^S)\:_$OP_P!+TKP^J^/?!^C>$!K<^A^,?#FEMI'C
M2STCQ'I.MW(U35K[PUXD\+WEYYL9=WV]'=Z6Z)6[;.]^EMQ=]$^VK[+NN][W
MO?1ZWLOPG_X+&?\ !4OQ?X;_ &S_ -AG_@JY^Q#\'=6^/G[,/[%GB#X[_LUZ
MO\?/&-GJ&F?LT_&?XA?'+PIJGA[Q#H?PA\5V$DVN:SH?AO1O#GB2S/QN\+Z;
M/X(U'QYINF^%8+_Q-I]G/I>M\GH'[*_[<O[?O_!)']L3]O+]NOXM:SX;_9Z\
M6?"W]JW]M/\ 9;_8P^$GBC6?#6B>-O&GQ%UKXF_%:T^('[3US?>&9O$/CGP[
M\/[FT\ 77[,7@N'QI=:'9^%_"OABXU%?#FDWNOZ7XK_M9^*7[(/[,7QI_9\O
M?V4OB3\#?AUX@_9SO=*TS11\((= M_#_ (,TS3M$O8-2T6/P[I_ADZ,_A>XT
M;4;:"^TF_P##<^DW^F7<8N+&Z@F)<^P67@#P/IO@.T^%MAX/\,VOPUL/",'@
M"R\ 1:)IR^#;;P-:Z,GAVV\'Q>&_L_\ 9*^&8M C314T3[(=.&EJ+'[.;7]U
M3ZNUDKZ:.^VM[-7UO;M??1,K2]TOD_QVUUZ]MD?R_?LV_MEZ;X;_ ."8'[#W
M_!.G_@D_J'ACXM_MN>./V*_A+IFI>,_AJNJ^,/@I^QMXE\8_"VQ\1?%'X\_M
M'>/=+\,>-='^'?BN;X@:GXRU#P1\/O%OA^YUK6_BW?Z9I'B;P=I7AW[?!7M_
M_!M_\4/V>?AI_P $</@AK_B;XM?#CPOXSOOB-^T'JO[1^M>._BMX>7Q'%\=K
MSXT?$"37&^)NJ^(M1TZYT[QE>^"],\*:DEGJZK>7/A :%K<5]XATR]M_%&L_
ML1^RM^P7^QQ^Q!:^,K7]DW]G3X9? H?$*^MM0\:W?@?0_LNK>)7L+G4[S2K+
M5=<OIK[69]$T.YUO6'\.^'?MRZ#X=&J:@FAZ;I\=Y<(_R/\ $S_@@_\ \$D?
MC'\7?&?QW^)O[%/P]\7_ !3^(?B/Q!XO\:>(]1\3_%"*VU_Q1XKUF\\0^(M>
MN_#-CX[M?"::IJVMZA?:I=W=MH4$K7MW<3*R-*Q)]_Y+=OY:6T\O+5:>=O\
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MPCFL_#'CWX^ZMX=M(M)7Q-JGAO3[724\*67B)W\*?%6"_A_I]^'7A[P!X2\
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MK4WUS4KGQQ\3O%%UJOC'Q"VI:[(^KS:?<:JFAV5P+:VT;2=,TS3],L++DO\
M@F;_ ,$Y/A9_P3"_9[UC]GWX6>*_$_Q L?$/Q7\>_%KQ%X]\=6FBP^-_$^O^
M-;FSCBD\3WF@V=A9:MJ&D:#I.BZ&=5%G:MJ"Z>;PV=F;@V\?Z'4_3KO]ROV[
M;VNTE=NRL/\ KUZV\NWEZL**** "BBB@ I#],_YZTM% 'R=^SW^QU\,/V8_B
MA^U#\1_A/J_C72=-_:Q^+*_'CXB?"V\U+1KSX::-\:-3T+3M#\??$SP79-H$
M?BS2?$GQ531]&O\ Q_!?^+]7\.7>HZ-I]UX?T#P[*=1;4?K&BB@ HHHH ***
M* "BBB@ K^=+]OS]I[X>?L[?\%%_B1\?OCKJ27VB_L&_\$M/$'QZ_9<^'FO2
M7MIX;\2_M%_'CXO^*O@WJ-UH@LHC<:K\2O&$/AWX<_ WPFEO:>(9=/L/B;XA
M%I;Z#->W5SJW]%M?F/\ MJ?\$J_V>OVX_P!I7]BO]J'XF76O:/X]_8O^)-GX
M\T6WT!+$:=\3M'TC7='\<^'/ GCT7,;277A[P]\2?"_AWQ;IZ+YZ"W?Q9H+6
MOV?Q=>7=H?-KS2O^']>>E[FO3KI\M?ZZ==44_P#@CM^REXY_9+_84^''A[XU
M6+0_M-?&;7O&W[37[5VJ7%[/?ZIKG[0OQY\1WGCKQM-K4C.;&'5M LK[0O!5
MY;:-%#I*2^%VEA:_N9[O5M1_42D Q_GU))_G^E+1O_7F'X!1110 4444 %%%
@% !1110 4444 %%%% !1110 4444 %%%% !1110!_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>19
<FILENAME>ex23-2_001.jpg
<TEXT>
begin 644 ex23-2_001.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  $! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_
MVP!# 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_P  1" !@ +X# 2(  A$! Q$!_\0
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M8O$'[0_Q#OXC=V*:+:Z)IE_KWA*]>RGU+PO\.M0D@M=-D\9^*-2T;6?ZJ/\
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M&&?^T7_@K7^Q/X\_;D_81U[]DCX,WWA/PCJOB_QY\#88M<\4RW=OX<\&>#/
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M\'86\"CP0GBA+-&9(OC#-X@:?_A"7OO]'77?^%=2>,(;<O<W/PZB?9"/FO\
M;0UGXK?\%[?^"-GP]_:X^'GP5US1OVB?V5OBSXSU7Q9\-?#&@:[>:#\0O#EI
MI4FC?$EO@!J6J>?<?$6P.@77@[Q39P:?J5YJC>)O!GBWP&L,^O6>D1ZO]_\
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M!YB[?_!VF1'^T5^P:D2I''_PK+XF*L:*HB1!\1O 0$<8&Y5B5?DB5#A8PJH
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MA@Q&R4L8WZC_ ()U?MN_\$B/VV/VQO@C^S-X3_X(T? 7X2^)_'E[XGU7P_\
M$:2?X;>)!X9U7X:^ _$GQ.M-3CT72_AWH]]->&3P:L-G=6VHVTNGWDT.H&1S
M;F.3#_X.W+#4K_XQ?L*76GZ/JNJQ6WPQ^,<T@T_3KZ[A#1^+_AK/'!<S6EI=
MM:^?Y?[IS&68HTL4=RD3QG<\ ?\ !RW\,])\9>%7\+?\$=?"_A#6[G6])T2U
M\4^&_B?H6D:[ID6M7MOH]Y>VUQIG[)-A>K(+6\E::SM]0MUNXFFM9+J*%WE5
MPPF*Q_AYPY2P>4XS,Z\,OSV,<3A,^AE$LLG/'U[^VP*Q]%9C"I%*2ISHR48Q
ME_/9JI5IX3C/.*N)QN&P%.>)R:7)C\EJYA#'1IX6@O\ 9L0\/.&%E"ISN595
M(3O))Z0:7S=_P<>?LM_'/X1?\%#8/V\/&'PJN/C;^RKXSMO@G<S7.J'Q+/\
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MVD4L*R>)=,\-7^L7/A5KA_L,'B5-)N-026RAN(G_ #O^&O\ P3T^,W[,NJ^
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MT;J_[#?B_7?V/-;_ &8+GXNP:-J_Q>^+OBKXF_'_ ,?^$_#QTZ+4=/\ C/\
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!V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>20
<FILENAME>ex23-2_002.jpg
<TEXT>
begin 644 ex23-2_002.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  $! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_
MVP!# 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_P  1"  C /H# 2(  A$! Q$!_\0
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M@UW4_"7PQ^&OC#P)>WNC:K\4_B-XM\2ZG(VF^#?$NB_"6;Q?I&G:SX-_H"^
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M+BT>_DU[5O$?A^Z\4_!?PWXK BL=_B3XL:5X9TN1M4TK53;_ )#_ +,/C_\
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MG^*WQGLOVB_ASX[^+=U^T-XYT7X/>'/%'B34M=^'>@^$?"VG:)\'O#=GKO\
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M@#H /PI:** # /44QXHI-HDC1PCI(H=%8*\;;HW4$$!T;YD8?,K<J0:** '
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CR_EL]-@OKZ]MK=KNZFC@BC0HH ^\**** "BBB@ HHHH _]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>21
<FILENAME>stss-20240930.xsd
<DESCRIPTION>XBRL SCHEMA FILE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" ?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoFiler Complete; Version: 5.25a -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: https://www.novaworks.com -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x00000000 -->
    <!-- Field: Doc-Info; Name: Misc; Value: 96Mps7xRiXgen8uDanwsWaaDSbP9z5Z8+ekhvWB8bfm6Pyon9tewKCRguxcGgWAJ -->
<schema xmlns="http://www.w3.org/2001/XMLSchema" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:dei="http://xbrl.sec.gov/dei/2024" xmlns:us-gaap="http://fasb.org/us-gaap/2024" xmlns:srt="http://fasb.org/srt/2024" xmlns:srt-types="http://fasb.org/srt-types/2024" xmlns:dtr-types="http://www.xbrl.org/dtr/type/2022-03-31" xmlns:STSS="http://sharpstechnology.com/20240930" elementFormDefault="qualified" targetNamespace="http://sharpstechnology.com/20240930">
    <annotation>
      <appinfo>
        <link:roleType roleURI="http://sharpstechnology.com/role/Cover" id="Cover">
          <link:definition>00000001 - Document - Cover</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://sharpstechnology.com/role/BalanceSheets" id="BalanceSheets">
          <link:definition>00000002 - Statement - Condensed Consolidated Balance Sheets</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://sharpstechnology.com/role/BalanceSheetsParenthetical" id="BalanceSheetsParenthetical">
          <link:definition>00000003 - Statement - Condensed Consolidated Balance Sheets (Parenthetical)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://sharpstechnology.com/role/StatementsOfOperations" id="StatementsOfOperations">
          <link:definition>00000004 - Statement - Condensed Consolidated Statements of Operations</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://sharpstechnology.com/role/StatementsOfComprehensiveLoss" id="StatementsOfComprehensiveLoss">
          <link:definition>00000005 - Statement - Condensed Consolidated Statements of Comprehensive Loss</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://sharpstechnology.com/role/StatementOfStockholdersEquity" id="StatementOfStockholdersEquity">
          <link:definition>00000006 - Statement - Condensed Consolidated Statement of Stockholders' Equity</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://sharpstechnology.com/role/StatementsOfCashFlows" id="StatementsOfCashFlows">
          <link:definition>00000007 - Statement - Condensed Consolidated Statements of Cash Flows</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://sharpstechnology.com/role/DescriptionOfBusiness" id="DescriptionOfBusiness">
          <link:definition>00000008 - Disclosure - Description of Business</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://sharpstechnology.com/role/SummaryOfSignificantAccountingPolicies" id="SummaryOfSignificantAccountingPolicies">
          <link:definition>00000009 - Disclosure - Summary of Significant Accounting Policies</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://sharpstechnology.com/role/Inventories" id="Inventories">
          <link:definition>00000010 - Disclosure - Inventories</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://sharpstechnology.com/role/FixedAssets" id="FixedAssets">
          <link:definition>00000011 - Disclosure - Fixed Assets</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://sharpstechnology.com/role/AssetAcquisition" id="AssetAcquisition">
          <link:definition>00000012 - Disclosure - Asset Acquisition</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://sharpstechnology.com/role/OtherAssets" id="OtherAssets">
          <link:definition>00000013 - Disclosure - Other Assets</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://sharpstechnology.com/role/DebtFinancing" id="DebtFinancing">
          <link:definition>00000014 - Disclosure - Debt Financing</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://sharpstechnology.com/role/NotePurchaseAgreement" id="NotePurchaseAgreement">
          <link:definition>00000015 - Disclosure - Note Purchase Agreement</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://sharpstechnology.com/role/StockholdersEquity" id="StockholdersEquity">
          <link:definition>00000016 - Disclosure - Stockholders&#8217; Equity</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://sharpstechnology.com/role/PreferredStock" id="PreferredStock">
          <link:definition>00000017 - Disclosure - Preferred Stock</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://sharpstechnology.com/role/WarrantLiability" id="WarrantLiability">
          <link:definition>00000018 - Disclosure - Warrant Liability</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://sharpstechnology.com/role/StockOptions" id="StockOptions">
          <link:definition>00000019 - Disclosure - Stock Options</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://sharpstechnology.com/role/IncomeTaxes" id="IncomeTaxes">
          <link:definition>00000020 - Disclosure - Income Taxes</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://sharpstechnology.com/role/RelatedPartyTransactionsAndBalances" id="RelatedPartyTransactionsAndBalances">
          <link:definition>00000021 - Disclosure - Related Party Transactions and Balances</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://sharpstechnology.com/role/FairValueMeasurements" id="FairValueMeasurements">
          <link:definition>00000022 - Disclosure - Fair Value Measurements</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://sharpstechnology.com/role/CommitmentsAndContingencies" id="CommitmentsAndContingencies">
          <link:definition>00000023 - Disclosure - Commitments and Contingencies</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://sharpstechnology.com/role/SubsequentEvents" id="SubsequentEvents">
          <link:definition>00000024 - Disclosure - Subsequent Events</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://sharpstechnology.com/role/SummaryOfSignificantAccountingPoliciesPolicies" id="SummaryOfSignificantAccountingPoliciesPolicies">
          <link:definition>00000025 - Disclosure - Summary of Significant Accounting Policies (Policies)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://sharpstechnology.com/role/InventoriesTables" id="InventoriesTables">
          <link:definition>00000026 - Disclosure - Inventories (Tables)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://sharpstechnology.com/role/FixedAssetsTables" id="FixedAssetsTables">
          <link:definition>00000027 - Disclosure - Fixed Assets (Tables)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://sharpstechnology.com/role/AssetAcquisitionTables" id="AssetAcquisitionTables">
          <link:definition>00000028 - Disclosure - Asset Acquisition (Tables)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://sharpstechnology.com/role/OtherAssetsTables" id="OtherAssetsTables">
          <link:definition>00000029 - Disclosure - Other Assets (Tables)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://sharpstechnology.com/role/WarrantLiabilityTables" id="WarrantLiabilityTables">
          <link:definition>00000030 - Disclosure - Warrant Liability (Tables)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://sharpstechnology.com/role/StockOptionsTables" id="StockOptionsTables">
          <link:definition>00000031 - Disclosure - Stock Options (Tables)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://sharpstechnology.com/role/IncomeTaxesTables" id="IncomeTaxesTables">
          <link:definition>00000032 - Disclosure - Income Taxes (Tables)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://sharpstechnology.com/role/FairValueMeasurementsTables" id="FairValueMeasurementsTables">
          <link:definition>00000033 - Disclosure - Fair Value Measurements (Tables)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://sharpstechnology.com/role/DescriptionOfBusinessDetailsNarrative" id="DescriptionOfBusinessDetailsNarrative">
          <link:definition>00000034 - Disclosure - Description of Business (Details Narrative)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://sharpstechnology.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative" id="SummaryOfSignificantAccountingPoliciesDetailsNarrative">
          <link:definition>00000035 - Disclosure - Summary of Significant Accounting Policies (Details Narrative)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://sharpstechnology.com/role/ScheduleOfInventoriesDetails" id="ScheduleOfInventoriesDetails">
          <link:definition>00000036 - Disclosure - Schedule of Inventories (Details)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://sharpstechnology.com/role/ScheduleOfPropertyPlantAndEquipmentDetails" id="ScheduleOfPropertyPlantAndEquipmentDetails">
          <link:definition>00000037 - Disclosure - Schedule of Property, Plant and Equipment (Details)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://sharpstechnology.com/role/FixedAssetsDetailsNarrative" id="FixedAssetsDetailsNarrative">
          <link:definition>00000038 - Disclosure - Fixed Assets (Details Narrative)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://sharpstechnology.com/role/ScheduleOfFairValueOfAssetsAcquisitionDetails" id="ScheduleOfFairValueOfAssetsAcquisitionDetails">
          <link:definition>00000039 - Disclosure - Schedule of Fair Value of the Assets Acquisition (Details)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://sharpstechnology.com/role/AssetAcquisitionDetailsNarrative" id="AssetAcquisitionDetailsNarrative">
          <link:definition>00000040 - Disclosure - Asset Acquisition (Details Narrative)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://sharpstechnology.com/role/ScheduleOfOtherAssetsDetails" id="ScheduleOfOtherAssetsDetails">
          <link:definition>00000041 - Disclosure - Schedule of Other Assets (Details)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://sharpstechnology.com/role/OtherAssetsDetailsNarrative" id="OtherAssetsDetailsNarrative">
          <link:definition>00000042 - Disclosure - Other Assets (Details Narrative)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://sharpstechnology.com/role/DebtFinancingDetailsNarrative" id="DebtFinancingDetailsNarrative">
          <link:definition>00000043 - Disclosure - Debt Financing (Details Narrative)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://sharpstechnology.com/role/NotePurchaseAgreementDetailsNarrative" id="NotePurchaseAgreementDetailsNarrative">
          <link:definition>00000044 - Disclosure - Note Purchase Agreement (Details Narrative)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://sharpstechnology.com/role/StockholdersEquityDetailsNarrative" id="StockholdersEquityDetailsNarrative">
          <link:definition>00000045 - Disclosure - Stockholders&#8217; Equity (Details Narrative)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://sharpstechnology.com/role/PreferredStockDetailsNarrative" id="PreferredStockDetailsNarrative">
          <link:definition>00000046 - Disclosure - Preferred Stock (Details Narrative)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://sharpstechnology.com/role/ScheduleOfFairValueOfWarrantDetails" id="ScheduleOfFairValueOfWarrantDetails">
          <link:definition>00000047 - Disclosure - Schedule of Fair Value of Warrant (Details)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://sharpstechnology.com/role/ScheduleOfWarrantLiabilityDetails" id="ScheduleOfWarrantLiabilityDetails">
          <link:definition>00000048 - Disclosure - Schedule of Warrant Liability (Details)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://sharpstechnology.com/role/ScheduleOfWarrantOutstandingDetails" id="ScheduleOfWarrantOutstandingDetails">
          <link:definition>00000049 - Disclosure - Schedule of Warrant Outstanding (Details)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://sharpstechnology.com/role/WarrantLiabilityDetailsNarrative" id="WarrantLiabilityDetailsNarrative">
          <link:definition>00000050 - Disclosure - Warrant Liability (Details Narrative)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://sharpstechnology.com/role/ScheduleOfStockOptionsGrantedAndOutstandingDetails" id="ScheduleOfStockOptionsGrantedAndOutstandingDetails">
          <link:definition>00000051 - Disclosure - Schedule of Stock Options Granted and Outstanding (Details)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://sharpstechnology.com/role/ScheduleOfInformationAboutOptionsOutstandingDetails" id="ScheduleOfInformationAboutOptionsOutstandingDetails">
          <link:definition>00000052 - Disclosure - Schedule of Information About Options Outstanding (Details)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://sharpstechnology.com/role/ScheduleOfFairValueOfStockOptionAwardsDetails" id="ScheduleOfFairValueOfStockOptionAwardsDetails">
          <link:definition>00000053 - Disclosure - Schedule of Fair Value of Stock Option Awards (Details)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://sharpstechnology.com/role/StockOptionsDetailsNarrative" id="StockOptionsDetailsNarrative">
          <link:definition>00000054 - Disclosure - Stock Options (Details Narrative)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://sharpstechnology.com/role/ScheduleOfReconciliationOfFederalStatutoryRateToTotalEffectiveRateDetails" id="ScheduleOfReconciliationOfFederalStatutoryRateToTotalEffectiveRateDetails">
          <link:definition>00000055 - Disclosure - Schedule of Reconciliation of Federal Statutory Rate to Total Effective Rate (Details)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://sharpstechnology.com/role/ScheduleOfComponentsOfDeferredTaxAssetsDetails" id="ScheduleOfComponentsOfDeferredTaxAssetsDetails">
          <link:definition>00000056 - Disclosure - Schedule of Components of Deferred tax Assets (Details)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://sharpstechnology.com/role/ScheduleOfGeographicalComponentsOfLossBeforeIncomeTaxesDetails" id="ScheduleOfGeographicalComponentsOfLossBeforeIncomeTaxesDetails">
          <link:definition>00000057 - Disclosure - Schedule of Geographical Components of Loss Before Income Taxes (Details)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://sharpstechnology.com/role/IncomeTaxesDetailsNarrative" id="IncomeTaxesDetailsNarrative">
          <link:definition>00000058 - Disclosure - Income Taxes (Details Narrative)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://sharpstechnology.com/role/RelatedPartyTransactionsAndBalancesDetailsNarrative" id="RelatedPartyTransactionsAndBalancesDetailsNarrative">
          <link:definition>00000059 - Disclosure - Related Party Transactions and Balances (Details Narrative)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://sharpstechnology.com/role/ScheduleOfAssetsAndLiabilitiesMeasuredAtFairValueOnRecurringBasisDetails" id="ScheduleOfAssetsAndLiabilitiesMeasuredAtFairValueOnRecurringBasisDetails">
          <link:definition>00000060 - Disclosure - Schedule of Assets and Liabilities Measured at Fair Value on Recurring Basis (Details)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://sharpstechnology.com/role/CommitmentsAndContingenciesDetailsNarrative" id="CommitmentsAndContingenciesDetailsNarrative">
          <link:definition>00000061 - Disclosure - Commitments and Contingencies (Details Narrative)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://sharpstechnology.com/role/ScheduleOfFixedAssetsNetDetails" id="ScheduleOfFixedAssetsNetDetails">
          <link:definition>00000062 - Disclosure - Schedule of Fixed Assets, Net (Details)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://sharpstechnology.com/role/ScheduleOfFairValueOfAssetsAcquisitionDetailsDisclosure" id="ScheduleOfFairValueOfAssetsAcquisitionDetailsDisclosure">
          <link:definition>00000063 - Disclosure - Schedule of Fair Value of Assets Acquisition (Details)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://sharpstechnology.com/role/SubsequentEventsDetailsNarrative" id="SubsequentEventsDetailsNarrative">
          <link:definition>00000064 - Disclosure - Subsequent Events (Details Narrative)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:linkbaseRef xlink:type="simple" xlink:href="stss-20240930_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:title="Presentation Links" />
        <link:linkbaseRef xlink:type="simple" xlink:href="stss-20240930_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:title="Label Links" />
        <link:linkbaseRef xlink:type="simple" xlink:href="stss-20240930_cal.xml" xlink:role="http://www.xbrl.org/2003/role/calculationLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:title="Calculation Links" />
        <link:linkbaseRef xlink:type="simple" xlink:href="stss-20240930_def.xml" xlink:role="http://www.xbrl.org/2003/role/definitionLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:title="Definition Links" />
      </appinfo>
    </annotation>
    <import namespace="http://www.xbrl.org/2003/instance" schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd" />
    <import namespace="http://www.xbrl.org/2003/linkbase" schemaLocation="http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd" />
    <import namespace="http://xbrl.org/2005/xbrldt" schemaLocation="http://www.xbrl.org/2005/xbrldt-2005.xsd" />
    <import namespace="http://xbrl.sec.gov/dei/2024" schemaLocation="https://xbrl.sec.gov/dei/2024/dei-2024.xsd" />
    <import namespace="http://fasb.org/us-gaap/2024" schemaLocation="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd" />
    <import namespace="http://fasb.org/us-types/2024" schemaLocation="https://xbrl.fasb.org/us-gaap/2024/elts/us-types-2024.xsd" />
    <import namespace="http://www.xbrl.org/dtr/type/2022-03-31" schemaLocation="https://www.xbrl.org/dtr/type/2022-03-31/types.xsd" />
    <import namespace="http://xbrl.sec.gov/country/2024" schemaLocation="https://xbrl.sec.gov/country/2024/country-2024.xsd" />
    <import namespace="http://fasb.org/srt/2024" schemaLocation="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd" />
    <import namespace="http://fasb.org/srt-types/2024" schemaLocation="https://xbrl.fasb.org/srt/2024/elts/srt-types-2024.xsd" />
    <element id="STSS_ReverseStockSplitMember" name="ReverseStockSplitMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="STSS_CommonStockSubscriptionReceivableMember" name="CommonStockSubscriptionReceivableMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="STSS_WebsiteMember" name="WebsiteMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="STSS_PrefundendWarrantsMember" name="PrefundendWarrantsMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="STSS_StockOptionsAndWarrantsMember" name="StockOptionsAndWarrantsMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="STSS_StockOptionAndWarrantsMember" name="StockOptionAndWarrantsMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="STSS_ComputerSystemsAndWebsiteAndOtherWebsiteMember" name="ComputerSystemsAndWebsiteAndOtherWebsiteMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="STSS_SharePurchaseAgreementMember" name="SharePurchaseAgreementMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="STSS_StockOptionOneMember" name="StockOptionOneMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="STSS_SafegardMedicalIncMember" name="SafegardMedicalIncMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="STSS_SecuritiesPurchaseAgreementMember" name="SecuritiesPurchaseAgreementMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="STSS_SeniorSecuredNoteMember" name="SeniorSecuredNoteMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="STSS_PreReverseMember" name="PreReverseMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="STSS_NotePurchaseAgreementMember" name="NotePurchaseAgreementMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="STSS_UnrelatedThirdPartyPurchasersMember" name="UnrelatedThirdPartyPurchasersMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="STSS_ShelfOfferingMember" name="ShelfOfferingMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="STSS_PIPEPreFundedWarrantsMember" name="PIPEPreFundedWarrantsMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="STSS_NonTradingWarrantsMember" name="NonTradingWarrantsMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="STSS_PurchaseAgreementMember" name="PurchaseAgreementMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="STSS_PIPEWarrantMember" name="PIPEWarrantMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="STSS_TradingWarrantsMember" name="TradingWarrantsMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="STSS_NoteWarrantsMember" name="NoteWarrantsMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="STSS_SubscriptionAgreementsMember" name="SubscriptionAgreementsMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="STSS_InvestorsMember" name="InvestorsMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="STSS_InducementAgreementMember" name="InducementAgreementMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="STSS_InducementWarrantsMember" name="InducementWarrantsMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="STSS_WarrantHoldersMember" name="WarrantHoldersMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="STSS_PreFundedWarrantsMember" name="PreFundedWarrantsMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="STSS_WarrantHolderMember" name="WarrantHolderMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="STSS_OverAllotmentWarrantsMember" name="OverAllotmentWarrantsMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="STSS_AlanBlackmanMember" name="AlanBlackmanMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="STSS_TradingAndOverallotmentWarrantsMember" name="TradingAndOverallotmentWarrantsMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="STSS_OfferingWarrantsFebruaryTwentyTwentyThreeMember" name="OfferingWarrantsFebruaryTwentyTwentyThreeMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="STSS_OfferingWarrantsSeptemberTwentyTwentyThreeMember" name="OfferingWarrantsSeptemberTwentyTwentyThreeMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="STSS_OfferingWarrantsFebruaryTwoThousandTwentyThreeMember" name="OfferingWarrantsFebruaryTwoThousandTwentyThreeMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="STSS_OfferingWarrantsSeptemberTwoThousandTwentyThreeMember" name="OfferingWarrantsSeptemberTwoThousandTwentyThreeMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="STSS_WarrantsIssuedForServiceManagementMember" name="WarrantsIssuedForServiceManagementMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="STSS_InducementWarrantsMayTwoThousandTwentyFourMember" name="InducementWarrantsMayTwoThousandTwentyFourMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="STSS_TwoThousandTwentyThreeEquityIncentivePlanMember" name="TwoThousandTwentyThreeEquityIncentivePlanMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="STSS_EmployeesAndConsultantMember" name="EmployeesAndConsultantMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="STSS_TwoThousandTwentyTwoEquityIncentivePlanMember" name="TwoThousandTwentyTwoEquityIncentivePlanMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="STSS_ExercisePriceRangeOneMember" name="ExercisePriceRangeOneMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="STSS_ExercisePriceRangeTwoMember" name="ExercisePriceRangeTwoMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="STSS_ExercisePriceRangeThreeMember" name="ExercisePriceRangeThreeMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="STSS_ExercisePriceRangeFourMember" name="ExercisePriceRangeFourMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="STSS_ExercisePriceRangeFiveMember" name="ExercisePriceRangeFiveMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="STSS_ExercisePriceRangeSixMember" name="ExercisePriceRangeSixMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="STSS_ExercisePriceRangeSevenMember" name="ExercisePriceRangeSevenMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="STSS_ExercisePriceRangeEightMember" name="ExercisePriceRangeEightMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="STSS_ExercisePriceRangeNineMember" name="ExercisePriceRangeNineMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="STSS_ExercisePriceRangeTenMember" name="ExercisePriceRangeTenMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="STSS_ExpiresOnTwoThousandTwentyEightMember" name="ExpiresOnTwoThousandTwentyEightMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="STSS_NotExpireMember" name="NotExpireMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="STSS_OfficersAndDirectorsMember" name="OfficersAndDirectorsMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="STSS_RoyaltyAgreementMember" name="RoyaltyAgreementMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="STSS_BarryBerlerMember" name="BarryBerlerMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="STSS_EmploymentAgreementMember" name="EmploymentAgreementMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="STSS_Mr.BlackmanMember" name="Mr.BlackmanMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="STSS_ServiceAgreementMember" name="ServiceAgreementMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="STSS_BerlerMember" name="BerlerMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="STSS_PlastomoldMember" name="PlastomoldMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="STSS_AssetPurchaseAgreementMember" name="AssetPurchaseAgreementMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="STSS_InjectEZLLCMember" name="InjectEZLLCMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="STSS_ComputerSystemsAndWebsiteAndOtherMember" name="ComputerSystemsAndWebsiteAndOtherMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="STSS_WarrantLiabilitiesCurrent" name="WarrantLiabilitiesCurrent" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="STSS_SubsequentEvents" name="SubsequentEvents" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="STSS_CommonStockReverseSplitValue" name="CommonStockReverseSplitValue" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="STSS_FairMarketValueAdjustmentForContingentStockAndWarrants" name="FairMarketValueAdjustmentForContingentStockAndWarrants" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="STSS_FairMarketValueAdjustmentForContingentWarrantsAndWarrants" name="FairMarketValueAdjustmentForContingentWarrantsAndWarrants" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="STSS_ForeignCurrencyAndNonOperatingIncomeExpenses" name="ForeignCurrencyAndNonOperatingIncomeExpenses" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="STSS_AwardsTypeAxis" name="AwardsTypeAxis" abstract="true" nillable="true" xbrli:periodType="duration" type="xbrli:stringItemType" substitutionGroup="xbrldt:dimensionItem" />
    <element id="STSS_AwardsTypeDomain" name="AwardsTypeDomain" abstract="true" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="STSS_StockIssuedDuringPeriodValueInitialPublicOffering" name="StockIssuedDuringPeriodValueInitialPublicOffering" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="STSS_StockIssuedDuringPeriodSharesInitialPublicOffering" name="StockIssuedDuringPeriodSharesInitialPublicOffering" nillable="true" xbrli:periodType="duration" type="xbrli:sharesItemType" substitutionGroup="xbrli:item" />
    <element id="STSS_StockIssuedDuringPeriodValueContingentStockLiability" name="StockIssuedDuringPeriodValueContingentStockLiability" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="STSS_StockIssuedDuringPeriodSharesContingentStockLiability" name="StockIssuedDuringPeriodSharesContingentStockLiability" nillable="true" xbrli:periodType="duration" type="xbrli:sharesItemType" substitutionGroup="xbrli:item" />
    <element id="STSS_StockIssuedDuringPeriodValueFractionalShareAdjustment" name="StockIssuedDuringPeriodValueFractionalShareAdjustment" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="STSS_StockIssuedDuringPeriodSharesFractionalShareAdjustment" name="StockIssuedDuringPeriodSharesFractionalShareAdjustment" nillable="true" xbrli:periodType="duration" type="xbrli:sharesItemType" substitutionGroup="xbrli:item" />
    <element id="STSS_StockIssuedDuringPeriodCollectionsOfCommonStockSubscriptionsValue" name="StockIssuedDuringPeriodCollectionsOfCommonStockSubscriptionsValue" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="STSS_StockIssuedDuringPeriodValueShelfRegistrationOffering" name="StockIssuedDuringPeriodValueShelfRegistrationOffering" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="STSS_StockIssuedDuringPeriodSharesShelfRegistrationOffering" name="StockIssuedDuringPeriodSharesShelfRegistrationOffering" nillable="true" xbrli:periodType="duration" type="xbrli:sharesItemType" substitutionGroup="xbrli:item" />
    <element id="STSS_StockIssuedDuringPeriodValuePrivatePlacement" name="StockIssuedDuringPeriodValuePrivatePlacement" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="STSS_StockIssuedDuringPeriodValueExerciseOfPrefundedWarrants" name="StockIssuedDuringPeriodValueExerciseOfPrefundedWarrants" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="STSS_StockIssuedDuringPeriodSharesExerciseOfPrefundedWarrants" name="StockIssuedDuringPeriodSharesExerciseOfPrefundedWarrants" nillable="true" xbrli:periodType="duration" type="xbrli:sharesItemType" substitutionGroup="xbrli:item" />
    <element id="STSS_StockIssuedDuringPeriodValueExerciseOfPrefundedWarrant" name="StockIssuedDuringPeriodValueExerciseOfPrefundedWarrant" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="STSS_StockIssuedDuringPeriodValueRegistrationOffering" name="StockIssuedDuringPeriodValueRegistrationOffering" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="STSS_StockIssuedDuringPeriodSharesRegistrationOffering" name="StockIssuedDuringPeriodSharesRegistrationOffering" nillable="true" xbrli:periodType="duration" type="xbrli:sharesItemType" substitutionGroup="xbrli:item" />
    <element id="STSS_StockIssuedDuringPeriodValueWarrantInducements" name="StockIssuedDuringPeriodValueWarrantInducements" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="STSS_StockIssuedDuringPeriodSharesWarrantInducements" name="StockIssuedDuringPeriodSharesWarrantInducements" nillable="true" xbrli:periodType="duration" type="xbrli:sharesItemType" substitutionGroup="xbrli:item" />
    <element id="STSS_StockIssuedDuringPeriodValueWarrantExericse" name="StockIssuedDuringPeriodValueWarrantExericse" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="STSS_StockIssuedDuringPeriodSharesWarrantExericse" name="StockIssuedDuringPeriodSharesWarrantExericse" nillable="true" xbrli:periodType="duration" type="xbrli:sharesItemType" substitutionGroup="xbrli:item" />
    <element id="STSS_EscrowDepositForfeited" name="EscrowDepositForfeited" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="STSS_FairMarketValueAdjustmentForContingentWarrants" name="FairMarketValueAdjustmentForContingentWarrants" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="STSS_IpoIssuanceCostsRelatingToWarrants" name="IpoIssuanceCostsRelatingToWarrants" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="STSS_EscrowPaymentUnderAgreement" name="EscrowPaymentUnderAgreement" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="STSS_PaymentsToAssetAcquisition" name="PaymentsToAssetAcquisition" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="STSS_NetProceedsFromInitialPublicOfferingAndAdditionalOffering" name="NetProceedsFromInitialPublicOfferingAndAdditionalOffering" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="STSS_NetProceedsFromOfferingsAndWarrantExercises" name="NetProceedsFromOfferingsAndWarrantExercises" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="STSS_ProceedsFromSubscriptionsReceivable" name="ProceedsFromSubscriptionsReceivable" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="STSS_FmvForCommonStockIssuedForContingentShares" name="FmvForCommonStockIssuedForContingentShares" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="STSS_FmvForWarrantsIssuedForContingentWarrants" name="FmvForWarrantsIssuedForContingentWarrants" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="STSS_CommonStockIssuedAndVestedStockOptionsForFixedAssetsAcquired" name="CommonStockIssuedAndVestedStockOptionsForFixedAssetsAcquired" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="STSS_CommonStockIssuedAndVestedStockOptionsIssuedAsConsiderationForAcquisition" name="CommonStockIssuedAndVestedStockOptionsIssuedAsConsiderationForAcquisition" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="STSS_DisclosureNotePurchaseAgreementAbstract" name="DisclosureNotePurchaseAgreementAbstract" abstract="true" nillable="true" xbrli:periodType="duration" type="xbrli:stringItemType" substitutionGroup="xbrli:item" />
    <element id="STSS_NotePurchaseAgreementTextBlock" name="NotePurchaseAgreementTextBlock" nillable="true" xbrli:periodType="duration" type="dtr-types:textBlockItemType" substitutionGroup="xbrli:item" />
    <element id="STSS_DisclosureWarrantLiabilityAbstract" name="DisclosureWarrantLiabilityAbstract" abstract="true" nillable="true" xbrli:periodType="duration" type="xbrli:stringItemType" substitutionGroup="xbrli:item" />
    <element id="STSS_WarrantLiabilityTextBlock" name="WarrantLiabilityTextBlock" nillable="true" xbrli:periodType="duration" type="dtr-types:textBlockItemType" substitutionGroup="xbrli:item" />
    <element id="STSS_ScheduleOfWarrantLiabilityTableTextBlock" name="ScheduleOfWarrantLiabilityTableTextBlock" nillable="true" xbrli:periodType="duration" type="dtr-types:textBlockItemType" substitutionGroup="xbrli:item" />
    <element id="STSS_WorkingCapital" name="WorkingCapital" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="STSS_ReverseStockSplitDescription" name="ReverseStockSplitDescription" nillable="true" xbrli:periodType="duration" type="xbrli:stringItemType" substitutionGroup="xbrli:item" />
    <element id="STSS_RemainingPaymentsDueOnMachinery" name="RemainingPaymentsDueOnMachinery" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="STSS_FairMarketValueOfCommonStock" name="FairMarketValueOfCommonStock" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="STSS_NumberOfUnregisteredCommonStockIssuedDuringPostReverseShares" name="NumberOfUnregisteredCommonStockIssuedDuringPostReverseShares" nillable="true" xbrli:periodType="duration" type="xbrli:sharesItemType" substitutionGroup="xbrli:item" />
    <element id="STSS_NumberOfUnregisteredCommonStockIssuedDuringPreReverseShares" name="NumberOfUnregisteredCommonStockIssuedDuringPreReverseShares" nillable="true" xbrli:periodType="duration" type="xbrli:sharesItemType" substitutionGroup="xbrli:item" />
    <element id="STSS_PlacementAgentAndOtherOfferingExpenses" name="PlacementAgentAndOtherOfferingExpenses" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="STSS_CommonStockFairValue" name="CommonStockFairValue" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="STSS_AccretedInterestFees" name="AccretedInterestFees" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="STSS_ContingentStockLiability" name="ContingentStockLiability" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="STSS_ContingentWarrantLiability" name="ContingentWarrantLiability" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="STSS_AllocationOfDebtIssuanceCostToContingentStockAndContingentWarrants" name="AllocationOfDebtIssuanceCostToContingentStockAndContingentWarrants" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="STSS_ContingentWarrants" name="ContingentWarrants" nillable="true" xbrli:periodType="duration" type="xbrli:sharesItemType" substitutionGroup="xbrli:item" />
    <element id="STSS_NetProceedsFromIssuanceInitialPublicOffering" name="NetProceedsFromIssuanceInitialPublicOffering" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="STSS_ClassOfWarrantOrRightExercisePriceOfWarrantsAdjusted" name="ClassOfWarrantOrRightExercisePriceOfWarrantsAdjusted" nillable="true" xbrli:periodType="instant" type="dtr-types:perShareItemType" substitutionGroup="xbrli:item" />
    <element id="STSS_PaymentsForRepurchaseOfLiability" name="PaymentsForRepurchaseOfLiability" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="STSS_DescriptionForOfferingShares" name="DescriptionForOfferingShares" nillable="true" xbrli:periodType="duration" type="xbrli:stringItemType" substitutionGroup="xbrli:item" />
    <element id="STSS_FairValueAdjustmentOfModificationCharge" name="FairValueAdjustmentOfModificationCharge" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="STSS_ClassOfWarrantOrRightIssued" name="ClassOfWarrantOrRightIssued" nillable="true" xbrli:periodType="instant" type="xbrli:sharesItemType" substitutionGroup="xbrli:item" />
    <element id="STSS_WarrantLiability" name="WarrantLiability" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="STSS_ClassOfWarrantsOrRightOutstanding" name="ClassOfWarrantsOrRightOutstanding" nillable="true" xbrli:periodType="instant" type="xbrli:sharesItemType" substitutionGroup="xbrli:item" />
    <element id="STSS_GainLossOnSaleOfDerivative" name="GainLossOnSaleOfDerivative" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="STSS_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionOutstandingNumber" name="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionOutstandingNumber" nillable="true" xbrli:periodType="instant" type="xbrli:sharesItemType" substitutionGroup="xbrli:item" />
    <element id="STSS_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionOutstandingWeightedAverageExercisePrice" name="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionOutstandingWeightedAverageExercisePrice" nillable="true" xbrli:periodType="instant" type="dtr-types:perShareItemType" substitutionGroup="xbrli:item" />
    <element id="STSS_ShareBasedCompensationOptionsExercisableWeightedAverageExercisePrice" name="ShareBasedCompensationOptionsExercisableWeightedAverageExercisePrice" nillable="true" xbrli:periodType="instant" type="dtr-types:perShareItemType" substitutionGroup="xbrli:item" />
    <element id="STSS_StockBasedChargesRelatingToPurchaseOfMachinery" name="StockBasedChargesRelatingToPurchaseOfMachinery" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="STSS_StockBasedChargesRelatingToAcquisition" name="StockBasedChargesRelatingToAcquisition" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="STSS_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantedInYear" name="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantedInYear" nillable="true" xbrli:periodType="duration" type="xbrli:durationItemType" substitutionGroup="xbrli:item" />
    <element id="STSS_DeferredTaxAssetsPropertyPlantAndEquipments" name="DeferredTaxAssetsPropertyPlantAndEquipments" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="STSS_OrderCostsToPurchaseEquipmentMoldsAndComponentPartsForResearchAndDevelopment" name="OrderCostsToPurchaseEquipmentMoldsAndComponentPartsForResearchAndDevelopment" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="STSS_ProgressPayments" name="ProgressPayments" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="STSS_RoyaltyPercentage" name="RoyaltyPercentage" nillable="true" xbrli:periodType="duration" type="dtr-types:percentItemType" substitutionGroup="xbrli:item" />
    <element id="STSS_SinglePaymentObligation" name="SinglePaymentObligation" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="STSS_PaymentForBonuses" name="PaymentForBonuses" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="STSS_MedicalBenefitsCost" name="MedicalBenefitsCost" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="STSS_AnnualCompensation" name="AnnualCompensation" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="STSS_InitialFee" name="InitialFee" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="STSS_MonthlyFee" name="MonthlyFee" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="STSS_ValueOfDigitalMarketingActivities" name="ValueOfDigitalMarketingActivities" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
</schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.CAL
<SEQUENCE>22
<FILENAME>stss-20240930_cal.xml
<DESCRIPTION>XBRL CALCULATION FILE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" standalone="no"?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoFiler Complete; Version: 5.25a -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: https://www.novaworks.com -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x00000000 -->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
    <link:roleRef roleURI="http://sharpstechnology.com/role/Cover" xlink:href="stss-20240930.xsd#Cover" xlink:type="simple" />
    <link:roleRef roleURI="http://sharpstechnology.com/role/BalanceSheets" xlink:href="stss-20240930.xsd#BalanceSheets" xlink:type="simple" />
    <link:roleRef roleURI="http://sharpstechnology.com/role/BalanceSheetsParenthetical" xlink:href="stss-20240930.xsd#BalanceSheetsParenthetical" xlink:type="simple" />
    <link:roleRef roleURI="http://sharpstechnology.com/role/StatementsOfOperations" xlink:href="stss-20240930.xsd#StatementsOfOperations" xlink:type="simple" />
    <link:roleRef roleURI="http://sharpstechnology.com/role/StatementsOfComprehensiveLoss" xlink:href="stss-20240930.xsd#StatementsOfComprehensiveLoss" xlink:type="simple" />
    <link:roleRef roleURI="http://sharpstechnology.com/role/StatementOfStockholdersEquity" xlink:href="stss-20240930.xsd#StatementOfStockholdersEquity" xlink:type="simple" />
    <link:roleRef roleURI="http://sharpstechnology.com/role/StatementsOfCashFlows" xlink:href="stss-20240930.xsd#StatementsOfCashFlows" xlink:type="simple" />
    <link:roleRef roleURI="http://sharpstechnology.com/role/DescriptionOfBusiness" xlink:href="stss-20240930.xsd#DescriptionOfBusiness" xlink:type="simple" />
    <link:roleRef roleURI="http://sharpstechnology.com/role/SummaryOfSignificantAccountingPolicies" xlink:href="stss-20240930.xsd#SummaryOfSignificantAccountingPolicies" xlink:type="simple" />
    <link:roleRef roleURI="http://sharpstechnology.com/role/Inventories" xlink:href="stss-20240930.xsd#Inventories" xlink:type="simple" />
    <link:roleRef roleURI="http://sharpstechnology.com/role/FixedAssets" xlink:href="stss-20240930.xsd#FixedAssets" xlink:type="simple" />
    <link:roleRef roleURI="http://sharpstechnology.com/role/AssetAcquisition" xlink:href="stss-20240930.xsd#AssetAcquisition" xlink:type="simple" />
    <link:roleRef roleURI="http://sharpstechnology.com/role/OtherAssets" xlink:href="stss-20240930.xsd#OtherAssets" xlink:type="simple" />
    <link:roleRef roleURI="http://sharpstechnology.com/role/DebtFinancing" xlink:href="stss-20240930.xsd#DebtFinancing" xlink:type="simple" />
    <link:roleRef roleURI="http://sharpstechnology.com/role/NotePurchaseAgreement" xlink:href="stss-20240930.xsd#NotePurchaseAgreement" xlink:type="simple" />
    <link:roleRef roleURI="http://sharpstechnology.com/role/StockholdersEquity" xlink:href="stss-20240930.xsd#StockholdersEquity" xlink:type="simple" />
    <link:roleRef roleURI="http://sharpstechnology.com/role/PreferredStock" xlink:href="stss-20240930.xsd#PreferredStock" xlink:type="simple" />
    <link:roleRef roleURI="http://sharpstechnology.com/role/WarrantLiability" xlink:href="stss-20240930.xsd#WarrantLiability" xlink:type="simple" />
    <link:roleRef roleURI="http://sharpstechnology.com/role/StockOptions" xlink:href="stss-20240930.xsd#StockOptions" xlink:type="simple" />
    <link:roleRef roleURI="http://sharpstechnology.com/role/IncomeTaxes" xlink:href="stss-20240930.xsd#IncomeTaxes" xlink:type="simple" />
    <link:roleRef roleURI="http://sharpstechnology.com/role/RelatedPartyTransactionsAndBalances" xlink:href="stss-20240930.xsd#RelatedPartyTransactionsAndBalances" xlink:type="simple" />
    <link:roleRef roleURI="http://sharpstechnology.com/role/FairValueMeasurements" xlink:href="stss-20240930.xsd#FairValueMeasurements" xlink:type="simple" />
    <link:roleRef roleURI="http://sharpstechnology.com/role/CommitmentsAndContingencies" xlink:href="stss-20240930.xsd#CommitmentsAndContingencies" xlink:type="simple" />
    <link:roleRef roleURI="http://sharpstechnology.com/role/SubsequentEvents" xlink:href="stss-20240930.xsd#SubsequentEvents" xlink:type="simple" />
    <link:roleRef roleURI="http://sharpstechnology.com/role/SummaryOfSignificantAccountingPoliciesPolicies" xlink:href="stss-20240930.xsd#SummaryOfSignificantAccountingPoliciesPolicies" xlink:type="simple" />
    <link:roleRef roleURI="http://sharpstechnology.com/role/InventoriesTables" xlink:href="stss-20240930.xsd#InventoriesTables" xlink:type="simple" />
    <link:roleRef roleURI="http://sharpstechnology.com/role/FixedAssetsTables" xlink:href="stss-20240930.xsd#FixedAssetsTables" xlink:type="simple" />
    <link:roleRef roleURI="http://sharpstechnology.com/role/AssetAcquisitionTables" xlink:href="stss-20240930.xsd#AssetAcquisitionTables" xlink:type="simple" />
    <link:roleRef roleURI="http://sharpstechnology.com/role/OtherAssetsTables" xlink:href="stss-20240930.xsd#OtherAssetsTables" xlink:type="simple" />
    <link:roleRef roleURI="http://sharpstechnology.com/role/WarrantLiabilityTables" xlink:href="stss-20240930.xsd#WarrantLiabilityTables" xlink:type="simple" />
    <link:roleRef roleURI="http://sharpstechnology.com/role/StockOptionsTables" xlink:href="stss-20240930.xsd#StockOptionsTables" xlink:type="simple" />
    <link:roleRef roleURI="http://sharpstechnology.com/role/IncomeTaxesTables" xlink:href="stss-20240930.xsd#IncomeTaxesTables" xlink:type="simple" />
    <link:roleRef roleURI="http://sharpstechnology.com/role/FairValueMeasurementsTables" xlink:href="stss-20240930.xsd#FairValueMeasurementsTables" xlink:type="simple" />
    <link:roleRef roleURI="http://sharpstechnology.com/role/DescriptionOfBusinessDetailsNarrative" xlink:href="stss-20240930.xsd#DescriptionOfBusinessDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://sharpstechnology.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative" xlink:href="stss-20240930.xsd#SummaryOfSignificantAccountingPoliciesDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://sharpstechnology.com/role/ScheduleOfInventoriesDetails" xlink:href="stss-20240930.xsd#ScheduleOfInventoriesDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://sharpstechnology.com/role/ScheduleOfPropertyPlantAndEquipmentDetails" xlink:href="stss-20240930.xsd#ScheduleOfPropertyPlantAndEquipmentDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://sharpstechnology.com/role/FixedAssetsDetailsNarrative" xlink:href="stss-20240930.xsd#FixedAssetsDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://sharpstechnology.com/role/ScheduleOfFairValueOfAssetsAcquisitionDetails" xlink:href="stss-20240930.xsd#ScheduleOfFairValueOfAssetsAcquisitionDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://sharpstechnology.com/role/AssetAcquisitionDetailsNarrative" xlink:href="stss-20240930.xsd#AssetAcquisitionDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://sharpstechnology.com/role/ScheduleOfOtherAssetsDetails" xlink:href="stss-20240930.xsd#ScheduleOfOtherAssetsDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://sharpstechnology.com/role/OtherAssetsDetailsNarrative" xlink:href="stss-20240930.xsd#OtherAssetsDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://sharpstechnology.com/role/DebtFinancingDetailsNarrative" xlink:href="stss-20240930.xsd#DebtFinancingDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://sharpstechnology.com/role/NotePurchaseAgreementDetailsNarrative" xlink:href="stss-20240930.xsd#NotePurchaseAgreementDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://sharpstechnology.com/role/StockholdersEquityDetailsNarrative" xlink:href="stss-20240930.xsd#StockholdersEquityDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://sharpstechnology.com/role/PreferredStockDetailsNarrative" xlink:href="stss-20240930.xsd#PreferredStockDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://sharpstechnology.com/role/ScheduleOfFairValueOfWarrantDetails" xlink:href="stss-20240930.xsd#ScheduleOfFairValueOfWarrantDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://sharpstechnology.com/role/ScheduleOfWarrantLiabilityDetails" xlink:href="stss-20240930.xsd#ScheduleOfWarrantLiabilityDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://sharpstechnology.com/role/ScheduleOfWarrantOutstandingDetails" xlink:href="stss-20240930.xsd#ScheduleOfWarrantOutstandingDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://sharpstechnology.com/role/WarrantLiabilityDetailsNarrative" xlink:href="stss-20240930.xsd#WarrantLiabilityDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://sharpstechnology.com/role/ScheduleOfStockOptionsGrantedAndOutstandingDetails" xlink:href="stss-20240930.xsd#ScheduleOfStockOptionsGrantedAndOutstandingDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://sharpstechnology.com/role/ScheduleOfInformationAboutOptionsOutstandingDetails" xlink:href="stss-20240930.xsd#ScheduleOfInformationAboutOptionsOutstandingDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://sharpstechnology.com/role/ScheduleOfFairValueOfStockOptionAwardsDetails" xlink:href="stss-20240930.xsd#ScheduleOfFairValueOfStockOptionAwardsDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://sharpstechnology.com/role/StockOptionsDetailsNarrative" xlink:href="stss-20240930.xsd#StockOptionsDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://sharpstechnology.com/role/ScheduleOfReconciliationOfFederalStatutoryRateToTotalEffectiveRateDetails" xlink:href="stss-20240930.xsd#ScheduleOfReconciliationOfFederalStatutoryRateToTotalEffectiveRateDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://sharpstechnology.com/role/ScheduleOfComponentsOfDeferredTaxAssetsDetails" xlink:href="stss-20240930.xsd#ScheduleOfComponentsOfDeferredTaxAssetsDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://sharpstechnology.com/role/ScheduleOfGeographicalComponentsOfLossBeforeIncomeTaxesDetails" xlink:href="stss-20240930.xsd#ScheduleOfGeographicalComponentsOfLossBeforeIncomeTaxesDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://sharpstechnology.com/role/IncomeTaxesDetailsNarrative" xlink:href="stss-20240930.xsd#IncomeTaxesDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://sharpstechnology.com/role/RelatedPartyTransactionsAndBalancesDetailsNarrative" xlink:href="stss-20240930.xsd#RelatedPartyTransactionsAndBalancesDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://sharpstechnology.com/role/ScheduleOfAssetsAndLiabilitiesMeasuredAtFairValueOnRecurringBasisDetails" xlink:href="stss-20240930.xsd#ScheduleOfAssetsAndLiabilitiesMeasuredAtFairValueOnRecurringBasisDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://sharpstechnology.com/role/CommitmentsAndContingenciesDetailsNarrative" xlink:href="stss-20240930.xsd#CommitmentsAndContingenciesDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://sharpstechnology.com/role/ScheduleOfFixedAssetsNetDetails" xlink:href="stss-20240930.xsd#ScheduleOfFixedAssetsNetDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://sharpstechnology.com/role/ScheduleOfFairValueOfAssetsAcquisitionDetailsDisclosure" xlink:href="stss-20240930.xsd#ScheduleOfFairValueOfAssetsAcquisitionDetailsDisclosure" xlink:type="simple" />
    <link:roleRef roleURI="http://sharpstechnology.com/role/SubsequentEventsDetailsNarrative" xlink:href="stss-20240930.xsd#SubsequentEventsDetailsNarrative" xlink:type="simple" />
    <link:calculationLink xlink:type="extended" xlink:role="http://sharpstechnology.com/role/Cover" xlink:title="00000001 - Document - Cover" />
    <link:calculationLink xlink:type="extended" xlink:role="http://sharpstechnology.com/role/BalanceSheets" xlink:title="00000002 - Statement - Condensed Consolidated Balance Sheets">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AssetsCurrent" xlink:label="loc_us-gaapAssetsCurrent" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:label="loc_us-gaapCashAndCashEquivalentsAtCarryingValue" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAssetsCurrent" xlink:to="loc_us-gaapCashAndCashEquivalentsAtCarryingValue" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:label="loc_us-gaapPrepaidExpenseAndOtherAssetsCurrent" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAssetsCurrent" xlink:to="loc_us-gaapPrepaidExpenseAndOtherAssetsCurrent" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_InventoryNet" xlink:label="loc_us-gaapInventoryNet" />
      <link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAssetsCurrent" xlink:to="loc_us-gaapInventoryNet" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_Assets" xlink:label="loc_us-gaapAssets" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAssets" xlink:to="loc_us-gaapAssetsCurrent" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentNet" xlink:label="loc_us-gaapPropertyPlantAndEquipmentNet" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAssets" xlink:to="loc_us-gaapPropertyPlantAndEquipmentNet" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherAssetsNoncurrent" xlink:label="loc_us-gaapOtherAssetsNoncurrent" />
      <link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAssets" xlink:to="loc_us-gaapOtherAssetsNoncurrent" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LiabilitiesCurrent" xlink:label="loc_us-gaapLiabilitiesCurrent" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccountsPayableCurrent" xlink:label="loc_us-gaapAccountsPayableCurrent" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilitiesCurrent" xlink:to="loc_us-gaapAccountsPayableCurrent" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccountsPayableAndOtherAccruedLiabilitiesCurrent" xlink:label="loc_us-gaapAccountsPayableAndOtherAccruedLiabilitiesCurrent" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilitiesCurrent" xlink:to="loc_us-gaapAccountsPayableAndOtherAccruedLiabilitiesCurrent" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NotesPayableCurrent" xlink:label="loc_us-gaapNotesPayableCurrent" />
      <link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilitiesCurrent" xlink:to="loc_us-gaapNotesPayableCurrent" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="stss-20240930.xsd#STSS_WarrantLiabilitiesCurrent" xlink:label="loc_STSSWarrantLiabilitiesCurrent" />
      <link:calculationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilitiesCurrent" xlink:to="loc_STSSWarrantLiabilitiesCurrent" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_Liabilities" xlink:label="loc_us-gaapLiabilities" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilities" xlink:to="loc_us-gaapLiabilitiesCurrent" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredIncomeTaxLiabilitiesNet" xlink:label="loc_us-gaapDeferredIncomeTaxLiabilitiesNet" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilities" xlink:to="loc_us-gaapDeferredIncomeTaxLiabilitiesNet" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockholdersEquity" xlink:label="loc_us-gaapStockholdersEquity" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PreferredStockValue" xlink:label="loc_us-gaapPreferredStockValue" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapStockholdersEquity" xlink:to="loc_us-gaapPreferredStockValue" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockValue" xlink:label="loc_us-gaapCommonStockValue" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapStockholdersEquity" xlink:to="loc_us-gaapCommonStockValue" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="stss-20240930.xsd#STSS_CommonStockReverseSplitValue" xlink:label="loc_STSSCommonStockReverseSplitValue" />
      <link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapStockholdersEquity" xlink:to="loc_STSSCommonStockReverseSplitValue" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AdditionalPaidInCapital" xlink:label="loc_us-gaapAdditionalPaidInCapital" />
      <link:calculationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapStockholdersEquity" xlink:to="loc_us-gaapAdditionalPaidInCapital" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:label="loc_us-gaapAccumulatedOtherComprehensiveIncomeLossNetOfTax" />
      <link:calculationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapStockholdersEquity" xlink:to="loc_us-gaapAccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RetainedEarningsAccumulatedDeficit" xlink:label="loc_us-gaapRetainedEarningsAccumulatedDeficit" />
      <link:calculationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapStockholdersEquity" xlink:to="loc_us-gaapRetainedEarningsAccumulatedDeficit" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LiabilitiesAndStockholdersEquity" xlink:label="loc_us-gaapLiabilitiesAndStockholdersEquity" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilitiesAndStockholdersEquity" xlink:to="loc_us-gaapLiabilities" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommitmentsAndContingencies" xlink:label="loc_us-gaapCommitmentsAndContingencies" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilitiesAndStockholdersEquity" xlink:to="loc_us-gaapCommitmentsAndContingencies" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="stss-20240930.xsd#STSS_SubsequentEvents" xlink:label="loc_STSSSubsequentEvents" />
      <link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilitiesAndStockholdersEquity" xlink:to="loc_STSSSubsequentEvents" xlink:type="arc" weight="1" />
      <link:calculationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilitiesAndStockholdersEquity" xlink:to="loc_us-gaapStockholdersEquity" xlink:type="arc" weight="1" />
    </link:calculationLink>
    <link:calculationLink xlink:type="extended" xlink:role="http://sharpstechnology.com/role/BalanceSheetsParenthetical" xlink:title="00000003 - Statement - Condensed Consolidated Balance Sheets (Parenthetical)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://sharpstechnology.com/role/StatementsOfOperations" xlink:title="00000004 - Statement - Condensed Consolidated Statements of Operations">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingExpenses" xlink:label="loc_us-gaapOperatingExpenses" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ResearchAndDevelopmentExpense" xlink:label="loc_us-gaapResearchAndDevelopmentExpense" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapOperatingExpenses" xlink:to="loc_us-gaapResearchAndDevelopmentExpense" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_GeneralAndAdministrativeExpense" xlink:label="loc_us-gaapGeneralAndAdministrativeExpense" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapOperatingExpenses" xlink:to="loc_us-gaapGeneralAndAdministrativeExpense" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingIncomeLoss" xlink:label="loc_us-gaapOperatingIncomeLoss" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:label="loc_us-gaapRevenueFromContractWithCustomerExcludingAssessedTax" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapOperatingIncomeLoss" xlink:to="loc_us-gaapRevenueFromContractWithCustomerExcludingAssessedTax" xlink:type="arc" weight="1" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapOperatingIncomeLoss" xlink:to="loc_us-gaapOperatingExpenses" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NonoperatingIncomeExpense" xlink:label="loc_us-gaapNonoperatingIncomeExpense" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_InterestIncomeExpenseNet" xlink:label="loc_us-gaapInterestIncomeExpenseNet" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNonoperatingIncomeExpense" xlink:to="loc_us-gaapInterestIncomeExpenseNet" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherNonoperatingIncomeExpense" xlink:label="loc_us-gaapOtherNonoperatingIncomeExpense" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNonoperatingIncomeExpense" xlink:to="loc_us-gaapOtherNonoperatingIncomeExpense" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="stss-20240930.xsd#STSS_FairMarketValueAdjustmentForContingentStockAndWarrants" xlink:label="loc_STSSFairMarketValueAdjustmentForContingentStockAndWarrants" />
      <link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNonoperatingIncomeExpense" xlink:to="loc_STSSFairMarketValueAdjustmentForContingentStockAndWarrants" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_GainLossOnSaleOfDerivatives" xlink:label="loc_us-gaapGainLossOnSaleOfDerivatives" />
      <link:calculationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNonoperatingIncomeExpense" xlink:to="loc_us-gaapGainLossOnSaleOfDerivatives" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="stss-20240930.xsd#STSS_FairMarketValueAdjustmentForContingentWarrantsAndWarrants" xlink:label="loc_STSSFairMarketValueAdjustmentForContingentWarrantsAndWarrants" />
      <link:calculationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNonoperatingIncomeExpense" xlink:to="loc_STSSFairMarketValueAdjustmentForContingentWarrantsAndWarrants" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="stss-20240930.xsd#STSS_ForeignCurrencyAndNonOperatingIncomeExpenses" xlink:label="loc_STSSForeignCurrencyAndNonOperatingIncomeExpenses" />
      <link:calculationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNonoperatingIncomeExpense" xlink:to="loc_STSSForeignCurrencyAndNonOperatingIncomeExpenses" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:label="loc_us-gaapIncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapIncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:to="loc_us-gaapOperatingIncomeLoss" xlink:type="arc" weight="1" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapIncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:to="loc_us-gaapNonoperatingIncomeExpense" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetIncomeLoss" xlink:label="loc_us-gaapNetIncomeLoss" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetIncomeLoss" xlink:to="loc_us-gaapIncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredIncomeTaxExpenseBenefit" xlink:label="loc_us-gaapDeferredIncomeTaxExpenseBenefit" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetIncomeLoss" xlink:to="loc_us-gaapDeferredIncomeTaxExpenseBenefit" xlink:type="arc" weight="-1" />
    </link:calculationLink>
    <link:calculationLink xlink:type="extended" xlink:role="http://sharpstechnology.com/role/StatementsOfComprehensiveLoss" xlink:title="00000005 - Statement - Condensed Consolidated Statements of Comprehensive Loss">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ComprehensiveIncomeNetOfTax" xlink:label="loc_us-gaapComprehensiveIncomeNetOfTax" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetIncomeLoss" xlink:label="loc_us-gaapNetIncomeLoss" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapComprehensiveIncomeNetOfTax" xlink:to="loc_us-gaapNetIncomeLoss" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent" xlink:label="loc_us-gaapOtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapComprehensiveIncomeNetOfTax" xlink:to="loc_us-gaapOtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent" xlink:type="arc" weight="1" />
    </link:calculationLink>
    <link:calculationLink xlink:type="extended" xlink:role="http://sharpstechnology.com/role/StatementOfStockholdersEquity" xlink:title="00000006 - Statement - Condensed Consolidated Statement of Stockholders&apos; Equity" />
    <link:calculationLink xlink:type="extended" xlink:role="http://sharpstechnology.com/role/StatementsOfCashFlows" xlink:title="00000007 - Statement - Condensed Consolidated Statements of Cash Flows">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:label="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetIncomeLoss" xlink:label="loc_us-gaapNetIncomeLoss" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_us-gaapNetIncomeLoss" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DepreciationAndAmortization" xlink:label="loc_us-gaapDepreciationAndAmortization" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_us-gaapDepreciationAndAmortization" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensation" xlink:label="loc_us-gaapShareBasedCompensation" />
      <link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_us-gaapShareBasedCompensation" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IssuanceOfStockAndWarrantsForServicesOrClaims" xlink:label="loc_us-gaapIssuanceOfStockAndWarrantsForServicesOrClaims" />
      <link:calculationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_us-gaapIssuanceOfStockAndWarrantsForServicesOrClaims" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AmortizationOfDebtDiscountPremium" xlink:label="loc_us-gaapAmortizationOfDebtDiscountPremium" />
      <link:calculationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_us-gaapAmortizationOfDebtDiscountPremium" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_GainLossOnSaleOfDerivatives" xlink:label="loc_us-gaapGainLossOnSaleOfDerivatives" />
      <link:calculationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_us-gaapGainLossOnSaleOfDerivatives" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AmortizationOfFinancingCosts" xlink:label="loc_us-gaapAmortizationOfFinancingCosts" />
      <link:calculationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_us-gaapAmortizationOfFinancingCosts" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="stss-20240930.xsd#STSS_EscrowDepositForfeited" xlink:label="loc_STSSEscrowDepositForfeited" />
      <link:calculationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_STSSEscrowDepositForfeited" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="stss-20240930.xsd#STSS_FairMarketValueAdjustmentForContingentWarrants" xlink:label="loc_STSSFairMarketValueAdjustmentForContingentWarrants" />
      <link:calculationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_STSSFairMarketValueAdjustmentForContingentWarrants" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="stss-20240930.xsd#STSS_FairMarketValueAdjustmentForContingentWarrantsAndWarrants" xlink:label="loc_STSSFairMarketValueAdjustmentForContingentWarrantsAndWarrants" />
      <link:calculationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_STSSFairMarketValueAdjustmentForContingentWarrantsAndWarrants" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ImpairmentOfLongLivedAssetsHeldForUse" xlink:label="loc_us-gaapImpairmentOfLongLivedAssetsHeldForUse" />
      <link:calculationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_us-gaapImpairmentOfLongLivedAssetsHeldForUse" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredIncomeTaxExpenseBenefit" xlink:label="loc_us-gaapDeferredIncomeTaxExpenseBenefit" />
      <link:calculationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_us-gaapDeferredIncomeTaxExpenseBenefit" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="stss-20240930.xsd#STSS_IpoIssuanceCostsRelatingToWarrants" xlink:label="loc_STSSIpoIssuanceCostsRelatingToWarrants" />
      <link:calculationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_STSSIpoIssuanceCostsRelatingToWarrants" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ForeignCurrencyTransactionGainLossBeforeTax" xlink:label="loc_us-gaapForeignCurrencyTransactionGainLossBeforeTax" />
      <link:calculationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_us-gaapForeignCurrencyTransactionGainLossBeforeTax" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncreaseDecreaseInPrepaidExpense" xlink:label="loc_us-gaapIncreaseDecreaseInPrepaidExpense" />
      <link:calculationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_us-gaapIncreaseDecreaseInPrepaidExpense" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncreaseDecreaseInInventories" xlink:label="loc_us-gaapIncreaseDecreaseInInventories" />
      <link:calculationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_us-gaapIncreaseDecreaseInInventories" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncreaseDecreaseInOtherOperatingAssets" xlink:label="loc_us-gaapIncreaseDecreaseInOtherOperatingAssets" />
      <link:calculationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_us-gaapIncreaseDecreaseInOtherOperatingAssets" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" xlink:label="loc_us-gaapIncreaseDecreaseInAccountsPayableAndAccruedLiabilities" />
      <link:calculationArc order="18" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_us-gaapIncreaseDecreaseInAccountsPayableAndAccruedLiabilities" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:label="loc_us-gaapNetCashProvidedByUsedInInvestingActivities" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PaymentsForProceedsFromOtherInvestingActivities" xlink:label="loc_us-gaapPaymentsForProceedsFromOtherInvestingActivities" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInInvestingActivities" xlink:to="loc_us-gaapPaymentsForProceedsFromOtherInvestingActivities" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="stss-20240930.xsd#STSS_EscrowPaymentUnderAgreement" xlink:label="loc_STSSEscrowPaymentUnderAgreement" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInInvestingActivities" xlink:to="loc_STSSEscrowPaymentUnderAgreement" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:label="loc_us-gaapPaymentsToAcquirePropertyPlantAndEquipment" />
      <link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInInvestingActivities" xlink:to="loc_us-gaapPaymentsToAcquirePropertyPlantAndEquipment" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="stss-20240930.xsd#STSS_PaymentsToAssetAcquisition" xlink:label="loc_STSSPaymentsToAssetAcquisition" />
      <link:calculationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInInvestingActivities" xlink:to="loc_STSSPaymentsToAssetAcquisition" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:label="loc_us-gaapNetCashProvidedByUsedInFinancingActivities" />
      <link:loc xlink:type="locator" xlink:href="stss-20240930.xsd#STSS_NetProceedsFromInitialPublicOfferingAndAdditionalOffering" xlink:label="loc_STSSNetProceedsFromInitialPublicOfferingAndAdditionalOffering" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInFinancingActivities" xlink:to="loc_STSSNetProceedsFromInitialPublicOfferingAndAdditionalOffering" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="stss-20240930.xsd#STSS_NetProceedsFromOfferingsAndWarrantExercises" xlink:label="loc_STSSNetProceedsFromOfferingsAndWarrantExercises" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInFinancingActivities" xlink:to="loc_STSSNetProceedsFromOfferingsAndWarrantExercises" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ProceedsFromIssuanceOfLongTermDebt" xlink:label="loc_us-gaapProceedsFromIssuanceOfLongTermDebt" />
      <link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInFinancingActivities" xlink:to="loc_us-gaapProceedsFromIssuanceOfLongTermDebt" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RepaymentsOfNotesPayable" xlink:label="loc_us-gaapRepaymentsOfNotesPayable" />
      <link:calculationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInFinancingActivities" xlink:to="loc_us-gaapRepaymentsOfNotesPayable" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="stss-20240930.xsd#STSS_ProceedsFromSubscriptionsReceivable" xlink:label="loc_STSSProceedsFromSubscriptionsReceivable" />
      <link:calculationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInFinancingActivities" xlink:to="loc_STSSProceedsFromSubscriptionsReceivable" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:label="loc_us-gaapCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:to="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:type="arc" weight="1" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:to="loc_us-gaapNetCashProvidedByUsedInInvestingActivities" xlink:type="arc" weight="1" />
      <link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:to="loc_us-gaapNetCashProvidedByUsedInFinancingActivities" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations" xlink:label="loc_us-gaapEffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations" />
      <link:calculationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:to="loc_us-gaapEffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations" xlink:type="arc" weight="1" />
    </link:calculationLink>
    <link:calculationLink xlink:type="extended" xlink:role="http://sharpstechnology.com/role/DescriptionOfBusiness" xlink:title="00000008 - Disclosure - Description of Business" />
    <link:calculationLink xlink:type="extended" xlink:role="http://sharpstechnology.com/role/SummaryOfSignificantAccountingPolicies" xlink:title="00000009 - Disclosure - Summary of Significant Accounting Policies" />
    <link:calculationLink xlink:type="extended" xlink:role="http://sharpstechnology.com/role/Inventories" xlink:title="00000010 - Disclosure - Inventories" />
    <link:calculationLink xlink:type="extended" xlink:role="http://sharpstechnology.com/role/FixedAssets" xlink:title="00000011 - Disclosure - Fixed Assets" />
    <link:calculationLink xlink:type="extended" xlink:role="http://sharpstechnology.com/role/AssetAcquisition" xlink:title="00000012 - Disclosure - Asset Acquisition" />
    <link:calculationLink xlink:type="extended" xlink:role="http://sharpstechnology.com/role/OtherAssets" xlink:title="00000013 - Disclosure - Other Assets" />
    <link:calculationLink xlink:type="extended" xlink:role="http://sharpstechnology.com/role/DebtFinancing" xlink:title="00000014 - Disclosure - Debt Financing" />
    <link:calculationLink xlink:type="extended" xlink:role="http://sharpstechnology.com/role/NotePurchaseAgreement" xlink:title="00000015 - Disclosure - Note Purchase Agreement" />
    <link:calculationLink xlink:type="extended" xlink:role="http://sharpstechnology.com/role/StockholdersEquity" xlink:title="00000016 - Disclosure - Stockholders&#8217; Equity" />
    <link:calculationLink xlink:type="extended" xlink:role="http://sharpstechnology.com/role/PreferredStock" xlink:title="00000017 - Disclosure - Preferred Stock" />
    <link:calculationLink xlink:type="extended" xlink:role="http://sharpstechnology.com/role/WarrantLiability" xlink:title="00000018 - Disclosure - Warrant Liability" />
    <link:calculationLink xlink:type="extended" xlink:role="http://sharpstechnology.com/role/StockOptions" xlink:title="00000019 - Disclosure - Stock Options" />
    <link:calculationLink xlink:type="extended" xlink:role="http://sharpstechnology.com/role/IncomeTaxes" xlink:title="00000020 - Disclosure - Income Taxes" />
    <link:calculationLink xlink:type="extended" xlink:role="http://sharpstechnology.com/role/RelatedPartyTransactionsAndBalances" xlink:title="00000021 - Disclosure - Related Party Transactions and Balances" />
    <link:calculationLink xlink:type="extended" xlink:role="http://sharpstechnology.com/role/FairValueMeasurements" xlink:title="00000022 - Disclosure - Fair Value Measurements" />
    <link:calculationLink xlink:type="extended" xlink:role="http://sharpstechnology.com/role/CommitmentsAndContingencies" xlink:title="00000023 - Disclosure - Commitments and Contingencies" />
    <link:calculationLink xlink:type="extended" xlink:role="http://sharpstechnology.com/role/SubsequentEvents" xlink:title="00000024 - Disclosure - Subsequent Events" />
    <link:calculationLink xlink:type="extended" xlink:role="http://sharpstechnology.com/role/SummaryOfSignificantAccountingPoliciesPolicies" xlink:title="00000025 - Disclosure - Summary of Significant Accounting Policies (Policies)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://sharpstechnology.com/role/InventoriesTables" xlink:title="00000026 - Disclosure - Inventories (Tables)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://sharpstechnology.com/role/FixedAssetsTables" xlink:title="00000027 - Disclosure - Fixed Assets (Tables)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://sharpstechnology.com/role/AssetAcquisitionTables" xlink:title="00000028 - Disclosure - Asset Acquisition (Tables)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://sharpstechnology.com/role/OtherAssetsTables" xlink:title="00000029 - Disclosure - Other Assets (Tables)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://sharpstechnology.com/role/WarrantLiabilityTables" xlink:title="00000030 - Disclosure - Warrant Liability (Tables)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://sharpstechnology.com/role/StockOptionsTables" xlink:title="00000031 - Disclosure - Stock Options (Tables)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://sharpstechnology.com/role/IncomeTaxesTables" xlink:title="00000032 - Disclosure - Income Taxes (Tables)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://sharpstechnology.com/role/FairValueMeasurementsTables" xlink:title="00000033 - Disclosure - Fair Value Measurements (Tables)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://sharpstechnology.com/role/DescriptionOfBusinessDetailsNarrative" xlink:title="00000034 - Disclosure - Description of Business (Details Narrative)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://sharpstechnology.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative" xlink:title="00000035 - Disclosure - Summary of Significant Accounting Policies (Details Narrative)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://sharpstechnology.com/role/ScheduleOfInventoriesDetails" xlink:title="00000036 - Disclosure - Schedule of Inventories (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_InventoryNet" xlink:label="loc_us-gaapInventoryNet" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_InventoryRawMaterialsNetOfReserves" xlink:label="loc_us-gaapInventoryRawMaterialsNetOfReserves" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapInventoryNet" xlink:to="loc_us-gaapInventoryRawMaterialsNetOfReserves" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_InventoryWorkInProcessNetOfReserves" xlink:label="loc_us-gaapInventoryWorkInProcessNetOfReserves" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapInventoryNet" xlink:to="loc_us-gaapInventoryWorkInProcessNetOfReserves" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_InventoryFinishedGoodsNetOfReserves" xlink:label="loc_us-gaapInventoryFinishedGoodsNetOfReserves" />
      <link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapInventoryNet" xlink:to="loc_us-gaapInventoryFinishedGoodsNetOfReserves" xlink:type="arc" weight="1" />
    </link:calculationLink>
    <link:calculationLink xlink:type="extended" xlink:role="http://sharpstechnology.com/role/ScheduleOfPropertyPlantAndEquipmentDetails" xlink:title="00000037 - Disclosure - Schedule of Property, Plant and Equipment (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentNet" xlink:label="loc_us-gaapPropertyPlantAndEquipmentNet" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentGross" xlink:label="loc_us-gaapPropertyPlantAndEquipmentGross" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapPropertyPlantAndEquipmentNet" xlink:to="loc_us-gaapPropertyPlantAndEquipmentGross" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:label="loc_us-gaapAccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapPropertyPlantAndEquipmentNet" xlink:to="loc_us-gaapAccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:type="arc" weight="-1" />
    </link:calculationLink>
    <link:calculationLink xlink:type="extended" xlink:role="http://sharpstechnology.com/role/FixedAssetsDetailsNarrative" xlink:title="00000038 - Disclosure - Fixed Assets (Details Narrative)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://sharpstechnology.com/role/ScheduleOfFairValueOfAssetsAcquisitionDetails" xlink:title="00000039 - Disclosure - Schedule of Fair Value of the Assets Acquisition (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets" xlink:label="loc_us-gaapBusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLand" xlink:label="loc_us-gaapBusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLand" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapBusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets" xlink:to="loc_us-gaapBusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLand" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedBuildings" xlink:label="loc_us-gaapBusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedBuildings" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapBusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets" xlink:to="loc_us-gaapBusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedBuildings" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedEquipment" xlink:label="loc_us-gaapBusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedEquipment" />
      <link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapBusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets" xlink:to="loc_us-gaapBusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedEquipment" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory" xlink:label="loc_us-gaapBusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory" />
      <link:calculationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapBusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets" xlink:to="loc_us-gaapBusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles" xlink:label="loc_us-gaapBusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles" />
      <link:calculationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapBusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets" xlink:to="loc_us-gaapBusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities" xlink:label="loc_us-gaapBusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities" />
      <link:calculationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapBusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets" xlink:to="loc_us-gaapBusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment" xlink:label="loc_us-gaapBusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment" />
      <link:calculationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapBusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets" xlink:to="loc_us-gaapBusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment" xlink:type="arc" weight="1" />
    </link:calculationLink>
    <link:calculationLink xlink:type="extended" xlink:role="http://sharpstechnology.com/role/AssetAcquisitionDetailsNarrative" xlink:title="00000040 - Disclosure - Asset Acquisition (Details Narrative)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://sharpstechnology.com/role/ScheduleOfOtherAssetsDetails" xlink:title="00000041 - Disclosure - Schedule of Other Assets (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherAssetsNoncurrent" xlink:label="loc_us-gaapOtherAssetsNoncurrent" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:label="loc_us-gaapIntangibleAssetsNetExcludingGoodwill" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapOtherAssetsNoncurrent" xlink:to="loc_us-gaapIntangibleAssetsNetExcludingGoodwill" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DepositsAssets" xlink:label="loc_us-gaapDepositsAssets" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapOtherAssetsNoncurrent" xlink:to="loc_us-gaapDepositsAssets" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherAssetsMiscellaneousNoncurrent" xlink:label="loc_us-gaapOtherAssetsMiscellaneousNoncurrent" />
      <link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapOtherAssetsNoncurrent" xlink:to="loc_us-gaapOtherAssetsMiscellaneousNoncurrent" xlink:type="arc" weight="1" />
    </link:calculationLink>
    <link:calculationLink xlink:type="extended" xlink:role="http://sharpstechnology.com/role/OtherAssetsDetailsNarrative" xlink:title="00000042 - Disclosure - Other Assets (Details Narrative)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://sharpstechnology.com/role/DebtFinancingDetailsNarrative" xlink:title="00000043 - Disclosure - Debt Financing (Details Narrative)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://sharpstechnology.com/role/NotePurchaseAgreementDetailsNarrative" xlink:title="00000044 - Disclosure - Note Purchase Agreement (Details Narrative)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://sharpstechnology.com/role/StockholdersEquityDetailsNarrative" xlink:title="00000045 - Disclosure - Stockholders&#8217; Equity (Details Narrative)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://sharpstechnology.com/role/PreferredStockDetailsNarrative" xlink:title="00000046 - Disclosure - Preferred Stock (Details Narrative)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://sharpstechnology.com/role/ScheduleOfFairValueOfWarrantDetails" xlink:title="00000047 - Disclosure - Schedule of Fair Value of Warrant (Details)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://sharpstechnology.com/role/ScheduleOfWarrantLiabilityDetails" xlink:title="00000048 - Disclosure - Schedule of Warrant Liability (Details)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://sharpstechnology.com/role/ScheduleOfWarrantOutstandingDetails" xlink:title="00000049 - Disclosure - Schedule of Warrant Outstanding (Details)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://sharpstechnology.com/role/WarrantLiabilityDetailsNarrative" xlink:title="00000050 - Disclosure - Warrant Liability (Details Narrative)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://sharpstechnology.com/role/ScheduleOfStockOptionsGrantedAndOutstandingDetails" xlink:title="00000051 - Disclosure - Schedule of Stock Options Granted and Outstanding (Details)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://sharpstechnology.com/role/ScheduleOfInformationAboutOptionsOutstandingDetails" xlink:title="00000052 - Disclosure - Schedule of Information About Options Outstanding (Details)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://sharpstechnology.com/role/ScheduleOfFairValueOfStockOptionAwardsDetails" xlink:title="00000053 - Disclosure - Schedule of Fair Value of Stock Option Awards (Details)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://sharpstechnology.com/role/StockOptionsDetailsNarrative" xlink:title="00000054 - Disclosure - Stock Options (Details Narrative)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://sharpstechnology.com/role/ScheduleOfReconciliationOfFederalStatutoryRateToTotalEffectiveRateDetails" xlink:title="00000055 - Disclosure - Schedule of Reconciliation of Federal Statutory Rate to Total Effective Rate (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeTaxExpenseBenefit" xlink:label="loc_us-gaapIncomeTaxExpenseBenefit" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate" xlink:label="loc_us-gaapIncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapIncomeTaxExpenseBenefit" xlink:to="loc_us-gaapIncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeTaxReconciliationChangeInEnactedTaxRate" xlink:label="loc_us-gaapIncomeTaxReconciliationChangeInEnactedTaxRate" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapIncomeTaxExpenseBenefit" xlink:to="loc_us-gaapIncomeTaxReconciliationChangeInEnactedTaxRate" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes" xlink:label="loc_us-gaapIncomeTaxReconciliationStateAndLocalIncomeTaxes" />
      <link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapIncomeTaxExpenseBenefit" xlink:to="loc_us-gaapIncomeTaxReconciliationStateAndLocalIncomeTaxes" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeTaxReconciliationOtherAdjustments" xlink:label="loc_us-gaapIncomeTaxReconciliationOtherAdjustments" />
      <link:calculationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapIncomeTaxExpenseBenefit" xlink:to="loc_us-gaapIncomeTaxReconciliationOtherAdjustments" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance" xlink:label="loc_us-gaapIncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance" />
      <link:calculationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapIncomeTaxExpenseBenefit" xlink:to="loc_us-gaapIncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance" xlink:type="arc" weight="1" />
    </link:calculationLink>
    <link:calculationLink xlink:type="extended" xlink:role="http://sharpstechnology.com/role/ScheduleOfComponentsOfDeferredTaxAssetsDetails" xlink:title="00000056 - Disclosure - Schedule of Components of Deferred tax Assets (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredTaxLiabilities" xlink:label="loc_us-gaapDeferredTaxLiabilities" />
      <link:loc xlink:type="locator" xlink:href="stss-20240930.xsd#STSS_DeferredTaxAssetsPropertyPlantAndEquipments" xlink:label="loc_STSSDeferredTaxAssetsPropertyPlantAndEquipments" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapDeferredTaxLiabilities" xlink:to="loc_STSSDeferredTaxAssetsPropertyPlantAndEquipments" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredTaxAssetInterestCarryforward" xlink:label="loc_us-gaapDeferredTaxAssetInterestCarryforward" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapDeferredTaxLiabilities" xlink:to="loc_us-gaapDeferredTaxAssetInterestCarryforward" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredTaxAssetsInProcessResearchAndDevelopment" xlink:label="loc_us-gaapDeferredTaxAssetsInProcessResearchAndDevelopment" />
      <link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapDeferredTaxLiabilities" xlink:to="loc_us-gaapDeferredTaxAssetsInProcessResearchAndDevelopment" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost" xlink:label="loc_us-gaapDeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost" />
      <link:calculationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapDeferredTaxLiabilities" xlink:to="loc_us-gaapDeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredTaxAssetsCharitableContributionCarryforwards" xlink:label="loc_us-gaapDeferredTaxAssetsCharitableContributionCarryforwards" />
      <link:calculationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapDeferredTaxLiabilities" xlink:to="loc_us-gaapDeferredTaxAssetsCharitableContributionCarryforwards" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsDomestic" xlink:label="loc_us-gaapDeferredTaxAssetsOperatingLossCarryforwardsDomestic" />
      <link:calculationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapDeferredTaxLiabilities" xlink:to="loc_us-gaapDeferredTaxAssetsOperatingLossCarryforwardsDomestic" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsStateAndLocal" xlink:label="loc_us-gaapDeferredTaxAssetsOperatingLossCarryforwardsStateAndLocal" />
      <link:calculationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapDeferredTaxLiabilities" xlink:to="loc_us-gaapDeferredTaxAssetsOperatingLossCarryforwardsStateAndLocal" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsForeign" xlink:label="loc_us-gaapDeferredTaxAssetsOperatingLossCarryforwardsForeign" />
      <link:calculationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapDeferredTaxLiabilities" xlink:to="loc_us-gaapDeferredTaxAssetsOperatingLossCarryforwardsForeign" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsResearch" xlink:label="loc_us-gaapDeferredTaxAssetsTaxCreditCarryforwardsResearch" />
      <link:calculationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapDeferredTaxLiabilities" xlink:to="loc_us-gaapDeferredTaxAssetsTaxCreditCarryforwardsResearch" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredTaxAssetsValuationAllowance" xlink:label="loc_us-gaapDeferredTaxAssetsValuationAllowance" />
      <link:calculationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapDeferredTaxLiabilities" xlink:to="loc_us-gaapDeferredTaxAssetsValuationAllowance" xlink:type="arc" weight="1" />
    </link:calculationLink>
    <link:calculationLink xlink:type="extended" xlink:role="http://sharpstechnology.com/role/ScheduleOfGeographicalComponentsOfLossBeforeIncomeTaxesDetails" xlink:title="00000057 - Disclosure - Schedule of Geographical Components of Loss Before Income Taxes (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:label="loc_us-gaapIncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic" xlink:label="loc_us-gaapIncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapIncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:to="loc_us-gaapIncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign" xlink:label="loc_us-gaapIncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapIncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:to="loc_us-gaapIncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign" xlink:type="arc" weight="1" />
    </link:calculationLink>
    <link:calculationLink xlink:type="extended" xlink:role="http://sharpstechnology.com/role/IncomeTaxesDetailsNarrative" xlink:title="00000058 - Disclosure - Income Taxes (Details Narrative)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://sharpstechnology.com/role/RelatedPartyTransactionsAndBalancesDetailsNarrative" xlink:title="00000059 - Disclosure - Related Party Transactions and Balances (Details Narrative)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://sharpstechnology.com/role/ScheduleOfAssetsAndLiabilitiesMeasuredAtFairValueOnRecurringBasisDetails" xlink:title="00000060 - Disclosure - Schedule of Assets and Liabilities Measured at Fair Value on Recurring Basis (Details)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://sharpstechnology.com/role/CommitmentsAndContingenciesDetailsNarrative" xlink:title="00000061 - Disclosure - Commitments and Contingencies (Details Narrative)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://sharpstechnology.com/role/ScheduleOfFixedAssetsNetDetails" xlink:title="00000062 - Disclosure - Schedule of Fixed Assets, Net (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentNet" xlink:label="loc_us-gaapPropertyPlantAndEquipmentNet" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentGross" xlink:label="loc_us-gaapPropertyPlantAndEquipmentGross" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapPropertyPlantAndEquipmentNet" xlink:to="loc_us-gaapPropertyPlantAndEquipmentGross" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:label="loc_us-gaapAccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapPropertyPlantAndEquipmentNet" xlink:to="loc_us-gaapAccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:type="arc" weight="-1" />
    </link:calculationLink>
    <link:calculationLink xlink:type="extended" xlink:role="http://sharpstechnology.com/role/ScheduleOfFairValueOfAssetsAcquisitionDetailsDisclosure" xlink:title="00000063 - Disclosure - Schedule of Fair Value of Assets Acquisition (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets" xlink:label="loc_us-gaapBusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLand" xlink:label="loc_us-gaapBusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLand" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapBusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets" xlink:to="loc_us-gaapBusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLand" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedBuildings" xlink:label="loc_us-gaapBusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedBuildings" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapBusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets" xlink:to="loc_us-gaapBusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedBuildings" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedEquipment" xlink:label="loc_us-gaapBusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedEquipment" />
      <link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapBusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets" xlink:to="loc_us-gaapBusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedEquipment" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory" xlink:label="loc_us-gaapBusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory" />
      <link:calculationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapBusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets" xlink:to="loc_us-gaapBusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles" xlink:label="loc_us-gaapBusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles" />
      <link:calculationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapBusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets" xlink:to="loc_us-gaapBusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities" xlink:label="loc_us-gaapBusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities" />
      <link:calculationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapBusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets" xlink:to="loc_us-gaapBusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment" xlink:label="loc_us-gaapBusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment" />
      <link:calculationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapBusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets" xlink:to="loc_us-gaapBusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment" xlink:type="arc" weight="1" />
    </link:calculationLink>
    <link:calculationLink xlink:type="extended" xlink:role="http://sharpstechnology.com/role/SubsequentEventsDetailsNarrative" xlink:title="00000064 - Disclosure - Subsequent Events (Details Narrative)" />
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.DEF
<SEQUENCE>23
<FILENAME>stss-20240930_def.xml
<DESCRIPTION>XBRL DEFINITION FILE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" standalone="no"?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoFiler Complete; Version: 5.25a -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: https://www.novaworks.com -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x00000000 -->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:xbrli="http://www.xbrl.org/2003/instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
    <link:roleRef roleURI="http://sharpstechnology.com/role/Cover" xlink:href="stss-20240930.xsd#Cover" xlink:type="simple" />
    <link:roleRef roleURI="http://sharpstechnology.com/role/BalanceSheets" xlink:href="stss-20240930.xsd#BalanceSheets" xlink:type="simple" />
    <link:roleRef roleURI="http://sharpstechnology.com/role/BalanceSheetsParenthetical" xlink:href="stss-20240930.xsd#BalanceSheetsParenthetical" xlink:type="simple" />
    <link:roleRef roleURI="http://sharpstechnology.com/role/StatementsOfOperations" xlink:href="stss-20240930.xsd#StatementsOfOperations" xlink:type="simple" />
    <link:roleRef roleURI="http://sharpstechnology.com/role/StatementsOfComprehensiveLoss" xlink:href="stss-20240930.xsd#StatementsOfComprehensiveLoss" xlink:type="simple" />
    <link:roleRef roleURI="http://sharpstechnology.com/role/StatementOfStockholdersEquity" xlink:href="stss-20240930.xsd#StatementOfStockholdersEquity" xlink:type="simple" />
    <link:roleRef roleURI="http://sharpstechnology.com/role/StatementsOfCashFlows" xlink:href="stss-20240930.xsd#StatementsOfCashFlows" xlink:type="simple" />
    <link:roleRef roleURI="http://sharpstechnology.com/role/DescriptionOfBusiness" xlink:href="stss-20240930.xsd#DescriptionOfBusiness" xlink:type="simple" />
    <link:roleRef roleURI="http://sharpstechnology.com/role/SummaryOfSignificantAccountingPolicies" xlink:href="stss-20240930.xsd#SummaryOfSignificantAccountingPolicies" xlink:type="simple" />
    <link:roleRef roleURI="http://sharpstechnology.com/role/Inventories" xlink:href="stss-20240930.xsd#Inventories" xlink:type="simple" />
    <link:roleRef roleURI="http://sharpstechnology.com/role/FixedAssets" xlink:href="stss-20240930.xsd#FixedAssets" xlink:type="simple" />
    <link:roleRef roleURI="http://sharpstechnology.com/role/AssetAcquisition" xlink:href="stss-20240930.xsd#AssetAcquisition" xlink:type="simple" />
    <link:roleRef roleURI="http://sharpstechnology.com/role/OtherAssets" xlink:href="stss-20240930.xsd#OtherAssets" xlink:type="simple" />
    <link:roleRef roleURI="http://sharpstechnology.com/role/DebtFinancing" xlink:href="stss-20240930.xsd#DebtFinancing" xlink:type="simple" />
    <link:roleRef roleURI="http://sharpstechnology.com/role/NotePurchaseAgreement" xlink:href="stss-20240930.xsd#NotePurchaseAgreement" xlink:type="simple" />
    <link:roleRef roleURI="http://sharpstechnology.com/role/StockholdersEquity" xlink:href="stss-20240930.xsd#StockholdersEquity" xlink:type="simple" />
    <link:roleRef roleURI="http://sharpstechnology.com/role/PreferredStock" xlink:href="stss-20240930.xsd#PreferredStock" xlink:type="simple" />
    <link:roleRef roleURI="http://sharpstechnology.com/role/WarrantLiability" xlink:href="stss-20240930.xsd#WarrantLiability" xlink:type="simple" />
    <link:roleRef roleURI="http://sharpstechnology.com/role/StockOptions" xlink:href="stss-20240930.xsd#StockOptions" xlink:type="simple" />
    <link:roleRef roleURI="http://sharpstechnology.com/role/IncomeTaxes" xlink:href="stss-20240930.xsd#IncomeTaxes" xlink:type="simple" />
    <link:roleRef roleURI="http://sharpstechnology.com/role/RelatedPartyTransactionsAndBalances" xlink:href="stss-20240930.xsd#RelatedPartyTransactionsAndBalances" xlink:type="simple" />
    <link:roleRef roleURI="http://sharpstechnology.com/role/FairValueMeasurements" xlink:href="stss-20240930.xsd#FairValueMeasurements" xlink:type="simple" />
    <link:roleRef roleURI="http://sharpstechnology.com/role/CommitmentsAndContingencies" xlink:href="stss-20240930.xsd#CommitmentsAndContingencies" xlink:type="simple" />
    <link:roleRef roleURI="http://sharpstechnology.com/role/SubsequentEvents" xlink:href="stss-20240930.xsd#SubsequentEvents" xlink:type="simple" />
    <link:roleRef roleURI="http://sharpstechnology.com/role/SummaryOfSignificantAccountingPoliciesPolicies" xlink:href="stss-20240930.xsd#SummaryOfSignificantAccountingPoliciesPolicies" xlink:type="simple" />
    <link:roleRef roleURI="http://sharpstechnology.com/role/InventoriesTables" xlink:href="stss-20240930.xsd#InventoriesTables" xlink:type="simple" />
    <link:roleRef roleURI="http://sharpstechnology.com/role/FixedAssetsTables" xlink:href="stss-20240930.xsd#FixedAssetsTables" xlink:type="simple" />
    <link:roleRef roleURI="http://sharpstechnology.com/role/AssetAcquisitionTables" xlink:href="stss-20240930.xsd#AssetAcquisitionTables" xlink:type="simple" />
    <link:roleRef roleURI="http://sharpstechnology.com/role/OtherAssetsTables" xlink:href="stss-20240930.xsd#OtherAssetsTables" xlink:type="simple" />
    <link:roleRef roleURI="http://sharpstechnology.com/role/WarrantLiabilityTables" xlink:href="stss-20240930.xsd#WarrantLiabilityTables" xlink:type="simple" />
    <link:roleRef roleURI="http://sharpstechnology.com/role/StockOptionsTables" xlink:href="stss-20240930.xsd#StockOptionsTables" xlink:type="simple" />
    <link:roleRef roleURI="http://sharpstechnology.com/role/IncomeTaxesTables" xlink:href="stss-20240930.xsd#IncomeTaxesTables" xlink:type="simple" />
    <link:roleRef roleURI="http://sharpstechnology.com/role/FairValueMeasurementsTables" xlink:href="stss-20240930.xsd#FairValueMeasurementsTables" xlink:type="simple" />
    <link:roleRef roleURI="http://sharpstechnology.com/role/DescriptionOfBusinessDetailsNarrative" xlink:href="stss-20240930.xsd#DescriptionOfBusinessDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://sharpstechnology.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative" xlink:href="stss-20240930.xsd#SummaryOfSignificantAccountingPoliciesDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://sharpstechnology.com/role/ScheduleOfInventoriesDetails" xlink:href="stss-20240930.xsd#ScheduleOfInventoriesDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://sharpstechnology.com/role/ScheduleOfPropertyPlantAndEquipmentDetails" xlink:href="stss-20240930.xsd#ScheduleOfPropertyPlantAndEquipmentDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://sharpstechnology.com/role/FixedAssetsDetailsNarrative" xlink:href="stss-20240930.xsd#FixedAssetsDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://sharpstechnology.com/role/ScheduleOfFairValueOfAssetsAcquisitionDetails" xlink:href="stss-20240930.xsd#ScheduleOfFairValueOfAssetsAcquisitionDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://sharpstechnology.com/role/AssetAcquisitionDetailsNarrative" xlink:href="stss-20240930.xsd#AssetAcquisitionDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://sharpstechnology.com/role/ScheduleOfOtherAssetsDetails" xlink:href="stss-20240930.xsd#ScheduleOfOtherAssetsDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://sharpstechnology.com/role/OtherAssetsDetailsNarrative" xlink:href="stss-20240930.xsd#OtherAssetsDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://sharpstechnology.com/role/DebtFinancingDetailsNarrative" xlink:href="stss-20240930.xsd#DebtFinancingDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://sharpstechnology.com/role/NotePurchaseAgreementDetailsNarrative" xlink:href="stss-20240930.xsd#NotePurchaseAgreementDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://sharpstechnology.com/role/StockholdersEquityDetailsNarrative" xlink:href="stss-20240930.xsd#StockholdersEquityDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://sharpstechnology.com/role/PreferredStockDetailsNarrative" xlink:href="stss-20240930.xsd#PreferredStockDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://sharpstechnology.com/role/ScheduleOfFairValueOfWarrantDetails" xlink:href="stss-20240930.xsd#ScheduleOfFairValueOfWarrantDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://sharpstechnology.com/role/ScheduleOfWarrantLiabilityDetails" xlink:href="stss-20240930.xsd#ScheduleOfWarrantLiabilityDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://sharpstechnology.com/role/ScheduleOfWarrantOutstandingDetails" xlink:href="stss-20240930.xsd#ScheduleOfWarrantOutstandingDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://sharpstechnology.com/role/WarrantLiabilityDetailsNarrative" xlink:href="stss-20240930.xsd#WarrantLiabilityDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://sharpstechnology.com/role/ScheduleOfStockOptionsGrantedAndOutstandingDetails" xlink:href="stss-20240930.xsd#ScheduleOfStockOptionsGrantedAndOutstandingDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://sharpstechnology.com/role/ScheduleOfInformationAboutOptionsOutstandingDetails" xlink:href="stss-20240930.xsd#ScheduleOfInformationAboutOptionsOutstandingDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://sharpstechnology.com/role/ScheduleOfFairValueOfStockOptionAwardsDetails" xlink:href="stss-20240930.xsd#ScheduleOfFairValueOfStockOptionAwardsDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://sharpstechnology.com/role/StockOptionsDetailsNarrative" xlink:href="stss-20240930.xsd#StockOptionsDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://sharpstechnology.com/role/ScheduleOfReconciliationOfFederalStatutoryRateToTotalEffectiveRateDetails" xlink:href="stss-20240930.xsd#ScheduleOfReconciliationOfFederalStatutoryRateToTotalEffectiveRateDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://sharpstechnology.com/role/ScheduleOfComponentsOfDeferredTaxAssetsDetails" xlink:href="stss-20240930.xsd#ScheduleOfComponentsOfDeferredTaxAssetsDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://sharpstechnology.com/role/ScheduleOfGeographicalComponentsOfLossBeforeIncomeTaxesDetails" xlink:href="stss-20240930.xsd#ScheduleOfGeographicalComponentsOfLossBeforeIncomeTaxesDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://sharpstechnology.com/role/IncomeTaxesDetailsNarrative" xlink:href="stss-20240930.xsd#IncomeTaxesDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://sharpstechnology.com/role/RelatedPartyTransactionsAndBalancesDetailsNarrative" xlink:href="stss-20240930.xsd#RelatedPartyTransactionsAndBalancesDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://sharpstechnology.com/role/ScheduleOfAssetsAndLiabilitiesMeasuredAtFairValueOnRecurringBasisDetails" xlink:href="stss-20240930.xsd#ScheduleOfAssetsAndLiabilitiesMeasuredAtFairValueOnRecurringBasisDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://sharpstechnology.com/role/CommitmentsAndContingenciesDetailsNarrative" xlink:href="stss-20240930.xsd#CommitmentsAndContingenciesDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://sharpstechnology.com/role/ScheduleOfFixedAssetsNetDetails" xlink:href="stss-20240930.xsd#ScheduleOfFixedAssetsNetDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://sharpstechnology.com/role/ScheduleOfFairValueOfAssetsAcquisitionDetailsDisclosure" xlink:href="stss-20240930.xsd#ScheduleOfFairValueOfAssetsAcquisitionDetailsDisclosure" xlink:type="simple" />
    <link:roleRef roleURI="http://sharpstechnology.com/role/SubsequentEventsDetailsNarrative" xlink:href="stss-20240930.xsd#SubsequentEventsDetailsNarrative" xlink:type="simple" />
    <link:arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#hypercube-dimension" arcroleURI="http://xbrl.org/int/dim/arcrole/hypercube-dimension" />
    <link:arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-domain" arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-domain" />
    <link:arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#domain-member" arcroleURI="http://xbrl.org/int/dim/arcrole/domain-member" />
    <link:arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#all" arcroleURI="http://xbrl.org/int/dim/arcrole/all" />
    <link:arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#notAll" arcroleURI="http://xbrl.org/int/dim/arcrole/notAll" />
    <link:arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-default" arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-default" />
    <link:definitionLink xlink:type="extended" xlink:role="http://sharpstechnology.com/role/Cover" xlink:title="00000001 - Document - Cover">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressesLineItems" xlink:label="loc_deiEntityAddressesLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressesTable" xlink:label="loc_deiEntityAddressesTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiEntityAddressesTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressesAddressTypeAxis" xlink:label="loc_deiEntityAddressesAddressTypeAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_deiEntityAddressesTable" xlink:to="loc_deiEntityAddressesAddressTypeAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_AddressTypeDomain" xlink:label="loc_deiAddressTypeDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_deiEntityAddressesAddressTypeAxis" xlink:to="loc_deiAddressTypeDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_AddressTypeDomain" xlink:label="loc_deiAddressTypeDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_deiEntityAddressesAddressTypeAxis" xlink:to="loc_deiAddressTypeDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_BusinessContactMember" xlink:label="loc_deiBusinessContactMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiAddressTypeDomain" xlink:to="loc_deiBusinessContactMember_10" xlink:type="arc" order="11" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentType" xlink:label="loc_deiDocumentType_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiDocumentType_30" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_AmendmentFlag" xlink:label="loc_deiAmendmentFlag_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiAmendmentFlag_30" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_AmendmentDescription" xlink:label="loc_deiAmendmentDescription_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiAmendmentDescription_30" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentRegistrationStatement" xlink:label="loc_deiDocumentRegistrationStatement_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiDocumentRegistrationStatement_30" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentAnnualReport" xlink:label="loc_deiDocumentAnnualReport_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiDocumentAnnualReport_30" xlink:type="arc" order="4" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentQuarterlyReport" xlink:label="loc_deiDocumentQuarterlyReport_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiDocumentQuarterlyReport_30" xlink:type="arc" order="5" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentTransitionReport" xlink:label="loc_deiDocumentTransitionReport_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiDocumentTransitionReport_30" xlink:type="arc" order="6" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentShellCompanyReport" xlink:label="loc_deiDocumentShellCompanyReport_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiDocumentShellCompanyReport_30" xlink:type="arc" order="7" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentShellCompanyEventDate" xlink:label="loc_deiDocumentShellCompanyEventDate_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiDocumentShellCompanyEventDate_30" xlink:type="arc" order="8" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentPeriodStartDate" xlink:label="loc_deiDocumentPeriodStartDate_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiDocumentPeriodStartDate_30" xlink:type="arc" order="9" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentPeriodEndDate" xlink:label="loc_deiDocumentPeriodEndDate_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiDocumentPeriodEndDate_30" xlink:type="arc" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentFiscalPeriodFocus" xlink:label="loc_deiDocumentFiscalPeriodFocus_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiDocumentFiscalPeriodFocus_30" xlink:type="arc" order="11" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentFiscalYearFocus" xlink:label="loc_deiDocumentFiscalYearFocus_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiDocumentFiscalYearFocus_30" xlink:type="arc" order="12" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_CurrentFiscalYearEndDate" xlink:label="loc_deiCurrentFiscalYearEndDate_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiCurrentFiscalYearEndDate_30" xlink:type="arc" order="13" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityFileNumber" xlink:label="loc_deiEntityFileNumber_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiEntityFileNumber_30" xlink:type="arc" order="14" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityRegistrantName" xlink:label="loc_deiEntityRegistrantName_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiEntityRegistrantName_30" xlink:type="arc" order="15" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityCentralIndexKey" xlink:label="loc_deiEntityCentralIndexKey_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiEntityCentralIndexKey_30" xlink:type="arc" order="16" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityPrimarySicNumber" xlink:label="loc_deiEntityPrimarySicNumber_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiEntityPrimarySicNumber_30" xlink:type="arc" order="17" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityTaxIdentificationNumber" xlink:label="loc_deiEntityTaxIdentificationNumber_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiEntityTaxIdentificationNumber_30" xlink:type="arc" order="18" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityIncorporationStateCountryCode" xlink:label="loc_deiEntityIncorporationStateCountryCode_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiEntityIncorporationStateCountryCode_30" xlink:type="arc" order="19" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressAddressLine1" xlink:label="loc_deiEntityAddressAddressLine1_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiEntityAddressAddressLine1_30" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressAddressLine2" xlink:label="loc_deiEntityAddressAddressLine2_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiEntityAddressAddressLine2_30" xlink:type="arc" order="21" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressAddressLine3" xlink:label="loc_deiEntityAddressAddressLine3_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiEntityAddressAddressLine3_30" xlink:type="arc" order="22" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressCityOrTown" xlink:label="loc_deiEntityAddressCityOrTown_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiEntityAddressCityOrTown_30" xlink:type="arc" order="23" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressStateOrProvince" xlink:label="loc_deiEntityAddressStateOrProvince_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiEntityAddressStateOrProvince_30" xlink:type="arc" order="24" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressCountry" xlink:label="loc_deiEntityAddressCountry_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiEntityAddressCountry_30" xlink:type="arc" order="25" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressPostalZipCode" xlink:label="loc_deiEntityAddressPostalZipCode_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiEntityAddressPostalZipCode_30" xlink:type="arc" order="26" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_CountryRegion" xlink:label="loc_deiCountryRegion_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiCountryRegion_30" xlink:type="arc" order="27" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_CityAreaCode" xlink:label="loc_deiCityAreaCode_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiCityAreaCode_30" xlink:type="arc" order="28" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_LocalPhoneNumber" xlink:label="loc_deiLocalPhoneNumber_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiLocalPhoneNumber_30" xlink:type="arc" order="29" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_Extension" xlink:label="loc_deiExtension_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiExtension_30" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_WrittenCommunications" xlink:label="loc_deiWrittenCommunications_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiWrittenCommunications_30" xlink:type="arc" order="31" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_SolicitingMaterial" xlink:label="loc_deiSolicitingMaterial_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiSolicitingMaterial_30" xlink:type="arc" order="32" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_PreCommencementTenderOffer" xlink:label="loc_deiPreCommencementTenderOffer_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiPreCommencementTenderOffer_30" xlink:type="arc" order="33" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_PreCommencementIssuerTenderOffer" xlink:label="loc_deiPreCommencementIssuerTenderOffer_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiPreCommencementIssuerTenderOffer_30" xlink:type="arc" order="34" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_Security12bTitle" xlink:label="loc_deiSecurity12bTitle_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiSecurity12bTitle_30" xlink:type="arc" order="35" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_NoTradingSymbolFlag" xlink:label="loc_deiNoTradingSymbolFlag_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiNoTradingSymbolFlag_30" xlink:type="arc" order="36" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_TradingSymbol" xlink:label="loc_deiTradingSymbol_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiTradingSymbol_30" xlink:type="arc" order="37" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_SecurityExchangeName" xlink:label="loc_deiSecurityExchangeName_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiSecurityExchangeName_30" xlink:type="arc" order="38" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_Security12gTitle" xlink:label="loc_deiSecurity12gTitle_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiSecurity12gTitle_30" xlink:type="arc" order="39" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_SecurityReportingObligation" xlink:label="loc_deiSecurityReportingObligation_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiSecurityReportingObligation_30" xlink:type="arc" order="40" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_AnnualInformationForm" xlink:label="loc_deiAnnualInformationForm_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiAnnualInformationForm_30" xlink:type="arc" order="41" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_AuditedAnnualFinancialStatements" xlink:label="loc_deiAuditedAnnualFinancialStatements_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiAuditedAnnualFinancialStatements_30" xlink:type="arc" order="42" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityWellKnownSeasonedIssuer" xlink:label="loc_deiEntityWellKnownSeasonedIssuer_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiEntityWellKnownSeasonedIssuer_30" xlink:type="arc" order="43" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityVoluntaryFilers" xlink:label="loc_deiEntityVoluntaryFilers_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiEntityVoluntaryFilers_30" xlink:type="arc" order="44" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityCurrentReportingStatus" xlink:label="loc_deiEntityCurrentReportingStatus_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiEntityCurrentReportingStatus_30" xlink:type="arc" order="45" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityInteractiveDataCurrent" xlink:label="loc_deiEntityInteractiveDataCurrent_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiEntityInteractiveDataCurrent_30" xlink:type="arc" order="46" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityFilerCategory" xlink:label="loc_deiEntityFilerCategory_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiEntityFilerCategory_30" xlink:type="arc" order="47" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntitySmallBusiness" xlink:label="loc_deiEntitySmallBusiness_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiEntitySmallBusiness_30" xlink:type="arc" order="48" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityEmergingGrowthCompany" xlink:label="loc_deiEntityEmergingGrowthCompany_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiEntityEmergingGrowthCompany_30" xlink:type="arc" order="49" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityExTransitionPeriod" xlink:label="loc_deiEntityExTransitionPeriod_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiEntityExTransitionPeriod_30" xlink:type="arc" order="50" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentAccountingStandard" xlink:label="loc_deiDocumentAccountingStandard_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiDocumentAccountingStandard_30" xlink:type="arc" order="51" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_OtherReportingStandardItemNumber" xlink:label="loc_deiOtherReportingStandardItemNumber_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiOtherReportingStandardItemNumber_30" xlink:type="arc" order="52" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityShellCompany" xlink:label="loc_deiEntityShellCompany_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiEntityShellCompany_30" xlink:type="arc" order="53" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityPublicFloat" xlink:label="loc_deiEntityPublicFloat_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiEntityPublicFloat_30" xlink:type="arc" order="54" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityBankruptcyProceedingsReportingCurrent" xlink:label="loc_deiEntityBankruptcyProceedingsReportingCurrent_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiEntityBankruptcyProceedingsReportingCurrent_30" xlink:type="arc" order="55" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityCommonStockSharesOutstanding" xlink:label="loc_deiEntityCommonStockSharesOutstanding_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiEntityCommonStockSharesOutstanding_30" xlink:type="arc" order="56" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentsIncorporatedByReferenceTextBlock" xlink:label="loc_deiDocumentsIncorporatedByReferenceTextBlock_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiDocumentsIncorporatedByReferenceTextBlock_30" xlink:type="arc" order="57" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_ContactPersonnelName" xlink:label="loc_deiContactPersonnelName_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiContactPersonnelName_30" xlink:type="arc" order="58" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://sharpstechnology.com/role/BalanceSheets" xlink:title="00000002 - Statement - Condensed Consolidated Balance Sheets">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:label="loc_us-gaapScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AwardTypeAxis" xlink:label="loc_us-gaapAwardTypeAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="loc_us-gaapAwardTypeAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:label="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapAwardTypeAxis" xlink:to="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:label="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapAwardTypeAxis" xlink:to="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="stss-20240930.xsd#STSS_ReverseStockSplitMember" xlink:label="loc_STSSReverseStockSplitMember_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="loc_STSSReverseStockSplitMember_20" xlink:type="arc" order="21" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AssetsAbstract" xlink:label="loc_us-gaapAssetsAbstract_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapAssetsAbstract_60" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AssetsCurrentAbstract" xlink:label="loc_us-gaapAssetsCurrentAbstract_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapAssetsAbstract_60" xlink:to="loc_us-gaapAssetsCurrentAbstract_60" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:label="loc_us-gaapCashAndCashEquivalentsAtCarryingValue_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapAssetsCurrentAbstract_60" xlink:to="loc_us-gaapCashAndCashEquivalentsAtCarryingValue_60" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:label="loc_us-gaapPrepaidExpenseAndOtherAssetsCurrent_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapAssetsCurrentAbstract_60" xlink:to="loc_us-gaapPrepaidExpenseAndOtherAssetsCurrent_60" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_InventoryNet" xlink:label="loc_us-gaapInventoryNet_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapAssetsCurrentAbstract_60" xlink:to="loc_us-gaapInventoryNet_60" xlink:type="arc" order="4" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AssetsCurrent" xlink:label="loc_us-gaapAssetsCurrent_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapAssetsAbstract_60" xlink:to="loc_us-gaapAssetsCurrent_60" xlink:type="arc" order="5" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentNet" xlink:label="loc_us-gaapPropertyPlantAndEquipmentNet_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapAssetsAbstract_60" xlink:to="loc_us-gaapPropertyPlantAndEquipmentNet_60" xlink:type="arc" order="6" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherAssetsNoncurrent" xlink:label="loc_us-gaapOtherAssetsNoncurrent_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapAssetsAbstract_60" xlink:to="loc_us-gaapOtherAssetsNoncurrent_60" xlink:type="arc" order="7" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_Assets" xlink:label="loc_us-gaapAssets_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapAssetsAbstract_60" xlink:to="loc_us-gaapAssets_60" xlink:type="arc" order="8" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LiabilitiesAbstract" xlink:label="loc_us-gaapLiabilitiesAbstract_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapLiabilitiesAbstract_60" xlink:type="arc" order="9" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LiabilitiesCurrentAbstract" xlink:label="loc_us-gaapLiabilitiesCurrentAbstract_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapLiabilitiesAbstract_60" xlink:to="loc_us-gaapLiabilitiesCurrentAbstract_60" xlink:type="arc" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccountsPayableCurrent" xlink:label="loc_us-gaapAccountsPayableCurrent_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapLiabilitiesCurrentAbstract_60" xlink:to="loc_us-gaapAccountsPayableCurrent_60" xlink:type="arc" order="11" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccountsPayableAndOtherAccruedLiabilitiesCurrent" xlink:label="loc_us-gaapAccountsPayableAndOtherAccruedLiabilitiesCurrent_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapLiabilitiesCurrentAbstract_60" xlink:to="loc_us-gaapAccountsPayableAndOtherAccruedLiabilitiesCurrent_60" xlink:type="arc" order="12" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NotesPayableCurrent" xlink:label="loc_us-gaapNotesPayableCurrent_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapLiabilitiesCurrentAbstract_60" xlink:to="loc_us-gaapNotesPayableCurrent_60" xlink:type="arc" order="13" />
      <link:loc xlink:type="locator" xlink:href="stss-20240930.xsd#STSS_WarrantLiabilitiesCurrent" xlink:label="loc_STSSWarrantLiabilitiesCurrent_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapLiabilitiesCurrentAbstract_60" xlink:to="loc_STSSWarrantLiabilitiesCurrent_60" xlink:type="arc" order="14" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LiabilitiesCurrent" xlink:label="loc_us-gaapLiabilitiesCurrent_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapLiabilitiesCurrentAbstract_60" xlink:to="loc_us-gaapLiabilitiesCurrent_60" xlink:type="arc" order="15" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredIncomeTaxLiabilitiesNet" xlink:label="loc_us-gaapDeferredIncomeTaxLiabilitiesNet_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapLiabilitiesAbstract_60" xlink:to="loc_us-gaapDeferredIncomeTaxLiabilitiesNet_60" xlink:type="arc" order="16" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_Liabilities" xlink:label="loc_us-gaapLiabilities_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapLiabilitiesAbstract_60" xlink:to="loc_us-gaapLiabilities_60" xlink:type="arc" order="17" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommitmentsAndContingencies" xlink:label="loc_us-gaapCommitmentsAndContingencies_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapLiabilitiesAbstract_60" xlink:to="loc_us-gaapCommitmentsAndContingencies_60" xlink:type="arc" order="18" />
      <link:loc xlink:type="locator" xlink:href="stss-20240930.xsd#STSS_SubsequentEvents" xlink:label="loc_STSSSubsequentEvents_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapLiabilitiesAbstract_60" xlink:to="loc_STSSSubsequentEvents_60" xlink:type="arc" order="19" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockholdersEquityAbstract" xlink:label="loc_us-gaapStockholdersEquityAbstract_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapLiabilitiesAbstract_60" xlink:to="loc_us-gaapStockholdersEquityAbstract_60" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PreferredStockValue" xlink:label="loc_us-gaapPreferredStockValue_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStockholdersEquityAbstract_60" xlink:to="loc_us-gaapPreferredStockValue_60" xlink:type="arc" order="21" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockValue" xlink:label="loc_us-gaapCommonStockValue_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStockholdersEquityAbstract_60" xlink:to="loc_us-gaapCommonStockValue_60" xlink:type="arc" order="22" />
      <link:loc xlink:type="locator" xlink:href="stss-20240930.xsd#STSS_CommonStockReverseSplitValue" xlink:label="loc_STSSCommonStockReverseSplitValue_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStockholdersEquityAbstract_60" xlink:to="loc_STSSCommonStockReverseSplitValue_60" xlink:type="arc" order="23" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AdditionalPaidInCapital" xlink:label="loc_us-gaapAdditionalPaidInCapital_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStockholdersEquityAbstract_60" xlink:to="loc_us-gaapAdditionalPaidInCapital_60" xlink:type="arc" order="24" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:label="loc_us-gaapAccumulatedOtherComprehensiveIncomeLossNetOfTax_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStockholdersEquityAbstract_60" xlink:to="loc_us-gaapAccumulatedOtherComprehensiveIncomeLossNetOfTax_60" xlink:type="arc" order="25" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RetainedEarningsAccumulatedDeficit" xlink:label="loc_us-gaapRetainedEarningsAccumulatedDeficit_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStockholdersEquityAbstract_60" xlink:to="loc_us-gaapRetainedEarningsAccumulatedDeficit_60" xlink:type="arc" order="26" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockholdersEquity" xlink:label="loc_us-gaapStockholdersEquity_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStockholdersEquityAbstract_60" xlink:to="loc_us-gaapStockholdersEquity_60" xlink:type="arc" order="27" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LiabilitiesAndStockholdersEquity" xlink:label="loc_us-gaapLiabilitiesAndStockholdersEquity_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapLiabilitiesAbstract_60" xlink:to="loc_us-gaapLiabilitiesAndStockholdersEquity_60" xlink:type="arc" order="28" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://sharpstechnology.com/role/BalanceSheetsParenthetical" xlink:title="00000003 - Statement - Condensed Consolidated Balance Sheets (Parenthetical)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:label="loc_us-gaapScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AwardTypeAxis" xlink:label="loc_us-gaapAwardTypeAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="loc_us-gaapAwardTypeAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:label="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapAwardTypeAxis" xlink:to="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:label="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapAwardTypeAxis" xlink:to="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="stss-20240930.xsd#STSS_ReverseStockSplitMember" xlink:label="loc_STSSReverseStockSplitMember_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="loc_STSSReverseStockSplitMember_20" xlink:type="arc" order="21" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PreferredStockParOrStatedValuePerShare" xlink:label="loc_us-gaapPreferredStockParOrStatedValuePerShare_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapPreferredStockParOrStatedValuePerShare_50" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PreferredStockSharesAuthorized" xlink:label="loc_us-gaapPreferredStockSharesAuthorized_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapPreferredStockSharesAuthorized_50" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PreferredStockSharesIssued" xlink:label="loc_us-gaapPreferredStockSharesIssued_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapPreferredStockSharesIssued_50" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PreferredStockSharesOutstanding" xlink:label="loc_us-gaapPreferredStockSharesOutstanding_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapPreferredStockSharesOutstanding_50" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockParOrStatedValuePerShare" xlink:label="loc_us-gaapCommonStockParOrStatedValuePerShare_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapCommonStockParOrStatedValuePerShare_50" xlink:type="arc" order="4" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockSharesAuthorized" xlink:label="loc_us-gaapCommonStockSharesAuthorized_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapCommonStockSharesAuthorized_50" xlink:type="arc" order="5" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockSharesIssued" xlink:label="loc_us-gaapCommonStockSharesIssued_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapCommonStockSharesIssued_50" xlink:type="arc" order="6" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockSharesOutstanding" xlink:label="loc_us-gaapCommonStockSharesOutstanding_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapCommonStockSharesOutstanding_50" xlink:type="arc" order="7" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://sharpstechnology.com/role/StatementsOfOperations" xlink:title="00000004 - Statement - Condensed Consolidated Statements of Operations" />
    <link:definitionLink xlink:type="extended" xlink:role="http://sharpstechnology.com/role/StatementsOfComprehensiveLoss" xlink:title="00000005 - Statement - Condensed Consolidated Statements of Comprehensive Loss" />
    <link:definitionLink xlink:type="extended" xlink:role="http://sharpstechnology.com/role/StatementOfStockholdersEquity" xlink:title="00000006 - Statement - Condensed Consolidated Statement of Stockholders&apos; Equity">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStatementTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementEquityComponentsAxis" xlink:label="loc_us-gaapStatementEquityComponentsAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementEquityComponentsAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EquityComponentDomain" xlink:label="loc_us-gaapEquityComponentDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapStatementEquityComponentsAxis" xlink:to="loc_us-gaapEquityComponentDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EquityComponentDomain" xlink:label="loc_us-gaapEquityComponentDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapStatementEquityComponentsAxis" xlink:to="loc_us-gaapEquityComponentDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PreferredStockMember" xlink:label="loc_us-gaapPreferredStockMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapEquityComponentDomain" xlink:to="loc_us-gaapPreferredStockMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockMember" xlink:label="loc_us-gaapCommonStockMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapEquityComponentDomain" xlink:to="loc_us-gaapCommonStockMember_10" xlink:type="arc" order="11" />
      <link:loc xlink:type="locator" xlink:href="stss-20240930.xsd#STSS_CommonStockSubscriptionReceivableMember" xlink:label="loc_STSSCommonStockSubscriptionReceivableMember_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapEquityComponentDomain" xlink:to="loc_STSSCommonStockSubscriptionReceivableMember_20" xlink:type="arc" order="21" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AdditionalPaidInCapitalMember" xlink:label="loc_us-gaapAdditionalPaidInCapitalMember_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapEquityComponentDomain" xlink:to="loc_us-gaapAdditionalPaidInCapitalMember_30" xlink:type="arc" order="31" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:label="loc_us-gaapAccumulatedOtherComprehensiveIncomeMember_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapEquityComponentDomain" xlink:to="loc_us-gaapAccumulatedOtherComprehensiveIncomeMember_40" xlink:type="arc" order="41" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RetainedEarningsMember" xlink:label="loc_us-gaapRetainedEarningsMember_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapEquityComponentDomain" xlink:to="loc_us-gaapRetainedEarningsMember_50" xlink:type="arc" order="51" />
      <link:loc xlink:type="locator" xlink:href="stss-20240930.xsd#STSS_AwardsTypeAxis" xlink:label="loc_STSSAwardsTypeAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_STSSAwardsTypeAxis" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="stss-20240930.xsd#STSS_AwardsTypeDomain" xlink:label="loc_STSSAwardsTypeDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_STSSAwardsTypeAxis" xlink:to="loc_STSSAwardsTypeDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="stss-20240930.xsd#STSS_AwardsTypeDomain" xlink:label="loc_STSSAwardsTypeDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_STSSAwardsTypeAxis" xlink:to="loc_STSSAwardsTypeDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="stss-20240930.xsd#STSS_ReverseStockSplitMember" xlink:label="loc_STSSReverseStockSplitMember_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_STSSAwardsTypeDomain" xlink:to="loc_STSSReverseStockSplitMember_70" xlink:type="arc" order="71" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AwardTypeAxis" xlink:label="loc_us-gaapAwardTypeAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapAwardTypeAxis" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:label="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapAwardTypeAxis" xlink:to="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:label="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapAwardTypeAxis" xlink:to="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="stss-20240930.xsd#STSS_ReverseStockSplitMember" xlink:label="loc_STSSReverseStockSplitMember_140" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="loc_STSSReverseStockSplitMember_140" xlink:type="arc" order="142" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockholdersEquity" xlink:label="loc_us-gaapStockholdersEquity_220" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockholdersEquity_220" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SharesOutstanding" xlink:label="loc_us-gaapSharesOutstanding_220" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapSharesOutstanding_220" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetIncomeLoss" xlink:label="loc_us-gaapNetIncomeLoss_220" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapNetIncomeLoss_220" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="stss-20240930.xsd#STSS_StockIssuedDuringPeriodValueInitialPublicOffering" xlink:label="loc_STSSStockIssuedDuringPeriodValueInitialPublicOffering_220" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_STSSStockIssuedDuringPeriodValueInitialPublicOffering_220" xlink:type="arc" order="4" />
      <link:loc xlink:type="locator" xlink:href="stss-20240930.xsd#STSS_StockIssuedDuringPeriodSharesInitialPublicOffering" xlink:label="loc_STSSStockIssuedDuringPeriodSharesInitialPublicOffering_220" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_STSSStockIssuedDuringPeriodSharesInitialPublicOffering_220" xlink:type="arc" order="5" />
      <link:loc xlink:type="locator" xlink:href="stss-20240930.xsd#STSS_StockIssuedDuringPeriodValueContingentStockLiability" xlink:label="loc_STSSStockIssuedDuringPeriodValueContingentStockLiability_220" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_STSSStockIssuedDuringPeriodValueContingentStockLiability_220" xlink:type="arc" order="6" />
      <link:loc xlink:type="locator" xlink:href="stss-20240930.xsd#STSS_StockIssuedDuringPeriodSharesContingentStockLiability" xlink:label="loc_STSSStockIssuedDuringPeriodSharesContingentStockLiability_220" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_STSSStockIssuedDuringPeriodSharesContingentStockLiability_220" xlink:type="arc" order="7" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:label="loc_us-gaapAdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_220" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapAdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_220" xlink:type="arc" order="8" />
      <link:loc xlink:type="locator" xlink:href="stss-20240930.xsd#STSS_StockIssuedDuringPeriodValueFractionalShareAdjustment" xlink:label="loc_STSSStockIssuedDuringPeriodValueFractionalShareAdjustment_220" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_STSSStockIssuedDuringPeriodValueFractionalShareAdjustment_220" xlink:type="arc" order="9" />
      <link:loc xlink:type="locator" xlink:href="stss-20240930.xsd#STSS_StockIssuedDuringPeriodSharesFractionalShareAdjustment" xlink:label="loc_STSSStockIssuedDuringPeriodSharesFractionalShareAdjustment_220" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_STSSStockIssuedDuringPeriodSharesFractionalShareAdjustment_220" xlink:type="arc" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockIssuedDuringPeriodValueIssuedForServices" xlink:label="loc_us-gaapStockIssuedDuringPeriodValueIssuedForServices_220" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodValueIssuedForServices_220" xlink:type="arc" order="11" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockIssuedDuringPeriodSharesIssuedForServices" xlink:label="loc_us-gaapStockIssuedDuringPeriodSharesIssuedForServices_220" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodSharesIssuedForServices_220" xlink:type="arc" order="12" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax" xlink:label="loc_us-gaapOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax_220" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax_220" xlink:type="arc" order="13" />
      <link:loc xlink:type="locator" xlink:href="stss-20240930.xsd#STSS_StockIssuedDuringPeriodCollectionsOfCommonStockSubscriptionsValue" xlink:label="loc_STSSStockIssuedDuringPeriodCollectionsOfCommonStockSubscriptionsValue_220" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_STSSStockIssuedDuringPeriodCollectionsOfCommonStockSubscriptionsValue_220" xlink:type="arc" order="14" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockIssuedDuringPeriodValueNewIssues" xlink:label="loc_us-gaapStockIssuedDuringPeriodValueNewIssues_220" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodValueNewIssues_220" xlink:type="arc" order="15" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:label="loc_us-gaapStockIssuedDuringPeriodSharesNewIssues_220" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodSharesNewIssues_220" xlink:type="arc" order="16" />
      <link:loc xlink:type="locator" xlink:href="stss-20240930.xsd#STSS_StockIssuedDuringPeriodValueShelfRegistrationOffering" xlink:label="loc_STSSStockIssuedDuringPeriodValueShelfRegistrationOffering_220" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_STSSStockIssuedDuringPeriodValueShelfRegistrationOffering_220" xlink:type="arc" order="17" />
      <link:loc xlink:type="locator" xlink:href="stss-20240930.xsd#STSS_StockIssuedDuringPeriodSharesShelfRegistrationOffering" xlink:label="loc_STSSStockIssuedDuringPeriodSharesShelfRegistrationOffering_220" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_STSSStockIssuedDuringPeriodSharesShelfRegistrationOffering_220" xlink:type="arc" order="18" />
      <link:loc xlink:type="locator" xlink:href="stss-20240930.xsd#STSS_StockIssuedDuringPeriodValuePrivatePlacement" xlink:label="loc_STSSStockIssuedDuringPeriodValuePrivatePlacement_220" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_STSSStockIssuedDuringPeriodValuePrivatePlacement_220" xlink:type="arc" order="19" />
      <link:loc xlink:type="locator" xlink:href="stss-20240930.xsd#STSS_StockIssuedDuringPeriodValueExerciseOfPrefundedWarrants" xlink:label="loc_STSSStockIssuedDuringPeriodValueExerciseOfPrefundedWarrants_220" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_STSSStockIssuedDuringPeriodValueExerciseOfPrefundedWarrants_220" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="stss-20240930.xsd#STSS_StockIssuedDuringPeriodSharesExerciseOfPrefundedWarrants" xlink:label="loc_STSSStockIssuedDuringPeriodSharesExerciseOfPrefundedWarrants_220" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_STSSStockIssuedDuringPeriodSharesExerciseOfPrefundedWarrants_220" xlink:type="arc" order="21" />
      <link:loc xlink:type="locator" xlink:href="stss-20240930.xsd#STSS_StockIssuedDuringPeriodValueExerciseOfPrefundedWarrant" xlink:label="loc_STSSStockIssuedDuringPeriodValueExerciseOfPrefundedWarrant_220" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_STSSStockIssuedDuringPeriodValueExerciseOfPrefundedWarrant_220" xlink:type="arc" order="22" />
      <link:loc xlink:type="locator" xlink:href="stss-20240930.xsd#STSS_StockIssuedDuringPeriodValueRegistrationOffering" xlink:label="loc_STSSStockIssuedDuringPeriodValueRegistrationOffering_220" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_STSSStockIssuedDuringPeriodValueRegistrationOffering_220" xlink:type="arc" order="23" />
      <link:loc xlink:type="locator" xlink:href="stss-20240930.xsd#STSS_StockIssuedDuringPeriodSharesRegistrationOffering" xlink:label="loc_STSSStockIssuedDuringPeriodSharesRegistrationOffering_220" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_STSSStockIssuedDuringPeriodSharesRegistrationOffering_220" xlink:type="arc" order="24" />
      <link:loc xlink:type="locator" xlink:href="stss-20240930.xsd#STSS_StockIssuedDuringPeriodValueWarrantInducements" xlink:label="loc_STSSStockIssuedDuringPeriodValueWarrantInducements_220" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_STSSStockIssuedDuringPeriodValueWarrantInducements_220" xlink:type="arc" order="25" />
      <link:loc xlink:type="locator" xlink:href="stss-20240930.xsd#STSS_StockIssuedDuringPeriodSharesWarrantInducements" xlink:label="loc_STSSStockIssuedDuringPeriodSharesWarrantInducements_220" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_STSSStockIssuedDuringPeriodSharesWarrantInducements_220" xlink:type="arc" order="26" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockRedeemedOrCalledDuringPeriodValue" xlink:label="loc_us-gaapStockRedeemedOrCalledDuringPeriodValue_220" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockRedeemedOrCalledDuringPeriodValue_220" xlink:type="arc" order="27" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockRedeemedOrCalledDuringPeriodShares" xlink:label="loc_us-gaapStockRedeemedOrCalledDuringPeriodShares_220" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockRedeemedOrCalledDuringPeriodShares_220" xlink:type="arc" order="28" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockIssuedDuringPeriodValueOther" xlink:label="loc_us-gaapStockIssuedDuringPeriodValueOther_220" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodValueOther_220" xlink:type="arc" order="29" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockIssuedDuringPeriodSharesOther" xlink:label="loc_us-gaapStockIssuedDuringPeriodSharesOther_220" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodSharesOther_220" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="stss-20240930.xsd#STSS_StockIssuedDuringPeriodValueWarrantExericse" xlink:label="loc_STSSStockIssuedDuringPeriodValueWarrantExericse_220" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_STSSStockIssuedDuringPeriodValueWarrantExericse_220" xlink:type="arc" order="31" />
      <link:loc xlink:type="locator" xlink:href="stss-20240930.xsd#STSS_StockIssuedDuringPeriodSharesWarrantExericse" xlink:label="loc_STSSStockIssuedDuringPeriodSharesWarrantExericse_220" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_STSSStockIssuedDuringPeriodSharesWarrantExericse_220" xlink:type="arc" order="32" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://sharpstechnology.com/role/StatementsOfCashFlows" xlink:title="00000007 - Statement - Condensed Consolidated Statements of Cash Flows" />
    <link:definitionLink xlink:type="extended" xlink:role="http://sharpstechnology.com/role/DescriptionOfBusiness" xlink:title="00000008 - Disclosure - Description of Business" />
    <link:definitionLink xlink:type="extended" xlink:role="http://sharpstechnology.com/role/SummaryOfSignificantAccountingPolicies" xlink:title="00000009 - Disclosure - Summary of Significant Accounting Policies" />
    <link:definitionLink xlink:type="extended" xlink:role="http://sharpstechnology.com/role/Inventories" xlink:title="00000010 - Disclosure - Inventories" />
    <link:definitionLink xlink:type="extended" xlink:role="http://sharpstechnology.com/role/FixedAssets" xlink:title="00000011 - Disclosure - Fixed Assets" />
    <link:definitionLink xlink:type="extended" xlink:role="http://sharpstechnology.com/role/AssetAcquisition" xlink:title="00000012 - Disclosure - Asset Acquisition" />
    <link:definitionLink xlink:type="extended" xlink:role="http://sharpstechnology.com/role/OtherAssets" xlink:title="00000013 - Disclosure - Other Assets" />
    <link:definitionLink xlink:type="extended" xlink:role="http://sharpstechnology.com/role/DebtFinancing" xlink:title="00000014 - Disclosure - Debt Financing" />
    <link:definitionLink xlink:type="extended" xlink:role="http://sharpstechnology.com/role/NotePurchaseAgreement" xlink:title="00000015 - Disclosure - Note Purchase Agreement" />
    <link:definitionLink xlink:type="extended" xlink:role="http://sharpstechnology.com/role/StockholdersEquity" xlink:title="00000016 - Disclosure - Stockholders&#8217; Equity" />
    <link:definitionLink xlink:type="extended" xlink:role="http://sharpstechnology.com/role/PreferredStock" xlink:title="00000017 - Disclosure - Preferred Stock" />
    <link:definitionLink xlink:type="extended" xlink:role="http://sharpstechnology.com/role/WarrantLiability" xlink:title="00000018 - Disclosure - Warrant Liability" />
    <link:definitionLink xlink:type="extended" xlink:role="http://sharpstechnology.com/role/StockOptions" xlink:title="00000019 - Disclosure - Stock Options" />
    <link:definitionLink xlink:type="extended" xlink:role="http://sharpstechnology.com/role/IncomeTaxes" xlink:title="00000020 - Disclosure - Income Taxes" />
    <link:definitionLink xlink:type="extended" xlink:role="http://sharpstechnology.com/role/RelatedPartyTransactionsAndBalances" xlink:title="00000021 - Disclosure - Related Party Transactions and Balances" />
    <link:definitionLink xlink:type="extended" xlink:role="http://sharpstechnology.com/role/FairValueMeasurements" xlink:title="00000022 - Disclosure - Fair Value Measurements" />
    <link:definitionLink xlink:type="extended" xlink:role="http://sharpstechnology.com/role/CommitmentsAndContingencies" xlink:title="00000023 - Disclosure - Commitments and Contingencies" />
    <link:definitionLink xlink:type="extended" xlink:role="http://sharpstechnology.com/role/SubsequentEvents" xlink:title="00000024 - Disclosure - Subsequent Events" />
    <link:definitionLink xlink:type="extended" xlink:role="http://sharpstechnology.com/role/SummaryOfSignificantAccountingPoliciesPolicies" xlink:title="00000025 - Disclosure - Summary of Significant Accounting Policies (Policies)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://sharpstechnology.com/role/InventoriesTables" xlink:title="00000026 - Disclosure - Inventories (Tables)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://sharpstechnology.com/role/FixedAssetsTables" xlink:title="00000027 - Disclosure - Fixed Assets (Tables)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://sharpstechnology.com/role/AssetAcquisitionTables" xlink:title="00000028 - Disclosure - Asset Acquisition (Tables)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://sharpstechnology.com/role/OtherAssetsTables" xlink:title="00000029 - Disclosure - Other Assets (Tables)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://sharpstechnology.com/role/WarrantLiabilityTables" xlink:title="00000030 - Disclosure - Warrant Liability (Tables)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStatementTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementEquityComponentsAxis" xlink:label="loc_us-gaapStatementEquityComponentsAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementEquityComponentsAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EquityComponentDomain" xlink:label="loc_us-gaapEquityComponentDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapStatementEquityComponentsAxis" xlink:to="loc_us-gaapEquityComponentDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EquityComponentDomain" xlink:label="loc_us-gaapEquityComponentDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapStatementEquityComponentsAxis" xlink:to="loc_us-gaapEquityComponentDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_WarrantMember" xlink:label="loc_us-gaapWarrantMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapEquityComponentDomain" xlink:to="loc_us-gaapWarrantMember_10" xlink:type="arc" order="11" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" xlink:label="loc_us-gaapScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock_50" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="stss-20240930.xsd#STSS_ScheduleOfWarrantLiabilityTableTextBlock" xlink:label="loc_STSSScheduleOfWarrantLiabilityTableTextBlock_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_STSSScheduleOfWarrantLiabilityTableTextBlock_50" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock" xlink:label="loc_us-gaapScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock_50" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock" xlink:label="loc_us-gaapFairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapFairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock_50" xlink:type="arc" order="3" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://sharpstechnology.com/role/StockOptionsTables" xlink:title="00000031 - Disclosure - Stock Options (Tables)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://sharpstechnology.com/role/IncomeTaxesTables" xlink:title="00000032 - Disclosure - Income Taxes (Tables)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://sharpstechnology.com/role/FairValueMeasurementsTables" xlink:title="00000033 - Disclosure - Fair Value Measurements (Tables)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://sharpstechnology.com/role/DescriptionOfBusinessDetailsNarrative" xlink:title="00000034 - Disclosure - Description of Business (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubsidiarySaleOfStockLineItems" xlink:label="loc_us-gaapSubsidiarySaleOfStockLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable" xlink:label="loc_us-gaapSubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapSubsidiarySaleOfStockLineItems" xlink:to="loc_us-gaapSubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubsidiarySaleOfStockAxis" xlink:label="loc_us-gaapSubsidiarySaleOfStockAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapSubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable" xlink:to="loc_us-gaapSubsidiarySaleOfStockAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SaleOfStockNameOfTransactionDomain" xlink:label="loc_us-gaapSaleOfStockNameOfTransactionDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapSubsidiarySaleOfStockAxis" xlink:to="loc_us-gaapSaleOfStockNameOfTransactionDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SaleOfStockNameOfTransactionDomain" xlink:label="loc_us-gaapSaleOfStockNameOfTransactionDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapSubsidiarySaleOfStockAxis" xlink:to="loc_us-gaapSaleOfStockNameOfTransactionDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IPOMember" xlink:label="loc_us-gaapIPOMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapSaleOfStockNameOfTransactionDomain" xlink:to="loc_us-gaapIPOMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ProceedsFromIssuanceInitialPublicOffering" xlink:label="loc_us-gaapProceedsFromIssuanceInitialPublicOffering_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapSubsidiarySaleOfStockLineItems" xlink:to="loc_us-gaapProceedsFromIssuanceInitialPublicOffering_40" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="stss-20240930.xsd#STSS_WorkingCapital" xlink:label="loc_STSSWorkingCapital_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapSubsidiarySaleOfStockLineItems" xlink:to="loc_STSSWorkingCapital_40" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="stss-20240930.xsd#STSS_ReverseStockSplitDescription" xlink:label="loc_STSSReverseStockSplitDescription_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapSubsidiarySaleOfStockLineItems" xlink:to="loc_STSSReverseStockSplitDescription_40" xlink:type="arc" order="2" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://sharpstechnology.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative" xlink:title="00000035 - Disclosure - Summary of Significant Accounting Policies (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentLineItems" xlink:label="loc_us-gaapPropertyPlantAndEquipmentLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:label="loc_us-gaapScheduleOfPropertyPlantAndEquipmentTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapPropertyPlantAndEquipmentLineItems" xlink:to="loc_us-gaapScheduleOfPropertyPlantAndEquipmentTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:label="loc_us-gaapPropertyPlantAndEquipmentByTypeAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapScheduleOfPropertyPlantAndEquipmentTable" xlink:to="loc_us-gaapPropertyPlantAndEquipmentByTypeAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:label="loc_us-gaapPropertyPlantAndEquipmentTypeDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapPropertyPlantAndEquipmentByTypeAxis" xlink:to="loc_us-gaapPropertyPlantAndEquipmentTypeDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:label="loc_us-gaapPropertyPlantAndEquipmentTypeDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapPropertyPlantAndEquipmentByTypeAxis" xlink:to="loc_us-gaapPropertyPlantAndEquipmentTypeDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BuildingMember" xlink:label="loc_us-gaapBuildingMember_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapPropertyPlantAndEquipmentTypeDomain" xlink:to="loc_us-gaapBuildingMember_30" xlink:type="arc" order="31" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_MachineryAndEquipmentMember" xlink:label="loc_us-gaapMachineryAndEquipmentMember_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapPropertyPlantAndEquipmentTypeDomain" xlink:to="loc_us-gaapMachineryAndEquipmentMember_40" xlink:type="arc" order="41" />
      <link:loc xlink:type="locator" xlink:href="stss-20240930.xsd#STSS_WebsiteMember" xlink:label="loc_STSSWebsiteMember_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapPropertyPlantAndEquipmentTypeDomain" xlink:to="loc_STSSWebsiteMember_60" xlink:type="arc" order="61" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RangeAxis" xlink:label="loc_srtRangeAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapScheduleOfPropertyPlantAndEquipmentTable" xlink:to="loc_srtRangeAxis" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RangeMember" xlink:label="loc_srtRangeMember" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srtRangeAxis" xlink:to="loc_srtRangeMember" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RangeMember" xlink:label="loc_srtRangeMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_srtRangeAxis" xlink:to="loc_srtRangeMember_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_MinimumMember" xlink:label="loc_srtMinimumMember_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtRangeMember" xlink:to="loc_srtMinimumMember_40" xlink:type="arc" order="42" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_MaximumMember" xlink:label="loc_srtMaximumMember_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtRangeMember" xlink:to="loc_srtMaximumMember_50" xlink:type="arc" order="52" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementEquityComponentsAxis" xlink:label="loc_us-gaapStatementEquityComponentsAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapScheduleOfPropertyPlantAndEquipmentTable" xlink:to="loc_us-gaapStatementEquityComponentsAxis" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EquityComponentDomain" xlink:label="loc_us-gaapEquityComponentDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapStatementEquityComponentsAxis" xlink:to="loc_us-gaapEquityComponentDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EquityComponentDomain" xlink:label="loc_us-gaapEquityComponentDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapStatementEquityComponentsAxis" xlink:to="loc_us-gaapEquityComponentDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="stss-20240930.xsd#STSS_PrefundendWarrantsMember" xlink:label="loc_STSSPrefundendWarrantsMember_80" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapEquityComponentDomain" xlink:to="loc_STSSPrefundendWarrantsMember_80" xlink:type="arc" order="81" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:label="loc_us-gaapAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapScheduleOfPropertyPlantAndEquipmentTable" xlink:to="loc_us-gaapAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:type="arc" order="4" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AntidilutiveSecuritiesNameDomain" xlink:label="loc_us-gaapAntidilutiveSecuritiesNameDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:to="loc_us-gaapAntidilutiveSecuritiesNameDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AntidilutiveSecuritiesNameDomain" xlink:label="loc_us-gaapAntidilutiveSecuritiesNameDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:to="loc_us-gaapAntidilutiveSecuritiesNameDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="stss-20240930.xsd#STSS_StockOptionsAndWarrantsMember" xlink:label="loc_STSSStockOptionsAndWarrantsMember_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapAntidilutiveSecuritiesNameDomain" xlink:to="loc_STSSStockOptionsAndWarrantsMember_90" xlink:type="arc" order="91" />
      <link:loc xlink:type="locator" xlink:href="stss-20240930.xsd#STSS_StockOptionAndWarrantsMember" xlink:label="loc_STSSStockOptionAndWarrantsMember_190" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapAntidilutiveSecuritiesNameDomain" xlink:to="loc_STSSStockOptionAndWarrantsMember_190" xlink:type="arc" order="191" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:label="loc_us-gaapNetCashProvidedByUsedInOperatingActivities_210" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapPropertyPlantAndEquipmentLineItems" xlink:to="loc_us-gaapNetCashProvidedByUsedInOperatingActivities_210" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_Cash" xlink:label="loc_us-gaapCash_210" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapPropertyPlantAndEquipmentLineItems" xlink:to="loc_us-gaapCash_210" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CashEquivalentsAtCarryingValue" xlink:label="loc_us-gaapCashEquivalentsAtCarryingValue_210" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapPropertyPlantAndEquipmentLineItems" xlink:to="loc_us-gaapCashEquivalentsAtCarryingValue_210" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentUsefulLife" xlink:label="loc_us-gaapPropertyPlantAndEquipmentUsefulLife_210" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapPropertyPlantAndEquipmentLineItems" xlink:to="loc_us-gaapPropertyPlantAndEquipmentUsefulLife_210" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ImpairmentOfLongLivedAssetsHeldForUse" xlink:label="loc_us-gaapImpairmentOfLongLivedAssetsHeldForUse_210" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapPropertyPlantAndEquipmentLineItems" xlink:to="loc_us-gaapImpairmentOfLongLivedAssetsHeldForUse_210" xlink:type="arc" order="4" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:label="loc_us-gaapWeightedAverageNumberOfSharesOutstandingBasic_210" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapPropertyPlantAndEquipmentLineItems" xlink:to="loc_us-gaapWeightedAverageNumberOfSharesOutstandingBasic_210" xlink:type="arc" order="5" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:label="loc_us-gaapAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_210" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapPropertyPlantAndEquipmentLineItems" xlink:to="loc_us-gaapAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_210" xlink:type="arc" order="6" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://sharpstechnology.com/role/ScheduleOfInventoriesDetails" xlink:title="00000036 - Disclosure - Schedule of Inventories (Details)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://sharpstechnology.com/role/ScheduleOfPropertyPlantAndEquipmentDetails" xlink:title="00000037 - Disclosure - Schedule of Property, Plant and Equipment (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentLineItems" xlink:label="loc_us-gaapPropertyPlantAndEquipmentLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:label="loc_us-gaapScheduleOfPropertyPlantAndEquipmentTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapPropertyPlantAndEquipmentLineItems" xlink:to="loc_us-gaapScheduleOfPropertyPlantAndEquipmentTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:label="loc_us-gaapPropertyPlantAndEquipmentByTypeAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapScheduleOfPropertyPlantAndEquipmentTable" xlink:to="loc_us-gaapPropertyPlantAndEquipmentByTypeAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:label="loc_us-gaapPropertyPlantAndEquipmentTypeDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapPropertyPlantAndEquipmentByTypeAxis" xlink:to="loc_us-gaapPropertyPlantAndEquipmentTypeDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:label="loc_us-gaapPropertyPlantAndEquipmentTypeDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapPropertyPlantAndEquipmentByTypeAxis" xlink:to="loc_us-gaapPropertyPlantAndEquipmentTypeDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LandMember" xlink:label="loc_us-gaapLandMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapPropertyPlantAndEquipmentTypeDomain" xlink:to="loc_us-gaapLandMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BuildingMember" xlink:label="loc_us-gaapBuildingMember_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapPropertyPlantAndEquipmentTypeDomain" xlink:to="loc_us-gaapBuildingMember_20" xlink:type="arc" order="21" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_MachineryAndEquipmentMember" xlink:label="loc_us-gaapMachineryAndEquipmentMember_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapPropertyPlantAndEquipmentTypeDomain" xlink:to="loc_us-gaapMachineryAndEquipmentMember_40" xlink:type="arc" order="41" />
      <link:loc xlink:type="locator" xlink:href="stss-20240930.xsd#STSS_ComputerSystemsAndWebsiteAndOtherWebsiteMember" xlink:label="loc_STSSComputerSystemsAndWebsiteAndOtherWebsiteMember_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapPropertyPlantAndEquipmentTypeDomain" xlink:to="loc_STSSComputerSystemsAndWebsiteAndOtherWebsiteMember_60" xlink:type="arc" order="61" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentGross" xlink:label="loc_us-gaapPropertyPlantAndEquipmentGross_110" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapPropertyPlantAndEquipmentLineItems" xlink:to="loc_us-gaapPropertyPlantAndEquipmentGross_110" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:label="loc_us-gaapAccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_110" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapPropertyPlantAndEquipmentLineItems" xlink:to="loc_us-gaapAccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_110" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentNet" xlink:label="loc_us-gaapPropertyPlantAndEquipmentNet_110" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapPropertyPlantAndEquipmentLineItems" xlink:to="loc_us-gaapPropertyPlantAndEquipmentNet_110" xlink:type="arc" order="2" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://sharpstechnology.com/role/FixedAssetsDetailsNarrative" xlink:title="00000038 - Disclosure - Fixed Assets (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentLineItems" xlink:label="loc_us-gaapPropertyPlantAndEquipmentLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:label="loc_us-gaapScheduleOfPropertyPlantAndEquipmentTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapPropertyPlantAndEquipmentLineItems" xlink:to="loc_us-gaapScheduleOfPropertyPlantAndEquipmentTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:label="loc_us-gaapPropertyPlantAndEquipmentByTypeAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapScheduleOfPropertyPlantAndEquipmentTable" xlink:to="loc_us-gaapPropertyPlantAndEquipmentByTypeAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:label="loc_us-gaapPropertyPlantAndEquipmentTypeDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapPropertyPlantAndEquipmentByTypeAxis" xlink:to="loc_us-gaapPropertyPlantAndEquipmentTypeDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:label="loc_us-gaapPropertyPlantAndEquipmentTypeDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapPropertyPlantAndEquipmentByTypeAxis" xlink:to="loc_us-gaapPropertyPlantAndEquipmentTypeDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_MachineryAndEquipmentMember" xlink:label="loc_us-gaapMachineryAndEquipmentMember_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapPropertyPlantAndEquipmentTypeDomain" xlink:to="loc_us-gaapMachineryAndEquipmentMember_20" xlink:type="arc" order="21" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AwardTypeAxis" xlink:label="loc_us-gaapAwardTypeAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapScheduleOfPropertyPlantAndEquipmentTable" xlink:to="loc_us-gaapAwardTypeAxis" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:label="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapAwardTypeAxis" xlink:to="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:label="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapAwardTypeAxis" xlink:to="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockOptionMember" xlink:label="loc_us-gaapStockOptionMember_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="loc_us-gaapStockOptionMember_30" xlink:type="arc" order="31" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_Depreciation" xlink:label="loc_us-gaapDepreciation_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapPropertyPlantAndEquipmentLineItems" xlink:to="loc_us-gaapDepreciation_70" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AssetImpairmentCharges" xlink:label="loc_us-gaapAssetImpairmentCharges_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapPropertyPlantAndEquipmentLineItems" xlink:to="loc_us-gaapAssetImpairmentCharges_70" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PaymentsToAcquireMachineryAndEquipment" xlink:label="loc_us-gaapPaymentsToAcquireMachineryAndEquipment_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapPropertyPlantAndEquipmentLineItems" xlink:to="loc_us-gaapPaymentsToAcquireMachineryAndEquipment_70" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="stss-20240930.xsd#STSS_RemainingPaymentsDueOnMachinery" xlink:label="loc_STSSRemainingPaymentsDueOnMachinery_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapPropertyPlantAndEquipmentLineItems" xlink:to="loc_STSSRemainingPaymentsDueOnMachinery_70" xlink:type="arc" order="3" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://sharpstechnology.com/role/ScheduleOfFairValueOfAssetsAcquisitionDetails" xlink:title="00000039 - Disclosure - Schedule of Fair Value of the Assets Acquisition (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessAcquisitionLineItems" xlink:label="loc_us-gaapBusinessAcquisitionLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:label="loc_us-gaapScheduleOfBusinessAcquisitionsByAcquisitionTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapBusinessAcquisitionLineItems" xlink:to="loc_us-gaapScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessAcquisitionAxis" xlink:label="loc_us-gaapBusinessAcquisitionAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:to="loc_us-gaapBusinessAcquisitionAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessAcquisitionAcquireeDomain" xlink:label="loc_us-gaapBusinessAcquisitionAcquireeDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapBusinessAcquisitionAxis" xlink:to="loc_us-gaapBusinessAcquisitionAcquireeDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessAcquisitionAcquireeDomain" xlink:label="loc_us-gaapBusinessAcquisitionAcquireeDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapBusinessAcquisitionAxis" xlink:to="loc_us-gaapBusinessAcquisitionAcquireeDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="stss-20240930.xsd#STSS_SafegardMedicalIncMember" xlink:label="loc_STSSSafegardMedicalIncMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapBusinessAcquisitionAcquireeDomain" xlink:to="loc_STSSSafegardMedicalIncMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLand" xlink:label="loc_us-gaapBusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLand_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapBusinessAcquisitionLineItems" xlink:to="loc_us-gaapBusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLand_20" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedBuildings" xlink:label="loc_us-gaapBusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedBuildings_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapBusinessAcquisitionLineItems" xlink:to="loc_us-gaapBusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedBuildings_20" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedEquipment" xlink:label="loc_us-gaapBusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedEquipment_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapBusinessAcquisitionLineItems" xlink:to="loc_us-gaapBusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedEquipment_20" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory" xlink:label="loc_us-gaapBusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapBusinessAcquisitionLineItems" xlink:to="loc_us-gaapBusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory_20" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles" xlink:label="loc_us-gaapBusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapBusinessAcquisitionLineItems" xlink:to="loc_us-gaapBusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles_20" xlink:type="arc" order="4" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities" xlink:label="loc_us-gaapBusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapBusinessAcquisitionLineItems" xlink:to="loc_us-gaapBusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities_20" xlink:type="arc" order="5" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets" xlink:label="loc_us-gaapBusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapBusinessAcquisitionLineItems" xlink:to="loc_us-gaapBusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets_20" xlink:type="arc" order="6" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://sharpstechnology.com/role/AssetAcquisitionDetailsNarrative" xlink:title="00000040 - Disclosure - Asset Acquisition (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessAcquisitionLineItems" xlink:label="loc_us-gaapBusinessAcquisitionLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:label="loc_us-gaapScheduleOfBusinessAcquisitionsByAcquisitionTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapBusinessAcquisitionLineItems" xlink:to="loc_us-gaapScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TypeOfArrangementAxis" xlink:label="loc_us-gaapTypeOfArrangementAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:to="loc_us-gaapTypeOfArrangementAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:label="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapTypeOfArrangementAxis" xlink:to="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:label="loc_us-gaapArrangementsAndNonarrangementTransactionsMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapTypeOfArrangementAxis" xlink:to="loc_us-gaapArrangementsAndNonarrangementTransactionsMember_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="stss-20240930.xsd#STSS_SharePurchaseAgreementMember" xlink:label="loc_STSSSharePurchaseAgreementMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" xlink:to="loc_STSSSharePurchaseAgreementMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementEquityComponentsAxis" xlink:label="loc_us-gaapStatementEquityComponentsAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:to="loc_us-gaapStatementEquityComponentsAxis" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EquityComponentDomain" xlink:label="loc_us-gaapEquityComponentDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapStatementEquityComponentsAxis" xlink:to="loc_us-gaapEquityComponentDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EquityComponentDomain" xlink:label="loc_us-gaapEquityComponentDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapStatementEquityComponentsAxis" xlink:to="loc_us-gaapEquityComponentDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockMember" xlink:label="loc_us-gaapCommonStockMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapEquityComponentDomain" xlink:to="loc_us-gaapCommonStockMember_10" xlink:type="arc" order="12" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AwardTypeAxis" xlink:label="loc_us-gaapAwardTypeAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:to="loc_us-gaapAwardTypeAxis" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:label="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapAwardTypeAxis" xlink:to="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:label="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapAwardTypeAxis" xlink:to="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockOptionMember" xlink:label="loc_us-gaapStockOptionMember_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="loc_us-gaapStockOptionMember_30" xlink:type="arc" order="32" />
      <link:loc xlink:type="locator" xlink:href="stss-20240930.xsd#STSS_StockOptionOneMember" xlink:label="loc_STSSStockOptionOneMember_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="loc_STSSStockOptionOneMember_40" xlink:type="arc" order="42" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessAcquisitionAxis" xlink:label="loc_us-gaapBusinessAcquisitionAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:to="loc_us-gaapBusinessAcquisitionAxis" xlink:type="arc" order="4" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessAcquisitionAcquireeDomain" xlink:label="loc_us-gaapBusinessAcquisitionAcquireeDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapBusinessAcquisitionAxis" xlink:to="loc_us-gaapBusinessAcquisitionAcquireeDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessAcquisitionAcquireeDomain" xlink:label="loc_us-gaapBusinessAcquisitionAcquireeDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapBusinessAcquisitionAxis" xlink:to="loc_us-gaapBusinessAcquisitionAcquireeDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="stss-20240930.xsd#STSS_SafegardMedicalIncMember" xlink:label="loc_STSSSafegardMedicalIncMember_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapBusinessAcquisitionAcquireeDomain" xlink:to="loc_STSSSafegardMedicalIncMember_70" xlink:type="arc" order="71" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:label="loc_us-gaapPropertyPlantAndEquipmentByTypeAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:to="loc_us-gaapPropertyPlantAndEquipmentByTypeAxis" xlink:type="arc" order="5" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:label="loc_us-gaapPropertyPlantAndEquipmentTypeDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapPropertyPlantAndEquipmentByTypeAxis" xlink:to="loc_us-gaapPropertyPlantAndEquipmentTypeDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:label="loc_us-gaapPropertyPlantAndEquipmentTypeDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapPropertyPlantAndEquipmentByTypeAxis" xlink:to="loc_us-gaapPropertyPlantAndEquipmentTypeDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BuildingMember" xlink:label="loc_us-gaapBuildingMember_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapPropertyPlantAndEquipmentTypeDomain" xlink:to="loc_us-gaapBuildingMember_90" xlink:type="arc" order="91" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_MachineryAndEquipmentMember" xlink:label="loc_us-gaapMachineryAndEquipmentMember_100" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapPropertyPlantAndEquipmentTypeDomain" xlink:to="loc_us-gaapMachineryAndEquipmentMember_100" xlink:type="arc" order="101" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FiniteLivedIntangibleAssetsMember" xlink:label="loc_us-gaapFiniteLivedIntangibleAssetsMember_120" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapPropertyPlantAndEquipmentTypeDomain" xlink:to="loc_us-gaapFiniteLivedIntangibleAssetsMember_120" xlink:type="arc" order="121" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RangeAxis" xlink:label="loc_srtRangeAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:to="loc_srtRangeAxis" xlink:type="arc" order="6" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RangeMember" xlink:label="loc_srtRangeMember" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srtRangeAxis" xlink:to="loc_srtRangeMember" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RangeMember" xlink:label="loc_srtRangeMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_srtRangeAxis" xlink:to="loc_srtRangeMember_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_MinimumMember" xlink:label="loc_srtMinimumMember_100" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtRangeMember" xlink:to="loc_srtMinimumMember_100" xlink:type="arc" order="102" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_MaximumMember" xlink:label="loc_srtMaximumMember_110" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtRangeMember" xlink:to="loc_srtMaximumMember_110" xlink:type="arc" order="112" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DerivativeInstrumentRiskAxis" xlink:label="loc_us-gaapDerivativeInstrumentRiskAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:to="loc_us-gaapDerivativeInstrumentRiskAxis" xlink:type="arc" order="7" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DerivativeContractTypeDomain" xlink:label="loc_us-gaapDerivativeContractTypeDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapDerivativeInstrumentRiskAxis" xlink:to="loc_us-gaapDerivativeContractTypeDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DerivativeContractTypeDomain" xlink:label="loc_us-gaapDerivativeContractTypeDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapDerivativeInstrumentRiskAxis" xlink:to="loc_us-gaapDerivativeContractTypeDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockOptionMember" xlink:label="loc_us-gaapStockOptionMember_150" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapDerivativeContractTypeDomain" xlink:to="loc_us-gaapStockOptionMember_150" xlink:type="arc" order="153" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AssetAcquisitionConsiderationTransferred" xlink:label="loc_us-gaapAssetAcquisitionConsiderationTransferred_200" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapBusinessAcquisitionLineItems" xlink:to="loc_us-gaapAssetAcquisitionConsiderationTransferred_200" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockIssuedDuringPeriodSharesAcquisitions" xlink:label="loc_us-gaapStockIssuedDuringPeriodSharesAcquisitions_200" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapBusinessAcquisitionLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodSharesAcquisitions_200" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SharePrice" xlink:label="loc_us-gaapSharePrice_200" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapBusinessAcquisitionLineItems" xlink:to="loc_us-gaapSharePrice_200" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod_200" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapBusinessAcquisitionLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod_200" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:label="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_200" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapBusinessAcquisitionLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_200" xlink:type="arc" order="4" />
      <link:loc xlink:type="locator" xlink:href="stss-20240930.xsd#STSS_FairMarketValueOfCommonStock" xlink:label="loc_STSSFairMarketValueOfCommonStock_200" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapBusinessAcquisitionLineItems" xlink:to="loc_STSSFairMarketValueOfCommonStock_200" xlink:type="arc" order="5" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1" xlink:label="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1_200" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapBusinessAcquisitionLineItems" xlink:to="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1_200" xlink:type="arc" order="6" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingCostsAndExpenses" xlink:label="loc_us-gaapOperatingCostsAndExpenses_200" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapBusinessAcquisitionLineItems" xlink:to="loc_us-gaapOperatingCostsAndExpenses_200" xlink:type="arc" order="7" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets" xlink:label="loc_us-gaapBusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets_200" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapBusinessAcquisitionLineItems" xlink:to="loc_us-gaapBusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets_200" xlink:type="arc" order="8" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueOfAssetsAcquired" xlink:label="loc_us-gaapFairValueOfAssetsAcquired_200" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapBusinessAcquisitionLineItems" xlink:to="loc_us-gaapFairValueOfAssetsAcquired_200" xlink:type="arc" order="9" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FiniteLivedIntangibleAssetUsefulLife" xlink:label="loc_us-gaapFiniteLivedIntangibleAssetUsefulLife_200" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapBusinessAcquisitionLineItems" xlink:to="loc_us-gaapFiniteLivedIntangibleAssetUsefulLife_200" xlink:type="arc" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PaymentsToAcquireBusinessesGross" xlink:label="loc_us-gaapPaymentsToAcquireBusinessesGross_200" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapBusinessAcquisitionLineItems" xlink:to="loc_us-gaapPaymentsToAcquireBusinessesGross_200" xlink:type="arc" order="11" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessAcquisitionCostOfAcquiredEntityTransactionCosts" xlink:label="loc_us-gaapBusinessAcquisitionCostOfAcquiredEntityTransactionCosts_200" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapBusinessAcquisitionLineItems" xlink:to="loc_us-gaapBusinessAcquisitionCostOfAcquiredEntityTransactionCosts_200" xlink:type="arc" order="12" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentUsefulLife" xlink:label="loc_us-gaapPropertyPlantAndEquipmentUsefulLife_200" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapBusinessAcquisitionLineItems" xlink:to="loc_us-gaapPropertyPlantAndEquipmentUsefulLife_200" xlink:type="arc" order="13" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://sharpstechnology.com/role/ScheduleOfOtherAssetsDetails" xlink:title="00000041 - Disclosure - Schedule of Other Assets (Details)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://sharpstechnology.com/role/OtherAssetsDetailsNarrative" xlink:title="00000042 - Disclosure - Other Assets (Details Narrative)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://sharpstechnology.com/role/DebtFinancingDetailsNarrative" xlink:title="00000043 - Disclosure - Debt Financing (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShortTermDebtLineItems" xlink:label="loc_us-gaapShortTermDebtLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfShortTermDebtTable" xlink:label="loc_us-gaapScheduleOfShortTermDebtTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapShortTermDebtLineItems" xlink:to="loc_us-gaapScheduleOfShortTermDebtTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TypeOfArrangementAxis" xlink:label="loc_us-gaapTypeOfArrangementAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapScheduleOfShortTermDebtTable" xlink:to="loc_us-gaapTypeOfArrangementAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:label="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapTypeOfArrangementAxis" xlink:to="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:label="loc_us-gaapArrangementsAndNonarrangementTransactionsMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapTypeOfArrangementAxis" xlink:to="loc_us-gaapArrangementsAndNonarrangementTransactionsMember_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="stss-20240930.xsd#STSS_SecuritiesPurchaseAgreementMember" xlink:label="loc_STSSSecuritiesPurchaseAgreementMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" xlink:to="loc_STSSSecuritiesPurchaseAgreementMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentAxis" xlink:label="loc_us-gaapDebtInstrumentAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapScheduleOfShortTermDebtTable" xlink:to="loc_us-gaapDebtInstrumentAxis" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentNameDomain" xlink:label="loc_us-gaapDebtInstrumentNameDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapDebtInstrumentAxis" xlink:to="loc_us-gaapDebtInstrumentNameDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentNameDomain" xlink:label="loc_us-gaapDebtInstrumentNameDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapDebtInstrumentAxis" xlink:to="loc_us-gaapDebtInstrumentNameDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="stss-20240930.xsd#STSS_SeniorSecuredNoteMember" xlink:label="loc_STSSSeniorSecuredNoteMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapDebtInstrumentNameDomain" xlink:to="loc_STSSSeniorSecuredNoteMember_0" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AwardTypeAxis" xlink:label="loc_us-gaapAwardTypeAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapScheduleOfShortTermDebtTable" xlink:to="loc_us-gaapAwardTypeAxis" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:label="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapAwardTypeAxis" xlink:to="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:label="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapAwardTypeAxis" xlink:to="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="stss-20240930.xsd#STSS_PreReverseMember" xlink:label="loc_STSSPreReverseMember_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="loc_STSSPreReverseMember_20" xlink:type="arc" order="23" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentFaceAmount" xlink:label="loc_us-gaapDebtInstrumentFaceAmount_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShortTermDebtLineItems" xlink:to="loc_us-gaapDebtInstrumentFaceAmount_50" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentIncreaseAccruedInterest" xlink:label="loc_us-gaapDebtInstrumentIncreaseAccruedInterest_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShortTermDebtLineItems" xlink:to="loc_us-gaapDebtInstrumentIncreaseAccruedInterest_50" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentMaturityDate" xlink:label="loc_us-gaapDebtInstrumentMaturityDate_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShortTermDebtLineItems" xlink:to="loc_us-gaapDebtInstrumentMaturityDate_50" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="stss-20240930.xsd#STSS_NumberOfUnregisteredCommonStockIssuedDuringPostReverseShares" xlink:label="loc_STSSNumberOfUnregisteredCommonStockIssuedDuringPostReverseShares_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShortTermDebtLineItems" xlink:to="loc_STSSNumberOfUnregisteredCommonStockIssuedDuringPostReverseShares_50" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="stss-20240930.xsd#STSS_NumberOfUnregisteredCommonStockIssuedDuringPreReverseShares" xlink:label="loc_STSSNumberOfUnregisteredCommonStockIssuedDuringPreReverseShares_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShortTermDebtLineItems" xlink:to="loc_STSSNumberOfUnregisteredCommonStockIssuedDuringPreReverseShares_50" xlink:type="arc" order="4" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ProceedsFromIssuanceOfDebt" xlink:label="loc_us-gaapProceedsFromIssuanceOfDebt_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShortTermDebtLineItems" xlink:to="loc_us-gaapProceedsFromIssuanceOfDebt_50" xlink:type="arc" order="5" />
      <link:loc xlink:type="locator" xlink:href="stss-20240930.xsd#STSS_PlacementAgentAndOtherOfferingExpenses" xlink:label="loc_STSSPlacementAgentAndOtherOfferingExpenses_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShortTermDebtLineItems" xlink:to="loc_STSSPlacementAgentAndOtherOfferingExpenses_50" xlink:type="arc" order="6" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EscrowDeposit" xlink:label="loc_us-gaapEscrowDeposit_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShortTermDebtLineItems" xlink:to="loc_us-gaapEscrowDeposit_50" xlink:type="arc" order="7" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentFairValue" xlink:label="loc_us-gaapDebtInstrumentFairValue_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShortTermDebtLineItems" xlink:to="loc_us-gaapDebtInstrumentFairValue_50" xlink:type="arc" order="8" />
      <link:loc xlink:type="locator" xlink:href="stss-20240930.xsd#STSS_CommonStockFairValue" xlink:label="loc_STSSCommonStockFairValue_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShortTermDebtLineItems" xlink:to="loc_STSSCommonStockFairValue_50" xlink:type="arc" order="9" />
      <link:loc xlink:type="locator" xlink:href="stss-20240930.xsd#STSS_AccretedInterestFees" xlink:label="loc_STSSAccretedInterestFees_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShortTermDebtLineItems" xlink:to="loc_STSSAccretedInterestFees_50" xlink:type="arc" order="10" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://sharpstechnology.com/role/NotePurchaseAgreementDetailsNarrative" xlink:title="00000044 - Disclosure - Note Purchase Agreement (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:label="loc_us-gaapCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" xlink:label="loc_us-gaapScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="loc_us-gaapScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TypeOfArrangementAxis" xlink:label="loc_us-gaapTypeOfArrangementAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" xlink:to="loc_us-gaapTypeOfArrangementAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:label="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapTypeOfArrangementAxis" xlink:to="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:label="loc_us-gaapArrangementsAndNonarrangementTransactionsMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapTypeOfArrangementAxis" xlink:to="loc_us-gaapArrangementsAndNonarrangementTransactionsMember_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="stss-20240930.xsd#STSS_NotePurchaseAgreementMember" xlink:label="loc_STSSNotePurchaseAgreementMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" xlink:to="loc_STSSNotePurchaseAgreementMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_TitleOfIndividualAxis" xlink:label="loc_srtTitleOfIndividualAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" xlink:to="loc_srtTitleOfIndividualAxis" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:label="loc_srtTitleOfIndividualWithRelationshipToEntityDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srtTitleOfIndividualAxis" xlink:to="loc_srtTitleOfIndividualWithRelationshipToEntityDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:label="loc_srtTitleOfIndividualWithRelationshipToEntityDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_srtTitleOfIndividualAxis" xlink:to="loc_srtTitleOfIndividualWithRelationshipToEntityDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="stss-20240930.xsd#STSS_UnrelatedThirdPartyPurchasersMember" xlink:label="loc_STSSUnrelatedThirdPartyPurchasersMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtTitleOfIndividualWithRelationshipToEntityDomain" xlink:to="loc_STSSUnrelatedThirdPartyPurchasersMember_0" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubsidiarySaleOfStockAxis" xlink:label="loc_us-gaapSubsidiarySaleOfStockAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" xlink:to="loc_us-gaapSubsidiarySaleOfStockAxis" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SaleOfStockNameOfTransactionDomain" xlink:label="loc_us-gaapSaleOfStockNameOfTransactionDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapSubsidiarySaleOfStockAxis" xlink:to="loc_us-gaapSaleOfStockNameOfTransactionDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SaleOfStockNameOfTransactionDomain" xlink:label="loc_us-gaapSaleOfStockNameOfTransactionDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapSubsidiarySaleOfStockAxis" xlink:to="loc_us-gaapSaleOfStockNameOfTransactionDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NoteWarrantMember" xlink:label="loc_us-gaapNoteWarrantMember_80" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapSaleOfStockNameOfTransactionDomain" xlink:to="loc_us-gaapNoteWarrantMember_80" xlink:type="arc" order="82" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentFaceAmount" xlink:label="loc_us-gaapDebtInstrumentFaceAmount_110" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="loc_us-gaapDebtInstrumentFaceAmount_110" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:label="loc_us-gaapDebtInstrumentInterestRateStatedPercentage_110" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="loc_us-gaapDebtInstrumentInterestRateStatedPercentage_110" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentDescription" xlink:label="loc_us-gaapDebtInstrumentDescription_110" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="loc_us-gaapDebtInstrumentDescription_110" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="stss-20240930.xsd#STSS_ContingentStockLiability" xlink:label="loc_STSSContingentStockLiability_110" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="loc_STSSContingentStockLiability_110" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="stss-20240930.xsd#STSS_ContingentWarrantLiability" xlink:label="loc_STSSContingentWarrantLiability_110" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="loc_STSSContingentWarrantLiability_110" xlink:type="arc" order="4" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PaymentsOfDebtIssuanceCosts" xlink:label="loc_us-gaapPaymentsOfDebtIssuanceCosts_110" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="loc_us-gaapPaymentsOfDebtIssuanceCosts_110" xlink:type="arc" order="5" />
      <link:loc xlink:type="locator" xlink:href="stss-20240930.xsd#STSS_AllocationOfDebtIssuanceCostToContingentStockAndContingentWarrants" xlink:label="loc_STSSAllocationOfDebtIssuanceCostToContingentStockAndContingentWarrants_110" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="loc_STSSAllocationOfDebtIssuanceCostToContingentStockAndContingentWarrants_110" xlink:type="arc" order="6" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NotesPayable" xlink:label="loc_us-gaapNotesPayable_110" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="loc_us-gaapNotesPayable_110" xlink:type="arc" order="7" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentUnamortizedDiscount" xlink:label="loc_us-gaapDebtInstrumentUnamortizedDiscount_110" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="loc_us-gaapDebtInstrumentUnamortizedDiscount_110" xlink:type="arc" order="8" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_InterestExpense" xlink:label="loc_us-gaapInterestExpense_110" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="loc_us-gaapInterestExpense_110" xlink:type="arc" order="9" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_InterestPayableCurrent" xlink:label="loc_us-gaapInterestPayableCurrent_110" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="loc_us-gaapInterestPayableCurrent_110" xlink:type="arc" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RepaymentsOfDebt" xlink:label="loc_us-gaapRepaymentsOfDebt_110" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="loc_us-gaapRepaymentsOfDebt_110" xlink:type="arc" order="11" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockSharesIssued" xlink:label="loc_us-gaapCommonStockSharesIssued_110" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="loc_us-gaapCommonStockSharesIssued_110" xlink:type="arc" order="12" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueAdjustmentOfWarrants" xlink:label="loc_us-gaapFairValueAdjustmentOfWarrants_110" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="loc_us-gaapFairValueAdjustmentOfWarrants_110" xlink:type="arc" order="13" />
      <link:loc xlink:type="locator" xlink:href="stss-20240930.xsd#STSS_ContingentWarrants" xlink:label="loc_STSSContingentWarrants_110" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="loc_STSSContingentWarrants_110" xlink:type="arc" order="14" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice" xlink:label="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice_110" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice_110" xlink:type="arc" order="15" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://sharpstechnology.com/role/StockholdersEquityDetailsNarrative" xlink:title="00000045 - Disclosure - Stockholders&#8217; Equity (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubsidiarySaleOfStockLineItems" xlink:label="loc_us-gaapSubsidiarySaleOfStockLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable" xlink:label="loc_us-gaapSubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapSubsidiarySaleOfStockLineItems" xlink:to="loc_us-gaapSubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubsidiarySaleOfStockAxis" xlink:label="loc_us-gaapSubsidiarySaleOfStockAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapSubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable" xlink:to="loc_us-gaapSubsidiarySaleOfStockAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SaleOfStockNameOfTransactionDomain" xlink:label="loc_us-gaapSaleOfStockNameOfTransactionDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapSubsidiarySaleOfStockAxis" xlink:to="loc_us-gaapSaleOfStockNameOfTransactionDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SaleOfStockNameOfTransactionDomain" xlink:label="loc_us-gaapSaleOfStockNameOfTransactionDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapSubsidiarySaleOfStockAxis" xlink:to="loc_us-gaapSaleOfStockNameOfTransactionDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="stss-20240930.xsd#STSS_ShelfOfferingMember" xlink:label="loc_STSSShelfOfferingMember_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapSaleOfStockNameOfTransactionDomain" xlink:to="loc_STSSShelfOfferingMember_60" xlink:type="arc" order="61" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PrivatePlacementMember" xlink:label="loc_us-gaapPrivatePlacementMember_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapSaleOfStockNameOfTransactionDomain" xlink:to="loc_us-gaapPrivatePlacementMember_90" xlink:type="arc" order="91" />
      <link:loc xlink:type="locator" xlink:href="stss-20240930.xsd#STSS_NonTradingWarrantsMember" xlink:label="loc_STSSNonTradingWarrantsMember_110" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapSaleOfStockNameOfTransactionDomain" xlink:to="loc_STSSNonTradingWarrantsMember_110" xlink:type="arc" order="111" />
      <link:loc xlink:type="locator" xlink:href="stss-20240930.xsd#STSS_SecuritiesPurchaseAgreementMember" xlink:label="loc_STSSSecuritiesPurchaseAgreementMember_120" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapSaleOfStockNameOfTransactionDomain" xlink:to="loc_STSSSecuritiesPurchaseAgreementMember_120" xlink:type="arc" order="122" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IPOMember" xlink:label="loc_us-gaapIPOMember_220" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapSaleOfStockNameOfTransactionDomain" xlink:to="loc_us-gaapIPOMember_220" xlink:type="arc" order="221" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NoteWarrantMember" xlink:label="loc_us-gaapNoteWarrantMember_280" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapSaleOfStockNameOfTransactionDomain" xlink:to="loc_us-gaapNoteWarrantMember_280" xlink:type="arc" order="281" />
      <link:loc xlink:type="locator" xlink:href="stss-20240930.xsd#STSS_TradingWarrantsMember" xlink:label="loc_STSSTradingWarrantsMember_370" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapSaleOfStockNameOfTransactionDomain" xlink:to="loc_STSSTradingWarrantsMember_370" xlink:type="arc" order="371" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OverAllotmentOptionMember" xlink:label="loc_us-gaapOverAllotmentOptionMember_380" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapSaleOfStockNameOfTransactionDomain" xlink:to="loc_us-gaapOverAllotmentOptionMember_380" xlink:type="arc" order="381" />
      <link:loc xlink:type="locator" xlink:href="stss-20240930.xsd#STSS_NoteWarrantsMember" xlink:label="loc_STSSNoteWarrantsMember_450" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapSaleOfStockNameOfTransactionDomain" xlink:to="loc_STSSNoteWarrantsMember_450" xlink:type="arc" order="451" />
      <link:loc xlink:type="locator" xlink:href="stss-20240930.xsd#STSS_InducementWarrantsMember" xlink:label="loc_STSSInducementWarrantsMember_710" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapSaleOfStockNameOfTransactionDomain" xlink:to="loc_STSSInducementWarrantsMember_710" xlink:type="arc" order="711" />
      <link:loc xlink:type="locator" xlink:href="stss-20240930.xsd#STSS_OverAllotmentWarrantsMember" xlink:label="loc_STSSOverAllotmentWarrantsMember_1440" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapSaleOfStockNameOfTransactionDomain" xlink:to="loc_STSSOverAllotmentWarrantsMember_1440" xlink:type="arc" order="1441" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TypeOfArrangementAxis" xlink:label="loc_us-gaapTypeOfArrangementAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapSubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable" xlink:to="loc_us-gaapTypeOfArrangementAxis" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:label="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapTypeOfArrangementAxis" xlink:to="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:label="loc_us-gaapArrangementsAndNonarrangementTransactionsMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapTypeOfArrangementAxis" xlink:to="loc_us-gaapArrangementsAndNonarrangementTransactionsMember_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="stss-20240930.xsd#STSS_SecuritiesPurchaseAgreementMember" xlink:label="loc_STSSSecuritiesPurchaseAgreementMember_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" xlink:to="loc_STSSSecuritiesPurchaseAgreementMember_60" xlink:type="arc" order="62" />
      <link:loc xlink:type="locator" xlink:href="stss-20240930.xsd#STSS_PurchaseAgreementMember" xlink:label="loc_STSSPurchaseAgreementMember_120" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" xlink:to="loc_STSSPurchaseAgreementMember_120" xlink:type="arc" order="121" />
      <link:loc xlink:type="locator" xlink:href="stss-20240930.xsd#STSS_NotePurchaseAgreementMember" xlink:label="loc_STSSNotePurchaseAgreementMember_260" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" xlink:to="loc_STSSNotePurchaseAgreementMember_260" xlink:type="arc" order="261" />
      <link:loc xlink:type="locator" xlink:href="stss-20240930.xsd#STSS_SubscriptionAgreementsMember" xlink:label="loc_STSSSubscriptionAgreementsMember_550" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" xlink:to="loc_STSSSubscriptionAgreementsMember_550" xlink:type="arc" order="551" />
      <link:loc xlink:type="locator" xlink:href="stss-20240930.xsd#STSS_InducementAgreementMember" xlink:label="loc_STSSInducementAgreementMember_630" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" xlink:to="loc_STSSInducementAgreementMember_630" xlink:type="arc" order="631" />
      <link:loc xlink:type="locator" xlink:href="stss-20240930.xsd#STSS_InducementWarrantsMember" xlink:label="loc_STSSInducementWarrantsMember_690" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" xlink:to="loc_STSSInducementWarrantsMember_690" xlink:type="arc" order="691" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementEquityComponentsAxis" xlink:label="loc_us-gaapStatementEquityComponentsAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapSubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable" xlink:to="loc_us-gaapStatementEquityComponentsAxis" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EquityComponentDomain" xlink:label="loc_us-gaapEquityComponentDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapStatementEquityComponentsAxis" xlink:to="loc_us-gaapEquityComponentDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EquityComponentDomain" xlink:label="loc_us-gaapEquityComponentDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapStatementEquityComponentsAxis" xlink:to="loc_us-gaapEquityComponentDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_WarrantMember" xlink:label="loc_us-gaapWarrantMember_80" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapEquityComponentDomain" xlink:to="loc_us-gaapWarrantMember_80" xlink:type="arc" order="83" />
      <link:loc xlink:type="locator" xlink:href="stss-20240930.xsd#STSS_PIPEPreFundedWarrantsMember" xlink:label="loc_STSSPIPEPreFundedWarrantsMember_100" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapEquityComponentDomain" xlink:to="loc_STSSPIPEPreFundedWarrantsMember_100" xlink:type="arc" order="103" />
      <link:loc xlink:type="locator" xlink:href="stss-20240930.xsd#STSS_PIPEWarrantMember" xlink:label="loc_STSSPIPEWarrantMember_310" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapEquityComponentDomain" xlink:to="loc_STSSPIPEWarrantMember_310" xlink:type="arc" order="312" />
      <link:loc xlink:type="locator" xlink:href="stss-20240930.xsd#STSS_PreFundedWarrantsMember" xlink:label="loc_STSSPreFundedWarrantsMember_810" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapEquityComponentDomain" xlink:to="loc_STSSPreFundedWarrantsMember_810" xlink:type="arc" order="813" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AwardTypeAxis" xlink:label="loc_us-gaapAwardTypeAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapSubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable" xlink:to="loc_us-gaapAwardTypeAxis" xlink:type="arc" order="4" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:label="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapAwardTypeAxis" xlink:to="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:label="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapAwardTypeAxis" xlink:to="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="stss-20240930.xsd#STSS_PreReverseMember" xlink:label="loc_STSSPreReverseMember_540" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="loc_STSSPreReverseMember_540" xlink:type="arc" order="542" />
      <link:loc xlink:type="locator" xlink:href="stss-20240930.xsd#STSS_ReverseStockSplitMember" xlink:label="loc_STSSReverseStockSplitMember_770" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="loc_STSSReverseStockSplitMember_770" xlink:type="arc" order="773" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_TitleOfIndividualAxis" xlink:label="loc_srtTitleOfIndividualAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapSubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable" xlink:to="loc_srtTitleOfIndividualAxis" xlink:type="arc" order="5" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:label="loc_srtTitleOfIndividualWithRelationshipToEntityDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srtTitleOfIndividualAxis" xlink:to="loc_srtTitleOfIndividualWithRelationshipToEntityDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:label="loc_srtTitleOfIndividualWithRelationshipToEntityDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_srtTitleOfIndividualAxis" xlink:to="loc_srtTitleOfIndividualWithRelationshipToEntityDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="stss-20240930.xsd#STSS_InvestorsMember" xlink:label="loc_STSSInvestorsMember_550" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtTitleOfIndividualWithRelationshipToEntityDomain" xlink:to="loc_STSSInvestorsMember_550" xlink:type="arc" order="552" />
      <link:loc xlink:type="locator" xlink:href="stss-20240930.xsd#STSS_WarrantHoldersMember" xlink:label="loc_STSSWarrantHoldersMember_690" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtTitleOfIndividualWithRelationshipToEntityDomain" xlink:to="loc_STSSWarrantHoldersMember_690" xlink:type="arc" order="692" />
      <link:loc xlink:type="locator" xlink:href="stss-20240930.xsd#STSS_WarrantHolderMember" xlink:label="loc_STSSWarrantHolderMember_1150" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtTitleOfIndividualWithRelationshipToEntityDomain" xlink:to="loc_STSSWarrantHolderMember_1150" xlink:type="arc" order="1151" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RangeAxis" xlink:label="loc_srtRangeAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapSubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable" xlink:to="loc_srtRangeAxis" xlink:type="arc" order="6" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RangeMember" xlink:label="loc_srtRangeMember" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srtRangeAxis" xlink:to="loc_srtRangeMember" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RangeMember" xlink:label="loc_srtRangeMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_srtRangeAxis" xlink:to="loc_srtRangeMember_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_MaximumMember" xlink:label="loc_srtMaximumMember_660" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtRangeMember" xlink:to="loc_srtMaximumMember_660" xlink:type="arc" order="663" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_MinimumMember" xlink:label="loc_srtMinimumMember_680" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtRangeMember" xlink:to="loc_srtMinimumMember_680" xlink:type="arc" order="683" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockSharesAuthorized" xlink:label="loc_us-gaapCommonStockSharesAuthorized_1590" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapSubsidiarySaleOfStockLineItems" xlink:to="loc_us-gaapCommonStockSharesAuthorized_1590" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockParOrStatedValuePerShare" xlink:label="loc_us-gaapCommonStockParOrStatedValuePerShare_1590" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapSubsidiarySaleOfStockLineItems" xlink:to="loc_us-gaapCommonStockParOrStatedValuePerShare_1590" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PreferredStockSharesAuthorized" xlink:label="loc_us-gaapPreferredStockSharesAuthorized_1590" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapSubsidiarySaleOfStockLineItems" xlink:to="loc_us-gaapPreferredStockSharesAuthorized_1590" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PreferredStockParOrStatedValuePerShare" xlink:label="loc_us-gaapPreferredStockParOrStatedValuePerShare_1590" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapSubsidiarySaleOfStockLineItems" xlink:to="loc_us-gaapPreferredStockParOrStatedValuePerShare_1590" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ConversionOfStockDescription" xlink:label="loc_us-gaapConversionOfStockDescription_1590" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapSubsidiarySaleOfStockLineItems" xlink:to="loc_us-gaapConversionOfStockDescription_1590" xlink:type="arc" order="4" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ProceedsFromIssuanceOfCommonStock" xlink:label="loc_us-gaapProceedsFromIssuanceOfCommonStock_1590" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapSubsidiarySaleOfStockLineItems" xlink:to="loc_us-gaapProceedsFromIssuanceOfCommonStock_1590" xlink:type="arc" order="5" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherExpenses" xlink:label="loc_us-gaapOtherExpenses_1590" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapSubsidiarySaleOfStockLineItems" xlink:to="loc_us-gaapOtherExpenses_1590" xlink:type="arc" order="6" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ProceedsFromIssuanceInitialPublicOffering" xlink:label="loc_us-gaapProceedsFromIssuanceInitialPublicOffering_1590" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapSubsidiarySaleOfStockLineItems" xlink:to="loc_us-gaapProceedsFromIssuanceInitialPublicOffering_1590" xlink:type="arc" order="7" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LegalFees" xlink:label="loc_us-gaapLegalFees_1590" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapSubsidiarySaleOfStockLineItems" xlink:to="loc_us-gaapLegalFees_1590" xlink:type="arc" order="8" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:label="loc_us-gaapStockIssuedDuringPeriodSharesNewIssues_1590" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapSubsidiarySaleOfStockLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodSharesNewIssues_1590" xlink:type="arc" order="9" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SharesIssuedPricePerShare" xlink:label="loc_us-gaapSharesIssuedPricePerShare_1590" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapSubsidiarySaleOfStockLineItems" xlink:to="loc_us-gaapSharesIssuedPricePerShare_1590" xlink:type="arc" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight" xlink:label="loc_us-gaapClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight_1590" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapSubsidiarySaleOfStockLineItems" xlink:to="loc_us-gaapClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight_1590" xlink:type="arc" order="11" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" xlink:label="loc_us-gaapClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_1590" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapSubsidiarySaleOfStockLineItems" xlink:to="loc_us-gaapClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_1590" xlink:type="arc" order="12" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ProceedsFromIssuanceOfPrivatePlacement" xlink:label="loc_us-gaapProceedsFromIssuanceOfPrivatePlacement_1590" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapSubsidiarySaleOfStockLineItems" xlink:to="loc_us-gaapProceedsFromIssuanceOfPrivatePlacement_1590" xlink:type="arc" order="13" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_WarrantsAndRightsOutstandingTerm" xlink:label="loc_us-gaapWarrantsAndRightsOutstandingTerm_1590" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapSubsidiarySaleOfStockLineItems" xlink:to="loc_us-gaapWarrantsAndRightsOutstandingTerm_1590" xlink:type="arc" order="14" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AdditionalPaidInCapital" xlink:label="loc_us-gaapAdditionalPaidInCapital_1590" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapSubsidiarySaleOfStockLineItems" xlink:to="loc_us-gaapAdditionalPaidInCapital_1590" xlink:type="arc" order="15" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueAdjustmentOfWarrants" xlink:label="loc_us-gaapFairValueAdjustmentOfWarrants_1590" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapSubsidiarySaleOfStockLineItems" xlink:to="loc_us-gaapFairValueAdjustmentOfWarrants_1590" xlink:type="arc" order="16" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_WarrantsAndRightsOutstanding" xlink:label="loc_us-gaapWarrantsAndRightsOutstanding_1590" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapSubsidiarySaleOfStockLineItems" xlink:to="loc_us-gaapWarrantsAndRightsOutstanding_1590" xlink:type="arc" order="17" />
      <link:loc xlink:type="locator" xlink:href="stss-20240930.xsd#STSS_NetProceedsFromIssuanceInitialPublicOffering" xlink:label="loc_STSSNetProceedsFromIssuanceInitialPublicOffering_1590" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapSubsidiarySaleOfStockLineItems" xlink:to="loc_STSSNetProceedsFromIssuanceInitialPublicOffering_1590" xlink:type="arc" order="18" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NoninterestExpenseOfferingCost" xlink:label="loc_us-gaapNoninterestExpenseOfferingCost_1590" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapSubsidiarySaleOfStockLineItems" xlink:to="loc_us-gaapNoninterestExpenseOfferingCost_1590" xlink:type="arc" order="19" />
      <link:loc xlink:type="locator" xlink:href="stss-20240930.xsd#STSS_ClassOfWarrantOrRightExercisePriceOfWarrantsAdjusted" xlink:label="loc_STSSClassOfWarrantOrRightExercisePriceOfWarrantsAdjusted_1590" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapSubsidiarySaleOfStockLineItems" xlink:to="loc_STSSClassOfWarrantOrRightExercisePriceOfWarrantsAdjusted_1590" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="stss-20240930.xsd#STSS_StockIssuedDuringPeriodSharesInitialPublicOffering" xlink:label="loc_STSSStockIssuedDuringPeriodSharesInitialPublicOffering_1590" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapSubsidiarySaleOfStockLineItems" xlink:to="loc_STSSStockIssuedDuringPeriodSharesInitialPublicOffering_1590" xlink:type="arc" order="21" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice" xlink:label="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice_1590" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapSubsidiarySaleOfStockLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice_1590" xlink:type="arc" order="22" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfWarrantOrRightOutstanding" xlink:label="loc_us-gaapClassOfWarrantOrRightOutstanding_1590" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapSubsidiarySaleOfStockLineItems" xlink:to="loc_us-gaapClassOfWarrantOrRightOutstanding_1590" xlink:type="arc" order="23" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockIssuedDuringPeriodSharesIssuedForServices" xlink:label="loc_us-gaapStockIssuedDuringPeriodSharesIssuedForServices_1590" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapSubsidiarySaleOfStockLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodSharesIssuedForServices_1590" xlink:type="arc" order="24" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockIssuedDuringPeriodValueIssuedForServices" xlink:label="loc_us-gaapStockIssuedDuringPeriodValueIssuedForServices_1590" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapSubsidiarySaleOfStockLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodValueIssuedForServices_1590" xlink:type="arc" order="25" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:label="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_1590" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapSubsidiarySaleOfStockLineItems" xlink:to="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_1590" xlink:type="arc" order="26" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum_1590" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapSubsidiarySaleOfStockLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum_1590" xlink:type="arc" order="27" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum_1590" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapSubsidiarySaleOfStockLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum_1590" xlink:type="arc" order="28" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum_1590" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapSubsidiarySaleOfStockLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum_1590" xlink:type="arc" order="29" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum_1590" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapSubsidiarySaleOfStockLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum_1590" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_1590" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapSubsidiarySaleOfStockLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_1590" xlink:type="arc" order="31" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_MarketRiskBenefitChangeInFairValueGainLoss" xlink:label="loc_us-gaapMarketRiskBenefitChangeInFairValueGainLoss_1590" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapSubsidiarySaleOfStockLineItems" xlink:to="loc_us-gaapMarketRiskBenefitChangeInFairValueGainLoss_1590" xlink:type="arc" order="32" />
      <link:loc xlink:type="locator" xlink:href="stss-20240930.xsd#STSS_PaymentsForRepurchaseOfLiability" xlink:label="loc_STSSPaymentsForRepurchaseOfLiability_1590" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapSubsidiarySaleOfStockLineItems" xlink:to="loc_STSSPaymentsForRepurchaseOfLiability_1590" xlink:type="arc" order="33" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PaymentsOfStockIssuanceCosts" xlink:label="loc_us-gaapPaymentsOfStockIssuanceCosts_1590" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapSubsidiarySaleOfStockLineItems" xlink:to="loc_us-gaapPaymentsOfStockIssuanceCosts_1590" xlink:type="arc" order="34" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate_1590" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapSubsidiarySaleOfStockLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate_1590" xlink:type="arc" order="35" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_1590" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapSubsidiarySaleOfStockLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_1590" xlink:type="arc" order="36" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockIssuedDuringPeriodSharesOther" xlink:label="loc_us-gaapStockIssuedDuringPeriodSharesOther_1590" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapSubsidiarySaleOfStockLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodSharesOther_1590" xlink:type="arc" order="37" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction" xlink:label="loc_us-gaapSaleOfStockNumberOfSharesIssuedInTransaction_1590" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapSubsidiarySaleOfStockLineItems" xlink:to="loc_us-gaapSaleOfStockNumberOfSharesIssuedInTransaction_1590" xlink:type="arc" order="38" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SaleOfStockPricePerShare" xlink:label="loc_us-gaapSaleOfStockPricePerShare_1590" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapSubsidiarySaleOfStockLineItems" xlink:to="loc_us-gaapSaleOfStockPricePerShare_1590" xlink:type="arc" order="39" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" xlink:label="loc_us-gaapClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_1590" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapSubsidiarySaleOfStockLineItems" xlink:to="loc_us-gaapClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_1590" xlink:type="arc" order="40" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ProceedsFromIssuanceOfWarrants" xlink:label="loc_us-gaapProceedsFromIssuanceOfWarrants_1590" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapSubsidiarySaleOfStockLineItems" xlink:to="loc_us-gaapProceedsFromIssuanceOfWarrants_1590" xlink:type="arc" order="41" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ProceedsFromIssuanceOrSaleOfEquity" xlink:label="loc_us-gaapProceedsFromIssuanceOrSaleOfEquity_1590" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapSubsidiarySaleOfStockLineItems" xlink:to="loc_us-gaapProceedsFromIssuanceOrSaleOfEquity_1590" xlink:type="arc" order="42" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SaleOfStockDescriptionOfTransaction" xlink:label="loc_us-gaapSaleOfStockDescriptionOfTransaction_1590" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapSubsidiarySaleOfStockLineItems" xlink:to="loc_us-gaapSaleOfStockDescriptionOfTransaction_1590" xlink:type="arc" order="43" />
      <link:loc xlink:type="locator" xlink:href="stss-20240930.xsd#STSS_DescriptionForOfferingShares" xlink:label="loc_STSSDescriptionForOfferingShares_1590" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapSubsidiarySaleOfStockLineItems" xlink:to="loc_STSSDescriptionForOfferingShares_1590" xlink:type="arc" order="44" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised_1590" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapSubsidiarySaleOfStockLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised_1590" xlink:type="arc" order="45" />
      <link:loc xlink:type="locator" xlink:href="stss-20240930.xsd#STSS_WarrantLiabilitiesCurrent" xlink:label="loc_STSSWarrantLiabilitiesCurrent_1590" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapSubsidiarySaleOfStockLineItems" xlink:to="loc_STSSWarrantLiabilitiesCurrent_1590" xlink:type="arc" order="46" />
      <link:loc xlink:type="locator" xlink:href="stss-20240930.xsd#STSS_FairValueAdjustmentOfModificationCharge" xlink:label="loc_STSSFairValueAdjustmentOfModificationCharge_1590" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapSubsidiarySaleOfStockLineItems" xlink:to="loc_STSSFairValueAdjustmentOfModificationCharge_1590" xlink:type="arc" order="47" />
      <link:loc xlink:type="locator" xlink:href="stss-20240930.xsd#STSS_ClassOfWarrantOrRightIssued" xlink:label="loc_STSSClassOfWarrantOrRightIssued_1590" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapSubsidiarySaleOfStockLineItems" xlink:to="loc_STSSClassOfWarrantOrRightIssued_1590" xlink:type="arc" order="48" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://sharpstechnology.com/role/PreferredStockDetailsNarrative" xlink:title="00000046 - Disclosure - Preferred Stock (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfStockLineItems" xlink:label="loc_us-gaapClassOfStockLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfStockByClassTable" xlink:label="loc_us-gaapScheduleOfStockByClassTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapClassOfStockLineItems" xlink:to="loc_us-gaapScheduleOfStockByClassTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="loc_us-gaapStatementClassOfStockAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapScheduleOfStockByClassTable" xlink:to="loc_us-gaapStatementClassOfStockAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaapClassOfStockDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapStatementClassOfStockAxis" xlink:to="loc_us-gaapClassOfStockDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaapClassOfStockDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapStatementClassOfStockAxis" xlink:to="loc_us-gaapClassOfStockDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SeriesAPreferredStockMember" xlink:label="loc_us-gaapSeriesAPreferredStockMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_us-gaapSeriesAPreferredStockMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_TitleOfIndividualAxis" xlink:label="loc_srtTitleOfIndividualAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapScheduleOfStockByClassTable" xlink:to="loc_srtTitleOfIndividualAxis" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:label="loc_srtTitleOfIndividualWithRelationshipToEntityDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srtTitleOfIndividualAxis" xlink:to="loc_srtTitleOfIndividualWithRelationshipToEntityDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:label="loc_srtTitleOfIndividualWithRelationshipToEntityDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_srtTitleOfIndividualAxis" xlink:to="loc_srtTitleOfIndividualWithRelationshipToEntityDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_DirectorMember" xlink:label="loc_srtDirectorMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtTitleOfIndividualWithRelationshipToEntityDomain" xlink:to="loc_srtDirectorMember_0" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis" xlink:label="loc_srtScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapScheduleOfStockByClassTable" xlink:to="loc_srtScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_EquityMethodInvesteeNameDomain" xlink:label="loc_srtEquityMethodInvesteeNameDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srtScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis" xlink:to="loc_srtEquityMethodInvesteeNameDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_EquityMethodInvesteeNameDomain" xlink:label="loc_srtEquityMethodInvesteeNameDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_srtScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis" xlink:to="loc_srtEquityMethodInvesteeNameDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="stss-20240930.xsd#STSS_AlanBlackmanMember" xlink:label="loc_STSSAlanBlackmanMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtEquityMethodInvesteeNameDomain" xlink:to="loc_STSSAlanBlackmanMember_0" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubsidiarySaleOfStockAxis" xlink:label="loc_us-gaapSubsidiarySaleOfStockAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapScheduleOfStockByClassTable" xlink:to="loc_us-gaapSubsidiarySaleOfStockAxis" xlink:type="arc" order="4" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SaleOfStockNameOfTransactionDomain" xlink:label="loc_us-gaapSaleOfStockNameOfTransactionDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapSubsidiarySaleOfStockAxis" xlink:to="loc_us-gaapSaleOfStockNameOfTransactionDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SaleOfStockNameOfTransactionDomain" xlink:label="loc_us-gaapSaleOfStockNameOfTransactionDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapSubsidiarySaleOfStockAxis" xlink:to="loc_us-gaapSaleOfStockNameOfTransactionDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IPOMember" xlink:label="loc_us-gaapIPOMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapSaleOfStockNameOfTransactionDomain" xlink:to="loc_us-gaapIPOMember_10" xlink:type="arc" order="13" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EquityMethodInvestmentOwnershipPercentage" xlink:label="loc_us-gaapEquityMethodInvestmentOwnershipPercentage_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapClassOfStockLineItems" xlink:to="loc_us-gaapEquityMethodInvestmentOwnershipPercentage_50" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PreferredStockVotingRights" xlink:label="loc_us-gaapPreferredStockVotingRights_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapClassOfStockLineItems" xlink:to="loc_us-gaapPreferredStockVotingRights_50" xlink:type="arc" order="1" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://sharpstechnology.com/role/ScheduleOfFairValueOfWarrantDetails" xlink:title="00000047 - Disclosure - Schedule of Fair Value of Warrant (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStatementTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RangeAxis" xlink:label="loc_srtRangeAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_srtRangeAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RangeMember" xlink:label="loc_srtRangeMember" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srtRangeAxis" xlink:to="loc_srtRangeMember" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RangeMember" xlink:label="loc_srtRangeMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_srtRangeAxis" xlink:to="loc_srtRangeMember_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_MinimumMember" xlink:label="loc_srtMinimumMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtRangeMember" xlink:to="loc_srtMinimumMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_MaximumMember" xlink:label="loc_srtMaximumMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtRangeMember" xlink:to="loc_srtMaximumMember_10" xlink:type="arc" order="11" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementEquityComponentsAxis" xlink:label="loc_us-gaapStatementEquityComponentsAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementEquityComponentsAxis" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EquityComponentDomain" xlink:label="loc_us-gaapEquityComponentDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapStatementEquityComponentsAxis" xlink:to="loc_us-gaapEquityComponentDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EquityComponentDomain" xlink:label="loc_us-gaapEquityComponentDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapStatementEquityComponentsAxis" xlink:to="loc_us-gaapEquityComponentDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_WarrantMember" xlink:label="loc_us-gaapWarrantMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapEquityComponentDomain" xlink:to="loc_us-gaapWarrantMember_0" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_MeasurementInputTypeAxis" xlink:label="loc_us-gaapMeasurementInputTypeAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapMeasurementInputTypeAxis" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_MeasurementInputTypeDomain" xlink:label="loc_us-gaapMeasurementInputTypeDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapMeasurementInputTypeAxis" xlink:to="loc_us-gaapMeasurementInputTypeDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_MeasurementInputTypeDomain" xlink:label="loc_us-gaapMeasurementInputTypeDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapMeasurementInputTypeAxis" xlink:to="loc_us-gaapMeasurementInputTypeDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_MeasurementInputExpectedTermMember" xlink:label="loc_us-gaapMeasurementInputExpectedTermMember_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapMeasurementInputTypeDomain" xlink:to="loc_us-gaapMeasurementInputExpectedTermMember_30" xlink:type="arc" order="32" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_MeasurementInputOptionVolatilityMember" xlink:label="loc_us-gaapMeasurementInputOptionVolatilityMember_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapMeasurementInputTypeDomain" xlink:to="loc_us-gaapMeasurementInputOptionVolatilityMember_70" xlink:type="arc" order="72" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_MeasurementInputRiskFreeInterestRateMember" xlink:label="loc_us-gaapMeasurementInputRiskFreeInterestRateMember_110" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapMeasurementInputTypeDomain" xlink:to="loc_us-gaapMeasurementInputRiskFreeInterestRateMember_110" xlink:type="arc" order="112" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_MeasurementInputExpectedDividendRateMember" xlink:label="loc_us-gaapMeasurementInputExpectedDividendRateMember_150" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapMeasurementInputTypeDomain" xlink:to="loc_us-gaapMeasurementInputExpectedDividendRateMember_150" xlink:type="arc" order="152" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:label="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_180" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_180" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_180" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_180" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_180" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_180" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_180" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_180" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_WarrantsAndRightsOutstandingTerm" xlink:label="loc_us-gaapWarrantsAndRightsOutstandingTerm_180" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapWarrantsAndRightsOutstandingTerm_180" xlink:type="arc" order="4" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_WarrantsAndRightsOutstandingMeasurementInput" xlink:label="loc_us-gaapWarrantsAndRightsOutstandingMeasurementInput_180" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapWarrantsAndRightsOutstandingMeasurementInput_180" xlink:type="arc" order="5" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://sharpstechnology.com/role/ScheduleOfWarrantLiabilityDetails" xlink:title="00000048 - Disclosure - Schedule of Warrant Liability (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubsidiarySaleOfStockLineItems" xlink:label="loc_us-gaapSubsidiarySaleOfStockLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable" xlink:label="loc_us-gaapSubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapSubsidiarySaleOfStockLineItems" xlink:to="loc_us-gaapSubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubsidiarySaleOfStockAxis" xlink:label="loc_us-gaapSubsidiarySaleOfStockAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapSubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable" xlink:to="loc_us-gaapSubsidiarySaleOfStockAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SaleOfStockNameOfTransactionDomain" xlink:label="loc_us-gaapSaleOfStockNameOfTransactionDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapSubsidiarySaleOfStockAxis" xlink:to="loc_us-gaapSaleOfStockNameOfTransactionDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SaleOfStockNameOfTransactionDomain" xlink:label="loc_us-gaapSaleOfStockNameOfTransactionDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapSubsidiarySaleOfStockAxis" xlink:to="loc_us-gaapSaleOfStockNameOfTransactionDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="stss-20240930.xsd#STSS_TradingAndOverallotmentWarrantsMember" xlink:label="loc_STSSTradingAndOverallotmentWarrantsMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapSaleOfStockNameOfTransactionDomain" xlink:to="loc_STSSTradingAndOverallotmentWarrantsMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="stss-20240930.xsd#STSS_NoteWarrantsMember" xlink:label="loc_STSSNoteWarrantsMember_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapSaleOfStockNameOfTransactionDomain" xlink:to="loc_STSSNoteWarrantsMember_20" xlink:type="arc" order="21" />
      <link:loc xlink:type="locator" xlink:href="stss-20240930.xsd#STSS_OfferingWarrantsFebruaryTwentyTwentyThreeMember" xlink:label="loc_STSSOfferingWarrantsFebruaryTwentyTwentyThreeMember_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapSaleOfStockNameOfTransactionDomain" xlink:to="loc_STSSOfferingWarrantsFebruaryTwentyTwentyThreeMember_40" xlink:type="arc" order="41" />
      <link:loc xlink:type="locator" xlink:href="stss-20240930.xsd#STSS_OfferingWarrantsSeptemberTwentyTwentyThreeMember" xlink:label="loc_STSSOfferingWarrantsSeptemberTwentyTwentyThreeMember_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapSaleOfStockNameOfTransactionDomain" xlink:to="loc_STSSOfferingWarrantsSeptemberTwentyTwentyThreeMember_60" xlink:type="arc" order="61" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfWarrantOrRightAxis" xlink:label="loc_us-gaapClassOfWarrantOrRightAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapSubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable" xlink:to="loc_us-gaapClassOfWarrantOrRightAxis" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfWarrantOrRightDomain" xlink:label="loc_us-gaapClassOfWarrantOrRightDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapClassOfWarrantOrRightAxis" xlink:to="loc_us-gaapClassOfWarrantOrRightDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfWarrantOrRightDomain" xlink:label="loc_us-gaapClassOfWarrantOrRightDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapClassOfWarrantOrRightAxis" xlink:to="loc_us-gaapClassOfWarrantOrRightDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="stss-20240930.xsd#STSS_TradingAndOverallotmentWarrantsMember" xlink:label="loc_STSSTradingAndOverallotmentWarrantsMember_100" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapClassOfWarrantOrRightDomain" xlink:to="loc_STSSTradingAndOverallotmentWarrantsMember_100" xlink:type="arc" order="101" />
      <link:loc xlink:type="locator" xlink:href="stss-20240930.xsd#STSS_NoteWarrantsMember" xlink:label="loc_STSSNoteWarrantsMember_120" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapClassOfWarrantOrRightDomain" xlink:to="loc_STSSNoteWarrantsMember_120" xlink:type="arc" order="121" />
      <link:loc xlink:type="locator" xlink:href="stss-20240930.xsd#STSS_OfferingWarrantsFebruaryTwoThousandTwentyThreeMember" xlink:label="loc_STSSOfferingWarrantsFebruaryTwoThousandTwentyThreeMember_140" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapClassOfWarrantOrRightDomain" xlink:to="loc_STSSOfferingWarrantsFebruaryTwoThousandTwentyThreeMember_140" xlink:type="arc" order="141" />
      <link:loc xlink:type="locator" xlink:href="stss-20240930.xsd#STSS_OfferingWarrantsSeptemberTwoThousandTwentyThreeMember" xlink:label="loc_STSSOfferingWarrantsSeptemberTwoThousandTwentyThreeMember_160" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapClassOfWarrantOrRightDomain" xlink:to="loc_STSSOfferingWarrantsSeptemberTwoThousandTwentyThreeMember_160" xlink:type="arc" order="161" />
      <link:loc xlink:type="locator" xlink:href="stss-20240930.xsd#STSS_InducementWarrantsMember" xlink:label="loc_STSSInducementWarrantsMember_180" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapClassOfWarrantOrRightDomain" xlink:to="loc_STSSInducementWarrantsMember_180" xlink:type="arc" order="181" />
      <link:loc xlink:type="locator" xlink:href="stss-20240930.xsd#STSS_WarrantLiability" xlink:label="loc_STSSWarrantLiability_220" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapSubsidiarySaleOfStockLineItems" xlink:to="loc_STSSWarrantLiability_220" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="stss-20240930.xsd#STSS_WarrantLiabilitiesCurrent" xlink:label="loc_STSSWarrantLiabilitiesCurrent_220" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapSubsidiarySaleOfStockLineItems" xlink:to="loc_STSSWarrantLiabilitiesCurrent_220" xlink:type="arc" order="1" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://sharpstechnology.com/role/ScheduleOfWarrantOutstandingDetails" xlink:title="00000049 - Disclosure - Schedule of Warrant Outstanding (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubsidiarySaleOfStockLineItems" xlink:label="loc_us-gaapSubsidiarySaleOfStockLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable" xlink:label="loc_us-gaapSubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapSubsidiarySaleOfStockLineItems" xlink:to="loc_us-gaapSubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubsidiarySaleOfStockAxis" xlink:label="loc_us-gaapSubsidiarySaleOfStockAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapSubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable" xlink:to="loc_us-gaapSubsidiarySaleOfStockAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SaleOfStockNameOfTransactionDomain" xlink:label="loc_us-gaapSaleOfStockNameOfTransactionDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapSubsidiarySaleOfStockAxis" xlink:to="loc_us-gaapSaleOfStockNameOfTransactionDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SaleOfStockNameOfTransactionDomain" xlink:label="loc_us-gaapSaleOfStockNameOfTransactionDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapSubsidiarySaleOfStockAxis" xlink:to="loc_us-gaapSaleOfStockNameOfTransactionDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="stss-20240930.xsd#STSS_TradingAndOverallotmentWarrantsMember" xlink:label="loc_STSSTradingAndOverallotmentWarrantsMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapSaleOfStockNameOfTransactionDomain" xlink:to="loc_STSSTradingAndOverallotmentWarrantsMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="stss-20240930.xsd#STSS_NoteWarrantsMember" xlink:label="loc_STSSNoteWarrantsMember_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapSaleOfStockNameOfTransactionDomain" xlink:to="loc_STSSNoteWarrantsMember_20" xlink:type="arc" order="21" />
      <link:loc xlink:type="locator" xlink:href="stss-20240930.xsd#STSS_OfferingWarrantsFebruaryTwentyTwentyThreeMember" xlink:label="loc_STSSOfferingWarrantsFebruaryTwentyTwentyThreeMember_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapSaleOfStockNameOfTransactionDomain" xlink:to="loc_STSSOfferingWarrantsFebruaryTwentyTwentyThreeMember_40" xlink:type="arc" order="41" />
      <link:loc xlink:type="locator" xlink:href="stss-20240930.xsd#STSS_OfferingWarrantsSeptemberTwentyTwentyThreeMember" xlink:label="loc_STSSOfferingWarrantsSeptemberTwentyTwentyThreeMember_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapSaleOfStockNameOfTransactionDomain" xlink:to="loc_STSSOfferingWarrantsSeptemberTwentyTwentyThreeMember_60" xlink:type="arc" order="61" />
      <link:loc xlink:type="locator" xlink:href="stss-20240930.xsd#STSS_WarrantsIssuedForServiceManagementMember" xlink:label="loc_STSSWarrantsIssuedForServiceManagementMember_80" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapSaleOfStockNameOfTransactionDomain" xlink:to="loc_STSSWarrantsIssuedForServiceManagementMember_80" xlink:type="arc" order="81" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfWarrantOrRightAxis" xlink:label="loc_us-gaapClassOfWarrantOrRightAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapSubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable" xlink:to="loc_us-gaapClassOfWarrantOrRightAxis" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfWarrantOrRightDomain" xlink:label="loc_us-gaapClassOfWarrantOrRightDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapClassOfWarrantOrRightAxis" xlink:to="loc_us-gaapClassOfWarrantOrRightDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfWarrantOrRightDomain" xlink:label="loc_us-gaapClassOfWarrantOrRightDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapClassOfWarrantOrRightAxis" xlink:to="loc_us-gaapClassOfWarrantOrRightDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="stss-20240930.xsd#STSS_TradingAndOverallotmentWarrantsMember" xlink:label="loc_STSSTradingAndOverallotmentWarrantsMember_120" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapClassOfWarrantOrRightDomain" xlink:to="loc_STSSTradingAndOverallotmentWarrantsMember_120" xlink:type="arc" order="121" />
      <link:loc xlink:type="locator" xlink:href="stss-20240930.xsd#STSS_NoteWarrantsMember" xlink:label="loc_STSSNoteWarrantsMember_140" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapClassOfWarrantOrRightDomain" xlink:to="loc_STSSNoteWarrantsMember_140" xlink:type="arc" order="141" />
      <link:loc xlink:type="locator" xlink:href="stss-20240930.xsd#STSS_OfferingWarrantsFebruaryTwoThousandTwentyThreeMember" xlink:label="loc_STSSOfferingWarrantsFebruaryTwoThousandTwentyThreeMember_160" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapClassOfWarrantOrRightDomain" xlink:to="loc_STSSOfferingWarrantsFebruaryTwoThousandTwentyThreeMember_160" xlink:type="arc" order="161" />
      <link:loc xlink:type="locator" xlink:href="stss-20240930.xsd#STSS_OfferingWarrantsSeptemberTwoThousandTwentyThreeMember" xlink:label="loc_STSSOfferingWarrantsSeptemberTwoThousandTwentyThreeMember_180" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapClassOfWarrantOrRightDomain" xlink:to="loc_STSSOfferingWarrantsSeptemberTwoThousandTwentyThreeMember_180" xlink:type="arc" order="181" />
      <link:loc xlink:type="locator" xlink:href="stss-20240930.xsd#STSS_InducementWarrantsMayTwoThousandTwentyFourMember" xlink:label="loc_STSSInducementWarrantsMayTwoThousandTwentyFourMember_200" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapClassOfWarrantOrRightDomain" xlink:to="loc_STSSInducementWarrantsMayTwoThousandTwentyFourMember_200" xlink:type="arc" order="201" />
      <link:loc xlink:type="locator" xlink:href="stss-20240930.xsd#STSS_WarrantsIssuedForServiceManagementMember" xlink:label="loc_STSSWarrantsIssuedForServiceManagementMember_220" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapClassOfWarrantOrRightDomain" xlink:to="loc_STSSWarrantsIssuedForServiceManagementMember_220" xlink:type="arc" order="221" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfWarrantOrRightOutstanding" xlink:label="loc_us-gaapClassOfWarrantOrRightOutstanding_260" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapSubsidiarySaleOfStockLineItems" xlink:to="loc_us-gaapClassOfWarrantOrRightOutstanding_260" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="stss-20240930.xsd#STSS_ClassOfWarrantsOrRightOutstanding" xlink:label="loc_STSSClassOfWarrantsOrRightOutstanding_260" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapSubsidiarySaleOfStockLineItems" xlink:to="loc_STSSClassOfWarrantsOrRightOutstanding_260" xlink:type="arc" order="1" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://sharpstechnology.com/role/WarrantLiabilityDetailsNarrative" xlink:title="00000050 - Disclosure - Warrant Liability (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:label="loc_us-gaapCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" xlink:label="loc_us-gaapScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="loc_us-gaapScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TypeOfArrangementAxis" xlink:label="loc_us-gaapTypeOfArrangementAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" xlink:to="loc_us-gaapTypeOfArrangementAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:label="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapTypeOfArrangementAxis" xlink:to="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:label="loc_us-gaapArrangementsAndNonarrangementTransactionsMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapTypeOfArrangementAxis" xlink:to="loc_us-gaapArrangementsAndNonarrangementTransactionsMember_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="stss-20240930.xsd#STSS_InducementAgreementMember" xlink:label="loc_STSSInducementAgreementMember_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" xlink:to="loc_STSSInducementAgreementMember_30" xlink:type="arc" order="31" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_MarketRiskBenefitChangeInFairValueGainLoss" xlink:label="loc_us-gaapMarketRiskBenefitChangeInFairValueGainLoss_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="loc_us-gaapMarketRiskBenefitChangeInFairValueGainLoss_90" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_GainLossOnSaleOfDerivatives" xlink:label="loc_us-gaapGainLossOnSaleOfDerivatives_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="loc_us-gaapGainLossOnSaleOfDerivatives_90" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="stss-20240930.xsd#STSS_FairValueAdjustmentOfModificationCharge" xlink:label="loc_STSSFairValueAdjustmentOfModificationCharge_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="loc_STSSFairValueAdjustmentOfModificationCharge_90" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="stss-20240930.xsd#STSS_GainLossOnSaleOfDerivative" xlink:label="loc_STSSGainLossOnSaleOfDerivative_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="loc_STSSGainLossOnSaleOfDerivative_90" xlink:type="arc" order="3" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://sharpstechnology.com/role/ScheduleOfStockOptionsGrantedAndOutstandingDetails" xlink:title="00000051 - Disclosure - Schedule of Stock Options Granted and Outstanding (Details)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://sharpstechnology.com/role/ScheduleOfInformationAboutOptionsOutstandingDetails" xlink:title="00000052 - Disclosure - Schedule of Information About Options Outstanding (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems" xlink:label="loc_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTable" xlink:label="loc_us-gaapScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems" xlink:to="loc_us-gaapScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis" xlink:label="loc_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTable" xlink:to="loc_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain" xlink:label="loc_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis" xlink:to="loc_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain" xlink:label="loc_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis" xlink:to="loc_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="stss-20240930.xsd#STSS_ExercisePriceRangeOneMember" xlink:label="loc_STSSExercisePriceRangeOneMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain" xlink:to="loc_STSSExercisePriceRangeOneMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="stss-20240930.xsd#STSS_ExercisePriceRangeTwoMember" xlink:label="loc_STSSExercisePriceRangeTwoMember_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain" xlink:to="loc_STSSExercisePriceRangeTwoMember_40" xlink:type="arc" order="41" />
      <link:loc xlink:type="locator" xlink:href="stss-20240930.xsd#STSS_ExercisePriceRangeThreeMember" xlink:label="loc_STSSExercisePriceRangeThreeMember_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain" xlink:to="loc_STSSExercisePriceRangeThreeMember_60" xlink:type="arc" order="61" />
      <link:loc xlink:type="locator" xlink:href="stss-20240930.xsd#STSS_ExercisePriceRangeFourMember" xlink:label="loc_STSSExercisePriceRangeFourMember_80" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain" xlink:to="loc_STSSExercisePriceRangeFourMember_80" xlink:type="arc" order="81" />
      <link:loc xlink:type="locator" xlink:href="stss-20240930.xsd#STSS_ExercisePriceRangeFiveMember" xlink:label="loc_STSSExercisePriceRangeFiveMember_100" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain" xlink:to="loc_STSSExercisePriceRangeFiveMember_100" xlink:type="arc" order="101" />
      <link:loc xlink:type="locator" xlink:href="stss-20240930.xsd#STSS_ExercisePriceRangeSixMember" xlink:label="loc_STSSExercisePriceRangeSixMember_120" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain" xlink:to="loc_STSSExercisePriceRangeSixMember_120" xlink:type="arc" order="121" />
      <link:loc xlink:type="locator" xlink:href="stss-20240930.xsd#STSS_ExercisePriceRangeSevenMember" xlink:label="loc_STSSExercisePriceRangeSevenMember_140" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain" xlink:to="loc_STSSExercisePriceRangeSevenMember_140" xlink:type="arc" order="141" />
      <link:loc xlink:type="locator" xlink:href="stss-20240930.xsd#STSS_ExercisePriceRangeEightMember" xlink:label="loc_STSSExercisePriceRangeEightMember_160" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain" xlink:to="loc_STSSExercisePriceRangeEightMember_160" xlink:type="arc" order="161" />
      <link:loc xlink:type="locator" xlink:href="stss-20240930.xsd#STSS_ExercisePriceRangeNineMember" xlink:label="loc_STSSExercisePriceRangeNineMember_180" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain" xlink:to="loc_STSSExercisePriceRangeNineMember_180" xlink:type="arc" order="181" />
      <link:loc xlink:type="locator" xlink:href="stss-20240930.xsd#STSS_ExercisePriceRangeTenMember" xlink:label="loc_STSSExercisePriceRangeTenMember_200" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain" xlink:to="loc_STSSExercisePriceRangeTenMember_200" xlink:type="arc" order="201" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RangeAxis" xlink:label="loc_srtRangeAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTable" xlink:to="loc_srtRangeAxis" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RangeMember" xlink:label="loc_srtRangeMember" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srtRangeAxis" xlink:to="loc_srtRangeMember" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RangeMember" xlink:label="loc_srtRangeMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_srtRangeAxis" xlink:to="loc_srtRangeMember_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_MinimumMember" xlink:label="loc_srtMinimumMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtRangeMember" xlink:to="loc_srtMinimumMember_0" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_MaximumMember" xlink:label="loc_srtMaximumMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtRangeMember" xlink:to="loc_srtMaximumMember_10" xlink:type="arc" order="12" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit" xlink:label="loc_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit_230" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems" xlink:to="loc_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit_230" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions" xlink:label="loc_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions_230" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems" xlink:to="loc_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions_230" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_230" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_230" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2" xlink:label="loc_us-gaapSharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2_230" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems" xlink:to="loc_us-gaapSharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2_230" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions" xlink:label="loc_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions_230" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems" xlink:to="loc_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions_230" xlink:type="arc" order="4" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1" xlink:label="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1_230" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems" xlink:to="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1_230" xlink:type="arc" order="5" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://sharpstechnology.com/role/ScheduleOfFairValueOfStockOptionAwardsDetails" xlink:title="00000053 - Disclosure - Schedule of Fair Value of Stock Option Awards (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:label="loc_us-gaapScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RangeAxis" xlink:label="loc_srtRangeAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="loc_srtRangeAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RangeMember" xlink:label="loc_srtRangeMember" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srtRangeAxis" xlink:to="loc_srtRangeMember" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RangeMember" xlink:label="loc_srtRangeMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_srtRangeAxis" xlink:to="loc_srtRangeMember_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_MinimumMember" xlink:label="loc_srtMinimumMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtRangeMember" xlink:to="loc_srtMinimumMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_MaximumMember" xlink:label="loc_srtMaximumMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtRangeMember" xlink:to="loc_srtMaximumMember_10" xlink:type="arc" order="11" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:label="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_130" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_130" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate_130" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate_130" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_130" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_130" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_130" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_130" xlink:type="arc" order="3" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://sharpstechnology.com/role/StockOptionsDetailsNarrative" xlink:title="00000054 - Disclosure - Stock Options (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:label="loc_us-gaapScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PlanNameAxis" xlink:label="loc_us-gaapPlanNameAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="loc_us-gaapPlanNameAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PlanNameDomain" xlink:label="loc_us-gaapPlanNameDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapPlanNameAxis" xlink:to="loc_us-gaapPlanNameDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PlanNameDomain" xlink:label="loc_us-gaapPlanNameDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapPlanNameAxis" xlink:to="loc_us-gaapPlanNameDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="stss-20240930.xsd#STSS_TwoThousandTwentyThreeEquityIncentivePlanMember" xlink:label="loc_STSSTwoThousandTwentyThreeEquityIncentivePlanMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapPlanNameDomain" xlink:to="loc_STSSTwoThousandTwentyThreeEquityIncentivePlanMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="stss-20240930.xsd#STSS_TwoThousandTwentyTwoEquityIncentivePlanMember" xlink:label="loc_STSSTwoThousandTwentyTwoEquityIncentivePlanMember_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapPlanNameDomain" xlink:to="loc_STSSTwoThousandTwentyTwoEquityIncentivePlanMember_70" xlink:type="arc" order="71" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_TitleOfIndividualAxis" xlink:label="loc_srtTitleOfIndividualAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="loc_srtTitleOfIndividualAxis" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:label="loc_srtTitleOfIndividualWithRelationshipToEntityDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srtTitleOfIndividualAxis" xlink:to="loc_srtTitleOfIndividualWithRelationshipToEntityDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:label="loc_srtTitleOfIndividualWithRelationshipToEntityDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_srtTitleOfIndividualAxis" xlink:to="loc_srtTitleOfIndividualWithRelationshipToEntityDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="stss-20240930.xsd#STSS_EmployeesAndConsultantMember" xlink:label="loc_STSSEmployeesAndConsultantMember_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtTitleOfIndividualWithRelationshipToEntityDomain" xlink:to="loc_STSSEmployeesAndConsultantMember_40" xlink:type="arc" order="41" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RangeAxis" xlink:label="loc_srtRangeAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="loc_srtRangeAxis" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RangeMember" xlink:label="loc_srtRangeMember" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srtRangeAxis" xlink:to="loc_srtRangeMember" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RangeMember" xlink:label="loc_srtRangeMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_srtRangeAxis" xlink:to="loc_srtRangeMember_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_MinimumMember" xlink:label="loc_srtMinimumMember_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtRangeMember" xlink:to="loc_srtMinimumMember_50" xlink:type="arc" order="52" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_MaximumMember" xlink:label="loc_srtMaximumMember_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtRangeMember" xlink:to="loc_srtMaximumMember_60" xlink:type="arc" order="62" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeStatementLocationAxis" xlink:label="loc_us-gaapIncomeStatementLocationAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="loc_us-gaapIncomeStatementLocationAxis" xlink:type="arc" order="4" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeStatementLocationDomain" xlink:label="loc_us-gaapIncomeStatementLocationDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapIncomeStatementLocationAxis" xlink:to="loc_us-gaapIncomeStatementLocationDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeStatementLocationDomain" xlink:label="loc_us-gaapIncomeStatementLocationDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapIncomeStatementLocationAxis" xlink:to="loc_us-gaapIncomeStatementLocationDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_GeneralAndAdministrativeExpenseMember" xlink:label="loc_us-gaapGeneralAndAdministrativeExpenseMember_130" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapIncomeStatementLocationDomain" xlink:to="loc_us-gaapGeneralAndAdministrativeExpenseMember_130" xlink:type="arc" order="131" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ResearchAndDevelopmentExpenseMember" xlink:label="loc_us-gaapResearchAndDevelopmentExpenseMember_140" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapIncomeStatementLocationDomain" xlink:to="loc_us-gaapResearchAndDevelopmentExpenseMember_140" xlink:type="arc" order="141" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_260" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_260" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod_260" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod_260" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:label="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_260" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_260" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation" xlink:label="loc_us-gaapStockIssuedDuringPeriodSharesShareBasedCompensation_260" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodSharesShareBasedCompensation_260" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockParOrStatedValuePerShare" xlink:label="loc_us-gaapCommonStockParOrStatedValuePerShare_260" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapCommonStockParOrStatedValuePerShare_260" xlink:type="arc" order="4" />
      <link:loc xlink:type="locator" xlink:href="stss-20240930.xsd#STSS_ShareBasedCompensationOptionsExercisableWeightedAverageExercisePrice" xlink:label="loc_STSSShareBasedCompensationOptionsExercisableWeightedAverageExercisePrice_260" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_STSSShareBasedCompensationOptionsExercisableWeightedAverageExercisePrice_260" xlink:type="arc" order="5" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_260" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_260" xlink:type="arc" order="6" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_260" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_260" xlink:type="arc" order="7" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_260" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_260" xlink:type="arc" order="8" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized" xlink:label="loc_us-gaapEmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized_260" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapEmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized_260" xlink:type="arc" order="9" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:label="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue_260" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue_260" xlink:type="arc" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AllocatedShareBasedCompensationExpense" xlink:label="loc_us-gaapAllocatedShareBasedCompensationExpense_260" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapAllocatedShareBasedCompensationExpense_260" xlink:type="arc" order="11" />
      <link:loc xlink:type="locator" xlink:href="stss-20240930.xsd#STSS_StockBasedChargesRelatingToPurchaseOfMachinery" xlink:label="loc_STSSStockBasedChargesRelatingToPurchaseOfMachinery_260" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_STSSStockBasedChargesRelatingToPurchaseOfMachinery_260" xlink:type="arc" order="12" />
      <link:loc xlink:type="locator" xlink:href="stss-20240930.xsd#STSS_StockBasedChargesRelatingToAcquisition" xlink:label="loc_STSSStockBasedChargesRelatingToAcquisition_260" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_STSSStockBasedChargesRelatingToAcquisition_260" xlink:type="arc" order="13" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" xlink:label="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_260" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_260" xlink:type="arc" order="14" />
      <link:loc xlink:type="locator" xlink:href="stss-20240930.xsd#STSS_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantedInYear" xlink:label="loc_STSSShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantedInYear_260" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_STSSShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantedInYear_260" xlink:type="arc" order="15" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" xlink:label="loc_us-gaapEmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_260" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapEmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_260" xlink:type="arc" order="16" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://sharpstechnology.com/role/ScheduleOfReconciliationOfFederalStatutoryRateToTotalEffectiveRateDetails" xlink:title="00000055 - Disclosure - Schedule of Reconciliation of Federal Statutory Rate to Total Effective Rate (Details)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://sharpstechnology.com/role/ScheduleOfComponentsOfDeferredTaxAssetsDetails" xlink:title="00000056 - Disclosure - Schedule of Components of Deferred tax Assets (Details)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://sharpstechnology.com/role/ScheduleOfGeographicalComponentsOfLossBeforeIncomeTaxesDetails" xlink:title="00000057 - Disclosure - Schedule of Geographical Components of Loss Before Income Taxes (Details)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://sharpstechnology.com/role/IncomeTaxesDetailsNarrative" xlink:title="00000058 - Disclosure - Income Taxes (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationLineItems" xlink:label="loc_us-gaapEffectiveIncomeTaxRateReconciliationLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationTable" xlink:label="loc_us-gaapEffectiveIncomeTaxRateReconciliationTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapEffectiveIncomeTaxRateReconciliationLineItems" xlink:to="loc_us-gaapEffectiveIncomeTaxRateReconciliationTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeTaxAuthorityAxis" xlink:label="loc_us-gaapIncomeTaxAuthorityAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapEffectiveIncomeTaxRateReconciliationTable" xlink:to="loc_us-gaapIncomeTaxAuthorityAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeTaxAuthorityDomain" xlink:label="loc_us-gaapIncomeTaxAuthorityDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapIncomeTaxAuthorityAxis" xlink:to="loc_us-gaapIncomeTaxAuthorityDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeTaxAuthorityDomain" xlink:label="loc_us-gaapIncomeTaxAuthorityDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapIncomeTaxAuthorityAxis" xlink:to="loc_us-gaapIncomeTaxAuthorityDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DomesticCountryMember" xlink:label="loc_us-gaapDomesticCountryMember_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapIncomeTaxAuthorityDomain" xlink:to="loc_us-gaapDomesticCountryMember_20" xlink:type="arc" order="21" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ForeignCountryMember" xlink:label="loc_us-gaapForeignCountryMember_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapIncomeTaxAuthorityDomain" xlink:to="loc_us-gaapForeignCountryMember_50" xlink:type="arc" order="51" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_StatementScenarioAxis" xlink:label="loc_srtStatementScenarioAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapEffectiveIncomeTaxRateReconciliationTable" xlink:to="loc_srtStatementScenarioAxis" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_ScenarioUnspecifiedDomain" xlink:label="loc_srtScenarioUnspecifiedDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srtStatementScenarioAxis" xlink:to="loc_srtScenarioUnspecifiedDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_ScenarioUnspecifiedDomain" xlink:label="loc_srtScenarioUnspecifiedDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_srtStatementScenarioAxis" xlink:to="loc_srtScenarioUnspecifiedDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="stss-20240930.xsd#STSS_ExpiresOnTwoThousandTwentyEightMember" xlink:label="loc_STSSExpiresOnTwoThousandTwentyEightMember_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtScenarioUnspecifiedDomain" xlink:to="loc_STSSExpiresOnTwoThousandTwentyEightMember_30" xlink:type="arc" order="32" />
      <link:loc xlink:type="locator" xlink:href="stss-20240930.xsd#STSS_NotExpireMember" xlink:label="loc_STSSNotExpireMember_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtScenarioUnspecifiedDomain" xlink:to="loc_STSSNotExpireMember_40" xlink:type="arc" order="41" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:label="loc_us-gaapEffectiveIncomeTaxRateContinuingOperations_110" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapEffectiveIncomeTaxRateReconciliationLineItems" xlink:to="loc_us-gaapEffectiveIncomeTaxRateContinuingOperations_110" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingLossCarryforwards" xlink:label="loc_us-gaapOperatingLossCarryforwards_110" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapEffectiveIncomeTaxRateReconciliationLineItems" xlink:to="loc_us-gaapOperatingLossCarryforwards_110" xlink:type="arc" order="1" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://sharpstechnology.com/role/RelatedPartyTransactionsAndBalancesDetailsNarrative" xlink:title="00000059 - Disclosure - Related Party Transactions and Balances (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStatementTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_TitleOfIndividualAxis" xlink:label="loc_srtTitleOfIndividualAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_srtTitleOfIndividualAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:label="loc_srtTitleOfIndividualWithRelationshipToEntityDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srtTitleOfIndividualAxis" xlink:to="loc_srtTitleOfIndividualWithRelationshipToEntityDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:label="loc_srtTitleOfIndividualWithRelationshipToEntityDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_srtTitleOfIndividualAxis" xlink:to="loc_srtTitleOfIndividualWithRelationshipToEntityDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="stss-20240930.xsd#STSS_OfficersAndDirectorsMember" xlink:label="loc_STSSOfficersAndDirectorsMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtTitleOfIndividualWithRelationshipToEntityDomain" xlink:to="loc_STSSOfficersAndDirectorsMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent" xlink:label="loc_us-gaapAccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapAccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent_40" xlink:type="arc" order="0" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://sharpstechnology.com/role/ScheduleOfAssetsAndLiabilitiesMeasuredAtFairValueOnRecurringBasisDetails" xlink:title="00000060 - Disclosure - Schedule of Assets and Liabilities Measured at Fair Value on Recurring Basis (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:label="loc_us-gaapFairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:label="loc_us-gaapFairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapFairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:to="loc_us-gaapFairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:label="loc_us-gaapFairValueByFairValueHierarchyLevelAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapFairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:to="loc_us-gaapFairValueByFairValueHierarchyLevelAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:label="loc_us-gaapFairValueMeasurementsFairValueHierarchyDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapFairValueByFairValueHierarchyLevelAxis" xlink:to="loc_us-gaapFairValueMeasurementsFairValueHierarchyDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:label="loc_us-gaapFairValueMeasurementsFairValueHierarchyDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapFairValueByFairValueHierarchyLevelAxis" xlink:to="loc_us-gaapFairValueMeasurementsFairValueHierarchyDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueInputsLevel1Member" xlink:label="loc_us-gaapFairValueInputsLevel1Member_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapFairValueMeasurementsFairValueHierarchyDomain" xlink:to="loc_us-gaapFairValueInputsLevel1Member_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueInputsLevel2Member" xlink:label="loc_us-gaapFairValueInputsLevel2Member_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapFairValueMeasurementsFairValueHierarchyDomain" xlink:to="loc_us-gaapFairValueInputsLevel2Member_10" xlink:type="arc" order="11" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueInputsLevel3Member" xlink:label="loc_us-gaapFairValueInputsLevel3Member_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapFairValueMeasurementsFairValueHierarchyDomain" xlink:to="loc_us-gaapFairValueInputsLevel3Member_20" xlink:type="arc" order="21" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FinancialInstrumentsFinancialAssetsBalanceSheetGroupingsAbstract" xlink:label="loc_us-gaapFinancialInstrumentsFinancialAssetsBalanceSheetGroupingsAbstract_130" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapFairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:to="loc_us-gaapFinancialInstrumentsFinancialAssetsBalanceSheetGroupingsAbstract_130" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CashAndCashEquivalentsFairValueDisclosure" xlink:label="loc_us-gaapCashAndCashEquivalentsFairValueDisclosure_130" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapFairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:to="loc_us-gaapCashAndCashEquivalentsFairValueDisclosure_130" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AssetsFairValueDisclosure" xlink:label="loc_us-gaapAssetsFairValueDisclosure_130" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapFairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:to="loc_us-gaapAssetsFairValueDisclosure_130" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FinancialInstrumentsFinancialLiabilitiesBalanceSheetGroupingsAbstract" xlink:label="loc_us-gaapFinancialInstrumentsFinancialLiabilitiesBalanceSheetGroupingsAbstract_130" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapFairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:to="loc_us-gaapFinancialInstrumentsFinancialLiabilitiesBalanceSheetGroupingsAbstract_130" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="stss-20240930.xsd#STSS_WarrantLiability" xlink:label="loc_STSSWarrantLiability_130" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapFairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:to="loc_STSSWarrantLiability_130" xlink:type="arc" order="4" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LiabilitiesFairValueDisclosure" xlink:label="loc_us-gaapLiabilitiesFairValueDisclosure_130" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapFairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:to="loc_us-gaapLiabilitiesFairValueDisclosure_130" xlink:type="arc" order="5" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AssetsFairValueDisclosureAbstract" xlink:label="loc_us-gaapAssetsFairValueDisclosureAbstract_130" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapFairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:to="loc_us-gaapAssetsFairValueDisclosureAbstract_130" xlink:type="arc" order="6" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LiabilitiesFairValueDisclosureAbstract" xlink:label="loc_us-gaapLiabilitiesFairValueDisclosureAbstract_130" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapFairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:to="loc_us-gaapLiabilitiesFairValueDisclosureAbstract_130" xlink:type="arc" order="7" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DerivativeLiabilities" xlink:label="loc_us-gaapDerivativeLiabilities_130" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapLiabilitiesFairValueDisclosureAbstract_130" xlink:to="loc_us-gaapDerivativeLiabilities_130" xlink:type="arc" order="8" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://sharpstechnology.com/role/CommitmentsAndContingenciesDetailsNarrative" xlink:title="00000061 - Disclosure - Commitments and Contingencies (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LossContingenciesLineItems" xlink:label="loc_us-gaapLossContingenciesLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LossContingenciesTable" xlink:label="loc_us-gaapLossContingenciesTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapLossContingenciesLineItems" xlink:to="loc_us-gaapLossContingenciesTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TypeOfArrangementAxis" xlink:label="loc_us-gaapTypeOfArrangementAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapLossContingenciesTable" xlink:to="loc_us-gaapTypeOfArrangementAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:label="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapTypeOfArrangementAxis" xlink:to="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:label="loc_us-gaapArrangementsAndNonarrangementTransactionsMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapTypeOfArrangementAxis" xlink:to="loc_us-gaapArrangementsAndNonarrangementTransactionsMember_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="stss-20240930.xsd#STSS_RoyaltyAgreementMember" xlink:label="loc_STSSRoyaltyAgreementMember_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" xlink:to="loc_STSSRoyaltyAgreementMember_30" xlink:type="arc" order="31" />
      <link:loc xlink:type="locator" xlink:href="stss-20240930.xsd#STSS_EmploymentAgreementMember" xlink:label="loc_STSSEmploymentAgreementMember_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" xlink:to="loc_STSSEmploymentAgreementMember_70" xlink:type="arc" order="71" />
      <link:loc xlink:type="locator" xlink:href="stss-20240930.xsd#STSS_ServiceAgreementMember" xlink:label="loc_STSSServiceAgreementMember_150" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" xlink:to="loc_STSSServiceAgreementMember_150" xlink:type="arc" order="151" />
      <link:loc xlink:type="locator" xlink:href="stss-20240930.xsd#STSS_AssetPurchaseAgreementMember" xlink:label="loc_STSSAssetPurchaseAgreementMember_310" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" xlink:to="loc_STSSAssetPurchaseAgreementMember_310" xlink:type="arc" order="311" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_TitleOfIndividualAxis" xlink:label="loc_srtTitleOfIndividualAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapLossContingenciesTable" xlink:to="loc_srtTitleOfIndividualAxis" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:label="loc_srtTitleOfIndividualWithRelationshipToEntityDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srtTitleOfIndividualAxis" xlink:to="loc_srtTitleOfIndividualWithRelationshipToEntityDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:label="loc_srtTitleOfIndividualWithRelationshipToEntityDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_srtTitleOfIndividualAxis" xlink:to="loc_srtTitleOfIndividualWithRelationshipToEntityDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="stss-20240930.xsd#STSS_BarryBerlerMember" xlink:label="loc_STSSBarryBerlerMember_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtTitleOfIndividualWithRelationshipToEntityDomain" xlink:to="loc_STSSBarryBerlerMember_30" xlink:type="arc" order="32" />
      <link:loc xlink:type="locator" xlink:href="stss-20240930.xsd#STSS_Mr.BlackmanMember" xlink:label="loc_STSSMr.BlackmanMember_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtTitleOfIndividualWithRelationshipToEntityDomain" xlink:to="loc_STSSMr.BlackmanMember_90" xlink:type="arc" order="91" />
      <link:loc xlink:type="locator" xlink:href="stss-20240930.xsd#STSS_AlanBlackmanMember" xlink:label="loc_STSSAlanBlackmanMember_240" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtTitleOfIndividualWithRelationshipToEntityDomain" xlink:to="loc_STSSAlanBlackmanMember_240" xlink:type="arc" order="242" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_LitigationCaseAxis" xlink:label="loc_srtLitigationCaseAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapLossContingenciesTable" xlink:to="loc_srtLitigationCaseAxis" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_LitigationCaseTypeDomain" xlink:label="loc_srtLitigationCaseTypeDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srtLitigationCaseAxis" xlink:to="loc_srtLitigationCaseTypeDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_LitigationCaseTypeDomain" xlink:label="loc_srtLitigationCaseTypeDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_srtLitigationCaseAxis" xlink:to="loc_srtLitigationCaseTypeDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="stss-20240930.xsd#STSS_BerlerMember" xlink:label="loc_STSSBerlerMember_210" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtLitigationCaseTypeDomain" xlink:to="loc_STSSBerlerMember_210" xlink:type="arc" order="211" />
      <link:loc xlink:type="locator" xlink:href="stss-20240930.xsd#STSS_PlastomoldMember" xlink:label="loc_STSSPlastomoldMember_230" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtLitigationCaseTypeDomain" xlink:to="loc_STSSPlastomoldMember_230" xlink:type="arc" order="231" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AssetAcquisitionAxis" xlink:label="loc_us-gaapAssetAcquisitionAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapLossContingenciesTable" xlink:to="loc_us-gaapAssetAcquisitionAxis" xlink:type="arc" order="4" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AssetAcquisitionDomain" xlink:label="loc_us-gaapAssetAcquisitionDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapAssetAcquisitionAxis" xlink:to="loc_us-gaapAssetAcquisitionDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AssetAcquisitionDomain" xlink:label="loc_us-gaapAssetAcquisitionDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapAssetAcquisitionAxis" xlink:to="loc_us-gaapAssetAcquisitionDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="stss-20240930.xsd#STSS_InjectEZLLCMember" xlink:label="loc_STSSInjectEZLLCMember_310" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapAssetAcquisitionDomain" xlink:to="loc_STSSInjectEZLLCMember_310" xlink:type="arc" order="312" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccountsPayableCurrentAndNoncurrent" xlink:label="loc_us-gaapAccountsPayableCurrentAndNoncurrent_350" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapLossContingenciesLineItems" xlink:to="loc_us-gaapAccountsPayableCurrentAndNoncurrent_350" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="stss-20240930.xsd#STSS_OrderCostsToPurchaseEquipmentMoldsAndComponentPartsForResearchAndDevelopment" xlink:label="loc_STSSOrderCostsToPurchaseEquipmentMoldsAndComponentPartsForResearchAndDevelopment_350" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapLossContingenciesLineItems" xlink:to="loc_STSSOrderCostsToPurchaseEquipmentMoldsAndComponentPartsForResearchAndDevelopment_350" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="stss-20240930.xsd#STSS_ProgressPayments" xlink:label="loc_STSSProgressPayments_350" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapLossContingenciesLineItems" xlink:to="loc_STSSProgressPayments_350" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="stss-20240930.xsd#STSS_RoyaltyPercentage" xlink:label="loc_STSSRoyaltyPercentage_350" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapLossContingenciesLineItems" xlink:to="loc_STSSRoyaltyPercentage_350" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="stss-20240930.xsd#STSS_SinglePaymentObligation" xlink:label="loc_STSSSinglePaymentObligation_350" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapLossContingenciesLineItems" xlink:to="loc_STSSSinglePaymentObligation_350" xlink:type="arc" order="4" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SalariesAndWages" xlink:label="loc_us-gaapSalariesAndWages_350" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapLossContingenciesLineItems" xlink:to="loc_us-gaapSalariesAndWages_350" xlink:type="arc" order="5" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccruedBonusesCurrentAndNoncurrent" xlink:label="loc_us-gaapAccruedBonusesCurrentAndNoncurrent_350" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapLossContingenciesLineItems" xlink:to="loc_us-gaapAccruedBonusesCurrentAndNoncurrent_350" xlink:type="arc" order="6" />
      <link:loc xlink:type="locator" xlink:href="stss-20240930.xsd#STSS_PaymentForBonuses" xlink:label="loc_STSSPaymentForBonuses_350" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapLossContingenciesLineItems" xlink:to="loc_STSSPaymentForBonuses_350" xlink:type="arc" order="7" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SeveranceCosts1" xlink:label="loc_us-gaapSeveranceCosts1_350" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapLossContingenciesLineItems" xlink:to="loc_us-gaapSeveranceCosts1_350" xlink:type="arc" order="8" />
      <link:loc xlink:type="locator" xlink:href="stss-20240930.xsd#STSS_MedicalBenefitsCost" xlink:label="loc_STSSMedicalBenefitsCost_350" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapLossContingenciesLineItems" xlink:to="loc_STSSMedicalBenefitsCost_350" xlink:type="arc" order="9" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue_350" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapLossContingenciesLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue_350" xlink:type="arc" order="10" />
      <link:loc xlink:type="locator" xlink:href="stss-20240930.xsd#STSS_AnnualCompensation" xlink:label="loc_STSSAnnualCompensation_350" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapLossContingenciesLineItems" xlink:to="loc_STSSAnnualCompensation_350" xlink:type="arc" order="11" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PaymentForIncentiveFee" xlink:label="loc_us-gaapPaymentForIncentiveFee_350" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapLossContingenciesLineItems" xlink:to="loc_us-gaapPaymentForIncentiveFee_350" xlink:type="arc" order="12" />
      <link:loc xlink:type="locator" xlink:href="stss-20240930.xsd#STSS_InitialFee" xlink:label="loc_STSSInitialFee_350" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapLossContingenciesLineItems" xlink:to="loc_STSSInitialFee_350" xlink:type="arc" order="13" />
      <link:loc xlink:type="locator" xlink:href="stss-20240930.xsd#STSS_MonthlyFee" xlink:label="loc_STSSMonthlyFee_350" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapLossContingenciesLineItems" xlink:to="loc_STSSMonthlyFee_350" xlink:type="arc" order="14" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures" xlink:label="loc_us-gaapStockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures_350" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapLossContingenciesLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures_350" xlink:type="arc" order="15" />
      <link:loc xlink:type="locator" xlink:href="stss-20240930.xsd#STSS_ValueOfDigitalMarketingActivities" xlink:label="loc_STSSValueOfDigitalMarketingActivities_350" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapLossContingenciesLineItems" xlink:to="loc_STSSValueOfDigitalMarketingActivities_350" xlink:type="arc" order="16" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures" xlink:label="loc_us-gaapStockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures_350" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapLossContingenciesLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures_350" xlink:type="arc" order="17" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EmployeeBenefitsAndShareBasedCompensation" xlink:label="loc_us-gaapEmployeeBenefitsAndShareBasedCompensation_350" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapLossContingenciesLineItems" xlink:to="loc_us-gaapEmployeeBenefitsAndShareBasedCompensation_350" xlink:type="arc" order="18" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation" xlink:label="loc_us-gaapStockIssuedDuringPeriodSharesShareBasedCompensation_350" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapLossContingenciesLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodSharesShareBasedCompensation_350" xlink:type="arc" order="19" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1" xlink:label="loc_us-gaapSharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1_350" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapLossContingenciesLineItems" xlink:to="loc_us-gaapSharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1_350" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LossContingencyDamagesSoughtValue" xlink:label="loc_us-gaapLossContingencyDamagesSoughtValue_350" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapLossContingenciesLineItems" xlink:to="loc_us-gaapLossContingencyDamagesSoughtValue_350" xlink:type="arc" order="21" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LossContingencyDamagesSought" xlink:label="loc_us-gaapLossContingencyDamagesSought_350" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapLossContingenciesLineItems" xlink:to="loc_us-gaapLossContingencyDamagesSought_350" xlink:type="arc" order="22" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensation" xlink:label="loc_us-gaapShareBasedCompensation_350" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapLossContingenciesLineItems" xlink:to="loc_us-gaapShareBasedCompensation_350" xlink:type="arc" order="23" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PaymentsToAcquireProductiveAssets" xlink:label="loc_us-gaapPaymentsToAcquireProductiveAssets_350" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapLossContingenciesLineItems" xlink:to="loc_us-gaapPaymentsToAcquireProductiveAssets_350" xlink:type="arc" order="24" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EscrowDeposit" xlink:label="loc_us-gaapEscrowDeposit_350" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapLossContingenciesLineItems" xlink:to="loc_us-gaapEscrowDeposit_350" xlink:type="arc" order="25" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EscrowDepositDisbursementsRelatedToPropertyAcquisition1" xlink:label="loc_us-gaapEscrowDepositDisbursementsRelatedToPropertyAcquisition1_350" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapLossContingenciesLineItems" xlink:to="loc_us-gaapEscrowDepositDisbursementsRelatedToPropertyAcquisition1_350" xlink:type="arc" order="26" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://sharpstechnology.com/role/ScheduleOfFixedAssetsNetDetails" xlink:title="00000062 - Disclosure - Schedule of Fixed Assets, Net (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentLineItems" xlink:label="loc_us-gaapPropertyPlantAndEquipmentLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:label="loc_us-gaapScheduleOfPropertyPlantAndEquipmentTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapPropertyPlantAndEquipmentLineItems" xlink:to="loc_us-gaapScheduleOfPropertyPlantAndEquipmentTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:label="loc_us-gaapPropertyPlantAndEquipmentByTypeAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapScheduleOfPropertyPlantAndEquipmentTable" xlink:to="loc_us-gaapPropertyPlantAndEquipmentByTypeAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:label="loc_us-gaapPropertyPlantAndEquipmentTypeDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapPropertyPlantAndEquipmentByTypeAxis" xlink:to="loc_us-gaapPropertyPlantAndEquipmentTypeDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:label="loc_us-gaapPropertyPlantAndEquipmentTypeDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapPropertyPlantAndEquipmentByTypeAxis" xlink:to="loc_us-gaapPropertyPlantAndEquipmentTypeDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LandMember" xlink:label="loc_us-gaapLandMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapPropertyPlantAndEquipmentTypeDomain" xlink:to="loc_us-gaapLandMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BuildingMember" xlink:label="loc_us-gaapBuildingMember_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapPropertyPlantAndEquipmentTypeDomain" xlink:to="loc_us-gaapBuildingMember_20" xlink:type="arc" order="21" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_MachineryAndEquipmentMember" xlink:label="loc_us-gaapMachineryAndEquipmentMember_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapPropertyPlantAndEquipmentTypeDomain" xlink:to="loc_us-gaapMachineryAndEquipmentMember_40" xlink:type="arc" order="41" />
      <link:loc xlink:type="locator" xlink:href="stss-20240930.xsd#STSS_ComputerSystemsAndWebsiteAndOtherMember" xlink:label="loc_STSSComputerSystemsAndWebsiteAndOtherMember_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapPropertyPlantAndEquipmentTypeDomain" xlink:to="loc_STSSComputerSystemsAndWebsiteAndOtherMember_60" xlink:type="arc" order="61" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentGross" xlink:label="loc_us-gaapPropertyPlantAndEquipmentGross_110" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapPropertyPlantAndEquipmentLineItems" xlink:to="loc_us-gaapPropertyPlantAndEquipmentGross_110" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:label="loc_us-gaapAccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_110" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapPropertyPlantAndEquipmentLineItems" xlink:to="loc_us-gaapAccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_110" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentNet" xlink:label="loc_us-gaapPropertyPlantAndEquipmentNet_110" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapPropertyPlantAndEquipmentLineItems" xlink:to="loc_us-gaapPropertyPlantAndEquipmentNet_110" xlink:type="arc" order="2" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://sharpstechnology.com/role/ScheduleOfFairValueOfAssetsAcquisitionDetailsDisclosure" xlink:title="00000063 - Disclosure - Schedule of Fair Value of Assets Acquisition (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RestructuringCostAndReserveLineItems" xlink:label="loc_us-gaapRestructuringCostAndReserveLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfRestructuringAndRelatedCostsTable" xlink:label="loc_us-gaapScheduleOfRestructuringAndRelatedCostsTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapRestructuringCostAndReserveLineItems" xlink:to="loc_us-gaapScheduleOfRestructuringAndRelatedCostsTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessAcquisitionAxis" xlink:label="loc_us-gaapBusinessAcquisitionAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapScheduleOfRestructuringAndRelatedCostsTable" xlink:to="loc_us-gaapBusinessAcquisitionAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessAcquisitionAcquireeDomain" xlink:label="loc_us-gaapBusinessAcquisitionAcquireeDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapBusinessAcquisitionAxis" xlink:to="loc_us-gaapBusinessAcquisitionAcquireeDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessAcquisitionAcquireeDomain" xlink:label="loc_us-gaapBusinessAcquisitionAcquireeDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapBusinessAcquisitionAxis" xlink:to="loc_us-gaapBusinessAcquisitionAcquireeDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="stss-20240930.xsd#STSS_SafegardMedicalIncMember" xlink:label="loc_STSSSafegardMedicalIncMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapBusinessAcquisitionAcquireeDomain" xlink:to="loc_STSSSafegardMedicalIncMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLand" xlink:label="loc_us-gaapBusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLand_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapRestructuringCostAndReserveLineItems" xlink:to="loc_us-gaapBusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLand_20" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment" xlink:label="loc_us-gaapBusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapRestructuringCostAndReserveLineItems" xlink:to="loc_us-gaapBusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment_20" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedEquipment" xlink:label="loc_us-gaapBusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedEquipment_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapRestructuringCostAndReserveLineItems" xlink:to="loc_us-gaapBusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedEquipment_20" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory" xlink:label="loc_us-gaapBusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapRestructuringCostAndReserveLineItems" xlink:to="loc_us-gaapBusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory_20" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles" xlink:label="loc_us-gaapBusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapRestructuringCostAndReserveLineItems" xlink:to="loc_us-gaapBusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles_20" xlink:type="arc" order="4" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities" xlink:label="loc_us-gaapBusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapRestructuringCostAndReserveLineItems" xlink:to="loc_us-gaapBusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities_20" xlink:type="arc" order="5" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets" xlink:label="loc_us-gaapBusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapRestructuringCostAndReserveLineItems" xlink:to="loc_us-gaapBusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets_20" xlink:type="arc" order="6" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://sharpstechnology.com/role/SubsequentEventsDetailsNarrative" xlink:title="00000064 - Disclosure - Subsequent Events (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubsequentEventLineItems" xlink:label="loc_us-gaapSubsequentEventLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubsequentEventTable" xlink:label="loc_us-gaapSubsequentEventTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapSubsequentEventLineItems" xlink:to="loc_us-gaapSubsequentEventTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementEquityComponentsAxis" xlink:label="loc_us-gaapStatementEquityComponentsAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapSubsequentEventTable" xlink:to="loc_us-gaapStatementEquityComponentsAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EquityComponentDomain" xlink:label="loc_us-gaapEquityComponentDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapStatementEquityComponentsAxis" xlink:to="loc_us-gaapEquityComponentDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EquityComponentDomain" xlink:label="loc_us-gaapEquityComponentDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapStatementEquityComponentsAxis" xlink:to="loc_us-gaapEquityComponentDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_WarrantMember" xlink:label="loc_us-gaapWarrantMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapEquityComponentDomain" xlink:to="loc_us-gaapWarrantMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubsequentEventTypeAxis" xlink:label="loc_us-gaapSubsequentEventTypeAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapSubsequentEventTable" xlink:to="loc_us-gaapSubsequentEventTypeAxis" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubsequentEventTypeDomain" xlink:label="loc_us-gaapSubsequentEventTypeDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapSubsequentEventTypeAxis" xlink:to="loc_us-gaapSubsequentEventTypeDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubsequentEventTypeDomain" xlink:label="loc_us-gaapSubsequentEventTypeDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapSubsequentEventTypeAxis" xlink:to="loc_us-gaapSubsequentEventTypeDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubsequentEventMember" xlink:label="loc_us-gaapSubsequentEventMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapSubsequentEventTypeDomain" xlink:to="loc_us-gaapSubsequentEventMember_0" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight" xlink:label="loc_us-gaapClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapSubsequentEventLineItems" xlink:to="loc_us-gaapClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight_20" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" xlink:label="loc_us-gaapClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapSubsequentEventLineItems" xlink:to="loc_us-gaapClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_20" xlink:type="arc" order="1" />
    </link:definitionLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>24
<FILENAME>stss-20240930_lab.xml
<DESCRIPTION>XBRL LABEL FILE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" standalone="no"?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoFiler Complete; Version: 5.25a -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: https://www.novaworks.com -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x00000000 -->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedLabel" roleURI="http://www.xbrl.org/2009/role/negatedLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodEndLabel" roleURI="http://www.xbrl.org/2009/role/negatedPeriodEndLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodStartLabel" roleURI="http://www.xbrl.org/2009/role/negatedPeriodStartLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTotalLabel" roleURI="http://www.xbrl.org/2009/role/negatedTotalLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedNetLabel" roleURI="http://www.xbrl.org/2009/role/negatedNetLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTerseLabel" roleURI="http://www.xbrl.org/2009/role/negatedTerseLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd#netLabel" roleURI="http://www.xbrl.org/2009/role/netLabel" />
    <link:labelLink xlink:type="extended" xlink:role="http://www.xbrl.org/2003/role/link">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressesAddressTypeAxis" xlink:label="dei_EntityAddressesAddressTypeAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressesAddressTypeAxis" xlink:to="dei_EntityAddressesAddressTypeAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressesAddressTypeAxis_lbl" xml:lang="en-US">Entity Addresses, Address Type [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_BusinessContactMember" xlink:label="dei_BusinessContactMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_BusinessContactMember" xlink:to="dei_BusinessContactMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_BusinessContactMember_lbl" xml:lang="en-US">Business Contact [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AwardTypeAxis" xlink:label="us-gaap_AwardTypeAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AwardTypeAxis" xlink:to="us-gaap_AwardTypeAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AwardTypeAxis_lbl" xml:lang="en-US">Award Type [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="stss-20240930.xsd#STSS_ReverseStockSplitMember" xlink:label="STSS_ReverseStockSplitMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="STSS_ReverseStockSplitMember" xlink:to="STSS_ReverseStockSplitMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="STSS_ReverseStockSplitMember_lbl" xml:lang="en-US">Reverse Stock Split [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementEquityComponentsAxis" xlink:label="us-gaap_StatementEquityComponentsAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StatementEquityComponentsAxis" xlink:to="us-gaap_StatementEquityComponentsAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StatementEquityComponentsAxis_lbl" xml:lang="en-US">Equity Components [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PreferredStockMember" xlink:label="us-gaap_PreferredStockMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PreferredStockMember" xlink:to="us-gaap_PreferredStockMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PreferredStockMember_lbl" xml:lang="en-US">Preferred Stock [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockMember" xlink:label="us-gaap_CommonStockMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockMember" xlink:to="us-gaap_CommonStockMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CommonStockMember_lbl" xml:lang="en-US">Common Stock [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="stss-20240930.xsd#STSS_CommonStockSubscriptionReceivableMember" xlink:label="STSS_CommonStockSubscriptionReceivableMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="STSS_CommonStockSubscriptionReceivableMember" xlink:to="STSS_CommonStockSubscriptionReceivableMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="STSS_CommonStockSubscriptionReceivableMember_lbl" xml:lang="en-US">Common Stock Subscription Receivable [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AdditionalPaidInCapitalMember" xlink:label="us-gaap_AdditionalPaidInCapitalMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AdditionalPaidInCapitalMember" xlink:to="us-gaap_AdditionalPaidInCapitalMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AdditionalPaidInCapitalMember_lbl" xml:lang="en-US">Additional Paid-in Capital [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:label="us-gaap_AccumulatedOtherComprehensiveIncomeMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:to="us-gaap_AccumulatedOtherComprehensiveIncomeMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AccumulatedOtherComprehensiveIncomeMember_lbl" xml:lang="en-US">AOCI Attributable to Parent [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RetainedEarningsMember" xlink:label="us-gaap_RetainedEarningsMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RetainedEarningsMember" xlink:to="us-gaap_RetainedEarningsMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_RetainedEarningsMember_lbl" xml:lang="en-US">Retained Earnings [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="stss-20240930.xsd#STSS_AwardsTypeAxis" xlink:label="STSS_AwardsTypeAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="STSS_AwardsTypeAxis" xlink:to="STSS_AwardsTypeAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="STSS_AwardsTypeAxis_lbl" xml:lang="en-US">Awards Type [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubsidiarySaleOfStockAxis" xlink:label="us-gaap_SubsidiarySaleOfStockAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SubsidiarySaleOfStockAxis" xlink:to="us-gaap_SubsidiarySaleOfStockAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SubsidiarySaleOfStockAxis_lbl" xml:lang="en-US">Sale of Stock [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IPOMember" xlink:label="us-gaap_IPOMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IPOMember" xlink:to="us-gaap_IPOMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IPOMember_lbl" xml:lang="en-US">IPO [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:label="us-gaap_PropertyPlantAndEquipmentByTypeAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:to="us-gaap_PropertyPlantAndEquipmentByTypeAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PropertyPlantAndEquipmentByTypeAxis_lbl" xml:lang="en-US">Long-Lived Tangible Asset [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BuildingMember" xlink:label="us-gaap_BuildingMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_BuildingMember" xlink:to="us-gaap_BuildingMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_BuildingMember_lbl" xml:lang="en-US">Building [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_MachineryAndEquipmentMember" xlink:label="us-gaap_MachineryAndEquipmentMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_MachineryAndEquipmentMember" xlink:to="us-gaap_MachineryAndEquipmentMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_MachineryAndEquipmentMember_lbl" xml:lang="en-US">Machinery and Equipment [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RangeAxis" xlink:label="srt_RangeAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_RangeAxis" xlink:to="srt_RangeAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="srt_RangeAxis_lbl" xml:lang="en-US">Statistical Measurement [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_MinimumMember" xlink:label="srt_MinimumMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_MinimumMember" xlink:to="srt_MinimumMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="srt_MinimumMember_lbl" xml:lang="en-US">Minimum [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_MaximumMember" xlink:label="srt_MaximumMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_MaximumMember" xlink:to="srt_MaximumMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="srt_MaximumMember_lbl" xml:lang="en-US">Maximum [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="stss-20240930.xsd#STSS_WebsiteMember" xlink:label="STSS_WebsiteMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="STSS_WebsiteMember" xlink:to="STSS_WebsiteMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="STSS_WebsiteMember_lbl" xml:lang="en-US">Website [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="stss-20240930.xsd#STSS_PrefundendWarrantsMember" xlink:label="STSS_PrefundendWarrantsMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="STSS_PrefundendWarrantsMember" xlink:to="STSS_PrefundendWarrantsMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="STSS_PrefundendWarrantsMember_lbl" xml:lang="en-US">Prefundend Warrants [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:label="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:to="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_lbl" xml:lang="en-US">Antidilutive Securities [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="stss-20240930.xsd#STSS_StockOptionsAndWarrantsMember" xlink:label="STSS_StockOptionsAndWarrantsMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="STSS_StockOptionsAndWarrantsMember" xlink:to="STSS_StockOptionsAndWarrantsMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="STSS_StockOptionsAndWarrantsMember_lbl" xml:lang="en-US">Stock Options and Warrants [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="stss-20240930.xsd#STSS_StockOptionAndWarrantsMember" xlink:label="STSS_StockOptionAndWarrantsMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="STSS_StockOptionAndWarrantsMember" xlink:to="STSS_StockOptionAndWarrantsMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="STSS_StockOptionAndWarrantsMember_lbl" xml:lang="en-US">Stock Option and Warrants [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LandMember" xlink:label="us-gaap_LandMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LandMember" xlink:to="us-gaap_LandMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LandMember_lbl" xml:lang="en-US">Land [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="stss-20240930.xsd#STSS_ComputerSystemsAndWebsiteAndOtherWebsiteMember" xlink:label="STSS_ComputerSystemsAndWebsiteAndOtherWebsiteMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="STSS_ComputerSystemsAndWebsiteAndOtherWebsiteMember" xlink:to="STSS_ComputerSystemsAndWebsiteAndOtherWebsiteMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="STSS_ComputerSystemsAndWebsiteAndOtherWebsiteMember_lbl" xml:lang="en-US">Computer Systems and Website and Other Website [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockOptionMember" xlink:label="us-gaap_StockOptionMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockOptionMember" xlink:to="us-gaap_StockOptionMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockOptionMember_lbl" xml:lang="en-US">Equity Option [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TypeOfArrangementAxis" xlink:label="us-gaap_TypeOfArrangementAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_TypeOfArrangementAxis" xlink:to="us-gaap_TypeOfArrangementAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_TypeOfArrangementAxis_lbl" xml:lang="en-US">Collaborative Arrangement and Arrangement Other than Collaborative [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="stss-20240930.xsd#STSS_SharePurchaseAgreementMember" xlink:label="STSS_SharePurchaseAgreementMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="STSS_SharePurchaseAgreementMember" xlink:to="STSS_SharePurchaseAgreementMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="STSS_SharePurchaseAgreementMember_lbl" xml:lang="en-US">Share Purchase Agreement [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="stss-20240930.xsd#STSS_StockOptionOneMember" xlink:label="STSS_StockOptionOneMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="STSS_StockOptionOneMember" xlink:to="STSS_StockOptionOneMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="STSS_StockOptionOneMember_lbl" xml:lang="en-US">Stock Option One [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessAcquisitionAxis" xlink:label="us-gaap_BusinessAcquisitionAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_BusinessAcquisitionAxis" xlink:to="us-gaap_BusinessAcquisitionAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_BusinessAcquisitionAxis_lbl" xml:lang="en-US">Business Acquisition [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="stss-20240930.xsd#STSS_SafegardMedicalIncMember" xlink:label="STSS_SafegardMedicalIncMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="STSS_SafegardMedicalIncMember" xlink:to="STSS_SafegardMedicalIncMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="STSS_SafegardMedicalIncMember_lbl" xml:lang="en-US">Safegard Medical, Inc [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FiniteLivedIntangibleAssetsMember" xlink:label="us-gaap_FiniteLivedIntangibleAssetsMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FiniteLivedIntangibleAssetsMember" xlink:to="us-gaap_FiniteLivedIntangibleAssetsMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FiniteLivedIntangibleAssetsMember_lbl" xml:lang="en-US">Finite-Lived Intangible Assets [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DerivativeInstrumentRiskAxis" xlink:label="us-gaap_DerivativeInstrumentRiskAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DerivativeInstrumentRiskAxis" xlink:to="us-gaap_DerivativeInstrumentRiskAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DerivativeInstrumentRiskAxis_lbl" xml:lang="en-US">Derivative Instrument [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="stss-20240930.xsd#STSS_SecuritiesPurchaseAgreementMember" xlink:label="STSS_SecuritiesPurchaseAgreementMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="STSS_SecuritiesPurchaseAgreementMember" xlink:to="STSS_SecuritiesPurchaseAgreementMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="STSS_SecuritiesPurchaseAgreementMember_lbl" xml:lang="en-US">Securities Purchase Agreement [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentAxis" xlink:label="us-gaap_DebtInstrumentAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtInstrumentAxis" xlink:to="us-gaap_DebtInstrumentAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DebtInstrumentAxis_lbl" xml:lang="en-US">Debt Instrument [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="stss-20240930.xsd#STSS_SeniorSecuredNoteMember" xlink:label="STSS_SeniorSecuredNoteMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="STSS_SeniorSecuredNoteMember" xlink:to="STSS_SeniorSecuredNoteMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="STSS_SeniorSecuredNoteMember_lbl" xml:lang="en-US">Senior Secured Note [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="stss-20240930.xsd#STSS_PreReverseMember" xlink:label="STSS_PreReverseMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="STSS_PreReverseMember" xlink:to="STSS_PreReverseMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="STSS_PreReverseMember_lbl" xml:lang="en-US">Pre Reverse [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="stss-20240930.xsd#STSS_NotePurchaseAgreementMember" xlink:label="STSS_NotePurchaseAgreementMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="STSS_NotePurchaseAgreementMember" xlink:to="STSS_NotePurchaseAgreementMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="STSS_NotePurchaseAgreementMember_lbl" xml:lang="en-US">Note Purchase Agreement [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_TitleOfIndividualAxis" xlink:label="srt_TitleOfIndividualAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_TitleOfIndividualAxis" xlink:to="srt_TitleOfIndividualAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="srt_TitleOfIndividualAxis_lbl" xml:lang="en-US">Title and Position [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="stss-20240930.xsd#STSS_UnrelatedThirdPartyPurchasersMember" xlink:label="STSS_UnrelatedThirdPartyPurchasersMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="STSS_UnrelatedThirdPartyPurchasersMember" xlink:to="STSS_UnrelatedThirdPartyPurchasersMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="STSS_UnrelatedThirdPartyPurchasersMember_lbl" xml:lang="en-US">Unrelated Third Party Purchasers [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NoteWarrantMember" xlink:label="us-gaap_NoteWarrantMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NoteWarrantMember" xlink:to="us-gaap_NoteWarrantMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NoteWarrantMember_lbl" xml:lang="en-US">Note Warrant [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="stss-20240930.xsd#STSS_ShelfOfferingMember" xlink:label="STSS_ShelfOfferingMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="STSS_ShelfOfferingMember" xlink:to="STSS_ShelfOfferingMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="STSS_ShelfOfferingMember_lbl" xml:lang="en-US">Shelf Offering [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_WarrantMember" xlink:label="us-gaap_WarrantMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_WarrantMember" xlink:to="us-gaap_WarrantMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_WarrantMember_lbl" xml:lang="en-US">Warrant [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PrivatePlacementMember" xlink:label="us-gaap_PrivatePlacementMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PrivatePlacementMember" xlink:to="us-gaap_PrivatePlacementMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PrivatePlacementMember_lbl" xml:lang="en-US">Private Placement [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="stss-20240930.xsd#STSS_PIPEPreFundedWarrantsMember" xlink:label="STSS_PIPEPreFundedWarrantsMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="STSS_PIPEPreFundedWarrantsMember" xlink:to="STSS_PIPEPreFundedWarrantsMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="STSS_PIPEPreFundedWarrantsMember_lbl" xml:lang="en-US">PIPE Pre Funded Warrants [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="stss-20240930.xsd#STSS_NonTradingWarrantsMember" xlink:label="STSS_NonTradingWarrantsMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="STSS_NonTradingWarrantsMember" xlink:to="STSS_NonTradingWarrantsMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="STSS_NonTradingWarrantsMember_lbl" xml:lang="en-US">Non Trading Warrants [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="stss-20240930.xsd#STSS_PurchaseAgreementMember" xlink:label="STSS_PurchaseAgreementMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="STSS_PurchaseAgreementMember" xlink:to="STSS_PurchaseAgreementMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="STSS_PurchaseAgreementMember_lbl" xml:lang="en-US">Purchase Agreement [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="stss-20240930.xsd#STSS_PIPEWarrantMember" xlink:label="STSS_PIPEWarrantMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="STSS_PIPEWarrantMember" xlink:to="STSS_PIPEWarrantMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="STSS_PIPEWarrantMember_lbl" xml:lang="en-US">PIPE Warrant [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="stss-20240930.xsd#STSS_TradingWarrantsMember" xlink:label="STSS_TradingWarrantsMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="STSS_TradingWarrantsMember" xlink:to="STSS_TradingWarrantsMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="STSS_TradingWarrantsMember_lbl" xml:lang="en-US">Trading Warrants [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OverAllotmentOptionMember" xlink:label="us-gaap_OverAllotmentOptionMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OverAllotmentOptionMember" xlink:to="us-gaap_OverAllotmentOptionMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OverAllotmentOptionMember_lbl" xml:lang="en-US">Over-Allotment Option [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="stss-20240930.xsd#STSS_NoteWarrantsMember" xlink:label="STSS_NoteWarrantsMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="STSS_NoteWarrantsMember" xlink:to="STSS_NoteWarrantsMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="STSS_NoteWarrantsMember_lbl" xml:lang="en-US">Note Warrants [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="stss-20240930.xsd#STSS_SubscriptionAgreementsMember" xlink:label="STSS_SubscriptionAgreementsMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="STSS_SubscriptionAgreementsMember" xlink:to="STSS_SubscriptionAgreementsMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="STSS_SubscriptionAgreementsMember_lbl" xml:lang="en-US">Subscription Agreements [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="stss-20240930.xsd#STSS_InvestorsMember" xlink:label="STSS_InvestorsMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="STSS_InvestorsMember" xlink:to="STSS_InvestorsMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="STSS_InvestorsMember_lbl" xml:lang="en-US">Investors [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="stss-20240930.xsd#STSS_InducementAgreementMember" xlink:label="STSS_InducementAgreementMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="STSS_InducementAgreementMember" xlink:to="STSS_InducementAgreementMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="STSS_InducementAgreementMember_lbl" xml:lang="en-US">Inducement Agreement [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="stss-20240930.xsd#STSS_InducementWarrantsMember" xlink:label="STSS_InducementWarrantsMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="STSS_InducementWarrantsMember" xlink:to="STSS_InducementWarrantsMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="STSS_InducementWarrantsMember_lbl" xml:lang="en-US">Inducement Warrants [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="stss-20240930.xsd#STSS_WarrantHoldersMember" xlink:label="STSS_WarrantHoldersMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="STSS_WarrantHoldersMember" xlink:to="STSS_WarrantHoldersMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="STSS_WarrantHoldersMember_lbl" xml:lang="en-US">Warrant Holders [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="stss-20240930.xsd#STSS_PreFundedWarrantsMember" xlink:label="STSS_PreFundedWarrantsMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="STSS_PreFundedWarrantsMember" xlink:to="STSS_PreFundedWarrantsMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="STSS_PreFundedWarrantsMember_lbl" xml:lang="en-US">Pre-funded Warrants [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="stss-20240930.xsd#STSS_WarrantHolderMember" xlink:label="STSS_WarrantHolderMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="STSS_WarrantHolderMember" xlink:to="STSS_WarrantHolderMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="STSS_WarrantHolderMember_lbl" xml:lang="en-US">Warrant Holder [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="stss-20240930.xsd#STSS_OverAllotmentWarrantsMember" xlink:label="STSS_OverAllotmentWarrantsMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="STSS_OverAllotmentWarrantsMember" xlink:to="STSS_OverAllotmentWarrantsMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="STSS_OverAllotmentWarrantsMember_lbl" xml:lang="en-US">Over-Allotment Warrants [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="us-gaap_StatementClassOfStockAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StatementClassOfStockAxis" xlink:to="us-gaap_StatementClassOfStockAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StatementClassOfStockAxis_lbl" xml:lang="en-US">Class of Stock [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SeriesAPreferredStockMember" xlink:label="us-gaap_SeriesAPreferredStockMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SeriesAPreferredStockMember" xlink:to="us-gaap_SeriesAPreferredStockMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SeriesAPreferredStockMember_lbl" xml:lang="en-US">Series A Preferred Stock [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_DirectorMember" xlink:label="srt_DirectorMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_DirectorMember" xlink:to="srt_DirectorMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="srt_DirectorMember_lbl" xml:lang="en-US">Director [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis" xlink:label="srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis" xlink:to="srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_lbl" xml:lang="en-US">Investment, Name [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="stss-20240930.xsd#STSS_AlanBlackmanMember" xlink:label="STSS_AlanBlackmanMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="STSS_AlanBlackmanMember" xlink:to="STSS_AlanBlackmanMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="STSS_AlanBlackmanMember_lbl" xml:lang="en-US">Alan Blackman [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_MeasurementInputTypeAxis" xlink:label="us-gaap_MeasurementInputTypeAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_MeasurementInputTypeAxis" xlink:to="us-gaap_MeasurementInputTypeAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_MeasurementInputTypeAxis_lbl" xml:lang="en-US">Measurement Input Type [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_MeasurementInputExpectedTermMember" xlink:label="us-gaap_MeasurementInputExpectedTermMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_MeasurementInputExpectedTermMember" xlink:to="us-gaap_MeasurementInputExpectedTermMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_MeasurementInputExpectedTermMember_lbl" xml:lang="en-US">Measurement Input, Expected Term [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_MeasurementInputOptionVolatilityMember" xlink:label="us-gaap_MeasurementInputOptionVolatilityMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_MeasurementInputOptionVolatilityMember" xlink:to="us-gaap_MeasurementInputOptionVolatilityMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_MeasurementInputOptionVolatilityMember_lbl" xml:lang="en-US">Measurement Input, Option Volatility [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_MeasurementInputRiskFreeInterestRateMember" xlink:label="us-gaap_MeasurementInputRiskFreeInterestRateMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_MeasurementInputRiskFreeInterestRateMember" xlink:to="us-gaap_MeasurementInputRiskFreeInterestRateMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_MeasurementInputRiskFreeInterestRateMember_lbl" xml:lang="en-US">Measurement Input, Risk Free Interest Rate [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_MeasurementInputExpectedDividendRateMember" xlink:label="us-gaap_MeasurementInputExpectedDividendRateMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_MeasurementInputExpectedDividendRateMember" xlink:to="us-gaap_MeasurementInputExpectedDividendRateMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_MeasurementInputExpectedDividendRateMember_lbl" xml:lang="en-US">Measurement Input, Expected Dividend Rate [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="stss-20240930.xsd#STSS_TradingAndOverallotmentWarrantsMember" xlink:label="STSS_TradingAndOverallotmentWarrantsMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="STSS_TradingAndOverallotmentWarrantsMember" xlink:to="STSS_TradingAndOverallotmentWarrantsMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="STSS_TradingAndOverallotmentWarrantsMember_lbl" xml:lang="en-US">Trading and Over allotment Warrants [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="stss-20240930.xsd#STSS_OfferingWarrantsFebruaryTwentyTwentyThreeMember" xlink:label="STSS_OfferingWarrantsFebruaryTwentyTwentyThreeMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="STSS_OfferingWarrantsFebruaryTwentyTwentyThreeMember" xlink:to="STSS_OfferingWarrantsFebruaryTwentyTwentyThreeMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="STSS_OfferingWarrantsFebruaryTwentyTwentyThreeMember_lbl" xml:lang="en-US">Offering Warrants - February 2023 [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="stss-20240930.xsd#STSS_OfferingWarrantsSeptemberTwentyTwentyThreeMember" xlink:label="STSS_OfferingWarrantsSeptemberTwentyTwentyThreeMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="STSS_OfferingWarrantsSeptemberTwentyTwentyThreeMember" xlink:to="STSS_OfferingWarrantsSeptemberTwentyTwentyThreeMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="STSS_OfferingWarrantsSeptemberTwentyTwentyThreeMember_lbl" xml:lang="en-US">Offering Warrants - September 2023 [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfWarrantOrRightAxis" xlink:label="us-gaap_ClassOfWarrantOrRightAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ClassOfWarrantOrRightAxis" xlink:to="us-gaap_ClassOfWarrantOrRightAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ClassOfWarrantOrRightAxis_lbl" xml:lang="en-US">Class of Warrant or Right [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="stss-20240930.xsd#STSS_OfferingWarrantsFebruaryTwoThousandTwentyThreeMember" xlink:label="STSS_OfferingWarrantsFebruaryTwoThousandTwentyThreeMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="STSS_OfferingWarrantsFebruaryTwoThousandTwentyThreeMember" xlink:to="STSS_OfferingWarrantsFebruaryTwoThousandTwentyThreeMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="STSS_OfferingWarrantsFebruaryTwoThousandTwentyThreeMember_lbl" xml:lang="en-US">Offering Warrants - February 2023 [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="stss-20240930.xsd#STSS_OfferingWarrantsSeptemberTwoThousandTwentyThreeMember" xlink:label="STSS_OfferingWarrantsSeptemberTwoThousandTwentyThreeMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="STSS_OfferingWarrantsSeptemberTwoThousandTwentyThreeMember" xlink:to="STSS_OfferingWarrantsSeptemberTwoThousandTwentyThreeMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="STSS_OfferingWarrantsSeptemberTwoThousandTwentyThreeMember_lbl" xml:lang="en-US">Offering Warrants - September 2023 [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="stss-20240930.xsd#STSS_WarrantsIssuedForServiceManagementMember" xlink:label="STSS_WarrantsIssuedForServiceManagementMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="STSS_WarrantsIssuedForServiceManagementMember" xlink:to="STSS_WarrantsIssuedForServiceManagementMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="STSS_WarrantsIssuedForServiceManagementMember_lbl" xml:lang="en-US">Warrants Issued for Services Arrangement [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="stss-20240930.xsd#STSS_InducementWarrantsMayTwoThousandTwentyFourMember" xlink:label="STSS_InducementWarrantsMayTwoThousandTwentyFourMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="STSS_InducementWarrantsMayTwoThousandTwentyFourMember" xlink:to="STSS_InducementWarrantsMayTwoThousandTwentyFourMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="STSS_InducementWarrantsMayTwoThousandTwentyFourMember_lbl" xml:lang="en-US">Inducement Warrants - May 2024 [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PlanNameAxis" xlink:label="us-gaap_PlanNameAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PlanNameAxis" xlink:to="us-gaap_PlanNameAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PlanNameAxis_lbl" xml:lang="en-US">Plan Name [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="stss-20240930.xsd#STSS_TwoThousandTwentyThreeEquityIncentivePlanMember" xlink:label="STSS_TwoThousandTwentyThreeEquityIncentivePlanMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="STSS_TwoThousandTwentyThreeEquityIncentivePlanMember" xlink:to="STSS_TwoThousandTwentyThreeEquityIncentivePlanMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="STSS_TwoThousandTwentyThreeEquityIncentivePlanMember_lbl" xml:lang="en-US">2023 Equity Incentive Plan [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="stss-20240930.xsd#STSS_EmployeesAndConsultantMember" xlink:label="STSS_EmployeesAndConsultantMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="STSS_EmployeesAndConsultantMember" xlink:to="STSS_EmployeesAndConsultantMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="STSS_EmployeesAndConsultantMember_lbl" xml:lang="en-US">Employees and Consultant [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="stss-20240930.xsd#STSS_TwoThousandTwentyTwoEquityIncentivePlanMember" xlink:label="STSS_TwoThousandTwentyTwoEquityIncentivePlanMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="STSS_TwoThousandTwentyTwoEquityIncentivePlanMember" xlink:to="STSS_TwoThousandTwentyTwoEquityIncentivePlanMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="STSS_TwoThousandTwentyTwoEquityIncentivePlanMember_lbl" xml:lang="en-US">2022 Equity Incentive Plan [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeStatementLocationAxis" xlink:label="us-gaap_IncomeStatementLocationAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeStatementLocationAxis" xlink:to="us-gaap_IncomeStatementLocationAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncomeStatementLocationAxis_lbl" xml:lang="en-US">Statement of Income Location, Balance [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_GeneralAndAdministrativeExpenseMember" xlink:label="us-gaap_GeneralAndAdministrativeExpenseMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_GeneralAndAdministrativeExpenseMember" xlink:to="us-gaap_GeneralAndAdministrativeExpenseMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_GeneralAndAdministrativeExpenseMember_lbl" xml:lang="en-US">General and Administrative Expense [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ResearchAndDevelopmentExpenseMember" xlink:label="us-gaap_ResearchAndDevelopmentExpenseMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ResearchAndDevelopmentExpenseMember" xlink:to="us-gaap_ResearchAndDevelopmentExpenseMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ResearchAndDevelopmentExpenseMember_lbl" xml:lang="en-US">Research and Development Expense [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis" xlink:label="us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis" xlink:to="us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis_lbl" xml:lang="en-US">Exercise Price Range [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="stss-20240930.xsd#STSS_ExercisePriceRangeOneMember" xlink:label="STSS_ExercisePriceRangeOneMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="STSS_ExercisePriceRangeOneMember" xlink:to="STSS_ExercisePriceRangeOneMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="STSS_ExercisePriceRangeOneMember_lbl" xml:lang="en-US">Exercise Price Range One [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="stss-20240930.xsd#STSS_ExercisePriceRangeTwoMember" xlink:label="STSS_ExercisePriceRangeTwoMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="STSS_ExercisePriceRangeTwoMember" xlink:to="STSS_ExercisePriceRangeTwoMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="STSS_ExercisePriceRangeTwoMember_lbl" xml:lang="en-US">Exercise Price Range Two [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="stss-20240930.xsd#STSS_ExercisePriceRangeThreeMember" xlink:label="STSS_ExercisePriceRangeThreeMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="STSS_ExercisePriceRangeThreeMember" xlink:to="STSS_ExercisePriceRangeThreeMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="STSS_ExercisePriceRangeThreeMember_lbl" xml:lang="en-US">Exercise Price Range Three [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="stss-20240930.xsd#STSS_ExercisePriceRangeFourMember" xlink:label="STSS_ExercisePriceRangeFourMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="STSS_ExercisePriceRangeFourMember" xlink:to="STSS_ExercisePriceRangeFourMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="STSS_ExercisePriceRangeFourMember_lbl" xml:lang="en-US">Exercise Price Range Four [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="stss-20240930.xsd#STSS_ExercisePriceRangeFiveMember" xlink:label="STSS_ExercisePriceRangeFiveMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="STSS_ExercisePriceRangeFiveMember" xlink:to="STSS_ExercisePriceRangeFiveMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="STSS_ExercisePriceRangeFiveMember_lbl" xml:lang="en-US">Exercise Price Range Five [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="stss-20240930.xsd#STSS_ExercisePriceRangeSixMember" xlink:label="STSS_ExercisePriceRangeSixMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="STSS_ExercisePriceRangeSixMember" xlink:to="STSS_ExercisePriceRangeSixMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="STSS_ExercisePriceRangeSixMember_lbl" xml:lang="en-US">Exercise Price Range Six [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="stss-20240930.xsd#STSS_ExercisePriceRangeSevenMember" xlink:label="STSS_ExercisePriceRangeSevenMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="STSS_ExercisePriceRangeSevenMember" xlink:to="STSS_ExercisePriceRangeSevenMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="STSS_ExercisePriceRangeSevenMember_lbl" xml:lang="en-US">Exercise Price Range Seven [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="stss-20240930.xsd#STSS_ExercisePriceRangeEightMember" xlink:label="STSS_ExercisePriceRangeEightMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="STSS_ExercisePriceRangeEightMember" xlink:to="STSS_ExercisePriceRangeEightMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="STSS_ExercisePriceRangeEightMember_lbl" xml:lang="en-US">Exercise Price Range Eight [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="stss-20240930.xsd#STSS_ExercisePriceRangeNineMember" xlink:label="STSS_ExercisePriceRangeNineMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="STSS_ExercisePriceRangeNineMember" xlink:to="STSS_ExercisePriceRangeNineMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="STSS_ExercisePriceRangeNineMember_lbl" xml:lang="en-US">Exercise Price Range Nine [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="stss-20240930.xsd#STSS_ExercisePriceRangeTenMember" xlink:label="STSS_ExercisePriceRangeTenMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="STSS_ExercisePriceRangeTenMember" xlink:to="STSS_ExercisePriceRangeTenMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="STSS_ExercisePriceRangeTenMember_lbl" xml:lang="en-US">Exercise Price Range Ten [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeTaxAuthorityAxis" xlink:label="us-gaap_IncomeTaxAuthorityAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeTaxAuthorityAxis" xlink:to="us-gaap_IncomeTaxAuthorityAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncomeTaxAuthorityAxis_lbl" xml:lang="en-US">Income Tax Jurisdiction [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DomesticCountryMember" xlink:label="us-gaap_DomesticCountryMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DomesticCountryMember" xlink:to="us-gaap_DomesticCountryMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DomesticCountryMember_lbl" xml:lang="en-US">Domestic Tax Jurisdiction [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_StatementScenarioAxis" xlink:label="srt_StatementScenarioAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_StatementScenarioAxis" xlink:to="srt_StatementScenarioAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="srt_StatementScenarioAxis_lbl" xml:lang="en-US">Scenario [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="stss-20240930.xsd#STSS_ExpiresOnTwoThousandTwentyEightMember" xlink:label="STSS_ExpiresOnTwoThousandTwentyEightMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="STSS_ExpiresOnTwoThousandTwentyEightMember" xlink:to="STSS_ExpiresOnTwoThousandTwentyEightMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="STSS_ExpiresOnTwoThousandTwentyEightMember_lbl" xml:lang="en-US">Expires On 2028 [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="stss-20240930.xsd#STSS_NotExpireMember" xlink:label="STSS_NotExpireMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="STSS_NotExpireMember" xlink:to="STSS_NotExpireMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="STSS_NotExpireMember_lbl" xml:lang="en-US">No Expire [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ForeignCountryMember" xlink:label="us-gaap_ForeignCountryMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ForeignCountryMember" xlink:to="us-gaap_ForeignCountryMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ForeignCountryMember_lbl" xml:lang="en-US">Foreign Tax Jurisdiction [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="stss-20240930.xsd#STSS_OfficersAndDirectorsMember" xlink:label="STSS_OfficersAndDirectorsMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="STSS_OfficersAndDirectorsMember" xlink:to="STSS_OfficersAndDirectorsMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="STSS_OfficersAndDirectorsMember_lbl" xml:lang="en-US">Officers and Directors [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:label="us-gaap_FairValueByFairValueHierarchyLevelAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:to="us-gaap_FairValueByFairValueHierarchyLevelAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FairValueByFairValueHierarchyLevelAxis_lbl" xml:lang="en-US">Fair Value Hierarchy and NAV [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueInputsLevel1Member" xlink:label="us-gaap_FairValueInputsLevel1Member" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueInputsLevel1Member" xlink:to="us-gaap_FairValueInputsLevel1Member_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FairValueInputsLevel1Member_lbl" xml:lang="en-US">Fair Value, Inputs, Level 1 [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueInputsLevel2Member" xlink:label="us-gaap_FairValueInputsLevel2Member" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueInputsLevel2Member" xlink:to="us-gaap_FairValueInputsLevel2Member_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FairValueInputsLevel2Member_lbl" xml:lang="en-US">Fair Value, Inputs, Level 2 [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueInputsLevel3Member" xlink:label="us-gaap_FairValueInputsLevel3Member" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueInputsLevel3Member" xlink:to="us-gaap_FairValueInputsLevel3Member_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FairValueInputsLevel3Member_lbl" xml:lang="en-US">Fair Value, Inputs, Level 3 [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="stss-20240930.xsd#STSS_RoyaltyAgreementMember" xlink:label="STSS_RoyaltyAgreementMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="STSS_RoyaltyAgreementMember" xlink:to="STSS_RoyaltyAgreementMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="STSS_RoyaltyAgreementMember_lbl" xml:lang="en-US">Royalty Agreement [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="stss-20240930.xsd#STSS_BarryBerlerMember" xlink:label="STSS_BarryBerlerMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="STSS_BarryBerlerMember" xlink:to="STSS_BarryBerlerMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="STSS_BarryBerlerMember_lbl" xml:lang="en-US">Barry Berler [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="stss-20240930.xsd#STSS_EmploymentAgreementMember" xlink:label="STSS_EmploymentAgreementMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="STSS_EmploymentAgreementMember" xlink:to="STSS_EmploymentAgreementMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="STSS_EmploymentAgreementMember_lbl" xml:lang="en-US">Employment Agreement [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="stss-20240930.xsd#STSS_Mr.BlackmanMember" xlink:label="STSS_Mr.BlackmanMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="STSS_Mr.BlackmanMember" xlink:to="STSS_Mr.BlackmanMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="STSS_Mr.BlackmanMember_lbl" xml:lang="en-US">Mr. Blackman [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="stss-20240930.xsd#STSS_ServiceAgreementMember" xlink:label="STSS_ServiceAgreementMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="STSS_ServiceAgreementMember" xlink:to="STSS_ServiceAgreementMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="STSS_ServiceAgreementMember_lbl" xml:lang="en-US">Service Agreement [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_LitigationCaseAxis" xlink:label="srt_LitigationCaseAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_LitigationCaseAxis" xlink:to="srt_LitigationCaseAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="srt_LitigationCaseAxis_lbl" xml:lang="en-US">Litigation Case [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="stss-20240930.xsd#STSS_BerlerMember" xlink:label="STSS_BerlerMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="STSS_BerlerMember" xlink:to="STSS_BerlerMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="STSS_BerlerMember_lbl" xml:lang="en-US">Berler [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="stss-20240930.xsd#STSS_PlastomoldMember" xlink:label="STSS_PlastomoldMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="STSS_PlastomoldMember" xlink:to="STSS_PlastomoldMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="STSS_PlastomoldMember_lbl" xml:lang="en-US">Plastomold [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="stss-20240930.xsd#STSS_AssetPurchaseAgreementMember" xlink:label="STSS_AssetPurchaseAgreementMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="STSS_AssetPurchaseAgreementMember" xlink:to="STSS_AssetPurchaseAgreementMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="STSS_AssetPurchaseAgreementMember_lbl" xml:lang="en-US">Asset Purchase Agreement [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AssetAcquisitionAxis" xlink:label="us-gaap_AssetAcquisitionAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AssetAcquisitionAxis" xlink:to="us-gaap_AssetAcquisitionAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AssetAcquisitionAxis_lbl" xml:lang="en-US">Asset Acquisition [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="stss-20240930.xsd#STSS_InjectEZLLCMember" xlink:label="STSS_InjectEZLLCMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="STSS_InjectEZLLCMember" xlink:to="STSS_InjectEZLLCMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="STSS_InjectEZLLCMember_lbl" xml:lang="en-US">InjectEZ, LLC [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubsequentEventTypeAxis" xlink:label="us-gaap_SubsequentEventTypeAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SubsequentEventTypeAxis" xlink:to="us-gaap_SubsequentEventTypeAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SubsequentEventTypeAxis_lbl" xml:lang="en-US">Subsequent Event Type [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubsequentEventMember" xlink:label="us-gaap_SubsequentEventMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SubsequentEventMember" xlink:to="us-gaap_SubsequentEventMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SubsequentEventMember_lbl" xml:lang="en-US">Subsequent Event [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="stss-20240930.xsd#STSS_ComputerSystemsAndWebsiteAndOtherMember" xlink:label="STSS_ComputerSystemsAndWebsiteAndOtherMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="STSS_ComputerSystemsAndWebsiteAndOtherMember" xlink:to="STSS_ComputerSystemsAndWebsiteAndOtherMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="STSS_ComputerSystemsAndWebsiteAndOtherMember_lbl" xml:lang="en-US">Computer Systems and Website &amp; Other [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressesTable" xlink:label="dei_EntityAddressesTable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressesTable" xlink:to="dei_EntityAddressesTable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressesTable_lbl" xml:lang="en-US">Entity Addresses [Table]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressesLineItems" xlink:label="dei_EntityAddressesLineItems" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressesLineItems" xlink:to="dei_EntityAddressesLineItems_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressesLineItems_lbl" xml:lang="en-US">Entity Addresses [Line Items]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentType" xlink:label="dei_DocumentType" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentType" xlink:to="dei_DocumentType_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentType_lbl" xml:lang="en-US">Document Type</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_AmendmentFlag" xlink:label="dei_AmendmentFlag" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AmendmentFlag" xlink:to="dei_AmendmentFlag_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AmendmentFlag_lbl" xml:lang="en-US">Amendment Flag</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_AmendmentDescription" xlink:label="dei_AmendmentDescription" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AmendmentDescription" xlink:to="dei_AmendmentDescription_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AmendmentDescription_lbl" xml:lang="en-US">Amendment Description</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentRegistrationStatement" xlink:label="dei_DocumentRegistrationStatement" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentRegistrationStatement" xlink:to="dei_DocumentRegistrationStatement_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentRegistrationStatement_lbl" xml:lang="en-US">Document Registration Statement</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentAnnualReport" xlink:label="dei_DocumentAnnualReport" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentAnnualReport" xlink:to="dei_DocumentAnnualReport_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentAnnualReport_lbl" xml:lang="en-US">Document Annual Report</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentQuarterlyReport" xlink:label="dei_DocumentQuarterlyReport" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentQuarterlyReport" xlink:to="dei_DocumentQuarterlyReport_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentQuarterlyReport_lbl" xml:lang="en-US">Document Quarterly Report</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentTransitionReport" xlink:label="dei_DocumentTransitionReport" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentTransitionReport" xlink:to="dei_DocumentTransitionReport_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentTransitionReport_lbl" xml:lang="en-US">Document Transition Report</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentShellCompanyReport" xlink:label="dei_DocumentShellCompanyReport" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentShellCompanyReport" xlink:to="dei_DocumentShellCompanyReport_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentShellCompanyReport_lbl" xml:lang="en-US">Document Shell Company Report</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentShellCompanyEventDate" xlink:label="dei_DocumentShellCompanyEventDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentShellCompanyEventDate" xlink:to="dei_DocumentShellCompanyEventDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentShellCompanyEventDate_lbl" xml:lang="en-US">Document Shell Company Event Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentPeriodStartDate" xlink:label="dei_DocumentPeriodStartDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentPeriodStartDate" xlink:to="dei_DocumentPeriodStartDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentPeriodStartDate_lbl" xml:lang="en-US">Document Period Start Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentPeriodEndDate" xlink:label="dei_DocumentPeriodEndDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentPeriodEndDate" xlink:to="dei_DocumentPeriodEndDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentPeriodEndDate_lbl" xml:lang="en-US">Document Period End Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentFiscalPeriodFocus" xlink:label="dei_DocumentFiscalPeriodFocus" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentFiscalPeriodFocus" xlink:to="dei_DocumentFiscalPeriodFocus_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentFiscalPeriodFocus_lbl" xml:lang="en-US">Document Fiscal Period Focus</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentFiscalYearFocus" xlink:label="dei_DocumentFiscalYearFocus" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentFiscalYearFocus" xlink:to="dei_DocumentFiscalYearFocus_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentFiscalYearFocus_lbl" xml:lang="en-US">Document Fiscal Year Focus</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_CurrentFiscalYearEndDate" xlink:label="dei_CurrentFiscalYearEndDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CurrentFiscalYearEndDate" xlink:to="dei_CurrentFiscalYearEndDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CurrentFiscalYearEndDate_lbl" xml:lang="en-US">Current Fiscal Year End Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityFileNumber" xlink:label="dei_EntityFileNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityFileNumber" xlink:to="dei_EntityFileNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityFileNumber_lbl" xml:lang="en-US">Entity File Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityRegistrantName" xlink:label="dei_EntityRegistrantName" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityRegistrantName" xlink:to="dei_EntityRegistrantName_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityRegistrantName_lbl" xml:lang="en-US">Entity Registrant Name</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityCentralIndexKey" xlink:label="dei_EntityCentralIndexKey" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCentralIndexKey" xlink:to="dei_EntityCentralIndexKey_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityCentralIndexKey_lbl" xml:lang="en-US">Entity Central Index Key</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityPrimarySicNumber" xlink:label="dei_EntityPrimarySicNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityPrimarySicNumber" xlink:to="dei_EntityPrimarySicNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityPrimarySicNumber_lbl" xml:lang="en-US">Entity Primary SIC Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityTaxIdentificationNumber" xlink:label="dei_EntityTaxIdentificationNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityTaxIdentificationNumber" xlink:to="dei_EntityTaxIdentificationNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityTaxIdentificationNumber_lbl" xml:lang="en-US">Entity Tax Identification Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityIncorporationStateCountryCode" xlink:label="dei_EntityIncorporationStateCountryCode" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityIncorporationStateCountryCode" xlink:to="dei_EntityIncorporationStateCountryCode_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityIncorporationStateCountryCode_lbl" xml:lang="en-US">Entity Incorporation, State or Country Code</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressAddressLine1" xlink:label="dei_EntityAddressAddressLine1" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine1" xlink:to="dei_EntityAddressAddressLine1_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressAddressLine1_lbl" xml:lang="en-US">Entity Address, Address Line One</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressAddressLine2" xlink:label="dei_EntityAddressAddressLine2" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine2" xlink:to="dei_EntityAddressAddressLine2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressAddressLine2_lbl" xml:lang="en-US">Entity Address, Address Line Two</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressAddressLine3" xlink:label="dei_EntityAddressAddressLine3" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine3" xlink:to="dei_EntityAddressAddressLine3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressAddressLine3_lbl" xml:lang="en-US">Entity Address, Address Line Three</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressCityOrTown" xlink:label="dei_EntityAddressCityOrTown" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressCityOrTown" xlink:to="dei_EntityAddressCityOrTown_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressCityOrTown_lbl" xml:lang="en-US">Entity Address, City or Town</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressStateOrProvince" xlink:label="dei_EntityAddressStateOrProvince" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressStateOrProvince" xlink:to="dei_EntityAddressStateOrProvince_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressStateOrProvince_lbl" xml:lang="en-US">Entity Address, State or Province</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressCountry" xlink:label="dei_EntityAddressCountry" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressCountry" xlink:to="dei_EntityAddressCountry_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressCountry_lbl" xml:lang="en-US">Entity Address, Country</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressPostalZipCode" xlink:label="dei_EntityAddressPostalZipCode" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressPostalZipCode" xlink:to="dei_EntityAddressPostalZipCode_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressPostalZipCode_lbl" xml:lang="en-US">Entity Address, Postal Zip Code</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_CountryRegion" xlink:label="dei_CountryRegion" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CountryRegion" xlink:to="dei_CountryRegion_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CountryRegion_lbl" xml:lang="en-US">Country Region</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_CityAreaCode" xlink:label="dei_CityAreaCode" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CityAreaCode" xlink:to="dei_CityAreaCode_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CityAreaCode_lbl" xml:lang="en-US">City Area Code</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_LocalPhoneNumber" xlink:label="dei_LocalPhoneNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_LocalPhoneNumber" xlink:to="dei_LocalPhoneNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_LocalPhoneNumber_lbl" xml:lang="en-US">Local Phone Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_Extension" xlink:label="dei_Extension" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_Extension" xlink:to="dei_Extension_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_Extension_lbl" xml:lang="en-US">Extension</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_WrittenCommunications" xlink:label="dei_WrittenCommunications" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_WrittenCommunications" xlink:to="dei_WrittenCommunications_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_WrittenCommunications_lbl" xml:lang="en-US">Written Communications</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_SolicitingMaterial" xlink:label="dei_SolicitingMaterial" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SolicitingMaterial" xlink:to="dei_SolicitingMaterial_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_SolicitingMaterial_lbl" xml:lang="en-US">Soliciting Material</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_PreCommencementTenderOffer" xlink:label="dei_PreCommencementTenderOffer" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_PreCommencementTenderOffer" xlink:to="dei_PreCommencementTenderOffer_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_PreCommencementTenderOffer_lbl" xml:lang="en-US">Pre-commencement Tender Offer</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_PreCommencementIssuerTenderOffer" xlink:label="dei_PreCommencementIssuerTenderOffer" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_PreCommencementIssuerTenderOffer" xlink:to="dei_PreCommencementIssuerTenderOffer_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_PreCommencementIssuerTenderOffer_lbl" xml:lang="en-US">Pre-commencement Issuer Tender Offer</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_Security12bTitle" xlink:label="dei_Security12bTitle" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_Security12bTitle" xlink:to="dei_Security12bTitle_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_Security12bTitle_lbl" xml:lang="en-US">Title of 12(b) Security</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_NoTradingSymbolFlag" xlink:label="dei_NoTradingSymbolFlag" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_NoTradingSymbolFlag" xlink:to="dei_NoTradingSymbolFlag_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_NoTradingSymbolFlag_lbl" xml:lang="en-US">No Trading Symbol Flag</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_TradingSymbol" xlink:label="dei_TradingSymbol" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_TradingSymbol" xlink:to="dei_TradingSymbol_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_TradingSymbol_lbl" xml:lang="en-US">Trading Symbol</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_SecurityExchangeName" xlink:label="dei_SecurityExchangeName" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SecurityExchangeName" xlink:to="dei_SecurityExchangeName_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_SecurityExchangeName_lbl" xml:lang="en-US">Security Exchange Name</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_Security12gTitle" xlink:label="dei_Security12gTitle" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_Security12gTitle" xlink:to="dei_Security12gTitle_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_Security12gTitle_lbl" xml:lang="en-US">Title of 12(g) Security</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_SecurityReportingObligation" xlink:label="dei_SecurityReportingObligation" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SecurityReportingObligation" xlink:to="dei_SecurityReportingObligation_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_SecurityReportingObligation_lbl" xml:lang="en-US">Security Reporting Obligation</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_AnnualInformationForm" xlink:label="dei_AnnualInformationForm" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AnnualInformationForm" xlink:to="dei_AnnualInformationForm_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AnnualInformationForm_lbl" xml:lang="en-US">Annual Information Form</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_AuditedAnnualFinancialStatements" xlink:label="dei_AuditedAnnualFinancialStatements" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AuditedAnnualFinancialStatements" xlink:to="dei_AuditedAnnualFinancialStatements_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AuditedAnnualFinancialStatements_lbl" xml:lang="en-US">Audited Annual Financial Statements</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityWellKnownSeasonedIssuer" xlink:label="dei_EntityWellKnownSeasonedIssuer" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityWellKnownSeasonedIssuer" xlink:to="dei_EntityWellKnownSeasonedIssuer_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityWellKnownSeasonedIssuer_lbl" xml:lang="en-US">Entity Well-known Seasoned Issuer</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityVoluntaryFilers" xlink:label="dei_EntityVoluntaryFilers" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityVoluntaryFilers" xlink:to="dei_EntityVoluntaryFilers_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityVoluntaryFilers_lbl" xml:lang="en-US">Entity Voluntary Filers</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityCurrentReportingStatus" xlink:label="dei_EntityCurrentReportingStatus" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCurrentReportingStatus" xlink:to="dei_EntityCurrentReportingStatus_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityCurrentReportingStatus_lbl" xml:lang="en-US">Entity Current Reporting Status</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityInteractiveDataCurrent" xlink:label="dei_EntityInteractiveDataCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityInteractiveDataCurrent" xlink:to="dei_EntityInteractiveDataCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityInteractiveDataCurrent_lbl" xml:lang="en-US">Entity Interactive Data Current</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityFilerCategory" xlink:label="dei_EntityFilerCategory" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityFilerCategory" xlink:to="dei_EntityFilerCategory_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityFilerCategory_lbl" xml:lang="en-US">Entity Filer Category</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntitySmallBusiness" xlink:label="dei_EntitySmallBusiness" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntitySmallBusiness" xlink:to="dei_EntitySmallBusiness_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntitySmallBusiness_lbl" xml:lang="en-US">Entity Small Business</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityEmergingGrowthCompany" xlink:label="dei_EntityEmergingGrowthCompany" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityEmergingGrowthCompany" xlink:to="dei_EntityEmergingGrowthCompany_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityEmergingGrowthCompany_lbl" xml:lang="en-US">Entity Emerging Growth Company</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityExTransitionPeriod" xlink:label="dei_EntityExTransitionPeriod" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityExTransitionPeriod" xlink:to="dei_EntityExTransitionPeriod_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityExTransitionPeriod_lbl" xml:lang="en-US">Elected Not To Use the Extended Transition Period</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentAccountingStandard" xlink:label="dei_DocumentAccountingStandard" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentAccountingStandard" xlink:to="dei_DocumentAccountingStandard_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentAccountingStandard_lbl" xml:lang="en-US">Document Accounting Standard</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_OtherReportingStandardItemNumber" xlink:label="dei_OtherReportingStandardItemNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_OtherReportingStandardItemNumber" xlink:to="dei_OtherReportingStandardItemNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_OtherReportingStandardItemNumber_lbl" xml:lang="en-US">Other Reporting Standard Item Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityShellCompany" xlink:label="dei_EntityShellCompany" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityShellCompany" xlink:to="dei_EntityShellCompany_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityShellCompany_lbl" xml:lang="en-US">Entity Shell Company</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityPublicFloat" xlink:label="dei_EntityPublicFloat" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityPublicFloat" xlink:to="dei_EntityPublicFloat_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityPublicFloat_lbl" xml:lang="en-US">Entity Public Float</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityBankruptcyProceedingsReportingCurrent" xlink:label="dei_EntityBankruptcyProceedingsReportingCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityBankruptcyProceedingsReportingCurrent" xlink:to="dei_EntityBankruptcyProceedingsReportingCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityBankruptcyProceedingsReportingCurrent_lbl" xml:lang="en-US">Entity Bankruptcy Proceedings, Reporting Current</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityCommonStockSharesOutstanding" xlink:label="dei_EntityCommonStockSharesOutstanding" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCommonStockSharesOutstanding" xlink:to="dei_EntityCommonStockSharesOutstanding_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityCommonStockSharesOutstanding_lbl" xml:lang="en-US">Entity Common Stock, Shares Outstanding</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentsIncorporatedByReferenceTextBlock" xlink:label="dei_DocumentsIncorporatedByReferenceTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentsIncorporatedByReferenceTextBlock" xlink:to="dei_DocumentsIncorporatedByReferenceTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentsIncorporatedByReferenceTextBlock_lbl" xml:lang="en-US">Documents Incorporated by Reference [Text Block]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_ContactPersonnelName" xlink:label="dei_ContactPersonnelName" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_ContactPersonnelName" xlink:to="dei_ContactPersonnelName_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_ContactPersonnelName_lbl" xml:lang="en-US">Contact Personnel Name</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:label="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_lbl" xml:lang="en-US">Schedule of Share-Based Compensation Arrangements by Share-Based Payment Award [Table]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_lbl" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AssetsAbstract" xlink:label="us-gaap_AssetsAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AssetsAbstract" xlink:to="us-gaap_AssetsAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AssetsAbstract_lbl" xml:lang="en-US">Assets:</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AssetsCurrentAbstract" xlink:label="us-gaap_AssetsCurrentAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AssetsCurrentAbstract" xlink:to="us-gaap_AssetsCurrentAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AssetsCurrentAbstract_lbl" xml:lang="en-US">Current Assets</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:label="us-gaap_CashAndCashEquivalentsAtCarryingValue" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:to="us-gaap_CashAndCashEquivalentsAtCarryingValue_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CashAndCashEquivalentsAtCarryingValue_lbl" xml:lang="en-US">Cash</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:label="us-gaap_PrepaidExpenseAndOtherAssetsCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:to="us-gaap_PrepaidExpenseAndOtherAssetsCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PrepaidExpenseAndOtherAssetsCurrent_lbl" xml:lang="en-US">Prepaid expenses and other current assets</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_InventoryNet" xlink:label="us-gaap_InventoryNet" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InventoryNet" xlink:to="us-gaap_InventoryNet_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_InventoryNet_lbl" xml:lang="en-US">Inventories, net (Note 3)</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AssetsCurrent" xlink:label="us-gaap_AssetsCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AssetsCurrent" xlink:to="us-gaap_AssetsCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_AssetsCurrent_lbl" xml:lang="en-US">Current Assets</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentNet" xlink:label="us-gaap_PropertyPlantAndEquipmentNet" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PropertyPlantAndEquipmentNet" xlink:to="us-gaap_PropertyPlantAndEquipmentNet_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PropertyPlantAndEquipmentNet_lbl" xml:lang="en-US">Fixed Assets, net of accumulated depreciation (Notes 4 and 5)</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherAssetsNoncurrent" xlink:label="us-gaap_OtherAssetsNoncurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherAssetsNoncurrent" xlink:to="us-gaap_OtherAssetsNoncurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OtherAssetsNoncurrent_lbl" xml:lang="en-US">Other Assets (Notes 6 and 7)</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_Assets" xlink:label="us-gaap_Assets" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_Assets" xlink:to="us-gaap_Assets_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_Assets_lbl" xml:lang="en-US">TOTAL ASSETS</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LiabilitiesAbstract" xlink:label="us-gaap_LiabilitiesAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LiabilitiesAbstract" xlink:to="us-gaap_LiabilitiesAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LiabilitiesAbstract_lbl" xml:lang="en-US">Liabilities:</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LiabilitiesCurrentAbstract" xlink:label="us-gaap_LiabilitiesCurrentAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LiabilitiesCurrentAbstract" xlink:to="us-gaap_LiabilitiesCurrentAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LiabilitiesCurrentAbstract_lbl" xml:lang="en-US">Current Liabilities</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccountsPayableCurrent" xlink:label="us-gaap_AccountsPayableCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccountsPayableCurrent" xlink:to="us-gaap_AccountsPayableCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AccountsPayableCurrent_lbl" xml:lang="en-US">Accounts payable</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccountsPayableAndOtherAccruedLiabilitiesCurrent" xlink:label="us-gaap_AccountsPayableAndOtherAccruedLiabilitiesCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccountsPayableAndOtherAccruedLiabilitiesCurrent" xlink:to="us-gaap_AccountsPayableAndOtherAccruedLiabilitiesCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AccountsPayableAndOtherAccruedLiabilitiesCurrent_lbl" xml:lang="en-US">Accrued and other current liabilities (Notes 13 and 15)</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NotesPayableCurrent" xlink:label="us-gaap_NotesPayableCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NotesPayableCurrent" xlink:to="us-gaap_NotesPayableCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NotesPayableCurrent_lbl" xml:lang="en-US">Notes Payable (Note 7)</link:label>
      <link:loc xlink:type="locator" xlink:href="stss-20240930.xsd#STSS_WarrantLiabilitiesCurrent" xlink:label="STSS_WarrantLiabilitiesCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="STSS_WarrantLiabilitiesCurrent" xlink:to="STSS_WarrantLiabilitiesCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="STSS_WarrantLiabilitiesCurrent_lbl" xml:lang="en-US">Warrant liability (Notes 8 and 10)</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LiabilitiesCurrent" xlink:label="us-gaap_LiabilitiesCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LiabilitiesCurrent" xlink:to="us-gaap_LiabilitiesCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_LiabilitiesCurrent_lbl" xml:lang="en-US">Total Current Liabilities</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredIncomeTaxLiabilitiesNet" xlink:label="us-gaap_DeferredIncomeTaxLiabilitiesNet" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredIncomeTaxLiabilitiesNet" xlink:to="us-gaap_DeferredIncomeTaxLiabilitiesNet_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DeferredIncomeTaxLiabilitiesNet_lbl" xml:lang="en-US">Deferred Tax Liability</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_Liabilities" xlink:label="us-gaap_Liabilities" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_Liabilities" xlink:to="us-gaap_Liabilities_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_Liabilities_lbl" xml:lang="en-US">Total Liabilities</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommitmentsAndContingencies" xlink:label="us-gaap_CommitmentsAndContingencies" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommitmentsAndContingencies" xlink:to="us-gaap_CommitmentsAndContingencies_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CommitmentsAndContingencies_lbl" xml:lang="en-US">Commitments and Contingencies (Note 15)</link:label>
      <link:loc xlink:type="locator" xlink:href="stss-20240930.xsd#STSS_SubsequentEvents" xlink:label="STSS_SubsequentEvents" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="STSS_SubsequentEvents" xlink:to="STSS_SubsequentEvents_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="STSS_SubsequentEvents_lbl" xml:lang="en-US">Subsequent Events (Note 16)</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockholdersEquityAbstract" xlink:label="us-gaap_StockholdersEquityAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockholdersEquityAbstract" xlink:to="us-gaap_StockholdersEquityAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockholdersEquityAbstract_lbl" xml:lang="en-US">Stockholders&#8217; Equity:</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PreferredStockValue" xlink:label="us-gaap_PreferredStockValue" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PreferredStockValue" xlink:to="us-gaap_PreferredStockValue_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PreferredStockValue_lbl" xml:lang="en-US">Preferred stock, $.0001 par value; 1,000,000 shares authorized; 0 shares issued and outstanding (2023: 1)</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockValue" xlink:label="us-gaap_CommonStockValue" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockValue" xlink:to="us-gaap_CommonStockValue_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CommonStockValue_lbl" xml:lang="en-US">Common stock, $.0001 par value; 500,000,000, shares authorized; (100,000,000 in 2023), 1,694,110 shares issued and outstanding (2023: 694,294)</link:label>
      <link:loc xlink:type="locator" xlink:href="stss-20240930.xsd#STSS_CommonStockReverseSplitValue" xlink:label="STSS_CommonStockReverseSplitValue" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="STSS_CommonStockReverseSplitValue" xlink:to="STSS_CommonStockReverseSplitValue_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="STSS_CommonStockReverseSplitValue_lbl" xml:lang="en-US">Common stock, $.0001 par value; 100,000,000, shares authorized; 15,274,457 shares issued and outstanding and (2022: 9,407,415)</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AdditionalPaidInCapital" xlink:label="us-gaap_AdditionalPaidInCapital" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AdditionalPaidInCapital" xlink:to="us-gaap_AdditionalPaidInCapital_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AdditionalPaidInCapital_lbl" xml:lang="en-US">Additional paid-in capital</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:label="us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:to="us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_lbl" xml:lang="en-US">Accumulated other comprehensive income</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RetainedEarningsAccumulatedDeficit" xlink:label="us-gaap_RetainedEarningsAccumulatedDeficit" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RetainedEarningsAccumulatedDeficit" xlink:to="us-gaap_RetainedEarningsAccumulatedDeficit_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_RetainedEarningsAccumulatedDeficit_lbl" xml:lang="en-US">Accumulated deficit</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockholdersEquity" xlink:label="us-gaap_StockholdersEquity" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockholdersEquity" xlink:to="us-gaap_StockholdersEquity_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_StockholdersEquity_lbl" xml:lang="en-US">Total Stockholders&#8217; Equity</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LiabilitiesAndStockholdersEquity" xlink:label="us-gaap_LiabilitiesAndStockholdersEquity" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LiabilitiesAndStockholdersEquity" xlink:to="us-gaap_LiabilitiesAndStockholdersEquity_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_LiabilitiesAndStockholdersEquity_lbl" xml:lang="en-US">TOTAL LIABILITIES AND STOCKHOLDERS&#8217; EQUITY</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PreferredStockParOrStatedValuePerShare" xlink:label="us-gaap_PreferredStockParOrStatedValuePerShare" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PreferredStockParOrStatedValuePerShare" xlink:to="us-gaap_PreferredStockParOrStatedValuePerShare_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PreferredStockParOrStatedValuePerShare_lbl" xml:lang="en-US">Preferred stock, par value</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PreferredStockSharesAuthorized" xlink:label="us-gaap_PreferredStockSharesAuthorized" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PreferredStockSharesAuthorized" xlink:to="us-gaap_PreferredStockSharesAuthorized_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PreferredStockSharesAuthorized_lbl" xml:lang="en-US">Preferred stock, shares authorized</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PreferredStockSharesIssued" xlink:label="us-gaap_PreferredStockSharesIssued" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PreferredStockSharesIssued" xlink:to="us-gaap_PreferredStockSharesIssued_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PreferredStockSharesIssued_lbl" xml:lang="en-US">Preferred stock, shares issued</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PreferredStockSharesOutstanding" xlink:label="us-gaap_PreferredStockSharesOutstanding" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PreferredStockSharesOutstanding" xlink:to="us-gaap_PreferredStockSharesOutstanding_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PreferredStockSharesOutstanding_lbl" xml:lang="en-US">Preferred stock, shares outstanding</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockParOrStatedValuePerShare" xlink:label="us-gaap_CommonStockParOrStatedValuePerShare" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockParOrStatedValuePerShare" xlink:to="us-gaap_CommonStockParOrStatedValuePerShare_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CommonStockParOrStatedValuePerShare_lbl" xml:lang="en-US">Common stock, par value</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockSharesAuthorized" xlink:label="us-gaap_CommonStockSharesAuthorized" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockSharesAuthorized" xlink:to="us-gaap_CommonStockSharesAuthorized_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CommonStockSharesAuthorized_lbl" xml:lang="en-US">Common stock, shares authorized</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockSharesIssued" xlink:label="us-gaap_CommonStockSharesIssued" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockSharesIssued" xlink:to="us-gaap_CommonStockSharesIssued_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CommonStockSharesIssued_lbl" xml:lang="en-US">Common stock, shares issued</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockSharesOutstanding" xlink:label="us-gaap_CommonStockSharesOutstanding" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockSharesOutstanding" xlink:to="us-gaap_CommonStockSharesOutstanding_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CommonStockSharesOutstanding_lbl" xml:lang="en-US">Common stock, shares outstanding</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeStatementAbstract" xlink:label="us-gaap_IncomeStatementAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeStatementAbstract" xlink:to="us-gaap_IncomeStatementAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncomeStatementAbstract_lbl" xml:lang="en-US">Income Statement [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:label="us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:to="us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_lbl" xml:lang="en-US">Revenue, net</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingExpensesAbstract" xlink:label="us-gaap_OperatingExpensesAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingExpensesAbstract" xlink:to="us-gaap_OperatingExpensesAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OperatingExpensesAbstract_lbl" xml:lang="en-US">Operating expenses:</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ResearchAndDevelopmentExpense" xlink:label="us-gaap_ResearchAndDevelopmentExpense" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ResearchAndDevelopmentExpense" xlink:to="us-gaap_ResearchAndDevelopmentExpense_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ResearchAndDevelopmentExpense_lbl" xml:lang="en-US">Research and development</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_GeneralAndAdministrativeExpense" xlink:label="us-gaap_GeneralAndAdministrativeExpense" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_GeneralAndAdministrativeExpense" xlink:to="us-gaap_GeneralAndAdministrativeExpense_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_GeneralAndAdministrativeExpense_lbl" xml:lang="en-US">General and administrative</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingExpenses" xlink:label="us-gaap_OperatingExpenses" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingExpenses" xlink:to="us-gaap_OperatingExpenses_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_OperatingExpenses_lbl" xml:lang="en-US">Total operating expenses</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingIncomeLoss" xlink:label="us-gaap_OperatingIncomeLoss" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingIncomeLoss" xlink:to="us-gaap_OperatingIncomeLoss_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_OperatingIncomeLoss_lbl" xml:lang="en-US">Loss from operations</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NonoperatingIncomeExpenseAbstract" xlink:label="us-gaap_NonoperatingIncomeExpenseAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NonoperatingIncomeExpenseAbstract" xlink:to="us-gaap_NonoperatingIncomeExpenseAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NonoperatingIncomeExpenseAbstract_lbl" xml:lang="en-US">Other income (expense)</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_InterestIncomeExpenseNet" xlink:label="us-gaap_InterestIncomeExpenseNet" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InterestIncomeExpenseNet" xlink:to="us-gaap_InterestIncomeExpenseNet_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_InterestIncomeExpenseNet_lbl" xml:lang="en-US">Interest income (expense)</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherNonoperatingIncomeExpense" xlink:label="us-gaap_OtherNonoperatingIncomeExpense" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherNonoperatingIncomeExpense" xlink:to="us-gaap_OtherNonoperatingIncomeExpense_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OtherNonoperatingIncomeExpense_lbl" xml:lang="en-US">Other (expense) income (Note 15)</link:label>
      <link:loc xlink:type="locator" xlink:href="stss-20240930.xsd#STSS_FairMarketValueAdjustmentForContingentStockAndWarrants" xlink:label="STSS_FairMarketValueAdjustmentForContingentStockAndWarrants" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="STSS_FairMarketValueAdjustmentForContingentStockAndWarrants" xlink:to="STSS_FairMarketValueAdjustmentForContingentStockAndWarrants_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="STSS_FairMarketValueAdjustmentForContingentStockAndWarrants_lbl" xml:lang="en-US">FMV adjustment on contingent stock &amp; warrants</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_GainLossOnSaleOfDerivatives" xlink:label="us-gaap_GainLossOnSaleOfDerivatives" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_GainLossOnSaleOfDerivatives" xlink:to="us-gaap_GainLossOnSaleOfDerivatives_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_GainLossOnSaleOfDerivatives_lbl" xml:lang="en-US">FMV adjustment warrants</link:label>
      <link:loc xlink:type="locator" xlink:href="stss-20240930.xsd#STSS_FairMarketValueAdjustmentForContingentWarrantsAndWarrants" xlink:label="STSS_FairMarketValueAdjustmentForContingentWarrantsAndWarrants" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="STSS_FairMarketValueAdjustmentForContingentWarrantsAndWarrants" xlink:to="STSS_FairMarketValueAdjustmentForContingentWarrantsAndWarrants_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="STSS_FairMarketValueAdjustmentForContingentWarrantsAndWarrants_lbl" xml:lang="en-US">FMV adjustment warrants (Note 10)</link:label>
      <link:loc xlink:type="locator" xlink:href="stss-20240930.xsd#STSS_ForeignCurrencyAndNonOperatingIncomeExpenses" xlink:label="STSS_ForeignCurrencyAndNonOperatingIncomeExpenses" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="STSS_ForeignCurrencyAndNonOperatingIncomeExpenses" xlink:to="STSS_ForeignCurrencyAndNonOperatingIncomeExpenses_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="STSS_ForeignCurrencyAndNonOperatingIncomeExpenses_lbl" xml:lang="en-US">Foreign currency</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NonoperatingIncomeExpense" xlink:label="us-gaap_NonoperatingIncomeExpense" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NonoperatingIncomeExpense" xlink:to="us-gaap_NonoperatingIncomeExpense_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_NonoperatingIncomeExpense_lbl" xml:lang="en-US">Total other income (expense)</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:label="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:to="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_lbl" xml:lang="en-US">Net loss Before Provision for Taxes</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredIncomeTaxExpenseBenefit" xlink:label="us-gaap_DeferredIncomeTaxExpenseBenefit" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredIncomeTaxExpenseBenefit" xlink:to="us-gaap_DeferredIncomeTaxExpenseBenefit_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_DeferredIncomeTaxExpenseBenefit_lbl" xml:lang="en-US">Deferred Tax Benefit</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetIncomeLoss" xlink:label="us-gaap_NetIncomeLoss" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetIncomeLoss" xlink:to="us-gaap_NetIncomeLoss_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_NetIncomeLoss_lbl" xml:lang="en-US">Net Loss</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EarningsPerShareBasic" xlink:label="us-gaap_EarningsPerShareBasic" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EarningsPerShareBasic" xlink:to="us-gaap_EarningsPerShareBasic_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_EarningsPerShareBasic_lbl" xml:lang="en-US">Net loss per share, basic</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EarningsPerShareDiluted" xlink:label="us-gaap_EarningsPerShareDiluted" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EarningsPerShareDiluted" xlink:to="us-gaap_EarningsPerShareDiluted_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_EarningsPerShareDiluted_lbl" xml:lang="en-US">Net loss per share, diluted</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:label="us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:to="us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_lbl" xml:lang="en-US">Weighted average shares used to compute net loss per share, basic</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:label="us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:to="us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_lbl" xml:lang="en-US">Weighted average shares used to compute net loss per share, diluted</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetIncomeLoss" xlink:to="us-gaap_NetIncomeLoss_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NetIncomeLoss_2_lbl" xml:lang="en-US">Net loss</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherComprehensiveIncomeLossTaxAbstract" xlink:label="us-gaap_OtherComprehensiveIncomeLossTaxAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherComprehensiveIncomeLossTaxAbstract" xlink:to="us-gaap_OtherComprehensiveIncomeLossTaxAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OtherComprehensiveIncomeLossTaxAbstract_lbl" xml:lang="en-US">Other comprehensive income:</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent" xlink:label="us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent" xlink:to="us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent_lbl" xml:lang="en-US">Foreign currency translation adjustments gain/(loss)</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ComprehensiveIncomeNetOfTax" xlink:label="us-gaap_ComprehensiveIncomeNetOfTax" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ComprehensiveIncomeNetOfTax" xlink:to="us-gaap_ComprehensiveIncomeNetOfTax_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_ComprehensiveIncomeNetOfTax_lbl" xml:lang="en-US">Comprehensive loss</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementTable" xlink:label="us-gaap_StatementTable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementTable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StatementTable_lbl" xml:lang="en-US">Statement [Table]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementLineItems" xlink:label="us-gaap_StatementLineItems" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StatementLineItems_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StatementLineItems_lbl" xml:lang="en-US">Statement [Line Items]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="STSS_AwardsTypeAxis" xlink:to="STSS_AwardsTypeAxis_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="STSS_AwardsTypeAxis_2_lbl" xml:lang="en-US">AwardsTypeAxis [Axis]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockholdersEquity" xlink:to="us-gaap_StockholdersEquity_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:label="us-gaap_StockholdersEquity_2_lbl" xml:lang="en-US">Balance</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SharesOutstanding" xlink:label="us-gaap_SharesOutstanding" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharesOutstanding" xlink:to="us-gaap_SharesOutstanding_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:label="us-gaap_SharesOutstanding_lbl" xml:lang="en-US">Balance, shares</link:label>
      <link:loc xlink:type="locator" xlink:href="stss-20240930.xsd#STSS_StockIssuedDuringPeriodValueInitialPublicOffering" xlink:label="STSS_StockIssuedDuringPeriodValueInitialPublicOffering" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="STSS_StockIssuedDuringPeriodValueInitialPublicOffering" xlink:to="STSS_StockIssuedDuringPeriodValueInitialPublicOffering_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="STSS_StockIssuedDuringPeriodValueInitialPublicOffering_lbl" xml:lang="en-US">Shares issued in Initial Public Offering</link:label>
      <link:loc xlink:type="locator" xlink:href="stss-20240930.xsd#STSS_StockIssuedDuringPeriodSharesInitialPublicOffering" xlink:label="STSS_StockIssuedDuringPeriodSharesInitialPublicOffering" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="STSS_StockIssuedDuringPeriodSharesInitialPublicOffering" xlink:to="STSS_StockIssuedDuringPeriodSharesInitialPublicOffering_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="STSS_StockIssuedDuringPeriodSharesInitialPublicOffering_lbl" xml:lang="en-US">Shares issued in Initial Public Offering, shares</link:label>
      <link:loc xlink:type="locator" xlink:href="stss-20240930.xsd#STSS_StockIssuedDuringPeriodValueContingentStockLiability" xlink:label="STSS_StockIssuedDuringPeriodValueContingentStockLiability" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="STSS_StockIssuedDuringPeriodValueContingentStockLiability" xlink:to="STSS_StockIssuedDuringPeriodValueContingentStockLiability_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="STSS_StockIssuedDuringPeriodValueContingentStockLiability_lbl" xml:lang="en-US">Issuance of shares for contingent stock liability</link:label>
      <link:loc xlink:type="locator" xlink:href="stss-20240930.xsd#STSS_StockIssuedDuringPeriodSharesContingentStockLiability" xlink:label="STSS_StockIssuedDuringPeriodSharesContingentStockLiability" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="STSS_StockIssuedDuringPeriodSharesContingentStockLiability" xlink:to="STSS_StockIssuedDuringPeriodSharesContingentStockLiability_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="STSS_StockIssuedDuringPeriodSharesContingentStockLiability_lbl" xml:lang="en-US">Issuance of shares for contingent stock liability, shares</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:label="us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:to="us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_lbl" xml:lang="en-US">Share-based compensation charges</link:label>
      <link:loc xlink:type="locator" xlink:href="stss-20240930.xsd#STSS_StockIssuedDuringPeriodValueFractionalShareAdjustment" xlink:label="STSS_StockIssuedDuringPeriodValueFractionalShareAdjustment" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="STSS_StockIssuedDuringPeriodValueFractionalShareAdjustment" xlink:to="STSS_StockIssuedDuringPeriodValueFractionalShareAdjustment_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="STSS_StockIssuedDuringPeriodValueFractionalShareAdjustment_lbl" xml:lang="en-US">Fractional share adjustment</link:label>
      <link:loc xlink:type="locator" xlink:href="stss-20240930.xsd#STSS_StockIssuedDuringPeriodSharesFractionalShareAdjustment" xlink:label="STSS_StockIssuedDuringPeriodSharesFractionalShareAdjustment" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="STSS_StockIssuedDuringPeriodSharesFractionalShareAdjustment" xlink:to="STSS_StockIssuedDuringPeriodSharesFractionalShareAdjustment_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="STSS_StockIssuedDuringPeriodSharesFractionalShareAdjustment_lbl" xml:lang="en-US">Fractional share adjustment, shares</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockIssuedDuringPeriodValueIssuedForServices" xlink:label="us-gaap_StockIssuedDuringPeriodValueIssuedForServices" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodValueIssuedForServices" xlink:to="us-gaap_StockIssuedDuringPeriodValueIssuedForServices_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockIssuedDuringPeriodValueIssuedForServices_lbl" xml:lang="en-US">Issuance of common stock for services</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockIssuedDuringPeriodSharesIssuedForServices" xlink:label="us-gaap_StockIssuedDuringPeriodSharesIssuedForServices" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodSharesIssuedForServices" xlink:to="us-gaap_StockIssuedDuringPeriodSharesIssuedForServices_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockIssuedDuringPeriodSharesIssuedForServices_lbl" xml:lang="en-US">Issuance of common stock for services, shares</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax" xlink:label="us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax" xlink:to="us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax_lbl" xml:lang="en-US">Foreign Currency Translation</link:label>
      <link:loc xlink:type="locator" xlink:href="stss-20240930.xsd#STSS_StockIssuedDuringPeriodCollectionsOfCommonStockSubscriptionsValue" xlink:label="STSS_StockIssuedDuringPeriodCollectionsOfCommonStockSubscriptionsValue" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="STSS_StockIssuedDuringPeriodCollectionsOfCommonStockSubscriptionsValue" xlink:to="STSS_StockIssuedDuringPeriodCollectionsOfCommonStockSubscriptionsValue_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="STSS_StockIssuedDuringPeriodCollectionsOfCommonStockSubscriptionsValue_lbl" xml:lang="en-US">Collection of stock subscription</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockIssuedDuringPeriodValueNewIssues" xlink:label="us-gaap_StockIssuedDuringPeriodValueNewIssues" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodValueNewIssues" xlink:to="us-gaap_StockIssuedDuringPeriodValueNewIssues_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockIssuedDuringPeriodValueNewIssues_lbl" xml:lang="en-US">Shares issued in Offering</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:label="us-gaap_StockIssuedDuringPeriodSharesNewIssues" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:to="us-gaap_StockIssuedDuringPeriodSharesNewIssues_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockIssuedDuringPeriodSharesNewIssues_lbl" xml:lang="en-US">Shares issued in Offering, shares</link:label>
      <link:loc xlink:type="locator" xlink:href="stss-20240930.xsd#STSS_StockIssuedDuringPeriodValueShelfRegistrationOffering" xlink:label="STSS_StockIssuedDuringPeriodValueShelfRegistrationOffering" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="STSS_StockIssuedDuringPeriodValueShelfRegistrationOffering" xlink:to="STSS_StockIssuedDuringPeriodValueShelfRegistrationOffering_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="STSS_StockIssuedDuringPeriodValueShelfRegistrationOffering_lbl" xml:lang="en-US">Shelf Registration Offering &#8211; see Note 8</link:label>
      <link:loc xlink:type="locator" xlink:href="stss-20240930.xsd#STSS_StockIssuedDuringPeriodSharesShelfRegistrationOffering" xlink:label="STSS_StockIssuedDuringPeriodSharesShelfRegistrationOffering" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="STSS_StockIssuedDuringPeriodSharesShelfRegistrationOffering" xlink:to="STSS_StockIssuedDuringPeriodSharesShelfRegistrationOffering_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="STSS_StockIssuedDuringPeriodSharesShelfRegistrationOffering_lbl" xml:lang="en-US">Shelf Registration Offering - see Note 8, shares</link:label>
      <link:loc xlink:type="locator" xlink:href="stss-20240930.xsd#STSS_StockIssuedDuringPeriodValuePrivatePlacement" xlink:label="STSS_StockIssuedDuringPeriodValuePrivatePlacement" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="STSS_StockIssuedDuringPeriodValuePrivatePlacement" xlink:to="STSS_StockIssuedDuringPeriodValuePrivatePlacement_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="STSS_StockIssuedDuringPeriodValuePrivatePlacement_lbl" xml:lang="en-US">Private Placement Offering &#8211; see Note 8</link:label>
      <link:loc xlink:type="locator" xlink:href="stss-20240930.xsd#STSS_StockIssuedDuringPeriodValueExerciseOfPrefundedWarrants" xlink:label="STSS_StockIssuedDuringPeriodValueExerciseOfPrefundedWarrants" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="STSS_StockIssuedDuringPeriodValueExerciseOfPrefundedWarrants" xlink:to="STSS_StockIssuedDuringPeriodValueExerciseOfPrefundedWarrants_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="STSS_StockIssuedDuringPeriodValueExerciseOfPrefundedWarrants_lbl" xml:lang="en-US">Exercise of Pre-Funded Warrants</link:label>
      <link:loc xlink:type="locator" xlink:href="stss-20240930.xsd#STSS_StockIssuedDuringPeriodSharesExerciseOfPrefundedWarrants" xlink:label="STSS_StockIssuedDuringPeriodSharesExerciseOfPrefundedWarrants" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="STSS_StockIssuedDuringPeriodSharesExerciseOfPrefundedWarrants" xlink:to="STSS_StockIssuedDuringPeriodSharesExerciseOfPrefundedWarrants_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="STSS_StockIssuedDuringPeriodSharesExerciseOfPrefundedWarrants_lbl" xml:lang="en-US">Exercise of Pre-Funded Warrants, shares</link:label>
      <link:loc xlink:type="locator" xlink:href="stss-20240930.xsd#STSS_StockIssuedDuringPeriodValueExerciseOfPrefundedWarrant" xlink:label="STSS_StockIssuedDuringPeriodValueExerciseOfPrefundedWarrant" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="STSS_StockIssuedDuringPeriodValueExerciseOfPrefundedWarrant" xlink:to="STSS_StockIssuedDuringPeriodValueExerciseOfPrefundedWarrant_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="STSS_StockIssuedDuringPeriodValueExerciseOfPrefundedWarrant_lbl" xml:lang="en-US">Exercise of Pre-Funded Warrants</link:label>
      <link:loc xlink:type="locator" xlink:href="stss-20240930.xsd#STSS_StockIssuedDuringPeriodValueRegistrationOffering" xlink:label="STSS_StockIssuedDuringPeriodValueRegistrationOffering" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="STSS_StockIssuedDuringPeriodValueRegistrationOffering" xlink:to="STSS_StockIssuedDuringPeriodValueRegistrationOffering_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="STSS_StockIssuedDuringPeriodValueRegistrationOffering_lbl" xml:lang="en-US">Registration A Offering</link:label>
      <link:loc xlink:type="locator" xlink:href="stss-20240930.xsd#STSS_StockIssuedDuringPeriodSharesRegistrationOffering" xlink:label="STSS_StockIssuedDuringPeriodSharesRegistrationOffering" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="STSS_StockIssuedDuringPeriodSharesRegistrationOffering" xlink:to="STSS_StockIssuedDuringPeriodSharesRegistrationOffering_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="STSS_StockIssuedDuringPeriodSharesRegistrationOffering_lbl" xml:lang="en-US">Registration A Offering, shares</link:label>
      <link:loc xlink:type="locator" xlink:href="stss-20240930.xsd#STSS_StockIssuedDuringPeriodValueWarrantInducements" xlink:label="STSS_StockIssuedDuringPeriodValueWarrantInducements" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="STSS_StockIssuedDuringPeriodValueWarrantInducements" xlink:to="STSS_StockIssuedDuringPeriodValueWarrantInducements_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="STSS_StockIssuedDuringPeriodValueWarrantInducements_lbl" xml:lang="en-US">Warrant Inducements</link:label>
      <link:loc xlink:type="locator" xlink:href="stss-20240930.xsd#STSS_StockIssuedDuringPeriodSharesWarrantInducements" xlink:label="STSS_StockIssuedDuringPeriodSharesWarrantInducements" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="STSS_StockIssuedDuringPeriodSharesWarrantInducements" xlink:to="STSS_StockIssuedDuringPeriodSharesWarrantInducements_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="STSS_StockIssuedDuringPeriodSharesWarrantInducements_lbl" xml:lang="en-US">Warrant Inducements, shares</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockRedeemedOrCalledDuringPeriodValue" xlink:label="us-gaap_StockRedeemedOrCalledDuringPeriodValue" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockRedeemedOrCalledDuringPeriodValue" xlink:to="us-gaap_StockRedeemedOrCalledDuringPeriodValue_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockRedeemedOrCalledDuringPeriodValue_lbl" xml:lang="en-US">Cancellation of Preferred Share</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockRedeemedOrCalledDuringPeriodShares" xlink:label="us-gaap_StockRedeemedOrCalledDuringPeriodShares" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockRedeemedOrCalledDuringPeriodShares" xlink:to="us-gaap_StockRedeemedOrCalledDuringPeriodShares_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockRedeemedOrCalledDuringPeriodShares_lbl" xml:lang="en-US">Cancellation of Preferred Share, shares</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockIssuedDuringPeriodValueOther" xlink:label="us-gaap_StockIssuedDuringPeriodValueOther" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodValueOther" xlink:to="us-gaap_StockIssuedDuringPeriodValueOther_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockIssuedDuringPeriodValueOther_lbl" xml:lang="en-US">Issuance of Common Stock &#8211; see Note 7</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockIssuedDuringPeriodSharesOther" xlink:label="us-gaap_StockIssuedDuringPeriodSharesOther" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodSharesOther" xlink:to="us-gaap_StockIssuedDuringPeriodSharesOther_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockIssuedDuringPeriodSharesOther_lbl" xml:lang="en-US">Issuance of Common Stock, shares</link:label>
      <link:loc xlink:type="locator" xlink:href="stss-20240930.xsd#STSS_StockIssuedDuringPeriodValueWarrantExericse" xlink:label="STSS_StockIssuedDuringPeriodValueWarrantExericse" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="STSS_StockIssuedDuringPeriodValueWarrantExericse" xlink:to="STSS_StockIssuedDuringPeriodValueWarrantExericse_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="STSS_StockIssuedDuringPeriodValueWarrantExericse_lbl" xml:lang="en-US">Warrant exercise</link:label>
      <link:loc xlink:type="locator" xlink:href="stss-20240930.xsd#STSS_StockIssuedDuringPeriodSharesWarrantExericse" xlink:label="STSS_StockIssuedDuringPeriodSharesWarrantExericse" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="STSS_StockIssuedDuringPeriodSharesWarrantExericse" xlink:to="STSS_StockIssuedDuringPeriodSharesWarrantExericse_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="STSS_StockIssuedDuringPeriodSharesWarrantExericse_lbl" xml:lang="en-US">Warrant exercise, shares</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockholdersEquity" xlink:to="us-gaap_StockholdersEquity_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="us-gaap_StockholdersEquity_3_lbl" xml:lang="en-US">Balance</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharesOutstanding" xlink:to="us-gaap_SharesOutstanding_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="us-gaap_SharesOutstanding_2_lbl" xml:lang="en-US">Balance, shares</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementOfCashFlowsAbstract" xlink:label="us-gaap_StatementOfCashFlowsAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StatementOfCashFlowsAbstract" xlink:to="us-gaap_StatementOfCashFlowsAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StatementOfCashFlowsAbstract_lbl" xml:lang="en-US">Statement of Cash Flows [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_lbl" xml:lang="en-US">CASH FLOWS FROM OPERATING ACTIVITIES:</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:label="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_lbl" xml:lang="en-US">Adjustments to reconcile net loss to net cash used in operating activities:</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DepreciationAndAmortization" xlink:label="us-gaap_DepreciationAndAmortization" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DepreciationAndAmortization" xlink:to="us-gaap_DepreciationAndAmortization_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DepreciationAndAmortization_lbl" xml:lang="en-US">Depreciation and amortization</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensation" xlink:label="us-gaap_ShareBasedCompensation" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensation" xlink:to="us-gaap_ShareBasedCompensation_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensation_lbl" xml:lang="en-US">Stock-based compensation</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IssuanceOfStockAndWarrantsForServicesOrClaims" xlink:label="us-gaap_IssuanceOfStockAndWarrantsForServicesOrClaims" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IssuanceOfStockAndWarrantsForServicesOrClaims" xlink:to="us-gaap_IssuanceOfStockAndWarrantsForServicesOrClaims_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_IssuanceOfStockAndWarrantsForServicesOrClaims_lbl" xml:lang="en-US">Issuance of common stock for services</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AmortizationOfDebtDiscountPremium" xlink:label="us-gaap_AmortizationOfDebtDiscountPremium" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AmortizationOfDebtDiscountPremium" xlink:to="us-gaap_AmortizationOfDebtDiscountPremium_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AmortizationOfDebtDiscountPremium_lbl" xml:lang="en-US">Accretion of debt discount</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_GainLossOnSaleOfDerivatives" xlink:to="us-gaap_GainLossOnSaleOfDerivatives_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_GainLossOnSaleOfDerivatives_2_lbl" xml:lang="en-US">FMV adjustment for Warrants</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AmortizationOfFinancingCosts" xlink:label="us-gaap_AmortizationOfFinancingCosts" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AmortizationOfFinancingCosts" xlink:to="us-gaap_AmortizationOfFinancingCosts_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AmortizationOfFinancingCosts_lbl" xml:lang="en-US">Equity Issuance costs</link:label>
      <link:loc xlink:type="locator" xlink:href="stss-20240930.xsd#STSS_EscrowDepositForfeited" xlink:label="STSS_EscrowDepositForfeited" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="STSS_EscrowDepositForfeited" xlink:to="STSS_EscrowDepositForfeited_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="STSS_EscrowDepositForfeited_lbl" xml:lang="en-US">Escrow forfeited</link:label>
      <link:loc xlink:type="locator" xlink:href="stss-20240930.xsd#STSS_FairMarketValueAdjustmentForContingentWarrants" xlink:label="STSS_FairMarketValueAdjustmentForContingentWarrants" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="STSS_FairMarketValueAdjustmentForContingentWarrants" xlink:to="STSS_FairMarketValueAdjustmentForContingentWarrants_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="STSS_FairMarketValueAdjustmentForContingentWarrants_lbl" xml:lang="en-US">FMV for adjustment for contingent stock</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="STSS_FairMarketValueAdjustmentForContingentWarrantsAndWarrants" xlink:to="STSS_FairMarketValueAdjustmentForContingentWarrantsAndWarrants_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="STSS_FairMarketValueAdjustmentForContingentWarrantsAndWarrants_2_lbl" xml:lang="en-US">FMV adjustment for Contingent warrants and warrants</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ImpairmentOfLongLivedAssetsHeldForUse" xlink:label="us-gaap_ImpairmentOfLongLivedAssetsHeldForUse" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ImpairmentOfLongLivedAssetsHeldForUse" xlink:to="us-gaap_ImpairmentOfLongLivedAssetsHeldForUse_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ImpairmentOfLongLivedAssetsHeldForUse_lbl" xml:lang="en-US">Fixed asset impairment</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredIncomeTaxExpenseBenefit" xlink:to="us-gaap_DeferredIncomeTaxExpenseBenefit_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DeferredIncomeTaxExpenseBenefit_2_lbl" xml:lang="en-US">Deferred tax benefit</link:label>
      <link:loc xlink:type="locator" xlink:href="stss-20240930.xsd#STSS_IpoIssuanceCostsRelatingToWarrants" xlink:label="STSS_IpoIssuanceCostsRelatingToWarrants" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="STSS_IpoIssuanceCostsRelatingToWarrants" xlink:to="STSS_IpoIssuanceCostsRelatingToWarrants_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="STSS_IpoIssuanceCostsRelatingToWarrants_lbl" xml:lang="en-US">IPO issuance costs relating to warrants</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ForeignCurrencyTransactionGainLossBeforeTax" xlink:label="us-gaap_ForeignCurrencyTransactionGainLossBeforeTax" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ForeignCurrencyTransactionGainLossBeforeTax" xlink:to="us-gaap_ForeignCurrencyTransactionGainLossBeforeTax_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_ForeignCurrencyTransactionGainLossBeforeTax_lbl" xml:lang="en-US">Foreign exchange (gain)/loss</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:label="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:to="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_lbl" xml:lang="en-US">Changes in operating assets:</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncreaseDecreaseInPrepaidExpense" xlink:label="us-gaap_IncreaseDecreaseInPrepaidExpense" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInPrepaidExpense" xlink:to="us-gaap_IncreaseDecreaseInPrepaidExpense_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_IncreaseDecreaseInPrepaidExpense_lbl" xml:lang="en-US">Prepaid expenses and other current assets</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncreaseDecreaseInInventories" xlink:label="us-gaap_IncreaseDecreaseInInventories" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInInventories" xlink:to="us-gaap_IncreaseDecreaseInInventories_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_IncreaseDecreaseInInventories_lbl" xml:lang="en-US">Inventory</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncreaseDecreaseInOtherOperatingAssets" xlink:label="us-gaap_IncreaseDecreaseInOtherOperatingAssets" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInOtherOperatingAssets" xlink:to="us-gaap_IncreaseDecreaseInOtherOperatingAssets_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_IncreaseDecreaseInOtherOperatingAssets_lbl" xml:lang="en-US">Other assets</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" xlink:label="us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" xlink:to="us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities_lbl" xml:lang="en-US">Accounts payable and accrued liabilities</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivities" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="us-gaap_NetCashProvidedByUsedInOperatingActivities_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivities_lbl" xml:lang="en-US">Net cash used in operating activities</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:label="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:to="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_lbl" xml:lang="en-US">CASH FLOWS FROM INVESTING ACTIVITIES:</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PaymentsForProceedsFromOtherInvestingActivities" xlink:label="us-gaap_PaymentsForProceedsFromOtherInvestingActivities" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PaymentsForProceedsFromOtherInvestingActivities" xlink:to="us-gaap_PaymentsForProceedsFromOtherInvestingActivities_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_PaymentsForProceedsFromOtherInvestingActivities_lbl" xml:lang="en-US">Acquisition of fixed assets or deposits paid</link:label>
      <link:loc xlink:type="locator" xlink:href="stss-20240930.xsd#STSS_EscrowPaymentUnderAgreement" xlink:label="STSS_EscrowPaymentUnderAgreement" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="STSS_EscrowPaymentUnderAgreement" xlink:to="STSS_EscrowPaymentUnderAgreement_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="STSS_EscrowPaymentUnderAgreement_lbl" xml:lang="en-US">Escrow payment under agreement</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:label="us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:to="us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_lbl" xml:lang="en-US">Purchase of fixed assets</link:label>
      <link:loc xlink:type="locator" xlink:href="stss-20240930.xsd#STSS_PaymentsToAssetAcquisition" xlink:label="STSS_PaymentsToAssetAcquisition" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="STSS_PaymentsToAssetAcquisition" xlink:to="STSS_PaymentsToAssetAcquisition_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="STSS_PaymentsToAssetAcquisition_lbl" xml:lang="en-US">Asset acquisition</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:label="us-gaap_NetCashProvidedByUsedInInvestingActivities" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:to="us-gaap_NetCashProvidedByUsedInInvestingActivities_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_NetCashProvidedByUsedInInvestingActivities_lbl" xml:lang="en-US">Net cash used in investing activities</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:label="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_lbl" xml:lang="en-US">CASH FLOWS FROM FINANCING ACTIVITIES:</link:label>
      <link:loc xlink:type="locator" xlink:href="stss-20240930.xsd#STSS_NetProceedsFromInitialPublicOfferingAndAdditionalOffering" xlink:label="STSS_NetProceedsFromInitialPublicOfferingAndAdditionalOffering" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="STSS_NetProceedsFromInitialPublicOfferingAndAdditionalOffering" xlink:to="STSS_NetProceedsFromInitialPublicOfferingAndAdditionalOffering_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="STSS_NetProceedsFromInitialPublicOfferingAndAdditionalOffering_lbl" xml:lang="en-US">Net proceeds from Initial Public Offering and additional offerings</link:label>
      <link:loc xlink:type="locator" xlink:href="stss-20240930.xsd#STSS_NetProceedsFromOfferingsAndWarrantExercises" xlink:label="STSS_NetProceedsFromOfferingsAndWarrantExercises" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="STSS_NetProceedsFromOfferingsAndWarrantExercises" xlink:to="STSS_NetProceedsFromOfferingsAndWarrantExercises_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="STSS_NetProceedsFromOfferingsAndWarrantExercises_lbl" xml:lang="en-US">Net proceeds from offerings and warrant exercises</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ProceedsFromIssuanceOfLongTermDebt" xlink:label="us-gaap_ProceedsFromIssuanceOfLongTermDebt" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProceedsFromIssuanceOfLongTermDebt" xlink:to="us-gaap_ProceedsFromIssuanceOfLongTermDebt_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ProceedsFromIssuanceOfLongTermDebt_lbl" xml:lang="en-US">Net proceeds from Debt financing</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RepaymentsOfNotesPayable" xlink:label="us-gaap_RepaymentsOfNotesPayable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RepaymentsOfNotesPayable" xlink:to="us-gaap_RepaymentsOfNotesPayable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_RepaymentsOfNotesPayable_lbl" xml:lang="en-US">Repayment of note payable</link:label>
      <link:loc xlink:type="locator" xlink:href="stss-20240930.xsd#STSS_ProceedsFromSubscriptionsReceivable" xlink:label="STSS_ProceedsFromSubscriptionsReceivable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="STSS_ProceedsFromSubscriptionsReceivable" xlink:to="STSS_ProceedsFromSubscriptionsReceivable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="STSS_ProceedsFromSubscriptionsReceivable_lbl" xml:lang="en-US">Proceeds from subscriptions receivable</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:label="us-gaap_NetCashProvidedByUsedInFinancingActivities" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:to="us-gaap_NetCashProvidedByUsedInFinancingActivities_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_NetCashProvidedByUsedInFinancingActivities_lbl" xml:lang="en-US">Net cash provided by financing activities</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations" xlink:label="us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations" xlink:to="us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations_lbl" xml:lang="en-US">Effect of exchange rate changes on cash</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:to="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_lbl" xml:lang="en-US">NET INCREASE (DECREASE) IN CASH</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations" xlink:to="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations_lbl" xml:lang="en-US">CASH &#8212; BEGINNING OF YEAR</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations" xlink:to="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations_2_lbl" xml:lang="en-US">CASH &#8212; END OF PERIOD</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SupplementalCashFlowInformationAbstract" xlink:label="us-gaap_SupplementalCashFlowInformationAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SupplementalCashFlowInformationAbstract" xlink:to="us-gaap_SupplementalCashFlowInformationAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SupplementalCashFlowInformationAbstract_lbl" xml:lang="en-US">SUPPLEMENTAL DISCLOSURE OF CASH FLOW INFORMATION:</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_InterestPaidNet" xlink:label="us-gaap_InterestPaidNet" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InterestPaidNet" xlink:to="us-gaap_InterestPaidNet_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_InterestPaidNet_lbl" xml:lang="en-US">Cash paid for interest</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeTaxesPaidNet" xlink:label="us-gaap_IncomeTaxesPaidNet" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeTaxesPaidNet" xlink:to="us-gaap_IncomeTaxesPaidNet_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncomeTaxesPaidNet_lbl" xml:lang="en-US">Cash paid for taxes</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NoncashInvestingAndFinancingItemsAbstract" xlink:label="us-gaap_NoncashInvestingAndFinancingItemsAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NoncashInvestingAndFinancingItemsAbstract" xlink:to="us-gaap_NoncashInvestingAndFinancingItemsAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NoncashInvestingAndFinancingItemsAbstract_lbl" xml:lang="en-US">Non-cash investing and financing activity:</link:label>
      <link:loc xlink:type="locator" xlink:href="stss-20240930.xsd#STSS_FmvForCommonStockIssuedForContingentShares" xlink:label="STSS_FmvForCommonStockIssuedForContingentShares" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="STSS_FmvForCommonStockIssuedForContingentShares" xlink:to="STSS_FmvForCommonStockIssuedForContingentShares_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="STSS_FmvForCommonStockIssuedForContingentShares_lbl" xml:lang="en-US">FMV for Common stock issued for contingent shares</link:label>
      <link:loc xlink:type="locator" xlink:href="stss-20240930.xsd#STSS_FmvForWarrantsIssuedForContingentWarrants" xlink:label="STSS_FmvForWarrantsIssuedForContingentWarrants" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="STSS_FmvForWarrantsIssuedForContingentWarrants" xlink:to="STSS_FmvForWarrantsIssuedForContingentWarrants_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="STSS_FmvForWarrantsIssuedForContingentWarrants_lbl" xml:lang="en-US">FMV for Warrants issued for contingent warrants</link:label>
      <link:loc xlink:type="locator" xlink:href="stss-20240930.xsd#STSS_CommonStockIssuedAndVestedStockOptionsForFixedAssetsAcquired" xlink:label="STSS_CommonStockIssuedAndVestedStockOptionsForFixedAssetsAcquired" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="STSS_CommonStockIssuedAndVestedStockOptionsForFixedAssetsAcquired" xlink:to="STSS_CommonStockIssuedAndVestedStockOptionsForFixedAssetsAcquired_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="STSS_CommonStockIssuedAndVestedStockOptionsForFixedAssetsAcquired_lbl" xml:lang="en-US">Common stock issued and vested stock options for fixed assets acquired</link:label>
      <link:loc xlink:type="locator" xlink:href="stss-20240930.xsd#STSS_CommonStockIssuedAndVestedStockOptionsIssuedAsConsiderationForAcquisition" xlink:label="STSS_CommonStockIssuedAndVestedStockOptionsIssuedAsConsiderationForAcquisition" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="STSS_CommonStockIssuedAndVestedStockOptionsIssuedAsConsiderationForAcquisition" xlink:to="STSS_CommonStockIssuedAndVestedStockOptionsIssuedAsConsiderationForAcquisition_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="STSS_CommonStockIssuedAndVestedStockOptionsIssuedAsConsiderationForAcquisition_lbl" xml:lang="en-US">Common stock issued and vested stock options issued as consideration for acquisition</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccountingPoliciesAbstract" xlink:label="us-gaap_AccountingPoliciesAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_AccountingPoliciesAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AccountingPoliciesAbstract_lbl" xml:lang="en-US">Accounting Policies [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessDescriptionAndBasisOfPresentationTextBlock" xlink:label="us-gaap_BusinessDescriptionAndBasisOfPresentationTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_BusinessDescriptionAndBasisOfPresentationTextBlock" xlink:to="us-gaap_BusinessDescriptionAndBasisOfPresentationTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_BusinessDescriptionAndBasisOfPresentationTextBlock_lbl" xml:lang="en-US">Description of Business</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SignificantAccountingPoliciesTextBlock" xlink:label="us-gaap_SignificantAccountingPoliciesTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SignificantAccountingPoliciesTextBlock" xlink:to="us-gaap_SignificantAccountingPoliciesTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SignificantAccountingPoliciesTextBlock_lbl" xml:lang="en-US">Summary of Significant Accounting Policies</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_InventoryDisclosureAbstract" xlink:label="us-gaap_InventoryDisclosureAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InventoryDisclosureAbstract" xlink:to="us-gaap_InventoryDisclosureAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_InventoryDisclosureAbstract_lbl" xml:lang="en-US">Inventory Disclosure [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_InventoryDisclosureTextBlock" xlink:label="us-gaap_InventoryDisclosureTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InventoryDisclosureTextBlock" xlink:to="us-gaap_InventoryDisclosureTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_InventoryDisclosureTextBlock_lbl" xml:lang="en-US">Inventories</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentAbstract" xlink:label="us-gaap_PropertyPlantAndEquipmentAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PropertyPlantAndEquipmentAbstract" xlink:to="us-gaap_PropertyPlantAndEquipmentAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PropertyPlantAndEquipmentAbstract_lbl" xml:lang="en-US">Property, Plant and Equipment [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock" xlink:label="us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock" xlink:to="us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock_lbl" xml:lang="en-US">Fixed Assets</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessCombinationAndAssetAcquisitionAbstract" xlink:label="us-gaap_BusinessCombinationAndAssetAcquisitionAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_BusinessCombinationAndAssetAcquisitionAbstract" xlink:to="us-gaap_BusinessCombinationAndAssetAcquisitionAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_BusinessCombinationAndAssetAcquisitionAbstract_lbl" xml:lang="en-US">Business Combination, Asset Acquisition, and Joint Venture Formation [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AssetAcquisitionTextBlock" xlink:label="us-gaap_AssetAcquisitionTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AssetAcquisitionTextBlock" xlink:to="us-gaap_AssetAcquisitionTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AssetAcquisitionTextBlock_lbl" xml:lang="en-US">Asset Acquisition</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureAbstract" xlink:label="us-gaap_DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureAbstract" xlink:to="us-gaap_DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureAbstract_lbl" xml:lang="en-US">Deferred Costs, Capitalized, Prepaid, and Other Assets Disclosure [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherAssetsDisclosureTextBlock" xlink:label="us-gaap_OtherAssetsDisclosureTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherAssetsDisclosureTextBlock" xlink:to="us-gaap_OtherAssetsDisclosureTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OtherAssetsDisclosureTextBlock_lbl" xml:lang="en-US">Other Assets</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtDisclosureAbstract" xlink:label="us-gaap_DebtDisclosureAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtDisclosureAbstract" xlink:to="us-gaap_DebtDisclosureAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DebtDisclosureAbstract_lbl" xml:lang="en-US">Debt Disclosure [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtDisclosureTextBlock" xlink:label="us-gaap_DebtDisclosureTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtDisclosureTextBlock" xlink:to="us-gaap_DebtDisclosureTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DebtDisclosureTextBlock_lbl" xml:lang="en-US">Debt Financing</link:label>
      <link:loc xlink:type="locator" xlink:href="stss-20240930.xsd#STSS_DisclosureNotePurchaseAgreementAbstract" xlink:label="STSS_DisclosureNotePurchaseAgreementAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="STSS_DisclosureNotePurchaseAgreementAbstract" xlink:to="STSS_DisclosureNotePurchaseAgreementAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="STSS_DisclosureNotePurchaseAgreementAbstract_lbl" xml:lang="en-US">Note Purchase Agreement</link:label>
      <link:loc xlink:type="locator" xlink:href="stss-20240930.xsd#STSS_NotePurchaseAgreementTextBlock" xlink:label="STSS_NotePurchaseAgreementTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="STSS_NotePurchaseAgreementTextBlock" xlink:to="STSS_NotePurchaseAgreementTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="STSS_NotePurchaseAgreementTextBlock_lbl" xml:lang="en-US">Note Purchase Agreement</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EquityAbstract" xlink:label="us-gaap_EquityAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EquityAbstract" xlink:to="us-gaap_EquityAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_EquityAbstract_lbl" xml:lang="en-US">Equity [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:label="us-gaap_StockholdersEquityNoteDisclosureTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:to="us-gaap_StockholdersEquityNoteDisclosureTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockholdersEquityNoteDisclosureTextBlock_lbl" xml:lang="en-US">Stockholders&#8217; Equity</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PreferredStockTextBlock" xlink:label="us-gaap_PreferredStockTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PreferredStockTextBlock" xlink:to="us-gaap_PreferredStockTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PreferredStockTextBlock_lbl" xml:lang="en-US">Preferred Stock</link:label>
      <link:loc xlink:type="locator" xlink:href="stss-20240930.xsd#STSS_DisclosureWarrantLiabilityAbstract" xlink:label="STSS_DisclosureWarrantLiabilityAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="STSS_DisclosureWarrantLiabilityAbstract" xlink:to="STSS_DisclosureWarrantLiabilityAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="STSS_DisclosureWarrantLiabilityAbstract_lbl" xml:lang="en-US">Warrant Liability</link:label>
      <link:loc xlink:type="locator" xlink:href="stss-20240930.xsd#STSS_WarrantLiabilityTextBlock" xlink:label="STSS_WarrantLiabilityTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="STSS_WarrantLiabilityTextBlock" xlink:to="STSS_WarrantLiabilityTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="STSS_WarrantLiabilityTextBlock_lbl" xml:lang="en-US">Warrant Liability</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:label="us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:to="us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_lbl" xml:lang="en-US">Share-Based Payment Arrangement [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" xlink:label="us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" xlink:to="us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock_lbl" xml:lang="en-US">Stock Options</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeTaxDisclosureAbstract" xlink:label="us-gaap_IncomeTaxDisclosureAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeTaxDisclosureAbstract" xlink:to="us-gaap_IncomeTaxDisclosureAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncomeTaxDisclosureAbstract_lbl" xml:lang="en-US">Income Tax Disclosure [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeTaxDisclosureTextBlock" xlink:label="us-gaap_IncomeTaxDisclosureTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeTaxDisclosureTextBlock" xlink:to="us-gaap_IncomeTaxDisclosureTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncomeTaxDisclosureTextBlock_lbl" xml:lang="en-US">Income Taxes</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RelatedPartyTransactionsAbstract" xlink:label="us-gaap_RelatedPartyTransactionsAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RelatedPartyTransactionsAbstract" xlink:to="us-gaap_RelatedPartyTransactionsAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_RelatedPartyTransactionsAbstract_lbl" xml:lang="en-US">Related Party Transactions [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RelatedPartyTransactionsDisclosureTextBlock" xlink:label="us-gaap_RelatedPartyTransactionsDisclosureTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RelatedPartyTransactionsDisclosureTextBlock" xlink:to="us-gaap_RelatedPartyTransactionsDisclosureTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_RelatedPartyTransactionsDisclosureTextBlock_lbl" xml:lang="en-US">Related Party Transactions and Balances</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueDisclosuresAbstract" xlink:label="us-gaap_FairValueDisclosuresAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueDisclosuresAbstract" xlink:to="us-gaap_FairValueDisclosuresAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FairValueDisclosuresAbstract_lbl" xml:lang="en-US">Fair Value Disclosures [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueMeasurementInputsDisclosureTextBlock" xlink:label="us-gaap_FairValueMeasurementInputsDisclosureTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueMeasurementInputsDisclosureTextBlock" xlink:to="us-gaap_FairValueMeasurementInputsDisclosureTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FairValueMeasurementInputsDisclosureTextBlock_lbl" xml:lang="en-US">Fair Value Measurements</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:label="us-gaap_CommitmentsAndContingenciesDisclosureAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:to="us-gaap_CommitmentsAndContingenciesDisclosureAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CommitmentsAndContingenciesDisclosureAbstract_lbl" xml:lang="en-US">Commitments and Contingencies Disclosure [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:label="us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:to="us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_lbl" xml:lang="en-US">Commitments and Contingencies</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubsequentEventsAbstract" xlink:label="us-gaap_SubsequentEventsAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SubsequentEventsAbstract" xlink:to="us-gaap_SubsequentEventsAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SubsequentEventsAbstract_lbl" xml:lang="en-US">Subsequent Events [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubsequentEventsTextBlock" xlink:label="us-gaap_SubsequentEventsTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SubsequentEventsTextBlock" xlink:to="us-gaap_SubsequentEventsTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SubsequentEventsTextBlock_lbl" xml:lang="en-US">Subsequent Events</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BasisOfAccountingPolicyPolicyTextBlock" xlink:label="us-gaap_BasisOfAccountingPolicyPolicyTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_BasisOfAccountingPolicyPolicyTextBlock" xlink:to="us-gaap_BasisOfAccountingPolicyPolicyTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_BasisOfAccountingPolicyPolicyTextBlock_lbl" xml:lang="en-US">Basis of Presentation</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_UseOfEstimates" xlink:label="us-gaap_UseOfEstimates" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_UseOfEstimates" xlink:to="us-gaap_UseOfEstimates_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_UseOfEstimates_lbl" xml:lang="en-US">Use of Estimates</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CashAndCashEquivalentsPolicyTextBlock" xlink:label="us-gaap_CashAndCashEquivalentsPolicyTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashAndCashEquivalentsPolicyTextBlock" xlink:to="us-gaap_CashAndCashEquivalentsPolicyTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CashAndCashEquivalentsPolicyTextBlock_lbl" xml:lang="en-US">Cash and Cash Equivalents</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_InventoryPolicyTextBlock" xlink:label="us-gaap_InventoryPolicyTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InventoryPolicyTextBlock" xlink:to="us-gaap_InventoryPolicyTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_InventoryPolicyTextBlock_lbl" xml:lang="en-US">Inventories</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueMeasurementPolicyPolicyTextBlock" xlink:label="us-gaap_FairValueMeasurementPolicyPolicyTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueMeasurementPolicyPolicyTextBlock" xlink:to="us-gaap_FairValueMeasurementPolicyPolicyTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_FairValueMeasurementPolicyPolicyTextBlock_lbl" xml:lang="en-US">Fair Value Measurements</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentPolicyTextBlock" xlink:label="us-gaap_PropertyPlantAndEquipmentPolicyTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PropertyPlantAndEquipmentPolicyTextBlock" xlink:to="us-gaap_PropertyPlantAndEquipmentPolicyTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_PropertyPlantAndEquipmentPolicyTextBlock_lbl" xml:lang="en-US">Fixed Assets</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock" xlink:label="us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock" xlink:to="us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock_lbl" xml:lang="en-US">Impairment of Long-Lived Assets</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IntangibleAssetsFiniteLivedPolicy" xlink:label="us-gaap_IntangibleAssetsFiniteLivedPolicy" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IntangibleAssetsFiniteLivedPolicy" xlink:to="us-gaap_IntangibleAssetsFiniteLivedPolicy_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IntangibleAssetsFiniteLivedPolicy_lbl" xml:lang="en-US">Purchased Identified Intangible Assets</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CompensationRelatedCostsPolicyTextBlock" xlink:label="us-gaap_CompensationRelatedCostsPolicyTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CompensationRelatedCostsPolicyTextBlock" xlink:to="us-gaap_CompensationRelatedCostsPolicyTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CompensationRelatedCostsPolicyTextBlock_lbl" xml:lang="en-US">Stock-based Compensation Expense</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DerivativesPolicyTextBlock" xlink:label="us-gaap_DerivativesPolicyTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DerivativesPolicyTextBlock" xlink:to="us-gaap_DerivativesPolicyTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DerivativesPolicyTextBlock_lbl" xml:lang="en-US">Derivative Instruments</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock" xlink:label="us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock" xlink:to="us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock_lbl" xml:lang="en-US">Foreign Currency Translation/Transactions</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ComprehensiveIncomePolicyPolicyTextBlock" xlink:label="us-gaap_ComprehensiveIncomePolicyPolicyTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ComprehensiveIncomePolicyPolicyTextBlock" xlink:to="us-gaap_ComprehensiveIncomePolicyPolicyTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ComprehensiveIncomePolicyPolicyTextBlock_lbl" xml:lang="en-US">Comprehensive income (loss)</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EarningsPerSharePolicyTextBlock" xlink:label="us-gaap_EarningsPerSharePolicyTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EarningsPerSharePolicyTextBlock" xlink:to="us-gaap_EarningsPerSharePolicyTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_EarningsPerSharePolicyTextBlock_lbl" xml:lang="en-US">Basic and Diluted Loss Per Share</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeTaxPolicyTextBlock" xlink:label="us-gaap_IncomeTaxPolicyTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeTaxPolicyTextBlock" xlink:to="us-gaap_IncomeTaxPolicyTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_IncomeTaxPolicyTextBlock_lbl" xml:lang="en-US">Income Taxes</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ResearchAndDevelopmentExpensePolicy" xlink:label="us-gaap_ResearchAndDevelopmentExpensePolicy" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ResearchAndDevelopmentExpensePolicy" xlink:to="us-gaap_ResearchAndDevelopmentExpensePolicy_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ResearchAndDevelopmentExpensePolicy_lbl" xml:lang="en-US">Research and Development Costs</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommitmentsAndContingenciesPolicyTextBlock" xlink:label="us-gaap_CommitmentsAndContingenciesPolicyTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommitmentsAndContingenciesPolicyTextBlock" xlink:to="us-gaap_CommitmentsAndContingenciesPolicyTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CommitmentsAndContingenciesPolicyTextBlock_lbl" xml:lang="en-US">Contingencies</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:label="us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:to="us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_lbl" xml:lang="en-US">Recent Accounting Pronouncements</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfInventoryCurrentTableTextBlock" xlink:label="us-gaap_ScheduleOfInventoryCurrentTableTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfInventoryCurrentTableTextBlock" xlink:to="us-gaap_ScheduleOfInventoryCurrentTableTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfInventoryCurrentTableTextBlock_lbl" xml:lang="en-US">Schedule of Inventories</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentTextBlock" xlink:label="us-gaap_PropertyPlantAndEquipmentTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PropertyPlantAndEquipmentTextBlock" xlink:to="us-gaap_PropertyPlantAndEquipmentTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PropertyPlantAndEquipmentTextBlock_lbl" xml:lang="en-US">Schedule of Fixed Assets, Net</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock" xlink:label="us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock" xlink:to="us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock_lbl" xml:lang="en-US">Schedule of Fair Value of Assets Acquisition</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfOtherAssetsTableTextBlock" xlink:label="us-gaap_ScheduleOfOtherAssetsTableTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfOtherAssetsTableTextBlock" xlink:to="us-gaap_ScheduleOfOtherAssetsTableTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfOtherAssetsTableTextBlock_lbl" xml:lang="en-US">Schedule of Other Assets</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" xlink:label="us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" xlink:to="us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock_lbl" xml:lang="en-US">Schedule of Fair Value of Warrant</link:label>
      <link:loc xlink:type="locator" xlink:href="stss-20240930.xsd#STSS_ScheduleOfWarrantLiabilityTableTextBlock" xlink:label="STSS_ScheduleOfWarrantLiabilityTableTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="STSS_ScheduleOfWarrantLiabilityTableTextBlock" xlink:to="STSS_ScheduleOfWarrantLiabilityTableTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="STSS_ScheduleOfWarrantLiabilityTableTextBlock_lbl" xml:lang="en-US">Schedule of Warrant Liability</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock" xlink:label="us-gaap_ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock" xlink:to="us-gaap_ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock_lbl" xml:lang="en-US">Schedule of Warrant Outstanding</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock" xlink:label="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock" xlink:to="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock_lbl" xml:lang="en-US">Schedule of Fair Value of Warrant</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" xlink:label="us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" xlink:to="us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock_lbl" xml:lang="en-US">Schedule of Stock Options Granted and Outstanding</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTextBlock" xlink:label="us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTextBlock" xlink:to="us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTextBlock_lbl" xml:lang="en-US">Schedule of Information About Options Outstanding</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" xlink:to="us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock_2_lbl" xml:lang="en-US">Schedule of Fair Value of Stock Option Awards</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock" xlink:to="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock_2_lbl" xml:lang="en-US">Schedule of Fair Value of Stock Option Awards</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock" xlink:label="us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock" xlink:to="us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock_lbl" xml:lang="en-US">Schedule of Reconciliation of Federal Statutory Rate to Total Effective Rate</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" xlink:label="us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" xlink:to="us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock_lbl" xml:lang="en-US">Schedule of Components of Deferred tax Assets</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock" xlink:label="us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock" xlink:to="us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock_lbl" xml:lang="en-US">Schedule of Geographical Components of Loss Before Income Taxes</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock" xlink:label="us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock" xlink:to="us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock_lbl" xml:lang="en-US">Schedule of Assets and Liabilities Measured at Fair Value on Recurring Basis</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable" xlink:label="us-gaap_SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable" xlink:to="us-gaap_SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable_lbl" xml:lang="en-US">Subsidiary or Equity Method Investee, Sale of Stock, Type [Table]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubsidiarySaleOfStockLineItems" xlink:label="us-gaap_SubsidiarySaleOfStockLineItems" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SubsidiarySaleOfStockLineItems" xlink:to="us-gaap_SubsidiarySaleOfStockLineItems_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SubsidiarySaleOfStockLineItems_lbl" xml:lang="en-US">Subsidiary, Sale of Stock [Line Items]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ProceedsFromIssuanceInitialPublicOffering" xlink:label="us-gaap_ProceedsFromIssuanceInitialPublicOffering" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProceedsFromIssuanceInitialPublicOffering" xlink:to="us-gaap_ProceedsFromIssuanceInitialPublicOffering_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ProceedsFromIssuanceInitialPublicOffering_lbl" xml:lang="en-US">Initial public offering</link:label>
      <link:loc xlink:type="locator" xlink:href="stss-20240930.xsd#STSS_WorkingCapital" xlink:label="STSS_WorkingCapital" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="STSS_WorkingCapital" xlink:to="STSS_WorkingCapital_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="STSS_WorkingCapital_lbl" xml:lang="en-US">Working capital</link:label>
      <link:loc xlink:type="locator" xlink:href="stss-20240930.xsd#STSS_ReverseStockSplitDescription" xlink:label="STSS_ReverseStockSplitDescription" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="STSS_ReverseStockSplitDescription" xlink:to="STSS_ReverseStockSplitDescription_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="STSS_ReverseStockSplitDescription_lbl" xml:lang="en-US">Reverse stock split description</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:label="us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:to="us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_lbl" xml:lang="en-US">Property, Plant and Equipment [Table]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentLineItems" xlink:label="us-gaap_PropertyPlantAndEquipmentLineItems" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PropertyPlantAndEquipmentLineItems" xlink:to="us-gaap_PropertyPlantAndEquipmentLineItems_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PropertyPlantAndEquipmentLineItems_lbl" xml:lang="en-US">Property, Plant and Equipment [Line Items]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="us-gaap_NetCashProvidedByUsedInOperatingActivities_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivities_2_lbl" xml:lang="en-US">Cash in operations</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_Cash" xlink:label="us-gaap_Cash" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_Cash" xlink:to="us-gaap_Cash_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_Cash_lbl" xml:lang="en-US">Cash</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CashEquivalentsAtCarryingValue" xlink:label="us-gaap_CashEquivalentsAtCarryingValue" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashEquivalentsAtCarryingValue" xlink:to="us-gaap_CashEquivalentsAtCarryingValue_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CashEquivalentsAtCarryingValue_lbl" xml:lang="en-US">Cash equivalents</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentUsefulLife" xlink:label="us-gaap_PropertyPlantAndEquipmentUsefulLife" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PropertyPlantAndEquipmentUsefulLife" xlink:to="us-gaap_PropertyPlantAndEquipmentUsefulLife_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PropertyPlantAndEquipmentUsefulLife_lbl" xml:lang="en-US">Property plant and equipment asset useful life</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ImpairmentOfLongLivedAssetsHeldForUse" xlink:to="us-gaap_ImpairmentOfLongLivedAssetsHeldForUse_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_ImpairmentOfLongLivedAssetsHeldForUse_2_lbl" xml:lang="en-US">Impairment losses</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:to="us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_2_lbl" xml:lang="en-US">Weighted average shares outstanding basic</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:label="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:to="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_lbl" xml:lang="en-US">Antidilutive shares amount</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_InventoryRawMaterialsNetOfReserves" xlink:label="us-gaap_InventoryRawMaterialsNetOfReserves" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InventoryRawMaterialsNetOfReserves" xlink:to="us-gaap_InventoryRawMaterialsNetOfReserves_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_InventoryRawMaterialsNetOfReserves_lbl" xml:lang="en-US">Raw materials</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_InventoryWorkInProcessNetOfReserves" xlink:label="us-gaap_InventoryWorkInProcessNetOfReserves" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InventoryWorkInProcessNetOfReserves" xlink:to="us-gaap_InventoryWorkInProcessNetOfReserves_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_InventoryWorkInProcessNetOfReserves_lbl" xml:lang="en-US">Work in process</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_InventoryFinishedGoodsNetOfReserves" xlink:label="us-gaap_InventoryFinishedGoodsNetOfReserves" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InventoryFinishedGoodsNetOfReserves" xlink:to="us-gaap_InventoryFinishedGoodsNetOfReserves_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_InventoryFinishedGoodsNetOfReserves_lbl" xml:lang="en-US">Finished goods</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InventoryNet" xlink:to="us-gaap_InventoryNet_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_InventoryNet_2_lbl" xml:lang="en-US">Total</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentGross" xlink:label="us-gaap_PropertyPlantAndEquipmentGross" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PropertyPlantAndEquipmentGross" xlink:to="us-gaap_PropertyPlantAndEquipmentGross_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PropertyPlantAndEquipmentGross_lbl" xml:lang="en-US">&#160;Total Fixed Assets</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:label="us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:to="us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_lbl" xml:lang="en-US">Less: accumulated depreciation</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PropertyPlantAndEquipmentNet" xlink:to="us-gaap_PropertyPlantAndEquipmentNet_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_PropertyPlantAndEquipmentNet_2_lbl" xml:lang="en-US">Fixed asset, net</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_Depreciation" xlink:label="us-gaap_Depreciation" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_Depreciation" xlink:to="us-gaap_Depreciation_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_Depreciation_lbl" xml:lang="en-US">Depreciation</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AssetImpairmentCharges" xlink:label="us-gaap_AssetImpairmentCharges" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AssetImpairmentCharges" xlink:to="us-gaap_AssetImpairmentCharges_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AssetImpairmentCharges_lbl" xml:lang="en-US">Asset impairment</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PaymentsToAcquireMachineryAndEquipment" xlink:label="us-gaap_PaymentsToAcquireMachineryAndEquipment" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PaymentsToAcquireMachineryAndEquipment" xlink:to="us-gaap_PaymentsToAcquireMachineryAndEquipment_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PaymentsToAcquireMachineryAndEquipment_lbl" xml:lang="en-US">Acquisition of machinery</link:label>
      <link:loc xlink:type="locator" xlink:href="stss-20240930.xsd#STSS_RemainingPaymentsDueOnMachinery" xlink:label="STSS_RemainingPaymentsDueOnMachinery" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="STSS_RemainingPaymentsDueOnMachinery" xlink:to="STSS_RemainingPaymentsDueOnMachinery_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="STSS_RemainingPaymentsDueOnMachinery_lbl" xml:lang="en-US">Balance due on machinery</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:label="us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:to="us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_lbl" xml:lang="en-US">Schedule of Business Acquisitions, by Acquisition [Table]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessAcquisitionLineItems" xlink:label="us-gaap_BusinessAcquisitionLineItems" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_BusinessAcquisitionLineItems" xlink:to="us-gaap_BusinessAcquisitionLineItems_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_BusinessAcquisitionLineItems_lbl" xml:lang="en-US">Business Acquisition [Line Items]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLand" xlink:label="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLand" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLand" xlink:to="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLand_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLand_lbl" xml:lang="en-US">Land</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedBuildings" xlink:label="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedBuildings" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedBuildings" xlink:to="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedBuildings_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedBuildings_lbl" xml:lang="en-US">Building and affixed assets</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedEquipment" xlink:label="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedEquipment" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedEquipment" xlink:to="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedEquipment_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedEquipment_lbl" xml:lang="en-US">Machinery</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory" xlink:label="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory" xlink:to="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory_lbl" xml:lang="en-US">Inventory</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles" xlink:label="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles" xlink:to="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles_lbl" xml:lang="en-US">Intangibles</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities" xlink:label="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities" xlink:to="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities_lbl" xml:lang="en-US">Deferred tax liability</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets" xlink:label="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets" xlink:to="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets_lbl" xml:lang="en-US">Total</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AssetAcquisitionConsiderationTransferred" xlink:label="us-gaap_AssetAcquisitionConsiderationTransferred" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AssetAcquisitionConsiderationTransferred" xlink:to="us-gaap_AssetAcquisitionConsiderationTransferred_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AssetAcquisitionConsiderationTransferred_lbl" xml:lang="en-US">Asset acquisition</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockIssuedDuringPeriodSharesAcquisitions" xlink:label="us-gaap_StockIssuedDuringPeriodSharesAcquisitions" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodSharesAcquisitions" xlink:to="us-gaap_StockIssuedDuringPeriodSharesAcquisitions_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockIssuedDuringPeriodSharesAcquisitions_lbl" xml:lang="en-US">Additional consideration, shares</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SharePrice" xlink:label="us-gaap_SharePrice" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharePrice" xlink:to="us-gaap_SharePrice_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SharePrice_lbl" xml:lang="en-US">Share price</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod_lbl" xml:lang="en-US">Stock options issued</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_lbl" xml:lang="en-US">Exercise price</link:label>
      <link:loc xlink:type="locator" xlink:href="stss-20240930.xsd#STSS_FairMarketValueOfCommonStock" xlink:label="STSS_FairMarketValueOfCommonStock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="STSS_FairMarketValueOfCommonStock" xlink:to="STSS_FairMarketValueOfCommonStock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="STSS_FairMarketValueOfCommonStock_lbl" xml:lang="en-US">Fair market value of common stock</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1_lbl" xml:lang="en-US">Vested options, value</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingCostsAndExpenses" xlink:label="us-gaap_OperatingCostsAndExpenses" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingCostsAndExpenses" xlink:to="us-gaap_OperatingCostsAndExpenses_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OperatingCostsAndExpenses_lbl" xml:lang="en-US">Operating costs</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets" xlink:to="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets_2_lbl" xml:lang="en-US">Acquisition cost</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueOfAssetsAcquired" xlink:label="us-gaap_FairValueOfAssetsAcquired" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueOfAssetsAcquired" xlink:to="us-gaap_FairValueOfAssetsAcquired_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FairValueOfAssetsAcquired_lbl" xml:lang="en-US">Fair value of assets acquired</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FiniteLivedIntangibleAssetUsefulLife" xlink:label="us-gaap_FiniteLivedIntangibleAssetUsefulLife" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FiniteLivedIntangibleAssetUsefulLife" xlink:to="us-gaap_FiniteLivedIntangibleAssetUsefulLife_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FiniteLivedIntangibleAssetUsefulLife_lbl" xml:lang="en-US">Intangible asset acquired, useful lives</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PaymentsToAcquireBusinessesGross" xlink:label="us-gaap_PaymentsToAcquireBusinessesGross" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PaymentsToAcquireBusinessesGross" xlink:to="us-gaap_PaymentsToAcquireBusinessesGross_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PaymentsToAcquireBusinessesGross_lbl" xml:lang="en-US">Consideration paid in cash</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessAcquisitionCostOfAcquiredEntityTransactionCosts" xlink:label="us-gaap_BusinessAcquisitionCostOfAcquiredEntityTransactionCosts" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_BusinessAcquisitionCostOfAcquiredEntityTransactionCosts" xlink:to="us-gaap_BusinessAcquisitionCostOfAcquiredEntityTransactionCosts_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_BusinessAcquisitionCostOfAcquiredEntityTransactionCosts_lbl" xml:lang="en-US">Transaction costs</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PropertyPlantAndEquipmentUsefulLife" xlink:to="us-gaap_PropertyPlantAndEquipmentUsefulLife_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_PropertyPlantAndEquipmentUsefulLife_2_lbl" xml:lang="en-US">Fixed assets acquired, useful lives</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:label="us-gaap_IntangibleAssetsNetExcludingGoodwill" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:to="us-gaap_IntangibleAssetsNetExcludingGoodwill_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IntangibleAssetsNetExcludingGoodwill_lbl" xml:lang="en-US">Intangibles, net &#8211; See Note 6</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DepositsAssets" xlink:label="us-gaap_DepositsAssets" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DepositsAssets" xlink:to="us-gaap_DepositsAssets_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DepositsAssets_lbl" xml:lang="en-US">Deposits or advance payments on machinery, molds and components (see Note 15)</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherAssetsMiscellaneousNoncurrent" xlink:label="us-gaap_OtherAssetsMiscellaneousNoncurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherAssetsMiscellaneousNoncurrent" xlink:to="us-gaap_OtherAssetsMiscellaneousNoncurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OtherAssetsMiscellaneousNoncurrent_lbl" xml:lang="en-US">Other &#8211; See Note 7</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherAssetsNoncurrent" xlink:to="us-gaap_OtherAssetsNoncurrent_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_OtherAssetsNoncurrent_2_lbl" xml:lang="en-US">&#160;Total Other assets</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AmortizationOfIntangibleAssets" xlink:label="us-gaap_AmortizationOfIntangibleAssets" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AmortizationOfIntangibleAssets" xlink:to="us-gaap_AmortizationOfIntangibleAssets_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AmortizationOfIntangibleAssets_lbl" xml:lang="en-US">Amortization of intangible assets</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfShortTermDebtTable" xlink:label="us-gaap_ScheduleOfShortTermDebtTable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfShortTermDebtTable" xlink:to="us-gaap_ScheduleOfShortTermDebtTable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfShortTermDebtTable_lbl" xml:lang="en-US">Short-Term Debt [Table]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShortTermDebtLineItems" xlink:label="us-gaap_ShortTermDebtLineItems" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShortTermDebtLineItems" xlink:to="us-gaap_ShortTermDebtLineItems_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShortTermDebtLineItems_lbl" xml:lang="en-US">Short-Term Debt [Line Items]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentFaceAmount" xlink:label="us-gaap_DebtInstrumentFaceAmount" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtInstrumentFaceAmount" xlink:to="us-gaap_DebtInstrumentFaceAmount_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DebtInstrumentFaceAmount_lbl" xml:lang="en-US">Debt Instrument, Face Amount</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentIncreaseAccruedInterest" xlink:label="us-gaap_DebtInstrumentIncreaseAccruedInterest" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtInstrumentIncreaseAccruedInterest" xlink:to="us-gaap_DebtInstrumentIncreaseAccruedInterest_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DebtInstrumentIncreaseAccruedInterest_lbl" xml:lang="en-US">Original issue discount (OID)</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentMaturityDate" xlink:label="us-gaap_DebtInstrumentMaturityDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtInstrumentMaturityDate" xlink:to="us-gaap_DebtInstrumentMaturityDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DebtInstrumentMaturityDate_lbl" xml:lang="en-US">Debt Instrument, Maturity Date</link:label>
      <link:loc xlink:type="locator" xlink:href="stss-20240930.xsd#STSS_NumberOfUnregisteredCommonStockIssuedDuringPostReverseShares" xlink:label="STSS_NumberOfUnregisteredCommonStockIssuedDuringPostReverseShares" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="STSS_NumberOfUnregisteredCommonStockIssuedDuringPostReverseShares" xlink:to="STSS_NumberOfUnregisteredCommonStockIssuedDuringPostReverseShares_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="STSS_NumberOfUnregisteredCommonStockIssuedDuringPostReverseShares_lbl" xml:lang="en-US">Number of unregistered common stock issued during post reverse shares</link:label>
      <link:loc xlink:type="locator" xlink:href="stss-20240930.xsd#STSS_NumberOfUnregisteredCommonStockIssuedDuringPreReverseShares" xlink:label="STSS_NumberOfUnregisteredCommonStockIssuedDuringPreReverseShares" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="STSS_NumberOfUnregisteredCommonStockIssuedDuringPreReverseShares" xlink:to="STSS_NumberOfUnregisteredCommonStockIssuedDuringPreReverseShares_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="STSS_NumberOfUnregisteredCommonStockIssuedDuringPreReverseShares_lbl" xml:lang="en-US">Pre reverse</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ProceedsFromIssuanceOfDebt" xlink:label="us-gaap_ProceedsFromIssuanceOfDebt" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProceedsFromIssuanceOfDebt" xlink:to="us-gaap_ProceedsFromIssuanceOfDebt_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ProceedsFromIssuanceOfDebt_lbl" xml:lang="en-US">Proceeds from Issuance of Debt</link:label>
      <link:loc xlink:type="locator" xlink:href="stss-20240930.xsd#STSS_PlacementAgentAndOtherOfferingExpenses" xlink:label="STSS_PlacementAgentAndOtherOfferingExpenses" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="STSS_PlacementAgentAndOtherOfferingExpenses" xlink:to="STSS_PlacementAgentAndOtherOfferingExpenses_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="STSS_PlacementAgentAndOtherOfferingExpenses_lbl" xml:lang="en-US">Closing costs</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EscrowDeposit" xlink:label="us-gaap_EscrowDeposit" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EscrowDeposit" xlink:to="us-gaap_EscrowDeposit_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_EscrowDeposit_lbl" xml:lang="en-US">Escrow Deposit</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentFairValue" xlink:label="us-gaap_DebtInstrumentFairValue" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtInstrumentFairValue" xlink:to="us-gaap_DebtInstrumentFairValue_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DebtInstrumentFairValue_lbl" xml:lang="en-US">Debt Instrument, Fair Value Disclosure</link:label>
      <link:loc xlink:type="locator" xlink:href="stss-20240930.xsd#STSS_CommonStockFairValue" xlink:label="STSS_CommonStockFairValue" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="STSS_CommonStockFairValue" xlink:to="STSS_CommonStockFairValue_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="STSS_CommonStockFairValue_lbl" xml:lang="en-US">Common stock fair value</link:label>
      <link:loc xlink:type="locator" xlink:href="stss-20240930.xsd#STSS_AccretedInterestFees" xlink:label="STSS_AccretedInterestFees" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="STSS_AccretedInterestFees" xlink:to="STSS_AccretedInterestFees_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="STSS_AccretedInterestFees_lbl" xml:lang="en-US">Accreted interest fees</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" xlink:label="us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" xlink:to="us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable_lbl" xml:lang="en-US">Collaborative Arrangement and Arrangement Other than Collaborative [Table]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:label="us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems_lbl" xml:lang="en-US">Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtInstrumentFaceAmount" xlink:to="us-gaap_DebtInstrumentFaceAmount_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_DebtInstrumentFaceAmount_2_lbl" xml:lang="en-US">Debt instrument face amount</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:label="us-gaap_DebtInstrumentInterestRateStatedPercentage" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:to="us-gaap_DebtInstrumentInterestRateStatedPercentage_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DebtInstrumentInterestRateStatedPercentage_lbl" xml:lang="en-US">Interest rate</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentDescription" xlink:label="us-gaap_DebtInstrumentDescription" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtInstrumentDescription" xlink:to="us-gaap_DebtInstrumentDescription_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DebtInstrumentDescription_lbl" xml:lang="en-US">Debt description</link:label>
      <link:loc xlink:type="locator" xlink:href="stss-20240930.xsd#STSS_ContingentStockLiability" xlink:label="STSS_ContingentStockLiability" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="STSS_ContingentStockLiability" xlink:to="STSS_ContingentStockLiability_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="STSS_ContingentStockLiability_lbl" xml:lang="en-US">Contingent stock liability</link:label>
      <link:loc xlink:type="locator" xlink:href="stss-20240930.xsd#STSS_ContingentWarrantLiability" xlink:label="STSS_ContingentWarrantLiability" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="STSS_ContingentWarrantLiability" xlink:to="STSS_ContingentWarrantLiability_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="STSS_ContingentWarrantLiability_lbl" xml:lang="en-US">Contingent warrants liability</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PaymentsOfDebtIssuanceCosts" xlink:label="us-gaap_PaymentsOfDebtIssuanceCosts" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PaymentsOfDebtIssuanceCosts" xlink:to="us-gaap_PaymentsOfDebtIssuanceCosts_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PaymentsOfDebtIssuanceCosts_lbl" xml:lang="en-US">Debt issuance costs</link:label>
      <link:loc xlink:type="locator" xlink:href="stss-20240930.xsd#STSS_AllocationOfDebtIssuanceCostToContingentStockAndContingentWarrants" xlink:label="STSS_AllocationOfDebtIssuanceCostToContingentStockAndContingentWarrants" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="STSS_AllocationOfDebtIssuanceCostToContingentStockAndContingentWarrants" xlink:to="STSS_AllocationOfDebtIssuanceCostToContingentStockAndContingentWarrants_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="STSS_AllocationOfDebtIssuanceCostToContingentStockAndContingentWarrants_lbl" xml:lang="en-US">Allocation of debt issuance cost to contingent stock and contingent warrants</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NotesPayable" xlink:label="us-gaap_NotesPayable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NotesPayable" xlink:to="us-gaap_NotesPayable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NotesPayable_lbl" xml:lang="en-US">Notes payable</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentUnamortizedDiscount" xlink:label="us-gaap_DebtInstrumentUnamortizedDiscount" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtInstrumentUnamortizedDiscount" xlink:to="us-gaap_DebtInstrumentUnamortizedDiscount_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DebtInstrumentUnamortizedDiscount_lbl" xml:lang="en-US">Debt discount</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_InterestExpense" xlink:label="us-gaap_InterestExpense" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InterestExpense" xlink:to="us-gaap_InterestExpense_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_InterestExpense_lbl" xml:lang="en-US">Interest expense</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_InterestPayableCurrent" xlink:label="us-gaap_InterestPayableCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InterestPayableCurrent" xlink:to="us-gaap_InterestPayableCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_InterestPayableCurrent_lbl" xml:lang="en-US">Accreted interest</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RepaymentsOfDebt" xlink:label="us-gaap_RepaymentsOfDebt" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RepaymentsOfDebt" xlink:to="us-gaap_RepaymentsOfDebt_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_RepaymentsOfDebt_lbl" xml:lang="en-US">Notes payable</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueAdjustmentOfWarrants" xlink:label="us-gaap_FairValueAdjustmentOfWarrants" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueAdjustmentOfWarrants" xlink:to="us-gaap_FairValueAdjustmentOfWarrants_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FairValueAdjustmentOfWarrants_lbl" xml:lang="en-US">Fair market value of warrant</link:label>
      <link:loc xlink:type="locator" xlink:href="stss-20240930.xsd#STSS_ContingentWarrants" xlink:label="STSS_ContingentWarrants" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="STSS_ContingentWarrants" xlink:to="STSS_ContingentWarrants_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="STSS_ContingentWarrants_lbl" xml:lang="en-US">Contingent warrant</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice_lbl" xml:lang="en-US">Exercise price</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockSharesAuthorized" xlink:to="us-gaap_CommonStockSharesAuthorized_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_CommonStockSharesAuthorized_2_lbl" xml:lang="en-US">Common stock, share authorized</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ConversionOfStockDescription" xlink:label="us-gaap_ConversionOfStockDescription" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ConversionOfStockDescription" xlink:to="us-gaap_ConversionOfStockDescription_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ConversionOfStockDescription_lbl" xml:lang="en-US">Conversion of stock, description</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ProceedsFromIssuanceOfCommonStock" xlink:label="us-gaap_ProceedsFromIssuanceOfCommonStock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProceedsFromIssuanceOfCommonStock" xlink:to="us-gaap_ProceedsFromIssuanceOfCommonStock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ProceedsFromIssuanceOfCommonStock_lbl" xml:lang="en-US">Gross proceeds</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherExpenses" xlink:label="us-gaap_OtherExpenses" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherExpenses" xlink:to="us-gaap_OtherExpenses_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OtherExpenses_lbl" xml:lang="en-US">Other offering expenses</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProceedsFromIssuanceInitialPublicOffering" xlink:to="us-gaap_ProceedsFromIssuanceInitialPublicOffering_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_ProceedsFromIssuanceInitialPublicOffering_2_lbl" xml:lang="en-US">Net proceeds from IPO</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LegalFees" xlink:label="us-gaap_LegalFees" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LegalFees" xlink:to="us-gaap_LegalFees_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LegalFees_lbl" xml:lang="en-US">Placement agent fees</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:to="us-gaap_StockIssuedDuringPeriodSharesNewIssues_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_StockIssuedDuringPeriodSharesNewIssues_2_lbl" xml:lang="en-US">Warrants issued</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SharesIssuedPricePerShare" xlink:label="us-gaap_SharesIssuedPricePerShare" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharesIssuedPricePerShare" xlink:to="us-gaap_SharesIssuedPricePerShare_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SharesIssuedPricePerShare_lbl" xml:lang="en-US">Purchase price pre reverse</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight" xlink:label="us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight" xlink:to="us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight_lbl" xml:lang="en-US">Prefunded warrants</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" xlink:label="us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" xlink:to="us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_lbl" xml:lang="en-US">Exercise price</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ProceedsFromIssuanceOfPrivatePlacement" xlink:label="us-gaap_ProceedsFromIssuanceOfPrivatePlacement" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProceedsFromIssuanceOfPrivatePlacement" xlink:to="us-gaap_ProceedsFromIssuanceOfPrivatePlacement_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ProceedsFromIssuanceOfPrivatePlacement_lbl" xml:lang="en-US">Net proceeds from the Private Placement</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_WarrantsAndRightsOutstandingTerm" xlink:label="us-gaap_WarrantsAndRightsOutstandingTerm" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_WarrantsAndRightsOutstandingTerm" xlink:to="us-gaap_WarrantsAndRightsOutstandingTerm_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_WarrantsAndRightsOutstandingTerm_lbl" xml:lang="en-US">Warrants exercise price term</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AdditionalPaidInCapital" xlink:to="us-gaap_AdditionalPaidInCapital_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_AdditionalPaidInCapital_2_lbl" xml:lang="en-US">Additional paid in capital</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueAdjustmentOfWarrants" xlink:to="us-gaap_FairValueAdjustmentOfWarrants_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_FairValueAdjustmentOfWarrants_2_lbl" xml:lang="en-US">Fair value adjustment of warrants</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_WarrantsAndRightsOutstanding" xlink:label="us-gaap_WarrantsAndRightsOutstanding" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_WarrantsAndRightsOutstanding" xlink:to="us-gaap_WarrantsAndRightsOutstanding_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_WarrantsAndRightsOutstanding_lbl" xml:lang="en-US">Nominal cost of warrant</link:label>
      <link:loc xlink:type="locator" xlink:href="stss-20240930.xsd#STSS_NetProceedsFromIssuanceInitialPublicOffering" xlink:label="STSS_NetProceedsFromIssuanceInitialPublicOffering" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="STSS_NetProceedsFromIssuanceInitialPublicOffering" xlink:to="STSS_NetProceedsFromIssuanceInitialPublicOffering_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="STSS_NetProceedsFromIssuanceInitialPublicOffering_lbl" xml:lang="en-US">Net proceeds from offering</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NoninterestExpenseOfferingCost" xlink:label="us-gaap_NoninterestExpenseOfferingCost" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NoninterestExpenseOfferingCost" xlink:to="us-gaap_NoninterestExpenseOfferingCost_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NoninterestExpenseOfferingCost_lbl" xml:lang="en-US">Offering expenses</link:label>
      <link:loc xlink:type="locator" xlink:href="stss-20240930.xsd#STSS_ClassOfWarrantOrRightExercisePriceOfWarrantsAdjusted" xlink:label="STSS_ClassOfWarrantOrRightExercisePriceOfWarrantsAdjusted" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="STSS_ClassOfWarrantOrRightExercisePriceOfWarrantsAdjusted" xlink:to="STSS_ClassOfWarrantOrRightExercisePriceOfWarrantsAdjusted_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="STSS_ClassOfWarrantOrRightExercisePriceOfWarrantsAdjusted_lbl" xml:lang="en-US">Warrant exerice price</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="STSS_StockIssuedDuringPeriodSharesInitialPublicOffering" xlink:to="STSS_StockIssuedDuringPeriodSharesInitialPublicOffering_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="STSS_StockIssuedDuringPeriodSharesInitialPublicOffering_2_lbl" xml:lang="en-US">Initial public offering</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfWarrantOrRightOutstanding" xlink:label="us-gaap_ClassOfWarrantOrRightOutstanding" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ClassOfWarrantOrRightOutstanding" xlink:to="us-gaap_ClassOfWarrantOrRightOutstanding_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ClassOfWarrantOrRightOutstanding_lbl" xml:lang="en-US">Warrants issued</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodSharesIssuedForServices" xlink:to="us-gaap_StockIssuedDuringPeriodSharesIssuedForServices_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_StockIssuedDuringPeriodSharesIssuedForServices_2_lbl" xml:lang="en-US">Common stock issued for services, shares</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodValueIssuedForServices" xlink:to="us-gaap_StockIssuedDuringPeriodValueIssuedForServices_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_StockIssuedDuringPeriodValueIssuedForServices_2_lbl" xml:lang="en-US">Common stock issued for services, value</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_lbl" xml:lang="en-US">Expected term</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum_lbl" xml:lang="en-US">Volatility, minimum</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum_lbl" xml:lang="en-US">Volatility, maximum</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum_lbl" xml:lang="en-US">Risk free interest rate, minimum</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum_lbl" xml:lang="en-US">Risk free interest rate, maximum</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_lbl" xml:lang="en-US">Dividend rate</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_MarketRiskBenefitChangeInFairValueGainLoss" xlink:label="us-gaap_MarketRiskBenefitChangeInFairValueGainLoss" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_MarketRiskBenefitChangeInFairValueGainLoss" xlink:to="us-gaap_MarketRiskBenefitChangeInFairValueGainLoss_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_MarketRiskBenefitChangeInFairValueGainLoss_lbl" xml:lang="en-US">Fair market value adjustment</link:label>
      <link:loc xlink:type="locator" xlink:href="stss-20240930.xsd#STSS_PaymentsForRepurchaseOfLiability" xlink:label="STSS_PaymentsForRepurchaseOfLiability" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="STSS_PaymentsForRepurchaseOfLiability" xlink:to="STSS_PaymentsForRepurchaseOfLiability_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="STSS_PaymentsForRepurchaseOfLiability_lbl" xml:lang="en-US">Warrant outstanding</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PaymentsOfStockIssuanceCosts" xlink:label="us-gaap_PaymentsOfStockIssuanceCosts" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PaymentsOfStockIssuanceCosts" xlink:to="us-gaap_PaymentsOfStockIssuanceCosts_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PaymentsOfStockIssuanceCosts_lbl" xml:lang="en-US">Nominal cost</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate_lbl" xml:lang="en-US">Volatility</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_lbl" xml:lang="en-US">Risk free interest rate</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodSharesOther" xlink:to="us-gaap_StockIssuedDuringPeriodSharesOther_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_StockIssuedDuringPeriodSharesOther_2_lbl" xml:lang="en-US">Issued shares of common stock</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction" xlink:label="us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction" xlink:to="us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction_lbl" xml:lang="en-US">Number of units sold</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SaleOfStockPricePerShare" xlink:label="us-gaap_SaleOfStockPricePerShare" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SaleOfStockPricePerShare" xlink:to="us-gaap_SaleOfStockPricePerShare_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SaleOfStockPricePerShare_lbl" xml:lang="en-US">Shares price pre reverse</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" xlink:label="us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" xlink:to="us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_lbl" xml:lang="en-US">Warrants exercised shares pre reverse</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ProceedsFromIssuanceOfWarrants" xlink:label="us-gaap_ProceedsFromIssuanceOfWarrants" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProceedsFromIssuanceOfWarrants" xlink:to="us-gaap_ProceedsFromIssuanceOfWarrants_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ProceedsFromIssuanceOfWarrants_lbl" xml:lang="en-US">Proceeds from Issuance of Warrants</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ProceedsFromIssuanceOrSaleOfEquity" xlink:label="us-gaap_ProceedsFromIssuanceOrSaleOfEquity" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProceedsFromIssuanceOrSaleOfEquity" xlink:to="us-gaap_ProceedsFromIssuanceOrSaleOfEquity_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_ProceedsFromIssuanceOrSaleOfEquity_lbl" xml:lang="en-US">Net proceeds from offering</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SaleOfStockDescriptionOfTransaction" xlink:label="us-gaap_SaleOfStockDescriptionOfTransaction" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SaleOfStockDescriptionOfTransaction" xlink:to="us-gaap_SaleOfStockDescriptionOfTransaction_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SaleOfStockDescriptionOfTransaction_lbl" xml:lang="en-US">Units description</link:label>
      <link:loc xlink:type="locator" xlink:href="stss-20240930.xsd#STSS_DescriptionForOfferingShares" xlink:label="STSS_DescriptionForOfferingShares" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="STSS_DescriptionForOfferingShares" xlink:to="STSS_DescriptionForOfferingShares_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="STSS_DescriptionForOfferingShares_lbl" xml:lang="en-US">Description for offering shares</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised_lbl" xml:lang="en-US">Warrants exercised</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="STSS_WarrantLiabilitiesCurrent" xlink:to="STSS_WarrantLiabilitiesCurrent_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="STSS_WarrantLiabilitiesCurrent_2_lbl" xml:lang="en-US">Warrants liability</link:label>
      <link:loc xlink:type="locator" xlink:href="stss-20240930.xsd#STSS_FairValueAdjustmentOfModificationCharge" xlink:label="STSS_FairValueAdjustmentOfModificationCharge" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="STSS_FairValueAdjustmentOfModificationCharge" xlink:to="STSS_FairValueAdjustmentOfModificationCharge_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="STSS_FairValueAdjustmentOfModificationCharge_lbl" xml:lang="en-US">Fair value adjustment of modification charge</link:label>
      <link:loc xlink:type="locator" xlink:href="stss-20240930.xsd#STSS_ClassOfWarrantOrRightIssued" xlink:label="STSS_ClassOfWarrantOrRightIssued" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="STSS_ClassOfWarrantOrRightIssued" xlink:to="STSS_ClassOfWarrantOrRightIssued_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="STSS_ClassOfWarrantOrRightIssued_lbl" xml:lang="en-US">Aggregate warrants issued</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfStockByClassTable" xlink:label="us-gaap_ScheduleOfStockByClassTable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfStockByClassTable" xlink:to="us-gaap_ScheduleOfStockByClassTable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfStockByClassTable_lbl" xml:lang="en-US">Stock, Class of Stock [Table]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfStockLineItems" xlink:label="us-gaap_ClassOfStockLineItems" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ClassOfStockLineItems" xlink:to="us-gaap_ClassOfStockLineItems_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ClassOfStockLineItems_lbl" xml:lang="en-US">Class of Stock [Line Items]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EquityMethodInvestmentOwnershipPercentage" xlink:label="us-gaap_EquityMethodInvestmentOwnershipPercentage" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EquityMethodInvestmentOwnershipPercentage" xlink:to="us-gaap_EquityMethodInvestmentOwnershipPercentage_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_EquityMethodInvestmentOwnershipPercentage_lbl" xml:lang="en-US">Ownership interest percentage</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PreferredStockVotingRights" xlink:label="us-gaap_PreferredStockVotingRights" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PreferredStockVotingRights" xlink:to="us-gaap_PreferredStockVotingRights_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PreferredStockVotingRights_lbl" xml:lang="en-US">Preferred stock, voting rights</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_2_lbl" xml:lang="en-US">Expected term (in years)</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_lbl" xml:lang="en-US">Expected volatility</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_2_lbl" xml:lang="en-US">Risk-free interest rate</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_2_lbl" xml:lang="en-US">Risk-free interest rate</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_WarrantsAndRightsOutstandingTerm" xlink:to="us-gaap_WarrantsAndRightsOutstandingTerm_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_WarrantsAndRightsOutstandingTerm_2_lbl" xml:lang="en-US">Expected term (in years)</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_WarrantsAndRightsOutstandingMeasurementInput" xlink:label="us-gaap_WarrantsAndRightsOutstandingMeasurementInput" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_WarrantsAndRightsOutstandingMeasurementInput" xlink:to="us-gaap_WarrantsAndRightsOutstandingMeasurementInput_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_WarrantsAndRightsOutstandingMeasurementInput_lbl" xml:lang="en-US">Warrants liabilities measurement input</link:label>
      <link:loc xlink:type="locator" xlink:href="stss-20240930.xsd#STSS_WarrantLiability" xlink:label="STSS_WarrantLiability" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="STSS_WarrantLiability" xlink:to="STSS_WarrantLiability_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="STSS_WarrantLiability_lbl" xml:lang="en-US">Total Warrant Liability</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="STSS_WarrantLiabilitiesCurrent" xlink:to="STSS_WarrantLiabilitiesCurrent_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="STSS_WarrantLiabilitiesCurrent_3_lbl" xml:lang="en-US">Total Warrant Liability</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ClassOfWarrantOrRightOutstanding" xlink:to="us-gaap_ClassOfWarrantOrRightOutstanding_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_ClassOfWarrantOrRightOutstanding_2_lbl" xml:lang="en-US">Warrants issued for services arrangement</link:label>
      <link:loc xlink:type="locator" xlink:href="stss-20240930.xsd#STSS_ClassOfWarrantsOrRightOutstanding" xlink:label="STSS_ClassOfWarrantsOrRightOutstanding" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="STSS_ClassOfWarrantsOrRightOutstanding" xlink:to="STSS_ClassOfWarrantsOrRightOutstanding_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="STSS_ClassOfWarrantsOrRightOutstanding_lbl" xml:lang="en-US">Total Warrants Outstanding</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_GainLossOnSaleOfDerivatives" xlink:to="us-gaap_GainLossOnSaleOfDerivatives_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_GainLossOnSaleOfDerivatives_3_lbl" xml:lang="en-US">Fair market value adjustment</link:label>
      <link:loc xlink:type="locator" xlink:href="stss-20240930.xsd#STSS_GainLossOnSaleOfDerivative" xlink:label="STSS_GainLossOnSaleOfDerivative" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="STSS_GainLossOnSaleOfDerivative" xlink:to="STSS_GainLossOnSaleOfDerivative_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="STSS_GainLossOnSaleOfDerivative_lbl" xml:lang="en-US">Fair market value adjustment</link:label>
      <link:loc xlink:type="locator" xlink:href="stss-20240930.xsd#STSS_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionOutstandingNumber" xlink:label="STSS_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionOutstandingNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="STSS_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionOutstandingNumber" xlink:to="STSS_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionOutstandingNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:label="STSS_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionOutstandingNumber_lbl" xml:lang="en-US">Stock option, beginning balance</link:label>
      <link:loc xlink:type="locator" xlink:href="stss-20240930.xsd#STSS_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionOutstandingWeightedAverageExercisePrice" xlink:label="STSS_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionOutstandingWeightedAverageExercisePrice" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="STSS_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionOutstandingWeightedAverageExercisePrice" xlink:to="STSS_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionOutstandingWeightedAverageExercisePrice_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:label="STSS_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionOutstandingWeightedAverageExercisePrice_lbl" xml:lang="en-US">Weighted average exercise price, beginning balance</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_lbl" xml:lang="en-US">Stock option, beginning balance</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_lbl" xml:lang="en-US">Weighted average exercise price, beginning balance</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_lbl" xml:lang="en-US">Shares, options granted</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_lbl" xml:lang="en-US">Weighted average exercise price, options granted</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod_lbl" xml:lang="en-US">Shares, options cancelled</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice_2_lbl" xml:lang="en-US">Weighted average exercise price, options cancelled</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedNumberOfShares" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedNumberOfShares" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedNumberOfShares" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedNumberOfShares_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedNumberOfShares_lbl" xml:lang="en-US">Shares, options forfeited</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice_lbl" xml:lang="en-US">Weighted average exercise price, forfeited or cancelled</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_lbl" xml:lang="en-US">Shares, options forfeited</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice_2_lbl" xml:lang="en-US">Weighted average exercise price, options forfeited</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="STSS_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionOutstandingNumber" xlink:to="STSS_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionOutstandingNumber_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="STSS_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionOutstandingNumber_2_lbl" xml:lang="en-US">Stock option, ending balance</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="STSS_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionOutstandingWeightedAverageExercisePrice" xlink:to="STSS_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionOutstandingWeightedAverageExercisePrice_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="STSS_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionOutstandingWeightedAverageExercisePrice_2_lbl" xml:lang="en-US">Weighted average exercise price, ending balance</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_2_lbl" xml:lang="en-US">Stock option, ending balance</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_2_lbl" xml:lang="en-US">Weighted average exercise price, ending balance</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_lbl" xml:lang="en-US">Stock option, exercisable ending balance</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_lbl" xml:lang="en-US">Weighted average exercise price, exercisable ending balance</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTable" xlink:label="us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTable" xlink:to="us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTable_lbl" xml:lang="en-US">Share-Based Payment Arrangement, Option, Exercise Price Range [Table]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems" xlink:label="us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems" xlink:to="us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems_lbl" xml:lang="en-US">Share-Based Payment Arrangement, Option, Exercise Price Range [Line Items]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit" xlink:label="us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit" xlink:to="us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit_lbl" xml:lang="en-US">Stock option, exercise price</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions" xlink:label="us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions" xlink:to="us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions_lbl" xml:lang="en-US">Options, shares outstanding</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_lbl" xml:lang="en-US">Stock option, aggregate intrinsic value</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2" xlink:label="us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2" xlink:to="us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2_lbl" xml:lang="en-US">Stock option, weighted average remaining contractual life</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions" xlink:label="us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions" xlink:to="us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions_lbl" xml:lang="en-US">Options, shares exercisable</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1_lbl" xml:lang="en-US">Stock option, aggregate intrinsic value on exercisable shares</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_3_lbl" xml:lang="en-US">Expected term (years)</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate_2_lbl" xml:lang="en-US">Expected volatility</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_lbl" xml:lang="en-US">Stock available for issuance</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod_lbl" xml:lang="en-US">Number of stock issuance</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation" xlink:label="us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation" xlink:to="us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation_lbl" xml:lang="en-US">Purchase of shares</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockParOrStatedValuePerShare" xlink:to="us-gaap_CommonStockParOrStatedValuePerShare_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_CommonStockParOrStatedValuePerShare_2_lbl" xml:lang="en-US">Common stock par value</link:label>
      <link:loc xlink:type="locator" xlink:href="stss-20240930.xsd#STSS_ShareBasedCompensationOptionsExercisableWeightedAverageExercisePrice" xlink:label="STSS_ShareBasedCompensationOptionsExercisableWeightedAverageExercisePrice" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="STSS_ShareBasedCompensationOptionsExercisableWeightedAverageExercisePrice" xlink:to="STSS_ShareBasedCompensationOptionsExercisableWeightedAverageExercisePrice_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="STSS_ShareBasedCompensationOptionsExercisableWeightedAverageExercisePrice_lbl" xml:lang="en-US">Options exercisable</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_2_lbl" xml:lang="en-US">Granted shares</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_3_lbl" xml:lang="en-US">Options outstanding</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_lbl" xml:lang="en-US">Weighted-average grant-date fair value of options granted</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized" xlink:label="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized" xlink:to="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized_lbl" xml:lang="en-US">Unrecognized stock-based compensation</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue_lbl" xml:lang="en-US">Unvested stock options weighted average fair value</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AllocatedShareBasedCompensationExpense" xlink:label="us-gaap_AllocatedShareBasedCompensationExpense" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AllocatedShareBasedCompensationExpense" xlink:to="us-gaap_AllocatedShareBasedCompensationExpense_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AllocatedShareBasedCompensationExpense_lbl" xml:lang="en-US">Share based compensation</link:label>
      <link:loc xlink:type="locator" xlink:href="stss-20240930.xsd#STSS_StockBasedChargesRelatingToPurchaseOfMachinery" xlink:label="STSS_StockBasedChargesRelatingToPurchaseOfMachinery" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="STSS_StockBasedChargesRelatingToPurchaseOfMachinery" xlink:to="STSS_StockBasedChargesRelatingToPurchaseOfMachinery_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="STSS_StockBasedChargesRelatingToPurchaseOfMachinery_lbl" xml:lang="en-US">Stock based charges relating to purchase of machinery</link:label>
      <link:loc xlink:type="locator" xlink:href="stss-20240930.xsd#STSS_StockBasedChargesRelatingToAcquisition" xlink:label="STSS_StockBasedChargesRelatingToAcquisition" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="STSS_StockBasedChargesRelatingToAcquisition" xlink:to="STSS_StockBasedChargesRelatingToAcquisition_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="STSS_StockBasedChargesRelatingToAcquisition_lbl" xml:lang="en-US">Stock based charges relating to acquisition</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_lbl" xml:lang="en-US">Weighted average remaining contractual life</link:label>
      <link:loc xlink:type="locator" xlink:href="stss-20240930.xsd#STSS_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantedInYear" xlink:label="STSS_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantedInYear" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="STSS_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantedInYear" xlink:to="STSS_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantedInYear_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="STSS_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantedInYear_lbl" xml:lang="en-US">Granted options</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" xlink:label="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" xlink:to="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_lbl" xml:lang="en-US">Recognized over a weighted-average period</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate" xlink:label="us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate" xlink:to="us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate_lbl" xml:lang="en-US">Expected benefit at statutory federal tax rate</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeTaxReconciliationChangeInEnactedTaxRate" xlink:label="us-gaap_IncomeTaxReconciliationChangeInEnactedTaxRate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeTaxReconciliationChangeInEnactedTaxRate" xlink:to="us-gaap_IncomeTaxReconciliationChangeInEnactedTaxRate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncomeTaxReconciliationChangeInEnactedTaxRate_lbl" xml:lang="en-US">Permanent differences &#8211; net</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes" xlink:label="us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes" xlink:to="us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes_lbl" xml:lang="en-US">State and local taxes, net of federal tax benefit</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeTaxReconciliationOtherAdjustments" xlink:label="us-gaap_IncomeTaxReconciliationOtherAdjustments" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeTaxReconciliationOtherAdjustments" xlink:to="us-gaap_IncomeTaxReconciliationOtherAdjustments_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncomeTaxReconciliationOtherAdjustments_lbl" xml:lang="en-US">Other</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance" xlink:label="us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance" xlink:to="us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance_lbl" xml:lang="en-US">Change in valuation allowance</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeTaxExpenseBenefit" xlink:label="us-gaap_IncomeTaxExpenseBenefit" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeTaxExpenseBenefit" xlink:to="us-gaap_IncomeTaxExpenseBenefit_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_IncomeTaxExpenseBenefit_lbl" xml:lang="en-US">Income tax expense (benefit)</link:label>
      <link:loc xlink:type="locator" xlink:href="stss-20240930.xsd#STSS_DeferredTaxAssetsPropertyPlantAndEquipments" xlink:label="STSS_DeferredTaxAssetsPropertyPlantAndEquipments" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="STSS_DeferredTaxAssetsPropertyPlantAndEquipments" xlink:to="STSS_DeferredTaxAssetsPropertyPlantAndEquipments_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="STSS_DeferredTaxAssetsPropertyPlantAndEquipments_lbl" xml:lang="en-US">Fixed assets</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredTaxAssetInterestCarryforward" xlink:label="us-gaap_DeferredTaxAssetInterestCarryforward" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxAssetInterestCarryforward" xlink:to="us-gaap_DeferredTaxAssetInterestCarryforward_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DeferredTaxAssetInterestCarryforward_lbl" xml:lang="en-US">Interest</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredTaxAssetsInProcessResearchAndDevelopment" xlink:label="us-gaap_DeferredTaxAssetsInProcessResearchAndDevelopment" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxAssetsInProcessResearchAndDevelopment" xlink:to="us-gaap_DeferredTaxAssetsInProcessResearchAndDevelopment_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DeferredTaxAssetsInProcessResearchAndDevelopment_lbl" xml:lang="en-US">Research and development expenses</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost" xlink:label="us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost" xlink:to="us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost_lbl" xml:lang="en-US">Stock-based compensation</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredTaxAssetsCharitableContributionCarryforwards" xlink:label="us-gaap_DeferredTaxAssetsCharitableContributionCarryforwards" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxAssetsCharitableContributionCarryforwards" xlink:to="us-gaap_DeferredTaxAssetsCharitableContributionCarryforwards_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DeferredTaxAssetsCharitableContributionCarryforwards_lbl" xml:lang="en-US">Charitable Contributions</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsDomestic" xlink:label="us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsDomestic" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsDomestic" xlink:to="us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsDomestic_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsDomestic_lbl" xml:lang="en-US">Net operating losses - federal</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsStateAndLocal" xlink:label="us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsStateAndLocal" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsStateAndLocal" xlink:to="us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsStateAndLocal_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsStateAndLocal_lbl" xml:lang="en-US">Net operating losses &#8211; state and local</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsForeign" xlink:label="us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsForeign" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsForeign" xlink:to="us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsForeign_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsForeign_lbl" xml:lang="en-US">Net operating losses - foreign</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsResearch" xlink:label="us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsResearch" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsResearch" xlink:to="us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsResearch_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsResearch_lbl" xml:lang="en-US">Research credit</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredTaxAssetsValuationAllowance" xlink:label="us-gaap_DeferredTaxAssetsValuationAllowance" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxAssetsValuationAllowance" xlink:to="us-gaap_DeferredTaxAssetsValuationAllowance_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_DeferredTaxAssetsValuationAllowance_lbl" xml:lang="en-US">Less valuation allowance</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredTaxLiabilities" xlink:label="us-gaap_DeferredTaxLiabilities" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxLiabilities" xlink:to="us-gaap_DeferredTaxLiabilities_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedTotalLabel" xlink:label="us-gaap_DeferredTaxLiabilities_lbl" xml:lang="en-US">Net deferred tax liability</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic" xlink:label="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic" xlink:to="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic_lbl" xml:lang="en-US">United Stated Operations</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign" xlink:label="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign" xlink:to="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign_lbl" xml:lang="en-US">International Operations</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationTable" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationTable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EffectiveIncomeTaxRateReconciliationTable" xlink:to="us-gaap_EffectiveIncomeTaxRateReconciliationTable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationTable_lbl" xml:lang="en-US">Effective Income Tax Rate Reconciliation [Table]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationLineItems" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationLineItems" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EffectiveIncomeTaxRateReconciliationLineItems" xlink:to="us-gaap_EffectiveIncomeTaxRateReconciliationLineItems_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationLineItems_lbl" xml:lang="en-US">Effective Income Tax Rate Reconciliation [Line Items]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:label="us-gaap_EffectiveIncomeTaxRateContinuingOperations" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:to="us-gaap_EffectiveIncomeTaxRateContinuingOperations_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_EffectiveIncomeTaxRateContinuingOperations_lbl" xml:lang="en-US">Effective income tax rate percentage</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingLossCarryforwards" xlink:label="us-gaap_OperatingLossCarryforwards" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingLossCarryforwards" xlink:to="us-gaap_OperatingLossCarryforwards_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OperatingLossCarryforwards_lbl" xml:lang="en-US">Net operating loss carryforwards</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent" xlink:label="us-gaap_AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent" xlink:to="us-gaap_AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent_lbl" xml:lang="en-US">Accounts payable and accrued liabilities</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:label="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:to="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_lbl" xml:lang="en-US">Fair Value, Recurring and Nonrecurring [Table]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:label="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:to="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_lbl" xml:lang="en-US">Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FinancialInstrumentsFinancialAssetsBalanceSheetGroupingsAbstract" xlink:label="us-gaap_FinancialInstrumentsFinancialAssetsBalanceSheetGroupingsAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FinancialInstrumentsFinancialAssetsBalanceSheetGroupingsAbstract" xlink:to="us-gaap_FinancialInstrumentsFinancialAssetsBalanceSheetGroupingsAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FinancialInstrumentsFinancialAssetsBalanceSheetGroupingsAbstract_lbl" xml:lang="en-US">Assets</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CashAndCashEquivalentsFairValueDisclosure" xlink:label="us-gaap_CashAndCashEquivalentsFairValueDisclosure" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashAndCashEquivalentsFairValueDisclosure" xlink:to="us-gaap_CashAndCashEquivalentsFairValueDisclosure_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_CashAndCashEquivalentsFairValueDisclosure_lbl" xml:lang="en-US">Cash</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AssetsFairValueDisclosure" xlink:label="us-gaap_AssetsFairValueDisclosure" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AssetsFairValueDisclosure" xlink:to="us-gaap_AssetsFairValueDisclosure_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AssetsFairValueDisclosure_lbl" xml:lang="en-US">Total assets measured at fair value</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FinancialInstrumentsFinancialLiabilitiesBalanceSheetGroupingsAbstract" xlink:label="us-gaap_FinancialInstrumentsFinancialLiabilitiesBalanceSheetGroupingsAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FinancialInstrumentsFinancialLiabilitiesBalanceSheetGroupingsAbstract" xlink:to="us-gaap_FinancialInstrumentsFinancialLiabilitiesBalanceSheetGroupingsAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FinancialInstrumentsFinancialLiabilitiesBalanceSheetGroupingsAbstract_lbl" xml:lang="en-US">Liabilities</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="STSS_WarrantLiability" xlink:to="STSS_WarrantLiability_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="STSS_WarrantLiability_2_lbl" xml:lang="en-US">Warrant liability</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LiabilitiesFairValueDisclosure" xlink:label="us-gaap_LiabilitiesFairValueDisclosure" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LiabilitiesFairValueDisclosure" xlink:to="us-gaap_LiabilitiesFairValueDisclosure_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LiabilitiesFairValueDisclosure_lbl" xml:lang="en-US">Total liabilities measured at fair value</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AssetsFairValueDisclosureAbstract" xlink:label="us-gaap_AssetsFairValueDisclosureAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AssetsFairValueDisclosureAbstract" xlink:to="us-gaap_AssetsFairValueDisclosureAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_AssetsFairValueDisclosureAbstract_lbl" xml:lang="en-US">Assets</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LiabilitiesFairValueDisclosureAbstract" xlink:label="us-gaap_LiabilitiesFairValueDisclosureAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LiabilitiesFairValueDisclosureAbstract" xlink:to="us-gaap_LiabilitiesFairValueDisclosureAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_LiabilitiesFairValueDisclosureAbstract_lbl" xml:lang="en-US">Liabilities</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DerivativeLiabilities" xlink:label="us-gaap_DerivativeLiabilities" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DerivativeLiabilities" xlink:to="us-gaap_DerivativeLiabilities_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DerivativeLiabilities_lbl" xml:lang="en-US">Warrant liability</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LossContingenciesTable" xlink:label="us-gaap_LossContingenciesTable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LossContingenciesTable" xlink:to="us-gaap_LossContingenciesTable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LossContingenciesTable_lbl" xml:lang="en-US">Loss Contingencies [Table]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LossContingenciesLineItems" xlink:label="us-gaap_LossContingenciesLineItems" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LossContingenciesLineItems" xlink:to="us-gaap_LossContingenciesLineItems_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LossContingenciesLineItems_lbl" xml:lang="en-US">Loss Contingencies [Line Items]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccountsPayableCurrentAndNoncurrent" xlink:label="us-gaap_AccountsPayableCurrentAndNoncurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccountsPayableCurrentAndNoncurrent" xlink:to="us-gaap_AccountsPayableCurrentAndNoncurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_AccountsPayableCurrentAndNoncurrent_lbl" xml:lang="en-US">Accounts payable</link:label>
      <link:loc xlink:type="locator" xlink:href="stss-20240930.xsd#STSS_OrderCostsToPurchaseEquipmentMoldsAndComponentPartsForResearchAndDevelopment" xlink:label="STSS_OrderCostsToPurchaseEquipmentMoldsAndComponentPartsForResearchAndDevelopment" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="STSS_OrderCostsToPurchaseEquipmentMoldsAndComponentPartsForResearchAndDevelopment" xlink:to="STSS_OrderCostsToPurchaseEquipmentMoldsAndComponentPartsForResearchAndDevelopment_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="STSS_OrderCostsToPurchaseEquipmentMoldsAndComponentPartsForResearchAndDevelopment_lbl" xml:lang="en-US">Total order costs to purchase equipment, molds and component parts for research and development</link:label>
      <link:loc xlink:type="locator" xlink:href="stss-20240930.xsd#STSS_ProgressPayments" xlink:label="STSS_ProgressPayments" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="STSS_ProgressPayments" xlink:to="STSS_ProgressPayments_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="STSS_ProgressPayments_lbl" xml:lang="en-US">Progress payments</link:label>
      <link:loc xlink:type="locator" xlink:href="stss-20240930.xsd#STSS_RoyaltyPercentage" xlink:label="STSS_RoyaltyPercentage" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="STSS_RoyaltyPercentage" xlink:to="STSS_RoyaltyPercentage_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="STSS_RoyaltyPercentage_lbl" xml:lang="en-US">Royalty percentage</link:label>
      <link:loc xlink:type="locator" xlink:href="stss-20240930.xsd#STSS_SinglePaymentObligation" xlink:label="STSS_SinglePaymentObligation" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="STSS_SinglePaymentObligation" xlink:to="STSS_SinglePaymentObligation_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="STSS_SinglePaymentObligation_lbl" xml:lang="en-US">Single payment obligation</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SalariesAndWages" xlink:label="us-gaap_SalariesAndWages" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SalariesAndWages" xlink:to="us-gaap_SalariesAndWages_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SalariesAndWages_lbl" xml:lang="en-US">Salaries and wages</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccruedBonusesCurrentAndNoncurrent" xlink:label="us-gaap_AccruedBonusesCurrentAndNoncurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccruedBonusesCurrentAndNoncurrent" xlink:to="us-gaap_AccruedBonusesCurrentAndNoncurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AccruedBonusesCurrentAndNoncurrent_lbl" xml:lang="en-US">Accrued bonus</link:label>
      <link:loc xlink:type="locator" xlink:href="stss-20240930.xsd#STSS_PaymentForBonuses" xlink:label="STSS_PaymentForBonuses" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="STSS_PaymentForBonuses" xlink:to="STSS_PaymentForBonuses_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="STSS_PaymentForBonuses_lbl" xml:lang="en-US">Payment for bonuses</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SeveranceCosts1" xlink:label="us-gaap_SeveranceCosts1" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SeveranceCosts1" xlink:to="us-gaap_SeveranceCosts1_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SeveranceCosts1_lbl" xml:lang="en-US">Severance costs</link:label>
      <link:loc xlink:type="locator" xlink:href="stss-20240930.xsd#STSS_MedicalBenefitsCost" xlink:label="STSS_MedicalBenefitsCost" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="STSS_MedicalBenefitsCost" xlink:to="STSS_MedicalBenefitsCost_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="STSS_MedicalBenefitsCost_lbl" xml:lang="en-US">Medical benefit cost</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue_lbl" xml:lang="en-US">Fully vested</link:label>
      <link:loc xlink:type="locator" xlink:href="stss-20240930.xsd#STSS_AnnualCompensation" xlink:label="STSS_AnnualCompensation" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="STSS_AnnualCompensation" xlink:to="STSS_AnnualCompensation_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="STSS_AnnualCompensation_lbl" xml:lang="en-US">Annual compensation</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PaymentForIncentiveFee" xlink:label="us-gaap_PaymentForIncentiveFee" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PaymentForIncentiveFee" xlink:to="us-gaap_PaymentForIncentiveFee_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PaymentForIncentiveFee_lbl" xml:lang="en-US">Payment for incentive fee</link:label>
      <link:loc xlink:type="locator" xlink:href="stss-20240930.xsd#STSS_InitialFee" xlink:label="STSS_InitialFee" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="STSS_InitialFee" xlink:to="STSS_InitialFee_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="STSS_InitialFee_lbl" xml:lang="en-US">Initial fee</link:label>
      <link:loc xlink:type="locator" xlink:href="stss-20240930.xsd#STSS_MonthlyFee" xlink:label="STSS_MonthlyFee" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="STSS_MonthlyFee" xlink:to="STSS_MonthlyFee_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="STSS_MonthlyFee_lbl" xml:lang="en-US">Monthly fee</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures" xlink:label="us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures" xlink:to="us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures_lbl" xml:lang="en-US">Shares of restricted common stock</link:label>
      <link:loc xlink:type="locator" xlink:href="stss-20240930.xsd#STSS_ValueOfDigitalMarketingActivities" xlink:label="STSS_ValueOfDigitalMarketingActivities" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="STSS_ValueOfDigitalMarketingActivities" xlink:to="STSS_ValueOfDigitalMarketingActivities_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="STSS_ValueOfDigitalMarketingActivities_lbl" xml:lang="en-US">Value of digital marketing activities</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures" xlink:label="us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures" xlink:to="us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures_lbl" xml:lang="en-US">Value of restricted common stock</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EmployeeBenefitsAndShareBasedCompensation" xlink:label="us-gaap_EmployeeBenefitsAndShareBasedCompensation" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EmployeeBenefitsAndShareBasedCompensation" xlink:to="us-gaap_EmployeeBenefitsAndShareBasedCompensation_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_EmployeeBenefitsAndShareBasedCompensation_lbl" xml:lang="en-US">Compensation cost</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation" xlink:to="us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation_2_lbl" xml:lang="en-US">Options to purchase shares</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1" xlink:label="us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1" xlink:to="us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1_lbl" xml:lang="en-US">Stock option, exercise price</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LossContingencyDamagesSoughtValue" xlink:label="us-gaap_LossContingencyDamagesSoughtValue" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LossContingencyDamagesSoughtValue" xlink:to="us-gaap_LossContingencyDamagesSoughtValue_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LossContingencyDamagesSoughtValue_lbl" xml:lang="en-US">Loss contingency, claims for damages</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LossContingencyDamagesSought" xlink:label="us-gaap_LossContingencyDamagesSought" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LossContingencyDamagesSought" xlink:to="us-gaap_LossContingencyDamagesSought_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LossContingencyDamagesSought_lbl" xml:lang="en-US">Description of loss contingency</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensation" xlink:to="us-gaap_ShareBasedCompensation_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_ShareBasedCompensation_2_lbl" xml:lang="en-US">Share based compensation</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PaymentsToAcquireProductiveAssets" xlink:label="us-gaap_PaymentsToAcquireProductiveAssets" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PaymentsToAcquireProductiveAssets" xlink:to="us-gaap_PaymentsToAcquireProductiveAssets_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PaymentsToAcquireProductiveAssets_lbl" xml:lang="en-US">Payments to acquire assets</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EscrowDeposit" xlink:to="us-gaap_EscrowDeposit_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_EscrowDeposit_2_lbl" xml:lang="en-US">Escrow deposit</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EscrowDepositDisbursementsRelatedToPropertyAcquisition1" xlink:label="us-gaap_EscrowDepositDisbursementsRelatedToPropertyAcquisition1" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EscrowDepositDisbursementsRelatedToPropertyAcquisition1" xlink:to="us-gaap_EscrowDepositDisbursementsRelatedToPropertyAcquisition1_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_EscrowDepositDisbursementsRelatedToPropertyAcquisition1_lbl" xml:lang="en-US">Escrow deposit disbursements related to property acquisition</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PropertyPlantAndEquipmentGross" xlink:to="us-gaap_PropertyPlantAndEquipmentGross_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_PropertyPlantAndEquipmentGross_2_lbl" xml:lang="en-US">Total Fixed Assets</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfRestructuringAndRelatedCostsTable" xlink:label="us-gaap_ScheduleOfRestructuringAndRelatedCostsTable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfRestructuringAndRelatedCostsTable" xlink:to="us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_lbl" xml:lang="en-US">Restructuring Cost [Table]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RestructuringCostAndReserveLineItems" xlink:label="us-gaap_RestructuringCostAndReserveLineItems" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RestructuringCostAndReserveLineItems" xlink:to="us-gaap_RestructuringCostAndReserveLineItems_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_RestructuringCostAndReserveLineItems_lbl" xml:lang="en-US">Restructuring Cost and Reserve [Line Items]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment" xlink:label="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment" xlink:to="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment_lbl" xml:lang="en-US">Building and affixed assets</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubsequentEventTable" xlink:label="us-gaap_SubsequentEventTable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SubsequentEventTable" xlink:to="us-gaap_SubsequentEventTable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SubsequentEventTable_lbl" xml:lang="en-US">Subsequent Event [Table]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubsequentEventLineItems" xlink:label="us-gaap_SubsequentEventLineItems" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SubsequentEventLineItems" xlink:to="us-gaap_SubsequentEventLineItems_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SubsequentEventLineItems_lbl" xml:lang="en-US">Subsequent Event [Line Items]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight" xlink:to="us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight_2_lbl" xml:lang="en-US">Class of Warrant or Right, Number of Securities Called by Each Warrant or Right</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" xlink:to="us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_2_lbl" xml:lang="en-US">Class of Warrant or Right, Exercise Price of Warrants or Rights</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="STSS_WarrantLiabilitiesCurrent" xlink:to="STSS_WarrantLiabilitiesCurrent_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="STSS_WarrantLiabilitiesCurrent_doc" xml:lang="en-US">Warrant liabilities current.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="STSS_ForeignCurrencyAndNonOperatingIncomeExpenses" xlink:to="STSS_ForeignCurrencyAndNonOperatingIncomeExpenses_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="STSS_ForeignCurrencyAndNonOperatingIncomeExpenses_doc" xml:lang="en-US">Foreign currency and non operating income expenses.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="STSS_SafegardMedicalIncMember" xlink:to="STSS_SafegardMedicalIncMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="STSS_SafegardMedicalIncMember_doc" xml:lang="en-US">Safegard Medical, Inc [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="STSS_SharePurchaseAgreementMember" xlink:to="STSS_SharePurchaseAgreementMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="STSS_SharePurchaseAgreementMember_doc" xml:lang="en-US">Share Purchase Agreement [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="STSS_FairMarketValueOfCommonStock" xlink:to="STSS_FairMarketValueOfCommonStock_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="STSS_FairMarketValueOfCommonStock_doc" xml:lang="en-US">Fair market value of common stock.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="STSS_NonTradingWarrantsMember" xlink:to="STSS_NonTradingWarrantsMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="STSS_NonTradingWarrantsMember_doc" xml:lang="en-US">Non Trading Warrants [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="STSS_SecuritiesPurchaseAgreementMember" xlink:to="STSS_SecuritiesPurchaseAgreementMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="STSS_SecuritiesPurchaseAgreementMember_doc" xml:lang="en-US">Securities Purchase Agreement [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="STSS_SubscriptionAgreementsMember" xlink:to="STSS_SubscriptionAgreementsMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="STSS_SubscriptionAgreementsMember_doc" xml:lang="en-US">Subscription Agreements [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="STSS_InvestorsMember" xlink:to="STSS_InvestorsMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="STSS_InvestorsMember_doc" xml:lang="en-US">Investors [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="STSS_StockIssuedDuringPeriodValueExerciseOfPrefundedWarrants" xlink:to="STSS_StockIssuedDuringPeriodValueExerciseOfPrefundedWarrants_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="STSS_StockIssuedDuringPeriodValueExerciseOfPrefundedWarrants_doc" xml:lang="en-US">Stock issued during period value exercise of prefunded warrants.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="STSS_StockIssuedDuringPeriodSharesExerciseOfPrefundedWarrants" xlink:to="STSS_StockIssuedDuringPeriodSharesExerciseOfPrefundedWarrants_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="STSS_StockIssuedDuringPeriodSharesExerciseOfPrefundedWarrants_doc" xml:lang="en-US">Stock issued during period shares exercise of prefunded warrants.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="STSS_StockIssuedDuringPeriodValueExerciseOfPrefundedWarrant" xlink:to="STSS_StockIssuedDuringPeriodValueExerciseOfPrefundedWarrant_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="STSS_StockIssuedDuringPeriodValueExerciseOfPrefundedWarrant_doc" xml:lang="en-US">Stock issued during period value exercise of prefunded warrants.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="STSS_StockIssuedDuringPeriodValueRegistrationOffering" xlink:to="STSS_StockIssuedDuringPeriodValueRegistrationOffering_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="STSS_StockIssuedDuringPeriodValueRegistrationOffering_doc" xml:lang="en-US">Stock issued during period value registration offering.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="STSS_StockIssuedDuringPeriodSharesRegistrationOffering" xlink:to="STSS_StockIssuedDuringPeriodSharesRegistrationOffering_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="STSS_StockIssuedDuringPeriodSharesRegistrationOffering_doc" xml:lang="en-US">Stock issued during period shares registration offering.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="STSS_StockIssuedDuringPeriodValueWarrantInducements" xlink:to="STSS_StockIssuedDuringPeriodValueWarrantInducements_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="STSS_StockIssuedDuringPeriodValueWarrantInducements_doc" xml:lang="en-US">Stock issued during period value warrant inducements.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="STSS_StockIssuedDuringPeriodSharesWarrantInducements" xlink:to="STSS_StockIssuedDuringPeriodSharesWarrantInducements_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="STSS_StockIssuedDuringPeriodSharesWarrantInducements_doc" xml:lang="en-US">Stock issued during period shares warrant inducements.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="STSS_InducementAgreementMember" xlink:to="STSS_InducementAgreementMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="STSS_InducementAgreementMember_doc" xml:lang="en-US">Inducement Agreement [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="STSS_PreReverseMember" xlink:to="STSS_PreReverseMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="STSS_PreReverseMember_doc" xml:lang="en-US">Pre Reverse [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="STSS_StockIssuedDuringPeriodValueShelfRegistrationOffering" xlink:to="STSS_StockIssuedDuringPeriodValueShelfRegistrationOffering_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="STSS_StockIssuedDuringPeriodValueShelfRegistrationOffering_doc" xml:lang="en-US">Stock issued during period value shelf registration offering.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="STSS_StockIssuedDuringPeriodSharesShelfRegistrationOffering" xlink:to="STSS_StockIssuedDuringPeriodSharesShelfRegistrationOffering_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="STSS_StockIssuedDuringPeriodSharesShelfRegistrationOffering_doc" xml:lang="en-US">Stock issued during period shares shelf registration offering.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="STSS_StockIssuedDuringPeriodValuePrivatePlacement" xlink:to="STSS_StockIssuedDuringPeriodValuePrivatePlacement_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="STSS_StockIssuedDuringPeriodValuePrivatePlacement_doc" xml:lang="en-US">Stock issued during period value private placement.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="STSS_InducementWarrantsMember" xlink:to="STSS_InducementWarrantsMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="STSS_InducementWarrantsMember_doc" xml:lang="en-US">Inducement Warrants [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="STSS_WarrantHoldersMember" xlink:to="STSS_WarrantHoldersMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="STSS_WarrantHoldersMember_doc" xml:lang="en-US">Warrant Holders [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="STSS_StockIssuedDuringPeriodValueWarrantExericse" xlink:to="STSS_StockIssuedDuringPeriodValueWarrantExericse_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="STSS_StockIssuedDuringPeriodValueWarrantExericse_doc" xml:lang="en-US">Stock issued during period value warrant exericse.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="STSS_StockIssuedDuringPeriodSharesWarrantExericse" xlink:to="STSS_StockIssuedDuringPeriodSharesWarrantExericse_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="STSS_StockIssuedDuringPeriodSharesWarrantExericse_doc" xml:lang="en-US">Stock issued during period shares warrant exericse.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="STSS_EscrowDepositForfeited" xlink:to="STSS_EscrowDepositForfeited_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="STSS_EscrowDepositForfeited_doc" xml:lang="en-US">Escrow deposit forfeited.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="STSS_EscrowPaymentUnderAgreement" xlink:to="STSS_EscrowPaymentUnderAgreement_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="STSS_EscrowPaymentUnderAgreement_doc" xml:lang="en-US">Escrow payment under agreement.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="STSS_NetProceedsFromOfferingsAndWarrantExercises" xlink:to="STSS_NetProceedsFromOfferingsAndWarrantExercises_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="STSS_NetProceedsFromOfferingsAndWarrantExercises_doc" xml:lang="en-US">Net proceeds from offerings and warrant exercises.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="STSS_ShelfOfferingMember" xlink:to="STSS_ShelfOfferingMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="STSS_ShelfOfferingMember_doc" xml:lang="en-US">Shelf Offering [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="STSS_PreFundedWarrantsMember" xlink:to="STSS_PreFundedWarrantsMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="STSS_PreFundedWarrantsMember_doc" xml:lang="en-US">Pre-funded Warrants [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="STSS_WorkingCapital" xlink:to="STSS_WorkingCapital_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="STSS_WorkingCapital_doc" xml:lang="en-US">Working capital.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="STSS_PIPEPreFundedWarrantsMember" xlink:to="STSS_PIPEPreFundedWarrantsMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="STSS_PIPEPreFundedWarrantsMember_doc" xml:lang="en-US">PIPE Pre Funded Warrants [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="STSS_ReverseStockSplitDescription" xlink:to="STSS_ReverseStockSplitDescription_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="STSS_ReverseStockSplitDescription_doc" xml:lang="en-US">Reverse stock split description.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="STSS_WebsiteMember" xlink:to="STSS_WebsiteMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="STSS_WebsiteMember_doc" xml:lang="en-US">Website [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="STSS_StockOptionAndWarrantsMember" xlink:to="STSS_StockOptionAndWarrantsMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="STSS_StockOptionAndWarrantsMember_doc" xml:lang="en-US">Stock Option and Warrants [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="STSS_DescriptionForOfferingShares" xlink:to="STSS_DescriptionForOfferingShares_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="STSS_DescriptionForOfferingShares_doc" xml:lang="en-US">Description for offering, shares.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="STSS_NoteWarrantsMember" xlink:to="STSS_NoteWarrantsMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="STSS_NoteWarrantsMember_doc" xml:lang="en-US">Note Warrants [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="STSS_TradingWarrantsMember" xlink:to="STSS_TradingWarrantsMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="STSS_TradingWarrantsMember_doc" xml:lang="en-US">Trading Warrants [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="STSS_OverAllotmentWarrantsMember" xlink:to="STSS_OverAllotmentWarrantsMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="STSS_OverAllotmentWarrantsMember_doc" xml:lang="en-US">Over-Allotment Warrants [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="STSS_FairValueAdjustmentOfModificationCharge" xlink:to="STSS_FairValueAdjustmentOfModificationCharge_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="STSS_FairValueAdjustmentOfModificationCharge_doc" xml:lang="en-US">Fair value adjustment of modification charge.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="STSS_PIPEWarrantMember" xlink:to="STSS_PIPEWarrantMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="STSS_PIPEWarrantMember_doc" xml:lang="en-US">PIPE Warrant [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="STSS_ClassOfWarrantOrRightIssued" xlink:to="STSS_ClassOfWarrantOrRightIssued_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="STSS_ClassOfWarrantOrRightIssued_doc" xml:lang="en-US">Aggregate warrants issued.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="STSS_WarrantHolderMember" xlink:to="STSS_WarrantHolderMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="STSS_WarrantHolderMember_doc" xml:lang="en-US">Warrant Holder [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="STSS_SeniorSecuredNoteMember" xlink:to="STSS_SeniorSecuredNoteMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="STSS_SeniorSecuredNoteMember_doc" xml:lang="en-US">Senior Secured Note [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="STSS_WarrantLiabilityTextBlock" xlink:to="STSS_WarrantLiabilityTextBlock_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="STSS_WarrantLiabilityTextBlock_doc" xml:lang="en-US">Warrant Liability [Text Block]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="STSS_ScheduleOfWarrantLiabilityTableTextBlock" xlink:to="STSS_ScheduleOfWarrantLiabilityTableTextBlock_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="STSS_ScheduleOfWarrantLiabilityTableTextBlock_doc" xml:lang="en-US">Schedule of warrant liability [Table Text Block]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="STSS_TradingAndOverallotmentWarrantsMember" xlink:to="STSS_TradingAndOverallotmentWarrantsMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="STSS_TradingAndOverallotmentWarrantsMember_doc" xml:lang="en-US">Trading and Over allotment Warrants [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="STSS_OfferingWarrantsFebruaryTwoThousandTwentyThreeMember" xlink:to="STSS_OfferingWarrantsFebruaryTwoThousandTwentyThreeMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="STSS_OfferingWarrantsFebruaryTwoThousandTwentyThreeMember_doc" xml:lang="en-US">Offering Warrants - February 2023 [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="STSS_OfferingWarrantsSeptemberTwoThousandTwentyThreeMember" xlink:to="STSS_OfferingWarrantsSeptemberTwoThousandTwentyThreeMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="STSS_OfferingWarrantsSeptemberTwoThousandTwentyThreeMember_doc" xml:lang="en-US">Offering Warrants - September 2023 [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="STSS_GainLossOnSaleOfDerivative" xlink:to="STSS_GainLossOnSaleOfDerivative_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="STSS_GainLossOnSaleOfDerivative_doc" xml:lang="en-US">Gain loss on sale of derivative.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="STSS_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantedInYear" xlink:to="STSS_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantedInYear_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="STSS_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantedInYear_doc" xml:lang="en-US">Share based compensation arrangement by share based payment award options granted in year.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="STSS_ShareBasedCompensationOptionsExercisableWeightedAverageExercisePrice" xlink:to="STSS_ShareBasedCompensationOptionsExercisableWeightedAverageExercisePrice_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="STSS_ShareBasedCompensationOptionsExercisableWeightedAverageExercisePrice_doc" xml:lang="en-US">Share based compensation options exercisable weighted average exercise price.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="STSS_OfficersAndDirectorsMember" xlink:to="STSS_OfficersAndDirectorsMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="STSS_OfficersAndDirectorsMember_doc" xml:lang="en-US">Officers and Directors [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="STSS_EmploymentAgreementMember" xlink:to="STSS_EmploymentAgreementMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="STSS_EmploymentAgreementMember_doc" xml:lang="en-US">Employment Agreement [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="STSS_AlanBlackmanMember" xlink:to="STSS_AlanBlackmanMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="STSS_AlanBlackmanMember_doc" xml:lang="en-US">Alan Blackman [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="STSS_PaymentForBonuses" xlink:to="STSS_PaymentForBonuses_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="STSS_PaymentForBonuses_doc" xml:lang="en-US">Payment for bonuses.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="STSS_MedicalBenefitsCost" xlink:to="STSS_MedicalBenefitsCost_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="STSS_MedicalBenefitsCost_doc" xml:lang="en-US">Medical benefits cost.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="STSS_AssetPurchaseAgreementMember" xlink:to="STSS_AssetPurchaseAgreementMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="STSS_AssetPurchaseAgreementMember_doc" xml:lang="en-US">Asset Purchase Agreement [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="STSS_InjectEZLLCMember" xlink:to="STSS_InjectEZLLCMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="STSS_InjectEZLLCMember_doc" xml:lang="en-US">InjectEZ, LLC [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="STSS_CommonStockFairValue" xlink:to="STSS_CommonStockFairValue_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="STSS_CommonStockFairValue_doc" xml:lang="en-US">Common stock fair value.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="STSS_CommonStockSubscriptionReceivableMember" xlink:to="STSS_CommonStockSubscriptionReceivableMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="STSS_CommonStockSubscriptionReceivableMember_doc" xml:lang="en-US">Common Stock Subscription Receivable [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="STSS_ComputerSystemsAndWebsiteAndOtherMember" xlink:to="STSS_ComputerSystemsAndWebsiteAndOtherMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="STSS_ComputerSystemsAndWebsiteAndOtherMember_doc" xml:lang="en-US">Computer Systems and Website &amp; Other [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="STSS_InducementWarrantsMayTwoThousandTwentyFourMember" xlink:to="STSS_InducementWarrantsMayTwoThousandTwentyFourMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="STSS_InducementWarrantsMayTwoThousandTwentyFourMember_doc" xml:lang="en-US">Inducement Warrants - May 2024 [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="STSS_WarrantsIssuedForServiceManagementMember" xlink:to="STSS_WarrantsIssuedForServiceManagementMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="STSS_WarrantsIssuedForServiceManagementMember_doc" xml:lang="en-US">Warrants Issued for Services Arrangement [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="STSS_AccretedInterestFees" xlink:to="STSS_AccretedInterestFees_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="STSS_AccretedInterestFees_doc" xml:lang="en-US">Accreted interest fee.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="STSS_BerlerMember" xlink:to="STSS_BerlerMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="STSS_BerlerMember_doc" xml:lang="en-US">Berler [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="STSS_PlastomoldMember" xlink:to="STSS_PlastomoldMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="STSS_PlastomoldMember_doc" xml:lang="en-US">Plastomold [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="STSS_PlacementAgentAndOtherOfferingExpenses" xlink:to="STSS_PlacementAgentAndOtherOfferingExpenses_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="STSS_PlacementAgentAndOtherOfferingExpenses_doc" xml:lang="en-US">Placement agent and other offering expenses.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="STSS_NumberOfUnregisteredCommonStockIssuedDuringPreReverseShares" xlink:to="STSS_NumberOfUnregisteredCommonStockIssuedDuringPreReverseShares_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="STSS_NumberOfUnregisteredCommonStockIssuedDuringPreReverseShares_doc" xml:lang="en-US">Number of unregistered common stock issued during pre reverse shares.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="STSS_NumberOfUnregisteredCommonStockIssuedDuringPostReverseShares" xlink:to="STSS_NumberOfUnregisteredCommonStockIssuedDuringPostReverseShares_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="STSS_NumberOfUnregisteredCommonStockIssuedDuringPostReverseShares_doc" xml:lang="en-US">Number of unregistered common stock issued during post reverse shares.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="STSS_SubsequentEvents" xlink:to="STSS_SubsequentEvents_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="STSS_SubsequentEvents_doc" xml:lang="en-US">Subsequent events.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="STSS_StockIssuedDuringPeriodValueInitialPublicOffering" xlink:to="STSS_StockIssuedDuringPeriodValueInitialPublicOffering_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="STSS_StockIssuedDuringPeriodValueInitialPublicOffering_doc" xml:lang="en-US">Stock issued during period value initial public offering.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="STSS_StockIssuedDuringPeriodSharesInitialPublicOffering" xlink:to="STSS_StockIssuedDuringPeriodSharesInitialPublicOffering_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="STSS_StockIssuedDuringPeriodSharesInitialPublicOffering_doc" xml:lang="en-US">Stock issued during period shares initial public offering.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="STSS_StockIssuedDuringPeriodValueContingentStockLiability" xlink:to="STSS_StockIssuedDuringPeriodValueContingentStockLiability_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="STSS_StockIssuedDuringPeriodValueContingentStockLiability_doc" xml:lang="en-US">Stock issued during period value contingent stock liability.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="STSS_StockIssuedDuringPeriodSharesContingentStockLiability" xlink:to="STSS_StockIssuedDuringPeriodSharesContingentStockLiability_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="STSS_StockIssuedDuringPeriodSharesContingentStockLiability_doc" xml:lang="en-US">Stock issued during period shares contingent stock liability.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="STSS_StockIssuedDuringPeriodValueFractionalShareAdjustment" xlink:to="STSS_StockIssuedDuringPeriodValueFractionalShareAdjustment_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="STSS_StockIssuedDuringPeriodValueFractionalShareAdjustment_doc" xml:lang="en-US">Stock issued during period value fractional share adjustment.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="STSS_StockIssuedDuringPeriodSharesFractionalShareAdjustment" xlink:to="STSS_StockIssuedDuringPeriodSharesFractionalShareAdjustment_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="STSS_StockIssuedDuringPeriodSharesFractionalShareAdjustment_doc" xml:lang="en-US">Stock issued during shares fractional share adjustment.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="STSS_StockIssuedDuringPeriodCollectionsOfCommonStockSubscriptionsValue" xlink:to="STSS_StockIssuedDuringPeriodCollectionsOfCommonStockSubscriptionsValue_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="STSS_StockIssuedDuringPeriodCollectionsOfCommonStockSubscriptionsValue_doc" xml:lang="en-US">Stock issued during period collections of common stock subscriptions value.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="STSS_FairMarketValueAdjustmentForContingentWarrants" xlink:to="STSS_FairMarketValueAdjustmentForContingentWarrants_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="STSS_FairMarketValueAdjustmentForContingentWarrants_doc" xml:lang="en-US">Fair market value for adjustment for contingent warrants.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="STSS_FairMarketValueAdjustmentForContingentWarrantsAndWarrants" xlink:to="STSS_FairMarketValueAdjustmentForContingentWarrantsAndWarrants_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="STSS_FairMarketValueAdjustmentForContingentWarrantsAndWarrants_doc" xml:lang="en-US">Fair market valuea djustment for Contingent Warrants and Warrants.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="STSS_IpoIssuanceCostsRelatingToWarrants" xlink:to="STSS_IpoIssuanceCostsRelatingToWarrants_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="STSS_IpoIssuanceCostsRelatingToWarrants_doc" xml:lang="en-US">IPO issuance cost relating to warrants.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="STSS_PaymentsToAssetAcquisition" xlink:to="STSS_PaymentsToAssetAcquisition_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="STSS_PaymentsToAssetAcquisition_doc" xml:lang="en-US">Payments to asset acquisition.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="STSS_NetProceedsFromInitialPublicOfferingAndAdditionalOffering" xlink:to="STSS_NetProceedsFromInitialPublicOfferingAndAdditionalOffering_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="STSS_NetProceedsFromInitialPublicOfferingAndAdditionalOffering_doc" xml:lang="en-US">Net proceeds from Initial Public Offering and additional offering.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="STSS_ProceedsFromSubscriptionsReceivable" xlink:to="STSS_ProceedsFromSubscriptionsReceivable_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="STSS_ProceedsFromSubscriptionsReceivable_doc" xml:lang="en-US">Proceeds from subscriptions receivable.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="STSS_FmvForCommonStockIssuedForContingentShares" xlink:to="STSS_FmvForCommonStockIssuedForContingentShares_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="STSS_FmvForCommonStockIssuedForContingentShares_doc" xml:lang="en-US">FMV for common stock issued for cintingent shares.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="STSS_CommonStockIssuedAndVestedStockOptionsForFixedAssetsAcquired" xlink:to="STSS_CommonStockIssuedAndVestedStockOptionsForFixedAssetsAcquired_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="STSS_CommonStockIssuedAndVestedStockOptionsForFixedAssetsAcquired_doc" xml:lang="en-US">Common stock issued and vested stock options for fixed assets acquired.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="STSS_CommonStockIssuedAndVestedStockOptionsIssuedAsConsiderationForAcquisition" xlink:to="STSS_CommonStockIssuedAndVestedStockOptionsIssuedAsConsiderationForAcquisition_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="STSS_CommonStockIssuedAndVestedStockOptionsIssuedAsConsiderationForAcquisition_doc" xml:lang="en-US">Common stock issued and vested stock options issued as consideration for acquisition.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="STSS_FmvForWarrantsIssuedForContingentWarrants" xlink:to="STSS_FmvForWarrantsIssuedForContingentWarrants_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="STSS_FmvForWarrantsIssuedForContingentWarrants_doc" xml:lang="en-US">Fmv for warrants issued for contingent warrants.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="STSS_RemainingPaymentsDueOnMachinery" xlink:to="STSS_RemainingPaymentsDueOnMachinery_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="STSS_RemainingPaymentsDueOnMachinery_doc" xml:lang="en-US">Remaining payments uue on machinery.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="STSS_ContingentStockLiability" xlink:to="STSS_ContingentStockLiability_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="STSS_ContingentStockLiability_doc" xml:lang="en-US">Contingent stock liability.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="STSS_AllocationOfDebtIssuanceCostToContingentStockAndContingentWarrants" xlink:to="STSS_AllocationOfDebtIssuanceCostToContingentStockAndContingentWarrants_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="STSS_AllocationOfDebtIssuanceCostToContingentStockAndContingentWarrants_doc" xml:lang="en-US">Allocation of debt issuance cost to contingent stock and contingent warrants.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="STSS_ContingentWarrants" xlink:to="STSS_ContingentWarrants_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="STSS_ContingentWarrants_doc" xml:lang="en-US">Contingent warrants.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="STSS_NetProceedsFromIssuanceInitialPublicOffering" xlink:to="STSS_NetProceedsFromIssuanceInitialPublicOffering_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="STSS_NetProceedsFromIssuanceInitialPublicOffering_doc" xml:lang="en-US">Net proceeds from issuance initial public offering.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="STSS_ClassOfWarrantOrRightExercisePriceOfWarrantsAdjusted" xlink:to="STSS_ClassOfWarrantOrRightExercisePriceOfWarrantsAdjusted_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="STSS_ClassOfWarrantOrRightExercisePriceOfWarrantsAdjusted_doc" xml:lang="en-US">Class of warrant or right exercise price of warrants adjusted.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="STSS_PaymentsForRepurchaseOfLiability" xlink:to="STSS_PaymentsForRepurchaseOfLiability_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="STSS_PaymentsForRepurchaseOfLiability_doc" xml:lang="en-US">Payments for repurchase of liability.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="STSS_StockBasedChargesRelatingToPurchaseOfMachinery" xlink:to="STSS_StockBasedChargesRelatingToPurchaseOfMachinery_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="STSS_StockBasedChargesRelatingToPurchaseOfMachinery_doc" xml:lang="en-US">Stock based charges relating to purchase of machinery.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="STSS_StockBasedChargesRelatingToAcquisition" xlink:to="STSS_StockBasedChargesRelatingToAcquisition_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="STSS_StockBasedChargesRelatingToAcquisition_doc" xml:lang="en-US">Stock based charges relating to acquisition.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="STSS_DeferredTaxAssetsPropertyPlantAndEquipments" xlink:to="STSS_DeferredTaxAssetsPropertyPlantAndEquipments_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="STSS_DeferredTaxAssetsPropertyPlantAndEquipments_doc" xml:lang="en-US">Deferred tax assets property plant and equipments.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="STSS_OrderCostsToPurchaseEquipmentMoldsAndComponentPartsForResearchAndDevelopment" xlink:to="STSS_OrderCostsToPurchaseEquipmentMoldsAndComponentPartsForResearchAndDevelopment_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="STSS_OrderCostsToPurchaseEquipmentMoldsAndComponentPartsForResearchAndDevelopment_doc" xml:lang="en-US">Order costs to purchase equipment molds and component parts for research and development.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="STSS_ProgressPayments" xlink:to="STSS_ProgressPayments_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="STSS_ProgressPayments_doc" xml:lang="en-US">Progress payments.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="STSS_RoyaltyPercentage" xlink:to="STSS_RoyaltyPercentage_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="STSS_RoyaltyPercentage_doc" xml:lang="en-US">Royalty percentage.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="STSS_SinglePaymentObligation" xlink:to="STSS_SinglePaymentObligation_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="STSS_SinglePaymentObligation_doc" xml:lang="en-US">Single payment obligation.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="STSS_AnnualCompensation" xlink:to="STSS_AnnualCompensation_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="STSS_AnnualCompensation_doc" xml:lang="en-US">Annual compensation.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="STSS_InitialFee" xlink:to="STSS_InitialFee_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="STSS_InitialFee_doc" xml:lang="en-US">Initial fee.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="STSS_ValueOfDigitalMarketingActivities" xlink:to="STSS_ValueOfDigitalMarketingActivities_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="STSS_ValueOfDigitalMarketingActivities_doc" xml:lang="en-US">Value of digital marketing activities.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="STSS_CommonStockReverseSplitValue" xlink:to="STSS_CommonStockReverseSplitValue_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="STSS_CommonStockReverseSplitValue_doc" xml:lang="en-US">Common stock reverse split value.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="STSS_ReverseStockSplitMember" xlink:to="STSS_ReverseStockSplitMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="STSS_ReverseStockSplitMember_doc" xml:lang="en-US">Reverse Stock Split [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="STSS_NotePurchaseAgreementTextBlock" xlink:to="STSS_NotePurchaseAgreementTextBlock_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="STSS_NotePurchaseAgreementTextBlock_doc" xml:lang="en-US">Note Purchase Agreement [Text Block]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="STSS_ContingentWarrantLiability" xlink:to="STSS_ContingentWarrantLiability_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="STSS_ContingentWarrantLiability_doc" xml:lang="en-US">Contingent warrant liability.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="STSS_MonthlyFee" xlink:to="STSS_MonthlyFee_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="STSS_MonthlyFee_doc" xml:lang="en-US">Monthly fee.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="STSS_ServiceAgreementMember" xlink:to="STSS_ServiceAgreementMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="STSS_ServiceAgreementMember_doc" xml:lang="en-US">Service Agreement [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="STSS_WarrantLiability" xlink:to="STSS_WarrantLiability_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="STSS_WarrantLiability_doc" xml:lang="en-US">Warrant liability.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="STSS_ClassOfWarrantsOrRightOutstanding" xlink:to="STSS_ClassOfWarrantsOrRightOutstanding_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="STSS_ClassOfWarrantsOrRightOutstanding_doc" xml:lang="en-US">Class of warrants or right outstanding.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="STSS_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionOutstandingNumber" xlink:to="STSS_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionOutstandingNumber_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="STSS_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionOutstandingNumber_doc" xml:lang="en-US">Share based compensation arrangement by share based payment award option outstanding number.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="STSS_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionOutstandingWeightedAverageExercisePrice" xlink:to="STSS_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionOutstandingWeightedAverageExercisePrice_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="STSS_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionOutstandingWeightedAverageExercisePrice_doc" xml:lang="en-US">Share based compensation arrangement by share based payment award option outstanding weighted average exercise price.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="STSS_NotePurchaseAgreementMember" xlink:to="STSS_NotePurchaseAgreementMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="STSS_NotePurchaseAgreementMember_doc" xml:lang="en-US">Note Purchase Agreement [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="STSS_UnrelatedThirdPartyPurchasersMember" xlink:to="STSS_UnrelatedThirdPartyPurchasersMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="STSS_UnrelatedThirdPartyPurchasersMember_doc" xml:lang="en-US">Unrelated Third Party Purchasers [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="STSS_FairMarketValueAdjustmentForContingentStockAndWarrants" xlink:to="STSS_FairMarketValueAdjustmentForContingentStockAndWarrants_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="STSS_FairMarketValueAdjustmentForContingentStockAndWarrants_doc" xml:lang="en-US">Fair market value adjustment for contingent stock and warrants.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="STSS_PrefundendWarrantsMember" xlink:to="STSS_PrefundendWarrantsMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="STSS_PrefundendWarrantsMember_doc" xml:lang="en-US">Prefundend Warrants [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="STSS_StockOptionsAndWarrantsMember" xlink:to="STSS_StockOptionsAndWarrantsMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="STSS_StockOptionsAndWarrantsMember_doc" xml:lang="en-US">Stock Options and Warrants [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="STSS_ComputerSystemsAndWebsiteAndOtherWebsiteMember" xlink:to="STSS_ComputerSystemsAndWebsiteAndOtherWebsiteMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="STSS_ComputerSystemsAndWebsiteAndOtherWebsiteMember_doc" xml:lang="en-US">Computer Systems and Website and Other Website [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="STSS_StockOptionOneMember" xlink:to="STSS_StockOptionOneMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="STSS_StockOptionOneMember_doc" xml:lang="en-US">Stock Option One [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="STSS_OfferingWarrantsFebruaryTwentyTwentyThreeMember" xlink:to="STSS_OfferingWarrantsFebruaryTwentyTwentyThreeMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="STSS_OfferingWarrantsFebruaryTwentyTwentyThreeMember_doc" xml:lang="en-US">Offering Warrants - February 2023 [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="STSS_OfferingWarrantsSeptemberTwentyTwentyThreeMember" xlink:to="STSS_OfferingWarrantsSeptemberTwentyTwentyThreeMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="STSS_OfferingWarrantsSeptemberTwentyTwentyThreeMember_doc" xml:lang="en-US">Offering Warrants - September 2023 [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="STSS_TwoThousandTwentyThreeEquityIncentivePlanMember" xlink:to="STSS_TwoThousandTwentyThreeEquityIncentivePlanMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="STSS_TwoThousandTwentyThreeEquityIncentivePlanMember_doc" xml:lang="en-US">2023 Equity Incentive Plan [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="STSS_EmployeesAndConsultantMember" xlink:to="STSS_EmployeesAndConsultantMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="STSS_EmployeesAndConsultantMember_doc" xml:lang="en-US">Employees and Consultant [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="STSS_TwoThousandTwentyTwoEquityIncentivePlanMember" xlink:to="STSS_TwoThousandTwentyTwoEquityIncentivePlanMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="STSS_TwoThousandTwentyTwoEquityIncentivePlanMember_doc" xml:lang="en-US">2022 Equity Incentive Plan [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="STSS_ExercisePriceRangeOneMember" xlink:to="STSS_ExercisePriceRangeOneMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="STSS_ExercisePriceRangeOneMember_doc" xml:lang="en-US">Exercise Price Range One [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="STSS_ExercisePriceRangeTwoMember" xlink:to="STSS_ExercisePriceRangeTwoMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="STSS_ExercisePriceRangeTwoMember_doc" xml:lang="en-US">Exercise Price Range Two [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="STSS_ExercisePriceRangeThreeMember" xlink:to="STSS_ExercisePriceRangeThreeMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="STSS_ExercisePriceRangeThreeMember_doc" xml:lang="en-US">Exercise Price Range Three [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="STSS_ExercisePriceRangeFourMember" xlink:to="STSS_ExercisePriceRangeFourMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="STSS_ExercisePriceRangeFourMember_doc" xml:lang="en-US">Exercise Price Range Four [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="STSS_ExercisePriceRangeFiveMember" xlink:to="STSS_ExercisePriceRangeFiveMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="STSS_ExercisePriceRangeFiveMember_doc" xml:lang="en-US">Exercise Price Range Five [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="STSS_ExercisePriceRangeSixMember" xlink:to="STSS_ExercisePriceRangeSixMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="STSS_ExercisePriceRangeSixMember_doc" xml:lang="en-US">Exercise Price Range Six [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="STSS_ExercisePriceRangeSevenMember" xlink:to="STSS_ExercisePriceRangeSevenMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="STSS_ExercisePriceRangeSevenMember_doc" xml:lang="en-US">Exercise Price Range Seven [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="STSS_ExercisePriceRangeEightMember" xlink:to="STSS_ExercisePriceRangeEightMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="STSS_ExercisePriceRangeEightMember_doc" xml:lang="en-US">Exercise Price Range Eight [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="STSS_ExercisePriceRangeNineMember" xlink:to="STSS_ExercisePriceRangeNineMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="STSS_ExercisePriceRangeNineMember_doc" xml:lang="en-US">Exercise Price Range Nine [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="STSS_ExercisePriceRangeTenMember" xlink:to="STSS_ExercisePriceRangeTenMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="STSS_ExercisePriceRangeTenMember_doc" xml:lang="en-US">Exercise Price Range Ten [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="STSS_ExpiresOnTwoThousandTwentyEightMember" xlink:to="STSS_ExpiresOnTwoThousandTwentyEightMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="STSS_ExpiresOnTwoThousandTwentyEightMember_doc" xml:lang="en-US">Expires On 2028 [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="STSS_NotExpireMember" xlink:to="STSS_NotExpireMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="STSS_NotExpireMember_doc" xml:lang="en-US">No Expire [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="STSS_RoyaltyAgreementMember" xlink:to="STSS_RoyaltyAgreementMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="STSS_RoyaltyAgreementMember_doc" xml:lang="en-US">Royalty Agreement [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="STSS_BarryBerlerMember" xlink:to="STSS_BarryBerlerMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="STSS_BarryBerlerMember_doc" xml:lang="en-US">Barry Berler [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="STSS_Mr.BlackmanMember" xlink:to="STSS_Mr.BlackmanMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="STSS_Mr.BlackmanMember_doc" xml:lang="en-US">Mr. Blackman [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="STSS_OfferingWarrantsFebruaryTwoThousandTwentyThreeMember" xlink:to="STSS_OfferingWarrantsFebruaryTwoThousandTwentyThreeMember_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="STSS_OfferingWarrantsFebruaryTwoThousandTwentyThreeMember_3_lbl" xml:lang="en-US">Offering Warrants - February 2023 [Member] [Default Label]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="STSS_OfferingWarrantsSeptemberTwoThousandTwentyThreeMember" xlink:to="STSS_OfferingWarrantsSeptemberTwoThousandTwentyThreeMember_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="STSS_OfferingWarrantsSeptemberTwoThousandTwentyThreeMember_3_lbl" xml:lang="en-US">Offering Warrants - September 2023 [Member] [Default Label]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AssetsCurrent" xlink:to="us-gaap_AssetsCurrent_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AssetsCurrent_2_lbl" xml:lang="en-US">Assets, Current</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_Assets" xlink:to="us-gaap_Assets_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_Assets_2_lbl" xml:lang="en-US">Assets [Default Label]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LiabilitiesCurrent" xlink:to="us-gaap_LiabilitiesCurrent_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LiabilitiesCurrent_2_lbl" xml:lang="en-US">Liabilities, Current</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_Liabilities" xlink:to="us-gaap_Liabilities_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_Liabilities_2_lbl" xml:lang="en-US">Liabilities [Default Label]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockholdersEquity" xlink:to="us-gaap_StockholdersEquity_4_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockholdersEquity_4_lbl" xml:lang="en-US">Equity, Attributable to Parent</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LiabilitiesAndStockholdersEquity" xlink:to="us-gaap_LiabilitiesAndStockholdersEquity_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LiabilitiesAndStockholdersEquity_2_lbl" xml:lang="en-US">Liabilities and Equity</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingExpenses" xlink:to="us-gaap_OperatingExpenses_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OperatingExpenses_2_lbl" xml:lang="en-US">Operating Expenses</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingIncomeLoss" xlink:to="us-gaap_OperatingIncomeLoss_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OperatingIncomeLoss_2_lbl" xml:lang="en-US">Operating Income (Loss)</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="STSS_FairMarketValueAdjustmentForContingentStockAndWarrants" xlink:to="STSS_FairMarketValueAdjustmentForContingentStockAndWarrants_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="STSS_FairMarketValueAdjustmentForContingentStockAndWarrants_3_lbl" xml:lang="en-US">FairMarketValueAdjustmentForContingentStockAndWarrants</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NonoperatingIncomeExpense" xlink:to="us-gaap_NonoperatingIncomeExpense_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NonoperatingIncomeExpense_2_lbl" xml:lang="en-US">Nonoperating Income (Expense)</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:to="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_2_lbl" xml:lang="en-US">Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ComprehensiveIncomeNetOfTax" xlink:to="us-gaap_ComprehensiveIncomeNetOfTax_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ComprehensiveIncomeNetOfTax_2_lbl" xml:lang="en-US">Comprehensive Income (Loss), Net of Tax, Attributable to Parent</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharesOutstanding" xlink:to="us-gaap_SharesOutstanding_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SharesOutstanding_3_lbl" xml:lang="en-US">Shares, Outstanding</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="STSS_StockIssuedDuringPeriodValueExerciseOfPrefundedWarrant" xlink:to="STSS_StockIssuedDuringPeriodValueExerciseOfPrefundedWarrant_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="STSS_StockIssuedDuringPeriodValueExerciseOfPrefundedWarrant_3_lbl" xml:lang="en-US">StockIssuedDuringPeriodValueExerciseOfPrefundedWarrant</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IssuanceOfStockAndWarrantsForServicesOrClaims" xlink:to="us-gaap_IssuanceOfStockAndWarrantsForServicesOrClaims_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IssuanceOfStockAndWarrantsForServicesOrClaims_2_lbl" xml:lang="en-US">Issuance of Stock and Warrants for Services or Claims</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ForeignCurrencyTransactionGainLossBeforeTax" xlink:to="us-gaap_ForeignCurrencyTransactionGainLossBeforeTax_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ForeignCurrencyTransactionGainLossBeforeTax_2_lbl" xml:lang="en-US">Gain (Loss), Foreign Currency Transaction, before Tax</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInPrepaidExpense" xlink:to="us-gaap_IncreaseDecreaseInPrepaidExpense_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncreaseDecreaseInPrepaidExpense_2_lbl" xml:lang="en-US">Increase (Decrease) in Prepaid Expense</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInInventories" xlink:to="us-gaap_IncreaseDecreaseInInventories_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncreaseDecreaseInInventories_2_lbl" xml:lang="en-US">Increase (Decrease) in Inventories</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInOtherOperatingAssets" xlink:to="us-gaap_IncreaseDecreaseInOtherOperatingAssets_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncreaseDecreaseInOtherOperatingAssets_2_lbl" xml:lang="en-US">Increase (Decrease) in Other Operating Assets</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="us-gaap_NetCashProvidedByUsedInOperatingActivities_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivities_3_lbl" xml:lang="en-US">Net Cash Provided by (Used in) Operating Activities</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PaymentsForProceedsFromOtherInvestingActivities" xlink:to="us-gaap_PaymentsForProceedsFromOtherInvestingActivities_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PaymentsForProceedsFromOtherInvestingActivities_2_lbl" xml:lang="en-US">Payments for (Proceeds from) Other Investing Activities</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="STSS_EscrowPaymentUnderAgreement" xlink:to="STSS_EscrowPaymentUnderAgreement_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="STSS_EscrowPaymentUnderAgreement_3_lbl" xml:lang="en-US">EscrowPaymentUnderAgreement</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:to="us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_2_lbl" xml:lang="en-US">Payments to Acquire Property, Plant, and Equipment</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="STSS_PaymentsToAssetAcquisition" xlink:to="STSS_PaymentsToAssetAcquisition_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="STSS_PaymentsToAssetAcquisition_3_lbl" xml:lang="en-US">PaymentsToAssetAcquisition</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:to="us-gaap_NetCashProvidedByUsedInInvestingActivities_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NetCashProvidedByUsedInInvestingActivities_2_lbl" xml:lang="en-US">Net Cash Provided by (Used in) Investing Activities</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RepaymentsOfNotesPayable" xlink:to="us-gaap_RepaymentsOfNotesPayable_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_RepaymentsOfNotesPayable_2_lbl" xml:lang="en-US">Repayments of Notes Payable</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:to="us-gaap_NetCashProvidedByUsedInFinancingActivities_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NetCashProvidedByUsedInFinancingActivities_2_lbl" xml:lang="en-US">Net Cash Provided by (Used in) Financing Activities</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:to="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_2_lbl" xml:lang="en-US">Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations" xlink:to="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations_3_lbl" xml:lang="en-US">Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Including Disposal Group and Discontinued Operations</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="STSS_NotePurchaseAgreementTextBlock" xlink:to="STSS_NotePurchaseAgreementTextBlock_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="STSS_NotePurchaseAgreementTextBlock_3_lbl" xml:lang="en-US">Note Purchase Agreement [Text Block]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="STSS_WarrantLiabilityTextBlock" xlink:to="STSS_WarrantLiabilityTextBlock_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="STSS_WarrantLiabilityTextBlock_3_lbl" xml:lang="en-US">Warrant Liability [Text Block]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InventoryPolicyTextBlock" xlink:to="us-gaap_InventoryPolicyTextBlock_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_InventoryPolicyTextBlock_2_lbl" xml:lang="en-US">Inventory, Policy [Policy Text Block]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueMeasurementPolicyPolicyTextBlock" xlink:to="us-gaap_FairValueMeasurementPolicyPolicyTextBlock_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FairValueMeasurementPolicyPolicyTextBlock_2_lbl" xml:lang="en-US">Fair Value Measurement, Policy [Policy Text Block]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PropertyPlantAndEquipmentPolicyTextBlock" xlink:to="us-gaap_PropertyPlantAndEquipmentPolicyTextBlock_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PropertyPlantAndEquipmentPolicyTextBlock_2_lbl" xml:lang="en-US">Property, Plant and Equipment, Policy [Policy Text Block]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeTaxPolicyTextBlock" xlink:to="us-gaap_IncomeTaxPolicyTextBlock_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncomeTaxPolicyTextBlock_2_lbl" xml:lang="en-US">Income Tax, Policy [Policy Text Block]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_Cash" xlink:to="us-gaap_Cash_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_Cash_2_lbl" xml:lang="en-US">Cash [Default Label]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:to="us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_2_lbl" xml:lang="en-US">Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities" xlink:to="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities_2_lbl" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Deferred Tax Liabilities</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RepaymentsOfDebt" xlink:to="us-gaap_RepaymentsOfDebt_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_RepaymentsOfDebt_2_lbl" xml:lang="en-US">Repayments of Debt</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice_3_lbl" xml:lang="en-US">Share-Based Compensation Arrangements by Share-Based Payment Award, Options, Expirations in Period, Weighted Average Exercise Price</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProceedsFromIssuanceOrSaleOfEquity" xlink:to="us-gaap_ProceedsFromIssuanceOrSaleOfEquity_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ProceedsFromIssuanceOrSaleOfEquity_2_lbl" xml:lang="en-US">Proceeds from Issuance or Sale of Equity</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="STSS_GainLossOnSaleOfDerivative" xlink:to="STSS_GainLossOnSaleOfDerivative_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="STSS_GainLossOnSaleOfDerivative_3_lbl" xml:lang="en-US">GainLossOnSaleOfDerivative</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="STSS_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionOutstandingNumber" xlink:to="STSS_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionOutstandingNumber_4_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="STSS_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionOutstandingNumber_4_lbl" xml:lang="en-US">ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionOutstandingNumber</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="STSS_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionOutstandingWeightedAverageExercisePrice" xlink:to="STSS_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionOutstandingWeightedAverageExercisePrice_4_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="STSS_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionOutstandingWeightedAverageExercisePrice_4_lbl" xml:lang="en-US">ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionOutstandingWeightedAverageExercisePrice</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_3_lbl" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Exercise Price</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod_2_lbl" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Expirations in Period</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedNumberOfShares" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedNumberOfShares_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedNumberOfShares_2_lbl" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Nonvested Options Forfeited, Number of Shares</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_2_lbl" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Forfeitures in Period</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_2_lbl" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Number</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_2_lbl" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Weighted Average Exercise Price</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeTaxExpenseBenefit" xlink:to="us-gaap_IncomeTaxExpenseBenefit_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncomeTaxExpenseBenefit_2_lbl" xml:lang="en-US">Income Tax Expense (Benefit)</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost" xlink:to="us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost_2_lbl" xml:lang="en-US">Deferred Tax Assets, Tax Deferred Expense, Compensation and Benefits, Share-Based Compensation Cost</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxAssetsValuationAllowance" xlink:to="us-gaap_DeferredTaxAssetsValuationAllowance_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DeferredTaxAssetsValuationAllowance_2_lbl" xml:lang="en-US">Deferred Tax Assets, Valuation Allowance</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxLiabilities" xlink:to="us-gaap_DeferredTaxLiabilities_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DeferredTaxLiabilities_2_lbl" xml:lang="en-US">Deferred Tax Liabilities, Net</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent" xlink:to="us-gaap_AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent_2_lbl" xml:lang="en-US">Accounts Payable and Accrued Liabilities</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashAndCashEquivalentsFairValueDisclosure" xlink:to="us-gaap_CashAndCashEquivalentsFairValueDisclosure_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CashAndCashEquivalentsFairValueDisclosure_2_lbl" xml:lang="en-US">Cash and Cash Equivalents, Fair Value Disclosure</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccountsPayableCurrentAndNoncurrent" xlink:to="us-gaap_AccountsPayableCurrentAndNoncurrent_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AccountsPayableCurrentAndNoncurrent_2_lbl" xml:lang="en-US">Accounts Payable</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1" xlink:to="us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1_2_lbl" xml:lang="en-US">Share-Based Payment Arrangement, Option, Exercise Price Range, Outstanding, Weighted Average Exercise Price</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment" xlink:to="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment_2_lbl" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Property, Plant, and Equipment</link:label>
    </link:labelLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>25
<FILENAME>stss-20240930_pre.xml
<DESCRIPTION>XBRL PRESENTATION FILE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" standalone="no"?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoFiler Complete; Version: 5.25a -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: https://www.novaworks.com -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x00000000 -->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
    <link:roleRef roleURI="http://sharpstechnology.com/role/Cover" xlink:href="stss-20240930.xsd#Cover" xlink:type="simple" />
    <link:roleRef roleURI="http://sharpstechnology.com/role/BalanceSheets" xlink:href="stss-20240930.xsd#BalanceSheets" xlink:type="simple" />
    <link:roleRef roleURI="http://sharpstechnology.com/role/BalanceSheetsParenthetical" xlink:href="stss-20240930.xsd#BalanceSheetsParenthetical" xlink:type="simple" />
    <link:roleRef roleURI="http://sharpstechnology.com/role/StatementsOfOperations" xlink:href="stss-20240930.xsd#StatementsOfOperations" xlink:type="simple" />
    <link:roleRef roleURI="http://sharpstechnology.com/role/StatementsOfComprehensiveLoss" xlink:href="stss-20240930.xsd#StatementsOfComprehensiveLoss" xlink:type="simple" />
    <link:roleRef roleURI="http://sharpstechnology.com/role/StatementOfStockholdersEquity" xlink:href="stss-20240930.xsd#StatementOfStockholdersEquity" xlink:type="simple" />
    <link:roleRef roleURI="http://sharpstechnology.com/role/StatementsOfCashFlows" xlink:href="stss-20240930.xsd#StatementsOfCashFlows" xlink:type="simple" />
    <link:roleRef roleURI="http://sharpstechnology.com/role/DescriptionOfBusiness" xlink:href="stss-20240930.xsd#DescriptionOfBusiness" xlink:type="simple" />
    <link:roleRef roleURI="http://sharpstechnology.com/role/SummaryOfSignificantAccountingPolicies" xlink:href="stss-20240930.xsd#SummaryOfSignificantAccountingPolicies" xlink:type="simple" />
    <link:roleRef roleURI="http://sharpstechnology.com/role/Inventories" xlink:href="stss-20240930.xsd#Inventories" xlink:type="simple" />
    <link:roleRef roleURI="http://sharpstechnology.com/role/FixedAssets" xlink:href="stss-20240930.xsd#FixedAssets" xlink:type="simple" />
    <link:roleRef roleURI="http://sharpstechnology.com/role/AssetAcquisition" xlink:href="stss-20240930.xsd#AssetAcquisition" xlink:type="simple" />
    <link:roleRef roleURI="http://sharpstechnology.com/role/OtherAssets" xlink:href="stss-20240930.xsd#OtherAssets" xlink:type="simple" />
    <link:roleRef roleURI="http://sharpstechnology.com/role/DebtFinancing" xlink:href="stss-20240930.xsd#DebtFinancing" xlink:type="simple" />
    <link:roleRef roleURI="http://sharpstechnology.com/role/NotePurchaseAgreement" xlink:href="stss-20240930.xsd#NotePurchaseAgreement" xlink:type="simple" />
    <link:roleRef roleURI="http://sharpstechnology.com/role/StockholdersEquity" xlink:href="stss-20240930.xsd#StockholdersEquity" xlink:type="simple" />
    <link:roleRef roleURI="http://sharpstechnology.com/role/PreferredStock" xlink:href="stss-20240930.xsd#PreferredStock" xlink:type="simple" />
    <link:roleRef roleURI="http://sharpstechnology.com/role/WarrantLiability" xlink:href="stss-20240930.xsd#WarrantLiability" xlink:type="simple" />
    <link:roleRef roleURI="http://sharpstechnology.com/role/StockOptions" xlink:href="stss-20240930.xsd#StockOptions" xlink:type="simple" />
    <link:roleRef roleURI="http://sharpstechnology.com/role/IncomeTaxes" xlink:href="stss-20240930.xsd#IncomeTaxes" xlink:type="simple" />
    <link:roleRef roleURI="http://sharpstechnology.com/role/RelatedPartyTransactionsAndBalances" xlink:href="stss-20240930.xsd#RelatedPartyTransactionsAndBalances" xlink:type="simple" />
    <link:roleRef roleURI="http://sharpstechnology.com/role/FairValueMeasurements" xlink:href="stss-20240930.xsd#FairValueMeasurements" xlink:type="simple" />
    <link:roleRef roleURI="http://sharpstechnology.com/role/CommitmentsAndContingencies" xlink:href="stss-20240930.xsd#CommitmentsAndContingencies" xlink:type="simple" />
    <link:roleRef roleURI="http://sharpstechnology.com/role/SubsequentEvents" xlink:href="stss-20240930.xsd#SubsequentEvents" xlink:type="simple" />
    <link:roleRef roleURI="http://sharpstechnology.com/role/SummaryOfSignificantAccountingPoliciesPolicies" xlink:href="stss-20240930.xsd#SummaryOfSignificantAccountingPoliciesPolicies" xlink:type="simple" />
    <link:roleRef roleURI="http://sharpstechnology.com/role/InventoriesTables" xlink:href="stss-20240930.xsd#InventoriesTables" xlink:type="simple" />
    <link:roleRef roleURI="http://sharpstechnology.com/role/FixedAssetsTables" xlink:href="stss-20240930.xsd#FixedAssetsTables" xlink:type="simple" />
    <link:roleRef roleURI="http://sharpstechnology.com/role/AssetAcquisitionTables" xlink:href="stss-20240930.xsd#AssetAcquisitionTables" xlink:type="simple" />
    <link:roleRef roleURI="http://sharpstechnology.com/role/OtherAssetsTables" xlink:href="stss-20240930.xsd#OtherAssetsTables" xlink:type="simple" />
    <link:roleRef roleURI="http://sharpstechnology.com/role/WarrantLiabilityTables" xlink:href="stss-20240930.xsd#WarrantLiabilityTables" xlink:type="simple" />
    <link:roleRef roleURI="http://sharpstechnology.com/role/StockOptionsTables" xlink:href="stss-20240930.xsd#StockOptionsTables" xlink:type="simple" />
    <link:roleRef roleURI="http://sharpstechnology.com/role/IncomeTaxesTables" xlink:href="stss-20240930.xsd#IncomeTaxesTables" xlink:type="simple" />
    <link:roleRef roleURI="http://sharpstechnology.com/role/FairValueMeasurementsTables" xlink:href="stss-20240930.xsd#FairValueMeasurementsTables" xlink:type="simple" />
    <link:roleRef roleURI="http://sharpstechnology.com/role/DescriptionOfBusinessDetailsNarrative" xlink:href="stss-20240930.xsd#DescriptionOfBusinessDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://sharpstechnology.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative" xlink:href="stss-20240930.xsd#SummaryOfSignificantAccountingPoliciesDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://sharpstechnology.com/role/ScheduleOfInventoriesDetails" xlink:href="stss-20240930.xsd#ScheduleOfInventoriesDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://sharpstechnology.com/role/ScheduleOfPropertyPlantAndEquipmentDetails" xlink:href="stss-20240930.xsd#ScheduleOfPropertyPlantAndEquipmentDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://sharpstechnology.com/role/FixedAssetsDetailsNarrative" xlink:href="stss-20240930.xsd#FixedAssetsDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://sharpstechnology.com/role/ScheduleOfFairValueOfAssetsAcquisitionDetails" xlink:href="stss-20240930.xsd#ScheduleOfFairValueOfAssetsAcquisitionDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://sharpstechnology.com/role/AssetAcquisitionDetailsNarrative" xlink:href="stss-20240930.xsd#AssetAcquisitionDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://sharpstechnology.com/role/ScheduleOfOtherAssetsDetails" xlink:href="stss-20240930.xsd#ScheduleOfOtherAssetsDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://sharpstechnology.com/role/OtherAssetsDetailsNarrative" xlink:href="stss-20240930.xsd#OtherAssetsDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://sharpstechnology.com/role/DebtFinancingDetailsNarrative" xlink:href="stss-20240930.xsd#DebtFinancingDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://sharpstechnology.com/role/NotePurchaseAgreementDetailsNarrative" xlink:href="stss-20240930.xsd#NotePurchaseAgreementDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://sharpstechnology.com/role/StockholdersEquityDetailsNarrative" xlink:href="stss-20240930.xsd#StockholdersEquityDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://sharpstechnology.com/role/PreferredStockDetailsNarrative" xlink:href="stss-20240930.xsd#PreferredStockDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://sharpstechnology.com/role/ScheduleOfFairValueOfWarrantDetails" xlink:href="stss-20240930.xsd#ScheduleOfFairValueOfWarrantDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://sharpstechnology.com/role/ScheduleOfWarrantLiabilityDetails" xlink:href="stss-20240930.xsd#ScheduleOfWarrantLiabilityDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://sharpstechnology.com/role/ScheduleOfWarrantOutstandingDetails" xlink:href="stss-20240930.xsd#ScheduleOfWarrantOutstandingDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://sharpstechnology.com/role/WarrantLiabilityDetailsNarrative" xlink:href="stss-20240930.xsd#WarrantLiabilityDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://sharpstechnology.com/role/ScheduleOfStockOptionsGrantedAndOutstandingDetails" xlink:href="stss-20240930.xsd#ScheduleOfStockOptionsGrantedAndOutstandingDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://sharpstechnology.com/role/ScheduleOfInformationAboutOptionsOutstandingDetails" xlink:href="stss-20240930.xsd#ScheduleOfInformationAboutOptionsOutstandingDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://sharpstechnology.com/role/ScheduleOfFairValueOfStockOptionAwardsDetails" xlink:href="stss-20240930.xsd#ScheduleOfFairValueOfStockOptionAwardsDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://sharpstechnology.com/role/StockOptionsDetailsNarrative" xlink:href="stss-20240930.xsd#StockOptionsDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://sharpstechnology.com/role/ScheduleOfReconciliationOfFederalStatutoryRateToTotalEffectiveRateDetails" xlink:href="stss-20240930.xsd#ScheduleOfReconciliationOfFederalStatutoryRateToTotalEffectiveRateDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://sharpstechnology.com/role/ScheduleOfComponentsOfDeferredTaxAssetsDetails" xlink:href="stss-20240930.xsd#ScheduleOfComponentsOfDeferredTaxAssetsDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://sharpstechnology.com/role/ScheduleOfGeographicalComponentsOfLossBeforeIncomeTaxesDetails" xlink:href="stss-20240930.xsd#ScheduleOfGeographicalComponentsOfLossBeforeIncomeTaxesDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://sharpstechnology.com/role/IncomeTaxesDetailsNarrative" xlink:href="stss-20240930.xsd#IncomeTaxesDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://sharpstechnology.com/role/RelatedPartyTransactionsAndBalancesDetailsNarrative" xlink:href="stss-20240930.xsd#RelatedPartyTransactionsAndBalancesDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://sharpstechnology.com/role/ScheduleOfAssetsAndLiabilitiesMeasuredAtFairValueOnRecurringBasisDetails" xlink:href="stss-20240930.xsd#ScheduleOfAssetsAndLiabilitiesMeasuredAtFairValueOnRecurringBasisDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://sharpstechnology.com/role/CommitmentsAndContingenciesDetailsNarrative" xlink:href="stss-20240930.xsd#CommitmentsAndContingenciesDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://sharpstechnology.com/role/ScheduleOfFixedAssetsNetDetails" xlink:href="stss-20240930.xsd#ScheduleOfFixedAssetsNetDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://sharpstechnology.com/role/ScheduleOfFairValueOfAssetsAcquisitionDetailsDisclosure" xlink:href="stss-20240930.xsd#ScheduleOfFairValueOfAssetsAcquisitionDetailsDisclosure" xlink:type="simple" />
    <link:roleRef roleURI="http://sharpstechnology.com/role/SubsequentEventsDetailsNarrative" xlink:href="stss-20240930.xsd#SubsequentEventsDetailsNarrative" xlink:type="simple" />
    <link:presentationLink xlink:type="extended" xlink:role="http://sharpstechnology.com/role/Cover" xlink:title="00000001 - Document - Cover">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_CoverAbstract" xlink:label="loc_deiCoverAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressesTable" xlink:label="loc_deiEntityAddressesTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressesTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressesLineItems" xlink:label="loc_deiEntityAddressesLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityAddressesTable" xlink:to="loc_deiEntityAddressesLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressesAddressTypeAxis" xlink:label="loc_deiEntityAddressesAddressTypeAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityAddressesTable" xlink:to="loc_deiEntityAddressesAddressTypeAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_AddressTypeDomain" xlink:label="loc_deiAddressTypeDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityAddressesAddressTypeAxis" xlink:to="loc_deiAddressTypeDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_BusinessContactMember" xlink:label="loc_deiBusinessContactMember" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiAddressTypeDomain" xlink:to="loc_deiBusinessContactMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentType" xlink:label="loc_deiDocumentType" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiDocumentType" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_AmendmentFlag" xlink:label="loc_deiAmendmentFlag" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiAmendmentFlag" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_AmendmentDescription" xlink:label="loc_deiAmendmentDescription" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiAmendmentDescription" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentRegistrationStatement" xlink:label="loc_deiDocumentRegistrationStatement" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiDocumentRegistrationStatement" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentAnnualReport" xlink:label="loc_deiDocumentAnnualReport" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiDocumentAnnualReport" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentQuarterlyReport" xlink:label="loc_deiDocumentQuarterlyReport" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiDocumentQuarterlyReport" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentTransitionReport" xlink:label="loc_deiDocumentTransitionReport" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiDocumentTransitionReport" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentShellCompanyReport" xlink:label="loc_deiDocumentShellCompanyReport" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiDocumentShellCompanyReport" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentShellCompanyEventDate" xlink:label="loc_deiDocumentShellCompanyEventDate" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiDocumentShellCompanyEventDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentPeriodStartDate" xlink:label="loc_deiDocumentPeriodStartDate" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiDocumentPeriodStartDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentPeriodEndDate" xlink:label="loc_deiDocumentPeriodEndDate" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiDocumentPeriodEndDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentFiscalPeriodFocus" xlink:label="loc_deiDocumentFiscalPeriodFocus" />
      <link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiDocumentFiscalPeriodFocus" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentFiscalYearFocus" xlink:label="loc_deiDocumentFiscalYearFocus" />
      <link:presentationArc order="120" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiDocumentFiscalYearFocus" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_CurrentFiscalYearEndDate" xlink:label="loc_deiCurrentFiscalYearEndDate" />
      <link:presentationArc order="130" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiCurrentFiscalYearEndDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityFileNumber" xlink:label="loc_deiEntityFileNumber" />
      <link:presentationArc order="140" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiEntityFileNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityRegistrantName" xlink:label="loc_deiEntityRegistrantName" />
      <link:presentationArc order="150" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiEntityRegistrantName" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityCentralIndexKey" xlink:label="loc_deiEntityCentralIndexKey" />
      <link:presentationArc order="160" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiEntityCentralIndexKey" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityPrimarySicNumber" xlink:label="loc_deiEntityPrimarySicNumber" />
      <link:presentationArc order="170" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiEntityPrimarySicNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityTaxIdentificationNumber" xlink:label="loc_deiEntityTaxIdentificationNumber" />
      <link:presentationArc order="180" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiEntityTaxIdentificationNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityIncorporationStateCountryCode" xlink:label="loc_deiEntityIncorporationStateCountryCode" />
      <link:presentationArc order="190" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiEntityIncorporationStateCountryCode" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressAddressLine1" xlink:label="loc_deiEntityAddressAddressLine1" />
      <link:presentationArc order="200" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiEntityAddressAddressLine1" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressAddressLine2" xlink:label="loc_deiEntityAddressAddressLine2" />
      <link:presentationArc order="210" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiEntityAddressAddressLine2" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressAddressLine3" xlink:label="loc_deiEntityAddressAddressLine3" />
      <link:presentationArc order="220" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiEntityAddressAddressLine3" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressCityOrTown" xlink:label="loc_deiEntityAddressCityOrTown" />
      <link:presentationArc order="230" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiEntityAddressCityOrTown" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressStateOrProvince" xlink:label="loc_deiEntityAddressStateOrProvince" />
      <link:presentationArc order="240" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiEntityAddressStateOrProvince" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressCountry" xlink:label="loc_deiEntityAddressCountry" />
      <link:presentationArc order="250" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiEntityAddressCountry" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressPostalZipCode" xlink:label="loc_deiEntityAddressPostalZipCode" />
      <link:presentationArc order="260" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiEntityAddressPostalZipCode" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_CountryRegion" xlink:label="loc_deiCountryRegion" />
      <link:presentationArc order="270" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiCountryRegion" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_CityAreaCode" xlink:label="loc_deiCityAreaCode" />
      <link:presentationArc order="280" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiCityAreaCode" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_LocalPhoneNumber" xlink:label="loc_deiLocalPhoneNumber" />
      <link:presentationArc order="290" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiLocalPhoneNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_Extension" xlink:label="loc_deiExtension" />
      <link:presentationArc order="300" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiExtension" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_WrittenCommunications" xlink:label="loc_deiWrittenCommunications" />
      <link:presentationArc order="310" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiWrittenCommunications" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_SolicitingMaterial" xlink:label="loc_deiSolicitingMaterial" />
      <link:presentationArc order="320" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiSolicitingMaterial" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_PreCommencementTenderOffer" xlink:label="loc_deiPreCommencementTenderOffer" />
      <link:presentationArc order="330" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiPreCommencementTenderOffer" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_PreCommencementIssuerTenderOffer" xlink:label="loc_deiPreCommencementIssuerTenderOffer" />
      <link:presentationArc order="340" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiPreCommencementIssuerTenderOffer" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_Security12bTitle" xlink:label="loc_deiSecurity12bTitle" />
      <link:presentationArc order="350" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiSecurity12bTitle" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_NoTradingSymbolFlag" xlink:label="loc_deiNoTradingSymbolFlag" />
      <link:presentationArc order="360" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiNoTradingSymbolFlag" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_TradingSymbol" xlink:label="loc_deiTradingSymbol" />
      <link:presentationArc order="370" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiTradingSymbol" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_SecurityExchangeName" xlink:label="loc_deiSecurityExchangeName" />
      <link:presentationArc order="380" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiSecurityExchangeName" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_Security12gTitle" xlink:label="loc_deiSecurity12gTitle" />
      <link:presentationArc order="390" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiSecurity12gTitle" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_SecurityReportingObligation" xlink:label="loc_deiSecurityReportingObligation" />
      <link:presentationArc order="400" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiSecurityReportingObligation" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_AnnualInformationForm" xlink:label="loc_deiAnnualInformationForm" />
      <link:presentationArc order="410" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiAnnualInformationForm" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_AuditedAnnualFinancialStatements" xlink:label="loc_deiAuditedAnnualFinancialStatements" />
      <link:presentationArc order="420" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiAuditedAnnualFinancialStatements" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityWellKnownSeasonedIssuer" xlink:label="loc_deiEntityWellKnownSeasonedIssuer" />
      <link:presentationArc order="430" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiEntityWellKnownSeasonedIssuer" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityVoluntaryFilers" xlink:label="loc_deiEntityVoluntaryFilers" />
      <link:presentationArc order="440" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiEntityVoluntaryFilers" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityCurrentReportingStatus" xlink:label="loc_deiEntityCurrentReportingStatus" />
      <link:presentationArc order="450" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiEntityCurrentReportingStatus" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityInteractiveDataCurrent" xlink:label="loc_deiEntityInteractiveDataCurrent" />
      <link:presentationArc order="460" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiEntityInteractiveDataCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityFilerCategory" xlink:label="loc_deiEntityFilerCategory" />
      <link:presentationArc order="470" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiEntityFilerCategory" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntitySmallBusiness" xlink:label="loc_deiEntitySmallBusiness" />
      <link:presentationArc order="480" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiEntitySmallBusiness" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityEmergingGrowthCompany" xlink:label="loc_deiEntityEmergingGrowthCompany" />
      <link:presentationArc order="490" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiEntityEmergingGrowthCompany" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityExTransitionPeriod" xlink:label="loc_deiEntityExTransitionPeriod" />
      <link:presentationArc order="500" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiEntityExTransitionPeriod" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentAccountingStandard" xlink:label="loc_deiDocumentAccountingStandard" />
      <link:presentationArc order="510" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiDocumentAccountingStandard" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_OtherReportingStandardItemNumber" xlink:label="loc_deiOtherReportingStandardItemNumber" />
      <link:presentationArc order="520" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiOtherReportingStandardItemNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityShellCompany" xlink:label="loc_deiEntityShellCompany" />
      <link:presentationArc order="530" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiEntityShellCompany" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityPublicFloat" xlink:label="loc_deiEntityPublicFloat" />
      <link:presentationArc order="540" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiEntityPublicFloat" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityBankruptcyProceedingsReportingCurrent" xlink:label="loc_deiEntityBankruptcyProceedingsReportingCurrent" />
      <link:presentationArc order="550" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiEntityBankruptcyProceedingsReportingCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityCommonStockSharesOutstanding" xlink:label="loc_deiEntityCommonStockSharesOutstanding" />
      <link:presentationArc order="560" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiEntityCommonStockSharesOutstanding" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentsIncorporatedByReferenceTextBlock" xlink:label="loc_deiDocumentsIncorporatedByReferenceTextBlock" />
      <link:presentationArc order="570" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiDocumentsIncorporatedByReferenceTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_ContactPersonnelName" xlink:label="loc_deiContactPersonnelName" />
      <link:presentationArc order="580" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiContactPersonnelName" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://sharpstechnology.com/role/BalanceSheets" xlink:title="00000002 - Statement - Condensed Consolidated Balance Sheets">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementOfFinancialPositionAbstract" xlink:label="loc_us-gaapStatementOfFinancialPositionAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:label="loc_us-gaapScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfFinancialPositionAbstract" xlink:to="loc_us-gaapScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AwardTypeAxis" xlink:label="loc_us-gaapAwardTypeAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="loc_us-gaapAwardTypeAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:label="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAwardTypeAxis" xlink:to="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="stss-20240930.xsd#STSS_ReverseStockSplitMember" xlink:label="loc_STSSReverseStockSplitMember" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="loc_STSSReverseStockSplitMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AssetsAbstract" xlink:label="loc_us-gaapAssetsAbstract" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapAssetsAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AssetsCurrentAbstract" xlink:label="loc_us-gaapAssetsCurrentAbstract" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAssetsAbstract" xlink:to="loc_us-gaapAssetsCurrentAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:label="loc_us-gaapCashAndCashEquivalentsAtCarryingValue" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAssetsCurrentAbstract" xlink:to="loc_us-gaapCashAndCashEquivalentsAtCarryingValue" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:label="loc_us-gaapPrepaidExpenseAndOtherAssetsCurrent" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAssetsCurrentAbstract" xlink:to="loc_us-gaapPrepaidExpenseAndOtherAssetsCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_InventoryNet" xlink:label="loc_us-gaapInventoryNet" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAssetsCurrentAbstract" xlink:to="loc_us-gaapInventoryNet" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AssetsCurrent" xlink:label="loc_us-gaapAssetsCurrent" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAssetsAbstract" xlink:to="loc_us-gaapAssetsCurrent" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentNet" xlink:label="loc_us-gaapPropertyPlantAndEquipmentNet" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAssetsAbstract" xlink:to="loc_us-gaapPropertyPlantAndEquipmentNet" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherAssetsNoncurrent" xlink:label="loc_us-gaapOtherAssetsNoncurrent" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAssetsAbstract" xlink:to="loc_us-gaapOtherAssetsNoncurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_Assets" xlink:label="loc_us-gaapAssets" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAssetsAbstract" xlink:to="loc_us-gaapAssets" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LiabilitiesAbstract" xlink:label="loc_us-gaapLiabilitiesAbstract" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapLiabilitiesAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LiabilitiesCurrentAbstract" xlink:label="loc_us-gaapLiabilitiesCurrentAbstract" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLiabilitiesAbstract" xlink:to="loc_us-gaapLiabilitiesCurrentAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccountsPayableCurrent" xlink:label="loc_us-gaapAccountsPayableCurrent" />
      <link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLiabilitiesCurrentAbstract" xlink:to="loc_us-gaapAccountsPayableCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccountsPayableAndOtherAccruedLiabilitiesCurrent" xlink:label="loc_us-gaapAccountsPayableAndOtherAccruedLiabilitiesCurrent" />
      <link:presentationArc order="120" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLiabilitiesCurrentAbstract" xlink:to="loc_us-gaapAccountsPayableAndOtherAccruedLiabilitiesCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NotesPayableCurrent" xlink:label="loc_us-gaapNotesPayableCurrent" />
      <link:presentationArc order="130" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLiabilitiesCurrentAbstract" xlink:to="loc_us-gaapNotesPayableCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="stss-20240930.xsd#STSS_WarrantLiabilitiesCurrent" xlink:label="loc_STSSWarrantLiabilitiesCurrent" />
      <link:presentationArc order="140" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLiabilitiesCurrentAbstract" xlink:to="loc_STSSWarrantLiabilitiesCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LiabilitiesCurrent" xlink:label="loc_us-gaapLiabilitiesCurrent" />
      <link:presentationArc order="150" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLiabilitiesCurrentAbstract" xlink:to="loc_us-gaapLiabilitiesCurrent" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredIncomeTaxLiabilitiesNet" xlink:label="loc_us-gaapDeferredIncomeTaxLiabilitiesNet" />
      <link:presentationArc order="160" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLiabilitiesAbstract" xlink:to="loc_us-gaapDeferredIncomeTaxLiabilitiesNet" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_Liabilities" xlink:label="loc_us-gaapLiabilities" />
      <link:presentationArc order="170" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLiabilitiesAbstract" xlink:to="loc_us-gaapLiabilities" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommitmentsAndContingencies" xlink:label="loc_us-gaapCommitmentsAndContingencies" />
      <link:presentationArc order="180" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLiabilitiesAbstract" xlink:to="loc_us-gaapCommitmentsAndContingencies" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="stss-20240930.xsd#STSS_SubsequentEvents" xlink:label="loc_STSSSubsequentEvents" />
      <link:presentationArc order="190" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLiabilitiesAbstract" xlink:to="loc_STSSSubsequentEvents" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockholdersEquityAbstract" xlink:label="loc_us-gaapStockholdersEquityAbstract" />
      <link:presentationArc order="200" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLiabilitiesAbstract" xlink:to="loc_us-gaapStockholdersEquityAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PreferredStockValue" xlink:label="loc_us-gaapPreferredStockValue" />
      <link:presentationArc order="210" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStockholdersEquityAbstract" xlink:to="loc_us-gaapPreferredStockValue" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockValue" xlink:label="loc_us-gaapCommonStockValue" />
      <link:presentationArc order="220" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStockholdersEquityAbstract" xlink:to="loc_us-gaapCommonStockValue" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="stss-20240930.xsd#STSS_CommonStockReverseSplitValue" xlink:label="loc_STSSCommonStockReverseSplitValue" />
      <link:presentationArc order="230" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStockholdersEquityAbstract" xlink:to="loc_STSSCommonStockReverseSplitValue" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AdditionalPaidInCapital" xlink:label="loc_us-gaapAdditionalPaidInCapital" />
      <link:presentationArc order="240" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStockholdersEquityAbstract" xlink:to="loc_us-gaapAdditionalPaidInCapital" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:label="loc_us-gaapAccumulatedOtherComprehensiveIncomeLossNetOfTax" />
      <link:presentationArc order="250" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStockholdersEquityAbstract" xlink:to="loc_us-gaapAccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RetainedEarningsAccumulatedDeficit" xlink:label="loc_us-gaapRetainedEarningsAccumulatedDeficit" />
      <link:presentationArc order="260" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStockholdersEquityAbstract" xlink:to="loc_us-gaapRetainedEarningsAccumulatedDeficit" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockholdersEquity" xlink:label="loc_us-gaapStockholdersEquity" />
      <link:presentationArc order="270" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStockholdersEquityAbstract" xlink:to="loc_us-gaapStockholdersEquity" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LiabilitiesAndStockholdersEquity" xlink:label="loc_us-gaapLiabilitiesAndStockholdersEquity" />
      <link:presentationArc order="280" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLiabilitiesAbstract" xlink:to="loc_us-gaapLiabilitiesAndStockholdersEquity" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://sharpstechnology.com/role/BalanceSheetsParenthetical" xlink:title="00000003 - Statement - Condensed Consolidated Balance Sheets (Parenthetical)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementOfFinancialPositionAbstract" xlink:label="loc_us-gaapStatementOfFinancialPositionAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:label="loc_us-gaapScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfFinancialPositionAbstract" xlink:to="loc_us-gaapScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AwardTypeAxis" xlink:label="loc_us-gaapAwardTypeAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="loc_us-gaapAwardTypeAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:label="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAwardTypeAxis" xlink:to="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="stss-20240930.xsd#STSS_ReverseStockSplitMember" xlink:label="loc_STSSReverseStockSplitMember" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="loc_STSSReverseStockSplitMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PreferredStockParOrStatedValuePerShare" xlink:label="loc_us-gaapPreferredStockParOrStatedValuePerShare" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapPreferredStockParOrStatedValuePerShare" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PreferredStockSharesAuthorized" xlink:label="loc_us-gaapPreferredStockSharesAuthorized" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapPreferredStockSharesAuthorized" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PreferredStockSharesIssued" xlink:label="loc_us-gaapPreferredStockSharesIssued" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapPreferredStockSharesIssued" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PreferredStockSharesOutstanding" xlink:label="loc_us-gaapPreferredStockSharesOutstanding" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapPreferredStockSharesOutstanding" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockParOrStatedValuePerShare" xlink:label="loc_us-gaapCommonStockParOrStatedValuePerShare" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapCommonStockParOrStatedValuePerShare" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockSharesAuthorized" xlink:label="loc_us-gaapCommonStockSharesAuthorized" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapCommonStockSharesAuthorized" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockSharesIssued" xlink:label="loc_us-gaapCommonStockSharesIssued" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapCommonStockSharesIssued" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockSharesOutstanding" xlink:label="loc_us-gaapCommonStockSharesOutstanding" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapCommonStockSharesOutstanding" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://sharpstechnology.com/role/StatementsOfOperations" xlink:title="00000004 - Statement - Condensed Consolidated Statements of Operations">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeStatementAbstract" xlink:label="loc_us-gaapIncomeStatementAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:label="loc_us-gaapRevenueFromContractWithCustomerExcludingAssessedTax" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeStatementAbstract" xlink:to="loc_us-gaapRevenueFromContractWithCustomerExcludingAssessedTax" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingExpensesAbstract" xlink:label="loc_us-gaapOperatingExpensesAbstract" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeStatementAbstract" xlink:to="loc_us-gaapOperatingExpensesAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ResearchAndDevelopmentExpense" xlink:label="loc_us-gaapResearchAndDevelopmentExpense" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapOperatingExpensesAbstract" xlink:to="loc_us-gaapResearchAndDevelopmentExpense" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_GeneralAndAdministrativeExpense" xlink:label="loc_us-gaapGeneralAndAdministrativeExpense" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapOperatingExpensesAbstract" xlink:to="loc_us-gaapGeneralAndAdministrativeExpense" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingExpenses" xlink:label="loc_us-gaapOperatingExpenses" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapOperatingExpensesAbstract" xlink:to="loc_us-gaapOperatingExpenses" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingIncomeLoss" xlink:label="loc_us-gaapOperatingIncomeLoss" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeStatementAbstract" xlink:to="loc_us-gaapOperatingIncomeLoss" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NonoperatingIncomeExpenseAbstract" xlink:label="loc_us-gaapNonoperatingIncomeExpenseAbstract" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeStatementAbstract" xlink:to="loc_us-gaapNonoperatingIncomeExpenseAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_InterestIncomeExpenseNet" xlink:label="loc_us-gaapInterestIncomeExpenseNet" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNonoperatingIncomeExpenseAbstract" xlink:to="loc_us-gaapInterestIncomeExpenseNet" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherNonoperatingIncomeExpense" xlink:label="loc_us-gaapOtherNonoperatingIncomeExpense" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNonoperatingIncomeExpenseAbstract" xlink:to="loc_us-gaapOtherNonoperatingIncomeExpense" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="stss-20240930.xsd#STSS_FairMarketValueAdjustmentForContingentStockAndWarrants" xlink:label="loc_STSSFairMarketValueAdjustmentForContingentStockAndWarrants" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNonoperatingIncomeExpenseAbstract" xlink:to="loc_STSSFairMarketValueAdjustmentForContingentStockAndWarrants" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_GainLossOnSaleOfDerivatives" xlink:label="loc_us-gaapGainLossOnSaleOfDerivatives" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNonoperatingIncomeExpenseAbstract" xlink:to="loc_us-gaapGainLossOnSaleOfDerivatives" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="stss-20240930.xsd#STSS_FairMarketValueAdjustmentForContingentWarrantsAndWarrants" xlink:label="loc_STSSFairMarketValueAdjustmentForContingentWarrantsAndWarrants" />
      <link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNonoperatingIncomeExpenseAbstract" xlink:to="loc_STSSFairMarketValueAdjustmentForContingentWarrantsAndWarrants" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="stss-20240930.xsd#STSS_ForeignCurrencyAndNonOperatingIncomeExpenses" xlink:label="loc_STSSForeignCurrencyAndNonOperatingIncomeExpenses" />
      <link:presentationArc order="120" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNonoperatingIncomeExpenseAbstract" xlink:to="loc_STSSForeignCurrencyAndNonOperatingIncomeExpenses" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NonoperatingIncomeExpense" xlink:label="loc_us-gaapNonoperatingIncomeExpense" />
      <link:presentationArc order="130" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNonoperatingIncomeExpenseAbstract" xlink:to="loc_us-gaapNonoperatingIncomeExpense" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:label="loc_us-gaapIncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" />
      <link:presentationArc order="140" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeStatementAbstract" xlink:to="loc_us-gaapIncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredIncomeTaxExpenseBenefit" xlink:label="loc_us-gaapDeferredIncomeTaxExpenseBenefit" />
      <link:presentationArc order="150" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeStatementAbstract" xlink:to="loc_us-gaapDeferredIncomeTaxExpenseBenefit" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetIncomeLoss" xlink:label="loc_us-gaapNetIncomeLoss" />
      <link:presentationArc order="160" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeStatementAbstract" xlink:to="loc_us-gaapNetIncomeLoss" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EarningsPerShareBasic" xlink:label="loc_us-gaapEarningsPerShareBasic" />
      <link:presentationArc order="170" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeStatementAbstract" xlink:to="loc_us-gaapEarningsPerShareBasic" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EarningsPerShareDiluted" xlink:label="loc_us-gaapEarningsPerShareDiluted" />
      <link:presentationArc order="180" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeStatementAbstract" xlink:to="loc_us-gaapEarningsPerShareDiluted" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:label="loc_us-gaapWeightedAverageNumberOfSharesOutstandingBasic" />
      <link:presentationArc order="190" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeStatementAbstract" xlink:to="loc_us-gaapWeightedAverageNumberOfSharesOutstandingBasic" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:label="loc_us-gaapWeightedAverageNumberOfDilutedSharesOutstanding" />
      <link:presentationArc order="200" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeStatementAbstract" xlink:to="loc_us-gaapWeightedAverageNumberOfDilutedSharesOutstanding" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://sharpstechnology.com/role/StatementsOfComprehensiveLoss" xlink:title="00000005 - Statement - Condensed Consolidated Statements of Comprehensive Loss">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeStatementAbstract" xlink:label="loc_us-gaapIncomeStatementAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetIncomeLoss" xlink:label="loc_us-gaapNetIncomeLoss" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeStatementAbstract" xlink:to="loc_us-gaapNetIncomeLoss" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherComprehensiveIncomeLossTaxAbstract" xlink:label="loc_us-gaapOtherComprehensiveIncomeLossTaxAbstract" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeStatementAbstract" xlink:to="loc_us-gaapOtherComprehensiveIncomeLossTaxAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent" xlink:label="loc_us-gaapOtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapOtherComprehensiveIncomeLossTaxAbstract" xlink:to="loc_us-gaapOtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ComprehensiveIncomeNetOfTax" xlink:label="loc_us-gaapComprehensiveIncomeNetOfTax" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapOtherComprehensiveIncomeLossTaxAbstract" xlink:to="loc_us-gaapComprehensiveIncomeNetOfTax" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://sharpstechnology.com/role/StatementOfStockholdersEquity" xlink:title="00000006 - Statement - Condensed Consolidated Statement of Stockholders&apos; Equity">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementOfStockholdersEquityAbstract" xlink:label="loc_us-gaapStatementOfStockholdersEquityAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfStockholdersEquityAbstract" xlink:to="loc_us-gaapStatementTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementEquityComponentsAxis" xlink:label="loc_us-gaapStatementEquityComponentsAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementEquityComponentsAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EquityComponentDomain" xlink:label="loc_us-gaapEquityComponentDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementEquityComponentsAxis" xlink:to="loc_us-gaapEquityComponentDomain" order="70" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PreferredStockMember" xlink:label="loc_us-gaapPreferredStockMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementEquityComponentsAxis" xlink:to="loc_us-gaapPreferredStockMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockMember" xlink:label="loc_us-gaapCommonStockMember" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementEquityComponentsAxis" xlink:to="loc_us-gaapCommonStockMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="stss-20240930.xsd#STSS_CommonStockSubscriptionReceivableMember" xlink:label="loc_STSSCommonStockSubscriptionReceivableMember" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementEquityComponentsAxis" xlink:to="loc_STSSCommonStockSubscriptionReceivableMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AdditionalPaidInCapitalMember" xlink:label="loc_us-gaapAdditionalPaidInCapitalMember" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementEquityComponentsAxis" xlink:to="loc_us-gaapAdditionalPaidInCapitalMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:label="loc_us-gaapAccumulatedOtherComprehensiveIncomeMember" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementEquityComponentsAxis" xlink:to="loc_us-gaapAccumulatedOtherComprehensiveIncomeMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RetainedEarningsMember" xlink:label="loc_us-gaapRetainedEarningsMember" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementEquityComponentsAxis" xlink:to="loc_us-gaapRetainedEarningsMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="stss-20240930.xsd#STSS_AwardsTypeAxis" xlink:label="loc_STSSAwardsTypeAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_STSSAwardsTypeAxis" order="20" />
      <link:loc xlink:type="locator" xlink:href="stss-20240930.xsd#STSS_AwardsTypeDomain" xlink:label="loc_STSSAwardsTypeDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_STSSAwardsTypeAxis" xlink:to="loc_STSSAwardsTypeDomain" order="70" />
      <link:loc xlink:type="locator" xlink:href="stss-20240930.xsd#STSS_ReverseStockSplitMember" xlink:label="loc_STSSReverseStockSplitMember" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_STSSAwardsTypeAxis" xlink:to="loc_STSSReverseStockSplitMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AwardTypeAxis" xlink:label="loc_us-gaapAwardTypeAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapAwardTypeAxis" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:label="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAwardTypeAxis" xlink:to="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" order="70" />
      <link:loc xlink:type="locator" xlink:href="stss-20240930.xsd#STSS_ReverseStockSplitMember" xlink:label="loc_STSSReverseStockSplitMember_2" />
      <link:presentationArc order="150" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAwardTypeAxis" xlink:to="loc_STSSReverseStockSplitMember_2" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockholdersEquity" xlink:label="loc_us-gaapStockholdersEquity" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockholdersEquity" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SharesOutstanding" xlink:label="loc_us-gaapSharesOutstanding" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapSharesOutstanding" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetIncomeLoss" xlink:label="loc_us-gaapNetIncomeLoss" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapNetIncomeLoss" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="stss-20240930.xsd#STSS_StockIssuedDuringPeriodValueInitialPublicOffering" xlink:label="loc_STSSStockIssuedDuringPeriodValueInitialPublicOffering" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_STSSStockIssuedDuringPeriodValueInitialPublicOffering" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="stss-20240930.xsd#STSS_StockIssuedDuringPeriodSharesInitialPublicOffering" xlink:label="loc_STSSStockIssuedDuringPeriodSharesInitialPublicOffering" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_STSSStockIssuedDuringPeriodSharesInitialPublicOffering" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="stss-20240930.xsd#STSS_StockIssuedDuringPeriodValueContingentStockLiability" xlink:label="loc_STSSStockIssuedDuringPeriodValueContingentStockLiability" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_STSSStockIssuedDuringPeriodValueContingentStockLiability" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="stss-20240930.xsd#STSS_StockIssuedDuringPeriodSharesContingentStockLiability" xlink:label="loc_STSSStockIssuedDuringPeriodSharesContingentStockLiability" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_STSSStockIssuedDuringPeriodSharesContingentStockLiability" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:label="loc_us-gaapAdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapAdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="stss-20240930.xsd#STSS_StockIssuedDuringPeriodValueFractionalShareAdjustment" xlink:label="loc_STSSStockIssuedDuringPeriodValueFractionalShareAdjustment" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_STSSStockIssuedDuringPeriodValueFractionalShareAdjustment" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="stss-20240930.xsd#STSS_StockIssuedDuringPeriodSharesFractionalShareAdjustment" xlink:label="loc_STSSStockIssuedDuringPeriodSharesFractionalShareAdjustment" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_STSSStockIssuedDuringPeriodSharesFractionalShareAdjustment" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockIssuedDuringPeriodValueIssuedForServices" xlink:label="loc_us-gaapStockIssuedDuringPeriodValueIssuedForServices" />
      <link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodValueIssuedForServices" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockIssuedDuringPeriodSharesIssuedForServices" xlink:label="loc_us-gaapStockIssuedDuringPeriodSharesIssuedForServices" />
      <link:presentationArc order="120" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodSharesIssuedForServices" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax" xlink:label="loc_us-gaapOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax" />
      <link:presentationArc order="130" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="stss-20240930.xsd#STSS_StockIssuedDuringPeriodCollectionsOfCommonStockSubscriptionsValue" xlink:label="loc_STSSStockIssuedDuringPeriodCollectionsOfCommonStockSubscriptionsValue" />
      <link:presentationArc order="140" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_STSSStockIssuedDuringPeriodCollectionsOfCommonStockSubscriptionsValue" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockIssuedDuringPeriodValueNewIssues" xlink:label="loc_us-gaapStockIssuedDuringPeriodValueNewIssues" />
      <link:presentationArc order="150" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodValueNewIssues" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:label="loc_us-gaapStockIssuedDuringPeriodSharesNewIssues" />
      <link:presentationArc order="160" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodSharesNewIssues" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="stss-20240930.xsd#STSS_StockIssuedDuringPeriodValueShelfRegistrationOffering" xlink:label="loc_STSSStockIssuedDuringPeriodValueShelfRegistrationOffering" />
      <link:presentationArc order="170" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_STSSStockIssuedDuringPeriodValueShelfRegistrationOffering" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="stss-20240930.xsd#STSS_StockIssuedDuringPeriodSharesShelfRegistrationOffering" xlink:label="loc_STSSStockIssuedDuringPeriodSharesShelfRegistrationOffering" />
      <link:presentationArc order="180" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_STSSStockIssuedDuringPeriodSharesShelfRegistrationOffering" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="stss-20240930.xsd#STSS_StockIssuedDuringPeriodValuePrivatePlacement" xlink:label="loc_STSSStockIssuedDuringPeriodValuePrivatePlacement" />
      <link:presentationArc order="190" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_STSSStockIssuedDuringPeriodValuePrivatePlacement" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="stss-20240930.xsd#STSS_StockIssuedDuringPeriodValueExerciseOfPrefundedWarrants" xlink:label="loc_STSSStockIssuedDuringPeriodValueExerciseOfPrefundedWarrants" />
      <link:presentationArc order="200" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_STSSStockIssuedDuringPeriodValueExerciseOfPrefundedWarrants" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="stss-20240930.xsd#STSS_StockIssuedDuringPeriodSharesExerciseOfPrefundedWarrants" xlink:label="loc_STSSStockIssuedDuringPeriodSharesExerciseOfPrefundedWarrants" />
      <link:presentationArc order="210" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_STSSStockIssuedDuringPeriodSharesExerciseOfPrefundedWarrants" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="stss-20240930.xsd#STSS_StockIssuedDuringPeriodValueExerciseOfPrefundedWarrant" xlink:label="loc_STSSStockIssuedDuringPeriodValueExerciseOfPrefundedWarrant" />
      <link:presentationArc order="220" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_STSSStockIssuedDuringPeriodValueExerciseOfPrefundedWarrant" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="stss-20240930.xsd#STSS_StockIssuedDuringPeriodValueRegistrationOffering" xlink:label="loc_STSSStockIssuedDuringPeriodValueRegistrationOffering" />
      <link:presentationArc order="230" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_STSSStockIssuedDuringPeriodValueRegistrationOffering" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="stss-20240930.xsd#STSS_StockIssuedDuringPeriodSharesRegistrationOffering" xlink:label="loc_STSSStockIssuedDuringPeriodSharesRegistrationOffering" />
      <link:presentationArc order="240" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_STSSStockIssuedDuringPeriodSharesRegistrationOffering" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="stss-20240930.xsd#STSS_StockIssuedDuringPeriodValueWarrantInducements" xlink:label="loc_STSSStockIssuedDuringPeriodValueWarrantInducements" />
      <link:presentationArc order="250" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_STSSStockIssuedDuringPeriodValueWarrantInducements" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="stss-20240930.xsd#STSS_StockIssuedDuringPeriodSharesWarrantInducements" xlink:label="loc_STSSStockIssuedDuringPeriodSharesWarrantInducements" />
      <link:presentationArc order="260" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_STSSStockIssuedDuringPeriodSharesWarrantInducements" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockRedeemedOrCalledDuringPeriodValue" xlink:label="loc_us-gaapStockRedeemedOrCalledDuringPeriodValue" />
      <link:presentationArc order="270" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockRedeemedOrCalledDuringPeriodValue" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockRedeemedOrCalledDuringPeriodShares" xlink:label="loc_us-gaapStockRedeemedOrCalledDuringPeriodShares" />
      <link:presentationArc order="280" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockRedeemedOrCalledDuringPeriodShares" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockIssuedDuringPeriodValueOther" xlink:label="loc_us-gaapStockIssuedDuringPeriodValueOther" />
      <link:presentationArc order="290" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodValueOther" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockIssuedDuringPeriodSharesOther" xlink:label="loc_us-gaapStockIssuedDuringPeriodSharesOther" />
      <link:presentationArc order="300" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodSharesOther" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="stss-20240930.xsd#STSS_StockIssuedDuringPeriodValueWarrantExericse" xlink:label="loc_STSSStockIssuedDuringPeriodValueWarrantExericse" />
      <link:presentationArc order="310" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_STSSStockIssuedDuringPeriodValueWarrantExericse" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="stss-20240930.xsd#STSS_StockIssuedDuringPeriodSharesWarrantExericse" xlink:label="loc_STSSStockIssuedDuringPeriodSharesWarrantExericse" />
      <link:presentationArc order="320" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_STSSStockIssuedDuringPeriodSharesWarrantExericse" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockholdersEquity" xlink:label="loc_us-gaapStockholdersEquity_2" />
      <link:presentationArc order="330" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockholdersEquity_2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SharesOutstanding" xlink:label="loc_us-gaapSharesOutstanding_2" />
      <link:presentationArc order="340" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapSharesOutstanding_2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://sharpstechnology.com/role/StatementsOfCashFlows" xlink:title="00000007 - Statement - Condensed Consolidated Statements of Cash Flows">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementOfCashFlowsAbstract" xlink:label="loc_us-gaapStatementOfCashFlowsAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:label="loc_us-gaapNetCashProvidedByUsedInOperatingActivitiesAbstract" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfCashFlowsAbstract" xlink:to="loc_us-gaapNetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetIncomeLoss" xlink:label="loc_us-gaapNetIncomeLoss" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="loc_us-gaapNetIncomeLoss" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:label="loc_us-gaapAdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="loc_us-gaapAdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DepreciationAndAmortization" xlink:label="loc_us-gaapDepreciationAndAmortization" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="loc_us-gaapDepreciationAndAmortization" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensation" xlink:label="loc_us-gaapShareBasedCompensation" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="loc_us-gaapShareBasedCompensation" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IssuanceOfStockAndWarrantsForServicesOrClaims" xlink:label="loc_us-gaapIssuanceOfStockAndWarrantsForServicesOrClaims" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="loc_us-gaapIssuanceOfStockAndWarrantsForServicesOrClaims" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AmortizationOfDebtDiscountPremium" xlink:label="loc_us-gaapAmortizationOfDebtDiscountPremium" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="loc_us-gaapAmortizationOfDebtDiscountPremium" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_GainLossOnSaleOfDerivatives" xlink:label="loc_us-gaapGainLossOnSaleOfDerivatives" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="loc_us-gaapGainLossOnSaleOfDerivatives" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AmortizationOfFinancingCosts" xlink:label="loc_us-gaapAmortizationOfFinancingCosts" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="loc_us-gaapAmortizationOfFinancingCosts" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="stss-20240930.xsd#STSS_EscrowDepositForfeited" xlink:label="loc_STSSEscrowDepositForfeited" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="loc_STSSEscrowDepositForfeited" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="stss-20240930.xsd#STSS_FairMarketValueAdjustmentForContingentWarrants" xlink:label="loc_STSSFairMarketValueAdjustmentForContingentWarrants" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="loc_STSSFairMarketValueAdjustmentForContingentWarrants" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="stss-20240930.xsd#STSS_FairMarketValueAdjustmentForContingentWarrantsAndWarrants" xlink:label="loc_STSSFairMarketValueAdjustmentForContingentWarrantsAndWarrants" />
      <link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="loc_STSSFairMarketValueAdjustmentForContingentWarrantsAndWarrants" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ImpairmentOfLongLivedAssetsHeldForUse" xlink:label="loc_us-gaapImpairmentOfLongLivedAssetsHeldForUse" />
      <link:presentationArc order="120" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="loc_us-gaapImpairmentOfLongLivedAssetsHeldForUse" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredIncomeTaxExpenseBenefit" xlink:label="loc_us-gaapDeferredIncomeTaxExpenseBenefit" />
      <link:presentationArc order="130" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="loc_us-gaapDeferredIncomeTaxExpenseBenefit" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="stss-20240930.xsd#STSS_IpoIssuanceCostsRelatingToWarrants" xlink:label="loc_STSSIpoIssuanceCostsRelatingToWarrants" />
      <link:presentationArc order="140" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="loc_STSSIpoIssuanceCostsRelatingToWarrants" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ForeignCurrencyTransactionGainLossBeforeTax" xlink:label="loc_us-gaapForeignCurrencyTransactionGainLossBeforeTax" />
      <link:presentationArc order="150" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="loc_us-gaapForeignCurrencyTransactionGainLossBeforeTax" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:label="loc_us-gaapIncreaseDecreaseInOperatingCapitalAbstract" />
      <link:presentationArc order="160" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="loc_us-gaapIncreaseDecreaseInOperatingCapitalAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncreaseDecreaseInPrepaidExpense" xlink:label="loc_us-gaapIncreaseDecreaseInPrepaidExpense" />
      <link:presentationArc order="170" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncreaseDecreaseInOperatingCapitalAbstract" xlink:to="loc_us-gaapIncreaseDecreaseInPrepaidExpense" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncreaseDecreaseInInventories" xlink:label="loc_us-gaapIncreaseDecreaseInInventories" />
      <link:presentationArc order="180" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncreaseDecreaseInOperatingCapitalAbstract" xlink:to="loc_us-gaapIncreaseDecreaseInInventories" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncreaseDecreaseInOtherOperatingAssets" xlink:label="loc_us-gaapIncreaseDecreaseInOtherOperatingAssets" />
      <link:presentationArc order="190" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncreaseDecreaseInOperatingCapitalAbstract" xlink:to="loc_us-gaapIncreaseDecreaseInOtherOperatingAssets" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" xlink:label="loc_us-gaapIncreaseDecreaseInAccountsPayableAndAccruedLiabilities" />
      <link:presentationArc order="200" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncreaseDecreaseInOperatingCapitalAbstract" xlink:to="loc_us-gaapIncreaseDecreaseInAccountsPayableAndAccruedLiabilities" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:label="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" />
      <link:presentationArc order="210" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:label="loc_us-gaapNetCashProvidedByUsedInInvestingActivitiesAbstract" />
      <link:presentationArc order="220" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfCashFlowsAbstract" xlink:to="loc_us-gaapNetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PaymentsForProceedsFromOtherInvestingActivities" xlink:label="loc_us-gaapPaymentsForProceedsFromOtherInvestingActivities" />
      <link:presentationArc order="230" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:to="loc_us-gaapPaymentsForProceedsFromOtherInvestingActivities" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="stss-20240930.xsd#STSS_EscrowPaymentUnderAgreement" xlink:label="loc_STSSEscrowPaymentUnderAgreement" />
      <link:presentationArc order="240" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:to="loc_STSSEscrowPaymentUnderAgreement" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:label="loc_us-gaapPaymentsToAcquirePropertyPlantAndEquipment" />
      <link:presentationArc order="250" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:to="loc_us-gaapPaymentsToAcquirePropertyPlantAndEquipment" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="stss-20240930.xsd#STSS_PaymentsToAssetAcquisition" xlink:label="loc_STSSPaymentsToAssetAcquisition" />
      <link:presentationArc order="260" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:to="loc_STSSPaymentsToAssetAcquisition" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:label="loc_us-gaapNetCashProvidedByUsedInInvestingActivities" />
      <link:presentationArc order="270" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:to="loc_us-gaapNetCashProvidedByUsedInInvestingActivities" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:label="loc_us-gaapNetCashProvidedByUsedInFinancingActivitiesAbstract" />
      <link:presentationArc order="280" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfCashFlowsAbstract" xlink:to="loc_us-gaapNetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="stss-20240930.xsd#STSS_NetProceedsFromInitialPublicOfferingAndAdditionalOffering" xlink:label="loc_STSSNetProceedsFromInitialPublicOfferingAndAdditionalOffering" />
      <link:presentationArc order="290" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="loc_STSSNetProceedsFromInitialPublicOfferingAndAdditionalOffering" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="stss-20240930.xsd#STSS_NetProceedsFromOfferingsAndWarrantExercises" xlink:label="loc_STSSNetProceedsFromOfferingsAndWarrantExercises" />
      <link:presentationArc order="300" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="loc_STSSNetProceedsFromOfferingsAndWarrantExercises" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ProceedsFromIssuanceOfLongTermDebt" xlink:label="loc_us-gaapProceedsFromIssuanceOfLongTermDebt" />
      <link:presentationArc order="310" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="loc_us-gaapProceedsFromIssuanceOfLongTermDebt" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RepaymentsOfNotesPayable" xlink:label="loc_us-gaapRepaymentsOfNotesPayable" />
      <link:presentationArc order="320" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="loc_us-gaapRepaymentsOfNotesPayable" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="stss-20240930.xsd#STSS_ProceedsFromSubscriptionsReceivable" xlink:label="loc_STSSProceedsFromSubscriptionsReceivable" />
      <link:presentationArc order="330" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="loc_STSSProceedsFromSubscriptionsReceivable" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:label="loc_us-gaapNetCashProvidedByUsedInFinancingActivities" />
      <link:presentationArc order="340" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="loc_us-gaapNetCashProvidedByUsedInFinancingActivities" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations" xlink:label="loc_us-gaapEffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations" />
      <link:presentationArc order="350" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfCashFlowsAbstract" xlink:to="loc_us-gaapEffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:label="loc_us-gaapCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" />
      <link:presentationArc order="360" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfCashFlowsAbstract" xlink:to="loc_us-gaapCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations" xlink:label="loc_us-gaapCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations" />
      <link:presentationArc order="370" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfCashFlowsAbstract" xlink:to="loc_us-gaapCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations" xlink:label="loc_us-gaapCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations_2" />
      <link:presentationArc order="380" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfCashFlowsAbstract" xlink:to="loc_us-gaapCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations_2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SupplementalCashFlowInformationAbstract" xlink:label="loc_us-gaapSupplementalCashFlowInformationAbstract" />
      <link:presentationArc order="390" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfCashFlowsAbstract" xlink:to="loc_us-gaapSupplementalCashFlowInformationAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_InterestPaidNet" xlink:label="loc_us-gaapInterestPaidNet" />
      <link:presentationArc order="400" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSupplementalCashFlowInformationAbstract" xlink:to="loc_us-gaapInterestPaidNet" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeTaxesPaidNet" xlink:label="loc_us-gaapIncomeTaxesPaidNet" />
      <link:presentationArc order="410" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSupplementalCashFlowInformationAbstract" xlink:to="loc_us-gaapIncomeTaxesPaidNet" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NoncashInvestingAndFinancingItemsAbstract" xlink:label="loc_us-gaapNoncashInvestingAndFinancingItemsAbstract" />
      <link:presentationArc order="420" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfCashFlowsAbstract" xlink:to="loc_us-gaapNoncashInvestingAndFinancingItemsAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="stss-20240930.xsd#STSS_FmvForCommonStockIssuedForContingentShares" xlink:label="loc_STSSFmvForCommonStockIssuedForContingentShares" />
      <link:presentationArc order="430" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNoncashInvestingAndFinancingItemsAbstract" xlink:to="loc_STSSFmvForCommonStockIssuedForContingentShares" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="stss-20240930.xsd#STSS_FmvForWarrantsIssuedForContingentWarrants" xlink:label="loc_STSSFmvForWarrantsIssuedForContingentWarrants" />
      <link:presentationArc order="440" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNoncashInvestingAndFinancingItemsAbstract" xlink:to="loc_STSSFmvForWarrantsIssuedForContingentWarrants" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="stss-20240930.xsd#STSS_CommonStockIssuedAndVestedStockOptionsForFixedAssetsAcquired" xlink:label="loc_STSSCommonStockIssuedAndVestedStockOptionsForFixedAssetsAcquired" />
      <link:presentationArc order="450" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNoncashInvestingAndFinancingItemsAbstract" xlink:to="loc_STSSCommonStockIssuedAndVestedStockOptionsForFixedAssetsAcquired" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="stss-20240930.xsd#STSS_CommonStockIssuedAndVestedStockOptionsIssuedAsConsiderationForAcquisition" xlink:label="loc_STSSCommonStockIssuedAndVestedStockOptionsIssuedAsConsiderationForAcquisition" />
      <link:presentationArc order="460" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNoncashInvestingAndFinancingItemsAbstract" xlink:to="loc_STSSCommonStockIssuedAndVestedStockOptionsIssuedAsConsiderationForAcquisition" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://sharpstechnology.com/role/DescriptionOfBusiness" xlink:title="00000008 - Disclosure - Description of Business">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccountingPoliciesAbstract" xlink:label="loc_us-gaapAccountingPoliciesAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessDescriptionAndBasisOfPresentationTextBlock" xlink:label="loc_us-gaapBusinessDescriptionAndBasisOfPresentationTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapBusinessDescriptionAndBasisOfPresentationTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://sharpstechnology.com/role/SummaryOfSignificantAccountingPolicies" xlink:title="00000009 - Disclosure - Summary of Significant Accounting Policies">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccountingPoliciesAbstract" xlink:label="loc_us-gaapAccountingPoliciesAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SignificantAccountingPoliciesTextBlock" xlink:label="loc_us-gaapSignificantAccountingPoliciesTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapSignificantAccountingPoliciesTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://sharpstechnology.com/role/Inventories" xlink:title="00000010 - Disclosure - Inventories">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_InventoryDisclosureAbstract" xlink:label="loc_us-gaapInventoryDisclosureAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_InventoryDisclosureTextBlock" xlink:label="loc_us-gaapInventoryDisclosureTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapInventoryDisclosureAbstract" xlink:to="loc_us-gaapInventoryDisclosureTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://sharpstechnology.com/role/FixedAssets" xlink:title="00000011 - Disclosure - Fixed Assets">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentAbstract" xlink:label="loc_us-gaapPropertyPlantAndEquipmentAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock" xlink:label="loc_us-gaapPropertyPlantAndEquipmentDisclosureTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPropertyPlantAndEquipmentAbstract" xlink:to="loc_us-gaapPropertyPlantAndEquipmentDisclosureTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://sharpstechnology.com/role/AssetAcquisition" xlink:title="00000012 - Disclosure - Asset Acquisition">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessCombinationAndAssetAcquisitionAbstract" xlink:label="loc_us-gaapBusinessCombinationAndAssetAcquisitionAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AssetAcquisitionTextBlock" xlink:label="loc_us-gaapAssetAcquisitionTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapBusinessCombinationAndAssetAcquisitionAbstract" xlink:to="loc_us-gaapAssetAcquisitionTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://sharpstechnology.com/role/OtherAssets" xlink:title="00000013 - Disclosure - Other Assets">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureAbstract" xlink:label="loc_us-gaapDeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherAssetsDisclosureTextBlock" xlink:label="loc_us-gaapOtherAssetsDisclosureTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureAbstract" xlink:to="loc_us-gaapOtherAssetsDisclosureTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://sharpstechnology.com/role/DebtFinancing" xlink:title="00000014 - Disclosure - Debt Financing">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtDisclosureAbstract" xlink:label="loc_us-gaapDebtDisclosureAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtDisclosureTextBlock" xlink:label="loc_us-gaapDebtDisclosureTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDebtDisclosureAbstract" xlink:to="loc_us-gaapDebtDisclosureTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://sharpstechnology.com/role/NotePurchaseAgreement" xlink:title="00000015 - Disclosure - Note Purchase Agreement">
      <link:loc xlink:type="locator" xlink:href="stss-20240930.xsd#STSS_DisclosureNotePurchaseAgreementAbstract" xlink:label="loc_STSSDisclosureNotePurchaseAgreementAbstract" />
      <link:loc xlink:type="locator" xlink:href="stss-20240930.xsd#STSS_NotePurchaseAgreementTextBlock" xlink:label="loc_STSSNotePurchaseAgreementTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_STSSDisclosureNotePurchaseAgreementAbstract" xlink:to="loc_STSSNotePurchaseAgreementTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://sharpstechnology.com/role/StockholdersEquity" xlink:title="00000016 - Disclosure - Stockholders&#8217; Equity">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EquityAbstract" xlink:label="loc_us-gaapEquityAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:label="loc_us-gaapStockholdersEquityNoteDisclosureTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEquityAbstract" xlink:to="loc_us-gaapStockholdersEquityNoteDisclosureTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://sharpstechnology.com/role/PreferredStock" xlink:title="00000017 - Disclosure - Preferred Stock">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EquityAbstract" xlink:label="loc_us-gaapEquityAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PreferredStockTextBlock" xlink:label="loc_us-gaapPreferredStockTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEquityAbstract" xlink:to="loc_us-gaapPreferredStockTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://sharpstechnology.com/role/WarrantLiability" xlink:title="00000018 - Disclosure - Warrant Liability">
      <link:loc xlink:type="locator" xlink:href="stss-20240930.xsd#STSS_DisclosureWarrantLiabilityAbstract" xlink:label="loc_STSSDisclosureWarrantLiabilityAbstract" />
      <link:loc xlink:type="locator" xlink:href="stss-20240930.xsd#STSS_WarrantLiabilityTextBlock" xlink:label="loc_STSSWarrantLiabilityTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_STSSDisclosureWarrantLiabilityAbstract" xlink:to="loc_STSSWarrantLiabilityTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://sharpstechnology.com/role/StockOptions" xlink:title="00000019 - Disclosure - Stock Options">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:label="loc_us-gaapDisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" xlink:label="loc_us-gaapDisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:to="loc_us-gaapDisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://sharpstechnology.com/role/IncomeTaxes" xlink:title="00000020 - Disclosure - Income Taxes">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeTaxDisclosureAbstract" xlink:label="loc_us-gaapIncomeTaxDisclosureAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeTaxDisclosureTextBlock" xlink:label="loc_us-gaapIncomeTaxDisclosureTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeTaxDisclosureAbstract" xlink:to="loc_us-gaapIncomeTaxDisclosureTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://sharpstechnology.com/role/RelatedPartyTransactionsAndBalances" xlink:title="00000021 - Disclosure - Related Party Transactions and Balances">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RelatedPartyTransactionsAbstract" xlink:label="loc_us-gaapRelatedPartyTransactionsAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RelatedPartyTransactionsDisclosureTextBlock" xlink:label="loc_us-gaapRelatedPartyTransactionsDisclosureTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRelatedPartyTransactionsAbstract" xlink:to="loc_us-gaapRelatedPartyTransactionsDisclosureTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://sharpstechnology.com/role/FairValueMeasurements" xlink:title="00000022 - Disclosure - Fair Value Measurements">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueDisclosuresAbstract" xlink:label="loc_us-gaapFairValueDisclosuresAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueMeasurementInputsDisclosureTextBlock" xlink:label="loc_us-gaapFairValueMeasurementInputsDisclosureTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapFairValueDisclosuresAbstract" xlink:to="loc_us-gaapFairValueMeasurementInputsDisclosureTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://sharpstechnology.com/role/CommitmentsAndContingencies" xlink:title="00000023 - Disclosure - Commitments and Contingencies">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:label="loc_us-gaapCommitmentsAndContingenciesDisclosureAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:label="loc_us-gaapCommitmentsAndContingenciesDisclosureTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapCommitmentsAndContingenciesDisclosureAbstract" xlink:to="loc_us-gaapCommitmentsAndContingenciesDisclosureTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://sharpstechnology.com/role/SubsequentEvents" xlink:title="00000024 - Disclosure - Subsequent Events">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubsequentEventsAbstract" xlink:label="loc_us-gaapSubsequentEventsAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubsequentEventsTextBlock" xlink:label="loc_us-gaapSubsequentEventsTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsequentEventsAbstract" xlink:to="loc_us-gaapSubsequentEventsTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://sharpstechnology.com/role/SummaryOfSignificantAccountingPoliciesPolicies" xlink:title="00000025 - Disclosure - Summary of Significant Accounting Policies (Policies)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccountingPoliciesAbstract" xlink:label="loc_us-gaapAccountingPoliciesAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BasisOfAccountingPolicyPolicyTextBlock" xlink:label="loc_us-gaapBasisOfAccountingPolicyPolicyTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapBasisOfAccountingPolicyPolicyTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_UseOfEstimates" xlink:label="loc_us-gaapUseOfEstimates" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapUseOfEstimates" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CashAndCashEquivalentsPolicyTextBlock" xlink:label="loc_us-gaapCashAndCashEquivalentsPolicyTextBlock" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapCashAndCashEquivalentsPolicyTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_InventoryPolicyTextBlock" xlink:label="loc_us-gaapInventoryPolicyTextBlock" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapInventoryPolicyTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueMeasurementPolicyPolicyTextBlock" xlink:label="loc_us-gaapFairValueMeasurementPolicyPolicyTextBlock" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapFairValueMeasurementPolicyPolicyTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentPolicyTextBlock" xlink:label="loc_us-gaapPropertyPlantAndEquipmentPolicyTextBlock" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapPropertyPlantAndEquipmentPolicyTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock" xlink:label="loc_us-gaapImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IntangibleAssetsFiniteLivedPolicy" xlink:label="loc_us-gaapIntangibleAssetsFiniteLivedPolicy" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapIntangibleAssetsFiniteLivedPolicy" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CompensationRelatedCostsPolicyTextBlock" xlink:label="loc_us-gaapCompensationRelatedCostsPolicyTextBlock" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapCompensationRelatedCostsPolicyTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DerivativesPolicyTextBlock" xlink:label="loc_us-gaapDerivativesPolicyTextBlock" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapDerivativesPolicyTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock" xlink:label="loc_us-gaapForeignCurrencyTransactionsAndTranslationsPolicyTextBlock" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapForeignCurrencyTransactionsAndTranslationsPolicyTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ComprehensiveIncomePolicyPolicyTextBlock" xlink:label="loc_us-gaapComprehensiveIncomePolicyPolicyTextBlock" />
      <link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapComprehensiveIncomePolicyPolicyTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EarningsPerSharePolicyTextBlock" xlink:label="loc_us-gaapEarningsPerSharePolicyTextBlock" />
      <link:presentationArc order="120" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapEarningsPerSharePolicyTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeTaxPolicyTextBlock" xlink:label="loc_us-gaapIncomeTaxPolicyTextBlock" />
      <link:presentationArc order="130" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapIncomeTaxPolicyTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ResearchAndDevelopmentExpensePolicy" xlink:label="loc_us-gaapResearchAndDevelopmentExpensePolicy" />
      <link:presentationArc order="140" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapResearchAndDevelopmentExpensePolicy" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommitmentsAndContingenciesPolicyTextBlock" xlink:label="loc_us-gaapCommitmentsAndContingenciesPolicyTextBlock" />
      <link:presentationArc order="150" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapCommitmentsAndContingenciesPolicyTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:label="loc_us-gaapNewAccountingPronouncementsPolicyPolicyTextBlock" />
      <link:presentationArc order="160" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapNewAccountingPronouncementsPolicyPolicyTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://sharpstechnology.com/role/InventoriesTables" xlink:title="00000026 - Disclosure - Inventories (Tables)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_InventoryDisclosureAbstract" xlink:label="loc_us-gaapInventoryDisclosureAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfInventoryCurrentTableTextBlock" xlink:label="loc_us-gaapScheduleOfInventoryCurrentTableTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapInventoryDisclosureAbstract" xlink:to="loc_us-gaapScheduleOfInventoryCurrentTableTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://sharpstechnology.com/role/FixedAssetsTables" xlink:title="00000027 - Disclosure - Fixed Assets (Tables)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentAbstract" xlink:label="loc_us-gaapPropertyPlantAndEquipmentAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentTextBlock" xlink:label="loc_us-gaapPropertyPlantAndEquipmentTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPropertyPlantAndEquipmentAbstract" xlink:to="loc_us-gaapPropertyPlantAndEquipmentTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://sharpstechnology.com/role/AssetAcquisitionTables" xlink:title="00000028 - Disclosure - Asset Acquisition (Tables)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessCombinationAndAssetAcquisitionAbstract" xlink:label="loc_us-gaapBusinessCombinationAndAssetAcquisitionAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock" xlink:label="loc_us-gaapScheduleOfBusinessAcquisitionsByAcquisitionTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapBusinessCombinationAndAssetAcquisitionAbstract" xlink:to="loc_us-gaapScheduleOfBusinessAcquisitionsByAcquisitionTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://sharpstechnology.com/role/OtherAssetsTables" xlink:title="00000029 - Disclosure - Other Assets (Tables)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureAbstract" xlink:label="loc_us-gaapDeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfOtherAssetsTableTextBlock" xlink:label="loc_us-gaapScheduleOfOtherAssetsTableTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureAbstract" xlink:to="loc_us-gaapScheduleOfOtherAssetsTableTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://sharpstechnology.com/role/WarrantLiabilityTables" xlink:title="00000030 - Disclosure - Warrant Liability (Tables)">
      <link:loc xlink:type="locator" xlink:href="stss-20240930.xsd#STSS_DisclosureWarrantLiabilityAbstract" xlink:label="loc_STSSDisclosureWarrantLiabilityAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_STSSDisclosureWarrantLiabilityAbstract" xlink:to="loc_us-gaapStatementTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementEquityComponentsAxis" xlink:label="loc_us-gaapStatementEquityComponentsAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementEquityComponentsAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EquityComponentDomain" xlink:label="loc_us-gaapEquityComponentDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementEquityComponentsAxis" xlink:to="loc_us-gaapEquityComponentDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_WarrantMember" xlink:label="loc_us-gaapWarrantMember" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEquityComponentDomain" xlink:to="loc_us-gaapWarrantMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" xlink:label="loc_us-gaapScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="stss-20240930.xsd#STSS_ScheduleOfWarrantLiabilityTableTextBlock" xlink:label="loc_STSSScheduleOfWarrantLiabilityTableTextBlock" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_STSSScheduleOfWarrantLiabilityTableTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock" xlink:label="loc_us-gaapScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock" xlink:label="loc_us-gaapFairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapFairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://sharpstechnology.com/role/StockOptionsTables" xlink:title="00000031 - Disclosure - Stock Options (Tables)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:label="loc_us-gaapDisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" xlink:label="loc_us-gaapScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:to="loc_us-gaapScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTextBlock" xlink:label="loc_us-gaapScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTextBlock" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:to="loc_us-gaapScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" xlink:label="loc_us-gaapScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:to="loc_us-gaapScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock" xlink:label="loc_us-gaapFairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:to="loc_us-gaapFairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://sharpstechnology.com/role/IncomeTaxesTables" xlink:title="00000032 - Disclosure - Income Taxes (Tables)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeTaxDisclosureAbstract" xlink:label="loc_us-gaapIncomeTaxDisclosureAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock" xlink:label="loc_us-gaapScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeTaxDisclosureAbstract" xlink:to="loc_us-gaapScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" xlink:label="loc_us-gaapScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeTaxDisclosureAbstract" xlink:to="loc_us-gaapScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock" xlink:label="loc_us-gaapScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeTaxDisclosureAbstract" xlink:to="loc_us-gaapScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://sharpstechnology.com/role/FairValueMeasurementsTables" xlink:title="00000033 - Disclosure - Fair Value Measurements (Tables)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueDisclosuresAbstract" xlink:label="loc_us-gaapFairValueDisclosuresAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock" xlink:label="loc_us-gaapScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapFairValueDisclosuresAbstract" xlink:to="loc_us-gaapScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://sharpstechnology.com/role/DescriptionOfBusinessDetailsNarrative" xlink:title="00000034 - Disclosure - Description of Business (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccountingPoliciesAbstract" xlink:label="loc_us-gaapAccountingPoliciesAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable" xlink:label="loc_us-gaapSubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapSubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubsidiarySaleOfStockLineItems" xlink:label="loc_us-gaapSubsidiarySaleOfStockLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable" xlink:to="loc_us-gaapSubsidiarySaleOfStockLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubsidiarySaleOfStockAxis" xlink:label="loc_us-gaapSubsidiarySaleOfStockAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable" xlink:to="loc_us-gaapSubsidiarySaleOfStockAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SaleOfStockNameOfTransactionDomain" xlink:label="loc_us-gaapSaleOfStockNameOfTransactionDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsidiarySaleOfStockAxis" xlink:to="loc_us-gaapSaleOfStockNameOfTransactionDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IPOMember" xlink:label="loc_us-gaapIPOMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSaleOfStockNameOfTransactionDomain" xlink:to="loc_us-gaapIPOMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ProceedsFromIssuanceInitialPublicOffering" xlink:label="loc_us-gaapProceedsFromIssuanceInitialPublicOffering" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsidiarySaleOfStockLineItems" xlink:to="loc_us-gaapProceedsFromIssuanceInitialPublicOffering" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="stss-20240930.xsd#STSS_WorkingCapital" xlink:label="loc_STSSWorkingCapital" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsidiarySaleOfStockLineItems" xlink:to="loc_STSSWorkingCapital" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="stss-20240930.xsd#STSS_ReverseStockSplitDescription" xlink:label="loc_STSSReverseStockSplitDescription" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsidiarySaleOfStockLineItems" xlink:to="loc_STSSReverseStockSplitDescription" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://sharpstechnology.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative" xlink:title="00000035 - Disclosure - Summary of Significant Accounting Policies (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccountingPoliciesAbstract" xlink:label="loc_us-gaapAccountingPoliciesAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:label="loc_us-gaapScheduleOfPropertyPlantAndEquipmentTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapScheduleOfPropertyPlantAndEquipmentTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentLineItems" xlink:label="loc_us-gaapPropertyPlantAndEquipmentLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfPropertyPlantAndEquipmentTable" xlink:to="loc_us-gaapPropertyPlantAndEquipmentLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:label="loc_us-gaapPropertyPlantAndEquipmentByTypeAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfPropertyPlantAndEquipmentTable" xlink:to="loc_us-gaapPropertyPlantAndEquipmentByTypeAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:label="loc_us-gaapPropertyPlantAndEquipmentTypeDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPropertyPlantAndEquipmentByTypeAxis" xlink:to="loc_us-gaapPropertyPlantAndEquipmentTypeDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BuildingMember" xlink:label="loc_us-gaapBuildingMember" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPropertyPlantAndEquipmentTypeDomain" xlink:to="loc_us-gaapBuildingMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_MachineryAndEquipmentMember" xlink:label="loc_us-gaapMachineryAndEquipmentMember" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPropertyPlantAndEquipmentTypeDomain" xlink:to="loc_us-gaapMachineryAndEquipmentMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="stss-20240930.xsd#STSS_WebsiteMember" xlink:label="loc_STSSWebsiteMember" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPropertyPlantAndEquipmentTypeDomain" xlink:to="loc_STSSWebsiteMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RangeAxis" xlink:label="loc_srtRangeAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfPropertyPlantAndEquipmentTable" xlink:to="loc_srtRangeAxis" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RangeMember" xlink:label="loc_srtRangeMember" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtRangeAxis" xlink:to="loc_srtRangeMember" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_MinimumMember" xlink:label="loc_srtMinimumMember" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtRangeMember" xlink:to="loc_srtMinimumMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_MaximumMember" xlink:label="loc_srtMaximumMember" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtRangeMember" xlink:to="loc_srtMaximumMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementEquityComponentsAxis" xlink:label="loc_us-gaapStatementEquityComponentsAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfPropertyPlantAndEquipmentTable" xlink:to="loc_us-gaapStatementEquityComponentsAxis" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EquityComponentDomain" xlink:label="loc_us-gaapEquityComponentDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementEquityComponentsAxis" xlink:to="loc_us-gaapEquityComponentDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="stss-20240930.xsd#STSS_PrefundendWarrantsMember" xlink:label="loc_STSSPrefundendWarrantsMember" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEquityComponentDomain" xlink:to="loc_STSSPrefundendWarrantsMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:label="loc_us-gaapAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfPropertyPlantAndEquipmentTable" xlink:to="loc_us-gaapAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" order="40" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AntidilutiveSecuritiesNameDomain" xlink:label="loc_us-gaapAntidilutiveSecuritiesNameDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:to="loc_us-gaapAntidilutiveSecuritiesNameDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="stss-20240930.xsd#STSS_StockOptionsAndWarrantsMember" xlink:label="loc_STSSStockOptionsAndWarrantsMember" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAntidilutiveSecuritiesNameDomain" xlink:to="loc_STSSStockOptionsAndWarrantsMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="stss-20240930.xsd#STSS_StockOptionAndWarrantsMember" xlink:label="loc_STSSStockOptionAndWarrantsMember" />
      <link:presentationArc order="200" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAntidilutiveSecuritiesNameDomain" xlink:to="loc_STSSStockOptionAndWarrantsMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:label="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPropertyPlantAndEquipmentLineItems" xlink:to="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_Cash" xlink:label="loc_us-gaapCash" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPropertyPlantAndEquipmentLineItems" xlink:to="loc_us-gaapCash" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CashEquivalentsAtCarryingValue" xlink:label="loc_us-gaapCashEquivalentsAtCarryingValue" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPropertyPlantAndEquipmentLineItems" xlink:to="loc_us-gaapCashEquivalentsAtCarryingValue" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentUsefulLife" xlink:label="loc_us-gaapPropertyPlantAndEquipmentUsefulLife" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPropertyPlantAndEquipmentLineItems" xlink:to="loc_us-gaapPropertyPlantAndEquipmentUsefulLife" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ImpairmentOfLongLivedAssetsHeldForUse" xlink:label="loc_us-gaapImpairmentOfLongLivedAssetsHeldForUse" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPropertyPlantAndEquipmentLineItems" xlink:to="loc_us-gaapImpairmentOfLongLivedAssetsHeldForUse" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:label="loc_us-gaapWeightedAverageNumberOfSharesOutstandingBasic" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPropertyPlantAndEquipmentLineItems" xlink:to="loc_us-gaapWeightedAverageNumberOfSharesOutstandingBasic" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:label="loc_us-gaapAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPropertyPlantAndEquipmentLineItems" xlink:to="loc_us-gaapAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://sharpstechnology.com/role/ScheduleOfInventoriesDetails" xlink:title="00000036 - Disclosure - Schedule of Inventories (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_InventoryDisclosureAbstract" xlink:label="loc_us-gaapInventoryDisclosureAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_InventoryRawMaterialsNetOfReserves" xlink:label="loc_us-gaapInventoryRawMaterialsNetOfReserves" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapInventoryDisclosureAbstract" xlink:to="loc_us-gaapInventoryRawMaterialsNetOfReserves" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_InventoryWorkInProcessNetOfReserves" xlink:label="loc_us-gaapInventoryWorkInProcessNetOfReserves" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapInventoryDisclosureAbstract" xlink:to="loc_us-gaapInventoryWorkInProcessNetOfReserves" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_InventoryFinishedGoodsNetOfReserves" xlink:label="loc_us-gaapInventoryFinishedGoodsNetOfReserves" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapInventoryDisclosureAbstract" xlink:to="loc_us-gaapInventoryFinishedGoodsNetOfReserves" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_InventoryNet" xlink:label="loc_us-gaapInventoryNet" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapInventoryDisclosureAbstract" xlink:to="loc_us-gaapInventoryNet" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://sharpstechnology.com/role/ScheduleOfPropertyPlantAndEquipmentDetails" xlink:title="00000037 - Disclosure - Schedule of Property, Plant and Equipment (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentAbstract" xlink:label="loc_us-gaapPropertyPlantAndEquipmentAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:label="loc_us-gaapScheduleOfPropertyPlantAndEquipmentTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPropertyPlantAndEquipmentAbstract" xlink:to="loc_us-gaapScheduleOfPropertyPlantAndEquipmentTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentLineItems" xlink:label="loc_us-gaapPropertyPlantAndEquipmentLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfPropertyPlantAndEquipmentTable" xlink:to="loc_us-gaapPropertyPlantAndEquipmentLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:label="loc_us-gaapPropertyPlantAndEquipmentByTypeAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfPropertyPlantAndEquipmentTable" xlink:to="loc_us-gaapPropertyPlantAndEquipmentByTypeAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:label="loc_us-gaapPropertyPlantAndEquipmentTypeDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPropertyPlantAndEquipmentByTypeAxis" xlink:to="loc_us-gaapPropertyPlantAndEquipmentTypeDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LandMember" xlink:label="loc_us-gaapLandMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPropertyPlantAndEquipmentTypeDomain" xlink:to="loc_us-gaapLandMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BuildingMember" xlink:label="loc_us-gaapBuildingMember" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPropertyPlantAndEquipmentTypeDomain" xlink:to="loc_us-gaapBuildingMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_MachineryAndEquipmentMember" xlink:label="loc_us-gaapMachineryAndEquipmentMember" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPropertyPlantAndEquipmentTypeDomain" xlink:to="loc_us-gaapMachineryAndEquipmentMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="stss-20240930.xsd#STSS_ComputerSystemsAndWebsiteAndOtherWebsiteMember" xlink:label="loc_STSSComputerSystemsAndWebsiteAndOtherWebsiteMember" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPropertyPlantAndEquipmentTypeDomain" xlink:to="loc_STSSComputerSystemsAndWebsiteAndOtherWebsiteMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentGross" xlink:label="loc_us-gaapPropertyPlantAndEquipmentGross" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPropertyPlantAndEquipmentLineItems" xlink:to="loc_us-gaapPropertyPlantAndEquipmentGross" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:label="loc_us-gaapAccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPropertyPlantAndEquipmentLineItems" xlink:to="loc_us-gaapAccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentNet" xlink:label="loc_us-gaapPropertyPlantAndEquipmentNet" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPropertyPlantAndEquipmentLineItems" xlink:to="loc_us-gaapPropertyPlantAndEquipmentNet" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://sharpstechnology.com/role/FixedAssetsDetailsNarrative" xlink:title="00000038 - Disclosure - Fixed Assets (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentAbstract" xlink:label="loc_us-gaapPropertyPlantAndEquipmentAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:label="loc_us-gaapScheduleOfPropertyPlantAndEquipmentTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPropertyPlantAndEquipmentAbstract" xlink:to="loc_us-gaapScheduleOfPropertyPlantAndEquipmentTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentLineItems" xlink:label="loc_us-gaapPropertyPlantAndEquipmentLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfPropertyPlantAndEquipmentTable" xlink:to="loc_us-gaapPropertyPlantAndEquipmentLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:label="loc_us-gaapPropertyPlantAndEquipmentByTypeAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfPropertyPlantAndEquipmentTable" xlink:to="loc_us-gaapPropertyPlantAndEquipmentByTypeAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:label="loc_us-gaapPropertyPlantAndEquipmentTypeDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPropertyPlantAndEquipmentByTypeAxis" xlink:to="loc_us-gaapPropertyPlantAndEquipmentTypeDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_MachineryAndEquipmentMember" xlink:label="loc_us-gaapMachineryAndEquipmentMember" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPropertyPlantAndEquipmentTypeDomain" xlink:to="loc_us-gaapMachineryAndEquipmentMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AwardTypeAxis" xlink:label="loc_us-gaapAwardTypeAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfPropertyPlantAndEquipmentTable" xlink:to="loc_us-gaapAwardTypeAxis" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:label="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAwardTypeAxis" xlink:to="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockOptionMember" xlink:label="loc_us-gaapStockOptionMember" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="loc_us-gaapStockOptionMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_Depreciation" xlink:label="loc_us-gaapDepreciation" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPropertyPlantAndEquipmentLineItems" xlink:to="loc_us-gaapDepreciation" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AssetImpairmentCharges" xlink:label="loc_us-gaapAssetImpairmentCharges" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPropertyPlantAndEquipmentLineItems" xlink:to="loc_us-gaapAssetImpairmentCharges" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PaymentsToAcquireMachineryAndEquipment" xlink:label="loc_us-gaapPaymentsToAcquireMachineryAndEquipment" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPropertyPlantAndEquipmentLineItems" xlink:to="loc_us-gaapPaymentsToAcquireMachineryAndEquipment" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="stss-20240930.xsd#STSS_RemainingPaymentsDueOnMachinery" xlink:label="loc_STSSRemainingPaymentsDueOnMachinery" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPropertyPlantAndEquipmentLineItems" xlink:to="loc_STSSRemainingPaymentsDueOnMachinery" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://sharpstechnology.com/role/ScheduleOfFairValueOfAssetsAcquisitionDetails" xlink:title="00000039 - Disclosure - Schedule of Fair Value of the Assets Acquisition (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessCombinationAndAssetAcquisitionAbstract" xlink:label="loc_us-gaapBusinessCombinationAndAssetAcquisitionAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:label="loc_us-gaapScheduleOfBusinessAcquisitionsByAcquisitionTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapBusinessCombinationAndAssetAcquisitionAbstract" xlink:to="loc_us-gaapScheduleOfBusinessAcquisitionsByAcquisitionTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessAcquisitionLineItems" xlink:label="loc_us-gaapBusinessAcquisitionLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:to="loc_us-gaapBusinessAcquisitionLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessAcquisitionAxis" xlink:label="loc_us-gaapBusinessAcquisitionAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:to="loc_us-gaapBusinessAcquisitionAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessAcquisitionAcquireeDomain" xlink:label="loc_us-gaapBusinessAcquisitionAcquireeDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapBusinessAcquisitionAxis" xlink:to="loc_us-gaapBusinessAcquisitionAcquireeDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="stss-20240930.xsd#STSS_SafegardMedicalIncMember" xlink:label="loc_STSSSafegardMedicalIncMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapBusinessAcquisitionAcquireeDomain" xlink:to="loc_STSSSafegardMedicalIncMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLand" xlink:label="loc_us-gaapBusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLand" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapBusinessAcquisitionLineItems" xlink:to="loc_us-gaapBusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLand" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedBuildings" xlink:label="loc_us-gaapBusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedBuildings" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapBusinessAcquisitionLineItems" xlink:to="loc_us-gaapBusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedBuildings" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedEquipment" xlink:label="loc_us-gaapBusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedEquipment" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapBusinessAcquisitionLineItems" xlink:to="loc_us-gaapBusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedEquipment" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory" xlink:label="loc_us-gaapBusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapBusinessAcquisitionLineItems" xlink:to="loc_us-gaapBusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles" xlink:label="loc_us-gaapBusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapBusinessAcquisitionLineItems" xlink:to="loc_us-gaapBusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities" xlink:label="loc_us-gaapBusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapBusinessAcquisitionLineItems" xlink:to="loc_us-gaapBusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets" xlink:label="loc_us-gaapBusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapBusinessAcquisitionLineItems" xlink:to="loc_us-gaapBusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://sharpstechnology.com/role/AssetAcquisitionDetailsNarrative" xlink:title="00000040 - Disclosure - Asset Acquisition (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessCombinationAndAssetAcquisitionAbstract" xlink:label="loc_us-gaapBusinessCombinationAndAssetAcquisitionAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:label="loc_us-gaapScheduleOfBusinessAcquisitionsByAcquisitionTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapBusinessCombinationAndAssetAcquisitionAbstract" xlink:to="loc_us-gaapScheduleOfBusinessAcquisitionsByAcquisitionTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessAcquisitionLineItems" xlink:label="loc_us-gaapBusinessAcquisitionLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:to="loc_us-gaapBusinessAcquisitionLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TypeOfArrangementAxis" xlink:label="loc_us-gaapTypeOfArrangementAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:to="loc_us-gaapTypeOfArrangementAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:label="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapTypeOfArrangementAxis" xlink:to="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" order="0" />
      <link:loc xlink:type="locator" xlink:href="stss-20240930.xsd#STSS_SharePurchaseAgreementMember" xlink:label="loc_STSSSharePurchaseAgreementMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" xlink:to="loc_STSSSharePurchaseAgreementMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementEquityComponentsAxis" xlink:label="loc_us-gaapStatementEquityComponentsAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:to="loc_us-gaapStatementEquityComponentsAxis" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EquityComponentDomain" xlink:label="loc_us-gaapEquityComponentDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementEquityComponentsAxis" xlink:to="loc_us-gaapEquityComponentDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockMember" xlink:label="loc_us-gaapCommonStockMember" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEquityComponentDomain" xlink:to="loc_us-gaapCommonStockMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AwardTypeAxis" xlink:label="loc_us-gaapAwardTypeAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:to="loc_us-gaapAwardTypeAxis" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:label="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAwardTypeAxis" xlink:to="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockOptionMember" xlink:label="loc_us-gaapStockOptionMember" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="loc_us-gaapStockOptionMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="stss-20240930.xsd#STSS_StockOptionOneMember" xlink:label="loc_STSSStockOptionOneMember" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="loc_STSSStockOptionOneMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessAcquisitionAxis" xlink:label="loc_us-gaapBusinessAcquisitionAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:to="loc_us-gaapBusinessAcquisitionAxis" order="40" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessAcquisitionAcquireeDomain" xlink:label="loc_us-gaapBusinessAcquisitionAcquireeDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapBusinessAcquisitionAxis" xlink:to="loc_us-gaapBusinessAcquisitionAcquireeDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="stss-20240930.xsd#STSS_SafegardMedicalIncMember" xlink:label="loc_STSSSafegardMedicalIncMember" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapBusinessAcquisitionAcquireeDomain" xlink:to="loc_STSSSafegardMedicalIncMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:label="loc_us-gaapPropertyPlantAndEquipmentByTypeAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:to="loc_us-gaapPropertyPlantAndEquipmentByTypeAxis" order="50" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:label="loc_us-gaapPropertyPlantAndEquipmentTypeDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPropertyPlantAndEquipmentByTypeAxis" xlink:to="loc_us-gaapPropertyPlantAndEquipmentTypeDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BuildingMember" xlink:label="loc_us-gaapBuildingMember" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPropertyPlantAndEquipmentTypeDomain" xlink:to="loc_us-gaapBuildingMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_MachineryAndEquipmentMember" xlink:label="loc_us-gaapMachineryAndEquipmentMember" />
      <link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPropertyPlantAndEquipmentTypeDomain" xlink:to="loc_us-gaapMachineryAndEquipmentMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FiniteLivedIntangibleAssetsMember" xlink:label="loc_us-gaapFiniteLivedIntangibleAssetsMember" />
      <link:presentationArc order="130" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPropertyPlantAndEquipmentTypeDomain" xlink:to="loc_us-gaapFiniteLivedIntangibleAssetsMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RangeAxis" xlink:label="loc_srtRangeAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:to="loc_srtRangeAxis" order="60" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RangeMember" xlink:label="loc_srtRangeMember" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtRangeAxis" xlink:to="loc_srtRangeMember" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_MinimumMember" xlink:label="loc_srtMinimumMember" />
      <link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtRangeMember" xlink:to="loc_srtMinimumMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_MaximumMember" xlink:label="loc_srtMaximumMember" />
      <link:presentationArc order="120" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtRangeMember" xlink:to="loc_srtMaximumMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DerivativeInstrumentRiskAxis" xlink:label="loc_us-gaapDerivativeInstrumentRiskAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:to="loc_us-gaapDerivativeInstrumentRiskAxis" order="70" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DerivativeContractTypeDomain" xlink:label="loc_us-gaapDerivativeContractTypeDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDerivativeInstrumentRiskAxis" xlink:to="loc_us-gaapDerivativeContractTypeDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockOptionMember" xlink:label="loc_us-gaapStockOptionMember_2" />
      <link:presentationArc order="160" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDerivativeContractTypeDomain" xlink:to="loc_us-gaapStockOptionMember_2" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AssetAcquisitionConsiderationTransferred" xlink:label="loc_us-gaapAssetAcquisitionConsiderationTransferred" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapBusinessAcquisitionLineItems" xlink:to="loc_us-gaapAssetAcquisitionConsiderationTransferred" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockIssuedDuringPeriodSharesAcquisitions" xlink:label="loc_us-gaapStockIssuedDuringPeriodSharesAcquisitions" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapBusinessAcquisitionLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodSharesAcquisitions" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SharePrice" xlink:label="loc_us-gaapSharePrice" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapBusinessAcquisitionLineItems" xlink:to="loc_us-gaapSharePrice" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapBusinessAcquisitionLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:label="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapBusinessAcquisitionLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="stss-20240930.xsd#STSS_FairMarketValueOfCommonStock" xlink:label="loc_STSSFairMarketValueOfCommonStock" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapBusinessAcquisitionLineItems" xlink:to="loc_STSSFairMarketValueOfCommonStock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1" xlink:label="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapBusinessAcquisitionLineItems" xlink:to="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingCostsAndExpenses" xlink:label="loc_us-gaapOperatingCostsAndExpenses" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapBusinessAcquisitionLineItems" xlink:to="loc_us-gaapOperatingCostsAndExpenses" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets" xlink:label="loc_us-gaapBusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapBusinessAcquisitionLineItems" xlink:to="loc_us-gaapBusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueOfAssetsAcquired" xlink:label="loc_us-gaapFairValueOfAssetsAcquired" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapBusinessAcquisitionLineItems" xlink:to="loc_us-gaapFairValueOfAssetsAcquired" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FiniteLivedIntangibleAssetUsefulLife" xlink:label="loc_us-gaapFiniteLivedIntangibleAssetUsefulLife" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapBusinessAcquisitionLineItems" xlink:to="loc_us-gaapFiniteLivedIntangibleAssetUsefulLife" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PaymentsToAcquireBusinessesGross" xlink:label="loc_us-gaapPaymentsToAcquireBusinessesGross" />
      <link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapBusinessAcquisitionLineItems" xlink:to="loc_us-gaapPaymentsToAcquireBusinessesGross" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessAcquisitionCostOfAcquiredEntityTransactionCosts" xlink:label="loc_us-gaapBusinessAcquisitionCostOfAcquiredEntityTransactionCosts" />
      <link:presentationArc order="120" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapBusinessAcquisitionLineItems" xlink:to="loc_us-gaapBusinessAcquisitionCostOfAcquiredEntityTransactionCosts" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentUsefulLife" xlink:label="loc_us-gaapPropertyPlantAndEquipmentUsefulLife" />
      <link:presentationArc order="130" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapBusinessAcquisitionLineItems" xlink:to="loc_us-gaapPropertyPlantAndEquipmentUsefulLife" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://sharpstechnology.com/role/ScheduleOfOtherAssetsDetails" xlink:title="00000041 - Disclosure - Schedule of Other Assets (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureAbstract" xlink:label="loc_us-gaapDeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:label="loc_us-gaapIntangibleAssetsNetExcludingGoodwill" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureAbstract" xlink:to="loc_us-gaapIntangibleAssetsNetExcludingGoodwill" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DepositsAssets" xlink:label="loc_us-gaapDepositsAssets" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureAbstract" xlink:to="loc_us-gaapDepositsAssets" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherAssetsMiscellaneousNoncurrent" xlink:label="loc_us-gaapOtherAssetsMiscellaneousNoncurrent" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureAbstract" xlink:to="loc_us-gaapOtherAssetsMiscellaneousNoncurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherAssetsNoncurrent" xlink:label="loc_us-gaapOtherAssetsNoncurrent" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureAbstract" xlink:to="loc_us-gaapOtherAssetsNoncurrent" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://sharpstechnology.com/role/OtherAssetsDetailsNarrative" xlink:title="00000042 - Disclosure - Other Assets (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureAbstract" xlink:label="loc_us-gaapDeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AmortizationOfIntangibleAssets" xlink:label="loc_us-gaapAmortizationOfIntangibleAssets" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureAbstract" xlink:to="loc_us-gaapAmortizationOfIntangibleAssets" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://sharpstechnology.com/role/DebtFinancingDetailsNarrative" xlink:title="00000043 - Disclosure - Debt Financing (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtDisclosureAbstract" xlink:label="loc_us-gaapDebtDisclosureAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfShortTermDebtTable" xlink:label="loc_us-gaapScheduleOfShortTermDebtTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDebtDisclosureAbstract" xlink:to="loc_us-gaapScheduleOfShortTermDebtTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShortTermDebtLineItems" xlink:label="loc_us-gaapShortTermDebtLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfShortTermDebtTable" xlink:to="loc_us-gaapShortTermDebtLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TypeOfArrangementAxis" xlink:label="loc_us-gaapTypeOfArrangementAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfShortTermDebtTable" xlink:to="loc_us-gaapTypeOfArrangementAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:label="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapTypeOfArrangementAxis" xlink:to="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" order="0" />
      <link:loc xlink:type="locator" xlink:href="stss-20240930.xsd#STSS_SecuritiesPurchaseAgreementMember" xlink:label="loc_STSSSecuritiesPurchaseAgreementMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" xlink:to="loc_STSSSecuritiesPurchaseAgreementMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentAxis" xlink:label="loc_us-gaapDebtInstrumentAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfShortTermDebtTable" xlink:to="loc_us-gaapDebtInstrumentAxis" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentNameDomain" xlink:label="loc_us-gaapDebtInstrumentNameDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDebtInstrumentAxis" xlink:to="loc_us-gaapDebtInstrumentNameDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="stss-20240930.xsd#STSS_SeniorSecuredNoteMember" xlink:label="loc_STSSSeniorSecuredNoteMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDebtInstrumentNameDomain" xlink:to="loc_STSSSeniorSecuredNoteMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AwardTypeAxis" xlink:label="loc_us-gaapAwardTypeAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfShortTermDebtTable" xlink:to="loc_us-gaapAwardTypeAxis" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:label="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAwardTypeAxis" xlink:to="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="stss-20240930.xsd#STSS_PreReverseMember" xlink:label="loc_STSSPreReverseMember" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="loc_STSSPreReverseMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentFaceAmount" xlink:label="loc_us-gaapDebtInstrumentFaceAmount" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShortTermDebtLineItems" xlink:to="loc_us-gaapDebtInstrumentFaceAmount" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentIncreaseAccruedInterest" xlink:label="loc_us-gaapDebtInstrumentIncreaseAccruedInterest" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShortTermDebtLineItems" xlink:to="loc_us-gaapDebtInstrumentIncreaseAccruedInterest" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentMaturityDate" xlink:label="loc_us-gaapDebtInstrumentMaturityDate" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShortTermDebtLineItems" xlink:to="loc_us-gaapDebtInstrumentMaturityDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="stss-20240930.xsd#STSS_NumberOfUnregisteredCommonStockIssuedDuringPostReverseShares" xlink:label="loc_STSSNumberOfUnregisteredCommonStockIssuedDuringPostReverseShares" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShortTermDebtLineItems" xlink:to="loc_STSSNumberOfUnregisteredCommonStockIssuedDuringPostReverseShares" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="stss-20240930.xsd#STSS_NumberOfUnregisteredCommonStockIssuedDuringPreReverseShares" xlink:label="loc_STSSNumberOfUnregisteredCommonStockIssuedDuringPreReverseShares" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShortTermDebtLineItems" xlink:to="loc_STSSNumberOfUnregisteredCommonStockIssuedDuringPreReverseShares" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ProceedsFromIssuanceOfDebt" xlink:label="loc_us-gaapProceedsFromIssuanceOfDebt" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShortTermDebtLineItems" xlink:to="loc_us-gaapProceedsFromIssuanceOfDebt" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="stss-20240930.xsd#STSS_PlacementAgentAndOtherOfferingExpenses" xlink:label="loc_STSSPlacementAgentAndOtherOfferingExpenses" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShortTermDebtLineItems" xlink:to="loc_STSSPlacementAgentAndOtherOfferingExpenses" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EscrowDeposit" xlink:label="loc_us-gaapEscrowDeposit" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShortTermDebtLineItems" xlink:to="loc_us-gaapEscrowDeposit" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentFairValue" xlink:label="loc_us-gaapDebtInstrumentFairValue" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShortTermDebtLineItems" xlink:to="loc_us-gaapDebtInstrumentFairValue" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="stss-20240930.xsd#STSS_CommonStockFairValue" xlink:label="loc_STSSCommonStockFairValue" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShortTermDebtLineItems" xlink:to="loc_STSSCommonStockFairValue" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="stss-20240930.xsd#STSS_AccretedInterestFees" xlink:label="loc_STSSAccretedInterestFees" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShortTermDebtLineItems" xlink:to="loc_STSSAccretedInterestFees" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://sharpstechnology.com/role/NotePurchaseAgreementDetailsNarrative" xlink:title="00000044 - Disclosure - Note Purchase Agreement (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="stss-20240930.xsd#STSS_DisclosureNotePurchaseAgreementAbstract" xlink:label="loc_STSSDisclosureNotePurchaseAgreementAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" xlink:label="loc_us-gaapScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_STSSDisclosureNotePurchaseAgreementAbstract" xlink:to="loc_us-gaapScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:label="loc_us-gaapCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" xlink:to="loc_us-gaapCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TypeOfArrangementAxis" xlink:label="loc_us-gaapTypeOfArrangementAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" xlink:to="loc_us-gaapTypeOfArrangementAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:label="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapTypeOfArrangementAxis" xlink:to="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" order="0" />
      <link:loc xlink:type="locator" xlink:href="stss-20240930.xsd#STSS_NotePurchaseAgreementMember" xlink:label="loc_STSSNotePurchaseAgreementMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" xlink:to="loc_STSSNotePurchaseAgreementMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_TitleOfIndividualAxis" xlink:label="loc_srtTitleOfIndividualAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" xlink:to="loc_srtTitleOfIndividualAxis" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:label="loc_srtTitleOfIndividualWithRelationshipToEntityDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtTitleOfIndividualAxis" xlink:to="loc_srtTitleOfIndividualWithRelationshipToEntityDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="stss-20240930.xsd#STSS_UnrelatedThirdPartyPurchasersMember" xlink:label="loc_STSSUnrelatedThirdPartyPurchasersMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtTitleOfIndividualWithRelationshipToEntityDomain" xlink:to="loc_STSSUnrelatedThirdPartyPurchasersMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubsidiarySaleOfStockAxis" xlink:label="loc_us-gaapSubsidiarySaleOfStockAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" xlink:to="loc_us-gaapSubsidiarySaleOfStockAxis" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SaleOfStockNameOfTransactionDomain" xlink:label="loc_us-gaapSaleOfStockNameOfTransactionDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsidiarySaleOfStockAxis" xlink:to="loc_us-gaapSaleOfStockNameOfTransactionDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NoteWarrantMember" xlink:label="loc_us-gaapNoteWarrantMember" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSaleOfStockNameOfTransactionDomain" xlink:to="loc_us-gaapNoteWarrantMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentFaceAmount" xlink:label="loc_us-gaapDebtInstrumentFaceAmount" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="loc_us-gaapDebtInstrumentFaceAmount" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:label="loc_us-gaapDebtInstrumentInterestRateStatedPercentage" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="loc_us-gaapDebtInstrumentInterestRateStatedPercentage" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentDescription" xlink:label="loc_us-gaapDebtInstrumentDescription" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="loc_us-gaapDebtInstrumentDescription" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="stss-20240930.xsd#STSS_ContingentStockLiability" xlink:label="loc_STSSContingentStockLiability" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="loc_STSSContingentStockLiability" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="stss-20240930.xsd#STSS_ContingentWarrantLiability" xlink:label="loc_STSSContingentWarrantLiability" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="loc_STSSContingentWarrantLiability" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PaymentsOfDebtIssuanceCosts" xlink:label="loc_us-gaapPaymentsOfDebtIssuanceCosts" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="loc_us-gaapPaymentsOfDebtIssuanceCosts" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="stss-20240930.xsd#STSS_AllocationOfDebtIssuanceCostToContingentStockAndContingentWarrants" xlink:label="loc_STSSAllocationOfDebtIssuanceCostToContingentStockAndContingentWarrants" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="loc_STSSAllocationOfDebtIssuanceCostToContingentStockAndContingentWarrants" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NotesPayable" xlink:label="loc_us-gaapNotesPayable" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="loc_us-gaapNotesPayable" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentUnamortizedDiscount" xlink:label="loc_us-gaapDebtInstrumentUnamortizedDiscount" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="loc_us-gaapDebtInstrumentUnamortizedDiscount" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_InterestExpense" xlink:label="loc_us-gaapInterestExpense" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="loc_us-gaapInterestExpense" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_InterestPayableCurrent" xlink:label="loc_us-gaapInterestPayableCurrent" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="loc_us-gaapInterestPayableCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RepaymentsOfDebt" xlink:label="loc_us-gaapRepaymentsOfDebt" />
      <link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="loc_us-gaapRepaymentsOfDebt" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockSharesIssued" xlink:label="loc_us-gaapCommonStockSharesIssued" />
      <link:presentationArc order="120" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="loc_us-gaapCommonStockSharesIssued" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueAdjustmentOfWarrants" xlink:label="loc_us-gaapFairValueAdjustmentOfWarrants" />
      <link:presentationArc order="130" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="loc_us-gaapFairValueAdjustmentOfWarrants" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="stss-20240930.xsd#STSS_ContingentWarrants" xlink:label="loc_STSSContingentWarrants" />
      <link:presentationArc order="140" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="loc_STSSContingentWarrants" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice" xlink:label="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice" />
      <link:presentationArc order="150" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://sharpstechnology.com/role/StockholdersEquityDetailsNarrative" xlink:title="00000045 - Disclosure - Stockholders&#8217; Equity (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EquityAbstract" xlink:label="loc_us-gaapEquityAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable" xlink:label="loc_us-gaapSubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEquityAbstract" xlink:to="loc_us-gaapSubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubsidiarySaleOfStockLineItems" xlink:label="loc_us-gaapSubsidiarySaleOfStockLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable" xlink:to="loc_us-gaapSubsidiarySaleOfStockLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubsidiarySaleOfStockAxis" xlink:label="loc_us-gaapSubsidiarySaleOfStockAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable" xlink:to="loc_us-gaapSubsidiarySaleOfStockAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SaleOfStockNameOfTransactionDomain" xlink:label="loc_us-gaapSaleOfStockNameOfTransactionDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsidiarySaleOfStockAxis" xlink:to="loc_us-gaapSaleOfStockNameOfTransactionDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="stss-20240930.xsd#STSS_ShelfOfferingMember" xlink:label="loc_STSSShelfOfferingMember" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSaleOfStockNameOfTransactionDomain" xlink:to="loc_STSSShelfOfferingMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PrivatePlacementMember" xlink:label="loc_us-gaapPrivatePlacementMember" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSaleOfStockNameOfTransactionDomain" xlink:to="loc_us-gaapPrivatePlacementMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="stss-20240930.xsd#STSS_NonTradingWarrantsMember" xlink:label="loc_STSSNonTradingWarrantsMember" />
      <link:presentationArc order="120" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSaleOfStockNameOfTransactionDomain" xlink:to="loc_STSSNonTradingWarrantsMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="stss-20240930.xsd#STSS_SecuritiesPurchaseAgreementMember" xlink:label="loc_STSSSecuritiesPurchaseAgreementMember" />
      <link:presentationArc order="130" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSaleOfStockNameOfTransactionDomain" xlink:to="loc_STSSSecuritiesPurchaseAgreementMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IPOMember" xlink:label="loc_us-gaapIPOMember" />
      <link:presentationArc order="230" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSaleOfStockNameOfTransactionDomain" xlink:to="loc_us-gaapIPOMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NoteWarrantMember" xlink:label="loc_us-gaapNoteWarrantMember" />
      <link:presentationArc order="290" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSaleOfStockNameOfTransactionDomain" xlink:to="loc_us-gaapNoteWarrantMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="stss-20240930.xsd#STSS_TradingWarrantsMember" xlink:label="loc_STSSTradingWarrantsMember" />
      <link:presentationArc order="380" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSaleOfStockNameOfTransactionDomain" xlink:to="loc_STSSTradingWarrantsMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OverAllotmentOptionMember" xlink:label="loc_us-gaapOverAllotmentOptionMember" />
      <link:presentationArc order="390" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSaleOfStockNameOfTransactionDomain" xlink:to="loc_us-gaapOverAllotmentOptionMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="stss-20240930.xsd#STSS_NoteWarrantsMember" xlink:label="loc_STSSNoteWarrantsMember" />
      <link:presentationArc order="460" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSaleOfStockNameOfTransactionDomain" xlink:to="loc_STSSNoteWarrantsMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="stss-20240930.xsd#STSS_InducementWarrantsMember" xlink:label="loc_STSSInducementWarrantsMember" />
      <link:presentationArc order="720" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSaleOfStockNameOfTransactionDomain" xlink:to="loc_STSSInducementWarrantsMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="stss-20240930.xsd#STSS_OverAllotmentWarrantsMember" xlink:label="loc_STSSOverAllotmentWarrantsMember" />
      <link:presentationArc order="1450" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSaleOfStockNameOfTransactionDomain" xlink:to="loc_STSSOverAllotmentWarrantsMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TypeOfArrangementAxis" xlink:label="loc_us-gaapTypeOfArrangementAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable" xlink:to="loc_us-gaapTypeOfArrangementAxis" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:label="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapTypeOfArrangementAxis" xlink:to="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" order="0" />
      <link:loc xlink:type="locator" xlink:href="stss-20240930.xsd#STSS_SecuritiesPurchaseAgreementMember" xlink:label="loc_STSSSecuritiesPurchaseAgreementMember_2" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" xlink:to="loc_STSSSecuritiesPurchaseAgreementMember_2" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="stss-20240930.xsd#STSS_PurchaseAgreementMember" xlink:label="loc_STSSPurchaseAgreementMember" />
      <link:presentationArc order="130" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" xlink:to="loc_STSSPurchaseAgreementMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="stss-20240930.xsd#STSS_NotePurchaseAgreementMember" xlink:label="loc_STSSNotePurchaseAgreementMember" />
      <link:presentationArc order="270" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" xlink:to="loc_STSSNotePurchaseAgreementMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="stss-20240930.xsd#STSS_SubscriptionAgreementsMember" xlink:label="loc_STSSSubscriptionAgreementsMember" />
      <link:presentationArc order="560" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" xlink:to="loc_STSSSubscriptionAgreementsMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="stss-20240930.xsd#STSS_InducementAgreementMember" xlink:label="loc_STSSInducementAgreementMember" />
      <link:presentationArc order="640" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" xlink:to="loc_STSSInducementAgreementMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="stss-20240930.xsd#STSS_InducementWarrantsMember" xlink:label="loc_STSSInducementWarrantsMember_2" />
      <link:presentationArc order="700" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" xlink:to="loc_STSSInducementWarrantsMember_2" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementEquityComponentsAxis" xlink:label="loc_us-gaapStatementEquityComponentsAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable" xlink:to="loc_us-gaapStatementEquityComponentsAxis" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EquityComponentDomain" xlink:label="loc_us-gaapEquityComponentDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementEquityComponentsAxis" xlink:to="loc_us-gaapEquityComponentDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_WarrantMember" xlink:label="loc_us-gaapWarrantMember" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEquityComponentDomain" xlink:to="loc_us-gaapWarrantMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="stss-20240930.xsd#STSS_PIPEPreFundedWarrantsMember" xlink:label="loc_STSSPIPEPreFundedWarrantsMember" />
      <link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEquityComponentDomain" xlink:to="loc_STSSPIPEPreFundedWarrantsMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="stss-20240930.xsd#STSS_PIPEWarrantMember" xlink:label="loc_STSSPIPEWarrantMember" />
      <link:presentationArc order="320" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEquityComponentDomain" xlink:to="loc_STSSPIPEWarrantMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="stss-20240930.xsd#STSS_PreFundedWarrantsMember" xlink:label="loc_STSSPreFundedWarrantsMember" />
      <link:presentationArc order="820" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEquityComponentDomain" xlink:to="loc_STSSPreFundedWarrantsMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AwardTypeAxis" xlink:label="loc_us-gaapAwardTypeAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable" xlink:to="loc_us-gaapAwardTypeAxis" order="40" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:label="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAwardTypeAxis" xlink:to="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="stss-20240930.xsd#STSS_PreReverseMember" xlink:label="loc_STSSPreReverseMember" />
      <link:presentationArc order="550" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="loc_STSSPreReverseMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="stss-20240930.xsd#STSS_ReverseStockSplitMember" xlink:label="loc_STSSReverseStockSplitMember" />
      <link:presentationArc order="780" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="loc_STSSReverseStockSplitMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_TitleOfIndividualAxis" xlink:label="loc_srtTitleOfIndividualAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable" xlink:to="loc_srtTitleOfIndividualAxis" order="50" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:label="loc_srtTitleOfIndividualWithRelationshipToEntityDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtTitleOfIndividualAxis" xlink:to="loc_srtTitleOfIndividualWithRelationshipToEntityDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="stss-20240930.xsd#STSS_InvestorsMember" xlink:label="loc_STSSInvestorsMember" />
      <link:presentationArc order="560" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtTitleOfIndividualWithRelationshipToEntityDomain" xlink:to="loc_STSSInvestorsMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="stss-20240930.xsd#STSS_WarrantHoldersMember" xlink:label="loc_STSSWarrantHoldersMember" />
      <link:presentationArc order="700" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtTitleOfIndividualWithRelationshipToEntityDomain" xlink:to="loc_STSSWarrantHoldersMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="stss-20240930.xsd#STSS_WarrantHolderMember" xlink:label="loc_STSSWarrantHolderMember" />
      <link:presentationArc order="1160" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtTitleOfIndividualWithRelationshipToEntityDomain" xlink:to="loc_STSSWarrantHolderMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RangeAxis" xlink:label="loc_srtRangeAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable" xlink:to="loc_srtRangeAxis" order="60" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RangeMember" xlink:label="loc_srtRangeMember" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtRangeAxis" xlink:to="loc_srtRangeMember" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_MaximumMember" xlink:label="loc_srtMaximumMember" />
      <link:presentationArc order="670" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtRangeMember" xlink:to="loc_srtMaximumMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_MinimumMember" xlink:label="loc_srtMinimumMember" />
      <link:presentationArc order="690" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtRangeMember" xlink:to="loc_srtMinimumMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockSharesAuthorized" xlink:label="loc_us-gaapCommonStockSharesAuthorized" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsidiarySaleOfStockLineItems" xlink:to="loc_us-gaapCommonStockSharesAuthorized" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockParOrStatedValuePerShare" xlink:label="loc_us-gaapCommonStockParOrStatedValuePerShare" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsidiarySaleOfStockLineItems" xlink:to="loc_us-gaapCommonStockParOrStatedValuePerShare" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PreferredStockSharesAuthorized" xlink:label="loc_us-gaapPreferredStockSharesAuthorized" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsidiarySaleOfStockLineItems" xlink:to="loc_us-gaapPreferredStockSharesAuthorized" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PreferredStockParOrStatedValuePerShare" xlink:label="loc_us-gaapPreferredStockParOrStatedValuePerShare" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsidiarySaleOfStockLineItems" xlink:to="loc_us-gaapPreferredStockParOrStatedValuePerShare" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ConversionOfStockDescription" xlink:label="loc_us-gaapConversionOfStockDescription" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsidiarySaleOfStockLineItems" xlink:to="loc_us-gaapConversionOfStockDescription" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ProceedsFromIssuanceOfCommonStock" xlink:label="loc_us-gaapProceedsFromIssuanceOfCommonStock" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsidiarySaleOfStockLineItems" xlink:to="loc_us-gaapProceedsFromIssuanceOfCommonStock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherExpenses" xlink:label="loc_us-gaapOtherExpenses" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsidiarySaleOfStockLineItems" xlink:to="loc_us-gaapOtherExpenses" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ProceedsFromIssuanceInitialPublicOffering" xlink:label="loc_us-gaapProceedsFromIssuanceInitialPublicOffering" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsidiarySaleOfStockLineItems" xlink:to="loc_us-gaapProceedsFromIssuanceInitialPublicOffering" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LegalFees" xlink:label="loc_us-gaapLegalFees" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsidiarySaleOfStockLineItems" xlink:to="loc_us-gaapLegalFees" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:label="loc_us-gaapStockIssuedDuringPeriodSharesNewIssues" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsidiarySaleOfStockLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodSharesNewIssues" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SharesIssuedPricePerShare" xlink:label="loc_us-gaapSharesIssuedPricePerShare" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsidiarySaleOfStockLineItems" xlink:to="loc_us-gaapSharesIssuedPricePerShare" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight" xlink:label="loc_us-gaapClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight" />
      <link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsidiarySaleOfStockLineItems" xlink:to="loc_us-gaapClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" xlink:label="loc_us-gaapClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" />
      <link:presentationArc order="120" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsidiarySaleOfStockLineItems" xlink:to="loc_us-gaapClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ProceedsFromIssuanceOfPrivatePlacement" xlink:label="loc_us-gaapProceedsFromIssuanceOfPrivatePlacement" />
      <link:presentationArc order="130" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsidiarySaleOfStockLineItems" xlink:to="loc_us-gaapProceedsFromIssuanceOfPrivatePlacement" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_WarrantsAndRightsOutstandingTerm" xlink:label="loc_us-gaapWarrantsAndRightsOutstandingTerm" />
      <link:presentationArc order="140" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsidiarySaleOfStockLineItems" xlink:to="loc_us-gaapWarrantsAndRightsOutstandingTerm" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AdditionalPaidInCapital" xlink:label="loc_us-gaapAdditionalPaidInCapital" />
      <link:presentationArc order="150" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsidiarySaleOfStockLineItems" xlink:to="loc_us-gaapAdditionalPaidInCapital" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueAdjustmentOfWarrants" xlink:label="loc_us-gaapFairValueAdjustmentOfWarrants" />
      <link:presentationArc order="160" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsidiarySaleOfStockLineItems" xlink:to="loc_us-gaapFairValueAdjustmentOfWarrants" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_WarrantsAndRightsOutstanding" xlink:label="loc_us-gaapWarrantsAndRightsOutstanding" />
      <link:presentationArc order="170" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsidiarySaleOfStockLineItems" xlink:to="loc_us-gaapWarrantsAndRightsOutstanding" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="stss-20240930.xsd#STSS_NetProceedsFromIssuanceInitialPublicOffering" xlink:label="loc_STSSNetProceedsFromIssuanceInitialPublicOffering" />
      <link:presentationArc order="180" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsidiarySaleOfStockLineItems" xlink:to="loc_STSSNetProceedsFromIssuanceInitialPublicOffering" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NoninterestExpenseOfferingCost" xlink:label="loc_us-gaapNoninterestExpenseOfferingCost" />
      <link:presentationArc order="190" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsidiarySaleOfStockLineItems" xlink:to="loc_us-gaapNoninterestExpenseOfferingCost" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="stss-20240930.xsd#STSS_ClassOfWarrantOrRightExercisePriceOfWarrantsAdjusted" xlink:label="loc_STSSClassOfWarrantOrRightExercisePriceOfWarrantsAdjusted" />
      <link:presentationArc order="200" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsidiarySaleOfStockLineItems" xlink:to="loc_STSSClassOfWarrantOrRightExercisePriceOfWarrantsAdjusted" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="stss-20240930.xsd#STSS_StockIssuedDuringPeriodSharesInitialPublicOffering" xlink:label="loc_STSSStockIssuedDuringPeriodSharesInitialPublicOffering" />
      <link:presentationArc order="210" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsidiarySaleOfStockLineItems" xlink:to="loc_STSSStockIssuedDuringPeriodSharesInitialPublicOffering" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice" xlink:label="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice" />
      <link:presentationArc order="220" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsidiarySaleOfStockLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfWarrantOrRightOutstanding" xlink:label="loc_us-gaapClassOfWarrantOrRightOutstanding" />
      <link:presentationArc order="230" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsidiarySaleOfStockLineItems" xlink:to="loc_us-gaapClassOfWarrantOrRightOutstanding" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockIssuedDuringPeriodSharesIssuedForServices" xlink:label="loc_us-gaapStockIssuedDuringPeriodSharesIssuedForServices" />
      <link:presentationArc order="240" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsidiarySaleOfStockLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodSharesIssuedForServices" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockIssuedDuringPeriodValueIssuedForServices" xlink:label="loc_us-gaapStockIssuedDuringPeriodValueIssuedForServices" />
      <link:presentationArc order="250" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsidiarySaleOfStockLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodValueIssuedForServices" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:label="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" />
      <link:presentationArc order="260" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsidiarySaleOfStockLineItems" xlink:to="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum" />
      <link:presentationArc order="270" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsidiarySaleOfStockLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum" />
      <link:presentationArc order="280" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsidiarySaleOfStockLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum" />
      <link:presentationArc order="290" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsidiarySaleOfStockLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum" />
      <link:presentationArc order="300" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsidiarySaleOfStockLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" />
      <link:presentationArc order="310" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsidiarySaleOfStockLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_MarketRiskBenefitChangeInFairValueGainLoss" xlink:label="loc_us-gaapMarketRiskBenefitChangeInFairValueGainLoss" />
      <link:presentationArc order="320" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsidiarySaleOfStockLineItems" xlink:to="loc_us-gaapMarketRiskBenefitChangeInFairValueGainLoss" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="stss-20240930.xsd#STSS_PaymentsForRepurchaseOfLiability" xlink:label="loc_STSSPaymentsForRepurchaseOfLiability" />
      <link:presentationArc order="330" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsidiarySaleOfStockLineItems" xlink:to="loc_STSSPaymentsForRepurchaseOfLiability" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PaymentsOfStockIssuanceCosts" xlink:label="loc_us-gaapPaymentsOfStockIssuanceCosts" />
      <link:presentationArc order="340" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsidiarySaleOfStockLineItems" xlink:to="loc_us-gaapPaymentsOfStockIssuanceCosts" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate" />
      <link:presentationArc order="350" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsidiarySaleOfStockLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" />
      <link:presentationArc order="360" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsidiarySaleOfStockLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockIssuedDuringPeriodSharesOther" xlink:label="loc_us-gaapStockIssuedDuringPeriodSharesOther" />
      <link:presentationArc order="370" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsidiarySaleOfStockLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodSharesOther" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction" xlink:label="loc_us-gaapSaleOfStockNumberOfSharesIssuedInTransaction" />
      <link:presentationArc order="380" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsidiarySaleOfStockLineItems" xlink:to="loc_us-gaapSaleOfStockNumberOfSharesIssuedInTransaction" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SaleOfStockPricePerShare" xlink:label="loc_us-gaapSaleOfStockPricePerShare" />
      <link:presentationArc order="390" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsidiarySaleOfStockLineItems" xlink:to="loc_us-gaapSaleOfStockPricePerShare" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" xlink:label="loc_us-gaapClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" />
      <link:presentationArc order="400" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsidiarySaleOfStockLineItems" xlink:to="loc_us-gaapClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ProceedsFromIssuanceOfWarrants" xlink:label="loc_us-gaapProceedsFromIssuanceOfWarrants" />
      <link:presentationArc order="410" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsidiarySaleOfStockLineItems" xlink:to="loc_us-gaapProceedsFromIssuanceOfWarrants" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ProceedsFromIssuanceOrSaleOfEquity" xlink:label="loc_us-gaapProceedsFromIssuanceOrSaleOfEquity" />
      <link:presentationArc order="420" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsidiarySaleOfStockLineItems" xlink:to="loc_us-gaapProceedsFromIssuanceOrSaleOfEquity" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SaleOfStockDescriptionOfTransaction" xlink:label="loc_us-gaapSaleOfStockDescriptionOfTransaction" />
      <link:presentationArc order="430" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsidiarySaleOfStockLineItems" xlink:to="loc_us-gaapSaleOfStockDescriptionOfTransaction" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="stss-20240930.xsd#STSS_DescriptionForOfferingShares" xlink:label="loc_STSSDescriptionForOfferingShares" />
      <link:presentationArc order="440" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsidiarySaleOfStockLineItems" xlink:to="loc_STSSDescriptionForOfferingShares" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised" />
      <link:presentationArc order="450" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsidiarySaleOfStockLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="stss-20240930.xsd#STSS_WarrantLiabilitiesCurrent" xlink:label="loc_STSSWarrantLiabilitiesCurrent" />
      <link:presentationArc order="460" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsidiarySaleOfStockLineItems" xlink:to="loc_STSSWarrantLiabilitiesCurrent" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="stss-20240930.xsd#STSS_FairValueAdjustmentOfModificationCharge" xlink:label="loc_STSSFairValueAdjustmentOfModificationCharge" />
      <link:presentationArc order="470" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsidiarySaleOfStockLineItems" xlink:to="loc_STSSFairValueAdjustmentOfModificationCharge" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="stss-20240930.xsd#STSS_ClassOfWarrantOrRightIssued" xlink:label="loc_STSSClassOfWarrantOrRightIssued" />
      <link:presentationArc order="480" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsidiarySaleOfStockLineItems" xlink:to="loc_STSSClassOfWarrantOrRightIssued" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://sharpstechnology.com/role/PreferredStockDetailsNarrative" xlink:title="00000046 - Disclosure - Preferred Stock (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EquityAbstract" xlink:label="loc_us-gaapEquityAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfStockByClassTable" xlink:label="loc_us-gaapScheduleOfStockByClassTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEquityAbstract" xlink:to="loc_us-gaapScheduleOfStockByClassTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfStockLineItems" xlink:label="loc_us-gaapClassOfStockLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfStockByClassTable" xlink:to="loc_us-gaapClassOfStockLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="loc_us-gaapStatementClassOfStockAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfStockByClassTable" xlink:to="loc_us-gaapStatementClassOfStockAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaapClassOfStockDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementClassOfStockAxis" xlink:to="loc_us-gaapClassOfStockDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SeriesAPreferredStockMember" xlink:label="loc_us-gaapSeriesAPreferredStockMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_us-gaapSeriesAPreferredStockMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_TitleOfIndividualAxis" xlink:label="loc_srtTitleOfIndividualAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfStockByClassTable" xlink:to="loc_srtTitleOfIndividualAxis" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:label="loc_srtTitleOfIndividualWithRelationshipToEntityDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtTitleOfIndividualAxis" xlink:to="loc_srtTitleOfIndividualWithRelationshipToEntityDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_DirectorMember" xlink:label="loc_srtDirectorMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtTitleOfIndividualWithRelationshipToEntityDomain" xlink:to="loc_srtDirectorMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis" xlink:label="loc_srtScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfStockByClassTable" xlink:to="loc_srtScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_EquityMethodInvesteeNameDomain" xlink:label="loc_srtEquityMethodInvesteeNameDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis" xlink:to="loc_srtEquityMethodInvesteeNameDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="stss-20240930.xsd#STSS_AlanBlackmanMember" xlink:label="loc_STSSAlanBlackmanMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtEquityMethodInvesteeNameDomain" xlink:to="loc_STSSAlanBlackmanMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubsidiarySaleOfStockAxis" xlink:label="loc_us-gaapSubsidiarySaleOfStockAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfStockByClassTable" xlink:to="loc_us-gaapSubsidiarySaleOfStockAxis" order="40" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SaleOfStockNameOfTransactionDomain" xlink:label="loc_us-gaapSaleOfStockNameOfTransactionDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsidiarySaleOfStockAxis" xlink:to="loc_us-gaapSaleOfStockNameOfTransactionDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IPOMember" xlink:label="loc_us-gaapIPOMember" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSaleOfStockNameOfTransactionDomain" xlink:to="loc_us-gaapIPOMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EquityMethodInvestmentOwnershipPercentage" xlink:label="loc_us-gaapEquityMethodInvestmentOwnershipPercentage" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfStockLineItems" xlink:to="loc_us-gaapEquityMethodInvestmentOwnershipPercentage" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PreferredStockVotingRights" xlink:label="loc_us-gaapPreferredStockVotingRights" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfStockLineItems" xlink:to="loc_us-gaapPreferredStockVotingRights" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://sharpstechnology.com/role/ScheduleOfFairValueOfWarrantDetails" xlink:title="00000047 - Disclosure - Schedule of Fair Value of Warrant (Details)">
      <link:loc xlink:type="locator" xlink:href="stss-20240930.xsd#STSS_DisclosureWarrantLiabilityAbstract" xlink:label="loc_STSSDisclosureWarrantLiabilityAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_STSSDisclosureWarrantLiabilityAbstract" xlink:to="loc_us-gaapStatementTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RangeAxis" xlink:label="loc_srtRangeAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_srtRangeAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RangeMember" xlink:label="loc_srtRangeMember" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtRangeAxis" xlink:to="loc_srtRangeMember" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_MinimumMember" xlink:label="loc_srtMinimumMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtRangeMember" xlink:to="loc_srtMinimumMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_MaximumMember" xlink:label="loc_srtMaximumMember" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtRangeMember" xlink:to="loc_srtMaximumMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementEquityComponentsAxis" xlink:label="loc_us-gaapStatementEquityComponentsAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementEquityComponentsAxis" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EquityComponentDomain" xlink:label="loc_us-gaapEquityComponentDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementEquityComponentsAxis" xlink:to="loc_us-gaapEquityComponentDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_WarrantMember" xlink:label="loc_us-gaapWarrantMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEquityComponentDomain" xlink:to="loc_us-gaapWarrantMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_MeasurementInputTypeAxis" xlink:label="loc_us-gaapMeasurementInputTypeAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapMeasurementInputTypeAxis" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_MeasurementInputTypeDomain" xlink:label="loc_us-gaapMeasurementInputTypeDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapMeasurementInputTypeAxis" xlink:to="loc_us-gaapMeasurementInputTypeDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_MeasurementInputExpectedTermMember" xlink:label="loc_us-gaapMeasurementInputExpectedTermMember" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapMeasurementInputTypeDomain" xlink:to="loc_us-gaapMeasurementInputExpectedTermMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_MeasurementInputOptionVolatilityMember" xlink:label="loc_us-gaapMeasurementInputOptionVolatilityMember" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapMeasurementInputTypeDomain" xlink:to="loc_us-gaapMeasurementInputOptionVolatilityMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_MeasurementInputRiskFreeInterestRateMember" xlink:label="loc_us-gaapMeasurementInputRiskFreeInterestRateMember" />
      <link:presentationArc order="120" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapMeasurementInputTypeDomain" xlink:to="loc_us-gaapMeasurementInputRiskFreeInterestRateMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_MeasurementInputExpectedDividendRateMember" xlink:label="loc_us-gaapMeasurementInputExpectedDividendRateMember" />
      <link:presentationArc order="160" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapMeasurementInputTypeDomain" xlink:to="loc_us-gaapMeasurementInputExpectedDividendRateMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:label="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_WarrantsAndRightsOutstandingTerm" xlink:label="loc_us-gaapWarrantsAndRightsOutstandingTerm" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapWarrantsAndRightsOutstandingTerm" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_WarrantsAndRightsOutstandingMeasurementInput" xlink:label="loc_us-gaapWarrantsAndRightsOutstandingMeasurementInput" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapWarrantsAndRightsOutstandingMeasurementInput" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://sharpstechnology.com/role/ScheduleOfWarrantLiabilityDetails" xlink:title="00000048 - Disclosure - Schedule of Warrant Liability (Details)">
      <link:loc xlink:type="locator" xlink:href="stss-20240930.xsd#STSS_DisclosureWarrantLiabilityAbstract" xlink:label="loc_STSSDisclosureWarrantLiabilityAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable" xlink:label="loc_us-gaapSubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_STSSDisclosureWarrantLiabilityAbstract" xlink:to="loc_us-gaapSubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubsidiarySaleOfStockLineItems" xlink:label="loc_us-gaapSubsidiarySaleOfStockLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable" xlink:to="loc_us-gaapSubsidiarySaleOfStockLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubsidiarySaleOfStockAxis" xlink:label="loc_us-gaapSubsidiarySaleOfStockAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable" xlink:to="loc_us-gaapSubsidiarySaleOfStockAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SaleOfStockNameOfTransactionDomain" xlink:label="loc_us-gaapSaleOfStockNameOfTransactionDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsidiarySaleOfStockAxis" xlink:to="loc_us-gaapSaleOfStockNameOfTransactionDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="stss-20240930.xsd#STSS_TradingAndOverallotmentWarrantsMember" xlink:label="loc_STSSTradingAndOverallotmentWarrantsMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSaleOfStockNameOfTransactionDomain" xlink:to="loc_STSSTradingAndOverallotmentWarrantsMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="stss-20240930.xsd#STSS_NoteWarrantsMember" xlink:label="loc_STSSNoteWarrantsMember" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSaleOfStockNameOfTransactionDomain" xlink:to="loc_STSSNoteWarrantsMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="stss-20240930.xsd#STSS_OfferingWarrantsFebruaryTwentyTwentyThreeMember" xlink:label="loc_STSSOfferingWarrantsFebruaryTwentyTwentyThreeMember" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSaleOfStockNameOfTransactionDomain" xlink:to="loc_STSSOfferingWarrantsFebruaryTwentyTwentyThreeMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="stss-20240930.xsd#STSS_OfferingWarrantsSeptemberTwentyTwentyThreeMember" xlink:label="loc_STSSOfferingWarrantsSeptemberTwentyTwentyThreeMember" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSaleOfStockNameOfTransactionDomain" xlink:to="loc_STSSOfferingWarrantsSeptemberTwentyTwentyThreeMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfWarrantOrRightAxis" xlink:label="loc_us-gaapClassOfWarrantOrRightAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable" xlink:to="loc_us-gaapClassOfWarrantOrRightAxis" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfWarrantOrRightDomain" xlink:label="loc_us-gaapClassOfWarrantOrRightDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfWarrantOrRightAxis" xlink:to="loc_us-gaapClassOfWarrantOrRightDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="stss-20240930.xsd#STSS_TradingAndOverallotmentWarrantsMember" xlink:label="loc_STSSTradingAndOverallotmentWarrantsMember_2" />
      <link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfWarrantOrRightDomain" xlink:to="loc_STSSTradingAndOverallotmentWarrantsMember_2" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="stss-20240930.xsd#STSS_NoteWarrantsMember" xlink:label="loc_STSSNoteWarrantsMember_2" />
      <link:presentationArc order="130" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfWarrantOrRightDomain" xlink:to="loc_STSSNoteWarrantsMember_2" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="stss-20240930.xsd#STSS_OfferingWarrantsFebruaryTwoThousandTwentyThreeMember" xlink:label="loc_STSSOfferingWarrantsFebruaryTwoThousandTwentyThreeMember" />
      <link:presentationArc order="150" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfWarrantOrRightDomain" xlink:to="loc_STSSOfferingWarrantsFebruaryTwoThousandTwentyThreeMember" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="stss-20240930.xsd#STSS_OfferingWarrantsSeptemberTwoThousandTwentyThreeMember" xlink:label="loc_STSSOfferingWarrantsSeptemberTwoThousandTwentyThreeMember" />
      <link:presentationArc order="170" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfWarrantOrRightDomain" xlink:to="loc_STSSOfferingWarrantsSeptemberTwoThousandTwentyThreeMember" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="stss-20240930.xsd#STSS_InducementWarrantsMember" xlink:label="loc_STSSInducementWarrantsMember" />
      <link:presentationArc order="190" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfWarrantOrRightDomain" xlink:to="loc_STSSInducementWarrantsMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="stss-20240930.xsd#STSS_WarrantLiability" xlink:label="loc_STSSWarrantLiability" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsidiarySaleOfStockLineItems" xlink:to="loc_STSSWarrantLiability" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="stss-20240930.xsd#STSS_WarrantLiabilitiesCurrent" xlink:label="loc_STSSWarrantLiabilitiesCurrent" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsidiarySaleOfStockLineItems" xlink:to="loc_STSSWarrantLiabilitiesCurrent" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://sharpstechnology.com/role/ScheduleOfWarrantOutstandingDetails" xlink:title="00000049 - Disclosure - Schedule of Warrant Outstanding (Details)">
      <link:loc xlink:type="locator" xlink:href="stss-20240930.xsd#STSS_DisclosureWarrantLiabilityAbstract" xlink:label="loc_STSSDisclosureWarrantLiabilityAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable" xlink:label="loc_us-gaapSubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_STSSDisclosureWarrantLiabilityAbstract" xlink:to="loc_us-gaapSubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubsidiarySaleOfStockLineItems" xlink:label="loc_us-gaapSubsidiarySaleOfStockLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable" xlink:to="loc_us-gaapSubsidiarySaleOfStockLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubsidiarySaleOfStockAxis" xlink:label="loc_us-gaapSubsidiarySaleOfStockAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable" xlink:to="loc_us-gaapSubsidiarySaleOfStockAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SaleOfStockNameOfTransactionDomain" xlink:label="loc_us-gaapSaleOfStockNameOfTransactionDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsidiarySaleOfStockAxis" xlink:to="loc_us-gaapSaleOfStockNameOfTransactionDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="stss-20240930.xsd#STSS_TradingAndOverallotmentWarrantsMember" xlink:label="loc_STSSTradingAndOverallotmentWarrantsMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSaleOfStockNameOfTransactionDomain" xlink:to="loc_STSSTradingAndOverallotmentWarrantsMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="stss-20240930.xsd#STSS_NoteWarrantsMember" xlink:label="loc_STSSNoteWarrantsMember" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSaleOfStockNameOfTransactionDomain" xlink:to="loc_STSSNoteWarrantsMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="stss-20240930.xsd#STSS_OfferingWarrantsFebruaryTwentyTwentyThreeMember" xlink:label="loc_STSSOfferingWarrantsFebruaryTwentyTwentyThreeMember" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSaleOfStockNameOfTransactionDomain" xlink:to="loc_STSSOfferingWarrantsFebruaryTwentyTwentyThreeMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="stss-20240930.xsd#STSS_OfferingWarrantsSeptemberTwentyTwentyThreeMember" xlink:label="loc_STSSOfferingWarrantsSeptemberTwentyTwentyThreeMember" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSaleOfStockNameOfTransactionDomain" xlink:to="loc_STSSOfferingWarrantsSeptemberTwentyTwentyThreeMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="stss-20240930.xsd#STSS_WarrantsIssuedForServiceManagementMember" xlink:label="loc_STSSWarrantsIssuedForServiceManagementMember" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSaleOfStockNameOfTransactionDomain" xlink:to="loc_STSSWarrantsIssuedForServiceManagementMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfWarrantOrRightAxis" xlink:label="loc_us-gaapClassOfWarrantOrRightAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable" xlink:to="loc_us-gaapClassOfWarrantOrRightAxis" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfWarrantOrRightDomain" xlink:label="loc_us-gaapClassOfWarrantOrRightDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfWarrantOrRightAxis" xlink:to="loc_us-gaapClassOfWarrantOrRightDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="stss-20240930.xsd#STSS_TradingAndOverallotmentWarrantsMember" xlink:label="loc_STSSTradingAndOverallotmentWarrantsMember_2" />
      <link:presentationArc order="130" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfWarrantOrRightDomain" xlink:to="loc_STSSTradingAndOverallotmentWarrantsMember_2" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="stss-20240930.xsd#STSS_NoteWarrantsMember" xlink:label="loc_STSSNoteWarrantsMember_2" />
      <link:presentationArc order="150" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfWarrantOrRightDomain" xlink:to="loc_STSSNoteWarrantsMember_2" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="stss-20240930.xsd#STSS_OfferingWarrantsFebruaryTwoThousandTwentyThreeMember" xlink:label="loc_STSSOfferingWarrantsFebruaryTwoThousandTwentyThreeMember" />
      <link:presentationArc order="170" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfWarrantOrRightDomain" xlink:to="loc_STSSOfferingWarrantsFebruaryTwoThousandTwentyThreeMember" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="stss-20240930.xsd#STSS_OfferingWarrantsSeptemberTwoThousandTwentyThreeMember" xlink:label="loc_STSSOfferingWarrantsSeptemberTwoThousandTwentyThreeMember" />
      <link:presentationArc order="190" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfWarrantOrRightDomain" xlink:to="loc_STSSOfferingWarrantsSeptemberTwoThousandTwentyThreeMember" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="stss-20240930.xsd#STSS_InducementWarrantsMayTwoThousandTwentyFourMember" xlink:label="loc_STSSInducementWarrantsMayTwoThousandTwentyFourMember" />
      <link:presentationArc order="210" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfWarrantOrRightDomain" xlink:to="loc_STSSInducementWarrantsMayTwoThousandTwentyFourMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="stss-20240930.xsd#STSS_WarrantsIssuedForServiceManagementMember" xlink:label="loc_STSSWarrantsIssuedForServiceManagementMember_2" />
      <link:presentationArc order="230" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfWarrantOrRightDomain" xlink:to="loc_STSSWarrantsIssuedForServiceManagementMember_2" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfWarrantOrRightOutstanding" xlink:label="loc_us-gaapClassOfWarrantOrRightOutstanding" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsidiarySaleOfStockLineItems" xlink:to="loc_us-gaapClassOfWarrantOrRightOutstanding" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="stss-20240930.xsd#STSS_ClassOfWarrantsOrRightOutstanding" xlink:label="loc_STSSClassOfWarrantsOrRightOutstanding" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsidiarySaleOfStockLineItems" xlink:to="loc_STSSClassOfWarrantsOrRightOutstanding" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://sharpstechnology.com/role/WarrantLiabilityDetailsNarrative" xlink:title="00000050 - Disclosure - Warrant Liability (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="stss-20240930.xsd#STSS_DisclosureWarrantLiabilityAbstract" xlink:label="loc_STSSDisclosureWarrantLiabilityAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" xlink:label="loc_us-gaapScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_STSSDisclosureWarrantLiabilityAbstract" xlink:to="loc_us-gaapScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:label="loc_us-gaapCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" xlink:to="loc_us-gaapCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TypeOfArrangementAxis" xlink:label="loc_us-gaapTypeOfArrangementAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" xlink:to="loc_us-gaapTypeOfArrangementAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:label="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapTypeOfArrangementAxis" xlink:to="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" order="0" />
      <link:loc xlink:type="locator" xlink:href="stss-20240930.xsd#STSS_InducementAgreementMember" xlink:label="loc_STSSInducementAgreementMember" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" xlink:to="loc_STSSInducementAgreementMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_MarketRiskBenefitChangeInFairValueGainLoss" xlink:label="loc_us-gaapMarketRiskBenefitChangeInFairValueGainLoss" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="loc_us-gaapMarketRiskBenefitChangeInFairValueGainLoss" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_GainLossOnSaleOfDerivatives" xlink:label="loc_us-gaapGainLossOnSaleOfDerivatives" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="loc_us-gaapGainLossOnSaleOfDerivatives" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="stss-20240930.xsd#STSS_FairValueAdjustmentOfModificationCharge" xlink:label="loc_STSSFairValueAdjustmentOfModificationCharge" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="loc_STSSFairValueAdjustmentOfModificationCharge" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="stss-20240930.xsd#STSS_GainLossOnSaleOfDerivative" xlink:label="loc_STSSGainLossOnSaleOfDerivative" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="loc_STSSGainLossOnSaleOfDerivative" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://sharpstechnology.com/role/ScheduleOfStockOptionsGrantedAndOutstandingDetails" xlink:title="00000051 - Disclosure - Schedule of Stock Options Granted and Outstanding (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:label="loc_us-gaapDisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" />
      <link:loc xlink:type="locator" xlink:href="stss-20240930.xsd#STSS_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionOutstandingNumber" xlink:label="loc_STSSShareBasedCompensationArrangementByShareBasedPaymentAwardOptionOutstandingNumber" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:to="loc_STSSShareBasedCompensationArrangementByShareBasedPaymentAwardOptionOutstandingNumber" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" />
      <link:loc xlink:type="locator" xlink:href="stss-20240930.xsd#STSS_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionOutstandingWeightedAverageExercisePrice" xlink:label="loc_STSSShareBasedCompensationArrangementByShareBasedPaymentAwardOptionOutstandingWeightedAverageExercisePrice" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:to="loc_STSSShareBasedCompensationArrangementByShareBasedPaymentAwardOptionOutstandingWeightedAverageExercisePrice" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:label="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:to="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice" xlink:label="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:to="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedNumberOfShares" xlink:label="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedNumberOfShares" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:to="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedNumberOfShares" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice" xlink:label="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:to="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice" xlink:label="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice_2" />
      <link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:to="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice_2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="stss-20240930.xsd#STSS_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionOutstandingNumber" xlink:label="loc_STSSShareBasedCompensationArrangementByShareBasedPaymentAwardOptionOutstandingNumber_2" />
      <link:presentationArc order="120" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:to="loc_STSSShareBasedCompensationArrangementByShareBasedPaymentAwardOptionOutstandingNumber_2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" />
      <link:loc xlink:type="locator" xlink:href="stss-20240930.xsd#STSS_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionOutstandingWeightedAverageExercisePrice" xlink:label="loc_STSSShareBasedCompensationArrangementByShareBasedPaymentAwardOptionOutstandingWeightedAverageExercisePrice_2" />
      <link:presentationArc order="130" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:to="loc_STSSShareBasedCompensationArrangementByShareBasedPaymentAwardOptionOutstandingWeightedAverageExercisePrice_2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_2" />
      <link:presentationArc order="140" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_2" />
      <link:presentationArc order="150" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" />
      <link:presentationArc order="160" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" />
      <link:presentationArc order="170" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://sharpstechnology.com/role/ScheduleOfInformationAboutOptionsOutstandingDetails" xlink:title="00000052 - Disclosure - Schedule of Information About Options Outstanding (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:label="loc_us-gaapDisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTable" xlink:label="loc_us-gaapScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:to="loc_us-gaapScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems" xlink:label="loc_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTable" xlink:to="loc_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis" xlink:label="loc_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTable" xlink:to="loc_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain" xlink:label="loc_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis" xlink:to="loc_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="stss-20240930.xsd#STSS_ExercisePriceRangeOneMember" xlink:label="loc_STSSExercisePriceRangeOneMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain" xlink:to="loc_STSSExercisePriceRangeOneMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="stss-20240930.xsd#STSS_ExercisePriceRangeTwoMember" xlink:label="loc_STSSExercisePriceRangeTwoMember" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain" xlink:to="loc_STSSExercisePriceRangeTwoMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="stss-20240930.xsd#STSS_ExercisePriceRangeThreeMember" xlink:label="loc_STSSExercisePriceRangeThreeMember" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain" xlink:to="loc_STSSExercisePriceRangeThreeMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="stss-20240930.xsd#STSS_ExercisePriceRangeFourMember" xlink:label="loc_STSSExercisePriceRangeFourMember" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain" xlink:to="loc_STSSExercisePriceRangeFourMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="stss-20240930.xsd#STSS_ExercisePriceRangeFiveMember" xlink:label="loc_STSSExercisePriceRangeFiveMember" />
      <link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain" xlink:to="loc_STSSExercisePriceRangeFiveMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="stss-20240930.xsd#STSS_ExercisePriceRangeSixMember" xlink:label="loc_STSSExercisePriceRangeSixMember" />
      <link:presentationArc order="130" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain" xlink:to="loc_STSSExercisePriceRangeSixMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="stss-20240930.xsd#STSS_ExercisePriceRangeSevenMember" xlink:label="loc_STSSExercisePriceRangeSevenMember" />
      <link:presentationArc order="150" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain" xlink:to="loc_STSSExercisePriceRangeSevenMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="stss-20240930.xsd#STSS_ExercisePriceRangeEightMember" xlink:label="loc_STSSExercisePriceRangeEightMember" />
      <link:presentationArc order="170" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain" xlink:to="loc_STSSExercisePriceRangeEightMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="stss-20240930.xsd#STSS_ExercisePriceRangeNineMember" xlink:label="loc_STSSExercisePriceRangeNineMember" />
      <link:presentationArc order="190" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain" xlink:to="loc_STSSExercisePriceRangeNineMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="stss-20240930.xsd#STSS_ExercisePriceRangeTenMember" xlink:label="loc_STSSExercisePriceRangeTenMember" />
      <link:presentationArc order="210" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain" xlink:to="loc_STSSExercisePriceRangeTenMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RangeAxis" xlink:label="loc_srtRangeAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTable" xlink:to="loc_srtRangeAxis" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RangeMember" xlink:label="loc_srtRangeMember" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtRangeAxis" xlink:to="loc_srtRangeMember" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_MinimumMember" xlink:label="loc_srtMinimumMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtRangeMember" xlink:to="loc_srtMinimumMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_MaximumMember" xlink:label="loc_srtMaximumMember" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtRangeMember" xlink:to="loc_srtMaximumMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit" xlink:label="loc_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems" xlink:to="loc_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions" xlink:label="loc_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems" xlink:to="loc_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2" xlink:label="loc_us-gaapSharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems" xlink:to="loc_us-gaapSharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions" xlink:label="loc_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems" xlink:to="loc_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1" xlink:label="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems" xlink:to="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://sharpstechnology.com/role/ScheduleOfFairValueOfStockOptionAwardsDetails" xlink:title="00000053 - Disclosure - Schedule of Fair Value of Stock Option Awards (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:label="loc_us-gaapDisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:label="loc_us-gaapScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:to="loc_us-gaapScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RangeAxis" xlink:label="loc_srtRangeAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="loc_srtRangeAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RangeMember" xlink:label="loc_srtRangeMember" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtRangeAxis" xlink:to="loc_srtRangeMember" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_MinimumMember" xlink:label="loc_srtMinimumMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtRangeMember" xlink:to="loc_srtMinimumMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_MaximumMember" xlink:label="loc_srtMaximumMember" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtRangeMember" xlink:to="loc_srtMaximumMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:label="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://sharpstechnology.com/role/StockOptionsDetailsNarrative" xlink:title="00000054 - Disclosure - Stock Options (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:label="loc_us-gaapDisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:label="loc_us-gaapScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:to="loc_us-gaapScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PlanNameAxis" xlink:label="loc_us-gaapPlanNameAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="loc_us-gaapPlanNameAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PlanNameDomain" xlink:label="loc_us-gaapPlanNameDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPlanNameAxis" xlink:to="loc_us-gaapPlanNameDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="stss-20240930.xsd#STSS_TwoThousandTwentyThreeEquityIncentivePlanMember" xlink:label="loc_STSSTwoThousandTwentyThreeEquityIncentivePlanMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPlanNameDomain" xlink:to="loc_STSSTwoThousandTwentyThreeEquityIncentivePlanMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="stss-20240930.xsd#STSS_TwoThousandTwentyTwoEquityIncentivePlanMember" xlink:label="loc_STSSTwoThousandTwentyTwoEquityIncentivePlanMember" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPlanNameDomain" xlink:to="loc_STSSTwoThousandTwentyTwoEquityIncentivePlanMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_TitleOfIndividualAxis" xlink:label="loc_srtTitleOfIndividualAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="loc_srtTitleOfIndividualAxis" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:label="loc_srtTitleOfIndividualWithRelationshipToEntityDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtTitleOfIndividualAxis" xlink:to="loc_srtTitleOfIndividualWithRelationshipToEntityDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="stss-20240930.xsd#STSS_EmployeesAndConsultantMember" xlink:label="loc_STSSEmployeesAndConsultantMember" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtTitleOfIndividualWithRelationshipToEntityDomain" xlink:to="loc_STSSEmployeesAndConsultantMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RangeAxis" xlink:label="loc_srtRangeAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="loc_srtRangeAxis" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RangeMember" xlink:label="loc_srtRangeMember" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtRangeAxis" xlink:to="loc_srtRangeMember" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_MinimumMember" xlink:label="loc_srtMinimumMember" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtRangeMember" xlink:to="loc_srtMinimumMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_MaximumMember" xlink:label="loc_srtMaximumMember" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtRangeMember" xlink:to="loc_srtMaximumMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeStatementLocationAxis" xlink:label="loc_us-gaapIncomeStatementLocationAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="loc_us-gaapIncomeStatementLocationAxis" order="40" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeStatementLocationDomain" xlink:label="loc_us-gaapIncomeStatementLocationDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeStatementLocationAxis" xlink:to="loc_us-gaapIncomeStatementLocationDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_GeneralAndAdministrativeExpenseMember" xlink:label="loc_us-gaapGeneralAndAdministrativeExpenseMember" />
      <link:presentationArc order="140" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeStatementLocationDomain" xlink:to="loc_us-gaapGeneralAndAdministrativeExpenseMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ResearchAndDevelopmentExpenseMember" xlink:label="loc_us-gaapResearchAndDevelopmentExpenseMember" />
      <link:presentationArc order="150" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeStatementLocationDomain" xlink:to="loc_us-gaapResearchAndDevelopmentExpenseMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:label="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation" xlink:label="loc_us-gaapStockIssuedDuringPeriodSharesShareBasedCompensation" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodSharesShareBasedCompensation" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockParOrStatedValuePerShare" xlink:label="loc_us-gaapCommonStockParOrStatedValuePerShare" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapCommonStockParOrStatedValuePerShare" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="stss-20240930.xsd#STSS_ShareBasedCompensationOptionsExercisableWeightedAverageExercisePrice" xlink:label="loc_STSSShareBasedCompensationOptionsExercisableWeightedAverageExercisePrice" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_STSSShareBasedCompensationOptionsExercisableWeightedAverageExercisePrice" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized" xlink:label="loc_us-gaapEmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapEmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:label="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AllocatedShareBasedCompensationExpense" xlink:label="loc_us-gaapAllocatedShareBasedCompensationExpense" />
      <link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapAllocatedShareBasedCompensationExpense" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="stss-20240930.xsd#STSS_StockBasedChargesRelatingToPurchaseOfMachinery" xlink:label="loc_STSSStockBasedChargesRelatingToPurchaseOfMachinery" />
      <link:presentationArc order="120" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_STSSStockBasedChargesRelatingToPurchaseOfMachinery" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="stss-20240930.xsd#STSS_StockBasedChargesRelatingToAcquisition" xlink:label="loc_STSSStockBasedChargesRelatingToAcquisition" />
      <link:presentationArc order="130" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_STSSStockBasedChargesRelatingToAcquisition" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" xlink:label="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" />
      <link:presentationArc order="140" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="stss-20240930.xsd#STSS_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantedInYear" xlink:label="loc_STSSShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantedInYear" />
      <link:presentationArc order="150" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_STSSShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantedInYear" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" xlink:label="loc_us-gaapEmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" />
      <link:presentationArc order="160" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapEmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://sharpstechnology.com/role/ScheduleOfReconciliationOfFederalStatutoryRateToTotalEffectiveRateDetails" xlink:title="00000055 - Disclosure - Schedule of Reconciliation of Federal Statutory Rate to Total Effective Rate (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeTaxDisclosureAbstract" xlink:label="loc_us-gaapIncomeTaxDisclosureAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate" xlink:label="loc_us-gaapIncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeTaxDisclosureAbstract" xlink:to="loc_us-gaapIncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeTaxReconciliationChangeInEnactedTaxRate" xlink:label="loc_us-gaapIncomeTaxReconciliationChangeInEnactedTaxRate" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeTaxDisclosureAbstract" xlink:to="loc_us-gaapIncomeTaxReconciliationChangeInEnactedTaxRate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes" xlink:label="loc_us-gaapIncomeTaxReconciliationStateAndLocalIncomeTaxes" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeTaxDisclosureAbstract" xlink:to="loc_us-gaapIncomeTaxReconciliationStateAndLocalIncomeTaxes" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeTaxReconciliationOtherAdjustments" xlink:label="loc_us-gaapIncomeTaxReconciliationOtherAdjustments" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeTaxDisclosureAbstract" xlink:to="loc_us-gaapIncomeTaxReconciliationOtherAdjustments" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance" xlink:label="loc_us-gaapIncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeTaxDisclosureAbstract" xlink:to="loc_us-gaapIncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeTaxExpenseBenefit" xlink:label="loc_us-gaapIncomeTaxExpenseBenefit" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeTaxDisclosureAbstract" xlink:to="loc_us-gaapIncomeTaxExpenseBenefit" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://sharpstechnology.com/role/ScheduleOfComponentsOfDeferredTaxAssetsDetails" xlink:title="00000056 - Disclosure - Schedule of Components of Deferred tax Assets (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeTaxDisclosureAbstract" xlink:label="loc_us-gaapIncomeTaxDisclosureAbstract" />
      <link:loc xlink:type="locator" xlink:href="stss-20240930.xsd#STSS_DeferredTaxAssetsPropertyPlantAndEquipments" xlink:label="loc_STSSDeferredTaxAssetsPropertyPlantAndEquipments" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeTaxDisclosureAbstract" xlink:to="loc_STSSDeferredTaxAssetsPropertyPlantAndEquipments" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredTaxAssetInterestCarryforward" xlink:label="loc_us-gaapDeferredTaxAssetInterestCarryforward" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeTaxDisclosureAbstract" xlink:to="loc_us-gaapDeferredTaxAssetInterestCarryforward" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredTaxAssetsInProcessResearchAndDevelopment" xlink:label="loc_us-gaapDeferredTaxAssetsInProcessResearchAndDevelopment" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeTaxDisclosureAbstract" xlink:to="loc_us-gaapDeferredTaxAssetsInProcessResearchAndDevelopment" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost" xlink:label="loc_us-gaapDeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeTaxDisclosureAbstract" xlink:to="loc_us-gaapDeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredTaxAssetsCharitableContributionCarryforwards" xlink:label="loc_us-gaapDeferredTaxAssetsCharitableContributionCarryforwards" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeTaxDisclosureAbstract" xlink:to="loc_us-gaapDeferredTaxAssetsCharitableContributionCarryforwards" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsDomestic" xlink:label="loc_us-gaapDeferredTaxAssetsOperatingLossCarryforwardsDomestic" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeTaxDisclosureAbstract" xlink:to="loc_us-gaapDeferredTaxAssetsOperatingLossCarryforwardsDomestic" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsStateAndLocal" xlink:label="loc_us-gaapDeferredTaxAssetsOperatingLossCarryforwardsStateAndLocal" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeTaxDisclosureAbstract" xlink:to="loc_us-gaapDeferredTaxAssetsOperatingLossCarryforwardsStateAndLocal" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsForeign" xlink:label="loc_us-gaapDeferredTaxAssetsOperatingLossCarryforwardsForeign" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeTaxDisclosureAbstract" xlink:to="loc_us-gaapDeferredTaxAssetsOperatingLossCarryforwardsForeign" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsResearch" xlink:label="loc_us-gaapDeferredTaxAssetsTaxCreditCarryforwardsResearch" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeTaxDisclosureAbstract" xlink:to="loc_us-gaapDeferredTaxAssetsTaxCreditCarryforwardsResearch" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredTaxAssetsValuationAllowance" xlink:label="loc_us-gaapDeferredTaxAssetsValuationAllowance" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeTaxDisclosureAbstract" xlink:to="loc_us-gaapDeferredTaxAssetsValuationAllowance" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredTaxLiabilities" xlink:label="loc_us-gaapDeferredTaxLiabilities" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeTaxDisclosureAbstract" xlink:to="loc_us-gaapDeferredTaxLiabilities" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTotalLabel" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://sharpstechnology.com/role/ScheduleOfGeographicalComponentsOfLossBeforeIncomeTaxesDetails" xlink:title="00000057 - Disclosure - Schedule of Geographical Components of Loss Before Income Taxes (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeTaxDisclosureAbstract" xlink:label="loc_us-gaapIncomeTaxDisclosureAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic" xlink:label="loc_us-gaapIncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeTaxDisclosureAbstract" xlink:to="loc_us-gaapIncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign" xlink:label="loc_us-gaapIncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeTaxDisclosureAbstract" xlink:to="loc_us-gaapIncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:label="loc_us-gaapIncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeTaxDisclosureAbstract" xlink:to="loc_us-gaapIncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://sharpstechnology.com/role/IncomeTaxesDetailsNarrative" xlink:title="00000058 - Disclosure - Income Taxes (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeTaxDisclosureAbstract" xlink:label="loc_us-gaapIncomeTaxDisclosureAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationTable" xlink:label="loc_us-gaapEffectiveIncomeTaxRateReconciliationTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeTaxDisclosureAbstract" xlink:to="loc_us-gaapEffectiveIncomeTaxRateReconciliationTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationLineItems" xlink:label="loc_us-gaapEffectiveIncomeTaxRateReconciliationLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEffectiveIncomeTaxRateReconciliationTable" xlink:to="loc_us-gaapEffectiveIncomeTaxRateReconciliationLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeTaxAuthorityAxis" xlink:label="loc_us-gaapIncomeTaxAuthorityAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEffectiveIncomeTaxRateReconciliationTable" xlink:to="loc_us-gaapIncomeTaxAuthorityAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeTaxAuthorityDomain" xlink:label="loc_us-gaapIncomeTaxAuthorityDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeTaxAuthorityAxis" xlink:to="loc_us-gaapIncomeTaxAuthorityDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DomesticCountryMember" xlink:label="loc_us-gaapDomesticCountryMember" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeTaxAuthorityDomain" xlink:to="loc_us-gaapDomesticCountryMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ForeignCountryMember" xlink:label="loc_us-gaapForeignCountryMember" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeTaxAuthorityDomain" xlink:to="loc_us-gaapForeignCountryMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_StatementScenarioAxis" xlink:label="loc_srtStatementScenarioAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEffectiveIncomeTaxRateReconciliationTable" xlink:to="loc_srtStatementScenarioAxis" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_ScenarioUnspecifiedDomain" xlink:label="loc_srtScenarioUnspecifiedDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtStatementScenarioAxis" xlink:to="loc_srtScenarioUnspecifiedDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="stss-20240930.xsd#STSS_ExpiresOnTwoThousandTwentyEightMember" xlink:label="loc_STSSExpiresOnTwoThousandTwentyEightMember" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtScenarioUnspecifiedDomain" xlink:to="loc_STSSExpiresOnTwoThousandTwentyEightMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="stss-20240930.xsd#STSS_NotExpireMember" xlink:label="loc_STSSNotExpireMember" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtScenarioUnspecifiedDomain" xlink:to="loc_STSSNotExpireMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:label="loc_us-gaapEffectiveIncomeTaxRateContinuingOperations" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEffectiveIncomeTaxRateReconciliationLineItems" xlink:to="loc_us-gaapEffectiveIncomeTaxRateContinuingOperations" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingLossCarryforwards" xlink:label="loc_us-gaapOperatingLossCarryforwards" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEffectiveIncomeTaxRateReconciliationLineItems" xlink:to="loc_us-gaapOperatingLossCarryforwards" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://sharpstechnology.com/role/RelatedPartyTransactionsAndBalancesDetailsNarrative" xlink:title="00000059 - Disclosure - Related Party Transactions and Balances (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RelatedPartyTransactionsAbstract" xlink:label="loc_us-gaapRelatedPartyTransactionsAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRelatedPartyTransactionsAbstract" xlink:to="loc_us-gaapStatementTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_TitleOfIndividualAxis" xlink:label="loc_srtTitleOfIndividualAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_srtTitleOfIndividualAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:label="loc_srtTitleOfIndividualWithRelationshipToEntityDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtTitleOfIndividualAxis" xlink:to="loc_srtTitleOfIndividualWithRelationshipToEntityDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="stss-20240930.xsd#STSS_OfficersAndDirectorsMember" xlink:label="loc_STSSOfficersAndDirectorsMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtTitleOfIndividualWithRelationshipToEntityDomain" xlink:to="loc_STSSOfficersAndDirectorsMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent" xlink:label="loc_us-gaapAccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapAccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://sharpstechnology.com/role/ScheduleOfAssetsAndLiabilitiesMeasuredAtFairValueOnRecurringBasisDetails" xlink:title="00000060 - Disclosure - Schedule of Assets and Liabilities Measured at Fair Value on Recurring Basis (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueDisclosuresAbstract" xlink:label="loc_us-gaapFairValueDisclosuresAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:label="loc_us-gaapFairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapFairValueDisclosuresAbstract" xlink:to="loc_us-gaapFairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:label="loc_us-gaapFairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapFairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:to="loc_us-gaapFairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:label="loc_us-gaapFairValueByFairValueHierarchyLevelAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapFairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:to="loc_us-gaapFairValueByFairValueHierarchyLevelAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:label="loc_us-gaapFairValueMeasurementsFairValueHierarchyDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapFairValueByFairValueHierarchyLevelAxis" xlink:to="loc_us-gaapFairValueMeasurementsFairValueHierarchyDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueInputsLevel1Member" xlink:label="loc_us-gaapFairValueInputsLevel1Member" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapFairValueMeasurementsFairValueHierarchyDomain" xlink:to="loc_us-gaapFairValueInputsLevel1Member" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueInputsLevel2Member" xlink:label="loc_us-gaapFairValueInputsLevel2Member" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapFairValueMeasurementsFairValueHierarchyDomain" xlink:to="loc_us-gaapFairValueInputsLevel2Member" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueInputsLevel3Member" xlink:label="loc_us-gaapFairValueInputsLevel3Member" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapFairValueMeasurementsFairValueHierarchyDomain" xlink:to="loc_us-gaapFairValueInputsLevel3Member" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FinancialInstrumentsFinancialAssetsBalanceSheetGroupingsAbstract" xlink:label="loc_us-gaapFinancialInstrumentsFinancialAssetsBalanceSheetGroupingsAbstract" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapFairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:to="loc_us-gaapFinancialInstrumentsFinancialAssetsBalanceSheetGroupingsAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CashAndCashEquivalentsFairValueDisclosure" xlink:label="loc_us-gaapCashAndCashEquivalentsFairValueDisclosure" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapFairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:to="loc_us-gaapCashAndCashEquivalentsFairValueDisclosure" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AssetsFairValueDisclosure" xlink:label="loc_us-gaapAssetsFairValueDisclosure" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapFairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:to="loc_us-gaapAssetsFairValueDisclosure" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FinancialInstrumentsFinancialLiabilitiesBalanceSheetGroupingsAbstract" xlink:label="loc_us-gaapFinancialInstrumentsFinancialLiabilitiesBalanceSheetGroupingsAbstract" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapFairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:to="loc_us-gaapFinancialInstrumentsFinancialLiabilitiesBalanceSheetGroupingsAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="stss-20240930.xsd#STSS_WarrantLiability" xlink:label="loc_STSSWarrantLiability" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapFairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:to="loc_STSSWarrantLiability" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LiabilitiesFairValueDisclosure" xlink:label="loc_us-gaapLiabilitiesFairValueDisclosure" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapFairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:to="loc_us-gaapLiabilitiesFairValueDisclosure" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AssetsFairValueDisclosureAbstract" xlink:label="loc_us-gaapAssetsFairValueDisclosureAbstract" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapFairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:to="loc_us-gaapAssetsFairValueDisclosureAbstract" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LiabilitiesFairValueDisclosureAbstract" xlink:label="loc_us-gaapLiabilitiesFairValueDisclosureAbstract" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapFairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:to="loc_us-gaapLiabilitiesFairValueDisclosureAbstract" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DerivativeLiabilities" xlink:label="loc_us-gaapDerivativeLiabilities" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLiabilitiesFairValueDisclosureAbstract" xlink:to="loc_us-gaapDerivativeLiabilities" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://sharpstechnology.com/role/CommitmentsAndContingenciesDetailsNarrative" xlink:title="00000061 - Disclosure - Commitments and Contingencies (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:label="loc_us-gaapCommitmentsAndContingenciesDisclosureAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LossContingenciesTable" xlink:label="loc_us-gaapLossContingenciesTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapCommitmentsAndContingenciesDisclosureAbstract" xlink:to="loc_us-gaapLossContingenciesTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LossContingenciesLineItems" xlink:label="loc_us-gaapLossContingenciesLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLossContingenciesTable" xlink:to="loc_us-gaapLossContingenciesLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TypeOfArrangementAxis" xlink:label="loc_us-gaapTypeOfArrangementAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLossContingenciesTable" xlink:to="loc_us-gaapTypeOfArrangementAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:label="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapTypeOfArrangementAxis" xlink:to="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" order="0" />
      <link:loc xlink:type="locator" xlink:href="stss-20240930.xsd#STSS_RoyaltyAgreementMember" xlink:label="loc_STSSRoyaltyAgreementMember" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" xlink:to="loc_STSSRoyaltyAgreementMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="stss-20240930.xsd#STSS_EmploymentAgreementMember" xlink:label="loc_STSSEmploymentAgreementMember" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" xlink:to="loc_STSSEmploymentAgreementMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="stss-20240930.xsd#STSS_ServiceAgreementMember" xlink:label="loc_STSSServiceAgreementMember" />
      <link:presentationArc order="160" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" xlink:to="loc_STSSServiceAgreementMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="stss-20240930.xsd#STSS_AssetPurchaseAgreementMember" xlink:label="loc_STSSAssetPurchaseAgreementMember" />
      <link:presentationArc order="320" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" xlink:to="loc_STSSAssetPurchaseAgreementMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_TitleOfIndividualAxis" xlink:label="loc_srtTitleOfIndividualAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLossContingenciesTable" xlink:to="loc_srtTitleOfIndividualAxis" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:label="loc_srtTitleOfIndividualWithRelationshipToEntityDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtTitleOfIndividualAxis" xlink:to="loc_srtTitleOfIndividualWithRelationshipToEntityDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="stss-20240930.xsd#STSS_BarryBerlerMember" xlink:label="loc_STSSBarryBerlerMember" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtTitleOfIndividualWithRelationshipToEntityDomain" xlink:to="loc_STSSBarryBerlerMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="stss-20240930.xsd#STSS_Mr.BlackmanMember" xlink:label="loc_STSSMr.BlackmanMember" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtTitleOfIndividualWithRelationshipToEntityDomain" xlink:to="loc_STSSMr.BlackmanMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="stss-20240930.xsd#STSS_AlanBlackmanMember" xlink:label="loc_STSSAlanBlackmanMember" />
      <link:presentationArc order="250" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtTitleOfIndividualWithRelationshipToEntityDomain" xlink:to="loc_STSSAlanBlackmanMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_LitigationCaseAxis" xlink:label="loc_srtLitigationCaseAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLossContingenciesTable" xlink:to="loc_srtLitigationCaseAxis" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_LitigationCaseTypeDomain" xlink:label="loc_srtLitigationCaseTypeDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtLitigationCaseAxis" xlink:to="loc_srtLitigationCaseTypeDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="stss-20240930.xsd#STSS_BerlerMember" xlink:label="loc_STSSBerlerMember" />
      <link:presentationArc order="220" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtLitigationCaseTypeDomain" xlink:to="loc_STSSBerlerMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="stss-20240930.xsd#STSS_PlastomoldMember" xlink:label="loc_STSSPlastomoldMember" />
      <link:presentationArc order="240" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtLitigationCaseTypeDomain" xlink:to="loc_STSSPlastomoldMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AssetAcquisitionAxis" xlink:label="loc_us-gaapAssetAcquisitionAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLossContingenciesTable" xlink:to="loc_us-gaapAssetAcquisitionAxis" order="40" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AssetAcquisitionDomain" xlink:label="loc_us-gaapAssetAcquisitionDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAssetAcquisitionAxis" xlink:to="loc_us-gaapAssetAcquisitionDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="stss-20240930.xsd#STSS_InjectEZLLCMember" xlink:label="loc_STSSInjectEZLLCMember" />
      <link:presentationArc order="320" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAssetAcquisitionDomain" xlink:to="loc_STSSInjectEZLLCMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccountsPayableCurrentAndNoncurrent" xlink:label="loc_us-gaapAccountsPayableCurrentAndNoncurrent" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLossContingenciesLineItems" xlink:to="loc_us-gaapAccountsPayableCurrentAndNoncurrent" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="stss-20240930.xsd#STSS_OrderCostsToPurchaseEquipmentMoldsAndComponentPartsForResearchAndDevelopment" xlink:label="loc_STSSOrderCostsToPurchaseEquipmentMoldsAndComponentPartsForResearchAndDevelopment" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLossContingenciesLineItems" xlink:to="loc_STSSOrderCostsToPurchaseEquipmentMoldsAndComponentPartsForResearchAndDevelopment" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="stss-20240930.xsd#STSS_ProgressPayments" xlink:label="loc_STSSProgressPayments" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLossContingenciesLineItems" xlink:to="loc_STSSProgressPayments" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="stss-20240930.xsd#STSS_RoyaltyPercentage" xlink:label="loc_STSSRoyaltyPercentage" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLossContingenciesLineItems" xlink:to="loc_STSSRoyaltyPercentage" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="stss-20240930.xsd#STSS_SinglePaymentObligation" xlink:label="loc_STSSSinglePaymentObligation" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLossContingenciesLineItems" xlink:to="loc_STSSSinglePaymentObligation" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SalariesAndWages" xlink:label="loc_us-gaapSalariesAndWages" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLossContingenciesLineItems" xlink:to="loc_us-gaapSalariesAndWages" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccruedBonusesCurrentAndNoncurrent" xlink:label="loc_us-gaapAccruedBonusesCurrentAndNoncurrent" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLossContingenciesLineItems" xlink:to="loc_us-gaapAccruedBonusesCurrentAndNoncurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="stss-20240930.xsd#STSS_PaymentForBonuses" xlink:label="loc_STSSPaymentForBonuses" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLossContingenciesLineItems" xlink:to="loc_STSSPaymentForBonuses" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SeveranceCosts1" xlink:label="loc_us-gaapSeveranceCosts1" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLossContingenciesLineItems" xlink:to="loc_us-gaapSeveranceCosts1" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="stss-20240930.xsd#STSS_MedicalBenefitsCost" xlink:label="loc_STSSMedicalBenefitsCost" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLossContingenciesLineItems" xlink:to="loc_STSSMedicalBenefitsCost" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLossContingenciesLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="stss-20240930.xsd#STSS_AnnualCompensation" xlink:label="loc_STSSAnnualCompensation" />
      <link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLossContingenciesLineItems" xlink:to="loc_STSSAnnualCompensation" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PaymentForIncentiveFee" xlink:label="loc_us-gaapPaymentForIncentiveFee" />
      <link:presentationArc order="120" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLossContingenciesLineItems" xlink:to="loc_us-gaapPaymentForIncentiveFee" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="stss-20240930.xsd#STSS_InitialFee" xlink:label="loc_STSSInitialFee" />
      <link:presentationArc order="130" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLossContingenciesLineItems" xlink:to="loc_STSSInitialFee" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="stss-20240930.xsd#STSS_MonthlyFee" xlink:label="loc_STSSMonthlyFee" />
      <link:presentationArc order="140" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLossContingenciesLineItems" xlink:to="loc_STSSMonthlyFee" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures" xlink:label="loc_us-gaapStockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures" />
      <link:presentationArc order="150" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLossContingenciesLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="stss-20240930.xsd#STSS_ValueOfDigitalMarketingActivities" xlink:label="loc_STSSValueOfDigitalMarketingActivities" />
      <link:presentationArc order="160" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLossContingenciesLineItems" xlink:to="loc_STSSValueOfDigitalMarketingActivities" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures" xlink:label="loc_us-gaapStockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures" />
      <link:presentationArc order="170" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLossContingenciesLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EmployeeBenefitsAndShareBasedCompensation" xlink:label="loc_us-gaapEmployeeBenefitsAndShareBasedCompensation" />
      <link:presentationArc order="180" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLossContingenciesLineItems" xlink:to="loc_us-gaapEmployeeBenefitsAndShareBasedCompensation" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation" xlink:label="loc_us-gaapStockIssuedDuringPeriodSharesShareBasedCompensation" />
      <link:presentationArc order="190" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLossContingenciesLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodSharesShareBasedCompensation" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1" xlink:label="loc_us-gaapSharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1" />
      <link:presentationArc order="200" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLossContingenciesLineItems" xlink:to="loc_us-gaapSharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LossContingencyDamagesSoughtValue" xlink:label="loc_us-gaapLossContingencyDamagesSoughtValue" />
      <link:presentationArc order="210" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLossContingenciesLineItems" xlink:to="loc_us-gaapLossContingencyDamagesSoughtValue" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LossContingencyDamagesSought" xlink:label="loc_us-gaapLossContingencyDamagesSought" />
      <link:presentationArc order="220" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLossContingenciesLineItems" xlink:to="loc_us-gaapLossContingencyDamagesSought" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensation" xlink:label="loc_us-gaapShareBasedCompensation" />
      <link:presentationArc order="230" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLossContingenciesLineItems" xlink:to="loc_us-gaapShareBasedCompensation" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PaymentsToAcquireProductiveAssets" xlink:label="loc_us-gaapPaymentsToAcquireProductiveAssets" />
      <link:presentationArc order="240" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLossContingenciesLineItems" xlink:to="loc_us-gaapPaymentsToAcquireProductiveAssets" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EscrowDeposit" xlink:label="loc_us-gaapEscrowDeposit" />
      <link:presentationArc order="250" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLossContingenciesLineItems" xlink:to="loc_us-gaapEscrowDeposit" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EscrowDepositDisbursementsRelatedToPropertyAcquisition1" xlink:label="loc_us-gaapEscrowDepositDisbursementsRelatedToPropertyAcquisition1" />
      <link:presentationArc order="260" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLossContingenciesLineItems" xlink:to="loc_us-gaapEscrowDepositDisbursementsRelatedToPropertyAcquisition1" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://sharpstechnology.com/role/ScheduleOfFixedAssetsNetDetails" xlink:title="00000062 - Disclosure - Schedule of Fixed Assets, Net (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubsequentEventsAbstract" xlink:label="loc_us-gaapSubsequentEventsAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:label="loc_us-gaapScheduleOfPropertyPlantAndEquipmentTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsequentEventsAbstract" xlink:to="loc_us-gaapScheduleOfPropertyPlantAndEquipmentTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentLineItems" xlink:label="loc_us-gaapPropertyPlantAndEquipmentLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfPropertyPlantAndEquipmentTable" xlink:to="loc_us-gaapPropertyPlantAndEquipmentLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:label="loc_us-gaapPropertyPlantAndEquipmentByTypeAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfPropertyPlantAndEquipmentTable" xlink:to="loc_us-gaapPropertyPlantAndEquipmentByTypeAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:label="loc_us-gaapPropertyPlantAndEquipmentTypeDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPropertyPlantAndEquipmentByTypeAxis" xlink:to="loc_us-gaapPropertyPlantAndEquipmentTypeDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LandMember" xlink:label="loc_us-gaapLandMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPropertyPlantAndEquipmentTypeDomain" xlink:to="loc_us-gaapLandMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BuildingMember" xlink:label="loc_us-gaapBuildingMember" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPropertyPlantAndEquipmentTypeDomain" xlink:to="loc_us-gaapBuildingMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_MachineryAndEquipmentMember" xlink:label="loc_us-gaapMachineryAndEquipmentMember" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPropertyPlantAndEquipmentTypeDomain" xlink:to="loc_us-gaapMachineryAndEquipmentMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="stss-20240930.xsd#STSS_ComputerSystemsAndWebsiteAndOtherMember" xlink:label="loc_STSSComputerSystemsAndWebsiteAndOtherMember" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPropertyPlantAndEquipmentTypeDomain" xlink:to="loc_STSSComputerSystemsAndWebsiteAndOtherMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentGross" xlink:label="loc_us-gaapPropertyPlantAndEquipmentGross" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPropertyPlantAndEquipmentLineItems" xlink:to="loc_us-gaapPropertyPlantAndEquipmentGross" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:label="loc_us-gaapAccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPropertyPlantAndEquipmentLineItems" xlink:to="loc_us-gaapAccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentNet" xlink:label="loc_us-gaapPropertyPlantAndEquipmentNet" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPropertyPlantAndEquipmentLineItems" xlink:to="loc_us-gaapPropertyPlantAndEquipmentNet" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://sharpstechnology.com/role/ScheduleOfFairValueOfAssetsAcquisitionDetailsDisclosure" xlink:title="00000063 - Disclosure - Schedule of Fair Value of Assets Acquisition (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubsequentEventsAbstract" xlink:label="loc_us-gaapSubsequentEventsAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfRestructuringAndRelatedCostsTable" xlink:label="loc_us-gaapScheduleOfRestructuringAndRelatedCostsTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsequentEventsAbstract" xlink:to="loc_us-gaapScheduleOfRestructuringAndRelatedCostsTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RestructuringCostAndReserveLineItems" xlink:label="loc_us-gaapRestructuringCostAndReserveLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfRestructuringAndRelatedCostsTable" xlink:to="loc_us-gaapRestructuringCostAndReserveLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessAcquisitionAxis" xlink:label="loc_us-gaapBusinessAcquisitionAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfRestructuringAndRelatedCostsTable" xlink:to="loc_us-gaapBusinessAcquisitionAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessAcquisitionAcquireeDomain" xlink:label="loc_us-gaapBusinessAcquisitionAcquireeDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapBusinessAcquisitionAxis" xlink:to="loc_us-gaapBusinessAcquisitionAcquireeDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="stss-20240930.xsd#STSS_SafegardMedicalIncMember" xlink:label="loc_STSSSafegardMedicalIncMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapBusinessAcquisitionAcquireeDomain" xlink:to="loc_STSSSafegardMedicalIncMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLand" xlink:label="loc_us-gaapBusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLand" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRestructuringCostAndReserveLineItems" xlink:to="loc_us-gaapBusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLand" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment" xlink:label="loc_us-gaapBusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRestructuringCostAndReserveLineItems" xlink:to="loc_us-gaapBusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedEquipment" xlink:label="loc_us-gaapBusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedEquipment" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRestructuringCostAndReserveLineItems" xlink:to="loc_us-gaapBusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedEquipment" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory" xlink:label="loc_us-gaapBusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRestructuringCostAndReserveLineItems" xlink:to="loc_us-gaapBusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles" xlink:label="loc_us-gaapBusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRestructuringCostAndReserveLineItems" xlink:to="loc_us-gaapBusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities" xlink:label="loc_us-gaapBusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRestructuringCostAndReserveLineItems" xlink:to="loc_us-gaapBusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets" xlink:label="loc_us-gaapBusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRestructuringCostAndReserveLineItems" xlink:to="loc_us-gaapBusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://sharpstechnology.com/role/SubsequentEventsDetailsNarrative" xlink:title="00000064 - Disclosure - Subsequent Events (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubsequentEventsAbstract" xlink:label="loc_us-gaapSubsequentEventsAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubsequentEventTable" xlink:label="loc_us-gaapSubsequentEventTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsequentEventsAbstract" xlink:to="loc_us-gaapSubsequentEventTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubsequentEventLineItems" xlink:label="loc_us-gaapSubsequentEventLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsequentEventTable" xlink:to="loc_us-gaapSubsequentEventLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementEquityComponentsAxis" xlink:label="loc_us-gaapStatementEquityComponentsAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsequentEventTable" xlink:to="loc_us-gaapStatementEquityComponentsAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EquityComponentDomain" xlink:label="loc_us-gaapEquityComponentDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementEquityComponentsAxis" xlink:to="loc_us-gaapEquityComponentDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_WarrantMember" xlink:label="loc_us-gaapWarrantMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEquityComponentDomain" xlink:to="loc_us-gaapWarrantMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubsequentEventTypeAxis" xlink:label="loc_us-gaapSubsequentEventTypeAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsequentEventTable" xlink:to="loc_us-gaapSubsequentEventTypeAxis" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubsequentEventTypeDomain" xlink:label="loc_us-gaapSubsequentEventTypeDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsequentEventTypeAxis" xlink:to="loc_us-gaapSubsequentEventTypeDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubsequentEventMember" xlink:label="loc_us-gaapSubsequentEventMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsequentEventTypeDomain" xlink:to="loc_us-gaapSubsequentEventMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight" xlink:label="loc_us-gaapClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsequentEventLineItems" xlink:to="loc_us-gaapClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" xlink:label="loc_us-gaapClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsequentEventLineItems" xlink:to="loc_us-gaapClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" xlink:type="arc" />
    </link:presentationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EXCEL
<SEQUENCE>91
<FILENAME>Financial_Report.xlsx
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 Financial_Report.xlsx
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M/%D5[U#<)GF>1,7ADC,1,0D0W]\E2?Y\(E_+J-_;&?\'4$L#!!0    ( +6
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M*K<76JV;(WW?E=9JU7Q=R&PFRQI@?I\KI>\OZ@:ZDZVC_P!02P,$%     @
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M):I5J%:C6D-IW1JEMC5*WM__^@+2W??E3;Y?,3I>1CJ&6]^=J5)4M_\UD*1
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M%:A6HEJ%:C6J-6]_+KOEIVV /OPH*S]CEY65<Z-+#ZG-4,U%M3FJ>:CFHUJ
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MU2I4JU&MH;1NJ5#;4B%OGA_S_%4Y->8[-MI'CVJN/NR&'3Q_%8WHH9I/35*
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MV>\WC\\_?EDM[U?;XPL.__YIL]F__.']P?]ML_WE.<:'_P=02P,$%     @
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MC\1,2P/Q^3S+RK<WLH/=#W-<_ ]02P,$%     @ M8 V6OLQ6JV[!@  E1,
M !@   !X;"]W;W)K<VAE971S+W-H965T."YX;6SM6%MOW,85?N>O.-@4@0UL
M]JK8KBT)D&4G,0S'0J2T#T4?9LFSRXG)&69FJ/7VU_<[,UR*DG?5M GZ4/1%
M(H?G?KYSV3G=6O?)E\R!/M>5\6>C,H3FY73J\Y)KY2>V88,O:^MJ%?#J-E/?
M.%9%9*JKZ6(V>S:ME3:C\]-X=N7.3VT;*FWXRI%OZUJYW6NN[/9L-!_M#W[2
MFS+(P?3\M%$;ON;P<W/E\#;MI12Z9N.U->1X?3:ZF+^\/!'Z2/ 7S5L_>";Q
M9&7M)WEY5YR-9F(05YP'D:#P[Y8ON:I$$,SXM9,YZE4*X_!Y+_V[Z#M\62G/
ME[;ZJRY">39Z,:*"UZJMPD]V^P-W_GPK\G);^?B7MHEV"8UYZX.M.V:\U]JD
M_^IS%X<!PXO9$89%Q[#XK0S+CF$9'4V61;?>J*#.3YW=DA-J2).'&)O(#6^T
MD2Q>!X>O&GSA_ W[W.DFAM2NZ77K0>#]Z31 N)!,\T[0ZR1H<430G^F#-:'T
M]-847!S@OWR<?[YX1, 47O6N+?:NO5X\*O&:FPDM9V-:S!8GAPQZG/T-YV"?
M1_;E(^8L^T@OH[SE$7D7>6Y;$[39T)6M=*[9T]\N5CXX0/GOAP*>Y)T<EB?E
M_=(W*N>S$>K7L[OET?G77\V?S5X=<O8/$G;/]9/>]9/'I/\[('M4T&$S?[2!
ML_F$CFBA'U5H'6?#(V4*^MY**BZMR=D9NBZ5:WQVPWEI;&4WNS&],P# DZ^_
M>K%8S%ZE[_%E_HJLHU R==\N;=THL^L^/B4-!03[OG%\RZ9EJKG0N:K07FYU
MSI0G>HA0@4KE<>[UQG 1[6I48!.XR&Z5T[;UY-6:PX[\SL%@3L9#A6?^)!Y
M6LTNUZK2_U#1^=4.'<*T:^"J%9[(46@@3:_:?7AT\+#1%FV.*4 W)6<J[PQ+
M4E&%QL,F/'G@M8!9!:VU449TD0\X0#N'&&WRJBTXAD0EE'M1D6)&#V,Z3AZ
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M,B6]@.>3 JZS_4('^#]!_N+_ 5!+ P04    " "U@#9:T0)BO0 #  #Y!P
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MM#>R:</4QJ QF[30MQ@K@5]3Q*GA5?K$5S"2DBMYWE7(J/>[28.^K-'T W0
MMV6A-A+"8L57!_#CXWB''B'H8BIM/O0EGTMZE#'FVU-P;0+4IMZA@([#)SQ!
MN&/@[I%PW+:\KN%S/^";"]2;4,\$YADK%+!B!>%#E6Y1" I^&]U));"3?S]4
M^IK9.\RLU7TFMRSA%QV4K^3BD7>&GWYR?/OKH;3_([(W1?#:(GC'V/^VQXZB
M#\<6E8I;WBGL4]<+BYD%@8(K JELWJ?T#_1C$M9EA@^7U&:Y/H,87\55E7%<
M-/!1 X^XLK"9%,_ON+!>.@JP09J=IDFL&WVG)T![+ND/'&WY-O%\V[JLTFR5
M%O= 2> %)+!M<(E-*?$"V[IER083%<_O6L(C?3S+=_IH>;Y'7*=OC<M\6RD\
M,WZ6&(\TD._\3J:*PR>6;[_"3&VX !H@U*?-KV,M2\6RMS4:$$H]$O@V6K;;
M)P$=6#=<RC.+)4F55QE3Z+SB6.HD9>:E_>R0('"(Z_?@BUY0IX>9^O#%VBNX
MJ3<F[Q/JNJ07](P]P&P=CV+57ODL_H3_@J0I^=J$5M\87HT 3 ,*K OD];/
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M]GL=$/7<5R]4N36CTUVI<! SY@9'92ZT WY?EZC'9J$/:(?OX9]02P,$%
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M]IVD#B)7 J%HX9&7"(F9-S'%@ECE:5(Q]@UCB;P+FX@'$?G,:<UQ$@K$VA;
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M8X0L1&D8Z/Y"4 <5%\9 ]4GGXB]02P,$%     @ M8 V6AK_-(\$!   PPD
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M<89K<8>O+,J5 >YO&&:F6:@#3N^VX5]02P,$%     @ M8 V6E6/"WX/!0
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MW?;"8TGW<;0L0/LK0YGO7MA ?\.?_0502P,$%     @ M8 V6ET\BGP("
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M! =!T@%\OU+HN.J&##1OTZ[^ U!+ P04    " "U@#9:,ZA%:]X.  "],0
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M_!;P\L:V?)'%0E]Z/A92%G.]G#&*/VL4 >Y/"\Q(]:(4U-?FE_\&4$L#!!0
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M_X&\>J?^%.7H?PI*Y!*LT-SM45Z]_5:#,MNJY].;K"RSC?I<RPCGSP187V8
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M&H/*I\$S&F%BTUKG],GB=SM;VZ@UX>I/W'@,MC FE@@/$\B %G;LQ]E@[R-
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M- HXOQ!(:(5@%BBOJ?K_ E!+ P04    " "U@#9:JR&?P/P*  !;'   &0
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M1E"S1\]I 5(?)/6\8)6HNO90_JI$^=NL75\WY5;:J@93/X8OT(AM!3<%E>U
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M7C_AO2"_+R:^IT$2X=2!7"[=W2FX80+Y<6Y/4,;4B!%1W) O\VIOF<NON%J
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M)>XM(8,YZ+7IRK\&CGIN !RSM7(P;'G"(<V!_ U+DET+,*R*)F$K2=+SE2/
M9FQ0V @=? D[%V+4>"=8V;*+Z'H'OG70+]J?=T:=H(5-5JQM"0U>+@XG25W6
M?*>XMU'<'U#0.\1;QN)]U6I@]AWE7'1T//\4.6<O>$@7 %ZH6CU[.M?E5)_J
M/*?++ 4(/G8J\]_"VB88USX^&>X=PLCP^+.G"S75KU4YQ1K+7$]@:/_@P?&>
M+/'HU'T <4*0>$1<FSG]B6_OU"4^ +]/#)A=^P$GP#>C$GK/_A]02P,$%
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M#-QVT0**3%'W- F0I"VVP&93-&F+Q6(?:(NVA>CBI>BX^?L=4A??9,4N\K)
M4Y$F9S0SY\QPQ+-E(1[*&><2?F9I7IX/9E+.3X?#<CSC&2NM8LYS7)D4(F,2
MIV(Z+.>"LU@+9>F0$N(/,Y;D@XLS_=L7<7%6+&2:Y/R+@'*194P\7?&T6)X/
M[$'SP]=D.I/JA^'%V9Q-^1V7W^9?!,Z&K98XR7A>)D4.@D_.!Y?VZ76D]NL-
MWQ.^+-?&H#P9%<6#FGR.SP=$&<13/I9* \/'([_F::H4H1G_UCH'[2N5X/JX
MT?Y)^XZ^C%C)KXOT1Q++V?D@'$#,)VR1RJ_%\G=>^^,I?>,B+?7_L*SV.NX
MQHM2%EDMC!9D25X]V<\Z#FL"(=DC0&L!>JB 4PLXVM'*,NW6!R;9Q9DHEB#4
M;M2F!CHV6AJ]27*%XIT4N)J@G+SXP81@N80_$C9*TD0^P=M[-DIY^>YL*%&_
MVC4<U[JN*EUTCZX(;HI<SDKXF,<\[I"_[I>W:8^"(3K6>D<;[ZYHK\8[/K?
M(2900MTN@_K%/_ QBMM:W.DQQVF#[6A][CYS, ?C1<JAF, GE@CXSM*%GM4P
M=,6\5Z5*\M-RSL;\?(!97'+QR <7O[VR??*^R]]^^^YGW)@HNQX;NY!_XP<H
MYE7*+9F(2\R\<;'()8\!BP@L$"H!EW?7$-@A+%D)O)0)YA>N,PERQB'&B5(V
MU4Q;E$D^!097*1L_G&!("F1;_8J3N4C&N&QD1<Q5*LB9UC I4BPW6J[$>J/W
MEJ?0Q-/8B>>=MONVLOM2VVW\Q9DP-+,TGK YI\;'GW.L+3B37&3P]@F7RW=
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MU;2/T';C]-(__";:T3/2+Q?T;D?# O1]IK5;;]C!YC^!\;]02P,$%     @
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MY@/TZ_,D44]/\@35O>OC_P%02P,$%     @ M8 V6NVD.+>_ @  (@@  !D
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M'*@,$.=7A/!]0P[0%W#G_P)02P,$%     @ M8 V6J7[@VZQ @  #P<  !D
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MA%$DC-G#<"?DN^"EM.0ZW>0ZM:)8\B+B=:1R0*96Z-!,D; 0":/V;=<=PSK
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M68Q5,)GY^^.4AJB$)F%TBLJ'J)3&TZ!'G?B*>U_Q15\Y-%)SK ^I""OWK"Z
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M??'TM+UX^H2/OZ.]TJ@FHYJ":BJJ::BFHYJ!:B:J6:AFHYJ#:BZJ>:CFHUJ
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MF^4<EG-9SF,YG^4"E@M9+F*YF.42EDM9+F.YG.4*EBM93@C8@W. @(. X))
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MZ2QGL)S)<A;+V2SGL)S+<A[+^2P7L%S(<A'+Q2R7L%S*<AG+Y2Q7L%S)<D+
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M<B;+62QGLYS#<B[+>2SGLUS <B'+12P7LUS"<BG+92R7LUS!<B7+B:ZX<$8
M8_O588]+ HT -JH%L-$';9K:R5C&0GO764YA.97E-);36<Y@.9/E+):S6<YA
M.9?E/);S62Y@N9#E(I:+62YAN93E,I;+6:Y@N9+EA( ]. <(. @(+@DT,M:X
MEK':V]GW;VXMOCS_^W-5'=TVU>'T3U1HI3K+*2RG[KAI[7K@>#IYNVV*75=G
M.8/E3):S6,YF.8?E7);S6,YGN8#E0I:+6"YFN83E4I;+6"YGN8+E2I8379/]
MC*S$EJ7#'C?C&UEI4LM*D]:LY%8;Z6%U?U55UVOI\^K^5MI\K:0WEPF/QZ=6
MNG]\(CF9Y1264W=<?=?Y:')LVSF[L,YR!LN9+&>QG,UR#LNY+.>QG,]R <N%
M+!>Q7,QR"<NE+)>Q7,YR!<N5+">ZIOT9^0GUX!DON"'?R$_36GYJ+T(7U]?+
MS?+^;G$C/2R6U]+R3KI:/"PWBYOCD0DM1&<YF>44EE-W7#TR/1U[-#*AE>@L
M9["<R7(6R]DLY["<RW(>R_DL%[!<R'(1R\4LE[!<RG(9R^4L5[!<R7*B:\"?
M$9G82G38XX9\(S+-:I&IO1)=72Q7TK?%S6,E+:[_]KC>O%RJN__<6G'0@?9/
M3FA+.LLI+*?NN/JUNOGE]"D\OPE.:$DZRQDL9[*<Q7(VRSDLY[*<QW(^RP4L
M%[)<Q'(QRR4LE[)<QG(YRQ4L5[*<Z!KS9P0GMB0=]K@9WPA.%[7@U%Z2[M[?
M+I_?:+JZ7]?STO&XA+:8LYS,<@K+J2RGL9S.<@;+F2QGL9S-<@[+N2SGL9S/
M<@'+A2P7L5S,<@G+I3NN_M?#X6 \N[R8'O[],&,7SEFN8+F2Y437=#\C+[$%
MY;#'#?E&7KJLY:76>DZB[.#YQC&&K[S</49]Y^8RQ_,7VG#.<C++*2RGLIS&
M<CK+&2QGLIS%<C;+.2SGLIS'<C[+!2P7LES$<C'+)2R7LES&<CG+%2Q7LISH
MBA1GA#2VX1SVN"30"&GS6DA[;0;]B$($M/6<Y6264UA.93F-Y726,UC.9#F+
MY6R6<UC.93F/Y7R6"U@N9+F(Y6*62U@N9;F,Y7*6*UBN9#DA8 _. 0(. H)+
M H<9:UCK1A^V=Z-_?\MJN5X_5M='PU0[T3M,H9S,<@K+J3ONX,-\T\OAY.)-
M.SJZL,YR!LN9+&>QG,UR#LNY+.>QG,]R <N%+!>Q7,QR"<NE+)>Q7,YR!<N5
M+">ZIGK_G,1Z\(P7W)!OY*1:._JPO1W]A'O(M O]8Q);=(YRRHX;CFO!YN+3
M:':8:M3=<9>UPP:?9F]VEZ./3F<Y@^5,EK-8SF8YA^5<EO-8SF>Y@.5"EHM8
M+F:YA.52ELM8+F>Y@N5*EA-=H_J,\ ,WD[,>-[H;X6=4"S^MO9S[-XFJ@Q0D
M;:K5[?$HQ/:1HYS,<@K+J5VOQ53ZHUJLUM),NKV_VWP]]HE(C7U(.LL9+&>R
MG,5R-LLY+.>RG,=R/LL%+!>R7,1R,<LE+)>R7,9R.<L5+%>RG.@:_F?$*;B$
MG/6X\=^(4[42\F%'"?G_SN;SYV.>?CJLOE6K)Z1U3WK[(^X?V-BZ<Y136$YE
M.8WE=)8S6,YD.8OE;)9S6,YE.8_E?)8+6"YDN8CE8I9+6"YEN8SE<I8K6*YD
M.=&5-,[(;G I.NMQ2:"1W6JEZ$]?/Z_P 7O2MS*6L4A.9CF%Y526TUA.9SF#
MY4R6LUC.9CF'Y5R6\UC.9[F Y4*6BU@N9KF$Y5*6RU@N9[F"Y4J6$P+VX!P@
MX" @N"30R%BUXO1A>W'Z27O2V;9TE)-93F$Y=<>=LB>=;4M'.8/E3):S6,YF
M.8?E7);S6,YGN8#E0I:+6"YFN83E4I;+6"YGN8+E2I8375/]C)P$MZ6S'C?D
M&SFIUI8^;&]+_]^[CKB[AOCZ3E?T<+/<=%Q/9"O944YF.87E5);36$YG.8/E
M3):S6,YF.8?E7);S6,YGN8#E0I:+6"YFN83E4I;+6"YGN8+E2I8378GCC P'
M%[>S'I<$&AFN5MP^O/BPZXELCSO*R2RGL)S*<AK+Z2QGL)S)<A;+V2SGL)S+
M<A[+^2P7L%S(<A'+Q2R7L%S*<AG+Y2Q7L%S)<D+ 'IP#!!P$!)<$&AFK5O8^
M;"][/^EZ(EO*CG(RRRDLI^ZX@[LO#R_&DS<W7T;7U5G.8#F3Y2R6LUG.83F7
MY3R6\UDN8+F0Y2*6BUDN8;F4Y3*6RUFN8+F2Y4374#\C)L%UZZS'S?A&3*K5
MK0];RT9/JKAB:]513F8YA>74'5=OPAI./@TNWX0DMB\=Y0R6,UG.8CF;Y1R6
M<UG.8SF?Y0*6"UDN8KF8Y1*62UDN8[F<Y0J6*UE.=(WT,T(2W)?.>MR(/PQ)
MHUI?^JB]+]V]OY/BU>)Z>??EQ-O]M8.],Q/*R2RGL)S*<AK+Z2QGL)S)<A;+
MV2SGL)S+<A[+^2P7L%S(<A'+Q2R7L%S*<AG+Y2Q7L%S)<J(K"/2/5JP'!P'!
M)8%&M*I5K(^&'[45:L16KZ.<S'(*RZDLI[&<SG(&RYDL9[&<S7(.R[DLY[&<
MSW(!RX4L%[%<S'()RZ4LE[%<SG(%RY4L)P3LP3E P$% <$F@D;%&M8QU8I-[
MRU:H=J)_F&++VU%.83EUQ]6W0EU>3 >#P;AYF0]=6&<Y@^5,EK-8SF8YY^1?
M ^ZQ(T>CR>5T-#P\TF,?HL]R <N%+!>Q7,QR"<NEQWY)3>;/O_@.?T5E[+HY
MRQ4L5[*<Z)JR9^06N#*=];BAV\@MM<KT47MENKI8KJ1OBYO'2EI<_^UQO7EI
M,;C_+/VV#33'DPS;:HYR,LLI+*>RG,9R.LL9+&>RG,5R]O^O[=YZV[;2-8[?
MSZ<@"NR[-M71LHO9 1:&Y_/Y--@7&IM)M.M8WK+<3H!^^"T[PY2B&%)B_QZ@
M UMA?DMV(K]/Q,6'+.>PG,MR'LOY-;=LC-?5\JH5[ )VU;#FFD-]>35=S8Z7
MC=AEXZXO=C9=3*:MFKBD\\#Y(?.VGF#:>>!L.ELN3M()6PJ.<@7+E2PGAF;I
MB'0"EX*S'C=(6^FD40I^^+A_4]#GS</Z7KK=/C5#27<FZ:4NSR0D)[.<PG(J
MRVDLI[.<P7(FRUDL9[.<PW)NS37'UF*YG+?O=NVQZ_HL%[!<R'(1R\4LE[!<
M6G-'[_S-%Y-VI,O8=7.6*UBN9#DQ-+9'!"'4@X>WX*9W*P@UFKMG_<W=WWV;
MYO/V;O-A<[O>;[8/TNVG]>YC]P5F_?[EZ8BM]48YA>54EM-83F<Y@^5,EK-8
MSF8YA^5<EO-8SJ^YYJ1=74UG)^_8L)W>*!>Q7-SU/9DNYU?MPHZ$73=EN8SE
M<I8K6*YD.3$TR4=D([BMF_6XV=W*1HVV[EE_6W?OE6.7W*NW?YW+,Q+;K8UR
M"LNI+*>QG,YR!LN9+&>QG,UR#LNY+.>QG,]R <N%+!>Q7,QR"<NE+)>Q7,YR
M!<N5+">&\L&(Q 5W:[,>EP1:B:O1K3U[LV[M&=NMC7(RRRDLI[*<QG(ZRQDL
M9[*<Q7(VRSDLY[*<QW(^RP4L%[)<Q'(QRR4LE[)<QG(YRQ4L5[*<$+ 'YP !
M!P'!)8%6QFIT:\_^>K=V/W%YF&*[M5%.83FUYLZYH(PMUT8Y@^5,EK-8SF8Y
MY^R_ V[7D=^[H(RMQ$:Y@.5"EHM8+F:YA.52ELM8+F>Y@N5*EA-#LWA$NH$K
ML5F/&\VM=-.HQ)[U5V(/G;.[^+ZX_>M='H78 FV44UA.93F-Y726,UC.9#F+
MY6R6<UC.93F/Y7R6"U@N9+F(Y6*62U@N9;F,Y7*6*UBN9#DQE!-&)"^X9YOU
MN"1PG+SFC9[M^>2MSMW-V<)ME)-93F$YE>4TEM-9SF YD^4LEK-9SF$YE^4\
MEO-9+F"YD.4BEHM9+F&YE.4RELM9KF"YDN6$@#TX!P@X" @N";0R5J-P>]Y;
M-WG6N;M^XO(PQ39KHYS"<FK--<_&S&]6J]FJ?>H.75=G.8/E3):S6,YF.>?<
MOP)NUX'3R6PV.:D80)^@SW(!RX4L%[%<S'()RZ4LE[%<SG(%RY4L)X8&\8AH
M _=<LQXWEUO19M:(-OT]UX,7VQF^4O]"_QF[_H4N#T!L&S;**2RGLIS&<CK+
M&2QGLIS%<C;+.2SGLIS'<C[+!2P7LES$<C'+)2R7LES&<CG+%2Q7LIP8"@@C
M(A=<T<UZ7!)H1:Y&1?=\_F9G[-B>;I2364YA.97E-);36<Y@.9/E+):S6<YA
M.9?E/);S62Y@N9#E(I:+62YAN93E,I;+6:Y@N9+EA( ]. <(. @(+@FT,E:C
M:/SP<=_;6N-N@]*/7AZO2$YF.87E5);36$YG.8/E3):S6,YF.8?E7);S6,ZO
MN>;9RI^FU]/IZ9U0T(5#EHM8+N[ZMBQ6DU7[ZLN$73=EN8SE<I8K6*YD.3$T
MP4=D(M2#I[?@QG<K$S4ZQ^?]G>.7W'REG[H\";'UXBBGL)Q:<\V;8-Q<+V>3
MQ<EN)K8X'.4,EC-9SF(YF^4<EG-9SF,YG^4"E@M9+F*YF.42EDMK[GBOW?SJ
M>K5LWWT%73AGN8+E2I830W-[1!*"&\99CQO?K234:!B?]S>,O[X[]'F]^[7:
MG[Q)U!V'V"9QE)-93F$YE>4TEM-9SF YD^4LEK-9SF$YE^4\EO-9+F"YD.4B
MEHM9+F&YM.:.[D$\O5I-3R(36Q&.<@7+E2PGA@;\B,@$5X2S'C?B6Y&I41$^
M[RW(_.LWK.OW+X]0;%$XRBDLI[*<QG(ZRQDL9[*<Q7(VRSDLY[*<QW)^S1V?
M6UM<3VZF)^?6V YPE(M8+N[\MES-5_/IU<G)-;;>&^4RELM9KF"YDN7$T#0?
MD8_@>F_6X^9W*Q\UZKWG_?7>477[O-OL-]63Y#_O#CGHJ9+$QUU5O>:DY@5U
M_;_Z<KF=OZLD]?GAKKH[O22O.UNQO>$H)[.<PG(JRVDLI[.<P7(FRUDL9[.<
MPW(NRWDLY[-<P'(ART4L%[-<PG(IRV4LE[-<P7(ERXFA3#$BI<$UY:S')8%6
M2FO4E,^_UG&^Q:5W;"$YRLDLI["<RG(:R^DL9["<R7(6R]DLY["<RW(>R_DL
M%[!<R'(1R\4LE[!<RG(9R^4L5[!<R7)"P!Z< P0<! 27!(XSUJ)12+[HK>-\
M_^T-KL?=YO;E_RMI]_7N+YVYJE^[.%>AG,QR"LNI+*?5W'32.'4P?3=9M3:N
MZ^RZ!LN9+&>QG,UR#LNY+.>QG,]R <N%+!>Q7,QR"<NE+)>Q7,YR!<N5+">&
MYOOEB8GUX!$ON!G?2DR->O%%?[VXX7O]Y_?Z?__E&8GM%D<YA>54EM-83F<Y
M@^5,EK-8SF8YA^5<EO-8SF>Y@.5"EHM8+F:YA.52ELM8+F>Y@N5*EA-#<W]$
MDH+;S%F/2P*M)#5K)*G96YW?6[#UY2@GLYS"<BK+:2RGLYS!<B;+62QGLYS#
M<B[+>2SGLUS <B'+12P7LUS"<BG+92R7LUS!<B7+"0%[< X0<! 07!)H9:Q&
M??FBM[SSO5OMI<?=]K:J[IZD#[OM9\GPO>Y(Q;:5HYS,<@K+J2RGL9S.<D;-
M-1NSIHO9Y.5_QZ<>S?,/M=@G:;.<PW(NRWDLY[-<P'(ART4L%[-<PG(IRV4L
ME[-<P7(ERXFAP3TB"L$MXZS'3?!6%&JTC!\^[HM"Y]P7N)^X/ 21G,QR"LNI
M+*>QG,YR1LTUK]N^7L[F)P&(7-5B.9OE')9S6<YC.9_E I8+62YBN9CE$I9+
M62YCN9SE"I8K64X,C?01(0GUX $ON G?"DF-VO%%?^VX\N]J=[NI]X-W9R2V
M;1SE9)93:NZZ,>=7[V:M<A:UZ[#IXMWDNETBWG'<?/%N/CO9L]WA35?OVJWD
MQKD'FNSWQ>I:]V;^KM4T;+.K.BSGLIS'<C[+!2P7LES$<C'+)2R7LES&<CG+
M%2Q7LIP073_(EB<_D 4\]00\]@0W]UK)H5'3O>BOZ?[V]DIU%"&D?;7[W)TC
MV)INE)-93F$YE>4TEM-9SF YD^6LH9?%4OI2K7===S"TV6?BL)S+<A[+^2P7
ML%S(<A'+Q2R7L%S*<AG+Y2Q7L%S)<F)HYH]X_P5N[F8];NJW4E2CN7LQLKF[
M]U:X_>CE48JMZT8YA>54EM-83F<YH^::&W)FL^O5\G3G#EO$C7(VRSDLY[*<
MQW(^RP4L%[)<Q'(QRR4LEY[[XL[8=7.6*UBN9#DQ-,!'1"*XK)OUN.G=BD2-
MLNY%?UGW)7?"[:<N#T)LMS;**2RGLIS&<GK-'6TEGL[:/]N,,X\SV:=GL9S-
M<@[+N2SGL9S/<@'+A2P7L5S,<@G+I2R7L5S.<@7+E2PGAH;VB!@$MV&S'C>[
M6S&HT8:]Z.V"/&_[,EM[C7(RRRDLI[*<QG(ZRQDL9[*<Q7(VRSDLY[*<QW(^
MRP4L%[)<Q'(QRR4LE]9<\PJ&Z<N;1:?O%K&%UBA7L%S)<F)HJ(^(27"A->MQ
M,_XX)BT;A=;+_D)KY=^/U>V^NOO^OJ-^X.*0A'(RRRDLI[*<QG(ZRQDL9[*<
MQ7(VRSDLY[*<QW(^RP4L%[)<Q'(QRR4LEPX-F^]O[LO89Y*S7,%R)<N)H2%_
M>6QB/7CH"V[JMV)3H]5ZV=]J+6]^V]Q5#W?2;KWOONRK'[@\-K&UUBBGL)S*
M<AK+Z2QGU-Q-XQ^6)V??T"4MEK-9SF$YE^4\EO-9+F"YD.4BEHM9+F&Y](S7
M=<8NF;-<P7(ERXFA$3TB], %U*S'S>Q6Z)DU0D]O_>+1SJ+NS,/63*.<S'(*
MRZDLI[&<SG(&RYDL9[&<S7(.R[DLY[&<SW(!RX4L%[%<S'()RZ4U-[#Q,&.7
MS5FN8+F2Y<300!\1D>#^:-;C1GPK(C7ZHY?]_='I]GZ]W]QO]E^Z Q);&HUR
M,LLI+*>RG,9R.LL9-3>=-O_U^.YFOEB=O#5$+FRQG,UR#LNY+.>QG,]R <N%
M+!>Q7,QR"<NE9[^Z,W;AG.4*EBM93@S-ZA'I!ZZ,9CUN?K?23Z,R^O!Q7_H)
M-T^_2A]V525M'O;588U]S_FQ7NKR*$1R,LLI+*>RG,9R.LL9-=?Z83F9K4ZC
M$+FPQ7(VRSDLY[*<QW(^RP4L%[)<Q'(QRR4LEY[]ZL[8A7.6*UBN9#DQ-+A'
M1"'4@\>WX.9W*PHUBJ&7_<70[O/+'>]?KK]_?MCLGZ2G[7WW-6C]SN4YB*V'
M1CF%Y526TUA.9SF#Y4R6LVKNZ/*8U62Q7+0KKM%U'99S6<YC.9_E I8+62YB
MN9CE$I9+62YCN9SE"I8K64X,3?8160FNPF8];L:WLE*C"GO9W_F;O":DN^KI
M=K=YW&^V#]U!B>V_1CF9Y1264UE.8SF=Y0R6,UG.&GHM5.O;3]+M]N%I\[3?
M/'Q\^0?$]J&2GCZM=]7AD[_=;C]_WCY(3_OM[:_2^N%.VO^^_59V^J.TWTJ/
MS[O;3^NGZNCW24>_[\-V)[TN]/NG[7W5TQ!FLU^]PW(NRWDLY[-<P'(ART4L
M%[-<PG(IRV4LE[-<P7(ERXFA<#$BKL&=VZS')8U67&MT;B_[.[?E/X/:ZR39
M?OA0[5YFU>NPZ6[<[B<O#V]LXS;**2RGLIS&<CK+&2QGLIPU],K8?ZJD?VP_
M/ZX?OD@?7R)5=2>)ZN/F2?K'^G&S7]\??G7W^.Y':?TD/3_<5;O?=YM]M9/6
MTF+YT]WZB[3]K=K]M+Z_W_ZGQ_[KBZP9ZIX?7SZ=+O_K)=2]K/?P[8WFKR^_
MOVT>;N^?[PXK;QY>#_CS_>?ZD?H%^^-+@/SY\ I>W]UM7E8Z/,'?O]V6Z/^>
M#Y]^;ZT_V]6^N]K?3E8[// UWKY\(8=#JOLO+PO<OGS5K2^]^P8PZ)^FPW(N
MRWDLY[-<P'(ART4L%[-<PG(IRV4LE[-<P7(ERXFAZ#0BC,)MYZS'):=6&&VT
MG2_[V\X-WY/^Z50O<^E_I#\D?U=)8748)8<)4S_<'4C9YG.4DUE.83F5Y326
MTUG.8#F3Y2R6LUG.83F7Y3R6\UDN8+F0Y2*6BUDN8;F4Y3*6RUFN8+F2Y<10
M'!@1L. >==;CDD K8#5ZU)=?*TCGWPE8T?._GC9WF_7NRX]2M+Y_/9D4O9Y%
M^J=].%0R]M7GI^]D++9>'>5DEE-83F4YC>5TEC-8SF0YB^5LEG-8SF4YC^5\
ME@M8+F2YB.5BEDM8+F6YC.5REBM8KF0Y(6 /S@$"#@*"2P+'&>NJ4<)^-53"
M7NUN-T^5]+C;W'9?+MDO7)RE4$YF.87E5);36$ZON>M7[NO.^>6[^:Q]H[ZS
M#C/9)V=UK;IX-UNV-_6CJSHLY[*<QW(^RP4L%[)<Q'(QRR4LE[)<QG(YRQ4L
M5[*<&)K EV<:UH,'LN F<BO3-!K2K_H;TL^Y_UX_<7FH83O244YA.97E-);3
M:V[H;EG&N0>:[!.T6,YF.8?E7);S6,YGN8#E0I:+6"YFN83E4I;+6"YGN8+E
M2I830^-Z1 ""V])9CYO>K0 T:P2@@;;T<QL@^IW+4Q#;FHYR"LNI+*>QG,YR
M!LN9+&?57#/)S5^"7#O*V>S"#LNY+.>QG,]R <N%+!>Q7,QR"<NE+)>Q7,YR
M!<N5+">&1ON(L 3WIK,>-^1;8:G1FW[5WYON;O=5?5%1_\;M?NCRM,16J*.<
MPG(JRVDLI[.<P7(FRUDL9[.<PW(NRWDLY[-<P'(ART4L%[-<PG(IRV4LE[-<
MP7(ERXFA # B4L%E[*S')8%6I&J4L1\^?EGA#39N_T?&,A;)R2RGL)S*<AK+
MZ2QGL)S)<A;+V2SGL)S+<A[+^2P7L%S(<A'+Q2R7L%S*<AG+Y2Q7L%S)<D+
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M0?K7=K_??G[]\%.UOJMV+P<<?OW#=KNO/WE9X/?M[M?7;\O[_P=02P,$%
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MB<JK@Y6J(5EICAHV3$I6F,L4B=H)Z0[J><+4;JANZ &:XZWE_U!+ P04
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MKZ\R;0*K@^*>]_J_**;_ U!+ P04    " "V@#9:FL7.^*L%  !F,   &0
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M:M_?B&Q3'?.>9T)D276YYFS)\[* ?+[*I+NN;\J3X\V_%DS^!U!+ P04
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M)(R1O'I, ,= A0%_OR*$O32$@[80[?T'4$L#!!0    ( +: -EHGL](AV00
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M!LC?UXR)UYMR@.8X?O$?4$L#!!0    ( +: -EH;&@W=I@<  !0_   9
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M9_GN@ZE2^2&7519+OW^.EW=QVODQ-+%^=F[1N@FJ6:AFHYJ#:BZJ>:CFHUJ
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M]_LDR5]^*"=X2M+OVYMY\S]02P,$%     @ MH V6J)IH-5@ P  G D  !D
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M>+CC;,/3/"![?9LD\N4B/W=9'<Q=_0=02P,$%     @ MH V6A;PP?GP%P
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M4&V$:BZJ>:CF;[3G=TKK=LYW(F2,]AJ@6DAI]7C;5OCIME9*N/R11/,]+TE
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MCVG.D4*NU"P>-8?20$3;8T.P6BP^0"X99K>]9!:G<Z17B%S7G:4]VR]/06^
MKSI,<4)I2$LS#O#-TG\R]_,,-47E2B.56QIXT^7^=N!)T:$B6!::1<G3HAVE
M?QW']I#3Z:]C(K1Z6^CY<6A4"H[<8R6,<6*T_C6"R0_L?@!02P,$%     @
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M              "  0    !D;V-0<F]P<R]A<' N>&UL4$L! A0#%     @
MM8 V6H,Z7;ON    *P(  !$              ( !KP   &1O8U!R;W!S+V-O
M<F4N>&UL4$L! A0#%     @ M8 V6IE<G",0!@  G"<  !,
M ( !S $  'AL+W1H96UE+W1H96UE,2YX;6Q02P$"% ,4    " "U@#9:]JY$
MU\D$   $%0  &               @($-"   >&PO=V]R:W-H965T<R]S:&5E
M=#$N>&UL4$L! A0#%     @ M8 V6ABS?CIP!P  PR,  !@
M ("!# T  'AL+W=O<FMS:&5E=',O<VAE970R+GAM;%!+ 0(4 Q0    ( +6
M-EH<5CW/I@,  !81   8              " @;(4  !X;"]W;W)K<VAE971S
M+W-H965T,RYX;6Q02P$"% ,4    " "U@#9:'=E96UT'  #E*@  &
M        @(&.&   >&PO=V]R:W-H965T<R]S:&5E=#0N>&UL4$L! A0#%
M  @ M8 V6K6! QBW P  R0X  !@              ("!(2   'AL+W=O<FMS
M:&5E=',O<VAE970U+GAM;%!+ 0(4 Q0    ( +6 -EIX;>HT/2,  &A8 @ 8
M              " @0XD  !X;"]W;W)K<VAE971S+W-H965T-BYX;6Q02P$"
M% ,4    " "U@#9:W<;H+U4+  "D0P  &               @(&!1P  >&PO
M=V]R:W-H965T<R]S:&5E=#<N>&UL4$L! A0#%     @ M8 V6OLQ6JV[!@
ME1,  !@              ("!#%,  'AL+W=O<FMS:&5E=',O<VAE970X+GAM
M;%!+ 0(4 Q0    ( +6 -EI17Y@&UA@  (Y\   8              " @?U9
M  !X;"]W;W)K<VAE971S+W-H965T.2YX;6Q02P$"% ,4    " "U@#9:T0)B
MO0 #  #Y!P  &0              @($)<P  >&PO=V]R:W-H965T<R]S:&5E
M=#$P+GAM;%!+ 0(4 Q0    ( +6 -EJI63:2NP0  (@+   9
M  " @4!V  !X;"]W;W)K<VAE971S+W-H965T,3$N>&UL4$L! A0#%     @
MM8 V6KK$_&JQ!0  WA$  !D              ("!,GL  'AL+W=O<FMS:&5E
M=',O<VAE970Q,BYX;6Q02P$"% ,4    " "U@#9:&O\TCP0$  ##"0  &0
M            @($:@0  >&PO=V]R:W-H965T<R]S:&5E=#$S+GAM;%!+ 0(4
M Q0    ( +6 -EI5CPM^#P4  .T/   9              " @56%  !X;"]W
M;W)K<VAE971S+W-H965T,30N>&UL4$L! A0#%     @ M8 V6ET\BGP("
M61,  !D              ("!FXH  'AL+W=O<FMS:&5E=',O<VAE970Q-2YX
M;6Q02P$"% ,4    " "U@#9:,ZA%:]X.  "],0  &0              @(':
MD@  >&PO=V]R:W-H965T<R]S:&5E=#$V+GAM;%!+ 0(4 Q0    ( +6 -EI=
MJ[4+ P,  )8(   9              " @>^A  !X;"]W;W)K<VAE971S+W-H
M965T,3<N>&UL4$L! A0#%     @ M8 V6HUMY[-E!P  0A<  !D
M     ("!*:4  'AL+W=O<FMS:&5E=',O<VAE970Q."YX;6Q02P$"% ,4
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M+GAM;%!+ 0(4 Q0    ( +6 -EJK(9_ _ H  %L<   9              "
M@:3%  !X;"]W;W)K<VAE971S+W-H965T,C,N>&UL4$L! A0#%     @ M8 V
M6A12><Y( @  (04  !D              ("!U]   'AL+W=O<FMS:&5E=',O
M<VAE970R-"YX;6Q02P$"% ,4    " "U@#9:)M4NCIL:  !,B@  &0
M        @(%6TP  >&PO=V]R:W-H965T<R]S:&5E=#(U+GAM;%!+ 0(4 Q0
M   ( +6 -EH+0I\B P,  .8'   9              " @2CN  !X;"]W;W)K
M<VAE971S+W-H965T,C8N>&UL4$L! A0#%     @ M8 V6AA=*%.G P  1@D
M !D              ("!8O$  'AL+W=O<FMS:&5E=',O<VAE970R-RYX;6Q0
M2P$"% ,4    " "U@#9:30)!5PH#  "H"   &0              @(% ]0
M>&PO=V]R:W-H965T<R]S:&5E=#(X+GAM;%!+ 0(4 Q0    ( +6 -EKAX9+Q
M1@,  &X(   9              " @8'X  !X;"]W;W)K<VAE971S+W-H965T
M,CDN>&UL4$L! A0#%     @ M8 V6IM'N@$B!@  :A8  !D
M ("!_OL  'AL+W=O<FMS:&5E=',O<VAE970S,"YX;6Q02P$"% ,4    " "U
M@#9:3,J?"-T%  #@$0  &0              @(%7 @$ >&PO=V]R:W-H965T
M<R]S:&5E=#,Q+GAM;%!+ 0(4 Q0    ( +6 -EI<_B4U^@0  !4,   9
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M970S-BYX;6Q02P$"% ,4    " "U@#9:28!)J!D$   1%@  &0
M    @(%Q'P$ >&PO=V]R:W-H965T<R]S:&5E=#,W+GAM;%!+ 0(4 Q0    (
M +6 -EH\. $GPP,  ,P5   9              " @<$C 0!X;"]W;W)K<VAE
M971S+W-H965T,S@N>&UL4$L! A0#%     @ M8 V6J7[@VZQ @  #P<  !D
M             ("!NR<! 'AL+W=O<FMS:&5E=',O<VAE970S.2YX;6Q02P$"
M% ,4    " "U@#9:7@!)N&L)   _<   &0              @(&C*@$ >&PO
M=V]R:W-H965T<R]S:&5E=#0P+GAM;%!+ 0(4 Q0    ( +6 -EKK9(#Q#@,
M !8)   9              " @44T 0!X;"]W;W)K<VAE971S+W-H965T-#$N
M>&UL4$L! A0#%     @ M8 V6BW@#6)+ @  V 0  !D              ("!
MBC<! 'AL+W=O<FMS:&5E=',O<VAE970T,BYX;6Q02P$"% ,4    " "U@#9:
M7^3=ADL$  !\$@  &0              @($,.@$ >&PO=V]R:W-H965T<R]S
M:&5E=#0S+GAM;%!+ 0(4 Q0    ( +6 -EKJP K(D@@  -51   9
M      " @8X^ 0!X;"]W;W)K<VAE971S+W-H965T-#0N>&UL4$L! A0#%
M  @ MH V6M-,J5HP>0  >-T* !D              ("!5T<! 'AL+W=O<FMS
M:&5E=',O<VAE970T-2YX;6Q02P$"% ,4    " "V@#9:-XT)_M,#  #J$@
M&0              @(&^P $ >&PO=V]R:W-H965T<R]S:&5E=#0V+GAM;%!+
M 0(4 Q0    ( +: -EKR91Q]$P<  $9"   9              " @<C$ 0!X
M;"]W;W)K<VAE971S+W-H965T-#<N>&UL4$L! A0#%     @ MH V6G4\G-]L
M!0  43$  !D              ("!$LP! 'AL+W=O<FMS:&5E=',O<VAE970T
M."YX;6Q02P$"% ,4    " "V@#9:FL7.^*L%  !F,   &0
M@(&UT0$ >&PO=V]R:W-H965T<R]S:&5E=#0Y+GAM;%!+ 0(4 Q0    ( +:
M-EH+GJCB] ,  )06   9              " @9?7 0!X;"]W;W)K<VAE971S
M+W-H965T-3 N>&UL4$L! A0#%     @ MH V6B>STB'9!   FA<  !D
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M=#4U+GAM;%!+ 0(4 Q0    ( +: -EI"?P7\N@,  .T+   9
M  " @<G^ 0!X;"]W;W)K<VAE971S+W-H965T-38N>&UL4$L! A0#%     @
MMH V6OK(,+/* @  ,P<  !D              ("!N@(" 'AL+W=O<FMS:&5E
M=',O<VAE970U-RYX;6Q02P$"% ,4    " "V@#9:9@KZ=) $  !H)   &0
M            @(&[!0( >&PO=V]R:W-H965T<R]S:&5E=#4X+GAM;%!+ 0(4
M Q0    ( +: -EK!:]UF70(   H&   9              " @8(* @!X;"]W
M;W)K<VAE971S+W-H965T-3DN>&UL4$L! A0#%     @ MH V6M011DM,!0
MI"L  !D              ("!%@T" 'AL+W=O<FMS:&5E=',O<VAE970V,"YX
M;6Q02P$"% ,4    " "V@#9:%O#!^? 7  !JD $ &0              @(&9
M$@( >&PO=V]R:W-H965T<R]S:&5E=#8Q+GAM;%!+ 0(4 Q0    ( +: -EI#
M3C.B&@0  'D5   9              " @< J @!X;"]W;W)K<VAE971S+W-H
M965T-C(N>&UL4$L! A0#%     @ MH V6A'REB.Y @  %0<  !D
M     ("!$2\" 'AL+W=O<FMS:&5E=',O<VAE970V,RYX;6Q02P$"% ,4
M" "V@#9:M'[R0*\"  !-"0  &0              @($!,@( >&PO=V]R:W-H
M965T<R]S:&5E=#8T+GAM;%!+ 0(4 Q0    ( +: -EK5TFU75@,  +@5   -
M              "  ><T @!X;"]S='EL97,N>&UL4$L! A0#%     @ MH V
M6I>*NQS     $P(   L              ( !:#@" %]R96QS+RYR96QS4$L!
M A0#%     @ MH V6B67CCT(!0  ("H   \              ( !43D" 'AL
M+W=O<FMB;V]K+GAM;%!+ 0(4 Q0    ( +: -EK22;QM$0(  !<F   :
M          "  88^ @!X;"]?<F5L<R]W;W)K8F]O:RYX;6PN<F5L<U!+ 0(4
M Q0    ( +: -EK B&UTZ0$  'XE   3              "  <]  @!;0V]N
E=&5N=%]4>7!E<UTN>&UL4$L%!@    !( $@ KQ,  .E" @    $!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>92
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>93
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
.report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

.report table.authRefData a {
	display: block;
	font-weight: bold;
}

.report table.authRefData p {
	margin-top: 0px;
}

.report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

.report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

.report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

.report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
.pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
.report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

.report hr {
	border: 1px solid #acf;
}

/* Top labels */
.report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

.report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

.report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

.report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

.report td.pl div.a {
	width: 200px;
}

.report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
.report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
.report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
.report .re, .report .reu {
	background-color: #def;
}

.report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
.report .ro, .report .rou {
	background-color: white;
}

.report .rou td {
	border-bottom: 1px solid black;
}

.report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
.report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
.report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

.report .nump {
	padding-left: 2em;
}

.report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
.report .text {
	text-align: left;
	white-space: normal;
}

.report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

.report .text .more {
	display: none;
}

.report .text .note {
	font-style: italic;
	font-weight: bold;
}

.report .text .small {
	width: 10em;
}

.report sup {
	font-style: italic;
}

.report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>99
<FILENAME>0001493152-25-003225-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0001493152-25-003225-xbrl.zip
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M@IJ<P8K@CYOKB.M7VF#"]X>'P?]$!ZN#;]?P/_\;O(I*." S^BDX([24"XQ
ML!$RK.--K>-)<QV?@Z$8O$X6<? *#;8BSY(YW"U:@,V?7W8OJ_$.9_CC)?XX
MMC\N\,<E_%A_U+ Y>1>?G$S.IY-'X$CW;69PA\^CRK.043NL(GA<=!$E*0D?
M6E5Y78'Q65;@ Y.E!=:?#)!</!@3C7O+>,:C;6J%''-\_CHNRCR[)]+Y)9*H
M3_U_'CP H8G3Q??!N^@L?@:W_E<=@\\#(P@>/%";X^6;_VX<8_J,Q_B,65[
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MK."5X:GG^2H.=6GTN_,XE8# &I1<Z_LLSQ[ XF)(&P8:K]9IOHECO0C>ODQ
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M;#PB6&&:$#XM=X1ALI@:%ZP1S0"%PJ&\QR?/!Q5R)V6PE77Y]>##@?'S7W#
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M):PTFI]+JL[ L5*5!_>E)EH9[13A-[+63Q,8*G(4FGR++F&P!IMDKH]>)LA
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MJV@>UZ0Y,%*.US7?)!3+K?-B/-R9R'7?UR1$@/^>NUYS=V&4YWKQ$N&B,.!
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MWQCX0NZ.RW,,COGOH7T"S)RXLS4U%M+:Y(ZVO9C>L_UJ9F#MJWGB2 5$#14
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M5F[ARUPEJ/]H".I?9U#_T1#4OXO;]19: 8^-%?!J%>/SSX(?B_P2;#T]]?'
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M:_ [7O#V=N:Y>P$Y(M-*'GH)/M8)0E25-6*8YNA]E<+$%'F6S!%@& 4_1JA
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M05V-9MCE34FS%L.D,;N$625Q_U5*"7PLJU96YX+PLO%\M3%HKVZF4;81C:C
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M5LUL"S=+ZYN++ MOT@%1=)YS/5^G<582TIVA<DX/7TF+<?[2>Q_D1:>!%M9
M:P*;K7;[[Z\_O/DWUJ'\_:?//[__Q_\"4$L#!!0    ( +* -EK\4:_[H60
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M<.8P?@)O#:^-$=MN*0&W10V/;23&Y*':BOR#YD@Q_6+7;9-27RA,W<#!WBW
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M.D_?-59K^H:'+TT4O2 #8\<B5[!?HS7KCTI*4,E>=(6IMQLG#5&,/#Q!P+3
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MP:CX#$G P!,H>':"R@XN4HAY38-)IP0O;!:R!0,=')J4I$S=RJW"%:?&&#&
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M$1T,5,"7"QVEO0-S)VJG0]S^Q-,\"<8^"\8*!*.'A2(R::EHCC )K@%OU+B
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MX0X@P_*!!?+T\NB.'45Y]!56M=!XCCG[T:_C&*A2^!0(S=#"#Z4,1=0LQ"?
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MH"5@.I07,3,V.H;WD!*_E0+ PI2J4'H' X5MH?M!M<J5F 3#'>.I'J8&#!G
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M9PT[1!)2KFA:2#R9L<;_8O,8O%<IW?MS?',%OC>\-.BVW:FW_C3-5N-#LC+
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M$YK26*EF5]YO-N4:R!U91LRWJ"SX1(&$B8![BRGI#),-]VEN()UC;BW&@I)
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M816H;1&_3?6EJUT4"E,%Y[PT>/ $L=DX? 7.A05GX85H..4V8-8X)41=8J2
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M7#]\Q[F66J5NM(&I4^R]@(N^=<G.#YWLO!]))]8,#RLZQK*TO)@"ZZ#HB[#
M8S"+<K12RC&<FDFFRE!:N'U)TBOJ^!2EL3(F3*RN!K7-ME;8)()!(G1I.Z^
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M%9I:-C<$D<#)(,PF PBL4%C+%=D8LD8Q4,)7'CP3)( H$,)/0_QU>.TZ+<-
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M-T2'4Q6:4L(?_I$I0\+F'N2NH13H !.V"8V&35X)$91O@OXLAKW]50=Q T_
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MM-TIG,/2:S-6"MTL<-7HX"!;A/E<*IN_[ +<.,F"$9>C,L4\S?^#G3^_RKM
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M:_ '17C47N'4@<GW,HRD1I;KY\Y0Q[/G-)!AXNGOB:I2]*\"C!SK*ZVK58"
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MCS+%]GMT/I$P4(V,:\?_DRV*GHNL]VMNGE*-Y#<T7S+G?VF6S,%X1/O":9/
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M<ZIL_U&F'^<IJJE)CLK"TK*AV*-B51>EZ,4R;=ZE_B))Q*-5$X3[;K%6 X=
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MVVA[ O;\%N!L9[LXA]^H1O.-]4'O)U2?L\8S7B_2[-PX%OR!'A/5W +5_K?
M/QH3YL,)%4@K_+]/A/*R\F"J<_[F)Y/R.S:65M#!IJ6["KQ#\"9:1-^ZBN-Z
M)?)D>K,8\Q)MLW!VHYV.BKRLNRO3GY7(4=X"@_D0K5L@$'P-8J$W3@U>Q>9?
M,!DBY=<=2X-[5X_5#^7W><1OPE*/X8B<<VGB6V#O /J=WC#_!F.R97D+A.+]
M@^K> HENQ=>>">>D5U=ST,WK0_F]?:B0"F@P!%L6*&RI=M5R(JM\0RI_!VZQ
MI^/D"II8[7&= =V,\0??-.JK&'4LO=[EAK:JGY!RY[5.-?[W>NG_3[U=^-\
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M[[%XIS$%=PEPDQMPI?^@9J(DH=-"6HM E_% "6*(2 @CD0_O+5T"#CE;G1L
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M0?<TZ-"JQ'UP/_#G>$-=:MQ(!ROV)+9=J#@\KL<V,*_8/<H25+^5+FQR^I:
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M78PC"4PVR^+WT6+K=-LW_I*HRW@Y\S\ 4$L#!!0    ( +* -EJZK[Y0-A$
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ME&@^I(($ALXAP)$^CA>BYC_;_Y!-2SX$<(D6*\]=8_*./]0.K6Y_N95J@+B
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MGE]8_+&TO+)*_;F]\VMWC[9_\)L+!(!!_Z'_E@MVPL7$S QF9OW-!6(*_MT
M8X:<567ANVS-^J<?OY1:%)O 'ZGY. *[M+H-1=#-?XA#2$:#)$O]C?:O9/\[
ML.C_%]E_@OT7UQ3 !0:=+ \, PR!HUL%+<WDA U-2C?Q:+$_ 4-WQZZ$=@BM
M^&NDJ(>OKR[$PHSR6N(PSYEB^L,:*>T,#F6RE;"WJR G76^LODSC4D.X=GMH
MH-3Y"DXV*3FR]\KW_?N=D5/_X-QN@Y,&66?C<.;B\H+;1TN=Y^>F3@=6L9*Z
M:@/R[^\Y>KRMKD85"$A$Y"+]Q/JX_Q&%V*U>\?UB&59TML8A\QT#3 \=H4L>
MGO62Y(5+H8JQ(S[]"^>KYG32R R1+3G,-R)7KT;BDS91-[08<."(V1Z(1I\*
M4Z?N$:K(5EP&9(3)(]F,L<SBOWTWUY>2Z$,W8+IV!+L#E>H_ONO\B!3"W&@?
M+W/TSOX[O]35WG%5J%%[7%9H<UPT8['Q8O-S\[Q%;1Y3O]1^P*42*HK::Y^#
M!DZ'&W=\^/CVJ8??(\&D.\(I.(D0A(]?S&IWL;?# ZWL%TI*Q5^TK<_7>1"?
MZ\7?BG=*)D:SK9L$A#9D$%N?\EJ5K/)ZP<\EF(S.AU3]-?FP(6OHSQ'_[0:3
M[U4Q/3UY/#C+\#(O-4C(7#<TV>4T#4;2J<]!;FAGW<GB="]>/O Q]9ZQ7&$L
M\)KJWC.XN@STYD%-"EJ6B%9=(&ICVS$PO47:L/C46./RW6OB [Q2>*#A?5S#
M![X6%=;647=,X>'-,*=6FB!%N1.O/;Q3,H[<J?! ^=9<8PF^S7<U.:QNYB-N
M\@80FO)/7J0ENRBXZ1C0Q7HF3;2WXAJCZ9Q4XVY)"NX7-$E[3@A^\3[UR2-1
M'Z1<PHV1<=)I9MCE>MO"+M+F[5,<6PR5,#.J<I=5HM[ ISD ]:1%G'0,<%_)
M<M&AKJM!T@C7LH2TOI@.J5HW+<CO>6]U N'&/T*CX?7=-/5Y[:@(*52,PR!=
ME=PO[S*VXR9\LW9D,\U!Z:??-A#Z%RQU#D.KO3H49A9,;.6@BP[J7R4G^L#E
MO;.FFE>S%[>MRB91+LPI_6B-GRF!01LB^R8$D377/R*^HJ%T9239V;B#P3-T
M84>2Q6L7W"XA8:%@"UF']>')&R^Y>JH5XTS=_*64CP$E=2.)A/FYQ-"YV# _
MHB__=8IE,=D"RNMB@417.KSGO4\M>AR;_M!?A*(7J+\$[$WVA^1&P0U1=\BN
M'=5B*.WVJI#P8)*T0.B;HIJ4FLJM9I4+3?M%SMB'7:S5@@L,T%&IOBL52A9*
MJ;1?$5.J)GQT=_A(V<T*UA]&/YCK0W)]G>A17ZQJ>AQR$[SMSN5G)&G#GSQ9
MK7&4C]>V#P-HMRI0^,VQ^DNEUX.F(M+%-[)NMF1$&S,]M'1(N?L0I$/&*U&[
M-VSGH=/&W6+(J C!,(/Q3;H!*=Q&R:KSB5\%PEZ3B#%>0+"/O;+32M56M;%@
M)OJEYU=))LW5[6WX%JPXQJ<06WFZ*24ZOUX_TR(?A-L,(2^^2.0JT4P)I);O
M8UH4YG.S(^%'E(V9#48,UFE5"SUY$#L^U!=P7Q(5;6?D8C"SFV;ZF%SG+?VI
M(;LS/@')TUJ&6)VJZ7VS.3ZRCM.5>2ZDMGD;%-7'YY<]D<><CS# V4O J>,I
ME!&"XQRFY7+@A1U?B6&+OK*4FQCUR$OI@SP+42[NAW(SJ/F.61">VIV"E+<X
M!D1<M7#897^5R<*5+_F^OJ-!2"7;N2.L[I(&:&,T@P0WH$V010V]K)C#%"G7
MM;*2SX8C._>"V9SLO=H$,"J7]STRC;L>7_2+R?ZEG!BA/XP7IHD[4UV:M%.+
MEG?37)RT_<O5ZT)K3RF<[F6*5$9_0A0< Y_,PRX=57@>X97P4X&M!A$C"W]/
M_]@/F:D-%L<EC6.SZ_?#WRIE8?"R8094:'P](@>]FSL69NU=X<UJG+JII''Z
M7!L4Z_3AAP;F?-@YFV!U=O8UU]*0/"C'T5O&V?MH"$/(%356AU"ZU46\F$&*
MD2VP"#Q(6JAD%X>]![I#"*?.5<M1LZ)\T6Y;-/F]IQ<N$-.MJ<Z,3,JJ8ZS*
M*[G6L6H<_^=U744))Z90Q>2CB$:J?&R@JXBQNU!CT>3JT+>9;K1/X_/* O'$
MK^X9:CJ/#*#6C@&(;C]VS&T'ZP\5I7=#!HR-)"^%Z=,>(P\5&!U[CO>?F!;F
MTUR6K$>+DYZ/S#Z]%V*?%I#3IK##D1?(A#>Q$C&C#+C2K$C.WNW!^ OC^N)$
M);4U0@1_;6W(GV._^GIZWU"3.=8;;;OF!VM3^R-BZ6$4?/Z\8=0QP!O(K:BN
MA2U'11Q\'9<]$Y+6PE/:I,^5QA*^ F?Y;E9)/T-1.EQIU/.=6L[$:>(+'PPZ
M(]YUE%/?U7PO4GMS:5X#1$&O>U(].[)<N;;TSU,V#QE\U<_P6F.;+<;DC^[6
MM8$UE%IS!L*@&_SE!=MHI72%ZBG05VS;)4G,[$5:)[60A(R+D%F[P^!\-[HQ
MXD"+*3?WP,<OF#2LSA+08YTR:4+[";#*NY%7!0^$2Y;%@I(FE+ KNYG01V>S
M@QJBW-5U5P?JN/LW0TKU#4BGA3\]*]-**798\2US_GBT4AOG?FC2#HC=:=O_
M)TY4?C@2+D^SHFYWSL)JJ$B",M1Y-4*'UNA._FAV8]B0),5G<911%'^+^XB^
MP$V-<_L,WTXKU2&\%2<*$[9$4<V[,;29/)2W\V@=FO5UGY)T)UPO8V"WI#H
M*1Y>?NE>K_VLEX?_5]#/0:FW[(('NCPIGLA2)]=V+Z3@K\_E-P)3%3)M73^(
M1O:!OO%W6G%7!AW22X<-UIT;%$3=1W-O;1E)YDI"(E3,#@WNM_+#H2AIX_>C
M#,7&9X_<3^XV^_5TMJK*5X+$YLP[S"%,FK,(OXO=IQ$:<Y/RNVE#=&F*7'O[
M+.OP+VBBI)"F53TJIE.;OUVV*C[GL4;22'_IC,JT6!<@?E-=Q0CHK1Z4';XP
M81-^V5>I\]!L43R?;[\8U&-#^ZH^K9%Y8)!3% PC>/IR.-7JKYVZ5F"GS]<&
M?9D;>G+PB$M=DE-/R<$$ R3Y4=Q$ C)P[;3IVLWAP$F-AJLM9A[B=PG"7^ #
M$J/I?0$?S-RT>?7VY5/0#S9<R1,;-R0Q<.&5*<\G=RPH&'A6^=K;%7?BS.I6
MZ8QSUVVW1U.XGZ$ R\:WZM%P:7,<A9'EB_5J"#H(RO46P7 B[#O\KL04E$<"
MX,$[2]@-2,'WB,&#OS,\L-,F!30T61XS/T0W*/)B:]@H=6Q;K*ZO^!DIFIA\
M[HIUZ^?\U,0+[8#D%30!CJ1;E$5\9D#?4^UR--\4&N;ZG1[K&I++YWI7UQMT
MV[_$2B7W=?I>RFRY8:-GEZ\K"1W;HEJP<A!-L["D>ARN?, FRS>$D :KHO\.
MGBI'/S[SN603Q)QKO5.243*U?."<$_?" I)1>8X9=N93T8-\6Z,= &2)KVD<
MK2IJ:(X^7^'%,GGV%;@0^@>4)1*N19.E3N\Z'V7#)1UIWB<+?H(F23>]K$Q'
MNW^S*GV07=4._946XK?X<BFJS8D(<C$AYI[V8D"H$XET=6K7A /-CS*/F$#J
M>Q2O'.!S9-)1L0-:5*%\#3DC(2;AHU.1B,59<V?L3H %93,KO[SD=<GDRG)%
MO=WXC!00RIWG=^>OQF1?O(^7W$AJTV7"+]$\Z$#KE'B7A#1MIHH60,Z*"N,F
M/TV)QPMBYJ]/(.\:>Y:N'=CVF>V6KE>]NA(OPYO4VO-%)';Y1O"LS%%-,;7[
M4[^WR5$.G?OM:C8^M_"S=$OK\,)(X(:8#DG'J8=E_X4"[%/D(BX-T-QUUDS
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M;!:C %XW.2S(Q"@ !?]S@(\G_P502P,$%     @ LH V6KN=( &_&0  B!H
M  \   !F;W)M<RTQ7S P,2YJ<&>=EW=05%VSKS<Y@R0) J. I$% @F1&1++
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ML[ ^Y.'EXQ<0EW@B*24MH_1<645535U#W\#0R-C$U,S6SOZ5@Z.3LX^OGW]
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M@.@R8?>XK<!J8=+2-$B0,4FLYC!>L&6\\$775Q>+[F#$=K\.GOOKY)N@4/1
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MKOO+#F21+I@U*A]6&O>L#W-"^L1OH J^3^-JO=]CIZ/M=>6E;F\/J'.1$51
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MN?^!N3N1.H_MIU;OKO/0_4\;5O?I/]6:]$OKX4OKZ8__=.EZ23UOP0ZE.WT
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M(>"9JT!%3K!8JYZ?5T_/=A3/R!OH"K[4\^(J)<Y(S#( L@H=(C-R!HDS_KZ
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MBWEFX(TW1#?&JK[@G0OG(_K2F,>Z/P>'OW@:P8$D\U=I A^76J-/']2WCS
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M_J/HZ]LH$0N?I-TYD2TQ6O?=SN<[D-CM&^GV[J'U<'T'*AO%>:?W<_N)R_*
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MVPAL"*].IJOB*NZU\]3RK!,!?&'R$HJ6H1%MZA4&[@,G#E7;E4F<F6G)0P=
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M<O.=W8R8&:DOQ&_AJ1+B-RW7&_CAB-<S:3V;A/7D$,#9V!,':Q%,/1.N]"H
M'_I'C-P:P/A?NJUF2QJ1T:TE.EJ.F!,EO:M58P_>A[U\=J@$ETXY]!QOV4W*
MAKLOJI@+;*V6#AASB"28D\LE+C6)#_FA:^RL@K4QW7Q(]BW1!S39]E!ZYJ>C
MI^XQ ]=@=G>F@M4Q:6=%GME-V\4FGQ8PO*+UOK=/6Q@"RV%7/AY_-F@?Q, )
M'?HG"PIX=0/FO";8L)#E@KS"RW"]4+T2W>OP1^,I^!LQXS5-*?(<BT,\:_Y3
M\:'E-G\$\P9S7(,&$6_L1)18@XAZ@U8(L_@ ONX>=M@96@R8]:>LZ(%W@"O^
M\!9N0Z!/'#S^E:D#RI+@9_>$A^$0'*L!,9,L'\<=-(F=5F9Q3Y&%$P<JP=,+
MW)0+YBB'"@S0+M6O,&M]XX4&';W6YEY*D$=+,#>!DN85<V[4J#/?#(ZB$AC%
MXCOI01LG4'F7\7^D!97#FDO%X@L$#&UU?\A?0:<)C\M]%-F'A<\^I/7+"W7"
MW2.\OAW*+T[/+GX(1?IR;;O19)Q:-<MTPP4E4H(G?WSW-; GS2P>9H:Y9[?<
M8WM'[K&]F//%S?KQ^;FO7WZ0\NG:%(J;!*E%\);%.A58(M=/3PZKU>U*9#R>
M;6(KGR%M'H%=U;P3GY00MF&.)C :B5+[;P>+#M[IZ+3C.?='3=99,3G!$7D'
M6*%)%9#*)ZE4R!:"UK-J]?#TXF*'%F_4VGUULX("!59G W%+6KT7QXUFH*1E
M2:)Q)>G;T,9>>Q@:^LDT7F%)W<Y=?C[:+YVK+K9B*O XTX^<+M=9K9YR:[6O
MI(+E">!5M+BH[N[O$KZ(TC-;1-XVV=WC#:RE,YZ &VO:$C9'NW);HG7Q*V=B
MX3(CR]:KV+G5"*__L=2B[W1?5@F_C+9FH]L@M(PQJ[QBTYYE?F_;(=AUBC.
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ME/-^(45YP\/PZ+!S=/C+D84>-]45$JMIC[I=2FP.YS2TB=N4?XH(^YF'Q,(
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M8"66",P*-N\#)><22L[D"M2>4D<#6&:.J"J\-,Q( FL"H^TL7CB+B7,#"8<
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M(GL9CJ%;;Y36_QV]T.CXTHU3)660%X<[<!]V1F>?<$$48OUQ,;*NAC3D%A9
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MQ9(9(($21$!*S5*P<H4 VK-TCF@N]!N"C6>\>Y5E:1;G\\"_G*5CK.8#UJ:
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MTJ5!B$8;GR>&&*JPA81!;?9F K2AV]@*Z*AC!&T&KK3PA4X-)NZ&'<,\C%O
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M(!KY$G.&= MC]GARVJS"-/P%V"\Z:Q,]'+,T1VK)%.D<'"FU71:PK73]NZE
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M+[PA!=Y1/"9B:S0<KV$2%A*A"\N+!5+9N+[4AB%OHR+F(A2S0^:;%L)#0M9
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MU6PL]%O#H"NA>$RTZ7:#=G_DV "84V*U\6U\]8YMMF9G>6Z>"4V#)B26BDG
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M3-TB()&.@^F4ZXNT1W*77DWRG5(WPSC^S I4&"Y:%7MFXSBE2R.EJ.$ A'P
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M377C02TX7?N9B[.^^4:H!DI)VBP@,D@%\PH7$<3J9RPPC06S G.8-7%6I[;
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M0S,;[I%;5$#NX-C O&GO>$%F7#[)_V0[$D._>GMQ"<Q;1N086##M1CJLB'3
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MN-EPB;<8-@:_Z+79Z\*T1XBY[[F_7?:)I$M0-/ZMDA#^3;X:)/$2;B6X47G
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MCTQ!]47H9UCWR-?D)9>#;[M3_;%5T\TO10&NHB$"M<-_##+8*(SO8#+7B*B
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M^U5[RX8*&&I"W286W*JN/T!?,S6S(,NQN(?%/KP\.=;W%W]^ R,EW <HRY(
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M_-\")$</;HG$O<5K';]ZTV[!;SL(2L(/>)3(V*D990K"5B6)&CIS \V-\JJ
M?T^M(6[((?IM&D<(*CL-50%?'>#6PK;"A8_P,EYG;]?K]7J+8$ )R/I:$;P?
M:L8(VE] SWGNW3@8C$%A3G.D+8IMN+^_;I ,>29XFI(R5=*>Y[6XDG+UK4Z)
M)[#U2ZG(*^ P^,__.-H_."JY-58Q#:MWA-B[>\Z\Y\# 1Q*# K=-&9F3SZ-[
M>G'N#M4@)*0N9;HJ"C8EZ$^(Z\LM]3H]@K[L_H0![6ZG+HJF7^8(9V>Q=.,
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MB 'S,ACY,*,7Q@'(AB^ ^2^V?A6T?AEV03)35]2%Z(%58FAA&9M1.05K=>)
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M##T!P^==5EV#QXXIJ!F[A&3;T?3;BM$15'^])%(!X^Z@GGA*'4UN!(N/F=*
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M<A_1S,P<VI=^A8VVAGI%##->H,&'ZM!2@6RVK.4+&?5M3BM6LEJA7"7^OW'
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M\+FL1H-/_YRX,%G99=Z%E/(?XCRQ*'2?]-BW>^Q/R<Z\1PWED)K-GMV=^(J
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MP[KA S'->.,A/;M@&A "<#Z!,K]W5!.>[?R-")P7QT7AR^?4H2DT T"G*:,
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M/?2,+IUG:;-!9P:-;?,?X+NP81VB@6 JFL:"96_9<X75[,'#HW[ 3[U3W'M
MAA>A> 0;I)XY5I?@6&8QAADT!/YF2&<QLY]& YVMF/P2UNW0W].?@EW_; H
MSFSC@7KQXU\*^1D&4$C+AJ0 L2HG,).3$#XT=#K&69_!4Y#,;GU\0-9SP +]
M?:+MB!TZ?4=;*T:.^0@[XA'.#P$OC2X=;*WP;(1$;)_-I] "<RILZ!GNC*6
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M(<BU0%C6T/S%H]X,1QR8,,)(1U_SAEJC&N<_40^0CW$5U8!RA%-2;X0\;!R
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MHH#"0(N<N;(LF40[H)VAII#;FU )/QL#UZ#^*:6#KD40X,&T80N\V<,'P$8
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M'_^<?=4W9TO,ZI[<81&;PIMMJ.%OM;#V9OX>L*\DY3?\&HY@'!BQPN8)GY+
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MVRK76A^[>JM3Z?(D%BWM((M6<_O+HODUL.BJ*G!W[XV=(F:A(R*/F*[C6-9
M#>?%6>UK-M=IG(Y[6U(*K9")L92TM&1WF>.N^>%[J-^-F^R#WB*WP.#!(9;*
M33\SS'TVO]2W7LDIJ%-Q:K"F_N$!_<):JH&V8'DM5[K3=!!FM8?+NC(<F)1,
MEM>X'9F]VZZ'+NH^'W]OM2Z?BY_OWJAC<PP$SKQZI#OJ(R(Y?0@2<;P2$0P4
M\_QGZ>+?^\F7[C@F$8O@;V*0$=N5S6:RLD/4N#SUNT17^#AW@U2%>7#93#X>
M58?PX1!?;>87\BP0;[/_4H,GGHL\<?K*VF1\;SO$'.F%L-NQ4?SGN=_)U!ZS
MT2?MXG-473QHENW*2Q'!V.U+X:F3LTK6PT<C&1$)#CA(1@)VBPNXY#_S9;@P
M%I'AW!<W?A!.9!:"C1$!Q_F,.7,LLPP:K9+HZQNN.PEESOKQ\&?K)DN(SR_D
M"Q,?,LN8V<0O9TPY&4T^U1Z__ENQ<TN_/+/@Y<W)F,]J#%E^_[G1'=I?GY_S
MW844V-Z3DMP)<\E@&T$4H>W<5X_/3SH)R4C,^?0P$HAFW!+X=8GF' )#Q3(;
M-Z&\+@*EHXR_C=FX>:5M41F^EZOIX5AW;C+E%Z8*F2Z@;0+>,G?%/:[LKV>_
M=-QL8:,*A!-M*]KKR-V?E%M?+N_S7[,;*W]?HMY]Y1"J;2$5W)]!RQ1_(UF;
M16H7X/_13\]>^&^SWH?P,Z:%0\+>:6I6*T%[5C8C?S=<1-2W\)WW*GPA5RT$
MRP)>I)@HR!D)=.K2"9W2JA"=N^_U%[W(K[3#UP:1(M=HC0;F.%0.OQ?:-]-O
MUZ7/V?L7[ BC%$=& 4KABB5!".#)&;BU7K[UI5D6!I?_I7/\_]SRKV?VGNN,
M+HWBT\-S+AOC]7'%9W6W/Q?3P=X,2:$F2:[X0CY_.?R48SC\]UDS\U"J5\K?
MJQ&G&\/;CV"R.*[^QR^-SMWG3YU>@K?'/=#E??S<:N[S>BD,9[757!WIAD[*
MAR%G,LN0]7D<X?G8'B/>>FW"3[K3@T&!M5^F>WO++P9^&^!CX$JXP.DXM\]U
M_=,O\Z[W7'\RY_-0E%>>GT=KP!=>!\&/5Z8]&#]6,]^[\PE.X#U'[/$\CF>$
MWD;0Z6>W_"8=UWF;OKX5K.;49HM:KES0"L4P8(%8(;$(*Q=^!DLW]WY&B"KQ
MA8BIT^;)^5/CK%HYORLN)PMS7QDB"^R]5W</4[WQ>')EO@Q+AZK(_"8#M8EY
M-IS$U>Z9JE;(E+5"-JS]:BY/OGL1+PJ[H.89^ DNZ.61N[1B;L_F1BRW;^%F
MP](=+=7"JD#?:47%3CC;/C!)XN#"2>J#*]WL-:QC?02%E]31OE_6PO$\]/.C
MSO2?K_<-X\LRXW36AMDB5JG"W)4#TU*[=*$O&DR*V/SU63Q+ P+E<UJA4M6J
M*V/5[\'.YI;8V<+2MT^NH)7S>2V?V0;:$L=E1^0:<G^,'./>L%SST:"=+.>V
M"_TKS7Y;_Q6,K35.BXV?]O5QXV:94JJ5*FLDROG\*YEVU43B7Y;!DFUN?+MF
M^0%KQ6I6JV3WM$EW'?L9:N\4EFZ1RV7)Q5/,;T),Y8##M3'63<OHU77'(J+A
M2CMQ8O3-KCD.2N;5]>>OG[[6W(E;VK6^T9IO%@12O\=M/6_G\^SBDTL@]@F&
MN+F$QO^^.9CAUZ*6+51A-,*Z&G_V><;99LXN7,4DZ*2+.+MLD5@$92U?6AND
M_+N85L)L234'YO!Z+89CD7#[]WCJW)UT/M;7.+%F!7U#>SRC:[#WF('G\^_L
ML270-<LCJVK5/+DY*AL9?/#[GE*X5EG:>:MJI4)6R^:W-[*O%@&-;O5"U0OM
M(/=:N2J#HZQ[5<A] W2C+71M+!AC<=ZH'37.&^U&O:76+D_45KMY_,]9\_RD
M?MT2ZN7SET;[VZ+]W.=1"HO.,;Z^67YB7CH$8VLG%ZJ#BDL[H]L:C_'G&+!8
M/RC*WR.Y"HZ:$8MJX(:Z<V=:!V-[]%Y%JX/]@E,R8XET#;)OSCJK[@*HCZ/]
M7<G?YH?VO:'H78C5Z!;,EE<MA&*$(EC(,9(WWCD8@G5P<"#Q\UU#[9N6;G5-
M\GL7*F^PA_O0UP*[[*;,KC?61FWX>)6__]?!@7IJ&H/>>_5*OR,2WL)>X"[Y
M5C'WEXH)'?( ]>" *9V>^1C71%FTOA*N#X6&[,E@P(0/)1A^)H1V^<_^5Y+;
M=J"/7$(9_]=?ZI/9&]_#6C/_">.(Z#P/H2\47#7\SN:')[WNS8?3 WDC^1;^
MI4*6XKU:<X@.[/ZE7A+-2+?YTH8-+<A?^I-_"_[BZ16N5/[^DVQ\R!$XAOYP
MT#&(8B2/'N$)RMM>BF2K/=AVWQ;_K:OW#JCT_WU]<4LL4F(@X0J([ +  DCJ
MWW_J"W9.WF\X!V3K5R3/+Z"NX8J^:-]F,GD/K7I]>KSSH756N[YJ*>WZ\=EE
M\[SY\9NF-BZ/B5+NK*Z4=^&FZGPX;EZVFN>-DUJ[?J*TVN1_+NJ7[9;:/%6;
M5_7K6KM!/O!:UAO&M/%4$??P\IGCVVPV?_O\XZ)2NSXIW=7_!="-R9 L9HH?
M(1J8W][J 6B''@S'0" 6O)DP(BP^XH(*:8X,!P<%NV^2;VL\[?@F5KE!9%6!
M;_>?#+"]X3N#7KAC0$B +?[OFYRW<X5J_1;\(FA2OKWUJFZ=<BO[E*T_3:T?
M;R)?$\X8I[8#II,Z-71'-<A&]Y+1NZZ%96$Y.;$P5@@V^G7Y_=.-?E9I=K:^
ML+CU)<D//"+\N&BS8AIM,??'4S^Q;KT3HXN9:S6?U5#JU37_)R$]P/Q 1ZP@
MU/(LG![56HXJMZZC6EDH%QW=G(^O^.V%J.90*V)-C%/''H)!#!&.&W-\?XR5
M)(93_]4=3&##8"PI^?\]*+, ]%^KU[Y]OKYXKA>^?[K\]^KA)0>'LS5HJF6\
M0*XV7D!L00P^7L-HMEB(;AC=\7S%5K>IN-9M2HL^=Z+H\TA26\SRMN[J;(:=
M;X;MN=V__V643AMWYI8PM 0]8JA>BIVUS!D?^ZXFEYC1W?N:U3LA&GY@C\#Q
M8@<..3AR$37KS\:/J]OG=OWT_-CZ\C/[;9G\6X*L/G/-2A"W"@E#K<WCY8O'
MWIJ>MWP/9C$4"#00!,O]9ZX6YWYFZ%K"SY1_I?2?)=(Z<T_4G],!@P2S<9GL
M ;1*A.?E5AA^KI4R1:U86#QC=?E-VOO=SXG=#\VME588+9*K9+1J?G%I8NQ-
M"E4G,E+21\,B.GI 5E_K#4W+A/MB;#X:X0K%'(VJ7\^/NS^=XJY5*+*%H&;0
M?4MYM54H"\YN*=6Q=%4M()-GM6QF,?/NN$F^PX>W2/,L/82B!.VO6J6TO3$4
M<\U6+"6Z';K4H1Z.N?KY?G+>T%ONT8_6,A9L8CR>D(I$>\:BW6,&75!*.W,L
M2RF4-=309K1LKJ258O0LI?7/\0YMD2)) &D4<6@5K4QN^7)U;=?!O+KG;)@R
M\9I+;LTV#K9!9:(WSD^/F\^GV?[M\[!G?+UXRCY,1R\:J0,:U3XY&:Y>;.MW
M4"O> 2VE6!*4T::*97O'MD"UE!/XIB^G6M* YFX Q5_:ENWG.W:M^0*;=Y^J
MUP_GN>'GNV4&82\5V,3F5=JNJKYEIN"FH3=>YW'+8R :D&0UW+'OJ-EX37)S
M7S;JS_]6?MX^?_OGY]G)4;%WWU\&?&"E%F9.XK8/?[YRCMJX92[6<H*.Q<!]
M2B0HF]U9")8%%URB/5QTRZW!Z]'RN8Q6R"X#)S#/5I9GAZ$:B]2Q0:D[LK+%
M>GMR?Y^O;@P<-YX04O4K1&\[N &O4_WF/(#64]UT+G3GP:#00[7>#_('"(:?
MVHZ8NS;&MI.:U6,S[S%6<WG;,V^'KN"4_NCJ\_BAE[L!B,T7"A._^7!Z\575
MQ2)4(O!=L0H5P<O4_]&'H[_4)[:4%U'A" &UW-8OH]V3##Z/TDREJE:LK(J?
ML.?;O. "J"1HL(K8YJ*6K^:T:G:-X%SAL\T_ZJ8%[ES3:ND#H]D_,1SS$6/1
M;O *Z'UYO)A4>E/C4V[U*V!#<KXE<?[SY5D] 0G(!)'0W/'D@LO# N5_-+!R
MA>>+<>UH9UF$<XC*1C-F4M<M.?^<2/QC.P;YXO'$<0RK.R4,0HS*9JA1.:-2
MGC+N]=GCL_TCV]D)Y FV%K7+%D-A7<'@?'VQ/7HI)CB\92R.ZNH1OV).*U46
M#TOX#8*TFSS'!29-=?FZEI)6RF\$6B1JVO#B ")+,8^Y'O+EA7Y4]9^?._U:
MQQJ\J*<[+Q6-S[/GQB'WD+]C%WV\RHJ1M:U^88.#E\3A/0ZF-2$O\7KWCK /
MFGZNK?\RW/JOL:.3-9F6[DP;8X.8?+8%:L2Q!P,4+QH_PVPKN=_/GS_>_" 2
M)LE5^=.@ZS2O,A_+@Y?,MUX:8W4 .5>Z1O7*L1]-%]0I^5'%Q:[*1#'/;*;\
M?^'WXL8R-W:\2YD JX=#JUJEG"772'+ F$U9 ;_9$2^R#E8O&2F0XZUJI=)B
MI-,UE(S(XQ!.V-Q"L57,1C@R+*,/,)W"Q:4Z[;F6=Z;CR>?KTG5__3Z+;U'Q
MW%N^ -!=*J-ZCZ_!^8R_X+26TD^KUY+DHR;N_)Z63,R>M%PFLZF>M/!8)[GZ
M@W5A0JIOOG4SHU_-=N,X^T+6"0,G _L$Z%NT(1O",DO ! L!S19<8K[C6$)R
MR:_785D4EK,L(@'-%MH6O\/)S3<8<ID$G09K-Q@6G=P:2\&BXZO"#2$6&YVB
MI)''N6:7=K>9@\G80\I(%@N>,3HC573XJ#^.GLP')1X!6=Z P2#HR:<O%]-N
ML=Y\:'B#)"-71YAEH+LN?>WHWAK??LE?W_<^?AU_OREF&L>9N\^YZN3[QZ^3
M;N[K0Z-^^=BQR/]]'#Q\^_=Z\/WXJ-W[>)KY?I,==*SKY\;'ZK!1KSY]__<3
M><: ?/:BEFQM)W2CHU?W\Z+SX_+3M_KXH3MW=>S$MK&^!<(9>GQ+J==$@[9"
MQ33FM,Z(4UF*Z$2CM^83G3DLAP4N%PP+CUF?LPVI+L66ZAG$'_OJ_-M9\Z;1
MURN[*=6G":1Z9G5W]Y>USNF/[-2=O[I]E.I%5V^B":/;DNH%1&<3S:E<)-7)
MASTN4W7WDD[$#0+WP%A*\GJ 9V1S&B> WC:V<?(..0M AXEOA>RQ/1M4'C*F
M M^K&MVJRPE@-C7[,^,?%YA!1W>MWN?[7T]'=][$Y96/X244:V'QWC!)GAT?
M&KD[O[Z<M0KY2:.NWZ]E=[:HF.<KN43<LXQ!DUUMP.U2U$>=[U+TKS:N-9O7
M,OF<5LZNK+/W TM^DUJOMK+6FS&DC.\/]G3\]>&FD]UOK9=9@]:;V9VC^O<G
M_=]^X9^!F6J]9 ;?:A.4-Z_U%M&?R,J>H;^B93/0_Q&64]B\TDO',.S:2M(Q
M#.&;PD\XL*#YTQCRZ32&67=RC=,8BNDTAKG;GDYC6%*L7W(H0R$=RK#VH0S'
MS8NKZ_I9_;+5^%I7SYNM=#B#-)PA2X<SW!Q7;X;3[^,SA/%<;3B#;_ZR2I.W
MB;=W?X8TG(0.:;#KTT]?3;=IW77W=4C#:>B0AD\?/U>/<^;%LX2$D0YI2)'_
MTR$-^W54FQC2$ X!X2^(&^K'C<MF^[G0.[E]=J\_WNM.M?_M;#-@K_-!HWDN
M-K@+:T 1GLFC+P 0WG016V[UGOSX16QS=V:F<&T?=WM!7"ZW>LE@_,*S.+N=
MXH[M!!)*(0B,XS.5/9YKZ[]\Z&-7XR_C0KMQT30WHR:CX&^Z/DN>]@"FXQ7B
MGWPJ:R\G:_48LA;H9VX[NN52+5NS>OC3 /N</+0*<C4T^T0\KVP'_S >.V9G
M@DYWV[[2R6,XDIQDY7PSAI^M4OYT7"]O27QG$ ;&WF(DE(J7@2,2<)_;/)6E
MC*8$#6>!5IUR62L6%\,)O)"0[?JY+#*O*DO#!&2)'!57Q95*-?Q.:'BYO"Z$
M73GS<1@&22$7RF=/9Q?UHX=/I8THY 5!A#E]X_[8:9ASNA\#XQ9X6'..:QE%
MG5\=_Z6J%4H%+5/>9PB8'3RX!9H\OWI8HJ 5<D6MD%GWP;V6\I2_.X+)7D?6
M*ZU2B9<*G%^>4DC+4S9:GE)*RU/2\I2TJ'"FPJ7H5;C\YG4IK7;S^)^SYOE)
M_;KU/_^[DLN6_U+KG[\TVM]>T?I/F]=*^ZRN?JO7KEMJ_?*D?J*>U(_K%T?U
M:TB&JF#2J[7+$Y6F)%_'PM=1F%.]S68+M\_Y[M>S_M/]C^GQ*G4YH$D1<_J>
M.*.&X_Y_:OWGQ!Q/MU:8$PO:<-:1]GTM*G00>/:6"P86OSV,UV@)_H*5K%8X
ML:%M$?&7H\RM"+\(1J-L!5XB>2D .?\R7>]C5PX#5D)>O,"2B-OGVM X=H[S
MW\T?^0WO>FUH3ZP9V*I]V/64&1<P8S$Q,Y+?#VW+QXD__OGQF#\]=X>7>LJ)
M"[?\*.Z6<PQO:<=;DX[;=<P1!&JNC:YA/L+UR,_A;'Q6G!C#HY,OA0V?@_?N
M_3Z+4F+VKY'WP>[K@RO=[#6L8WUDCO4!/X*C'X.CTL6OP=69L>$C8"_>[_TO
M)-__;G<RG S 3HM*N/&S.)^TK>_W1\71I;GALVCXIAS]+D=Q;8QUTS)Z'$J$
M[_N7;^6?Q>[5P/ZT:</DQ.B;W5E S?W:^*/;Y\GG4>OSZ5'VOM/=\([1$]W
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MU);AF/V_5/RL:SX;Q/#(C!87$<8:DY+0+0G;;9\55LBL-BDEK)@G'0KAXYD
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MGDK&!/#3<KJ6JJ@8,<GN,&(.9%.)73/\_GSIZ/B#Z1?IYWD[3BQS! 6)""^
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MR0X7'9IKK]&9]2Z;D^(?93:XRQR1'R3@!*ET9ME'[?%RV"Y>38I8R\7PB1$
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M?KY_Z@\J6=7%#D6UQIJ,+P83 ?KTG:,: #>,,1#8O<K(6/]TZYDCGT#I7V*
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MS2%!?KH<B=@!6!W2J7?4)AC/6D,2NN<;8J\3:A_<*G+1O\X2#Z&AHO?+T#,
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M0;H83R;GFQ5RQP%SL <*[U<U<^&'9M*W[(T=ZVWYBJ[__*ZELA=_QI:RN%'
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MTH+>R-A<2BT694):GR^3$6.2A6P,GW"*<B.#<1_)P&_=KT@$%%,9%O,JS2(
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MC:!YRK7MX$5*!?H40?LZLPJ3$G \$32K!+N9BG+]<?'X5/LJ\;-"S  ?7_H
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M\^(<M;;C9/0:)8#Z34U*P](+KI"OQ568W7@!IC*?@>['X%.*I$S'Y=[RB;I
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M=1XRSR_N JD0#AIDK6>%QYK7)/\6TTOE@HAM%A1AGXTA=.:Q_.FW6!='D?=
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MI<'#8QX78,U+UC,#V(9Q<Y=#/N 4J)WSR@1P!N($7H4-%J; C@'L^8KZ-$S
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MA35B(\C-L/J#.\>,JS%CO6)M2UI['-P4L@IS"L%<%*UXQE(LH%B&1Q<$N(?
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M/>IN@H?6+FJN%L/KG3JP'D?S1&'4B?<X&>N^[%;2]$5/<9P\?)+!=KZK30L
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M079+8+P%RB'+%PJQ\ZF"L#ZA2FM<^B.LW$X,'9W2H,?:P.DL<5S5B?+!\+]
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M<'0-ZXZP6,L(9E)ES'05S>R_L;2I7[\_F^J+?TR:.EK.\V:/&!JSA-]<7^E
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MIVDRX,#0 V/HJDINUR-KV$;GJ6?T\0G>(OW1[;>YYB>9<[R\^_GO?XH"7_C
M./N"ODT'C71@Z($Q-+"'W*TYR7=1F?^F]$=H>O\$'R$OI%)KW/YZ_OV'?2\6
M[@K)E2QL?72]LRO\-+PMEOG#>?:4!O+"Y!\O#6X5LVXV;#(6AY+C%IF-GF)B
MLE1;'1+1YV21:XT+ZIF5J[;[XR_R.\;6;++FI=<.%9-Y)@^9;FZV@$+L!8@\
M_J\UYD15+P\K/Y3O8K@%!,WQ#K&$\"F.@N -\E9K%_-AWEOZ.&N+J_*-2A=R
MX5;UGL.?]HD_KPI(T[\F_70F!/_ +')<6LEQY[6ED=TS3(QB=0%J=U]^HML:
MU[@NKX&:19_!*.Y#EB''1U[ !&IOYU>Z_'3^:T"N'T190 3F+BXA M3"7OB>
MYW<<!(9:I#_RPE8#^"^2)P4!*XH"@D&YQ)IE<)8#L%&UK-$2,)MJ^?9K(R]_
M^R$%XD*C#U@&92[@Q?61;=F*3HS%PMMUY6HP_GS=^=7X%?AV8_:4.!QW=A\>
MDL6P"=ZD(.FA4H15AKU,Y+_*C;#HP,'I(#-;._,7D9]_E]!9B83.B=8:%LY[
MXW-U.,P]QD;G:BN]$IV3MRN_ZC_NOEU7SU![C^CTU47%L'=/=H5._U5NIM8C
MFV_H2[2_Z''J+N\#^W?(_@*7-O8'#O4CJ4E#7SPS#X?<D/.<G N-\8O<;X_[
M/W('T?O-V;5CQD.<JSU$"GFHKG440?C]5'HH=5RCZ3PEQ(EZ!7]"'J>+_?Q#
MK_MT__5:"/'JM28PQ,O#.VDRG\1!.NZ2?"VS+.[Q%'WNS^6 (_3]P^?ZEQ\5
M413X%=R-?'Q=\_((W U[&]/?R<D[A\)UU>+LJA/@7XN4%:)1=B(WU5]=]..U
M8_9K^0B4#2>Z :\6&J^O\G7O5]\2]\54?_D(>]TECG^=S KES7SKM; +%F]-
M9\C*_F:7I%M>!P3?&(1H7W.O/[YPIK)*;P<<\<KK7KDZ^H ^7^K7-G_[0-I)
MK'MOA,/=BAV'5B<2%[;J-A'DQ0DZ2%S81L*K F$2Z2?,[S#XL%8Y^48>2M^N
MO^>LW\4KI1</DRN\J*"8@Z147J4[Z[%[_FLOF/33-1*WF8E+&)/^2]Q,81-$
M"G(. @[[/W&&!0OU?"-$2B/<Y;/PX0[YW>HKI+6S+$ O'=#S#X.&==760$^2
M4XH\WSB+Z.V^KZH:6:_2OU4TM:J?*4/-5OJ+)0KU?*\G?!$?'G_N9%KTECKK
MNWN=G($U]11[RAUGRR"Q.VY0[H^\"(YN!,%=N &79^4<SQ;$T&-PP6 <,_Q\
M?5H^]AUC46!S,L_B<VY*X>=K-?CYF2VCP:A/0IQTJ@"VOD,3]9!N:<_(:>QP
M;5BDG4.]VU1>%ZU)_E*W1U>=0N_Z,,+V'G+0I4Q&MGB)PFB4*B#E.Y^"$06H
MX8T/'[M/;*XHL/E"6GO\ 28S@4E_BQ1[A%@>FZ,BGU9,!IJC.V0KFH[4BF+J
M6,M;'@J?HZ[6T>Q%"W1=+5V;]4?KX;N\XRYQN[9%JD, Z!>2I7XA?ZW7(,%X
MCV#((K2KM?!N__?N=*GSN<S*?)$M%$+/(-QY1Y'%4##@_PCQ[V\T(TPS6X7_
M/,OG9);C_#(4:<1_H$%=OF\YZ?H_+<!R^U\,[*E)_?I34!KG+P_//]J'.T5G
MUFYN]15.4#594C7K-<VR($2PK GDM"0VS^79 B>F5K- .[HCQ;R_-4T@F59@
M91$;@F+HX;5IP'Q@HLW3Y*^DJ[X&EI\96'O68*KZ='U3NVD_&N(N3ZK"^WS"
MEK/>+%T[C5JKI7+UNMJL5AI,J7;.-)KULR^7]>OSREW#M:1?[ZO-'R'YG?A:
M8^H5N@Y&-4;M/MHN /^(HE56+VM_?2Y]12"\:14B-+]<62["8T=39(MRZ"2@
M+^Y29%U!#@Y8#GS-K1 A"[%&#@I%F16DC,G!U.+^8Y.QR)].3CX.O:]R?C/H
M10/%?-3P>LE'W3_S6^D@S MSBYL99FGM'[5/S1XZ43HDNZGH;Z2L5Z<#9!43
M,:3&%K_QT53ZY(J)S1A=QNXA"S%=35?TCH:_;Y&;,;3GY/NYCI)9(\.4BPM;
M./GX?Z>GS(6&^NJ_S*WRB%5- _T>(;V#?[F0_\#0\C3\'.;T=*).5>TY[+'
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M[1[9,O>G'PU6)UWQ^GSU@7]JU6'/W.O>?;HX]1)R2L(/3/-MB%=0,I6VUOG
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M( 60$EV[K=-)^6,TG7NKEB]R4KAJ^0.B_6;X+!PC/D'Y[09<10 7@&MOYX:
M"N&Y4,^J%NTYMT6[="IR4<J$BYR\>9DPRW,"*PJ%Y&L2TUP.# )U+ (U+S%\
M C,/#D%BH%(7M,;A: T(Q0'^ '^ O]02#O '^$L/;P%_@#_ 7P;)"/@#_ '^
M,D@XP!_@+SV\!?RMKM3->RIU9Q-VK::QHGD:;4_:5BRDDGY,2+<4\J$[]'ND
M69J-\'*>M0ZZQ:LRU#O4,1YU^I1O2G^$6N/F!?IE?_TZXG)J1HI_M\LE2LU3
M2DZZP(Z'IDP'__ 16:!#TB"?4/T+T$L1]-:4B/ "@ O !7H-H)<ZPFVFUT0
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MT5K5E;[@=J67HQ9&%_(;%T;SK%3,LYRTA0N*:2Z !H$Z%H%:D)C-QSP<A,1
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M=K>:<4BNEGN[7*+4/*7DI OL>&C*=/ /'Y$%&N<@-0X$:0!Z\:&WSD05 5P
M+M!K +W4$6XSO28#N !<^SLAKJVSV/;1*6*!1H1QH7+L<:$\+[&\+&:K0@-D
M--TRNL8 R (8  !7ZD.$,@2T :W[1VL&W)4%1R3V<,9#<41VT^<D1=7XH($.
M6 -E\W(-X _PERTR OX ?X"_#!(.\ ?X2P]O 7^ /\!?!LD(^ /\ ?XR2#C
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M1%QQIWAQYN0M^Z6K/^@^%J^5D.A_[X1W*W_3]Q@0YZWX@X&+<,M*RUS8PH"
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M'1A#=V:+%HYGL>^Q3JQ,,:U6QC>ZZPTCE-1?(\LF(0"K::PPS/08VE8LI)(
M =(MQ9FY_GND69J-\'*>M0YRF'&'.L:C3I]"^=(:*[6Z:0^JUP;ZM966O%N/
M$9_2K6-8S?;.=/ /'I?&L8 &@+(QX&5T[TP"[^P V0^B?#B\#"W*!1#E8V8_
MU/(?)/O7'LNV?8387G11BAU=%/&IC^<@T7'(H ^I\PH06SQJ]D/5^T&R/P,F
M;]Z8%6(',=-MS (+5%>UKB7UOA>&B?!"ST:FB?3.6]-4=*M/&3%C85-Y;8W1
MY\ZWV[N'1[R'[96O;GU^W62[=!W3/3.>3:_@Z/ZFZDT>'V62WDYU3)2%[2R
MXCNU;V\D O"D$CRA_9=<H/\"> .\)<XS0! @"! $"-J+S0M.. +> &_)X2TX
M*P9X [QM&)1*( X2-=42;WY0H1B[W*[ L7(Q]/P@$"H0JN24>'!S*\ ;X"TK
M2GQ>)1?CCW3+GDK>9'S/3EK10E(/[HL 0X&AP%!@*# 4& H,!88"0X&AP%!@
M*# 4&+KM\DI1FO2-R[E]XR216VP^-S<TNJ4U6N.GUS+_T![?V9VGY(HHZ2;F
MQSTO!I&$]_ED8YMEI:_H'427<KI^ZL^JP%;B:XH9;Z7K8%1CU.ZC?81<9]T+
MRUX T<YV]9%MV8I.Z$;PXX>YZ+T*;TW41::)U+EVA9?"@,M=U)\_&P6W7>&$
MRTO-"2/2<===,!9)YSNO?3%5YT>5^1"P'#8$O*)'8=P(,"5LBM(DQR>X?T1)
MD^Q2#D)FYHK!DP< =&D#79"UX'=C+7PZVWYM='/63?>QJ':.TE0$- :5P]XS
M\K<3>4%FBWSH7K9I$]Q]>*.)R++/PE-J4P)6.I6AH7>=SFN#5CE0S$<-/X+#
MO]X.TVQL[HB3A/ 4(XPSF<^SY_U2['@3_PS#RLR.$0#V+^$"E31Z7KG,>5Z@
MP-.BP'?E!,53Y!':B!3S\8NG6)GC6*D@;^@/I4FW@X2!A(62L'C5XT4IKK3E
MBGE6$#<]>H"H@:AM4=0"IMG%E+4PHQ:+$29^K)ASQQ?8'"^SO)PQ(5N<R@CR
M=;#RE:1X+<A/[&M-/,?*DL06"D*VQ 9JZZ&F(8TU#<!08"@P%!@*# 6& D.!
MH<!08"@P%!@*# 6&[KNVGA,]A6TU9,_:.[3&PM?^_?EW]4?Q)LZHM(7Z^02W
MAI?)]/$*27B+L7L(_S$18@;X<SV+0;J*5.9JI"-&Y'QKY '6&[\9ABD=#B_#
M5M?(P=4UP/[LL1]$^7!X&5J4\R#*Q\Q^F'!YU.R'J8A'S7Z8BGB([ ^HU)H[
MVZ_JR9AS>S)*IR(7J5Q+CC"\<$6YEL!*7)XM"JF87K]8@P4(32%"O1 4."Y"
MU]#L0= W>I?W1.^V/06N-7X;_LK7?IM-_:(;(R"XNIYJ%\2D.S^E6\?0FNV=
MZ> ?/"(+Q!T""\#+S7Q+K(*#>Q\ ^[/'?A#EP^%E:%$6092/F?V0[3E(]J=R
MD/2*N$/H2\\8KO$O/>=S;"X7^H88@#Z#H ^K\R O<M3LA[S(0;(_ R9OP9C%
MGTB7:F/F&\*4/"',!,9-M<:#QF7>>+I^>[Y5DVO[NTBIY9O7"<\SFVR7KF.Z
M9\:SZ9 W<6'*6IR%[2R DH;Y8P">E(,GK/_"<S 2$O"V>YX!@@!!@"! T%YL
M7O1FZX WP%M\O 5GQ0!O@+<-@U);'+N]*M42I_LE%H=<W$A5062+A=A]^4"F
M0*;BZ_#@VT^ -\!;5G3X@D:.W8\X>QH9NCL>:4HO35TU@*' 4& H,!08"@P%
MA@)#@:' 4& H,!08"@S==W&EF)O,)2ZX<XEED?..,EX:,$)F&8_S.?[JXK+T
M^_5:2*Z$DFYBQ]-K)H.2Z5).US:%7!772N= G=V+TVP4]GFX4=CSD(L^"OO6
M1%UDFDB=GX9M#.J7\M>7M\_%8YF&/9>G\Z/*? !8"!L ]A^(S6=U%#8([@9C
MK]*1EPMN3 6@2QOH@JQ%>3?68FG0>6ML6*.:6.QTA_)QFHJUL]_QY\->,O*W
M$WE!9HO\IH,5]R:X^W!&$Y%EGX6GU*8$K#2UHQ2C"!$?H>O=?+8]+V9^N"*8
MP4VJ5%+H@ G1+Q"!'@<]G@4]'J&5B,#'OGU=9/E\GN7#MX_,@&X'"0,)"R5A
M\2K(!2&V!Y6769[/_HQJ$+4#%K6 GL<Q92VX(3?YI<V[(7,L)^3QGTV#PCO&
MQV+O;I"O@Y6O),5K07YB7VTJLE)19@5)SI;4;#FG?&WPS]^_5;4:FK7E435K
MV%?P6C&1,'@V3C$O/"^FO/L]9<,$] K&+[QIUXM+1#<M+"@ H=M=_GSJ0=IG
MHKJB7-<*5?1K_+V=1/9A#97]=&J29-Y/&EO<+#T1VF,)(X(I0#4HC 26OX%?
MLT_Y"QF]%8.CMP#VXP%[D'64]Y:8OWPPVFWY^Y5>!],8.>.8"SOD*)&T?:85
M1@K<_VWHD.C'PG3:T!BA@AW*[E;*!<38J:7PY0+A1':_( *SOQ_2IMR:AG5T
M@WN^@=U*GQ" W4JOW8I0'B%&R"MM6AYQ:+8,)!LD.QME&6+L[%?$L@P0<1#Q
MXQ'Q_96#B!$&I"56#I(%X5Y5+ )R#7*=@C(4,78_Q\AE*%F0UE5%*M #<K56
M@-X;VW\Q,!08"@P%A@)#@:' 4& H,!08"@P%A@)#@:'[O:_#%3R%GC5DSZ:0
MM,:UE[N?7RY_Z97GQ\W[/":X-;Q,IH]72")?C-U#^(^)$#/ G^M9#-)5I.+?
M'=HTSKVJHR-@>^,WKQI;#7HJ>[P,6UV5"ZZN O9GC_T@RH?#R]"B'#RL%-A_
MP.S/ ?N/F?W!8RZ!_0?,?@G8?X#L#Z@@FSO@KYH?6G#GA\I1R\ARA<W+R%A.
M$%@QEPM;E[++5D& T!0B= &"83M#9!*"OB&\\]4AO+OV2Z/*_7H\OR[LIJW.
M%HN[IF&_,/5I>ZVS3.GUOCW>W5L57L@"I0!*J8)26 <W'[G?22J)"^A+%?I
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M3&_QK_M:Z?Z\BEGX=W;WX>=2AC-'TZH9D>-;/"^TQMWQC<3=CIO=)PD;J]$
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M\AH%6)>Z"AJ4+$A8Y4?4:K'YPJLB,B]42P7 "_1754;:'GK$[B-=COE!D65
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M6=D7KB(^#E4!.%F'&C.*8*NZ3JOM<'4**6*$R@7P62%;!))XS&Z&Y?&+1!L
M4&(34K''$'E4M X-?*"5>]6ANDIL'H5"T9'IXKI*,-]D6@4#-IMJO>&YH7FA
M<<A.X)PAM/GJ.]XE*.-KVR8D:V6X[:$)YV-6WC6RH-0/+.QNC-9 IA&A-OC'
MJ]FDO%7#]8/(()5'WM[;(LV@Q\%2N?,B(^+LB3B)'_:/G>IW&,$T2 7G]!'O
M1,4"HF+*G7>,;&:L&5PB.G1)J4227 _>ADL\1FM2,:V+\>.X.N%Z\6WZ04$$
M :TP@Y<H<&NT=Q+E<R9?:QYF*CG$A>!<A.ES(7S)\[>AD3R/'YH!>H(6:@WD
M=VT I5? JEW,GH$U(AZ*>;!F#%TZV "QG/"3KN$_FZ'/COI0^HVG@AU/,#\J
MK-"D!31ICC-#M8W_!#(]D=!#MB#BOMC,I(5FNOJFXC)%S?#*T$0TS6=:,:!"
M?10N/78M# X,[)34IN,IX7;TL%BR0<$YA<Q$DA/K52YT$*?N(>% 2\C OJ1R
M+7+:B-F3F;,BN0R(=21PN26@*1%'*@")<$Y!6BK%C3OP#]3?/"1)3"@^FY":
M;[9&7"U'C&W\K4"A<F;&#FSI!=CJVQM5WF2B4W1D4C9(FR(3]P8^)GP79 [4
MH0VY=W[M/JN7(:H7*6(E?NN.#)>UJ[O@U"9N?$3!'IY#AGFYJ1HZ[0[?TCW>
M:@*Y@"N<D;9T]E]AZP5Y.-1Q2:G)PE/@O>2B4V!3D(N&H3?P77UU33"$\"VT
M2;XDEE!H*2\JQ?0 6873K*+'W<?2G-S4#(SIB<+@X"069Q&8$8"L "%MJ3U7
MEP'+17Z3-9W*<!#Y@8F0:!PIX86\70W-)2"+%+4'D@3)JV=7Z6$!M*7'^05H
M,;>EL_\*6T_9@+(8&Z 5_WTT%SR.($4HU;C87[9#UQJ&LY&BC6XQ_6 F],$I
MKO)/Q!!SF P,PG@2UB&0ZNMC";R9.M*"X17-Z%HXZ=7)!#"LOI,P3F :/S V
MW\!45'V/X?N\>:P,ODBVB><SS+Z /?,W"$.?&."!8>/01')(-,>H#"+!CD#:
M?MLDL"GML<@/0?F<(CORCG-]XO7ARPRI!8I(! ?MO+P3)F*P5+)=:M9AG CB
M.Y,IFAV[2]R@^P!GA7\AXY1X1754:T#"D P6S7L8BU.:C$%N&+6Y_&<0T7EJ
MM!*7)4,N5W<,0E,&WR0(2C8D!PX2,&*1-@XVH87!Q3(L1"J2TDY$S.#Y= 0*
MLH;Q2?Q).>.A*@:W!^HF;150_TBO! 7MF )9*_3[8WP9D68/Y1?\I#R]@13>
M9Z+VPQN#WXU_B-80V& 5,SJ973?LZR2Q9%P(@ME#U";NM(JT)9M)2T-RN]*0
M]9:&%':E(9M7&O)!EW#;^%3;^FM[\_=W12B[(I1=$<IG<Y)_<Q'*%[#$\ELZ
M^Z^P]>E\2'QLE?E)J'GF>56$ 3+ 3(7 PGN&7410D8LD,B1'+LY(?Q/CC@:0
M-6;UD:_"=(DMGH\R\&V_Z"&)E?^5;,!U9Z_DIJH/;BP(Y3GC&QT0<0P%$E^'
M?OI)7/)*+8B!EVB(UD2];1[G[H8/)Z67;<I=^8_V\UA[5Y5,#5/XEF="SB^)
MW)JED%-AU5\6[>&@0"P:LO_VA3H4;"D:].\A7!+G^JL$Y9<$O*#DB;S<Z0-N
M+V:S/$XN[MCA0D>,: SD+C\)+D$2W09%%-JNIBLX*6\@=_J:H5ICKX9J2/HQ
M#$Q=(3DR([5M:X!1?Z0.+;6C$78)7C%9[[@Z7AOD/O9HPPI+!JC:/1VCU&-6
MG@D"7GKE;QY_AM'\9@PT%V4D,QAD MK"L5W(X23\'AG]Y@A><FVUZ^H"5([9
M?PL'=(&D4[;TSU2%PU$25O& Q[S0NJ3HP/G-U3FTYK]^, 9O2P@ID\V,P65V
MCX^/'OYDB^UVSRM>8"-BT&TG>#)TP[SE=M5OLSARL%;!0\ ,SF*Z(D!Q+8"D
M#?'I?&(^[>_<MY\^+GD(QB\#GT 7Z3) @]X8L6<G?=;9>1/EGZ0'V;(M9V_O
M#GI+D+?POR\AO\P=L,.^/=)/W\>_7W6N-F;]ASUKVFB6K< DD]+"% A>(EK(
MQR$Z[DV=<GF+3AGR#?U3;FB#MZ/7JX/C1FF33IF?9-)3GBI!273*4MR-QSC7
M1*H\$JF"?P;AY2)=7&B.;4<=V+$WO_K!-.%UBR"390=\WZZ,;Y\.#JY.NQ]P
MP&02K< <DI[?5%[X<K<4'Q]1.+PN$K <K,5<8HU!LS.A-%>T=HM98X:+2PJ@
M/%*V6-\9W%RDK=+N<;CI#C> ]R'02* # ,/;1Y\LTAEMJ:;X^3@@^2G3J^&5
MVU];1[0NY;I[81J]"TA:(,;& O5G*89K33J']T_=CO[\?E39,I,L!'%:RK<F
MQZ^=]\J+]'QVF_OVT]\/<%G /NSAC1"8%4=/?ZLMH.WV;WD %+P-9ZEOFCJB
M15<^)(6 ?5RJ 5C. H!R$%<3Z3%&T$HTJ^,.2":'S3IPJ7Z'I0XMXZ7P'AAL
MQ* " _+<#=/)M+E>(SHRQ.Z"C4>0\41=8=A.(LDEFDU05.9]HV>9[M!+TW?!
M*,55>5!P8&/?MTHJU#/0L\GV)\YM#M]1B/5\VA<:798-YCW(Y5&0JGBRDZI"
M2M*Y?25_AE7W#'0X"K_(#$7PI*M!__+<C%%+Y28+E7+00 %^A:3-,YDUMU!N
M [P^53!US?8:WWC#;:O4V>K;>0^NY,P(_,FS.F!P8B<L;$Y573DV+:3OM)3W
M"ZH;EI%1V?(Q##K/#SU'ZSU=''3\'A8^<4(O3]7^^^^GHZ>__]Z;#6:PV$SR
MWDSR=":-4_W]0CLWC%Z:F927V!,IN">O3P=GE3_/^H.22S.3HR7V1 KNB>P4
M1K^RRM7;G99\)I3X0%?>T][W^IJBJ(A$T>1RVGO;TI$NE%_@V>("SY87>+9*
M8!9X$(7D_\<S4+(+/ ?EX*%2=H[=<;S/T"NUGS<,HB;3($F:$'=K&$BGZ&D0
M2.,C %NYQJT^H*BZ-\T_)\T_)TX30NJ)Y>!KB4O@@EYS4@;'G-R:Q:$1\&YN
M4&Z8!1SHOPF =[87FX0>AJ;+"N$"FB-!V=,<E2*N3<_54VX!0(%X;J(UVHRG
M&')N#EP-V@?X.EHXP*"5]#&W)@Q0,$,=)C.ARK 05H:IFIF)FZ#ZKME.$/((
M1O2X([<=OO),^:2O(P;4X;!Z:-LFA$70_?1*%PD$'L.P0RLD>K:_'.YT?8PI
M<JQR3X8 M/=7>TA+@D.;8Z/%^^!XHJ"!6C\6@_55Q(5" ")BK $OF!(*G@,<
M()DMWN7D9YOQSC:X[R-<NPF8^CJV$<A.42!$>B-DKY<VNR)T/]D>>=.G,V6S
M-]"%I?/)<-,,MM54298!C>:'AR*UV$EO1)2YEUF!N1>B<)(B#[J4+]Q)4)#N
M9]!.<LP,.7('FU$SOLL;9YQA%& W7[.D>MU>M<(TG"*'<7E'6,,A(,$L *B8
M;(36Y/EW^:E\.SF9/&P5% =2<YH^*&B&7RX)F-OJSBNV$4H.\\/8N-DPC^0J
MCV1+ 4FM8-1#=3#4S;$:KAF*XBZ><*)#R-XO>A8NW<4>)6089DAG.'-(Q 1^
M.BAD7)MR=US]L=?L]$UHU4+>V(.J'XSF"!5]^T(S!H>6@>J"D..8*Q,V&9P4
MAN-7D,T&Z 0$6(#4.(46',A'PT $Q#7';]U0'I-($5D_@]* 4B?8*]"7."<;
MH%<&53YODCBCI*O2[)+05_S=Q8A09J?C6D0!19J.IV9@]?,K\?NMF3S/ 2/)
M$4-^D4/$%X.0 Q)>>_YED_UZ-3^SD9(IIF;249;W&O-).1";4RT<7D0Z3(;J
M#].)E<%O>,.:T;JD&M6BD32 %(G[%NM4M$(6%U,B%5K#^&ELFE^()).7O.5W
M)6_K+7DK[DK>-J_D;;MO]S;5\.P*T7:%:+M"M,]F(O_F0K3/SX(J3"4V'ZFL
M;\D"+IKXEUH3^[J9L[.C=_E^V]"V_55E&K[NOO/%;(8OAG;#(74D4&9A&L3B
MY^ 6;4'5,*0),<'V.KILVR0XQ97%!7[/6VF>+X,ZJFV;9#YUL:,9O ; HP2H
MI?.\-O['P7<-E8(=K"?*KM,'H$],3T+/U4C77<U "B$#+.4X71.P([&U>V"B
M__.ZZ![7F@>LBVXF\OE#4\&<$QNG[#5 &RU4LNQ-$;!DX3U7L_OP^@5?O0BY
M/G5BL\:\CQ>'$4REHICA;C_^PZFJ .YUX&7T('N9Q"6X_?3[E3 $FN!& L"I
MI:H>G&84PJN=&;J6[=(:23I=$1G0*NU-0H(;U/\D^V<O1+Z'$7+A75G7V<G2
M<DA"&D!TU*YGQ$.V/.,::"G>YOB X/&+@]#+._%G<.X\'TETQ @;UR1QH_1-
M'6];F/0P4FAF:()5HN&0(\-J\N)WMNHX.BDI @"R0.008Y>B V'CAB<$8L<R
M ;,=W;D>14>#UM0:*=&*W1MPW&DV=_34 1*L-*5@Q$/+[*+'T&OHH%E$5Z28
M1(K;H85E.*E#&^!7Z 9@[XI74D8<JJH,4&5NVZ;P9Z^N#/$RP*@G[DL5P)#
M"X1FI*O3A\3AN7XA;\SV3+[F9$B(SCM<?%K^"4>A^7>0S2\#4AT[R>^VJ@J@
M;]I"!;\K97\(.*>.BA/67, .=J[#E&FK 8:C: H.6J;C$T* 3^P5LD'/>4"F
MR.!>@?'0>] 5B:X&,U(*^,O!# =GCMV)>YZ_$]T8?!7:LHXWT>ZK!%</*M0=
M36=QT'?5ZF@VQNY3WX<:\76R@.R8QGV!=?CNSDPP8D!K&2.81U0+>Z[1(4"6
M>_6>7^FNK5V9GZI,.T9T@U9X".6R!M+*.<S'FJ'@?^IDGV?K^GR":>HQ6Y.F
M?O90F5S*I4%IRTP!NN@,6[7 K?,O?@MVUL%F6 =]Q+(9R@6H5BP;I.L:^*"0
M3M%A9XD+&PBOAD/&:H*F:#+I]D*:^72X%PA(I:^%<ACKKC4T;0"$C&F!BEB?
MB7$W"(-D7Z0C,X;M4.*BI?/XCPYDJA"N:WG-7$%'TDC)'62]^C91<!0(98U4
MR+*#$6DGHN!P4%K!Y(CCT[: $[*\#ZA,8<7>:BQY9:1*XMZUJN!UM?&"KU1!
MI<P_0P6AC"?J#F@%/=,?!T-+[2/1 /81^H))(&OAL_O""9X&_2>.Y;')DLH$
M'LP6N]E( I.)L?%]]%X(8$=1 )&2'8@RX$6Q<_'V:&H;-(8"NI-FZY)F4Q6X
MASR)-#"%)&GL4PGE$B49HC6YG_P>WSCYP\Z@O66R*K#&#+U)WX%N?VRY=/I"
M4"DS#HF!EM@S[&^?U8!%3WB_H83ER3C RF4%UL&@G0CO!0Z)L<N9Q-O/'"<=
MPY,"N#,YS[WQ?+!5!?:1([\+*FXR3I@KG[+4QQ*DZR+KR4?!D@'9A*5@Q!1E
M3/5H@S;?B60*W60MG>@RE*GCH5^%3R3=_YT<6$ .3%7RUV4+\J'M&]5J]I'H
MGLW^<QS[G_-F:W+\IW?0>#5/[PY[6\;U#V1;ZY"NQYKNPAVX@%MX ]@2L-0M
MYY=?QC#I$,0/VV?<2#L4[#[1J[$&;Y'0 *ZH /]0KH0X'R-=_#@^T7WV1]]]
M.H1^F09IGPGLJ8WX($YJ[!"P=T(9&94?BWSZ>_VF^8,YG[IR)Y#L-E^O%3#Y
M"6@0UB#3)5T<! QD#XHZK#? @C-^3QLDAO@(#O-K?S> B\B.:?T0:.7SE!GC
MXVK@A00;;WWW["T8@BL#)$[??797,C#Q'@Y@$$F%L1V14,([!IS=<Z9[$YW^
MVM3X'#B88V$/W)AZ\@DZ&!,G.#4)>NZA\^NJ &U&'_/?U[I[]$'  \%O[PL-
M@VXU_CJ]]F@I)"V8[1 9BG02Z](D13H_C3;30X3'-0+(!/%*Z$J118M.@Y6O
M^[WCO=)PWV=(12C-/,9VF^^S//+G*="T)SMFKS/TTUJ7N27)X8#L1@_LL3?0
M38AU 1,$SLBR:1XTL8;&8\,UO>X*=3(_!207@>K!]'[=#0N2&JXMB2P?;JWJ
M&P?CZ &"@#TXD?8:;WS-4![IMC/\GH,+UVR<CV_S[WFO@)@?U3MLO)YO<SJS
MKV33OLW0$::Q@&8M+Z@W%*4 5!"T>E=,AS9YY[N]-ZZ.N7[O>&;VMY_58D4L
M5?-Q;=Y#%(XC<W0R(B)@&_HKH_MG0YA8UYP,4X!%XHHBO?SX"!VYOI198SYJ
M\, 4!"Z(J=2\ZDV8M+?-< \X5H#N*ND8B*ZM8F9LDY9.]65(=U=5(WB30@S"
MDRC_TA3DPBX%>;TIR*5="O(N!7DKS()="O(N!7F7@KQ+0=ZE(*_8OU><2D$F
M<9E[^3UY7"?NE=9$R]V^FAWSV3&?M\RC1]:408M2=VD%&^*]&[BX"\:+ZJ66
ML9IN8@/ZR#-!EPKS?.%8"*EH);EA?A:!YUOSL@AP?I?MEXW;F> G<%L1F[,"
M*2H]M0+A6Z0-)=2)HW^T54/M>O]"YJ-+(N8B[4\9-0A;IL(<4PZ0(YX(#!+H
M+,)S3 8,0G):^45@L \2OZ>]K-'>@'<,A_N164Y^CDF&A8\.+?--@\30#$Y=
M];,ZF5MO2PEMZV^)=S DI<8C>330B/9^M32<Y!@3V*29+CQET9B;#ROJ42)W
MI:*S;0A.0/A6X(A=U'<TX\W4WW"2#MHFR*<$![QKT"O ^BQCURK)Z_<NB0E=
M8]_)>/+(YGJWT[[O1MC'2M**O&]CMPN0MFEK]$Y23"/TZQ?58)[YJ.M@J8YK
M&794]"!0=)#QB@Y,@V4*X0P:]&U_E; /@:.#[A=3.TX3@;@,JT#VJJ)UT2LJ
M1@)JJ\X(_$S8F<6X7<;/F6*LA$)_=>,.,X!FA/DPR2.G._FBZEK?-&FJE^9C
M:[,  P46BMK&#,_=>. G^@[. P._&_[,F.!&0*7^'OG%'B07[6$ (UA$$)4#
M3]5C<1!MC[\F@.]*\I#PSD3%Q'F,+"%BWM[Z?8:+=P)FQV%JA+'$3LT1^"M%
M )*"X@'B-H?MXW)]HRB043"WP[#&B)F)#%@LED=@SV171V()D*H 5(J+53#<
M)C*=K\3CUZYA3^4%WR&)+%N=?LU0CJ#QEXF!\"G8$%&A0\KV,:=L)WB[-2F\
MO?VZ_/WL5K1M S)GRR/!='^! D:=VFGBGS?YP,DHW,E =RD?D!OG8_)]HK9T
MN5M]5C7E#:=P47@G8NWT3(@I\: \@388V)@Q ?C1(%#IV$(B 3"+GKT0/GN9
M]!W4/)6$"AZL-LI#I/SH4(^RGVEBU+^!GR#-%:M &IJ/-423U%B2')DU&1RP
M$2T?[,=;!_R5@@=M+\'-<.:M749%9?L.-)(NAP3-(7:V]4B2_&R_T'$PWS?A
M(*W)X*C=[\OCV\>[;2M4#ZQK)Z ^L8.&;Z]DNK1:0>CPIQ/LJ-#196T _A>O
M(A;] ][OR=0*1!83J_50#5DG;,Y@":ZVZ5J,^W#<#(!:P030;##)V\0"PNUD
M.9,34F]Q @ 3D\02\[M+< TD6*$VP2@#2\8T,$"9AVA(2C2FUJIZN+,*%MI@
MA7 3]4H.<8$%@1P$=DW"FA;]U_8RU$_1]J?R9=%\_0#&C64:)IC[F-J2U$_P
M:5*+#M6:7!Q?/N2L8>/E<=MJ_NY4")?Q( O!!>\8[>=-_MK(U-P>>%:*.)2:
M)<X%0,>@V(I"K?F _[*7+8D"1G-I^XTU\3^PB^P09U7:#'K[&O/5:YK6];WI
MMAUSB.YEH9S=RV5_T-H##^\BP^-=L,%!'%L8DQWQM#HB'<=WEUR/# ];PQN<
M%(#CZAR&B&!K@Z$.B"1$%0VYZYA7WO>G\; E>%T E(WF@*:*-K^#'6N!NG#:
MI<\9\Q 57"YJ  B%YJG251% %#6X,'-DT"()XJF#[4?\')K=,4G"L$OP\VR!
MU(N*P3GPGK(= ,E(O$K0&@^)"D,%+'>(SE)_*W':"@_[321]:K4;2(A^R- S
M#^\@C[CBO<'\E9AD+-^G%=IM;E<4(!QN:T0_^1IO"/Z<23SA"C9'9=Q;!##T
MD3: H6E)4P(*CN(7^^,"'E7VX&MC#H/"J.#'^^:(S)\[*R^SC_I8_?A0Z,0B
M0D_@]00L QNV?6"",QSK*3Y*P5ZNN"=E/0),@OJ1(9#VR*:SO??XT_!2W-$E
MG<YR)Y?"C,QSA/S&\ '%DFTFCFP%1K8U]E>LZ$#2)$4/HA5*T*\:@^NHX-UW
M.-Q@>8@.'& 5(&U<,8?$.XNHT?L.6S")2?!_P3OC!_1(HBA+Q;0'LJZC&0S=
M-I*K0AL2PL'G[=%:%]$5.D'27;2M(CZ$HPMR%YH3>$524I$527%.](QBJL2M
M30"6F7O6%W&P'$Q.L@!*GH4A=]"[Z-E@/(+DOVHXB1O3.0%0,3 QTV@(Z(P$
M6P.Z$>@JB3WZS3,"+3R^D,*7/-NTN,LV76^V:7F7;;K+-MT*E7F7;;K+-MUE
MF^ZR3;]8MNE6^QP:1L93J.$:Q;H<\GO9*K9F2 :G@#,X!3!DOM]C>[\,QK[V
M\V]H8H8,15I1BY1M_P4 Z&0&([Q)-'<#3999$AG/\$0ZM]SK66J/P@J1JC?L
MT?#:W_EF!4X9@O0*\,,B^T_79+_QF$*L.0RMZ0\#RCY>PU#6:((- ;T37@$Y
MD^4706]-&VIWIR<+KH"@94,M&MQUSM!H-J1L&&X04(F6H<VS; JB((O8\0'%
MS?J86&$P]R$D*#G80\TG$&E>MIGN]4;S:FVQB>/A.P36 :X*QPZ8\_!5'P[(
M*Y;.1-K76TK[6WUQ^03>*)O7HQ7<DF[,NW\"YK ]WQZ.P8/R_70[4OC4R3\"
MVZ3][#%D)_;O6-C3KX\9'X\G .QT PH UDE*<'$_*9D6YG* SXB=^73FU<W;
MOIS/T!3GD+?1A,94<8AAX> 1%Z<I2JV)TI,;3Y?M\U,IMS7!EL^(D96FVA0V
M#.AI:5IC7^[&Q,.RAX&ZD_C76I.Z8I_7WOIMR^YLS7$P]32_'\)+J.0JK<G3
MGX/CV_=[2Y&>02$BB\=)!_3XOI1JNG*RFRIU:G;ZJN+JZG77HR0",>I@9TL,
M"59Y/-:D0[0F9V/-.:J/7N6+XM:0(T=C8@:CEQ/T+;^(H&M":C16#9V_OQ#Q
M;<WD5[X-0;9S<-B:R-+HCWZ5'<H%GW*1"C[49?05=$75;S_9-0"RB&),@?];
MZ\$MY.A-?KC)7,+?P/$ZPPE,?-+?J'L67+?KV@L8VW<MXZ<)>!-,0E?^$>CN
M>&YR:2W$Q$V'K1EV#G[[?]]RWSPZ*U0+/F;/I#0:--^4CCRVI+!//C;\$K'$
M]7K#/+@CO##FYHLY@(C=CICR>@]@N^@A#_20E]!_6I.[^_'OM^'5U< J;2X]
M,*<((0>*B[G)Y !1(\JNO&W/9J/4ZSMY=$DM;OM*=:Z[4 I@O:EV2VNT!G+C
M:M)Y4%N32?;RUUFCUC7'?M%)- =$_!0=5\]"EI<"/-6T_A:L7OM[+EL0<_F*
MF"L6?_A<,A0@*T'H+2*2MKI"!WGD>1CLF!.D<\G]SP==DE",<,T[\-^S5RV5
M0M^W@&A7JM7,1#Z;3YA!6+.:?=WE;82 55!,"%26Y6#*'II'WW[F2UFQFBW'
M893%[=V:CVXFW]]1[?91;7Y/RNWEI1#5EM)2;:Y8$ LE:?.I-E(\5:/$TZ-I
MO32,&\N$#,49\JGS<O34;E;/;VT]A7QZ[&N..BV4UKDKL##(T1N2I86.Z$.O
M\*>QK$VXL/$$MH"<J:2]L5(A*V9SQ:0W]L-/:D>'&TJ'T9*CFIH.RUDD.0H;
M2H>1XN(X2EP<:X9F]U7E! I+9XB+[D/'/J^^Y+O#E[68,^$-6KL-SA:.)X++
M:I.;IQ^K,,XS[C^-"RPRL<_B$O'TG5Q:E9/"-T]S";$H5<1BH9J43T3Z0C[M
M@'>D_R\B_4@!6<ZE)_U<!3%\*;M-I!\I-TM1<A/M9TN[1Q+281+RR=4;U6+N
MZJC;7IU!%=Z4W'YQM7?PWG1D/>&)K/SC*1D GH>@F&Y;5S_'B;+@M#Z+ R B
M74#*%5)[4<2L5!4+E<1^E$C"VB YMR/T+T+HT3(MM9-;$LO9JBCE$[L?-H/0
MF52C15&S<_=JE=:D6G[Z?=_O-QZL\M9DYWQ&[EYY"BGHQH)\26=\H\N&4S,4
MJ*_'V%#S<_EX\WR185J3_,G$M7O=PY*^-:?%4OL*TZE]Q=;D(O>H/TKO(^NR
M"(;Z.]0S8-S&76Y?(K*<@EV)I:>XK+YZ$F+D2/#DX5(=U@?M<WE[:! 35H8!
M@AJJ(T(IAHT+H1@2&\GH@XYC@MG]X)2^+:/L=>?>%5J3H7O45-N5@_Z)E"3W
MCAQPC1XPTA%V&7B[#+R$&5=U+@//>GLRJY8VNCO7-S?C:I>!MU9ZR'$9>&^G
MX\N+<[-W<:!M+CUL<P;>AK"KCZ>WB&#8ZBGCX]>ZV\MU^ZAK2?3U$\NT<5BW
M/__9@S$ V)!^KM[3%[*AL/:MDG5_HI>&$_>UL^;\UI6BHJ(5[-(!-R\=<#;-
MSG)B,^IL^<09M(8KJ:.WN6)>+"?W:N]R6G=$O"@14P?U?").'8<%.,-"*7$4
M=L-27',?(M<.7$T'!9C)MG%7[]O'3R>_BL_+AW)7N&MLGKN<PXV_V&'I%"2Q
MT.5>(O):+53%:C;Q]=[EP^YH<TKHS*3-]!5!(GI=+%0WE3;GYOJL3]Y<RIV^
M9JC6F'^2"9^KB^-&YZI=O"SW/B33=I7;["T,H]-X2]OQA(WG"6%Y-8-$0PRB
MG)9!%,1R/BN6I,1%@SOAM2/4*>&5G%!3UQQ!C6!!S&\LH<ZM]EBY).NX-I(_
MN*?5T'54JSFV'74 ?:T>U;:-S!_T$VY?X7D+K]_DRN#\^<]U<7W5AFN/&K'E
MXHG0-6-)1U<M_*\\&/Y#&G?L4NJ_3DK]$O*4W)16PHL2Y%C5;&J[L(H$:RFW
M3:GWNROR;[LB3)(O=472._?Q%4F=LKXQU2F+R?F!?'-3JU]-3G\]M"8W]7+C
MO5I\NZW*6V=IXKH5(3(W=*>[;^J-CZP[J>;37F%$=[F"6$T>W-@9D#LBC*X)
MJ:9VP5?$;+XL5G.5#27"2*'!IW?7.AUWX.+VTD?JT$(KE6'ZZ&==A1_0KM8&
M@($_P;^/W?&6=M5H*5IK8',B9C#LGBO6X?NPEB9+9%/LO@O5MO_&LY#]S4)$
MX>_63I7=)E7V^VRFLJH;L8 ,3(U@)8G5JB3F2ZE+TM:NR/[8W8W=W4AV-Z)%
M<^H @R3FI*)8KI2VY&Y$BNIR$OO.1R/@9._QU<G9_57S4'E2OPIDSSO%Z\%%
M6[AF:\=<EBSFWG#WT4(0!M74<%XE1.=YL5C=7#&Z<YG^F\D]2C+FLZGC R6Q
MDLN)4F&K(@2+P1@46I-Z\^B]\E+NO#:VIB9YJ[MO\ IA!II-&3:NP^UB+RTI
MM :"):WL-$,5!FB(/K00A^Y57@6CWR848JM _<)(MH7_#E8$5[,'G&K$?[O5
MP;6;4E9J<56<A<+(K#4[V;8I?Q,<S8'E\F_-N[.!9Q-7Z0?N:^HD[F*Y():E
M6!0YO$]3VY.?M3UY;WOR9'O.W6O]IOPF/5V4UK,]>;(]M"GE].:D]L"5"B6Q
MF(_UOXF"I=I#TNY1'T.GT[;M0*M(6=?'8@;]+]_S_7__JY*3RO_80:*%GFJZ
MV<%NGV"/>._Y4]?H00-5_!CZ?*!;VO;<X:6ZQI=V7>.G3:-5=HVO[+K&S]SW
M7=?X35$O=EWCD\(@[;K&[[K&?P!863Y;"J-"X;R)6@?9GC9NM1V'3,8KDK'O
MM":_':U]G'^]*O6VIZ<CPR$K3N.0E5N3<JGVIZKVG_LWE6\_\<H%;NE?$XQL
M:R;_'^UG4^ZJ2.E6,I>J HJ"*)QW'6A1OZ5+VNKS:!B9,Q?9](@;(7[-F4@"
MYJ+(<M(,QQ1DH=D'<^K&M3I]V5:%6L]2<4MKX3L84[GL/]YO\+^E?W[@OO8"
M.VV!/^T,>XG]U7L';&+$[@S%ZY<.<_+&%K%&RLQ",?A'M$ST_)!-4=5P;VYX
MQ'80KX.&VAVDG,J:0?'C<+]VM/&&VT7LUK5P!VVD%.N:,\8NCRGK/)"W)X_Q
M5^]-S%XL]<"U-4-%(]LD<V]H%(T2MMNSV1*UV]%/R&[GBYC).QR'"B;KLQVB
MV]<P.C0[WQ\#S(_K;LVR9*.'-R(T IP<.SAOLUB._\M11_E=O]<.[8KG03B$
M%KD*[2".K T-J$#HR'9_KHMTSIY$^ABR>]D2\3'@G_S\Z]BUL[_/6%E(C"8M
M(]D#*8B^A=94FDH^W8\--%QFZ :)PE!W;0%,+?B[K)-^P]YF(HKKF(.!:5":
M!'HWA[A3.[DO,J) S0)N\(($UQL8YO#2%"466RH[X&/TPB5^'MOQU]U#_(4F
M?&##R<\?I>G(#OX+>-6=,7 ATP!2"E5A<FMC)/Q:>'TT3O3BW9/O!#N.VD1^
MY^,HN7G?;/X]:T<_CH2]:JFI-0>)6TI?<9#-BMGX.O1,I(>R\,4H[PB)QC<9
M)$K#L)$&#@_=:?9+B/#PHJ[Q566$5S4ZQ:NKUY,C^?EK$M[4FD.$E[[/1"4_
M"Y%;S 2]O_<!,0_-Y-XT"#[P^LJ;;&DF8KU#=)RF0D(6"MI^!8GS'G:X 34/
M3=L)_AH\S5A4D;'A-62.6>8H,Z3"#'W&,MU>'W\.@)Q!3U 0N_)TGT/ZRR/T
M2Z;*[&^I1KC5ZNP].:D,)@SN4,*:8C0)80$,O\!N0AL1G^"28!C\TM,,D:A'
M#_2!Z6!RH702?HX%&3(0-4;\!4VE@ZC/)N2,@V@Z4C-5GXRNO0</X4%&2:(P
MZFN=/IJS!B#'Z*6.^89U\ZC/":'/B3@,-T!:KS[.($:$1K'1JW2RMHK4:<M[
M=V1:+VA)Z++0=[TFPD13P1JUA?B_A95EMHC@)W>4_RF4KV9D7Y;"^3(1P.@'
M6!><O"&<N>C02M@_EQ,1*U0$PW2$@:J2*)FB=C7#&T86VE16@VUENS(B=61G
MU9J'0B5;W).0W8BMMD['M"# @,@,* [^[1H0>X,[ K\P2&!.X*>)[A)Y408.
MC2\@&[B8)3<%2(J1*__JW.@R4S'0]6YK!M:_[]2.V3, )[RAH"NK=36('9!2
M)&JQ*#5#N4"_ADNEJ3;Z&]((%/((%&.!6I/+EK.EE2@S$^O2E!OUV^>30<_3
M(;AA\.KG65VK7VAD.DMN+UM&2L8\#2.D(RP#DY0OB64I-MU%1-0#X1S@.P[2
M 6WRYPQF79%&4R&".KC-!JZ+]$FZ/76T;<[XWA\8,^4UD,!K]?;V_<ZUZ@=E
MCP2XSQ)6G)0&%ES."@\Z=39\,2\6R['IOJ(OEF6=Q>F98XA%^ND:@;?)2#[I
M6)TGEC11PMNRK5')JQD.$MT:N@XV>53%;B/5&F@.$7-R1M?0/]!XOCQDG]@7
M'@QDS7-<2D3,$_>B'&FZ#LT(+._ND0_ZTA%IM:Y.E4S/,09^-4+(V-M&M$P3
M?<1 W#H#[@.(L^,L!L26$9]$XAB)#&HN^[DY1/$5VBJ2/@9\3>XZU/_%E-80
MZ_]*@GK5@1>I$@Z\L"8%U]V(NV8?C.?'9*H2QW_2#->:-.Y/S^^+S?/:^?/6
MA&M -8FZDTRFA^XPW$!R+Z%:JZM:6-.5WP6="JLQ,N"P^@DTC-4 O^?'!W?[
M"$:?#NJM2?%^='&OYY^E;J)F%[ ;O]ANT)KHJ'#55BNYG]Q4HSS=4R-P)/\(
MJRBP\':6%A%S_YQ?\QM\E^M@4&ZM5M<X&3V=CRLE]4]=CP1;IRG5H?DDFO?<
M0IA5JJD N4N@$0X.[QJUR>NO-[2X_.BJ,/CS?GJS5G3SR@[=?*TE !L"#+UJ
M<EV=JIU+[_#/E68Y_+<(5WJ5IS.C.C[$823+R3_(W;/![\KZ*N-7N;4,)9;8
M-5T^/WJ'>K&]_&2Q"MUT3"8]>+U8*E0683.;P%NB7$.K.*EX7O(D'5WU;X\-
M^[JT4FUE'<C .UZQO;QB';PAM5-7*FX=9ZBMB3-X?;"G.(,R.#_+:G>GVI_-
MZF3AS7C'#K:7'7B'N$)VD-KUG\]M&S?(KHT;>%&)*7XPZ%3>KN^?GQ[TW*9J
M"MST=\QAFYF#=XPK9 ^I,=Q+A5GQWTUD#^O*/SBB@9![^9W[HX_>QW&+7^>'
MC8KR>'QP7=UB]#ZV8#R10/1GAZ;RA9#)UG]'5L?'\JG=KE)U(3UG<Q#--E/9
MV*'VKN>N)O[R5Y.N++L/@_%QHO1J4J@[V:M[W996)TK#MSNW7URMJ,(HZPE9
MR\H_GE).XGD(BNFB ]L@X+'X:6VQDK_J%,_\$I&".2F>B<AWPS'-RJU)+=NH
MG1A';X43=6NRMK8^&]ZUU:ZK([OA3?63)/TL,Y)JI=F"%R+="Z$)!/.%8T-N
M#_@[%UI7!<>-XOQ><7YP:_X4$O5'?GU\Z)5.7XS[PXY?K1; RZ)[(PK\UGV;
M!6JQ&-N([5W*<8\]6^W\K;C66)7#;*80SLA,<"10XSAU.RG^&GS"_D?PVU_B
M,ACIGRDRR&XS&<QJ6]JR+6=O[PXJF<A;^-^7FJ$-W &CF_S-U<U=73\\*G<_
MFVYFK05-O168>5*RFD)82416Q3BJ<LPI^DG4#_T+T8_\SM//1;M0?SF\OSQV
MGC>>?OB9)Z6?J43Q1/0CS6-+G"LVEC$5.<(ZAI(M]0)M'>?%Q:K>NBEK<GCR
M?G>C](OJJW? _A3XHJ]U'G+"XRIDP\>59.-FW'=\7*30@V:M9_@>(Q31Q ?7
M!Y6CK9)J$"A\8U4KMF/)8%/LZ8"Q2NI5ME3[BE(=UPV45<B%SQ6WGR.VSI%F
M0PF,:ZEQ:%E5[B;-?K$UN<O5+^OMSN32[&^--L\@LTK3D%FEUN3XESWY_?AX
M4OQ3^O83+S_<GNU+H66MG/:F-%._N(<C)@QD&5<:=!19&A3[=FN2;1COD_KO
MZV= AMB2P\#+8>!+,J[1G,:/)N7$1VJ'_EH2"9HTU,G9[@!*X"=8>=B,FI]*
M:R(I:M,YSBNWIYTD13]1%VRM]/YIE3<$TC5)+.'CX@2!D4<JB%R8A*ZL/:0Y
MPS6*=@Y^^W_?<M^XXA^) T+73MMO>O%L_/9<#L/UQ@;V(I:X7J!,[S+CA;$+
MO4B4:VK*'Q;?V )Z.,3([Q+Z#Z*'LZO?C<9=+GM5V5QZ8$R<D -EY)M,#DE#
MGU\MK,G1VU8O:+=A*XFS\MC!(9O8OE*=^CN%W3BAJ <D8_&Z=C69'-VV)J7!
MO?+X=*-V;O5UUF&6LFNN2^-<,+AMF>>'::JJ .:44/I7%F[.E*,;4KV9A&P3
M]RC+%U)G.!>R8BY7WOR"RQWM?@':C6PX5DC=BK.8$XM2?O-I-U*&'45[]"XU
M&PQ?V5!-U[XR#8"R\ZKS/ DV.FDV#XY56RN5UY?XLV)S@K@5ID14>9<ONTWY
MLK,YPWQ"7D"FI>Z[F0<4@9*TL>FLNZZ;.[J/EX?%U&G<92#[K>R^&9",,;$N
M7ACB1%A/&MX=GNG2P=')L+C:2O7D5S*$U[2";<))LM05'XF'L>,7BR;+;ARK
M2",5BZF36?.EDIBKQ':TW$3VL*/RKT_ET3(PG[J4*5<1B^6MZKB^6+IVM37I
MGTPN&^Y9SSK:G@2/I5K EG<M8*>+G%;9 K:Z:P&[:P&[%<48NQ:P2=/I=BU@
M_T4M8#\CI;58#*<5'JEM9WXN:X6S[V/>:$W<X_.BTBVZ<DW>&AV');&6IY-8
M#UL3M7)4RI?K)U:E#YDG;0?Q?PR7;_2V/XUU1@OBK5G#M9'QLSUS7K;GC*:C
M-G0:PJ6K?EM/V>\\"F^R1J+^D],]2H/=1=$D# T:,, KZ%LX2L*/!;_P7L'-
M:PST5318#WI%#"T-T=10UB&KWR5MGZ8:C>1#5]#O+(<NMUK#+[).(H5L-9==
MH*N=M](DK>WX3X?'@5V@FP!+9M4<NN:>:M;9[^[%W':?<4N+=[?D_ 9U<]?A
M/1@YT1"O3!^@%_/EXFQTCA6GZ(H9OV_-=>,(B!T1O;TH)36,#C()T+9U.DAT
M0.T*'H6GJ0VDKN>LI35?C-&%HGO%0M>6AMB1#,U3;-R:S\:MHX3O:'=^+$:#
M,9L2V3N1$N3:23,U_%4EAC"%=5$FFB/NK)%!NYR<$"_Q6\X8&NVU%&7#"?#@
M\NC/G^;[T_VD,+/Z;/U$PA,%]/?!W?04>0P59:H1(J)JE"X8?0;??I[)ABM;
MXPQ-N8VK75L]9R.]FFB7;4]F6S:6KQDJ7V^\7_L=#D$R@P@&#H!;P4'CN>'0
M,M\U:$&HCZ?HL>:WH47+0AMZW7TPD(S6;*Q"<(U3&\!5E"-,V3>FC8[W#7U;
MQ1U0[=90VW2*?9O\*;WFI*=R7_98)EDR[)+++3K86QIS4X4UR\&=3RVR=,'&
M:X]CK;@5[3*;^IGLMB0E9+>-JV..X=*)_\P5JV*V.IW;$.*YWX<6-#4BNSD-
M')%/1YR6NF6TZ;]=&\F6XI>/LQ?])3%J[M@7+X=WE]<O1WZW;O04(\V5T61H
M+S^6)-F?P\L/D6K2*$PTJ1;%,N[?'=LZ3_@1Y [DUK.^6]3F\GJ_DHT4\$Z2
M>F;?Z.E9IHV;YG945;%9]SVO;RX:/1/DUE-Z['$0 P&/ Z?0H S_N@OTUQH:
M1:.TV30_.2_<%E\?#FX5);:9-P<%$+/23V612>';]XK?!+LCPQ4M386[]Z>#
M@,+J-5)-U]'(8H8$/M#<%+>#>REV5=4CQ*&.3$_L$Y![^'^]7L5FMZMB\:>^
M#Z&AH@W=FG$TH3T.T'"4[57QN?@-^T(-/E S%!R O::CU^G@&TZXA5.UF=5/
MM-/??8_ULB[9,YN,8N:;; L^E:[3MR"5"L!,/\[20A2:04.13O-H9D@[T^8[
M .KX\2/R]*;ZCZJ5^O%CLUAKJI5Y[#&PGH]W&I529\;GBMF/M<PME<"G9%S#
MT73/PJ(.TK&@:^CVX1+YKJ:SQK/8L\DLJX!I !+;QQ^12=OOB!Z=T6V4LS.\
MFYJ%,PF .*=D^<:0Z%OVRJZ_WCP.&^U%79QT?9] K$G=2+.$=FX_5EE<.<E>
M9H#T9@E53G4/$,XFDLQ%]?QE=%FSZU4?/>^0OU+^I9DI1:/6_/'$5$Z= UTI
MSH&R7KFS')DL0[4#C$D?0\MW0>X W\)>(NQN@E;<A7(6;=9>KKB7H[8+J(NP
M.VARB,5YZA_F?#)I)(Y^WT8;B0&8G.EW.#:8@2;#B$%BY=-O/]Z1+6N,N^MY
MH2#XM0+!1QQKXEZA?P,^COAUS#**V>*>E-UG8N28HE8Z?734^#H9  Z%'86V
MH!K O*, 5'C%UN?RG8ZE.B2X1N(-,"!6HV/T#G8I:O1-YDT_5CU55\I*+0ZE
MXK9VW)5N[R?R'\6[);6I[\(W9UZ2J _&*9;3$?4 H:=.YRT71:D:F^R_OVW!
MURV-&6\U"FW#R"":-51"W_B2P\V<&:O&EQ+8]LS ^!UVZE@R'O@.4H]M;@CO
M2[ZG/<,'N&>^[?ODB<X)[(V?"?H^J)B8M]E(RQ L?C3;@4!&.#K/?S#39(]X
M,79OO@_[S7U^>V OZN]H"4CF8_^49MOP%7YL_]?>>&B*S.N%AXUP@F5P,B'O
M\())(*Z,F(4SWNN"&OR]4/PA@")E*+(E*/*8(4ZQ+4'[ #]"[$841GVMTP=P
M/S0,&D+XGL_^("_)73:1#C6VX0TLIC)L5['63K5PBE \>WO1/ZX[CHE3*?*$
M[^_@ I/G5I6G(=N #/JFKJ#;4L="&F[A_&RK.@_<EG2,UD17A_?R6[99SU:W
M+O^J,IU_56E-.M6#R?W+K]/"!/#.N)V@'F:![,CVYV)MM4Q"9_@?[>>A/-0<
M64>\V$+J*:),=.&V^4C(JMC!;/52KHV,AWTHX?B]5 [J B-DC&@&TNJ'IB43
MQ5IX')L#D"Q8E(95>;[@D[,_21RIYCI]$T,J4M-;*DLY26I-KMO'RM%CX_WJ
MK!AI\8I$E JR-\ \7\J,;T>9P%(92I>D4.E2.:F3-R:^BQUWLTQ8+DP6\)GY
MZR2[+,_VU7*+O9&M:PNK/0JV]V]4"T\GM.&3/^:@TRBT7SK]F T?RG-<#!$[
M'??Q!78\J><IN./(BKIANY[=1QL>"QC@KVL_4^]VB;$O"K6AI>F"5,%WH"I&
M!BVY0PDZ.,D=P;E@2A0F^_%B=Z*:+4A(QAT4'FL7E[^,L=W[I#M1W<L6]J1*
M\(0J2=TY,8'DM'>"NEJ@VD<G.K7/ES#VM6Z;_!&%#^$@$!2F[=N2G(,VN;FI
ME&\?5;O+)Q&0 0)'82]P%K.GL,!Q)'4Z1!^'-/LHAOXZR0+CN%$I=G?G,22Z
MR^WWDX=J]]=;8S1CEQ/SI&136&"7DT:Q9[.E)%QI2U6)K594/4&0N90M9%GG
M<MC*S05U(<2-ACKV+LJ0!4#A]CU/".)(R&+L(54*7Q(X]Z$MW*N=OF'J9F\L
M"@VCLR^BEZ_4-UF1!9Y[?6>U!?BM#'F".1G")E P*G9H&I#U@T:Y[F)R/X)(
MKS:$<6GWA;Q4Q9Y3]%,NUYK(AF,]=O(GM]T<)UG8*+ 0>M\4?Z0D^:NYO6Q^
M3ZJRGW*YT"6:ZGXR:^K??MZX%F2Q.,P#3G?7VW%1^*[]")P0?H*I3 ;U8-&#
M(%L*[Z"75!F=<GZ_."5K,D2D!].6B"._@R?K,,>8:=#4QBGE#9#&^6_BJ:#/
MTLDR$29,BS#T7'NLRR,LWD+S;JL=M'>)1V!+L%WK37LC61?><_MQ#2;NDZ@]
M=(_@6\,@A^;4H"XBB2FRK2RD"&%R1;IJI>$V2[<O3_5?TN<H0I2<0ZIJ)9VJ
MNH B%*%*'BV^@^C"9^7VX$]6TVO#]J?N8(@A5)=3):7L_"T$(IV='IA $V2$
M^%+*W_YI:NWG<?]3-<%H>JRN51.,H,5LJGU$Y'C0M_-7S>KQNZQOPCZ&J3*=
MKN?M8T+[!F(>?K"96#>>%@C<V^.ME-^B#_.\=:9#8"$5G)'WY.ZA/BK>#]X+
M\J>JX#'DG<X7DUP%1Q0^M:?EI?84D?I)]<[)VR/U]'H3MC1,Z>MWMB!]#9/[
MSJSYG)CPF:N/N40-?!8T5$)JGMYH*)!I;DQOC'-V1>IUBSE]<X5L&=I*O-SU
MSAI/S\=/KY_D](7@73F,5U7(KE\KB1"FQ46W$.? W)NOA[<#^>WI\K-4XZA,
MF$)V.56DF& +20@<7*^VV[8QR)&CCS,DM@T95,@80D:B@DUS:D#&VTU>5@ .
M>L/?B=FU8UN?%S8DMB:FQ"T/LWVMB"&'JY'WNJC9@F'2\"!! L?9D^DSD@+N
M%UI<&F:94C@;(E"3AQ9@*H2CX.*10(%CWJN9R:\R[W>BWPR>CPNY[LFIG[E+
M9A43U9C'CN>O:T813-[_*7%J;XB1+V<+Q16X4N+/0&6K$%_96MNX TY2@VH%
M:U#/]5?[QAC8!XWG+26)1 6FA>QRL?*Y!:8_,OYVQ=:A?R%YG1Q1L[)#U%PK
MHF8ANT/4_,J(FM^^ KO8GLDC%?)2'@MY"2M[9ZZA"E)^+D ;6'DL-.B' .T@
M"(QFH-DZ+CP#"$_&FXJD@H7F,N1"B=ARS/ ?PL/AS!T""@7SLM$%8W:C-]"4
MAI+C-109NBACZ<RP(XAP([*Z8=PCM<,F0HW358IY5M6"?TJLJW#[X<EKFZDI
MMN6@$4#9N.XV#'2O-,65]> (#;8J#R[K[$6OC5\+@X-V!/8+E;XVUQ@SVD^:
M<A]*$M/9\$^?N ^3N[?VL3R^1J_-W8?9FMH".Q&GLQ7W\I+_DZ>SS5HU?2:T
MKI"VMESP<OWK+NU)>?^GE:U;6M*Y5\V*Y7)4F[*9)8KS#)V#+\1&4IA(RFVG
M\'0H/4D'L^^;, Q@]WQA'I1B$_N_ZN-C<]A\>NPLM(O;P\&2V:'2<K[G+>)L
M"?=C.1=.092JY1A/_$R>Y]GK >A<_"NO>"Y4&,>%0J=#L;G%\]U#W/$358K#
MSH76?^O<WQW&5/3S,>!5+ORS=2GC5^E:K17J^M7S_(6OH\Q@Y9J3M'P>PMH6
MNEI5:8W9 ;.U)2]K()R'*3N0>FMI!+-SBD44HC6 &WAA,_E"H71Z(/^YR=_F
M?8!"LGEDF=/<X'#A-7XV"WC_TZCDLR]J^7<Q;HU)96Y@E1]RVW/I[(7DMWW1
MU:WTBN?2Z4K\ZBK[^2B7_2+FT-0]EK;M'J=0U^\&O\OV<;/N-BJ1MV*VK7.T
M;5P@Q0[57]#*3N_<6K&79(<VB8<DT\QSRQ<5;11O2;CJ5>1QYJ-:7X9^\2/$
M=,"K:ZD=58.4M]D@LU'*17DNJ"RGN 7PZ#;&-3-1FJ.J6NP7>P-?W3@)[,1L
MA6.Q=6^,-V7BJ,,_O3-;D9_R\>M. :[+K?R#_;>Y52#TK6G):W+=YI.J8K.6
M+$6"$L[45BX]0& /V"T%%' 42^'U')RX$<+VW1S&\:Z5<UHU7VJJ?B.5Z(5.
M,Y#:G%5N#IMXN3?[[[<G^G'A)<$RY_?,G8=3O";>D$^-0[>"-:WK\B?5E:;A
M<ZN5-.[+# XL&ZKCB0B1@FM9:E=7"2ZXY[P2A;[\I@IM535\$$3-$&J*HM%H
M](VLX5]1.)RY#@S_57BS8=#W_ 3PS^8)FI:7\^=/OPN2'R[FUCNDZ^V0>4_S
MA>-%%OO9K,&N-\]5Y6QP-:@F6^S,FQ2SW _Q:.13 Y>O=$VKY0ZIVUY)8JY:
M$JO9A4.Z^YE[5D]CLP1EC4"[>L("EXWC?V'@ZSWTQ[V!;+T@IN(:"F(E5S+2
M25\%R]4I .$P5/(>KL4^1HL4I+U:H,<1@\47IM .(0D;'8JLZPSU+]2)("HK
M.PX(D4PY^'"FUL' !U(UG\=9X+CF@J#<0I)/3O(RQ-&HK^B>:5W-_S-#D?U"
M:9O;,WF6AQ6)Y,NH=B0#DW40'2ENAZ9<\0&]AO?[B!:8B(A99A8;A]6>\?3[
M2/]VZD/X$:A.7.*#:QXAW]+&$Z0#V0*7 0Q],S%^)2'1MDF).AK.T@;JPQ>I
MN2=EOF. T2MS7\CG\WNY4KXL%7'SSK\H'G(\)B8;0_A^'!BC7,Q*T@_A.^1>
M^F#2<R%*[4 ?4'<H8/15QZ3*PBS$G4-=MA%GI1MY;6&<52] [=W60\0(5.5@
M3)^SZ8-VV)>Z !:Z?_Y3M1 G+T^]X<&-FM?]T!_[,JS-Z[(ZNT&8%Q9;;HTS
M9&O6ES$QBPE*F\)R.42%:E6LYF/1GN?E"E4V_-Q3>'K-W^5\_OQUXG3D))2R
MB./W,ZDFF3^TL#1L0Q59.,5<(;YP8C1C+V,:='4"1:0STC(*RZ5EK(;5/*O]
MX\MVXU=C4(DI@_V@-(.%6<EJ<,7B*_#]6/J^$,93BI+=1$ZI[ZK5T6S5C[63
MWR*IA?5:1D]0?HN[#L2"4AS/XU9U^BD<H/#^Z%U *40PN>I*"*;0/S/^&+>V
M7?0]/?7 HE,QEGF+B:<<M*X%*6?Y,(I4V,]&Q5$2Q6B+&WFPBPL?X@ZX@P^1
M)_&_+^5W;> .O/0MY?U7^]U]&C\^QY#+TC)IK:03)XE@L:W 6D-$MHH4H-*T
M9/HQG>DS#WUEFVEL<I^_;F?_U-J'6N]+T4^06HK+Y\J4]W.Q!:#S.%+ABU!+
M#$?2#)XC_;'&)R>U<D^S]"]%480C\6L-T=CR&4O9_7R4MX_JRIR^U# $F3HU
M16R38]1(YLEP^K*#%2"F+"G$ 0:P7J[N]6>*5[)BJL]P95K()1(L>/;5+X)S
M&:&NK5T/2Z>XLU$7<<73=^A.,/I_O,Q>792O1X6.MAD*7)3J'UHN_7O4@D)$
MOKQ54-VOQF+GA#T,:]?M/IE84@CLU[-W_;>6O7CJES>/O2Y':@EE^2JRM K3
M79LC-+_OTZYDMAH? +E!N^:Q+N'B;)#]#?"+K8[7%:L7M\==^ZQ<?9EVCWG2
M9Q/=J*D9X'+5J;E25BQ7JPGYW\)6Q[824@H^F)>4H[-:XZS\UIM/>AOKEUTU
M<RPMV0)#+.?+8C&RC#CLL<4A9'^C$RJ8!)D>]_S4C!Y$GV:!Q39G 0I=J2/\
M)SM,R!$D#7%\3=%D:\QE'B<DZ\GSGX.2=5'N_GY2 SA)N&DI6BO;DJ7@D;S5
MS$C)RB8GI1!9+.?)G\>U(N0C(0^2?;#/@[?')CI'V0;S,WS9]T)IS=%4D-Y4
M3B\B3]R;B\G N.R^5-.EM;(5IJ6+&/-VOJ@KY5>2U1I+-I>+)Z_.S%D]CLWF
M' ZSP^P&TL:KGI7O1_<'+Z?]4%;GJI,YUT0AQ>3)391 II,@*\59:*HDF6F1
M9$=[Z5S'<K+TORFJ^E1:*M]/C)-![KI>TC\E#7"E=%5>GJZJY8I8+4Z;>7S-
M#?924:S[B- CX[S0&$?7Y+:F0\]RDLD#;<HK4I'&&7U2PZ:@UP9]9C,J-GS-
M4(CJ>.TZMH/FA4AZ\^C+ZO3<V[?[HG4_5X[-6MA'4= ":9=Q%%2JYL5L1(C(
MXTR'-(/,])?GZ8+B(B[0PXWP:JU2L+V=_+GJ/\FC9VES?:"IB:N\?#1IJ0!W
M_8N1RYI"X]VS4;7T6&S4WS8DDV))(DP;*B^O(C 5SP=_B!ELZ[%LFZAP^=S,
MP"]/L9.38?6LWCL=6X_*EZ;&$.TM'R]:)O"^&;'%#>24P9!][^KMRGQ]J5Y=
M]K\T;<X+X:=LJIT\A-_&3;)P-T1'VU,T'0/""LB<'=C,>O![;WD!?1]4=E>.
M\@F3O^^K&<Y[26P]6>C*&LL][J#3[ZGL!)T^.BYA@(;IDYHE0S.\?Y,B)+]3
M!2MR ;E)71JDI:BI:%VM0XH[B$,]$S(E9(=B .-"*JX01E"@54R7EHD@2MQS
M+#E@GJ!/Z3+VG5"S]UAM6ZYLC?%\N3X:V5S>>RG35G5SM"]\;ZHJ:84A97]L
MZ9DN!6M?W<':KQ?67MK!VG]E6/LO)&X(U:^X)5/SM'9WT\S<UP]/KZXOKD]^
MBT+CZG#_HYHSK65-5]?W=;2D:^'^M"X<7E\=U:^:]2/XJ7E]T3BJW:-_'#>N
M:E>'C=J%T+Q'O[BL7]TWMWK1Q]=W&5CO_>E=O2[4KHZ$J\957;B\OKH_;0IU
MM E'0K-^@Y9Z4+_S50%X$"3O%G?CVFJ%#\@5J3>9"@'_[?O5OU+Y'Z'^ZD(<
MX#L8+YKAJLJ/W3EM0LNW*KX]^6 *<P?]OZY"_S=G9 HVLOQT1S94T[4], 2B
MHWMI"5XB7T2" NY+^HZ,0$?5Q[,K#A<!),MGJY#2[_TT&=U7S]S^[_LK5?]0
M5+ \[K]5]7\*V<>K@/8J1N)<D=:9B QTR&E?%ZQ5;B;@T]0QW"O.V42]'1J_
MDX!++1FHG[/WE:1!AZDX5EDJS8RP;^GE7RGGBK?%\+>$%<J6@,G)3=G;1:_I
M4S)#A%@@O$V2?/$!$R713F1FVRW?P)R8-E2R^[FB9JSQ])%I0^R8V$]#PUSR
M5(S]NA['D=#5+-OQ^ 7M=>U#VGA%[YZ/S^<MP?8$JMX5&)Z.#T0"0>:8WE*8
M.SJ!S#O(SO3S%((9>?!%/L^&E$UC4)W M[UA,:X)XK)#2]WKN@1;9ZZ(K,T3
MD19)T"1*U@P9N5!N)UX!6\"4+WWYYJJ76C6O'!Z95<O'X+H)[*.-]Y =;2KI
M'=B99"+$@[&*6#_[TV)M5RM)@XFS5(#<?FQ>CJ<"0!ML<#P0;!WB9J5YQ1S!
M<?Y,+MWKIG$H8EJ.T@%X@.H+I.CIQVJ,_-\H$BMU'GH/[8/J;=U7"6]"ZE!7
MG:^(>$O^- I*C9>8+^5F-EY'1P\[,.7;7D!K)*G*(88'.5[8XZXPEWLL5!HN
M!XKL+1T8,FBCQ#21+BR>"+_I5#PW?DG#=7AFS:&N>>1O2_;AZ'I<N^< 4)L\
MQ-T:D^_7<BG8@S$K#MV9Y3H82Z6"B(RWV(LSN^JH_B^DPPC,_U[S]?RY_ZM7
MT[X6 <Y.X*@L5^^6%TL20$!-HP"QP.%TJW'22H?IQ?%9DP&ZY%J=3;6:Z&PG
M#<;RPM*MHUU>G5?>-;]EUTU@O^;28MQV1:9D?!;7JZXYSU* 2E]X311D!<R_
MF.RU["*$EJ+R;-VJ8T.IUDK'TFWA5/D0>@FE\*Q.=:PNG\DX*YM,^,YDH(IF
MVT'D\ .841"*-$D*CV>5@*:Y0G3,NMSI!Y_=!O;FP8@2RQ6T7M. J/24R#W&
M1EVX_'*DO;OG![]KOT85SKA60Q;@BLMZI[?ZHUACS#Z$;L)RK3/S);$4V1PK
MB3Z8WQ'P0@2<INUPOC9 RF)[<*3\BTD^F89:7<XVJF2SLYP*/R*]34@JS&R9
MDCK7^(M?A<GO0NWJ7CIJ'S0_/PO^TWCW\M"%H-86D]KSZZD?^N*4FH)I9RNC
MTY'\+)V4XH#OOB)M)V+2Q>SRIEQVOY2/Q1+X@6VY"%9-'+K1J,%1G'VDZ;K0
MCD"3_L+L?3(Y/[DP?W=>"YWJ5Z+<$ FNH@QN!IZUX.,S\F%IG'&;,&KN1;6Y
M<';H=Z'?+#+Z7_Z8JPMQM_=#,?B/C:[;*B(A)1A>1Y-(&F"GP75$H&^0\.7%
MT]+&UVD*F:$Z:!+3@?2I[R0(F)?FYI314;U!EPV:<Y\+#KP&SO-'OKRX>9JX
MA\=:NHRV\!P3^L_IH*V8):;D,*L S,GM3U?:"L$&3ZN[0EZ^G1 ;+B^L-ES^
MD<35R([.SW)GXURVL^JH^'KH)WUDO%B(-&+71CB:@4AFR6![;*Q\BDU&A<O_
M%KYK/Z:<J[4/C%5^("DO;M8T;NJI39O8P)/^^"ZU+_1;==#]T&CGBFZ;9ZK,
MV)P%XE/%;%+XJYBHO%06\X4/O+3@%D#7-KZ!4WEW>Y:_/=..@=^5L2T_G?_.
M9LM?_-K,<0(LYZG-B<6*)!;*L4Z E5^8'^BVP*H%FNCQW;3(O]$Z]\@^^("7
MFB'HFNJ"J+)4LXL[]2$9A804?L5[[CM7C_TCT/=JELLAX75D6!5+)=]<F<8]
MF=_*),=Q_N&R^O[TF/TM?4:>3.R*%F+W25'I8F)NU;)8SI4_C]W/ N79#O*:
M9JUJ9=P?O[Y?/SX7-I&NYO##Y7*K*F*Y"+&K6+R1M?!#/UW+=*U0,SZ<N85^
MU=8,54F2PE59+(4KEUVDU?8'ZP6)NG7=G3C]%_D]YQ97GJ*5V\OF5RK39\.*
M%;/5I?VIN?Q^:9IZ/XPAS@1^W79R7 ^F7E_K#NIOSQ/G;;X<_W0"3H>75Y16
MD':XGRW' N:MA2VS5$8!J:A3='WPA>@Z"9Z9<_SG\&7R()4FFT^DLR')BI*T
M$BZ;G4[V^C@WP\Q8ZK;3XWH0^8Y.3Z71:/ST_"NW^22<#FVO*"T?D 4^^['J
M;RC- &9%4@R"1GY??E.1+@Q9P:#X=@'-#WO"#76O+^M=X?LL'CT+0/L>#0E7
M0W%^1Z83K/)ZK,)[MX([-E$O?ZLE7>W<='P'VI4[0,?429)",'?)R1QE,Z88
M(.0]6^W\K;C66)7#%)__M@!4.IPTP&5XM;)TR6NE;Y@T%['66)L;C"B(>_?X
M77\P/ &@#*(#I1W3_"H>;!)BBS ,@<X:.) D>Y:,<]UQ3+23: H8 HE)#QN\
M,6*D\;B27H#KOD*KE# KN8^+>NZT(W=8_&,;UX/<QN4&K4)X);O[B1R$4KIX
M4/)ZI97?>%;VA&Y=5.'3W$S_I#=L0>CD;;QADW9!M5^'I:<_SQO7]_4#+DKH
M)J1SE2<NU%KY14 78*E*KWW!P\2M?)=_^(H@ALS%0K+K6C@-@MPYV#FB. :3
MQ=;?W:B8L+M1.(ELPX*ZDRLS7W8OKQ[-BU4V,UIK@H^T"OPT*0(_;=T)8G ]
M8OHE!>T>'Q[;GM$T:5[3K6-9LS# <LV[*URGOVU(.9AT^F.GVZX]O-;:\\AS
MYFH_,Q]-2NKAGVZ^52F*N>S'>4#W$8%>&\R&$*12%!1D5].!, VAN2<)W^]4
MP*_Z(=SA[O46P5GWE G<*BU):AJUZN'[].,Y^G$"^X(^-8+'B+&CO:DA^/2H
M7'$*S[P4XO(<&+<U ZFO&T1PRZ *KXV,AZ^?GXU2*L_)76<IZPLCP67X[/2(
MW'0/[6A^2GHN/89;+BM1KKUBI^ZD/;G\8[C/[@"RC*CZ?36UTO4#L.7VLE(*
M/VN0\^:2>OUG*0KY_5QLWQP/92TN[9N/S%^9A@;@V(B8*((I(Y9#TW;6?K*/
M;W\.NV>UH[=#'X1U4?C5V4M8[UDFK0J8;D XNS0YLS*\L[1(9YDH$;D0QEDN
M;<;I^LBMD\_ITD5)'5Z5/@/H:34TMV1F<C:'U+>D7;>F#C4U8-C:#C5%9IE5
MMQ!I6X.S?'6+R"!9XEENN4Q&1!R%:% OK]$5O&,G1O(Z_-1X\.2I.7F['PPO
MCG/R1^%I+7.WE\^[RI?WI:3=1S<W:2_Q51Z^5\:#AE.ZJ\7AI0G<DC<DWC[S
M N>7SPJ1]DOQU?09EDZT/\7<^9:*G(?E2+4[EC:$4:Z[]^AT;3+DVL7US5NU
MT%&,\Y<WOW?A ^8^BC^EF5'C%<O>_%20-\$V??L)Z#N8;<+<; V#T4&2;7QH
ME:03>.W=<#26=0P,FXF>A\ZS%V-CN)G0AV*BSY2YSPWH)@[GKJ1'['H$1._Y
M09/[MZ<WKB\@Z.?Q/A(.\M&AT&5H=/E(9;ZPGX^U+\7,3$#%HXV-W$^&]4N]
M,GZY' VJ&W34"T6]0T>]?"@N.BC-8@ZR$]&$AV C1!Q];F-#RI/A6[/;/5#N
MY&9_4XY^T3ANZ.B7UQ1G-E]>'AO3SY";E7J0*!VNLR;>WRAVJC=M%^F0Y3!5
MV'CV"3/2%N36$?ED(]-2;-4(GG%!6CRE#+(1,SC1*T:VAZ/9L\+74QI&9.[C
MK+2R?8'WCTN1#O)5Q&X"#4S0'VKH,NN"5*#?RZ#1:^A]!8]!76DX?B/;WO>5
MV=&<72NE3PFNT),DE),+4 YMVF=[79*';EM'EW0* ZAQ<^W'4F2P'CHZXH&*
M?]9">TQHHGX(3@V@8$PGH[[6P126"3D[@5QL4\=TZW>5BV!V4K1-Y4%U<A9G
MPP@;5[EL02+&%?R47S 4CI;MN4'^G)S?WU<'SI.O^I IP)R)1P>6,]= 7F %
MD>XOQ"H+>Y+D_93WPMO>;$-,,*F+/<;=6<Z*A6)LM%KX+@QGX>&6-N'T4KA%
MG-Z%<]ZT:K_-WL:?=S*W2&$YMW>>%M3. (,EN\)X!O8S,*XASO:#)W25K.PV
MW_3:S^>'?_*'S\_+^446OXWE5 X0549<E/H^:!R:=WYDIIP?T-"3:9-B $@A
MWFD"F@S^T*AO^NZ2&#5()+H#G"D5'M,XDO\]=>J'J[!P6*']DD30;PS.J\_G
MU^6>].DYJ4FI9WFCI9K?+\9'3>> XY8WY_A2\/2'<W52.I35P]/GS3WP9,R\
MN+R/N["?BVTT]\/'ZPRV__ 2'4'7\UV: 0]FP+DISNX8LE)?YH+WO_C+;4Y.
M>MG":,IX_6S'Y1PV4$RGTB7V4(+[.IR3%>NT6N%Q+IZLRAUGU7I[?SNL5.PW
M+?(X/[,F9]YYKKDV!IQ1"[@A5Q9L6*#=3^0%/3MZU8_;S>YH<TZ4.1WGG>B:
M:SR6\BZ*<]R+V73NQ275L9I^.)'>VX/'R\JT+S&D6R9U+<Y0JY+Z$(O5=#Y$
M8;8/L8%.BE9>B)F(<F>FQ7 FP;%I,2\=H9'5VD1W:M;./@UJO?."M__<UTD<
ME#F&;$JD:["02I[3MGG?;/X]:P.^_>3=H#TX%70):N#X]*I\#DUKN"]"R05.
MTQM9&D1C9:%0W%/0#3*1XK(GZ[KI$,AILE;>7G*'\$^I^#\L=FMX;@"R"QG:
MC-=K'>U[!]AO? AN1"9_F99W]FB"GL]??771/^.^Q4'IQ7TM,_4U] MB.<)"
MT".0L8P^T(%5AY8>1ZJB[\*+VEDHP +K#PW,[NAT*<S<E*8#X%YPCBHR>6%?
MN*#$P=A_Y$8>XS@%:/Q7R$C&IT52CAN&[5@N7@EC[+Z94?8N2$#!F%T=&>:!
M[*)D]?.;L^K3[>^;YWA&-=\QM,9USW DE;V??*TDL+[095S.>5B41"F^E59F
MCN^PL,UDDL(^O?M]?&\-M??A\.4+$E8RP[:T9'*N*.6*L[V4'K_UHUQ$(<[M
M;VF09ZLC5/=^:,@+1TUY,[TS:ZL]]%T*$ LG"&*)9MXSN71)LO)-+R4_',[,
M>;7%P0*8# R&M!(1M$ST.F@!Y'Z0#KRJY<@8R);X8&%BZ/VN:MM$DN-Z@Q&Z
MU?-JA([GU @UB$?U!D?CF,K#E0K-X%6+Z7R3EX>\?5Y[J"GE&75!Z(4T)4&1
MJUB0@\3IB$G-JYFUPH7X&B"!U@!-4\IT#7IFQ37H1XO6H ,1%%J3IXIN%_-O
M;N4B[QTF]^DA_72'%GBOL"Z<G%HA=$9)?=6SSJBZ'\O)V1'%%E][HC.NW#H3
M5VY=].TO.L@%?1LZ0KJ6A5A"Y!&<ZIHQJKIN4<E/2W!O!G%;C^V=V \FW_GR
M*@KDBO&7XW*7V+%<;2[:5O4=6W$___/_]O:$8TW5E;\1<^BI_Z!A7UT5L<^_
MA2H:!M>^HXD(>WNT0Y6BO;%)MH'%6%[Q\H$N(WDIH>\C4T]3YE<[EW"U,RZH
M1M)-UX=@EAH]7&T'_T8[TV'_#GZR8^JZ/+31S-A/_Z [J#A]V+/L_T3L]NPV
M7,']TM4N?B.R659'A5K%P.>^_3S>XS>2;>$_ JC=?PLU"UVFSC]('QBH9)NO
M3-C00HY_ZR_V&OS)+SEG%>?_^0OM?,096*K\LM=6T85#8P_Q$?+[7HJM,M^"
M?0_L\7]DH6\!?_BON\M6%C&=G_=X!8B#'@)GPCX$><[.\?L-!T'VFKL0.P[R
M09/_3]OZZ^='S)U<V-5._6?SM'9WT\S<U_\_>^_:G#:PK M_YU=H9ZV<2DX!
M01+7)#M5V&";Q ;;X-C)6V^Y!!(@6TA$%]OXUY_I&5U! B$$"%NKUM[+=D":
MF;[W=#]]?-;NG'=._V2I5OL817#]P]U3N]-KHBUUJ-Y9DSKNM!O-=K?9@)^Z
MG?-6H]Y#OYRTVO7V<:M^3G5[Z \7S7:O>]";/NE<9V"_O;/K9I.JMQM4N]5N
M4A>==N^L2S71(32H;O,2;?6H>6U?>. /PB76X>[]P)7'#_#^,M4\A4/,L2(A
M\Z29$3Q%,DC4)_!81=D0^,\IG?9%I^_B#RL$08;VQZX(L;7-6/3PVTHXEXKX
M4F[O*OS./<Y6.#0AQP$+_QK_2;4NSVSM%1?R3$F4/WSY$<-#X@39=*)'<!NC
MK,V7ZUHR]C??_']<91VX#L [<I<W *U$#QSRO7;EAUW#;#?I''.2)/!',VC1
M]7[6J0*I014(1G+O04ZD,VS)*"(0>8.3O'<BY@/.B#6Q>\\:I:OSRFR"@EJG
M11U%(M[IY)%J0-;93U ]2,W5A.:W@;GDS&8W:@SR@ JUX#G;G@).;([I;X=!
MYB@#KFH->2B<]BJ=\2$R1K@;L<IF-V*E+%->7K?_/A2EXA3I.-=)9B^2*#OE
MCG9EG$>SLG91A49]T@2!0-=^)O<C2\=";UPFS188IKJ)^FS=LC\GS/#9Z#]:
MEMM_LD(,2]U0TU_^;!R=EQ^['6/E_43,1;?HB,.K\&BC.MW%?3LM0%W+/&VM
M<'$IVNG[T$&KP(.:2=(;46#!^.J->OSOY+=>6]0TL505QZ5I(FSN=/PX.BT_
M:?\N:XG232&]B&CC-!.JLT+N>?-NJ4*>]1NAM%27O1.'RJ]S();^L$V4EXU_
M7[\9S$ZKE9[&!;=Z;0]C"3>R1%[\Z+55?:F=,=/'P=[[U)8I(#^9JV[>F+8G
MZ*#56]N\ZZJ01X&87_"^5*'DWX=":?DCD^ L%OZ36=X^WPOBR7A9$Q:HB<*+
M0W% X$\&Z/Q'_O":KEX+WUD#%Z[G'./'F-F.BHG:MW%ZBYY.Y;&NWW9N^[:X
MPU)(39D+4P;6[[.M14U6B;HG.JX]/5QW1D;IEWK\2$?=4W")5,@]^98:%G.%
M"@$R7#MS5PV;B%G JM[>7NBH>PD;YBWLA2Z5LA7?L>II@&=I*'VL"@)B:UD?
M:Y2 DY%.-LFZPLY3==WGSXM(&2M'^;GZS^:2L9NVNM2N2N/+?_W'DSO!%F.\
M!!!;,XL&A=8J+"/KSK%%,N.NC2S-J89H7*E&\_T=D&\V6ZX&]L=GWP<[6Y7.
M'GA2.WFJ"A,HAW<1/4]!_3FNHL-5N(O<36G&8&Q^TY.)A;+Y]W&H=B-/?K%2
M[I!NX_=7/IO$6_[,\CI+/$0OH*#5W-X6+]GG2(6XCA1C+A1ZQO_J_N>YURX_
MA#A?[1]/9"#0@'MQ['VZNFJQY=90 "'SU#^#4W72=[MXK1XPK:.T_F '*YM9
M+!1MQ[L<%C'!<L"=W5B;L1M5KX7?[9__^%-78&$UY[@,^,J0>X-A#47H3[!<
MU+++10U:M=>*UZ)E$^S+\G(A6ZD%(KEG%C+R2]'KDD#3"'EKIGQW6KUEG]F3
MT<%P0;C\;FW#YN1LA:UD2Q6_6,9.Y%H \N"L^.D-3D,?T<D=\C%I6^R2ML6^
M @BHT#[F^SW$=P/P@5&@MS@1TD;S@"XE"H^%A"MI%;E6(F;8B<!IAFK.,=))
MD[\J3!65#$7%E%G^<B=50F89G5S\SN)1:P;LQM#PR"3T=]Q4@M;0'0 HG(8#
M>!*I3P1]#&^!E67=J1?T*&H$KJ$WS%]V2[YZJ*4[.1&GCKS5K^Z>_]9'_0=O
MHL*<[32?K_CPX[]Q#ZSTA/$1=&3DM 13@R!G$=K3 B^')B]$^273&#?W>G;C
MYFS[)?O<HSD7\]T18I HSU*1A1P@_F0X_DG4%'6&7$GU21P(H&UMZ 4*5Z=C
M:X'"8]'J2U^$]+9!DI=C(Q>=1*]O0H68:^=>JAA'4JC]YZK4+-T:?\:!%^$X
MM;ED14'W,<60V9U:M H<VR^L9LL^L"29;4W@7>%E%O9 Q2B.9(4]HXNSUNOS
MP^[H'M(3W&QF6YE=6B$9.S]\SC@@)(#$A$&;3 6"L<VR>("0[ >I.\\\]7C+
M:F+1$-K%M/Y'O6O]52L[O<X-K3XV+X;QQ\_<D0;9SLR@>)D@@H(I2\91^WDX
M$(7=5G]NK'TVKS.B\Z5%>_1Y:^S4<\^:L4:2P*65HX+,>1ZJD!D:@.X&T[))
M3&K-)\E3) _@NO*"[\BBO/+N*U1"[6B3Y,O<[?RF&NWH[\_77[.'UU-<0[W%
M/,G<Y?1J958N%#:R?8M6;VM<!]P1:]:4CI?(5S='OUXNJ]77IRT3F5Z?R)LE
M0DO96F$Q#;HO?[>V#9J'MS)*E69FS[-IL[13*H<Q)>4"L]FU=8 CNSU+XES@
MXFD0./?GYZ:RD9-]L8AV<\B5^RWAD1^/5Q%]PP1>:(D.F[Q>2-M5LZ7:[F*5
M?":JE6?#&/GCZ+J M8T\&P^3_&S?GM5$X>2H$!C@QJ 96-O(LVMP2W'#<I8L
MPU028P"*VR!Z: -P=\*TA^6?)78XV"F9PQF S;H]F0#TT^T9 #^GCMV$OG2\
M0EV31T?]U]NCN\$VG3K6-@'K"/5F64RZG&7+BY>76Q7JG"74L>KQ()*'%NE6
M5QV5?G7_G!KL3HD<3J0W2TZRR]NW[;OJW?MTM;5\NMC-=5T[:\AZM:/^+<?O
MTT6STF'SBHM7L4RV6-EQ*+Y S^,UZ1FSIG[F[TIZH_RG(A:W0L\("CIL8F^!
MGD4FRQ8"@>]C)V<V8V+?BD^"-".%'Z;4>L9*.W@'>+A$B$P='O<:5!:R6!22
MF2B\(#G-.T-%DI1GC):-7CW!\/+:5XK[3#TI$OH&KG99-?0U*J"]PR7.NYLO
M<$P"_]M^_35BU@M1%B?&!)LD?GIO7!IJ0$O,IDRN_QQJ=W?__IY(*Z]&=K?O
M^*):>JUDI(D]G&-<X@-'CXP>FR_N3GP^9GR&E%1VS(+<RXY8L/FWQ/V9G!1*
M<C\)+$CV'2,+KI4J#6;!*ITO!T)@;X$%Y_F/F>>__FHZ]->A \RJH@F_O9QO
MA]78DZ=AZV6@_A2<_J&O7^\:=U^_7K)_YDIR8 Q73GS)C46>%^2O%#H&1GSI
MJQ*B*0.CGJS[J7FO*&Y:D!MX5=0>J2'DNT1<M*/IE!I0AM/<EJJX1FLX04MH
MF2O8K:VZOBI*XE55?OPI[E11+-EUC&IBK>+A8#51S#.[2\;Z&JKR3KEO9V;J
MIM&XF/7D<5UE]L]]L1NIM?*Y2[DOL$EQ"]RW,MFW#7^A 7WG*#X!0NR [X0F
M?=H^/WH^OZONQ3UR;S=&AELKKQS,<+O4=;QY$MCNA@UJU[RB"A/>9EP]#_&$
MM[6$A+>QYW"XF]\719UI&B^[5=KKA[>1$D+T6AG[)>%M)5_<I=[V\1IVS8)!
M?D/L+#BN%$=7+UQG]GLE3-*>P]MH++C6;<(2SZ&8KP9VOL7/@MG,&O'4UER*
MM>*IV#FS)!NO5\_2Z%=O98)[K_%4-+Y<JZ9ZB6K,EP+GV.]&,\8R=G;C>"IV
M[FLWU=+#ZU^MIJX$9]EK/!6-^]8JP5X63Q5WIQ3S_@%5?;\!5>R,UQTQ4^&T
MV;_]32<SH(K$<4Q,-QU["ZB\,QS3YMZTN3=!A.#WU]P;@$.)UG"IBD\@.)<2
M9R(JB/+<F(!0C2T;H(H@E1RDG%>C(+05N4>@+-9%%3&KF_ SNP #9NGVZK_)
MZ9^;B=!\%?<%+H)UME]55N!VS7\/V-2<FM^L()^M5;(5G\I;WW$M2V\ #X)/
M%BOS*JUB^_1RUFX9S,$QR/*R/F:SDNQJME*"PKY@]!D/]LQEZ[(Y-]%Z8/E?
MZ!R1=@+%<X/>$@J29NYQH<%HED/1H%4L!Z-9?.U:,#1+0&A.%-5)_\(Z(G4B
M^H'8?)(43?L\AV6S4#M'K]G?$MB?&(MXKO#4;7%%Y)B/$E];DW+W;VMR08?$
MP_FTA78:?XC>E?(ZOYTY@0V;O 7$0.1=('=] ?RV2F=IGYIKRUO)(IF#,<86
MU[J1C1%3+H&A9F*"H4X,(]&(CX[:MQ=WPB B G0 8VT/ GI3_EJC^C>(OXI5
MW^EN%G]1OG6[U;AZZ_;,,M<RUWYX*/][[A1#ZI[M=_+%PQILV&3!8B%QI8 <
MR.!Y?\'Z9IFVJ<<$$)\8UJGQU].+DRON]9E+GK;9#DN%#4R"M4V9K619V@=W
MPK9F[JKR-%^4YHL22P@A46!P)%W4,2=&+HR7#)4DVJBACK&#?SQ&:<])HM;1
M:%R:/,_:K+#'' !CYP#< XUB21*QFW9G,UDFN%MH :8X1@R5/;'*8IZH/KUC
MSWYQS?;P\>!X9'F>B-T0JS#+H*"@%.P"SJ,4VW5QMOX)3ANMES3R>2 >VA!'
MZFA%XFCQU0!-9>=K2.(IMOQ1Z.R16Y&C-=CIH^#DD>97[U))0/+HM7-7YCOC
M&_&\XPK8%Y&<MP. O%Y /B=@D;MN*]F23S+'->/%B:["#Q0K)2F3\UH^[LZN
MFMW6[4_I0 9QA2-Z,7)$7<F6Z<"^+BS$2-4 1B]!Z#4#GJQ_ZJ64@-3+Z^CT
M<?8T_'7-'->62^[>TR5S-%PCA)UKEZ>+V0(=.-@AJN@VDY06>6T_O/PYUH[J
MW.DP<:*[$=G#>LL^L^?8+)+\(++#G,Q(=IQ=?0NTXOJG$!<4QB8,<ST;C&XO
MSL]HO;1;/1"(=122(=:XF/$R1*F<I2N!RIQD'A /(+Y8BIN\$=C%)A0[_L56
M&YV^QLG"SBGF#V43DF+1@4Y8N/A>;G_3G&.:<SP 0@R3EG.D6I<=[/E0]E@)
M9MNCRYA"D:Y@Q0@_U=93C %:L=@R.N5"2;C6Q_O*!3& "HY,B_63/24\A'(L
M;0;(S!8+V5HPWM?*;. &56-;(&:$5.!#F:V=3H:LHG&'0?YP><#29I6$E6RI
ML!0(#O* =N[OD[E0.U_V>4GR3Z/\VA VN(#8B(\ZZ 3KDJ3H?N.ZV%GY62Q,
M'Z^48>)X8\G"YSAAL^N"$IVE?:;7A!YJN $ZY]8(&T%--!^NGJ9'7+E;VMN-
M0116"*DL-H0&S=(!0+!^RD)7L"HP4'"L/JLB##[]!#O@K!TX6B0;ZJ+ 4CZ@
M5OP?9,U[]BW_[ LVWK3Y('O\C;OQ/PL7"Z;;0PG#(0D:*!Y*].'-\$_+2ES1
MZ\\#;RK(1LRONVXTS,L++>3MA?/<H.VX"!';0 WG5.70&8R3W=U!!+A]S$AX
MNJF>BJ,RXY?O$F5DO+9>_N6?DP[C]44.B>E:-<M6 N$ S&+FC0FV08XR@&"S
M,3.XZFK=*^YA?P3SST2&(%@Y\@U"N0:.6."%;'8NB1%=K /SDN'%>KVKQ8T2
MDP%<PG4:BL*5_S[]\KV!V@&7!*8GPW!)]#N*$F[QB)2<;.XN.1ET&_SKJLA>
MTR?<O]'^J.:?H@Q#M>A7#!4& JWPLIUF*-,,95(),=I?AK*WU0K'C>)0$-9Y
M=<>?_BY)TV:M93A79W;L0-:_CSAR<:ES>F[#,+&0+=>6.9[+,XT;C'&)FX 1
M\@=/S<Z?TI^GV]XQGVR2A\L8E*/--+7+#-E2E@GFA<].)/WI__RGBJCV#=L\
MZZ_X;_2WSU8N 5($U%B1>+1<R!3XW5:@6)D@>+CC>,6\O$#,1]>P$\R04-SS
MNBSU/!91N!W001H^@^#7^3J7%$ KF4\+>-:R=CUCE&@ +2)<MZI?#+!N?]A&
MA6B+NO7E3OQ;O:[\N3T1%RZYORP42.XPJE^E72N1(\12MD@']VSYAO-'NZPD
M6R32TYT^$";TW>/L85]$"JHI6D&DR $:7<TBI17HZ<_Y^1L4%B'A72*RBZ<;
M5%:ZNPJC1?[H"/W)]<.U1C^7P_''$LR3K9?;+"[_LMA@3XS6F39<+(W:!7LO
MJ9!:P=Z1(]D=E@RMV$+D\JY*ME#R*_)<"IBU.B1'_Y_K2P**S=%_OD^M>&?"
MJ2-1SJ%8\"M5^$:9O_85'6T2_66+T=\4T@1H4\(+U*P*/[[_3RY'G8B"Q'^E
M+KF1\ T]Z)\AR /T@!K]C<*$0\^B<CDS;.3%)VMA?5 PJKUNTOA 3W5*4R21
MM_=%MCG5%S9:A@5^QR=$#01)FG(\>%"8// [6O/ ^MW[RH$B2=Q40RNS?OJ&
MO#U>'\.V"Q]]SF%Y2/Z-<@>IDC#$W_"-8 <"H MZ7O?AQTG.?9#6$7ZC(#KX
M2M55Y.8-OE%M)!?DF-L*'&B1=7_KB_4U^">'ARP6^OX%G;P/#52!>\SU!<3V
MZ-E33$+WN9=]SKUP*.?N.>/O'(4,(A+8_UQ?W!?H(HK\\0Z0"3L&'8)TPO<O
MW(J3<Y\W$(*<M4L@/'(*NR$;625WY(3QT3K_MVTYCFN=7BH0!H]S[=_[]O+[
M/W:ZA8,[I^Y9_?JRF^DUC\_:G?/.Z9\LU6H?YW=^<''NJ=WI-=&6.E3OK$D=
M=]J-9KO;;,!/W<YYJU'OH5].6NUZ^[A5/Z>Z/?2'BV:[USWH39]TKC.PW][9
M=;-)U=L-JMUJ-ZF+3KMWUJ6:Z! :5+=YB;9ZU+QVNOS@@^#W[&KOV\\W'];B
M@5V1.Y>IYDFMB9E8@J037?E&$;00ZA,XK:)L"  >N2U";9LFCOUWV_MY?V#M
MO7C<@4"WP;P#4==_?M"%BN?*8>WE%O),291W+1NNNYBDK_S3>/Z&)^*RMW\;
MA-?F+C%3A8$@/OG<"Q76OU:(?*5@?Z9UV;&A")Z,\<F_ETFM4TO$Q8 %1FTO
M<2Z\WBSQ#]@"@3W0F&@KRDG=Y#J&5+J=1^BHU^)HK'<,7=,Y&937O=BR:16=
M0A$N>V;ZE5&79L?M462:KMJ;EYIU]-%E- QWJ5/=K)6 KE:6%3-\QN2URT #
MKFG@5@:M@>(H69F(,B>A3VFKBXVLTZW+/#XI+78V>*V<_?O3J%\HP[[3)]*>
M6Z.YNU7$7;;:]0@[1\#HV6DZRP17#^4QZ7KN"M<Q]P1Y:4IX$=2!B$35OO):
M"E;JR]9-\QF7\ @G+VC^JT8# =U7N1L0L5MZJ2HZ=W;4JMI$;'JV$$DP5^U@
M(Z)&J]]'9+VT)9.NY O%==3N A'+R2%B!(5,GXPDY8&CKZ_YY)(]I)*.5H3A
M9H=2G@V\B"):&BZ<X++:E&X<)7!#\*,Z UV!*R?/;3G<;9CWX;PY9$FT>B-@
MY-V&[="Q^5IMX_F\P[1?7%P0"'$0MJ%C_:N-M7VN:O3^9V9I52BF]3KP1?',
M(]S:R*-; >1.X.O0!3(2O+/1%F?/Q,97KU>7=]/.7\-0'1AKY^4['4.S] CB
M8<=:3+-H:FR^&#BKX&,6,^<0Q6QX"C>U?$SVTFJ_;<^7VB)G751?7GZ^:JT[
MP>E2N?8_@[V/V8J)N]9J7 WF+B9?"68NV\@M;6?>_32LV/CF=ZD@B7</IT;5
MJ8)JN.<Q)7,VUOK<$M-DZT 325C%9S8P8GKT:-V$W\.#?;V5?3POPH-0=&C[
M0A F:CXE A1E%PD<3IK<+Y]L'F+;F* O#2P6,W]=4HBE*TXIU@=TM -N"E?N
MJB',D1LYOUX^O;0 U+! ]-#CCR3T ]KHU!;KJJ?#)> ;]Z^WXF_ISVO]Z&CR
M&"'GO=^[BEI^3I55F3K2 E>M,U;F>[_OQ \_['V36PV;<.DETSX6WY(S+I1F
MNNJMM3U2D"8%U[DAJDAS*JH]=UR1!4H#Q0O_"@]';ZU3<[2%NNBZA%:*'7F\
M'-?3S8LL+3-0<D,%)\FQ+00]BGZT7CG/45Z_W2M%OQ6H.291[ZJ*40MUWXRH
M_0P9V5?=^P[+M/VJCNHW=VRG]=/IQ'?VK\%'LR@ P470*E[1A_"*R%41:EF>
M)8N94T[5Y<K)?4CDDB*0?NAX8&.DJYS</P)-GZ#*#)EJ8!%D>W0H=U<%"5LA
MLQ1>D,R,*F(/WF8>("^8*/0&8X ^/$2;IDJ%//TQ@^+VAC PZTAI'-73\#"F
MEB]]S+HZW=TIVOR"IC>+C<$R!NYJC+OY"5'@%995A=YZ-<.+FJZ*?0-[#) >
MQMMY,L-QP/G]9X@\"41A/R*&!@!:XNM 2%$@?UB!>!9@ C CY/W&ZPUQRE83
M='3".-J'OV8N$,-;XH)+\(T1DGI7'7S@MC V\  ,O"3A=EDL2D-!!++ LQ5#
MQR0;&BIZD H+0KX<BL]@3=B;\.,$0B_=4&6'NAH2'@.#^J)%<@9ZM(IT"D^A
M4P./AJ@(6SU,O5)A00!82L95N%AR%2X>EA[=@Q=2*10^N,$MS62/W<@1Y(2X
MQJ $?N7^]>[F]WESR-.C7_S!>2%T8=$-:=R_/DCG4DWN]H09\K0MD M[[X?O
MB.R\MFT+>SA&.I03Y8P'PH0;#)!_ &H,7\EI-C()Z"I  QA ?P%)\X)F-=N6
M<L6"G4%&.D@3\"-PM],BQ(FIZ.%16"TA$XD<$^24R !E JH2"HFQB>MS$GZ7
M-A8$P"_I.<U5GI7!>\WF*-RG-73E>&&*ZD"8VE8$_@>* PP5MTGU.4V$?B^P
M"(,QQ+IXHZXG.!N"#YFK#UBP9ODZ6&4K4U/EFTOW9ED[>$TYN$J A9!4JP$=
M88&I5DP5W/\6!CP>=@ME92Z]7YU7^QNX2;?>X4%+M"<S[R:Y4P8"OA4]=ZAY
M81*R(U];5$(?:"NR3;0CH-EO*TG=$P9C&;D*@H9+@P.4<8WUO8'8XOOOQV$'
M3\U?:MNW%\.'HO'<?:W^&>S$,MB'=52X?RT=LT_Z4X=]/'%>CCRVJ<0A98-X
M!FEVQ,G(O92$#.)U?*V"SQ0XW]Q([#/&EY>TA2AI#W]\X8K?XRMI(W7ZFU2U
M;;>\U0?V8'Z1?12WA%CICFKK$+W@K__[@9EO: CL75EK&]L^<%NCXQU96CWY
M!$CFJMXV6[#))X"=^(Y/62(EC2@U4B&E!8I:4;]2ZJC_B2D4LP $SI1*G^-2
MJ&:;4FP'9-V0X-7!52?U"6X]M<]+*;EO(B;S+$/HH'67B%-6L8:,2VKDEE4'
M]A!K0"45K_\Q\ZP!V=6U7$OG[Q<.ID1+GAJZ4UP5^!&+=6%IUO,T5<_EKB%\
M(E_&OU^(LC@QK,^\3NXNILVI/.3KKI(L\BA3 E!P181@:0+7+*M:&H_8?PVQ
M>+36>\]2/3>,.4T8?.4-%18V%]<4Y^.:583\\(/-LY6 5"J6K;#_T96E4[[>
M+$=Q+VZ.8H;]G\=C]JG\-X$<Y5YJ6(Y:N.U<S5&E?*T6P%&Q:L1$*NW4VAV&
MM:M&U$T+\!Q)UDU>:_>3[KSP7'<PN!!B44[LWLW=PFWG:N54S#M(\IN8NSW^
MQ\?2,N^!F[V6]ESZU338F\=_C5("N3F"J:4+44QMZ8U8VMW$XK=C41<.(@!W
MRM=3A^1=."1L2!4^KX% G3O5NPD(G<@MHE/UOXZ+<G?W^[97*_R]/O%Q49Y"
MMS.L<WZ^#5+1XJZ G?NX-QZ]'VU,$BD:+E7SE>KRPN$-W(JP*:$WQI->1^/J
M]5GX17<46AN_,9[T.BD>GHS6\$EXDF;H)=U]6W!,/B;,<J0F]S!,[DDLZBT!
M,=0F)O?ZB>[5:@]CO5[<JWJ+%G]%-+G1&IB)>BN6\FP@U/''3?+@;XS/O&;T
M]Y^KWW)'/>I?<V^,SY:8T6A(-:9K5\O7 G%J#LZ*IG?M[@."WM4<],_BY7EZ
M:%/?XUWX'L6W$EKYM6&OXW\,2PK]7"\]%4[%A(902W:XRL^H;:#_V7PQV,W8
M-+)_,]FF]=G/ZY84?CT*Q9-&ZU6N'BC[!;L?3#0P-=/-S9<"1RX?G/>1VM$D
MV-&XK5\"(J)-K5_C^)&A7U[^_/+V^T=W,Y(8/$4WH R]D0$M+<9/F=@[0'RL
MZ_'[96^O=2V]<J.)=F-<S08'RIM+K.LF]S;(N@:"(6[%NA[2);O9S50&Z.YM
MVCL+"PBO-(;8VUXY\S&I[H/5*+;EDXW)D[!66_ZXX^B\]E;"(S_8*TLY*]S9
MG\O.X/?5PR)"M+N7V3WD4<3J-YF!4O!>YQ3W)I>;@2A=L3'[08EFJND.7-,U
MWXJKNDS3E>@Q]WAS_E08#)*FZC8K.UVIZC:YZ'R+JFX>ZW#[\"C^>$ N'(CZ
MR?WK=>WJ9MBM796&AX.X$S#2,5:8(Z;J@3FRX!UL=&L'O6@9T,:Q@WH4]@GW
MKP\GCU+Y\O&N/BH>#$D QFL1WH;3@[!8YE'76(SXQ6DFUHOV=0](0@[D1_'^
ME:MI58/KS.A2*,B/0&"G]P/WL0K$8Y>N3^X9(X&3=O]OE'DZ-JH!/=VRMO=%
M6+#XJU@K.]B0K_I1Z?7LWW-+:;)K@3#,;3%!^!L^I^VSY)VZP@GGAR,\?IM&
M_T7\,#IO\$+S\:*08'ZPU#=A!WHI[D8BV,&5?[2/'3HQ S )D4=^;*@J.C>(
M-ASP*M]!*-[Y*SV5XPE,5@>F$"!KAL=BS$])Y[MC\4IYN&I>E3XLUZ#1JHUV
ME<DTMXN-NF?#>$'6K@-88T^A_(Z"@/\NW_4.(F[? -(/MM/A]Z59,7-&3R@6
M][K3;-B"@(4I+D5VZ72NH,/=9_(E9>O#8&LV1S,Y9'/786NZ4*V6Z6IECKW#
MWA8OSI[+TLR!,+BO#66W84,!GW/>8$[E?ZW^T_-('%<B&,R F\%MGB &&0TP
M@#O5"WO3@X>A!>:,VR+OS8DZN\&8R4JY%%;.=TZUE">3PY-SEFF1)P/,4-C[
MQ07>1"%]J1K8SKMGWO0U/(UM&)[.<"@ JK%UV-:4DMZSTALKAH:BG-XS>O"L
M-U8%9^*QT7OY>_M\^RH\QAK+Q7BJUL:<&;9X$ K]C7(-8ED(X5.5D!R5,&>F
MHG#JG+((>T.W.%BSD"WX%#@F0UFD7)LDKITS9#%P;24RU[+%;*&R!!T@>3;N
M:!<VSL[M+S=R?R=G?>GJ7&?Z48S<7/RU$\OF7#VFIBW12F*%:0O%H'-:(FS[
MVZ*6H,O9&AW8_I8:MY1OPQJW"'Q;C)PFI[,%MIRM5I*:7_"U;^5MV+>6#&/^
M_.[<7G_6_Y5/!Q?3-K^5.[<M7RL[&UNP=7@E%]QLS6OYW=Y/K+K%WINV66=A
MR=5&<U8T2 SF%$[85J+%C%&QDJ69T%&@;Q7 WBB>RD(R9<']),"KS8DON;'(
M\P)Z&S(9C/C25R7$M>R''[GE)<%)X#=?FU<*:?->JP_EBR-QU.)<0\=BO_!:
MK(5B\J5XA:&GZ)SDK@;QF7ZYG':Q+RFB?.)U4+QB]"5A/W?L:RXK\<9JSAB5
M-O!^&62."J&S.[XLEB"#E++\FV-Y,UJ<8_GH2?ALD6&RE6KH@"\9++_8!K.L
M0:5T_WI;4PL5[K':H$L'TPVQBP:5XL(("J?#!(]F'RL2$AR-],&Y;Y#-J%D+
M:EIQ-^9%?N;]:Z5[<W5T(DBW-X=#.%<;BT8I3D/=>ITL DR/3D@KR_']ZY@1
MCR;]FPHSX-9I97'U$Z;-+$$3:?<\9S;A?0T55Y_+Y#=[6AO(L_%S+;E]#6F?
MRU;YH>[J<VG\O"Q?_:Y?J<5Q<OEAOL_E@-I<0BJRMW%?Y6*W@][0/@YL)W=N
M>SC*H'+UY7=)+J]G6ZU?C?'M8_'B7T$\*;^%UJ\L?K]GQ]@QOI&1+G]61:22
MWW<?6)A>H7UUS5BQXRI9V%);6"D:3FQWS*F"]N%'L5#(ELJARY831.^4U0^+
MU>-K%2M% Q8].);W-;_,-LVO7]?8T6VIVE;_JO\F:==86ONU"RNXJG^L%+9_
MS%_^Z4*V7$MJD5?*HLEDT8CM9*5H<)4'P:I!/67;,T_1>LM^WPZNV.G?UWIU
MG/:6I9IBQ\9L\WZ=4C0<2$N'5+/E0B6A*B3EX63R<.P]9Z6P/6=!=I#),H4E
M(VV29PA/=FD(0S:@3>3Z[5&?.>5OI;0!+=4=>[%_$5IZ2M$FL5G*HU;*%H+G
MK*<6,.7BG32FE3=+U+.U2K;")-61\S6!E6V:0)_F'&[1(3E1#-6R?BU9D/J-
M7NOIE4UJ'+BD/RVH-RU5'TE4'ZL[R98RZYSFB#:LRM(<3+F0K=1J"=4<*0?'
MP<'N)RWI^BJO[OI*@N$H;M-P6!+8TC1#X$\4%:WV21P(%YS,C;",6@;C?%;C
M'JZ:REBJ[;)]+.820VN_9%HYWC1H$THCV]8H_.]DYVFOYT'U>F[=;H65E3E[
M%;8)+<!>5;-E-G2N)PE=JJFDO#])F0L0PTH*OB9DB^R<Q&R6XF>8;*D0&OXX
M"1(39/8M(^TEB>9O]E]_7LF,=/'SXO)E.Q, DM#JK?EU$:6MKQNKGF3TOZ[D
M\_"MW^7J9M>$2!+8:F0PDK3[.Q6!78J ;RMX>;.+ CI+UXK98OB"FV0(P4(_
M^/*&\"H*;*>2V!"KK2?]P;:;I$,VIRO3K] 9:_YJ[:RP@]YNX64@&;SPX_O_
MY'+4B2A(_%?J$CE/< OXSQ#D 7I C?E&_>8D YY%Y7*F#/+B4U@WT[--(-;<
M1LN86]=JI W7'NLG%,$]9FA]OGRTK&UVKAOW).<^2.L(OU$PCO4K55>YOCCX
M1K61())C;BMPH,6B^UM?K*_!/SG<9K':]R_HY'UHH K<8ZXO(%%$SYYB$KK/
MO>QS[H5#.7?/&7_GJ+$**N0_UQ?W!;J(_#>\ V5('8/.P@7(W(J3<Y\W$(*<
MM4L@,KOJ>=^6<&]G\?'WJG[O_^B>U:\ONYE>\_BLW3GOG/[)4JWV<?[[E_Z/
M@]U3N]-KHBUUJ-Y9DSKNM!O-=K?9@)^ZG?-6H]Y#OYRTVO7V<:M^3G5[Z \7
MS7:O>]";/NE<9V"_O;/K9I.JMQM4N]5N4A>==N^L2S71(32H;O,2;?6H>>W@
M4< '2:G) >_=DL'=;&$+2@285M&%#%W(+T*>49_ 'Q1E0^ _'_ >=Z<HM[#X
M$T7-Z&.!TJ':@9J@?QYKE"#S N\#\I*EX*,G%[^I$2?*%,?#@B EEJ6>Q^)@
M3(D:A:RHA*>B4^@3UL>=3U(H9K 3(N03F1N9,W@1OH)L+2_(&OD).WH<_-D>
M9*^!0>Y,!94#;U[#@Y*]*"\U -*U;Y%.T3+/%125R%T.@'L:Z!2>T'>?!.U^
M@/$X*@7ZWH7,<?KK[]_3RY^%HXNB/:/^A!-5H,ZCH%-/X+*ZM@-874M3DDM6
M\"$ ^:B2*]!!N8%*Y.%J1;J<+94#<XO9C$E!&;LJ&B;=1.'%(?*J\+X&*+@:
M88]H_L0K3KH/S@J[]77[B#K#"]=CCO%3_ ^_JLFB^E#N*@\/WL.?/W58A,_:
M HF!P].02XM$E>ASL$JE;*40F*S)0//X?^?/^V0##K^WOPGA0V=8=^X,@\IR
MZB.D&MS7J7Q;'HNB\7QZUP\I)%N6D<7JC+DUSY$K,K8B6ZQEF6(@N;(9K!?A
M4A;$Y]G2<\*+H Y$C>A$M"%9(,?P+.IC_$E7N9"]<HWZU$4J&3=!5C_G#]2^
MO GC*(NR;1MW914I'ZN8B6X5C]?2&;17,==.VQVA=#%MGC_NS2HNX@%Z1#KZ
M*)QLH5K-5HJ!!9DV%2-81B:J99PCP'6_>#?A+R1&+R?/,JZ@3.3Q(Y5:(5LK
M!=8/4+ZV<3WOCX[=-CX^2Z\S]N[GU<-H7[:1WL0V5B,[F*ML(^5K&S.I;3S,
MQ7L#1Y!%MY4,B"#9.&PE_N8G"0G%9V0W,R'LYAK1Y()"<=4R!,OB/2]BC<+:
MWC9+%'?]^O*H]'-00^>PD3K >CKX_;ZJ@+7=9-9/,5?7"%HTQ$7_^R&W(/(,
MG:U5 P=$ 5=D(AXH.4W:>YH#952]4$[DBVEE'Z=)+SO-R#%%D2XA,Q?8UI3-
MJ((V!:7X)$@SZI/V-O7>_$5GW!#1@.?@M:P-41L@)6*HB/;'RF2*- 76 ]>"
M!&KB6-%T#5\H'W%(A5QR,ZPR H"B/97.&S[Y_K71>QES)Z/.X(@_&+AH.]-+
MY^?<X"K#W+^>7TTGO]0F7RT-/_S ^-E(\V*U:_/!FTH Q\Z_M240YS8ON;D-
M'[)YQG50'Z(^PY>:05CG17^L\X@/OW]]^?WWN#2\N:J?#0Z&B^L9S9A, *8#
MN08*V1\U O\".0[@Y+B!T)&O,D7*6<#_V!<DY7D?&MG!-V_>OU;/?][];MQP
MM58E#+ZY1Q"I4]<^4\3S/0(%>YZ<.!CK<FB,:K_2EH4]O6_,\N2A5">;^9CD
M,M^\/Y- ;DNI&[W[#C]7X+_WU2]DY76 .QT)^ ]4TTQC49?(WQ.2S -A-4ZR
M ;<[GH$T>!5' O*<9/@#\FQF J>FL,/VUNWT2[7@]O)]?7M7VOMHMA"GUI\Y
ME3=5G8L(*-*!_+?8];_ *$UZ)\7??]CCLZ&=N2'.)W&RL\A_MJC7YR1.'@@?
MY@]NSUC)L1]6^'+XVF8XR72AEBW60G>$) @?^XW*Z,)\/T<\2]L13\MZF3;+
MLE;86 4*[616N_E;UR]^'SG):^M!%$>>9-<VH% 8/>M]R?&R4UU#NJ.A(-]T
M&Y>6A)<K>3KTO,]$X*!OBL(0XT+-M,?[ C-Q-$XS1HUS2EJGY4NT%H4_514M
MH*+D\F^Q>7G>^]>]<:[)"3-GY]-NNQG*LUV=X7,NT:HI:ILA,I39+") "B"T
M;YFCUY$Y;2WF6FKI?661[DY;E1-C_/MD'-[,'Z*0QG>0$84W&G:NQ]#G#P$Y
M\&T@.)PHZE" 0A*\%D6E!N#.2M*"JY"VKH?5>XT8?0V3/ :2"TMD[\6V58FS
MH.4>[_[4V\WKA^Z #O0XAA;%EZ<A=]AN_VF[?HG/&494;1LV[%>SI5KH "9T
MM_[G%+,B(8*_5EICE9WVX=KUO1[^[]G9[>5$FDS62&[8"L)C#A*C+;;L'ZUY
M[I$T2;40+=?I=I+82IX.+$I,-O1'#)F1G2DE[Q4,E/Q2RA"O8HIY(U66$95E
M=;M7-$U_A?CG7^'X_.RY^?.?$'!%(Q!:S^=U#USKQ7)MXZ_*-AQO5RIF63HR
M&F *Y!5-SO_K(Y%'^[B5"9#37S>WPO75K/_K7WB_Y;U+[MH7-?[R'"WYZG9-
MBDR^&GJ"23(D>CMYG325G'@L^M!O3N\&4H*^AX#'-!NX4CT->/9U';;"ZKN(
MM"+@F4XNN.)3XU&9C(("'A?!WZ4+M7"8:SA+&PZ*9)AEW>3)=)52F0]5XW:R
M'7&/%$U-[XR'V_/7J^/.:(UP*M4+H4Y]#6T1[?[('5J5"OEJY&$C"0%\7HKW
M7+M_/;H2!B5C=G-#<P?34GG0*!=U/1,$^&1K"9/SJ6MAPHFX\A4@@X$!#4ZB
MSL6A )VB\S (M7DEV%\MCOVU,QWVFEQ+Z@GJA+GG=7^%V*B.2T6U=#04I&"%
MJ-I;';BV*J&M?HC:NN^2?IA[]I4WU&>D0S5!]FH*FEYHA-[]Z<$43Q/J9$%D
M":._)6R&@UG\$FG57(Z]YNGBAFYG^(3U;V[C/D8,/V?] ?\+@K^7@2#PKD>;
M$"3X,QGT@<6%X#=Q&J49@S$E*Y2(>$J4-20C!+=$>!$U7<M3K;F_(^7!"T-1
M%O"WX8V\"%-L,9Q[7]"?!8$@WW@7"OW=[GU9^W0OE#(_ X+#R3,\H;3R34-"
M.T'<37:6<O(>%M\P8$CQ OC@<F!>DXHV7H$/-IJ%O!-+0;/ M^0_ J?>\R_G
M_L9$[C4*-]51KS-UVKXLE &3+[]^O6O<??UZ6?HS=W[!TR^K-/OAQU!\<MHL
M\?_DH.?/9O=/<"+ T$SAF[EH_!O][3.E*]344 =CM#F*0[_IR'CYH/>5]U$9
MK\K&W5-YR'>N'A>.3#-=W<,H5J_2VRQ6SY##"*/!LM24LZ 2EP(&'N,OX1S0
M):=V5(P4QF-H1'08>%TPKFS@4.OJZ*5U=R0/>G<.,..QZ]7.FU=1+<2[PX=3
M].:5QH5\H5 (AO::(NV#*> 1-'/K>!=N:1-U9,-$51CHBJKA^'E@ * 5LE%#
M9(;PWR9329D) C%4:*.:(>D8UPV)JF8 <#QZD!^IH:^*:OXS %&^)4,S.'HR
M=8GB\3S50Y^WX$U@L8(WA8LXP71I,[8]7."0XU5J<]U4A(>#ZN>WK_0K\\P^
M5VT.ZBRZ(DNAS.)8UAK,M7FLOJR,W<5:!!(08/FP[PXHN<   *X%GIM),O)'
M!R6-V#\*P/ZTU'G9AQNN86PA?R\%R.J'L^B^ VB:NL <O>G/WFU%?A(TX&:P
M71J>M^C^=X!9:ROZ'P&QWT 9R6B!_)SL,5?2Z%&A7X0SUI:]&UFU/TYT>(XP
MW\#U[%7*?&L;""^E3&0@5X9ELFPI,/4..M((<TA()#'>'>AMP]SJ7!R&05XY
MZGDNOY 9.MC&?AJY$F/NQ*;"G'+$7E #K=]&1YYCGEFKV!T<_3[J'DDNYO'?
MYGS^Q-E?*&=N)]M;@[4V;UBNY)G X7R. 7"!P@HO4X()BYBI#]K>9C\%;<C%
M0SGKC,F=K)]?7]V%JB'>\XFBFG^"S]&!6;?7T<\F.VC/C YC,]-UV#UN/>?&
ME.9S;KL]-K@.7)YN@\R(K\U)'8!#P8:>2V*$,3"@%&3-WT:XA;PN2<H 3)$_
MGS;)8_R'TO2:=:E9O2J.2F-OE<"2!:U2ZN'6$V$2396)/ >!ILM9.A@D)@/T
M4'D"RCT29*1_))+0Y">B+&HZ@&@_"?Z@_/6HM)C3DIW3H?);>#P5Y5)":+$\
M <)$GGU09$M9Q,/A0*&S( #$4OH%KW$<O3,: 478RD2P,=3/%3(B@@Q(<$8O
M$ ZIRWS=PQ_F.ZQI":.*R+2Y/]7NA$\005W#$\R'WH?:CY?X;/117<@!+Y4#
M V3_H5"U_1#Z6M $3AV,T<DT!,2,RA0^/$?FH^,"+<O/Q<(?*=ED#K&;.2)'
MGOS%9MEB8'HM R'R&AI7-=>-?^&=E5N'F>9!#L8-8N-U@R+J__E!%EO2_S_/
MAF-N-!;[%<;;E$^MGW/90"$L3,K82.]'G@1!5ZK9:O#0>B(+*Z<>K45E>A=4
MKO[B^^/7HF1,N3U3F8Z/RI$=[4JMG"T7 BO5LI3'M<LX.?!P]N -:7H\1<&:
MG>Z>KGZ))]%;(^V_4C7V&X5S6.AA,'1]<9#]"C1A]U#[@L]0^_*A#+7W@T7V
M -V?Y-P':1WA-PHFGGVEZBK7%P??J#:2.7+,;04.M%CR#+>WOD8&W%N5C%89
MX_<OZ.1]:* *'#)? I(:].PI)J'[W,L^YUXXE'/WG/%WCD(6'\G[?ZXO[@MT
M\<,//!H#[#,4D@'2PO<OW(J3<Y\W$(*<M4L@,@<NW8<TA[U[5K^^[&9ZS>.S
M=N>\<_HG2[7:Q_F#GBW?[O2::$L=JG?6I(X[[4:SW6TVX*=NY[S5J/?0+R>M
M=KU]W*J?4]T>^L-%L]WK'O2F3SK7&=AO[^RZV:3J[0;5;K6;U$6GW3OK4DUT
M" VJV[Q$6SUJ7CN5>_!!\!L.>N^6#![LG"7WB"GOY)I/X.Z)LB'PGP][?T$T
MBGF<5)5=&"?E#('5-$'7D"]\+B)G0!)U4= N! [&F?$=^5H8&"K4)J(/M!6X
M!B:_(D]<U.#[V WO"8.Q+"(G05LZ<<H-/;N3]T-%XLW#Q=.H?JH6#Z:#HC>>
MOQ%W7R]3'+Y=H[C!0#%PF2#,6#5DY 51]>XQ5:&K.'P0T+HF^#Z>TTD5,?H%
M'D;*90Q<4L,1WQCF?RD25-?A5^2@T@;J42<*+TC.:-8A<JV49_P]33,F#HJ>
MI_#8*D?E<4TK%;:F%<<VH'3W.U2+OG\5)M<_Q\VVSA='JX9JP7GBB92_+5*Y
M%15%+D+3@5KS,XV"PY=T($[($'9A_>][KE9*V.B$99-,V-W"#,<+'V&5, GJ
MA/H$W0K:YQ3E)/;.YVTT6KJ]4\O1L>@)'8%0V?7'_T)54_5<[AI>0++G^/<+
M418GQL3*D$^5X=G)8^_I1G/Z9'S998U2+]?U)GKEO>>-OJ5?\ 9OE%",K]=R
MY0%^^,'DR^6 \B[,N6'_HRL+%7_U1/( ]^+F 46:G?YF+_7+OZ6M\8#[C6%Y
M@-TE#[#Y0A /) .W*%716U#1[&[%<^':,XR*;M,3<7#<Z$S'_.;BN7@5&5E%
M+Y3F;E=%.^B%,:OHA;F$B> !KXH>W F"=%*OO KCK?% %!5=V:V*=DKW$ZFB
MMP MMY.PX$F1$)DD49^E%F?;%B<6Q#D_89EKL_EMT_2:TX5[?AH]1NA<G968
M5DF?UFN+RL?AG:UUAZ^]VY"UESZ6SZ/<UNHVU9"4 W8 XZJZN314)-)5.D\'
MEE:M9;P^^IFO6##;M\U07FMV=78Q>+@T3B_9Q[?'4%XSZF:HTEH#)I8P%(I5
MBL%X8R$MX<<T6CDTVQ$+&'QD48\4O Q_BVJ+.Q[(;>& 13U4U.01];4:58-%
MO5+*%P/G,'S<-/)92% FD9_F<U5M[=^OJT?]?/#V^&F)Z5@+T&:)Z:CEEXUC
M#VTZ#OQ"Y%K4'G-#Z(T0X:I7T'1*1;1*+=BV+5@L0^;]9! H>H((VC+IN7'0
MH_VZTT[4VY/1P.D<"V";G2H;OXW&$^^4UH)N"M8QQ7PEN+ULXW!G:S8K!@[R
MFJKFK_/)^</@6;LHOBD.6F*E8HJ8$0<MP5->STBE:GP+:CP6?,)UA3!2_#&^
M/>F.KEXJY[7180KAVJ%'.:8L [M$C6\<>6PM"QH# WFU>*EY<C'I<$=#%TK>
M6V"@8"U>CBEV+2Z=&+^[4"/@9L4L&BU#2]8VM79#?!)YF-CC$V',K87YN-M!
M'5;=[)9/8*G=LM90_KCMN12[LF%6.L(B_#)'\O7W\WG;:)_\.WUR@  ]'+-3
MI>*W]&@ -.68$A9+AI N9:<$L'0JS3N4YH4BCEU(\[Q#\5J^*8JG2KO0<@WV
M.@!I7G 1YF0YIL3 X<CR>N-QF/O7UJ_3R5/[^>]D/#J8YBZ_WIWY;<;=_5=>
MZ/XC>!\][J4A:@"OC#@EH&G/ [ZZ[&OWKTVMS#[=WO*7XL/!D,/N,67R<^%2
ME4$<5KHYFLG-7JFHCS_\(+NGT/8%NZ?K37:?'LP>ZCH&7"*3.2F! ^Q8B,S$
M":4*4P7%*@ ;CB%&O3!+5G.DAJ'JA>'0A!+7N1=L,>;Q9[GI5!+-5DO<"6E(
M$@65>?E,;RPZS98 76MHY&N\ "6"T/D(WQ )\\ +IJKR)&I@AM#3^H(L#$4=
M8,TY_,2<KN1PJV8?6EQQ5^2$FU&#,1@CP(+1C+Z& 3ET:[,9LD4M3]4'@!F#
M=@TH@7[@^3Y;M?:T'GJGW:Z)FTV7N?E-ZY6V]@"3>$PZN-%2.VCUV.!J]U.1
M!RMO@.7RA^=\?CJZNKPYDEH-!T'*?H'[D/'6T).AK9 ;"8N^RTEL2YP++IY_
M&1?,GZ/2OV=ZPR4V8EKB/+K7ZR7W4%/H@<&_E#=<8ER$7G#J]-ZQKDH_3^_Z
ME767N!RJ/?0BH^"Q5F)* VY[#\O#R$I,N:BM[F(!Q&UN#S&%PMO>P[(0H++%
M$"#"'[Q1@_M_/H(9#&-L"%I 7]''IED&L'P561W\261HILB<<2IR!JC^#!E$
M;&>?+)@'B@/\ 9B["N:21P>.S.Z D@4]PPM#057!\*(W<1A2X@TAHVT]0J@L
M1 C79)C#):?JLQX*A#7"!MKJ@,%]R[#&4^Y?I<83._KW^Y8]'AY>_, NQ@_5
M^U>VW%<[)R_<Y5/MPP_S,"A\&I3[.+ S=41&"K^!T.*@45R#IME@&C6$@?E7
MVD)O-7%8-&K*S<B<*<!H' R0C/&4Y&#:@,\"0&XKT#S-IUV2AP%$)7F4"QWG
MV$":3M8)(LZ _.(=5D+NU'K@-76&+9F'5)3!2>2^S1INU3%G<0'XL36KRP;J
MIOO2 W]^U)PZ=3CUD!M=">D9<8O+!I:8F[H/WI-7WU4C@W73)29;*@0FU?P!
M\4]BI#!+H_]N3N&_\K_S*^/N\>?90[(IS.9H)H=VO"Z%HR-U,]E:);#2?PZO
MU3JJ# KXK>%V!)7;6MS<Q$(RHXZ;D(,&4%Q#U@#52N"S "Z4LR^W^P*G6@-K
MX7.\0=P> 6DQ/G5NPCLWU86>63MO;P*-04*_)4\-/81[4_0#,0OSG/M7=7RL
M_SQ29B?0Y'0@!+,=G.*B@].\?^T;OR];$O=GQC,??KB0L%P'\@8<FK>0*P54
MN?D ;2C*R.44.0DY)QH2'$PNVU$9<-IXT;_)8H7TS*D81LZR"DBO':./^_\;
M5E\3$],/AF4[Z'8D9>DQ.J)F?Q;/[)Q 'O<5XX9K.M&&TZFJO)@)7!=2'FA(
M<_JH-D;? @@Z'#B^)6T9NW9<["8WP>TZPW5!&C$JXU((2$\)6ISO03XKUSB^
MO:JV&'#N#H3 <\$&H;=W0)8#NNA(*TEP8%EP1Q@XE>*6'3>*)-POV/"9YN7"
M% :) %ACQIRJNCA66>8!$I],Z 6 ,AS!]DFHBJ1,$/2O>\5K1#;H]>+ZO-VM
M/[7@RGPY7B.<=MTY/!>7618+GYL;TE&F;+:C,-^]/SA'SV%^HU)TQ^@@@!;C
M%I$F]!G"9"O"HYG]XYDHJ##L9W8.@W[F1G+8GR)N)_X(;<5XQ5]2Y[GY?'?Y
M=P/XP6TC5>,EX[.BDXQ#>%"\5=T:;S$6;]4FA9_G$W&DS\:'P%M,RELQ\=;Q
MUGB+M7A+K]U<7BI7\GA8.@3>2C1^ZJ'RUBM[-IO^[%W]G#1JR64"/.,XR>3'
M-94I,O?F?$HOC!Q*#A>",L4K7LR]43> \Y]D#EVZG/W!=.]1 '9^#J$;O5(]
ML4V@]S322BF<QCLIA=.HXSU3^#!"BNWA[>[(BTCQ27;WYA2G/R5H2M"4H"E!
MWQ)!77Z G<'U( *0BW8[T^^4Q-7[,+U^H-^+1_>OG;K^^T1]^-6J\Q_6=RA6
M(UINU3TB6TSY_"WS>4K0E* I05."I@3=KVOA1C&&6N.ZS,/_-/\9XA,GP667
MCZMQ+Q;HUOWK\?CUX>1%+?.38@0G8SF67;'X<>LY+=CH*MRK?2;60B;3=H0M
M]-^ HPJ[O'EPPOAQM):V3X5F[J4=<>;3[I=4"'H+P6O%J!U33+988;-T;0GP
M9"#&E&]*<]](:JDPA3ROY$B4^TDP.B\GON3&(L\+Z&W(?C#B2U^5$).7/OS(
MA09 2YDS9<Y=,F<Y9<XWQ)RI&S(/:%,+"VCSYER,[4SM2</J-*Q."9H2-"5H
M2M"4H$DD:/1+4L#[>1T6JM?U2O&O^OLAOKSEPHWHHC>T=2<>5[GAA9F][/YM
MZX=05!C2JP]QZDD(/E8L<\<Q2*!TQ)SZ##M";?.X)%P)YQX#^<0+4F+S24G(
M(=4*A94YI"3$PRF_O15^HP^,WU+?(?4=0N8K:P7FO?L%:=XR#:+W'D2G!$T)
MFA(T)6A*T/WF+1E7WM(%G;BJPX,^>KP1]*OF:9_;/(D99R^ULX64F=\R,Z<$
M30F:$C0E:$K0_?H/39?_T$#/>N)@BH;+#)O=&H9*G_YL'_5>?_:WTA*Z\]O.
M6X*(C]=AH^*G^?#X,H_)2(77#BP5GK):XEAM:4;;5V=&O@EG?&[":P!S&7$P
M5K; 5+)T@=DHXYW*0GH-&47WTH=V#?FN^>T]Z-XYO1KY)O$@]6J,&'%IX)D&
MGBE!4X*F!$T)FA(TB01=B=:R_*[03/I-;_JW,^GA[/?)XVYPX,)T/3#YTK;Z
M'MR#^]9J?MCZ&B/&#G@=%*\8?4E(4/@0O*S]!:O%M8-5O(MD5\TFDP]#B'U"
M6'/%2G<<[R[7V3$G'4M["XY-N=HQEZR5&4JF7"4K'9E$);\:S"55\JF2/U E
M/Z? (^.ZO!T%;D5!7_#HYD,?,X_GS LO \G@A1_?_R>7HTY$0>*_4I?<"+%Q
M5_AG"/( /:%6_$;&SJ&'4;F<*;V\^!0VIT^VG-.5*=ZV_0?K"V7,QFO-PPXW
MY=I/6H+SU6A]OBSE'W63(29S0[5/<NZ#M([P&]6;3=$*ZBJ2Q<$WJHTDE!QS
M6X$#+9;=W_IB?0W^R6$\B^N^?T$G[T,#5> ><WT!R2AZ]A23T'WN99]S+QS*
MN7O.^#M'C570+O^YOK@O0*#5PSM0AM0Q*#,9T-JY%2?G/F\@!#EKET!D#ERZ
MM[3X^$?W?.__Z)[5KR^[F5[S^*S=.>^<_LE2K?9Q_ON7_H^#W5.[TVNB+76H
MWEF3.NZT&\UVM]F G[J=\U:CWD._G+3:]?9QJWY.=7OH#Q?-=J][T)L^Z5QG
M8+^]L^MFDZJW&U2[U6Y2%YUV[ZQ+-=$A-*AN\Q)M]:AY3;&%+ 7N!OX@^H$]
MZ+U;,KB;+6Q!B0#3*KJ0H8MY"EQ%OU&SG\!=%&5#X#\?\$YWIRZWL/BZED&6
MKB$,<):%8FDL1&R6TL<"^K0D*<_(9E-#4>;D@<A)%OH.)_.>A/2SH H!66D*
M11$<I0H#0U7A67U.$S5JJ@H:" X/_XQ>ECE6)FA3L__SGRI#5[YI$$J@"%D3
M8 B?C%T_#C[=YR0.O!EM+ CZUP,]=3^66<MQ"K_!<"[6A[GB"U[4IA*'=H8"
M+/3)5<-]$Y1OV/=$^C),I&=I]-_[>_L^RXZ5CV;VCV>BH'+J8#S#:<[ZBZCY
M?6$1B.C^M77=/.U,A]4SZ3&Y4RG3V<'Q\U9C:[S%6+QU*_PZ+1<,YO@NP1-/
MTZG%\?-686N\Q5J\U:G_NK@R_O'L:>T0>"N=EQP7;S$.;[TV'I2?_+\J_>N*
M2RX3',9(Y97%LJF#1IB17L@X)H?50&/B%?O$QS<:.K@DLV$2NA-<*N?-;C9T
M>7PJ\;;Y2:K IX'1^Z%P&IZ\=0JG0<+;I/!A1 !IPUS:O9&VXZ0$30F:$C0E
MZ-LEJ&_#7#',4" /KN:(;;.-_N2E(#"[Z9B+MU(!MICR^5OF\Y2@*4%3@J8$
M30FZ7]?BR.5:A)[J;+;E]^^.ANVF?CD1HK3E!TP@-$O5BL7M3PN'C0:0)AU9
MOK#0=SVRG,W13(ZEUQX?6&.*4=O?V&R!9K*U0O5 QYJGPA1K&_->),K]I"7]
MS$QI93]SRIPI<^Z).5<WVZ?,>3C,F;HA+#WG8D3NL#]T%R.=0)B&U7L/JU."
MI@1-"9H2-"7H?C.9=)A+TGNQ=?_Z7#H:S>JC5KM3C"]ON7 C&@9#-&8GWD$0
M-7NWUP(/]=E!XH..$*>>A.!CQ3(3/?T\>NJSMK.X)*$3TE/9VE76:><"%C+Y
MQ!:BS9Y)TMFGO/M.>3?BW*0DG7W*NZE/$S:/RD:>P_16_)4TGYH&]WL/[E."
MI@1-"9H2-"5H<BI#EX/!>SI/!K?_F'/U=Z_T)&V>7(VSD=O90LK,;YF94X*F
M!$T)FA(T)>A^_8=CE__@.R';["*YK*ML0SVY/A^-MM*JNO-;V%M.53E9]TQR
MG(5/!"4K&9G$S&,RLN.U:-GQQ,R.2UEM[ZRV-*/MJS,CW]#[#E<L%J)FO)EL
MD6&RE6IIHXQW*@O[D(6-+BL3H7N+-.RBRM#,MU0#'PC7O0<-/*==(]\G'J1V
M36'JTO SS2>D!$T)FA(T)>@;)ZAOQJ\4^L80MV%,*T]GC_1M^?HOO1N,NC =
M&;$/,7=Z,MQ#].)NS$AGKZ\;8NQY]GK82+>X=I8Q,5//4P9^RPR\-')>KOUC
M3F*6]A9FIZ)VL**V?A+T0 S&:K2;E(O?#!>G!F,^YQH9"^?M& ,K-ON"YTS#
MP&ES1VUC@IXR^/%]:@=MU3IS_WI45?F?@R%K/$>8.IV<L=KSN_3\ZN&@$U69
M( XJY@HT^J^ND)]K.19QA: -N"D$U*HAS/%6[<,\F),RF8@ZGN 'F$X*C+@?
M"?( <;'#O#WTUB-)&3Q^\!R\!]1]O0?=O[+"BSQC"A?G=.E@2/:]_Z.MZ$*&
M+N4I\E3[+)C&_:LX/3JZ_CFEN2;]X8?K//#\><^)V%3O__ RP,$,A?\NV@PL
M'O >YJ@2[U;VHD*VL^2M/=O\HR@C+Q ]LI OB7*<1]21,S\-:89^RU*@([/4
M$:>J,^I(4"5!I3[!'3Q3^$9^Q;_0WSYG*0XIV]P0DG7H0R"^8)'1C\=C41A2
M/6$PEA5)&<VHSG H#M _*$-*'PM(RB=HY;,L^OH$R?X TF.4Q#UKAJAG1!E_
MY@89;?3WKL[I:"M(.>I(N>OHJX:JPWOPAYJ<I@NJ[/PS>@'L^H^B/L[MX2E/
M=<><.M5<Z\I2+7F0QRNO2^@HL?L$YY4YYC2!:BMYBOF*+,;@*5<H5JJ5//H\
M>J^H40/T[UGKT8#!HB(%-I X<:+AQ?'<A!NA=:/UH.=RHY$JC-!&X/?_>G5B
MS8-G<ZYHFB-MLP9Y3%<QD)>!?:7[ ="G4*$+]_?.3YJJ0R96%]%+D"<#JR=3
MO >(?Y1)+D=6:DWM[I64LW^UY]\O_. #I8LZ\ ^\&=M.\]59G^VL=.Y6K?Y#
M@'6NY.B"\Y.YZGOWHKT6ND1']?Z*I7*V4"@$^7YXMYPD"2.!GZ=3.22=8B$1
M1_]LG8K-@GXCV"1J()=%%:?XX!$C27,4^_"#"N4*K7W8[+P[M&SW'WY\HC]#
MJEM"G@RE*TBW/0K4T)"DS)2;@:6'M2-EH'-(TB?H*6.D>,Q_TBBB2["(*;)F
M2/ .)#^J@.<G4\^B/G:K$.H3_&*JIV/G&W7K&Y:RHDRUPDV0NM(S((<E)ELJ
M((7WB?&L%RT%::.^(AL:>1U'Z4@]"WC=_V5HS#_F.LE*%M^*'LI^IOY+5ROD
M%:HP505-P"=&E0H?3468T80G0>60 K0. /VOR%/]F6>/:%$7:M[13NY_Q-51
ME6_:4DW<F:*WX'=;BICX6KGC,8K!T",S\#L'<B-Q*N9/_ E1?C#D =3%H!U(
M\"1!@UA#U,;P,'W,Z98.1 2#5>%H$A&;4IYEHN^=W2XL&:P1TI%UZE(5AH*J
M"GRFJR.WE_KT/!8'8VIJ_1G9./@S>H>L(+9'7(<>;>AH+3)$9I_S"R&!*<T]
MURF..>1B#@;(V^=M^X%5'/[-D/')6_SH8KZA(&AY>%+&>E(?SN))T-P'X-"!
M:$T.,1-P#UHF!6M"+"$B891Y#<C)HXW!^>J:( VI)W&DJ(JAH??"J<-"5>&?
M@<X:+947M8FH:9QDGJ(F9,@KL#&"T!3(E:40R;K"5,?R2]$5RXZ[^6@H2F!I
M@;;:L\D$ Q '0357C?D=<>I40+84?545= 46/I ,'I\%.BE50-^9 K-F7(*,
M+/E4D#7"._K<L2-"/HED@_B4T0F04\NGCN2>G#U9H"2;24P9-OD#<>?$5"&(
MC?NB[M((&KACMA+'TN-H0NS-J0,1\:K[>ZHA$4\(/E/' HIV4G<^D:EKFH*^
MAC]M^9KU>MW6W<3! @9T^20N:[+@4E4CN%1ENF+::_S3FO;Z[$AX+(_&ES]_
MCY/A4I5S=,7Y*825CWR[ A9NF4LUE9 E!>6'% M2@V[+Z;4'JC+C)'TV9^XS
M9,THVD!:%?V5%W@PJ-H :453V:@"]K-Y]&=D3\E?+15C,1XL /EU ]U [#E5
M%602T:NPO=(HS>@_N%1>WF,X+'6?64?=F_9SM<;'NE.6!4)\R[_13-ND;5]#
M;EO=O!VM69^JHD2QEM:\E#B0*47BD27F#8A T1//=3YO*S'G([8N\PEY$<,C
M$ZKI'KNY- S.K!,&!ZYS24R<I;P1\/'O7($I50O9!5V<<8>['B?;5S,WUM+,
M4YF5RZ9^+A984S_CGU;J9V?;EHYN#\Y>_[P,6^<#-ADZ&OV7=7ZR=/3\PN?T
M=-B+CQS:I#;@8)/E>95-YRME)E!A(P&18)>N6)C:,!C>G'BM0N_YB#V9/HEL
M^( X5#P<B0H+5P1KQ<008XKRDX)B,:1RT-))P,--D6%Z0?1#IFJ&PD>;$L^*
M(8%UDR"'I"L9#JE#;%QP[.C82Q+)B)!,)W1#CT'*S1BB99,J-/#A0!,8&HCP
MA!N@2$Y09R24>48F%@P5"?FL6$0&HXI,Y  M5H- ?@;VDS>0#LN ID*QB0 7
M4.9?=8V$U'U50$^WS>]DBJPHQ!M/L&JL'$:*PL.I0(PM\Z0\CA>06I=')( V
M9%#NE" CXHU)7 T?_%0$-2J;ICZ?<2DX*Q6'E"I:S9/(PRO-$,5:'CD$07V"
MTP=J>&(D=(*$&'"*%HTH%"X)*/C4*7/_*(I9YB1X]7XLCD)@C-N1*>S.LR%"
M/A+G#X<0]&,:X[=I@K80"V;-4W#_#0)PM[;'6]5]#L'D5^%E(*"WVX&V9I('
M\4U_YCJC+-5'"H"GS,@1F4(#TA0BR!'PB<]IVN2#=>/$@P#QNF9Y@^Z@%?[9
M+7N$+QS>SPRX*>9?]"I(<Z"?W5)C/8(7-.1O<&"-;4XR U_T'9!#[+R1CU$0
M0HMH$UB_D64.<2Y%D3EH$\<1OJABL=4P6V>\P;=B$@"9?=W>'6Q#X#T^8=*#
MYGTY?H=P-O&[QKN^%[1O;P_X@O.@J0!AB3$"*TEC_<]X]?\ %),D65HX,*7N
MO?Z"U#!EY89)KC@XCYP1<&B/C9@"IJ:)%*)"<C-V0CQ/62E=TRACWU*6(1A'
M_@.GSGRC!3>T2!<^AB*7NLS?@OG!GB53J+#DFH4I5 OT_;W]\=YL*G2&=4#H
M&.$E>!U,9Y'V&DU/DSBG/? P.T,4,(EHP6B9WJ_#>5G'97FHC"*^3*:M7^WK
MH>VAUMU;7!5'S._0-VQ@X-J&+9"?JCFT9]-A#=Z1^8'%-7M]VG+D2S5F^:5:
M-N,A/G$BD'U&#J(F$.-'_DW#MM*32N9X$!K32@HO\ _$,]6Y%XH7AT/$>LCI
M1F>L"N*D;ZB:95+[@BP,1>+N9?!U#N3QZS@3Z<J4NZ7&RY#(VUE@R/)JAJRR
MM,F0M3TSI/K[\<_/ZO3?Y+IJ,Z2U:'R&SV&BV[!<6<VQ-/FI%BM7LI'!FIFE
M><E\IJZ[&($M^.E/')$]F8&3=7O$+4\XU\G'C@C+'1LJ<"@ZO;8B#\@OT!5%
MF*4&VFN/+-+HC1I_3HWR3XEQ=):Y32PS*^&X5V[6MZ:3(55X\7%)]-Z TE(N
M(9IC_@H6:S [!K&-&@H'" O9$?T"HS#W@IWC(!<8)XIJGA[F";9 %X@"80LL
MNU\%PDW_/+]>-AX4UZ6&N6I\ J96#>*1;J_;_;JP2U_]P9(*3?(3"^TAL7%&
MY$+A<FDI8T"R!-]F:D9?@^M:&4=M#6%@*A33M'CS!,A5FH@DBG0SE!W8^CE/
ME#"T<C(7W,PT66P^X^%(DO<"N46+ -84X,*$Z+*<QY?CJ E9H9F:.5(XE8=?
M&B@>'>B*BLQDU[,GDE\@"I+U*$B<4/"LP^L-HI5,[8H"Q^6$(+T_RWJ_Z1SH
M?%4$J:/R)L?F!<N-8MNU'G"L:+I&FW)5L>6J2A>C"X7<:CR67PRE6><<JVJO
M> !O7&E2O>L+DHB*+1'5'%IQ6(://HVIN-2-R^"+/ 4R+(B#>.C>=9RLU01B
M'<UW0;Y]9'X93L$RB6RAS!:B$^=D-BG\G/[JJRV;-A?>I6(*+=58/JL+Z$LH
ME%TV;!5=*M'=Z]IR180M#<Y0.ME)J"$R T-3$17SU(FA O6RD!U&[W@B%2;*
ME.2H7$\@_Y*ULVN6]H+:#Y7'+M!@#$51B.Z9Y4XR^IAP!.F]8Y=;/V_I: 8L
M752B/X^?[ZZ/^6&[ZUP-X/>:>45W0+%2-'W7N])FD9;&L)P0V:4M+_=5B/_!
MXLH@GTME7V4\IX2= BML0R"C[C$@R.H3>V':$&Q0X%G8[CQ!W3\4[RV6=E&D
MM LM<<@]*;;Q$22R2+C2=WY&3_T"B68SY6K>[^#[!-%F#+16RY2Z31Z7X4T[
M9B64%PP<?$P;@Q#T!409"""'(O'?P$9.IQ)2 .:-QLO,5?1"TNESY7G8%S30
MTJSU@U#PCBWM@%V +]C6C#>$.=/G%5YB8@//$'^:!_*A)4] %1.5ZR1[(.1%
MRQH*^/(8AWKFG<.0J "<"D([)]Q 7!2?]\'U3U\09$0<W5!E<M*8D]"1&'9Y
MLX&>K8JO<#3H%8AE-0TY(AD-RR#ZS'PAG[<>,-82AS1O&#IO"+XD4_"[-9K/
MZ.&RFXGI#.(J+AC"1%T:*K("FOL"TJ[>\GS +G[ FJ@E0ZU-\V\V<WY^;'^C
M"YQK]Q;8I0U3ZQVN6D-SYBE\9,'V5%RVQPP]M)Y2'^#+EDMR;X,<:3)%ZGXJ
ME^WZ@A)=,Z^H2\P:03E^DK71A<C+.Z@6+T/#!9O>AUA'@@[$,FJB/OA[^??Z
M;^_7<#[VPN$H1[9D'L8JL[;R*()*%$HYNF;]Q#B^SK)-FY]9V-.<$0P;L>?*
MP74,;& 3YT4^$V $ WG7+0'8A>*0A9%S2'<9,H_- 2],%40^WU2UF_&:VD!5
MGAODT^#9>O@L"=RE%OM/DD!?SJ:TS5UDU=8F5W&49X^^_O$6>"9T[<L2GJ$#
M62:#Q HY!&-!PJZ 0,[#JJDGG(+YP/P7AW7 [7"X0_9JKJDJ#@1B8@-Y#^GW
MJ0'5'7S&OE4_<!8;WOQI7!SWRRU7D]$!L%C8Z#DBBUE,0BHD^@(IY$'_A\RM
M@?Q0B2*->#7++D-9#@[P>,0=64H<6C=YR"6=2L3[1935S!.$) K4J>"KO@G$
MXMB;5*$."?U#9L@9DFXY8,3F$MMO\K2]+A5YLSAZ,DT^^:SE^]H2@._V>LY?
M(JG(AJ@Y-S?7N,J)[RF79I&NB^EHD\&MP+&X7@)]6ZQ^^L@/D2,VKMR6 U@=
MVCB<+9J57+Q9CD)*D3GGA6L)1OC#"[+Q9A1;].;D8Q"F:N24!PUQ[LKT:P"/
MDDIP.U/A"H1L?0M)(-#Q'1P,-<F]HEV_*B-Q)*U &H4+SA?OB8KYC#NM"Z^T
MWHZ<,O/J PGRLZ(^X@HBY1D%H6 FK C,<:JMU@BO<7#=G??(]A#EL+&Q'I%Q
M'H%";N%%&!BFN$/!E8(K_%8\&[E%) JVRR:Q_5+ZH)*LRB?D0@F:!E>B0Q$J
M#G'] ,D,P5XY.=.'XCAP10V2!;5MV-PRL+.*"P;)BY4!.JFY^&\)A@7=N'_]
MJ5ZV'E^:,[EQ,( (/H%BYOO_Y'+4B8A<C:_4)5*CW]"W(=\^0-^JE;Y1N&X8
M/8#*Y4QX&EY\"@NE3;:9TY6I6<=D_L'Z0AG7[V#4$ HR!B;""99#^!TM=&#]
M[GWE0)$D;JJAE5D_?4.4Y/4Q[+7PT:],*!@F&JW/%S/%'^QR@*-2S^L^_#C)
MN0_2.L)O%!B"KU1=Y?KBX!O51H)"CKFMP($6*^YO?;&^!O_D(*M8L"K?OZ"3
M]Z&!*G"/N;Z M MZ]A23T'WN99]S+QS*N7O.^#M'C570S/^YOK@OT,4//WI6
MN204/)/J+V[%R;G/&PB!^?J0$B:Q9GN"17.A[)"P?<SX+)?UZUZFU8H1667I
MCA)(!S_-LN.=(#JTVB>=ZXMZK]5I9]J='G7=O+II73<;5*M-75YWNI?-X]Y-
M]QV3:0\D07Y>AF;S\ZXATG8MY-^0A@OD_)!>J[Z!\^?OF$*^%=GAM9Q3MEV,
MN6$/.O:'R%@JS]B/Q2;+RAM#QPER/P6+N"3QX\9>4(41$!@Z5?P[-"G1S0V\
MBQLL9U=#_KB*D>[,Q!)Y)F36L^8U.O*399)@>H9/HG6B!^&6"ZLC8S(A;:Y0
MNHA63#KKX/9*>99QJ"&@(Y_@YD!HMY@Z38'=YK&]"]QE/12$KXEFTAUK#>*(
M4Q2&-U_')PN_D'#>FXEH[AFI$OX=FR"ISR%QKB_Q<:,<(J8USR+<?]P,#D@=
M2V!&PVQNMS"CR3CR(&C1:*N+'4ZTFBVPE7RE%.LJ]S(E:1LB/3=/:?U7F6JH
M4OVXW1,Z%T;F= 3 T\'&S;*^&U/6W /S,:GB:^GZ+9_QYI)L+72>&V*7:MI.
M[\:TXBT?[=X$/-STD_UKP/H NZW(4]J*D"=5LI,MSEL58:84BP"_2:G=V"QO
M\U1NK'A34*VCB>W9N&*&([J E$J8+7N>[KQ4&;PU99!+]<"VK??.1[]>B!HD
M0#A94 QM2ZY[XB<E)X.!H\Y43HAV8 I9.@97(9G#CW?N/\"LD4CGM9V1A[&3
M-;D#?PY,$<2Q@?@C_Q*;I>/)Z 4,YMGW%)[W?J\2_VUL$3K:>&$BVXA:GG9E
M[)*8B#3:>[Z+7;NX) A"*^Z[V(ZA9C@P?B82M"@/%'6JN("E^S, 0Z4D<2*2
MRD%KB"X&!E(,:!@D!#;O6]VTMR#="(BA65LHFAPS\WP[X_EV%M?Y0ULA&>AA
MUI%")Q[ KID%EU/HV==UI_.O+3QQ/$=="T^B9H*S&CI&<B17K^WK;EQ-;2D+
MQK0_1)-,U[S#KU21^2DP#B 19AR89N,P)>D/=9@(JGPMOLE:[)2E!(S7( A
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M&1)+3N#Z$8!2DVU4WV%/>2";+.)#>1%53>Y@2K5LH49;W &I//3L4K[RV>0
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M01O"?W5/!G:0>CW;<T\<LW)'Q4_<9[A^]_\&F:B1N3:0CBL5RG!EB3Z(8A=
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M!48JW!#.: 3H9OHDR-+_EZ+++QA9ZV(N*CN!:Z[D:ZFM13D7U=V"1*9+$C&
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MC#KVI&C^WD!*7?3J_2Y!/N?+A !JJ2@"Y.62&EO61,Z2>!Q2TA[*8E#7=L1
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MJ0]Z="X)N\%)ZD7_'3[*;%5>>Y<0:!(.XC#02;K4">9<@0*UMII8+NTFK:"
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M<8'EBG4W1]'T%LU"5N"9B7"'2P-P+(MAVY$G$,*N/K NQUE-&$H&<Q-$):9
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MSN)P&OI4=4Y\'V=YP/P-%:L?(H"++W4NRL'RHLB;X4:;\4:; ?MF["I^HDJ
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MG%I)H,;#:]N/Q1V*_AS<K <WZ\'->G"S6N"=.[A9]P3(@YO5+C>K=M^2<RY
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M27J/R((1V)A4/"<,O[WIBK9;="E7K^7ULJ92K1@:L$8M+ F^L7FH1ZL_9$V
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M;?7=!PQY#($X&HLCK7!9J=(UGK:UE*#.CB&ISA$(I>;'+"MD7&*RBJ0OK#;
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MB()^N#E$%!PB"@X1!<:]BH>(@D-$@?O8V>QX/$04'"(*#A$%AXB"0T3!(:+
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MIW#;C6*H.!&@_7@G/G0O6LHX_<2[HR088_+)'9!D;$ 8?1KTUN&>G2-8?>*
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M6X%(22VZ%D-84VNN$\3U#;.MZ*PO&[=FI'P[*EVJ) LVVQO+$VP/"2\1"1*
M10&_34+5TLEX/4PF_H&BEN%B>[J?#FCL3_+;$3Y+4_LH<?2,$_IG.(M3LI1E
M?W&;3W@*.%BZEV"F8$7:P8EE;,VC)T@4SF)%5'BM!Z_0T T4D'0(DP^#UMI9
MYQ+>^2CVZ-D>KKL#-'7//H!Y >?)H)"4)/T1)X_(#Z<A"D15Q@3-AZ_%(Y8K
M5B%Z("-@(!"LW/9U #5L^;;GQY"@9!PW*GE>L*L:<1TWE;Z3H7/SE>8 [L(%
MB(GF*_-KG!9$":5?:V6B<%XK.?/HA21J+B^>O_6Q^\DPSL)X-J:[:%$7L*VG
MAS?&Y&CHU^QZ=^S ;$)@&SO E 3&,^8E/O,(64XQR2]L8&SA/DYC*6-+P;-C
MX@(JCXQA]W<D7=X3+TX\/U>XDS@X]2(O]E5=[E_J+O=RY%$^]*@Z]HCN#Z/5
MZ/9XXS>E2Q3>C.&T-94 75(B>\BEULX:#SDL]D9B,H]3,[[N/2Z.SI=RYPKG
M9HO2'RJ<'RJ<'RJ<FZYP/IY.0Q\19E2<T^.+3_LEPI,9W,' F^ :BIN+^;'N
MTN_$]YE+.+GQEFP38)7V?)]NH<'7T'M@S\J&*#G+"&$17W%P3:WDX@?8^N@Z
MXN!G\K9&R4Z,*9SGS :E%:%/E/ *-]^0QRS\X"1=YSB-8WI6HGS1T\^IEX3"
M0*2/;T6!2&6L%3L@5#XY6GUSY*4C]M51_MD1CD?K#X_R+U>BDLQ<'57**(&2
MJXBKT FR)3V%XX?FSQBZ9M/ A.30H_$3UIR7>E&Q^L6@;FBLCTA:<WRZ7/_S
M/T)$*,GSY5=6FU0<H:3:W]BY3C^D@,HH"= B8V=-;2D$-OF2)@NRV)J6PYB)
MA6H)$H!P&T'9%#!E FDKCY6#:X.E\5=K<J_BQRQ-<I:/I/$^<"=#+X%VFY@
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MND3!Z?+"\^?;;6$ =Q[:E)^JY6E8#Y_6A4IPV=JJ4;?^8U+^5?2V2Z?A7-8
M)=X4+%3( 5G^GOT?*U%(?_/_ 5!+ P04    " "S@#9:53? Z;&%   WW0<
M%0   '-T<W,M,C R-# Y,S!?;&%B+GAM;.R]>W/D-K(G^O^-V.^ Z[DQX8F0
M;'>WYV'[S&Z47CVU1ZW22FI[YSA.."@25>*8199)EEJ:3W_Q(%DD\605"63U
MS(V[<]RJ3/"7P ^)5R+Q'__K99V@9YP7<9;^]8LW7WWS!<)IF$5QNOKK%Q_O
M3V?WY_/Y%Z@H@S0*DBS%?_TBS;[X7__S?_P_B/Q___'_GIZBJQ@GT??H(@M/
MY^DR^P'=!&O\/7J/4YP'99;_@'X,DBW]2W85)SA'Y]EZD^ 2DQ_XA[]'?_SJ
M[1\#='IJ4>Z/.(VR_./=O"GWJ2PWQ?=??_WITZ>OTNPY^)3EOQ9?A=G:KL#[
M,BBW15/:-R_?5/\?5_^/)$Y__9[^SV-08$3J*RV^?RGBOWY!OUM]]M.[K[)\
M]?7;;[YY\_7__7!]'S[A=7 :I[3>0OQ%K45+D>F]^>Z[[[YFO]:B@N3+8Y[4
MWWCW=0VG*9G\&FOD6TB*^/N"P;O.PJ!DS6[\#%)*T'^=UF*G]$^G;]Z>OGOS
MU4L1?5%7/JO!/$OP'5XB9N;WY>N&4*F(*1.^J/[VE..E'$R2YU]3_:]3O I*
M'-$/?4<_].9/]$._J_Y\'3SBY M$)0D_E'9]URFK4OK:-=A;G,=9=)GNA[JO
M[0D^Z3MY>8 !;7WG)CQD99#L!;ZMZ1SV#=ZOQG=Z[FN:^'F\7TVW-">!78J0
M!U>OO%X3^L=K\E\=B/BE) ,8CFJ0M B-!V9?8 -#5793>A9VRDVH-\]RT78Z
M,K(R"QQ^M<J>OXYP3,I^^RW]CU/Z'\QL\H]?+M,R+E]G493CHL!%]1\/I/S9
M2US413.[_OJ%C<+7?=!4=9;7R(,\-)A?27P=9F3PVI2G":]HKK[,L[4=CJJB
M,AOI7Y+'Y@N\:@D(A2D=,5)(MLU#/*AEV_985VP%<9T0%3I/P^GIQ_LO_B=7
M0HW62?V?B"JBGZGJ?__'U[MO.:#4V;:(4P+A/$O+("P_X/4CSB4&*^1<$4@+
ML^:-5 @$773(^BRI95$EC'[FXN,R8QD4CPS\MCA=!<&&TP,G95'_9<>3Z@^_
MS#X%>:3P-@H9%_S0PJ/<D IXYX4.59\33&9,+U&41<$:^)OOWGW#&OG^X?[^
MESM,EYKXOLS"7^\W22SW!WI1%TUN Y:VO$[..P$LP/5Y4$DC)HZ8/!SW0-?I
M>(W3\O*W+1GGZ"Y"EI)_%AIW8=!QZ3ZLX+?=B5;!.[N&H!0F*DP4[62GF)OL
M0[%;4@S.<QRQ#B!U3GI1EX32@6WS2"8'ACX:<'W6-**5>P+CF B/UUEJIHQ$
MSB5?E##;9!&$P#!%A:Q/$RXW,D<4\YD6IOOM8Q'F\8;NJ-[A$,?/P6."U?,;
M:U5G\YV!QC3S'TL][T3: ZR66VU]M"L CE\BJ_^8@@N2VR".YNEYL(G+(-'Z
M*(..T_66#?S.^DNGX)U^0U *Z[-&!U&ETSA%E1H@MH7A=KU-Z*;MHGS".9W=
MY?@)IT7\C.=IF*WEWG /?:<L'&I6AY&VRG#8.1"QP-3%^1S-RC*/'[<E<X=E
M1CB;DUD^'*K>X3*(4QQ=!GD:IZM"RTN5L$L2Z@&W&2>7!$,O+3QQ-X(+HUIZ
MZND<VP93G7=()9Q-SN30FCE8]V?OS:W&)-UYG.Z 8J]])C*OBZ,XR%_O@P0O
MEFRVI]MC4LL[W5\RP>[L+:F$O5/'%F&?2%0*9<MZW0>#2O/;A79L:?WNDBH"
MK#8UFA_!4*&/J-_TY'<X<XO;/-O@O'R])1#+61K1O<X-W1\]>S4<;5EINMU@
MM#:EN]]H5 -#+7NL?=)=9^GJ])I,BB/T0/X>TZGNK"AP"<7WG&WCA(9Q:AU0
M7\@EO>0 VTSJ2H AC126>,S.A>!XI@]!^$2FT_EKF^=:=F@U7%+% GJ;-QIQ
M,"0R8^PSJM% 04K61+7.Q 0K\K)%+O*O';'(/WZY(PAE@UKO-Q=DD<*AM.C\
MX)T ,C3"9+8,RK@HXS!(T <<%-L<\Z:><&@Q-/2'.(W7V[747TA^=]7@4EAU
MHW=^!-'P,D1"/^<R?OOUA^!%W]S=WYTUMPQ6T]SM'V$TMP21Z-9?1FUNQ=[6
M3YBLITO-@61/P-G.EA18L['5^=5[FRHA]1NUDIFZ46E(Q#:-<!K]%.0Y6<+(
MM[(-LLZ:V@2W:765( P"&-#)XE:X.*KEX2P*9FD91W&R+<E*]AZ'VSPN8UQ<
MOH3)-L+1%6D[>@*T+=E-L<6RWHF_Q?G]4Y#CLU=Y ;H(WBF_Z/1D</JJZYPE
M3O<Y[]W*G8W"^4-+ >TTI@V#9GO4"Q8X4LQL?+=!P9D#MP+>>'&MM'?.64,4
M%V?TA*%28FOQT=VZF3=#:0.$-8-( Y\S^U!F&L8</!&X)K"TFX%M 9?#K BL
M/2KN?O5.#B4DX>B ,F#ZR%0R3I)Q\;4H\9KY-KXD(?_% GN,Z\&A);B,4]W#
MM':XZ@!U[ZS:'[,D>)45@JI2N".J%JKTOUE):.REZPCW?AI_JW50$CFW]WL4
M,+MW>GI"WOEE0J:XNU.-96!(0D]K%\L9'557;*]<LP)5R+HDBQ9NFS!203"D
MT:$3W4]"M+,\8$NME@[S/>U_<S]4/@4IZBI-NRBC*\A;4CM/08%GJQQCY?FH
MA;R[R;4%[-WD6B/LG52V"(7)-55!M0YJE!RNQA:I9B(EE_.Q^A)@RE9=C1 0
M0JB1:5=91!C.Z%3G7)B%9/0LV%4.S?BDE'8;G:.%W W3D8IZYX\=/F5^C);X
MQ"-/L,2K(">+QHB>^,_34.-,E++N'(H![LZI* 2]$\,&G1A?S,51)7^"B 8<
M#W,5IV31QN(1YVE9!22R>$3][18+/9=>Q]J,MO\Q*GDGW%"D??)QO2K<=*?)
M TX!;2)>X#Q^9G/U>5J4^99.P^[B0G=[0J_BDGLVX-NTT\F#89P%R#[9=BIH
MIS/Q"-@<O U9@)F5W(V)M@;L!D>3AG<*#8(I#)>[H]0)5V8C.*S'<D=RK9L2
M!=TZ)Q70KDOJ2WEGD1&:Z'X>2X>.)XVSG)$51S>9[CQ$*>K0R6C!MER+5,X[
M%2S B6Z$2J-*'%%Y!S%U51HT;2Q=3\9E#)T47CMVKB, H]D5J"2Q<JA.0C=Q
M.U,N#9AM:,6=M;X%Z(8(&ED8G# #[-.#]7_G\PE#J/Q#7-(+RO,TBI_C:!LD
MBNLP"CE7H?-:F'4(O53(.UM,R/HT8;+L6.DV<[&!]S'-,4N9\O 4Y]%M0"^4
M5B3-->%95FK.7,L (QH78Z'CG3P#@?:YU&@BIHJ8+MHIPUG+4.=8Q95IM_PD
M<BY7,DJ8[86,(.2=1B9DTJ&J$IS\)/())\O%<HESU7UOM9C#@VHER-;YM"#C
MO>$-P,33:"*):E$XWL'&,WCT"D:/ -,;V'B"L9W ""E*Z/XNODV"4+WH,0F[
M342B ]S-/2*3!$,7+3QQ+<R$42,]^<['_/:2+,"OZ&4UFPN%.G%W^R%FT+NM
M$;6L=XI8 A1(0C00W37A.LZNHMQDZ4,>T 0G9J*H91WNF^CAMC9-Y((P^&%
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M;0>SBBL&V8*O>622!\$F2Y!]3O%W5#N+:Z;(WD7TF<VHG=Q>/<7K"#F>&4L
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M6OR) )D]DQG@"M]LUX\X7RR%ZQXZWS2P#)><V\N\-A,'%0"&G_N@%IX>JLI
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M%:1+%W%4[3&12C#<ZANQ<&#]84"%#.P<%B4?4T^Q-^>@;E/_7M !8_<A_OX
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MM"OB]BE6$5SW\=7=[V"&/PDH\8%5NY[I9H"C9-SMUY\_!?E*N1Y2"3L=?+2
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M0\NAB 5>1A'[/4A0V&;T2765US]-*0SV%)^J!EH"3HDF .LPJ?D5#E7ZD(0
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M5X7.6@5>(3Z4BD%E8#UZ7& R&N1L^)@5!2X+>K#.-R>2)/M$;ZSM-RQ9%0R
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MAVB<-BHPFH;>*F7G$+/H']N" 5LL/V11O(Q#9OHY<9<K<;?>4@]6DPT#+;V
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MQ]ZK+#_+TJTLQER0@%7G*GB*MW197,<CE_0R'E0YK,]PBI=Q6="WR(0JE\C
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M5',%8%"75Q5R%*UO8\'@CA\VY56C;G,S A(#./$/I8"^E*/@@)4)PYW <;"
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M 0=2*./+=+N+LI18&TNTODJJEWM6OF9\'7;Y_GM%4][.MHG.+"+SM1$L<_<
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M^,]OWGW_/0J?F9R3JY2L$Q"O:ZWQ^:V2&#G;:R24K'^/Q/KR'X]L_).W  9
MI\^^PM A9+L.IL&B]OWS>.T%D9C]@F;.<5PB1S7>"Z@HV3T1MZM7;J[PL<WQ
MAJR?=J=BD^.2ICJN;]>R!7Y+9:7&8B6%-6&8@MN54L$G+&9RLP60MS98JSN-
M:AP6434Q8T_8]Q=\#I>AMY)L&,TF0-:^0^:MD# LYM;\8S0\;K3$W"'ZL%I
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M=31X5;W"*3MA)U^8$&8 \\SW X<J73?%^#*(V';(^',6)T*7":'PMWMAYU9
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M20]%K]CZIS=\=9N>0YJ"H09#N)0)W62U&Y"(7\T3,MEK?>%.PV'<@-98G'L
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MA4;*MNT?D_*OJJ(G/8=S;)?H)3I0IAGE "G_PO^')^QCO_G_ 5!+ 0(4 Q0
M   ( +* -EI.5BD>>[$  "<K!0 )              "  0    !E>#$M,2YH
M=&U02P$"% ,4    " "R@#9:_%&O^Z%D   GY ( "P              @ &B
ML0  97@Q,"TS-BYH=&U02P$"% ,4    " "R@#9:'0AOC58)  !MA0  "0
M            @ %L%@$ 97@Q,#<N:'1M4$L! A0#%     @ LH V6O^/_L+S
M P  WQ0   H              ( !Z1\! &5X,C,M,2YH=&U02P$"% ,4
M" "R@#9:C]-N.*L$  "W'@  "@              @ $$) $ 97@R,RTR+FAT
M;5!+ 0(4 Q0    ( +* -EHYVV$C# <  /5N   *              "  =<H
M 0!E>#(T+3$N:'1M4$L! A0#%     @ LH V6JSH/<^).P  \$$"  D
M         ( !"S ! &5X,RTQ+FAT;5!+ 0(4 Q0    ( +* -EKXLT%7Y T
M +55   )              "  ;MK 0!E>#4M,2YH=&U02P$"% ,4    " "R
M@#9:)CQ:GU<J  " *P  $               @ '&>0$ 9F]R;3$P+6M?,# Q
M+FIP9U!+ 0(4 Q0    ( +* -EK >C/PUR$  *XB   0              "
M 4ND 0!F;W)M,3 M:U\P,#(N:G!G4$L! A0#%     @ LH V6KJOOE V$0
MVA$  !               ( !4,8! &9O<FTQ,"UK7S P-"YJ<&=02P$"% ,4
M    " "R@#9:?,G!U*,/  !@$   $               @ &TUP$ 9F]R;3$P
M+6M?,# U+FIP9U!+ 0(4 Q0    ( +* -EJ[G2 !OQD  (@:   /
M      "  87G 0!F;W)M<RTQ7S P,2YJ<&=02P$"% ,4    " "R@#9:'C^G
MH[44  " %P  #P              @ %Q 0( 9F]R;7,M,5\P,#(N:G!G4$L!
M A0#%     @ LH V6CE$;]2$V0, .U,M  P              ( !4Q8" &9O
M<FUS+3%A+FAT;5!+ 0(4 Q0    ( +. -EJ< 1(7(10  -CZ   1
M      "  0'P!0!S='-S+3(P,C0P.3,P+GAS9%!+ 0(4 Q0    ( +. -EH6
M*/]E"Q<  $U$ 0 5              "  5$$!@!S='-S+3(P,C0P.3,P7V-A
M;"YX;6Q02P$"% ,4    " "S@#9:5FR0ZDI.  "2>P4 %0
M@ &/&P8 <W1S<RTR,#(T,#DS,%]D968N>&UL4$L! A0#%     @ LX V6E4W
MP.FQA0  -]T' !4              ( !#&H& '-T<W,M,C R-# Y,S!?;&%B
M+GAM;%!+ 0(4 Q0    ( +. -EK%<$.Z4EX  $"C!@ 5              "
M ?#O!@!S='-S+3(P,C0P.3,P7W!R92YX;6Q02P4&     !0 % "T!   =4X'
#

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>102
<FILENAME>forms-1a_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:STSS="http://sharpstechnology.com/20240930"
  xmlns:dei="http://xbrl.sec.gov/dei/2024"
  xmlns:iso4217="http://www.xbrl.org/2003/iso4217"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:srt="http://fasb.org/srt/2024"
  xmlns:us-gaap="http://fasb.org/us-gaap/2024"
  xmlns:xbrldi="http://xbrl.org/2006/xbrldi"
  xmlns:xlink="http://www.w3.org/1999/xlink"
  xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
    <link:schemaRef xlink:href="stss-20240930.xsd" xlink:type="simple"/>
    <context id="From2024-01-01to2024-09-30">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001737995</identifier>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-09-30</endDate>
        </period>
    </context>
    <context id="From2024-01-012024-09-30_dei_BusinessContactMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001737995</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:EntityAddressesAddressTypeAxis">dei:BusinessContactMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-09-30</endDate>
        </period>
    </context>
    <context id="AsOf2023-12-31">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001737995</identifier>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="AsOf2022-12-31">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001737995</identifier>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="AsOf2023-12-31_custom_ReverseStockSplitMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001737995</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">STSS:ReverseStockSplitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="AsOf2022-12-31_custom_ReverseStockSplitMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001737995</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">STSS:ReverseStockSplitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="AsOf2024-09-30">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001737995</identifier>
        </entity>
        <period>
            <instant>2024-09-30</instant>
        </period>
    </context>
    <context id="From2023-01-012023-12-31">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001737995</identifier>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="From2022-01-012022-12-31">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001737995</identifier>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="From2024-07-012024-09-30">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001737995</identifier>
        </entity>
        <period>
            <startDate>2024-07-01</startDate>
            <endDate>2024-09-30</endDate>
        </period>
    </context>
    <context id="From2023-07-012023-09-30">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001737995</identifier>
        </entity>
        <period>
            <startDate>2023-07-01</startDate>
            <endDate>2023-09-30</endDate>
        </period>
    </context>
    <context id="From2023-01-012023-09-30">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001737995</identifier>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-09-30</endDate>
        </period>
    </context>
    <context id="AsOf2021-12-31_us-gaap_PreferredStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001737995</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="AsOf2021-12-31_us-gaap_CommonStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001737995</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="AsOf2021-12-31_custom_CommonStockSubscriptionReceivableMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001737995</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">STSS:CommonStockSubscriptionReceivableMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="AsOf2021-12-31_us-gaap_AdditionalPaidInCapitalMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001737995</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="AsOf2021-12-31_us-gaap_AccumulatedOtherComprehensiveIncomeMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001737995</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="AsOf2021-12-31_us-gaap_RetainedEarningsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001737995</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="AsOf2021-12-31">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001737995</identifier>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="AsOf2022-12-31_custom_ReverseStockSplitMember_us-gaap_PreferredStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001737995</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="STSS:AwardsTypeAxis">STSS:ReverseStockSplitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="AsOf2022-12-31_custom_ReverseStockSplitMember_us-gaap_CommonStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001737995</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="STSS:AwardsTypeAxis">STSS:ReverseStockSplitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="AsOf2022-12-31_custom_ReverseStockSplitMember_custom_CommonStockSubscriptionReceivableMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001737995</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">STSS:CommonStockSubscriptionReceivableMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="STSS:AwardsTypeAxis">STSS:ReverseStockSplitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="AsOf2022-12-31_custom_ReverseStockSplitMember_us-gaap_AdditionalPaidInCapitalMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001737995</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="STSS:AwardsTypeAxis">STSS:ReverseStockSplitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="AsOf2022-12-31_custom_ReverseStockSplitMember_us-gaap_AccumulatedOtherComprehensiveIncomeMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001737995</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="STSS:AwardsTypeAxis">STSS:ReverseStockSplitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="AsOf2022-12-31_custom_ReverseStockSplitMember_us-gaap_RetainedEarningsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001737995</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="STSS:AwardsTypeAxis">STSS:ReverseStockSplitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="AsOf2022-12-31_custom_ReverseStockSplitMember10880671">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001737995</identifier>
            <segment>
                <xbrldi:explicitMember dimension="STSS:AwardsTypeAxis">STSS:ReverseStockSplitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="AsOf2022-12-31_us-gaap_PreferredStockMember_custom_ReverseStockSplitMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001737995</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">STSS:ReverseStockSplitMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="AsOf2022-12-31_us-gaap_CommonStockMember_custom_ReverseStockSplitMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001737995</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">STSS:ReverseStockSplitMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="AsOf2023-12-31_us-gaap_PreferredStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001737995</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="AsOf2023-12-31_us-gaap_CommonStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001737995</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="AsOf2023-12-31_custom_CommonStockSubscriptionReceivableMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001737995</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">STSS:CommonStockSubscriptionReceivableMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="AsOf2023-12-31_us-gaap_AdditionalPaidInCapitalMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001737995</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="AsOf2023-12-31_us-gaap_AccumulatedOtherComprehensiveIncomeMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001737995</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="AsOf2023-12-31_us-gaap_RetainedEarningsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001737995</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="AsOf2024-03-31_us-gaap_PreferredStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001737995</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-03-31</instant>
        </period>
    </context>
    <context id="AsOf2024-03-31_us-gaap_CommonStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001737995</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-03-31</instant>
        </period>
    </context>
    <context id="AsOf2024-03-31_custom_CommonStockSubscriptionReceivableMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001737995</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">STSS:CommonStockSubscriptionReceivableMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-03-31</instant>
        </period>
    </context>
    <context id="AsOf2024-03-31_us-gaap_AdditionalPaidInCapitalMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001737995</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-03-31</instant>
        </period>
    </context>
    <context id="AsOf2024-03-31_us-gaap_AccumulatedOtherComprehensiveIncomeMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001737995</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-03-31</instant>
        </period>
    </context>
    <context id="AsOf2024-03-31_us-gaap_RetainedEarningsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001737995</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-03-31</instant>
        </period>
    </context>
    <context id="AsOf2024-03-31">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001737995</identifier>
        </entity>
        <period>
            <instant>2024-03-31</instant>
        </period>
    </context>
    <context id="AsOf2024-06-30_us-gaap_PreferredStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001737995</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-06-30</instant>
        </period>
    </context>
    <context id="AsOf2024-06-30_us-gaap_CommonStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001737995</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-06-30</instant>
        </period>
    </context>
    <context id="AsOf2024-06-30_custom_CommonStockSubscriptionReceivableMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001737995</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">STSS:CommonStockSubscriptionReceivableMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-06-30</instant>
        </period>
    </context>
    <context id="AsOf2024-06-30_us-gaap_AdditionalPaidInCapitalMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001737995</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-06-30</instant>
        </period>
    </context>
    <context id="AsOf2024-06-30_us-gaap_AccumulatedOtherComprehensiveIncomeMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001737995</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-06-30</instant>
        </period>
    </context>
    <context id="AsOf2024-06-30_us-gaap_RetainedEarningsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001737995</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-06-30</instant>
        </period>
    </context>
    <context id="AsOf2024-06-30">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001737995</identifier>
        </entity>
        <period>
            <instant>2024-06-30</instant>
        </period>
    </context>
    <context id="AsOf2022-12-31_us-gaap_PreferredStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001737995</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="AsOf2022-12-31_us-gaap_CommonStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001737995</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="AsOf2022-12-31_custom_CommonStockSubscriptionReceivableMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001737995</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">STSS:CommonStockSubscriptionReceivableMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="AsOf2022-12-31_us-gaap_AdditionalPaidInCapitalMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001737995</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="AsOf2022-12-31_us-gaap_AccumulatedOtherComprehensiveIncomeMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001737995</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="AsOf2022-12-31_us-gaap_RetainedEarningsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001737995</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="AsOf2023-03-31_us-gaap_PreferredStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001737995</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="AsOf2023-03-31_us-gaap_CommonStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001737995</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="AsOf2023-03-31_custom_CommonStockSubscriptionReceivableMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001737995</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">STSS:CommonStockSubscriptionReceivableMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="AsOf2023-03-31_us-gaap_AdditionalPaidInCapitalMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001737995</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="AsOf2023-03-31_us-gaap_AccumulatedOtherComprehensiveIncomeMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001737995</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="AsOf2023-03-31_us-gaap_RetainedEarningsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001737995</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="AsOf2023-03-31">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001737995</identifier>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="AsOf2023-06-30_us-gaap_PreferredStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001737995</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-06-30</instant>
        </period>
    </context>
    <context id="AsOf2023-06-30_us-gaap_CommonStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001737995</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-06-30</instant>
        </period>
    </context>
    <context id="AsOf2023-06-30_custom_CommonStockSubscriptionReceivableMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001737995</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">STSS:CommonStockSubscriptionReceivableMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-06-30</instant>
        </period>
    </context>
    <context id="AsOf2023-06-30_us-gaap_AdditionalPaidInCapitalMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001737995</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-06-30</instant>
        </period>
    </context>
    <context id="AsOf2023-06-30_us-gaap_AccumulatedOtherComprehensiveIncomeMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001737995</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-06-30</instant>
        </period>
    </context>
    <context id="AsOf2023-06-30_us-gaap_RetainedEarningsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001737995</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-06-30</instant>
        </period>
    </context>
    <context id="AsOf2023-06-30">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001737995</identifier>
        </entity>
        <period>
            <instant>2023-06-30</instant>
        </period>
    </context>
    <context id="From2022-01-012022-12-31_us-gaap_PreferredStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001737995</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="From2022-01-012022-12-31_us-gaap_CommonStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001737995</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="From2022-01-012022-12-31_custom_CommonStockSubscriptionReceivableMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001737995</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">STSS:CommonStockSubscriptionReceivableMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="From2022-01-012022-12-31_us-gaap_AdditionalPaidInCapitalMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001737995</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="From2022-01-012022-12-31_us-gaap_AccumulatedOtherComprehensiveIncomeMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001737995</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="From2022-01-012022-12-31_us-gaap_RetainedEarningsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001737995</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="From2023-01-012023-12-31_custom_ReverseStockSplitMember_us-gaap_PreferredStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001737995</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="STSS:AwardsTypeAxis">STSS:ReverseStockSplitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="From2023-01-012023-12-31_custom_ReverseStockSplitMember_us-gaap_CommonStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001737995</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="STSS:AwardsTypeAxis">STSS:ReverseStockSplitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="From2023-01-012023-12-31_custom_ReverseStockSplitMember_custom_CommonStockSubscriptionReceivableMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001737995</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">STSS:CommonStockSubscriptionReceivableMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="STSS:AwardsTypeAxis">STSS:ReverseStockSplitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="From2023-01-012023-12-31_custom_ReverseStockSplitMember_us-gaap_AdditionalPaidInCapitalMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001737995</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="STSS:AwardsTypeAxis">STSS:ReverseStockSplitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="From2023-01-012023-12-31_custom_ReverseStockSplitMember_us-gaap_AccumulatedOtherComprehensiveIncomeMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001737995</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="STSS:AwardsTypeAxis">STSS:ReverseStockSplitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="From2023-01-012023-12-31_custom_ReverseStockSplitMember_us-gaap_RetainedEarningsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001737995</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="STSS:AwardsTypeAxis">STSS:ReverseStockSplitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="From2023-01-012023-12-31_custom_ReverseStockSplitMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001737995</identifier>
            <segment>
                <xbrldi:explicitMember dimension="STSS:AwardsTypeAxis">STSS:ReverseStockSplitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="From2023-01-012023-12-31_us-gaap_CommonStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001737995</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="From2024-01-012024-03-31_us-gaap_PreferredStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001737995</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-03-31</endDate>
        </period>
    </context>
    <context id="From2024-01-012024-03-31_us-gaap_CommonStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001737995</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-03-31</endDate>
        </period>
    </context>
    <context id="From2024-01-012024-03-31_custom_CommonStockSubscriptionReceivableMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001737995</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">STSS:CommonStockSubscriptionReceivableMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-03-31</endDate>
        </period>
    </context>
    <context id="From2024-01-012024-03-31_us-gaap_AdditionalPaidInCapitalMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001737995</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-03-31</endDate>
        </period>
    </context>
    <context id="From2024-01-012024-03-31_us-gaap_AccumulatedOtherComprehensiveIncomeMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001737995</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-03-31</endDate>
        </period>
    </context>
    <context id="From2024-01-012024-03-31_us-gaap_RetainedEarningsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001737995</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-03-31</endDate>
        </period>
    </context>
    <context id="From2024-01-012024-03-31">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001737995</identifier>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-03-31</endDate>
        </period>
    </context>
    <context id="From2024-04-012024-06-30_us-gaap_PreferredStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001737995</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-04-01</startDate>
            <endDate>2024-06-30</endDate>
        </period>
    </context>
    <context id="From2024-04-012024-06-30_us-gaap_CommonStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001737995</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-04-01</startDate>
            <endDate>2024-06-30</endDate>
        </period>
    </context>
    <context id="From2024-04-012024-06-30_custom_CommonStockSubscriptionReceivableMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001737995</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">STSS:CommonStockSubscriptionReceivableMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-04-01</startDate>
            <endDate>2024-06-30</endDate>
        </period>
    </context>
    <context id="From2024-04-012024-06-30_us-gaap_AdditionalPaidInCapitalMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001737995</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-04-01</startDate>
            <endDate>2024-06-30</endDate>
        </period>
    </context>
    <context id="From2024-04-012024-06-30_us-gaap_AccumulatedOtherComprehensiveIncomeMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001737995</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-04-01</startDate>
            <endDate>2024-06-30</endDate>
        </period>
    </context>
    <context id="From2024-04-012024-06-30_us-gaap_RetainedEarningsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001737995</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-04-01</startDate>
            <endDate>2024-06-30</endDate>
        </period>
    </context>
    <context id="From2024-04-012024-06-30">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001737995</identifier>
        </entity>
        <period>
            <startDate>2024-04-01</startDate>
            <endDate>2024-06-30</endDate>
        </period>
    </context>
    <context id="From2024-07-012024-09-30_us-gaap_PreferredStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001737995</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-07-01</startDate>
            <endDate>2024-09-30</endDate>
        </period>
    </context>
    <context id="From2024-07-012024-09-30_us-gaap_CommonStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001737995</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-07-01</startDate>
            <endDate>2024-09-30</endDate>
        </period>
    </context>
    <context id="From2024-07-012024-09-30_custom_CommonStockSubscriptionReceivableMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001737995</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">STSS:CommonStockSubscriptionReceivableMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-07-01</startDate>
            <endDate>2024-09-30</endDate>
        </period>
    </context>
    <context id="From2024-07-012024-09-30_us-gaap_AdditionalPaidInCapitalMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001737995</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-07-01</startDate>
            <endDate>2024-09-30</endDate>
        </period>
    </context>
    <context id="From2024-07-012024-09-30_us-gaap_AccumulatedOtherComprehensiveIncomeMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001737995</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-07-01</startDate>
            <endDate>2024-09-30</endDate>
        </period>
    </context>
    <context id="From2024-07-012024-09-30_us-gaap_RetainedEarningsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001737995</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-07-01</startDate>
            <endDate>2024-09-30</endDate>
        </period>
    </context>
    <context id="From2023-01-012023-03-31_us-gaap_PreferredStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001737995</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="From2023-01-012023-03-31_us-gaap_CommonStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001737995</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="From2023-01-012023-03-31_custom_CommonStockSubscriptionReceivableMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001737995</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">STSS:CommonStockSubscriptionReceivableMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="From2023-01-012023-03-31_us-gaap_AdditionalPaidInCapitalMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001737995</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="From2023-01-012023-03-31_us-gaap_AccumulatedOtherComprehensiveIncomeMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001737995</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="From2023-01-012023-03-31_us-gaap_RetainedEarningsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001737995</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="From2023-01-012023-03-31">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001737995</identifier>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="From2023-04-012023-06-30_us-gaap_PreferredStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001737995</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-04-01</startDate>
            <endDate>2023-06-30</endDate>
        </period>
    </context>
    <context id="From2023-04-012023-06-30_us-gaap_CommonStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001737995</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-04-01</startDate>
            <endDate>2023-06-30</endDate>
        </period>
    </context>
    <context id="From2023-04-012023-06-30_custom_CommonStockSubscriptionReceivableMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001737995</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">STSS:CommonStockSubscriptionReceivableMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-04-01</startDate>
            <endDate>2023-06-30</endDate>
        </period>
    </context>
    <context id="From2023-04-012023-06-30_us-gaap_AdditionalPaidInCapitalMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001737995</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-04-01</startDate>
            <endDate>2023-06-30</endDate>
        </period>
    </context>
    <context id="From2023-04-012023-06-30_us-gaap_AccumulatedOtherComprehensiveIncomeMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001737995</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-04-01</startDate>
            <endDate>2023-06-30</endDate>
        </period>
    </context>
    <context id="From2023-04-012023-06-30_us-gaap_RetainedEarningsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001737995</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-04-01</startDate>
            <endDate>2023-06-30</endDate>
        </period>
    </context>
    <context id="From2023-04-012023-06-30">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001737995</identifier>
        </entity>
        <period>
            <startDate>2023-04-01</startDate>
            <endDate>2023-06-30</endDate>
        </period>
    </context>
    <context id="From2023-07-012023-09-30_us-gaap_PreferredStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001737995</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-07-01</startDate>
            <endDate>2023-09-30</endDate>
        </period>
    </context>
    <context id="From2023-07-012023-09-30_us-gaap_CommonStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001737995</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-07-01</startDate>
            <endDate>2023-09-30</endDate>
        </period>
    </context>
    <context id="From2023-07-012023-09-30_custom_CommonStockSubscriptionReceivableMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001737995</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">STSS:CommonStockSubscriptionReceivableMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-07-01</startDate>
            <endDate>2023-09-30</endDate>
        </period>
    </context>
    <context id="From2023-07-012023-09-30_us-gaap_AdditionalPaidInCapitalMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001737995</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-07-01</startDate>
            <endDate>2023-09-30</endDate>
        </period>
    </context>
    <context id="From2023-07-012023-09-30_us-gaap_AccumulatedOtherComprehensiveIncomeMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001737995</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-07-01</startDate>
            <endDate>2023-09-30</endDate>
        </period>
    </context>
    <context id="From2023-07-012023-09-30_us-gaap_RetainedEarningsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001737995</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-07-01</startDate>
            <endDate>2023-09-30</endDate>
        </period>
    </context>
    <context id="AsOf2023-12-31_custom_ReverseStockSplitMember_us-gaap_PreferredStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001737995</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">STSS:ReverseStockSplitMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="AsOf2023-12-31_custom_ReverseStockSplitMember_us-gaap_CommonStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001737995</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">STSS:ReverseStockSplitMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="AsOf2023-12-31_custom_ReverseStockSplitMember_custom_CommonStockSubscriptionReceivableMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001737995</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">STSS:ReverseStockSplitMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">STSS:CommonStockSubscriptionReceivableMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="AsOf2023-12-31_custom_ReverseStockSplitMember_us-gaap_AdditionalPaidInCapitalMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001737995</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">STSS:ReverseStockSplitMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="AsOf2023-12-31_custom_ReverseStockSplitMember_us-gaap_AccumulatedOtherComprehensiveIncomeMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001737995</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">STSS:ReverseStockSplitMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="AsOf2023-12-31_custom_ReverseStockSplitMember_us-gaap_RetainedEarningsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001737995</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">STSS:ReverseStockSplitMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="AsOf2024-09-30_us-gaap_PreferredStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001737995</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-09-30</instant>
        </period>
    </context>
    <context id="AsOf2024-09-30_us-gaap_CommonStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001737995</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-09-30</instant>
        </period>
    </context>
    <context id="AsOf2024-09-30_custom_CommonStockSubscriptionReceivableMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001737995</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">STSS:CommonStockSubscriptionReceivableMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-09-30</instant>
        </period>
    </context>
    <context id="AsOf2024-09-30_us-gaap_AdditionalPaidInCapitalMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001737995</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-09-30</instant>
        </period>
    </context>
    <context id="AsOf2024-09-30_us-gaap_AccumulatedOtherComprehensiveIncomeMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001737995</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-09-30</instant>
        </period>
    </context>
    <context id="AsOf2024-09-30_us-gaap_RetainedEarningsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001737995</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-09-30</instant>
        </period>
    </context>
    <context id="AsOf2023-09-30_us-gaap_PreferredStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001737995</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-09-30</instant>
        </period>
    </context>
    <context id="AsOf2023-09-30_us-gaap_CommonStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001737995</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-09-30</instant>
        </period>
    </context>
    <context id="AsOf2023-09-30_custom_CommonStockSubscriptionReceivableMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001737995</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">STSS:CommonStockSubscriptionReceivableMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-09-30</instant>
        </period>
    </context>
    <context id="AsOf2023-09-30_us-gaap_AdditionalPaidInCapitalMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001737995</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-09-30</instant>
        </period>
    </context>
    <context id="AsOf2023-09-30_us-gaap_AccumulatedOtherComprehensiveIncomeMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001737995</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-09-30</instant>
        </period>
    </context>
    <context id="AsOf2023-09-30_us-gaap_RetainedEarningsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001737995</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-09-30</instant>
        </period>
    </context>
    <context id="AsOf2023-09-30">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001737995</identifier>
        </entity>
        <period>
            <instant>2023-09-30</instant>
        </period>
    </context>
    <context id="From2022-04-172022-04-19_us-gaap_IPOMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001737995</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:IPOMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-17</startDate>
            <endDate>2022-04-19</endDate>
        </period>
    </context>
    <context id="From2024-10-062024-10-16">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001737995</identifier>
        </entity>
        <period>
            <startDate>2024-10-06</startDate>
            <endDate>2024-10-16</endDate>
        </period>
    </context>
    <context id="AsOf2023-12-31_us-gaap_BuildingMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001737995</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:BuildingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="AsOf2023-12-31_us-gaap_MachineryAndEquipmentMember_srt_MinimumMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001737995</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:MachineryAndEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="AsOf2023-12-31_us-gaap_MachineryAndEquipmentMember_srt_MaximumMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001737995</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:MachineryAndEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="AsOf2023-12-31_custom_WebsiteMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001737995</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">STSS:WebsiteMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="From2023-01-012023-12-31_custom_PrefundendWarrantsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001737995</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">STSS:PrefundendWarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="From2023-01-012023-12-31_custom_StockOptionsAndWarrantsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001737995</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">STSS:StockOptionsAndWarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="AsOf2024-09-30_us-gaap_BuildingMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001737995</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:BuildingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-09-30</instant>
        </period>
    </context>
    <context id="AsOf2024-09-30_us-gaap_MachineryAndEquipmentMember_srt_MinimumMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001737995</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:MachineryAndEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-09-30</instant>
        </period>
    </context>
    <context id="AsOf2024-09-30_us-gaap_MachineryAndEquipmentMember_srt_MaximumMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001737995</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:MachineryAndEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-09-30</instant>
        </period>
    </context>
    <context id="AsOf2024-09-30_custom_WebsiteMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001737995</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">STSS:WebsiteMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-09-30</instant>
        </period>
    </context>
    <context id="From2024-01-012024-09-30_custom_StockOptionAndWarrantsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001737995</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">STSS:StockOptionAndWarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-09-30</endDate>
        </period>
    </context>
    <context id="AsOf2023-12-31_us-gaap_LandMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001737995</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:LandMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="AsOf2022-12-31_us-gaap_LandMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001737995</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:LandMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="AsOf2022-12-31_us-gaap_BuildingMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001737995</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:BuildingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="AsOf2023-12-31_us-gaap_MachineryAndEquipmentMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001737995</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:MachineryAndEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="AsOf2022-12-31_us-gaap_MachineryAndEquipmentMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001737995</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:MachineryAndEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="AsOf2023-12-31_custom_ComputerSystemsAndWebsiteAndOtherWebsiteMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001737995</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">STSS:ComputerSystemsAndWebsiteAndOtherWebsiteMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="AsOf2022-12-31_custom_ComputerSystemsAndWebsiteAndOtherWebsiteMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001737995</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">STSS:ComputerSystemsAndWebsiteAndOtherWebsiteMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="From2023-10-012023-12-31_us-gaap_MachineryAndEquipmentMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001737995</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:MachineryAndEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-10-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="From2022-01-012022-12-31_us-gaap_StockOptionMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001737995</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:StockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="From2020-06-012020-06-30_custom_SharePurchaseAgreementMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001737995</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">STSS:SharePurchaseAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-06-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="From2020-06-012020-06-30_custom_SharePurchaseAgreementMember_us-gaap_CommonStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001737995</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">STSS:SharePurchaseAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-06-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="AsOf2020-06-30_custom_SharePurchaseAgreementMember_us-gaap_CommonStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001737995</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">STSS:SharePurchaseAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-06-30</instant>
        </period>
    </context>
    <context id="From2020-06-012020-06-30_custom_SharePurchaseAgreementMember_us-gaap_StockOptionMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001737995</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:StockOptionMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">STSS:SharePurchaseAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-06-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="From2020-06-012020-06-30_custom_SharePurchaseAgreementMember_custom_StockOptionOneMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001737995</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">STSS:StockOptionOneMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">STSS:SharePurchaseAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-06-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="From2022-07-052022-07-06_custom_SharePurchaseAgreementMember_custom_StockOptionOneMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001737995</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">STSS:StockOptionOneMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">STSS:SharePurchaseAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-05</startDate>
            <endDate>2022-07-06</endDate>
        </period>
    </context>
    <context id="From2022-01-012022-12-31_custom_SharePurchaseAgreementMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001737995</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">STSS:SharePurchaseAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="AsOf2022-07-06_custom_SafegardMedicalIncMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001737995</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">STSS:SafegardMedicalIncMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-07-06</instant>
        </period>
    </context>
    <context id="From2022-07-052022-07-06_custom_SafegardMedicalIncMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001737995</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">STSS:SafegardMedicalIncMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-05</startDate>
            <endDate>2022-07-06</endDate>
        </period>
    </context>
    <context id="AsOf2023-12-31_us-gaap_FiniteLivedIntangibleAssetsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001737995</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:FiniteLivedIntangibleAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="From2020-06-012020-06-30_custom_SafegardMedicalIncMember_custom_SharePurchaseAgreementMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001737995</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">STSS:SafegardMedicalIncMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">STSS:SharePurchaseAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-06-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="From2020-06-012020-06-30_custom_SafegardMedicalIncMember_custom_SharePurchaseAgreementMember_us-gaap_CommonStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001737995</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">STSS:SafegardMedicalIncMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">STSS:SharePurchaseAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-06-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="From2020-06-012020-06-30_custom_SafegardMedicalIncMember_custom_SharePurchaseAgreementMember_us-gaap_StockOptionMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001737995</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">STSS:SafegardMedicalIncMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:StockOptionMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">STSS:SharePurchaseAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-06-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="AsOf2022-07-06_custom_SafegardMedicalIncMember_us-gaap_BuildingMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001737995</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">STSS:SafegardMedicalIncMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:BuildingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-07-06</instant>
        </period>
    </context>
    <context id="AsOf2022-07-06_custom_SafegardMedicalIncMember_us-gaap_MachineryAndEquipmentMember_srt_MinimumMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001737995</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">STSS:SafegardMedicalIncMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:MachineryAndEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-07-06</instant>
        </period>
    </context>
    <context id="AsOf2022-07-06_custom_SafegardMedicalIncMember_us-gaap_MachineryAndEquipmentMember_srt_MaximumMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001737995</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">STSS:SafegardMedicalIncMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:MachineryAndEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-07-06</instant>
        </period>
    </context>
    <context id="AsOf2024-09-20_custom_SecuritiesPurchaseAgreementMember_custom_SeniorSecuredNoteMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001737995</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">STSS:SeniorSecuredNoteMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">STSS:SecuritiesPurchaseAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-09-20</instant>
        </period>
    </context>
    <context id="From2024-09-202024-09-20_custom_SecuritiesPurchaseAgreementMember_custom_SeniorSecuredNoteMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001737995</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">STSS:SeniorSecuredNoteMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">STSS:SecuritiesPurchaseAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-09-20</startDate>
            <endDate>2024-09-20</endDate>
        </period>
    </context>
    <context id="From2024-09-202024-09-20_custom_SecuritiesPurchaseAgreementMember_custom_SeniorSecuredNoteMember_custom_PreReverseMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001737995</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">STSS:PreReverseMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">STSS:SeniorSecuredNoteMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">STSS:SecuritiesPurchaseAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-09-20</startDate>
            <endDate>2024-09-20</endDate>
        </period>
    </context>
    <context id="AsOf2021-12-14_custom_NotePurchaseAgreementMember_custom_UnrelatedThirdPartyPurchasersMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001737995</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">STSS:UnrelatedThirdPartyPurchasersMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">STSS:NotePurchaseAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-14</instant>
        </period>
    </context>
    <context id="From2021-12-132021-12-14_custom_NotePurchaseAgreementMember_custom_UnrelatedThirdPartyPurchasersMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001737995</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">STSS:UnrelatedThirdPartyPurchasersMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">STSS:NotePurchaseAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-12-13</startDate>
            <endDate>2021-12-14</endDate>
        </period>
    </context>
    <context id="AsOf2021-12-14_custom_NotePurchaseAgreementMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001737995</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">STSS:NotePurchaseAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-14</instant>
        </period>
    </context>
    <context id="AsOf2021-12-31_custom_NotePurchaseAgreementMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001737995</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">STSS:NotePurchaseAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="From2022-01-012022-12-31_custom_NotePurchaseAgreementMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001737995</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">STSS:NotePurchaseAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="AsOf2022-12-31_custom_NotePurchaseAgreementMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001737995</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">STSS:NotePurchaseAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="AsOf2022-04-19_custom_NotePurchaseAgreementMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001737995</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">STSS:NotePurchaseAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-04-19</instant>
        </period>
    </context>
    <context id="From2022-04-172022-04-19_custom_NotePurchaseAgreementMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001737995</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">STSS:NotePurchaseAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-17</startDate>
            <endDate>2022-04-19</endDate>
        </period>
    </context>
    <context id="From2022-01-012022-12-31_custom_NotePurchaseAgreementMember_us-gaap_NoteWarrantMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001737995</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:NoteWarrantMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">STSS:NotePurchaseAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="From2023-09-292023-09-29_custom_NotePurchaseAgreementMember_us-gaap_NoteWarrantMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001737995</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:NoteWarrantMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">STSS:NotePurchaseAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-09-29</startDate>
            <endDate>2023-09-29</endDate>
        </period>
    </context>
    <context id="AsOf2017-12-11">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001737995</identifier>
        </entity>
        <period>
            <instant>2017-12-11</instant>
        </period>
    </context>
    <context id="AsOf2019-04-18">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001737995</identifier>
        </entity>
        <period>
            <instant>2019-04-18</instant>
        </period>
    </context>
    <context id="From2022-03-192022-03-22">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001737995</identifier>
        </entity>
        <period>
            <startDate>2022-03-19</startDate>
            <endDate>2022-03-22</endDate>
        </period>
    </context>
    <context id="AsOf2022-03-21">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001737995</identifier>
        </entity>
        <period>
            <instant>2022-03-21</instant>
        </period>
    </context>
    <context id="From2023-09-292023-09-29">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001737995</identifier>
        </entity>
        <period>
            <startDate>2023-09-29</startDate>
            <endDate>2023-09-29</endDate>
        </period>
    </context>
    <context id="From2023-09-292023-09-29_custom_ShelfOfferingMember_custom_SecuritiesPurchaseAgreementMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001737995</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">STSS:ShelfOfferingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">STSS:SecuritiesPurchaseAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-09-29</startDate>
            <endDate>2023-09-29</endDate>
        </period>
    </context>
    <context id="AsOf2023-09-29_custom_ShelfOfferingMember_custom_SecuritiesPurchaseAgreementMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001737995</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">STSS:ShelfOfferingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">STSS:SecuritiesPurchaseAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-09-29</instant>
        </period>
    </context>
    <context id="AsOf2023-09-29_custom_ShelfOfferingMember_custom_SecuritiesPurchaseAgreementMember_us-gaap_WarrantMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001737995</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:WarrantMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">STSS:ShelfOfferingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">STSS:SecuritiesPurchaseAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-09-29</instant>
        </period>
    </context>
    <context id="From2023-09-292023-09-29_us-gaap_PrivatePlacementMember_custom_SecuritiesPurchaseAgreementMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001737995</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:PrivatePlacementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">STSS:SecuritiesPurchaseAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-09-29</startDate>
            <endDate>2023-09-29</endDate>
        </period>
    </context>
    <context id="From2023-09-292023-09-29_us-gaap_PrivatePlacementMember_custom_SecuritiesPurchaseAgreementMember_custom_PIPEPreFundedWarrantsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001737995</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">STSS:PIPEPreFundedWarrantsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:PrivatePlacementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">STSS:SecuritiesPurchaseAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-09-29</startDate>
            <endDate>2023-09-29</endDate>
        </period>
    </context>
    <context id="From2023-09-292023-09-29_custom_NonTradingWarrantsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001737995</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">STSS:NonTradingWarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-09-29</startDate>
            <endDate>2023-09-29</endDate>
        </period>
    </context>
    <context id="AsOf2023-02-03_custom_PurchaseAgreementMember_custom_SecuritiesPurchaseAgreementMember_custom_PIPEPreFundedWarrantsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001737995</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">STSS:PIPEPreFundedWarrantsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">STSS:SecuritiesPurchaseAgreementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">STSS:PurchaseAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-02-03</instant>
        </period>
    </context>
    <context id="AsOf2023-09-29_custom_SecuritiesPurchaseAgreementMember_us-gaap_PrivatePlacementMember_custom_PIPEPreFundedWarrantsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001737995</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">STSS:PIPEPreFundedWarrantsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:PrivatePlacementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">STSS:SecuritiesPurchaseAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-09-29</instant>
        </period>
    </context>
    <context id="AsOf2023-09-29_us-gaap_PrivatePlacementMember_custom_SecuritiesPurchaseAgreementMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001737995</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:PrivatePlacementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">STSS:SecuritiesPurchaseAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-09-29</instant>
        </period>
    </context>
    <context id="AsOf2023-12-31_us-gaap_PrivatePlacementMember_custom_SecuritiesPurchaseAgreementMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001737995</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:PrivatePlacementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">STSS:SecuritiesPurchaseAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="From2023-02-012023-02-03_custom_PurchaseAgreementMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001737995</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">STSS:PurchaseAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-02-01</startDate>
            <endDate>2023-02-03</endDate>
        </period>
    </context>
    <context id="AsOf2023-02-03_custom_PurchaseAgreementMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001737995</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">STSS:PurchaseAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-02-03</instant>
        </period>
    </context>
    <context id="AsOf2023-09-29_custom_PurchaseAgreementMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001737995</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">STSS:PurchaseAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-09-29</instant>
        </period>
    </context>
    <context id="From2022-04-112022-04-13_us-gaap_WarrantMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001737995</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:WarrantMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-11</startDate>
            <endDate>2022-04-13</endDate>
        </period>
    </context>
    <context id="AsOf2022-04-13_us-gaap_WarrantMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001737995</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:WarrantMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-04-13</instant>
        </period>
    </context>
    <context id="AsOf2022-04-19_us-gaap_WarrantMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001737995</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:WarrantMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-04-19</instant>
        </period>
    </context>
    <context id="From2022-04-122022-04-14_us-gaap_IPOMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001737995</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:IPOMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-12</startDate>
            <endDate>2022-04-14</endDate>
        </period>
    </context>
    <context id="AsOf2022-04-14">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001737995</identifier>
        </entity>
        <period>
            <instant>2022-04-14</instant>
        </period>
    </context>
    <context id="From2022-04-122022-04-14">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001737995</identifier>
        </entity>
        <period>
            <startDate>2022-04-12</startDate>
            <endDate>2022-04-14</endDate>
        </period>
    </context>
    <context id="From2023-01-012023-12-31_custom_NonTradingWarrantsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001737995</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">STSS:NonTradingWarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="AsOf2023-12-31_us-gaap_NoteWarrantMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001737995</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:NoteWarrantMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="From2023-09-012023-09-30_custom_NonTradingWarrantsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001737995</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">STSS:NonTradingWarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-09-01</startDate>
            <endDate>2023-09-30</endDate>
        </period>
    </context>
    <context id="AsOf2023-09-29_custom_NonTradingWarrantsMember_custom_PIPEWarrantMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001737995</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">STSS:PIPEWarrantMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">STSS:NonTradingWarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-09-29</instant>
        </period>
    </context>
    <context id="AsOf2023-12-31_custom_NonTradingWarrantsMember_custom_PIPEWarrantMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001737995</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">STSS:PIPEWarrantMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">STSS:NonTradingWarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="From2023-01-012023-12-31_custom_NonTradingWarrantsMember_custom_PIPEWarrantMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001737995</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">STSS:PIPEWarrantMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">STSS:NonTradingWarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="From2023-02-012023-02-28_custom_NonTradingWarrantsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001737995</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">STSS:NonTradingWarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-02-01</startDate>
            <endDate>2023-02-28</endDate>
        </period>
    </context>
    <context id="AsOf2023-02-28_custom_NonTradingWarrantsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001737995</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">STSS:NonTradingWarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-02-28</instant>
        </period>
    </context>
    <context id="AsOf2023-12-31_custom_NonTradingWarrantsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001737995</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">STSS:NonTradingWarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="From2022-04-012022-04-30_custom_TradingWarrantsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001737995</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">STSS:TradingWarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-01</startDate>
            <endDate>2022-04-30</endDate>
        </period>
    </context>
    <context id="From2022-04-012022-04-30_us-gaap_OverAllotmentOptionMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001737995</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:OverAllotmentOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-01</startDate>
            <endDate>2022-04-30</endDate>
        </period>
    </context>
    <context id="AsOf2023-12-31_custom_TradingWarrantsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001737995</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">STSS:TradingWarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="AsOf2022-12-31_custom_TradingWarrantsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001737995</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">STSS:TradingWarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="From2023-01-012023-12-31_custom_TradingWarrantsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001737995</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">STSS:TradingWarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="From2022-01-012022-12-31_custom_TradingWarrantsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001737995</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">STSS:TradingWarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="From2022-04-192022-04-19_us-gaap_NoteWarrantMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001737995</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:NoteWarrantMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-19</startDate>
            <endDate>2022-04-19</endDate>
        </period>
    </context>
    <context id="AsOf2022-04-19_us-gaap_NoteWarrantMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001737995</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:NoteWarrantMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-04-19</instant>
        </period>
    </context>
    <context id="From2022-01-012022-12-31_custom_NoteWarrantsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001737995</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">STSS:NoteWarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="From2023-01-012023-12-31_custom_NoteWarrantsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001737995</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">STSS:NoteWarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="AsOf2023-12-31_us-gaap_IPOMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001737995</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:IPOMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="From2023-01-012023-12-31_us-gaap_IPOMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001737995</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:IPOMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="AsOf2022-10-09_us-gaap_IPOMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001737995</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:IPOMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-10-09</instant>
        </period>
    </context>
    <context id="AsOf2022-03-22">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001737995</identifier>
        </entity>
        <period>
            <instant>2022-03-22</instant>
        </period>
    </context>
    <context id="AsOf2024-07-31">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001737995</identifier>
        </entity>
        <period>
            <instant>2024-07-31</instant>
        </period>
    </context>
    <context id="From2024-09-232024-09-23_custom_SecuritiesPurchaseAgreementMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001737995</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">STSS:SecuritiesPurchaseAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-09-23</startDate>
            <endDate>2024-09-23</endDate>
        </period>
    </context>
    <context id="From2024-09-232024-09-23_custom_SecuritiesPurchaseAgreementMember_custom_PreReverseMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001737995</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">STSS:PreReverseMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">STSS:SecuritiesPurchaseAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-09-23</startDate>
            <endDate>2024-09-23</endDate>
        </period>
    </context>
    <context id="From2024-05-312024-05-31_custom_SubscriptionAgreementsMember_custom_InvestorsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001737995</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">STSS:InvestorsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">STSS:SubscriptionAgreementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-05-31</startDate>
            <endDate>2024-05-31</endDate>
        </period>
    </context>
    <context id="From2024-06-132024-06-13_custom_SubscriptionAgreementsMember_custom_InvestorsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001737995</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">STSS:InvestorsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">STSS:SubscriptionAgreementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-06-13</startDate>
            <endDate>2024-06-13</endDate>
        </period>
    </context>
    <context id="From2024-05-312024-05-31_custom_SubscriptionAgreementsMember_custom_InvestorsMember_custom_PreReverseMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001737995</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">STSS:InvestorsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">STSS:PreReverseMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">STSS:SubscriptionAgreementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-05-31</startDate>
            <endDate>2024-05-31</endDate>
        </period>
    </context>
    <context id="From2024-06-132024-06-13_custom_SubscriptionAgreementsMember_custom_InvestorsMember_custom_PreReverseMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001737995</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">STSS:InvestorsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">STSS:PreReverseMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">STSS:SubscriptionAgreementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-06-13</startDate>
            <endDate>2024-06-13</endDate>
        </period>
    </context>
    <context id="AsOf2024-05-31_custom_SubscriptionAgreementsMember_custom_InvestorsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001737995</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">STSS:InvestorsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">STSS:SubscriptionAgreementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-05-31</instant>
        </period>
    </context>
    <context id="AsOf2024-06-13_custom_SubscriptionAgreementsMember_custom_InvestorsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001737995</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">STSS:InvestorsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">STSS:SubscriptionAgreementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-06-13</instant>
        </period>
    </context>
    <context id="AsOf2024-05-31_custom_SubscriptionAgreementsMember_custom_InvestorsMember_custom_PreReverseMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001737995</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">STSS:InvestorsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">STSS:PreReverseMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">STSS:SubscriptionAgreementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-05-31</instant>
        </period>
    </context>
    <context id="AsOf2024-06-13_custom_SubscriptionAgreementsMember_custom_InvestorsMember_custom_PreReverseMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001737995</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">STSS:InvestorsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">STSS:PreReverseMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">STSS:SubscriptionAgreementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-06-13</instant>
        </period>
    </context>
    <context id="AsOf2024-05-30_custom_InducementAgreementMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001737995</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">STSS:InducementAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-05-30</instant>
        </period>
    </context>
    <context id="AsOf2024-05-30_custom_InducementAgreementMember_custom_PreReverseMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001737995</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">STSS:PreReverseMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">STSS:InducementAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-05-30</instant>
        </period>
    </context>
    <context id="AsOf2024-05-29_custom_InducementAgreementMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001737995</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">STSS:InducementAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-05-29</instant>
        </period>
    </context>
    <context id="AsOf2024-05-29_custom_InducementAgreementMember_custom_PreReverseMember_srt_MaximumMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001737995</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">STSS:PreReverseMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">STSS:InducementAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-05-29</instant>
        </period>
    </context>
    <context id="AsOf2024-05-29_custom_InducementAgreementMember_custom_PreReverseMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001737995</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">STSS:PreReverseMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">STSS:InducementAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-05-29</instant>
        </period>
    </context>
    <context id="AsOf2024-05-29_custom_InducementAgreementMember_custom_PreReverseMember_srt_MinimumMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001737995</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">STSS:PreReverseMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">STSS:InducementAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-05-29</instant>
        </period>
    </context>
    <context id="AsOf2024-05-30_custom_InducementWarrantsMember_custom_WarrantHoldersMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001737995</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">STSS:WarrantHoldersMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">STSS:InducementWarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-05-30</instant>
        </period>
    </context>
    <context id="AsOf2024-05-30_custom_InducementWarrantsMember_custom_WarrantHoldersMember_custom_PreReverseMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001737995</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">STSS:WarrantHoldersMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">STSS:PreReverseMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">STSS:InducementWarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-05-30</instant>
        </period>
    </context>
    <context id="From2024-05-302024-05-30_custom_InducementWarrantsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001737995</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">STSS:InducementWarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-05-30</startDate>
            <endDate>2024-05-30</endDate>
        </period>
    </context>
    <context id="From2024-05-302024-05-30_custom_InducementAgreementMember_custom_WarrantHoldersMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001737995</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">STSS:WarrantHoldersMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">STSS:InducementAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-05-30</startDate>
            <endDate>2024-05-30</endDate>
        </period>
    </context>
    <context id="AsOf2024-05-30_custom_InducementAgreementMember_custom_WarrantHoldersMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001737995</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">STSS:WarrantHoldersMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">STSS:InducementAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-05-30</instant>
        </period>
    </context>
    <context id="AsOf2024-05-30_custom_InducementAgreementMember_custom_WarrantHoldersMember_custom_PreReverseMember_srt_MaximumMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001737995</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">STSS:WarrantHoldersMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">STSS:PreReverseMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">STSS:InducementAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-05-30</instant>
        </period>
    </context>
    <context id="AsOf2024-05-30_custom_InducementAgreementMember_custom_WarrantHoldersMember_custom_PreReverseMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001737995</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">STSS:WarrantHoldersMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">STSS:PreReverseMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">STSS:InducementAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-05-30</instant>
        </period>
    </context>
    <context id="AsOf2024-05-30_custom_InducementAgreementMember_custom_WarrantHoldersMember_custom_PreReverseMember_srt_MinimumMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001737995</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">STSS:WarrantHoldersMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">STSS:PreReverseMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">STSS:InducementAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-05-30</instant>
        </period>
    </context>
    <context id="From2023-09-292023-09-29_custom_ShelfOfferingMember_custom_SecuritiesPurchaseAgreementMember_custom_ReverseStockSplitMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001737995</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">STSS:ReverseStockSplitMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">STSS:ShelfOfferingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">STSS:SecuritiesPurchaseAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-09-29</startDate>
            <endDate>2023-09-29</endDate>
        </period>
    </context>
    <context id="From2023-09-292023-09-29_custom_ShelfOfferingMember_custom_SecuritiesPurchaseAgreementMember_custom_PreReverseMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001737995</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">STSS:PreReverseMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">STSS:ShelfOfferingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">STSS:SecuritiesPurchaseAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-09-29</startDate>
            <endDate>2023-09-29</endDate>
        </period>
    </context>
    <context id="AsOf2023-09-29_custom_ShelfOfferingMember_custom_SecuritiesPurchaseAgreementMember_custom_ReverseStockSplitMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001737995</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">STSS:ReverseStockSplitMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">STSS:ShelfOfferingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">STSS:SecuritiesPurchaseAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-09-29</instant>
        </period>
    </context>
    <context id="AsOf2024-05-30_custom_ShelfOfferingMember_custom_SecuritiesPurchaseAgreementMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001737995</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">STSS:ShelfOfferingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">STSS:SecuritiesPurchaseAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-05-30</instant>
        </period>
    </context>
    <context id="AsOf2023-09-29_custom_ShelfOfferingMember_custom_SecuritiesPurchaseAgreementMember_custom_PreFundedWarrantsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001737995</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">STSS:PreFundedWarrantsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">STSS:ShelfOfferingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">STSS:SecuritiesPurchaseAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-09-29</instant>
        </period>
    </context>
    <context id="AsOf2023-09-29_custom_ShelfOfferingMember_custom_SecuritiesPurchaseAgreementMember_custom_PreFundedWarrantsMember_custom_PreReverseMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001737995</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">STSS:PreReverseMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">STSS:PreFundedWarrantsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">STSS:ShelfOfferingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">STSS:SecuritiesPurchaseAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-09-29</instant>
        </period>
    </context>
    <context id="From2023-09-292023-09-29_us-gaap_PrivatePlacementMember_custom_SecuritiesPurchaseAgreementMember_custom_PIPEPreFundedWarrantsMember_custom_ReverseStockSplitMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001737995</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">STSS:ReverseStockSplitMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">STSS:PIPEPreFundedWarrantsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:PrivatePlacementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">STSS:SecuritiesPurchaseAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-09-29</startDate>
            <endDate>2023-09-29</endDate>
        </period>
    </context>
    <context id="From2023-09-292023-09-29_us-gaap_PrivatePlacementMember_custom_SecuritiesPurchaseAgreementMember_custom_PIPEPreFundedWarrantsMember_custom_PreReverseMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001737995</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">STSS:PreReverseMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">STSS:PIPEPreFundedWarrantsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:PrivatePlacementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">STSS:SecuritiesPurchaseAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-09-29</startDate>
            <endDate>2023-09-29</endDate>
        </period>
    </context>
    <context id="From2023-09-292023-09-29_custom_NonTradingWarrantsMember_custom_ReverseStockSplitMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001737995</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">STSS:ReverseStockSplitMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">STSS:NonTradingWarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-09-29</startDate>
            <endDate>2023-09-29</endDate>
        </period>
    </context>
    <context id="From2023-09-292023-09-29_custom_NonTradingWarrantsMember_custom_PreReverseMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001737995</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">STSS:PreReverseMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">STSS:NonTradingWarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-09-29</startDate>
            <endDate>2023-09-29</endDate>
        </period>
    </context>
    <context id="AsOf2023-02-03_custom_SecuritiesPurchaseAgreementMember_custom_PIPEPreFundedWarrantsMember_srt_MaximumMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001737995</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">STSS:PIPEPreFundedWarrantsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">STSS:SecuritiesPurchaseAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-02-03</instant>
        </period>
    </context>
    <context id="AsOf2023-02-03_custom_SecuritiesPurchaseAgreementMember_custom_PIPEPreFundedWarrantsMember_custom_PreReverseMember_srt_MaximumMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001737995</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">STSS:PreReverseMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">STSS:PIPEPreFundedWarrantsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">STSS:SecuritiesPurchaseAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-02-03</instant>
        </period>
    </context>
    <context id="AsOf2023-02-03_custom_SecuritiesPurchaseAgreementMember_custom_PIPEPreFundedWarrantsMember_srt_MinimumMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001737995</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">STSS:PIPEPreFundedWarrantsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">STSS:SecuritiesPurchaseAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-02-03</instant>
        </period>
    </context>
    <context id="AsOf2023-02-03_custom_SecuritiesPurchaseAgreementMember_custom_PIPEPreFundedWarrantsMember_custom_PreReverseMember_srt_MinimumMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001737995</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">STSS:PreReverseMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">STSS:PIPEPreFundedWarrantsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">STSS:SecuritiesPurchaseAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-02-03</instant>
        </period>
    </context>
    <context id="AsOf2023-09-29_custom_SecuritiesPurchaseAgreementMember_custom_PIPEPreFundedWarrantsMember_us-gaap_PrivatePlacementMember_custom_ReverseStockSplitMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001737995</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">STSS:ReverseStockSplitMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">STSS:PIPEPreFundedWarrantsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:PrivatePlacementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">STSS:SecuritiesPurchaseAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-09-29</instant>
        </period>
    </context>
    <context id="AsOf2024-05-30_custom_SecuritiesPurchaseAgreementMember_custom_PIPEPreFundedWarrantsMember_us-gaap_PrivatePlacementMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001737995</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">STSS:PIPEPreFundedWarrantsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:PrivatePlacementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">STSS:SecuritiesPurchaseAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-05-30</instant>
        </period>
    </context>
    <context id="From2023-02-012023-02-03_custom_SecuritiesPurchaseAgreementMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001737995</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">STSS:SecuritiesPurchaseAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-02-01</startDate>
            <endDate>2023-02-03</endDate>
        </period>
    </context>
    <context id="From2023-02-012023-02-03_custom_SecuritiesPurchaseAgreementMember_custom_PreReverseMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001737995</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">STSS:PreReverseMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">STSS:SecuritiesPurchaseAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-02-01</startDate>
            <endDate>2023-02-03</endDate>
        </period>
    </context>
    <context id="AsOf2023-02-03_custom_SecuritiesPurchaseAgreementMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001737995</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">STSS:SecuritiesPurchaseAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-02-03</instant>
        </period>
    </context>
    <context id="AsOf2023-02-03_custom_SecuritiesPurchaseAgreementMember_custom_PreReverseMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001737995</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">STSS:PreReverseMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">STSS:SecuritiesPurchaseAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-02-03</instant>
        </period>
    </context>
    <context id="AsOf2023-09-29_custom_SecuritiesPurchaseAgreementMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001737995</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">STSS:SecuritiesPurchaseAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-09-29</instant>
        </period>
    </context>
    <context id="AsOf2024-05-30_custom_SecuritiesPurchaseAgreementMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001737995</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">STSS:SecuritiesPurchaseAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-05-30</instant>
        </period>
    </context>
    <context id="From2022-04-112022-04-13_us-gaap_IPOMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001737995</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:IPOMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-11</startDate>
            <endDate>2022-04-13</endDate>
        </period>
    </context>
    <context id="From2022-04-112022-04-13_us-gaap_IPOMember_custom_PreReverseMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001737995</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">STSS:PreReverseMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:IPOMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-11</startDate>
            <endDate>2022-04-13</endDate>
        </period>
    </context>
    <context id="AsOf2022-04-13_us-gaap_IPOMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001737995</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:IPOMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-04-13</instant>
        </period>
    </context>
    <context id="AsOf2022-04-13_us-gaap_IPOMember_custom_PreReverseMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001737995</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">STSS:PreReverseMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:IPOMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-04-13</instant>
        </period>
    </context>
    <context id="AsOf2023-02-03_us-gaap_IPOMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001737995</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:IPOMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-02-03</instant>
        </period>
    </context>
    <context id="AsOf2023-09-29_us-gaap_IPOMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001737995</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:IPOMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-09-29</instant>
        </period>
    </context>
    <context id="AsOf2024-05-30_us-gaap_IPOMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001737995</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:IPOMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-05-30</instant>
        </period>
    </context>
    <context id="From2022-04-172022-04-19_us-gaap_WarrantMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001737995</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:WarrantMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-17</startDate>
            <endDate>2022-04-19</endDate>
        </period>
    </context>
    <context id="From2022-04-172022-04-19_us-gaap_WarrantMember_custom_PreReverseMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001737995</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">STSS:PreReverseMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:WarrantMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-17</startDate>
            <endDate>2022-04-19</endDate>
        </period>
    </context>
    <context id="AsOf2024-09-30_custom_WarrantHoldersMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001737995</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">STSS:WarrantHoldersMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-09-30</instant>
        </period>
    </context>
    <context id="AsOf2024-09-30_custom_WarrantHoldersMember_custom_PreReverseMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001737995</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">STSS:WarrantHoldersMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">STSS:PreReverseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-09-30</instant>
        </period>
    </context>
    <context id="AsOf2023-02-28_custom_WarrantHoldersMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001737995</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">STSS:WarrantHoldersMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-02-28</instant>
        </period>
    </context>
    <context id="AsOf2023-09-30_custom_WarrantHoldersMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001737995</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">STSS:WarrantHoldersMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-09-30</instant>
        </period>
    </context>
    <context id="AsOf2023-02-28_custom_WarrantHoldersMember_custom_PreReverseMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001737995</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">STSS:WarrantHoldersMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">STSS:PreReverseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-02-28</instant>
        </period>
    </context>
    <context id="AsOf2023-09-30_custom_WarrantHoldersMember_custom_PreReverseMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001737995</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">STSS:WarrantHoldersMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">STSS:PreReverseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-09-30</instant>
        </period>
    </context>
    <context id="AsOf2023-02-28_custom_WarrantHolderMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001737995</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">STSS:WarrantHolderMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-02-28</instant>
        </period>
    </context>
    <context id="AsOf2023-09-29_custom_WarrantHolderMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001737995</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">STSS:WarrantHolderMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-09-29</instant>
        </period>
    </context>
    <context id="From2024-07-012024-09-30_custom_WarrantHoldersMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001737995</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">STSS:WarrantHoldersMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-07-01</startDate>
            <endDate>2024-09-30</endDate>
        </period>
    </context>
    <context id="From2024-01-012024-09-30_custom_WarrantHoldersMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001737995</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">STSS:WarrantHoldersMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-09-30</endDate>
        </period>
    </context>
    <context id="AsOf2024-09-30_us-gaap_WarrantMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001737995</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:WarrantMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-09-30</instant>
        </period>
    </context>
    <context id="From2024-04-012024-06-30_custom_InducementWarrantsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001737995</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">STSS:InducementWarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-04-01</startDate>
            <endDate>2024-06-30</endDate>
        </period>
    </context>
    <context id="From2024-04-012024-06-30_custom_InducementWarrantsMember_custom_PreReverseMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001737995</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">STSS:PreReverseMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">STSS:InducementWarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-04-01</startDate>
            <endDate>2024-06-30</endDate>
        </period>
    </context>
    <context id="From2024-01-012024-06-30_custom_InducementWarrantsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001737995</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">STSS:InducementWarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-06-30</endDate>
        </period>
    </context>
    <context id="AsOf2023-04-30_us-gaap_WarrantMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001737995</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:WarrantMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-04-30</instant>
        </period>
    </context>
    <context id="AsOf2023-04-30_us-gaap_WarrantMember_custom_PreReverseMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001737995</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">STSS:PreReverseMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:WarrantMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-04-30</instant>
        </period>
    </context>
    <context id="From2024-07-012024-09-30_us-gaap_WarrantMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001737995</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:WarrantMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-07-01</startDate>
            <endDate>2024-09-30</endDate>
        </period>
    </context>
    <context id="From2024-01-012024-09-30_us-gaap_WarrantMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001737995</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:WarrantMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-09-30</endDate>
        </period>
    </context>
    <context id="From2024-01-012024-09-30_custom_PreReverseMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001737995</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">STSS:PreReverseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-09-30</endDate>
        </period>
    </context>
    <context id="From2023-07-012023-09-30_us-gaap_WarrantMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001737995</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:WarrantMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-07-01</startDate>
            <endDate>2023-09-30</endDate>
        </period>
    </context>
    <context id="From2023-07-012023-09-30_custom_PreReverseMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001737995</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">STSS:PreReverseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-07-01</startDate>
            <endDate>2023-09-30</endDate>
        </period>
    </context>
    <context id="From2023-01-012023-09-30_us-gaap_WarrantMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001737995</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:WarrantMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-09-30</endDate>
        </period>
    </context>
    <context id="From2023-01-012023-09-30_custom_PreReverseMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001737995</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">STSS:PreReverseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-09-30</endDate>
        </period>
    </context>
    <context id="From2023-09-012023-09-30_custom_NonTradingWarrantsMember_custom_ReverseStockSplitMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001737995</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">STSS:ReverseStockSplitMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">STSS:NonTradingWarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-09-01</startDate>
            <endDate>2023-09-30</endDate>
        </period>
    </context>
    <context id="From2023-09-012023-09-30_custom_NonTradingWarrantsMember_custom_PreReverseMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001737995</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">STSS:PreReverseMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">STSS:NonTradingWarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-09-01</startDate>
            <endDate>2023-09-30</endDate>
        </period>
    </context>
    <context id="From2024-07-012024-09-30_custom_NonTradingWarrantsMember_custom_PIPEWarrantMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001737995</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">STSS:PIPEWarrantMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">STSS:NonTradingWarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-07-01</startDate>
            <endDate>2024-09-30</endDate>
        </period>
    </context>
    <context id="From2024-01-012024-09-30_custom_NonTradingWarrantsMember_custom_PIPEWarrantMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001737995</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">STSS:PIPEWarrantMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">STSS:NonTradingWarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-09-30</endDate>
        </period>
    </context>
    <context id="From2023-02-012023-02-28_custom_NonTradingWarrantsMember_custom_ReverseStockSplitMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001737995</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">STSS:ReverseStockSplitMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">STSS:NonTradingWarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-02-01</startDate>
            <endDate>2023-02-28</endDate>
        </period>
    </context>
    <context id="From2023-02-012023-02-28_custom_NonTradingWarrantsMember_custom_PreReverseMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001737995</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">STSS:PreReverseMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">STSS:NonTradingWarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-02-01</startDate>
            <endDate>2023-02-28</endDate>
        </period>
    </context>
    <context id="From2024-07-012024-09-30_custom_NonTradingWarrantsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001737995</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">STSS:NonTradingWarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-07-01</startDate>
            <endDate>2024-09-30</endDate>
        </period>
    </context>
    <context id="From2024-01-012024-09-30_custom_NonTradingWarrantsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001737995</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">STSS:NonTradingWarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-09-30</endDate>
        </period>
    </context>
    <context id="From2023-07-012023-09-30_custom_NonTradingWarrantsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001737995</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">STSS:NonTradingWarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-07-01</startDate>
            <endDate>2023-09-30</endDate>
        </period>
    </context>
    <context id="From2023-01-012023-09-30_custom_NonTradingWarrantsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001737995</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">STSS:NonTradingWarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-09-30</endDate>
        </period>
    </context>
    <context id="From2022-04-172022-04-19_custom_TradingWarrantsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001737995</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">STSS:TradingWarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-17</startDate>
            <endDate>2022-04-19</endDate>
        </period>
    </context>
    <context id="From2022-04-172022-04-19_custom_TradingWarrantsMember_custom_PreReverseMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001737995</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">STSS:PreReverseMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">STSS:TradingWarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-17</startDate>
            <endDate>2022-04-19</endDate>
        </period>
    </context>
    <context id="From2022-04-172022-04-19_custom_OverAllotmentWarrantsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001737995</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">STSS:OverAllotmentWarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-17</startDate>
            <endDate>2022-04-19</endDate>
        </period>
    </context>
    <context id="From2022-04-172022-04-19_custom_OverAllotmentWarrantsMember_custom_PreReverseMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001737995</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">STSS:PreReverseMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">STSS:OverAllotmentWarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-17</startDate>
            <endDate>2022-04-19</endDate>
        </period>
    </context>
    <context id="From2024-07-012024-09-30_custom_TradingWarrantsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001737995</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">STSS:TradingWarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-07-01</startDate>
            <endDate>2024-09-30</endDate>
        </period>
    </context>
    <context id="From2024-01-012024-09-30_custom_TradingWarrantsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001737995</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">STSS:TradingWarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-09-30</endDate>
        </period>
    </context>
    <context id="From2023-07-012023-09-30_custom_TradingWarrantsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001737995</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">STSS:TradingWarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-07-01</startDate>
            <endDate>2023-09-30</endDate>
        </period>
    </context>
    <context id="From2023-01-012023-09-30_custom_TradingWarrantsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001737995</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">STSS:TradingWarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-09-30</endDate>
        </period>
    </context>
    <context id="From2022-04-172022-04-19_custom_NoteWarrantsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001737995</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">STSS:NoteWarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-17</startDate>
            <endDate>2022-04-19</endDate>
        </period>
    </context>
    <context id="From2022-04-172022-04-19_custom_NoteWarrantsMember_custom_PreReverseMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001737995</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">STSS:PreReverseMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">STSS:NoteWarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-17</startDate>
            <endDate>2022-04-19</endDate>
        </period>
    </context>
    <context id="From2024-07-012024-09-30_custom_NoteWarrantsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001737995</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">STSS:NoteWarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-07-01</startDate>
            <endDate>2024-09-30</endDate>
        </period>
    </context>
    <context id="From2024-01-012024-09-30_custom_NoteWarrantsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001737995</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">STSS:NoteWarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-09-30</endDate>
        </period>
    </context>
    <context id="From2023-07-012023-09-30_custom_NoteWarrantsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001737995</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">STSS:NoteWarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-07-01</startDate>
            <endDate>2023-09-30</endDate>
        </period>
    </context>
    <context id="From2023-01-012023-09-30_custom_NoteWarrantsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001737995</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">STSS:NoteWarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-09-30</endDate>
        </period>
    </context>
    <context id="AsOf2022-04-19_us-gaap_IPOMember_custom_PreReverseMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001737995</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">STSS:PreReverseMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:IPOMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-04-19</instant>
        </period>
    </context>
    <context id="AsOf2022-04-19_us-gaap_IPOMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001737995</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:IPOMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-04-19</instant>
        </period>
    </context>
    <context id="AsOf2022-12-31_us-gaap_SeriesAPreferredStockMember_srt_DirectorMember_custom_AlanBlackmanMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001737995</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">STSS:AlanBlackmanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">srt:DirectorMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesAPreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="AsOf2022-12-31_us-gaap_SeriesAPreferredStockMember_srt_DirectorMember_us-gaap_IPOMember_custom_AlanBlackmanMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001737995</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">STSS:AlanBlackmanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">srt:DirectorMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesAPreferredStockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:IPOMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="AsOf2018-02-28_us-gaap_SeriesAPreferredStockMember_us-gaap_IPOMember_custom_AlanBlackmanMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001737995</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">STSS:AlanBlackmanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesAPreferredStockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:IPOMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-02-28</instant>
        </period>
    </context>
    <context id="From2024-01-012024-09-30_us-gaap_SeriesAPreferredStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001737995</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesAPreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-09-30</endDate>
        </period>
    </context>
    <context id="From2023-01-012023-12-31_us-gaap_WarrantMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001737995</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:WarrantMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="From2023-01-012023-12-31_srt_MinimumMember_us-gaap_WarrantMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001737995</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:WarrantMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="From2023-01-012023-12-31_srt_MaximumMember_us-gaap_WarrantMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001737995</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:WarrantMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="AsOf2024-09-30_us-gaap_WarrantMember_us-gaap_MeasurementInputExpectedTermMember_srt_MinimumMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001737995</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputExpectedTermMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:WarrantMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-09-30</instant>
        </period>
    </context>
    <context id="AsOf2024-09-30_us-gaap_WarrantMember_us-gaap_MeasurementInputExpectedTermMember_srt_MaximumMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001737995</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputExpectedTermMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:WarrantMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-09-30</instant>
        </period>
    </context>
    <context id="AsOf2023-09-30_us-gaap_WarrantMember_us-gaap_MeasurementInputExpectedTermMember_srt_MinimumMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001737995</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputExpectedTermMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:WarrantMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-09-30</instant>
        </period>
    </context>
    <context id="AsOf2023-09-30_us-gaap_WarrantMember_us-gaap_MeasurementInputExpectedTermMember_srt_MaximumMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001737995</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputExpectedTermMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:WarrantMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-09-30</instant>
        </period>
    </context>
    <context id="AsOf2024-09-30_us-gaap_WarrantMember_us-gaap_MeasurementInputOptionVolatilityMember_srt_MinimumMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001737995</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputOptionVolatilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:WarrantMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-09-30</instant>
        </period>
    </context>
    <context id="AsOf2024-09-30_us-gaap_WarrantMember_us-gaap_MeasurementInputOptionVolatilityMember_srt_MaximumMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001737995</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputOptionVolatilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:WarrantMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-09-30</instant>
        </period>
    </context>
    <context id="AsOf2023-09-30_us-gaap_WarrantMember_us-gaap_MeasurementInputOptionVolatilityMember_srt_MinimumMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001737995</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputOptionVolatilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:WarrantMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-09-30</instant>
        </period>
    </context>
    <context id="AsOf2023-09-30_us-gaap_WarrantMember_us-gaap_MeasurementInputOptionVolatilityMember_srt_MaximumMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001737995</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputOptionVolatilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:WarrantMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-09-30</instant>
        </period>
    </context>
    <context id="AsOf2024-09-30_us-gaap_WarrantMember_us-gaap_MeasurementInputRiskFreeInterestRateMember_srt_MinimumMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001737995</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputRiskFreeInterestRateMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:WarrantMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-09-30</instant>
        </period>
    </context>
    <context id="AsOf2024-09-30_us-gaap_WarrantMember_us-gaap_MeasurementInputRiskFreeInterestRateMember_srt_MaximumMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001737995</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputRiskFreeInterestRateMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:WarrantMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-09-30</instant>
        </period>
    </context>
    <context id="AsOf2023-09-30_us-gaap_WarrantMember_us-gaap_MeasurementInputRiskFreeInterestRateMember_srt_MinimumMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001737995</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputRiskFreeInterestRateMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:WarrantMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-09-30</instant>
        </period>
    </context>
    <context id="AsOf2023-09-30_us-gaap_WarrantMember_us-gaap_MeasurementInputRiskFreeInterestRateMember_srt_MaximumMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001737995</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputRiskFreeInterestRateMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:WarrantMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-09-30</instant>
        </period>
    </context>
    <context id="AsOf2024-09-30_us-gaap_WarrantMember_us-gaap_MeasurementInputExpectedDividendRateMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001737995</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputExpectedDividendRateMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:WarrantMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-09-30</instant>
        </period>
    </context>
    <context id="AsOf2023-09-30_us-gaap_WarrantMember_us-gaap_MeasurementInputExpectedDividendRateMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001737995</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputExpectedDividendRateMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:WarrantMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-09-30</instant>
        </period>
    </context>
    <context id="AsOf2023-12-31_custom_TradingAndOverallotmentWarrantsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001737995</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">STSS:TradingAndOverallotmentWarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="AsOf2022-12-31_custom_TradingAndOverallotmentWarrantsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001737995</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">STSS:TradingAndOverallotmentWarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="AsOf2023-12-31_custom_NoteWarrantsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001737995</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">STSS:NoteWarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="AsOf2022-12-31_custom_NoteWarrantsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001737995</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">STSS:NoteWarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="AsOf2023-12-31_custom_OfferingWarrantsFebruaryTwentyTwentyThreeMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001737995</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">STSS:OfferingWarrantsFebruaryTwentyTwentyThreeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="AsOf2022-12-31_custom_OfferingWarrantsFebruaryTwentyTwentyThreeMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001737995</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">STSS:OfferingWarrantsFebruaryTwentyTwentyThreeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="AsOf2023-12-31_custom_OfferingWarrantsSeptemberTwentyTwentyThreeMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001737995</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">STSS:OfferingWarrantsSeptemberTwentyTwentyThreeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="AsOf2022-12-31_custom_OfferingWarrantsSeptemberTwentyTwentyThreeMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001737995</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">STSS:OfferingWarrantsSeptemberTwentyTwentyThreeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="AsOf2024-09-30_custom_TradingAndOverallotmentWarrantsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001737995</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">STSS:TradingAndOverallotmentWarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-09-30</instant>
        </period>
    </context>
    <context id="AsOf2023-12-31_custom_TradingAndOverallotmentWarrantsMember10886187">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001737995</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">STSS:TradingAndOverallotmentWarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="AsOf2024-09-30_custom_NoteWarrantsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001737995</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">STSS:NoteWarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-09-30</instant>
        </period>
    </context>
    <context id="AsOf2023-12-31_custom_NoteWarrantsMember10886187">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001737995</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">STSS:NoteWarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="AsOf2024-09-30_custom_OfferingWarrantsFebruaryTwoThousandTwentyThreeMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001737995</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">STSS:OfferingWarrantsFebruaryTwoThousandTwentyThreeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-09-30</instant>
        </period>
    </context>
    <context id="AsOf2023-12-31_custom_OfferingWarrantsFebruaryTwoThousandTwentyThreeMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001737995</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">STSS:OfferingWarrantsFebruaryTwoThousandTwentyThreeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="AsOf2024-09-30_custom_OfferingWarrantsSeptemberTwoThousandTwentyThreeMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001737995</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">STSS:OfferingWarrantsSeptemberTwoThousandTwentyThreeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-09-30</instant>
        </period>
    </context>
    <context id="AsOf2023-12-31_custom_OfferingWarrantsSeptemberTwoThousandTwentyThreeMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001737995</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">STSS:OfferingWarrantsSeptemberTwoThousandTwentyThreeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="AsOf2024-09-30_custom_InducementWarrantsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001737995</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">STSS:InducementWarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-09-30</instant>
        </period>
    </context>
    <context id="AsOf2023-12-31_custom_InducementWarrantsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001737995</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">STSS:InducementWarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="AsOf2023-12-31_custom_WarrantsIssuedForServiceManagementMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001737995</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">STSS:WarrantsIssuedForServiceManagementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="AsOf2022-12-31_custom_WarrantsIssuedForServiceManagementMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001737995</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">STSS:WarrantsIssuedForServiceManagementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="AsOf2024-09-30_custom_InducementWarrantsMayTwoThousandTwentyFourMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001737995</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">STSS:InducementWarrantsMayTwoThousandTwentyFourMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-09-30</instant>
        </period>
    </context>
    <context id="AsOf2023-12-31_custom_InducementWarrantsMayTwoThousandTwentyFourMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001737995</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">STSS:InducementWarrantsMayTwoThousandTwentyFourMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="AsOf2024-09-30_custom_WarrantsIssuedForServiceManagementMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001737995</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">STSS:WarrantsIssuedForServiceManagementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-09-30</instant>
        </period>
    </context>
    <context id="AsOf2023-12-31_custom_WarrantsIssuedForServiceManagementMember10886343">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001737995</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">STSS:WarrantsIssuedForServiceManagementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="From2024-07-012024-09-30_custom_InducementAgreementMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001737995</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">STSS:InducementAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-07-01</startDate>
            <endDate>2024-09-30</endDate>
        </period>
    </context>
    <context id="From2024-01-012024-09-30_custom_InducementAgreementMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001737995</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">STSS:InducementAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-09-30</endDate>
        </period>
    </context>
    <context id="AsOf2023-01-24_custom_TwoThousandTwentyThreeEquityIncentivePlanMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001737995</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">STSS:TwoThousandTwentyThreeEquityIncentivePlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-01-24</instant>
        </period>
    </context>
    <context id="From2023-01-242023-01-24_custom_TwoThousandTwentyThreeEquityIncentivePlanMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001737995</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">STSS:TwoThousandTwentyThreeEquityIncentivePlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-24</startDate>
            <endDate>2023-01-24</endDate>
        </period>
    </context>
    <context id="From2023-01-012023-12-31_custom_TwoThousandTwentyThreeEquityIncentivePlanMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001737995</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">STSS:TwoThousandTwentyThreeEquityIncentivePlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="AsOf2023-12-31_custom_TwoThousandTwentyThreeEquityIncentivePlanMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001737995</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">STSS:TwoThousandTwentyThreeEquityIncentivePlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="From2023-01-012023-12-31_custom_EmployeesAndConsultantMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001737995</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">STSS:EmployeesAndConsultantMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="AsOf2023-12-31_custom_EmployeesAndConsultantMember_srt_MinimumMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001737995</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">STSS:EmployeesAndConsultantMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="AsOf2023-12-31_custom_EmployeesAndConsultantMember_srt_MaximumMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001737995</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">STSS:EmployeesAndConsultantMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="From2023-01-012023-12-31_custom_TwoThousandTwentyTwoEquityIncentivePlanMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001737995</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">STSS:TwoThousandTwentyTwoEquityIncentivePlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="AsOf2023-12-31_custom_TwoThousandTwentyTwoEquityIncentivePlanMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001737995</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">STSS:TwoThousandTwentyTwoEquityIncentivePlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="From2023-01-012023-12-31_us-gaap_GeneralAndAdministrativeExpenseMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001737995</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:GeneralAndAdministrativeExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="From2023-01-012023-12-31_us-gaap_ResearchAndDevelopmentExpenseMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001737995</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="From2022-01-012022-12-31_us-gaap_GeneralAndAdministrativeExpenseMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001737995</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:GeneralAndAdministrativeExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="From2022-01-012022-12-31_us-gaap_ResearchAndDevelopmentExpenseMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001737995</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="From2022-01-012022-03-31">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001737995</identifier>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="From2024-01-012024-09-30_us-gaap_GeneralAndAdministrativeExpenseMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001737995</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:GeneralAndAdministrativeExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-09-30</endDate>
        </period>
    </context>
    <context id="From2024-01-012024-09-30_us-gaap_ResearchAndDevelopmentExpenseMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001737995</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-09-30</endDate>
        </period>
    </context>
    <context id="From2023-07-012023-09-30_us-gaap_GeneralAndAdministrativeExpenseMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001737995</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:GeneralAndAdministrativeExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-07-01</startDate>
            <endDate>2023-09-30</endDate>
        </period>
    </context>
    <context id="From2023-01-012023-09-30_us-gaap_GeneralAndAdministrativeExpenseMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001737995</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:GeneralAndAdministrativeExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-09-30</endDate>
        </period>
    </context>
    <context id="From2023-01-012023-12-31_custom_ExercisePriceRangeOneMember_srt_MinimumMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001737995</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis">STSS:ExercisePriceRangeOneMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="From2023-01-012023-12-31_custom_ExercisePriceRangeOneMember_srt_MaximumMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001737995</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis">STSS:ExercisePriceRangeOneMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="AsOf2023-12-31_custom_ExercisePriceRangeOneMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001737995</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis">STSS:ExercisePriceRangeOneMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="From2023-01-012023-12-31_custom_ExercisePriceRangeOneMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001737995</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis">STSS:ExercisePriceRangeOneMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="From2023-01-012023-12-31_custom_ExercisePriceRangeTwoMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001737995</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis">STSS:ExercisePriceRangeTwoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="AsOf2023-12-31_custom_ExercisePriceRangeTwoMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001737995</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis">STSS:ExercisePriceRangeTwoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="From2023-01-012023-12-31_custom_ExercisePriceRangeThreeMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001737995</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis">STSS:ExercisePriceRangeThreeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="AsOf2023-12-31_custom_ExercisePriceRangeThreeMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001737995</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis">STSS:ExercisePriceRangeThreeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="From2023-01-012023-12-31_custom_ExercisePriceRangeFourMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001737995</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis">STSS:ExercisePriceRangeFourMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="AsOf2023-12-31_custom_ExercisePriceRangeFourMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001737995</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis">STSS:ExercisePriceRangeFourMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="From2023-01-012023-12-31_custom_ExercisePriceRangeFiveMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001737995</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis">STSS:ExercisePriceRangeFiveMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="AsOf2023-12-31_custom_ExercisePriceRangeFiveMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001737995</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis">STSS:ExercisePriceRangeFiveMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="From2023-01-012023-12-31_custom_ExercisePriceRangeSixMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001737995</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis">STSS:ExercisePriceRangeSixMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="AsOf2023-12-31_custom_ExercisePriceRangeSixMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001737995</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis">STSS:ExercisePriceRangeSixMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="From2023-01-012023-12-31_custom_ExercisePriceRangeSevenMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001737995</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis">STSS:ExercisePriceRangeSevenMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="AsOf2023-12-31_custom_ExercisePriceRangeSevenMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001737995</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis">STSS:ExercisePriceRangeSevenMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="From2023-01-012023-12-31_custom_ExercisePriceRangeEightMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001737995</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis">STSS:ExercisePriceRangeEightMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="AsOf2023-12-31_custom_ExercisePriceRangeEightMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001737995</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis">STSS:ExercisePriceRangeEightMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="From2023-01-012023-12-31_custom_ExercisePriceRangeNineMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001737995</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis">STSS:ExercisePriceRangeNineMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="AsOf2023-12-31_custom_ExercisePriceRangeNineMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001737995</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis">STSS:ExercisePriceRangeNineMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="From2023-01-012023-12-31_custom_ExercisePriceRangeTenMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001737995</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis">STSS:ExercisePriceRangeTenMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="AsOf2023-12-31_custom_ExercisePriceRangeTenMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001737995</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis">STSS:ExercisePriceRangeTenMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="From2023-01-012023-12-31_srt_MinimumMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001737995</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="From2023-01-012023-12-31_srt_MaximumMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001737995</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="From2022-01-012022-12-31_srt_MinimumMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001737995</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="From2022-01-012022-12-31_srt_MaximumMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001737995</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="From2024-01-012024-09-30_srt_MinimumMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001737995</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-09-30</endDate>
        </period>
    </context>
    <context id="From2024-01-012024-09-30_srt_MaximumMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001737995</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-09-30</endDate>
        </period>
    </context>
    <context id="From2023-01-012023-09-30_srt_MinimumMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001737995</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-09-30</endDate>
        </period>
    </context>
    <context id="From2023-01-012023-09-30_srt_MaximumMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001737995</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-09-30</endDate>
        </period>
    </context>
    <context id="AsOf2023-12-31_us-gaap_DomesticCountryMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001737995</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:DomesticCountryMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="AsOf2023-12-31_us-gaap_DomesticCountryMember_custom_ExpiresOnTwoThousandTwentyEightMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001737995</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementScenarioAxis">STSS:ExpiresOnTwoThousandTwentyEightMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:DomesticCountryMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="AsOf2023-12-31_custom_NotExpireMember_us-gaap_DomesticCountryMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001737995</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementScenarioAxis">STSS:NotExpireMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:DomesticCountryMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="AsOf2023-12-31_us-gaap_ForeignCountryMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001737995</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:ForeignCountryMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="AsOf2023-12-31_custom_OfficersAndDirectorsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001737995</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">STSS:OfficersAndDirectorsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="AsOf2022-12-31_custom_OfficersAndDirectorsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001737995</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">STSS:OfficersAndDirectorsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="AsOf2024-09-30_custom_OfficersAndDirectorsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001737995</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">STSS:OfficersAndDirectorsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-09-30</instant>
        </period>
    </context>
    <context id="AsOf2023-12-31_us-gaap_FairValueInputsLevel1Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001737995</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="AsOf2023-12-31_us-gaap_FairValueInputsLevel2Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001737995</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="AsOf2023-12-31_us-gaap_FairValueInputsLevel3Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001737995</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="AsOf2022-12-31_us-gaap_FairValueInputsLevel1Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001737995</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="AsOf2022-12-31_us-gaap_FairValueInputsLevel2Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001737995</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="AsOf2022-12-31_us-gaap_FairValueInputsLevel3Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001737995</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="AsOf2024-09-30_us-gaap_FairValueInputsLevel1Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001737995</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-09-30</instant>
        </period>
    </context>
    <context id="AsOf2024-09-30_us-gaap_FairValueInputsLevel2Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001737995</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-09-30</instant>
        </period>
    </context>
    <context id="AsOf2024-09-30_us-gaap_FairValueInputsLevel3Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001737995</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-09-30</instant>
        </period>
    </context>
    <context id="From2017-07-012017-07-31_custom_RoyaltyAgreementMember_custom_BarryBerlerMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001737995</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">STSS:BarryBerlerMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">STSS:RoyaltyAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2017-07-01</startDate>
            <endDate>2017-07-31</endDate>
        </period>
    </context>
    <context id="From2018-09-012018-09-30_custom_RoyaltyAgreementMember_custom_BarryBerlerMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001737995</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">STSS:BarryBerlerMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">STSS:RoyaltyAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-09-01</startDate>
            <endDate>2018-09-30</endDate>
        </period>
    </context>
    <context id="AsOf2018-09-30_custom_RoyaltyAgreementMember_custom_BarryBerlerMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001737995</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">STSS:BarryBerlerMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">STSS:RoyaltyAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-09-30</instant>
        </period>
    </context>
    <context id="From2019-05-012019-05-31_custom_RoyaltyAgreementMember_custom_BarryBerlerMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001737995</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">STSS:BarryBerlerMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">STSS:RoyaltyAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-05-01</startDate>
            <endDate>2019-05-31</endDate>
        </period>
    </context>
    <context id="From2022-07-302022-08-01_custom_EmploymentAgreementMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001737995</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">STSS:EmploymentAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-30</startDate>
            <endDate>2022-08-01</endDate>
        </period>
    </context>
    <context id="From2022-08-312022-09-01_custom_EmploymentAgreementMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001737995</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">STSS:EmploymentAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-08-31</startDate>
            <endDate>2022-09-01</endDate>
        </period>
    </context>
    <context id="AsOf2022-06-30_custom_Mr.BlackmanMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001737995</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">STSS:Mr.BlackmanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="From2023-01-012023-03-31_custom_Mr.BlackmanMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001737995</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">STSS:Mr.BlackmanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="From2023-07-012023-08-14_custom_Mr.BlackmanMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001737995</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">STSS:Mr.BlackmanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-07-01</startDate>
            <endDate>2023-08-14</endDate>
        </period>
    </context>
    <context id="AsOf2023-06-30_custom_Mr.BlackmanMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001737995</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">STSS:Mr.BlackmanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-06-30</instant>
        </period>
    </context>
    <context id="AsOf2023-12-31_custom_Mr.BlackmanMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001737995</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">STSS:Mr.BlackmanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="From2022-09-302022-09-30_custom_EmploymentAgreementMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001737995</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">STSS:EmploymentAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-09-30</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="From2022-10-012022-10-31_custom_ServiceAgreementMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001737995</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">STSS:ServiceAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-10-01</startDate>
            <endDate>2022-10-31</endDate>
        </period>
    </context>
    <context id="AsOf2022-10-31_custom_ServiceAgreementMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001737995</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">STSS:ServiceAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-10-31</instant>
        </period>
    </context>
    <context id="From2023-02-082023-02-09">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001737995</identifier>
        </entity>
        <period>
            <startDate>2023-02-08</startDate>
            <endDate>2023-02-09</endDate>
        </period>
    </context>
    <context id="AsOf2023-02-09">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001737995</identifier>
        </entity>
        <period>
            <instant>2023-02-09</instant>
        </period>
    </context>
    <context id="From2023-06-012023-06-01_custom_EmploymentAgreementMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001737995</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">STSS:EmploymentAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-06-01</startDate>
            <endDate>2023-06-01</endDate>
        </period>
    </context>
    <context id="From2023-05-312023-05-31_custom_EmploymentAgreementMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001737995</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">STSS:EmploymentAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-05-31</startDate>
            <endDate>2023-05-31</endDate>
        </period>
    </context>
    <context id="From2024-07-102024-07-10_custom_BerlerMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001737995</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">STSS:BerlerMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-07-10</startDate>
            <endDate>2024-07-10</endDate>
        </period>
    </context>
    <context id="From2024-06-172024-06-17_custom_BerlerMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001737995</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">STSS:BerlerMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-06-17</startDate>
            <endDate>2024-06-17</endDate>
        </period>
    </context>
    <context id="From2024-04-032024-04-03_custom_PlastomoldMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001737995</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">STSS:PlastomoldMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-04-03</startDate>
            <endDate>2024-04-03</endDate>
        </period>
    </context>
    <context id="From2022-07-302022-08-01_custom_EmploymentAgreementMember_custom_AlanBlackmanMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001737995</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">STSS:AlanBlackmanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">STSS:EmploymentAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-30</startDate>
            <endDate>2022-08-01</endDate>
        </period>
    </context>
    <context id="From2022-08-312022-09-01_custom_EmploymentAgreementMember_custom_AlanBlackmanMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001737995</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">STSS:AlanBlackmanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">STSS:EmploymentAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-08-31</startDate>
            <endDate>2022-09-01</endDate>
        </period>
    </context>
    <context id="AsOf2022-09-30_custom_EmploymentAgreementMember_custom_AlanBlackmanMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001737995</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">STSS:AlanBlackmanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">STSS:EmploymentAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="From2023-01-012023-03-31_custom_EmploymentAgreementMember_custom_AlanBlackmanMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001737995</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">STSS:AlanBlackmanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">STSS:EmploymentAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="From2023-07-012023-08-14_custom_AlanBlackmanMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001737995</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">STSS:AlanBlackmanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-07-01</startDate>
            <endDate>2023-08-14</endDate>
        </period>
    </context>
    <context id="AsOf2023-06-30_custom_AlanBlackmanMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001737995</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">STSS:AlanBlackmanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-06-30</instant>
        </period>
    </context>
    <context id="From2023-01-012023-12-31_custom_AlanBlackmanMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001737995</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">STSS:AlanBlackmanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="From2024-05-192024-05-20_custom_AssetPurchaseAgreementMember_custom_InjectEZLLCMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001737995</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AssetAcquisitionAxis">STSS:InjectEZLLCMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">STSS:AssetPurchaseAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-05-19</startDate>
            <endDate>2024-05-20</endDate>
        </period>
    </context>
    <context id="AsOf2024-05-20_custom_AssetPurchaseAgreementMember_custom_InjectEZLLCMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001737995</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AssetAcquisitionAxis">STSS:InjectEZLLCMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">STSS:AssetPurchaseAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-05-20</instant>
        </period>
    </context>
    <context id="From2024-01-012024-09-30_custom_AssetPurchaseAgreementMember_custom_InjectEZLLCMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001737995</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AssetAcquisitionAxis">STSS:InjectEZLLCMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">STSS:AssetPurchaseAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-09-30</endDate>
        </period>
    </context>
    <context id="AsOf2024-01-01_us-gaap_WarrantMember_us-gaap_SubsequentEventMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001737995</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:WarrantMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-01-01</instant>
        </period>
    </context>
    <context id="AsOf2024-09-30_us-gaap_LandMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001737995</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:LandMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-09-30</instant>
        </period>
    </context>
    <context id="AsOf2024-09-30_us-gaap_MachineryAndEquipmentMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001737995</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:MachineryAndEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-09-30</instant>
        </period>
    </context>
    <context id="AsOf2024-09-30_custom_ComputerSystemsAndWebsiteAndOtherMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001737995</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">STSS:ComputerSystemsAndWebsiteAndOtherMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-09-30</instant>
        </period>
    </context>
    <context id="AsOf2023-12-31_custom_ComputerSystemsAndWebsiteAndOtherMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001737995</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">STSS:ComputerSystemsAndWebsiteAndOtherMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <unit id="USD">
        <measure>iso4217:USD</measure>
    </unit>
    <unit id="Shares">
        <measure>shares</measure>
    </unit>
    <unit id="USDPShares">
        <divide>
            <unitNumerator>
                <measure>iso4217:USD</measure>
            </unitNumerator>
            <unitDenominator>
                <measure>shares</measure>
            </unitDenominator>
        </divide>
    </unit>
    <unit id="Pure">
        <measure>pure</measure>
    </unit>
    <dei:AmendmentFlag contextRef="From2024-01-01to2024-09-30" id="Fact000003">true</dei:AmendmentFlag>
    <dei:AmendmentDescription contextRef="From2024-01-01to2024-09-30" id="Fact000004">AMENDMENT NO. 1</dei:AmendmentDescription>
    <dei:EntityCentralIndexKey contextRef="From2024-01-01to2024-09-30" id="Fact000005">0001737995</dei:EntityCentralIndexKey>
    <dei:DocumentType contextRef="From2024-01-01to2024-09-30" id="xdx2ixbrl0011">S-1/A</dei:DocumentType>
    <us-gaap:CommitmentsAndContingencies
      contextRef="AsOf2023-12-31"
      id="xdx2ixbrl0089"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:CommitmentsAndContingencies
      contextRef="AsOf2022-12-31"
      id="xdx2ixbrl0090"
      unitRef="USD"
      xsi:nil="true"/>
    <STSS:SubsequentEvents
      contextRef="AsOf2023-12-31"
      id="xdx2ixbrl0092"
      unitRef="USD"
      xsi:nil="true"/>
    <STSS:SubsequentEvents
      contextRef="AsOf2022-12-31"
      id="xdx2ixbrl0093"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:PreferredStockValue
      contextRef="AsOf2023-12-31"
      id="xdx2ixbrl0098"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:PreferredStockValue
      contextRef="AsOf2022-12-31"
      id="xdx2ixbrl0099"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="From2023-01-012023-12-31"
      id="xdx2ixbrl0154"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="From2022-01-012022-12-31"
      id="xdx2ixbrl0155"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:DeferredIncomeTaxExpenseBenefit
      contextRef="From2022-01-012022-12-31"
      id="xdx2ixbrl0200"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2021-12-31_us-gaap_PreferredStockMember"
      id="xdx2ixbrl0233"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2021-12-31_us-gaap_AccumulatedOtherComprehensiveIncomeMember"
      id="xdx2ixbrl0237"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:NetIncomeLoss
      contextRef="From2022-01-012022-12-31_us-gaap_PreferredStockMember"
      id="xdx2ixbrl0245"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:NetIncomeLoss
      contextRef="From2022-01-012022-12-31_us-gaap_CommonStockMember"
      id="xdx2ixbrl0246"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:NetIncomeLoss
      contextRef="From2022-01-012022-12-31_custom_CommonStockSubscriptionReceivableMember"
      id="xdx2ixbrl0247"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:NetIncomeLoss
      contextRef="From2022-01-012022-12-31_us-gaap_AdditionalPaidInCapitalMember"
      id="xdx2ixbrl0248"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:NetIncomeLoss
      contextRef="From2022-01-012022-12-31_us-gaap_AccumulatedOtherComprehensiveIncomeMember"
      id="xdx2ixbrl0249"
      unitRef="USD"
      xsi:nil="true"/>
    <STSS:StockIssuedDuringPeriodValueInitialPublicOffering
      contextRef="From2022-01-012022-12-31_custom_CommonStockSubscriptionReceivableMember"
      id="xdx2ixbrl0255"
      unitRef="USD"
      xsi:nil="true"/>
    <STSS:StockIssuedDuringPeriodValueInitialPublicOffering
      contextRef="From2022-01-012022-12-31_us-gaap_AccumulatedOtherComprehensiveIncomeMember"
      id="xdx2ixbrl0257"
      unitRef="USD"
      xsi:nil="true"/>
    <STSS:StockIssuedDuringPeriodValueInitialPublicOffering
      contextRef="From2022-01-012022-12-31_us-gaap_RetainedEarningsMember"
      id="xdx2ixbrl0258"
      unitRef="USD"
      xsi:nil="true"/>
    <STSS:StockIssuedDuringPeriodValueContingentStockLiability
      contextRef="From2022-01-012022-12-31_custom_CommonStockSubscriptionReceivableMember"
      id="xdx2ixbrl0265"
      unitRef="USD"
      xsi:nil="true"/>
    <STSS:StockIssuedDuringPeriodValueContingentStockLiability
      contextRef="From2022-01-012022-12-31_us-gaap_AccumulatedOtherComprehensiveIncomeMember"
      id="xdx2ixbrl0267"
      unitRef="USD"
      xsi:nil="true"/>
    <STSS:StockIssuedDuringPeriodValueContingentStockLiability
      contextRef="From2022-01-012022-12-31_us-gaap_RetainedEarningsMember"
      id="xdx2ixbrl0268"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="From2022-01-012022-12-31_us-gaap_PreferredStockMember"
      id="xdx2ixbrl0273"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="From2022-01-012022-12-31_us-gaap_CommonStockMember"
      id="xdx2ixbrl0274"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="From2022-01-012022-12-31_custom_CommonStockSubscriptionReceivableMember"
      id="xdx2ixbrl0275"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="From2022-01-012022-12-31_us-gaap_AccumulatedOtherComprehensiveIncomeMember"
      id="xdx2ixbrl0277"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="From2022-01-012022-12-31_us-gaap_RetainedEarningsMember"
      id="xdx2ixbrl0278"
      unitRef="USD"
      xsi:nil="true"/>
    <STSS:StockIssuedDuringPeriodValueFractionalShareAdjustment
      contextRef="From2022-01-012022-12-31_us-gaap_PreferredStockMember"
      id="xdx2ixbrl0281"
      unitRef="USD"
      xsi:nil="true"/>
    <STSS:StockIssuedDuringPeriodValueFractionalShareAdjustment
      contextRef="From2022-01-012022-12-31_us-gaap_CommonStockMember"
      id="xdx2ixbrl0282"
      unitRef="USD"
      xsi:nil="true"/>
    <STSS:StockIssuedDuringPeriodValueFractionalShareAdjustment
      contextRef="From2022-01-012022-12-31_custom_CommonStockSubscriptionReceivableMember"
      id="xdx2ixbrl0283"
      unitRef="USD"
      xsi:nil="true"/>
    <STSS:StockIssuedDuringPeriodValueFractionalShareAdjustment
      contextRef="From2022-01-012022-12-31_us-gaap_AdditionalPaidInCapitalMember"
      id="xdx2ixbrl0284"
      unitRef="USD"
      xsi:nil="true"/>
    <STSS:StockIssuedDuringPeriodValueFractionalShareAdjustment
      contextRef="From2022-01-012022-12-31_us-gaap_AccumulatedOtherComprehensiveIncomeMember"
      id="xdx2ixbrl0285"
      unitRef="USD"
      xsi:nil="true"/>
    <STSS:StockIssuedDuringPeriodValueFractionalShareAdjustment
      contextRef="From2022-01-012022-12-31_us-gaap_RetainedEarningsMember"
      id="xdx2ixbrl0286"
      unitRef="USD"
      xsi:nil="true"/>
    <STSS:StockIssuedDuringPeriodValueFractionalShareAdjustment
      contextRef="From2022-01-012022-12-31"
      id="xdx2ixbrl0287"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodValueIssuedForServices
      contextRef="From2022-01-012022-12-31_us-gaap_PreferredStockMember"
      id="xdx2ixbrl0291"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodValueIssuedForServices
      contextRef="From2022-01-012022-12-31_custom_CommonStockSubscriptionReceivableMember"
      id="xdx2ixbrl0293"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodValueIssuedForServices
      contextRef="From2022-01-012022-12-31_us-gaap_AccumulatedOtherComprehensiveIncomeMember"
      id="xdx2ixbrl0295"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodValueIssuedForServices
      contextRef="From2022-01-012022-12-31_us-gaap_RetainedEarningsMember"
      id="xdx2ixbrl0296"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax
      contextRef="From2022-01-012022-12-31_us-gaap_PreferredStockMember"
      id="xdx2ixbrl0301"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax
      contextRef="From2022-01-012022-12-31_us-gaap_CommonStockMember"
      id="xdx2ixbrl0302"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax
      contextRef="From2022-01-012022-12-31_custom_CommonStockSubscriptionReceivableMember"
      id="xdx2ixbrl0303"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax
      contextRef="From2022-01-012022-12-31_us-gaap_AdditionalPaidInCapitalMember"
      id="xdx2ixbrl0304"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax
      contextRef="From2022-01-012022-12-31_us-gaap_RetainedEarningsMember"
      id="xdx2ixbrl0306"
      unitRef="USD"
      xsi:nil="true"/>
    <STSS:StockIssuedDuringPeriodCollectionsOfCommonStockSubscriptionsValue
      contextRef="From2022-01-012022-12-31_us-gaap_PreferredStockMember"
      id="xdx2ixbrl0309"
      unitRef="USD"
      xsi:nil="true"/>
    <STSS:StockIssuedDuringPeriodCollectionsOfCommonStockSubscriptionsValue
      contextRef="From2022-01-012022-12-31_us-gaap_CommonStockMember"
      id="xdx2ixbrl0310"
      unitRef="USD"
      xsi:nil="true"/>
    <STSS:StockIssuedDuringPeriodCollectionsOfCommonStockSubscriptionsValue
      contextRef="From2022-01-012022-12-31_us-gaap_AdditionalPaidInCapitalMember"
      id="xdx2ixbrl0312"
      unitRef="USD"
      xsi:nil="true"/>
    <STSS:StockIssuedDuringPeriodCollectionsOfCommonStockSubscriptionsValue
      contextRef="From2022-01-012022-12-31_us-gaap_AccumulatedOtherComprehensiveIncomeMember"
      id="xdx2ixbrl0313"
      unitRef="USD"
      xsi:nil="true"/>
    <STSS:StockIssuedDuringPeriodCollectionsOfCommonStockSubscriptionsValue
      contextRef="From2022-01-012022-12-31_us-gaap_RetainedEarningsMember"
      id="xdx2ixbrl0314"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2022-12-31_custom_ReverseStockSplitMember_us-gaap_PreferredStockMember"
      id="xdx2ixbrl0317"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2022-12-31_custom_ReverseStockSplitMember_custom_CommonStockSubscriptionReceivableMember"
      id="xdx2ixbrl0319"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2022-12-31_custom_ReverseStockSplitMember_us-gaap_PreferredStockMember"
      id="xdx2ixbrl0329"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2022-12-31_custom_ReverseStockSplitMember_custom_CommonStockSubscriptionReceivableMember"
      id="xdx2ixbrl0331"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:NetIncomeLoss
      contextRef="From2023-01-012023-12-31_custom_ReverseStockSplitMember_us-gaap_PreferredStockMember"
      id="xdx2ixbrl0349"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:NetIncomeLoss
      contextRef="From2023-01-012023-12-31_custom_ReverseStockSplitMember_custom_CommonStockSubscriptionReceivableMember"
      id="xdx2ixbrl0351"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2023-12-31_custom_ReverseStockSplitMember_us-gaap_PreferredStockMember"
      id="xdx2ixbrl0401"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2023-12-31_custom_ReverseStockSplitMember_custom_CommonStockSubscriptionReceivableMember"
      id="xdx2ixbrl0403"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2023-12-31_custom_ReverseStockSplitMember_us-gaap_PreferredStockMember"
      id="xdx2ixbrl0413"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2023-12-31_custom_ReverseStockSplitMember_custom_CommonStockSubscriptionReceivableMember"
      id="xdx2ixbrl0415"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:IssuanceOfStockAndWarrantsForServicesOrClaims
      contextRef="From2023-01-012023-12-31"
      id="xdx2ixbrl0440"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:AmortizationOfDebtDiscountPremium
      contextRef="From2023-01-012023-12-31"
      id="xdx2ixbrl0443"
      unitRef="USD"
      xsi:nil="true"/>
    <STSS:FairMarketValueAdjustmentForContingentWarrants
      contextRef="From2023-01-012023-12-31"
      id="xdx2ixbrl0455"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:ImpairmentOfLongLivedAssetsHeldForUse
      contextRef="From2022-01-012022-12-31"
      id="xdx2ixbrl0462"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:DeferredIncomeTaxExpenseBenefit
      contextRef="From2022-01-012022-12-31"
      id="xdx2ixbrl0465"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:PaymentsForProceedsFromOtherInvestingActivities
      contextRef="From2023-01-012023-12-31"
      id="xdx2ixbrl0494"
      unitRef="USD"
      xsi:nil="true"/>
    <STSS:PaymentsToAssetAcquisition
      contextRef="From2023-01-012023-12-31"
      id="xdx2ixbrl0503"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:RepaymentsOfNotesPayable
      contextRef="From2023-01-012023-12-31"
      id="xdx2ixbrl0521"
      unitRef="USD"
      xsi:nil="true"/>
    <STSS:ProceedsFromSubscriptionsReceivable
      contextRef="From2023-01-012023-12-31"
      id="xdx2ixbrl0524"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:InterestPaidNet
      contextRef="From2023-01-012023-12-31"
      id="xdx2ixbrl0545"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:IncomeTaxesPaidNet
      contextRef="From2023-01-012023-12-31"
      id="xdx2ixbrl0548"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:IncomeTaxesPaidNet
      contextRef="From2022-01-012022-12-31"
      id="xdx2ixbrl0549"
      unitRef="USD"
      xsi:nil="true"/>
    <STSS:FmvForCommonStockIssuedForContingentShares
      contextRef="From2023-01-012023-12-31"
      id="xdx2ixbrl0554"
      unitRef="USD"
      xsi:nil="true"/>
    <STSS:FmvForWarrantsIssuedForContingentWarrants
      contextRef="From2023-01-012023-12-31"
      id="xdx2ixbrl0557"
      unitRef="USD"
      xsi:nil="true"/>
    <STSS:CommonStockIssuedAndVestedStockOptionsForFixedAssetsAcquired
      contextRef="From2023-01-012023-12-31"
      id="xdx2ixbrl0560"
      unitRef="USD"
      xsi:nil="true"/>
    <STSS:CommonStockIssuedAndVestedStockOptionsIssuedAsConsiderationForAcquisition
      contextRef="From2023-01-012023-12-31"
      id="xdx2ixbrl0563"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:ImpairmentOfLongLivedAssetsHeldForUse
      contextRef="From2022-01-012022-12-31"
      id="xdx2ixbrl0604"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:DepositsAssets
      contextRef="AsOf2023-12-31"
      id="xdx2ixbrl0738"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
      contextRef="From2023-01-012023-12-31_us-gaap_IPOMember"
      id="xdx2ixbrl0970">P5Y</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1>
    <STSS:WarrantLiability
      contextRef="AsOf2022-12-31_custom_OfferingWarrantsFebruaryTwentyTwentyThreeMember"
      id="xdx2ixbrl1011"
      unitRef="USD"
      xsi:nil="true"/>
    <STSS:WarrantLiability
      contextRef="AsOf2022-12-31_custom_OfferingWarrantsSeptemberTwentyTwentyThreeMember"
      id="xdx2ixbrl1014"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:ClassOfWarrantOrRightOutstanding
      contextRef="AsOf2022-12-31_custom_OfferingWarrantsFebruaryTwentyTwentyThreeMember"
      id="xdx2ixbrl1028"
      unitRef="Shares"
      xsi:nil="true"/>
    <us-gaap:ClassOfWarrantOrRightOutstanding
      contextRef="AsOf2022-12-31_custom_OfferingWarrantsSeptemberTwentyTwentyThreeMember"
      id="xdx2ixbrl1031"
      unitRef="Shares"
      xsi:nil="true"/>
    <us-gaap:ClassOfWarrantOrRightOutstanding
      contextRef="AsOf2022-12-31_custom_WarrantsIssuedForServiceManagementMember"
      id="xdx2ixbrl1034"
      unitRef="Shares"
      xsi:nil="true"/>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
      contextRef="From2023-01-012023-12-31_custom_TwoThousandTwentyThreeEquityIncentivePlanMember"
      id="xdx2ixbrl1095">P5Y</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
      contextRef="AsOf2023-12-31_custom_ExercisePriceRangeOneMember"
      id="xdx2ixbrl1135"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1
      contextRef="AsOf2023-12-31_custom_ExercisePriceRangeOneMember"
      id="xdx2ixbrl1141"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
      contextRef="AsOf2023-12-31_custom_ExercisePriceRangeTwoMember"
      id="xdx2ixbrl1147"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1
      contextRef="AsOf2023-12-31_custom_ExercisePriceRangeTwoMember"
      id="xdx2ixbrl1153"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
      contextRef="AsOf2023-12-31_custom_ExercisePriceRangeThreeMember"
      id="xdx2ixbrl1159"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1
      contextRef="AsOf2023-12-31_custom_ExercisePriceRangeThreeMember"
      id="xdx2ixbrl1165"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
      contextRef="AsOf2023-12-31_custom_ExercisePriceRangeFourMember"
      id="xdx2ixbrl1171"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1
      contextRef="AsOf2023-12-31_custom_ExercisePriceRangeFourMember"
      id="xdx2ixbrl1177"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
      contextRef="AsOf2023-12-31_custom_ExercisePriceRangeFiveMember"
      id="xdx2ixbrl1183"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1
      contextRef="AsOf2023-12-31_custom_ExercisePriceRangeFiveMember"
      id="xdx2ixbrl1189"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
      contextRef="AsOf2023-12-31_custom_ExercisePriceRangeSixMember"
      id="xdx2ixbrl1195"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1
      contextRef="AsOf2023-12-31_custom_ExercisePriceRangeSixMember"
      id="xdx2ixbrl1201"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
      contextRef="AsOf2023-12-31_custom_ExercisePriceRangeSevenMember"
      id="xdx2ixbrl1207"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1
      contextRef="AsOf2023-12-31_custom_ExercisePriceRangeSevenMember"
      id="xdx2ixbrl1213"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
      contextRef="AsOf2023-12-31_custom_ExercisePriceRangeEightMember"
      id="xdx2ixbrl1219"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1
      contextRef="AsOf2023-12-31_custom_ExercisePriceRangeEightMember"
      id="xdx2ixbrl1225"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
      contextRef="AsOf2023-12-31_custom_ExercisePriceRangeNineMember"
      id="xdx2ixbrl1231"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1
      contextRef="AsOf2023-12-31_custom_ExercisePriceRangeNineMember"
      id="xdx2ixbrl1237"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
      contextRef="AsOf2023-12-31_custom_ExercisePriceRangeTenMember"
      id="xdx2ixbrl1243"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1
      contextRef="AsOf2023-12-31_custom_ExercisePriceRangeTenMember"
      id="xdx2ixbrl1249"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:IncomeTaxReconciliationStateAndLocalIncomeTaxes
      contextRef="From2023-01-012023-12-31"
      id="xdx2ixbrl1311"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="From2022-01-012022-12-31"
      id="xdx2ixbrl1321"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:CashAndCashEquivalentsFairValueDisclosure
      contextRef="AsOf2023-12-31_us-gaap_FairValueInputsLevel2Member"
      id="xdx2ixbrl1393"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:CashAndCashEquivalentsFairValueDisclosure
      contextRef="AsOf2023-12-31_us-gaap_FairValueInputsLevel3Member"
      id="xdx2ixbrl1394"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="AsOf2023-12-31_us-gaap_FairValueInputsLevel2Member"
      id="xdx2ixbrl1398"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="AsOf2023-12-31_us-gaap_FairValueInputsLevel3Member"
      id="xdx2ixbrl1399"
      unitRef="USD"
      xsi:nil="true"/>
    <STSS:WarrantLiability
      contextRef="AsOf2023-12-31_us-gaap_FairValueInputsLevel1Member"
      id="xdx2ixbrl1407"
      unitRef="USD"
      xsi:nil="true"/>
    <STSS:WarrantLiability
      contextRef="AsOf2023-12-31_us-gaap_FairValueInputsLevel3Member"
      id="xdx2ixbrl1409"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:LiabilitiesFairValueDisclosure
      contextRef="AsOf2023-12-31_us-gaap_FairValueInputsLevel1Member"
      id="xdx2ixbrl1412"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:LiabilitiesFairValueDisclosure
      contextRef="AsOf2023-12-31_us-gaap_FairValueInputsLevel3Member"
      id="xdx2ixbrl1414"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:CashAndCashEquivalentsFairValueDisclosure
      contextRef="AsOf2022-12-31_us-gaap_FairValueInputsLevel2Member"
      id="xdx2ixbrl1423"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:CashAndCashEquivalentsFairValueDisclosure
      contextRef="AsOf2022-12-31_us-gaap_FairValueInputsLevel3Member"
      id="xdx2ixbrl1424"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="AsOf2022-12-31_us-gaap_FairValueInputsLevel2Member"
      id="xdx2ixbrl1428"
      unitRef="USD"
      xsi:nil="true"/>
    <STSS:WarrantLiability
      contextRef="AsOf2022-12-31_us-gaap_FairValueInputsLevel2Member"
      id="xdx2ixbrl1438"
      unitRef="USD"
      xsi:nil="true"/>
    <STSS:WarrantLiability
      contextRef="AsOf2022-12-31_us-gaap_FairValueInputsLevel3Member"
      id="xdx2ixbrl1439"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:LiabilitiesFairValueDisclosure
      contextRef="AsOf2022-12-31_us-gaap_FairValueInputsLevel2Member"
      id="xdx2ixbrl1443"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:LiabilitiesFairValueDisclosure
      contextRef="AsOf2022-12-31_us-gaap_FairValueInputsLevel3Member"
      id="xdx2ixbrl1444"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:NotesPayableCurrent
      contextRef="AsOf2023-12-31"
      id="xdx2ixbrl1549"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:CommitmentsAndContingencies
      contextRef="AsOf2024-09-30"
      id="xdx2ixbrl1563"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:CommitmentsAndContingencies
      contextRef="AsOf2023-12-31"
      id="xdx2ixbrl1564"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:PreferredStockValue
      contextRef="AsOf2024-09-30"
      id="xdx2ixbrl1569"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:PreferredStockValue
      contextRef="AsOf2023-12-31"
      id="xdx2ixbrl1570"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="From2024-07-012024-09-30"
      id="xdx2ixbrl1624"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="From2023-07-012023-09-30"
      id="xdx2ixbrl1625"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="From2024-01-01to2024-09-30"
      id="xdx2ixbrl1626"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="From2023-01-012023-09-30"
      id="xdx2ixbrl1627"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2023-12-31_us-gaap_PreferredStockMember"
      id="xdx2ixbrl1746"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2023-12-31_custom_CommonStockSubscriptionReceivableMember"
      id="xdx2ixbrl1748"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:NetIncomeLoss
      contextRef="From2024-01-012024-03-31_us-gaap_PreferredStockMember"
      id="xdx2ixbrl1758"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:NetIncomeLoss
      contextRef="From2024-01-012024-03-31_us-gaap_CommonStockMember"
      id="xdx2ixbrl1759"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:NetIncomeLoss
      contextRef="From2024-01-012024-03-31_custom_CommonStockSubscriptionReceivableMember"
      id="xdx2ixbrl1760"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:NetIncomeLoss
      contextRef="From2024-01-012024-03-31_us-gaap_AdditionalPaidInCapitalMember"
      id="xdx2ixbrl1761"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:NetIncomeLoss
      contextRef="From2024-01-012024-03-31_us-gaap_AccumulatedOtherComprehensiveIncomeMember"
      id="xdx2ixbrl1762"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="From2024-01-012024-03-31_us-gaap_PreferredStockMember"
      id="xdx2ixbrl1766"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="From2024-01-012024-03-31_us-gaap_CommonStockMember"
      id="xdx2ixbrl1767"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="From2024-01-012024-03-31_us-gaap_AccumulatedOtherComprehensiveIncomeMember"
      id="xdx2ixbrl1770"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="From2024-01-012024-03-31_us-gaap_RetainedEarningsMember"
      id="xdx2ixbrl1771"
      unitRef="USD"
      xsi:nil="true"/>
    <STSS:StockIssuedDuringPeriodValueExerciseOfPrefundedWarrants
      contextRef="From2024-01-012024-03-31_us-gaap_PreferredStockMember"
      id="xdx2ixbrl1774"
      unitRef="USD"
      xsi:nil="true"/>
    <STSS:StockIssuedDuringPeriodValueExerciseOfPrefundedWarrants
      contextRef="From2024-01-012024-03-31_us-gaap_AccumulatedOtherComprehensiveIncomeMember"
      id="xdx2ixbrl1778"
      unitRef="USD"
      xsi:nil="true"/>
    <STSS:StockIssuedDuringPeriodValueExerciseOfPrefundedWarrants
      contextRef="From2024-01-012024-03-31_us-gaap_RetainedEarningsMember"
      id="xdx2ixbrl1779"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax
      contextRef="From2024-01-012024-03-31_us-gaap_PreferredStockMember"
      id="xdx2ixbrl1784"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax
      contextRef="From2024-01-012024-03-31_us-gaap_CommonStockMember"
      id="xdx2ixbrl1785"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax
      contextRef="From2024-01-012024-03-31_us-gaap_AdditionalPaidInCapitalMember"
      id="xdx2ixbrl1787"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax
      contextRef="From2024-01-012024-03-31_us-gaap_RetainedEarningsMember"
      id="xdx2ixbrl1789"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2024-03-31_us-gaap_PreferredStockMember"
      id="xdx2ixbrl1792"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2024-03-31_custom_CommonStockSubscriptionReceivableMember"
      id="xdx2ixbrl1794"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:NetIncomeLoss
      contextRef="From2024-04-012024-06-30_us-gaap_PreferredStockMember"
      id="xdx2ixbrl1804"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:NetIncomeLoss
      contextRef="From2024-04-012024-06-30_us-gaap_CommonStockMember"
      id="xdx2ixbrl1805"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:NetIncomeLoss
      contextRef="From2024-04-012024-06-30_custom_CommonStockSubscriptionReceivableMember"
      id="xdx2ixbrl1806"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:NetIncomeLoss
      contextRef="From2024-04-012024-06-30_us-gaap_AdditionalPaidInCapitalMember"
      id="xdx2ixbrl1807"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:NetIncomeLoss
      contextRef="From2024-04-012024-06-30_us-gaap_AccumulatedOtherComprehensiveIncomeMember"
      id="xdx2ixbrl1808"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="From2024-04-012024-06-30_us-gaap_PreferredStockMember"
      id="xdx2ixbrl1812"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="From2024-04-012024-06-30_us-gaap_CommonStockMember"
      id="xdx2ixbrl1813"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="From2024-04-012024-06-30_us-gaap_AccumulatedOtherComprehensiveIncomeMember"
      id="xdx2ixbrl1816"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="From2024-04-012024-06-30_us-gaap_RetainedEarningsMember"
      id="xdx2ixbrl1817"
      unitRef="USD"
      xsi:nil="true"/>
    <STSS:StockIssuedDuringPeriodValueExerciseOfPrefundedWarrant
      contextRef="From2024-04-012024-06-30_us-gaap_PreferredStockMember"
      id="xdx2ixbrl1820"
      unitRef="USD"
      xsi:nil="true"/>
    <STSS:StockIssuedDuringPeriodValueExerciseOfPrefundedWarrant
      contextRef="From2024-04-012024-06-30_us-gaap_AccumulatedOtherComprehensiveIncomeMember"
      id="xdx2ixbrl1824"
      unitRef="USD"
      xsi:nil="true"/>
    <STSS:StockIssuedDuringPeriodValueExerciseOfPrefundedWarrant
      contextRef="From2024-04-012024-06-30_us-gaap_RetainedEarningsMember"
      id="xdx2ixbrl1825"
      unitRef="USD"
      xsi:nil="true"/>
    <STSS:StockIssuedDuringPeriodValueRegistrationOffering
      contextRef="From2024-04-012024-06-30_us-gaap_PreferredStockMember"
      id="xdx2ixbrl1830"
      unitRef="USD"
      xsi:nil="true"/>
    <STSS:StockIssuedDuringPeriodValueRegistrationOffering
      contextRef="From2024-04-012024-06-30_us-gaap_AccumulatedOtherComprehensiveIncomeMember"
      id="xdx2ixbrl1834"
      unitRef="USD"
      xsi:nil="true"/>
    <STSS:StockIssuedDuringPeriodValueRegistrationOffering
      contextRef="From2024-04-012024-06-30_us-gaap_RetainedEarningsMember"
      id="xdx2ixbrl1835"
      unitRef="USD"
      xsi:nil="true"/>
    <STSS:StockIssuedDuringPeriodValueWarrantInducements
      contextRef="From2024-04-012024-06-30_us-gaap_AccumulatedOtherComprehensiveIncomeMember"
      id="xdx2ixbrl1844"
      unitRef="USD"
      xsi:nil="true"/>
    <STSS:StockIssuedDuringPeriodValueWarrantInducements
      contextRef="From2024-04-012024-06-30_us-gaap_RetainedEarningsMember"
      id="xdx2ixbrl1845"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax
      contextRef="From2024-04-012024-06-30_us-gaap_PreferredStockMember"
      id="xdx2ixbrl1850"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax
      contextRef="From2024-04-012024-06-30_us-gaap_CommonStockMember"
      id="xdx2ixbrl1851"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax
      contextRef="From2024-04-012024-06-30_us-gaap_AdditionalPaidInCapitalMember"
      id="xdx2ixbrl1853"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax
      contextRef="From2024-04-012024-06-30_us-gaap_RetainedEarningsMember"
      id="xdx2ixbrl1855"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2024-06-30_us-gaap_PreferredStockMember"
      id="xdx2ixbrl1858"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2024-06-30_custom_CommonStockSubscriptionReceivableMember"
      id="xdx2ixbrl1860"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:NetIncomeLoss
      contextRef="From2024-07-012024-09-30_us-gaap_PreferredStockMember"
      id="xdx2ixbrl1870"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:NetIncomeLoss
      contextRef="From2024-07-012024-09-30_us-gaap_CommonStockMember"
      id="xdx2ixbrl1871"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:NetIncomeLoss
      contextRef="From2024-07-012024-09-30_custom_CommonStockSubscriptionReceivableMember"
      id="xdx2ixbrl1872"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:NetIncomeLoss
      contextRef="From2024-07-012024-09-30_us-gaap_AdditionalPaidInCapitalMember"
      id="xdx2ixbrl1873"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:NetIncomeLoss
      contextRef="From2024-07-012024-09-30_us-gaap_AccumulatedOtherComprehensiveIncomeMember"
      id="xdx2ixbrl1874"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockRedeemedOrCalledDuringPeriodValue
      contextRef="From2024-07-012024-09-30_us-gaap_PreferredStockMember"
      id="xdx2ixbrl1878"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockRedeemedOrCalledDuringPeriodValue
      contextRef="From2024-07-012024-09-30_us-gaap_CommonStockMember"
      id="xdx2ixbrl1879"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockRedeemedOrCalledDuringPeriodValue
      contextRef="From2024-07-012024-09-30_us-gaap_AdditionalPaidInCapitalMember"
      id="xdx2ixbrl1881"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockRedeemedOrCalledDuringPeriodValue
      contextRef="From2024-07-012024-09-30_us-gaap_AccumulatedOtherComprehensiveIncomeMember"
      id="xdx2ixbrl1882"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockRedeemedOrCalledDuringPeriodValue
      contextRef="From2024-07-012024-09-30_us-gaap_RetainedEarningsMember"
      id="xdx2ixbrl1883"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockRedeemedOrCalledDuringPeriodValue
      contextRef="From2024-07-012024-09-30"
      id="xdx2ixbrl1884"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="From2024-07-012024-09-30_us-gaap_PreferredStockMember"
      id="xdx2ixbrl1888"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="From2024-07-012024-09-30_us-gaap_CommonStockMember"
      id="xdx2ixbrl1889"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="From2024-07-012024-09-30_us-gaap_AccumulatedOtherComprehensiveIncomeMember"
      id="xdx2ixbrl1892"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="From2024-07-012024-09-30_us-gaap_RetainedEarningsMember"
      id="xdx2ixbrl1893"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodValueOther
      contextRef="From2024-07-012024-09-30_us-gaap_PreferredStockMember"
      id="xdx2ixbrl1896"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodValueOther
      contextRef="From2024-07-012024-09-30_us-gaap_AccumulatedOtherComprehensiveIncomeMember"
      id="xdx2ixbrl1900"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodValueOther
      contextRef="From2024-07-012024-09-30_us-gaap_RetainedEarningsMember"
      id="xdx2ixbrl1901"
      unitRef="USD"
      xsi:nil="true"/>
    <STSS:StockIssuedDuringPeriodValueWarrantExericse
      contextRef="From2024-07-012024-09-30_us-gaap_PreferredStockMember"
      id="xdx2ixbrl1906"
      unitRef="USD"
      xsi:nil="true"/>
    <STSS:StockIssuedDuringPeriodValueWarrantExericse
      contextRef="From2024-07-012024-09-30_us-gaap_AccumulatedOtherComprehensiveIncomeMember"
      id="xdx2ixbrl1910"
      unitRef="USD"
      xsi:nil="true"/>
    <STSS:StockIssuedDuringPeriodValueWarrantExericse
      contextRef="From2024-07-012024-09-30_us-gaap_RetainedEarningsMember"
      id="xdx2ixbrl1911"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax
      contextRef="From2024-07-012024-09-30_us-gaap_PreferredStockMember"
      id="xdx2ixbrl1916"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax
      contextRef="From2024-07-012024-09-30_us-gaap_CommonStockMember"
      id="xdx2ixbrl1917"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax
      contextRef="From2024-07-012024-09-30_us-gaap_AdditionalPaidInCapitalMember"
      id="xdx2ixbrl1919"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax
      contextRef="From2024-07-012024-09-30_us-gaap_RetainedEarningsMember"
      id="xdx2ixbrl1921"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2024-09-30_us-gaap_PreferredStockMember"
      id="xdx2ixbrl1924"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2024-09-30_custom_CommonStockSubscriptionReceivableMember"
      id="xdx2ixbrl1926"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:SharesOutstanding
      contextRef="AsOf2024-09-30_us-gaap_PreferredStockMember"
      id="xdx2ixbrl1932"
      unitRef="Shares"
      xsi:nil="true"/>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2022-12-31_us-gaap_PreferredStockMember"
      id="xdx2ixbrl1936"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2022-12-31_custom_CommonStockSubscriptionReceivableMember"
      id="xdx2ixbrl1938"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:NetIncomeLoss
      contextRef="From2023-01-012023-03-31_us-gaap_PreferredStockMember"
      id="xdx2ixbrl1948"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:NetIncomeLoss
      contextRef="From2023-01-012023-03-31_us-gaap_CommonStockMember"
      id="xdx2ixbrl1949"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:NetIncomeLoss
      contextRef="From2023-01-012023-03-31_custom_CommonStockSubscriptionReceivableMember"
      id="xdx2ixbrl1950"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:NetIncomeLoss
      contextRef="From2023-01-012023-03-31_us-gaap_AdditionalPaidInCapitalMember"
      id="xdx2ixbrl1951"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:NetIncomeLoss
      contextRef="From2023-01-012023-03-31_us-gaap_AccumulatedOtherComprehensiveIncomeMember"
      id="xdx2ixbrl1952"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues
      contextRef="From2023-01-012023-03-31_us-gaap_AccumulatedOtherComprehensiveIncomeMember"
      id="xdx2ixbrl1960"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="From2023-01-012023-03-31_us-gaap_PreferredStockMember"
      id="xdx2ixbrl1966"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="From2023-01-012023-03-31_us-gaap_CommonStockMember"
      id="xdx2ixbrl1967"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="From2023-01-012023-03-31_custom_CommonStockSubscriptionReceivableMember"
      id="xdx2ixbrl1968"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="From2023-01-012023-03-31_us-gaap_AccumulatedOtherComprehensiveIncomeMember"
      id="xdx2ixbrl1970"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="From2023-01-012023-03-31_us-gaap_RetainedEarningsMember"
      id="xdx2ixbrl1971"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax
      contextRef="From2023-01-012023-03-31_us-gaap_PreferredStockMember"
      id="xdx2ixbrl1974"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax
      contextRef="From2023-01-012023-03-31_custom_CommonStockSubscriptionReceivableMember"
      id="xdx2ixbrl1976"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax
      contextRef="From2023-01-012023-03-31_us-gaap_AdditionalPaidInCapitalMember"
      id="xdx2ixbrl1977"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax
      contextRef="From2023-01-012023-03-31_us-gaap_RetainedEarningsMember"
      id="xdx2ixbrl1979"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2023-03-31_us-gaap_PreferredStockMember"
      id="xdx2ixbrl1982"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2023-03-31_custom_CommonStockSubscriptionReceivableMember"
      id="xdx2ixbrl1984"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:NetIncomeLoss
      contextRef="From2023-04-012023-06-30_us-gaap_PreferredStockMember"
      id="xdx2ixbrl1994"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:NetIncomeLoss
      contextRef="From2023-04-012023-06-30_us-gaap_CommonStockMember"
      id="xdx2ixbrl1995"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:NetIncomeLoss
      contextRef="From2023-04-012023-06-30_custom_CommonStockSubscriptionReceivableMember"
      id="xdx2ixbrl1996"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:NetIncomeLoss
      contextRef="From2023-04-012023-06-30_us-gaap_AdditionalPaidInCapitalMember"
      id="xdx2ixbrl1997"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:NetIncomeLoss
      contextRef="From2023-04-012023-06-30_us-gaap_AccumulatedOtherComprehensiveIncomeMember"
      id="xdx2ixbrl1998"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="From2023-04-012023-06-30_us-gaap_PreferredStockMember"
      id="xdx2ixbrl2002"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="From2023-04-012023-06-30_us-gaap_CommonStockMember"
      id="xdx2ixbrl2003"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="From2023-04-012023-06-30_custom_CommonStockSubscriptionReceivableMember"
      id="xdx2ixbrl2004"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="From2023-04-012023-06-30_us-gaap_AccumulatedOtherComprehensiveIncomeMember"
      id="xdx2ixbrl2006"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="From2023-04-012023-06-30_us-gaap_RetainedEarningsMember"
      id="xdx2ixbrl2007"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax
      contextRef="From2023-04-012023-06-30_us-gaap_PreferredStockMember"
      id="xdx2ixbrl2010"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax
      contextRef="From2023-04-012023-06-30_custom_CommonStockSubscriptionReceivableMember"
      id="xdx2ixbrl2012"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax
      contextRef="From2023-04-012023-06-30_us-gaap_AdditionalPaidInCapitalMember"
      id="xdx2ixbrl2013"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax
      contextRef="From2023-04-012023-06-30_us-gaap_RetainedEarningsMember"
      id="xdx2ixbrl2015"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2023-06-30_us-gaap_PreferredStockMember"
      id="xdx2ixbrl2018"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2023-06-30_custom_CommonStockSubscriptionReceivableMember"
      id="xdx2ixbrl2020"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2023-06-30_us-gaap_PreferredStockMember"
      id="xdx2ixbrl2030"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2023-06-30_custom_CommonStockSubscriptionReceivableMember"
      id="xdx2ixbrl2032"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:NetIncomeLoss
      contextRef="From2023-07-012023-09-30_us-gaap_PreferredStockMember"
      id="xdx2ixbrl2042"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:NetIncomeLoss
      contextRef="From2023-07-012023-09-30_us-gaap_CommonStockMember"
      id="xdx2ixbrl2043"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:NetIncomeLoss
      contextRef="From2023-07-012023-09-30_custom_CommonStockSubscriptionReceivableMember"
      id="xdx2ixbrl2044"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:NetIncomeLoss
      contextRef="From2023-07-012023-09-30_us-gaap_AdditionalPaidInCapitalMember"
      id="xdx2ixbrl2045"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:NetIncomeLoss
      contextRef="From2023-07-012023-09-30_us-gaap_AccumulatedOtherComprehensiveIncomeMember"
      id="xdx2ixbrl2046"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:NetIncomeLoss
      contextRef="From2023-07-012023-09-30_us-gaap_PreferredStockMember"
      id="xdx2ixbrl2050"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:NetIncomeLoss
      contextRef="From2023-07-012023-09-30_us-gaap_CommonStockMember"
      id="xdx2ixbrl2051"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:NetIncomeLoss
      contextRef="From2023-07-012023-09-30_custom_CommonStockSubscriptionReceivableMember"
      id="xdx2ixbrl2052"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:NetIncomeLoss
      contextRef="From2023-07-012023-09-30_us-gaap_AdditionalPaidInCapitalMember"
      id="xdx2ixbrl2053"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:NetIncomeLoss
      contextRef="From2023-07-012023-09-30_us-gaap_AccumulatedOtherComprehensiveIncomeMember"
      id="xdx2ixbrl2054"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="From2023-07-012023-09-30_us-gaap_PreferredStockMember"
      id="xdx2ixbrl2058"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="From2023-07-012023-09-30_custom_CommonStockSubscriptionReceivableMember"
      id="xdx2ixbrl2060"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="From2023-07-012023-09-30_us-gaap_AccumulatedOtherComprehensiveIncomeMember"
      id="xdx2ixbrl2062"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="From2023-07-012023-09-30_us-gaap_RetainedEarningsMember"
      id="xdx2ixbrl2063"
      unitRef="USD"
      xsi:nil="true"/>
    <STSS:StockIssuedDuringPeriodValueShelfRegistrationOffering
      contextRef="From2023-07-012023-09-30_us-gaap_PreferredStockMember"
      id="xdx2ixbrl2066"
      unitRef="USD"
      xsi:nil="true"/>
    <STSS:StockIssuedDuringPeriodValuePrivatePlacement
      contextRef="From2023-07-012023-09-30_us-gaap_PreferredStockMember"
      id="xdx2ixbrl2076"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax
      contextRef="From2023-07-012023-09-30_us-gaap_PreferredStockMember"
      id="xdx2ixbrl2084"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2023-09-30_us-gaap_PreferredStockMember"
      id="xdx2ixbrl2092"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2023-09-30_custom_CommonStockSubscriptionReceivableMember"
      id="xdx2ixbrl2094"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2023-09-30_us-gaap_PreferredStockMember"
      id="xdx2ixbrl2104"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2023-09-30_custom_CommonStockSubscriptionReceivableMember"
      id="xdx2ixbrl2106"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:AmortizationOfDebtDiscountPremium
      contextRef="From2023-01-012023-09-30"
      id="xdx2ixbrl2132"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:AmortizationOfFinancingCosts
      contextRef="From2024-01-01to2024-09-30"
      id="xdx2ixbrl2137"
      unitRef="USD"
      xsi:nil="true"/>
    <STSS:EscrowDepositForfeited
      contextRef="From2023-01-012023-09-30"
      id="xdx2ixbrl2141"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:ProceedsFromIssuanceOfLongTermDebt
      contextRef="From2023-01-012023-09-30"
      id="xdx2ixbrl2180"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:ImpairmentOfLongLivedAssetsHeldForUse
      contextRef="From2024-07-012024-09-30"
      id="xdx2ixbrl2233"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:ImpairmentOfLongLivedAssetsHeldForUse
      contextRef="From2023-07-012023-09-30"
      id="xdx2ixbrl2235"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:ImpairmentOfLongLivedAssetsHeldForUse
      contextRef="From2024-01-01to2024-09-30"
      id="xdx2ixbrl2237"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:ImpairmentOfLongLivedAssetsHeldForUse
      contextRef="From2023-01-012023-09-30"
      id="xdx2ixbrl2239"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
      contextRef="From2024-01-012024-09-30_us-gaap_WarrantMember"
      id="xdx2ixbrl2612">P3Y</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1>
    <STSS:WarrantLiabilitiesCurrent
      contextRef="AsOf2023-12-31_custom_InducementWarrantsMember"
      id="xdx2ixbrl2743"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:ClassOfWarrantOrRightOutstanding
      contextRef="AsOf2023-12-31_custom_InducementWarrantsMayTwoThousandTwentyFourMember"
      id="xdx2ixbrl2763"
      unitRef="Shares"
      xsi:nil="true"/>
    <STSS:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantedInYear contextRef="From2024-01-01to2024-09-30" id="xdx2ixbrl2813">P5Y</STSS:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantedInYear>
    <us-gaap:CashAndCashEquivalentsFairValueDisclosure
      contextRef="AsOf2024-09-30_us-gaap_FairValueInputsLevel2Member"
      id="xdx2ixbrl2895"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:CashAndCashEquivalentsFairValueDisclosure
      contextRef="AsOf2024-09-30_us-gaap_FairValueInputsLevel3Member"
      id="xdx2ixbrl2896"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="AsOf2024-09-30_us-gaap_FairValueInputsLevel2Member"
      id="xdx2ixbrl2900"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="AsOf2024-09-30_us-gaap_FairValueInputsLevel3Member"
      id="xdx2ixbrl2901"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:DerivativeLiabilities
      contextRef="AsOf2024-09-30_us-gaap_FairValueInputsLevel1Member"
      id="xdx2ixbrl2909"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:DerivativeLiabilities
      contextRef="AsOf2024-09-30_us-gaap_FairValueInputsLevel3Member"
      id="xdx2ixbrl2911"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:LiabilitiesFairValueDisclosure
      contextRef="AsOf2024-09-30_us-gaap_FairValueInputsLevel1Member"
      id="xdx2ixbrl2914"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:LiabilitiesFairValueDisclosure
      contextRef="AsOf2024-09-30_us-gaap_FairValueInputsLevel3Member"
      id="xdx2ixbrl2916"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:CashAndCashEquivalentsFairValueDisclosure
      contextRef="AsOf2023-12-31_us-gaap_FairValueInputsLevel2Member"
      id="xdx2ixbrl2925"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:CashAndCashEquivalentsFairValueDisclosure
      contextRef="AsOf2023-12-31_us-gaap_FairValueInputsLevel3Member"
      id="xdx2ixbrl2926"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="AsOf2023-12-31_us-gaap_FairValueInputsLevel2Member"
      id="xdx2ixbrl2930"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="AsOf2023-12-31_us-gaap_FairValueInputsLevel3Member"
      id="xdx2ixbrl2931"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:DerivativeLiabilities
      contextRef="AsOf2023-12-31_us-gaap_FairValueInputsLevel1Member"
      id="xdx2ixbrl2939"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:DerivativeLiabilities
      contextRef="AsOf2023-12-31_us-gaap_FairValueInputsLevel3Member"
      id="xdx2ixbrl2941"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:LiabilitiesFairValueDisclosure
      contextRef="AsOf2023-12-31_us-gaap_FairValueInputsLevel1Member"
      id="xdx2ixbrl2944"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:LiabilitiesFairValueDisclosure
      contextRef="AsOf2023-12-31_us-gaap_FairValueInputsLevel3Member"
      id="xdx2ixbrl2946"
      unitRef="USD"
      xsi:nil="true"/>
    <dei:EntityRegistrantName contextRef="From2024-01-01to2024-09-30" id="Fact000012">Sharps Technology, Inc.</dei:EntityRegistrantName>
    <dei:EntityIncorporationStateCountryCode contextRef="From2024-01-01to2024-09-30" id="Fact000013">NV</dei:EntityIncorporationStateCountryCode>
    <dei:EntityTaxIdentificationNumber contextRef="From2024-01-01to2024-09-30" id="Fact000014">82-3751728</dei:EntityTaxIdentificationNumber>
    <dei:EntityAddressAddressLine1 contextRef="From2024-01-01to2024-09-30" id="Fact000015">105 Maxess Road</dei:EntityAddressAddressLine1>
    <dei:EntityAddressAddressLine2 contextRef="From2024-01-01to2024-09-30" id="Fact000016">Ste. 124</dei:EntityAddressAddressLine2>
    <dei:EntityAddressCityOrTown contextRef="From2024-01-01to2024-09-30" id="Fact000017">Melville</dei:EntityAddressCityOrTown>
    <dei:EntityAddressStateOrProvince contextRef="From2024-01-01to2024-09-30" id="Fact000018">NY</dei:EntityAddressStateOrProvince>
    <dei:EntityAddressPostalZipCode contextRef="From2024-01-01to2024-09-30" id="Fact000019">11747</dei:EntityAddressPostalZipCode>
    <dei:CityAreaCode contextRef="From2024-01-01to2024-09-30" id="Fact000020">(631)</dei:CityAreaCode>
    <dei:LocalPhoneNumber contextRef="From2024-01-01to2024-09-30" id="Fact000021">574 -4436</dei:LocalPhoneNumber>
    <dei:ContactPersonnelName
      contextRef="From2024-01-012024-09-30_dei_BusinessContactMember"
      id="Fact000022">Robert M. Hayes</dei:ContactPersonnelName>
    <dei:EntityAddressAddressLine1
      contextRef="From2024-01-012024-09-30_dei_BusinessContactMember"
      id="Fact000023">105 Maxess Road</dei:EntityAddressAddressLine1>
    <dei:EntityAddressAddressLine2
      contextRef="From2024-01-012024-09-30_dei_BusinessContactMember"
      id="Fact000024">Ste. 124</dei:EntityAddressAddressLine2>
    <dei:EntityAddressCityOrTown
      contextRef="From2024-01-012024-09-30_dei_BusinessContactMember"
      id="Fact000025">Melville</dei:EntityAddressCityOrTown>
    <dei:EntityAddressStateOrProvince
      contextRef="From2024-01-012024-09-30_dei_BusinessContactMember"
      id="Fact000026">NY</dei:EntityAddressStateOrProvince>
    <dei:EntityAddressPostalZipCode
      contextRef="From2024-01-012024-09-30_dei_BusinessContactMember"
      id="Fact000027">11747</dei:EntityAddressPostalZipCode>
    <dei:CityAreaCode
      contextRef="From2024-01-012024-09-30_dei_BusinessContactMember"
      id="Fact000028">(631)</dei:CityAreaCode>
    <dei:LocalPhoneNumber
      contextRef="From2024-01-012024-09-30_dei_BusinessContactMember"
      id="Fact000029">574 -4436</dei:LocalPhoneNumber>
    <dei:EntityFilerCategory contextRef="From2024-01-01to2024-09-30" id="Fact000030">Non-accelerated Filer</dei:EntityFilerCategory>
    <dei:EntitySmallBusiness contextRef="From2024-01-01to2024-09-30" id="Fact000031">true</dei:EntitySmallBusiness>
    <dei:EntityEmergingGrowthCompany contextRef="From2024-01-01to2024-09-30" id="Fact000032">true</dei:EntityEmergingGrowthCompany>
    <dei:EntityExTransitionPeriod contextRef="From2024-01-01to2024-09-30" id="Fact000033">false</dei:EntityExTransitionPeriod>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue
      contextRef="AsOf2023-12-31"
      decimals="0"
      id="Fact000041"
      unitRef="USD">3012908</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue
      contextRef="AsOf2022-12-31"
      decimals="0"
      id="Fact000042"
      unitRef="USD">4170897</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:PrepaidExpenseAndOtherAssetsCurrent
      contextRef="AsOf2023-12-31"
      decimals="0"
      id="Fact000044"
      unitRef="USD">116508</us-gaap:PrepaidExpenseAndOtherAssetsCurrent>
    <us-gaap:PrepaidExpenseAndOtherAssetsCurrent
      contextRef="AsOf2022-12-31"
      decimals="0"
      id="Fact000045"
      unitRef="USD">66749</us-gaap:PrepaidExpenseAndOtherAssetsCurrent>
    <us-gaap:InventoryNet
      contextRef="AsOf2023-12-31"
      decimals="0"
      id="Fact000047"
      unitRef="USD">1709135</us-gaap:InventoryNet>
    <us-gaap:InventoryNet
      contextRef="AsOf2022-12-31"
      decimals="0"
      id="Fact000048"
      unitRef="USD">185804</us-gaap:InventoryNet>
    <us-gaap:AssetsCurrent
      contextRef="AsOf2023-12-31"
      decimals="0"
      id="Fact000050"
      unitRef="USD">4838551</us-gaap:AssetsCurrent>
    <us-gaap:AssetsCurrent
      contextRef="AsOf2022-12-31"
      decimals="0"
      id="Fact000051"
      unitRef="USD">4423450</us-gaap:AssetsCurrent>
    <us-gaap:PropertyPlantAndEquipmentNet
      contextRef="AsOf2023-12-31"
      decimals="0"
      id="Fact000053"
      unitRef="USD">6822142</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:PropertyPlantAndEquipmentNet
      contextRef="AsOf2022-12-31"
      decimals="0"
      id="Fact000054"
      unitRef="USD">7004890</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:OtherAssetsNoncurrent
      contextRef="AsOf2023-12-31"
      decimals="0"
      id="Fact000056"
      unitRef="USD">128575</us-gaap:OtherAssetsNoncurrent>
    <us-gaap:OtherAssetsNoncurrent
      contextRef="AsOf2022-12-31"
      decimals="0"
      id="Fact000057"
      unitRef="USD">411316</us-gaap:OtherAssetsNoncurrent>
    <us-gaap:Assets
      contextRef="AsOf2023-12-31"
      decimals="0"
      id="Fact000059"
      unitRef="USD">11789268</us-gaap:Assets>
    <us-gaap:Assets
      contextRef="AsOf2022-12-31"
      decimals="0"
      id="Fact000060"
      unitRef="USD">11839656</us-gaap:Assets>
    <us-gaap:AccountsPayableCurrent
      contextRef="AsOf2023-12-31"
      decimals="0"
      id="Fact000068"
      unitRef="USD">794107</us-gaap:AccountsPayableCurrent>
    <us-gaap:AccountsPayableCurrent
      contextRef="AsOf2022-12-31"
      decimals="0"
      id="Fact000069"
      unitRef="USD">543226</us-gaap:AccountsPayableCurrent>
    <us-gaap:AccountsPayableAndOtherAccruedLiabilitiesCurrent
      contextRef="AsOf2023-12-31"
      decimals="0"
      id="Fact000071"
      unitRef="USD">476090</us-gaap:AccountsPayableAndOtherAccruedLiabilitiesCurrent>
    <us-gaap:AccountsPayableAndOtherAccruedLiabilitiesCurrent
      contextRef="AsOf2022-12-31"
      decimals="0"
      id="Fact000072"
      unitRef="USD">311458</us-gaap:AccountsPayableAndOtherAccruedLiabilitiesCurrent>
    <STSS:WarrantLiabilitiesCurrent
      contextRef="AsOf2023-12-31"
      decimals="0"
      id="Fact000077"
      unitRef="USD">2422785</STSS:WarrantLiabilitiesCurrent>
    <STSS:WarrantLiabilitiesCurrent
      contextRef="AsOf2022-12-31"
      decimals="0"
      id="Fact000078"
      unitRef="USD">1151838</STSS:WarrantLiabilitiesCurrent>
    <us-gaap:LiabilitiesCurrent
      contextRef="AsOf2023-12-31"
      decimals="0"
      id="Fact000080"
      unitRef="USD">3692982</us-gaap:LiabilitiesCurrent>
    <us-gaap:LiabilitiesCurrent
      contextRef="AsOf2022-12-31"
      decimals="0"
      id="Fact000081"
      unitRef="USD">2006522</us-gaap:LiabilitiesCurrent>
    <us-gaap:DeferredIncomeTaxLiabilitiesNet
      contextRef="AsOf2023-12-31"
      decimals="0"
      id="Fact000083"
      unitRef="USD">162000</us-gaap:DeferredIncomeTaxLiabilitiesNet>
    <us-gaap:DeferredIncomeTaxLiabilitiesNet
      contextRef="AsOf2022-12-31"
      decimals="0"
      id="Fact000084"
      unitRef="USD">192000</us-gaap:DeferredIncomeTaxLiabilitiesNet>
    <us-gaap:Liabilities
      contextRef="AsOf2023-12-31"
      decimals="0"
      id="Fact000086"
      unitRef="USD">3854982</us-gaap:Liabilities>
    <us-gaap:Liabilities
      contextRef="AsOf2022-12-31"
      decimals="0"
      id="Fact000087"
      unitRef="USD">2198522</us-gaap:Liabilities>
    <us-gaap:PreferredStockParOrStatedValuePerShare
      contextRef="AsOf2023-12-31"
      decimals="INF"
      id="Fact000101"
      unitRef="USDPShares">0.0001</us-gaap:PreferredStockParOrStatedValuePerShare>
    <us-gaap:PreferredStockParOrStatedValuePerShare
      contextRef="AsOf2022-12-31"
      decimals="INF"
      id="Fact000103"
      unitRef="USDPShares">0.0001</us-gaap:PreferredStockParOrStatedValuePerShare>
    <us-gaap:PreferredStockSharesAuthorized
      contextRef="AsOf2023-12-31"
      decimals="INF"
      id="Fact000105"
      unitRef="Shares">1000000</us-gaap:PreferredStockSharesAuthorized>
    <us-gaap:PreferredStockSharesAuthorized
      contextRef="AsOf2022-12-31"
      decimals="INF"
      id="Fact000107"
      unitRef="Shares">1000000</us-gaap:PreferredStockSharesAuthorized>
    <us-gaap:PreferredStockSharesIssued
      contextRef="AsOf2023-12-31"
      decimals="INF"
      id="Fact000109"
      unitRef="Shares">1</us-gaap:PreferredStockSharesIssued>
    <us-gaap:PreferredStockSharesIssued
      contextRef="AsOf2022-12-31"
      decimals="INF"
      id="Fact000111"
      unitRef="Shares">1</us-gaap:PreferredStockSharesIssued>
    <us-gaap:PreferredStockSharesOutstanding
      contextRef="AsOf2023-12-31"
      decimals="INF"
      id="Fact000113"
      unitRef="Shares">1</us-gaap:PreferredStockSharesOutstanding>
    <us-gaap:PreferredStockSharesOutstanding
      contextRef="AsOf2022-12-31"
      decimals="INF"
      id="Fact000115"
      unitRef="Shares">1</us-gaap:PreferredStockSharesOutstanding>
    <us-gaap:CommonStockValue
      contextRef="AsOf2023-12-31"
      decimals="0"
      id="Fact000117"
      unitRef="USD">69</us-gaap:CommonStockValue>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="AsOf2023-12-31"
      decimals="INF"
      id="Fact000123"
      unitRef="USDPShares">0.0001</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="AsOf2022-12-31"
      decimals="INF"
      id="Fact000125"
      unitRef="USDPShares">0.0001</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:CommonStockSharesAuthorized
      contextRef="AsOf2023-12-31"
      decimals="INF"
      id="Fact000127"
      unitRef="Shares">100000000</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:CommonStockSharesAuthorized
      contextRef="AsOf2022-12-31"
      decimals="INF"
      id="Fact000129"
      unitRef="Shares">100000000</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:CommonStockSharesIssued
      contextRef="AsOf2023-12-31_custom_ReverseStockSplitMember"
      decimals="INF"
      id="Fact000131"
      unitRef="Shares">15274457</us-gaap:CommonStockSharesIssued>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="AsOf2023-12-31_custom_ReverseStockSplitMember"
      decimals="INF"
      id="Fact000133"
      unitRef="Shares">15274457</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:CommonStockSharesIssued
      contextRef="AsOf2022-12-31"
      decimals="INF"
      id="Fact000135"
      unitRef="Shares">9407415</us-gaap:CommonStockSharesIssued>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="AsOf2022-12-31"
      decimals="INF"
      id="Fact000137"
      unitRef="Shares">9407415</us-gaap:CommonStockSharesOutstanding>
    <STSS:CommonStockReverseSplitValue
      contextRef="AsOf2023-12-31"
      decimals="0"
      id="Fact000120"
      unitRef="USD">1528</STSS:CommonStockReverseSplitValue>
    <STSS:CommonStockReverseSplitValue
      contextRef="AsOf2022-12-31"
      decimals="0"
      id="Fact000121"
      unitRef="USD">941</STSS:CommonStockReverseSplitValue>
    <us-gaap:AdditionalPaidInCapital
      contextRef="AsOf2023-12-31_custom_ReverseStockSplitMember"
      decimals="0"
      id="Fact000139"
      unitRef="USD">32489950</us-gaap:AdditionalPaidInCapital>
    <us-gaap:AdditionalPaidInCapital
      contextRef="AsOf2022-12-31_custom_ReverseStockSplitMember"
      decimals="0"
      id="Fact000140"
      unitRef="USD">24733306</us-gaap:AdditionalPaidInCapital>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax
      contextRef="AsOf2023-12-31"
      decimals="0"
      id="Fact000142"
      unitRef="USD">591812</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax
      contextRef="AsOf2022-12-31"
      decimals="0"
      id="Fact000143"
      unitRef="USD">214253</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:RetainedEarningsAccumulatedDeficit
      contextRef="AsOf2023-12-31"
      decimals="0"
      id="Fact000145"
      unitRef="USD">-25149004</us-gaap:RetainedEarningsAccumulatedDeficit>
    <us-gaap:RetainedEarningsAccumulatedDeficit
      contextRef="AsOf2022-12-31"
      decimals="0"
      id="Fact000146"
      unitRef="USD">-15307366</us-gaap:RetainedEarningsAccumulatedDeficit>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2023-12-31"
      decimals="0"
      id="Fact000148"
      unitRef="USD">7934286</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2022-12-31"
      decimals="0"
      id="Fact000149"
      unitRef="USD">9641134</us-gaap:StockholdersEquity>
    <us-gaap:LiabilitiesAndStockholdersEquity
      contextRef="AsOf2023-12-31"
      decimals="0"
      id="Fact000151"
      unitRef="USD">11789268</us-gaap:LiabilitiesAndStockholdersEquity>
    <us-gaap:LiabilitiesAndStockholdersEquity
      contextRef="AsOf2022-12-31"
      decimals="0"
      id="Fact000152"
      unitRef="USD">11839656</us-gaap:LiabilitiesAndStockholdersEquity>
    <us-gaap:ResearchAndDevelopmentExpense
      contextRef="From2023-01-012023-12-31"
      decimals="0"
      id="Fact000160"
      unitRef="USD">1605547</us-gaap:ResearchAndDevelopmentExpense>
    <us-gaap:ResearchAndDevelopmentExpense
      contextRef="From2022-01-012022-12-31"
      decimals="0"
      id="Fact000161"
      unitRef="USD">2280933</us-gaap:ResearchAndDevelopmentExpense>
    <us-gaap:GeneralAndAdministrativeExpense
      contextRef="From2023-01-012023-12-31"
      decimals="0"
      id="Fact000163"
      unitRef="USD">8521103</us-gaap:GeneralAndAdministrativeExpense>
    <us-gaap:GeneralAndAdministrativeExpense
      contextRef="From2022-01-012022-12-31"
      decimals="0"
      id="Fact000164"
      unitRef="USD">6457860</us-gaap:GeneralAndAdministrativeExpense>
    <us-gaap:OperatingExpenses
      contextRef="From2023-01-012023-12-31"
      decimals="0"
      id="Fact000166"
      unitRef="USD">-10126650</us-gaap:OperatingExpenses>
    <us-gaap:OperatingExpenses
      contextRef="From2022-01-012022-12-31"
      decimals="0"
      id="Fact000167"
      unitRef="USD">-8738793</us-gaap:OperatingExpenses>
    <us-gaap:OperatingIncomeLoss
      contextRef="From2023-01-012023-12-31"
      decimals="0"
      id="Fact000169"
      unitRef="USD">-10126650</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="From2022-01-012022-12-31"
      decimals="0"
      id="Fact000170"
      unitRef="USD">-8738793</us-gaap:OperatingIncomeLoss>
    <us-gaap:InterestIncomeExpenseNet
      contextRef="From2023-01-012023-12-31"
      decimals="0"
      id="Fact000175"
      unitRef="USD">138118</us-gaap:InterestIncomeExpenseNet>
    <us-gaap:InterestIncomeExpenseNet
      contextRef="From2022-01-012022-12-31"
      decimals="0"
      id="Fact000176"
      unitRef="USD">-1320416</us-gaap:InterestIncomeExpenseNet>
    <STSS:FairMarketValueAdjustmentForContingentStockAndWarrants
      contextRef="From2023-01-012023-12-31"
      decimals="0"
      id="Fact000181"
      unitRef="USD">-169583</STSS:FairMarketValueAdjustmentForContingentStockAndWarrants>
    <STSS:FairMarketValueAdjustmentForContingentStockAndWarrants
      contextRef="From2022-01-012022-12-31"
      decimals="0"
      id="Fact000182"
      unitRef="USD">-5392911</STSS:FairMarketValueAdjustmentForContingentStockAndWarrants>
    <STSS:ForeignCurrencyAndNonOperatingIncomeExpenses
      contextRef="From2023-01-012023-12-31"
      decimals="0"
      id="Fact000190"
      unitRef="USD">-52689</STSS:ForeignCurrencyAndNonOperatingIncomeExpenses>
    <STSS:ForeignCurrencyAndNonOperatingIncomeExpenses
      contextRef="From2022-01-012022-12-31"
      decimals="0"
      id="Fact000191"
      unitRef="USD">26636</STSS:ForeignCurrencyAndNonOperatingIncomeExpenses>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="From2023-01-012023-12-31"
      decimals="0"
      id="Fact000196"
      unitRef="USD">-9871638</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="From2022-01-012022-12-31"
      decimals="0"
      id="Fact000197"
      unitRef="USD">-4639662</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:DeferredIncomeTaxExpenseBenefit
      contextRef="From2023-01-012023-12-31"
      decimals="0"
      id="Fact000199"
      unitRef="USD">-30000</us-gaap:DeferredIncomeTaxExpenseBenefit>
    <us-gaap:NetIncomeLoss
      contextRef="From2023-01-012023-12-31"
      decimals="0"
      id="Fact000202"
      unitRef="USD">-9841638</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="From2022-01-012022-12-31"
      decimals="0"
      id="Fact000203"
      unitRef="USD">-4639662</us-gaap:NetIncomeLoss>
    <us-gaap:EarningsPerShareBasic
      contextRef="From2023-01-012023-12-31"
      decimals="INF"
      id="Fact000205"
      unitRef="USDPShares">-0.76</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareDiluted
      contextRef="From2023-01-012023-12-31"
      decimals="INF"
      id="Fact000207"
      unitRef="USDPShares">-0.76</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareBasic
      contextRef="From2022-01-012022-12-31"
      decimals="INF"
      id="Fact000209"
      unitRef="USDPShares">-0.57</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareDiluted
      contextRef="From2022-01-012022-12-31"
      decimals="INF"
      id="Fact000211"
      unitRef="USDPShares">-0.57</us-gaap:EarningsPerShareDiluted>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="From2023-01-012023-12-31"
      decimals="INF"
      id="Fact000213"
      unitRef="Shares">13032717</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="From2023-01-012023-12-31"
      decimals="INF"
      id="Fact000215"
      unitRef="Shares">13032717</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="From2022-01-012022-12-31"
      decimals="INF"
      id="Fact000217"
      unitRef="Shares">8100410</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="From2022-01-012022-12-31"
      decimals="INF"
      id="Fact000219"
      unitRef="Shares">8100410</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:NetIncomeLoss
      contextRef="From2023-01-012023-12-31"
      decimals="0"
      id="Fact000221"
      unitRef="USD">-9841638</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="From2022-01-012022-12-31"
      decimals="0"
      id="Fact000222"
      unitRef="USD">-4639662</us-gaap:NetIncomeLoss>
    <us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
      contextRef="From2023-01-012023-12-31"
      decimals="0"
      id="Fact000227"
      unitRef="USD">377559</us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
      contextRef="From2022-01-012022-12-31"
      decimals="0"
      id="Fact000228"
      unitRef="USD">214253</us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent>
    <us-gaap:ComprehensiveIncomeNetOfTax
      contextRef="From2023-01-012023-12-31"
      decimals="0"
      id="Fact000230"
      unitRef="USD">-9464079</us-gaap:ComprehensiveIncomeNetOfTax>
    <us-gaap:ComprehensiveIncomeNetOfTax
      contextRef="From2022-01-012022-12-31"
      decimals="0"
      id="Fact000231"
      unitRef="USD">-4425409</us-gaap:ComprehensiveIncomeNetOfTax>
    <us-gaap:SharesOutstanding
      contextRef="AsOf2021-12-31_us-gaap_PreferredStockMember"
      decimals="INF"
      id="Fact000241"
      unitRef="Shares">1</us-gaap:SharesOutstanding>
    <us-gaap:SharesOutstanding
      contextRef="AsOf2021-12-31_us-gaap_CommonStockMember"
      decimals="INF"
      id="Fact000243"
      unitRef="Shares">5187062</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2021-12-31_us-gaap_CommonStockMember"
      decimals="0"
      id="Fact000234"
      unitRef="USD">519</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2021-12-31_custom_CommonStockSubscriptionReceivableMember"
      decimals="0"
      id="Fact000235"
      unitRef="USD">-32500</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2021-12-31_us-gaap_AdditionalPaidInCapitalMember"
      decimals="0"
      id="Fact000236"
      unitRef="USD">13835882</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2021-12-31_us-gaap_RetainedEarningsMember"
      decimals="0"
      id="Fact000238"
      unitRef="USD">-10667704</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2021-12-31"
      decimals="0"
      id="Fact000239"
      unitRef="USD">3136197</us-gaap:StockholdersEquity>
    <us-gaap:NetIncomeLoss
      contextRef="From2022-01-012022-12-31_us-gaap_RetainedEarningsMember"
      decimals="0"
      id="Fact000250"
      unitRef="USD">-4639662</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="From2022-01-012022-12-31"
      decimals="0"
      id="Fact000251"
      unitRef="USD">-4639662</us-gaap:NetIncomeLoss>
    <STSS:StockIssuedDuringPeriodSharesInitialPublicOffering
      contextRef="From2022-01-012022-12-31_us-gaap_CommonStockMember"
      decimals="INF"
      id="Fact000261"
      unitRef="Shares">3750000</STSS:StockIssuedDuringPeriodSharesInitialPublicOffering>
    <STSS:StockIssuedDuringPeriodValueInitialPublicOffering
      contextRef="From2022-01-012022-12-31_us-gaap_CommonStockMember"
      decimals="0"
      id="Fact000254"
      unitRef="USD">375</STSS:StockIssuedDuringPeriodValueInitialPublicOffering>
    <STSS:StockIssuedDuringPeriodValueInitialPublicOffering
      contextRef="From2022-01-012022-12-31_us-gaap_AdditionalPaidInCapitalMember"
      decimals="0"
      id="Fact000256"
      unitRef="USD">8974282</STSS:StockIssuedDuringPeriodValueInitialPublicOffering>
    <STSS:StockIssuedDuringPeriodValueInitialPublicOffering
      contextRef="From2022-01-012022-12-31"
      decimals="0"
      id="Fact000259"
      unitRef="USD">8974657</STSS:StockIssuedDuringPeriodValueInitialPublicOffering>
    <STSS:StockIssuedDuringPeriodSharesContingentStockLiability
      contextRef="From2022-01-012022-12-31_us-gaap_CommonStockMember"
      decimals="INF"
      id="Fact000271"
      unitRef="Shares">235294</STSS:StockIssuedDuringPeriodSharesContingentStockLiability>
    <STSS:StockIssuedDuringPeriodValueContingentStockLiability
      contextRef="From2022-01-012022-12-31_us-gaap_CommonStockMember"
      decimals="0"
      id="Fact000264"
      unitRef="USD">24</STSS:StockIssuedDuringPeriodValueContingentStockLiability>
    <STSS:StockIssuedDuringPeriodValueContingentStockLiability
      contextRef="From2022-01-012022-12-31_us-gaap_AdditionalPaidInCapitalMember"
      decimals="0"
      id="Fact000266"
      unitRef="USD">495976</STSS:StockIssuedDuringPeriodValueContingentStockLiability>
    <STSS:StockIssuedDuringPeriodValueContingentStockLiability
      contextRef="From2022-01-012022-12-31"
      decimals="0"
      id="Fact000269"
      unitRef="USD">496000</STSS:StockIssuedDuringPeriodValueContingentStockLiability>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="From2022-01-012022-12-31_us-gaap_AdditionalPaidInCapitalMember"
      decimals="0"
      id="Fact000276"
      unitRef="USD">1136638</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="From2022-01-012022-12-31"
      decimals="0"
      id="Fact000279"
      unitRef="USD">1136638</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <STSS:StockIssuedDuringPeriodSharesFractionalShareAdjustment
      contextRef="From2022-01-012022-12-31_us-gaap_CommonStockMember"
      decimals="INF"
      id="Fact000289"
      unitRef="Shares">59</STSS:StockIssuedDuringPeriodSharesFractionalShareAdjustment>
    <us-gaap:StockIssuedDuringPeriodSharesIssuedForServices
      contextRef="From2022-01-012022-12-31_us-gaap_CommonStockMember"
      decimals="INF"
      id="Fact000299"
      unitRef="Shares">235000</us-gaap:StockIssuedDuringPeriodSharesIssuedForServices>
    <us-gaap:StockIssuedDuringPeriodValueIssuedForServices
      contextRef="From2022-01-012022-12-31_us-gaap_CommonStockMember"
      decimals="0"
      id="Fact000292"
      unitRef="USD">23</us-gaap:StockIssuedDuringPeriodValueIssuedForServices>
    <us-gaap:StockIssuedDuringPeriodValueIssuedForServices
      contextRef="From2022-01-012022-12-31_us-gaap_AdditionalPaidInCapitalMember"
      decimals="0"
      id="Fact000294"
      unitRef="USD">290528</us-gaap:StockIssuedDuringPeriodValueIssuedForServices>
    <us-gaap:StockIssuedDuringPeriodValueIssuedForServices
      contextRef="From2022-01-012022-12-31"
      decimals="0"
      id="Fact000297"
      unitRef="USD">290551</us-gaap:StockIssuedDuringPeriodValueIssuedForServices>
    <us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax
      contextRef="From2022-01-012022-12-31_us-gaap_AccumulatedOtherComprehensiveIncomeMember"
      decimals="0"
      id="Fact000305"
      unitRef="USD">214253</us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax>
    <us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax
      contextRef="From2022-01-012022-12-31"
      decimals="0"
      id="Fact000307"
      unitRef="USD">214253</us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax>
    <STSS:StockIssuedDuringPeriodCollectionsOfCommonStockSubscriptionsValue
      contextRef="From2022-01-012022-12-31_custom_CommonStockSubscriptionReceivableMember"
      decimals="0"
      id="Fact000311"
      unitRef="USD">32500</STSS:StockIssuedDuringPeriodCollectionsOfCommonStockSubscriptionsValue>
    <STSS:StockIssuedDuringPeriodCollectionsOfCommonStockSubscriptionsValue
      contextRef="From2022-01-012022-12-31"
      decimals="0"
      id="Fact000315"
      unitRef="USD">32500</STSS:StockIssuedDuringPeriodCollectionsOfCommonStockSubscriptionsValue>
    <us-gaap:SharesOutstanding
      contextRef="AsOf2022-12-31_us-gaap_PreferredStockMember_custom_ReverseStockSplitMember"
      decimals="INF"
      id="Fact000325"
      unitRef="Shares">1</us-gaap:SharesOutstanding>
    <us-gaap:SharesOutstanding
      contextRef="AsOf2022-12-31_us-gaap_CommonStockMember_custom_ReverseStockSplitMember"
      decimals="INF"
      id="Fact000327"
      unitRef="Shares">9407415</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2022-12-31_custom_ReverseStockSplitMember_us-gaap_CommonStockMember"
      decimals="0"
      id="Fact000318"
      unitRef="USD">941</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2022-12-31_custom_ReverseStockSplitMember_us-gaap_AdditionalPaidInCapitalMember"
      decimals="0"
      id="Fact000320"
      unitRef="USD">24733306</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2022-12-31_custom_ReverseStockSplitMember_us-gaap_AccumulatedOtherComprehensiveIncomeMember"
      decimals="0"
      id="Fact000321"
      unitRef="USD">214253</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2022-12-31_custom_ReverseStockSplitMember_us-gaap_RetainedEarningsMember"
      decimals="0"
      id="Fact000322"
      unitRef="USD">-15307366</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2022-12-31_custom_ReverseStockSplitMember10880671"
      decimals="0"
      id="Fact000323"
      unitRef="USD">9641134</us-gaap:StockholdersEquity>
    <us-gaap:SharesOutstanding
      contextRef="AsOf2022-12-31_us-gaap_PreferredStockMember_custom_ReverseStockSplitMember"
      decimals="INF"
      id="Fact000337"
      unitRef="Shares">1</us-gaap:SharesOutstanding>
    <us-gaap:SharesOutstanding
      contextRef="AsOf2022-12-31_us-gaap_CommonStockMember_custom_ReverseStockSplitMember"
      decimals="INF"
      id="Fact000339"
      unitRef="Shares">9407415</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2022-12-31_custom_ReverseStockSplitMember_us-gaap_CommonStockMember"
      decimals="0"
      id="Fact000330"
      unitRef="USD">941</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2022-12-31_custom_ReverseStockSplitMember_us-gaap_AdditionalPaidInCapitalMember"
      decimals="0"
      id="Fact000332"
      unitRef="USD">24733306</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2022-12-31_custom_ReverseStockSplitMember_us-gaap_AccumulatedOtherComprehensiveIncomeMember"
      decimals="0"
      id="Fact000333"
      unitRef="USD">214253</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2022-12-31_custom_ReverseStockSplitMember_us-gaap_RetainedEarningsMember"
      decimals="0"
      id="Fact000334"
      unitRef="USD">-15307366</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2022-12-31_custom_ReverseStockSplitMember10880671"
      decimals="0"
      id="Fact000335"
      unitRef="USD">9641134</us-gaap:StockholdersEquity>
    <us-gaap:NetIncomeLoss
      contextRef="From2023-01-012023-12-31_custom_ReverseStockSplitMember_us-gaap_RetainedEarningsMember"
      decimals="0"
      id="Fact000346"
      unitRef="USD">-9841638</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="From2023-01-012023-12-31_custom_ReverseStockSplitMember"
      decimals="0"
      id="Fact000347"
      unitRef="USD">-9841638</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="From2023-01-012023-12-31_custom_ReverseStockSplitMember_us-gaap_RetainedEarningsMember"
      decimals="0"
      id="Fact000354"
      unitRef="USD">-9841638</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="From2023-01-012023-12-31_custom_ReverseStockSplitMember"
      decimals="0"
      id="Fact000355"
      unitRef="USD">-9841638</us-gaap:NetIncomeLoss>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="From2023-01-012023-12-31_custom_ReverseStockSplitMember_us-gaap_AdditionalPaidInCapitalMember"
      decimals="0"
      id="Fact000360"
      unitRef="USD">963023</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="From2023-01-012023-12-31_custom_ReverseStockSplitMember"
      decimals="0"
      id="Fact000363"
      unitRef="USD">963023</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:StockIssuedDuringPeriodSharesNewIssues
      contextRef="From2023-01-012023-12-31_us-gaap_CommonStockMember"
      decimals="INF"
      id="Fact000373"
      unitRef="Shares">2248521</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues
      contextRef="From2023-01-012023-12-31_custom_ReverseStockSplitMember_us-gaap_CommonStockMember"
      decimals="0"
      id="Fact000366"
      unitRef="USD">225</us-gaap:StockIssuedDuringPeriodValueNewIssues>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues
      contextRef="From2023-01-012023-12-31_custom_ReverseStockSplitMember_us-gaap_AdditionalPaidInCapitalMember"
      decimals="0"
      id="Fact000368"
      unitRef="USD">2783160</us-gaap:StockIssuedDuringPeriodValueNewIssues>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues
      contextRef="From2023-01-012023-12-31_custom_ReverseStockSplitMember"
      decimals="0"
      id="Fact000371"
      unitRef="USD">2783385</us-gaap:StockIssuedDuringPeriodValueNewIssues>
    <STSS:StockIssuedDuringPeriodSharesShelfRegistrationOffering
      contextRef="From2023-01-012023-12-31_us-gaap_CommonStockMember"
      decimals="INF"
      id="Fact000383"
      unitRef="Shares">3618521</STSS:StockIssuedDuringPeriodSharesShelfRegistrationOffering>
    <STSS:StockIssuedDuringPeriodValueShelfRegistrationOffering
      contextRef="From2023-01-012023-12-31_custom_ReverseStockSplitMember_us-gaap_CommonStockMember"
      decimals="0"
      id="Fact000376"
      unitRef="USD">362</STSS:StockIssuedDuringPeriodValueShelfRegistrationOffering>
    <STSS:StockIssuedDuringPeriodValueShelfRegistrationOffering
      contextRef="From2023-01-012023-12-31_custom_ReverseStockSplitMember_us-gaap_AdditionalPaidInCapitalMember"
      decimals="0"
      id="Fact000378"
      unitRef="USD">2457642</STSS:StockIssuedDuringPeriodValueShelfRegistrationOffering>
    <STSS:StockIssuedDuringPeriodValueShelfRegistrationOffering
      contextRef="From2023-01-012023-12-31_custom_ReverseStockSplitMember"
      decimals="0"
      id="Fact000381"
      unitRef="USD">2458004</STSS:StockIssuedDuringPeriodValueShelfRegistrationOffering>
    <STSS:StockIssuedDuringPeriodValuePrivatePlacement
      contextRef="From2023-01-012023-12-31_custom_ReverseStockSplitMember_us-gaap_AdditionalPaidInCapitalMember"
      decimals="0"
      id="Fact000388"
      unitRef="USD">1552819</STSS:StockIssuedDuringPeriodValuePrivatePlacement>
    <STSS:StockIssuedDuringPeriodValuePrivatePlacement
      contextRef="From2023-01-012023-12-31_custom_ReverseStockSplitMember"
      decimals="0"
      id="Fact000391"
      unitRef="USD">1552819</STSS:StockIssuedDuringPeriodValuePrivatePlacement>
    <us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax
      contextRef="From2023-01-012023-12-31_custom_ReverseStockSplitMember_us-gaap_AccumulatedOtherComprehensiveIncomeMember"
      decimals="0"
      id="Fact000397"
      unitRef="USD">377559</us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax>
    <us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax
      contextRef="From2023-01-012023-12-31_custom_ReverseStockSplitMember"
      decimals="0"
      id="Fact000399"
      unitRef="USD">377559</us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax>
    <us-gaap:SharesOutstanding
      contextRef="AsOf2023-12-31_custom_ReverseStockSplitMember_us-gaap_PreferredStockMember"
      decimals="INF"
      id="Fact000409"
      unitRef="Shares">1</us-gaap:SharesOutstanding>
    <us-gaap:SharesOutstanding
      contextRef="AsOf2023-12-31_custom_ReverseStockSplitMember_us-gaap_CommonStockMember"
      decimals="INF"
      id="Fact000411"
      unitRef="Shares">15274457</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2023-12-31_custom_ReverseStockSplitMember_us-gaap_CommonStockMember"
      decimals="0"
      id="Fact000402"
      unitRef="USD">1528</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2023-12-31_custom_ReverseStockSplitMember_us-gaap_AdditionalPaidInCapitalMember"
      decimals="0"
      id="Fact000404"
      unitRef="USD">32489950</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2023-12-31_custom_ReverseStockSplitMember_us-gaap_AccumulatedOtherComprehensiveIncomeMember"
      decimals="0"
      id="Fact000405"
      unitRef="USD">591812</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2023-12-31_custom_ReverseStockSplitMember_us-gaap_RetainedEarningsMember"
      decimals="0"
      id="Fact000406"
      unitRef="USD">-25149004</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2023-12-31_custom_ReverseStockSplitMember"
      decimals="0"
      id="Fact000407"
      unitRef="USD">7934286</us-gaap:StockholdersEquity>
    <us-gaap:SharesOutstanding
      contextRef="AsOf2023-12-31_custom_ReverseStockSplitMember_us-gaap_PreferredStockMember"
      decimals="INF"
      id="Fact000421"
      unitRef="Shares">1</us-gaap:SharesOutstanding>
    <us-gaap:SharesOutstanding
      contextRef="AsOf2023-12-31_custom_ReverseStockSplitMember_us-gaap_CommonStockMember"
      decimals="INF"
      id="Fact000423"
      unitRef="Shares">15274457</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2023-12-31_custom_ReverseStockSplitMember_us-gaap_CommonStockMember"
      decimals="0"
      id="Fact000414"
      unitRef="USD">1528</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2023-12-31_custom_ReverseStockSplitMember_us-gaap_AdditionalPaidInCapitalMember"
      decimals="0"
      id="Fact000416"
      unitRef="USD">32489950</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2023-12-31_custom_ReverseStockSplitMember_us-gaap_AccumulatedOtherComprehensiveIncomeMember"
      decimals="0"
      id="Fact000417"
      unitRef="USD">591812</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2023-12-31_custom_ReverseStockSplitMember_us-gaap_RetainedEarningsMember"
      decimals="0"
      id="Fact000418"
      unitRef="USD">-25149004</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2023-12-31_custom_ReverseStockSplitMember"
      decimals="0"
      id="Fact000419"
      unitRef="USD">7934286</us-gaap:StockholdersEquity>
    <us-gaap:NetIncomeLoss
      contextRef="From2023-01-012023-12-31"
      decimals="0"
      id="Fact000428"
      unitRef="USD">-9841638</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="From2022-01-012022-12-31"
      decimals="0"
      id="Fact000429"
      unitRef="USD">-4639662</us-gaap:NetIncomeLoss>
    <us-gaap:DepreciationAndAmortization
      contextRef="From2023-01-012023-12-31"
      decimals="0"
      id="Fact000434"
      unitRef="USD">882177</us-gaap:DepreciationAndAmortization>
    <us-gaap:DepreciationAndAmortization
      contextRef="From2022-01-012022-12-31"
      decimals="0"
      id="Fact000435"
      unitRef="USD">654572</us-gaap:DepreciationAndAmortization>
    <us-gaap:ShareBasedCompensation
      contextRef="From2023-01-012023-12-31"
      decimals="0"
      id="Fact000437"
      unitRef="USD">963023</us-gaap:ShareBasedCompensation>
    <us-gaap:ShareBasedCompensation
      contextRef="From2022-01-012022-12-31"
      decimals="0"
      id="Fact000438"
      unitRef="USD">1012592</us-gaap:ShareBasedCompensation>
    <us-gaap:IssuanceOfStockAndWarrantsForServicesOrClaims
      contextRef="From2022-01-012022-12-31"
      decimals="0"
      id="Fact000441"
      unitRef="USD">290551</us-gaap:IssuanceOfStockAndWarrantsForServicesOrClaims>
    <us-gaap:AmortizationOfDebtDiscountPremium
      contextRef="From2022-01-012022-12-31"
      decimals="0"
      id="Fact000444"
      unitRef="USD">1299985</us-gaap:AmortizationOfDebtDiscountPremium>
    <STSS:FairMarketValueAdjustmentForContingentWarrants
      contextRef="From2022-01-012022-12-31"
      decimals="0"
      id="Fact000456"
      unitRef="USD">-181000</STSS:FairMarketValueAdjustmentForContingentWarrants>
    <STSS:FairMarketValueAdjustmentForContingentWarrantsAndWarrants
      contextRef="From2023-01-012023-12-31"
      decimals="0"
      id="Fact000458"
      unitRef="USD">-169583</STSS:FairMarketValueAdjustmentForContingentWarrantsAndWarrants>
    <STSS:FairMarketValueAdjustmentForContingentWarrantsAndWarrants
      contextRef="From2022-01-012022-12-31"
      decimals="0"
      id="Fact000459"
      unitRef="USD">-5211911</STSS:FairMarketValueAdjustmentForContingentWarrantsAndWarrants>
    <us-gaap:ImpairmentOfLongLivedAssetsHeldForUse
      contextRef="From2023-01-012023-12-31"
      decimals="0"
      id="Fact000461"
      unitRef="USD">560000</us-gaap:ImpairmentOfLongLivedAssetsHeldForUse>
    <us-gaap:DeferredIncomeTaxExpenseBenefit
      contextRef="From2023-01-012023-12-31"
      decimals="0"
      id="Fact000464"
      unitRef="USD">-30000</us-gaap:DeferredIncomeTaxExpenseBenefit>
    <STSS:IpoIssuanceCostsRelatingToWarrants
      contextRef="From2023-01-012023-12-31"
      decimals="0"
      id="Fact000467"
      unitRef="USD">205112</STSS:IpoIssuanceCostsRelatingToWarrants>
    <STSS:IpoIssuanceCostsRelatingToWarrants
      contextRef="From2022-01-012022-12-31"
      decimals="0"
      id="Fact000468"
      unitRef="USD">550433</STSS:IpoIssuanceCostsRelatingToWarrants>
    <us-gaap:ForeignCurrencyTransactionGainLossBeforeTax
      contextRef="From2023-01-012023-12-31"
      decimals="0"
      id="Fact000470"
      unitRef="USD">-44463</us-gaap:ForeignCurrencyTransactionGainLossBeforeTax>
    <us-gaap:ForeignCurrencyTransactionGainLossBeforeTax
      contextRef="From2022-01-012022-12-31"
      decimals="0"
      id="Fact000471"
      unitRef="USD">-496</us-gaap:ForeignCurrencyTransactionGainLossBeforeTax>
    <us-gaap:IncreaseDecreaseInPrepaidExpense
      contextRef="From2023-01-012023-12-31"
      decimals="0"
      id="Fact000476"
      unitRef="USD">82169</us-gaap:IncreaseDecreaseInPrepaidExpense>
    <us-gaap:IncreaseDecreaseInPrepaidExpense
      contextRef="From2022-01-012022-12-31"
      decimals="0"
      id="Fact000477"
      unitRef="USD">58754</us-gaap:IncreaseDecreaseInPrepaidExpense>
    <us-gaap:IncreaseDecreaseInInventories
      contextRef="From2023-01-012023-12-31"
      decimals="0"
      id="Fact000479"
      unitRef="USD">1441462</us-gaap:IncreaseDecreaseInInventories>
    <us-gaap:IncreaseDecreaseInInventories
      contextRef="From2022-01-012022-12-31"
      decimals="0"
      id="Fact000480"
      unitRef="USD">34109</us-gaap:IncreaseDecreaseInInventories>
    <us-gaap:IncreaseDecreaseInOtherOperatingAssets
      contextRef="From2023-01-012023-12-31"
      decimals="0"
      id="Fact000482"
      unitRef="USD">12735</us-gaap:IncreaseDecreaseInOtherOperatingAssets>
    <us-gaap:IncreaseDecreaseInOtherOperatingAssets
      contextRef="From2022-01-012022-12-31"
      decimals="0"
      id="Fact000483"
      unitRef="USD">12000</us-gaap:IncreaseDecreaseInOtherOperatingAssets>
    <us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
      contextRef="From2023-01-012023-12-31"
      decimals="0"
      id="Fact000485"
      unitRef="USD">415512</us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities>
    <us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
      contextRef="From2022-01-012022-12-31"
      decimals="0"
      id="Fact000486"
      unitRef="USD">-104352</us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities>
    <us-gaap:NetCashProvidedByUsedInOperatingActivities
      contextRef="From2023-01-012023-12-31"
      decimals="0"
      id="Fact000488"
      unitRef="USD">-8507300</us-gaap:NetCashProvidedByUsedInOperatingActivities>
    <us-gaap:NetCashProvidedByUsedInOperatingActivities
      contextRef="From2022-01-012022-12-31"
      decimals="0"
      id="Fact000489"
      unitRef="USD">-6433159</us-gaap:NetCashProvidedByUsedInOperatingActivities>
    <us-gaap:PaymentsForProceedsFromOtherInvestingActivities
      contextRef="From2022-01-012022-12-31"
      decimals="0"
      id="Fact000495"
      unitRef="USD">209678</us-gaap:PaymentsForProceedsFromOtherInvestingActivities>
    <us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
      contextRef="From2023-01-012023-12-31"
      decimals="0"
      id="Fact000500"
      unitRef="USD">698277</us-gaap:PaymentsToAcquirePropertyPlantAndEquipment>
    <us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
      contextRef="From2022-01-012022-12-31"
      decimals="0"
      id="Fact000501"
      unitRef="USD">542662</us-gaap:PaymentsToAcquirePropertyPlantAndEquipment>
    <STSS:PaymentsToAssetAcquisition
      contextRef="From2022-01-012022-12-31"
      decimals="0"
      id="Fact000504"
      unitRef="USD">2365576</STSS:PaymentsToAssetAcquisition>
    <us-gaap:NetCashProvidedByUsedInInvestingActivities
      contextRef="From2023-01-012023-12-31"
      decimals="0"
      id="Fact000506"
      unitRef="USD">-698277</us-gaap:NetCashProvidedByUsedInInvestingActivities>
    <us-gaap:NetCashProvidedByUsedInInvestingActivities
      contextRef="From2022-01-012022-12-31"
      decimals="0"
      id="Fact000507"
      unitRef="USD">-3117916</us-gaap:NetCashProvidedByUsedInInvestingActivities>
    <STSS:NetProceedsFromInitialPublicOfferingAndAdditionalOffering
      contextRef="From2023-01-012023-12-31"
      decimals="0"
      id="Fact000512"
      unitRef="USD">8029628</STSS:NetProceedsFromInitialPublicOfferingAndAdditionalOffering>
    <STSS:NetProceedsFromInitialPublicOfferingAndAdditionalOffering
      contextRef="From2022-01-012022-12-31"
      decimals="0"
      id="Fact000513"
      unitRef="USD">14202975</STSS:NetProceedsFromInitialPublicOfferingAndAdditionalOffering>
    <us-gaap:RepaymentsOfNotesPayable
      contextRef="From2022-01-012022-12-31"
      decimals="0"
      id="Fact000522"
      unitRef="USD">2000000</us-gaap:RepaymentsOfNotesPayable>
    <STSS:ProceedsFromSubscriptionsReceivable
      contextRef="From2022-01-012022-12-31"
      decimals="0"
      id="Fact000525"
      unitRef="USD">32500</STSS:ProceedsFromSubscriptionsReceivable>
    <us-gaap:NetCashProvidedByUsedInFinancingActivities
      contextRef="From2023-01-012023-12-31"
      decimals="0"
      id="Fact000527"
      unitRef="USD">8029628</us-gaap:NetCashProvidedByUsedInFinancingActivities>
    <us-gaap:NetCashProvidedByUsedInFinancingActivities
      contextRef="From2022-01-012022-12-31"
      decimals="0"
      id="Fact000528"
      unitRef="USD">12235475</us-gaap:NetCashProvidedByUsedInFinancingActivities>
    <us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
      contextRef="From2023-01-012023-12-31"
      decimals="0"
      id="Fact000530"
      unitRef="USD">17960</us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations>
    <us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
      contextRef="From2022-01-012022-12-31"
      decimals="0"
      id="Fact000531"
      unitRef="USD">7331</us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
      contextRef="From2023-01-012023-12-31"
      decimals="0"
      id="Fact000533"
      unitRef="USD">-1157989</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
      contextRef="From2022-01-012022-12-31"
      decimals="0"
      id="Fact000534"
      unitRef="USD">2691731</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
      contextRef="AsOf2022-12-31"
      decimals="0"
      id="Fact000536"
      unitRef="USD">4170897</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
      contextRef="AsOf2021-12-31"
      decimals="0"
      id="Fact000537"
      unitRef="USD">1479166</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
      contextRef="AsOf2023-12-31"
      decimals="0"
      id="Fact000539"
      unitRef="USD">3012908</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
      contextRef="AsOf2022-12-31"
      decimals="0"
      id="Fact000540"
      unitRef="USD">4170897</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations>
    <us-gaap:InterestPaidNet
      contextRef="From2022-01-012022-12-31"
      decimals="0"
      id="Fact000546"
      unitRef="USD">47111</us-gaap:InterestPaidNet>
    <STSS:FmvForCommonStockIssuedForContingentShares
      contextRef="From2022-01-012022-12-31"
      decimals="0"
      id="Fact000555"
      unitRef="USD">496000</STSS:FmvForCommonStockIssuedForContingentShares>
    <STSS:FmvForWarrantsIssuedForContingentWarrants
      contextRef="From2022-01-012022-12-31"
      decimals="0"
      id="Fact000558"
      unitRef="USD">554312</STSS:FmvForWarrantsIssuedForContingentWarrants>
    <STSS:CommonStockIssuedAndVestedStockOptionsForFixedAssetsAcquired
      contextRef="From2022-01-012022-12-31"
      decimals="0"
      id="Fact000561"
      unitRef="USD">63612</STSS:CommonStockIssuedAndVestedStockOptionsForFixedAssetsAcquired>
    <STSS:CommonStockIssuedAndVestedStockOptionsIssuedAsConsiderationForAcquisition
      contextRef="From2022-01-012022-12-31"
      decimals="0"
      id="Fact000564"
      unitRef="USD">60435</STSS:CommonStockIssuedAndVestedStockOptionsIssuedAsConsiderationForAcquisition>
    <us-gaap:BusinessDescriptionAndBasisOfPresentationTextBlock contextRef="From2023-01-012023-12-31" id="Fact000566">&lt;p id="xdx_801_eus-gaap--BusinessDescriptionAndBasisOfPresentationTextBlock_zxnnhTHlnSw1" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Note
1. &lt;span id="xdx_82C_zYQA66NqDZNa"&gt;Description of Business&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;Nature
of Business&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Sharps
Technology, Inc. (&#x201c;Sharps&#x201d; or the &#x201c;Company&#x201d;) is a pre-revenue medical device company that has designed and patented
various safety syringes and is seeking commercialization by manufacturing and distribution of its products.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
accompanying consolidated financial statements include the accounts of Sharps Technology, Inc. and its wholly owned subsidiaries, Safegard
Medical (Hungary) KFT, collectively referred to as the &#x201c;Company.&#x201d; All intercompany transactions and balances have been eliminated.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company&#x2019;s fiscal year ends on December 31.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;On
April 13, 2022, the Company&#x2019;s Initial Public Offering was deemed effective with trading commencing on April 14, 2022. The Company
received net proceeds of $&lt;span id="xdx_905_eus-gaap--ProceedsFromIssuanceInitialPublicOffering_pn5n6_c20220417__20220419__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--IPOMember_z7xqqpwnsDsa" title="Initial public offering"&gt;14.2 &lt;/span&gt;million on April 19, 2022 (See Note 8).&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

</us-gaap:BusinessDescriptionAndBasisOfPresentationTextBlock>
    <us-gaap:ProceedsFromIssuanceInitialPublicOffering
      contextRef="From2022-04-172022-04-19_us-gaap_IPOMember"
      decimals="-5"
      id="Fact000568"
      unitRef="USD">14200000</us-gaap:ProceedsFromIssuanceInitialPublicOffering>
    <us-gaap:SignificantAccountingPoliciesTextBlock contextRef="From2023-01-012023-12-31" id="Fact000570">&lt;p id="xdx_808_eus-gaap--SignificantAccountingPoliciesTextBlock_zrzxjXxnRAEb" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Note
2. &lt;span id="xdx_828_zPLqBXWYIVWl"&gt;Summary of Significant Accounting Policies&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_84C_eus-gaap--BasisOfAccountingPolicyPolicyTextBlock_zKVaVj20gVgj" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;&lt;span id="xdx_862_zp4lx1YGTOT3"&gt;Basis
of Presentation&lt;/span&gt;&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
accompanying consolidated financial statements have been prepared by the Company in accordance with generally accepted accounting principles
(&#x201c;GAAP&#x201d;) in the United States (&#x201c;U.S.&#x201d;) and are expressed in U.S. dollars.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
accompanying consolidated financial statements have been prepared assuming that the Company will continue as a going concern. The Company
has not generated revenue or cash flow from operations since inception. As of December 31, 2023, the Company used cash in operations
of $&lt;span id="xdx_90C_eus-gaap--NetCashProvidedByUsedInOperatingActivities_iN_di_c20230101__20231231_zB7ZnFfzNdP4" title="Cash in operations"&gt;8,507,300&lt;/span&gt; and has cash of $&lt;span id="xdx_904_eus-gaap--Cash_iI_c20231231_ziEF5XUdcyl5" title="Cash"&gt;3,012,908&lt;/span&gt; which is not sufficient to fund the Company&#x2019;s planned operations for the next 12 months.
These factors raise substantial doubt regarding the Company&#x2019;s ability to continue as a going concern. The Company&#x2019;s ability
to continue as a going concern is dependent upon the Company&#x2019;s ability to raise sufficient financing to acquire or commercialize
its products into a profitable business. The Company intends to finance its future development and commercialization activities and its
working capital needs largely from the sale of equity securities and/or with additional funding from other traditional financing sources
until such time that funds provided by operations are sufficient to fund working capital requirements. The financial statements of the
Company do not include any adjustments relating to the recoverability and classification of recorded assets, or the amounts and classifications
of liabilities that might be necessary should the Company be unable to continue as a going concern.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_849_eus-gaap--UseOfEstimates_zEaXZ5pgfJRi" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;&lt;span id="xdx_860_zAevqar0yAGg"&gt;Use
of Estimates&lt;/span&gt;&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
preparation of financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the
reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements
and the reported amounts of revenues and expenses during the reporting periods. Actual results could differ from those estimates. As
of December 31, 2023, the most significant estimates relate to derivative liabilities and stock-based compensation.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-indent: 24.75pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_847_eus-gaap--CashAndCashEquivalentsPolicyTextBlock_zbV2MKSLSyA9" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;&lt;span id="xdx_863_zpgJilAhQ4Bb"&gt;Cash
and Cash Equivalents&lt;/span&gt;&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company considers all highly liquid investments purchased with an original or remaining maturity of three months or less at the date
of purchase to be cash equivalents. Cash and cash equivalents are maintained with various financial institutions. At December 31,
2023 and 2022, the Company had &lt;span id="xdx_908_eus-gaap--CashEquivalentsAtCarryingValue_iI_do_c20231231_zWb6yOWVqK22" title="Cash equivalents"&gt;&lt;span id="xdx_903_eus-gaap--CashEquivalentsAtCarryingValue_iI_do_c20221231_zMq2PeuJTbLk" title="Cash equivalents"&gt;no&lt;/span&gt;&lt;/span&gt; cash equivalents.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_84D_eus-gaap--InventoryPolicyTextBlock_zOoB5UMrClt7" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;&lt;span id="xdx_86F_zdkCVDwqh8qb"&gt;Inventories&lt;/span&gt;&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company values inventory at the lower of cost (average cost) or net realizable value. Work-in-process and finished goods inventories
consist of material, labor, and manufacturing overhead. Net realizable value is the estimated selling price in the ordinary course of
business, less reasonably predictable costs of completion, disposal, and transportation. A reserve is established for any excess or obsolete
inventories or they may be written off. At December 31, 2023 and 2022, inventory is comprised of raw materials, components and finished
goods.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;




&lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;SHARPS
TECHNOLOGY, INC.&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;NOTES
TO THE CONSOLIDATED FINANCIAL STATEMENTS&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;FOR
THE YEARS ENDED DECEMBER 31, 2023 AND 2022&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Note
2. Summary of Significant Accounting Policies (continued)&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_848_eus-gaap--FairValueMeasurementPolicyPolicyTextBlock_zcHPw9YdzgV4" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;span id="xdx_86D_z5klkHhT9Lw9"&gt;Fair
Value Measurements&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;ASC
820, Fair Value Measurements and Disclosures, require an entity to maximize the use of observable inputs and minimize the use of unobservable
inputs when measuring fair value. ASC 820 establishes a fair value hierarchy based on the level of independent, objective evidence surrounding
the inputs used to measure fair value. A financial instrument&#x2019;s categorization within the fair value hierarchy is based upon the
lowest level of input that is significant to the fair value measurement. ASC 820 prioritizes the inputs into three levels that may be
used to measure fair value.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company&#x2019;s outstanding warrants are fair valued on a recurring basis with the trading price or FMV using Black Sholes which
could cause fluctuations in operating results at the reporting periods.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Level
1&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Level
1 applies to assets or liabilities for which there are quoted prices in active markets for identical assets or liabilities. Valuations
are based on quoted prices that are readily and regularly available in an active market and do not entail a significant degree of judgment.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Level
2&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Level
2 applied to assets or liabilities for which there are other than Level 1 observable inputs such as quoted prices for similar assets
or liabilities in active markets; quoted prices for identical assets or liabilities in markets with insufficient volume or infrequent
transactions (less active markets); or model-derived valuations in which significant inputs are observable or can be derived principally
from, or corroborated by, observable market data.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Level
2 instruments require more management judgment and subjectivity as compared to Level 1 instruments. For instance: determining which instruments
are most similar to the instrument being priced requires management to identify a sample of similar securities based on the coupon rates,
maturity, issuer credit rating and instrument type, and subjectively select an individual security or multiple securities that are deemed
most similar to the security being priced; and determining whether a market is considered active requires management judgment.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Level
3&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Level
3 applied to assets or liabilities for which there are unobservable inputs to the valuation methodology that are significant to the measurement
of the fair value of the assets or liabilities. The determination for Level 3 instruments requires the most management judgment and subjectivity.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_846_eus-gaap--PropertyPlantAndEquipmentPolicyTextBlock_zg8LPGtNVQJf" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;Fixed
Assets&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Fixed
assets are stated at cost. Expenditures for maintenance and repairs are charged to operations as incurred. The Company&#x2019;s fixed
assets consist of land, building, machinery and equipment, molds, computer system and website. Depreciation is calculated using the straight-line
method commencing on the date the asset is operating in the way intended by management over the following useful lives: Building &#x2013;
&lt;span id="xdx_900_eus-gaap--PropertyPlantAndEquipmentUsefulLife_iI_dtY_c20231231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--BuildingMember_zDcXnDaTcg23" title="Property plant and equipment asset useful life"&gt;20&lt;/span&gt; years, Machinery and Equipment &#x2013; &lt;span id="xdx_903_eus-gaap--PropertyPlantAndEquipmentUsefulLife_iI_dtY_c20231231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--MachineryAndEquipmentMember__srt--RangeAxis__srt--MinimumMember_zvfMOOj4TIpk" title="Property plant and equipment asset useful life"&gt;3&lt;/span&gt; -&lt;span id="xdx_90A_eus-gaap--PropertyPlantAndEquipmentUsefulLife_iI_dtY_c20231231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--MachineryAndEquipmentMember__srt--RangeAxis__srt--MaximumMember_zUMsxKx0X3a1" title="Property plant and equipment asset useful life"&gt;10&lt;/span&gt; years and Computer systems and Website &#x2013; &lt;span id="xdx_901_eus-gaap--PropertyPlantAndEquipmentUsefulLife_iI_dtY_c20231231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--WebsiteMember_zWiJepiw6Kn" title="Property plant and equipment asset useful life"&gt;3&lt;/span&gt; years. The expected life for Molds is
based lesser of the number of parts that will be produced based on the expected mold capability or 5 years.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_840_eus-gaap--ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock_zmMDNT8Ofh78" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;&lt;span id="xdx_860_zlWnFrL4mQhi"&gt;Impairment
of Long-Lived Assets&lt;/span&gt; &lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Long-lived
assets are reviewed annually for impairment or whenever events or changes in circumstances indicate that the carrying amount of an asset
may not be recoverable. Recoverability is measured by comparison of the carrying amount of an asset group to the future net undiscounted
cash flows that the assets are expected to generate. If such assets are considered to be impaired, the impairment to be recognized is
measured by the amount by which the carrying amount of the assets exceeds the projected discounted future net cash flows arising from
the asset.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company recorded an impairment of $&lt;span id="xdx_90F_eus-gaap--ImpairmentOfLongLivedAssetsHeldForUse_c20230101__20231231_z0rVCogZaeT4" title="Impairment losses"&gt;560,000&lt;/span&gt; during the year ended December 31, 2023 and &lt;span id="xdx_900_eus-gaap--ImpairmentOfLongLivedAssetsHeldForUse_dxL_c20220101__20221231_zPneDqTLg4uj" title="Impairment losses::XDX::-"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0604"&gt;no&lt;/span&gt;&lt;/span&gt;
impairment during the year ended December 31, 2022.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;




&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;SHARPS
TECHNOLOGY, INC.&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;NOTES
TO THE CONSOLIDATED FINANCIAL STATEMENTS&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;FOR
THE YEARS ENDED DECEMBER 31, 2023 AND 2022&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Note
2. Summary of Significant Accounting Policies (continued)&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_841_eus-gaap--IntangibleAssetsFiniteLivedPolicy_ziROBe3KcNL9" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;&lt;span id="xdx_86C_zxU4sxefa3ye"&gt;Purchased
Identified Intangible Assets&lt;/span&gt;&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;Identified
Intangible Assets&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company&#x2019;s identified intangible assets are amortized on a straight-line basis over their estimated useful lives of 5 years. The
Company makes judgments about the recoverability of finite-lived intangible assets whenever facts and circumstances indicate that the
useful life is shorter than originally estimated or that the carrying amount of assets may not be recoverable. If such facts and circumstances
exist, the Company assesses recoverability by comparing the projected undiscounted net cash flows associated with the related asset or
group of assets over their remaining lives against their respective carrying amounts. Impairments, if any, are based on the excess of
the carrying amount over the fair value of those assets. If the useful life is shorter than originally estimated, the Company would accelerate
the rate of amortization and amortize the remaining carrying value over the new shorter useful life. The Company evaluates the carrying
value of finite-lived intangible assets on an annual basis, and an impairment charge would be recognized to the extent that the carrying
amount of such assets exceeds their estimated fair value.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_843_eus-gaap--CompensationRelatedCostsPolicyTextBlock_zLto1WwGYnCh" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;&lt;span id="xdx_864_zVx4yLq85QPc"&gt;Stock-based
Compensation Expense&lt;/span&gt;&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company measures its stock-based awards made to employees based on the estimated fair values of the awards as of the grant date. For
stock option awards, the Company uses the Black-Scholes option-pricing model. For restricted stock awards, the estimated fair value is
generally the fair market value of the underlying stock on the grant date. Stock-based compensation expense is recognized over the requisite
service period and is based on the value of the portion of stock-based payment awards that is ultimately expected to vest. The Company
recognizes forfeitures of stock-based awards as they occur on a prospective basis.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Stock-based
compensation expense for awards granted to non-employees as consideration for services received is measured on the date of performance
at the fair value of the consideration received or the fair value of the equity instruments issued, whichever can be more reliably measured.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;




&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;SHARPS
TECHNOLOGY, INC.&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;NOTES
TO THE CONSOLIDATED FINANCIAL STATEMENTS&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;FOR
THE YEARS ENDED DECEMBER 31, 2023 AND 2022&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Note
2. Summary of Significant Accounting Policies (continued)&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_848_eus-gaap--DerivativesPolicyTextBlock_z4E35sPxqQwg" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;&lt;span id="xdx_861_zfSFtOldWiqd"&gt;Derivative
Instruments&lt;/span&gt;&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company accounts for common stock warrants as either equity-classified or liability-classified instruments based on an assessment of
the specific terms of the warrants and applicable authoritative guidance in Financial Accounting Standards Board (&#x201c;FASB&#x201d;)
Accounting Standards Codification (&#x201c;ASC 480&#x201d;), Distinguishing Liabilities from Equity (&#x201c;ASC 480&#x201d;) and ASC 815,
Derivatives and Hedging (&#x201c;ASC 815&#x201d;). The assessment considers whether the warrants are freestanding financial instruments
pursuant to ASC 480, meet the definition of a liability pursuant to ASC 480, and meet all of the requirements for equity classification
under ASC 815, including whether the warrants are indexed to the Company&#x2019;s own stock and whether the holders of the warrants could
potentially require net cash settlement in a circumstance outside of the Company&#x2019;s control, among other conditions for equity classification.
This assessment, which requires the use of professional judgment, is conducted at the time of warrant issuance and as of each subsequent
quarterly period end date while the warrants are outstanding.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;At
their issuance date and as of December 31, 2023, certain warrants (see Notes 8 and 10) are accounted for as liabilities as these instruments
did not meet all of the requirements for equity classification under ASC 815-40 based on the terms of the aforementioned warrants. The
resulting warrant liabilities are re-measured at each balance sheet date until their exercise or expiration, and any change in fair value
is recognized in the Company&#x2019;s consolidated statements of operations.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_84B_eus-gaap--ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock_z2SbVpJcwPed" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;&lt;span id="xdx_86F_zlEzljoZPcy4"&gt;Foreign
Currency Translation/Transactions&lt;/span&gt;&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company has determined that the functional currency for its foreign subsidiary is the local currency. For financial reporting purposes,
assets and liabilities denominated in foreign currencies are translated at current exchange rates and profit and loss accounts are translated
at weighted average exchange rates. Resulting translation gains and losses are included as a separate component of stockholders&#x2019;
equity as accumulated other comprehensive income or loss. Gains or losses resulting from transactions entered into in other than the
functional currency are recorded as foreign exchange gains and losses in the consolidated statements of operations.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_843_eus-gaap--ComprehensiveIncomePolicyPolicyTextBlock_zRifrGfr3Ls1" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;&lt;span id="xdx_86A_zUWfwARhhYRk"&gt;Comprehensive
income (loss)&lt;/span&gt;&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Comprehensive
income (loss) consists of the Company&#x2019;s consolidated net loss and foreign currency translation adjustments related to its subsidiary.
Foreign currency translation adjustments included in comprehensive loss were not tax effected as the Company has a full valuation allowance
at December 31, 2023 and 2022. Accumulated other comprehensive income (loss) is a separate component of stockholders&#x2019; equity and
consists of the cumulative foreign currency translation adjustments.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_84B_eus-gaap--EarningsPerSharePolicyTextBlock_zymxba8U4w66" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;&lt;span id="xdx_86C_z601WrOkquZf"&gt;Basic
and Diluted Loss Per Share&lt;/span&gt;&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company computes net loss per share in accordance with ASC 260, Earnings per Share. ASC 260 requires presentation of both basic and diluted
earnings per share (EPS) on the face of the consolidated statements of operations. Basic EPS is computed by dividing net income (loss)
available to common stockholders (numerator) by the weighted average number of shares outstanding (denominator) during the period. Basic
EPS includes the &lt;span id="xdx_907_eus-gaap--WeightedAverageNumberOfSharesOutstandingBasic_c20230101__20231231__us-gaap--StatementEquityComponentsAxis__custom--PrefundendWarrantsMember_zW6yW4DDWHHb" title="Weighted average shares outstanding basic"&gt;3,381,479&lt;/span&gt; of pre-funded warrants (see Note 8). Diluted EPS gives effect to all dilutive potential common shares outstanding
during the period using the treasury stock method and convertible preferred stock using the if-converted method. In computing diluted
EPS, the average stock price for the period is used in determining the number of shares assumed to be purchased from the exercise of
stock options or warrants. Diluted EPS excludes all dilutive potential shares if their effect is anti-dilutive. As of December 31, 2023,
there were &lt;span id="xdx_90F_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_c20230101__20231231__us-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__custom--StockOptionsAndWarrantsMember_zxFr2uIC5do7" title="Antidilutive securities shares"&gt;22,950,155&lt;/span&gt; stock options and warrants that could potentially dilute basic EPS in the future that were not included in the
computation of diluted EPS because to do so would have been anti-dilutive for the periods presented.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_845_eus-gaap--IncomeTaxPolicyTextBlock_ziEbuahOcoKj" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;&lt;span id="xdx_867_zl2OX7bMoBbl"&gt;Income
Taxes&lt;/span&gt;&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company must make certain estimates and judgments in determining income tax expense for financial statement purposes. These estimates
and judgments are used in the calculation of tax credits, tax benefits, tax deductions, and in the calculation of certain deferred taxes
and tax liabilities. Significant changes to these estimates may result in an increase or decrease to the Company&#x2019;s tax provision
in a subsequent period.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;




&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;SHARPS
TECHNOLOGY, INC.&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;NOTES
TO THE CONSOLIDATED FINANCIAL STATEMENTS&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;FOR
THE YEARS ENDED DECEMBER 31, 2023 AND 2022&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Note
2. Summary of Significant Accounting Policies (continued)&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
provision for income taxes was comprised of the Company&#x2019;s current tax liability and changes in deferred income tax assets and liabilities.
The calculation of the current tax liability involves dealing with uncertainties in the application of complex tax laws and regulations
and in determining the liability for tax positions, if any, taken on the Company&#x2019;s tax returns in accordance with authoritative
guidance on accounting for uncertainty in income taxes. Deferred income taxes are determined based on the differences between the financial
reporting and tax basis of assets and liabilities. The Company must assess the likelihood that it will be able to recover the Company&#x2019;s
deferred tax assets. If recovery is not likely on a more-likely-than-not basis, the Company must increase its provision for income taxes
by recording a valuation allowance against the deferred tax assets that it estimates will not ultimately be recoverable. However, should
there be a change in the Company&#x2019;s ability to recover its deferred tax assets, the provision for income taxes would fluctuate in
the period of such change.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_842_eus-gaap--ResearchAndDevelopmentExpensePolicy_zNrWRCEvd1X5" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;&lt;span id="xdx_86D_z3XLDfbXfP76"&gt;Research
and Development Costs&lt;/span&gt;&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Research
and development costs are expensed as incurred.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Advance
payments for goods or services that will be used or rendered for future research and development activities are deferred and capitalized.
Such amounts are recognized as an expense as the related goods are delivered or the services are performed.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_840_eus-gaap--CommitmentsAndContingenciesPolicyTextBlock_zMAjVtdbmft2" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;&lt;span id="xdx_861_znjPtJzomxrk"&gt;Contingencies&lt;/span&gt;&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; background-color: white"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Liabilities
for loss contingencies arising from claims, assessments, litigations, fines and penalties and other sources are recognized when it is
probable that a liability has been incurred and the amount of the assessment can be reasonably estimated. Gain contingencies are evaluated
and not recognized until the gain is realizable or realized.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_84E_eus-gaap--NewAccountingPronouncementsPolicyPolicyTextBlock_zC2pqT1WNqxh" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;&lt;span id="xdx_868_z2mR3DbjnDI9"&gt;Recent
Accounting Pronouncements&lt;/span&gt; &lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;On
August 5, 2020, the FASB issued ASU 2020-06, &lt;i&gt;Debt &#x2013; Debt with Conversion and Other Options (Subtopic 470-20) and Derivatives
and Hedging &#x2013; Contracts in Entity&#x2019;s Own Equity (Subtopic 815-40)&lt;/i&gt;, which simplifies the accounting for certain financial
instruments with characteristics of liabilities and equity, including convertible instruments and contracts on an entity&#x2019;s own
equity. The ASU is part of the FASB&#x2019;s simplification initiative, which aims to reduce unnecessary complexity in U.S. GAAP. ASU
2020-06 simplifies the guidance in U.S. GAAP on the issuer&#x2019;s accounting for convertible debt instruments, requires entities to
provide expanded disclosures about &#x201c;the terms and features of convertible instruments&#x201d; and how the instruments have been
reported in the entity&#x2019;s financial statements. It also removes from ASC 815-40-25-10 certain conditions for equity classification
and amends certain guidance in ASC 260, &lt;i&gt;Earnings per Share&lt;/i&gt;, on the computation of EPS for convertible instruments and contracts
on an entity&#x2019;s own equity. An entity can use either a full or modified retrospective approach to adopt the ASU&#x2019;s guidance.
The ASU&#x2019;s amendments are effective for smaller public business entities fiscal years beginning after December 15, 2023. The Company
is currently evaluating the impact of ASU 2020-06 on its consolidated financial statements and does not expect the adoption of this amended
guidance to have a material impact on the Company&#x2019;s consolidated financial statements.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;In
December 2023, the FASB issued ASU 2023-09, &lt;i&gt;Income Taxes &lt;/i&gt;(Topic 740)&lt;i&gt;: Improvements to Income Tax Disclosures&lt;/i&gt;. The new guidance
requires disaggregated information about the effective tax rate reconciliation and additional information on taxes paid that meet a quantitative
threshold. The new guidance is effective for public companies for annual reporting periods beginning after December 15, 2024, and for
non-public companies for annual reporting periods beginning after December 15, 2025, with early adoption permitted for both. The Company
will adopt the new standard in the annual reporting period beginning after December 15, 2025 and is currently evaluating the impacts of the
new guidance on its disclosures within the consolidated financial statements.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company does not expect the adoption of any accounting pronouncements to have a material impact on the consolidated financial statements.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company reviewed all other recently issued accounting pronouncements and have concluded they are not applicable or not expected to be
significant to the accounting for our operations.&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_85D_zBg1R3ZATai8" style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;




&lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;SHARPS
TECHNOLOGY, INC.&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;NOTES
TO THE CONSOLIDATED FINANCIAL STATEMENTS&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;FOR
THE YEARS ENDED DECEMBER 31, 2023 AND 2022&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

</us-gaap:SignificantAccountingPoliciesTextBlock>
    <us-gaap:BasisOfAccountingPolicyPolicyTextBlock contextRef="From2023-01-012023-12-31" id="Fact000572">&lt;p id="xdx_84C_eus-gaap--BasisOfAccountingPolicyPolicyTextBlock_zKVaVj20gVgj" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;&lt;span id="xdx_862_zp4lx1YGTOT3"&gt;Basis
of Presentation&lt;/span&gt;&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
accompanying consolidated financial statements have been prepared by the Company in accordance with generally accepted accounting principles
(&#x201c;GAAP&#x201d;) in the United States (&#x201c;U.S.&#x201d;) and are expressed in U.S. dollars.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
accompanying consolidated financial statements have been prepared assuming that the Company will continue as a going concern. The Company
has not generated revenue or cash flow from operations since inception. As of December 31, 2023, the Company used cash in operations
of $&lt;span id="xdx_90C_eus-gaap--NetCashProvidedByUsedInOperatingActivities_iN_di_c20230101__20231231_zB7ZnFfzNdP4" title="Cash in operations"&gt;8,507,300&lt;/span&gt; and has cash of $&lt;span id="xdx_904_eus-gaap--Cash_iI_c20231231_ziEF5XUdcyl5" title="Cash"&gt;3,012,908&lt;/span&gt; which is not sufficient to fund the Company&#x2019;s planned operations for the next 12 months.
These factors raise substantial doubt regarding the Company&#x2019;s ability to continue as a going concern. The Company&#x2019;s ability
to continue as a going concern is dependent upon the Company&#x2019;s ability to raise sufficient financing to acquire or commercialize
its products into a profitable business. The Company intends to finance its future development and commercialization activities and its
working capital needs largely from the sale of equity securities and/or with additional funding from other traditional financing sources
until such time that funds provided by operations are sufficient to fund working capital requirements. The financial statements of the
Company do not include any adjustments relating to the recoverability and classification of recorded assets, or the amounts and classifications
of liabilities that might be necessary should the Company be unable to continue as a going concern.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

</us-gaap:BasisOfAccountingPolicyPolicyTextBlock>
    <us-gaap:NetCashProvidedByUsedInOperatingActivities
      contextRef="From2023-01-012023-12-31"
      decimals="0"
      id="Fact000574"
      unitRef="USD">-8507300</us-gaap:NetCashProvidedByUsedInOperatingActivities>
    <us-gaap:Cash
      contextRef="AsOf2023-12-31"
      decimals="0"
      id="Fact000576"
      unitRef="USD">3012908</us-gaap:Cash>
    <us-gaap:UseOfEstimates contextRef="From2023-01-012023-12-31" id="Fact000578">&lt;p id="xdx_849_eus-gaap--UseOfEstimates_zEaXZ5pgfJRi" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;&lt;span id="xdx_860_zAevqar0yAGg"&gt;Use
of Estimates&lt;/span&gt;&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
preparation of financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the
reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements
and the reported amounts of revenues and expenses during the reporting periods. Actual results could differ from those estimates. As
of December 31, 2023, the most significant estimates relate to derivative liabilities and stock-based compensation.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-indent: 24.75pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

</us-gaap:UseOfEstimates>
    <us-gaap:CashAndCashEquivalentsPolicyTextBlock contextRef="From2023-01-012023-12-31" id="Fact000580">&lt;p id="xdx_847_eus-gaap--CashAndCashEquivalentsPolicyTextBlock_zbV2MKSLSyA9" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;&lt;span id="xdx_863_zpgJilAhQ4Bb"&gt;Cash
and Cash Equivalents&lt;/span&gt;&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company considers all highly liquid investments purchased with an original or remaining maturity of three months or less at the date
of purchase to be cash equivalents. Cash and cash equivalents are maintained with various financial institutions. At December 31,
2023 and 2022, the Company had &lt;span id="xdx_908_eus-gaap--CashEquivalentsAtCarryingValue_iI_do_c20231231_zWb6yOWVqK22" title="Cash equivalents"&gt;&lt;span id="xdx_903_eus-gaap--CashEquivalentsAtCarryingValue_iI_do_c20221231_zMq2PeuJTbLk" title="Cash equivalents"&gt;no&lt;/span&gt;&lt;/span&gt; cash equivalents.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

</us-gaap:CashAndCashEquivalentsPolicyTextBlock>
    <us-gaap:CashEquivalentsAtCarryingValue
      contextRef="AsOf2023-12-31"
      decimals="0"
      id="Fact000582"
      unitRef="USD">0</us-gaap:CashEquivalentsAtCarryingValue>
    <us-gaap:CashEquivalentsAtCarryingValue
      contextRef="AsOf2022-12-31"
      decimals="0"
      id="Fact000584"
      unitRef="USD">0</us-gaap:CashEquivalentsAtCarryingValue>
    <us-gaap:InventoryPolicyTextBlock contextRef="From2023-01-012023-12-31" id="Fact000586">&lt;p id="xdx_84D_eus-gaap--InventoryPolicyTextBlock_zOoB5UMrClt7" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;&lt;span id="xdx_86F_zdkCVDwqh8qb"&gt;Inventories&lt;/span&gt;&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company values inventory at the lower of cost (average cost) or net realizable value. Work-in-process and finished goods inventories
consist of material, labor, and manufacturing overhead. Net realizable value is the estimated selling price in the ordinary course of
business, less reasonably predictable costs of completion, disposal, and transportation. A reserve is established for any excess or obsolete
inventories or they may be written off. At December 31, 2023 and 2022, inventory is comprised of raw materials, components and finished
goods.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;




&lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;SHARPS
TECHNOLOGY, INC.&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;NOTES
TO THE CONSOLIDATED FINANCIAL STATEMENTS&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;FOR
THE YEARS ENDED DECEMBER 31, 2023 AND 2022&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Note
2. Summary of Significant Accounting Policies (continued)&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

</us-gaap:InventoryPolicyTextBlock>
    <us-gaap:FairValueMeasurementPolicyPolicyTextBlock contextRef="From2023-01-012023-12-31" id="Fact000588">&lt;p id="xdx_848_eus-gaap--FairValueMeasurementPolicyPolicyTextBlock_zcHPw9YdzgV4" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;span id="xdx_86D_z5klkHhT9Lw9"&gt;Fair
Value Measurements&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;ASC
820, Fair Value Measurements and Disclosures, require an entity to maximize the use of observable inputs and minimize the use of unobservable
inputs when measuring fair value. ASC 820 establishes a fair value hierarchy based on the level of independent, objective evidence surrounding
the inputs used to measure fair value. A financial instrument&#x2019;s categorization within the fair value hierarchy is based upon the
lowest level of input that is significant to the fair value measurement. ASC 820 prioritizes the inputs into three levels that may be
used to measure fair value.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company&#x2019;s outstanding warrants are fair valued on a recurring basis with the trading price or FMV using Black Sholes which
could cause fluctuations in operating results at the reporting periods.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Level
1&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Level
1 applies to assets or liabilities for which there are quoted prices in active markets for identical assets or liabilities. Valuations
are based on quoted prices that are readily and regularly available in an active market and do not entail a significant degree of judgment.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Level
2&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Level
2 applied to assets or liabilities for which there are other than Level 1 observable inputs such as quoted prices for similar assets
or liabilities in active markets; quoted prices for identical assets or liabilities in markets with insufficient volume or infrequent
transactions (less active markets); or model-derived valuations in which significant inputs are observable or can be derived principally
from, or corroborated by, observable market data.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Level
2 instruments require more management judgment and subjectivity as compared to Level 1 instruments. For instance: determining which instruments
are most similar to the instrument being priced requires management to identify a sample of similar securities based on the coupon rates,
maturity, issuer credit rating and instrument type, and subjectively select an individual security or multiple securities that are deemed
most similar to the security being priced; and determining whether a market is considered active requires management judgment.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Level
3&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Level
3 applied to assets or liabilities for which there are unobservable inputs to the valuation methodology that are significant to the measurement
of the fair value of the assets or liabilities. The determination for Level 3 instruments requires the most management judgment and subjectivity.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

</us-gaap:FairValueMeasurementPolicyPolicyTextBlock>
    <us-gaap:PropertyPlantAndEquipmentPolicyTextBlock contextRef="From2023-01-012023-12-31" id="Fact000590">&lt;p id="xdx_846_eus-gaap--PropertyPlantAndEquipmentPolicyTextBlock_zg8LPGtNVQJf" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;Fixed
Assets&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Fixed
assets are stated at cost. Expenditures for maintenance and repairs are charged to operations as incurred. The Company&#x2019;s fixed
assets consist of land, building, machinery and equipment, molds, computer system and website. Depreciation is calculated using the straight-line
method commencing on the date the asset is operating in the way intended by management over the following useful lives: Building &#x2013;
&lt;span id="xdx_900_eus-gaap--PropertyPlantAndEquipmentUsefulLife_iI_dtY_c20231231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--BuildingMember_zDcXnDaTcg23" title="Property plant and equipment asset useful life"&gt;20&lt;/span&gt; years, Machinery and Equipment &#x2013; &lt;span id="xdx_903_eus-gaap--PropertyPlantAndEquipmentUsefulLife_iI_dtY_c20231231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--MachineryAndEquipmentMember__srt--RangeAxis__srt--MinimumMember_zvfMOOj4TIpk" title="Property plant and equipment asset useful life"&gt;3&lt;/span&gt; -&lt;span id="xdx_90A_eus-gaap--PropertyPlantAndEquipmentUsefulLife_iI_dtY_c20231231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--MachineryAndEquipmentMember__srt--RangeAxis__srt--MaximumMember_zUMsxKx0X3a1" title="Property plant and equipment asset useful life"&gt;10&lt;/span&gt; years and Computer systems and Website &#x2013; &lt;span id="xdx_901_eus-gaap--PropertyPlantAndEquipmentUsefulLife_iI_dtY_c20231231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--WebsiteMember_zWiJepiw6Kn" title="Property plant and equipment asset useful life"&gt;3&lt;/span&gt; years. The expected life for Molds is
based lesser of the number of parts that will be produced based on the expected mold capability or 5 years.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

</us-gaap:PropertyPlantAndEquipmentPolicyTextBlock>
    <us-gaap:PropertyPlantAndEquipmentUsefulLife
      contextRef="AsOf2023-12-31_us-gaap_BuildingMember"
      id="Fact000592">P20Y</us-gaap:PropertyPlantAndEquipmentUsefulLife>
    <us-gaap:PropertyPlantAndEquipmentUsefulLife
      contextRef="AsOf2023-12-31_us-gaap_MachineryAndEquipmentMember_srt_MinimumMember"
      id="Fact000594">P3Y</us-gaap:PropertyPlantAndEquipmentUsefulLife>
    <us-gaap:PropertyPlantAndEquipmentUsefulLife
      contextRef="AsOf2023-12-31_us-gaap_MachineryAndEquipmentMember_srt_MaximumMember"
      id="Fact000596">P10Y</us-gaap:PropertyPlantAndEquipmentUsefulLife>
    <us-gaap:PropertyPlantAndEquipmentUsefulLife
      contextRef="AsOf2023-12-31_custom_WebsiteMember"
      id="Fact000598">P3Y</us-gaap:PropertyPlantAndEquipmentUsefulLife>
    <us-gaap:ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock contextRef="From2023-01-012023-12-31" id="Fact000600">&lt;p id="xdx_840_eus-gaap--ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock_zmMDNT8Ofh78" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;&lt;span id="xdx_860_zlWnFrL4mQhi"&gt;Impairment
of Long-Lived Assets&lt;/span&gt; &lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Long-lived
assets are reviewed annually for impairment or whenever events or changes in circumstances indicate that the carrying amount of an asset
may not be recoverable. Recoverability is measured by comparison of the carrying amount of an asset group to the future net undiscounted
cash flows that the assets are expected to generate. If such assets are considered to be impaired, the impairment to be recognized is
measured by the amount by which the carrying amount of the assets exceeds the projected discounted future net cash flows arising from
the asset.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company recorded an impairment of $&lt;span id="xdx_90F_eus-gaap--ImpairmentOfLongLivedAssetsHeldForUse_c20230101__20231231_z0rVCogZaeT4" title="Impairment losses"&gt;560,000&lt;/span&gt; during the year ended December 31, 2023 and &lt;span id="xdx_900_eus-gaap--ImpairmentOfLongLivedAssetsHeldForUse_dxL_c20220101__20221231_zPneDqTLg4uj" title="Impairment losses::XDX::-"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0604"&gt;no&lt;/span&gt;&lt;/span&gt;
impairment during the year ended December 31, 2022.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;




&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;SHARPS
TECHNOLOGY, INC.&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;NOTES
TO THE CONSOLIDATED FINANCIAL STATEMENTS&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;FOR
THE YEARS ENDED DECEMBER 31, 2023 AND 2022&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Note
2. Summary of Significant Accounting Policies (continued)&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

</us-gaap:ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock>
    <us-gaap:ImpairmentOfLongLivedAssetsHeldForUse
      contextRef="From2023-01-012023-12-31"
      decimals="0"
      id="Fact000602"
      unitRef="USD">560000</us-gaap:ImpairmentOfLongLivedAssetsHeldForUse>
    <us-gaap:IntangibleAssetsFiniteLivedPolicy contextRef="From2023-01-012023-12-31" id="Fact000606">&lt;p id="xdx_841_eus-gaap--IntangibleAssetsFiniteLivedPolicy_ziROBe3KcNL9" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;&lt;span id="xdx_86C_zxU4sxefa3ye"&gt;Purchased
Identified Intangible Assets&lt;/span&gt;&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;Identified
Intangible Assets&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company&#x2019;s identified intangible assets are amortized on a straight-line basis over their estimated useful lives of 5 years. The
Company makes judgments about the recoverability of finite-lived intangible assets whenever facts and circumstances indicate that the
useful life is shorter than originally estimated or that the carrying amount of assets may not be recoverable. If such facts and circumstances
exist, the Company assesses recoverability by comparing the projected undiscounted net cash flows associated with the related asset or
group of assets over their remaining lives against their respective carrying amounts. Impairments, if any, are based on the excess of
the carrying amount over the fair value of those assets. If the useful life is shorter than originally estimated, the Company would accelerate
the rate of amortization and amortize the remaining carrying value over the new shorter useful life. The Company evaluates the carrying
value of finite-lived intangible assets on an annual basis, and an impairment charge would be recognized to the extent that the carrying
amount of such assets exceeds their estimated fair value.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

</us-gaap:IntangibleAssetsFiniteLivedPolicy>
    <us-gaap:CompensationRelatedCostsPolicyTextBlock contextRef="From2023-01-012023-12-31" id="Fact000608">&lt;p id="xdx_843_eus-gaap--CompensationRelatedCostsPolicyTextBlock_zLto1WwGYnCh" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;&lt;span id="xdx_864_zVx4yLq85QPc"&gt;Stock-based
Compensation Expense&lt;/span&gt;&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company measures its stock-based awards made to employees based on the estimated fair values of the awards as of the grant date. For
stock option awards, the Company uses the Black-Scholes option-pricing model. For restricted stock awards, the estimated fair value is
generally the fair market value of the underlying stock on the grant date. Stock-based compensation expense is recognized over the requisite
service period and is based on the value of the portion of stock-based payment awards that is ultimately expected to vest. The Company
recognizes forfeitures of stock-based awards as they occur on a prospective basis.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Stock-based
compensation expense for awards granted to non-employees as consideration for services received is measured on the date of performance
at the fair value of the consideration received or the fair value of the equity instruments issued, whichever can be more reliably measured.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;




&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;SHARPS
TECHNOLOGY, INC.&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;NOTES
TO THE CONSOLIDATED FINANCIAL STATEMENTS&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;FOR
THE YEARS ENDED DECEMBER 31, 2023 AND 2022&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Note
2. Summary of Significant Accounting Policies (continued)&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

</us-gaap:CompensationRelatedCostsPolicyTextBlock>
    <us-gaap:DerivativesPolicyTextBlock contextRef="From2023-01-012023-12-31" id="Fact000610">&lt;p id="xdx_848_eus-gaap--DerivativesPolicyTextBlock_z4E35sPxqQwg" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;&lt;span id="xdx_861_zfSFtOldWiqd"&gt;Derivative
Instruments&lt;/span&gt;&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company accounts for common stock warrants as either equity-classified or liability-classified instruments based on an assessment of
the specific terms of the warrants and applicable authoritative guidance in Financial Accounting Standards Board (&#x201c;FASB&#x201d;)
Accounting Standards Codification (&#x201c;ASC 480&#x201d;), Distinguishing Liabilities from Equity (&#x201c;ASC 480&#x201d;) and ASC 815,
Derivatives and Hedging (&#x201c;ASC 815&#x201d;). The assessment considers whether the warrants are freestanding financial instruments
pursuant to ASC 480, meet the definition of a liability pursuant to ASC 480, and meet all of the requirements for equity classification
under ASC 815, including whether the warrants are indexed to the Company&#x2019;s own stock and whether the holders of the warrants could
potentially require net cash settlement in a circumstance outside of the Company&#x2019;s control, among other conditions for equity classification.
This assessment, which requires the use of professional judgment, is conducted at the time of warrant issuance and as of each subsequent
quarterly period end date while the warrants are outstanding.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;At
their issuance date and as of December 31, 2023, certain warrants (see Notes 8 and 10) are accounted for as liabilities as these instruments
did not meet all of the requirements for equity classification under ASC 815-40 based on the terms of the aforementioned warrants. The
resulting warrant liabilities are re-measured at each balance sheet date until their exercise or expiration, and any change in fair value
is recognized in the Company&#x2019;s consolidated statements of operations.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

</us-gaap:DerivativesPolicyTextBlock>
    <us-gaap:ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock contextRef="From2023-01-012023-12-31" id="Fact000612">&lt;p id="xdx_84B_eus-gaap--ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock_z2SbVpJcwPed" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;&lt;span id="xdx_86F_zlEzljoZPcy4"&gt;Foreign
Currency Translation/Transactions&lt;/span&gt;&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company has determined that the functional currency for its foreign subsidiary is the local currency. For financial reporting purposes,
assets and liabilities denominated in foreign currencies are translated at current exchange rates and profit and loss accounts are translated
at weighted average exchange rates. Resulting translation gains and losses are included as a separate component of stockholders&#x2019;
equity as accumulated other comprehensive income or loss. Gains or losses resulting from transactions entered into in other than the
functional currency are recorded as foreign exchange gains and losses in the consolidated statements of operations.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

</us-gaap:ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock>
    <us-gaap:ComprehensiveIncomePolicyPolicyTextBlock contextRef="From2023-01-012023-12-31" id="Fact000614">&lt;p id="xdx_843_eus-gaap--ComprehensiveIncomePolicyPolicyTextBlock_zRifrGfr3Ls1" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;&lt;span id="xdx_86A_zUWfwARhhYRk"&gt;Comprehensive
income (loss)&lt;/span&gt;&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Comprehensive
income (loss) consists of the Company&#x2019;s consolidated net loss and foreign currency translation adjustments related to its subsidiary.
Foreign currency translation adjustments included in comprehensive loss were not tax effected as the Company has a full valuation allowance
at December 31, 2023 and 2022. Accumulated other comprehensive income (loss) is a separate component of stockholders&#x2019; equity and
consists of the cumulative foreign currency translation adjustments.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

</us-gaap:ComprehensiveIncomePolicyPolicyTextBlock>
    <us-gaap:EarningsPerSharePolicyTextBlock contextRef="From2023-01-012023-12-31" id="Fact000616">&lt;p id="xdx_84B_eus-gaap--EarningsPerSharePolicyTextBlock_zymxba8U4w66" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;&lt;span id="xdx_86C_z601WrOkquZf"&gt;Basic
and Diluted Loss Per Share&lt;/span&gt;&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company computes net loss per share in accordance with ASC 260, Earnings per Share. ASC 260 requires presentation of both basic and diluted
earnings per share (EPS) on the face of the consolidated statements of operations. Basic EPS is computed by dividing net income (loss)
available to common stockholders (numerator) by the weighted average number of shares outstanding (denominator) during the period. Basic
EPS includes the &lt;span id="xdx_907_eus-gaap--WeightedAverageNumberOfSharesOutstandingBasic_c20230101__20231231__us-gaap--StatementEquityComponentsAxis__custom--PrefundendWarrantsMember_zW6yW4DDWHHb" title="Weighted average shares outstanding basic"&gt;3,381,479&lt;/span&gt; of pre-funded warrants (see Note 8). Diluted EPS gives effect to all dilutive potential common shares outstanding
during the period using the treasury stock method and convertible preferred stock using the if-converted method. In computing diluted
EPS, the average stock price for the period is used in determining the number of shares assumed to be purchased from the exercise of
stock options or warrants. Diluted EPS excludes all dilutive potential shares if their effect is anti-dilutive. As of December 31, 2023,
there were &lt;span id="xdx_90F_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_c20230101__20231231__us-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__custom--StockOptionsAndWarrantsMember_zxFr2uIC5do7" title="Antidilutive securities shares"&gt;22,950,155&lt;/span&gt; stock options and warrants that could potentially dilute basic EPS in the future that were not included in the
computation of diluted EPS because to do so would have been anti-dilutive for the periods presented.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

</us-gaap:EarningsPerSharePolicyTextBlock>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="From2023-01-012023-12-31_custom_PrefundendWarrantsMember"
      decimals="INF"
      id="Fact000618"
      unitRef="Shares">3381479</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="From2023-01-012023-12-31_custom_StockOptionsAndWarrantsMember"
      decimals="INF"
      id="Fact000620"
      unitRef="Shares">22950155</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:IncomeTaxPolicyTextBlock contextRef="From2023-01-012023-12-31" id="Fact000622">&lt;p id="xdx_845_eus-gaap--IncomeTaxPolicyTextBlock_ziEbuahOcoKj" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;&lt;span id="xdx_867_zl2OX7bMoBbl"&gt;Income
Taxes&lt;/span&gt;&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company must make certain estimates and judgments in determining income tax expense for financial statement purposes. These estimates
and judgments are used in the calculation of tax credits, tax benefits, tax deductions, and in the calculation of certain deferred taxes
and tax liabilities. Significant changes to these estimates may result in an increase or decrease to the Company&#x2019;s tax provision
in a subsequent period.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;




&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;SHARPS
TECHNOLOGY, INC.&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;NOTES
TO THE CONSOLIDATED FINANCIAL STATEMENTS&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;FOR
THE YEARS ENDED DECEMBER 31, 2023 AND 2022&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Note
2. Summary of Significant Accounting Policies (continued)&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
provision for income taxes was comprised of the Company&#x2019;s current tax liability and changes in deferred income tax assets and liabilities.
The calculation of the current tax liability involves dealing with uncertainties in the application of complex tax laws and regulations
and in determining the liability for tax positions, if any, taken on the Company&#x2019;s tax returns in accordance with authoritative
guidance on accounting for uncertainty in income taxes. Deferred income taxes are determined based on the differences between the financial
reporting and tax basis of assets and liabilities. The Company must assess the likelihood that it will be able to recover the Company&#x2019;s
deferred tax assets. If recovery is not likely on a more-likely-than-not basis, the Company must increase its provision for income taxes
by recording a valuation allowance against the deferred tax assets that it estimates will not ultimately be recoverable. However, should
there be a change in the Company&#x2019;s ability to recover its deferred tax assets, the provision for income taxes would fluctuate in
the period of such change.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

</us-gaap:IncomeTaxPolicyTextBlock>
    <us-gaap:ResearchAndDevelopmentExpensePolicy contextRef="From2023-01-012023-12-31" id="Fact000624">&lt;p id="xdx_842_eus-gaap--ResearchAndDevelopmentExpensePolicy_zNrWRCEvd1X5" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;&lt;span id="xdx_86D_z3XLDfbXfP76"&gt;Research
and Development Costs&lt;/span&gt;&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Research
and development costs are expensed as incurred.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Advance
payments for goods or services that will be used or rendered for future research and development activities are deferred and capitalized.
Such amounts are recognized as an expense as the related goods are delivered or the services are performed.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

</us-gaap:ResearchAndDevelopmentExpensePolicy>
    <us-gaap:CommitmentsAndContingenciesPolicyTextBlock contextRef="From2023-01-012023-12-31" id="Fact000626">&lt;p id="xdx_840_eus-gaap--CommitmentsAndContingenciesPolicyTextBlock_zMAjVtdbmft2" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;&lt;span id="xdx_861_znjPtJzomxrk"&gt;Contingencies&lt;/span&gt;&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; background-color: white"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Liabilities
for loss contingencies arising from claims, assessments, litigations, fines and penalties and other sources are recognized when it is
probable that a liability has been incurred and the amount of the assessment can be reasonably estimated. Gain contingencies are evaluated
and not recognized until the gain is realizable or realized.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

</us-gaap:CommitmentsAndContingenciesPolicyTextBlock>
    <us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock contextRef="From2023-01-012023-12-31" id="Fact000628">&lt;p id="xdx_84E_eus-gaap--NewAccountingPronouncementsPolicyPolicyTextBlock_zC2pqT1WNqxh" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;&lt;span id="xdx_868_z2mR3DbjnDI9"&gt;Recent
Accounting Pronouncements&lt;/span&gt; &lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;On
August 5, 2020, the FASB issued ASU 2020-06, &lt;i&gt;Debt &#x2013; Debt with Conversion and Other Options (Subtopic 470-20) and Derivatives
and Hedging &#x2013; Contracts in Entity&#x2019;s Own Equity (Subtopic 815-40)&lt;/i&gt;, which simplifies the accounting for certain financial
instruments with characteristics of liabilities and equity, including convertible instruments and contracts on an entity&#x2019;s own
equity. The ASU is part of the FASB&#x2019;s simplification initiative, which aims to reduce unnecessary complexity in U.S. GAAP. ASU
2020-06 simplifies the guidance in U.S. GAAP on the issuer&#x2019;s accounting for convertible debt instruments, requires entities to
provide expanded disclosures about &#x201c;the terms and features of convertible instruments&#x201d; and how the instruments have been
reported in the entity&#x2019;s financial statements. It also removes from ASC 815-40-25-10 certain conditions for equity classification
and amends certain guidance in ASC 260, &lt;i&gt;Earnings per Share&lt;/i&gt;, on the computation of EPS for convertible instruments and contracts
on an entity&#x2019;s own equity. An entity can use either a full or modified retrospective approach to adopt the ASU&#x2019;s guidance.
The ASU&#x2019;s amendments are effective for smaller public business entities fiscal years beginning after December 15, 2023. The Company
is currently evaluating the impact of ASU 2020-06 on its consolidated financial statements and does not expect the adoption of this amended
guidance to have a material impact on the Company&#x2019;s consolidated financial statements.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;In
December 2023, the FASB issued ASU 2023-09, &lt;i&gt;Income Taxes &lt;/i&gt;(Topic 740)&lt;i&gt;: Improvements to Income Tax Disclosures&lt;/i&gt;. The new guidance
requires disaggregated information about the effective tax rate reconciliation and additional information on taxes paid that meet a quantitative
threshold. The new guidance is effective for public companies for annual reporting periods beginning after December 15, 2024, and for
non-public companies for annual reporting periods beginning after December 15, 2025, with early adoption permitted for both. The Company
will adopt the new standard in the annual reporting period beginning after December 15, 2025 and is currently evaluating the impacts of the
new guidance on its disclosures within the consolidated financial statements.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company does not expect the adoption of any accounting pronouncements to have a material impact on the consolidated financial statements.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company reviewed all other recently issued accounting pronouncements and have concluded they are not applicable or not expected to be
significant to the accounting for our operations.&lt;/span&gt;&lt;/p&gt;

</us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock>
    <us-gaap:InventoryDisclosureTextBlock contextRef="From2023-01-012023-12-31" id="Fact000630">&lt;p id="xdx_80E_eus-gaap--InventoryDisclosureTextBlock_zbBN9a3Qqiwj" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Note
3. &lt;span id="xdx_82B_zTkTm91WsZFf"&gt;Inventories&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_897_eus-gaap--ScheduleOfInventoryCurrentTableTextBlock_z3TdlfDLqDOh" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Inventories,
net consisted of the following at December 31, 2023 and 2022:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span id="xdx_8B6_zCRavWqfgD5i" style="display: none"&gt;Schedule of Inventories&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_499_20231231_zP3RLzx3Hdr8" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;&lt;p style="margin-top: 0pt; margin-bottom: 0pt"&gt;December 31,&lt;/p&gt;
                                                                                &lt;p style="margin-top: 0pt; margin-bottom: 0pt"&gt;2023&lt;/p&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_494_20221231_zaiuNWHgSB5" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;&lt;p style="margin-top: 0pt; margin-bottom: 0pt"&gt;December 31,&lt;/p&gt;
                                                                                &lt;p style="margin-top: 0pt; margin-bottom: 0pt"&gt;2022&lt;/p&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_400_eus-gaap--InventoryRawMaterialsNetOfReserves_iI_maINzcUe_zj891ZoM6wF1" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 60%; text-align: left"&gt;Raw materials&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 16%; text-align: right"&gt;254,461&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 16%; text-align: right"&gt;106,088&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_409_eus-gaap--InventoryWorkInProcessNetOfReserves_iI_maINzcUe_zl5kEwucRDCe" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;Work in process&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;170,464&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;49,144&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40F_eus-gaap--InventoryFinishedGoodsNetOfReserves_iI_maINzcUe_zzZPgUwfNfLf" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-bottom: 1pt"&gt;Finished goods&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;1,284,210&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;30,572&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_406_eus-gaap--InventoryNet_iTI_mtINzcUe_zQlw3jmBTngg" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-bottom: 1pt"&gt;Total&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;1,709,135&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;185,804&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p id="xdx_8AD_zMxV2pgkb3Mk" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

</us-gaap:InventoryDisclosureTextBlock>
    <us-gaap:ScheduleOfInventoryCurrentTableTextBlock contextRef="From2023-01-012023-12-31" id="Fact000632">&lt;p id="xdx_897_eus-gaap--ScheduleOfInventoryCurrentTableTextBlock_z3TdlfDLqDOh" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Inventories,
net consisted of the following at December 31, 2023 and 2022:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span id="xdx_8B6_zCRavWqfgD5i" style="display: none"&gt;Schedule of Inventories&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_499_20231231_zP3RLzx3Hdr8" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;&lt;p style="margin-top: 0pt; margin-bottom: 0pt"&gt;December 31,&lt;/p&gt;
                                                                                &lt;p style="margin-top: 0pt; margin-bottom: 0pt"&gt;2023&lt;/p&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_494_20221231_zaiuNWHgSB5" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;&lt;p style="margin-top: 0pt; margin-bottom: 0pt"&gt;December 31,&lt;/p&gt;
                                                                                &lt;p style="margin-top: 0pt; margin-bottom: 0pt"&gt;2022&lt;/p&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_400_eus-gaap--InventoryRawMaterialsNetOfReserves_iI_maINzcUe_zj891ZoM6wF1" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 60%; text-align: left"&gt;Raw materials&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 16%; text-align: right"&gt;254,461&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 16%; text-align: right"&gt;106,088&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_409_eus-gaap--InventoryWorkInProcessNetOfReserves_iI_maINzcUe_zl5kEwucRDCe" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;Work in process&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;170,464&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;49,144&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40F_eus-gaap--InventoryFinishedGoodsNetOfReserves_iI_maINzcUe_zzZPgUwfNfLf" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-bottom: 1pt"&gt;Finished goods&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;1,284,210&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;30,572&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_406_eus-gaap--InventoryNet_iTI_mtINzcUe_zQlw3jmBTngg" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-bottom: 1pt"&gt;Total&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;1,709,135&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;185,804&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

</us-gaap:ScheduleOfInventoryCurrentTableTextBlock>
    <us-gaap:InventoryRawMaterialsNetOfReserves
      contextRef="AsOf2023-12-31"
      decimals="0"
      id="Fact000634"
      unitRef="USD">254461</us-gaap:InventoryRawMaterialsNetOfReserves>
    <us-gaap:InventoryRawMaterialsNetOfReserves
      contextRef="AsOf2022-12-31"
      decimals="0"
      id="Fact000635"
      unitRef="USD">106088</us-gaap:InventoryRawMaterialsNetOfReserves>
    <us-gaap:InventoryWorkInProcessNetOfReserves
      contextRef="AsOf2023-12-31"
      decimals="0"
      id="Fact000637"
      unitRef="USD">170464</us-gaap:InventoryWorkInProcessNetOfReserves>
    <us-gaap:InventoryWorkInProcessNetOfReserves
      contextRef="AsOf2022-12-31"
      decimals="0"
      id="Fact000638"
      unitRef="USD">49144</us-gaap:InventoryWorkInProcessNetOfReserves>
    <us-gaap:InventoryFinishedGoodsNetOfReserves
      contextRef="AsOf2023-12-31"
      decimals="0"
      id="Fact000640"
      unitRef="USD">1284210</us-gaap:InventoryFinishedGoodsNetOfReserves>
    <us-gaap:InventoryFinishedGoodsNetOfReserves
      contextRef="AsOf2022-12-31"
      decimals="0"
      id="Fact000641"
      unitRef="USD">30572</us-gaap:InventoryFinishedGoodsNetOfReserves>
    <us-gaap:InventoryNet
      contextRef="AsOf2023-12-31"
      decimals="0"
      id="Fact000643"
      unitRef="USD">1709135</us-gaap:InventoryNet>
    <us-gaap:InventoryNet
      contextRef="AsOf2022-12-31"
      decimals="0"
      id="Fact000644"
      unitRef="USD">185804</us-gaap:InventoryNet>
    <us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock contextRef="From2023-01-012023-12-31" id="Fact000646">&lt;p id="xdx_809_eus-gaap--PropertyPlantAndEquipmentDisclosureTextBlock_zoKkeKrJuN94" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Note
4. &lt;span id="xdx_82C_zow7dKL8AaDa"&gt;Fixed Assets&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_893_eus-gaap--PropertyPlantAndEquipmentTextBlock_zPUvEoseWjce" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Fixed
asset, net, as of December 31, 2023 and 2022, are summarized as follows:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;span id="xdx_8B0_zAFXDcVkUXue" style="display: none"&gt;Schedule of Property, Plant and Equipment&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 85%"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_49F_20231231_zWFwv1Q28DAl" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;&lt;p style="margin-top: 0pt; margin-bottom: 0pt"&gt;December 31,&lt;/p&gt;
                                                                                &lt;p style="margin-top: 0pt; margin-bottom: 0pt"&gt;2023&lt;/p&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_49F_20221231_z3IwxSHnt11c" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;December
31,&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;
                                                                                 &lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;2022&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40A_eus-gaap--PropertyPlantAndEquipmentGross_iI_hus-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--LandMember_zMoBJf64Ur01" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 56%"&gt;Land&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 18%; text-align: right"&gt;260,460&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 18%; text-align: right"&gt;242,240&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_402_eus-gaap--PropertyPlantAndEquipmentGross_iI_hus-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--BuildingMember_zABltg7WUrg8" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td&gt;Building&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;3,022,490&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;2,824,481&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_406_eus-gaap--PropertyPlantAndEquipmentGross_iI_hus-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--MachineryAndEquipmentMember_ziNklABgBeNb" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;Machinery and Equipment&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;4,464,317&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;4,601,293&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_402_eus-gaap--PropertyPlantAndEquipmentGross_iI_hus-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--ComputerSystemsAndWebsiteAndOtherWebsiteMember_zUXGTRCvI5Hf" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-bottom: 1pt"&gt;Computer and Website&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;290,661&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;16,600&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40F_eus-gaap--PropertyPlantAndEquipmentGross_iI_maPPAENzHVU_zO2D76mnsUuf" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td&gt;&#160;&lt;span style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Total Fixed Assets&lt;/span&gt; &lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;8,037,928&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;7,684,614&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_403_eus-gaap--AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_iNI_di_msPPAENzHVU_zaXpSGBuV5O7" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-bottom: 1pt"&gt;Less: accumulated depreciation&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;(1,215,786&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;(679,724&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_400_eus-gaap--PropertyPlantAndEquipmentNet_iTI_mtPPAENzHVU_zjZ9c7oVtg2e" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-bottom: 1pt"&gt;Fixed asset, net&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;6,822,142&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;7,004,890&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p id="xdx_8A4_zz5bPc94Na4f" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Depreciation
expense of fixed assets for the year ended December 31, 2023 and 2022 was $&lt;span id="xdx_90A_eus-gaap--Depreciation_c20230101__20231231_zk7cwwg7uoV" title="Depreciation"&gt;876,064&lt;/span&gt; and $&lt;span id="xdx_90D_eus-gaap--Depreciation_c20220101__20221231_zsjIq3dAbRo1" title="Depreciation"&gt;647,690&lt;/span&gt;, respectively. Substantially, all of
the Company&#x2019;s fixed assets are located at the Company&#x2019;s Hungary location.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;In
the fourth quarter of 2023, the Company recorded, in Research and Development expenses, an asset impairment of $&lt;span id="xdx_90C_eus-gaap--AssetImpairmentCharges_c20231001__20231231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--MachineryAndEquipmentMember_zp7fG2VATTmb" title="Asset impairment"&gt;560,000 &lt;/span&gt;
relating to Molds, which were included in Machinery and Equipment, due to a decision to discontinue usage of certain
molds.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;During
the year ended December 2022, the Company recorded $&lt;span id="xdx_90F_eus-gaap--PaymentsToAcquireMachineryAndEquipment_c20220101__20221231__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember_zbpXwKAloy3j" title="Acquisition of machinery"&gt;63,612&lt;/span&gt; in fixed asset costs relating to the estimated fair market value for options
granted in 2021 for the acquired machinery. As of December 31, 2023, the Company has $&lt;span id="xdx_906_ecustom--RemainingPaymentsDueOnMachinery_c20230101__20231231_zUjBnuOSWmMi" title="Balance due on machinery"&gt;100,000&lt;/span&gt; in remaining payments for machinery purchased,
which is included in accounts payable.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

</us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock>
    <us-gaap:PropertyPlantAndEquipmentTextBlock contextRef="From2023-01-012023-12-31" id="Fact000648">&lt;p id="xdx_893_eus-gaap--PropertyPlantAndEquipmentTextBlock_zPUvEoseWjce" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Fixed
asset, net, as of December 31, 2023 and 2022, are summarized as follows:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;span id="xdx_8B0_zAFXDcVkUXue" style="display: none"&gt;Schedule of Property, Plant and Equipment&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 85%"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_49F_20231231_zWFwv1Q28DAl" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;&lt;p style="margin-top: 0pt; margin-bottom: 0pt"&gt;December 31,&lt;/p&gt;
                                                                                &lt;p style="margin-top: 0pt; margin-bottom: 0pt"&gt;2023&lt;/p&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_49F_20221231_z3IwxSHnt11c" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;December
31,&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;
                                                                                 &lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;2022&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40A_eus-gaap--PropertyPlantAndEquipmentGross_iI_hus-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--LandMember_zMoBJf64Ur01" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 56%"&gt;Land&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 18%; text-align: right"&gt;260,460&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 18%; text-align: right"&gt;242,240&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_402_eus-gaap--PropertyPlantAndEquipmentGross_iI_hus-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--BuildingMember_zABltg7WUrg8" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td&gt;Building&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;3,022,490&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;2,824,481&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_406_eus-gaap--PropertyPlantAndEquipmentGross_iI_hus-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--MachineryAndEquipmentMember_ziNklABgBeNb" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;Machinery and Equipment&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;4,464,317&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;4,601,293&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_402_eus-gaap--PropertyPlantAndEquipmentGross_iI_hus-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--ComputerSystemsAndWebsiteAndOtherWebsiteMember_zUXGTRCvI5Hf" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-bottom: 1pt"&gt;Computer and Website&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;290,661&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;16,600&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40F_eus-gaap--PropertyPlantAndEquipmentGross_iI_maPPAENzHVU_zO2D76mnsUuf" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td&gt;&#160;&lt;span style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Total Fixed Assets&lt;/span&gt; &lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;8,037,928&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;7,684,614&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_403_eus-gaap--AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_iNI_di_msPPAENzHVU_zaXpSGBuV5O7" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-bottom: 1pt"&gt;Less: accumulated depreciation&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;(1,215,786&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;(679,724&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_400_eus-gaap--PropertyPlantAndEquipmentNet_iTI_mtPPAENzHVU_zjZ9c7oVtg2e" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-bottom: 1pt"&gt;Fixed asset, net&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;6,822,142&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;7,004,890&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

</us-gaap:PropertyPlantAndEquipmentTextBlock>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="AsOf2023-12-31_us-gaap_LandMember"
      decimals="0"
      id="Fact000650"
      unitRef="USD">260460</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="AsOf2022-12-31_us-gaap_LandMember"
      decimals="0"
      id="Fact000651"
      unitRef="USD">242240</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="AsOf2023-12-31_us-gaap_BuildingMember"
      decimals="0"
      id="Fact000653"
      unitRef="USD">3022490</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="AsOf2022-12-31_us-gaap_BuildingMember"
      decimals="0"
      id="Fact000654"
      unitRef="USD">2824481</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="AsOf2023-12-31_us-gaap_MachineryAndEquipmentMember"
      decimals="0"
      id="Fact000656"
      unitRef="USD">4464317</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="AsOf2022-12-31_us-gaap_MachineryAndEquipmentMember"
      decimals="0"
      id="Fact000657"
      unitRef="USD">4601293</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="AsOf2023-12-31_custom_ComputerSystemsAndWebsiteAndOtherWebsiteMember"
      decimals="0"
      id="Fact000659"
      unitRef="USD">290661</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="AsOf2022-12-31_custom_ComputerSystemsAndWebsiteAndOtherWebsiteMember"
      decimals="0"
      id="Fact000660"
      unitRef="USD">16600</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="AsOf2023-12-31"
      decimals="0"
      id="Fact000662"
      unitRef="USD">8037928</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="AsOf2022-12-31"
      decimals="0"
      id="Fact000663"
      unitRef="USD">7684614</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
      contextRef="AsOf2023-12-31"
      decimals="0"
      id="Fact000665"
      unitRef="USD">1215786</us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment>
    <us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
      contextRef="AsOf2022-12-31"
      decimals="0"
      id="Fact000666"
      unitRef="USD">679724</us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment>
    <us-gaap:PropertyPlantAndEquipmentNet
      contextRef="AsOf2023-12-31"
      decimals="0"
      id="Fact000668"
      unitRef="USD">6822142</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:PropertyPlantAndEquipmentNet
      contextRef="AsOf2022-12-31"
      decimals="0"
      id="Fact000669"
      unitRef="USD">7004890</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:Depreciation
      contextRef="From2023-01-012023-12-31"
      decimals="0"
      id="Fact000671"
      unitRef="USD">876064</us-gaap:Depreciation>
    <us-gaap:Depreciation
      contextRef="From2022-01-012022-12-31"
      decimals="0"
      id="Fact000673"
      unitRef="USD">647690</us-gaap:Depreciation>
    <us-gaap:AssetImpairmentCharges
      contextRef="From2023-10-012023-12-31_us-gaap_MachineryAndEquipmentMember"
      decimals="0"
      id="Fact000675"
      unitRef="USD">560000</us-gaap:AssetImpairmentCharges>
    <us-gaap:PaymentsToAcquireMachineryAndEquipment
      contextRef="From2022-01-012022-12-31_us-gaap_StockOptionMember"
      decimals="0"
      id="Fact000677"
      unitRef="USD">63612</us-gaap:PaymentsToAcquireMachineryAndEquipment>
    <STSS:RemainingPaymentsDueOnMachinery
      contextRef="From2023-01-012023-12-31"
      decimals="0"
      id="Fact000679"
      unitRef="USD">100000</STSS:RemainingPaymentsDueOnMachinery>
    <us-gaap:AssetAcquisitionTextBlock contextRef="From2023-01-012023-12-31" id="Fact000681">&lt;p id="xdx_808_eus-gaap--AssetAcquisitionTextBlock_zCulz1UGYe0g" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Note
5. &lt;span id="xdx_82F_zH1pkZyQBVAe"&gt;Asset Acquisition&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;In
June 2020, the Company entered into a Share Purchase Agreement (&#x201c;Agreement&#x201d;) with Safegard Medical (&#x201c;Safegard&#x201d;)
and amendments to the Agreement, collectively, the Agreements, to purchase either the stock or certain assets of a manufacturing facility
for $&lt;span id="xdx_906_eus-gaap--AssetAcquisitionConsiderationTransferred_pn5n6_c20200601__20200630__us-gaap--TypeOfArrangementAxis__custom--SharePurchaseAgreementMember_zXXflAkB7AT7" title="Asset acquisition"&gt;2.5&lt;/span&gt;M in cash, plus additional consideration of &lt;span id="xdx_906_eus-gaap--StockIssuedDuringPeriodSharesAcquisitions_c20200601__20200630__us-gaap--TypeOfArrangementAxis__custom--SharePurchaseAgreementMember__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zoUph2Jvco1l" title="Additional consideration, shares"&gt;28,571&lt;/span&gt; shares of common stock with an estimated fair market value of $&lt;span id="xdx_90D_eus-gaap--SharePrice_iI_c20200630__us-gaap--TypeOfArrangementAxis__custom--SharePurchaseAgreementMember__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zusBsFuv4O28" title="Share price"&gt;7.00&lt;/span&gt;, &lt;span id="xdx_90E_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod_c20200601__20200630__us-gaap--TypeOfArrangementAxis__custom--SharePurchaseAgreementMember__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember_znpAjWNBL8P" title="Stock options issued"&gt;35,714&lt;/span&gt;
stock options with an exercise price of $&lt;span id="xdx_905_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_pid_c20200601__20200630__us-gaap--TypeOfArrangementAxis__custom--SharePurchaseAgreementMember__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember_zxoaLKrp7J9f" title="Exercise price"&gt;7.00&lt;/span&gt; and &lt;span id="xdx_901_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod_c20200601__20200630__us-gaap--TypeOfArrangementAxis__custom--SharePurchaseAgreementMember__us-gaap--AwardTypeAxis__custom--StockOptionOneMember_zJSxH3qrSPkj" title="Stock options issued"&gt;50,000&lt;/span&gt; stock options with an exercise price of $&lt;span id="xdx_90D_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_pid_c20220705__20220706__us-gaap--TypeOfArrangementAxis__custom--SharePurchaseAgreementMember__us-gaap--AwardTypeAxis__custom--StockOptionOneMember_zw6xZry15Fl5" title="Exercise price"&gt;4.25&lt;/span&gt;. The purchase price includes the
fair market value of the common stock of $&lt;span id="xdx_904_ecustom--FairMarketValueOfCommonStock_c20200601__20200630__us-gaap--TypeOfArrangementAxis__custom--SharePurchaseAgreementMember__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zwJctNKXD3J6" title="Fair market value of common stock"&gt;200,000&lt;/span&gt; and the vested options of $&lt;span id="xdx_90E_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1_c20200601__20200630__us-gaap--TypeOfArrangementAxis__custom--SharePurchaseAgreementMember__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember_zfJ3E5Fk1Eeb" title="Vested options, value"&gt;183,135&lt;/span&gt;. The Agreements provided the Company various periods
for due diligence and post due diligence, requirements for escrow payments through the closing date (&#x201c;Closing Date&#x201d;).&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Through
the Closing Date, the Agreements provided the Company with the exclusive use of the facility in exchange for payment of the facility&#x2019;s
operating costs. The monthly fee (&#x201c;Operating Costs&#x201d;), which primarily covered the facility&#x2019;s operating costs, was mainly
comprised of the seller&#x2019;s workforce costs, materials and other recurring monthly operating cost.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;During
the year ended December 31, 2022, the Company had remitted &lt;span id="xdx_900_eus-gaap--OperatingCostsAndExpenses_c20220101__20221231__us-gaap--TypeOfArrangementAxis__custom--SharePurchaseAgreementMember_zTjHmH7uo4V2" title="Operating costs"&gt;$594,000&lt;/span&gt;, respectively for the aforementioned Operating Costs. The remittance
of operating costs was discontinued after the Closing Date. These costs were included in research and development expense in the consolidated
statement of operations as the activities at the facility in 2022 were related to design and testing of the Company&#x2019;s products.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;




&lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;SHARPS
TECHNOLOGY, INC.&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;NOTES
TO THE CONSOLIDATED FINANCIAL STATEMENTS&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;FOR
THE YEARS ENDED DECEMBER 31, 2023 AND 2022&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Note
5. Asset Acquisition (continued)&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
acquisition of Safegard, which closed on July 6, 2022, did not meet the definition of a business pursuant to ASC 805-10, and accordingly
was accounted for as an asset acquisition in accordance with ASC 805-50. The cost of the acquisition was $&lt;span id="xdx_90C_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets_iI_c20220706__us-gaap--BusinessAcquisitionAxis__custom--SafegardMedicalIncMember_zLK0DDXMciqc" title="Acquisition cost"&gt;2,936,712&lt;/span&gt;, including transaction
costs of $&lt;span id="xdx_90F_eus-gaap--FairValueOfAssetsAcquired_c20220705__20220706__us-gaap--BusinessAcquisitionAxis__custom--SafegardMedicalIncMember_zycTPxydM2i9" title="Fair value of assets acquired"&gt;53,576&lt;/span&gt;, with the allocation to the assets acquired on a relative fair value basis. The intangibles relate to permits and a
limited workforce acquired. Under ASC 805-50, no goodwill is recognized. The operating results for Safegard are included in the consolidated
balance sheet and consolidated statements of operations for the period beginning after the closing on July 6, 2022.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_897_eus-gaap--ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock_zYnRON4oCd9g" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
relative fair value of the assets acquired and related deferred tax liability is as follows:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&#160;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_8B4_zhBGM60lA9Y4" style="display: none"&gt;Schedule of Fair Value of the Assets Acquisition&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 60%"&gt;
  &lt;tr style="display: none; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_493_20220706__us-gaap--BusinessAcquisitionAxis__custom--SafegardMedicalIncMember_z8jfhEywzJwd" style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_407_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLand_iI_maBCRIAzqVv_zgKz5DNiWW1b" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 78%"&gt;Land&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 18%; text-align: right"&gt;226,000&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_407_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedBuildings_iI_maBCRIAzqVv_z4o0moTfk161" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;Building and affixed assets&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;2,684,000&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_404_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedEquipment_iI_maBCRIAzqVv_zxo4Cnum8AIj" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td&gt;Machinery&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;158,000&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40A_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory_iI_maBCRIAzqVv_z8bi35VTpHfb" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td&gt;Inventory&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;32,000&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_400_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles_iI_maBCRIAzqVv_zs0rD6bcn8G4" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td&gt;Intangibles&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;64,712&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40B_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities_iNI_di_msBCRIAzqVv_zY4qYyAyt4Md" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-bottom: 1pt"&gt;Deferred tax liability&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;(192,000&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40B_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets_iTI_mtBCRIAzqVv_zahGjZNGCkwk" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-bottom: 1pt"&gt;Total&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;2,936,712&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p id="xdx_8AD_zhd8uPXxv0fk" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
useful lives for the acquired assets is Building - &lt;span id="xdx_907_eus-gaap--FiniteLivedIntangibleAssetUsefulLife_iI_dtY_c20231231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--BuildingMember_zfpQnoySQNIb" title="Finite-lived intangible asset, useful life"&gt;20&lt;/span&gt; years; Machinery &#x2013; &lt;span id="xdx_90C_eus-gaap--FiniteLivedIntangibleAssetUsefulLife_iI_dtY_c20231231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--MachineryAndEquipmentMember__srt--RangeAxis__srt--MinimumMember_zHaPVOotDqZ4" title="Finite-lived intangible asset, useful life"&gt;5&lt;/span&gt; to &lt;span id="xdx_90A_eus-gaap--FiniteLivedIntangibleAssetUsefulLife_iI_dtY_c20231231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--MachineryAndEquipmentMember__srt--RangeAxis__srt--MaximumMember_zBlHM6Hpr8Fc" title="Finite-lived intangible asset, useful life"&gt;10&lt;/span&gt; years; Intangibles &#x2013; &lt;span id="xdx_908_eus-gaap--FiniteLivedIntangibleAssetUsefulLife_iI_dtY_c20231231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--FiniteLivedIntangibleAssetsMember_zBvMX8qJXeAi" title="Finite-lived intangible asset, useful life"&gt;5&lt;/span&gt; years. The related
depreciation and amortization is being recorded on a straight-line basis.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

</us-gaap:AssetAcquisitionTextBlock>
    <us-gaap:AssetAcquisitionConsiderationTransferred
      contextRef="From2020-06-012020-06-30_custom_SharePurchaseAgreementMember"
      decimals="-5"
      id="Fact000683"
      unitRef="USD">2500000</us-gaap:AssetAcquisitionConsiderationTransferred>
    <us-gaap:StockIssuedDuringPeriodSharesAcquisitions
      contextRef="From2020-06-012020-06-30_custom_SharePurchaseAgreementMember_us-gaap_CommonStockMember"
      decimals="INF"
      id="Fact000685"
      unitRef="Shares">28571</us-gaap:StockIssuedDuringPeriodSharesAcquisitions>
    <us-gaap:SharePrice
      contextRef="AsOf2020-06-30_custom_SharePurchaseAgreementMember_us-gaap_CommonStockMember"
      decimals="INF"
      id="Fact000687"
      unitRef="USDPShares">7.00</us-gaap:SharePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod
      contextRef="From2020-06-012020-06-30_custom_SharePurchaseAgreementMember_us-gaap_StockOptionMember"
      decimals="INF"
      id="Fact000689"
      unitRef="Shares">35714</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod>
    <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
      contextRef="From2020-06-012020-06-30_custom_SharePurchaseAgreementMember_us-gaap_StockOptionMember"
      decimals="INF"
      id="Fact000691"
      unitRef="USDPShares">7.00</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod
      contextRef="From2020-06-012020-06-30_custom_SharePurchaseAgreementMember_custom_StockOptionOneMember"
      decimals="INF"
      id="Fact000693"
      unitRef="Shares">50000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod>
    <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
      contextRef="From2022-07-052022-07-06_custom_SharePurchaseAgreementMember_custom_StockOptionOneMember"
      decimals="INF"
      id="Fact000695"
      unitRef="USDPShares">4.25</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice>
    <STSS:FairMarketValueOfCommonStock
      contextRef="From2020-06-012020-06-30_custom_SharePurchaseAgreementMember_us-gaap_CommonStockMember"
      decimals="0"
      id="Fact000697"
      unitRef="USD">200000</STSS:FairMarketValueOfCommonStock>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1
      contextRef="From2020-06-012020-06-30_custom_SharePurchaseAgreementMember_us-gaap_StockOptionMember"
      decimals="0"
      id="Fact000699"
      unitRef="USD">183135</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1>
    <us-gaap:OperatingCostsAndExpenses
      contextRef="From2022-01-012022-12-31_custom_SharePurchaseAgreementMember"
      decimals="0"
      id="Fact000701"
      unitRef="USD">594000</us-gaap:OperatingCostsAndExpenses>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets
      contextRef="AsOf2022-07-06_custom_SafegardMedicalIncMember"
      decimals="0"
      id="Fact000703"
      unitRef="USD">2936712</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets>
    <us-gaap:FairValueOfAssetsAcquired
      contextRef="From2022-07-052022-07-06_custom_SafegardMedicalIncMember"
      decimals="0"
      id="Fact000705"
      unitRef="USD">53576</us-gaap:FairValueOfAssetsAcquired>
    <us-gaap:ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock contextRef="From2023-01-012023-12-31" id="Fact000707">&lt;p id="xdx_897_eus-gaap--ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock_zYnRON4oCd9g" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
relative fair value of the assets acquired and related deferred tax liability is as follows:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&#160;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_8B4_zhBGM60lA9Y4" style="display: none"&gt;Schedule of Fair Value of the Assets Acquisition&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 60%"&gt;
  &lt;tr style="display: none; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_493_20220706__us-gaap--BusinessAcquisitionAxis__custom--SafegardMedicalIncMember_z8jfhEywzJwd" style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_407_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLand_iI_maBCRIAzqVv_zgKz5DNiWW1b" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 78%"&gt;Land&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 18%; text-align: right"&gt;226,000&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_407_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedBuildings_iI_maBCRIAzqVv_z4o0moTfk161" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;Building and affixed assets&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;2,684,000&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_404_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedEquipment_iI_maBCRIAzqVv_zxo4Cnum8AIj" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td&gt;Machinery&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;158,000&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40A_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory_iI_maBCRIAzqVv_z8bi35VTpHfb" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td&gt;Inventory&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;32,000&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_400_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles_iI_maBCRIAzqVv_zs0rD6bcn8G4" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td&gt;Intangibles&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;64,712&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40B_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities_iNI_di_msBCRIAzqVv_zY4qYyAyt4Md" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-bottom: 1pt"&gt;Deferred tax liability&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;(192,000&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40B_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets_iTI_mtBCRIAzqVv_zahGjZNGCkwk" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-bottom: 1pt"&gt;Total&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;2,936,712&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

</us-gaap:ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLand
      contextRef="AsOf2022-07-06_custom_SafegardMedicalIncMember"
      decimals="0"
      id="Fact000709"
      unitRef="USD">226000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLand>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedBuildings
      contextRef="AsOf2022-07-06_custom_SafegardMedicalIncMember"
      decimals="0"
      id="Fact000711"
      unitRef="USD">2684000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedBuildings>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedEquipment
      contextRef="AsOf2022-07-06_custom_SafegardMedicalIncMember"
      decimals="0"
      id="Fact000713"
      unitRef="USD">158000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedEquipment>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory
      contextRef="AsOf2022-07-06_custom_SafegardMedicalIncMember"
      decimals="0"
      id="Fact000715"
      unitRef="USD">32000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles
      contextRef="AsOf2022-07-06_custom_SafegardMedicalIncMember"
      decimals="0"
      id="Fact000717"
      unitRef="USD">64712</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities
      contextRef="AsOf2022-07-06_custom_SafegardMedicalIncMember"
      decimals="0"
      id="Fact000719"
      unitRef="USD">192000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets
      contextRef="AsOf2022-07-06_custom_SafegardMedicalIncMember"
      decimals="0"
      id="Fact000721"
      unitRef="USD">2936712</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets>
    <us-gaap:FiniteLivedIntangibleAssetUsefulLife
      contextRef="AsOf2023-12-31_us-gaap_BuildingMember"
      id="Fact000723">P20Y</us-gaap:FiniteLivedIntangibleAssetUsefulLife>
    <us-gaap:FiniteLivedIntangibleAssetUsefulLife
      contextRef="AsOf2023-12-31_us-gaap_MachineryAndEquipmentMember_srt_MinimumMember"
      id="Fact000725">P5Y</us-gaap:FiniteLivedIntangibleAssetUsefulLife>
    <us-gaap:FiniteLivedIntangibleAssetUsefulLife
      contextRef="AsOf2023-12-31_us-gaap_MachineryAndEquipmentMember_srt_MaximumMember"
      id="Fact000727">P10Y</us-gaap:FiniteLivedIntangibleAssetUsefulLife>
    <us-gaap:FiniteLivedIntangibleAssetUsefulLife
      contextRef="AsOf2023-12-31_us-gaap_FiniteLivedIntangibleAssetsMember"
      id="Fact000729">P5Y</us-gaap:FiniteLivedIntangibleAssetUsefulLife>
    <us-gaap:OtherAssetsDisclosureTextBlock contextRef="From2023-01-012023-12-31" id="Fact000731">&lt;p id="xdx_801_eus-gaap--OtherAssetsDisclosureTextBlock_zPmnljukSxi1" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Note
6. &lt;span id="xdx_825_zznUHocMli91"&gt;Other Assets&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_89A_eus-gaap--ScheduleOfOtherAssetsTableTextBlock_zIGFjiFojy87" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Other
assets as of December 31, 2023 and 2022 are summarized as follows:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;span id="xdx_8B9_zuK22lThk6sf" style="display: none"&gt;Schedule of Other Assets&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 80%"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_49F_20231231_z5bdXbgC7sBh" style="font-weight: bold; text-align: center"&gt;December 31,&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_491_20221231_zaS8ZjMFTSd6" style="font-weight: bold; text-align: center"&gt;December 31,&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;2023&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;2022&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_403_eus-gaap--IntangibleAssetsNetExcludingGoodwill_iI_maOANzzDQ_z3R17s4dQmzc" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 60%; text-align: left"&gt;Intangibles, net&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 16%; text-align: right"&gt;52,513&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 16%; text-align: right"&gt;62,480&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_401_eus-gaap--DepositsAssets_iI_maOANzzDQ_zMNSmwMjaYWa" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;Deposits or advance payments on machinery, molds and components (see Note 15)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;p style="margin: 0"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0738"&gt;-&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;336,466&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40C_eus-gaap--OtherAssetsMiscellaneousNoncurrent_iI_maOANzzDQ_zdth0WrOGOm8" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-bottom: 1pt"&gt;Other&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;76,062&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;12,370&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_409_eus-gaap--OtherAssetsNoncurrent_iTI_mtOANzzDQ_zOelROCnvAn1" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-bottom: 1pt"&gt;&lt;span style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Other
    assets&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;128,575&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;411,316&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p id="xdx_8AF_z7FLsV8gq8he" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Intangibles
are related to the Asset Acquisition (see Note 5) and consist of an acquired workforce and permits. Amortization for the year ended December
31, 2023 was $&lt;span id="xdx_903_eus-gaap--AmortizationOfIntangibleAssets_c20230101__20231231_zjVppxxqXbU1" title="Amortization of intangible assets"&gt;15,184&lt;/span&gt;.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

</us-gaap:OtherAssetsDisclosureTextBlock>
    <us-gaap:ScheduleOfOtherAssetsTableTextBlock contextRef="From2023-01-012023-12-31" id="Fact000733">&lt;p id="xdx_89A_eus-gaap--ScheduleOfOtherAssetsTableTextBlock_zIGFjiFojy87" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Other
assets as of December 31, 2023 and 2022 are summarized as follows:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;span id="xdx_8B9_zuK22lThk6sf" style="display: none"&gt;Schedule of Other Assets&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 80%"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_49F_20231231_z5bdXbgC7sBh" style="font-weight: bold; text-align: center"&gt;December 31,&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_491_20221231_zaS8ZjMFTSd6" style="font-weight: bold; text-align: center"&gt;December 31,&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;2023&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;2022&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_403_eus-gaap--IntangibleAssetsNetExcludingGoodwill_iI_maOANzzDQ_z3R17s4dQmzc" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 60%; text-align: left"&gt;Intangibles, net&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 16%; text-align: right"&gt;52,513&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 16%; text-align: right"&gt;62,480&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_401_eus-gaap--DepositsAssets_iI_maOANzzDQ_zMNSmwMjaYWa" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;Deposits or advance payments on machinery, molds and components (see Note 15)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;p style="margin: 0"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0738"&gt;-&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;336,466&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40C_eus-gaap--OtherAssetsMiscellaneousNoncurrent_iI_maOANzzDQ_zdth0WrOGOm8" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-bottom: 1pt"&gt;Other&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;76,062&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;12,370&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_409_eus-gaap--OtherAssetsNoncurrent_iTI_mtOANzzDQ_zOelROCnvAn1" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-bottom: 1pt"&gt;&lt;span style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Other
    assets&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;128,575&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;411,316&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

</us-gaap:ScheduleOfOtherAssetsTableTextBlock>
    <us-gaap:IntangibleAssetsNetExcludingGoodwill
      contextRef="AsOf2023-12-31"
      decimals="0"
      id="Fact000735"
      unitRef="USD">52513</us-gaap:IntangibleAssetsNetExcludingGoodwill>
    <us-gaap:IntangibleAssetsNetExcludingGoodwill
      contextRef="AsOf2022-12-31"
      decimals="0"
      id="Fact000736"
      unitRef="USD">62480</us-gaap:IntangibleAssetsNetExcludingGoodwill>
    <us-gaap:DepositsAssets
      contextRef="AsOf2022-12-31"
      decimals="0"
      id="Fact000739"
      unitRef="USD">336466</us-gaap:DepositsAssets>
    <us-gaap:OtherAssetsMiscellaneousNoncurrent
      contextRef="AsOf2023-12-31"
      decimals="0"
      id="Fact000741"
      unitRef="USD">76062</us-gaap:OtherAssetsMiscellaneousNoncurrent>
    <us-gaap:OtherAssetsMiscellaneousNoncurrent
      contextRef="AsOf2022-12-31"
      decimals="0"
      id="Fact000742"
      unitRef="USD">12370</us-gaap:OtherAssetsMiscellaneousNoncurrent>
    <us-gaap:OtherAssetsNoncurrent
      contextRef="AsOf2023-12-31"
      decimals="0"
      id="Fact000744"
      unitRef="USD">128575</us-gaap:OtherAssetsNoncurrent>
    <us-gaap:OtherAssetsNoncurrent
      contextRef="AsOf2022-12-31"
      decimals="0"
      id="Fact000745"
      unitRef="USD">411316</us-gaap:OtherAssetsNoncurrent>
    <us-gaap:AmortizationOfIntangibleAssets
      contextRef="From2023-01-012023-12-31"
      decimals="0"
      id="Fact000747"
      unitRef="USD">15184</us-gaap:AmortizationOfIntangibleAssets>
    <us-gaap:DebtDisclosureTextBlock contextRef="From2023-01-012023-12-31" id="Fact000749">&lt;p id="xdx_803_eus-gaap--DebtDisclosureTextBlock_zkgtYdG5woL8" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Note 7. &lt;span id="xdx_82A_zrkfsE3ylwCf"&gt;Debt Financing&lt;/span&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;
&lt;p style="font: 10pt Times New Roman, Times, Serif; display: none; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;On
September 20, 2024, the Company entered into a securities purchase agreement (the &#x201c;Securities Purchase Agreement&#x201d;) and a
Senior Secured Note (the &#x201c;Note&#x201d;) for an aggregate principal amount of $&lt;span id="xdx_900_eus-gaap--DebtInstrumentFaceAmount_iI_c20240920__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__us-gaap--DebtInstrumentAxis__custom--SeniorSecuredNoteMember_zUSgrLpLCko2"&gt;4,375,000&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;,
including OID interest of $&lt;span id="xdx_902_eus-gaap--DebtInstrumentIncreaseAccruedInterest_c20240920__20240920__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__us-gaap--DebtInstrumentAxis__custom--SeniorSecuredNoteMember_zBiOuGzRoV8j" title="Original issue discount (OID)"&gt;875,000 &lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;maturing
on &lt;span id="xdx_909_eus-gaap--DebtInstrumentMaturityDate_dd_c20240920__20240920__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__us-gaap--DebtInstrumentAxis__custom--SeniorSecuredNoteMember_zuMKRwZ44Unl"&gt;January
31, 2025&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;, with certain purchasers (the
&#x201c;Purchasers&#x201d;), and the issuance of approximately &lt;span id="xdx_909_ecustom--NumberOfUnregisteredCommonStockIssuedDuringPostReverseShares_pid_c20240920__20240920__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__us-gaap--DebtInstrumentAxis__custom--SeniorSecuredNoteMember_zsgBJOT2Re7b" title="Number of unregistered common stock issued during post reverse shares"&gt;259,091 &lt;/span&gt;&lt;/span&gt;(pre
reverse - &lt;span id="xdx_908_ecustom--NumberOfUnregisteredCommonStockIssuedDuringPreReverseShares_pid_c20240920__20240920__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__us-gaap--DebtInstrumentAxis__custom--SeniorSecuredNoteMember__us-gaap--AwardTypeAxis__custom--PreReverseMember_zaQgLgiCUT1h" title="Pre reverse"&gt;5,700,006&lt;/span&gt; ) unregistered shares of the Company&#x2019;s Common Stock. The aggregate gross proceeds to the Company were
approximately $&lt;span id="xdx_90B_eus-gaap--ProceedsFromIssuanceOfDebt_pn5n6_c20240920__20240920__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__us-gaap--DebtInstrumentAxis__custom--SeniorSecuredNoteMember_zMEoMg7hte0l"&gt;3.5 &lt;/span&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;million,
before deducting fees to the placement agent and other offering expenses payable by the Company of $&lt;span id="xdx_90E_ecustom--PlacementAgentAndOtherOfferingExpenses_pid_c20240920__20240920__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__us-gaap--DebtInstrumentAxis__custom--SeniorSecuredNoteMember_zss4mj0OW3bf" title="Closing costs"&gt;514,700 &lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;and
an escrow deposit of $&lt;span id="xdx_902_eus-gaap--EscrowDeposit_iI_c20240920__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__us-gaap--DebtInstrumentAxis__custom--SeniorSecuredNoteMember_zrRvCfl3u0Z1"&gt;250,000 &lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;required
until certain security liens are filed. The Note and the common stock were recorded at the relative fair values of $&lt;span id="xdx_904_eus-gaap--DebtInstrumentFairValue_iI_pn5n6_c20240920__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__us-gaap--DebtInstrumentAxis__custom--SeniorSecuredNoteMember_zYdWHTDxdjGk"&gt;2.6&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;M
and $&lt;span id="xdx_905_ecustom--CommonStockFairValue_iI_c20240920__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__us-gaap--DebtInstrumentAxis__custom--SeniorSecuredNoteMember_z0faco6l3FHk" title="Common stock fair value"&gt;852,000&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;,
respectively, in accordance with ASC 470-20-25-2. The aforementioned expenses were allocated based on the aforementioned fair values
as a reduction to the carrying amount of the debt and a reduction of the equity in accordance with ASC 505-10. &lt;/span&gt;For the three
and nine months ended September 30, 2024, the Company recorded accreted interest and fees of $&lt;span id="xdx_909_ecustom--AccretedInterestFees_c20240101__20240930_zFgDKJLkZCsf" title="Accreted interest fees"&gt;75,192&lt;/span&gt;.&lt;/p&gt;

</us-gaap:DebtDisclosureTextBlock>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="AsOf2024-09-20_custom_SecuritiesPurchaseAgreementMember_custom_SeniorSecuredNoteMember"
      decimals="0"
      id="Fact000750"
      unitRef="USD">4375000</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:DebtInstrumentIncreaseAccruedInterest
      contextRef="From2024-09-202024-09-20_custom_SecuritiesPurchaseAgreementMember_custom_SeniorSecuredNoteMember"
      decimals="0"
      id="Fact000752"
      unitRef="USD">875000</us-gaap:DebtInstrumentIncreaseAccruedInterest>
    <us-gaap:DebtInstrumentMaturityDate
      contextRef="From2024-09-202024-09-20_custom_SecuritiesPurchaseAgreementMember_custom_SeniorSecuredNoteMember"
      id="Fact000753">2025-01-31</us-gaap:DebtInstrumentMaturityDate>
    <STSS:NumberOfUnregisteredCommonStockIssuedDuringPostReverseShares
      contextRef="From2024-09-202024-09-20_custom_SecuritiesPurchaseAgreementMember_custom_SeniorSecuredNoteMember"
      decimals="INF"
      id="Fact000755"
      unitRef="Shares">259091</STSS:NumberOfUnregisteredCommonStockIssuedDuringPostReverseShares>
    <STSS:NumberOfUnregisteredCommonStockIssuedDuringPreReverseShares
      contextRef="From2024-09-202024-09-20_custom_SecuritiesPurchaseAgreementMember_custom_SeniorSecuredNoteMember_custom_PreReverseMember"
      decimals="INF"
      id="Fact000757"
      unitRef="Shares">5700006</STSS:NumberOfUnregisteredCommonStockIssuedDuringPreReverseShares>
    <us-gaap:ProceedsFromIssuanceOfDebt
      contextRef="From2024-09-202024-09-20_custom_SecuritiesPurchaseAgreementMember_custom_SeniorSecuredNoteMember"
      decimals="-5"
      id="Fact000758"
      unitRef="USD">3500000</us-gaap:ProceedsFromIssuanceOfDebt>
    <STSS:PlacementAgentAndOtherOfferingExpenses
      contextRef="From2024-09-202024-09-20_custom_SecuritiesPurchaseAgreementMember_custom_SeniorSecuredNoteMember"
      decimals="INF"
      id="Fact000760"
      unitRef="USD">514700</STSS:PlacementAgentAndOtherOfferingExpenses>
    <us-gaap:EscrowDeposit
      contextRef="AsOf2024-09-20_custom_SecuritiesPurchaseAgreementMember_custom_SeniorSecuredNoteMember"
      decimals="0"
      id="Fact000761"
      unitRef="USD">250000</us-gaap:EscrowDeposit>
    <us-gaap:DebtInstrumentFairValue
      contextRef="AsOf2024-09-20_custom_SecuritiesPurchaseAgreementMember_custom_SeniorSecuredNoteMember"
      decimals="-5"
      id="Fact000762"
      unitRef="USD">2600000</us-gaap:DebtInstrumentFairValue>
    <STSS:CommonStockFairValue
      contextRef="AsOf2024-09-20_custom_SecuritiesPurchaseAgreementMember_custom_SeniorSecuredNoteMember"
      decimals="0"
      id="Fact000764"
      unitRef="USD">852000</STSS:CommonStockFairValue>
    <STSS:AccretedInterestFees
      contextRef="From2024-01-01to2024-09-30"
      decimals="0"
      id="Fact000766"
      unitRef="USD">75192</STSS:AccretedInterestFees>
    <STSS:NotePurchaseAgreementTextBlock contextRef="From2023-01-012023-12-31" id="Fact000768">&lt;p id="xdx_807_ecustom--NotePurchaseAgreementTextBlock_zyE4rb7jrZB" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Note
7. &lt;span id="xdx_820_zrPl3EgnjBmh"&gt;Note Purchase Agreement&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;On
December 14, 2021, the Company entered into a Note Purchase Agreement (&#x201c;NPA&#x201d;) with three unrelated third-party purchasers
(&#x201c;Purchasers&#x201d;). The Purchasers provided financing to the Company in the form of bridge financing, aggregating principal of
$&lt;span id="xdx_903_eus-gaap--DebtInstrumentFaceAmount_iI_c20211214__us-gaap--TypeOfArrangementAxis__custom--NotePurchaseAgreementMember__srt--TitleOfIndividualAxis__custom--UnrelatedThirdPartyPurchasersMember_zNKzG7EyFY2g" title="Debt instrument face amount"&gt;2,000,000&lt;/span&gt; (the &#x201c;Notes&#x201d;). The principal under the Notes shall be payable on the earlier of (i) December 14, 2022, and (ii)
the date on which the Company consummates an initial public offering (&#x201c;IPO&#x201d;), herein referred to as the &#x201c;Maturity Date&#x201d;.
The Notes bore interest at &lt;span id="xdx_909_eus-gaap--DebtInstrumentInterestRateStatedPercentage_iI_pid_dp_uPure_c20211214__us-gaap--TypeOfArrangementAxis__custom--NotePurchaseAgreementMember__srt--TitleOfIndividualAxis__custom--UnrelatedThirdPartyPurchasersMember_z2KxI7DqUtib" title="Interest rate"&gt;8&lt;/span&gt;% with interest payments due monthly. The Company and the Purchasers had entered into a Security Agreement
whereby the Notes were collateralized by substantially all the assets of the Company, both tangible and intangible both currently owned
with stated exclusions, as defined, and any future acquired with stated exclusions, as defined.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;




&lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;SHARPS
TECHNOLOGY, INC.&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;NOTES
TO THE CONSOLIDATED FINANCIAL STATEMENTS&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;FOR
THE YEARS ENDED DECEMBER 31, 2023 AND 2022&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Note
7. Note Purchase Agreement (continued)&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
NPA provided for covenants that until all of the Notes have been converted, exchanged, redeemed or otherwise satisfied in accordance
with their terms, the Company shall not, and the Company shall not permit any of its subsidiaries without the prior written consent of
the Purchasers: a) incur or guarantee any new debt, b) issue any securities that would cause a breach or default under the NPA, c) incur
any liens other than permitted, d) redeem or repurchase shares, e) declare or pay any cash dividend or distribution, e) sell, lease or
dispose of assets other than in the ordinary course of business, or f) engage in different line of business.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_909_eus-gaap--DebtInstrumentDescription_c20211213__20211214__us-gaap--TypeOfArrangementAxis__custom--NotePurchaseAgreementMember__srt--TitleOfIndividualAxis__custom--UnrelatedThirdPartyPurchasersMember_zAcZWuH4Ihpg" title="Debt description"&gt;As
additional consideration to the Purchasers for providing the financing, the Company also agreed to a) issue each Purchaser a number of
shares of the Company&#x2019;s Common Stock equal to 50% of the original principal amount of each Purchaser&#x2019;s Note (the &#x201c;Contingent
Stock&#x201d;) and b) issue each Purchaser a number of warrants, which would allow the Purchasers to purchase additional shares of the
Company&#x2019;s Common Stock, equal to 50% of the original principal amount each Purchaser&#x2019;s Note for a term of 5.0 years (the
&#x201c;Contingent Warrants&#x201d;).&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;For
both the Contingent Stock and the Contingent Warrants, the number of shares and warrants that each Purchaser will be issued was unknown
at the time of the NPA and was determined based on a formula of 50% of the original principal amount divided by a &#x201c;Subsequent Offering
Price&#x201d; based on the valuation in a future offering of Common stock or other equity interest in the Company (such offering referred
to as a &#x201c;Consummated Offering&#x201d;) during the period beginning on December 14, 2021 through and including the date the Company
consummates an initial public offering (&#x201c;IPO&#x201d;) (such period referred to as the &#x201c;Subsequent Offering Period&#x201d;).&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;In
accordance with ASC 480-10-25-14, a fixed monetary amount exists at inception for the total value of Contingent Stock that may be issued
to each Purchaser. The Contingent Stock is not considered outstanding at inception, as it will only be issued upon the consummation of
a Consummated Offering, and accordingly, is a conditional obligation. As such the fair market value (&#x201c;FMV&#x201d;) of the Contingent
Stock at inception was &lt;span id="xdx_90B_ecustom--ContingentStockLiability_iI_c20211214__us-gaap--TypeOfArrangementAxis__custom--NotePurchaseAgreementMember_zp7B393ZHFh8" title="Contingent stock liability"&gt;$677,000&lt;/span&gt;, which was recorded as debt discount. Similarly, a fixed monetary amount further exists at inception
for the total value of Contingent Warrants that may be issued to each Purchaser. Accordingly, a conditional obligation exists and as
such the FMV of Contingent Warrants at inception was $&lt;span id="xdx_908_ecustom--ContingentWarrantLiability_iI_c20211214__us-gaap--TypeOfArrangementAxis__custom--NotePurchaseAgreementMember_zh7oj8PGg1ck" title="Contingent warrants liability"&gt;585,000&lt;/span&gt;, which was recorded as debt discount. The Company incurred $&lt;span id="xdx_90B_eus-gaap--PaymentsOfDebtIssuanceCosts_c20211213__20211214__us-gaap--TypeOfArrangementAxis__custom--NotePurchaseAgreementMember__srt--TitleOfIndividualAxis__custom--UnrelatedThirdPartyPurchasersMember_ziEU1TLBoVw9" title="Debt issuance costs"&gt;197,500&lt;/span&gt; of
debt issuance costs associated with the NPA. The debt issuance costs were allocated between the Notes, Contingent Stock and Contingent
Warrants in a manner that was consistent with the allocation of the proceeds of the Notes. The portion of the debt issuance costs which
were allocated to the Contingent Stock and Contingent Warrants, which was $&lt;span id="xdx_901_ecustom--AllocationOfDebtIssuanceCostToContingentStockAndContingentWarrants_iI_c20211231__us-gaap--TypeOfArrangementAxis__custom--NotePurchaseAgreementMember_zt9cjTpr152i" title="Allocation of debt issuance cost to contingent stock and contingent warrants"&gt;124,460&lt;/span&gt;, was expensed during the year ended December 31, 2021.
The debt issuance costs allocated to the Notes were recorded as a debt discount.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Contingent Stock and Contingent Warrant liabilities were measured at FMV on the date of issuance (based on the Black-Scholes valuation
model).&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;At
inception, the Notes were recorded at the net amount of approximately $&lt;span id="xdx_90D_eus-gaap--NotesPayable_iI_c20211231__us-gaap--TypeOfArrangementAxis__custom--NotePurchaseAgreementMember_zYJ5f1N3ps9j" title="Notes payable"&gt;665,000&lt;/span&gt;, after adjusting for debt discounts of approximately $&lt;span id="xdx_90C_eus-gaap--DebtInstrumentUnamortizedDiscount_iI_c20211231__us-gaap--TypeOfArrangementAxis__custom--NotePurchaseAgreementMember_zEWqvaCFQ1O1" title="Debt discount"&gt;1,335,000&lt;/span&gt;
relating to the debt issuance costs, Contingent Stock and Contingent Warrants. Management calculates the effective interest rate (&#x201c;EIR&#x201d;)
to consider the potential repayment at redemption date by reference to the face value amount after taking into account the stated &lt;span id="xdx_90F_eus-gaap--DebtInstrumentInterestRateStatedPercentage_iI_pid_dp_uPure_c20211231__us-gaap--TypeOfArrangementAxis__custom--NotePurchaseAgreementMember_zINeMPmlZFqg" title="Interest rate"&gt;8&lt;/span&gt;%
interest rate. In 2022, through the repayment date, the Company recorded interest expense of $&lt;span id="xdx_90E_eus-gaap--InterestExpense_c20220101__20221231__us-gaap--TypeOfArrangementAxis__custom--NotePurchaseAgreementMember_zUqbQ2PaQQ73" title="Interest expense"&gt;39,111&lt;/span&gt; and accreted interest of $&lt;span id="xdx_904_eus-gaap--InterestPayableCurrent_iI_c20221231__us-gaap--TypeOfArrangementAxis__custom--NotePurchaseAgreementMember_zMYXI25GYpsd" title="Accreted interest"&gt;1,299,895&lt;/span&gt;
and repaid the $&lt;span id="xdx_901_eus-gaap--RepaymentsOfDebt_c20220101__20221231__us-gaap--TypeOfArrangementAxis__custom--NotePurchaseAgreementMember_zCEEahMCeL1g" title="Notes payable"&gt;2,000,000&lt;/span&gt; in Notes with proceeds from the IPO that closed on April 19, 2022.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
value of the Contingent Stock and Contingent Warrants is required to be re-measured at FMV at each reporting date, using either the Black-Scholes
valuation model or other valuation method, if deemed more appropriate, with recognition of the changes in fair value to other income
or expense in the consolidated statement of operations in accordance with ASC 480, Debt and Equity. On April 19, 2022, the Company issued
&lt;span id="xdx_900_eus-gaap--CommonStockSharesIssued_iI_c20220419__us-gaap--TypeOfArrangementAxis__custom--NotePurchaseAgreementMember_z1DOe5O9ZtR2" title="Common stock, shares issued"&gt;235,295&lt;/span&gt; shares of Common Stock to settle the Contingent Stock liability, re-measured the liability at its estimated FMV based on the
stock&#x2019;s trading price and reclassified $&lt;span id="xdx_901_eus-gaap--FairValueAdjustmentOfWarrants_c20220417__20220419__us-gaap--TypeOfArrangementAxis__custom--NotePurchaseAgreementMember_zTEQWt79rGU9" title="Fair market value of warrant"&gt;496,000&lt;/span&gt; to Common Stock Par Value and Additional Paid in Capital.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;In
connection with the closing of the IPO, &lt;span id="xdx_906_ecustom--ContingentWarrants_c20220101__20221231__us-gaap--TypeOfArrangementAxis__custom--NotePurchaseAgreementMember__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--NoteWarrantMember_zoNMbOLItd9d" title="Contingent warrant"&gt;235,295&lt;/span&gt; warrants were issued to settle the Contingent Warrant liability (&#x201c;Note Warrants&#x201d;)
with an exercise price of $&lt;span id="xdx_908_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice_c20220101__20221231__us-gaap--TypeOfArrangementAxis__custom--NotePurchaseAgreementMember__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--NoteWarrantMember_zu2ogRvBjg83" title="Exercise price"&gt;4.25&lt;/span&gt; adjusted to &lt;span id="xdx_90E_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice_c20230929__20230929__us-gaap--TypeOfArrangementAxis__custom--NotePurchaseAgreementMember__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--NoteWarrantMember_z8wmUF9HzcFg" title="Exercise price"&gt;$0.64&lt;/span&gt; at September 29, 2023, based on anti-dilution terms in the warrants. The terms of the
Note Warrants continue to require classification as a liability under ASC 815 with recognition of the changes in fair value to other
income or expense in the consolidated statement of operations in accordance with ASC 480 Debt and Equity. (See Notes 8 and 10)&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;




&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;SHARPS
TECHNOLOGY, INC.&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;NOTES
TO THE CONSOLIDATED FINANCIAL STATEMENTS&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;FOR
THE YEARS ENDED DECEMBER 31, 2023 AND 2022&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

</STSS:NotePurchaseAgreementTextBlock>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="AsOf2021-12-14_custom_NotePurchaseAgreementMember_custom_UnrelatedThirdPartyPurchasersMember"
      decimals="0"
      id="Fact000770"
      unitRef="USD">2000000</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="AsOf2021-12-14_custom_NotePurchaseAgreementMember_custom_UnrelatedThirdPartyPurchasersMember"
      decimals="INF"
      id="Fact000772"
      unitRef="Pure">0.08</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentDescription
      contextRef="From2021-12-132021-12-14_custom_NotePurchaseAgreementMember_custom_UnrelatedThirdPartyPurchasersMember"
      id="Fact000774">As
additional consideration to the Purchasers for providing the financing, the Company also agreed to a) issue each Purchaser a number of
shares of the Company&#x2019;s Common Stock equal to 50% of the original principal amount of each Purchaser&#x2019;s Note (the &#x201c;Contingent
Stock&#x201d;) and b) issue each Purchaser a number of warrants, which would allow the Purchasers to purchase additional shares of the
Company&#x2019;s Common Stock, equal to 50% of the original principal amount each Purchaser&#x2019;s Note for a term of 5.0 years (the
&#x201c;Contingent Warrants&#x201d;).</us-gaap:DebtInstrumentDescription>
    <STSS:ContingentStockLiability
      contextRef="AsOf2021-12-14_custom_NotePurchaseAgreementMember"
      decimals="0"
      id="Fact000776"
      unitRef="USD">677000</STSS:ContingentStockLiability>
    <STSS:ContingentWarrantLiability
      contextRef="AsOf2021-12-14_custom_NotePurchaseAgreementMember"
      decimals="0"
      id="Fact000778"
      unitRef="USD">585000</STSS:ContingentWarrantLiability>
    <us-gaap:PaymentsOfDebtIssuanceCosts
      contextRef="From2021-12-132021-12-14_custom_NotePurchaseAgreementMember_custom_UnrelatedThirdPartyPurchasersMember"
      decimals="0"
      id="Fact000780"
      unitRef="USD">197500</us-gaap:PaymentsOfDebtIssuanceCosts>
    <STSS:AllocationOfDebtIssuanceCostToContingentStockAndContingentWarrants
      contextRef="AsOf2021-12-31_custom_NotePurchaseAgreementMember"
      decimals="0"
      id="Fact000782"
      unitRef="USD">124460</STSS:AllocationOfDebtIssuanceCostToContingentStockAndContingentWarrants>
    <us-gaap:NotesPayable
      contextRef="AsOf2021-12-31_custom_NotePurchaseAgreementMember"
      decimals="0"
      id="Fact000784"
      unitRef="USD">665000</us-gaap:NotesPayable>
    <us-gaap:DebtInstrumentUnamortizedDiscount
      contextRef="AsOf2021-12-31_custom_NotePurchaseAgreementMember"
      decimals="0"
      id="Fact000786"
      unitRef="USD">1335000</us-gaap:DebtInstrumentUnamortizedDiscount>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="AsOf2021-12-31_custom_NotePurchaseAgreementMember"
      decimals="INF"
      id="Fact000788"
      unitRef="Pure">0.08</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:InterestExpense
      contextRef="From2022-01-012022-12-31_custom_NotePurchaseAgreementMember"
      decimals="0"
      id="Fact000790"
      unitRef="USD">39111</us-gaap:InterestExpense>
    <us-gaap:InterestPayableCurrent
      contextRef="AsOf2022-12-31_custom_NotePurchaseAgreementMember"
      decimals="0"
      id="Fact000792"
      unitRef="USD">1299895</us-gaap:InterestPayableCurrent>
    <us-gaap:RepaymentsOfDebt
      contextRef="From2022-01-012022-12-31_custom_NotePurchaseAgreementMember"
      decimals="0"
      id="Fact000794"
      unitRef="USD">2000000</us-gaap:RepaymentsOfDebt>
    <us-gaap:CommonStockSharesIssued
      contextRef="AsOf2022-04-19_custom_NotePurchaseAgreementMember"
      decimals="INF"
      id="Fact000796"
      unitRef="Shares">235295</us-gaap:CommonStockSharesIssued>
    <us-gaap:FairValueAdjustmentOfWarrants
      contextRef="From2022-04-172022-04-19_custom_NotePurchaseAgreementMember"
      decimals="0"
      id="Fact000798"
      unitRef="USD">496000</us-gaap:FairValueAdjustmentOfWarrants>
    <STSS:ContingentWarrants
      contextRef="From2022-01-012022-12-31_custom_NotePurchaseAgreementMember_us-gaap_NoteWarrantMember"
      decimals="INF"
      id="Fact000800"
      unitRef="Shares">235295</STSS:ContingentWarrants>
    <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice
      contextRef="From2022-01-012022-12-31_custom_NotePurchaseAgreementMember_us-gaap_NoteWarrantMember"
      decimals="INF"
      id="Fact000802"
      unitRef="USDPShares">4.25</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice
      contextRef="From2023-09-292023-09-29_custom_NotePurchaseAgreementMember_us-gaap_NoteWarrantMember"
      decimals="INF"
      id="Fact000804"
      unitRef="USDPShares">0.64</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice>
    <us-gaap:StockholdersEquityNoteDisclosureTextBlock contextRef="From2023-01-012023-12-31" id="Fact000806">&lt;p id="xdx_80E_eus-gaap--StockholdersEquityNoteDisclosureTextBlock_zUx2arkJtLq2" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Note
8. &lt;span id="xdx_827_zDDuBTPCQfHe"&gt;Stockholders&#x2019; Equity&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;Capital
Structure&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;On
December 11, 2017, the Company was incorporated in Wyoming with &lt;span id="xdx_909_eus-gaap--CommonStockSharesAuthorized_iI_c20171211_zXRQ4AJbPYel" title="Common stock, share authorized"&gt;20,000,000&lt;/span&gt; shares of common stock authorized with a $&lt;span id="xdx_903_eus-gaap--CommonStockParOrStatedValuePerShare_iI_c20171211_zwMurzbuPL5j" title="Common stock, par value"&gt;0.0001&lt;/span&gt; par value.
Effective, April 18, 2019, the Company&#x2019;s authorized common stock was increased to &lt;span id="xdx_90F_eus-gaap--CommonStockSharesAuthorized_iI_c20190418_zhJZrLzOcNi6" title="Common stock, share authorized"&gt;50,000,000&lt;/span&gt; shares of common stock. The articles
of incorporation also authorized &lt;span id="xdx_90B_eus-gaap--PreferredStockSharesAuthorized_iI_c20190418_zd2nHb8NgPrh" title="Preferred stock, shares authorized"&gt;10,000&lt;/span&gt; preferred shares with a $&lt;span id="xdx_906_eus-gaap--PreferredStockParOrStatedValuePerShare_iI_c20190418_zlxVAKE7IUzl" title="Preferred stock, par value"&gt;0.001&lt;/span&gt; par value.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Effective
March 22, 2022, the Company completed a plan and agreement of merger with Sharps Technology, Inc., a Nevada corporation (&#x201c;Sharps
Nevada&#x201d;). &lt;span id="xdx_900_eus-gaap--ConversionOfStockDescription_c20220319__20220322_zRTCW2lPIq08" title="Conversion of stock, description"&gt;Pursuant to the merger agreement, (i) the Company merged with and into Sharps Nevada, (ii) each 3.5 shares of common
stock of the Company were converted into one share of common stock of Sharps Nevada and (iii) the articles of incorporation and bylaws
of Sharps Nevada, became the articles of incorporation and bylaws of the surviving corporation.&lt;/span&gt; The Company&#x2019;s authorized common
stock and preferred stock increased from &lt;span id="xdx_90E_eus-gaap--CommonStockSharesAuthorized_iI_c20220321_zqWIuaVMR1ab" title="Common stock, share authorized"&gt;50,000,000&lt;/span&gt; to &lt;span id="xdx_900_eus-gaap--CommonStockSharesAuthorized_iI_c20231231_zKr6XrguyaE5" title="Common stock, share authorized"&gt;100,000,000&lt;/span&gt; and &lt;span id="xdx_90E_eus-gaap--PreferredStockSharesAuthorized_iI_c20220321_z02GsXf6DB4i" title="Preferred stock, shares authorized"&gt;10,000&lt;/span&gt; to &lt;span id="xdx_900_eus-gaap--PreferredStockSharesAuthorized_iI_c20231231_zbGgSgndPBZ3" title="Preferred stock, shares authorized"&gt;1,000,000&lt;/span&gt; shares, respectively. The par value of preferred
stock decreased from $&lt;span id="xdx_900_eus-gaap--PreferredStockParOrStatedValuePerShare_iI_c20220321_zUiO4KHVaUGf" title="Preferred stock, par value"&gt;0.001&lt;/span&gt; to $&lt;span id="xdx_90B_eus-gaap--PreferredStockParOrStatedValuePerShare_iI_c20231231_zH9iCouNVhwg" title="Preferred stock, par value"&gt;0.0001&lt;/span&gt; per share.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;Common
Stock&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;On
September 29, 2023, the Company completed two simultaneous offerings and received aggregate gross proceeds of approximately $&lt;span id="xdx_904_eus-gaap--ProceedsFromIssuanceOfCommonStock_pn5n6_c20230929__20230929_zYKahFVLFYRd" title="Gross proceeds"&gt;5.6 &lt;/span&gt;million,
before expenses to the placement agent and other offering expenses of $&lt;span id="xdx_902_eus-gaap--OtherExpenses_c20230929__20230929_zSC9FNlo8Kq8" title="Other offering expenses"&gt;716,000&lt;/span&gt;.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%"&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;a.&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
    first offering, the securities purchase agreement offering (the &#x201c;Shelf Offering&#x201d;) with institutional investors and the
    Company resulted in the Company receiving net proceeds from the Shelf Offering and the sale of pre-funded warrants of approximately
    $&lt;span id="xdx_906_eus-gaap--ProceedsFromIssuanceInitialPublicOffering_pn5n6_c20230929__20230929__us-gaap--SubsidiarySaleOfStockAxis__custom--ShelfOfferingMember__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember_zTu5kue36XS8" title="Net proceeds from the Shelf Offering"&gt;2.5 &lt;/span&gt;million,
    includes the value of the pre-funded warrants recorded in Additional Paid in Capital, net of $&lt;span id="xdx_90B_eus-gaap--LegalFees_c20230929__20230929__us-gaap--SubsidiarySaleOfStockAxis__custom--ShelfOfferingMember__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember_zI2yRFb39Paf" title="Net fees"&gt;362,000&lt;/span&gt;
    in fees relating to the placement agent and other offering expenses. The Shelf Offering was priced at the market under Nasdaq rules.
    In connection with the Shelf Offering, the Company issued &lt;span id="xdx_907_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_c20230929__20230929__us-gaap--SubsidiarySaleOfStockAxis__custom--ShelfOfferingMember__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember_z8GHUbCSXj" title="Shares issued"&gt;3,618,521&lt;/span&gt;
    shares of common at a purchase price of $&lt;span id="xdx_90A_eus-gaap--SharesIssuedPricePerShare_iI_c20230929__us-gaap--SubsidiarySaleOfStockAxis__custom--ShelfOfferingMember__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember_z3RZkDYhS8wl" title="Purchase price"&gt;0.64&lt;/span&gt;
    per unit and &lt;span id="xdx_903_eus-gaap--ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight_iI_c20230929__us-gaap--SubsidiarySaleOfStockAxis__custom--ShelfOfferingMember__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_zLtKnbYObrJb" title="Prefunded warrants"&gt;800,000&lt;/span&gt;
    pre-funded warrants at $&lt;span id="xdx_901_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_c20230929__us-gaap--SubsidiarySaleOfStockAxis__custom--ShelfOfferingMember__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_z2wcn5m3ZUed" title="Exercise price"&gt;0.639&lt;/span&gt;
    per pre-funded warrants. The exercise price of the pre-funded warrants will be $&lt;span id="xdx_907_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_c20230929__us-gaap--SubsidiarySaleOfStockAxis__custom--ShelfOfferingMember__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember_zMcXQ1u7TWj3" title="Exercise price"&gt;0.001&lt;/span&gt;
    per share.&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;
&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%"&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;b.&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The second offering, the
    securities purchase agreement offering (&#x201c;Private Placement&#x201d;) with institutional investors and the Company received net
    proceeds from the Private Placement of approximately $&lt;span id="xdx_906_eus-gaap--ProceedsFromIssuanceOfPrivatePlacement_pn5n6_c20230929__20230929__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--PrivatePlacementMember__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember_zXZJYIRsMLId" title="Net proceeds from the Private Placement"&gt;2.4&lt;/span&gt; million, net of $&lt;span id="xdx_90F_eus-gaap--LegalFees_c20230929__20230929__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--PrivatePlacementMember__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember_zlAFHAVIVlrl" title="Net fees"&gt;354,000&lt;/span&gt; in fees relating to the placement agent and other
    offering expenses. In connection with the Private Placement, the Company issued: (i) &lt;span id="xdx_901_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_c20230929__20230929__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--PrivatePlacementMember__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__us-gaap--StatementEquityComponentsAxis__custom--PIPEPreFundedWarrantsMember_z15DD4ln76Pf" title="PIPE shares"&gt;2,581,479&lt;/span&gt; PIPE Shares (or PIPE Pre-Funded Warrants
    in lieu thereof) and (ii) PIPE Warrants (non-trading) to purchase &lt;span id="xdx_902_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_pid_c20230929__20230929__us-gaap--SubsidiarySaleOfStockAxis__custom--NonTradingWarrantsMember_zF7aBomdByx1" title="Issuance of warrants"&gt;8,750,003&lt;/span&gt; shares of our common stock, at a combined purchase price
    of $&lt;span id="xdx_90E_eus-gaap--SharesIssuedPricePerShare_iI_c20230203__us-gaap--TypeOfArrangementAxis__custom--PurchaseAgreementMember__us-gaap--SubsidiarySaleOfStockAxis__custom--SecuritiesPurchaseAgreementMember__us-gaap--StatementEquityComponentsAxis__custom--PIPEPreFundedWarrantsMember_zqv98FUv5Cni" title="Shares issued price per share"&gt;1.074&lt;/span&gt; per unit (or $1.073 per pre-funded unit). The PIPE Warrants have a term of five and one-half (&lt;span id="xdx_908_eus-gaap--WarrantsAndRightsOutstandingTerm_iI_dtY_c20230929__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--PrivatePlacementMember__us-gaap--StatementEquityComponentsAxis__custom--PIPEPreFundedWarrantsMember_zHZTCxNDSJt3" title="Warrant term"&gt;5.5&lt;/span&gt;) years from the issuance
    date and are exercisable for one share of common stock at an exercise price of $&lt;span id="xdx_906_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_c20230929__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__us-gaap--StatementEquityComponentsAxis__custom--PIPEPreFundedWarrantsMember__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--PrivatePlacementMember_zVyh5j3TiDkd" title="Warrant exerice price"&gt;0.64&lt;/span&gt;. The net proceeds, after reflecting par value,
    has been recorded in Additional Paid in Capital of $&lt;span id="xdx_909_eus-gaap--AdditionalPaidInCapital_iI_pn5n6_c20230929__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--PrivatePlacementMember__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember_zT7829pxvWjl" title="Additional paid in capital"&gt;1.6 &lt;/span&gt;million and with respect to the PIPE Warrants recorded as a liability under
    ASC 815 of $&lt;span id="xdx_908_eus-gaap--FairValueAdjustmentOfWarrants_c20230929__20230929__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--PrivatePlacementMember__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember_zi2YNCQgSb8d" title="Warrants liability"&gt;985,204&lt;/span&gt;. On October 16, 2023, the Company filed an S-1 (Resale) Registration Statement in connection with the Private
    Placement and on October 26, 2023 the S-1 went effective. At December 31, 2023, the warrant liability is $&lt;span id="xdx_908_eus-gaap--WarrantsAndRightsOutstanding_iI_c20231231__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--PrivatePlacementMember__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember_zPDkjUEgFjW8" title="Warrants liability"&gt;1,036,875&lt;/span&gt;. (See Notes 8
    and 10). &lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;
&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;On
February 3, 2023, the Company completed a securities purchase agreement (&#x201c;Offering&#x201d;) with institutional investors and received
net proceeds from the Offering were approximately $&lt;span id="xdx_90D_ecustom--NetProceedsFromIssuanceInitialPublicOffering_pn5n6_c20230201__20230203__us-gaap--TypeOfArrangementAxis__custom--PurchaseAgreementMember_z02g5b06SaD2" title="Net proceeds from offering"&gt;3.2&lt;/span&gt; million, net of $&lt;span id="xdx_906_eus-gaap--NoninterestExpenseOfferingCost_c20230201__20230203__us-gaap--TypeOfArrangementAxis__custom--PurchaseAgreementMember_znPveh7iLx48" title="Offering expenses"&gt;600,000&lt;/span&gt; in fees relating to the placement agent and other offering
expenses. The Offering was priced at the market under Nasdaq rules. In connection with the Offering, the Company issued &lt;span id="xdx_904_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_c20230201__20230203__us-gaap--TypeOfArrangementAxis__custom--PurchaseAgreementMember_zJXhUki3jsp3" title="Shares issued"&gt;2,248,521&lt;/span&gt; units
at a purchase price of $&lt;span id="xdx_90C_eus-gaap--SharesIssuedPricePerShare_iI_c20230203__us-gaap--TypeOfArrangementAxis__custom--PurchaseAgreementMember_z0TpS9HFbIfa" title="Shares issued price per share"&gt;1.69&lt;/span&gt; per unit. Each unit consists of one share of common stock and one non-tradable warrant exercisable for one
share of common stock at a price of $&lt;span id="xdx_905_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_c20230203__us-gaap--TypeOfArrangementAxis__custom--PurchaseAgreementMember_zLrpt5IcwEv7" title="Warrant exerice price"&gt;1.56&lt;/span&gt;, adjusted to $&lt;span id="xdx_906_ecustom--ClassOfWarrantOrRightExercisePriceOfWarrantsAdjusted_iI_c20230929__us-gaap--TypeOfArrangementAxis__custom--PurchaseAgreementMember_z0stdfsrlADk" title="Warrant exerice price"&gt;0.64&lt;/span&gt; at September 29, 2023, based on anti-dilution terms in the warrants. The
warrants have a term of five years from the issuance date. On February 13, 2023, the Company filed an S-1 (Resale) Registration Statement
in connection with the Offering.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;On
April 13, 2022, the Company&#x2019;s initial public offering (&#x201c;IPO&#x201d;) was declared effective by the SEC pursuant to which the
Company issued and sold an aggregate of &lt;span id="xdx_908_ecustom--StockIssuedDuringPeriodSharesInitialPublicOffering_c20220411__20220413__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_zTStDgZNt6Ib" title="Initial public offering"&gt;3,750,000&lt;/span&gt; units (&#x201c;Units&#x201d;), each consisting of one share of common stock and two warrants,
to purchase one share of common stock for each whole warrant, with an initial exercise price of $&lt;span id="xdx_906_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice_pid_c20220411__20220413__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_zeBqcDbb1GG1" title="Exercise price"&gt;4.25&lt;/span&gt; per share and a term of &lt;span id="xdx_900_eus-gaap--WarrantsAndRightsOutstandingTerm_iI_dc_c20220413__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_zl4vuM4lSJS7" title="Warrants exercise price term"&gt;five years&lt;/span&gt;.
In addition, the Company granted Aegis Capital Corp., as underwriter a 45-day over-allotment option to purchase up to 15% of the number
of shares included in the units sold in the offering, and/or additional warrants equal to 15% of the number of Warrants included in the
units sold in the offering, in each case solely to cover over-allotments, which the Aegis Capital Corp. partially exercised with respect
to &lt;span id="xdx_90A_eus-gaap--ClassOfWarrantOrRightOutstanding_iI_c20220419__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_zmyWhszUPMjl" title="Warrants exercised"&gt;1,125,000&lt;/span&gt; warrants on April 19, 2022.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"&gt;&lt;/p&gt;



&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;SHARPS
TECHNOLOGY, INC.&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;NOTES
TO THE CONSOLIDATED FINANCIAL STATEMENTS&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;FOR
THE YEARS ENDED DECEMBER 31, 2023 AND 2022&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Note
8. Stockholders&#x2019; Equity (continued)&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company&#x2019;s common stock and warrants began trading on the Nasdaq Capital Market or Nasdaq on April 14, 2022. The net proceeds from
the IPO, prior to payments of certain listing and professional fees were approximately $&lt;span id="xdx_90F_eus-gaap--ProceedsFromIssuanceInitialPublicOffering_pn5n6_c20220412__20220414__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--IPOMember_zlJEEwRhOnxk" title="Net proceeds from IPO"&gt;14.2&lt;/span&gt; million. The net proceeds, after reflecting
par value, has been recorded in Additional Paid in Capital of $&lt;span id="xdx_90D_eus-gaap--AdditionalPaidInCapital_iI_pn5n6_c20220414_zgjY5SnP4yTi" title="Additional paid in capital"&gt;9.0&lt;/span&gt; million and with respect to the Warrants as a liability under ASC
815 of $&lt;span id="xdx_90F_eus-gaap--FairValueAdjustmentOfWarrants_pn5n6_c20220412__20220414_zYwV2UNmH7U7" title="Warrants liability"&gt;5.2&lt;/span&gt;M. (See Note 10)&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;During
the year ended December 31, 2022, the Company issued &lt;span id="xdx_90F_eus-gaap--StockIssuedDuringPeriodSharesIssuedForServices_c20220101__20221231_zpVdD8C9ruH1" title="Common stock issued for services, shares"&gt;235,000&lt;/span&gt; shares of common stock at the trading stock price in connection with services
provided to the Company and recorded a charge of $&lt;span id="xdx_90A_eus-gaap--StockIssuedDuringPeriodValueIssuedForServices_c20220101__20221231_ztMvifOMz3Z6" title="Common stock issued for services, value"&gt;290,551&lt;/span&gt;, In addition, the Company issued &lt;span id="xdx_90C_eus-gaap--StockIssuedDuringPeriodSharesIssuedForServices_c20220101__20221231__us-gaap--TypeOfArrangementAxis__custom--NotePurchaseAgreementMember_zizbjT07WXd4" title="Common stock issued for services, shares"&gt;235,295&lt;/span&gt; common shares relating to the Note
Purchase agreement. (See Note 7)&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;Warrants&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;a)
                                                                              In connection with a one-year advisory services arrangement entered into in April 2023, the Company issued &lt;span id="xdx_909_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_pid_c20230101__20231231__us-gaap--SubsidiarySaleOfStockAxis__custom--NonTradingWarrantsMember_zELgINyTRe3l" title="Issuance of warrants"&gt;495,000&lt;/span&gt;
                                                                              warrants during the year ended December 31, 2023 at an exercise price of $&lt;span id="xdx_90E_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_pid_c20231231__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--NoteWarrantMember_zfj84Rof6t3l" title="Exercise price"&gt;1.56&lt;/span&gt;.
                                                                              The warrants have a three-year term and were fully vested on issuance. The FMV of the warrants recorded for the year end ended
                                                                              December 31, 2023 was $&lt;span id="xdx_901_eus-gaap--FairValueAdjustmentOfWarrants_c20230101__20231231_zIYSKGXPApI3" title="Fair value adjustment of warrants"&gt;42,915&lt;/span&gt;
                                                                              as computed using the Black Sholes valuation model. The assumptions for the year ended December 31, 2023 were: a) expected term
                                                                              &#x2013; &lt;span id="xdx_904_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_dtY_c20230101__20231231_zeP98f22ATXg" title="Expected term"&gt;3&lt;/span&gt;
                                                                              years, b) expected volatility &#x2013; &lt;span id="xdx_900_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum_pid_dp_uPure_c20230101__20231231_z1bbxmYc29mg" title="Volatility, minimum"&gt;24.49&lt;/span&gt;%
                                                                              to &lt;span id="xdx_900_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum_pid_dp_uPure_c20230101__20231231_zbD4y9mhK2ij" title="Volatility, maximum"&gt;44.83&lt;/span&gt;%,
                                                                              c) risk free rate- &lt;span id="xdx_90B_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum_pid_dp_uPure_c20230101__20231231_zWi8cNWnaqwk" title="Risk free interest rate, minimum"&gt;3.58&lt;/span&gt;%
                                                                              to &lt;span id="xdx_90F_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum_pid_dp_uPure_c20230101__20231231_zv9rdpUvMzDf" title="Risk free interest rate, maximum"&gt;4.67&lt;/span&gt;.%
                                                                              and d) dividend rate &#x2013; &lt;span id="xdx_905_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_pid_dp_uPure_c20230101__20231231_zdgoHMxRYC8i" title="Dividend rate"&gt;0&lt;/span&gt;%.&lt;/span&gt;&lt;/p&gt;
    &lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;
    &lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;b)
    In connection with the Private Placement in September 2023, the Company issued &lt;span id="xdx_904_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_pid_c20230901__20230930__us-gaap--SubsidiarySaleOfStockAxis__custom--NonTradingWarrantsMember_zgso18xUuiR2" title="Issuance of warrants"&gt;8,750,003&lt;/span&gt; non-trading PIPE Warrants as a component
    of the Unit as noted in Common Stock above. The PIPE Warrants were recorded at the FMV, computed using the Black Sholes valuation
    method. The PIPE Warrant&#x2019;s liability requires remeasurement at each reporting period. The PIPE Warrants are classified as a
    liability based on ASC 815. At the issuance date and December 31, 2023, the liability was $&lt;span id="xdx_90B_eus-gaap--WarrantsAndRightsOutstanding_iI_c20230929__us-gaap--SubsidiarySaleOfStockAxis__custom--NonTradingWarrantsMember__us-gaap--StatementEquityComponentsAxis__custom--PIPEWarrantMember_z5DPxJD7guRj" title="Warrant liability"&gt;985,204&lt;/span&gt; and $&lt;span id="xdx_903_eus-gaap--WarrantsAndRightsOutstanding_iI_c20231231__us-gaap--SubsidiarySaleOfStockAxis__custom--NonTradingWarrantsMember__us-gaap--StatementEquityComponentsAxis__custom--PIPEWarrantMember_z3oaGHVnP3Uc" title="Warrant liability"&gt;1,036,875&lt;/span&gt;, respectively and
    for the year ended December 31, 2023 a FMV loss adjustment of $&lt;span id="xdx_905_eus-gaap--MarketRiskBenefitChangeInFairValueGainLoss_c20230101__20231231__us-gaap--SubsidiarySaleOfStockAxis__custom--NonTradingWarrantsMember__us-gaap--StatementEquityComponentsAxis__custom--PIPEWarrantMember_zxvFZGyJqz21" title="Fair market value adjustment"&gt;51,671&lt;/span&gt; was recorded (See Note 10).&lt;/span&gt;&lt;/p&gt;
    &lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;
    &lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;c)
    In connection with the Offering in February 2023, the Company issued &lt;span id="xdx_904_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_pid_c20230201__20230228__us-gaap--SubsidiarySaleOfStockAxis__custom--NonTradingWarrantsMember_zH3NyuLUatJe" title="Issuance of warrants"&gt;2,248,521&lt;/span&gt; non-trading warrants Offering Warrants as a component
    of the Unit as noted in Common Stock above. The Offering Warrant&#x2019;s liability requires remeasurement at each reporting period.
    The Offering Warrants were recorded at the FMV, computed using the Black Sholes valuation method. The Offering Warrants are classified
    as a liability based on ASC 815. At the issuance date and at December 31, 2023 the liability was $&lt;span id="xdx_90A_eus-gaap--WarrantsAndRightsOutstanding_iI_c20230228__us-gaap--SubsidiarySaleOfStockAxis__custom--NonTradingWarrantsMember_zcOYbfymT5Y4" title="Warrants liability"&gt;455,326&lt;/span&gt; and $&lt;span id="xdx_909_eus-gaap--WarrantsAndRightsOutstanding_iI_c20231231__us-gaap--SubsidiarySaleOfStockAxis__custom--NonTradingWarrantsMember_zyTwSDCYZzh" title="Warrants liability"&gt;234,072&lt;/span&gt;, respectively.
    During the year ended December 31, 2023, the Company recorded a FMV gain adjustment of $&lt;span id="xdx_904_eus-gaap--FairValueAdjustmentOfWarrants_c20230101__20231231__us-gaap--SubsidiarySaleOfStockAxis__custom--NonTradingWarrantsMember_zl0ywqe0H9z4" title="FMV gain adjustment"&gt;221,254&lt;/span&gt;. (See Note 10).&lt;/span&gt;&lt;/p&gt;
    &lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;
    &lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;d)
    In connection with the IPO in April 2022, the Company issued &lt;span id="xdx_90F_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_pid_c20220401__20220430__us-gaap--SubsidiarySaleOfStockAxis__custom--TradingWarrantsMember_znjXLidnQO22" title="Issuance of warrants"&gt;7,500,000&lt;/span&gt;
    warrants (Trading Warrants) as a component of the Units and &lt;span id="xdx_907_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_pid_c20220401__20220430__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--OverAllotmentOptionMember_zZkqoNebekPi" title="Issuance of warrants"&gt;1,125,000&lt;/span&gt;
    warrants to the underwriter (Overallotment Warrants), as noted in Common Stock above. The Trading and Overallotment Warrants were
    recorded at the FMV, being the trading price of the warrants, on the IPO effective date and the Warrants are classified as a
    Liability based on ASC 815. The Warrant liability requires remeasurement at each reporting period. At December 31, 2023 and 2022,
    the liability was $&lt;span id="xdx_903_eus-gaap--WarrantsAndRightsOutstanding_iI_c20231231__us-gaap--SubsidiarySaleOfStockAxis__custom--TradingWarrantsMember_zMVfHLRw4r6e" title="Warrants liability"&gt;&lt;span id="xdx_909_eus-gaap--WarrantsAndRightsOutstanding_iI_c20221231__us-gaap--SubsidiarySaleOfStockAxis__custom--TradingWarrantsMember_zYfUFBuwMDa6" title="Warrants liability"&gt;1,121,250&lt;/span&gt;&lt;/span&gt;.
    During years ended December 31, 2023 and 2022, the Company recorded a FMV loss (gain) adjustment of $&lt;span id="xdx_903_eus-gaap--FairValueAdjustmentOfWarrants_c20230101__20231231__us-gaap--SubsidiarySaleOfStockAxis__custom--TradingWarrantsMember_zVxkcAIjVx79" title="Fair value income adjustment"&gt;0&lt;/span&gt;
    and $(&lt;span id="xdx_903_eus-gaap--FairValueAdjustmentOfWarrants_c20220101__20221231__us-gaap--SubsidiarySaleOfStockAxis__custom--TradingWarrantsMember_z4OtSAVVHNo5" title="Fair value income adjustment"&gt;4,784,559&lt;/span&gt;), &lt;span&gt;respectively&lt;/span&gt;
    (See Note 10).&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;
&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;




&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;SHARPS
TECHNOLOGY, INC.&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;NOTES
TO THE CONSOLIDATED FINANCIAL STATEMENTS&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;FOR
THE YEARS ENDED DECEMBER 31, 2023 AND 2022&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Note
8. Stockholders&#x2019; Equity (continued)&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;e)
    The Company has issued &lt;span id="xdx_901_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_pid_c20220419__20220419__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--NoteWarrantMember_zWkrZmKo9B98" title="Issuance of warrants"&gt;235,295&lt;/span&gt;
    Warrants (&#x201c;Note Warrants&#x201d;) to the Purchasers of the Notes on April 19, 2022. The Note Warrants have an exercise price of
    $&lt;span id="xdx_909_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_pid_c20220419__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--NoteWarrantMember_zTWD3cZiugV9" title="Exercise price"&gt;4.25&lt;/span&gt;
    and a term of &lt;span id="xdx_901_eus-gaap--WarrantsAndRightsOutstandingTerm_iI_dc_c20220419__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--NoteWarrantMember_zDYKm0TNpUIb" title="Warrants exercise price term"&gt;five years&lt;/span&gt;. At December 31,2023 and 2022, the liability was $&lt;span id="xdx_901_ecustom--PaymentsForRepurchaseOfLiability_c20220101__20221231__us-gaap--SubsidiarySaleOfStockAxis__custom--NoteWarrantsMember_zcsKXB287fPj" title="Warrant outstanding"&gt;30,588&lt;/span&gt;.
    During the years ended December 31, 2023 and 2022, the Company recorded a FMV loss (gain) of $&lt;span id="xdx_90C_eus-gaap--FairValueAdjustmentOfWarrants_c20230101__20231231__us-gaap--SubsidiarySaleOfStockAxis__custom--NoteWarrantsMember_zosuRDpp1wzg" title="Fair value income adjustment"&gt;0&lt;/span&gt;
    and ($&lt;span id="xdx_906_eus-gaap--FairValueAdjustmentOfWarrants_c20220101__20221231__us-gaap--SubsidiarySaleOfStockAxis__custom--NoteWarrantsMember_zLt5vdzjt1I4" title="Fair value income adjustment"&gt;127,059&lt;/span&gt;),
    respectively. (See Note 10)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;f)
    The underwriter received &lt;span id="xdx_909_eus-gaap--ClassOfWarrantOrRightOutstanding_iI_c20231231__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--IPOMember_zfYDNcLzcbFl" title="Warrants received"&gt;187,500&lt;/span&gt;
    warrants in connection with the IPO for a nominal cost of $&lt;span id="xdx_902_eus-gaap--PaymentsOfStockIssuanceCosts_c20230101__20231231__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--IPOMember_z5dlVSTPXmI3" title="Nominal cost"&gt;11,250&lt;/span&gt;.
    The Warrants have an exercise price of $&lt;span id="xdx_908_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_pid_c20221009__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--IPOMember_zPg6cTkzlLob" title="Exercise price"&gt;5.32&lt;/span&gt;
    and are exercisable after October 9, 2022. The FMV at the date of issuance was $&lt;span id="xdx_904_eus-gaap--FairValueAdjustmentOfWarrants_c20230101__20231231__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--IPOMember_zRSQVJyAfjge" title="Fair value adjustment of warrants"&gt;228,750&lt;/span&gt;
    computed using the Black Sholes valuation model with the following assumptions: a) volatility of &lt;span id="xdx_903_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate_pid_dp_uPure_c20230101__20231231__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--IPOMember_zyCRFn78Azn3" title="Volatility"&gt;93.47&lt;/span&gt;%, &lt;span id="xdx_904_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_dxL_c20230101__20231231__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--IPOMember_zl1sIXJl71Pf" title="Expected term::XDX::P5Y"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0970"&gt;five&lt;/span&gt;&lt;/span&gt;-year
    term, risk free interest rate &lt;span id="xdx_903_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_pid_dp_uPure_c20230101__20231231__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--IPOMember_zDjcnIFfCrNl" title="Risk free interest rate"&gt;2.77&lt;/span&gt;%
    and &lt;span id="xdx_907_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_pid_dp_uPure_c20230101__20231231__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--IPOMember_za612j0WtE3b" title="Dividend rate"&gt;0&lt;/span&gt;%
    dividend rate. These warrants were recorded in Equity at the estimated FMV and classified as additional issuance
    costs.&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;
&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

</us-gaap:StockholdersEquityNoteDisclosureTextBlock>
    <us-gaap:CommonStockSharesAuthorized
      contextRef="AsOf2017-12-11"
      decimals="INF"
      id="Fact000808"
      unitRef="Shares">20000000</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="AsOf2017-12-11"
      decimals="INF"
      id="Fact000810"
      unitRef="USDPShares">0.0001</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:CommonStockSharesAuthorized
      contextRef="AsOf2019-04-18"
      decimals="INF"
      id="Fact000812"
      unitRef="Shares">50000000</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:PreferredStockSharesAuthorized
      contextRef="AsOf2019-04-18"
      decimals="INF"
      id="Fact000814"
      unitRef="Shares">10000</us-gaap:PreferredStockSharesAuthorized>
    <us-gaap:PreferredStockParOrStatedValuePerShare
      contextRef="AsOf2019-04-18"
      decimals="INF"
      id="Fact000816"
      unitRef="USDPShares">0.001</us-gaap:PreferredStockParOrStatedValuePerShare>
    <us-gaap:ConversionOfStockDescription contextRef="From2022-03-192022-03-22" id="Fact000818">Pursuant to the merger agreement, (i) the Company merged with and into Sharps Nevada, (ii) each 3.5 shares of common
stock of the Company were converted into one share of common stock of Sharps Nevada and (iii) the articles of incorporation and bylaws
of Sharps Nevada, became the articles of incorporation and bylaws of the surviving corporation.</us-gaap:ConversionOfStockDescription>
    <us-gaap:CommonStockSharesAuthorized
      contextRef="AsOf2022-03-21"
      decimals="INF"
      id="Fact000820"
      unitRef="Shares">50000000</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:CommonStockSharesAuthorized
      contextRef="AsOf2023-12-31"
      decimals="INF"
      id="Fact000822"
      unitRef="Shares">100000000</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:PreferredStockSharesAuthorized
      contextRef="AsOf2022-03-21"
      decimals="INF"
      id="Fact000824"
      unitRef="Shares">10000</us-gaap:PreferredStockSharesAuthorized>
    <us-gaap:PreferredStockSharesAuthorized
      contextRef="AsOf2023-12-31"
      decimals="INF"
      id="Fact000826"
      unitRef="Shares">1000000</us-gaap:PreferredStockSharesAuthorized>
    <us-gaap:PreferredStockParOrStatedValuePerShare
      contextRef="AsOf2022-03-21"
      decimals="INF"
      id="Fact000828"
      unitRef="USDPShares">0.001</us-gaap:PreferredStockParOrStatedValuePerShare>
    <us-gaap:PreferredStockParOrStatedValuePerShare
      contextRef="AsOf2023-12-31"
      decimals="INF"
      id="Fact000830"
      unitRef="USDPShares">0.0001</us-gaap:PreferredStockParOrStatedValuePerShare>
    <us-gaap:ProceedsFromIssuanceOfCommonStock
      contextRef="From2023-09-292023-09-29"
      decimals="-5"
      id="Fact000832"
      unitRef="USD">5600000</us-gaap:ProceedsFromIssuanceOfCommonStock>
    <us-gaap:OtherExpenses
      contextRef="From2023-09-292023-09-29"
      decimals="0"
      id="Fact000834"
      unitRef="USD">716000</us-gaap:OtherExpenses>
    <us-gaap:ProceedsFromIssuanceInitialPublicOffering
      contextRef="From2023-09-292023-09-29_custom_ShelfOfferingMember_custom_SecuritiesPurchaseAgreementMember"
      decimals="-5"
      id="Fact000836"
      unitRef="USD">2500000</us-gaap:ProceedsFromIssuanceInitialPublicOffering>
    <us-gaap:LegalFees
      contextRef="From2023-09-292023-09-29_custom_ShelfOfferingMember_custom_SecuritiesPurchaseAgreementMember"
      decimals="0"
      id="Fact000838"
      unitRef="USD">362000</us-gaap:LegalFees>
    <us-gaap:StockIssuedDuringPeriodSharesNewIssues
      contextRef="From2023-09-292023-09-29_custom_ShelfOfferingMember_custom_SecuritiesPurchaseAgreementMember"
      decimals="INF"
      id="Fact000840"
      unitRef="Shares">3618521</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
    <us-gaap:SharesIssuedPricePerShare
      contextRef="AsOf2023-09-29_custom_ShelfOfferingMember_custom_SecuritiesPurchaseAgreementMember"
      decimals="INF"
      id="Fact000842"
      unitRef="USDPShares">0.64</us-gaap:SharesIssuedPricePerShare>
    <us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight
      contextRef="AsOf2023-09-29_custom_ShelfOfferingMember_custom_SecuritiesPurchaseAgreementMember_us-gaap_WarrantMember"
      decimals="INF"
      id="Fact000844"
      unitRef="Shares">800000</us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight>
    <us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
      contextRef="AsOf2023-09-29_custom_ShelfOfferingMember_custom_SecuritiesPurchaseAgreementMember_us-gaap_WarrantMember"
      decimals="INF"
      id="Fact000846"
      unitRef="USDPShares">0.639</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1>
    <us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
      contextRef="AsOf2023-09-29_custom_ShelfOfferingMember_custom_SecuritiesPurchaseAgreementMember"
      decimals="INF"
      id="Fact000848"
      unitRef="USDPShares">0.001</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1>
    <us-gaap:ProceedsFromIssuanceOfPrivatePlacement
      contextRef="From2023-09-292023-09-29_us-gaap_PrivatePlacementMember_custom_SecuritiesPurchaseAgreementMember"
      decimals="-5"
      id="Fact000850"
      unitRef="USD">2400000</us-gaap:ProceedsFromIssuanceOfPrivatePlacement>
    <us-gaap:LegalFees
      contextRef="From2023-09-292023-09-29_us-gaap_PrivatePlacementMember_custom_SecuritiesPurchaseAgreementMember"
      decimals="0"
      id="Fact000852"
      unitRef="USD">354000</us-gaap:LegalFees>
    <us-gaap:StockIssuedDuringPeriodSharesNewIssues
      contextRef="From2023-09-292023-09-29_us-gaap_PrivatePlacementMember_custom_SecuritiesPurchaseAgreementMember_custom_PIPEPreFundedWarrantsMember"
      decimals="INF"
      id="Fact000854"
      unitRef="Shares">2581479</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
    <us-gaap:StockIssuedDuringPeriodSharesNewIssues
      contextRef="From2023-09-292023-09-29_custom_NonTradingWarrantsMember"
      decimals="INF"
      id="Fact000856"
      unitRef="Shares">8750003</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
    <us-gaap:SharesIssuedPricePerShare
      contextRef="AsOf2023-02-03_custom_PurchaseAgreementMember_custom_SecuritiesPurchaseAgreementMember_custom_PIPEPreFundedWarrantsMember"
      decimals="INF"
      id="Fact000858"
      unitRef="USDPShares">1.074</us-gaap:SharesIssuedPricePerShare>
    <us-gaap:WarrantsAndRightsOutstandingTerm
      contextRef="AsOf2023-09-29_custom_SecuritiesPurchaseAgreementMember_us-gaap_PrivatePlacementMember_custom_PIPEPreFundedWarrantsMember"
      id="Fact000860">P5Y6M</us-gaap:WarrantsAndRightsOutstandingTerm>
    <us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
      contextRef="AsOf2023-09-29_custom_SecuritiesPurchaseAgreementMember_us-gaap_PrivatePlacementMember_custom_PIPEPreFundedWarrantsMember"
      decimals="INF"
      id="Fact000862"
      unitRef="USDPShares">0.64</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1>
    <us-gaap:AdditionalPaidInCapital
      contextRef="AsOf2023-09-29_us-gaap_PrivatePlacementMember_custom_SecuritiesPurchaseAgreementMember"
      decimals="-5"
      id="Fact000864"
      unitRef="USD">1600000</us-gaap:AdditionalPaidInCapital>
    <us-gaap:FairValueAdjustmentOfWarrants
      contextRef="From2023-09-292023-09-29_us-gaap_PrivatePlacementMember_custom_SecuritiesPurchaseAgreementMember"
      decimals="0"
      id="Fact000866"
      unitRef="USD">985204</us-gaap:FairValueAdjustmentOfWarrants>
    <us-gaap:WarrantsAndRightsOutstanding
      contextRef="AsOf2023-12-31_us-gaap_PrivatePlacementMember_custom_SecuritiesPurchaseAgreementMember"
      decimals="0"
      id="Fact000868"
      unitRef="USD">1036875</us-gaap:WarrantsAndRightsOutstanding>
    <STSS:NetProceedsFromIssuanceInitialPublicOffering
      contextRef="From2023-02-012023-02-03_custom_PurchaseAgreementMember"
      decimals="-5"
      id="Fact000870"
      unitRef="USD">3200000</STSS:NetProceedsFromIssuanceInitialPublicOffering>
    <us-gaap:NoninterestExpenseOfferingCost
      contextRef="From2023-02-012023-02-03_custom_PurchaseAgreementMember"
      decimals="0"
      id="Fact000872"
      unitRef="USD">600000</us-gaap:NoninterestExpenseOfferingCost>
    <us-gaap:StockIssuedDuringPeriodSharesNewIssues
      contextRef="From2023-02-012023-02-03_custom_PurchaseAgreementMember"
      decimals="INF"
      id="Fact000874"
      unitRef="Shares">2248521</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
    <us-gaap:SharesIssuedPricePerShare
      contextRef="AsOf2023-02-03_custom_PurchaseAgreementMember"
      decimals="INF"
      id="Fact000876"
      unitRef="USDPShares">1.69</us-gaap:SharesIssuedPricePerShare>
    <us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
      contextRef="AsOf2023-02-03_custom_PurchaseAgreementMember"
      decimals="INF"
      id="Fact000878"
      unitRef="USDPShares">1.56</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1>
    <STSS:ClassOfWarrantOrRightExercisePriceOfWarrantsAdjusted
      contextRef="AsOf2023-09-29_custom_PurchaseAgreementMember"
      decimals="INF"
      id="Fact000880"
      unitRef="USDPShares">0.64</STSS:ClassOfWarrantOrRightExercisePriceOfWarrantsAdjusted>
    <STSS:StockIssuedDuringPeriodSharesInitialPublicOffering
      contextRef="From2022-04-112022-04-13_us-gaap_WarrantMember"
      decimals="INF"
      id="Fact000882"
      unitRef="Shares">3750000</STSS:StockIssuedDuringPeriodSharesInitialPublicOffering>
    <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice
      contextRef="From2022-04-112022-04-13_us-gaap_WarrantMember"
      decimals="INF"
      id="Fact000884"
      unitRef="USDPShares">4.25</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice>
    <us-gaap:WarrantsAndRightsOutstandingTerm
      contextRef="AsOf2022-04-13_us-gaap_WarrantMember"
      id="Fact000886">P5Y</us-gaap:WarrantsAndRightsOutstandingTerm>
    <us-gaap:ClassOfWarrantOrRightOutstanding
      contextRef="AsOf2022-04-19_us-gaap_WarrantMember"
      decimals="INF"
      id="Fact000888"
      unitRef="Shares">1125000</us-gaap:ClassOfWarrantOrRightOutstanding>
    <us-gaap:ProceedsFromIssuanceInitialPublicOffering
      contextRef="From2022-04-122022-04-14_us-gaap_IPOMember"
      decimals="-5"
      id="Fact000890"
      unitRef="USD">14200000</us-gaap:ProceedsFromIssuanceInitialPublicOffering>
    <us-gaap:AdditionalPaidInCapital
      contextRef="AsOf2022-04-14"
      decimals="-5"
      id="Fact000892"
      unitRef="USD">9000000.0</us-gaap:AdditionalPaidInCapital>
    <us-gaap:FairValueAdjustmentOfWarrants
      contextRef="From2022-04-122022-04-14"
      decimals="-5"
      id="Fact000894"
      unitRef="USD">5200000</us-gaap:FairValueAdjustmentOfWarrants>
    <us-gaap:StockIssuedDuringPeriodSharesIssuedForServices
      contextRef="From2022-01-012022-12-31"
      decimals="INF"
      id="Fact000896"
      unitRef="Shares">235000</us-gaap:StockIssuedDuringPeriodSharesIssuedForServices>
    <us-gaap:StockIssuedDuringPeriodValueIssuedForServices
      contextRef="From2022-01-012022-12-31"
      decimals="0"
      id="Fact000898"
      unitRef="USD">290551</us-gaap:StockIssuedDuringPeriodValueIssuedForServices>
    <us-gaap:StockIssuedDuringPeriodSharesIssuedForServices
      contextRef="From2022-01-012022-12-31_custom_NotePurchaseAgreementMember"
      decimals="INF"
      id="Fact000900"
      unitRef="Shares">235295</us-gaap:StockIssuedDuringPeriodSharesIssuedForServices>
    <us-gaap:StockIssuedDuringPeriodSharesNewIssues
      contextRef="From2023-01-012023-12-31_custom_NonTradingWarrantsMember"
      decimals="INF"
      id="Fact000902"
      unitRef="Shares">495000</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
    <us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
      contextRef="AsOf2023-12-31_us-gaap_NoteWarrantMember"
      decimals="INF"
      id="Fact000904"
      unitRef="USDPShares">1.56</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1>
    <us-gaap:FairValueAdjustmentOfWarrants
      contextRef="From2023-01-012023-12-31"
      decimals="0"
      id="Fact000906"
      unitRef="USD">42915</us-gaap:FairValueAdjustmentOfWarrants>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1 contextRef="From2023-01-012023-12-31" id="Fact000908">P3Y</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum
      contextRef="From2023-01-012023-12-31"
      decimals="INF"
      id="Fact000910"
      unitRef="Pure">0.2449</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum
      contextRef="From2023-01-012023-12-31"
      decimals="INF"
      id="Fact000912"
      unitRef="Pure">0.4483</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum
      contextRef="From2023-01-012023-12-31"
      decimals="INF"
      id="Fact000914"
      unitRef="Pure">0.0358</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum
      contextRef="From2023-01-012023-12-31"
      decimals="INF"
      id="Fact000916"
      unitRef="Pure">0.0467</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
      contextRef="From2023-01-012023-12-31"
      decimals="INF"
      id="Fact000918"
      unitRef="Pure">0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate>
    <us-gaap:StockIssuedDuringPeriodSharesNewIssues
      contextRef="From2023-09-012023-09-30_custom_NonTradingWarrantsMember"
      decimals="INF"
      id="Fact000920"
      unitRef="Shares">8750003</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
    <us-gaap:WarrantsAndRightsOutstanding
      contextRef="AsOf2023-09-29_custom_NonTradingWarrantsMember_custom_PIPEWarrantMember"
      decimals="0"
      id="Fact000922"
      unitRef="USD">985204</us-gaap:WarrantsAndRightsOutstanding>
    <us-gaap:WarrantsAndRightsOutstanding
      contextRef="AsOf2023-12-31_custom_NonTradingWarrantsMember_custom_PIPEWarrantMember"
      decimals="0"
      id="Fact000924"
      unitRef="USD">1036875</us-gaap:WarrantsAndRightsOutstanding>
    <us-gaap:MarketRiskBenefitChangeInFairValueGainLoss
      contextRef="From2023-01-012023-12-31_custom_NonTradingWarrantsMember_custom_PIPEWarrantMember"
      decimals="0"
      id="Fact000926"
      unitRef="USD">51671</us-gaap:MarketRiskBenefitChangeInFairValueGainLoss>
    <us-gaap:StockIssuedDuringPeriodSharesNewIssues
      contextRef="From2023-02-012023-02-28_custom_NonTradingWarrantsMember"
      decimals="INF"
      id="Fact000928"
      unitRef="Shares">2248521</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
    <us-gaap:WarrantsAndRightsOutstanding
      contextRef="AsOf2023-02-28_custom_NonTradingWarrantsMember"
      decimals="0"
      id="Fact000930"
      unitRef="USD">455326</us-gaap:WarrantsAndRightsOutstanding>
    <us-gaap:WarrantsAndRightsOutstanding
      contextRef="AsOf2023-12-31_custom_NonTradingWarrantsMember"
      decimals="0"
      id="Fact000932"
      unitRef="USD">234072</us-gaap:WarrantsAndRightsOutstanding>
    <us-gaap:FairValueAdjustmentOfWarrants
      contextRef="From2023-01-012023-12-31_custom_NonTradingWarrantsMember"
      decimals="0"
      id="Fact000934"
      unitRef="USD">221254</us-gaap:FairValueAdjustmentOfWarrants>
    <us-gaap:StockIssuedDuringPeriodSharesNewIssues
      contextRef="From2022-04-012022-04-30_custom_TradingWarrantsMember"
      decimals="INF"
      id="Fact000936"
      unitRef="Shares">7500000</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
    <us-gaap:StockIssuedDuringPeriodSharesNewIssues
      contextRef="From2022-04-012022-04-30_us-gaap_OverAllotmentOptionMember"
      decimals="INF"
      id="Fact000938"
      unitRef="Shares">1125000</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
    <us-gaap:WarrantsAndRightsOutstanding
      contextRef="AsOf2023-12-31_custom_TradingWarrantsMember"
      decimals="0"
      id="Fact000940"
      unitRef="USD">1121250</us-gaap:WarrantsAndRightsOutstanding>
    <us-gaap:WarrantsAndRightsOutstanding
      contextRef="AsOf2022-12-31_custom_TradingWarrantsMember"
      decimals="0"
      id="Fact000942"
      unitRef="USD">1121250</us-gaap:WarrantsAndRightsOutstanding>
    <us-gaap:FairValueAdjustmentOfWarrants
      contextRef="From2023-01-012023-12-31_custom_TradingWarrantsMember"
      decimals="0"
      id="Fact000944"
      unitRef="USD">0</us-gaap:FairValueAdjustmentOfWarrants>
    <us-gaap:FairValueAdjustmentOfWarrants
      contextRef="From2022-01-012022-12-31_custom_TradingWarrantsMember"
      decimals="0"
      id="Fact000946"
      unitRef="USD">4784559</us-gaap:FairValueAdjustmentOfWarrants>
    <us-gaap:StockIssuedDuringPeriodSharesNewIssues
      contextRef="From2022-04-192022-04-19_us-gaap_NoteWarrantMember"
      decimals="INF"
      id="Fact000948"
      unitRef="Shares">235295</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
    <us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
      contextRef="AsOf2022-04-19_us-gaap_NoteWarrantMember"
      decimals="INF"
      id="Fact000950"
      unitRef="USDPShares">4.25</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1>
    <us-gaap:WarrantsAndRightsOutstandingTerm
      contextRef="AsOf2022-04-19_us-gaap_NoteWarrantMember"
      id="Fact000952">P5Y</us-gaap:WarrantsAndRightsOutstandingTerm>
    <STSS:PaymentsForRepurchaseOfLiability
      contextRef="From2022-01-012022-12-31_custom_NoteWarrantsMember"
      decimals="0"
      id="Fact000954"
      unitRef="USD">30588</STSS:PaymentsForRepurchaseOfLiability>
    <us-gaap:FairValueAdjustmentOfWarrants
      contextRef="From2023-01-012023-12-31_custom_NoteWarrantsMember"
      decimals="0"
      id="Fact000956"
      unitRef="USD">0</us-gaap:FairValueAdjustmentOfWarrants>
    <us-gaap:FairValueAdjustmentOfWarrants
      contextRef="From2022-01-012022-12-31_custom_NoteWarrantsMember"
      decimals="0"
      id="Fact000958"
      unitRef="USD">127059</us-gaap:FairValueAdjustmentOfWarrants>
    <us-gaap:ClassOfWarrantOrRightOutstanding
      contextRef="AsOf2023-12-31_us-gaap_IPOMember"
      decimals="INF"
      id="Fact000960"
      unitRef="Shares">187500</us-gaap:ClassOfWarrantOrRightOutstanding>
    <us-gaap:PaymentsOfStockIssuanceCosts
      contextRef="From2023-01-012023-12-31_us-gaap_IPOMember"
      decimals="0"
      id="Fact000962"
      unitRef="USD">11250</us-gaap:PaymentsOfStockIssuanceCosts>
    <us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
      contextRef="AsOf2022-10-09_us-gaap_IPOMember"
      decimals="INF"
      id="Fact000964"
      unitRef="USDPShares">5.32</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1>
    <us-gaap:FairValueAdjustmentOfWarrants
      contextRef="From2023-01-012023-12-31_us-gaap_IPOMember"
      decimals="0"
      id="Fact000966"
      unitRef="USD">228750</us-gaap:FairValueAdjustmentOfWarrants>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate
      contextRef="From2023-01-012023-12-31_us-gaap_IPOMember"
      decimals="INF"
      id="Fact000968"
      unitRef="Pure">0.9347</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
      contextRef="From2023-01-012023-12-31_us-gaap_IPOMember"
      decimals="INF"
      id="Fact000972"
      unitRef="Pure">0.0277</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
      contextRef="From2023-01-012023-12-31_us-gaap_IPOMember"
      decimals="INF"
      id="Fact000974"
      unitRef="Pure">0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate>
    <us-gaap:PreferredStockTextBlock contextRef="From2023-01-012023-12-31" id="Fact000976">&lt;p id="xdx_80E_eus-gaap--PreferredStockTextBlock_zq5XTcnSoNye" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Note
9. &lt;span id="xdx_82F_zUyqR4qiiuod"&gt;Preferred Stock&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;In
February 2018, the Company Board of Directors issued one share of Series A Preferred Stock to Alan Blackman, the Company&#x2019;s co-founder
and Director. The Series A Preferred Stock entitles the holder to vote on any matters related to the election of directors and was reduced
from &lt;span id="xdx_90F_eus-gaap--EquityMethodInvestmentOwnershipPercentage_iI_pid_dp_uPure_c20221231__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesAPreferredStockMember__srt--TitleOfIndividualAxis__srt--DirectorMember__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--AlanBlackmanMember_zR88SUr4h0z3" title="Ownership interest percentage"&gt;50.1&lt;/span&gt;% at December 31, 2022 to &lt;span id="xdx_90B_eus-gaap--EquityMethodInvestmentOwnershipPercentage_iI_pid_dp_uPure_c20221231__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesAPreferredStockMember__srt--TitleOfIndividualAxis__srt--DirectorMember__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--IPOMember__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--AlanBlackmanMember_zAtWfzVnO1Xb" title="Ownership interest percentage"&gt;29.5&lt;/span&gt;%, effective with the IPO. The Series A Preferred Stock has no right to dividends, or distributions
in the event of a liquidation and is not convertible into common stock. In the event the Company is sold during the two-year period following
completion of IPO at a price per share of more than 500% of the initial offering price per Unit in the IPO, the Series A Preferred Stock,
as in effect upon completion of the IPO, will entitle the holder to &lt;span id="xdx_90A_eus-gaap--EquityMethodInvestmentOwnershipPercentage_iI_pid_dp_uPure_c20180228__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesAPreferredStockMember__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--IPOMember__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--AlanBlackmanMember_z6r901oEkGc5" title="Ownership interest percentage"&gt;10&lt;/span&gt;% of the total purchase price. (See Note 15)&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

</us-gaap:PreferredStockTextBlock>
    <us-gaap:EquityMethodInvestmentOwnershipPercentage
      contextRef="AsOf2022-12-31_us-gaap_SeriesAPreferredStockMember_srt_DirectorMember_custom_AlanBlackmanMember"
      decimals="INF"
      id="Fact000978"
      unitRef="Pure">0.501</us-gaap:EquityMethodInvestmentOwnershipPercentage>
    <us-gaap:EquityMethodInvestmentOwnershipPercentage
      contextRef="AsOf2022-12-31_us-gaap_SeriesAPreferredStockMember_srt_DirectorMember_us-gaap_IPOMember_custom_AlanBlackmanMember"
      decimals="INF"
      id="Fact000980"
      unitRef="Pure">0.295</us-gaap:EquityMethodInvestmentOwnershipPercentage>
    <us-gaap:EquityMethodInvestmentOwnershipPercentage
      contextRef="AsOf2018-02-28_us-gaap_SeriesAPreferredStockMember_us-gaap_IPOMember_custom_AlanBlackmanMember"
      decimals="INF"
      id="Fact000982"
      unitRef="Pure">0.10</us-gaap:EquityMethodInvestmentOwnershipPercentage>
    <STSS:WarrantLiabilityTextBlock contextRef="From2023-01-012023-12-31" id="Fact000984">&lt;p id="xdx_80A_ecustom--WarrantLiabilityTextBlock_zW1LKxolH2c1" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Note
10. &lt;span id="xdx_82F_zOgOpLFNfquk"&gt;Warrant Liability&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Warrants were accounted for as liabilities in accordance with ASC 815-40 and are presented as a Warrant liability in the accompanying
consolidated balance sheet. The warrant liabilities are measured at fair value at inception and on a recurring basis, with changes in
fair value presented within the consolidated statement of operations, The non-trading warrants, related to the February 2023 and September
2023 offerings, are valued using the Black-Scholes pricing model. The assumptions for the year ended December 31, 2023 were as follows:
(See Notes 7 and 8)&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_898_eus-gaap--ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock_hus-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_z5jnmmRnTLx7" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_8B8_z3F43eQIYzn" style="display: none"&gt;Schedule
of Fair Value of Warrant&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 80%"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: center"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;p style="margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;b&gt;Year Ended
                                            &lt;br/&gt; December 31,&lt;/b&gt;&lt;/p&gt;
                                                                                &lt;p style="margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;b&gt;2023&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;Expected term (years)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_901_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_dtY_c20230101__20231231__srt--RangeAxis__srt--MinimumMember__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_zhDHBPzmJXlj" title="Expected term (in years)"&gt;4.10&lt;/span&gt; to &lt;span id="xdx_90E_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_dtY_c20230101__20231231__srt--RangeAxis__srt--MaximumMember__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_ziMLFjAReNCe" title="Expected term (in years)"&gt;5.50&lt;/span&gt; &lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;Expected volatility&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_903_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_dp_c20230101__20231231__srt--RangeAxis__srt--MinimumMember__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_zs6weAVJO24l" title="Expected volatility"&gt;45.30&lt;/span&gt;% to &lt;span id="xdx_908_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_dp_c20230101__20231231__srt--RangeAxis__srt--MaximumMember__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_zOF8yLPihQW5" title="Expected volatility"&gt;70.44&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;Risk-free interest rate&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_90F_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_dp_c20230101__20231231__srt--RangeAxis__srt--MinimumMember__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_zdXzuXI8kas6" title="Risk-free interest rate"&gt;3.53&lt;/span&gt;% to &lt;span id="xdx_908_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_dp_c20230101__20231231__srt--RangeAxis__srt--MaximumMember__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_ztxtPZ02OBVg" title="Risk-free interest rate"&gt;4.54&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="width: 74%; text-align: left"&gt;Dividend rate&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 22%; text-align: right"&gt;&lt;span id="xdx_909_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_dp_c20230101__20231231__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_zUjhAz4fKS7" title="Risk-free interest rate"&gt;0&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;%&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p id="xdx_8A6_zbvjlzTzd3eg" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_89C_ecustom--ScheduleOfWarrantLiabilityTableTextBlock_zofZl5BvTDx9" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Warrant liability at December 31, 2023 and 2022 was as follows:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;span id="xdx_8B1_zuJdiIA68dbg" style="display: none"&gt;Schedule
of Warrant Liability&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 60%"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_49B_20231231_z2NFHWe8Bhh1" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;2023&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_499_20221231_zOWC0nsZdO0d" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;2022&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_404_ecustom--WarrantLiability_iI_hus-gaap--SubsidiarySaleOfStockAxis__custom--TradingAndOverallotmentWarrantsMember_zRBDDKBQ78E7" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 60%; text-align: left"&gt;Trading and Overallotment Warrants&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 16%; text-align: right"&gt;1,121,250&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 16%; text-align: right"&gt;1,121,250&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40D_ecustom--WarrantLiability_iI_hus-gaap--SubsidiarySaleOfStockAxis__custom--NoteWarrantsMember_zYT4PuI8bfC9" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-bottom: 1pt"&gt;Note Warrants&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;30,588&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;30,588&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_407_ecustom--WarrantLiability_iI_hus-gaap--SubsidiarySaleOfStockAxis__custom--OfferingWarrantsFebruaryTwentyTwentyThreeMember_z1ffBxrNWm7k" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-bottom: 1pt"&gt;Offering Warrants &#x2013; February 2023&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;234,072&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1011"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40B_ecustom--WarrantLiability_iI_hus-gaap--SubsidiarySaleOfStockAxis__custom--OfferingWarrantsSeptemberTwentyTwentyThreeMember_zhnUtscNzZ2f" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-bottom: 1pt"&gt;Offering Warrants &#x2013; September 2023&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;1,036,875&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1014"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40A_ecustom--WarrantLiability_iI_zzc2JuUB9pr4" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-bottom: 2.5pt"&gt;Total Warrant Liability&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;2,422,785&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;1,151,838&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p id="xdx_8A4_zXdObG8qHmXi" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_89E_eus-gaap--ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock_z9SZsrKLqWS" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Warrants outstanding at December 31, 2023 and 2022 were as follows:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;span id="xdx_8B8_zbnpCBFP3bg4" style="display: none"&gt;Schedule
of Warrant Outstanding&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 80%"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="padding-bottom: 1pt; text-align: center"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: center"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_49A_20231231_zI5p3KsKabhh" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;p style="margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;b&gt;December
                                            31,&lt;/b&gt;&lt;/p&gt;
                                                                                &lt;p style="margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;b&gt;2023&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: center"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: center"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_496_20221231_zDuN70vGQSm4" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;p style="margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;b&gt;December
                                            31,&lt;/b&gt;&lt;/p&gt;
                                                                                &lt;p style="margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;b&gt;2022&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: center"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40D_eus-gaap--ClassOfWarrantOrRightOutstanding_iI_hus-gaap--SubsidiarySaleOfStockAxis__custom--TradingAndOverallotmentWarrantsMember_zSPQoDjVh74j" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 56%; text-align: left"&gt;Trading and Overallotment Warrants&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 18%; text-align: right"&gt;8,812,500&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 18%; text-align: right"&gt;8,812,500&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_400_eus-gaap--ClassOfWarrantOrRightOutstanding_iI_hus-gaap--SubsidiarySaleOfStockAxis__custom--NoteWarrantsMember_zo7OgdO4fGx1" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-bottom: 1pt"&gt;Note Warrants&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;235,294&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;235,294&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_400_eus-gaap--ClassOfWarrantOrRightOutstanding_iI_hus-gaap--SubsidiarySaleOfStockAxis__custom--OfferingWarrantsFebruaryTwentyTwentyThreeMember_zHoUIa6rrep2" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-bottom: 1pt"&gt;Offering Warrants &#x2013; February 2023&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;2,248,521&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;p style="margin: 0"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1028"&gt;-&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40E_eus-gaap--ClassOfWarrantOrRightOutstanding_iI_hus-gaap--SubsidiarySaleOfStockAxis__custom--OfferingWarrantsSeptemberTwentyTwentyThreeMember_zlCPbJattfxl" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-bottom: 1pt"&gt;Offering Warrants &#x2013; September 2023&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;8,750,003&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;p style="margin: 0"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1031"&gt;-&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40D_eus-gaap--ClassOfWarrantOrRightOutstanding_iI_hus-gaap--SubsidiarySaleOfStockAxis__custom--WarrantsIssuedForServiceManagementMember_zeaGnV6KO535" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-bottom: 1pt"&gt;Warrants issued for services arrangement&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;495,000&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1034"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_402_eus-gaap--ClassOfWarrantOrRightOutstanding_iI_zTXE7CeC9Zqd" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-bottom: 2.5pt"&gt;Total Warrants Outstanding&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;20,541,318&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;9,047,794&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p id="xdx_8A1_zHYTMlWynilh" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;




&lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;SHARPS
TECHNOLOGY, INC.&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;NOTES
TO THE CONSOLIDATED FINANCIAL STATEMENTS&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;FOR
THE YEARS ENDED DECEMBER 31, 2023 AND 2022&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Note
10. Warrant Liability (continued)&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;For
the years ended December 31, 2023 and 2022 the FMV loss (gain) adjustment, which is reflected in the FMV adjustment on Warrants in the
Consolidated Statements of Operations was ($&lt;span id="xdx_90D_eus-gaap--MarketRiskBenefitChangeInFairValueGainLoss_c20230101__20231231_zHXdAWQi0xDa" title="Fair market value adjustment"&gt;169,583&lt;/span&gt;) and ($&lt;span id="xdx_905_eus-gaap--MarketRiskBenefitChangeInFairValueGainLoss_c20220101__20221231_zcmjOxeaHFV2" title="Fair market value adjustment"&gt;4,784,559&lt;/span&gt;), respectively.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

</STSS:WarrantLiabilityTextBlock>
    <us-gaap:ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock
      contextRef="From2023-01-012023-12-31_us-gaap_WarrantMember"
      id="Fact000986">&lt;p id="xdx_898_eus-gaap--ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock_hus-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_z5jnmmRnTLx7" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_8B8_z3F43eQIYzn" style="display: none"&gt;Schedule
of Fair Value of Warrant&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 80%"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: center"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;p style="margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;b&gt;Year Ended
                                            &lt;br/&gt; December 31,&lt;/b&gt;&lt;/p&gt;
                                                                                &lt;p style="margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;b&gt;2023&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;Expected term (years)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_901_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_dtY_c20230101__20231231__srt--RangeAxis__srt--MinimumMember__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_zhDHBPzmJXlj" title="Expected term (in years)"&gt;4.10&lt;/span&gt; to &lt;span id="xdx_90E_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_dtY_c20230101__20231231__srt--RangeAxis__srt--MaximumMember__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_ziMLFjAReNCe" title="Expected term (in years)"&gt;5.50&lt;/span&gt; &lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;Expected volatility&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_903_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_dp_c20230101__20231231__srt--RangeAxis__srt--MinimumMember__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_zs6weAVJO24l" title="Expected volatility"&gt;45.30&lt;/span&gt;% to &lt;span id="xdx_908_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_dp_c20230101__20231231__srt--RangeAxis__srt--MaximumMember__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_zOF8yLPihQW5" title="Expected volatility"&gt;70.44&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;Risk-free interest rate&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_90F_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_dp_c20230101__20231231__srt--RangeAxis__srt--MinimumMember__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_zdXzuXI8kas6" title="Risk-free interest rate"&gt;3.53&lt;/span&gt;% to &lt;span id="xdx_908_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_dp_c20230101__20231231__srt--RangeAxis__srt--MaximumMember__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_ztxtPZ02OBVg" title="Risk-free interest rate"&gt;4.54&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="width: 74%; text-align: left"&gt;Dividend rate&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 22%; text-align: right"&gt;&lt;span id="xdx_909_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_dp_c20230101__20231231__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_zUjhAz4fKS7" title="Risk-free interest rate"&gt;0&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;%&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

</us-gaap:ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
      contextRef="From2023-01-012023-12-31_srt_MinimumMember_us-gaap_WarrantMember"
      id="Fact000988">P4Y1M6D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
      contextRef="From2023-01-012023-12-31_srt_MaximumMember_us-gaap_WarrantMember"
      id="Fact000990">P5Y6M</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
      contextRef="From2023-01-012023-12-31_srt_MinimumMember_us-gaap_WarrantMember"
      decimals="INF"
      id="Fact000992"
      unitRef="Pure">0.4530</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
      contextRef="From2023-01-012023-12-31_srt_MaximumMember_us-gaap_WarrantMember"
      decimals="INF"
      id="Fact000994"
      unitRef="Pure">0.7044</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
      contextRef="From2023-01-012023-12-31_srt_MinimumMember_us-gaap_WarrantMember"
      decimals="INF"
      id="Fact000996"
      unitRef="Pure">0.0353</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
      contextRef="From2023-01-012023-12-31_srt_MaximumMember_us-gaap_WarrantMember"
      decimals="INF"
      id="Fact000998"
      unitRef="Pure">0.0454</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
      contextRef="From2023-01-012023-12-31_us-gaap_WarrantMember"
      decimals="INF"
      id="Fact001000"
      unitRef="Pure">0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate>
    <STSS:ScheduleOfWarrantLiabilityTableTextBlock contextRef="From2023-01-012023-12-31" id="Fact001002">&lt;p id="xdx_89C_ecustom--ScheduleOfWarrantLiabilityTableTextBlock_zofZl5BvTDx9" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Warrant liability at December 31, 2023 and 2022 was as follows:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;span id="xdx_8B1_zuJdiIA68dbg" style="display: none"&gt;Schedule
of Warrant Liability&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 60%"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_49B_20231231_z2NFHWe8Bhh1" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;2023&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_499_20221231_zOWC0nsZdO0d" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;2022&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_404_ecustom--WarrantLiability_iI_hus-gaap--SubsidiarySaleOfStockAxis__custom--TradingAndOverallotmentWarrantsMember_zRBDDKBQ78E7" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 60%; text-align: left"&gt;Trading and Overallotment Warrants&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 16%; text-align: right"&gt;1,121,250&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 16%; text-align: right"&gt;1,121,250&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40D_ecustom--WarrantLiability_iI_hus-gaap--SubsidiarySaleOfStockAxis__custom--NoteWarrantsMember_zYT4PuI8bfC9" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-bottom: 1pt"&gt;Note Warrants&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;30,588&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;30,588&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_407_ecustom--WarrantLiability_iI_hus-gaap--SubsidiarySaleOfStockAxis__custom--OfferingWarrantsFebruaryTwentyTwentyThreeMember_z1ffBxrNWm7k" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-bottom: 1pt"&gt;Offering Warrants &#x2013; February 2023&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;234,072&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1011"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40B_ecustom--WarrantLiability_iI_hus-gaap--SubsidiarySaleOfStockAxis__custom--OfferingWarrantsSeptemberTwentyTwentyThreeMember_zhnUtscNzZ2f" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-bottom: 1pt"&gt;Offering Warrants &#x2013; September 2023&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;1,036,875&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1014"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40A_ecustom--WarrantLiability_iI_zzc2JuUB9pr4" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-bottom: 2.5pt"&gt;Total Warrant Liability&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;2,422,785&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;1,151,838&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

</STSS:ScheduleOfWarrantLiabilityTableTextBlock>
    <STSS:WarrantLiability
      contextRef="AsOf2023-12-31_custom_TradingAndOverallotmentWarrantsMember"
      decimals="0"
      id="Fact001004"
      unitRef="USD">1121250</STSS:WarrantLiability>
    <STSS:WarrantLiability
      contextRef="AsOf2022-12-31_custom_TradingAndOverallotmentWarrantsMember"
      decimals="0"
      id="Fact001005"
      unitRef="USD">1121250</STSS:WarrantLiability>
    <STSS:WarrantLiability
      contextRef="AsOf2023-12-31_custom_NoteWarrantsMember"
      decimals="0"
      id="Fact001007"
      unitRef="USD">30588</STSS:WarrantLiability>
    <STSS:WarrantLiability
      contextRef="AsOf2022-12-31_custom_NoteWarrantsMember"
      decimals="0"
      id="Fact001008"
      unitRef="USD">30588</STSS:WarrantLiability>
    <STSS:WarrantLiability
      contextRef="AsOf2023-12-31_custom_OfferingWarrantsFebruaryTwentyTwentyThreeMember"
      decimals="0"
      id="Fact001010"
      unitRef="USD">234072</STSS:WarrantLiability>
    <STSS:WarrantLiability
      contextRef="AsOf2023-12-31_custom_OfferingWarrantsSeptemberTwentyTwentyThreeMember"
      decimals="0"
      id="Fact001013"
      unitRef="USD">1036875</STSS:WarrantLiability>
    <STSS:WarrantLiability
      contextRef="AsOf2023-12-31"
      decimals="0"
      id="Fact001016"
      unitRef="USD">2422785</STSS:WarrantLiability>
    <STSS:WarrantLiability
      contextRef="AsOf2022-12-31"
      decimals="0"
      id="Fact001017"
      unitRef="USD">1151838</STSS:WarrantLiability>
    <us-gaap:ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock contextRef="From2023-01-012023-12-31" id="Fact001019">&lt;p id="xdx_89E_eus-gaap--ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock_z9SZsrKLqWS" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Warrants outstanding at December 31, 2023 and 2022 were as follows:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;span id="xdx_8B8_zbnpCBFP3bg4" style="display: none"&gt;Schedule
of Warrant Outstanding&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 80%"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="padding-bottom: 1pt; text-align: center"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: center"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_49A_20231231_zI5p3KsKabhh" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;p style="margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;b&gt;December
                                            31,&lt;/b&gt;&lt;/p&gt;
                                                                                &lt;p style="margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;b&gt;2023&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: center"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: center"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_496_20221231_zDuN70vGQSm4" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;p style="margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;b&gt;December
                                            31,&lt;/b&gt;&lt;/p&gt;
                                                                                &lt;p style="margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;b&gt;2022&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: center"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40D_eus-gaap--ClassOfWarrantOrRightOutstanding_iI_hus-gaap--SubsidiarySaleOfStockAxis__custom--TradingAndOverallotmentWarrantsMember_zSPQoDjVh74j" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 56%; text-align: left"&gt;Trading and Overallotment Warrants&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 18%; text-align: right"&gt;8,812,500&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 18%; text-align: right"&gt;8,812,500&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_400_eus-gaap--ClassOfWarrantOrRightOutstanding_iI_hus-gaap--SubsidiarySaleOfStockAxis__custom--NoteWarrantsMember_zo7OgdO4fGx1" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-bottom: 1pt"&gt;Note Warrants&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;235,294&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;235,294&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_400_eus-gaap--ClassOfWarrantOrRightOutstanding_iI_hus-gaap--SubsidiarySaleOfStockAxis__custom--OfferingWarrantsFebruaryTwentyTwentyThreeMember_zHoUIa6rrep2" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-bottom: 1pt"&gt;Offering Warrants &#x2013; February 2023&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;2,248,521&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;p style="margin: 0"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1028"&gt;-&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40E_eus-gaap--ClassOfWarrantOrRightOutstanding_iI_hus-gaap--SubsidiarySaleOfStockAxis__custom--OfferingWarrantsSeptemberTwentyTwentyThreeMember_zlCPbJattfxl" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-bottom: 1pt"&gt;Offering Warrants &#x2013; September 2023&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;8,750,003&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;p style="margin: 0"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1031"&gt;-&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40D_eus-gaap--ClassOfWarrantOrRightOutstanding_iI_hus-gaap--SubsidiarySaleOfStockAxis__custom--WarrantsIssuedForServiceManagementMember_zeaGnV6KO535" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-bottom: 1pt"&gt;Warrants issued for services arrangement&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;495,000&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1034"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_402_eus-gaap--ClassOfWarrantOrRightOutstanding_iI_zTXE7CeC9Zqd" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-bottom: 2.5pt"&gt;Total Warrants Outstanding&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;20,541,318&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;9,047,794&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

</us-gaap:ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock>
    <us-gaap:ClassOfWarrantOrRightOutstanding
      contextRef="AsOf2023-12-31_custom_TradingAndOverallotmentWarrantsMember"
      decimals="INF"
      id="Fact001021"
      unitRef="Shares">8812500</us-gaap:ClassOfWarrantOrRightOutstanding>
    <us-gaap:ClassOfWarrantOrRightOutstanding
      contextRef="AsOf2022-12-31_custom_TradingAndOverallotmentWarrantsMember"
      decimals="INF"
      id="Fact001022"
      unitRef="Shares">8812500</us-gaap:ClassOfWarrantOrRightOutstanding>
    <us-gaap:ClassOfWarrantOrRightOutstanding
      contextRef="AsOf2023-12-31_custom_NoteWarrantsMember"
      decimals="INF"
      id="Fact001024"
      unitRef="Shares">235294</us-gaap:ClassOfWarrantOrRightOutstanding>
    <us-gaap:ClassOfWarrantOrRightOutstanding
      contextRef="AsOf2022-12-31_custom_NoteWarrantsMember"
      decimals="INF"
      id="Fact001025"
      unitRef="Shares">235294</us-gaap:ClassOfWarrantOrRightOutstanding>
    <us-gaap:ClassOfWarrantOrRightOutstanding
      contextRef="AsOf2023-12-31_custom_OfferingWarrantsFebruaryTwentyTwentyThreeMember"
      decimals="INF"
      id="Fact001027"
      unitRef="Shares">2248521</us-gaap:ClassOfWarrantOrRightOutstanding>
    <us-gaap:ClassOfWarrantOrRightOutstanding
      contextRef="AsOf2023-12-31_custom_OfferingWarrantsSeptemberTwentyTwentyThreeMember"
      decimals="INF"
      id="Fact001030"
      unitRef="Shares">8750003</us-gaap:ClassOfWarrantOrRightOutstanding>
    <us-gaap:ClassOfWarrantOrRightOutstanding
      contextRef="AsOf2023-12-31_custom_WarrantsIssuedForServiceManagementMember"
      decimals="INF"
      id="Fact001033"
      unitRef="Shares">495000</us-gaap:ClassOfWarrantOrRightOutstanding>
    <us-gaap:ClassOfWarrantOrRightOutstanding
      contextRef="AsOf2023-12-31"
      decimals="INF"
      id="Fact001036"
      unitRef="Shares">20541318</us-gaap:ClassOfWarrantOrRightOutstanding>
    <us-gaap:ClassOfWarrantOrRightOutstanding
      contextRef="AsOf2022-12-31"
      decimals="INF"
      id="Fact001037"
      unitRef="Shares">9047794</us-gaap:ClassOfWarrantOrRightOutstanding>
    <us-gaap:MarketRiskBenefitChangeInFairValueGainLoss
      contextRef="From2023-01-012023-12-31"
      decimals="0"
      id="Fact001039"
      unitRef="USD">169583</us-gaap:MarketRiskBenefitChangeInFairValueGainLoss>
    <us-gaap:MarketRiskBenefitChangeInFairValueGainLoss
      contextRef="From2022-01-012022-12-31"
      decimals="0"
      id="Fact001041"
      unitRef="USD">4784559</us-gaap:MarketRiskBenefitChangeInFairValueGainLoss>
    <us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock contextRef="From2023-01-012023-12-31" id="Fact001043">&lt;p id="xdx_804_eus-gaap--DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock_zpi01Ls8aMjh" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Note
11. &lt;span id="xdx_82E_zQMlDZUjgcRe"&gt;Stock Options&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;On January 24, 2023, the Company&#x2019;s Board of Directors initially adopted the 2023 Equity Incentive Plan (the
&#x201c;2023 Plan&#x201d;), to provide for the issuance of up to &lt;span id="xdx_900_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_iI_c20230124__us-gaap--PlanNameAxis__custom--TwoThousandTwentyThreeEquityIncentivePlanMember_zI2Q6ZbymiB8" title="Stock available for issuance"&gt;1,400,000&lt;/span&gt; options and/or shares of restricted stock be available for issuance
to officers, directors, employees and consultants. The 2023 Plan was subsequently updated to provide for the issuance of up to &lt;span id="xdx_907_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod_c20230124__20230124__us-gaap--PlanNameAxis__custom--TwoThousandTwentyThreeEquityIncentivePlanMember_zUGy6rwkFzI5" title="Number of stock issuance"&gt;3,500,000&lt;/span&gt;
options and/or shares of restricted stock. The 2023 Plan was approved by shareholders at the annual meeting&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_894_eus-gaap--ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock_zxjRdzkmrjJa" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;A
summary of options granted and outstanding is presented below.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;span id="xdx_8B2_zh8qQm1k4QP7" style="display: none"&gt;Schedule
of Stock Options Granted and Outstanding&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="6" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;2023&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="6" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;2022&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;Options&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;Weighted&lt;br/&gt; Average&lt;br/&gt; Exercise &lt;br/&gt; Price&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;Options&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;Weighted&lt;br/&gt; Average&lt;br/&gt; Exercise &lt;br/&gt; Price&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 40%; text-align: left"&gt;Outstanding at Beginning of year&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_987_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionOutstandingNumber_iS_c20230101__20231231_zaUwzULDb3Bc" style="width: 11%; text-align: right" title="Stock option, beginning balance"&gt;1,358,122&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_987_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionOutstandingWeightedAverageExercisePrice_iS_c20230101__20231231_zNXsc1vFalU7" style="width: 11%; text-align: right" title="Weighted average exercise price, beginning balance"&gt;4.37&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_989_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iS_c20220101__20221231_zEpeaR5DmrI5" style="width: 11%; text-align: right" title="Stock option, beginning balance"&gt;1,137,479&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98D_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iS_c20220101__20221231_zslpPQdBI7th" style="width: 11%; text-align: right" title="Weighted average exercise price, beginning balance"&gt;5.18&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td&gt;Granted&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98B_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_c20230101__20231231_zjX1ZZxE5XLc" style="text-align: right" title="Shares, options granted"&gt;1,065,000&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_982_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_c20230101__20231231_z8uZ9XHkfcRh" style="text-align: right" title="Weighted average exercise price, options granted"&gt;1.35&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98D_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_c20220101__20221231_zh8BO9bo09Ll" style="text-align: right" title="Shares, options granted"&gt;367,500&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_989_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_c20220101__20221231_zdMAoRskatQ6" style="text-align: right" title="Weighted average exercise price, options granted"&gt;1.63&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td&gt;Cancelled&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_987_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod_iN_di_c20220101__20221231_zrwqbIejKl79" style="text-align: right" title="Shares, options cancelled"&gt;(3,571&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_989_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice_iN_di_c20220101__20221231_zdkd51rjznaf" style="text-align: right" title="Weighted average exercise price, options cancelled"&gt;(4.38&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-bottom: 1pt"&gt;Forfeited&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98A_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedNumberOfShares_iN_di_c20230101__20231231_zxzNhmrWXAq7" style="border-bottom: Black 1pt solid; text-align: right" title="Shares, options forfeited"&gt;(14,286&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_984_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice_c20230101__20231231_zHLduwboIknd" style="border-bottom: Black 1pt solid; text-align: right" title="Weighted average exercise price, options forfeited"&gt;1.75&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98E_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_iN_di_c20220101__20221231_zjHSUDyUObu4" style="border-bottom: Black 1pt solid; text-align: right" title="Shares, options forfeited"&gt;(143,286&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98F_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice_iN_di_c20220101__20221231_zcid2FMo7Tpa" style="border-bottom: Black 1pt solid; text-align: right" title="Weighted average exercise price, options forfeited"&gt;(3.77&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-bottom: 2.5pt"&gt;Outstanding at end of year&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_987_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionOutstandingNumber_iE_c20230101__20231231_zEch1ZGM8U6k" style="border-bottom: Black 2.5pt double; text-align: right" title="Stock option, ending balance"&gt;2,408,836&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_981_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionOutstandingWeightedAverageExercisePrice_iE_c20230101__20231231_z6ygFRMgPhS" style="border-bottom: Black 2.5pt double; text-align: right" title="Weighted average exercise price, ending balance"&gt;3.03&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98C_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iE_c20220101__20221231_zwehlMRbwH5g" style="border-bottom: Black 2.5pt double; text-align: right" title="Stock option, ending balance"&gt;1,358,122&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_982_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iE_c20220101__20221231_zzRFa28LDX26" style="border-bottom: Black 2.5pt double; text-align: right" title="Weighted average exercise price, ending balance"&gt;4.37&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-bottom: 2.5pt"&gt;Exercisable at end of year&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_986_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_iE_c20230101__20231231_zKGeCfCEswbd" style="border-bottom: Black 2.5pt double; text-align: right" title="Stock option, exercisable"&gt;1,881,327&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_982_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_iE_c20230101__20231231_zG3VY1yrDYC1" style="border-bottom: Black 2.5pt double; text-align: right" title="Weighted average exercise price, exercisable"&gt;3.47&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98E_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_iE_c20220101__20221231_zozaY861CnVe" style="border-bottom: Black 2.5pt double; text-align: right" title="Stock option, exercisable"&gt;1,132,861&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98D_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_iE_c20220101__20221231_z7ewT5InYWcj" style="border-bottom: Black 2.5pt double; text-align: right" title="Weighted average exercise price, exercisable"&gt;4.59&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p id="xdx_8A7_zOV7srWKoCB7" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;1)&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="3"&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;During the year ended December 31, 2023, the Company granted &lt;span id="xdx_903_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_dxL_c20230101__20231231__us-gaap--PlanNameAxis__custom--TwoThousandTwentyThreeEquityIncentivePlanMember_zPsIffusXqn1" title="Expected term::XDX::P5Y"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1095"&gt;five&lt;/span&gt;&lt;/span&gt;-year options (the &#x201c;Options&#x201d;) to purchase a total of:&lt;/span&gt;&lt;/p&gt;

&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="3"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 0.25in"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;a)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_906_eus-gaap--StockIssuedDuringPeriodSharesShareBasedCompensation_c20230101__20231231__us-gaap--PlanNameAxis__custom--TwoThousandTwentyThreeEquityIncentivePlanMember_zSLNgQzsbhQh" title="Purchase of total shares"&gt;975,000&lt;/span&gt;
    shares of the Company&#x2019;s common stock, par value $&lt;span id="xdx_90E_eus-gaap--CommonStockParOrStatedValuePerShare_iI_c20231231__us-gaap--PlanNameAxis__custom--TwoThousandTwentyThreeEquityIncentivePlanMember_zCgflDU6YbHa" title="Common stock, par value"&gt;0.0001&lt;/span&gt; per share (the &#x201c;Common Stock&#x201d;) to its directors, executive
    officers, employees and consultants pursuant to the Company&#x2019;s. 2022 and 2023 Equity Incentive Plans. The Options are exercisable
    at $&lt;span id="xdx_90E_ecustom--ShareBasedCompensationOptionsExercisableWeightedAverageExercisePrice_iI_c20231231__us-gaap--PlanNameAxis__custom--TwoThousandTwentyThreeEquityIncentivePlanMember_zFk0jOxv1Ri7" title="Options exercisable"&gt;1.37 &lt;/span&gt;per share which was the closing price on January 25, 2023.&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;b)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_90D_eus-gaap--StockIssuedDuringPeriodSharesShareBasedCompensation_c20230101__20231231__srt--TitleOfIndividualAxis__custom--EmployeesAndConsultantMember_zD1rIgmh3Yt1" title="Purchase of shares"&gt;90,000&lt;/span&gt;
    shares of the Company&#x2019;s Common Stock in connection with an employment or consulting agreements at the exercise price, representing
    the closing price on the grant date ranging from $&lt;span id="xdx_901_ecustom--ShareBasedCompensationOptionsExercisableWeightedAverageExercisePrice_iI_c20231231__srt--TitleOfIndividualAxis__custom--EmployeesAndConsultantMember__srt--RangeAxis__srt--MinimumMember_zAOt7mgEYNef" title="Options exercisable"&gt;0.82&lt;/span&gt; to $&lt;span id="xdx_900_ecustom--ShareBasedCompensationOptionsExercisableWeightedAverageExercisePrice_iI_c20231231__srt--TitleOfIndividualAxis__custom--EmployeesAndConsultantMember__srt--RangeAxis__srt--MaximumMember_zjeNUVus5YQ4" title="Options exercisable"&gt;1.30&lt;/span&gt;.&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="3" style="text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;During the year ended December 31, 2023, &lt;span id="xdx_90F_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_c20230101__20231231__us-gaap--PlanNameAxis__custom--TwoThousandTwentyThreeEquityIncentivePlanMember_zVxSy9wppG3h" title="Shares, options granted"&gt;660,000&lt;/span&gt; Options have been granted under the 2023 Equity Incentive Plan and the remaining &lt;span id="xdx_90C_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_c20230101__20231231__us-gaap--PlanNameAxis__custom--TwoThousandTwentyTwoEquityIncentivePlanMember_zdbKVrHFoQEh" title="Shares, options granted"&gt;405,000&lt;/span&gt; Options were issued under the 2022 Equity Incentive Plan. At December 31, 2023, &lt;span id="xdx_90C_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iI_c20231231__us-gaap--PlanNameAxis__custom--TwoThousandTwentyTwoEquityIncentivePlanMember_zJgJw3a7DfMc" title="Options outstanding"&gt;1,748,836&lt;/span&gt; Options are outstanding under the 2022 Equity Incentive Plan. &lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;
&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;During
the years ended December 31, 2023 and 2022, the estimated weighted-average grant-date fair value of options granted was $&lt;span id="xdx_901_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_pid_c20230101__20231231_zoysvO2ydjLd" title="Weighted-average grant-date fair value of options granted"&gt;.80&lt;/span&gt;
per share and $&lt;span id="xdx_907_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_pid_c20220101__20221231_zKmxekvmuGb5" title="Weighted-average grant-date fair value of options granted"&gt;1.63&lt;/span&gt;
per share, respectively. As of December 31, 2023 and 2022, there was $&lt;span id="xdx_90A_eus-gaap--EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized_iI_c20231231_zUhhSnLHdrBl" title="Unrecognized stock based compensation"&gt;498,454&lt;/span&gt;
and $&lt;span id="xdx_905_eus-gaap--EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized_iI_c20221231_zWE0SwUG2k3d" title="Unrecognized stock based compensation"&gt;475,097&lt;/span&gt;,
respectively, of unrecognized stock-based compensation related to unvested stock options with a weighted average fair value of $&lt;span id="xdx_90B_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue_iI_pid_c20231231_zoX2beRL7OB6" title="Unvested stock options weighted average fair value"&gt;.94&lt;/span&gt; and $&lt;span id="xdx_90C_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue_iI_pid_c20221231_zNaQhQeaH3Hb" title="Unvested stock options weighted average fair value"&gt;2.05&lt;/span&gt; per share, respectively, which is expected to be recognized over a
weighted-average period sixteen months as of December 31, 2023.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_896_eus-gaap--ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTextBlock_zyEjtYLsdPz3" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
following table summarizes information about options outstanding at December 31, 2023:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;span id="xdx_8B9_ztchLltpVJe3" style="display: none"&gt;Schedule
of Information About Options Outstanding&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 90%; border-collapse: collapse"&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"&gt;
    &lt;td colspan="2" style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Exercise
    &lt;br/&gt;
    Prices&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Options
    &lt;br/&gt;
    Outstanding&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Aggregate&lt;br/&gt;
    Intrinsic Value&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Weighted
    Average &lt;br/&gt;
    Remaining&lt;br/&gt;
    Contractual Life&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Options
    &lt;br/&gt;
    Exercisable&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif"&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Aggregate&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;
    &lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Intrinsic
    Value&lt;br/&gt;
    on Exercisable&lt;br/&gt;
    Shares&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"&gt;
    &lt;td colspan="2" style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 12%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_903_eus-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit_c20230101__20231231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeOneMember__srt--RangeAxis__srt--MinimumMember_zBCE1r4eLcAe" title="Stock option, exercise price"&gt;.82&lt;/span&gt; to &lt;span id="xdx_90E_eus-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit_c20230101__20231231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeOneMember__srt--RangeAxis__srt--MaximumMember_z4MAyw806t1h" title="Stock option, exercise price"&gt;.92&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 2%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_989_eus-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions_iI_c20231231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeOneMember_zeXCfV64B6X8" style="font: 10pt Times New Roman, Times, Serif; width: 12%; text-align: right" title="Options, shares outstanding"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;40,000&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 2%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98A_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_iI_c20231231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeOneMember_zzO9XqLgXdkg" style="font: 10pt Times New Roman, Times, Serif; width: 14%; text-align: right" title="Stock option, aggregate intrinsic value"&gt;&#160;&#160;&#160;&#160;&#160;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1135"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 2%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 14%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_90A_eus-gaap--SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2_dtY_c20230101__20231231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeOneMember_z3n6ybZBvqUk" title="Stock option, weighted average remaining contractual life"&gt;4.58&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 2%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98F_eus-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions_iI_c20231231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeOneMember_zVb4oEeNxaec" style="font: 10pt Times New Roman, Times, Serif; width: 12%; text-align: right" title="Options, shares exercisable"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;18,794&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 2%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_980_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1_iI_c20231231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeOneMember_zb0A1ijPx8A" style="font: 10pt Times New Roman, Times, Serif; width: 14%; text-align: right" title="Stock option, aggregate intrinsic value on exercisable shares"&gt;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1141"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_907_eus-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit_c20230101__20231231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeTwoMember_zxQgIHiwv0Ld" title="Stock option, exercise price"&gt;1.21&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98F_eus-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions_iI_c20231231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeTwoMember_zQrISQLiHbs9" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Options, shares outstanding"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;307,500&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_989_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_iI_c20231231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeTwoMember_z97JRxHuAKD4" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Stock option, aggregate intrinsic value"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1147"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_908_eus-gaap--SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2_dtY_c20230101__20231231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeTwoMember_zj2yoK181UGi" title="Stock option, weighted average remaining contractual life"&gt;3.42&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98D_eus-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions_iI_c20231231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeTwoMember_zATG1bSK1wc" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Options, shares exercisable"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;240,386&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98A_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1_iI_c20231231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeTwoMember_zxoxvZBfRNf6" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Stock option, aggregate intrinsic value on exercisable shares"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1153"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_903_eus-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit_c20230101__20231231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeThreeMember_zJbONXr9NGce" title="Stock option, exercise price"&gt;1.30&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_984_eus-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions_iI_c20231231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeThreeMember_zsdLopjx0gdf" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Options, shares outstanding"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;50,000&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_983_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_iI_c20231231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeThreeMember_zfhQwORB1ved" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Stock option, aggregate intrinsic value"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1159"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_903_eus-gaap--SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2_dtY_c20230101__20231231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeThreeMember_zEjbzr5a5Ubd" title="Stock option, weighted average remaining contractual life"&gt;4.21&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_988_eus-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions_iI_c20231231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeThreeMember_zAb9C5wh3HWd" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Options, shares exercisable"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;43,750&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98C_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1_iI_c20231231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeThreeMember_zKIzzXyAHRre" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Stock option, aggregate intrinsic value on exercisable shares"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1165"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_902_eus-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit_c20230101__20231231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeFourMember_zcNnTjlC5kDk" title="Stock option, exercise price"&gt;1.37&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_986_eus-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions_iI_c20231231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeFourMember_zjZBlmx33Pla" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Options, shares outstanding"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;975,000&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_984_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_iI_c20231231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeFourMember_zPmnrEYyYZD" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Stock option, aggregate intrinsic value"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1171"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_90A_eus-gaap--SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2_dtY_c20230101__20231231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeFourMember_zWykEPseBCKf" title="Stock option, weighted average remaining contractual life"&gt;4.17&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_985_eus-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions_iI_c20231231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeFourMember_zec5JlVXfHI" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Options, shares exercisable"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;561,719&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_983_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1_iI_c20231231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeFourMember_zodRTTHznA4e" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Stock option, aggregate intrinsic value on exercisable shares"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1177"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_908_eus-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit_c20230101__20231231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeFiveMember_zyIYAAlOEMPl" title="Stock option, exercise price"&gt;1.75&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_988_eus-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions_iI_c20231231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeFiveMember_zQptYFhsXte4" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Options, shares outstanding"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;54,285&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_981_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_iI_c20231231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeFiveMember_zo1fFXH87n81" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Stock option, aggregate intrinsic value"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1183"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_906_eus-gaap--SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2_dtY_c20230101__20231231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeFiveMember_zFcQNivy35Be" title="Stock option, weighted average remaining contractual life"&gt;2.25&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: right"&gt;&lt;/p&gt;
    &lt;p id="xdx_98F_eus-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions_iI_c20231231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeFiveMember_zzi5h6q58LCd" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: right" title="Options, shares exercisable"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;54,285&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_981_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1_iI_c20231231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeFiveMember_zO1AmwXzm5oc" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Stock option, aggregate intrinsic value on exercisable shares"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1189"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_90F_eus-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit_c20230101__20231231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeSixMember_zL6tgR1vlWN4" title="Stock option, exercise price"&gt;2.80&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98D_eus-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions_iI_c20231231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeSixMember_z1ijSAqahwj2" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Options, shares outstanding"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;141,429&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_988_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_iI_c20231231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeSixMember_zsYNwWzfoq9j" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Stock option, aggregate intrinsic value"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1195"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_90F_eus-gaap--SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2_dtY_c20230101__20231231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeSixMember_zsCLsRLdkKyh" title="Stock option, weighted average remaining contractual life"&gt;2.25&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98C_eus-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions_iI_c20231231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeSixMember_zsdstAMVSRJ8" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Options, shares exercisable"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;141,429&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98A_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1_iI_c20231231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeSixMember_z9tgdx3ulgGg" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Stock option, aggregate intrinsic value on exercisable shares"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1201"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_900_eus-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit_c20230101__20231231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeSevenMember_zDANi0kfYtca" title="Stock option, exercise price"&gt;1.39&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98B_eus-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions_iI_c20231231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeSevenMember_zpCZb5xXKeW4" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Options, shares outstanding"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;10,000&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_985_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_iI_c20231231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeSevenMember_zUu60m0y0Tq7" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Stock option, aggregate intrinsic value"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1207"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_903_eus-gaap--SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2_dtY_c20230101__20231231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeSevenMember_zgxXTuK5Yk09" title="Stock option, weighted average remaining contractual life"&gt;3.75&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_987_eus-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions_iI_c20231231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeSevenMember_zvlXcHh2AFB2" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Options, shares exercisable"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;10,000&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98A_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1_iI_c20231231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeSevenMember_zKme8A1lT2Le" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Stock option, aggregate intrinsic value on exercisable shares"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1213"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_906_eus-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit_c20230101__20231231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeEightMember_zIGBcB7uZsOe" title="Stock option, exercise price"&gt;4.25&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98B_eus-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions_iI_c20231231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeEightMember_zBBjbohhBN6j" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Options, shares outstanding"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;50,000&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98D_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_iI_c20231231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeEightMember_zcz5sVnxPIbc" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Stock option, aggregate intrinsic value"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1219"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_909_eus-gaap--SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2_dtY_c20230101__20231231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeEightMember_zrO1ZuGNb9R8" title="Stock option, weighted average remaining contractual life"&gt;3.75&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_989_eus-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions_iI_c20231231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeEightMember_zE2PWB9ZoCf9" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Options, shares exercisable"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;50,000&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_980_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1_iI_c20231231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeEightMember_z8KaCTDq5sw6" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Stock option, aggregate intrinsic value on exercisable shares"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1225"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_90C_eus-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit_c20230101__20231231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeNineMember_zg6IcBmTQjU3" title="Stock option, exercise price"&gt;4.38&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98C_eus-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions_iI_c20231231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeNineMember_zq47EDyJeyF1" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Options, shares outstanding"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;244,286&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_981_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_iI_c20231231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeNineMember_ziqdd7G72LNh" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Stock option, aggregate intrinsic value"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1231"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_902_eus-gaap--SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2_dtY_c20230101__20231231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeNineMember_ztN3xB6cqDx6" title="Stock option, weighted average remaining contractual life"&gt;1.25&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_981_eus-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions_iI_c20231231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeNineMember_z0Xhb2DgSedh" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Options, shares exercisable"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;244,286&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_987_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1_iI_c20231231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeNineMember_z2OxjzEZCZ4g" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Stock option, aggregate intrinsic value on exercisable shares"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1237"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_903_eus-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit_c20230101__20231231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeTenMember_z65Kidvx3JX3" title="Stock option, exercise price"&gt;7.00&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_983_eus-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions_iI_c20231231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeTenMember_zrWWgPsF0bfc" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Options, shares outstanding"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;536,335&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98C_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_iI_c20231231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeTenMember_zFvHlCXX4VM9" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Stock option, aggregate intrinsic value"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1243"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_904_eus-gaap--SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2_dtY_c20230101__20231231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeTenMember_zsSwHVvDh4Z6" title="Stock option, weighted average remaining contractual life"&gt;2.00&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_986_eus-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions_iI_c20231231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeTenMember_zEku6u3Bb35h" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Options, shares exercisable"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;516,679&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_986_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1_iI_c20231231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeTenMember_zT2dgOLkzh3" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Stock option, aggregate intrinsic value on exercisable shares"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1249"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;
&lt;p id="xdx_8A4_zXim3hru36g" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;At
December 31,2023, the stock options outstanding and the options exercisable have exercise prices that exceed the stock market price at
December 31, 2023 and as such no intrinsic value exist. Intrinsic value is defined as the difference between the exercise price of the
options and the market price of the Company&#x2019;s common stock.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;




&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;SHARPS
TECHNOLOGY, INC.&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;NOTES
TO THE CONSOLIDATED FINANCIAL STATEMENTS&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;FOR
THE YEARS ENDED DECEMBER 31, 2023 AND 2022&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Note
11. Stock Options (continued)&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;In
2023 and 2022, the Company recognized stock-based compensation expense of $&lt;span id="xdx_90D_eus-gaap--AllocatedShareBasedCompensationExpense_c20230101__20231231_zY0qg8KJESb6" title="Share based compensation"&gt;920,108&lt;/span&gt;, of which $&lt;span id="xdx_905_eus-gaap--AllocatedShareBasedCompensationExpense_c20230101__20231231__us-gaap--IncomeStatementLocationAxis__us-gaap--GeneralAndAdministrativeExpenseMember_zrQvrcNADPh5" title="Share based compensation"&gt;906,745&lt;/span&gt; and $&lt;span id="xdx_90E_eus-gaap--AllocatedShareBasedCompensationExpense_c20230101__20231231__us-gaap--IncomeStatementLocationAxis__us-gaap--ResearchAndDevelopmentExpenseMember_zSL8xRr5zLg7" title="Share based compensation"&gt;13,363&lt;/span&gt; was recorded in general
and administrative and research and development expenses, respectively and $&lt;span id="xdx_900_eus-gaap--AllocatedShareBasedCompensationExpense_c20220101__20221231_zoJQkHHv8Awa" title="Share based compensation"&gt;1,012,592&lt;/span&gt;, of which $&lt;span id="xdx_904_eus-gaap--AllocatedShareBasedCompensationExpense_c20220101__20221231__us-gaap--IncomeStatementLocationAxis__us-gaap--GeneralAndAdministrativeExpenseMember_zY2v5U3RykU3" title="Share based compensation"&gt;915,797&lt;/span&gt; and $&lt;span id="xdx_909_eus-gaap--AllocatedShareBasedCompensationExpense_c20220101__20221231__us-gaap--IncomeStatementLocationAxis__us-gaap--ResearchAndDevelopmentExpenseMember_zlKC4gc67N0f" title="Share based compensation"&gt;96,795&lt;/span&gt; was recorded in
general and administrative and research and development expenses, respectively. Further, in 2022, the Company recorded stock-based charges
of $&lt;span id="xdx_90A_ecustom--StockBasedChargesRelatingToPurchaseOfMachinery_c20220101__20221231_z3l8vRBblJ82" title="Stock based charges relating to purchase of machinery"&gt;63,612&lt;/span&gt; relating to purchase of machinery (See Note 4) and $&lt;span id="xdx_90B_ecustom--StockBasedChargesRelatingToAcquisition_c20220101__20220331_z2vCFm4wcxVb" title="Stock based charges relating to acquisition"&gt;60,435&lt;/span&gt; relating to an Acquisition. (See Note 5.)&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_897_eus-gaap--ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock_zaVNnRXOWKLh" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
fair value of stock option awards accounted for under ASC 718 was estimated at the date of grant using a Black-Scholes option-pricing
model with the following assumptions:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_8BB_zSEmShr3UWYk" style="display: none"&gt;Schedule
of Fair Value of Stock Option Awards&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 90%; border-collapse: collapse"&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&#160;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"&gt;&lt;p style="margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: imes New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Year
                                            Ended &lt;br/&gt; December 31,&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;
                                                                                &lt;p style="margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;2023&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"&gt;&lt;p style="margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: imes New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Year
                                            Ended &lt;br/&gt; December 31,&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;
                                                                                &lt;p style="margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;2022&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Expected term (years)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_905_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_dtY_c20230101__20231231__srt--RangeAxis__srt--MinimumMember_zCwKHtEdnz3" title="Expected term (years)"&gt;2.88&lt;/span&gt; to &lt;span id="xdx_90B_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_dtY_c20230101__20231231__srt--RangeAxis__srt--MaximumMember_zZsfDdolkMLj" title="Expected term (years)"&gt;3.25&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_90A_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_dtY_c20220101__20221231__srt--RangeAxis__srt--MinimumMember_zYZfHI8kOjj9" title="Expected term (years)"&gt;2.50&lt;/span&gt; to &lt;span id="xdx_903_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_dtY_c20220101__20221231__srt--RangeAxis__srt--MaximumMember_zE8ABMl1Ims5" title="Expected term (years)"&gt;3.00&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Expected volatility&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_900_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate_pid_dp_c20230101__20231231__srt--RangeAxis__srt--MinimumMember_zPnYpozJcvrf" title="Expected volatility"&gt;75.40&lt;/span&gt;% to &lt;span id="xdx_903_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate_pid_dp_c20230101__20231231__srt--RangeAxis__srt--MaximumMember_zGQCMRJibS6b" title="Expected volatility"&gt;89.93&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;%&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_907_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate_pid_dp_c20220101__20221231__srt--RangeAxis__srt--MinimumMember_zaSbi4LYP76j" title="Expected volatility"&gt;100.81&lt;/span&gt;% to &lt;span id="xdx_902_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate_pid_dp_c20220101__20221231__srt--RangeAxis__srt--MaximumMember_z1SLChj224j2" title="Expected volatility"&gt;110.74&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Risk-free interest rate&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_90D_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_pid_dp_uPure_c20230101__20231231__srt--RangeAxis__srt--MinimumMember_zUNlHbmGIj35" title="Risk-free interest rate"&gt;3.71&lt;/span&gt;% to &lt;span id="xdx_908_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_pid_dp_uPure_c20230101__20231231__srt--RangeAxis__srt--MaximumMember_zLZSAvDhMWhe" title="Risk-free interest rate"&gt;4.27&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;%&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_907_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_pid_dp_uPure_c20220101__20221231__srt--RangeAxis__srt--MinimumMember_zPolfcc2Cfa3" title="Risk-free interest rate"&gt;2.90&lt;/span&gt;% to &lt;span id="xdx_90F_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_pid_dp_uPure_c20220101__20221231__srt--RangeAxis__srt--MaximumMember_zNO3zYXQfz4i" title="Risk-free interest rate"&gt;3.47&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 52%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Dividend rate&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 2%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 20%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_90D_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_pid_dp_uPure_c20230101__20231231_zYPm6pxYJgwi" title="Dividend rate"&gt;0&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;%&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 2%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 20%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_90D_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_pid_dp_uPure_c20220101__20221231_zWDNTz6ynvnd" title="Dividend rate"&gt;0&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;
&lt;p id="xdx_8A9_zXrf4AdsGHX9" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

</us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant
      contextRef="AsOf2023-01-24_custom_TwoThousandTwentyThreeEquityIncentivePlanMember"
      decimals="INF"
      id="Fact001045"
      unitRef="Shares">1400000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod
      contextRef="From2023-01-242023-01-24_custom_TwoThousandTwentyThreeEquityIncentivePlanMember"
      decimals="INF"
      id="Fact001047"
      unitRef="Shares">3500000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod>
    <us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock contextRef="From2023-01-012023-12-31" id="Fact001049">&lt;p id="xdx_894_eus-gaap--ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock_zxjRdzkmrjJa" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;A
summary of options granted and outstanding is presented below.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;span id="xdx_8B2_zh8qQm1k4QP7" style="display: none"&gt;Schedule
of Stock Options Granted and Outstanding&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="6" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;2023&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="6" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;2022&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;Options&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;Weighted&lt;br/&gt; Average&lt;br/&gt; Exercise &lt;br/&gt; Price&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;Options&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;Weighted&lt;br/&gt; Average&lt;br/&gt; Exercise &lt;br/&gt; Price&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 40%; text-align: left"&gt;Outstanding at Beginning of year&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_987_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionOutstandingNumber_iS_c20230101__20231231_zaUwzULDb3Bc" style="width: 11%; text-align: right" title="Stock option, beginning balance"&gt;1,358,122&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_987_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionOutstandingWeightedAverageExercisePrice_iS_c20230101__20231231_zNXsc1vFalU7" style="width: 11%; text-align: right" title="Weighted average exercise price, beginning balance"&gt;4.37&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_989_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iS_c20220101__20221231_zEpeaR5DmrI5" style="width: 11%; text-align: right" title="Stock option, beginning balance"&gt;1,137,479&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98D_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iS_c20220101__20221231_zslpPQdBI7th" style="width: 11%; text-align: right" title="Weighted average exercise price, beginning balance"&gt;5.18&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td&gt;Granted&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98B_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_c20230101__20231231_zjX1ZZxE5XLc" style="text-align: right" title="Shares, options granted"&gt;1,065,000&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_982_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_c20230101__20231231_z8uZ9XHkfcRh" style="text-align: right" title="Weighted average exercise price, options granted"&gt;1.35&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98D_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_c20220101__20221231_zh8BO9bo09Ll" style="text-align: right" title="Shares, options granted"&gt;367,500&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_989_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_c20220101__20221231_zdMAoRskatQ6" style="text-align: right" title="Weighted average exercise price, options granted"&gt;1.63&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td&gt;Cancelled&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_987_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod_iN_di_c20220101__20221231_zrwqbIejKl79" style="text-align: right" title="Shares, options cancelled"&gt;(3,571&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_989_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice_iN_di_c20220101__20221231_zdkd51rjznaf" style="text-align: right" title="Weighted average exercise price, options cancelled"&gt;(4.38&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-bottom: 1pt"&gt;Forfeited&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98A_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedNumberOfShares_iN_di_c20230101__20231231_zxzNhmrWXAq7" style="border-bottom: Black 1pt solid; text-align: right" title="Shares, options forfeited"&gt;(14,286&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_984_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice_c20230101__20231231_zHLduwboIknd" style="border-bottom: Black 1pt solid; text-align: right" title="Weighted average exercise price, options forfeited"&gt;1.75&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98E_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_iN_di_c20220101__20221231_zjHSUDyUObu4" style="border-bottom: Black 1pt solid; text-align: right" title="Shares, options forfeited"&gt;(143,286&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98F_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice_iN_di_c20220101__20221231_zcid2FMo7Tpa" style="border-bottom: Black 1pt solid; text-align: right" title="Weighted average exercise price, options forfeited"&gt;(3.77&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-bottom: 2.5pt"&gt;Outstanding at end of year&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_987_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionOutstandingNumber_iE_c20230101__20231231_zEch1ZGM8U6k" style="border-bottom: Black 2.5pt double; text-align: right" title="Stock option, ending balance"&gt;2,408,836&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_981_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionOutstandingWeightedAverageExercisePrice_iE_c20230101__20231231_z6ygFRMgPhS" style="border-bottom: Black 2.5pt double; text-align: right" title="Weighted average exercise price, ending balance"&gt;3.03&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98C_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iE_c20220101__20221231_zwehlMRbwH5g" style="border-bottom: Black 2.5pt double; text-align: right" title="Stock option, ending balance"&gt;1,358,122&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_982_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iE_c20220101__20221231_zzRFa28LDX26" style="border-bottom: Black 2.5pt double; text-align: right" title="Weighted average exercise price, ending balance"&gt;4.37&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-bottom: 2.5pt"&gt;Exercisable at end of year&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_986_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_iE_c20230101__20231231_zKGeCfCEswbd" style="border-bottom: Black 2.5pt double; text-align: right" title="Stock option, exercisable"&gt;1,881,327&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_982_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_iE_c20230101__20231231_zG3VY1yrDYC1" style="border-bottom: Black 2.5pt double; text-align: right" title="Weighted average exercise price, exercisable"&gt;3.47&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98E_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_iE_c20220101__20221231_zozaY861CnVe" style="border-bottom: Black 2.5pt double; text-align: right" title="Stock option, exercisable"&gt;1,132,861&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98D_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_iE_c20220101__20221231_z7ewT5InYWcj" style="border-bottom: Black 2.5pt double; text-align: right" title="Weighted average exercise price, exercisable"&gt;4.59&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

</us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock>
    <STSS:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionOutstandingNumber
      contextRef="AsOf2022-12-31"
      decimals="INF"
      id="Fact001051"
      unitRef="Shares">1358122</STSS:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionOutstandingNumber>
    <STSS:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionOutstandingWeightedAverageExercisePrice
      contextRef="AsOf2022-12-31"
      decimals="INF"
      id="Fact001053"
      unitRef="USDPShares">4.37</STSS:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionOutstandingWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
      contextRef="AsOf2021-12-31"
      decimals="INF"
      id="Fact001055"
      unitRef="Shares">1137479</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
      contextRef="AsOf2021-12-31"
      decimals="INF"
      id="Fact001057"
      unitRef="USDPShares">5.18</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
      contextRef="From2023-01-012023-12-31"
      decimals="INF"
      id="Fact001059"
      unitRef="Shares">1065000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross>
    <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
      contextRef="From2023-01-012023-12-31"
      decimals="INF"
      id="Fact001061"
      unitRef="USDPShares">1.35</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
      contextRef="From2022-01-012022-12-31"
      decimals="INF"
      id="Fact001063"
      unitRef="Shares">367500</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross>
    <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
      contextRef="From2022-01-012022-12-31"
      decimals="INF"
      id="Fact001065"
      unitRef="USDPShares">1.63</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod
      contextRef="From2022-01-012022-12-31"
      decimals="INF"
      id="Fact001067"
      unitRef="Shares">3571</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod>
    <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice
      contextRef="From2022-01-012022-12-31"
      decimals="INF"
      id="Fact001069"
      unitRef="USDPShares">4.38</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedNumberOfShares
      contextRef="From2023-01-012023-12-31"
      decimals="INF"
      id="Fact001071"
      unitRef="Shares">14286</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedNumberOfShares>
    <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice
      contextRef="From2023-01-012023-12-31"
      decimals="INF"
      id="Fact001073"
      unitRef="USDPShares">1.75</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
      contextRef="From2022-01-012022-12-31"
      decimals="INF"
      id="Fact001075"
      unitRef="Shares">143286</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod>
    <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice
      contextRef="From2022-01-012022-12-31"
      decimals="INF"
      id="Fact001077"
      unitRef="USDPShares">3.77</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice>
    <STSS:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionOutstandingNumber
      contextRef="AsOf2023-12-31"
      decimals="INF"
      id="Fact001079"
      unitRef="Shares">2408836</STSS:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionOutstandingNumber>
    <STSS:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionOutstandingWeightedAverageExercisePrice
      contextRef="AsOf2023-12-31"
      decimals="INF"
      id="Fact001081"
      unitRef="USDPShares">3.03</STSS:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionOutstandingWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
      contextRef="AsOf2022-12-31"
      decimals="INF"
      id="Fact001083"
      unitRef="Shares">1358122</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
      contextRef="AsOf2022-12-31"
      decimals="INF"
      id="Fact001085"
      unitRef="USDPShares">4.37</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
      contextRef="AsOf2023-12-31"
      decimals="INF"
      id="Fact001087"
      unitRef="Shares">1881327</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
      contextRef="AsOf2023-12-31"
      decimals="INF"
      id="Fact001089"
      unitRef="USDPShares">3.47</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
      contextRef="AsOf2022-12-31"
      decimals="INF"
      id="Fact001091"
      unitRef="Shares">1132861</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
      contextRef="AsOf2022-12-31"
      decimals="INF"
      id="Fact001093"
      unitRef="USDPShares">4.59</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice>
    <us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation
      contextRef="From2023-01-012023-12-31_custom_TwoThousandTwentyThreeEquityIncentivePlanMember"
      decimals="INF"
      id="Fact001097"
      unitRef="Shares">975000</us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="AsOf2023-12-31_custom_TwoThousandTwentyThreeEquityIncentivePlanMember"
      decimals="INF"
      id="Fact001099"
      unitRef="USDPShares">0.0001</us-gaap:CommonStockParOrStatedValuePerShare>
    <STSS:ShareBasedCompensationOptionsExercisableWeightedAverageExercisePrice
      contextRef="AsOf2023-12-31_custom_TwoThousandTwentyThreeEquityIncentivePlanMember"
      decimals="INF"
      id="Fact001101"
      unitRef="USDPShares">1.37</STSS:ShareBasedCompensationOptionsExercisableWeightedAverageExercisePrice>
    <us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation
      contextRef="From2023-01-012023-12-31_custom_EmployeesAndConsultantMember"
      decimals="INF"
      id="Fact001103"
      unitRef="Shares">90000</us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation>
    <STSS:ShareBasedCompensationOptionsExercisableWeightedAverageExercisePrice
      contextRef="AsOf2023-12-31_custom_EmployeesAndConsultantMember_srt_MinimumMember"
      decimals="INF"
      id="Fact001105"
      unitRef="USDPShares">0.82</STSS:ShareBasedCompensationOptionsExercisableWeightedAverageExercisePrice>
    <STSS:ShareBasedCompensationOptionsExercisableWeightedAverageExercisePrice
      contextRef="AsOf2023-12-31_custom_EmployeesAndConsultantMember_srt_MaximumMember"
      decimals="INF"
      id="Fact001107"
      unitRef="USDPShares">1.30</STSS:ShareBasedCompensationOptionsExercisableWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
      contextRef="From2023-01-012023-12-31_custom_TwoThousandTwentyThreeEquityIncentivePlanMember"
      decimals="INF"
      id="Fact001109"
      unitRef="Shares">660000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
      contextRef="From2023-01-012023-12-31_custom_TwoThousandTwentyTwoEquityIncentivePlanMember"
      decimals="INF"
      id="Fact001111"
      unitRef="Shares">405000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
      contextRef="AsOf2023-12-31_custom_TwoThousandTwentyTwoEquityIncentivePlanMember"
      decimals="INF"
      id="Fact001113"
      unitRef="Shares">1748836</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
      contextRef="From2023-01-012023-12-31"
      decimals="INF"
      id="Fact001115"
      unitRef="USDPShares">0.80</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
      contextRef="From2022-01-012022-12-31"
      decimals="INF"
      id="Fact001117"
      unitRef="USDPShares">1.63</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue>
    <us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized
      contextRef="AsOf2023-12-31"
      decimals="0"
      id="Fact001119"
      unitRef="USD">498454</us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized>
    <us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized
      contextRef="AsOf2022-12-31"
      decimals="0"
      id="Fact001121"
      unitRef="USD">475097</us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue
      contextRef="AsOf2023-12-31"
      decimals="INF"
      id="Fact001123"
      unitRef="USDPShares">0.94</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue
      contextRef="AsOf2022-12-31"
      decimals="INF"
      id="Fact001125"
      unitRef="USDPShares">2.05</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue>
    <us-gaap:ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTextBlock contextRef="From2023-01-012023-12-31" id="Fact001127">&lt;p id="xdx_896_eus-gaap--ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTextBlock_zyEjtYLsdPz3" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
following table summarizes information about options outstanding at December 31, 2023:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;span id="xdx_8B9_ztchLltpVJe3" style="display: none"&gt;Schedule
of Information About Options Outstanding&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 90%; border-collapse: collapse"&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"&gt;
    &lt;td colspan="2" style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Exercise
    &lt;br/&gt;
    Prices&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Options
    &lt;br/&gt;
    Outstanding&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Aggregate&lt;br/&gt;
    Intrinsic Value&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Weighted
    Average &lt;br/&gt;
    Remaining&lt;br/&gt;
    Contractual Life&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Options
    &lt;br/&gt;
    Exercisable&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif"&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Aggregate&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;
    &lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Intrinsic
    Value&lt;br/&gt;
    on Exercisable&lt;br/&gt;
    Shares&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"&gt;
    &lt;td colspan="2" style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 12%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_903_eus-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit_c20230101__20231231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeOneMember__srt--RangeAxis__srt--MinimumMember_zBCE1r4eLcAe" title="Stock option, exercise price"&gt;.82&lt;/span&gt; to &lt;span id="xdx_90E_eus-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit_c20230101__20231231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeOneMember__srt--RangeAxis__srt--MaximumMember_z4MAyw806t1h" title="Stock option, exercise price"&gt;.92&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 2%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_989_eus-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions_iI_c20231231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeOneMember_zeXCfV64B6X8" style="font: 10pt Times New Roman, Times, Serif; width: 12%; text-align: right" title="Options, shares outstanding"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;40,000&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 2%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98A_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_iI_c20231231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeOneMember_zzO9XqLgXdkg" style="font: 10pt Times New Roman, Times, Serif; width: 14%; text-align: right" title="Stock option, aggregate intrinsic value"&gt;&#160;&#160;&#160;&#160;&#160;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1135"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 2%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 14%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_90A_eus-gaap--SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2_dtY_c20230101__20231231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeOneMember_z3n6ybZBvqUk" title="Stock option, weighted average remaining contractual life"&gt;4.58&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 2%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98F_eus-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions_iI_c20231231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeOneMember_zVb4oEeNxaec" style="font: 10pt Times New Roman, Times, Serif; width: 12%; text-align: right" title="Options, shares exercisable"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;18,794&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 2%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_980_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1_iI_c20231231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeOneMember_zb0A1ijPx8A" style="font: 10pt Times New Roman, Times, Serif; width: 14%; text-align: right" title="Stock option, aggregate intrinsic value on exercisable shares"&gt;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1141"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_907_eus-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit_c20230101__20231231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeTwoMember_zxQgIHiwv0Ld" title="Stock option, exercise price"&gt;1.21&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98F_eus-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions_iI_c20231231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeTwoMember_zQrISQLiHbs9" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Options, shares outstanding"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;307,500&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_989_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_iI_c20231231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeTwoMember_z97JRxHuAKD4" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Stock option, aggregate intrinsic value"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1147"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_908_eus-gaap--SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2_dtY_c20230101__20231231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeTwoMember_zj2yoK181UGi" title="Stock option, weighted average remaining contractual life"&gt;3.42&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98D_eus-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions_iI_c20231231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeTwoMember_zATG1bSK1wc" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Options, shares exercisable"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;240,386&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98A_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1_iI_c20231231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeTwoMember_zxoxvZBfRNf6" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Stock option, aggregate intrinsic value on exercisable shares"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1153"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_903_eus-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit_c20230101__20231231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeThreeMember_zJbONXr9NGce" title="Stock option, exercise price"&gt;1.30&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_984_eus-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions_iI_c20231231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeThreeMember_zsdLopjx0gdf" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Options, shares outstanding"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;50,000&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_983_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_iI_c20231231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeThreeMember_zfhQwORB1ved" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Stock option, aggregate intrinsic value"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1159"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_903_eus-gaap--SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2_dtY_c20230101__20231231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeThreeMember_zEjbzr5a5Ubd" title="Stock option, weighted average remaining contractual life"&gt;4.21&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_988_eus-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions_iI_c20231231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeThreeMember_zAb9C5wh3HWd" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Options, shares exercisable"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;43,750&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98C_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1_iI_c20231231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeThreeMember_zKIzzXyAHRre" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Stock option, aggregate intrinsic value on exercisable shares"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1165"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_902_eus-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit_c20230101__20231231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeFourMember_zcNnTjlC5kDk" title="Stock option, exercise price"&gt;1.37&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_986_eus-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions_iI_c20231231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeFourMember_zjZBlmx33Pla" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Options, shares outstanding"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;975,000&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_984_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_iI_c20231231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeFourMember_zPmnrEYyYZD" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Stock option, aggregate intrinsic value"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1171"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_90A_eus-gaap--SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2_dtY_c20230101__20231231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeFourMember_zWykEPseBCKf" title="Stock option, weighted average remaining contractual life"&gt;4.17&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_985_eus-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions_iI_c20231231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeFourMember_zec5JlVXfHI" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Options, shares exercisable"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;561,719&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_983_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1_iI_c20231231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeFourMember_zodRTTHznA4e" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Stock option, aggregate intrinsic value on exercisable shares"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1177"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_908_eus-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit_c20230101__20231231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeFiveMember_zyIYAAlOEMPl" title="Stock option, exercise price"&gt;1.75&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_988_eus-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions_iI_c20231231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeFiveMember_zQptYFhsXte4" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Options, shares outstanding"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;54,285&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_981_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_iI_c20231231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeFiveMember_zo1fFXH87n81" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Stock option, aggregate intrinsic value"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1183"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_906_eus-gaap--SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2_dtY_c20230101__20231231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeFiveMember_zFcQNivy35Be" title="Stock option, weighted average remaining contractual life"&gt;2.25&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: right"&gt;&lt;/p&gt;
    &lt;p id="xdx_98F_eus-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions_iI_c20231231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeFiveMember_zzi5h6q58LCd" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: right" title="Options, shares exercisable"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;54,285&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_981_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1_iI_c20231231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeFiveMember_zO1AmwXzm5oc" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Stock option, aggregate intrinsic value on exercisable shares"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1189"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_90F_eus-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit_c20230101__20231231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeSixMember_zL6tgR1vlWN4" title="Stock option, exercise price"&gt;2.80&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98D_eus-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions_iI_c20231231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeSixMember_z1ijSAqahwj2" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Options, shares outstanding"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;141,429&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_988_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_iI_c20231231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeSixMember_zsYNwWzfoq9j" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Stock option, aggregate intrinsic value"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1195"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_90F_eus-gaap--SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2_dtY_c20230101__20231231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeSixMember_zsCLsRLdkKyh" title="Stock option, weighted average remaining contractual life"&gt;2.25&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98C_eus-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions_iI_c20231231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeSixMember_zsdstAMVSRJ8" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Options, shares exercisable"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;141,429&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98A_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1_iI_c20231231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeSixMember_z9tgdx3ulgGg" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Stock option, aggregate intrinsic value on exercisable shares"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1201"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_900_eus-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit_c20230101__20231231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeSevenMember_zDANi0kfYtca" title="Stock option, exercise price"&gt;1.39&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98B_eus-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions_iI_c20231231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeSevenMember_zpCZb5xXKeW4" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Options, shares outstanding"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;10,000&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_985_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_iI_c20231231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeSevenMember_zUu60m0y0Tq7" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Stock option, aggregate intrinsic value"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1207"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_903_eus-gaap--SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2_dtY_c20230101__20231231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeSevenMember_zgxXTuK5Yk09" title="Stock option, weighted average remaining contractual life"&gt;3.75&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_987_eus-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions_iI_c20231231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeSevenMember_zvlXcHh2AFB2" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Options, shares exercisable"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;10,000&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98A_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1_iI_c20231231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeSevenMember_zKme8A1lT2Le" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Stock option, aggregate intrinsic value on exercisable shares"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1213"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_906_eus-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit_c20230101__20231231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeEightMember_zIGBcB7uZsOe" title="Stock option, exercise price"&gt;4.25&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98B_eus-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions_iI_c20231231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeEightMember_zBBjbohhBN6j" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Options, shares outstanding"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;50,000&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98D_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_iI_c20231231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeEightMember_zcz5sVnxPIbc" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Stock option, aggregate intrinsic value"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1219"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_909_eus-gaap--SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2_dtY_c20230101__20231231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeEightMember_zrO1ZuGNb9R8" title="Stock option, weighted average remaining contractual life"&gt;3.75&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_989_eus-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions_iI_c20231231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeEightMember_zE2PWB9ZoCf9" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Options, shares exercisable"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;50,000&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_980_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1_iI_c20231231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeEightMember_z8KaCTDq5sw6" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Stock option, aggregate intrinsic value on exercisable shares"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1225"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_90C_eus-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit_c20230101__20231231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeNineMember_zg6IcBmTQjU3" title="Stock option, exercise price"&gt;4.38&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98C_eus-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions_iI_c20231231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeNineMember_zq47EDyJeyF1" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Options, shares outstanding"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;244,286&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_981_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_iI_c20231231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeNineMember_ziqdd7G72LNh" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Stock option, aggregate intrinsic value"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1231"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_902_eus-gaap--SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2_dtY_c20230101__20231231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeNineMember_ztN3xB6cqDx6" title="Stock option, weighted average remaining contractual life"&gt;1.25&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_981_eus-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions_iI_c20231231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeNineMember_z0Xhb2DgSedh" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Options, shares exercisable"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;244,286&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_987_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1_iI_c20231231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeNineMember_z2OxjzEZCZ4g" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Stock option, aggregate intrinsic value on exercisable shares"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1237"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_903_eus-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit_c20230101__20231231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeTenMember_z65Kidvx3JX3" title="Stock option, exercise price"&gt;7.00&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_983_eus-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions_iI_c20231231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeTenMember_zrWWgPsF0bfc" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Options, shares outstanding"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;536,335&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98C_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_iI_c20231231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeTenMember_zFvHlCXX4VM9" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Stock option, aggregate intrinsic value"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1243"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_904_eus-gaap--SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2_dtY_c20230101__20231231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeTenMember_zsSwHVvDh4Z6" title="Stock option, weighted average remaining contractual life"&gt;2.00&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_986_eus-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions_iI_c20231231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeTenMember_zEku6u3Bb35h" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Options, shares exercisable"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;516,679&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_986_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1_iI_c20231231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeTenMember_zT2dgOLkzh3" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Stock option, aggregate intrinsic value on exercisable shares"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1249"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;
</us-gaap:ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTextBlock>
    <us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit
      contextRef="From2023-01-012023-12-31_custom_ExercisePriceRangeOneMember_srt_MinimumMember"
      decimals="INF"
      id="Fact001129"
      unitRef="USDPShares">0.82</us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit>
    <us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit
      contextRef="From2023-01-012023-12-31_custom_ExercisePriceRangeOneMember_srt_MaximumMember"
      decimals="INF"
      id="Fact001131"
      unitRef="USDPShares">0.92</us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit>
    <us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions
      contextRef="AsOf2023-12-31_custom_ExercisePriceRangeOneMember"
      decimals="INF"
      id="Fact001133"
      unitRef="Shares">40000</us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions>
    <us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2
      contextRef="From2023-01-012023-12-31_custom_ExercisePriceRangeOneMember"
      id="Fact001137">P4Y6M29D</us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2>
    <us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions
      contextRef="AsOf2023-12-31_custom_ExercisePriceRangeOneMember"
      decimals="INF"
      id="Fact001139"
      unitRef="Shares">18794</us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions>
    <us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit
      contextRef="From2023-01-012023-12-31_custom_ExercisePriceRangeTwoMember"
      decimals="INF"
      id="Fact001143"
      unitRef="USDPShares">1.21</us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit>
    <us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions
      contextRef="AsOf2023-12-31_custom_ExercisePriceRangeTwoMember"
      decimals="INF"
      id="Fact001145"
      unitRef="Shares">307500</us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions>
    <us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2
      contextRef="From2023-01-012023-12-31_custom_ExercisePriceRangeTwoMember"
      id="Fact001149">P3Y5M1D</us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2>
    <us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions
      contextRef="AsOf2023-12-31_custom_ExercisePriceRangeTwoMember"
      decimals="INF"
      id="Fact001151"
      unitRef="Shares">240386</us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions>
    <us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit
      contextRef="From2023-01-012023-12-31_custom_ExercisePriceRangeThreeMember"
      decimals="INF"
      id="Fact001155"
      unitRef="USDPShares">1.30</us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit>
    <us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions
      contextRef="AsOf2023-12-31_custom_ExercisePriceRangeThreeMember"
      decimals="INF"
      id="Fact001157"
      unitRef="Shares">50000</us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions>
    <us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2
      contextRef="From2023-01-012023-12-31_custom_ExercisePriceRangeThreeMember"
      id="Fact001161">P4Y2M15D</us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2>
    <us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions
      contextRef="AsOf2023-12-31_custom_ExercisePriceRangeThreeMember"
      decimals="INF"
      id="Fact001163"
      unitRef="Shares">43750</us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions>
    <us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit
      contextRef="From2023-01-012023-12-31_custom_ExercisePriceRangeFourMember"
      decimals="INF"
      id="Fact001167"
      unitRef="USDPShares">1.37</us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit>
    <us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions
      contextRef="AsOf2023-12-31_custom_ExercisePriceRangeFourMember"
      decimals="INF"
      id="Fact001169"
      unitRef="Shares">975000</us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions>
    <us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2
      contextRef="From2023-01-012023-12-31_custom_ExercisePriceRangeFourMember"
      id="Fact001173">P4Y2M1D</us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2>
    <us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions
      contextRef="AsOf2023-12-31_custom_ExercisePriceRangeFourMember"
      decimals="INF"
      id="Fact001175"
      unitRef="Shares">561719</us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions>
    <us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit
      contextRef="From2023-01-012023-12-31_custom_ExercisePriceRangeFiveMember"
      decimals="INF"
      id="Fact001179"
      unitRef="USDPShares">1.75</us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit>
    <us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions
      contextRef="AsOf2023-12-31_custom_ExercisePriceRangeFiveMember"
      decimals="INF"
      id="Fact001181"
      unitRef="Shares">54285</us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions>
    <us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2
      contextRef="From2023-01-012023-12-31_custom_ExercisePriceRangeFiveMember"
      id="Fact001185">P2Y3M</us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2>
    <us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions
      contextRef="AsOf2023-12-31_custom_ExercisePriceRangeFiveMember"
      decimals="INF"
      id="Fact001187"
      unitRef="Shares">54285</us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions>
    <us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit
      contextRef="From2023-01-012023-12-31_custom_ExercisePriceRangeSixMember"
      decimals="INF"
      id="Fact001191"
      unitRef="USDPShares">2.80</us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit>
    <us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions
      contextRef="AsOf2023-12-31_custom_ExercisePriceRangeSixMember"
      decimals="INF"
      id="Fact001193"
      unitRef="Shares">141429</us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions>
    <us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2
      contextRef="From2023-01-012023-12-31_custom_ExercisePriceRangeSixMember"
      id="Fact001197">P2Y3M</us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2>
    <us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions
      contextRef="AsOf2023-12-31_custom_ExercisePriceRangeSixMember"
      decimals="INF"
      id="Fact001199"
      unitRef="Shares">141429</us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions>
    <us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit
      contextRef="From2023-01-012023-12-31_custom_ExercisePriceRangeSevenMember"
      decimals="INF"
      id="Fact001203"
      unitRef="USDPShares">1.39</us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit>
    <us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions
      contextRef="AsOf2023-12-31_custom_ExercisePriceRangeSevenMember"
      decimals="INF"
      id="Fact001205"
      unitRef="Shares">10000</us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions>
    <us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2
      contextRef="From2023-01-012023-12-31_custom_ExercisePriceRangeSevenMember"
      id="Fact001209">P3Y9M</us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2>
    <us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions
      contextRef="AsOf2023-12-31_custom_ExercisePriceRangeSevenMember"
      decimals="INF"
      id="Fact001211"
      unitRef="Shares">10000</us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions>
    <us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit
      contextRef="From2023-01-012023-12-31_custom_ExercisePriceRangeEightMember"
      decimals="INF"
      id="Fact001215"
      unitRef="USDPShares">4.25</us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit>
    <us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions
      contextRef="AsOf2023-12-31_custom_ExercisePriceRangeEightMember"
      decimals="INF"
      id="Fact001217"
      unitRef="Shares">50000</us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions>
    <us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2
      contextRef="From2023-01-012023-12-31_custom_ExercisePriceRangeEightMember"
      id="Fact001221">P3Y9M</us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2>
    <us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions
      contextRef="AsOf2023-12-31_custom_ExercisePriceRangeEightMember"
      decimals="INF"
      id="Fact001223"
      unitRef="Shares">50000</us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions>
    <us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit
      contextRef="From2023-01-012023-12-31_custom_ExercisePriceRangeNineMember"
      decimals="INF"
      id="Fact001227"
      unitRef="USDPShares">4.38</us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit>
    <us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions
      contextRef="AsOf2023-12-31_custom_ExercisePriceRangeNineMember"
      decimals="INF"
      id="Fact001229"
      unitRef="Shares">244286</us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions>
    <us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2
      contextRef="From2023-01-012023-12-31_custom_ExercisePriceRangeNineMember"
      id="Fact001233">P1Y3M</us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2>
    <us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions
      contextRef="AsOf2023-12-31_custom_ExercisePriceRangeNineMember"
      decimals="INF"
      id="Fact001235"
      unitRef="Shares">244286</us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions>
    <us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit
      contextRef="From2023-01-012023-12-31_custom_ExercisePriceRangeTenMember"
      decimals="INF"
      id="Fact001239"
      unitRef="USDPShares">7.00</us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit>
    <us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions
      contextRef="AsOf2023-12-31_custom_ExercisePriceRangeTenMember"
      decimals="INF"
      id="Fact001241"
      unitRef="Shares">536335</us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions>
    <us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2
      contextRef="From2023-01-012023-12-31_custom_ExercisePriceRangeTenMember"
      id="Fact001245">P2Y</us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2>
    <us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions
      contextRef="AsOf2023-12-31_custom_ExercisePriceRangeTenMember"
      decimals="INF"
      id="Fact001247"
      unitRef="Shares">516679</us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="From2023-01-012023-12-31"
      decimals="0"
      id="Fact001251"
      unitRef="USD">920108</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="From2023-01-012023-12-31_us-gaap_GeneralAndAdministrativeExpenseMember"
      decimals="0"
      id="Fact001253"
      unitRef="USD">906745</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="From2023-01-012023-12-31_us-gaap_ResearchAndDevelopmentExpenseMember"
      decimals="0"
      id="Fact001255"
      unitRef="USD">13363</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="From2022-01-012022-12-31"
      decimals="0"
      id="Fact001257"
      unitRef="USD">1012592</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="From2022-01-012022-12-31_us-gaap_GeneralAndAdministrativeExpenseMember"
      decimals="0"
      id="Fact001259"
      unitRef="USD">915797</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="From2022-01-012022-12-31_us-gaap_ResearchAndDevelopmentExpenseMember"
      decimals="0"
      id="Fact001261"
      unitRef="USD">96795</us-gaap:AllocatedShareBasedCompensationExpense>
    <STSS:StockBasedChargesRelatingToPurchaseOfMachinery
      contextRef="From2022-01-012022-12-31"
      decimals="0"
      id="Fact001263"
      unitRef="USD">63612</STSS:StockBasedChargesRelatingToPurchaseOfMachinery>
    <STSS:StockBasedChargesRelatingToAcquisition
      contextRef="From2022-01-012022-03-31"
      decimals="0"
      id="Fact001265"
      unitRef="USD">60435</STSS:StockBasedChargesRelatingToAcquisition>
    <us-gaap:ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock contextRef="From2023-01-012023-12-31" id="Fact001267">&lt;p id="xdx_897_eus-gaap--ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock_zaVNnRXOWKLh" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
fair value of stock option awards accounted for under ASC 718 was estimated at the date of grant using a Black-Scholes option-pricing
model with the following assumptions:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_8BB_zSEmShr3UWYk" style="display: none"&gt;Schedule
of Fair Value of Stock Option Awards&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 90%; border-collapse: collapse"&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&#160;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"&gt;&lt;p style="margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: imes New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Year
                                            Ended &lt;br/&gt; December 31,&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;
                                                                                &lt;p style="margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;2023&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"&gt;&lt;p style="margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: imes New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Year
                                            Ended &lt;br/&gt; December 31,&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;
                                                                                &lt;p style="margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;2022&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Expected term (years)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_905_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_dtY_c20230101__20231231__srt--RangeAxis__srt--MinimumMember_zCwKHtEdnz3" title="Expected term (years)"&gt;2.88&lt;/span&gt; to &lt;span id="xdx_90B_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_dtY_c20230101__20231231__srt--RangeAxis__srt--MaximumMember_zZsfDdolkMLj" title="Expected term (years)"&gt;3.25&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_90A_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_dtY_c20220101__20221231__srt--RangeAxis__srt--MinimumMember_zYZfHI8kOjj9" title="Expected term (years)"&gt;2.50&lt;/span&gt; to &lt;span id="xdx_903_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_dtY_c20220101__20221231__srt--RangeAxis__srt--MaximumMember_zE8ABMl1Ims5" title="Expected term (years)"&gt;3.00&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Expected volatility&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_900_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate_pid_dp_c20230101__20231231__srt--RangeAxis__srt--MinimumMember_zPnYpozJcvrf" title="Expected volatility"&gt;75.40&lt;/span&gt;% to &lt;span id="xdx_903_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate_pid_dp_c20230101__20231231__srt--RangeAxis__srt--MaximumMember_zGQCMRJibS6b" title="Expected volatility"&gt;89.93&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;%&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_907_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate_pid_dp_c20220101__20221231__srt--RangeAxis__srt--MinimumMember_zaSbi4LYP76j" title="Expected volatility"&gt;100.81&lt;/span&gt;% to &lt;span id="xdx_902_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate_pid_dp_c20220101__20221231__srt--RangeAxis__srt--MaximumMember_z1SLChj224j2" title="Expected volatility"&gt;110.74&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Risk-free interest rate&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_90D_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_pid_dp_uPure_c20230101__20231231__srt--RangeAxis__srt--MinimumMember_zUNlHbmGIj35" title="Risk-free interest rate"&gt;3.71&lt;/span&gt;% to &lt;span id="xdx_908_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_pid_dp_uPure_c20230101__20231231__srt--RangeAxis__srt--MaximumMember_zLZSAvDhMWhe" title="Risk-free interest rate"&gt;4.27&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;%&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_907_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_pid_dp_uPure_c20220101__20221231__srt--RangeAxis__srt--MinimumMember_zPolfcc2Cfa3" title="Risk-free interest rate"&gt;2.90&lt;/span&gt;% to &lt;span id="xdx_90F_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_pid_dp_uPure_c20220101__20221231__srt--RangeAxis__srt--MaximumMember_zNO3zYXQfz4i" title="Risk-free interest rate"&gt;3.47&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 52%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Dividend rate&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 2%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 20%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_90D_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_pid_dp_uPure_c20230101__20231231_zYPm6pxYJgwi" title="Dividend rate"&gt;0&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;%&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 2%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 20%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_90D_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_pid_dp_uPure_c20220101__20221231_zWDNTz6ynvnd" title="Dividend rate"&gt;0&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;
</us-gaap:ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
      contextRef="From2023-01-012023-12-31_srt_MinimumMember"
      id="Fact001269">P2Y10M17D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
      contextRef="From2023-01-012023-12-31_srt_MaximumMember"
      id="Fact001271">P3Y3M</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
      contextRef="From2022-01-012022-12-31_srt_MinimumMember"
      id="Fact001273">P2Y6M</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
      contextRef="From2022-01-012022-12-31_srt_MaximumMember"
      id="Fact001275">P3Y</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate
      contextRef="From2023-01-012023-12-31_srt_MinimumMember"
      decimals="INF"
      id="Fact001277"
      unitRef="Pure">0.7540</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate
      contextRef="From2023-01-012023-12-31_srt_MaximumMember"
      decimals="INF"
      id="Fact001279"
      unitRef="Pure">0.8993</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate
      contextRef="From2022-01-012022-12-31_srt_MinimumMember"
      decimals="INF"
      id="Fact001281"
      unitRef="Pure">1.0081</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate
      contextRef="From2022-01-012022-12-31_srt_MaximumMember"
      decimals="INF"
      id="Fact001283"
      unitRef="Pure">1.1074</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
      contextRef="From2023-01-012023-12-31_srt_MinimumMember"
      decimals="INF"
      id="Fact001285"
      unitRef="Pure">0.0371</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
      contextRef="From2023-01-012023-12-31_srt_MaximumMember"
      decimals="INF"
      id="Fact001287"
      unitRef="Pure">0.0427</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
      contextRef="From2022-01-012022-12-31_srt_MinimumMember"
      decimals="INF"
      id="Fact001289"
      unitRef="Pure">0.0290</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
      contextRef="From2022-01-012022-12-31_srt_MaximumMember"
      decimals="INF"
      id="Fact001291"
      unitRef="Pure">0.0347</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
      contextRef="From2023-01-012023-12-31"
      decimals="INF"
      id="Fact001293"
      unitRef="Pure">0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
      contextRef="From2022-01-012022-12-31"
      decimals="INF"
      id="Fact001295"
      unitRef="Pure">0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate>
    <us-gaap:IncomeTaxDisclosureTextBlock contextRef="From2023-01-012023-12-31" id="Fact001297">&lt;p id="xdx_807_eus-gaap--IncomeTaxDisclosureTextBlock_ztcF7iu1yaMi" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Note
12. &lt;span id="xdx_823_z8INrpPReKJe"&gt;Income Taxes &lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;A
reconciliation of the Federal statutory rate of &lt;span id="xdx_903_eus-gaap--EffectiveIncomeTaxRateContinuingOperations_pid_dp_uPure_c20230101__20231231_z4h9c9j1s3k8" title="Effective tax rate"&gt;21&lt;/span&gt;% and &lt;span id="xdx_90C_eus-gaap--EffectiveIncomeTaxRateContinuingOperations_pid_dp_uPure_c20220101__20221231_zliMhxaMet98" title="Effective tax rate"&gt;28&lt;/span&gt;% in the years ended December 31, 2023 and 2022, respectively to the total
effective rate applicable to income (loss) is as follows:&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_89F_eus-gaap--ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock_zGYVk5GmxaCd" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;span id="xdx_8B4_zqY6jMnLLYnl" style="display: none"&gt;Schedule
of Reconciliation of Federal Statutory Rate to Total Effective Rate&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 70%"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;&lt;td&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_495_20230101__20231231_z0UDmBlLfCNf" style="text-align: center"&gt;&lt;b&gt;Year Ended&lt;/b&gt;&lt;/td&gt;&lt;td&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;&lt;td&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_49F_20220101__20221231_zoxx9DBcUfgb" style="text-align: center"&gt;&lt;b&gt;Year Ended&lt;/b&gt;&lt;/td&gt;&lt;td&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;b&gt;December 31, 2023&lt;/b&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;b&gt;December 31, 2022&lt;/b&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_408_eus-gaap--IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate_maITEBzVgo_zsoxYDO4XEEc" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 56%; text-align: left"&gt;Expected benefit at statutory federal tax rate&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 18%; text-align: right"&gt;(2,073,230&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;)&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 18%; text-align: right"&gt;(974,329&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40A_eus-gaap--IncomeTaxReconciliationChangeInEnactedTaxRate_maITEBzVgo_zKbB9nlMYVCh" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;Permanent differences &#x2013; net&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(35,469&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(859,515&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40B_eus-gaap--IncomeTaxReconciliationStateAndLocalIncomeTaxes_maITEBzVgo_zJ9nwI8YtwXc" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;State and local taxes, net of federal tax benefit&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1311"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(265,607&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_404_eus-gaap--IncomeTaxReconciliationOtherAdjustments_maITEBzVgo_zIb7QHZpsA5k" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td&gt;Other&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(24,569&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(21,965&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40B_eus-gaap--IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance_maITEBzVgo_zsw2QihYgKd8" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-bottom: 1pt"&gt;Change in valuation allowance&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;2,103,268&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;2,121,416&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40A_eus-gaap--IncomeTaxExpenseBenefit_iT_mtITEBzVgo_zytKKJ8oxzZ8" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-bottom: 2.5pt"&gt;Income tax expense (benefit)&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;(30,000&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1321"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p id="xdx_8AD_zwZtbXllGFL9" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_890_eus-gaap--ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock_zGiKRNi3lW48" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
components of the Company&#x2019;s deferred tax assets (liabilities) are as follows:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;span id="xdx_8BD_zqVlxRt6W36c" style="display: none"&gt;Schedule
of Components of Deferred tax Assets&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 70%"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_49B_20231231_z0J5g5RXGe7k" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;b&gt;Year Ended &lt;br/&gt; December 31, &lt;br/&gt; 2023&lt;/b&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_499_20221231_ze9k3w767yP7" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;b&gt;Year Ended &lt;br/&gt; December 31, &lt;br/&gt; 2022&lt;/b&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;Deferred tax assets (liabilities):&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40A_ecustom--DeferredTaxAssetsPropertyPlantAndEquipments_iI_msDTLzq2T_zTwV5gIYuNc2" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="width: 56%; text-align: left"&gt;Fixed assets&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 18%; text-align: right"&gt;(281,073&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;)&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 18%; text-align: right"&gt;(268,594&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_409_eus-gaap--DeferredTaxAssetInterestCarryforward_iI_msDTLzq2T_z96ErXhSyqjb" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td&gt;Interest&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;35,178&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;62,310&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_409_eus-gaap--DeferredTaxAssetsInProcessResearchAndDevelopment_iI_msDTLzq2T_z7ulqOLfvNJ4" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;Research and development expenses&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;400,810&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;454,942&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_401_eus-gaap--DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost_iI_msDTLzq2T_zEB6thclwJQ" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;Stock-based compensation&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;895,509&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;917,351&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_407_eus-gaap--DeferredTaxAssetsCharitableContributionCarryforwards_iI_msDTLzq2T_zq5rACDRarhh" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;Charitable Contributions&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;420&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_402_eus-gaap--DeferredTaxAssetsOperatingLossCarryforwardsDomestic_iI_msDTLzq2T_zmMXtHjgfas9" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;Net operating losses - federal&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;4,456,242&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;2,898,411&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_405_eus-gaap--DeferredTaxAssetsOperatingLossCarryforwardsStateAndLocal_iI_msDTLzq2T_z44uMVdhXKF2" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;Net operating losses &#x2013; state and local&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;543,264&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;921,350&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40E_eus-gaap--DeferredTaxAssetsOperatingLossCarryforwardsForeign_iI_msDTLzq2T_zzGEKTr8ul1c" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;Net operating losses - foreign&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;233,114&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;37,686&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40C_eus-gaap--DeferredTaxAssetsTaxCreditCarryforwardsResearch_iI_msDTLzq2T_zTWDpY8yRTj3" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-bottom: 1pt"&gt;Research credit&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;28,985&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;28,985&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_403_eus-gaap--DeferredTaxAssetsValuationAllowance_iNI_di_maDTLzq2T_ziUKAGcGlkJ5" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-bottom: 1pt"&gt;Less valuation allowance&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;(6,474,449&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;(5,244,441&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40C_eus-gaap--DeferredTaxLiabilities_iNTI_di_mtDTLzq2T_zkOxNhILOU8e" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-bottom: 2.5pt"&gt;Net deferred tax liability&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;(162,000&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;(192,000&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p id="xdx_8AB_zaHXk6T49QI6" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;




&lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;SHARPS
TECHNOLOGY, INC.&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;NOTES
TO THE CONSOLIDATED FINANCIAL STATEMENTS&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;FOR
THE YEARS ENDED DECEMBER 31, 2023 AND 2022&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Note
12. Income Taxes (continued)&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
authoritative guidance requires the asset and liability method of accounting for deferred income taxes. Deferred tax assets and liabilities
are determined based on the difference between the financial statement and tax bases of assets and liabilities. Deferred tax assets or
liabilities at the end of each period are determined using the tax rate expected to be in effect when taxes are actually paid or recovered.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
guidance also requires that a valuation allowance be established when it is more likely than not that all or a portion of a deferred
tax asset will not be realized. A review of all available positive and negative evidence needs to be considered, including a company&#x2019;s
current and past performance, the market environment in which the company operates, length of carryback and carryforward periods and
existing contracts that will result in future profits. After reviewing all the evidence, the company has recorded a full valuation allowance.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;As
of December 31, 2023, the Company had U.S. federal net operating loss carryforwards of approximately $&lt;span id="xdx_901_eus-gaap--OperatingLossCarryforwards_iI_c20231231__us-gaap--IncomeTaxAuthorityAxis__us-gaap--DomesticCountryMember_zlhhhudquRJb" title="Net operating loss carryforwards"&gt;21,222,000&lt;/span&gt; of which $&lt;span id="xdx_906_eus-gaap--OperatingLossCarryforwards_iI_c20231231__us-gaap--IncomeTaxAuthorityAxis__us-gaap--DomesticCountryMember__srt--StatementScenarioAxis__custom--ExpiresOnTwoThousandTwentyEightMember_zoEWHYZ2Rerj" title="Net operating loss carryforwards"&gt;241,000&lt;/span&gt;, if
not fully utilized, expires by 2038 and which $&lt;span id="xdx_900_eus-gaap--OperatingLossCarryforwards_iI_c20231231__srt--StatementScenarioAxis__custom--NotExpireMember__us-gaap--IncomeTaxAuthorityAxis__us-gaap--DomesticCountryMember_z6GOzQBVOLB3" title="Net operating loss carryforwards"&gt;20,981,000&lt;/span&gt; do not expire. The Company has foreign net operating loss carryforwards of
$&lt;span id="xdx_901_eus-gaap--OperatingLossCarryforwards_iI_c20231231__us-gaap--IncomeTaxAuthorityAxis__us-gaap--ForeignCountryMember_z429voBPRPL" title="Net operating loss carryforwards"&gt;2,590,000&lt;/span&gt;, if not fully utilized, expire through 2028. Utilization is dependent on generating sufficient taxable income prior to expiration
of the tax loss carryforwards.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_896_eus-gaap--ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock_zBaxIPJlllzi" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
geographical components of loss before income taxes consisted of the following for the years ended December 31:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;span id="xdx_8B9_zO1BxVr7Nt6j" style="display: none"&gt;Schedule
of Geographical Components of Loss Before Income Taxes&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 80%"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;&lt;td&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_496_20230101__20231231_z8rQAVv08OLf" style="text-align: center"&gt;&lt;b&gt;Year Ended&lt;/b&gt;&lt;/td&gt;&lt;td&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;&lt;td&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_494_20220101__20221231_zQDtYGlN93ac" style="text-align: center"&gt;&lt;b&gt;Year Ended&lt;/b&gt;&lt;/td&gt;&lt;td&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;b&gt;December 31, &lt;br/&gt; 2023&lt;/b&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;b&gt;December 31,&lt;br/&gt; 2022&lt;/b&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_406_eus-gaap--IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic_maILFCOzLlh_z7Si8U5ZTw9j" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 60%; text-align: left"&gt;United Stated Operations&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 16%; text-align: right"&gt;(8,173,807&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;)&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 16%; text-align: right"&gt;(3,978,832&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_404_eus-gaap--IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign_maILFCOzLlh_zL5XFyf7DTp9" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-bottom: 1pt"&gt;International Operations&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;(1,667,831&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;(660,830&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_406_eus-gaap--IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_iT_mtILFCOzLlh_zust0jwVE531" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-bottom: 1pt"&gt;(Loss) Income before taxes&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;(9,871,638&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;(4,639,662&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p id="xdx_8AB_z2rxrpXOIFui" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

</us-gaap:IncomeTaxDisclosureTextBlock>
    <us-gaap:EffectiveIncomeTaxRateContinuingOperations
      contextRef="From2023-01-012023-12-31"
      decimals="INF"
      id="Fact001299"
      unitRef="Pure">0.21</us-gaap:EffectiveIncomeTaxRateContinuingOperations>
    <us-gaap:EffectiveIncomeTaxRateContinuingOperations
      contextRef="From2022-01-012022-12-31"
      decimals="INF"
      id="Fact001301"
      unitRef="Pure">0.28</us-gaap:EffectiveIncomeTaxRateContinuingOperations>
    <us-gaap:ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock contextRef="From2023-01-012023-12-31" id="Fact001303">&lt;p id="xdx_89F_eus-gaap--ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock_zGYVk5GmxaCd" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;span id="xdx_8B4_zqY6jMnLLYnl" style="display: none"&gt;Schedule
of Reconciliation of Federal Statutory Rate to Total Effective Rate&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 70%"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;&lt;td&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_495_20230101__20231231_z0UDmBlLfCNf" style="text-align: center"&gt;&lt;b&gt;Year Ended&lt;/b&gt;&lt;/td&gt;&lt;td&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;&lt;td&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_49F_20220101__20221231_zoxx9DBcUfgb" style="text-align: center"&gt;&lt;b&gt;Year Ended&lt;/b&gt;&lt;/td&gt;&lt;td&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;b&gt;December 31, 2023&lt;/b&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;b&gt;December 31, 2022&lt;/b&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_408_eus-gaap--IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate_maITEBzVgo_zsoxYDO4XEEc" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 56%; text-align: left"&gt;Expected benefit at statutory federal tax rate&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 18%; text-align: right"&gt;(2,073,230&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;)&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 18%; text-align: right"&gt;(974,329&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40A_eus-gaap--IncomeTaxReconciliationChangeInEnactedTaxRate_maITEBzVgo_zKbB9nlMYVCh" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;Permanent differences &#x2013; net&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(35,469&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(859,515&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40B_eus-gaap--IncomeTaxReconciliationStateAndLocalIncomeTaxes_maITEBzVgo_zJ9nwI8YtwXc" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;State and local taxes, net of federal tax benefit&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1311"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(265,607&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_404_eus-gaap--IncomeTaxReconciliationOtherAdjustments_maITEBzVgo_zIb7QHZpsA5k" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td&gt;Other&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(24,569&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(21,965&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40B_eus-gaap--IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance_maITEBzVgo_zsw2QihYgKd8" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-bottom: 1pt"&gt;Change in valuation allowance&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;2,103,268&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;2,121,416&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40A_eus-gaap--IncomeTaxExpenseBenefit_iT_mtITEBzVgo_zytKKJ8oxzZ8" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-bottom: 2.5pt"&gt;Income tax expense (benefit)&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;(30,000&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1321"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

</us-gaap:ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock>
    <us-gaap:IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate
      contextRef="From2023-01-012023-12-31"
      decimals="0"
      id="Fact001305"
      unitRef="USD">-2073230</us-gaap:IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate>
    <us-gaap:IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate
      contextRef="From2022-01-012022-12-31"
      decimals="0"
      id="Fact001306"
      unitRef="USD">-974329</us-gaap:IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate>
    <us-gaap:IncomeTaxReconciliationChangeInEnactedTaxRate
      contextRef="From2023-01-012023-12-31"
      decimals="0"
      id="Fact001308"
      unitRef="USD">-35469</us-gaap:IncomeTaxReconciliationChangeInEnactedTaxRate>
    <us-gaap:IncomeTaxReconciliationChangeInEnactedTaxRate
      contextRef="From2022-01-012022-12-31"
      decimals="0"
      id="Fact001309"
      unitRef="USD">-859515</us-gaap:IncomeTaxReconciliationChangeInEnactedTaxRate>
    <us-gaap:IncomeTaxReconciliationStateAndLocalIncomeTaxes
      contextRef="From2022-01-012022-12-31"
      decimals="0"
      id="Fact001312"
      unitRef="USD">-265607</us-gaap:IncomeTaxReconciliationStateAndLocalIncomeTaxes>
    <us-gaap:IncomeTaxReconciliationOtherAdjustments
      contextRef="From2023-01-012023-12-31"
      decimals="0"
      id="Fact001314"
      unitRef="USD">-24569</us-gaap:IncomeTaxReconciliationOtherAdjustments>
    <us-gaap:IncomeTaxReconciliationOtherAdjustments
      contextRef="From2022-01-012022-12-31"
      decimals="0"
      id="Fact001315"
      unitRef="USD">-21965</us-gaap:IncomeTaxReconciliationOtherAdjustments>
    <us-gaap:IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance
      contextRef="From2023-01-012023-12-31"
      decimals="0"
      id="Fact001317"
      unitRef="USD">2103268</us-gaap:IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance>
    <us-gaap:IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance
      contextRef="From2022-01-012022-12-31"
      decimals="0"
      id="Fact001318"
      unitRef="USD">2121416</us-gaap:IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="From2023-01-012023-12-31"
      decimals="0"
      id="Fact001320"
      unitRef="USD">-30000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock contextRef="From2023-01-012023-12-31" id="Fact001323">&lt;p id="xdx_890_eus-gaap--ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock_zGiKRNi3lW48" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
components of the Company&#x2019;s deferred tax assets (liabilities) are as follows:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;span id="xdx_8BD_zqVlxRt6W36c" style="display: none"&gt;Schedule
of Components of Deferred tax Assets&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 70%"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_49B_20231231_z0J5g5RXGe7k" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;b&gt;Year Ended &lt;br/&gt; December 31, &lt;br/&gt; 2023&lt;/b&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_499_20221231_ze9k3w767yP7" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;b&gt;Year Ended &lt;br/&gt; December 31, &lt;br/&gt; 2022&lt;/b&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;Deferred tax assets (liabilities):&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40A_ecustom--DeferredTaxAssetsPropertyPlantAndEquipments_iI_msDTLzq2T_zTwV5gIYuNc2" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="width: 56%; text-align: left"&gt;Fixed assets&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 18%; text-align: right"&gt;(281,073&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;)&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 18%; text-align: right"&gt;(268,594&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_409_eus-gaap--DeferredTaxAssetInterestCarryforward_iI_msDTLzq2T_z96ErXhSyqjb" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td&gt;Interest&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;35,178&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;62,310&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_409_eus-gaap--DeferredTaxAssetsInProcessResearchAndDevelopment_iI_msDTLzq2T_z7ulqOLfvNJ4" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;Research and development expenses&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;400,810&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;454,942&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_401_eus-gaap--DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost_iI_msDTLzq2T_zEB6thclwJQ" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;Stock-based compensation&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;895,509&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;917,351&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_407_eus-gaap--DeferredTaxAssetsCharitableContributionCarryforwards_iI_msDTLzq2T_zq5rACDRarhh" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;Charitable Contributions&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;420&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_402_eus-gaap--DeferredTaxAssetsOperatingLossCarryforwardsDomestic_iI_msDTLzq2T_zmMXtHjgfas9" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;Net operating losses - federal&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;4,456,242&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;2,898,411&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_405_eus-gaap--DeferredTaxAssetsOperatingLossCarryforwardsStateAndLocal_iI_msDTLzq2T_z44uMVdhXKF2" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;Net operating losses &#x2013; state and local&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;543,264&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;921,350&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40E_eus-gaap--DeferredTaxAssetsOperatingLossCarryforwardsForeign_iI_msDTLzq2T_zzGEKTr8ul1c" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;Net operating losses - foreign&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;233,114&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;37,686&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40C_eus-gaap--DeferredTaxAssetsTaxCreditCarryforwardsResearch_iI_msDTLzq2T_zTWDpY8yRTj3" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-bottom: 1pt"&gt;Research credit&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;28,985&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;28,985&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_403_eus-gaap--DeferredTaxAssetsValuationAllowance_iNI_di_maDTLzq2T_ziUKAGcGlkJ5" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-bottom: 1pt"&gt;Less valuation allowance&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;(6,474,449&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;(5,244,441&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40C_eus-gaap--DeferredTaxLiabilities_iNTI_di_mtDTLzq2T_zkOxNhILOU8e" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-bottom: 2.5pt"&gt;Net deferred tax liability&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;(162,000&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;(192,000&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

</us-gaap:ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock>
    <STSS:DeferredTaxAssetsPropertyPlantAndEquipments
      contextRef="AsOf2023-12-31"
      decimals="0"
      id="Fact001325"
      unitRef="USD">-281073</STSS:DeferredTaxAssetsPropertyPlantAndEquipments>
    <STSS:DeferredTaxAssetsPropertyPlantAndEquipments
      contextRef="AsOf2022-12-31"
      decimals="0"
      id="Fact001326"
      unitRef="USD">-268594</STSS:DeferredTaxAssetsPropertyPlantAndEquipments>
    <us-gaap:DeferredTaxAssetInterestCarryforward
      contextRef="AsOf2023-12-31"
      decimals="0"
      id="Fact001328"
      unitRef="USD">35178</us-gaap:DeferredTaxAssetInterestCarryforward>
    <us-gaap:DeferredTaxAssetInterestCarryforward
      contextRef="AsOf2022-12-31"
      decimals="0"
      id="Fact001329"
      unitRef="USD">62310</us-gaap:DeferredTaxAssetInterestCarryforward>
    <us-gaap:DeferredTaxAssetsInProcessResearchAndDevelopment
      contextRef="AsOf2023-12-31"
      decimals="0"
      id="Fact001331"
      unitRef="USD">400810</us-gaap:DeferredTaxAssetsInProcessResearchAndDevelopment>
    <us-gaap:DeferredTaxAssetsInProcessResearchAndDevelopment
      contextRef="AsOf2022-12-31"
      decimals="0"
      id="Fact001332"
      unitRef="USD">454942</us-gaap:DeferredTaxAssetsInProcessResearchAndDevelopment>
    <us-gaap:DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost
      contextRef="AsOf2023-12-31"
      decimals="0"
      id="Fact001334"
      unitRef="USD">895509</us-gaap:DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost>
    <us-gaap:DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost
      contextRef="AsOf2022-12-31"
      decimals="0"
      id="Fact001335"
      unitRef="USD">917351</us-gaap:DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost>
    <us-gaap:DeferredTaxAssetsCharitableContributionCarryforwards
      contextRef="AsOf2023-12-31"
      decimals="0"
      id="Fact001337"
      unitRef="USD">420</us-gaap:DeferredTaxAssetsCharitableContributionCarryforwards>
    <us-gaap:DeferredTaxAssetsOperatingLossCarryforwardsDomestic
      contextRef="AsOf2023-12-31"
      decimals="0"
      id="Fact001340"
      unitRef="USD">4456242</us-gaap:DeferredTaxAssetsOperatingLossCarryforwardsDomestic>
    <us-gaap:DeferredTaxAssetsOperatingLossCarryforwardsDomestic
      contextRef="AsOf2022-12-31"
      decimals="0"
      id="Fact001341"
      unitRef="USD">2898411</us-gaap:DeferredTaxAssetsOperatingLossCarryforwardsDomestic>
    <us-gaap:DeferredTaxAssetsOperatingLossCarryforwardsStateAndLocal
      contextRef="AsOf2023-12-31"
      decimals="0"
      id="Fact001343"
      unitRef="USD">543264</us-gaap:DeferredTaxAssetsOperatingLossCarryforwardsStateAndLocal>
    <us-gaap:DeferredTaxAssetsOperatingLossCarryforwardsStateAndLocal
      contextRef="AsOf2022-12-31"
      decimals="0"
      id="Fact001344"
      unitRef="USD">921350</us-gaap:DeferredTaxAssetsOperatingLossCarryforwardsStateAndLocal>
    <us-gaap:DeferredTaxAssetsOperatingLossCarryforwardsForeign
      contextRef="AsOf2023-12-31"
      decimals="0"
      id="Fact001346"
      unitRef="USD">233114</us-gaap:DeferredTaxAssetsOperatingLossCarryforwardsForeign>
    <us-gaap:DeferredTaxAssetsOperatingLossCarryforwardsForeign
      contextRef="AsOf2022-12-31"
      decimals="0"
      id="Fact001347"
      unitRef="USD">37686</us-gaap:DeferredTaxAssetsOperatingLossCarryforwardsForeign>
    <us-gaap:DeferredTaxAssetsTaxCreditCarryforwardsResearch
      contextRef="AsOf2023-12-31"
      decimals="0"
      id="Fact001349"
      unitRef="USD">28985</us-gaap:DeferredTaxAssetsTaxCreditCarryforwardsResearch>
    <us-gaap:DeferredTaxAssetsTaxCreditCarryforwardsResearch
      contextRef="AsOf2022-12-31"
      decimals="0"
      id="Fact001350"
      unitRef="USD">28985</us-gaap:DeferredTaxAssetsTaxCreditCarryforwardsResearch>
    <us-gaap:DeferredTaxAssetsValuationAllowance
      contextRef="AsOf2023-12-31"
      decimals="0"
      id="Fact001352"
      unitRef="USD">6474449</us-gaap:DeferredTaxAssetsValuationAllowance>
    <us-gaap:DeferredTaxAssetsValuationAllowance
      contextRef="AsOf2022-12-31"
      decimals="0"
      id="Fact001353"
      unitRef="USD">5244441</us-gaap:DeferredTaxAssetsValuationAllowance>
    <us-gaap:DeferredTaxLiabilities
      contextRef="AsOf2023-12-31"
      decimals="0"
      id="Fact001355"
      unitRef="USD">162000</us-gaap:DeferredTaxLiabilities>
    <us-gaap:DeferredTaxLiabilities
      contextRef="AsOf2022-12-31"
      decimals="0"
      id="Fact001356"
      unitRef="USD">192000</us-gaap:DeferredTaxLiabilities>
    <us-gaap:OperatingLossCarryforwards
      contextRef="AsOf2023-12-31_us-gaap_DomesticCountryMember"
      decimals="0"
      id="Fact001358"
      unitRef="USD">21222000</us-gaap:OperatingLossCarryforwards>
    <us-gaap:OperatingLossCarryforwards
      contextRef="AsOf2023-12-31_us-gaap_DomesticCountryMember_custom_ExpiresOnTwoThousandTwentyEightMember"
      decimals="0"
      id="Fact001360"
      unitRef="USD">241000</us-gaap:OperatingLossCarryforwards>
    <us-gaap:OperatingLossCarryforwards
      contextRef="AsOf2023-12-31_custom_NotExpireMember_us-gaap_DomesticCountryMember"
      decimals="0"
      id="Fact001362"
      unitRef="USD">20981000</us-gaap:OperatingLossCarryforwards>
    <us-gaap:OperatingLossCarryforwards
      contextRef="AsOf2023-12-31_us-gaap_ForeignCountryMember"
      decimals="0"
      id="Fact001364"
      unitRef="USD">2590000</us-gaap:OperatingLossCarryforwards>
    <us-gaap:ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock contextRef="From2023-01-012023-12-31" id="Fact001366">&lt;p id="xdx_896_eus-gaap--ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock_zBaxIPJlllzi" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
geographical components of loss before income taxes consisted of the following for the years ended December 31:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;span id="xdx_8B9_zO1BxVr7Nt6j" style="display: none"&gt;Schedule
of Geographical Components of Loss Before Income Taxes&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 80%"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;&lt;td&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_496_20230101__20231231_z8rQAVv08OLf" style="text-align: center"&gt;&lt;b&gt;Year Ended&lt;/b&gt;&lt;/td&gt;&lt;td&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;&lt;td&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_494_20220101__20221231_zQDtYGlN93ac" style="text-align: center"&gt;&lt;b&gt;Year Ended&lt;/b&gt;&lt;/td&gt;&lt;td&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;b&gt;December 31, &lt;br/&gt; 2023&lt;/b&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;b&gt;December 31,&lt;br/&gt; 2022&lt;/b&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_406_eus-gaap--IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic_maILFCOzLlh_z7Si8U5ZTw9j" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 60%; text-align: left"&gt;United Stated Operations&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 16%; text-align: right"&gt;(8,173,807&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;)&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 16%; text-align: right"&gt;(3,978,832&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_404_eus-gaap--IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign_maILFCOzLlh_zL5XFyf7DTp9" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-bottom: 1pt"&gt;International Operations&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;(1,667,831&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;(660,830&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_406_eus-gaap--IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_iT_mtILFCOzLlh_zust0jwVE531" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-bottom: 1pt"&gt;(Loss) Income before taxes&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;(9,871,638&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;(4,639,662&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

</us-gaap:ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic
      contextRef="From2023-01-012023-12-31"
      decimals="0"
      id="Fact001368"
      unitRef="USD">-8173807</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic
      contextRef="From2022-01-012022-12-31"
      decimals="0"
      id="Fact001369"
      unitRef="USD">-3978832</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign
      contextRef="From2023-01-012023-12-31"
      decimals="0"
      id="Fact001371"
      unitRef="USD">-1667831</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign
      contextRef="From2022-01-012022-12-31"
      decimals="0"
      id="Fact001372"
      unitRef="USD">-660830</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="From2023-01-012023-12-31"
      decimals="0"
      id="Fact001374"
      unitRef="USD">-9871638</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="From2022-01-012022-12-31"
      decimals="0"
      id="Fact001375"
      unitRef="USD">-4639662</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:RelatedPartyTransactionsDisclosureTextBlock contextRef="From2023-01-012023-12-31" id="Fact001377">&lt;p id="xdx_801_eus-gaap--RelatedPartyTransactionsDisclosureTextBlock_zazce8lT2Qij" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Note
13. &lt;span id="xdx_82F_zersyNF85ovb"&gt;Related Party Transactions and Balances&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;As
of December 31, 2023 and 2022, accounts payable and accrued liabilities include $&lt;span id="xdx_90F_eus-gaap--AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent_iI_c20231231__srt--TitleOfIndividualAxis__custom--OfficersAndDirectorsMember_zTvswU3GK5Se" title="Accounts payable and accrued liabilities"&gt;32,974&lt;/span&gt; and $&lt;span id="xdx_907_eus-gaap--AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent_iI_c20221231__srt--TitleOfIndividualAxis__custom--OfficersAndDirectorsMember_zlTqITki0d66" title="Accounts payable and accrued liabilities"&gt;105,667&lt;/span&gt;, respectively, payable to officers,
and directors of the Company. The amounts are unsecured, non-interest bearing and are due on demand (See Note 15).&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

</us-gaap:RelatedPartyTransactionsDisclosureTextBlock>
    <us-gaap:AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent
      contextRef="AsOf2023-12-31_custom_OfficersAndDirectorsMember"
      decimals="0"
      id="Fact001379"
      unitRef="USD">32974</us-gaap:AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent>
    <us-gaap:AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent
      contextRef="AsOf2022-12-31_custom_OfficersAndDirectorsMember"
      decimals="0"
      id="Fact001381"
      unitRef="USD">105667</us-gaap:AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent>
    <us-gaap:FairValueMeasurementInputsDisclosureTextBlock contextRef="From2023-01-012023-12-31" id="Fact001383">&lt;p id="xdx_804_eus-gaap--FairValueMeasurementInputsDisclosureTextBlock_zgRFoxIvXin8" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Note
14. &lt;span id="xdx_82C_zfLWUdTshi7h"&gt;Fair Value Measurements&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company&#x2019;s financial instruments include cash, accounts payable, notes payable, contingent stock and warrant liability and warrant
liability. Cash, contingent stock liability, contingent warrant liability and warrant liability are measured at fair value. Accounts
payable and notes payable are measured at amortized cost and approximates fair value due to their short duration and market rate for
similar instruments, respectively.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;/span&gt;&lt;/p&gt;



&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;SHARPS
TECHNOLOGY, INC.&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;NOTES
TO THE CONSOLIDATED FINANCIAL STATEMENTS&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;FOR
THE YEARS ENDED DECEMBER 31, 2023 AND 2022&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;


&lt;p style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Note
14. Fair Value Measurements (continued)&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_891_eus-gaap--ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock_zxDqW0yAu905" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;As
of December 31, 2023, the following financial assets and liabilities were measured at fair value on a recurring basis presented on the
Company&#x2019;s consolidated balance sheet:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_8BD_zYTR92xRFZoa" style="display: none"&gt;Schedule
of Assets and Liabilities Measured at Fair Value on Recurring Basis&lt;/span&gt;&#160;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="display: none; vertical-align: bottom"&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_49C_20231231__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member_z2GHeg2d5sg2" style="border-bottom: Black 1pt solid; text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_497_20231231__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member_z7evLALGnlZ" style="border-bottom: Black 1pt solid; text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_491_20231231__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member_zkIsZFCa7663" style="border-bottom: Black 1pt solid; text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_49C_20231231_z5mnI8unN3rb" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: center"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;
    &lt;td colspan="10" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;b&gt;Fair Value Measurements Using&lt;/b&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;
    &lt;td colspan="2"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: center"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;b&gt;Level 1&lt;/b&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;b&gt;Level 2&lt;/b&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;b&gt;Level 3&lt;/b&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;&lt;b&gt;Total&lt;/b&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: center"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;&lt;td&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: center"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;&lt;td&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;&lt;td&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: center"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;&lt;td&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;&lt;td&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: center"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;&lt;td&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;&lt;td&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: center"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;&lt;td&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_402_eus-gaap--FinancialInstrumentsFinancialAssetsBalanceSheetGroupingsAbstract_iB_zKCKiuWV95S4" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font-weight: bold"&gt;Assets&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_403_eus-gaap--CashAndCashEquivalentsFairValueDisclosure_iI_zILPeMbyrX79" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="width: 40%"&gt;Cash&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 11%; text-align: right"&gt;3,012,908&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 11%; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1393"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 11%; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1394"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 11%; text-align: right"&gt;3,012,908&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_406_eus-gaap--AssetsFairValueDisclosure_iI_zG7RiQmAR0rg" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font-weight: bold; text-align: left; padding-bottom: 1pt"&gt;Total assets measured at fair value&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right"&gt;3,012,908&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1398"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1399"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right"&gt;3,012,908&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_402_eus-gaap--FinancialInstrumentsFinancialLiabilitiesBalanceSheetGroupingsAbstract_iB_z0jzKRAX0egb" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td&gt;Liabilities&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_405_ecustom--WarrantLiability_iI_zNVO650ZxiGk" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-bottom: 1pt"&gt;Warrant liability&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1407"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;2,422,785&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1409"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;2,422,785&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40B_eus-gaap--LiabilitiesFairValueDisclosure_iI_zgxCT7I3IgY4" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font-weight: bold; text-align: left; padding-bottom: 2.5pt"&gt;Total liabilities measured at fair value&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1412"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right"&gt;2,422,785&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1414"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right"&gt;2,422,785&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;As
of December 31, 2022, the following financial assets and liabilities were measured at fair value on a recurring basis presented on the
Company&#x2019;s consolidated balance sheet:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="display: none; vertical-align: bottom"&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_49F_20221231__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member_zI2ZrE6i1D56" style="border-bottom: Black 1pt solid; text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_493_20221231__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member_zyEkrfBqNYPj" style="border-bottom: Black 1pt solid; text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_49D_20221231__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member_zepFhAwEIj67" style="border-bottom: Black 1pt solid; text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_49F_20221231_zMO0YGfq3qv8" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: center"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;
    &lt;td colspan="10" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;b&gt;Fair Value Measurements Using&lt;/b&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;
    &lt;td colspan="2"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: center"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;b&gt;Level 1&lt;/b&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;b&gt;Level 2&lt;/b&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;b&gt;Level 3&lt;/b&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;&lt;b&gt;Total&lt;/b&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: center"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: center"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: center"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: center"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: center"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_402_eus-gaap--FinancialInstrumentsFinancialAssetsBalanceSheetGroupingsAbstract_iB_zZ0h4m5zpCV6" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font-weight: bold"&gt;Assets&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_403_eus-gaap--CashAndCashEquivalentsFairValueDisclosure_iI_zFsKH6PntU33" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="width: 40%"&gt;Cash&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 11%; text-align: right"&gt;4,170,897&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 11%; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1423"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 11%; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1424"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 11%; text-align: right"&gt;4,170,897&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;-&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;-&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;-&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_406_eus-gaap--AssetsFairValueDisclosure_iI_z9gso5OGflrl" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font-weight: bold; text-align: left; padding-bottom: 1pt"&gt;Total assets measured at fair value&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right"&gt;4,170,897&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1428"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right"&gt;4,170,897&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_404_eus-gaap--FinancialInstrumentsFinancialLiabilitiesBalanceSheetGroupingsAbstract_iB_znHNORGK6ow4" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td&gt;Liabilities&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_403_ecustom--WarrantLiability_iI_zeHj02xUXIze" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-bottom: 1pt"&gt;Warrant liability&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;1,151,838&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1438"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1439"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;1,151,838&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40B_eus-gaap--LiabilitiesFairValueDisclosure_iI_zArStOtPTi4i" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font-weight: bold; text-align: left; padding-bottom: 2.5pt"&gt;Total liabilities measured at fair value&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right"&gt;1,151,838&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1443"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1444"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right"&gt;1,151,838&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p id="xdx_8A7_zj88tgPEyzml" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

</us-gaap:FairValueMeasurementInputsDisclosureTextBlock>
    <us-gaap:ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock contextRef="From2023-01-012023-12-31" id="Fact001385">&lt;p id="xdx_891_eus-gaap--ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock_zxDqW0yAu905" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;As
of December 31, 2023, the following financial assets and liabilities were measured at fair value on a recurring basis presented on the
Company&#x2019;s consolidated balance sheet:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_8BD_zYTR92xRFZoa" style="display: none"&gt;Schedule
of Assets and Liabilities Measured at Fair Value on Recurring Basis&lt;/span&gt;&#160;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="display: none; vertical-align: bottom"&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_49C_20231231__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member_z2GHeg2d5sg2" style="border-bottom: Black 1pt solid; text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_497_20231231__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member_z7evLALGnlZ" style="border-bottom: Black 1pt solid; text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_491_20231231__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member_zkIsZFCa7663" style="border-bottom: Black 1pt solid; text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_49C_20231231_z5mnI8unN3rb" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: center"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;
    &lt;td colspan="10" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;b&gt;Fair Value Measurements Using&lt;/b&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;
    &lt;td colspan="2"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: center"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;b&gt;Level 1&lt;/b&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;b&gt;Level 2&lt;/b&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;b&gt;Level 3&lt;/b&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;&lt;b&gt;Total&lt;/b&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: center"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;&lt;td&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: center"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;&lt;td&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;&lt;td&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: center"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;&lt;td&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;&lt;td&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: center"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;&lt;td&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;&lt;td&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: center"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;&lt;td&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_402_eus-gaap--FinancialInstrumentsFinancialAssetsBalanceSheetGroupingsAbstract_iB_zKCKiuWV95S4" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font-weight: bold"&gt;Assets&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_403_eus-gaap--CashAndCashEquivalentsFairValueDisclosure_iI_zILPeMbyrX79" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="width: 40%"&gt;Cash&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 11%; text-align: right"&gt;3,012,908&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 11%; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1393"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 11%; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1394"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 11%; text-align: right"&gt;3,012,908&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_406_eus-gaap--AssetsFairValueDisclosure_iI_zG7RiQmAR0rg" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font-weight: bold; text-align: left; padding-bottom: 1pt"&gt;Total assets measured at fair value&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right"&gt;3,012,908&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1398"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1399"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right"&gt;3,012,908&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_402_eus-gaap--FinancialInstrumentsFinancialLiabilitiesBalanceSheetGroupingsAbstract_iB_z0jzKRAX0egb" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td&gt;Liabilities&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_405_ecustom--WarrantLiability_iI_zNVO650ZxiGk" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-bottom: 1pt"&gt;Warrant liability&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1407"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;2,422,785&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1409"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;2,422,785&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40B_eus-gaap--LiabilitiesFairValueDisclosure_iI_zgxCT7I3IgY4" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font-weight: bold; text-align: left; padding-bottom: 2.5pt"&gt;Total liabilities measured at fair value&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1412"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right"&gt;2,422,785&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1414"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right"&gt;2,422,785&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;As
of December 31, 2022, the following financial assets and liabilities were measured at fair value on a recurring basis presented on the
Company&#x2019;s consolidated balance sheet:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="display: none; vertical-align: bottom"&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_49F_20221231__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member_zI2ZrE6i1D56" style="border-bottom: Black 1pt solid; text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_493_20221231__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member_zyEkrfBqNYPj" style="border-bottom: Black 1pt solid; text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_49D_20221231__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member_zepFhAwEIj67" style="border-bottom: Black 1pt solid; text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_49F_20221231_zMO0YGfq3qv8" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: center"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;
    &lt;td colspan="10" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;b&gt;Fair Value Measurements Using&lt;/b&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;
    &lt;td colspan="2"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: center"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;b&gt;Level 1&lt;/b&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;b&gt;Level 2&lt;/b&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;b&gt;Level 3&lt;/b&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;&lt;b&gt;Total&lt;/b&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: center"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: center"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: center"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: center"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: center"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_402_eus-gaap--FinancialInstrumentsFinancialAssetsBalanceSheetGroupingsAbstract_iB_zZ0h4m5zpCV6" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font-weight: bold"&gt;Assets&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_403_eus-gaap--CashAndCashEquivalentsFairValueDisclosure_iI_zFsKH6PntU33" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="width: 40%"&gt;Cash&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 11%; text-align: right"&gt;4,170,897&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 11%; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1423"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 11%; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1424"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 11%; text-align: right"&gt;4,170,897&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;-&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;-&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;-&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_406_eus-gaap--AssetsFairValueDisclosure_iI_z9gso5OGflrl" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font-weight: bold; text-align: left; padding-bottom: 1pt"&gt;Total assets measured at fair value&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right"&gt;4,170,897&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1428"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right"&gt;4,170,897&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_404_eus-gaap--FinancialInstrumentsFinancialLiabilitiesBalanceSheetGroupingsAbstract_iB_znHNORGK6ow4" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td&gt;Liabilities&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_403_ecustom--WarrantLiability_iI_zeHj02xUXIze" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-bottom: 1pt"&gt;Warrant liability&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;1,151,838&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1438"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1439"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;1,151,838&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40B_eus-gaap--LiabilitiesFairValueDisclosure_iI_zArStOtPTi4i" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font-weight: bold; text-align: left; padding-bottom: 2.5pt"&gt;Total liabilities measured at fair value&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right"&gt;1,151,838&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1443"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1444"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right"&gt;1,151,838&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

</us-gaap:ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock>
    <us-gaap:CashAndCashEquivalentsFairValueDisclosure
      contextRef="AsOf2023-12-31_us-gaap_FairValueInputsLevel1Member"
      decimals="0"
      id="Fact001392"
      unitRef="USD">3012908</us-gaap:CashAndCashEquivalentsFairValueDisclosure>
    <us-gaap:CashAndCashEquivalentsFairValueDisclosure
      contextRef="AsOf2023-12-31"
      decimals="0"
      id="Fact001395"
      unitRef="USD">3012908</us-gaap:CashAndCashEquivalentsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="AsOf2023-12-31_us-gaap_FairValueInputsLevel1Member"
      decimals="0"
      id="Fact001397"
      unitRef="USD">3012908</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="AsOf2023-12-31"
      decimals="0"
      id="Fact001400"
      unitRef="USD">3012908</us-gaap:AssetsFairValueDisclosure>
    <STSS:WarrantLiability
      contextRef="AsOf2023-12-31_us-gaap_FairValueInputsLevel2Member"
      decimals="0"
      id="Fact001408"
      unitRef="USD">2422785</STSS:WarrantLiability>
    <STSS:WarrantLiability
      contextRef="AsOf2023-12-31"
      decimals="0"
      id="Fact001410"
      unitRef="USD">2422785</STSS:WarrantLiability>
    <us-gaap:LiabilitiesFairValueDisclosure
      contextRef="AsOf2023-12-31_us-gaap_FairValueInputsLevel2Member"
      decimals="0"
      id="Fact001413"
      unitRef="USD">2422785</us-gaap:LiabilitiesFairValueDisclosure>
    <us-gaap:LiabilitiesFairValueDisclosure
      contextRef="AsOf2023-12-31"
      decimals="0"
      id="Fact001415"
      unitRef="USD">2422785</us-gaap:LiabilitiesFairValueDisclosure>
    <us-gaap:CashAndCashEquivalentsFairValueDisclosure
      contextRef="AsOf2022-12-31_us-gaap_FairValueInputsLevel1Member"
      decimals="0"
      id="Fact001422"
      unitRef="USD">4170897</us-gaap:CashAndCashEquivalentsFairValueDisclosure>
    <us-gaap:CashAndCashEquivalentsFairValueDisclosure
      contextRef="AsOf2022-12-31"
      decimals="0"
      id="Fact001425"
      unitRef="USD">4170897</us-gaap:CashAndCashEquivalentsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="AsOf2022-12-31_us-gaap_FairValueInputsLevel1Member"
      decimals="0"
      id="Fact001427"
      unitRef="USD">4170897</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="AsOf2022-12-31"
      decimals="0"
      id="Fact001430"
      unitRef="USD">4170897</us-gaap:AssetsFairValueDisclosure>
    <STSS:WarrantLiability
      contextRef="AsOf2022-12-31_us-gaap_FairValueInputsLevel1Member"
      decimals="0"
      id="Fact001437"
      unitRef="USD">1151838</STSS:WarrantLiability>
    <STSS:WarrantLiability
      contextRef="AsOf2022-12-31"
      decimals="0"
      id="Fact001440"
      unitRef="USD">1151838</STSS:WarrantLiability>
    <us-gaap:LiabilitiesFairValueDisclosure
      contextRef="AsOf2022-12-31_us-gaap_FairValueInputsLevel1Member"
      decimals="0"
      id="Fact001442"
      unitRef="USD">1151838</us-gaap:LiabilitiesFairValueDisclosure>
    <us-gaap:LiabilitiesFairValueDisclosure
      contextRef="AsOf2022-12-31"
      decimals="0"
      id="Fact001445"
      unitRef="USD">1151838</us-gaap:LiabilitiesFairValueDisclosure>
    <us-gaap:CommitmentsAndContingenciesDisclosureTextBlock contextRef="From2023-01-012023-12-31" id="Fact001447">&lt;p id="xdx_804_eus-gaap--CommitmentsAndContingenciesDisclosureTextBlock_zefowiuQzQ6b" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Note
15. &lt;span id="xdx_827_z7839IJqGyv"&gt;Commitments and Contingencies&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;Fixed
Assets and Other&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;At
December 31, 2023, the remaining amounts due under outstanding orders of $&lt;span id="xdx_904_eus-gaap--AccountsPayableCurrentAndNoncurrent_iI_c20231231_zcPrOlkCQnKk" title="Accounts payable"&gt;56,874&lt;/span&gt; is recorded in Accounts Payable. At December 31, 2022,
the Company has outstanding orders to purchase equipment, molds and component parts for research and development of $&lt;span id="xdx_90E_ecustom--OrderCostsToPurchaseEquipmentMoldsAndComponentPartsForResearchAndDevelopment_c20220101__20221231_zHpZqn5gyJ34" title="Total order costs to purchase equipment, molds and component parts for research and development"&gt;609,953&lt;/span&gt; of which
advance payments of $&lt;span id="xdx_904_ecustom--ProgressPayments_c20230101__20231231_zUnn4PRK9KC9" title="Progress payments"&gt;209,678&lt;/span&gt; have been made and recorded in Other Assets (See Note 6).&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;




&lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;SHARPS
TECHNOLOGY, INC.&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;NOTES
TO THE CONSOLIDATED FINANCIAL STATEMENTS&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;FOR
THE YEARS ENDED DECEMBER 31, 2023 AND 2022&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Note
15. Commitments and Contingencies (continued)&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;Contingencies&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;At
each reporting period, the Company evaluates whether or not a potential loss amount or a potential range of loss is probable and reasonably
estimable under the provisions of the authoritative guidance that addresses accounting for contingencies. The Company is currently not
involved in any material litigation or other loss contingencies.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;Royalty
Agreement&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;In
connection with the purchase of certain intellectual property in July 2017, Barry Berler and Alan Blackman entered into a royalty agreement
which provides that Barry Berler will be entitled to a royalty of four percent (&lt;span id="xdx_909_ecustom--RoyaltyPercentage_pid_dp_uPure_c20170701__20170731__us-gaap--TypeOfArrangementAxis__custom--RoyaltyAgreementMember__srt--TitleOfIndividualAxis__custom--BarryBerlerMember_zCKFauY0XfLa" title="Royalty percentage"&gt;4&lt;/span&gt;%) of net sales derived from the use, sale, lease, rent
and export of products related to the intellectual property. The royalty continues until the patent expires or is no longer used in the
Company&#x2019;s product. The royalty agreement was assumed by the Company in December 2017.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;In
September 2018, the Royalty Agreement was amended to reduce the royalty to &lt;span id="xdx_90B_ecustom--RoyaltyPercentage_pid_dp_uPure_c20180901__20180930__us-gaap--TypeOfArrangementAxis__custom--RoyaltyAgreementMember__srt--TitleOfIndividualAxis__custom--BarryBerlerMember_zmTJWkuUvy2i" title="Royalty percentage"&gt;2&lt;/span&gt;% and further provided for a single payment of $&lt;span id="xdx_908_ecustom--SinglePaymentObligation_iI_c20180930__us-gaap--TypeOfArrangementAxis__custom--RoyaltyAgreementMember__srt--TitleOfIndividualAxis__custom--BarryBerlerMember_zL0b5olKvHjg" title="Single payment obligation"&gt;500,000&lt;/span&gt; to
Barry Berler within three years in return for cancellation of all further royalty obligations of the Company. In May 2019, the Royalty
Agreement was further amended to change the payment date to on or before May 31, 2021 or during the term of the amended Royalty Agreement
should the Company be acquired or a controlling interest be acquired. The Company has not made the aforementioned payment or incur any
change in control as such the &lt;span id="xdx_909_ecustom--RoyaltyPercentage_pid_dp_uPure_c20190501__20190531__us-gaap--TypeOfArrangementAxis__custom--RoyaltyAgreementMember__srt--TitleOfIndividualAxis__custom--BarryBerlerMember_zPAN73PHhcW5" title="Royalty percentage"&gt;2&lt;/span&gt;% royalty remains in place.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;Employment
Agreements&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;On
August 1, 2022, the Company cancelled the consulting agreement with Alan Blackman, Co- Chairman and Chief Operating Officer and entered
into an Employment Agreement which provides for annual salary of $&lt;span id="xdx_904_eus-gaap--SalariesAndWages_c20220730__20220801__us-gaap--TypeOfArrangementAxis__custom--EmploymentAgreementMember_z5RdEglnML6c" title="Annual salary"&gt;256,000&lt;/span&gt;, which provides for increases, and provisions compensation
adjustments, expense and tax differential reimbursements, benefits and bonuses. As of September 1, 2022, the annual salary is $&lt;span id="xdx_901_eus-gaap--SalariesAndWages_c20220831__20220901__us-gaap--TypeOfArrangementAxis__custom--EmploymentAgreementMember_zszDBP8Hz4ze" title="Salaries and wages"&gt;320,000&lt;/span&gt;.
At June 30, 2022, the Company approved and accrued a $&lt;span id="xdx_904_eus-gaap--AccruedBonusesCurrentAndNoncurrent_iI_c20220630__srt--TitleOfIndividualAxis__custom--Mr.BlackmanMember_zmC2Lxzl00ya" title="Accrued bonus"&gt;250,000&lt;/span&gt; bonus to Mr. Blackman for services provided in 2022, of which $&lt;span id="xdx_90E_ecustom--PaymentForBonuses_c20230101__20230331__srt--TitleOfIndividualAxis__custom--Mr.BlackmanMember_zTXP89phwRC8" title="Payment for bonuses"&gt;65,000&lt;/span&gt; was
paid subsequent to December 31, 2022. The Company terminated Mr. Blackman&#x2019;s Employment Agreement effective May 1, 2023. Mr. Blackman
continued to serve as the Co-Chairman and a member of the Board of Directors. Subsequent to June 30, 2023, the Company and Mr. Blackman
entered into a separation agreement whereby, Mr. Blackman will be paid severance payments of approximately $&lt;span id="xdx_904_eus-gaap--SeveranceCosts1_c20230701__20230814__srt--TitleOfIndividualAxis__custom--Mr.BlackmanMember_zO0JJdrZaLP" title="Severance costs"&gt;346,000&lt;/span&gt;, which was recorded
as an expense and an accrued expense as of June 30, 2023, over thirteen months, continue his medical benefits for such period with a
cost of approximately $&lt;span id="xdx_90D_ecustom--MedicalBenefitsCost_iI_c20230630__srt--TitleOfIndividualAxis__custom--Mr.BlackmanMember_zaW4S3Krdbth" title="Medical benefit cost"&gt;29,000&lt;/span&gt; which has been accrued at June 30, 2023. At December 31, 2023, the outstanding balance due Mr. Blackman
is $&lt;span id="xdx_905_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue_iI_c20231231__srt--TitleOfIndividualAxis__custom--Mr.BlackmanMember_zXvEch9i2bGa" title="Outstanding balance"&gt;218,000&lt;/span&gt;, which is recorded in accrued expenses. Further, all unvested options were fully vested and the Company recorded a charge
of $&lt;span id="xdx_904_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue_iI_c20231231_zoLvJBETXsHd" title="Fully vested"&gt;60,000&lt;/span&gt;. In connection with the separation agreement, Mr. Blackman no longer serves as Co-Chairman or Board member and has agreed
to vote his Series A Preferred Stock in favor of the election, reelection, and/or designation of each individual nominated to serve as
a director on the Board of Director as shall be identified in an applicable proxy statement filed by the Company for such election of
directors. Once the payments due Mr. Blackman are fully paid, the Series A Preferred Stock shall be deemed immediately cancelled and
forfeited and without further consideration. The Series A Preferred shall at such time be returned to the status of an authorized but
unissued share of preferred stock of the Company.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;/span&gt;&lt;/p&gt;



&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;SHARPS
TECHNOLOGY, INC.&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;NOTES
TO THE CONSOLIDATED FINANCIAL STATEMENTS&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;FOR
THE YEARS ENDED DECEMBER 31, 2023 AND 2022&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Note
15. Commitments and Contingencies (continued)&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;


&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;On
September 30, 2022, the Company entered into a formal employment agreement, effective on such date and will continue until terminated
by either party, subject to the terms of the agreement, with Andrew R. Crescenzo who has been serving as the Company&#x2019;s Chief Financial
Officer on a contract services basis for the last three years. The agreement provided for annual compensation of $&lt;span id="xdx_90B_ecustom--AnnualCompensation_c20220930__20220930__us-gaap--TypeOfArrangementAxis__custom--EmploymentAgreementMember_zGqZGdJoj4ih" title="Annual compensation"&gt;225,000&lt;/span&gt; and plus a
one-time $&lt;span id="xdx_904_eus-gaap--PaymentForIncentiveFee_c20220930__20220930__us-gaap--TypeOfArrangementAxis__custom--EmploymentAgreementMember_zgjWTX2HcIU5" title="Payment  for incentive fee"&gt;18,750&lt;/span&gt; incentive payment upon the commencement of the agreement. During the course of the term, Mr. Crescenzo will be eligible
for (i) performance bonuses to be granted at the discretion of the Company&#x2019;s Compensation Committee and (ii) to participate in
the Company&#x2019;s 2022 Equity Incentive Plan. The agreement contains customary employment terms and conditions.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;In
October 2022, the Company entered into a service agreement (&#x201c;Service Agreement&#x201d;) with an unrelated third-party for marketing
and investor relations services. The Service Agreement, which has a term of one year, has various deliverables and provides payments
to the third party as follows; a) an initial fee of $&lt;span id="xdx_90B_ecustom--InitialFee_c20221001__20221031__us-gaap--TypeOfArrangementAxis__custom--ServiceAgreementMember_z16F9lSyXzJa" title="Initial fee"&gt;90,000&lt;/span&gt;, b) monthly fees through the term of $&lt;span id="xdx_90D_ecustom--MonthlyFee_c20221001__20221031__us-gaap--TypeOfArrangementAxis__custom--ServiceAgreementMember_z9y9NK2Xeg4f" title="Monthly fee"&gt;12,500&lt;/span&gt;, c) &lt;span id="xdx_906_eus-gaap--StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures_c20221001__20221031__us-gaap--TypeOfArrangementAxis__custom--ServiceAgreementMember_z9aPNmc6VNUf" title="Shares of restricted common stock"&gt;200,000&lt;/span&gt; shares of restricted
common stock and d) $&lt;span id="xdx_902_ecustom--ValueOfDigitalMarketingActivities_iI_c20221031__us-gaap--TypeOfArrangementAxis__custom--ServiceAgreementMember_zo6xW8uqi6w4" title="Value of digital marketing activities"&gt;300,000&lt;/span&gt; specifically related to digital marketing activities. As stated in Note 8, the &lt;span id="xdx_90B_eus-gaap--StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures_c20221001__20221031__us-gaap--TypeOfArrangementAxis__custom--ServiceAgreementMember_zNBHiUObJaNj" title="Shares of restricted common stock"&gt;200,000&lt;/span&gt; shares of restricted
common stock were valued at $&lt;span id="xdx_906_eus-gaap--StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures_c20221001__20221031__us-gaap--TypeOfArrangementAxis__custom--ServiceAgreementMember_zgaDgDDNAXv5" title="Value of restricted common stock"&gt;230,000&lt;/span&gt;, representative of the trading price on the issuance.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;On
February 9, 2023, the Company, appointed Justin Page, as Vice President of Technical Operations with a start date of February 15, 2023.
The agreement provides for annual compensation of $&lt;span id="xdx_906_eus-gaap--EmployeeBenefitsAndShareBasedCompensation_c20230208__20230209_zUnxmjli64Yf" title="Compensation cost"&gt;235,000&lt;/span&gt; and Options to purchase &lt;span id="xdx_903_eus-gaap--StockIssuedDuringPeriodSharesShareBasedCompensation_c20230208__20230209_z0jVrcLx4Cal" title="Options to purchase shares"&gt;50,000&lt;/span&gt; shares of Common Stock at the exercise price
of $&lt;span id="xdx_907_eus-gaap--SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1_iI_c20230209_zETnKyLdlt4g" title="Stock option, exercise price"&gt;1.30&lt;/span&gt;, the closing price on the grant date. During the course of the term, Mr. Paige will be eligible for (i) performance bonuses
to be granted at the discretion of the Company&#x2019;s Compensation Committee and (ii) to participate in the Company&#x2019;s Equity Incentive
Plan. The agreement contains customary employment terms and conditions and provides for severance of six months if a change in control
occurs, as defined.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;On
November 10, 2023, the Company executed an Employment Agreement with Robert Hayes, its Chief Executive Officer amending the employment
letter dated September 6, 2021. The agreement term automatically renews for successive one-year terms as of the commencement date unless
prior written notice by either party within ninety days prior to end of the current term. The agreement provides for termination of employment
and severance benefits under stated conditions and restrictive covenants. The agreement provides for annual compensation retroactive
to June 1, 2023 of $&lt;span id="xdx_90D_ecustom--AnnualCompensation_c20230601__20230601__us-gaap--TypeOfArrangementAxis__custom--EmploymentAgreementMember_zxErqHiMWyNg" title="Annual compensation"&gt;600,000&lt;/span&gt; from $&lt;span id="xdx_905_ecustom--AnnualCompensation_c20230531__20230531__us-gaap--TypeOfArrangementAxis__custom--EmploymentAgreementMember_zI0ExhBPboic" title="Annual compensation"&gt;400,000&lt;/span&gt; and a stated increase with the successful acquisition of InjectEZ and other terms of the acquisition
agreement (See Note 5). The agreement provides for bonus compensation for: (i) closing the Nephron acquisition agreement, (ii) long-term
incentives for achieving revenue targets and market caps for the Company&#x2019;s stock and (iii) other Company achievements. In addition,
the agreement provides for benefits and paid time off.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

</us-gaap:CommitmentsAndContingenciesDisclosureTextBlock>
    <us-gaap:AccountsPayableCurrentAndNoncurrent
      contextRef="AsOf2023-12-31"
      decimals="0"
      id="Fact001449"
      unitRef="USD">56874</us-gaap:AccountsPayableCurrentAndNoncurrent>
    <STSS:OrderCostsToPurchaseEquipmentMoldsAndComponentPartsForResearchAndDevelopment
      contextRef="From2022-01-012022-12-31"
      decimals="0"
      id="Fact001451"
      unitRef="USD">609953</STSS:OrderCostsToPurchaseEquipmentMoldsAndComponentPartsForResearchAndDevelopment>
    <STSS:ProgressPayments
      contextRef="From2023-01-012023-12-31"
      decimals="0"
      id="Fact001453"
      unitRef="USD">209678</STSS:ProgressPayments>
    <STSS:RoyaltyPercentage
      contextRef="From2017-07-012017-07-31_custom_RoyaltyAgreementMember_custom_BarryBerlerMember"
      decimals="INF"
      id="Fact001455"
      unitRef="Pure">0.04</STSS:RoyaltyPercentage>
    <STSS:RoyaltyPercentage
      contextRef="From2018-09-012018-09-30_custom_RoyaltyAgreementMember_custom_BarryBerlerMember"
      decimals="INF"
      id="Fact001457"
      unitRef="Pure">0.02</STSS:RoyaltyPercentage>
    <STSS:SinglePaymentObligation
      contextRef="AsOf2018-09-30_custom_RoyaltyAgreementMember_custom_BarryBerlerMember"
      decimals="0"
      id="Fact001459"
      unitRef="USD">500000</STSS:SinglePaymentObligation>
    <STSS:RoyaltyPercentage
      contextRef="From2019-05-012019-05-31_custom_RoyaltyAgreementMember_custom_BarryBerlerMember"
      decimals="INF"
      id="Fact001461"
      unitRef="Pure">0.02</STSS:RoyaltyPercentage>
    <us-gaap:SalariesAndWages
      contextRef="From2022-07-302022-08-01_custom_EmploymentAgreementMember"
      decimals="0"
      id="Fact001463"
      unitRef="USD">256000</us-gaap:SalariesAndWages>
    <us-gaap:SalariesAndWages
      contextRef="From2022-08-312022-09-01_custom_EmploymentAgreementMember"
      decimals="0"
      id="Fact001465"
      unitRef="USD">320000</us-gaap:SalariesAndWages>
    <us-gaap:AccruedBonusesCurrentAndNoncurrent
      contextRef="AsOf2022-06-30_custom_Mr.BlackmanMember"
      decimals="0"
      id="Fact001467"
      unitRef="USD">250000</us-gaap:AccruedBonusesCurrentAndNoncurrent>
    <STSS:PaymentForBonuses
      contextRef="From2023-01-012023-03-31_custom_Mr.BlackmanMember"
      decimals="0"
      id="Fact001469"
      unitRef="USD">65000</STSS:PaymentForBonuses>
    <us-gaap:SeveranceCosts1
      contextRef="From2023-07-012023-08-14_custom_Mr.BlackmanMember"
      decimals="0"
      id="Fact001471"
      unitRef="USD">346000</us-gaap:SeveranceCosts1>
    <STSS:MedicalBenefitsCost
      contextRef="AsOf2023-06-30_custom_Mr.BlackmanMember"
      decimals="0"
      id="Fact001473"
      unitRef="USD">29000</STSS:MedicalBenefitsCost>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue
      contextRef="AsOf2023-12-31_custom_Mr.BlackmanMember"
      decimals="0"
      id="Fact001475"
      unitRef="USD">218000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue
      contextRef="AsOf2023-12-31"
      decimals="0"
      id="Fact001477"
      unitRef="USD">60000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue>
    <STSS:AnnualCompensation
      contextRef="From2022-09-302022-09-30_custom_EmploymentAgreementMember"
      decimals="0"
      id="Fact001479"
      unitRef="USD">225000</STSS:AnnualCompensation>
    <us-gaap:PaymentForIncentiveFee
      contextRef="From2022-09-302022-09-30_custom_EmploymentAgreementMember"
      decimals="0"
      id="Fact001481"
      unitRef="USD">18750</us-gaap:PaymentForIncentiveFee>
    <STSS:InitialFee
      contextRef="From2022-10-012022-10-31_custom_ServiceAgreementMember"
      decimals="0"
      id="Fact001483"
      unitRef="USD">90000</STSS:InitialFee>
    <STSS:MonthlyFee
      contextRef="From2022-10-012022-10-31_custom_ServiceAgreementMember"
      decimals="0"
      id="Fact001485"
      unitRef="USD">12500</STSS:MonthlyFee>
    <us-gaap:StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures
      contextRef="From2022-10-012022-10-31_custom_ServiceAgreementMember"
      decimals="INF"
      id="Fact001487"
      unitRef="Shares">200000</us-gaap:StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures>
    <STSS:ValueOfDigitalMarketingActivities
      contextRef="AsOf2022-10-31_custom_ServiceAgreementMember"
      decimals="0"
      id="Fact001489"
      unitRef="USD">300000</STSS:ValueOfDigitalMarketingActivities>
    <us-gaap:StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures
      contextRef="From2022-10-012022-10-31_custom_ServiceAgreementMember"
      decimals="INF"
      id="Fact001491"
      unitRef="Shares">200000</us-gaap:StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures>
    <us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures
      contextRef="From2022-10-012022-10-31_custom_ServiceAgreementMember"
      decimals="0"
      id="Fact001493"
      unitRef="USD">230000</us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures>
    <us-gaap:EmployeeBenefitsAndShareBasedCompensation
      contextRef="From2023-02-082023-02-09"
      decimals="0"
      id="Fact001495"
      unitRef="USD">235000</us-gaap:EmployeeBenefitsAndShareBasedCompensation>
    <us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation
      contextRef="From2023-02-082023-02-09"
      decimals="INF"
      id="Fact001497"
      unitRef="Shares">50000</us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation>
    <us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1
      contextRef="AsOf2023-02-09"
      decimals="INF"
      id="Fact001499"
      unitRef="USDPShares">1.30</us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1>
    <STSS:AnnualCompensation
      contextRef="From2023-06-012023-06-01_custom_EmploymentAgreementMember"
      decimals="0"
      id="Fact001501"
      unitRef="USD">600000</STSS:AnnualCompensation>
    <STSS:AnnualCompensation
      contextRef="From2023-05-312023-05-31_custom_EmploymentAgreementMember"
      decimals="0"
      id="Fact001503"
      unitRef="USD">400000</STSS:AnnualCompensation>
    <us-gaap:SubsequentEventsTextBlock contextRef="From2023-01-012023-12-31" id="Fact001505">&lt;p id="xdx_804_eus-gaap--SubsequentEventsTextBlock_zQ7JBnCW0Jad" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Note
16. &lt;span id="xdx_822_zESbKdMP8av2"&gt;Subsequent Events&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;In
January 2024, the holders of &lt;span id="xdx_90B_eus-gaap--ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight_iI_c20240101__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_ziQEJ9963WM6"&gt;398,441
&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;of pre-funded warrants exercised their warrants
at the exercise price of $&lt;span id="xdx_904_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_pid_c20240101__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_zB5i2WPshI4d"&gt;.001&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;.&lt;/span&gt;&lt;/p&gt;

</us-gaap:SubsequentEventsTextBlock>
    <us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight
      contextRef="AsOf2024-01-01_us-gaap_WarrantMember_us-gaap_SubsequentEventMember"
      decimals="INF"
      id="Fact001506"
      unitRef="Shares">398441</us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight>
    <us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
      contextRef="AsOf2024-01-01_us-gaap_WarrantMember_us-gaap_SubsequentEventMember"
      decimals="INF"
      id="Fact001507"
      unitRef="USDPShares">0.001</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue
      contextRef="AsOf2024-09-30"
      decimals="0"
      id="Fact001515"
      unitRef="USD">2473197</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue
      contextRef="AsOf2023-12-31"
      decimals="0"
      id="Fact001516"
      unitRef="USD">3012908</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:PrepaidExpenseAndOtherAssetsCurrent
      contextRef="AsOf2024-09-30"
      decimals="0"
      id="Fact001518"
      unitRef="USD">161337</us-gaap:PrepaidExpenseAndOtherAssetsCurrent>
    <us-gaap:PrepaidExpenseAndOtherAssetsCurrent
      contextRef="AsOf2023-12-31"
      decimals="0"
      id="Fact001519"
      unitRef="USD">116508</us-gaap:PrepaidExpenseAndOtherAssetsCurrent>
    <us-gaap:InventoryNet
      contextRef="AsOf2024-09-30"
      decimals="0"
      id="Fact001521"
      unitRef="USD">2019481</us-gaap:InventoryNet>
    <us-gaap:InventoryNet
      contextRef="AsOf2023-12-31"
      decimals="0"
      id="Fact001522"
      unitRef="USD">1709135</us-gaap:InventoryNet>
    <us-gaap:AssetsCurrent
      contextRef="AsOf2024-09-30"
      decimals="0"
      id="Fact001524"
      unitRef="USD">4654015</us-gaap:AssetsCurrent>
    <us-gaap:AssetsCurrent
      contextRef="AsOf2023-12-31"
      decimals="0"
      id="Fact001525"
      unitRef="USD">4838551</us-gaap:AssetsCurrent>
    <us-gaap:PropertyPlantAndEquipmentNet
      contextRef="AsOf2024-09-30"
      decimals="0"
      id="Fact001527"
      unitRef="USD">6233595</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:PropertyPlantAndEquipmentNet
      contextRef="AsOf2023-12-31"
      decimals="0"
      id="Fact001528"
      unitRef="USD">6822142</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:OtherAssetsNoncurrent
      contextRef="AsOf2024-09-30"
      decimals="0"
      id="Fact001530"
      unitRef="USD">366288</us-gaap:OtherAssetsNoncurrent>
    <us-gaap:OtherAssetsNoncurrent
      contextRef="AsOf2023-12-31"
      decimals="0"
      id="Fact001531"
      unitRef="USD">128575</us-gaap:OtherAssetsNoncurrent>
    <us-gaap:Assets
      contextRef="AsOf2024-09-30"
      decimals="0"
      id="Fact001533"
      unitRef="USD">11253898</us-gaap:Assets>
    <us-gaap:Assets
      contextRef="AsOf2023-12-31"
      decimals="0"
      id="Fact001534"
      unitRef="USD">11789268</us-gaap:Assets>
    <us-gaap:AccountsPayableCurrent
      contextRef="AsOf2024-09-30"
      decimals="0"
      id="Fact001542"
      unitRef="USD">945625</us-gaap:AccountsPayableCurrent>
    <us-gaap:AccountsPayableCurrent
      contextRef="AsOf2023-12-31"
      decimals="0"
      id="Fact001543"
      unitRef="USD">794107</us-gaap:AccountsPayableCurrent>
    <us-gaap:AccountsPayableAndOtherAccruedLiabilitiesCurrent
      contextRef="AsOf2024-09-30"
      decimals="0"
      id="Fact001545"
      unitRef="USD">279326</us-gaap:AccountsPayableAndOtherAccruedLiabilitiesCurrent>
    <us-gaap:AccountsPayableAndOtherAccruedLiabilitiesCurrent
      contextRef="AsOf2023-12-31"
      decimals="0"
      id="Fact001546"
      unitRef="USD">476090</us-gaap:AccountsPayableAndOtherAccruedLiabilitiesCurrent>
    <us-gaap:NotesPayableCurrent
      contextRef="AsOf2024-09-30"
      decimals="0"
      id="Fact001548"
      unitRef="USD">2334142</us-gaap:NotesPayableCurrent>
    <STSS:WarrantLiabilitiesCurrent
      contextRef="AsOf2024-09-30"
      decimals="0"
      id="Fact001551"
      unitRef="USD">1027102</STSS:WarrantLiabilitiesCurrent>
    <STSS:WarrantLiabilitiesCurrent
      contextRef="AsOf2023-12-31"
      decimals="0"
      id="Fact001552"
      unitRef="USD">2422785</STSS:WarrantLiabilitiesCurrent>
    <us-gaap:LiabilitiesCurrent
      contextRef="AsOf2024-09-30"
      decimals="0"
      id="Fact001554"
      unitRef="USD">4586195</us-gaap:LiabilitiesCurrent>
    <us-gaap:LiabilitiesCurrent
      contextRef="AsOf2023-12-31"
      decimals="0"
      id="Fact001555"
      unitRef="USD">3692982</us-gaap:LiabilitiesCurrent>
    <us-gaap:DeferredIncomeTaxLiabilitiesNet
      contextRef="AsOf2024-09-30"
      decimals="0"
      id="Fact001557"
      unitRef="USD">162000</us-gaap:DeferredIncomeTaxLiabilitiesNet>
    <us-gaap:DeferredIncomeTaxLiabilitiesNet
      contextRef="AsOf2023-12-31"
      decimals="0"
      id="Fact001558"
      unitRef="USD">162000</us-gaap:DeferredIncomeTaxLiabilitiesNet>
    <us-gaap:Liabilities
      contextRef="AsOf2024-09-30"
      decimals="0"
      id="Fact001560"
      unitRef="USD">4748195</us-gaap:Liabilities>
    <us-gaap:Liabilities
      contextRef="AsOf2023-12-31"
      decimals="0"
      id="Fact001561"
      unitRef="USD">3854982</us-gaap:Liabilities>
    <us-gaap:PreferredStockParOrStatedValuePerShare
      contextRef="AsOf2024-09-30"
      decimals="INF"
      id="Fact001572"
      unitRef="USDPShares">0.0001</us-gaap:PreferredStockParOrStatedValuePerShare>
    <us-gaap:PreferredStockParOrStatedValuePerShare
      contextRef="AsOf2023-12-31"
      decimals="INF"
      id="Fact001574"
      unitRef="USDPShares">0.0001</us-gaap:PreferredStockParOrStatedValuePerShare>
    <us-gaap:PreferredStockSharesAuthorized
      contextRef="AsOf2024-09-30"
      decimals="INF"
      id="Fact001576"
      unitRef="Shares">1000000</us-gaap:PreferredStockSharesAuthorized>
    <us-gaap:PreferredStockSharesAuthorized
      contextRef="AsOf2023-12-31"
      decimals="INF"
      id="Fact001578"
      unitRef="Shares">1000000</us-gaap:PreferredStockSharesAuthorized>
    <us-gaap:PreferredStockSharesIssued
      contextRef="AsOf2024-09-30"
      decimals="INF"
      id="Fact001580"
      unitRef="Shares">0</us-gaap:PreferredStockSharesIssued>
    <us-gaap:PreferredStockSharesOutstanding
      contextRef="AsOf2024-09-30"
      decimals="INF"
      id="Fact001582"
      unitRef="Shares">0</us-gaap:PreferredStockSharesOutstanding>
    <us-gaap:PreferredStockSharesIssued
      contextRef="AsOf2023-12-31"
      decimals="INF"
      id="Fact001584"
      unitRef="Shares">1</us-gaap:PreferredStockSharesIssued>
    <us-gaap:PreferredStockSharesOutstanding
      contextRef="AsOf2023-12-31"
      decimals="INF"
      id="Fact001586"
      unitRef="Shares">1</us-gaap:PreferredStockSharesOutstanding>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="AsOf2024-09-30"
      decimals="INF"
      id="Fact001591"
      unitRef="USDPShares">0.0001</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="AsOf2023-12-31"
      decimals="INF"
      id="Fact001593"
      unitRef="USDPShares">0.0001</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:CommonStockSharesAuthorized
      contextRef="AsOf2024-09-30"
      decimals="INF"
      id="Fact001595"
      unitRef="Shares">500000000</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:CommonStockSharesAuthorized
      contextRef="AsOf2023-12-31"
      decimals="INF"
      id="Fact001597"
      unitRef="Shares">100000000</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:CommonStockSharesAuthorized
      contextRef="AsOf2023-12-31"
      decimals="INF"
      id="Fact001599"
      unitRef="Shares">100000000</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:CommonStockSharesIssued
      contextRef="AsOf2024-09-30"
      decimals="INF"
      id="Fact001601"
      unitRef="Shares">1694110</us-gaap:CommonStockSharesIssued>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="AsOf2024-09-30"
      decimals="INF"
      id="Fact001603"
      unitRef="Shares">1694110</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:CommonStockSharesIssued
      contextRef="AsOf2023-12-31"
      decimals="INF"
      id="Fact001605"
      unitRef="Shares">694294</us-gaap:CommonStockSharesIssued>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="AsOf2023-12-31"
      decimals="INF"
      id="Fact001607"
      unitRef="Shares">694294</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:CommonStockValue
      contextRef="AsOf2024-09-30"
      decimals="0"
      id="Fact001588"
      unitRef="USD">170</us-gaap:CommonStockValue>
    <us-gaap:CommonStockValue
      contextRef="AsOf2023-12-31"
      decimals="0"
      id="Fact001589"
      unitRef="USD">69</us-gaap:CommonStockValue>
    <us-gaap:AdditionalPaidInCapital
      contextRef="AsOf2024-09-30"
      decimals="0"
      id="Fact001609"
      unitRef="USD">35941738</us-gaap:AdditionalPaidInCapital>
    <us-gaap:AdditionalPaidInCapital
      contextRef="AsOf2023-12-31"
      decimals="0"
      id="Fact001610"
      unitRef="USD">32491409</us-gaap:AdditionalPaidInCapital>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax
      contextRef="AsOf2024-09-30"
      decimals="0"
      id="Fact001612"
      unitRef="USD">482572</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax
      contextRef="AsOf2023-12-31"
      decimals="0"
      id="Fact001613"
      unitRef="USD">591812</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:RetainedEarningsAccumulatedDeficit
      contextRef="AsOf2024-09-30"
      decimals="0"
      id="Fact001615"
      unitRef="USD">-29918777</us-gaap:RetainedEarningsAccumulatedDeficit>
    <us-gaap:RetainedEarningsAccumulatedDeficit
      contextRef="AsOf2023-12-31"
      decimals="0"
      id="Fact001616"
      unitRef="USD">-25149004</us-gaap:RetainedEarningsAccumulatedDeficit>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2024-09-30"
      decimals="0"
      id="Fact001618"
      unitRef="USD">6505703</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2023-12-31"
      decimals="0"
      id="Fact001619"
      unitRef="USD">7934286</us-gaap:StockholdersEquity>
    <us-gaap:LiabilitiesAndStockholdersEquity
      contextRef="AsOf2024-09-30"
      decimals="0"
      id="Fact001621"
      unitRef="USD">11253898</us-gaap:LiabilitiesAndStockholdersEquity>
    <us-gaap:LiabilitiesAndStockholdersEquity
      contextRef="AsOf2023-12-31"
      decimals="0"
      id="Fact001622"
      unitRef="USD">11789268</us-gaap:LiabilitiesAndStockholdersEquity>
    <us-gaap:ResearchAndDevelopmentExpense
      contextRef="From2024-07-012024-09-30"
      decimals="0"
      id="Fact001634"
      unitRef="USD">145611</us-gaap:ResearchAndDevelopmentExpense>
    <us-gaap:ResearchAndDevelopmentExpense
      contextRef="From2023-07-012023-09-30"
      decimals="0"
      id="Fact001635"
      unitRef="USD">225191</us-gaap:ResearchAndDevelopmentExpense>
    <us-gaap:ResearchAndDevelopmentExpense
      contextRef="From2024-01-01to2024-09-30"
      decimals="0"
      id="Fact001636"
      unitRef="USD">523347</us-gaap:ResearchAndDevelopmentExpense>
    <us-gaap:ResearchAndDevelopmentExpense
      contextRef="From2023-01-012023-09-30"
      decimals="0"
      id="Fact001637"
      unitRef="USD">783340</us-gaap:ResearchAndDevelopmentExpense>
    <us-gaap:GeneralAndAdministrativeExpense
      contextRef="From2024-07-012024-09-30"
      decimals="0"
      id="Fact001639"
      unitRef="USD">1869598</us-gaap:GeneralAndAdministrativeExpense>
    <us-gaap:GeneralAndAdministrativeExpense
      contextRef="From2023-07-012023-09-30"
      decimals="0"
      id="Fact001640"
      unitRef="USD">2133167</us-gaap:GeneralAndAdministrativeExpense>
    <us-gaap:GeneralAndAdministrativeExpense
      contextRef="From2024-01-01to2024-09-30"
      decimals="0"
      id="Fact001641"
      unitRef="USD">5257015</us-gaap:GeneralAndAdministrativeExpense>
    <us-gaap:GeneralAndAdministrativeExpense
      contextRef="From2023-01-012023-09-30"
      decimals="0"
      id="Fact001642"
      unitRef="USD">6425154</us-gaap:GeneralAndAdministrativeExpense>
    <us-gaap:OperatingExpenses
      contextRef="From2024-07-012024-09-30"
      decimals="0"
      id="Fact001644"
      unitRef="USD">2015209</us-gaap:OperatingExpenses>
    <us-gaap:OperatingExpenses
      contextRef="From2023-07-012023-09-30"
      decimals="0"
      id="Fact001645"
      unitRef="USD">2358358</us-gaap:OperatingExpenses>
    <us-gaap:OperatingExpenses
      contextRef="From2024-01-01to2024-09-30"
      decimals="0"
      id="Fact001646"
      unitRef="USD">5780362</us-gaap:OperatingExpenses>
    <us-gaap:OperatingExpenses
      contextRef="From2023-01-012023-09-30"
      decimals="0"
      id="Fact001647"
      unitRef="USD">7208494</us-gaap:OperatingExpenses>
    <us-gaap:OperatingIncomeLoss
      contextRef="From2024-07-012024-09-30"
      decimals="0"
      id="Fact001649"
      unitRef="USD">-2015209</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="From2023-07-012023-09-30"
      decimals="0"
      id="Fact001650"
      unitRef="USD">-2358358</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="From2024-01-01to2024-09-30"
      decimals="0"
      id="Fact001651"
      unitRef="USD">-5780362</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="From2023-01-012023-09-30"
      decimals="0"
      id="Fact001652"
      unitRef="USD">-7208494</us-gaap:OperatingIncomeLoss>
    <us-gaap:OtherNonoperatingIncomeExpense
      contextRef="From2024-07-012024-09-30"
      decimals="0"
      id="Fact001659"
      unitRef="USD">-70905</us-gaap:OtherNonoperatingIncomeExpense>
    <us-gaap:OtherNonoperatingIncomeExpense
      contextRef="From2023-07-012023-09-30"
      decimals="0"
      id="Fact001660"
      unitRef="USD">17620</us-gaap:OtherNonoperatingIncomeExpense>
    <us-gaap:OtherNonoperatingIncomeExpense
      contextRef="From2024-01-01to2024-09-30"
      decimals="0"
      id="Fact001661"
      unitRef="USD">-1046593</us-gaap:OtherNonoperatingIncomeExpense>
    <us-gaap:OtherNonoperatingIncomeExpense
      contextRef="From2023-01-012023-09-30"
      decimals="0"
      id="Fact001662"
      unitRef="USD">94492</us-gaap:OtherNonoperatingIncomeExpense>
    <us-gaap:GainLossOnSaleOfDerivatives
      contextRef="From2024-07-012024-09-30"
      decimals="0"
      id="Fact001664"
      unitRef="USD">416560</us-gaap:GainLossOnSaleOfDerivatives>
    <us-gaap:GainLossOnSaleOfDerivatives
      contextRef="From2023-07-012023-09-30"
      decimals="0"
      id="Fact001665"
      unitRef="USD">321981</us-gaap:GainLossOnSaleOfDerivatives>
    <us-gaap:GainLossOnSaleOfDerivatives
      contextRef="From2024-01-01to2024-09-30"
      decimals="0"
      id="Fact001666"
      unitRef="USD">2088747</us-gaap:GainLossOnSaleOfDerivatives>
    <us-gaap:GainLossOnSaleOfDerivatives
      contextRef="From2023-01-012023-09-30"
      decimals="0"
      id="Fact001667"
      unitRef="USD">415958</us-gaap:GainLossOnSaleOfDerivatives>
    <us-gaap:GainLossOnSaleOfDerivatives
      contextRef="From2024-07-012024-09-30"
      decimals="0"
      id="Fact001669"
      unitRef="USD">416560</us-gaap:GainLossOnSaleOfDerivatives>
    <us-gaap:GainLossOnSaleOfDerivatives
      contextRef="From2023-07-012023-09-30"
      decimals="0"
      id="Fact001670"
      unitRef="USD">321981</us-gaap:GainLossOnSaleOfDerivatives>
    <us-gaap:GainLossOnSaleOfDerivatives
      contextRef="From2024-01-01to2024-09-30"
      decimals="0"
      id="Fact001671"
      unitRef="USD">2088747</us-gaap:GainLossOnSaleOfDerivatives>
    <us-gaap:GainLossOnSaleOfDerivatives
      contextRef="From2023-01-012023-09-30"
      decimals="0"
      id="Fact001672"
      unitRef="USD">415958</us-gaap:GainLossOnSaleOfDerivatives>
    <STSS:ForeignCurrencyAndNonOperatingIncomeExpenses
      contextRef="From2024-07-012024-09-30"
      decimals="0"
      id="Fact001679"
      unitRef="USD">-15506</STSS:ForeignCurrencyAndNonOperatingIncomeExpenses>
    <STSS:ForeignCurrencyAndNonOperatingIncomeExpenses
      contextRef="From2023-07-012023-09-30"
      decimals="0"
      id="Fact001680"
      unitRef="USD">-3587</STSS:ForeignCurrencyAndNonOperatingIncomeExpenses>
    <STSS:ForeignCurrencyAndNonOperatingIncomeExpenses
      contextRef="From2024-01-01to2024-09-30"
      decimals="0"
      id="Fact001681"
      unitRef="USD">-31566</STSS:ForeignCurrencyAndNonOperatingIncomeExpenses>
    <STSS:ForeignCurrencyAndNonOperatingIncomeExpenses
      contextRef="From2023-01-012023-09-30"
      decimals="0"
      id="Fact001682"
      unitRef="USD">-41955</STSS:ForeignCurrencyAndNonOperatingIncomeExpenses>
    <us-gaap:NonoperatingIncomeExpense
      contextRef="From2024-07-012024-09-30"
      decimals="0"
      id="Fact001684"
      unitRef="USD">330149</us-gaap:NonoperatingIncomeExpense>
    <us-gaap:NonoperatingIncomeExpense
      contextRef="From2023-07-012023-09-30"
      decimals="0"
      id="Fact001685"
      unitRef="USD">336014</us-gaap:NonoperatingIncomeExpense>
    <us-gaap:NonoperatingIncomeExpense
      contextRef="From2024-01-01to2024-09-30"
      decimals="0"
      id="Fact001686"
      unitRef="USD">1010588</us-gaap:NonoperatingIncomeExpense>
    <us-gaap:NonoperatingIncomeExpense
      contextRef="From2023-01-012023-09-30"
      decimals="0"
      id="Fact001687"
      unitRef="USD">468495</us-gaap:NonoperatingIncomeExpense>
    <us-gaap:NetIncomeLoss
      contextRef="From2024-07-012024-09-30"
      decimals="0"
      id="Fact001689"
      unitRef="USD">-1685060</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="From2023-07-012023-09-30"
      decimals="0"
      id="Fact001690"
      unitRef="USD">-2022344</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="From2024-01-01to2024-09-30"
      decimals="0"
      id="Fact001691"
      unitRef="USD">-4769774</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="From2023-01-012023-09-30"
      decimals="0"
      id="Fact001692"
      unitRef="USD">-6739999</us-gaap:NetIncomeLoss>
    <us-gaap:EarningsPerShareBasic
      contextRef="From2024-07-012024-09-30"
      decimals="INF"
      id="Fact001694"
      unitRef="USDPShares">-1.27</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareDiluted
      contextRef="From2024-07-012024-09-30"
      decimals="INF"
      id="Fact001696"
      unitRef="USDPShares">-1.27</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareBasic
      contextRef="From2023-07-012023-09-30"
      decimals="INF"
      id="Fact001698"
      unitRef="USDPShares">-3.77</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareDiluted
      contextRef="From2023-07-012023-09-30"
      decimals="INF"
      id="Fact001700"
      unitRef="USDPShares">-3.77</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareBasic
      contextRef="From2024-01-01to2024-09-30"
      decimals="INF"
      id="Fact001702"
      unitRef="USDPShares">-4.53</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareDiluted
      contextRef="From2024-01-01to2024-09-30"
      decimals="INF"
      id="Fact001704"
      unitRef="USDPShares">-4.53</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareBasic
      contextRef="From2023-01-012023-09-30"
      decimals="INF"
      id="Fact001706"
      unitRef="USDPShares">-13.01</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareDiluted
      contextRef="From2023-01-012023-09-30"
      decimals="INF"
      id="Fact001708"
      unitRef="USDPShares">-13.01</us-gaap:EarningsPerShareDiluted>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="From2024-07-012024-09-30"
      decimals="INF"
      id="Fact001710"
      unitRef="Shares">1331891</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="From2024-07-012024-09-30"
      decimals="INF"
      id="Fact001712"
      unitRef="Shares">1331891</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="From2023-07-012023-09-30"
      decimals="INF"
      id="Fact001714"
      unitRef="Shares">536886</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="From2023-07-012023-09-30"
      decimals="INF"
      id="Fact001716"
      unitRef="Shares">536886</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="From2024-01-01to2024-09-30"
      decimals="INF"
      id="Fact001718"
      unitRef="Shares">1053259</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="From2024-01-01to2024-09-30"
      decimals="INF"
      id="Fact001720"
      unitRef="Shares">1053259</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="From2023-01-012023-09-30"
      decimals="INF"
      id="Fact001722"
      unitRef="Shares">518166</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="From2023-01-012023-09-30"
      decimals="INF"
      id="Fact001724"
      unitRef="Shares">518166</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:NetIncomeLoss
      contextRef="From2024-07-012024-09-30"
      decimals="0"
      id="Fact001726"
      unitRef="USD">-1685060</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="From2023-07-012023-09-30"
      decimals="0"
      id="Fact001727"
      unitRef="USD">-2022344</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="From2024-01-01to2024-09-30"
      decimals="0"
      id="Fact001728"
      unitRef="USD">-4769774</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="From2023-01-012023-09-30"
      decimals="0"
      id="Fact001729"
      unitRef="USD">-6739999</us-gaap:NetIncomeLoss>
    <us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
      contextRef="From2024-07-012024-09-30"
      decimals="0"
      id="Fact001736"
      unitRef="USD">130723</us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
      contextRef="From2023-07-012023-09-30"
      decimals="0"
      id="Fact001737"
      unitRef="USD">-283544</us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
      contextRef="From2024-01-01to2024-09-30"
      decimals="0"
      id="Fact001738"
      unitRef="USD">-109241</us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
      contextRef="From2023-01-012023-09-30"
      decimals="0"
      id="Fact001739"
      unitRef="USD">61314</us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent>
    <us-gaap:ComprehensiveIncomeNetOfTax
      contextRef="From2024-07-012024-09-30"
      decimals="0"
      id="Fact001741"
      unitRef="USD">-1554337</us-gaap:ComprehensiveIncomeNetOfTax>
    <us-gaap:ComprehensiveIncomeNetOfTax
      contextRef="From2023-07-012023-09-30"
      decimals="0"
      id="Fact001742"
      unitRef="USD">-2305888</us-gaap:ComprehensiveIncomeNetOfTax>
    <us-gaap:ComprehensiveIncomeNetOfTax
      contextRef="From2024-01-01to2024-09-30"
      decimals="0"
      id="Fact001743"
      unitRef="USD">-4879015</us-gaap:ComprehensiveIncomeNetOfTax>
    <us-gaap:ComprehensiveIncomeNetOfTax
      contextRef="From2023-01-012023-09-30"
      decimals="0"
      id="Fact001744"
      unitRef="USD">-6678685</us-gaap:ComprehensiveIncomeNetOfTax>
    <us-gaap:SharesOutstanding
      contextRef="AsOf2023-12-31_us-gaap_PreferredStockMember"
      decimals="INF"
      id="Fact001754"
      unitRef="Shares">1</us-gaap:SharesOutstanding>
    <us-gaap:SharesOutstanding
      contextRef="AsOf2023-12-31_us-gaap_CommonStockMember"
      decimals="INF"
      id="Fact001756"
      unitRef="Shares">694294</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2023-12-31_us-gaap_CommonStockMember"
      decimals="0"
      id="Fact001747"
      unitRef="USD">69</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2023-12-31_us-gaap_AdditionalPaidInCapitalMember"
      decimals="0"
      id="Fact001749"
      unitRef="USD">32491409</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2023-12-31_us-gaap_AccumulatedOtherComprehensiveIncomeMember"
      decimals="0"
      id="Fact001750"
      unitRef="USD">591812</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2023-12-31_us-gaap_RetainedEarningsMember"
      decimals="0"
      id="Fact001751"
      unitRef="USD">-25149004</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2023-12-31"
      decimals="0"
      id="Fact001752"
      unitRef="USD">7934286</us-gaap:StockholdersEquity>
    <us-gaap:NetIncomeLoss
      contextRef="From2024-01-012024-03-31_us-gaap_RetainedEarningsMember"
      decimals="0"
      id="Fact001763"
      unitRef="USD">-982386</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="From2024-01-012024-03-31"
      decimals="0"
      id="Fact001764"
      unitRef="USD">-982386</us-gaap:NetIncomeLoss>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="From2024-01-012024-03-31_us-gaap_AdditionalPaidInCapitalMember"
      decimals="0"
      id="Fact001769"
      unitRef="USD">126387</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="From2024-01-012024-03-31"
      decimals="0"
      id="Fact001772"
      unitRef="USD">126387</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <STSS:StockIssuedDuringPeriodSharesExerciseOfPrefundedWarrants
      contextRef="From2024-01-012024-03-31_us-gaap_CommonStockMember"
      decimals="INF"
      id="Fact001782"
      unitRef="Shares">18020</STSS:StockIssuedDuringPeriodSharesExerciseOfPrefundedWarrants>
    <STSS:StockIssuedDuringPeriodValueExerciseOfPrefundedWarrants
      contextRef="From2024-01-012024-03-31_us-gaap_CommonStockMember"
      decimals="0"
      id="Fact001775"
      unitRef="USD">2</STSS:StockIssuedDuringPeriodValueExerciseOfPrefundedWarrants>
    <STSS:StockIssuedDuringPeriodValueExerciseOfPrefundedWarrants
      contextRef="From2024-01-012024-03-31_us-gaap_AdditionalPaidInCapitalMember"
      decimals="0"
      id="Fact001777"
      unitRef="USD">394</STSS:StockIssuedDuringPeriodValueExerciseOfPrefundedWarrants>
    <STSS:StockIssuedDuringPeriodValueExerciseOfPrefundedWarrants
      contextRef="From2024-01-012024-03-31"
      decimals="0"
      id="Fact001780"
      unitRef="USD">396</STSS:StockIssuedDuringPeriodValueExerciseOfPrefundedWarrants>
    <us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax
      contextRef="From2024-01-012024-03-31_us-gaap_AccumulatedOtherComprehensiveIncomeMember"
      decimals="0"
      id="Fact001788"
      unitRef="USD">-218053</us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax>
    <us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax
      contextRef="From2024-01-012024-03-31"
      decimals="0"
      id="Fact001790"
      unitRef="USD">-218053</us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax>
    <us-gaap:SharesOutstanding
      contextRef="AsOf2024-03-31_us-gaap_PreferredStockMember"
      decimals="INF"
      id="Fact001800"
      unitRef="Shares">1</us-gaap:SharesOutstanding>
    <us-gaap:SharesOutstanding
      contextRef="AsOf2024-03-31_us-gaap_CommonStockMember"
      decimals="INF"
      id="Fact001802"
      unitRef="Shares">712314</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2024-03-31_us-gaap_CommonStockMember"
      decimals="0"
      id="Fact001793"
      unitRef="USD">71</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2024-03-31_us-gaap_AdditionalPaidInCapitalMember"
      decimals="0"
      id="Fact001795"
      unitRef="USD">32618190</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2024-03-31_us-gaap_AccumulatedOtherComprehensiveIncomeMember"
      decimals="0"
      id="Fact001796"
      unitRef="USD">373759</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2024-03-31_us-gaap_RetainedEarningsMember"
      decimals="0"
      id="Fact001797"
      unitRef="USD">-26131390</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2024-03-31"
      decimals="0"
      id="Fact001798"
      unitRef="USD">6860630</us-gaap:StockholdersEquity>
    <us-gaap:NetIncomeLoss
      contextRef="From2024-04-012024-06-30_us-gaap_RetainedEarningsMember"
      decimals="0"
      id="Fact001809"
      unitRef="USD">-2102327</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="From2024-04-012024-06-30"
      decimals="0"
      id="Fact001810"
      unitRef="USD">-2102327</us-gaap:NetIncomeLoss>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="From2024-04-012024-06-30_us-gaap_AdditionalPaidInCapitalMember"
      decimals="0"
      id="Fact001815"
      unitRef="USD">201918</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="From2024-04-012024-06-30"
      decimals="0"
      id="Fact001818"
      unitRef="USD">201918</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <STSS:StockIssuedDuringPeriodSharesExerciseOfPrefundedWarrants
      contextRef="From2024-04-012024-06-30_us-gaap_CommonStockMember"
      decimals="INF"
      id="Fact001828"
      unitRef="Shares">135683</STSS:StockIssuedDuringPeriodSharesExerciseOfPrefundedWarrants>
    <STSS:StockIssuedDuringPeriodValueExerciseOfPrefundedWarrant
      contextRef="From2024-04-012024-06-30_us-gaap_CommonStockMember"
      decimals="0"
      id="Fact001821"
      unitRef="USD">14</STSS:StockIssuedDuringPeriodValueExerciseOfPrefundedWarrant>
    <STSS:StockIssuedDuringPeriodValueExerciseOfPrefundedWarrant
      contextRef="From2024-04-012024-06-30_us-gaap_AdditionalPaidInCapitalMember"
      decimals="0"
      id="Fact001823"
      unitRef="USD">2971</STSS:StockIssuedDuringPeriodValueExerciseOfPrefundedWarrant>
    <STSS:StockIssuedDuringPeriodValueExerciseOfPrefundedWarrant
      contextRef="From2024-04-012024-06-30"
      decimals="0"
      id="Fact001826"
      unitRef="USD">2985</STSS:StockIssuedDuringPeriodValueExerciseOfPrefundedWarrant>
    <STSS:StockIssuedDuringPeriodSharesRegistrationOffering
      contextRef="From2024-04-012024-06-30_us-gaap_CommonStockMember"
      decimals="INF"
      id="Fact001838"
      unitRef="Shares">190773</STSS:StockIssuedDuringPeriodSharesRegistrationOffering>
    <STSS:StockIssuedDuringPeriodValueRegistrationOffering
      contextRef="From2024-04-012024-06-30_us-gaap_CommonStockMember"
      decimals="0"
      id="Fact001831"
      unitRef="USD">19</STSS:StockIssuedDuringPeriodValueRegistrationOffering>
    <STSS:StockIssuedDuringPeriodValueRegistrationOffering
      contextRef="From2024-04-012024-06-30_us-gaap_AdditionalPaidInCapitalMember"
      decimals="0"
      id="Fact001833"
      unitRef="USD">1296903</STSS:StockIssuedDuringPeriodValueRegistrationOffering>
    <STSS:StockIssuedDuringPeriodValueRegistrationOffering
      contextRef="From2024-04-012024-06-30"
      decimals="0"
      id="Fact001836"
      unitRef="USD">1296922</STSS:StockIssuedDuringPeriodValueRegistrationOffering>
    <STSS:StockIssuedDuringPeriodSharesWarrantInducements
      contextRef="From2024-04-012024-06-30_us-gaap_CommonStockMember"
      decimals="INF"
      id="Fact001848"
      unitRef="Shares">260799</STSS:StockIssuedDuringPeriodSharesWarrantInducements>
    <STSS:StockIssuedDuringPeriodValueWarrantInducements
      contextRef="From2024-04-012024-06-30_us-gaap_CommonStockMember"
      decimals="0"
      id="Fact001841"
      unitRef="USD">26</STSS:StockIssuedDuringPeriodValueWarrantInducements>
    <STSS:StockIssuedDuringPeriodValueWarrantInducements
      contextRef="From2024-04-012024-06-30_us-gaap_AdditionalPaidInCapitalMember"
      decimals="0"
      id="Fact001843"
      unitRef="USD">978955</STSS:StockIssuedDuringPeriodValueWarrantInducements>
    <STSS:StockIssuedDuringPeriodValueWarrantInducements
      contextRef="From2024-04-012024-06-30"
      decimals="0"
      id="Fact001846"
      unitRef="USD">978981</STSS:StockIssuedDuringPeriodValueWarrantInducements>
    <us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax
      contextRef="From2024-04-012024-06-30_us-gaap_AccumulatedOtherComprehensiveIncomeMember"
      decimals="0"
      id="Fact001854"
      unitRef="USD">-21911</us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax>
    <us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax
      contextRef="From2024-04-012024-06-30"
      decimals="0"
      id="Fact001856"
      unitRef="USD">-21911</us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax>
    <us-gaap:SharesOutstanding
      contextRef="AsOf2024-06-30_us-gaap_PreferredStockMember"
      decimals="INF"
      id="Fact001866"
      unitRef="Shares">1</us-gaap:SharesOutstanding>
    <us-gaap:SharesOutstanding
      contextRef="AsOf2024-06-30_us-gaap_CommonStockMember"
      decimals="INF"
      id="Fact001868"
      unitRef="Shares">1299569</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2024-06-30_us-gaap_CommonStockMember"
      decimals="0"
      id="Fact001859"
      unitRef="USD">130</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2024-06-30_us-gaap_AdditionalPaidInCapitalMember"
      decimals="0"
      id="Fact001861"
      unitRef="USD">35098937</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2024-06-30_us-gaap_AccumulatedOtherComprehensiveIncomeMember"
      decimals="0"
      id="Fact001862"
      unitRef="USD">351848</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2024-06-30_us-gaap_RetainedEarningsMember"
      decimals="0"
      id="Fact001863"
      unitRef="USD">-28233717</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2024-06-30"
      decimals="0"
      id="Fact001864"
      unitRef="USD">7217198</us-gaap:StockholdersEquity>
    <us-gaap:NetIncomeLoss
      contextRef="From2024-07-012024-09-30_us-gaap_RetainedEarningsMember"
      decimals="0"
      id="Fact001875"
      unitRef="USD">-1685060</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="From2024-07-012024-09-30"
      decimals="0"
      id="Fact001876"
      unitRef="USD">-1685060</us-gaap:NetIncomeLoss>
    <us-gaap:StockRedeemedOrCalledDuringPeriodShares
      contextRef="From2024-07-012024-09-30_us-gaap_PreferredStockMember"
      decimals="INF"
      id="Fact001886"
      unitRef="Shares">-1</us-gaap:StockRedeemedOrCalledDuringPeriodShares>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="From2024-07-012024-09-30_us-gaap_AdditionalPaidInCapitalMember"
      decimals="0"
      id="Fact001891"
      unitRef="USD">116193</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="From2024-07-012024-09-30"
      decimals="0"
      id="Fact001894"
      unitRef="USD">116193</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:StockIssuedDuringPeriodSharesOther
      contextRef="From2024-07-012024-09-30_us-gaap_CommonStockMember"
      decimals="INF"
      id="Fact001904"
      unitRef="Shares">259091</us-gaap:StockIssuedDuringPeriodSharesOther>
    <us-gaap:StockIssuedDuringPeriodValueOther
      contextRef="From2024-07-012024-09-30_us-gaap_CommonStockMember"
      decimals="0"
      id="Fact001897"
      unitRef="USD">26</us-gaap:StockIssuedDuringPeriodValueOther>
    <us-gaap:StockIssuedDuringPeriodValueOther
      contextRef="From2024-07-012024-09-30_us-gaap_AdditionalPaidInCapitalMember"
      decimals="0"
      id="Fact001899"
      unitRef="USD">726324</us-gaap:StockIssuedDuringPeriodValueOther>
    <us-gaap:StockIssuedDuringPeriodValueOther
      contextRef="From2024-07-012024-09-30"
      decimals="0"
      id="Fact001902"
      unitRef="USD">726350</us-gaap:StockIssuedDuringPeriodValueOther>
    <STSS:StockIssuedDuringPeriodSharesWarrantExericse
      contextRef="From2024-07-012024-09-30_us-gaap_CommonStockMember"
      decimals="INF"
      id="Fact001914"
      unitRef="Shares">135450</STSS:StockIssuedDuringPeriodSharesWarrantExericse>
    <STSS:StockIssuedDuringPeriodValueWarrantExericse
      contextRef="From2024-07-012024-09-30_us-gaap_CommonStockMember"
      decimals="0"
      id="Fact001907"
      unitRef="USD">14</STSS:StockIssuedDuringPeriodValueWarrantExericse>
    <STSS:StockIssuedDuringPeriodValueWarrantExericse
      contextRef="From2024-07-012024-09-30_us-gaap_AdditionalPaidInCapitalMember"
      decimals="0"
      id="Fact001909"
      unitRef="USD">284</STSS:StockIssuedDuringPeriodValueWarrantExericse>
    <STSS:StockIssuedDuringPeriodValueWarrantExericse
      contextRef="From2024-07-012024-09-30"
      decimals="0"
      id="Fact001912"
      unitRef="USD">298</STSS:StockIssuedDuringPeriodValueWarrantExericse>
    <us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax
      contextRef="From2024-07-012024-09-30_us-gaap_AccumulatedOtherComprehensiveIncomeMember"
      decimals="0"
      id="Fact001920"
      unitRef="USD">130723</us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax>
    <us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax
      contextRef="From2024-07-012024-09-30"
      decimals="0"
      id="Fact001922"
      unitRef="USD">130723</us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax>
    <us-gaap:SharesOutstanding
      contextRef="AsOf2024-09-30_us-gaap_CommonStockMember"
      decimals="INF"
      id="Fact001934"
      unitRef="Shares">1694110</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2024-09-30_us-gaap_CommonStockMember"
      decimals="0"
      id="Fact001925"
      unitRef="USD">170</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2024-09-30_us-gaap_AdditionalPaidInCapitalMember"
      decimals="0"
      id="Fact001927"
      unitRef="USD">35941738</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2024-09-30_us-gaap_AccumulatedOtherComprehensiveIncomeMember"
      decimals="0"
      id="Fact001928"
      unitRef="USD">482572</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2024-09-30_us-gaap_RetainedEarningsMember"
      decimals="0"
      id="Fact001929"
      unitRef="USD">-29918777</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2024-09-30"
      decimals="0"
      id="Fact001930"
      unitRef="USD">6505703</us-gaap:StockholdersEquity>
    <us-gaap:SharesOutstanding
      contextRef="AsOf2022-12-31_us-gaap_PreferredStockMember"
      decimals="INF"
      id="Fact001944"
      unitRef="Shares">1</us-gaap:SharesOutstanding>
    <us-gaap:SharesOutstanding
      contextRef="AsOf2022-12-31_us-gaap_CommonStockMember"
      decimals="INF"
      id="Fact001946"
      unitRef="Shares">427610</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2022-12-31_us-gaap_CommonStockMember"
      decimals="0"
      id="Fact001937"
      unitRef="USD">43</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2022-12-31_us-gaap_AdditionalPaidInCapitalMember"
      decimals="0"
      id="Fact001939"
      unitRef="USD">24734204</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2022-12-31_us-gaap_AccumulatedOtherComprehensiveIncomeMember"
      decimals="0"
      id="Fact001940"
      unitRef="USD">214253</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2022-12-31_us-gaap_RetainedEarningsMember"
      decimals="0"
      id="Fact001941"
      unitRef="USD">-15307366</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2022-12-31"
      decimals="0"
      id="Fact001942"
      unitRef="USD">9641134</us-gaap:StockholdersEquity>
    <us-gaap:NetIncomeLoss
      contextRef="From2023-01-012023-03-31_us-gaap_RetainedEarningsMember"
      decimals="0"
      id="Fact001953"
      unitRef="USD">-2111830</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="From2023-01-012023-03-31"
      decimals="0"
      id="Fact001954"
      unitRef="USD">-2111830</us-gaap:NetIncomeLoss>
    <us-gaap:StockIssuedDuringPeriodSharesNewIssues
      contextRef="From2023-01-012023-03-31_us-gaap_CommonStockMember"
      decimals="INF"
      id="Fact001964"
      unitRef="Shares">102206</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues
      contextRef="From2023-01-012023-03-31_us-gaap_CommonStockMember"
      decimals="0"
      id="Fact001957"
      unitRef="USD">10</us-gaap:StockIssuedDuringPeriodValueNewIssues>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues
      contextRef="From2023-01-012023-03-31_us-gaap_AdditionalPaidInCapitalMember"
      decimals="0"
      id="Fact001959"
      unitRef="USD">2783375</us-gaap:StockIssuedDuringPeriodValueNewIssues>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues
      contextRef="From2023-01-012023-03-31"
      decimals="0"
      id="Fact001962"
      unitRef="USD">2783385</us-gaap:StockIssuedDuringPeriodValueNewIssues>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="From2023-01-012023-03-31_us-gaap_AdditionalPaidInCapitalMember"
      decimals="0"
      id="Fact001969"
      unitRef="USD">383100</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="From2023-01-012023-03-31"
      decimals="0"
      id="Fact001972"
      unitRef="USD">383100</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax
      contextRef="From2023-01-012023-03-31_us-gaap_AccumulatedOtherComprehensiveIncomeMember"
      decimals="0"
      id="Fact001978"
      unitRef="USD">270983</us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax>
    <us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax
      contextRef="From2023-01-012023-03-31"
      decimals="0"
      id="Fact001980"
      unitRef="USD">270983</us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax>
    <us-gaap:SharesOutstanding
      contextRef="AsOf2023-03-31_us-gaap_PreferredStockMember"
      decimals="INF"
      id="Fact001990"
      unitRef="Shares">1</us-gaap:SharesOutstanding>
    <us-gaap:SharesOutstanding
      contextRef="AsOf2023-03-31_us-gaap_CommonStockMember"
      decimals="INF"
      id="Fact001992"
      unitRef="Shares">529816</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2023-03-31_us-gaap_CommonStockMember"
      decimals="0"
      id="Fact001983"
      unitRef="USD">53</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2023-03-31_us-gaap_AdditionalPaidInCapitalMember"
      decimals="0"
      id="Fact001985"
      unitRef="USD">27900679</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2023-03-31_us-gaap_AccumulatedOtherComprehensiveIncomeMember"
      decimals="0"
      id="Fact001986"
      unitRef="USD">485236</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2023-03-31_us-gaap_RetainedEarningsMember"
      decimals="0"
      id="Fact001987"
      unitRef="USD">-17419196</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2023-03-31"
      decimals="0"
      id="Fact001988"
      unitRef="USD">10966772</us-gaap:StockholdersEquity>
    <us-gaap:NetIncomeLoss
      contextRef="From2023-04-012023-06-30_us-gaap_RetainedEarningsMember"
      decimals="0"
      id="Fact001999"
      unitRef="USD">-2605825</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="From2023-04-012023-06-30"
      decimals="0"
      id="Fact002000"
      unitRef="USD">-2605825</us-gaap:NetIncomeLoss>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="From2023-04-012023-06-30_us-gaap_AdditionalPaidInCapitalMember"
      decimals="0"
      id="Fact002005"
      unitRef="USD">254446</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="From2023-04-012023-06-30"
      decimals="0"
      id="Fact002008"
      unitRef="USD">254446</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax
      contextRef="From2023-04-012023-06-30_us-gaap_AccumulatedOtherComprehensiveIncomeMember"
      decimals="0"
      id="Fact002014"
      unitRef="USD">73876</us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax>
    <us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax
      contextRef="From2023-04-012023-06-30"
      decimals="0"
      id="Fact002016"
      unitRef="USD">73876</us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax>
    <us-gaap:SharesOutstanding
      contextRef="AsOf2023-06-30_us-gaap_PreferredStockMember"
      decimals="INF"
      id="Fact002026"
      unitRef="Shares">1</us-gaap:SharesOutstanding>
    <us-gaap:SharesOutstanding
      contextRef="AsOf2023-06-30_us-gaap_CommonStockMember"
      decimals="INF"
      id="Fact002028"
      unitRef="Shares">529816</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2023-06-30_us-gaap_CommonStockMember"
      decimals="0"
      id="Fact002019"
      unitRef="USD">53</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2023-06-30_us-gaap_AdditionalPaidInCapitalMember"
      decimals="0"
      id="Fact002021"
      unitRef="USD">28155125</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2023-06-30_us-gaap_AccumulatedOtherComprehensiveIncomeMember"
      decimals="0"
      id="Fact002022"
      unitRef="USD">559112</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2023-06-30_us-gaap_RetainedEarningsMember"
      decimals="0"
      id="Fact002023"
      unitRef="USD">-20025021</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2023-06-30"
      decimals="0"
      id="Fact002024"
      unitRef="USD">8689269</us-gaap:StockholdersEquity>
    <us-gaap:SharesOutstanding
      contextRef="AsOf2023-06-30_us-gaap_PreferredStockMember"
      decimals="INF"
      id="Fact002038"
      unitRef="Shares">1</us-gaap:SharesOutstanding>
    <us-gaap:SharesOutstanding
      contextRef="AsOf2023-06-30_us-gaap_CommonStockMember"
      decimals="INF"
      id="Fact002040"
      unitRef="Shares">529816</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2023-06-30_us-gaap_CommonStockMember"
      decimals="0"
      id="Fact002031"
      unitRef="USD">53</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2023-06-30_us-gaap_AdditionalPaidInCapitalMember"
      decimals="0"
      id="Fact002033"
      unitRef="USD">28155125</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2023-06-30_us-gaap_AccumulatedOtherComprehensiveIncomeMember"
      decimals="0"
      id="Fact002034"
      unitRef="USD">559112</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2023-06-30_us-gaap_RetainedEarningsMember"
      decimals="0"
      id="Fact002035"
      unitRef="USD">-20025021</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2023-06-30"
      decimals="0"
      id="Fact002036"
      unitRef="USD">8689269</us-gaap:StockholdersEquity>
    <us-gaap:NetIncomeLoss
      contextRef="From2023-07-012023-09-30_us-gaap_RetainedEarningsMember"
      decimals="0"
      id="Fact002047"
      unitRef="USD">-2022344</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="From2023-07-012023-09-30"
      decimals="0"
      id="Fact002048"
      unitRef="USD">-2022344</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="From2023-07-012023-09-30_us-gaap_RetainedEarningsMember"
      decimals="0"
      id="Fact002055"
      unitRef="USD">-2022344</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="From2023-07-012023-09-30"
      decimals="0"
      id="Fact002056"
      unitRef="USD">-2022344</us-gaap:NetIncomeLoss>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="From2023-07-012023-09-30_us-gaap_AdditionalPaidInCapitalMember"
      decimals="0"
      id="Fact002061"
      unitRef="USD">201365</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="From2023-07-012023-09-30"
      decimals="0"
      id="Fact002064"
      unitRef="USD">201365</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <STSS:StockIssuedDuringPeriodSharesShelfRegistrationOffering
      contextRef="From2023-07-012023-09-30_us-gaap_CommonStockMember"
      decimals="INF"
      id="Fact002074"
      unitRef="Shares">164478</STSS:StockIssuedDuringPeriodSharesShelfRegistrationOffering>
    <STSS:StockIssuedDuringPeriodValueShelfRegistrationOffering
      contextRef="From2023-07-012023-09-30_us-gaap_CommonStockMember"
      decimals="0"
      id="Fact002067"
      unitRef="USD">16</STSS:StockIssuedDuringPeriodValueShelfRegistrationOffering>
    <STSS:StockIssuedDuringPeriodValueShelfRegistrationOffering
      contextRef="From2023-07-012023-09-30_us-gaap_AdditionalPaidInCapitalMember"
      decimals="0"
      id="Fact002069"
      unitRef="USD">2457988</STSS:StockIssuedDuringPeriodValueShelfRegistrationOffering>
    <STSS:StockIssuedDuringPeriodValueShelfRegistrationOffering
      contextRef="From2023-07-012023-09-30"
      decimals="0"
      id="Fact002072"
      unitRef="USD">2458004</STSS:StockIssuedDuringPeriodValueShelfRegistrationOffering>
    <STSS:StockIssuedDuringPeriodValuePrivatePlacement
      contextRef="From2023-07-012023-09-30_us-gaap_AdditionalPaidInCapitalMember"
      decimals="0"
      id="Fact002079"
      unitRef="USD">1552819</STSS:StockIssuedDuringPeriodValuePrivatePlacement>
    <STSS:StockIssuedDuringPeriodValuePrivatePlacement
      contextRef="From2023-07-012023-09-30"
      decimals="0"
      id="Fact002082"
      unitRef="USD">1552819</STSS:StockIssuedDuringPeriodValuePrivatePlacement>
    <us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax
      contextRef="From2023-07-012023-09-30_us-gaap_AccumulatedOtherComprehensiveIncomeMember"
      decimals="0"
      id="Fact002088"
      unitRef="USD">-283544</us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax>
    <us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax
      contextRef="From2023-07-012023-09-30"
      decimals="0"
      id="Fact002090"
      unitRef="USD">-283544</us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax>
    <us-gaap:SharesOutstanding
      contextRef="AsOf2023-09-30_us-gaap_PreferredStockMember"
      decimals="INF"
      id="Fact002100"
      unitRef="Shares">1</us-gaap:SharesOutstanding>
    <us-gaap:SharesOutstanding
      contextRef="AsOf2023-09-30_us-gaap_CommonStockMember"
      decimals="INF"
      id="Fact002102"
      unitRef="Shares">694294</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2023-09-30_us-gaap_CommonStockMember"
      decimals="0"
      id="Fact002093"
      unitRef="USD">69</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2023-09-30_us-gaap_AdditionalPaidInCapitalMember"
      decimals="0"
      id="Fact002095"
      unitRef="USD">32367297</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2023-09-30_us-gaap_AccumulatedOtherComprehensiveIncomeMember"
      decimals="0"
      id="Fact002096"
      unitRef="USD">275568</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2023-09-30_us-gaap_RetainedEarningsMember"
      decimals="0"
      id="Fact002097"
      unitRef="USD">-22047365</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2023-09-30"
      decimals="0"
      id="Fact002098"
      unitRef="USD">10595569</us-gaap:StockholdersEquity>
    <us-gaap:SharesOutstanding
      contextRef="AsOf2023-09-30_us-gaap_PreferredStockMember"
      decimals="INF"
      id="Fact002112"
      unitRef="Shares">1</us-gaap:SharesOutstanding>
    <us-gaap:SharesOutstanding
      contextRef="AsOf2023-09-30_us-gaap_CommonStockMember"
      decimals="INF"
      id="Fact002114"
      unitRef="Shares">694294</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2023-09-30_us-gaap_CommonStockMember"
      decimals="0"
      id="Fact002105"
      unitRef="USD">69</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2023-09-30_us-gaap_AdditionalPaidInCapitalMember"
      decimals="0"
      id="Fact002107"
      unitRef="USD">32367297</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2023-09-30_us-gaap_AccumulatedOtherComprehensiveIncomeMember"
      decimals="0"
      id="Fact002108"
      unitRef="USD">275568</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2023-09-30_us-gaap_RetainedEarningsMember"
      decimals="0"
      id="Fact002109"
      unitRef="USD">-22047365</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2023-09-30"
      decimals="0"
      id="Fact002110"
      unitRef="USD">10595569</us-gaap:StockholdersEquity>
    <us-gaap:NetIncomeLoss
      contextRef="From2024-01-01to2024-09-30"
      decimals="0"
      id="Fact002119"
      unitRef="USD">-4769774</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="From2023-01-012023-09-30"
      decimals="0"
      id="Fact002120"
      unitRef="USD">-6739999</us-gaap:NetIncomeLoss>
    <us-gaap:DepreciationAndAmortization
      contextRef="From2024-01-01to2024-09-30"
      decimals="0"
      id="Fact002125"
      unitRef="USD">583006</us-gaap:DepreciationAndAmortization>
    <us-gaap:DepreciationAndAmortization
      contextRef="From2023-01-012023-09-30"
      decimals="0"
      id="Fact002126"
      unitRef="USD">656100</us-gaap:DepreciationAndAmortization>
    <us-gaap:ShareBasedCompensation
      contextRef="From2024-01-01to2024-09-30"
      decimals="0"
      id="Fact002128"
      unitRef="USD">444498</us-gaap:ShareBasedCompensation>
    <us-gaap:ShareBasedCompensation
      contextRef="From2023-01-012023-09-30"
      decimals="0"
      id="Fact002129"
      unitRef="USD">838911</us-gaap:ShareBasedCompensation>
    <us-gaap:AmortizationOfDebtDiscountPremium
      contextRef="From2024-01-01to2024-09-30"
      decimals="0"
      id="Fact002131"
      unitRef="USD">75192</us-gaap:AmortizationOfDebtDiscountPremium>
    <us-gaap:GainLossOnSaleOfDerivatives
      contextRef="From2024-01-01to2024-09-30"
      decimals="0"
      id="Fact002134"
      unitRef="USD">2088747</us-gaap:GainLossOnSaleOfDerivatives>
    <us-gaap:GainLossOnSaleOfDerivatives
      contextRef="From2023-01-012023-09-30"
      decimals="0"
      id="Fact002135"
      unitRef="USD">415958</us-gaap:GainLossOnSaleOfDerivatives>
    <us-gaap:AmortizationOfFinancingCosts
      contextRef="From2023-01-012023-09-30"
      decimals="0"
      id="Fact002138"
      unitRef="USD">205112</us-gaap:AmortizationOfFinancingCosts>
    <STSS:EscrowDepositForfeited
      contextRef="From2024-01-01to2024-09-30"
      decimals="0"
      id="Fact002140"
      unitRef="USD">1000000</STSS:EscrowDepositForfeited>
    <us-gaap:ForeignCurrencyTransactionGainLossBeforeTax
      contextRef="From2024-01-01to2024-09-30"
      decimals="0"
      id="Fact002143"
      unitRef="USD">-31566</us-gaap:ForeignCurrencyTransactionGainLossBeforeTax>
    <us-gaap:ForeignCurrencyTransactionGainLossBeforeTax
      contextRef="From2023-01-012023-09-30"
      decimals="0"
      id="Fact002144"
      unitRef="USD">-33729</us-gaap:ForeignCurrencyTransactionGainLossBeforeTax>
    <us-gaap:IncreaseDecreaseInPrepaidExpense
      contextRef="From2024-01-01to2024-09-30"
      decimals="0"
      id="Fact002149"
      unitRef="USD">47233</us-gaap:IncreaseDecreaseInPrepaidExpense>
    <us-gaap:IncreaseDecreaseInPrepaidExpense
      contextRef="From2023-01-012023-09-30"
      decimals="0"
      id="Fact002150"
      unitRef="USD">23032</us-gaap:IncreaseDecreaseInPrepaidExpense>
    <us-gaap:IncreaseDecreaseInInventories
      contextRef="From2024-01-01to2024-09-30"
      decimals="0"
      id="Fact002152"
      unitRef="USD">349317</us-gaap:IncreaseDecreaseInInventories>
    <us-gaap:IncreaseDecreaseInInventories
      contextRef="From2023-01-012023-09-30"
      decimals="0"
      id="Fact002153"
      unitRef="USD">1039152</us-gaap:IncreaseDecreaseInInventories>
    <us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
      contextRef="From2024-01-01to2024-09-30"
      decimals="0"
      id="Fact002155"
      unitRef="USD">-51326</us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities>
    <us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
      contextRef="From2023-01-012023-09-30"
      decimals="0"
      id="Fact002156"
      unitRef="USD">339352</us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities>
    <us-gaap:NetCashProvidedByUsedInOperatingActivities
      contextRef="From2024-01-01to2024-09-30"
      decimals="0"
      id="Fact002158"
      unitRef="USD">-5172135</us-gaap:NetCashProvidedByUsedInOperatingActivities>
    <us-gaap:NetCashProvidedByUsedInOperatingActivities
      contextRef="From2023-01-012023-09-30"
      decimals="0"
      id="Fact002159"
      unitRef="USD">-6144937</us-gaap:NetCashProvidedByUsedInOperatingActivities>
    <us-gaap:PaymentsForProceedsFromOtherInvestingActivities
      contextRef="From2024-01-01to2024-09-30"
      decimals="0"
      id="Fact002164"
      unitRef="USD">69659</us-gaap:PaymentsForProceedsFromOtherInvestingActivities>
    <us-gaap:PaymentsForProceedsFromOtherInvestingActivities
      contextRef="From2023-01-012023-09-30"
      decimals="0"
      id="Fact002165"
      unitRef="USD">232295</us-gaap:PaymentsForProceedsFromOtherInvestingActivities>
    <STSS:EscrowPaymentUnderAgreement
      contextRef="From2024-01-01to2024-09-30"
      decimals="0"
      id="Fact002167"
      unitRef="USD">1000000</STSS:EscrowPaymentUnderAgreement>
    <STSS:EscrowPaymentUnderAgreement
      contextRef="From2023-01-012023-09-30"
      decimals="0"
      id="Fact002168"
      unitRef="USD">199084</STSS:EscrowPaymentUnderAgreement>
    <us-gaap:NetCashProvidedByUsedInInvestingActivities
      contextRef="From2024-01-01to2024-09-30"
      decimals="0"
      id="Fact002170"
      unitRef="USD">-1069659</us-gaap:NetCashProvidedByUsedInInvestingActivities>
    <us-gaap:NetCashProvidedByUsedInInvestingActivities
      contextRef="From2023-01-012023-09-30"
      decimals="0"
      id="Fact002171"
      unitRef="USD">-431379</us-gaap:NetCashProvidedByUsedInInvestingActivities>
    <STSS:NetProceedsFromOfferingsAndWarrantExercises
      contextRef="From2024-01-01to2024-09-30"
      decimals="0"
      id="Fact002176"
      unitRef="USD">2972646</STSS:NetProceedsFromOfferingsAndWarrantExercises>
    <STSS:NetProceedsFromOfferingsAndWarrantExercises
      contextRef="From2023-01-012023-09-30"
      decimals="0"
      id="Fact002177"
      unitRef="USD">8029628</STSS:NetProceedsFromOfferingsAndWarrantExercises>
    <us-gaap:ProceedsFromIssuanceOfLongTermDebt
      contextRef="From2024-01-01to2024-09-30"
      decimals="0"
      id="Fact002179"
      unitRef="USD">2735300</us-gaap:ProceedsFromIssuanceOfLongTermDebt>
    <us-gaap:NetCashProvidedByUsedInFinancingActivities
      contextRef="From2024-01-01to2024-09-30"
      decimals="0"
      id="Fact002182"
      unitRef="USD">5707946</us-gaap:NetCashProvidedByUsedInFinancingActivities>
    <us-gaap:NetCashProvidedByUsedInFinancingActivities
      contextRef="From2023-01-012023-09-30"
      decimals="0"
      id="Fact002183"
      unitRef="USD">8029628</us-gaap:NetCashProvidedByUsedInFinancingActivities>
    <us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
      contextRef="From2024-01-01to2024-09-30"
      decimals="0"
      id="Fact002185"
      unitRef="USD">-5863</us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations>
    <us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
      contextRef="From2023-01-012023-09-30"
      decimals="0"
      id="Fact002186"
      unitRef="USD">-69792</us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
      contextRef="From2024-01-01to2024-09-30"
      decimals="0"
      id="Fact002188"
      unitRef="USD">-539711</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
      contextRef="From2023-01-012023-09-30"
      decimals="0"
      id="Fact002189"
      unitRef="USD">1383520</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
      contextRef="AsOf2023-12-31"
      decimals="0"
      id="Fact002191"
      unitRef="USD">3012908</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
      contextRef="AsOf2022-12-31"
      decimals="0"
      id="Fact002192"
      unitRef="USD">4170897</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
      contextRef="AsOf2024-09-30"
      decimals="0"
      id="Fact002194"
      unitRef="USD">2473197</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
      contextRef="AsOf2023-09-30"
      decimals="0"
      id="Fact002195"
      unitRef="USD">5554417</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations>
    <us-gaap:BusinessDescriptionAndBasisOfPresentationTextBlock contextRef="From2024-01-01to2024-09-30" id="Fact002197">&lt;p id="xdx_80C_eus-gaap--BusinessDescriptionAndBasisOfPresentationTextBlock_z2aG7dHE8Noe" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Note
1. &lt;span id="xdx_821_z1tr3jvM5ini"&gt;Description of Business&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;Nature
of Business and Going Concern&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Sharps
Technology, Inc. (&#x201c;Sharps&#x201d; or the &#x201c;Company&#x201d;) is a pre-revenue medical device company that has designed and patented
various safety syringes and is seeking commercialization by manufacturing and distribution of its products.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
accompanying condensed consolidated financial statements include the accounts of Sharps Technology, Inc., and its wholly owned subsidiaries,
Safegard Medical, Kft. and Sharps Technology Acquisition Corp. collectively referred to as the &#x201c;Company.&#x201d; The condensed consolidated
balance sheet as of September 30, 2024 and the condensed consolidated statements of operations, statements of comprehensive loss, statements
of stockholders&#x2019; equity and the statements of cash flow for three and nine months ended September 30, 2024 and 2023 (the &#x201c;interim
statements&#x201d;) are unaudited. All intercompany transactions and balances have been eliminated. In the opinion of management, all
adjustments (which include normal recurring adjustments) necessary to present fairly the financial position and operating results for
the interim periods have been made. Certain information and footnote disclosure, normally included in annual financial statements prepared
in accordance with accounting principles generally accepted in the United States, have been condensed or omitted. The interim statements
should be read in conjunction with the consolidated financial statements for the year ended December 31, 2023 and notes thereto contained
in the Company&#x2019;s Form 10-K filed with the Securities and Exchange Commission. The condensed consolidated balance sheet at December
31, 2023 has been derived from the audited financial statements at that date. The results of operations for the three and nine months
ended September 30, 2024 are not necessarily indicative of the results that may be expected for the fiscal year ending December 31, 2024.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
accompanying condensed consolidated financial statements have been prepared assuming that the Company will continue as a going concern.
The Company has not generated revenue or cash flow from operations since inception. As of September 30, 2024, the Company had a working
capital of $&lt;span id="xdx_900_ecustom--WorkingCapital_iI_c20240930_zlkTftU9qWw3" title="Working capital"&gt;67,820&lt;/span&gt; which is not expected to be sufficient to fund the Company&#x2019;s planned operations for the next 12 months. These
factors raise substantial doubt regarding the Company&#x2019;s ability to continue as a going concern. The Company&#x2019;s ability to
continue as a going concern is dependent upon the Company&#x2019;s ability to raise sufficient financing to acquire or commercialize its
products into a profitable business. The Company intends to finance its commercialization activities and its working capital needs largely
from the sale of equity securities and/or with additional funding from other traditional financing sources until such time that funds
provided by operations are sufficient to fund working capital requirements. The unaudited condensed consolidated financial statements
of the Company do not include any adjustments relating to the recoverability and classification of recorded assets, or the amounts and
classifications of liabilities that might be necessary should the Company be unable to continue as a going concern.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company&#x2019;s fiscal year ends on December 31.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;On
April 13, 2022, the Company&#x2019;s Initial Public Offering was deemed effective with trading commencing on April 14, 2022. The Company
received net proceeds of $&lt;span id="xdx_900_eus-gaap--ProceedsFromIssuanceInitialPublicOffering_pn5n6_c20220417__20220419__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--IPOMember_zW1ccizfuWk1" title="Initial public offering"&gt;14.2&lt;/span&gt; million on April 19, 2022 (See Note 7).&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Effective
October 16, 2024, &lt;span id="xdx_908_ecustom--ReverseStockSplitDescription_c20241006__20241016_zv26HyC6O2li" title="Reverse stock split description"&gt;the Company completed a 1 for 22 reverse split, whereby for each 22 shares of common stock the Company issued one share
of common stock .&lt;/span&gt; All share, other equity instruments and per share information in the accompanying condensed consolidated financial
statements and footnotes have been retroactively adjusted for the effects of the reverse split for all periods presented.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;/p&gt;

</us-gaap:BusinessDescriptionAndBasisOfPresentationTextBlock>
    <STSS:WorkingCapital
      contextRef="AsOf2024-09-30"
      decimals="0"
      id="Fact002199"
      unitRef="USD">67820</STSS:WorkingCapital>
    <us-gaap:ProceedsFromIssuanceInitialPublicOffering
      contextRef="From2022-04-172022-04-19_us-gaap_IPOMember"
      decimals="-5"
      id="Fact002201"
      unitRef="USD">14200000</us-gaap:ProceedsFromIssuanceInitialPublicOffering>
    <STSS:ReverseStockSplitDescription contextRef="From2024-10-062024-10-16" id="Fact002203">the Company completed a 1 for 22 reverse split, whereby for each 22 shares of common stock the Company issued one share
of common stock .</STSS:ReverseStockSplitDescription>
    <us-gaap:SignificantAccountingPoliciesTextBlock contextRef="From2024-01-01to2024-09-30" id="Fact002205">&lt;p id="xdx_801_eus-gaap--SignificantAccountingPoliciesTextBlock_zA9wf4rUPnq5" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Note
2. &lt;span id="xdx_829_z09g9XOryKKi"&gt;Summary of Significant Accounting Policies&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_840_eus-gaap--BasisOfAccountingPolicyPolicyTextBlock_zzowRwhjjZ34" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;Basis
of Presentation&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
accompanying condensed consolidated financial statements have been prepared by the Company in accordance with generally accepted accounting
principles (&#x201c;GAAP&#x201d;) in the United States (&#x201c;U.S.&#x201d;) and are expressed in U.S. dollars.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;





&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;SHARPS
TECHNOLOGY, INC.&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;NOTES
TO THE CONDENSED CONSOLIDATED FINANCIAL STATEMENTS&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;FOR
THE THREE AND NINE MONTHS ENDED SEPTEMBER 30, 2024 AND 2023&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Note
2. Summary of Significant Accounting Policies (continued)&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_84C_eus-gaap--UseOfEstimates_zGgGkPhMhNe2" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;Use
of Estimates&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
preparation of financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the
reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements
and the reported amounts of revenues and expenses during the reporting periods. Actual results could differ from those estimates. As
of September 30, 2024, the most significant estimates relate to derivative liabilities, stock-based compensation, long-lived asset impairments and accounting for debt and equity financing.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_84D_eus-gaap--CashAndCashEquivalentsPolicyTextBlock_zpVN0CaOHznd" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;Cash
and Cash Equivalents&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company considers all highly liquid investments purchased with an original or remaining maturity of three months or less at the date
of purchase to be cash equivalents. Cash and cash equivalents are maintained with various financial institutions. At September 30, 2024
and December 31, 2023, the Company had &lt;span id="xdx_90E_eus-gaap--CashEquivalentsAtCarryingValue_iI_do_c20240930_zwmnXV8kgRR4" title="Cash equivalents"&gt;&lt;span id="xdx_905_eus-gaap--CashEquivalentsAtCarryingValue_iI_do_c20231231_zGf0aAiwxUi6" title="Cash equivalents"&gt;no&lt;/span&gt;&lt;/span&gt; cash equivalents.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_844_eus-gaap--InventoryPolicyTextBlock_zGOqIcJQKIza" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;Inventories&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company values inventory at the lower of cost (average cost) or net realizable value. Work-in-process and finished goods inventories
consist of material, labor, and manufacturing overhead. Net realizable value is the estimated selling price in the ordinary course of
business, less reasonably predictable costs of completion, disposal, and transportation. A reserve is established for any excess or obsolete
inventories or they may be written off. At September 30, 2024, and December 31, 2023, inventory is comprised of raw materials, including
packaging, work in process (components) and finished goods.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_84D_eus-gaap--FairValueMeasurementPolicyPolicyTextBlock_z8orLyWy9zmh" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Fair
Value Measurements&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;ASC
820, Fair Value Measurements and Disclosures, requires an entity to maximize the use of observable inputs and minimize the use of unobservable
inputs when measuring fair value. ASC 820 establishes a fair value hierarchy based on the level of independent, objective evidence surrounding
the inputs used to measure fair value. A financial instrument&#x2019;s categorization within the fair value hierarchy is based upon the
lowest level of input that is significant to the fair value measurement. ASC 820 prioritizes the inputs into three levels that may be
used to measure fair value.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company&#x2019;s outstanding warrants are valued on a recurring basis with the trading price which could cause fluctuations in operating
results at the reporting periods.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Level
1&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Level
1 applies to assets or liabilities for which there are quoted prices in active markets for identical assets or liabilities. Valuations
are based on quoted prices that are readily and regularly available in an active market and do not entail a significant degree of judgment.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Level
2&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Level
2 applied to assets or liabilities for which there are other than Level 1 observable inputs such as quoted prices for similar assets
or liabilities in active markets; quoted prices for identical assets or liabilities in markets with insufficient volume or infrequent
transactions (less active markets); or model-derived valuations in which significant inputs are observable or can be derived principally
from, or corroborated by, observable market data.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Level
2 instruments require more management judgment and subjectivity as compared to Level 1 instruments. For instance: determining which instruments
are most similar to the instrument being priced requires management to identify a sample of similar securities based on the coupon rates,
maturity, issuer credit rating and instrument type, and subjectively select an individual security or multiple securities that are deemed
most similar to the security being priced; and determining whether a market is considered active requires management judgment.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;/p&gt;



&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;br/&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;SHARPS
TECHNOLOGY, INC.&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;NOTES
TO THE CONDENSED CONSOLIDATED FINANCIAL STATEMENTS&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;FOR
THE THREE AND NINE MONTHS ENDED SEPTEMBER 30, 2024 AND 2023&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Note
2. Summary of Significant Accounting Policies (continued)&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Level
3&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Level
3 applied to assets or liabilities for which there are unobservable inputs to the valuation methodology that are significant to the measurement
of the fair value of the assets or liabilities. The determination for Level 3 instruments requires the most management judgment and subjectivity.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_84A_eus-gaap--PropertyPlantAndEquipmentPolicyTextBlock_zeQSF2RpUG6k" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;Fixed
Assets&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Fixed
assets are stated at cost. Expenditures for maintenance and repairs are charged to operations as incurred. The Company&#x2019;s fixed
assets consist of land, building, machinery and equipment, molds and website. Depreciation is calculated using the straight-line method
commencing on the date the asset is operating in the way intended by management over the following useful lives: Building &#x2013; &lt;span id="xdx_90D_eus-gaap--PropertyPlantAndEquipmentUsefulLife_iI_dtY_c20240930__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--BuildingMember_zfFFDUZ05bbg" title="Property plant and equipment asset useful life"&gt;20&lt;/span&gt;
years, Machinery and Equipment &#x2013; &lt;span id="xdx_901_eus-gaap--PropertyPlantAndEquipmentUsefulLife_iI_dtY_c20240930__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--MachineryAndEquipmentMember__srt--RangeAxis__srt--MinimumMember_zQDlHxyYqlR4" title="Property plant and equipment asset useful life"&gt;3&lt;/span&gt; - &lt;span id="xdx_907_eus-gaap--PropertyPlantAndEquipmentUsefulLife_iI_dtY_c20240930__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--MachineryAndEquipmentMember__srt--RangeAxis__srt--MaximumMember_zIimvDqNBFI6" title="Property plant and equipment asset useful life"&gt;10&lt;/span&gt; years and Website and Computer Systems &#x2013; &lt;span id="xdx_909_eus-gaap--PropertyPlantAndEquipmentUsefulLife_iI_dtY_c20240930__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--WebsiteMember_zTb8yQXBBNHf" title="Property plant and equipment asset useful life"&gt;3&lt;/span&gt; years. The expected life for Molds is
based on the lesser of the number of parts that will be produced based on the expected mold capability or 5 years.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_844_eus-gaap--ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock_zcCTXfcljxD8" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;&lt;span id="xdx_863_zFqcx8k1jJQ2"&gt;Impairment
of Long-Lived Assets&lt;/span&gt;&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Long-lived
assets are reviewed for impairment or whenever events or changes in circumstances indicate that the carrying amount of an asset may not
be recoverable. Recoverability is measured by comparison of the carrying amount of an asset group to the future net undiscounted cash
flows that the assets are expected to generate. If such assets are considered to be impaired, the impairment to be recognized is measured
by the amount by which the carrying amount of the assets exceeds the projected discounted future net cash flows arising from the asset.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;There
were &lt;span id="xdx_900_eus-gaap--ImpairmentOfLongLivedAssetsHeldForUse_dxL_c20240701__20240930_zcjUgtigXLBc" title="Impairment losses::XDX::-"&gt;&lt;span id="xdx_905_eus-gaap--ImpairmentOfLongLivedAssetsHeldForUse_dxL_c20230701__20230930_zcIHlxLiKnng" title="Impairment losses::XDX::-"&gt;&lt;span id="xdx_907_eus-gaap--ImpairmentOfLongLivedAssetsHeldForUse_dxL_c20240101__20240930_zqXBJ8ZjlUd2" title="Impairment losses::XDX::-"&gt;&lt;span id="xdx_90D_eus-gaap--ImpairmentOfLongLivedAssetsHeldForUse_dxL_c20230101__20230930_zat4wV0dNvRi" title="Impairment losses::XDX::-"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2233"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2235"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2237"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2239"&gt;no&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt; impairment losses recognized during the three and nine months ended September 30, 2024 and 2023.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;Purchased
Identified Intangible Assets&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company&#x2019;s identified intangible assets are amortized on a straight-line basis over their estimated useful lives of 5 years.
The Company makes judgments about the recoverability of finite-lived intangible assets whenever facts and circumstances indicate
that the useful life is shorter than originally estimated or that the carrying amount of assets may not be recoverable. If such
facts and circumstances exist, the Company assesses recoverability by comparing the projected undiscounted net cash flows associated
with the related asset or group of assets over their remaining lives against their respective carrying amounts. Impairments, if any,
are based on the excess of the carrying amount over the fair value of those assets. If the useful life is shorter than originally
estimated, the Company would accelerate the rate of amortization and amortize the remaining carrying value over the new shorter
useful life. The Company evaluates the carrying value of indefinite-lived intangible assets whenever events or changes in
circumstances indicate that the carrying amount of an asset may not be recoverable, and an impairment charge would be recognized to
the extent that the carrying amount of such assets exceeds their estimated fair value.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_84D_eus-gaap--CompensationRelatedCostsPolicyTextBlock_zjY7X7QzGzUh" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;Stock-based
Compensation Expense&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company measures its stock-based awards made to employees based on the estimated fair values of the awards as of the grant date. For
stock option awards, the Company uses the Black-Scholes option-pricing model. Stock-based compensation expense is recognized over the
requisite service period and is based on the value of the portion of stock-based payment awards that is ultimately expected to vest.
The Company recognizes forfeitures of stock-based awards as they occur on a prospective basis.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Stock-based
compensation expense for awards granted to non-employees as consideration for services received is measured on the date of performance
at the fair value of the consideration received or the fair value of the equity instruments issued, whichever can be more reliably measured.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;





&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;SHARPS
TECHNOLOGY, INC.&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;NOTES
TO THE CONDENSED CONSOLIDATED FINANCIAL STATEMENTS&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;FOR
THE THREE AND NINE MONTHS ENDED SEPTEMBER 30, 2024 AND 2023&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Note
2. Summary of Significant Accounting Policies (continued)&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_84D_eus-gaap--DerivativesPolicyTextBlock_zsOS2s0wxaTa" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;Derivative
Instruments&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company accounts for common stock warrants as either equity-classified or liability-classified instruments based on an assessment of
the specific terms of the warrants and applicable authoritative guidance in Financial Accounting Standards Board (&#x201c;FASB&#x201d;)
Accounting Standards Codification (&#x201c;ASC 480&#x201d;), Distinguishing Liabilities from Equity (&#x201c;ASC 480&#x201d;) and ASC 815,
Derivatives and Hedging (&#x201c;ASC 815&#x201d;). The assessment considers whether the warrants are freestanding financial instruments
pursuant to ASC 480, meet the definition of a liability pursuant to ASC 480, and meet all of the requirements for equity classification
under ASC 815, including whether the warrants are indexed to the Company&#x2019;s own stock and whether the holders of the warrants could
potentially require net cash settlement in a circumstance outside of the Company&#x2019;s control, among other conditions for equity classification.
This assessment, which requires the use of professional judgment, is conducted at the time of warrant issuance and as of each subsequent
quarterly period end date while the warrants are outstanding.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;At
their issuance date and as of September 30, 2024, certain warrants (see Notes 8 and 10) were accounted for as liabilities as these instruments
did not meet all of the requirements for equity classification under ASC 815-40 based on the terms of the aforementioned warrants. The
resulting warrant liabilities are re-measured at each balance sheet date until their exercise or expiration, and any change in fair value
is recognized in the Company&#x2019;s condensed consolidated statements of operations.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_840_eus-gaap--ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock_zSlJU8zMa6m6" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;Foreign
Currency Translation/Transactions&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company has determined that the functional currency for its foreign subsidiary is the local currency. For financial reporting purposes,
assets and liabilities denominated in foreign currencies are translated at current exchange rates and profit and loss accounts are translated
at weighted average exchange rates. Resulting translation gains and losses are included as a separate component of stockholders&#x2019;
equity as accumulated other comprehensive income or loss. Gains or losses resulting from transactions entered into in other than the
functional currency are recorded as foreign exchange gains and losses in the condensed consolidated statements of operations.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_848_eus-gaap--ComprehensiveIncomePolicyPolicyTextBlock_zTzYyPt3Ccmb" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;Comprehensive
income (loss)&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Comprehensive
income (loss) consists of the Company&#x2019;s consolidated net loss and foreign currency translation adjustments related to its subsidiary.
Foreign currency translation adjustments included in comprehensive loss were not tax effected as the Company has a full valuation allowance
at September 30, 2024 and December 31, 2023. Accumulated other comprehensive income (loss) is a separate component of stockholders&#x2019;
equity and consists of the cumulative foreign currency translation adjustments.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_842_eus-gaap--EarningsPerSharePolicyTextBlock_zFZgBIqoHRCg" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;Basic
and Diluted Loss Per Share&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company computes net loss per share in accordance with ASC 260, Earnings per Share. ASC 260 requires presentation of both basic and diluted
earnings per share (EPS) on the face of the consolidated statements of operations. Basic EPS is computed by dividing net income (loss)
available to common stockholders (numerator) by the weighted average number of shares outstanding (denominator) during the period. Diluted
EPS gives effect to all dilutive potential common shares outstanding during the period using the treasury stock method and convertible
preferred stock using the if-converted method. In computing diluted EPS, the average stock price for the period is used in determining
the number of shares assumed to be purchased from the exercise of stock options or warrants. Diluted EPS excludes all dilutive potential
shares if their effect is anti-dilutive. As of September 30, 2024, there were &lt;span id="xdx_90A_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_c20240101__20240930__us-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__custom--StockOptionAndWarrantsMember_zBLuoIKyQ3x3" title="Antidilutive shares amount"&gt;958,693&lt;/span&gt; stock options and warrants, post reverse split
effected, that could potentially dilute basic EPS in the future that were not included in the computation of diluted EPS because to do
so would have been anti-dilutive for the periods presented.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;





&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;SHARPS
TECHNOLOGY, INC.&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;NOTES
TO THE CONDENSED CONSOLIDATED FINANCIAL STATEMENTS&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;FOR
THE THREE AND NINE MONTHS ENDED SEPTEMBER 30, 2024 AND 2023&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Note
2. Summary of Significant Accounting Policies (continued)&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_848_eus-gaap--IncomeTaxPolicyTextBlock_zi2Qqocojtoj" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;Income
Taxes&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company must make certain estimates and judgments in determining income tax expenses for financial statement purposes. These estimates
and judgments are used in the calculation of tax credits, tax benefits, tax deductions, and in the calculation of certain deferred taxes
and tax liabilities. Significant changes to these estimates may result in an increase or decrease to the Company&#x2019;s tax provision
in a subsequent period.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
provision for income taxes was comprised of the Company&#x2019;s current tax liability and changes in deferred income tax assets and liabilities.
The calculation of the current tax liability involves dealing with uncertainties in the application of complex tax laws and regulations
and in determining the liability for tax positions, if any, taken on the Company&#x2019;s tax returns in accordance with authoritative
guidance on accounting for uncertainty in income taxes. Deferred income taxes are determined based on the differences between the financial
reporting and tax basis of assets and liabilities. The Company must assess the likelihood that it will be able to recover the Company&#x2019;s
deferred tax assets. If recovery is not likely on a more-likely-than-not basis, the Company must increase its provision for income taxes
by recording a valuation allowance against the deferred tax assets that it estimates will not ultimately be recoverable. However, should
there be a change in the Company&#x2019;s ability to recover its deferred tax assets, the provision for income taxes would fluctuate in
the period of such change.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_84F_eus-gaap--ResearchAndDevelopmentExpensePolicy_z4vvVMYju8i8" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;Research
and Development Costs&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Research
and development costs are expensed as incurred.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Advance
payments for goods or services that will be used or rendered for future research and development activities are deferred and capitalized.
Such amounts are recognized as an expense as the related goods are delivered or the services are performed.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_84F_eus-gaap--CommitmentsAndContingenciesPolicyTextBlock_zmDbhhayQWRa" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;Contingencies&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Liabilities
for loss contingencies arising from claims, assessments, litigations, fines and penalties and other sources are recognized when it is
probable that a liability has been incurred and the amount of the assessment can be reasonably estimated. Gain contingencies are evaluated
and not recognized until the gain is realizable or realized.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_84A_eus-gaap--NewAccountingPronouncementsPolicyPolicyTextBlock_zLFMU2rpIkW6" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;Recent
Accounting Pronouncements&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;On
August 5, 2020, the FASB issued ASU 2020-06, &lt;i&gt;Debt &#x2013; Debt with Conversion and Other Options (Subtopic 470-20) and Derivatives
and Hedging &#x2013; Contracts in Entity&#x2019;s Own Equity (Subtopic 815-40)&lt;/i&gt;, which simplifies the accounting for certain financial
instruments with characteristics of liabilities and equity, including convertible instruments and contracts on an entity&#x2019;s own
equity. The ASU is part of the FASB&#x2019;s simplification initiative, which aims to reduce unnecessary complexity in U.S. GAAP. ASU
2020-06 simplifies the guidance in U.S. GAAP on the issuer&#x2019;s accounting for convertible debt instruments, requires entities to
provide expanded disclosures about &#x201c;the terms and features of convertible instruments&#x201d; and how the instruments have been
reported in the entity&#x2019;s financial statements. It also removes from ASC 815-40-25-10 certain conditions for equity classification
and amends certain guidance in ASC 260, &lt;i&gt;Earnings per Share&lt;/i&gt;, on the computation of EPS for convertible instruments and contracts
on an entity&#x2019;s own equity. An entity can use either a full or modified retrospective approach to adopt the ASU&#x2019;s guidance.
The ASU&#x2019;s amendments are effective for smaller public business entities fiscal years beginning after December 15, 2023. The Company
does not expect the pronouncement to have a material impact on the Company and will disclose the nature and reason for any elections
that the Company makes.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;





&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;SHARPS
TECHNOLOGY, INC.&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;NOTES
TO THE CONDENSED CONSOLIDATED FINANCIAL STATEMENTS&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;FOR
THE THREE AND NINE MONTHS ENDED SEPTEMBER 30, 2024 AND 2023&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Note
2. Summary of Significant Accounting Policies (continued)&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;In
December 2023, the FASB issued ASU 2023-09, &lt;i&gt;Income Taxes &lt;/i&gt;(Topic 740)&lt;i&gt;: Improvements to Income Tax Disclosures&lt;/i&gt;. The new guidance
requires disaggregated information about the effective tax rate reconciliation and additional information on taxes paid that meet a quantitative
threshold. The new guidance is effective for public companies for annual reporting periods beginning after December 15, 2024, a, with
early adoption permitted. The Company is currently evaluating the impacts of the new guidance on its disclosures within the consolidated
financial statements.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company does not expect the adoption of any accounting pronouncements to have a material impact on the condensed consolidated financial
statements.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;We
reviewed all other recently issued accounting pronouncements and have concluded they are not applicable or not expected to be significant
to the accounting for our operations.&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_851_zdgaIXMbKH12" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

</us-gaap:SignificantAccountingPoliciesTextBlock>
    <us-gaap:BasisOfAccountingPolicyPolicyTextBlock contextRef="From2024-01-01to2024-09-30" id="Fact002207">&lt;p id="xdx_840_eus-gaap--BasisOfAccountingPolicyPolicyTextBlock_zzowRwhjjZ34" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;Basis
of Presentation&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
accompanying condensed consolidated financial statements have been prepared by the Company in accordance with generally accepted accounting
principles (&#x201c;GAAP&#x201d;) in the United States (&#x201c;U.S.&#x201d;) and are expressed in U.S. dollars.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;





&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;SHARPS
TECHNOLOGY, INC.&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;NOTES
TO THE CONDENSED CONSOLIDATED FINANCIAL STATEMENTS&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;FOR
THE THREE AND NINE MONTHS ENDED SEPTEMBER 30, 2024 AND 2023&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Note
2. Summary of Significant Accounting Policies (continued)&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

</us-gaap:BasisOfAccountingPolicyPolicyTextBlock>
    <us-gaap:UseOfEstimates contextRef="From2024-01-01to2024-09-30" id="Fact002209">&lt;p id="xdx_84C_eus-gaap--UseOfEstimates_zGgGkPhMhNe2" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;Use
of Estimates&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
preparation of financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the
reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements
and the reported amounts of revenues and expenses during the reporting periods. Actual results could differ from those estimates. As
of September 30, 2024, the most significant estimates relate to derivative liabilities, stock-based compensation, long-lived asset impairments and accounting for debt and equity financing.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

</us-gaap:UseOfEstimates>
    <us-gaap:CashAndCashEquivalentsPolicyTextBlock contextRef="From2024-01-01to2024-09-30" id="Fact002211">&lt;p id="xdx_84D_eus-gaap--CashAndCashEquivalentsPolicyTextBlock_zpVN0CaOHznd" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;Cash
and Cash Equivalents&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company considers all highly liquid investments purchased with an original or remaining maturity of three months or less at the date
of purchase to be cash equivalents. Cash and cash equivalents are maintained with various financial institutions. At September 30, 2024
and December 31, 2023, the Company had &lt;span id="xdx_90E_eus-gaap--CashEquivalentsAtCarryingValue_iI_do_c20240930_zwmnXV8kgRR4" title="Cash equivalents"&gt;&lt;span id="xdx_905_eus-gaap--CashEquivalentsAtCarryingValue_iI_do_c20231231_zGf0aAiwxUi6" title="Cash equivalents"&gt;no&lt;/span&gt;&lt;/span&gt; cash equivalents.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

</us-gaap:CashAndCashEquivalentsPolicyTextBlock>
    <us-gaap:CashEquivalentsAtCarryingValue
      contextRef="AsOf2024-09-30"
      decimals="0"
      id="Fact002213"
      unitRef="USD">0</us-gaap:CashEquivalentsAtCarryingValue>
    <us-gaap:CashEquivalentsAtCarryingValue
      contextRef="AsOf2023-12-31"
      decimals="0"
      id="Fact002215"
      unitRef="USD">0</us-gaap:CashEquivalentsAtCarryingValue>
    <us-gaap:InventoryPolicyTextBlock contextRef="From2024-01-01to2024-09-30" id="Fact002217">&lt;p id="xdx_844_eus-gaap--InventoryPolicyTextBlock_zGOqIcJQKIza" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;Inventories&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company values inventory at the lower of cost (average cost) or net realizable value. Work-in-process and finished goods inventories
consist of material, labor, and manufacturing overhead. Net realizable value is the estimated selling price in the ordinary course of
business, less reasonably predictable costs of completion, disposal, and transportation. A reserve is established for any excess or obsolete
inventories or they may be written off. At September 30, 2024, and December 31, 2023, inventory is comprised of raw materials, including
packaging, work in process (components) and finished goods.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

</us-gaap:InventoryPolicyTextBlock>
    <us-gaap:FairValueMeasurementPolicyPolicyTextBlock contextRef="From2024-01-01to2024-09-30" id="Fact002219">&lt;p id="xdx_84D_eus-gaap--FairValueMeasurementPolicyPolicyTextBlock_z8orLyWy9zmh" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Fair
Value Measurements&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;ASC
820, Fair Value Measurements and Disclosures, requires an entity to maximize the use of observable inputs and minimize the use of unobservable
inputs when measuring fair value. ASC 820 establishes a fair value hierarchy based on the level of independent, objective evidence surrounding
the inputs used to measure fair value. A financial instrument&#x2019;s categorization within the fair value hierarchy is based upon the
lowest level of input that is significant to the fair value measurement. ASC 820 prioritizes the inputs into three levels that may be
used to measure fair value.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company&#x2019;s outstanding warrants are valued on a recurring basis with the trading price which could cause fluctuations in operating
results at the reporting periods.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Level
1&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Level
1 applies to assets or liabilities for which there are quoted prices in active markets for identical assets or liabilities. Valuations
are based on quoted prices that are readily and regularly available in an active market and do not entail a significant degree of judgment.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Level
2&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Level
2 applied to assets or liabilities for which there are other than Level 1 observable inputs such as quoted prices for similar assets
or liabilities in active markets; quoted prices for identical assets or liabilities in markets with insufficient volume or infrequent
transactions (less active markets); or model-derived valuations in which significant inputs are observable or can be derived principally
from, or corroborated by, observable market data.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Level
2 instruments require more management judgment and subjectivity as compared to Level 1 instruments. For instance: determining which instruments
are most similar to the instrument being priced requires management to identify a sample of similar securities based on the coupon rates,
maturity, issuer credit rating and instrument type, and subjectively select an individual security or multiple securities that are deemed
most similar to the security being priced; and determining whether a market is considered active requires management judgment.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;/p&gt;



&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;br/&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;SHARPS
TECHNOLOGY, INC.&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;NOTES
TO THE CONDENSED CONSOLIDATED FINANCIAL STATEMENTS&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;FOR
THE THREE AND NINE MONTHS ENDED SEPTEMBER 30, 2024 AND 2023&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Note
2. Summary of Significant Accounting Policies (continued)&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Level
3&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Level
3 applied to assets or liabilities for which there are unobservable inputs to the valuation methodology that are significant to the measurement
of the fair value of the assets or liabilities. The determination for Level 3 instruments requires the most management judgment and subjectivity.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

</us-gaap:FairValueMeasurementPolicyPolicyTextBlock>
    <us-gaap:PropertyPlantAndEquipmentPolicyTextBlock contextRef="From2024-01-01to2024-09-30" id="Fact002221">&lt;p id="xdx_84A_eus-gaap--PropertyPlantAndEquipmentPolicyTextBlock_zeQSF2RpUG6k" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;Fixed
Assets&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Fixed
assets are stated at cost. Expenditures for maintenance and repairs are charged to operations as incurred. The Company&#x2019;s fixed
assets consist of land, building, machinery and equipment, molds and website. Depreciation is calculated using the straight-line method
commencing on the date the asset is operating in the way intended by management over the following useful lives: Building &#x2013; &lt;span id="xdx_90D_eus-gaap--PropertyPlantAndEquipmentUsefulLife_iI_dtY_c20240930__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--BuildingMember_zfFFDUZ05bbg" title="Property plant and equipment asset useful life"&gt;20&lt;/span&gt;
years, Machinery and Equipment &#x2013; &lt;span id="xdx_901_eus-gaap--PropertyPlantAndEquipmentUsefulLife_iI_dtY_c20240930__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--MachineryAndEquipmentMember__srt--RangeAxis__srt--MinimumMember_zQDlHxyYqlR4" title="Property plant and equipment asset useful life"&gt;3&lt;/span&gt; - &lt;span id="xdx_907_eus-gaap--PropertyPlantAndEquipmentUsefulLife_iI_dtY_c20240930__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--MachineryAndEquipmentMember__srt--RangeAxis__srt--MaximumMember_zIimvDqNBFI6" title="Property plant and equipment asset useful life"&gt;10&lt;/span&gt; years and Website and Computer Systems &#x2013; &lt;span id="xdx_909_eus-gaap--PropertyPlantAndEquipmentUsefulLife_iI_dtY_c20240930__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--WebsiteMember_zTb8yQXBBNHf" title="Property plant and equipment asset useful life"&gt;3&lt;/span&gt; years. The expected life for Molds is
based on the lesser of the number of parts that will be produced based on the expected mold capability or 5 years.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

</us-gaap:PropertyPlantAndEquipmentPolicyTextBlock>
    <us-gaap:PropertyPlantAndEquipmentUsefulLife
      contextRef="AsOf2024-09-30_us-gaap_BuildingMember"
      id="Fact002223">P20Y</us-gaap:PropertyPlantAndEquipmentUsefulLife>
    <us-gaap:PropertyPlantAndEquipmentUsefulLife
      contextRef="AsOf2024-09-30_us-gaap_MachineryAndEquipmentMember_srt_MinimumMember"
      id="Fact002225">P3Y</us-gaap:PropertyPlantAndEquipmentUsefulLife>
    <us-gaap:PropertyPlantAndEquipmentUsefulLife
      contextRef="AsOf2024-09-30_us-gaap_MachineryAndEquipmentMember_srt_MaximumMember"
      id="Fact002227">P10Y</us-gaap:PropertyPlantAndEquipmentUsefulLife>
    <us-gaap:PropertyPlantAndEquipmentUsefulLife
      contextRef="AsOf2024-09-30_custom_WebsiteMember"
      id="Fact002229">P3Y</us-gaap:PropertyPlantAndEquipmentUsefulLife>
    <us-gaap:ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock contextRef="From2024-01-01to2024-09-30" id="Fact002231">&lt;p id="xdx_844_eus-gaap--ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock_zcCTXfcljxD8" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;&lt;span id="xdx_863_zFqcx8k1jJQ2"&gt;Impairment
of Long-Lived Assets&lt;/span&gt;&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Long-lived
assets are reviewed for impairment or whenever events or changes in circumstances indicate that the carrying amount of an asset may not
be recoverable. Recoverability is measured by comparison of the carrying amount of an asset group to the future net undiscounted cash
flows that the assets are expected to generate. If such assets are considered to be impaired, the impairment to be recognized is measured
by the amount by which the carrying amount of the assets exceeds the projected discounted future net cash flows arising from the asset.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;There
were &lt;span id="xdx_900_eus-gaap--ImpairmentOfLongLivedAssetsHeldForUse_dxL_c20240701__20240930_zcjUgtigXLBc" title="Impairment losses::XDX::-"&gt;&lt;span id="xdx_905_eus-gaap--ImpairmentOfLongLivedAssetsHeldForUse_dxL_c20230701__20230930_zcIHlxLiKnng" title="Impairment losses::XDX::-"&gt;&lt;span id="xdx_907_eus-gaap--ImpairmentOfLongLivedAssetsHeldForUse_dxL_c20240101__20240930_zqXBJ8ZjlUd2" title="Impairment losses::XDX::-"&gt;&lt;span id="xdx_90D_eus-gaap--ImpairmentOfLongLivedAssetsHeldForUse_dxL_c20230101__20230930_zat4wV0dNvRi" title="Impairment losses::XDX::-"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2233"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2235"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2237"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2239"&gt;no&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt; impairment losses recognized during the three and nine months ended September 30, 2024 and 2023.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;Purchased
Identified Intangible Assets&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company&#x2019;s identified intangible assets are amortized on a straight-line basis over their estimated useful lives of 5 years.
The Company makes judgments about the recoverability of finite-lived intangible assets whenever facts and circumstances indicate
that the useful life is shorter than originally estimated or that the carrying amount of assets may not be recoverable. If such
facts and circumstances exist, the Company assesses recoverability by comparing the projected undiscounted net cash flows associated
with the related asset or group of assets over their remaining lives against their respective carrying amounts. Impairments, if any,
are based on the excess of the carrying amount over the fair value of those assets. If the useful life is shorter than originally
estimated, the Company would accelerate the rate of amortization and amortize the remaining carrying value over the new shorter
useful life. The Company evaluates the carrying value of indefinite-lived intangible assets whenever events or changes in
circumstances indicate that the carrying amount of an asset may not be recoverable, and an impairment charge would be recognized to
the extent that the carrying amount of such assets exceeds their estimated fair value.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

</us-gaap:ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock>
    <us-gaap:CompensationRelatedCostsPolicyTextBlock contextRef="From2024-01-01to2024-09-30" id="Fact002241">&lt;p id="xdx_84D_eus-gaap--CompensationRelatedCostsPolicyTextBlock_zjY7X7QzGzUh" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;Stock-based
Compensation Expense&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company measures its stock-based awards made to employees based on the estimated fair values of the awards as of the grant date. For
stock option awards, the Company uses the Black-Scholes option-pricing model. Stock-based compensation expense is recognized over the
requisite service period and is based on the value of the portion of stock-based payment awards that is ultimately expected to vest.
The Company recognizes forfeitures of stock-based awards as they occur on a prospective basis.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Stock-based
compensation expense for awards granted to non-employees as consideration for services received is measured on the date of performance
at the fair value of the consideration received or the fair value of the equity instruments issued, whichever can be more reliably measured.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;





&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;SHARPS
TECHNOLOGY, INC.&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;NOTES
TO THE CONDENSED CONSOLIDATED FINANCIAL STATEMENTS&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;FOR
THE THREE AND NINE MONTHS ENDED SEPTEMBER 30, 2024 AND 2023&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Note
2. Summary of Significant Accounting Policies (continued)&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

</us-gaap:CompensationRelatedCostsPolicyTextBlock>
    <us-gaap:DerivativesPolicyTextBlock contextRef="From2024-01-01to2024-09-30" id="Fact002243">&lt;p id="xdx_84D_eus-gaap--DerivativesPolicyTextBlock_zsOS2s0wxaTa" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;Derivative
Instruments&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company accounts for common stock warrants as either equity-classified or liability-classified instruments based on an assessment of
the specific terms of the warrants and applicable authoritative guidance in Financial Accounting Standards Board (&#x201c;FASB&#x201d;)
Accounting Standards Codification (&#x201c;ASC 480&#x201d;), Distinguishing Liabilities from Equity (&#x201c;ASC 480&#x201d;) and ASC 815,
Derivatives and Hedging (&#x201c;ASC 815&#x201d;). The assessment considers whether the warrants are freestanding financial instruments
pursuant to ASC 480, meet the definition of a liability pursuant to ASC 480, and meet all of the requirements for equity classification
under ASC 815, including whether the warrants are indexed to the Company&#x2019;s own stock and whether the holders of the warrants could
potentially require net cash settlement in a circumstance outside of the Company&#x2019;s control, among other conditions for equity classification.
This assessment, which requires the use of professional judgment, is conducted at the time of warrant issuance and as of each subsequent
quarterly period end date while the warrants are outstanding.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;At
their issuance date and as of September 30, 2024, certain warrants (see Notes 8 and 10) were accounted for as liabilities as these instruments
did not meet all of the requirements for equity classification under ASC 815-40 based on the terms of the aforementioned warrants. The
resulting warrant liabilities are re-measured at each balance sheet date until their exercise or expiration, and any change in fair value
is recognized in the Company&#x2019;s condensed consolidated statements of operations.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

</us-gaap:DerivativesPolicyTextBlock>
    <us-gaap:ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock contextRef="From2024-01-01to2024-09-30" id="Fact002245">&lt;p id="xdx_840_eus-gaap--ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock_zSlJU8zMa6m6" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;Foreign
Currency Translation/Transactions&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company has determined that the functional currency for its foreign subsidiary is the local currency. For financial reporting purposes,
assets and liabilities denominated in foreign currencies are translated at current exchange rates and profit and loss accounts are translated
at weighted average exchange rates. Resulting translation gains and losses are included as a separate component of stockholders&#x2019;
equity as accumulated other comprehensive income or loss. Gains or losses resulting from transactions entered into in other than the
functional currency are recorded as foreign exchange gains and losses in the condensed consolidated statements of operations.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

</us-gaap:ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock>
    <us-gaap:ComprehensiveIncomePolicyPolicyTextBlock contextRef="From2024-01-01to2024-09-30" id="Fact002247">&lt;p id="xdx_848_eus-gaap--ComprehensiveIncomePolicyPolicyTextBlock_zTzYyPt3Ccmb" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;Comprehensive
income (loss)&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Comprehensive
income (loss) consists of the Company&#x2019;s consolidated net loss and foreign currency translation adjustments related to its subsidiary.
Foreign currency translation adjustments included in comprehensive loss were not tax effected as the Company has a full valuation allowance
at September 30, 2024 and December 31, 2023. Accumulated other comprehensive income (loss) is a separate component of stockholders&#x2019;
equity and consists of the cumulative foreign currency translation adjustments.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

</us-gaap:ComprehensiveIncomePolicyPolicyTextBlock>
    <us-gaap:EarningsPerSharePolicyTextBlock contextRef="From2024-01-01to2024-09-30" id="Fact002249">&lt;p id="xdx_842_eus-gaap--EarningsPerSharePolicyTextBlock_zFZgBIqoHRCg" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;Basic
and Diluted Loss Per Share&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company computes net loss per share in accordance with ASC 260, Earnings per Share. ASC 260 requires presentation of both basic and diluted
earnings per share (EPS) on the face of the consolidated statements of operations. Basic EPS is computed by dividing net income (loss)
available to common stockholders (numerator) by the weighted average number of shares outstanding (denominator) during the period. Diluted
EPS gives effect to all dilutive potential common shares outstanding during the period using the treasury stock method and convertible
preferred stock using the if-converted method. In computing diluted EPS, the average stock price for the period is used in determining
the number of shares assumed to be purchased from the exercise of stock options or warrants. Diluted EPS excludes all dilutive potential
shares if their effect is anti-dilutive. As of September 30, 2024, there were &lt;span id="xdx_90A_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_c20240101__20240930__us-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__custom--StockOptionAndWarrantsMember_zBLuoIKyQ3x3" title="Antidilutive shares amount"&gt;958,693&lt;/span&gt; stock options and warrants, post reverse split
effected, that could potentially dilute basic EPS in the future that were not included in the computation of diluted EPS because to do
so would have been anti-dilutive for the periods presented.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;





&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;SHARPS
TECHNOLOGY, INC.&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;NOTES
TO THE CONDENSED CONSOLIDATED FINANCIAL STATEMENTS&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;FOR
THE THREE AND NINE MONTHS ENDED SEPTEMBER 30, 2024 AND 2023&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Note
2. Summary of Significant Accounting Policies (continued)&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

</us-gaap:EarningsPerSharePolicyTextBlock>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="From2024-01-012024-09-30_custom_StockOptionAndWarrantsMember"
      decimals="INF"
      id="Fact002251"
      unitRef="Shares">958693</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:IncomeTaxPolicyTextBlock contextRef="From2024-01-01to2024-09-30" id="Fact002253">&lt;p id="xdx_848_eus-gaap--IncomeTaxPolicyTextBlock_zi2Qqocojtoj" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;Income
Taxes&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company must make certain estimates and judgments in determining income tax expenses for financial statement purposes. These estimates
and judgments are used in the calculation of tax credits, tax benefits, tax deductions, and in the calculation of certain deferred taxes
and tax liabilities. Significant changes to these estimates may result in an increase or decrease to the Company&#x2019;s tax provision
in a subsequent period.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
provision for income taxes was comprised of the Company&#x2019;s current tax liability and changes in deferred income tax assets and liabilities.
The calculation of the current tax liability involves dealing with uncertainties in the application of complex tax laws and regulations
and in determining the liability for tax positions, if any, taken on the Company&#x2019;s tax returns in accordance with authoritative
guidance on accounting for uncertainty in income taxes. Deferred income taxes are determined based on the differences between the financial
reporting and tax basis of assets and liabilities. The Company must assess the likelihood that it will be able to recover the Company&#x2019;s
deferred tax assets. If recovery is not likely on a more-likely-than-not basis, the Company must increase its provision for income taxes
by recording a valuation allowance against the deferred tax assets that it estimates will not ultimately be recoverable. However, should
there be a change in the Company&#x2019;s ability to recover its deferred tax assets, the provision for income taxes would fluctuate in
the period of such change.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

</us-gaap:IncomeTaxPolicyTextBlock>
    <us-gaap:ResearchAndDevelopmentExpensePolicy contextRef="From2024-01-01to2024-09-30" id="Fact002255">&lt;p id="xdx_84F_eus-gaap--ResearchAndDevelopmentExpensePolicy_z4vvVMYju8i8" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;Research
and Development Costs&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Research
and development costs are expensed as incurred.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Advance
payments for goods or services that will be used or rendered for future research and development activities are deferred and capitalized.
Such amounts are recognized as an expense as the related goods are delivered or the services are performed.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

</us-gaap:ResearchAndDevelopmentExpensePolicy>
    <us-gaap:CommitmentsAndContingenciesPolicyTextBlock contextRef="From2024-01-01to2024-09-30" id="Fact002257">&lt;p id="xdx_84F_eus-gaap--CommitmentsAndContingenciesPolicyTextBlock_zmDbhhayQWRa" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;Contingencies&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Liabilities
for loss contingencies arising from claims, assessments, litigations, fines and penalties and other sources are recognized when it is
probable that a liability has been incurred and the amount of the assessment can be reasonably estimated. Gain contingencies are evaluated
and not recognized until the gain is realizable or realized.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

</us-gaap:CommitmentsAndContingenciesPolicyTextBlock>
    <us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock contextRef="From2024-01-01to2024-09-30" id="Fact002259">&lt;p id="xdx_84A_eus-gaap--NewAccountingPronouncementsPolicyPolicyTextBlock_zLFMU2rpIkW6" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;Recent
Accounting Pronouncements&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;On
August 5, 2020, the FASB issued ASU 2020-06, &lt;i&gt;Debt &#x2013; Debt with Conversion and Other Options (Subtopic 470-20) and Derivatives
and Hedging &#x2013; Contracts in Entity&#x2019;s Own Equity (Subtopic 815-40)&lt;/i&gt;, which simplifies the accounting for certain financial
instruments with characteristics of liabilities and equity, including convertible instruments and contracts on an entity&#x2019;s own
equity. The ASU is part of the FASB&#x2019;s simplification initiative, which aims to reduce unnecessary complexity in U.S. GAAP. ASU
2020-06 simplifies the guidance in U.S. GAAP on the issuer&#x2019;s accounting for convertible debt instruments, requires entities to
provide expanded disclosures about &#x201c;the terms and features of convertible instruments&#x201d; and how the instruments have been
reported in the entity&#x2019;s financial statements. It also removes from ASC 815-40-25-10 certain conditions for equity classification
and amends certain guidance in ASC 260, &lt;i&gt;Earnings per Share&lt;/i&gt;, on the computation of EPS for convertible instruments and contracts
on an entity&#x2019;s own equity. An entity can use either a full or modified retrospective approach to adopt the ASU&#x2019;s guidance.
The ASU&#x2019;s amendments are effective for smaller public business entities fiscal years beginning after December 15, 2023. The Company
does not expect the pronouncement to have a material impact on the Company and will disclose the nature and reason for any elections
that the Company makes.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;





&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;SHARPS
TECHNOLOGY, INC.&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;NOTES
TO THE CONDENSED CONSOLIDATED FINANCIAL STATEMENTS&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;FOR
THE THREE AND NINE MONTHS ENDED SEPTEMBER 30, 2024 AND 2023&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Note
2. Summary of Significant Accounting Policies (continued)&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;In
December 2023, the FASB issued ASU 2023-09, &lt;i&gt;Income Taxes &lt;/i&gt;(Topic 740)&lt;i&gt;: Improvements to Income Tax Disclosures&lt;/i&gt;. The new guidance
requires disaggregated information about the effective tax rate reconciliation and additional information on taxes paid that meet a quantitative
threshold. The new guidance is effective for public companies for annual reporting periods beginning after December 15, 2024, a, with
early adoption permitted. The Company is currently evaluating the impacts of the new guidance on its disclosures within the consolidated
financial statements.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company does not expect the adoption of any accounting pronouncements to have a material impact on the condensed consolidated financial
statements.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;We
reviewed all other recently issued accounting pronouncements and have concluded they are not applicable or not expected to be significant
to the accounting for our operations.&lt;/span&gt;&lt;/p&gt;

</us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock>
    <us-gaap:InventoryDisclosureTextBlock contextRef="From2024-01-01to2024-09-30" id="Fact002261">&lt;p id="xdx_80C_eus-gaap--InventoryDisclosureTextBlock_zEdsKAvhbrsc" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Note
3. &lt;span id="xdx_828_zXZBFQxTrd1j"&gt;Inventories&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_890_eus-gaap--ScheduleOfInventoryCurrentTableTextBlock_zJyitDEwqaL5" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Inventories,
net consisted of the following at:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;span id="xdx_8BC_za1wZlN0pa45" style="display: none"&gt;Schedule of Inventories&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_494_20240930_z6wmSvdcayr1" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;September
    30, 2024&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_493_20231231_zRTyYvpNNmr6" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;December
    31, 2023&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_400_eus-gaap--InventoryRawMaterialsNetOfReserves_iI_maINzcUe_zz0MVJIAfoy8" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 60%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Raw materials&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 2%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 16%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;360,907&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 2%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 16%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;254,461&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_409_eus-gaap--InventoryWorkInProcessNetOfReserves_iI_maINzcUe_zckDXbS9KQsl" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Work in process&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;140,025&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;170,464&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40F_eus-gaap--InventoryFinishedGoodsNetOfReserves_iI_maINzcUe_zfUcsK9k3fpk" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Finished
    goods&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;1,518,549&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;1,284,210&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_406_eus-gaap--InventoryNet_iTI_mtINzcUe_zXulI952NDfb" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;2,019,481&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;1,709,135&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p id="xdx_8A8_z97XYThhIUr7" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

</us-gaap:InventoryDisclosureTextBlock>
    <us-gaap:ScheduleOfInventoryCurrentTableTextBlock contextRef="From2024-01-01to2024-09-30" id="Fact002263">&lt;p id="xdx_890_eus-gaap--ScheduleOfInventoryCurrentTableTextBlock_zJyitDEwqaL5" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Inventories,
net consisted of the following at:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;span id="xdx_8BC_za1wZlN0pa45" style="display: none"&gt;Schedule of Inventories&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_494_20240930_z6wmSvdcayr1" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;September
    30, 2024&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_493_20231231_zRTyYvpNNmr6" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;December
    31, 2023&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_400_eus-gaap--InventoryRawMaterialsNetOfReserves_iI_maINzcUe_zz0MVJIAfoy8" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 60%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Raw materials&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 2%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 16%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;360,907&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 2%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 16%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;254,461&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_409_eus-gaap--InventoryWorkInProcessNetOfReserves_iI_maINzcUe_zckDXbS9KQsl" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Work in process&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;140,025&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;170,464&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40F_eus-gaap--InventoryFinishedGoodsNetOfReserves_iI_maINzcUe_zfUcsK9k3fpk" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Finished
    goods&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;1,518,549&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;1,284,210&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_406_eus-gaap--InventoryNet_iTI_mtINzcUe_zXulI952NDfb" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;2,019,481&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;1,709,135&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

</us-gaap:ScheduleOfInventoryCurrentTableTextBlock>
    <us-gaap:InventoryRawMaterialsNetOfReserves
      contextRef="AsOf2024-09-30"
      decimals="0"
      id="Fact002265"
      unitRef="USD">360907</us-gaap:InventoryRawMaterialsNetOfReserves>
    <us-gaap:InventoryRawMaterialsNetOfReserves
      contextRef="AsOf2023-12-31"
      decimals="0"
      id="Fact002266"
      unitRef="USD">254461</us-gaap:InventoryRawMaterialsNetOfReserves>
    <us-gaap:InventoryWorkInProcessNetOfReserves
      contextRef="AsOf2024-09-30"
      decimals="0"
      id="Fact002268"
      unitRef="USD">140025</us-gaap:InventoryWorkInProcessNetOfReserves>
    <us-gaap:InventoryWorkInProcessNetOfReserves
      contextRef="AsOf2023-12-31"
      decimals="0"
      id="Fact002269"
      unitRef="USD">170464</us-gaap:InventoryWorkInProcessNetOfReserves>
    <us-gaap:InventoryFinishedGoodsNetOfReserves
      contextRef="AsOf2024-09-30"
      decimals="0"
      id="Fact002271"
      unitRef="USD">1518549</us-gaap:InventoryFinishedGoodsNetOfReserves>
    <us-gaap:InventoryFinishedGoodsNetOfReserves
      contextRef="AsOf2023-12-31"
      decimals="0"
      id="Fact002272"
      unitRef="USD">1284210</us-gaap:InventoryFinishedGoodsNetOfReserves>
    <us-gaap:InventoryNet
      contextRef="AsOf2024-09-30"
      decimals="0"
      id="Fact002274"
      unitRef="USD">2019481</us-gaap:InventoryNet>
    <us-gaap:InventoryNet
      contextRef="AsOf2023-12-31"
      decimals="0"
      id="Fact002275"
      unitRef="USD">1709135</us-gaap:InventoryNet>
    <us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock contextRef="From2024-01-01to2024-09-30" id="Fact002277">&lt;p id="xdx_80F_eus-gaap--PropertyPlantAndEquipmentDisclosureTextBlock_z3GzusgfC6l" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Note
4. &lt;span id="xdx_825_zL2WlW1xwrM5"&gt;Fixed Assets&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_89E_eus-gaap--PropertyPlantAndEquipmentTextBlock_zGUMepEmbKal" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Fixed
assets, net, is summarized as follows as of:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;span id="xdx_8B4_zpuDSeb8BhG1" style="display: none"&gt;Schedule of Fixed
Assets, Net&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_49E_20240930_zrvXo9riwRKl" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;September
    30, 2024&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_492_20231231_zvHyMLKogLBi" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;December
    31, 2023&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40A_eus-gaap--PropertyPlantAndEquipmentGross_iI_hus-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--LandMember_z1rTGl6pzuqc" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 60%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Land&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 2%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 16%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;253,781&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 2%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 16%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;260,460&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_402_eus-gaap--PropertyPlantAndEquipmentGross_iI_hus-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--BuildingMember_zyflhsFXGV5j" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Building&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;2,949,900&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;3,022,490&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_406_eus-gaap--PropertyPlantAndEquipmentGross_iI_hus-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--MachineryAndEquipmentMember_zNLFIcNb5M7g" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Machinery and Equipment&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;4,730,617&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;4,464,317&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40F_eus-gaap--PropertyPlantAndEquipmentGross_iI_hus-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--ComputerSystemsAndWebsiteAndOtherMember_z1Ova8mKjZO5" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Computer
    Systems and Website &amp;amp; Other&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;290,662&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;290,661&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40F_eus-gaap--PropertyPlantAndEquipmentGross_iI_maPPAENzHVU_zPE7Ix95vQ9a" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Total Fixed Assets&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;8,224,960&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;8,037,928&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40E_eus-gaap--AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_iNI_di_msPPAENzHVU_zmpfKdrCxpAc" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Less:
    accumulated depreciation&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(1,991,365&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(1,215,786&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_407_eus-gaap--PropertyPlantAndEquipmentNet_iTI_mtPPAENzHVU_zFNGJTNSCdXe" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Fixed
    asset, net&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;6,233,595&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;6,822,142&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p id="xdx_8A4_zESDx8k7cqI" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Depreciation
expense of fixed assets for the nine months ended September 30, 2024 and 2023 was $&lt;span id="xdx_90B_eus-gaap--Depreciation_c20240101__20240930_z44woASc0boa" title="Depreciation"&gt;574,719&lt;/span&gt; and $&lt;span id="xdx_903_eus-gaap--Depreciation_c20230101__20230930_zKuOlP7v1XL6" title="Depreciation"&gt;646,538&lt;/span&gt;, respectively. Substantially,
all the Company&#x2019;s fixed assets are located at the Company&#x2019;s Hungary location.&lt;/span&gt;&lt;/p&gt;
&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;





&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;SHARPS
TECHNOLOGY, INC.&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;NOTES
TO THE CONDENSED CONSOLIDATED FINANCIAL STATEMENTS&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;FOR
THE THREE AND NINE MONTHS ENDED SEPTEMBER 30, 2024 AND 2023&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

</us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock>
    <us-gaap:PropertyPlantAndEquipmentTextBlock contextRef="From2024-01-01to2024-09-30" id="Fact002279">&lt;p id="xdx_89E_eus-gaap--PropertyPlantAndEquipmentTextBlock_zGUMepEmbKal" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Fixed
assets, net, is summarized as follows as of:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;span id="xdx_8B4_zpuDSeb8BhG1" style="display: none"&gt;Schedule of Fixed
Assets, Net&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_49E_20240930_zrvXo9riwRKl" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;September
    30, 2024&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_492_20231231_zvHyMLKogLBi" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;December
    31, 2023&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40A_eus-gaap--PropertyPlantAndEquipmentGross_iI_hus-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--LandMember_z1rTGl6pzuqc" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 60%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Land&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 2%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 16%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;253,781&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 2%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 16%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;260,460&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_402_eus-gaap--PropertyPlantAndEquipmentGross_iI_hus-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--BuildingMember_zyflhsFXGV5j" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Building&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;2,949,900&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;3,022,490&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_406_eus-gaap--PropertyPlantAndEquipmentGross_iI_hus-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--MachineryAndEquipmentMember_zNLFIcNb5M7g" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Machinery and Equipment&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;4,730,617&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;4,464,317&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40F_eus-gaap--PropertyPlantAndEquipmentGross_iI_hus-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--ComputerSystemsAndWebsiteAndOtherMember_z1Ova8mKjZO5" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Computer
    Systems and Website &amp;amp; Other&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;290,662&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;290,661&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40F_eus-gaap--PropertyPlantAndEquipmentGross_iI_maPPAENzHVU_zPE7Ix95vQ9a" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Total Fixed Assets&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;8,224,960&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;8,037,928&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40E_eus-gaap--AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_iNI_di_msPPAENzHVU_zmpfKdrCxpAc" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Less:
    accumulated depreciation&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(1,991,365&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(1,215,786&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_407_eus-gaap--PropertyPlantAndEquipmentNet_iTI_mtPPAENzHVU_zFNGJTNSCdXe" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Fixed
    asset, net&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;6,233,595&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;6,822,142&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

</us-gaap:PropertyPlantAndEquipmentTextBlock>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="AsOf2024-09-30_us-gaap_LandMember"
      decimals="0"
      id="Fact002281"
      unitRef="USD">253781</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="AsOf2023-12-31_us-gaap_LandMember"
      decimals="0"
      id="Fact002282"
      unitRef="USD">260460</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="AsOf2024-09-30_us-gaap_BuildingMember"
      decimals="0"
      id="Fact002284"
      unitRef="USD">2949900</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="AsOf2023-12-31_us-gaap_BuildingMember"
      decimals="0"
      id="Fact002285"
      unitRef="USD">3022490</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="AsOf2024-09-30_us-gaap_MachineryAndEquipmentMember"
      decimals="0"
      id="Fact002287"
      unitRef="USD">4730617</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="AsOf2023-12-31_us-gaap_MachineryAndEquipmentMember"
      decimals="0"
      id="Fact002288"
      unitRef="USD">4464317</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="AsOf2024-09-30_custom_ComputerSystemsAndWebsiteAndOtherMember"
      decimals="0"
      id="Fact002290"
      unitRef="USD">290662</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="AsOf2023-12-31_custom_ComputerSystemsAndWebsiteAndOtherMember"
      decimals="0"
      id="Fact002291"
      unitRef="USD">290661</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="AsOf2024-09-30"
      decimals="0"
      id="Fact002293"
      unitRef="USD">8224960</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="AsOf2023-12-31"
      decimals="0"
      id="Fact002294"
      unitRef="USD">8037928</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
      contextRef="AsOf2024-09-30"
      decimals="0"
      id="Fact002296"
      unitRef="USD">1991365</us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment>
    <us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
      contextRef="AsOf2023-12-31"
      decimals="0"
      id="Fact002297"
      unitRef="USD">1215786</us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment>
    <us-gaap:PropertyPlantAndEquipmentNet
      contextRef="AsOf2024-09-30"
      decimals="0"
      id="Fact002299"
      unitRef="USD">6233595</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:PropertyPlantAndEquipmentNet
      contextRef="AsOf2023-12-31"
      decimals="0"
      id="Fact002300"
      unitRef="USD">6822142</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:Depreciation
      contextRef="From2024-01-01to2024-09-30"
      decimals="0"
      id="Fact002302"
      unitRef="USD">574719</us-gaap:Depreciation>
    <us-gaap:Depreciation
      contextRef="From2023-01-012023-09-30"
      decimals="0"
      id="Fact002304"
      unitRef="USD">646538</us-gaap:Depreciation>
    <us-gaap:AssetAcquisitionTextBlock contextRef="From2024-01-01to2024-09-30" id="Fact002306">&lt;p id="xdx_803_eus-gaap--AssetAcquisitionTextBlock_zYtibF3qN6g5" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Note
5. &lt;span id="xdx_827_z76AZ9ehjhP8"&gt;Asset Acquisition&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;Safegard
Medical, Kft&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;In
June 2020, the Company entered into a Share Purchase Agreement (&#x201c;Agreement&#x201d;) with Safegard Medical, Kft
(&#x201c;Safegard&#x201d;) and amendments to the Agreement, collectively, the Agreements, to purchase either the stock or certain
assets of a manufacturing facility for $&lt;span id="xdx_90F_eus-gaap--PaymentsToAcquireBusinessesGross_pn5n6_c20200601__20200630__us-gaap--BusinessAcquisitionAxis__custom--SafegardMedicalIncMember__us-gaap--TypeOfArrangementAxis__custom--SharePurchaseAgreementMember_zkDcdYETiCs8" title="Consideration paid in cash"&gt;2.5&lt;/span&gt;M
in cash, plus additional consideration of common stock and options with a fair market value of $&lt;span id="xdx_905_ecustom--FairMarketValueOfCommonStock_c20200601__20200630__us-gaap--BusinessAcquisitionAxis__custom--SafegardMedicalIncMember__us-gaap--TypeOfArrangementAxis__custom--SharePurchaseAgreementMember__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zq4qWnGl5RX6" title="Fair market value of common stock"&gt;200,000&lt;/span&gt;
and $&lt;span id="xdx_904_ecustom--FairMarketValueOfCommonStock_c20200601__20200630__us-gaap--BusinessAcquisitionAxis__custom--SafegardMedicalIncMember__us-gaap--TypeOfArrangementAxis__custom--SharePurchaseAgreementMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_z9nc5NNqGDaj" title="Fair market value of common stock"&gt;183,135&lt;/span&gt;,
respectively. The Agreements provided the Company various periods for due diligence and post due diligence, requirements for escrow
payments through the closing date (&#x201c;Closing Date&#x201d;).&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Through
the Closing Date, the Agreements provided the Company with the exclusive use of the facility in exchange for payment of the facility&#x2019;s
operating costs. The monthly fee (&#x201c;Operating Costs&#x201d;), which primarily covered the facility&#x2019;s operating costs, was mainly
comprised of the seller&#x2019;s workforce costs, materials and other recurring monthly operating cost.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
acquisition of Safegard, which closed on July 6, 2022, did not meet the definition of a business pursuant to ASC 805-10, and accordingly
was accounted for as an asset acquisition in accordance with ASC 805-50. The cost of the acquisition was $&lt;span id="xdx_90B_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets_iI_c20220706__us-gaap--BusinessAcquisitionAxis__custom--SafegardMedicalIncMember_zrMoaIEQjGmg" title="Acquisition cost"&gt;2,936,712&lt;/span&gt;, including transaction
costs of $&lt;span id="xdx_904_eus-gaap--BusinessAcquisitionCostOfAcquiredEntityTransactionCosts_iI_c20220706__us-gaap--BusinessAcquisitionAxis__custom--SafegardMedicalIncMember_zq9QQxRurEB7" title="Transaction costs"&gt;53,576&lt;/span&gt;, with the allocation to the assets acquired on a relative fair value basis. The intangibles relate to permits and a
limited workforce acquired. Under ASC 805-50, no goodwill is recognized. The operating results for Safegard are included in the condensed
consolidated financial statements for the period beginning after the closing on July 6, 2022.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_891_eus-gaap--ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock_zITHKT5SKAKj" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
relative fair value of the assets acquired and related deferred tax liability during 2022 was as follows:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span id="xdx_8BE_z5TwLTl3j1f" style="display: none"&gt;Schedule of Fair Value of  Assets Acquisition&lt;/span&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 70%"&gt;
  &lt;tr style="display: none; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_497_20220706__us-gaap--BusinessAcquisitionAxis__custom--SafegardMedicalIncMember_zGwXKy86eZEl" style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_407_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLand_iI_maBCRIAzqVv_zG3wN4mZxHPc" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 80%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Land&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 2%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 16%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;226,000&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_402_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment_iI_maBCRIAzqVv_z1rt3UafJmY8" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Building and affixed assets&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;2,648,000&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_404_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedEquipment_iI_maBCRIAzqVv_zX1DNhQFnsO6" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Machinery&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;158,000&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40A_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory_iI_maBCRIAzqVv_zdmKJ0iRHiZj" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Inventory&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;32,000&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_400_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles_iI_maBCRIAzqVv_zmc8vOTjXUl2" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Intangibles&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;64,712&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40B_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities_iNI_di_msBCRIAzqVv_zVKCI8dWFBO9" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Deferred
    tax liability&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(192,000&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40B_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets_iTI_mtBCRIAzqVv_zNz4Et0NTls1" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;2,936,712&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p id="xdx_8A7_zA0IAGnDv4Ge" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
useful lives for the acquired assets is Building - &lt;span id="xdx_904_eus-gaap--PropertyPlantAndEquipmentUsefulLife_iI_dtY_c20220706__us-gaap--BusinessAcquisitionAxis__custom--SafegardMedicalIncMember__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--BuildingMember_zqWUg6HknTCc" title="Fixed assets acquired, useful lives"&gt;20&lt;/span&gt; years; Machinery &#x2013; &lt;span id="xdx_900_eus-gaap--PropertyPlantAndEquipmentUsefulLife_iI_dtY_c20220706__us-gaap--BusinessAcquisitionAxis__custom--SafegardMedicalIncMember__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--MachineryAndEquipmentMember__srt--RangeAxis__srt--MinimumMember_z3PNPRElCD7f" title="Fixed assets acquired, useful lives"&gt;5&lt;/span&gt; to &lt;span id="xdx_902_eus-gaap--PropertyPlantAndEquipmentUsefulLife_iI_dtY_c20220706__us-gaap--BusinessAcquisitionAxis__custom--SafegardMedicalIncMember__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--MachineryAndEquipmentMember__srt--RangeAxis__srt--MaximumMember_zLb4EkCTMFtj" title="Fixed assets acquired, useful lives"&gt;10&lt;/span&gt; years; Intangibles &#x2013; &lt;span id="xdx_905_eus-gaap--FiniteLivedIntangibleAssetUsefulLife_iI_dtY_c20220706__us-gaap--BusinessAcquisitionAxis__custom--SafegardMedicalIncMember_zCGxRPdh5eq" title="Intangible asset acquired, useful lives"&gt;5&lt;/span&gt; years. The related
depreciation and amortization is being recorded on a straight-line basis.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

</us-gaap:AssetAcquisitionTextBlock>
    <us-gaap:PaymentsToAcquireBusinessesGross
      contextRef="From2020-06-012020-06-30_custom_SafegardMedicalIncMember_custom_SharePurchaseAgreementMember"
      decimals="-5"
      id="Fact002308"
      unitRef="USD">2500000</us-gaap:PaymentsToAcquireBusinessesGross>
    <STSS:FairMarketValueOfCommonStock
      contextRef="From2020-06-012020-06-30_custom_SafegardMedicalIncMember_custom_SharePurchaseAgreementMember_us-gaap_CommonStockMember"
      decimals="0"
      id="Fact002310"
      unitRef="USD">200000</STSS:FairMarketValueOfCommonStock>
    <STSS:FairMarketValueOfCommonStock
      contextRef="From2020-06-012020-06-30_custom_SafegardMedicalIncMember_custom_SharePurchaseAgreementMember_us-gaap_StockOptionMember"
      decimals="0"
      id="Fact002312"
      unitRef="USD">183135</STSS:FairMarketValueOfCommonStock>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets
      contextRef="AsOf2022-07-06_custom_SafegardMedicalIncMember"
      decimals="0"
      id="Fact002314"
      unitRef="USD">2936712</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets>
    <us-gaap:BusinessAcquisitionCostOfAcquiredEntityTransactionCosts
      contextRef="AsOf2022-07-06_custom_SafegardMedicalIncMember"
      decimals="0"
      id="Fact002316"
      unitRef="USD">53576</us-gaap:BusinessAcquisitionCostOfAcquiredEntityTransactionCosts>
    <us-gaap:ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock contextRef="From2024-01-01to2024-09-30" id="Fact002318">&lt;p id="xdx_891_eus-gaap--ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock_zITHKT5SKAKj" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
relative fair value of the assets acquired and related deferred tax liability during 2022 was as follows:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span id="xdx_8BE_z5TwLTl3j1f" style="display: none"&gt;Schedule of Fair Value of  Assets Acquisition&lt;/span&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 70%"&gt;
  &lt;tr style="display: none; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_497_20220706__us-gaap--BusinessAcquisitionAxis__custom--SafegardMedicalIncMember_zGwXKy86eZEl" style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_407_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLand_iI_maBCRIAzqVv_zG3wN4mZxHPc" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 80%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Land&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 2%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 16%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;226,000&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_402_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment_iI_maBCRIAzqVv_z1rt3UafJmY8" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Building and affixed assets&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;2,648,000&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_404_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedEquipment_iI_maBCRIAzqVv_zX1DNhQFnsO6" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Machinery&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;158,000&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40A_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory_iI_maBCRIAzqVv_zdmKJ0iRHiZj" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Inventory&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;32,000&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_400_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles_iI_maBCRIAzqVv_zmc8vOTjXUl2" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Intangibles&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;64,712&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40B_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities_iNI_di_msBCRIAzqVv_zVKCI8dWFBO9" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Deferred
    tax liability&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(192,000&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40B_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets_iTI_mtBCRIAzqVv_zNz4Et0NTls1" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;2,936,712&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

</us-gaap:ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLand
      contextRef="AsOf2022-07-06_custom_SafegardMedicalIncMember"
      decimals="0"
      id="Fact002320"
      unitRef="USD">226000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLand>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment
      contextRef="AsOf2022-07-06_custom_SafegardMedicalIncMember"
      decimals="0"
      id="Fact002322"
      unitRef="USD">2648000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedEquipment
      contextRef="AsOf2022-07-06_custom_SafegardMedicalIncMember"
      decimals="0"
      id="Fact002324"
      unitRef="USD">158000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedEquipment>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory
      contextRef="AsOf2022-07-06_custom_SafegardMedicalIncMember"
      decimals="0"
      id="Fact002326"
      unitRef="USD">32000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles
      contextRef="AsOf2022-07-06_custom_SafegardMedicalIncMember"
      decimals="0"
      id="Fact002328"
      unitRef="USD">64712</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities
      contextRef="AsOf2022-07-06_custom_SafegardMedicalIncMember"
      decimals="0"
      id="Fact002330"
      unitRef="USD">192000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets
      contextRef="AsOf2022-07-06_custom_SafegardMedicalIncMember"
      decimals="0"
      id="Fact002332"
      unitRef="USD">2936712</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets>
    <us-gaap:PropertyPlantAndEquipmentUsefulLife
      contextRef="AsOf2022-07-06_custom_SafegardMedicalIncMember_us-gaap_BuildingMember"
      id="Fact002334">P20Y</us-gaap:PropertyPlantAndEquipmentUsefulLife>
    <us-gaap:PropertyPlantAndEquipmentUsefulLife
      contextRef="AsOf2022-07-06_custom_SafegardMedicalIncMember_us-gaap_MachineryAndEquipmentMember_srt_MinimumMember"
      id="Fact002336">P5Y</us-gaap:PropertyPlantAndEquipmentUsefulLife>
    <us-gaap:PropertyPlantAndEquipmentUsefulLife
      contextRef="AsOf2022-07-06_custom_SafegardMedicalIncMember_us-gaap_MachineryAndEquipmentMember_srt_MaximumMember"
      id="Fact002338">P10Y</us-gaap:PropertyPlantAndEquipmentUsefulLife>
    <us-gaap:FiniteLivedIntangibleAssetUsefulLife
      contextRef="AsOf2022-07-06_custom_SafegardMedicalIncMember"
      id="Fact002340">P5Y</us-gaap:FiniteLivedIntangibleAssetUsefulLife>
    <us-gaap:OtherAssetsDisclosureTextBlock contextRef="From2024-01-01to2024-09-30" id="Fact002342">&lt;p id="xdx_809_eus-gaap--OtherAssetsDisclosureTextBlock_zR2EMEbczMoh" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Note
6. &lt;span id="xdx_826_zFVszYWWG5Z6"&gt;Other Assets&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_89D_eus-gaap--ScheduleOfOtherAssetsTableTextBlock_z0InxzEYOjck" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Other
assets as of September 30, 2024, and December 31, 2023 are summarized as follows:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span id="xdx_8B8_z1deStF3dQHc" style="display: none"&gt;Schedule of Other Assets&lt;/span&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_491_20240930_ziHbvl5Jyvj7" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;September
    30, 2024&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_49C_20231231_ziJNYIIR20N8" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;December
    31, 2023&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_403_eus-gaap--IntangibleAssetsNetExcludingGoodwill_iI_maOANzzDQ_z6mTdWXPecQl" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 60%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Intangibles, net &#x2013; See Note 6&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 2%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 16%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;40,227&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 2%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 16%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;52,513&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40D_eus-gaap--OtherAssetsMiscellaneousNoncurrent_iI_maOANzzDQ_zwGSSBFesi67" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Other &#x2013; See Note 7&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;326,061&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;76,062&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_409_eus-gaap--OtherAssetsNoncurrent_iTI_mtOANzzDQ_zRCJl1BDGp56" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-bottom: 1pt"&gt;&lt;span style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;Total Other assets&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;366,288&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;128,575&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p id="xdx_8A9_zhGzMIuJgrDh" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;





&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;SHARPS
TECHNOLOGY, INC.&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;NOTES
TO THE CONDENSED CONSOLIDATED FINANCIAL STATEMENTS&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;FOR
THE THREE AND NINE MONTHS ENDED SEPTEMBER 30, 2024 AND 2023&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

</us-gaap:OtherAssetsDisclosureTextBlock>
    <us-gaap:ScheduleOfOtherAssetsTableTextBlock contextRef="From2024-01-01to2024-09-30" id="Fact002344">&lt;p id="xdx_89D_eus-gaap--ScheduleOfOtherAssetsTableTextBlock_z0InxzEYOjck" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Other
assets as of September 30, 2024, and December 31, 2023 are summarized as follows:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span id="xdx_8B8_z1deStF3dQHc" style="display: none"&gt;Schedule of Other Assets&lt;/span&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_491_20240930_ziHbvl5Jyvj7" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;September
    30, 2024&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_49C_20231231_ziJNYIIR20N8" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;December
    31, 2023&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_403_eus-gaap--IntangibleAssetsNetExcludingGoodwill_iI_maOANzzDQ_z6mTdWXPecQl" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 60%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Intangibles, net &#x2013; See Note 6&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 2%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 16%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;40,227&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 2%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 16%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;52,513&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40D_eus-gaap--OtherAssetsMiscellaneousNoncurrent_iI_maOANzzDQ_zwGSSBFesi67" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Other &#x2013; See Note 7&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;326,061&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;76,062&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_409_eus-gaap--OtherAssetsNoncurrent_iTI_mtOANzzDQ_zRCJl1BDGp56" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-bottom: 1pt"&gt;&lt;span style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;Total Other assets&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;366,288&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;128,575&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

</us-gaap:ScheduleOfOtherAssetsTableTextBlock>
    <us-gaap:IntangibleAssetsNetExcludingGoodwill
      contextRef="AsOf2024-09-30"
      decimals="0"
      id="Fact002346"
      unitRef="USD">40227</us-gaap:IntangibleAssetsNetExcludingGoodwill>
    <us-gaap:IntangibleAssetsNetExcludingGoodwill
      contextRef="AsOf2023-12-31"
      decimals="0"
      id="Fact002347"
      unitRef="USD">52513</us-gaap:IntangibleAssetsNetExcludingGoodwill>
    <us-gaap:OtherAssetsMiscellaneousNoncurrent
      contextRef="AsOf2024-09-30"
      decimals="0"
      id="Fact002349"
      unitRef="USD">326061</us-gaap:OtherAssetsMiscellaneousNoncurrent>
    <us-gaap:OtherAssetsMiscellaneousNoncurrent
      contextRef="AsOf2023-12-31"
      decimals="0"
      id="Fact002350"
      unitRef="USD">76062</us-gaap:OtherAssetsMiscellaneousNoncurrent>
    <us-gaap:OtherAssetsNoncurrent
      contextRef="AsOf2024-09-30"
      decimals="0"
      id="Fact002352"
      unitRef="USD">366288</us-gaap:OtherAssetsNoncurrent>
    <us-gaap:OtherAssetsNoncurrent
      contextRef="AsOf2023-12-31"
      decimals="0"
      id="Fact002353"
      unitRef="USD">128575</us-gaap:OtherAssetsNoncurrent>
    <us-gaap:DebtDisclosureTextBlock contextRef="From2024-01-01to2024-09-30" id="Fact002355">&lt;p id="xdx_808_eus-gaap--DebtDisclosureTextBlock_zuFK5df5uaAa" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Note
7. &lt;span id="xdx_82C_ze8D637EGr8h"&gt;Debt Financing&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;On
September 20, 2024, the Company entered into a securities purchase agreement (the &#x201c;Securities Purchase Agreement&#x201d;) and a
Senior Secured Note (the &#x201c;Note&#x201d;) for an aggregate principal amount of $&lt;span id="xdx_903_eus-gaap--DebtInstrumentFaceAmount_iI_c20240920__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__us-gaap--DebtInstrumentAxis__custom--SeniorSecuredNoteMember_zliuHirJYfLh"&gt;4,375,000&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;,
including OID interest of $&lt;span id="xdx_903_eus-gaap--DebtInstrumentIncreaseAccruedInterest_c20240920__20240920__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__us-gaap--DebtInstrumentAxis__custom--SeniorSecuredNoteMember_zj0riSknwLdl" title="Original issue discount (OID)"&gt;875,000 &lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;maturing
on &lt;span id="xdx_903_eus-gaap--DebtInstrumentMaturityDate_dd_c20240920__20240920__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__us-gaap--DebtInstrumentAxis__custom--SeniorSecuredNoteMember_zBMDZZSxXTz4"&gt;January
31, 2025&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;, with certain purchasers (the
&#x201c;Purchasers&#x201d;), and the issuance of approximately &lt;span id="xdx_90A_ecustom--NumberOfUnregisteredCommonStockIssuedDuringPostReverseShares_pid_c20240920__20240920__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__us-gaap--DebtInstrumentAxis__custom--SeniorSecuredNoteMember_zvzZ6q21X7ha" title="Number of unregistered common stock issued during post reverse shares"&gt;259,091 &lt;/span&gt;&lt;/span&gt;(pre
reverse - &lt;span id="xdx_903_ecustom--NumberOfUnregisteredCommonStockIssuedDuringPreReverseShares_pid_c20240920__20240920__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__us-gaap--DebtInstrumentAxis__custom--SeniorSecuredNoteMember__us-gaap--AwardTypeAxis__custom--PreReverseMember_zcsLkCRMOkD6" title="Pre reverse"&gt;5,700,006&lt;/span&gt; ) unregistered shares of the Company&#x2019;s Common Stock. The aggregate gross proceeds to the Company were
approximately $&lt;span id="xdx_90F_eus-gaap--ProceedsFromIssuanceOfDebt_pn5n6_c20240920__20240920__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__us-gaap--DebtInstrumentAxis__custom--SeniorSecuredNoteMember_zK4Q5qUBQddk"&gt;3.5 &lt;/span&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;million,
before deducting fees to the placement agent and other offering expenses payable by the Company of $&lt;span id="xdx_908_ecustom--PlacementAgentAndOtherOfferingExpenses_c20240920__20240920__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__us-gaap--DebtInstrumentAxis__custom--SeniorSecuredNoteMember_z4HeS0lGiHYh" title="Closing costs"&gt;514,700 &lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;and
an escrow deposit of $&lt;span id="xdx_903_eus-gaap--EscrowDeposit_iI_c20240920__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__us-gaap--DebtInstrumentAxis__custom--SeniorSecuredNoteMember_z98EFWS5ASe8"&gt;250,000 &lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;required
until certain security liens are filed. The Note and the common stock were recorded at the relative fair values of $&lt;span id="xdx_900_eus-gaap--DebtInstrumentFairValue_iI_pn5n6_c20240920__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__us-gaap--DebtInstrumentAxis__custom--SeniorSecuredNoteMember_zv0NsEqPWpIb"&gt;2.6&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;M
and $&lt;span id="xdx_908_ecustom--CommonStockFairValue_iI_c20240920__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__us-gaap--DebtInstrumentAxis__custom--SeniorSecuredNoteMember_zL9KkwMAsE9c" title="Common stock fair value"&gt;852,000&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;,
respectively, in accordance with ASC 470-20-25-2. The aforementioned expenses were allocated based on the aforementioned fair values
as a reduction to the carrying amount of the debt and a reduction of the equity in accordance with ASC 505-10. &lt;/span&gt;For the three
and nine months ended September 30, 2024, the Company recorded accreted interest and fees of $&lt;span id="xdx_903_ecustom--AccretedInterestFees_c20240101__20240930_zQAFf1QTzaZd" title="Accreted interest fees"&gt;75,192&lt;/span&gt;.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;In
connection with the Securities Purchase Agreement and Note, the Company entered into a Registration Rights Agreement with the Purchasers
(the &#x201c;Registration Rights Agreement&#x201d;), requiring the Company to file a resale registration statement (the &#x201c;Registration
Statement&#x201d;) with the U.S. Securities and Exchange Commission (the &#x201c;Commission&#x201d;) to register the unregistered shares
of Common Stock. within forty-five (45) calendar days following the filing date, which is thirty (30) days after the closing date. The
Company filed the required resale registration statement on October 23, 2024.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

</us-gaap:DebtDisclosureTextBlock>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="AsOf2024-09-20_custom_SecuritiesPurchaseAgreementMember_custom_SeniorSecuredNoteMember"
      decimals="0"
      id="Fact002356"
      unitRef="USD">4375000</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:DebtInstrumentIncreaseAccruedInterest
      contextRef="From2024-09-202024-09-20_custom_SecuritiesPurchaseAgreementMember_custom_SeniorSecuredNoteMember"
      decimals="0"
      id="Fact002358"
      unitRef="USD">875000</us-gaap:DebtInstrumentIncreaseAccruedInterest>
    <us-gaap:DebtInstrumentMaturityDate
      contextRef="From2024-09-202024-09-20_custom_SecuritiesPurchaseAgreementMember_custom_SeniorSecuredNoteMember"
      id="Fact002359">2025-01-31</us-gaap:DebtInstrumentMaturityDate>
    <STSS:NumberOfUnregisteredCommonStockIssuedDuringPostReverseShares
      contextRef="From2024-09-202024-09-20_custom_SecuritiesPurchaseAgreementMember_custom_SeniorSecuredNoteMember"
      decimals="INF"
      id="Fact002361"
      unitRef="Shares">259091</STSS:NumberOfUnregisteredCommonStockIssuedDuringPostReverseShares>
    <STSS:NumberOfUnregisteredCommonStockIssuedDuringPreReverseShares
      contextRef="From2024-09-202024-09-20_custom_SecuritiesPurchaseAgreementMember_custom_SeniorSecuredNoteMember_custom_PreReverseMember"
      decimals="INF"
      id="Fact002363"
      unitRef="Shares">5700006</STSS:NumberOfUnregisteredCommonStockIssuedDuringPreReverseShares>
    <us-gaap:ProceedsFromIssuanceOfDebt
      contextRef="From2024-09-202024-09-20_custom_SecuritiesPurchaseAgreementMember_custom_SeniorSecuredNoteMember"
      decimals="-5"
      id="Fact002364"
      unitRef="USD">3500000</us-gaap:ProceedsFromIssuanceOfDebt>
    <STSS:PlacementAgentAndOtherOfferingExpenses
      contextRef="From2024-09-202024-09-20_custom_SecuritiesPurchaseAgreementMember_custom_SeniorSecuredNoteMember"
      decimals="0"
      id="Fact002366"
      unitRef="USD">514700</STSS:PlacementAgentAndOtherOfferingExpenses>
    <us-gaap:EscrowDeposit
      contextRef="AsOf2024-09-20_custom_SecuritiesPurchaseAgreementMember_custom_SeniorSecuredNoteMember"
      decimals="0"
      id="Fact002367"
      unitRef="USD">250000</us-gaap:EscrowDeposit>
    <us-gaap:DebtInstrumentFairValue
      contextRef="AsOf2024-09-20_custom_SecuritiesPurchaseAgreementMember_custom_SeniorSecuredNoteMember"
      decimals="-5"
      id="Fact002368"
      unitRef="USD">2600000</us-gaap:DebtInstrumentFairValue>
    <STSS:CommonStockFairValue
      contextRef="AsOf2024-09-20_custom_SecuritiesPurchaseAgreementMember_custom_SeniorSecuredNoteMember"
      decimals="0"
      id="Fact002370"
      unitRef="USD">852000</STSS:CommonStockFairValue>
    <STSS:AccretedInterestFees
      contextRef="From2024-01-01to2024-09-30"
      decimals="0"
      id="Fact002372"
      unitRef="USD">75192</STSS:AccretedInterestFees>
    <us-gaap:StockholdersEquityNoteDisclosureTextBlock contextRef="From2024-01-01to2024-09-30" id="Fact002374">&lt;p id="xdx_80E_eus-gaap--StockholdersEquityNoteDisclosureTextBlock_zlepTav0SE09" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Note
8. &lt;span id="xdx_828_zc9BzTkVH4ze"&gt;Stockholders&#x2019; Equity&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;Capital
Structure&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;On
December 11, 2017, the Company was incorporated in Wyoming with &lt;span id="xdx_909_eus-gaap--CommonStockSharesAuthorized_iI_c20171211_zObFdDWIxNJ5" title="Common stock, share authorized"&gt;20,000,000&lt;/span&gt; shares of common stock authorized with a $&lt;span id="xdx_903_eus-gaap--CommonStockParOrStatedValuePerShare_iI_c20171211_zzZomcI4bkch" title="Common stock, par value"&gt;0.0001&lt;/span&gt; par value.
Effective, April 18, 2019, the Company&#x2019;s authorized common stock was increased to &lt;span id="xdx_90F_eus-gaap--CommonStockSharesAuthorized_iI_c20190418_zB4WALMVnysg" title="Common stock, share authorized"&gt;50,000,000&lt;/span&gt; shares of common stock. The articles
of incorporation also authorized &lt;span id="xdx_90B_eus-gaap--PreferredStockSharesAuthorized_iI_c20190418_zizPP87QWesf" title="Preferred stock, shares authorized"&gt;10,000&lt;/span&gt; preferred shares with a $&lt;span id="xdx_906_eus-gaap--PreferredStockParOrStatedValuePerShare_iI_c20190418_zbxGU9fVvIwf" title="Preferred stock, par value"&gt;0.001&lt;/span&gt; par value.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Effective
March 22, 2022, the Company completed a plan and agreement of merger with Sharps Technology, Inc., a Nevada corporation (&#x201c;Sharps
Nevada&#x201d;). &lt;span id="xdx_900_eus-gaap--ConversionOfStockDescription_c20220319__20220322_zantrWc3GQf2" title="Conversion of stock, description"&gt;Pursuant to the merger agreement, (i) the Company merged with and into Sharps Nevada, (ii) each 3.5 shares of common
stock of the Company were converted into one share of common stock of Sharps Nevada and (iii) the articles of incorporation and bylaws
of Sharps Nevada, became the articles of incorporation and bylaws of the surviving corporation.&lt;/span&gt; The Company&#x2019;s authorized common
stock and preferred stock increased from &lt;span id="xdx_908_eus-gaap--CommonStockSharesAuthorized_iI_c20220321_z8IuS6QkXEV1" title="Common stock, share authorized"&gt;50,000,000&lt;/span&gt; to &lt;span id="xdx_90D_eus-gaap--CommonStockSharesAuthorized_iI_c20220322_z0abmZ0ilApb" title="Common stock, share authorized"&gt;100,000,000&lt;/span&gt; and &lt;span id="xdx_90F_eus-gaap--PreferredStockSharesAuthorized_iI_c20220321_zk63QZSibjyh" title="Preferred stock, shares authorized"&gt;10,000&lt;/span&gt; to &lt;span id="xdx_900_eus-gaap--PreferredStockSharesAuthorized_iI_c20220322_zBhs3NS9Fxal" title="Preferred stock, shares authorized"&gt;1,000,000&lt;/span&gt; shares, respectively. The par value of preferred
stock decreased from $&lt;span id="xdx_903_eus-gaap--PreferredStockParOrStatedValuePerShare_iI_c20220321_zzRUEw5Tmx4a" title="Preferred stock, par value"&gt;0.001&lt;/span&gt; to $&lt;span id="xdx_907_eus-gaap--PreferredStockParOrStatedValuePerShare_iI_c20220322_zG9Rt3sweHO" title="Preferred stock, par value"&gt;0.0001&lt;/span&gt; per share.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;In
July 2024, the shareholders approved the increase of the authorized common stock from &lt;span id="xdx_909_eus-gaap--CommonStockSharesAuthorized_iI_c20240731_zkRgJIXjFXq5" title="Common stock, share authorized"&gt;100,000,000&lt;/span&gt; to &lt;span id="xdx_905_eus-gaap--CommonStockSharesAuthorized_iI_c20240930_zToqCQmavXM1" title="Common stock, share authorized"&gt;500,000,000&lt;/span&gt; which was subsequently
filed as an amendment to the articles of incorporation with the state of Nevada.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;Common
Stock&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;On
September 23, 2024, as noted in Note 7, in connection with the Securities Purchase Agreement and Note the Company issued &lt;span id="xdx_901_eus-gaap--StockIssuedDuringPeriodSharesOther_pid_c20240923__20240923__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember_zlPmjF42fGHc" title="Issued shares of common stock"&gt;259,091&lt;/span&gt;
(pre reverse - &lt;span id="xdx_90A_eus-gaap--StockIssuedDuringPeriodSharesOther_pid_c20240923__20240923__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__us-gaap--AwardTypeAxis__custom--PrereverseMember_zKlqsPnmsBIj" title="Issued shares of common stock"&gt;5,700,006&lt;/span&gt;)
shares of unregistered common stock.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;





&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;On
May 31 and June 13, 2024, the Company entered into subscription agreements with certain institutional investors, pursuant to which
the Company agreed to issue and sell to the investors &lt;span id="xdx_902_eus-gaap--SaleOfStockNumberOfSharesIssuedInTransaction_pid_c20240531__20240531__us-gaap--TypeOfArrangementAxis__custom--SubscriptionAgreementsMember__srt--TitleOfIndividualAxis__custom--InvestorsMember_zjJklAyq4mBb" title="Number of shares sold"&gt;&lt;span id="xdx_907_eus-gaap--SaleOfStockNumberOfSharesIssuedInTransaction_pid_c20240613__20240613__us-gaap--TypeOfArrangementAxis__custom--SubscriptionAgreementsMember__srt--TitleOfIndividualAxis__custom--InvestorsMember_zzRvbFayOitl" title="Number of shares sold"&gt;190,773&lt;/span&gt;&lt;/span&gt;
(pre reverse - &lt;span id="xdx_90B_eus-gaap--SaleOfStockNumberOfSharesIssuedInTransaction_pid_c20240531__20240531__us-gaap--TypeOfArrangementAxis__custom--SubscriptionAgreementsMember__srt--TitleOfIndividualAxis__custom--InvestorsMember__us-gaap--AwardTypeAxis__custom--PrereverseMember_zdQc4XC1X1B" title="Number of shares sold pre reverse"&gt;&lt;span id="xdx_907_eus-gaap--SaleOfStockNumberOfSharesIssuedInTransaction_pid_c20240613__20240613__us-gaap--TypeOfArrangementAxis__custom--SubscriptionAgreementsMember__srt--TitleOfIndividualAxis__custom--InvestorsMember__us-gaap--AwardTypeAxis__custom--PrereverseMember_zhVEyFopSXWc" title="Number of shares sold pre reverse"&gt;4,197,000&lt;/span&gt;&lt;/span&gt;)
shares (the &#x201c;Shares&#x201d;) of Common Stock, par value $&lt;span id="xdx_902_eus-gaap--CommonStockParOrStatedValuePerShare_iI_pid_c20240531__us-gaap--TypeOfArrangementAxis__custom--SubscriptionAgreementsMember__srt--TitleOfIndividualAxis__custom--InvestorsMember_zCcLihvcTRCc" title="Common stock par value"&gt;&lt;span id="xdx_902_eus-gaap--CommonStockParOrStatedValuePerShare_iI_pid_c20240613__us-gaap--TypeOfArrangementAxis__custom--SubscriptionAgreementsMember__srt--TitleOfIndividualAxis__custom--InvestorsMember_znV6OeA4ElNj" title="Common stock par value"&gt;0.0001&lt;/span&gt;&lt;/span&gt;
per share of the Company at a price of $&lt;span id="xdx_904_eus-gaap--SaleOfStockPricePerShare_iI_pid_c20240531__us-gaap--TypeOfArrangementAxis__custom--SubscriptionAgreementsMember__srt--TitleOfIndividualAxis__custom--InvestorsMember_z46HBaZP3Q36" title="Shares price"&gt;&lt;span id="xdx_90C_eus-gaap--SaleOfStockPricePerShare_iI_pid_c20240613__us-gaap--TypeOfArrangementAxis__custom--SubscriptionAgreementsMember__srt--TitleOfIndividualAxis__custom--InvestorsMember_zxZI830ke7Y5" title="Shares price"&gt;8.36&lt;/span&gt;&lt;/span&gt;
(pre reverse -$&lt;span id="xdx_901_eus-gaap--SaleOfStockPricePerShare_iI_pid_c20240531__us-gaap--TypeOfArrangementAxis__custom--SubscriptionAgreementsMember__srt--TitleOfIndividualAxis__custom--InvestorsMember__us-gaap--AwardTypeAxis__custom--PrereverseMember_zRmY7sFSEuI8" title="Shares price pre reverse"&gt;&lt;span id="xdx_90D_eus-gaap--SaleOfStockPricePerShare_iI_pid_c20240613__us-gaap--TypeOfArrangementAxis__custom--SubscriptionAgreementsMember__srt--TitleOfIndividualAxis__custom--InvestorsMember__us-gaap--AwardTypeAxis__custom--PrereverseMember_zEkSalHRuA5g" title="Shares price pre reverse"&gt;0.38)&lt;/span&gt;&lt;/span&gt;
and received gross proceeds to the Company of $&lt;span id="xdx_907_eus-gaap--ProceedsFromIssuanceOfCommonStock_pn5n6_c20240531__20240531__us-gaap--TypeOfArrangementAxis__custom--SubscriptionAgreementsMember__srt--TitleOfIndividualAxis__custom--InvestorsMember_zdSw9e5h5gm6" title="Gross proceeds"&gt;&lt;span id="xdx_90C_eus-gaap--ProceedsFromIssuanceOfCommonStock_pn5n6_c20240613__20240613__us-gaap--TypeOfArrangementAxis__custom--SubscriptionAgreementsMember__srt--TitleOfIndividualAxis__custom--InvestorsMember_ztepZgJsdaX3" title="Gross proceeds"&gt;1.6&lt;/span&gt;&lt;/span&gt;M,
before expenses to the placement agent and other offering expenses of $&lt;span id="xdx_901_eus-gaap--OtherExpenses_c20240531__20240531__us-gaap--TypeOfArrangementAxis__custom--SubscriptionAgreementsMember__srt--TitleOfIndividualAxis__custom--InvestorsMember_zxi72i936Se" title="Other offering expenses"&gt;&lt;span id="xdx_90A_eus-gaap--OtherExpenses_c20240613__20240613__us-gaap--TypeOfArrangementAxis__custom--SubscriptionAgreementsMember__srt--TitleOfIndividualAxis__custom--InvestorsMember_zkTohxQGlF4k" title="Other offering expenses"&gt;298,000&lt;/span&gt;&lt;/span&gt;
with net proceeds, after reflecting par value, have been recorded in Additional Paid in Capital of $&lt;span id="xdx_904_eus-gaap--AdditionalPaidInCapital_iI_c20240531__us-gaap--TypeOfArrangementAxis__custom--SubscriptionAgreementsMember__srt--TitleOfIndividualAxis__custom--InvestorsMember_zii3a3KXY41b" title="Additional paid in capital"&gt;&lt;span id="xdx_90F_eus-gaap--AdditionalPaidInCapital_iI_c20240613__us-gaap--TypeOfArrangementAxis__custom--SubscriptionAgreementsMember__srt--TitleOfIndividualAxis__custom--InvestorsMember_zsESKedJmNm9" title="Additional paid in capital"&gt;1,296,903&lt;/span&gt;&lt;/span&gt;.
The shares issued in the offering were offered at-the-market under Nasdaq rules and pursuant to the Company&#x2019;s Form 1-A (the
&#x201c;Offering Statement&#x201d;), initially filed by the Company with the Securities and Exchange Commission under the Securities
Act of 1933, as amended on May 21, 2024, and qualified on May 30, 2024.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;On
May 30, 2024, the Company offered warrant inducements (the &#x201c;Inducement Agreement&#x201d;) to certain warrant holders (the
&#x201c;Warrant Holders&#x201d;) which references the warrants registered for sale under both the registration statements on Form S-1
(file No. 333-263715) and/or the registration statement on Form S-1 (File No. 333-275011) (collectively, the &#x201c;Registration
Statements&#x201d;) for up to a total of &lt;span id="xdx_906_eus-gaap--ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_iI_pid_c20240530__us-gaap--TypeOfArrangementAxis__custom--InducementAgreementMember_zGkXgpBPe3lj" title="Warrants to purchase shares"&gt;499,932&lt;/span&gt;
(pre reverse - &lt;span id="xdx_908_eus-gaap--ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_iI_pid_c20240530__us-gaap--TypeOfArrangementAxis__custom--InducementAgreementMember__us-gaap--AwardTypeAxis__custom--PrereverseMember_zoY733Kqztca" title="Warrants to purchase shares pre reverse"&gt;10,998,524&lt;/span&gt;)
warrants to purchase shares of the Company&#x2019;s common stock, par value $&lt;span id="xdx_904_eus-gaap--CommonStockParOrStatedValuePerShare_iI_pid_c20240530__us-gaap--TypeOfArrangementAxis__custom--InducementAgreementMember_zjehFMbIVIm8" title="Common stock, par value"&gt;0.0001&lt;/span&gt;
per share. Pursuant to the Inducement Agreement, the exercise price of the existing warrants was reduced from $&lt;span id="xdx_90F_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_pid_c20240529__us-gaap--TypeOfArrangementAxis__custom--InducementAgreementMember_z4hJnZnQss5k" title="Exercise price"&gt;14.08&lt;/span&gt;
(pre reverse -$&lt;span id="xdx_905_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_pid_c20240529__us-gaap--TypeOfArrangementAxis__custom--InducementAgreementMember__us-gaap--AwardTypeAxis__custom--PrereverseMember__srt--RangeAxis__srt--MaximumMember_zCdxVbxuXyWj" title="Exercise price pre reverse"&gt;0.64)&lt;/span&gt;
per share to $&lt;span id="xdx_907_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_pid_c20240529__us-gaap--TypeOfArrangementAxis__custom--InducementAgreementMember__us-gaap--AwardTypeAxis__custom--PrereverseMember_zT3Ob0ZAbCig" title="Exercise price pre reverse"&gt;7.26&lt;/span&gt;
(pre reverse -$&lt;span id="xdx_904_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_pid_c20240529__us-gaap--TypeOfArrangementAxis__custom--InducementAgreementMember__us-gaap--AwardTypeAxis__custom--PrereverseMember__srt--RangeAxis__srt--MinimumMember_zZryGGA7girl" title="Exercise price pre reverse"&gt;0.33&lt;/span&gt;)
per share. In addition, for each warrant that was exercised, as a result of the Inducement Agreement, the Company agreed to issue
the Warrant Holders unregistered warrants with an exercise price of $&lt;span id="xdx_90F_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_pid_c20240530__us-gaap--TypeOfArrangementAxis__custom--InducementWarrantsMember__srt--TitleOfIndividualAxis__custom--WarrantHoldersMember_zWM0NL7Ow4ci" title="Exercise price"&gt;9.90&lt;/span&gt;
(pre reverse - $&lt;span id="xdx_905_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_pid_c20240530__us-gaap--TypeOfArrangementAxis__custom--InducementWarrantsMember__srt--TitleOfIndividualAxis__custom--WarrantHoldersMember__us-gaap--AwardTypeAxis__custom--PrereverseMember_zqJxlYi0LXh7" title="Exercise price pre reverse"&gt;0.45)&lt;/span&gt;
per share (&#x201c;Inducement Warrants&#x201d;). In the aggregate, &lt;span id="xdx_90F_eus-gaap--ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_iI_pid_c20240530__us-gaap--TypeOfArrangementAxis__custom--InducementWarrantsMember__srt--TitleOfIndividualAxis__custom--WarrantHoldersMember_z59LQFfsJ79k" title="Warrants exercised shares"&gt;260,799&lt;/span&gt;
(pre reverse -&lt;span id="xdx_907_eus-gaap--ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_iI_pid_c20240530__us-gaap--TypeOfArrangementAxis__custom--InducementWarrantsMember__srt--TitleOfIndividualAxis__custom--WarrantHoldersMember__us-gaap--AwardTypeAxis__custom--PrereverseMember_z31dDJAIJ7vg" title="Warrants exercised shares pre reverse"&gt;5,737,573&lt;/span&gt;)
warrants were exercised as a result of the Inducement Agreement and accordingly, &lt;span id="xdx_903_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_pid_c20240530__20240530__us-gaap--SubsidiarySaleOfStockAxis__custom--InducementWarrantsMember_zjZB6rL7fYXe" title="Issuance of warrants"&gt;260,799&lt;/span&gt;
Inducement Warrants were issued. The Company received gross proceeds of $&lt;span id="xdx_90C_eus-gaap--ProceedsFromIssuanceOfWarrants_pn5n6_c20240530__20240530__us-gaap--TypeOfArrangementAxis__custom--InducementAgreementMember__srt--TitleOfIndividualAxis__custom--WarrantHoldersMember_zGuPLzmnMfk9"&gt;1.9&lt;/span&gt;M
before expenses to the placement agent and other expenses of $&lt;span id="xdx_90F_eus-gaap--OtherExpenses_pp0p0_c20240530__20240530__us-gaap--TypeOfArrangementAxis__custom--InducementAgreementMember__srt--TitleOfIndividualAxis__custom--WarrantHoldersMember_zql0aTwTBkHh" title="Other expenses"&gt;285,000&lt;/span&gt;.
The net proceeds, after reflecting par value, has been recorded in Additional Paid in Capital of $&lt;span id="xdx_907_eus-gaap--AdditionalPaidInCapital_iI_pp0p0_c20240530__us-gaap--TypeOfArrangementAxis__custom--InducementAgreementMember__srt--TitleOfIndividualAxis__custom--WarrantHoldersMember_z7TznGm2OE6l" title="Additional paid in capital"&gt;978,955&lt;/span&gt;
and with respect to the Inducement Warrants, a liability under ASC 815 was recorded in the amount of $&lt;span id="xdx_906_eus-gaap--WarrantsAndRightsOutstanding_iI_pp0p0_c20240530__us-gaap--TypeOfArrangementAxis__custom--InducementAgreementMember__srt--TitleOfIndividualAxis__custom--WarrantHoldersMember_zrcguQvT5rT9"&gt;693,064&lt;/span&gt;.
Certain outstanding warrants, with an exercise price of $&lt;span id="xdx_90C_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_pid_c20240530__us-gaap--TypeOfArrangementAxis__custom--InducementAgreementMember__srt--TitleOfIndividualAxis__custom--WarrantHoldersMember_zqvGZNhXawj1" title="Exercise price"&gt;14.08&lt;/span&gt;
(pre reverse -$&lt;span id="xdx_90E_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_pid_c20240530__us-gaap--TypeOfArrangementAxis__custom--InducementAgreementMember__srt--TitleOfIndividualAxis__custom--WarrantHoldersMember__us-gaap--AwardTypeAxis__custom--PrereverseMember__srt--RangeAxis__srt--MaximumMember_zfJw96W5IEvk" title="Exercise price"&gt;0.64&lt;/span&gt;),
were reduced to $&lt;span id="xdx_908_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_pid_c20240530__us-gaap--TypeOfArrangementAxis__custom--InducementAgreementMember__srt--TitleOfIndividualAxis__custom--WarrantHoldersMember__us-gaap--AwardTypeAxis__custom--PrereverseMember_zGp9JEgHyrWd" title="Exercise price"&gt;7.26&lt;/span&gt;
(pre reverse -$&lt;span id="xdx_90F_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_pid_c20240530__us-gaap--TypeOfArrangementAxis__custom--InducementAgreementMember__srt--TitleOfIndividualAxis__custom--WarrantHoldersMember__us-gaap--AwardTypeAxis__custom--PrereverseMember__srt--RangeAxis__srt--MinimumMember_zgNvNoqk9NMh" title="Exercise price"&gt;0.33&lt;/span&gt;)
based on anti-dilution terms in the respective warrant agreements.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company recorded a fair value charge in the three months and nine months ended September 30, 2024 to reflect the modification of the
exercise price at the initial inducement date for the non-trading warrants relating to the February and September 2023 warrants
below. (See Note 10)&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;





&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;SHARPS
TECHNOLOGY, INC.&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;NOTES
TO THE CONDENSED CONSOLIDATED FINANCIAL STATEMENTS&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;FOR
THE THREE AND NINE MONTHS ENDED SEPTEMBER 30, 2024 AND 2023&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Note
8 Stockholders&#x2019; Equity (continued)&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;On
September 29, 2023, the Company completed two simultaneous offerings and received aggregate gross proceeds of approximately $&lt;span id="xdx_904_eus-gaap--ProceedsFromIssuanceOfCommonStock_pn5n6_c20230929__20230929_zwT9JuhYTNel" title="Gross proceeds"&gt;5.6&lt;/span&gt; million,
before expenses to the placement agent and other offering expenses of $&lt;span id="xdx_902_eus-gaap--OtherExpenses_c20230929__20230929_zTdtJzeQpnYe" title="Other offering expenses"&gt;716,000&lt;/span&gt;.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"&gt; &lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;/span&gt;&lt;/p&gt;



&lt;p style="margin: 0"&gt;&lt;/p&gt;

&lt;table border="0" cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"&gt;
&lt;tr style="vertical-align: top"&gt;
  &lt;td style="width: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 0.25in"&gt;a.&lt;/td&gt;
  &lt;td style="text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The first offering, the securities purchase agreement offering (the &#x201c;Shelf Offering&#x201d;) with institutional investors and the Company resulted in the Company receiving net proceeds from the Shelf Offering and the sale of pre-funded of approximately $&lt;span id="xdx_90A_eus-gaap--ProceedsFromIssuanceOrSaleOfEquity_pn5n6_c20230929__20230929__us-gaap--SubsidiarySaleOfStockAxis__custom--ShelfOfferingMember__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember_zMi93dCDo9r9" title="Proceeds from shelf offering"&gt;2.5&lt;/span&gt; million, includes the value of the pre-funded warrants recorded in APIC, net of $&lt;span id="xdx_90D_eus-gaap--LegalFees_c20230929__20230929__us-gaap--SubsidiarySaleOfStockAxis__custom--ShelfOfferingMember__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember_z6cUgUbB9QEl" title="Placement agent fees"&gt;362,000&lt;/span&gt; in fees relating to the placement agent and other offering expenses. The Shelf Offering was priced at the market under Nasdaq rules. In connection with the Shelf Offering, the Company issued &lt;span id="xdx_904_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_c20230929__20230929__us-gaap--SubsidiarySaleOfStockAxis__custom--ShelfOfferingMember__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__us-gaap--AwardTypeAxis__custom--ReverseStockSplitMember_zs1sCwOyAT4k" title="Shares issued"&gt;164,478&lt;/span&gt; (pre reverse -&lt;span id="xdx_90E_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_c20230929__20230929__us-gaap--SubsidiarySaleOfStockAxis__custom--ShelfOfferingMember__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__us-gaap--AwardTypeAxis__custom--PrereverseMember_zEgSqKjhVgAi" title="Shares issued"&gt;3,618,521)&lt;/span&gt; shares of common at a purchase price of $&lt;span id="xdx_90E_eus-gaap--SharesIssuedPricePerShare_iI_c20230929__us-gaap--SubsidiarySaleOfStockAxis__custom--ShelfOfferingMember__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__us-gaap--AwardTypeAxis__custom--ReverseStockSplitMember_z6QtiMNK8xic" title="Purchase price"&gt;14.08&lt;/span&gt; per unit, adjusted to $&lt;span id="xdx_900_eus-gaap--SharesIssuedPricePerShare_iI_c20240530__us-gaap--SubsidiarySaleOfStockAxis__custom--ShelfOfferingMember__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember_zId9A6F1Q4Hd" title="Purchase price"&gt;7.26&lt;/span&gt; (reverse effected) at May 30, 2024, based on anti-dilution terms in the warrants and &lt;span id="xdx_906_eus-gaap--ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight_iI_c20230929__us-gaap--SubsidiarySaleOfStockAxis__custom--ShelfOfferingMember__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__us-gaap--StatementEquityComponentsAxis__custom--PreFundedWarrantsMember_zwixuKBYAVw8" title="Prefunded warrants"&gt;36,636&lt;/span&gt; (pre reverse -&lt;span id="xdx_903_eus-gaap--ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight_iI_c20230929__us-gaap--SubsidiarySaleOfStockAxis__custom--ShelfOfferingMember__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__us-gaap--StatementEquityComponentsAxis__custom--PreFundedWarrantsMember__us-gaap--AwardTypeAxis__custom--PrereverseMember_zd3AmckIbmDd" title="Prefunded warrants"&gt;800,000&lt;/span&gt;) pre-funded warrants at $&lt;span id="xdx_901_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_c20230929__us-gaap--SubsidiarySaleOfStockAxis__custom--ShelfOfferingMember__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__us-gaap--StatementEquityComponentsAxis__custom--PreFundedWarrantsMember_zY4ANT1DbBSd" title="Exercise price"&gt;14.058&lt;/span&gt; (pre reverse -$&lt;span id="xdx_90E_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_c20230929__us-gaap--SubsidiarySaleOfStockAxis__custom--ShelfOfferingMember__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__us-gaap--StatementEquityComponentsAxis__custom--PreFundedWarrantsMember__us-gaap--AwardTypeAxis__custom--PrereverseMember_z08wHwaj1G6l" title="Exercise price"&gt;0.639&lt;/span&gt;) per pre-funded warrants. The exercise price of the pre-funded warrants will be $&lt;span id="xdx_901_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_c20230929__us-gaap--SubsidiarySaleOfStockAxis__custom--ShelfOfferingMember__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember_zzKGLoYcq4c9" title="Exercise price"&gt;0.001&lt;/span&gt; per share.&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: top"&gt;
  &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
  &lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: top"&gt;
  &lt;td&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;b.&lt;/span&gt;&lt;/td&gt;
  &lt;td style="text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The second offering, the
  securities purchase agreement offering (&#x201c;Private Placement&#x201d;) with institutional investors and the Company received net
  proceeds from the Private Placement of approximately $&lt;span id="xdx_906_eus-gaap--ProceedsFromIssuanceOfPrivatePlacement_pn5n6_c20230929__20230929__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--PrivatePlacementMember__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember_zZaMLPXzuCFi"&gt;2.4 &lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;million,
  net of $&lt;span id="xdx_904_eus-gaap--LegalFees_c20230929__20230929__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--PrivatePlacementMember__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember_zI0wKJ2Jy20c"&gt;354,000 &lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;in
  fees relating to the placement agent and other offering expense. In connection with the Private Placement, the Company issued: (i) &lt;span id="xdx_90A_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_c20230929__20230929__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--PrivatePlacementMember__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__us-gaap--StatementEquityComponentsAxis__custom--PIPEPreFundedWarrantsMember__us-gaap--AwardTypeAxis__custom--ReverseStockSplitMember_zlWx1bLlQemf"&gt;117,340 &lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(pre
  reverse - &lt;span id="xdx_907_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_c20230929__20230929__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--PrivatePlacementMember__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__us-gaap--StatementEquityComponentsAxis__custom--PIPEPreFundedWarrantsMember__us-gaap--AwardTypeAxis__custom--PrereverseMember_zY8ysaXKY007"&gt;2,581,479&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;)
  PIPE Shares (or PIPE Pre-Funded Warrants in lieu thereof) and (ii) PIPE Warrants (non-trading) to purchase &lt;span id="xdx_901_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_pid_c20230929__20230929__us-gaap--SubsidiarySaleOfStockAxis__custom--NonTradingWarrantsMember__us-gaap--AwardTypeAxis__custom--ReverseStockSplitMember_zF3UM9xXW0Y1"&gt;397,727 &lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(pre
  reverse -&lt;span id="xdx_908_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_pid_c20230929__20230929__us-gaap--SubsidiarySaleOfStockAxis__custom--NonTradingWarrantsMember__us-gaap--AwardTypeAxis__custom--PrereverseMember_ze8yhyqxOWj4"&gt;8,750,003&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;)
  shares of our common stock, at a combined purchase price of $&lt;span id="xdx_908_eus-gaap--SharesIssuedPricePerShare_iI_c20230203__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__us-gaap--StatementEquityComponentsAxis__custom--PIPEPreFundedWarrantsMember__srt--RangeAxis__srt--MaximumMember_zCRGthkax2u5"&gt;23.63 &lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(pre
  reverse -$&lt;span id="xdx_907_eus-gaap--SharesIssuedPricePerShare_iI_c20230203__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__us-gaap--StatementEquityComponentsAxis__custom--PIPEPreFundedWarrantsMember__us-gaap--AwardTypeAxis__custom--PrereverseMember__srt--RangeAxis__srt--MaximumMember_zhifmEvjztv1"&gt;1.074&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;)
  per unit or $&lt;span id="xdx_90B_eus-gaap--SharesIssuedPricePerShare_iI_c20230203__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__us-gaap--StatementEquityComponentsAxis__custom--PIPEPreFundedWarrantsMember__srt--RangeAxis__srt--MinimumMember_ztFZCkzU16z"&gt;23.606 &lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(pre
  reverse - $&lt;span id="xdx_901_eus-gaap--SharesIssuedPricePerShare_iI_c20230203__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__us-gaap--StatementEquityComponentsAxis__custom--PIPEPreFundedWarrantsMember__us-gaap--AwardTypeAxis__custom--PrereverseMember__srt--RangeAxis__srt--MinimumMember_zDHH1wwyXjV2"&gt;1.073&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;)
  per pre-funded unit. The PIPE Warrants have a term of five and one-half (&lt;span id="xdx_90B_eus-gaap--WarrantsAndRightsOutstandingTerm_iI_dtY_c20230929__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--PrivatePlacementMember__us-gaap--StatementEquityComponentsAxis__custom--PIPEPreFundedWarrantsMember_zeMYe6lecPc7"&gt;5.5&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;)
  years from the issuance date and are exercisable for one share of common stock at an exercise price, after effect of the October
  2024 reverse split, of $&lt;span id="xdx_905_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_c20230929__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__us-gaap--StatementEquityComponentsAxis__custom--PIPEPreFundedWarrantsMember__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--PrivatePlacementMember__us-gaap--AwardTypeAxis__custom--ReverseStockSplitMember_ziDup5ZsnOm2" title="Exercise price"&gt;14.08&lt;/span&gt; &lt;/span&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;adjusted
  to $&lt;span id="xdx_903_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_c20240530__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__us-gaap--StatementEquityComponentsAxis__custom--PIPEPreFundedWarrantsMember__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--PrivatePlacementMember_zb4esqp6XZji" title="Exercise price"&gt;7.26&lt;/span&gt; &lt;/span&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;
  at May 30, 2024, based on anti-dilution terms in the warrants. See Note 8(a) Warrants below for further adjustment. The net
  proceeds, after reflecting par value, has been recorded in Additional Paid in Capital of $&lt;span id="xdx_905_eus-gaap--AdditionalPaidInCapital_iI_pn5n6_c20230929__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--PrivatePlacementMember__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember_zNo37uMNWoL"&gt;1.6 &lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;million
  and with respect to the PIPE Warrants recorded as a liability under ASC 815 of $&lt;span id="xdx_907_eus-gaap--FairValueAdjustmentOfWarrants_c20230929__20230929__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--PrivatePlacementMember__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember_zchytfbAUqAb"&gt;985,204&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;.
  On October 16, 2023, the Company filed an S-1 (Resale) Registration Statement in connection with the Private Placement and on
  October 26, 2023 the S-1 went effective. (See Note 10).&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;


&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;


&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;On
February 3, 2023, the Company completed a securities purchase agreement (&#x201c;Offering&#x201d;) with institutional investors and
received net proceeds from the Offering of approximately $&lt;span id="xdx_902_eus-gaap--ProceedsFromIssuanceOrSaleOfEquity_pn5n6_c20230201__20230203__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember_zbzMZnujum06" title="Net proceeds from offering"&gt;3.2&lt;/span&gt;
million, net of $&lt;span id="xdx_908_eus-gaap--NoninterestExpenseOfferingCost_c20230201__20230203__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember_zWvZCfJADvC" title="Offering expenses"&gt;600,000&lt;/span&gt;
in fees relating to the placement agent and other offering expenses. The Offering was priced at the market under Nasdaq rules. In
connection with the Offering, the Company issued &lt;span id="xdx_902_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_c20230201__20230203__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember_zc32l1L6epN6" title="Shares issued"&gt;102,206&lt;/span&gt;
(pre reverse - &lt;span id="xdx_90E_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_c20230201__20230203__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__us-gaap--AwardTypeAxis__custom--PrereverseMember_zrErnecrmJ39" title="Shares issued"&gt;2,248,521&lt;/span&gt;)
units at a purchase price of $&lt;span id="xdx_90C_eus-gaap--SharesIssuedPricePerShare_iI_c20230203__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember_zXSzvTmpLF2a" title="Purchase price"&gt;37.18&lt;/span&gt;
(pre reverse - $&lt;span id="xdx_908_eus-gaap--SharesIssuedPricePerShare_iI_c20230203__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__us-gaap--AwardTypeAxis__custom--PrereverseMember_zpx8ymIt6RAc" title="Purchase price pre reverse"&gt;1.69&lt;/span&gt;)
per unit. &lt;span id="xdx_90F_eus-gaap--SaleOfStockDescriptionOfTransaction_c20230201__20230203__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember_zPv94cdnKkvh" title="Units description"&gt;Each
unit consisted of one share of common stock and one non-tradable warrant (&#x201c;Offering Warrants&#x201d;) exercisable for one share
of common stock&lt;/span&gt; at a price, after effect of the October 2024 reverse split, of $&lt;span id="xdx_908_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_c20230203__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember_zgjUiahQHPua" title="Warrant exerice price"&gt;34.32&lt;/span&gt;,
adjusted to $&lt;span id="xdx_90D_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_c20230929__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember_zpEMl8ykMwm9" title="Warrant exerice price"&gt;14.08 &lt;/span&gt;at
September 29, 2023 and to $&lt;span id="xdx_902_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_c20240530__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember_zpvSffBdRaSh" title="Warrant exerice price"&gt;7.26&lt;/span&gt;
at May 30, 2024, based on anti-dilution terms in the warrants and a term of &lt;span id="xdx_903_eus-gaap--WarrantsAndRightsOutstandingTerm_iI_dc_c20230203__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember_zI5c9Pbupx87" title="Warrants term"&gt;five
years&lt;/span&gt;. See Note 8(a) for further adjustment. The Offering Warrants have a term of five years from the issuance date. On
February 13, 2023, the Company filed an S-1 (Resale) Registration Statement in connection with the Offering and on April 14, 2023,
an Amendment to the S-1 was filed and went effective. (See Note 10)&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;On
April 13, 2022, the Company&#x2019;s initial public offering (&#x201c;IPO&#x201d;) was declared effective by the SEC pursuant to which the
Company issued and sold an aggregate of &lt;span id="xdx_901_eus-gaap--SaleOfStockNumberOfSharesIssuedInTransaction_c20220411__20220413__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--IPOMember_zXZGKTT9mtX9" title="Number of units sold"&gt;170,454&lt;/span&gt; ( pre reverse -&lt;span id="xdx_906_eus-gaap--SaleOfStockNumberOfSharesIssuedInTransaction_c20220411__20220413__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--IPOMember__us-gaap--AwardTypeAxis__custom--PrereverseMember_ztgLtKSrAYog" title="Number of units sold"&gt;3,750,000&lt;/span&gt;) units (&#x201c;Units&#x201d;), &lt;span id="xdx_90E_eus-gaap--SaleOfStockDescriptionOfTransaction_c20220411__20220413__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--IPOMember_zPgbjKCZ3Cjj" title="Units description"&gt;each consisting of one share of
common stock and two warrants, to purchase one share of common stock for each whole warrant&lt;/span&gt;, with an initial exercise price of $ &lt;span id="xdx_90C_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_pid_c20220413__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--IPOMember_zhImK9jKO7g1" title="Exercise price"&gt;93.50&lt;/span&gt;
(pre reverse -$&lt;span id="xdx_907_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_pid_c20220413__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--IPOMember__us-gaap--AwardTypeAxis__custom--PrereverseMember_zUKez6CaeCHj" title="Exercise price"&gt;4.25&lt;/span&gt;) per share, adjusted to and with the effect of reverse split October 2024, $&lt;span id="xdx_900_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_c20230203__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--IPOMember_z5VuSzGg04w7" title="Warrant exerice price"&gt;34.32&lt;/span&gt; at February 3, 2023 and to $&lt;span id="xdx_900_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_c20230929__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--IPOMember_z9rvxvC88svi" title="Warrant exercise price"&gt;14.08&lt;/span&gt;
at September 29, 2023 and to $&lt;span id="xdx_908_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_c20240530__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--IPOMember_z5JDqlFbSfwi" title="Warrant exercise price"&gt;7.26&lt;/span&gt; at May 30, 2024, based on anti-dilution terms in the warrants, and a term of &lt;span id="xdx_900_eus-gaap--WarrantsAndRightsOutstandingTerm_iI_dc_c20220413__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--IPOMember_zAlCz1xbmWM8" title="Warrants exercise price term"&gt;five years&lt;/span&gt;. In addition,
&lt;span id="xdx_90B_ecustom--DescriptionForOfferingShares_c20220411__20220413__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--IPOMember_zRe0s0XmAgK4" title="Description for offering shares"&gt;the Company granted Aegis Capital Corp., as underwriter a 45-day over-allotment option to purchase up to 15% of the number of shares
included in the units sold in the offering, and/or additional warrants equal to 15% of the number of Warrants included in the units sold
in the offering, in each case solely to cover over-allotments&lt;/span&gt;, which the Aegis Capital Corp. partially exercised with respect to &lt;span id="xdx_90C_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised_c20220417__20220419__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_z0lKPJ9XQYPj" title="Warrants exercised"&gt;51,136&lt;/span&gt;
( pre reverse -&lt;span id="xdx_904_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised_c20220417__20220419__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember__us-gaap--AwardTypeAxis__custom--PrereverseMember_zRYFTrpixppk" title="Warrants exercised"&gt;1,125,000&lt;/span&gt;) warrants on April 19, 2022.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company&#x2019;s common stock and warrants began trading on the Nasdaq Capital Market or Nasdaq on April 14, 2022. The net proceeds from
the IPO, prior to payments of certain listing and professional fees were approximately $&lt;span id="xdx_90F_eus-gaap--ProceedsFromIssuanceInitialPublicOffering_pn5n6_c20220417__20220419__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--IPOMember_zzkU3sKAUAd7" title="Net proceeds from IPO"&gt;14.2&lt;/span&gt; million. The net proceeds, after reflecting
par value, has been recorded in Additional Paid in Capital of $&lt;span id="xdx_90D_eus-gaap--AdditionalPaidInCapital_iI_pn5n6_c20220414_zX8ls53vu8L3" title="Additional paid in capital"&gt;9.0&lt;/span&gt; million and with respect to the Warrants as a liability under ASC
815 of $&lt;span id="xdx_905_ecustom--WarrantLiabilitiesCurrent_iI_pn5n6_c20220414_zHlinw9uu5d3" title="Warrants liability"&gt;5.2&lt;/span&gt;M. (See Note 10)&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;/p&gt;



&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;SHARPS
TECHNOLOGY, INC.&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;NOTES
TO THE CONDENSED CONSOLIDATED FINANCIAL STATEMENTS&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;FOR
THE THREE AND NINE MONTHS ENDED SEPTEMBER 30, 2024 AND 2023&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Note
8. Stockholders&#x2019; Equity (continued)&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;Warrants&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;table border="0" cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;a)&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;In
                                                                                                                                                                                                                                     September 2024, the Company reduced the exercise price of the &lt;span id="xdx_908_eus-gaap--ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight_iI_c20240930__srt--TitleOfIndividualAxis__custom--WarrantHoldersMember_zpD5QL7ymoli" title="Prefunded warrants"&gt;230,091&lt;/span&gt; (pre reverse &#x2013; &lt;span id="xdx_908_eus-gaap--ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight_iI_c20240930__srt--TitleOfIndividualAxis__custom--WarrantHoldersMember__us-gaap--AwardTypeAxis__custom--PrereverseMember_ze9DnfeGT7Oh" title="Prefunded warrants"&gt;5,260,000&lt;/span&gt;)
                                                                                                                                                                                                                                     outstanding warrants issued in February 2023 and September 2023 offerings (see below) from $&lt;span id="xdx_904_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_pid_c20230228__srt--TitleOfIndividualAxis__custom--WarrantHoldersMember_zIW3Jm2fwubk"&gt;&lt;span id="xdx_90B_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_pid_c20230930__srt--TitleOfIndividualAxis__custom--WarrantHoldersMember_zPJDBL6kSOul"&gt;7.26&lt;/span&gt;&lt;/span&gt;
                                                                                                                                                                                                                                     (pre reverse - $&lt;span id="xdx_90E_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_pid_c20230228__srt--TitleOfIndividualAxis__custom--WarrantHoldersMember__us-gaap--AwardTypeAxis__custom--PrereverseMember_zrd8UrCqFVt9"&gt;&lt;span id="xdx_908_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_pid_c20230930__srt--TitleOfIndividualAxis__custom--WarrantHoldersMember__us-gaap--AwardTypeAxis__custom--PrereverseMember_zGhkgG6vsqP9"&gt;0.33&lt;/span&gt;&lt;/span&gt;)
                                                                                                                                                                                                                                     to $&lt;span id="xdx_907_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_c20230228__srt--TitleOfIndividualAxis__custom--WarrantHolderMember_zNAUcyG87Tsa" title="Exercise price"&gt;&lt;span id="xdx_908_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_c20230929__srt--TitleOfIndividualAxis__custom--WarrantHolderMember_zgzI8x9H2pkc" title="Exercise price"&gt;0.0001&lt;/span&gt;&lt;/span&gt;.
                                                                                                                                                                                                                                     In connection with the reduction in the exercise price the Company recorded a modification charge of $&lt;span id="xdx_90B_ecustom--FairValueAdjustmentOfModificationCharge_c20240701__20240930__srt--TitleOfIndividualAxis__custom--WarrantHoldersMember_z1ppnhttWOWb" title="Fair value adjustment of modification charge"&gt;&lt;span id="xdx_907_ecustom--FairValueAdjustmentOfModificationCharge_c20240101__20240930__srt--TitleOfIndividualAxis__custom--WarrantHoldersMember_zjROgu5KrCk1" title="Fair value adjustment of modification charge"&gt;155,703&lt;/span&gt;&lt;/span&gt;
                                                                                                                                                                                                                                     in the three months ended September 30, 2024. At September 30, 2024, &lt;span id="xdx_905_eus-gaap--ClassOfWarrantOrRightOutstanding_iI_c20240930__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_z9Q5hPqbkFXe" title="Class of warrant or right, outstanding"&gt;103,685&lt;/span&gt;,
                                                                                                                                                                                                                                     after reverse split, warrants remain outstanding. Subsequent to September 30, 2024 such remaining warrants were
                                                                                                                                                                                                                                     exercised.&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;/p&gt;

&lt;table border="0" cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"&gt;
&lt;tr style="vertical-align: top"&gt;
  &lt;td style="text-align: justify; width: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;b)&lt;/span&gt;&lt;/td&gt;
  &lt;td style="text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;In connection with the
  Inducement Warrants in the second quarter of 2024, the Company issued &lt;span id="xdx_905_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_pid_c20240401__20240630__us-gaap--SubsidiarySaleOfStockAxis__custom--InducementWarrantsMember_z0ReVNJqdGWb" title="Issuance of warrants"&gt;260,799&lt;/span&gt;
  (pre reverse - &lt;span id="xdx_906_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_pid_c20240401__20240630__us-gaap--SubsidiarySaleOfStockAxis__custom--InducementWarrantsMember__us-gaap--AwardTypeAxis__custom--PrereverseMember_z26XG8W3w3Fg" title="Issuance of warrants"&gt;5,737,573&lt;/span&gt;)
  non-trading Inducement Warrants as noted in Common Stock above. The Inducement Warrants are classified as a liability based on ASC
  815 and require remeasurement at each reporting period. The Inducement Warrants are recorded at the FMV, computed using the Black
  Scholes valuation method. and , recorded a FMV gain adjustment of &lt;span id="xdx_904_eus-gaap--FairValueAdjustmentOfWarrants_c20240101__20240630__us-gaap--SubsidiarySaleOfStockAxis__custom--InducementWarrantsMember_z0WtQXwZAgbj" title="Fair market value adjustment"&gt;$293,684 &lt;/span&gt;(See
  Note 10).&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;

&lt;tr style="vertical-align: top"&gt;
  &lt;td style="text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
  &lt;td style="text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: top"&gt;
  &lt;td style="text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;c)&lt;/span&gt;&lt;/td&gt;
  &lt;td style="text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;In connection with one-year
advisory services arrangement entered into in April 2023, the Company issued an aggregate of &lt;span id="xdx_904_ecustom--ClassOfWarrantOrRightIssued_iI_c20230430__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_zNYQ5E5WuYh9"&gt;28,636
&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(pre reverse - &lt;span id="xdx_900_ecustom--ClassOfWarrantOrRightIssued_iI_c20230430__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember__us-gaap--AwardTypeAxis__custom--PrereverseMember_z273H14yIzwj"&gt;630,000&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;)
warrants over the one-year term, at an exercise price of $&lt;span id="xdx_90A_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_pid_c20230430__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_zsMpAYrXIZr7"&gt;34.32
&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(pre reverse -$&lt;span id="xdx_90D_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_pid_c20230430__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember__us-gaap--AwardTypeAxis__custom--PrereverseMember_z6luBNwfciel"&gt;1.56)
&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The warrants have a three-year term and were
fully vested on issuance. During the three and nine months ended September 30, 2024, the Company issued &lt;span id="xdx_90B_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_pid_c20240701__20240930__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_zBZJzKyjzGbk"&gt;0
&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;and &lt;span id="xdx_905_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_pid_c20240101__20240930__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_zQUBKxP88zvk"&gt;5,909
&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(pre reverse - &lt;span id="xdx_909_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_pid_c20240101__20240930__us-gaap--AwardTypeAxis__custom--PrereverseMember_z6o812ywypE5"&gt;130,000)
&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;warrants with a FMV of $&lt;span id="xdx_903_eus-gaap--FairValueAdjustmentOfWarrants_c20240101__20240930__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_zEfa6bIekdhh"&gt;8,590&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;.
During the three and nine months ended September 30, 2023 the Company issued &lt;span id="xdx_90C_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_pid_c20230701__20230930__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_zJNWH9ieFB0j"&gt;10,227
&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(pre reverse - &lt;span id="xdx_904_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_pid_c20230701__20230930__us-gaap--AwardTypeAxis__custom--PrereverseMember_zXF2Nf6J53fc"&gt;225,000)
&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;and &lt;span id="xdx_903_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_pid_c20230101__20230930__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_z9ngBbzWBXck"&gt;16,363
&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(pre-reverse &lt;span id="xdx_90C_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_pid_c20230101__20230930__us-gaap--AwardTypeAxis__custom--PrereverseMember_zISrg5KSYGu3"&gt;360,000&lt;/span&gt;&lt;/span&gt;)
&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;warrants with a FMV of $&lt;span id="xdx_909_eus-gaap--FairValueAdjustmentOfWarrants_c20230701__20230930__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_zAsHDnt8OrZ6"&gt;22,470
&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;and $&lt;span id="xdx_90C_eus-gaap--FairValueAdjustmentOfWarrants_c20230101__20230930__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_zwdX5tD6Y7i4"&gt;42,306&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;,
respectively. The FMV of the warrants issued in the nine months ended September 30, 2024 was computed using the Black Scholes valuation
model with the following assumptions: a) volatility of &lt;span id="xdx_901_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum_pid_dp_uPure_c20240101__20240930__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_ztJfsXXqZFl7"&gt;33.46&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;%
to &lt;span id="xdx_907_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum_pid_dp_uPure_c20240101__20240930__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_zEZ5aYmF05nb"&gt;81.62&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;%
&lt;span id="xdx_902_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_pid_dxL_c20240101__20240930__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_z3FvfIxcrJee" title="::XDX::P3Y"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2612"&gt;three-year
&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;term, risk free interest rate of &lt;span id="xdx_90E_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum_pid_dp_uPure_c20240101__20240930__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_zRQ4liQ8nkJi"&gt;4.20&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;%
to &lt;span id="xdx_906_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum_pid_dp_uPure_c20240101__20240930__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_zUDDMyTnhAr2"&gt;4.25&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;%
and &lt;span id="xdx_903_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_pid_dp_uPure_c20240101__20240930__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_zeE1GNLBwLX8"&gt;0&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;%
dividend rate. The FMV of the warrants issued in the three and nine months ended September 30, 2023 was computed using the Black Scholes
valuation model with the following assumptions: a) volatility of &lt;span id="xdx_909_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum_pid_dp_uPure_c20230101__20230930__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_zaUVM4t2Eux2"&gt;37.45&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;%
to &lt;span id="xdx_909_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum_pid_dp_uPure_c20230101__20230930__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_zh74gQxaOyVe"&gt;44.83&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;%,
risk free interest rate of &lt;span id="xdx_903_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum_pid_dp_uPure_c20230101__20230930__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_z5nuzQwlgKT4"&gt;3.58&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;%
to &lt;span id="xdx_904_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum_pid_dp_uPure_c20230101__20230930__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_zNEr5jzZs9rg"&gt;4.43&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;.%
and &lt;span id="xdx_90A_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_pid_dp_uPure_c20230101__20230930__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_zSg2peGEbWV1"&gt;0&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;%
dividend rate (See Note 10).&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;

&lt;tr style="vertical-align: top"&gt;
  &lt;td style="text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
  &lt;td style="text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: top"&gt;
  &lt;td style="text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;d)&lt;/span&gt;&lt;/td&gt;
  &lt;td style="text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt; In connection with the
  Private Placement in September 2023, the Company issued &lt;span id="xdx_906_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_pid_c20230901__20230930__us-gaap--SubsidiarySaleOfStockAxis__custom--NonTradingWarrantsMember__us-gaap--AwardTypeAxis__custom--ReverseStockSplitMember_z8qmGYUmeEzi" title="Issuance of warrants"&gt;397,727&lt;/span&gt; (pre reverse &lt;span id="xdx_902_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_pid_c20230901__20230930__us-gaap--SubsidiarySaleOfStockAxis__custom--NonTradingWarrantsMember__us-gaap--AwardTypeAxis__custom--PrereverseMember_z7I4NGPyNIu2" title="Issuance of warrants"&gt;8,750,003&lt;/span&gt;) non-trading PIPE Warrants as a component of
  the Unit as noted in Common Stock above. The PIPE Warrants are classified as a liability based on ASC 815 and require remeasurement
  at each reporting period. The PIPE Warrants are recorded at the FMV, computed using the Black Scholes valuation method. For the three
  and nine months ended September 30, 2024, the Company recorded a FMV gain (loss) adjustment of $&lt;span id="xdx_901_eus-gaap--FairValueAdjustmentOfWarrants_c20240701__20240930__us-gaap--SubsidiarySaleOfStockAxis__custom--NonTradingWarrantsMember__us-gaap--StatementEquityComponentsAxis__custom--PIPEWarrantMember_zNzIm6SZImM1" title="Fair market value adjustment"&gt;(181,163)&lt;/span&gt;, including the modification
  charge of $&lt;span id="xdx_902_ecustom--FairValueAdjustmentOfModificationCharge_c20240701__20240930__us-gaap--SubsidiarySaleOfStockAxis__custom--NonTradingWarrantsMember__us-gaap--StatementEquityComponentsAxis__custom--PIPEWarrantMember_z1Im6BNWMXec" title="Fair value adjustment of modification charge"&gt;(148,091)&lt;/span&gt; and $&lt;span id="xdx_908_eus-gaap--FairValueAdjustmentOfWarrants_c20240101__20240930__us-gaap--SubsidiarySaleOfStockAxis__custom--NonTradingWarrantsMember__us-gaap--StatementEquityComponentsAxis__custom--PIPEWarrantMember_zRnaNjj6qwO4" title="Fair market value adjustment"&gt;470,721&lt;/span&gt; including the modification charge of $&lt;span id="xdx_90A_ecustom--FairValueAdjustmentOfModificationCharge_c20240101__20240930__us-gaap--SubsidiarySaleOfStockAxis__custom--NonTradingWarrantsMember__us-gaap--StatementEquityComponentsAxis__custom--PIPEWarrantMember_z9dRpMFQazwa" title="Fair value adjustment of modification charge"&gt;(637,316)&lt;/span&gt;, respectively (See Note 10).&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;

&lt;tr style="vertical-align: top"&gt;
  &lt;td style="text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
  &lt;td style="text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: top"&gt;
  &lt;td style="text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;e)&lt;/span&gt;&lt;/td&gt;
  &lt;td style="text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;In connection with the
  Offering in February 2023, the Company issued &lt;span id="xdx_90C_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_pid_c20230201__20230228__us-gaap--SubsidiarySaleOfStockAxis__custom--NonTradingWarrantsMember__us-gaap--AwardTypeAxis__custom--ReverseStockSplitMember_zIBgh5mwyN3e" title="Issuance of warrants"&gt;102,206&lt;/span&gt;
  (pre reverse -&lt;span id="xdx_905_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_pid_c20230201__20230228__us-gaap--SubsidiarySaleOfStockAxis__custom--NonTradingWarrantsMember__us-gaap--AwardTypeAxis__custom--PrereverseMember_zApX3HKaENfk" title="Issuance of warrants"&gt;2,248,521&lt;/span&gt;)
  non-trading warrants Offering Warrants as a component of the Unit as noted in Common Stock above. The Offering Warrants are
  classified as a liability based on ASC 815 and require remeasurement at each reporting period. The Offering Warrants were recorded
  at the FMV, computed using the Black Scholes valuation method. For the three and nine months ended September 30, 2024 the Company
  recorded FMV gain (loss) adjustments of &lt;span id="xdx_907_eus-gaap--FairValueAdjustmentOfWarrants_c20240701__20240930__us-gaap--SubsidiarySaleOfStockAxis__custom--NonTradingWarrantsMember_zOX6dOhUiLOc" title="FMV gain adjustment"&gt;$7,563&lt;/span&gt;,
  including a modification charge of $&lt;span id="xdx_905_ecustom--FairValueAdjustmentOfModificationCharge_c20240701__20240930__us-gaap--SubsidiarySaleOfStockAxis__custom--NonTradingWarrantsMember_z6CSyQESIWJl" title="Fair value adjustment of modification charge"&gt;7,612&lt;/span&gt;
  referred to in Note 10, and $&lt;span id="xdx_905_eus-gaap--FairValueAdjustmentOfWarrants_c20240101__20240930__us-gaap--SubsidiarySaleOfStockAxis__custom--NonTradingWarrantsMember_zgGkyvfKR2C9" title="FMV gain adjustment"&gt;214,019&lt;/span&gt;,
  including a modification charge of $&lt;span id="xdx_90E_ecustom--FairValueAdjustmentOfModificationCharge_c20240101__20240930__us-gaap--SubsidiarySaleOfStockAxis__custom--NonTradingWarrantsMember_zNjxYCsBAaGf" title="Fair value adjustment of modification charge"&gt;153,640&lt;/span&gt;.
  For the three and nine months ended September 30, 2023, the Company recorded a FMV gain adjustment of $&lt;span id="xdx_900_eus-gaap--FairValueAdjustmentOfWarrants_c20230701__20230930__us-gaap--SubsidiarySaleOfStockAxis__custom--NonTradingWarrantsMember_zRycgWMLH1t5" title="FMV gain adjustment"&gt;56,172&lt;/span&gt;&#160;and
  $&lt;span id="xdx_90A_eus-gaap--FairValueAdjustmentOfWarrants_c20230101__20230930__us-gaap--SubsidiarySaleOfStockAxis__custom--NonTradingWarrantsMember_zCK38DObsane" title="FMV gain adjustment"&gt;238,752&lt;/span&gt;
  respectively (See Note 10).&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;

&lt;tr style="vertical-align: top"&gt;
  &lt;td style="text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
  &lt;td style="text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: top"&gt;
  &lt;td style="text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;f)&lt;/span&gt;&lt;/td&gt;
  &lt;td style="text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;In connection with the IPO
  in April 2022, the Company issued &lt;span id="xdx_905_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_pid_c20220417__20220419__us-gaap--SubsidiarySaleOfStockAxis__custom--TradingWarrantsMember_z4IuO605eRth" title="Issuance of warrants"&gt;340,900&lt;/span&gt;
  (pre reverse -&lt;span id="xdx_902_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_pid_c20220417__20220419__us-gaap--SubsidiarySaleOfStockAxis__custom--TradingWarrantsMember__us-gaap--AwardTypeAxis__custom--PrereverseMember_zj639Gmf3osa" title="Issuance of warrants"&gt;7,500,000&lt;/span&gt;)
  warrants (Trading Warrants) as a component of the Units and &lt;span id="xdx_90C_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_pid_c20220417__20220419__us-gaap--SubsidiarySaleOfStockAxis__custom--OverAllotmentWarrantsMember_z3y6wi0pkQof" title="Issuance of warrants"&gt;51,136&lt;/span&gt;
  (pre reverse - &lt;span id="xdx_903_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_pid_c20220417__20220419__us-gaap--SubsidiarySaleOfStockAxis__custom--OverAllotmentWarrantsMember__us-gaap--AwardTypeAxis__custom--PrereverseMember_zEjQvpBa6S5k" title="Issuance of warrants"&gt;1,125,000&lt;/span&gt;)
  warrants to the underwriter (Overallotment Warrants), as noted in Common Stock above. The Trading and Overallotment Warrants were
  recorded at the FMV, being the trading price of the warrants, on the IPO effective date and the Warrants are classified as a
  Liability based on ASC 815. The Warrant liability requires remeasurement at each reporting period based on the trading price of the
  warrants. During the three and nine months ended September 30, 2024, the Company recorded an FMV gain adjustment of $&lt;span id="xdx_90F_eus-gaap--FairValueAdjustmentOfWarrants_c20240701__20240930__us-gaap--SubsidiarySaleOfStockAxis__custom--TradingWarrantsMember_z2gevU8Gig62" title="Fair value income adjustment"&gt;198,375&lt;/span&gt;
  and $&lt;span id="xdx_90F_eus-gaap--FairValueAdjustmentOfWarrants_c20240101__20240930__us-gaap--SubsidiarySaleOfStockAxis__custom--TradingWarrantsMember_zyh2cQSsSQaj" title="Fair value income adjustment"&gt;690,001&lt;/span&gt;,
  respectively. During the three and nine months ended September 30, 2023, the Company recorded an FMV gain adjustment of $&lt;span id="xdx_907_eus-gaap--FairValueAdjustmentOfWarrants_c20230701__20230930__us-gaap--SubsidiarySaleOfStockAxis__custom--TradingWarrantsMember_zaODooa6ZvKl" title="Fair value income adjustment"&gt;258,750&lt;/span&gt;&#160;and
  $&lt;span id="xdx_90E_eus-gaap--FairValueAdjustmentOfWarrants_c20230101__20230930__us-gaap--SubsidiarySaleOfStockAxis__custom--TradingWarrantsMember_zOKQ43R1Faqg" title="Fair value income adjustment"&gt;172,500&lt;/span&gt;,
  respectively. (See Note 10).&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;

&lt;tr style="vertical-align: top"&gt;
  &lt;td style="text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
  &lt;td style="text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: top"&gt;
  &lt;td style="text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;g)&lt;/span&gt;&lt;/td&gt;
  &lt;td style="text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The Company issued &lt;span id="xdx_90C_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_pid_c20220417__20220419__us-gaap--SubsidiarySaleOfStockAxis__custom--NoteWarrantsMember_zdGV5lpE9Iu5" title="Warrants issued"&gt;10,695&lt;/span&gt;
  (pre reverse -&lt;span id="xdx_904_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_pid_c20220417__20220419__us-gaap--SubsidiarySaleOfStockAxis__custom--NoteWarrantsMember__us-gaap--AwardTypeAxis__custom--PrereverseMember_zvEOY5YvWTCd" title="Warrants issued"&gt;235,295&lt;/span&gt;) Warrants (&#x201c;Note Warrants&#x201d;) to the note holders in connection with the repayment on the IPO on April
  19, 2022. The Note Warrants, which are recorded at the FMV being the trading price of the warrants, are classified as a Liability based
  on ASC 815. The Note Warrants require remeasurement at each reporting period. During the three and nine months ended September 30,
  2024, the Company recorded a FMV gain of $&lt;span id="xdx_908_eus-gaap--FairValueAdjustmentOfWarrants_c20240701__20240930__us-gaap--SubsidiarySaleOfStockAxis__custom--NoteWarrantsMember_zxXiZ8R7YWFi" title="FMV gain/(loss) adjustment"&gt;5,411&lt;/span&gt; and $&lt;span id="xdx_90B_eus-gaap--FairValueAdjustmentOfWarrants_c20240101__20240930__us-gaap--SubsidiarySaleOfStockAxis__custom--NoteWarrantsMember_zvXtcem1Xkyj" title="FMV gain/(loss) adjustment"&gt;18,822&lt;/span&gt;, respectively. For the three and nine months ended September 30, 2023, the
  Company recorded a FMV gain/(loss) adjustment of $&lt;span id="xdx_905_eus-gaap--FairValueAdjustmentOfWarrants_c20230701__20230930__us-gaap--SubsidiarySaleOfStockAxis__custom--NoteWarrantsMember_zOebmRjRs1w6" title="FMV gain/(loss) adjustment"&gt;&lt;span id="xdx_906_eus-gaap--FairValueAdjustmentOfWarrants_c20230101__20230930__us-gaap--SubsidiarySaleOfStockAxis__custom--NoteWarrantsMember_zP4D3FuIHsf5" title="FMV gain/(loss) adjustment"&gt;7,059&lt;/span&gt;&lt;/span&gt;. (See Note 10).&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;




&lt;p style="margin-top: 0; margin-bottom: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;




&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;SHARPS
TECHNOLOGY, INC.&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;NOTES
TO THE CONDENSED CONSOLIDATED FINANCIAL STATEMENTS&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;FOR
THE THREE AND NINE MONTHS ENDED SEPTEMBER 30, 2024 AND 2023&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Note
8. Stockholders&#x2019; Equity (continued)&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(h)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
    underwriter received &lt;span id="xdx_900_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_c20220417__20220419__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--IPOMember_zAvuhFqxm9O9" title="Warrants issued"&gt;8,523&lt;/span&gt;
    (pre reverse - &lt;span id="xdx_900_eus-gaap--ClassOfWarrantOrRightOutstanding_iI_c20220419__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--IPOMember__us-gaap--AwardTypeAxis__custom--PrereverseMember_zytQuAlyCNg9" title="Warrants issued"&gt;187,500&lt;/span&gt;)
    warrants in connection with the IPO for a nominal cost of $&lt;span id="xdx_907_eus-gaap--WarrantsAndRightsOutstanding_iI_c20220419__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--IPOMember_z7HqYDAMofbh" title="Nominal cost of warrant"&gt;11,250&lt;/span&gt;.
    The Warrants have an exercise price of $&lt;span id="xdx_901_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_pid_c20220419__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--IPOMember_zS5x8otaHBI8" title="Exercise price"&gt;117.04&lt;/span&gt;
    (pre reverse - $&lt;span id="xdx_906_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_pid_c20220419__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--IPOMember__us-gaap--AwardTypeAxis__custom--PrereverseMember_z1Fgloja1RRd" title="Exercise price"&gt;5.32&lt;/span&gt;)
    and are exercisable after October 9, 2022. The FMV at the date of issuance was $&lt;span id="xdx_90A_eus-gaap--FairValueAdjustmentOfWarrants_c20220417__20220419__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--IPOMember_zNuwLO2NxRd" title="Fair value adjustment of warrants"&gt;228,750&lt;/span&gt;
    computed using the Black Scholes valuation model with the following assumptions: a) volatility of &lt;span id="xdx_904_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate_pid_dp_uPure_c20220417__20220419__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--IPOMember_zzQPXpOZuur1" title="Volatility"&gt;93.47&lt;/span&gt;%,
    five-year term, risk free interest rate &lt;span id="xdx_90C_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_pid_dp_uPure_c20220417__20220419__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--IPOMember_zM8xxJzsIXe2" title="Risk free interest rate"&gt;2.77&lt;/span&gt;%
    and &lt;span id="xdx_902_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_pid_dp_uPure_c20220417__20220419__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--IPOMember_zV50liXjGu8i" title="Dividend rate"&gt;0&lt;/span&gt;%
    dividend rate. The estimated FMV was classified as additional issuance costs.&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;
&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

</us-gaap:StockholdersEquityNoteDisclosureTextBlock>
    <us-gaap:CommonStockSharesAuthorized
      contextRef="AsOf2017-12-11"
      decimals="INF"
      id="Fact002376"
      unitRef="Shares">20000000</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="AsOf2017-12-11"
      decimals="INF"
      id="Fact002378"
      unitRef="USDPShares">0.0001</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:CommonStockSharesAuthorized
      contextRef="AsOf2019-04-18"
      decimals="INF"
      id="Fact002380"
      unitRef="Shares">50000000</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:PreferredStockSharesAuthorized
      contextRef="AsOf2019-04-18"
      decimals="INF"
      id="Fact002382"
      unitRef="Shares">10000</us-gaap:PreferredStockSharesAuthorized>
    <us-gaap:PreferredStockParOrStatedValuePerShare
      contextRef="AsOf2019-04-18"
      decimals="INF"
      id="Fact002384"
      unitRef="USDPShares">0.001</us-gaap:PreferredStockParOrStatedValuePerShare>
    <us-gaap:ConversionOfStockDescription contextRef="From2022-03-192022-03-22" id="Fact002386">Pursuant to the merger agreement, (i) the Company merged with and into Sharps Nevada, (ii) each 3.5 shares of common
stock of the Company were converted into one share of common stock of Sharps Nevada and (iii) the articles of incorporation and bylaws
of Sharps Nevada, became the articles of incorporation and bylaws of the surviving corporation.</us-gaap:ConversionOfStockDescription>
    <us-gaap:CommonStockSharesAuthorized
      contextRef="AsOf2022-03-21"
      decimals="INF"
      id="Fact002388"
      unitRef="Shares">50000000</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:CommonStockSharesAuthorized
      contextRef="AsOf2022-03-22"
      decimals="INF"
      id="Fact002390"
      unitRef="Shares">100000000</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:PreferredStockSharesAuthorized
      contextRef="AsOf2022-03-21"
      decimals="INF"
      id="Fact002392"
      unitRef="Shares">10000</us-gaap:PreferredStockSharesAuthorized>
    <us-gaap:PreferredStockSharesAuthorized
      contextRef="AsOf2022-03-22"
      decimals="INF"
      id="Fact002394"
      unitRef="Shares">1000000</us-gaap:PreferredStockSharesAuthorized>
    <us-gaap:PreferredStockParOrStatedValuePerShare
      contextRef="AsOf2022-03-21"
      decimals="INF"
      id="Fact002396"
      unitRef="USDPShares">0.001</us-gaap:PreferredStockParOrStatedValuePerShare>
    <us-gaap:PreferredStockParOrStatedValuePerShare
      contextRef="AsOf2022-03-22"
      decimals="INF"
      id="Fact002398"
      unitRef="USDPShares">0.0001</us-gaap:PreferredStockParOrStatedValuePerShare>
    <us-gaap:CommonStockSharesAuthorized
      contextRef="AsOf2024-07-31"
      decimals="INF"
      id="Fact002400"
      unitRef="Shares">100000000</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:CommonStockSharesAuthorized
      contextRef="AsOf2024-09-30"
      decimals="INF"
      id="Fact002402"
      unitRef="Shares">500000000</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:StockIssuedDuringPeriodSharesOther
      contextRef="From2024-09-232024-09-23_custom_SecuritiesPurchaseAgreementMember"
      decimals="INF"
      id="Fact002404"
      unitRef="Shares">259091</us-gaap:StockIssuedDuringPeriodSharesOther>
    <us-gaap:StockIssuedDuringPeriodSharesOther
      contextRef="From2024-09-232024-09-23_custom_SecuritiesPurchaseAgreementMember_custom_PreReverseMember"
      decimals="INF"
      id="Fact002406"
      unitRef="Shares">5700006</us-gaap:StockIssuedDuringPeriodSharesOther>
    <us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction
      contextRef="From2024-05-312024-05-31_custom_SubscriptionAgreementsMember_custom_InvestorsMember"
      decimals="INF"
      id="Fact002408"
      unitRef="Shares">190773</us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction>
    <us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction
      contextRef="From2024-06-132024-06-13_custom_SubscriptionAgreementsMember_custom_InvestorsMember"
      decimals="INF"
      id="Fact002410"
      unitRef="Shares">190773</us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction>
    <us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction
      contextRef="From2024-05-312024-05-31_custom_SubscriptionAgreementsMember_custom_InvestorsMember_custom_PreReverseMember"
      decimals="INF"
      id="Fact002412"
      unitRef="Shares">4197000</us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction>
    <us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction
      contextRef="From2024-06-132024-06-13_custom_SubscriptionAgreementsMember_custom_InvestorsMember_custom_PreReverseMember"
      decimals="INF"
      id="Fact002414"
      unitRef="Shares">4197000</us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="AsOf2024-05-31_custom_SubscriptionAgreementsMember_custom_InvestorsMember"
      decimals="INF"
      id="Fact002416"
      unitRef="USDPShares">0.0001</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="AsOf2024-06-13_custom_SubscriptionAgreementsMember_custom_InvestorsMember"
      decimals="INF"
      id="Fact002418"
      unitRef="USDPShares">0.0001</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:SaleOfStockPricePerShare
      contextRef="AsOf2024-05-31_custom_SubscriptionAgreementsMember_custom_InvestorsMember"
      decimals="INF"
      id="Fact002420"
      unitRef="USDPShares">8.36</us-gaap:SaleOfStockPricePerShare>
    <us-gaap:SaleOfStockPricePerShare
      contextRef="AsOf2024-06-13_custom_SubscriptionAgreementsMember_custom_InvestorsMember"
      decimals="INF"
      id="Fact002422"
      unitRef="USDPShares">8.36</us-gaap:SaleOfStockPricePerShare>
    <us-gaap:SaleOfStockPricePerShare
      contextRef="AsOf2024-05-31_custom_SubscriptionAgreementsMember_custom_InvestorsMember_custom_PreReverseMember"
      decimals="INF"
      id="Fact002424"
      unitRef="USDPShares">0.38</us-gaap:SaleOfStockPricePerShare>
    <us-gaap:SaleOfStockPricePerShare
      contextRef="AsOf2024-06-13_custom_SubscriptionAgreementsMember_custom_InvestorsMember_custom_PreReverseMember"
      decimals="INF"
      id="Fact002426"
      unitRef="USDPShares">0.38</us-gaap:SaleOfStockPricePerShare>
    <us-gaap:ProceedsFromIssuanceOfCommonStock
      contextRef="From2024-05-312024-05-31_custom_SubscriptionAgreementsMember_custom_InvestorsMember"
      decimals="-5"
      id="Fact002428"
      unitRef="USD">1600000</us-gaap:ProceedsFromIssuanceOfCommonStock>
    <us-gaap:ProceedsFromIssuanceOfCommonStock
      contextRef="From2024-06-132024-06-13_custom_SubscriptionAgreementsMember_custom_InvestorsMember"
      decimals="-5"
      id="Fact002430"
      unitRef="USD">1600000</us-gaap:ProceedsFromIssuanceOfCommonStock>
    <us-gaap:OtherExpenses
      contextRef="From2024-05-312024-05-31_custom_SubscriptionAgreementsMember_custom_InvestorsMember"
      decimals="0"
      id="Fact002432"
      unitRef="USD">298000</us-gaap:OtherExpenses>
    <us-gaap:OtherExpenses
      contextRef="From2024-06-132024-06-13_custom_SubscriptionAgreementsMember_custom_InvestorsMember"
      decimals="0"
      id="Fact002434"
      unitRef="USD">298000</us-gaap:OtherExpenses>
    <us-gaap:AdditionalPaidInCapital
      contextRef="AsOf2024-05-31_custom_SubscriptionAgreementsMember_custom_InvestorsMember"
      decimals="0"
      id="Fact002436"
      unitRef="USD">1296903</us-gaap:AdditionalPaidInCapital>
    <us-gaap:AdditionalPaidInCapital
      contextRef="AsOf2024-06-13_custom_SubscriptionAgreementsMember_custom_InvestorsMember"
      decimals="0"
      id="Fact002438"
      unitRef="USD">1296903</us-gaap:AdditionalPaidInCapital>
    <us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights
      contextRef="AsOf2024-05-30_custom_InducementAgreementMember"
      decimals="INF"
      id="Fact002440"
      unitRef="Shares">499932</us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights>
    <us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights
      contextRef="AsOf2024-05-30_custom_InducementAgreementMember_custom_PreReverseMember"
      decimals="INF"
      id="Fact002442"
      unitRef="Shares">10998524</us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="AsOf2024-05-30_custom_InducementAgreementMember"
      decimals="INF"
      id="Fact002444"
      unitRef="USDPShares">0.0001</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
      contextRef="AsOf2024-05-29_custom_InducementAgreementMember"
      decimals="INF"
      id="Fact002446"
      unitRef="USDPShares">14.08</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1>
    <us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
      contextRef="AsOf2024-05-29_custom_InducementAgreementMember_custom_PreReverseMember_srt_MaximumMember"
      decimals="INF"
      id="Fact002448"
      unitRef="USDPShares">0.64</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1>
    <us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
      contextRef="AsOf2024-05-29_custom_InducementAgreementMember_custom_PreReverseMember"
      decimals="INF"
      id="Fact002450"
      unitRef="USDPShares">7.26</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1>
    <us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
      contextRef="AsOf2024-05-29_custom_InducementAgreementMember_custom_PreReverseMember_srt_MinimumMember"
      decimals="INF"
      id="Fact002452"
      unitRef="USDPShares">0.33</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1>
    <us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
      contextRef="AsOf2024-05-30_custom_InducementWarrantsMember_custom_WarrantHoldersMember"
      decimals="INF"
      id="Fact002454"
      unitRef="USDPShares">9.90</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1>
    <us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
      contextRef="AsOf2024-05-30_custom_InducementWarrantsMember_custom_WarrantHoldersMember_custom_PreReverseMember"
      decimals="INF"
      id="Fact002456"
      unitRef="USDPShares">0.45</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1>
    <us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights
      contextRef="AsOf2024-05-30_custom_InducementWarrantsMember_custom_WarrantHoldersMember"
      decimals="INF"
      id="Fact002458"
      unitRef="Shares">260799</us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights>
    <us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights
      contextRef="AsOf2024-05-30_custom_InducementWarrantsMember_custom_WarrantHoldersMember_custom_PreReverseMember"
      decimals="INF"
      id="Fact002460"
      unitRef="Shares">5737573</us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights>
    <us-gaap:StockIssuedDuringPeriodSharesNewIssues
      contextRef="From2024-05-302024-05-30_custom_InducementWarrantsMember"
      decimals="INF"
      id="Fact002462"
      unitRef="Shares">260799</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
    <us-gaap:ProceedsFromIssuanceOfWarrants
      contextRef="From2024-05-302024-05-30_custom_InducementAgreementMember_custom_WarrantHoldersMember"
      decimals="-5"
      id="Fact002463"
      unitRef="USD">1900000</us-gaap:ProceedsFromIssuanceOfWarrants>
    <us-gaap:OtherExpenses
      contextRef="From2024-05-302024-05-30_custom_InducementAgreementMember_custom_WarrantHoldersMember"
      decimals="0"
      id="Fact002465"
      unitRef="USD">285000</us-gaap:OtherExpenses>
    <us-gaap:AdditionalPaidInCapital
      contextRef="AsOf2024-05-30_custom_InducementAgreementMember_custom_WarrantHoldersMember"
      decimals="0"
      id="Fact002467"
      unitRef="USD">978955</us-gaap:AdditionalPaidInCapital>
    <us-gaap:WarrantsAndRightsOutstanding
      contextRef="AsOf2024-05-30_custom_InducementAgreementMember_custom_WarrantHoldersMember"
      decimals="0"
      id="Fact002468"
      unitRef="USD">693064</us-gaap:WarrantsAndRightsOutstanding>
    <us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
      contextRef="AsOf2024-05-30_custom_InducementAgreementMember_custom_WarrantHoldersMember"
      decimals="INF"
      id="Fact002470"
      unitRef="USDPShares">14.08</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1>
    <us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
      contextRef="AsOf2024-05-30_custom_InducementAgreementMember_custom_WarrantHoldersMember_custom_PreReverseMember_srt_MaximumMember"
      decimals="INF"
      id="Fact002472"
      unitRef="USDPShares">0.64</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1>
    <us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
      contextRef="AsOf2024-05-30_custom_InducementAgreementMember_custom_WarrantHoldersMember_custom_PreReverseMember"
      decimals="INF"
      id="Fact002474"
      unitRef="USDPShares">7.26</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1>
    <us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
      contextRef="AsOf2024-05-30_custom_InducementAgreementMember_custom_WarrantHoldersMember_custom_PreReverseMember_srt_MinimumMember"
      decimals="INF"
      id="Fact002476"
      unitRef="USDPShares">0.33</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1>
    <us-gaap:ProceedsFromIssuanceOfCommonStock
      contextRef="From2023-09-292023-09-29"
      decimals="-5"
      id="Fact002478"
      unitRef="USD">5600000</us-gaap:ProceedsFromIssuanceOfCommonStock>
    <us-gaap:OtherExpenses
      contextRef="From2023-09-292023-09-29"
      decimals="0"
      id="Fact002480"
      unitRef="USD">716000</us-gaap:OtherExpenses>
    <us-gaap:ProceedsFromIssuanceOrSaleOfEquity
      contextRef="From2023-09-292023-09-29_custom_ShelfOfferingMember_custom_SecuritiesPurchaseAgreementMember"
      decimals="-5"
      id="Fact002482"
      unitRef="USD">2500000</us-gaap:ProceedsFromIssuanceOrSaleOfEquity>
    <us-gaap:LegalFees
      contextRef="From2023-09-292023-09-29_custom_ShelfOfferingMember_custom_SecuritiesPurchaseAgreementMember"
      decimals="0"
      id="Fact002484"
      unitRef="USD">362000</us-gaap:LegalFees>
    <us-gaap:StockIssuedDuringPeriodSharesNewIssues
      contextRef="From2023-09-292023-09-29_custom_ShelfOfferingMember_custom_SecuritiesPurchaseAgreementMember_custom_ReverseStockSplitMember"
      decimals="INF"
      id="Fact002486"
      unitRef="Shares">164478</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
    <us-gaap:StockIssuedDuringPeriodSharesNewIssues
      contextRef="From2023-09-292023-09-29_custom_ShelfOfferingMember_custom_SecuritiesPurchaseAgreementMember_custom_PreReverseMember"
      decimals="INF"
      id="Fact002488"
      unitRef="Shares">3618521</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
    <us-gaap:SharesIssuedPricePerShare
      contextRef="AsOf2023-09-29_custom_ShelfOfferingMember_custom_SecuritiesPurchaseAgreementMember_custom_ReverseStockSplitMember"
      decimals="INF"
      id="Fact002490"
      unitRef="USDPShares">14.08</us-gaap:SharesIssuedPricePerShare>
    <us-gaap:SharesIssuedPricePerShare
      contextRef="AsOf2024-05-30_custom_ShelfOfferingMember_custom_SecuritiesPurchaseAgreementMember"
      decimals="INF"
      id="Fact002492"
      unitRef="USDPShares">7.26</us-gaap:SharesIssuedPricePerShare>
    <us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight
      contextRef="AsOf2023-09-29_custom_ShelfOfferingMember_custom_SecuritiesPurchaseAgreementMember_custom_PreFundedWarrantsMember"
      decimals="INF"
      id="Fact002494"
      unitRef="Shares">36636</us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight>
    <us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight
      contextRef="AsOf2023-09-29_custom_ShelfOfferingMember_custom_SecuritiesPurchaseAgreementMember_custom_PreFundedWarrantsMember_custom_PreReverseMember"
      decimals="INF"
      id="Fact002496"
      unitRef="Shares">800000</us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight>
    <us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
      contextRef="AsOf2023-09-29_custom_ShelfOfferingMember_custom_SecuritiesPurchaseAgreementMember_custom_PreFundedWarrantsMember"
      decimals="INF"
      id="Fact002498"
      unitRef="USDPShares">14.058</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1>
    <us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
      contextRef="AsOf2023-09-29_custom_ShelfOfferingMember_custom_SecuritiesPurchaseAgreementMember_custom_PreFundedWarrantsMember_custom_PreReverseMember"
      decimals="INF"
      id="Fact002500"
      unitRef="USDPShares">0.639</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1>
    <us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
      contextRef="AsOf2023-09-29_custom_ShelfOfferingMember_custom_SecuritiesPurchaseAgreementMember"
      decimals="INF"
      id="Fact002502"
      unitRef="USDPShares">0.001</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1>
    <us-gaap:ProceedsFromIssuanceOfPrivatePlacement
      contextRef="From2023-09-292023-09-29_us-gaap_PrivatePlacementMember_custom_SecuritiesPurchaseAgreementMember"
      decimals="-5"
      id="Fact002503"
      unitRef="USD">2400000</us-gaap:ProceedsFromIssuanceOfPrivatePlacement>
    <us-gaap:LegalFees
      contextRef="From2023-09-292023-09-29_us-gaap_PrivatePlacementMember_custom_SecuritiesPurchaseAgreementMember"
      decimals="0"
      id="Fact002504"
      unitRef="USD">354000</us-gaap:LegalFees>
    <us-gaap:StockIssuedDuringPeriodSharesNewIssues
      contextRef="From2023-09-292023-09-29_us-gaap_PrivatePlacementMember_custom_SecuritiesPurchaseAgreementMember_custom_PIPEPreFundedWarrantsMember_custom_ReverseStockSplitMember"
      decimals="INF"
      id="Fact002505"
      unitRef="Shares">117340</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
    <us-gaap:StockIssuedDuringPeriodSharesNewIssues
      contextRef="From2023-09-292023-09-29_us-gaap_PrivatePlacementMember_custom_SecuritiesPurchaseAgreementMember_custom_PIPEPreFundedWarrantsMember_custom_PreReverseMember"
      decimals="INF"
      id="Fact002506"
      unitRef="Shares">2581479</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
    <us-gaap:StockIssuedDuringPeriodSharesNewIssues
      contextRef="From2023-09-292023-09-29_custom_NonTradingWarrantsMember_custom_ReverseStockSplitMember"
      decimals="INF"
      id="Fact002507"
      unitRef="Shares">397727</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
    <us-gaap:StockIssuedDuringPeriodSharesNewIssues
      contextRef="From2023-09-292023-09-29_custom_NonTradingWarrantsMember_custom_PreReverseMember"
      decimals="INF"
      id="Fact002508"
      unitRef="Shares">8750003</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
    <us-gaap:SharesIssuedPricePerShare
      contextRef="AsOf2023-02-03_custom_SecuritiesPurchaseAgreementMember_custom_PIPEPreFundedWarrantsMember_srt_MaximumMember"
      decimals="INF"
      id="Fact002509"
      unitRef="USDPShares">23.63</us-gaap:SharesIssuedPricePerShare>
    <us-gaap:SharesIssuedPricePerShare
      contextRef="AsOf2023-02-03_custom_SecuritiesPurchaseAgreementMember_custom_PIPEPreFundedWarrantsMember_custom_PreReverseMember_srt_MaximumMember"
      decimals="INF"
      id="Fact002510"
      unitRef="USDPShares">1.074</us-gaap:SharesIssuedPricePerShare>
    <us-gaap:SharesIssuedPricePerShare
      contextRef="AsOf2023-02-03_custom_SecuritiesPurchaseAgreementMember_custom_PIPEPreFundedWarrantsMember_srt_MinimumMember"
      decimals="INF"
      id="Fact002511"
      unitRef="USDPShares">23.606</us-gaap:SharesIssuedPricePerShare>
    <us-gaap:SharesIssuedPricePerShare
      contextRef="AsOf2023-02-03_custom_SecuritiesPurchaseAgreementMember_custom_PIPEPreFundedWarrantsMember_custom_PreReverseMember_srt_MinimumMember"
      decimals="INF"
      id="Fact002512"
      unitRef="USDPShares">1.073</us-gaap:SharesIssuedPricePerShare>
    <us-gaap:WarrantsAndRightsOutstandingTerm
      contextRef="AsOf2023-09-29_custom_SecuritiesPurchaseAgreementMember_us-gaap_PrivatePlacementMember_custom_PIPEPreFundedWarrantsMember"
      id="Fact002513">P5Y6M</us-gaap:WarrantsAndRightsOutstandingTerm>
    <us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
      contextRef="AsOf2023-09-29_custom_SecuritiesPurchaseAgreementMember_custom_PIPEPreFundedWarrantsMember_us-gaap_PrivatePlacementMember_custom_ReverseStockSplitMember"
      decimals="INF"
      id="Fact002515"
      unitRef="USDPShares">14.08</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1>
    <us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
      contextRef="AsOf2024-05-30_custom_SecuritiesPurchaseAgreementMember_custom_PIPEPreFundedWarrantsMember_us-gaap_PrivatePlacementMember"
      decimals="INF"
      id="Fact002517"
      unitRef="USDPShares">7.26</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1>
    <us-gaap:AdditionalPaidInCapital
      contextRef="AsOf2023-09-29_us-gaap_PrivatePlacementMember_custom_SecuritiesPurchaseAgreementMember"
      decimals="-5"
      id="Fact002518"
      unitRef="USD">1600000</us-gaap:AdditionalPaidInCapital>
    <us-gaap:FairValueAdjustmentOfWarrants
      contextRef="From2023-09-292023-09-29_us-gaap_PrivatePlacementMember_custom_SecuritiesPurchaseAgreementMember"
      decimals="0"
      id="Fact002519"
      unitRef="USD">985204</us-gaap:FairValueAdjustmentOfWarrants>
    <us-gaap:ProceedsFromIssuanceOrSaleOfEquity
      contextRef="From2023-02-012023-02-03_custom_SecuritiesPurchaseAgreementMember"
      decimals="-5"
      id="Fact002521"
      unitRef="USD">3200000</us-gaap:ProceedsFromIssuanceOrSaleOfEquity>
    <us-gaap:NoninterestExpenseOfferingCost
      contextRef="From2023-02-012023-02-03_custom_SecuritiesPurchaseAgreementMember"
      decimals="0"
      id="Fact002523"
      unitRef="USD">600000</us-gaap:NoninterestExpenseOfferingCost>
    <us-gaap:StockIssuedDuringPeriodSharesNewIssues
      contextRef="From2023-02-012023-02-03_custom_SecuritiesPurchaseAgreementMember"
      decimals="INF"
      id="Fact002525"
      unitRef="Shares">102206</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
    <us-gaap:StockIssuedDuringPeriodSharesNewIssues
      contextRef="From2023-02-012023-02-03_custom_SecuritiesPurchaseAgreementMember_custom_PreReverseMember"
      decimals="INF"
      id="Fact002527"
      unitRef="Shares">2248521</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
    <us-gaap:SharesIssuedPricePerShare
      contextRef="AsOf2023-02-03_custom_SecuritiesPurchaseAgreementMember"
      decimals="INF"
      id="Fact002529"
      unitRef="USDPShares">37.18</us-gaap:SharesIssuedPricePerShare>
    <us-gaap:SharesIssuedPricePerShare
      contextRef="AsOf2023-02-03_custom_SecuritiesPurchaseAgreementMember_custom_PreReverseMember"
      decimals="INF"
      id="Fact002531"
      unitRef="USDPShares">1.69</us-gaap:SharesIssuedPricePerShare>
    <us-gaap:SaleOfStockDescriptionOfTransaction
      contextRef="From2023-02-012023-02-03_custom_SecuritiesPurchaseAgreementMember"
      id="Fact002533">Each
unit consisted of one share of common stock and one non-tradable warrant (&#x201c;Offering Warrants&#x201d;) exercisable for one share
of common stock</us-gaap:SaleOfStockDescriptionOfTransaction>
    <us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
      contextRef="AsOf2023-02-03_custom_SecuritiesPurchaseAgreementMember"
      decimals="INF"
      id="Fact002535"
      unitRef="USDPShares">34.32</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1>
    <us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
      contextRef="AsOf2023-09-29_custom_SecuritiesPurchaseAgreementMember"
      decimals="INF"
      id="Fact002537"
      unitRef="USDPShares">14.08</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1>
    <us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
      contextRef="AsOf2024-05-30_custom_SecuritiesPurchaseAgreementMember"
      decimals="INF"
      id="Fact002539"
      unitRef="USDPShares">7.26</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1>
    <us-gaap:WarrantsAndRightsOutstandingTerm
      contextRef="AsOf2023-02-03_custom_SecuritiesPurchaseAgreementMember"
      id="Fact002541">P5Y</us-gaap:WarrantsAndRightsOutstandingTerm>
    <us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction
      contextRef="From2022-04-112022-04-13_us-gaap_IPOMember"
      decimals="INF"
      id="Fact002543"
      unitRef="Shares">170454</us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction>
    <us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction
      contextRef="From2022-04-112022-04-13_us-gaap_IPOMember_custom_PreReverseMember"
      decimals="INF"
      id="Fact002545"
      unitRef="Shares">3750000</us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction>
    <us-gaap:SaleOfStockDescriptionOfTransaction
      contextRef="From2022-04-112022-04-13_us-gaap_IPOMember"
      id="Fact002547">each consisting of one share of
common stock and two warrants, to purchase one share of common stock for each whole warrant</us-gaap:SaleOfStockDescriptionOfTransaction>
    <us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
      contextRef="AsOf2022-04-13_us-gaap_IPOMember"
      decimals="INF"
      id="Fact002549"
      unitRef="USDPShares">93.50</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1>
    <us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
      contextRef="AsOf2022-04-13_us-gaap_IPOMember_custom_PreReverseMember"
      decimals="INF"
      id="Fact002551"
      unitRef="USDPShares">4.25</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1>
    <us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
      contextRef="AsOf2023-02-03_us-gaap_IPOMember"
      decimals="INF"
      id="Fact002553"
      unitRef="USDPShares">34.32</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1>
    <us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
      contextRef="AsOf2023-09-29_us-gaap_IPOMember"
      decimals="INF"
      id="Fact002555"
      unitRef="USDPShares">14.08</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1>
    <us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
      contextRef="AsOf2024-05-30_us-gaap_IPOMember"
      decimals="INF"
      id="Fact002557"
      unitRef="USDPShares">7.26</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1>
    <us-gaap:WarrantsAndRightsOutstandingTerm
      contextRef="AsOf2022-04-13_us-gaap_IPOMember"
      id="Fact002559">P5Y</us-gaap:WarrantsAndRightsOutstandingTerm>
    <STSS:DescriptionForOfferingShares
      contextRef="From2022-04-112022-04-13_us-gaap_IPOMember"
      id="Fact002561">the Company granted Aegis Capital Corp., as underwriter a 45-day over-allotment option to purchase up to 15% of the number of shares
included in the units sold in the offering, and/or additional warrants equal to 15% of the number of Warrants included in the units sold
in the offering, in each case solely to cover over-allotments</STSS:DescriptionForOfferingShares>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised
      contextRef="From2022-04-172022-04-19_us-gaap_WarrantMember"
      decimals="INF"
      id="Fact002563"
      unitRef="Shares">51136</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised
      contextRef="From2022-04-172022-04-19_us-gaap_WarrantMember_custom_PreReverseMember"
      decimals="INF"
      id="Fact002565"
      unitRef="Shares">1125000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised>
    <us-gaap:ProceedsFromIssuanceInitialPublicOffering
      contextRef="From2022-04-172022-04-19_us-gaap_IPOMember"
      decimals="-5"
      id="Fact002567"
      unitRef="USD">14200000</us-gaap:ProceedsFromIssuanceInitialPublicOffering>
    <us-gaap:AdditionalPaidInCapital
      contextRef="AsOf2022-04-14"
      decimals="-5"
      id="Fact002569"
      unitRef="USD">9000000.0</us-gaap:AdditionalPaidInCapital>
    <STSS:WarrantLiabilitiesCurrent
      contextRef="AsOf2022-04-14"
      decimals="-5"
      id="Fact002571"
      unitRef="USD">5200000</STSS:WarrantLiabilitiesCurrent>
    <us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight
      contextRef="AsOf2024-09-30_custom_WarrantHoldersMember"
      decimals="INF"
      id="Fact002573"
      unitRef="Shares">230091</us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight>
    <us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight
      contextRef="AsOf2024-09-30_custom_WarrantHoldersMember_custom_PreReverseMember"
      decimals="INF"
      id="Fact002575"
      unitRef="Shares">5260000</us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight>
    <us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
      contextRef="AsOf2023-02-28_custom_WarrantHoldersMember"
      decimals="INF"
      id="Fact002576"
      unitRef="USDPShares">7.26</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1>
    <us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
      contextRef="AsOf2023-09-30_custom_WarrantHoldersMember"
      decimals="INF"
      id="Fact002577"
      unitRef="USDPShares">7.26</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1>
    <us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
      contextRef="AsOf2023-02-28_custom_WarrantHoldersMember_custom_PreReverseMember"
      decimals="INF"
      id="Fact002578"
      unitRef="USDPShares">0.33</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1>
    <us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
      contextRef="AsOf2023-09-30_custom_WarrantHoldersMember_custom_PreReverseMember"
      decimals="INF"
      id="Fact002579"
      unitRef="USDPShares">0.33</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1>
    <us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
      contextRef="AsOf2023-02-28_custom_WarrantHolderMember"
      decimals="INF"
      id="Fact002581"
      unitRef="USDPShares">0.0001</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1>
    <us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
      contextRef="AsOf2023-09-29_custom_WarrantHolderMember"
      decimals="INF"
      id="Fact002583"
      unitRef="USDPShares">0.0001</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1>
    <STSS:FairValueAdjustmentOfModificationCharge
      contextRef="From2024-07-012024-09-30_custom_WarrantHoldersMember"
      decimals="0"
      id="Fact002585"
      unitRef="USD">155703</STSS:FairValueAdjustmentOfModificationCharge>
    <STSS:FairValueAdjustmentOfModificationCharge
      contextRef="From2024-01-012024-09-30_custom_WarrantHoldersMember"
      decimals="0"
      id="Fact002587"
      unitRef="USD">155703</STSS:FairValueAdjustmentOfModificationCharge>
    <us-gaap:ClassOfWarrantOrRightOutstanding
      contextRef="AsOf2024-09-30_us-gaap_WarrantMember"
      decimals="INF"
      id="Fact002589"
      unitRef="Shares">103685</us-gaap:ClassOfWarrantOrRightOutstanding>
    <us-gaap:StockIssuedDuringPeriodSharesNewIssues
      contextRef="From2024-04-012024-06-30_custom_InducementWarrantsMember"
      decimals="INF"
      id="Fact002591"
      unitRef="Shares">260799</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
    <us-gaap:StockIssuedDuringPeriodSharesNewIssues
      contextRef="From2024-04-012024-06-30_custom_InducementWarrantsMember_custom_PreReverseMember"
      decimals="INF"
      id="Fact002593"
      unitRef="Shares">5737573</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
    <us-gaap:FairValueAdjustmentOfWarrants
      contextRef="From2024-01-012024-06-30_custom_InducementWarrantsMember"
      decimals="0"
      id="Fact002595"
      unitRef="USD">293684</us-gaap:FairValueAdjustmentOfWarrants>
    <STSS:ClassOfWarrantOrRightIssued
      contextRef="AsOf2023-04-30_us-gaap_WarrantMember"
      decimals="INF"
      id="Fact002596"
      unitRef="Shares">28636</STSS:ClassOfWarrantOrRightIssued>
    <STSS:ClassOfWarrantOrRightIssued
      contextRef="AsOf2023-04-30_us-gaap_WarrantMember_custom_PreReverseMember"
      decimals="INF"
      id="Fact002597"
      unitRef="Shares">630000</STSS:ClassOfWarrantOrRightIssued>
    <us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
      contextRef="AsOf2023-04-30_us-gaap_WarrantMember"
      decimals="INF"
      id="Fact002598"
      unitRef="USDPShares">34.32</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1>
    <us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
      contextRef="AsOf2023-04-30_us-gaap_WarrantMember_custom_PreReverseMember"
      decimals="INF"
      id="Fact002599"
      unitRef="USDPShares">1.56</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1>
    <us-gaap:StockIssuedDuringPeriodSharesNewIssues
      contextRef="From2024-07-012024-09-30_us-gaap_WarrantMember"
      decimals="INF"
      id="Fact002600"
      unitRef="Shares">0</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
    <us-gaap:StockIssuedDuringPeriodSharesNewIssues
      contextRef="From2024-01-012024-09-30_us-gaap_WarrantMember"
      decimals="INF"
      id="Fact002601"
      unitRef="Shares">5909</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
    <us-gaap:StockIssuedDuringPeriodSharesNewIssues
      contextRef="From2024-01-012024-09-30_custom_PreReverseMember"
      decimals="INF"
      id="Fact002602"
      unitRef="Shares">130000</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
    <us-gaap:FairValueAdjustmentOfWarrants
      contextRef="From2024-01-012024-09-30_us-gaap_WarrantMember"
      decimals="0"
      id="Fact002603"
      unitRef="USD">8590</us-gaap:FairValueAdjustmentOfWarrants>
    <us-gaap:StockIssuedDuringPeriodSharesNewIssues
      contextRef="From2023-07-012023-09-30_us-gaap_WarrantMember"
      decimals="INF"
      id="Fact002604"
      unitRef="Shares">10227</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
    <us-gaap:StockIssuedDuringPeriodSharesNewIssues
      contextRef="From2023-07-012023-09-30_custom_PreReverseMember"
      decimals="INF"
      id="Fact002605"
      unitRef="Shares">225000</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
    <us-gaap:StockIssuedDuringPeriodSharesNewIssues
      contextRef="From2023-01-012023-09-30_us-gaap_WarrantMember"
      decimals="INF"
      id="Fact002606"
      unitRef="Shares">16363</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
    <us-gaap:StockIssuedDuringPeriodSharesNewIssues
      contextRef="From2023-01-012023-09-30_custom_PreReverseMember"
      decimals="INF"
      id="Fact002607"
      unitRef="Shares">360000</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
    <us-gaap:FairValueAdjustmentOfWarrants
      contextRef="From2023-07-012023-09-30_us-gaap_WarrantMember"
      decimals="0"
      id="Fact002608"
      unitRef="USD">22470</us-gaap:FairValueAdjustmentOfWarrants>
    <us-gaap:FairValueAdjustmentOfWarrants
      contextRef="From2023-01-012023-09-30_us-gaap_WarrantMember"
      decimals="0"
      id="Fact002609"
      unitRef="USD">42306</us-gaap:FairValueAdjustmentOfWarrants>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum
      contextRef="From2024-01-012024-09-30_us-gaap_WarrantMember"
      decimals="INF"
      id="Fact002610"
      unitRef="Pure">0.3346</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum
      contextRef="From2024-01-012024-09-30_us-gaap_WarrantMember"
      decimals="INF"
      id="Fact002611"
      unitRef="Pure">0.8162</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum
      contextRef="From2024-01-012024-09-30_us-gaap_WarrantMember"
      decimals="INF"
      id="Fact002613"
      unitRef="Pure">0.0420</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum
      contextRef="From2024-01-012024-09-30_us-gaap_WarrantMember"
      decimals="INF"
      id="Fact002614"
      unitRef="Pure">0.0425</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
      contextRef="From2024-01-012024-09-30_us-gaap_WarrantMember"
      decimals="INF"
      id="Fact002615"
      unitRef="Pure">0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum
      contextRef="From2023-01-012023-09-30_us-gaap_WarrantMember"
      decimals="INF"
      id="Fact002616"
      unitRef="Pure">0.3745</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum
      contextRef="From2023-01-012023-09-30_us-gaap_WarrantMember"
      decimals="INF"
      id="Fact002617"
      unitRef="Pure">0.4483</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum
      contextRef="From2023-01-012023-09-30_us-gaap_WarrantMember"
      decimals="INF"
      id="Fact002618"
      unitRef="Pure">0.0358</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum
      contextRef="From2023-01-012023-09-30_us-gaap_WarrantMember"
      decimals="INF"
      id="Fact002619"
      unitRef="Pure">0.0443</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
      contextRef="From2023-01-012023-09-30_us-gaap_WarrantMember"
      decimals="INF"
      id="Fact002620"
      unitRef="Pure">0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate>
    <us-gaap:StockIssuedDuringPeriodSharesNewIssues
      contextRef="From2023-09-012023-09-30_custom_NonTradingWarrantsMember_custom_ReverseStockSplitMember"
      decimals="INF"
      id="Fact002622"
      unitRef="Shares">397727</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
    <us-gaap:StockIssuedDuringPeriodSharesNewIssues
      contextRef="From2023-09-012023-09-30_custom_NonTradingWarrantsMember_custom_PreReverseMember"
      decimals="INF"
      id="Fact002624"
      unitRef="Shares">8750003</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
    <us-gaap:FairValueAdjustmentOfWarrants
      contextRef="From2024-07-012024-09-30_custom_NonTradingWarrantsMember_custom_PIPEWarrantMember"
      decimals="0"
      id="Fact002626"
      unitRef="USD">-181163</us-gaap:FairValueAdjustmentOfWarrants>
    <STSS:FairValueAdjustmentOfModificationCharge
      contextRef="From2024-07-012024-09-30_custom_NonTradingWarrantsMember_custom_PIPEWarrantMember"
      decimals="0"
      id="Fact002628"
      unitRef="USD">-148091</STSS:FairValueAdjustmentOfModificationCharge>
    <us-gaap:FairValueAdjustmentOfWarrants
      contextRef="From2024-01-012024-09-30_custom_NonTradingWarrantsMember_custom_PIPEWarrantMember"
      decimals="0"
      id="Fact002630"
      unitRef="USD">470721</us-gaap:FairValueAdjustmentOfWarrants>
    <STSS:FairValueAdjustmentOfModificationCharge
      contextRef="From2024-01-012024-09-30_custom_NonTradingWarrantsMember_custom_PIPEWarrantMember"
      decimals="0"
      id="Fact002632"
      unitRef="USD">-637316</STSS:FairValueAdjustmentOfModificationCharge>
    <us-gaap:StockIssuedDuringPeriodSharesNewIssues
      contextRef="From2023-02-012023-02-28_custom_NonTradingWarrantsMember_custom_ReverseStockSplitMember"
      decimals="INF"
      id="Fact002634"
      unitRef="Shares">102206</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
    <us-gaap:StockIssuedDuringPeriodSharesNewIssues
      contextRef="From2023-02-012023-02-28_custom_NonTradingWarrantsMember_custom_PreReverseMember"
      decimals="INF"
      id="Fact002636"
      unitRef="Shares">2248521</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
    <us-gaap:FairValueAdjustmentOfWarrants
      contextRef="From2024-07-012024-09-30_custom_NonTradingWarrantsMember"
      decimals="0"
      id="Fact002638"
      unitRef="USD">7563</us-gaap:FairValueAdjustmentOfWarrants>
    <STSS:FairValueAdjustmentOfModificationCharge
      contextRef="From2024-07-012024-09-30_custom_NonTradingWarrantsMember"
      decimals="0"
      id="Fact002640"
      unitRef="USD">7612</STSS:FairValueAdjustmentOfModificationCharge>
    <us-gaap:FairValueAdjustmentOfWarrants
      contextRef="From2024-01-012024-09-30_custom_NonTradingWarrantsMember"
      decimals="0"
      id="Fact002642"
      unitRef="USD">214019</us-gaap:FairValueAdjustmentOfWarrants>
    <STSS:FairValueAdjustmentOfModificationCharge
      contextRef="From2024-01-012024-09-30_custom_NonTradingWarrantsMember"
      decimals="0"
      id="Fact002644"
      unitRef="USD">153640</STSS:FairValueAdjustmentOfModificationCharge>
    <us-gaap:FairValueAdjustmentOfWarrants
      contextRef="From2023-07-012023-09-30_custom_NonTradingWarrantsMember"
      decimals="0"
      id="Fact002646"
      unitRef="USD">56172</us-gaap:FairValueAdjustmentOfWarrants>
    <us-gaap:FairValueAdjustmentOfWarrants
      contextRef="From2023-01-012023-09-30_custom_NonTradingWarrantsMember"
      decimals="0"
      id="Fact002648"
      unitRef="USD">238752</us-gaap:FairValueAdjustmentOfWarrants>
    <us-gaap:StockIssuedDuringPeriodSharesNewIssues
      contextRef="From2022-04-172022-04-19_custom_TradingWarrantsMember"
      decimals="INF"
      id="Fact002650"
      unitRef="Shares">340900</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
    <us-gaap:StockIssuedDuringPeriodSharesNewIssues
      contextRef="From2022-04-172022-04-19_custom_TradingWarrantsMember_custom_PreReverseMember"
      decimals="INF"
      id="Fact002652"
      unitRef="Shares">7500000</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
    <us-gaap:StockIssuedDuringPeriodSharesNewIssues
      contextRef="From2022-04-172022-04-19_custom_OverAllotmentWarrantsMember"
      decimals="INF"
      id="Fact002654"
      unitRef="Shares">51136</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
    <us-gaap:StockIssuedDuringPeriodSharesNewIssues
      contextRef="From2022-04-172022-04-19_custom_OverAllotmentWarrantsMember_custom_PreReverseMember"
      decimals="INF"
      id="Fact002656"
      unitRef="Shares">1125000</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
    <us-gaap:FairValueAdjustmentOfWarrants
      contextRef="From2024-07-012024-09-30_custom_TradingWarrantsMember"
      decimals="0"
      id="Fact002658"
      unitRef="USD">198375</us-gaap:FairValueAdjustmentOfWarrants>
    <us-gaap:FairValueAdjustmentOfWarrants
      contextRef="From2024-01-012024-09-30_custom_TradingWarrantsMember"
      decimals="0"
      id="Fact002660"
      unitRef="USD">690001</us-gaap:FairValueAdjustmentOfWarrants>
    <us-gaap:FairValueAdjustmentOfWarrants
      contextRef="From2023-07-012023-09-30_custom_TradingWarrantsMember"
      decimals="0"
      id="Fact002662"
      unitRef="USD">258750</us-gaap:FairValueAdjustmentOfWarrants>
    <us-gaap:FairValueAdjustmentOfWarrants
      contextRef="From2023-01-012023-09-30_custom_TradingWarrantsMember"
      decimals="0"
      id="Fact002664"
      unitRef="USD">172500</us-gaap:FairValueAdjustmentOfWarrants>
    <us-gaap:StockIssuedDuringPeriodSharesNewIssues
      contextRef="From2022-04-172022-04-19_custom_NoteWarrantsMember"
      decimals="INF"
      id="Fact002666"
      unitRef="Shares">10695</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
    <us-gaap:StockIssuedDuringPeriodSharesNewIssues
      contextRef="From2022-04-172022-04-19_custom_NoteWarrantsMember_custom_PreReverseMember"
      decimals="INF"
      id="Fact002668"
      unitRef="Shares">235295</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
    <us-gaap:FairValueAdjustmentOfWarrants
      contextRef="From2024-07-012024-09-30_custom_NoteWarrantsMember"
      decimals="0"
      id="Fact002670"
      unitRef="USD">5411</us-gaap:FairValueAdjustmentOfWarrants>
    <us-gaap:FairValueAdjustmentOfWarrants
      contextRef="From2024-01-012024-09-30_custom_NoteWarrantsMember"
      decimals="0"
      id="Fact002672"
      unitRef="USD">18822</us-gaap:FairValueAdjustmentOfWarrants>
    <us-gaap:FairValueAdjustmentOfWarrants
      contextRef="From2023-07-012023-09-30_custom_NoteWarrantsMember"
      decimals="0"
      id="Fact002674"
      unitRef="USD">7059</us-gaap:FairValueAdjustmentOfWarrants>
    <us-gaap:FairValueAdjustmentOfWarrants
      contextRef="From2023-01-012023-09-30_custom_NoteWarrantsMember"
      decimals="0"
      id="Fact002676"
      unitRef="USD">7059</us-gaap:FairValueAdjustmentOfWarrants>
    <us-gaap:StockIssuedDuringPeriodSharesNewIssues
      contextRef="From2022-04-172022-04-19_us-gaap_IPOMember"
      decimals="INF"
      id="Fact002678"
      unitRef="Shares">8523</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
    <us-gaap:ClassOfWarrantOrRightOutstanding
      contextRef="AsOf2022-04-19_us-gaap_IPOMember_custom_PreReverseMember"
      decimals="INF"
      id="Fact002680"
      unitRef="Shares">187500</us-gaap:ClassOfWarrantOrRightOutstanding>
    <us-gaap:WarrantsAndRightsOutstanding
      contextRef="AsOf2022-04-19_us-gaap_IPOMember"
      decimals="0"
      id="Fact002682"
      unitRef="USD">11250</us-gaap:WarrantsAndRightsOutstanding>
    <us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
      contextRef="AsOf2022-04-19_us-gaap_IPOMember"
      decimals="INF"
      id="Fact002684"
      unitRef="USDPShares">117.04</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1>
    <us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
      contextRef="AsOf2022-04-19_us-gaap_IPOMember_custom_PreReverseMember"
      decimals="INF"
      id="Fact002686"
      unitRef="USDPShares">5.32</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1>
    <us-gaap:FairValueAdjustmentOfWarrants
      contextRef="From2022-04-172022-04-19_us-gaap_IPOMember"
      decimals="0"
      id="Fact002688"
      unitRef="USD">228750</us-gaap:FairValueAdjustmentOfWarrants>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate
      contextRef="From2022-04-172022-04-19_us-gaap_IPOMember"
      decimals="INF"
      id="Fact002690"
      unitRef="Pure">0.9347</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
      contextRef="From2022-04-172022-04-19_us-gaap_IPOMember"
      decimals="INF"
      id="Fact002692"
      unitRef="Pure">0.0277</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
      contextRef="From2022-04-172022-04-19_us-gaap_IPOMember"
      decimals="INF"
      id="Fact002694"
      unitRef="Pure">0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate>
    <us-gaap:PreferredStockTextBlock contextRef="From2024-01-01to2024-09-30" id="Fact002696">&lt;p id="xdx_80E_eus-gaap--PreferredStockTextBlock_zWiVlYzABBmk" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Note
9. &lt;span id="xdx_82A_zVQIH3ndTVXi"&gt;Preferred Stock&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;In
February 2018, the Company Board of Directors issued one share of Series A Preferred Stock to Alan Blackman, the Company&#x2019;s
co-founder and former Director. &lt;span id="xdx_904_eus-gaap--PreferredStockVotingRights_c20240101__20240930__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesAPreferredStockMember_zK8gAUX3OIJk" title="Preferred stock, voting rights"&gt;The
Series A Preferred Stock entitled the holder to vote on any matters related to the election of directors and was reduced from 50.1%
at December 31, 2021 to 29.5%, effective with the IPO.&lt;/span&gt; The Series A Preferred Stock has no right to dividends, or
distributions in the event of a liquidation and is not convertible into common stock. In connection with final settlement with
Mr. Blackman on August 2024, the Series A Preferred Stock were cancelled and forfeited without any further consideration. The
Series A Preferred was returned to the status of an authorized but unissued share of preferred stock of the
Company (See Note 15).&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

</us-gaap:PreferredStockTextBlock>
    <us-gaap:PreferredStockVotingRights
      contextRef="From2024-01-012024-09-30_us-gaap_SeriesAPreferredStockMember"
      id="Fact002698">The
Series A Preferred Stock entitled the holder to vote on any matters related to the election of directors and was reduced from 50.1%
at December 31, 2021 to 29.5%, effective with the IPO.</us-gaap:PreferredStockVotingRights>
    <STSS:WarrantLiabilityTextBlock contextRef="From2024-01-01to2024-09-30" id="Fact002700">&lt;p id="xdx_80A_ecustom--WarrantLiabilityTextBlock_zXUVLEfd1gKd" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Note
10. &lt;span id="xdx_82D_zjlLl9nSTeye"&gt;Warrant Liability&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Certain
Warrants are accounted for as liabilities in accordance with ASC 815-40 and are presented as a Warrant liability in the accompanying
condensed consolidated balance sheets. The warrant liabilities are measured at fair value at inception and on a recurring basis, with
changes in fair value presented within the condensed consolidated statements of operations. The Black Scholes Option-Pricing model used
the following assumptions for the nine months ended September 30, 2024 and 2023 (See Note 8).&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_893_eus-gaap--FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock_hus-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_zNfj4uwSz8Yc" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span id="xdx_8B0_z5C3vtvO3kFc" style="display: none"&gt;Schedule
of Fair Value of Warrant&lt;/span&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;September
    30, 2024&lt;/span&gt;&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;September
    30, 2023&lt;/span&gt;&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Expected
    term (years)&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_901_eus-gaap--WarrantsAndRightsOutstandingTerm_iI_dtY_c20240930__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputExpectedTermMember__srt--RangeAxis__srt--MinimumMember_zmXMpEpnfdA" title="Expected term (in years)"&gt;3.37&lt;/span&gt;
                                            to &lt;span id="xdx_907_eus-gaap--WarrantsAndRightsOutstandingTerm_iI_dtY_c20240930__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputExpectedTermMember__srt--RangeAxis__srt--MaximumMember_z2fbJCh3v6Z" title="Expected term (in years)"&gt;5.99&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_908_eus-gaap--WarrantsAndRightsOutstandingTerm_iI_dtY_c20230930__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputExpectedTermMember__srt--RangeAxis__srt--MinimumMember_zJ1OxdaSccMe" title="Expected term (in years)"&gt;4.36&lt;/span&gt;
                                                                                                                                                                       to &lt;span id="xdx_902_eus-gaap--WarrantsAndRightsOutstandingTerm_iI_dtY_c20230930__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputExpectedTermMember__srt--RangeAxis__srt--MaximumMember_zLlKEu3UkqD5" title="Expected term (in years)"&gt;5.5&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Expected
    volatility&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_903_eus-gaap--WarrantsAndRightsOutstandingMeasurementInput_iI_uPure_c20240930__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputOptionVolatilityMember__srt--RangeAxis__srt--MinimumMember_zXXVWT90ZRFe" title="Expected volatility"&gt;58.78&lt;/span&gt;%
                                            to &lt;span id="xdx_901_eus-gaap--WarrantsAndRightsOutstandingMeasurementInput_iI_uPure_c20240930__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputOptionVolatilityMember__srt--RangeAxis__srt--MaximumMember_zQzweK1Oo1sh" title="Expected volatility"&gt;121.32&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;%&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_90F_eus-gaap--WarrantsAndRightsOutstandingMeasurementInput_iI_uPure_c20230930__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputOptionVolatilityMember__srt--RangeAxis__srt--MinimumMember_zRv1T99jhtA4" title="Expected volatility"&gt;45.31&lt;/span&gt;% to &lt;span id="xdx_907_eus-gaap--WarrantsAndRightsOutstandingMeasurementInput_iI_uPure_c20230930__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputOptionVolatilityMember__srt--RangeAxis__srt--MaximumMember_zVYQVnOrBbRa" title="Expected volatility"&gt;59.93&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;%&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Risk-free
    interest rate&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_904_eus-gaap--WarrantsAndRightsOutstandingMeasurementInput_iI_uPure_c20240930__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputRiskFreeInterestRateMember__srt--RangeAxis__srt--MinimumMember_zf5o1wA5v0Gi"&gt;3.41&lt;/span&gt;%
                                            to &lt;span id="xdx_903_eus-gaap--WarrantsAndRightsOutstandingMeasurementInput_iI_uPure_c20240930__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputRiskFreeInterestRateMember__srt--RangeAxis__srt--MaximumMember_z0Kke4FDIzn8"&gt;4.56&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;%&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span id="xdx_904_eus-gaap--WarrantsAndRightsOutstandingMeasurementInput_iI_uPure_c20230930__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputRiskFreeInterestRateMember__srt--RangeAxis__srt--MinimumMember_zDCk21xxYKk" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;3.53
&lt;/span&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;to &lt;span id="xdx_90C_eus-gaap--WarrantsAndRightsOutstandingMeasurementInput_iI_uPure_c20230930__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputRiskFreeInterestRateMember__srt--RangeAxis__srt--MaximumMember_z5zagmsUuQyc"&gt;4.54&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;%&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 60%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Dividend
    rate&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 2%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 16%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_909_eus-gaap--WarrantsAndRightsOutstandingMeasurementInput_iI_uPure_c20240930__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputExpectedDividendRateMember_zoaHYPOcVQj" title="Warrants liabilities measurement input"&gt;0&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 2%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 16%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_90E_eus-gaap--WarrantsAndRightsOutstandingMeasurementInput_iI_uPure_c20230930__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputExpectedDividendRateMember_z51hakULv0cc" title="Warrants liabilities measurement input"&gt;0&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;/p&gt;

&lt;p id="xdx_8AF_zR9QUfS9Q5fd" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_89C_ecustom--ScheduleOfWarrantLiabilityTableTextBlock_zjFkl6PkXAg4" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Warrant liability at September 30, 2024 and December 31, 2023 was as follows:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span id="xdx_8B4_za9s8uaOy15c" style="display: none"&gt;Schedule
of Warrant Liability&lt;/span&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_496_20240930_ztB5zHqwIoE3" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;September
    30, 2024&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_49B_20231231_ztgLDdeEkM03" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;December
    31, 2023&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_408_ecustom--WarrantLiabilitiesCurrent_iI_hus-gaap--ClassOfWarrantOrRightAxis__custom--TradingAndOverallotmentWarrantsMember_zdShiQojQEQ5" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 60%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Trading and Overallotment
    Warrants&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 2%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 16%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;431,250&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 2%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 16%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;1,121,250&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_403_ecustom--WarrantLiabilitiesCurrent_iI_hus-gaap--ClassOfWarrantOrRightAxis__custom--NoteWarrantsMember_zpnqIbvwgih7" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Note Warrants&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;11,765&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;30,588&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40D_ecustom--WarrantLiabilitiesCurrent_iI_hus-gaap--ClassOfWarrantOrRightAxis__custom--OfferingWarrantsFebruaryTwoThousandTwentyThreeMember_zyuTxZWwWzek" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Offering Warrants &#x2013; February 2023&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;20,053&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;234,072&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40B_ecustom--WarrantLiabilitiesCurrent_iI_hus-gaap--ClassOfWarrantOrRightAxis__custom--OfferingWarrantsSeptemberTwoThousandTwentyThreeMember_zZmHblQLt2bk" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Offering Warrants &#x2013; September 2023&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;216,911&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;1,036,875&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_406_ecustom--WarrantLiabilitiesCurrent_iI_hus-gaap--ClassOfWarrantOrRightAxis__custom--InducementWarrantsMember_zzJAq6GcMpNd" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Inducement Warrants &#x2013;
    May 2024&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;347,123&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2743"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_405_ecustom--WarrantLiabilitiesCurrent_iI_z8j6MBigIaFc" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Total
    Warrant Liability&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;1,027,102&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;2,422,785&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p id="xdx_8A5_zW9r07ak8D15" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_89E_eus-gaap--ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock_z7SUQBFelWU5" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Warrants outstanding at September 30, 2024 and December 31, 2023 were as follows:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span id="xdx_8BC_zh2iBmbU72ca" style="display: none"&gt;Schedule
of Warrant Outstanding&lt;/span&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_497_20240930_zmV3G9cnyhw9" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;September
    30, 2024&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_49A_20231231_zDJP6QVAQr4h" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;December
    31,2023&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_403_eus-gaap--ClassOfWarrantOrRightOutstanding_iI_hus-gaap--ClassOfWarrantOrRightAxis__custom--TradingAndOverallotmentWarrantsMember_zDhWk4Mq0iF6" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 60%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Trading,
    Overallotment and Underwriter Warrants&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 2%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 16%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;400,568&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 2%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 16%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;400,568&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_402_eus-gaap--ClassOfWarrantOrRightOutstanding_iI_hus-gaap--ClassOfWarrantOrRightAxis__custom--NoteWarrantsMember_zBW58NrZrqm7" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Note Warrants&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;10,695&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;10,695&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40D_eus-gaap--ClassOfWarrantOrRightOutstanding_iI_hus-gaap--ClassOfWarrantOrRightAxis__custom--OfferingWarrantsFebruaryTwoThousandTwentyThreeMember_zVWcQ3pZzA8h" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Offering Warrants &#x2013; February 2023&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;8,607&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;102,206&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40F_eus-gaap--ClassOfWarrantOrRightOutstanding_iI_hus-gaap--ClassOfWarrantOrRightAxis__custom--OfferingWarrantsSeptemberTwoThousandTwentyThreeMember_zmnAWBb2GdWl" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Offering Warrants &#x2013; September 2023&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;95,078&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;397,727&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_407_eus-gaap--ClassOfWarrantOrRightOutstanding_iI_hus-gaap--ClassOfWarrantOrRightAxis__custom--InducementWarrantsMayTwoThousandTwentyFourMember_zInelbDTIvz3" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Inducement Warrants &#x2013; May 2024&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;260,799&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2763"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_404_eus-gaap--ClassOfWarrantOrRightOutstanding_iI_hus-gaap--ClassOfWarrantOrRightAxis__custom--WarrantsIssuedForServiceManagementMember_zLy9ajQEohl9" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Warrants
    issued for services arrangement&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;28,636&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;22,500&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_404_ecustom--ClassOfWarrantsOrRightOutstanding_iI_zJQn2lMJMPx5" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Total
    Warrants Outstanding&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;804,383&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;1,194,495&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;


&lt;p id="xdx_8A8_zLpliDi8Ivtj" style="margin-top: 0; margin-bottom: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;




&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;SHARPS
TECHNOLOGY, INC.&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;NOTES
TO THE CONDENSED CONSOLIDATED FINANCIAL STATEMENTS&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;FOR
THE THREE AND NINE MONTHS ENDED SEPTEMBER 30, 2024 AND 2023&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Note
10. Warrant Liability (continued)&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;For
the three months ended September 30, 2024, the FMV gain adjustment, which is reflected in the FMV adjustment on Warrants in the
Unaudited Condensed Consolidated Statements of Operations was &lt;span id="xdx_906_eus-gaap--GainLossOnSaleOfDerivatives_c20240701__20240930_zGKZZGPJ0BM4" title="Fair market value adjustment"&gt;$416,560&lt;/span&gt;,
which includes the modification charge of &lt;span id="xdx_907_ecustom--FairValueAdjustmentOfModificationCharge_c20240701__20240930_z8snirj6Sojj" title="Fair value adjustment of modification charge"&gt;$155,703&lt;/span&gt;
and $&lt;span id="xdx_90F_eus-gaap--GainLossOnSaleOfDerivatives_c20240701__20240930__us-gaap--TypeOfArrangementAxis__custom--InducementAgreementMember_zdNnhiiuwGXb" title="Fair market value adjustment"&gt;349,243&lt;/span&gt;,
gain for the warrants exercised in connection with the Inducement Agreements (See Note 8).&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;For
the nine months September 30, 2024, the FMV gain adjustment, which is reflected in the FMV adjustment on Warrants in the Unaudited Condensed
Consolidated Statements of Operations was &lt;span id="xdx_90C_eus-gaap--GainLossOnSaleOfDerivatives_c20240101__20240930_z9GNOe5MpELk" title="Fair market value adjustment"&gt;$2,088,747&lt;/span&gt;, which includes the modification charge of &lt;span id="xdx_902_ecustom--FairValueAdjustmentOfModificationCharge_c20240101__20240930_zRb4XmdMl2t6" title="Fair value adjustment of modification charge"&gt;$790,956&lt;/span&gt; and $&lt;span id="xdx_906_eus-gaap--GainLossOnSaleOfDerivatives_c20240101__20240930__us-gaap--TypeOfArrangementAxis__custom--InducementAgreementMember_zkwlzy3XJQjg" title="Fair market value adjustment"&gt;349,243&lt;/span&gt;, gain for the warrants
exercised in connection with the Inducement Agreements (See Note 8).&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;For
the three and nine months ended September 30, 2023, the FMV gain adjustment, which is reflected in the FMV adjustment gain (loss) on
Warrants in the Unaudited Condensed Consolidated Statements of Operations was $&lt;span id="xdx_904_ecustom--GainLossOnSaleOfDerivative_di_c20230701__20230930_zARPB5Jc9pte" title="Fair market value adjustment"&gt;321,981&lt;/span&gt; and
$&lt;span id="xdx_904_ecustom--GainLossOnSaleOfDerivative_c20230101__20230930_zcog8MoFnMp7" title="Fair market value adjustment"&gt;415,958&lt;/span&gt;,
respectively (see Note 8).&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

</STSS:WarrantLiabilityTextBlock>
    <us-gaap:FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock
      contextRef="From2024-01-012024-09-30_us-gaap_WarrantMember"
      id="Fact002702">&lt;p id="xdx_893_eus-gaap--FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock_hus-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_zNfj4uwSz8Yc" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span id="xdx_8B0_z5C3vtvO3kFc" style="display: none"&gt;Schedule
of Fair Value of Warrant&lt;/span&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;September
    30, 2024&lt;/span&gt;&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;September
    30, 2023&lt;/span&gt;&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Expected
    term (years)&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_901_eus-gaap--WarrantsAndRightsOutstandingTerm_iI_dtY_c20240930__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputExpectedTermMember__srt--RangeAxis__srt--MinimumMember_zmXMpEpnfdA" title="Expected term (in years)"&gt;3.37&lt;/span&gt;
                                            to &lt;span id="xdx_907_eus-gaap--WarrantsAndRightsOutstandingTerm_iI_dtY_c20240930__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputExpectedTermMember__srt--RangeAxis__srt--MaximumMember_z2fbJCh3v6Z" title="Expected term (in years)"&gt;5.99&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_908_eus-gaap--WarrantsAndRightsOutstandingTerm_iI_dtY_c20230930__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputExpectedTermMember__srt--RangeAxis__srt--MinimumMember_zJ1OxdaSccMe" title="Expected term (in years)"&gt;4.36&lt;/span&gt;
                                                                                                                                                                       to &lt;span id="xdx_902_eus-gaap--WarrantsAndRightsOutstandingTerm_iI_dtY_c20230930__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputExpectedTermMember__srt--RangeAxis__srt--MaximumMember_zLlKEu3UkqD5" title="Expected term (in years)"&gt;5.5&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Expected
    volatility&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_903_eus-gaap--WarrantsAndRightsOutstandingMeasurementInput_iI_uPure_c20240930__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputOptionVolatilityMember__srt--RangeAxis__srt--MinimumMember_zXXVWT90ZRFe" title="Expected volatility"&gt;58.78&lt;/span&gt;%
                                            to &lt;span id="xdx_901_eus-gaap--WarrantsAndRightsOutstandingMeasurementInput_iI_uPure_c20240930__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputOptionVolatilityMember__srt--RangeAxis__srt--MaximumMember_zQzweK1Oo1sh" title="Expected volatility"&gt;121.32&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;%&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_90F_eus-gaap--WarrantsAndRightsOutstandingMeasurementInput_iI_uPure_c20230930__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputOptionVolatilityMember__srt--RangeAxis__srt--MinimumMember_zRv1T99jhtA4" title="Expected volatility"&gt;45.31&lt;/span&gt;% to &lt;span id="xdx_907_eus-gaap--WarrantsAndRightsOutstandingMeasurementInput_iI_uPure_c20230930__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputOptionVolatilityMember__srt--RangeAxis__srt--MaximumMember_zVYQVnOrBbRa" title="Expected volatility"&gt;59.93&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;%&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Risk-free
    interest rate&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_904_eus-gaap--WarrantsAndRightsOutstandingMeasurementInput_iI_uPure_c20240930__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputRiskFreeInterestRateMember__srt--RangeAxis__srt--MinimumMember_zf5o1wA5v0Gi"&gt;3.41&lt;/span&gt;%
                                            to &lt;span id="xdx_903_eus-gaap--WarrantsAndRightsOutstandingMeasurementInput_iI_uPure_c20240930__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputRiskFreeInterestRateMember__srt--RangeAxis__srt--MaximumMember_z0Kke4FDIzn8"&gt;4.56&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;%&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span id="xdx_904_eus-gaap--WarrantsAndRightsOutstandingMeasurementInput_iI_uPure_c20230930__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputRiskFreeInterestRateMember__srt--RangeAxis__srt--MinimumMember_zDCk21xxYKk" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;3.53
&lt;/span&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;to &lt;span id="xdx_90C_eus-gaap--WarrantsAndRightsOutstandingMeasurementInput_iI_uPure_c20230930__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputRiskFreeInterestRateMember__srt--RangeAxis__srt--MaximumMember_z5zagmsUuQyc"&gt;4.54&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;%&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 60%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Dividend
    rate&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 2%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 16%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_909_eus-gaap--WarrantsAndRightsOutstandingMeasurementInput_iI_uPure_c20240930__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputExpectedDividendRateMember_zoaHYPOcVQj" title="Warrants liabilities measurement input"&gt;0&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 2%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 16%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_90E_eus-gaap--WarrantsAndRightsOutstandingMeasurementInput_iI_uPure_c20230930__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputExpectedDividendRateMember_z51hakULv0cc" title="Warrants liabilities measurement input"&gt;0&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;/p&gt;

</us-gaap:FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock>
    <us-gaap:WarrantsAndRightsOutstandingTerm
      contextRef="AsOf2024-09-30_us-gaap_WarrantMember_us-gaap_MeasurementInputExpectedTermMember_srt_MinimumMember"
      id="Fact002704">P3Y4M13D</us-gaap:WarrantsAndRightsOutstandingTerm>
    <us-gaap:WarrantsAndRightsOutstandingTerm
      contextRef="AsOf2024-09-30_us-gaap_WarrantMember_us-gaap_MeasurementInputExpectedTermMember_srt_MaximumMember"
      id="Fact002706">P5Y11M26D</us-gaap:WarrantsAndRightsOutstandingTerm>
    <us-gaap:WarrantsAndRightsOutstandingTerm
      contextRef="AsOf2023-09-30_us-gaap_WarrantMember_us-gaap_MeasurementInputExpectedTermMember_srt_MinimumMember"
      id="Fact002708">P4Y4M9D</us-gaap:WarrantsAndRightsOutstandingTerm>
    <us-gaap:WarrantsAndRightsOutstandingTerm
      contextRef="AsOf2023-09-30_us-gaap_WarrantMember_us-gaap_MeasurementInputExpectedTermMember_srt_MaximumMember"
      id="Fact002710">P5Y6M</us-gaap:WarrantsAndRightsOutstandingTerm>
    <us-gaap:WarrantsAndRightsOutstandingMeasurementInput
      contextRef="AsOf2024-09-30_us-gaap_WarrantMember_us-gaap_MeasurementInputOptionVolatilityMember_srt_MinimumMember"
      decimals="INF"
      id="Fact002712"
      unitRef="Pure">58.78</us-gaap:WarrantsAndRightsOutstandingMeasurementInput>
    <us-gaap:WarrantsAndRightsOutstandingMeasurementInput
      contextRef="AsOf2024-09-30_us-gaap_WarrantMember_us-gaap_MeasurementInputOptionVolatilityMember_srt_MaximumMember"
      decimals="INF"
      id="Fact002714"
      unitRef="Pure">121.32</us-gaap:WarrantsAndRightsOutstandingMeasurementInput>
    <us-gaap:WarrantsAndRightsOutstandingMeasurementInput
      contextRef="AsOf2023-09-30_us-gaap_WarrantMember_us-gaap_MeasurementInputOptionVolatilityMember_srt_MinimumMember"
      decimals="INF"
      id="Fact002716"
      unitRef="Pure">45.31</us-gaap:WarrantsAndRightsOutstandingMeasurementInput>
    <us-gaap:WarrantsAndRightsOutstandingMeasurementInput
      contextRef="AsOf2023-09-30_us-gaap_WarrantMember_us-gaap_MeasurementInputOptionVolatilityMember_srt_MaximumMember"
      decimals="INF"
      id="Fact002718"
      unitRef="Pure">59.93</us-gaap:WarrantsAndRightsOutstandingMeasurementInput>
    <us-gaap:WarrantsAndRightsOutstandingMeasurementInput
      contextRef="AsOf2024-09-30_us-gaap_WarrantMember_us-gaap_MeasurementInputRiskFreeInterestRateMember_srt_MinimumMember"
      decimals="INF"
      id="Fact002719"
      unitRef="Pure">3.41</us-gaap:WarrantsAndRightsOutstandingMeasurementInput>
    <us-gaap:WarrantsAndRightsOutstandingMeasurementInput
      contextRef="AsOf2024-09-30_us-gaap_WarrantMember_us-gaap_MeasurementInputRiskFreeInterestRateMember_srt_MaximumMember"
      decimals="INF"
      id="Fact002720"
      unitRef="Pure">4.56</us-gaap:WarrantsAndRightsOutstandingMeasurementInput>
    <us-gaap:WarrantsAndRightsOutstandingMeasurementInput
      contextRef="AsOf2023-09-30_us-gaap_WarrantMember_us-gaap_MeasurementInputRiskFreeInterestRateMember_srt_MinimumMember"
      decimals="INF"
      id="Fact002721"
      unitRef="Pure">3.53</us-gaap:WarrantsAndRightsOutstandingMeasurementInput>
    <us-gaap:WarrantsAndRightsOutstandingMeasurementInput
      contextRef="AsOf2023-09-30_us-gaap_WarrantMember_us-gaap_MeasurementInputRiskFreeInterestRateMember_srt_MaximumMember"
      decimals="INF"
      id="Fact002722"
      unitRef="Pure">4.54</us-gaap:WarrantsAndRightsOutstandingMeasurementInput>
    <us-gaap:WarrantsAndRightsOutstandingMeasurementInput
      contextRef="AsOf2024-09-30_us-gaap_WarrantMember_us-gaap_MeasurementInputExpectedDividendRateMember"
      decimals="INF"
      id="Fact002724"
      unitRef="Pure">0</us-gaap:WarrantsAndRightsOutstandingMeasurementInput>
    <us-gaap:WarrantsAndRightsOutstandingMeasurementInput
      contextRef="AsOf2023-09-30_us-gaap_WarrantMember_us-gaap_MeasurementInputExpectedDividendRateMember"
      decimals="INF"
      id="Fact002726"
      unitRef="Pure">0</us-gaap:WarrantsAndRightsOutstandingMeasurementInput>
    <STSS:ScheduleOfWarrantLiabilityTableTextBlock contextRef="From2024-01-01to2024-09-30" id="Fact002728">&lt;p id="xdx_89C_ecustom--ScheduleOfWarrantLiabilityTableTextBlock_zjFkl6PkXAg4" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Warrant liability at September 30, 2024 and December 31, 2023 was as follows:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span id="xdx_8B4_za9s8uaOy15c" style="display: none"&gt;Schedule
of Warrant Liability&lt;/span&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_496_20240930_ztB5zHqwIoE3" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;September
    30, 2024&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_49B_20231231_ztgLDdeEkM03" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;December
    31, 2023&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_408_ecustom--WarrantLiabilitiesCurrent_iI_hus-gaap--ClassOfWarrantOrRightAxis__custom--TradingAndOverallotmentWarrantsMember_zdShiQojQEQ5" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 60%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Trading and Overallotment
    Warrants&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 2%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 16%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;431,250&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 2%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 16%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;1,121,250&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_403_ecustom--WarrantLiabilitiesCurrent_iI_hus-gaap--ClassOfWarrantOrRightAxis__custom--NoteWarrantsMember_zpnqIbvwgih7" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Note Warrants&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;11,765&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;30,588&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40D_ecustom--WarrantLiabilitiesCurrent_iI_hus-gaap--ClassOfWarrantOrRightAxis__custom--OfferingWarrantsFebruaryTwoThousandTwentyThreeMember_zyuTxZWwWzek" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Offering Warrants &#x2013; February 2023&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;20,053&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;234,072&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40B_ecustom--WarrantLiabilitiesCurrent_iI_hus-gaap--ClassOfWarrantOrRightAxis__custom--OfferingWarrantsSeptemberTwoThousandTwentyThreeMember_zZmHblQLt2bk" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Offering Warrants &#x2013; September 2023&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;216,911&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;1,036,875&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_406_ecustom--WarrantLiabilitiesCurrent_iI_hus-gaap--ClassOfWarrantOrRightAxis__custom--InducementWarrantsMember_zzJAq6GcMpNd" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Inducement Warrants &#x2013;
    May 2024&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;347,123&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2743"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_405_ecustom--WarrantLiabilitiesCurrent_iI_z8j6MBigIaFc" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Total
    Warrant Liability&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;1,027,102&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;2,422,785&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

</STSS:ScheduleOfWarrantLiabilityTableTextBlock>
    <STSS:WarrantLiabilitiesCurrent
      contextRef="AsOf2024-09-30_custom_TradingAndOverallotmentWarrantsMember"
      decimals="0"
      id="Fact002730"
      unitRef="USD">431250</STSS:WarrantLiabilitiesCurrent>
    <STSS:WarrantLiabilitiesCurrent
      contextRef="AsOf2023-12-31_custom_TradingAndOverallotmentWarrantsMember10886187"
      decimals="0"
      id="Fact002731"
      unitRef="USD">1121250</STSS:WarrantLiabilitiesCurrent>
    <STSS:WarrantLiabilitiesCurrent
      contextRef="AsOf2024-09-30_custom_NoteWarrantsMember"
      decimals="0"
      id="Fact002733"
      unitRef="USD">11765</STSS:WarrantLiabilitiesCurrent>
    <STSS:WarrantLiabilitiesCurrent
      contextRef="AsOf2023-12-31_custom_NoteWarrantsMember10886187"
      decimals="0"
      id="Fact002734"
      unitRef="USD">30588</STSS:WarrantLiabilitiesCurrent>
    <STSS:WarrantLiabilitiesCurrent
      contextRef="AsOf2024-09-30_custom_OfferingWarrantsFebruaryTwoThousandTwentyThreeMember"
      decimals="0"
      id="Fact002736"
      unitRef="USD">20053</STSS:WarrantLiabilitiesCurrent>
    <STSS:WarrantLiabilitiesCurrent
      contextRef="AsOf2023-12-31_custom_OfferingWarrantsFebruaryTwoThousandTwentyThreeMember"
      decimals="0"
      id="Fact002737"
      unitRef="USD">234072</STSS:WarrantLiabilitiesCurrent>
    <STSS:WarrantLiabilitiesCurrent
      contextRef="AsOf2024-09-30_custom_OfferingWarrantsSeptemberTwoThousandTwentyThreeMember"
      decimals="0"
      id="Fact002739"
      unitRef="USD">216911</STSS:WarrantLiabilitiesCurrent>
    <STSS:WarrantLiabilitiesCurrent
      contextRef="AsOf2023-12-31_custom_OfferingWarrantsSeptemberTwoThousandTwentyThreeMember"
      decimals="0"
      id="Fact002740"
      unitRef="USD">1036875</STSS:WarrantLiabilitiesCurrent>
    <STSS:WarrantLiabilitiesCurrent
      contextRef="AsOf2024-09-30_custom_InducementWarrantsMember"
      decimals="0"
      id="Fact002742"
      unitRef="USD">347123</STSS:WarrantLiabilitiesCurrent>
    <STSS:WarrantLiabilitiesCurrent
      contextRef="AsOf2024-09-30"
      decimals="0"
      id="Fact002745"
      unitRef="USD">1027102</STSS:WarrantLiabilitiesCurrent>
    <STSS:WarrantLiabilitiesCurrent
      contextRef="AsOf2023-12-31"
      decimals="0"
      id="Fact002746"
      unitRef="USD">2422785</STSS:WarrantLiabilitiesCurrent>
    <us-gaap:ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock contextRef="From2024-01-01to2024-09-30" id="Fact002748">&lt;p id="xdx_89E_eus-gaap--ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock_z7SUQBFelWU5" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Warrants outstanding at September 30, 2024 and December 31, 2023 were as follows:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span id="xdx_8BC_zh2iBmbU72ca" style="display: none"&gt;Schedule
of Warrant Outstanding&lt;/span&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_497_20240930_zmV3G9cnyhw9" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;September
    30, 2024&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_49A_20231231_zDJP6QVAQr4h" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;December
    31,2023&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_403_eus-gaap--ClassOfWarrantOrRightOutstanding_iI_hus-gaap--ClassOfWarrantOrRightAxis__custom--TradingAndOverallotmentWarrantsMember_zDhWk4Mq0iF6" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 60%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Trading,
    Overallotment and Underwriter Warrants&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 2%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 16%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;400,568&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 2%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 16%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;400,568&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_402_eus-gaap--ClassOfWarrantOrRightOutstanding_iI_hus-gaap--ClassOfWarrantOrRightAxis__custom--NoteWarrantsMember_zBW58NrZrqm7" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Note Warrants&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;10,695&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;10,695&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40D_eus-gaap--ClassOfWarrantOrRightOutstanding_iI_hus-gaap--ClassOfWarrantOrRightAxis__custom--OfferingWarrantsFebruaryTwoThousandTwentyThreeMember_zVWcQ3pZzA8h" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Offering Warrants &#x2013; February 2023&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;8,607&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;102,206&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40F_eus-gaap--ClassOfWarrantOrRightOutstanding_iI_hus-gaap--ClassOfWarrantOrRightAxis__custom--OfferingWarrantsSeptemberTwoThousandTwentyThreeMember_zmnAWBb2GdWl" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Offering Warrants &#x2013; September 2023&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;95,078&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;397,727&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_407_eus-gaap--ClassOfWarrantOrRightOutstanding_iI_hus-gaap--ClassOfWarrantOrRightAxis__custom--InducementWarrantsMayTwoThousandTwentyFourMember_zInelbDTIvz3" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Inducement Warrants &#x2013; May 2024&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;260,799&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2763"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_404_eus-gaap--ClassOfWarrantOrRightOutstanding_iI_hus-gaap--ClassOfWarrantOrRightAxis__custom--WarrantsIssuedForServiceManagementMember_zLy9ajQEohl9" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Warrants
    issued for services arrangement&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;28,636&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;22,500&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_404_ecustom--ClassOfWarrantsOrRightOutstanding_iI_zJQn2lMJMPx5" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Total
    Warrants Outstanding&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;804,383&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;1,194,495&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;


</us-gaap:ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock>
    <us-gaap:ClassOfWarrantOrRightOutstanding
      contextRef="AsOf2024-09-30_custom_TradingAndOverallotmentWarrantsMember"
      decimals="INF"
      id="Fact002750"
      unitRef="Shares">400568</us-gaap:ClassOfWarrantOrRightOutstanding>
    <us-gaap:ClassOfWarrantOrRightOutstanding
      contextRef="AsOf2023-12-31_custom_TradingAndOverallotmentWarrantsMember10886187"
      decimals="INF"
      id="Fact002751"
      unitRef="Shares">400568</us-gaap:ClassOfWarrantOrRightOutstanding>
    <us-gaap:ClassOfWarrantOrRightOutstanding
      contextRef="AsOf2024-09-30_custom_NoteWarrantsMember"
      decimals="INF"
      id="Fact002753"
      unitRef="Shares">10695</us-gaap:ClassOfWarrantOrRightOutstanding>
    <us-gaap:ClassOfWarrantOrRightOutstanding
      contextRef="AsOf2023-12-31_custom_NoteWarrantsMember10886187"
      decimals="INF"
      id="Fact002754"
      unitRef="Shares">10695</us-gaap:ClassOfWarrantOrRightOutstanding>
    <us-gaap:ClassOfWarrantOrRightOutstanding
      contextRef="AsOf2024-09-30_custom_OfferingWarrantsFebruaryTwoThousandTwentyThreeMember"
      decimals="INF"
      id="Fact002756"
      unitRef="Shares">8607</us-gaap:ClassOfWarrantOrRightOutstanding>
    <us-gaap:ClassOfWarrantOrRightOutstanding
      contextRef="AsOf2023-12-31_custom_OfferingWarrantsFebruaryTwoThousandTwentyThreeMember"
      decimals="INF"
      id="Fact002757"
      unitRef="Shares">102206</us-gaap:ClassOfWarrantOrRightOutstanding>
    <us-gaap:ClassOfWarrantOrRightOutstanding
      contextRef="AsOf2024-09-30_custom_OfferingWarrantsSeptemberTwoThousandTwentyThreeMember"
      decimals="INF"
      id="Fact002759"
      unitRef="Shares">95078</us-gaap:ClassOfWarrantOrRightOutstanding>
    <us-gaap:ClassOfWarrantOrRightOutstanding
      contextRef="AsOf2023-12-31_custom_OfferingWarrantsSeptemberTwoThousandTwentyThreeMember"
      decimals="INF"
      id="Fact002760"
      unitRef="Shares">397727</us-gaap:ClassOfWarrantOrRightOutstanding>
    <us-gaap:ClassOfWarrantOrRightOutstanding
      contextRef="AsOf2024-09-30_custom_InducementWarrantsMayTwoThousandTwentyFourMember"
      decimals="INF"
      id="Fact002762"
      unitRef="Shares">260799</us-gaap:ClassOfWarrantOrRightOutstanding>
    <us-gaap:ClassOfWarrantOrRightOutstanding
      contextRef="AsOf2024-09-30_custom_WarrantsIssuedForServiceManagementMember"
      decimals="INF"
      id="Fact002765"
      unitRef="Shares">28636</us-gaap:ClassOfWarrantOrRightOutstanding>
    <us-gaap:ClassOfWarrantOrRightOutstanding
      contextRef="AsOf2023-12-31_custom_WarrantsIssuedForServiceManagementMember10886343"
      decimals="INF"
      id="Fact002766"
      unitRef="Shares">22500</us-gaap:ClassOfWarrantOrRightOutstanding>
    <STSS:ClassOfWarrantsOrRightOutstanding
      contextRef="AsOf2024-09-30"
      decimals="INF"
      id="Fact002768"
      unitRef="Shares">804383</STSS:ClassOfWarrantsOrRightOutstanding>
    <STSS:ClassOfWarrantsOrRightOutstanding
      contextRef="AsOf2023-12-31"
      decimals="INF"
      id="Fact002769"
      unitRef="Shares">1194495</STSS:ClassOfWarrantsOrRightOutstanding>
    <us-gaap:GainLossOnSaleOfDerivatives
      contextRef="From2024-07-012024-09-30"
      decimals="0"
      id="Fact002771"
      unitRef="USD">416560</us-gaap:GainLossOnSaleOfDerivatives>
    <STSS:FairValueAdjustmentOfModificationCharge
      contextRef="From2024-07-012024-09-30"
      decimals="0"
      id="Fact002773"
      unitRef="USD">155703</STSS:FairValueAdjustmentOfModificationCharge>
    <us-gaap:GainLossOnSaleOfDerivatives
      contextRef="From2024-07-012024-09-30_custom_InducementAgreementMember"
      decimals="0"
      id="Fact002775"
      unitRef="USD">349243</us-gaap:GainLossOnSaleOfDerivatives>
    <us-gaap:GainLossOnSaleOfDerivatives
      contextRef="From2024-01-01to2024-09-30"
      decimals="0"
      id="Fact002777"
      unitRef="USD">2088747</us-gaap:GainLossOnSaleOfDerivatives>
    <STSS:FairValueAdjustmentOfModificationCharge
      contextRef="From2024-01-01to2024-09-30"
      decimals="0"
      id="Fact002779"
      unitRef="USD">790956</STSS:FairValueAdjustmentOfModificationCharge>
    <us-gaap:GainLossOnSaleOfDerivatives
      contextRef="From2024-01-012024-09-30_custom_InducementAgreementMember"
      decimals="0"
      id="Fact002781"
      unitRef="USD">349243</us-gaap:GainLossOnSaleOfDerivatives>
    <STSS:GainLossOnSaleOfDerivative
      contextRef="From2023-07-012023-09-30"
      decimals="0"
      id="Fact002783"
      unitRef="USD">-321981</STSS:GainLossOnSaleOfDerivative>
    <STSS:GainLossOnSaleOfDerivative
      contextRef="From2023-01-012023-09-30"
      decimals="0"
      id="Fact002785"
      unitRef="USD">415958</STSS:GainLossOnSaleOfDerivative>
    <us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock contextRef="From2024-01-01to2024-09-30" id="Fact002787">&lt;p id="xdx_804_eus-gaap--DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock_zDTxhaFgOcBd" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Note
11. &lt;span id="xdx_822_zLQpmKrEd85f"&gt;Stock Options&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_894_eus-gaap--ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock_zxVZC5fUQAHc" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;A
summary of options granted and outstanding is presented below.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span id="xdx_8BE_z8LJXVDUa9I7" style="display: none"&gt;Schedule
of Stock Options Granted and Outstanding&lt;/span&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="6" style="border-bottom: Black 1pt solid; text-align: center; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;September
    30, 2024&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; text-align: center; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Options&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; text-align: center; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Weighted&lt;br/&gt;
    Average&lt;br/&gt; Exercise Price&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 60%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Outstanding at
    Beginning of year&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 2%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_980_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iS_c20240101__20240930_z5mTF4VY3CHf" style="width: 16%; text-align: right" title="Stock option, beginning balance"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;109,493&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 2%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_985_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iS_c20240101__20240930_zmy9UZAtMVBe" style="width: 16%; text-align: right" title="Weighted average exercise price, beginning balance"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;67.12&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Granted&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98E_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_c20240101__20240930_zPZ4EPLTqSUg" style="text-align: right" title="Shares, options granted"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;63,409&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_981_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_c20240101__20240930_z1SpI7FuhVFh" style="text-align: right" title="Weighted average exercise price, options granted"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;6.27&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Forfeited
    or cancelled&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98D_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_iN_di_c20240101__20240930_zkXYANERjSc1" style="border-bottom: Black 2.5pt double; text-align: right" title="Shares, options forfeited"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(18,592&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;)&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_985_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice_c20240101__20240930_zdZHHWPmlmme" style="border-bottom: Black 2.5pt double; text-align: right" title="Weighted average exercise price, forfeited or cancelled"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;37.11&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Outstanding at end of
    period&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_988_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iE_c20240101__20240930_zYq0CLHwEJqe" style="border-bottom: Black 2.5pt double; text-align: right" title="Stock option, ending balance"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;154,310&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98B_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iE_c20240101__20240930_zKUWeRQybKq" style="border-bottom: Black 2.5pt double; text-align: right" title="Weighted average exercise price, ending balance"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;42.88&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Exercisable at end of
    period&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_981_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_iE_c20240101__20240930_zpmMa4vDkomg" style="border-bottom: Black 2.5pt double; text-align: right" title="Stock option, exercisable ending balance"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;122,243&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98F_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_iE_c20240101__20240930_zpXujWLzQCOg" style="border-bottom: Black 2.5pt double; text-align: right" title="Weighted average exercise price, exercisable ending balance"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;50.86&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p id="xdx_8A9_zBQec5uyUU1a" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;At
September 30, 2024, the Weighted Average Remaining Contractual Life is &lt;span id="xdx_909_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_dt_c20240101__20240930_zD8h54r5Bfel" title="Weighted average remaining contractual life"&gt;39 months&lt;/span&gt;.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;At
September 30, 2024, the stock options outstanding and the options exercisable have exercise prices that exceed the stock market price
at September 30, 2024 and as such no intrinsic value exists. Intrinsic value is defined as the difference between the exercise price
of the options and the market price of the Company&#x2019;s common stock.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;During
the nine months ended September 30, 2024, the Company granted &lt;span id="xdx_906_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantedInYear_dxL_c20240101__20240930_znTD0U8gTOpf" title="Granted options::XDX::P5Y"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2813"&gt;five&lt;/span&gt;&lt;/span&gt;-year options (the &#x201c;Options&#x201d;) to purchase a total of &lt;span id="xdx_906_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_c20240101__20240930_zrnuXv6fdOQk" title="Granted shares"&gt;63,409&lt;/span&gt;
shares of the Company&#x2019;s common stock, par value $&lt;span id="xdx_906_eus-gaap--CommonStockParOrStatedValuePerShare_iI_c20240930_zQBxIXBncTX6" title="Common stock par value"&gt;0.0001&lt;/span&gt; per share (the &#x201c;Common Stock&#x201d;) to its directors, executive
officers, employees and consultants pursuant to the Company&#x2019;s 2023 Equity Incentive Plan. The Options are exercisable at an average
price of $&lt;span id="xdx_90C_ecustom--ShareBasedCompensationOptionsExercisableWeightedAverageExercisePrice_iI_c20240930_zALWz1z2w3w8" title="Options exercisable"&gt;6.27&lt;/span&gt; per share which was based on the closing price on the respective grant dates.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;As
of September 30, 2024, there was $&lt;span id="xdx_901_eus-gaap--EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized_iI_c20240930_z2Qlgko1xeH3" title="Unrecognized stock-based compensation"&gt;232,353&lt;/span&gt; of unrecognized stock-based compensation related to unvested stock options with a weighted average
fair value of $&lt;span id="xdx_907_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue_iI_c20240930_zyI4ScBVBSBl" title="Unvested stock options weighted average fair value"&gt;7.25&lt;/span&gt; per share, which is expected to be recognized over a weighted-average period of &lt;span id="xdx_908_eus-gaap--EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_dt_c20240101__20240930_zzgJE3cNyuO2" title="Recognized over a weighted-average period"&gt;12 months&lt;/span&gt; as of September 30, 2024.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;For
the three and nine months ended September 30, 2024, the Company recognized stock-based compensation expense of $&lt;span id="xdx_908_eus-gaap--AllocatedShareBasedCompensationExpense_c20240701__20240930_zTEAlE8Q4g5h" title="Stock-based compensation expense"&gt;116,193&lt;/span&gt;
recorded in general and administrative and $&lt;span id="xdx_90A_eus-gaap--AllocatedShareBasedCompensationExpense_c20240101__20240930_zOGfoVekGin5" title="Stock-based compensation expense"&gt;435,908&lt;/span&gt;,
respectively, of which $&lt;span id="xdx_90C_eus-gaap--AllocatedShareBasedCompensationExpense_c20240101__20240930__us-gaap--IncomeStatementLocationAxis__us-gaap--GeneralAndAdministrativeExpenseMember_zg7i2NaY8Smd" title="Stock-based compensation expense"&gt;432,567&lt;/span&gt;
and $&lt;span id="xdx_909_eus-gaap--AllocatedShareBasedCompensationExpense_c20240101__20240930__us-gaap--IncomeStatementLocationAxis__us-gaap--ResearchAndDevelopmentExpenseMember_zBC01nnw40Yl" title="Stock-based compensation expense"&gt;3,341&lt;/span&gt;
was recorded in general and administrative and research and development expenses.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;For
the three and nine months ended September 30, 2023, the Company recognized stock-based compensation expense of $&lt;span id="xdx_90C_eus-gaap--AllocatedShareBasedCompensationExpense_c20230701__20230930__us-gaap--IncomeStatementLocationAxis__us-gaap--GeneralAndAdministrativeExpenseMember_zJHfhaghib72" title="Share based compensation"&gt;178,895&lt;/span&gt;&#160;and $&lt;span id="xdx_906_eus-gaap--AllocatedShareBasedCompensationExpense_c20230101__20230930__us-gaap--IncomeStatementLocationAxis__us-gaap--GeneralAndAdministrativeExpenseMember_z8Kdbhz4lupa" title="Share based compensation"&gt;796,606&lt;/span&gt;, respectively,
which was recorded in general and administrative.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;





&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;SHARPS
TECHNOLOGY, INC.&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;NOTES
TO THE CONDENSED CONSOLIDATED FINANCIAL STATEMENTS&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;FOR
THE THREE AND NINE MONTHS ENDED SEPTEMBER 30, 2024 AND 2023&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Note
11. Stock Options (continued)&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_89E_eus-gaap--FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock_znTUjMvgAGr4" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
fair value of stock option awards accounted for under ASC 718 was estimated at the date of grant using a Black-Scholes option-pricing
model with the following assumptions for the options granted during the nine months ended September 30, 2024 and 2023.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span id="xdx_8B1_zemRJhENtd4g" style="display: none"&gt;Schedule of Fair Value of Stock Option Awards&lt;/span&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;September
    30, 2024&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;September
    30, 2023&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Expected term (years)&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_909_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_dtY_c20240101__20240930__srt--RangeAxis__srt--MinimumMember_zpofHFkTvUsf" title="Expected term (years)"&gt;2.66&lt;/span&gt;
                                            to &lt;span id="xdx_90A_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_dtY_c20240101__20240930__srt--RangeAxis__srt--MaximumMember_zolyGV3PtPZ5" title="Expected term (years)"&gt;3.06&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_903_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_dtY_c20230101__20230930__srt--RangeAxis__srt--MinimumMember_zN1micCDOphd" title="Expected term (years)"&gt;2.88&lt;/span&gt;
                                            to &lt;span id="xdx_900_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_dtY_c20230101__20230930__srt--RangeAxis__srt--MaximumMember_zcXeelFA7zeh" title="Expected term (years)"&gt;3.25&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Expected volatility&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_901_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate_dp_c20240101__20240930__srt--RangeAxis__srt--MinimumMember_zOQH52I5tpA9" title="Expected volatility"&gt;81.15&lt;/span&gt;
                                            % to &lt;span id="xdx_908_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate_dp_c20240101__20240930__srt--RangeAxis__srt--MaximumMember_zQHMcjPuGP3k" title="Expected volatility"&gt;83.04&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_90B_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate_dp_c20230101__20230930__srt--RangeAxis__srt--MinimumMember_zfVirIaCcnNe" title="Expected volatility"&gt;75.40&lt;/span&gt;%
                                            to &lt;span id="xdx_909_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate_dp_c20230101__20230930__srt--RangeAxis__srt--MaximumMember_zolNsqKQktLc" title="Expected volatility"&gt;89.93&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Risk-free interest rate&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_905_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_dp_c20240101__20240930__srt--RangeAxis__srt--MinimumMember_zsKXsFrWFgcl" title="Risk-free interest rate"&gt;4.71&lt;/span&gt;
                                            % to &lt;span id="xdx_909_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_dp_c20240101__20240930__srt--RangeAxis__srt--MaximumMember_zEKLmLjcwsM4" title="Risk-free interest rate"&gt;4.76&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_906_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_dp_c20230101__20230930__srt--RangeAxis__srt--MinimumMember_zhWFSgQx7L9g" title="Risk-free interest rate"&gt;3.71&lt;/span&gt;%
                                            to &lt;span id="xdx_901_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_dp_c20230101__20230930__srt--RangeAxis__srt--MaximumMember_z5EFMmOaBfw8" title="Risk-free interest rate"&gt;4.27&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="width: 60%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Dividend rate&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 2%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 16%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_906_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_dp_c20240101__20240930_zVwLNuNFqGv3" title="Dividend rate"&gt;0&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 2%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 16%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_900_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_dp_c20230101__20230930_z6U4iGoN0Img" title="Dividend rate"&gt;0&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p id="xdx_8A2_zIKGmvNwZmhg" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

</us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock>
    <us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock contextRef="From2024-01-01to2024-09-30" id="Fact002789">&lt;p id="xdx_894_eus-gaap--ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock_zxVZC5fUQAHc" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;A
summary of options granted and outstanding is presented below.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span id="xdx_8BE_z8LJXVDUa9I7" style="display: none"&gt;Schedule
of Stock Options Granted and Outstanding&lt;/span&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="6" style="border-bottom: Black 1pt solid; text-align: center; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;September
    30, 2024&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; text-align: center; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Options&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; text-align: center; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Weighted&lt;br/&gt;
    Average&lt;br/&gt; Exercise Price&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 60%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Outstanding at
    Beginning of year&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 2%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_980_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iS_c20240101__20240930_z5mTF4VY3CHf" style="width: 16%; text-align: right" title="Stock option, beginning balance"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;109,493&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 2%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_985_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iS_c20240101__20240930_zmy9UZAtMVBe" style="width: 16%; text-align: right" title="Weighted average exercise price, beginning balance"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;67.12&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Granted&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98E_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_c20240101__20240930_zPZ4EPLTqSUg" style="text-align: right" title="Shares, options granted"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;63,409&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_981_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_c20240101__20240930_z1SpI7FuhVFh" style="text-align: right" title="Weighted average exercise price, options granted"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;6.27&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Forfeited
    or cancelled&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98D_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_iN_di_c20240101__20240930_zkXYANERjSc1" style="border-bottom: Black 2.5pt double; text-align: right" title="Shares, options forfeited"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(18,592&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;)&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_985_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice_c20240101__20240930_zdZHHWPmlmme" style="border-bottom: Black 2.5pt double; text-align: right" title="Weighted average exercise price, forfeited or cancelled"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;37.11&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Outstanding at end of
    period&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_988_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iE_c20240101__20240930_zYq0CLHwEJqe" style="border-bottom: Black 2.5pt double; text-align: right" title="Stock option, ending balance"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;154,310&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98B_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iE_c20240101__20240930_zKUWeRQybKq" style="border-bottom: Black 2.5pt double; text-align: right" title="Weighted average exercise price, ending balance"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;42.88&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Exercisable at end of
    period&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_981_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_iE_c20240101__20240930_zpmMa4vDkomg" style="border-bottom: Black 2.5pt double; text-align: right" title="Stock option, exercisable ending balance"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;122,243&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98F_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_iE_c20240101__20240930_zpXujWLzQCOg" style="border-bottom: Black 2.5pt double; text-align: right" title="Weighted average exercise price, exercisable ending balance"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;50.86&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

</us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
      contextRef="AsOf2023-12-31"
      decimals="INF"
      id="Fact002791"
      unitRef="Shares">109493</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
      contextRef="AsOf2023-12-31"
      decimals="INF"
      id="Fact002793"
      unitRef="USDPShares">67.12</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
      contextRef="From2024-01-01to2024-09-30"
      decimals="INF"
      id="Fact002795"
      unitRef="Shares">63409</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross>
    <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
      contextRef="From2024-01-01to2024-09-30"
      decimals="INF"
      id="Fact002797"
      unitRef="USDPShares">6.27</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
      contextRef="From2024-01-01to2024-09-30"
      decimals="INF"
      id="Fact002799"
      unitRef="Shares">18592</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod>
    <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice
      contextRef="From2024-01-01to2024-09-30"
      decimals="INF"
      id="Fact002801"
      unitRef="USDPShares">37.11</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
      contextRef="AsOf2024-09-30"
      decimals="INF"
      id="Fact002803"
      unitRef="Shares">154310</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
      contextRef="AsOf2024-09-30"
      decimals="INF"
      id="Fact002805"
      unitRef="USDPShares">42.88</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
      contextRef="AsOf2024-09-30"
      decimals="INF"
      id="Fact002807"
      unitRef="Shares">122243</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
      contextRef="AsOf2024-09-30"
      decimals="INF"
      id="Fact002809"
      unitRef="USDPShares">50.86</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2 contextRef="From2024-01-01to2024-09-30" id="Fact002811">P39M</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
      contextRef="From2024-01-01to2024-09-30"
      decimals="INF"
      id="Fact002815"
      unitRef="Shares">63409</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="AsOf2024-09-30"
      decimals="INF"
      id="Fact002817"
      unitRef="USDPShares">0.0001</us-gaap:CommonStockParOrStatedValuePerShare>
    <STSS:ShareBasedCompensationOptionsExercisableWeightedAverageExercisePrice
      contextRef="AsOf2024-09-30"
      decimals="INF"
      id="Fact002819"
      unitRef="USDPShares">6.27</STSS:ShareBasedCompensationOptionsExercisableWeightedAverageExercisePrice>
    <us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized
      contextRef="AsOf2024-09-30"
      decimals="0"
      id="Fact002821"
      unitRef="USD">232353</us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue
      contextRef="AsOf2024-09-30"
      decimals="INF"
      id="Fact002823"
      unitRef="USDPShares">7.25</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue>
    <us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1 contextRef="From2024-01-01to2024-09-30" id="Fact002825">P12M</us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="From2024-07-012024-09-30"
      decimals="0"
      id="Fact002827"
      unitRef="USD">116193</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="From2024-01-01to2024-09-30"
      decimals="0"
      id="Fact002829"
      unitRef="USD">435908</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="From2024-01-012024-09-30_us-gaap_GeneralAndAdministrativeExpenseMember"
      decimals="0"
      id="Fact002831"
      unitRef="USD">432567</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="From2024-01-012024-09-30_us-gaap_ResearchAndDevelopmentExpenseMember"
      decimals="0"
      id="Fact002833"
      unitRef="USD">3341</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="From2023-07-012023-09-30_us-gaap_GeneralAndAdministrativeExpenseMember"
      decimals="0"
      id="Fact002835"
      unitRef="USD">178895</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="From2023-01-012023-09-30_us-gaap_GeneralAndAdministrativeExpenseMember"
      decimals="0"
      id="Fact002837"
      unitRef="USD">796606</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock contextRef="From2024-01-01to2024-09-30" id="Fact002839">&lt;p id="xdx_89E_eus-gaap--FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock_znTUjMvgAGr4" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
fair value of stock option awards accounted for under ASC 718 was estimated at the date of grant using a Black-Scholes option-pricing
model with the following assumptions for the options granted during the nine months ended September 30, 2024 and 2023.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span id="xdx_8B1_zemRJhENtd4g" style="display: none"&gt;Schedule of Fair Value of Stock Option Awards&lt;/span&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;September
    30, 2024&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;September
    30, 2023&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Expected term (years)&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_909_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_dtY_c20240101__20240930__srt--RangeAxis__srt--MinimumMember_zpofHFkTvUsf" title="Expected term (years)"&gt;2.66&lt;/span&gt;
                                            to &lt;span id="xdx_90A_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_dtY_c20240101__20240930__srt--RangeAxis__srt--MaximumMember_zolyGV3PtPZ5" title="Expected term (years)"&gt;3.06&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_903_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_dtY_c20230101__20230930__srt--RangeAxis__srt--MinimumMember_zN1micCDOphd" title="Expected term (years)"&gt;2.88&lt;/span&gt;
                                            to &lt;span id="xdx_900_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_dtY_c20230101__20230930__srt--RangeAxis__srt--MaximumMember_zcXeelFA7zeh" title="Expected term (years)"&gt;3.25&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Expected volatility&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_901_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate_dp_c20240101__20240930__srt--RangeAxis__srt--MinimumMember_zOQH52I5tpA9" title="Expected volatility"&gt;81.15&lt;/span&gt;
                                            % to &lt;span id="xdx_908_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate_dp_c20240101__20240930__srt--RangeAxis__srt--MaximumMember_zQHMcjPuGP3k" title="Expected volatility"&gt;83.04&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_90B_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate_dp_c20230101__20230930__srt--RangeAxis__srt--MinimumMember_zfVirIaCcnNe" title="Expected volatility"&gt;75.40&lt;/span&gt;%
                                            to &lt;span id="xdx_909_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate_dp_c20230101__20230930__srt--RangeAxis__srt--MaximumMember_zolNsqKQktLc" title="Expected volatility"&gt;89.93&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Risk-free interest rate&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_905_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_dp_c20240101__20240930__srt--RangeAxis__srt--MinimumMember_zsKXsFrWFgcl" title="Risk-free interest rate"&gt;4.71&lt;/span&gt;
                                            % to &lt;span id="xdx_909_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_dp_c20240101__20240930__srt--RangeAxis__srt--MaximumMember_zEKLmLjcwsM4" title="Risk-free interest rate"&gt;4.76&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_906_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_dp_c20230101__20230930__srt--RangeAxis__srt--MinimumMember_zhWFSgQx7L9g" title="Risk-free interest rate"&gt;3.71&lt;/span&gt;%
                                            to &lt;span id="xdx_901_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_dp_c20230101__20230930__srt--RangeAxis__srt--MaximumMember_z5EFMmOaBfw8" title="Risk-free interest rate"&gt;4.27&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="width: 60%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Dividend rate&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 2%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 16%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_906_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_dp_c20240101__20240930_zVwLNuNFqGv3" title="Dividend rate"&gt;0&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 2%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 16%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_900_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_dp_c20230101__20230930_z6U4iGoN0Img" title="Dividend rate"&gt;0&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

</us-gaap:FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
      contextRef="From2024-01-012024-09-30_srt_MinimumMember"
      id="Fact002841">P2Y7M28D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
      contextRef="From2024-01-012024-09-30_srt_MaximumMember"
      id="Fact002843">P3Y21D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
      contextRef="From2023-01-012023-09-30_srt_MinimumMember"
      id="Fact002845">P2Y10M17D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
      contextRef="From2023-01-012023-09-30_srt_MaximumMember"
      id="Fact002847">P3Y3M</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate
      contextRef="From2024-01-012024-09-30_srt_MinimumMember"
      decimals="INF"
      id="Fact002849"
      unitRef="Pure">0.8115</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate
      contextRef="From2024-01-012024-09-30_srt_MaximumMember"
      decimals="INF"
      id="Fact002851"
      unitRef="Pure">0.8304</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate
      contextRef="From2023-01-012023-09-30_srt_MinimumMember"
      decimals="INF"
      id="Fact002853"
      unitRef="Pure">0.7540</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate
      contextRef="From2023-01-012023-09-30_srt_MaximumMember"
      decimals="INF"
      id="Fact002855"
      unitRef="Pure">0.8993</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
      contextRef="From2024-01-012024-09-30_srt_MinimumMember"
      decimals="INF"
      id="Fact002857"
      unitRef="Pure">0.0471</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
      contextRef="From2024-01-012024-09-30_srt_MaximumMember"
      decimals="INF"
      id="Fact002859"
      unitRef="Pure">0.0476</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
      contextRef="From2023-01-012023-09-30_srt_MinimumMember"
      decimals="INF"
      id="Fact002861"
      unitRef="Pure">0.0371</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
      contextRef="From2023-01-012023-09-30_srt_MaximumMember"
      decimals="INF"
      id="Fact002863"
      unitRef="Pure">0.0427</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
      contextRef="From2024-01-01to2024-09-30"
      decimals="INF"
      id="Fact002865"
      unitRef="Pure">0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
      contextRef="From2023-01-012023-09-30"
      decimals="INF"
      id="Fact002867"
      unitRef="Pure">0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate>
    <us-gaap:IncomeTaxDisclosureTextBlock contextRef="From2024-01-01to2024-09-30" id="Fact002869">&lt;p id="xdx_807_eus-gaap--IncomeTaxDisclosureTextBlock_zEs63vWWdPij" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Note
12. &lt;span id="xdx_822_z5UBynET54th"&gt;Income Taxes&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;At
the end of each interim reporting period, the Company estimates its effective tax rate expected to be applied for the full year.
This estimate is used to determine the income tax provision or benefit on a year-to-date basis and may change in subsequent interim
periods. Accordingly, the Company&#x2019;s effective tax rate for the three and nine months ended September 30, 2024 and 2023 was &lt;span id="xdx_906_eus-gaap--EffectiveIncomeTaxRateContinuingOperations_pid_dp_uPure_c20240701__20240930_zwvBQPUBlID2" title="Effective income tax rate percentage"&gt;&lt;span id="xdx_90F_eus-gaap--EffectiveIncomeTaxRateContinuingOperations_pid_dp_uPure_c20240101__20240930_zwKuM2YB5qw1" title="Effective income tax rate percentage"&gt;&lt;span id="xdx_90D_eus-gaap--EffectiveIncomeTaxRateContinuingOperations_pid_dp_uPure_c20230701__20230930_zPaj9o1cudx6" title="Effective income tax rate percentage"&gt;&lt;span id="xdx_906_eus-gaap--EffectiveIncomeTaxRateContinuingOperations_pid_dp_uPure_c20230101__20230930_ztTCtrlJGXb7" title="Effective income tax rate percentage"&gt;0&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;%.
The Company&#x2019;s effective tax rates for both periods were affected primarily by a full valuation allowance on domestic net
deferred tax assets.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

</us-gaap:IncomeTaxDisclosureTextBlock>
    <us-gaap:EffectiveIncomeTaxRateContinuingOperations
      contextRef="From2024-07-012024-09-30"
      decimals="INF"
      id="Fact002871"
      unitRef="Pure">0</us-gaap:EffectiveIncomeTaxRateContinuingOperations>
    <us-gaap:EffectiveIncomeTaxRateContinuingOperations
      contextRef="From2024-01-01to2024-09-30"
      decimals="INF"
      id="Fact002873"
      unitRef="Pure">0</us-gaap:EffectiveIncomeTaxRateContinuingOperations>
    <us-gaap:EffectiveIncomeTaxRateContinuingOperations
      contextRef="From2023-07-012023-09-30"
      decimals="INF"
      id="Fact002875"
      unitRef="Pure">0</us-gaap:EffectiveIncomeTaxRateContinuingOperations>
    <us-gaap:EffectiveIncomeTaxRateContinuingOperations
      contextRef="From2023-01-012023-09-30"
      decimals="INF"
      id="Fact002877"
      unitRef="Pure">0</us-gaap:EffectiveIncomeTaxRateContinuingOperations>
    <us-gaap:RelatedPartyTransactionsDisclosureTextBlock contextRef="From2024-01-01to2024-09-30" id="Fact002879">&lt;p id="xdx_801_eus-gaap--RelatedPartyTransactionsDisclosureTextBlock_zlDv3gqVW3Cf" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Note
13. &lt;span id="xdx_828_z36brOFxaPv9"&gt;Related Party Transactions and Balances&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;As
of September 30, 2024 and December 31, 2023, accounts payable and accrued liabilities include $&lt;span id="xdx_906_eus-gaap--AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent_iI_c20240930__srt--TitleOfIndividualAxis__custom--OfficersAndDirectorsMember_zg1bljdLBEpl" title="Accounts payable and accrued liabilities"&gt;152,500&lt;/span&gt; and $&lt;span id="xdx_90F_eus-gaap--AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent_iI_c20231231__srt--TitleOfIndividualAxis__custom--OfficersAndDirectorsMember_zZnqLQuXkJHj" title="Accounts payable and accrued liabilities"&gt;32,974&lt;/span&gt;, respectively, payable
to officers and directors of the Company. The amounts are unsecured, non-interest bearing and are due on demand.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

</us-gaap:RelatedPartyTransactionsDisclosureTextBlock>
    <us-gaap:AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent
      contextRef="AsOf2024-09-30_custom_OfficersAndDirectorsMember"
      decimals="0"
      id="Fact002881"
      unitRef="USD">152500</us-gaap:AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent>
    <us-gaap:AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent
      contextRef="AsOf2023-12-31_custom_OfficersAndDirectorsMember"
      decimals="0"
      id="Fact002883"
      unitRef="USD">32974</us-gaap:AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent>
    <us-gaap:FairValueMeasurementInputsDisclosureTextBlock contextRef="From2024-01-01to2024-09-30" id="Fact002885">&lt;p id="xdx_804_eus-gaap--FairValueMeasurementInputsDisclosureTextBlock_zrhCtJBoyF49" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Note
14. &lt;span id="xdx_82E_zbuVPIlaYyd2"&gt;Fair Value Measurements&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company&#x2019;s financial instruments include cash, accounts payable, and warrant liability. Cash and warrant liability are measured
at fair value. Accounts payable is measured at amortized cost and approximates fair value due to its short duration.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_891_eus-gaap--ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock_zgaDCWQ8I281" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;As
of September&#160;30, 2024, the following financial assets and liabilities were measured at fair value on a recurring basis presented
on the Company&#x2019;s condensed consolidated balance sheet:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span id="xdx_8BE_zzMRLNSAvI67" style="display: none"&gt;Schedule
of Assets and Liabilities Measured at Fair Value on Recurring Basis&lt;/span&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="display: none; vertical-align: bottom"&gt;
    &lt;td style="text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_491_20240930__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member_z4KlOwEwXPZ2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Level
    1&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_498_20240930__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member_z9m0JLmigtyh" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Level
    2&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_49C_20240930__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member_zt9UPPoQnhf5" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Level
    3&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_49C_20240930_z3HypJTQJmD9" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="10" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Fair
    Value Measurements Using&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Level
    1&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Level
    2&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Level
    3&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_400_eus-gaap--AssetsFairValueDisclosureAbstract_iB_zOAtVFrjKIAd" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Assets&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_405_eus-gaap--CashAndCashEquivalentsFairValueDisclosure_i01I_zChzjFxr6dm4" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="width: 44%; padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Cash&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 2%; padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; width: 10%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;2,473,197&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 1pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 2%; padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; width: 10%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2895"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 1pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 2%; padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; width: 10%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2896"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 1pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 2%; padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; width: 10%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;2,473,197&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 1pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_400_eus-gaap--AssetsFairValueDisclosure_iI_zf08RA74ZrVj" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font-weight: bold; text-align: left; padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Total
    assets measured at fair value&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;2,473,197&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2900"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2901"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;2,473,197&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_402_eus-gaap--LiabilitiesFairValueDisclosureAbstract_iB_z1BkUetQEGba" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Liabilities&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40E_eus-gaap--DerivativeLiabilities_i01I_zur1GJNBTzJb" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Warrant
    liability&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2909"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;1,027,102&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2911"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;1,027,102&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_405_eus-gaap--LiabilitiesFairValueDisclosure_i01I_zpUbWyljHVFk" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font-weight: bold; text-align: left; padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Total
    liabilities measured at fair value&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2914"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;1,027,102&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2916"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;1,027,102&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;





&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;SHARPS
TECHNOLOGY, INC.&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;NOTES
TO THE CONDENSED CONSOLIDATED FINANCIAL STATEMENTS&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;FOR
THE THREE AND NINE MONTHS ENDED SEPTEMBER 30, 2024 AND 2023&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Note
14. Fair Value Measurements (continued)&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;As
of December 31, 2023, the following financial assets and liabilities were measured at fair value on a recurring basis presented on the
Company&#x2019;s condensed consolidated balance sheet:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="display: none; vertical-align: bottom"&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_496_20231231__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member_zIREGOpf8Hlk" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Level
    1&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_49D_20231231__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member_zWeKG60u2CX2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Level
    2&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_490_20231231__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member_zOAKMQuqd3G9" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Level
    3&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_492_20231231_zDjoJdq81KQa" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="10" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Fair
    Value Measurements Using&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Level
    1&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Level
    2&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Level
    3&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_404_eus-gaap--AssetsFairValueDisclosureAbstract_iB_zg3N3Dbmx0e2" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Assets&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40B_eus-gaap--CashAndCashEquivalentsFairValueDisclosure_i01I_zbXBfNEtPmek" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="width: 44%; padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Cash&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 2%; padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; width: 10%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;3,012,908&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 1pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 2%; padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; width: 10%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2925"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 1pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 2%; padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; width: 10%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2926"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 1pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 2%; padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; width: 10%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;3,012,908&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 1pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_401_eus-gaap--AssetsFairValueDisclosure_iI_zw5BgyAgINO4" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font-weight: bold; text-align: left; padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Total
    assets measured at fair value&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;3,012,908&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2930"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2931"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;3,012,908&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40B_eus-gaap--LiabilitiesFairValueDisclosureAbstract_iB_zcWq2LrVT5vl" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Liabilities&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40C_eus-gaap--DerivativeLiabilities_i01I_zPAr3DrFRLgg" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Warrant
    liability&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2939"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;2,422,785&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2941"&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;2,422,785&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_405_eus-gaap--LiabilitiesFairValueDisclosure_iI_zp7vHk1W6RZ1" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font-weight: bold; text-align: left; padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Total
    liabilities measured at fair value&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2944"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;2,422,785&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2946"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;2,422,785&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p id="xdx_8A2_zB8rdJcf3uw" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

</us-gaap:FairValueMeasurementInputsDisclosureTextBlock>
    <us-gaap:ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock contextRef="From2024-01-01to2024-09-30" id="Fact002887">&lt;p id="xdx_891_eus-gaap--ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock_zgaDCWQ8I281" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;As
of September&#160;30, 2024, the following financial assets and liabilities were measured at fair value on a recurring basis presented
on the Company&#x2019;s condensed consolidated balance sheet:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span id="xdx_8BE_zzMRLNSAvI67" style="display: none"&gt;Schedule
of Assets and Liabilities Measured at Fair Value on Recurring Basis&lt;/span&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="display: none; vertical-align: bottom"&gt;
    &lt;td style="text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_491_20240930__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member_z4KlOwEwXPZ2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Level
    1&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_498_20240930__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member_z9m0JLmigtyh" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Level
    2&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_49C_20240930__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member_zt9UPPoQnhf5" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Level
    3&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_49C_20240930_z3HypJTQJmD9" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="10" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Fair
    Value Measurements Using&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Level
    1&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Level
    2&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Level
    3&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_400_eus-gaap--AssetsFairValueDisclosureAbstract_iB_zOAtVFrjKIAd" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Assets&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_405_eus-gaap--CashAndCashEquivalentsFairValueDisclosure_i01I_zChzjFxr6dm4" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="width: 44%; padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Cash&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 2%; padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; width: 10%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;2,473,197&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 1pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 2%; padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; width: 10%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2895"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 1pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 2%; padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; width: 10%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2896"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 1pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 2%; padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; width: 10%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;2,473,197&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 1pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_400_eus-gaap--AssetsFairValueDisclosure_iI_zf08RA74ZrVj" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font-weight: bold; text-align: left; padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Total
    assets measured at fair value&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;2,473,197&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2900"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2901"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;2,473,197&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_402_eus-gaap--LiabilitiesFairValueDisclosureAbstract_iB_z1BkUetQEGba" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Liabilities&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40E_eus-gaap--DerivativeLiabilities_i01I_zur1GJNBTzJb" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Warrant
    liability&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2909"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;1,027,102&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2911"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;1,027,102&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_405_eus-gaap--LiabilitiesFairValueDisclosure_i01I_zpUbWyljHVFk" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font-weight: bold; text-align: left; padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Total
    liabilities measured at fair value&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2914"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;1,027,102&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2916"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;1,027,102&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;





&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;SHARPS
TECHNOLOGY, INC.&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;NOTES
TO THE CONDENSED CONSOLIDATED FINANCIAL STATEMENTS&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;FOR
THE THREE AND NINE MONTHS ENDED SEPTEMBER 30, 2024 AND 2023&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Note
14. Fair Value Measurements (continued)&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;As
of December 31, 2023, the following financial assets and liabilities were measured at fair value on a recurring basis presented on the
Company&#x2019;s condensed consolidated balance sheet:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="display: none; vertical-align: bottom"&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_496_20231231__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member_zIREGOpf8Hlk" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Level
    1&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_49D_20231231__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member_zWeKG60u2CX2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Level
    2&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_490_20231231__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member_zOAKMQuqd3G9" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Level
    3&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_492_20231231_zDjoJdq81KQa" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="10" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Fair
    Value Measurements Using&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Level
    1&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Level
    2&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Level
    3&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_404_eus-gaap--AssetsFairValueDisclosureAbstract_iB_zg3N3Dbmx0e2" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Assets&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40B_eus-gaap--CashAndCashEquivalentsFairValueDisclosure_i01I_zbXBfNEtPmek" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="width: 44%; padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Cash&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 2%; padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; width: 10%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;3,012,908&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 1pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 2%; padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; width: 10%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2925"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 1pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 2%; padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; width: 10%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2926"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 1pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 2%; padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; width: 10%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;3,012,908&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 1pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_401_eus-gaap--AssetsFairValueDisclosure_iI_zw5BgyAgINO4" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font-weight: bold; text-align: left; padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Total
    assets measured at fair value&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;3,012,908&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2930"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2931"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;3,012,908&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40B_eus-gaap--LiabilitiesFairValueDisclosureAbstract_iB_zcWq2LrVT5vl" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Liabilities&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40C_eus-gaap--DerivativeLiabilities_i01I_zPAr3DrFRLgg" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Warrant
    liability&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2939"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;2,422,785&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2941"&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;2,422,785&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_405_eus-gaap--LiabilitiesFairValueDisclosure_iI_zp7vHk1W6RZ1" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font-weight: bold; text-align: left; padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Total
    liabilities measured at fair value&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2944"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;2,422,785&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2946"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;2,422,785&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

</us-gaap:ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock>
    <us-gaap:CashAndCashEquivalentsFairValueDisclosure
      contextRef="AsOf2024-09-30_us-gaap_FairValueInputsLevel1Member"
      decimals="0"
      id="Fact002894"
      unitRef="USD">2473197</us-gaap:CashAndCashEquivalentsFairValueDisclosure>
    <us-gaap:CashAndCashEquivalentsFairValueDisclosure
      contextRef="AsOf2024-09-30"
      decimals="0"
      id="Fact002897"
      unitRef="USD">2473197</us-gaap:CashAndCashEquivalentsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="AsOf2024-09-30_us-gaap_FairValueInputsLevel1Member"
      decimals="0"
      id="Fact002899"
      unitRef="USD">2473197</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="AsOf2024-09-30"
      decimals="0"
      id="Fact002902"
      unitRef="USD">2473197</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:DerivativeLiabilities
      contextRef="AsOf2024-09-30_us-gaap_FairValueInputsLevel2Member"
      decimals="0"
      id="Fact002910"
      unitRef="USD">1027102</us-gaap:DerivativeLiabilities>
    <us-gaap:DerivativeLiabilities
      contextRef="AsOf2024-09-30"
      decimals="0"
      id="Fact002912"
      unitRef="USD">1027102</us-gaap:DerivativeLiabilities>
    <us-gaap:LiabilitiesFairValueDisclosure
      contextRef="AsOf2024-09-30_us-gaap_FairValueInputsLevel2Member"
      decimals="0"
      id="Fact002915"
      unitRef="USD">1027102</us-gaap:LiabilitiesFairValueDisclosure>
    <us-gaap:LiabilitiesFairValueDisclosure
      contextRef="AsOf2024-09-30"
      decimals="0"
      id="Fact002917"
      unitRef="USD">1027102</us-gaap:LiabilitiesFairValueDisclosure>
    <us-gaap:CashAndCashEquivalentsFairValueDisclosure
      contextRef="AsOf2023-12-31_us-gaap_FairValueInputsLevel1Member"
      decimals="0"
      id="Fact002924"
      unitRef="USD">3012908</us-gaap:CashAndCashEquivalentsFairValueDisclosure>
    <us-gaap:CashAndCashEquivalentsFairValueDisclosure
      contextRef="AsOf2023-12-31"
      decimals="0"
      id="Fact002927"
      unitRef="USD">3012908</us-gaap:CashAndCashEquivalentsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="AsOf2023-12-31_us-gaap_FairValueInputsLevel1Member"
      decimals="0"
      id="Fact002929"
      unitRef="USD">3012908</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="AsOf2023-12-31"
      decimals="0"
      id="Fact002932"
      unitRef="USD">3012908</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:DerivativeLiabilities
      contextRef="AsOf2023-12-31_us-gaap_FairValueInputsLevel2Member"
      decimals="0"
      id="Fact002940"
      unitRef="USD">2422785</us-gaap:DerivativeLiabilities>
    <us-gaap:DerivativeLiabilities
      contextRef="AsOf2023-12-31"
      decimals="0"
      id="Fact002942"
      unitRef="USD">2422785</us-gaap:DerivativeLiabilities>
    <us-gaap:LiabilitiesFairValueDisclosure
      contextRef="AsOf2023-12-31_us-gaap_FairValueInputsLevel2Member"
      decimals="0"
      id="Fact002945"
      unitRef="USD">2422785</us-gaap:LiabilitiesFairValueDisclosure>
    <us-gaap:LiabilitiesFairValueDisclosure
      contextRef="AsOf2023-12-31"
      decimals="0"
      id="Fact002947"
      unitRef="USD">2422785</us-gaap:LiabilitiesFairValueDisclosure>
    <us-gaap:CommitmentsAndContingenciesDisclosureTextBlock contextRef="From2024-01-01to2024-09-30" id="Fact002949">&lt;p id="xdx_804_eus-gaap--CommitmentsAndContingenciesDisclosureTextBlock_z3exny20ML15" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Note
15. &lt;span id="xdx_82D_zipBBRJp1aE1"&gt;Commitments and Contingencies&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;Contingencies&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;On
July 10, 2024, Barry Berler (&#x201c;Berler&#x201d;), a co-founder and former Chief Technology Officer of the Company, commenced a lawsuit
in the United States District Court for the Eastern District of New York, Barry Berler v. Sharps Technology, Inc. and Alan Blackman,
Case No. 2:24-cv-04787. In this case, Berler asserts claims for damages of an aggregate of $&lt;span id="xdx_901_eus-gaap--LossContingencyDamagesSoughtValue_c20240710__20240710__srt--LitigationCaseAxis__custom--BerlerMember_zT5oHq9wVxdc" title="Loss contingency, claims for damages"&gt;456,000&lt;/span&gt; for alleged&lt;span id="xdx_906_eus-gaap--LossContingencyDamagesSought_c20240710__20240710__srt--LitigationCaseAxis__custom--BerlerMember_za1JIGiE0tUe" title="Description of loss contingency"&gt; (1) failure to make full
payment of certain monthly payments under his consulting agreement with the Company (the &#x201c;Consulting Agreement&#x201d;) in the amount
of $52,500, (2) failure to pay a bonus with a target of $216,000 under the Consulting Agreement, (3) $187,500, representing 50% of the
severance payment paid by the Company to Mr. Blackman, the Company&#x2019;s co-founder and former Chief Operating Officer and Co-Chairman
and a declaration and injunctive relief establishing that Berler is the rightful owner of 50% of the Company&#x2019;s Series A Preferred
Stock (which preferred stock is no longer outstanding).&lt;/span&gt; The Company has accrued for the claim for unpaid monthly consulting fees. The
Company believes that Berler&#x2019;s claims are without merit, intends to defend itself vigorously and has requested dismissal of these
claims. In addition, on September 17, 2024, the Company filed an answer and counterclaims with respect thereto, including for recoupment
of certain compensation the Company has previously paid to Berler.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;On
June l7, 2024, Berler filed a demand for arbitration and statement of claim under the commercial arbitration rules of the American Arbitration
Association (&#x201c;AAA&#x201d;) asserting claims for payment of $&lt;span id="xdx_908_eus-gaap--LossContingencyDamagesSoughtValue_c20240617__20240617__srt--LitigationCaseAxis__custom--BerlerMember_zHBek6ghPJVh" title="Loss contingency, claims for damages"&gt;500,000&lt;/span&gt; plus interest, under the Company&#x2019;s royalty agreement with
Berler, as amended, rescission thereof and reversion to Berler of the intellectual property rights subject thereto. The Company believes
that Berler&#x2019;s claims are without merit and intends to defend itself vigorously in connection with these claims.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;On
April 3, 2024, Plastomold Industries Ltd. (&#x201c;Plastomold&#x201d;) commenced a lawsuit against the Company in the United States District
Court for the Eastern District of New York, Plastomold Industries Ltd v. Sharps Technology, Inc., Case No. 2:24-CV-02580, asserting claims
for damages in the amount of $&lt;span id="xdx_90D_eus-gaap--LossContingencyDamagesSoughtValue_pn3n6_c20240403__20240403__srt--LitigationCaseAxis__custom--PlastomoldMember_zNcHzYxfILc3" title="Loss contingency, claims for damages"&gt;1.762&lt;/span&gt; million for alleged &lt;span id="xdx_906_eus-gaap--LossContingencyDamagesSought_c20240403__20240403__srt--LitigationCaseAxis__custom--PlastomoldMember_zI0TwB3Fpvi3" title="Description of loss contingency"&gt;(1) failure to pay invoices, of which approximately $1 million would relate to
a maintenance agreement for units allegedly manufactured and sold using machinery that was defective and has never successfully produced
any saleable products, (2) breach of the implied covenant of good faith and fair dealing, (3) unjust enrichment, and (4) conversion.
Plastomold asserts it provided certain products and services to the Company for which its invoices were not fully paid. The Company believes
that Plastomold&#x2019;s claims are without merit and intends to defend itself vigorously.&lt;/span&gt; On June 3, 2024, the Company filed an answer
and affirmative defenses and counterclaim, which counterclaim is for damages that the Company believes would exceed the claims asserted
by Plastomold, based on the insufficiency of Plastomold&#x2019;s services and the results thereof, including the failure to provide machinery
capable of reliably manufacturing the designated products in compliance with design specifications and functionality requirements, and
with respect to which test results failed.&lt;/span&gt;&lt;/p&gt;
&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"&gt;&lt;/p&gt;
&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;Commitments&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;On
August 1, 2022, the Company cancelled the consulting agreement with Alan Blackman, Co- Chairman and Chief Operating Officer and
entered into an Employment Agreement. which provided for annual salary of $&lt;span id="xdx_90C_eus-gaap--SalariesAndWages_c20220730__20220801__us-gaap--TypeOfArrangementAxis__custom--EmploymentAgreementMember__srt--TitleOfIndividualAxis__custom--AlanBlackmanMember_z2oixmpIKNRf" title="Annual salary"&gt;256,000&lt;/span&gt;,
which provides for increases, and provisions compensation adjustments, expense and tax differential reimbursements, benefits and
bonuses. As of September 1, 2022, the annual salary is $&lt;span id="xdx_906_eus-gaap--SalariesAndWages_c20220831__20220901__us-gaap--TypeOfArrangementAxis__custom--EmploymentAgreementMember__srt--TitleOfIndividualAxis__custom--AlanBlackmanMember_zrVkYJ8pqmR8" title="Salaries and wages"&gt;320,000&lt;/span&gt;.
At September 30, 2022, the Company approved and accrued a $&lt;span id="xdx_908_eus-gaap--AccruedBonusesCurrentAndNoncurrent_iI_c20220930__us-gaap--TypeOfArrangementAxis__custom--EmploymentAgreementMember__srt--TitleOfIndividualAxis__custom--AlanBlackmanMember_zDTgDYGu6Jl2" title="Accrued bonus"&gt;250,000&lt;/span&gt;
bonus to Mr. Blackman for services provided in 2022, of which $&lt;span id="xdx_902_ecustom--PaymentForBonuses_c20230101__20230331__us-gaap--TypeOfArrangementAxis__custom--EmploymentAgreementMember__srt--TitleOfIndividualAxis__custom--AlanBlackmanMember_zapYwzPDjoVh" title="Payment for bonuses"&gt;65,000&lt;/span&gt;
was paid subsequent to December 31, 2022. The Company terminated Mr. Blackman&#x2019;s Employment Agreement effective May 1, 2023.
Mr. Blackman continued to serve as the Co-Chairman and a member of the Board of Directors. Subsequent to June 30, 2023, the Company
and Mr. Blackman entered into a separation agreement whereby, Mr. Blackman was paid severance payments of approximately $&lt;span id="xdx_90B_eus-gaap--SeveranceCosts1_c20230701__20230814__srt--TitleOfIndividualAxis__custom--AlanBlackmanMember_znIDk6xuoEAa" title="Severance costs"&gt;346,000&lt;/span&gt;
plus other medical benefits of approximately $&lt;span id="xdx_903_ecustom--MedicalBenefitsCost_iI_c20230630__srt--TitleOfIndividualAxis__custom--AlanBlackmanMember_zFym0JpKbrI" title="Medical benefit cost"&gt;29,000&lt;/span&gt;
which were fully paid by August 31, 2024. Further, all unvested options were fully vested, and the Company recorded a charge of
$&lt;span id="xdx_906_eus-gaap--ShareBasedCompensation_c20230101__20231231__srt--TitleOfIndividualAxis__custom--AlanBlackmanMember_zwhwXRCdfNS3" title="Share based compensation"&gt;60,000&lt;/span&gt;
in 2023. In connection with the separation agreement, Mr. Blackman no longer served as Co-Chairman or Board member and agreed to vote
his Series A Preferred Stock in favor of the election, reelection, and/or designation of each individual nominated to serve as a
director on the Board of Director as shall be identified in an applicable proxy statement filed by the Company for such election of
directors. Once the payments due Mr. Blackman were fully paid, the Series A Preferred Stock were deemed immediately cancelled and
forfeited and without further consideration. The Series A Preferred has been returned to the status of an authorized but unissued
share of preferred stock of the Company.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;On
May 20, 2024, the Company entered into an amendment to the Asset Purchase agreement (&#x201c;Asset Purchase&#x201d;) with InjectEZ,
LLC (&#x201c;Seller&#x201d;) for the purchase of certain assets for $&lt;span id="xdx_907_eus-gaap--PaymentsToAcquireProductiveAssets_pn6n6_c20240519__20240520__us-gaap--TypeOfArrangementAxis__custom--AssetPurchaseAgreementMember__us-gaap--AssetAcquisitionAxis__custom--InjectEZLLCMember_zitcZPZRZTKf" title="Payments to acquire assets"&gt;35&lt;/span&gt;M.
In connection with the Asset Purchase agreement the Company paid a non-refundable deposit of $&lt;span id="xdx_907_eus-gaap--EscrowDeposit_iI_pn6n6_c20240520__us-gaap--TypeOfArrangementAxis__custom--AssetPurchaseAgreementMember__us-gaap--AssetAcquisitionAxis__custom--InjectEZLLCMember_zr4bvle1Pyp1" title="Escrow deposit"&gt;1&lt;/span&gt;M
to be held in escrow under an agreeable escrow agreement as a deposit on the purchase price. The Asset Purchase agreement stipulated
that the $&lt;span id="xdx_907_eus-gaap--EscrowDeposit_iI_pn6n6_c20240520__us-gaap--TypeOfArrangementAxis__custom--AssetPurchaseAgreementMember__us-gaap--AssetAcquisitionAxis__custom--InjectEZLLCMember_zfUYDMCb6Idc" title="Escrow deposit"&gt;1&lt;/span&gt;M
deposit would be maintained until July 19, 2024, at which date, if the contemplated transaction was not consummated, through no
fault of the Seller, the escrow would be released to the Seller by the escrow agent. The escrow deposit of $&lt;span id="xdx_907_eus-gaap--EscrowDepositDisbursementsRelatedToPropertyAcquisition1_c20240101__20240930__us-gaap--TypeOfArrangementAxis__custom--AssetPurchaseAgreementMember__us-gaap--AssetAcquisitionAxis__custom--InjectEZLLCMember_zGkdffamh7W6" title="Escrow deposit disbursements related to property acquisition"&gt;1,000,000&lt;/span&gt;
was released to the Seller and recorded a forfeited agreement cost in Other Expenses in the nine months ended September 30, 2024.
The Company and Seller are currently working towards a further amendment of the Asset Purchase Agreement. To the extent a further
amendment is executed, the closing of the Asset Purchase Agreement will be contingent on obtaining the necessary financing and there can
be no assurance that the closing of the asset sale will occur.&lt;/span&gt;&lt;/p&gt;

</us-gaap:CommitmentsAndContingenciesDisclosureTextBlock>
    <us-gaap:LossContingencyDamagesSoughtValue
      contextRef="From2024-07-102024-07-10_custom_BerlerMember"
      decimals="0"
      id="Fact002951"
      unitRef="USD">456000</us-gaap:LossContingencyDamagesSoughtValue>
    <us-gaap:LossContingencyDamagesSought
      contextRef="From2024-07-102024-07-10_custom_BerlerMember"
      id="Fact002953">(1) failure to make full
payment of certain monthly payments under his consulting agreement with the Company (the &#x201c;Consulting Agreement&#x201d;) in the amount
of $52,500, (2) failure to pay a bonus with a target of $216,000 under the Consulting Agreement, (3) $187,500, representing 50% of the
severance payment paid by the Company to Mr. Blackman, the Company&#x2019;s co-founder and former Chief Operating Officer and Co-Chairman
and a declaration and injunctive relief establishing that Berler is the rightful owner of 50% of the Company&#x2019;s Series A Preferred
Stock (which preferred stock is no longer outstanding).</us-gaap:LossContingencyDamagesSought>
    <us-gaap:LossContingencyDamagesSoughtValue
      contextRef="From2024-06-172024-06-17_custom_BerlerMember"
      decimals="0"
      id="Fact002955"
      unitRef="USD">500000</us-gaap:LossContingencyDamagesSoughtValue>
    <us-gaap:LossContingencyDamagesSoughtValue
      contextRef="From2024-04-032024-04-03_custom_PlastomoldMember"
      decimals="-3"
      id="Fact002957"
      unitRef="USD">1762000</us-gaap:LossContingencyDamagesSoughtValue>
    <us-gaap:LossContingencyDamagesSought
      contextRef="From2024-04-032024-04-03_custom_PlastomoldMember"
      id="Fact002959">(1) failure to pay invoices, of which approximately $1 million would relate to
a maintenance agreement for units allegedly manufactured and sold using machinery that was defective and has never successfully produced
any saleable products, (2) breach of the implied covenant of good faith and fair dealing, (3) unjust enrichment, and (4) conversion.
Plastomold asserts it provided certain products and services to the Company for which its invoices were not fully paid. The Company believes
that Plastomold&#x2019;s claims are without merit and intends to defend itself vigorously.</us-gaap:LossContingencyDamagesSought>
    <us-gaap:SalariesAndWages
      contextRef="From2022-07-302022-08-01_custom_EmploymentAgreementMember_custom_AlanBlackmanMember"
      decimals="0"
      id="Fact002961"
      unitRef="USD">256000</us-gaap:SalariesAndWages>
    <us-gaap:SalariesAndWages
      contextRef="From2022-08-312022-09-01_custom_EmploymentAgreementMember_custom_AlanBlackmanMember"
      decimals="0"
      id="Fact002963"
      unitRef="USD">320000</us-gaap:SalariesAndWages>
    <us-gaap:AccruedBonusesCurrentAndNoncurrent
      contextRef="AsOf2022-09-30_custom_EmploymentAgreementMember_custom_AlanBlackmanMember"
      decimals="0"
      id="Fact002965"
      unitRef="USD">250000</us-gaap:AccruedBonusesCurrentAndNoncurrent>
    <STSS:PaymentForBonuses
      contextRef="From2023-01-012023-03-31_custom_EmploymentAgreementMember_custom_AlanBlackmanMember"
      decimals="0"
      id="Fact002967"
      unitRef="USD">65000</STSS:PaymentForBonuses>
    <us-gaap:SeveranceCosts1
      contextRef="From2023-07-012023-08-14_custom_AlanBlackmanMember"
      decimals="0"
      id="Fact002969"
      unitRef="USD">346000</us-gaap:SeveranceCosts1>
    <STSS:MedicalBenefitsCost
      contextRef="AsOf2023-06-30_custom_AlanBlackmanMember"
      decimals="0"
      id="Fact002971"
      unitRef="USD">29000</STSS:MedicalBenefitsCost>
    <us-gaap:ShareBasedCompensation
      contextRef="From2023-01-012023-12-31_custom_AlanBlackmanMember"
      decimals="0"
      id="Fact002973"
      unitRef="USD">60000</us-gaap:ShareBasedCompensation>
    <us-gaap:PaymentsToAcquireProductiveAssets
      contextRef="From2024-05-192024-05-20_custom_AssetPurchaseAgreementMember_custom_InjectEZLLCMember"
      decimals="-6"
      id="Fact002975"
      unitRef="USD">35000000</us-gaap:PaymentsToAcquireProductiveAssets>
    <us-gaap:EscrowDeposit
      contextRef="AsOf2024-05-20_custom_AssetPurchaseAgreementMember_custom_InjectEZLLCMember"
      decimals="-6"
      id="Fact002977"
      unitRef="USD">1000000</us-gaap:EscrowDeposit>
    <us-gaap:EscrowDeposit
      contextRef="AsOf2024-05-20_custom_AssetPurchaseAgreementMember_custom_InjectEZLLCMember"
      decimals="-6"
      id="Fact002979"
      unitRef="USD">1000000</us-gaap:EscrowDeposit>
    <us-gaap:EscrowDepositDisbursementsRelatedToPropertyAcquisition1
      contextRef="From2024-01-012024-09-30_custom_AssetPurchaseAgreementMember_custom_InjectEZLLCMember"
      decimals="0"
      id="Fact002981"
      unitRef="USD">1000000</us-gaap:EscrowDepositDisbursementsRelatedToPropertyAcquisition1>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>103
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.4</span><table class="report" border="0" cellspacing="2" id="idm45095370495344">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Cover<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressesLineItems', window );"><strong>Entity Addresses [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="text">S-1/A<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">true<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_AmendmentDescription', window );">Amendment Description</a></td>
<td class="text">AMENDMENT NO. 1<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
<td class="text">Sharps
Technology, Inc.<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
<td class="text">0001737995<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityTaxIdentificationNumber', window );">Entity Tax Identification Number</a></td>
<td class="text">82-3751728<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityIncorporationStateCountryCode', window );">Entity Incorporation, State or Country Code</a></td>
<td class="text">NV<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressAddressLine1', window );">Entity Address, Address Line One</a></td>
<td class="text">105
Maxess Road<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressAddressLine2', window );">Entity Address, Address Line Two</a></td>
<td class="text">Ste. 124<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressCityOrTown', window );">Entity Address, City or Town</a></td>
<td class="text">Melville<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressStateOrProvince', window );">Entity Address, State or Province</a></td>
<td class="text">NY<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressPostalZipCode', window );">Entity Address, Postal Zip Code</a></td>
<td class="text">11747<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_CityAreaCode', window );">City Area Code</a></td>
<td class="text">(631)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_LocalPhoneNumber', window );">Local Phone Number</a></td>
<td class="text">574 -4436<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityFilerCategory', window );">Entity Filer Category</a></td>
<td class="text">Non-accelerated Filer<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntitySmallBusiness', window );">Entity Small Business</a></td>
<td class="text">true<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityEmergingGrowthCompany', window );">Entity Emerging Growth Company</a></td>
<td class="text">true<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityExTransitionPeriod', window );">Elected Not To Use the Extended Transition Period</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressesAddressTypeAxis=dei_BusinessContactMember', window );">Business Contact [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressesLineItems', window );"><strong>Entity Addresses [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressAddressLine1', window );">Entity Address, Address Line One</a></td>
<td class="text">105
Maxess Road<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressAddressLine2', window );">Entity Address, Address Line Two</a></td>
<td class="text">Ste. 124<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressCityOrTown', window );">Entity Address, City or Town</a></td>
<td class="text">Melville<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressStateOrProvince', window );">Entity Address, State or Province</a></td>
<td class="text">NY<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressPostalZipCode', window );">Entity Address, Postal Zip Code</a></td>
<td class="text">11747<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_CityAreaCode', window );">City Area Code</a></td>
<td class="text">(631)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_LocalPhoneNumber', window );">Local Phone Number</a></td>
<td class="text">574 -4436<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_ContactPersonnelName', window );">Contact Personnel Name</a></td>
<td class="text">Robert
M. Hayes<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentDescription">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Description of changes contained within amended document.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentDescription</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CityAreaCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Area code of city</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CityAreaCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_ContactPersonnelName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Name of contact personnel</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_ContactPersonnelName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Address Line 1 such as Attn, Building Name, Street Name</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine2">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Address Line 2 such as Street or Suite number</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine2</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCityOrTown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Name of the City or Town</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCityOrTown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressPostalZipCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Code for the postal or zip code</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressPostalZipCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressStateOrProvince">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Name of the state or province.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressStateOrProvince</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:stateOrProvinceItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressesLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressesLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityEmergingGrowthCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate if registrant meets the emerging growth company criteria.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityEmergingGrowthCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityExTransitionPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate if an emerging growth company has elected not to use the extended transition period for complying with any new or revised financial accounting standards.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 7A<br> -Section B<br> -Subsection 2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityExTransitionPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFilerCategory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFilerCategory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:filerCategoryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityIncorporationStateCountryCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Two-character EDGAR code representing the state or country of incorporation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityIncorporationStateCountryCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarStateCountryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntitySmallBusiness">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicates that the company is a Smaller Reporting Company (SRC).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntitySmallBusiness</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityTaxIdentificationNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityTaxIdentificationNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:employerIdItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LocalPhoneNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Local phone number for entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LocalPhoneNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressesAddressTypeAxis=dei_BusinessContactMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressesAddressTypeAxis=dei_BusinessContactMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>104
<FILENAME>R2.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.4</span><table class="report" border="0" cellspacing="2" id="idm45095358080240">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Condensed Consolidated Balance Sheets - USD ($)<br></strong></div></th>
<th class="th"><div>Sep. 30, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsCurrentAbstract', window );"><strong>Current Assets</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsAtCarryingValue', window );">Cash</a></td>
<td class="nump">$ 2,473,197<span></span>
</td>
<td class="nump">$ 3,012,908<span></span>
</td>
<td class="nump">$ 4,170,897<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PrepaidExpenseAndOtherAssetsCurrent', window );">Prepaid expenses and other current assets</a></td>
<td class="nump">161,337<span></span>
</td>
<td class="nump">116,508<span></span>
</td>
<td class="nump">66,749<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InventoryNet', window );">Inventories, net (Note 3)</a></td>
<td class="nump">2,019,481<span></span>
</td>
<td class="nump">1,709,135<span></span>
</td>
<td class="nump">185,804<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsCurrent', window );">Current Assets</a></td>
<td class="nump">4,654,015<span></span>
</td>
<td class="nump">4,838,551<span></span>
</td>
<td class="nump">4,423,450<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentNet', window );">Fixed Assets, net of accumulated depreciation (Notes 4 and 5)</a></td>
<td class="nump">6,233,595<span></span>
</td>
<td class="nump">6,822,142<span></span>
</td>
<td class="nump">7,004,890<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherAssetsNoncurrent', window );">Other Assets (Notes 6 and 7)</a></td>
<td class="nump">366,288<span></span>
</td>
<td class="nump">128,575<span></span>
</td>
<td class="nump">411,316<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Assets', window );">TOTAL ASSETS</a></td>
<td class="nump">11,253,898<span></span>
</td>
<td class="nump">11,789,268<span></span>
</td>
<td class="nump">11,839,656<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesCurrentAbstract', window );"><strong>Current Liabilities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountsPayableCurrent', window );">Accounts payable</a></td>
<td class="nump">945,625<span></span>
</td>
<td class="nump">794,107<span></span>
</td>
<td class="nump">543,226<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountsPayableAndOtherAccruedLiabilitiesCurrent', window );">Accrued and other current liabilities (Notes 13 and 15)</a></td>
<td class="nump">279,326<span></span>
</td>
<td class="nump">476,090<span></span>
</td>
<td class="nump">311,458<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NotesPayableCurrent', window );">Notes Payable (Note 7)</a></td>
<td class="nump">2,334,142<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_STSS_WarrantLiabilitiesCurrent', window );">Warrant liability (Notes 8 and 10)</a></td>
<td class="nump">1,027,102<span></span>
</td>
<td class="nump">2,422,785<span></span>
</td>
<td class="nump">1,151,838<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesCurrent', window );">Total Current Liabilities</a></td>
<td class="nump">4,586,195<span></span>
</td>
<td class="nump">3,692,982<span></span>
</td>
<td class="nump">2,006,522<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredIncomeTaxLiabilitiesNet', window );">Deferred Tax Liability</a></td>
<td class="nump">162,000<span></span>
</td>
<td class="nump">162,000<span></span>
</td>
<td class="nump">192,000<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Liabilities', window );">Total Liabilities</a></td>
<td class="nump">4,748,195<span></span>
</td>
<td class="nump">3,854,982<span></span>
</td>
<td class="nump">2,198,522<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingencies', window );">Commitments and Contingencies (Note 15)</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_STSS_SubsequentEvents', window );">Subsequent Events (Note 16)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityAbstract', window );"><strong>Stockholders&#8217; Equity:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockValue', window );">Preferred stock, $.0001 par value; 1,000,000 shares authorized; 0 shares issued and outstanding (2023: 1)</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockValue', window );">Common stock, $.0001 par value; 500,000,000, shares authorized; (100,000,000 in 2023), 1,694,110 shares issued and outstanding (2023: 694,294)</a></td>
<td class="nump">170<span></span>
</td>
<td class="nump">69<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_STSS_CommonStockReverseSplitValue', window );">Common stock, $.0001 par value; 100,000,000, shares authorized; 15,274,457 shares issued and outstanding and (2022: 9,407,415)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,528<span></span>
</td>
<td class="nump">941<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdditionalPaidInCapital', window );">Additional paid-in capital</a></td>
<td class="nump">35,941,738<span></span>
</td>
<td class="nump">32,491,409<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax', window );">Accumulated other comprehensive income</a></td>
<td class="nump">482,572<span></span>
</td>
<td class="nump">591,812<span></span>
</td>
<td class="nump">214,253<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RetainedEarningsAccumulatedDeficit', window );">Accumulated deficit</a></td>
<td class="num">(29,918,777)<span></span>
</td>
<td class="num">(25,149,004)<span></span>
</td>
<td class="num">(15,307,366)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Total Stockholders&#8217; Equity</a></td>
<td class="nump">6,505,703<span></span>
</td>
<td class="nump">7,934,286<span></span>
</td>
<td class="nump">9,641,134<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesAndStockholdersEquity', window );">TOTAL LIABILITIES AND STOCKHOLDERS&#8217; EQUITY</a></td>
<td class="nump">$ 11,253,898<span></span>
</td>
<td class="nump">11,789,268<span></span>
</td>
<td class="nump">11,839,656<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=STSS_ReverseStockSplitMember', window );">Reverse Stock Split [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityAbstract', window );"><strong>Stockholders&#8217; Equity:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdditionalPaidInCapital', window );">Additional paid-in capital</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">32,489,950<span></span>
</td>
<td class="nump">$ 24,733,306<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Total Stockholders&#8217; Equity</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 7,934,286<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_STSS_CommonStockReverseSplitValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Common stock reverse split value.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">STSS_CommonStockReverseSplitValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>STSS_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_STSS_SubsequentEvents">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Subsequent events.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">STSS_SubsequentEvents</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>STSS_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_STSS_WarrantLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Warrant liabilities current.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">STSS_WarrantLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>STSS_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsPayableAndOtherAccruedLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities incurred to vendors for goods and services received, and accrued liabilities classified as other, payable within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsPayableAndOtherAccruedLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsPayableCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(19)(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481372/852-10-55-10<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsPayableCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after tax, of accumulated increase (decrease) in equity from transaction and other event and circumstance from nonowner source.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14A<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-14A<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-11<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480016/944-40-65-2<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480016/944-40-65-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(23)(a)(3))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478777/944-210-S99-1<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-14<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdditionalPaidInCapital">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of excess of issue price over par or stated value of stock and from other transaction involving stock or stockholder. Includes, but is not limited to, additional paid-in capital (APIC) for common and preferred stock.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481372/852-10-55-10<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(18))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdditionalPaidInCapital</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Assets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of asset recognized for present right to economic benefit.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 48<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-48<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 49<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-49<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 270<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482964/270-10-50-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (ee)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-22<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481203/810-10-50-3<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481231/810-10-45-25<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481687/323-10-50-3<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-28<br><br>Reference 12: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481372/852-10-55-10<br><br>Reference 13: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479168/946-830-55-12<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(12))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478777/944-210-S99-1<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(8))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-1<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(18))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 18: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 19: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 28: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481404/852-10-50-7<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-30<br><br>Reference 30: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(11))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478546/942-210-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Assets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of asset recognized for present right to economic benefit, classified as current.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481203/810-10-50-3<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481231/810-10-45-25<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481687/323-10-50-3<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-28<br><br>Reference 6: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481372/852-10-55-10<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483467/210-10-45-1<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(9))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 10: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 11: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 20: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481404/852-10-50-7<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsCurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsCurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsAtCarryingValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483467/210-10-45-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-4<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsAtCarryingValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingencies">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Represents the caption on the face of the balance sheet to indicate that the entity has entered into (1) purchase or supply arrangements that will require expending a portion of its resources to meet the terms thereof, and (2) is exposed to potential losses or, less frequently, gains, arising from (a) possible claims against a company's resources due to future performance under contract terms, and (b) possible losses or likely gains from uncertainties that will ultimately be resolved when one or more future events that are deemed likely to occur do occur or fail to occur.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(17))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478546/942-210-S99-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(25))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(19))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478777/944-210-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(15))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingencies</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481372/852-10-55-10<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(22))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478777/944-210-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredIncomeTaxLiabilitiesNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after deferred tax asset, of deferred tax liability attributable to taxable differences with jurisdictional netting.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(15)(b)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478777/944-210-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482525/740-10-45-4<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482525/740-10-45-6<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredIncomeTaxLiabilitiesNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after valuation and LIFO reserves of inventory expected to be sold, or consumed within one year or operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481372/852-10-55-10<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483467/210-10-45-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Liabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of liability recognized for present obligation requiring transfer or otherwise providing economic benefit to others.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -SubTopic 10<br> -Topic 210<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(20))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(24))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(19))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(25))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(26))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(23))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(21))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481203/810-10-50-3<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481231/810-10-45-25<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481203/810-10-50-3<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481687/323-10-50-3<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-28<br><br>Reference 15: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479168/946-830-55-12<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(14))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-1<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 18: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 27: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481404/852-10-50-7<br><br>Reference 28: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481404/852-10-50-7<br><br>Reference 29: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-30<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Liabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesAndStockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481372/852-10-55-10<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(25))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478777/944-210-S99-1<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481687/323-10-50-3<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-28<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(23))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478546/942-210-S99-1<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(32))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesAndStockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(21))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481203/810-10-50-3<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481231/810-10-45-25<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481203/810-10-50-3<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481687/323-10-50-3<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-28<br><br>Reference 8: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481372/852-10-55-10<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 5<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483467/210-10-45-5<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 11: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 20: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481404/852-10-50-7<br><br>Reference 21: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481404/852-10-50-7<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesCurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesCurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NotesPayableCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying values as of the balance sheet date of the portions of long-term notes payable due within one year or the operating cycle if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(20))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(19))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NotesPayableCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherAssetsNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of noncurrent assets classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(17))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherAssetsNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregate par or stated value of issued nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable preferred shares, par value and other disclosure concepts are in another section within stockholders' equity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481372/852-10-55-10<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(21))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478777/944-210-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PrepaidExpenseAndOtherAssetsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of asset related to consideration paid in advance for costs that provide economic benefits in future periods, and amount of other assets that are expected to be realized or consumed within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(9))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PrepaidExpenseAndOtherAssetsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -SubTopic 10<br> -Topic 360<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482099/360-10-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7A<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478964/842-20-50-7A<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481372/852-10-55-10<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(8))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478777/944-210-S99-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 360<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478451/942-360-50-1<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RetainedEarningsAccumulatedDeficit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of accumulated undistributed earnings (deficit).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(3))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481372/852-10-55-10<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480016/944-40-65-2<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480016/944-40-65-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480990/946-20-50-11<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(23)(a)(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478777/944-210-S99-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(17))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-1<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480008/505-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RetainedEarningsAccumulatedDeficit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of equity (deficit) attributable to parent. Excludes temporary equity and equity attributable to noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(31))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481372/852-10-55-10<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479168/946-830-55-12<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(19))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.6-05(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-2<br><br>Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(4)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(6))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(7))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br><br>Reference 11: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 12: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481687/323-10-50-3<br><br>Reference 13: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-28<br><br>Reference 14: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 310<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 4.E)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480418/310-10-S99-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=STSS_ReverseStockSplitMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=STSS_ReverseStockSplitMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>105
<FILENAME>R3.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.4</span><table class="report" border="0" cellspacing="2" id="idm45095368827872">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Condensed Consolidated Balance Sheets (Parenthetical) - $ / shares<br></strong></div></th>
<th class="th"><div>Sep. 30, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockParOrStatedValuePerShare', window );">Preferred stock, par value</a></td>
<td class="nump">$ 0.0001<span></span>
</td>
<td class="nump">$ 0.0001<span></span>
</td>
<td class="nump">$ 0.0001<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockSharesAuthorized', window );">Preferred stock, shares authorized</a></td>
<td class="nump">1,000,000<span></span>
</td>
<td class="nump">1,000,000<span></span>
</td>
<td class="nump">1,000,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockSharesIssued', window );">Preferred stock, shares issued</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">1<span></span>
</td>
<td class="nump">1<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockSharesOutstanding', window );">Preferred stock, shares outstanding</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">1<span></span>
</td>
<td class="nump">1<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockParOrStatedValuePerShare', window );">Common stock, par value</a></td>
<td class="nump">$ 0.0001<span></span>
</td>
<td class="nump">$ 0.0001<span></span>
</td>
<td class="nump">$ 0.0001<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesAuthorized', window );">Common stock, shares authorized</a></td>
<td class="nump">500,000,000<span></span>
</td>
<td class="nump">100,000,000<span></span>
</td>
<td class="nump">100,000,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesIssued', window );">Common stock, shares issued</a></td>
<td class="nump">1,694,110<span></span>
</td>
<td class="nump">694,294<span></span>
</td>
<td class="nump">9,407,415<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Common stock, shares outstanding</a></td>
<td class="nump">1,694,110<span></span>
</td>
<td class="nump">694,294<span></span>
</td>
<td class="nump">9,407,415<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=STSS_ReverseStockSplitMember', window );">Reverse Stock Split [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesIssued', window );">Common stock, shares issued</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">15,274,457<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Common stock, shares outstanding</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">15,274,457<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockParOrStatedValuePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Face amount or stated value per share of common stock.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockParOrStatedValuePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The maximum number of common shares permitted to be issued by an entity's charter and bylaws.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(16)(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 505<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-2<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.6-05(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-2<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(4)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(16)(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-1<br><br>Reference 6: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(7))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockParOrStatedValuePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Face amount or stated value per share of preferred stock nonredeemable or redeemable solely at the option of the issuer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-13<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockParOrStatedValuePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The maximum number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) permitted to be issued by an entity's charter and bylaws.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(16)(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockSharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares issued for nonredeemable preferred shares and preferred shares redeemable solely at option of issuer. Includes, but is not limited to, preferred shares issued, repurchased, and held as treasury shares. Excludes preferred shares classified as debt.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-13<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockSharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregate share number for all nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer) held by stockholders. Does not include preferred shares that have been repurchased.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.6-05(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-2<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(4)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(16)(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-1<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(7))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 35<br> -Paragraph 1D<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480483/718-10-35-1D<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 35<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480483/718-10-35-3<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(01)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(02)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(03)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(04)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(01)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(02)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(03)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(iii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(iv)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(v)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=STSS_ReverseStockSplitMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=STSS_ReverseStockSplitMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>106
<FILENAME>R4.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.4</span><table class="report" border="0" cellspacing="2" id="idm45095246720240">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Condensed Consolidated Statements of Operations - USD ($)<br></strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">9 Months Ended</th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2024</div></th>
<th class="th"><div>Sep. 30, 2023</div></th>
<th class="th"><div>Sep. 30, 2024</div></th>
<th class="th"><div>Sep. 30, 2023</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeStatementAbstract', window );"><strong>Income Statement [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Revenue, net</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingExpensesAbstract', window );"><strong>Operating expenses:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ResearchAndDevelopmentExpense', window );">Research and development</a></td>
<td class="nump">145,611<span></span>
</td>
<td class="nump">225,191<span></span>
</td>
<td class="nump">523,347<span></span>
</td>
<td class="nump">783,340<span></span>
</td>
<td class="nump">1,605,547<span></span>
</td>
<td class="nump">2,280,933<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GeneralAndAdministrativeExpense', window );">General and administrative</a></td>
<td class="nump">1,869,598<span></span>
</td>
<td class="nump">2,133,167<span></span>
</td>
<td class="nump">5,257,015<span></span>
</td>
<td class="nump">6,425,154<span></span>
</td>
<td class="nump">8,521,103<span></span>
</td>
<td class="nump">6,457,860<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingExpenses', window );">Total operating expenses</a></td>
<td class="nump">2,015,209<span></span>
</td>
<td class="nump">2,358,358<span></span>
</td>
<td class="nump">5,780,362<span></span>
</td>
<td class="nump">7,208,494<span></span>
</td>
<td class="num">(10,126,650)<span></span>
</td>
<td class="num">(8,738,793)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingIncomeLoss', window );">Loss from operations</a></td>
<td class="num">(2,015,209)<span></span>
</td>
<td class="num">(2,358,358)<span></span>
</td>
<td class="num">(5,780,362)<span></span>
</td>
<td class="num">(7,208,494)<span></span>
</td>
<td class="num">(10,126,650)<span></span>
</td>
<td class="num">(8,738,793)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NonoperatingIncomeExpenseAbstract', window );"><strong>Other income (expense)</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InterestIncomeExpenseNet', window );">Interest income (expense)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">138,118<span></span>
</td>
<td class="num">(1,320,416)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherNonoperatingIncomeExpense', window );">Other (expense) income (Note 15)</a></td>
<td class="num">(70,905)<span></span>
</td>
<td class="nump">17,620<span></span>
</td>
<td class="num">(1,046,593)<span></span>
</td>
<td class="nump">94,492<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_STSS_FairMarketValueAdjustmentForContingentStockAndWarrants', window );">FMV adjustment on contingent stock &amp; warrants</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">169,583<span></span>
</td>
<td class="nump">5,392,911<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GainLossOnSaleOfDerivatives', window );">FMV adjustment warrants</a></td>
<td class="nump">416,560<span></span>
</td>
<td class="nump">321,981<span></span>
</td>
<td class="nump">2,088,747<span></span>
</td>
<td class="nump">415,958<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_STSS_FairMarketValueAdjustmentForContingentWarrantsAndWarrants', window );">FMV adjustment warrants (Note 10)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">169,583<span></span>
</td>
<td class="nump">5,211,911<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_STSS_ForeignCurrencyAndNonOperatingIncomeExpenses', window );">Foreign currency</a></td>
<td class="num">(15,506)<span></span>
</td>
<td class="num">(3,587)<span></span>
</td>
<td class="num">(31,566)<span></span>
</td>
<td class="num">(41,955)<span></span>
</td>
<td class="num">(52,689)<span></span>
</td>
<td class="nump">26,636<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NonoperatingIncomeExpense', window );">Total other income (expense)</a></td>
<td class="nump">330,149<span></span>
</td>
<td class="nump">336,014<span></span>
</td>
<td class="nump">1,010,588<span></span>
</td>
<td class="nump">468,495<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest', window );">Net loss Before Provision for Taxes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(9,871,638)<span></span>
</td>
<td class="num">(4,639,662)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredIncomeTaxExpenseBenefit', window );">Deferred Tax Benefit</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">30,000<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net Loss</a></td>
<td class="num">$ (1,685,060)<span></span>
</td>
<td class="num">$ (2,022,344)<span></span>
</td>
<td class="num">$ (4,769,774)<span></span>
</td>
<td class="num">$ (6,739,999)<span></span>
</td>
<td class="num">$ (9,841,638)<span></span>
</td>
<td class="num">$ (4,639,662)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareBasic', window );">Net loss per share, basic</a></td>
<td class="num">$ (1.27)<span></span>
</td>
<td class="num">$ (3.77)<span></span>
</td>
<td class="num">$ (4.53)<span></span>
</td>
<td class="num">$ (13.01)<span></span>
</td>
<td class="num">$ (0.76)<span></span>
</td>
<td class="num">$ (0.57)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareDiluted', window );">Net loss per share, diluted</a></td>
<td class="num">$ (1.27)<span></span>
</td>
<td class="num">$ (3.77)<span></span>
</td>
<td class="num">$ (4.53)<span></span>
</td>
<td class="num">$ (13.01)<span></span>
</td>
<td class="num">$ (0.76)<span></span>
</td>
<td class="num">$ (0.57)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic', window );">Weighted average shares used to compute net loss per share, basic</a></td>
<td class="nump">1,331,891<span></span>
</td>
<td class="nump">536,886<span></span>
</td>
<td class="nump">1,053,259<span></span>
</td>
<td class="nump">518,166<span></span>
</td>
<td class="nump">13,032,717<span></span>
</td>
<td class="nump">8,100,410<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding', window );">Weighted average shares used to compute net loss per share, diluted</a></td>
<td class="nump">1,331,891<span></span>
</td>
<td class="nump">536,886<span></span>
</td>
<td class="nump">1,053,259<span></span>
</td>
<td class="nump">518,166<span></span>
</td>
<td class="nump">13,032,717<span></span>
</td>
<td class="nump">8,100,410<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_STSS_FairMarketValueAdjustmentForContingentStockAndWarrants">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair market value adjustment for contingent stock and warrants.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">STSS_FairMarketValueAdjustmentForContingentStockAndWarrants</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>STSS_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_STSS_FairMarketValueAdjustmentForContingentWarrantsAndWarrants">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair market valuea djustment for Contingent Warrants and Warrants.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">STSS_FairMarketValueAdjustmentForContingentWarrantsAndWarrants</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>STSS_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_STSS_ForeignCurrencyAndNonOperatingIncomeExpenses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Foreign currency and non operating income expenses.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">STSS_ForeignCurrencyAndNonOperatingIncomeExpenses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>STSS_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredIncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred income tax expense (benefit) pertaining to income (loss) from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(1)(Note 1))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (b)<br> -SubTopic 10<br> -Topic 740<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-9<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredIncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-6<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 52<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482635/260-10-55-52<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 60<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (g)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476176/805-60-65-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 323<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478666/740-323-65-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-3<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 15<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482635/260-10-55-15<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(4)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480175/815-40-65-1<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480175/815-40-65-1<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-7<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-2<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-60B<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-4<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482662/260-10-50-1<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-10<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478524/942-220-S99-1<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477250/944-220-S99-1<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-7<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareDiluted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-6<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 52<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482635/260-10-55-52<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 60<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (g)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476176/805-60-65-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 323<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478666/740-323-65-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-3<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 15<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482635/260-10-55-15<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(4)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480175/815-40-65-1<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480175/815-40-65-1<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-7<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-2<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-60B<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-4<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482662/260-10-50-1<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478524/942-220-S99-1<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477250/944-220-S99-1<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-7<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareDiluted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GainLossOnSaleOfDerivatives">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The difference between the book value and the sale price of options, swaps, futures, forward contracts, and other derivative instruments. This element refers to the gain (loss) included in earnings.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(13)(h))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478524/942-220-S99-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(7)(a)(7))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(7)(a)(3))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(7)(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-1<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(7)(a)(6))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GainLossOnSaleOfDerivatives</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GeneralAndAdministrativeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate total of expenses of managing and administering the affairs of an entity, including affiliates of the reporting entity, which are not directly or indirectly associated with the manufacture, sale or creation of a product or product line.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(2)(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GeneralAndAdministrativeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-22<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 48<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-48<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-30<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 270<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482964/270-10-50-1<br><br>Reference 6: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (ee)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(11))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477250/944-220-S99-1<br><br>Reference 9: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 31<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-31<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 235<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477314/942-235-S99-1<br><br>Reference 11: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(10))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br><br>Reference 12: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(15))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478524/942-220-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestIncomeExpenseNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of interest income (expense) classified as operating.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-22<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(10))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478524/942-220-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestIncomeExpenseNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-6<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-9<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 60<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (g)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476176/805-60-65-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 323<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478666/740-323-65-2<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481687/323-10-50-3<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-28<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482765/220-10-50-6<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-3<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-1<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480175/815-40-65-1<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-8<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-4<br><br>Reference 17: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479168/946-830-55-10<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479105/946-220-45-7<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477250/944-220-S99-1<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(9))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-1<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(1)(d))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 23: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-60B<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483499/205-20-50-7<br><br>Reference 34: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-1A<br><br>Reference 36: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-1B<br><br>Reference 37: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478524/942-220-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NonoperatingIncomeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(7))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NonoperatingIncomeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NonoperatingIncomeExpenseAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NonoperatingIncomeExpenseAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingExpenses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Generally recurring costs associated with normal operations except for the portion of these expenses which can be clearly related to production and included in cost of sales or services. Includes selling, general and administrative expense.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingExpenses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingExpensesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingExpensesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The net result for the period of deducting operating expenses from operating revenues.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-22<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-30<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 270<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482964/270-10-50-1<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (ee)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 7: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 31<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-31<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherNonoperatingIncomeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of income (expense) related to nonoperating activities, classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(9))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherNonoperatingIncomeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ResearchAndDevelopmentExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of expense for research and development. Includes, but is not limited to, cost for computer software product to be sold, leased, or otherwise marketed and writeoff of research and development assets acquired in transaction other than business combination or joint venture formation or both. Excludes write-down of intangible asset acquired in business combination or from joint venture formation or both, used in research and development activity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 48<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-48<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 985<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481283/985-20-50-2<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 730<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482916/730-10-50-1<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 912<br> -SubTopic 730<br> -Name Accounting Standards Codification<br> -Section 25<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479532/912-730-25-1<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ResearchAndDevelopmentExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-41<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 270<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482964/270-10-50-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (ee)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 924<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 11.L)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479941/924-10-S99-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479806/606-10-50-5<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-30<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 42<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-42<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-22<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 40<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-40<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-22<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479806/606-10-50-4<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482662/260-10-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 16<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-16<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482662/260-10-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-10<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfSharesOutstandingBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>107
<FILENAME>R5.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.4</span><table class="report" border="0" cellspacing="2" id="idm45095372683648">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Condensed Consolidated Statements of Comprehensive Loss - USD ($)<br></strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">9 Months Ended</th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2024</div></th>
<th class="th"><div>Sep. 30, 2023</div></th>
<th class="th"><div>Sep. 30, 2024</div></th>
<th class="th"><div>Sep. 30, 2023</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeStatementAbstract', window );"><strong>Income Statement [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net loss</a></td>
<td class="num">$ (1,685,060)<span></span>
</td>
<td class="num">$ (2,022,344)<span></span>
</td>
<td class="num">$ (4,769,774)<span></span>
</td>
<td class="num">$ (6,739,999)<span></span>
</td>
<td class="num">$ (9,841,638)<span></span>
</td>
<td class="num">$ (4,639,662)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossTaxAbstract', window );"><strong>Other comprehensive income:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent', window );">Foreign currency translation adjustments gain/(loss)</a></td>
<td class="nump">130,723<span></span>
</td>
<td class="num">(283,544)<span></span>
</td>
<td class="num">(109,241)<span></span>
</td>
<td class="nump">61,314<span></span>
</td>
<td class="nump">377,559<span></span>
</td>
<td class="nump">214,253<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ComprehensiveIncomeNetOfTax', window );">Comprehensive loss</a></td>
<td class="num">$ (1,554,337)<span></span>
</td>
<td class="num">$ (2,305,888)<span></span>
</td>
<td class="num">$ (4,879,015)<span></span>
</td>
<td class="num">$ (6,678,685)<span></span>
</td>
<td class="num">$ (9,464,079)<span></span>
</td>
<td class="num">$ (4,425,409)<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ComprehensiveIncomeNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income, attributable to parent entity. Excludes changes in equity resulting from investments by owners and distributions to owners.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(24))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(26))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478524/942-220-S99-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(22))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477250/944-220-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-1A<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-1B<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(20))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477250/944-220-S99-1<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 5<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-5<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ComprehensiveIncomeNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-6<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-9<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 60<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (g)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476176/805-60-65-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 323<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478666/740-323-65-2<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481687/323-10-50-3<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-28<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482765/220-10-50-6<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-3<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-1<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480175/815-40-65-1<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-8<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-4<br><br>Reference 17: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479168/946-830-55-10<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479105/946-220-45-7<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477250/944-220-S99-1<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(9))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-1<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(1)(d))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 23: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-60B<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483499/205-20-50-7<br><br>Reference 34: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-1A<br><br>Reference 36: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-1B<br><br>Reference 37: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478524/942-220-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax and reclassification adjustments of gain (loss) on foreign currency translation adjustments, foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature, attributable to parent entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 19<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481231/810-10-45-19<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 20<br> -SubTopic 10<br> -Topic 810<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481231/810-10-45-20<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (c)(3)<br> -SubTopic 10<br> -Topic 810<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481203/810-10-50-1A<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossTaxAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossTaxAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>108
<FILENAME>R6.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.4</span><table class="report" border="0" cellspacing="2" id="idm45095324893424">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Condensed Consolidated Statement of Stockholders' Equity - USD ($)<br></strong></div></th>
<th class="th"><div>Preferred Stock [Member]</div></th>
<th class="th">
<div>Preferred Stock [Member] </div>
<div>Reverse Stock Split [Member]</div>
</th>
<th class="th">
<div>Preferred Stock [Member] </div>
<div>Reverse Stock Split [Member]</div>
</th>
<th class="th"><div>Common Stock [Member]</div></th>
<th class="th">
<div>Common Stock [Member] </div>
<div>Reverse Stock Split [Member]</div>
</th>
<th class="th">
<div>Common Stock [Member] </div>
<div>Reverse Stock Split [Member]</div>
</th>
<th class="th"><div>Common Stock Subscription Receivable [Member]</div></th>
<th class="th">
<div>Common Stock Subscription Receivable [Member] </div>
<div>Reverse Stock Split [Member]</div>
</th>
<th class="th">
<div>Common Stock Subscription Receivable [Member] </div>
<div>Reverse Stock Split [Member]</div>
</th>
<th class="th"><div>Additional Paid-in Capital [Member]</div></th>
<th class="th">
<div>Additional Paid-in Capital [Member] </div>
<div>Reverse Stock Split [Member]</div>
</th>
<th class="th">
<div>Additional Paid-in Capital [Member] </div>
<div>Reverse Stock Split [Member]</div>
</th>
<th class="th"><div>AOCI Attributable to Parent [Member]</div></th>
<th class="th">
<div>AOCI Attributable to Parent [Member] </div>
<div>Reverse Stock Split [Member]</div>
</th>
<th class="th">
<div>AOCI Attributable to Parent [Member] </div>
<div>Reverse Stock Split [Member]</div>
</th>
<th class="th"><div>Retained Earnings [Member]</div></th>
<th class="th">
<div>Retained Earnings [Member] </div>
<div>Reverse Stock Split [Member]</div>
</th>
<th class="th">
<div>Retained Earnings [Member] </div>
<div>Reverse Stock Split [Member]</div>
</th>
<th class="th"><div>Total</div></th>
<th class="th"><div>Reverse Stock Split [Member]</div></th>
<th class="th"><div>Reverse Stock Split [Member]</div></th>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Balance at Dec. 31, 2021</a></td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 519<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (32,500)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 13,835,882<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (10,667,704)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 3,136,197<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Balance, shares at Dec. 31, 2021</a></td>
<td class="nump">1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5,187,062<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net loss</a></td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(4,639,662)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(4,639,662)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_STSS_StockIssuedDuringPeriodValueInitialPublicOffering', window );">Shares issued in Initial Public Offering</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 375<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">8,974,282<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">8,974,657<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_STSS_StockIssuedDuringPeriodSharesInitialPublicOffering', window );">Shares issued in Initial Public Offering, shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,750,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_STSS_StockIssuedDuringPeriodValueContingentStockLiability', window );">Issuance of shares for contingent stock liability</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 24<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">495,976<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">496,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_STSS_StockIssuedDuringPeriodSharesContingentStockLiability', window );">Issuance of shares for contingent stock liability, shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">235,294<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue', window );">Share-based compensation charges</a></td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,136,638<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,136,638<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_STSS_StockIssuedDuringPeriodValueFractionalShareAdjustment', window );">Fractional share adjustment</a></td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_STSS_StockIssuedDuringPeriodSharesFractionalShareAdjustment', window );">Fractional share adjustment, shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">59<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueIssuedForServices', window );">Issuance of common stock for services</a></td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 23<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">290,528<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 290,551<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesIssuedForServices', window );">Issuance of common stock for services, shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">235,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">235,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax', window );">Foreign Currency Translation</a></td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">214,253<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 214,253<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_STSS_StockIssuedDuringPeriodCollectionsOfCommonStockSubscriptionsValue', window );">Collection of stock subscription</a></td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">32,500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">32,500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Balance at Dec. 31, 2022</a></td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">$ 43<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 941<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">24,734,204<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 24,733,306<span></span>
</td>
<td class="nump">214,253<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 214,253<span></span>
</td>
<td class="num">(15,307,366)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (15,307,366)<span></span>
</td>
<td class="nump">9,641,134<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 9,641,134<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Balance, shares at Dec. 31, 2022</a></td>
<td class="nump">1<span></span>
</td>
<td class="nump">1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">427,610<span></span>
</td>
<td class="nump">9,407,415<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net loss</a></td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(2,111,830)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(2,111,830)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue', window );">Share-based compensation charges</a></td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">383,100<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">383,100<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax', window );">Foreign Currency Translation</a></td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">270,983<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">270,983<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueNewIssues', window );">Shares issued in Offering</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 10<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,783,375<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,783,385<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues', window );">Shares issued in Offering, shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">102,206<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Balance at Mar. 31, 2023</a></td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 53<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">27,900,679<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">485,236<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(17,419,196)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">10,966,772<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Balance, shares at Mar. 31, 2023</a></td>
<td class="nump">1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">529,816<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Balance at Dec. 31, 2022</a></td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">$ 43<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">941<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">24,734,204<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">24,733,306<span></span>
</td>
<td class="nump">214,253<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">214,253<span></span>
</td>
<td class="num">(15,307,366)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(15,307,366)<span></span>
</td>
<td class="nump">9,641,134<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">9,641,134<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Balance, shares at Dec. 31, 2022</a></td>
<td class="nump">1<span></span>
</td>
<td class="nump">1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">427,610<span></span>
</td>
<td class="nump">9,407,415<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net loss</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(6,739,999)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Balance at Sep. 30, 2023</a></td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 69<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">32,367,297<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">275,568<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(22,047,365)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">10,595,569<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Balance, shares at Sep. 30, 2023</a></td>
<td class="nump">1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">694,294<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Balance at Dec. 31, 2022</a></td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">$ 43<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">941<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">24,734,204<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">24,733,306<span></span>
</td>
<td class="nump">214,253<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">214,253<span></span>
</td>
<td class="num">(15,307,366)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(15,307,366)<span></span>
</td>
<td class="nump">9,641,134<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">9,641,134<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Balance, shares at Dec. 31, 2022</a></td>
<td class="nump">1<span></span>
</td>
<td class="nump">1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">427,610<span></span>
</td>
<td class="nump">9,407,415<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net loss</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (9,841,638)<span></span>
</td>
<td class="num">(9,841,638)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(9,841,638)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue', window );">Share-based compensation charges</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">963,023<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">963,023<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax', window );">Foreign Currency Translation</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 377,559<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">377,559<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueNewIssues', window );">Shares issued in Offering</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">225<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,783,160<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,783,385<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues', window );">Shares issued in Offering, shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,248,521<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_STSS_StockIssuedDuringPeriodValueShelfRegistrationOffering', window );">Shelf Registration Offering &#8211; see Note 8</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 362<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,457,642<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,458,004<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_STSS_StockIssuedDuringPeriodSharesShelfRegistrationOffering', window );">Shelf Registration Offering - see Note 8, shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,618,521<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_STSS_StockIssuedDuringPeriodValuePrivatePlacement', window );">Private Placement Offering &#8211; see Note 8</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,552,819<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,552,819<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Balance at Dec. 31, 2023</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 69<span></span>
</td>
<td class="nump">$ 1,528<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">32,491,409<span></span>
</td>
<td class="nump">$ 32,489,950<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">591,812<span></span>
</td>
<td class="nump">$ 591,812<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(25,149,004)<span></span>
</td>
<td class="num">$ (25,149,004)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">7,934,286<span></span>
</td>
<td class="nump">$ 7,934,286<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Balance, shares at Dec. 31, 2023</a></td>
<td class="nump">1<span></span>
</td>
<td class="nump">1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">694,294<span></span>
</td>
<td class="nump">15,274,457<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Balance at Mar. 31, 2023</a></td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 53<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">27,900,679<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">485,236<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(17,419,196)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">10,966,772<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Balance, shares at Mar. 31, 2023</a></td>
<td class="nump">1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">529,816<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net loss</a></td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(2,605,825)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(2,605,825)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue', window );">Share-based compensation charges</a></td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">254,446<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">254,446<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax', window );">Foreign Currency Translation</a></td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">73,876<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">73,876<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Balance at Jun. 30, 2023</a></td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 53<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">28,155,125<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">559,112<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(20,025,021)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">8,689,269<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Balance, shares at Jun. 30, 2023</a></td>
<td class="nump">1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">529,816<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net loss</a></td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(2,022,344)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(2,022,344)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue', window );">Share-based compensation charges</a></td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">201,365<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">201,365<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax', window );">Foreign Currency Translation</a></td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(283,544)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(283,544)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_STSS_StockIssuedDuringPeriodValueShelfRegistrationOffering', window );">Shelf Registration Offering &#8211; see Note 8</a></td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 16<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,457,988<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,458,004<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_STSS_StockIssuedDuringPeriodSharesShelfRegistrationOffering', window );">Shelf Registration Offering - see Note 8, shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">164,478<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_STSS_StockIssuedDuringPeriodValuePrivatePlacement', window );">Private Placement Offering &#8211; see Note 8</a></td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,552,819<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,552,819<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Balance at Sep. 30, 2023</a></td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 69<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">32,367,297<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">275,568<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(22,047,365)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">10,595,569<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Balance, shares at Sep. 30, 2023</a></td>
<td class="nump">1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">694,294<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Balance at Dec. 31, 2023</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 69<span></span>
</td>
<td class="nump">$ 1,528<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">32,491,409<span></span>
</td>
<td class="nump">32,489,950<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">591,812<span></span>
</td>
<td class="nump">591,812<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(25,149,004)<span></span>
</td>
<td class="num">(25,149,004)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">7,934,286<span></span>
</td>
<td class="nump">7,934,286<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Balance, shares at Dec. 31, 2023</a></td>
<td class="nump">1<span></span>
</td>
<td class="nump">1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">694,294<span></span>
</td>
<td class="nump">15,274,457<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net loss</a></td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(982,386)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(982,386)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue', window );">Share-based compensation charges</a></td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">126,387<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">126,387<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax', window );">Foreign Currency Translation</a></td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(218,053)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(218,053)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_STSS_StockIssuedDuringPeriodValueExerciseOfPrefundedWarrants', window );">Exercise of Pre-Funded Warrants</a></td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">394<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">396<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_STSS_StockIssuedDuringPeriodSharesExerciseOfPrefundedWarrants', window );">Exercise of Pre-Funded Warrants, shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">18,020<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Balance at Mar. 31, 2024</a></td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 71<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">32,618,190<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">373,759<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(26,131,390)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">6,860,630<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Balance, shares at Mar. 31, 2024</a></td>
<td class="nump">1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">712,314<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Balance at Dec. 31, 2023</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 69<span></span>
</td>
<td class="nump">$ 1,528<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">32,491,409<span></span>
</td>
<td class="nump">$ 32,489,950<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">591,812<span></span>
</td>
<td class="nump">$ 591,812<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(25,149,004)<span></span>
</td>
<td class="num">$ (25,149,004)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">7,934,286<span></span>
</td>
<td class="nump">$ 7,934,286<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Balance, shares at Dec. 31, 2023</a></td>
<td class="nump">1<span></span>
</td>
<td class="nump">1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">694,294<span></span>
</td>
<td class="nump">15,274,457<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net loss</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(4,769,774)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Balance at Sep. 30, 2024</a></td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 170<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">35,941,738<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">482,572<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(29,918,777)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">6,505,703<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Balance, shares at Sep. 30, 2024</a></td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,694,110<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Balance at Mar. 31, 2024</a></td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 71<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">32,618,190<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">373,759<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(26,131,390)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">6,860,630<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Balance, shares at Mar. 31, 2024</a></td>
<td class="nump">1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">712,314<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net loss</a></td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(2,102,327)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(2,102,327)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue', window );">Share-based compensation charges</a></td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">201,918<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">201,918<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax', window );">Foreign Currency Translation</a></td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(21,911)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(21,911)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_STSS_StockIssuedDuringPeriodSharesExerciseOfPrefundedWarrants', window );">Exercise of Pre-Funded Warrants, shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">135,683<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_STSS_StockIssuedDuringPeriodValueExerciseOfPrefundedWarrant', window );">Exercise of Pre-Funded Warrants</a></td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 14<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,971<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,985<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_STSS_StockIssuedDuringPeriodValueRegistrationOffering', window );">Registration A Offering</a></td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 19<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,296,903<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,296,922<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_STSS_StockIssuedDuringPeriodSharesRegistrationOffering', window );">Registration A Offering, shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">190,773<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_STSS_StockIssuedDuringPeriodValueWarrantInducements', window );">Warrant Inducements</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 26<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">978,955<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">978,981<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_STSS_StockIssuedDuringPeriodSharesWarrantInducements', window );">Warrant Inducements, shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">260,799<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Balance at Jun. 30, 2024</a></td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 130<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">35,098,937<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">351,848<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(28,233,717)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">7,217,198<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Balance, shares at Jun. 30, 2024</a></td>
<td class="nump">1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,299,569<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net loss</a></td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(1,685,060)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(1,685,060)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue', window );">Share-based compensation charges</a></td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">116,193<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">116,193<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax', window );">Foreign Currency Translation</a></td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">130,723<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">130,723<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockRedeemedOrCalledDuringPeriodValue', window );">Cancellation of Preferred Share</a></td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockRedeemedOrCalledDuringPeriodShares', window );">Cancellation of Preferred Share, shares</a></td>
<td class="num">(1)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueOther', window );">Issuance of Common Stock &#8211; see Note 7</a></td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 26<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">726,324<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">726,350<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesOther', window );">Issuance of Common Stock, shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">259,091<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_STSS_StockIssuedDuringPeriodValueWarrantExericse', window );">Warrant exercise</a></td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 14<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">284<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">298<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_STSS_StockIssuedDuringPeriodSharesWarrantExericse', window );">Warrant exercise, shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">135,450<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Balance at Sep. 30, 2024</a></td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 170<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 35,941,738<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 482,572<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (29,918,777)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 6,505,703<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Balance, shares at Sep. 30, 2024</a></td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,694,110<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_STSS_StockIssuedDuringPeriodCollectionsOfCommonStockSubscriptionsValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Stock issued during period collections of common stock subscriptions value.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">STSS_StockIssuedDuringPeriodCollectionsOfCommonStockSubscriptionsValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>STSS_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_STSS_StockIssuedDuringPeriodSharesContingentStockLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Stock issued during period shares contingent stock liability.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">STSS_StockIssuedDuringPeriodSharesContingentStockLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>STSS_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_STSS_StockIssuedDuringPeriodSharesExerciseOfPrefundedWarrants">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Stock issued during period shares exercise of prefunded warrants.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">STSS_StockIssuedDuringPeriodSharesExerciseOfPrefundedWarrants</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>STSS_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_STSS_StockIssuedDuringPeriodSharesFractionalShareAdjustment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Stock issued during shares fractional share adjustment.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">STSS_StockIssuedDuringPeriodSharesFractionalShareAdjustment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>STSS_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_STSS_StockIssuedDuringPeriodSharesInitialPublicOffering">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Stock issued during period shares initial public offering.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">STSS_StockIssuedDuringPeriodSharesInitialPublicOffering</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>STSS_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_STSS_StockIssuedDuringPeriodSharesRegistrationOffering">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Stock issued during period shares registration offering.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">STSS_StockIssuedDuringPeriodSharesRegistrationOffering</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>STSS_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_STSS_StockIssuedDuringPeriodSharesShelfRegistrationOffering">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Stock issued during period shares shelf registration offering.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">STSS_StockIssuedDuringPeriodSharesShelfRegistrationOffering</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>STSS_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_STSS_StockIssuedDuringPeriodSharesWarrantExericse">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Stock issued during period shares warrant exericse.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">STSS_StockIssuedDuringPeriodSharesWarrantExericse</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>STSS_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_STSS_StockIssuedDuringPeriodSharesWarrantInducements">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Stock issued during period shares warrant inducements.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">STSS_StockIssuedDuringPeriodSharesWarrantInducements</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>STSS_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_STSS_StockIssuedDuringPeriodValueContingentStockLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Stock issued during period value contingent stock liability.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">STSS_StockIssuedDuringPeriodValueContingentStockLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>STSS_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_STSS_StockIssuedDuringPeriodValueExerciseOfPrefundedWarrant">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Stock issued during period value exercise of prefunded warrants.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">STSS_StockIssuedDuringPeriodValueExerciseOfPrefundedWarrant</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>STSS_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_STSS_StockIssuedDuringPeriodValueExerciseOfPrefundedWarrants">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Stock issued during period value exercise of prefunded warrants.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">STSS_StockIssuedDuringPeriodValueExerciseOfPrefundedWarrants</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>STSS_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_STSS_StockIssuedDuringPeriodValueFractionalShareAdjustment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Stock issued during period value fractional share adjustment.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">STSS_StockIssuedDuringPeriodValueFractionalShareAdjustment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>STSS_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_STSS_StockIssuedDuringPeriodValueInitialPublicOffering">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Stock issued during period value initial public offering.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">STSS_StockIssuedDuringPeriodValueInitialPublicOffering</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>STSS_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_STSS_StockIssuedDuringPeriodValuePrivatePlacement">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Stock issued during period value private placement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">STSS_StockIssuedDuringPeriodValuePrivatePlacement</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>STSS_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_STSS_StockIssuedDuringPeriodValueRegistrationOffering">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Stock issued during period value registration offering.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">STSS_StockIssuedDuringPeriodValueRegistrationOffering</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>STSS_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_STSS_StockIssuedDuringPeriodValueShelfRegistrationOffering">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Stock issued during period value shelf registration offering.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">STSS_StockIssuedDuringPeriodValueShelfRegistrationOffering</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>STSS_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_STSS_StockIssuedDuringPeriodValueWarrantExericse">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Stock issued during period value warrant exericse.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">STSS_StockIssuedDuringPeriodValueWarrantExericse</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>STSS_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_STSS_StockIssuedDuringPeriodValueWarrantInducements">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Stock issued during period value warrant inducements.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">STSS_StockIssuedDuringPeriodValueWarrantInducements</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>STSS_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase to additional paid-in capital (APIC) for recognition of cost for award under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 35<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480483/718-10-35-2<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 20<br> -Section 55<br> -Paragraph 13<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481089/718-20-55-13<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 20<br> -Section 55<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481089/718-20-55-12<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-6<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-9<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 60<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (g)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476176/805-60-65-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 323<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478666/740-323-65-2<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481687/323-10-50-3<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-28<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482765/220-10-50-6<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-3<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-1<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480175/815-40-65-1<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-8<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-4<br><br>Reference 17: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479168/946-830-55-10<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479105/946-220-45-7<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477250/944-220-S99-1<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(9))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-1<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(1)(d))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 23: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-60B<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483499/205-20-50-7<br><br>Reference 34: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-1A<br><br>Reference 36: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-1B<br><br>Reference 37: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478524/942-220-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of tax expense (benefit), after reclassification adjustments of gain (loss) on foreign currency translation adjustments, foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 220<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-10A<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 12<br> -SubTopic 10<br> -Topic 220<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-12<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 830<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 5<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481956/830-20-45-5<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 830<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 21<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481694/830-30-45-21<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares issued which are neither cancelled nor held in the treasury.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesIssuedForServices">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares issued in lieu of cash for services contributed to the entity. Number of shares includes, but is not limited to, shares issued for services contributed by vendors and founders.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesIssuedForServices</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of new stock issued during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 505<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-2<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 505<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478448/946-505-50-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(4)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-03(i)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479886/946-10-S99-3<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480008/505-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesNewIssues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesOther">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares of stock issued attributable to transactions classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesOther</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodValueIssuedForServices">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Value of stock issued in lieu of cash for services contributed to the entity. Value of the stock issued includes, but is not limited to, services contributed by vendors and founders.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodValueIssuedForServices</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodValueNewIssues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Equity impact of the value of new stock issued during the period. Includes shares issued in an initial public offering or a secondary public offering.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 505<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-2<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479168/946-830-55-11<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 205<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 4<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478009/946-205-45-4<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 505<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478448/946-505-50-2<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(4)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480008/505-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodValueNewIssues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodValueOther">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Value of shares of stock issued attributable to transactions classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodValueOther</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockRedeemedOrCalledDuringPeriodShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of stock bought back by the entity at the exercise price or redemption price.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 505<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockRedeemedOrCalledDuringPeriodShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockRedeemedOrCalledDuringPeriodValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Equity impact of the value of stock bought back by the entity at the exercise price or redemption price.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 505<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockRedeemedOrCalledDuringPeriodValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of equity (deficit) attributable to parent. Excludes temporary equity and equity attributable to noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(31))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481372/852-10-55-10<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479168/946-830-55-12<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(19))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.6-05(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-2<br><br>Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(4)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(6))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(7))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br><br>Reference 11: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 12: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481687/323-10-50-3<br><br>Reference 13: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-28<br><br>Reference 14: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 310<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 4.E)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480418/310-10-S99-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>109
<FILENAME>R7.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.4</span><table class="report" border="0" cellspacing="2" id="idm45095355927632">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Condensed Consolidated Statements of Cash Flows - USD ($)<br></strong></div></th>
<th class="th" colspan="2">9 Months Ended</th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2024</div></th>
<th class="th"><div>Sep. 30, 2023</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract', window );"><strong>CASH FLOWS FROM OPERATING ACTIVITIES:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net loss</a></td>
<td class="num">$ (4,769,774)<span></span>
</td>
<td class="num">$ (6,739,999)<span></span>
</td>
<td class="num">$ (9,841,638)<span></span>
</td>
<td class="num">$ (4,639,662)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract', window );"><strong>Adjustments to reconcile net loss to net cash used in operating activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DepreciationAndAmortization', window );">Depreciation and amortization</a></td>
<td class="nump">583,006<span></span>
</td>
<td class="nump">656,100<span></span>
</td>
<td class="nump">882,177<span></span>
</td>
<td class="nump">654,572<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensation', window );">Stock-based compensation</a></td>
<td class="nump">444,498<span></span>
</td>
<td class="nump">838,911<span></span>
</td>
<td class="nump">963,023<span></span>
</td>
<td class="nump">1,012,592<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IssuanceOfStockAndWarrantsForServicesOrClaims', window );">Issuance of common stock for services</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">290,551<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AmortizationOfDebtDiscountPremium', window );">Accretion of debt discount</a></td>
<td class="nump">75,192<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">1,299,985<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GainLossOnSaleOfDerivatives', window );">FMV adjustment for Warrants</a></td>
<td class="num">(2,088,747)<span></span>
</td>
<td class="num">(415,958)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AmortizationOfFinancingCosts', window );">Equity Issuance costs</a></td>
<td class="text"> <span></span>
</td>
<td class="nump">205,112<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_STSS_EscrowDepositForfeited', window );">Escrow forfeited</a></td>
<td class="nump">1,000,000<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_STSS_FairMarketValueAdjustmentForContingentWarrants', window );">FMV for adjustment for contingent stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="num">(181,000)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_STSS_FairMarketValueAdjustmentForContingentWarrantsAndWarrants', window );">FMV adjustment for Contingent warrants and warrants</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(169,583)<span></span>
</td>
<td class="num">(5,211,911)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ImpairmentOfLongLivedAssetsHeldForUse', window );">Fixed asset impairment</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">560,000<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredIncomeTaxExpenseBenefit', window );">Deferred tax benefit</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(30,000)<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_STSS_IpoIssuanceCostsRelatingToWarrants', window );">IPO issuance costs relating to warrants</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">205,112<span></span>
</td>
<td class="nump">550,433<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ForeignCurrencyTransactionGainLossBeforeTax', window );">Foreign exchange (gain)/loss</a></td>
<td class="nump">31,566<span></span>
</td>
<td class="nump">33,729<span></span>
</td>
<td class="nump">44,463<span></span>
</td>
<td class="nump">496<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract', window );"><strong>Changes in operating assets:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInPrepaidExpense', window );">Prepaid expenses and other current assets</a></td>
<td class="num">(47,233)<span></span>
</td>
<td class="num">(23,032)<span></span>
</td>
<td class="num">(82,169)<span></span>
</td>
<td class="num">(58,754)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInInventories', window );">Inventory</a></td>
<td class="num">(349,317)<span></span>
</td>
<td class="num">(1,039,152)<span></span>
</td>
<td class="num">(1,441,462)<span></span>
</td>
<td class="num">(34,109)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInOtherOperatingAssets', window );">Other assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(12,735)<span></span>
</td>
<td class="num">(12,000)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities', window );">Accounts payable and accrued liabilities</a></td>
<td class="num">(51,326)<span></span>
</td>
<td class="nump">339,352<span></span>
</td>
<td class="nump">415,512<span></span>
</td>
<td class="num">(104,352)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInOperatingActivities', window );">Net cash used in operating activities</a></td>
<td class="num">(5,172,135)<span></span>
</td>
<td class="num">(6,144,937)<span></span>
</td>
<td class="num">(8,507,300)<span></span>
</td>
<td class="num">(6,433,159)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract', window );"><strong>CASH FLOWS FROM INVESTING ACTIVITIES:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsForProceedsFromOtherInvestingActivities', window );">Acquisition of fixed assets or deposits paid</a></td>
<td class="num">(69,659)<span></span>
</td>
<td class="num">(232,295)<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="num">(209,678)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_STSS_EscrowPaymentUnderAgreement', window );">Escrow payment under agreement</a></td>
<td class="num">(1,000,000)<span></span>
</td>
<td class="num">(199,084)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment', window );">Purchase of fixed assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(698,277)<span></span>
</td>
<td class="num">(542,662)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_STSS_PaymentsToAssetAcquisition', window );">Asset acquisition</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="num">(2,365,576)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInInvestingActivities', window );">Net cash used in investing activities</a></td>
<td class="num">(1,069,659)<span></span>
</td>
<td class="num">(431,379)<span></span>
</td>
<td class="num">(698,277)<span></span>
</td>
<td class="num">(3,117,916)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract', window );"><strong>CASH FLOWS FROM FINANCING ACTIVITIES:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_STSS_NetProceedsFromInitialPublicOfferingAndAdditionalOffering', window );">Net proceeds from Initial Public Offering and additional offerings</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">8,029,628<span></span>
</td>
<td class="nump">14,202,975<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_STSS_NetProceedsFromOfferingsAndWarrantExercises', window );">Net proceeds from offerings and warrant exercises</a></td>
<td class="nump">2,972,646<span></span>
</td>
<td class="nump">8,029,628<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOfLongTermDebt', window );">Net proceeds from Debt financing</a></td>
<td class="nump">2,735,300<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RepaymentsOfNotesPayable', window );">Repayment of note payable</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="num">(2,000,000)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_STSS_ProceedsFromSubscriptionsReceivable', window );">Proceeds from subscriptions receivable</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">32,500<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInFinancingActivities', window );">Net cash provided by financing activities</a></td>
<td class="nump">5,707,946<span></span>
</td>
<td class="nump">8,029,628<span></span>
</td>
<td class="nump">8,029,628<span></span>
</td>
<td class="nump">12,235,475<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations', window );">Effect of exchange rate changes on cash</a></td>
<td class="num">(5,863)<span></span>
</td>
<td class="num">(69,792)<span></span>
</td>
<td class="nump">17,960<span></span>
</td>
<td class="nump">7,331<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect', window );">NET INCREASE (DECREASE) IN CASH</a></td>
<td class="num">(539,711)<span></span>
</td>
<td class="nump">1,383,520<span></span>
</td>
<td class="num">(1,157,989)<span></span>
</td>
<td class="nump">2,691,731<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations', window );">CASH &#8212; BEGINNING OF YEAR</a></td>
<td class="nump">3,012,908<span></span>
</td>
<td class="nump">4,170,897<span></span>
</td>
<td class="nump">4,170,897<span></span>
</td>
<td class="nump">1,479,166<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations', window );">CASH &#8212; END OF PERIOD</a></td>
<td class="nump">$ 2,473,197<span></span>
</td>
<td class="nump">$ 5,554,417<span></span>
</td>
<td class="nump">3,012,908<span></span>
</td>
<td class="nump">4,170,897<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SupplementalCashFlowInformationAbstract', window );"><strong>SUPPLEMENTAL DISCLOSURE OF CASH FLOW INFORMATION:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InterestPaidNet', window );">Cash paid for interest</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">47,111<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxesPaidNet', window );">Cash paid for taxes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NoncashInvestingAndFinancingItemsAbstract', window );"><strong>Non-cash investing and financing activity:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_STSS_FmvForCommonStockIssuedForContingentShares', window );">FMV for Common stock issued for contingent shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">496,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_STSS_FmvForWarrantsIssuedForContingentWarrants', window );">FMV for Warrants issued for contingent warrants</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">554,312<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_STSS_CommonStockIssuedAndVestedStockOptionsForFixedAssetsAcquired', window );">Common stock issued and vested stock options for fixed assets acquired</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">63,612<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_STSS_CommonStockIssuedAndVestedStockOptionsIssuedAsConsiderationForAcquisition', window );">Common stock issued and vested stock options issued as consideration for acquisition</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">$ 60,435<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_STSS_CommonStockIssuedAndVestedStockOptionsForFixedAssetsAcquired">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Common stock issued and vested stock options for fixed assets acquired.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">STSS_CommonStockIssuedAndVestedStockOptionsForFixedAssetsAcquired</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>STSS_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_STSS_CommonStockIssuedAndVestedStockOptionsIssuedAsConsiderationForAcquisition">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Common stock issued and vested stock options issued as consideration for acquisition.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">STSS_CommonStockIssuedAndVestedStockOptionsIssuedAsConsiderationForAcquisition</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>STSS_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_STSS_EscrowDepositForfeited">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Escrow deposit forfeited.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">STSS_EscrowDepositForfeited</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>STSS_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_STSS_EscrowPaymentUnderAgreement">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Escrow payment under agreement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">STSS_EscrowPaymentUnderAgreement</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>STSS_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_STSS_FairMarketValueAdjustmentForContingentWarrants">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair market value for adjustment for contingent warrants.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">STSS_FairMarketValueAdjustmentForContingentWarrants</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>STSS_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_STSS_FairMarketValueAdjustmentForContingentWarrantsAndWarrants">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair market valuea djustment for Contingent Warrants and Warrants.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">STSS_FairMarketValueAdjustmentForContingentWarrantsAndWarrants</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>STSS_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_STSS_FmvForCommonStockIssuedForContingentShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>FMV for common stock issued for cintingent shares.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">STSS_FmvForCommonStockIssuedForContingentShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>STSS_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_STSS_FmvForWarrantsIssuedForContingentWarrants">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fmv for warrants issued for contingent warrants.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">STSS_FmvForWarrantsIssuedForContingentWarrants</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>STSS_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_STSS_IpoIssuanceCostsRelatingToWarrants">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>IPO issuance cost relating to warrants.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">STSS_IpoIssuanceCostsRelatingToWarrants</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>STSS_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_STSS_NetProceedsFromInitialPublicOfferingAndAdditionalOffering">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Net proceeds from Initial Public Offering and additional offering.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">STSS_NetProceedsFromInitialPublicOfferingAndAdditionalOffering</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>STSS_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_STSS_NetProceedsFromOfferingsAndWarrantExercises">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Net proceeds from offerings and warrant exercises.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">STSS_NetProceedsFromOfferingsAndWarrantExercises</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>STSS_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_STSS_PaymentsToAssetAcquisition">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Payments to asset acquisition.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">STSS_PaymentsToAssetAcquisition</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>STSS_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_STSS_ProceedsFromSubscriptionsReceivable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Proceeds from subscriptions receivable.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">STSS_ProceedsFromSubscriptionsReceivable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>STSS_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AmortizationOfDebtDiscountPremium">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of noncash expense included in interest expense to amortize debt discount and premium associated with the related debt instruments. Excludes amortization of financing costs. Alternate captions include noncash interest expense.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(8))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1F<br> -Subparagraph (b)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1F<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 835<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482925/835-30-45-3<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AmortizationOfDebtDiscountPremium</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AmortizationOfFinancingCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization expense attributable to debt issuance costs.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(8))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1F<br> -Subparagraph (b)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1F<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 835<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482925/835-30-45-3<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AmortizationOfFinancingCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including, but not limited to, disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482913/230-10-50-8<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 24<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-24<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-4<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in cash, cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 24<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-24<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -SubTopic 230<br> -Topic 830<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477401/830-230-45-1<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredIncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred income tax expense (benefit) pertaining to income (loss) from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(1)(Note 1))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (b)<br> -SubTopic 10<br> -Topic 740<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-9<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredIncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DepreciationAndAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The current period expense charged against earnings on long-lived, physical assets not used in production, and which are not intended for resale, to allocate or recognize the cost of such assets over their useful lives; or to record the reduction in book value of an intangible asset over the benefit period of such asset; or to reflect consumption during the period of an asset that is not used in production.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482099/360-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DepreciationAndAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) from effect of exchange rate changes on cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; held in foreign currencies; including, but not limited to, disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 830<br> -SubTopic 230<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477401/830-230-45-1<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ForeignCurrencyTransactionGainLossBeforeTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, before tax, of realized and unrealized gain (loss) from foreign currency transaction.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(7))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 830<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 35<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482014/830-20-35-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 830<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481956/830-20-45-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 830<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481926/830-20-50-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 830<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 17<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481839/830-10-45-17<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ForeignCurrencyTransactionGainLossBeforeTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GainLossOnSaleOfDerivatives">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The difference between the book value and the sale price of options, swaps, futures, forward contracts, and other derivative instruments. This element refers to the gain (loss) included in earnings.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(13)(h))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478524/942-220-S99-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(7)(a)(7))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(7)(a)(3))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(7)(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-1<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(7)(a)(6))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GainLossOnSaleOfDerivatives</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ImpairmentOfLongLivedAssetsHeldForUse">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate amount of write-downs for impairments recognized during the period for long lived assets held for use (including those held for disposal by means other than sale).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 100<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482078/820-10-55-100<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 360<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482099/360-10-50-2<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482130/360-10-45-4<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ImpairmentOfLongLivedAssetsHeldForUse</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxesPaidNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after refund, of cash paid to foreign, federal, state, and local jurisdictions as income tax.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2A<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482913/230-10-50-2A<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 23<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-23<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-22<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482913/230-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxesPaidNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in the amounts payable to vendors for goods and services received and the amount of obligations and expenses incurred but not paid.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInInventories">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in the aggregate value of all inventory held by the reporting entity, associated with underlying transactions that are classified as operating activities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInInventories</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInOperatingCapitalAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInOtherOperatingAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in operating assets classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInOtherOperatingAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInPrepaidExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in the amount of outstanding money paid in advance for goods or services that bring economic benefits for future periods.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInPrepaidExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestPaidNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash paid for interest, excluding capitalized interest, classified as operating activity. Includes, but is not limited to, payment to settle zero-coupon bond for accreted interest of debt discount and debt instrument with insignificant coupon interest rate in relation to effective interest rate of borrowing attributable to accreted interest of debt discount.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 17<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-17<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-25<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482913/230-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestPaidNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IssuanceOfStockAndWarrantsForServicesOrClaims">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value of share-based compensation granted to nonemployees as payment for services rendered or acknowledged claims.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IssuanceOfStockAndWarrantsForServicesOrClaims</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInFinancingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 24<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-24<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInFinancingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInInvestingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 24<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-24<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInInvestingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInOperatingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 24<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-24<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 25<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-25<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInOperatingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-6<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-9<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 60<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (g)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476176/805-60-65-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 323<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478666/740-323-65-2<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481687/323-10-50-3<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-28<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482765/220-10-50-6<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-3<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-1<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480175/815-40-65-1<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-8<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-4<br><br>Reference 17: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479168/946-830-55-10<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479105/946-220-45-7<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477250/944-220-S99-1<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(9))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-1<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(1)(d))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 23: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-60B<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483499/205-20-50-7<br><br>Reference 34: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-1A<br><br>Reference 36: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-1B<br><br>Reference 37: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478524/942-220-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NoncashInvestingAndFinancingItemsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NoncashInvestingAndFinancingItemsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsForProceedsFromOtherInvestingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash (inflow) outflow from investing activities classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 13<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-13<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 12<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-12<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsForProceedsFromOtherInvestingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow associated with the acquisition of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale; includes cash outflows to pay for construction of self-constructed assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-13<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquirePropertyPlantAndEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromIssuanceOfLongTermDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from a debt initially having maturity due after one year or beyond the operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-03(i)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479886/946-10-S99-3<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-14<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromIssuanceOfLongTermDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RepaymentsOfNotesPayable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow for a borrowing supported by a written promise to pay an obligation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-15<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RepaymentsOfNotesPayable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of noncash expense for share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SupplementalCashFlowInformationAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SupplementalCashFlowInformationAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>110
<FILENAME>R8.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.4</span><table class="report" border="0" cellspacing="2" id="idm45095366396672">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Description of Business<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>Accounting Policies [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessDescriptionAndBasisOfPresentationTextBlock', window );">Description of Business</a></td>
<td class="text"><p id="xdx_80C_eus-gaap--BusinessDescriptionAndBasisOfPresentationTextBlock_z2aG7dHE8Noe" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Note
1. <span id="xdx_821_z1tr3jvM5ini">Description of Business</span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Nature
of Business and Going Concern</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Sharps
Technology, Inc. (&#8220;Sharps&#8221; or the &#8220;Company&#8221;) is a pre-revenue medical device company that has designed and patented
various safety syringes and is seeking commercialization by manufacturing and distribution of its products.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
accompanying condensed consolidated financial statements include the accounts of Sharps Technology, Inc., and its wholly owned subsidiaries,
Safegard Medical, Kft. and Sharps Technology Acquisition Corp. collectively referred to as the &#8220;Company.&#8221; The condensed consolidated
balance sheet as of September 30, 2024 and the condensed consolidated statements of operations, statements of comprehensive loss, statements
of stockholders&#8217; equity and the statements of cash flow for three and nine months ended September 30, 2024 and 2023 (the &#8220;interim
statements&#8221;) are unaudited. All intercompany transactions and balances have been eliminated. In the opinion of management, all
adjustments (which include normal recurring adjustments) necessary to present fairly the financial position and operating results for
the interim periods have been made. Certain information and footnote disclosure, normally included in annual financial statements prepared
in accordance with accounting principles generally accepted in the United States, have been condensed or omitted. The interim statements
should be read in conjunction with the consolidated financial statements for the year ended December 31, 2023 and notes thereto contained
in the Company&#8217;s Form 10-K filed with the Securities and Exchange Commission. The condensed consolidated balance sheet at December
31, 2023 has been derived from the audited financial statements at that date. The results of operations for the three and nine months
ended September 30, 2024 are not necessarily indicative of the results that may be expected for the fiscal year ending December 31, 2024.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
accompanying condensed consolidated financial statements have been prepared assuming that the Company will continue as a going concern.
The Company has not generated revenue or cash flow from operations since inception. As of September 30, 2024, the Company had a working
capital of $<span id="xdx_900_ecustom--WorkingCapital_iI_c20240930_zlkTftU9qWw3" title="Working capital">67,820</span> which is not expected to be sufficient to fund the Company&#8217;s planned operations for the next 12 months. These
factors raise substantial doubt regarding the Company&#8217;s ability to continue as a going concern. The Company&#8217;s ability to
continue as a going concern is dependent upon the Company&#8217;s ability to raise sufficient financing to acquire or commercialize its
products into a profitable business. The Company intends to finance its commercialization activities and its working capital needs largely
from the sale of equity securities and/or with additional funding from other traditional financing sources until such time that funds
provided by operations are sufficient to fund working capital requirements. The unaudited condensed consolidated financial statements
of the Company do not include any adjustments relating to the recoverability and classification of recorded assets, or the amounts and
classifications of liabilities that might be necessary should the Company be unable to continue as a going concern.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company&#8217;s fiscal year ends on December 31.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
April 13, 2022, the Company&#8217;s Initial Public Offering was deemed effective with trading commencing on April 14, 2022. The Company
received net proceeds of $<span id="xdx_900_eus-gaap--ProceedsFromIssuanceInitialPublicOffering_pn5n6_c20220417__20220419__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--IPOMember_zW1ccizfuWk1" title="Initial public offering">14.2</span> million on April 19, 2022 (See Note 7).</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Effective
October 16, 2024, <span id="xdx_908_ecustom--ReverseStockSplitDescription_c20241006__20241016_zv26HyC6O2li" title="Reverse stock split description">the Company completed a 1 for 22 reverse split, whereby for each 22 shares of common stock the Company issued one share
of common stock .</span> All share, other equity instruments and per share information in the accompanying condensed consolidated financial
statements and footnotes have been retroactively adjusted for the effects of the reverse split for all periods presented.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"></p>

<span></span>
</td>
<td class="text"><p id="xdx_801_eus-gaap--BusinessDescriptionAndBasisOfPresentationTextBlock_zxnnhTHlnSw1" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Note
1. <span id="xdx_82C_zYQA66NqDZNa">Description of Business</span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Nature
of Business</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Sharps
Technology, Inc. (&#8220;Sharps&#8221; or the &#8220;Company&#8221;) is a pre-revenue medical device company that has designed and patented
various safety syringes and is seeking commercialization by manufacturing and distribution of its products.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
accompanying consolidated financial statements include the accounts of Sharps Technology, Inc. and its wholly owned subsidiaries, Safegard
Medical (Hungary) KFT, collectively referred to as the &#8220;Company.&#8221; All intercompany transactions and balances have been eliminated.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company&#8217;s fiscal year ends on December 31.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
April 13, 2022, the Company&#8217;s Initial Public Offering was deemed effective with trading commencing on April 14, 2022. The Company
received net proceeds of $<span id="xdx_905_eus-gaap--ProceedsFromIssuanceInitialPublicOffering_pn5n6_c20220417__20220419__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--IPOMember_z7xqqpwnsDsa" title="Initial public offering">14.2 </span>million on April 19, 2022 (See Note 8).</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessDescriptionAndBasisOfPresentationTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for the business description and basis of presentation concepts. Business description describes the nature and type of organization including but not limited to organizational structure as may be applicable to holding companies, parent and subsidiary relationships, business divisions, business units, business segments, affiliates and information about significant ownership of the reporting entity. Basis of presentation describes the underlying basis used to prepare the financial statements (for example, US Generally Accepted Accounting Principles, Other Comprehensive Basis of Accounting, IFRS).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 235<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org/235/tableOfContent<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 275<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org/275/tableOfContent<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 205<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org/205/tableOfContent<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessDescriptionAndBasisOfPresentationTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>111
<FILENAME>R9.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.4</span><table class="report" border="0" cellspacing="2" id="idm45095369492048">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Summary of Significant Accounting Policies<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>Accounting Policies [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SignificantAccountingPoliciesTextBlock', window );">Summary of Significant Accounting Policies</a></td>
<td class="text"><p id="xdx_801_eus-gaap--SignificantAccountingPoliciesTextBlock_zA9wf4rUPnq5" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Note
2. <span id="xdx_829_z09g9XOryKKi">Summary of Significant Accounting Policies</span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p id="xdx_840_eus-gaap--BasisOfAccountingPolicyPolicyTextBlock_zzowRwhjjZ34" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Basis
of Presentation</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
accompanying condensed consolidated financial statements have been prepared by the Company in accordance with generally accepted accounting
principles (&#8220;GAAP&#8221;) in the United States (&#8220;U.S.&#8221;) and are expressed in U.S. dollars.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>





<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>SHARPS
TECHNOLOGY, INC.</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTES
TO THE CONDENSED CONSOLIDATED FINANCIAL STATEMENTS</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>FOR
THE THREE AND NINE MONTHS ENDED SEPTEMBER 30, 2024 AND 2023</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Note
2. Summary of Significant Accounting Policies (continued)</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>&#160;</i></b></span></p>

<p id="xdx_84C_eus-gaap--UseOfEstimates_zGgGkPhMhNe2" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Use
of Estimates</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
preparation of financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the
reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements
and the reported amounts of revenues and expenses during the reporting periods. Actual results could differ from those estimates. As
of September 30, 2024, the most significant estimates relate to derivative liabilities, stock-based compensation, long-lived asset impairments and accounting for debt and equity financing.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p id="xdx_84D_eus-gaap--CashAndCashEquivalentsPolicyTextBlock_zpVN0CaOHznd" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Cash
and Cash Equivalents</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company considers all highly liquid investments purchased with an original or remaining maturity of three months or less at the date
of purchase to be cash equivalents. Cash and cash equivalents are maintained with various financial institutions. At September 30, 2024
and December 31, 2023, the Company had <span id="xdx_90E_eus-gaap--CashEquivalentsAtCarryingValue_iI_do_c20240930_zwmnXV8kgRR4" title="Cash equivalents"><span id="xdx_905_eus-gaap--CashEquivalentsAtCarryingValue_iI_do_c20231231_zGf0aAiwxUi6" title="Cash equivalents">no</span></span> cash equivalents.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p id="xdx_844_eus-gaap--InventoryPolicyTextBlock_zGOqIcJQKIza" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Inventories</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company values inventory at the lower of cost (average cost) or net realizable value. Work-in-process and finished goods inventories
consist of material, labor, and manufacturing overhead. Net realizable value is the estimated selling price in the ordinary course of
business, less reasonably predictable costs of completion, disposal, and transportation. A reserve is established for any excess or obsolete
inventories or they may be written off. At September 30, 2024, and December 31, 2023, inventory is comprised of raw materials, including
packaging, work in process (components) and finished goods.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p id="xdx_84D_eus-gaap--FairValueMeasurementPolicyPolicyTextBlock_z8orLyWy9zmh" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Fair
Value Measurements</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">ASC
820, Fair Value Measurements and Disclosures, requires an entity to maximize the use of observable inputs and minimize the use of unobservable
inputs when measuring fair value. ASC 820 establishes a fair value hierarchy based on the level of independent, objective evidence surrounding
the inputs used to measure fair value. A financial instrument&#8217;s categorization within the fair value hierarchy is based upon the
lowest level of input that is significant to the fair value measurement. ASC 820 prioritizes the inputs into three levels that may be
used to measure fair value.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company&#8217;s outstanding warrants are valued on a recurring basis with the trading price which could cause fluctuations in operating
results at the reporting periods.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Level
1</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Level
1 applies to assets or liabilities for which there are quoted prices in active markets for identical assets or liabilities. Valuations
are based on quoted prices that are readily and regularly available in an active market and do not entail a significant degree of judgment.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Level
2</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Level
2 applied to assets or liabilities for which there are other than Level 1 observable inputs such as quoted prices for similar assets
or liabilities in active markets; quoted prices for identical assets or liabilities in markets with insufficient volume or infrequent
transactions (less active markets); or model-derived valuations in which significant inputs are observable or can be derived principally
from, or corroborated by, observable market data.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Level
2 instruments require more management judgment and subjectivity as compared to Level 1 instruments. For instance: determining which instruments
are most similar to the instrument being priced requires management to identify a sample of similar securities based on the coupon rates,
maturity, issuer credit rating and instrument type, and subjectively select an individual security or multiple securities that are deemed
most similar to the security being priced; and determining whether a market is considered active requires management judgment.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"></p>



<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;<br/></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>SHARPS
TECHNOLOGY, INC.</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTES
TO THE CONDENSED CONSOLIDATED FINANCIAL STATEMENTS</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>FOR
THE THREE AND NINE MONTHS ENDED SEPTEMBER 30, 2024 AND 2023</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Note
2. Summary of Significant Accounting Policies (continued)</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Level
3</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Level
3 applied to assets or liabilities for which there are unobservable inputs to the valuation methodology that are significant to the measurement
of the fair value of the assets or liabilities. The determination for Level 3 instruments requires the most management judgment and subjectivity.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p id="xdx_84A_eus-gaap--PropertyPlantAndEquipmentPolicyTextBlock_zeQSF2RpUG6k" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Fixed
Assets</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>&#160;</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Fixed
assets are stated at cost. Expenditures for maintenance and repairs are charged to operations as incurred. The Company&#8217;s fixed
assets consist of land, building, machinery and equipment, molds and website. Depreciation is calculated using the straight-line method
commencing on the date the asset is operating in the way intended by management over the following useful lives: Building &#8211; <span id="xdx_90D_eus-gaap--PropertyPlantAndEquipmentUsefulLife_iI_dtY_c20240930__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--BuildingMember_zfFFDUZ05bbg" title="Property plant and equipment asset useful life">20</span>
years, Machinery and Equipment &#8211; <span id="xdx_901_eus-gaap--PropertyPlantAndEquipmentUsefulLife_iI_dtY_c20240930__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--MachineryAndEquipmentMember__srt--RangeAxis__srt--MinimumMember_zQDlHxyYqlR4" title="Property plant and equipment asset useful life">3</span> - <span id="xdx_907_eus-gaap--PropertyPlantAndEquipmentUsefulLife_iI_dtY_c20240930__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--MachineryAndEquipmentMember__srt--RangeAxis__srt--MaximumMember_zIimvDqNBFI6" title="Property plant and equipment asset useful life">10</span> years and Website and Computer Systems &#8211; <span id="xdx_909_eus-gaap--PropertyPlantAndEquipmentUsefulLife_iI_dtY_c20240930__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--WebsiteMember_zTb8yQXBBNHf" title="Property plant and equipment asset useful life">3</span> years. The expected life for Molds is
based on the lesser of the number of parts that will be produced based on the expected mold capability or 5 years.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>&#160;</i></b></span></p>

<p id="xdx_844_eus-gaap--ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock_zcCTXfcljxD8" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i><span id="xdx_863_zFqcx8k1jJQ2">Impairment
of Long-Lived Assets</span></i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Long-lived
assets are reviewed for impairment or whenever events or changes in circumstances indicate that the carrying amount of an asset may not
be recoverable. Recoverability is measured by comparison of the carrying amount of an asset group to the future net undiscounted cash
flows that the assets are expected to generate. If such assets are considered to be impaired, the impairment to be recognized is measured
by the amount by which the carrying amount of the assets exceeds the projected discounted future net cash flows arising from the asset.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">There
were <span id="xdx_900_eus-gaap--ImpairmentOfLongLivedAssetsHeldForUse_dxL_c20240701__20240930_zcjUgtigXLBc" title="Impairment losses::XDX::-"><span id="xdx_905_eus-gaap--ImpairmentOfLongLivedAssetsHeldForUse_dxL_c20230701__20230930_zcIHlxLiKnng" title="Impairment losses::XDX::-"><span id="xdx_907_eus-gaap--ImpairmentOfLongLivedAssetsHeldForUse_dxL_c20240101__20240930_zqXBJ8ZjlUd2" title="Impairment losses::XDX::-"><span id="xdx_90D_eus-gaap--ImpairmentOfLongLivedAssetsHeldForUse_dxL_c20230101__20230930_zat4wV0dNvRi" title="Impairment losses::XDX::-"><span style="-sec-ix-hidden: xdx2ixbrl2233"><span style="-sec-ix-hidden: xdx2ixbrl2235"><span style="-sec-ix-hidden: xdx2ixbrl2237"><span style="-sec-ix-hidden: xdx2ixbrl2239">no</span></span></span></span></span></span></span></span> impairment losses recognized during the three and nine months ended September 30, 2024 and 2023.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Purchased
Identified Intangible Assets</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company&#8217;s identified intangible assets are amortized on a straight-line basis over their estimated useful lives of 5 years.
The Company makes judgments about the recoverability of finite-lived intangible assets whenever facts and circumstances indicate
that the useful life is shorter than originally estimated or that the carrying amount of assets may not be recoverable. If such
facts and circumstances exist, the Company assesses recoverability by comparing the projected undiscounted net cash flows associated
with the related asset or group of assets over their remaining lives against their respective carrying amounts. Impairments, if any,
are based on the excess of the carrying amount over the fair value of those assets. If the useful life is shorter than originally
estimated, the Company would accelerate the rate of amortization and amortize the remaining carrying value over the new shorter
useful life. The Company evaluates the carrying value of indefinite-lived intangible assets whenever events or changes in
circumstances indicate that the carrying amount of an asset may not be recoverable, and an impairment charge would be recognized to
the extent that the carrying amount of such assets exceeds their estimated fair value.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p id="xdx_84D_eus-gaap--CompensationRelatedCostsPolicyTextBlock_zjY7X7QzGzUh" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Stock-based
Compensation Expense</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company measures its stock-based awards made to employees based on the estimated fair values of the awards as of the grant date. For
stock option awards, the Company uses the Black-Scholes option-pricing model. Stock-based compensation expense is recognized over the
requisite service period and is based on the value of the portion of stock-based payment awards that is ultimately expected to vest.
The Company recognizes forfeitures of stock-based awards as they occur on a prospective basis.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Stock-based
compensation expense for awards granted to non-employees as consideration for services received is measured on the date of performance
at the fair value of the consideration received or the fair value of the equity instruments issued, whichever can be more reliably measured.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>





<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>SHARPS
TECHNOLOGY, INC.</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTES
TO THE CONDENSED CONSOLIDATED FINANCIAL STATEMENTS</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>FOR
THE THREE AND NINE MONTHS ENDED SEPTEMBER 30, 2024 AND 2023</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Note
2. Summary of Significant Accounting Policies (continued)</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>&#160;</i></b></span></p>

<p id="xdx_84D_eus-gaap--DerivativesPolicyTextBlock_zsOS2s0wxaTa" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Derivative
Instruments</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company accounts for common stock warrants as either equity-classified or liability-classified instruments based on an assessment of
the specific terms of the warrants and applicable authoritative guidance in Financial Accounting Standards Board (&#8220;FASB&#8221;)
Accounting Standards Codification (&#8220;ASC 480&#8221;), Distinguishing Liabilities from Equity (&#8220;ASC 480&#8221;) and ASC 815,
Derivatives and Hedging (&#8220;ASC 815&#8221;). The assessment considers whether the warrants are freestanding financial instruments
pursuant to ASC 480, meet the definition of a liability pursuant to ASC 480, and meet all of the requirements for equity classification
under ASC 815, including whether the warrants are indexed to the Company&#8217;s own stock and whether the holders of the warrants could
potentially require net cash settlement in a circumstance outside of the Company&#8217;s control, among other conditions for equity classification.
This assessment, which requires the use of professional judgment, is conducted at the time of warrant issuance and as of each subsequent
quarterly period end date while the warrants are outstanding.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">At
their issuance date and as of September 30, 2024, certain warrants (see Notes 8 and 10) were accounted for as liabilities as these instruments
did not meet all of the requirements for equity classification under ASC 815-40 based on the terms of the aforementioned warrants. The
resulting warrant liabilities are re-measured at each balance sheet date until their exercise or expiration, and any change in fair value
is recognized in the Company&#8217;s condensed consolidated statements of operations.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p id="xdx_840_eus-gaap--ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock_zSlJU8zMa6m6" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Foreign
Currency Translation/Transactions</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company has determined that the functional currency for its foreign subsidiary is the local currency. For financial reporting purposes,
assets and liabilities denominated in foreign currencies are translated at current exchange rates and profit and loss accounts are translated
at weighted average exchange rates. Resulting translation gains and losses are included as a separate component of stockholders&#8217;
equity as accumulated other comprehensive income or loss. Gains or losses resulting from transactions entered into in other than the
functional currency are recorded as foreign exchange gains and losses in the condensed consolidated statements of operations.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p id="xdx_848_eus-gaap--ComprehensiveIncomePolicyPolicyTextBlock_zTzYyPt3Ccmb" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Comprehensive
income (loss)</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>&#160;</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Comprehensive
income (loss) consists of the Company&#8217;s consolidated net loss and foreign currency translation adjustments related to its subsidiary.
Foreign currency translation adjustments included in comprehensive loss were not tax effected as the Company has a full valuation allowance
at September 30, 2024 and December 31, 2023. Accumulated other comprehensive income (loss) is a separate component of stockholders&#8217;
equity and consists of the cumulative foreign currency translation adjustments.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p id="xdx_842_eus-gaap--EarningsPerSharePolicyTextBlock_zFZgBIqoHRCg" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Basic
and Diluted Loss Per Share</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company computes net loss per share in accordance with ASC 260, Earnings per Share. ASC 260 requires presentation of both basic and diluted
earnings per share (EPS) on the face of the consolidated statements of operations. Basic EPS is computed by dividing net income (loss)
available to common stockholders (numerator) by the weighted average number of shares outstanding (denominator) during the period. Diluted
EPS gives effect to all dilutive potential common shares outstanding during the period using the treasury stock method and convertible
preferred stock using the if-converted method. In computing diluted EPS, the average stock price for the period is used in determining
the number of shares assumed to be purchased from the exercise of stock options or warrants. Diluted EPS excludes all dilutive potential
shares if their effect is anti-dilutive. As of September 30, 2024, there were <span id="xdx_90A_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_c20240101__20240930__us-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__custom--StockOptionAndWarrantsMember_zBLuoIKyQ3x3" title="Antidilutive shares amount">958,693</span> stock options and warrants, post reverse split
effected, that could potentially dilute basic EPS in the future that were not included in the computation of diluted EPS because to do
so would have been anti-dilutive for the periods presented.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>





<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>SHARPS
TECHNOLOGY, INC.</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTES
TO THE CONDENSED CONSOLIDATED FINANCIAL STATEMENTS</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>FOR
THE THREE AND NINE MONTHS ENDED SEPTEMBER 30, 2024 AND 2023</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Note
2. Summary of Significant Accounting Policies (continued)</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>&#160;</i></b></span></p>

<p id="xdx_848_eus-gaap--IncomeTaxPolicyTextBlock_zi2Qqocojtoj" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Income
Taxes</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company must make certain estimates and judgments in determining income tax expenses for financial statement purposes. These estimates
and judgments are used in the calculation of tax credits, tax benefits, tax deductions, and in the calculation of certain deferred taxes
and tax liabilities. Significant changes to these estimates may result in an increase or decrease to the Company&#8217;s tax provision
in a subsequent period.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
provision for income taxes was comprised of the Company&#8217;s current tax liability and changes in deferred income tax assets and liabilities.
The calculation of the current tax liability involves dealing with uncertainties in the application of complex tax laws and regulations
and in determining the liability for tax positions, if any, taken on the Company&#8217;s tax returns in accordance with authoritative
guidance on accounting for uncertainty in income taxes. Deferred income taxes are determined based on the differences between the financial
reporting and tax basis of assets and liabilities. The Company must assess the likelihood that it will be able to recover the Company&#8217;s
deferred tax assets. If recovery is not likely on a more-likely-than-not basis, the Company must increase its provision for income taxes
by recording a valuation allowance against the deferred tax assets that it estimates will not ultimately be recoverable. However, should
there be a change in the Company&#8217;s ability to recover its deferred tax assets, the provision for income taxes would fluctuate in
the period of such change.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p id="xdx_84F_eus-gaap--ResearchAndDevelopmentExpensePolicy_z4vvVMYju8i8" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Research
and Development Costs</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Research
and development costs are expensed as incurred.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Advance
payments for goods or services that will be used or rendered for future research and development activities are deferred and capitalized.
Such amounts are recognized as an expense as the related goods are delivered or the services are performed.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p id="xdx_84F_eus-gaap--CommitmentsAndContingenciesPolicyTextBlock_zmDbhhayQWRa" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Contingencies</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Liabilities
for loss contingencies arising from claims, assessments, litigations, fines and penalties and other sources are recognized when it is
probable that a liability has been incurred and the amount of the assessment can be reasonably estimated. Gain contingencies are evaluated
and not recognized until the gain is realizable or realized.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p id="xdx_84A_eus-gaap--NewAccountingPronouncementsPolicyPolicyTextBlock_zLFMU2rpIkW6" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Recent
Accounting Pronouncements</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
August 5, 2020, the FASB issued ASU 2020-06, <i>Debt &#8211; Debt with Conversion and Other Options (Subtopic 470-20) and Derivatives
and Hedging &#8211; Contracts in Entity&#8217;s Own Equity (Subtopic 815-40)</i>, which simplifies the accounting for certain financial
instruments with characteristics of liabilities and equity, including convertible instruments and contracts on an entity&#8217;s own
equity. The ASU is part of the FASB&#8217;s simplification initiative, which aims to reduce unnecessary complexity in U.S. GAAP. ASU
2020-06 simplifies the guidance in U.S. GAAP on the issuer&#8217;s accounting for convertible debt instruments, requires entities to
provide expanded disclosures about &#8220;the terms and features of convertible instruments&#8221; and how the instruments have been
reported in the entity&#8217;s financial statements. It also removes from ASC 815-40-25-10 certain conditions for equity classification
and amends certain guidance in ASC 260, <i>Earnings per Share</i>, on the computation of EPS for convertible instruments and contracts
on an entity&#8217;s own equity. An entity can use either a full or modified retrospective approach to adopt the ASU&#8217;s guidance.
The ASU&#8217;s amendments are effective for smaller public business entities fiscal years beginning after December 15, 2023. The Company
does not expect the pronouncement to have a material impact on the Company and will disclose the nature and reason for any elections
that the Company makes.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>





<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>SHARPS
TECHNOLOGY, INC.</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTES
TO THE CONDENSED CONSOLIDATED FINANCIAL STATEMENTS</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>FOR
THE THREE AND NINE MONTHS ENDED SEPTEMBER 30, 2024 AND 2023</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Note
2. Summary of Significant Accounting Policies (continued)</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
December 2023, the FASB issued ASU 2023-09, <i>Income Taxes </i>(Topic 740)<i>: Improvements to Income Tax Disclosures</i>. The new guidance
requires disaggregated information about the effective tax rate reconciliation and additional information on taxes paid that meet a quantitative
threshold. The new guidance is effective for public companies for annual reporting periods beginning after December 15, 2024, a, with
early adoption permitted. The Company is currently evaluating the impacts of the new guidance on its disclosures within the consolidated
financial statements.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company does not expect the adoption of any accounting pronouncements to have a material impact on the condensed consolidated financial
statements.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
reviewed all other recently issued accounting pronouncements and have concluded they are not applicable or not expected to be significant
to the accounting for our operations.</span></p>

<p id="xdx_851_zdgaIXMbKH12" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<span></span>
</td>
<td class="text"><p id="xdx_808_eus-gaap--SignificantAccountingPoliciesTextBlock_zrzxjXxnRAEb" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Note
2. <span id="xdx_828_zPLqBXWYIVWl">Summary of Significant Accounting Policies</span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p id="xdx_84C_eus-gaap--BasisOfAccountingPolicyPolicyTextBlock_zKVaVj20gVgj" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i><span id="xdx_862_zp4lx1YGTOT3">Basis
of Presentation</span></i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
accompanying consolidated financial statements have been prepared by the Company in accordance with generally accepted accounting principles
(&#8220;GAAP&#8221;) in the United States (&#8220;U.S.&#8221;) and are expressed in U.S. dollars.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
accompanying consolidated financial statements have been prepared assuming that the Company will continue as a going concern. The Company
has not generated revenue or cash flow from operations since inception. As of December 31, 2023, the Company used cash in operations
of $<span id="xdx_90C_eus-gaap--NetCashProvidedByUsedInOperatingActivities_iN_di_c20230101__20231231_zB7ZnFfzNdP4" title="Cash in operations">8,507,300</span> and has cash of $<span id="xdx_904_eus-gaap--Cash_iI_c20231231_ziEF5XUdcyl5" title="Cash">3,012,908</span> which is not sufficient to fund the Company&#8217;s planned operations for the next 12 months.
These factors raise substantial doubt regarding the Company&#8217;s ability to continue as a going concern. The Company&#8217;s ability
to continue as a going concern is dependent upon the Company&#8217;s ability to raise sufficient financing to acquire or commercialize
its products into a profitable business. The Company intends to finance its future development and commercialization activities and its
working capital needs largely from the sale of equity securities and/or with additional funding from other traditional financing sources
until such time that funds provided by operations are sufficient to fund working capital requirements. The financial statements of the
Company do not include any adjustments relating to the recoverability and classification of recorded assets, or the amounts and classifications
of liabilities that might be necessary should the Company be unable to continue as a going concern.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p id="xdx_849_eus-gaap--UseOfEstimates_zEaXZ5pgfJRi" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i><span id="xdx_860_zAevqar0yAGg">Use
of Estimates</span></i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
preparation of financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the
reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements
and the reported amounts of revenues and expenses during the reporting periods. Actual results could differ from those estimates. As
of December 31, 2023, the most significant estimates relate to derivative liabilities and stock-based compensation.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-indent: 24.75pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p id="xdx_847_eus-gaap--CashAndCashEquivalentsPolicyTextBlock_zbV2MKSLSyA9" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i><span id="xdx_863_zpgJilAhQ4Bb">Cash
and Cash Equivalents</span></i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company considers all highly liquid investments purchased with an original or remaining maturity of three months or less at the date
of purchase to be cash equivalents. Cash and cash equivalents are maintained with various financial institutions. At December 31,
2023 and 2022, the Company had <span id="xdx_908_eus-gaap--CashEquivalentsAtCarryingValue_iI_do_c20231231_zWb6yOWVqK22" title="Cash equivalents"><span id="xdx_903_eus-gaap--CashEquivalentsAtCarryingValue_iI_do_c20221231_zMq2PeuJTbLk" title="Cash equivalents">no</span></span> cash equivalents.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p id="xdx_84D_eus-gaap--InventoryPolicyTextBlock_zOoB5UMrClt7" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i><span id="xdx_86F_zdkCVDwqh8qb">Inventories</span></i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company values inventory at the lower of cost (average cost) or net realizable value. Work-in-process and finished goods inventories
consist of material, labor, and manufacturing overhead. Net realizable value is the estimated selling price in the ordinary course of
business, less reasonably predictable costs of completion, disposal, and transportation. A reserve is established for any excess or obsolete
inventories or they may be written off. At December 31, 2023 and 2022, inventory is comprised of raw materials, components and finished
goods.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>




<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>SHARPS
TECHNOLOGY, INC.</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTES
TO THE CONSOLIDATED FINANCIAL STATEMENTS</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>FOR
THE YEARS ENDED DECEMBER 31, 2023 AND 2022</b></span></p>

<p style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Note
2. Summary of Significant Accounting Policies (continued)</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p id="xdx_848_eus-gaap--FairValueMeasurementPolicyPolicyTextBlock_zcHPw9YdzgV4" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_86D_z5klkHhT9Lw9">Fair
Value Measurements</span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">ASC
820, Fair Value Measurements and Disclosures, require an entity to maximize the use of observable inputs and minimize the use of unobservable
inputs when measuring fair value. ASC 820 establishes a fair value hierarchy based on the level of independent, objective evidence surrounding
the inputs used to measure fair value. A financial instrument&#8217;s categorization within the fair value hierarchy is based upon the
lowest level of input that is significant to the fair value measurement. ASC 820 prioritizes the inputs into three levels that may be
used to measure fair value.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company&#8217;s outstanding warrants are fair valued on a recurring basis with the trading price or FMV using Black Sholes which
could cause fluctuations in operating results at the reporting periods.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Level
1</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Level
1 applies to assets or liabilities for which there are quoted prices in active markets for identical assets or liabilities. Valuations
are based on quoted prices that are readily and regularly available in an active market and do not entail a significant degree of judgment.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Level
2</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Level
2 applied to assets or liabilities for which there are other than Level 1 observable inputs such as quoted prices for similar assets
or liabilities in active markets; quoted prices for identical assets or liabilities in markets with insufficient volume or infrequent
transactions (less active markets); or model-derived valuations in which significant inputs are observable or can be derived principally
from, or corroborated by, observable market data.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Level
2 instruments require more management judgment and subjectivity as compared to Level 1 instruments. For instance: determining which instruments
are most similar to the instrument being priced requires management to identify a sample of similar securities based on the coupon rates,
maturity, issuer credit rating and instrument type, and subjectively select an individual security or multiple securities that are deemed
most similar to the security being priced; and determining whether a market is considered active requires management judgment.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Level
3</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Level
3 applied to assets or liabilities for which there are unobservable inputs to the valuation methodology that are significant to the measurement
of the fair value of the assets or liabilities. The determination for Level 3 instruments requires the most management judgment and subjectivity.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p id="xdx_846_eus-gaap--PropertyPlantAndEquipmentPolicyTextBlock_zg8LPGtNVQJf" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Fixed
Assets</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Fixed
assets are stated at cost. Expenditures for maintenance and repairs are charged to operations as incurred. The Company&#8217;s fixed
assets consist of land, building, machinery and equipment, molds, computer system and website. Depreciation is calculated using the straight-line
method commencing on the date the asset is operating in the way intended by management over the following useful lives: Building &#8211;
<span id="xdx_900_eus-gaap--PropertyPlantAndEquipmentUsefulLife_iI_dtY_c20231231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--BuildingMember_zDcXnDaTcg23" title="Property plant and equipment asset useful life">20</span> years, Machinery and Equipment &#8211; <span id="xdx_903_eus-gaap--PropertyPlantAndEquipmentUsefulLife_iI_dtY_c20231231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--MachineryAndEquipmentMember__srt--RangeAxis__srt--MinimumMember_zvfMOOj4TIpk" title="Property plant and equipment asset useful life">3</span> -<span id="xdx_90A_eus-gaap--PropertyPlantAndEquipmentUsefulLife_iI_dtY_c20231231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--MachineryAndEquipmentMember__srt--RangeAxis__srt--MaximumMember_zUMsxKx0X3a1" title="Property plant and equipment asset useful life">10</span> years and Computer systems and Website &#8211; <span id="xdx_901_eus-gaap--PropertyPlantAndEquipmentUsefulLife_iI_dtY_c20231231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--WebsiteMember_zWiJepiw6Kn" title="Property plant and equipment asset useful life">3</span> years. The expected life for Molds is
based lesser of the number of parts that will be produced based on the expected mold capability or 5 years.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>&#160;</i></b></span></p>

<p id="xdx_840_eus-gaap--ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock_zmMDNT8Ofh78" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i><span id="xdx_860_zlWnFrL4mQhi">Impairment
of Long-Lived Assets</span> </i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Long-lived
assets are reviewed annually for impairment or whenever events or changes in circumstances indicate that the carrying amount of an asset
may not be recoverable. Recoverability is measured by comparison of the carrying amount of an asset group to the future net undiscounted
cash flows that the assets are expected to generate. If such assets are considered to be impaired, the impairment to be recognized is
measured by the amount by which the carrying amount of the assets exceeds the projected discounted future net cash flows arising from
the asset.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company recorded an impairment of $<span id="xdx_90F_eus-gaap--ImpairmentOfLongLivedAssetsHeldForUse_c20230101__20231231_z0rVCogZaeT4" title="Impairment losses">560,000</span> during the year ended December 31, 2023 and <span id="xdx_900_eus-gaap--ImpairmentOfLongLivedAssetsHeldForUse_dxL_c20220101__20221231_zPneDqTLg4uj" title="Impairment losses::XDX::-"><span style="-sec-ix-hidden: xdx2ixbrl0604">no</span></span>
impairment during the year ended December 31, 2022.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>




<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>SHARPS
TECHNOLOGY, INC.</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTES
TO THE CONSOLIDATED FINANCIAL STATEMENTS</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>FOR
THE YEARS ENDED DECEMBER 31, 2023 AND 2022</b></span></p>

<p style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Note
2. Summary of Significant Accounting Policies (continued)</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p id="xdx_841_eus-gaap--IntangibleAssetsFiniteLivedPolicy_ziROBe3KcNL9" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i><span id="xdx_86C_zxU4sxefa3ye">Purchased
Identified Intangible Assets</span></i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Identified
Intangible Assets</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company&#8217;s identified intangible assets are amortized on a straight-line basis over their estimated useful lives of 5 years. The
Company makes judgments about the recoverability of finite-lived intangible assets whenever facts and circumstances indicate that the
useful life is shorter than originally estimated or that the carrying amount of assets may not be recoverable. If such facts and circumstances
exist, the Company assesses recoverability by comparing the projected undiscounted net cash flows associated with the related asset or
group of assets over their remaining lives against their respective carrying amounts. Impairments, if any, are based on the excess of
the carrying amount over the fair value of those assets. If the useful life is shorter than originally estimated, the Company would accelerate
the rate of amortization and amortize the remaining carrying value over the new shorter useful life. The Company evaluates the carrying
value of finite-lived intangible assets on an annual basis, and an impairment charge would be recognized to the extent that the carrying
amount of such assets exceeds their estimated fair value.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>&#160;</i></b></span></p>

<p id="xdx_843_eus-gaap--CompensationRelatedCostsPolicyTextBlock_zLto1WwGYnCh" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i><span id="xdx_864_zVx4yLq85QPc">Stock-based
Compensation Expense</span></i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company measures its stock-based awards made to employees based on the estimated fair values of the awards as of the grant date. For
stock option awards, the Company uses the Black-Scholes option-pricing model. For restricted stock awards, the estimated fair value is
generally the fair market value of the underlying stock on the grant date. Stock-based compensation expense is recognized over the requisite
service period and is based on the value of the portion of stock-based payment awards that is ultimately expected to vest. The Company
recognizes forfeitures of stock-based awards as they occur on a prospective basis.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Stock-based
compensation expense for awards granted to non-employees as consideration for services received is measured on the date of performance
at the fair value of the consideration received or the fair value of the equity instruments issued, whichever can be more reliably measured.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>




<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>SHARPS
TECHNOLOGY, INC.</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTES
TO THE CONSOLIDATED FINANCIAL STATEMENTS</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>FOR
THE YEARS ENDED DECEMBER 31, 2023 AND 2022</b></span></p>

<p style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Note
2. Summary of Significant Accounting Policies (continued)</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p id="xdx_848_eus-gaap--DerivativesPolicyTextBlock_z4E35sPxqQwg" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i><span id="xdx_861_zfSFtOldWiqd">Derivative
Instruments</span></i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company accounts for common stock warrants as either equity-classified or liability-classified instruments based on an assessment of
the specific terms of the warrants and applicable authoritative guidance in Financial Accounting Standards Board (&#8220;FASB&#8221;)
Accounting Standards Codification (&#8220;ASC 480&#8221;), Distinguishing Liabilities from Equity (&#8220;ASC 480&#8221;) and ASC 815,
Derivatives and Hedging (&#8220;ASC 815&#8221;). The assessment considers whether the warrants are freestanding financial instruments
pursuant to ASC 480, meet the definition of a liability pursuant to ASC 480, and meet all of the requirements for equity classification
under ASC 815, including whether the warrants are indexed to the Company&#8217;s own stock and whether the holders of the warrants could
potentially require net cash settlement in a circumstance outside of the Company&#8217;s control, among other conditions for equity classification.
This assessment, which requires the use of professional judgment, is conducted at the time of warrant issuance and as of each subsequent
quarterly period end date while the warrants are outstanding.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">At
their issuance date and as of December 31, 2023, certain warrants (see Notes 8 and 10) are accounted for as liabilities as these instruments
did not meet all of the requirements for equity classification under ASC 815-40 based on the terms of the aforementioned warrants. The
resulting warrant liabilities are re-measured at each balance sheet date until their exercise or expiration, and any change in fair value
is recognized in the Company&#8217;s consolidated statements of operations.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p id="xdx_84B_eus-gaap--ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock_z2SbVpJcwPed" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i><span id="xdx_86F_zlEzljoZPcy4">Foreign
Currency Translation/Transactions</span></i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company has determined that the functional currency for its foreign subsidiary is the local currency. For financial reporting purposes,
assets and liabilities denominated in foreign currencies are translated at current exchange rates and profit and loss accounts are translated
at weighted average exchange rates. Resulting translation gains and losses are included as a separate component of stockholders&#8217;
equity as accumulated other comprehensive income or loss. Gains or losses resulting from transactions entered into in other than the
functional currency are recorded as foreign exchange gains and losses in the consolidated statements of operations.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p id="xdx_843_eus-gaap--ComprehensiveIncomePolicyPolicyTextBlock_zRifrGfr3Ls1" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i><span id="xdx_86A_zUWfwARhhYRk">Comprehensive
income (loss)</span></i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>&#160;</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Comprehensive
income (loss) consists of the Company&#8217;s consolidated net loss and foreign currency translation adjustments related to its subsidiary.
Foreign currency translation adjustments included in comprehensive loss were not tax effected as the Company has a full valuation allowance
at December 31, 2023 and 2022. Accumulated other comprehensive income (loss) is a separate component of stockholders&#8217; equity and
consists of the cumulative foreign currency translation adjustments.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>&#160;</i></b></span></p>

<p id="xdx_84B_eus-gaap--EarningsPerSharePolicyTextBlock_zymxba8U4w66" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i><span id="xdx_86C_z601WrOkquZf">Basic
and Diluted Loss Per Share</span></i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company computes net loss per share in accordance with ASC 260, Earnings per Share. ASC 260 requires presentation of both basic and diluted
earnings per share (EPS) on the face of the consolidated statements of operations. Basic EPS is computed by dividing net income (loss)
available to common stockholders (numerator) by the weighted average number of shares outstanding (denominator) during the period. Basic
EPS includes the <span id="xdx_907_eus-gaap--WeightedAverageNumberOfSharesOutstandingBasic_c20230101__20231231__us-gaap--StatementEquityComponentsAxis__custom--PrefundendWarrantsMember_zW6yW4DDWHHb" title="Weighted average shares outstanding basic">3,381,479</span> of pre-funded warrants (see Note 8). Diluted EPS gives effect to all dilutive potential common shares outstanding
during the period using the treasury stock method and convertible preferred stock using the if-converted method. In computing diluted
EPS, the average stock price for the period is used in determining the number of shares assumed to be purchased from the exercise of
stock options or warrants. Diluted EPS excludes all dilutive potential shares if their effect is anti-dilutive. As of December 31, 2023,
there were <span id="xdx_90F_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_c20230101__20231231__us-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__custom--StockOptionsAndWarrantsMember_zxFr2uIC5do7" title="Antidilutive securities shares">22,950,155</span> stock options and warrants that could potentially dilute basic EPS in the future that were not included in the
computation of diluted EPS because to do so would have been anti-dilutive for the periods presented.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p id="xdx_845_eus-gaap--IncomeTaxPolicyTextBlock_ziEbuahOcoKj" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i><span id="xdx_867_zl2OX7bMoBbl">Income
Taxes</span></i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company must make certain estimates and judgments in determining income tax expense for financial statement purposes. These estimates
and judgments are used in the calculation of tax credits, tax benefits, tax deductions, and in the calculation of certain deferred taxes
and tax liabilities. Significant changes to these estimates may result in an increase or decrease to the Company&#8217;s tax provision
in a subsequent period.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>




<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>SHARPS
TECHNOLOGY, INC.</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTES
TO THE CONSOLIDATED FINANCIAL STATEMENTS</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>FOR
THE YEARS ENDED DECEMBER 31, 2023 AND 2022</b></span></p>

<p style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Note
2. Summary of Significant Accounting Policies (continued)</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
provision for income taxes was comprised of the Company&#8217;s current tax liability and changes in deferred income tax assets and liabilities.
The calculation of the current tax liability involves dealing with uncertainties in the application of complex tax laws and regulations
and in determining the liability for tax positions, if any, taken on the Company&#8217;s tax returns in accordance with authoritative
guidance on accounting for uncertainty in income taxes. Deferred income taxes are determined based on the differences between the financial
reporting and tax basis of assets and liabilities. The Company must assess the likelihood that it will be able to recover the Company&#8217;s
deferred tax assets. If recovery is not likely on a more-likely-than-not basis, the Company must increase its provision for income taxes
by recording a valuation allowance against the deferred tax assets that it estimates will not ultimately be recoverable. However, should
there be a change in the Company&#8217;s ability to recover its deferred tax assets, the provision for income taxes would fluctuate in
the period of such change.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p id="xdx_842_eus-gaap--ResearchAndDevelopmentExpensePolicy_zNrWRCEvd1X5" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i><span id="xdx_86D_z3XLDfbXfP76">Research
and Development Costs</span></i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Research
and development costs are expensed as incurred.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Advance
payments for goods or services that will be used or rendered for future research and development activities are deferred and capitalized.
Such amounts are recognized as an expense as the related goods are delivered or the services are performed.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p id="xdx_840_eus-gaap--CommitmentsAndContingenciesPolicyTextBlock_zMAjVtdbmft2" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i><span id="xdx_861_znjPtJzomxrk">Contingencies</span></i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Liabilities
for loss contingencies arising from claims, assessments, litigations, fines and penalties and other sources are recognized when it is
probable that a liability has been incurred and the amount of the assessment can be reasonably estimated. Gain contingencies are evaluated
and not recognized until the gain is realizable or realized.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p id="xdx_84E_eus-gaap--NewAccountingPronouncementsPolicyPolicyTextBlock_zC2pqT1WNqxh" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i><span id="xdx_868_z2mR3DbjnDI9">Recent
Accounting Pronouncements</span> </i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
August 5, 2020, the FASB issued ASU 2020-06, <i>Debt &#8211; Debt with Conversion and Other Options (Subtopic 470-20) and Derivatives
and Hedging &#8211; Contracts in Entity&#8217;s Own Equity (Subtopic 815-40)</i>, which simplifies the accounting for certain financial
instruments with characteristics of liabilities and equity, including convertible instruments and contracts on an entity&#8217;s own
equity. The ASU is part of the FASB&#8217;s simplification initiative, which aims to reduce unnecessary complexity in U.S. GAAP. ASU
2020-06 simplifies the guidance in U.S. GAAP on the issuer&#8217;s accounting for convertible debt instruments, requires entities to
provide expanded disclosures about &#8220;the terms and features of convertible instruments&#8221; and how the instruments have been
reported in the entity&#8217;s financial statements. It also removes from ASC 815-40-25-10 certain conditions for equity classification
and amends certain guidance in ASC 260, <i>Earnings per Share</i>, on the computation of EPS for convertible instruments and contracts
on an entity&#8217;s own equity. An entity can use either a full or modified retrospective approach to adopt the ASU&#8217;s guidance.
The ASU&#8217;s amendments are effective for smaller public business entities fiscal years beginning after December 15, 2023. The Company
is currently evaluating the impact of ASU 2020-06 on its consolidated financial statements and does not expect the adoption of this amended
guidance to have a material impact on the Company&#8217;s consolidated financial statements.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
December 2023, the FASB issued ASU 2023-09, <i>Income Taxes </i>(Topic 740)<i>: Improvements to Income Tax Disclosures</i>. The new guidance
requires disaggregated information about the effective tax rate reconciliation and additional information on taxes paid that meet a quantitative
threshold. The new guidance is effective for public companies for annual reporting periods beginning after December 15, 2024, and for
non-public companies for annual reporting periods beginning after December 15, 2025, with early adoption permitted for both. The Company
will adopt the new standard in the annual reporting period beginning after December 15, 2025 and is currently evaluating the impacts of the
new guidance on its disclosures within the consolidated financial statements.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company does not expect the adoption of any accounting pronouncements to have a material impact on the consolidated financial statements.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company reviewed all other recently issued accounting pronouncements and have concluded they are not applicable or not expected to be
significant to the accounting for our operations.</span></p>

<p id="xdx_85D_zBg1R3ZATai8" style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>




<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>SHARPS
TECHNOLOGY, INC.</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTES
TO THE CONSOLIDATED FINANCIAL STATEMENTS</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>FOR
THE YEARS ENDED DECEMBER 31, 2023 AND 2022</b></span></p>

<p style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SignificantAccountingPoliciesTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for all significant accounting policies of the reporting entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483426/235-10-50-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 235<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org/235/tableOfContent<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SignificantAccountingPoliciesTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>112
<FILENAME>R10.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.4</span><table class="report" border="0" cellspacing="2" id="idm45095369572992">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Inventories<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InventoryDisclosureAbstract', window );"><strong>Inventory Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InventoryDisclosureTextBlock', window );">Inventories</a></td>
<td class="text"><p id="xdx_80C_eus-gaap--InventoryDisclosureTextBlock_zEdsKAvhbrsc" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Note
3. <span id="xdx_828_zXZBFQxTrd1j">Inventories</span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p id="xdx_890_eus-gaap--ScheduleOfInventoryCurrentTableTextBlock_zJyitDEwqaL5" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Inventories,
net consisted of the following at:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;<span id="xdx_8BC_za1wZlN0pa45" style="display: none">Schedule of Inventories</span></span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" id="xdx_494_20240930_z6wmSvdcayr1" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">September
    30, 2024</span></td><td style="padding-bottom: 1pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" id="xdx_493_20231231_zRTyYvpNNmr6" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">December
    31, 2023</span></td><td style="padding-bottom: 1pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr id="xdx_400_eus-gaap--InventoryRawMaterialsNetOfReserves_iI_maINzcUe_zz0MVJIAfoy8" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 60%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Raw materials</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="width: 16%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">360,907</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="width: 16%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">254,461</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr id="xdx_409_eus-gaap--InventoryWorkInProcessNetOfReserves_iI_maINzcUe_zckDXbS9KQsl" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Work in process</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">140,025</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">170,464</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr id="xdx_40F_eus-gaap--InventoryFinishedGoodsNetOfReserves_iI_maINzcUe_zfUcsK9k3fpk" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Finished
    goods</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,518,549</span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,284,210</span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr id="xdx_406_eus-gaap--InventoryNet_iTI_mtINzcUe_zXulI952NDfb" style="vertical-align: bottom; background-color: White">
    <td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Total</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2,019,481</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,709,135</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  </table>

<p id="xdx_8A8_z97XYThhIUr7" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<span></span>
</td>
<td class="text"><p id="xdx_80E_eus-gaap--InventoryDisclosureTextBlock_zbBN9a3Qqiwj" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Note
3. <span id="xdx_82B_zTkTm91WsZFf">Inventories</span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p id="xdx_897_eus-gaap--ScheduleOfInventoryCurrentTableTextBlock_z3TdlfDLqDOh" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Inventories,
net consisted of the following at December 31, 2023 and 2022:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span id="xdx_8B6_zCRavWqfgD5i" style="display: none">Schedule of Inventories</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td style="text-align: center">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" id="xdx_499_20231231_zP3RLzx3Hdr8" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><p style="margin-top: 0pt; margin-bottom: 0pt">December 31,</p>
                                                                                <p style="margin-top: 0pt; margin-bottom: 0pt">2023</p></td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" id="xdx_494_20221231_zaiuNWHgSB5" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><p style="margin-top: 0pt; margin-bottom: 0pt">December 31,</p>
                                                                                <p style="margin-top: 0pt; margin-bottom: 0pt">2022</p></td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
  <tr id="xdx_400_eus-gaap--InventoryRawMaterialsNetOfReserves_iI_maINzcUe_zj891ZoM6wF1" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 60%; text-align: left">Raw materials</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 16%; text-align: right">254,461</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 16%; text-align: right">106,088</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr id="xdx_409_eus-gaap--InventoryWorkInProcessNetOfReserves_iI_maINzcUe_zl5kEwucRDCe" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Work in process</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">170,464</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">49,144</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40F_eus-gaap--InventoryFinishedGoodsNetOfReserves_iI_maINzcUe_zzZPgUwfNfLf" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1pt">Finished goods</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">1,284,210</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">30,572</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_406_eus-gaap--InventoryNet_iTI_mtINzcUe_zQlw3jmBTngg" style="vertical-align: bottom; background-color: White">
    <td style="padding-bottom: 1pt">Total</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">$</td><td style="border-bottom: Black 1pt solid; text-align: right">1,709,135</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">$</td><td style="border-bottom: Black 1pt solid; text-align: right">185,804</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  </table>

<p id="xdx_8AD_zMxV2pgkb3Mk" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for inventory. Includes, but is not limited to, the basis of stating inventory, the method of determining inventory cost, the classes of inventory, and the nature of the cost elements included in inventory.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 330<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org/330/tableOfContent<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>113
<FILENAME>R11.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.4</span><table class="report" border="0" cellspacing="2" id="idm45095369686192">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Fixed Assets<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentAbstract', window );"><strong>Property, Plant and Equipment [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock', window );">Fixed Assets</a></td>
<td class="text"><p id="xdx_80F_eus-gaap--PropertyPlantAndEquipmentDisclosureTextBlock_z3GzusgfC6l" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Note
4. <span id="xdx_825_zL2WlW1xwrM5">Fixed Assets</span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p id="xdx_89E_eus-gaap--PropertyPlantAndEquipmentTextBlock_zGUMepEmbKal" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Fixed
assets, net, is summarized as follows as of:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;<span id="xdx_8B4_zpuDSeb8BhG1" style="display: none">Schedule of Fixed
Assets, Net</span></span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" id="xdx_49E_20240930_zrvXo9riwRKl" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">September
    30, 2024</span></td><td style="padding-bottom: 1pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" id="xdx_492_20231231_zvHyMLKogLBi" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">December
    31, 2023</span></td><td style="padding-bottom: 1pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr id="xdx_40A_eus-gaap--PropertyPlantAndEquipmentGross_iI_hus-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--LandMember_z1rTGl6pzuqc" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 60%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Land</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="width: 16%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">253,781</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="width: 16%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">260,460</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr id="xdx_402_eus-gaap--PropertyPlantAndEquipmentGross_iI_hus-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--BuildingMember_zyflhsFXGV5j" style="vertical-align: bottom; background-color: White">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Building</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2,949,900</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">3,022,490</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr id="xdx_406_eus-gaap--PropertyPlantAndEquipmentGross_iI_hus-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--MachineryAndEquipmentMember_zNLFIcNb5M7g" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Machinery and Equipment</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">4,730,617</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">4,464,317</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr id="xdx_40F_eus-gaap--PropertyPlantAndEquipmentGross_iI_hus-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--ComputerSystemsAndWebsiteAndOtherMember_z1Ova8mKjZO5" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Computer
    Systems and Website &amp; Other</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">290,662</span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">290,661</span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr id="xdx_40F_eus-gaap--PropertyPlantAndEquipmentGross_iI_maPPAENzHVU_zPE7Ix95vQ9a" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Total Fixed Assets</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">8,224,960</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">8,037,928</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr id="xdx_40E_eus-gaap--AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_iNI_di_msPPAENzHVU_zmpfKdrCxpAc" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Less:
    accumulated depreciation</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(1,991,365</span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(1,215,786</span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td></tr>
  <tr id="xdx_407_eus-gaap--PropertyPlantAndEquipmentNet_iTI_mtPPAENzHVU_zFNGJTNSCdXe" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Fixed
    asset, net</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">6,233,595</span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">6,822,142</span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  </table>

<p id="xdx_8A4_zESDx8k7cqI" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Depreciation
expense of fixed assets for the nine months ended September 30, 2024 and 2023 was $<span id="xdx_90B_eus-gaap--Depreciation_c20240101__20240930_z44woASc0boa" title="Depreciation">574,719</span> and $<span id="xdx_903_eus-gaap--Depreciation_c20230101__20230930_zKuOlP7v1XL6" title="Depreciation">646,538</span>, respectively. Substantially,
all the Company&#8217;s fixed assets are located at the Company&#8217;s Hungary location.</span></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>





<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>SHARPS
TECHNOLOGY, INC.</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTES
TO THE CONDENSED CONSOLIDATED FINANCIAL STATEMENTS</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>FOR
THE THREE AND NINE MONTHS ENDED SEPTEMBER 30, 2024 AND 2023</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<span></span>
</td>
<td class="text"><p id="xdx_809_eus-gaap--PropertyPlantAndEquipmentDisclosureTextBlock_zoKkeKrJuN94" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Note
4. <span id="xdx_82C_zow7dKL8AaDa">Fixed Assets</span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p id="xdx_893_eus-gaap--PropertyPlantAndEquipmentTextBlock_zPUvEoseWjce" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Fixed
asset, net, as of December 31, 2023 and 2022, are summarized as follows:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;<span id="xdx_8B0_zAFXDcVkUXue" style="display: none">Schedule of Property, Plant and Equipment</span></span></span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 85%">
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" id="xdx_49F_20231231_zWFwv1Q28DAl" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><p style="margin-top: 0pt; margin-bottom: 0pt">December 31,</p>
                                                                                <p style="margin-top: 0pt; margin-bottom: 0pt">2023</p></td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2" id="xdx_49F_20221231_z3IwxSHnt11c" style="border-bottom: Black 1pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>December
31,</b></span></p>
                                                                                 <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>2022</b></span></p></td><td style="padding-bottom: 1pt">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: center">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: center">&#160;</td><td>&#160;</td></tr>
  <tr id="xdx_40A_eus-gaap--PropertyPlantAndEquipmentGross_iI_hus-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--LandMember_zMoBJf64Ur01" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 56%">Land</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 18%; text-align: right">260,460</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 18%; text-align: right">242,240</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr id="xdx_402_eus-gaap--PropertyPlantAndEquipmentGross_iI_hus-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--BuildingMember_zABltg7WUrg8" style="vertical-align: bottom; background-color: White">
    <td>Building</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">3,022,490</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">2,824,481</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_406_eus-gaap--PropertyPlantAndEquipmentGross_iI_hus-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--MachineryAndEquipmentMember_ziNklABgBeNb" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Machinery and Equipment</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">4,464,317</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">4,601,293</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_402_eus-gaap--PropertyPlantAndEquipmentGross_iI_hus-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--ComputerSystemsAndWebsiteAndOtherWebsiteMember_zUXGTRCvI5Hf" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1pt">Computer and Website</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">290,661</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">16,600</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_40F_eus-gaap--PropertyPlantAndEquipmentGross_iI_maPPAENzHVU_zO2D76mnsUuf" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>&#160;<span style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt">Total Fixed Assets</span> </td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">8,037,928</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">7,684,614</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_403_eus-gaap--AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_iNI_di_msPPAENzHVU_zaXpSGBuV5O7" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1pt">Less: accumulated depreciation</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(1,215,786</td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(679,724</td><td style="padding-bottom: 1pt; text-align: left">)</td></tr>
  <tr id="xdx_400_eus-gaap--PropertyPlantAndEquipmentNet_iTI_mtPPAENzHVU_zjZ9c7oVtg2e" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1pt">Fixed asset, net</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">$</td><td style="border-bottom: Black 1pt solid; text-align: right">6,822,142</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">$</td><td style="border-bottom: Black 1pt solid; text-align: right">7,004,890</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  </table>

<p id="xdx_8A4_zz5bPc94Na4f" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Depreciation
expense of fixed assets for the year ended December 31, 2023 and 2022 was $<span id="xdx_90A_eus-gaap--Depreciation_c20230101__20231231_zk7cwwg7uoV" title="Depreciation">876,064</span> and $<span id="xdx_90D_eus-gaap--Depreciation_c20220101__20221231_zsjIq3dAbRo1" title="Depreciation">647,690</span>, respectively. Substantially, all of
the Company&#8217;s fixed assets are located at the Company&#8217;s Hungary location.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
the fourth quarter of 2023, the Company recorded, in Research and Development expenses, an asset impairment of $<span id="xdx_90C_eus-gaap--AssetImpairmentCharges_c20231001__20231231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--MachineryAndEquipmentMember_zp7fG2VATTmb" title="Asset impairment">560,000 </span>
relating to Molds, which were included in Machinery and Equipment, due to a decision to discontinue usage of certain
molds.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">During
the year ended December 2022, the Company recorded $<span id="xdx_90F_eus-gaap--PaymentsToAcquireMachineryAndEquipment_c20220101__20221231__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember_zbpXwKAloy3j" title="Acquisition of machinery">63,612</span> in fixed asset costs relating to the estimated fair market value for options
granted in 2021 for the acquired machinery. As of December 31, 2023, the Company has $<span id="xdx_906_ecustom--RemainingPaymentsDueOnMachinery_c20230101__20231231_zUjBnuOSWmMi" title="Balance due on machinery">100,000</span> in remaining payments for machinery purchased,
which is included in accounts payable.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for long-lived, physical asset used in normal conduct of business and not intended for resale. Includes, but is not limited to, work of art, historical treasure, and similar asset classified as collections.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 360<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org/360/tableOfContent<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -SubTopic 360<br> -Topic 958<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477798/958-360-50-6<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -SubTopic 360<br> -Topic 958<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477798/958-360-50-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -SubTopic 360<br> -Topic 958<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477798/958-360-50-7<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>114
<FILENAME>R12.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.4</span><table class="report" border="0" cellspacing="2" id="idm45095367613536">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Asset Acquisition<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract', window );"><strong>Business Combination, Asset Acquisition, and Joint Venture Formation [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetAcquisitionTextBlock', window );">Asset Acquisition</a></td>
<td class="text"><p id="xdx_803_eus-gaap--AssetAcquisitionTextBlock_zYtibF3qN6g5" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Note
5. <span id="xdx_827_z76AZ9ehjhP8">Asset Acquisition</span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Safegard
Medical, Kft</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
June 2020, the Company entered into a Share Purchase Agreement (&#8220;Agreement&#8221;) with Safegard Medical, Kft
(&#8220;Safegard&#8221;) and amendments to the Agreement, collectively, the Agreements, to purchase either the stock or certain
assets of a manufacturing facility for $<span id="xdx_90F_eus-gaap--PaymentsToAcquireBusinessesGross_pn5n6_c20200601__20200630__us-gaap--BusinessAcquisitionAxis__custom--SafegardMedicalIncMember__us-gaap--TypeOfArrangementAxis__custom--SharePurchaseAgreementMember_zkDcdYETiCs8" title="Consideration paid in cash">2.5</span>M
in cash, plus additional consideration of common stock and options with a fair market value of $<span id="xdx_905_ecustom--FairMarketValueOfCommonStock_c20200601__20200630__us-gaap--BusinessAcquisitionAxis__custom--SafegardMedicalIncMember__us-gaap--TypeOfArrangementAxis__custom--SharePurchaseAgreementMember__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zq4qWnGl5RX6" title="Fair market value of common stock">200,000</span>
and $<span id="xdx_904_ecustom--FairMarketValueOfCommonStock_c20200601__20200630__us-gaap--BusinessAcquisitionAxis__custom--SafegardMedicalIncMember__us-gaap--TypeOfArrangementAxis__custom--SharePurchaseAgreementMember__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_z9nc5NNqGDaj" title="Fair market value of common stock">183,135</span>,
respectively. The Agreements provided the Company various periods for due diligence and post due diligence, requirements for escrow
payments through the closing date (&#8220;Closing Date&#8221;).</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Through
the Closing Date, the Agreements provided the Company with the exclusive use of the facility in exchange for payment of the facility&#8217;s
operating costs. The monthly fee (&#8220;Operating Costs&#8221;), which primarily covered the facility&#8217;s operating costs, was mainly
comprised of the seller&#8217;s workforce costs, materials and other recurring monthly operating cost.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
acquisition of Safegard, which closed on July 6, 2022, did not meet the definition of a business pursuant to ASC 805-10, and accordingly
was accounted for as an asset acquisition in accordance with ASC 805-50. The cost of the acquisition was $<span id="xdx_90B_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets_iI_c20220706__us-gaap--BusinessAcquisitionAxis__custom--SafegardMedicalIncMember_zrMoaIEQjGmg" title="Acquisition cost">2,936,712</span>, including transaction
costs of $<span id="xdx_904_eus-gaap--BusinessAcquisitionCostOfAcquiredEntityTransactionCosts_iI_c20220706__us-gaap--BusinessAcquisitionAxis__custom--SafegardMedicalIncMember_zq9QQxRurEB7" title="Transaction costs">53,576</span>, with the allocation to the assets acquired on a relative fair value basis. The intangibles relate to permits and a
limited workforce acquired. Under ASC 805-50, no goodwill is recognized. The operating results for Safegard are included in the condensed
consolidated financial statements for the period beginning after the closing on July 6, 2022.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p id="xdx_891_eus-gaap--ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock_zITHKT5SKAKj" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
relative fair value of the assets acquired and related deferred tax liability during 2022 was as follows:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span id="xdx_8BE_z5TwLTl3j1f" style="display: none">Schedule of Fair Value of  Assets Acquisition</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 70%">
  <tr style="display: none; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_497_20220706__us-gaap--BusinessAcquisitionAxis__custom--SafegardMedicalIncMember_zGwXKy86eZEl" style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_407_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLand_iI_maBCRIAzqVv_zG3wN4mZxHPc" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 80%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Land</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="width: 16%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">226,000</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr id="xdx_402_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment_iI_maBCRIAzqVv_z1rt3UafJmY8" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Building and affixed assets</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2,648,000</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr id="xdx_404_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedEquipment_iI_maBCRIAzqVv_zX1DNhQFnsO6" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Machinery</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">158,000</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr id="xdx_40A_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory_iI_maBCRIAzqVv_zdmKJ0iRHiZj" style="vertical-align: bottom; background-color: White">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Inventory</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">32,000</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr id="xdx_400_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles_iI_maBCRIAzqVv_zmc8vOTjXUl2" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Intangibles</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">64,712</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr id="xdx_40B_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities_iNI_di_msBCRIAzqVv_zVKCI8dWFBO9" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Deferred
    tax liability</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(192,000</span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr id="xdx_40B_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets_iTI_mtBCRIAzqVv_zNz4Et0NTls1" style="vertical-align: bottom; background-color: White">
    <td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Total</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2,936,712</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  </table>

<p id="xdx_8A7_zA0IAGnDv4Ge" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
useful lives for the acquired assets is Building - <span id="xdx_904_eus-gaap--PropertyPlantAndEquipmentUsefulLife_iI_dtY_c20220706__us-gaap--BusinessAcquisitionAxis__custom--SafegardMedicalIncMember__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--BuildingMember_zqWUg6HknTCc" title="Fixed assets acquired, useful lives">20</span> years; Machinery &#8211; <span id="xdx_900_eus-gaap--PropertyPlantAndEquipmentUsefulLife_iI_dtY_c20220706__us-gaap--BusinessAcquisitionAxis__custom--SafegardMedicalIncMember__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--MachineryAndEquipmentMember__srt--RangeAxis__srt--MinimumMember_z3PNPRElCD7f" title="Fixed assets acquired, useful lives">5</span> to <span id="xdx_902_eus-gaap--PropertyPlantAndEquipmentUsefulLife_iI_dtY_c20220706__us-gaap--BusinessAcquisitionAxis__custom--SafegardMedicalIncMember__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--MachineryAndEquipmentMember__srt--RangeAxis__srt--MaximumMember_zLb4EkCTMFtj" title="Fixed assets acquired, useful lives">10</span> years; Intangibles &#8211; <span id="xdx_905_eus-gaap--FiniteLivedIntangibleAssetUsefulLife_iI_dtY_c20220706__us-gaap--BusinessAcquisitionAxis__custom--SafegardMedicalIncMember_zCGxRPdh5eq" title="Intangible asset acquired, useful lives">5</span> years. The related
depreciation and amortization is being recorded on a straight-line basis.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<span></span>
</td>
<td class="text"><p id="xdx_808_eus-gaap--AssetAcquisitionTextBlock_zCulz1UGYe0g" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Note
5. <span id="xdx_82F_zH1pkZyQBVAe">Asset Acquisition</span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
June 2020, the Company entered into a Share Purchase Agreement (&#8220;Agreement&#8221;) with Safegard Medical (&#8220;Safegard&#8221;)
and amendments to the Agreement, collectively, the Agreements, to purchase either the stock or certain assets of a manufacturing facility
for $<span id="xdx_906_eus-gaap--AssetAcquisitionConsiderationTransferred_pn5n6_c20200601__20200630__us-gaap--TypeOfArrangementAxis__custom--SharePurchaseAgreementMember_zXXflAkB7AT7" title="Asset acquisition">2.5</span>M in cash, plus additional consideration of <span id="xdx_906_eus-gaap--StockIssuedDuringPeriodSharesAcquisitions_c20200601__20200630__us-gaap--TypeOfArrangementAxis__custom--SharePurchaseAgreementMember__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zoUph2Jvco1l" title="Additional consideration, shares">28,571</span> shares of common stock with an estimated fair market value of $<span id="xdx_90D_eus-gaap--SharePrice_iI_c20200630__us-gaap--TypeOfArrangementAxis__custom--SharePurchaseAgreementMember__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zusBsFuv4O28" title="Share price">7.00</span>, <span id="xdx_90E_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod_c20200601__20200630__us-gaap--TypeOfArrangementAxis__custom--SharePurchaseAgreementMember__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember_znpAjWNBL8P" title="Stock options issued">35,714</span>
stock options with an exercise price of $<span id="xdx_905_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_pid_c20200601__20200630__us-gaap--TypeOfArrangementAxis__custom--SharePurchaseAgreementMember__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember_zxoaLKrp7J9f" title="Exercise price">7.00</span> and <span id="xdx_901_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod_c20200601__20200630__us-gaap--TypeOfArrangementAxis__custom--SharePurchaseAgreementMember__us-gaap--AwardTypeAxis__custom--StockOptionOneMember_zJSxH3qrSPkj" title="Stock options issued">50,000</span> stock options with an exercise price of $<span id="xdx_90D_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_pid_c20220705__20220706__us-gaap--TypeOfArrangementAxis__custom--SharePurchaseAgreementMember__us-gaap--AwardTypeAxis__custom--StockOptionOneMember_zw6xZry15Fl5" title="Exercise price">4.25</span>. The purchase price includes the
fair market value of the common stock of $<span id="xdx_904_ecustom--FairMarketValueOfCommonStock_c20200601__20200630__us-gaap--TypeOfArrangementAxis__custom--SharePurchaseAgreementMember__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zwJctNKXD3J6" title="Fair market value of common stock">200,000</span> and the vested options of $<span id="xdx_90E_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1_c20200601__20200630__us-gaap--TypeOfArrangementAxis__custom--SharePurchaseAgreementMember__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember_zfJ3E5Fk1Eeb" title="Vested options, value">183,135</span>. The Agreements provided the Company various periods
for due diligence and post due diligence, requirements for escrow payments through the closing date (&#8220;Closing Date&#8221;).</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Through
the Closing Date, the Agreements provided the Company with the exclusive use of the facility in exchange for payment of the facility&#8217;s
operating costs. The monthly fee (&#8220;Operating Costs&#8221;), which primarily covered the facility&#8217;s operating costs, was mainly
comprised of the seller&#8217;s workforce costs, materials and other recurring monthly operating cost.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">During
the year ended December 31, 2022, the Company had remitted <span id="xdx_900_eus-gaap--OperatingCostsAndExpenses_c20220101__20221231__us-gaap--TypeOfArrangementAxis__custom--SharePurchaseAgreementMember_zTjHmH7uo4V2" title="Operating costs">$594,000</span>, respectively for the aforementioned Operating Costs. The remittance
of operating costs was discontinued after the Closing Date. These costs were included in research and development expense in the consolidated
statement of operations as the activities at the facility in 2022 were related to design and testing of the Company&#8217;s products.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>




<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>SHARPS
TECHNOLOGY, INC.</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTES
TO THE CONSOLIDATED FINANCIAL STATEMENTS</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>FOR
THE YEARS ENDED DECEMBER 31, 2023 AND 2022</b></span></p>

<p style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Note
5. Asset Acquisition (continued)</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
acquisition of Safegard, which closed on July 6, 2022, did not meet the definition of a business pursuant to ASC 805-10, and accordingly
was accounted for as an asset acquisition in accordance with ASC 805-50. The cost of the acquisition was $<span id="xdx_90C_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets_iI_c20220706__us-gaap--BusinessAcquisitionAxis__custom--SafegardMedicalIncMember_zLK0DDXMciqc" title="Acquisition cost">2,936,712</span>, including transaction
costs of $<span id="xdx_90F_eus-gaap--FairValueOfAssetsAcquired_c20220705__20220706__us-gaap--BusinessAcquisitionAxis__custom--SafegardMedicalIncMember_zycTPxydM2i9" title="Fair value of assets acquired">53,576</span>, with the allocation to the assets acquired on a relative fair value basis. The intangibles relate to permits and a
limited workforce acquired. Under ASC 805-50, no goodwill is recognized. The operating results for Safegard are included in the consolidated
balance sheet and consolidated statements of operations for the period beginning after the closing on July 6, 2022.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p id="xdx_897_eus-gaap--ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock_zYnRON4oCd9g" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
relative fair value of the assets acquired and related deferred tax liability is as follows:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify">&#160;<span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_8B4_zhBGM60lA9Y4" style="display: none">Schedule of Fair Value of the Assets Acquisition</span></span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 60%">
  <tr style="display: none; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_493_20220706__us-gaap--BusinessAcquisitionAxis__custom--SafegardMedicalIncMember_z8jfhEywzJwd" style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_407_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLand_iI_maBCRIAzqVv_zgKz5DNiWW1b" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 78%">Land</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 18%; text-align: right">226,000</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr id="xdx_407_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedBuildings_iI_maBCRIAzqVv_z4o0moTfk161" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Building and affixed assets</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">2,684,000</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_404_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedEquipment_iI_maBCRIAzqVv_zxo4Cnum8AIj" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>Machinery</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">158,000</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40A_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory_iI_maBCRIAzqVv_z8bi35VTpHfb" style="vertical-align: bottom; background-color: White">
    <td>Inventory</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">32,000</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_400_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles_iI_maBCRIAzqVv_zs0rD6bcn8G4" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>Intangibles</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">64,712</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40B_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities_iNI_di_msBCRIAzqVv_zY4qYyAyt4Md" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1pt">Deferred tax liability</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(192,000</td><td style="padding-bottom: 1pt; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40B_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets_iTI_mtBCRIAzqVv_zahGjZNGCkwk" style="vertical-align: bottom; background-color: White">
    <td style="padding-bottom: 1pt">Total</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">$</td><td style="border-bottom: Black 1pt solid; text-align: right">2,936,712</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  </table>

<p id="xdx_8AD_zhd8uPXxv0fk" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
useful lives for the acquired assets is Building - <span id="xdx_907_eus-gaap--FiniteLivedIntangibleAssetUsefulLife_iI_dtY_c20231231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--BuildingMember_zfpQnoySQNIb" title="Finite-lived intangible asset, useful life">20</span> years; Machinery &#8211; <span id="xdx_90C_eus-gaap--FiniteLivedIntangibleAssetUsefulLife_iI_dtY_c20231231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--MachineryAndEquipmentMember__srt--RangeAxis__srt--MinimumMember_zHaPVOotDqZ4" title="Finite-lived intangible asset, useful life">5</span> to <span id="xdx_90A_eus-gaap--FiniteLivedIntangibleAssetUsefulLife_iI_dtY_c20231231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--MachineryAndEquipmentMember__srt--RangeAxis__srt--MaximumMember_zBlHM6Hpr8Fc" title="Finite-lived intangible asset, useful life">10</span> years; Intangibles &#8211; <span id="xdx_908_eus-gaap--FiniteLivedIntangibleAssetUsefulLife_iI_dtY_c20231231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--FiniteLivedIntangibleAssetsMember_zBvMX8qJXeAi" title="Finite-lived intangible asset, useful life">5</span> years. The related
depreciation and amortization is being recorded on a straight-line basis.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetAcquisitionTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for asset acquisition.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 805<br> -SubTopic 50<br> -Name Accounting Standards Codification<br> -Section 15<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480123/805-50-15-3<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetAcquisitionTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationAndAssetAcquisitionAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>115
<FILENAME>R13.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.4</span><table class="report" border="0" cellspacing="2" id="idm45095369510272">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Other Assets<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureAbstract', window );"><strong>Deferred Costs, Capitalized, Prepaid, and Other Assets Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherAssetsDisclosureTextBlock', window );">Other Assets</a></td>
<td class="text"><p id="xdx_809_eus-gaap--OtherAssetsDisclosureTextBlock_zR2EMEbczMoh" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Note
6. <span id="xdx_826_zFVszYWWG5Z6">Other Assets</span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p id="xdx_89D_eus-gaap--ScheduleOfOtherAssetsTableTextBlock_z0InxzEYOjck" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Other
assets as of September 30, 2024, and December 31, 2023 are summarized as follows:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span id="xdx_8B8_z1deStF3dQHc" style="display: none">Schedule of Other Assets</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" id="xdx_491_20240930_ziHbvl5Jyvj7" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">September
    30, 2024</span></td><td style="padding-bottom: 1pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" id="xdx_49C_20231231_ziJNYIIR20N8" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">December
    31, 2023</span></td><td style="padding-bottom: 1pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr id="xdx_403_eus-gaap--IntangibleAssetsNetExcludingGoodwill_iI_maOANzzDQ_z6mTdWXPecQl" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 60%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Intangibles, net &#8211; See Note 6</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="width: 16%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">40,227</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="width: 16%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">52,513</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr id="xdx_40D_eus-gaap--OtherAssetsMiscellaneousNoncurrent_iI_maOANzzDQ_zwGSSBFesi67" style="vertical-align: bottom; background-color: White">
    <td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Other &#8211; See Note 7</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">326,061</span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">76,062</span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr id="xdx_409_eus-gaap--OtherAssetsNoncurrent_iTI_mtOANzzDQ_zRCJl1BDGp56" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 1pt"><span style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;Total Other assets</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">366,288</span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">128,575</span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  </table>

<p id="xdx_8A9_zhGzMIuJgrDh" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>





<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>SHARPS
TECHNOLOGY, INC.</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTES
TO THE CONDENSED CONSOLIDATED FINANCIAL STATEMENTS</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>FOR
THE THREE AND NINE MONTHS ENDED SEPTEMBER 30, 2024 AND 2023</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<span></span>
</td>
<td class="text"><p id="xdx_801_eus-gaap--OtherAssetsDisclosureTextBlock_zPmnljukSxi1" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Note
6. <span id="xdx_825_zznUHocMli91">Other Assets</span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p id="xdx_89A_eus-gaap--ScheduleOfOtherAssetsTableTextBlock_zIGFjiFojy87" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Other
assets as of December 31, 2023 and 2022 are summarized as follows:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;<span id="xdx_8B9_zuK22lThk6sf" style="display: none">Schedule of Other Assets</span></span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 80%">
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" id="xdx_49F_20231231_z5bdXbgC7sBh" style="font-weight: bold; text-align: center">December 31,</td><td style="font-weight: bold">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" id="xdx_491_20221231_zaS8ZjMFTSd6" style="font-weight: bold; text-align: center">December 31,</td><td style="font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2023</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2022</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td></tr>
  <tr id="xdx_403_eus-gaap--IntangibleAssetsNetExcludingGoodwill_iI_maOANzzDQ_z3R17s4dQmzc" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 60%; text-align: left">Intangibles, net</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 16%; text-align: right">52,513</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 16%; text-align: right">62,480</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr id="xdx_401_eus-gaap--DepositsAssets_iI_maOANzzDQ_zMNSmwMjaYWa" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Deposits or advance payments on machinery, molds and components (see Note 15)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><p style="margin: 0"><span style="-sec-ix-hidden: xdx2ixbrl0738">-</span></p></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">336,466</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40C_eus-gaap--OtherAssetsMiscellaneousNoncurrent_iI_maOANzzDQ_zdth0WrOGOm8" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 1pt">Other</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">76,062</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">12,370</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_409_eus-gaap--OtherAssetsNoncurrent_iTI_mtOANzzDQ_zOelROCnvAn1" style="vertical-align: bottom; background-color: White">
    <td style="padding-bottom: 1pt"><span style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt">Other
    assets</span></td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">$</td><td style="border-bottom: Black 1pt solid; text-align: right">128,575</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">$</td><td style="border-bottom: Black 1pt solid; text-align: right">411,316</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  </table>

<p id="xdx_8AF_z7FLsV8gq8he" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Intangibles
are related to the Asset Acquisition (see Note 5) and consist of an acquired workforce and permits. Amortization for the year ended December
31, 2023 was $<span id="xdx_903_eus-gaap--AmortizationOfIntangibleAssets_c20230101__20231231_zjVppxxqXbU1" title="Amortization of intangible assets">15,184</span>.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherAssetsDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for other assets. This disclosure includes other current assets and other noncurrent assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherAssetsDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>116
<FILENAME>R14.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.4</span><table class="report" border="0" cellspacing="2" id="idm45095367605520">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Debt Financing<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtDisclosureAbstract', window );"><strong>Debt Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtDisclosureTextBlock', window );">Debt Financing</a></td>
<td class="text"><p id="xdx_808_eus-gaap--DebtDisclosureTextBlock_zuFK5df5uaAa" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Note
7. <span id="xdx_82C_ze8D637EGr8h">Debt Financing</span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
September 20, 2024, the Company entered into a securities purchase agreement (the &#8220;Securities Purchase Agreement&#8221;) and a
Senior Secured Note (the &#8220;Note&#8221;) for an aggregate principal amount of $<span id="xdx_903_eus-gaap--DebtInstrumentFaceAmount_iI_c20240920__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__us-gaap--DebtInstrumentAxis__custom--SeniorSecuredNoteMember_zliuHirJYfLh">4,375,000</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">,
including OID interest of $<span id="xdx_903_eus-gaap--DebtInstrumentIncreaseAccruedInterest_c20240920__20240920__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__us-gaap--DebtInstrumentAxis__custom--SeniorSecuredNoteMember_zj0riSknwLdl" title="Original issue discount (OID)">875,000 </span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">maturing
on <span id="xdx_903_eus-gaap--DebtInstrumentMaturityDate_dd_c20240920__20240920__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__us-gaap--DebtInstrumentAxis__custom--SeniorSecuredNoteMember_zBMDZZSxXTz4">January
31, 2025</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">, with certain purchasers (the
&#8220;Purchasers&#8221;), and the issuance of approximately <span id="xdx_90A_ecustom--NumberOfUnregisteredCommonStockIssuedDuringPostReverseShares_pid_c20240920__20240920__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__us-gaap--DebtInstrumentAxis__custom--SeniorSecuredNoteMember_zvzZ6q21X7ha" title="Number of unregistered common stock issued during post reverse shares">259,091 </span></span>(pre
reverse - <span id="xdx_903_ecustom--NumberOfUnregisteredCommonStockIssuedDuringPreReverseShares_pid_c20240920__20240920__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__us-gaap--DebtInstrumentAxis__custom--SeniorSecuredNoteMember__us-gaap--AwardTypeAxis__custom--PreReverseMember_zcsLkCRMOkD6" title="Pre reverse">5,700,006</span> ) unregistered shares of the Company&#8217;s Common Stock. The aggregate gross proceeds to the Company were
approximately $<span id="xdx_90F_eus-gaap--ProceedsFromIssuanceOfDebt_pn5n6_c20240920__20240920__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__us-gaap--DebtInstrumentAxis__custom--SeniorSecuredNoteMember_zK4Q5qUBQddk">3.5 </span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">million,
before deducting fees to the placement agent and other offering expenses payable by the Company of $<span id="xdx_908_ecustom--PlacementAgentAndOtherOfferingExpenses_c20240920__20240920__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__us-gaap--DebtInstrumentAxis__custom--SeniorSecuredNoteMember_z4HeS0lGiHYh" title="Closing costs">514,700 </span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">and
an escrow deposit of $<span id="xdx_903_eus-gaap--EscrowDeposit_iI_c20240920__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__us-gaap--DebtInstrumentAxis__custom--SeniorSecuredNoteMember_z98EFWS5ASe8">250,000 </span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">required
until certain security liens are filed. The Note and the common stock were recorded at the relative fair values of $<span id="xdx_900_eus-gaap--DebtInstrumentFairValue_iI_pn5n6_c20240920__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__us-gaap--DebtInstrumentAxis__custom--SeniorSecuredNoteMember_zv0NsEqPWpIb">2.6</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">M
and $<span id="xdx_908_ecustom--CommonStockFairValue_iI_c20240920__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__us-gaap--DebtInstrumentAxis__custom--SeniorSecuredNoteMember_zL9KkwMAsE9c" title="Common stock fair value">852,000</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">,
respectively, in accordance with ASC 470-20-25-2. The aforementioned expenses were allocated based on the aforementioned fair values
as a reduction to the carrying amount of the debt and a reduction of the equity in accordance with ASC 505-10. </span>For the three
and nine months ended September 30, 2024, the Company recorded accreted interest and fees of $<span id="xdx_903_ecustom--AccretedInterestFees_c20240101__20240930_zQAFf1QTzaZd" title="Accreted interest fees">75,192</span>.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
connection with the Securities Purchase Agreement and Note, the Company entered into a Registration Rights Agreement with the Purchasers
(the &#8220;Registration Rights Agreement&#8221;), requiring the Company to file a resale registration statement (the &#8220;Registration
Statement&#8221;) with the U.S. Securities and Exchange Commission (the &#8220;Commission&#8221;) to register the unregistered shares
of Common Stock. within forty-five (45) calendar days following the filing date, which is thirty (30) days after the closing date. The
Company filed the required resale registration statement on October 23, 2024.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<span></span>
</td>
<td class="text"><p id="xdx_803_eus-gaap--DebtDisclosureTextBlock_zkgtYdG5woL8" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Note 7. <span id="xdx_82A_zrkfsE3ylwCf">Debt Financing</span>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>
<p style="font: 10pt Times New Roman, Times, Serif; display: none; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
September 20, 2024, the Company entered into a securities purchase agreement (the &#8220;Securities Purchase Agreement&#8221;) and a
Senior Secured Note (the &#8220;Note&#8221;) for an aggregate principal amount of $<span id="xdx_900_eus-gaap--DebtInstrumentFaceAmount_iI_c20240920__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__us-gaap--DebtInstrumentAxis__custom--SeniorSecuredNoteMember_zUSgrLpLCko2">4,375,000</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">,
including OID interest of $<span id="xdx_902_eus-gaap--DebtInstrumentIncreaseAccruedInterest_c20240920__20240920__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__us-gaap--DebtInstrumentAxis__custom--SeniorSecuredNoteMember_zBiOuGzRoV8j" title="Original issue discount (OID)">875,000 </span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">maturing
on <span id="xdx_909_eus-gaap--DebtInstrumentMaturityDate_dd_c20240920__20240920__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__us-gaap--DebtInstrumentAxis__custom--SeniorSecuredNoteMember_zuMKRwZ44Unl">January
31, 2025</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">, with certain purchasers (the
&#8220;Purchasers&#8221;), and the issuance of approximately <span id="xdx_909_ecustom--NumberOfUnregisteredCommonStockIssuedDuringPostReverseShares_pid_c20240920__20240920__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__us-gaap--DebtInstrumentAxis__custom--SeniorSecuredNoteMember_zsgBJOT2Re7b" title="Number of unregistered common stock issued during post reverse shares">259,091 </span></span>(pre
reverse - <span id="xdx_908_ecustom--NumberOfUnregisteredCommonStockIssuedDuringPreReverseShares_pid_c20240920__20240920__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__us-gaap--DebtInstrumentAxis__custom--SeniorSecuredNoteMember__us-gaap--AwardTypeAxis__custom--PreReverseMember_zaQgLgiCUT1h" title="Pre reverse">5,700,006</span> ) unregistered shares of the Company&#8217;s Common Stock. The aggregate gross proceeds to the Company were
approximately $<span id="xdx_90B_eus-gaap--ProceedsFromIssuanceOfDebt_pn5n6_c20240920__20240920__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__us-gaap--DebtInstrumentAxis__custom--SeniorSecuredNoteMember_zMEoMg7hte0l">3.5 </span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">million,
before deducting fees to the placement agent and other offering expenses payable by the Company of $<span id="xdx_90E_ecustom--PlacementAgentAndOtherOfferingExpenses_pid_c20240920__20240920__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__us-gaap--DebtInstrumentAxis__custom--SeniorSecuredNoteMember_zss4mj0OW3bf" title="Closing costs">514,700 </span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">and
an escrow deposit of $<span id="xdx_902_eus-gaap--EscrowDeposit_iI_c20240920__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__us-gaap--DebtInstrumentAxis__custom--SeniorSecuredNoteMember_zrRvCfl3u0Z1">250,000 </span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">required
until certain security liens are filed. The Note and the common stock were recorded at the relative fair values of $<span id="xdx_904_eus-gaap--DebtInstrumentFairValue_iI_pn5n6_c20240920__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__us-gaap--DebtInstrumentAxis__custom--SeniorSecuredNoteMember_zYdWHTDxdjGk">2.6</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">M
and $<span id="xdx_905_ecustom--CommonStockFairValue_iI_c20240920__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__us-gaap--DebtInstrumentAxis__custom--SeniorSecuredNoteMember_z0faco6l3FHk" title="Common stock fair value">852,000</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">,
respectively, in accordance with ASC 470-20-25-2. The aforementioned expenses were allocated based on the aforementioned fair values
as a reduction to the carrying amount of the debt and a reduction of the equity in accordance with ASC 505-10. </span>For the three
and nine months ended September 30, 2024, the Company recorded accreted interest and fees of $<span id="xdx_909_ecustom--AccretedInterestFees_c20240101__20240930_zFgDKJLkZCsf" title="Accreted interest fees">75,192</span>.</p>

<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for information about short-term and long-term debt arrangements, which includes amounts of borrowings under each line of credit, note payable, commercial paper issue, bonds indenture, debenture issue, own-share lending arrangements and any other contractual agreement to repay funds, and about the underlying arrangements, rationale for a classification as long-term, including repayment terms, interest rates, collateral provided, restrictions on use of assets and activities, whether or not in compliance with debt covenants, and other matters important to users of the financial statements, such as the effects of refinancing and noncompliance with debt covenants.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481544/470-10-50-6<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481544/470-10-50-6<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 405<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477092/405-40-50-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 405<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477092/405-40-50-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 405<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477092/405-40-50-1<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 405<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477092/405-40-50-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 405<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477092/405-40-50-1<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (h)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1B<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(c))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 10: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 470<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org/470/tableOfContent<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 835<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482925/835-30-45-2<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1B<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (g)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1B<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1B<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1C<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1C<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1C<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1C<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1C<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1C<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1E<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1E<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1I<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1I<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1I<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1I<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1I<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1I<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>117
<FILENAME>R15.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.4</span><table class="report" border="0" cellspacing="2" id="idm45095372949376">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Note Purchase Agreement<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_STSS_DisclosureNotePurchaseAgreementAbstract', window );"><strong>Note Purchase Agreement</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_STSS_NotePurchaseAgreementTextBlock', window );">Note Purchase Agreement</a></td>
<td class="text"><p id="xdx_807_ecustom--NotePurchaseAgreementTextBlock_zyE4rb7jrZB" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Note
7. <span id="xdx_820_zrPl3EgnjBmh">Note Purchase Agreement</span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
December 14, 2021, the Company entered into a Note Purchase Agreement (&#8220;NPA&#8221;) with three unrelated third-party purchasers
(&#8220;Purchasers&#8221;). The Purchasers provided financing to the Company in the form of bridge financing, aggregating principal of
$<span id="xdx_903_eus-gaap--DebtInstrumentFaceAmount_iI_c20211214__us-gaap--TypeOfArrangementAxis__custom--NotePurchaseAgreementMember__srt--TitleOfIndividualAxis__custom--UnrelatedThirdPartyPurchasersMember_zNKzG7EyFY2g" title="Debt instrument face amount">2,000,000</span> (the &#8220;Notes&#8221;). The principal under the Notes shall be payable on the earlier of (i) December 14, 2022, and (ii)
the date on which the Company consummates an initial public offering (&#8220;IPO&#8221;), herein referred to as the &#8220;Maturity Date&#8221;.
The Notes bore interest at <span id="xdx_909_eus-gaap--DebtInstrumentInterestRateStatedPercentage_iI_pid_dp_uPure_c20211214__us-gaap--TypeOfArrangementAxis__custom--NotePurchaseAgreementMember__srt--TitleOfIndividualAxis__custom--UnrelatedThirdPartyPurchasersMember_z2KxI7DqUtib" title="Interest rate">8</span>% with interest payments due monthly. The Company and the Purchasers had entered into a Security Agreement
whereby the Notes were collateralized by substantially all the assets of the Company, both tangible and intangible both currently owned
with stated exclusions, as defined, and any future acquired with stated exclusions, as defined.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>




<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>SHARPS
TECHNOLOGY, INC.</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTES
TO THE CONSOLIDATED FINANCIAL STATEMENTS</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>FOR
THE YEARS ENDED DECEMBER 31, 2023 AND 2022</b></span></p>

<p style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Note
7. Note Purchase Agreement (continued)</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
NPA provided for covenants that until all of the Notes have been converted, exchanged, redeemed or otherwise satisfied in accordance
with their terms, the Company shall not, and the Company shall not permit any of its subsidiaries without the prior written consent of
the Purchasers: a) incur or guarantee any new debt, b) issue any securities that would cause a breach or default under the NPA, c) incur
any liens other than permitted, d) redeem or repurchase shares, e) declare or pay any cash dividend or distribution, e) sell, lease or
dispose of assets other than in the ordinary course of business, or f) engage in different line of business.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_909_eus-gaap--DebtInstrumentDescription_c20211213__20211214__us-gaap--TypeOfArrangementAxis__custom--NotePurchaseAgreementMember__srt--TitleOfIndividualAxis__custom--UnrelatedThirdPartyPurchasersMember_zAcZWuH4Ihpg" title="Debt description">As
additional consideration to the Purchasers for providing the financing, the Company also agreed to a) issue each Purchaser a number of
shares of the Company&#8217;s Common Stock equal to 50% of the original principal amount of each Purchaser&#8217;s Note (the &#8220;Contingent
Stock&#8221;) and b) issue each Purchaser a number of warrants, which would allow the Purchasers to purchase additional shares of the
Company&#8217;s Common Stock, equal to 50% of the original principal amount each Purchaser&#8217;s Note for a term of 5.0 years (the
&#8220;Contingent Warrants&#8221;).</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">For
both the Contingent Stock and the Contingent Warrants, the number of shares and warrants that each Purchaser will be issued was unknown
at the time of the NPA and was determined based on a formula of 50% of the original principal amount divided by a &#8220;Subsequent Offering
Price&#8221; based on the valuation in a future offering of Common stock or other equity interest in the Company (such offering referred
to as a &#8220;Consummated Offering&#8221;) during the period beginning on December 14, 2021 through and including the date the Company
consummates an initial public offering (&#8220;IPO&#8221;) (such period referred to as the &#8220;Subsequent Offering Period&#8221;).</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
accordance with ASC 480-10-25-14, a fixed monetary amount exists at inception for the total value of Contingent Stock that may be issued
to each Purchaser. The Contingent Stock is not considered outstanding at inception, as it will only be issued upon the consummation of
a Consummated Offering, and accordingly, is a conditional obligation. As such the fair market value (&#8220;FMV&#8221;) of the Contingent
Stock at inception was <span id="xdx_90B_ecustom--ContingentStockLiability_iI_c20211214__us-gaap--TypeOfArrangementAxis__custom--NotePurchaseAgreementMember_zp7B393ZHFh8" title="Contingent stock liability">$677,000</span>, which was recorded as debt discount. Similarly, a fixed monetary amount further exists at inception
for the total value of Contingent Warrants that may be issued to each Purchaser. Accordingly, a conditional obligation exists and as
such the FMV of Contingent Warrants at inception was $<span id="xdx_908_ecustom--ContingentWarrantLiability_iI_c20211214__us-gaap--TypeOfArrangementAxis__custom--NotePurchaseAgreementMember_zh7oj8PGg1ck" title="Contingent warrants liability">585,000</span>, which was recorded as debt discount. The Company incurred $<span id="xdx_90B_eus-gaap--PaymentsOfDebtIssuanceCosts_c20211213__20211214__us-gaap--TypeOfArrangementAxis__custom--NotePurchaseAgreementMember__srt--TitleOfIndividualAxis__custom--UnrelatedThirdPartyPurchasersMember_ziEU1TLBoVw9" title="Debt issuance costs">197,500</span> of
debt issuance costs associated with the NPA. The debt issuance costs were allocated between the Notes, Contingent Stock and Contingent
Warrants in a manner that was consistent with the allocation of the proceeds of the Notes. The portion of the debt issuance costs which
were allocated to the Contingent Stock and Contingent Warrants, which was $<span id="xdx_901_ecustom--AllocationOfDebtIssuanceCostToContingentStockAndContingentWarrants_iI_c20211231__us-gaap--TypeOfArrangementAxis__custom--NotePurchaseAgreementMember_zt9cjTpr152i" title="Allocation of debt issuance cost to contingent stock and contingent warrants">124,460</span>, was expensed during the year ended December 31, 2021.
The debt issuance costs allocated to the Notes were recorded as a debt discount.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Contingent Stock and Contingent Warrant liabilities were measured at FMV on the date of issuance (based on the Black-Scholes valuation
model).</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">At
inception, the Notes were recorded at the net amount of approximately $<span id="xdx_90D_eus-gaap--NotesPayable_iI_c20211231__us-gaap--TypeOfArrangementAxis__custom--NotePurchaseAgreementMember_zYJ5f1N3ps9j" title="Notes payable">665,000</span>, after adjusting for debt discounts of approximately $<span id="xdx_90C_eus-gaap--DebtInstrumentUnamortizedDiscount_iI_c20211231__us-gaap--TypeOfArrangementAxis__custom--NotePurchaseAgreementMember_zEWqvaCFQ1O1" title="Debt discount">1,335,000</span>
relating to the debt issuance costs, Contingent Stock and Contingent Warrants. Management calculates the effective interest rate (&#8220;EIR&#8221;)
to consider the potential repayment at redemption date by reference to the face value amount after taking into account the stated <span id="xdx_90F_eus-gaap--DebtInstrumentInterestRateStatedPercentage_iI_pid_dp_uPure_c20211231__us-gaap--TypeOfArrangementAxis__custom--NotePurchaseAgreementMember_zINeMPmlZFqg" title="Interest rate">8</span>%
interest rate. In 2022, through the repayment date, the Company recorded interest expense of $<span id="xdx_90E_eus-gaap--InterestExpense_c20220101__20221231__us-gaap--TypeOfArrangementAxis__custom--NotePurchaseAgreementMember_zUqbQ2PaQQ73" title="Interest expense">39,111</span> and accreted interest of $<span id="xdx_904_eus-gaap--InterestPayableCurrent_iI_c20221231__us-gaap--TypeOfArrangementAxis__custom--NotePurchaseAgreementMember_zMYXI25GYpsd" title="Accreted interest">1,299,895</span>
and repaid the $<span id="xdx_901_eus-gaap--RepaymentsOfDebt_c20220101__20221231__us-gaap--TypeOfArrangementAxis__custom--NotePurchaseAgreementMember_zCEEahMCeL1g" title="Notes payable">2,000,000</span> in Notes with proceeds from the IPO that closed on April 19, 2022.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
value of the Contingent Stock and Contingent Warrants is required to be re-measured at FMV at each reporting date, using either the Black-Scholes
valuation model or other valuation method, if deemed more appropriate, with recognition of the changes in fair value to other income
or expense in the consolidated statement of operations in accordance with ASC 480, Debt and Equity. On April 19, 2022, the Company issued
<span id="xdx_900_eus-gaap--CommonStockSharesIssued_iI_c20220419__us-gaap--TypeOfArrangementAxis__custom--NotePurchaseAgreementMember_z1DOe5O9ZtR2" title="Common stock, shares issued">235,295</span> shares of Common Stock to settle the Contingent Stock liability, re-measured the liability at its estimated FMV based on the
stock&#8217;s trading price and reclassified $<span id="xdx_901_eus-gaap--FairValueAdjustmentOfWarrants_c20220417__20220419__us-gaap--TypeOfArrangementAxis__custom--NotePurchaseAgreementMember_zTEQWt79rGU9" title="Fair market value of warrant">496,000</span> to Common Stock Par Value and Additional Paid in Capital.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
connection with the closing of the IPO, <span id="xdx_906_ecustom--ContingentWarrants_c20220101__20221231__us-gaap--TypeOfArrangementAxis__custom--NotePurchaseAgreementMember__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--NoteWarrantMember_zoNMbOLItd9d" title="Contingent warrant">235,295</span> warrants were issued to settle the Contingent Warrant liability (&#8220;Note Warrants&#8221;)
with an exercise price of $<span id="xdx_908_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice_c20220101__20221231__us-gaap--TypeOfArrangementAxis__custom--NotePurchaseAgreementMember__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--NoteWarrantMember_zu2ogRvBjg83" title="Exercise price">4.25</span> adjusted to <span id="xdx_90E_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice_c20230929__20230929__us-gaap--TypeOfArrangementAxis__custom--NotePurchaseAgreementMember__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--NoteWarrantMember_z8wmUF9HzcFg" title="Exercise price">$0.64</span> at September 29, 2023, based on anti-dilution terms in the warrants. The terms of the
Note Warrants continue to require classification as a liability under ASC 815 with recognition of the changes in fair value to other
income or expense in the consolidated statement of operations in accordance with ASC 480 Debt and Equity. (See Notes 8 and 10)</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>




<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>SHARPS
TECHNOLOGY, INC.</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTES
TO THE CONSOLIDATED FINANCIAL STATEMENTS</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>FOR
THE YEARS ENDED DECEMBER 31, 2023 AND 2022</b></span></p>

<p style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_STSS_DisclosureNotePurchaseAgreementAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">STSS_DisclosureNotePurchaseAgreementAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>STSS_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_STSS_NotePurchaseAgreementTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Note Purchase Agreement [Text Block]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">STSS_NotePurchaseAgreementTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>STSS_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>118
<FILENAME>R16.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.4</span><table class="report" border="0" cellspacing="2" id="idm45095366258192">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Stockholders&#8217; Equity<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquityAbstract', window );"><strong>Equity [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityNoteDisclosureTextBlock', window );">Stockholders&#8217; Equity</a></td>
<td class="text"><p id="xdx_80E_eus-gaap--StockholdersEquityNoteDisclosureTextBlock_zlepTav0SE09" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Note
8. <span id="xdx_828_zc9BzTkVH4ze">Stockholders&#8217; Equity</span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Capital
Structure</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>&#160;</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
December 11, 2017, the Company was incorporated in Wyoming with <span id="xdx_909_eus-gaap--CommonStockSharesAuthorized_iI_c20171211_zObFdDWIxNJ5" title="Common stock, share authorized">20,000,000</span> shares of common stock authorized with a $<span id="xdx_903_eus-gaap--CommonStockParOrStatedValuePerShare_iI_c20171211_zzZomcI4bkch" title="Common stock, par value">0.0001</span> par value.
Effective, April 18, 2019, the Company&#8217;s authorized common stock was increased to <span id="xdx_90F_eus-gaap--CommonStockSharesAuthorized_iI_c20190418_zB4WALMVnysg" title="Common stock, share authorized">50,000,000</span> shares of common stock. The articles
of incorporation also authorized <span id="xdx_90B_eus-gaap--PreferredStockSharesAuthorized_iI_c20190418_zizPP87QWesf" title="Preferred stock, shares authorized">10,000</span> preferred shares with a $<span id="xdx_906_eus-gaap--PreferredStockParOrStatedValuePerShare_iI_c20190418_zbxGU9fVvIwf" title="Preferred stock, par value">0.001</span> par value.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Effective
March 22, 2022, the Company completed a plan and agreement of merger with Sharps Technology, Inc., a Nevada corporation (&#8220;Sharps
Nevada&#8221;). <span id="xdx_900_eus-gaap--ConversionOfStockDescription_c20220319__20220322_zantrWc3GQf2" title="Conversion of stock, description">Pursuant to the merger agreement, (i) the Company merged with and into Sharps Nevada, (ii) each 3.5 shares of common
stock of the Company were converted into one share of common stock of Sharps Nevada and (iii) the articles of incorporation and bylaws
of Sharps Nevada, became the articles of incorporation and bylaws of the surviving corporation.</span> The Company&#8217;s authorized common
stock and preferred stock increased from <span id="xdx_908_eus-gaap--CommonStockSharesAuthorized_iI_c20220321_z8IuS6QkXEV1" title="Common stock, share authorized">50,000,000</span> to <span id="xdx_90D_eus-gaap--CommonStockSharesAuthorized_iI_c20220322_z0abmZ0ilApb" title="Common stock, share authorized">100,000,000</span> and <span id="xdx_90F_eus-gaap--PreferredStockSharesAuthorized_iI_c20220321_zk63QZSibjyh" title="Preferred stock, shares authorized">10,000</span> to <span id="xdx_900_eus-gaap--PreferredStockSharesAuthorized_iI_c20220322_zBhs3NS9Fxal" title="Preferred stock, shares authorized">1,000,000</span> shares, respectively. The par value of preferred
stock decreased from $<span id="xdx_903_eus-gaap--PreferredStockParOrStatedValuePerShare_iI_c20220321_zzRUEw5Tmx4a" title="Preferred stock, par value">0.001</span> to $<span id="xdx_907_eus-gaap--PreferredStockParOrStatedValuePerShare_iI_c20220322_zG9Rt3sweHO" title="Preferred stock, par value">0.0001</span> per share.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
July 2024, the shareholders approved the increase of the authorized common stock from <span id="xdx_909_eus-gaap--CommonStockSharesAuthorized_iI_c20240731_zkRgJIXjFXq5" title="Common stock, share authorized">100,000,000</span> to <span id="xdx_905_eus-gaap--CommonStockSharesAuthorized_iI_c20240930_zToqCQmavXM1" title="Common stock, share authorized">500,000,000</span> which was subsequently
filed as an amendment to the articles of incorporation with the state of Nevada.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Common
Stock</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>&#160;</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
September 23, 2024, as noted in Note 7, in connection with the Securities Purchase Agreement and Note the Company issued <span id="xdx_901_eus-gaap--StockIssuedDuringPeriodSharesOther_pid_c20240923__20240923__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember_zlPmjF42fGHc" title="Issued shares of common stock">259,091</span>
(pre reverse - <span id="xdx_90A_eus-gaap--StockIssuedDuringPeriodSharesOther_pid_c20240923__20240923__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__us-gaap--AwardTypeAxis__custom--PrereverseMember_zKlqsPnmsBIj" title="Issued shares of common stock">5,700,006</span>)
shares of unregistered common stock.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>





<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
May 31 and June 13, 2024, the Company entered into subscription agreements with certain institutional investors, pursuant to which
the Company agreed to issue and sell to the investors <span id="xdx_902_eus-gaap--SaleOfStockNumberOfSharesIssuedInTransaction_pid_c20240531__20240531__us-gaap--TypeOfArrangementAxis__custom--SubscriptionAgreementsMember__srt--TitleOfIndividualAxis__custom--InvestorsMember_zjJklAyq4mBb" title="Number of shares sold"><span id="xdx_907_eus-gaap--SaleOfStockNumberOfSharesIssuedInTransaction_pid_c20240613__20240613__us-gaap--TypeOfArrangementAxis__custom--SubscriptionAgreementsMember__srt--TitleOfIndividualAxis__custom--InvestorsMember_zzRvbFayOitl" title="Number of shares sold">190,773</span></span>
(pre reverse - <span id="xdx_90B_eus-gaap--SaleOfStockNumberOfSharesIssuedInTransaction_pid_c20240531__20240531__us-gaap--TypeOfArrangementAxis__custom--SubscriptionAgreementsMember__srt--TitleOfIndividualAxis__custom--InvestorsMember__us-gaap--AwardTypeAxis__custom--PrereverseMember_zdQc4XC1X1B" title="Number of shares sold pre reverse"><span id="xdx_907_eus-gaap--SaleOfStockNumberOfSharesIssuedInTransaction_pid_c20240613__20240613__us-gaap--TypeOfArrangementAxis__custom--SubscriptionAgreementsMember__srt--TitleOfIndividualAxis__custom--InvestorsMember__us-gaap--AwardTypeAxis__custom--PrereverseMember_zhVEyFopSXWc" title="Number of shares sold pre reverse">4,197,000</span></span>)
shares (the &#8220;Shares&#8221;) of Common Stock, par value $<span id="xdx_902_eus-gaap--CommonStockParOrStatedValuePerShare_iI_pid_c20240531__us-gaap--TypeOfArrangementAxis__custom--SubscriptionAgreementsMember__srt--TitleOfIndividualAxis__custom--InvestorsMember_zCcLihvcTRCc" title="Common stock par value"><span id="xdx_902_eus-gaap--CommonStockParOrStatedValuePerShare_iI_pid_c20240613__us-gaap--TypeOfArrangementAxis__custom--SubscriptionAgreementsMember__srt--TitleOfIndividualAxis__custom--InvestorsMember_znV6OeA4ElNj" title="Common stock par value">0.0001</span></span>
per share of the Company at a price of $<span id="xdx_904_eus-gaap--SaleOfStockPricePerShare_iI_pid_c20240531__us-gaap--TypeOfArrangementAxis__custom--SubscriptionAgreementsMember__srt--TitleOfIndividualAxis__custom--InvestorsMember_z46HBaZP3Q36" title="Shares price"><span id="xdx_90C_eus-gaap--SaleOfStockPricePerShare_iI_pid_c20240613__us-gaap--TypeOfArrangementAxis__custom--SubscriptionAgreementsMember__srt--TitleOfIndividualAxis__custom--InvestorsMember_zxZI830ke7Y5" title="Shares price">8.36</span></span>
(pre reverse -$<span id="xdx_901_eus-gaap--SaleOfStockPricePerShare_iI_pid_c20240531__us-gaap--TypeOfArrangementAxis__custom--SubscriptionAgreementsMember__srt--TitleOfIndividualAxis__custom--InvestorsMember__us-gaap--AwardTypeAxis__custom--PrereverseMember_zRmY7sFSEuI8" title="Shares price pre reverse"><span id="xdx_90D_eus-gaap--SaleOfStockPricePerShare_iI_pid_c20240613__us-gaap--TypeOfArrangementAxis__custom--SubscriptionAgreementsMember__srt--TitleOfIndividualAxis__custom--InvestorsMember__us-gaap--AwardTypeAxis__custom--PrereverseMember_zEkSalHRuA5g" title="Shares price pre reverse">0.38)</span></span>
and received gross proceeds to the Company of $<span id="xdx_907_eus-gaap--ProceedsFromIssuanceOfCommonStock_pn5n6_c20240531__20240531__us-gaap--TypeOfArrangementAxis__custom--SubscriptionAgreementsMember__srt--TitleOfIndividualAxis__custom--InvestorsMember_zdSw9e5h5gm6" title="Gross proceeds"><span id="xdx_90C_eus-gaap--ProceedsFromIssuanceOfCommonStock_pn5n6_c20240613__20240613__us-gaap--TypeOfArrangementAxis__custom--SubscriptionAgreementsMember__srt--TitleOfIndividualAxis__custom--InvestorsMember_ztepZgJsdaX3" title="Gross proceeds">1.6</span></span>M,
before expenses to the placement agent and other offering expenses of $<span id="xdx_901_eus-gaap--OtherExpenses_c20240531__20240531__us-gaap--TypeOfArrangementAxis__custom--SubscriptionAgreementsMember__srt--TitleOfIndividualAxis__custom--InvestorsMember_zxi72i936Se" title="Other offering expenses"><span id="xdx_90A_eus-gaap--OtherExpenses_c20240613__20240613__us-gaap--TypeOfArrangementAxis__custom--SubscriptionAgreementsMember__srt--TitleOfIndividualAxis__custom--InvestorsMember_zkTohxQGlF4k" title="Other offering expenses">298,000</span></span>
with net proceeds, after reflecting par value, have been recorded in Additional Paid in Capital of $<span id="xdx_904_eus-gaap--AdditionalPaidInCapital_iI_c20240531__us-gaap--TypeOfArrangementAxis__custom--SubscriptionAgreementsMember__srt--TitleOfIndividualAxis__custom--InvestorsMember_zii3a3KXY41b" title="Additional paid in capital"><span id="xdx_90F_eus-gaap--AdditionalPaidInCapital_iI_c20240613__us-gaap--TypeOfArrangementAxis__custom--SubscriptionAgreementsMember__srt--TitleOfIndividualAxis__custom--InvestorsMember_zsESKedJmNm9" title="Additional paid in capital">1,296,903</span></span>.
The shares issued in the offering were offered at-the-market under Nasdaq rules and pursuant to the Company&#8217;s Form 1-A (the
&#8220;Offering Statement&#8221;), initially filed by the Company with the Securities and Exchange Commission under the Securities
Act of 1933, as amended on May 21, 2024, and qualified on May 30, 2024.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
May 30, 2024, the Company offered warrant inducements (the &#8220;Inducement Agreement&#8221;) to certain warrant holders (the
&#8220;Warrant Holders&#8221;) which references the warrants registered for sale under both the registration statements on Form S-1
(file No. 333-263715) and/or the registration statement on Form S-1 (File No. 333-275011) (collectively, the &#8220;Registration
Statements&#8221;) for up to a total of <span id="xdx_906_eus-gaap--ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_iI_pid_c20240530__us-gaap--TypeOfArrangementAxis__custom--InducementAgreementMember_zGkXgpBPe3lj" title="Warrants to purchase shares">499,932</span>
(pre reverse - <span id="xdx_908_eus-gaap--ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_iI_pid_c20240530__us-gaap--TypeOfArrangementAxis__custom--InducementAgreementMember__us-gaap--AwardTypeAxis__custom--PrereverseMember_zoY733Kqztca" title="Warrants to purchase shares pre reverse">10,998,524</span>)
warrants to purchase shares of the Company&#8217;s common stock, par value $<span id="xdx_904_eus-gaap--CommonStockParOrStatedValuePerShare_iI_pid_c20240530__us-gaap--TypeOfArrangementAxis__custom--InducementAgreementMember_zjehFMbIVIm8" title="Common stock, par value">0.0001</span>
per share. Pursuant to the Inducement Agreement, the exercise price of the existing warrants was reduced from $<span id="xdx_90F_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_pid_c20240529__us-gaap--TypeOfArrangementAxis__custom--InducementAgreementMember_z4hJnZnQss5k" title="Exercise price">14.08</span>
(pre reverse -$<span id="xdx_905_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_pid_c20240529__us-gaap--TypeOfArrangementAxis__custom--InducementAgreementMember__us-gaap--AwardTypeAxis__custom--PrereverseMember__srt--RangeAxis__srt--MaximumMember_zCdxVbxuXyWj" title="Exercise price pre reverse">0.64)</span>
per share to $<span id="xdx_907_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_pid_c20240529__us-gaap--TypeOfArrangementAxis__custom--InducementAgreementMember__us-gaap--AwardTypeAxis__custom--PrereverseMember_zT3Ob0ZAbCig" title="Exercise price pre reverse">7.26</span>
(pre reverse -$<span id="xdx_904_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_pid_c20240529__us-gaap--TypeOfArrangementAxis__custom--InducementAgreementMember__us-gaap--AwardTypeAxis__custom--PrereverseMember__srt--RangeAxis__srt--MinimumMember_zZryGGA7girl" title="Exercise price pre reverse">0.33</span>)
per share. In addition, for each warrant that was exercised, as a result of the Inducement Agreement, the Company agreed to issue
the Warrant Holders unregistered warrants with an exercise price of $<span id="xdx_90F_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_pid_c20240530__us-gaap--TypeOfArrangementAxis__custom--InducementWarrantsMember__srt--TitleOfIndividualAxis__custom--WarrantHoldersMember_zWM0NL7Ow4ci" title="Exercise price">9.90</span>
(pre reverse - $<span id="xdx_905_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_pid_c20240530__us-gaap--TypeOfArrangementAxis__custom--InducementWarrantsMember__srt--TitleOfIndividualAxis__custom--WarrantHoldersMember__us-gaap--AwardTypeAxis__custom--PrereverseMember_zqJxlYi0LXh7" title="Exercise price pre reverse">0.45)</span>
per share (&#8220;Inducement Warrants&#8221;). In the aggregate, <span id="xdx_90F_eus-gaap--ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_iI_pid_c20240530__us-gaap--TypeOfArrangementAxis__custom--InducementWarrantsMember__srt--TitleOfIndividualAxis__custom--WarrantHoldersMember_z59LQFfsJ79k" title="Warrants exercised shares">260,799</span>
(pre reverse -<span id="xdx_907_eus-gaap--ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_iI_pid_c20240530__us-gaap--TypeOfArrangementAxis__custom--InducementWarrantsMember__srt--TitleOfIndividualAxis__custom--WarrantHoldersMember__us-gaap--AwardTypeAxis__custom--PrereverseMember_z31dDJAIJ7vg" title="Warrants exercised shares pre reverse">5,737,573</span>)
warrants were exercised as a result of the Inducement Agreement and accordingly, <span id="xdx_903_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_pid_c20240530__20240530__us-gaap--SubsidiarySaleOfStockAxis__custom--InducementWarrantsMember_zjZB6rL7fYXe" title="Issuance of warrants">260,799</span>
Inducement Warrants were issued. The Company received gross proceeds of $<span id="xdx_90C_eus-gaap--ProceedsFromIssuanceOfWarrants_pn5n6_c20240530__20240530__us-gaap--TypeOfArrangementAxis__custom--InducementAgreementMember__srt--TitleOfIndividualAxis__custom--WarrantHoldersMember_zGuPLzmnMfk9">1.9</span>M
before expenses to the placement agent and other expenses of $<span id="xdx_90F_eus-gaap--OtherExpenses_pp0p0_c20240530__20240530__us-gaap--TypeOfArrangementAxis__custom--InducementAgreementMember__srt--TitleOfIndividualAxis__custom--WarrantHoldersMember_zql0aTwTBkHh" title="Other expenses">285,000</span>.
The net proceeds, after reflecting par value, has been recorded in Additional Paid in Capital of $<span id="xdx_907_eus-gaap--AdditionalPaidInCapital_iI_pp0p0_c20240530__us-gaap--TypeOfArrangementAxis__custom--InducementAgreementMember__srt--TitleOfIndividualAxis__custom--WarrantHoldersMember_z7TznGm2OE6l" title="Additional paid in capital">978,955</span>
and with respect to the Inducement Warrants, a liability under ASC 815 was recorded in the amount of $<span id="xdx_906_eus-gaap--WarrantsAndRightsOutstanding_iI_pp0p0_c20240530__us-gaap--TypeOfArrangementAxis__custom--InducementAgreementMember__srt--TitleOfIndividualAxis__custom--WarrantHoldersMember_zrcguQvT5rT9">693,064</span>.
Certain outstanding warrants, with an exercise price of $<span id="xdx_90C_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_pid_c20240530__us-gaap--TypeOfArrangementAxis__custom--InducementAgreementMember__srt--TitleOfIndividualAxis__custom--WarrantHoldersMember_zqvGZNhXawj1" title="Exercise price">14.08</span>
(pre reverse -$<span id="xdx_90E_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_pid_c20240530__us-gaap--TypeOfArrangementAxis__custom--InducementAgreementMember__srt--TitleOfIndividualAxis__custom--WarrantHoldersMember__us-gaap--AwardTypeAxis__custom--PrereverseMember__srt--RangeAxis__srt--MaximumMember_zfJw96W5IEvk" title="Exercise price">0.64</span>),
were reduced to $<span id="xdx_908_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_pid_c20240530__us-gaap--TypeOfArrangementAxis__custom--InducementAgreementMember__srt--TitleOfIndividualAxis__custom--WarrantHoldersMember__us-gaap--AwardTypeAxis__custom--PrereverseMember_zGp9JEgHyrWd" title="Exercise price">7.26</span>
(pre reverse -$<span id="xdx_90F_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_pid_c20240530__us-gaap--TypeOfArrangementAxis__custom--InducementAgreementMember__srt--TitleOfIndividualAxis__custom--WarrantHoldersMember__us-gaap--AwardTypeAxis__custom--PrereverseMember__srt--RangeAxis__srt--MinimumMember_zgNvNoqk9NMh" title="Exercise price">0.33</span>)
based on anti-dilution terms in the respective warrant agreements.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company recorded a fair value charge in the three months and nine months ended September 30, 2024 to reflect the modification of the
exercise price at the initial inducement date for the non-trading warrants relating to the February and September 2023 warrants
below. (See Note 10)</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>





<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>SHARPS
TECHNOLOGY, INC.</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTES
TO THE CONDENSED CONSOLIDATED FINANCIAL STATEMENTS</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>FOR
THE THREE AND NINE MONTHS ENDED SEPTEMBER 30, 2024 AND 2023</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Note
8 Stockholders&#8217; Equity (continued)</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
September 29, 2023, the Company completed two simultaneous offerings and received aggregate gross proceeds of approximately $<span id="xdx_904_eus-gaap--ProceedsFromIssuanceOfCommonStock_pn5n6_c20230929__20230929_zwT9JuhYTNel" title="Gross proceeds">5.6</span> million,
before expenses to the placement agent and other offering expenses of $<span id="xdx_902_eus-gaap--OtherExpenses_c20230929__20230929_zTdtJzeQpnYe" title="Other offering expenses">716,000</span>.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"> <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>



<p style="margin: 0"></p>

<table border="0" cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt">
<tr style="vertical-align: top">
  <td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 0.25in">a.</td>
  <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The first offering, the securities purchase agreement offering (the &#8220;Shelf Offering&#8221;) with institutional investors and the Company resulted in the Company receiving net proceeds from the Shelf Offering and the sale of pre-funded of approximately $<span id="xdx_90A_eus-gaap--ProceedsFromIssuanceOrSaleOfEquity_pn5n6_c20230929__20230929__us-gaap--SubsidiarySaleOfStockAxis__custom--ShelfOfferingMember__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember_zMi93dCDo9r9" title="Proceeds from shelf offering">2.5</span> million, includes the value of the pre-funded warrants recorded in APIC, net of $<span id="xdx_90D_eus-gaap--LegalFees_c20230929__20230929__us-gaap--SubsidiarySaleOfStockAxis__custom--ShelfOfferingMember__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember_z6cUgUbB9QEl" title="Placement agent fees">362,000</span> in fees relating to the placement agent and other offering expenses. The Shelf Offering was priced at the market under Nasdaq rules. In connection with the Shelf Offering, the Company issued <span id="xdx_904_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_c20230929__20230929__us-gaap--SubsidiarySaleOfStockAxis__custom--ShelfOfferingMember__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__us-gaap--AwardTypeAxis__custom--ReverseStockSplitMember_zs1sCwOyAT4k" title="Shares issued">164,478</span> (pre reverse -<span id="xdx_90E_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_c20230929__20230929__us-gaap--SubsidiarySaleOfStockAxis__custom--ShelfOfferingMember__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__us-gaap--AwardTypeAxis__custom--PrereverseMember_zEgSqKjhVgAi" title="Shares issued">3,618,521)</span> shares of common at a purchase price of $<span id="xdx_90E_eus-gaap--SharesIssuedPricePerShare_iI_c20230929__us-gaap--SubsidiarySaleOfStockAxis__custom--ShelfOfferingMember__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__us-gaap--AwardTypeAxis__custom--ReverseStockSplitMember_z6QtiMNK8xic" title="Purchase price">14.08</span> per unit, adjusted to $<span id="xdx_900_eus-gaap--SharesIssuedPricePerShare_iI_c20240530__us-gaap--SubsidiarySaleOfStockAxis__custom--ShelfOfferingMember__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember_zId9A6F1Q4Hd" title="Purchase price">7.26</span> (reverse effected) at May 30, 2024, based on anti-dilution terms in the warrants and <span id="xdx_906_eus-gaap--ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight_iI_c20230929__us-gaap--SubsidiarySaleOfStockAxis__custom--ShelfOfferingMember__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__us-gaap--StatementEquityComponentsAxis__custom--PreFundedWarrantsMember_zwixuKBYAVw8" title="Prefunded warrants">36,636</span> (pre reverse -<span id="xdx_903_eus-gaap--ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight_iI_c20230929__us-gaap--SubsidiarySaleOfStockAxis__custom--ShelfOfferingMember__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__us-gaap--StatementEquityComponentsAxis__custom--PreFundedWarrantsMember__us-gaap--AwardTypeAxis__custom--PrereverseMember_zd3AmckIbmDd" title="Prefunded warrants">800,000</span>) pre-funded warrants at $<span id="xdx_901_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_c20230929__us-gaap--SubsidiarySaleOfStockAxis__custom--ShelfOfferingMember__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__us-gaap--StatementEquityComponentsAxis__custom--PreFundedWarrantsMember_zY4ANT1DbBSd" title="Exercise price">14.058</span> (pre reverse -$<span id="xdx_90E_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_c20230929__us-gaap--SubsidiarySaleOfStockAxis__custom--ShelfOfferingMember__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__us-gaap--StatementEquityComponentsAxis__custom--PreFundedWarrantsMember__us-gaap--AwardTypeAxis__custom--PrereverseMember_z08wHwaj1G6l" title="Exercise price">0.639</span>) per pre-funded warrants. The exercise price of the pre-funded warrants will be $<span id="xdx_901_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_c20230929__us-gaap--SubsidiarySaleOfStockAxis__custom--ShelfOfferingMember__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember_zzKGLoYcq4c9" title="Exercise price">0.001</span> per share.</span></td></tr>
<tr style="vertical-align: top">
  <td>&#160;</td>
    <td>&#160;</td>
  <td>&#160;</td></tr>
<tr style="vertical-align: top">
  <td></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">b.</span></td>
  <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The second offering, the
  securities purchase agreement offering (&#8220;Private Placement&#8221;) with institutional investors and the Company received net
  proceeds from the Private Placement of approximately $<span id="xdx_906_eus-gaap--ProceedsFromIssuanceOfPrivatePlacement_pn5n6_c20230929__20230929__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--PrivatePlacementMember__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember_zZaMLPXzuCFi">2.4 </span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">million,
  net of $<span id="xdx_904_eus-gaap--LegalFees_c20230929__20230929__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--PrivatePlacementMember__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember_zI0wKJ2Jy20c">354,000 </span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">in
  fees relating to the placement agent and other offering expense. In connection with the Private Placement, the Company issued: (i) <span id="xdx_90A_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_c20230929__20230929__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--PrivatePlacementMember__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__us-gaap--StatementEquityComponentsAxis__custom--PIPEPreFundedWarrantsMember__us-gaap--AwardTypeAxis__custom--ReverseStockSplitMember_zlWx1bLlQemf">117,340 </span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(pre
  reverse - <span id="xdx_907_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_c20230929__20230929__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--PrivatePlacementMember__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__us-gaap--StatementEquityComponentsAxis__custom--PIPEPreFundedWarrantsMember__us-gaap--AwardTypeAxis__custom--PrereverseMember_zY8ysaXKY007">2,581,479</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)
  PIPE Shares (or PIPE Pre-Funded Warrants in lieu thereof) and (ii) PIPE Warrants (non-trading) to purchase <span id="xdx_901_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_pid_c20230929__20230929__us-gaap--SubsidiarySaleOfStockAxis__custom--NonTradingWarrantsMember__us-gaap--AwardTypeAxis__custom--ReverseStockSplitMember_zF3UM9xXW0Y1">397,727 </span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(pre
  reverse -<span id="xdx_908_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_pid_c20230929__20230929__us-gaap--SubsidiarySaleOfStockAxis__custom--NonTradingWarrantsMember__us-gaap--AwardTypeAxis__custom--PrereverseMember_ze8yhyqxOWj4">8,750,003</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)
  shares of our common stock, at a combined purchase price of $<span id="xdx_908_eus-gaap--SharesIssuedPricePerShare_iI_c20230203__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__us-gaap--StatementEquityComponentsAxis__custom--PIPEPreFundedWarrantsMember__srt--RangeAxis__srt--MaximumMember_zCRGthkax2u5">23.63 </span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(pre
  reverse -$<span id="xdx_907_eus-gaap--SharesIssuedPricePerShare_iI_c20230203__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__us-gaap--StatementEquityComponentsAxis__custom--PIPEPreFundedWarrantsMember__us-gaap--AwardTypeAxis__custom--PrereverseMember__srt--RangeAxis__srt--MaximumMember_zhifmEvjztv1">1.074</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)
  per unit or $<span id="xdx_90B_eus-gaap--SharesIssuedPricePerShare_iI_c20230203__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__us-gaap--StatementEquityComponentsAxis__custom--PIPEPreFundedWarrantsMember__srt--RangeAxis__srt--MinimumMember_ztFZCkzU16z">23.606 </span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(pre
  reverse - $<span id="xdx_901_eus-gaap--SharesIssuedPricePerShare_iI_c20230203__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__us-gaap--StatementEquityComponentsAxis__custom--PIPEPreFundedWarrantsMember__us-gaap--AwardTypeAxis__custom--PrereverseMember__srt--RangeAxis__srt--MinimumMember_zDHH1wwyXjV2">1.073</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)
  per pre-funded unit. The PIPE Warrants have a term of five and one-half (<span id="xdx_90B_eus-gaap--WarrantsAndRightsOutstandingTerm_iI_dtY_c20230929__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--PrivatePlacementMember__us-gaap--StatementEquityComponentsAxis__custom--PIPEPreFundedWarrantsMember_zeMYe6lecPc7">5.5</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)
  years from the issuance date and are exercisable for one share of common stock at an exercise price, after effect of the October
  2024 reverse split, of $<span id="xdx_905_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_c20230929__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__us-gaap--StatementEquityComponentsAxis__custom--PIPEPreFundedWarrantsMember__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--PrivatePlacementMember__us-gaap--AwardTypeAxis__custom--ReverseStockSplitMember_ziDup5ZsnOm2" title="Exercise price">14.08</span> </span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">adjusted
  to $<span id="xdx_903_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_c20240530__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__us-gaap--StatementEquityComponentsAxis__custom--PIPEPreFundedWarrantsMember__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--PrivatePlacementMember_zb4esqp6XZji" title="Exercise price">7.26</span> </span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
  at May 30, 2024, based on anti-dilution terms in the warrants. See Note 8(a) Warrants below for further adjustment. The net
  proceeds, after reflecting par value, has been recorded in Additional Paid in Capital of $<span id="xdx_905_eus-gaap--AdditionalPaidInCapital_iI_pn5n6_c20230929__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--PrivatePlacementMember__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember_zNo37uMNWoL">1.6 </span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">million
  and with respect to the PIPE Warrants recorded as a liability under ASC 815 of $<span id="xdx_907_eus-gaap--FairValueAdjustmentOfWarrants_c20230929__20230929__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--PrivatePlacementMember__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember_zchytfbAUqAb">985,204</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">.
  On October 16, 2023, the Company filed an S-1 (Resale) Registration Statement in connection with the Private Placement and on
  October 26, 2023 the S-1 went effective. (See Note 10).</span></td></tr>
</table>


<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
February 3, 2023, the Company completed a securities purchase agreement (&#8220;Offering&#8221;) with institutional investors and
received net proceeds from the Offering of approximately $<span id="xdx_902_eus-gaap--ProceedsFromIssuanceOrSaleOfEquity_pn5n6_c20230201__20230203__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember_zbzMZnujum06" title="Net proceeds from offering">3.2</span>
million, net of $<span id="xdx_908_eus-gaap--NoninterestExpenseOfferingCost_c20230201__20230203__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember_zWvZCfJADvC" title="Offering expenses">600,000</span>
in fees relating to the placement agent and other offering expenses. The Offering was priced at the market under Nasdaq rules. In
connection with the Offering, the Company issued <span id="xdx_902_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_c20230201__20230203__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember_zc32l1L6epN6" title="Shares issued">102,206</span>
(pre reverse - <span id="xdx_90E_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_c20230201__20230203__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__us-gaap--AwardTypeAxis__custom--PrereverseMember_zrErnecrmJ39" title="Shares issued">2,248,521</span>)
units at a purchase price of $<span id="xdx_90C_eus-gaap--SharesIssuedPricePerShare_iI_c20230203__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember_zXSzvTmpLF2a" title="Purchase price">37.18</span>
(pre reverse - $<span id="xdx_908_eus-gaap--SharesIssuedPricePerShare_iI_c20230203__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__us-gaap--AwardTypeAxis__custom--PrereverseMember_zpx8ymIt6RAc" title="Purchase price pre reverse">1.69</span>)
per unit. <span id="xdx_90F_eus-gaap--SaleOfStockDescriptionOfTransaction_c20230201__20230203__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember_zPv94cdnKkvh" title="Units description">Each
unit consisted of one share of common stock and one non-tradable warrant (&#8220;Offering Warrants&#8221;) exercisable for one share
of common stock</span> at a price, after effect of the October 2024 reverse split, of $<span id="xdx_908_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_c20230203__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember_zgjUiahQHPua" title="Warrant exerice price">34.32</span>,
adjusted to $<span id="xdx_90D_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_c20230929__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember_zpEMl8ykMwm9" title="Warrant exerice price">14.08 </span>at
September 29, 2023 and to $<span id="xdx_902_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_c20240530__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember_zpvSffBdRaSh" title="Warrant exerice price">7.26</span>
at May 30, 2024, based on anti-dilution terms in the warrants and a term of <span id="xdx_903_eus-gaap--WarrantsAndRightsOutstandingTerm_iI_dc_c20230203__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember_zI5c9Pbupx87" title="Warrants term">five
years</span>. See Note 8(a) for further adjustment. The Offering Warrants have a term of five years from the issuance date. On
February 13, 2023, the Company filed an S-1 (Resale) Registration Statement in connection with the Offering and on April 14, 2023,
an Amendment to the S-1 was filed and went effective. (See Note 10)</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
April 13, 2022, the Company&#8217;s initial public offering (&#8220;IPO&#8221;) was declared effective by the SEC pursuant to which the
Company issued and sold an aggregate of <span id="xdx_901_eus-gaap--SaleOfStockNumberOfSharesIssuedInTransaction_c20220411__20220413__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--IPOMember_zXZGKTT9mtX9" title="Number of units sold">170,454</span> ( pre reverse -<span id="xdx_906_eus-gaap--SaleOfStockNumberOfSharesIssuedInTransaction_c20220411__20220413__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--IPOMember__us-gaap--AwardTypeAxis__custom--PrereverseMember_ztgLtKSrAYog" title="Number of units sold">3,750,000</span>) units (&#8220;Units&#8221;), <span id="xdx_90E_eus-gaap--SaleOfStockDescriptionOfTransaction_c20220411__20220413__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--IPOMember_zPgbjKCZ3Cjj" title="Units description">each consisting of one share of
common stock and two warrants, to purchase one share of common stock for each whole warrant</span>, with an initial exercise price of $ <span id="xdx_90C_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_pid_c20220413__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--IPOMember_zhImK9jKO7g1" title="Exercise price">93.50</span>
(pre reverse -$<span id="xdx_907_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_pid_c20220413__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--IPOMember__us-gaap--AwardTypeAxis__custom--PrereverseMember_zUKez6CaeCHj" title="Exercise price">4.25</span>) per share, adjusted to and with the effect of reverse split October 2024, $<span id="xdx_900_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_c20230203__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--IPOMember_z5VuSzGg04w7" title="Warrant exerice price">34.32</span> at February 3, 2023 and to $<span id="xdx_900_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_c20230929__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--IPOMember_z9rvxvC88svi" title="Warrant exercise price">14.08</span>
at September 29, 2023 and to $<span id="xdx_908_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_c20240530__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--IPOMember_z5JDqlFbSfwi" title="Warrant exercise price">7.26</span> at May 30, 2024, based on anti-dilution terms in the warrants, and a term of <span id="xdx_900_eus-gaap--WarrantsAndRightsOutstandingTerm_iI_dc_c20220413__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--IPOMember_zAlCz1xbmWM8" title="Warrants exercise price term">five years</span>. In addition,
<span id="xdx_90B_ecustom--DescriptionForOfferingShares_c20220411__20220413__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--IPOMember_zRe0s0XmAgK4" title="Description for offering shares">the Company granted Aegis Capital Corp., as underwriter a 45-day over-allotment option to purchase up to 15% of the number of shares
included in the units sold in the offering, and/or additional warrants equal to 15% of the number of Warrants included in the units sold
in the offering, in each case solely to cover over-allotments</span>, which the Aegis Capital Corp. partially exercised with respect to <span id="xdx_90C_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised_c20220417__20220419__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_z0lKPJ9XQYPj" title="Warrants exercised">51,136</span>
( pre reverse -<span id="xdx_904_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised_c20220417__20220419__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember__us-gaap--AwardTypeAxis__custom--PrereverseMember_zRYFTrpixppk" title="Warrants exercised">1,125,000</span>) warrants on April 19, 2022.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company&#8217;s common stock and warrants began trading on the Nasdaq Capital Market or Nasdaq on April 14, 2022. The net proceeds from
the IPO, prior to payments of certain listing and professional fees were approximately $<span id="xdx_90F_eus-gaap--ProceedsFromIssuanceInitialPublicOffering_pn5n6_c20220417__20220419__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--IPOMember_zzkU3sKAUAd7" title="Net proceeds from IPO">14.2</span> million. The net proceeds, after reflecting
par value, has been recorded in Additional Paid in Capital of $<span id="xdx_90D_eus-gaap--AdditionalPaidInCapital_iI_pn5n6_c20220414_zX8ls53vu8L3" title="Additional paid in capital">9.0</span> million and with respect to the Warrants as a liability under ASC
815 of $<span id="xdx_905_ecustom--WarrantLiabilitiesCurrent_iI_pn5n6_c20220414_zHlinw9uu5d3" title="Warrants liability">5.2</span>M. (See Note 10)</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"></p>



<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><br/></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>SHARPS
TECHNOLOGY, INC.</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTES
TO THE CONDENSED CONSOLIDATED FINANCIAL STATEMENTS</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>FOR
THE THREE AND NINE MONTHS ENDED SEPTEMBER 30, 2024 AND 2023</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Note
8. Stockholders&#8217; Equity (continued)</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Warrants</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>&#160;</i></b></span></p>

<table border="0" cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"></td><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">a)</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">In
                                                                                                                                                                                                                                     September 2024, the Company reduced the exercise price of the <span id="xdx_908_eus-gaap--ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight_iI_c20240930__srt--TitleOfIndividualAxis__custom--WarrantHoldersMember_zpD5QL7ymoli" title="Prefunded warrants">230,091</span> (pre reverse &#8211; <span id="xdx_908_eus-gaap--ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight_iI_c20240930__srt--TitleOfIndividualAxis__custom--WarrantHoldersMember__us-gaap--AwardTypeAxis__custom--PrereverseMember_ze9DnfeGT7Oh" title="Prefunded warrants">5,260,000</span>)
                                                                                                                                                                                                                                     outstanding warrants issued in February 2023 and September 2023 offerings (see below) from $<span id="xdx_904_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_pid_c20230228__srt--TitleOfIndividualAxis__custom--WarrantHoldersMember_zIW3Jm2fwubk"><span id="xdx_90B_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_pid_c20230930__srt--TitleOfIndividualAxis__custom--WarrantHoldersMember_zPJDBL6kSOul">7.26</span></span>
                                                                                                                                                                                                                                     (pre reverse - $<span id="xdx_90E_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_pid_c20230228__srt--TitleOfIndividualAxis__custom--WarrantHoldersMember__us-gaap--AwardTypeAxis__custom--PrereverseMember_zrd8UrCqFVt9"><span id="xdx_908_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_pid_c20230930__srt--TitleOfIndividualAxis__custom--WarrantHoldersMember__us-gaap--AwardTypeAxis__custom--PrereverseMember_zGhkgG6vsqP9">0.33</span></span>)
                                                                                                                                                                                                                                     to $<span id="xdx_907_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_c20230228__srt--TitleOfIndividualAxis__custom--WarrantHolderMember_zNAUcyG87Tsa" title="Exercise price"><span id="xdx_908_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_c20230929__srt--TitleOfIndividualAxis__custom--WarrantHolderMember_zgzI8x9H2pkc" title="Exercise price">0.0001</span></span>.
                                                                                                                                                                                                                                     In connection with the reduction in the exercise price the Company recorded a modification charge of $<span id="xdx_90B_ecustom--FairValueAdjustmentOfModificationCharge_c20240701__20240930__srt--TitleOfIndividualAxis__custom--WarrantHoldersMember_z1ppnhttWOWb" title="Fair value adjustment of modification charge"><span id="xdx_907_ecustom--FairValueAdjustmentOfModificationCharge_c20240101__20240930__srt--TitleOfIndividualAxis__custom--WarrantHoldersMember_zjROgu5KrCk1" title="Fair value adjustment of modification charge">155,703</span></span>
                                                                                                                                                                                                                                     in the three months ended September 30, 2024. At September 30, 2024, <span id="xdx_905_eus-gaap--ClassOfWarrantOrRightOutstanding_iI_c20240930__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_z9Q5hPqbkFXe" title="Class of warrant or right, outstanding">103,685</span>,
                                                                                                                                                                                                                                     after reverse split, warrants remain outstanding. Subsequent to September 30, 2024 such remaining warrants were
                                                                                                                                                                                                                                     exercised.</td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"></p>

<table border="0" cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt">
<tr style="vertical-align: top">
  <td style="text-align: justify; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">b)</span></td>
  <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In connection with the
  Inducement Warrants in the second quarter of 2024, the Company issued <span id="xdx_905_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_pid_c20240401__20240630__us-gaap--SubsidiarySaleOfStockAxis__custom--InducementWarrantsMember_z0ReVNJqdGWb" title="Issuance of warrants">260,799</span>
  (pre reverse - <span id="xdx_906_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_pid_c20240401__20240630__us-gaap--SubsidiarySaleOfStockAxis__custom--InducementWarrantsMember__us-gaap--AwardTypeAxis__custom--PrereverseMember_z26XG8W3w3Fg" title="Issuance of warrants">5,737,573</span>)
  non-trading Inducement Warrants as noted in Common Stock above. The Inducement Warrants are classified as a liability based on ASC
  815 and require remeasurement at each reporting period. The Inducement Warrants are recorded at the FMV, computed using the Black
  Scholes valuation method. and , recorded a FMV gain adjustment of <span id="xdx_904_eus-gaap--FairValueAdjustmentOfWarrants_c20240101__20240630__us-gaap--SubsidiarySaleOfStockAxis__custom--InducementWarrantsMember_z0WtQXwZAgbj" title="Fair market value adjustment">$293,684 </span>(See
  Note 10).</span></td></tr>

<tr style="vertical-align: top">
  <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
  <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
<tr style="vertical-align: top">
  <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">c)</span></td>
  <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In connection with one-year
advisory services arrangement entered into in April 2023, the Company issued an aggregate of <span id="xdx_904_ecustom--ClassOfWarrantOrRightIssued_iI_c20230430__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_zNYQ5E5WuYh9">28,636
</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(pre reverse - <span id="xdx_900_ecustom--ClassOfWarrantOrRightIssued_iI_c20230430__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember__us-gaap--AwardTypeAxis__custom--PrereverseMember_z273H14yIzwj">630,000</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)
warrants over the one-year term, at an exercise price of $<span id="xdx_90A_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_pid_c20230430__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_zsMpAYrXIZr7">34.32
</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(pre reverse -$<span id="xdx_90D_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_pid_c20230430__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember__us-gaap--AwardTypeAxis__custom--PrereverseMember_z6luBNwfciel">1.56)
</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The warrants have a three-year term and were
fully vested on issuance. During the three and nine months ended September 30, 2024, the Company issued <span id="xdx_90B_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_pid_c20240701__20240930__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_zBZJzKyjzGbk">0
</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">and <span id="xdx_905_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_pid_c20240101__20240930__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_zQUBKxP88zvk">5,909
</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(pre reverse - <span id="xdx_909_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_pid_c20240101__20240930__us-gaap--AwardTypeAxis__custom--PrereverseMember_z6o812ywypE5">130,000)
</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">warrants with a FMV of $<span id="xdx_903_eus-gaap--FairValueAdjustmentOfWarrants_c20240101__20240930__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_zEfa6bIekdhh">8,590</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">.
During the three and nine months ended September 30, 2023 the Company issued <span id="xdx_90C_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_pid_c20230701__20230930__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_zJNWH9ieFB0j">10,227
</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(pre reverse - <span id="xdx_904_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_pid_c20230701__20230930__us-gaap--AwardTypeAxis__custom--PrereverseMember_zXF2Nf6J53fc">225,000)
</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">and <span id="xdx_903_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_pid_c20230101__20230930__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_z9ngBbzWBXck">16,363
</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(pre-reverse <span id="xdx_90C_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_pid_c20230101__20230930__us-gaap--AwardTypeAxis__custom--PrereverseMember_zISrg5KSYGu3">360,000</span></span>)
<span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">warrants with a FMV of $<span id="xdx_909_eus-gaap--FairValueAdjustmentOfWarrants_c20230701__20230930__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_zAsHDnt8OrZ6">22,470
</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">and $<span id="xdx_90C_eus-gaap--FairValueAdjustmentOfWarrants_c20230101__20230930__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_zwdX5tD6Y7i4">42,306</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">,
respectively. The FMV of the warrants issued in the nine months ended September 30, 2024 was computed using the Black Scholes valuation
model with the following assumptions: a) volatility of <span id="xdx_901_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum_pid_dp_uPure_c20240101__20240930__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_ztJfsXXqZFl7">33.46</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">%
to <span id="xdx_907_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum_pid_dp_uPure_c20240101__20240930__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_zEZ5aYmF05nb">81.62</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">%
<span id="xdx_902_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_pid_dxL_c20240101__20240930__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_z3FvfIxcrJee" title="::XDX::P3Y"><span style="-sec-ix-hidden: xdx2ixbrl2612">three-year
</span></span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">term, risk free interest rate of <span id="xdx_90E_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum_pid_dp_uPure_c20240101__20240930__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_zRQ4liQ8nkJi">4.20</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">%
to <span id="xdx_906_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum_pid_dp_uPure_c20240101__20240930__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_zUDDMyTnhAr2">4.25</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">%
and <span id="xdx_903_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_pid_dp_uPure_c20240101__20240930__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_zeE1GNLBwLX8">0</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">%
dividend rate. The FMV of the warrants issued in the three and nine months ended September 30, 2023 was computed using the Black Scholes
valuation model with the following assumptions: a) volatility of <span id="xdx_909_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum_pid_dp_uPure_c20230101__20230930__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_zaUVM4t2Eux2">37.45</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">%
to <span id="xdx_909_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum_pid_dp_uPure_c20230101__20230930__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_zh74gQxaOyVe">44.83</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">%,
risk free interest rate of <span id="xdx_903_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum_pid_dp_uPure_c20230101__20230930__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_z5nuzQwlgKT4">3.58</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">%
to <span id="xdx_904_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum_pid_dp_uPure_c20230101__20230930__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_zNEr5jzZs9rg">4.43</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">.%
and <span id="xdx_90A_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_pid_dp_uPure_c20230101__20230930__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_zSg2peGEbWV1">0</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">%
dividend rate (See Note 10).</span></td></tr>

<tr style="vertical-align: top">
  <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
  <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
<tr style="vertical-align: top">
  <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">d)</span></td>
  <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> In connection with the
  Private Placement in September 2023, the Company issued <span id="xdx_906_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_pid_c20230901__20230930__us-gaap--SubsidiarySaleOfStockAxis__custom--NonTradingWarrantsMember__us-gaap--AwardTypeAxis__custom--ReverseStockSplitMember_z8qmGYUmeEzi" title="Issuance of warrants">397,727</span> (pre reverse <span id="xdx_902_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_pid_c20230901__20230930__us-gaap--SubsidiarySaleOfStockAxis__custom--NonTradingWarrantsMember__us-gaap--AwardTypeAxis__custom--PrereverseMember_z7I4NGPyNIu2" title="Issuance of warrants">8,750,003</span>) non-trading PIPE Warrants as a component of
  the Unit as noted in Common Stock above. The PIPE Warrants are classified as a liability based on ASC 815 and require remeasurement
  at each reporting period. The PIPE Warrants are recorded at the FMV, computed using the Black Scholes valuation method. For the three
  and nine months ended September 30, 2024, the Company recorded a FMV gain (loss) adjustment of $<span id="xdx_901_eus-gaap--FairValueAdjustmentOfWarrants_c20240701__20240930__us-gaap--SubsidiarySaleOfStockAxis__custom--NonTradingWarrantsMember__us-gaap--StatementEquityComponentsAxis__custom--PIPEWarrantMember_zNzIm6SZImM1" title="Fair market value adjustment">(181,163)</span>, including the modification
  charge of $<span id="xdx_902_ecustom--FairValueAdjustmentOfModificationCharge_c20240701__20240930__us-gaap--SubsidiarySaleOfStockAxis__custom--NonTradingWarrantsMember__us-gaap--StatementEquityComponentsAxis__custom--PIPEWarrantMember_z1Im6BNWMXec" title="Fair value adjustment of modification charge">(148,091)</span> and $<span id="xdx_908_eus-gaap--FairValueAdjustmentOfWarrants_c20240101__20240930__us-gaap--SubsidiarySaleOfStockAxis__custom--NonTradingWarrantsMember__us-gaap--StatementEquityComponentsAxis__custom--PIPEWarrantMember_zRnaNjj6qwO4" title="Fair market value adjustment">470,721</span> including the modification charge of $<span id="xdx_90A_ecustom--FairValueAdjustmentOfModificationCharge_c20240101__20240930__us-gaap--SubsidiarySaleOfStockAxis__custom--NonTradingWarrantsMember__us-gaap--StatementEquityComponentsAxis__custom--PIPEWarrantMember_z9dRpMFQazwa" title="Fair value adjustment of modification charge">(637,316)</span>, respectively (See Note 10).</span></td></tr>

<tr style="vertical-align: top">
  <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
  <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
<tr style="vertical-align: top">
  <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">e)</span></td>
  <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In connection with the
  Offering in February 2023, the Company issued <span id="xdx_90C_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_pid_c20230201__20230228__us-gaap--SubsidiarySaleOfStockAxis__custom--NonTradingWarrantsMember__us-gaap--AwardTypeAxis__custom--ReverseStockSplitMember_zIBgh5mwyN3e" title="Issuance of warrants">102,206</span>
  (pre reverse -<span id="xdx_905_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_pid_c20230201__20230228__us-gaap--SubsidiarySaleOfStockAxis__custom--NonTradingWarrantsMember__us-gaap--AwardTypeAxis__custom--PrereverseMember_zApX3HKaENfk" title="Issuance of warrants">2,248,521</span>)
  non-trading warrants Offering Warrants as a component of the Unit as noted in Common Stock above. The Offering Warrants are
  classified as a liability based on ASC 815 and require remeasurement at each reporting period. The Offering Warrants were recorded
  at the FMV, computed using the Black Scholes valuation method. For the three and nine months ended September 30, 2024 the Company
  recorded FMV gain (loss) adjustments of <span id="xdx_907_eus-gaap--FairValueAdjustmentOfWarrants_c20240701__20240930__us-gaap--SubsidiarySaleOfStockAxis__custom--NonTradingWarrantsMember_zOX6dOhUiLOc" title="FMV gain adjustment">$7,563</span>,
  including a modification charge of $<span id="xdx_905_ecustom--FairValueAdjustmentOfModificationCharge_c20240701__20240930__us-gaap--SubsidiarySaleOfStockAxis__custom--NonTradingWarrantsMember_z6CSyQESIWJl" title="Fair value adjustment of modification charge">7,612</span>
  referred to in Note 10, and $<span id="xdx_905_eus-gaap--FairValueAdjustmentOfWarrants_c20240101__20240930__us-gaap--SubsidiarySaleOfStockAxis__custom--NonTradingWarrantsMember_zgGkyvfKR2C9" title="FMV gain adjustment">214,019</span>,
  including a modification charge of $<span id="xdx_90E_ecustom--FairValueAdjustmentOfModificationCharge_c20240101__20240930__us-gaap--SubsidiarySaleOfStockAxis__custom--NonTradingWarrantsMember_zNjxYCsBAaGf" title="Fair value adjustment of modification charge">153,640</span>.
  For the three and nine months ended September 30, 2023, the Company recorded a FMV gain adjustment of $<span id="xdx_900_eus-gaap--FairValueAdjustmentOfWarrants_c20230701__20230930__us-gaap--SubsidiarySaleOfStockAxis__custom--NonTradingWarrantsMember_zRycgWMLH1t5" title="FMV gain adjustment">56,172</span>&#160;and
  $<span id="xdx_90A_eus-gaap--FairValueAdjustmentOfWarrants_c20230101__20230930__us-gaap--SubsidiarySaleOfStockAxis__custom--NonTradingWarrantsMember_zCK38DObsane" title="FMV gain adjustment">238,752</span>
  respectively (See Note 10).</span></td></tr>

<tr style="vertical-align: top">
  <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
  <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
<tr style="vertical-align: top">
  <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">f)</span></td>
  <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In connection with the IPO
  in April 2022, the Company issued <span id="xdx_905_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_pid_c20220417__20220419__us-gaap--SubsidiarySaleOfStockAxis__custom--TradingWarrantsMember_z4IuO605eRth" title="Issuance of warrants">340,900</span>
  (pre reverse -<span id="xdx_902_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_pid_c20220417__20220419__us-gaap--SubsidiarySaleOfStockAxis__custom--TradingWarrantsMember__us-gaap--AwardTypeAxis__custom--PrereverseMember_zj639Gmf3osa" title="Issuance of warrants">7,500,000</span>)
  warrants (Trading Warrants) as a component of the Units and <span id="xdx_90C_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_pid_c20220417__20220419__us-gaap--SubsidiarySaleOfStockAxis__custom--OverAllotmentWarrantsMember_z3y6wi0pkQof" title="Issuance of warrants">51,136</span>
  (pre reverse - <span id="xdx_903_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_pid_c20220417__20220419__us-gaap--SubsidiarySaleOfStockAxis__custom--OverAllotmentWarrantsMember__us-gaap--AwardTypeAxis__custom--PrereverseMember_zEjQvpBa6S5k" title="Issuance of warrants">1,125,000</span>)
  warrants to the underwriter (Overallotment Warrants), as noted in Common Stock above. The Trading and Overallotment Warrants were
  recorded at the FMV, being the trading price of the warrants, on the IPO effective date and the Warrants are classified as a
  Liability based on ASC 815. The Warrant liability requires remeasurement at each reporting period based on the trading price of the
  warrants. During the three and nine months ended September 30, 2024, the Company recorded an FMV gain adjustment of $<span id="xdx_90F_eus-gaap--FairValueAdjustmentOfWarrants_c20240701__20240930__us-gaap--SubsidiarySaleOfStockAxis__custom--TradingWarrantsMember_z2gevU8Gig62" title="Fair value income adjustment">198,375</span>
  and $<span id="xdx_90F_eus-gaap--FairValueAdjustmentOfWarrants_c20240101__20240930__us-gaap--SubsidiarySaleOfStockAxis__custom--TradingWarrantsMember_zyh2cQSsSQaj" title="Fair value income adjustment">690,001</span>,
  respectively. During the three and nine months ended September 30, 2023, the Company recorded an FMV gain adjustment of $<span id="xdx_907_eus-gaap--FairValueAdjustmentOfWarrants_c20230701__20230930__us-gaap--SubsidiarySaleOfStockAxis__custom--TradingWarrantsMember_zaODooa6ZvKl" title="Fair value income adjustment">258,750</span>&#160;and
  $<span id="xdx_90E_eus-gaap--FairValueAdjustmentOfWarrants_c20230101__20230930__us-gaap--SubsidiarySaleOfStockAxis__custom--TradingWarrantsMember_zOKQ43R1Faqg" title="Fair value income adjustment">172,500</span>,
  respectively. (See Note 10).</span></td></tr>

<tr style="vertical-align: top">
  <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
  <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
<tr style="vertical-align: top">
  <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">g)</span></td>
  <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company issued <span id="xdx_90C_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_pid_c20220417__20220419__us-gaap--SubsidiarySaleOfStockAxis__custom--NoteWarrantsMember_zdGV5lpE9Iu5" title="Warrants issued">10,695</span>
  (pre reverse -<span id="xdx_904_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_pid_c20220417__20220419__us-gaap--SubsidiarySaleOfStockAxis__custom--NoteWarrantsMember__us-gaap--AwardTypeAxis__custom--PrereverseMember_zvEOY5YvWTCd" title="Warrants issued">235,295</span>) Warrants (&#8220;Note Warrants&#8221;) to the note holders in connection with the repayment on the IPO on April
  19, 2022. The Note Warrants, which are recorded at the FMV being the trading price of the warrants, are classified as a Liability based
  on ASC 815. The Note Warrants require remeasurement at each reporting period. During the three and nine months ended September 30,
  2024, the Company recorded a FMV gain of $<span id="xdx_908_eus-gaap--FairValueAdjustmentOfWarrants_c20240701__20240930__us-gaap--SubsidiarySaleOfStockAxis__custom--NoteWarrantsMember_zxXiZ8R7YWFi" title="FMV gain/(loss) adjustment">5,411</span> and $<span id="xdx_90B_eus-gaap--FairValueAdjustmentOfWarrants_c20240101__20240930__us-gaap--SubsidiarySaleOfStockAxis__custom--NoteWarrantsMember_zvXtcem1Xkyj" title="FMV gain/(loss) adjustment">18,822</span>, respectively. For the three and nine months ended September 30, 2023, the
  Company recorded a FMV gain/(loss) adjustment of $<span id="xdx_905_eus-gaap--FairValueAdjustmentOfWarrants_c20230701__20230930__us-gaap--SubsidiarySaleOfStockAxis__custom--NoteWarrantsMember_zOebmRjRs1w6" title="FMV gain/(loss) adjustment"><span id="xdx_906_eus-gaap--FairValueAdjustmentOfWarrants_c20230101__20230930__us-gaap--SubsidiarySaleOfStockAxis__custom--NoteWarrantsMember_zP4D3FuIHsf5" title="FMV gain/(loss) adjustment">7,059</span></span>. (See Note 10).</span></td></tr>
</table>




<p style="margin-top: 0; margin-bottom: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>




<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>SHARPS
TECHNOLOGY, INC.</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTES
TO THE CONDENSED CONSOLIDATED FINANCIAL STATEMENTS</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>FOR
THE THREE AND NINE MONTHS ENDED SEPTEMBER 30, 2024 AND 2023</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Note
8. Stockholders&#8217; Equity (continued)</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(h)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
    underwriter received <span id="xdx_900_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_c20220417__20220419__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--IPOMember_zAvuhFqxm9O9" title="Warrants issued">8,523</span>
    (pre reverse - <span id="xdx_900_eus-gaap--ClassOfWarrantOrRightOutstanding_iI_c20220419__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--IPOMember__us-gaap--AwardTypeAxis__custom--PrereverseMember_zytQuAlyCNg9" title="Warrants issued">187,500</span>)
    warrants in connection with the IPO for a nominal cost of $<span id="xdx_907_eus-gaap--WarrantsAndRightsOutstanding_iI_c20220419__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--IPOMember_z7HqYDAMofbh" title="Nominal cost of warrant">11,250</span>.
    The Warrants have an exercise price of $<span id="xdx_901_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_pid_c20220419__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--IPOMember_zS5x8otaHBI8" title="Exercise price">117.04</span>
    (pre reverse - $<span id="xdx_906_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_pid_c20220419__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--IPOMember__us-gaap--AwardTypeAxis__custom--PrereverseMember_z1Fgloja1RRd" title="Exercise price">5.32</span>)
    and are exercisable after October 9, 2022. The FMV at the date of issuance was $<span id="xdx_90A_eus-gaap--FairValueAdjustmentOfWarrants_c20220417__20220419__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--IPOMember_zNuwLO2NxRd" title="Fair value adjustment of warrants">228,750</span>
    computed using the Black Scholes valuation model with the following assumptions: a) volatility of <span id="xdx_904_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate_pid_dp_uPure_c20220417__20220419__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--IPOMember_zzQPXpOZuur1" title="Volatility">93.47</span>%,
    five-year term, risk free interest rate <span id="xdx_90C_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_pid_dp_uPure_c20220417__20220419__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--IPOMember_zM8xxJzsIXe2" title="Risk free interest rate">2.77</span>%
    and <span id="xdx_902_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_pid_dp_uPure_c20220417__20220419__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--IPOMember_zV50liXjGu8i" title="Dividend rate">0</span>%
    dividend rate. The estimated FMV was classified as additional issuance costs.</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<span></span>
</td>
<td class="text"><p id="xdx_80E_eus-gaap--StockholdersEquityNoteDisclosureTextBlock_zUx2arkJtLq2" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Note
8. <span id="xdx_827_zDDuBTPCQfHe">Stockholders&#8217; Equity</span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Capital
Structure</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
December 11, 2017, the Company was incorporated in Wyoming with <span id="xdx_909_eus-gaap--CommonStockSharesAuthorized_iI_c20171211_zXRQ4AJbPYel" title="Common stock, share authorized">20,000,000</span> shares of common stock authorized with a $<span id="xdx_903_eus-gaap--CommonStockParOrStatedValuePerShare_iI_c20171211_zwMurzbuPL5j" title="Common stock, par value">0.0001</span> par value.
Effective, April 18, 2019, the Company&#8217;s authorized common stock was increased to <span id="xdx_90F_eus-gaap--CommonStockSharesAuthorized_iI_c20190418_zhJZrLzOcNi6" title="Common stock, share authorized">50,000,000</span> shares of common stock. The articles
of incorporation also authorized <span id="xdx_90B_eus-gaap--PreferredStockSharesAuthorized_iI_c20190418_zd2nHb8NgPrh" title="Preferred stock, shares authorized">10,000</span> preferred shares with a $<span id="xdx_906_eus-gaap--PreferredStockParOrStatedValuePerShare_iI_c20190418_zlxVAKE7IUzl" title="Preferred stock, par value">0.001</span> par value.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Effective
March 22, 2022, the Company completed a plan and agreement of merger with Sharps Technology, Inc., a Nevada corporation (&#8220;Sharps
Nevada&#8221;). <span id="xdx_900_eus-gaap--ConversionOfStockDescription_c20220319__20220322_zRTCW2lPIq08" title="Conversion of stock, description">Pursuant to the merger agreement, (i) the Company merged with and into Sharps Nevada, (ii) each 3.5 shares of common
stock of the Company were converted into one share of common stock of Sharps Nevada and (iii) the articles of incorporation and bylaws
of Sharps Nevada, became the articles of incorporation and bylaws of the surviving corporation.</span> The Company&#8217;s authorized common
stock and preferred stock increased from <span id="xdx_90E_eus-gaap--CommonStockSharesAuthorized_iI_c20220321_zqWIuaVMR1ab" title="Common stock, share authorized">50,000,000</span> to <span id="xdx_900_eus-gaap--CommonStockSharesAuthorized_iI_c20231231_zKr6XrguyaE5" title="Common stock, share authorized">100,000,000</span> and <span id="xdx_90E_eus-gaap--PreferredStockSharesAuthorized_iI_c20220321_z02GsXf6DB4i" title="Preferred stock, shares authorized">10,000</span> to <span id="xdx_900_eus-gaap--PreferredStockSharesAuthorized_iI_c20231231_zbGgSgndPBZ3" title="Preferred stock, shares authorized">1,000,000</span> shares, respectively. The par value of preferred
stock decreased from $<span id="xdx_900_eus-gaap--PreferredStockParOrStatedValuePerShare_iI_c20220321_zUiO4KHVaUGf" title="Preferred stock, par value">0.001</span> to $<span id="xdx_90B_eus-gaap--PreferredStockParOrStatedValuePerShare_iI_c20231231_zH9iCouNVhwg" title="Preferred stock, par value">0.0001</span> per share.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>&#160;</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Common
Stock</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
September 29, 2023, the Company completed two simultaneous offerings and received aggregate gross proceeds of approximately $<span id="xdx_904_eus-gaap--ProceedsFromIssuanceOfCommonStock_pn5n6_c20230929__20230929_zYKahFVLFYRd" title="Gross proceeds">5.6 </span>million,
before expenses to the placement agent and other offering expenses of $<span id="xdx_902_eus-gaap--OtherExpenses_c20230929__20230929_zSC9FNlo8Kq8" title="Other offering expenses">716,000</span>.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">a.</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
    first offering, the securities purchase agreement offering (the &#8220;Shelf Offering&#8221;) with institutional investors and the
    Company resulted in the Company receiving net proceeds from the Shelf Offering and the sale of pre-funded warrants of approximately
    $<span id="xdx_906_eus-gaap--ProceedsFromIssuanceInitialPublicOffering_pn5n6_c20230929__20230929__us-gaap--SubsidiarySaleOfStockAxis__custom--ShelfOfferingMember__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember_zTu5kue36XS8" title="Net proceeds from the Shelf Offering">2.5 </span>million,
    includes the value of the pre-funded warrants recorded in Additional Paid in Capital, net of $<span id="xdx_90B_eus-gaap--LegalFees_c20230929__20230929__us-gaap--SubsidiarySaleOfStockAxis__custom--ShelfOfferingMember__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember_zI2yRFb39Paf" title="Net fees">362,000</span>
    in fees relating to the placement agent and other offering expenses. The Shelf Offering was priced at the market under Nasdaq rules.
    In connection with the Shelf Offering, the Company issued <span id="xdx_907_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_c20230929__20230929__us-gaap--SubsidiarySaleOfStockAxis__custom--ShelfOfferingMember__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember_z8GHUbCSXj" title="Shares issued">3,618,521</span>
    shares of common at a purchase price of $<span id="xdx_90A_eus-gaap--SharesIssuedPricePerShare_iI_c20230929__us-gaap--SubsidiarySaleOfStockAxis__custom--ShelfOfferingMember__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember_z3RZkDYhS8wl" title="Purchase price">0.64</span>
    per unit and <span id="xdx_903_eus-gaap--ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight_iI_c20230929__us-gaap--SubsidiarySaleOfStockAxis__custom--ShelfOfferingMember__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_zLtKnbYObrJb" title="Prefunded warrants">800,000</span>
    pre-funded warrants at $<span id="xdx_901_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_c20230929__us-gaap--SubsidiarySaleOfStockAxis__custom--ShelfOfferingMember__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_z2wcn5m3ZUed" title="Exercise price">0.639</span>
    per pre-funded warrants. The exercise price of the pre-funded warrants will be $<span id="xdx_907_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_c20230929__us-gaap--SubsidiarySaleOfStockAxis__custom--ShelfOfferingMember__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember_zMcXQ1u7TWj3" title="Exercise price">0.001</span>
    per share.</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">b.</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The second offering, the
    securities purchase agreement offering (&#8220;Private Placement&#8221;) with institutional investors and the Company received net
    proceeds from the Private Placement of approximately $<span id="xdx_906_eus-gaap--ProceedsFromIssuanceOfPrivatePlacement_pn5n6_c20230929__20230929__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--PrivatePlacementMember__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember_zXZJYIRsMLId" title="Net proceeds from the Private Placement">2.4</span> million, net of $<span id="xdx_90F_eus-gaap--LegalFees_c20230929__20230929__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--PrivatePlacementMember__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember_zlAFHAVIVlrl" title="Net fees">354,000</span> in fees relating to the placement agent and other
    offering expenses. In connection with the Private Placement, the Company issued: (i) <span id="xdx_901_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_c20230929__20230929__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--PrivatePlacementMember__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__us-gaap--StatementEquityComponentsAxis__custom--PIPEPreFundedWarrantsMember_z15DD4ln76Pf" title="PIPE shares">2,581,479</span> PIPE Shares (or PIPE Pre-Funded Warrants
    in lieu thereof) and (ii) PIPE Warrants (non-trading) to purchase <span id="xdx_902_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_pid_c20230929__20230929__us-gaap--SubsidiarySaleOfStockAxis__custom--NonTradingWarrantsMember_zF7aBomdByx1" title="Issuance of warrants">8,750,003</span> shares of our common stock, at a combined purchase price
    of $<span id="xdx_90E_eus-gaap--SharesIssuedPricePerShare_iI_c20230203__us-gaap--TypeOfArrangementAxis__custom--PurchaseAgreementMember__us-gaap--SubsidiarySaleOfStockAxis__custom--SecuritiesPurchaseAgreementMember__us-gaap--StatementEquityComponentsAxis__custom--PIPEPreFundedWarrantsMember_zqv98FUv5Cni" title="Shares issued price per share">1.074</span> per unit (or $1.073 per pre-funded unit). The PIPE Warrants have a term of five and one-half (<span id="xdx_908_eus-gaap--WarrantsAndRightsOutstandingTerm_iI_dtY_c20230929__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--PrivatePlacementMember__us-gaap--StatementEquityComponentsAxis__custom--PIPEPreFundedWarrantsMember_zHZTCxNDSJt3" title="Warrant term">5.5</span>) years from the issuance
    date and are exercisable for one share of common stock at an exercise price of $<span id="xdx_906_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_c20230929__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__us-gaap--StatementEquityComponentsAxis__custom--PIPEPreFundedWarrantsMember__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--PrivatePlacementMember_zVyh5j3TiDkd" title="Warrant exerice price">0.64</span>. The net proceeds, after reflecting par value,
    has been recorded in Additional Paid in Capital of $<span id="xdx_909_eus-gaap--AdditionalPaidInCapital_iI_pn5n6_c20230929__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--PrivatePlacementMember__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember_zT7829pxvWjl" title="Additional paid in capital">1.6 </span>million and with respect to the PIPE Warrants recorded as a liability under
    ASC 815 of $<span id="xdx_908_eus-gaap--FairValueAdjustmentOfWarrants_c20230929__20230929__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--PrivatePlacementMember__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember_zi2YNCQgSb8d" title="Warrants liability">985,204</span>. On October 16, 2023, the Company filed an S-1 (Resale) Registration Statement in connection with the Private
    Placement and on October 26, 2023 the S-1 went effective. At December 31, 2023, the warrant liability is $<span id="xdx_908_eus-gaap--WarrantsAndRightsOutstanding_iI_c20231231__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--PrivatePlacementMember__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember_zPDkjUEgFjW8" title="Warrants liability">1,036,875</span>. (See Notes 8
    and 10). </span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
February 3, 2023, the Company completed a securities purchase agreement (&#8220;Offering&#8221;) with institutional investors and received
net proceeds from the Offering were approximately $<span id="xdx_90D_ecustom--NetProceedsFromIssuanceInitialPublicOffering_pn5n6_c20230201__20230203__us-gaap--TypeOfArrangementAxis__custom--PurchaseAgreementMember_z02g5b06SaD2" title="Net proceeds from offering">3.2</span> million, net of $<span id="xdx_906_eus-gaap--NoninterestExpenseOfferingCost_c20230201__20230203__us-gaap--TypeOfArrangementAxis__custom--PurchaseAgreementMember_znPveh7iLx48" title="Offering expenses">600,000</span> in fees relating to the placement agent and other offering
expenses. The Offering was priced at the market under Nasdaq rules. In connection with the Offering, the Company issued <span id="xdx_904_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_c20230201__20230203__us-gaap--TypeOfArrangementAxis__custom--PurchaseAgreementMember_zJXhUki3jsp3" title="Shares issued">2,248,521</span> units
at a purchase price of $<span id="xdx_90C_eus-gaap--SharesIssuedPricePerShare_iI_c20230203__us-gaap--TypeOfArrangementAxis__custom--PurchaseAgreementMember_z0TpS9HFbIfa" title="Shares issued price per share">1.69</span> per unit. Each unit consists of one share of common stock and one non-tradable warrant exercisable for one
share of common stock at a price of $<span id="xdx_905_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_c20230203__us-gaap--TypeOfArrangementAxis__custom--PurchaseAgreementMember_zLrpt5IcwEv7" title="Warrant exerice price">1.56</span>, adjusted to $<span id="xdx_906_ecustom--ClassOfWarrantOrRightExercisePriceOfWarrantsAdjusted_iI_c20230929__us-gaap--TypeOfArrangementAxis__custom--PurchaseAgreementMember_z0stdfsrlADk" title="Warrant exerice price">0.64</span> at September 29, 2023, based on anti-dilution terms in the warrants. The
warrants have a term of five years from the issuance date. On February 13, 2023, the Company filed an S-1 (Resale) Registration Statement
in connection with the Offering.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
April 13, 2022, the Company&#8217;s initial public offering (&#8220;IPO&#8221;) was declared effective by the SEC pursuant to which the
Company issued and sold an aggregate of <span id="xdx_908_ecustom--StockIssuedDuringPeriodSharesInitialPublicOffering_c20220411__20220413__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_zTStDgZNt6Ib" title="Initial public offering">3,750,000</span> units (&#8220;Units&#8221;), each consisting of one share of common stock and two warrants,
to purchase one share of common stock for each whole warrant, with an initial exercise price of $<span id="xdx_906_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice_pid_c20220411__20220413__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_zeBqcDbb1GG1" title="Exercise price">4.25</span> per share and a term of <span id="xdx_900_eus-gaap--WarrantsAndRightsOutstandingTerm_iI_dc_c20220413__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_zl4vuM4lSJS7" title="Warrants exercise price term">five years</span>.
In addition, the Company granted Aegis Capital Corp., as underwriter a 45-day over-allotment option to purchase up to 15% of the number
of shares included in the units sold in the offering, and/or additional warrants equal to 15% of the number of Warrants included in the
units sold in the offering, in each case solely to cover over-allotments, which the Aegis Capital Corp. partially exercised with respect
to <span id="xdx_90A_eus-gaap--ClassOfWarrantOrRightOutstanding_iI_c20220419__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_zmyWhszUPMjl" title="Warrants exercised">1,125,000</span> warrants on April 19, 2022.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"></p>



<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>SHARPS
TECHNOLOGY, INC.</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTES
TO THE CONSOLIDATED FINANCIAL STATEMENTS</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>FOR
THE YEARS ENDED DECEMBER 31, 2023 AND 2022</b></span></p>

<p style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Note
8. Stockholders&#8217; Equity (continued)</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company&#8217;s common stock and warrants began trading on the Nasdaq Capital Market or Nasdaq on April 14, 2022. The net proceeds from
the IPO, prior to payments of certain listing and professional fees were approximately $<span id="xdx_90F_eus-gaap--ProceedsFromIssuanceInitialPublicOffering_pn5n6_c20220412__20220414__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--IPOMember_zlJEEwRhOnxk" title="Net proceeds from IPO">14.2</span> million. The net proceeds, after reflecting
par value, has been recorded in Additional Paid in Capital of $<span id="xdx_90D_eus-gaap--AdditionalPaidInCapital_iI_pn5n6_c20220414_zgjY5SnP4yTi" title="Additional paid in capital">9.0</span> million and with respect to the Warrants as a liability under ASC
815 of $<span id="xdx_90F_eus-gaap--FairValueAdjustmentOfWarrants_pn5n6_c20220412__20220414_zYwV2UNmH7U7" title="Warrants liability">5.2</span>M. (See Note 10)</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">During
the year ended December 31, 2022, the Company issued <span id="xdx_90F_eus-gaap--StockIssuedDuringPeriodSharesIssuedForServices_c20220101__20221231_zpVdD8C9ruH1" title="Common stock issued for services, shares">235,000</span> shares of common stock at the trading stock price in connection with services
provided to the Company and recorded a charge of $<span id="xdx_90A_eus-gaap--StockIssuedDuringPeriodValueIssuedForServices_c20220101__20221231_ztMvifOMz3Z6" title="Common stock issued for services, value">290,551</span>, In addition, the Company issued <span id="xdx_90C_eus-gaap--StockIssuedDuringPeriodSharesIssuedForServices_c20220101__20221231__us-gaap--TypeOfArrangementAxis__custom--NotePurchaseAgreementMember_zizbjT07WXd4" title="Common stock issued for services, shares">235,295</span> common shares relating to the Note
Purchase agreement. (See Note 7)</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Warrants</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">a)
                                                                              In connection with a one-year advisory services arrangement entered into in April 2023, the Company issued <span id="xdx_909_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_pid_c20230101__20231231__us-gaap--SubsidiarySaleOfStockAxis__custom--NonTradingWarrantsMember_zELgINyTRe3l" title="Issuance of warrants">495,000</span>
                                                                              warrants during the year ended December 31, 2023 at an exercise price of $<span id="xdx_90E_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_pid_c20231231__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--NoteWarrantMember_zfj84Rof6t3l" title="Exercise price">1.56</span>.
                                                                              The warrants have a three-year term and were fully vested on issuance. The FMV of the warrants recorded for the year end ended
                                                                              December 31, 2023 was $<span id="xdx_901_eus-gaap--FairValueAdjustmentOfWarrants_c20230101__20231231_zIYSKGXPApI3" title="Fair value adjustment of warrants">42,915</span>
                                                                              as computed using the Black Sholes valuation model. The assumptions for the year ended December 31, 2023 were: a) expected term
                                                                              &#8211; <span id="xdx_904_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_dtY_c20230101__20231231_zeP98f22ATXg" title="Expected term">3</span>
                                                                              years, b) expected volatility &#8211; <span id="xdx_900_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum_pid_dp_uPure_c20230101__20231231_z1bbxmYc29mg" title="Volatility, minimum">24.49</span>%
                                                                              to <span id="xdx_900_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum_pid_dp_uPure_c20230101__20231231_zbD4y9mhK2ij" title="Volatility, maximum">44.83</span>%,
                                                                              c) risk free rate- <span id="xdx_90B_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum_pid_dp_uPure_c20230101__20231231_zWi8cNWnaqwk" title="Risk free interest rate, minimum">3.58</span>%
                                                                              to <span id="xdx_90F_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum_pid_dp_uPure_c20230101__20231231_zv9rdpUvMzDf" title="Risk free interest rate, maximum">4.67</span>.%
                                                                              and d) dividend rate &#8211; <span id="xdx_905_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_pid_dp_uPure_c20230101__20231231_zdgoHMxRYC8i" title="Dividend rate">0</span>%.</span></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">b)
    In connection with the Private Placement in September 2023, the Company issued <span id="xdx_904_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_pid_c20230901__20230930__us-gaap--SubsidiarySaleOfStockAxis__custom--NonTradingWarrantsMember_zgso18xUuiR2" title="Issuance of warrants">8,750,003</span> non-trading PIPE Warrants as a component
    of the Unit as noted in Common Stock above. The PIPE Warrants were recorded at the FMV, computed using the Black Sholes valuation
    method. The PIPE Warrant&#8217;s liability requires remeasurement at each reporting period. The PIPE Warrants are classified as a
    liability based on ASC 815. At the issuance date and December 31, 2023, the liability was $<span id="xdx_90B_eus-gaap--WarrantsAndRightsOutstanding_iI_c20230929__us-gaap--SubsidiarySaleOfStockAxis__custom--NonTradingWarrantsMember__us-gaap--StatementEquityComponentsAxis__custom--PIPEWarrantMember_z5DPxJD7guRj" title="Warrant liability">985,204</span> and $<span id="xdx_903_eus-gaap--WarrantsAndRightsOutstanding_iI_c20231231__us-gaap--SubsidiarySaleOfStockAxis__custom--NonTradingWarrantsMember__us-gaap--StatementEquityComponentsAxis__custom--PIPEWarrantMember_z3oaGHVnP3Uc" title="Warrant liability">1,036,875</span>, respectively and
    for the year ended December 31, 2023 a FMV loss adjustment of $<span id="xdx_905_eus-gaap--MarketRiskBenefitChangeInFairValueGainLoss_c20230101__20231231__us-gaap--SubsidiarySaleOfStockAxis__custom--NonTradingWarrantsMember__us-gaap--StatementEquityComponentsAxis__custom--PIPEWarrantMember_zxvFZGyJqz21" title="Fair market value adjustment">51,671</span> was recorded (See Note 10).</span></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">c)
    In connection with the Offering in February 2023, the Company issued <span id="xdx_904_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_pid_c20230201__20230228__us-gaap--SubsidiarySaleOfStockAxis__custom--NonTradingWarrantsMember_zH3NyuLUatJe" title="Issuance of warrants">2,248,521</span> non-trading warrants Offering Warrants as a component
    of the Unit as noted in Common Stock above. The Offering Warrant&#8217;s liability requires remeasurement at each reporting period.
    The Offering Warrants were recorded at the FMV, computed using the Black Sholes valuation method. The Offering Warrants are classified
    as a liability based on ASC 815. At the issuance date and at December 31, 2023 the liability was $<span id="xdx_90A_eus-gaap--WarrantsAndRightsOutstanding_iI_c20230228__us-gaap--SubsidiarySaleOfStockAxis__custom--NonTradingWarrantsMember_zcOYbfymT5Y4" title="Warrants liability">455,326</span> and $<span id="xdx_909_eus-gaap--WarrantsAndRightsOutstanding_iI_c20231231__us-gaap--SubsidiarySaleOfStockAxis__custom--NonTradingWarrantsMember_zyTwSDCYZzh" title="Warrants liability">234,072</span>, respectively.
    During the year ended December 31, 2023, the Company recorded a FMV gain adjustment of $<span id="xdx_904_eus-gaap--FairValueAdjustmentOfWarrants_c20230101__20231231__us-gaap--SubsidiarySaleOfStockAxis__custom--NonTradingWarrantsMember_zl0ywqe0H9z4" title="FMV gain adjustment">221,254</span>. (See Note 10).</span></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">d)
    In connection with the IPO in April 2022, the Company issued <span id="xdx_90F_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_pid_c20220401__20220430__us-gaap--SubsidiarySaleOfStockAxis__custom--TradingWarrantsMember_znjXLidnQO22" title="Issuance of warrants">7,500,000</span>
    warrants (Trading Warrants) as a component of the Units and <span id="xdx_907_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_pid_c20220401__20220430__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--OverAllotmentOptionMember_zZkqoNebekPi" title="Issuance of warrants">1,125,000</span>
    warrants to the underwriter (Overallotment Warrants), as noted in Common Stock above. The Trading and Overallotment Warrants were
    recorded at the FMV, being the trading price of the warrants, on the IPO effective date and the Warrants are classified as a
    Liability based on ASC 815. The Warrant liability requires remeasurement at each reporting period. At December 31, 2023 and 2022,
    the liability was $<span id="xdx_903_eus-gaap--WarrantsAndRightsOutstanding_iI_c20231231__us-gaap--SubsidiarySaleOfStockAxis__custom--TradingWarrantsMember_zMVfHLRw4r6e" title="Warrants liability"><span id="xdx_909_eus-gaap--WarrantsAndRightsOutstanding_iI_c20221231__us-gaap--SubsidiarySaleOfStockAxis__custom--TradingWarrantsMember_zYfUFBuwMDa6" title="Warrants liability">1,121,250</span></span>.
    During years ended December 31, 2023 and 2022, the Company recorded a FMV loss (gain) adjustment of $<span id="xdx_903_eus-gaap--FairValueAdjustmentOfWarrants_c20230101__20231231__us-gaap--SubsidiarySaleOfStockAxis__custom--TradingWarrantsMember_zVxkcAIjVx79" title="Fair value income adjustment">0</span>
    and $(<span id="xdx_903_eus-gaap--FairValueAdjustmentOfWarrants_c20220101__20221231__us-gaap--SubsidiarySaleOfStockAxis__custom--TradingWarrantsMember_z4OtSAVVHNo5" title="Fair value income adjustment">4,784,559</span>), <span>respectively</span>
    (See Note 10).</span></p></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>




<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>SHARPS
TECHNOLOGY, INC.</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTES
TO THE CONSOLIDATED FINANCIAL STATEMENTS</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>FOR
THE YEARS ENDED DECEMBER 31, 2023 AND 2022</b></span></p>

<p style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Note
8. Stockholders&#8217; Equity (continued)</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">e)
    The Company has issued <span id="xdx_901_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_pid_c20220419__20220419__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--NoteWarrantMember_zWkrZmKo9B98" title="Issuance of warrants">235,295</span>
    Warrants (&#8220;Note Warrants&#8221;) to the Purchasers of the Notes on April 19, 2022. The Note Warrants have an exercise price of
    $<span id="xdx_909_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_pid_c20220419__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--NoteWarrantMember_zTWD3cZiugV9" title="Exercise price">4.25</span>
    and a term of <span id="xdx_901_eus-gaap--WarrantsAndRightsOutstandingTerm_iI_dc_c20220419__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--NoteWarrantMember_zDYKm0TNpUIb" title="Warrants exercise price term">five years</span>. At December 31,2023 and 2022, the liability was $<span id="xdx_901_ecustom--PaymentsForRepurchaseOfLiability_c20220101__20221231__us-gaap--SubsidiarySaleOfStockAxis__custom--NoteWarrantsMember_zcsKXB287fPj" title="Warrant outstanding">30,588</span>.
    During the years ended December 31, 2023 and 2022, the Company recorded a FMV loss (gain) of $<span id="xdx_90C_eus-gaap--FairValueAdjustmentOfWarrants_c20230101__20231231__us-gaap--SubsidiarySaleOfStockAxis__custom--NoteWarrantsMember_zosuRDpp1wzg" title="Fair value income adjustment">0</span>
    and ($<span id="xdx_906_eus-gaap--FairValueAdjustmentOfWarrants_c20220101__20221231__us-gaap--SubsidiarySaleOfStockAxis__custom--NoteWarrantsMember_zLt5vdzjt1I4" title="Fair value income adjustment">127,059</span>),
    respectively. (See Note 10)</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">f)
    The underwriter received <span id="xdx_909_eus-gaap--ClassOfWarrantOrRightOutstanding_iI_c20231231__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--IPOMember_zfYDNcLzcbFl" title="Warrants received">187,500</span>
    warrants in connection with the IPO for a nominal cost of $<span id="xdx_902_eus-gaap--PaymentsOfStockIssuanceCosts_c20230101__20231231__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--IPOMember_z5dlVSTPXmI3" title="Nominal cost">11,250</span>.
    The Warrants have an exercise price of $<span id="xdx_908_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_pid_c20221009__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--IPOMember_zPg6cTkzlLob" title="Exercise price">5.32</span>
    and are exercisable after October 9, 2022. The FMV at the date of issuance was $<span id="xdx_904_eus-gaap--FairValueAdjustmentOfWarrants_c20230101__20231231__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--IPOMember_zRSQVJyAfjge" title="Fair value adjustment of warrants">228,750</span>
    computed using the Black Sholes valuation model with the following assumptions: a) volatility of <span id="xdx_903_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate_pid_dp_uPure_c20230101__20231231__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--IPOMember_zyCRFn78Azn3" title="Volatility">93.47</span>%, <span id="xdx_904_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_dxL_c20230101__20231231__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--IPOMember_zl1sIXJl71Pf" title="Expected term::XDX::P5Y"><span style="-sec-ix-hidden: xdx2ixbrl0970">five</span></span>-year
    term, risk free interest rate <span id="xdx_903_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_pid_dp_uPure_c20230101__20231231__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--IPOMember_zDjcnIFfCrNl" title="Risk free interest rate">2.77</span>%
    and <span id="xdx_907_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_pid_dp_uPure_c20230101__20231231__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--IPOMember_za612j0WtE3b" title="Dividend rate">0</span>%
    dividend rate. These warrants were recorded in Equity at the estimated FMV and classified as additional issuance
    costs.</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityNoteDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for equity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-13<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (h)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-13<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 14<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-14<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 235<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477968/946-235-50-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 235<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477968/946-235-50-2<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 505<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478448/946-505-50-6<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480237/815-40-50-6<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480008/505-10-S99-1<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(e)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 10: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org/505/tableOfContent<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-13<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (g)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-13<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-13<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 14<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-14<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 14<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-14<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 16<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-16<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 18<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-18<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 18<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-18<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 18<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-18<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityNoteDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>119
<FILENAME>R17.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.4</span><table class="report" border="0" cellspacing="2" id="idm45095369630896">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Preferred Stock<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquityAbstract', window );"><strong>Equity [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockTextBlock', window );">Preferred Stock</a></td>
<td class="text"><p id="xdx_80E_eus-gaap--PreferredStockTextBlock_zWiVlYzABBmk" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Note
9. <span id="xdx_82A_zVQIH3ndTVXi">Preferred Stock</span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
February 2018, the Company Board of Directors issued one share of Series A Preferred Stock to Alan Blackman, the Company&#8217;s
co-founder and former Director. <span id="xdx_904_eus-gaap--PreferredStockVotingRights_c20240101__20240930__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesAPreferredStockMember_zK8gAUX3OIJk" title="Preferred stock, voting rights">The
Series A Preferred Stock entitled the holder to vote on any matters related to the election of directors and was reduced from 50.1%
at December 31, 2021 to 29.5%, effective with the IPO.</span> The Series A Preferred Stock has no right to dividends, or
distributions in the event of a liquidation and is not convertible into common stock. In connection with final settlement with
Mr. Blackman on August 2024, the Series A Preferred Stock were cancelled and forfeited without any further consideration. The
Series A Preferred was returned to the status of an authorized but unissued share of preferred stock of the
Company (See Note 15).</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<span></span>
</td>
<td class="text"><p id="xdx_80E_eus-gaap--PreferredStockTextBlock_zq5XTcnSoNye" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Note
9. <span id="xdx_82F_zUyqR4qiiuod">Preferred Stock</span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
February 2018, the Company Board of Directors issued one share of Series A Preferred Stock to Alan Blackman, the Company&#8217;s co-founder
and Director. The Series A Preferred Stock entitles the holder to vote on any matters related to the election of directors and was reduced
from <span id="xdx_90F_eus-gaap--EquityMethodInvestmentOwnershipPercentage_iI_pid_dp_uPure_c20221231__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesAPreferredStockMember__srt--TitleOfIndividualAxis__srt--DirectorMember__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--AlanBlackmanMember_zR88SUr4h0z3" title="Ownership interest percentage">50.1</span>% at December 31, 2022 to <span id="xdx_90B_eus-gaap--EquityMethodInvestmentOwnershipPercentage_iI_pid_dp_uPure_c20221231__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesAPreferredStockMember__srt--TitleOfIndividualAxis__srt--DirectorMember__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--IPOMember__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--AlanBlackmanMember_zAtWfzVnO1Xb" title="Ownership interest percentage">29.5</span>%, effective with the IPO. The Series A Preferred Stock has no right to dividends, or distributions
in the event of a liquidation and is not convertible into common stock. In the event the Company is sold during the two-year period following
completion of IPO at a price per share of more than 500% of the initial offering price per Unit in the IPO, the Series A Preferred Stock,
as in effect upon completion of the IPO, will entitle the holder to <span id="xdx_90A_eus-gaap--EquityMethodInvestmentOwnershipPercentage_iI_pid_dp_uPure_c20180228__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesAPreferredStockMember__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--IPOMember__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--AlanBlackmanMember_z6r901oEkGc5" title="Ownership interest percentage">10</span>% of the total purchase price. (See Note 15)</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for terms, amounts, nature of changes, rights and privileges, dividends, and other matters related to preferred stock.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org/505/tableOfContent<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>120
<FILENAME>R18.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.4</span><table class="report" border="0" cellspacing="2" id="idm45095366604400">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Warrant Liability<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_STSS_DisclosureWarrantLiabilityAbstract', window );"><strong>Warrant Liability</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_STSS_WarrantLiabilityTextBlock', window );">Warrant Liability</a></td>
<td class="text"><p id="xdx_80A_ecustom--WarrantLiabilityTextBlock_zXUVLEfd1gKd" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Note
10. <span id="xdx_82D_zjlLl9nSTeye">Warrant Liability</span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Certain
Warrants are accounted for as liabilities in accordance with ASC 815-40 and are presented as a Warrant liability in the accompanying
condensed consolidated balance sheets. The warrant liabilities are measured at fair value at inception and on a recurring basis, with
changes in fair value presented within the condensed consolidated statements of operations. The Black Scholes Option-Pricing model used
the following assumptions for the nine months ended September 30, 2024 and 2023 (See Note 8).</span></p>

<p id="xdx_893_eus-gaap--FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock_hus-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_zNfj4uwSz8Yc" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span id="xdx_8B0_z5C3vtvO3kFc" style="display: none">Schedule
of Fair Value of Warrant</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">September
    30, 2024</span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">September
    30, 2023</span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Expected
    term (years)</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_901_eus-gaap--WarrantsAndRightsOutstandingTerm_iI_dtY_c20240930__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputExpectedTermMember__srt--RangeAxis__srt--MinimumMember_zmXMpEpnfdA" title="Expected term (in years)">3.37</span>
                                            to <span id="xdx_907_eus-gaap--WarrantsAndRightsOutstandingTerm_iI_dtY_c20240930__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputExpectedTermMember__srt--RangeAxis__srt--MaximumMember_z2fbJCh3v6Z" title="Expected term (in years)">5.99</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_908_eus-gaap--WarrantsAndRightsOutstandingTerm_iI_dtY_c20230930__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputExpectedTermMember__srt--RangeAxis__srt--MinimumMember_zJ1OxdaSccMe" title="Expected term (in years)">4.36</span>
                                                                                                                                                                       to <span id="xdx_902_eus-gaap--WarrantsAndRightsOutstandingTerm_iI_dtY_c20230930__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputExpectedTermMember__srt--RangeAxis__srt--MaximumMember_zLlKEu3UkqD5" title="Expected term (in years)">5.5</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Expected
    volatility</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_903_eus-gaap--WarrantsAndRightsOutstandingMeasurementInput_iI_uPure_c20240930__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputOptionVolatilityMember__srt--RangeAxis__srt--MinimumMember_zXXVWT90ZRFe" title="Expected volatility">58.78</span>%
                                            to <span id="xdx_901_eus-gaap--WarrantsAndRightsOutstandingMeasurementInput_iI_uPure_c20240930__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputOptionVolatilityMember__srt--RangeAxis__srt--MaximumMember_zQzweK1Oo1sh" title="Expected volatility">121.32</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">%<span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90F_eus-gaap--WarrantsAndRightsOutstandingMeasurementInput_iI_uPure_c20230930__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputOptionVolatilityMember__srt--RangeAxis__srt--MinimumMember_zRv1T99jhtA4" title="Expected volatility">45.31</span>% to <span id="xdx_907_eus-gaap--WarrantsAndRightsOutstandingMeasurementInput_iI_uPure_c20230930__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputOptionVolatilityMember__srt--RangeAxis__srt--MaximumMember_zVYQVnOrBbRa" title="Expected volatility">59.93</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">%<span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Risk-free
    interest rate</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_904_eus-gaap--WarrantsAndRightsOutstandingMeasurementInput_iI_uPure_c20240930__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputRiskFreeInterestRateMember__srt--RangeAxis__srt--MinimumMember_zf5o1wA5v0Gi">3.41</span>%
                                            to <span id="xdx_903_eus-gaap--WarrantsAndRightsOutstandingMeasurementInput_iI_uPure_c20240930__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputRiskFreeInterestRateMember__srt--RangeAxis__srt--MaximumMember_z0Kke4FDIzn8">4.56</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">%<span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span id="xdx_904_eus-gaap--WarrantsAndRightsOutstandingMeasurementInput_iI_uPure_c20230930__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputRiskFreeInterestRateMember__srt--RangeAxis__srt--MinimumMember_zDCk21xxYKk" style="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.53
</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">to <span id="xdx_90C_eus-gaap--WarrantsAndRightsOutstandingMeasurementInput_iI_uPure_c20230930__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputRiskFreeInterestRateMember__srt--RangeAxis__srt--MaximumMember_z5zagmsUuQyc">4.54</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">%</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 60%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Dividend
    rate</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 16%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_909_eus-gaap--WarrantsAndRightsOutstandingMeasurementInput_iI_uPure_c20240930__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputExpectedDividendRateMember_zoaHYPOcVQj" title="Warrants liabilities measurement input">0</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 16%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90E_eus-gaap--WarrantsAndRightsOutstandingMeasurementInput_iI_uPure_c20230930__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputExpectedDividendRateMember_z51hakULv0cc" title="Warrants liabilities measurement input">0</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"></p>

<p id="xdx_8AF_zR9QUfS9Q5fd" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p id="xdx_89C_ecustom--ScheduleOfWarrantLiabilityTableTextBlock_zjFkl6PkXAg4" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Warrant liability at September 30, 2024 and December 31, 2023 was as follows:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span id="xdx_8B4_za9s8uaOy15c" style="display: none">Schedule
of Warrant Liability</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" id="xdx_496_20240930_ztB5zHqwIoE3" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">September
    30, 2024</span></td><td style="padding-bottom: 1pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" id="xdx_49B_20231231_ztgLDdeEkM03" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">December
    31, 2023</span></td><td style="padding-bottom: 1pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr id="xdx_408_ecustom--WarrantLiabilitiesCurrent_iI_hus-gaap--ClassOfWarrantOrRightAxis__custom--TradingAndOverallotmentWarrantsMember_zdShiQojQEQ5" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 60%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Trading and Overallotment
    Warrants</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="width: 16%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">431,250</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="width: 16%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,121,250</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr id="xdx_403_ecustom--WarrantLiabilitiesCurrent_iI_hus-gaap--ClassOfWarrantOrRightAxis__custom--NoteWarrantsMember_zpnqIbvwgih7" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Note Warrants</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">11,765</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">30,588</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr id="xdx_40D_ecustom--WarrantLiabilitiesCurrent_iI_hus-gaap--ClassOfWarrantOrRightAxis__custom--OfferingWarrantsFebruaryTwoThousandTwentyThreeMember_zyuTxZWwWzek" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Offering Warrants &#8211; February 2023</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">20,053</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">234,072</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr id="xdx_40B_ecustom--WarrantLiabilitiesCurrent_iI_hus-gaap--ClassOfWarrantOrRightAxis__custom--OfferingWarrantsSeptemberTwoThousandTwentyThreeMember_zZmHblQLt2bk" style="vertical-align: bottom; background-color: White">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Offering Warrants &#8211; September 2023</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">216,911</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,036,875</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr id="xdx_406_ecustom--WarrantLiabilitiesCurrent_iI_hus-gaap--ClassOfWarrantOrRightAxis__custom--InducementWarrantsMember_zzJAq6GcMpNd" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Inducement Warrants &#8211;
    May 2024</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">347,123</span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl2743">-</span></span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr id="xdx_405_ecustom--WarrantLiabilitiesCurrent_iI_z8j6MBigIaFc" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Total
    Warrant Liability</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,027,102</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2,422,785</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  </table>

<p id="xdx_8A5_zW9r07ak8D15" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p id="xdx_89E_eus-gaap--ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock_z7SUQBFelWU5" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Warrants outstanding at September 30, 2024 and December 31, 2023 were as follows:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span id="xdx_8BC_zh2iBmbU72ca" style="display: none">Schedule
of Warrant Outstanding</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" id="xdx_497_20240930_zmV3G9cnyhw9" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">September
    30, 2024</span></td><td style="padding-bottom: 1pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" id="xdx_49A_20231231_zDJP6QVAQr4h" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">December
    31,2023</span></td><td style="padding-bottom: 1pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr id="xdx_403_eus-gaap--ClassOfWarrantOrRightOutstanding_iI_hus-gaap--ClassOfWarrantOrRightAxis__custom--TradingAndOverallotmentWarrantsMember_zDhWk4Mq0iF6" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 60%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Trading,
    Overallotment and Underwriter Warrants</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="width: 16%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">400,568</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="width: 16%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">400,568</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr id="xdx_402_eus-gaap--ClassOfWarrantOrRightOutstanding_iI_hus-gaap--ClassOfWarrantOrRightAxis__custom--NoteWarrantsMember_zBW58NrZrqm7" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Note Warrants</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10,695</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10,695</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr id="xdx_40D_eus-gaap--ClassOfWarrantOrRightOutstanding_iI_hus-gaap--ClassOfWarrantOrRightAxis__custom--OfferingWarrantsFebruaryTwoThousandTwentyThreeMember_zVWcQ3pZzA8h" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Offering Warrants &#8211; February 2023</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">8,607</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">102,206</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr id="xdx_40F_eus-gaap--ClassOfWarrantOrRightOutstanding_iI_hus-gaap--ClassOfWarrantOrRightAxis__custom--OfferingWarrantsSeptemberTwoThousandTwentyThreeMember_zmnAWBb2GdWl" style="vertical-align: bottom; background-color: White">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Offering Warrants &#8211; September 2023</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">95,078</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">397,727</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr id="xdx_407_eus-gaap--ClassOfWarrantOrRightOutstanding_iI_hus-gaap--ClassOfWarrantOrRightAxis__custom--InducementWarrantsMayTwoThousandTwentyFourMember_zInelbDTIvz3" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Inducement Warrants &#8211; May 2024</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">260,799</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl2763">-</span></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr id="xdx_404_eus-gaap--ClassOfWarrantOrRightOutstanding_iI_hus-gaap--ClassOfWarrantOrRightAxis__custom--WarrantsIssuedForServiceManagementMember_zLy9ajQEohl9" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Warrants
    issued for services arrangement</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">28,636</span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">22,500</span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr id="xdx_404_ecustom--ClassOfWarrantsOrRightOutstanding_iI_zJQn2lMJMPx5" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Total
    Warrants Outstanding</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">804,383</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,194,495</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  </table>


<p id="xdx_8A8_zLpliDi8Ivtj" style="margin-top: 0; margin-bottom: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>




<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>SHARPS
TECHNOLOGY, INC.</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTES
TO THE CONDENSED CONSOLIDATED FINANCIAL STATEMENTS</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>FOR
THE THREE AND NINE MONTHS ENDED SEPTEMBER 30, 2024 AND 2023</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Note
10. Warrant Liability (continued)</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">For
the three months ended September 30, 2024, the FMV gain adjustment, which is reflected in the FMV adjustment on Warrants in the
Unaudited Condensed Consolidated Statements of Operations was <span id="xdx_906_eus-gaap--GainLossOnSaleOfDerivatives_c20240701__20240930_zGKZZGPJ0BM4" title="Fair market value adjustment">$416,560</span>,
which includes the modification charge of <span id="xdx_907_ecustom--FairValueAdjustmentOfModificationCharge_c20240701__20240930_z8snirj6Sojj" title="Fair value adjustment of modification charge">$155,703</span>
and $<span id="xdx_90F_eus-gaap--GainLossOnSaleOfDerivatives_c20240701__20240930__us-gaap--TypeOfArrangementAxis__custom--InducementAgreementMember_zdNnhiiuwGXb" title="Fair market value adjustment">349,243</span>,
gain for the warrants exercised in connection with the Inducement Agreements (See Note 8).</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">For
the nine months September 30, 2024, the FMV gain adjustment, which is reflected in the FMV adjustment on Warrants in the Unaudited Condensed
Consolidated Statements of Operations was <span id="xdx_90C_eus-gaap--GainLossOnSaleOfDerivatives_c20240101__20240930_z9GNOe5MpELk" title="Fair market value adjustment">$2,088,747</span>, which includes the modification charge of <span id="xdx_902_ecustom--FairValueAdjustmentOfModificationCharge_c20240101__20240930_zRb4XmdMl2t6" title="Fair value adjustment of modification charge">$790,956</span> and $<span id="xdx_906_eus-gaap--GainLossOnSaleOfDerivatives_c20240101__20240930__us-gaap--TypeOfArrangementAxis__custom--InducementAgreementMember_zkwlzy3XJQjg" title="Fair market value adjustment">349,243</span>, gain for the warrants
exercised in connection with the Inducement Agreements (See Note 8).</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">For
the three and nine months ended September 30, 2023, the FMV gain adjustment, which is reflected in the FMV adjustment gain (loss) on
Warrants in the Unaudited Condensed Consolidated Statements of Operations was $<span id="xdx_904_ecustom--GainLossOnSaleOfDerivative_di_c20230701__20230930_zARPB5Jc9pte" title="Fair market value adjustment">321,981</span> and
$<span id="xdx_904_ecustom--GainLossOnSaleOfDerivative_c20230101__20230930_zcog8MoFnMp7" title="Fair market value adjustment">415,958</span>,
respectively (see Note 8).</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<span></span>
</td>
<td class="text"><p id="xdx_80A_ecustom--WarrantLiabilityTextBlock_zW1LKxolH2c1" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Note
10. <span id="xdx_82F_zOgOpLFNfquk">Warrant Liability</span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Warrants were accounted for as liabilities in accordance with ASC 815-40 and are presented as a Warrant liability in the accompanying
consolidated balance sheet. The warrant liabilities are measured at fair value at inception and on a recurring basis, with changes in
fair value presented within the consolidated statement of operations, The non-trading warrants, related to the February 2023 and September
2023 offerings, are valued using the Black-Scholes pricing model. The assumptions for the year ended December 31, 2023 were as follows:
(See Notes 7 and 8)</span></p>

<p id="xdx_898_eus-gaap--ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock_hus-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_z5jnmmRnTLx7" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_8B8_z3F43eQIYzn" style="display: none">Schedule
of Fair Value of Warrant</span></span></span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 80%">
  <tr style="vertical-align: bottom">
    <td style="text-align: center"><b>&#160;</b></td><td style="padding-bottom: 1pt"><b>&#160;</b></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"><p style="margin-top: 0pt; margin-bottom: 0pt"><b>Year Ended
                                            <br/> December 31,</b></p>
                                                                                <p style="margin-top: 0pt; margin-bottom: 0pt"><b>2023</b></p></td><td style="padding-bottom: 1pt"><b>&#160;</b></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Expected term (years)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_901_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_dtY_c20230101__20231231__srt--RangeAxis__srt--MinimumMember__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_zhDHBPzmJXlj" title="Expected term (in years)">4.10</span> to <span id="xdx_90E_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_dtY_c20230101__20231231__srt--RangeAxis__srt--MaximumMember__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_ziMLFjAReNCe" title="Expected term (in years)">5.50</span> </span></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Expected volatility</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_903_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_dp_c20230101__20231231__srt--RangeAxis__srt--MinimumMember__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_zs6weAVJO24l" title="Expected volatility">45.30</span>% to <span id="xdx_908_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_dp_c20230101__20231231__srt--RangeAxis__srt--MaximumMember__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_zOF8yLPihQW5" title="Expected volatility">70.44</span></span></td><td style="text-align: left">%</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Risk-free interest rate</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90F_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_dp_c20230101__20231231__srt--RangeAxis__srt--MinimumMember__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_zdXzuXI8kas6" title="Risk-free interest rate">3.53</span>% to <span id="xdx_908_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_dp_c20230101__20231231__srt--RangeAxis__srt--MaximumMember__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_ztxtPZ02OBVg" title="Risk-free interest rate">4.54</span></span></td><td style="text-align: left">%</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="width: 74%; text-align: left">Dividend rate</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 22%; text-align: right"><span id="xdx_909_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_dp_c20230101__20231231__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_zUjhAz4fKS7" title="Risk-free interest rate">0</span></td><td style="width: 1%; text-align: left">%</td></tr>
  </table>

<p id="xdx_8A6_zbvjlzTzd3eg" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p id="xdx_89C_ecustom--ScheduleOfWarrantLiabilityTableTextBlock_zofZl5BvTDx9" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Warrant liability at December 31, 2023 and 2022 was as follows:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span><span id="xdx_8B1_zuJdiIA68dbg" style="display: none">Schedule
of Warrant Liability</span></span></span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 60%">
  <tr style="vertical-align: bottom">
    <td style="padding-bottom: 1pt">&#160;</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td>
    <td colspan="2" id="xdx_49B_20231231_z2NFHWe8Bhh1" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2023</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td>
    <td colspan="2" id="xdx_499_20221231_zOWC0nsZdO0d" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2022</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
  <tr id="xdx_404_ecustom--WarrantLiability_iI_hus-gaap--SubsidiarySaleOfStockAxis__custom--TradingAndOverallotmentWarrantsMember_zRBDDKBQ78E7" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 60%; text-align: left">Trading and Overallotment Warrants</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 16%; text-align: right">1,121,250</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 16%; text-align: right">1,121,250</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr id="xdx_40D_ecustom--WarrantLiability_iI_hus-gaap--SubsidiarySaleOfStockAxis__custom--NoteWarrantsMember_zYT4PuI8bfC9" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1pt">Note Warrants</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">30,588</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">30,588</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_407_ecustom--WarrantLiability_iI_hus-gaap--SubsidiarySaleOfStockAxis__custom--OfferingWarrantsFebruaryTwentyTwentyThreeMember_z1ffBxrNWm7k" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 1pt">Offering Warrants &#8211; February 2023</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">234,072</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl1011">-</span></span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_40B_ecustom--WarrantLiability_iI_hus-gaap--SubsidiarySaleOfStockAxis__custom--OfferingWarrantsSeptemberTwentyTwentyThreeMember_zhnUtscNzZ2f" style="vertical-align: bottom; background-color: White">
    <td style="padding-bottom: 1pt">Offering Warrants &#8211; September 2023</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">1,036,875</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1014">-</span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_40A_ecustom--WarrantLiability_iI_zzc2JuUB9pr4" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 2.5pt">Total Warrant Liability</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">2,422,785</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td style="border-bottom: Black 2.5pt double; text-align: right">1,151,838</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  </table>

<p id="xdx_8A4_zXdObG8qHmXi" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p id="xdx_89E_eus-gaap--ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock_z9SZsrKLqWS" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Warrants outstanding at December 31, 2023 and 2022 were as follows:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;<span id="xdx_8B8_zbnpCBFP3bg4" style="display: none">Schedule
of Warrant Outstanding</span></span></span></span></span></span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 80%">
  <tr style="vertical-align: bottom">
    <td style="padding-bottom: 1pt; text-align: center"><b>&#160;</b></td><td style="padding-bottom: 1pt; text-align: center"><b>&#160;</b></td>
    <td colspan="2" id="xdx_49A_20231231_zI5p3KsKabhh" style="border-bottom: Black 1pt solid; text-align: center"><p style="margin-top: 0pt; margin-bottom: 0pt"><b>December
                                            31,</b></p>
                                                                                <p style="margin-top: 0pt; margin-bottom: 0pt"><b>2023</b></p></td><td style="padding-bottom: 1pt; text-align: center"><b>&#160;</b></td><td style="padding-bottom: 1pt; text-align: center"><b>&#160;</b></td>
    <td colspan="2" id="xdx_496_20221231_zDuN70vGQSm4" style="border-bottom: Black 1pt solid; text-align: center"><p style="margin-top: 0pt; margin-bottom: 0pt"><b>December
                                            31,</b></p>
                                                                                <p style="margin-top: 0pt; margin-bottom: 0pt"><b>2022</b></p></td><td style="padding-bottom: 1pt; text-align: center"><b>&#160;</b></td></tr>
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: right">&#160;</td><td>&#160;</td></tr>
  <tr id="xdx_40D_eus-gaap--ClassOfWarrantOrRightOutstanding_iI_hus-gaap--SubsidiarySaleOfStockAxis__custom--TradingAndOverallotmentWarrantsMember_zSPQoDjVh74j" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 56%; text-align: left">Trading and Overallotment Warrants</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 18%; text-align: right">8,812,500</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 18%; text-align: right">8,812,500</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr id="xdx_400_eus-gaap--ClassOfWarrantOrRightOutstanding_iI_hus-gaap--SubsidiarySaleOfStockAxis__custom--NoteWarrantsMember_zo7OgdO4fGx1" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1pt">Note Warrants</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">235,294</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">235,294</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_400_eus-gaap--ClassOfWarrantOrRightOutstanding_iI_hus-gaap--SubsidiarySaleOfStockAxis__custom--OfferingWarrantsFebruaryTwentyTwentyThreeMember_zHoUIa6rrep2" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 1pt">Offering Warrants &#8211; February 2023</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">2,248,521</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><p style="margin: 0"><span style="-sec-ix-hidden: xdx2ixbrl1028">-</span></p></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_40E_eus-gaap--ClassOfWarrantOrRightOutstanding_iI_hus-gaap--SubsidiarySaleOfStockAxis__custom--OfferingWarrantsSeptemberTwentyTwentyThreeMember_zlCPbJattfxl" style="vertical-align: bottom; background-color: White">
    <td style="padding-bottom: 1pt">Offering Warrants &#8211; September 2023</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">8,750,003</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><p style="margin: 0"><span style="-sec-ix-hidden: xdx2ixbrl1031">-</span></p></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_40D_eus-gaap--ClassOfWarrantOrRightOutstanding_iI_hus-gaap--SubsidiarySaleOfStockAxis__custom--WarrantsIssuedForServiceManagementMember_zeaGnV6KO535" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1pt">Warrants issued for services arrangement</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">495,000</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl1034">-</span></span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_402_eus-gaap--ClassOfWarrantOrRightOutstanding_iI_zTXE7CeC9Zqd" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 2.5pt">Total Warrants Outstanding</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td style="border-bottom: Black 2.5pt double; text-align: right">20,541,318</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td style="border-bottom: Black 2.5pt double; text-align: right">9,047,794</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  </table>

<p id="xdx_8A1_zHYTMlWynilh" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>




<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>SHARPS
TECHNOLOGY, INC.</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTES
TO THE CONSOLIDATED FINANCIAL STATEMENTS</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>FOR
THE YEARS ENDED DECEMBER 31, 2023 AND 2022</b></span></p>

<p style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Note
10. Warrant Liability (continued)</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">For
the years ended December 31, 2023 and 2022 the FMV loss (gain) adjustment, which is reflected in the FMV adjustment on Warrants in the
Consolidated Statements of Operations was ($<span id="xdx_90D_eus-gaap--MarketRiskBenefitChangeInFairValueGainLoss_c20230101__20231231_zHXdAWQi0xDa" title="Fair market value adjustment">169,583</span>) and ($<span id="xdx_905_eus-gaap--MarketRiskBenefitChangeInFairValueGainLoss_c20220101__20221231_zcmjOxeaHFV2" title="Fair market value adjustment">4,784,559</span>), respectively.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_STSS_DisclosureWarrantLiabilityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">STSS_DisclosureWarrantLiabilityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>STSS_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_STSS_WarrantLiabilityTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Warrant Liability [Text Block]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">STSS_WarrantLiabilityTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>STSS_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>121
<FILENAME>R19.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.4</span><table class="report" border="0" cellspacing="2" id="idm45095369502384">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Stock Options<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract', window );"><strong>Share-Based Payment Arrangement [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock', window );">Stock Options</a></td>
<td class="text"><p id="xdx_804_eus-gaap--DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock_zDTxhaFgOcBd" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Note
11. <span id="xdx_822_zLQpmKrEd85f">Stock Options</span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p id="xdx_894_eus-gaap--ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock_zxVZC5fUQAHc" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">A
summary of options granted and outstanding is presented below.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span id="xdx_8BE_z8LJXVDUa9I7" style="display: none">Schedule
of Stock Options Granted and Outstanding</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="6" style="border-bottom: Black 1pt solid; text-align: center; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">September
    30, 2024</span></td><td style="padding-bottom: 1pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Options</span></td><td style="padding-bottom: 1pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Weighted<br/>
    Average<br/> Exercise Price</span></td><td style="padding-bottom: 1pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 60%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Outstanding at
    Beginning of year</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td id="xdx_980_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iS_c20240101__20240930_z5mTF4VY3CHf" style="width: 16%; text-align: right" title="Stock option, beginning balance"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">109,493</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td id="xdx_985_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iS_c20240101__20240930_zmy9UZAtMVBe" style="width: 16%; text-align: right" title="Weighted average exercise price, beginning balance"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">67.12</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Granted</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td id="xdx_98E_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_c20240101__20240930_zPZ4EPLTqSUg" style="text-align: right" title="Shares, options granted"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">63,409</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td id="xdx_981_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_c20240101__20240930_z1SpI7FuhVFh" style="text-align: right" title="Weighted average exercise price, options granted"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">6.27</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Forfeited
    or cancelled</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td id="xdx_98D_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_iN_di_c20240101__20240930_zkXYANERjSc1" style="border-bottom: Black 2.5pt double; text-align: right" title="Shares, options forfeited"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(18,592</span></td><td style="padding-bottom: 2.5pt; text-align: left">)<span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td id="xdx_985_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice_c20240101__20240930_zdZHHWPmlmme" style="border-bottom: Black 2.5pt double; text-align: right" title="Weighted average exercise price, forfeited or cancelled"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">37.11</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Outstanding at end of
    period</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td id="xdx_988_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iE_c20240101__20240930_zYq0CLHwEJqe" style="border-bottom: Black 2.5pt double; text-align: right" title="Stock option, ending balance"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">154,310</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_98B_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iE_c20240101__20240930_zKUWeRQybKq" style="border-bottom: Black 2.5pt double; text-align: right" title="Weighted average exercise price, ending balance"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">42.88</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Exercisable at end of
    period</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td id="xdx_981_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_iE_c20240101__20240930_zpmMa4vDkomg" style="border-bottom: Black 2.5pt double; text-align: right" title="Stock option, exercisable ending balance"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">122,243</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td id="xdx_98F_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_iE_c20240101__20240930_zpXujWLzQCOg" style="border-bottom: Black 2.5pt double; text-align: right" title="Weighted average exercise price, exercisable ending balance"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">50.86</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  </table>

<p id="xdx_8A9_zBQec5uyUU1a" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">At
September 30, 2024, the Weighted Average Remaining Contractual Life is <span id="xdx_909_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_dt_c20240101__20240930_zD8h54r5Bfel" title="Weighted average remaining contractual life">39 months</span>.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">At
September 30, 2024, the stock options outstanding and the options exercisable have exercise prices that exceed the stock market price
at September 30, 2024 and as such no intrinsic value exists. Intrinsic value is defined as the difference between the exercise price
of the options and the market price of the Company&#8217;s common stock.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">During
the nine months ended September 30, 2024, the Company granted <span id="xdx_906_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantedInYear_dxL_c20240101__20240930_znTD0U8gTOpf" title="Granted options::XDX::P5Y"><span style="-sec-ix-hidden: xdx2ixbrl2813">five</span></span>-year options (the &#8220;Options&#8221;) to purchase a total of <span id="xdx_906_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_c20240101__20240930_zrnuXv6fdOQk" title="Granted shares">63,409</span>
shares of the Company&#8217;s common stock, par value $<span id="xdx_906_eus-gaap--CommonStockParOrStatedValuePerShare_iI_c20240930_zQBxIXBncTX6" title="Common stock par value">0.0001</span> per share (the &#8220;Common Stock&#8221;) to its directors, executive
officers, employees and consultants pursuant to the Company&#8217;s 2023 Equity Incentive Plan. The Options are exercisable at an average
price of $<span id="xdx_90C_ecustom--ShareBasedCompensationOptionsExercisableWeightedAverageExercisePrice_iI_c20240930_zALWz1z2w3w8" title="Options exercisable">6.27</span> per share which was based on the closing price on the respective grant dates.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
of September 30, 2024, there was $<span id="xdx_901_eus-gaap--EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized_iI_c20240930_z2Qlgko1xeH3" title="Unrecognized stock-based compensation">232,353</span> of unrecognized stock-based compensation related to unvested stock options with a weighted average
fair value of $<span id="xdx_907_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue_iI_c20240930_zyI4ScBVBSBl" title="Unvested stock options weighted average fair value">7.25</span> per share, which is expected to be recognized over a weighted-average period of <span id="xdx_908_eus-gaap--EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_dt_c20240101__20240930_zzgJE3cNyuO2" title="Recognized over a weighted-average period">12 months</span> as of September 30, 2024.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">For
the three and nine months ended September 30, 2024, the Company recognized stock-based compensation expense of $<span id="xdx_908_eus-gaap--AllocatedShareBasedCompensationExpense_c20240701__20240930_zTEAlE8Q4g5h" title="Stock-based compensation expense">116,193</span>
recorded in general and administrative and $<span id="xdx_90A_eus-gaap--AllocatedShareBasedCompensationExpense_c20240101__20240930_zOGfoVekGin5" title="Stock-based compensation expense">435,908</span>,
respectively, of which $<span id="xdx_90C_eus-gaap--AllocatedShareBasedCompensationExpense_c20240101__20240930__us-gaap--IncomeStatementLocationAxis__us-gaap--GeneralAndAdministrativeExpenseMember_zg7i2NaY8Smd" title="Stock-based compensation expense">432,567</span>
and $<span id="xdx_909_eus-gaap--AllocatedShareBasedCompensationExpense_c20240101__20240930__us-gaap--IncomeStatementLocationAxis__us-gaap--ResearchAndDevelopmentExpenseMember_zBC01nnw40Yl" title="Stock-based compensation expense">3,341</span>
was recorded in general and administrative and research and development expenses.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">For
the three and nine months ended September 30, 2023, the Company recognized stock-based compensation expense of $<span id="xdx_90C_eus-gaap--AllocatedShareBasedCompensationExpense_c20230701__20230930__us-gaap--IncomeStatementLocationAxis__us-gaap--GeneralAndAdministrativeExpenseMember_zJHfhaghib72" title="Share based compensation">178,895</span>&#160;and $<span id="xdx_906_eus-gaap--AllocatedShareBasedCompensationExpense_c20230101__20230930__us-gaap--IncomeStatementLocationAxis__us-gaap--GeneralAndAdministrativeExpenseMember_z8Kdbhz4lupa" title="Share based compensation">796,606</span>, respectively,
which was recorded in general and administrative.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>





<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>SHARPS
TECHNOLOGY, INC.</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTES
TO THE CONDENSED CONSOLIDATED FINANCIAL STATEMENTS</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>FOR
THE THREE AND NINE MONTHS ENDED SEPTEMBER 30, 2024 AND 2023</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Note
11. Stock Options (continued)</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p id="xdx_89E_eus-gaap--FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock_znTUjMvgAGr4" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
fair value of stock option awards accounted for under ASC 718 was estimated at the date of grant using a Black-Scholes option-pricing
model with the following assumptions for the options granted during the nine months ended September 30, 2024 and 2023.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span id="xdx_8B1_zemRJhENtd4g" style="display: none">Schedule of Fair Value of Stock Option Awards</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">September
    30, 2024</span></td><td style="padding-bottom: 1pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">September
    30, 2023</span></td><td style="padding-bottom: 1pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Expected term (years)</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_909_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_dtY_c20240101__20240930__srt--RangeAxis__srt--MinimumMember_zpofHFkTvUsf" title="Expected term (years)">2.66</span>
                                            to <span id="xdx_90A_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_dtY_c20240101__20240930__srt--RangeAxis__srt--MaximumMember_zolyGV3PtPZ5" title="Expected term (years)">3.06</span></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_903_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_dtY_c20230101__20230930__srt--RangeAxis__srt--MinimumMember_zN1micCDOphd" title="Expected term (years)">2.88</span>
                                            to <span id="xdx_900_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_dtY_c20230101__20230930__srt--RangeAxis__srt--MaximumMember_zcXeelFA7zeh" title="Expected term (years)">3.25</span></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Expected volatility</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_901_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate_dp_c20240101__20240930__srt--RangeAxis__srt--MinimumMember_zOQH52I5tpA9" title="Expected volatility">81.15</span>
                                            % to <span id="xdx_908_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate_dp_c20240101__20240930__srt--RangeAxis__srt--MaximumMember_zQHMcjPuGP3k" title="Expected volatility">83.04</span></span></td><td style="text-align: left">%<span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90B_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate_dp_c20230101__20230930__srt--RangeAxis__srt--MinimumMember_zfVirIaCcnNe" title="Expected volatility">75.40</span>%
                                            to <span id="xdx_909_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate_dp_c20230101__20230930__srt--RangeAxis__srt--MaximumMember_zolNsqKQktLc" title="Expected volatility">89.93</span></span></td><td style="text-align: left">%</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Risk-free interest rate</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_905_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_dp_c20240101__20240930__srt--RangeAxis__srt--MinimumMember_zsKXsFrWFgcl" title="Risk-free interest rate">4.71</span>
                                            % to <span id="xdx_909_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_dp_c20240101__20240930__srt--RangeAxis__srt--MaximumMember_zEKLmLjcwsM4" title="Risk-free interest rate">4.76</span></span></td><td style="text-align: left">%</td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_906_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_dp_c20230101__20230930__srt--RangeAxis__srt--MinimumMember_zhWFSgQx7L9g" title="Risk-free interest rate">3.71</span>%
                                            to <span id="xdx_901_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_dp_c20230101__20230930__srt--RangeAxis__srt--MaximumMember_z5EFMmOaBfw8" title="Risk-free interest rate">4.27</span></span></td><td style="text-align: left">%</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="width: 60%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Dividend rate</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="width: 16%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_906_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_dp_c20240101__20240930_zVwLNuNFqGv3" title="Dividend rate">0</span></span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="width: 16%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_900_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_dp_c20230101__20230930_z6U4iGoN0Img" title="Dividend rate">0</span></span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  </table>

<p id="xdx_8A2_zIKGmvNwZmhg" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<span></span>
</td>
<td class="text"><p id="xdx_804_eus-gaap--DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock_zpi01Ls8aMjh" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Note
11. <span id="xdx_82E_zQMlDZUjgcRe">Stock Options</span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On January 24, 2023, the Company&#8217;s Board of Directors initially adopted the 2023 Equity Incentive Plan (the
&#8220;2023 Plan&#8221;), to provide for the issuance of up to <span id="xdx_900_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_iI_c20230124__us-gaap--PlanNameAxis__custom--TwoThousandTwentyThreeEquityIncentivePlanMember_zI2Q6ZbymiB8" title="Stock available for issuance">1,400,000</span> options and/or shares of restricted stock be available for issuance
to officers, directors, employees and consultants. The 2023 Plan was subsequently updated to provide for the issuance of up to <span id="xdx_907_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod_c20230124__20230124__us-gaap--PlanNameAxis__custom--TwoThousandTwentyThreeEquityIncentivePlanMember_zUGy6rwkFzI5" title="Number of stock issuance">3,500,000</span>
options and/or shares of restricted stock. The 2023 Plan was approved by shareholders at the annual meeting</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p id="xdx_894_eus-gaap--ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock_zxjRdzkmrjJa" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">A
summary of options granted and outstanding is presented below.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span><span id="xdx_8B2_zh8qQm1k4QP7" style="display: none">Schedule
of Stock Options Granted and Outstanding</span></span></span></span></span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="6" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2023</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="6" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2022</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Options</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Weighted<br/> Average<br/> Exercise <br/> Price</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Options</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Weighted<br/> Average<br/> Exercise <br/> Price</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 40%; text-align: left">Outstanding at Beginning of year</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td id="xdx_987_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionOutstandingNumber_iS_c20230101__20231231_zaUwzULDb3Bc" style="width: 11%; text-align: right" title="Stock option, beginning balance">1,358,122</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_987_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionOutstandingWeightedAverageExercisePrice_iS_c20230101__20231231_zNXsc1vFalU7" style="width: 11%; text-align: right" title="Weighted average exercise price, beginning balance">4.37</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td id="xdx_989_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iS_c20220101__20221231_zEpeaR5DmrI5" style="width: 11%; text-align: right" title="Stock option, beginning balance">1,137,479</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_98D_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iS_c20220101__20221231_zslpPQdBI7th" style="width: 11%; text-align: right" title="Weighted average exercise price, beginning balance">5.18</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td>Granted</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98B_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_c20230101__20231231_zjX1ZZxE5XLc" style="text-align: right" title="Shares, options granted">1,065,000</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_982_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_c20230101__20231231_z8uZ9XHkfcRh" style="text-align: right" title="Weighted average exercise price, options granted">1.35</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98D_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_c20220101__20221231_zh8BO9bo09Ll" style="text-align: right" title="Shares, options granted">367,500</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_989_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_c20220101__20221231_zdMAoRskatQ6" style="text-align: right" title="Weighted average exercise price, options granted">1.63</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>Cancelled</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_987_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod_iN_di_c20220101__20221231_zrwqbIejKl79" style="text-align: right" title="Shares, options cancelled">(3,571</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_989_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice_iN_di_c20220101__20221231_zdkd51rjznaf" style="text-align: right" title="Weighted average exercise price, options cancelled">(4.38</td><td style="text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-bottom: 1pt">Forfeited</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_98A_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedNumberOfShares_iN_di_c20230101__20231231_zxzNhmrWXAq7" style="border-bottom: Black 1pt solid; text-align: right" title="Shares, options forfeited">(14,286</td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">$</td><td id="xdx_984_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice_c20230101__20231231_zHLduwboIknd" style="border-bottom: Black 1pt solid; text-align: right" title="Weighted average exercise price, options forfeited">1.75</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_98E_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_iN_di_c20220101__20221231_zjHSUDyUObu4" style="border-bottom: Black 1pt solid; text-align: right" title="Shares, options forfeited">(143,286</td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">$</td><td id="xdx_98F_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice_iN_di_c20220101__20221231_zcid2FMo7Tpa" style="border-bottom: Black 1pt solid; text-align: right" title="Weighted average exercise price, options forfeited">(3.77</td><td style="padding-bottom: 1pt; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 2.5pt">Outstanding at end of year</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td id="xdx_987_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionOutstandingNumber_iE_c20230101__20231231_zEch1ZGM8U6k" style="border-bottom: Black 2.5pt double; text-align: right" title="Stock option, ending balance">2,408,836</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_981_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionOutstandingWeightedAverageExercisePrice_iE_c20230101__20231231_z6ygFRMgPhS" style="border-bottom: Black 2.5pt double; text-align: right" title="Weighted average exercise price, ending balance">3.03</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td id="xdx_98C_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iE_c20220101__20221231_zwehlMRbwH5g" style="border-bottom: Black 2.5pt double; text-align: right" title="Stock option, ending balance">1,358,122</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_982_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iE_c20220101__20221231_zzRFa28LDX26" style="border-bottom: Black 2.5pt double; text-align: right" title="Weighted average exercise price, ending balance">4.37</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 2.5pt">Exercisable at end of year</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td id="xdx_986_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_iE_c20230101__20231231_zKGeCfCEswbd" style="border-bottom: Black 2.5pt double; text-align: right" title="Stock option, exercisable">1,881,327</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_982_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_iE_c20230101__20231231_zG3VY1yrDYC1" style="border-bottom: Black 2.5pt double; text-align: right" title="Weighted average exercise price, exercisable">3.47</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td id="xdx_98E_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_iE_c20220101__20221231_zozaY861CnVe" style="border-bottom: Black 2.5pt double; text-align: right" title="Stock option, exercisable">1,132,861</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_98D_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_iE_c20220101__20221231_z7ewT5InYWcj" style="border-bottom: Black 2.5pt double; text-align: right" title="Weighted average exercise price, exercisable">4.59</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  </table>

<p id="xdx_8A7_zOV7srWKoCB7" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1)</span></td>
    <td colspan="3"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">During the year ended December 31, 2023, the Company granted <span id="xdx_903_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_dxL_c20230101__20231231__us-gaap--PlanNameAxis__custom--TwoThousandTwentyThreeEquityIncentivePlanMember_zPsIffusXqn1" title="Expected term::XDX::P5Y"><span style="-sec-ix-hidden: xdx2ixbrl1095">five</span></span>-year options (the &#8220;Options&#8221;) to purchase a total of:</span></p>

</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td colspan="3">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 0.25in">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">a)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_906_eus-gaap--StockIssuedDuringPeriodSharesShareBasedCompensation_c20230101__20231231__us-gaap--PlanNameAxis__custom--TwoThousandTwentyThreeEquityIncentivePlanMember_zSLNgQzsbhQh" title="Purchase of total shares">975,000</span>
    shares of the Company&#8217;s common stock, par value $<span id="xdx_90E_eus-gaap--CommonStockParOrStatedValuePerShare_iI_c20231231__us-gaap--PlanNameAxis__custom--TwoThousandTwentyThreeEquityIncentivePlanMember_zCgflDU6YbHa" title="Common stock, par value">0.0001</span> per share (the &#8220;Common Stock&#8221;) to its directors, executive
    officers, employees and consultants pursuant to the Company&#8217;s. 2022 and 2023 Equity Incentive Plans. The Options are exercisable
    at $<span id="xdx_90E_ecustom--ShareBasedCompensationOptionsExercisableWeightedAverageExercisePrice_iI_c20231231__us-gaap--PlanNameAxis__custom--TwoThousandTwentyThreeEquityIncentivePlanMember_zFk0jOxv1Ri7" title="Options exercisable">1.37 </span>per share which was the closing price on January 25, 2023.</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td>&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">b)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90D_eus-gaap--StockIssuedDuringPeriodSharesShareBasedCompensation_c20230101__20231231__srt--TitleOfIndividualAxis__custom--EmployeesAndConsultantMember_zD1rIgmh3Yt1" title="Purchase of shares">90,000</span>
    shares of the Company&#8217;s Common Stock in connection with an employment or consulting agreements at the exercise price, representing
    the closing price on the grant date ranging from $<span id="xdx_901_ecustom--ShareBasedCompensationOptionsExercisableWeightedAverageExercisePrice_iI_c20231231__srt--TitleOfIndividualAxis__custom--EmployeesAndConsultantMember__srt--RangeAxis__srt--MinimumMember_zAOt7mgEYNef" title="Options exercisable">0.82</span> to $<span id="xdx_900_ecustom--ShareBasedCompensationOptionsExercisableWeightedAverageExercisePrice_iI_c20231231__srt--TitleOfIndividualAxis__custom--EmployeesAndConsultantMember__srt--RangeAxis__srt--MaximumMember_zjeNUVus5YQ4" title="Options exercisable">1.30</span>.</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td>&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="3" style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">During the year ended December 31, 2023, <span id="xdx_90F_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_c20230101__20231231__us-gaap--PlanNameAxis__custom--TwoThousandTwentyThreeEquityIncentivePlanMember_zVxSy9wppG3h" title="Shares, options granted">660,000</span> Options have been granted under the 2023 Equity Incentive Plan and the remaining <span id="xdx_90C_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_c20230101__20231231__us-gaap--PlanNameAxis__custom--TwoThousandTwentyTwoEquityIncentivePlanMember_zdbKVrHFoQEh" title="Shares, options granted">405,000</span> Options were issued under the 2022 Equity Incentive Plan. At December 31, 2023, <span id="xdx_90C_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iI_c20231231__us-gaap--PlanNameAxis__custom--TwoThousandTwentyTwoEquityIncentivePlanMember_zJgJw3a7DfMc" title="Options outstanding">1,748,836</span> Options are outstanding under the 2022 Equity Incentive Plan. </span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">During
the years ended December 31, 2023 and 2022, the estimated weighted-average grant-date fair value of options granted was $<span id="xdx_901_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_pid_c20230101__20231231_zoysvO2ydjLd" title="Weighted-average grant-date fair value of options granted">.80</span>
per share and $<span id="xdx_907_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_pid_c20220101__20221231_zKmxekvmuGb5" title="Weighted-average grant-date fair value of options granted">1.63</span>
per share, respectively. As of December 31, 2023 and 2022, there was $<span id="xdx_90A_eus-gaap--EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized_iI_c20231231_zUhhSnLHdrBl" title="Unrecognized stock based compensation">498,454</span>
and $<span id="xdx_905_eus-gaap--EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized_iI_c20221231_zWE0SwUG2k3d" title="Unrecognized stock based compensation">475,097</span>,
respectively, of unrecognized stock-based compensation related to unvested stock options with a weighted average fair value of $<span id="xdx_90B_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue_iI_pid_c20231231_zoX2beRL7OB6" title="Unvested stock options weighted average fair value">.94</span> and $<span id="xdx_90C_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue_iI_pid_c20221231_zNaQhQeaH3Hb" title="Unvested stock options weighted average fair value">2.05</span> per share, respectively, which is expected to be recognized over a
weighted-average period sixteen months as of December 31, 2023.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p id="xdx_896_eus-gaap--ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTextBlock_zyEjtYLsdPz3" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
following table summarizes information about options outstanding at December 31, 2023:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span><span id="xdx_8B9_ztchLltpVJe3" style="display: none">Schedule
of Information About Options Outstanding</span></span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 90%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td colspan="2" style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Exercise
    <br/>
    Prices</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></td>
    <td colspan="2" style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Options
    <br/>
    Outstanding</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></td>
    <td colspan="2" style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Aggregate<br/>
    Intrinsic Value</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></td>
    <td colspan="2" style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Weighted
    Average <br/>
    Remaining<br/>
    Contractual Life</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></td>
    <td colspan="2" style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Options
    <br/>
    Exercisable</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Aggregate</b></span></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Intrinsic
    Value<br/>
    on Exercisable<br/>
    Shares</b></span></p></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td colspan="2" style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 12%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_903_eus-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit_c20230101__20231231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeOneMember__srt--RangeAxis__srt--MinimumMember_zBCE1r4eLcAe" title="Stock option, exercise price">.82</span> to <span id="xdx_90E_eus-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit_c20230101__20231231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeOneMember__srt--RangeAxis__srt--MaximumMember_z4MAyw806t1h" title="Stock option, exercise price">.92</span></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td id="xdx_989_eus-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions_iI_c20231231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeOneMember_zeXCfV64B6X8" style="font: 10pt Times New Roman, Times, Serif; width: 12%; text-align: right" title="Options, shares outstanding"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">40,000</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td id="xdx_98A_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_iI_c20231231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeOneMember_zzO9XqLgXdkg" style="font: 10pt Times New Roman, Times, Serif; width: 14%; text-align: right" title="Stock option, aggregate intrinsic value">&#160;&#160;&#160;&#160;&#160;<span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl1135">-</span></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 14%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90A_eus-gaap--SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2_dtY_c20230101__20231231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeOneMember_z3n6ybZBvqUk" title="Stock option, weighted average remaining contractual life">4.58</span></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td id="xdx_98F_eus-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions_iI_c20231231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeOneMember_zVb4oEeNxaec" style="font: 10pt Times New Roman, Times, Serif; width: 12%; text-align: right" title="Options, shares exercisable"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">18,794</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td id="xdx_980_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1_iI_c20231231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeOneMember_zb0A1ijPx8A" style="font: 10pt Times New Roman, Times, Serif; width: 14%; text-align: right" title="Stock option, aggregate intrinsic value on exercisable shares">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl1141">-</span></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_907_eus-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit_c20230101__20231231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeTwoMember_zxQgIHiwv0Ld" title="Stock option, exercise price">1.21</span></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td id="xdx_98F_eus-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions_iI_c20231231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeTwoMember_zQrISQLiHbs9" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Options, shares outstanding"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">307,500</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td id="xdx_989_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_iI_c20231231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeTwoMember_z97JRxHuAKD4" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Stock option, aggregate intrinsic value"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl1147">-</span></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_908_eus-gaap--SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2_dtY_c20230101__20231231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeTwoMember_zj2yoK181UGi" title="Stock option, weighted average remaining contractual life">3.42</span></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td id="xdx_98D_eus-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions_iI_c20231231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeTwoMember_zATG1bSK1wc" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Options, shares exercisable"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">240,386</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td id="xdx_98A_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1_iI_c20231231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeTwoMember_zxoxvZBfRNf6" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Stock option, aggregate intrinsic value on exercisable shares"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl1153">-</span></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_903_eus-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit_c20230101__20231231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeThreeMember_zJbONXr9NGce" title="Stock option, exercise price">1.30</span></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td id="xdx_984_eus-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions_iI_c20231231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeThreeMember_zsdLopjx0gdf" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Options, shares outstanding"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">50,000</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td id="xdx_983_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_iI_c20231231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeThreeMember_zfhQwORB1ved" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Stock option, aggregate intrinsic value"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl1159">-</span></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_903_eus-gaap--SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2_dtY_c20230101__20231231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeThreeMember_zEjbzr5a5Ubd" title="Stock option, weighted average remaining contractual life">4.21</span></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td id="xdx_988_eus-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions_iI_c20231231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeThreeMember_zAb9C5wh3HWd" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Options, shares exercisable"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">43,750</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td id="xdx_98C_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1_iI_c20231231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeThreeMember_zKIzzXyAHRre" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Stock option, aggregate intrinsic value on exercisable shares"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl1165">-</span></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_902_eus-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit_c20230101__20231231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeFourMember_zcNnTjlC5kDk" title="Stock option, exercise price">1.37</span></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td id="xdx_986_eus-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions_iI_c20231231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeFourMember_zjZBlmx33Pla" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Options, shares outstanding"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">975,000</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td id="xdx_984_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_iI_c20231231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeFourMember_zPmnrEYyYZD" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Stock option, aggregate intrinsic value"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl1171">-</span></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90A_eus-gaap--SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2_dtY_c20230101__20231231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeFourMember_zWykEPseBCKf" title="Stock option, weighted average remaining contractual life">4.17</span></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td id="xdx_985_eus-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions_iI_c20231231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeFourMember_zec5JlVXfHI" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Options, shares exercisable"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">561,719</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td id="xdx_983_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1_iI_c20231231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeFourMember_zodRTTHznA4e" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Stock option, aggregate intrinsic value on exercisable shares"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl1177">-</span></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_908_eus-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit_c20230101__20231231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeFiveMember_zyIYAAlOEMPl" title="Stock option, exercise price">1.75</span></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td id="xdx_988_eus-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions_iI_c20231231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeFiveMember_zQptYFhsXte4" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Options, shares outstanding"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">54,285</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td id="xdx_981_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_iI_c20231231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeFiveMember_zo1fFXH87n81" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Stock option, aggregate intrinsic value"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl1183">-</span></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_906_eus-gaap--SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2_dtY_c20230101__20231231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeFiveMember_zFcQNivy35Be" title="Stock option, weighted average remaining contractual life">2.25</span></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: right"></p>
    <p id="xdx_98F_eus-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions_iI_c20231231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeFiveMember_zzi5h6q58LCd" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: right" title="Options, shares exercisable"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">54,285</span></p></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td id="xdx_981_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1_iI_c20231231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeFiveMember_zO1AmwXzm5oc" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Stock option, aggregate intrinsic value on exercisable shares"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl1189">-</span></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90F_eus-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit_c20230101__20231231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeSixMember_zL6tgR1vlWN4" title="Stock option, exercise price">2.80</span></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td id="xdx_98D_eus-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions_iI_c20231231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeSixMember_z1ijSAqahwj2" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Options, shares outstanding"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">141,429</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td id="xdx_988_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_iI_c20231231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeSixMember_zsYNwWzfoq9j" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Stock option, aggregate intrinsic value"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl1195">-</span></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90F_eus-gaap--SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2_dtY_c20230101__20231231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeSixMember_zsCLsRLdkKyh" title="Stock option, weighted average remaining contractual life">2.25</span></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td id="xdx_98C_eus-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions_iI_c20231231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeSixMember_zsdstAMVSRJ8" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Options, shares exercisable"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">141,429</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td id="xdx_98A_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1_iI_c20231231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeSixMember_z9tgdx3ulgGg" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Stock option, aggregate intrinsic value on exercisable shares"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl1201">-</span></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_900_eus-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit_c20230101__20231231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeSevenMember_zDANi0kfYtca" title="Stock option, exercise price">1.39</span></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td id="xdx_98B_eus-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions_iI_c20231231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeSevenMember_zpCZb5xXKeW4" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Options, shares outstanding"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10,000</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td id="xdx_985_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_iI_c20231231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeSevenMember_zUu60m0y0Tq7" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Stock option, aggregate intrinsic value"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl1207">-</span></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_903_eus-gaap--SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2_dtY_c20230101__20231231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeSevenMember_zgxXTuK5Yk09" title="Stock option, weighted average remaining contractual life">3.75</span></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td id="xdx_987_eus-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions_iI_c20231231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeSevenMember_zvlXcHh2AFB2" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Options, shares exercisable"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10,000</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td id="xdx_98A_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1_iI_c20231231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeSevenMember_zKme8A1lT2Le" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Stock option, aggregate intrinsic value on exercisable shares"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl1213">-</span></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_906_eus-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit_c20230101__20231231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeEightMember_zIGBcB7uZsOe" title="Stock option, exercise price">4.25</span></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td id="xdx_98B_eus-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions_iI_c20231231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeEightMember_zBBjbohhBN6j" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Options, shares outstanding"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">50,000</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td id="xdx_98D_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_iI_c20231231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeEightMember_zcz5sVnxPIbc" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Stock option, aggregate intrinsic value"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl1219">-</span></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_909_eus-gaap--SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2_dtY_c20230101__20231231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeEightMember_zrO1ZuGNb9R8" title="Stock option, weighted average remaining contractual life">3.75</span></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td id="xdx_989_eus-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions_iI_c20231231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeEightMember_zE2PWB9ZoCf9" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Options, shares exercisable"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">50,000</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td id="xdx_980_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1_iI_c20231231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeEightMember_z8KaCTDq5sw6" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Stock option, aggregate intrinsic value on exercisable shares"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl1225">-</span></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90C_eus-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit_c20230101__20231231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeNineMember_zg6IcBmTQjU3" title="Stock option, exercise price">4.38</span></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td id="xdx_98C_eus-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions_iI_c20231231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeNineMember_zq47EDyJeyF1" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Options, shares outstanding"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">244,286</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td id="xdx_981_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_iI_c20231231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeNineMember_ziqdd7G72LNh" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Stock option, aggregate intrinsic value"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl1231">-</span></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_902_eus-gaap--SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2_dtY_c20230101__20231231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeNineMember_ztN3xB6cqDx6" title="Stock option, weighted average remaining contractual life">1.25</span></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td id="xdx_981_eus-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions_iI_c20231231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeNineMember_z0Xhb2DgSedh" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Options, shares exercisable"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">244,286</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td id="xdx_987_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1_iI_c20231231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeNineMember_z2OxjzEZCZ4g" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Stock option, aggregate intrinsic value on exercisable shares"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl1237">-</span></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_903_eus-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit_c20230101__20231231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeTenMember_z65Kidvx3JX3" title="Stock option, exercise price">7.00</span></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td id="xdx_983_eus-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions_iI_c20231231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeTenMember_zrWWgPsF0bfc" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Options, shares outstanding"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">536,335</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td id="xdx_98C_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_iI_c20231231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeTenMember_zFvHlCXX4VM9" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Stock option, aggregate intrinsic value"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl1243">-</span></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_904_eus-gaap--SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2_dtY_c20230101__20231231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeTenMember_zsSwHVvDh4Z6" title="Stock option, weighted average remaining contractual life">2.00</span></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td id="xdx_986_eus-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions_iI_c20231231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeTenMember_zEku6u3Bb35h" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Options, shares exercisable"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">516,679</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td id="xdx_986_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1_iI_c20231231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeTenMember_zT2dgOLkzh3" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Stock option, aggregate intrinsic value on exercisable shares"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl1249">-</span></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  </table>
<p id="xdx_8A4_zXim3hru36g" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">At
December 31,2023, the stock options outstanding and the options exercisable have exercise prices that exceed the stock market price at
December 31, 2023 and as such no intrinsic value exist. Intrinsic value is defined as the difference between the exercise price of the
options and the market price of the Company&#8217;s common stock.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>




<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>SHARPS
TECHNOLOGY, INC.</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTES
TO THE CONSOLIDATED FINANCIAL STATEMENTS</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>FOR
THE YEARS ENDED DECEMBER 31, 2023 AND 2022</b></span></p>

<p style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Note
11. Stock Options (continued)</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
2023 and 2022, the Company recognized stock-based compensation expense of $<span id="xdx_90D_eus-gaap--AllocatedShareBasedCompensationExpense_c20230101__20231231_zY0qg8KJESb6" title="Share based compensation">920,108</span>, of which $<span id="xdx_905_eus-gaap--AllocatedShareBasedCompensationExpense_c20230101__20231231__us-gaap--IncomeStatementLocationAxis__us-gaap--GeneralAndAdministrativeExpenseMember_zrQvrcNADPh5" title="Share based compensation">906,745</span> and $<span id="xdx_90E_eus-gaap--AllocatedShareBasedCompensationExpense_c20230101__20231231__us-gaap--IncomeStatementLocationAxis__us-gaap--ResearchAndDevelopmentExpenseMember_zSL8xRr5zLg7" title="Share based compensation">13,363</span> was recorded in general
and administrative and research and development expenses, respectively and $<span id="xdx_900_eus-gaap--AllocatedShareBasedCompensationExpense_c20220101__20221231_zoJQkHHv8Awa" title="Share based compensation">1,012,592</span>, of which $<span id="xdx_904_eus-gaap--AllocatedShareBasedCompensationExpense_c20220101__20221231__us-gaap--IncomeStatementLocationAxis__us-gaap--GeneralAndAdministrativeExpenseMember_zY2v5U3RykU3" title="Share based compensation">915,797</span> and $<span id="xdx_909_eus-gaap--AllocatedShareBasedCompensationExpense_c20220101__20221231__us-gaap--IncomeStatementLocationAxis__us-gaap--ResearchAndDevelopmentExpenseMember_zlKC4gc67N0f" title="Share based compensation">96,795</span> was recorded in
general and administrative and research and development expenses, respectively. Further, in 2022, the Company recorded stock-based charges
of $<span id="xdx_90A_ecustom--StockBasedChargesRelatingToPurchaseOfMachinery_c20220101__20221231_z3l8vRBblJ82" title="Stock based charges relating to purchase of machinery">63,612</span> relating to purchase of machinery (See Note 4) and $<span id="xdx_90B_ecustom--StockBasedChargesRelatingToAcquisition_c20220101__20220331_z2vCFm4wcxVb" title="Stock based charges relating to acquisition">60,435</span> relating to an Acquisition. (See Note 5.)</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p id="xdx_897_eus-gaap--ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock_zaVNnRXOWKLh" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
fair value of stock option awards accounted for under ASC 718 was estimated at the date of grant using a Black-Scholes option-pricing
model with the following assumptions:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_8BB_zSEmShr3UWYk" style="display: none">Schedule
of Fair Value of Stock Option Awards</span></span></span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 90%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;&#160;</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></td>
    <td colspan="2" style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"><p style="margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: imes New Roman, Times, Serif; font-size: 10pt"><b>Year
                                            Ended <br/> December 31,</b></span></p>
                                                                                <p style="margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>2023</b></span></p></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></td>
    <td colspan="2" style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"><p style="margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: imes New Roman, Times, Serif; font-size: 10pt"><b>Year
                                            Ended <br/> December 31,</b></span></p>
                                                                                <p style="margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>2022</b></span></p></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Expected term (years)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_905_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_dtY_c20230101__20231231__srt--RangeAxis__srt--MinimumMember_zCwKHtEdnz3" title="Expected term (years)">2.88</span> to <span id="xdx_90B_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_dtY_c20230101__20231231__srt--RangeAxis__srt--MaximumMember_zZsfDdolkMLj" title="Expected term (years)">3.25</span></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90A_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_dtY_c20220101__20221231__srt--RangeAxis__srt--MinimumMember_zYZfHI8kOjj9" title="Expected term (years)">2.50</span> to <span id="xdx_903_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_dtY_c20220101__20221231__srt--RangeAxis__srt--MaximumMember_zE8ABMl1Ims5" title="Expected term (years)">3.00</span></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Expected volatility</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_900_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate_pid_dp_c20230101__20231231__srt--RangeAxis__srt--MinimumMember_zPnYpozJcvrf" title="Expected volatility">75.40</span>% to <span id="xdx_903_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate_pid_dp_c20230101__20231231__srt--RangeAxis__srt--MaximumMember_zGQCMRJibS6b" title="Expected volatility">89.93</span></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">%</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_907_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate_pid_dp_c20220101__20221231__srt--RangeAxis__srt--MinimumMember_zaSbi4LYP76j" title="Expected volatility">100.81</span>% to <span id="xdx_902_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate_pid_dp_c20220101__20221231__srt--RangeAxis__srt--MaximumMember_z1SLChj224j2" title="Expected volatility">110.74</span></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">%</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Risk-free interest rate</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90D_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_pid_dp_uPure_c20230101__20231231__srt--RangeAxis__srt--MinimumMember_zUNlHbmGIj35" title="Risk-free interest rate">3.71</span>% to <span id="xdx_908_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_pid_dp_uPure_c20230101__20231231__srt--RangeAxis__srt--MaximumMember_zLZSAvDhMWhe" title="Risk-free interest rate">4.27</span></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">%</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_907_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_pid_dp_uPure_c20220101__20221231__srt--RangeAxis__srt--MinimumMember_zPolfcc2Cfa3" title="Risk-free interest rate">2.90</span>% to <span id="xdx_90F_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_pid_dp_uPure_c20220101__20221231__srt--RangeAxis__srt--MaximumMember_zNO3zYXQfz4i" title="Risk-free interest rate">3.47</span></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">%</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 52%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Dividend rate</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 20%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90D_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_pid_dp_uPure_c20230101__20231231_zYPm6pxYJgwi" title="Dividend rate">0</span></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">%</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 20%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90D_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_pid_dp_uPure_c20220101__20221231_zWDNTz6ynvnd" title="Dividend rate">0</span></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">%</span></td></tr>
  </table>
<p id="xdx_8A9_zXrf4AdsGHX9" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org/718/tableOfContent<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(2)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (l)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>122
<FILENAME>R20.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.4</span><table class="report" border="0" cellspacing="2" id="idm45095366613072">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Income Taxes<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureAbstract', window );"><strong>Income Tax Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureTextBlock', window );">Income Taxes</a></td>
<td class="text"><p id="xdx_807_eus-gaap--IncomeTaxDisclosureTextBlock_zEs63vWWdPij" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Note
12. <span id="xdx_822_z5UBynET54th">Income Taxes</span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">At
the end of each interim reporting period, the Company estimates its effective tax rate expected to be applied for the full year.
This estimate is used to determine the income tax provision or benefit on a year-to-date basis and may change in subsequent interim
periods. Accordingly, the Company&#8217;s effective tax rate for the three and nine months ended September 30, 2024 and 2023 was <span id="xdx_906_eus-gaap--EffectiveIncomeTaxRateContinuingOperations_pid_dp_uPure_c20240701__20240930_zwvBQPUBlID2" title="Effective income tax rate percentage"><span id="xdx_90F_eus-gaap--EffectiveIncomeTaxRateContinuingOperations_pid_dp_uPure_c20240101__20240930_zwKuM2YB5qw1" title="Effective income tax rate percentage"><span id="xdx_90D_eus-gaap--EffectiveIncomeTaxRateContinuingOperations_pid_dp_uPure_c20230701__20230930_zPaj9o1cudx6" title="Effective income tax rate percentage"><span id="xdx_906_eus-gaap--EffectiveIncomeTaxRateContinuingOperations_pid_dp_uPure_c20230101__20230930_ztTCtrlJGXb7" title="Effective income tax rate percentage">0</span></span></span></span>%.
The Company&#8217;s effective tax rates for both periods were affected primarily by a full valuation allowance on domestic net
deferred tax assets.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<span></span>
</td>
<td class="text"><p id="xdx_807_eus-gaap--IncomeTaxDisclosureTextBlock_ztcF7iu1yaMi" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Note
12. <span id="xdx_823_z8INrpPReKJe">Income Taxes </span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">A
reconciliation of the Federal statutory rate of <span id="xdx_903_eus-gaap--EffectiveIncomeTaxRateContinuingOperations_pid_dp_uPure_c20230101__20231231_z4h9c9j1s3k8" title="Effective tax rate">21</span>% and <span id="xdx_90C_eus-gaap--EffectiveIncomeTaxRateContinuingOperations_pid_dp_uPure_c20220101__20221231_zliMhxaMet98" title="Effective tax rate">28</span>% in the years ended December 31, 2023 and 2022, respectively to the total
effective rate applicable to income (loss) is as follows:</span></p>

<p id="xdx_89F_eus-gaap--ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock_zGYVk5GmxaCd" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span><span id="xdx_8B4_zqY6jMnLLYnl" style="display: none">Schedule
of Reconciliation of Federal Statutory Rate to Total Effective Rate</span></span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 70%">
  <tr style="vertical-align: bottom">
    <td><b>&#160;</b></td><td><b>&#160;</b></td>
    <td colspan="2" id="xdx_495_20230101__20231231_z0UDmBlLfCNf" style="text-align: center"><b>Year Ended</b></td><td><b>&#160;</b></td><td><b>&#160;</b></td>
    <td colspan="2" id="xdx_49F_20220101__20221231_zoxx9DBcUfgb" style="text-align: center"><b>Year Ended</b></td><td><b>&#160;</b></td></tr>
  <tr style="vertical-align: bottom">
    <td><b>&#160;</b></td><td style="padding-bottom: 1pt"><b>&#160;</b></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"><b>December 31, 2023</b></td><td style="padding-bottom: 1pt"><b>&#160;</b></td><td style="padding-bottom: 1pt"><b>&#160;</b></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"><b>December 31, 2022</b></td><td style="padding-bottom: 1pt"><b>&#160;</b></td></tr>
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: right">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: right">&#160;</td><td>&#160;</td></tr>
  <tr id="xdx_408_eus-gaap--IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate_maITEBzVgo_zsoxYDO4XEEc" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 56%; text-align: left">Expected benefit at statutory federal tax rate</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 18%; text-align: right">(2,073,230</td><td style="width: 1%; text-align: left">)</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 18%; text-align: right">(974,329</td><td style="width: 1%; text-align: left">)</td></tr>
  <tr id="xdx_40A_eus-gaap--IncomeTaxReconciliationChangeInEnactedTaxRate_maITEBzVgo_zKbB9nlMYVCh" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Permanent differences &#8211; net</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(35,469</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(859,515</td><td style="text-align: left">)</td></tr>
  <tr id="xdx_40B_eus-gaap--IncomeTaxReconciliationStateAndLocalIncomeTaxes_maITEBzVgo_zJ9nwI8YtwXc" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">State and local taxes, net of federal tax benefit</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1311">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(265,607</td><td style="text-align: left">)</td></tr>
  <tr id="xdx_404_eus-gaap--IncomeTaxReconciliationOtherAdjustments_maITEBzVgo_zIb7QHZpsA5k" style="vertical-align: bottom; background-color: White">
    <td>Other</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(24,569</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(21,965</td><td style="text-align: left">)</td></tr>
  <tr id="xdx_40B_eus-gaap--IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance_maITEBzVgo_zsw2QihYgKd8" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1pt">Change in valuation allowance</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">2,103,268</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">2,121,416</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_40A_eus-gaap--IncomeTaxExpenseBenefit_iT_mtITEBzVgo_zytKKJ8oxzZ8" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 2.5pt">Income tax expense (benefit)</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">(30,000</td><td style="padding-bottom: 2.5pt; text-align: left">)</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1321">-</span></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  </table>

<p id="xdx_8AD_zwZtbXllGFL9" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p id="xdx_890_eus-gaap--ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock_zGiKRNi3lW48" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
components of the Company&#8217;s deferred tax assets (liabilities) are as follows:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span><span id="xdx_8BD_zqVlxRt6W36c" style="display: none">Schedule
of Components of Deferred tax Assets</span></span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 70%">
  <tr style="vertical-align: bottom">
    <td><b>&#160;</b></td><td style="padding-bottom: 1pt"><b>&#160;</b></td>
    <td colspan="2" id="xdx_49B_20231231_z0J5g5RXGe7k" style="border-bottom: Black 1pt solid; text-align: center"><b>Year Ended <br/> December 31, <br/> 2023</b></td><td style="padding-bottom: 1pt"><b>&#160;</b></td><td style="padding-bottom: 1pt"><b>&#160;</b></td>
    <td colspan="2" id="xdx_499_20221231_ze9k3w767yP7" style="border-bottom: Black 1pt solid; text-align: center"><b>Year Ended <br/> December 31, <br/> 2022</b></td><td style="padding-bottom: 1pt"><b>&#160;</b></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Deferred tax assets (liabilities):</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40A_ecustom--DeferredTaxAssetsPropertyPlantAndEquipments_iI_msDTLzq2T_zTwV5gIYuNc2" style="vertical-align: bottom; background-color: White">
    <td style="width: 56%; text-align: left">Fixed assets</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 18%; text-align: right">(281,073</td><td style="width: 1%; text-align: left">)</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 18%; text-align: right">(268,594</td><td style="width: 1%; text-align: left">)</td></tr>
  <tr id="xdx_409_eus-gaap--DeferredTaxAssetInterestCarryforward_iI_msDTLzq2T_z96ErXhSyqjb" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>Interest</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">35,178</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">62,310</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_409_eus-gaap--DeferredTaxAssetsInProcessResearchAndDevelopment_iI_msDTLzq2T_z7ulqOLfvNJ4" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Research and development expenses</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">400,810</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">454,942</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_401_eus-gaap--DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost_iI_msDTLzq2T_zEB6thclwJQ" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Stock-based compensation</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">895,509</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">917,351</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_407_eus-gaap--DeferredTaxAssetsCharitableContributionCarryforwards_iI_msDTLzq2T_zq5rACDRarhh" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Charitable Contributions</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">420</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_402_eus-gaap--DeferredTaxAssetsOperatingLossCarryforwardsDomestic_iI_msDTLzq2T_zmMXtHjgfas9" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Net operating losses - federal</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">4,456,242</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">2,898,411</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_405_eus-gaap--DeferredTaxAssetsOperatingLossCarryforwardsStateAndLocal_iI_msDTLzq2T_z44uMVdhXKF2" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Net operating losses &#8211; state and local</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">543,264</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">921,350</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40E_eus-gaap--DeferredTaxAssetsOperatingLossCarryforwardsForeign_iI_msDTLzq2T_zzGEKTr8ul1c" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Net operating losses - foreign</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">233,114</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">37,686</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40C_eus-gaap--DeferredTaxAssetsTaxCreditCarryforwardsResearch_iI_msDTLzq2T_zTWDpY8yRTj3" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1pt">Research credit</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">28,985</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">28,985</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_403_eus-gaap--DeferredTaxAssetsValuationAllowance_iNI_di_maDTLzq2T_ziUKAGcGlkJ5" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1pt">Less valuation allowance</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(6,474,449</td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(5,244,441</td><td style="padding-bottom: 1pt; text-align: left">)</td></tr>
  <tr id="xdx_40C_eus-gaap--DeferredTaxLiabilities_iNTI_di_mtDTLzq2T_zkOxNhILOU8e" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 2.5pt">Net deferred tax liability</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">(162,000</td><td style="padding-bottom: 2.5pt; text-align: left">)</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">(192,000</td><td style="padding-bottom: 2.5pt; text-align: left">)</td></tr>
  </table>

<p id="xdx_8AB_zaHXk6T49QI6" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>




<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>SHARPS
TECHNOLOGY, INC.</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTES
TO THE CONSOLIDATED FINANCIAL STATEMENTS</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>FOR
THE YEARS ENDED DECEMBER 31, 2023 AND 2022</b></span></p>

<p style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Note
12. Income Taxes (continued)</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
authoritative guidance requires the asset and liability method of accounting for deferred income taxes. Deferred tax assets and liabilities
are determined based on the difference between the financial statement and tax bases of assets and liabilities. Deferred tax assets or
liabilities at the end of each period are determined using the tax rate expected to be in effect when taxes are actually paid or recovered.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
guidance also requires that a valuation allowance be established when it is more likely than not that all or a portion of a deferred
tax asset will not be realized. A review of all available positive and negative evidence needs to be considered, including a company&#8217;s
current and past performance, the market environment in which the company operates, length of carryback and carryforward periods and
existing contracts that will result in future profits. After reviewing all the evidence, the company has recorded a full valuation allowance.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
of December 31, 2023, the Company had U.S. federal net operating loss carryforwards of approximately $<span id="xdx_901_eus-gaap--OperatingLossCarryforwards_iI_c20231231__us-gaap--IncomeTaxAuthorityAxis__us-gaap--DomesticCountryMember_zlhhhudquRJb" title="Net operating loss carryforwards">21,222,000</span> of which $<span id="xdx_906_eus-gaap--OperatingLossCarryforwards_iI_c20231231__us-gaap--IncomeTaxAuthorityAxis__us-gaap--DomesticCountryMember__srt--StatementScenarioAxis__custom--ExpiresOnTwoThousandTwentyEightMember_zoEWHYZ2Rerj" title="Net operating loss carryforwards">241,000</span>, if
not fully utilized, expires by 2038 and which $<span id="xdx_900_eus-gaap--OperatingLossCarryforwards_iI_c20231231__srt--StatementScenarioAxis__custom--NotExpireMember__us-gaap--IncomeTaxAuthorityAxis__us-gaap--DomesticCountryMember_z6GOzQBVOLB3" title="Net operating loss carryforwards">20,981,000</span> do not expire. The Company has foreign net operating loss carryforwards of
$<span id="xdx_901_eus-gaap--OperatingLossCarryforwards_iI_c20231231__us-gaap--IncomeTaxAuthorityAxis__us-gaap--ForeignCountryMember_z429voBPRPL" title="Net operating loss carryforwards">2,590,000</span>, if not fully utilized, expire through 2028. Utilization is dependent on generating sufficient taxable income prior to expiration
of the tax loss carryforwards.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p id="xdx_896_eus-gaap--ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock_zBaxIPJlllzi" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
geographical components of loss before income taxes consisted of the following for the years ended December 31:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span><span id="xdx_8B9_zO1BxVr7Nt6j" style="display: none">Schedule
of Geographical Components of Loss Before Income Taxes</span></span></span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 80%">
  <tr style="vertical-align: bottom">
    <td><b>&#160;</b></td><td><b>&#160;</b></td>
    <td colspan="2" id="xdx_496_20230101__20231231_z8rQAVv08OLf" style="text-align: center"><b>Year Ended</b></td><td><b>&#160;</b></td><td><b>&#160;</b></td>
    <td colspan="2" id="xdx_494_20220101__20221231_zQDtYGlN93ac" style="text-align: center"><b>Year Ended</b></td><td><b>&#160;</b></td></tr>
  <tr style="vertical-align: bottom">
    <td><b>&#160;</b></td><td style="padding-bottom: 1pt"><b>&#160;</b></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"><b>December 31, <br/> 2023</b></td><td style="padding-bottom: 1pt"><b>&#160;</b></td><td style="padding-bottom: 1pt"><b>&#160;</b></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"><b>December 31,<br/> 2022</b></td><td style="padding-bottom: 1pt"><b>&#160;</b></td></tr>
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2">&#160;</td><td style="padding-bottom: 1pt">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="text-align: right">&#160;</td><td style="padding-bottom: 1pt">&#160;</td></tr>
  <tr id="xdx_406_eus-gaap--IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic_maILFCOzLlh_z7Si8U5ZTw9j" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 60%; text-align: left">United Stated Operations</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 16%; text-align: right">(8,173,807</td><td style="width: 1%; text-align: left">)</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 16%; text-align: right">(3,978,832</td><td style="width: 1%; text-align: left">)</td></tr>
  <tr id="xdx_404_eus-gaap--IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign_maILFCOzLlh_zL5XFyf7DTp9" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1pt">International Operations</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(1,667,831</td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(660,830</td><td style="padding-bottom: 1pt; text-align: left">)</td></tr>
  <tr id="xdx_406_eus-gaap--IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_iT_mtILFCOzLlh_zust0jwVE531" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1pt">(Loss) Income before taxes</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(9,871,638</td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(4,639,662</td><td style="padding-bottom: 1pt; text-align: left">)</td></tr>
  </table>

<p id="xdx_8AB_z2rxrpXOIFui" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for income tax.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-12<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 231<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482663/740-10-55-231<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12C<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-12C<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12B<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-12B<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 270<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477891/740-270-50-1<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.5.Q1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479360/740-10-S99-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480990/946-20-50-13<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org/740/tableOfContent<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 14<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-14<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 21<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-21<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 17<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-17<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 11.C)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479360/740-10-S99-2<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482603/740-30-50-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>123
<FILENAME>R21.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.4</span><table class="report" border="0" cellspacing="2" id="idm45095370612720">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Related Party Transactions and Balances<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionsAbstract', window );"><strong>Related Party Transactions [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionsDisclosureTextBlock', window );">Related Party Transactions and Balances</a></td>
<td class="text"><p id="xdx_801_eus-gaap--RelatedPartyTransactionsDisclosureTextBlock_zlDv3gqVW3Cf" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Note
13. <span id="xdx_828_z36brOFxaPv9">Related Party Transactions and Balances</span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
of September 30, 2024 and December 31, 2023, accounts payable and accrued liabilities include $<span id="xdx_906_eus-gaap--AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent_iI_c20240930__srt--TitleOfIndividualAxis__custom--OfficersAndDirectorsMember_zg1bljdLBEpl" title="Accounts payable and accrued liabilities">152,500</span> and $<span id="xdx_90F_eus-gaap--AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent_iI_c20231231__srt--TitleOfIndividualAxis__custom--OfficersAndDirectorsMember_zZnqLQuXkJHj" title="Accounts payable and accrued liabilities">32,974</span>, respectively, payable
to officers and directors of the Company. The amounts are unsecured, non-interest bearing and are due on demand.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<span></span>
</td>
<td class="text"><p id="xdx_801_eus-gaap--RelatedPartyTransactionsDisclosureTextBlock_zazce8lT2Qij" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Note
13. <span id="xdx_82F_zersyNF85ovb">Related Party Transactions and Balances</span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
of December 31, 2023 and 2022, accounts payable and accrued liabilities include $<span id="xdx_90F_eus-gaap--AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent_iI_c20231231__srt--TitleOfIndividualAxis__custom--OfficersAndDirectorsMember_zTvswU3GK5Se" title="Accounts payable and accrued liabilities">32,974</span> and $<span id="xdx_907_eus-gaap--AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent_iI_c20221231__srt--TitleOfIndividualAxis__custom--OfficersAndDirectorsMember_zlTqITki0d66" title="Accounts payable and accrued liabilities">105,667</span>, respectively, payable to officers,
and directors of the Company. The amounts are unsecured, non-interest bearing and are due on demand (See Note 15).</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionsDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for related party transactions. Examples of related party transactions include transactions between (a) a parent company and its subsidiary; (b) subsidiaries of a common parent; (c) and entity and its principal owners; and (d) affiliates.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480990/946-20-50-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480990/946-20-50-5<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480990/946-20-50-6<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 235<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477968/946-235-50-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 235<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477968/946-235-50-2<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 850<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483326/850-10-50-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(2)(g)(3))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-1<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(2)(c))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-1<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(2)(e))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-1<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 850<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org/850/tableOfContent<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 850<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483326/850-10-50-6<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 850<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483326/850-10-50-1<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 850<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483326/850-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionsDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>124
<FILENAME>R22.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.4</span><table class="report" border="0" cellspacing="2" id="idm45095367626528">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Fair Value Measurements<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueDisclosuresAbstract', window );"><strong>Fair Value Disclosures [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueMeasurementInputsDisclosureTextBlock', window );">Fair Value Measurements</a></td>
<td class="text"><p id="xdx_804_eus-gaap--FairValueMeasurementInputsDisclosureTextBlock_zrhCtJBoyF49" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Note
14. <span id="xdx_82E_zbuVPIlaYyd2">Fair Value Measurements</span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company&#8217;s financial instruments include cash, accounts payable, and warrant liability. Cash and warrant liability are measured
at fair value. Accounts payable is measured at amortized cost and approximates fair value due to its short duration.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p id="xdx_891_eus-gaap--ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock_zgaDCWQ8I281" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
of September&#160;30, 2024, the following financial assets and liabilities were measured at fair value on a recurring basis presented
on the Company&#8217;s condensed consolidated balance sheet:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span id="xdx_8BE_zzMRLNSAvI67" style="display: none">Schedule
of Assets and Liabilities Measured at Fair Value on Recurring Basis</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="display: none; vertical-align: bottom">
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" id="xdx_491_20240930__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member_z4KlOwEwXPZ2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Level
    1</span></td><td style="padding-bottom: 1pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" id="xdx_498_20240930__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member_z9m0JLmigtyh" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Level
    2</span></td><td style="padding-bottom: 1pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" id="xdx_49C_20240930__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member_zt9UPPoQnhf5" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Level
    3</span></td><td style="padding-bottom: 1pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" id="xdx_49C_20240930_z3HypJTQJmD9" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Total</span></td><td style="padding-bottom: 1pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
<tr style="vertical-align: bottom">
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="10" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Fair
    Value Measurements Using</span></td><td style="padding-bottom: 1pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Level
    1</span></td><td style="padding-bottom: 1pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Level
    2</span></td><td style="padding-bottom: 1pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Level
    3</span></td><td style="padding-bottom: 1pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Total</span></td><td style="padding-bottom: 1pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr id="xdx_400_eus-gaap--AssetsFairValueDisclosureAbstract_iB_zOAtVFrjKIAd" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Assets</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr id="xdx_405_eus-gaap--CashAndCashEquivalentsFairValueDisclosure_i01I_zChzjFxr6dm4" style="vertical-align: bottom; background-color: White">
    <td style="width: 44%; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Cash</span></td><td style="width: 2%; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="border-bottom: Black 1pt solid; width: 10%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2,473,197</span></td><td style="width: 1%; padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="width: 2%; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1pt solid; width: 10%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl2895">-</span></span></td><td style="width: 1%; padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="width: 2%; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1pt solid; width: 10%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl2896">-</span></span></td><td style="width: 1%; padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="width: 2%; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="border-bottom: Black 1pt solid; width: 10%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2,473,197</span></td><td style="width: 1%; padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr id="xdx_400_eus-gaap--AssetsFairValueDisclosure_iI_zf08RA74ZrVj" style="vertical-align: bottom; background-color: White">
    <td style="font-weight: bold; text-align: left; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Total
    assets measured at fair value</span></td><td style="font-weight: bold; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2,473,197</span></td><td style="padding-bottom: 1pt; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl2900">-</span></span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl2901">-</span></span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2,473,197</span></td><td style="padding-bottom: 1pt; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr id="xdx_402_eus-gaap--LiabilitiesFairValueDisclosureAbstract_iB_z1BkUetQEGba" style="vertical-align: bottom; background-color: White">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Liabilities</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr id="xdx_40E_eus-gaap--DerivativeLiabilities_i01I_zur1GJNBTzJb" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Warrant
    liability</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl2909">-</span></span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,027,102</span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl2911">-</span></span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,027,102</span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr id="xdx_405_eus-gaap--LiabilitiesFairValueDisclosure_i01I_zpUbWyljHVFk" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; text-align: left; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Total
    liabilities measured at fair value</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl2914">-</span></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,027,102</span></td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl2916">-</span></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,027,102</span></td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>





<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>SHARPS
TECHNOLOGY, INC.</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTES
TO THE CONDENSED CONSOLIDATED FINANCIAL STATEMENTS</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>FOR
THE THREE AND NINE MONTHS ENDED SEPTEMBER 30, 2024 AND 2023</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Note
14. Fair Value Measurements (continued)</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
of December 31, 2023, the following financial assets and liabilities were measured at fair value on a recurring basis presented on the
Company&#8217;s condensed consolidated balance sheet:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="display: none; vertical-align: bottom">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" id="xdx_496_20231231__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member_zIREGOpf8Hlk" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Level
    1</span></td><td style="padding-bottom: 1pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" id="xdx_49D_20231231__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member_zWeKG60u2CX2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Level
    2</span></td><td style="padding-bottom: 1pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" id="xdx_490_20231231__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member_zOAKMQuqd3G9" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Level
    3</span></td><td style="padding-bottom: 1pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" id="xdx_492_20231231_zDjoJdq81KQa" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Total</span></td><td style="padding-bottom: 1pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
<tr style="vertical-align: bottom">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="10" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Fair
    Value Measurements Using</span></td><td style="padding-bottom: 1pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Level
    1</span></td><td style="padding-bottom: 1pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Level
    2</span></td><td style="padding-bottom: 1pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Level
    3</span></td><td style="padding-bottom: 1pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Total</span></td><td style="padding-bottom: 1pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr id="xdx_404_eus-gaap--AssetsFairValueDisclosureAbstract_iB_zg3N3Dbmx0e2" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Assets</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr id="xdx_40B_eus-gaap--CashAndCashEquivalentsFairValueDisclosure_i01I_zbXBfNEtPmek" style="vertical-align: bottom; background-color: White">
    <td style="width: 44%; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Cash</span></td><td style="width: 2%; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="border-bottom: Black 1pt solid; width: 10%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">3,012,908</span></td><td style="width: 1%; padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="width: 2%; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1pt solid; width: 10%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl2925">-</span></span></td><td style="width: 1%; padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="width: 2%; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1pt solid; width: 10%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl2926">-</span></span></td><td style="width: 1%; padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="width: 2%; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="border-bottom: Black 1pt solid; width: 10%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">3,012,908</span></td><td style="width: 1%; padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr id="xdx_401_eus-gaap--AssetsFairValueDisclosure_iI_zw5BgyAgINO4" style="vertical-align: bottom; background-color: White">
    <td style="font-weight: bold; text-align: left; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Total
    assets measured at fair value</span></td><td style="font-weight: bold; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">3,012,908</span></td><td style="padding-bottom: 1pt; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl2930">-</span></span></td><td style="padding-bottom: 1pt; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl2931">-</span></span></td><td style="padding-bottom: 1pt; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">3,012,908</span></td><td style="padding-bottom: 1pt; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr id="xdx_40B_eus-gaap--LiabilitiesFairValueDisclosureAbstract_iB_zcWq2LrVT5vl" style="vertical-align: bottom; background-color: White">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Liabilities</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr id="xdx_40C_eus-gaap--DerivativeLiabilities_i01I_zPAr3DrFRLgg" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Warrant
    liability</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl2939">-</span></span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2,422,785</span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl2941">&#8212;</span></span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2,422,785</span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr id="xdx_405_eus-gaap--LiabilitiesFairValueDisclosure_iI_zp7vHk1W6RZ1" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; text-align: left; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Total
    liabilities measured at fair value</span></td><td style="font-weight: bold; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl2944">-</span></span></td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2,422,785</span></td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl2946">-</span></span></td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2,422,785</span></td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  </table>

<p id="xdx_8A2_zB8rdJcf3uw" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<span></span>
</td>
<td class="text"><p id="xdx_804_eus-gaap--FairValueMeasurementInputsDisclosureTextBlock_zgRFoxIvXin8" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Note
14. <span id="xdx_82C_zfLWUdTshi7h">Fair Value Measurements</span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company&#8217;s financial instruments include cash, accounts payable, notes payable, contingent stock and warrant liability and warrant
liability. Cash, contingent stock liability, contingent warrant liability and warrant liability are measured at fair value. Accounts
payable and notes payable are measured at amortized cost and approximates fair value due to their short duration and market rate for
similar instruments, respectively.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>



<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"></p><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>SHARPS
TECHNOLOGY, INC.</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTES
TO THE CONSOLIDATED FINANCIAL STATEMENTS</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>FOR
THE YEARS ENDED DECEMBER 31, 2023 AND 2022</b></span></p>


<p style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Note
14. Fair Value Measurements (continued)</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p id="xdx_891_eus-gaap--ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock_zxDqW0yAu905" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
of December 31, 2023, the following financial assets and liabilities were measured at fair value on a recurring basis presented on the
Company&#8217;s consolidated balance sheet:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_8BD_zYTR92xRFZoa" style="display: none">Schedule
of Assets and Liabilities Measured at Fair Value on Recurring Basis</span>&#160;</span></span></span></span></span></span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="display: none; vertical-align: bottom">
    <td style="text-align: center">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2" id="xdx_49C_20231231__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member_z2GHeg2d5sg2" style="border-bottom: Black 1pt solid; text-align: center">&#160;</td><td style="padding-bottom: 1pt">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2" id="xdx_497_20231231__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member_z7evLALGnlZ" style="border-bottom: Black 1pt solid; text-align: center">&#160;</td><td style="padding-bottom: 1pt">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2" id="xdx_491_20231231__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member_zkIsZFCa7663" style="border-bottom: Black 1pt solid; text-align: center">&#160;</td><td style="padding-bottom: 1pt">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" id="xdx_49C_20231231_z5mnI8unN3rb" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">&#160;</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: center"><b>&#160;</b></td><td style="padding-bottom: 1pt"><b>&#160;</b></td>
    <td colspan="10" style="border-bottom: Black 1pt solid; text-align: center"><b>Fair Value Measurements Using</b></td><td style="padding-bottom: 1pt"><b>&#160;</b></td><td style="padding-bottom: 1pt"><b>&#160;</b></td>
    <td colspan="2"><b>&#160;</b></td><td style="padding-bottom: 1pt"><b>&#160;</b></td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: center"><b>&#160;</b></td><td style="padding-bottom: 1pt"><b>&#160;</b></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"><b>Level 1</b></td><td style="padding-bottom: 1pt"><b>&#160;</b></td><td style="padding-bottom: 1pt"><b>&#160;</b></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"><b>Level 2</b></td><td style="padding-bottom: 1pt"><b>&#160;</b></td><td style="padding-bottom: 1pt"><b>&#160;</b></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"><b>Level 3</b></td><td style="padding-bottom: 1pt"><b>&#160;</b></td><td style="font-weight: bold; padding-bottom: 1pt"><b>&#160;</b></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><b>Total</b></td><td style="padding-bottom: 1pt; font-weight: bold"><b>&#160;</b></td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: center"><b>&#160;</b></td><td><b>&#160;</b></td>
    <td colspan="2" style="text-align: center"><b>&#160;</b></td><td><b>&#160;</b></td><td><b>&#160;</b></td>
    <td colspan="2" style="text-align: center"><b>&#160;</b></td><td><b>&#160;</b></td><td><b>&#160;</b></td>
    <td colspan="2" style="text-align: center"><b>&#160;</b></td><td><b>&#160;</b></td><td><b>&#160;</b></td>
    <td colspan="2" style="text-align: center"><b>&#160;</b></td><td><b>&#160;</b></td></tr>
  <tr id="xdx_402_eus-gaap--FinancialInstrumentsFinancialAssetsBalanceSheetGroupingsAbstract_iB_zKCKiuWV95S4" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold">Assets</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_403_eus-gaap--CashAndCashEquivalentsFairValueDisclosure_iI_zILPeMbyrX79" style="vertical-align: bottom; background-color: White">
    <td style="width: 40%">Cash</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 11%; text-align: right">3,012,908</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 11%; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1393">-</span></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 11%; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1394">-</span></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 11%; text-align: right">3,012,908</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 1pt">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">&#160;</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">&#160;</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">&#160;</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">&#160;</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_406_eus-gaap--AssetsFairValueDisclosure_iI_zG7RiQmAR0rg" style="vertical-align: bottom; background-color: White">
    <td style="font-weight: bold; text-align: left; padding-bottom: 1pt">Total assets measured at fair value</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right">3,012,908</td><td style="padding-bottom: 1pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1398">-</span></td><td style="padding-bottom: 1pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1399">-</span></td><td style="padding-bottom: 1pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right">3,012,908</td><td style="padding-bottom: 1pt; font-weight: bold; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_402_eus-gaap--FinancialInstrumentsFinancialLiabilitiesBalanceSheetGroupingsAbstract_iB_z0jzKRAX0egb" style="vertical-align: bottom; background-color: White">
    <td>Liabilities</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_405_ecustom--WarrantLiability_iI_zNVO650ZxiGk" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1pt">Warrant liability</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">$</td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1407">-</span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">2,422,785</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1409">-</span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">$</td><td style="border-bottom: Black 1pt solid; text-align: right">2,422,785</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40B_eus-gaap--LiabilitiesFairValueDisclosure_iI_zgxCT7I3IgY4" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; text-align: left; padding-bottom: 2.5pt">Total liabilities measured at fair value</td><td style="font-weight: bold; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1412">-</span></td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right">2,422,785</td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1414">-</span></td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right">2,422,785</td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">&#160;</td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
of December 31, 2022, the following financial assets and liabilities were measured at fair value on a recurring basis presented on the
Company&#8217;s consolidated balance sheet:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="display: none; vertical-align: bottom">
    <td style="text-align: center">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2" id="xdx_49F_20221231__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member_zI2ZrE6i1D56" style="border-bottom: Black 1pt solid; text-align: center">&#160;</td><td style="padding-bottom: 1pt">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2" id="xdx_493_20221231__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member_zyEkrfBqNYPj" style="border-bottom: Black 1pt solid; text-align: center">&#160;</td><td style="padding-bottom: 1pt">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2" id="xdx_49D_20221231__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member_zepFhAwEIj67" style="border-bottom: Black 1pt solid; text-align: center">&#160;</td><td style="padding-bottom: 1pt">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" id="xdx_49F_20221231_zMO0YGfq3qv8" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">&#160;</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="text-align: center"><b>&#160;</b></td><td style="padding-bottom: 1pt"><b>&#160;</b></td>
    <td colspan="10" style="border-bottom: Black 1pt solid; text-align: center"><b>Fair Value Measurements Using</b></td><td style="padding-bottom: 1pt"><b>&#160;</b></td><td style="padding-bottom: 1pt"><b>&#160;</b></td>
    <td colspan="2"><b>&#160;</b></td><td style="padding-bottom: 1pt"><b>&#160;</b></td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: center"><b>&#160;</b></td><td style="padding-bottom: 1pt"><b>&#160;</b></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"><b>Level 1</b></td><td style="padding-bottom: 1pt"><b>&#160;</b></td><td style="padding-bottom: 1pt"><b>&#160;</b></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"><b>Level 2</b></td><td style="padding-bottom: 1pt"><b>&#160;</b></td><td style="padding-bottom: 1pt"><b>&#160;</b></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"><b>Level 3</b></td><td style="padding-bottom: 1pt"><b>&#160;</b></td><td style="font-weight: bold; padding-bottom: 1pt"><b>&#160;</b></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><b>Total</b></td><td style="padding-bottom: 1pt; font-weight: bold"><b>&#160;</b></td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: center"><b>&#160;</b></td><td style="padding-bottom: 1pt"><b>&#160;</b></td>
    <td colspan="2" style="text-align: center"><b>&#160;</b></td><td style="padding-bottom: 1pt"><b>&#160;</b></td><td style="padding-bottom: 1pt"><b>&#160;</b></td>
    <td colspan="2" style="text-align: center"><b>&#160;</b></td><td style="padding-bottom: 1pt"><b>&#160;</b></td><td style="padding-bottom: 1pt"><b>&#160;</b></td>
    <td colspan="2" style="text-align: center"><b>&#160;</b></td><td style="padding-bottom: 1pt"><b>&#160;</b></td><td style="padding-bottom: 1pt"><b>&#160;</b></td>
    <td colspan="2" style="text-align: center"><b>&#160;</b></td><td style="padding-bottom: 1pt"><b>&#160;</b></td></tr>
  <tr id="xdx_402_eus-gaap--FinancialInstrumentsFinancialAssetsBalanceSheetGroupingsAbstract_iB_zZ0h4m5zpCV6" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold">Assets</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_403_eus-gaap--CashAndCashEquivalentsFairValueDisclosure_iI_zFsKH6PntU33" style="vertical-align: bottom; background-color: White">
    <td style="width: 40%">Cash</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 11%; text-align: right">4,170,897</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 11%; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1423">-</span></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 11%; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1424">-</span></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 11%; text-align: right">4,170,897</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 1pt">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">-</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">-</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">-</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">&#160;</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_406_eus-gaap--AssetsFairValueDisclosure_iI_z9gso5OGflrl" style="vertical-align: bottom; background-color: White">
    <td style="font-weight: bold; text-align: left; padding-bottom: 1pt">Total assets measured at fair value</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right">4,170,897</td><td style="padding-bottom: 1pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1428">-</span></td><td style="padding-bottom: 1pt; font-weight: bold; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">&#160;</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right">4,170,897</td><td style="padding-bottom: 1pt; font-weight: bold; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_404_eus-gaap--FinancialInstrumentsFinancialLiabilitiesBalanceSheetGroupingsAbstract_iB_znHNORGK6ow4" style="vertical-align: bottom; background-color: White">
    <td>Liabilities</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_403_ecustom--WarrantLiability_iI_zeHj02xUXIze" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1pt">Warrant liability</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">$</td><td style="border-bottom: Black 1pt solid; text-align: right">1,151,838</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1438">-</span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1439">-</span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">$</td><td style="border-bottom: Black 1pt solid; text-align: right">1,151,838</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40B_eus-gaap--LiabilitiesFairValueDisclosure_iI_zArStOtPTi4i" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; text-align: left; padding-bottom: 2.5pt">Total liabilities measured at fair value</td><td style="font-weight: bold; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right">1,151,838</td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1443">-</span></td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1444">-</span></td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right">1,151,838</td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">&#160;</td></tr>
  </table>

<p id="xdx_8A7_zj88tgPEyzml" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueDisclosuresAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueDisclosuresAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueMeasurementInputsDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure of the fair value measurement of assets and liabilities, which includes financial instruments measured at fair value that are classified in shareholders' equity, which may be measured on a recurring or nonrecurring basis.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 820<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org/820/tableOfContent<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueMeasurementInputsDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>125
<FILENAME>R23.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.4</span><table class="report" border="0" cellspacing="2" id="idm45095366455040">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Commitments and Contingencies<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract', window );"><strong>Commitments and Contingencies Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock', window );">Commitments and Contingencies</a></td>
<td class="text"><p id="xdx_804_eus-gaap--CommitmentsAndContingenciesDisclosureTextBlock_z3exny20ML15" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Note
15. <span id="xdx_82D_zipBBRJp1aE1">Commitments and Contingencies</span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>&#160;</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Contingencies</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
July 10, 2024, Barry Berler (&#8220;Berler&#8221;), a co-founder and former Chief Technology Officer of the Company, commenced a lawsuit
in the United States District Court for the Eastern District of New York, Barry Berler v. Sharps Technology, Inc. and Alan Blackman,
Case No. 2:24-cv-04787. In this case, Berler asserts claims for damages of an aggregate of $<span id="xdx_901_eus-gaap--LossContingencyDamagesSoughtValue_c20240710__20240710__srt--LitigationCaseAxis__custom--BerlerMember_zT5oHq9wVxdc" title="Loss contingency, claims for damages">456,000</span> for alleged<span id="xdx_906_eus-gaap--LossContingencyDamagesSought_c20240710__20240710__srt--LitigationCaseAxis__custom--BerlerMember_za1JIGiE0tUe" title="Description of loss contingency"> (1) failure to make full
payment of certain monthly payments under his consulting agreement with the Company (the &#8220;Consulting Agreement&#8221;) in the amount
of $52,500, (2) failure to pay a bonus with a target of $216,000 under the Consulting Agreement, (3) $187,500, representing 50% of the
severance payment paid by the Company to Mr. Blackman, the Company&#8217;s co-founder and former Chief Operating Officer and Co-Chairman
and a declaration and injunctive relief establishing that Berler is the rightful owner of 50% of the Company&#8217;s Series A Preferred
Stock (which preferred stock is no longer outstanding).</span> The Company has accrued for the claim for unpaid monthly consulting fees. The
Company believes that Berler&#8217;s claims are without merit, intends to defend itself vigorously and has requested dismissal of these
claims. In addition, on September 17, 2024, the Company filed an answer and counterclaims with respect thereto, including for recoupment
of certain compensation the Company has previously paid to Berler.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
June l7, 2024, Berler filed a demand for arbitration and statement of claim under the commercial arbitration rules of the American Arbitration
Association (&#8220;AAA&#8221;) asserting claims for payment of $<span id="xdx_908_eus-gaap--LossContingencyDamagesSoughtValue_c20240617__20240617__srt--LitigationCaseAxis__custom--BerlerMember_zHBek6ghPJVh" title="Loss contingency, claims for damages">500,000</span> plus interest, under the Company&#8217;s royalty agreement with
Berler, as amended, rescission thereof and reversion to Berler of the intellectual property rights subject thereto. The Company believes
that Berler&#8217;s claims are without merit and intends to defend itself vigorously in connection with these claims.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
April 3, 2024, Plastomold Industries Ltd. (&#8220;Plastomold&#8221;) commenced a lawsuit against the Company in the United States District
Court for the Eastern District of New York, Plastomold Industries Ltd v. Sharps Technology, Inc., Case No. 2:24-CV-02580, asserting claims
for damages in the amount of $<span id="xdx_90D_eus-gaap--LossContingencyDamagesSoughtValue_pn3n6_c20240403__20240403__srt--LitigationCaseAxis__custom--PlastomoldMember_zNcHzYxfILc3" title="Loss contingency, claims for damages">1.762</span> million for alleged <span id="xdx_906_eus-gaap--LossContingencyDamagesSought_c20240403__20240403__srt--LitigationCaseAxis__custom--PlastomoldMember_zI0TwB3Fpvi3" title="Description of loss contingency">(1) failure to pay invoices, of which approximately $1 million would relate to
a maintenance agreement for units allegedly manufactured and sold using machinery that was defective and has never successfully produced
any saleable products, (2) breach of the implied covenant of good faith and fair dealing, (3) unjust enrichment, and (4) conversion.
Plastomold asserts it provided certain products and services to the Company for which its invoices were not fully paid. The Company believes
that Plastomold&#8217;s claims are without merit and intends to defend itself vigorously.</span> On June 3, 2024, the Company filed an answer
and affirmative defenses and counterclaim, which counterclaim is for damages that the Company believes would exceed the claims asserted
by Plastomold, based on the insufficiency of Plastomold&#8217;s services and the results thereof, including the failure to provide machinery
capable of reliably manufacturing the designated products in compliance with design specifications and functionality requirements, and
with respect to which test results failed.</span></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Commitments</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
August 1, 2022, the Company cancelled the consulting agreement with Alan Blackman, Co- Chairman and Chief Operating Officer and
entered into an Employment Agreement. which provided for annual salary of $<span id="xdx_90C_eus-gaap--SalariesAndWages_c20220730__20220801__us-gaap--TypeOfArrangementAxis__custom--EmploymentAgreementMember__srt--TitleOfIndividualAxis__custom--AlanBlackmanMember_z2oixmpIKNRf" title="Annual salary">256,000</span>,
which provides for increases, and provisions compensation adjustments, expense and tax differential reimbursements, benefits and
bonuses. As of September 1, 2022, the annual salary is $<span id="xdx_906_eus-gaap--SalariesAndWages_c20220831__20220901__us-gaap--TypeOfArrangementAxis__custom--EmploymentAgreementMember__srt--TitleOfIndividualAxis__custom--AlanBlackmanMember_zrVkYJ8pqmR8" title="Salaries and wages">320,000</span>.
At September 30, 2022, the Company approved and accrued a $<span id="xdx_908_eus-gaap--AccruedBonusesCurrentAndNoncurrent_iI_c20220930__us-gaap--TypeOfArrangementAxis__custom--EmploymentAgreementMember__srt--TitleOfIndividualAxis__custom--AlanBlackmanMember_zDTgDYGu6Jl2" title="Accrued bonus">250,000</span>
bonus to Mr. Blackman for services provided in 2022, of which $<span id="xdx_902_ecustom--PaymentForBonuses_c20230101__20230331__us-gaap--TypeOfArrangementAxis__custom--EmploymentAgreementMember__srt--TitleOfIndividualAxis__custom--AlanBlackmanMember_zapYwzPDjoVh" title="Payment for bonuses">65,000</span>
was paid subsequent to December 31, 2022. The Company terminated Mr. Blackman&#8217;s Employment Agreement effective May 1, 2023.
Mr. Blackman continued to serve as the Co-Chairman and a member of the Board of Directors. Subsequent to June 30, 2023, the Company
and Mr. Blackman entered into a separation agreement whereby, Mr. Blackman was paid severance payments of approximately $<span id="xdx_90B_eus-gaap--SeveranceCosts1_c20230701__20230814__srt--TitleOfIndividualAxis__custom--AlanBlackmanMember_znIDk6xuoEAa" title="Severance costs">346,000</span>
plus other medical benefits of approximately $<span id="xdx_903_ecustom--MedicalBenefitsCost_iI_c20230630__srt--TitleOfIndividualAxis__custom--AlanBlackmanMember_zFym0JpKbrI" title="Medical benefit cost">29,000</span>
which were fully paid by August 31, 2024. Further, all unvested options were fully vested, and the Company recorded a charge of
$<span id="xdx_906_eus-gaap--ShareBasedCompensation_c20230101__20231231__srt--TitleOfIndividualAxis__custom--AlanBlackmanMember_zwhwXRCdfNS3" title="Share based compensation">60,000</span>
in 2023. In connection with the separation agreement, Mr. Blackman no longer served as Co-Chairman or Board member and agreed to vote
his Series A Preferred Stock in favor of the election, reelection, and/or designation of each individual nominated to serve as a
director on the Board of Director as shall be identified in an applicable proxy statement filed by the Company for such election of
directors. Once the payments due Mr. Blackman were fully paid, the Series A Preferred Stock were deemed immediately cancelled and
forfeited and without further consideration. The Series A Preferred has been returned to the status of an authorized but unissued
share of preferred stock of the Company.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
May 20, 2024, the Company entered into an amendment to the Asset Purchase agreement (&#8220;Asset Purchase&#8221;) with InjectEZ,
LLC (&#8220;Seller&#8221;) for the purchase of certain assets for $<span id="xdx_907_eus-gaap--PaymentsToAcquireProductiveAssets_pn6n6_c20240519__20240520__us-gaap--TypeOfArrangementAxis__custom--AssetPurchaseAgreementMember__us-gaap--AssetAcquisitionAxis__custom--InjectEZLLCMember_zitcZPZRZTKf" title="Payments to acquire assets">35</span>M.
In connection with the Asset Purchase agreement the Company paid a non-refundable deposit of $<span id="xdx_907_eus-gaap--EscrowDeposit_iI_pn6n6_c20240520__us-gaap--TypeOfArrangementAxis__custom--AssetPurchaseAgreementMember__us-gaap--AssetAcquisitionAxis__custom--InjectEZLLCMember_zr4bvle1Pyp1" title="Escrow deposit">1</span>M
to be held in escrow under an agreeable escrow agreement as a deposit on the purchase price. The Asset Purchase agreement stipulated
that the $<span id="xdx_907_eus-gaap--EscrowDeposit_iI_pn6n6_c20240520__us-gaap--TypeOfArrangementAxis__custom--AssetPurchaseAgreementMember__us-gaap--AssetAcquisitionAxis__custom--InjectEZLLCMember_zfUYDMCb6Idc" title="Escrow deposit">1</span>M
deposit would be maintained until July 19, 2024, at which date, if the contemplated transaction was not consummated, through no
fault of the Seller, the escrow would be released to the Seller by the escrow agent. The escrow deposit of $<span id="xdx_907_eus-gaap--EscrowDepositDisbursementsRelatedToPropertyAcquisition1_c20240101__20240930__us-gaap--TypeOfArrangementAxis__custom--AssetPurchaseAgreementMember__us-gaap--AssetAcquisitionAxis__custom--InjectEZLLCMember_zGkdffamh7W6" title="Escrow deposit disbursements related to property acquisition">1,000,000</span>
was released to the Seller and recorded a forfeited agreement cost in Other Expenses in the nine months ended September 30, 2024.
The Company and Seller are currently working towards a further amendment of the Asset Purchase Agreement. To the extent a further
amendment is executed, the closing of the Asset Purchase Agreement will be contingent on obtaining the necessary financing and there can
be no assurance that the closing of the asset sale will occur.</span></p>

<span></span>
</td>
<td class="text"><p id="xdx_804_eus-gaap--CommitmentsAndContingenciesDisclosureTextBlock_zefowiuQzQ6b" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Note
15. <span id="xdx_827_z7839IJqGyv">Commitments and Contingencies</span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>&#160;</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Fixed
Assets and Other</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">At
December 31, 2023, the remaining amounts due under outstanding orders of $<span id="xdx_904_eus-gaap--AccountsPayableCurrentAndNoncurrent_iI_c20231231_zcPrOlkCQnKk" title="Accounts payable">56,874</span> is recorded in Accounts Payable. At December 31, 2022,
the Company has outstanding orders to purchase equipment, molds and component parts for research and development of $<span id="xdx_90E_ecustom--OrderCostsToPurchaseEquipmentMoldsAndComponentPartsForResearchAndDevelopment_c20220101__20221231_zHpZqn5gyJ34" title="Total order costs to purchase equipment, molds and component parts for research and development">609,953</span> of which
advance payments of $<span id="xdx_904_ecustom--ProgressPayments_c20230101__20231231_zUnn4PRK9KC9" title="Progress payments">209,678</span> have been made and recorded in Other Assets (See Note 6).</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>




<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>SHARPS
TECHNOLOGY, INC.</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTES
TO THE CONSOLIDATED FINANCIAL STATEMENTS</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>FOR
THE YEARS ENDED DECEMBER 31, 2023 AND 2022</b></span></p>

<p style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Note
15. Commitments and Contingencies (continued)</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Contingencies</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">At
each reporting period, the Company evaluates whether or not a potential loss amount or a potential range of loss is probable and reasonably
estimable under the provisions of the authoritative guidance that addresses accounting for contingencies. The Company is currently not
involved in any material litigation or other loss contingencies.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Royalty
Agreement</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
connection with the purchase of certain intellectual property in July 2017, Barry Berler and Alan Blackman entered into a royalty agreement
which provides that Barry Berler will be entitled to a royalty of four percent (<span id="xdx_909_ecustom--RoyaltyPercentage_pid_dp_uPure_c20170701__20170731__us-gaap--TypeOfArrangementAxis__custom--RoyaltyAgreementMember__srt--TitleOfIndividualAxis__custom--BarryBerlerMember_zCKFauY0XfLa" title="Royalty percentage">4</span>%) of net sales derived from the use, sale, lease, rent
and export of products related to the intellectual property. The royalty continues until the patent expires or is no longer used in the
Company&#8217;s product. The royalty agreement was assumed by the Company in December 2017.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
September 2018, the Royalty Agreement was amended to reduce the royalty to <span id="xdx_90B_ecustom--RoyaltyPercentage_pid_dp_uPure_c20180901__20180930__us-gaap--TypeOfArrangementAxis__custom--RoyaltyAgreementMember__srt--TitleOfIndividualAxis__custom--BarryBerlerMember_zmTJWkuUvy2i" title="Royalty percentage">2</span>% and further provided for a single payment of $<span id="xdx_908_ecustom--SinglePaymentObligation_iI_c20180930__us-gaap--TypeOfArrangementAxis__custom--RoyaltyAgreementMember__srt--TitleOfIndividualAxis__custom--BarryBerlerMember_zL0b5olKvHjg" title="Single payment obligation">500,000</span> to
Barry Berler within three years in return for cancellation of all further royalty obligations of the Company. In May 2019, the Royalty
Agreement was further amended to change the payment date to on or before May 31, 2021 or during the term of the amended Royalty Agreement
should the Company be acquired or a controlling interest be acquired. The Company has not made the aforementioned payment or incur any
change in control as such the <span id="xdx_909_ecustom--RoyaltyPercentage_pid_dp_uPure_c20190501__20190531__us-gaap--TypeOfArrangementAxis__custom--RoyaltyAgreementMember__srt--TitleOfIndividualAxis__custom--BarryBerlerMember_zPAN73PHhcW5" title="Royalty percentage">2</span>% royalty remains in place.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Employment
Agreements</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
August 1, 2022, the Company cancelled the consulting agreement with Alan Blackman, Co- Chairman and Chief Operating Officer and entered
into an Employment Agreement which provides for annual salary of $<span id="xdx_904_eus-gaap--SalariesAndWages_c20220730__20220801__us-gaap--TypeOfArrangementAxis__custom--EmploymentAgreementMember_z5RdEglnML6c" title="Annual salary">256,000</span>, which provides for increases, and provisions compensation
adjustments, expense and tax differential reimbursements, benefits and bonuses. As of September 1, 2022, the annual salary is $<span id="xdx_901_eus-gaap--SalariesAndWages_c20220831__20220901__us-gaap--TypeOfArrangementAxis__custom--EmploymentAgreementMember_zszDBP8Hz4ze" title="Salaries and wages">320,000</span>.
At June 30, 2022, the Company approved and accrued a $<span id="xdx_904_eus-gaap--AccruedBonusesCurrentAndNoncurrent_iI_c20220630__srt--TitleOfIndividualAxis__custom--Mr.BlackmanMember_zmC2Lxzl00ya" title="Accrued bonus">250,000</span> bonus to Mr. Blackman for services provided in 2022, of which $<span id="xdx_90E_ecustom--PaymentForBonuses_c20230101__20230331__srt--TitleOfIndividualAxis__custom--Mr.BlackmanMember_zTXP89phwRC8" title="Payment for bonuses">65,000</span> was
paid subsequent to December 31, 2022. The Company terminated Mr. Blackman&#8217;s Employment Agreement effective May 1, 2023. Mr. Blackman
continued to serve as the Co-Chairman and a member of the Board of Directors. Subsequent to June 30, 2023, the Company and Mr. Blackman
entered into a separation agreement whereby, Mr. Blackman will be paid severance payments of approximately $<span id="xdx_904_eus-gaap--SeveranceCosts1_c20230701__20230814__srt--TitleOfIndividualAxis__custom--Mr.BlackmanMember_zO0JJdrZaLP" title="Severance costs">346,000</span>, which was recorded
as an expense and an accrued expense as of June 30, 2023, over thirteen months, continue his medical benefits for such period with a
cost of approximately $<span id="xdx_90D_ecustom--MedicalBenefitsCost_iI_c20230630__srt--TitleOfIndividualAxis__custom--Mr.BlackmanMember_zaW4S3Krdbth" title="Medical benefit cost">29,000</span> which has been accrued at June 30, 2023. At December 31, 2023, the outstanding balance due Mr. Blackman
is $<span id="xdx_905_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue_iI_c20231231__srt--TitleOfIndividualAxis__custom--Mr.BlackmanMember_zXvEch9i2bGa" title="Outstanding balance">218,000</span>, which is recorded in accrued expenses. Further, all unvested options were fully vested and the Company recorded a charge
of $<span id="xdx_904_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue_iI_c20231231_zoLvJBETXsHd" title="Fully vested">60,000</span>. In connection with the separation agreement, Mr. Blackman no longer serves as Co-Chairman or Board member and has agreed
to vote his Series A Preferred Stock in favor of the election, reelection, and/or designation of each individual nominated to serve as
a director on the Board of Director as shall be identified in an applicable proxy statement filed by the Company for such election of
directors. Once the payments due Mr. Blackman are fully paid, the Series A Preferred Stock shall be deemed immediately cancelled and
forfeited and without further consideration. The Series A Preferred shall at such time be returned to the status of an authorized but
unissued share of preferred stock of the Company.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>



<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"></p><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>SHARPS
TECHNOLOGY, INC.</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTES
TO THE CONSOLIDATED FINANCIAL STATEMENTS</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>FOR
THE YEARS ENDED DECEMBER 31, 2023 AND 2022</b></span></p>

<p style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Note
15. Commitments and Contingencies (continued)</b></span></p>


<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
September 30, 2022, the Company entered into a formal employment agreement, effective on such date and will continue until terminated
by either party, subject to the terms of the agreement, with Andrew R. Crescenzo who has been serving as the Company&#8217;s Chief Financial
Officer on a contract services basis for the last three years. The agreement provided for annual compensation of $<span id="xdx_90B_ecustom--AnnualCompensation_c20220930__20220930__us-gaap--TypeOfArrangementAxis__custom--EmploymentAgreementMember_zGqZGdJoj4ih" title="Annual compensation">225,000</span> and plus a
one-time $<span id="xdx_904_eus-gaap--PaymentForIncentiveFee_c20220930__20220930__us-gaap--TypeOfArrangementAxis__custom--EmploymentAgreementMember_zgjWTX2HcIU5" title="Payment  for incentive fee">18,750</span> incentive payment upon the commencement of the agreement. During the course of the term, Mr. Crescenzo will be eligible
for (i) performance bonuses to be granted at the discretion of the Company&#8217;s Compensation Committee and (ii) to participate in
the Company&#8217;s 2022 Equity Incentive Plan. The agreement contains customary employment terms and conditions.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
October 2022, the Company entered into a service agreement (&#8220;Service Agreement&#8221;) with an unrelated third-party for marketing
and investor relations services. The Service Agreement, which has a term of one year, has various deliverables and provides payments
to the third party as follows; a) an initial fee of $<span id="xdx_90B_ecustom--InitialFee_c20221001__20221031__us-gaap--TypeOfArrangementAxis__custom--ServiceAgreementMember_z16F9lSyXzJa" title="Initial fee">90,000</span>, b) monthly fees through the term of $<span id="xdx_90D_ecustom--MonthlyFee_c20221001__20221031__us-gaap--TypeOfArrangementAxis__custom--ServiceAgreementMember_z9y9NK2Xeg4f" title="Monthly fee">12,500</span>, c) <span id="xdx_906_eus-gaap--StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures_c20221001__20221031__us-gaap--TypeOfArrangementAxis__custom--ServiceAgreementMember_z9aPNmc6VNUf" title="Shares of restricted common stock">200,000</span> shares of restricted
common stock and d) $<span id="xdx_902_ecustom--ValueOfDigitalMarketingActivities_iI_c20221031__us-gaap--TypeOfArrangementAxis__custom--ServiceAgreementMember_zo6xW8uqi6w4" title="Value of digital marketing activities">300,000</span> specifically related to digital marketing activities. As stated in Note 8, the <span id="xdx_90B_eus-gaap--StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures_c20221001__20221031__us-gaap--TypeOfArrangementAxis__custom--ServiceAgreementMember_zNBHiUObJaNj" title="Shares of restricted common stock">200,000</span> shares of restricted
common stock were valued at $<span id="xdx_906_eus-gaap--StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures_c20221001__20221031__us-gaap--TypeOfArrangementAxis__custom--ServiceAgreementMember_zgaDgDDNAXv5" title="Value of restricted common stock">230,000</span>, representative of the trading price on the issuance.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
February 9, 2023, the Company, appointed Justin Page, as Vice President of Technical Operations with a start date of February 15, 2023.
The agreement provides for annual compensation of $<span id="xdx_906_eus-gaap--EmployeeBenefitsAndShareBasedCompensation_c20230208__20230209_zUnxmjli64Yf" title="Compensation cost">235,000</span> and Options to purchase <span id="xdx_903_eus-gaap--StockIssuedDuringPeriodSharesShareBasedCompensation_c20230208__20230209_z0jVrcLx4Cal" title="Options to purchase shares">50,000</span> shares of Common Stock at the exercise price
of $<span id="xdx_907_eus-gaap--SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1_iI_c20230209_zETnKyLdlt4g" title="Stock option, exercise price">1.30</span>, the closing price on the grant date. During the course of the term, Mr. Paige will be eligible for (i) performance bonuses
to be granted at the discretion of the Company&#8217;s Compensation Committee and (ii) to participate in the Company&#8217;s Equity Incentive
Plan. The agreement contains customary employment terms and conditions and provides for severance of six months if a change in control
occurs, as defined.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
November 10, 2023, the Company executed an Employment Agreement with Robert Hayes, its Chief Executive Officer amending the employment
letter dated September 6, 2021. The agreement term automatically renews for successive one-year terms as of the commencement date unless
prior written notice by either party within ninety days prior to end of the current term. The agreement provides for termination of employment
and severance benefits under stated conditions and restrictive covenants. The agreement provides for annual compensation retroactive
to June 1, 2023 of $<span id="xdx_90D_ecustom--AnnualCompensation_c20230601__20230601__us-gaap--TypeOfArrangementAxis__custom--EmploymentAgreementMember_zxErqHiMWyNg" title="Annual compensation">600,000</span> from $<span id="xdx_905_ecustom--AnnualCompensation_c20230531__20230531__us-gaap--TypeOfArrangementAxis__custom--EmploymentAgreementMember_zI0ExhBPboic" title="Annual compensation">400,000</span> and a stated increase with the successful acquisition of InjectEZ and other terms of the acquisition
agreement (See Note 5). The agreement provides for bonus compensation for: (i) closing the Nephron acquisition agreement, (ii) long-term
incentives for achieving revenue targets and market caps for the Company&#8217;s stock and (iii) other Company achievements. In addition,
the agreement provides for benefits and paid time off.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingenciesDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for commitments and contingencies.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 405<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org/405-30/tableOfContent<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 440<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482648/440-10-50-4<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 450<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org/450/tableOfContent<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 954<br> -SubTopic 440<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478522/954-440-50-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 440<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482648/440-10-50-4<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 440<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org/440/tableOfContent<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingenciesDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>126
<FILENAME>R24.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.4</span><table class="report" border="0" cellspacing="2" id="idm45095369652352">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Subsequent Events<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsequentEventsAbstract', window );"><strong>Subsequent Events [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsequentEventsTextBlock', window );">Subsequent Events</a></td>
<td class="text"><p id="xdx_804_eus-gaap--SubsequentEventsTextBlock_zQ7JBnCW0Jad" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Note
16. <span id="xdx_822_zESbKdMP8av2">Subsequent Events</span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
January 2024, the holders of <span id="xdx_90B_eus-gaap--ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight_iI_c20240101__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_ziQEJ9963WM6">398,441
</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">of pre-funded warrants exercised their warrants
at the exercise price of $<span id="xdx_904_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_pid_c20240101__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_zB5i2WPshI4d">.001</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">.</span></p>

<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsequentEventsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsequentEventsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsequentEventsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for significant events or transactions that occurred after the balance sheet date through the date the financial statements were issued or the date the financial statements were available to be issued. Examples include: the sale of a capital stock issue, purchase of a business, settlement of litigation, catastrophic loss, significant foreign exchange rate changes, loans to insiders or affiliates, and transactions not in the ordinary course of business.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 855<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org/855/tableOfContent<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 855<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483399/855-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsequentEventsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>127
<FILENAME>R25.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.4</span><table class="report" border="0" cellspacing="2" id="idm45095357034368">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Summary of Significant Accounting Policies (Policies)<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>Accounting Policies [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BasisOfAccountingPolicyPolicyTextBlock', window );">Basis of Presentation</a></td>
<td class="text"><p id="xdx_840_eus-gaap--BasisOfAccountingPolicyPolicyTextBlock_zzowRwhjjZ34" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Basis
of Presentation</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
accompanying condensed consolidated financial statements have been prepared by the Company in accordance with generally accepted accounting
principles (&#8220;GAAP&#8221;) in the United States (&#8220;U.S.&#8221;) and are expressed in U.S. dollars.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>





<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>SHARPS
TECHNOLOGY, INC.</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTES
TO THE CONDENSED CONSOLIDATED FINANCIAL STATEMENTS</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>FOR
THE THREE AND NINE MONTHS ENDED SEPTEMBER 30, 2024 AND 2023</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Note
2. Summary of Significant Accounting Policies (continued)</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>&#160;</i></b></span></p>

<span></span>
</td>
<td class="text"><p id="xdx_84C_eus-gaap--BasisOfAccountingPolicyPolicyTextBlock_zKVaVj20gVgj" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i><span id="xdx_862_zp4lx1YGTOT3">Basis
of Presentation</span></i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
accompanying consolidated financial statements have been prepared by the Company in accordance with generally accepted accounting principles
(&#8220;GAAP&#8221;) in the United States (&#8220;U.S.&#8221;) and are expressed in U.S. dollars.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
accompanying consolidated financial statements have been prepared assuming that the Company will continue as a going concern. The Company
has not generated revenue or cash flow from operations since inception. As of December 31, 2023, the Company used cash in operations
of $<span id="xdx_90C_eus-gaap--NetCashProvidedByUsedInOperatingActivities_iN_di_c20230101__20231231_zB7ZnFfzNdP4" title="Cash in operations">8,507,300</span> and has cash of $<span id="xdx_904_eus-gaap--Cash_iI_c20231231_ziEF5XUdcyl5" title="Cash">3,012,908</span> which is not sufficient to fund the Company&#8217;s planned operations for the next 12 months.
These factors raise substantial doubt regarding the Company&#8217;s ability to continue as a going concern. The Company&#8217;s ability
to continue as a going concern is dependent upon the Company&#8217;s ability to raise sufficient financing to acquire or commercialize
its products into a profitable business. The Company intends to finance its future development and commercialization activities and its
working capital needs largely from the sale of equity securities and/or with additional funding from other traditional financing sources
until such time that funds provided by operations are sufficient to fund working capital requirements. The financial statements of the
Company do not include any adjustments relating to the recoverability and classification of recorded assets, or the amounts and classifications
of liabilities that might be necessary should the Company be unable to continue as a going concern.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_UseOfEstimates', window );">Use of Estimates</a></td>
<td class="text"><p id="xdx_84C_eus-gaap--UseOfEstimates_zGgGkPhMhNe2" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Use
of Estimates</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
preparation of financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the
reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements
and the reported amounts of revenues and expenses during the reporting periods. Actual results could differ from those estimates. As
of September 30, 2024, the most significant estimates relate to derivative liabilities, stock-based compensation, long-lived asset impairments and accounting for debt and equity financing.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<span></span>
</td>
<td class="text"><p id="xdx_849_eus-gaap--UseOfEstimates_zEaXZ5pgfJRi" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i><span id="xdx_860_zAevqar0yAGg">Use
of Estimates</span></i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
preparation of financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the
reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements
and the reported amounts of revenues and expenses during the reporting periods. Actual results could differ from those estimates. As
of December 31, 2023, the most significant estimates relate to derivative liabilities and stock-based compensation.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-indent: 24.75pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsPolicyTextBlock', window );">Cash and Cash Equivalents</a></td>
<td class="text"><p id="xdx_84D_eus-gaap--CashAndCashEquivalentsPolicyTextBlock_zpVN0CaOHznd" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Cash
and Cash Equivalents</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company considers all highly liquid investments purchased with an original or remaining maturity of three months or less at the date
of purchase to be cash equivalents. Cash and cash equivalents are maintained with various financial institutions. At September 30, 2024
and December 31, 2023, the Company had <span id="xdx_90E_eus-gaap--CashEquivalentsAtCarryingValue_iI_do_c20240930_zwmnXV8kgRR4" title="Cash equivalents"><span id="xdx_905_eus-gaap--CashEquivalentsAtCarryingValue_iI_do_c20231231_zGf0aAiwxUi6" title="Cash equivalents">no</span></span> cash equivalents.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<span></span>
</td>
<td class="text"><p id="xdx_847_eus-gaap--CashAndCashEquivalentsPolicyTextBlock_zbV2MKSLSyA9" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i><span id="xdx_863_zpgJilAhQ4Bb">Cash
and Cash Equivalents</span></i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company considers all highly liquid investments purchased with an original or remaining maturity of three months or less at the date
of purchase to be cash equivalents. Cash and cash equivalents are maintained with various financial institutions. At December 31,
2023 and 2022, the Company had <span id="xdx_908_eus-gaap--CashEquivalentsAtCarryingValue_iI_do_c20231231_zWb6yOWVqK22" title="Cash equivalents"><span id="xdx_903_eus-gaap--CashEquivalentsAtCarryingValue_iI_do_c20221231_zMq2PeuJTbLk" title="Cash equivalents">no</span></span> cash equivalents.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InventoryPolicyTextBlock', window );">Inventories</a></td>
<td class="text"><p id="xdx_844_eus-gaap--InventoryPolicyTextBlock_zGOqIcJQKIza" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Inventories</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company values inventory at the lower of cost (average cost) or net realizable value. Work-in-process and finished goods inventories
consist of material, labor, and manufacturing overhead. Net realizable value is the estimated selling price in the ordinary course of
business, less reasonably predictable costs of completion, disposal, and transportation. A reserve is established for any excess or obsolete
inventories or they may be written off. At September 30, 2024, and December 31, 2023, inventory is comprised of raw materials, including
packaging, work in process (components) and finished goods.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<span></span>
</td>
<td class="text"><p id="xdx_84D_eus-gaap--InventoryPolicyTextBlock_zOoB5UMrClt7" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i><span id="xdx_86F_zdkCVDwqh8qb">Inventories</span></i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company values inventory at the lower of cost (average cost) or net realizable value. Work-in-process and finished goods inventories
consist of material, labor, and manufacturing overhead. Net realizable value is the estimated selling price in the ordinary course of
business, less reasonably predictable costs of completion, disposal, and transportation. A reserve is established for any excess or obsolete
inventories or they may be written off. At December 31, 2023 and 2022, inventory is comprised of raw materials, components and finished
goods.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>




<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>SHARPS
TECHNOLOGY, INC.</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTES
TO THE CONSOLIDATED FINANCIAL STATEMENTS</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>FOR
THE YEARS ENDED DECEMBER 31, 2023 AND 2022</b></span></p>

<p style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Note
2. Summary of Significant Accounting Policies (continued)</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueMeasurementPolicyPolicyTextBlock', window );">Fair Value Measurements</a></td>
<td class="text"><p id="xdx_84D_eus-gaap--FairValueMeasurementPolicyPolicyTextBlock_z8orLyWy9zmh" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Fair
Value Measurements</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">ASC
820, Fair Value Measurements and Disclosures, requires an entity to maximize the use of observable inputs and minimize the use of unobservable
inputs when measuring fair value. ASC 820 establishes a fair value hierarchy based on the level of independent, objective evidence surrounding
the inputs used to measure fair value. A financial instrument&#8217;s categorization within the fair value hierarchy is based upon the
lowest level of input that is significant to the fair value measurement. ASC 820 prioritizes the inputs into three levels that may be
used to measure fair value.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company&#8217;s outstanding warrants are valued on a recurring basis with the trading price which could cause fluctuations in operating
results at the reporting periods.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Level
1</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Level
1 applies to assets or liabilities for which there are quoted prices in active markets for identical assets or liabilities. Valuations
are based on quoted prices that are readily and regularly available in an active market and do not entail a significant degree of judgment.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Level
2</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Level
2 applied to assets or liabilities for which there are other than Level 1 observable inputs such as quoted prices for similar assets
or liabilities in active markets; quoted prices for identical assets or liabilities in markets with insufficient volume or infrequent
transactions (less active markets); or model-derived valuations in which significant inputs are observable or can be derived principally
from, or corroborated by, observable market data.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Level
2 instruments require more management judgment and subjectivity as compared to Level 1 instruments. For instance: determining which instruments
are most similar to the instrument being priced requires management to identify a sample of similar securities based on the coupon rates,
maturity, issuer credit rating and instrument type, and subjectively select an individual security or multiple securities that are deemed
most similar to the security being priced; and determining whether a market is considered active requires management judgment.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"></p>



<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;<br/></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>SHARPS
TECHNOLOGY, INC.</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTES
TO THE CONDENSED CONSOLIDATED FINANCIAL STATEMENTS</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>FOR
THE THREE AND NINE MONTHS ENDED SEPTEMBER 30, 2024 AND 2023</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Note
2. Summary of Significant Accounting Policies (continued)</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Level
3</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Level
3 applied to assets or liabilities for which there are unobservable inputs to the valuation methodology that are significant to the measurement
of the fair value of the assets or liabilities. The determination for Level 3 instruments requires the most management judgment and subjectivity.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<span></span>
</td>
<td class="text"><p id="xdx_848_eus-gaap--FairValueMeasurementPolicyPolicyTextBlock_zcHPw9YdzgV4" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_86D_z5klkHhT9Lw9">Fair
Value Measurements</span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">ASC
820, Fair Value Measurements and Disclosures, require an entity to maximize the use of observable inputs and minimize the use of unobservable
inputs when measuring fair value. ASC 820 establishes a fair value hierarchy based on the level of independent, objective evidence surrounding
the inputs used to measure fair value. A financial instrument&#8217;s categorization within the fair value hierarchy is based upon the
lowest level of input that is significant to the fair value measurement. ASC 820 prioritizes the inputs into three levels that may be
used to measure fair value.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company&#8217;s outstanding warrants are fair valued on a recurring basis with the trading price or FMV using Black Sholes which
could cause fluctuations in operating results at the reporting periods.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Level
1</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Level
1 applies to assets or liabilities for which there are quoted prices in active markets for identical assets or liabilities. Valuations
are based on quoted prices that are readily and regularly available in an active market and do not entail a significant degree of judgment.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Level
2</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Level
2 applied to assets or liabilities for which there are other than Level 1 observable inputs such as quoted prices for similar assets
or liabilities in active markets; quoted prices for identical assets or liabilities in markets with insufficient volume or infrequent
transactions (less active markets); or model-derived valuations in which significant inputs are observable or can be derived principally
from, or corroborated by, observable market data.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Level
2 instruments require more management judgment and subjectivity as compared to Level 1 instruments. For instance: determining which instruments
are most similar to the instrument being priced requires management to identify a sample of similar securities based on the coupon rates,
maturity, issuer credit rating and instrument type, and subjectively select an individual security or multiple securities that are deemed
most similar to the security being priced; and determining whether a market is considered active requires management judgment.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Level
3</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Level
3 applied to assets or liabilities for which there are unobservable inputs to the valuation methodology that are significant to the measurement
of the fair value of the assets or liabilities. The determination for Level 3 instruments requires the most management judgment and subjectivity.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock', window );">Fixed Assets</a></td>
<td class="text"><p id="xdx_84A_eus-gaap--PropertyPlantAndEquipmentPolicyTextBlock_zeQSF2RpUG6k" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Fixed
Assets</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>&#160;</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Fixed
assets are stated at cost. Expenditures for maintenance and repairs are charged to operations as incurred. The Company&#8217;s fixed
assets consist of land, building, machinery and equipment, molds and website. Depreciation is calculated using the straight-line method
commencing on the date the asset is operating in the way intended by management over the following useful lives: Building &#8211; <span id="xdx_90D_eus-gaap--PropertyPlantAndEquipmentUsefulLife_iI_dtY_c20240930__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--BuildingMember_zfFFDUZ05bbg" title="Property plant and equipment asset useful life">20</span>
years, Machinery and Equipment &#8211; <span id="xdx_901_eus-gaap--PropertyPlantAndEquipmentUsefulLife_iI_dtY_c20240930__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--MachineryAndEquipmentMember__srt--RangeAxis__srt--MinimumMember_zQDlHxyYqlR4" title="Property plant and equipment asset useful life">3</span> - <span id="xdx_907_eus-gaap--PropertyPlantAndEquipmentUsefulLife_iI_dtY_c20240930__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--MachineryAndEquipmentMember__srt--RangeAxis__srt--MaximumMember_zIimvDqNBFI6" title="Property plant and equipment asset useful life">10</span> years and Website and Computer Systems &#8211; <span id="xdx_909_eus-gaap--PropertyPlantAndEquipmentUsefulLife_iI_dtY_c20240930__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--WebsiteMember_zTb8yQXBBNHf" title="Property plant and equipment asset useful life">3</span> years. The expected life for Molds is
based on the lesser of the number of parts that will be produced based on the expected mold capability or 5 years.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>&#160;</i></b></span></p>

<span></span>
</td>
<td class="text"><p id="xdx_846_eus-gaap--PropertyPlantAndEquipmentPolicyTextBlock_zg8LPGtNVQJf" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Fixed
Assets</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Fixed
assets are stated at cost. Expenditures for maintenance and repairs are charged to operations as incurred. The Company&#8217;s fixed
assets consist of land, building, machinery and equipment, molds, computer system and website. Depreciation is calculated using the straight-line
method commencing on the date the asset is operating in the way intended by management over the following useful lives: Building &#8211;
<span id="xdx_900_eus-gaap--PropertyPlantAndEquipmentUsefulLife_iI_dtY_c20231231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--BuildingMember_zDcXnDaTcg23" title="Property plant and equipment asset useful life">20</span> years, Machinery and Equipment &#8211; <span id="xdx_903_eus-gaap--PropertyPlantAndEquipmentUsefulLife_iI_dtY_c20231231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--MachineryAndEquipmentMember__srt--RangeAxis__srt--MinimumMember_zvfMOOj4TIpk" title="Property plant and equipment asset useful life">3</span> -<span id="xdx_90A_eus-gaap--PropertyPlantAndEquipmentUsefulLife_iI_dtY_c20231231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--MachineryAndEquipmentMember__srt--RangeAxis__srt--MaximumMember_zUMsxKx0X3a1" title="Property plant and equipment asset useful life">10</span> years and Computer systems and Website &#8211; <span id="xdx_901_eus-gaap--PropertyPlantAndEquipmentUsefulLife_iI_dtY_c20231231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--WebsiteMember_zWiJepiw6Kn" title="Property plant and equipment asset useful life">3</span> years. The expected life for Molds is
based lesser of the number of parts that will be produced based on the expected mold capability or 5 years.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>&#160;</i></b></span></p>

<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock', window );">Impairment of Long-Lived Assets</a></td>
<td class="text"><p id="xdx_844_eus-gaap--ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock_zcCTXfcljxD8" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i><span id="xdx_863_zFqcx8k1jJQ2">Impairment
of Long-Lived Assets</span></i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Long-lived
assets are reviewed for impairment or whenever events or changes in circumstances indicate that the carrying amount of an asset may not
be recoverable. Recoverability is measured by comparison of the carrying amount of an asset group to the future net undiscounted cash
flows that the assets are expected to generate. If such assets are considered to be impaired, the impairment to be recognized is measured
by the amount by which the carrying amount of the assets exceeds the projected discounted future net cash flows arising from the asset.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">There
were <span id="xdx_900_eus-gaap--ImpairmentOfLongLivedAssetsHeldForUse_dxL_c20240701__20240930_zcjUgtigXLBc" title="Impairment losses::XDX::-"><span id="xdx_905_eus-gaap--ImpairmentOfLongLivedAssetsHeldForUse_dxL_c20230701__20230930_zcIHlxLiKnng" title="Impairment losses::XDX::-"><span id="xdx_907_eus-gaap--ImpairmentOfLongLivedAssetsHeldForUse_dxL_c20240101__20240930_zqXBJ8ZjlUd2" title="Impairment losses::XDX::-"><span id="xdx_90D_eus-gaap--ImpairmentOfLongLivedAssetsHeldForUse_dxL_c20230101__20230930_zat4wV0dNvRi" title="Impairment losses::XDX::-"><span style="-sec-ix-hidden: xdx2ixbrl2233"><span style="-sec-ix-hidden: xdx2ixbrl2235"><span style="-sec-ix-hidden: xdx2ixbrl2237"><span style="-sec-ix-hidden: xdx2ixbrl2239">no</span></span></span></span></span></span></span></span> impairment losses recognized during the three and nine months ended September 30, 2024 and 2023.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Purchased
Identified Intangible Assets</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company&#8217;s identified intangible assets are amortized on a straight-line basis over their estimated useful lives of 5 years.
The Company makes judgments about the recoverability of finite-lived intangible assets whenever facts and circumstances indicate
that the useful life is shorter than originally estimated or that the carrying amount of assets may not be recoverable. If such
facts and circumstances exist, the Company assesses recoverability by comparing the projected undiscounted net cash flows associated
with the related asset or group of assets over their remaining lives against their respective carrying amounts. Impairments, if any,
are based on the excess of the carrying amount over the fair value of those assets. If the useful life is shorter than originally
estimated, the Company would accelerate the rate of amortization and amortize the remaining carrying value over the new shorter
useful life. The Company evaluates the carrying value of indefinite-lived intangible assets whenever events or changes in
circumstances indicate that the carrying amount of an asset may not be recoverable, and an impairment charge would be recognized to
the extent that the carrying amount of such assets exceeds their estimated fair value.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<span></span>
</td>
<td class="text"><p id="xdx_840_eus-gaap--ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock_zmMDNT8Ofh78" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i><span id="xdx_860_zlWnFrL4mQhi">Impairment
of Long-Lived Assets</span> </i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Long-lived
assets are reviewed annually for impairment or whenever events or changes in circumstances indicate that the carrying amount of an asset
may not be recoverable. Recoverability is measured by comparison of the carrying amount of an asset group to the future net undiscounted
cash flows that the assets are expected to generate. If such assets are considered to be impaired, the impairment to be recognized is
measured by the amount by which the carrying amount of the assets exceeds the projected discounted future net cash flows arising from
the asset.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company recorded an impairment of $<span id="xdx_90F_eus-gaap--ImpairmentOfLongLivedAssetsHeldForUse_c20230101__20231231_z0rVCogZaeT4" title="Impairment losses">560,000</span> during the year ended December 31, 2023 and <span id="xdx_900_eus-gaap--ImpairmentOfLongLivedAssetsHeldForUse_dxL_c20220101__20221231_zPneDqTLg4uj" title="Impairment losses::XDX::-"><span style="-sec-ix-hidden: xdx2ixbrl0604">no</span></span>
impairment during the year ended December 31, 2022.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>




<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>SHARPS
TECHNOLOGY, INC.</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTES
TO THE CONSOLIDATED FINANCIAL STATEMENTS</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>FOR
THE YEARS ENDED DECEMBER 31, 2023 AND 2022</b></span></p>

<p style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Note
2. Summary of Significant Accounting Policies (continued)</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IntangibleAssetsFiniteLivedPolicy', window );">Purchased Identified Intangible Assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text"><p id="xdx_841_eus-gaap--IntangibleAssetsFiniteLivedPolicy_ziROBe3KcNL9" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i><span id="xdx_86C_zxU4sxefa3ye">Purchased
Identified Intangible Assets</span></i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Identified
Intangible Assets</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company&#8217;s identified intangible assets are amortized on a straight-line basis over their estimated useful lives of 5 years. The
Company makes judgments about the recoverability of finite-lived intangible assets whenever facts and circumstances indicate that the
useful life is shorter than originally estimated or that the carrying amount of assets may not be recoverable. If such facts and circumstances
exist, the Company assesses recoverability by comparing the projected undiscounted net cash flows associated with the related asset or
group of assets over their remaining lives against their respective carrying amounts. Impairments, if any, are based on the excess of
the carrying amount over the fair value of those assets. If the useful life is shorter than originally estimated, the Company would accelerate
the rate of amortization and amortize the remaining carrying value over the new shorter useful life. The Company evaluates the carrying
value of finite-lived intangible assets on an annual basis, and an impairment charge would be recognized to the extent that the carrying
amount of such assets exceeds their estimated fair value.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>&#160;</i></b></span></p>

<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CompensationRelatedCostsPolicyTextBlock', window );">Stock-based Compensation Expense</a></td>
<td class="text"><p id="xdx_84D_eus-gaap--CompensationRelatedCostsPolicyTextBlock_zjY7X7QzGzUh" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Stock-based
Compensation Expense</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company measures its stock-based awards made to employees based on the estimated fair values of the awards as of the grant date. For
stock option awards, the Company uses the Black-Scholes option-pricing model. Stock-based compensation expense is recognized over the
requisite service period and is based on the value of the portion of stock-based payment awards that is ultimately expected to vest.
The Company recognizes forfeitures of stock-based awards as they occur on a prospective basis.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Stock-based
compensation expense for awards granted to non-employees as consideration for services received is measured on the date of performance
at the fair value of the consideration received or the fair value of the equity instruments issued, whichever can be more reliably measured.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>





<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>SHARPS
TECHNOLOGY, INC.</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTES
TO THE CONDENSED CONSOLIDATED FINANCIAL STATEMENTS</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>FOR
THE THREE AND NINE MONTHS ENDED SEPTEMBER 30, 2024 AND 2023</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Note
2. Summary of Significant Accounting Policies (continued)</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>&#160;</i></b></span></p>

<span></span>
</td>
<td class="text"><p id="xdx_843_eus-gaap--CompensationRelatedCostsPolicyTextBlock_zLto1WwGYnCh" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i><span id="xdx_864_zVx4yLq85QPc">Stock-based
Compensation Expense</span></i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company measures its stock-based awards made to employees based on the estimated fair values of the awards as of the grant date. For
stock option awards, the Company uses the Black-Scholes option-pricing model. For restricted stock awards, the estimated fair value is
generally the fair market value of the underlying stock on the grant date. Stock-based compensation expense is recognized over the requisite
service period and is based on the value of the portion of stock-based payment awards that is ultimately expected to vest. The Company
recognizes forfeitures of stock-based awards as they occur on a prospective basis.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Stock-based
compensation expense for awards granted to non-employees as consideration for services received is measured on the date of performance
at the fair value of the consideration received or the fair value of the equity instruments issued, whichever can be more reliably measured.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>




<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>SHARPS
TECHNOLOGY, INC.</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTES
TO THE CONSOLIDATED FINANCIAL STATEMENTS</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>FOR
THE YEARS ENDED DECEMBER 31, 2023 AND 2022</b></span></p>

<p style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Note
2. Summary of Significant Accounting Policies (continued)</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativesPolicyTextBlock', window );">Derivative Instruments</a></td>
<td class="text"><p id="xdx_84D_eus-gaap--DerivativesPolicyTextBlock_zsOS2s0wxaTa" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Derivative
Instruments</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company accounts for common stock warrants as either equity-classified or liability-classified instruments based on an assessment of
the specific terms of the warrants and applicable authoritative guidance in Financial Accounting Standards Board (&#8220;FASB&#8221;)
Accounting Standards Codification (&#8220;ASC 480&#8221;), Distinguishing Liabilities from Equity (&#8220;ASC 480&#8221;) and ASC 815,
Derivatives and Hedging (&#8220;ASC 815&#8221;). The assessment considers whether the warrants are freestanding financial instruments
pursuant to ASC 480, meet the definition of a liability pursuant to ASC 480, and meet all of the requirements for equity classification
under ASC 815, including whether the warrants are indexed to the Company&#8217;s own stock and whether the holders of the warrants could
potentially require net cash settlement in a circumstance outside of the Company&#8217;s control, among other conditions for equity classification.
This assessment, which requires the use of professional judgment, is conducted at the time of warrant issuance and as of each subsequent
quarterly period end date while the warrants are outstanding.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">At
their issuance date and as of September 30, 2024, certain warrants (see Notes 8 and 10) were accounted for as liabilities as these instruments
did not meet all of the requirements for equity classification under ASC 815-40 based on the terms of the aforementioned warrants. The
resulting warrant liabilities are re-measured at each balance sheet date until their exercise or expiration, and any change in fair value
is recognized in the Company&#8217;s condensed consolidated statements of operations.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<span></span>
</td>
<td class="text"><p id="xdx_848_eus-gaap--DerivativesPolicyTextBlock_z4E35sPxqQwg" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i><span id="xdx_861_zfSFtOldWiqd">Derivative
Instruments</span></i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company accounts for common stock warrants as either equity-classified or liability-classified instruments based on an assessment of
the specific terms of the warrants and applicable authoritative guidance in Financial Accounting Standards Board (&#8220;FASB&#8221;)
Accounting Standards Codification (&#8220;ASC 480&#8221;), Distinguishing Liabilities from Equity (&#8220;ASC 480&#8221;) and ASC 815,
Derivatives and Hedging (&#8220;ASC 815&#8221;). The assessment considers whether the warrants are freestanding financial instruments
pursuant to ASC 480, meet the definition of a liability pursuant to ASC 480, and meet all of the requirements for equity classification
under ASC 815, including whether the warrants are indexed to the Company&#8217;s own stock and whether the holders of the warrants could
potentially require net cash settlement in a circumstance outside of the Company&#8217;s control, among other conditions for equity classification.
This assessment, which requires the use of professional judgment, is conducted at the time of warrant issuance and as of each subsequent
quarterly period end date while the warrants are outstanding.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">At
their issuance date and as of December 31, 2023, certain warrants (see Notes 8 and 10) are accounted for as liabilities as these instruments
did not meet all of the requirements for equity classification under ASC 815-40 based on the terms of the aforementioned warrants. The
resulting warrant liabilities are re-measured at each balance sheet date until their exercise or expiration, and any change in fair value
is recognized in the Company&#8217;s consolidated statements of operations.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock', window );">Foreign Currency Translation/Transactions</a></td>
<td class="text"><p id="xdx_840_eus-gaap--ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock_zSlJU8zMa6m6" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Foreign
Currency Translation/Transactions</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company has determined that the functional currency for its foreign subsidiary is the local currency. For financial reporting purposes,
assets and liabilities denominated in foreign currencies are translated at current exchange rates and profit and loss accounts are translated
at weighted average exchange rates. Resulting translation gains and losses are included as a separate component of stockholders&#8217;
equity as accumulated other comprehensive income or loss. Gains or losses resulting from transactions entered into in other than the
functional currency are recorded as foreign exchange gains and losses in the condensed consolidated statements of operations.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<span></span>
</td>
<td class="text"><p id="xdx_84B_eus-gaap--ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock_z2SbVpJcwPed" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i><span id="xdx_86F_zlEzljoZPcy4">Foreign
Currency Translation/Transactions</span></i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company has determined that the functional currency for its foreign subsidiary is the local currency. For financial reporting purposes,
assets and liabilities denominated in foreign currencies are translated at current exchange rates and profit and loss accounts are translated
at weighted average exchange rates. Resulting translation gains and losses are included as a separate component of stockholders&#8217;
equity as accumulated other comprehensive income or loss. Gains or losses resulting from transactions entered into in other than the
functional currency are recorded as foreign exchange gains and losses in the consolidated statements of operations.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ComprehensiveIncomePolicyPolicyTextBlock', window );">Comprehensive income (loss)</a></td>
<td class="text"><p id="xdx_848_eus-gaap--ComprehensiveIncomePolicyPolicyTextBlock_zTzYyPt3Ccmb" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Comprehensive
income (loss)</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>&#160;</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Comprehensive
income (loss) consists of the Company&#8217;s consolidated net loss and foreign currency translation adjustments related to its subsidiary.
Foreign currency translation adjustments included in comprehensive loss were not tax effected as the Company has a full valuation allowance
at September 30, 2024 and December 31, 2023. Accumulated other comprehensive income (loss) is a separate component of stockholders&#8217;
equity and consists of the cumulative foreign currency translation adjustments.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<span></span>
</td>
<td class="text"><p id="xdx_843_eus-gaap--ComprehensiveIncomePolicyPolicyTextBlock_zRifrGfr3Ls1" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i><span id="xdx_86A_zUWfwARhhYRk">Comprehensive
income (loss)</span></i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>&#160;</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Comprehensive
income (loss) consists of the Company&#8217;s consolidated net loss and foreign currency translation adjustments related to its subsidiary.
Foreign currency translation adjustments included in comprehensive loss were not tax effected as the Company has a full valuation allowance
at December 31, 2023 and 2022. Accumulated other comprehensive income (loss) is a separate component of stockholders&#8217; equity and
consists of the cumulative foreign currency translation adjustments.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>&#160;</i></b></span></p>

<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerSharePolicyTextBlock', window );">Basic and Diluted Loss Per Share</a></td>
<td class="text"><p id="xdx_842_eus-gaap--EarningsPerSharePolicyTextBlock_zFZgBIqoHRCg" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Basic
and Diluted Loss Per Share</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company computes net loss per share in accordance with ASC 260, Earnings per Share. ASC 260 requires presentation of both basic and diluted
earnings per share (EPS) on the face of the consolidated statements of operations. Basic EPS is computed by dividing net income (loss)
available to common stockholders (numerator) by the weighted average number of shares outstanding (denominator) during the period. Diluted
EPS gives effect to all dilutive potential common shares outstanding during the period using the treasury stock method and convertible
preferred stock using the if-converted method. In computing diluted EPS, the average stock price for the period is used in determining
the number of shares assumed to be purchased from the exercise of stock options or warrants. Diluted EPS excludes all dilutive potential
shares if their effect is anti-dilutive. As of September 30, 2024, there were <span id="xdx_90A_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_c20240101__20240930__us-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__custom--StockOptionAndWarrantsMember_zBLuoIKyQ3x3" title="Antidilutive shares amount">958,693</span> stock options and warrants, post reverse split
effected, that could potentially dilute basic EPS in the future that were not included in the computation of diluted EPS because to do
so would have been anti-dilutive for the periods presented.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>





<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>SHARPS
TECHNOLOGY, INC.</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTES
TO THE CONDENSED CONSOLIDATED FINANCIAL STATEMENTS</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>FOR
THE THREE AND NINE MONTHS ENDED SEPTEMBER 30, 2024 AND 2023</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Note
2. Summary of Significant Accounting Policies (continued)</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>&#160;</i></b></span></p>

<span></span>
</td>
<td class="text"><p id="xdx_84B_eus-gaap--EarningsPerSharePolicyTextBlock_zymxba8U4w66" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i><span id="xdx_86C_z601WrOkquZf">Basic
and Diluted Loss Per Share</span></i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company computes net loss per share in accordance with ASC 260, Earnings per Share. ASC 260 requires presentation of both basic and diluted
earnings per share (EPS) on the face of the consolidated statements of operations. Basic EPS is computed by dividing net income (loss)
available to common stockholders (numerator) by the weighted average number of shares outstanding (denominator) during the period. Basic
EPS includes the <span id="xdx_907_eus-gaap--WeightedAverageNumberOfSharesOutstandingBasic_c20230101__20231231__us-gaap--StatementEquityComponentsAxis__custom--PrefundendWarrantsMember_zW6yW4DDWHHb" title="Weighted average shares outstanding basic">3,381,479</span> of pre-funded warrants (see Note 8). Diluted EPS gives effect to all dilutive potential common shares outstanding
during the period using the treasury stock method and convertible preferred stock using the if-converted method. In computing diluted
EPS, the average stock price for the period is used in determining the number of shares assumed to be purchased from the exercise of
stock options or warrants. Diluted EPS excludes all dilutive potential shares if their effect is anti-dilutive. As of December 31, 2023,
there were <span id="xdx_90F_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_c20230101__20231231__us-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__custom--StockOptionsAndWarrantsMember_zxFr2uIC5do7" title="Antidilutive securities shares">22,950,155</span> stock options and warrants that could potentially dilute basic EPS in the future that were not included in the
computation of diluted EPS because to do so would have been anti-dilutive for the periods presented.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxPolicyTextBlock', window );">Income Taxes</a></td>
<td class="text"><p id="xdx_848_eus-gaap--IncomeTaxPolicyTextBlock_zi2Qqocojtoj" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Income
Taxes</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company must make certain estimates and judgments in determining income tax expenses for financial statement purposes. These estimates
and judgments are used in the calculation of tax credits, tax benefits, tax deductions, and in the calculation of certain deferred taxes
and tax liabilities. Significant changes to these estimates may result in an increase or decrease to the Company&#8217;s tax provision
in a subsequent period.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
provision for income taxes was comprised of the Company&#8217;s current tax liability and changes in deferred income tax assets and liabilities.
The calculation of the current tax liability involves dealing with uncertainties in the application of complex tax laws and regulations
and in determining the liability for tax positions, if any, taken on the Company&#8217;s tax returns in accordance with authoritative
guidance on accounting for uncertainty in income taxes. Deferred income taxes are determined based on the differences between the financial
reporting and tax basis of assets and liabilities. The Company must assess the likelihood that it will be able to recover the Company&#8217;s
deferred tax assets. If recovery is not likely on a more-likely-than-not basis, the Company must increase its provision for income taxes
by recording a valuation allowance against the deferred tax assets that it estimates will not ultimately be recoverable. However, should
there be a change in the Company&#8217;s ability to recover its deferred tax assets, the provision for income taxes would fluctuate in
the period of such change.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<span></span>
</td>
<td class="text"><p id="xdx_845_eus-gaap--IncomeTaxPolicyTextBlock_ziEbuahOcoKj" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i><span id="xdx_867_zl2OX7bMoBbl">Income
Taxes</span></i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company must make certain estimates and judgments in determining income tax expense for financial statement purposes. These estimates
and judgments are used in the calculation of tax credits, tax benefits, tax deductions, and in the calculation of certain deferred taxes
and tax liabilities. Significant changes to these estimates may result in an increase or decrease to the Company&#8217;s tax provision
in a subsequent period.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>




<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>SHARPS
TECHNOLOGY, INC.</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTES
TO THE CONSOLIDATED FINANCIAL STATEMENTS</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>FOR
THE YEARS ENDED DECEMBER 31, 2023 AND 2022</b></span></p>

<p style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Note
2. Summary of Significant Accounting Policies (continued)</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
provision for income taxes was comprised of the Company&#8217;s current tax liability and changes in deferred income tax assets and liabilities.
The calculation of the current tax liability involves dealing with uncertainties in the application of complex tax laws and regulations
and in determining the liability for tax positions, if any, taken on the Company&#8217;s tax returns in accordance with authoritative
guidance on accounting for uncertainty in income taxes. Deferred income taxes are determined based on the differences between the financial
reporting and tax basis of assets and liabilities. The Company must assess the likelihood that it will be able to recover the Company&#8217;s
deferred tax assets. If recovery is not likely on a more-likely-than-not basis, the Company must increase its provision for income taxes
by recording a valuation allowance against the deferred tax assets that it estimates will not ultimately be recoverable. However, should
there be a change in the Company&#8217;s ability to recover its deferred tax assets, the provision for income taxes would fluctuate in
the period of such change.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ResearchAndDevelopmentExpensePolicy', window );">Research and Development Costs</a></td>
<td class="text"><p id="xdx_84F_eus-gaap--ResearchAndDevelopmentExpensePolicy_z4vvVMYju8i8" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Research
and Development Costs</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Research
and development costs are expensed as incurred.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Advance
payments for goods or services that will be used or rendered for future research and development activities are deferred and capitalized.
Such amounts are recognized as an expense as the related goods are delivered or the services are performed.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<span></span>
</td>
<td class="text"><p id="xdx_842_eus-gaap--ResearchAndDevelopmentExpensePolicy_zNrWRCEvd1X5" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i><span id="xdx_86D_z3XLDfbXfP76">Research
and Development Costs</span></i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Research
and development costs are expensed as incurred.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Advance
payments for goods or services that will be used or rendered for future research and development activities are deferred and capitalized.
Such amounts are recognized as an expense as the related goods are delivered or the services are performed.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingenciesPolicyTextBlock', window );">Contingencies</a></td>
<td class="text"><p id="xdx_84F_eus-gaap--CommitmentsAndContingenciesPolicyTextBlock_zmDbhhayQWRa" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Contingencies</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Liabilities
for loss contingencies arising from claims, assessments, litigations, fines and penalties and other sources are recognized when it is
probable that a liability has been incurred and the amount of the assessment can be reasonably estimated. Gain contingencies are evaluated
and not recognized until the gain is realizable or realized.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<span></span>
</td>
<td class="text"><p id="xdx_840_eus-gaap--CommitmentsAndContingenciesPolicyTextBlock_zMAjVtdbmft2" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i><span id="xdx_861_znjPtJzomxrk">Contingencies</span></i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Liabilities
for loss contingencies arising from claims, assessments, litigations, fines and penalties and other sources are recognized when it is
probable that a liability has been incurred and the amount of the assessment can be reasonably estimated. Gain contingencies are evaluated
and not recognized until the gain is realizable or realized.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock', window );">Recent Accounting Pronouncements</a></td>
<td class="text"><p id="xdx_84A_eus-gaap--NewAccountingPronouncementsPolicyPolicyTextBlock_zLFMU2rpIkW6" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Recent
Accounting Pronouncements</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
August 5, 2020, the FASB issued ASU 2020-06, <i>Debt &#8211; Debt with Conversion and Other Options (Subtopic 470-20) and Derivatives
and Hedging &#8211; Contracts in Entity&#8217;s Own Equity (Subtopic 815-40)</i>, which simplifies the accounting for certain financial
instruments with characteristics of liabilities and equity, including convertible instruments and contracts on an entity&#8217;s own
equity. The ASU is part of the FASB&#8217;s simplification initiative, which aims to reduce unnecessary complexity in U.S. GAAP. ASU
2020-06 simplifies the guidance in U.S. GAAP on the issuer&#8217;s accounting for convertible debt instruments, requires entities to
provide expanded disclosures about &#8220;the terms and features of convertible instruments&#8221; and how the instruments have been
reported in the entity&#8217;s financial statements. It also removes from ASC 815-40-25-10 certain conditions for equity classification
and amends certain guidance in ASC 260, <i>Earnings per Share</i>, on the computation of EPS for convertible instruments and contracts
on an entity&#8217;s own equity. An entity can use either a full or modified retrospective approach to adopt the ASU&#8217;s guidance.
The ASU&#8217;s amendments are effective for smaller public business entities fiscal years beginning after December 15, 2023. The Company
does not expect the pronouncement to have a material impact on the Company and will disclose the nature and reason for any elections
that the Company makes.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>





<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>SHARPS
TECHNOLOGY, INC.</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTES
TO THE CONDENSED CONSOLIDATED FINANCIAL STATEMENTS</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>FOR
THE THREE AND NINE MONTHS ENDED SEPTEMBER 30, 2024 AND 2023</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Note
2. Summary of Significant Accounting Policies (continued)</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
December 2023, the FASB issued ASU 2023-09, <i>Income Taxes </i>(Topic 740)<i>: Improvements to Income Tax Disclosures</i>. The new guidance
requires disaggregated information about the effective tax rate reconciliation and additional information on taxes paid that meet a quantitative
threshold. The new guidance is effective for public companies for annual reporting periods beginning after December 15, 2024, a, with
early adoption permitted. The Company is currently evaluating the impacts of the new guidance on its disclosures within the consolidated
financial statements.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company does not expect the adoption of any accounting pronouncements to have a material impact on the condensed consolidated financial
statements.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
reviewed all other recently issued accounting pronouncements and have concluded they are not applicable or not expected to be significant
to the accounting for our operations.</span></p>

<span></span>
</td>
<td class="text"><p id="xdx_84E_eus-gaap--NewAccountingPronouncementsPolicyPolicyTextBlock_zC2pqT1WNqxh" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i><span id="xdx_868_z2mR3DbjnDI9">Recent
Accounting Pronouncements</span> </i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
August 5, 2020, the FASB issued ASU 2020-06, <i>Debt &#8211; Debt with Conversion and Other Options (Subtopic 470-20) and Derivatives
and Hedging &#8211; Contracts in Entity&#8217;s Own Equity (Subtopic 815-40)</i>, which simplifies the accounting for certain financial
instruments with characteristics of liabilities and equity, including convertible instruments and contracts on an entity&#8217;s own
equity. The ASU is part of the FASB&#8217;s simplification initiative, which aims to reduce unnecessary complexity in U.S. GAAP. ASU
2020-06 simplifies the guidance in U.S. GAAP on the issuer&#8217;s accounting for convertible debt instruments, requires entities to
provide expanded disclosures about &#8220;the terms and features of convertible instruments&#8221; and how the instruments have been
reported in the entity&#8217;s financial statements. It also removes from ASC 815-40-25-10 certain conditions for equity classification
and amends certain guidance in ASC 260, <i>Earnings per Share</i>, on the computation of EPS for convertible instruments and contracts
on an entity&#8217;s own equity. An entity can use either a full or modified retrospective approach to adopt the ASU&#8217;s guidance.
The ASU&#8217;s amendments are effective for smaller public business entities fiscal years beginning after December 15, 2023. The Company
is currently evaluating the impact of ASU 2020-06 on its consolidated financial statements and does not expect the adoption of this amended
guidance to have a material impact on the Company&#8217;s consolidated financial statements.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
December 2023, the FASB issued ASU 2023-09, <i>Income Taxes </i>(Topic 740)<i>: Improvements to Income Tax Disclosures</i>. The new guidance
requires disaggregated information about the effective tax rate reconciliation and additional information on taxes paid that meet a quantitative
threshold. The new guidance is effective for public companies for annual reporting periods beginning after December 15, 2024, and for
non-public companies for annual reporting periods beginning after December 15, 2025, with early adoption permitted for both. The Company
will adopt the new standard in the annual reporting period beginning after December 15, 2025 and is currently evaluating the impacts of the
new guidance on its disclosures within the consolidated financial statements.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company does not expect the adoption of any accounting pronouncements to have a material impact on the consolidated financial statements.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company reviewed all other recently issued accounting pronouncements and have concluded they are not applicable or not expected to be
significant to the accounting for our operations.</span></p>

<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BasisOfAccountingPolicyPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for basis of accounting, or basis of presentation, used to prepare the financial statements (for example, US Generally Accepted Accounting Principles, Other Comprehensive Basis of Accounting, IFRS).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BasisOfAccountingPolicyPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for cash and cash equivalents, including the policy for determining which items are treated as cash equivalents. Other information that may be disclosed includes (1) the nature of any restrictions on the entity's use of its cash and cash equivalents, (2) whether the entity's cash and cash equivalents are insured or expose the entity to credit risk, (3) the classification of any negative balance accounts (overdrafts), and (4) the carrying basis of cash equivalents (for example, at cost) and whether the carrying amount of cash equivalents approximates fair value.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482913/230-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingenciesPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for commitments and contingencies, which may include policies for recognizing and measuring loss and gain contingencies.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 954<br> -SubTopic 450<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477850/954-450-50-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 460<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482425/460-10-50-8<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingenciesPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CompensationRelatedCostsPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for salaries, bonuses, incentive awards, postretirement and postemployment benefits granted to employees, including equity-based arrangements; discloses methodologies for measurement, and the bases for recognizing related assets and liabilities and recognizing and reporting compensation expense.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CompensationRelatedCostsPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ComprehensiveIncomePolicyPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for comprehensive income.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ComprehensiveIncomePolicyPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativesPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for its derivative instruments and hedging activities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 815<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480434/815-10-50-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-9<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(n))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480434/815-10-50-1A<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480434/815-10-50-1<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480434/815-10-50-4<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480434/815-10-50-7<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativesPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerSharePolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for computing basic and diluted earnings or loss per share for each class of common stock and participating security. Addresses all significant policy factors, including any antidilutive items that have been excluded from the computation and takes into account stock dividends, splits and reverse splits that occur after the balance sheet date of the latest reporting period but before the issuance of the financial statements.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482662/260-10-50-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482662/260-10-50-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482662/260-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerSharePolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueMeasurementPolicyPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for fair value measurements of financial and non-financial assets, liabilities and instruments classified in shareholders' equity. Disclosures include, but are not limited to, how an entity that manages a group of financial assets and liabilities on the basis of its net exposure measures the fair value of those assets and liabilities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueMeasurementPolicyPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for (1) transactions denominated in a currency other than the reporting enterprise's functional currency, (2) translating foreign currency financial statements that are incorporated into the financial statements of the reporting enterprise by consolidation, combination, or the equity method of accounting, and (3) remeasurement of the financial statements of a foreign reporting enterprise in a hyperinflationary economy.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 830<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org/830/tableOfContent<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for recognizing and measuring the impairment of long-lived assets. An entity also may disclose its accounting policy for long-lived assets to be sold. This policy excludes goodwill and intangible assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 360<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 5.CC)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480091/360-10-S99-2<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 05<br> -Paragraph 4<br> -SubTopic 10<br> -Topic 360<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482338/360-10-05-4<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for income taxes, which may include its accounting policies for recognizing and measuring deferred tax assets and liabilities and related valuation allowances, recognizing investment tax credits, operating loss carryforwards, tax credit carryforwards, and other carryforwards, methodologies for determining its effective income tax rate and the characterization of interest and penalties in the financial statements.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 20<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-20<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 19<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-19<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 25<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482525/740-10-45-25<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-03(h)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479886/946-10-S99-3<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 17<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-17<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-9<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482525/740-10-45-28<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482765/220-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IntangibleAssetsFiniteLivedPolicy">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for finite-lived intangible assets. This accounting policy also might address: (1) the amortization method used; (2) the useful lives of such assets; and (3) how the entity assesses and measures impairment of such assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483426/235-10-50-4<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 350<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org/350-30/tableOfContent<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 926<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483154/926-20-50-5<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 920<br> -SubTopic 350<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478609/920-350-50-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 920<br> -SubTopic 350<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478609/920-350-50-1<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 920<br> -SubTopic 350<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478609/920-350-50-4<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IntangibleAssetsFiniteLivedPolicy</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of inventory accounting policy for inventory classes, including, but not limited to, basis for determining inventory amounts, methods by which amounts are added and removed from inventory classes, loss recognition on impairment of inventories, and situations in which inventories are stated above cost.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 330<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483080/330-10-50-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483489/210-10-50-1<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483426/235-10-50-4<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 912<br> -SubTopic 330<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478411/912-330-50-1<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 330<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org/330/tableOfContent<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 330<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483080/330-10-50-4<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 6<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 270<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482989/270-10-45-6<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy pertaining to new accounting pronouncements that may impact the entity's financial reporting. Includes, but is not limited to, quantification of the expected or actual impact.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for long-lived, physical asset used in normal conduct of business and not intended for resale. Includes, but is not limited to, work of art, historical treasure, and similar asset classified as collections.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -SubTopic 10<br> -Topic 360<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482099/360-10-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(8)(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478777/944-210-S99-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -SubTopic 360<br> -Topic 958<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477798/958-360-50-6<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -SubTopic 360<br> -Topic 958<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477798/958-360-50-1<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ResearchAndDevelopmentExpensePolicy">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for costs it has incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 730<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 05<br> -Paragraph 1<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483044/730-10-05-1<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ResearchAndDevelopmentExpensePolicy</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UseOfEstimates">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for the use of estimates in the preparation of financial statements in conformity with generally accepted accounting principles.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482861/275-10-50-9<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482861/275-10-50-4<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -SubTopic 10<br> -Topic 275<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482861/275-10-50-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -SubTopic 10<br> -Topic 275<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482861/275-10-50-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -SubTopic 10<br> -Topic 275<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482861/275-10-50-11<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12<br> -SubTopic 10<br> -Topic 275<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482861/275-10-50-12<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482861/275-10-50-8<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UseOfEstimates</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>128
<FILENAME>R26.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.4</span><table class="report" border="0" cellspacing="2" id="idm45095370730320">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Inventories (Tables)<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InventoryDisclosureAbstract', window );"><strong>Inventory Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfInventoryCurrentTableTextBlock', window );">Schedule of Inventories</a></td>
<td class="text"><p id="xdx_890_eus-gaap--ScheduleOfInventoryCurrentTableTextBlock_zJyitDEwqaL5" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Inventories,
net consisted of the following at:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;<span id="xdx_8BC_za1wZlN0pa45" style="display: none">Schedule of Inventories</span></span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" id="xdx_494_20240930_z6wmSvdcayr1" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">September
    30, 2024</span></td><td style="padding-bottom: 1pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" id="xdx_493_20231231_zRTyYvpNNmr6" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">December
    31, 2023</span></td><td style="padding-bottom: 1pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr id="xdx_400_eus-gaap--InventoryRawMaterialsNetOfReserves_iI_maINzcUe_zz0MVJIAfoy8" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 60%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Raw materials</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="width: 16%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">360,907</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="width: 16%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">254,461</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr id="xdx_409_eus-gaap--InventoryWorkInProcessNetOfReserves_iI_maINzcUe_zckDXbS9KQsl" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Work in process</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">140,025</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">170,464</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr id="xdx_40F_eus-gaap--InventoryFinishedGoodsNetOfReserves_iI_maINzcUe_zfUcsK9k3fpk" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Finished
    goods</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,518,549</span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,284,210</span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr id="xdx_406_eus-gaap--InventoryNet_iTI_mtINzcUe_zXulI952NDfb" style="vertical-align: bottom; background-color: White">
    <td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Total</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2,019,481</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,709,135</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  </table>

<span></span>
</td>
<td class="text"><p id="xdx_897_eus-gaap--ScheduleOfInventoryCurrentTableTextBlock_z3TdlfDLqDOh" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Inventories,
net consisted of the following at December 31, 2023 and 2022:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span id="xdx_8B6_zCRavWqfgD5i" style="display: none">Schedule of Inventories</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td style="text-align: center">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" id="xdx_499_20231231_zP3RLzx3Hdr8" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><p style="margin-top: 0pt; margin-bottom: 0pt">December 31,</p>
                                                                                <p style="margin-top: 0pt; margin-bottom: 0pt">2023</p></td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" id="xdx_494_20221231_zaiuNWHgSB5" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><p style="margin-top: 0pt; margin-bottom: 0pt">December 31,</p>
                                                                                <p style="margin-top: 0pt; margin-bottom: 0pt">2022</p></td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
  <tr id="xdx_400_eus-gaap--InventoryRawMaterialsNetOfReserves_iI_maINzcUe_zj891ZoM6wF1" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 60%; text-align: left">Raw materials</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 16%; text-align: right">254,461</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 16%; text-align: right">106,088</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr id="xdx_409_eus-gaap--InventoryWorkInProcessNetOfReserves_iI_maINzcUe_zl5kEwucRDCe" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Work in process</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">170,464</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">49,144</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40F_eus-gaap--InventoryFinishedGoodsNetOfReserves_iI_maINzcUe_zzZPgUwfNfLf" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1pt">Finished goods</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">1,284,210</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">30,572</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_406_eus-gaap--InventoryNet_iTI_mtINzcUe_zQlw3jmBTngg" style="vertical-align: bottom; background-color: White">
    <td style="padding-bottom: 1pt">Total</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">$</td><td style="border-bottom: Black 1pt solid; text-align: right">1,709,135</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">$</td><td style="border-bottom: Black 1pt solid; text-align: right">185,804</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  </table>

<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfInventoryCurrentTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the carrying amount as of the balance sheet date of merchandise, goods, commodities, or supplies held for future sale or to be used in manufacturing, servicing or production process.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6)(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6)(c))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483489/210-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfInventoryCurrentTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>129
<FILENAME>R27.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.4</span><table class="report" border="0" cellspacing="2" id="idm45095373020800">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Fixed Assets (Tables)<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentAbstract', window );"><strong>Property, Plant and Equipment [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentTextBlock', window );">Schedule of Fixed Assets, Net</a></td>
<td class="text"><p id="xdx_89E_eus-gaap--PropertyPlantAndEquipmentTextBlock_zGUMepEmbKal" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Fixed
assets, net, is summarized as follows as of:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;<span id="xdx_8B4_zpuDSeb8BhG1" style="display: none">Schedule of Fixed
Assets, Net</span></span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" id="xdx_49E_20240930_zrvXo9riwRKl" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">September
    30, 2024</span></td><td style="padding-bottom: 1pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" id="xdx_492_20231231_zvHyMLKogLBi" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">December
    31, 2023</span></td><td style="padding-bottom: 1pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr id="xdx_40A_eus-gaap--PropertyPlantAndEquipmentGross_iI_hus-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--LandMember_z1rTGl6pzuqc" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 60%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Land</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="width: 16%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">253,781</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="width: 16%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">260,460</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr id="xdx_402_eus-gaap--PropertyPlantAndEquipmentGross_iI_hus-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--BuildingMember_zyflhsFXGV5j" style="vertical-align: bottom; background-color: White">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Building</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2,949,900</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">3,022,490</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr id="xdx_406_eus-gaap--PropertyPlantAndEquipmentGross_iI_hus-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--MachineryAndEquipmentMember_zNLFIcNb5M7g" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Machinery and Equipment</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">4,730,617</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">4,464,317</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr id="xdx_40F_eus-gaap--PropertyPlantAndEquipmentGross_iI_hus-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--ComputerSystemsAndWebsiteAndOtherMember_z1Ova8mKjZO5" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Computer
    Systems and Website &amp; Other</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">290,662</span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">290,661</span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr id="xdx_40F_eus-gaap--PropertyPlantAndEquipmentGross_iI_maPPAENzHVU_zPE7Ix95vQ9a" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Total Fixed Assets</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">8,224,960</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">8,037,928</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr id="xdx_40E_eus-gaap--AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_iNI_di_msPPAENzHVU_zmpfKdrCxpAc" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Less:
    accumulated depreciation</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(1,991,365</span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(1,215,786</span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td></tr>
  <tr id="xdx_407_eus-gaap--PropertyPlantAndEquipmentNet_iTI_mtPPAENzHVU_zFNGJTNSCdXe" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Fixed
    asset, net</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">6,233,595</span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">6,822,142</span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  </table>

<span></span>
</td>
<td class="text"><p id="xdx_893_eus-gaap--PropertyPlantAndEquipmentTextBlock_zPUvEoseWjce" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Fixed
asset, net, as of December 31, 2023 and 2022, are summarized as follows:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;<span id="xdx_8B0_zAFXDcVkUXue" style="display: none">Schedule of Property, Plant and Equipment</span></span></span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 85%">
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" id="xdx_49F_20231231_zWFwv1Q28DAl" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><p style="margin-top: 0pt; margin-bottom: 0pt">December 31,</p>
                                                                                <p style="margin-top: 0pt; margin-bottom: 0pt">2023</p></td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2" id="xdx_49F_20221231_z3IwxSHnt11c" style="border-bottom: Black 1pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>December
31,</b></span></p>
                                                                                 <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>2022</b></span></p></td><td style="padding-bottom: 1pt">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: center">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: center">&#160;</td><td>&#160;</td></tr>
  <tr id="xdx_40A_eus-gaap--PropertyPlantAndEquipmentGross_iI_hus-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--LandMember_zMoBJf64Ur01" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 56%">Land</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 18%; text-align: right">260,460</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 18%; text-align: right">242,240</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr id="xdx_402_eus-gaap--PropertyPlantAndEquipmentGross_iI_hus-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--BuildingMember_zABltg7WUrg8" style="vertical-align: bottom; background-color: White">
    <td>Building</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">3,022,490</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">2,824,481</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_406_eus-gaap--PropertyPlantAndEquipmentGross_iI_hus-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--MachineryAndEquipmentMember_ziNklABgBeNb" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Machinery and Equipment</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">4,464,317</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">4,601,293</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_402_eus-gaap--PropertyPlantAndEquipmentGross_iI_hus-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--ComputerSystemsAndWebsiteAndOtherWebsiteMember_zUXGTRCvI5Hf" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1pt">Computer and Website</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">290,661</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">16,600</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_40F_eus-gaap--PropertyPlantAndEquipmentGross_iI_maPPAENzHVU_zO2D76mnsUuf" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>&#160;<span style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt">Total Fixed Assets</span> </td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">8,037,928</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">7,684,614</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_403_eus-gaap--AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_iNI_di_msPPAENzHVU_zaXpSGBuV5O7" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1pt">Less: accumulated depreciation</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(1,215,786</td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(679,724</td><td style="padding-bottom: 1pt; text-align: left">)</td></tr>
  <tr id="xdx_400_eus-gaap--PropertyPlantAndEquipmentNet_iTI_mtPPAENzHVU_zjZ9c7oVtg2e" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1pt">Fixed asset, net</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">$</td><td style="border-bottom: Black 1pt solid; text-align: right">6,822,142</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">$</td><td style="border-bottom: Black 1pt solid; text-align: right">7,004,890</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  </table>

<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of physical assets used in the normal conduct of business and not intended for resale. Includes, but is not limited to, balances by class of assets, depreciation and depletion expense and method used, including composite depreciation, and accumulated deprecation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -SubTopic 10<br> -Topic 360<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482099/360-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>130
<FILENAME>R28.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.4</span><table class="report" border="0" cellspacing="2" id="idm45095370853920">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Asset Acquisition (Tables)<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract', window );"><strong>Business Combination, Asset Acquisition, and Joint Venture Formation [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock', window );">Schedule of Fair Value of Assets Acquisition</a></td>
<td class="text"><p id="xdx_891_eus-gaap--ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock_zITHKT5SKAKj" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
relative fair value of the assets acquired and related deferred tax liability during 2022 was as follows:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span id="xdx_8BE_z5TwLTl3j1f" style="display: none">Schedule of Fair Value of  Assets Acquisition</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 70%">
  <tr style="display: none; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_497_20220706__us-gaap--BusinessAcquisitionAxis__custom--SafegardMedicalIncMember_zGwXKy86eZEl" style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_407_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLand_iI_maBCRIAzqVv_zG3wN4mZxHPc" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 80%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Land</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="width: 16%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">226,000</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr id="xdx_402_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment_iI_maBCRIAzqVv_z1rt3UafJmY8" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Building and affixed assets</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2,648,000</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr id="xdx_404_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedEquipment_iI_maBCRIAzqVv_zX1DNhQFnsO6" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Machinery</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">158,000</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr id="xdx_40A_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory_iI_maBCRIAzqVv_zdmKJ0iRHiZj" style="vertical-align: bottom; background-color: White">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Inventory</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">32,000</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr id="xdx_400_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles_iI_maBCRIAzqVv_zmc8vOTjXUl2" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Intangibles</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">64,712</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr id="xdx_40B_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities_iNI_di_msBCRIAzqVv_zVKCI8dWFBO9" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Deferred
    tax liability</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(192,000</span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr id="xdx_40B_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets_iTI_mtBCRIAzqVv_zNz4Et0NTls1" style="vertical-align: bottom; background-color: White">
    <td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Total</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2,936,712</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  </table>

<span></span>
</td>
<td class="text"><p id="xdx_897_eus-gaap--ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock_zYnRON4oCd9g" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
relative fair value of the assets acquired and related deferred tax liability is as follows:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify">&#160;<span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_8B4_zhBGM60lA9Y4" style="display: none">Schedule of Fair Value of the Assets Acquisition</span></span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 60%">
  <tr style="display: none; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_493_20220706__us-gaap--BusinessAcquisitionAxis__custom--SafegardMedicalIncMember_z8jfhEywzJwd" style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_407_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLand_iI_maBCRIAzqVv_zgKz5DNiWW1b" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 78%">Land</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 18%; text-align: right">226,000</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr id="xdx_407_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedBuildings_iI_maBCRIAzqVv_z4o0moTfk161" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Building and affixed assets</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">2,684,000</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_404_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedEquipment_iI_maBCRIAzqVv_zxo4Cnum8AIj" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>Machinery</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">158,000</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40A_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory_iI_maBCRIAzqVv_z8bi35VTpHfb" style="vertical-align: bottom; background-color: White">
    <td>Inventory</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">32,000</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_400_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles_iI_maBCRIAzqVv_zs0rD6bcn8G4" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>Intangibles</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">64,712</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40B_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities_iNI_di_msBCRIAzqVv_zY4qYyAyt4Md" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1pt">Deferred tax liability</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(192,000</td><td style="padding-bottom: 1pt; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40B_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets_iTI_mtBCRIAzqVv_zahGjZNGCkwk" style="vertical-align: bottom; background-color: White">
    <td style="padding-bottom: 1pt">Total</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">$</td><td style="border-bottom: Black 1pt solid; text-align: right">2,936,712</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  </table>

<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationAndAssetAcquisitionAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of a material business combination completed during the period, including background, timing, and recognized assets and liabilities. This table does not include leveraged buyouts.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479328/805-10-50-3<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479328/805-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>131
<FILENAME>R29.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.4</span><table class="report" border="0" cellspacing="2" id="idm45095369584352">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Other Assets (Tables)<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureAbstract', window );"><strong>Deferred Costs, Capitalized, Prepaid, and Other Assets Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfOtherAssetsTableTextBlock', window );">Schedule of Other Assets</a></td>
<td class="text"><p id="xdx_89D_eus-gaap--ScheduleOfOtherAssetsTableTextBlock_z0InxzEYOjck" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Other
assets as of September 30, 2024, and December 31, 2023 are summarized as follows:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span id="xdx_8B8_z1deStF3dQHc" style="display: none">Schedule of Other Assets</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" id="xdx_491_20240930_ziHbvl5Jyvj7" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">September
    30, 2024</span></td><td style="padding-bottom: 1pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" id="xdx_49C_20231231_ziJNYIIR20N8" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">December
    31, 2023</span></td><td style="padding-bottom: 1pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr id="xdx_403_eus-gaap--IntangibleAssetsNetExcludingGoodwill_iI_maOANzzDQ_z6mTdWXPecQl" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 60%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Intangibles, net &#8211; See Note 6</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="width: 16%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">40,227</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="width: 16%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">52,513</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr id="xdx_40D_eus-gaap--OtherAssetsMiscellaneousNoncurrent_iI_maOANzzDQ_zwGSSBFesi67" style="vertical-align: bottom; background-color: White">
    <td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Other &#8211; See Note 7</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">326,061</span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">76,062</span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr id="xdx_409_eus-gaap--OtherAssetsNoncurrent_iTI_mtOANzzDQ_zRCJl1BDGp56" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 1pt"><span style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;Total Other assets</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">366,288</span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">128,575</span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  </table>

<span></span>
</td>
<td class="text"><p id="xdx_89A_eus-gaap--ScheduleOfOtherAssetsTableTextBlock_zIGFjiFojy87" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Other
assets as of December 31, 2023 and 2022 are summarized as follows:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;<span id="xdx_8B9_zuK22lThk6sf" style="display: none">Schedule of Other Assets</span></span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 80%">
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" id="xdx_49F_20231231_z5bdXbgC7sBh" style="font-weight: bold; text-align: center">December 31,</td><td style="font-weight: bold">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" id="xdx_491_20221231_zaS8ZjMFTSd6" style="font-weight: bold; text-align: center">December 31,</td><td style="font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2023</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2022</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td></tr>
  <tr id="xdx_403_eus-gaap--IntangibleAssetsNetExcludingGoodwill_iI_maOANzzDQ_z3R17s4dQmzc" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 60%; text-align: left">Intangibles, net</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 16%; text-align: right">52,513</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 16%; text-align: right">62,480</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr id="xdx_401_eus-gaap--DepositsAssets_iI_maOANzzDQ_zMNSmwMjaYWa" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Deposits or advance payments on machinery, molds and components (see Note 15)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><p style="margin: 0"><span style="-sec-ix-hidden: xdx2ixbrl0738">-</span></p></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">336,466</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40C_eus-gaap--OtherAssetsMiscellaneousNoncurrent_iI_maOANzzDQ_zdth0WrOGOm8" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 1pt">Other</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">76,062</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">12,370</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_409_eus-gaap--OtherAssetsNoncurrent_iTI_mtOANzzDQ_zOelROCnvAn1" style="vertical-align: bottom; background-color: White">
    <td style="padding-bottom: 1pt"><span style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt">Other
    assets</span></td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">$</td><td style="border-bottom: Black 1pt solid; text-align: right">128,575</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">$</td><td style="border-bottom: Black 1pt solid; text-align: right">411,316</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  </table>

<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfOtherAssetsTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the carrying amounts of other assets. This disclosure includes other current assets and other noncurrent assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfOtherAssetsTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>132
<FILENAME>R30.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.4</span><table class="report" border="0" cellspacing="2" id="idm45095366720576">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Warrant Liability (Tables)<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock', window );">Schedule of Fair Value of Warrant</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text"><p id="xdx_897_eus-gaap--ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock_zaVNnRXOWKLh" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
fair value of stock option awards accounted for under ASC 718 was estimated at the date of grant using a Black-Scholes option-pricing
model with the following assumptions:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_8BB_zSEmShr3UWYk" style="display: none">Schedule
of Fair Value of Stock Option Awards</span></span></span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 90%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;&#160;</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></td>
    <td colspan="2" style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"><p style="margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: imes New Roman, Times, Serif; font-size: 10pt"><b>Year
                                            Ended <br/> December 31,</b></span></p>
                                                                                <p style="margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>2023</b></span></p></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></td>
    <td colspan="2" style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"><p style="margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: imes New Roman, Times, Serif; font-size: 10pt"><b>Year
                                            Ended <br/> December 31,</b></span></p>
                                                                                <p style="margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>2022</b></span></p></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Expected term (years)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_905_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_dtY_c20230101__20231231__srt--RangeAxis__srt--MinimumMember_zCwKHtEdnz3" title="Expected term (years)">2.88</span> to <span id="xdx_90B_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_dtY_c20230101__20231231__srt--RangeAxis__srt--MaximumMember_zZsfDdolkMLj" title="Expected term (years)">3.25</span></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90A_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_dtY_c20220101__20221231__srt--RangeAxis__srt--MinimumMember_zYZfHI8kOjj9" title="Expected term (years)">2.50</span> to <span id="xdx_903_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_dtY_c20220101__20221231__srt--RangeAxis__srt--MaximumMember_zE8ABMl1Ims5" title="Expected term (years)">3.00</span></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Expected volatility</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_900_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate_pid_dp_c20230101__20231231__srt--RangeAxis__srt--MinimumMember_zPnYpozJcvrf" title="Expected volatility">75.40</span>% to <span id="xdx_903_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate_pid_dp_c20230101__20231231__srt--RangeAxis__srt--MaximumMember_zGQCMRJibS6b" title="Expected volatility">89.93</span></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">%</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_907_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate_pid_dp_c20220101__20221231__srt--RangeAxis__srt--MinimumMember_zaSbi4LYP76j" title="Expected volatility">100.81</span>% to <span id="xdx_902_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate_pid_dp_c20220101__20221231__srt--RangeAxis__srt--MaximumMember_z1SLChj224j2" title="Expected volatility">110.74</span></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">%</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Risk-free interest rate</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90D_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_pid_dp_uPure_c20230101__20231231__srt--RangeAxis__srt--MinimumMember_zUNlHbmGIj35" title="Risk-free interest rate">3.71</span>% to <span id="xdx_908_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_pid_dp_uPure_c20230101__20231231__srt--RangeAxis__srt--MaximumMember_zLZSAvDhMWhe" title="Risk-free interest rate">4.27</span></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">%</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_907_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_pid_dp_uPure_c20220101__20221231__srt--RangeAxis__srt--MinimumMember_zPolfcc2Cfa3" title="Risk-free interest rate">2.90</span>% to <span id="xdx_90F_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_pid_dp_uPure_c20220101__20221231__srt--RangeAxis__srt--MaximumMember_zNO3zYXQfz4i" title="Risk-free interest rate">3.47</span></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">%</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 52%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Dividend rate</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 20%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90D_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_pid_dp_uPure_c20230101__20231231_zYPm6pxYJgwi" title="Dividend rate">0</span></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">%</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 20%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90D_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_pid_dp_uPure_c20220101__20221231_zWDNTz6ynvnd" title="Dividend rate">0</span></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">%</span></td></tr>
  </table>
<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_STSS_ScheduleOfWarrantLiabilityTableTextBlock', window );">Schedule of Warrant Liability</a></td>
<td class="text"><p id="xdx_89C_ecustom--ScheduleOfWarrantLiabilityTableTextBlock_zjFkl6PkXAg4" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Warrant liability at September 30, 2024 and December 31, 2023 was as follows:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span id="xdx_8B4_za9s8uaOy15c" style="display: none">Schedule
of Warrant Liability</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" id="xdx_496_20240930_ztB5zHqwIoE3" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">September
    30, 2024</span></td><td style="padding-bottom: 1pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" id="xdx_49B_20231231_ztgLDdeEkM03" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">December
    31, 2023</span></td><td style="padding-bottom: 1pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr id="xdx_408_ecustom--WarrantLiabilitiesCurrent_iI_hus-gaap--ClassOfWarrantOrRightAxis__custom--TradingAndOverallotmentWarrantsMember_zdShiQojQEQ5" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 60%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Trading and Overallotment
    Warrants</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="width: 16%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">431,250</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="width: 16%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,121,250</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr id="xdx_403_ecustom--WarrantLiabilitiesCurrent_iI_hus-gaap--ClassOfWarrantOrRightAxis__custom--NoteWarrantsMember_zpnqIbvwgih7" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Note Warrants</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">11,765</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">30,588</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr id="xdx_40D_ecustom--WarrantLiabilitiesCurrent_iI_hus-gaap--ClassOfWarrantOrRightAxis__custom--OfferingWarrantsFebruaryTwoThousandTwentyThreeMember_zyuTxZWwWzek" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Offering Warrants &#8211; February 2023</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">20,053</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">234,072</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr id="xdx_40B_ecustom--WarrantLiabilitiesCurrent_iI_hus-gaap--ClassOfWarrantOrRightAxis__custom--OfferingWarrantsSeptemberTwoThousandTwentyThreeMember_zZmHblQLt2bk" style="vertical-align: bottom; background-color: White">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Offering Warrants &#8211; September 2023</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">216,911</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,036,875</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr id="xdx_406_ecustom--WarrantLiabilitiesCurrent_iI_hus-gaap--ClassOfWarrantOrRightAxis__custom--InducementWarrantsMember_zzJAq6GcMpNd" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Inducement Warrants &#8211;
    May 2024</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">347,123</span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl2743">-</span></span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr id="xdx_405_ecustom--WarrantLiabilitiesCurrent_iI_z8j6MBigIaFc" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Total
    Warrant Liability</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,027,102</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2,422,785</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  </table>

<span></span>
</td>
<td class="text"><p id="xdx_89C_ecustom--ScheduleOfWarrantLiabilityTableTextBlock_zofZl5BvTDx9" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Warrant liability at December 31, 2023 and 2022 was as follows:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span><span id="xdx_8B1_zuJdiIA68dbg" style="display: none">Schedule
of Warrant Liability</span></span></span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 60%">
  <tr style="vertical-align: bottom">
    <td style="padding-bottom: 1pt">&#160;</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td>
    <td colspan="2" id="xdx_49B_20231231_z2NFHWe8Bhh1" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2023</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td>
    <td colspan="2" id="xdx_499_20221231_zOWC0nsZdO0d" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2022</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
  <tr id="xdx_404_ecustom--WarrantLiability_iI_hus-gaap--SubsidiarySaleOfStockAxis__custom--TradingAndOverallotmentWarrantsMember_zRBDDKBQ78E7" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 60%; text-align: left">Trading and Overallotment Warrants</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 16%; text-align: right">1,121,250</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 16%; text-align: right">1,121,250</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr id="xdx_40D_ecustom--WarrantLiability_iI_hus-gaap--SubsidiarySaleOfStockAxis__custom--NoteWarrantsMember_zYT4PuI8bfC9" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1pt">Note Warrants</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">30,588</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">30,588</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_407_ecustom--WarrantLiability_iI_hus-gaap--SubsidiarySaleOfStockAxis__custom--OfferingWarrantsFebruaryTwentyTwentyThreeMember_z1ffBxrNWm7k" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 1pt">Offering Warrants &#8211; February 2023</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">234,072</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl1011">-</span></span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_40B_ecustom--WarrantLiability_iI_hus-gaap--SubsidiarySaleOfStockAxis__custom--OfferingWarrantsSeptemberTwentyTwentyThreeMember_zhnUtscNzZ2f" style="vertical-align: bottom; background-color: White">
    <td style="padding-bottom: 1pt">Offering Warrants &#8211; September 2023</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">1,036,875</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1014">-</span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_40A_ecustom--WarrantLiability_iI_zzc2JuUB9pr4" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 2.5pt">Total Warrant Liability</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">2,422,785</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td style="border-bottom: Black 2.5pt double; text-align: right">1,151,838</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  </table>

<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock', window );">Schedule of Warrant Outstanding</a></td>
<td class="text"><p id="xdx_89E_eus-gaap--ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock_z7SUQBFelWU5" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Warrants outstanding at September 30, 2024 and December 31, 2023 were as follows:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span id="xdx_8BC_zh2iBmbU72ca" style="display: none">Schedule
of Warrant Outstanding</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" id="xdx_497_20240930_zmV3G9cnyhw9" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">September
    30, 2024</span></td><td style="padding-bottom: 1pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" id="xdx_49A_20231231_zDJP6QVAQr4h" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">December
    31,2023</span></td><td style="padding-bottom: 1pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr id="xdx_403_eus-gaap--ClassOfWarrantOrRightOutstanding_iI_hus-gaap--ClassOfWarrantOrRightAxis__custom--TradingAndOverallotmentWarrantsMember_zDhWk4Mq0iF6" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 60%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Trading,
    Overallotment and Underwriter Warrants</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="width: 16%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">400,568</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="width: 16%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">400,568</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr id="xdx_402_eus-gaap--ClassOfWarrantOrRightOutstanding_iI_hus-gaap--ClassOfWarrantOrRightAxis__custom--NoteWarrantsMember_zBW58NrZrqm7" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Note Warrants</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10,695</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10,695</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr id="xdx_40D_eus-gaap--ClassOfWarrantOrRightOutstanding_iI_hus-gaap--ClassOfWarrantOrRightAxis__custom--OfferingWarrantsFebruaryTwoThousandTwentyThreeMember_zVWcQ3pZzA8h" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Offering Warrants &#8211; February 2023</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">8,607</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">102,206</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr id="xdx_40F_eus-gaap--ClassOfWarrantOrRightOutstanding_iI_hus-gaap--ClassOfWarrantOrRightAxis__custom--OfferingWarrantsSeptemberTwoThousandTwentyThreeMember_zmnAWBb2GdWl" style="vertical-align: bottom; background-color: White">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Offering Warrants &#8211; September 2023</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">95,078</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">397,727</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr id="xdx_407_eus-gaap--ClassOfWarrantOrRightOutstanding_iI_hus-gaap--ClassOfWarrantOrRightAxis__custom--InducementWarrantsMayTwoThousandTwentyFourMember_zInelbDTIvz3" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Inducement Warrants &#8211; May 2024</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">260,799</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl2763">-</span></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr id="xdx_404_eus-gaap--ClassOfWarrantOrRightOutstanding_iI_hus-gaap--ClassOfWarrantOrRightAxis__custom--WarrantsIssuedForServiceManagementMember_zLy9ajQEohl9" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Warrants
    issued for services arrangement</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">28,636</span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">22,500</span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr id="xdx_404_ecustom--ClassOfWarrantsOrRightOutstanding_iI_zJQn2lMJMPx5" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Total
    Warrants Outstanding</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">804,383</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,194,495</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  </table>


<span></span>
</td>
<td class="text"><p id="xdx_89E_eus-gaap--ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock_z9SZsrKLqWS" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Warrants outstanding at December 31, 2023 and 2022 were as follows:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;<span id="xdx_8B8_zbnpCBFP3bg4" style="display: none">Schedule
of Warrant Outstanding</span></span></span></span></span></span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 80%">
  <tr style="vertical-align: bottom">
    <td style="padding-bottom: 1pt; text-align: center"><b>&#160;</b></td><td style="padding-bottom: 1pt; text-align: center"><b>&#160;</b></td>
    <td colspan="2" id="xdx_49A_20231231_zI5p3KsKabhh" style="border-bottom: Black 1pt solid; text-align: center"><p style="margin-top: 0pt; margin-bottom: 0pt"><b>December
                                            31,</b></p>
                                                                                <p style="margin-top: 0pt; margin-bottom: 0pt"><b>2023</b></p></td><td style="padding-bottom: 1pt; text-align: center"><b>&#160;</b></td><td style="padding-bottom: 1pt; text-align: center"><b>&#160;</b></td>
    <td colspan="2" id="xdx_496_20221231_zDuN70vGQSm4" style="border-bottom: Black 1pt solid; text-align: center"><p style="margin-top: 0pt; margin-bottom: 0pt"><b>December
                                            31,</b></p>
                                                                                <p style="margin-top: 0pt; margin-bottom: 0pt"><b>2022</b></p></td><td style="padding-bottom: 1pt; text-align: center"><b>&#160;</b></td></tr>
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: right">&#160;</td><td>&#160;</td></tr>
  <tr id="xdx_40D_eus-gaap--ClassOfWarrantOrRightOutstanding_iI_hus-gaap--SubsidiarySaleOfStockAxis__custom--TradingAndOverallotmentWarrantsMember_zSPQoDjVh74j" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 56%; text-align: left">Trading and Overallotment Warrants</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 18%; text-align: right">8,812,500</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 18%; text-align: right">8,812,500</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr id="xdx_400_eus-gaap--ClassOfWarrantOrRightOutstanding_iI_hus-gaap--SubsidiarySaleOfStockAxis__custom--NoteWarrantsMember_zo7OgdO4fGx1" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1pt">Note Warrants</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">235,294</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">235,294</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_400_eus-gaap--ClassOfWarrantOrRightOutstanding_iI_hus-gaap--SubsidiarySaleOfStockAxis__custom--OfferingWarrantsFebruaryTwentyTwentyThreeMember_zHoUIa6rrep2" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 1pt">Offering Warrants &#8211; February 2023</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">2,248,521</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><p style="margin: 0"><span style="-sec-ix-hidden: xdx2ixbrl1028">-</span></p></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_40E_eus-gaap--ClassOfWarrantOrRightOutstanding_iI_hus-gaap--SubsidiarySaleOfStockAxis__custom--OfferingWarrantsSeptemberTwentyTwentyThreeMember_zlCPbJattfxl" style="vertical-align: bottom; background-color: White">
    <td style="padding-bottom: 1pt">Offering Warrants &#8211; September 2023</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">8,750,003</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><p style="margin: 0"><span style="-sec-ix-hidden: xdx2ixbrl1031">-</span></p></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_40D_eus-gaap--ClassOfWarrantOrRightOutstanding_iI_hus-gaap--SubsidiarySaleOfStockAxis__custom--WarrantsIssuedForServiceManagementMember_zeaGnV6KO535" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1pt">Warrants issued for services arrangement</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">495,000</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl1034">-</span></span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_402_eus-gaap--ClassOfWarrantOrRightOutstanding_iI_zTXE7CeC9Zqd" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 2.5pt">Total Warrants Outstanding</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td style="border-bottom: Black 2.5pt double; text-align: right">20,541,318</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td style="border-bottom: Black 2.5pt double; text-align: right">9,047,794</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  </table>

<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock', window );">Schedule of Fair Value of Warrant</a></td>
<td class="text"><p id="xdx_89E_eus-gaap--FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock_znTUjMvgAGr4" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
fair value of stock option awards accounted for under ASC 718 was estimated at the date of grant using a Black-Scholes option-pricing
model with the following assumptions for the options granted during the nine months ended September 30, 2024 and 2023.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span id="xdx_8B1_zemRJhENtd4g" style="display: none">Schedule of Fair Value of Stock Option Awards</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">September
    30, 2024</span></td><td style="padding-bottom: 1pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">September
    30, 2023</span></td><td style="padding-bottom: 1pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Expected term (years)</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_909_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_dtY_c20240101__20240930__srt--RangeAxis__srt--MinimumMember_zpofHFkTvUsf" title="Expected term (years)">2.66</span>
                                            to <span id="xdx_90A_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_dtY_c20240101__20240930__srt--RangeAxis__srt--MaximumMember_zolyGV3PtPZ5" title="Expected term (years)">3.06</span></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_903_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_dtY_c20230101__20230930__srt--RangeAxis__srt--MinimumMember_zN1micCDOphd" title="Expected term (years)">2.88</span>
                                            to <span id="xdx_900_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_dtY_c20230101__20230930__srt--RangeAxis__srt--MaximumMember_zcXeelFA7zeh" title="Expected term (years)">3.25</span></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Expected volatility</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_901_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate_dp_c20240101__20240930__srt--RangeAxis__srt--MinimumMember_zOQH52I5tpA9" title="Expected volatility">81.15</span>
                                            % to <span id="xdx_908_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate_dp_c20240101__20240930__srt--RangeAxis__srt--MaximumMember_zQHMcjPuGP3k" title="Expected volatility">83.04</span></span></td><td style="text-align: left">%<span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90B_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate_dp_c20230101__20230930__srt--RangeAxis__srt--MinimumMember_zfVirIaCcnNe" title="Expected volatility">75.40</span>%
                                            to <span id="xdx_909_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate_dp_c20230101__20230930__srt--RangeAxis__srt--MaximumMember_zolNsqKQktLc" title="Expected volatility">89.93</span></span></td><td style="text-align: left">%</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Risk-free interest rate</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_905_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_dp_c20240101__20240930__srt--RangeAxis__srt--MinimumMember_zsKXsFrWFgcl" title="Risk-free interest rate">4.71</span>
                                            % to <span id="xdx_909_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_dp_c20240101__20240930__srt--RangeAxis__srt--MaximumMember_zEKLmLjcwsM4" title="Risk-free interest rate">4.76</span></span></td><td style="text-align: left">%</td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_906_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_dp_c20230101__20230930__srt--RangeAxis__srt--MinimumMember_zhWFSgQx7L9g" title="Risk-free interest rate">3.71</span>%
                                            to <span id="xdx_901_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_dp_c20230101__20230930__srt--RangeAxis__srt--MaximumMember_z5EFMmOaBfw8" title="Risk-free interest rate">4.27</span></span></td><td style="text-align: left">%</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="width: 60%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Dividend rate</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="width: 16%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_906_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_dp_c20240101__20240930_zVwLNuNFqGv3" title="Dividend rate">0</span></span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="width: 16%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_900_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_dp_c20230101__20230930_z6U4iGoN0Img" title="Dividend rate">0</span></span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  </table>

<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_WarrantMember', window );">Warrant [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock', window );">Schedule of Fair Value of Warrant</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text"><p id="xdx_898_eus-gaap--ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock_hus-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_z5jnmmRnTLx7" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_8B8_z3F43eQIYzn" style="display: none">Schedule
of Fair Value of Warrant</span></span></span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 80%">
  <tr style="vertical-align: bottom">
    <td style="text-align: center"><b>&#160;</b></td><td style="padding-bottom: 1pt"><b>&#160;</b></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"><p style="margin-top: 0pt; margin-bottom: 0pt"><b>Year Ended
                                            <br/> December 31,</b></p>
                                                                                <p style="margin-top: 0pt; margin-bottom: 0pt"><b>2023</b></p></td><td style="padding-bottom: 1pt"><b>&#160;</b></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Expected term (years)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_901_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_dtY_c20230101__20231231__srt--RangeAxis__srt--MinimumMember__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_zhDHBPzmJXlj" title="Expected term (in years)">4.10</span> to <span id="xdx_90E_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_dtY_c20230101__20231231__srt--RangeAxis__srt--MaximumMember__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_ziMLFjAReNCe" title="Expected term (in years)">5.50</span> </span></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Expected volatility</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_903_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_dp_c20230101__20231231__srt--RangeAxis__srt--MinimumMember__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_zs6weAVJO24l" title="Expected volatility">45.30</span>% to <span id="xdx_908_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_dp_c20230101__20231231__srt--RangeAxis__srt--MaximumMember__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_zOF8yLPihQW5" title="Expected volatility">70.44</span></span></td><td style="text-align: left">%</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Risk-free interest rate</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90F_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_dp_c20230101__20231231__srt--RangeAxis__srt--MinimumMember__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_zdXzuXI8kas6" title="Risk-free interest rate">3.53</span>% to <span id="xdx_908_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_dp_c20230101__20231231__srt--RangeAxis__srt--MaximumMember__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_ztxtPZ02OBVg" title="Risk-free interest rate">4.54</span></span></td><td style="text-align: left">%</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="width: 74%; text-align: left">Dividend rate</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 22%; text-align: right"><span id="xdx_909_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_dp_c20230101__20231231__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_zUjhAz4fKS7" title="Risk-free interest rate">0</span></td><td style="width: 1%; text-align: left">%</td></tr>
  </table>

<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock', window );">Schedule of Fair Value of Warrant</a></td>
<td class="text"><p id="xdx_893_eus-gaap--FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock_hus-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_zNfj4uwSz8Yc" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span id="xdx_8B0_z5C3vtvO3kFc" style="display: none">Schedule
of Fair Value of Warrant</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">September
    30, 2024</span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">September
    30, 2023</span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Expected
    term (years)</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_901_eus-gaap--WarrantsAndRightsOutstandingTerm_iI_dtY_c20240930__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputExpectedTermMember__srt--RangeAxis__srt--MinimumMember_zmXMpEpnfdA" title="Expected term (in years)">3.37</span>
                                            to <span id="xdx_907_eus-gaap--WarrantsAndRightsOutstandingTerm_iI_dtY_c20240930__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputExpectedTermMember__srt--RangeAxis__srt--MaximumMember_z2fbJCh3v6Z" title="Expected term (in years)">5.99</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_908_eus-gaap--WarrantsAndRightsOutstandingTerm_iI_dtY_c20230930__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputExpectedTermMember__srt--RangeAxis__srt--MinimumMember_zJ1OxdaSccMe" title="Expected term (in years)">4.36</span>
                                                                                                                                                                       to <span id="xdx_902_eus-gaap--WarrantsAndRightsOutstandingTerm_iI_dtY_c20230930__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputExpectedTermMember__srt--RangeAxis__srt--MaximumMember_zLlKEu3UkqD5" title="Expected term (in years)">5.5</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Expected
    volatility</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_903_eus-gaap--WarrantsAndRightsOutstandingMeasurementInput_iI_uPure_c20240930__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputOptionVolatilityMember__srt--RangeAxis__srt--MinimumMember_zXXVWT90ZRFe" title="Expected volatility">58.78</span>%
                                            to <span id="xdx_901_eus-gaap--WarrantsAndRightsOutstandingMeasurementInput_iI_uPure_c20240930__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputOptionVolatilityMember__srt--RangeAxis__srt--MaximumMember_zQzweK1Oo1sh" title="Expected volatility">121.32</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">%<span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90F_eus-gaap--WarrantsAndRightsOutstandingMeasurementInput_iI_uPure_c20230930__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputOptionVolatilityMember__srt--RangeAxis__srt--MinimumMember_zRv1T99jhtA4" title="Expected volatility">45.31</span>% to <span id="xdx_907_eus-gaap--WarrantsAndRightsOutstandingMeasurementInput_iI_uPure_c20230930__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputOptionVolatilityMember__srt--RangeAxis__srt--MaximumMember_zVYQVnOrBbRa" title="Expected volatility">59.93</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">%<span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Risk-free
    interest rate</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_904_eus-gaap--WarrantsAndRightsOutstandingMeasurementInput_iI_uPure_c20240930__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputRiskFreeInterestRateMember__srt--RangeAxis__srt--MinimumMember_zf5o1wA5v0Gi">3.41</span>%
                                            to <span id="xdx_903_eus-gaap--WarrantsAndRightsOutstandingMeasurementInput_iI_uPure_c20240930__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputRiskFreeInterestRateMember__srt--RangeAxis__srt--MaximumMember_z0Kke4FDIzn8">4.56</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">%<span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span id="xdx_904_eus-gaap--WarrantsAndRightsOutstandingMeasurementInput_iI_uPure_c20230930__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputRiskFreeInterestRateMember__srt--RangeAxis__srt--MinimumMember_zDCk21xxYKk" style="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.53
</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">to <span id="xdx_90C_eus-gaap--WarrantsAndRightsOutstandingMeasurementInput_iI_uPure_c20230930__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputRiskFreeInterestRateMember__srt--RangeAxis__srt--MaximumMember_z5zagmsUuQyc">4.54</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">%</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 60%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Dividend
    rate</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 16%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_909_eus-gaap--WarrantsAndRightsOutstandingMeasurementInput_iI_uPure_c20240930__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputExpectedDividendRateMember_zoaHYPOcVQj" title="Warrants liabilities measurement input">0</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 16%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90E_eus-gaap--WarrantsAndRightsOutstandingMeasurementInput_iI_uPure_c20230930__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputExpectedDividendRateMember_z51hakULv0cc" title="Warrants liabilities measurement input">0</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"></p>

<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_STSS_ScheduleOfWarrantLiabilityTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Schedule of warrant liability [Table Text Block]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">STSS_ScheduleOfWarrantLiabilityTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>STSS_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of input and valuation technique used to measure fair value and change in valuation approach and technique for each separate class of asset and liability measured on recurring and nonrecurring basis.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 103<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482078/820-10-55-103<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (bbb)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (bbb)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the significant assumptions used during the year to estimate the fair value of stock options, including, but not limited to: (a) expected term of share options and similar instruments, (b) expected volatility of the entity's shares, (c) expected dividends, (d) risk-free rate(s), and (e) discount for post-vesting restrictions.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 718<br> -SubTopic 10<br> -Subparagraph (f)(2)<br> -Name Accounting Standards Codification<br> -Paragraph 2<br> -Section 50<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of warrants or rights issued. Warrants and rights outstanding are derivative securities that give the holder the right to purchase securities (usually equity) from the issuer at a specific price within a certain time frame. Warrants are often included in a new debt issue to entice investors by a higher return potential. The main difference between warrants and call options is that warrants are issued and guaranteed by the company, whereas options are exchange instruments and are not issued by the company. Also, the lifetime of a warrant is often measured in years, while the lifetime of a typical option is measured in months. Disclose the title of issue of securities called for by warrants and rights outstanding, the aggregate amount of securities called for by warrants and rights outstanding, the date from which the warrants or rights are exercisable, and the price at which the warrant or right is exercisable.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_WarrantMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_WarrantMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>133
<FILENAME>R31.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.4</span><table class="report" border="0" cellspacing="2" id="idm45095357037312">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Stock Options (Tables)<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract', window );"><strong>Share-Based Payment Arrangement [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock', window );">Schedule of Stock Options Granted and Outstanding</a></td>
<td class="text"><p id="xdx_894_eus-gaap--ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock_zxVZC5fUQAHc" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">A
summary of options granted and outstanding is presented below.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span id="xdx_8BE_z8LJXVDUa9I7" style="display: none">Schedule
of Stock Options Granted and Outstanding</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="6" style="border-bottom: Black 1pt solid; text-align: center; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">September
    30, 2024</span></td><td style="padding-bottom: 1pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Options</span></td><td style="padding-bottom: 1pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Weighted<br/>
    Average<br/> Exercise Price</span></td><td style="padding-bottom: 1pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 60%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Outstanding at
    Beginning of year</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td id="xdx_980_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iS_c20240101__20240930_z5mTF4VY3CHf" style="width: 16%; text-align: right" title="Stock option, beginning balance"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">109,493</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td id="xdx_985_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iS_c20240101__20240930_zmy9UZAtMVBe" style="width: 16%; text-align: right" title="Weighted average exercise price, beginning balance"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">67.12</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Granted</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td id="xdx_98E_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_c20240101__20240930_zPZ4EPLTqSUg" style="text-align: right" title="Shares, options granted"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">63,409</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td id="xdx_981_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_c20240101__20240930_z1SpI7FuhVFh" style="text-align: right" title="Weighted average exercise price, options granted"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">6.27</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Forfeited
    or cancelled</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td id="xdx_98D_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_iN_di_c20240101__20240930_zkXYANERjSc1" style="border-bottom: Black 2.5pt double; text-align: right" title="Shares, options forfeited"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(18,592</span></td><td style="padding-bottom: 2.5pt; text-align: left">)<span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td id="xdx_985_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice_c20240101__20240930_zdZHHWPmlmme" style="border-bottom: Black 2.5pt double; text-align: right" title="Weighted average exercise price, forfeited or cancelled"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">37.11</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Outstanding at end of
    period</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td id="xdx_988_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iE_c20240101__20240930_zYq0CLHwEJqe" style="border-bottom: Black 2.5pt double; text-align: right" title="Stock option, ending balance"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">154,310</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_98B_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iE_c20240101__20240930_zKUWeRQybKq" style="border-bottom: Black 2.5pt double; text-align: right" title="Weighted average exercise price, ending balance"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">42.88</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Exercisable at end of
    period</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td id="xdx_981_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_iE_c20240101__20240930_zpmMa4vDkomg" style="border-bottom: Black 2.5pt double; text-align: right" title="Stock option, exercisable ending balance"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">122,243</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td id="xdx_98F_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_iE_c20240101__20240930_zpXujWLzQCOg" style="border-bottom: Black 2.5pt double; text-align: right" title="Weighted average exercise price, exercisable ending balance"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">50.86</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  </table>

<span></span>
</td>
<td class="text"><p id="xdx_894_eus-gaap--ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock_zxjRdzkmrjJa" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">A
summary of options granted and outstanding is presented below.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span><span id="xdx_8B2_zh8qQm1k4QP7" style="display: none">Schedule
of Stock Options Granted and Outstanding</span></span></span></span></span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="6" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2023</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="6" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2022</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Options</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Weighted<br/> Average<br/> Exercise <br/> Price</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Options</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Weighted<br/> Average<br/> Exercise <br/> Price</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 40%; text-align: left">Outstanding at Beginning of year</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td id="xdx_987_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionOutstandingNumber_iS_c20230101__20231231_zaUwzULDb3Bc" style="width: 11%; text-align: right" title="Stock option, beginning balance">1,358,122</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_987_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionOutstandingWeightedAverageExercisePrice_iS_c20230101__20231231_zNXsc1vFalU7" style="width: 11%; text-align: right" title="Weighted average exercise price, beginning balance">4.37</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td id="xdx_989_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iS_c20220101__20221231_zEpeaR5DmrI5" style="width: 11%; text-align: right" title="Stock option, beginning balance">1,137,479</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_98D_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iS_c20220101__20221231_zslpPQdBI7th" style="width: 11%; text-align: right" title="Weighted average exercise price, beginning balance">5.18</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td>Granted</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98B_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_c20230101__20231231_zjX1ZZxE5XLc" style="text-align: right" title="Shares, options granted">1,065,000</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_982_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_c20230101__20231231_z8uZ9XHkfcRh" style="text-align: right" title="Weighted average exercise price, options granted">1.35</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98D_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_c20220101__20221231_zh8BO9bo09Ll" style="text-align: right" title="Shares, options granted">367,500</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_989_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_c20220101__20221231_zdMAoRskatQ6" style="text-align: right" title="Weighted average exercise price, options granted">1.63</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>Cancelled</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_987_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod_iN_di_c20220101__20221231_zrwqbIejKl79" style="text-align: right" title="Shares, options cancelled">(3,571</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_989_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice_iN_di_c20220101__20221231_zdkd51rjznaf" style="text-align: right" title="Weighted average exercise price, options cancelled">(4.38</td><td style="text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-bottom: 1pt">Forfeited</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_98A_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedNumberOfShares_iN_di_c20230101__20231231_zxzNhmrWXAq7" style="border-bottom: Black 1pt solid; text-align: right" title="Shares, options forfeited">(14,286</td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">$</td><td id="xdx_984_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice_c20230101__20231231_zHLduwboIknd" style="border-bottom: Black 1pt solid; text-align: right" title="Weighted average exercise price, options forfeited">1.75</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_98E_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_iN_di_c20220101__20221231_zjHSUDyUObu4" style="border-bottom: Black 1pt solid; text-align: right" title="Shares, options forfeited">(143,286</td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">$</td><td id="xdx_98F_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice_iN_di_c20220101__20221231_zcid2FMo7Tpa" style="border-bottom: Black 1pt solid; text-align: right" title="Weighted average exercise price, options forfeited">(3.77</td><td style="padding-bottom: 1pt; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 2.5pt">Outstanding at end of year</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td id="xdx_987_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionOutstandingNumber_iE_c20230101__20231231_zEch1ZGM8U6k" style="border-bottom: Black 2.5pt double; text-align: right" title="Stock option, ending balance">2,408,836</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_981_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionOutstandingWeightedAverageExercisePrice_iE_c20230101__20231231_z6ygFRMgPhS" style="border-bottom: Black 2.5pt double; text-align: right" title="Weighted average exercise price, ending balance">3.03</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td id="xdx_98C_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iE_c20220101__20221231_zwehlMRbwH5g" style="border-bottom: Black 2.5pt double; text-align: right" title="Stock option, ending balance">1,358,122</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_982_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iE_c20220101__20221231_zzRFa28LDX26" style="border-bottom: Black 2.5pt double; text-align: right" title="Weighted average exercise price, ending balance">4.37</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 2.5pt">Exercisable at end of year</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td id="xdx_986_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_iE_c20230101__20231231_zKGeCfCEswbd" style="border-bottom: Black 2.5pt double; text-align: right" title="Stock option, exercisable">1,881,327</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_982_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_iE_c20230101__20231231_zG3VY1yrDYC1" style="border-bottom: Black 2.5pt double; text-align: right" title="Weighted average exercise price, exercisable">3.47</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td id="xdx_98E_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_iE_c20220101__20221231_zozaY861CnVe" style="border-bottom: Black 2.5pt double; text-align: right" title="Stock option, exercisable">1,132,861</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_98D_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_iE_c20220101__20221231_z7ewT5InYWcj" style="border-bottom: Black 2.5pt double; text-align: right" title="Weighted average exercise price, exercisable">4.59</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  </table>

<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTextBlock', window );">Schedule of Information About Options Outstanding</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text"><p id="xdx_896_eus-gaap--ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTextBlock_zyEjtYLsdPz3" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
following table summarizes information about options outstanding at December 31, 2023:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span><span id="xdx_8B9_ztchLltpVJe3" style="display: none">Schedule
of Information About Options Outstanding</span></span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 90%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td colspan="2" style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Exercise
    <br/>
    Prices</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></td>
    <td colspan="2" style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Options
    <br/>
    Outstanding</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></td>
    <td colspan="2" style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Aggregate<br/>
    Intrinsic Value</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></td>
    <td colspan="2" style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Weighted
    Average <br/>
    Remaining<br/>
    Contractual Life</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></td>
    <td colspan="2" style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Options
    <br/>
    Exercisable</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Aggregate</b></span></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Intrinsic
    Value<br/>
    on Exercisable<br/>
    Shares</b></span></p></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td colspan="2" style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 12%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_903_eus-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit_c20230101__20231231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeOneMember__srt--RangeAxis__srt--MinimumMember_zBCE1r4eLcAe" title="Stock option, exercise price">.82</span> to <span id="xdx_90E_eus-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit_c20230101__20231231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeOneMember__srt--RangeAxis__srt--MaximumMember_z4MAyw806t1h" title="Stock option, exercise price">.92</span></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td id="xdx_989_eus-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions_iI_c20231231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeOneMember_zeXCfV64B6X8" style="font: 10pt Times New Roman, Times, Serif; width: 12%; text-align: right" title="Options, shares outstanding"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">40,000</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td id="xdx_98A_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_iI_c20231231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeOneMember_zzO9XqLgXdkg" style="font: 10pt Times New Roman, Times, Serif; width: 14%; text-align: right" title="Stock option, aggregate intrinsic value">&#160;&#160;&#160;&#160;&#160;<span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl1135">-</span></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 14%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90A_eus-gaap--SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2_dtY_c20230101__20231231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeOneMember_z3n6ybZBvqUk" title="Stock option, weighted average remaining contractual life">4.58</span></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td id="xdx_98F_eus-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions_iI_c20231231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeOneMember_zVb4oEeNxaec" style="font: 10pt Times New Roman, Times, Serif; width: 12%; text-align: right" title="Options, shares exercisable"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">18,794</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td id="xdx_980_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1_iI_c20231231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeOneMember_zb0A1ijPx8A" style="font: 10pt Times New Roman, Times, Serif; width: 14%; text-align: right" title="Stock option, aggregate intrinsic value on exercisable shares">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl1141">-</span></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_907_eus-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit_c20230101__20231231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeTwoMember_zxQgIHiwv0Ld" title="Stock option, exercise price">1.21</span></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td id="xdx_98F_eus-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions_iI_c20231231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeTwoMember_zQrISQLiHbs9" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Options, shares outstanding"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">307,500</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td id="xdx_989_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_iI_c20231231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeTwoMember_z97JRxHuAKD4" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Stock option, aggregate intrinsic value"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl1147">-</span></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_908_eus-gaap--SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2_dtY_c20230101__20231231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeTwoMember_zj2yoK181UGi" title="Stock option, weighted average remaining contractual life">3.42</span></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td id="xdx_98D_eus-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions_iI_c20231231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeTwoMember_zATG1bSK1wc" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Options, shares exercisable"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">240,386</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td id="xdx_98A_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1_iI_c20231231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeTwoMember_zxoxvZBfRNf6" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Stock option, aggregate intrinsic value on exercisable shares"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl1153">-</span></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_903_eus-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit_c20230101__20231231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeThreeMember_zJbONXr9NGce" title="Stock option, exercise price">1.30</span></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td id="xdx_984_eus-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions_iI_c20231231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeThreeMember_zsdLopjx0gdf" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Options, shares outstanding"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">50,000</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td id="xdx_983_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_iI_c20231231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeThreeMember_zfhQwORB1ved" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Stock option, aggregate intrinsic value"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl1159">-</span></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_903_eus-gaap--SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2_dtY_c20230101__20231231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeThreeMember_zEjbzr5a5Ubd" title="Stock option, weighted average remaining contractual life">4.21</span></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td id="xdx_988_eus-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions_iI_c20231231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeThreeMember_zAb9C5wh3HWd" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Options, shares exercisable"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">43,750</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td id="xdx_98C_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1_iI_c20231231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeThreeMember_zKIzzXyAHRre" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Stock option, aggregate intrinsic value on exercisable shares"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl1165">-</span></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_902_eus-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit_c20230101__20231231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeFourMember_zcNnTjlC5kDk" title="Stock option, exercise price">1.37</span></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td id="xdx_986_eus-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions_iI_c20231231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeFourMember_zjZBlmx33Pla" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Options, shares outstanding"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">975,000</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td id="xdx_984_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_iI_c20231231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeFourMember_zPmnrEYyYZD" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Stock option, aggregate intrinsic value"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl1171">-</span></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90A_eus-gaap--SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2_dtY_c20230101__20231231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeFourMember_zWykEPseBCKf" title="Stock option, weighted average remaining contractual life">4.17</span></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td id="xdx_985_eus-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions_iI_c20231231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeFourMember_zec5JlVXfHI" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Options, shares exercisable"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">561,719</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td id="xdx_983_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1_iI_c20231231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeFourMember_zodRTTHznA4e" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Stock option, aggregate intrinsic value on exercisable shares"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl1177">-</span></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_908_eus-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit_c20230101__20231231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeFiveMember_zyIYAAlOEMPl" title="Stock option, exercise price">1.75</span></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td id="xdx_988_eus-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions_iI_c20231231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeFiveMember_zQptYFhsXte4" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Options, shares outstanding"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">54,285</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td id="xdx_981_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_iI_c20231231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeFiveMember_zo1fFXH87n81" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Stock option, aggregate intrinsic value"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl1183">-</span></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_906_eus-gaap--SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2_dtY_c20230101__20231231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeFiveMember_zFcQNivy35Be" title="Stock option, weighted average remaining contractual life">2.25</span></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: right"></p>
    <p id="xdx_98F_eus-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions_iI_c20231231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeFiveMember_zzi5h6q58LCd" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: right" title="Options, shares exercisable"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">54,285</span></p></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td id="xdx_981_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1_iI_c20231231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeFiveMember_zO1AmwXzm5oc" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Stock option, aggregate intrinsic value on exercisable shares"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl1189">-</span></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90F_eus-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit_c20230101__20231231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeSixMember_zL6tgR1vlWN4" title="Stock option, exercise price">2.80</span></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td id="xdx_98D_eus-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions_iI_c20231231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeSixMember_z1ijSAqahwj2" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Options, shares outstanding"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">141,429</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td id="xdx_988_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_iI_c20231231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeSixMember_zsYNwWzfoq9j" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Stock option, aggregate intrinsic value"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl1195">-</span></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90F_eus-gaap--SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2_dtY_c20230101__20231231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeSixMember_zsCLsRLdkKyh" title="Stock option, weighted average remaining contractual life">2.25</span></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td id="xdx_98C_eus-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions_iI_c20231231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeSixMember_zsdstAMVSRJ8" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Options, shares exercisable"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">141,429</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td id="xdx_98A_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1_iI_c20231231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeSixMember_z9tgdx3ulgGg" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Stock option, aggregate intrinsic value on exercisable shares"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl1201">-</span></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_900_eus-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit_c20230101__20231231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeSevenMember_zDANi0kfYtca" title="Stock option, exercise price">1.39</span></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td id="xdx_98B_eus-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions_iI_c20231231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeSevenMember_zpCZb5xXKeW4" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Options, shares outstanding"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10,000</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td id="xdx_985_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_iI_c20231231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeSevenMember_zUu60m0y0Tq7" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Stock option, aggregate intrinsic value"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl1207">-</span></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_903_eus-gaap--SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2_dtY_c20230101__20231231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeSevenMember_zgxXTuK5Yk09" title="Stock option, weighted average remaining contractual life">3.75</span></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td id="xdx_987_eus-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions_iI_c20231231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeSevenMember_zvlXcHh2AFB2" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Options, shares exercisable"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10,000</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td id="xdx_98A_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1_iI_c20231231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeSevenMember_zKme8A1lT2Le" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Stock option, aggregate intrinsic value on exercisable shares"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl1213">-</span></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_906_eus-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit_c20230101__20231231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeEightMember_zIGBcB7uZsOe" title="Stock option, exercise price">4.25</span></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td id="xdx_98B_eus-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions_iI_c20231231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeEightMember_zBBjbohhBN6j" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Options, shares outstanding"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">50,000</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td id="xdx_98D_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_iI_c20231231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeEightMember_zcz5sVnxPIbc" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Stock option, aggregate intrinsic value"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl1219">-</span></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_909_eus-gaap--SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2_dtY_c20230101__20231231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeEightMember_zrO1ZuGNb9R8" title="Stock option, weighted average remaining contractual life">3.75</span></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td id="xdx_989_eus-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions_iI_c20231231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeEightMember_zE2PWB9ZoCf9" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Options, shares exercisable"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">50,000</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td id="xdx_980_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1_iI_c20231231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeEightMember_z8KaCTDq5sw6" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Stock option, aggregate intrinsic value on exercisable shares"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl1225">-</span></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90C_eus-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit_c20230101__20231231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeNineMember_zg6IcBmTQjU3" title="Stock option, exercise price">4.38</span></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td id="xdx_98C_eus-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions_iI_c20231231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeNineMember_zq47EDyJeyF1" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Options, shares outstanding"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">244,286</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td id="xdx_981_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_iI_c20231231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeNineMember_ziqdd7G72LNh" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Stock option, aggregate intrinsic value"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl1231">-</span></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_902_eus-gaap--SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2_dtY_c20230101__20231231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeNineMember_ztN3xB6cqDx6" title="Stock option, weighted average remaining contractual life">1.25</span></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td id="xdx_981_eus-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions_iI_c20231231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeNineMember_z0Xhb2DgSedh" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Options, shares exercisable"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">244,286</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td id="xdx_987_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1_iI_c20231231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeNineMember_z2OxjzEZCZ4g" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Stock option, aggregate intrinsic value on exercisable shares"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl1237">-</span></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_903_eus-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit_c20230101__20231231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeTenMember_z65Kidvx3JX3" title="Stock option, exercise price">7.00</span></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td id="xdx_983_eus-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions_iI_c20231231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeTenMember_zrWWgPsF0bfc" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Options, shares outstanding"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">536,335</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td id="xdx_98C_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_iI_c20231231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeTenMember_zFvHlCXX4VM9" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Stock option, aggregate intrinsic value"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl1243">-</span></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_904_eus-gaap--SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2_dtY_c20230101__20231231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeTenMember_zsSwHVvDh4Z6" title="Stock option, weighted average remaining contractual life">2.00</span></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td id="xdx_986_eus-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions_iI_c20231231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeTenMember_zEku6u3Bb35h" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Options, shares exercisable"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">516,679</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td id="xdx_986_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1_iI_c20231231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeTenMember_zT2dgOLkzh3" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Stock option, aggregate intrinsic value on exercisable shares"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl1249">-</span></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  </table>
<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock', window );">Schedule of Fair Value of Stock Option Awards</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text"><p id="xdx_897_eus-gaap--ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock_zaVNnRXOWKLh" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
fair value of stock option awards accounted for under ASC 718 was estimated at the date of grant using a Black-Scholes option-pricing
model with the following assumptions:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_8BB_zSEmShr3UWYk" style="display: none">Schedule
of Fair Value of Stock Option Awards</span></span></span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 90%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;&#160;</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></td>
    <td colspan="2" style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"><p style="margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: imes New Roman, Times, Serif; font-size: 10pt"><b>Year
                                            Ended <br/> December 31,</b></span></p>
                                                                                <p style="margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>2023</b></span></p></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></td>
    <td colspan="2" style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"><p style="margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: imes New Roman, Times, Serif; font-size: 10pt"><b>Year
                                            Ended <br/> December 31,</b></span></p>
                                                                                <p style="margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>2022</b></span></p></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Expected term (years)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_905_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_dtY_c20230101__20231231__srt--RangeAxis__srt--MinimumMember_zCwKHtEdnz3" title="Expected term (years)">2.88</span> to <span id="xdx_90B_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_dtY_c20230101__20231231__srt--RangeAxis__srt--MaximumMember_zZsfDdolkMLj" title="Expected term (years)">3.25</span></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90A_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_dtY_c20220101__20221231__srt--RangeAxis__srt--MinimumMember_zYZfHI8kOjj9" title="Expected term (years)">2.50</span> to <span id="xdx_903_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_dtY_c20220101__20221231__srt--RangeAxis__srt--MaximumMember_zE8ABMl1Ims5" title="Expected term (years)">3.00</span></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Expected volatility</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_900_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate_pid_dp_c20230101__20231231__srt--RangeAxis__srt--MinimumMember_zPnYpozJcvrf" title="Expected volatility">75.40</span>% to <span id="xdx_903_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate_pid_dp_c20230101__20231231__srt--RangeAxis__srt--MaximumMember_zGQCMRJibS6b" title="Expected volatility">89.93</span></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">%</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_907_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate_pid_dp_c20220101__20221231__srt--RangeAxis__srt--MinimumMember_zaSbi4LYP76j" title="Expected volatility">100.81</span>% to <span id="xdx_902_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate_pid_dp_c20220101__20221231__srt--RangeAxis__srt--MaximumMember_z1SLChj224j2" title="Expected volatility">110.74</span></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">%</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Risk-free interest rate</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90D_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_pid_dp_uPure_c20230101__20231231__srt--RangeAxis__srt--MinimumMember_zUNlHbmGIj35" title="Risk-free interest rate">3.71</span>% to <span id="xdx_908_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_pid_dp_uPure_c20230101__20231231__srt--RangeAxis__srt--MaximumMember_zLZSAvDhMWhe" title="Risk-free interest rate">4.27</span></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">%</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_907_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_pid_dp_uPure_c20220101__20221231__srt--RangeAxis__srt--MinimumMember_zPolfcc2Cfa3" title="Risk-free interest rate">2.90</span>% to <span id="xdx_90F_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_pid_dp_uPure_c20220101__20221231__srt--RangeAxis__srt--MaximumMember_zNO3zYXQfz4i" title="Risk-free interest rate">3.47</span></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">%</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 52%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Dividend rate</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 20%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90D_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_pid_dp_uPure_c20230101__20231231_zYPm6pxYJgwi" title="Dividend rate">0</span></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">%</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 20%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90D_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_pid_dp_uPure_c20220101__20221231_zWDNTz6ynvnd" title="Dividend rate">0</span></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">%</span></td></tr>
  </table>
<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock', window );">Schedule of Fair Value of Stock Option Awards</a></td>
<td class="text"><p id="xdx_89E_eus-gaap--FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock_znTUjMvgAGr4" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
fair value of stock option awards accounted for under ASC 718 was estimated at the date of grant using a Black-Scholes option-pricing
model with the following assumptions for the options granted during the nine months ended September 30, 2024 and 2023.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span id="xdx_8B1_zemRJhENtd4g" style="display: none">Schedule of Fair Value of Stock Option Awards</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">September
    30, 2024</span></td><td style="padding-bottom: 1pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">September
    30, 2023</span></td><td style="padding-bottom: 1pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Expected term (years)</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_909_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_dtY_c20240101__20240930__srt--RangeAxis__srt--MinimumMember_zpofHFkTvUsf" title="Expected term (years)">2.66</span>
                                            to <span id="xdx_90A_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_dtY_c20240101__20240930__srt--RangeAxis__srt--MaximumMember_zolyGV3PtPZ5" title="Expected term (years)">3.06</span></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_903_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_dtY_c20230101__20230930__srt--RangeAxis__srt--MinimumMember_zN1micCDOphd" title="Expected term (years)">2.88</span>
                                            to <span id="xdx_900_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_dtY_c20230101__20230930__srt--RangeAxis__srt--MaximumMember_zcXeelFA7zeh" title="Expected term (years)">3.25</span></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Expected volatility</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_901_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate_dp_c20240101__20240930__srt--RangeAxis__srt--MinimumMember_zOQH52I5tpA9" title="Expected volatility">81.15</span>
                                            % to <span id="xdx_908_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate_dp_c20240101__20240930__srt--RangeAxis__srt--MaximumMember_zQHMcjPuGP3k" title="Expected volatility">83.04</span></span></td><td style="text-align: left">%<span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90B_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate_dp_c20230101__20230930__srt--RangeAxis__srt--MinimumMember_zfVirIaCcnNe" title="Expected volatility">75.40</span>%
                                            to <span id="xdx_909_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate_dp_c20230101__20230930__srt--RangeAxis__srt--MaximumMember_zolNsqKQktLc" title="Expected volatility">89.93</span></span></td><td style="text-align: left">%</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Risk-free interest rate</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_905_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_dp_c20240101__20240930__srt--RangeAxis__srt--MinimumMember_zsKXsFrWFgcl" title="Risk-free interest rate">4.71</span>
                                            % to <span id="xdx_909_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_dp_c20240101__20240930__srt--RangeAxis__srt--MaximumMember_zEKLmLjcwsM4" title="Risk-free interest rate">4.76</span></span></td><td style="text-align: left">%</td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_906_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_dp_c20230101__20230930__srt--RangeAxis__srt--MinimumMember_zhWFSgQx7L9g" title="Risk-free interest rate">3.71</span>%
                                            to <span id="xdx_901_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_dp_c20230101__20230930__srt--RangeAxis__srt--MaximumMember_z5EFMmOaBfw8" title="Risk-free interest rate">4.27</span></span></td><td style="text-align: left">%</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="width: 60%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Dividend rate</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="width: 16%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_906_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_dp_c20240101__20240930_zVwLNuNFqGv3" title="Dividend rate">0</span></span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="width: 16%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_900_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_dp_c20230101__20230930_z6U4iGoN0Img" title="Dividend rate">0</span></span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  </table>

<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of input and valuation technique used to measure fair value and change in valuation approach and technique for each separate class of asset and liability measured on recurring and nonrecurring basis.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 103<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482078/820-10-55-103<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (bbb)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (bbb)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of option exercise prices, by grouped ranges, including the upper and lower limits of the price range, the number of shares under option, weighted average exercise price and remaining contractual option terms.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure for stock option plans. Includes, but is not limited to, outstanding awards at beginning and end of year, grants, exercises, forfeitures, and weighted-average grant date fair value.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)<br> -SubTopic 10<br> -Topic 718<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)<br> -SubTopic 10<br> -Topic 718<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the significant assumptions used during the year to estimate the fair value of stock options, including, but not limited to: (a) expected term of share options and similar instruments, (b) expected volatility of the entity's shares, (c) expected dividends, (d) risk-free rate(s), and (e) discount for post-vesting restrictions.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 718<br> -SubTopic 10<br> -Subparagraph (f)(2)<br> -Name Accounting Standards Codification<br> -Paragraph 2<br> -Section 50<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>134
<FILENAME>R32.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.4</span><table class="report" border="0" cellspacing="2" id="idm45095246680208">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Income Taxes (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureAbstract', window );"><strong>Income Tax Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock', window );">Schedule of Reconciliation of Federal Statutory Rate to Total Effective Rate</a></td>
<td class="text"><p id="xdx_89F_eus-gaap--ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock_zGYVk5GmxaCd" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span><span id="xdx_8B4_zqY6jMnLLYnl" style="display: none">Schedule
of Reconciliation of Federal Statutory Rate to Total Effective Rate</span></span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 70%">
  <tr style="vertical-align: bottom">
    <td><b>&#160;</b></td><td><b>&#160;</b></td>
    <td colspan="2" id="xdx_495_20230101__20231231_z0UDmBlLfCNf" style="text-align: center"><b>Year Ended</b></td><td><b>&#160;</b></td><td><b>&#160;</b></td>
    <td colspan="2" id="xdx_49F_20220101__20221231_zoxx9DBcUfgb" style="text-align: center"><b>Year Ended</b></td><td><b>&#160;</b></td></tr>
  <tr style="vertical-align: bottom">
    <td><b>&#160;</b></td><td style="padding-bottom: 1pt"><b>&#160;</b></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"><b>December 31, 2023</b></td><td style="padding-bottom: 1pt"><b>&#160;</b></td><td style="padding-bottom: 1pt"><b>&#160;</b></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"><b>December 31, 2022</b></td><td style="padding-bottom: 1pt"><b>&#160;</b></td></tr>
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: right">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: right">&#160;</td><td>&#160;</td></tr>
  <tr id="xdx_408_eus-gaap--IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate_maITEBzVgo_zsoxYDO4XEEc" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 56%; text-align: left">Expected benefit at statutory federal tax rate</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 18%; text-align: right">(2,073,230</td><td style="width: 1%; text-align: left">)</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 18%; text-align: right">(974,329</td><td style="width: 1%; text-align: left">)</td></tr>
  <tr id="xdx_40A_eus-gaap--IncomeTaxReconciliationChangeInEnactedTaxRate_maITEBzVgo_zKbB9nlMYVCh" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Permanent differences &#8211; net</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(35,469</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(859,515</td><td style="text-align: left">)</td></tr>
  <tr id="xdx_40B_eus-gaap--IncomeTaxReconciliationStateAndLocalIncomeTaxes_maITEBzVgo_zJ9nwI8YtwXc" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">State and local taxes, net of federal tax benefit</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1311">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(265,607</td><td style="text-align: left">)</td></tr>
  <tr id="xdx_404_eus-gaap--IncomeTaxReconciliationOtherAdjustments_maITEBzVgo_zIb7QHZpsA5k" style="vertical-align: bottom; background-color: White">
    <td>Other</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(24,569</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(21,965</td><td style="text-align: left">)</td></tr>
  <tr id="xdx_40B_eus-gaap--IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance_maITEBzVgo_zsw2QihYgKd8" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1pt">Change in valuation allowance</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">2,103,268</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">2,121,416</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_40A_eus-gaap--IncomeTaxExpenseBenefit_iT_mtITEBzVgo_zytKKJ8oxzZ8" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 2.5pt">Income tax expense (benefit)</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">(30,000</td><td style="padding-bottom: 2.5pt; text-align: left">)</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1321">-</span></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  </table>

<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock', window );">Schedule of Components of Deferred tax Assets</a></td>
<td class="text"><p id="xdx_890_eus-gaap--ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock_zGiKRNi3lW48" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
components of the Company&#8217;s deferred tax assets (liabilities) are as follows:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span><span id="xdx_8BD_zqVlxRt6W36c" style="display: none">Schedule
of Components of Deferred tax Assets</span></span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 70%">
  <tr style="vertical-align: bottom">
    <td><b>&#160;</b></td><td style="padding-bottom: 1pt"><b>&#160;</b></td>
    <td colspan="2" id="xdx_49B_20231231_z0J5g5RXGe7k" style="border-bottom: Black 1pt solid; text-align: center"><b>Year Ended <br/> December 31, <br/> 2023</b></td><td style="padding-bottom: 1pt"><b>&#160;</b></td><td style="padding-bottom: 1pt"><b>&#160;</b></td>
    <td colspan="2" id="xdx_499_20221231_ze9k3w767yP7" style="border-bottom: Black 1pt solid; text-align: center"><b>Year Ended <br/> December 31, <br/> 2022</b></td><td style="padding-bottom: 1pt"><b>&#160;</b></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Deferred tax assets (liabilities):</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40A_ecustom--DeferredTaxAssetsPropertyPlantAndEquipments_iI_msDTLzq2T_zTwV5gIYuNc2" style="vertical-align: bottom; background-color: White">
    <td style="width: 56%; text-align: left">Fixed assets</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 18%; text-align: right">(281,073</td><td style="width: 1%; text-align: left">)</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 18%; text-align: right">(268,594</td><td style="width: 1%; text-align: left">)</td></tr>
  <tr id="xdx_409_eus-gaap--DeferredTaxAssetInterestCarryforward_iI_msDTLzq2T_z96ErXhSyqjb" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>Interest</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">35,178</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">62,310</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_409_eus-gaap--DeferredTaxAssetsInProcessResearchAndDevelopment_iI_msDTLzq2T_z7ulqOLfvNJ4" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Research and development expenses</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">400,810</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">454,942</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_401_eus-gaap--DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost_iI_msDTLzq2T_zEB6thclwJQ" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Stock-based compensation</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">895,509</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">917,351</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_407_eus-gaap--DeferredTaxAssetsCharitableContributionCarryforwards_iI_msDTLzq2T_zq5rACDRarhh" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Charitable Contributions</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">420</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_402_eus-gaap--DeferredTaxAssetsOperatingLossCarryforwardsDomestic_iI_msDTLzq2T_zmMXtHjgfas9" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Net operating losses - federal</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">4,456,242</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">2,898,411</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_405_eus-gaap--DeferredTaxAssetsOperatingLossCarryforwardsStateAndLocal_iI_msDTLzq2T_z44uMVdhXKF2" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Net operating losses &#8211; state and local</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">543,264</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">921,350</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40E_eus-gaap--DeferredTaxAssetsOperatingLossCarryforwardsForeign_iI_msDTLzq2T_zzGEKTr8ul1c" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Net operating losses - foreign</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">233,114</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">37,686</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40C_eus-gaap--DeferredTaxAssetsTaxCreditCarryforwardsResearch_iI_msDTLzq2T_zTWDpY8yRTj3" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1pt">Research credit</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">28,985</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">28,985</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_403_eus-gaap--DeferredTaxAssetsValuationAllowance_iNI_di_maDTLzq2T_ziUKAGcGlkJ5" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1pt">Less valuation allowance</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(6,474,449</td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(5,244,441</td><td style="padding-bottom: 1pt; text-align: left">)</td></tr>
  <tr id="xdx_40C_eus-gaap--DeferredTaxLiabilities_iNTI_di_mtDTLzq2T_zkOxNhILOU8e" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 2.5pt">Net deferred tax liability</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">(162,000</td><td style="padding-bottom: 2.5pt; text-align: left">)</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">(192,000</td><td style="padding-bottom: 2.5pt; text-align: left">)</td></tr>
  </table>

<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock', window );">Schedule of Geographical Components of Loss Before Income Taxes</a></td>
<td class="text"><p id="xdx_896_eus-gaap--ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock_zBaxIPJlllzi" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
geographical components of loss before income taxes consisted of the following for the years ended December 31:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span><span id="xdx_8B9_zO1BxVr7Nt6j" style="display: none">Schedule
of Geographical Components of Loss Before Income Taxes</span></span></span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 80%">
  <tr style="vertical-align: bottom">
    <td><b>&#160;</b></td><td><b>&#160;</b></td>
    <td colspan="2" id="xdx_496_20230101__20231231_z8rQAVv08OLf" style="text-align: center"><b>Year Ended</b></td><td><b>&#160;</b></td><td><b>&#160;</b></td>
    <td colspan="2" id="xdx_494_20220101__20221231_zQDtYGlN93ac" style="text-align: center"><b>Year Ended</b></td><td><b>&#160;</b></td></tr>
  <tr style="vertical-align: bottom">
    <td><b>&#160;</b></td><td style="padding-bottom: 1pt"><b>&#160;</b></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"><b>December 31, <br/> 2023</b></td><td style="padding-bottom: 1pt"><b>&#160;</b></td><td style="padding-bottom: 1pt"><b>&#160;</b></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"><b>December 31,<br/> 2022</b></td><td style="padding-bottom: 1pt"><b>&#160;</b></td></tr>
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2">&#160;</td><td style="padding-bottom: 1pt">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="text-align: right">&#160;</td><td style="padding-bottom: 1pt">&#160;</td></tr>
  <tr id="xdx_406_eus-gaap--IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic_maILFCOzLlh_z7Si8U5ZTw9j" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 60%; text-align: left">United Stated Operations</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 16%; text-align: right">(8,173,807</td><td style="width: 1%; text-align: left">)</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 16%; text-align: right">(3,978,832</td><td style="width: 1%; text-align: left">)</td></tr>
  <tr id="xdx_404_eus-gaap--IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign_maILFCOzLlh_zL5XFyf7DTp9" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1pt">International Operations</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(1,667,831</td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(660,830</td><td style="padding-bottom: 1pt; text-align: left">)</td></tr>
  <tr id="xdx_406_eus-gaap--IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_iT_mtILFCOzLlh_zust0jwVE531" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1pt">(Loss) Income before taxes</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(9,871,638</td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(4,639,662</td><td style="padding-bottom: 1pt; text-align: left">)</td></tr>
  </table>

<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the components of net deferred tax asset or liability recognized in an entity's statement of financial position, including the following: the total of all deferred tax liabilities, the total of all deferred tax assets, the total valuation allowance recognized for deferred tax assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the reconciliation using percentage or dollar amounts of the reported amount of income tax expense attributable to continuing operations for the year to the amount of income tax expense that would result from applying domestic federal statutory tax rates to pretax income from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 231<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482663/740-10-55-231<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12A<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-12A<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-12<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of income before income tax between domestic and foreign jurisdictions.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(1)(Note 1))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>135
<FILENAME>R33.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.4</span><table class="report" border="0" cellspacing="2" id="idm45095370727728">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Fair Value Measurements (Tables)<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueDisclosuresAbstract', window );"><strong>Fair Value Disclosures [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock', window );">Schedule of Assets and Liabilities Measured at Fair Value on Recurring Basis</a></td>
<td class="text"><p id="xdx_891_eus-gaap--ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock_zgaDCWQ8I281" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
of September&#160;30, 2024, the following financial assets and liabilities were measured at fair value on a recurring basis presented
on the Company&#8217;s condensed consolidated balance sheet:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span id="xdx_8BE_zzMRLNSAvI67" style="display: none">Schedule
of Assets and Liabilities Measured at Fair Value on Recurring Basis</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="display: none; vertical-align: bottom">
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" id="xdx_491_20240930__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member_z4KlOwEwXPZ2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Level
    1</span></td><td style="padding-bottom: 1pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" id="xdx_498_20240930__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member_z9m0JLmigtyh" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Level
    2</span></td><td style="padding-bottom: 1pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" id="xdx_49C_20240930__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member_zt9UPPoQnhf5" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Level
    3</span></td><td style="padding-bottom: 1pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" id="xdx_49C_20240930_z3HypJTQJmD9" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Total</span></td><td style="padding-bottom: 1pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
<tr style="vertical-align: bottom">
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="10" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Fair
    Value Measurements Using</span></td><td style="padding-bottom: 1pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Level
    1</span></td><td style="padding-bottom: 1pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Level
    2</span></td><td style="padding-bottom: 1pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Level
    3</span></td><td style="padding-bottom: 1pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Total</span></td><td style="padding-bottom: 1pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr id="xdx_400_eus-gaap--AssetsFairValueDisclosureAbstract_iB_zOAtVFrjKIAd" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Assets</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr id="xdx_405_eus-gaap--CashAndCashEquivalentsFairValueDisclosure_i01I_zChzjFxr6dm4" style="vertical-align: bottom; background-color: White">
    <td style="width: 44%; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Cash</span></td><td style="width: 2%; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="border-bottom: Black 1pt solid; width: 10%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2,473,197</span></td><td style="width: 1%; padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="width: 2%; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1pt solid; width: 10%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl2895">-</span></span></td><td style="width: 1%; padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="width: 2%; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1pt solid; width: 10%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl2896">-</span></span></td><td style="width: 1%; padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="width: 2%; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="border-bottom: Black 1pt solid; width: 10%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2,473,197</span></td><td style="width: 1%; padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr id="xdx_400_eus-gaap--AssetsFairValueDisclosure_iI_zf08RA74ZrVj" style="vertical-align: bottom; background-color: White">
    <td style="font-weight: bold; text-align: left; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Total
    assets measured at fair value</span></td><td style="font-weight: bold; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2,473,197</span></td><td style="padding-bottom: 1pt; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl2900">-</span></span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl2901">-</span></span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2,473,197</span></td><td style="padding-bottom: 1pt; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr id="xdx_402_eus-gaap--LiabilitiesFairValueDisclosureAbstract_iB_z1BkUetQEGba" style="vertical-align: bottom; background-color: White">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Liabilities</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr id="xdx_40E_eus-gaap--DerivativeLiabilities_i01I_zur1GJNBTzJb" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Warrant
    liability</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl2909">-</span></span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,027,102</span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl2911">-</span></span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,027,102</span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr id="xdx_405_eus-gaap--LiabilitiesFairValueDisclosure_i01I_zpUbWyljHVFk" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; text-align: left; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Total
    liabilities measured at fair value</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl2914">-</span></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,027,102</span></td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl2916">-</span></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,027,102</span></td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>





<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>SHARPS
TECHNOLOGY, INC.</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTES
TO THE CONDENSED CONSOLIDATED FINANCIAL STATEMENTS</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>FOR
THE THREE AND NINE MONTHS ENDED SEPTEMBER 30, 2024 AND 2023</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Note
14. Fair Value Measurements (continued)</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
of December 31, 2023, the following financial assets and liabilities were measured at fair value on a recurring basis presented on the
Company&#8217;s condensed consolidated balance sheet:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="display: none; vertical-align: bottom">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" id="xdx_496_20231231__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member_zIREGOpf8Hlk" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Level
    1</span></td><td style="padding-bottom: 1pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" id="xdx_49D_20231231__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member_zWeKG60u2CX2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Level
    2</span></td><td style="padding-bottom: 1pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" id="xdx_490_20231231__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member_zOAKMQuqd3G9" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Level
    3</span></td><td style="padding-bottom: 1pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" id="xdx_492_20231231_zDjoJdq81KQa" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Total</span></td><td style="padding-bottom: 1pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
<tr style="vertical-align: bottom">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="10" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Fair
    Value Measurements Using</span></td><td style="padding-bottom: 1pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Level
    1</span></td><td style="padding-bottom: 1pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Level
    2</span></td><td style="padding-bottom: 1pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Level
    3</span></td><td style="padding-bottom: 1pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Total</span></td><td style="padding-bottom: 1pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr id="xdx_404_eus-gaap--AssetsFairValueDisclosureAbstract_iB_zg3N3Dbmx0e2" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Assets</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr id="xdx_40B_eus-gaap--CashAndCashEquivalentsFairValueDisclosure_i01I_zbXBfNEtPmek" style="vertical-align: bottom; background-color: White">
    <td style="width: 44%; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Cash</span></td><td style="width: 2%; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="border-bottom: Black 1pt solid; width: 10%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">3,012,908</span></td><td style="width: 1%; padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="width: 2%; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1pt solid; width: 10%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl2925">-</span></span></td><td style="width: 1%; padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="width: 2%; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1pt solid; width: 10%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl2926">-</span></span></td><td style="width: 1%; padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="width: 2%; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="border-bottom: Black 1pt solid; width: 10%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">3,012,908</span></td><td style="width: 1%; padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr id="xdx_401_eus-gaap--AssetsFairValueDisclosure_iI_zw5BgyAgINO4" style="vertical-align: bottom; background-color: White">
    <td style="font-weight: bold; text-align: left; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Total
    assets measured at fair value</span></td><td style="font-weight: bold; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">3,012,908</span></td><td style="padding-bottom: 1pt; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl2930">-</span></span></td><td style="padding-bottom: 1pt; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl2931">-</span></span></td><td style="padding-bottom: 1pt; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">3,012,908</span></td><td style="padding-bottom: 1pt; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr id="xdx_40B_eus-gaap--LiabilitiesFairValueDisclosureAbstract_iB_zcWq2LrVT5vl" style="vertical-align: bottom; background-color: White">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Liabilities</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr id="xdx_40C_eus-gaap--DerivativeLiabilities_i01I_zPAr3DrFRLgg" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Warrant
    liability</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl2939">-</span></span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2,422,785</span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl2941">&#8212;</span></span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2,422,785</span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr id="xdx_405_eus-gaap--LiabilitiesFairValueDisclosure_iI_zp7vHk1W6RZ1" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; text-align: left; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Total
    liabilities measured at fair value</span></td><td style="font-weight: bold; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl2944">-</span></span></td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2,422,785</span></td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl2946">-</span></span></td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2,422,785</span></td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  </table>

<span></span>
</td>
<td class="text"><p id="xdx_891_eus-gaap--ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock_zxDqW0yAu905" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
of December 31, 2023, the following financial assets and liabilities were measured at fair value on a recurring basis presented on the
Company&#8217;s consolidated balance sheet:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_8BD_zYTR92xRFZoa" style="display: none">Schedule
of Assets and Liabilities Measured at Fair Value on Recurring Basis</span>&#160;</span></span></span></span></span></span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="display: none; vertical-align: bottom">
    <td style="text-align: center">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2" id="xdx_49C_20231231__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member_z2GHeg2d5sg2" style="border-bottom: Black 1pt solid; text-align: center">&#160;</td><td style="padding-bottom: 1pt">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2" id="xdx_497_20231231__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member_z7evLALGnlZ" style="border-bottom: Black 1pt solid; text-align: center">&#160;</td><td style="padding-bottom: 1pt">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2" id="xdx_491_20231231__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member_zkIsZFCa7663" style="border-bottom: Black 1pt solid; text-align: center">&#160;</td><td style="padding-bottom: 1pt">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" id="xdx_49C_20231231_z5mnI8unN3rb" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">&#160;</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: center"><b>&#160;</b></td><td style="padding-bottom: 1pt"><b>&#160;</b></td>
    <td colspan="10" style="border-bottom: Black 1pt solid; text-align: center"><b>Fair Value Measurements Using</b></td><td style="padding-bottom: 1pt"><b>&#160;</b></td><td style="padding-bottom: 1pt"><b>&#160;</b></td>
    <td colspan="2"><b>&#160;</b></td><td style="padding-bottom: 1pt"><b>&#160;</b></td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: center"><b>&#160;</b></td><td style="padding-bottom: 1pt"><b>&#160;</b></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"><b>Level 1</b></td><td style="padding-bottom: 1pt"><b>&#160;</b></td><td style="padding-bottom: 1pt"><b>&#160;</b></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"><b>Level 2</b></td><td style="padding-bottom: 1pt"><b>&#160;</b></td><td style="padding-bottom: 1pt"><b>&#160;</b></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"><b>Level 3</b></td><td style="padding-bottom: 1pt"><b>&#160;</b></td><td style="font-weight: bold; padding-bottom: 1pt"><b>&#160;</b></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><b>Total</b></td><td style="padding-bottom: 1pt; font-weight: bold"><b>&#160;</b></td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: center"><b>&#160;</b></td><td><b>&#160;</b></td>
    <td colspan="2" style="text-align: center"><b>&#160;</b></td><td><b>&#160;</b></td><td><b>&#160;</b></td>
    <td colspan="2" style="text-align: center"><b>&#160;</b></td><td><b>&#160;</b></td><td><b>&#160;</b></td>
    <td colspan="2" style="text-align: center"><b>&#160;</b></td><td><b>&#160;</b></td><td><b>&#160;</b></td>
    <td colspan="2" style="text-align: center"><b>&#160;</b></td><td><b>&#160;</b></td></tr>
  <tr id="xdx_402_eus-gaap--FinancialInstrumentsFinancialAssetsBalanceSheetGroupingsAbstract_iB_zKCKiuWV95S4" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold">Assets</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_403_eus-gaap--CashAndCashEquivalentsFairValueDisclosure_iI_zILPeMbyrX79" style="vertical-align: bottom; background-color: White">
    <td style="width: 40%">Cash</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 11%; text-align: right">3,012,908</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 11%; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1393">-</span></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 11%; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1394">-</span></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 11%; text-align: right">3,012,908</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 1pt">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">&#160;</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">&#160;</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">&#160;</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">&#160;</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_406_eus-gaap--AssetsFairValueDisclosure_iI_zG7RiQmAR0rg" style="vertical-align: bottom; background-color: White">
    <td style="font-weight: bold; text-align: left; padding-bottom: 1pt">Total assets measured at fair value</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right">3,012,908</td><td style="padding-bottom: 1pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1398">-</span></td><td style="padding-bottom: 1pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1399">-</span></td><td style="padding-bottom: 1pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right">3,012,908</td><td style="padding-bottom: 1pt; font-weight: bold; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_402_eus-gaap--FinancialInstrumentsFinancialLiabilitiesBalanceSheetGroupingsAbstract_iB_z0jzKRAX0egb" style="vertical-align: bottom; background-color: White">
    <td>Liabilities</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_405_ecustom--WarrantLiability_iI_zNVO650ZxiGk" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1pt">Warrant liability</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">$</td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1407">-</span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">2,422,785</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1409">-</span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">$</td><td style="border-bottom: Black 1pt solid; text-align: right">2,422,785</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40B_eus-gaap--LiabilitiesFairValueDisclosure_iI_zgxCT7I3IgY4" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; text-align: left; padding-bottom: 2.5pt">Total liabilities measured at fair value</td><td style="font-weight: bold; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1412">-</span></td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right">2,422,785</td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1414">-</span></td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right">2,422,785</td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">&#160;</td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
of December 31, 2022, the following financial assets and liabilities were measured at fair value on a recurring basis presented on the
Company&#8217;s consolidated balance sheet:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="display: none; vertical-align: bottom">
    <td style="text-align: center">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2" id="xdx_49F_20221231__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member_zI2ZrE6i1D56" style="border-bottom: Black 1pt solid; text-align: center">&#160;</td><td style="padding-bottom: 1pt">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2" id="xdx_493_20221231__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member_zyEkrfBqNYPj" style="border-bottom: Black 1pt solid; text-align: center">&#160;</td><td style="padding-bottom: 1pt">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2" id="xdx_49D_20221231__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member_zepFhAwEIj67" style="border-bottom: Black 1pt solid; text-align: center">&#160;</td><td style="padding-bottom: 1pt">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" id="xdx_49F_20221231_zMO0YGfq3qv8" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">&#160;</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="text-align: center"><b>&#160;</b></td><td style="padding-bottom: 1pt"><b>&#160;</b></td>
    <td colspan="10" style="border-bottom: Black 1pt solid; text-align: center"><b>Fair Value Measurements Using</b></td><td style="padding-bottom: 1pt"><b>&#160;</b></td><td style="padding-bottom: 1pt"><b>&#160;</b></td>
    <td colspan="2"><b>&#160;</b></td><td style="padding-bottom: 1pt"><b>&#160;</b></td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: center"><b>&#160;</b></td><td style="padding-bottom: 1pt"><b>&#160;</b></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"><b>Level 1</b></td><td style="padding-bottom: 1pt"><b>&#160;</b></td><td style="padding-bottom: 1pt"><b>&#160;</b></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"><b>Level 2</b></td><td style="padding-bottom: 1pt"><b>&#160;</b></td><td style="padding-bottom: 1pt"><b>&#160;</b></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"><b>Level 3</b></td><td style="padding-bottom: 1pt"><b>&#160;</b></td><td style="font-weight: bold; padding-bottom: 1pt"><b>&#160;</b></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><b>Total</b></td><td style="padding-bottom: 1pt; font-weight: bold"><b>&#160;</b></td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: center"><b>&#160;</b></td><td style="padding-bottom: 1pt"><b>&#160;</b></td>
    <td colspan="2" style="text-align: center"><b>&#160;</b></td><td style="padding-bottom: 1pt"><b>&#160;</b></td><td style="padding-bottom: 1pt"><b>&#160;</b></td>
    <td colspan="2" style="text-align: center"><b>&#160;</b></td><td style="padding-bottom: 1pt"><b>&#160;</b></td><td style="padding-bottom: 1pt"><b>&#160;</b></td>
    <td colspan="2" style="text-align: center"><b>&#160;</b></td><td style="padding-bottom: 1pt"><b>&#160;</b></td><td style="padding-bottom: 1pt"><b>&#160;</b></td>
    <td colspan="2" style="text-align: center"><b>&#160;</b></td><td style="padding-bottom: 1pt"><b>&#160;</b></td></tr>
  <tr id="xdx_402_eus-gaap--FinancialInstrumentsFinancialAssetsBalanceSheetGroupingsAbstract_iB_zZ0h4m5zpCV6" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold">Assets</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_403_eus-gaap--CashAndCashEquivalentsFairValueDisclosure_iI_zFsKH6PntU33" style="vertical-align: bottom; background-color: White">
    <td style="width: 40%">Cash</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 11%; text-align: right">4,170,897</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 11%; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1423">-</span></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 11%; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1424">-</span></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 11%; text-align: right">4,170,897</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 1pt">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">-</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">-</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">-</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">&#160;</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_406_eus-gaap--AssetsFairValueDisclosure_iI_z9gso5OGflrl" style="vertical-align: bottom; background-color: White">
    <td style="font-weight: bold; text-align: left; padding-bottom: 1pt">Total assets measured at fair value</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right">4,170,897</td><td style="padding-bottom: 1pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1428">-</span></td><td style="padding-bottom: 1pt; font-weight: bold; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">&#160;</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right">4,170,897</td><td style="padding-bottom: 1pt; font-weight: bold; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_404_eus-gaap--FinancialInstrumentsFinancialLiabilitiesBalanceSheetGroupingsAbstract_iB_znHNORGK6ow4" style="vertical-align: bottom; background-color: White">
    <td>Liabilities</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_403_ecustom--WarrantLiability_iI_zeHj02xUXIze" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1pt">Warrant liability</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">$</td><td style="border-bottom: Black 1pt solid; text-align: right">1,151,838</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1438">-</span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1439">-</span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">$</td><td style="border-bottom: Black 1pt solid; text-align: right">1,151,838</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40B_eus-gaap--LiabilitiesFairValueDisclosure_iI_zArStOtPTi4i" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; text-align: left; padding-bottom: 2.5pt">Total liabilities measured at fair value</td><td style="font-weight: bold; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right">1,151,838</td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1443">-</span></td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1444">-</span></td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right">1,151,838</td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">&#160;</td></tr>
  </table>

<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueDisclosuresAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueDisclosuresAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of assets and liabilities, including [financial] instruments measured at fair value that are classified in stockholders' equity, if any, that are measured at fair value on a recurring basis. The disclosures contemplated herein include the fair value measurements at the reporting date by the level within the fair value hierarchy in which the fair value measurements in their entirety fall, segregating fair value measurements using quoted prices in active markets for identical assets (Level 1), significant other observable inputs (Level 2), and significant unobservable inputs (Level 3).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>136
<FILENAME>R34.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.4</span><table class="report" border="0" cellspacing="2" id="idm45095368292000">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Description of Business (Details Narrative) - USD ($)<br></strong></div></th>
<th class="th"><div>Oct. 16, 2024</div></th>
<th class="th"><div>Apr. 19, 2022</div></th>
<th class="th"><div>Apr. 14, 2022</div></th>
<th class="th"><div>Sep. 30, 2024</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockLineItems', window );"><strong>Subsidiary, Sale of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_STSS_WorkingCapital', window );">Working capital</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 67,820<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_STSS_ReverseStockSplitDescription', window );">Reverse stock split description</a></td>
<td class="text">the Company completed a 1 for 22 reverse split, whereby for each 22 shares of common stock the Company issued one share
of common stock .<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockAxis=us-gaap_IPOMember', window );">IPO [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockLineItems', window );"><strong>Subsidiary, Sale of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceInitialPublicOffering', window );">Initial public offering</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 14,200,000<span></span>
</td>
<td class="nump">$ 14,200,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_STSS_ReverseStockSplitDescription">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Reverse stock split description.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">STSS_ReverseStockSplitDescription</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>STSS_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_STSS_WorkingCapital">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Working capital.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">STSS_WorkingCapital</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>STSS_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromIssuanceInitialPublicOffering">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash inflow associated with the amount received from entity's first offering of stock to the public.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-14<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromIssuanceInitialPublicOffering</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsidiarySaleOfStockLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsidiarySaleOfStockLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsidiarySaleOfStockAxis=us-gaap_IPOMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsidiarySaleOfStockAxis=us-gaap_IPOMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>137
<FILENAME>R35.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.4</span><table class="report" border="0" cellspacing="2" id="idm45095357144544">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Summary of Significant Accounting Policies (Details Narrative) - USD ($)<br></strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">9 Months Ended</th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2024</div></th>
<th class="th"><div>Sep. 30, 2023</div></th>
<th class="th"><div>Sep. 30, 2024</div></th>
<th class="th"><div>Sep. 30, 2023</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInOperatingActivities', window );">Cash in operations</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 5,172,135<span></span>
</td>
<td class="nump">$ 6,144,937<span></span>
</td>
<td class="nump">$ 8,507,300<span></span>
</td>
<td class="nump">$ 6,433,159<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Cash', window );">Cash</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,012,908<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashEquivalentsAtCarryingValue', window );">Cash equivalents</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ImpairmentOfLongLivedAssetsHeldForUse', window );">Impairment losses</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">$ 560,000<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic', window );">Weighted average shares outstanding basic</a></td>
<td class="nump">1,331,891<span></span>
</td>
<td class="nump">536,886<span></span>
</td>
<td class="nump">1,053,259<span></span>
</td>
<td class="nump">518,166<span></span>
</td>
<td class="nump">13,032,717<span></span>
</td>
<td class="nump">8,100,410<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=STSS_StockOptionsAndWarrantsMember', window );">Stock Options and Warrants [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount', window );">Antidilutive shares amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">22,950,155<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=STSS_StockOptionAndWarrantsMember', window );">Stock Option and Warrants [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount', window );">Antidilutive shares amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">958,693<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=STSS_PrefundendWarrantsMember', window );">Prefundend Warrants [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic', window );">Weighted average shares outstanding basic</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,381,479<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_BuildingMember', window );">Building [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentUsefulLife', window );">Property plant and equipment asset useful life</a></td>
<td class="text">20 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">20 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">20 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_MachineryAndEquipmentMember', window );">Machinery and Equipment [Member] | Minimum [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentUsefulLife', window );">Property plant and equipment asset useful life</a></td>
<td class="text">3 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">3 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">3 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_MachineryAndEquipmentMember', window );">Machinery and Equipment [Member] | Maximum [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentUsefulLife', window );">Property plant and equipment asset useful life</a></td>
<td class="text">10 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">10 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">10 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=STSS_WebsiteMember', window );">Website [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentUsefulLife', window );">Property plant and equipment asset useful life</a></td>
<td class="text">3 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">3 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">3 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) or earnings per unit (EPU) in the future that were not included in the computation of diluted EPS or EPU because to do so would increase EPS or EPU amounts or decrease loss per share or unit amounts for the period presented.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482662/260-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Cash">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Excludes cash and cash equivalents within disposal group and discontinued operation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481372/852-10-55-10<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479168/946-830-55-12<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478777/944-210-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 21<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477796/946-210-45-21<br><br>Reference 6: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 20<br> -SubTopic 210<br> -Topic 946<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477796/946-210-45-20<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Cash</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashEquivalentsAtCarryingValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478777/944-210-S99-1<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashEquivalentsAtCarryingValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ImpairmentOfLongLivedAssetsHeldForUse">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate amount of write-downs for impairments recognized during the period for long lived assets held for use (including those held for disposal by means other than sale).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 100<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482078/820-10-55-100<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 360<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482099/360-10-50-2<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482130/360-10-45-4<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ImpairmentOfLongLivedAssetsHeldForUse</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInOperatingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 24<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-24<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 25<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-25<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInOperatingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7A<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478964/842-20-50-7A<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentUsefulLife">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Useful life of long lived, physical assets used in the normal conduct of business and not intended for resale, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days. Examples include, but not limited to, land, buildings, machinery and equipment, office equipment, furniture and fixtures, and computer equipment.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentUsefulLife</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482662/260-10-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-10<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfSharesOutstandingBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=STSS_StockOptionsAndWarrantsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=STSS_StockOptionsAndWarrantsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=STSS_StockOptionAndWarrantsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=STSS_StockOptionAndWarrantsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=STSS_PrefundendWarrantsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=STSS_PrefundendWarrantsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_BuildingMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_BuildingMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_MachineryAndEquipmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_MachineryAndEquipmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MinimumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MinimumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=STSS_WebsiteMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=STSS_WebsiteMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>138
<FILENAME>R36.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.4</span><table class="report" border="0" cellspacing="2" id="idm45095356322512">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Schedule of Inventories (Details) - USD ($)<br></strong></div></th>
<th class="th"><div>Sep. 30, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InventoryDisclosureAbstract', window );"><strong>Inventory Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InventoryRawMaterialsNetOfReserves', window );">Raw materials</a></td>
<td class="nump">$ 360,907<span></span>
</td>
<td class="nump">$ 254,461<span></span>
</td>
<td class="nump">$ 106,088<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InventoryWorkInProcessNetOfReserves', window );">Work in process</a></td>
<td class="nump">140,025<span></span>
</td>
<td class="nump">170,464<span></span>
</td>
<td class="nump">49,144<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InventoryFinishedGoodsNetOfReserves', window );">Finished goods</a></td>
<td class="nump">1,518,549<span></span>
</td>
<td class="nump">1,284,210<span></span>
</td>
<td class="nump">30,572<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InventoryNet', window );">Total</a></td>
<td class="nump">$ 2,019,481<span></span>
</td>
<td class="nump">$ 1,709,135<span></span>
</td>
<td class="nump">$ 185,804<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryFinishedGoodsNetOfReserves">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying amount, net of valuation reserves and adjustments, as of the balance sheet date of merchandise or goods held by the company that are readily available for sale.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 330<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 5.BB)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480581/330-10-S99-2<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6)(a)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryFinishedGoodsNetOfReserves</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after valuation and LIFO reserves of inventory expected to be sold, or consumed within one year or operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481372/852-10-55-10<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483467/210-10-45-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryRawMaterialsNetOfReserves">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying amount, net of valuation reserves and adjustments, as of the balance sheet date of unprocessed items to be consumed in the manufacturing or production process.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 330<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 5.BB)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480581/330-10-S99-2<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6)(a)(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryRawMaterialsNetOfReserves</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryWorkInProcessNetOfReserves">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying amount, net of reserves and adjustments, as of the balance sheet date of merchandise or goods which are partially completed. This inventory is generally comprised of raw materials, labor and factory overhead costs, which require further materials, labor and overhead to be converted into finished goods, and which generally require the use of estimates to determine percentage complete and pricing.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 330<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 5.BB)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480581/330-10-S99-2<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6)(a)(3))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryWorkInProcessNetOfReserves</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>139
<FILENAME>R37.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.4</span><table class="report" border="0" cellspacing="2" id="idm45095370478208">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Schedule of Property, Plant and Equipment (Details) - USD ($)<br></strong></div></th>
<th class="th"><div>Sep. 30, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentGross', window );">&#160;Total Fixed Assets</a></td>
<td class="nump">$ 8,224,960<span></span>
</td>
<td class="nump">$ 8,037,928<span></span>
</td>
<td class="nump">$ 7,684,614<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment', window );">Less: accumulated depreciation</a></td>
<td class="num">(1,991,365)<span></span>
</td>
<td class="num">(1,215,786)<span></span>
</td>
<td class="num">(679,724)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentNet', window );">Fixed asset, net</a></td>
<td class="nump">6,233,595<span></span>
</td>
<td class="nump">6,822,142<span></span>
</td>
<td class="nump">7,004,890<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_LandMember', window );">Land [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentGross', window );">&#160;Total Fixed Assets</a></td>
<td class="nump">253,781<span></span>
</td>
<td class="nump">260,460<span></span>
</td>
<td class="nump">242,240<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_BuildingMember', window );">Building [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentGross', window );">&#160;Total Fixed Assets</a></td>
<td class="nump">2,949,900<span></span>
</td>
<td class="nump">3,022,490<span></span>
</td>
<td class="nump">2,824,481<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_MachineryAndEquipmentMember', window );">Machinery and Equipment [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentGross', window );">&#160;Total Fixed Assets</a></td>
<td class="nump">$ 4,730,617<span></span>
</td>
<td class="nump">4,464,317<span></span>
</td>
<td class="nump">4,601,293<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=STSS_ComputerSystemsAndWebsiteAndOtherWebsiteMember', window );">Computer Systems and Website and Other Website [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentGross', window );">&#160;Total Fixed Assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 290,661<span></span>
</td>
<td class="nump">$ 16,600<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of accumulated depreciation, depletion and amortization for physical assets used in the normal conduct of business to produce goods and services.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(8)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478777/944-210-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(14))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482099/360-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(8))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478777/944-210-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(13))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 360<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482099/360-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7A<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478964/842-20-50-7A<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -SubTopic 10<br> -Topic 360<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482099/360-10-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7A<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478964/842-20-50-7A<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481372/852-10-55-10<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(8))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478777/944-210-S99-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 360<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478451/942-360-50-1<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_LandMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_LandMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_BuildingMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_BuildingMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_MachineryAndEquipmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_MachineryAndEquipmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=STSS_ComputerSystemsAndWebsiteAndOtherWebsiteMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=STSS_ComputerSystemsAndWebsiteAndOtherWebsiteMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>140
<FILENAME>R38.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.4</span><table class="report" border="0" cellspacing="2" id="idm45095368652176">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Fixed Assets (Details Narrative) - USD ($)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
<th class="th" colspan="2">9 Months Ended</th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Sep. 30, 2024</div></th>
<th class="th"><div>Sep. 30, 2023</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Depreciation', window );">Depreciation</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 574,719<span></span>
</td>
<td class="nump">$ 646,538<span></span>
</td>
<td class="nump">$ 876,064<span></span>
</td>
<td class="nump">$ 647,690<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_STSS_RemainingPaymentsDueOnMachinery', window );">Balance due on machinery</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 100,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_StockOptionMember', window );">Equity Option [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireMachineryAndEquipment', window );">Acquisition of machinery</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 63,612<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_MachineryAndEquipmentMember', window );">Machinery and Equipment [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetImpairmentCharges', window );">Asset impairment</a></td>
<td class="nump">$ 560,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_STSS_RemainingPaymentsDueOnMachinery">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Remaining payments uue on machinery.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">STSS_RemainingPaymentsDueOnMachinery</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>STSS_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetImpairmentCharges">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of write-down of assets recognized in the income statement. Includes, but is not limited to, losses from tangible assets, intangible assets and goodwill.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482130/360-10-45-4<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetImpairmentCharges</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Depreciation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482099/360-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Depreciation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquireMachineryAndEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow for acquisition of machinery and equipment.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-13<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquireMachineryAndEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7A<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478964/842-20-50-7A<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_StockOptionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_StockOptionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_MachineryAndEquipmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_MachineryAndEquipmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>141
<FILENAME>R39.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.4</span><table class="report" border="0" cellspacing="2" id="idm45095365998272">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Schedule of Fair Value of the Assets Acquisition (Details) - Safegard Medical, Inc [Member]<br></strong></div></th>
<th class="th">
<div>Jul. 06, 2022 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLand', window );">Land</a></td>
<td class="nump">$ 226,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedBuildings', window );">Building and affixed assets</a></td>
<td class="nump">2,684,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedEquipment', window );">Machinery</a></td>
<td class="nump">158,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory', window );">Inventory</a></td>
<td class="nump">32,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles', window );">Intangibles</a></td>
<td class="nump">64,712<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities', window );">Deferred tax liability</a></td>
<td class="num">(192,000)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets', window );">Total</a></td>
<td class="nump">$ 2,936,712<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479907/805-20-50-5<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of assets acquired at the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479907/805-20-50-1<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedBuildings">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of facility held for productive use including, but not limited to, office, production, storage and distribution facilities, acquired at the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479907/805-20-50-1<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedBuildings</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred tax liability attributable to taxable temporary differences assumed at the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479907/805-20-50-1<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of tangible personal property used to produce goods and services, including, but is not limited to, tools, dies and molds, computer and office equipment, acquired at the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479907/805-20-50-1<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of identifiable intangible assets recognized as of the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 55<br> -Paragraph 37<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479303/805-10-55-37<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479907/805-20-50-1<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of inventory recognized as of the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 55<br> -Paragraph 37<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479303/805-10-55-37<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479907/805-20-50-1<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLand">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of real estate acquired, at the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479907/805-20-50-1<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLand</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=STSS_SafegardMedicalIncMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=STSS_SafegardMedicalIncMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>142
<FILENAME>R40.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.4</span><table class="report" border="0" cellspacing="2" id="idm45095359083792">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Asset Acquisition (Details Narrative) - USD ($)<br></strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1">1 Months Ended</th>
<th class="th" colspan="1">12 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Jul. 06, 2022</div></th>
<th class="th"><div>Jun. 30, 2020</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Sep. 30, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_BuildingMember', window );">Building [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetUsefulLife', window );">Intangible asset acquired, useful lives</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">20 years<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentUsefulLife', window );">Fixed assets acquired, useful lives</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">20 years<span></span>
</td>
<td class="text">20 years<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_MachineryAndEquipmentMember', window );">Machinery and Equipment [Member] | Minimum [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetUsefulLife', window );">Intangible asset acquired, useful lives</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">5 years<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentUsefulLife', window );">Fixed assets acquired, useful lives</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">3 years<span></span>
</td>
<td class="text">3 years<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_MachineryAndEquipmentMember', window );">Machinery and Equipment [Member] | Maximum [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetUsefulLife', window );">Intangible asset acquired, useful lives</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">10 years<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentUsefulLife', window );">Fixed assets acquired, useful lives</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">10 years<span></span>
</td>
<td class="text">10 years<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_FiniteLivedIntangibleAssetsMember', window );">Finite-Lived Intangible Assets [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetUsefulLife', window );">Intangible asset acquired, useful lives</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">5 years<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=STSS_SafegardMedicalIncMember', window );">Safegard Medical, Inc [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets', window );">Acquisition cost</a></td>
<td class="nump">$ 2,936,712<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueOfAssetsAcquired', window );">Fair value of assets acquired</a></td>
<td class="nump">$ 53,576<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetUsefulLife', window );">Intangible asset acquired, useful lives</a></td>
<td class="text">5 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionCostOfAcquiredEntityTransactionCosts', window );">Transaction costs</a></td>
<td class="nump">$ 53,576<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=STSS_SafegardMedicalIncMember', window );">Safegard Medical, Inc [Member] | Building [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentUsefulLife', window );">Fixed assets acquired, useful lives</a></td>
<td class="text">20 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=STSS_SafegardMedicalIncMember', window );">Safegard Medical, Inc [Member] | Machinery and Equipment [Member] | Minimum [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentUsefulLife', window );">Fixed assets acquired, useful lives</a></td>
<td class="text">5 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=STSS_SafegardMedicalIncMember', window );">Safegard Medical, Inc [Member] | Machinery and Equipment [Member] | Maximum [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentUsefulLife', window );">Fixed assets acquired, useful lives</a></td>
<td class="text">10 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TypeOfArrangementAxis=STSS_SharePurchaseAgreementMember', window );">Share Purchase Agreement [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetAcquisitionConsiderationTransferred', window );">Asset acquisition</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2,500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingCostsAndExpenses', window );">Operating costs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 594,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TypeOfArrangementAxis=STSS_SharePurchaseAgreementMember', window );">Share Purchase Agreement [Member] | Safegard Medical, Inc [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireBusinessesGross', window );">Consideration paid in cash</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TypeOfArrangementAxis=STSS_SharePurchaseAgreementMember', window );">Share Purchase Agreement [Member] | Safegard Medical, Inc [Member] | Equity Option [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_STSS_FairMarketValueOfCommonStock', window );">Fair market value of common stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 183,135<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TypeOfArrangementAxis=STSS_SharePurchaseAgreementMember', window );">Share Purchase Agreement [Member] | Equity Option [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod', window );">Stock options issued</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">35,714<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice', window );">Exercise price</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 7.00<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1', window );">Vested options, value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 183,135<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TypeOfArrangementAxis=STSS_SharePurchaseAgreementMember', window );">Share Purchase Agreement [Member] | Stock Option One [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod', window );">Stock options issued</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">50,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice', window );">Exercise price</a></td>
<td class="nump">$ 4.25<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TypeOfArrangementAxis=STSS_SharePurchaseAgreementMember', window );">Share Purchase Agreement [Member] | Common Stock [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesAcquisitions', window );">Additional consideration, shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">28,571<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharePrice', window );">Share price</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 7.00<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_STSS_FairMarketValueOfCommonStock', window );">Fair market value of common stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 200,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TypeOfArrangementAxis=STSS_SharePurchaseAgreementMember', window );">Share Purchase Agreement [Member] | Common Stock [Member] | Safegard Medical, Inc [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_STSS_FairMarketValueOfCommonStock', window );">Fair market value of common stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 200,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_STSS_FairMarketValueOfCommonStock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair market value of common stock.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">STSS_FairMarketValueOfCommonStock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>STSS_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetAcquisitionConsiderationTransferred">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of consideration transferred in asset acquisition. Includes, but is not limited to, cash, liability incurred by acquirer, and equity interest issued by acquirer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 805<br> -SubTopic 50<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479908/805-50-55-1<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 805<br> -SubTopic 50<br> -Name Accounting Standards Codification<br> -Section 25<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480060/805-50-25-1<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 805<br> -SubTopic 50<br> -Name Accounting Standards Codification<br> -Section 30<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480027/805-50-30-1<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 805<br> -SubTopic 50<br> -Name Accounting Standards Codification<br> -Section 30<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480027/805-50-30-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetAcquisitionConsiderationTransferred</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionCostOfAcquiredEntityTransactionCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of direct costs of the business combination including legal, accounting, and other costs incurred to consummate the business acquisition.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionCostOfAcquiredEntityTransactionCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479907/805-20-50-5<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of assets acquired at the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479907/805-20-50-1<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueOfAssetsAcquired">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The fair value of assets acquired in noncash investing or financing activities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482913/230-10-50-4<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482913/230-10-50-3<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482913/230-10-50-5<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueOfAssetsAcquired</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetUsefulLife">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Useful life of finite-lived intangible assets, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetUsefulLife</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingCostsAndExpenses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Generally recurring costs associated with normal operations except for the portion of these expenses which can be clearly related to production and included in cost of sales or services. Excludes Selling, General and Administrative Expense.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingCostsAndExpenses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquireBusinessesGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow associated with the acquisition of business during the period. The cash portion only of the acquisition price.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479581/805-30-50-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-13<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquireBusinessesGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentUsefulLife">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Useful life of long lived, physical assets used in the normal conduct of business and not intended for resale, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days. Examples include, but not limited to, land, buildings, machinery and equipment, office equipment, furniture and fixtures, and computer equipment.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentUsefulLife</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Net number of share options (or share units) granted during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(01)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average price at which option holders acquired shares when converting their stock options into shares.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(02)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Price of a single share of a number of saleable stocks of a company.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value of options vested. Excludes equity instruments other than options, for example, but not limited to, share units, stock appreciation rights, restricted stock.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesAcquisitions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares of stock issued during the period pursuant to acquisitions.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480008/505-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesAcquisitions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_BuildingMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_BuildingMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_MachineryAndEquipmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_MachineryAndEquipmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MinimumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MinimumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_FiniteLivedIntangibleAssetsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_FiniteLivedIntangibleAssetsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=STSS_SafegardMedicalIncMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=STSS_SafegardMedicalIncMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TypeOfArrangementAxis=STSS_SharePurchaseAgreementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TypeOfArrangementAxis=STSS_SharePurchaseAgreementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_StockOptionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentRiskAxis=us-gaap_StockOptionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_StockOptionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_StockOptionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=STSS_StockOptionOneMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=STSS_StockOptionOneMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_CommonStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_CommonStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>143
<FILENAME>R41.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.4</span><table class="report" border="0" cellspacing="2" id="idm45095358904336">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Schedule of Other Assets (Details) - USD ($)<br></strong></div></th>
<th class="th"><div>Sep. 30, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureAbstract', window );"><strong>Deferred Costs, Capitalized, Prepaid, and Other Assets Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IntangibleAssetsNetExcludingGoodwill', window );">Intangibles, net &#8211; See Note 6</a></td>
<td class="nump">$ 40,227<span></span>
</td>
<td class="nump">$ 52,513<span></span>
</td>
<td class="nump">$ 62,480<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DepositsAssets', window );">Deposits or advance payments on machinery, molds and components (see Note 15)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">336,466<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherAssetsMiscellaneousNoncurrent', window );">Other &#8211; See Note 7</a></td>
<td class="nump">326,061<span></span>
</td>
<td class="nump">76,062<span></span>
</td>
<td class="nump">12,370<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherAssetsNoncurrent', window );">&#160;Total Other assets</a></td>
<td class="nump">$ 366,288<span></span>
</td>
<td class="nump">$ 128,575<span></span>
</td>
<td class="nump">$ 411,316<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DepositsAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying value of amounts transferred to third parties for security purposes that are expected to be returned or applied towards payment in the future.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(17))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DepositsAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IntangibleAssetsNetExcludingGoodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts of all intangible assets, excluding goodwill, as of the balance sheet date, net of accumulated amortization and impairment charges.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 350<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482665/350-30-50-2<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 350<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482665/350-30-50-2<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 350<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482686/350-30-45-1<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IntangibleAssetsNetExcludingGoodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherAssetsMiscellaneousNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of other miscellaneous assets expected to be realized or consumed after one year or normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherAssetsMiscellaneousNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherAssetsNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of noncurrent assets classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(17))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherAssetsNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>144
<FILENAME>R42.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.4</span><table class="report" border="0" cellspacing="2" id="idm45095324627504">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Other Assets (Details Narrative)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th">
<div>Dec. 31, 2023 </div>
<div>USD ($)</div>
</th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureAbstract', window );"><strong>Deferred Costs, Capitalized, Prepaid, and Other Assets Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AmortizationOfIntangibleAssets', window );">Amortization of intangible assets</a></td>
<td class="nump">$ 15,184<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AmortizationOfIntangibleAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate expense charged against earnings to allocate the cost of intangible assets (nonphysical assets not used in production) in a systematic and rational manner to the periods expected to benefit from such assets. As a noncash expense, this element is added back to net income when calculating cash provided by or used in operations using the indirect method.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 350<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 40<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482640/350-30-55-40<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 350<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482665/350-30-50-2<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 350<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482686/350-30-45-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AmortizationOfIntangibleAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>145
<FILENAME>R43.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.4</span><table class="report" border="0" cellspacing="2" id="idm45095355307120">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Debt Financing (Details Narrative) - USD ($)<br></strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 20, 2024</div></th>
<th class="th"><div>Sep. 30, 2024</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShortTermDebtLineItems', window );"><strong>Short-Term Debt [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_STSS_AccretedInterestFees', window );">Accreted interest fees</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 75,192<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TypeOfArrangementAxis=STSS_SecuritiesPurchaseAgreementMember', window );">Securities Purchase Agreement [Member] | Senior Secured Note [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShortTermDebtLineItems', window );"><strong>Short-Term Debt [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Debt Instrument, Face Amount</a></td>
<td class="nump">$ 4,375,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentIncreaseAccruedInterest', window );">Original issue discount (OID)</a></td>
<td class="nump">$ 875,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentMaturityDate', window );">Debt Instrument, Maturity Date</a></td>
<td class="text">Jan. 31,  2025<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_STSS_NumberOfUnregisteredCommonStockIssuedDuringPostReverseShares', window );">Number of unregistered common stock issued during post reverse shares</a></td>
<td class="nump">259,091<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOfDebt', window );">Proceeds from Issuance of Debt</a></td>
<td class="nump">$ 3,500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_STSS_PlacementAgentAndOtherOfferingExpenses', window );">Closing costs</a></td>
<td class="nump">514,700<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EscrowDeposit', window );">Escrow Deposit</a></td>
<td class="nump">250,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentFairValue', window );">Debt Instrument, Fair Value Disclosure</a></td>
<td class="nump">2,600,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_STSS_CommonStockFairValue', window );">Common stock fair value</a></td>
<td class="nump">$ 852,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TypeOfArrangementAxis=STSS_SecuritiesPurchaseAgreementMember', window );">Securities Purchase Agreement [Member] | Senior Secured Note [Member] | Pre Reverse [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShortTermDebtLineItems', window );"><strong>Short-Term Debt [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_STSS_NumberOfUnregisteredCommonStockIssuedDuringPreReverseShares', window );">Pre reverse</a></td>
<td class="nump">5,700,006<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_STSS_AccretedInterestFees">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Accreted interest fee.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">STSS_AccretedInterestFees</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>STSS_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_STSS_CommonStockFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Common stock fair value.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">STSS_CommonStockFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>STSS_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_STSS_NumberOfUnregisteredCommonStockIssuedDuringPostReverseShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of unregistered common stock issued during post reverse shares.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">STSS_NumberOfUnregisteredCommonStockIssuedDuringPostReverseShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>STSS_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_STSS_NumberOfUnregisteredCommonStockIssuedDuringPreReverseShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of unregistered common stock issued during pre reverse shares.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">STSS_NumberOfUnregisteredCommonStockIssuedDuringPreReverseShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>STSS_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_STSS_PlacementAgentAndOtherOfferingExpenses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Placement agent and other offering expenses.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">STSS_PlacementAgentAndOtherOfferingExpenses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>STSS_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentFaceAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Face (par) amount of debt instrument at time of issuance.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 835<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482949/835-30-55-8<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1B<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 69B<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481568/470-20-55-69B<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 69C<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481568/470-20-55-69C<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 835<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482900/835-30-50-1<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 835<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482925/835-30-45-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentFaceAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value portion of debt instrument payable, including, but not limited to, notes payable and loans payable.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2E<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2E<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (bbb)(2)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (bbb)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (bbb)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br><br>Reference 6: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 69B<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481568/470-20-55-69B<br><br>Reference 7: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 69C<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481568/470-20-55-69C<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1D<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1D<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-10<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentIncreaseAccruedInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Increase for accrued, but unpaid interest on the debt instrument for the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(f))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentIncreaseAccruedInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentMaturityDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Date when the debt instrument is scheduled to be fully repaid, in YYYY-MM-DD format.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (bbb)(2)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (bbb)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22)(a)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1B<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentMaturityDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EscrowDeposit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The designation of funds furnished by a borrower to a lender to assure future payments of the borrower's real estate taxes and insurance obligations with respect to a mortgaged property. Escrow deposits may be made for a variety of other purposes such as earnest money and contingent payments. This element excludes replacement reserves which are an escrow separately provided for within the US GAAP taxonomy.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(10))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478546/942-210-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 954<br> -SubTopic 440<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478522/954-440-50-1<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EscrowDeposit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromIssuanceOfDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash inflow during the period from additional borrowings in aggregate debt. Includes proceeds from short-term and long-term debt.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-14<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromIssuanceOfDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShortTermDebtLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShortTermDebtLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TypeOfArrangementAxis=STSS_SecuritiesPurchaseAgreementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TypeOfArrangementAxis=STSS_SecuritiesPurchaseAgreementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=STSS_SeniorSecuredNoteMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=STSS_SeniorSecuredNoteMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=STSS_PreReverseMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=STSS_PreReverseMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>146
<FILENAME>R44.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.4</span><table class="report" border="0" cellspacing="2" id="idm45095357162272">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Note Purchase Agreement (Details Narrative) - USD ($)<br></strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="2">12 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Sep. 29, 2023</div></th>
<th class="th"><div>Apr. 19, 2022</div></th>
<th class="th"><div>Apr. 14, 2022</div></th>
<th class="th"><div>Dec. 14, 2021</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Sep. 30, 2024</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems', window );"><strong>Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesIssued', window );">Common stock, shares issued</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">694,294<span></span>
</td>
<td class="nump">9,407,415<span></span>
</td>
<td class="nump">1,694,110<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAdjustmentOfWarrants', window );">Fair market value of warrant</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 5,200,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 42,915<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice', window );">Exercise price</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 4.38<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TypeOfArrangementAxis=STSS_NotePurchaseAgreementMember', window );">Note Purchase Agreement [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems', window );"><strong>Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Interest rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">8.00%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_STSS_ContingentStockLiability', window );">Contingent stock liability</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 677,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_STSS_ContingentWarrantLiability', window );">Contingent warrants liability</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">585,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_STSS_AllocationOfDebtIssuanceCostToContingentStockAndContingentWarrants', window );">Allocation of debt issuance cost to contingent stock and contingent warrants</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 124,460<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NotesPayable', window );">Notes payable</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">665,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentUnamortizedDiscount', window );">Debt discount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,335,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InterestExpense', window );">Interest expense</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 39,111<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InterestPayableCurrent', window );">Accreted interest</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,299,895<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RepaymentsOfDebt', window );">Notes payable</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesIssued', window );">Common stock, shares issued</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">235,295<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAdjustmentOfWarrants', window );">Fair market value of warrant</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 496,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TypeOfArrangementAxis=STSS_NotePurchaseAgreementMember', window );">Note Purchase Agreement [Member] | Note Warrant [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems', window );"><strong>Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_STSS_ContingentWarrants', window );">Contingent warrant</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">235,295<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice', window );">Exercise price</a></td>
<td class="nump">$ 0.64<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 4.25<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TypeOfArrangementAxis=STSS_NotePurchaseAgreementMember', window );">Note Purchase Agreement [Member] | Unrelated Third Party Purchasers [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems', window );"><strong>Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Debt instrument face amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Interest rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">8.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentDescription', window );">Debt description</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">As
additional consideration to the Purchasers for providing the financing, the Company also agreed to a) issue each Purchaser a number of
shares of the Company&#8217;s Common Stock equal to 50% of the original principal amount of each Purchaser&#8217;s Note (the &#8220;Contingent
Stock&#8221;) and b) issue each Purchaser a number of warrants, which would allow the Purchasers to purchase additional shares of the
Company&#8217;s Common Stock, equal to 50% of the original principal amount each Purchaser&#8217;s Note for a term of 5.0 years (the
&#8220;Contingent Warrants&#8221;).<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsOfDebtIssuanceCosts', window );">Debt issuance costs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 197,500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_STSS_AllocationOfDebtIssuanceCostToContingentStockAndContingentWarrants">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Allocation of debt issuance cost to contingent stock and contingent warrants.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">STSS_AllocationOfDebtIssuanceCostToContingentStockAndContingentWarrants</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>STSS_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_STSS_ContingentStockLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Contingent stock liability.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">STSS_ContingentStockLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>STSS_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_STSS_ContingentWarrantLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Contingent warrant liability.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">STSS_ContingentWarrantLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>STSS_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_STSS_ContingentWarrants">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Contingent warrants.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">STSS_ContingentWarrants</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>STSS_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 808<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479402/808-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentDescription">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Identification of the lender and information about a contractual promise to repay a short-term or long-term obligation, which includes borrowings under lines of credit, notes payable, commercial paper, bonds payable, debentures, and other contractual obligations for payment. This may include rationale for entering into the arrangement, significant terms of the arrangement, which may include amount, repayment terms, priority, collateral required, debt covenants, borrowing capacity, call features, participation rights, conversion provisions, sinking-fund requirements, voting rights, basis for conversion if convertible and remarketing provisions. The description may be provided for individual debt instruments, rational groupings of debt instruments, or by debt in total.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -SubTopic 10<br> -Topic 210<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(19))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(16))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478546/942-210-S99-1<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(13))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478546/942-210-S99-1<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-3<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 470<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477734/942-470-50-3<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 835<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482925/835-30-45-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentDescription</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentFaceAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Face (par) amount of debt instrument at time of issuance.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 835<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482949/835-30-55-8<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1B<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 69B<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481568/470-20-55-69B<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 69C<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481568/470-20-55-69C<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 835<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482900/835-30-50-1<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 835<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482925/835-30-45-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentFaceAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentInterestRateStatedPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Contractual interest rate for funds borrowed, under the debt agreement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22)(a)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1B<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentInterestRateStatedPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentUnamortizedDiscount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after accumulated amortization, of debt discount.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 835<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1A<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482925/835-30-45-1A<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 835<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482925/835-30-45-2<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 835<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482900/835-30-50-1<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1D<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1D<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentUnamortizedDiscount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueAdjustmentOfWarrants">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of expense (income) related to adjustment to fair value of warrant liability.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 25<br> -Paragraph 13<br> -SubTopic 10<br> -Topic 480<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481766/480-10-25-13<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueAdjustmentOfWarrants</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of interest expense classified as operating and nonoperating. Includes, but is not limited to, cost of borrowing accounted for as interest expense.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-22<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 48<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-48<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 49<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-49<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 270<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482964/270-10-50-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (ee)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 24<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-24<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-22<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 835<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483013/835-20-50-1<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestPayableCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of [accrued] interest payable on all forms of debt, including trade payables, that has been incurred and is unpaid. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(20))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestPayableCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NotesPayable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Including the current and noncurrent portions, aggregate carrying amount of all types of notes payable, as of the balance sheet date, with initial maturities beyond one year or beyond the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -SubTopic 10<br> -Topic 210<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(16))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478546/942-210-S99-1<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(16)(a)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478777/944-210-S99-1<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(17))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478777/944-210-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NotesPayable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsOfDebtIssuanceCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow paid to third parties in connection with debt origination, which will be amortized over the remaining maturity period of the associated long-term debt.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-15<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsOfDebtIssuanceCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RepaymentsOfDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash outflow for short-term and long-term debt. Excludes payment of lease obligation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-15<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RepaymentsOfDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average price at which grantees could have acquired the underlying shares with respect to stock options of the plan that expired.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(04)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TypeOfArrangementAxis=STSS_NotePurchaseAgreementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TypeOfArrangementAxis=STSS_NotePurchaseAgreementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsidiarySaleOfStockAxis=us-gaap_NoteWarrantMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsidiarySaleOfStockAxis=us-gaap_NoteWarrantMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_TitleOfIndividualAxis=STSS_UnrelatedThirdPartyPurchasersMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_TitleOfIndividualAxis=STSS_UnrelatedThirdPartyPurchasersMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>147
<FILENAME>R45.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.4</span><table class="report" border="0" cellspacing="2" id="idm45095328966112">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Stockholders&#8217; Equity (Details Narrative) - USD ($)<br></strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="2"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="3">1 Months Ended</th>
<th class="th" colspan="3">3 Months Ended</th>
<th class="th" colspan="1">6 Months Ended</th>
<th class="th" colspan="2">9 Months Ended</th>
<th class="th" colspan="2">12 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Sep. 23, 2024</div></th>
<th class="th"><div>Jun. 13, 2024</div></th>
<th class="th"><div>May 31, 2024</div></th>
<th class="th"><div>May 30, 2024</div></th>
<th class="th"><div>Sep. 29, 2023</div></th>
<th class="th"><div>Feb. 03, 2023</div></th>
<th class="th"><div>Apr. 19, 2022</div></th>
<th class="th"><div>Apr. 19, 2022</div></th>
<th class="th"><div>Apr. 14, 2022</div></th>
<th class="th"><div>Apr. 13, 2022</div></th>
<th class="th"><div>Mar. 22, 2022</div></th>
<th class="th"><div>Sep. 30, 2023</div></th>
<th class="th"><div>Feb. 28, 2023</div></th>
<th class="th"><div>Apr. 30, 2022</div></th>
<th class="th"><div>Sep. 30, 2024</div></th>
<th class="th"><div>Jun. 30, 2024</div></th>
<th class="th"><div>Sep. 30, 2023</div></th>
<th class="th"><div>Jun. 30, 2024</div></th>
<th class="th"><div>Sep. 30, 2024</div></th>
<th class="th"><div>Sep. 30, 2023</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Jul. 31, 2024</div></th>
<th class="th"><div>May 29, 2024</div></th>
<th class="th"><div>Apr. 30, 2023</div></th>
<th class="th"><div>Oct. 09, 2022</div></th>
<th class="th"><div>Mar. 21, 2022</div></th>
<th class="th"><div>Apr. 18, 2019</div></th>
<th class="th"><div>Dec. 11, 2017</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockLineItems', window );"><strong>Subsidiary, Sale of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesAuthorized', window );">Common stock, share authorized</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">100,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">500,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">500,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">100,000,000<span></span>
</td>
<td class="nump">100,000,000<span></span>
</td>
<td class="nump">100,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">50,000,000<span></span>
</td>
<td class="nump">50,000,000<span></span>
</td>
<td class="nump">20,000,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockParOrStatedValuePerShare', window );">Common stock, par value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.0001<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.0001<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.0001<span></span>
</td>
<td class="nump">$ 0.0001<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.0001<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockSharesAuthorized', window );">Preferred stock, shares authorized</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,000,000<span></span>
</td>
<td class="nump">1,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">10,000<span></span>
</td>
<td class="nump">10,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockParOrStatedValuePerShare', window );">Preferred stock, par value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.0001<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.0001<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.0001<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.0001<span></span>
</td>
<td class="nump">$ 0.0001<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.001<span></span>
</td>
<td class="nump">$ 0.001<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConversionOfStockDescription', window );">Conversion of stock, description</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">Pursuant to the merger agreement, (i) the Company merged with and into Sharps Nevada, (ii) each 3.5 shares of common
stock of the Company were converted into one share of common stock of Sharps Nevada and (iii) the articles of incorporation and bylaws
of Sharps Nevada, became the articles of incorporation and bylaws of the surviving corporation.<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOfCommonStock', window );">Gross proceeds</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 5,600,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherExpenses', window );">Other offering expenses</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 716,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdditionalPaidInCapital', window );">Additional paid in capital</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 9,000,000.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 35,941,738<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 35,941,738<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 32,491,409<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAdjustmentOfWarrants', window );">Fair value adjustment of warrants</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5,200,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 42,915<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice', window );">Exercise price</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 4.38<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightOutstanding', window );">Warrants issued</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">20,541,318<span></span>
</td>
<td class="nump">9,047,794<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesIssuedForServices', window );">Common stock issued for services, shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">235,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueIssuedForServices', window );">Common stock issued for services, value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 290,551<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1', window );">Expected term</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">3 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum', window );">Volatility, minimum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">24.49%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum', window );">Volatility, maximum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">44.83%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum', window );">Risk free interest rate, minimum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3.58%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum', window );">Risk free interest rate, maximum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4.67%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate', window );">Dividend rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.00%<span></span>
</td>
<td class="nump">0.00%<span></span>
</td>
<td class="nump">0.00%<span></span>
</td>
<td class="nump">0.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MarketRiskBenefitChangeInFairValueGainLoss', window );">Fair market value adjustment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 169,583<span></span>
</td>
<td class="nump">$ 4,784,559<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_STSS_WarrantLiabilitiesCurrent', window );">Warrants liability</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5,200,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,027,102<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,027,102<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2,422,785<span></span>
</td>
<td class="nump">$ 1,151,838<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_STSS_FairValueAdjustmentOfModificationCharge', window );">Fair value adjustment of modification charge</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 155,703<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 790,956<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_RangeAxis=srt_MaximumMember', window );">Maximum [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockLineItems', window );"><strong>Subsidiary, Sale of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1', window );">Expected term</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">3 years 21 days<span></span>
</td>
<td class="text">3 years 3 months<span></span>
</td>
<td class="text">3 years 3 months<span></span>
</td>
<td class="text">3 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate', window );">Volatility</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">83.04%<span></span>
</td>
<td class="nump">89.93%<span></span>
</td>
<td class="nump">89.93%<span></span>
</td>
<td class="nump">110.74%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate', window );">Risk free interest rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4.76%<span></span>
</td>
<td class="nump">4.27%<span></span>
</td>
<td class="nump">4.27%<span></span>
</td>
<td class="nump">3.47%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_RangeAxis=srt_MinimumMember', window );">Minimum [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockLineItems', window );"><strong>Subsidiary, Sale of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1', window );">Expected term</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">2 years 7 months 28 days<span></span>
</td>
<td class="text">2 years 10 months 17 days<span></span>
</td>
<td class="text">2 years 10 months 17 days<span></span>
</td>
<td class="text">2 years 6 months<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate', window );">Volatility</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">81.15%<span></span>
</td>
<td class="nump">75.40%<span></span>
</td>
<td class="nump">75.40%<span></span>
</td>
<td class="nump">100.81%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate', window );">Risk free interest rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4.71%<span></span>
</td>
<td class="nump">3.71%<span></span>
</td>
<td class="nump">3.71%<span></span>
</td>
<td class="nump">2.90%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_TitleOfIndividualAxis=STSS_WarrantHoldersMember', window );">Warrant Holders [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockLineItems', window );"><strong>Subsidiary, Sale of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight', window );">Prefunded warrants</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">230,091<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">230,091<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1', window );">Exercise price</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 7.26<span></span>
</td>
<td class="nump">$ 7.26<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 7.26<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 7.26<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_STSS_FairValueAdjustmentOfModificationCharge', window );">Fair value adjustment of modification charge</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 155,703<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 155,703<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_TitleOfIndividualAxis=STSS_WarrantHolderMember', window );">Warrant Holder [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockLineItems', window );"><strong>Subsidiary, Sale of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1', window );">Exercise price</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.0001<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.0001<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=STSS_PreReverseMember', window );">Pre Reverse [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockLineItems', window );"><strong>Subsidiary, Sale of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues', window );">Warrants issued</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">225,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">130,000<span></span>
</td>
<td class="nump">360,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=STSS_PreReverseMember', window );">Pre Reverse [Member] | Warrant Holders [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockLineItems', window );"><strong>Subsidiary, Sale of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight', window );">Prefunded warrants</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5,260,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5,260,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1', window );">Exercise price</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.33<span></span>
</td>
<td class="nump">$ 0.33<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.33<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.33<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=STSS_ReverseStockSplitMember', window );">Reverse Stock Split [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockLineItems', window );"><strong>Subsidiary, Sale of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdditionalPaidInCapital', window );">Additional paid in capital</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 32,489,950<span></span>
</td>
<td class="nump">$ 24,733,306<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_WarrantMember', window );">Warrant [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockLineItems', window );"><strong>Subsidiary, Sale of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues', window );">Warrants issued</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">10,227<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5,909<span></span>
</td>
<td class="nump">16,363<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1', window );">Exercise price</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 34.32<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WarrantsAndRightsOutstandingTerm', window );">Warrants exercise price term</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">5 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAdjustmentOfWarrants', window );">Fair value adjustment of warrants</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 22,470<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 8,590<span></span>
</td>
<td class="nump">$ 42,306<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_STSS_StockIssuedDuringPeriodSharesInitialPublicOffering', window );">Initial public offering</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,750,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice', window );">Exercise price</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 4.25<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightOutstanding', window );">Warrants issued</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,125,000<span></span>
</td>
<td class="nump">1,125,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">103,685<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">103,685<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1', window );">Expected term</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">3 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum', window );">Volatility, minimum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">33.46%<span></span>
</td>
<td class="nump">37.45%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum', window );">Volatility, maximum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">81.62%<span></span>
</td>
<td class="nump">44.83%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum', window );">Risk free interest rate, minimum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4.20%<span></span>
</td>
<td class="nump">3.58%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum', window );">Risk free interest rate, maximum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4.25%<span></span>
</td>
<td class="nump">4.43%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate', window );">Dividend rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.00%<span></span>
</td>
<td class="nump">0.00%<span></span>
</td>
<td class="nump">0.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised', window );">Warrants exercised</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">51,136<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_STSS_ClassOfWarrantOrRightIssued', window );">Aggregate warrants issued</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">28,636<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_WarrantMember', window );">Warrant [Member] | Maximum [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockLineItems', window );"><strong>Subsidiary, Sale of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1', window );">Expected term</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">5 years 6 months<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate', window );">Risk free interest rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4.54%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_WarrantMember', window );">Warrant [Member] | Minimum [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockLineItems', window );"><strong>Subsidiary, Sale of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1', window );">Expected term</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">4 years 1 month 6 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate', window );">Risk free interest rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3.53%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_WarrantMember', window );">Warrant [Member] | Pre Reverse [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockLineItems', window );"><strong>Subsidiary, Sale of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1', window );">Exercise price</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1.56<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised', window );">Warrants exercised</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,125,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_STSS_ClassOfWarrantOrRightIssued', window );">Aggregate warrants issued</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">630,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TypeOfArrangementAxis=STSS_SecuritiesPurchaseAgreementMember', window );">Securities Purchase Agreement [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockLineItems', window );"><strong>Subsidiary, Sale of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues', window );">Warrants issued</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">102,206<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesIssuedPricePerShare', window );">Purchase price pre reverse</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 37.18<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1', window );">Exercise price</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 7.26<span></span>
</td>
<td class="nump">14.08<span></span>
</td>
<td class="nump">$ 34.32<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WarrantsAndRightsOutstandingTerm', window );">Warrants exercise price term</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">5 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NoninterestExpenseOfferingCost', window );">Offering expenses</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 600,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesOther', window );">Issued shares of common stock</a></td>
<td class="nump">259,091<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOrSaleOfEquity', window );">Net proceeds from offering</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 3,200,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SaleOfStockDescriptionOfTransaction', window );">Units description</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">Each
unit consisted of one share of common stock and one non-tradable warrant (&#8220;Offering Warrants&#8221;) exercisable for one share
of common stock<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TypeOfArrangementAxis=STSS_SecuritiesPurchaseAgreementMember', window );">Securities Purchase Agreement [Member] | Pre Reverse [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockLineItems', window );"><strong>Subsidiary, Sale of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues', window );">Warrants issued</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,248,521<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesIssuedPricePerShare', window );">Purchase price pre reverse</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1.69<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesOther', window );">Issued shares of common stock</a></td>
<td class="nump">5,700,006<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TypeOfArrangementAxis=STSS_SecuritiesPurchaseAgreementMember', window );">Securities Purchase Agreement [Member] | PIPE Pre Funded Warrants [Member] | Maximum [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockLineItems', window );"><strong>Subsidiary, Sale of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesIssuedPricePerShare', window );">Purchase price pre reverse</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">23.63<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TypeOfArrangementAxis=STSS_SecuritiesPurchaseAgreementMember', window );">Securities Purchase Agreement [Member] | PIPE Pre Funded Warrants [Member] | Minimum [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockLineItems', window );"><strong>Subsidiary, Sale of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesIssuedPricePerShare', window );">Purchase price pre reverse</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">23.606<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TypeOfArrangementAxis=STSS_SecuritiesPurchaseAgreementMember', window );">Securities Purchase Agreement [Member] | PIPE Pre Funded Warrants [Member] | Pre Reverse [Member] | Maximum [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockLineItems', window );"><strong>Subsidiary, Sale of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesIssuedPricePerShare', window );">Purchase price pre reverse</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1.074<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TypeOfArrangementAxis=STSS_SecuritiesPurchaseAgreementMember', window );">Securities Purchase Agreement [Member] | PIPE Pre Funded Warrants [Member] | Pre Reverse [Member] | Minimum [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockLineItems', window );"><strong>Subsidiary, Sale of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesIssuedPricePerShare', window );">Purchase price pre reverse</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1.073<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TypeOfArrangementAxis=STSS_PurchaseAgreementMember', window );">Purchase Agreement [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockLineItems', window );"><strong>Subsidiary, Sale of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues', window );">Warrants issued</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,248,521<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesIssuedPricePerShare', window );">Purchase price pre reverse</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1.69<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1', window );">Exercise price</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1.56<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_STSS_NetProceedsFromIssuanceInitialPublicOffering', window );">Net proceeds from offering</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 3,200,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NoninterestExpenseOfferingCost', window );">Offering expenses</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 600,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_STSS_ClassOfWarrantOrRightExercisePriceOfWarrantsAdjusted', window );">Warrant exerice price</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.64<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TypeOfArrangementAxis=STSS_NotePurchaseAgreementMember', window );">Note Purchase Agreement [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockLineItems', window );"><strong>Subsidiary, Sale of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAdjustmentOfWarrants', window );">Fair value adjustment of warrants</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 496,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesIssuedForServices', window );">Common stock issued for services, shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">235,295<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TypeOfArrangementAxis=STSS_SubscriptionAgreementsMember', window );">Subscription Agreements [Member] | Investors [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockLineItems', window );"><strong>Subsidiary, Sale of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockParOrStatedValuePerShare', window );">Common stock, par value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.0001<span></span>
</td>
<td class="nump">$ 0.0001<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOfCommonStock', window );">Gross proceeds</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,600,000<span></span>
</td>
<td class="nump">$ 1,600,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherExpenses', window );">Other offering expenses</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">298,000<span></span>
</td>
<td class="nump">298,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdditionalPaidInCapital', window );">Additional paid in capital</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,296,903<span></span>
</td>
<td class="nump">$ 1,296,903<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction', window );">Number of units sold</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">190,773<span></span>
</td>
<td class="nump">190,773<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SaleOfStockPricePerShare', window );">Shares price pre reverse</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 8.36<span></span>
</td>
<td class="nump">$ 8.36<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TypeOfArrangementAxis=STSS_SubscriptionAgreementsMember', window );">Subscription Agreements [Member] | Pre Reverse [Member] | Investors [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockLineItems', window );"><strong>Subsidiary, Sale of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction', window );">Number of units sold</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4,197,000<span></span>
</td>
<td class="nump">4,197,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SaleOfStockPricePerShare', window );">Shares price pre reverse</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.38<span></span>
</td>
<td class="nump">$ 0.38<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TypeOfArrangementAxis=STSS_InducementAgreementMember', window );">Inducement Agreement [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockLineItems', window );"><strong>Subsidiary, Sale of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockParOrStatedValuePerShare', window );">Common stock, par value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.0001<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1', window );">Exercise price</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 14.08<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights', window );">Warrants exercised shares pre reverse</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">499,932<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TypeOfArrangementAxis=STSS_InducementAgreementMember', window );">Inducement Agreement [Member] | Warrant Holders [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockLineItems', window );"><strong>Subsidiary, Sale of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherExpenses', window );">Other offering expenses</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 285,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1', window );">Exercise price</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 14.08<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdditionalPaidInCapital', window );">Additional paid in capital</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 978,955<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WarrantsAndRightsOutstanding', window );">Nominal cost of warrant</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">693,064<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOfWarrants', window );">Proceeds from Issuance of Warrants</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,900,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TypeOfArrangementAxis=STSS_InducementAgreementMember', window );">Inducement Agreement [Member] | Pre Reverse [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockLineItems', window );"><strong>Subsidiary, Sale of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1', window );">Exercise price</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">7.26<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights', window );">Warrants exercised shares pre reverse</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">10,998,524<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TypeOfArrangementAxis=STSS_InducementAgreementMember', window );">Inducement Agreement [Member] | Pre Reverse [Member] | Maximum [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockLineItems', window );"><strong>Subsidiary, Sale of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1', window );">Exercise price</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.64<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TypeOfArrangementAxis=STSS_InducementAgreementMember', window );">Inducement Agreement [Member] | Pre Reverse [Member] | Minimum [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockLineItems', window );"><strong>Subsidiary, Sale of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1', window );">Exercise price</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.33<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TypeOfArrangementAxis=STSS_InducementAgreementMember', window );">Inducement Agreement [Member] | Pre Reverse [Member] | Warrant Holders [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockLineItems', window );"><strong>Subsidiary, Sale of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1', window );">Exercise price</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 7.26<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TypeOfArrangementAxis=STSS_InducementAgreementMember', window );">Inducement Agreement [Member] | Pre Reverse [Member] | Warrant Holders [Member] | Maximum [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockLineItems', window );"><strong>Subsidiary, Sale of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1', window );">Exercise price</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.64<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TypeOfArrangementAxis=STSS_InducementAgreementMember', window );">Inducement Agreement [Member] | Pre Reverse [Member] | Warrant Holders [Member] | Minimum [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockLineItems', window );"><strong>Subsidiary, Sale of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1', window );">Exercise price</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.33<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TypeOfArrangementAxis=STSS_InducementWarrantsMember', window );">Inducement Warrants [Member] | Warrant Holders [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockLineItems', window );"><strong>Subsidiary, Sale of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1', window );">Exercise price</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 9.90<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights', window );">Warrants exercised shares pre reverse</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">260,799<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TypeOfArrangementAxis=STSS_InducementWarrantsMember', window );">Inducement Warrants [Member] | Pre Reverse [Member] | Warrant Holders [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockLineItems', window );"><strong>Subsidiary, Sale of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1', window );">Exercise price</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.45<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights', window );">Warrants exercised shares pre reverse</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5,737,573<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockAxis=STSS_ShelfOfferingMember', window );">Shelf Offering [Member] | Securities Purchase Agreement [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockLineItems', window );"><strong>Subsidiary, Sale of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceInitialPublicOffering', window );">Net proceeds from IPO</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2,500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LegalFees', window );">Placement agent fees</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 362,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues', window );">Warrants issued</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,618,521<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesIssuedPricePerShare', window );">Purchase price pre reverse</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 7.26<span></span>
</td>
<td class="nump">$ 0.64<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1', window );">Exercise price</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.001<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOrSaleOfEquity', window );">Net proceeds from offering</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2,500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockAxis=STSS_ShelfOfferingMember', window );">Shelf Offering [Member] | Securities Purchase Agreement [Member] | Pre Reverse [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockLineItems', window );"><strong>Subsidiary, Sale of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues', window );">Warrants issued</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,618,521<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockAxis=STSS_ShelfOfferingMember', window );">Shelf Offering [Member] | Securities Purchase Agreement [Member] | Reverse Stock Split [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockLineItems', window );"><strong>Subsidiary, Sale of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues', window );">Warrants issued</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">164,478<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesIssuedPricePerShare', window );">Purchase price pre reverse</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 14.08<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockAxis=STSS_ShelfOfferingMember', window );">Shelf Offering [Member] | Securities Purchase Agreement [Member] | Warrant [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockLineItems', window );"><strong>Subsidiary, Sale of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight', window );">Prefunded warrants</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">800,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1', window );">Exercise price</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.639<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockAxis=STSS_ShelfOfferingMember', window );">Shelf Offering [Member] | Securities Purchase Agreement [Member] | Pre-funded Warrants [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockLineItems', window );"><strong>Subsidiary, Sale of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight', window );">Prefunded warrants</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">36,636<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1', window );">Exercise price</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 14.058<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockAxis=STSS_ShelfOfferingMember', window );">Shelf Offering [Member] | Securities Purchase Agreement [Member] | Pre-funded Warrants [Member] | Pre Reverse [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockLineItems', window );"><strong>Subsidiary, Sale of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight', window );">Prefunded warrants</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">800,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1', window );">Exercise price</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.639<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockAxis=us-gaap_PrivatePlacementMember', window );">Private Placement [Member] | Securities Purchase Agreement [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockLineItems', window );"><strong>Subsidiary, Sale of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LegalFees', window );">Placement agent fees</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 354,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOfPrivatePlacement', window );">Net proceeds from the Private Placement</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,400,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdditionalPaidInCapital', window );">Additional paid in capital</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,600,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAdjustmentOfWarrants', window );">Fair value adjustment of warrants</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 985,204<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WarrantsAndRightsOutstanding', window );">Nominal cost of warrant</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,036,875<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockAxis=us-gaap_PrivatePlacementMember', window );">Private Placement [Member] | Securities Purchase Agreement [Member] | PIPE Pre Funded Warrants [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockLineItems', window );"><strong>Subsidiary, Sale of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues', window );">Warrants issued</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,581,479<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1', window );">Exercise price</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">7.26<span></span>
</td>
<td class="nump">$ 0.64<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WarrantsAndRightsOutstandingTerm', window );">Warrants exercise price term</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">5 years 6 months<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockAxis=us-gaap_PrivatePlacementMember', window );">Private Placement [Member] | Securities Purchase Agreement [Member] | PIPE Pre Funded Warrants [Member] | Pre Reverse [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockLineItems', window );"><strong>Subsidiary, Sale of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues', window );">Warrants issued</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,581,479<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockAxis=us-gaap_PrivatePlacementMember', window );">Private Placement [Member] | Securities Purchase Agreement [Member] | PIPE Pre Funded Warrants [Member] | Reverse Stock Split [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockLineItems', window );"><strong>Subsidiary, Sale of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues', window );">Warrants issued</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">117,340<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1', window );">Exercise price</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 14.08<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockAxis=STSS_NonTradingWarrantsMember', window );">Non Trading Warrants [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockLineItems', window );"><strong>Subsidiary, Sale of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues', window );">Warrants issued</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">8,750,003<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">8,750,003<span></span>
</td>
<td class="nump">2,248,521<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">495,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAdjustmentOfWarrants', window );">Fair value adjustment of warrants</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 7,563<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">56,172<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 214,019<span></span>
</td>
<td class="nump">$ 238,752<span></span>
</td>
<td class="nump">$ 221,254<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WarrantsAndRightsOutstanding', window );">Nominal cost of warrant</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 455,326<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">234,072<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_STSS_FairValueAdjustmentOfModificationCharge', window );">Fair value adjustment of modification charge</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">7,612<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">153,640<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockAxis=STSS_NonTradingWarrantsMember', window );">Non Trading Warrants [Member] | Pre Reverse [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockLineItems', window );"><strong>Subsidiary, Sale of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues', window );">Warrants issued</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">8,750,003<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">8,750,003<span></span>
</td>
<td class="nump">2,248,521<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockAxis=STSS_NonTradingWarrantsMember', window );">Non Trading Warrants [Member] | Reverse Stock Split [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockLineItems', window );"><strong>Subsidiary, Sale of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues', window );">Warrants issued</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">397,727<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">397,727<span></span>
</td>
<td class="nump">102,206<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockAxis=STSS_NonTradingWarrantsMember', window );">Non Trading Warrants [Member] | PIPE Warrant [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockLineItems', window );"><strong>Subsidiary, Sale of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAdjustmentOfWarrants', window );">Fair value adjustment of warrants</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(181,163)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">470,721<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WarrantsAndRightsOutstanding', window );">Nominal cost of warrant</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 985,204<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,036,875<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MarketRiskBenefitChangeInFairValueGainLoss', window );">Fair market value adjustment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">51,671<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_STSS_FairValueAdjustmentOfModificationCharge', window );">Fair value adjustment of modification charge</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(148,091)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(637,316)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockAxis=STSS_SecuritiesPurchaseAgreementMember', window );">Securities Purchase Agreement [Member] | Purchase Agreement [Member] | PIPE Pre Funded Warrants [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockLineItems', window );"><strong>Subsidiary, Sale of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesIssuedPricePerShare', window );">Purchase price pre reverse</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1.074<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockAxis=us-gaap_IPOMember', window );">IPO [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockLineItems', window );"><strong>Subsidiary, Sale of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceInitialPublicOffering', window );">Net proceeds from IPO</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 14,200,000<span></span>
</td>
<td class="nump">$ 14,200,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues', window );">Warrants issued</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">8,523<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1', window );">Exercise price</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 7.26<span></span>
</td>
<td class="nump">$ 14.08<span></span>
</td>
<td class="nump">$ 34.32<span></span>
</td>
<td class="nump">$ 117.04<span></span>
</td>
<td class="nump">$ 117.04<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 93.50<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 5.32<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WarrantsAndRightsOutstandingTerm', window );">Warrants exercise price term</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">5 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAdjustmentOfWarrants', window );">Fair value adjustment of warrants</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 228,750<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 228,750<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WarrantsAndRightsOutstanding', window );">Nominal cost of warrant</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 11,250<span></span>
</td>
<td class="nump">$ 11,250<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightOutstanding', window );">Warrants issued</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">187,500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1', window );">Expected term</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">5 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate', window );">Dividend rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsOfStockIssuanceCosts', window );">Nominal cost</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 11,250<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate', window );">Volatility</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">93.47%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">93.47%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate', window );">Risk free interest rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2.77%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2.77%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction', window );">Number of units sold</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">170,454<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SaleOfStockDescriptionOfTransaction', window );">Units description</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">each consisting of one share of
common stock and two warrants, to purchase one share of common stock for each whole warrant<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_STSS_DescriptionForOfferingShares', window );">Description for offering shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">the Company granted Aegis Capital Corp., as underwriter a 45-day over-allotment option to purchase up to 15% of the number of shares
included in the units sold in the offering, and/or additional warrants equal to 15% of the number of Warrants included in the units sold
in the offering, in each case solely to cover over-allotments<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockAxis=us-gaap_IPOMember', window );">IPO [Member] | Pre Reverse [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockLineItems', window );"><strong>Subsidiary, Sale of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1', window );">Exercise price</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 5.32<span></span>
</td>
<td class="nump">$ 5.32<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 4.25<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightOutstanding', window );">Warrants issued</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">187,500<span></span>
</td>
<td class="nump">187,500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction', window );">Number of units sold</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,750,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockAxis=us-gaap_NoteWarrantMember', window );">Note Warrant [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockLineItems', window );"><strong>Subsidiary, Sale of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues', window );">Warrants issued</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">235,295<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1', window );">Exercise price</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 4.25<span></span>
</td>
<td class="nump">$ 4.25<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1.56<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WarrantsAndRightsOutstandingTerm', window );">Warrants exercise price term</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">5 years<span></span>
</td>
<td class="text">5 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockAxis=us-gaap_NoteWarrantMember', window );">Note Warrant [Member] | Note Purchase Agreement [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockLineItems', window );"><strong>Subsidiary, Sale of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice', window );">Exercise price</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.64<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 4.25<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockAxis=STSS_TradingWarrantsMember', window );">Trading Warrants [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockLineItems', window );"><strong>Subsidiary, Sale of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues', window );">Warrants issued</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">340,900<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">7,500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAdjustmentOfWarrants', window );">Fair value adjustment of warrants</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">198,375<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">258,750<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">690,001<span></span>
</td>
<td class="nump">172,500<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 4,784,559<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WarrantsAndRightsOutstanding', window );">Nominal cost of warrant</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,121,250<span></span>
</td>
<td class="nump">1,121,250<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockAxis=STSS_TradingWarrantsMember', window );">Trading Warrants [Member] | Pre Reverse [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockLineItems', window );"><strong>Subsidiary, Sale of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues', window );">Warrants issued</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">7,500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockAxis=us-gaap_OverAllotmentOptionMember', window );">Over-Allotment Option [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockLineItems', window );"><strong>Subsidiary, Sale of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues', window );">Warrants issued</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,125,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockAxis=STSS_NoteWarrantsMember', window );">Note Warrants [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockLineItems', window );"><strong>Subsidiary, Sale of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues', window );">Warrants issued</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">10,695<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAdjustmentOfWarrants', window );">Fair value adjustment of warrants</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 5,411<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 7,059<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 18,822<span></span>
</td>
<td class="nump">$ 7,059<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 127,059<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightOutstanding', window );">Warrants issued</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">235,294<span></span>
</td>
<td class="nump">235,294<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_STSS_PaymentsForRepurchaseOfLiability', window );">Warrant outstanding</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 30,588<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockAxis=STSS_NoteWarrantsMember', window );">Note Warrants [Member] | Pre Reverse [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockLineItems', window );"><strong>Subsidiary, Sale of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues', window );">Warrants issued</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">235,295<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockAxis=STSS_InducementWarrantsMember', window );">Inducement Warrants [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockLineItems', window );"><strong>Subsidiary, Sale of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues', window );">Warrants issued</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">260,799<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">260,799<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAdjustmentOfWarrants', window );">Fair value adjustment of warrants</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 293,684<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockAxis=STSS_InducementWarrantsMember', window );">Inducement Warrants [Member] | Pre Reverse [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockLineItems', window );"><strong>Subsidiary, Sale of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues', window );">Warrants issued</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5,737,573<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockAxis=STSS_OverAllotmentWarrantsMember', window );">Over-Allotment Warrants [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockLineItems', window );"><strong>Subsidiary, Sale of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues', window );">Warrants issued</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">51,136<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockAxis=STSS_OverAllotmentWarrantsMember', window );">Over-Allotment Warrants [Member] | Pre Reverse [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockLineItems', window );"><strong>Subsidiary, Sale of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues', window );">Warrants issued</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,125,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_STSS_ClassOfWarrantOrRightExercisePriceOfWarrantsAdjusted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Class of warrant or right exercise price of warrants adjusted.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">STSS_ClassOfWarrantOrRightExercisePriceOfWarrantsAdjusted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>STSS_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_STSS_ClassOfWarrantOrRightIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregate warrants issued.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">STSS_ClassOfWarrantOrRightIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>STSS_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_STSS_DescriptionForOfferingShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Description for offering, shares.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">STSS_DescriptionForOfferingShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>STSS_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_STSS_FairValueAdjustmentOfModificationCharge">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value adjustment of modification charge.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">STSS_FairValueAdjustmentOfModificationCharge</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>STSS_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_STSS_NetProceedsFromIssuanceInitialPublicOffering">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Net proceeds from issuance initial public offering.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">STSS_NetProceedsFromIssuanceInitialPublicOffering</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>STSS_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_STSS_PaymentsForRepurchaseOfLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Payments for repurchase of liability.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">STSS_PaymentsForRepurchaseOfLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>STSS_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_STSS_StockIssuedDuringPeriodSharesInitialPublicOffering">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Stock issued during period shares initial public offering.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">STSS_StockIssuedDuringPeriodSharesInitialPublicOffering</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>STSS_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_STSS_WarrantLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Warrant liabilities current.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">STSS_WarrantLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>STSS_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdditionalPaidInCapital">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of excess of issue price over par or stated value of stock and from other transaction involving stock or stockholder. Includes, but is not limited to, additional paid-in capital (APIC) for common and preferred stock.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481372/852-10-55-10<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(18))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdditionalPaidInCapital</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Exercise price per share or per unit of warrants or rights outstanding.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-3<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of securities into which each warrant or right may be converted. For example, but not limited to, each warrant may be converted into two shares.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of securities into which the class of warrant or right may be converted. For example, but not limited to, 500,000 warrants may be converted into 1,000,000 shares.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-3<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of warrants or rights outstanding.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockParOrStatedValuePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Face amount or stated value per share of common stock.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockParOrStatedValuePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The maximum number of common shares permitted to be issued by an entity's charter and bylaws.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(16)(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConversionOfStockDescription">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A unique description of a noncash or part noncash stock conversion. The description would be expected to include sufficient information to provide an understanding of the nature and purpose of the conversion. Noncash is defined as transactions during a period that do not result in cash receipts or cash payments in the period. "Part noncash" refers to that portion of the transaction not resulting in cash receipts or cash payments in the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482913/230-10-50-4<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482913/230-10-50-3<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482913/230-10-50-5<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConversionOfStockDescription</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueAdjustmentOfWarrants">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of expense (income) related to adjustment to fair value of warrant liability.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 25<br> -Paragraph 13<br> -SubTopic 10<br> -Topic 480<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481766/480-10-25-13<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueAdjustmentOfWarrants</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LegalFees">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of expense provided in the period for legal costs incurred on or before the balance sheet date pertaining to resolved, pending or threatened litigation, including arbitration and mediation proceedings.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(6))<br> -SubTopic 10<br> -Topic 220<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LegalFees</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MarketRiskBenefitChangeInFairValueGainLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of gain (loss) from (increase) decrease in fair value of contract or contract feature in long-duration contract issued by insurance entity that both protects contract holder from other-than-nominal capital market risk and exposes insurance entity to other-than-nominal capital market risk. Excludes change attributable to instrument-specific credit risk.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480112/944-40-45-3<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MarketRiskBenefitChangeInFairValueGainLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NoninterestExpenseOfferingCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Includes offering costs of open-end investment companies, and closed-end funds with a continuous offering period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(14))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478524/942-220-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NoninterestExpenseOfferingCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherExpenses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of expense classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(6))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherExpenses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsOfStockIssuanceCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow for cost incurred directly with the issuance of an equity security.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-15<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsOfStockIssuanceCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockParOrStatedValuePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Face amount or stated value per share of preferred stock nonredeemable or redeemable solely at the option of the issuer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-13<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockParOrStatedValuePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The maximum number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) permitted to be issued by an entity's charter and bylaws.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(16)(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromIssuanceInitialPublicOffering">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash inflow associated with the amount received from entity's first offering of stock to the public.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-14<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromIssuanceInitialPublicOffering</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromIssuanceOfCommonStock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from the additional capital contribution to the entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-14<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromIssuanceOfCommonStock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromIssuanceOfPrivatePlacement">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash inflow associated with the amount received from entity's raising of capital via private rather than public placement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-14<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromIssuanceOfPrivatePlacement</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromIssuanceOfWarrants">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from issuance of rights to purchase common shares at predetermined price (usually issued together with corporate debt).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-14<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromIssuanceOfWarrants</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromIssuanceOrSaleOfEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from the issuance of common stock, preferred stock, treasury stock, stock options, and other types of equity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-14<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-03(i)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479886/946-10-S99-3<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromIssuanceOrSaleOfEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SaleOfStockDescriptionOfTransaction">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Description of stock transaction which may include details of the offering (IPO, private placement), a description of the stock sold, percentage of subsidiary's or equity investee's stock sold, a description of the investors and whether the stock was issued in a business combination.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 23<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481231/810-10-45-23<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481203/810-10-50-1A<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -SubTopic 10<br> -Topic 810<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481203/810-10-50-1B<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SaleOfStockDescriptionOfTransaction</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of shares issued or sold by the subsidiary or equity method investee per stock transaction.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SaleOfStockPricePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Per share amount received by subsidiary or equity investee for each share of common stock issued or sold in the stock transaction.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SaleOfStockPricePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The estimated dividend rate (a percentage of the share price) to be paid (expected dividends) to holders of the underlying shares over the option's term.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(iii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The estimated measure of the maximum percentage by which a share price is expected to fluctuate during a period. Volatility also may be defined as a probability-weighted measure of the dispersion of returns about the mean. The volatility of a share price is the standard deviation of the continuously compounded rates of return on the share over a specified period. That is the same as the standard deviation of the differences in the natural logarithms of the stock prices plus dividends, if any, over the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The estimated measure of the minimum percentage by which a share price is expected to fluctuate during a period. Volatility also may be defined as a probability-weighted measure of the dispersion of returns about the mean. The volatility of a share price is the standard deviation of the continuously compounded rates of return on the share over a specified period. That is the same as the standard deviation of the differences in the natural logarithms of the stock prices plus dividends, if any, over the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The risk-free interest rate assumption that is used in valuing an option on its own shares.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(iv)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The maximum risk-free interest rate assumption that is used in valuing an option on its own shares.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The minimum risk-free interest rate assumption that is used in valuing an option on its own shares.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Rate of weighted-average expected volatility for award under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of non-option equity instruments exercised by participants.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(02)<br> -SubTopic 10<br> -Topic 718<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average price at which grantees could have acquired the underlying shares with respect to stock options of the plan that expired.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(04)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Expected term of award under share-based payment arrangement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharesIssuedPricePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Per share or per unit amount of equity securities issued.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharesIssuedPricePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesIssuedForServices">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares issued in lieu of cash for services contributed to the entity. Number of shares includes, but is not limited to, shares issued for services contributed by vendors and founders.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesIssuedForServices</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of new stock issued during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 505<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-2<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 505<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478448/946-505-50-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(4)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-03(i)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479886/946-10-S99-3<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480008/505-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesNewIssues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesOther">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares of stock issued attributable to transactions classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesOther</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodValueIssuedForServices">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Value of stock issued in lieu of cash for services contributed to the entity. Value of the stock issued includes, but is not limited to, services contributed by vendors and founders.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodValueIssuedForServices</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsidiarySaleOfStockLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsidiarySaleOfStockLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WarrantsAndRightsOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Value of outstanding derivative securities that permit the holder the right to purchase securities (usually equity) from the issuer at a specified price.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (bbb)(2)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (bbb)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (bbb)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WarrantsAndRightsOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WarrantsAndRightsOutstandingTerm">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Period between issuance and expiration of outstanding warrant and right embodying unconditional obligation requiring redemption by transferring asset at specified or determinable date or upon event certain to occur, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (bbb)(2)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (bbb)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (bbb)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WarrantsAndRightsOutstandingTerm</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MinimumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MinimumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_TitleOfIndividualAxis=STSS_WarrantHoldersMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_TitleOfIndividualAxis=STSS_WarrantHoldersMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_TitleOfIndividualAxis=STSS_WarrantHolderMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_TitleOfIndividualAxis=STSS_WarrantHolderMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=STSS_PreReverseMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=STSS_PreReverseMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=STSS_ReverseStockSplitMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=STSS_ReverseStockSplitMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_WarrantMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_WarrantMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TypeOfArrangementAxis=STSS_SecuritiesPurchaseAgreementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TypeOfArrangementAxis=STSS_SecuritiesPurchaseAgreementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=STSS_PIPEPreFundedWarrantsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=STSS_PIPEPreFundedWarrantsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TypeOfArrangementAxis=STSS_PurchaseAgreementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TypeOfArrangementAxis=STSS_PurchaseAgreementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TypeOfArrangementAxis=STSS_NotePurchaseAgreementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TypeOfArrangementAxis=STSS_NotePurchaseAgreementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TypeOfArrangementAxis=STSS_SubscriptionAgreementsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TypeOfArrangementAxis=STSS_SubscriptionAgreementsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_TitleOfIndividualAxis=STSS_InvestorsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_TitleOfIndividualAxis=STSS_InvestorsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TypeOfArrangementAxis=STSS_InducementAgreementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TypeOfArrangementAxis=STSS_InducementAgreementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TypeOfArrangementAxis=STSS_InducementWarrantsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TypeOfArrangementAxis=STSS_InducementWarrantsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsidiarySaleOfStockAxis=STSS_ShelfOfferingMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsidiarySaleOfStockAxis=STSS_ShelfOfferingMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=STSS_PreFundedWarrantsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=STSS_PreFundedWarrantsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsidiarySaleOfStockAxis=us-gaap_PrivatePlacementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsidiarySaleOfStockAxis=us-gaap_PrivatePlacementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsidiarySaleOfStockAxis=STSS_NonTradingWarrantsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsidiarySaleOfStockAxis=STSS_NonTradingWarrantsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=STSS_PIPEWarrantMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=STSS_PIPEWarrantMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsidiarySaleOfStockAxis=STSS_SecuritiesPurchaseAgreementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsidiarySaleOfStockAxis=STSS_SecuritiesPurchaseAgreementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsidiarySaleOfStockAxis=us-gaap_IPOMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsidiarySaleOfStockAxis=us-gaap_IPOMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsidiarySaleOfStockAxis=us-gaap_NoteWarrantMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsidiarySaleOfStockAxis=us-gaap_NoteWarrantMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsidiarySaleOfStockAxis=STSS_TradingWarrantsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsidiarySaleOfStockAxis=STSS_TradingWarrantsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsidiarySaleOfStockAxis=us-gaap_OverAllotmentOptionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsidiarySaleOfStockAxis=us-gaap_OverAllotmentOptionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsidiarySaleOfStockAxis=STSS_NoteWarrantsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsidiarySaleOfStockAxis=STSS_NoteWarrantsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsidiarySaleOfStockAxis=STSS_InducementWarrantsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsidiarySaleOfStockAxis=STSS_InducementWarrantsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsidiarySaleOfStockAxis=STSS_OverAllotmentWarrantsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsidiarySaleOfStockAxis=STSS_OverAllotmentWarrantsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>148
<FILENAME>R46.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.4</span><table class="report" border="0" cellspacing="2" id="idm45095368646752">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Preferred Stock (Details Narrative) - Series A Preferred Stock [Member]<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2024</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Feb. 28, 2018</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Class of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockVotingRights', window );">Preferred stock, voting rights</a></td>
<td class="text">The
Series A Preferred Stock entitled the holder to vote on any matters related to the election of directors and was reduced from 50.1%
at December 31, 2021 to 29.5%, effective with the IPO.<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=us-gaap_SeriesAPreferredStockMember', window );">Alan Blackman [Member] | IPO [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Class of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquityMethodInvestmentOwnershipPercentage', window );">Ownership interest percentage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">10.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=us-gaap_SeriesAPreferredStockMember', window );">Director [Member] | Alan Blackman [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Class of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquityMethodInvestmentOwnershipPercentage', window );">Ownership interest percentage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">50.10%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=us-gaap_SeriesAPreferredStockMember', window );">Director [Member] | Alan Blackman [Member] | IPO [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Class of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquityMethodInvestmentOwnershipPercentage', window );">Ownership interest percentage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">29.50%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfStockLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-13<br><br>Reference 2: http://www.xbrl.org/2003/role/recommendedDisclosureRef<br> -Topic 272<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483014/272-10-45-3<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 272<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482987/272-10-50-1<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(d))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-13<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-13<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-13<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (h)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-13<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 14<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-14<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 18<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-18<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(27)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-2<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-03(i)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479886/946-10-S99-3<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-03(i)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479886/946-10-S99-3<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-03(i)(2)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479886/946-10-S99-3<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-03(i)(2)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479886/946-10-S99-3<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfStockLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityMethodInvestmentOwnershipPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The percentage of ownership of common stock or equity participation in the investee accounted for under the equity method of accounting.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481687/323-10-50-3<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityMethodInvestmentOwnershipPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockVotingRights">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Description of voting rights of nonredeemable preferred stock. Includes eligibility to vote and votes per share owned. Include also, if any, unusual voting rights.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-3<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockVotingRights</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=us-gaap_SeriesAPreferredStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=us-gaap_SeriesAPreferredStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=STSS_AlanBlackmanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=STSS_AlanBlackmanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsidiarySaleOfStockAxis=us-gaap_IPOMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsidiarySaleOfStockAxis=us-gaap_IPOMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_TitleOfIndividualAxis=srt_DirectorMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_TitleOfIndividualAxis=srt_DirectorMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>149
<FILENAME>R47.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.4</span><table class="report" border="0" cellspacing="2" id="idm45095246395408">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Schedule of Fair Value of Warrant (Details)<br></strong></div></th>
<th class="th" colspan="2">9 Months Ended</th>
<th class="th" colspan="2">12 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2024</div></th>
<th class="th"><div>Sep. 30, 2023</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Apr. 13, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1', window );">Expected term (in years)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">3 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate', window );">Risk-free interest rate</a></td>
<td class="nump">0.00%<span></span>
</td>
<td class="nump">0.00%<span></span>
</td>
<td class="nump">0.00%<span></span>
</td>
<td class="nump">0.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_WarrantMember', window );">Warrant [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1', window );">Expected term (in years)</a></td>
<td class="text">3 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate', window );">Risk-free interest rate</a></td>
<td class="nump">0.00%<span></span>
</td>
<td class="nump">0.00%<span></span>
</td>
<td class="nump">0.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WarrantsAndRightsOutstandingTerm', window );">Expected term (in years)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">5 years<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_WarrantMember', window );">Warrant [Member] | Measurement Input, Expected Dividend Rate [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WarrantsAndRightsOutstandingMeasurementInput', window );">Warrants liabilities measurement input</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_RangeAxis=srt_MinimumMember', window );">Minimum [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1', window );">Expected term (in years)</a></td>
<td class="text">2 years 7 months 28 days<span></span>
</td>
<td class="text">2 years 10 months 17 days<span></span>
</td>
<td class="text">2 years 10 months 17 days<span></span>
</td>
<td class="text">2 years 6 months<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate', window );">Risk-free interest rate</a></td>
<td class="nump">4.71%<span></span>
</td>
<td class="nump">3.71%<span></span>
</td>
<td class="nump">3.71%<span></span>
</td>
<td class="nump">2.90%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_RangeAxis=srt_MinimumMember', window );">Minimum [Member] | Warrant [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1', window );">Expected term (in years)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">4 years 1 month 6 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate', window );">Expected volatility</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">45.30%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate', window );">Risk-free interest rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3.53%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_RangeAxis=srt_MinimumMember', window );">Minimum [Member] | Warrant [Member] | Measurement Input, Expected Term [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WarrantsAndRightsOutstandingTerm', window );">Expected term (in years)</a></td>
<td class="text">3 years 4 months 13 days<span></span>
</td>
<td class="text">4 years 4 months 9 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_RangeAxis=srt_MinimumMember', window );">Minimum [Member] | Warrant [Member] | Measurement Input, Option Volatility [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WarrantsAndRightsOutstandingMeasurementInput', window );">Warrants liabilities measurement input</a></td>
<td class="nump">58.78<span></span>
</td>
<td class="nump">45.31<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_RangeAxis=srt_MinimumMember', window );">Minimum [Member] | Warrant [Member] | Measurement Input, Risk Free Interest Rate [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WarrantsAndRightsOutstandingMeasurementInput', window );">Warrants liabilities measurement input</a></td>
<td class="nump">3.41<span></span>
</td>
<td class="nump">3.53<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_RangeAxis=srt_MaximumMember', window );">Maximum [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1', window );">Expected term (in years)</a></td>
<td class="text">3 years 21 days<span></span>
</td>
<td class="text">3 years 3 months<span></span>
</td>
<td class="text">3 years 3 months<span></span>
</td>
<td class="text">3 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate', window );">Risk-free interest rate</a></td>
<td class="nump">4.76%<span></span>
</td>
<td class="nump">4.27%<span></span>
</td>
<td class="nump">4.27%<span></span>
</td>
<td class="nump">3.47%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_RangeAxis=srt_MaximumMember', window );">Maximum [Member] | Warrant [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1', window );">Expected term (in years)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">5 years 6 months<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate', window );">Expected volatility</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">70.44%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate', window );">Risk-free interest rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4.54%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_RangeAxis=srt_MaximumMember', window );">Maximum [Member] | Warrant [Member] | Measurement Input, Expected Term [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WarrantsAndRightsOutstandingTerm', window );">Expected term (in years)</a></td>
<td class="text">5 years 11 months 26 days<span></span>
</td>
<td class="text">5 years 6 months<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_RangeAxis=srt_MaximumMember', window );">Maximum [Member] | Warrant [Member] | Measurement Input, Option Volatility [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WarrantsAndRightsOutstandingMeasurementInput', window );">Warrants liabilities measurement input</a></td>
<td class="nump">121.32<span></span>
</td>
<td class="nump">59.93<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_RangeAxis=srt_MaximumMember', window );">Maximum [Member] | Warrant [Member] | Measurement Input, Risk Free Interest Rate [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WarrantsAndRightsOutstandingMeasurementInput', window );">Warrants liabilities measurement input</a></td>
<td class="nump">4.56<span></span>
</td>
<td class="nump">4.54<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The estimated dividend rate (a percentage of the share price) to be paid (expected dividends) to holders of the underlying shares over the option's term.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(iii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The estimated measure of the percentage by which a share price is expected to fluctuate during a period. Volatility also may be defined as a probability-weighted measure of the dispersion of returns about the mean. The volatility of a share price is the standard deviation of the continuously compounded rates of return on the share over a specified period. That is the same as the standard deviation of the differences in the natural logarithms of the stock prices plus dividends, if any, over the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The risk-free interest rate assumption that is used in valuing an option on its own shares.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(iv)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Expected term of award under share-based payment arrangement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WarrantsAndRightsOutstandingMeasurementInput">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Value of input used to measure outstanding warrant and right embodying unconditional obligation requiring redemption by transferring asset at specified or determinable date or upon event certain to occur.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (bbb)(2)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (bbb)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (bbb)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WarrantsAndRightsOutstandingMeasurementInput</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:decimalItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WarrantsAndRightsOutstandingTerm">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Period between issuance and expiration of outstanding warrant and right embodying unconditional obligation requiring redemption by transferring asset at specified or determinable date or upon event certain to occur, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (bbb)(2)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (bbb)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (bbb)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WarrantsAndRightsOutstandingTerm</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_WarrantMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_WarrantMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputExpectedDividendRateMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputExpectedDividendRateMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MinimumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MinimumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputExpectedTermMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputExpectedTermMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputOptionVolatilityMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputOptionVolatilityMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputRiskFreeInterestRateMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputRiskFreeInterestRateMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>150
<FILENAME>R48.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.4</span><table class="report" border="0" cellspacing="2" id="idm45095369932448">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Schedule of Warrant Liability (Details) - USD ($)<br></strong></div></th>
<th class="th"><div>Sep. 30, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Apr. 14, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockLineItems', window );"><strong>Subsidiary, Sale of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_STSS_WarrantLiability', window );">Total Warrant Liability</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2,422,785<span></span>
</td>
<td class="nump">$ 1,151,838<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_STSS_WarrantLiabilitiesCurrent', window );">Total Warrant Liability</a></td>
<td class="nump">$ 1,027,102<span></span>
</td>
<td class="nump">2,422,785<span></span>
</td>
<td class="nump">1,151,838<span></span>
</td>
<td class="nump">$ 5,200,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightAxis=STSS_TradingAndOverallotmentWarrantsMember', window );">Trading and Over allotment Warrants [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockLineItems', window );"><strong>Subsidiary, Sale of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_STSS_WarrantLiabilitiesCurrent', window );">Total Warrant Liability</a></td>
<td class="nump">431,250<span></span>
</td>
<td class="nump">1,121,250<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightAxis=STSS_NoteWarrantsMember', window );">Note Warrants [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockLineItems', window );"><strong>Subsidiary, Sale of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_STSS_WarrantLiabilitiesCurrent', window );">Total Warrant Liability</a></td>
<td class="nump">11,765<span></span>
</td>
<td class="nump">30,588<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightAxis=STSS_OfferingWarrantsFebruaryTwoThousandTwentyThreeMember', window );">Offering Warrants - February 2023 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockLineItems', window );"><strong>Subsidiary, Sale of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_STSS_WarrantLiabilitiesCurrent', window );">Total Warrant Liability</a></td>
<td class="nump">20,053<span></span>
</td>
<td class="nump">234,072<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightAxis=STSS_OfferingWarrantsSeptemberTwoThousandTwentyThreeMember', window );">Offering Warrants - September 2023 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockLineItems', window );"><strong>Subsidiary, Sale of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_STSS_WarrantLiabilitiesCurrent', window );">Total Warrant Liability</a></td>
<td class="nump">216,911<span></span>
</td>
<td class="nump">1,036,875<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightAxis=STSS_InducementWarrantsMember', window );">Inducement Warrants [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockLineItems', window );"><strong>Subsidiary, Sale of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_STSS_WarrantLiabilitiesCurrent', window );">Total Warrant Liability</a></td>
<td class="nump">$ 347,123<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockAxis=STSS_TradingAndOverallotmentWarrantsMember', window );">Trading and Over allotment Warrants [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockLineItems', window );"><strong>Subsidiary, Sale of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_STSS_WarrantLiability', window );">Total Warrant Liability</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,121,250<span></span>
</td>
<td class="nump">1,121,250<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockAxis=STSS_NoteWarrantsMember', window );">Note Warrants [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockLineItems', window );"><strong>Subsidiary, Sale of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_STSS_WarrantLiability', window );">Total Warrant Liability</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">30,588<span></span>
</td>
<td class="nump">30,588<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockAxis=STSS_OfferingWarrantsFebruaryTwentyTwentyThreeMember', window );">Offering Warrants - February 2023 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockLineItems', window );"><strong>Subsidiary, Sale of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_STSS_WarrantLiability', window );">Total Warrant Liability</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">234,072<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockAxis=STSS_OfferingWarrantsSeptemberTwentyTwentyThreeMember', window );">Offering Warrants - September 2023 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockLineItems', window );"><strong>Subsidiary, Sale of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_STSS_WarrantLiability', window );">Total Warrant Liability</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,036,875<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_STSS_WarrantLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Warrant liabilities current.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">STSS_WarrantLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>STSS_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_STSS_WarrantLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Warrant liability.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">STSS_WarrantLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>STSS_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsidiarySaleOfStockLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsidiarySaleOfStockLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightAxis=STSS_TradingAndOverallotmentWarrantsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightAxis=STSS_TradingAndOverallotmentWarrantsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightAxis=STSS_NoteWarrantsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightAxis=STSS_NoteWarrantsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightAxis=STSS_OfferingWarrantsFebruaryTwoThousandTwentyThreeMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightAxis=STSS_OfferingWarrantsFebruaryTwoThousandTwentyThreeMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightAxis=STSS_OfferingWarrantsSeptemberTwoThousandTwentyThreeMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightAxis=STSS_OfferingWarrantsSeptemberTwoThousandTwentyThreeMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightAxis=STSS_InducementWarrantsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightAxis=STSS_InducementWarrantsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsidiarySaleOfStockAxis=STSS_TradingAndOverallotmentWarrantsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsidiarySaleOfStockAxis=STSS_TradingAndOverallotmentWarrantsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsidiarySaleOfStockAxis=STSS_NoteWarrantsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsidiarySaleOfStockAxis=STSS_NoteWarrantsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsidiarySaleOfStockAxis=STSS_OfferingWarrantsFebruaryTwentyTwentyThreeMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsidiarySaleOfStockAxis=STSS_OfferingWarrantsFebruaryTwentyTwentyThreeMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsidiarySaleOfStockAxis=STSS_OfferingWarrantsSeptemberTwentyTwentyThreeMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsidiarySaleOfStockAxis=STSS_OfferingWarrantsSeptemberTwentyTwentyThreeMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>151
<FILENAME>R49.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.4</span><table class="report" border="0" cellspacing="2" id="idm45095328720944">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Schedule of Warrant Outstanding (Details) - shares<br></strong></div></th>
<th class="th"><div>Sep. 30, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockLineItems', window );"><strong>Subsidiary, Sale of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightOutstanding', window );">Warrants issued for services arrangement</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">20,541,318<span></span>
</td>
<td class="nump">9,047,794<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_STSS_ClassOfWarrantsOrRightOutstanding', window );">Total Warrants Outstanding</a></td>
<td class="nump">804,383<span></span>
</td>
<td class="nump">1,194,495<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightAxis=STSS_TradingAndOverallotmentWarrantsMember', window );">Trading and Over allotment Warrants [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockLineItems', window );"><strong>Subsidiary, Sale of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightOutstanding', window );">Warrants issued for services arrangement</a></td>
<td class="nump">400,568<span></span>
</td>
<td class="nump">400,568<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightAxis=STSS_NoteWarrantsMember', window );">Note Warrants [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockLineItems', window );"><strong>Subsidiary, Sale of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightOutstanding', window );">Warrants issued for services arrangement</a></td>
<td class="nump">10,695<span></span>
</td>
<td class="nump">10,695<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightAxis=STSS_OfferingWarrantsFebruaryTwoThousandTwentyThreeMember', window );">Offering Warrants - February 2023 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockLineItems', window );"><strong>Subsidiary, Sale of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightOutstanding', window );">Warrants issued for services arrangement</a></td>
<td class="nump">8,607<span></span>
</td>
<td class="nump">102,206<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightAxis=STSS_OfferingWarrantsSeptemberTwoThousandTwentyThreeMember', window );">Offering Warrants - September 2023 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockLineItems', window );"><strong>Subsidiary, Sale of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightOutstanding', window );">Warrants issued for services arrangement</a></td>
<td class="nump">95,078<span></span>
</td>
<td class="nump">397,727<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightAxis=STSS_InducementWarrantsMayTwoThousandTwentyFourMember', window );">Inducement Warrants - May 2024 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockLineItems', window );"><strong>Subsidiary, Sale of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightOutstanding', window );">Warrants issued for services arrangement</a></td>
<td class="nump">260,799<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightAxis=STSS_WarrantsIssuedForServiceManagementMember', window );">Warrants Issued for Services Arrangement [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockLineItems', window );"><strong>Subsidiary, Sale of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightOutstanding', window );">Warrants issued for services arrangement</a></td>
<td class="nump">28,636<span></span>
</td>
<td class="nump">22,500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockAxis=STSS_TradingAndOverallotmentWarrantsMember', window );">Trading and Over allotment Warrants [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockLineItems', window );"><strong>Subsidiary, Sale of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightOutstanding', window );">Warrants issued for services arrangement</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">8,812,500<span></span>
</td>
<td class="nump">8,812,500<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockAxis=STSS_NoteWarrantsMember', window );">Note Warrants [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockLineItems', window );"><strong>Subsidiary, Sale of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightOutstanding', window );">Warrants issued for services arrangement</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">235,294<span></span>
</td>
<td class="nump">235,294<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockAxis=STSS_OfferingWarrantsFebruaryTwentyTwentyThreeMember', window );">Offering Warrants - February 2023 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockLineItems', window );"><strong>Subsidiary, Sale of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightOutstanding', window );">Warrants issued for services arrangement</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,248,521<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockAxis=STSS_OfferingWarrantsSeptemberTwentyTwentyThreeMember', window );">Offering Warrants - September 2023 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockLineItems', window );"><strong>Subsidiary, Sale of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightOutstanding', window );">Warrants issued for services arrangement</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">8,750,003<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockAxis=STSS_WarrantsIssuedForServiceManagementMember', window );">Warrants Issued for Services Arrangement [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockLineItems', window );"><strong>Subsidiary, Sale of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightOutstanding', window );">Warrants issued for services arrangement</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">495,000<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_STSS_ClassOfWarrantsOrRightOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Class of warrants or right outstanding.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">STSS_ClassOfWarrantsOrRightOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>STSS_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of warrants or rights outstanding.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsidiarySaleOfStockLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsidiarySaleOfStockLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightAxis=STSS_TradingAndOverallotmentWarrantsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightAxis=STSS_TradingAndOverallotmentWarrantsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightAxis=STSS_NoteWarrantsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightAxis=STSS_NoteWarrantsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightAxis=STSS_OfferingWarrantsFebruaryTwoThousandTwentyThreeMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightAxis=STSS_OfferingWarrantsFebruaryTwoThousandTwentyThreeMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightAxis=STSS_OfferingWarrantsSeptemberTwoThousandTwentyThreeMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightAxis=STSS_OfferingWarrantsSeptemberTwoThousandTwentyThreeMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightAxis=STSS_InducementWarrantsMayTwoThousandTwentyFourMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightAxis=STSS_InducementWarrantsMayTwoThousandTwentyFourMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightAxis=STSS_WarrantsIssuedForServiceManagementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightAxis=STSS_WarrantsIssuedForServiceManagementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsidiarySaleOfStockAxis=STSS_TradingAndOverallotmentWarrantsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsidiarySaleOfStockAxis=STSS_TradingAndOverallotmentWarrantsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsidiarySaleOfStockAxis=STSS_NoteWarrantsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsidiarySaleOfStockAxis=STSS_NoteWarrantsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsidiarySaleOfStockAxis=STSS_OfferingWarrantsFebruaryTwentyTwentyThreeMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsidiarySaleOfStockAxis=STSS_OfferingWarrantsFebruaryTwentyTwentyThreeMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsidiarySaleOfStockAxis=STSS_OfferingWarrantsSeptemberTwentyTwentyThreeMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsidiarySaleOfStockAxis=STSS_OfferingWarrantsSeptemberTwentyTwentyThreeMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsidiarySaleOfStockAxis=STSS_WarrantsIssuedForServiceManagementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsidiarySaleOfStockAxis=STSS_WarrantsIssuedForServiceManagementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>152
<FILENAME>R50.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.4</span><table class="report" border="0" cellspacing="2" id="idm45095368728576">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Warrant Liability (Details Narrative) - USD ($)<br></strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">9 Months Ended</th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2024</div></th>
<th class="th"><div>Sep. 30, 2023</div></th>
<th class="th"><div>Sep. 30, 2024</div></th>
<th class="th"><div>Sep. 30, 2023</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems', window );"><strong>Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MarketRiskBenefitChangeInFairValueGainLoss', window );">Fair market value adjustment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 169,583<span></span>
</td>
<td class="nump">$ 4,784,559<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GainLossOnSaleOfDerivatives', window );">Fair market value adjustment</a></td>
<td class="nump">$ 416,560<span></span>
</td>
<td class="nump">$ 321,981<span></span>
</td>
<td class="nump">$ 2,088,747<span></span>
</td>
<td class="nump">$ 415,958<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_STSS_FairValueAdjustmentOfModificationCharge', window );">Fair value adjustment of modification charge</a></td>
<td class="nump">155,703<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">790,956<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_STSS_GainLossOnSaleOfDerivative', window );">Fair market value adjustment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (321,981)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 415,958<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TypeOfArrangementAxis=STSS_InducementAgreementMember', window );">Inducement Agreement [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems', window );"><strong>Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GainLossOnSaleOfDerivatives', window );">Fair market value adjustment</a></td>
<td class="nump">$ 349,243<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 349,243<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_STSS_FairValueAdjustmentOfModificationCharge">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value adjustment of modification charge.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">STSS_FairValueAdjustmentOfModificationCharge</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>STSS_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_STSS_GainLossOnSaleOfDerivative">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Gain loss on sale of derivative.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">STSS_GainLossOnSaleOfDerivative</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>STSS_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 808<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479402/808-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GainLossOnSaleOfDerivatives">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The difference between the book value and the sale price of options, swaps, futures, forward contracts, and other derivative instruments. This element refers to the gain (loss) included in earnings.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(13)(h))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478524/942-220-S99-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(7)(a)(7))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(7)(a)(3))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(7)(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-1<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(7)(a)(6))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GainLossOnSaleOfDerivatives</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MarketRiskBenefitChangeInFairValueGainLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of gain (loss) from (increase) decrease in fair value of contract or contract feature in long-duration contract issued by insurance entity that both protects contract holder from other-than-nominal capital market risk and exposes insurance entity to other-than-nominal capital market risk. Excludes change attributable to instrument-specific credit risk.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480112/944-40-45-3<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MarketRiskBenefitChangeInFairValueGainLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TypeOfArrangementAxis=STSS_InducementAgreementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TypeOfArrangementAxis=STSS_InducementAgreementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>153
<FILENAME>R51.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.4</span><table class="report" border="0" cellspacing="2" id="idm45095357025664">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Schedule of Stock Options Granted and Outstanding (Details) - $ / shares<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract', window );"><strong>Share-Based Payment Arrangement [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_STSS_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionOutstandingNumber', window );">Stock option, beginning balance</a></td>
<td class="nump">2,408,836<span></span>
</td>
<td class="nump">1,358,122<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_STSS_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionOutstandingWeightedAverageExercisePrice', window );">Weighted average exercise price, beginning balance</a></td>
<td class="nump">$ 3.03<span></span>
</td>
<td class="nump">$ 4.37<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber', window );">Stock option, beginning balance</a></td>
<td class="nump">109,493<span></span>
</td>
<td class="nump">1,358,122<span></span>
</td>
<td class="nump">1,137,479<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice', window );">Weighted average exercise price, beginning balance</a></td>
<td class="nump">$ 67.12<span></span>
</td>
<td class="nump">$ 4.37<span></span>
</td>
<td class="nump">$ 5.18<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross', window );">Shares, options granted</a></td>
<td class="nump">63,409<span></span>
</td>
<td class="nump">1,065,000<span></span>
</td>
<td class="nump">367,500<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice', window );">Weighted average exercise price, options granted</a></td>
<td class="nump">$ 6.27<span></span>
</td>
<td class="nump">$ 1.35<span></span>
</td>
<td class="nump">$ 1.63<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod', window );">Shares, options cancelled</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(3,571)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice', window );">Weighted average exercise price, options cancelled</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (4.38)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedNumberOfShares', window );">Shares, options forfeited</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(14,286)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice', window );">Weighted average exercise price, forfeited or cancelled</a></td>
<td class="nump">$ 37.11<span></span>
</td>
<td class="nump">$ 1.75<span></span>
</td>
<td class="nump">$ 3.77<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod', window );">Shares, options forfeited</a></td>
<td class="num">(18,592)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(143,286)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice', window );">Weighted average exercise price, options forfeited</a></td>
<td class="num">$ (37.11)<span></span>
</td>
<td class="num">$ (1.75)<span></span>
</td>
<td class="num">$ (3.77)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_STSS_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionOutstandingNumber', window );">Stock option, ending balance</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,408,836<span></span>
</td>
<td class="nump">1,358,122<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_STSS_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionOutstandingWeightedAverageExercisePrice', window );">Weighted average exercise price, ending balance</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 3.03<span></span>
</td>
<td class="nump">$ 4.37<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber', window );">Stock option, ending balance</a></td>
<td class="nump">154,310<span></span>
</td>
<td class="nump">109,493<span></span>
</td>
<td class="nump">1,358,122<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice', window );">Weighted average exercise price, ending balance</a></td>
<td class="nump">$ 42.88<span></span>
</td>
<td class="nump">$ 67.12<span></span>
</td>
<td class="nump">$ 4.37<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber', window );">Stock option, exercisable ending balance</a></td>
<td class="nump">122,243<span></span>
</td>
<td class="nump">1,881,327<span></span>
</td>
<td class="nump">1,132,861<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice', window );">Weighted average exercise price, exercisable ending balance</a></td>
<td class="nump">$ 50.86<span></span>
</td>
<td class="nump">$ 3.47<span></span>
</td>
<td class="nump">$ 4.59<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_STSS_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionOutstandingNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Share based compensation arrangement by share based payment award option outstanding number.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">STSS_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionOutstandingNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>STSS_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_STSS_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionOutstandingWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Share based compensation arrangement by share based payment award option outstanding weighted average exercise price.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">STSS_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionOutstandingWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>STSS_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of shares into which fully or partially vested stock options outstanding as of the balance sheet date can be currently converted under the option plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The weighted-average price as of the balance sheet date at which grantees can acquire the shares reserved for issuance on vested portions of options outstanding and currently exercisable under the stock option plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of options or other stock instruments for which the right to exercise has lapsed under the terms of the plan agreements.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(04)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of shares under options that were cancelled during the reporting period as a result of occurrence of a terminating event specified in contractual agreements pertaining to the stock option plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(03)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Gross number of share options (or share units) granted during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(01)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of options outstanding, including both vested and non-vested options.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average price at which grantees can acquire the shares reserved for issuance under the stock option plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average price at which grantees could have acquired the underlying shares with respect to stock options of the plan that expired.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(04)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average price at which grantees could have acquired the underlying shares with respect to stock options that were terminated.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(03)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average per share amount at which grantees can acquire shares of common stock by exercise of options.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(01)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedNumberOfShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of non-vested options forfeited.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedNumberOfShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>154
<FILENAME>R52.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.4</span><table class="report" border="0" cellspacing="2" id="idm45095356346528">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Schedule of Information About Options Outstanding (Details)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th">
<div>Dec. 31, 2023 </div>
<div>USD ($) </div>
<div>$ / shares </div>
<div>shares</div>
</th></tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis=STSS_ExercisePriceRangeOneMember', window );">Exercise Price Range One [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems', window );"><strong>Share-Based Payment Arrangement, Option, Exercise Price Range [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions', window );">Options, shares outstanding | shares</a></td>
<td class="nump">40,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue', window );">Stock option, aggregate intrinsic value | $</a></td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2', window );">Stock option, weighted average remaining contractual life</a></td>
<td class="text">4 years 6 months 29 days<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions', window );">Options, shares exercisable | shares</a></td>
<td class="nump">18,794<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1', window );">Stock option, aggregate intrinsic value on exercisable shares | $</a></td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis=STSS_ExercisePriceRangeOneMember', window );">Exercise Price Range One [Member] | Minimum [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems', window );"><strong>Share-Based Payment Arrangement, Option, Exercise Price Range [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit', window );">Stock option, exercise price | $ / shares</a></td>
<td class="nump">$ 0.82<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis=STSS_ExercisePriceRangeOneMember', window );">Exercise Price Range One [Member] | Maximum [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems', window );"><strong>Share-Based Payment Arrangement, Option, Exercise Price Range [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit', window );">Stock option, exercise price | $ / shares</a></td>
<td class="nump">0.92<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis=STSS_ExercisePriceRangeTwoMember', window );">Exercise Price Range Two [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems', window );"><strong>Share-Based Payment Arrangement, Option, Exercise Price Range [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit', window );">Stock option, exercise price | $ / shares</a></td>
<td class="nump">$ 1.21<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions', window );">Options, shares outstanding | shares</a></td>
<td class="nump">307,500<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue', window );">Stock option, aggregate intrinsic value | $</a></td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2', window );">Stock option, weighted average remaining contractual life</a></td>
<td class="text">3 years 5 months 1 day<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions', window );">Options, shares exercisable | shares</a></td>
<td class="nump">240,386<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1', window );">Stock option, aggregate intrinsic value on exercisable shares | $</a></td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis=STSS_ExercisePriceRangeThreeMember', window );">Exercise Price Range Three [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems', window );"><strong>Share-Based Payment Arrangement, Option, Exercise Price Range [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit', window );">Stock option, exercise price | $ / shares</a></td>
<td class="nump">$ 1.30<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions', window );">Options, shares outstanding | shares</a></td>
<td class="nump">50,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue', window );">Stock option, aggregate intrinsic value | $</a></td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2', window );">Stock option, weighted average remaining contractual life</a></td>
<td class="text">4 years 2 months 15 days<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions', window );">Options, shares exercisable | shares</a></td>
<td class="nump">43,750<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1', window );">Stock option, aggregate intrinsic value on exercisable shares | $</a></td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis=STSS_ExercisePriceRangeFourMember', window );">Exercise Price Range Four [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems', window );"><strong>Share-Based Payment Arrangement, Option, Exercise Price Range [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit', window );">Stock option, exercise price | $ / shares</a></td>
<td class="nump">$ 1.37<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions', window );">Options, shares outstanding | shares</a></td>
<td class="nump">975,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue', window );">Stock option, aggregate intrinsic value | $</a></td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2', window );">Stock option, weighted average remaining contractual life</a></td>
<td class="text">4 years 2 months 1 day<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions', window );">Options, shares exercisable | shares</a></td>
<td class="nump">561,719<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1', window );">Stock option, aggregate intrinsic value on exercisable shares | $</a></td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis=STSS_ExercisePriceRangeFiveMember', window );">Exercise Price Range Five [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems', window );"><strong>Share-Based Payment Arrangement, Option, Exercise Price Range [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit', window );">Stock option, exercise price | $ / shares</a></td>
<td class="nump">$ 1.75<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions', window );">Options, shares outstanding | shares</a></td>
<td class="nump">54,285<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue', window );">Stock option, aggregate intrinsic value | $</a></td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2', window );">Stock option, weighted average remaining contractual life</a></td>
<td class="text">2 years 3 months<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions', window );">Options, shares exercisable | shares</a></td>
<td class="nump">54,285<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1', window );">Stock option, aggregate intrinsic value on exercisable shares | $</a></td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis=STSS_ExercisePriceRangeSixMember', window );">Exercise Price Range Six [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems', window );"><strong>Share-Based Payment Arrangement, Option, Exercise Price Range [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit', window );">Stock option, exercise price | $ / shares</a></td>
<td class="nump">$ 2.80<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions', window );">Options, shares outstanding | shares</a></td>
<td class="nump">141,429<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue', window );">Stock option, aggregate intrinsic value | $</a></td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2', window );">Stock option, weighted average remaining contractual life</a></td>
<td class="text">2 years 3 months<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions', window );">Options, shares exercisable | shares</a></td>
<td class="nump">141,429<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1', window );">Stock option, aggregate intrinsic value on exercisable shares | $</a></td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis=STSS_ExercisePriceRangeSevenMember', window );">Exercise Price Range Seven [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems', window );"><strong>Share-Based Payment Arrangement, Option, Exercise Price Range [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit', window );">Stock option, exercise price | $ / shares</a></td>
<td class="nump">$ 1.39<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions', window );">Options, shares outstanding | shares</a></td>
<td class="nump">10,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue', window );">Stock option, aggregate intrinsic value | $</a></td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2', window );">Stock option, weighted average remaining contractual life</a></td>
<td class="text">3 years 9 months<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions', window );">Options, shares exercisable | shares</a></td>
<td class="nump">10,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1', window );">Stock option, aggregate intrinsic value on exercisable shares | $</a></td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis=STSS_ExercisePriceRangeEightMember', window );">Exercise Price Range Eight [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems', window );"><strong>Share-Based Payment Arrangement, Option, Exercise Price Range [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit', window );">Stock option, exercise price | $ / shares</a></td>
<td class="nump">$ 4.25<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions', window );">Options, shares outstanding | shares</a></td>
<td class="nump">50,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue', window );">Stock option, aggregate intrinsic value | $</a></td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2', window );">Stock option, weighted average remaining contractual life</a></td>
<td class="text">3 years 9 months<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions', window );">Options, shares exercisable | shares</a></td>
<td class="nump">50,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1', window );">Stock option, aggregate intrinsic value on exercisable shares | $</a></td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis=STSS_ExercisePriceRangeNineMember', window );">Exercise Price Range Nine [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems', window );"><strong>Share-Based Payment Arrangement, Option, Exercise Price Range [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit', window );">Stock option, exercise price | $ / shares</a></td>
<td class="nump">$ 4.38<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions', window );">Options, shares outstanding | shares</a></td>
<td class="nump">244,286<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue', window );">Stock option, aggregate intrinsic value | $</a></td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2', window );">Stock option, weighted average remaining contractual life</a></td>
<td class="text">1 year 3 months<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions', window );">Options, shares exercisable | shares</a></td>
<td class="nump">244,286<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1', window );">Stock option, aggregate intrinsic value on exercisable shares | $</a></td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis=STSS_ExercisePriceRangeTenMember', window );">Exercise Price Range Ten [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems', window );"><strong>Share-Based Payment Arrangement, Option, Exercise Price Range [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit', window );">Stock option, exercise price | $ / shares</a></td>
<td class="nump">$ 7.00<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions', window );">Options, shares outstanding | shares</a></td>
<td class="nump">536,335<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue', window );">Stock option, aggregate intrinsic value | $</a></td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2', window );">Stock option, weighted average remaining contractual life</a></td>
<td class="text">2 years<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions', window );">Options, shares exercisable | shares</a></td>
<td class="nump">516,679<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1', window );">Stock option, aggregate intrinsic value on exercisable shares | $</a></td>
<td class="text"> <span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount by which the current fair value of the underlying stock exceeds the exercise price of options outstanding.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of shares reserved for issuance pertaining to the outstanding exercisable stock options as of the balance sheet date in the customized range of exercise prices for which the market and performance vesting condition has been satisfied.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(iii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of shares reserved for issuance pertaining to the outstanding stock options as of the balance sheet date for all option plans in the customized range of exercise prices.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The ceiling of a customized range of exercise prices for purposes of disclosing shares potentially issuable under outstanding stock option awards on all stock option plans and other required information pertaining to awards in the customized range.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (g)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of difference between fair value of the underlying shares reserved for issuance and exercise price of vested portions of options outstanding and currently exercisable.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average remaining contractual term of outstanding stock options, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 718<br> -SubTopic 10<br> -Subparagraph (e)(1)<br> -Name Accounting Standards Codification<br> -Paragraph 2<br> -Section 50<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis=STSS_ExercisePriceRangeOneMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis=STSS_ExercisePriceRangeOneMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MinimumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MinimumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis=STSS_ExercisePriceRangeTwoMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis=STSS_ExercisePriceRangeTwoMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis=STSS_ExercisePriceRangeThreeMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis=STSS_ExercisePriceRangeThreeMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis=STSS_ExercisePriceRangeFourMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis=STSS_ExercisePriceRangeFourMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis=STSS_ExercisePriceRangeFiveMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis=STSS_ExercisePriceRangeFiveMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis=STSS_ExercisePriceRangeSixMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis=STSS_ExercisePriceRangeSixMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis=STSS_ExercisePriceRangeSevenMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis=STSS_ExercisePriceRangeSevenMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis=STSS_ExercisePriceRangeEightMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis=STSS_ExercisePriceRangeEightMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis=STSS_ExercisePriceRangeNineMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis=STSS_ExercisePriceRangeNineMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis=STSS_ExercisePriceRangeTenMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis=STSS_ExercisePriceRangeTenMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>155
<FILENAME>R53.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.4</span><table class="report" border="0" cellspacing="2" id="idm45095368589824">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Schedule of Fair Value of Stock Option Awards (Details)<br></strong></div></th>
<th class="th" colspan="2">9 Months Ended</th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2024</div></th>
<th class="th"><div>Sep. 30, 2023</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1', window );">Expected term (years)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">3 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate', window );">Dividend rate</a></td>
<td class="nump">0.00%<span></span>
</td>
<td class="nump">0.00%<span></span>
</td>
<td class="nump">0.00%<span></span>
</td>
<td class="nump">0.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_RangeAxis=srt_MinimumMember', window );">Minimum [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1', window );">Expected term (years)</a></td>
<td class="text">2 years 7 months 28 days<span></span>
</td>
<td class="text">2 years 10 months 17 days<span></span>
</td>
<td class="text">2 years 10 months 17 days<span></span>
</td>
<td class="text">2 years 6 months<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate', window );">Expected volatility</a></td>
<td class="nump">81.15%<span></span>
</td>
<td class="nump">75.40%<span></span>
</td>
<td class="nump">75.40%<span></span>
</td>
<td class="nump">100.81%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate', window );">Risk-free interest rate</a></td>
<td class="nump">4.71%<span></span>
</td>
<td class="nump">3.71%<span></span>
</td>
<td class="nump">3.71%<span></span>
</td>
<td class="nump">2.90%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_RangeAxis=srt_MaximumMember', window );">Maximum [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1', window );">Expected term (years)</a></td>
<td class="text">3 years 21 days<span></span>
</td>
<td class="text">3 years 3 months<span></span>
</td>
<td class="text">3 years 3 months<span></span>
</td>
<td class="text">3 years<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate', window );">Expected volatility</a></td>
<td class="nump">83.04%<span></span>
</td>
<td class="nump">89.93%<span></span>
</td>
<td class="nump">89.93%<span></span>
</td>
<td class="nump">110.74%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate', window );">Risk-free interest rate</a></td>
<td class="nump">4.76%<span></span>
</td>
<td class="nump">4.27%<span></span>
</td>
<td class="nump">4.27%<span></span>
</td>
<td class="nump">3.47%<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The estimated dividend rate (a percentage of the share price) to be paid (expected dividends) to holders of the underlying shares over the option's term.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(iii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The risk-free interest rate assumption that is used in valuing an option on its own shares.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(iv)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Rate of weighted-average expected volatility for award under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 35<br> -Paragraph 1D<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480483/718-10-35-1D<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 35<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480483/718-10-35-3<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(01)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(02)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(03)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(04)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(01)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(02)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(03)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(iii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(iv)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(v)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Expected term of award under share-based payment arrangement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MinimumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MinimumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>156
<FILENAME>R54.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.4</span><table class="report" border="0" cellspacing="2" id="idm45095355397360">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Stock Options (Details Narrative) - USD ($)<br></strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="3">3 Months Ended</th>
<th class="th" colspan="2">9 Months Ended</th>
<th class="th" colspan="2">12 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Feb. 09, 2023</div></th>
<th class="th"><div>Jan. 24, 2023</div></th>
<th class="th"><div>Sep. 30, 2024</div></th>
<th class="th"><div>Sep. 30, 2023</div></th>
<th class="th"><div>Mar. 31, 2022</div></th>
<th class="th"><div>Sep. 30, 2024</div></th>
<th class="th"><div>Sep. 30, 2023</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 11, 2017</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1', window );">Expected term</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">3 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation', window );">Purchase of shares</a></td>
<td class="nump">50,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockParOrStatedValuePerShare', window );">Common stock par value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.0001<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.0001<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.0001<span></span>
</td>
<td class="nump">$ 0.0001<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.0001<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_STSS_ShareBasedCompensationOptionsExercisableWeightedAverageExercisePrice', window );">Options exercisable</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 6.27<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 6.27<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross', window );">Granted shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">63,409<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,065,000<span></span>
</td>
<td class="nump">367,500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber', window );">Options outstanding</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">154,310<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">154,310<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">109,493<span></span>
</td>
<td class="nump">1,358,122<span></span>
</td>
<td class="nump">1,137,479<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue', window );">Weighted-average grant-date fair value of options granted</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.80<span></span>
</td>
<td class="nump">$ 1.63<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized', window );">Unrecognized stock-based compensation</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 232,353<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 232,353<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 498,454<span></span>
</td>
<td class="nump">$ 475,097<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue', window );">Unvested stock options weighted average fair value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 7.25<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 7.25<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.94<span></span>
</td>
<td class="nump">$ 2.05<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpense', window );">Share based compensation</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 116,193<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 435,908<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 920,108<span></span>
</td>
<td class="nump">$ 1,012,592<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_STSS_StockBasedChargesRelatingToPurchaseOfMachinery', window );">Stock based charges relating to purchase of machinery</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">63,612<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_STSS_StockBasedChargesRelatingToAcquisition', window );">Stock based charges relating to acquisition</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 60,435<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2', window );">Weighted average remaining contractual life</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">39 months<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_STSS_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantedInYear', window );">Granted options</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">5 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1', window );">Recognized over a weighted-average period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">12 months<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeStatementLocationAxis=us-gaap_GeneralAndAdministrativeExpenseMember', window );">General and Administrative Expense [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpense', window );">Share based compensation</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 178,895<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 432,567<span></span>
</td>
<td class="nump">$ 796,606<span></span>
</td>
<td class="nump">906,745<span></span>
</td>
<td class="nump">915,797<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeStatementLocationAxis=us-gaap_ResearchAndDevelopmentExpenseMember', window );">Research and Development Expense [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpense', window );">Share based compensation</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 3,341<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 13,363<span></span>
</td>
<td class="nump">$ 96,795<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_RangeAxis=srt_MinimumMember', window );">Minimum [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1', window );">Expected term</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">2 years 7 months 28 days<span></span>
</td>
<td class="text">2 years 10 months 17 days<span></span>
</td>
<td class="text">2 years 10 months 17 days<span></span>
</td>
<td class="text">2 years 6 months<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_RangeAxis=srt_MaximumMember', window );">Maximum [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1', window );">Expected term</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">3 years 21 days<span></span>
</td>
<td class="text">3 years 3 months<span></span>
</td>
<td class="text">3 years 3 months<span></span>
</td>
<td class="text">3 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_TitleOfIndividualAxis=STSS_EmployeesAndConsultantMember', window );">Employees and Consultant [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation', window );">Purchase of shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">90,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_TitleOfIndividualAxis=STSS_EmployeesAndConsultantMember', window );">Employees and Consultant [Member] | Minimum [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_STSS_ShareBasedCompensationOptionsExercisableWeightedAverageExercisePrice', window );">Options exercisable</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.82<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_TitleOfIndividualAxis=STSS_EmployeesAndConsultantMember', window );">Employees and Consultant [Member] | Maximum [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_STSS_ShareBasedCompensationOptionsExercisableWeightedAverageExercisePrice', window );">Options exercisable</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1.30<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PlanNameAxis=STSS_TwoThousandTwentyThreeEquityIncentivePlanMember', window );">2023 Equity Incentive Plan [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant', window );">Stock available for issuance</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,400,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod', window );">Number of stock issuance</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1', window );">Expected term</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">5 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation', window );">Purchase of shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">975,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockParOrStatedValuePerShare', window );">Common stock par value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.0001<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_STSS_ShareBasedCompensationOptionsExercisableWeightedAverageExercisePrice', window );">Options exercisable</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1.37<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross', window );">Granted shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">660,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PlanNameAxis=STSS_TwoThousandTwentyTwoEquityIncentivePlanMember', window );">2022 Equity Incentive Plan [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross', window );">Granted shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">405,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber', window );">Options outstanding</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,748,836<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_STSS_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantedInYear">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Share based compensation arrangement by share based payment award options granted in year.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">STSS_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantedInYear</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>STSS_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_STSS_ShareBasedCompensationOptionsExercisableWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Share based compensation options exercisable weighted average exercise price.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">STSS_ShareBasedCompensationOptionsExercisableWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>STSS_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_STSS_StockBasedChargesRelatingToAcquisition">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Stock based charges relating to acquisition.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">STSS_StockBasedChargesRelatingToAcquisition</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>STSS_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_STSS_StockBasedChargesRelatingToPurchaseOfMachinery">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Stock based charges relating to purchase of machinery.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">STSS_StockBasedChargesRelatingToPurchaseOfMachinery</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>STSS_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AllocatedShareBasedCompensationExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 14.F)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479830/718-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(1)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AllocatedShareBasedCompensationExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockParOrStatedValuePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Face amount or stated value per share of common stock.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockParOrStatedValuePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cost not yet recognized for nonvested award under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted-average period over which cost not yet recognized is expected to be recognized for award under share-based payment arrangement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 35<br> -Paragraph 1D<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480483/718-10-35-1D<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 35<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480483/718-10-35-3<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(01)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(02)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(03)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(04)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(01)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(02)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(03)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(iii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(iv)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(v)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The difference between the maximum number of shares (or other type of equity) authorized for issuance under the plan (including the effects of amendments and adjustments), and the sum of: 1) the number of shares (or other type of equity) already issued upon exercise of options or other equity-based awards under the plan; and 2) shares (or other type of equity) reserved for issuance on granting of outstanding awards, net of cancellations and forfeitures, if applicable.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Gross number of share options (or share units) granted during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(01)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The weighted average grant-date fair value of options granted during the reporting period as calculated by applying the disclosed option pricing methodology.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of options outstanding, including both vested and non-vested options.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares issued under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Expected term of award under share-based payment arrangement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average grant-date fair value of non-vested options outstanding.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average remaining contractual term for option awards outstanding, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 718<br> -SubTopic 10<br> -Subparagraph (e)(1)<br> -Name Accounting Standards Codification<br> -Paragraph 2<br> -Section 50<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number, after forfeiture, of shares or units issued under share-based payment arrangement. Excludes shares or units issued under employee stock ownership plan (ESOP).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 505<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-2<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480008/505-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementLocationAxis=us-gaap_GeneralAndAdministrativeExpenseMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementLocationAxis=us-gaap_GeneralAndAdministrativeExpenseMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementLocationAxis=us-gaap_ResearchAndDevelopmentExpenseMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementLocationAxis=us-gaap_ResearchAndDevelopmentExpenseMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MinimumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MinimumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_TitleOfIndividualAxis=STSS_EmployeesAndConsultantMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_TitleOfIndividualAxis=STSS_EmployeesAndConsultantMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PlanNameAxis=STSS_TwoThousandTwentyThreeEquityIncentivePlanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PlanNameAxis=STSS_TwoThousandTwentyThreeEquityIncentivePlanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PlanNameAxis=STSS_TwoThousandTwentyTwoEquityIncentivePlanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PlanNameAxis=STSS_TwoThousandTwentyTwoEquityIncentivePlanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>157
<FILENAME>R55.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.4</span><table class="report" border="0" cellspacing="2" id="idm45095370640752">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Schedule of Reconciliation of Federal Statutory Rate to Total Effective Rate (Details) - USD ($)<br></strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureAbstract', window );"><strong>Income Tax Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate', window );">Expected benefit at statutory federal tax rate</a></td>
<td class="num">$ (2,073,230)<span></span>
</td>
<td class="num">$ (974,329)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxReconciliationChangeInEnactedTaxRate', window );">Permanent differences &#8211; net</a></td>
<td class="num">(35,469)<span></span>
</td>
<td class="num">(859,515)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes', window );">State and local taxes, net of federal tax benefit</a></td>
<td class="text"> <span></span>
</td>
<td class="num">(265,607)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxReconciliationOtherAdjustments', window );">Other</a></td>
<td class="num">(24,569)<span></span>
</td>
<td class="num">(21,965)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance', window );">Change in valuation allowance</a></td>
<td class="nump">2,103,268<span></span>
</td>
<td class="nump">2,121,416<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxExpenseBenefit', window );">Income tax expense (benefit)</a></td>
<td class="num">$ (30,000)<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 270<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482964/270-10-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (ee)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-12<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 231<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482663/740-10-55-231<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-9<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.7)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479360/740-10-S99-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-8<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-10<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (h)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-22<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(9))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477250/944-220-S99-1<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Subparagraph (a)<br> -SubTopic 20<br> -Topic 740<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482659/740-20-45-2<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h))<br> -SubTopic 10<br> -Topic 235<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to increase (decrease) in the valuation allowance for deferred tax assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 231<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482663/740-10-55-231<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12A<br> -Subparagraph (a)(6)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-12A<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-12<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxReconciliationChangeInEnactedTaxRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations, attributable to increase (decrease) in the income tax rates.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-12<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 231<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482663/740-10-55-231<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12A<br> -Subparagraph (a)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-12A<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 15<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482525/740-10-45-15<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxReconciliationChangeInEnactedTaxRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of income tax expense or benefit for the period computed by applying the domestic federal statutory tax rates to pretax income from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-12<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 231<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482663/740-10-55-231<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxReconciliationOtherAdjustments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to other adjustments.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 231<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482663/740-10-55-231<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12<br> -Subparagraph (b)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-12<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-12<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxReconciliationOtherAdjustments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to state and local income tax expense (benefit).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 231<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482663/740-10-55-231<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12A<br> -Subparagraph (a)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-12A<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-12<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>158
<FILENAME>R56.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.4</span><table class="report" border="0" cellspacing="2" id="idm45095356584000">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Schedule of Components of Deferred tax Assets (Details) - USD ($)<br></strong></div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureAbstract', window );"><strong>Income Tax Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_STSS_DeferredTaxAssetsPropertyPlantAndEquipments', window );">Fixed assets</a></td>
<td class="num">$ (281,073)<span></span>
</td>
<td class="num">$ (268,594)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetInterestCarryforward', window );">Interest</a></td>
<td class="nump">35,178<span></span>
</td>
<td class="nump">62,310<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsInProcessResearchAndDevelopment', window );">Research and development expenses</a></td>
<td class="nump">400,810<span></span>
</td>
<td class="nump">454,942<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost', window );">Stock-based compensation</a></td>
<td class="nump">895,509<span></span>
</td>
<td class="nump">917,351<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsCharitableContributionCarryforwards', window );">Charitable Contributions</a></td>
<td class="nump">420<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsDomestic', window );">Net operating losses - federal</a></td>
<td class="nump">4,456,242<span></span>
</td>
<td class="nump">2,898,411<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsStateAndLocal', window );">Net operating losses &#8211; state and local</a></td>
<td class="nump">543,264<span></span>
</td>
<td class="nump">921,350<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsForeign', window );">Net operating losses - foreign</a></td>
<td class="nump">233,114<span></span>
</td>
<td class="nump">37,686<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsResearch', window );">Research credit</a></td>
<td class="nump">28,985<span></span>
</td>
<td class="nump">28,985<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsValuationAllowance', window );">Less valuation allowance</a></td>
<td class="num">(6,474,449)<span></span>
</td>
<td class="num">(5,244,441)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxLiabilities', window );">Net deferred tax liability</a></td>
<td class="num">$ (162,000)<span></span>
</td>
<td class="num">$ (192,000)<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_STSS_DeferredTaxAssetsPropertyPlantAndEquipments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Deferred tax assets property plant and equipments.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">STSS_DeferredTaxAssetsPropertyPlantAndEquipments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>STSS_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetInterestCarryforward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, before allocation of valuation allowance, of deferred tax asset attributable to deductible interest carryforward.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-6<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetInterestCarryforward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsCharitableContributionCarryforwards">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before allocation of valuation allowances of deferred tax asset attributable to deductible charitable contribution carryforwards.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-6<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsCharitableContributionCarryforwards</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsInProcessResearchAndDevelopment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, before allocation of valuation allowance, of deferred tax asset attributable to deductible temporary difference from in-process research and development cost acquired in business combination or from joint venture formation or both.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-6<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsInProcessResearchAndDevelopment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsDomestic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before allocation of valuation allowances of deferred tax asset attributable to deductible domestic operating loss carryforwards. Excludes state and local operating loss carryforwards.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-6<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsDomestic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsForeign">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before allocation of valuation allowances of deferred tax asset attributable to deductible foreign operating loss carryforwards.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-6<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsForeign</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsStateAndLocal">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before allocation of valuation allowances of deferred tax asset attributable to deductible state and local operating loss carryforwards.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-6<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsStateAndLocal</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsResearch">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before allocation of valuation allowances of deferred tax asset attributable to deductible research tax credit carryforwards.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-6<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsResearch</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from share-based compensation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-6<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsValuationAllowance">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred tax assets for which it is more likely than not that a tax benefit will not be realized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsValuationAllowance</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after deferred tax asset, of deferred tax liability attributable to taxable differences without jurisdictional netting.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>159
<FILENAME>R57.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.4</span><table class="report" border="0" cellspacing="2" id="idm45095246684704">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Schedule of Geographical Components of Loss Before Income Taxes (Details) - USD ($)<br></strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureAbstract', window );"><strong>Income Tax Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic', window );">United Stated Operations</a></td>
<td class="num">$ (8,173,807)<span></span>
</td>
<td class="num">$ (3,978,832)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign', window );">International Operations</a></td>
<td class="num">(1,667,831)<span></span>
</td>
<td class="num">(660,830)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest', window );">Net loss Before Provision for Taxes</a></td>
<td class="num">$ (9,871,638)<span></span>
</td>
<td class="num">$ (4,639,662)<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The portion of earnings or loss from continuing operations before income taxes that is attributable to domestic operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 10A<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-10A<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-22<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 48<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-48<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-30<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 270<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482964/270-10-50-1<br><br>Reference 6: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (ee)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(11))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477250/944-220-S99-1<br><br>Reference 9: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 31<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-31<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 235<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477314/942-235-S99-1<br><br>Reference 11: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(10))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br><br>Reference 12: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(15))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478524/942-220-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The portion of earnings or loss from continuing operations before income taxes that is attributable to foreign operations, which is defined as Income or Loss generated from operations located outside the entity's country of domicile.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 10A<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-10A<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>160
<FILENAME>R58.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.4</span><table class="report" border="0" cellspacing="2" id="idm45095358175296">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Income Taxes (Details Narrative) - USD ($)<br></strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">9 Months Ended</th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2024</div></th>
<th class="th"><div>Sep. 30, 2023</div></th>
<th class="th"><div>Sep. 30, 2024</div></th>
<th class="th"><div>Sep. 30, 2023</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateReconciliationLineItems', window );"><strong>Effective Income Tax Rate Reconciliation [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateContinuingOperations', window );">Effective income tax rate percentage</a></td>
<td class="nump">0.00%<span></span>
</td>
<td class="nump">0.00%<span></span>
</td>
<td class="nump">0.00%<span></span>
</td>
<td class="nump">0.00%<span></span>
</td>
<td class="nump">21.00%<span></span>
</td>
<td class="nump">28.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxAuthorityAxis=us-gaap_DomesticCountryMember', window );">Domestic Tax Jurisdiction [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateReconciliationLineItems', window );"><strong>Effective Income Tax Rate Reconciliation [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLossCarryforwards', window );">Net operating loss carryforwards</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 21,222,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxAuthorityAxis=us-gaap_DomesticCountryMember', window );">Domestic Tax Jurisdiction [Member] | Expires On 2028 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateReconciliationLineItems', window );"><strong>Effective Income Tax Rate Reconciliation [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLossCarryforwards', window );">Net operating loss carryforwards</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">241,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxAuthorityAxis=us-gaap_DomesticCountryMember', window );">Domestic Tax Jurisdiction [Member] | No Expire [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateReconciliationLineItems', window );"><strong>Effective Income Tax Rate Reconciliation [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLossCarryforwards', window );">Net operating loss carryforwards</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">20,981,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxAuthorityAxis=us-gaap_ForeignCountryMember', window );">Foreign Tax Jurisdiction [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateReconciliationLineItems', window );"><strong>Effective Income Tax Rate Reconciliation [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLossCarryforwards', window );">Net operating loss carryforwards</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2,590,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectiveIncomeTaxRateContinuingOperations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Percentage of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-12<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 231<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482663/740-10-55-231<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectiveIncomeTaxRateContinuingOperations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectiveIncomeTaxRateReconciliationLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-12<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 231<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482663/740-10-55-231<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12<br> -Subparagraph (b)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-12<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectiveIncomeTaxRateReconciliationLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLossCarryforwards">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of operating loss carryforward, before tax effects, available to reduce future taxable income under enacted tax laws.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-3<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLossCarryforwards</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxAuthorityAxis=us-gaap_DomesticCountryMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxAuthorityAxis=us-gaap_DomesticCountryMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementScenarioAxis=STSS_ExpiresOnTwoThousandTwentyEightMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementScenarioAxis=STSS_ExpiresOnTwoThousandTwentyEightMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementScenarioAxis=STSS_NotExpireMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementScenarioAxis=STSS_NotExpireMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxAuthorityAxis=us-gaap_ForeignCountryMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxAuthorityAxis=us-gaap_ForeignCountryMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>161
<FILENAME>R59.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.4</span><table class="report" border="0" cellspacing="2" id="idm45095369565072">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Related Party Transactions and Balances (Details Narrative) - USD ($)<br></strong></div></th>
<th class="th"><div>Sep. 30, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_TitleOfIndividualAxis=STSS_OfficersAndDirectorsMember', window );">Officers and Directors [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent', window );">Accounts payable and accrued liabilities</a></td>
<td class="nump">$ 152,500<span></span>
</td>
<td class="nump">$ 32,974<span></span>
</td>
<td class="nump">$ 105,667<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying values as of the balance sheet date of obligations incurred through that date, including liabilities incurred and payable to vendors for goods and services received, taxes, interest, rent and utilities, compensation costs, payroll taxes and fringe benefits (other than pension and postretirement obligations), contractual rights and obligations, and statutory obligations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(15)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478546/942-210-S99-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(15)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478546/942-210-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_TitleOfIndividualAxis=STSS_OfficersAndDirectorsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_TitleOfIndividualAxis=STSS_OfficersAndDirectorsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>162
<FILENAME>R60.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.4</span><table class="report" border="0" cellspacing="2" id="idm45095328075152">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Schedule of Assets and Liabilities Measured at Fair Value on Recurring Basis (Details) - USD ($)<br></strong></div></th>
<th class="th"><div>Sep. 30, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancialInstrumentsFinancialAssetsBalanceSheetGroupingsAbstract', window );"><strong>Assets</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsFairValueDisclosure', window );">Cash</a></td>
<td class="nump">$ 2,473,197<span></span>
</td>
<td class="nump">$ 3,012,908<span></span>
</td>
<td class="nump">$ 4,170,897<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosure', window );">Total assets measured at fair value</a></td>
<td class="nump">2,473,197<span></span>
</td>
<td class="nump">3,012,908<span></span>
</td>
<td class="nump">4,170,897<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancialInstrumentsFinancialLiabilitiesBalanceSheetGroupingsAbstract', window );"><strong>Liabilities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_STSS_WarrantLiability', window );">Warrant liability</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,422,785<span></span>
</td>
<td class="nump">1,151,838<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesFairValueDisclosure', window );">Total liabilities measured at fair value</a></td>
<td class="nump">1,027,102<span></span>
</td>
<td class="nump">2,422,785<span></span>
</td>
<td class="nump">1,151,838<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesFairValueDisclosureAbstract', window );"><strong>Liabilities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeLiabilities', window );">Warrant liability</a></td>
<td class="nump">1,027,102<span></span>
</td>
<td class="nump">2,422,785<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member', window );">Fair Value, Inputs, Level 1 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancialInstrumentsFinancialAssetsBalanceSheetGroupingsAbstract', window );"><strong>Assets</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsFairValueDisclosure', window );">Cash</a></td>
<td class="nump">2,473,197<span></span>
</td>
<td class="nump">3,012,908<span></span>
</td>
<td class="nump">4,170,897<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosure', window );">Total assets measured at fair value</a></td>
<td class="nump">2,473,197<span></span>
</td>
<td class="nump">3,012,908<span></span>
</td>
<td class="nump">4,170,897<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancialInstrumentsFinancialLiabilitiesBalanceSheetGroupingsAbstract', window );"><strong>Liabilities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_STSS_WarrantLiability', window );">Warrant liability</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">1,151,838<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesFairValueDisclosure', window );">Total liabilities measured at fair value</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">1,151,838<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesFairValueDisclosureAbstract', window );"><strong>Liabilities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeLiabilities', window );">Warrant liability</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member', window );">Fair Value, Inputs, Level 2 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancialInstrumentsFinancialAssetsBalanceSheetGroupingsAbstract', window );"><strong>Assets</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsFairValueDisclosure', window );">Cash</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosure', window );">Total assets measured at fair value</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancialInstrumentsFinancialLiabilitiesBalanceSheetGroupingsAbstract', window );"><strong>Liabilities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_STSS_WarrantLiability', window );">Warrant liability</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,422,785<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesFairValueDisclosure', window );">Total liabilities measured at fair value</a></td>
<td class="nump">1,027,102<span></span>
</td>
<td class="nump">2,422,785<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesFairValueDisclosureAbstract', window );"><strong>Liabilities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeLiabilities', window );">Warrant liability</a></td>
<td class="nump">1,027,102<span></span>
</td>
<td class="nump">2,422,785<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member', window );">Fair Value, Inputs, Level 3 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancialInstrumentsFinancialAssetsBalanceSheetGroupingsAbstract', window );"><strong>Assets</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsFairValueDisclosure', window );">Cash</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosure', window );">Total assets measured at fair value</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancialInstrumentsFinancialLiabilitiesBalanceSheetGroupingsAbstract', window );"><strong>Liabilities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_STSS_WarrantLiability', window );">Warrant liability</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesFairValueDisclosure', window );">Total liabilities measured at fair value</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesFairValueDisclosureAbstract', window );"><strong>Liabilities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeLiabilities', window );">Warrant liability</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_STSS_WarrantLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Warrant liability.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">STSS_WarrantLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>STSS_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsFairValueDisclosure">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value portion of asset recognized for present right to economic benefit.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 100<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482078/820-10-55-100<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsFairValueDisclosure</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsFairValueDisclosure">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value portion of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsFairValueDisclosure</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value, after the effects of master netting arrangements, of a financial liability or contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset. Includes liabilities not subject to a master netting arrangement and not elected to be offset.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (bbb)(2)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (bbb)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (bbb)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-3<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478795/946-210-50-6<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (a)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478795/946-210-50-6<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (a)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478795/946-210-50-6<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (a)(4)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478795/946-210-50-6<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478795/946-210-50-1<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478795/946-210-50-1<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478795/946-210-50-1<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478795/946-210-50-1<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478795/946-210-50-6<br><br>Reference 16: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (a)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478795/946-210-50-6<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(9)(e))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-1<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 5C<br> -Subparagraph (SX 210.12-13C(Column H)(Footnote 7))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477271/946-320-S99-5C<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(9)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-1<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(9)(d))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-1<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 5<br> -Subparagraph (SX 210.12-13(Column G)(Footnote 8))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477271/946-320-S99-5<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 5C<br> -Subparagraph (SX 210.12-13C(Column H))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477271/946-320-S99-5C<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 5<br> -Subparagraph (SX 210.12-13(Column G))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477271/946-320-S99-5<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 5A<br> -Subparagraph (SX 210.12-13A(Column E))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477271/946-320-S99-5A<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 5B<br> -Subparagraph (SX 210.12-13B(Column E))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477271/946-320-S99-5B<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 5B<br> -Subparagraph (SX 210.12-13B(Column E)(Footnote 4))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477271/946-320-S99-5B<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483466/210-20-50-3<br><br>Reference 28: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 210<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 22<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483444/210-20-55-22<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483444/210-20-55-10<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-10<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentsFinancialAssetsBalanceSheetGroupingsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentsFinancialAssetsBalanceSheetGroupingsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentsFinancialLiabilitiesBalanceSheetGroupingsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentsFinancialLiabilitiesBalanceSheetGroupingsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesFairValueDisclosure">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value of financial and nonfinancial obligations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesFairValueDisclosure</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesFairValueDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesFairValueDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>163
<FILENAME>R61.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.4</span><table class="report" border="0" cellspacing="2" id="idm45095361335040">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Commitments and Contingencies (Details Narrative) - USD ($)<br></strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="5">1 Months Ended</th>
<th class="th" colspan="1">3 Months Ended</th>
<th class="th" colspan="2">9 Months Ended</th>
<th class="th" colspan="2">12 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Jul. 10, 2024</div></th>
<th class="th"><div>Jun. 17, 2024</div></th>
<th class="th"><div>May 20, 2024</div></th>
<th class="th"><div>Apr. 03, 2024</div></th>
<th class="th"><div>Jun. 01, 2023</div></th>
<th class="th"><div>May 31, 2023</div></th>
<th class="th"><div>Feb. 09, 2023</div></th>
<th class="th"><div>Sep. 30, 2022</div></th>
<th class="th"><div>Sep. 01, 2022</div></th>
<th class="th"><div>Aug. 01, 2022</div></th>
<th class="th"><div>Aug. 14, 2023</div></th>
<th class="th"><div>Oct. 31, 2022</div></th>
<th class="th"><div>May 31, 2019</div></th>
<th class="th"><div>Sep. 30, 2018</div></th>
<th class="th"><div>Jul. 31, 2017</div></th>
<th class="th"><div>Mar. 31, 2023</div></th>
<th class="th"><div>Sep. 30, 2024</div></th>
<th class="th"><div>Sep. 30, 2023</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Jun. 30, 2023</div></th>
<th class="th"><div>Jun. 30, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountsPayableCurrentAndNoncurrent', window );">Accounts payable</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 56,874<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_STSS_OrderCostsToPurchaseEquipmentMoldsAndComponentPartsForResearchAndDevelopment', window );">Total order costs to purchase equipment, molds and component parts for research and development</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 609,953<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_STSS_ProgressPayments', window );">Progress payments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">209,678<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue', window );">Fully vested</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">60,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EmployeeBenefitsAndShareBasedCompensation', window );">Compensation cost</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 235,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation', window );">Options to purchase shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">50,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1', window );">Stock option, exercise price</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1.30<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensation', window );">Share based compensation</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 444,498<span></span>
</td>
<td class="nump">$ 838,911<span></span>
</td>
<td class="nump">963,023<span></span>
</td>
<td class="nump">$ 1,012,592<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_LitigationCaseAxis=STSS_BerlerMember', window );">Berler [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingencyDamagesSoughtValue', window );">Loss contingency, claims for damages</a></td>
<td class="nump">$ 456,000<span></span>
</td>
<td class="nump">$ 500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingencyDamagesSought', window );">Description of loss contingency</a></td>
<td class="text">(1) failure to make full
payment of certain monthly payments under his consulting agreement with the Company (the &#8220;Consulting Agreement&#8221;) in the amount
of $52,500, (2) failure to pay a bonus with a target of $216,000 under the Consulting Agreement, (3) $187,500, representing 50% of the
severance payment paid by the Company to Mr. Blackman, the Company&#8217;s co-founder and former Chief Operating Officer and Co-Chairman
and a declaration and injunctive relief establishing that Berler is the rightful owner of 50% of the Company&#8217;s Series A Preferred
Stock (which preferred stock is no longer outstanding).<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_LitigationCaseAxis=STSS_PlastomoldMember', window );">Plastomold [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingencyDamagesSoughtValue', window );">Loss contingency, claims for damages</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,762,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingencyDamagesSought', window );">Description of loss contingency</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">(1) failure to pay invoices, of which approximately $1 million would relate to
a maintenance agreement for units allegedly manufactured and sold using machinery that was defective and has never successfully produced
any saleable products, (2) breach of the implied covenant of good faith and fair dealing, (3) unjust enrichment, and (4) conversion.
Plastomold asserts it provided certain products and services to the Company for which its invoices were not fully paid. The Company believes
that Plastomold&#8217;s claims are without merit and intends to defend itself vigorously.<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_TitleOfIndividualAxis=STSS_Mr.BlackmanMember', window );">Mr. Blackman [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccruedBonusesCurrentAndNoncurrent', window );">Accrued bonus</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 250,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_STSS_PaymentForBonuses', window );">Payment for bonuses</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 65,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SeveranceCosts1', window );">Severance costs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 346,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_STSS_MedicalBenefitsCost', window );">Medical benefit cost</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 29,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue', window );">Fully vested</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">218,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_TitleOfIndividualAxis=STSS_AlanBlackmanMember', window );">Alan Blackman [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SeveranceCosts1', window );">Severance costs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 346,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_STSS_MedicalBenefitsCost', window );">Medical benefit cost</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 29,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensation', window );">Share based compensation</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 60,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TypeOfArrangementAxis=STSS_RoyaltyAgreementMember', window );">Royalty Agreement [Member] | Barry Berler [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_STSS_RoyaltyPercentage', window );">Royalty percentage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2.00%<span></span>
</td>
<td class="nump">2.00%<span></span>
</td>
<td class="nump">4.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_STSS_SinglePaymentObligation', window );">Single payment obligation</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TypeOfArrangementAxis=STSS_EmploymentAgreementMember', window );">Employment Agreement [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SalariesAndWages', window );">Salaries and wages</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 320,000<span></span>
</td>
<td class="nump">$ 256,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_STSS_AnnualCompensation', window );">Annual compensation</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 600,000<span></span>
</td>
<td class="nump">$ 400,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 225,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentForIncentiveFee', window );">Payment for incentive fee</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">18,750<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TypeOfArrangementAxis=STSS_EmploymentAgreementMember', window );">Employment Agreement [Member] | Alan Blackman [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SalariesAndWages', window );">Salaries and wages</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 320,000<span></span>
</td>
<td class="nump">$ 256,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccruedBonusesCurrentAndNoncurrent', window );">Accrued bonus</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 250,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_STSS_PaymentForBonuses', window );">Payment for bonuses</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 65,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TypeOfArrangementAxis=STSS_ServiceAgreementMember', window );">Service Agreement [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_STSS_InitialFee', window );">Initial fee</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 90,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_STSS_MonthlyFee', window );">Monthly fee</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 12,500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures', window );">Shares of restricted common stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">200,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_STSS_ValueOfDigitalMarketingActivities', window );">Value of digital marketing activities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 300,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures', window );">Value of restricted common stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 230,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TypeOfArrangementAxis=STSS_AssetPurchaseAgreementMember', window );">Asset Purchase Agreement [Member] | InjectEZ, LLC [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireProductiveAssets', window );">Payments to acquire assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 35,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EscrowDeposit', window );">Escrow deposit</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EscrowDepositDisbursementsRelatedToPropertyAcquisition1', window );">Escrow deposit disbursements related to property acquisition</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_STSS_AnnualCompensation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Annual compensation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">STSS_AnnualCompensation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>STSS_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_STSS_InitialFee">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Initial fee.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">STSS_InitialFee</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>STSS_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_STSS_MedicalBenefitsCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Medical benefits cost.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">STSS_MedicalBenefitsCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>STSS_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_STSS_MonthlyFee">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Monthly fee.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">STSS_MonthlyFee</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>STSS_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_STSS_OrderCostsToPurchaseEquipmentMoldsAndComponentPartsForResearchAndDevelopment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Order costs to purchase equipment molds and component parts for research and development.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">STSS_OrderCostsToPurchaseEquipmentMoldsAndComponentPartsForResearchAndDevelopment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>STSS_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_STSS_PaymentForBonuses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Payment for bonuses.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">STSS_PaymentForBonuses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>STSS_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_STSS_ProgressPayments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Progress payments.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">STSS_ProgressPayments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>STSS_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_STSS_RoyaltyPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Royalty percentage.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">STSS_RoyaltyPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>STSS_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_STSS_SinglePaymentObligation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Single payment obligation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">STSS_SinglePaymentObligation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>STSS_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_STSS_ValueOfDigitalMarketingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Value of digital marketing activities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">STSS_ValueOfDigitalMarketingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>STSS_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsPayableCurrentAndNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(15)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478546/942-210-S99-1<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(15)(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478777/944-210-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsPayableCurrentAndNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccruedBonusesCurrentAndNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of obligations incurred and payable for incentive compensation awarded to employees and directors or earned by them based on the terms of one or more relevant arrangements.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(15)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478546/942-210-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccruedBonusesCurrentAndNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EmployeeBenefitsAndShareBasedCompensation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of expense for employee benefit and equity-based compensation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EmployeeBenefitsAndShareBasedCompensation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EscrowDeposit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The designation of funds furnished by a borrower to a lender to assure future payments of the borrower's real estate taxes and insurance obligations with respect to a mortgaged property. Escrow deposits may be made for a variety of other purposes such as earnest money and contingent payments. This element excludes replacement reserves which are an escrow separately provided for within the US GAAP taxonomy.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(10))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478546/942-210-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 954<br> -SubTopic 440<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478522/954-440-50-1<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EscrowDeposit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EscrowDepositDisbursementsRelatedToPropertyAcquisition1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of escrow deposit disbursements related to property acquisition in noncash investing or financing transactions.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482913/230-10-50-4<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482913/230-10-50-3<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482913/230-10-50-5<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EscrowDepositDisbursementsRelatedToPropertyAcquisition1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LossContingenciesLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 450<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483076/450-20-50-4<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 450<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483076/450-20-50-9<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 720<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483359/720-20-50-1<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 460<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 27<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482395/460-10-55-27<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 450<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483076/450-20-50-9<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 450<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483076/450-20-50-4<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 460<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482425/460-10-50-3<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 450<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483076/450-20-50-1<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LossContingenciesLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LossContingencyDamagesSought">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Describes the form and magnitude of the award the plaintiff seeks in the legal matter, which may include an unspecified amount of money.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 450<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483076/450-20-50-4<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 450<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483076/450-20-50-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 450<br> -SubTopic 20<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483076/450-20-50-9<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LossContingencyDamagesSought</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LossContingencyDamagesSoughtValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The value (monetary amount) of the award the plaintiff seeks in the legal matter.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 450<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483076/450-20-50-1<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 450<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483076/450-20-50-4<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 450<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483076/450-20-50-9<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LossContingencyDamagesSoughtValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentForIncentiveFee">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount paid for incentive rights held by the managing member or general partner, of limited liability company (LLC) or limited partnership (LP).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 850<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483326/850-10-50-1<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 17<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-17<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentForIncentiveFee</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquireProductiveAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow for purchases of and capital improvements on property, plant and equipment (capital expenditures), software, and other intangible assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 805<br> -SubTopic 50<br> -Name Accounting Standards Codification<br> -Section 25<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480060/805-50-25-1<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 805<br> -SubTopic 50<br> -Name Accounting Standards Codification<br> -Section 30<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480027/805-50-30-1<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 805<br> -SubTopic 50<br> -Name Accounting Standards Codification<br> -Section 30<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480027/805-50-30-2<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (c)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-13<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquireProductiveAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SalariesAndWages">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of expense for salary and wage arising from service rendered by nonofficer employee. Excludes allocated cost, labor-related nonsalary expense, and direct and overhead labor cost included in cost of good and service sold.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SalariesAndWages</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SeveranceCosts1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of expenses for special or contractual termination benefits provided to current employees involuntarily terminated under a benefit arrangement associated exit or disposal activities pursuant to an authorized plan. Excludes expenses related to one-time termination benefits, a discontinued operation or an asset retirement obligation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SeveranceCosts1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of noncash expense for share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount by which current fair value of underlying stock exceeds exercise price of fully vested and expected to vest options outstanding. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The weighted average price as of the balance sheet date at which grantees could acquire the underlying shares with respect to all outstanding stock options which are in the customized range of exercise prices.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares issued during the period related to Restricted Stock Awards, net of any shares forfeited.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 505<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-2<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480008/505-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number, after forfeiture, of shares or units issued under share-based payment arrangement. Excludes shares or units issued under employee stock ownership plan (ESOP).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 505<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-2<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480008/505-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Value of stock related to Restricted Stock Awards issued during the period, net of the stock value of such awards forfeited.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 505<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-2<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480008/505-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_LitigationCaseAxis=STSS_BerlerMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_LitigationCaseAxis=STSS_BerlerMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_LitigationCaseAxis=STSS_PlastomoldMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_LitigationCaseAxis=STSS_PlastomoldMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_TitleOfIndividualAxis=STSS_Mr.BlackmanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_TitleOfIndividualAxis=STSS_Mr.BlackmanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_TitleOfIndividualAxis=STSS_AlanBlackmanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_TitleOfIndividualAxis=STSS_AlanBlackmanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TypeOfArrangementAxis=STSS_RoyaltyAgreementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TypeOfArrangementAxis=STSS_RoyaltyAgreementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_TitleOfIndividualAxis=STSS_BarryBerlerMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_TitleOfIndividualAxis=STSS_BarryBerlerMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TypeOfArrangementAxis=STSS_EmploymentAgreementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TypeOfArrangementAxis=STSS_EmploymentAgreementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TypeOfArrangementAxis=STSS_ServiceAgreementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TypeOfArrangementAxis=STSS_ServiceAgreementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TypeOfArrangementAxis=STSS_AssetPurchaseAgreementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TypeOfArrangementAxis=STSS_AssetPurchaseAgreementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetAcquisitionAxis=STSS_InjectEZLLCMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetAcquisitionAxis=STSS_InjectEZLLCMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>164
<FILENAME>R62.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.4</span><table class="report" border="0" cellspacing="2" id="idm45095365675440">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Schedule of Fixed Assets, Net (Details) - USD ($)<br></strong></div></th>
<th class="th"><div>Sep. 30, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentGross', window );">Total Fixed Assets</a></td>
<td class="nump">$ 8,224,960<span></span>
</td>
<td class="nump">$ 8,037,928<span></span>
</td>
<td class="nump">$ 7,684,614<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment', window );">Less: accumulated depreciation</a></td>
<td class="num">(1,991,365)<span></span>
</td>
<td class="num">(1,215,786)<span></span>
</td>
<td class="num">(679,724)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentNet', window );">Fixed asset, net</a></td>
<td class="nump">6,233,595<span></span>
</td>
<td class="nump">6,822,142<span></span>
</td>
<td class="nump">7,004,890<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_LandMember', window );">Land [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentGross', window );">Total Fixed Assets</a></td>
<td class="nump">253,781<span></span>
</td>
<td class="nump">260,460<span></span>
</td>
<td class="nump">242,240<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_BuildingMember', window );">Building [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentGross', window );">Total Fixed Assets</a></td>
<td class="nump">2,949,900<span></span>
</td>
<td class="nump">3,022,490<span></span>
</td>
<td class="nump">2,824,481<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_MachineryAndEquipmentMember', window );">Machinery and Equipment [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentGross', window );">Total Fixed Assets</a></td>
<td class="nump">4,730,617<span></span>
</td>
<td class="nump">4,464,317<span></span>
</td>
<td class="nump">$ 4,601,293<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=STSS_ComputerSystemsAndWebsiteAndOtherMember', window );">Computer Systems and Website &amp; Other [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentGross', window );">Total Fixed Assets</a></td>
<td class="nump">$ 290,662<span></span>
</td>
<td class="nump">$ 290,661<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of accumulated depreciation, depletion and amortization for physical assets used in the normal conduct of business to produce goods and services.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(8)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478777/944-210-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(14))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482099/360-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(8))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478777/944-210-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(13))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 360<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482099/360-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7A<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478964/842-20-50-7A<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -SubTopic 10<br> -Topic 360<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482099/360-10-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7A<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478964/842-20-50-7A<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481372/852-10-55-10<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(8))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478777/944-210-S99-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 360<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478451/942-360-50-1<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_LandMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_LandMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_BuildingMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_BuildingMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_MachineryAndEquipmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_MachineryAndEquipmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=STSS_ComputerSystemsAndWebsiteAndOtherMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=STSS_ComputerSystemsAndWebsiteAndOtherMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>165
<FILENAME>R63.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.4</span><table class="report" border="0" cellspacing="2" id="idm45095369475792">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Schedule of Fair Value of Assets Acquisition (Details) - Safegard Medical, Inc [Member]<br></strong></div></th>
<th class="th">
<div>Jul. 06, 2022 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringCostAndReserveLineItems', window );"><strong>Restructuring Cost and Reserve [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLand', window );">Land</a></td>
<td class="nump">$ 226,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment', window );">Building and affixed assets</a></td>
<td class="nump">2,648,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedEquipment', window );">Machinery</a></td>
<td class="nump">158,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory', window );">Inventory</a></td>
<td class="nump">32,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles', window );">Intangibles</a></td>
<td class="nump">64,712<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities', window );">Deferred tax liability</a></td>
<td class="num">(192,000)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets', window );">Total</a></td>
<td class="nump">$ 2,936,712<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of assets acquired at the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479907/805-20-50-1<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred tax liability attributable to taxable temporary differences assumed at the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479907/805-20-50-1<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of tangible personal property used to produce goods and services, including, but is not limited to, tools, dies and molds, computer and office equipment, acquired at the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479907/805-20-50-1<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of identifiable intangible assets recognized as of the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 55<br> -Paragraph 37<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479303/805-10-55-37<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479907/805-20-50-1<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of inventory recognized as of the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 55<br> -Paragraph 37<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479303/805-10-55-37<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479907/805-20-50-1<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLand">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of real estate acquired, at the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479907/805-20-50-1<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLand</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of property, plant, and equipment recognized as of the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 55<br> -Paragraph 37<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479303/805-10-55-37<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479907/805-20-50-1<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringCostAndReserveLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 420<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 5.P.4.d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479823/420-10-S99-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 420<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 5.P.4.b.1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479823/420-10-S99-2<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 420<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 5.P.4.b.2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479823/420-10-S99-2<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 420<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482017/420-10-50-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 420<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482017/420-10-50-1<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 420<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482017/420-10-50-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 420<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482017/420-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringCostAndReserveLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=STSS_SafegardMedicalIncMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=STSS_SafegardMedicalIncMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>166
<FILENAME>R64.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.4</span><table class="report" border="0" cellspacing="2" id="idm45095355305200">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Subsequent Events (Details Narrative) - Warrant [Member] - $ / shares<br></strong></div></th>
<th class="th"><div>Jan. 01, 2024</div></th>
<th class="th"><div>Apr. 30, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsequentEventLineItems', window );"><strong>Subsequent Event [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1', window );">Class of Warrant or Right, Exercise Price of Warrants or Rights</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 34.32<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_WarrantMember', window );">Subsequent Event [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsequentEventLineItems', window );"><strong>Subsequent Event [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight', window );">Class of Warrant or Right, Number of Securities Called by Each Warrant or Right</a></td>
<td class="nump">398,441<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1', window );">Class of Warrant or Right, Exercise Price of Warrants or Rights</a></td>
<td class="nump">$ 0.001<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Exercise price per share or per unit of warrants or rights outstanding.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-3<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of securities into which each warrant or right may be converted. For example, but not limited to, each warrant may be converted into two shares.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsequentEventLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Detail information of subsequent event by type. User is expected to use existing line items from elsewhere in the taxonomy as the primary line items for this disclosure, which is further associated with dimension and member elements pertaining to a subsequent event.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 830<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481674/830-30-50-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 855<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483399/855-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsequentEventLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_WarrantMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_WarrantMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>167
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.24.4</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>491</ContextCount>
  <ElementCount>373</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>false</FootnotesReported>
  <SegmentCount>105</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>4</UnitCount>
  <MyReports>
    <Report instance="forms-1a.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>00000001 - Document - Cover</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://sharpstechnology.com/role/Cover</Role>
      <ShortName>Cover</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report instance="forms-1a.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R2.htm</HtmlFileName>
      <LongName>00000002 - Statement - Condensed Consolidated Balance Sheets</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://sharpstechnology.com/role/BalanceSheets</Role>
      <ShortName>Condensed Consolidated Balance Sheets</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>2</Position>
    </Report>
    <Report instance="forms-1a.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R3.htm</HtmlFileName>
      <LongName>00000003 - Statement - Condensed Consolidated Balance Sheets (Parenthetical)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://sharpstechnology.com/role/BalanceSheetsParenthetical</Role>
      <ShortName>Condensed Consolidated Balance Sheets (Parenthetical)</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>3</Position>
    </Report>
    <Report instance="forms-1a.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R4.htm</HtmlFileName>
      <LongName>00000004 - Statement - Condensed Consolidated Statements of Operations</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://sharpstechnology.com/role/StatementsOfOperations</Role>
      <ShortName>Condensed Consolidated Statements of Operations</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>4</Position>
    </Report>
    <Report instance="forms-1a.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R5.htm</HtmlFileName>
      <LongName>00000005 - Statement - Condensed Consolidated Statements of Comprehensive Loss</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://sharpstechnology.com/role/StatementsOfComprehensiveLoss</Role>
      <ShortName>Condensed Consolidated Statements of Comprehensive Loss</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>5</Position>
    </Report>
    <Report instance="forms-1a.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R6.htm</HtmlFileName>
      <LongName>00000006 - Statement - Condensed Consolidated Statement of Stockholders' Equity</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://sharpstechnology.com/role/StatementOfStockholdersEquity</Role>
      <ShortName>Condensed Consolidated Statement of Stockholders' Equity</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>6</Position>
    </Report>
    <Report instance="forms-1a.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R7.htm</HtmlFileName>
      <LongName>00000007 - Statement - Condensed Consolidated Statements of Cash Flows</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://sharpstechnology.com/role/StatementsOfCashFlows</Role>
      <ShortName>Condensed Consolidated Statements of Cash Flows</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>7</Position>
    </Report>
    <Report instance="forms-1a.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R8.htm</HtmlFileName>
      <LongName>00000008 - Disclosure - Description of Business</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://sharpstechnology.com/role/DescriptionOfBusiness</Role>
      <ShortName>Description of Business</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>8</Position>
    </Report>
    <Report instance="forms-1a.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R9.htm</HtmlFileName>
      <LongName>00000009 - Disclosure - Summary of Significant Accounting Policies</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://sharpstechnology.com/role/SummaryOfSignificantAccountingPolicies</Role>
      <ShortName>Summary of Significant Accounting Policies</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>9</Position>
    </Report>
    <Report instance="forms-1a.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R10.htm</HtmlFileName>
      <LongName>00000010 - Disclosure - Inventories</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://sharpstechnology.com/role/Inventories</Role>
      <ShortName>Inventories</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>10</Position>
    </Report>
    <Report instance="forms-1a.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R11.htm</HtmlFileName>
      <LongName>00000011 - Disclosure - Fixed Assets</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://sharpstechnology.com/role/FixedAssets</Role>
      <ShortName>Fixed Assets</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>11</Position>
    </Report>
    <Report instance="forms-1a.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R12.htm</HtmlFileName>
      <LongName>00000012 - Disclosure - Asset Acquisition</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://sharpstechnology.com/role/AssetAcquisition</Role>
      <ShortName>Asset Acquisition</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>12</Position>
    </Report>
    <Report instance="forms-1a.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R13.htm</HtmlFileName>
      <LongName>00000013 - Disclosure - Other Assets</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://sharpstechnology.com/role/OtherAssets</Role>
      <ShortName>Other Assets</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>13</Position>
    </Report>
    <Report instance="forms-1a.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R14.htm</HtmlFileName>
      <LongName>00000014 - Disclosure - Debt Financing</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://sharpstechnology.com/role/DebtFinancing</Role>
      <ShortName>Debt Financing</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>14</Position>
    </Report>
    <Report instance="forms-1a.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R15.htm</HtmlFileName>
      <LongName>00000015 - Disclosure - Note Purchase Agreement</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://sharpstechnology.com/role/NotePurchaseAgreement</Role>
      <ShortName>Note Purchase Agreement</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>15</Position>
    </Report>
    <Report instance="forms-1a.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R16.htm</HtmlFileName>
      <LongName>00000016 - Disclosure - Stockholders??? Equity</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://sharpstechnology.com/role/StockholdersEquity</Role>
      <ShortName>Stockholders??? Equity</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>16</Position>
    </Report>
    <Report instance="forms-1a.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R17.htm</HtmlFileName>
      <LongName>00000017 - Disclosure - Preferred Stock</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://sharpstechnology.com/role/PreferredStock</Role>
      <ShortName>Preferred Stock</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>17</Position>
    </Report>
    <Report instance="forms-1a.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R18.htm</HtmlFileName>
      <LongName>00000018 - Disclosure - Warrant Liability</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://sharpstechnology.com/role/WarrantLiability</Role>
      <ShortName>Warrant Liability</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>18</Position>
    </Report>
    <Report instance="forms-1a.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R19.htm</HtmlFileName>
      <LongName>00000019 - Disclosure - Stock Options</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://sharpstechnology.com/role/StockOptions</Role>
      <ShortName>Stock Options</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>19</Position>
    </Report>
    <Report instance="forms-1a.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R20.htm</HtmlFileName>
      <LongName>00000020 - Disclosure - Income Taxes</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://sharpstechnology.com/role/IncomeTaxes</Role>
      <ShortName>Income Taxes</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>20</Position>
    </Report>
    <Report instance="forms-1a.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R21.htm</HtmlFileName>
      <LongName>00000021 - Disclosure - Related Party Transactions and Balances</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://sharpstechnology.com/role/RelatedPartyTransactionsAndBalances</Role>
      <ShortName>Related Party Transactions and Balances</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>21</Position>
    </Report>
    <Report instance="forms-1a.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R22.htm</HtmlFileName>
      <LongName>00000022 - Disclosure - Fair Value Measurements</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://sharpstechnology.com/role/FairValueMeasurements</Role>
      <ShortName>Fair Value Measurements</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>22</Position>
    </Report>
    <Report instance="forms-1a.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R23.htm</HtmlFileName>
      <LongName>00000023 - Disclosure - Commitments and Contingencies</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://sharpstechnology.com/role/CommitmentsAndContingencies</Role>
      <ShortName>Commitments and Contingencies</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>23</Position>
    </Report>
    <Report instance="forms-1a.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R24.htm</HtmlFileName>
      <LongName>00000024 - Disclosure - Subsequent Events</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://sharpstechnology.com/role/SubsequentEvents</Role>
      <ShortName>Subsequent Events</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>24</Position>
    </Report>
    <Report instance="forms-1a.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R25.htm</HtmlFileName>
      <LongName>00000025 - Disclosure - Summary of Significant Accounting Policies (Policies)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://sharpstechnology.com/role/SummaryOfSignificantAccountingPoliciesPolicies</Role>
      <ShortName>Summary of Significant Accounting Policies (Policies)</ShortName>
      <MenuCategory>Policies</MenuCategory>
      <ParentRole>http://sharpstechnology.com/role/SummaryOfSignificantAccountingPolicies</ParentRole>
      <Position>25</Position>
    </Report>
    <Report instance="forms-1a.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R26.htm</HtmlFileName>
      <LongName>00000026 - Disclosure - Inventories (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://sharpstechnology.com/role/InventoriesTables</Role>
      <ShortName>Inventories (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://sharpstechnology.com/role/Inventories</ParentRole>
      <Position>26</Position>
    </Report>
    <Report instance="forms-1a.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R27.htm</HtmlFileName>
      <LongName>00000027 - Disclosure - Fixed Assets (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://sharpstechnology.com/role/FixedAssetsTables</Role>
      <ShortName>Fixed Assets (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://sharpstechnology.com/role/FixedAssets</ParentRole>
      <Position>27</Position>
    </Report>
    <Report instance="forms-1a.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R28.htm</HtmlFileName>
      <LongName>00000028 - Disclosure - Asset Acquisition (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://sharpstechnology.com/role/AssetAcquisitionTables</Role>
      <ShortName>Asset Acquisition (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://sharpstechnology.com/role/AssetAcquisition</ParentRole>
      <Position>28</Position>
    </Report>
    <Report instance="forms-1a.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R29.htm</HtmlFileName>
      <LongName>00000029 - Disclosure - Other Assets (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://sharpstechnology.com/role/OtherAssetsTables</Role>
      <ShortName>Other Assets (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://sharpstechnology.com/role/OtherAssets</ParentRole>
      <Position>29</Position>
    </Report>
    <Report instance="forms-1a.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R30.htm</HtmlFileName>
      <LongName>00000030 - Disclosure - Warrant Liability (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://sharpstechnology.com/role/WarrantLiabilityTables</Role>
      <ShortName>Warrant Liability (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://sharpstechnology.com/role/WarrantLiability</ParentRole>
      <Position>30</Position>
    </Report>
    <Report instance="forms-1a.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R31.htm</HtmlFileName>
      <LongName>00000031 - Disclosure - Stock Options (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://sharpstechnology.com/role/StockOptionsTables</Role>
      <ShortName>Stock Options (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://sharpstechnology.com/role/StockOptions</ParentRole>
      <Position>31</Position>
    </Report>
    <Report instance="forms-1a.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R32.htm</HtmlFileName>
      <LongName>00000032 - Disclosure - Income Taxes (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://sharpstechnology.com/role/IncomeTaxesTables</Role>
      <ShortName>Income Taxes (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://sharpstechnology.com/role/IncomeTaxes</ParentRole>
      <Position>32</Position>
    </Report>
    <Report instance="forms-1a.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R33.htm</HtmlFileName>
      <LongName>00000033 - Disclosure - Fair Value Measurements (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://sharpstechnology.com/role/FairValueMeasurementsTables</Role>
      <ShortName>Fair Value Measurements (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://sharpstechnology.com/role/FairValueMeasurements</ParentRole>
      <Position>33</Position>
    </Report>
    <Report instance="forms-1a.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R34.htm</HtmlFileName>
      <LongName>00000034 - Disclosure - Description of Business (Details Narrative)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://sharpstechnology.com/role/DescriptionOfBusinessDetailsNarrative</Role>
      <ShortName>Description of Business (Details Narrative)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://sharpstechnology.com/role/DescriptionOfBusiness</ParentRole>
      <Position>34</Position>
    </Report>
    <Report instance="forms-1a.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R35.htm</HtmlFileName>
      <LongName>00000035 - Disclosure - Summary of Significant Accounting Policies (Details Narrative)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://sharpstechnology.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative</Role>
      <ShortName>Summary of Significant Accounting Policies (Details Narrative)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://sharpstechnology.com/role/SummaryOfSignificantAccountingPoliciesPolicies</ParentRole>
      <Position>35</Position>
    </Report>
    <Report instance="forms-1a.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R36.htm</HtmlFileName>
      <LongName>00000036 - Disclosure - Schedule of Inventories (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://sharpstechnology.com/role/ScheduleOfInventoriesDetails</Role>
      <ShortName>Schedule of Inventories (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>36</Position>
    </Report>
    <Report instance="forms-1a.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R37.htm</HtmlFileName>
      <LongName>00000037 - Disclosure - Schedule of Property, Plant and Equipment (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://sharpstechnology.com/role/ScheduleOfPropertyPlantAndEquipmentDetails</Role>
      <ShortName>Schedule of Property, Plant and Equipment (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>37</Position>
    </Report>
    <Report instance="forms-1a.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R38.htm</HtmlFileName>
      <LongName>00000038 - Disclosure - Fixed Assets (Details Narrative)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://sharpstechnology.com/role/FixedAssetsDetailsNarrative</Role>
      <ShortName>Fixed Assets (Details Narrative)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://sharpstechnology.com/role/FixedAssetsTables</ParentRole>
      <Position>38</Position>
    </Report>
    <Report instance="forms-1a.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R39.htm</HtmlFileName>
      <LongName>00000039 - Disclosure - Schedule of Fair Value of the Assets Acquisition (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://sharpstechnology.com/role/ScheduleOfFairValueOfAssetsAcquisitionDetails</Role>
      <ShortName>Schedule of Fair Value of the Assets Acquisition (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>39</Position>
    </Report>
    <Report instance="forms-1a.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R40.htm</HtmlFileName>
      <LongName>00000040 - Disclosure - Asset Acquisition (Details Narrative)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://sharpstechnology.com/role/AssetAcquisitionDetailsNarrative</Role>
      <ShortName>Asset Acquisition (Details Narrative)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://sharpstechnology.com/role/AssetAcquisitionTables</ParentRole>
      <Position>40</Position>
    </Report>
    <Report instance="forms-1a.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R41.htm</HtmlFileName>
      <LongName>00000041 - Disclosure - Schedule of Other Assets (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://sharpstechnology.com/role/ScheduleOfOtherAssetsDetails</Role>
      <ShortName>Schedule of Other Assets (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>41</Position>
    </Report>
    <Report instance="forms-1a.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R42.htm</HtmlFileName>
      <LongName>00000042 - Disclosure - Other Assets (Details Narrative)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://sharpstechnology.com/role/OtherAssetsDetailsNarrative</Role>
      <ShortName>Other Assets (Details Narrative)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://sharpstechnology.com/role/OtherAssetsTables</ParentRole>
      <Position>42</Position>
    </Report>
    <Report instance="forms-1a.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R43.htm</HtmlFileName>
      <LongName>00000043 - Disclosure - Debt Financing (Details Narrative)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://sharpstechnology.com/role/DebtFinancingDetailsNarrative</Role>
      <ShortName>Debt Financing (Details Narrative)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://sharpstechnology.com/role/DebtFinancing</ParentRole>
      <Position>43</Position>
    </Report>
    <Report instance="forms-1a.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R44.htm</HtmlFileName>
      <LongName>00000044 - Disclosure - Note Purchase Agreement (Details Narrative)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://sharpstechnology.com/role/NotePurchaseAgreementDetailsNarrative</Role>
      <ShortName>Note Purchase Agreement (Details Narrative)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://sharpstechnology.com/role/NotePurchaseAgreement</ParentRole>
      <Position>44</Position>
    </Report>
    <Report instance="forms-1a.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R45.htm</HtmlFileName>
      <LongName>00000045 - Disclosure - Stockholders??? Equity (Details Narrative)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://sharpstechnology.com/role/StockholdersEquityDetailsNarrative</Role>
      <ShortName>Stockholders??? Equity (Details Narrative)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://sharpstechnology.com/role/StockholdersEquity</ParentRole>
      <Position>45</Position>
    </Report>
    <Report instance="forms-1a.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R46.htm</HtmlFileName>
      <LongName>00000046 - Disclosure - Preferred Stock (Details Narrative)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://sharpstechnology.com/role/PreferredStockDetailsNarrative</Role>
      <ShortName>Preferred Stock (Details Narrative)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://sharpstechnology.com/role/PreferredStock</ParentRole>
      <Position>46</Position>
    </Report>
    <Report instance="forms-1a.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R47.htm</HtmlFileName>
      <LongName>00000047 - Disclosure - Schedule of Fair Value of Warrant (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://sharpstechnology.com/role/ScheduleOfFairValueOfWarrantDetails</Role>
      <ShortName>Schedule of Fair Value of Warrant (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>47</Position>
    </Report>
    <Report instance="forms-1a.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R48.htm</HtmlFileName>
      <LongName>00000048 - Disclosure - Schedule of Warrant Liability (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://sharpstechnology.com/role/ScheduleOfWarrantLiabilityDetails</Role>
      <ShortName>Schedule of Warrant Liability (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>48</Position>
    </Report>
    <Report instance="forms-1a.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R49.htm</HtmlFileName>
      <LongName>00000049 - Disclosure - Schedule of Warrant Outstanding (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://sharpstechnology.com/role/ScheduleOfWarrantOutstandingDetails</Role>
      <ShortName>Schedule of Warrant Outstanding (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>49</Position>
    </Report>
    <Report instance="forms-1a.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R50.htm</HtmlFileName>
      <LongName>00000050 - Disclosure - Warrant Liability (Details Narrative)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://sharpstechnology.com/role/WarrantLiabilityDetailsNarrative</Role>
      <ShortName>Warrant Liability (Details Narrative)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://sharpstechnology.com/role/WarrantLiabilityTables</ParentRole>
      <Position>50</Position>
    </Report>
    <Report instance="forms-1a.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R51.htm</HtmlFileName>
      <LongName>00000051 - Disclosure - Schedule of Stock Options Granted and Outstanding (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://sharpstechnology.com/role/ScheduleOfStockOptionsGrantedAndOutstandingDetails</Role>
      <ShortName>Schedule of Stock Options Granted and Outstanding (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>51</Position>
    </Report>
    <Report instance="forms-1a.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R52.htm</HtmlFileName>
      <LongName>00000052 - Disclosure - Schedule of Information About Options Outstanding (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://sharpstechnology.com/role/ScheduleOfInformationAboutOptionsOutstandingDetails</Role>
      <ShortName>Schedule of Information About Options Outstanding (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>52</Position>
    </Report>
    <Report instance="forms-1a.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R53.htm</HtmlFileName>
      <LongName>00000053 - Disclosure - Schedule of Fair Value of Stock Option Awards (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://sharpstechnology.com/role/ScheduleOfFairValueOfStockOptionAwardsDetails</Role>
      <ShortName>Schedule of Fair Value of Stock Option Awards (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>53</Position>
    </Report>
    <Report instance="forms-1a.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R54.htm</HtmlFileName>
      <LongName>00000054 - Disclosure - Stock Options (Details Narrative)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://sharpstechnology.com/role/StockOptionsDetailsNarrative</Role>
      <ShortName>Stock Options (Details Narrative)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://sharpstechnology.com/role/StockOptionsTables</ParentRole>
      <Position>54</Position>
    </Report>
    <Report instance="forms-1a.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R55.htm</HtmlFileName>
      <LongName>00000055 - Disclosure - Schedule of Reconciliation of Federal Statutory Rate to Total Effective Rate (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://sharpstechnology.com/role/ScheduleOfReconciliationOfFederalStatutoryRateToTotalEffectiveRateDetails</Role>
      <ShortName>Schedule of Reconciliation of Federal Statutory Rate to Total Effective Rate (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>55</Position>
    </Report>
    <Report instance="forms-1a.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R56.htm</HtmlFileName>
      <LongName>00000056 - Disclosure - Schedule of Components of Deferred tax Assets (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://sharpstechnology.com/role/ScheduleOfComponentsOfDeferredTaxAssetsDetails</Role>
      <ShortName>Schedule of Components of Deferred tax Assets (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>56</Position>
    </Report>
    <Report instance="forms-1a.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R57.htm</HtmlFileName>
      <LongName>00000057 - Disclosure - Schedule of Geographical Components of Loss Before Income Taxes (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://sharpstechnology.com/role/ScheduleOfGeographicalComponentsOfLossBeforeIncomeTaxesDetails</Role>
      <ShortName>Schedule of Geographical Components of Loss Before Income Taxes (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>57</Position>
    </Report>
    <Report instance="forms-1a.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R58.htm</HtmlFileName>
      <LongName>00000058 - Disclosure - Income Taxes (Details Narrative)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://sharpstechnology.com/role/IncomeTaxesDetailsNarrative</Role>
      <ShortName>Income Taxes (Details Narrative)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://sharpstechnology.com/role/IncomeTaxesTables</ParentRole>
      <Position>58</Position>
    </Report>
    <Report instance="forms-1a.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R59.htm</HtmlFileName>
      <LongName>00000059 - Disclosure - Related Party Transactions and Balances (Details Narrative)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://sharpstechnology.com/role/RelatedPartyTransactionsAndBalancesDetailsNarrative</Role>
      <ShortName>Related Party Transactions and Balances (Details Narrative)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://sharpstechnology.com/role/RelatedPartyTransactionsAndBalances</ParentRole>
      <Position>59</Position>
    </Report>
    <Report instance="forms-1a.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R60.htm</HtmlFileName>
      <LongName>00000060 - Disclosure - Schedule of Assets and Liabilities Measured at Fair Value on Recurring Basis (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://sharpstechnology.com/role/ScheduleOfAssetsAndLiabilitiesMeasuredAtFairValueOnRecurringBasisDetails</Role>
      <ShortName>Schedule of Assets and Liabilities Measured at Fair Value on Recurring Basis (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>60</Position>
    </Report>
    <Report instance="forms-1a.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R61.htm</HtmlFileName>
      <LongName>00000061 - Disclosure - Commitments and Contingencies (Details Narrative)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://sharpstechnology.com/role/CommitmentsAndContingenciesDetailsNarrative</Role>
      <ShortName>Commitments and Contingencies (Details Narrative)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://sharpstechnology.com/role/CommitmentsAndContingencies</ParentRole>
      <Position>61</Position>
    </Report>
    <Report instance="forms-1a.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R62.htm</HtmlFileName>
      <LongName>00000062 - Disclosure - Schedule of Fixed Assets, Net (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://sharpstechnology.com/role/ScheduleOfFixedAssetsNetDetails</Role>
      <ShortName>Schedule of Fixed Assets, Net (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>62</Position>
    </Report>
    <Report instance="forms-1a.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R63.htm</HtmlFileName>
      <LongName>00000063 - Disclosure - Schedule of Fair Value of Assets Acquisition (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://sharpstechnology.com/role/ScheduleOfFairValueOfAssetsAcquisitionDetailsDisclosure</Role>
      <ShortName>Schedule of Fair Value of Assets Acquisition (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>63</Position>
    </Report>
    <Report instance="forms-1a.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R64.htm</HtmlFileName>
      <LongName>00000064 - Disclosure - Subsequent Events (Details Narrative)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://sharpstechnology.com/role/SubsequentEventsDetailsNarrative</Role>
      <ShortName>Subsequent Events (Details Narrative)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://sharpstechnology.com/role/SubsequentEvents</ParentRole>
      <Position>64</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <InputFiles>
    <File doctype="S-1/A" isDefinitelyFs="true" isUsgaap="true" original="forms-1a.htm">forms-1a.htm</File>
    <File>stss-20240930.xsd</File>
    <File>stss-20240930_cal.xml</File>
    <File>stss-20240930_def.xml</File>
    <File>stss-20240930_lab.xml</File>
    <File>stss-20240930_pre.xml</File>
  </InputFiles>
  <SupplementalFiles>
    <File>form10-k_001.jpg</File>
    <File>form10-k_002.jpg</File>
    <File>form10-k_004.jpg</File>
    <File>form10-k_005.jpg</File>
    <File>forms-1_001.jpg</File>
    <File>forms-1_002.jpg</File>
  </SupplementalFiles>
  <BaseTaxonomies>
    <BaseTaxonomy items="1446">http://fasb.org/us-gaap/2024</BaseTaxonomy>
    <BaseTaxonomy items="26">http://xbrl.sec.gov/dei/2024</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>true</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>169
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "version": "2.2",
 "instance": {
  "forms-1a.htm": {
   "nsprefix": "STSS",
   "nsuri": "http://sharpstechnology.com/20240930",
   "dts": {
    "inline": {
     "local": [
      "forms-1a.htm"
     ]
    },
    "schema": {
     "local": [
      "stss-20240930.xsd"
     ],
     "remote": [
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "http://www.xbrl.org/2006/ref-2006-02-27.xsd",
      "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/reference-2009-12-16.xsd",
      "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd",
      "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd",
      "https://www.xbrl.org/dtr/type/2022-03-31/types.xsd",
      "https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd",
      "https://xbrl.fasb.org/srt/2024/elts/srt-roles-2024.xsd",
      "https://xbrl.fasb.org/srt/2024/elts/srt-types-2024.xsd",
      "https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd",
      "https://xbrl.fasb.org/us-gaap/2024/elts/us-roles-2024.xsd",
      "https://xbrl.fasb.org/us-gaap/2024/elts/us-types-2024.xsd",
      "https://xbrl.sec.gov/country/2024/country-2024.xsd",
      "https://xbrl.sec.gov/dei/2024/dei-2024.xsd",
      "https://xbrl.sec.gov/stpr/2024/stpr-2024.xsd"
     ]
    },
    "calculationLink": {
     "local": [
      "stss-20240930_cal.xml"
     ]
    },
    "definitionLink": {
     "local": [
      "stss-20240930_def.xml"
     ]
    },
    "labelLink": {
     "local": [
      "stss-20240930_lab.xml"
     ]
    },
    "presentationLink": {
     "local": [
      "stss-20240930_pre.xml"
     ]
    }
   },
   "keyStandard": 294,
   "keyCustom": 79,
   "axisStandard": 25,
   "axisCustom": 1,
   "memberStandard": 32,
   "memberCustom": 64,
   "hidden": {
    "total": 290,
    "http://sharpstechnology.com/20240930": 52,
    "http://fasb.org/us-gaap/2024": 234,
    "http://xbrl.sec.gov/dei/2024": 4
   },
   "contextCount": 491,
   "entityCount": 1,
   "segmentCount": 105,
   "elementCount": 630,
   "unitCount": 4,
   "baseTaxonomies": {
    "http://fasb.org/us-gaap/2024": 1446,
    "http://xbrl.sec.gov/dei/2024": 26
   },
   "report": {
    "R1": {
     "role": "http://sharpstechnology.com/role/Cover",
     "longName": "00000001 - Document - Cover",
     "shortName": "Cover",
     "isDefault": "true",
     "groupType": "document",
     "subGroupType": "",
     "menuCat": "Cover",
     "order": "1",
     "firstAnchor": {
      "contextRef": "From2024-01-01to2024-09-30",
      "name": "dei:EntityRegistrantName",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "b",
       "span",
       "p",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "forms-1a.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2024-01-01to2024-09-30",
      "name": "dei:EntityRegistrantName",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "b",
       "span",
       "p",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "forms-1a.htm",
      "first": true,
      "unique": true
     }
    },
    "R2": {
     "role": "http://sharpstechnology.com/role/BalanceSheets",
     "longName": "00000002 - Statement - Condensed Consolidated Balance Sheets",
     "shortName": "Condensed Consolidated Balance Sheets",
     "isDefault": "false",
     "groupType": "statement",
     "subGroupType": "",
     "menuCat": "Statements",
     "order": "2",
     "firstAnchor": {
      "contextRef": "AsOf2024-09-30",
      "name": "us-gaap:CashAndCashEquivalentsAtCarryingValue",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "forms-1a.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "AsOf2024-09-30",
      "name": "us-gaap:CashAndCashEquivalentsAtCarryingValue",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "forms-1a.htm",
      "first": true,
      "unique": true
     }
    },
    "R3": {
     "role": "http://sharpstechnology.com/role/BalanceSheetsParenthetical",
     "longName": "00000003 - Statement - Condensed Consolidated Balance Sheets (Parenthetical)",
     "shortName": "Condensed Consolidated Balance Sheets (Parenthetical)",
     "isDefault": "false",
     "groupType": "statement",
     "subGroupType": "parenthetical",
     "menuCat": "Statements",
     "order": "3",
     "firstAnchor": {
      "contextRef": "AsOf2024-09-30",
      "name": "us-gaap:PreferredStockParOrStatedValuePerShare",
      "unitRef": "USDPShares",
      "xsiNil": "false",
      "lang": null,
      "decimals": "INF",
      "ancestors": [
       "span",
       "span",
       "span",
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "forms-1a.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "AsOf2024-09-30",
      "name": "us-gaap:PreferredStockSharesIssued",
      "unitRef": "Shares",
      "xsiNil": "false",
      "lang": null,
      "decimals": "INF",
      "ancestors": [
       "span",
       "span",
       "span",
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "forms-1a.htm",
      "unique": true
     }
    },
    "R4": {
     "role": "http://sharpstechnology.com/role/StatementsOfOperations",
     "longName": "00000004 - Statement - Condensed Consolidated Statements of Operations",
     "shortName": "Condensed Consolidated Statements of Operations",
     "isDefault": "false",
     "groupType": "statement",
     "subGroupType": "",
     "menuCat": "Statements",
     "order": "4",
     "firstAnchor": {
      "contextRef": "From2024-07-012024-09-30",
      "name": "us-gaap:ResearchAndDevelopmentExpense",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "forms-1a.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2024-07-012024-09-30",
      "name": "us-gaap:ResearchAndDevelopmentExpense",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "forms-1a.htm",
      "first": true,
      "unique": true
     }
    },
    "R5": {
     "role": "http://sharpstechnology.com/role/StatementsOfComprehensiveLoss",
     "longName": "00000005 - Statement - Condensed Consolidated Statements of Comprehensive Loss",
     "shortName": "Condensed Consolidated Statements of Comprehensive Loss",
     "isDefault": "false",
     "groupType": "statement",
     "subGroupType": "",
     "menuCat": "Statements",
     "order": "5",
     "firstAnchor": {
      "contextRef": "From2024-07-012024-09-30",
      "name": "us-gaap:NetIncomeLoss",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "forms-1a.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "From2024-07-012024-09-30",
      "name": "us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "forms-1a.htm",
      "unique": true
     }
    },
    "R6": {
     "role": "http://sharpstechnology.com/role/StatementOfStockholdersEquity",
     "longName": "00000006 - Statement - Condensed Consolidated Statement of Stockholders' Equity",
     "shortName": "Condensed Consolidated Statement of Stockholders' Equity",
     "isDefault": "false",
     "groupType": "statement",
     "subGroupType": "",
     "menuCat": "Statements",
     "order": "6",
     "firstAnchor": {
      "contextRef": "AsOf2021-12-31_us-gaap_CommonStockMember",
      "name": "us-gaap:StockholdersEquity",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "forms-1a.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "AsOf2021-12-31_us-gaap_CommonStockMember",
      "name": "us-gaap:StockholdersEquity",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "forms-1a.htm",
      "first": true,
      "unique": true
     }
    },
    "R7": {
     "role": "http://sharpstechnology.com/role/StatementsOfCashFlows",
     "longName": "00000007 - Statement - Condensed Consolidated Statements of Cash Flows",
     "shortName": "Condensed Consolidated Statements of Cash Flows",
     "isDefault": "false",
     "groupType": "statement",
     "subGroupType": "",
     "menuCat": "Statements",
     "order": "7",
     "firstAnchor": {
      "contextRef": "From2024-01-01to2024-09-30",
      "name": "us-gaap:NetIncomeLoss",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "forms-1a.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "From2024-01-01to2024-09-30",
      "name": "us-gaap:DepreciationAndAmortization",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "forms-1a.htm",
      "unique": true
     }
    },
    "R8": {
     "role": "http://sharpstechnology.com/role/DescriptionOfBusiness",
     "longName": "00000008 - Disclosure - Description of Business",
     "shortName": "Description of Business",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "8",
     "firstAnchor": {
      "contextRef": "From2024-01-01to2024-09-30",
      "name": "us-gaap:BusinessDescriptionAndBasisOfPresentationTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "forms-1a.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2024-01-01to2024-09-30",
      "name": "us-gaap:BusinessDescriptionAndBasisOfPresentationTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "forms-1a.htm",
      "first": true,
      "unique": true
     }
    },
    "R9": {
     "role": "http://sharpstechnology.com/role/SummaryOfSignificantAccountingPolicies",
     "longName": "00000009 - Disclosure - Summary of Significant Accounting Policies",
     "shortName": "Summary of Significant Accounting Policies",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "9",
     "firstAnchor": {
      "contextRef": "From2024-01-01to2024-09-30",
      "name": "us-gaap:SignificantAccountingPoliciesTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "forms-1a.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2024-01-01to2024-09-30",
      "name": "us-gaap:SignificantAccountingPoliciesTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "forms-1a.htm",
      "first": true,
      "unique": true
     }
    },
    "R10": {
     "role": "http://sharpstechnology.com/role/Inventories",
     "longName": "00000010 - Disclosure - Inventories",
     "shortName": "Inventories",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "10",
     "firstAnchor": {
      "contextRef": "From2024-01-01to2024-09-30",
      "name": "us-gaap:InventoryDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "forms-1a.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2024-01-01to2024-09-30",
      "name": "us-gaap:InventoryDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "forms-1a.htm",
      "first": true,
      "unique": true
     }
    },
    "R11": {
     "role": "http://sharpstechnology.com/role/FixedAssets",
     "longName": "00000011 - Disclosure - Fixed Assets",
     "shortName": "Fixed Assets",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "11",
     "firstAnchor": {
      "contextRef": "From2024-01-01to2024-09-30",
      "name": "us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "forms-1a.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2024-01-01to2024-09-30",
      "name": "us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "forms-1a.htm",
      "first": true,
      "unique": true
     }
    },
    "R12": {
     "role": "http://sharpstechnology.com/role/AssetAcquisition",
     "longName": "00000012 - Disclosure - Asset Acquisition",
     "shortName": "Asset Acquisition",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "12",
     "firstAnchor": {
      "contextRef": "From2024-01-01to2024-09-30",
      "name": "us-gaap:AssetAcquisitionTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "forms-1a.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2024-01-01to2024-09-30",
      "name": "us-gaap:AssetAcquisitionTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "forms-1a.htm",
      "first": true,
      "unique": true
     }
    },
    "R13": {
     "role": "http://sharpstechnology.com/role/OtherAssets",
     "longName": "00000013 - Disclosure - Other Assets",
     "shortName": "Other Assets",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "13",
     "firstAnchor": {
      "contextRef": "From2024-01-01to2024-09-30",
      "name": "us-gaap:OtherAssetsDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "forms-1a.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2024-01-01to2024-09-30",
      "name": "us-gaap:OtherAssetsDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "forms-1a.htm",
      "first": true,
      "unique": true
     }
    },
    "R14": {
     "role": "http://sharpstechnology.com/role/DebtFinancing",
     "longName": "00000014 - Disclosure - Debt Financing",
     "shortName": "Debt Financing",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "14",
     "firstAnchor": {
      "contextRef": "From2024-01-01to2024-09-30",
      "name": "us-gaap:DebtDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "forms-1a.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2024-01-01to2024-09-30",
      "name": "us-gaap:DebtDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "forms-1a.htm",
      "first": true,
      "unique": true
     }
    },
    "R15": {
     "role": "http://sharpstechnology.com/role/NotePurchaseAgreement",
     "longName": "00000015 - Disclosure - Note Purchase Agreement",
     "shortName": "Note Purchase Agreement",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "15",
     "firstAnchor": {
      "contextRef": "From2023-01-012023-12-31",
      "name": "STSS:NotePurchaseAgreementTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "forms-1a.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2023-01-012023-12-31",
      "name": "STSS:NotePurchaseAgreementTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "forms-1a.htm",
      "first": true,
      "unique": true
     }
    },
    "R16": {
     "role": "http://sharpstechnology.com/role/StockholdersEquity",
     "longName": "00000016 - Disclosure - Stockholders\u2019 Equity",
     "shortName": "Stockholders\u2019 Equity",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "16",
     "firstAnchor": {
      "contextRef": "From2024-01-01to2024-09-30",
      "name": "us-gaap:StockholdersEquityNoteDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "forms-1a.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2024-01-01to2024-09-30",
      "name": "us-gaap:StockholdersEquityNoteDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "forms-1a.htm",
      "first": true,
      "unique": true
     }
    },
    "R17": {
     "role": "http://sharpstechnology.com/role/PreferredStock",
     "longName": "00000017 - Disclosure - Preferred Stock",
     "shortName": "Preferred Stock",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "17",
     "firstAnchor": {
      "contextRef": "From2024-01-01to2024-09-30",
      "name": "us-gaap:PreferredStockTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "forms-1a.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2024-01-01to2024-09-30",
      "name": "us-gaap:PreferredStockTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "forms-1a.htm",
      "first": true,
      "unique": true
     }
    },
    "R18": {
     "role": "http://sharpstechnology.com/role/WarrantLiability",
     "longName": "00000018 - Disclosure - Warrant Liability",
     "shortName": "Warrant Liability",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "18",
     "firstAnchor": {
      "contextRef": "From2024-01-01to2024-09-30",
      "name": "STSS:WarrantLiabilityTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "forms-1a.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2024-01-01to2024-09-30",
      "name": "STSS:WarrantLiabilityTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "forms-1a.htm",
      "first": true,
      "unique": true
     }
    },
    "R19": {
     "role": "http://sharpstechnology.com/role/StockOptions",
     "longName": "00000019 - Disclosure - Stock Options",
     "shortName": "Stock Options",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "19",
     "firstAnchor": {
      "contextRef": "From2024-01-01to2024-09-30",
      "name": "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "forms-1a.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2024-01-01to2024-09-30",
      "name": "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "forms-1a.htm",
      "first": true,
      "unique": true
     }
    },
    "R20": {
     "role": "http://sharpstechnology.com/role/IncomeTaxes",
     "longName": "00000020 - Disclosure - Income Taxes",
     "shortName": "Income Taxes",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "20",
     "firstAnchor": {
      "contextRef": "From2024-01-01to2024-09-30",
      "name": "us-gaap:IncomeTaxDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "forms-1a.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2024-01-01to2024-09-30",
      "name": "us-gaap:IncomeTaxDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "forms-1a.htm",
      "first": true,
      "unique": true
     }
    },
    "R21": {
     "role": "http://sharpstechnology.com/role/RelatedPartyTransactionsAndBalances",
     "longName": "00000021 - Disclosure - Related Party Transactions and Balances",
     "shortName": "Related Party Transactions and Balances",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "21",
     "firstAnchor": {
      "contextRef": "From2024-01-01to2024-09-30",
      "name": "us-gaap:RelatedPartyTransactionsDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "forms-1a.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2024-01-01to2024-09-30",
      "name": "us-gaap:RelatedPartyTransactionsDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "forms-1a.htm",
      "first": true,
      "unique": true
     }
    },
    "R22": {
     "role": "http://sharpstechnology.com/role/FairValueMeasurements",
     "longName": "00000022 - Disclosure - Fair Value Measurements",
     "shortName": "Fair Value Measurements",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "22",
     "firstAnchor": {
      "contextRef": "From2024-01-01to2024-09-30",
      "name": "us-gaap:FairValueMeasurementInputsDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "forms-1a.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2024-01-01to2024-09-30",
      "name": "us-gaap:FairValueMeasurementInputsDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "forms-1a.htm",
      "first": true,
      "unique": true
     }
    },
    "R23": {
     "role": "http://sharpstechnology.com/role/CommitmentsAndContingencies",
     "longName": "00000023 - Disclosure - Commitments and Contingencies",
     "shortName": "Commitments and Contingencies",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "23",
     "firstAnchor": {
      "contextRef": "From2024-01-01to2024-09-30",
      "name": "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "forms-1a.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2024-01-01to2024-09-30",
      "name": "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "forms-1a.htm",
      "first": true,
      "unique": true
     }
    },
    "R24": {
     "role": "http://sharpstechnology.com/role/SubsequentEvents",
     "longName": "00000024 - Disclosure - Subsequent Events",
     "shortName": "Subsequent Events",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "24",
     "firstAnchor": {
      "contextRef": "From2023-01-012023-12-31",
      "name": "us-gaap:SubsequentEventsTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "forms-1a.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2023-01-012023-12-31",
      "name": "us-gaap:SubsequentEventsTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "forms-1a.htm",
      "first": true,
      "unique": true
     }
    },
    "R25": {
     "role": "http://sharpstechnology.com/role/SummaryOfSignificantAccountingPoliciesPolicies",
     "longName": "00000025 - Disclosure - Summary of Significant Accounting Policies (Policies)",
     "shortName": "Summary of Significant Accounting Policies (Policies)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "policies",
     "menuCat": "Policies",
     "order": "25",
     "firstAnchor": {
      "contextRef": "From2024-01-01to2024-09-30",
      "name": "us-gaap:BasisOfAccountingPolicyPolicyTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "us-gaap:SignificantAccountingPoliciesTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "forms-1a.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2024-01-01to2024-09-30",
      "name": "us-gaap:BasisOfAccountingPolicyPolicyTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "us-gaap:SignificantAccountingPoliciesTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "forms-1a.htm",
      "first": true,
      "unique": true
     }
    },
    "R26": {
     "role": "http://sharpstechnology.com/role/InventoriesTables",
     "longName": "00000026 - Disclosure - Inventories (Tables)",
     "shortName": "Inventories (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "26",
     "firstAnchor": {
      "contextRef": "From2024-01-01to2024-09-30",
      "name": "us-gaap:ScheduleOfInventoryCurrentTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "us-gaap:InventoryDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "forms-1a.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2024-01-01to2024-09-30",
      "name": "us-gaap:ScheduleOfInventoryCurrentTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "us-gaap:InventoryDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "forms-1a.htm",
      "first": true,
      "unique": true
     }
    },
    "R27": {
     "role": "http://sharpstechnology.com/role/FixedAssetsTables",
     "longName": "00000027 - Disclosure - Fixed Assets (Tables)",
     "shortName": "Fixed Assets (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "27",
     "firstAnchor": {
      "contextRef": "From2024-01-01to2024-09-30",
      "name": "us-gaap:PropertyPlantAndEquipmentTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "forms-1a.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2024-01-01to2024-09-30",
      "name": "us-gaap:PropertyPlantAndEquipmentTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "forms-1a.htm",
      "first": true,
      "unique": true
     }
    },
    "R28": {
     "role": "http://sharpstechnology.com/role/AssetAcquisitionTables",
     "longName": "00000028 - Disclosure - Asset Acquisition (Tables)",
     "shortName": "Asset Acquisition (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "28",
     "firstAnchor": {
      "contextRef": "From2024-01-01to2024-09-30",
      "name": "us-gaap:ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "us-gaap:AssetAcquisitionTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "forms-1a.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2024-01-01to2024-09-30",
      "name": "us-gaap:ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "us-gaap:AssetAcquisitionTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "forms-1a.htm",
      "first": true,
      "unique": true
     }
    },
    "R29": {
     "role": "http://sharpstechnology.com/role/OtherAssetsTables",
     "longName": "00000029 - Disclosure - Other Assets (Tables)",
     "shortName": "Other Assets (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "29",
     "firstAnchor": {
      "contextRef": "From2024-01-01to2024-09-30",
      "name": "us-gaap:ScheduleOfOtherAssetsTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "us-gaap:OtherAssetsDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "forms-1a.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2024-01-01to2024-09-30",
      "name": "us-gaap:ScheduleOfOtherAssetsTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "us-gaap:OtherAssetsDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "forms-1a.htm",
      "first": true,
      "unique": true
     }
    },
    "R30": {
     "role": "http://sharpstechnology.com/role/WarrantLiabilityTables",
     "longName": "00000030 - Disclosure - Warrant Liability (Tables)",
     "shortName": "Warrant Liability (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "30",
     "firstAnchor": {
      "contextRef": "From2023-01-012023-12-31",
      "name": "us-gaap:ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "forms-1a.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "From2024-01-01to2024-09-30",
      "name": "STSS:ScheduleOfWarrantLiabilityTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "STSS:WarrantLiabilityTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "forms-1a.htm",
      "unique": true
     }
    },
    "R31": {
     "role": "http://sharpstechnology.com/role/StockOptionsTables",
     "longName": "00000031 - Disclosure - Stock Options (Tables)",
     "shortName": "Stock Options (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "31",
     "firstAnchor": {
      "contextRef": "From2024-01-01to2024-09-30",
      "name": "us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "forms-1a.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2024-01-01to2024-09-30",
      "name": "us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "forms-1a.htm",
      "first": true,
      "unique": true
     }
    },
    "R32": {
     "role": "http://sharpstechnology.com/role/IncomeTaxesTables",
     "longName": "00000032 - Disclosure - Income Taxes (Tables)",
     "shortName": "Income Taxes (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "32",
     "firstAnchor": {
      "contextRef": "From2023-01-012023-12-31",
      "name": "us-gaap:ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "us-gaap:IncomeTaxDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "forms-1a.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2023-01-012023-12-31",
      "name": "us-gaap:ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "us-gaap:IncomeTaxDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "forms-1a.htm",
      "first": true,
      "unique": true
     }
    },
    "R33": {
     "role": "http://sharpstechnology.com/role/FairValueMeasurementsTables",
     "longName": "00000033 - Disclosure - Fair Value Measurements (Tables)",
     "shortName": "Fair Value Measurements (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "33",
     "firstAnchor": {
      "contextRef": "From2024-01-01to2024-09-30",
      "name": "us-gaap:ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "us-gaap:FairValueMeasurementInputsDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "forms-1a.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2024-01-01to2024-09-30",
      "name": "us-gaap:ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "us-gaap:FairValueMeasurementInputsDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "forms-1a.htm",
      "first": true,
      "unique": true
     }
    },
    "R34": {
     "role": "http://sharpstechnology.com/role/DescriptionOfBusinessDetailsNarrative",
     "longName": "00000034 - Disclosure - Description of Business (Details Narrative)",
     "shortName": "Description of Business (Details Narrative)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "34",
     "firstAnchor": {
      "contextRef": "AsOf2024-09-30",
      "name": "STSS:WorkingCapital",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "span",
       "span",
       "p",
       "us-gaap:BusinessDescriptionAndBasisOfPresentationTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "forms-1a.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "AsOf2024-09-30",
      "name": "STSS:WorkingCapital",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "span",
       "span",
       "p",
       "us-gaap:BusinessDescriptionAndBasisOfPresentationTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "forms-1a.htm",
      "first": true,
      "unique": true
     }
    },
    "R35": {
     "role": "http://sharpstechnology.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative",
     "longName": "00000035 - Disclosure - Summary of Significant Accounting Policies (Details Narrative)",
     "shortName": "Summary of Significant Accounting Policies (Details Narrative)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "35",
     "firstAnchor": {
      "contextRef": "From2024-01-01to2024-09-30",
      "name": "us-gaap:NetCashProvidedByUsedInOperatingActivities",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "forms-1a.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "AsOf2023-12-31",
      "name": "us-gaap:Cash",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "span",
       "span",
       "p",
       "us-gaap:BasisOfAccountingPolicyPolicyTextBlock",
       "us-gaap:SignificantAccountingPoliciesTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "forms-1a.htm",
      "unique": true
     }
    },
    "R36": {
     "role": "http://sharpstechnology.com/role/ScheduleOfInventoriesDetails",
     "longName": "00000036 - Disclosure - Schedule of Inventories (Details)",
     "shortName": "Schedule of Inventories (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "36",
     "firstAnchor": {
      "contextRef": "AsOf2024-09-30",
      "name": "us-gaap:InventoryRawMaterialsNetOfReserves",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfInventoryCurrentTableTextBlock",
       "us-gaap:InventoryDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "forms-1a.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "AsOf2024-09-30",
      "name": "us-gaap:InventoryRawMaterialsNetOfReserves",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfInventoryCurrentTableTextBlock",
       "us-gaap:InventoryDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "forms-1a.htm",
      "first": true,
      "unique": true
     }
    },
    "R37": {
     "role": "http://sharpstechnology.com/role/ScheduleOfPropertyPlantAndEquipmentDetails",
     "longName": "00000037 - Disclosure - Schedule of Property, Plant and Equipment (Details)",
     "shortName": "Schedule of Property, Plant and Equipment (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "37",
     "firstAnchor": {
      "contextRef": "AsOf2024-09-30",
      "name": "us-gaap:PropertyPlantAndEquipmentGross",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:PropertyPlantAndEquipmentTextBlock",
       "us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "forms-1a.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "AsOf2023-12-31_custom_ComputerSystemsAndWebsiteAndOtherWebsiteMember",
      "name": "us-gaap:PropertyPlantAndEquipmentGross",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "td",
       "tr",
       "table",
       "us-gaap:PropertyPlantAndEquipmentTextBlock",
       "us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "forms-1a.htm",
      "unique": true
     }
    },
    "R38": {
     "role": "http://sharpstechnology.com/role/FixedAssetsDetailsNarrative",
     "longName": "00000038 - Disclosure - Fixed Assets (Details Narrative)",
     "shortName": "Fixed Assets (Details Narrative)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "38",
     "firstAnchor": {
      "contextRef": "From2024-01-01to2024-09-30",
      "name": "us-gaap:Depreciation",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "span",
       "span",
       "p",
       "us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "forms-1a.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2024-01-01to2024-09-30",
      "name": "us-gaap:Depreciation",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "span",
       "span",
       "p",
       "us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "forms-1a.htm",
      "first": true,
      "unique": true
     }
    },
    "R39": {
     "role": "http://sharpstechnology.com/role/ScheduleOfFairValueOfAssetsAcquisitionDetails",
     "longName": "00000039 - Disclosure - Schedule of Fair Value of the Assets Acquisition (Details)",
     "shortName": "Schedule of Fair Value of the Assets Acquisition (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "39",
     "firstAnchor": {
      "contextRef": "AsOf2022-07-06_custom_SafegardMedicalIncMember",
      "name": "us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLand",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock",
       "us-gaap:AssetAcquisitionTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "forms-1a.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "AsOf2022-07-06_custom_SafegardMedicalIncMember",
      "name": "us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedBuildings",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock",
       "us-gaap:AssetAcquisitionTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "forms-1a.htm",
      "unique": true
     }
    },
    "R40": {
     "role": "http://sharpstechnology.com/role/AssetAcquisitionDetailsNarrative",
     "longName": "00000040 - Disclosure - Asset Acquisition (Details Narrative)",
     "shortName": "Asset Acquisition (Details Narrative)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "40",
     "firstAnchor": {
      "contextRef": "AsOf2023-12-31_us-gaap_BuildingMember",
      "name": "us-gaap:FiniteLivedIntangibleAssetUsefulLife",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "span",
       "p",
       "us-gaap:AssetAcquisitionTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "forms-1a.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "AsOf2023-12-31_us-gaap_BuildingMember",
      "name": "us-gaap:FiniteLivedIntangibleAssetUsefulLife",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "span",
       "p",
       "us-gaap:AssetAcquisitionTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "forms-1a.htm",
      "first": true,
      "unique": true
     }
    },
    "R41": {
     "role": "http://sharpstechnology.com/role/ScheduleOfOtherAssetsDetails",
     "longName": "00000041 - Disclosure - Schedule of Other Assets (Details)",
     "shortName": "Schedule of Other Assets (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "41",
     "firstAnchor": {
      "contextRef": "AsOf2024-09-30",
      "name": "us-gaap:IntangibleAssetsNetExcludingGoodwill",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfOtherAssetsTableTextBlock",
       "us-gaap:OtherAssetsDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "forms-1a.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "AsOf2024-09-30",
      "name": "us-gaap:IntangibleAssetsNetExcludingGoodwill",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfOtherAssetsTableTextBlock",
       "us-gaap:OtherAssetsDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "forms-1a.htm",
      "first": true,
      "unique": true
     }
    },
    "R42": {
     "role": "http://sharpstechnology.com/role/OtherAssetsDetailsNarrative",
     "longName": "00000042 - Disclosure - Other Assets (Details Narrative)",
     "shortName": "Other Assets (Details Narrative)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "42",
     "firstAnchor": {
      "contextRef": "From2023-01-012023-12-31",
      "name": "us-gaap:AmortizationOfIntangibleAssets",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "span",
       "span",
       "p",
       "us-gaap:OtherAssetsDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "forms-1a.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2023-01-012023-12-31",
      "name": "us-gaap:AmortizationOfIntangibleAssets",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "span",
       "span",
       "p",
       "us-gaap:OtherAssetsDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "forms-1a.htm",
      "first": true,
      "unique": true
     }
    },
    "R43": {
     "role": "http://sharpstechnology.com/role/DebtFinancingDetailsNarrative",
     "longName": "00000043 - Disclosure - Debt Financing (Details Narrative)",
     "shortName": "Debt Financing (Details Narrative)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "43",
     "firstAnchor": {
      "contextRef": "From2024-01-01to2024-09-30",
      "name": "STSS:AccretedInterestFees",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "span",
       "p",
       "us-gaap:DebtDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "forms-1a.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2024-01-01to2024-09-30",
      "name": "STSS:AccretedInterestFees",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "span",
       "p",
       "us-gaap:DebtDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "forms-1a.htm",
      "first": true,
      "unique": true
     }
    },
    "R44": {
     "role": "http://sharpstechnology.com/role/NotePurchaseAgreementDetailsNarrative",
     "longName": "00000044 - Disclosure - Note Purchase Agreement (Details Narrative)",
     "shortName": "Note Purchase Agreement (Details Narrative)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "44",
     "firstAnchor": {
      "contextRef": "AsOf2023-12-31",
      "name": "us-gaap:CommonStockSharesIssued",
      "unitRef": "Shares",
      "xsiNil": "false",
      "lang": null,
      "decimals": "INF",
      "ancestors": [
       "span",
       "span",
       "span",
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "forms-1a.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "AsOf2021-12-31_custom_NotePurchaseAgreementMember",
      "name": "us-gaap:DebtInstrumentInterestRateStatedPercentage",
      "unitRef": "Pure",
      "xsiNil": "false",
      "lang": null,
      "decimals": "INF",
      "ancestors": [
       "span",
       "span",
       "p",
       "STSS:NotePurchaseAgreementTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "forms-1a.htm",
      "unique": true
     }
    },
    "R45": {
     "role": "http://sharpstechnology.com/role/StockholdersEquityDetailsNarrative",
     "longName": "00000045 - Disclosure - Stockholders\u2019 Equity (Details Narrative)",
     "shortName": "Stockholders\u2019 Equity (Details Narrative)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "45",
     "firstAnchor": {
      "contextRef": "AsOf2022-03-22",
      "name": "us-gaap:CommonStockSharesAuthorized",
      "unitRef": "Shares",
      "xsiNil": "false",
      "lang": null,
      "decimals": "INF",
      "ancestors": [
       "span",
       "span",
       "p",
       "us-gaap:StockholdersEquityNoteDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "forms-1a.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "AsOf2022-03-22",
      "name": "us-gaap:CommonStockSharesAuthorized",
      "unitRef": "Shares",
      "xsiNil": "false",
      "lang": null,
      "decimals": "INF",
      "ancestors": [
       "span",
       "span",
       "p",
       "us-gaap:StockholdersEquityNoteDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "forms-1a.htm",
      "first": true,
      "unique": true
     }
    },
    "R46": {
     "role": "http://sharpstechnology.com/role/PreferredStockDetailsNarrative",
     "longName": "00000046 - Disclosure - Preferred Stock (Details Narrative)",
     "shortName": "Preferred Stock (Details Narrative)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "46",
     "firstAnchor": {
      "contextRef": "From2024-01-012024-09-30_us-gaap_SeriesAPreferredStockMember",
      "name": "us-gaap:PreferredStockVotingRights",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "span",
       "p",
       "us-gaap:PreferredStockTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "forms-1a.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2024-01-012024-09-30_us-gaap_SeriesAPreferredStockMember",
      "name": "us-gaap:PreferredStockVotingRights",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "span",
       "p",
       "us-gaap:PreferredStockTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "forms-1a.htm",
      "first": true,
      "unique": true
     }
    },
    "R47": {
     "role": "http://sharpstechnology.com/role/ScheduleOfFairValueOfWarrantDetails",
     "longName": "00000047 - Disclosure - Schedule of Fair Value of Warrant (Details)",
     "shortName": "Schedule of Fair Value of Warrant (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "47",
     "firstAnchor": {
      "contextRef": "From2023-01-012023-12-31",
      "name": "us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "span",
       "p",
       "td",
       "tr",
       "table",
       "us-gaap:StockholdersEquityNoteDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "forms-1a.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "AsOf2024-09-30_us-gaap_WarrantMember_us-gaap_MeasurementInputExpectedDividendRateMember",
      "name": "us-gaap:WarrantsAndRightsOutstandingMeasurementInput",
      "unitRef": "Pure",
      "xsiNil": "false",
      "lang": null,
      "decimals": "INF",
      "ancestors": [
       "span",
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock",
       "STSS:WarrantLiabilityTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "forms-1a.htm",
      "unique": true
     }
    },
    "R48": {
     "role": "http://sharpstechnology.com/role/ScheduleOfWarrantLiabilityDetails",
     "longName": "00000048 - Disclosure - Schedule of Warrant Liability (Details)",
     "shortName": "Schedule of Warrant Liability (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "48",
     "firstAnchor": {
      "contextRef": "AsOf2023-12-31",
      "name": "STSS:WarrantLiability",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "td",
       "tr",
       "table",
       "STSS:ScheduleOfWarrantLiabilityTableTextBlock",
       "STSS:WarrantLiabilityTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "forms-1a.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "AsOf2024-09-30_custom_TradingAndOverallotmentWarrantsMember",
      "name": "STSS:WarrantLiabilitiesCurrent",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "STSS:ScheduleOfWarrantLiabilityTableTextBlock",
       "STSS:WarrantLiabilityTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "forms-1a.htm",
      "unique": true
     }
    },
    "R49": {
     "role": "http://sharpstechnology.com/role/ScheduleOfWarrantOutstandingDetails",
     "longName": "00000049 - Disclosure - Schedule of Warrant Outstanding (Details)",
     "shortName": "Schedule of Warrant Outstanding (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "49",
     "firstAnchor": {
      "contextRef": "AsOf2023-12-31",
      "name": "us-gaap:ClassOfWarrantOrRightOutstanding",
      "unitRef": "Shares",
      "xsiNil": "false",
      "lang": null,
      "decimals": "INF",
      "ancestors": [
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock",
       "STSS:WarrantLiabilityTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "forms-1a.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "AsOf2024-09-30",
      "name": "STSS:ClassOfWarrantsOrRightOutstanding",
      "unitRef": "Shares",
      "xsiNil": "false",
      "lang": null,
      "decimals": "INF",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock",
       "STSS:WarrantLiabilityTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "forms-1a.htm",
      "unique": true
     }
    },
    "R50": {
     "role": "http://sharpstechnology.com/role/WarrantLiabilityDetailsNarrative",
     "longName": "00000050 - Disclosure - Warrant Liability (Details Narrative)",
     "shortName": "Warrant Liability (Details Narrative)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "50",
     "firstAnchor": {
      "contextRef": "From2023-01-012023-12-31",
      "name": "us-gaap:MarketRiskBenefitChangeInFairValueGainLoss",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "span",
       "span",
       "p",
       "STSS:WarrantLiabilityTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "forms-1a.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "From2023-07-012023-09-30",
      "name": "STSS:GainLossOnSaleOfDerivative",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "span",
       "span",
       "p",
       "STSS:WarrantLiabilityTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "forms-1a.htm",
      "unique": true
     }
    },
    "R51": {
     "role": "http://sharpstechnology.com/role/ScheduleOfStockOptionsGrantedAndOutstandingDetails",
     "longName": "00000051 - Disclosure - Schedule of Stock Options Granted and Outstanding (Details)",
     "shortName": "Schedule of Stock Options Granted and Outstanding (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "51",
     "firstAnchor": {
      "contextRef": "AsOf2023-12-31",
      "name": "STSS:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionOutstandingNumber",
      "unitRef": "Shares",
      "xsiNil": "false",
      "lang": null,
      "decimals": "INF",
      "ancestors": [
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock",
       "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "forms-1a.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "AsOf2021-12-31",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice",
      "unitRef": "USDPShares",
      "xsiNil": "false",
      "lang": null,
      "decimals": "INF",
      "ancestors": [
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock",
       "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "forms-1a.htm",
      "unique": true
     }
    },
    "R52": {
     "role": "http://sharpstechnology.com/role/ScheduleOfInformationAboutOptionsOutstandingDetails",
     "longName": "00000052 - Disclosure - Schedule of Information About Options Outstanding (Details)",
     "shortName": "Schedule of Information About Options Outstanding (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "52",
     "firstAnchor": {
      "contextRef": "AsOf2023-12-31_custom_ExercisePriceRangeOneMember",
      "name": "us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions",
      "unitRef": "Shares",
      "xsiNil": "false",
      "lang": null,
      "decimals": "INF",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTextBlock",
       "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "forms-1a.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "AsOf2023-12-31_custom_ExercisePriceRangeOneMember",
      "name": "us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions",
      "unitRef": "Shares",
      "xsiNil": "false",
      "lang": null,
      "decimals": "INF",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTextBlock",
       "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "forms-1a.htm",
      "first": true,
      "unique": true
     }
    },
    "R53": {
     "role": "http://sharpstechnology.com/role/ScheduleOfFairValueOfStockOptionAwardsDetails",
     "longName": "00000053 - Disclosure - Schedule of Fair Value of Stock Option Awards (Details)",
     "shortName": "Schedule of Fair Value of Stock Option Awards (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "53",
     "firstAnchor": {
      "contextRef": "From2023-01-012023-12-31",
      "name": "us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "span",
       "p",
       "td",
       "tr",
       "table",
       "us-gaap:StockholdersEquityNoteDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "forms-1a.htm",
      "first": true
     },
     "uniqueAnchor": null
    },
    "R54": {
     "role": "http://sharpstechnology.com/role/StockOptionsDetailsNarrative",
     "longName": "00000054 - Disclosure - Stock Options (Details Narrative)",
     "shortName": "Stock Options (Details Narrative)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "54",
     "firstAnchor": {
      "contextRef": "From2023-01-012023-12-31",
      "name": "us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "span",
       "p",
       "td",
       "tr",
       "table",
       "us-gaap:StockholdersEquityNoteDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "forms-1a.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "From2023-01-012023-12-31",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue",
      "unitRef": "USDPShares",
      "xsiNil": "false",
      "lang": null,
      "decimals": "INF",
      "ancestors": [
       "span",
       "span",
       "p",
       "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "forms-1a.htm",
      "unique": true
     }
    },
    "R55": {
     "role": "http://sharpstechnology.com/role/ScheduleOfReconciliationOfFederalStatutoryRateToTotalEffectiveRateDetails",
     "longName": "00000055 - Disclosure - Schedule of Reconciliation of Federal Statutory Rate to Total Effective Rate (Details)",
     "shortName": "Schedule of Reconciliation of Federal Statutory Rate to Total Effective Rate (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "55",
     "firstAnchor": {
      "contextRef": "From2023-01-012023-12-31",
      "name": "us-gaap:IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock",
       "us-gaap:IncomeTaxDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "forms-1a.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2023-01-012023-12-31",
      "name": "us-gaap:IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock",
       "us-gaap:IncomeTaxDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "forms-1a.htm",
      "first": true,
      "unique": true
     }
    },
    "R56": {
     "role": "http://sharpstechnology.com/role/ScheduleOfComponentsOfDeferredTaxAssetsDetails",
     "longName": "00000056 - Disclosure - Schedule of Components of Deferred tax Assets (Details)",
     "shortName": "Schedule of Components of Deferred tax Assets (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "56",
     "firstAnchor": {
      "contextRef": "AsOf2023-12-31",
      "name": "STSS:DeferredTaxAssetsPropertyPlantAndEquipments",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock",
       "us-gaap:IncomeTaxDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "forms-1a.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "AsOf2023-12-31",
      "name": "STSS:DeferredTaxAssetsPropertyPlantAndEquipments",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock",
       "us-gaap:IncomeTaxDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "forms-1a.htm",
      "first": true,
      "unique": true
     }
    },
    "R57": {
     "role": "http://sharpstechnology.com/role/ScheduleOfGeographicalComponentsOfLossBeforeIncomeTaxesDetails",
     "longName": "00000057 - Disclosure - Schedule of Geographical Components of Loss Before Income Taxes (Details)",
     "shortName": "Schedule of Geographical Components of Loss Before Income Taxes (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "57",
     "firstAnchor": {
      "contextRef": "From2023-01-012023-12-31",
      "name": "us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock",
       "us-gaap:IncomeTaxDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "forms-1a.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2023-01-012023-12-31",
      "name": "us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock",
       "us-gaap:IncomeTaxDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "forms-1a.htm",
      "first": true,
      "unique": true
     }
    },
    "R58": {
     "role": "http://sharpstechnology.com/role/IncomeTaxesDetailsNarrative",
     "longName": "00000058 - Disclosure - Income Taxes (Details Narrative)",
     "shortName": "Income Taxes (Details Narrative)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "58",
     "firstAnchor": {
      "contextRef": "From2024-07-012024-09-30",
      "name": "us-gaap:EffectiveIncomeTaxRateContinuingOperations",
      "unitRef": "Pure",
      "xsiNil": "false",
      "lang": null,
      "decimals": "INF",
      "ancestors": [
       "span",
       "span",
       "span",
       "span",
       "span",
       "p",
       "us-gaap:IncomeTaxDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "forms-1a.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2024-07-012024-09-30",
      "name": "us-gaap:EffectiveIncomeTaxRateContinuingOperations",
      "unitRef": "Pure",
      "xsiNil": "false",
      "lang": null,
      "decimals": "INF",
      "ancestors": [
       "span",
       "span",
       "span",
       "span",
       "span",
       "p",
       "us-gaap:IncomeTaxDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "forms-1a.htm",
      "first": true,
      "unique": true
     }
    },
    "R59": {
     "role": "http://sharpstechnology.com/role/RelatedPartyTransactionsAndBalancesDetailsNarrative",
     "longName": "00000059 - Disclosure - Related Party Transactions and Balances (Details Narrative)",
     "shortName": "Related Party Transactions and Balances (Details Narrative)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "59",
     "firstAnchor": {
      "contextRef": "AsOf2024-09-30_custom_OfficersAndDirectorsMember",
      "name": "us-gaap:AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "span",
       "span",
       "p",
       "us-gaap:RelatedPartyTransactionsDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "forms-1a.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "AsOf2024-09-30_custom_OfficersAndDirectorsMember",
      "name": "us-gaap:AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "span",
       "span",
       "p",
       "us-gaap:RelatedPartyTransactionsDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "forms-1a.htm",
      "first": true,
      "unique": true
     }
    },
    "R60": {
     "role": "http://sharpstechnology.com/role/ScheduleOfAssetsAndLiabilitiesMeasuredAtFairValueOnRecurringBasisDetails",
     "longName": "00000060 - Disclosure - Schedule of Assets and Liabilities Measured at Fair Value on Recurring Basis (Details)",
     "shortName": "Schedule of Assets and Liabilities Measured at Fair Value on Recurring Basis (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "60",
     "firstAnchor": {
      "contextRef": "AsOf2024-09-30",
      "name": "us-gaap:CashAndCashEquivalentsFairValueDisclosure",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock",
       "us-gaap:FairValueMeasurementInputsDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "forms-1a.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "AsOf2024-09-30",
      "name": "us-gaap:CashAndCashEquivalentsFairValueDisclosure",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock",
       "us-gaap:FairValueMeasurementInputsDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "forms-1a.htm",
      "first": true,
      "unique": true
     }
    },
    "R61": {
     "role": "http://sharpstechnology.com/role/CommitmentsAndContingenciesDetailsNarrative",
     "longName": "00000061 - Disclosure - Commitments and Contingencies (Details Narrative)",
     "shortName": "Commitments and Contingencies (Details Narrative)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "61",
     "firstAnchor": {
      "contextRef": "AsOf2023-12-31",
      "name": "us-gaap:AccountsPayableCurrentAndNoncurrent",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "span",
       "span",
       "p",
       "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "forms-1a.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "AsOf2023-12-31",
      "name": "us-gaap:AccountsPayableCurrentAndNoncurrent",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "span",
       "span",
       "p",
       "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "forms-1a.htm",
      "first": true,
      "unique": true
     }
    },
    "R62": {
     "role": "http://sharpstechnology.com/role/ScheduleOfFixedAssetsNetDetails",
     "longName": "00000062 - Disclosure - Schedule of Fixed Assets, Net (Details)",
     "shortName": "Schedule of Fixed Assets, Net (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "62",
     "firstAnchor": {
      "contextRef": "AsOf2024-09-30",
      "name": "us-gaap:PropertyPlantAndEquipmentGross",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:PropertyPlantAndEquipmentTextBlock",
       "us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "forms-1a.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "AsOf2024-09-30_custom_ComputerSystemsAndWebsiteAndOtherMember",
      "name": "us-gaap:PropertyPlantAndEquipmentGross",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:PropertyPlantAndEquipmentTextBlock",
       "us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "forms-1a.htm",
      "unique": true
     }
    },
    "R63": {
     "role": "http://sharpstechnology.com/role/ScheduleOfFairValueOfAssetsAcquisitionDetailsDisclosure",
     "longName": "00000063 - Disclosure - Schedule of Fair Value of Assets Acquisition (Details)",
     "shortName": "Schedule of Fair Value of Assets Acquisition (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "63",
     "firstAnchor": {
      "contextRef": "AsOf2022-07-06_custom_SafegardMedicalIncMember",
      "name": "us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLand",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock",
       "us-gaap:AssetAcquisitionTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "forms-1a.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "AsOf2022-07-06_custom_SafegardMedicalIncMember",
      "name": "us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock",
       "us-gaap:AssetAcquisitionTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "forms-1a.htm",
      "unique": true
     }
    },
    "R64": {
     "role": "http://sharpstechnology.com/role/SubsequentEventsDetailsNarrative",
     "longName": "00000064 - Disclosure - Subsequent Events (Details Narrative)",
     "shortName": "Subsequent Events (Details Narrative)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "64",
     "firstAnchor": {
      "contextRef": "AsOf2023-04-30_us-gaap_WarrantMember",
      "name": "us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1",
      "unitRef": "USDPShares",
      "xsiNil": "false",
      "lang": null,
      "decimals": "INF",
      "ancestors": [
       "span",
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:StockholdersEquityNoteDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "forms-1a.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "AsOf2024-01-01_us-gaap_WarrantMember_us-gaap_SubsequentEventMember",
      "name": "us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight",
      "unitRef": "Shares",
      "xsiNil": "false",
      "lang": null,
      "decimals": "INF",
      "ancestors": [
       "span",
       "span",
       "p",
       "us-gaap:SubsequentEventsTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "forms-1a.htm",
      "unique": true
     }
    }
   },
   "tag": {
    "us-gaap_AccountingPoliciesAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "AccountingPoliciesAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Accounting Policies [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent",
     "crdr": "credit",
     "presentation": [
      "http://sharpstechnology.com/role/RelatedPartyTransactionsAndBalancesDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Accounts payable and accrued liabilities",
        "label": "Accounts Payable and Accrued Liabilities",
        "documentation": "Sum of the carrying values as of the balance sheet date of obligations incurred through that date, including liabilities incurred and payable to vendors for goods and services received, taxes, interest, rent and utilities, compensation costs, payroll taxes and fringe benefits (other than pension and postretirement obligations), contractual rights and obligations, and statutory obligations."
       }
      }
     },
     "auth_ref": [
      "r133",
      "r134"
     ]
    },
    "us-gaap_AccountsPayableAndOtherAccruedLiabilitiesCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "AccountsPayableAndOtherAccruedLiabilitiesCurrent",
     "crdr": "credit",
     "calculation": {
      "http://sharpstechnology.com/role/BalanceSheets": {
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://sharpstechnology.com/role/BalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Accrued and other current liabilities (Notes 13 and 15)",
        "documentation": "Amount of liabilities incurred to vendors for goods and services received, and accrued liabilities classified as other, payable within one year or the normal operating cycle, if longer."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_AccountsPayableCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "AccountsPayableCurrent",
     "crdr": "credit",
     "calculation": {
      "http://sharpstechnology.com/role/BalanceSheets": {
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://sharpstechnology.com/role/BalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Accounts payable",
        "documentation": "Carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer)."
       }
      }
     },
     "auth_ref": [
      "r71",
      "r698"
     ]
    },
    "us-gaap_AccountsPayableCurrentAndNoncurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "AccountsPayableCurrentAndNoncurrent",
     "crdr": "credit",
     "presentation": [
      "http://sharpstechnology.com/role/CommitmentsAndContingenciesDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Accounts payable",
        "label": "Accounts Payable",
        "documentation": "Carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business."
       }
      }
     },
     "auth_ref": [
      "r134",
      "r859"
     ]
    },
    "STSS_AccretedInterestFees": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://sharpstechnology.com/20240930",
     "localname": "AccretedInterestFees",
     "crdr": "debit",
     "presentation": [
      "http://sharpstechnology.com/role/DebtFinancingDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Accreted interest fees",
        "documentation": "Accreted interest fee."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_AccruedBonusesCurrentAndNoncurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "AccruedBonusesCurrentAndNoncurrent",
     "crdr": "credit",
     "presentation": [
      "http://sharpstechnology.com/role/CommitmentsAndContingenciesDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Accrued bonus",
        "documentation": "Carrying value as of the balance sheet date of obligations incurred and payable for incentive compensation awarded to employees and directors or earned by them based on the terms of one or more relevant arrangements."
       }
      }
     },
     "auth_ref": [
      "r134"
     ]
    },
    "us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment",
     "crdr": "credit",
     "calculation": {
      "http://sharpstechnology.com/role/ScheduleOfPropertyPlantAndEquipmentDetails": {
       "parentTag": "us-gaap_PropertyPlantAndEquipmentNet",
       "weight": -1.0,
       "order": 2.0
      },
      "http://sharpstechnology.com/role/ScheduleOfFixedAssetsNetDetails": {
       "parentTag": "us-gaap_PropertyPlantAndEquipmentNet",
       "weight": -1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://sharpstechnology.com/role/ScheduleOfFixedAssetsNetDetails",
      "http://sharpstechnology.com/role/ScheduleOfPropertyPlantAndEquipmentDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Less: accumulated depreciation",
        "label": "Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment",
        "documentation": "Amount of accumulated depreciation, depletion and amortization for physical assets used in the normal conduct of business to produce goods and services."
       }
      }
     },
     "auth_ref": [
      "r40",
      "r167",
      "r522"
     ]
    },
    "us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "AccumulatedOtherComprehensiveIncomeLossNetOfTax",
     "crdr": "credit",
     "calculation": {
      "http://sharpstechnology.com/role/BalanceSheets": {
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0,
       "order": 5.0
      }
     },
     "presentation": [
      "http://sharpstechnology.com/role/BalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Accumulated other comprehensive income",
        "documentation": "Amount, after tax, of accumulated increase (decrease) in equity from transaction and other event and circumstance from nonowner source."
       }
      }
     },
     "auth_ref": [
      "r20",
      "r21",
      "r90",
      "r174",
      "r518",
      "r540",
      "r541"
     ]
    },
    "us-gaap_AccumulatedOtherComprehensiveIncomeMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "AccumulatedOtherComprehensiveIncomeMember",
     "presentation": [
      "http://sharpstechnology.com/role/StatementOfStockholdersEquity"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "AOCI Attributable to Parent [Member]",
        "documentation": "Accumulated increase (decrease) in equity from transactions and other events and circumstances from non-owner sources, attributable to the parent. Excludes net income (loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners."
       }
      }
     },
     "auth_ref": [
      "r3",
      "r11",
      "r21",
      "r443",
      "r446",
      "r486",
      "r536",
      "r537",
      "r744",
      "r745",
      "r746",
      "r757",
      "r758",
      "r759",
      "r761"
     ]
    },
    "us-gaap_AdditionalPaidInCapital": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "AdditionalPaidInCapital",
     "crdr": "credit",
     "calculation": {
      "http://sharpstechnology.com/role/BalanceSheets": {
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0,
       "order": 4.0
      }
     },
     "presentation": [
      "http://sharpstechnology.com/role/BalanceSheets",
      "http://sharpstechnology.com/role/StockholdersEquityDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Additional paid-in capital",
        "verboseLabel": "Additional paid in capital",
        "documentation": "Amount of excess of issue price over par or stated value of stock and from other transaction involving stock or stockholder. Includes, but is not limited to, additional paid-in capital (APIC) for common and preferred stock."
       }
      }
     },
     "auth_ref": [
      "r82",
      "r698",
      "r867"
     ]
    },
    "us-gaap_AdditionalPaidInCapitalMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "AdditionalPaidInCapitalMember",
     "presentation": [
      "http://sharpstechnology.com/role/StatementOfStockholdersEquity"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Additional Paid-in Capital [Member]",
        "documentation": "Excess of issue price over par or stated value of the entity's capital stock and amounts received from other transactions involving the entity's stock or stockholders."
       }
      }
     },
     "auth_ref": [
      "r554",
      "r757",
      "r758",
      "r759",
      "r761",
      "r827",
      "r868"
     ]
    },
    "dei_AddressTypeDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "AddressTypeDomain",
     "presentation": [
      "http://sharpstechnology.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "An entity may have several addresses for different purposes and this domain represents all such types."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue",
     "crdr": "credit",
     "presentation": [
      "http://sharpstechnology.com/role/StatementOfStockholdersEquity"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share-based compensation charges",
        "documentation": "Amount of increase to additional paid-in capital (APIC) for recognition of cost for award under share-based payment arrangement."
       }
      }
     },
     "auth_ref": [
      "r55",
      "r56",
      "r355"
     ]
    },
    "us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract",
     "presentation": [
      "http://sharpstechnology.com/role/StatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Adjustments to reconcile net loss to net cash used in operating activities:"
       }
      }
     },
     "auth_ref": []
    },
    "STSS_AlanBlackmanMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://sharpstechnology.com/20240930",
     "localname": "AlanBlackmanMember",
     "presentation": [
      "http://sharpstechnology.com/role/CommitmentsAndContingenciesDetailsNarrative",
      "http://sharpstechnology.com/role/PreferredStockDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Alan Blackman [Member]",
        "documentation": "Alan Blackman [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_AllocatedShareBasedCompensationExpense": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "AllocatedShareBasedCompensationExpense",
     "crdr": "debit",
     "presentation": [
      "http://sharpstechnology.com/role/StockOptionsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share based compensation",
        "documentation": "Amount of expense for award under share-based payment arrangement. Excludes amount capitalized."
       }
      }
     },
     "auth_ref": [
      "r384",
      "r389"
     ]
    },
    "STSS_AllocationOfDebtIssuanceCostToContingentStockAndContingentWarrants": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://sharpstechnology.com/20240930",
     "localname": "AllocationOfDebtIssuanceCostToContingentStockAndContingentWarrants",
     "crdr": "debit",
     "presentation": [
      "http://sharpstechnology.com/role/NotePurchaseAgreementDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Allocation of debt issuance cost to contingent stock and contingent warrants",
        "documentation": "Allocation of debt issuance cost to contingent stock and contingent warrants."
       }
      }
     },
     "auth_ref": []
    },
    "dei_AmendmentDescription": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "AmendmentDescription",
     "presentation": [
      "http://sharpstechnology.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Amendment Description",
        "documentation": "Description of changes contained within amended document."
       }
      }
     },
     "auth_ref": []
    },
    "dei_AmendmentFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "AmendmentFlag",
     "presentation": [
      "http://sharpstechnology.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Amendment Flag",
        "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_AmortizationOfDebtDiscountPremium": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "AmortizationOfDebtDiscountPremium",
     "crdr": "debit",
     "calculation": {
      "http://sharpstechnology.com/role/StatementsOfCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0,
       "order": 5.0
      }
     },
     "presentation": [
      "http://sharpstechnology.com/role/StatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Accretion of debt discount",
        "documentation": "Amount of noncash expense included in interest expense to amortize debt discount and premium associated with the related debt instruments. Excludes amortization of financing costs. Alternate captions include noncash interest expense."
       }
      }
     },
     "auth_ref": [
      "r9",
      "r96",
      "r320",
      "r846"
     ]
    },
    "us-gaap_AmortizationOfFinancingCosts": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "AmortizationOfFinancingCosts",
     "crdr": "debit",
     "calculation": {
      "http://sharpstechnology.com/role/StatementsOfCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0,
       "order": 7.0
      }
     },
     "presentation": [
      "http://sharpstechnology.com/role/StatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Equity Issuance costs",
        "documentation": "Amount of amortization expense attributable to debt issuance costs."
       }
      }
     },
     "auth_ref": [
      "r96",
      "r320",
      "r752",
      "r846"
     ]
    },
    "us-gaap_AmortizationOfIntangibleAssets": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "AmortizationOfIntangibleAssets",
     "crdr": "debit",
     "presentation": [
      "http://sharpstechnology.com/role/OtherAssetsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Amortization of intangible assets",
        "documentation": "The aggregate expense charged against earnings to allocate the cost of intangible assets (nonphysical assets not used in production) in a systematic and rational manner to the periods expected to benefit from such assets. As a noncash expense, this element is added back to net income when calculating cash provided by or used in operations using the indirect method."
       }
      }
     },
     "auth_ref": [
      "r9",
      "r257",
      "r263",
      "r673"
     ]
    },
    "STSS_AnnualCompensation": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://sharpstechnology.com/20240930",
     "localname": "AnnualCompensation",
     "crdr": "debit",
     "presentation": [
      "http://sharpstechnology.com/role/CommitmentsAndContingenciesDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Annual compensation",
        "documentation": "Annual compensation."
       }
      }
     },
     "auth_ref": []
    },
    "dei_AnnualInformationForm": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "AnnualInformationForm",
     "presentation": [
      "http://sharpstechnology.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Annual Information Form",
        "documentation": "Boolean flag with value true on a form if it is an annual report containing an annual information form."
       }
      }
     },
     "auth_ref": [
      "r725"
     ]
    },
    "us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount",
     "presentation": [
      "http://sharpstechnology.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Antidilutive shares amount",
        "documentation": "Securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) or earnings per unit (EPU) in the future that were not included in the computation of diluted EPS or EPU because to do so would increase EPS or EPU amounts or decrease loss per share or unit amounts for the period presented."
       }
      }
     },
     "auth_ref": [
      "r227"
     ]
    },
    "us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis",
     "presentation": [
      "http://sharpstechnology.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Antidilutive Securities [Axis]",
        "documentation": "Information by type of antidilutive security."
       }
      }
     },
     "auth_ref": [
      "r33"
     ]
    },
    "us-gaap_AntidilutiveSecuritiesNameDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "AntidilutiveSecuritiesNameDomain",
     "presentation": [
      "http://sharpstechnology.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Incremental common shares attributable to securities that were not included in diluted earnings per share (EPS) because to do so would increase EPS amounts or decrease loss per share amounts for the period presented."
       }
      }
     },
     "auth_ref": [
      "r33"
     ]
    },
    "us-gaap_ArrangementsAndNonarrangementTransactionsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ArrangementsAndNonarrangementTransactionsMember",
     "presentation": [
      "http://sharpstechnology.com/role/AssetAcquisitionDetailsNarrative",
      "http://sharpstechnology.com/role/CommitmentsAndContingenciesDetailsNarrative",
      "http://sharpstechnology.com/role/DebtFinancingDetailsNarrative",
      "http://sharpstechnology.com/role/NotePurchaseAgreementDetailsNarrative",
      "http://sharpstechnology.com/role/StockholdersEquityDetailsNarrative",
      "http://sharpstechnology.com/role/WarrantLiabilityDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Collaborative arrangement and arrangement other than collaborative applicable to revenue-generating activity or operations."
       }
      }
     },
     "auth_ref": [
      "r437"
     ]
    },
    "us-gaap_AssetAcquisitionAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "AssetAcquisitionAxis",
     "presentation": [
      "http://sharpstechnology.com/role/CommitmentsAndContingenciesDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Asset Acquisition [Axis]",
        "documentation": "Information by asset acquisition."
       }
      }
     },
     "auth_ref": [
      "r258",
      "r259",
      "r260",
      "r261",
      "r262",
      "r823"
     ]
    },
    "us-gaap_AssetAcquisitionConsiderationTransferred": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "AssetAcquisitionConsiderationTransferred",
     "crdr": "credit",
     "presentation": [
      "http://sharpstechnology.com/role/AssetAcquisitionDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Asset acquisition",
        "documentation": "Amount of consideration transferred in asset acquisition. Includes, but is not limited to, cash, liability incurred by acquirer, and equity interest issued by acquirer."
       }
      }
     },
     "auth_ref": [
      "r689",
      "r824",
      "r825",
      "r826"
     ]
    },
    "us-gaap_AssetAcquisitionDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "AssetAcquisitionDomain",
     "presentation": [
      "http://sharpstechnology.com/role/CommitmentsAndContingenciesDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Asset acquisition."
       }
      }
     },
     "auth_ref": [
      "r258",
      "r259",
      "r260",
      "r261",
      "r262",
      "r823"
     ]
    },
    "us-gaap_AssetAcquisitionTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "AssetAcquisitionTextBlock",
     "presentation": [
      "http://sharpstechnology.com/role/AssetAcquisition"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Asset Acquisition",
        "documentation": "The entire disclosure for asset acquisition."
       }
      }
     },
     "auth_ref": [
      "r823"
     ]
    },
    "us-gaap_AssetImpairmentCharges": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "AssetImpairmentCharges",
     "crdr": "debit",
     "presentation": [
      "http://sharpstechnology.com/role/FixedAssetsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Asset impairment",
        "documentation": "Amount of write-down of assets recognized in the income statement. Includes, but is not limited to, losses from tangible assets, intangible assets and goodwill."
       }
      }
     },
     "auth_ref": [
      "r9",
      "r38"
     ]
    },
    "STSS_AssetPurchaseAgreementMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://sharpstechnology.com/20240930",
     "localname": "AssetPurchaseAgreementMember",
     "presentation": [
      "http://sharpstechnology.com/role/CommitmentsAndContingenciesDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Asset Purchase Agreement [Member]",
        "documentation": "Asset Purchase Agreement [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_Assets": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "Assets",
     "crdr": "debit",
     "calculation": {
      "http://sharpstechnology.com/role/BalanceSheets": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://sharpstechnology.com/role/BalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "TOTAL ASSETS",
        "label": "Assets [Default Label]",
        "documentation": "Amount of asset recognized for present right to economic benefit."
       }
      }
     },
     "auth_ref": [
      "r131",
      "r145",
      "r169",
      "r199",
      "r230",
      "r234",
      "r241",
      "r242",
      "r250",
      "r289",
      "r290",
      "r291",
      "r292",
      "r293",
      "r294",
      "r295",
      "r296",
      "r297",
      "r438",
      "r440",
      "r465",
      "r512",
      "r597",
      "r670",
      "r671",
      "r698",
      "r710",
      "r782",
      "r783",
      "r850"
     ]
    },
    "us-gaap_AssetsAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "AssetsAbstract",
     "presentation": [
      "http://sharpstechnology.com/role/BalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Assets:"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_AssetsCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "AssetsCurrent",
     "crdr": "debit",
     "calculation": {
      "http://sharpstechnology.com/role/BalanceSheets": {
       "parentTag": "us-gaap_Assets",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://sharpstechnology.com/role/BalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Current Assets",
        "label": "Assets, Current",
        "documentation": "Amount of asset recognized for present right to economic benefit, classified as current."
       }
      }
     },
     "auth_ref": [
      "r162",
      "r177",
      "r199",
      "r250",
      "r289",
      "r290",
      "r291",
      "r292",
      "r293",
      "r294",
      "r295",
      "r296",
      "r297",
      "r438",
      "r440",
      "r465",
      "r698",
      "r782",
      "r783",
      "r850"
     ]
    },
    "us-gaap_AssetsCurrentAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "AssetsCurrentAbstract",
     "presentation": [
      "http://sharpstechnology.com/role/BalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Current Assets"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_AssetsFairValueDisclosure": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "AssetsFairValueDisclosure",
     "crdr": "debit",
     "presentation": [
      "http://sharpstechnology.com/role/ScheduleOfAssetsAndLiabilitiesMeasuredAtFairValueOnRecurringBasisDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Total assets measured at fair value",
        "documentation": "Fair value portion of asset recognized for present right to economic benefit."
       }
      }
     },
     "auth_ref": [
      "r453",
      "r454",
      "r690"
     ]
    },
    "us-gaap_AssetsFairValueDisclosureAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "AssetsFairValueDisclosureAbstract",
     "presentation": [
      "http://sharpstechnology.com/role/ScheduleOfAssetsAndLiabilitiesMeasuredAtFairValueOnRecurringBasisDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Assets"
       }
      }
     },
     "auth_ref": []
    },
    "dei_AuditedAnnualFinancialStatements": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "AuditedAnnualFinancialStatements",
     "presentation": [
      "http://sharpstechnology.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Audited Annual Financial Statements",
        "documentation": "Boolean flag with value true on a form if it is an annual report containing audited financial statements."
       }
      }
     },
     "auth_ref": [
      "r725"
     ]
    },
    "us-gaap_AwardTypeAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "AwardTypeAxis",
     "presentation": [
      "http://sharpstechnology.com/role/AssetAcquisitionDetailsNarrative",
      "http://sharpstechnology.com/role/BalanceSheets",
      "http://sharpstechnology.com/role/BalanceSheetsParenthetical",
      "http://sharpstechnology.com/role/DebtFinancingDetailsNarrative",
      "http://sharpstechnology.com/role/FixedAssetsDetailsNarrative",
      "http://sharpstechnology.com/role/StatementOfStockholdersEquity",
      "http://sharpstechnology.com/role/StockholdersEquityDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Award Type [Axis]",
        "documentation": "Information by type of award under share-based payment arrangement."
       }
      }
     },
     "auth_ref": [
      "r358",
      "r359",
      "r360",
      "r361",
      "r362",
      "r363",
      "r364",
      "r365",
      "r366",
      "r367",
      "r368",
      "r369",
      "r370",
      "r371",
      "r372",
      "r373",
      "r374",
      "r375",
      "r376",
      "r377",
      "r378",
      "r379",
      "r380",
      "r381",
      "r382",
      "r383"
     ]
    },
    "STSS_AwardsTypeAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://sharpstechnology.com/20240930",
     "localname": "AwardsTypeAxis",
     "presentation": [
      "http://sharpstechnology.com/role/StatementOfStockholdersEquity"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Awards Type [Axis]",
        "verboseLabel": "AwardsTypeAxis [Axis]"
       }
      }
     },
     "auth_ref": []
    },
    "STSS_AwardsTypeDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://sharpstechnology.com/20240930",
     "localname": "AwardsTypeDomain",
     "presentation": [
      "http://sharpstechnology.com/role/StatementOfStockholdersEquity"
     ],
     "auth_ref": []
    },
    "STSS_BarryBerlerMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://sharpstechnology.com/20240930",
     "localname": "BarryBerlerMember",
     "presentation": [
      "http://sharpstechnology.com/role/CommitmentsAndContingenciesDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Barry Berler [Member]",
        "documentation": "Barry Berler [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_BasisOfAccountingPolicyPolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "BasisOfAccountingPolicyPolicyTextBlock",
     "presentation": [
      "http://sharpstechnology.com/role/SummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Basis of Presentation",
        "documentation": "Disclosure of accounting policy for basis of accounting, or basis of presentation, used to prepare the financial statements (for example, US Generally Accepted Accounting Principles, Other Comprehensive Basis of Accounting, IFRS)."
       }
      }
     },
     "auth_ref": []
    },
    "STSS_BerlerMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://sharpstechnology.com/20240930",
     "localname": "BerlerMember",
     "presentation": [
      "http://sharpstechnology.com/role/CommitmentsAndContingenciesDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Berler [Member]",
        "documentation": "Berler [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_BuildingMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "BuildingMember",
     "presentation": [
      "http://sharpstechnology.com/role/AssetAcquisitionDetailsNarrative",
      "http://sharpstechnology.com/role/ScheduleOfFixedAssetsNetDetails",
      "http://sharpstechnology.com/role/ScheduleOfPropertyPlantAndEquipmentDetails",
      "http://sharpstechnology.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Building [Member]",
        "documentation": "Facility held for productive use including, but not limited to, office, production, storage and distribution facilities."
       }
      }
     },
     "auth_ref": [
      "r108"
     ]
    },
    "us-gaap_BusinessAcquisitionAcquireeDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "BusinessAcquisitionAcquireeDomain",
     "presentation": [
      "http://sharpstechnology.com/role/AssetAcquisitionDetailsNarrative",
      "http://sharpstechnology.com/role/ScheduleOfFairValueOfAssetsAcquisitionDetails",
      "http://sharpstechnology.com/role/ScheduleOfFairValueOfAssetsAcquisitionDetailsDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Identification of the acquiree in a material business combination (or series of individually immaterial business combinations), which may include the name or other type of identification of the acquiree."
       }
      }
     },
     "auth_ref": [
      "r258",
      "r259",
      "r260",
      "r261",
      "r262",
      "r433",
      "r684",
      "r685"
     ]
    },
    "us-gaap_BusinessAcquisitionAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "BusinessAcquisitionAxis",
     "presentation": [
      "http://sharpstechnology.com/role/AssetAcquisitionDetailsNarrative",
      "http://sharpstechnology.com/role/ScheduleOfFairValueOfAssetsAcquisitionDetails",
      "http://sharpstechnology.com/role/ScheduleOfFairValueOfAssetsAcquisitionDetailsDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Business Acquisition [Axis]",
        "documentation": "Information by business combination or series of individually immaterial business combinations."
       }
      }
     },
     "auth_ref": [
      "r57",
      "r58",
      "r258",
      "r259",
      "r260",
      "r261",
      "r262",
      "r433",
      "r684",
      "r685"
     ]
    },
    "us-gaap_BusinessAcquisitionCostOfAcquiredEntityTransactionCosts": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "BusinessAcquisitionCostOfAcquiredEntityTransactionCosts",
     "crdr": "debit",
     "presentation": [
      "http://sharpstechnology.com/role/AssetAcquisitionDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Transaction costs",
        "documentation": "Amount of direct costs of the business combination including legal, accounting, and other costs incurred to consummate the business acquisition."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_BusinessAcquisitionLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "BusinessAcquisitionLineItems",
     "presentation": [
      "http://sharpstechnology.com/role/AssetAcquisitionDetailsNarrative",
      "http://sharpstechnology.com/role/ScheduleOfFairValueOfAssetsAcquisitionDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Business Acquisition [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": [
      "r433"
     ]
    },
    "us-gaap_BusinessCombinationAndAssetAcquisitionAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "BusinessCombinationAndAssetAcquisitionAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Business Combination, Asset Acquisition, and Joint Venture Formation [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets",
     "crdr": "debit",
     "calculation": {
      "http://sharpstechnology.com/role/ScheduleOfFairValueOfAssetsAcquisitionDetails": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      },
      "http://sharpstechnology.com/role/ScheduleOfFairValueOfAssetsAcquisitionDetailsDisclosure": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://sharpstechnology.com/role/AssetAcquisitionDetailsNarrative",
      "http://sharpstechnology.com/role/ScheduleOfFairValueOfAssetsAcquisitionDetails",
      "http://sharpstechnology.com/role/ScheduleOfFairValueOfAssetsAcquisitionDetailsDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Total",
        "label": "Acquisition cost",
        "documentation": "Amount of assets acquired at the acquisition date."
       }
      }
     },
     "auth_ref": [
      "r60"
     ]
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedBuildings": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedBuildings",
     "crdr": "debit",
     "calculation": {
      "http://sharpstechnology.com/role/ScheduleOfFairValueOfAssetsAcquisitionDetails": {
       "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets",
       "weight": 1.0,
       "order": 2.0
      },
      "http://sharpstechnology.com/role/ScheduleOfFairValueOfAssetsAcquisitionDetailsDisclosure": {
       "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://sharpstechnology.com/role/ScheduleOfFairValueOfAssetsAcquisitionDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Building and affixed assets",
        "documentation": "Amount of facility held for productive use including, but not limited to, office, production, storage and distribution facilities, acquired at the acquisition date."
       }
      }
     },
     "auth_ref": [
      "r60"
     ]
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities",
     "crdr": "credit",
     "calculation": {
      "http://sharpstechnology.com/role/ScheduleOfFairValueOfAssetsAcquisitionDetails": {
       "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets",
       "weight": -1.0,
       "order": 6.0
      },
      "http://sharpstechnology.com/role/ScheduleOfFairValueOfAssetsAcquisitionDetailsDisclosure": {
       "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets",
       "weight": -1.0,
       "order": 6.0
      }
     },
     "presentation": [
      "http://sharpstechnology.com/role/ScheduleOfFairValueOfAssetsAcquisitionDetails",
      "http://sharpstechnology.com/role/ScheduleOfFairValueOfAssetsAcquisitionDetailsDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Deferred tax liability",
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Deferred Tax Liabilities",
        "documentation": "Amount of deferred tax liability attributable to taxable temporary differences assumed at the acquisition date."
       }
      }
     },
     "auth_ref": [
      "r60"
     ]
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedEquipment": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedEquipment",
     "crdr": "debit",
     "calculation": {
      "http://sharpstechnology.com/role/ScheduleOfFairValueOfAssetsAcquisitionDetails": {
       "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets",
       "weight": 1.0,
       "order": 3.0
      },
      "http://sharpstechnology.com/role/ScheduleOfFairValueOfAssetsAcquisitionDetailsDisclosure": {
       "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://sharpstechnology.com/role/ScheduleOfFairValueOfAssetsAcquisitionDetails",
      "http://sharpstechnology.com/role/ScheduleOfFairValueOfAssetsAcquisitionDetailsDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Machinery",
        "documentation": "Amount of tangible personal property used to produce goods and services, including, but is not limited to, tools, dies and molds, computer and office equipment, acquired at the acquisition date."
       }
      }
     },
     "auth_ref": [
      "r60"
     ]
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles",
     "crdr": "debit",
     "calculation": {
      "http://sharpstechnology.com/role/ScheduleOfFairValueOfAssetsAcquisitionDetails": {
       "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets",
       "weight": 1.0,
       "order": 5.0
      },
      "http://sharpstechnology.com/role/ScheduleOfFairValueOfAssetsAcquisitionDetailsDisclosure": {
       "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets",
       "weight": 1.0,
       "order": 5.0
      }
     },
     "presentation": [
      "http://sharpstechnology.com/role/ScheduleOfFairValueOfAssetsAcquisitionDetails",
      "http://sharpstechnology.com/role/ScheduleOfFairValueOfAssetsAcquisitionDetailsDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Intangibles",
        "documentation": "The amount of identifiable intangible assets recognized as of the acquisition date."
       }
      }
     },
     "auth_ref": [
      "r59",
      "r60"
     ]
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory",
     "crdr": "debit",
     "calculation": {
      "http://sharpstechnology.com/role/ScheduleOfFairValueOfAssetsAcquisitionDetails": {
       "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets",
       "weight": 1.0,
       "order": 4.0
      },
      "http://sharpstechnology.com/role/ScheduleOfFairValueOfAssetsAcquisitionDetailsDisclosure": {
       "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets",
       "weight": 1.0,
       "order": 4.0
      }
     },
     "presentation": [
      "http://sharpstechnology.com/role/ScheduleOfFairValueOfAssetsAcquisitionDetails",
      "http://sharpstechnology.com/role/ScheduleOfFairValueOfAssetsAcquisitionDetailsDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Inventory",
        "documentation": "The amount of inventory recognized as of the acquisition date."
       }
      }
     },
     "auth_ref": [
      "r59",
      "r60"
     ]
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLand": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLand",
     "crdr": "debit",
     "calculation": {
      "http://sharpstechnology.com/role/ScheduleOfFairValueOfAssetsAcquisitionDetails": {
       "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets",
       "weight": 1.0,
       "order": 1.0
      },
      "http://sharpstechnology.com/role/ScheduleOfFairValueOfAssetsAcquisitionDetailsDisclosure": {
       "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://sharpstechnology.com/role/ScheduleOfFairValueOfAssetsAcquisitionDetails",
      "http://sharpstechnology.com/role/ScheduleOfFairValueOfAssetsAcquisitionDetailsDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Land",
        "documentation": "Amount of real estate acquired, at the acquisition date."
       }
      }
     },
     "auth_ref": [
      "r60"
     ]
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment",
     "crdr": "debit",
     "calculation": {
      "http://sharpstechnology.com/role/ScheduleOfFairValueOfAssetsAcquisitionDetails": {
       "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets",
       "weight": 1.0,
       "order": 8.0
      },
      "http://sharpstechnology.com/role/ScheduleOfFairValueOfAssetsAcquisitionDetailsDisclosure": {
       "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets",
       "weight": 1.0,
       "order": 8.0
      }
     },
     "presentation": [
      "http://sharpstechnology.com/role/ScheduleOfFairValueOfAssetsAcquisitionDetailsDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Building and affixed assets",
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Property, Plant, and Equipment",
        "documentation": "The amount of property, plant, and equipment recognized as of the acquisition date."
       }
      }
     },
     "auth_ref": [
      "r59",
      "r60"
     ]
    },
    "dei_BusinessContactMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "BusinessContactMember",
     "presentation": [
      "http://sharpstechnology.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Business Contact [Member]",
        "documentation": "Business contact for the entity"
       }
      }
     },
     "auth_ref": [
      "r724",
      "r725"
     ]
    },
    "us-gaap_BusinessDescriptionAndBasisOfPresentationTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "BusinessDescriptionAndBasisOfPresentationTextBlock",
     "presentation": [
      "http://sharpstechnology.com/role/DescriptionOfBusiness"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Description of Business",
        "documentation": "The entire disclosure for the business description and basis of presentation concepts. Business description describes the nature and type of organization including but not limited to organizational structure as may be applicable to holding companies, parent and subsidiary relationships, business divisions, business units, business segments, affiliates and information about significant ownership of the reporting entity. Basis of presentation describes the underlying basis used to prepare the financial statements (for example, US Generally Accepted Accounting Principles, Other Comprehensive Basis of Accounting, IFRS)."
       }
      }
     },
     "auth_ref": [
      "r70",
      "r103",
      "r104"
     ]
    },
    "us-gaap_Cash": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "Cash",
     "crdr": "debit",
     "presentation": [
      "http://sharpstechnology.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Cash",
        "label": "Cash [Default Label]",
        "documentation": "Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Excludes cash and cash equivalents within disposal group and discontinued operation."
       }
      }
     },
     "auth_ref": [
      "r148",
      "r515",
      "r565",
      "r592",
      "r698",
      "r710",
      "r739"
     ]
    },
    "us-gaap_CashAndCashEquivalentsAtCarryingValue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "CashAndCashEquivalentsAtCarryingValue",
     "crdr": "debit",
     "calculation": {
      "http://sharpstechnology.com/role/BalanceSheets": {
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://sharpstechnology.com/role/BalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cash",
        "documentation": "Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation."
       }
      }
     },
     "auth_ref": [
      "r27",
      "r165",
      "r659"
     ]
    },
    "us-gaap_CashAndCashEquivalentsFairValueDisclosure": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "CashAndCashEquivalentsFairValueDisclosure",
     "crdr": "debit",
     "presentation": [
      "http://sharpstechnology.com/role/ScheduleOfAssetsAndLiabilitiesMeasuredAtFairValueOnRecurringBasisDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Cash",
        "label": "Cash and Cash Equivalents, Fair Value Disclosure",
        "documentation": "Fair value portion of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates."
       }
      }
     },
     "auth_ref": [
      "r828",
      "r829"
     ]
    },
    "us-gaap_CashAndCashEquivalentsPolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "CashAndCashEquivalentsPolicyTextBlock",
     "presentation": [
      "http://sharpstechnology.com/role/SummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cash and Cash Equivalents",
        "documentation": "Disclosure of accounting policy for cash and cash equivalents, including the policy for determining which items are treated as cash equivalents. Other information that may be disclosed includes (1) the nature of any restrictions on the entity's use of its cash and cash equivalents, (2) whether the entity's cash and cash equivalents are insured or expose the entity to credit risk, (3) the classification of any negative balance accounts (overdrafts), and (4) the carrying basis of cash equivalents (for example, at cost) and whether the carrying amount of cash equivalents approximates fair value."
       }
      }
     },
     "auth_ref": [
      "r28"
     ]
    },
    "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations",
     "crdr": "debit",
     "presentation": [
      "http://sharpstechnology.com/role/StatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "periodStartLabel": "CASH \u2014 BEGINNING OF YEAR",
        "periodEndLabel": "CASH \u2014 END OF PERIOD",
        "label": "Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Including Disposal Group and Discontinued Operations",
        "documentation": "Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including, but not limited to, disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates."
       }
      }
     },
     "auth_ref": [
      "r27",
      "r100",
      "r195"
     ]
    },
    "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
     "crdr": "debit",
     "calculation": {
      "http://sharpstechnology.com/role/StatementsOfCashFlows": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://sharpstechnology.com/role/StatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "NET INCREASE (DECREASE) IN CASH",
        "label": "Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect",
        "documentation": "Amount of increase (decrease) in cash, cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates."
       }
      }
     },
     "auth_ref": [
      "r2",
      "r100"
     ]
    },
    "us-gaap_CashEquivalentsAtCarryingValue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "CashEquivalentsAtCarryingValue",
     "crdr": "debit",
     "presentation": [
      "http://sharpstechnology.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cash equivalents",
        "documentation": "Amount of short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation."
       }
      }
     },
     "auth_ref": [
      "r739",
      "r862"
     ]
    },
    "dei_CityAreaCode": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "CityAreaCode",
     "presentation": [
      "http://sharpstechnology.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "City Area Code",
        "documentation": "Area code of city"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ClassOfStockDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ClassOfStockDomain",
     "presentation": [
      "http://sharpstechnology.com/role/PreferredStockDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Share of stock differentiated by the voting rights the holder receives. Examples include, but are not limited to, common stock, redeemable preferred stock, nonredeemable preferred stock, and convertible stock."
       }
      }
     },
     "auth_ref": [
      "r159",
      "r171",
      "r172",
      "r173",
      "r199",
      "r221",
      "r222",
      "r224",
      "r226",
      "r232",
      "r233",
      "r250",
      "r289",
      "r291",
      "r292",
      "r293",
      "r296",
      "r297",
      "r325",
      "r326",
      "r329",
      "r332",
      "r339",
      "r465",
      "r545",
      "r546",
      "r547",
      "r548",
      "r554",
      "r555",
      "r556",
      "r557",
      "r558",
      "r559",
      "r560",
      "r561",
      "r562",
      "r563",
      "r564",
      "r566",
      "r584",
      "r606",
      "r627",
      "r647",
      "r648",
      "r649",
      "r650",
      "r651",
      "r731",
      "r753",
      "r762"
     ]
    },
    "us-gaap_ClassOfStockLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ClassOfStockLineItems",
     "presentation": [
      "http://sharpstechnology.com/role/PreferredStockDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Class of Stock [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": [
      "r171",
      "r172",
      "r173",
      "r232",
      "r325",
      "r326",
      "r327",
      "r329",
      "r332",
      "r337",
      "r339",
      "r545",
      "r546",
      "r547",
      "r548",
      "r680",
      "r731",
      "r753"
     ]
    },
    "us-gaap_ClassOfWarrantOrRightAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ClassOfWarrantOrRightAxis",
     "presentation": [
      "http://sharpstechnology.com/role/ScheduleOfWarrantLiabilityDetails",
      "http://sharpstechnology.com/role/ScheduleOfWarrantOutstandingDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Class of Warrant or Right [Axis]",
        "documentation": "Information by type of warrant or right issued."
       }
      }
     },
     "auth_ref": [
      "r50"
     ]
    },
    "us-gaap_ClassOfWarrantOrRightDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ClassOfWarrantOrRightDomain",
     "presentation": [
      "http://sharpstechnology.com/role/ScheduleOfWarrantLiabilityDetails",
      "http://sharpstechnology.com/role/ScheduleOfWarrantOutstandingDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the class or type of warrant or right outstanding. Warrants and rights represent derivative securities that give the holder the right to purchase securities (usually equity) from the issuer at a specific price within a certain time frame. Warrants are often included in a new debt issue to entice investors by a higher return potential. The main difference between warrants and call options is that warrants are issued and guaranteed by the company, whereas options are exchange instruments and are not issued by the company. Also, the lifetime of a warrant is often measured in years, while the lifetime of a typical option is measured in months."
       }
      }
     },
     "auth_ref": []
    },
    "STSS_ClassOfWarrantOrRightExercisePriceOfWarrantsAdjusted": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://sharpstechnology.com/20240930",
     "localname": "ClassOfWarrantOrRightExercisePriceOfWarrantsAdjusted",
     "presentation": [
      "http://sharpstechnology.com/role/StockholdersEquityDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Warrant exerice price",
        "documentation": "Class of warrant or right exercise price of warrants adjusted."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1",
     "presentation": [
      "http://sharpstechnology.com/role/StockholdersEquityDetailsNarrative",
      "http://sharpstechnology.com/role/SubsequentEventsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Exercise price",
        "label": "Class of Warrant or Right, Exercise Price of Warrants or Rights",
        "documentation": "Exercise price per share or per unit of warrants or rights outstanding."
       }
      }
     },
     "auth_ref": [
      "r340"
     ]
    },
    "STSS_ClassOfWarrantOrRightIssued": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://sharpstechnology.com/20240930",
     "localname": "ClassOfWarrantOrRightIssued",
     "presentation": [
      "http://sharpstechnology.com/role/StockholdersEquityDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Aggregate warrants issued",
        "documentation": "Aggregate warrants issued."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight",
     "presentation": [
      "http://sharpstechnology.com/role/StockholdersEquityDetailsNarrative",
      "http://sharpstechnology.com/role/SubsequentEventsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Prefunded warrants",
        "verboseLabel": "Class of Warrant or Right, Number of Securities Called by Each Warrant or Right",
        "documentation": "Number of securities into which each warrant or right may be converted. For example, but not limited to, each warrant may be converted into two shares."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights",
     "presentation": [
      "http://sharpstechnology.com/role/StockholdersEquityDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Warrants exercised shares pre reverse",
        "documentation": "Number of securities into which the class of warrant or right may be converted. For example, but not limited to, 500,000 warrants may be converted into 1,000,000 shares."
       }
      }
     },
     "auth_ref": [
      "r340"
     ]
    },
    "us-gaap_ClassOfWarrantOrRightOutstanding": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ClassOfWarrantOrRightOutstanding",
     "presentation": [
      "http://sharpstechnology.com/role/ScheduleOfWarrantOutstandingDetails",
      "http://sharpstechnology.com/role/StockholdersEquityDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Warrants issued",
        "verboseLabel": "Warrants issued for services arrangement",
        "documentation": "Number of warrants or rights outstanding."
       }
      }
     },
     "auth_ref": []
    },
    "STSS_ClassOfWarrantsOrRightOutstanding": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://sharpstechnology.com/20240930",
     "localname": "ClassOfWarrantsOrRightOutstanding",
     "presentation": [
      "http://sharpstechnology.com/role/ScheduleOfWarrantOutstandingDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Total Warrants Outstanding",
        "documentation": "Class of warrants or right outstanding."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems",
     "presentation": [
      "http://sharpstechnology.com/role/NotePurchaseAgreementDetailsNarrative",
      "http://sharpstechnology.com/role/WarrantLiabilityDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": [
      "r437"
     ]
    },
    "us-gaap_CommitmentsAndContingencies": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "CommitmentsAndContingencies",
     "crdr": "credit",
     "calculation": {
      "http://sharpstechnology.com/role/BalanceSheets": {
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://sharpstechnology.com/role/BalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Commitments and Contingencies (Note 15)",
        "documentation": "Represents the caption on the face of the balance sheet to indicate that the entity has entered into (1) purchase or supply arrangements that will require expending a portion of its resources to meet the terms thereof, and (2) is exposed to potential losses or, less frequently, gains, arising from (a) possible claims against a company's resources due to future performance under contract terms, and (b) possible losses or likely gains from uncertainties that will ultimately be resolved when one or more future events that are deemed likely to occur do occur or fail to occur."
       }
      }
     },
     "auth_ref": [
      "r78",
      "r136",
      "r514",
      "r583"
     ]
    },
    "us-gaap_CommitmentsAndContingenciesDisclosureAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "CommitmentsAndContingenciesDisclosureAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Commitments and Contingencies Disclosure [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_CommitmentsAndContingenciesDisclosureTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "CommitmentsAndContingenciesDisclosureTextBlock",
     "presentation": [
      "http://sharpstechnology.com/role/CommitmentsAndContingencies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Commitments and Contingencies",
        "documentation": "The entire disclosure for commitments and contingencies."
       }
      }
     },
     "auth_ref": [
      "r111",
      "r279",
      "r280",
      "r653",
      "r773",
      "r778"
     ]
    },
    "us-gaap_CommitmentsAndContingenciesPolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "CommitmentsAndContingenciesPolicyTextBlock",
     "presentation": [
      "http://sharpstechnology.com/role/SummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Contingencies",
        "documentation": "Disclosure of accounting policy for commitments and contingencies, which may include policies for recognizing and measuring loss and gain contingencies."
       }
      }
     },
     "auth_ref": [
      "r43",
      "r655"
     ]
    },
    "STSS_CommonStockFairValue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://sharpstechnology.com/20240930",
     "localname": "CommonStockFairValue",
     "crdr": "credit",
     "presentation": [
      "http://sharpstechnology.com/role/DebtFinancingDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Common stock fair value",
        "documentation": "Common stock fair value."
       }
      }
     },
     "auth_ref": []
    },
    "STSS_CommonStockIssuedAndVestedStockOptionsForFixedAssetsAcquired": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://sharpstechnology.com/20240930",
     "localname": "CommonStockIssuedAndVestedStockOptionsForFixedAssetsAcquired",
     "crdr": "credit",
     "presentation": [
      "http://sharpstechnology.com/role/StatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Common stock issued and vested stock options for fixed assets acquired",
        "documentation": "Common stock issued and vested stock options for fixed assets acquired."
       }
      }
     },
     "auth_ref": []
    },
    "STSS_CommonStockIssuedAndVestedStockOptionsIssuedAsConsiderationForAcquisition": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://sharpstechnology.com/20240930",
     "localname": "CommonStockIssuedAndVestedStockOptionsIssuedAsConsiderationForAcquisition",
     "crdr": "credit",
     "presentation": [
      "http://sharpstechnology.com/role/StatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Common stock issued and vested stock options issued as consideration for acquisition",
        "documentation": "Common stock issued and vested stock options issued as consideration for acquisition."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_CommonStockMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "CommonStockMember",
     "presentation": [
      "http://sharpstechnology.com/role/AssetAcquisitionDetailsNarrative",
      "http://sharpstechnology.com/role/StatementOfStockholdersEquity"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Common Stock [Member]",
        "documentation": "Stock that is subordinate to all other stock of the issuer."
       }
      }
     },
     "auth_ref": [
      "r700",
      "r701",
      "r702",
      "r704",
      "r705",
      "r706",
      "r707",
      "r757",
      "r758",
      "r761",
      "r827",
      "r864",
      "r868"
     ]
    },
    "us-gaap_CommonStockParOrStatedValuePerShare": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "CommonStockParOrStatedValuePerShare",
     "presentation": [
      "http://sharpstechnology.com/role/BalanceSheetsParenthetical",
      "http://sharpstechnology.com/role/StockOptionsDetailsNarrative",
      "http://sharpstechnology.com/role/StockholdersEquityDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Common stock, par value",
        "verboseLabel": "Common stock par value",
        "documentation": "Face amount or stated value per share of common stock."
       }
      }
     },
     "auth_ref": [
      "r81"
     ]
    },
    "STSS_CommonStockReverseSplitValue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://sharpstechnology.com/20240930",
     "localname": "CommonStockReverseSplitValue",
     "crdr": "credit",
     "calculation": {
      "http://sharpstechnology.com/role/BalanceSheets": {
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://sharpstechnology.com/role/BalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Common stock, $.0001 par value; 100,000,000, shares authorized; 15,274,457 shares issued and outstanding and (2022: 9,407,415)",
        "documentation": "Common stock reverse split value."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_CommonStockSharesAuthorized": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "CommonStockSharesAuthorized",
     "presentation": [
      "http://sharpstechnology.com/role/BalanceSheetsParenthetical",
      "http://sharpstechnology.com/role/StockholdersEquityDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Common stock, shares authorized",
        "verboseLabel": "Common stock, share authorized",
        "documentation": "The maximum number of common shares permitted to be issued by an entity's charter and bylaws."
       }
      }
     },
     "auth_ref": [
      "r81",
      "r584"
     ]
    },
    "us-gaap_CommonStockSharesIssued": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "CommonStockSharesIssued",
     "presentation": [
      "http://sharpstechnology.com/role/BalanceSheetsParenthetical",
      "http://sharpstechnology.com/role/NotePurchaseAgreementDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Common stock, shares issued",
        "documentation": "Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury."
       }
      }
     },
     "auth_ref": [
      "r81"
     ]
    },
    "us-gaap_CommonStockSharesOutstanding": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "CommonStockSharesOutstanding",
     "presentation": [
      "http://sharpstechnology.com/role/BalanceSheetsParenthetical"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Common stock, shares outstanding",
        "documentation": "Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation."
       }
      }
     },
     "auth_ref": [
      "r13",
      "r81",
      "r584",
      "r603",
      "r868",
      "r869"
     ]
    },
    "STSS_CommonStockSubscriptionReceivableMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://sharpstechnology.com/20240930",
     "localname": "CommonStockSubscriptionReceivableMember",
     "presentation": [
      "http://sharpstechnology.com/role/StatementOfStockholdersEquity"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Common Stock Subscription Receivable [Member]",
        "documentation": "Common Stock Subscription Receivable [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_CommonStockValue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "CommonStockValue",
     "crdr": "credit",
     "calculation": {
      "http://sharpstechnology.com/role/BalanceSheets": {
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://sharpstechnology.com/role/BalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Common stock, $.0001 par value; 500,000,000, shares authorized; (100,000,000 in 2023), 1,694,110 shares issued and outstanding (2023: 694,294)",
        "documentation": "Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity."
       }
      }
     },
     "auth_ref": [
      "r81",
      "r517",
      "r698"
     ]
    },
    "us-gaap_CompensationRelatedCostsPolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "CompensationRelatedCostsPolicyTextBlock",
     "presentation": [
      "http://sharpstechnology.com/role/SummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Stock-based Compensation Expense",
        "documentation": "Disclosure of accounting policy for salaries, bonuses, incentive awards, postretirement and postemployment benefits granted to employees, including equity-based arrangements; discloses methodologies for measurement, and the bases for recognizing related assets and liabilities and recognizing and reporting compensation expense."
       }
      }
     },
     "auth_ref": [
      "r119",
      "r123"
     ]
    },
    "us-gaap_ComprehensiveIncomeNetOfTax": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ComprehensiveIncomeNetOfTax",
     "crdr": "credit",
     "calculation": {
      "http://sharpstechnology.com/role/StatementsOfComprehensiveLoss": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://sharpstechnology.com/role/StatementsOfComprehensiveLoss"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Comprehensive loss",
        "label": "Comprehensive Income (Loss), Net of Tax, Attributable to Parent",
        "documentation": "Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income, attributable to parent entity. Excludes changes in equity resulting from investments by owners and distributions to owners."
       }
      }
     },
     "auth_ref": [
      "r22",
      "r181",
      "r183",
      "r188",
      "r508",
      "r527",
      "r528"
     ]
    },
    "us-gaap_ComprehensiveIncomePolicyPolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ComprehensiveIncomePolicyPolicyTextBlock",
     "presentation": [
      "http://sharpstechnology.com/role/SummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Comprehensive income (loss)",
        "documentation": "Disclosure of accounting policy for comprehensive income."
       }
      }
     },
     "auth_ref": []
    },
    "STSS_ComputerSystemsAndWebsiteAndOtherMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://sharpstechnology.com/20240930",
     "localname": "ComputerSystemsAndWebsiteAndOtherMember",
     "presentation": [
      "http://sharpstechnology.com/role/ScheduleOfFixedAssetsNetDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Computer Systems and Website &amp; Other [Member]",
        "documentation": "Computer Systems and Website &amp; Other [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "STSS_ComputerSystemsAndWebsiteAndOtherWebsiteMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://sharpstechnology.com/20240930",
     "localname": "ComputerSystemsAndWebsiteAndOtherWebsiteMember",
     "presentation": [
      "http://sharpstechnology.com/role/ScheduleOfPropertyPlantAndEquipmentDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Computer Systems and Website and Other Website [Member]",
        "documentation": "Computer Systems and Website and Other Website [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "dei_ContactPersonnelName": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "ContactPersonnelName",
     "presentation": [
      "http://sharpstechnology.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Contact Personnel Name",
        "documentation": "Name of contact personnel"
       }
      }
     },
     "auth_ref": []
    },
    "STSS_ContingentStockLiability": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://sharpstechnology.com/20240930",
     "localname": "ContingentStockLiability",
     "crdr": "credit",
     "presentation": [
      "http://sharpstechnology.com/role/NotePurchaseAgreementDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Contingent stock liability",
        "documentation": "Contingent stock liability."
       }
      }
     },
     "auth_ref": []
    },
    "STSS_ContingentWarrantLiability": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://sharpstechnology.com/20240930",
     "localname": "ContingentWarrantLiability",
     "crdr": "credit",
     "presentation": [
      "http://sharpstechnology.com/role/NotePurchaseAgreementDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Contingent warrants liability",
        "documentation": "Contingent warrant liability."
       }
      }
     },
     "auth_ref": []
    },
    "STSS_ContingentWarrants": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://sharpstechnology.com/20240930",
     "localname": "ContingentWarrants",
     "presentation": [
      "http://sharpstechnology.com/role/NotePurchaseAgreementDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Contingent warrant",
        "documentation": "Contingent warrants."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ConversionOfStockDescription": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ConversionOfStockDescription",
     "presentation": [
      "http://sharpstechnology.com/role/StockholdersEquityDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Conversion of stock, description",
        "documentation": "A unique description of a noncash or part noncash stock conversion. The description would be expected to include sufficient information to provide an understanding of the nature and purpose of the conversion. Noncash is defined as transactions during a period that do not result in cash receipts or cash payments in the period. \"Part noncash\" refers to that portion of the transaction not resulting in cash receipts or cash payments in the period."
       }
      }
     },
     "auth_ref": [
      "r30",
      "r31",
      "r32"
     ]
    },
    "dei_CountryRegion": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "CountryRegion",
     "presentation": [
      "http://sharpstechnology.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Country Region",
        "documentation": "Region code of country"
       }
      }
     },
     "auth_ref": []
    },
    "dei_CoverAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "CoverAbstract",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cover page."
       }
      }
     },
     "auth_ref": []
    },
    "dei_CurrentFiscalYearEndDate": {
     "xbrltype": "gMonthDayItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "CurrentFiscalYearEndDate",
     "presentation": [
      "http://sharpstechnology.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Current Fiscal Year End Date",
        "documentation": "End date of current fiscal year in the format --MM-DD."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_DebtDisclosureAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DebtDisclosureAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Debt Disclosure [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_DebtDisclosureTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DebtDisclosureTextBlock",
     "presentation": [
      "http://sharpstechnology.com/role/DebtFinancing"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Debt Financing",
        "documentation": "The entire disclosure for information about short-term and long-term debt arrangements, which includes amounts of borrowings under each line of credit, note payable, commercial paper issue, bonds indenture, debenture issue, own-share lending arrangements and any other contractual agreement to repay funds, and about the underlying arrangements, rationale for a classification as long-term, including repayment terms, interest rates, collateral provided, restrictions on use of assets and activities, whether or not in compliance with debt covenants, and other matters important to users of the financial statements, such as the effects of refinancing and noncompliance with debt covenants."
       }
      }
     },
     "auth_ref": [
      "r113",
      "r197",
      "r266",
      "r267",
      "r268",
      "r269",
      "r270",
      "r287",
      "r288",
      "r298",
      "r304",
      "r305",
      "r306",
      "r307",
      "r308",
      "r309",
      "r314",
      "r321",
      "r322",
      "r323",
      "r481"
     ]
    },
    "us-gaap_DebtInstrumentAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DebtInstrumentAxis",
     "presentation": [
      "http://sharpstechnology.com/role/DebtFinancingDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Debt Instrument [Axis]",
        "documentation": "Information by type of debt instrument, including, but not limited to, draws against credit facilities."
       }
      }
     },
     "auth_ref": [
      "r18",
      "r72",
      "r73",
      "r132",
      "r135",
      "r203",
      "r299",
      "r300",
      "r301",
      "r302",
      "r303",
      "r305",
      "r310",
      "r311",
      "r312",
      "r313",
      "r315",
      "r316",
      "r317",
      "r318",
      "r319",
      "r320",
      "r675",
      "r676",
      "r677",
      "r678",
      "r679",
      "r697",
      "r754",
      "r774",
      "r775",
      "r776",
      "r845",
      "r847"
     ]
    },
    "us-gaap_DebtInstrumentDescription": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DebtInstrumentDescription",
     "presentation": [
      "http://sharpstechnology.com/role/NotePurchaseAgreementDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Debt description",
        "documentation": "Identification of the lender and information about a contractual promise to repay a short-term or long-term obligation, which includes borrowings under lines of credit, notes payable, commercial paper, bonds payable, debentures, and other contractual obligations for payment. This may include rationale for entering into the arrangement, significant terms of the arrangement, which may include amount, repayment terms, priority, collateral required, debt covenants, borrowing capacity, call features, participation rights, conversion provisions, sinking-fund requirements, voting rights, basis for conversion if convertible and remarketing provisions. The description may be provided for individual debt instruments, rational groupings of debt instruments, or by debt in total."
       }
      }
     },
     "auth_ref": [
      "r18",
      "r46",
      "r69",
      "r72",
      "r132",
      "r135",
      "r481"
     ]
    },
    "us-gaap_DebtInstrumentFaceAmount": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DebtInstrumentFaceAmount",
     "crdr": "credit",
     "presentation": [
      "http://sharpstechnology.com/role/DebtFinancingDetailsNarrative",
      "http://sharpstechnology.com/role/NotePurchaseAgreementDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Debt Instrument, Face Amount",
        "verboseLabel": "Debt instrument face amount",
        "documentation": "Face (par) amount of debt instrument at time of issuance."
       }
      }
     },
     "auth_ref": [
      "r299",
      "r481",
      "r482",
      "r676",
      "r677",
      "r697"
     ]
    },
    "us-gaap_DebtInstrumentFairValue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DebtInstrumentFairValue",
     "crdr": "credit",
     "presentation": [
      "http://sharpstechnology.com/role/DebtFinancingDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Debt Instrument, Fair Value Disclosure",
        "documentation": "Fair value portion of debt instrument payable, including, but not limited to, notes payable and loans payable."
       }
      }
     },
     "auth_ref": [
      "r312",
      "r464",
      "r676",
      "r677",
      "r829",
      "r830",
      "r831",
      "r832",
      "r839"
     ]
    },
    "us-gaap_DebtInstrumentIncreaseAccruedInterest": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DebtInstrumentIncreaseAccruedInterest",
     "crdr": "credit",
     "presentation": [
      "http://sharpstechnology.com/role/DebtFinancingDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Original issue discount (OID)",
        "documentation": "Increase for accrued, but unpaid interest on the debt instrument for the period."
       }
      }
     },
     "auth_ref": [
      "r754"
     ]
    },
    "us-gaap_DebtInstrumentInterestRateStatedPercentage": {
     "xbrltype": "percentItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DebtInstrumentInterestRateStatedPercentage",
     "presentation": [
      "http://sharpstechnology.com/role/NotePurchaseAgreementDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Interest rate",
        "documentation": "Contractual interest rate for funds borrowed, under the debt agreement."
       }
      }
     },
     "auth_ref": [
      "r75",
      "r300"
     ]
    },
    "us-gaap_DebtInstrumentMaturityDate": {
     "xbrltype": "dateItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DebtInstrumentMaturityDate",
     "presentation": [
      "http://sharpstechnology.com/role/DebtFinancingDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Debt Instrument, Maturity Date",
        "documentation": "Date when the debt instrument is scheduled to be fully repaid, in YYYY-MM-DD format."
       }
      }
     },
     "auth_ref": [
      "r170",
      "r675",
      "r831",
      "r832"
     ]
    },
    "us-gaap_DebtInstrumentNameDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DebtInstrumentNameDomain",
     "presentation": [
      "http://sharpstechnology.com/role/DebtFinancingDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The name for the particular debt instrument or borrowing that distinguishes it from other debt instruments or borrowings, including draws against credit facilities."
       }
      }
     },
     "auth_ref": [
      "r18",
      "r203",
      "r299",
      "r300",
      "r301",
      "r302",
      "r303",
      "r305",
      "r310",
      "r311",
      "r312",
      "r313",
      "r315",
      "r316",
      "r317",
      "r318",
      "r319",
      "r320",
      "r675",
      "r676",
      "r677",
      "r678",
      "r679",
      "r697",
      "r754",
      "r774",
      "r775",
      "r776",
      "r845",
      "r847"
     ]
    },
    "us-gaap_DebtInstrumentUnamortizedDiscount": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DebtInstrumentUnamortizedDiscount",
     "crdr": "debit",
     "presentation": [
      "http://sharpstechnology.com/role/NotePurchaseAgreementDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Debt discount",
        "documentation": "Amount, after accumulated amortization, of debt discount."
       }
      }
     },
     "auth_ref": [
      "r785",
      "r844",
      "r845",
      "r847"
     ]
    },
    "us-gaap_DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Deferred Costs, Capitalized, Prepaid, and Other Assets Disclosure [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_DeferredIncomeTaxExpenseBenefit": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DeferredIncomeTaxExpenseBenefit",
     "crdr": "debit",
     "calculation": {
      "http://sharpstechnology.com/role/StatementsOfOperations": {
       "parentTag": "us-gaap_NetIncomeLoss",
       "weight": -1.0,
       "order": 2.0
      },
      "http://sharpstechnology.com/role/StatementsOfCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0,
       "order": 12.0
      }
     },
     "presentation": [
      "http://sharpstechnology.com/role/StatementsOfCashFlows",
      "http://sharpstechnology.com/role/StatementsOfOperations"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Deferred Tax Benefit",
        "label": "Deferred tax benefit",
        "documentation": "Amount of deferred income tax expense (benefit) pertaining to income (loss) from continuing operations."
       }
      }
     },
     "auth_ref": [
      "r9",
      "r157",
      "r756"
     ]
    },
    "us-gaap_DeferredIncomeTaxLiabilitiesNet": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DeferredIncomeTaxLiabilitiesNet",
     "crdr": "credit",
     "calculation": {
      "http://sharpstechnology.com/role/BalanceSheets": {
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://sharpstechnology.com/role/BalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Deferred Tax Liability",
        "documentation": "Amount, after deferred tax asset, of deferred tax liability attributable to taxable differences with jurisdictional netting."
       }
      }
     },
     "auth_ref": [
      "r397",
      "r398",
      "r513"
     ]
    },
    "us-gaap_DeferredTaxAssetInterestCarryforward": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DeferredTaxAssetInterestCarryforward",
     "crdr": "debit",
     "calculation": {
      "http://sharpstechnology.com/role/ScheduleOfComponentsOfDeferredTaxAssetsDetails": {
       "parentTag": "us-gaap_DeferredTaxLiabilities",
       "weight": -1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://sharpstechnology.com/role/ScheduleOfComponentsOfDeferredTaxAssetsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Interest",
        "documentation": "Amount, before allocation of valuation allowance, of deferred tax asset attributable to deductible interest carryforward."
       }
      }
     },
     "auth_ref": [
      "r818"
     ]
    },
    "us-gaap_DeferredTaxAssetsCharitableContributionCarryforwards": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DeferredTaxAssetsCharitableContributionCarryforwards",
     "crdr": "debit",
     "calculation": {
      "http://sharpstechnology.com/role/ScheduleOfComponentsOfDeferredTaxAssetsDetails": {
       "parentTag": "us-gaap_DeferredTaxLiabilities",
       "weight": -1.0,
       "order": 5.0
      }
     },
     "presentation": [
      "http://sharpstechnology.com/role/ScheduleOfComponentsOfDeferredTaxAssetsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Charitable Contributions",
        "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible charitable contribution carryforwards."
       }
      }
     },
     "auth_ref": [
      "r818"
     ]
    },
    "us-gaap_DeferredTaxAssetsInProcessResearchAndDevelopment": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DeferredTaxAssetsInProcessResearchAndDevelopment",
     "crdr": "debit",
     "calculation": {
      "http://sharpstechnology.com/role/ScheduleOfComponentsOfDeferredTaxAssetsDetails": {
       "parentTag": "us-gaap_DeferredTaxLiabilities",
       "weight": -1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://sharpstechnology.com/role/ScheduleOfComponentsOfDeferredTaxAssetsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Research and development expenses",
        "documentation": "Amount, before allocation of valuation allowance, of deferred tax asset attributable to deductible temporary difference from in-process research and development cost acquired in business combination or from joint venture formation or both."
       }
      }
     },
     "auth_ref": [
      "r818"
     ]
    },
    "us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsDomestic": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DeferredTaxAssetsOperatingLossCarryforwardsDomestic",
     "crdr": "debit",
     "calculation": {
      "http://sharpstechnology.com/role/ScheduleOfComponentsOfDeferredTaxAssetsDetails": {
       "parentTag": "us-gaap_DeferredTaxLiabilities",
       "weight": -1.0,
       "order": 6.0
      }
     },
     "presentation": [
      "http://sharpstechnology.com/role/ScheduleOfComponentsOfDeferredTaxAssetsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net operating losses - federal",
        "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible domestic operating loss carryforwards. Excludes state and local operating loss carryforwards."
       }
      }
     },
     "auth_ref": [
      "r818"
     ]
    },
    "us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsForeign": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DeferredTaxAssetsOperatingLossCarryforwardsForeign",
     "crdr": "debit",
     "calculation": {
      "http://sharpstechnology.com/role/ScheduleOfComponentsOfDeferredTaxAssetsDetails": {
       "parentTag": "us-gaap_DeferredTaxLiabilities",
       "weight": -1.0,
       "order": 8.0
      }
     },
     "presentation": [
      "http://sharpstechnology.com/role/ScheduleOfComponentsOfDeferredTaxAssetsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net operating losses - foreign",
        "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible foreign operating loss carryforwards."
       }
      }
     },
     "auth_ref": [
      "r818"
     ]
    },
    "us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsStateAndLocal": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DeferredTaxAssetsOperatingLossCarryforwardsStateAndLocal",
     "crdr": "debit",
     "calculation": {
      "http://sharpstechnology.com/role/ScheduleOfComponentsOfDeferredTaxAssetsDetails": {
       "parentTag": "us-gaap_DeferredTaxLiabilities",
       "weight": -1.0,
       "order": 7.0
      }
     },
     "presentation": [
      "http://sharpstechnology.com/role/ScheduleOfComponentsOfDeferredTaxAssetsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net operating losses \u2013 state and local",
        "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible state and local operating loss carryforwards."
       }
      }
     },
     "auth_ref": [
      "r818"
     ]
    },
    "STSS_DeferredTaxAssetsPropertyPlantAndEquipments": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://sharpstechnology.com/20240930",
     "localname": "DeferredTaxAssetsPropertyPlantAndEquipments",
     "crdr": "debit",
     "calculation": {
      "http://sharpstechnology.com/role/ScheduleOfComponentsOfDeferredTaxAssetsDetails": {
       "parentTag": "us-gaap_DeferredTaxLiabilities",
       "weight": -1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://sharpstechnology.com/role/ScheduleOfComponentsOfDeferredTaxAssetsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fixed assets",
        "documentation": "Deferred tax assets property plant and equipments."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsResearch": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DeferredTaxAssetsTaxCreditCarryforwardsResearch",
     "crdr": "debit",
     "calculation": {
      "http://sharpstechnology.com/role/ScheduleOfComponentsOfDeferredTaxAssetsDetails": {
       "parentTag": "us-gaap_DeferredTaxLiabilities",
       "weight": -1.0,
       "order": 9.0
      }
     },
     "presentation": [
      "http://sharpstechnology.com/role/ScheduleOfComponentsOfDeferredTaxAssetsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Research credit",
        "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible research tax credit carryforwards."
       }
      }
     },
     "auth_ref": [
      "r818"
     ]
    },
    "us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost",
     "crdr": "debit",
     "calculation": {
      "http://sharpstechnology.com/role/ScheduleOfComponentsOfDeferredTaxAssetsDetails": {
       "parentTag": "us-gaap_DeferredTaxLiabilities",
       "weight": -1.0,
       "order": 4.0
      }
     },
     "presentation": [
      "http://sharpstechnology.com/role/ScheduleOfComponentsOfDeferredTaxAssetsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Stock-based compensation",
        "label": "Deferred Tax Assets, Tax Deferred Expense, Compensation and Benefits, Share-Based Compensation Cost",
        "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from share-based compensation."
       }
      }
     },
     "auth_ref": [
      "r818"
     ]
    },
    "us-gaap_DeferredTaxAssetsValuationAllowance": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DeferredTaxAssetsValuationAllowance",
     "crdr": "credit",
     "calculation": {
      "http://sharpstechnology.com/role/ScheduleOfComponentsOfDeferredTaxAssetsDetails": {
       "parentTag": "us-gaap_DeferredTaxLiabilities",
       "weight": 1.0,
       "order": 10.0
      }
     },
     "presentation": [
      "http://sharpstechnology.com/role/ScheduleOfComponentsOfDeferredTaxAssetsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Less valuation allowance",
        "label": "Deferred Tax Assets, Valuation Allowance",
        "documentation": "Amount of deferred tax assets for which it is more likely than not that a tax benefit will not be realized."
       }
      }
     },
     "auth_ref": [
      "r413"
     ]
    },
    "us-gaap_DeferredTaxLiabilities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DeferredTaxLiabilities",
     "crdr": "credit",
     "calculation": {
      "http://sharpstechnology.com/role/ScheduleOfComponentsOfDeferredTaxAssetsDetails": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://sharpstechnology.com/role/ScheduleOfComponentsOfDeferredTaxAssetsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedTotalLabel": "Net deferred tax liability",
        "label": "Deferred Tax Liabilities, Net",
        "documentation": "Amount, after deferred tax asset, of deferred tax liability attributable to taxable differences without jurisdictional netting."
       }
      }
     },
     "auth_ref": [
      "r816"
     ]
    },
    "us-gaap_DepositsAssets": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DepositsAssets",
     "crdr": "debit",
     "calculation": {
      "http://sharpstechnology.com/role/ScheduleOfOtherAssetsDetails": {
       "parentTag": "us-gaap_OtherAssetsNoncurrent",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://sharpstechnology.com/role/ScheduleOfOtherAssetsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Deposits or advance payments on machinery, molds and components (see Note 15)",
        "documentation": "Carrying value of amounts transferred to third parties for security purposes that are expected to be returned or applied towards payment in the future."
       }
      }
     },
     "auth_ref": [
      "r740"
     ]
    },
    "us-gaap_Depreciation": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "Depreciation",
     "crdr": "debit",
     "presentation": [
      "http://sharpstechnology.com/role/FixedAssetsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Depreciation",
        "documentation": "The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation."
       }
      }
     },
     "auth_ref": [
      "r9",
      "r39"
     ]
    },
    "us-gaap_DepreciationAndAmortization": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DepreciationAndAmortization",
     "crdr": "debit",
     "calculation": {
      "http://sharpstechnology.com/role/StatementsOfCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://sharpstechnology.com/role/StatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Depreciation and amortization",
        "documentation": "The current period expense charged against earnings on long-lived, physical assets not used in production, and which are not intended for resale, to allocate or recognize the cost of such assets over their useful lives; or to record the reduction in book value of an intangible asset over the benefit period of such asset; or to reflect consumption during the period of an asset that is not used in production."
       }
      }
     },
     "auth_ref": [
      "r9",
      "r39"
     ]
    },
    "us-gaap_DerivativeContractTypeDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DerivativeContractTypeDomain",
     "presentation": [
      "http://sharpstechnology.com/role/AssetAcquisitionDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Financial instrument or contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset."
       }
      }
     },
     "auth_ref": [
      "r573",
      "r575",
      "r589",
      "r590",
      "r591",
      "r593",
      "r594",
      "r595",
      "r596",
      "r598",
      "r599",
      "r600",
      "r601",
      "r614",
      "r615",
      "r616",
      "r617",
      "r620",
      "r621",
      "r622",
      "r623",
      "r638",
      "r639",
      "r642",
      "r644",
      "r700",
      "r702",
      "r833",
      "r834",
      "r835",
      "r836",
      "r837",
      "r838",
      "r840",
      "r841"
     ]
    },
    "us-gaap_DerivativeInstrumentRiskAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DerivativeInstrumentRiskAxis",
     "presentation": [
      "http://sharpstechnology.com/role/AssetAcquisitionDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Derivative Instrument [Axis]",
        "documentation": "Information by type of derivative contract."
       }
      }
     },
     "auth_ref": [
      "r65",
      "r66",
      "r67",
      "r128",
      "r573",
      "r575",
      "r589",
      "r590",
      "r591",
      "r593",
      "r594",
      "r595",
      "r596",
      "r598",
      "r599",
      "r600",
      "r601",
      "r614",
      "r615",
      "r616",
      "r617",
      "r620",
      "r621",
      "r622",
      "r623",
      "r638",
      "r639",
      "r642",
      "r644",
      "r664",
      "r700",
      "r702",
      "r833",
      "r834",
      "r835",
      "r836",
      "r837",
      "r838",
      "r840",
      "r841"
     ]
    },
    "us-gaap_DerivativeLiabilities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DerivativeLiabilities",
     "crdr": "credit",
     "presentation": [
      "http://sharpstechnology.com/role/ScheduleOfAssetsAndLiabilitiesMeasuredAtFairValueOnRecurringBasisDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Warrant liability",
        "documentation": "Fair value, after the effects of master netting arrangements, of a financial liability or contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset. Includes liabilities not subject to a master netting arrangement and not elected to be offset."
       }
      }
     },
     "auth_ref": [
      "r178",
      "r179",
      "r453",
      "r454",
      "r461",
      "r464",
      "r567",
      "r568",
      "r569",
      "r570",
      "r571",
      "r572",
      "r573",
      "r574",
      "r575",
      "r598",
      "r600",
      "r601",
      "r639",
      "r640",
      "r641",
      "r642",
      "r643",
      "r644",
      "r645",
      "r664",
      "r830",
      "r831",
      "r832",
      "r865"
     ]
    },
    "us-gaap_DerivativesPolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DerivativesPolicyTextBlock",
     "presentation": [
      "http://sharpstechnology.com/role/SummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Derivative Instruments",
        "documentation": "Disclosure of accounting policy for its derivative instruments and hedging activities."
       }
      }
     },
     "auth_ref": [
      "r14",
      "r62",
      "r63",
      "r64",
      "r68",
      "r202",
      "r217"
     ]
    },
    "STSS_DescriptionForOfferingShares": {
     "xbrltype": "stringItemType",
     "nsuri": "http://sharpstechnology.com/20240930",
     "localname": "DescriptionForOfferingShares",
     "presentation": [
      "http://sharpstechnology.com/role/StockholdersEquityDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Description for offering shares",
        "documentation": "Description for offering, shares."
       }
      }
     },
     "auth_ref": []
    },
    "srt_DirectorMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/srt/2024",
     "localname": "DirectorMember",
     "presentation": [
      "http://sharpstechnology.com/role/PreferredStockDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Director [Member]"
       }
      }
     },
     "auth_ref": [
      "r768",
      "r866"
     ]
    },
    "STSS_DisclosureNotePurchaseAgreementAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://sharpstechnology.com/20240930",
     "localname": "DisclosureNotePurchaseAgreementAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Note Purchase Agreement"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock",
     "presentation": [
      "http://sharpstechnology.com/role/StockOptions"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Stock Options",
        "documentation": "The entire disclosure for share-based payment arrangement."
       }
      }
     },
     "auth_ref": [
      "r353",
      "r357",
      "r385",
      "r386",
      "r388",
      "r687"
     ]
    },
    "us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Share-Based Payment Arrangement [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "STSS_DisclosureWarrantLiabilityAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://sharpstechnology.com/20240930",
     "localname": "DisclosureWarrantLiabilityAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Warrant Liability"
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentAccountingStandard": {
     "xbrltype": "accountingStandardItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentAccountingStandard",
     "presentation": [
      "http://sharpstechnology.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Accounting Standard",
        "documentation": "The basis of accounting the registrant has used to prepare the financial statements included in this filing This can either be 'U.S. GAAP', 'International Financial Reporting Standards', or 'Other'."
       }
      }
     },
     "auth_ref": [
      "r724"
     ]
    },
    "dei_DocumentAnnualReport": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentAnnualReport",
     "presentation": [
      "http://sharpstechnology.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Annual Report",
        "documentation": "Boolean flag that is true only for a form used as an annual report."
       }
      }
     },
     "auth_ref": [
      "r722",
      "r724",
      "r725"
     ]
    },
    "dei_DocumentFiscalPeriodFocus": {
     "xbrltype": "fiscalPeriodItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentFiscalPeriodFocus",
     "presentation": [
      "http://sharpstechnology.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Fiscal Period Focus",
        "documentation": "Fiscal period values are FY, Q1, Q2, and Q3. 1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentFiscalYearFocus": {
     "xbrltype": "gYearItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentFiscalYearFocus",
     "presentation": [
      "http://sharpstechnology.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Fiscal Year Focus",
        "documentation": "This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentPeriodEndDate": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentPeriodEndDate",
     "presentation": [
      "http://sharpstechnology.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Period End Date",
        "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentPeriodStartDate": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentPeriodStartDate",
     "presentation": [
      "http://sharpstechnology.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Period Start Date",
        "documentation": "The start date of the period covered in the document, in YYYY-MM-DD format."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentQuarterlyReport": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentQuarterlyReport",
     "presentation": [
      "http://sharpstechnology.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Quarterly Report",
        "documentation": "Boolean flag that is true only for a form used as an quarterly report."
       }
      }
     },
     "auth_ref": [
      "r723"
     ]
    },
    "dei_DocumentRegistrationStatement": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentRegistrationStatement",
     "presentation": [
      "http://sharpstechnology.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Registration Statement",
        "documentation": "Boolean flag that is true only for a form used as a registration statement."
       }
      }
     },
     "auth_ref": [
      "r711"
     ]
    },
    "dei_DocumentShellCompanyEventDate": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentShellCompanyEventDate",
     "presentation": [
      "http://sharpstechnology.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Shell Company Event Date",
        "documentation": "Date of event requiring a shell company report."
       }
      }
     },
     "auth_ref": [
      "r724"
     ]
    },
    "dei_DocumentShellCompanyReport": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentShellCompanyReport",
     "presentation": [
      "http://sharpstechnology.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Shell Company Report",
        "documentation": "Boolean flag that is true for a Shell Company Report pursuant to section 13 or 15(d) of the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r724"
     ]
    },
    "dei_DocumentTransitionReport": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentTransitionReport",
     "presentation": [
      "http://sharpstechnology.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Transition Report",
        "documentation": "Boolean flag that is true only for a form used as a transition report."
       }
      }
     },
     "auth_ref": [
      "r726"
     ]
    },
    "dei_DocumentType": {
     "xbrltype": "submissionTypeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentType",
     "presentation": [
      "http://sharpstechnology.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Type",
        "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentsIncorporatedByReferenceTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentsIncorporatedByReferenceTextBlock",
     "presentation": [
      "http://sharpstechnology.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Documents Incorporated by Reference [Text Block]",
        "documentation": "Documents incorporated by reference."
       }
      }
     },
     "auth_ref": [
      "r714"
     ]
    },
    "us-gaap_DomesticCountryMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DomesticCountryMember",
     "presentation": [
      "http://sharpstechnology.com/role/IncomeTaxesDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Domestic Tax Jurisdiction [Member]",
        "documentation": "Designated federal jurisdiction entitled to levy and collect income tax in country of domicile. Includes, but is not limited to, national jurisdiction for non-U.S. jurisdiction."
       }
      }
     },
     "auth_ref": [
      "r401"
     ]
    },
    "us-gaap_EarningsPerShareBasic": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "EarningsPerShareBasic",
     "presentation": [
      "http://sharpstechnology.com/role/StatementsOfOperations"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net loss per share, basic",
        "documentation": "The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period."
       }
      }
     },
     "auth_ref": [
      "r189",
      "r209",
      "r210",
      "r211",
      "r212",
      "r213",
      "r214",
      "r219",
      "r221",
      "r224",
      "r225",
      "r226",
      "r229",
      "r431",
      "r436",
      "r450",
      "r451",
      "r509",
      "r529",
      "r667"
     ]
    },
    "us-gaap_EarningsPerShareDiluted": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "EarningsPerShareDiluted",
     "presentation": [
      "http://sharpstechnology.com/role/StatementsOfOperations"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net loss per share, diluted",
        "documentation": "The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period."
       }
      }
     },
     "auth_ref": [
      "r189",
      "r209",
      "r210",
      "r211",
      "r212",
      "r213",
      "r214",
      "r221",
      "r224",
      "r225",
      "r226",
      "r229",
      "r431",
      "r436",
      "r450",
      "r451",
      "r509",
      "r529",
      "r667"
     ]
    },
    "us-gaap_EarningsPerSharePolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "EarningsPerSharePolicyTextBlock",
     "presentation": [
      "http://sharpstechnology.com/role/SummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Basic and Diluted Loss Per Share",
        "documentation": "Disclosure of accounting policy for computing basic and diluted earnings or loss per share for each class of common stock and participating security. Addresses all significant policy factors, including any antidilutive items that have been excluded from the computation and takes into account stock dividends, splits and reverse splits that occur after the balance sheet date of the latest reporting period but before the issuance of the financial statements."
       }
      }
     },
     "auth_ref": [
      "r33",
      "r34",
      "r228"
     ]
    },
    "us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations",
     "crdr": "debit",
     "calculation": {
      "http://sharpstechnology.com/role/StatementsOfCashFlows": {
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
       "weight": 1.0,
       "order": 4.0
      }
     },
     "presentation": [
      "http://sharpstechnology.com/role/StatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Effect of exchange rate changes on cash",
        "documentation": "Amount of increase (decrease) from effect of exchange rate changes on cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; held in foreign currencies; including, but not limited to, disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates."
       }
      }
     },
     "auth_ref": [
      "r843"
     ]
    },
    "us-gaap_EffectiveIncomeTaxRateContinuingOperations": {
     "xbrltype": "percentItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "EffectiveIncomeTaxRateContinuingOperations",
     "presentation": [
      "http://sharpstechnology.com/role/IncomeTaxesDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Effective income tax rate percentage",
        "documentation": "Percentage of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations."
       }
      }
     },
     "auth_ref": [
      "r401",
      "r688"
     ]
    },
    "us-gaap_EffectiveIncomeTaxRateReconciliationLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "EffectiveIncomeTaxRateReconciliationLineItems",
     "presentation": [
      "http://sharpstechnology.com/role/IncomeTaxesDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Effective Income Tax Rate Reconciliation [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": [
      "r401",
      "r402",
      "r688"
     ]
    },
    "us-gaap_EffectiveIncomeTaxRateReconciliationTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "EffectiveIncomeTaxRateReconciliationTable",
     "presentation": [
      "http://sharpstechnology.com/role/IncomeTaxesDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Effective Income Tax Rate Reconciliation [Table]",
        "documentation": "Disclosure of information about income tax rate reconciliation between amount of reported income tax expense (benefit) attributable to continuing operation to amount of income tax expense(benefit) that would result from applying statutory federal (national) tax rate to pretax income (loss) from continuing operation."
       }
      }
     },
     "auth_ref": [
      "r401",
      "r402",
      "r688"
     ]
    },
    "us-gaap_EmployeeBenefitsAndShareBasedCompensation": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "EmployeeBenefitsAndShareBasedCompensation",
     "crdr": "debit",
     "presentation": [
      "http://sharpstechnology.com/role/CommitmentsAndContingenciesDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Compensation cost",
        "documentation": "Amount of expense for employee benefit and equity-based compensation."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized",
     "crdr": "debit",
     "presentation": [
      "http://sharpstechnology.com/role/StockOptionsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Unrecognized stock-based compensation",
        "documentation": "Amount of cost not yet recognized for nonvested award under share-based payment arrangement."
       }
      }
     },
     "auth_ref": [
      "r387"
     ]
    },
    "us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1": {
     "xbrltype": "durationItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1",
     "presentation": [
      "http://sharpstechnology.com/role/StockOptionsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Recognized over a weighted-average period",
        "documentation": "Weighted-average period over which cost not yet recognized is expected to be recognized for award under share-based payment arrangement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days."
       }
      }
     },
     "auth_ref": [
      "r387"
     ]
    },
    "STSS_EmployeesAndConsultantMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://sharpstechnology.com/20240930",
     "localname": "EmployeesAndConsultantMember",
     "presentation": [
      "http://sharpstechnology.com/role/StockOptionsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Employees and Consultant [Member]",
        "documentation": "Employees and Consultant [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "STSS_EmploymentAgreementMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://sharpstechnology.com/20240930",
     "localname": "EmploymentAgreementMember",
     "presentation": [
      "http://sharpstechnology.com/role/CommitmentsAndContingenciesDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Employment Agreement [Member]",
        "documentation": "Employment Agreement [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressAddressLine1": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityAddressAddressLine1",
     "presentation": [
      "http://sharpstechnology.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Address Line One",
        "documentation": "Address Line 1 such as Attn, Building Name, Street Name"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressAddressLine2": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityAddressAddressLine2",
     "presentation": [
      "http://sharpstechnology.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Address Line Two",
        "documentation": "Address Line 2 such as Street or Suite number"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressAddressLine3": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityAddressAddressLine3",
     "presentation": [
      "http://sharpstechnology.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Address Line Three",
        "documentation": "Address Line 3 such as an Office Park"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressCityOrTown": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityAddressCityOrTown",
     "presentation": [
      "http://sharpstechnology.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, City or Town",
        "documentation": "Name of the City or Town"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressCountry": {
     "xbrltype": "countryCodeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityAddressCountry",
     "presentation": [
      "http://sharpstechnology.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Country",
        "documentation": "ISO 3166-1 alpha-2 country code."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressPostalZipCode": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityAddressPostalZipCode",
     "presentation": [
      "http://sharpstechnology.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Postal Zip Code",
        "documentation": "Code for the postal or zip code"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressStateOrProvince": {
     "xbrltype": "stateOrProvinceItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityAddressStateOrProvince",
     "presentation": [
      "http://sharpstechnology.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, State or Province",
        "documentation": "Name of the state or province."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressesAddressTypeAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityAddressesAddressTypeAxis",
     "presentation": [
      "http://sharpstechnology.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Addresses, Address Type [Axis]",
        "documentation": "The axis of a table defines the relationship between the domain members or categories in the table and the line items or concepts that complete the table."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressesLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityAddressesLineItems",
     "presentation": [
      "http://sharpstechnology.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Addresses [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressesTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityAddressesTable",
     "presentation": [
      "http://sharpstechnology.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Addresses [Table]",
        "documentation": "Container of address information for the entity"
       }
      }
     },
     "auth_ref": [
      "r713"
     ]
    },
    "dei_EntityBankruptcyProceedingsReportingCurrent": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityBankruptcyProceedingsReportingCurrent",
     "presentation": [
      "http://sharpstechnology.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Bankruptcy Proceedings, Reporting Current",
        "documentation": "For registrants involved in bankruptcy proceedings during the preceding five years, the value Yes indicates that the registrant has filed all documents and reports required to be filed by Section 12, 13 or 15(d) of the Securities Exchange Act of 1934 subsequent to the distribution of securities under a plan confirmed by a court; the value No indicates the registrant has not. Registrants not involved in bankruptcy proceedings during the preceding five years should not report this element."
       }
      }
     },
     "auth_ref": [
      "r717"
     ]
    },
    "dei_EntityCentralIndexKey": {
     "xbrltype": "centralIndexKeyItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityCentralIndexKey",
     "presentation": [
      "http://sharpstechnology.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Central Index Key",
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK."
       }
      }
     },
     "auth_ref": [
      "r713"
     ]
    },
    "dei_EntityCommonStockSharesOutstanding": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityCommonStockSharesOutstanding",
     "presentation": [
      "http://sharpstechnology.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Common Stock, Shares Outstanding",
        "documentation": "Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityCurrentReportingStatus": {
     "xbrltype": "yesNoItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityCurrentReportingStatus",
     "presentation": [
      "http://sharpstechnology.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Current Reporting Status",
        "documentation": "Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityEmergingGrowthCompany": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityEmergingGrowthCompany",
     "presentation": [
      "http://sharpstechnology.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Emerging Growth Company",
        "documentation": "Indicate if registrant meets the emerging growth company criteria."
       }
      }
     },
     "auth_ref": [
      "r713"
     ]
    },
    "dei_EntityExTransitionPeriod": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityExTransitionPeriod",
     "presentation": [
      "http://sharpstechnology.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Elected Not To Use the Extended Transition Period",
        "documentation": "Indicate if an emerging growth company has elected not to use the extended transition period for complying with any new or revised financial accounting standards."
       }
      }
     },
     "auth_ref": [
      "r730"
     ]
    },
    "dei_EntityFileNumber": {
     "xbrltype": "fileNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityFileNumber",
     "presentation": [
      "http://sharpstechnology.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity File Number",
        "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityFilerCategory": {
     "xbrltype": "filerCategoryItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityFilerCategory",
     "presentation": [
      "http://sharpstechnology.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Filer Category",
        "documentation": "Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure."
       }
      }
     },
     "auth_ref": [
      "r713"
     ]
    },
    "dei_EntityIncorporationStateCountryCode": {
     "xbrltype": "edgarStateCountryItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityIncorporationStateCountryCode",
     "presentation": [
      "http://sharpstechnology.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Incorporation, State or Country Code",
        "documentation": "Two-character EDGAR code representing the state or country of incorporation."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityInteractiveDataCurrent": {
     "xbrltype": "yesNoItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityInteractiveDataCurrent",
     "presentation": [
      "http://sharpstechnology.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Interactive Data Current",
        "documentation": "Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files)."
       }
      }
     },
     "auth_ref": [
      "r727"
     ]
    },
    "dei_EntityPrimarySicNumber": {
     "xbrltype": "sicNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityPrimarySicNumber",
     "presentation": [
      "http://sharpstechnology.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Primary SIC Number",
        "documentation": "Primary Standard Industrial Classification (SIC) Number for the Entity."
       }
      }
     },
     "auth_ref": [
      "r725"
     ]
    },
    "dei_EntityPublicFloat": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityPublicFloat",
     "crdr": "credit",
     "presentation": [
      "http://sharpstechnology.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Public Float",
        "documentation": "The aggregate market value of the voting and non-voting common equity held by non-affiliates computed by reference to the price at which the common equity was last sold, or the average bid and asked price of such common equity, as of the last business day of the registrant's most recently completed second fiscal quarter."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityRegistrantName": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityRegistrantName",
     "presentation": [
      "http://sharpstechnology.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Registrant Name",
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC."
       }
      }
     },
     "auth_ref": [
      "r713"
     ]
    },
    "dei_EntityShellCompany": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityShellCompany",
     "presentation": [
      "http://sharpstechnology.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Shell Company",
        "documentation": "Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r713"
     ]
    },
    "dei_EntitySmallBusiness": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntitySmallBusiness",
     "presentation": [
      "http://sharpstechnology.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Small Business",
        "documentation": "Indicates that the company is a Smaller Reporting Company (SRC)."
       }
      }
     },
     "auth_ref": [
      "r713"
     ]
    },
    "dei_EntityTaxIdentificationNumber": {
     "xbrltype": "employerIdItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityTaxIdentificationNumber",
     "presentation": [
      "http://sharpstechnology.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Tax Identification Number",
        "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS."
       }
      }
     },
     "auth_ref": [
      "r713"
     ]
    },
    "dei_EntityVoluntaryFilers": {
     "xbrltype": "yesNoItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityVoluntaryFilers",
     "presentation": [
      "http://sharpstechnology.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Voluntary Filers",
        "documentation": "Indicate 'Yes' or 'No' if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityWellKnownSeasonedIssuer": {
     "xbrltype": "yesNoItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityWellKnownSeasonedIssuer",
     "presentation": [
      "http://sharpstechnology.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Well-known Seasoned Issuer",
        "documentation": "Indicate 'Yes' or 'No' if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Is used on Form Type: 10-K, 10-Q, 8-K, 20-F, 6-K, 10-K/A, 10-Q/A, 20-F/A, 6-K/A, N-CSR, N-Q, N-1A."
       }
      }
     },
     "auth_ref": [
      "r728"
     ]
    },
    "us-gaap_EquityAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "EquityAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Equity [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_EquityComponentDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "EquityComponentDomain",
     "presentation": [
      "http://sharpstechnology.com/role/AssetAcquisitionDetailsNarrative",
      "http://sharpstechnology.com/role/ScheduleOfFairValueOfWarrantDetails",
      "http://sharpstechnology.com/role/StatementOfStockholdersEquity",
      "http://sharpstechnology.com/role/StockholdersEquityDetailsNarrative",
      "http://sharpstechnology.com/role/SubsequentEventsDetailsNarrative",
      "http://sharpstechnology.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative",
      "http://sharpstechnology.com/role/WarrantLiabilityTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Components of equity are the parts of the total Equity balance including that which is allocated to common, preferred, treasury stock, retained earnings, etc."
       }
      }
     },
     "auth_ref": [
      "r13",
      "r160",
      "r185",
      "r186",
      "r187",
      "r204",
      "r205",
      "r206",
      "r208",
      "r213",
      "r215",
      "r217",
      "r231",
      "r251",
      "r252",
      "r264",
      "r341",
      "r420",
      "r421",
      "r428",
      "r429",
      "r430",
      "r432",
      "r435",
      "r436",
      "r442",
      "r443",
      "r444",
      "r445",
      "r446",
      "r447",
      "r449",
      "r472",
      "r473",
      "r474",
      "r475",
      "r476",
      "r478",
      "r483",
      "r484",
      "r486",
      "r526",
      "r536",
      "r537",
      "r538",
      "r554",
      "r627"
     ]
    },
    "srt_EquityMethodInvesteeNameDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/srt/2024",
     "localname": "EquityMethodInvesteeNameDomain",
     "presentation": [
      "http://sharpstechnology.com/role/PreferredStockDetailsNarrative"
     ],
     "auth_ref": [
      "r247",
      "r248",
      "r249",
      "r427",
      "r733",
      "r734",
      "r735",
      "r819",
      "r820",
      "r821",
      "r822"
     ]
    },
    "us-gaap_EquityMethodInvestmentOwnershipPercentage": {
     "xbrltype": "percentItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "EquityMethodInvestmentOwnershipPercentage",
     "presentation": [
      "http://sharpstechnology.com/role/PreferredStockDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Ownership interest percentage",
        "documentation": "The percentage of ownership of common stock or equity participation in the investee accounted for under the equity method of accounting."
       }
      }
     },
     "auth_ref": [
      "r247"
     ]
    },
    "us-gaap_EscrowDeposit": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "EscrowDeposit",
     "crdr": "debit",
     "presentation": [
      "http://sharpstechnology.com/role/CommitmentsAndContingenciesDetailsNarrative",
      "http://sharpstechnology.com/role/DebtFinancingDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Escrow Deposit",
        "verboseLabel": "Escrow deposit",
        "documentation": "The designation of funds furnished by a borrower to a lender to assure future payments of the borrower's real estate taxes and insurance obligations with respect to a mortgaged property. Escrow deposits may be made for a variety of other purposes such as earnest money and contingent payments. This element excludes replacement reserves which are an escrow separately provided for within the US GAAP taxonomy."
       }
      }
     },
     "auth_ref": [
      "r130",
      "r654"
     ]
    },
    "us-gaap_EscrowDepositDisbursementsRelatedToPropertyAcquisition1": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "EscrowDepositDisbursementsRelatedToPropertyAcquisition1",
     "crdr": "credit",
     "presentation": [
      "http://sharpstechnology.com/role/CommitmentsAndContingenciesDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Escrow deposit disbursements related to property acquisition",
        "documentation": "Amount of escrow deposit disbursements related to property acquisition in noncash investing or financing transactions."
       }
      }
     },
     "auth_ref": [
      "r30",
      "r31",
      "r32"
     ]
    },
    "STSS_EscrowDepositForfeited": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://sharpstechnology.com/20240930",
     "localname": "EscrowDepositForfeited",
     "crdr": "debit",
     "calculation": {
      "http://sharpstechnology.com/role/StatementsOfCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0,
       "order": 8.0
      }
     },
     "presentation": [
      "http://sharpstechnology.com/role/StatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Escrow forfeited",
        "documentation": "Escrow deposit forfeited."
       }
      }
     },
     "auth_ref": []
    },
    "STSS_EscrowPaymentUnderAgreement": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://sharpstechnology.com/20240930",
     "localname": "EscrowPaymentUnderAgreement",
     "crdr": "credit",
     "calculation": {
      "http://sharpstechnology.com/role/StatementsOfCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": -1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://sharpstechnology.com/role/StatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Escrow payment under agreement",
        "documentation": "Escrow payment under agreement.",
        "label": "EscrowPaymentUnderAgreement"
       }
      }
     },
     "auth_ref": []
    },
    "STSS_ExercisePriceRangeEightMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://sharpstechnology.com/20240930",
     "localname": "ExercisePriceRangeEightMember",
     "presentation": [
      "http://sharpstechnology.com/role/ScheduleOfInformationAboutOptionsOutstandingDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Exercise Price Range Eight [Member]",
        "documentation": "Exercise Price Range Eight [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "STSS_ExercisePriceRangeFiveMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://sharpstechnology.com/20240930",
     "localname": "ExercisePriceRangeFiveMember",
     "presentation": [
      "http://sharpstechnology.com/role/ScheduleOfInformationAboutOptionsOutstandingDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Exercise Price Range Five [Member]",
        "documentation": "Exercise Price Range Five [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "STSS_ExercisePriceRangeFourMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://sharpstechnology.com/20240930",
     "localname": "ExercisePriceRangeFourMember",
     "presentation": [
      "http://sharpstechnology.com/role/ScheduleOfInformationAboutOptionsOutstandingDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Exercise Price Range Four [Member]",
        "documentation": "Exercise Price Range Four [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "STSS_ExercisePriceRangeNineMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://sharpstechnology.com/20240930",
     "localname": "ExercisePriceRangeNineMember",
     "presentation": [
      "http://sharpstechnology.com/role/ScheduleOfInformationAboutOptionsOutstandingDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Exercise Price Range Nine [Member]",
        "documentation": "Exercise Price Range Nine [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "STSS_ExercisePriceRangeOneMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://sharpstechnology.com/20240930",
     "localname": "ExercisePriceRangeOneMember",
     "presentation": [
      "http://sharpstechnology.com/role/ScheduleOfInformationAboutOptionsOutstandingDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Exercise Price Range One [Member]",
        "documentation": "Exercise Price Range One [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "STSS_ExercisePriceRangeSevenMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://sharpstechnology.com/20240930",
     "localname": "ExercisePriceRangeSevenMember",
     "presentation": [
      "http://sharpstechnology.com/role/ScheduleOfInformationAboutOptionsOutstandingDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Exercise Price Range Seven [Member]",
        "documentation": "Exercise Price Range Seven [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "STSS_ExercisePriceRangeSixMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://sharpstechnology.com/20240930",
     "localname": "ExercisePriceRangeSixMember",
     "presentation": [
      "http://sharpstechnology.com/role/ScheduleOfInformationAboutOptionsOutstandingDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Exercise Price Range Six [Member]",
        "documentation": "Exercise Price Range Six [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "STSS_ExercisePriceRangeTenMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://sharpstechnology.com/20240930",
     "localname": "ExercisePriceRangeTenMember",
     "presentation": [
      "http://sharpstechnology.com/role/ScheduleOfInformationAboutOptionsOutstandingDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Exercise Price Range Ten [Member]",
        "documentation": "Exercise Price Range Ten [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "STSS_ExercisePriceRangeThreeMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://sharpstechnology.com/20240930",
     "localname": "ExercisePriceRangeThreeMember",
     "presentation": [
      "http://sharpstechnology.com/role/ScheduleOfInformationAboutOptionsOutstandingDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Exercise Price Range Three [Member]",
        "documentation": "Exercise Price Range Three [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "STSS_ExercisePriceRangeTwoMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://sharpstechnology.com/20240930",
     "localname": "ExercisePriceRangeTwoMember",
     "presentation": [
      "http://sharpstechnology.com/role/ScheduleOfInformationAboutOptionsOutstandingDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Exercise Price Range Two [Member]",
        "documentation": "Exercise Price Range Two [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "STSS_ExpiresOnTwoThousandTwentyEightMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://sharpstechnology.com/20240930",
     "localname": "ExpiresOnTwoThousandTwentyEightMember",
     "presentation": [
      "http://sharpstechnology.com/role/IncomeTaxesDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Expires On 2028 [Member]",
        "documentation": "Expires On 2028 [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "dei_Extension": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "Extension",
     "presentation": [
      "http://sharpstechnology.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Extension",
        "documentation": "Extension number for local phone number."
       }
      }
     },
     "auth_ref": []
    },
    "STSS_FairMarketValueAdjustmentForContingentStockAndWarrants": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://sharpstechnology.com/20240930",
     "localname": "FairMarketValueAdjustmentForContingentStockAndWarrants",
     "crdr": "debit",
     "calculation": {
      "http://sharpstechnology.com/role/StatementsOfOperations": {
       "parentTag": "us-gaap_NonoperatingIncomeExpense",
       "weight": -1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://sharpstechnology.com/role/StatementsOfOperations"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "FMV adjustment on contingent stock &amp; warrants",
        "documentation": "Fair market value adjustment for contingent stock and warrants.",
        "label": "FairMarketValueAdjustmentForContingentStockAndWarrants"
       }
      }
     },
     "auth_ref": []
    },
    "STSS_FairMarketValueAdjustmentForContingentWarrants": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://sharpstechnology.com/20240930",
     "localname": "FairMarketValueAdjustmentForContingentWarrants",
     "crdr": "debit",
     "calculation": {
      "http://sharpstechnology.com/role/StatementsOfCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0,
       "order": 9.0
      }
     },
     "presentation": [
      "http://sharpstechnology.com/role/StatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "FMV for adjustment for contingent stock",
        "documentation": "Fair market value for adjustment for contingent warrants."
       }
      }
     },
     "auth_ref": []
    },
    "STSS_FairMarketValueAdjustmentForContingentWarrantsAndWarrants": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://sharpstechnology.com/20240930",
     "localname": "FairMarketValueAdjustmentForContingentWarrantsAndWarrants",
     "crdr": "debit",
     "calculation": {
      "http://sharpstechnology.com/role/StatementsOfOperations": {
       "parentTag": "us-gaap_NonoperatingIncomeExpense",
       "weight": -1.0,
       "order": 5.0
      },
      "http://sharpstechnology.com/role/StatementsOfCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0,
       "order": 10.0
      }
     },
     "presentation": [
      "http://sharpstechnology.com/role/StatementsOfCashFlows",
      "http://sharpstechnology.com/role/StatementsOfOperations"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "FMV adjustment warrants (Note 10)",
        "label": "FMV adjustment for Contingent warrants and warrants",
        "documentation": "Fair market valuea djustment for Contingent Warrants and Warrants."
       }
      }
     },
     "auth_ref": []
    },
    "STSS_FairMarketValueOfCommonStock": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://sharpstechnology.com/20240930",
     "localname": "FairMarketValueOfCommonStock",
     "crdr": "credit",
     "presentation": [
      "http://sharpstechnology.com/role/AssetAcquisitionDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fair market value of common stock",
        "documentation": "Fair market value of common stock."
       }
      }
     },
     "auth_ref": []
    },
    "STSS_FairValueAdjustmentOfModificationCharge": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://sharpstechnology.com/20240930",
     "localname": "FairValueAdjustmentOfModificationCharge",
     "crdr": "debit",
     "presentation": [
      "http://sharpstechnology.com/role/StockholdersEquityDetailsNarrative",
      "http://sharpstechnology.com/role/WarrantLiabilityDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fair value adjustment of modification charge",
        "documentation": "Fair value adjustment of modification charge."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_FairValueAdjustmentOfWarrants": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "FairValueAdjustmentOfWarrants",
     "crdr": "debit",
     "presentation": [
      "http://sharpstechnology.com/role/NotePurchaseAgreementDetailsNarrative",
      "http://sharpstechnology.com/role/StockholdersEquityDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fair market value of warrant",
        "verboseLabel": "Fair value adjustment of warrants",
        "documentation": "Amount of expense (income) related to adjustment to fair value of warrant liability."
       }
      }
     },
     "auth_ref": [
      "r1",
      "r9"
     ]
    },
    "us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems",
     "presentation": [
      "http://sharpstechnology.com/role/ScheduleOfAssetsAndLiabilitiesMeasuredAtFairValueOnRecurringBasisDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": [
      "r453",
      "r454",
      "r461",
      "r690"
     ]
    },
    "us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable",
     "presentation": [
      "http://sharpstechnology.com/role/ScheduleOfAssetsAndLiabilitiesMeasuredAtFairValueOnRecurringBasisDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fair Value, Recurring and Nonrecurring [Table]",
        "documentation": "Disclosure of information about asset and liability measured at fair value on recurring and nonrecurring basis."
       }
      }
     },
     "auth_ref": [
      "r453",
      "r454",
      "r461",
      "r690"
     ]
    },
    "us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock",
     "presentation": [
      "http://sharpstechnology.com/role/StockOptionsTables",
      "http://sharpstechnology.com/role/WarrantLiabilityTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Schedule of Fair Value of Warrant",
        "label": "Schedule of Fair Value of Stock Option Awards",
        "documentation": "Tabular disclosure of input and valuation technique used to measure fair value and change in valuation approach and technique for each separate class of asset and liability measured on recurring and nonrecurring basis."
       }
      }
     },
     "auth_ref": [
      "r455",
      "r456",
      "r693"
     ]
    },
    "us-gaap_FairValueByFairValueHierarchyLevelAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "FairValueByFairValueHierarchyLevelAxis",
     "presentation": [
      "http://sharpstechnology.com/role/ScheduleOfAssetsAndLiabilitiesMeasuredAtFairValueOnRecurringBasisDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fair Value Hierarchy and NAV [Axis]",
        "documentation": "Information by level within fair value hierarchy and fair value measured at net asset value per share as practical expedient."
       }
      }
     },
     "auth_ref": [
      "r312",
      "r345",
      "r346",
      "r347",
      "r348",
      "r349",
      "r350",
      "r452",
      "r454",
      "r455",
      "r456",
      "r457",
      "r460",
      "r461",
      "r463",
      "r495",
      "r496",
      "r497",
      "r676",
      "r677",
      "r681",
      "r682",
      "r683",
      "r690",
      "r693"
     ]
    },
    "us-gaap_FairValueDisclosuresAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "FairValueDisclosuresAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Fair Value Disclosures [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_FairValueInputsLevel1Member": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "FairValueInputsLevel1Member",
     "presentation": [
      "http://sharpstechnology.com/role/ScheduleOfAssetsAndLiabilitiesMeasuredAtFairValueOnRecurringBasisDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fair Value, Inputs, Level 1 [Member]",
        "documentation": "Quoted prices in active markets for identical assets or liabilities that the reporting entity can access at the measurement date."
       }
      }
     },
     "auth_ref": [
      "r312",
      "r345",
      "r350",
      "r454",
      "r461",
      "r495",
      "r681",
      "r682",
      "r683",
      "r690"
     ]
    },
    "us-gaap_FairValueInputsLevel2Member": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "FairValueInputsLevel2Member",
     "presentation": [
      "http://sharpstechnology.com/role/ScheduleOfAssetsAndLiabilitiesMeasuredAtFairValueOnRecurringBasisDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fair Value, Inputs, Level 2 [Member]",
        "documentation": "Inputs other than quoted prices included within level 1 that are observable for an asset or liability, either directly or indirectly, including, but not limited to, quoted prices for similar assets or liabilities in active markets, or quoted prices for identical or similar assets or liabilities in inactive markets."
       }
      }
     },
     "auth_ref": [
      "r312",
      "r345",
      "r350",
      "r454",
      "r455",
      "r461",
      "r496",
      "r676",
      "r677",
      "r681",
      "r682",
      "r683",
      "r690"
     ]
    },
    "us-gaap_FairValueInputsLevel3Member": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "FairValueInputsLevel3Member",
     "presentation": [
      "http://sharpstechnology.com/role/ScheduleOfAssetsAndLiabilitiesMeasuredAtFairValueOnRecurringBasisDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fair Value, Inputs, Level 3 [Member]",
        "documentation": "Unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing."
       }
      }
     },
     "auth_ref": [
      "r312",
      "r345",
      "r346",
      "r347",
      "r348",
      "r349",
      "r350",
      "r454",
      "r455",
      "r456",
      "r457",
      "r461",
      "r497",
      "r676",
      "r677",
      "r681",
      "r682",
      "r683",
      "r690",
      "r693"
     ]
    },
    "us-gaap_FairValueMeasurementInputsDisclosureTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "FairValueMeasurementInputsDisclosureTextBlock",
     "presentation": [
      "http://sharpstechnology.com/role/FairValueMeasurements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fair Value Measurements",
        "documentation": "The entire disclosure of the fair value measurement of assets and liabilities, which includes financial instruments measured at fair value that are classified in shareholders' equity, which may be measured on a recurring or nonrecurring basis."
       }
      }
     },
     "auth_ref": [
      "r129"
     ]
    },
    "us-gaap_FairValueMeasurementPolicyPolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "FairValueMeasurementPolicyPolicyTextBlock",
     "presentation": [
      "http://sharpstechnology.com/role/SummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Fair Value Measurements",
        "label": "Fair Value Measurement, Policy [Policy Text Block]",
        "documentation": "Disclosure of accounting policy for fair value measurements of financial and non-financial assets, liabilities and instruments classified in shareholders' equity. Disclosures include, but are not limited to, how an entity that manages a group of financial assets and liabilities on the basis of its net exposure measures the fair value of those assets and liabilities."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_FairValueMeasurementsFairValueHierarchyDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "FairValueMeasurementsFairValueHierarchyDomain",
     "presentation": [
      "http://sharpstechnology.com/role/ScheduleOfAssetsAndLiabilitiesMeasuredAtFairValueOnRecurringBasisDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Categories used to prioritize the inputs to valuation techniques to measure fair value."
       }
      }
     },
     "auth_ref": [
      "r312",
      "r345",
      "r346",
      "r347",
      "r348",
      "r349",
      "r350",
      "r452",
      "r454",
      "r455",
      "r456",
      "r457",
      "r460",
      "r461",
      "r463",
      "r495",
      "r496",
      "r497",
      "r676",
      "r677",
      "r681",
      "r682",
      "r683",
      "r690",
      "r693"
     ]
    },
    "us-gaap_FairValueOfAssetsAcquired": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "FairValueOfAssetsAcquired",
     "crdr": "debit",
     "presentation": [
      "http://sharpstechnology.com/role/AssetAcquisitionDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fair value of assets acquired",
        "documentation": "The fair value of assets acquired in noncash investing or financing activities."
       }
      }
     },
     "auth_ref": [
      "r30",
      "r31",
      "r32"
     ]
    },
    "us-gaap_FinancialInstrumentsFinancialAssetsBalanceSheetGroupingsAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "FinancialInstrumentsFinancialAssetsBalanceSheetGroupingsAbstract",
     "presentation": [
      "http://sharpstechnology.com/role/ScheduleOfAssetsAndLiabilitiesMeasuredAtFairValueOnRecurringBasisDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Assets"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_FinancialInstrumentsFinancialLiabilitiesBalanceSheetGroupingsAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "FinancialInstrumentsFinancialLiabilitiesBalanceSheetGroupingsAbstract",
     "presentation": [
      "http://sharpstechnology.com/role/ScheduleOfAssetsAndLiabilitiesMeasuredAtFairValueOnRecurringBasisDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Liabilities"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_FiniteLivedIntangibleAssetUsefulLife": {
     "xbrltype": "durationItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "FiniteLivedIntangibleAssetUsefulLife",
     "presentation": [
      "http://sharpstechnology.com/role/AssetAcquisitionDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Intangible asset acquired, useful lives",
        "documentation": "Useful life of finite-lived intangible assets, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_FiniteLivedIntangibleAssetsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "FiniteLivedIntangibleAssetsMember",
     "presentation": [
      "http://sharpstechnology.com/role/AssetAcquisitionDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Finite-Lived Intangible Assets [Member]",
        "documentation": "Assets, excluding financial assets, that lack physical substance, having a limited useful life."
       }
      }
     },
     "auth_ref": []
    },
    "STSS_FmvForCommonStockIssuedForContingentShares": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://sharpstechnology.com/20240930",
     "localname": "FmvForCommonStockIssuedForContingentShares",
     "crdr": "credit",
     "presentation": [
      "http://sharpstechnology.com/role/StatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "FMV for Common stock issued for contingent shares",
        "documentation": "FMV for common stock issued for cintingent shares."
       }
      }
     },
     "auth_ref": []
    },
    "STSS_FmvForWarrantsIssuedForContingentWarrants": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://sharpstechnology.com/20240930",
     "localname": "FmvForWarrantsIssuedForContingentWarrants",
     "crdr": "credit",
     "presentation": [
      "http://sharpstechnology.com/role/StatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "FMV for Warrants issued for contingent warrants",
        "documentation": "Fmv for warrants issued for contingent warrants."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ForeignCountryMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ForeignCountryMember",
     "presentation": [
      "http://sharpstechnology.com/role/IncomeTaxesDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Foreign Tax Jurisdiction [Member]",
        "documentation": "Designated foreign jurisdiction entitled to levy and collect income tax outside country of domicile."
       }
      }
     },
     "auth_ref": [
      "r401",
      "r402"
     ]
    },
    "STSS_ForeignCurrencyAndNonOperatingIncomeExpenses": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://sharpstechnology.com/20240930",
     "localname": "ForeignCurrencyAndNonOperatingIncomeExpenses",
     "crdr": "credit",
     "calculation": {
      "http://sharpstechnology.com/role/StatementsOfOperations": {
       "parentTag": "us-gaap_NonoperatingIncomeExpense",
       "weight": 1.0,
       "order": 6.0
      }
     },
     "presentation": [
      "http://sharpstechnology.com/role/StatementsOfOperations"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Foreign currency",
        "documentation": "Foreign currency and non operating income expenses."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ForeignCurrencyTransactionGainLossBeforeTax": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ForeignCurrencyTransactionGainLossBeforeTax",
     "crdr": "credit",
     "calculation": {
      "http://sharpstechnology.com/role/StatementsOfCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0,
       "order": 14.0
      }
     },
     "presentation": [
      "http://sharpstechnology.com/role/StatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Foreign exchange (gain)/loss",
        "label": "Gain (Loss), Foreign Currency Transaction, before Tax",
        "documentation": "Amount, before tax, of realized and unrealized gain (loss) from foreign currency transaction."
       }
      }
     },
     "auth_ref": [
      "r467",
      "r468",
      "r469",
      "r471",
      "r624"
     ]
    },
    "us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock",
     "presentation": [
      "http://sharpstechnology.com/role/SummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Foreign Currency Translation/Transactions",
        "documentation": "Disclosure of accounting policy for (1) transactions denominated in a currency other than the reporting enterprise's functional currency, (2) translating foreign currency financial statements that are incorporated into the financial statements of the reporting enterprise by consolidation, combination, or the equity method of accounting, and (3) remeasurement of the financial statements of a foreign reporting enterprise in a hyperinflationary economy."
       }
      }
     },
     "auth_ref": [
      "r466"
     ]
    },
    "STSS_GainLossOnSaleOfDerivative": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://sharpstechnology.com/20240930",
     "localname": "GainLossOnSaleOfDerivative",
     "crdr": "credit",
     "presentation": [
      "http://sharpstechnology.com/role/WarrantLiabilityDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Fair market value adjustment",
        "documentation": "Gain loss on sale of derivative.",
        "label": "GainLossOnSaleOfDerivative"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_GainLossOnSaleOfDerivatives": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "GainLossOnSaleOfDerivatives",
     "crdr": "credit",
     "calculation": {
      "http://sharpstechnology.com/role/StatementsOfOperations": {
       "parentTag": "us-gaap_NonoperatingIncomeExpense",
       "weight": 1.0,
       "order": 4.0
      },
      "http://sharpstechnology.com/role/StatementsOfCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0,
       "order": 6.0
      }
     },
     "presentation": [
      "http://sharpstechnology.com/role/StatementsOfCashFlows",
      "http://sharpstechnology.com/role/StatementsOfOperations",
      "http://sharpstechnology.com/role/WarrantLiabilityDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "FMV adjustment warrants",
        "negatedLabel": "FMV adjustment for Warrants",
        "verboseLabel": "Fair market value adjustment",
        "documentation": "The difference between the book value and the sale price of options, swaps, futures, forward contracts, and other derivative instruments. This element refers to the gain (loss) included in earnings."
       }
      }
     },
     "auth_ref": [
      "r9",
      "r138",
      "r614",
      "r615",
      "r616",
      "r617"
     ]
    },
    "us-gaap_GeneralAndAdministrativeExpense": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "GeneralAndAdministrativeExpense",
     "crdr": "debit",
     "calculation": {
      "http://sharpstechnology.com/role/StatementsOfOperations": {
       "parentTag": "us-gaap_OperatingExpenses",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://sharpstechnology.com/role/StatementsOfOperations"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "General and administrative",
        "documentation": "The aggregate total of expenses of managing and administering the affairs of an entity, including affiliates of the reporting entity, which are not directly or indirectly associated with the manufacture, sale or creation of a product or product line."
       }
      }
     },
     "auth_ref": [
      "r93",
      "r608"
     ]
    },
    "us-gaap_GeneralAndAdministrativeExpenseMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "GeneralAndAdministrativeExpenseMember",
     "presentation": [
      "http://sharpstechnology.com/role/StockOptionsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "General and Administrative Expense [Member]",
        "documentation": "Primary financial statement caption encompassing general and administrative expense."
       }
      }
     },
     "auth_ref": [
      "r93"
     ]
    },
    "us-gaap_IPOMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "IPOMember",
     "presentation": [
      "http://sharpstechnology.com/role/DescriptionOfBusinessDetailsNarrative",
      "http://sharpstechnology.com/role/PreferredStockDetailsNarrative",
      "http://sharpstechnology.com/role/StockholdersEquityDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "IPO [Member]",
        "documentation": "First sale of stock by a private company to the public."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ImpairmentOfLongLivedAssetsHeldForUse": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ImpairmentOfLongLivedAssetsHeldForUse",
     "crdr": "debit",
     "calculation": {
      "http://sharpstechnology.com/role/StatementsOfCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0,
       "order": 11.0
      }
     },
     "presentation": [
      "http://sharpstechnology.com/role/StatementsOfCashFlows",
      "http://sharpstechnology.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fixed asset impairment",
        "verboseLabel": "Impairment losses",
        "documentation": "The aggregate amount of write-downs for impairments recognized during the period for long lived assets held for use (including those held for disposal by means other than sale)."
       }
      }
     },
     "auth_ref": [
      "r9",
      "r38",
      "r109",
      "r691"
     ]
    },
    "us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock",
     "presentation": [
      "http://sharpstechnology.com/role/SummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Impairment of Long-Lived Assets",
        "documentation": "Disclosure of accounting policy for recognizing and measuring the impairment of long-lived assets. An entity also may disclose its accounting policy for long-lived assets to be sold. This policy excludes goodwill and intangible assets."
       }
      }
     },
     "auth_ref": [
      "r0",
      "r110"
     ]
    },
    "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic",
     "crdr": "credit",
     "calculation": {
      "http://sharpstechnology.com/role/ScheduleOfGeographicalComponentsOfLossBeforeIncomeTaxesDetails": {
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://sharpstechnology.com/role/ScheduleOfGeographicalComponentsOfLossBeforeIncomeTaxesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "United Stated Operations",
        "documentation": "The portion of earnings or loss from continuing operations before income taxes that is attributable to domestic operations."
       }
      }
     },
     "auth_ref": [
      "r200",
      "r400"
     ]
    },
    "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
     "crdr": "credit",
     "calculation": {
      "http://sharpstechnology.com/role/StatementsOfOperations": {
       "parentTag": "us-gaap_NetIncomeLoss",
       "weight": 1.0,
       "order": 1.0
      },
      "http://sharpstechnology.com/role/ScheduleOfGeographicalComponentsOfLossBeforeIncomeTaxesDetails": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://sharpstechnology.com/role/ScheduleOfGeographicalComponentsOfLossBeforeIncomeTaxesDetails",
      "http://sharpstechnology.com/role/StatementsOfOperations"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Net loss Before Provision for Taxes",
        "label": "Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest",
        "documentation": "Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest."
       }
      }
     },
     "auth_ref": [
      "r91",
      "r140",
      "r144",
      "r510",
      "r524",
      "r669",
      "r670",
      "r763",
      "r764",
      "r765",
      "r766",
      "r767"
     ]
    },
    "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign",
     "crdr": "credit",
     "calculation": {
      "http://sharpstechnology.com/role/ScheduleOfGeographicalComponentsOfLossBeforeIncomeTaxesDetails": {
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://sharpstechnology.com/role/ScheduleOfGeographicalComponentsOfLossBeforeIncomeTaxesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "International Operations",
        "documentation": "The portion of earnings or loss from continuing operations before income taxes that is attributable to foreign operations, which is defined as Income or Loss generated from operations located outside the entity's country of domicile."
       }
      }
     },
     "auth_ref": [
      "r200",
      "r400"
     ]
    },
    "us-gaap_IncomeStatementAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "IncomeStatementAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Income Statement [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_IncomeStatementLocationAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "IncomeStatementLocationAxis",
     "presentation": [
      "http://sharpstechnology.com/role/StockOptionsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement of Income Location, Balance [Axis]",
        "documentation": "Information by location in statement of income where disaggregated amount has been reported."
       }
      }
     },
     "auth_ref": [
      "r265",
      "r271",
      "r274",
      "r458",
      "r459",
      "r462",
      "r533",
      "r535",
      "r611",
      "r658",
      "r692",
      "r863"
     ]
    },
    "us-gaap_IncomeStatementLocationDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "IncomeStatementLocationDomain",
     "presentation": [
      "http://sharpstechnology.com/role/StockOptionsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Location in statement of income where disaggregated amount has been reported."
       }
      }
     },
     "auth_ref": [
      "r271",
      "r274",
      "r458",
      "r459",
      "r462",
      "r533",
      "r535",
      "r611",
      "r658",
      "r692",
      "r863"
     ]
    },
    "us-gaap_IncomeTaxAuthorityAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "IncomeTaxAuthorityAxis",
     "presentation": [
      "http://sharpstechnology.com/role/IncomeTaxesDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Income Tax Jurisdiction [Axis]",
        "documentation": "Information by income tax jurisdiction."
       }
      }
     },
     "auth_ref": [
      "r194",
      "r401",
      "r402",
      "r410",
      "r417",
      "r688",
      "r817"
     ]
    },
    "us-gaap_IncomeTaxAuthorityDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "IncomeTaxAuthorityDomain",
     "presentation": [
      "http://sharpstechnology.com/role/IncomeTaxesDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Income tax jurisdiction."
       }
      }
     },
     "auth_ref": [
      "r194",
      "r401",
      "r402",
      "r410",
      "r417",
      "r688",
      "r817"
     ]
    },
    "us-gaap_IncomeTaxDisclosureAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "IncomeTaxDisclosureAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Income Tax Disclosure [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_IncomeTaxDisclosureTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "IncomeTaxDisclosureTextBlock",
     "presentation": [
      "http://sharpstechnology.com/role/IncomeTaxes"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Income Taxes",
        "documentation": "The entire disclosure for income tax."
       }
      }
     },
     "auth_ref": [
      "r201",
      "r393",
      "r401",
      "r407",
      "r408",
      "r409",
      "r411",
      "r415",
      "r422",
      "r424",
      "r425",
      "r426",
      "r550",
      "r688"
     ]
    },
    "us-gaap_IncomeTaxExpenseBenefit": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "IncomeTaxExpenseBenefit",
     "crdr": "debit",
     "calculation": {
      "http://sharpstechnology.com/role/ScheduleOfReconciliationOfFederalStatutoryRateToTotalEffectiveRateDetails": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://sharpstechnology.com/role/ScheduleOfReconciliationOfFederalStatutoryRateToTotalEffectiveRateDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Income tax expense (benefit)",
        "label": "Income Tax Expense (Benefit)",
        "documentation": "Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations."
       }
      }
     },
     "auth_ref": [
      "r147",
      "r158",
      "r216",
      "r217",
      "r230",
      "r238",
      "r242",
      "r399",
      "r401",
      "r423",
      "r530",
      "r688"
     ]
    },
    "us-gaap_IncomeTaxPolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "IncomeTaxPolicyTextBlock",
     "presentation": [
      "http://sharpstechnology.com/role/SummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Income Taxes",
        "label": "Income Tax, Policy [Policy Text Block]",
        "documentation": "Disclosure of accounting policy for income taxes, which may include its accounting policies for recognizing and measuring deferred tax assets and liabilities and related valuation allowances, recognizing investment tax credits, operating loss carryforwards, tax credit carryforwards, and other carryforwards, methodologies for determining its effective income tax rate and the characterization of interest and penalties in the financial statements."
       }
      }
     },
     "auth_ref": [
      "r184",
      "r395",
      "r396",
      "r411",
      "r412",
      "r414",
      "r419",
      "r544"
     ]
    },
    "us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance",
     "crdr": "debit",
     "calculation": {
      "http://sharpstechnology.com/role/ScheduleOfReconciliationOfFederalStatutoryRateToTotalEffectiveRateDetails": {
       "parentTag": "us-gaap_IncomeTaxExpenseBenefit",
       "weight": 1.0,
       "order": 5.0
      }
     },
     "presentation": [
      "http://sharpstechnology.com/role/ScheduleOfReconciliationOfFederalStatutoryRateToTotalEffectiveRateDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Change in valuation allowance",
        "documentation": "Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to increase (decrease) in the valuation allowance for deferred tax assets."
       }
      }
     },
     "auth_ref": [
      "r406",
      "r688",
      "r814"
     ]
    },
    "us-gaap_IncomeTaxReconciliationChangeInEnactedTaxRate": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "IncomeTaxReconciliationChangeInEnactedTaxRate",
     "crdr": "debit",
     "calculation": {
      "http://sharpstechnology.com/role/ScheduleOfReconciliationOfFederalStatutoryRateToTotalEffectiveRateDetails": {
       "parentTag": "us-gaap_IncomeTaxExpenseBenefit",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://sharpstechnology.com/role/ScheduleOfReconciliationOfFederalStatutoryRateToTotalEffectiveRateDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Permanent differences \u2013 net",
        "documentation": "Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations, attributable to increase (decrease) in the income tax rates."
       }
      }
     },
     "auth_ref": [
      "r394",
      "r401",
      "r405",
      "r688"
     ]
    },
    "us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate",
     "crdr": "debit",
     "calculation": {
      "http://sharpstechnology.com/role/ScheduleOfReconciliationOfFederalStatutoryRateToTotalEffectiveRateDetails": {
       "parentTag": "us-gaap_IncomeTaxExpenseBenefit",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://sharpstechnology.com/role/ScheduleOfReconciliationOfFederalStatutoryRateToTotalEffectiveRateDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Expected benefit at statutory federal tax rate",
        "documentation": "The amount of income tax expense or benefit for the period computed by applying the domestic federal statutory tax rates to pretax income from continuing operations."
       }
      }
     },
     "auth_ref": [
      "r401",
      "r688"
     ]
    },
    "us-gaap_IncomeTaxReconciliationOtherAdjustments": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "IncomeTaxReconciliationOtherAdjustments",
     "crdr": "debit",
     "calculation": {
      "http://sharpstechnology.com/role/ScheduleOfReconciliationOfFederalStatutoryRateToTotalEffectiveRateDetails": {
       "parentTag": "us-gaap_IncomeTaxExpenseBenefit",
       "weight": 1.0,
       "order": 4.0
      }
     },
     "presentation": [
      "http://sharpstechnology.com/role/ScheduleOfReconciliationOfFederalStatutoryRateToTotalEffectiveRateDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other",
        "documentation": "Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to other adjustments."
       }
      }
     },
     "auth_ref": [
      "r688",
      "r814",
      "r815"
     ]
    },
    "us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "IncomeTaxReconciliationStateAndLocalIncomeTaxes",
     "crdr": "debit",
     "calculation": {
      "http://sharpstechnology.com/role/ScheduleOfReconciliationOfFederalStatutoryRateToTotalEffectiveRateDetails": {
       "parentTag": "us-gaap_IncomeTaxExpenseBenefit",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://sharpstechnology.com/role/ScheduleOfReconciliationOfFederalStatutoryRateToTotalEffectiveRateDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "State and local taxes, net of federal tax benefit",
        "documentation": "Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to state and local income tax expense (benefit)."
       }
      }
     },
     "auth_ref": [
      "r404",
      "r688",
      "r814"
     ]
    },
    "us-gaap_IncomeTaxesPaidNet": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "IncomeTaxesPaidNet",
     "crdr": "credit",
     "presentation": [
      "http://sharpstechnology.com/role/StatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cash paid for taxes",
        "documentation": "Amount, after refund, of cash paid to foreign, federal, state, and local jurisdictions as income tax."
       }
      }
     },
     "auth_ref": [
      "r29",
      "r194",
      "r416",
      "r417"
     ]
    },
    "us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "IncreaseDecreaseInAccountsPayableAndAccruedLiabilities",
     "crdr": "debit",
     "calculation": {
      "http://sharpstechnology.com/role/StatementsOfCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0,
       "order": 18.0
      }
     },
     "presentation": [
      "http://sharpstechnology.com/role/StatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Accounts payable and accrued liabilities",
        "documentation": "The increase (decrease) during the reporting period in the amounts payable to vendors for goods and services received and the amount of obligations and expenses incurred but not paid."
       }
      }
     },
     "auth_ref": [
      "r8"
     ]
    },
    "us-gaap_IncreaseDecreaseInInventories": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "IncreaseDecreaseInInventories",
     "crdr": "credit",
     "calculation": {
      "http://sharpstechnology.com/role/StatementsOfCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0,
       "order": 16.0
      }
     },
     "presentation": [
      "http://sharpstechnology.com/role/StatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Inventory",
        "label": "Increase (Decrease) in Inventories",
        "documentation": "The increase (decrease) during the reporting period in the aggregate value of all inventory held by the reporting entity, associated with underlying transactions that are classified as operating activities."
       }
      }
     },
     "auth_ref": [
      "r8"
     ]
    },
    "us-gaap_IncreaseDecreaseInOperatingCapitalAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "IncreaseDecreaseInOperatingCapitalAbstract",
     "presentation": [
      "http://sharpstechnology.com/role/StatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Changes in operating assets:"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_IncreaseDecreaseInOtherOperatingAssets": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "IncreaseDecreaseInOtherOperatingAssets",
     "crdr": "credit",
     "calculation": {
      "http://sharpstechnology.com/role/StatementsOfCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0,
       "order": 17.0
      }
     },
     "presentation": [
      "http://sharpstechnology.com/role/StatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Other assets",
        "label": "Increase (Decrease) in Other Operating Assets",
        "documentation": "Amount of increase (decrease) in operating assets classified as other."
       }
      }
     },
     "auth_ref": [
      "r8"
     ]
    },
    "us-gaap_IncreaseDecreaseInPrepaidExpense": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "IncreaseDecreaseInPrepaidExpense",
     "crdr": "credit",
     "calculation": {
      "http://sharpstechnology.com/role/StatementsOfCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0,
       "order": 15.0
      }
     },
     "presentation": [
      "http://sharpstechnology.com/role/StatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Prepaid expenses and other current assets",
        "label": "Increase (Decrease) in Prepaid Expense",
        "documentation": "The increase (decrease) during the reporting period in the amount of outstanding money paid in advance for goods or services that bring economic benefits for future periods."
       }
      }
     },
     "auth_ref": [
      "r8"
     ]
    },
    "STSS_InducementAgreementMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://sharpstechnology.com/20240930",
     "localname": "InducementAgreementMember",
     "presentation": [
      "http://sharpstechnology.com/role/StockholdersEquityDetailsNarrative",
      "http://sharpstechnology.com/role/WarrantLiabilityDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Inducement Agreement [Member]",
        "documentation": "Inducement Agreement [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "STSS_InducementWarrantsMayTwoThousandTwentyFourMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://sharpstechnology.com/20240930",
     "localname": "InducementWarrantsMayTwoThousandTwentyFourMember",
     "presentation": [
      "http://sharpstechnology.com/role/ScheduleOfWarrantOutstandingDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Inducement Warrants - May 2024 [Member]",
        "documentation": "Inducement Warrants - May 2024 [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "STSS_InducementWarrantsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://sharpstechnology.com/20240930",
     "localname": "InducementWarrantsMember",
     "presentation": [
      "http://sharpstechnology.com/role/ScheduleOfWarrantLiabilityDetails",
      "http://sharpstechnology.com/role/StockholdersEquityDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Inducement Warrants [Member]",
        "documentation": "Inducement Warrants [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "STSS_InitialFee": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://sharpstechnology.com/20240930",
     "localname": "InitialFee",
     "crdr": "debit",
     "presentation": [
      "http://sharpstechnology.com/role/CommitmentsAndContingenciesDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Initial fee",
        "documentation": "Initial fee."
       }
      }
     },
     "auth_ref": []
    },
    "STSS_InjectEZLLCMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://sharpstechnology.com/20240930",
     "localname": "InjectEZLLCMember",
     "presentation": [
      "http://sharpstechnology.com/role/CommitmentsAndContingenciesDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "InjectEZ, LLC [Member]",
        "documentation": "InjectEZ, LLC [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_IntangibleAssetsFiniteLivedPolicy": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "IntangibleAssetsFiniteLivedPolicy",
     "presentation": [
      "http://sharpstechnology.com/role/SummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Purchased Identified Intangible Assets",
        "documentation": "Disclosure of accounting policy for finite-lived intangible assets. This accounting policy also might address: (1) the amortization method used; (2) the useful lives of such assets; and (3) how the entity assesses and measures impairment of such assets."
       }
      }
     },
     "auth_ref": [
      "r502",
      "r503",
      "r504",
      "r506",
      "r665",
      "r770"
     ]
    },
    "us-gaap_IntangibleAssetsNetExcludingGoodwill": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "IntangibleAssetsNetExcludingGoodwill",
     "crdr": "debit",
     "calculation": {
      "http://sharpstechnology.com/role/ScheduleOfOtherAssetsDetails": {
       "parentTag": "us-gaap_OtherAssetsNoncurrent",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://sharpstechnology.com/role/ScheduleOfOtherAssetsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Intangibles, net \u2013 See Note 6",
        "documentation": "Sum of the carrying amounts of all intangible assets, excluding goodwill, as of the balance sheet date, net of accumulated amortization and impairment charges."
       }
      }
     },
     "auth_ref": [
      "r256",
      "r771",
      "r772"
     ]
    },
    "us-gaap_InterestExpense": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "InterestExpense",
     "crdr": "debit",
     "presentation": [
      "http://sharpstechnology.com/role/NotePurchaseAgreementDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Interest expense",
        "documentation": "Amount of interest expense classified as operating and nonoperating. Includes, but is not limited to, cost of borrowing accounted for as interest expense."
       }
      }
     },
     "auth_ref": [
      "r230",
      "r234",
      "r237",
      "r239",
      "r242",
      "r480",
      "r670",
      "r671"
     ]
    },
    "us-gaap_InterestIncomeExpenseNet": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "InterestIncomeExpenseNet",
     "crdr": "credit",
     "calculation": {
      "http://sharpstechnology.com/role/StatementsOfOperations": {
       "parentTag": "us-gaap_NonoperatingIncomeExpense",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://sharpstechnology.com/role/StatementsOfOperations"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Interest income (expense)",
        "documentation": "Amount of interest income (expense) classified as operating."
       }
      }
     },
     "auth_ref": [
      "r507",
      "r764"
     ]
    },
    "us-gaap_InterestPaidNet": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "InterestPaidNet",
     "crdr": "credit",
     "presentation": [
      "http://sharpstechnology.com/role/StatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cash paid for interest",
        "documentation": "Amount of cash paid for interest, excluding capitalized interest, classified as operating activity. Includes, but is not limited to, payment to settle zero-coupon bond for accreted interest of debt discount and debt instrument with insignificant coupon interest rate in relation to effective interest rate of borrowing attributable to accreted interest of debt discount."
       }
      }
     },
     "auth_ref": [
      "r190",
      "r192",
      "r193"
     ]
    },
    "us-gaap_InterestPayableCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "InterestPayableCurrent",
     "crdr": "credit",
     "presentation": [
      "http://sharpstechnology.com/role/NotePurchaseAgreementDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Accreted interest",
        "documentation": "Carrying value as of the balance sheet date of [accrued] interest payable on all forms of debt, including trade payables, that has been incurred and is unpaid. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer)."
       }
      }
     },
     "auth_ref": [
      "r73"
     ]
    },
    "us-gaap_InventoryDisclosureAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "InventoryDisclosureAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Inventory Disclosure [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_InventoryDisclosureTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "InventoryDisclosureTextBlock",
     "presentation": [
      "http://sharpstechnology.com/role/Inventories"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Inventories",
        "documentation": "The entire disclosure for inventory. Includes, but is not limited to, the basis of stating inventory, the method of determining inventory cost, the classes of inventory, and the nature of the cost elements included in inventory."
       }
      }
     },
     "auth_ref": [
      "r253"
     ]
    },
    "us-gaap_InventoryFinishedGoodsNetOfReserves": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "InventoryFinishedGoodsNetOfReserves",
     "crdr": "debit",
     "calculation": {
      "http://sharpstechnology.com/role/ScheduleOfInventoriesDetails": {
       "parentTag": "us-gaap_InventoryNet",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://sharpstechnology.com/role/ScheduleOfInventoriesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Finished goods",
        "documentation": "Carrying amount, net of valuation reserves and adjustments, as of the balance sheet date of merchandise or goods held by the company that are readily available for sale."
       }
      }
     },
     "auth_ref": [
      "r106",
      "r661"
     ]
    },
    "us-gaap_InventoryNet": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "InventoryNet",
     "crdr": "debit",
     "calculation": {
      "http://sharpstechnology.com/role/BalanceSheets": {
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0,
       "order": 3.0
      },
      "http://sharpstechnology.com/role/ScheduleOfInventoriesDetails": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://sharpstechnology.com/role/BalanceSheets",
      "http://sharpstechnology.com/role/ScheduleOfInventoriesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Inventories, net (Note 3)",
        "totalLabel": "Total",
        "documentation": "Amount after valuation and LIFO reserves of inventory expected to be sold, or consumed within one year or operating cycle, if longer."
       }
      }
     },
     "auth_ref": [
      "r176",
      "r660",
      "r698"
     ]
    },
    "us-gaap_InventoryPolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "InventoryPolicyTextBlock",
     "presentation": [
      "http://sharpstechnology.com/role/SummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Inventories",
        "label": "Inventory, Policy [Policy Text Block]",
        "documentation": "Disclosure of inventory accounting policy for inventory classes, including, but not limited to, basis for determining inventory amounts, methods by which amounts are added and removed from inventory classes, loss recognition on impairment of inventories, and situations in which inventories are stated above cost."
       }
      }
     },
     "auth_ref": [
      "r149",
      "r164",
      "r175",
      "r253",
      "r254",
      "r255",
      "r501",
      "r666"
     ]
    },
    "us-gaap_InventoryRawMaterialsNetOfReserves": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "InventoryRawMaterialsNetOfReserves",
     "crdr": "debit",
     "calculation": {
      "http://sharpstechnology.com/role/ScheduleOfInventoriesDetails": {
       "parentTag": "us-gaap_InventoryNet",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://sharpstechnology.com/role/ScheduleOfInventoriesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Raw materials",
        "documentation": "Carrying amount, net of valuation reserves and adjustments, as of the balance sheet date of unprocessed items to be consumed in the manufacturing or production process."
       }
      }
     },
     "auth_ref": [
      "r106",
      "r663"
     ]
    },
    "us-gaap_InventoryWorkInProcessNetOfReserves": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "InventoryWorkInProcessNetOfReserves",
     "crdr": "debit",
     "calculation": {
      "http://sharpstechnology.com/role/ScheduleOfInventoriesDetails": {
       "parentTag": "us-gaap_InventoryNet",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://sharpstechnology.com/role/ScheduleOfInventoriesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Work in process",
        "documentation": "Carrying amount, net of reserves and adjustments, as of the balance sheet date of merchandise or goods which are partially completed. This inventory is generally comprised of raw materials, labor and factory overhead costs, which require further materials, labor and overhead to be converted into finished goods, and which generally require the use of estimates to determine percentage complete and pricing."
       }
      }
     },
     "auth_ref": [
      "r106",
      "r662"
     ]
    },
    "STSS_InvestorsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://sharpstechnology.com/20240930",
     "localname": "InvestorsMember",
     "presentation": [
      "http://sharpstechnology.com/role/StockholdersEquityDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Investors [Member]",
        "documentation": "Investors [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "STSS_IpoIssuanceCostsRelatingToWarrants": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://sharpstechnology.com/20240930",
     "localname": "IpoIssuanceCostsRelatingToWarrants",
     "crdr": "debit",
     "calculation": {
      "http://sharpstechnology.com/role/StatementsOfCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0,
       "order": 13.0
      }
     },
     "presentation": [
      "http://sharpstechnology.com/role/StatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "IPO issuance costs relating to warrants",
        "documentation": "IPO issuance cost relating to warrants."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_IssuanceOfStockAndWarrantsForServicesOrClaims": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "IssuanceOfStockAndWarrantsForServicesOrClaims",
     "crdr": "debit",
     "calculation": {
      "http://sharpstechnology.com/role/StatementsOfCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0,
       "order": 4.0
      }
     },
     "presentation": [
      "http://sharpstechnology.com/role/StatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Issuance of common stock for services",
        "label": "Issuance of Stock and Warrants for Services or Claims",
        "documentation": "Fair value of share-based compensation granted to nonemployees as payment for services rendered or acknowledged claims."
       }
      }
     },
     "auth_ref": [
      "r9"
     ]
    },
    "us-gaap_LandMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "LandMember",
     "presentation": [
      "http://sharpstechnology.com/role/ScheduleOfFixedAssetsNetDetails",
      "http://sharpstechnology.com/role/ScheduleOfPropertyPlantAndEquipmentDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Land [Member]",
        "documentation": "Part of earth's surface not covered by water."
       }
      }
     },
     "auth_ref": [
      "r787"
     ]
    },
    "us-gaap_LegalFees": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "LegalFees",
     "crdr": "debit",
     "presentation": [
      "http://sharpstechnology.com/role/StockholdersEquityDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Placement agent fees",
        "documentation": "The amount of expense provided in the period for legal costs incurred on or before the balance sheet date pertaining to resolved, pending or threatened litigation, including arbitration and mediation proceedings."
       }
      }
     },
     "auth_ref": [
      "r738"
     ]
    },
    "us-gaap_Liabilities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "Liabilities",
     "crdr": "credit",
     "calculation": {
      "http://sharpstechnology.com/role/BalanceSheets": {
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://sharpstechnology.com/role/BalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Total Liabilities",
        "label": "Liabilities [Default Label]",
        "documentation": "Amount of liability recognized for present obligation requiring transfer or otherwise providing economic benefit to others."
       }
      }
     },
     "auth_ref": [
      "r18",
      "r72",
      "r73",
      "r74",
      "r76",
      "r77",
      "r78",
      "r79",
      "r199",
      "r250",
      "r289",
      "r290",
      "r291",
      "r292",
      "r293",
      "r294",
      "r295",
      "r296",
      "r297",
      "r439",
      "r440",
      "r441",
      "r465",
      "r582",
      "r668",
      "r710",
      "r782",
      "r850",
      "r851"
     ]
    },
    "us-gaap_LiabilitiesAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "LiabilitiesAbstract",
     "presentation": [
      "http://sharpstechnology.com/role/BalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Liabilities:"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_LiabilitiesAndStockholdersEquity": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "LiabilitiesAndStockholdersEquity",
     "crdr": "credit",
     "calculation": {
      "http://sharpstechnology.com/role/BalanceSheets": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://sharpstechnology.com/role/BalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "TOTAL LIABILITIES AND STOCKHOLDERS\u2019 EQUITY",
        "label": "Liabilities and Equity",
        "documentation": "Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any."
       }
      }
     },
     "auth_ref": [
      "r86",
      "r137",
      "r520",
      "r698",
      "r755",
      "r769",
      "r842"
     ]
    },
    "us-gaap_LiabilitiesCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "LiabilitiesCurrent",
     "crdr": "credit",
     "calculation": {
      "http://sharpstechnology.com/role/BalanceSheets": {
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://sharpstechnology.com/role/BalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Total Current Liabilities",
        "label": "Liabilities, Current",
        "documentation": "Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer."
       }
      }
     },
     "auth_ref": [
      "r74",
      "r163",
      "r199",
      "r250",
      "r289",
      "r290",
      "r291",
      "r292",
      "r293",
      "r294",
      "r295",
      "r296",
      "r297",
      "r439",
      "r440",
      "r441",
      "r465",
      "r698",
      "r782",
      "r850",
      "r851"
     ]
    },
    "us-gaap_LiabilitiesCurrentAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "LiabilitiesCurrentAbstract",
     "presentation": [
      "http://sharpstechnology.com/role/BalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Current Liabilities"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_LiabilitiesFairValueDisclosure": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "LiabilitiesFairValueDisclosure",
     "crdr": "credit",
     "presentation": [
      "http://sharpstechnology.com/role/ScheduleOfAssetsAndLiabilitiesMeasuredAtFairValueOnRecurringBasisDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Total liabilities measured at fair value",
        "documentation": "Fair value of financial and nonfinancial obligations."
       }
      }
     },
     "auth_ref": [
      "r454",
      "r828"
     ]
    },
    "us-gaap_LiabilitiesFairValueDisclosureAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "LiabilitiesFairValueDisclosureAbstract",
     "presentation": [
      "http://sharpstechnology.com/role/ScheduleOfAssetsAndLiabilitiesMeasuredAtFairValueOnRecurringBasisDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Liabilities"
       }
      }
     },
     "auth_ref": []
    },
    "srt_LitigationCaseAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/srt/2024",
     "localname": "LitigationCaseAxis",
     "presentation": [
      "http://sharpstechnology.com/role/CommitmentsAndContingenciesDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Litigation Case [Axis]"
       }
      }
     },
     "auth_ref": []
    },
    "srt_LitigationCaseTypeDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/srt/2024",
     "localname": "LitigationCaseTypeDomain",
     "presentation": [
      "http://sharpstechnology.com/role/CommitmentsAndContingenciesDetailsNarrative"
     ],
     "auth_ref": []
    },
    "dei_LocalPhoneNumber": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "LocalPhoneNumber",
     "presentation": [
      "http://sharpstechnology.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Local Phone Number",
        "documentation": "Local phone number for entity."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_LossContingenciesLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "LossContingenciesLineItems",
     "presentation": [
      "http://sharpstechnology.com/role/CommitmentsAndContingenciesDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Loss Contingencies [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": [
      "r281",
      "r282",
      "r283",
      "r286",
      "r390",
      "r674",
      "r780",
      "r781"
     ]
    },
    "us-gaap_LossContingenciesTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "LossContingenciesTable",
     "presentation": [
      "http://sharpstechnology.com/role/CommitmentsAndContingenciesDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Loss Contingencies [Table]",
        "documentation": "Disclosure of information about loss contingency. Excludes environmental contingency, warranty, and unconditional purchase obligation."
       }
      }
     },
     "auth_ref": [
      "r281",
      "r282",
      "r283",
      "r286",
      "r390",
      "r674",
      "r780",
      "r781"
     ]
    },
    "us-gaap_LossContingencyDamagesSought": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "LossContingencyDamagesSought",
     "presentation": [
      "http://sharpstechnology.com/role/CommitmentsAndContingenciesDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Description of loss contingency",
        "documentation": "Describes the form and magnitude of the award the plaintiff seeks in the legal matter, which may include an unspecified amount of money."
       }
      }
     },
     "auth_ref": [
      "r41",
      "r42",
      "r112"
     ]
    },
    "us-gaap_LossContingencyDamagesSoughtValue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "LossContingencyDamagesSoughtValue",
     "crdr": "debit",
     "presentation": [
      "http://sharpstechnology.com/role/CommitmentsAndContingenciesDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Loss contingency, claims for damages",
        "documentation": "The value (monetary amount) of the award the plaintiff seeks in the legal matter."
       }
      }
     },
     "auth_ref": [
      "r779",
      "r780",
      "r781"
     ]
    },
    "us-gaap_MachineryAndEquipmentMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "MachineryAndEquipmentMember",
     "presentation": [
      "http://sharpstechnology.com/role/AssetAcquisitionDetailsNarrative",
      "http://sharpstechnology.com/role/FixedAssetsDetailsNarrative",
      "http://sharpstechnology.com/role/ScheduleOfFixedAssetsNetDetails",
      "http://sharpstechnology.com/role/ScheduleOfPropertyPlantAndEquipmentDetails",
      "http://sharpstechnology.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Machinery and Equipment [Member]",
        "documentation": "Tangible personal property used to produce goods and services, including, but is not limited to, tools, dies and molds, computer and office equipment."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_MarketRiskBenefitChangeInFairValueGainLoss": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "MarketRiskBenefitChangeInFairValueGainLoss",
     "crdr": "credit",
     "presentation": [
      "http://sharpstechnology.com/role/StockholdersEquityDetailsNarrative",
      "http://sharpstechnology.com/role/WarrantLiabilityDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fair market value adjustment",
        "documentation": "Amount of gain (loss) from (increase) decrease in fair value of contract or contract feature in long-duration contract issued by insurance entity that both protects contract holder from other-than-nominal capital market risk and exposes insurance entity to other-than-nominal capital market risk. Excludes change attributable to instrument-specific credit risk."
       }
      }
     },
     "auth_ref": [
      "r531"
     ]
    },
    "srt_MaximumMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/srt/2024",
     "localname": "MaximumMember",
     "presentation": [
      "http://sharpstechnology.com/role/AssetAcquisitionDetailsNarrative",
      "http://sharpstechnology.com/role/ScheduleOfFairValueOfStockOptionAwardsDetails",
      "http://sharpstechnology.com/role/ScheduleOfFairValueOfWarrantDetails",
      "http://sharpstechnology.com/role/ScheduleOfInformationAboutOptionsOutstandingDetails",
      "http://sharpstechnology.com/role/StockOptionsDetailsNarrative",
      "http://sharpstechnology.com/role/StockholdersEquityDetailsNarrative",
      "http://sharpstechnology.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Maximum [Member]"
       }
      }
     },
     "auth_ref": [
      "r282",
      "r283",
      "r284",
      "r285",
      "r351",
      "r390",
      "r457",
      "r500",
      "r532",
      "r534",
      "r542",
      "r574",
      "r575",
      "r634",
      "r635",
      "r636",
      "r637",
      "r646",
      "r656",
      "r657",
      "r672",
      "r680",
      "r686",
      "r693",
      "r694",
      "r695",
      "r696",
      "r699",
      "r784",
      "r852",
      "r853",
      "r854",
      "r855",
      "r856",
      "r857"
     ]
    },
    "us-gaap_MeasurementInputExpectedDividendRateMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "MeasurementInputExpectedDividendRateMember",
     "presentation": [
      "http://sharpstechnology.com/role/ScheduleOfFairValueOfWarrantDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Measurement Input, Expected Dividend Rate [Member]",
        "documentation": "Measurement input using expected dividend rate to be paid to holder of share per year."
       }
      }
     },
     "auth_ref": [
      "r830",
      "r831",
      "r832"
     ]
    },
    "us-gaap_MeasurementInputExpectedTermMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "MeasurementInputExpectedTermMember",
     "presentation": [
      "http://sharpstechnology.com/role/ScheduleOfFairValueOfWarrantDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Measurement Input, Expected Term [Member]",
        "documentation": "Measurement input using period financial instrument is expected to be outstanding. Excludes maturity date."
       }
      }
     },
     "auth_ref": [
      "r830",
      "r831",
      "r832"
     ]
    },
    "us-gaap_MeasurementInputOptionVolatilityMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "MeasurementInputOptionVolatilityMember",
     "presentation": [
      "http://sharpstechnology.com/role/ScheduleOfFairValueOfWarrantDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Measurement Input, Option Volatility [Member]",
        "documentation": "Measurement input using rate at which price of option increases (decreases) for given set of returns."
       }
      }
     },
     "auth_ref": [
      "r830",
      "r831",
      "r832"
     ]
    },
    "us-gaap_MeasurementInputRiskFreeInterestRateMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "MeasurementInputRiskFreeInterestRateMember",
     "presentation": [
      "http://sharpstechnology.com/role/ScheduleOfFairValueOfWarrantDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Measurement Input, Risk Free Interest Rate [Member]",
        "documentation": "Measurement input using interest rate on instrument with zero risk of financial loss."
       }
      }
     },
     "auth_ref": [
      "r830",
      "r831",
      "r832"
     ]
    },
    "us-gaap_MeasurementInputTypeAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "MeasurementInputTypeAxis",
     "presentation": [
      "http://sharpstechnology.com/role/ScheduleOfFairValueOfWarrantDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Measurement Input Type [Axis]",
        "documentation": "Information by type of measurement input used to determine value of asset and liability."
       }
      }
     },
     "auth_ref": [
      "r455",
      "r456",
      "r457",
      "r693"
     ]
    },
    "us-gaap_MeasurementInputTypeDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "MeasurementInputTypeDomain",
     "presentation": [
      "http://sharpstechnology.com/role/ScheduleOfFairValueOfWarrantDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Measurement input used to determine value of asset and liability."
       }
      }
     },
     "auth_ref": [
      "r455",
      "r456",
      "r457",
      "r693"
     ]
    },
    "STSS_MedicalBenefitsCost": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://sharpstechnology.com/20240930",
     "localname": "MedicalBenefitsCost",
     "crdr": "debit",
     "presentation": [
      "http://sharpstechnology.com/role/CommitmentsAndContingenciesDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Medical benefit cost",
        "documentation": "Medical benefits cost."
       }
      }
     },
     "auth_ref": []
    },
    "srt_MinimumMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/srt/2024",
     "localname": "MinimumMember",
     "presentation": [
      "http://sharpstechnology.com/role/AssetAcquisitionDetailsNarrative",
      "http://sharpstechnology.com/role/ScheduleOfFairValueOfStockOptionAwardsDetails",
      "http://sharpstechnology.com/role/ScheduleOfFairValueOfWarrantDetails",
      "http://sharpstechnology.com/role/ScheduleOfInformationAboutOptionsOutstandingDetails",
      "http://sharpstechnology.com/role/StockOptionsDetailsNarrative",
      "http://sharpstechnology.com/role/StockholdersEquityDetailsNarrative",
      "http://sharpstechnology.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Minimum [Member]"
       }
      }
     },
     "auth_ref": [
      "r282",
      "r283",
      "r284",
      "r285",
      "r351",
      "r390",
      "r457",
      "r500",
      "r532",
      "r534",
      "r542",
      "r574",
      "r575",
      "r634",
      "r635",
      "r636",
      "r637",
      "r646",
      "r656",
      "r657",
      "r672",
      "r680",
      "r686",
      "r693",
      "r694",
      "r695",
      "r699",
      "r784",
      "r852",
      "r853",
      "r854",
      "r855",
      "r856",
      "r857"
     ]
    },
    "STSS_MonthlyFee": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://sharpstechnology.com/20240930",
     "localname": "MonthlyFee",
     "crdr": "debit",
     "presentation": [
      "http://sharpstechnology.com/role/CommitmentsAndContingenciesDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Monthly fee",
        "documentation": "Monthly fee."
       }
      }
     },
     "auth_ref": []
    },
    "STSS_Mr.BlackmanMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://sharpstechnology.com/20240930",
     "localname": "Mr.BlackmanMember",
     "presentation": [
      "http://sharpstechnology.com/role/CommitmentsAndContingenciesDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Mr. Blackman [Member]",
        "documentation": "Mr. Blackman [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_NetCashProvidedByUsedInFinancingActivities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "NetCashProvidedByUsedInFinancingActivities",
     "crdr": "debit",
     "calculation": {
      "http://sharpstechnology.com/role/StatementsOfCashFlows": {
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://sharpstechnology.com/role/StatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Net cash provided by financing activities",
        "label": "Net Cash Provided by (Used in) Financing Activities",
        "documentation": "Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit."
       }
      }
     },
     "auth_ref": [
      "r191"
     ]
    },
    "us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "NetCashProvidedByUsedInFinancingActivitiesAbstract",
     "presentation": [
      "http://sharpstechnology.com/role/StatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "CASH FLOWS FROM FINANCING ACTIVITIES:"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_NetCashProvidedByUsedInInvestingActivities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "NetCashProvidedByUsedInInvestingActivities",
     "crdr": "debit",
     "calculation": {
      "http://sharpstechnology.com/role/StatementsOfCashFlows": {
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://sharpstechnology.com/role/StatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Net cash used in investing activities",
        "label": "Net Cash Provided by (Used in) Investing Activities",
        "documentation": "Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets."
       }
      }
     },
     "auth_ref": [
      "r191"
     ]
    },
    "us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "NetCashProvidedByUsedInInvestingActivitiesAbstract",
     "presentation": [
      "http://sharpstechnology.com/role/StatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "CASH FLOWS FROM INVESTING ACTIVITIES:"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_NetCashProvidedByUsedInOperatingActivities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "NetCashProvidedByUsedInOperatingActivities",
     "calculation": {
      "http://sharpstechnology.com/role/StatementsOfCashFlows": {
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://sharpstechnology.com/role/StatementsOfCashFlows",
      "http://sharpstechnology.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Net cash used in operating activities",
        "negatedLabel": "Cash in operations",
        "label": "Net Cash Provided by (Used in) Operating Activities",
        "documentation": "Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities."
       }
      }
     },
     "auth_ref": [
      "r100",
      "r101",
      "r102"
     ]
    },
    "us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "NetCashProvidedByUsedInOperatingActivitiesAbstract",
     "presentation": [
      "http://sharpstechnology.com/role/StatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "CASH FLOWS FROM OPERATING ACTIVITIES:"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_NetIncomeLoss": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "NetIncomeLoss",
     "crdr": "credit",
     "calculation": {
      "http://sharpstechnology.com/role/StatementsOfComprehensiveLoss": {
       "parentTag": "us-gaap_ComprehensiveIncomeNetOfTax",
       "weight": 1.0,
       "order": 1.0
      },
      "http://sharpstechnology.com/role/StatementsOfCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0,
       "order": 1.0
      },
      "http://sharpstechnology.com/role/StatementsOfOperations": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://sharpstechnology.com/role/StatementOfStockholdersEquity",
      "http://sharpstechnology.com/role/StatementsOfCashFlows",
      "http://sharpstechnology.com/role/StatementsOfComprehensiveLoss",
      "http://sharpstechnology.com/role/StatementsOfOperations"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Net Loss",
        "label": "Net loss",
        "documentation": "The portion of profit or loss for the period, net of income taxes, which is attributable to the parent."
       }
      }
     },
     "auth_ref": [
      "r92",
      "r102",
      "r141",
      "r161",
      "r180",
      "r182",
      "r187",
      "r199",
      "r207",
      "r209",
      "r210",
      "r211",
      "r212",
      "r213",
      "r216",
      "r217",
      "r223",
      "r250",
      "r289",
      "r290",
      "r291",
      "r292",
      "r293",
      "r294",
      "r295",
      "r296",
      "r297",
      "r431",
      "r436",
      "r451",
      "r465",
      "r525",
      "r605",
      "r625",
      "r626",
      "r708",
      "r782"
     ]
    },
    "STSS_NetProceedsFromInitialPublicOfferingAndAdditionalOffering": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://sharpstechnology.com/20240930",
     "localname": "NetProceedsFromInitialPublicOfferingAndAdditionalOffering",
     "crdr": "debit",
     "calculation": {
      "http://sharpstechnology.com/role/StatementsOfCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://sharpstechnology.com/role/StatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net proceeds from Initial Public Offering and additional offerings",
        "documentation": "Net proceeds from Initial Public Offering and additional offering."
       }
      }
     },
     "auth_ref": []
    },
    "STSS_NetProceedsFromIssuanceInitialPublicOffering": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://sharpstechnology.com/20240930",
     "localname": "NetProceedsFromIssuanceInitialPublicOffering",
     "crdr": "debit",
     "presentation": [
      "http://sharpstechnology.com/role/StockholdersEquityDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net proceeds from offering",
        "documentation": "Net proceeds from issuance initial public offering."
       }
      }
     },
     "auth_ref": []
    },
    "STSS_NetProceedsFromOfferingsAndWarrantExercises": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://sharpstechnology.com/20240930",
     "localname": "NetProceedsFromOfferingsAndWarrantExercises",
     "crdr": "debit",
     "calculation": {
      "http://sharpstechnology.com/role/StatementsOfCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://sharpstechnology.com/role/StatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net proceeds from offerings and warrant exercises",
        "documentation": "Net proceeds from offerings and warrant exercises."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "NewAccountingPronouncementsPolicyPolicyTextBlock",
     "presentation": [
      "http://sharpstechnology.com/role/SummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Recent Accounting Pronouncements",
        "documentation": "Disclosure of accounting policy pertaining to new accounting pronouncements that may impact the entity's financial reporting. Includes, but is not limited to, quantification of the expected or actual impact."
       }
      }
     },
     "auth_ref": []
    },
    "dei_NoTradingSymbolFlag": {
     "xbrltype": "trueItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "NoTradingSymbolFlag",
     "presentation": [
      "http://sharpstechnology.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "No Trading Symbol Flag",
        "documentation": "Boolean flag that is true only for a security having no trading symbol."
       }
      }
     },
     "auth_ref": []
    },
    "STSS_NonTradingWarrantsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://sharpstechnology.com/20240930",
     "localname": "NonTradingWarrantsMember",
     "presentation": [
      "http://sharpstechnology.com/role/StockholdersEquityDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Non Trading Warrants [Member]",
        "documentation": "Non Trading Warrants [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_NoncashInvestingAndFinancingItemsAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "NoncashInvestingAndFinancingItemsAbstract",
     "presentation": [
      "http://sharpstechnology.com/role/StatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Non-cash investing and financing activity:"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_NoninterestExpenseOfferingCost": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "NoninterestExpenseOfferingCost",
     "crdr": "debit",
     "presentation": [
      "http://sharpstechnology.com/role/StockholdersEquityDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offering expenses",
        "documentation": "Includes offering costs of open-end investment companies, and closed-end funds with a continuous offering period."
       }
      }
     },
     "auth_ref": [
      "r139"
     ]
    },
    "us-gaap_NonoperatingIncomeExpense": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "NonoperatingIncomeExpense",
     "crdr": "credit",
     "calculation": {
      "http://sharpstechnology.com/role/StatementsOfOperations": {
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://sharpstechnology.com/role/StatementsOfOperations"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Total other income (expense)",
        "label": "Nonoperating Income (Expense)",
        "documentation": "The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business)."
       }
      }
     },
     "auth_ref": [
      "r95"
     ]
    },
    "us-gaap_NonoperatingIncomeExpenseAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "NonoperatingIncomeExpenseAbstract",
     "presentation": [
      "http://sharpstechnology.com/role/StatementsOfOperations"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other income (expense)"
       }
      }
     },
     "auth_ref": []
    },
    "STSS_NotExpireMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://sharpstechnology.com/20240930",
     "localname": "NotExpireMember",
     "presentation": [
      "http://sharpstechnology.com/role/IncomeTaxesDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "No Expire [Member]",
        "documentation": "No Expire [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "STSS_NotePurchaseAgreementMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://sharpstechnology.com/20240930",
     "localname": "NotePurchaseAgreementMember",
     "presentation": [
      "http://sharpstechnology.com/role/NotePurchaseAgreementDetailsNarrative",
      "http://sharpstechnology.com/role/StockholdersEquityDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Note Purchase Agreement [Member]",
        "documentation": "Note Purchase Agreement [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "STSS_NotePurchaseAgreementTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://sharpstechnology.com/20240930",
     "localname": "NotePurchaseAgreementTextBlock",
     "presentation": [
      "http://sharpstechnology.com/role/NotePurchaseAgreement"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Note Purchase Agreement",
        "documentation": "Note Purchase Agreement [Text Block]",
        "label": "Note Purchase Agreement [Text Block]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_NoteWarrantMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "NoteWarrantMember",
     "presentation": [
      "http://sharpstechnology.com/role/NotePurchaseAgreementDetailsNarrative",
      "http://sharpstechnology.com/role/StockholdersEquityDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Note Warrant [Member]",
        "documentation": "A note that entitles the holder to buy stock of the company at a specified price, which is much higher than the stock price at the time of issue."
       }
      }
     },
     "auth_ref": []
    },
    "STSS_NoteWarrantsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://sharpstechnology.com/20240930",
     "localname": "NoteWarrantsMember",
     "presentation": [
      "http://sharpstechnology.com/role/ScheduleOfWarrantLiabilityDetails",
      "http://sharpstechnology.com/role/ScheduleOfWarrantOutstandingDetails",
      "http://sharpstechnology.com/role/StockholdersEquityDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Note Warrants [Member]",
        "documentation": "Note Warrants [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_NotesPayable": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "NotesPayable",
     "crdr": "credit",
     "presentation": [
      "http://sharpstechnology.com/role/NotePurchaseAgreementDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Notes payable",
        "documentation": "Including the current and noncurrent portions, aggregate carrying amount of all types of notes payable, as of the balance sheet date, with initial maturities beyond one year or beyond the normal operating cycle, if longer."
       }
      }
     },
     "auth_ref": [
      "r18",
      "r135",
      "r860",
      "r861"
     ]
    },
    "us-gaap_NotesPayableCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "NotesPayableCurrent",
     "crdr": "credit",
     "calculation": {
      "http://sharpstechnology.com/role/BalanceSheets": {
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://sharpstechnology.com/role/BalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Notes Payable (Note 7)",
        "documentation": "Sum of the carrying values as of the balance sheet date of the portions of long-term notes payable due within one year or the operating cycle if longer."
       }
      }
     },
     "auth_ref": [
      "r72",
      "r73"
     ]
    },
    "STSS_NumberOfUnregisteredCommonStockIssuedDuringPostReverseShares": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://sharpstechnology.com/20240930",
     "localname": "NumberOfUnregisteredCommonStockIssuedDuringPostReverseShares",
     "presentation": [
      "http://sharpstechnology.com/role/DebtFinancingDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Number of unregistered common stock issued during post reverse shares",
        "documentation": "Number of unregistered common stock issued during post reverse shares."
       }
      }
     },
     "auth_ref": []
    },
    "STSS_NumberOfUnregisteredCommonStockIssuedDuringPreReverseShares": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://sharpstechnology.com/20240930",
     "localname": "NumberOfUnregisteredCommonStockIssuedDuringPreReverseShares",
     "presentation": [
      "http://sharpstechnology.com/role/DebtFinancingDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Pre reverse",
        "documentation": "Number of unregistered common stock issued during pre reverse shares."
       }
      }
     },
     "auth_ref": []
    },
    "STSS_OfferingWarrantsFebruaryTwentyTwentyThreeMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://sharpstechnology.com/20240930",
     "localname": "OfferingWarrantsFebruaryTwentyTwentyThreeMember",
     "presentation": [
      "http://sharpstechnology.com/role/ScheduleOfWarrantLiabilityDetails",
      "http://sharpstechnology.com/role/ScheduleOfWarrantOutstandingDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offering Warrants - February 2023 [Member]",
        "documentation": "Offering Warrants - February 2023 [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "STSS_OfferingWarrantsFebruaryTwoThousandTwentyThreeMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://sharpstechnology.com/20240930",
     "localname": "OfferingWarrantsFebruaryTwoThousandTwentyThreeMember",
     "presentation": [
      "http://sharpstechnology.com/role/ScheduleOfWarrantLiabilityDetails",
      "http://sharpstechnology.com/role/ScheduleOfWarrantOutstandingDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Offering Warrants - February 2023 [Member]",
        "documentation": "Offering Warrants - February 2023 [Member]",
        "label": "Offering Warrants - February 2023 [Member] [Default Label]"
       }
      }
     },
     "auth_ref": []
    },
    "STSS_OfferingWarrantsSeptemberTwentyTwentyThreeMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://sharpstechnology.com/20240930",
     "localname": "OfferingWarrantsSeptemberTwentyTwentyThreeMember",
     "presentation": [
      "http://sharpstechnology.com/role/ScheduleOfWarrantLiabilityDetails",
      "http://sharpstechnology.com/role/ScheduleOfWarrantOutstandingDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offering Warrants - September 2023 [Member]",
        "documentation": "Offering Warrants - September 2023 [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "STSS_OfferingWarrantsSeptemberTwoThousandTwentyThreeMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://sharpstechnology.com/20240930",
     "localname": "OfferingWarrantsSeptemberTwoThousandTwentyThreeMember",
     "presentation": [
      "http://sharpstechnology.com/role/ScheduleOfWarrantLiabilityDetails",
      "http://sharpstechnology.com/role/ScheduleOfWarrantOutstandingDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Offering Warrants - September 2023 [Member]",
        "documentation": "Offering Warrants - September 2023 [Member]",
        "label": "Offering Warrants - September 2023 [Member] [Default Label]"
       }
      }
     },
     "auth_ref": []
    },
    "STSS_OfficersAndDirectorsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://sharpstechnology.com/20240930",
     "localname": "OfficersAndDirectorsMember",
     "presentation": [
      "http://sharpstechnology.com/role/RelatedPartyTransactionsAndBalancesDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Officers and Directors [Member]",
        "documentation": "Officers and Directors [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_OperatingCostsAndExpenses": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "OperatingCostsAndExpenses",
     "crdr": "debit",
     "presentation": [
      "http://sharpstechnology.com/role/AssetAcquisitionDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Operating costs",
        "documentation": "Generally recurring costs associated with normal operations except for the portion of these expenses which can be clearly related to production and included in cost of sales or services. Excludes Selling, General and Administrative Expense."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_OperatingExpenses": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "OperatingExpenses",
     "crdr": "debit",
     "calculation": {
      "http://sharpstechnology.com/role/StatementsOfOperations": {
       "parentTag": "us-gaap_OperatingIncomeLoss",
       "weight": -1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://sharpstechnology.com/role/StatementsOfOperations"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Total operating expenses",
        "label": "Operating Expenses",
        "documentation": "Generally recurring costs associated with normal operations except for the portion of these expenses which can be clearly related to production and included in cost of sales or services. Includes selling, general and administrative expense."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_OperatingExpensesAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "OperatingExpensesAbstract",
     "presentation": [
      "http://sharpstechnology.com/role/StatementsOfOperations"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Operating expenses:"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_OperatingIncomeLoss": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "OperatingIncomeLoss",
     "crdr": "credit",
     "calculation": {
      "http://sharpstechnology.com/role/StatementsOfOperations": {
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://sharpstechnology.com/role/StatementsOfOperations"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Loss from operations",
        "label": "Operating Income (Loss)",
        "documentation": "The net result for the period of deducting operating expenses from operating revenues."
       }
      }
     },
     "auth_ref": [
      "r144",
      "r669",
      "r763",
      "r764",
      "r765",
      "r766",
      "r767"
     ]
    },
    "us-gaap_OperatingLossCarryforwards": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "OperatingLossCarryforwards",
     "crdr": "debit",
     "presentation": [
      "http://sharpstechnology.com/role/IncomeTaxesDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net operating loss carryforwards",
        "documentation": "Amount of operating loss carryforward, before tax effects, available to reduce future taxable income under enacted tax laws."
       }
      }
     },
     "auth_ref": [
      "r418"
     ]
    },
    "STSS_OrderCostsToPurchaseEquipmentMoldsAndComponentPartsForResearchAndDevelopment": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://sharpstechnology.com/20240930",
     "localname": "OrderCostsToPurchaseEquipmentMoldsAndComponentPartsForResearchAndDevelopment",
     "crdr": "credit",
     "presentation": [
      "http://sharpstechnology.com/role/CommitmentsAndContingenciesDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Total order costs to purchase equipment, molds and component parts for research and development",
        "documentation": "Order costs to purchase equipment molds and component parts for research and development."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_OtherAssetsDisclosureTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "OtherAssetsDisclosureTextBlock",
     "presentation": [
      "http://sharpstechnology.com/role/OtherAssets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Assets",
        "documentation": "The entire disclosure for other assets. This disclosure includes other current assets and other noncurrent assets."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_OtherAssetsMiscellaneousNoncurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "OtherAssetsMiscellaneousNoncurrent",
     "crdr": "debit",
     "calculation": {
      "http://sharpstechnology.com/role/ScheduleOfOtherAssetsDetails": {
       "parentTag": "us-gaap_OtherAssetsNoncurrent",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://sharpstechnology.com/role/ScheduleOfOtherAssetsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other \u2013 See Note 7",
        "documentation": "Amount of other miscellaneous assets expected to be realized or consumed after one year or normal operating cycle, if longer."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_OtherAssetsNoncurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "OtherAssetsNoncurrent",
     "crdr": "debit",
     "calculation": {
      "http://sharpstechnology.com/role/BalanceSheets": {
       "parentTag": "us-gaap_Assets",
       "weight": 1.0,
       "order": 3.0
      },
      "http://sharpstechnology.com/role/ScheduleOfOtherAssetsDetails": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://sharpstechnology.com/role/BalanceSheets",
      "http://sharpstechnology.com/role/ScheduleOfOtherAssetsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Assets (Notes 6 and 7)",
        "totalLabel": "Total Other assets",
        "documentation": "Amount of noncurrent assets classified as other."
       }
      }
     },
     "auth_ref": [
      "r168"
     ]
    },
    "us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent",
     "crdr": "credit",
     "calculation": {
      "http://sharpstechnology.com/role/StatementsOfComprehensiveLoss": {
       "parentTag": "us-gaap_ComprehensiveIncomeNetOfTax",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://sharpstechnology.com/role/StatementsOfComprehensiveLoss"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Foreign currency translation adjustments gain/(loss)",
        "documentation": "Amount after tax and reclassification adjustments of gain (loss) on foreign currency translation adjustments, foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature, attributable to parent entity."
       }
      }
     },
     "auth_ref": [
      "r7",
      "r11",
      "r126"
     ]
    },
    "us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax",
     "crdr": "debit",
     "presentation": [
      "http://sharpstechnology.com/role/StatementOfStockholdersEquity"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Foreign Currency Translation",
        "documentation": "Amount of tax expense (benefit), after reclassification adjustments of gain (loss) on foreign currency translation adjustments, foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature."
       }
      }
     },
     "auth_ref": [
      "r4",
      "r5",
      "r470",
      "r477"
     ]
    },
    "us-gaap_OtherComprehensiveIncomeLossTaxAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "OtherComprehensiveIncomeLossTaxAbstract",
     "presentation": [
      "http://sharpstechnology.com/role/StatementsOfComprehensiveLoss"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other comprehensive income:"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_OtherExpenses": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "OtherExpenses",
     "crdr": "debit",
     "presentation": [
      "http://sharpstechnology.com/role/StockholdersEquityDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other offering expenses",
        "documentation": "Amount of expense classified as other."
       }
      }
     },
     "auth_ref": [
      "r93",
      "r94"
     ]
    },
    "us-gaap_OtherNonoperatingIncomeExpense": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "OtherNonoperatingIncomeExpense",
     "crdr": "credit",
     "calculation": {
      "http://sharpstechnology.com/role/StatementsOfOperations": {
       "parentTag": "us-gaap_NonoperatingIncomeExpense",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://sharpstechnology.com/role/StatementsOfOperations"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other (expense) income (Note 15)",
        "documentation": "Amount of income (expense) related to nonoperating activities, classified as other."
       }
      }
     },
     "auth_ref": [
      "r97"
     ]
    },
    "dei_OtherReportingStandardItemNumber": {
     "xbrltype": "otherReportingStandardItemNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "OtherReportingStandardItemNumber",
     "presentation": [
      "http://sharpstechnology.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Reporting Standard Item Number",
        "documentation": "\"Item 17\" or \"Item 18\" specified when the basis of accounting is neither US GAAP nor IFRS."
       }
      }
     },
     "auth_ref": [
      "r724"
     ]
    },
    "us-gaap_OverAllotmentOptionMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "OverAllotmentOptionMember",
     "presentation": [
      "http://sharpstechnology.com/role/StockholdersEquityDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Over-Allotment Option [Member]",
        "documentation": "Right given to the underwriter to sell additional shares over the initial allotment."
       }
      }
     },
     "auth_ref": []
    },
    "STSS_OverAllotmentWarrantsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://sharpstechnology.com/20240930",
     "localname": "OverAllotmentWarrantsMember",
     "presentation": [
      "http://sharpstechnology.com/role/StockholdersEquityDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Over-Allotment Warrants [Member]",
        "documentation": "Over-Allotment Warrants [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "STSS_PIPEPreFundedWarrantsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://sharpstechnology.com/20240930",
     "localname": "PIPEPreFundedWarrantsMember",
     "presentation": [
      "http://sharpstechnology.com/role/StockholdersEquityDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "PIPE Pre Funded Warrants [Member]",
        "documentation": "PIPE Pre Funded Warrants [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "STSS_PIPEWarrantMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://sharpstechnology.com/20240930",
     "localname": "PIPEWarrantMember",
     "presentation": [
      "http://sharpstechnology.com/role/StockholdersEquityDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "PIPE Warrant [Member]",
        "documentation": "PIPE Warrant [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "STSS_PaymentForBonuses": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://sharpstechnology.com/20240930",
     "localname": "PaymentForBonuses",
     "crdr": "credit",
     "presentation": [
      "http://sharpstechnology.com/role/CommitmentsAndContingenciesDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Payment for bonuses",
        "documentation": "Payment for bonuses."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_PaymentForIncentiveFee": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "PaymentForIncentiveFee",
     "crdr": "credit",
     "presentation": [
      "http://sharpstechnology.com/role/CommitmentsAndContingenciesDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Payment for incentive fee",
        "documentation": "Amount paid for incentive rights held by the managing member or general partner, of limited liability company (LLC) or limited partnership (LP)."
       }
      }
     },
     "auth_ref": [
      "r751",
      "r848"
     ]
    },
    "us-gaap_PaymentsForProceedsFromOtherInvestingActivities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "PaymentsForProceedsFromOtherInvestingActivities",
     "crdr": "credit",
     "calculation": {
      "http://sharpstechnology.com/role/StatementsOfCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": -1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://sharpstechnology.com/role/StatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Acquisition of fixed assets or deposits paid",
        "label": "Payments for (Proceeds from) Other Investing Activities",
        "documentation": "Amount of cash (inflow) outflow from investing activities classified as other."
       }
      }
     },
     "auth_ref": [
      "r737",
      "r748"
     ]
    },
    "STSS_PaymentsForRepurchaseOfLiability": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://sharpstechnology.com/20240930",
     "localname": "PaymentsForRepurchaseOfLiability",
     "crdr": "credit",
     "presentation": [
      "http://sharpstechnology.com/role/StockholdersEquityDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Warrant outstanding",
        "documentation": "Payments for repurchase of liability."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_PaymentsOfDebtIssuanceCosts": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "PaymentsOfDebtIssuanceCosts",
     "crdr": "credit",
     "presentation": [
      "http://sharpstechnology.com/role/NotePurchaseAgreementDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Debt issuance costs",
        "documentation": "The cash outflow paid to third parties in connection with debt origination, which will be amortized over the remaining maturity period of the associated long-term debt."
       }
      }
     },
     "auth_ref": [
      "r26"
     ]
    },
    "us-gaap_PaymentsOfStockIssuanceCosts": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "PaymentsOfStockIssuanceCosts",
     "crdr": "credit",
     "presentation": [
      "http://sharpstechnology.com/role/StockholdersEquityDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Nominal cost",
        "documentation": "The cash outflow for cost incurred directly with the issuance of an equity security."
       }
      }
     },
     "auth_ref": [
      "r25"
     ]
    },
    "us-gaap_PaymentsToAcquireBusinessesGross": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "PaymentsToAcquireBusinessesGross",
     "crdr": "credit",
     "presentation": [
      "http://sharpstechnology.com/role/AssetAcquisitionDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Consideration paid in cash",
        "documentation": "The cash outflow associated with the acquisition of business during the period. The cash portion only of the acquisition price."
       }
      }
     },
     "auth_ref": [
      "r23",
      "r434"
     ]
    },
    "us-gaap_PaymentsToAcquireMachineryAndEquipment": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "PaymentsToAcquireMachineryAndEquipment",
     "crdr": "credit",
     "presentation": [
      "http://sharpstechnology.com/role/FixedAssetsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Acquisition of machinery",
        "documentation": "The cash outflow for acquisition of machinery and equipment."
       }
      }
     },
     "auth_ref": [
      "r98"
     ]
    },
    "us-gaap_PaymentsToAcquireProductiveAssets": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "PaymentsToAcquireProductiveAssets",
     "crdr": "credit",
     "presentation": [
      "http://sharpstechnology.com/role/CommitmentsAndContingenciesDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Payments to acquire assets",
        "documentation": "The cash outflow for purchases of and capital improvements on property, plant and equipment (capital expenditures), software, and other intangible assets."
       }
      }
     },
     "auth_ref": [
      "r146",
      "r824",
      "r825",
      "r826"
     ]
    },
    "us-gaap_PaymentsToAcquirePropertyPlantAndEquipment": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "PaymentsToAcquirePropertyPlantAndEquipment",
     "crdr": "credit",
     "calculation": {
      "http://sharpstechnology.com/role/StatementsOfCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": -1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://sharpstechnology.com/role/StatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Purchase of fixed assets",
        "label": "Payments to Acquire Property, Plant, and Equipment",
        "documentation": "The cash outflow associated with the acquisition of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale; includes cash outflows to pay for construction of self-constructed assets."
       }
      }
     },
     "auth_ref": [
      "r98"
     ]
    },
    "STSS_PaymentsToAssetAcquisition": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://sharpstechnology.com/20240930",
     "localname": "PaymentsToAssetAcquisition",
     "crdr": "credit",
     "calculation": {
      "http://sharpstechnology.com/role/StatementsOfCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": -1.0,
       "order": 4.0
      }
     },
     "presentation": [
      "http://sharpstechnology.com/role/StatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Asset acquisition",
        "documentation": "Payments to asset acquisition.",
        "label": "PaymentsToAssetAcquisition"
       }
      }
     },
     "auth_ref": []
    },
    "STSS_PlacementAgentAndOtherOfferingExpenses": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://sharpstechnology.com/20240930",
     "localname": "PlacementAgentAndOtherOfferingExpenses",
     "crdr": "debit",
     "presentation": [
      "http://sharpstechnology.com/role/DebtFinancingDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Closing costs",
        "documentation": "Placement agent and other offering expenses."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_PlanNameAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "PlanNameAxis",
     "presentation": [
      "http://sharpstechnology.com/role/StockOptionsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Plan Name [Axis]",
        "documentation": "Information by plan name for share-based payment arrangement."
       }
      }
     },
     "auth_ref": [
      "r788",
      "r789",
      "r790",
      "r791",
      "r792",
      "r793",
      "r794",
      "r795",
      "r796",
      "r797",
      "r798",
      "r799",
      "r800",
      "r801",
      "r802",
      "r803",
      "r804",
      "r805",
      "r806",
      "r807",
      "r808",
      "r809",
      "r810",
      "r811",
      "r812",
      "r813"
     ]
    },
    "us-gaap_PlanNameDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "PlanNameDomain",
     "presentation": [
      "http://sharpstechnology.com/role/StockOptionsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Plan name for share-based payment arrangement."
       }
      }
     },
     "auth_ref": [
      "r788",
      "r789",
      "r790",
      "r791",
      "r792",
      "r793",
      "r794",
      "r795",
      "r796",
      "r797",
      "r798",
      "r799",
      "r800",
      "r801",
      "r802",
      "r803",
      "r804",
      "r805",
      "r806",
      "r807",
      "r808",
      "r809",
      "r810",
      "r811",
      "r812",
      "r813"
     ]
    },
    "STSS_PlastomoldMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://sharpstechnology.com/20240930",
     "localname": "PlastomoldMember",
     "presentation": [
      "http://sharpstechnology.com/role/CommitmentsAndContingenciesDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Plastomold [Member]",
        "documentation": "Plastomold [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "dei_PreCommencementIssuerTenderOffer": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "PreCommencementIssuerTenderOffer",
     "presentation": [
      "http://sharpstechnology.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Pre-commencement Issuer Tender Offer",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r718"
     ]
    },
    "dei_PreCommencementTenderOffer": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "PreCommencementTenderOffer",
     "presentation": [
      "http://sharpstechnology.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Pre-commencement Tender Offer",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r720"
     ]
    },
    "STSS_PreFundedWarrantsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://sharpstechnology.com/20240930",
     "localname": "PreFundedWarrantsMember",
     "presentation": [
      "http://sharpstechnology.com/role/StockholdersEquityDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Pre-funded Warrants [Member]",
        "documentation": "Pre-funded Warrants [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "STSS_PreReverseMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://sharpstechnology.com/20240930",
     "localname": "PreReverseMember",
     "presentation": [
      "http://sharpstechnology.com/role/DebtFinancingDetailsNarrative",
      "http://sharpstechnology.com/role/StockholdersEquityDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Pre Reverse [Member]",
        "documentation": "Pre Reverse [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_PreferredStockMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "PreferredStockMember",
     "presentation": [
      "http://sharpstechnology.com/role/StatementOfStockholdersEquity"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Preferred Stock [Member]",
        "documentation": "Preferred shares may provide a preferential dividend to the dividend on common stock and may take precedence over common stock in the event of a liquidation. Preferred shares typically represent an ownership interest in the company."
       }
      }
     },
     "auth_ref": [
      "r700",
      "r701",
      "r704",
      "r705",
      "r706",
      "r707",
      "r864",
      "r868"
     ]
    },
    "us-gaap_PreferredStockParOrStatedValuePerShare": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "PreferredStockParOrStatedValuePerShare",
     "presentation": [
      "http://sharpstechnology.com/role/BalanceSheetsParenthetical",
      "http://sharpstechnology.com/role/StockholdersEquityDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Preferred stock, par value",
        "documentation": "Face amount or stated value per share of preferred stock nonredeemable or redeemable solely at the option of the issuer."
       }
      }
     },
     "auth_ref": [
      "r80",
      "r325"
     ]
    },
    "us-gaap_PreferredStockSharesAuthorized": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "PreferredStockSharesAuthorized",
     "presentation": [
      "http://sharpstechnology.com/role/BalanceSheetsParenthetical",
      "http://sharpstechnology.com/role/StockholdersEquityDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Preferred stock, shares authorized",
        "documentation": "The maximum number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) permitted to be issued by an entity's charter and bylaws."
       }
      }
     },
     "auth_ref": [
      "r80",
      "r584"
     ]
    },
    "us-gaap_PreferredStockSharesIssued": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "PreferredStockSharesIssued",
     "presentation": [
      "http://sharpstechnology.com/role/BalanceSheetsParenthetical"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Preferred stock, shares issued",
        "documentation": "Number of shares issued for nonredeemable preferred shares and preferred shares redeemable solely at option of issuer. Includes, but is not limited to, preferred shares issued, repurchased, and held as treasury shares. Excludes preferred shares classified as debt."
       }
      }
     },
     "auth_ref": [
      "r80",
      "r325"
     ]
    },
    "us-gaap_PreferredStockSharesOutstanding": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "PreferredStockSharesOutstanding",
     "presentation": [
      "http://sharpstechnology.com/role/BalanceSheetsParenthetical"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Preferred stock, shares outstanding",
        "documentation": "Aggregate share number for all nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer) held by stockholders. Does not include preferred shares that have been repurchased."
       }
      }
     },
     "auth_ref": [
      "r80",
      "r584",
      "r603",
      "r868",
      "r869"
     ]
    },
    "us-gaap_PreferredStockTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "PreferredStockTextBlock",
     "presentation": [
      "http://sharpstechnology.com/role/PreferredStock"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Preferred Stock",
        "documentation": "The entire disclosure for terms, amounts, nature of changes, rights and privileges, dividends, and other matters related to preferred stock."
       }
      }
     },
     "auth_ref": [
      "r115"
     ]
    },
    "us-gaap_PreferredStockValue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "PreferredStockValue",
     "crdr": "credit",
     "calculation": {
      "http://sharpstechnology.com/role/BalanceSheets": {
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://sharpstechnology.com/role/BalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Preferred stock, $.0001 par value; 1,000,000 shares authorized; 0 shares issued and outstanding (2023: 1)",
        "documentation": "Aggregate par or stated value of issued nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable preferred shares, par value and other disclosure concepts are in another section within stockholders' equity."
       }
      }
     },
     "auth_ref": [
      "r80",
      "r516",
      "r698"
     ]
    },
    "us-gaap_PreferredStockVotingRights": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "PreferredStockVotingRights",
     "presentation": [
      "http://sharpstechnology.com/role/PreferredStockDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Preferred stock, voting rights",
        "documentation": "Description of voting rights of nonredeemable preferred stock. Includes eligibility to vote and votes per share owned. Include also, if any, unusual voting rights."
       }
      }
     },
     "auth_ref": [
      "r46",
      "r80"
     ]
    },
    "STSS_PrefundendWarrantsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://sharpstechnology.com/20240930",
     "localname": "PrefundendWarrantsMember",
     "presentation": [
      "http://sharpstechnology.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Prefundend Warrants [Member]",
        "documentation": "Prefundend Warrants [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_PrepaidExpenseAndOtherAssetsCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "PrepaidExpenseAndOtherAssetsCurrent",
     "crdr": "debit",
     "calculation": {
      "http://sharpstechnology.com/role/BalanceSheets": {
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://sharpstechnology.com/role/BalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Prepaid expenses and other current assets",
        "documentation": "Amount of asset related to consideration paid in advance for costs that provide economic benefits in future periods, and amount of other assets that are expected to be realized or consumed within one year or the normal operating cycle, if longer."
       }
      }
     },
     "auth_ref": [
      "r743"
     ]
    },
    "us-gaap_PrivatePlacementMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "PrivatePlacementMember",
     "presentation": [
      "http://sharpstechnology.com/role/StockholdersEquityDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Private Placement [Member]",
        "documentation": "A private placement is a direct offering of securities to a limited number of sophisticated investors such as insurance companies, pension funds, mezzanine funds, stock funds and trusts."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ProceedsFromIssuanceInitialPublicOffering": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ProceedsFromIssuanceInitialPublicOffering",
     "crdr": "debit",
     "presentation": [
      "http://sharpstechnology.com/role/DescriptionOfBusinessDetailsNarrative",
      "http://sharpstechnology.com/role/StockholdersEquityDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Initial public offering",
        "verboseLabel": "Net proceeds from IPO",
        "documentation": "The cash inflow associated with the amount received from entity's first offering of stock to the public."
       }
      }
     },
     "auth_ref": [
      "r6"
     ]
    },
    "us-gaap_ProceedsFromIssuanceOfCommonStock": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ProceedsFromIssuanceOfCommonStock",
     "crdr": "debit",
     "presentation": [
      "http://sharpstechnology.com/role/StockholdersEquityDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Gross proceeds",
        "documentation": "The cash inflow from the additional capital contribution to the entity."
       }
      }
     },
     "auth_ref": [
      "r6"
     ]
    },
    "us-gaap_ProceedsFromIssuanceOfDebt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ProceedsFromIssuanceOfDebt",
     "crdr": "debit",
     "presentation": [
      "http://sharpstechnology.com/role/DebtFinancingDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Proceeds from Issuance of Debt",
        "documentation": "The cash inflow during the period from additional borrowings in aggregate debt. Includes proceeds from short-term and long-term debt."
       }
      }
     },
     "auth_ref": [
      "r749"
     ]
    },
    "us-gaap_ProceedsFromIssuanceOfLongTermDebt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ProceedsFromIssuanceOfLongTermDebt",
     "crdr": "debit",
     "calculation": {
      "http://sharpstechnology.com/role/StatementsOfCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://sharpstechnology.com/role/StatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net proceeds from Debt financing",
        "documentation": "The cash inflow from a debt initially having maturity due after one year or beyond the operating cycle, if longer."
       }
      }
     },
     "auth_ref": [
      "r24",
      "r545"
     ]
    },
    "us-gaap_ProceedsFromIssuanceOfPrivatePlacement": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ProceedsFromIssuanceOfPrivatePlacement",
     "crdr": "debit",
     "presentation": [
      "http://sharpstechnology.com/role/StockholdersEquityDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net proceeds from the Private Placement",
        "documentation": "The cash inflow associated with the amount received from entity's raising of capital via private rather than public placement."
       }
      }
     },
     "auth_ref": [
      "r6"
     ]
    },
    "us-gaap_ProceedsFromIssuanceOfWarrants": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ProceedsFromIssuanceOfWarrants",
     "crdr": "debit",
     "presentation": [
      "http://sharpstechnology.com/role/StockholdersEquityDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Proceeds from Issuance of Warrants",
        "documentation": "The cash inflow from issuance of rights to purchase common shares at predetermined price (usually issued together with corporate debt)."
       }
      }
     },
     "auth_ref": [
      "r6"
     ]
    },
    "us-gaap_ProceedsFromIssuanceOrSaleOfEquity": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ProceedsFromIssuanceOrSaleOfEquity",
     "crdr": "debit",
     "presentation": [
      "http://sharpstechnology.com/role/StockholdersEquityDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Net proceeds from offering",
        "label": "Proceeds from Issuance or Sale of Equity",
        "documentation": "The cash inflow from the issuance of common stock, preferred stock, treasury stock, stock options, and other types of equity."
       }
      }
     },
     "auth_ref": [
      "r6",
      "r545"
     ]
    },
    "STSS_ProceedsFromSubscriptionsReceivable": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://sharpstechnology.com/20240930",
     "localname": "ProceedsFromSubscriptionsReceivable",
     "crdr": "debit",
     "calculation": {
      "http://sharpstechnology.com/role/StatementsOfCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0,
       "order": 5.0
      }
     },
     "presentation": [
      "http://sharpstechnology.com/role/StatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Proceeds from subscriptions receivable",
        "documentation": "Proceeds from subscriptions receivable."
       }
      }
     },
     "auth_ref": []
    },
    "STSS_ProgressPayments": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://sharpstechnology.com/20240930",
     "localname": "ProgressPayments",
     "crdr": "credit",
     "presentation": [
      "http://sharpstechnology.com/role/CommitmentsAndContingenciesDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Progress payments",
        "documentation": "Progress payments."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_PropertyPlantAndEquipmentAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "PropertyPlantAndEquipmentAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Property, Plant and Equipment [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_PropertyPlantAndEquipmentByTypeAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "PropertyPlantAndEquipmentByTypeAxis",
     "presentation": [
      "http://sharpstechnology.com/role/AssetAcquisitionDetailsNarrative",
      "http://sharpstechnology.com/role/FixedAssetsDetailsNarrative",
      "http://sharpstechnology.com/role/ScheduleOfFixedAssetsNetDetails",
      "http://sharpstechnology.com/role/ScheduleOfPropertyPlantAndEquipmentDetails",
      "http://sharpstechnology.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Long-Lived Tangible Asset [Axis]",
        "documentation": "Information by type of long-lived, physical assets used to produce goods and services and not intended for resale."
       }
      }
     },
     "auth_ref": [
      "r10",
      "r485"
     ]
    },
    "us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "PropertyPlantAndEquipmentDisclosureTextBlock",
     "presentation": [
      "http://sharpstechnology.com/role/FixedAssets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fixed Assets",
        "documentation": "The entire disclosure for long-lived, physical asset used in normal conduct of business and not intended for resale. Includes, but is not limited to, work of art, historical treasure, and similar asset classified as collections."
       }
      }
     },
     "auth_ref": [
      "r107",
      "r152",
      "r155",
      "r156"
     ]
    },
    "us-gaap_PropertyPlantAndEquipmentGross": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "PropertyPlantAndEquipmentGross",
     "crdr": "debit",
     "calculation": {
      "http://sharpstechnology.com/role/ScheduleOfPropertyPlantAndEquipmentDetails": {
       "parentTag": "us-gaap_PropertyPlantAndEquipmentNet",
       "weight": 1.0,
       "order": 1.0
      },
      "http://sharpstechnology.com/role/ScheduleOfFixedAssetsNetDetails": {
       "parentTag": "us-gaap_PropertyPlantAndEquipmentNet",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://sharpstechnology.com/role/ScheduleOfFixedAssetsNetDetails",
      "http://sharpstechnology.com/role/ScheduleOfPropertyPlantAndEquipmentDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Total Fixed Assets",
        "verboseLabel": "Total Fixed Assets",
        "documentation": "Amount before accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures."
       }
      }
     },
     "auth_ref": [
      "r108",
      "r166",
      "r523"
     ]
    },
    "us-gaap_PropertyPlantAndEquipmentLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "PropertyPlantAndEquipmentLineItems",
     "presentation": [
      "http://sharpstechnology.com/role/FixedAssetsDetailsNarrative",
      "http://sharpstechnology.com/role/ScheduleOfFixedAssetsNetDetails",
      "http://sharpstechnology.com/role/ScheduleOfPropertyPlantAndEquipmentDetails",
      "http://sharpstechnology.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Property, Plant and Equipment [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": [
      "r485"
     ]
    },
    "us-gaap_PropertyPlantAndEquipmentNet": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "PropertyPlantAndEquipmentNet",
     "crdr": "debit",
     "calculation": {
      "http://sharpstechnology.com/role/BalanceSheets": {
       "parentTag": "us-gaap_Assets",
       "weight": 1.0,
       "order": 2.0
      },
      "http://sharpstechnology.com/role/ScheduleOfPropertyPlantAndEquipmentDetails": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      },
      "http://sharpstechnology.com/role/ScheduleOfFixedAssetsNetDetails": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://sharpstechnology.com/role/BalanceSheets",
      "http://sharpstechnology.com/role/ScheduleOfFixedAssetsNetDetails",
      "http://sharpstechnology.com/role/ScheduleOfPropertyPlantAndEquipmentDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fixed Assets, net of accumulated depreciation (Notes 4 and 5)",
        "totalLabel": "Fixed asset, net",
        "documentation": "Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures."
       }
      }
     },
     "auth_ref": [
      "r10",
      "r485",
      "r511",
      "r523",
      "r698"
     ]
    },
    "us-gaap_PropertyPlantAndEquipmentPolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "PropertyPlantAndEquipmentPolicyTextBlock",
     "presentation": [
      "http://sharpstechnology.com/role/SummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Fixed Assets",
        "label": "Property, Plant and Equipment, Policy [Policy Text Block]",
        "documentation": "Disclosure of accounting policy for long-lived, physical asset used in normal conduct of business and not intended for resale. Includes, but is not limited to, work of art, historical treasure, and similar asset classified as collections."
       }
      }
     },
     "auth_ref": [
      "r10",
      "r152",
      "r155",
      "r521"
     ]
    },
    "us-gaap_PropertyPlantAndEquipmentTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "PropertyPlantAndEquipmentTextBlock",
     "presentation": [
      "http://sharpstechnology.com/role/FixedAssetsTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule of Fixed Assets, Net",
        "documentation": "Tabular disclosure of physical assets used in the normal conduct of business and not intended for resale. Includes, but is not limited to, balances by class of assets, depreciation and depletion expense and method used, including composite depreciation, and accumulated deprecation."
       }
      }
     },
     "auth_ref": [
      "r10"
     ]
    },
    "us-gaap_PropertyPlantAndEquipmentTypeDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "PropertyPlantAndEquipmentTypeDomain",
     "presentation": [
      "http://sharpstechnology.com/role/AssetAcquisitionDetailsNarrative",
      "http://sharpstechnology.com/role/FixedAssetsDetailsNarrative",
      "http://sharpstechnology.com/role/ScheduleOfFixedAssetsNetDetails",
      "http://sharpstechnology.com/role/ScheduleOfPropertyPlantAndEquipmentDetails",
      "http://sharpstechnology.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Listing of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale. Examples include land, buildings, machinery and equipment, and other types of furniture and equipment including, but not limited to, office equipment, furniture and fixtures, and computer equipment and software."
       }
      }
     },
     "auth_ref": [
      "r108",
      "r485"
     ]
    },
    "us-gaap_PropertyPlantAndEquipmentUsefulLife": {
     "xbrltype": "durationItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "PropertyPlantAndEquipmentUsefulLife",
     "presentation": [
      "http://sharpstechnology.com/role/AssetAcquisitionDetailsNarrative",
      "http://sharpstechnology.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Property plant and equipment asset useful life",
        "verboseLabel": "Fixed assets acquired, useful lives",
        "documentation": "Useful life of long lived, physical assets used in the normal conduct of business and not intended for resale, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days. Examples include, but not limited to, land, buildings, machinery and equipment, office equipment, furniture and fixtures, and computer equipment."
       }
      }
     },
     "auth_ref": []
    },
    "STSS_PurchaseAgreementMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://sharpstechnology.com/20240930",
     "localname": "PurchaseAgreementMember",
     "presentation": [
      "http://sharpstechnology.com/role/StockholdersEquityDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Purchase Agreement [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "srt_RangeAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/srt/2024",
     "localname": "RangeAxis",
     "presentation": [
      "http://sharpstechnology.com/role/AssetAcquisitionDetailsNarrative",
      "http://sharpstechnology.com/role/ScheduleOfFairValueOfStockOptionAwardsDetails",
      "http://sharpstechnology.com/role/ScheduleOfFairValueOfWarrantDetails",
      "http://sharpstechnology.com/role/ScheduleOfInformationAboutOptionsOutstandingDetails",
      "http://sharpstechnology.com/role/StockOptionsDetailsNarrative",
      "http://sharpstechnology.com/role/StockholdersEquityDetailsNarrative",
      "http://sharpstechnology.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statistical Measurement [Axis]"
       }
      }
     },
     "auth_ref": [
      "r282",
      "r283",
      "r284",
      "r285",
      "r344",
      "r351",
      "r380",
      "r381",
      "r382",
      "r390",
      "r457",
      "r498",
      "r499",
      "r500",
      "r532",
      "r534",
      "r542",
      "r574",
      "r575",
      "r634",
      "r635",
      "r636",
      "r637",
      "r646",
      "r656",
      "r657",
      "r672",
      "r680",
      "r686",
      "r693",
      "r694",
      "r695",
      "r696",
      "r699",
      "r702",
      "r777",
      "r784",
      "r831",
      "r853",
      "r854",
      "r855",
      "r856",
      "r857"
     ]
    },
    "srt_RangeMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/srt/2024",
     "localname": "RangeMember",
     "presentation": [
      "http://sharpstechnology.com/role/AssetAcquisitionDetailsNarrative",
      "http://sharpstechnology.com/role/ScheduleOfFairValueOfStockOptionAwardsDetails",
      "http://sharpstechnology.com/role/ScheduleOfFairValueOfWarrantDetails",
      "http://sharpstechnology.com/role/ScheduleOfInformationAboutOptionsOutstandingDetails",
      "http://sharpstechnology.com/role/StockOptionsDetailsNarrative",
      "http://sharpstechnology.com/role/StockholdersEquityDetailsNarrative",
      "http://sharpstechnology.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative"
     ],
     "auth_ref": [
      "r282",
      "r283",
      "r284",
      "r285",
      "r344",
      "r351",
      "r380",
      "r381",
      "r382",
      "r390",
      "r457",
      "r498",
      "r499",
      "r500",
      "r532",
      "r534",
      "r542",
      "r574",
      "r575",
      "r634",
      "r635",
      "r636",
      "r637",
      "r646",
      "r656",
      "r657",
      "r672",
      "r680",
      "r686",
      "r693",
      "r694",
      "r695",
      "r696",
      "r699",
      "r702",
      "r777",
      "r784",
      "r831",
      "r853",
      "r854",
      "r855",
      "r856",
      "r857"
     ]
    },
    "us-gaap_RelatedPartyTransactionsAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "RelatedPartyTransactionsAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Related Party Transactions [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_RelatedPartyTransactionsDisclosureTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "RelatedPartyTransactionsDisclosureTextBlock",
     "presentation": [
      "http://sharpstechnology.com/role/RelatedPartyTransactionsAndBalances"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Related Party Transactions and Balances",
        "documentation": "The entire disclosure for related party transactions. Examples of related party transactions include transactions between (a) a parent company and its subsidiary; (b) subsidiaries of a common parent; (c) and entity and its principal owners; and (d) affiliates."
       }
      }
     },
     "auth_ref": [
      "r487",
      "r488",
      "r489",
      "r490",
      "r491",
      "r551",
      "r552",
      "r553",
      "r609",
      "r610",
      "r611",
      "r631",
      "r633"
     ]
    },
    "STSS_RemainingPaymentsDueOnMachinery": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://sharpstechnology.com/20240930",
     "localname": "RemainingPaymentsDueOnMachinery",
     "crdr": "credit",
     "presentation": [
      "http://sharpstechnology.com/role/FixedAssetsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Balance due on machinery",
        "documentation": "Remaining payments uue on machinery."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_RepaymentsOfDebt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "RepaymentsOfDebt",
     "crdr": "credit",
     "presentation": [
      "http://sharpstechnology.com/role/NotePurchaseAgreementDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Notes payable",
        "label": "Repayments of Debt",
        "documentation": "Amount of cash outflow for short-term and long-term debt. Excludes payment of lease obligation."
       }
      }
     },
     "auth_ref": [
      "r750"
     ]
    },
    "us-gaap_RepaymentsOfNotesPayable": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "RepaymentsOfNotesPayable",
     "crdr": "credit",
     "calculation": {
      "http://sharpstechnology.com/role/StatementsOfCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0,
       "order": 4.0
      }
     },
     "presentation": [
      "http://sharpstechnology.com/role/StatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Repayment of note payable",
        "label": "Repayments of Notes Payable",
        "documentation": "The cash outflow for a borrowing supported by a written promise to pay an obligation."
       }
      }
     },
     "auth_ref": [
      "r99"
     ]
    },
    "us-gaap_ResearchAndDevelopmentExpense": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ResearchAndDevelopmentExpense",
     "crdr": "debit",
     "calculation": {
      "http://sharpstechnology.com/role/StatementsOfOperations": {
       "parentTag": "us-gaap_OperatingExpenses",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://sharpstechnology.com/role/StatementsOfOperations"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Research and development",
        "documentation": "Amount of expense for research and development. Includes, but is not limited to, cost for computer software product to be sold, leased, or otherwise marketed and writeoff of research and development assets acquired in transaction other than business combination or joint venture formation or both. Excludes write-down of intangible asset acquired in business combination or from joint venture formation or both, used in research and development activity."
       }
      }
     },
     "auth_ref": [
      "r392",
      "r658",
      "r670",
      "r858"
     ]
    },
    "us-gaap_ResearchAndDevelopmentExpenseMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ResearchAndDevelopmentExpenseMember",
     "presentation": [
      "http://sharpstechnology.com/role/StockOptionsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Research and Development Expense [Member]",
        "documentation": "Primary financial statement caption in which the reported facts about research and development expense have been included."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ResearchAndDevelopmentExpensePolicy": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ResearchAndDevelopmentExpensePolicy",
     "presentation": [
      "http://sharpstechnology.com/role/SummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Research and Development Costs",
        "documentation": "Disclosure of accounting policy for costs it has incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process."
       }
      }
     },
     "auth_ref": [
      "r391"
     ]
    },
    "us-gaap_RestructuringCostAndReserveLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "RestructuringCostAndReserveLineItems",
     "presentation": [
      "http://sharpstechnology.com/role/ScheduleOfFairValueOfAssetsAcquisitionDetailsDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Restructuring Cost and Reserve [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": [
      "r272",
      "r273",
      "r274",
      "r275",
      "r276",
      "r277",
      "r278"
     ]
    },
    "us-gaap_RetainedEarningsAccumulatedDeficit": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "RetainedEarningsAccumulatedDeficit",
     "crdr": "credit",
     "calculation": {
      "http://sharpstechnology.com/role/BalanceSheets": {
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0,
       "order": 6.0
      }
     },
     "presentation": [
      "http://sharpstechnology.com/role/BalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Accumulated deficit",
        "documentation": "Amount of accumulated undistributed earnings (deficit)."
       }
      }
     },
     "auth_ref": [
      "r83",
      "r118",
      "r519",
      "r539",
      "r541",
      "r549",
      "r585",
      "r698"
     ]
    },
    "us-gaap_RetainedEarningsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "RetainedEarningsMember",
     "presentation": [
      "http://sharpstechnology.com/role/StatementOfStockholdersEquity"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Retained Earnings [Member]",
        "documentation": "Accumulated undistributed earnings (deficit)."
       }
      }
     },
     "auth_ref": [
      "r160",
      "r204",
      "r205",
      "r206",
      "r208",
      "r213",
      "r215",
      "r217",
      "r251",
      "r252",
      "r264",
      "r420",
      "r421",
      "r428",
      "r429",
      "r430",
      "r432",
      "r435",
      "r436",
      "r442",
      "r444",
      "r445",
      "r447",
      "r449",
      "r483",
      "r484",
      "r536",
      "r538",
      "r554",
      "r868"
     ]
    },
    "us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "RevenueFromContractWithCustomerExcludingAssessedTax",
     "crdr": "credit",
     "calculation": {
      "http://sharpstechnology.com/role/StatementsOfOperations": {
       "parentTag": "us-gaap_OperatingIncomeLoss",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://sharpstechnology.com/role/StatementsOfOperations"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Revenue, net",
        "documentation": "Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise."
       }
      }
     },
     "auth_ref": [
      "r142",
      "r143",
      "r230",
      "r235",
      "r236",
      "r240",
      "r242",
      "r243",
      "r244",
      "r245",
      "r342",
      "r343",
      "r505"
     ]
    },
    "STSS_ReverseStockSplitDescription": {
     "xbrltype": "stringItemType",
     "nsuri": "http://sharpstechnology.com/20240930",
     "localname": "ReverseStockSplitDescription",
     "presentation": [
      "http://sharpstechnology.com/role/DescriptionOfBusinessDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Reverse stock split description",
        "documentation": "Reverse stock split description."
       }
      }
     },
     "auth_ref": []
    },
    "STSS_ReverseStockSplitMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://sharpstechnology.com/20240930",
     "localname": "ReverseStockSplitMember",
     "presentation": [
      "http://sharpstechnology.com/role/BalanceSheets",
      "http://sharpstechnology.com/role/BalanceSheetsParenthetical",
      "http://sharpstechnology.com/role/StatementOfStockholdersEquity",
      "http://sharpstechnology.com/role/StockholdersEquityDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Reverse Stock Split [Member]",
        "documentation": "Reverse Stock Split [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "STSS_RoyaltyAgreementMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://sharpstechnology.com/20240930",
     "localname": "RoyaltyAgreementMember",
     "presentation": [
      "http://sharpstechnology.com/role/CommitmentsAndContingenciesDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Royalty Agreement [Member]",
        "documentation": "Royalty Agreement [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "STSS_RoyaltyPercentage": {
     "xbrltype": "percentItemType",
     "nsuri": "http://sharpstechnology.com/20240930",
     "localname": "RoyaltyPercentage",
     "presentation": [
      "http://sharpstechnology.com/role/CommitmentsAndContingenciesDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Royalty percentage",
        "documentation": "Royalty percentage."
       }
      }
     },
     "auth_ref": []
    },
    "STSS_SafegardMedicalIncMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://sharpstechnology.com/20240930",
     "localname": "SafegardMedicalIncMember",
     "presentation": [
      "http://sharpstechnology.com/role/AssetAcquisitionDetailsNarrative",
      "http://sharpstechnology.com/role/ScheduleOfFairValueOfAssetsAcquisitionDetails",
      "http://sharpstechnology.com/role/ScheduleOfFairValueOfAssetsAcquisitionDetailsDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Safegard Medical, Inc [Member]",
        "documentation": "Safegard Medical, Inc [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_SalariesAndWages": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "SalariesAndWages",
     "crdr": "debit",
     "presentation": [
      "http://sharpstechnology.com/role/CommitmentsAndContingenciesDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Salaries and wages",
        "documentation": "Amount of expense for salary and wage arising from service rendered by nonofficer employee. Excludes allocated cost, labor-related nonsalary expense, and direct and overhead labor cost included in cost of good and service sold."
       }
      }
     },
     "auth_ref": [
      "r747"
     ]
    },
    "us-gaap_SaleOfStockDescriptionOfTransaction": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "SaleOfStockDescriptionOfTransaction",
     "presentation": [
      "http://sharpstechnology.com/role/StockholdersEquityDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Units description",
        "documentation": "Description of stock transaction which may include details of the offering (IPO, private placement), a description of the stock sold, percentage of subsidiary's or equity investee's stock sold, a description of the investors and whether the stock was issued in a business combination."
       }
      }
     },
     "auth_ref": [
      "r12",
      "r61",
      "r127"
     ]
    },
    "us-gaap_SaleOfStockNameOfTransactionDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "SaleOfStockNameOfTransactionDomain",
     "presentation": [
      "http://sharpstechnology.com/role/DescriptionOfBusinessDetailsNarrative",
      "http://sharpstechnology.com/role/NotePurchaseAgreementDetailsNarrative",
      "http://sharpstechnology.com/role/PreferredStockDetailsNarrative",
      "http://sharpstechnology.com/role/ScheduleOfWarrantLiabilityDetails",
      "http://sharpstechnology.com/role/ScheduleOfWarrantOutstandingDetails",
      "http://sharpstechnology.com/role/StockholdersEquityDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sale of the entity's stock, including, but not limited to, initial public offering (IPO) and private placement."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "SaleOfStockNumberOfSharesIssuedInTransaction",
     "presentation": [
      "http://sharpstechnology.com/role/StockholdersEquityDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Number of units sold",
        "documentation": "The number of shares issued or sold by the subsidiary or equity method investee per stock transaction."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_SaleOfStockPricePerShare": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "SaleOfStockPricePerShare",
     "presentation": [
      "http://sharpstechnology.com/role/StockholdersEquityDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Shares price pre reverse",
        "documentation": "Per share amount received by subsidiary or equity investee for each share of common stock issued or sold in the stock transaction."
       }
      }
     },
     "auth_ref": []
    },
    "srt_ScenarioUnspecifiedDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/srt/2024",
     "localname": "ScenarioUnspecifiedDomain",
     "presentation": [
      "http://sharpstechnology.com/role/IncomeTaxesDetailsNarrative"
     ],
     "auth_ref": [
      "r218",
      "r352",
      "r732",
      "r760"
     ]
    },
    "us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ScheduleOfBusinessAcquisitionsByAcquisitionTable",
     "presentation": [
      "http://sharpstechnology.com/role/AssetAcquisitionDetailsNarrative",
      "http://sharpstechnology.com/role/ScheduleOfFairValueOfAssetsAcquisitionDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule of Business Acquisitions, by Acquisition [Table]",
        "documentation": "Disclosure of information about business combination. Includes, but is not limited to, recognized asset and liability."
       }
      }
     },
     "auth_ref": [
      "r57",
      "r58",
      "r433"
     ]
    },
    "us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock",
     "presentation": [
      "http://sharpstechnology.com/role/AssetAcquisitionTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule of Fair Value of Assets Acquisition",
        "documentation": "Tabular disclosure of a material business combination completed during the period, including background, timing, and recognized assets and liabilities. This table does not include leveraged buyouts."
       }
      }
     },
     "auth_ref": [
      "r57",
      "r58"
     ]
    },
    "us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable",
     "presentation": [
      "http://sharpstechnology.com/role/NotePurchaseAgreementDetailsNarrative",
      "http://sharpstechnology.com/role/WarrantLiabilityDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Collaborative Arrangement and Arrangement Other than Collaborative [Table]",
        "documentation": "Disclosure of information about collaborative arrangement and arrangement other than collaborative applicable to revenue-generating activity or operations."
       }
      }
     },
     "auth_ref": [
      "r437"
     ]
    },
    "us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock",
     "presentation": [
      "http://sharpstechnology.com/role/IncomeTaxesTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule of Components of Deferred tax Assets",
        "documentation": "Tabular disclosure of the components of net deferred tax asset or liability recognized in an entity's statement of financial position, including the following: the total of all deferred tax liabilities, the total of all deferred tax assets, the total valuation allowance recognized for deferred tax assets."
       }
      }
     },
     "auth_ref": [
      "r816"
     ]
    },
    "us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock",
     "presentation": [
      "http://sharpstechnology.com/role/IncomeTaxesTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule of Reconciliation of Federal Statutory Rate to Total Effective Rate",
        "documentation": "Tabular disclosure of the reconciliation using percentage or dollar amounts of the reported amount of income tax expense attributable to continuing operations for the year to the amount of income tax expense that would result from applying domestic federal statutory tax rates to pretax income from continuing operations."
       }
      }
     },
     "auth_ref": [
      "r403",
      "r688",
      "r814"
     ]
    },
    "srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/srt/2024",
     "localname": "ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis",
     "presentation": [
      "http://sharpstechnology.com/role/PreferredStockDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Investment, Name [Axis]"
       }
      }
     },
     "auth_ref": [
      "r247",
      "r248",
      "r249",
      "r427",
      "r733",
      "r734",
      "r735",
      "r819",
      "r820",
      "r821",
      "r822"
     ]
    },
    "us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock",
     "presentation": [
      "http://sharpstechnology.com/role/FairValueMeasurementsTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule of Assets and Liabilities Measured at Fair Value on Recurring Basis",
        "documentation": "Tabular disclosure of assets and liabilities, including [financial] instruments measured at fair value that are classified in stockholders' equity, if any, that are measured at fair value on a recurring basis. The disclosures contemplated herein include the fair value measurements at the reporting date by the level within the fair value hierarchy in which the fair value measurements in their entirety fall, segregating fair value measurements using quoted prices in active markets for identical assets (Level 1), significant other observable inputs (Level 2), and significant unobservable inputs (Level 3)."
       }
      }
     },
     "auth_ref": [
      "r828",
      "r829"
     ]
    },
    "us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock",
     "presentation": [
      "http://sharpstechnology.com/role/IncomeTaxesTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule of Geographical Components of Loss Before Income Taxes",
        "documentation": "Tabular disclosure of income before income tax between domestic and foreign jurisdictions."
       }
      }
     },
     "auth_ref": [
      "r756"
     ]
    },
    "us-gaap_ScheduleOfInventoryCurrentTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ScheduleOfInventoryCurrentTableTextBlock",
     "presentation": [
      "http://sharpstechnology.com/role/InventoriesTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule of Inventories",
        "documentation": "Tabular disclosure of the carrying amount as of the balance sheet date of merchandise, goods, commodities, or supplies held for future sale or to be used in manufacturing, servicing or production process."
       }
      }
     },
     "auth_ref": [
      "r19",
      "r87",
      "r88",
      "r89"
     ]
    },
    "us-gaap_ScheduleOfOtherAssetsTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ScheduleOfOtherAssetsTableTextBlock",
     "presentation": [
      "http://sharpstechnology.com/role/OtherAssetsTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule of Other Assets",
        "documentation": "Tabular disclosure of the carrying amounts of other assets. This disclosure includes other current assets and other noncurrent assets."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ScheduleOfPropertyPlantAndEquipmentTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ScheduleOfPropertyPlantAndEquipmentTable",
     "presentation": [
      "http://sharpstechnology.com/role/FixedAssetsDetailsNarrative",
      "http://sharpstechnology.com/role/ScheduleOfFixedAssetsNetDetails",
      "http://sharpstechnology.com/role/ScheduleOfPropertyPlantAndEquipmentDetails",
      "http://sharpstechnology.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Property, Plant and Equipment [Table]",
        "documentation": "Disclosure of information about physical assets used in the normal conduct of business and not intended for resale. Includes, but is not limited to, balances by class of assets, depreciation and depletion expense and method used, including composite depreciation, and accumulated deprecation."
       }
      }
     },
     "auth_ref": [
      "r10",
      "r485"
     ]
    },
    "us-gaap_ScheduleOfRestructuringAndRelatedCostsTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ScheduleOfRestructuringAndRelatedCostsTable",
     "presentation": [
      "http://sharpstechnology.com/role/ScheduleOfFairValueOfAssetsAcquisitionDetailsDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Restructuring Cost [Table]",
        "documentation": "Disclosure of information about restructuring cost. Includes, but is not limited to, expected cost, cost incurred, statement of income caption that includes restructuring cost recognized, and amount of restructuring reserve."
       }
      }
     },
     "auth_ref": [
      "r272",
      "r273",
      "r274",
      "r275",
      "r276",
      "r277",
      "r278"
     ]
    },
    "us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable",
     "presentation": [
      "http://sharpstechnology.com/role/BalanceSheets",
      "http://sharpstechnology.com/role/BalanceSheetsParenthetical",
      "http://sharpstechnology.com/role/ScheduleOfFairValueOfStockOptionAwardsDetails",
      "http://sharpstechnology.com/role/StockOptionsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule of Share-Based Compensation Arrangements by Share-Based Payment Award [Table]",
        "documentation": "Disclosure of information about share-based payment arrangement."
       }
      }
     },
     "auth_ref": [
      "r354",
      "r356",
      "r358",
      "r359",
      "r360",
      "r361",
      "r362",
      "r363",
      "r364",
      "r365",
      "r366",
      "r367",
      "r368",
      "r369",
      "r370",
      "r371",
      "r372",
      "r373",
      "r374",
      "r375",
      "r376",
      "r377",
      "r378",
      "r379",
      "r380",
      "r381",
      "r382",
      "r383"
     ]
    },
    "us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTable",
     "presentation": [
      "http://sharpstechnology.com/role/ScheduleOfInformationAboutOptionsOutstandingDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share-Based Payment Arrangement, Option, Exercise Price Range [Table]",
        "documentation": "Disclosure of information about share-based payment arrangement by range of exercise prices."
       }
      }
     },
     "auth_ref": [
      "r51"
     ]
    },
    "us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTextBlock",
     "presentation": [
      "http://sharpstechnology.com/role/StockOptionsTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule of Information About Options Outstanding",
        "documentation": "Tabular disclosure of option exercise prices, by grouped ranges, including the upper and lower limits of the price range, the number of shares under option, weighted average exercise price and remaining contractual option terms."
       }
      }
     },
     "auth_ref": [
      "r51"
     ]
    },
    "us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock",
     "presentation": [
      "http://sharpstechnology.com/role/StockOptionsTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule of Stock Options Granted and Outstanding",
        "documentation": "Tabular disclosure for stock option plans. Includes, but is not limited to, outstanding awards at beginning and end of year, grants, exercises, forfeitures, and weighted-average grant date fair value."
       }
      }
     },
     "auth_ref": [
      "r16",
      "r17",
      "r120"
     ]
    },
    "us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock",
     "presentation": [
      "http://sharpstechnology.com/role/StockOptionsTables",
      "http://sharpstechnology.com/role/WarrantLiabilityTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule of Fair Value of Warrant",
        "verboseLabel": "Schedule of Fair Value of Stock Option Awards",
        "documentation": "Tabular disclosure of the significant assumptions used during the year to estimate the fair value of stock options, including, but not limited to: (a) expected term of share options and similar instruments, (b) expected volatility of the entity's shares, (c) expected dividends, (d) risk-free rate(s), and (e) discount for post-vesting restrictions."
       }
      }
     },
     "auth_ref": [
      "r125"
     ]
    },
    "us-gaap_ScheduleOfShortTermDebtTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ScheduleOfShortTermDebtTable",
     "presentation": [
      "http://sharpstechnology.com/role/DebtFinancingDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Short-Term Debt [Table]",
        "documentation": "Disclosure of information about short-term debt arrangement. Includes, but is not limited to, description of arrangement, lender, repayment term, weighted-average interest rate, borrowed amount, and description and amount of refinancing of short-term obligation when obligation is excluded from current liability."
       }
      }
     },
     "auth_ref": [
      "r72"
     ]
    },
    "us-gaap_ScheduleOfStockByClassTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ScheduleOfStockByClassTable",
     "presentation": [
      "http://sharpstechnology.com/role/PreferredStockDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Stock, Class of Stock [Table]",
        "documentation": "Disclosure of information about stock by class. Includes, but is not limited to, common, convertible, and preferred stocks."
       }
      }
     },
     "auth_ref": [
      "r44",
      "r45",
      "r46",
      "r47",
      "r48",
      "r49",
      "r114",
      "r116",
      "r117",
      "r118",
      "r171",
      "r172",
      "r173",
      "r232",
      "r325",
      "r326",
      "r327",
      "r329",
      "r332",
      "r337",
      "r339",
      "r545",
      "r546",
      "r547",
      "r548",
      "r680",
      "r731",
      "r753"
     ]
    },
    "us-gaap_ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock",
     "presentation": [
      "http://sharpstechnology.com/role/WarrantLiabilityTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule of Warrant Outstanding",
        "documentation": "Tabular disclosure of warrants or rights issued. Warrants and rights outstanding are derivative securities that give the holder the right to purchase securities (usually equity) from the issuer at a specific price within a certain time frame. Warrants are often included in a new debt issue to entice investors by a higher return potential. The main difference between warrants and call options is that warrants are issued and guaranteed by the company, whereas options are exchange instruments and are not issued by the company. Also, the lifetime of a warrant is often measured in years, while the lifetime of a typical option is measured in months. Disclose the title of issue of securities called for by warrants and rights outstanding, the aggregate amount of securities called for by warrants and rights outstanding, the date from which the warrants or rights are exercisable, and the price at which the warrant or right is exercisable."
       }
      }
     },
     "auth_ref": [
      "r50"
     ]
    },
    "STSS_ScheduleOfWarrantLiabilityTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://sharpstechnology.com/20240930",
     "localname": "ScheduleOfWarrantLiabilityTableTextBlock",
     "presentation": [
      "http://sharpstechnology.com/role/WarrantLiabilityTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule of Warrant Liability",
        "documentation": "Schedule of warrant liability [Table Text Block]"
       }
      }
     },
     "auth_ref": []
    },
    "STSS_SecuritiesPurchaseAgreementMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://sharpstechnology.com/20240930",
     "localname": "SecuritiesPurchaseAgreementMember",
     "presentation": [
      "http://sharpstechnology.com/role/DebtFinancingDetailsNarrative",
      "http://sharpstechnology.com/role/StockholdersEquityDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Securities Purchase Agreement [Member]",
        "documentation": "Securities Purchase Agreement [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "dei_Security12bTitle": {
     "xbrltype": "securityTitleItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "Security12bTitle",
     "presentation": [
      "http://sharpstechnology.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Title of 12(b) Security",
        "documentation": "Title of a 12(b) registered security."
       }
      }
     },
     "auth_ref": [
      "r712"
     ]
    },
    "dei_Security12gTitle": {
     "xbrltype": "securityTitleItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "Security12gTitle",
     "presentation": [
      "http://sharpstechnology.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Title of 12(g) Security",
        "documentation": "Title of a 12(g) registered security."
       }
      }
     },
     "auth_ref": [
      "r716"
     ]
    },
    "dei_SecurityExchangeName": {
     "xbrltype": "edgarExchangeCodeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "SecurityExchangeName",
     "presentation": [
      "http://sharpstechnology.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Security Exchange Name",
        "documentation": "Name of the Exchange on which a security is registered."
       }
      }
     },
     "auth_ref": [
      "r715"
     ]
    },
    "dei_SecurityReportingObligation": {
     "xbrltype": "securityReportingObligationItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "SecurityReportingObligation",
     "presentation": [
      "http://sharpstechnology.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Security Reporting Obligation",
        "documentation": "15(d), indicating whether the security has a reporting obligation under that section of the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r721"
     ]
    },
    "STSS_SeniorSecuredNoteMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://sharpstechnology.com/20240930",
     "localname": "SeniorSecuredNoteMember",
     "presentation": [
      "http://sharpstechnology.com/role/DebtFinancingDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Senior Secured Note [Member]",
        "documentation": "Senior Secured Note [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_SeriesAPreferredStockMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "SeriesAPreferredStockMember",
     "presentation": [
      "http://sharpstechnology.com/role/PreferredStockDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Series A Preferred Stock [Member]",
        "documentation": "Series A preferred stock."
       }
      }
     },
     "auth_ref": [
      "r741",
      "r742",
      "r786"
     ]
    },
    "STSS_ServiceAgreementMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://sharpstechnology.com/20240930",
     "localname": "ServiceAgreementMember",
     "presentation": [
      "http://sharpstechnology.com/role/CommitmentsAndContingenciesDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Service Agreement [Member]",
        "documentation": "Service Agreement [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_SeveranceCosts1": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "SeveranceCosts1",
     "crdr": "debit",
     "presentation": [
      "http://sharpstechnology.com/role/CommitmentsAndContingenciesDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Severance costs",
        "documentation": "Amount of expenses for special or contractual termination benefits provided to current employees involuntarily terminated under a benefit arrangement associated exit or disposal activities pursuant to an authorized plan. Excludes expenses related to one-time termination benefits, a discontinued operation or an asset retirement obligation."
       }
      }
     },
     "auth_ref": [
      "r9"
     ]
    },
    "us-gaap_ShareBasedCompensation": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ShareBasedCompensation",
     "crdr": "debit",
     "calculation": {
      "http://sharpstechnology.com/role/StatementsOfCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://sharpstechnology.com/role/CommitmentsAndContingenciesDetailsNarrative",
      "http://sharpstechnology.com/role/StatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Stock-based compensation",
        "verboseLabel": "Share based compensation",
        "documentation": "Amount of noncash expense for share-based payment arrangement."
       }
      }
     },
     "auth_ref": [
      "r8"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate": {
     "xbrltype": "percentItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate",
     "presentation": [
      "http://sharpstechnology.com/role/ScheduleOfFairValueOfStockOptionAwardsDetails",
      "http://sharpstechnology.com/role/ScheduleOfFairValueOfWarrantDetails",
      "http://sharpstechnology.com/role/StockholdersEquityDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Dividend rate",
        "verboseLabel": "Risk-free interest rate",
        "documentation": "The estimated dividend rate (a percentage of the share price) to be paid (expected dividends) to holders of the underlying shares over the option's term."
       }
      }
     },
     "auth_ref": [
      "r381"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate": {
     "xbrltype": "percentItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate",
     "presentation": [
      "http://sharpstechnology.com/role/ScheduleOfFairValueOfWarrantDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Expected volatility",
        "documentation": "The estimated measure of the percentage by which a share price is expected to fluctuate during a period. Volatility also may be defined as a probability-weighted measure of the dispersion of returns about the mean. The volatility of a share price is the standard deviation of the continuously compounded rates of return on the share over a specified period. That is the same as the standard deviation of the differences in the natural logarithms of the stock prices plus dividends, if any, over the period."
       }
      }
     },
     "auth_ref": [
      "r380"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum": {
     "xbrltype": "percentItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum",
     "presentation": [
      "http://sharpstechnology.com/role/StockholdersEquityDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Volatility, maximum",
        "documentation": "The estimated measure of the maximum percentage by which a share price is expected to fluctuate during a period. Volatility also may be defined as a probability-weighted measure of the dispersion of returns about the mean. The volatility of a share price is the standard deviation of the continuously compounded rates of return on the share over a specified period. That is the same as the standard deviation of the differences in the natural logarithms of the stock prices plus dividends, if any, over the period."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum": {
     "xbrltype": "percentItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum",
     "presentation": [
      "http://sharpstechnology.com/role/StockholdersEquityDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Volatility, minimum",
        "documentation": "The estimated measure of the minimum percentage by which a share price is expected to fluctuate during a period. Volatility also may be defined as a probability-weighted measure of the dispersion of returns about the mean. The volatility of a share price is the standard deviation of the continuously compounded rates of return on the share over a specified period. That is the same as the standard deviation of the differences in the natural logarithms of the stock prices plus dividends, if any, over the period."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate": {
     "xbrltype": "percentItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate",
     "presentation": [
      "http://sharpstechnology.com/role/ScheduleOfFairValueOfStockOptionAwardsDetails",
      "http://sharpstechnology.com/role/ScheduleOfFairValueOfWarrantDetails",
      "http://sharpstechnology.com/role/StockholdersEquityDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Risk free interest rate",
        "verboseLabel": "Risk-free interest rate",
        "documentation": "The risk-free interest rate assumption that is used in valuing an option on its own shares."
       }
      }
     },
     "auth_ref": [
      "r382"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum": {
     "xbrltype": "percentItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum",
     "presentation": [
      "http://sharpstechnology.com/role/StockholdersEquityDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Risk free interest rate, maximum",
        "documentation": "The maximum risk-free interest rate assumption that is used in valuing an option on its own shares."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum": {
     "xbrltype": "percentItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum",
     "presentation": [
      "http://sharpstechnology.com/role/StockholdersEquityDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Risk free interest rate, minimum",
        "documentation": "The minimum risk-free interest rate assumption that is used in valuing an option on its own shares."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate": {
     "xbrltype": "percentItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate",
     "presentation": [
      "http://sharpstechnology.com/role/ScheduleOfFairValueOfStockOptionAwardsDetails",
      "http://sharpstechnology.com/role/StockholdersEquityDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Volatility",
        "verboseLabel": "Expected volatility",
        "documentation": "Rate of weighted-average expected volatility for award under share-based payment arrangement."
       }
      }
     },
     "auth_ref": [
      "r380"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems",
     "presentation": [
      "http://sharpstechnology.com/role/BalanceSheets",
      "http://sharpstechnology.com/role/BalanceSheetsParenthetical",
      "http://sharpstechnology.com/role/ScheduleOfFairValueOfStockOptionAwardsDetails",
      "http://sharpstechnology.com/role/StockOptionsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": [
      "r354",
      "r356",
      "r358",
      "r359",
      "r360",
      "r361",
      "r362",
      "r363",
      "r364",
      "r365",
      "r366",
      "r367",
      "r368",
      "r369",
      "r370",
      "r371",
      "r372",
      "r373",
      "r374",
      "r375",
      "r376",
      "r377",
      "r378",
      "r379",
      "r380",
      "r381",
      "r382",
      "r383"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised",
     "presentation": [
      "http://sharpstechnology.com/role/StockholdersEquityDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Warrants exercised",
        "documentation": "Number of non-option equity instruments exercised by participants."
       }
      }
     },
     "auth_ref": [
      "r15"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant",
     "presentation": [
      "http://sharpstechnology.com/role/StockOptionsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Stock available for issuance",
        "documentation": "The difference between the maximum number of shares (or other type of equity) authorized for issuance under the plan (including the effects of amendments and adjustments), and the sum of: 1) the number of shares (or other type of equity) already issued upon exercise of options or other equity-based awards under the plan; and 2) shares (or other type of equity) reserved for issuance on granting of outstanding awards, net of cancellations and forfeitures, if applicable."
       }
      }
     },
     "auth_ref": [
      "r51"
     ]
    },
    "STSS_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionOutstandingNumber": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://sharpstechnology.com/20240930",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionOutstandingNumber",
     "presentation": [
      "http://sharpstechnology.com/role/ScheduleOfStockOptionsGrantedAndOutstandingDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "periodStartLabel": "Stock option, beginning balance",
        "periodEndLabel": "Stock option, ending balance",
        "documentation": "Share based compensation arrangement by share based payment award option outstanding number.",
        "label": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionOutstandingNumber"
       }
      }
     },
     "auth_ref": []
    },
    "STSS_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionOutstandingWeightedAverageExercisePrice": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://sharpstechnology.com/20240930",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionOutstandingWeightedAverageExercisePrice",
     "presentation": [
      "http://sharpstechnology.com/role/ScheduleOfStockOptionsGrantedAndOutstandingDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "periodStartLabel": "Weighted average exercise price, beginning balance",
        "periodEndLabel": "Weighted average exercise price, ending balance",
        "documentation": "Share based compensation arrangement by share based payment award option outstanding weighted average exercise price.",
        "label": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionOutstandingWeightedAverageExercisePrice"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber",
     "presentation": [
      "http://sharpstechnology.com/role/ScheduleOfStockOptionsGrantedAndOutstandingDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "periodEndLabel": "Stock option, exercisable ending balance",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Number",
        "documentation": "The number of shares into which fully or partially vested stock options outstanding as of the balance sheet date can be currently converted under the option plan."
       }
      }
     },
     "auth_ref": [
      "r363"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice",
     "presentation": [
      "http://sharpstechnology.com/role/ScheduleOfStockOptionsGrantedAndOutstandingDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "periodEndLabel": "Weighted average exercise price, exercisable ending balance",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Weighted Average Exercise Price",
        "documentation": "The weighted-average price as of the balance sheet date at which grantees can acquire the shares reserved for issuance on vested portions of options outstanding and currently exercisable under the stock option plan."
       }
      }
     },
     "auth_ref": [
      "r363"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod",
     "presentation": [
      "http://sharpstechnology.com/role/ScheduleOfStockOptionsGrantedAndOutstandingDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Shares, options cancelled",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Expirations in Period",
        "documentation": "Number of options or other stock instruments for which the right to exercise has lapsed under the terms of the plan agreements."
       }
      }
     },
     "auth_ref": [
      "r368"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod",
     "presentation": [
      "http://sharpstechnology.com/role/ScheduleOfStockOptionsGrantedAndOutstandingDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Shares, options forfeited",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Forfeitures in Period",
        "documentation": "The number of shares under options that were cancelled during the reporting period as a result of occurrence of a terminating event specified in contractual agreements pertaining to the stock option plan."
       }
      }
     },
     "auth_ref": [
      "r367"
     ]
    },
    "STSS_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantedInYear": {
     "xbrltype": "durationItemType",
     "nsuri": "http://sharpstechnology.com/20240930",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantedInYear",
     "presentation": [
      "http://sharpstechnology.com/role/StockOptionsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Granted options",
        "documentation": "Share based compensation arrangement by share based payment award options granted in year."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod",
     "presentation": [
      "http://sharpstechnology.com/role/AssetAcquisitionDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Stock options issued",
        "documentation": "Net number of share options (or share units) granted during the period."
       }
      }
     },
     "auth_ref": [
      "r795"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross",
     "presentation": [
      "http://sharpstechnology.com/role/ScheduleOfStockOptionsGrantedAndOutstandingDetails",
      "http://sharpstechnology.com/role/StockOptionsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Shares, options granted",
        "verboseLabel": "Granted shares",
        "documentation": "Gross number of share options (or share units) granted during the period."
       }
      }
     },
     "auth_ref": [
      "r365"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue",
     "presentation": [
      "http://sharpstechnology.com/role/StockOptionsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Weighted-average grant-date fair value of options granted",
        "documentation": "The weighted average grant-date fair value of options granted during the reporting period as calculated by applying the disclosed option pricing methodology."
       }
      }
     },
     "auth_ref": [
      "r375"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue",
     "crdr": "debit",
     "presentation": [
      "http://sharpstechnology.com/role/ScheduleOfInformationAboutOptionsOutstandingDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Stock option, aggregate intrinsic value",
        "documentation": "Amount by which the current fair value of the underlying stock exceeds the exercise price of options outstanding."
       }
      }
     },
     "auth_ref": [
      "r51"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber",
     "presentation": [
      "http://sharpstechnology.com/role/ScheduleOfStockOptionsGrantedAndOutstandingDetails",
      "http://sharpstechnology.com/role/StockOptionsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "periodStartLabel": "Stock option, beginning balance",
        "periodEndLabel": "Stock option, ending balance",
        "label": "Options outstanding",
        "documentation": "Number of options outstanding, including both vested and non-vested options."
       }
      }
     },
     "auth_ref": [
      "r361",
      "r362"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice",
     "presentation": [
      "http://sharpstechnology.com/role/ScheduleOfStockOptionsGrantedAndOutstandingDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "periodStartLabel": "Weighted average exercise price, beginning balance",
        "periodEndLabel": "Weighted average exercise price, ending balance",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Exercise Price",
        "documentation": "Weighted average price at which grantees can acquire the shares reserved for issuance under the stock option plan."
       }
      }
     },
     "auth_ref": [
      "r361",
      "r362"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue",
     "crdr": "debit",
     "presentation": [
      "http://sharpstechnology.com/role/CommitmentsAndContingenciesDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fully vested",
        "documentation": "Amount by which current fair value of underlying stock exceeds exercise price of fully vested and expected to vest options outstanding. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur."
       }
      }
     },
     "auth_ref": [
      "r377"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod",
     "presentation": [
      "http://sharpstechnology.com/role/StockOptionsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Number of stock issuance",
        "documentation": "Number of shares issued under share-based payment arrangement."
       }
      }
     },
     "auth_ref": [
      "r51"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain",
     "presentation": [
      "http://sharpstechnology.com/role/AssetAcquisitionDetailsNarrative",
      "http://sharpstechnology.com/role/BalanceSheets",
      "http://sharpstechnology.com/role/BalanceSheetsParenthetical",
      "http://sharpstechnology.com/role/DebtFinancingDetailsNarrative",
      "http://sharpstechnology.com/role/FixedAssetsDetailsNarrative",
      "http://sharpstechnology.com/role/StatementOfStockholdersEquity",
      "http://sharpstechnology.com/role/StockholdersEquityDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Award under share-based payment arrangement."
       }
      }
     },
     "auth_ref": [
      "r358",
      "r359",
      "r360",
      "r361",
      "r362",
      "r363",
      "r364",
      "r365",
      "r366",
      "r367",
      "r368",
      "r369",
      "r370",
      "r371",
      "r372",
      "r373",
      "r374",
      "r375",
      "r376",
      "r377",
      "r378",
      "r379",
      "r380",
      "r381",
      "r382",
      "r383"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice",
     "presentation": [
      "http://sharpstechnology.com/role/AssetAcquisitionDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Exercise price",
        "documentation": "Weighted average price at which option holders acquired shares when converting their stock options into shares."
       }
      }
     },
     "auth_ref": [
      "r366"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice",
     "presentation": [
      "http://sharpstechnology.com/role/NotePurchaseAgreementDetailsNarrative",
      "http://sharpstechnology.com/role/ScheduleOfStockOptionsGrantedAndOutstandingDetails",
      "http://sharpstechnology.com/role/StockholdersEquityDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Exercise price",
        "negatedLabel": "Weighted average exercise price, options cancelled",
        "label": "Share-Based Compensation Arrangements by Share-Based Payment Award, Options, Expirations in Period, Weighted Average Exercise Price",
        "documentation": "Weighted average price at which grantees could have acquired the underlying shares with respect to stock options of the plan that expired."
       }
      }
     },
     "auth_ref": [
      "r368"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice",
     "presentation": [
      "http://sharpstechnology.com/role/ScheduleOfStockOptionsGrantedAndOutstandingDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Weighted average exercise price, forfeited or cancelled",
        "negatedLabel": "Weighted average exercise price, options forfeited",
        "documentation": "Weighted average price at which grantees could have acquired the underlying shares with respect to stock options that were terminated."
       }
      }
     },
     "auth_ref": [
      "r367"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice",
     "presentation": [
      "http://sharpstechnology.com/role/ScheduleOfStockOptionsGrantedAndOutstandingDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Weighted average exercise price, options granted",
        "documentation": "Weighted average per share amount at which grantees can acquire shares of common stock by exercise of options."
       }
      }
     },
     "auth_ref": [
      "r365"
     ]
    },
    "STSS_ShareBasedCompensationOptionsExercisableWeightedAverageExercisePrice": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://sharpstechnology.com/20240930",
     "localname": "ShareBasedCompensationOptionsExercisableWeightedAverageExercisePrice",
     "presentation": [
      "http://sharpstechnology.com/role/StockOptionsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Options exercisable",
        "documentation": "Share based compensation options exercisable weighted average exercise price."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis",
     "presentation": [
      "http://sharpstechnology.com/role/ScheduleOfInformationAboutOptionsOutstandingDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Exercise Price Range [Axis]",
        "documentation": "Information by range of option prices pertaining to options granted."
       }
      }
     },
     "auth_ref": [
      "r53"
     ]
    },
    "us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain",
     "presentation": [
      "http://sharpstechnology.com/role/ScheduleOfInformationAboutOptionsOutstandingDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Supplementary information on outstanding and exercisable share awards as of the balance sheet date which stratifies outstanding options by ranges of exercise prices."
       }
      }
     },
     "auth_ref": [
      "r54"
     ]
    },
    "us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems",
     "presentation": [
      "http://sharpstechnology.com/role/ScheduleOfInformationAboutOptionsOutstandingDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share-Based Payment Arrangement, Option, Exercise Price Range [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions",
     "presentation": [
      "http://sharpstechnology.com/role/ScheduleOfInformationAboutOptionsOutstandingDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Options, shares exercisable",
        "documentation": "The number of shares reserved for issuance pertaining to the outstanding exercisable stock options as of the balance sheet date in the customized range of exercise prices for which the market and performance vesting condition has been satisfied."
       }
      }
     },
     "auth_ref": [
      "r52"
     ]
    },
    "us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions",
     "presentation": [
      "http://sharpstechnology.com/role/ScheduleOfInformationAboutOptionsOutstandingDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Options, shares outstanding",
        "documentation": "The number of shares reserved for issuance pertaining to the outstanding stock options as of the balance sheet date for all option plans in the customized range of exercise prices."
       }
      }
     },
     "auth_ref": [
      "r121",
      "r122"
     ]
    },
    "us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit",
     "presentation": [
      "http://sharpstechnology.com/role/ScheduleOfInformationAboutOptionsOutstandingDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Stock option, exercise price",
        "documentation": "The ceiling of a customized range of exercise prices for purposes of disclosing shares potentially issuable under outstanding stock option awards on all stock option plans and other required information pertaining to awards in the customized range."
       }
      }
     },
     "auth_ref": [
      "r54"
     ]
    },
    "us-gaap_SharePrice": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "SharePrice",
     "presentation": [
      "http://sharpstechnology.com/role/AssetAcquisitionDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share price",
        "documentation": "Price of a single share of a number of saleable stocks of a company."
       }
      }
     },
     "auth_ref": []
    },
    "STSS_SharePurchaseAgreementMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://sharpstechnology.com/20240930",
     "localname": "SharePurchaseAgreementMember",
     "presentation": [
      "http://sharpstechnology.com/role/AssetAcquisitionDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share Purchase Agreement [Member]",
        "documentation": "Share Purchase Agreement [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1": {
     "xbrltype": "durationItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1",
     "presentation": [
      "http://sharpstechnology.com/role/ScheduleOfFairValueOfStockOptionAwardsDetails",
      "http://sharpstechnology.com/role/ScheduleOfFairValueOfWarrantDetails",
      "http://sharpstechnology.com/role/StockOptionsDetailsNarrative",
      "http://sharpstechnology.com/role/StockholdersEquityDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Expected term",
        "verboseLabel": "Expected term (in years)",
        "terseLabel": "Expected term (years)",
        "documentation": "Expected term of award under share-based payment arrangement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days."
       }
      }
     },
     "auth_ref": [
      "r379"
     ]
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1",
     "crdr": "debit",
     "presentation": [
      "http://sharpstechnology.com/role/ScheduleOfInformationAboutOptionsOutstandingDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Stock option, aggregate intrinsic value on exercisable shares",
        "documentation": "Amount of difference between fair value of the underlying shares reserved for issuance and exercise price of vested portions of options outstanding and currently exercisable."
       }
      }
     },
     "auth_ref": [
      "r51"
     ]
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedNumberOfShares": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedNumberOfShares",
     "presentation": [
      "http://sharpstechnology.com/role/ScheduleOfStockOptionsGrantedAndOutstandingDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Shares, options forfeited",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Nonvested Options Forfeited, Number of Shares",
        "documentation": "Number of non-vested options forfeited."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue",
     "presentation": [
      "http://sharpstechnology.com/role/StockOptionsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Unvested stock options weighted average fair value",
        "documentation": "Weighted average grant-date fair value of non-vested options outstanding."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2": {
     "xbrltype": "durationItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2",
     "presentation": [
      "http://sharpstechnology.com/role/StockOptionsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Weighted average remaining contractual life",
        "documentation": "Weighted average remaining contractual term for option awards outstanding, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days."
       }
      }
     },
     "auth_ref": [
      "r124"
     ]
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1",
     "crdr": "credit",
     "presentation": [
      "http://sharpstechnology.com/role/AssetAcquisitionDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Vested options, value",
        "documentation": "Fair value of options vested. Excludes equity instruments other than options, for example, but not limited to, share units, stock appreciation rights, restricted stock."
       }
      }
     },
     "auth_ref": [
      "r376"
     ]
    },
    "us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1",
     "presentation": [
      "http://sharpstechnology.com/role/CommitmentsAndContingenciesDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Stock option, exercise price",
        "label": "Share-Based Payment Arrangement, Option, Exercise Price Range, Outstanding, Weighted Average Exercise Price",
        "documentation": "The weighted average price as of the balance sheet date at which grantees could acquire the underlying shares with respect to all outstanding stock options which are in the customized range of exercise prices."
       }
      }
     },
     "auth_ref": [
      "r121",
      "r122"
     ]
    },
    "us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2": {
     "xbrltype": "durationItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2",
     "presentation": [
      "http://sharpstechnology.com/role/ScheduleOfInformationAboutOptionsOutstandingDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Stock option, weighted average remaining contractual life",
        "documentation": "Weighted average remaining contractual term of outstanding stock options, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days."
       }
      }
     },
     "auth_ref": [
      "r124"
     ]
    },
    "us-gaap_SharesIssuedPricePerShare": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "SharesIssuedPricePerShare",
     "presentation": [
      "http://sharpstechnology.com/role/StockholdersEquityDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Purchase price pre reverse",
        "documentation": "Per share or per unit amount of equity securities issued."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_SharesOutstanding": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "SharesOutstanding",
     "presentation": [
      "http://sharpstechnology.com/role/StatementOfStockholdersEquity"
     ],
     "lang": {
      "en-us": {
       "role": {
        "periodStartLabel": "Balance, shares",
        "periodEndLabel": "Balance, shares",
        "label": "Shares, Outstanding",
        "documentation": "Number of shares issued which are neither cancelled nor held in the treasury."
       }
      }
     },
     "auth_ref": []
    },
    "STSS_ShelfOfferingMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://sharpstechnology.com/20240930",
     "localname": "ShelfOfferingMember",
     "presentation": [
      "http://sharpstechnology.com/role/StockholdersEquityDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Shelf Offering [Member]",
        "documentation": "Shelf Offering [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ShortTermDebtLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ShortTermDebtLineItems",
     "presentation": [
      "http://sharpstechnology.com/role/DebtFinancingDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Short-Term Debt [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_SignificantAccountingPoliciesTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "SignificantAccountingPoliciesTextBlock",
     "presentation": [
      "http://sharpstechnology.com/role/SummaryOfSignificantAccountingPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Summary of Significant Accounting Policies",
        "documentation": "The entire disclosure for all significant accounting policies of the reporting entity."
       }
      }
     },
     "auth_ref": [
      "r103",
      "r196"
     ]
    },
    "STSS_SinglePaymentObligation": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://sharpstechnology.com/20240930",
     "localname": "SinglePaymentObligation",
     "crdr": "credit",
     "presentation": [
      "http://sharpstechnology.com/role/CommitmentsAndContingenciesDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Single payment obligation",
        "documentation": "Single payment obligation."
       }
      }
     },
     "auth_ref": []
    },
    "dei_SolicitingMaterial": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "SolicitingMaterial",
     "presentation": [
      "http://sharpstechnology.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Soliciting Material",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r719"
     ]
    },
    "us-gaap_StatementClassOfStockAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "StatementClassOfStockAxis",
     "presentation": [
      "http://sharpstechnology.com/role/PreferredStockDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Class of Stock [Axis]",
        "documentation": "Information by the different classes of stock of the entity."
       }
      }
     },
     "auth_ref": [
      "r159",
      "r171",
      "r172",
      "r173",
      "r199",
      "r221",
      "r222",
      "r224",
      "r226",
      "r232",
      "r233",
      "r250",
      "r289",
      "r291",
      "r292",
      "r293",
      "r296",
      "r297",
      "r325",
      "r326",
      "r329",
      "r332",
      "r339",
      "r465",
      "r545",
      "r546",
      "r547",
      "r548",
      "r554",
      "r555",
      "r556",
      "r557",
      "r558",
      "r559",
      "r560",
      "r561",
      "r562",
      "r563",
      "r564",
      "r566",
      "r584",
      "r606",
      "r627",
      "r647",
      "r648",
      "r649",
      "r650",
      "r651",
      "r731",
      "r753",
      "r762"
     ]
    },
    "us-gaap_StatementEquityComponentsAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "StatementEquityComponentsAxis",
     "presentation": [
      "http://sharpstechnology.com/role/AssetAcquisitionDetailsNarrative",
      "http://sharpstechnology.com/role/ScheduleOfFairValueOfWarrantDetails",
      "http://sharpstechnology.com/role/StatementOfStockholdersEquity",
      "http://sharpstechnology.com/role/StockholdersEquityDetailsNarrative",
      "http://sharpstechnology.com/role/SubsequentEventsDetailsNarrative",
      "http://sharpstechnology.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative",
      "http://sharpstechnology.com/role/WarrantLiabilityTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Equity Components [Axis]",
        "documentation": "Information by component of equity."
       }
      }
     },
     "auth_ref": [
      "r13",
      "r81",
      "r84",
      "r85",
      "r160",
      "r185",
      "r186",
      "r187",
      "r204",
      "r205",
      "r206",
      "r208",
      "r213",
      "r215",
      "r217",
      "r231",
      "r251",
      "r252",
      "r264",
      "r341",
      "r420",
      "r421",
      "r428",
      "r429",
      "r430",
      "r432",
      "r435",
      "r436",
      "r442",
      "r443",
      "r444",
      "r445",
      "r446",
      "r447",
      "r449",
      "r472",
      "r473",
      "r474",
      "r475",
      "r476",
      "r478",
      "r483",
      "r484",
      "r486",
      "r526",
      "r536",
      "r537",
      "r538",
      "r554",
      "r627"
     ]
    },
    "us-gaap_StatementLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "StatementLineItems",
     "presentation": [
      "http://sharpstechnology.com/role/RelatedPartyTransactionsAndBalancesDetailsNarrative",
      "http://sharpstechnology.com/role/ScheduleOfFairValueOfWarrantDetails",
      "http://sharpstechnology.com/role/StatementOfStockholdersEquity",
      "http://sharpstechnology.com/role/WarrantLiabilityTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": [
      "r204",
      "r205",
      "r206",
      "r231",
      "r484",
      "r505",
      "r543",
      "r566",
      "r576",
      "r577",
      "r578",
      "r579",
      "r580",
      "r581",
      "r584",
      "r587",
      "r588",
      "r589",
      "r590",
      "r591",
      "r593",
      "r594",
      "r595",
      "r596",
      "r598",
      "r599",
      "r600",
      "r601",
      "r602",
      "r604",
      "r607",
      "r608",
      "r612",
      "r613",
      "r614",
      "r615",
      "r616",
      "r617",
      "r618",
      "r619",
      "r620",
      "r621",
      "r622",
      "r623",
      "r627",
      "r703"
     ]
    },
    "us-gaap_StatementOfCashFlowsAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "StatementOfCashFlowsAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement of Cash Flows [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_StatementOfFinancialPositionAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "StatementOfFinancialPositionAbstract",
     "auth_ref": []
    },
    "us-gaap_StatementOfStockholdersEquityAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "StatementOfStockholdersEquityAbstract",
     "auth_ref": []
    },
    "srt_StatementScenarioAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/srt/2024",
     "localname": "StatementScenarioAxis",
     "presentation": [
      "http://sharpstechnology.com/role/IncomeTaxesDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Scenario [Axis]"
       }
      }
     },
     "auth_ref": [
      "r218",
      "r352",
      "r732",
      "r736",
      "r760"
     ]
    },
    "us-gaap_StatementTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "StatementTable",
     "presentation": [
      "http://sharpstechnology.com/role/RelatedPartyTransactionsAndBalancesDetailsNarrative",
      "http://sharpstechnology.com/role/ScheduleOfFairValueOfWarrantDetails",
      "http://sharpstechnology.com/role/StatementOfStockholdersEquity",
      "http://sharpstechnology.com/role/WarrantLiabilityTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement [Table]",
        "documentation": "Disclosure of information about statement of comprehensive income, income, other comprehensive income, financial position, cash flows, and shareholders' equity."
       }
      }
     },
     "auth_ref": [
      "r204",
      "r205",
      "r206",
      "r231",
      "r246",
      "r484",
      "r505",
      "r543",
      "r566",
      "r576",
      "r577",
      "r578",
      "r579",
      "r580",
      "r581",
      "r584",
      "r587",
      "r588",
      "r589",
      "r590",
      "r591",
      "r593",
      "r594",
      "r595",
      "r596",
      "r598",
      "r599",
      "r600",
      "r601",
      "r602",
      "r604",
      "r607",
      "r608",
      "r612",
      "r613",
      "r614",
      "r615",
      "r616",
      "r617",
      "r618",
      "r619",
      "r620",
      "r621",
      "r622",
      "r623",
      "r627",
      "r703"
     ]
    },
    "STSS_StockBasedChargesRelatingToAcquisition": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://sharpstechnology.com/20240930",
     "localname": "StockBasedChargesRelatingToAcquisition",
     "crdr": "debit",
     "presentation": [
      "http://sharpstechnology.com/role/StockOptionsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Stock based charges relating to acquisition",
        "documentation": "Stock based charges relating to acquisition."
       }
      }
     },
     "auth_ref": []
    },
    "STSS_StockBasedChargesRelatingToPurchaseOfMachinery": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://sharpstechnology.com/20240930",
     "localname": "StockBasedChargesRelatingToPurchaseOfMachinery",
     "crdr": "debit",
     "presentation": [
      "http://sharpstechnology.com/role/StockOptionsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Stock based charges relating to purchase of machinery",
        "documentation": "Stock based charges relating to purchase of machinery."
       }
      }
     },
     "auth_ref": []
    },
    "STSS_StockIssuedDuringPeriodCollectionsOfCommonStockSubscriptionsValue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://sharpstechnology.com/20240930",
     "localname": "StockIssuedDuringPeriodCollectionsOfCommonStockSubscriptionsValue",
     "crdr": "credit",
     "presentation": [
      "http://sharpstechnology.com/role/StatementOfStockholdersEquity"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Collection of stock subscription",
        "documentation": "Stock issued during period collections of common stock subscriptions value."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_StockIssuedDuringPeriodSharesAcquisitions": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "StockIssuedDuringPeriodSharesAcquisitions",
     "presentation": [
      "http://sharpstechnology.com/role/AssetAcquisitionDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Additional consideration, shares",
        "documentation": "Number of shares of stock issued during the period pursuant to acquisitions."
       }
      }
     },
     "auth_ref": [
      "r80",
      "r81",
      "r118"
     ]
    },
    "STSS_StockIssuedDuringPeriodSharesContingentStockLiability": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://sharpstechnology.com/20240930",
     "localname": "StockIssuedDuringPeriodSharesContingentStockLiability",
     "presentation": [
      "http://sharpstechnology.com/role/StatementOfStockholdersEquity"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Issuance of shares for contingent stock liability, shares",
        "documentation": "Stock issued during period shares contingent stock liability."
       }
      }
     },
     "auth_ref": []
    },
    "STSS_StockIssuedDuringPeriodSharesExerciseOfPrefundedWarrants": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://sharpstechnology.com/20240930",
     "localname": "StockIssuedDuringPeriodSharesExerciseOfPrefundedWarrants",
     "presentation": [
      "http://sharpstechnology.com/role/StatementOfStockholdersEquity"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Exercise of Pre-Funded Warrants, shares",
        "documentation": "Stock issued during period shares exercise of prefunded warrants."
       }
      }
     },
     "auth_ref": []
    },
    "STSS_StockIssuedDuringPeriodSharesFractionalShareAdjustment": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://sharpstechnology.com/20240930",
     "localname": "StockIssuedDuringPeriodSharesFractionalShareAdjustment",
     "presentation": [
      "http://sharpstechnology.com/role/StatementOfStockholdersEquity"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fractional share adjustment, shares",
        "documentation": "Stock issued during shares fractional share adjustment."
       }
      }
     },
     "auth_ref": []
    },
    "STSS_StockIssuedDuringPeriodSharesInitialPublicOffering": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://sharpstechnology.com/20240930",
     "localname": "StockIssuedDuringPeriodSharesInitialPublicOffering",
     "presentation": [
      "http://sharpstechnology.com/role/StatementOfStockholdersEquity",
      "http://sharpstechnology.com/role/StockholdersEquityDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Shares issued in Initial Public Offering, shares",
        "verboseLabel": "Initial public offering",
        "documentation": "Stock issued during period shares initial public offering."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_StockIssuedDuringPeriodSharesIssuedForServices": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "StockIssuedDuringPeriodSharesIssuedForServices",
     "presentation": [
      "http://sharpstechnology.com/role/StatementOfStockholdersEquity",
      "http://sharpstechnology.com/role/StockholdersEquityDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Issuance of common stock for services, shares",
        "verboseLabel": "Common stock issued for services, shares",
        "documentation": "Number of shares issued in lieu of cash for services contributed to the entity. Number of shares includes, but is not limited to, shares issued for services contributed by vendors and founders."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_StockIssuedDuringPeriodSharesNewIssues": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "StockIssuedDuringPeriodSharesNewIssues",
     "presentation": [
      "http://sharpstechnology.com/role/StatementOfStockholdersEquity",
      "http://sharpstechnology.com/role/StockholdersEquityDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Shares issued in Offering, shares",
        "verboseLabel": "Warrants issued",
        "documentation": "Number of new stock issued during the period."
       }
      }
     },
     "auth_ref": [
      "r13",
      "r80",
      "r81",
      "r118",
      "r545",
      "r627",
      "r648"
     ]
    },
    "us-gaap_StockIssuedDuringPeriodSharesOther": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "StockIssuedDuringPeriodSharesOther",
     "presentation": [
      "http://sharpstechnology.com/role/StatementOfStockholdersEquity",
      "http://sharpstechnology.com/role/StockholdersEquityDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Issuance of Common Stock, shares",
        "verboseLabel": "Issued shares of common stock",
        "documentation": "Number of shares of stock issued attributable to transactions classified as other."
       }
      }
     },
     "auth_ref": []
    },
    "STSS_StockIssuedDuringPeriodSharesRegistrationOffering": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://sharpstechnology.com/20240930",
     "localname": "StockIssuedDuringPeriodSharesRegistrationOffering",
     "presentation": [
      "http://sharpstechnology.com/role/StatementOfStockholdersEquity"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Registration A Offering, shares",
        "documentation": "Stock issued during period shares registration offering."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures",
     "presentation": [
      "http://sharpstechnology.com/role/CommitmentsAndContingenciesDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Shares of restricted common stock",
        "documentation": "Number of shares issued during the period related to Restricted Stock Awards, net of any shares forfeited."
       }
      }
     },
     "auth_ref": [
      "r13",
      "r80",
      "r81",
      "r118"
     ]
    },
    "us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "StockIssuedDuringPeriodSharesShareBasedCompensation",
     "presentation": [
      "http://sharpstechnology.com/role/CommitmentsAndContingenciesDetailsNarrative",
      "http://sharpstechnology.com/role/StockOptionsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Purchase of shares",
        "verboseLabel": "Options to purchase shares",
        "documentation": "Number, after forfeiture, of shares or units issued under share-based payment arrangement. Excludes shares or units issued under employee stock ownership plan (ESOP)."
       }
      }
     },
     "auth_ref": [
      "r13",
      "r80",
      "r81",
      "r118"
     ]
    },
    "STSS_StockIssuedDuringPeriodSharesShelfRegistrationOffering": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://sharpstechnology.com/20240930",
     "localname": "StockIssuedDuringPeriodSharesShelfRegistrationOffering",
     "presentation": [
      "http://sharpstechnology.com/role/StatementOfStockholdersEquity"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Shelf Registration Offering - see Note 8, shares",
        "documentation": "Stock issued during period shares shelf registration offering."
       }
      }
     },
     "auth_ref": []
    },
    "STSS_StockIssuedDuringPeriodSharesWarrantExericse": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://sharpstechnology.com/20240930",
     "localname": "StockIssuedDuringPeriodSharesWarrantExericse",
     "presentation": [
      "http://sharpstechnology.com/role/StatementOfStockholdersEquity"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Warrant exercise, shares",
        "documentation": "Stock issued during period shares warrant exericse."
       }
      }
     },
     "auth_ref": []
    },
    "STSS_StockIssuedDuringPeriodSharesWarrantInducements": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://sharpstechnology.com/20240930",
     "localname": "StockIssuedDuringPeriodSharesWarrantInducements",
     "presentation": [
      "http://sharpstechnology.com/role/StatementOfStockholdersEquity"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Warrant Inducements, shares",
        "documentation": "Stock issued during period shares warrant inducements."
       }
      }
     },
     "auth_ref": []
    },
    "STSS_StockIssuedDuringPeriodValueContingentStockLiability": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://sharpstechnology.com/20240930",
     "localname": "StockIssuedDuringPeriodValueContingentStockLiability",
     "crdr": "credit",
     "presentation": [
      "http://sharpstechnology.com/role/StatementOfStockholdersEquity"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Issuance of shares for contingent stock liability",
        "documentation": "Stock issued during period value contingent stock liability."
       }
      }
     },
     "auth_ref": []
    },
    "STSS_StockIssuedDuringPeriodValueExerciseOfPrefundedWarrant": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://sharpstechnology.com/20240930",
     "localname": "StockIssuedDuringPeriodValueExerciseOfPrefundedWarrant",
     "crdr": "credit",
     "presentation": [
      "http://sharpstechnology.com/role/StatementOfStockholdersEquity"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Exercise of Pre-Funded Warrants",
        "documentation": "Stock issued during period value exercise of prefunded warrants.",
        "label": "StockIssuedDuringPeriodValueExerciseOfPrefundedWarrant"
       }
      }
     },
     "auth_ref": []
    },
    "STSS_StockIssuedDuringPeriodValueExerciseOfPrefundedWarrants": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://sharpstechnology.com/20240930",
     "localname": "StockIssuedDuringPeriodValueExerciseOfPrefundedWarrants",
     "crdr": "credit",
     "presentation": [
      "http://sharpstechnology.com/role/StatementOfStockholdersEquity"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Exercise of Pre-Funded Warrants",
        "documentation": "Stock issued during period value exercise of prefunded warrants."
       }
      }
     },
     "auth_ref": []
    },
    "STSS_StockIssuedDuringPeriodValueFractionalShareAdjustment": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://sharpstechnology.com/20240930",
     "localname": "StockIssuedDuringPeriodValueFractionalShareAdjustment",
     "crdr": "credit",
     "presentation": [
      "http://sharpstechnology.com/role/StatementOfStockholdersEquity"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fractional share adjustment",
        "documentation": "Stock issued during period value fractional share adjustment."
       }
      }
     },
     "auth_ref": []
    },
    "STSS_StockIssuedDuringPeriodValueInitialPublicOffering": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://sharpstechnology.com/20240930",
     "localname": "StockIssuedDuringPeriodValueInitialPublicOffering",
     "crdr": "credit",
     "presentation": [
      "http://sharpstechnology.com/role/StatementOfStockholdersEquity"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Shares issued in Initial Public Offering",
        "documentation": "Stock issued during period value initial public offering."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_StockIssuedDuringPeriodValueIssuedForServices": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "StockIssuedDuringPeriodValueIssuedForServices",
     "crdr": "credit",
     "presentation": [
      "http://sharpstechnology.com/role/StatementOfStockholdersEquity",
      "http://sharpstechnology.com/role/StockholdersEquityDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Issuance of common stock for services",
        "verboseLabel": "Common stock issued for services, value",
        "documentation": "Value of stock issued in lieu of cash for services contributed to the entity. Value of the stock issued includes, but is not limited to, services contributed by vendors and founders."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_StockIssuedDuringPeriodValueNewIssues": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "StockIssuedDuringPeriodValueNewIssues",
     "crdr": "credit",
     "presentation": [
      "http://sharpstechnology.com/role/StatementOfStockholdersEquity"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Shares issued in Offering",
        "documentation": "Equity impact of the value of new stock issued during the period. Includes shares issued in an initial public offering or a secondary public offering."
       }
      }
     },
     "auth_ref": [
      "r13",
      "r80",
      "r81",
      "r118",
      "r554",
      "r627",
      "r648",
      "r709"
     ]
    },
    "us-gaap_StockIssuedDuringPeriodValueOther": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "StockIssuedDuringPeriodValueOther",
     "crdr": "credit",
     "presentation": [
      "http://sharpstechnology.com/role/StatementOfStockholdersEquity"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Issuance of Common Stock \u2013 see Note 7",
        "documentation": "Value of shares of stock issued attributable to transactions classified as other."
       }
      }
     },
     "auth_ref": []
    },
    "STSS_StockIssuedDuringPeriodValuePrivatePlacement": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://sharpstechnology.com/20240930",
     "localname": "StockIssuedDuringPeriodValuePrivatePlacement",
     "crdr": "credit",
     "presentation": [
      "http://sharpstechnology.com/role/StatementOfStockholdersEquity"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Private Placement Offering \u2013 see Note 8",
        "documentation": "Stock issued during period value private placement."
       }
      }
     },
     "auth_ref": []
    },
    "STSS_StockIssuedDuringPeriodValueRegistrationOffering": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://sharpstechnology.com/20240930",
     "localname": "StockIssuedDuringPeriodValueRegistrationOffering",
     "crdr": "credit",
     "presentation": [
      "http://sharpstechnology.com/role/StatementOfStockholdersEquity"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Registration A Offering",
        "documentation": "Stock issued during period value registration offering."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures",
     "crdr": "credit",
     "presentation": [
      "http://sharpstechnology.com/role/CommitmentsAndContingenciesDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Value of restricted common stock",
        "documentation": "Value of stock related to Restricted Stock Awards issued during the period, net of the stock value of such awards forfeited."
       }
      }
     },
     "auth_ref": [
      "r13",
      "r118"
     ]
    },
    "STSS_StockIssuedDuringPeriodValueShelfRegistrationOffering": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://sharpstechnology.com/20240930",
     "localname": "StockIssuedDuringPeriodValueShelfRegistrationOffering",
     "crdr": "credit",
     "presentation": [
      "http://sharpstechnology.com/role/StatementOfStockholdersEquity"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Shelf Registration Offering \u2013 see Note 8",
        "documentation": "Stock issued during period value shelf registration offering."
       }
      }
     },
     "auth_ref": []
    },
    "STSS_StockIssuedDuringPeriodValueWarrantExericse": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://sharpstechnology.com/20240930",
     "localname": "StockIssuedDuringPeriodValueWarrantExericse",
     "crdr": "credit",
     "presentation": [
      "http://sharpstechnology.com/role/StatementOfStockholdersEquity"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Warrant exercise",
        "documentation": "Stock issued during period value warrant exericse."
       }
      }
     },
     "auth_ref": []
    },
    "STSS_StockIssuedDuringPeriodValueWarrantInducements": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://sharpstechnology.com/20240930",
     "localname": "StockIssuedDuringPeriodValueWarrantInducements",
     "crdr": "credit",
     "presentation": [
      "http://sharpstechnology.com/role/StatementOfStockholdersEquity"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Warrant Inducements",
        "documentation": "Stock issued during period value warrant inducements."
       }
      }
     },
     "auth_ref": []
    },
    "STSS_StockOptionAndWarrantsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://sharpstechnology.com/20240930",
     "localname": "StockOptionAndWarrantsMember",
     "presentation": [
      "http://sharpstechnology.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Stock Option and Warrants [Member]",
        "documentation": "Stock Option and Warrants [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_StockOptionMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "StockOptionMember",
     "presentation": [
      "http://sharpstechnology.com/role/AssetAcquisitionDetailsNarrative",
      "http://sharpstechnology.com/role/FixedAssetsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Equity Option [Member]",
        "documentation": "Contracts conveying rights, but not obligations, to buy or sell a specific quantity of stock at a specified price during a specified period (an American option) or at a specified date (a European option)."
       }
      }
     },
     "auth_ref": [
      "r702"
     ]
    },
    "STSS_StockOptionOneMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://sharpstechnology.com/20240930",
     "localname": "StockOptionOneMember",
     "presentation": [
      "http://sharpstechnology.com/role/AssetAcquisitionDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Stock Option One [Member]",
        "documentation": "Stock Option One [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "STSS_StockOptionsAndWarrantsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://sharpstechnology.com/20240930",
     "localname": "StockOptionsAndWarrantsMember",
     "presentation": [
      "http://sharpstechnology.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Stock Options and Warrants [Member]",
        "documentation": "Stock Options and Warrants [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_StockRedeemedOrCalledDuringPeriodShares": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "StockRedeemedOrCalledDuringPeriodShares",
     "presentation": [
      "http://sharpstechnology.com/role/StatementOfStockholdersEquity"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cancellation of Preferred Share, shares",
        "documentation": "Number of stock bought back by the entity at the exercise price or redemption price."
       }
      }
     },
     "auth_ref": [
      "r13"
     ]
    },
    "us-gaap_StockRedeemedOrCalledDuringPeriodValue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "StockRedeemedOrCalledDuringPeriodValue",
     "crdr": "debit",
     "presentation": [
      "http://sharpstechnology.com/role/StatementOfStockholdersEquity"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cancellation of Preferred Share",
        "documentation": "Equity impact of the value of stock bought back by the entity at the exercise price or redemption price."
       }
      }
     },
     "auth_ref": [
      "r13"
     ]
    },
    "us-gaap_StockholdersEquity": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "StockholdersEquity",
     "crdr": "credit",
     "calculation": {
      "http://sharpstechnology.com/role/BalanceSheets": {
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0,
       "order": 4.0
      }
     },
     "presentation": [
      "http://sharpstechnology.com/role/BalanceSheets",
      "http://sharpstechnology.com/role/StatementOfStockholdersEquity"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Total Stockholders\u2019 Equity",
        "periodStartLabel": "Balance",
        "periodEndLabel": "Balance",
        "label": "Equity, Attributable to Parent",
        "documentation": "Amount of equity (deficit) attributable to parent. Excludes temporary equity and equity attributable to noncontrolling interest."
       }
      }
     },
     "auth_ref": [
      "r81",
      "r84",
      "r85",
      "r105",
      "r586",
      "r603",
      "r628",
      "r629",
      "r698",
      "r710",
      "r755",
      "r769",
      "r842",
      "r868"
     ]
    },
    "us-gaap_StockholdersEquityAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "StockholdersEquityAbstract",
     "presentation": [
      "http://sharpstechnology.com/role/BalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Stockholders\u2019 Equity:"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_StockholdersEquityNoteDisclosureTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "StockholdersEquityNoteDisclosureTextBlock",
     "presentation": [
      "http://sharpstechnology.com/role/StockholdersEquity"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Stockholders\u2019 Equity",
        "documentation": "The entire disclosure for equity."
       }
      }
     },
     "auth_ref": [
      "r115",
      "r198",
      "r324",
      "r326",
      "r328",
      "r329",
      "r330",
      "r331",
      "r332",
      "r333",
      "r334",
      "r335",
      "r336",
      "r338",
      "r341",
      "r448",
      "r630",
      "r632",
      "r652"
     ]
    },
    "STSS_SubscriptionAgreementsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://sharpstechnology.com/20240930",
     "localname": "SubscriptionAgreementsMember",
     "presentation": [
      "http://sharpstechnology.com/role/StockholdersEquityDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Subscription Agreements [Member]",
        "documentation": "Subscription Agreements [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_SubsequentEventLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "SubsequentEventLineItems",
     "presentation": [
      "http://sharpstechnology.com/role/SubsequentEventsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Subsequent Event [Line Items]",
        "documentation": "Detail information of subsequent event by type. User is expected to use existing line items from elsewhere in the taxonomy as the primary line items for this disclosure, which is further associated with dimension and member elements pertaining to a subsequent event."
       }
      }
     },
     "auth_ref": [
      "r479",
      "r493"
     ]
    },
    "us-gaap_SubsequentEventMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "SubsequentEventMember",
     "presentation": [
      "http://sharpstechnology.com/role/SubsequentEventsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Subsequent Event [Member]",
        "documentation": "Identifies event that occurred after the balance sheet date but before financial statements are issued or available to be issued."
       }
      }
     },
     "auth_ref": [
      "r479",
      "r493"
     ]
    },
    "us-gaap_SubsequentEventTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "SubsequentEventTable",
     "presentation": [
      "http://sharpstechnology.com/role/SubsequentEventsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Subsequent Event [Table]",
        "documentation": "Disclosure of information about significant event or transaction occurring between statement of financial position date and date when financial statements were issued."
       }
      }
     },
     "auth_ref": [
      "r479",
      "r493"
     ]
    },
    "us-gaap_SubsequentEventTypeAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "SubsequentEventTypeAxis",
     "presentation": [
      "http://sharpstechnology.com/role/SubsequentEventsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Subsequent Event Type [Axis]",
        "documentation": "Information by event that occurred after the balance sheet date but before financial statements are issued or available to be issued."
       }
      }
     },
     "auth_ref": [
      "r479",
      "r493"
     ]
    },
    "us-gaap_SubsequentEventTypeDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "SubsequentEventTypeDomain",
     "presentation": [
      "http://sharpstechnology.com/role/SubsequentEventsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Event that occurred after the balance sheet date but before financial statements are issued or available to be issued."
       }
      }
     },
     "auth_ref": [
      "r479",
      "r493"
     ]
    },
    "STSS_SubsequentEvents": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://sharpstechnology.com/20240930",
     "localname": "SubsequentEvents",
     "crdr": "credit",
     "calculation": {
      "http://sharpstechnology.com/role/BalanceSheets": {
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://sharpstechnology.com/role/BalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Subsequent Events (Note 16)",
        "documentation": "Subsequent events."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_SubsequentEventsAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "SubsequentEventsAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Subsequent Events [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_SubsequentEventsTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "SubsequentEventsTextBlock",
     "presentation": [
      "http://sharpstechnology.com/role/SubsequentEvents"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Subsequent Events",
        "documentation": "The entire disclosure for significant events or transactions that occurred after the balance sheet date through the date the financial statements were issued or the date the financial statements were available to be issued. Examples include: the sale of a capital stock issue, purchase of a business, settlement of litigation, catastrophic loss, significant foreign exchange rate changes, loans to insiders or affiliates, and transactions not in the ordinary course of business."
       }
      }
     },
     "auth_ref": [
      "r492",
      "r494"
     ]
    },
    "us-gaap_SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable",
     "presentation": [
      "http://sharpstechnology.com/role/DescriptionOfBusinessDetailsNarrative",
      "http://sharpstechnology.com/role/ScheduleOfWarrantLiabilityDetails",
      "http://sharpstechnology.com/role/ScheduleOfWarrantOutstandingDetails",
      "http://sharpstechnology.com/role/StockholdersEquityDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Subsidiary or Equity Method Investee, Sale of Stock, Type [Table]",
        "documentation": "Disclosure of information about sale of stock made by subsidiary or equity method investee to investor outside consolidated group by type of sale. Includes, but is not limited to, stock issued in business combination in exchange for share of acquired entity."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_SubsidiarySaleOfStockAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "SubsidiarySaleOfStockAxis",
     "presentation": [
      "http://sharpstechnology.com/role/DescriptionOfBusinessDetailsNarrative",
      "http://sharpstechnology.com/role/NotePurchaseAgreementDetailsNarrative",
      "http://sharpstechnology.com/role/PreferredStockDetailsNarrative",
      "http://sharpstechnology.com/role/ScheduleOfWarrantLiabilityDetails",
      "http://sharpstechnology.com/role/ScheduleOfWarrantOutstandingDetails",
      "http://sharpstechnology.com/role/StockholdersEquityDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Sale of Stock [Axis]",
        "documentation": "Information by type of sale of the entity's stock."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_SubsidiarySaleOfStockLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "SubsidiarySaleOfStockLineItems",
     "presentation": [
      "http://sharpstechnology.com/role/DescriptionOfBusinessDetailsNarrative",
      "http://sharpstechnology.com/role/ScheduleOfWarrantLiabilityDetails",
      "http://sharpstechnology.com/role/ScheduleOfWarrantOutstandingDetails",
      "http://sharpstechnology.com/role/StockholdersEquityDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Subsidiary, Sale of Stock [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_SupplementalCashFlowInformationAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "SupplementalCashFlowInformationAbstract",
     "presentation": [
      "http://sharpstechnology.com/role/StatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "SUPPLEMENTAL DISCLOSURE OF CASH FLOW INFORMATION:"
       }
      }
     },
     "auth_ref": []
    },
    "srt_TitleOfIndividualAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/srt/2024",
     "localname": "TitleOfIndividualAxis",
     "presentation": [
      "http://sharpstechnology.com/role/CommitmentsAndContingenciesDetailsNarrative",
      "http://sharpstechnology.com/role/NotePurchaseAgreementDetailsNarrative",
      "http://sharpstechnology.com/role/PreferredStockDetailsNarrative",
      "http://sharpstechnology.com/role/RelatedPartyTransactionsAndBalancesDetailsNarrative",
      "http://sharpstechnology.com/role/StockOptionsDetailsNarrative",
      "http://sharpstechnology.com/role/StockholdersEquityDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Title and Position [Axis]"
       }
      }
     },
     "auth_ref": [
      "r768",
      "r849"
     ]
    },
    "srt_TitleOfIndividualWithRelationshipToEntityDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/srt/2024",
     "localname": "TitleOfIndividualWithRelationshipToEntityDomain",
     "presentation": [
      "http://sharpstechnology.com/role/CommitmentsAndContingenciesDetailsNarrative",
      "http://sharpstechnology.com/role/NotePurchaseAgreementDetailsNarrative",
      "http://sharpstechnology.com/role/PreferredStockDetailsNarrative",
      "http://sharpstechnology.com/role/RelatedPartyTransactionsAndBalancesDetailsNarrative",
      "http://sharpstechnology.com/role/StockOptionsDetailsNarrative",
      "http://sharpstechnology.com/role/StockholdersEquityDetailsNarrative"
     ],
     "auth_ref": []
    },
    "STSS_TradingAndOverallotmentWarrantsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://sharpstechnology.com/20240930",
     "localname": "TradingAndOverallotmentWarrantsMember",
     "presentation": [
      "http://sharpstechnology.com/role/ScheduleOfWarrantLiabilityDetails",
      "http://sharpstechnology.com/role/ScheduleOfWarrantOutstandingDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Trading and Over allotment Warrants [Member]",
        "documentation": "Trading and Over allotment Warrants [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "dei_TradingSymbol": {
     "xbrltype": "tradingSymbolItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "TradingSymbol",
     "presentation": [
      "http://sharpstechnology.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Trading Symbol",
        "documentation": "Trading symbol of an instrument as listed on an exchange."
       }
      }
     },
     "auth_ref": []
    },
    "STSS_TradingWarrantsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://sharpstechnology.com/20240930",
     "localname": "TradingWarrantsMember",
     "presentation": [
      "http://sharpstechnology.com/role/StockholdersEquityDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Trading Warrants [Member]",
        "documentation": "Trading Warrants [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "STSS_TwoThousandTwentyThreeEquityIncentivePlanMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://sharpstechnology.com/20240930",
     "localname": "TwoThousandTwentyThreeEquityIncentivePlanMember",
     "presentation": [
      "http://sharpstechnology.com/role/StockOptionsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "2023 Equity Incentive Plan [Member]",
        "documentation": "2023 Equity Incentive Plan [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "STSS_TwoThousandTwentyTwoEquityIncentivePlanMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://sharpstechnology.com/20240930",
     "localname": "TwoThousandTwentyTwoEquityIncentivePlanMember",
     "presentation": [
      "http://sharpstechnology.com/role/StockOptionsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "2022 Equity Incentive Plan [Member]",
        "documentation": "2022 Equity Incentive Plan [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_TypeOfArrangementAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "TypeOfArrangementAxis",
     "presentation": [
      "http://sharpstechnology.com/role/AssetAcquisitionDetailsNarrative",
      "http://sharpstechnology.com/role/CommitmentsAndContingenciesDetailsNarrative",
      "http://sharpstechnology.com/role/DebtFinancingDetailsNarrative",
      "http://sharpstechnology.com/role/NotePurchaseAgreementDetailsNarrative",
      "http://sharpstechnology.com/role/StockholdersEquityDetailsNarrative",
      "http://sharpstechnology.com/role/WarrantLiabilityDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Collaborative Arrangement and Arrangement Other than Collaborative [Axis]",
        "documentation": "Information by collaborative arrangement and arrangement other than collaborative applicable to revenue-generating activity or operations."
       }
      }
     },
     "auth_ref": [
      "r437"
     ]
    },
    "STSS_UnrelatedThirdPartyPurchasersMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://sharpstechnology.com/20240930",
     "localname": "UnrelatedThirdPartyPurchasersMember",
     "presentation": [
      "http://sharpstechnology.com/role/NotePurchaseAgreementDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Unrelated Third Party Purchasers [Member]",
        "documentation": "Unrelated Third Party Purchasers [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_UseOfEstimates": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "UseOfEstimates",
     "presentation": [
      "http://sharpstechnology.com/role/SummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Use of Estimates",
        "documentation": "Disclosure of accounting policy for the use of estimates in the preparation of financial statements in conformity with generally accepted accounting principles."
       }
      }
     },
     "auth_ref": [
      "r35",
      "r36",
      "r37",
      "r150",
      "r151",
      "r153",
      "r154"
     ]
    },
    "STSS_ValueOfDigitalMarketingActivities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://sharpstechnology.com/20240930",
     "localname": "ValueOfDigitalMarketingActivities",
     "crdr": "debit",
     "presentation": [
      "http://sharpstechnology.com/role/CommitmentsAndContingenciesDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Value of digital marketing activities",
        "documentation": "Value of digital marketing activities."
       }
      }
     },
     "auth_ref": []
    },
    "STSS_WarrantHolderMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://sharpstechnology.com/20240930",
     "localname": "WarrantHolderMember",
     "presentation": [
      "http://sharpstechnology.com/role/StockholdersEquityDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Warrant Holder [Member]",
        "documentation": "Warrant Holder [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "STSS_WarrantHoldersMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://sharpstechnology.com/20240930",
     "localname": "WarrantHoldersMember",
     "presentation": [
      "http://sharpstechnology.com/role/StockholdersEquityDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Warrant Holders [Member]",
        "documentation": "Warrant Holders [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "STSS_WarrantLiabilitiesCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://sharpstechnology.com/20240930",
     "localname": "WarrantLiabilitiesCurrent",
     "crdr": "credit",
     "calculation": {
      "http://sharpstechnology.com/role/BalanceSheets": {
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0,
       "order": 4.0
      }
     },
     "presentation": [
      "http://sharpstechnology.com/role/BalanceSheets",
      "http://sharpstechnology.com/role/ScheduleOfWarrantLiabilityDetails",
      "http://sharpstechnology.com/role/StockholdersEquityDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Warrant liability (Notes 8 and 10)",
        "verboseLabel": "Warrants liability",
        "terseLabel": "Total Warrant Liability",
        "documentation": "Warrant liabilities current."
       }
      }
     },
     "auth_ref": []
    },
    "STSS_WarrantLiability": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://sharpstechnology.com/20240930",
     "localname": "WarrantLiability",
     "crdr": "credit",
     "presentation": [
      "http://sharpstechnology.com/role/ScheduleOfAssetsAndLiabilitiesMeasuredAtFairValueOnRecurringBasisDetails",
      "http://sharpstechnology.com/role/ScheduleOfWarrantLiabilityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Total Warrant Liability",
        "verboseLabel": "Warrant liability",
        "documentation": "Warrant liability."
       }
      }
     },
     "auth_ref": []
    },
    "STSS_WarrantLiabilityTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://sharpstechnology.com/20240930",
     "localname": "WarrantLiabilityTextBlock",
     "presentation": [
      "http://sharpstechnology.com/role/WarrantLiability"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Warrant Liability",
        "documentation": "Warrant Liability [Text Block]",
        "label": "Warrant Liability [Text Block]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_WarrantMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "WarrantMember",
     "presentation": [
      "http://sharpstechnology.com/role/ScheduleOfFairValueOfWarrantDetails",
      "http://sharpstechnology.com/role/StockholdersEquityDetailsNarrative",
      "http://sharpstechnology.com/role/SubsequentEventsDetailsNarrative",
      "http://sharpstechnology.com/role/WarrantLiabilityTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Warrant [Member]",
        "documentation": "Security that gives the holder the right to purchase shares of stock in accordance with the terms of the instrument, usually upon payment of a specified amount."
       }
      }
     },
     "auth_ref": [
      "r700",
      "r701",
      "r704",
      "r705",
      "r706",
      "r707"
     ]
    },
    "us-gaap_WarrantsAndRightsOutstanding": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "WarrantsAndRightsOutstanding",
     "crdr": "credit",
     "presentation": [
      "http://sharpstechnology.com/role/StockholdersEquityDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Nominal cost of warrant",
        "documentation": "Value of outstanding derivative securities that permit the holder the right to purchase securities (usually equity) from the issuer at a specified price."
       }
      }
     },
     "auth_ref": [
      "r830",
      "r831",
      "r832"
     ]
    },
    "us-gaap_WarrantsAndRightsOutstandingMeasurementInput": {
     "xbrltype": "decimalItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "WarrantsAndRightsOutstandingMeasurementInput",
     "presentation": [
      "http://sharpstechnology.com/role/ScheduleOfFairValueOfWarrantDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Warrants liabilities measurement input",
        "documentation": "Value of input used to measure outstanding warrant and right embodying unconditional obligation requiring redemption by transferring asset at specified or determinable date or upon event certain to occur."
       }
      }
     },
     "auth_ref": [
      "r830",
      "r831",
      "r832"
     ]
    },
    "us-gaap_WarrantsAndRightsOutstandingTerm": {
     "xbrltype": "durationItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "WarrantsAndRightsOutstandingTerm",
     "presentation": [
      "http://sharpstechnology.com/role/ScheduleOfFairValueOfWarrantDetails",
      "http://sharpstechnology.com/role/StockholdersEquityDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Warrants exercise price term",
        "verboseLabel": "Expected term (in years)",
        "documentation": "Period between issuance and expiration of outstanding warrant and right embodying unconditional obligation requiring redemption by transferring asset at specified or determinable date or upon event certain to occur, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days."
       }
      }
     },
     "auth_ref": [
      "r830",
      "r831",
      "r832"
     ]
    },
    "STSS_WarrantsIssuedForServiceManagementMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://sharpstechnology.com/20240930",
     "localname": "WarrantsIssuedForServiceManagementMember",
     "presentation": [
      "http://sharpstechnology.com/role/ScheduleOfWarrantOutstandingDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Warrants Issued for Services Arrangement [Member]",
        "documentation": "Warrants Issued for Services Arrangement [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "STSS_WebsiteMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://sharpstechnology.com/20240930",
     "localname": "WebsiteMember",
     "presentation": [
      "http://sharpstechnology.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Website [Member]",
        "documentation": "Website [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "WeightedAverageNumberOfDilutedSharesOutstanding",
     "presentation": [
      "http://sharpstechnology.com/role/StatementsOfOperations"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Weighted average shares used to compute net loss per share, diluted",
        "documentation": "The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period."
       }
      }
     },
     "auth_ref": [
      "r220",
      "r226"
     ]
    },
    "us-gaap_WeightedAverageNumberOfSharesOutstandingBasic": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "WeightedAverageNumberOfSharesOutstandingBasic",
     "presentation": [
      "http://sharpstechnology.com/role/StatementsOfOperations",
      "http://sharpstechnology.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Weighted average shares used to compute net loss per share, basic",
        "verboseLabel": "Weighted average shares outstanding basic",
        "documentation": "Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period."
       }
      }
     },
     "auth_ref": [
      "r219",
      "r226"
     ]
    },
    "STSS_WorkingCapital": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://sharpstechnology.com/20240930",
     "localname": "WorkingCapital",
     "crdr": "credit",
     "presentation": [
      "http://sharpstechnology.com/role/DescriptionOfBusinessDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Working capital",
        "documentation": "Working capital."
       }
      }
     },
     "auth_ref": []
    },
    "dei_WrittenCommunications": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "WrittenCommunications",
     "presentation": [
      "http://sharpstechnology.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Written Communications",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act."
       }
      }
     },
     "auth_ref": [
      "r729"
     ]
    }
   }
  }
 },
 "std_ref": {
  "r0": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "05",
   "Paragraph": "4",
   "SubTopic": "10",
   "Topic": "360",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482338/360-10-05-4"
  },
  "r1": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "25",
   "Paragraph": "13",
   "SubTopic": "10",
   "Topic": "480",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481766/480-10-25-13"
  },
  "r2": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "SubTopic": "230",
   "Topic": "830",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477401/830-230-45-1"
  },
  "r3": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "10A",
   "SubTopic": "10",
   "Topic": "220",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482790/220-10-45-10A"
  },
  "r4": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "10A",
   "Subparagraph": "(a)",
   "SubTopic": "10",
   "Topic": "220",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482790/220-10-45-10A"
  },
  "r5": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "12",
   "SubTopic": "10",
   "Topic": "220",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482790/220-10-45-12"
  },
  "r6": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "14",
   "Subparagraph": "(a)",
   "SubTopic": "10",
   "Topic": "230",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-14"
  },
  "r7": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "20",
   "SubTopic": "10",
   "Topic": "810",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481231/810-10-45-20"
  },
  "r8": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "28",
   "Subparagraph": "(a)",
   "SubTopic": "10",
   "Topic": "230",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-28"
  },
  "r9": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "28",
   "Subparagraph": "(b)",
   "SubTopic": "10",
   "Topic": "230",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-28"
  },
  "r10": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "SubTopic": "10",
   "Topic": "360",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482099/360-10-50-1"
  },
  "r11": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1A",
   "Subparagraph": "(c)(3)",
   "SubTopic": "10",
   "Topic": "810",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481203/810-10-50-1A"
  },
  "r12": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1B",
   "SubTopic": "10",
   "Topic": "810",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481203/810-10-50-1B"
  },
  "r13": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "SubTopic": "10",
   "Topic": "505",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-2"
  },
  "r14": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "SubTopic": "10",
   "Topic": "815",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480434/815-10-50-2"
  },
  "r15": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iv)(02)",
   "SubTopic": "10",
   "Topic": "718",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r16": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(d)",
   "SubTopic": "10",
   "Topic": "718",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r17": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(e)",
   "SubTopic": "10",
   "Topic": "718",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r18": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(22))",
   "SubTopic": "10",
   "Topic": "210",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r19": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "210",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483489/210-10-50-1"
  },
  "r20": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "220",
   "SubTopic": "10",
   "Section": "45",
   "Paragraph": "14",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482790/220-10-45-14"
  },
  "r21": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "220",
   "SubTopic": "10",
   "Section": "45",
   "Paragraph": "14A",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482790/220-10-45-14A"
  },
  "r22": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "220",
   "SubTopic": "10",
   "Section": "45",
   "Paragraph": "5",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482790/220-10-45-5"
  },
  "r23": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "230",
   "SubTopic": "10",
   "Section": "45",
   "Paragraph": "13",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-13"
  },
  "r24": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "230",
   "SubTopic": "10",
   "Section": "45",
   "Paragraph": "14",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-14"
  },
  "r25": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "230",
   "SubTopic": "10",
   "Section": "45",
   "Paragraph": "15",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-15"
  },
  "r26": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "230",
   "SubTopic": "10",
   "Section": "45",
   "Paragraph": "15",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-15"
  },
  "r27": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "230",
   "SubTopic": "10",
   "Section": "45",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-4"
  },
  "r28": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "230",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482913/230-10-50-1"
  },
  "r29": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "230",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482913/230-10-50-2"
  },
  "r30": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "230",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482913/230-10-50-3"
  },
  "r31": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "230",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482913/230-10-50-4"
  },
  "r32": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "230",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "5",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482913/230-10-50-5"
  },
  "r33": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "260",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482662/260-10-50-1"
  },
  "r34": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "260",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482662/260-10-50-2"
  },
  "r35": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "275",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482861/275-10-50-4"
  },
  "r36": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "275",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "8",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482861/275-10-50-8"
  },
  "r37": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "275",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "9",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482861/275-10-50-9"
  },
  "r38": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "360",
   "SubTopic": "10",
   "Section": "45",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482130/360-10-45-4"
  },
  "r39": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "360",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482099/360-10-50-1"
  },
  "r40": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "360",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482099/360-10-50-1"
  },
  "r41": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "450",
   "SubTopic": "20",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483076/450-20-50-1"
  },
  "r42": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "450",
   "SubTopic": "20",
   "Section": "50",
   "Paragraph": "9",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483076/450-20-50-9"
  },
  "r43": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "460",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "8",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482425/460-10-50-8"
  },
  "r44": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "505",
   "SubTopic": "10",
   "Section": "45",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481142/505-10-45-2"
  },
  "r45": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "505",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "10",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-10"
  },
  "r46": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "505",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-3"
  },
  "r47": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "505",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-4"
  },
  "r48": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "505",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "5",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-5"
  },
  "r49": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "505",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "8",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-8"
  },
  "r50": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "718",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-1"
  },
  "r51": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "718",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r52": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "718",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(iii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r53": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "718",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r54": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "718",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(g)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r55": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "718",
   "SubTopic": "20",
   "Section": "55",
   "Paragraph": "12",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481089/718-20-55-12"
  },
  "r56": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "718",
   "SubTopic": "20",
   "Section": "55",
   "Paragraph": "13",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481089/718-20-55-13"
  },
  "r57": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "805",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479328/805-10-50-2"
  },
  "r58": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "805",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479328/805-10-50-3"
  },
  "r59": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "805",
   "SubTopic": "10",
   "Section": "55",
   "Paragraph": "37",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479303/805-10-55-37"
  },
  "r60": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "805",
   "SubTopic": "20",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479907/805-20-50-1"
  },
  "r61": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "810",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481203/810-10-50-1A"
  },
  "r62": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "815",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480434/815-10-50-1"
  },
  "r63": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "815",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480434/815-10-50-1A"
  },
  "r64": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "815",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480434/815-10-50-4"
  },
  "r65": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "815",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "4A",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480434/815-10-50-4A"
  },
  "r66": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "815",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "4C",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480434/815-10-50-4C"
  },
  "r67": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "815",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "4D",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480434/815-10-50-4D"
  },
  "r68": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "815",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "7",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480434/815-10-50-7"
  },
  "r69": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "942",
   "SubTopic": "470",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477734/942-470-50-3"
  },
  "r70": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "205",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/205/tableOfContent"
  },
  "r71": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(19)(a))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r72": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(19))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r73": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(20))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r74": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(21))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r75": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(22)(a)(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r76": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(23))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r77": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(24))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r78": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(25))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r79": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(26))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r80": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(28))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r81": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(29))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r82": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(30)(a)(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r83": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(30)(a)(3))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r84": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(30))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r85": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(31))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r86": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(32))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r87": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(6)(a))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r88": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(6)(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r89": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(6)(c))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r90": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "11",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482790/220-10-45-11"
  },
  "r91": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03(10))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483621/220-10-S99-2"
  },
  "r92": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03(20))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483621/220-10-S99-2"
  },
  "r93": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03(4))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483621/220-10-S99-2"
  },
  "r94": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03(6))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483621/220-10-S99-2"
  },
  "r95": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03(7))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483621/220-10-S99-2"
  },
  "r96": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03(8))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483621/220-10-S99-2"
  },
  "r97": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03(9))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483621/220-10-S99-2"
  },
  "r98": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "13",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-13"
  },
  "r99": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "15",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-15"
  },
  "r100": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "24",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-24"
  },
  "r101": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "25",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-25"
  },
  "r102": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "28",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-28"
  },
  "r103": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "235",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/235/tableOfContent"
  },
  "r104": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "275",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/275/tableOfContent"
  },
  "r105": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "310",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SAB Topic 4.E)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480418/310-10-S99-2"
  },
  "r106": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "330",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SAB Topic 5.BB)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480581/330-10-S99-2"
  },
  "r107": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "360",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/360/tableOfContent"
  },
  "r108": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "360",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482099/360-10-50-1"
  },
  "r109": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "360",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482099/360-10-50-2"
  },
  "r110": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "360",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SAB Topic 5.CC)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480091/360-10-S99-2"
  },
  "r111": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "440",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/440/tableOfContent"
  },
  "r112": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "450",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483076/450-20-50-4"
  },
  "r113": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "470",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/470/tableOfContent"
  },
  "r114": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "480",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(02)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480244/480-10-S99-1"
  },
  "r115": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "505",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/505/tableOfContent"
  },
  "r116": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-6"
  },
  "r117": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-7"
  },
  "r118": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.3-04)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480008/505-10-S99-1"
  },
  "r119": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r120": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r121": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r122": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(ii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r123": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r124": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "718",
   "SubTopic": "10",
   "Subparagraph": "(e)(1)",
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Section": "50",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r125": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "718",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)",
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Section": "50",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r126": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "810",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "19",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481231/810-10-45-19"
  },
  "r127": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "810",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "23",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481231/810-10-45-23"
  },
  "r128": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "815",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4B",
   "Subparagraph": "(c)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480434/815-10-50-4B"
  },
  "r129": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "820",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/820/tableOfContent"
  },
  "r130": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "942",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-03(10))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478546/942-210-S99-1"
  },
  "r131": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "942",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-03(11))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478546/942-210-S99-1"
  },
  "r132": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "942",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-03(13))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478546/942-210-S99-1"
  },
  "r133": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "942",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-03(15)(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478546/942-210-S99-1"
  },
  "r134": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "942",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-03(15)(5))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478546/942-210-S99-1"
  },
  "r135": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "942",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-03(16))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478546/942-210-S99-1"
  },
  "r136": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "942",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-03(17))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478546/942-210-S99-1"
  },
  "r137": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "942",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-03(23))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478546/942-210-S99-1"
  },
  "r138": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "942",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-04(13)(h))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478524/942-220-S99-1"
  },
  "r139": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "942",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-04(14))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478524/942-220-S99-1"
  },
  "r140": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "942",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-04(15))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478524/942-220-S99-1"
  },
  "r141": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "942",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-04(22))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478524/942-220-S99-1"
  },
  "r142": {
   "role": "http://fasb.org/us-gaap/role/ref/otherTransitionRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "32",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-32"
  },
  "r143": {
   "role": "http://fasb.org/us-gaap/role/ref/otherTransitionRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "32",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-32"
  },
  "r144": {
   "role": "http://fasb.org/us-gaap/role/ref/otherTransitionRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "32",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-32"
  },
  "r145": {
   "role": "http://fasb.org/us-gaap/role/ref/otherTransitionRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "32",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-32"
  },
  "r146": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "13",
   "Subparagraph": "(c)",
   "SubTopic": "10",
   "Topic": "230",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-13"
  },
  "r147": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "2",
   "Subparagraph": "(a)",
   "SubTopic": "20",
   "Topic": "740",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482659/740-20-45-2"
  },
  "r148": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "20",
   "SubTopic": "210",
   "Topic": "946",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477796/946-210-45-20"
  },
  "r149": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "6",
   "Subparagraph": "(a)",
   "SubTopic": "10",
   "Topic": "270",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482989/270-10-45-6"
  },
  "r150": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)",
   "SubTopic": "10",
   "Topic": "275",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482861/275-10-50-1"
  },
  "r151": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(c)",
   "SubTopic": "10",
   "Topic": "275",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482861/275-10-50-1"
  },
  "r152": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)",
   "SubTopic": "360",
   "Topic": "958",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477798/958-360-50-1"
  },
  "r153": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "11",
   "SubTopic": "10",
   "Topic": "275",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482861/275-10-50-11"
  },
  "r154": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "12",
   "SubTopic": "10",
   "Topic": "275",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482861/275-10-50-12"
  },
  "r155": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "SubTopic": "360",
   "Topic": "958",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477798/958-360-50-6"
  },
  "r156": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "SubTopic": "360",
   "Topic": "958",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477798/958-360-50-7"
  },
  "r157": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "9",
   "Subparagraph": "(b)",
   "SubTopic": "10",
   "Topic": "740",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-9"
  },
  "r158": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.4-08(h))",
   "SubTopic": "10",
   "Topic": "235",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480678/235-10-S99-1"
  },
  "r159": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Section": "1402",
   "Paragraph": "a",
   "Publisher": "SEC"
  },
  "r160": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "105",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "6",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479343/105-10-65-6"
  },
  "r161": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "205",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483499/205-20-50-7"
  },
  "r162": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483467/210-10-45-1"
  },
  "r163": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "5",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483467/210-10-45-5"
  },
  "r164": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483489/210-10-50-1"
  },
  "r165": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r166": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(13))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r167": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(14))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r168": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(17))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r169": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(18))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r170": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(22)(a)(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r171": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(27)(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r172": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(28))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r173": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(29))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r174": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(30)(a)(4))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r175": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(6)(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r176": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(6))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r177": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(9))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r178": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483466/210-20-50-3"
  },
  "r179": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "10",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483444/210-20-55-10"
  },
  "r180": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1A",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482790/220-10-45-1A"
  },
  "r181": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1A",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482790/220-10-45-1A"
  },
  "r182": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1B",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482790/220-10-45-1B"
  },
  "r183": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1B",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482790/220-10-45-1B"
  },
  "r184": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482765/220-10-50-1"
  },
  "r185": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482765/220-10-50-4"
  },
  "r186": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482765/220-10-50-5"
  },
  "r187": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482765/220-10-50-6"
  },
  "r188": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03(24))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483621/220-10-S99-2"
  },
  "r189": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03(25))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483621/220-10-S99-2"
  },
  "r190": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "17",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-17"
  },
  "r191": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "24",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-24"
  },
  "r192": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "25",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-25"
  },
  "r193": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482913/230-10-50-2"
  },
  "r194": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2A",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482913/230-10-50-2A"
  },
  "r195": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "8",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482913/230-10-50-8"
  },
  "r196": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483426/235-10-50-1"
  },
  "r197": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.4-08(c))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480678/235-10-S99-1"
  },
  "r198": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.4-08(e)(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480678/235-10-S99-1"
  },
  "r199": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.4-08(g)(1)(ii))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480678/235-10-S99-1"
  },
  "r200": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.4-08(h)(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480678/235-10-S99-1"
  },
  "r201": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.4-08(h)(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480678/235-10-S99-1"
  },
  "r202": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.4-08(n))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480678/235-10-S99-1"
  },
  "r203": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.12-04(a))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480678/235-10-S99-3"
  },
  "r204": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "23",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483421/250-10-45-23"
  },
  "r205": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "24",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483421/250-10-45-24"
  },
  "r206": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "5",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483421/250-10-45-5"
  },
  "r207": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-1"
  },
  "r208": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-1"
  },
  "r209": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "11",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-11"
  },
  "r210": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "11",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-11"
  },
  "r211": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-3"
  },
  "r212": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-4"
  },
  "r213": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-6"
  },
  "r214": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-7"
  },
  "r215": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-7"
  },
  "r216": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "8",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-8"
  },
  "r217": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "9",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-9"
  },
  "r218": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "5",
   "Subparagraph": "(SAB Topic 11.M.Q2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480530/250-10-S99-5"
  },
  "r219": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "10",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482689/260-10-45-10"
  },
  "r220": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "16",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482689/260-10-45-16"
  },
  "r221": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482689/260-10-45-2"
  },
  "r222": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482689/260-10-45-3"
  },
  "r223": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "60B",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482689/260-10-45-60B"
  },
  "r224": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "60B",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482689/260-10-45-60B"
  },
  "r225": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "7",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482689/260-10-45-7"
  },
  "r226": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482662/260-10-50-1"
  },
  "r227": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482662/260-10-50-1"
  },
  "r228": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482662/260-10-50-1"
  },
  "r229": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "15",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482635/260-10-55-15"
  },
  "r230": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "270",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482964/270-10-50-1"
  },
  "r231": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "272",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483014/272-10-45-1"
  },
  "r232": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "272",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482987/272-10-50-1"
  },
  "r233": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "272",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482987/272-10-50-3"
  },
  "r234": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "22",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-22"
  },
  "r235": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "22",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-22"
  },
  "r236": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "22",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-22"
  },
  "r237": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "22",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-22"
  },
  "r238": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "22",
   "Subparagraph": "(h)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-22"
  },
  "r239": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "24",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-24"
  },
  "r240": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "30",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-30"
  },
  "r241": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "30",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-30"
  },
  "r242": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "32",
   "Subparagraph": "(ee)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-32"
  },
  "r243": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "40",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-40"
  },
  "r244": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "41",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-41"
  },
  "r245": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "42",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-42"
  },
  "r246": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "310",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "13",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481990/310-10-45-13"
  },
  "r247": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "323",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(a)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481687/323-10-50-3"
  },
  "r248": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "323",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(a)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481687/323-10-50-3"
  },
  "r249": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "323",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481687/323-10-50-3"
  },
  "r250": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "323",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481687/323-10-50-3"
  },
  "r251": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "326",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "4",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479654/326-10-65-4"
  },
  "r252": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "326",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "5",
   "Subparagraph": "(c)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479654/326-10-65-5"
  },
  "r253": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "330",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/330/tableOfContent"
  },
  "r254": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "330",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483080/330-10-50-1"
  },
  "r255": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "330",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483080/330-10-50-4"
  },
  "r256": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482686/350-30-45-1"
  },
  "r257": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482686/350-30-45-2"
  },
  "r258": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482665/350-30-50-1"
  },
  "r259": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482665/350-30-50-1"
  },
  "r260": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482665/350-30-50-1"
  },
  "r261": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482665/350-30-50-1"
  },
  "r262": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482665/350-30-50-1"
  },
  "r263": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482665/350-30-50-2"
  },
  "r264": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "60",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "1",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147476166/350-60-65-1"
  },
  "r265": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "360",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482099/360-10-50-3"
  },
  "r266": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "405",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477092/405-40-50-1"
  },
  "r267": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "405",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477092/405-40-50-1"
  },
  "r268": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "405",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477092/405-40-50-1"
  },
  "r269": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "405",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477092/405-40-50-1"
  },
  "r270": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "405",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477092/405-40-50-1"
  },
  "r271": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "405",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(e)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477092/405-40-50-1"
  },
  "r272": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "420",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482017/420-10-50-1"
  },
  "r273": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "420",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482017/420-10-50-1"
  },
  "r274": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "420",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482017/420-10-50-1"
  },
  "r275": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "420",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482017/420-10-50-1"
  },
  "r276": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "420",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SAB Topic 5.P.4.b.1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479823/420-10-S99-2"
  },
  "r277": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "420",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SAB Topic 5.P.4.b.2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479823/420-10-S99-2"
  },
  "r278": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "420",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SAB Topic 5.P.4.d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479823/420-10-S99-2"
  },
  "r279": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "440",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482648/440-10-50-4"
  },
  "r280": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "440",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482648/440-10-50-4"
  },
  "r281": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "450",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483076/450-20-50-1"
  },
  "r282": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "450",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483076/450-20-50-4"
  },
  "r283": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "450",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "9",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483076/450-20-50-9"
  },
  "r284": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "450",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SAB Topic 5.Y.Q2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480102/450-20-S99-1"
  },
  "r285": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "450",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SAB Topic 5.Y.Q4)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480102/450-20-S99-1"
  },
  "r286": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "460",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482425/460-10-50-3"
  },
  "r287": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481544/470-10-50-6"
  },
  "r288": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481544/470-10-50-6"
  },
  "r289": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1A",
   "Subparagraph": "(SX 210.13-01(a)(4)(i))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1A"
  },
  "r290": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1A",
   "Subparagraph": "(SX 210.13-01(a)(4)(iii)(A))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1A"
  },
  "r291": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1A",
   "Subparagraph": "(SX 210.13-01(a)(4)(iv))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1A"
  },
  "r292": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1A",
   "Subparagraph": "(SX 210.13-01(a)(5))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1A"
  },
  "r293": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1B",
   "Subparagraph": "(SX 210.13-02(a)(4)(i))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1B"
  },
  "r294": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1B",
   "Subparagraph": "(SX 210.13-02(a)(4)(iii)(A))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1B"
  },
  "r295": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1B",
   "Subparagraph": "(SX 210.13-02(a)(4)(iii)(B))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1B"
  },
  "r296": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1B",
   "Subparagraph": "(SX 210.13-02(a)(4)(iv))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1B"
  },
  "r297": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1B",
   "Subparagraph": "(SX 210.13-02(a)(5))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1B"
  },
  "r298": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1B"
  },
  "r299": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1B",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1B"
  },
  "r300": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1B",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1B"
  },
  "r301": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1B",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1B"
  },
  "r302": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1B",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1B"
  },
  "r303": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1B",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1B"
  },
  "r304": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1B",
   "Subparagraph": "(g)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1B"
  },
  "r305": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1B",
   "Subparagraph": "(h)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1B"
  },
  "r306": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1B",
   "Subparagraph": "(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1B"
  },
  "r307": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1C",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1C"
  },
  "r308": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1C",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1C"
  },
  "r309": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1C",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1C"
  },
  "r310": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1D",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1D"
  },
  "r311": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1D",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1D"
  },
  "r312": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1D",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1D"
  },
  "r313": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1E",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1E"
  },
  "r314": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1E",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1E"
  },
  "r315": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1E",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1E"
  },
  "r316": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1E",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1E"
  },
  "r317": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1F",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1F"
  },
  "r318": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1F",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1F"
  },
  "r319": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1F",
   "Subparagraph": "(b)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1F"
  },
  "r320": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1F",
   "Subparagraph": "(b)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1F"
  },
  "r321": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1I",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1I"
  },
  "r322": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1I",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1I"
  },
  "r323": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1I",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1I"
  },
  "r324": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "13",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-13"
  },
  "r325": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "13",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-13"
  },
  "r326": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "13",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-13"
  },
  "r327": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "13",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-13"
  },
  "r328": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "13",
   "Subparagraph": "(g)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-13"
  },
  "r329": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "13",
   "Subparagraph": "(h)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-13"
  },
  "r330": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "13",
   "Subparagraph": "(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-13"
  },
  "r331": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "14",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-14"
  },
  "r332": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "14",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-14"
  },
  "r333": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "14",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-14"
  },
  "r334": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "16",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-16"
  },
  "r335": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "18",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-18"
  },
  "r336": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "18",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-18"
  },
  "r337": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "18",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-18"
  },
  "r338": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "18",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-18"
  },
  "r339": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-2"
  },
  "r340": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-3"
  },
  "r341": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.3-04)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480008/505-10-S99-1"
  },
  "r342": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479806/606-10-50-4"
  },
  "r343": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479806/606-10-50-5"
  },
  "r344": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1"
  },
  "r345": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)(iv)(01)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1"
  },
  "r346": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)(iv)(02)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1"
  },
  "r347": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)(iv)(02)(A)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1"
  },
  "r348": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)(iv)(02)(B)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1"
  },
  "r349": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)(iv)(02)(C)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1"
  },
  "r350": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)(iv)(03)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1"
  },
  "r351": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "80",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480576/715-80-50-5"
  },
  "r352": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "80",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(f)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480576/715-80-50-5"
  },
  "r353": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/718/tableOfContent"
  },
  "r354": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "35",
   "Paragraph": "1D",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480483/718-10-35-1D"
  },
  "r355": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "35",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480483/718-10-35-2"
  },
  "r356": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "35",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480483/718-10-35-3"
  },
  "r357": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r358": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r359": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r360": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r361": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r362": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(ii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r363": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r364": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iv)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r365": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iv)(01)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r366": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iv)(02)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r367": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iv)(03)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r368": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iv)(04)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r369": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r370": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)(ii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r371": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)(iii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r372": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)(iii)(01)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r373": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)(iii)(02)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r374": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)(iii)(03)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r375": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(d)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r376": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(d)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r377": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(e)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r378": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(e)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r379": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r380": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)(ii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r381": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)(iii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r382": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)(iv)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r383": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)(v)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r384": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(h)(1)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r385": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(h)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r386": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(h)(2)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r387": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r388": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(l)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r389": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SAB Topic 14.F)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479830/718-10-S99-1"
  },
  "r390": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "720",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483359/720-20-50-1"
  },
  "r391": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "730",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "05",
   "Paragraph": "1",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483044/730-10-05-1"
  },
  "r392": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "730",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482916/730-10-50-1"
  },
  "r393": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/740/tableOfContent"
  },
  "r394": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "15",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482525/740-10-45-15"
  },
  "r395": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "25",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482525/740-10-45-25"
  },
  "r396": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "28",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482525/740-10-45-28"
  },
  "r397": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482525/740-10-45-4"
  },
  "r398": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "6",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482525/740-10-45-6"
  },
  "r399": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "10",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-10"
  },
  "r400": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "10A",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-10A"
  },
  "r401": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "12",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-12"
  },
  "r402": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "12",
   "Subparagraph": "(b)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-12"
  },
  "r403": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "12A",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-12A"
  },
  "r404": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "12A",
   "Subparagraph": "(a)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-12A"
  },
  "r405": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "12A",
   "Subparagraph": "(a)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-12A"
  },
  "r406": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "12A",
   "Subparagraph": "(a)(6)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-12A"
  },
  "r407": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "12B",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-12B"
  },
  "r408": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "12C",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-12C"
  },
  "r409": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "14",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-14"
  },
  "r410": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "15",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-15"
  },
  "r411": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "17",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-17"
  },
  "r412": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "19",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-19"
  },
  "r413": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-2"
  },
  "r414": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "20",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-20"
  },
  "r415": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "21",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-21"
  },
  "r416": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "22",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-22"
  },
  "r417": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "23",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-23"
  },
  "r418": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-3"
  },
  "r419": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "9",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-9"
  },
  "r420": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "8",
   "Subparagraph": "(d)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482615/740-10-65-8"
  },
  "r421": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "8",
   "Subparagraph": "(d)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482615/740-10-65-8"
  },
  "r422": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SAB Topic 6.I.5.Q1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479360/740-10-S99-1"
  },
  "r423": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SAB Topic 6.I.7)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479360/740-10-S99-1"
  },
  "r424": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SAB Topic 11.C)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479360/740-10-S99-2"
  },
  "r425": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "270",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477891/740-270-50-1"
  },
  "r426": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482603/740-30-50-2"
  },
  "r427": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "323",
   "Name": "Accounting Standards Codification",
   "Section": "25",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478758/740-323-25-1"
  },
  "r428": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "323",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(d)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478666/740-323-65-2"
  },
  "r429": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "323",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(d)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478666/740-323-65-2"
  },
  "r430": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "323",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478666/740-323-65-2"
  },
  "r431": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "323",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(g)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478666/740-323-65-2"
  },
  "r432": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "323",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(g)(4)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478666/740-323-65-2"
  },
  "r433": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "805",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479907/805-20-50-5"
  },
  "r434": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "805",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479581/805-30-50-1"
  },
  "r435": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "805",
   "SubTopic": "60",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "1",
   "Subparagraph": "(d)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147476176/805-60-65-1"
  },
  "r436": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "805",
   "SubTopic": "60",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "1",
   "Subparagraph": "(g)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147476176/805-60-65-1"
  },
  "r437": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "808",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479402/808-10-50-1"
  },
  "r438": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "810",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "25",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481231/810-10-45-25"
  },
  "r439": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "810",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "25",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481231/810-10-45-25"
  },
  "r440": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "810",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(bb)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481203/810-10-50-3"
  },
  "r441": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "810",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481203/810-10-50-3"
  },
  "r442": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "6",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480528/815-20-65-6"
  },
  "r443": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "6",
   "Subparagraph": "(h)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480528/815-20-65-6"
  },
  "r444": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "6",
   "Subparagraph": "(h)(1)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480528/815-20-65-6"
  },
  "r445": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "6",
   "Subparagraph": "(h)(1)(iii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480528/815-20-65-6"
  },
  "r446": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "6",
   "Subparagraph": "(h)(1)(iv)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480528/815-20-65-6"
  },
  "r447": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "6",
   "Subparagraph": "(i)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480528/815-20-65-6"
  },
  "r448": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480237/815-40-50-6"
  },
  "r449": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "1",
   "Subparagraph": "(e)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480175/815-40-65-1"
  },
  "r450": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "1",
   "Subparagraph": "(e)(4)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480175/815-40-65-1"
  },
  "r451": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "1",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480175/815-40-65-1"
  },
  "r452": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "35",
   "Paragraph": "54B",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482134/820-10-35-54B"
  },
  "r453": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2"
  },
  "r454": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2"
  },
  "r455": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(bbb)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2"
  },
  "r456": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(bbb)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2"
  },
  "r457": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(bbb)(2)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2"
  },
  "r458": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2"
  },
  "r459": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2"
  },
  "r460": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2E",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2E"
  },
  "r461": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-3"
  },
  "r462": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-3"
  },
  "r463": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6A",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-6A"
  },
  "r464": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "825",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "10",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482907/825-10-50-10"
  },
  "r465": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "825",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "28",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482907/825-10-50-28"
  },
  "r466": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "830",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/830/tableOfContent"
  },
  "r467": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "830",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "17",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481839/830-10-45-17"
  },
  "r468": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "830",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "35",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482014/830-20-35-1"
  },
  "r469": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "830",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481956/830-20-45-1"
  },
  "r470": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "830",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "5",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481956/830-20-45-5"
  },
  "r471": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "830",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481926/830-20-50-1"
  },
  "r472": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "830",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "17",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481694/830-30-45-17"
  },
  "r473": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "830",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "20",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481694/830-30-45-20"
  },
  "r474": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "830",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "20",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481694/830-30-45-20"
  },
  "r475": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "830",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "20",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481694/830-30-45-20"
  },
  "r476": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "830",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "20",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481694/830-30-45-20"
  },
  "r477": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "830",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "21",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481694/830-30-45-21"
  },
  "r478": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "830",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481674/830-30-50-1"
  },
  "r479": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "830",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481674/830-30-50-2"
  },
  "r480": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "835",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483013/835-20-50-1"
  },
  "r481": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "835",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482925/835-30-45-2"
  },
  "r482": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "835",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482900/835-30-50-1"
  },
  "r483": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "842",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "8",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479832/842-10-65-8"
  },
  "r484": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "35",
   "Paragraph": "12A",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479165/842-20-35-12A"
  },
  "r485": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7A",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478964/842-20-50-7A"
  },
  "r486": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "848",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(a)(3)(iii)(03)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483550/848-10-65-2"
  },
  "r487": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "850",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/850/tableOfContent"
  },
  "r488": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "850",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483326/850-10-50-1"
  },
  "r489": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "850",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483326/850-10-50-1"
  },
  "r490": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "850",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483326/850-10-50-1"
  },
  "r491": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "850",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483326/850-10-50-6"
  },
  "r492": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "855",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/855/tableOfContent"
  },
  "r493": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "855",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483399/855-10-50-2"
  },
  "r494": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "855",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483399/855-10-50-2"
  },
  "r495": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(bb)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481326/860-20-50-3"
  },
  "r496": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(bb)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481326/860-20-50-3"
  },
  "r497": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(bb)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481326/860-20-50-3"
  },
  "r498": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(c)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481326/860-20-50-3"
  },
  "r499": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481420/860-30-50-7"
  },
  "r500": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "910",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482546/910-10-50-6"
  },
  "r501": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "912",
   "SubTopic": "330",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478411/912-330-50-1"
  },
  "r502": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "920",
   "SubTopic": "350",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478609/920-350-50-1"
  },
  "r503": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "920",
   "SubTopic": "350",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478609/920-350-50-1"
  },
  "r504": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "920",
   "SubTopic": "350",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478609/920-350-50-4"
  },
  "r505": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "924",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SAB Topic 11.L)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479941/924-10-S99-1"
  },
  "r506": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "926",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483154/926-20-50-5"
  },
  "r507": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "942",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-04(10))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478524/942-220-S99-1"
  },
  "r508": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "942",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-04(26))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478524/942-220-S99-1"
  },
  "r509": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "942",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-04(27))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478524/942-220-S99-1"
  },
  "r510": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "942",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-05(b)(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477314/942-235-S99-1"
  },
  "r511": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "942",
   "SubTopic": "360",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478451/942-360-50-1"
  },
  "r512": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(12))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1"
  },
  "r513": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(15)(b)(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1"
  },
  "r514": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(19))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1"
  },
  "r515": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1"
  },
  "r516": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(21))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1"
  },
  "r517": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(22))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1"
  },
  "r518": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(23)(a)(3))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1"
  },
  "r519": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(23)(a)(4))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1"
  },
  "r520": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(25))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1"
  },
  "r521": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(8)(a))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1"
  },
  "r522": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(8)(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1"
  },
  "r523": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(8))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1"
  },
  "r524": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-04(11))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477250/944-220-S99-1"
  },
  "r525": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-04(18))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477250/944-220-S99-1"
  },
  "r526": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-04(19))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477250/944-220-S99-1"
  },
  "r527": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-04(20))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477250/944-220-S99-1"
  },
  "r528": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-04(22))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477250/944-220-S99-1"
  },
  "r529": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-04(23))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477250/944-220-S99-1"
  },
  "r530": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-04(9))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477250/944-220-S99-1"
  },
  "r531": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480112/944-40-45-3"
  },
  "r532": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-5"
  },
  "r533": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-5"
  },
  "r534": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7A",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-7A"
  },
  "r535": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "9",
   "Subparagraph": "(a)(4)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-9"
  },
  "r536": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480016/944-40-65-2"
  },
  "r537": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(f)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480016/944-40-65-2"
  },
  "r538": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480016/944-40-65-2"
  },
  "r539": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(g)(2)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480016/944-40-65-2"
  },
  "r540": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(g)(2)(ii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480016/944-40-65-2"
  },
  "r541": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(h)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480016/944-40-65-2"
  },
  "r542": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SAB Topic 5.W.Q2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479583/944-40-S99-1"
  },
  "r543": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-03(d))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479886/946-10-S99-3"
  },
  "r544": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-03(h)(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479886/946-10-S99-3"
  },
  "r545": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-03(i)(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479886/946-10-S99-3"
  },
  "r546": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-03(i)(2)(i))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479886/946-10-S99-3"
  },
  "r547": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-03(i)(2)(ii))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479886/946-10-S99-3"
  },
  "r548": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-03(i)(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479886/946-10-S99-3"
  },
  "r549": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "11",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480990/946-20-50-11"
  },
  "r550": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "13",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480990/946-20-50-13"
  },
  "r551": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480990/946-20-50-2"
  },
  "r552": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480990/946-20-50-5"
  },
  "r553": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480990/946-20-50-6"
  },
  "r554": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "205",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "4",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478009/946-205-45-4"
  },
  "r555": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "205",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478494/946-205-50-2"
  },
  "r556": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "205",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "27",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478494/946-205-50-27"
  },
  "r557": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "205",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478494/946-205-50-7"
  },
  "r558": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "205",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478494/946-205-50-7"
  },
  "r559": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "205",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478494/946-205-50-7"
  },
  "r560": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "205",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478494/946-205-50-7"
  },
  "r561": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "205",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478494/946-205-50-7"
  },
  "r562": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "205",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478494/946-205-50-7"
  },
  "r563": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "205",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Subparagraph": "(g)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478494/946-205-50-7"
  },
  "r564": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "205",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Subparagraph": "(h)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478494/946-205-50-7"
  },
  "r565": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "21",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477796/946-210-45-21"
  },
  "r566": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477796/946-210-45-4"
  },
  "r567": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478795/946-210-50-1"
  },
  "r568": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478795/946-210-50-1"
  },
  "r569": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478795/946-210-50-1"
  },
  "r570": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(c)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478795/946-210-50-1"
  },
  "r571": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(a)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478795/946-210-50-6"
  },
  "r572": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(a)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478795/946-210-50-6"
  },
  "r573": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(a)(4)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478795/946-210-50-6"
  },
  "r574": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478795/946-210-50-6"
  },
  "r575": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478795/946-210-50-6"
  },
  "r576": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r577": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(12)(b)(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r578": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(12)(b)(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r579": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(12)(b)(3))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r580": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(13)(a)(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r581": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(13)(a)(3))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r582": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(14))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r583": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(15))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r584": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(16)(a))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r585": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(17))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r586": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(19))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r587": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(2)(a))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r588": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(2)(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r589": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(3)(a))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r590": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(3)(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r591": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(3)(c))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r592": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(4))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r593": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(6)(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r594": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(6)(c))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r595": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(6)(d))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r596": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(6)(e))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r597": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(8))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r598": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(9)(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r599": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(9)(c))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r600": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(9)(d))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r601": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(9)(e))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r602": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.6-05(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-2"
  },
  "r603": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.6-05(4))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-2"
  },
  "r604": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "3",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479105/946-220-45-3"
  },
  "r605": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "7",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479105/946-220-45-7"
  },
  "r606": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478297/946-220-50-3"
  },
  "r607": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r608": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(2)(a))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r609": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(2)(c))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r610": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(2)(e))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r611": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(2)(g)(3))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r612": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(a)(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r613": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(a)(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r614": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(a)(3))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r615": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(a)(5))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r616": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(a)(6))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r617": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(a)(7))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r618": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(c)(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r619": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(c)(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r620": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(c)(3))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r621": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(c)(5))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r622": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(c)(6))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r623": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(c)(7))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r624": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r625": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(9))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r626": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-09(1)(d))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-3"
  },
  "r627": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-09(4)(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-3"
  },
  "r628": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-09(6))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-3"
  },
  "r629": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-09(7))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-3"
  },
  "r630": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477968/946-235-50-2"
  },
  "r631": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477968/946-235-50-2"
  },
  "r632": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477968/946-235-50-2"
  },
  "r633": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477968/946-235-50-2"
  },
  "r634": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-12(Column A)(Footnote 2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-1"
  },
  "r635": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.12-12A(Column A)(Footnote 2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-2"
  },
  "r636": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.12-12B(Column A)(Footnote 4)(a))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-3"
  },
  "r637": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.12-12B(Column A)(Footnote 4)(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-3"
  },
  "r638": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "5",
   "Subparagraph": "(SX 210.12-13(Column A)(Footnote 3))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-5"
  },
  "r639": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "5",
   "Subparagraph": "(SX 210.12-13(Column G)(Footnote 8))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-5"
  },
  "r640": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "5",
   "Subparagraph": "(SX 210.12-13(Column G))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-5"
  },
  "r641": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "5A",
   "Subparagraph": "(SX 210.12-13A(Column E))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-5A"
  },
  "r642": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "5B",
   "Subparagraph": "(SX 210.12-13B(Column E)(Footnote 4))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-5B"
  },
  "r643": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "5B",
   "Subparagraph": "(SX 210.12-13B(Column E))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-5B"
  },
  "r644": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "5C",
   "Subparagraph": "(SX 210.12-13C(Column H)(Footnote 7))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-5C"
  },
  "r645": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "5C",
   "Subparagraph": "(SX 210.12-13C(Column H))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-5C"
  },
  "r646": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "6",
   "Subparagraph": "(SX 210.12-14(Column A)(Footnote 2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-6"
  },
  "r647": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "505",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478448/946-505-50-1"
  },
  "r648": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "505",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478448/946-505-50-2"
  },
  "r649": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "505",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478448/946-505-50-2"
  },
  "r650": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "505",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478448/946-505-50-2"
  },
  "r651": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "505",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478448/946-505-50-2"
  },
  "r652": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "505",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478448/946-505-50-6"
  },
  "r653": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "954",
   "SubTopic": "440",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478522/954-440-50-1"
  },
  "r654": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "954",
   "SubTopic": "440",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478522/954-440-50-1"
  },
  "r655": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "954",
   "SubTopic": "450",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477850/954-450-50-1"
  },
  "r656": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "976",
   "SubTopic": "310",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477332/976-310-50-1"
  },
  "r657": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "978",
   "SubTopic": "310",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479230/978-310-50-1"
  },
  "r658": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "985",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481283/985-20-50-2"
  },
  "r659": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483467/210-10-45-1"
  },
  "r660": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483467/210-10-45-1"
  },
  "r661": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(6)(a)(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r662": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(6)(a)(3))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r663": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(6)(a)(4))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r664": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "210",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "22",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483444/210-20-55-22"
  },
  "r665": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483426/235-10-50-4"
  },
  "r666": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483426/235-10-50-4"
  },
  "r667": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "52",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482635/260-10-55-52"
  },
  "r668": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "30",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-30"
  },
  "r669": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "31",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-31"
  },
  "r670": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "48",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482785/280-10-55-48"
  },
  "r671": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "49",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482785/280-10-55-49"
  },
  "r672": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "310",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "12A",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481933/310-10-55-12A"
  },
  "r673": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "350",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "40",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482640/350-30-55-40"
  },
  "r674": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "460",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "27",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482395/460-10-55-27"
  },
  "r675": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1B",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1B"
  },
  "r676": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "69B",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481568/470-20-55-69B"
  },
  "r677": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "69C",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481568/470-20-55-69C"
  },
  "r678": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "69E",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481568/470-20-55-69E"
  },
  "r679": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "69F",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481568/470-20-55-69F"
  },
  "r680": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "13",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-13"
  },
  "r681": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)(ii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1"
  },
  "r682": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)(iv)(01)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1"
  },
  "r683": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "17",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480482/715-20-55-17"
  },
  "r684": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "715",
   "SubTopic": "80",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "11",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480576/715-80-50-11"
  },
  "r685": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "715",
   "SubTopic": "80",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480576/715-80-50-6"
  },
  "r686": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "715",
   "SubTopic": "80",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "8",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480547/715-80-55-8"
  },
  "r687": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r688": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "231",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482663/740-10-55-231"
  },
  "r689": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "805",
   "SubTopic": "50",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479908/805-50-55-1"
  },
  "r690": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "100",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482078/820-10-55-100"
  },
  "r691": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "100",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482078/820-10-55-100"
  },
  "r692": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "102",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482078/820-10-55-102"
  },
  "r693": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "103",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482078/820-10-55-103"
  },
  "r694": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "107",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482078/820-10-55-107"
  },
  "r695": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "107",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482078/820-10-55-107"
  },
  "r696": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "107",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482078/820-10-55-107"
  },
  "r697": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "835",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "8",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482949/835-30-55-8"
  },
  "r698": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "852",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "10",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481372/852-10-55-10"
  },
  "r699": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "29F",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480046/944-40-55-29F"
  },
  "r700": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478795/946-210-50-1"
  },
  "r701": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(a)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478795/946-210-50-6"
  },
  "r702": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477439/946-210-55-1"
  },
  "r703": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "946",
   "SubTopic": "310",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477802/946-310-45-1"
  },
  "r704": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-12(Column A)(Footnote 2)(i))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-1"
  },
  "r705": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.12-12A(Column A)(Footnote 2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-2"
  },
  "r706": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.12-12B(Column A)(Footnote 1)(a))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-3"
  },
  "r707": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "6",
   "Subparagraph": "(SX 210.12-14(Column A)(Footnote 2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-6"
  },
  "r708": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "946",
   "SubTopic": "830",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "10",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479168/946-830-55-10"
  },
  "r709": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "946",
   "SubTopic": "830",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "11",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479168/946-830-55-11"
  },
  "r710": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "946",
   "SubTopic": "830",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "12",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479168/946-830-55-12"
  },
  "r711": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12"
  },
  "r712": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b"
  },
  "r713": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b-2"
  },
  "r714": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b-23"
  },
  "r715": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "d1-1"
  },
  "r716": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "g"
  },
  "r717": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12, 13, 15d"
  },
  "r718": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "13e",
   "Subsection": "4c"
  },
  "r719": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "14a",
   "Subsection": "12"
  },
  "r720": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "14d",
   "Subsection": "2b"
  },
  "r721": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "15",
   "Subsection": "d"
  },
  "r722": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 10-K",
   "Number": "249",
   "Section": "310"
  },
  "r723": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 10-Q",
   "Number": "240",
   "Section": "308",
   "Subsection": "a"
  },
  "r724": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Number": "249",
   "Section": "220",
   "Subsection": "f"
  },
  "r725": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Number": "249",
   "Section": "240",
   "Subsection": "f"
  },
  "r726": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Forms 10-K, 10-Q, 20-F",
   "Number": "240",
   "Section": "13",
   "Subsection": "a-1"
  },
  "r727": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-T",
   "Number": "232",
   "Section": "405"
  },
  "r728": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "405"
  },
  "r729": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "425"
  },
  "r730": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "7A",
   "Section": "B",
   "Subsection": "2"
  },
  "r731": {
   "role": "http://www.xbrl.org/2003/role/recommendedDisclosureRef",
   "Topic": "272",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483014/272-10-45-3"
  },
  "r732": {
   "role": "http://www.xbrl.org/2003/role/recommendedDisclosureRef",
   "Topic": "450",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "10",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483076/450-20-50-10"
  },
  "r733": {
   "role": "http://www.xbrl.org/2003/role/recommendedDisclosureRef",
   "Topic": "740",
   "SubTopic": "323",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478156/740-323-50-2"
  },
  "r734": {
   "role": "http://www.xbrl.org/2003/role/recommendedDisclosureRef",
   "Topic": "740",
   "SubTopic": "323",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478156/740-323-50-2"
  },
  "r735": {
   "role": "http://www.xbrl.org/2003/role/recommendedDisclosureRef",
   "Topic": "740",
   "SubTopic": "323",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478156/740-323-50-2"
  },
  "r736": {
   "role": "http://www.xbrl.org/2003/role/recommendedDisclosureRef",
   "Topic": "855",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483399/855-10-50-3"
  },
  "r737": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "12",
   "SubTopic": "10",
   "Topic": "230",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-12"
  },
  "r738": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03(6))",
   "SubTopic": "10",
   "Topic": "220",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483621/220-10-S99-2"
  },
  "r739": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r740": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(17))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r741": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(27)(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r742": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(28))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r743": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(9))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r744": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482765/220-10-50-4"
  },
  "r745": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482765/220-10-50-5"
  },
  "r746": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482765/220-10-50-6"
  },
  "r747": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03(4))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483621/220-10-S99-2"
  },
  "r748": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "13",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-13"
  },
  "r749": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "14",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-14"
  },
  "r750": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "15",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-15"
  },
  "r751": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "17",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-17"
  },
  "r752": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "28",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-28"
  },
  "r753": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.4-08(d))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480678/235-10-S99-1"
  },
  "r754": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.4-08(f))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480678/235-10-S99-1"
  },
  "r755": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.4-08(g)(1)(ii))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480678/235-10-S99-1"
  },
  "r756": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.4-08(h)(1)(Note 1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480678/235-10-S99-1"
  },
  "r757": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "23",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483421/250-10-45-23"
  },
  "r758": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "24",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483421/250-10-45-24"
  },
  "r759": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "5",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483421/250-10-45-5"
  },
  "r760": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-4"
  },
  "r761": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-6"
  },
  "r762": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "55",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482689/260-10-45-55"
  },
  "r763": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "270",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482964/270-10-50-1"
  },
  "r764": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "22",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-22"
  },
  "r765": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "30",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-30"
  },
  "r766": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "32",
   "Subparagraph": "(ee)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-32"
  },
  "r767": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "32",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-32"
  },
  "r768": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "310",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "13",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481990/310-10-45-13"
  },
  "r769": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "323",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481687/323-10-50-3"
  },
  "r770": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "350",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/350-30/tableOfContent"
  },
  "r771": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "350",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482665/350-30-50-2"
  },
  "r772": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "350",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482665/350-30-50-2"
  },
  "r773": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "405",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/405-30/tableOfContent"
  },
  "r774": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "405",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477092/405-40-50-1"
  },
  "r775": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "405",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477092/405-40-50-1"
  },
  "r776": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "405",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(e)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477092/405-40-50-1"
  },
  "r777": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "410",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "10",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481931/410-30-50-10"
  },
  "r778": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "450",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/450/tableOfContent"
  },
  "r779": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "450",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483076/450-20-50-1"
  },
  "r780": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "450",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483076/450-20-50-4"
  },
  "r781": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "450",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "9",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483076/450-20-50-9"
  },
  "r782": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1A",
   "Subparagraph": "(SX 210.13-01(a)(4)(ii))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1A"
  },
  "r783": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1A",
   "Subparagraph": "(SX 210.13-01(a)(4)(iii))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1A"
  },
  "r784": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1B",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1B"
  },
  "r785": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1D",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1D"
  },
  "r786": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-2"
  },
  "r787": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "91",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479777/606-10-55-91"
  },
  "r788": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r789": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r790": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r791": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r792": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(ii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r793": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r794": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iv)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r795": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iv)(01)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r796": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iv)(02)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r797": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iv)(03)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r798": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iv)(04)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r799": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r800": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)(ii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r801": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)(iii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r802": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)(iii)(01)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r803": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)(iii)(02)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r804": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)(iii)(03)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r805": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(d)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r806": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(d)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r807": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(e)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r808": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(e)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r809": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r810": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)(ii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r811": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)(iii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r812": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)(iv)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r813": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)(v)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r814": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "12",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-12"
  },
  "r815": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "12",
   "Subparagraph": "(b)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-12"
  },
  "r816": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-2"
  },
  "r817": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-3"
  },
  "r818": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-6"
  },
  "r819": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "740",
   "SubTopic": "323",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1A",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478156/740-323-50-1A"
  },
  "r820": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "740",
   "SubTopic": "323",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1A",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478156/740-323-50-1A"
  },
  "r821": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "740",
   "SubTopic": "323",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1A",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478156/740-323-50-1A"
  },
  "r822": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "740",
   "SubTopic": "323",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1A",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478156/740-323-50-1A"
  },
  "r823": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "805",
   "SubTopic": "50",
   "Name": "Accounting Standards Codification",
   "Section": "15",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480123/805-50-15-3"
  },
  "r824": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "805",
   "SubTopic": "50",
   "Name": "Accounting Standards Codification",
   "Section": "25",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480060/805-50-25-1"
  },
  "r825": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "805",
   "SubTopic": "50",
   "Name": "Accounting Standards Codification",
   "Section": "30",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480027/805-50-30-1"
  },
  "r826": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "805",
   "SubTopic": "50",
   "Name": "Accounting Standards Codification",
   "Section": "30",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480027/805-50-30-2"
  },
  "r827": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "815",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "1",
   "Subparagraph": "(e)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480175/815-40-65-1"
  },
  "r828": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2"
  },
  "r829": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2"
  },
  "r830": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(bbb)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2"
  },
  "r831": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(bbb)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2"
  },
  "r832": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(bbb)(2)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2"
  },
  "r833": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2"
  },
  "r834": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2"
  },
  "r835": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2"
  },
  "r836": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2"
  },
  "r837": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2"
  },
  "r838": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2"
  },
  "r839": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2E",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2E"
  },
  "r840": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-3"
  },
  "r841": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-3"
  },
  "r842": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "825",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "28",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482907/825-10-50-28"
  },
  "r843": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "830",
   "SubTopic": "230",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477401/830-230-45-1"
  },
  "r844": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "835",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482925/835-30-45-1A"
  },
  "r845": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "835",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482925/835-30-45-2"
  },
  "r846": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "835",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482925/835-30-45-3"
  },
  "r847": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "835",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482900/835-30-50-1"
  },
  "r848": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "850",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483326/850-10-50-1"
  },
  "r849": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "850",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483326/850-10-50-2"
  },
  "r850": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "852",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481404/852-10-50-7"
  },
  "r851": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "852",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481404/852-10-50-7"
  },
  "r852": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(c)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481326/860-20-50-3"
  },
  "r853": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(c)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481326/860-20-50-3"
  },
  "r854": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(c)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481326/860-20-50-3"
  },
  "r855": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(b)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481326/860-20-50-4"
  },
  "r856": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(b)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481326/860-20-50-4"
  },
  "r857": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(b)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481326/860-20-50-4"
  },
  "r858": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "912",
   "SubTopic": "730",
   "Name": "Accounting Standards Codification",
   "Section": "25",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479532/912-730-25-1"
  },
  "r859": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(15)(a))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1"
  },
  "r860": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(16)(a)(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1"
  },
  "r861": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(17))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1"
  },
  "r862": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1"
  },
  "r863": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "310",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(a)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477363/944-310-50-3"
  },
  "r864": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "946",
   "SubTopic": "205",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "4",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478009/946-205-45-4"
  },
  "r865": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(a)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478795/946-210-50-6"
  },
  "r866": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(12)(b)(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r867": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(18))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r868": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-09(4)(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-3"
  },
  "r869": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-09(7))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-3"
  }
 }
}
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
